PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Raman, MCC; Johnson, KA; Yard, BA; Lowther, J; Carter, LG; Naismith, JH; Campopiano, DJ				Raman, Marine C. C.; Johnson, Kenneth A.; Yard, Beverley A.; Lowther, Jonathan; Carter, Lester G.; Naismith, James H.; Campopiano, Dominic J.			The External Aldimine Form of Serine Palmitoyltransferase STRUCTURAL, KINETIC, AND SPECTROSCOPIC ANALYSIS OF THE WILD-TYPE ENZYME AND HSAN1 MUTANT MIMICS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY SENSORY NEUROPATHY; 8-AMINO-7-OXONONANOATE SYNTHASE; 5-AMINOLEVULINATE SYNTHASE; CRYSTAL-STRUCTURE; BASE SYNTHESIS; YEAST LCB1; 1ST STEP; ENZYME; SPTLC1; IDENTIFICATION	Sphingolipid biosynthesis begins with the condensation of L-serine and palmitoyl-CoA catalyzed by the PLP-dependent enzyme serine palmitoyltransferase (SPT). Mutations in human SPT cause hereditary sensory autonomic neuropathy type 1, a disease characterized by loss of feeling in extremities and severe pain. The human enzyme is a membrane-bound hetereodimer, and the most common mutations are located in the enzymatically incompetent monomer, suggesting a "dominant" or regulatory effect. The molecular basis of how these mutations perturb SPT activity is subtle and is not simply loss of activity. To further explore the structure and mechanism of SPT, we have studied the homodimeric bacterial enzyme from Sphingomonas paucimobilis. We have analyzed two mutants (N100Y and N100W) engineered to mimic the mutations seen in hereditary sensory autonomic neuropathy type 1 as well as a third mutant N100C designed to mimic the wild-type human SPT. The N100C mutant appears fully active, whereas both N100Y and N100W are significantly compromised. The structures of the holoenzymes reveal differences around the active site and in neighboring secondary structure that transmit across the dimeric interface in both N100Y and N100W. Comparison of the L-Ser external aldimine structures of both native and N100Y reveals significant differences that hinder the movement of a catalytically important Arg(378) residue into the active site. Spectroscopic analysis confirms that both N100Y and N100W mutants subtly affect the chemistry of the PLP. Furthermore, the N100Y and R378A mutants appear less able to stabilize a quinonoid intermediate. These data provide the first experimental insight into how the most common disease-associated mutations of human SPT may lead to perturbation of enzyme activity.	[Johnson, Kenneth A.; Carter, Lester G.; Naismith, James H.] Univ St Andrews, Scottish Struct Prote Facil, EaStChem, Edinburgh KY16 9RH, Midlothian, Scotland; [Johnson, Kenneth A.; Carter, Lester G.; Naismith, James H.] Univ St Andrews, Ctr Biomol Sci, Edinburgh KY16 9RH, Midlothian, Scotland; [Campopiano, Dominic J.] Univ Edinburgh, Sch Chem, EaStChem, Edinburgh EH9 3JJ, Midlothian, Scotland	University of St Andrews; University of St Andrews; University of Edinburgh	Naismith, JH (corresponding author), Univ St Andrews, Scottish Struct Prote Facil, EaStChem, Edinburgh KY16 9RH, Midlothian, Scotland.	naismith@st-andrews.ac.uk; Dominic.Campopiano@ed.ac.uk	Carter, Lester/G-6561-2014; Naismith, James Henderson/AAB-8614-2020; Naismith, James Henderson/H-3408-2012	Naismith, James Henderson/0000-0001-6744-5061; Naismith, James Henderson/0000-0001-6744-5061; Campopiano, Dominic/0000-0001-8573-6735	Biotechnology and Biological Sciences Research Council (BBSRC) [BB/F009739/1, BBS/B/14434]; Scottish Structural Proteomics Facility (SSPF); Biotechnology and Biological Sciences Research Council [BB/F008503/1, BBS/B/14434, BB/F009739/1] Funding Source: researchfish; Medical Research Council [G0500367] Funding Source: researchfish; BBSRC [BB/F009739/1, BB/F008503/1] Funding Source: UKRI; MRC [G0500367] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Scottish Structural Proteomics Facility (SSPF); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by Biotechnology and Biological Sciences Research Council (BBSRC) Grants BB/F009739/1 and BBS/B/14434 (to D.J.C. and J.H.N.) and the Scottish Structural Proteomics Facility (SSPF).	Alexeev D, 2006, ORG BIOMOL CHEM, V4, P1209, DOI 10.1039/b517922j; Alexeev D, 1998, J MOL BIOL, V284, P401, DOI 10.1006/jmbi.1998.2086; Astner I, 2005, EMBO J, V24, P3166, DOI 10.1038/sj.emboj.7600792; Auer-Grumbach M, 2004, DRUG TODAY, V40, P385, DOI 10.1358/dot.2004.40.5.850487; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bejaoui K, 2001, NAT GENET, V27, P261, DOI 10.1038/85817; Bejaoui K, 2002, J CLIN INVEST, V110, P1301, DOI 10.1172/JCI200216450; BUEDE R, 1991, J BACTERIOL, V173, P4325, DOI 10.1128/JB.173.14.4325-4332.1991; Chen JK, 1999, CHEM BIOL, V6, P221, DOI 10.1016/S1074-5521(99)80038-6; Dawkins JL, 2001, NAT GENET, V27, P309, DOI 10.1038/85879; DUNATHAN HC, 1966, P NATL ACAD SCI USA, V55, P712, DOI 10.1073/pnas.55.4.712; DYCK P, 1993, NEURONAL ATROPHY DEG; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FERREIRA GC, 1995, J BIOENERG BIOMEMBR, V27, P151, DOI 10.1007/BF02110030; Futerman AH, 2004, EMBO REP, V5, P777, DOI 10.1038/sj.embor.7400208; Gable K, 2002, J BIOL CHEM, V277, P10194, DOI 10.1074/jbc.M107873200; Gable K, 2000, J BIOL CHEM, V275, P7597, DOI 10.1074/jbc.275.11.7597; Han GS, 2006, J BIOL CHEM, V281, P39935, DOI 10.1074/jbc.M609365200; Han GS, 2004, J BIOL CHEM, V279, P53707, DOI 10.1074/jbc.M410014200; Hanada K, 1997, J BIOL CHEM, V272, P32108, DOI 10.1074/jbc.272.51.32108; Hanada K, 2000, J BIOL CHEM, V275, P8409, DOI 10.1074/jbc.275.12.8409; Hanada K, 1998, J BIOL CHEM, V273, P33787, DOI 10.1074/jbc.273.50.33787; Hanada K, 2003, BBA-MOL CELL BIOL L, V1632, P16, DOI 10.1016/S1388-1981(03)00059-3; Hornemann T, 2008, CHEM PHYS LIPIDS, V154, pS62, DOI 10.1016/j.chemphyslip.2008.05.170; HORNEMANN T, 2008, CHEM PHYS LIPIDS, V154, pPO111; Hornemann T, 2007, BIOCHEM J, V405, P157, DOI 10.1042/BJ20070025; Hornemann T, 2006, J BIOL CHEM, V281, P37275, DOI 10.1074/jbc.M608066200; Houlden H, 2006, BRAIN, V129, P411, DOI 10.1093/brain/awh712; Houlden H, 2004, CURR OPIN NEUROL, V17, P569, DOI 10.1097/00019052-200410000-00007; Hunter GA, 1999, BIOCHEMISTRY-US, V38, P3711, DOI 10.1021/bi982390w; Ikushiro H, 2004, BIOCHEMISTRY-US, V43, P1082, DOI 10.1021/bi035706v; Ikushiro H, 2001, J BIOL CHEM, V276, P18249, DOI 10.1074/jbc.M101550200; Ikushiro H, 2008, J BIOL CHEM, V283, P7542, DOI 10.1074/jbc.M706874200; Ikushiro H, 2007, J BACTERIOL, V189, P5749, DOI 10.1128/JB.00194-07; JORDAN PM, 1972, ENZYMES; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kerbarh O, 2006, CHEM COMMUN, P60, DOI 10.1039/b511837a; Kobayashi T, 2006, BIOL PHARM BULL, V29, P1526, DOI 10.1248/bpb.29.1526; McCampbell A, 2005, HUM MOL GENET, V14, P3507, DOI 10.1093/hmg/ddi380; Merrill AH, 2002, J BIOL CHEM, V277, P25843, DOI 10.1074/jbc.R200009200; Merrill AJ., 2006, SPHINGOLIPID BIOL; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nagiec MM, 1996, GENE, V177, P237, DOI 10.1016/0378-1119(96)00309-5; NAGIEC MM, 1994, P NATL ACAD SCI USA, V91, P7899, DOI 10.1073/pnas.91.17.7899; Nicholson GA, 1996, NAT GENET, V13, P101, DOI 10.1038/ng0596-101; RIDDLES PW, 1979, ANAL BIOCHEM, V94, P75, DOI 10.1016/0003-2697(79)90792-9; Schmidt A, 2001, BIOCHEMISTRY-US, V40, P5151, DOI 10.1021/bi002204y; Verhoeven K, 2004, NEUROLOGY, V62, P1001, DOI 10.1212/01.WNL.0000115388.10828.5C; Webster SP, 2000, BIOCHEMISTRY-US, V39, P516, DOI 10.1021/bi991620j; WILLIAMS RD, 1984, ARCH BIOCHEM BIOPHYS, V228, P282, DOI 10.1016/0003-9861(84)90069-9; Yard BA, 2007, J MOL BIOL, V370, P870, DOI 10.1016/j.jmb.2007.04.086; ZAMAN Z, 1973, BIOCHEM J, V135, P257, DOI 10.1042/bj1350257; Zhang JS, 2002, J BIOL CHEM, V277, P44660, DOI 10.1074/jbc.M203584200; Zitomer NC, 2009, J BIOL CHEM, V284, P4786, DOI 10.1074/jbc.M808798200	56	48	51	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					17328	17339		10.1074/jbc.M109.008680	http://dx.doi.org/10.1074/jbc.M109.008680			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19376777	hybrid, Green Published			2022-12-27	WOS:000266962400068
J	Saito, N; Robert, M; Kochi, H; Matsuo, G; Kakazu, Y; Soga, T; Tomita, M				Saito, Natsumi; Robert, Martin; Kochi, Hayataro; Matsuo, Goh; Kakazu, Yuji; Soga, Tomoyoshi; Tomita, Masaru			Metabolite Profiling Reveals YihU as a Novel Hydroxybutyrate Dehydrogenase for Alternative Succinic Semialdehyde Metabolism in Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTROPHORESIS-MASS-SPECTROMETRY; BETA-HYDROXYACID DEHYDROGENASES; GAMMA-HYDROXYBUTYRATE; CLOSTRIDIUM-AMINOBUTYRICUM; RAT-BRAIN; 2 GENES; ENZYME; METHYLGLYOXAL; METABOLOMICS; TRANSAMINASE	The search for novel enzymes and enzymatic activities is important to map out all metabolic activities and reveal cellular metabolic processes in a more exhaustive manner. Here we present biochemical and physiological evidence for the function of the uncharacterized protein YihU in Escherichia coli using metabolite profiling by capillary electrophoresis time-of-flight mass spectrometry. To detect enzymatic activity and simultaneously identify possible substrates and products of the putative enzyme, we profiled a complex mixture of metabolites in the presence or absence of YihU. In this manner, succinic semialdehyde was identified as a substrate for YihU. The purified YihU protein catalyzed in vitro the NADH-dependent reduction of succinic semialdehyde to gamma-hydroxybutyrate. Moreover, a yihU deletion mutant displayed reduced tolerance to the cytotoxic effects of exogenous addition of succinic semialdehyde. Profiling of intracellular metabolites following treatment of E. coli with succinic semialdehyde supports the existence of a YihU-catalyzed reduction of succinic semialdehyde to gamma-hydroxybutyrate in addition to its known oxidation to succinate and through the tricarboxylic acid cycle. These findings suggest that YihU is a novel gamma-hydroxybutyrate dehydrogenase involved in the metabolism of succinic semialdehyde, and other potentially toxic intermediates that may accumulate under stress conditions in E. coli.	[Saito, Natsumi; Robert, Martin; Kochi, Hayataro; Matsuo, Goh; Kakazu, Yuji; Soga, Tomoyoshi; Tomita, Masaru] Keio Univ, Inst Adv Biosci, Yamagata 9970017, Japan; [Soga, Tomoyoshi; Tomita, Masaru] Human Metabolome Technol Inc, Yamagata 9970052, Japan	Keio University	Saito, N (corresponding author), 403-1 Nipponkoku, Yamagata 9970017, Japan.	natsumi@ttck.keio.ac.jp	Robert, Martin/B-3970-2009; Soga, Tomoyoshi/B-8105-2014	Robert, Martin/0000-0002-7082-5142; Soga, Tomoyoshi/0000-0001-9502-2509	Japan Society for the Promotion of Science (JSPS); Yamagata prefectural government; Tsuruoka city	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Yamagata prefectural government; Tsuruoka city(Tsuruoka City Government)	This work was supported by a grant-in-aid for scientific research from the Japan Society for the Promotion of Science (JSPS) (to M. R.) and research funds from the Yamagata prefectural government and Tsuruoka city.	ADAMS MJ, 1994, STRUCTURE, V2, P651, DOI 10.1016/S0969-2126(00)00066-6; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Andriamampandry C, 1998, BIOCHEM J, V334, P43, DOI 10.1042/bj3340043; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Baran R, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-530; BARTSCH K, 1990, J BACTERIOL, V172, P7035, DOI 10.1128/jb.172.12.7035-7042.1990; Breitkreuz KE, 2003, J BIOL CHEM, V278, P41552, DOI 10.1074/jbc.M305717200; Busch K, 2000, BIOCHEMISTRY-US, V39, P10110, DOI 10.1021/bi000589e; Chen LF, 2007, TRENDS BIOTECHNOL, V25, P343, DOI 10.1016/j.tibtech.2007.06.001; COOPER RA, 1984, ANNU REV MICROBIOL, V38, P49, DOI 10.1146/annurev.mi.38.100184.000405; Cusa E, 1999, J BACTERIOL, V181, P7479, DOI 10.1128/JB.181.24.7479-7484.1999; De Biase D, 1999, MOL MICROBIOL, V32, P1198, DOI 10.1046/j.1365-2958.1999.01430.x; DONNELLY MI, 1981, EUR J BIOCHEM, V113, P555, DOI 10.1111/j.1432-1033.1981.tb05098.x; FERGUSON GP, 1993, MOL MICROBIOL, V9, P1297, DOI 10.1111/j.1365-2958.1993.tb01259.x; Fuhrer T, 2007, J BACTERIOL, V189, P8073, DOI 10.1128/JB.01027-07; Gerhardt A, 2000, ARCH MICROBIOL, V174, P189, DOI 10.1007/s002030000195; Gibson DL, 2006, J BACTERIOL, V188, P7722, DOI 10.1128/JB.00809-06; Goto S, 2002, NUCLEIC ACIDS RES, V30, P402, DOI 10.1093/nar/30.1.402; Grant AW, 2003, FEMS MICROBIOL LETT, V218, P93, DOI 10.1111/j.1574-6968.2003.tb11503.x; HARDMAN JK, 1962, METHOD ENZYMOL, V5, P778, DOI 10.1016/S0076-6879(62)05312-4; Hawes JW, 1996, FEBS LETT, V389, P263, DOI 10.1016/0014-5793(96)00597-2; Karp PD, 2002, NUCLEIC ACIDS RES, V30, P56, DOI 10.1093/nar/30.1.56; Kitagawa M, 2005, DNA RES, V12, P291, DOI 10.1093/dnares/dsi012; Ko J, 2005, J BACTERIOL, V187, P5782, DOI 10.1128/JB.187.16.5782-5789.2005; LETTIERI JT, 1979, J PHARMACOL EXP THER, V208, P7; MAITRE M, 1975, EUR J BIOCHEM, V52, P157, DOI 10.1111/j.1432-1033.1975.tb03983.x; MAREK LE, 1988, J BACTERIOL, V170, P991, DOI 10.1128/jb.170.2.991-994.1988; Marvel CS, 1929, J AM CHEM SOC, V51, P260, DOI 10.1021/ja01376a032; MISRA K, 1995, BIOCHEM J, V305, P999, DOI 10.1042/bj3050999; Misra K, 1996, MOL CELL BIOCHEM, V156, P117, DOI 10.1007/BF00426333; Njau RK, 2001, CHEM-BIOL INTERACT, V130, P785, DOI 10.1016/S0009-2797(00)00234-9; Njau RK, 2000, J BIOL CHEM, V275, P38780, DOI 10.1074/jbc.M007432200; Ohashi Y, 2008, MOL BIOSYST, V4, P135, DOI 10.1039/b714176a; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Rost B, 2002, J MOL BIOL, V318, P595, DOI 10.1016/S0022-2836(02)00016-5; Saito N, 2006, J PROTEOME RES, V5, P1979, DOI 10.1021/pr0600576; Schaub J, 2006, BIOTECHNOL PROGR, V22, P1434, DOI 10.1021/bp050381q; Schomburg I, 2002, NUCLEIC ACIDS RES, V30, P47, DOI 10.1093/nar/30.1.47; Soga T, 2002, ANAL CHEM, V74, P2233, DOI 10.1021/ac020064n; Soga T, 2003, J PROTEOME RES, V2, P488, DOI 10.1021/pr034020m; Soga T, 2000, ANAL CHEM, V72, P1236, DOI 10.1021/ac990976y; Soga T, 2007, J CHROMATOGR A, V1159, P125, DOI 10.1016/j.chroma.2007.05.054; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; Tian WD, 2003, J MOL BIOL, V333, P863, DOI 10.1016/j.jmb.2003.08.057; Totemeyer S, 1998, MOL MICROBIOL, V27, P553, DOI 10.1046/j.1365-2958.1998.00700.x; VALENTIN HE, 1995, EUR J BIOCHEM, V227, P43, DOI 10.1111/j.1432-1033.1995.tb20358.x; Van Cauwenberghe OR, 1999, PHYTOCHEMISTRY, V52, P575, DOI 10.1016/S0031-9422(99)00301-5; van der Werf MJ, 2007, ANAL BIOCHEM, V370, P17, DOI 10.1016/j.ab.2007.07.022; Wang C, 2006, MOL MICROBIOL, V62, P45, DOI 10.1111/j.1365-2958.2006.05351.x; Winder CL, 2008, ANAL CHEM, V80, P2939, DOI 10.1021/ac7023409; WOLFF RA, 1995, PROTEIN EXPRES PURIF, V6, P206, DOI 10.1006/prep.1995.1026	52	51	52	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16442	16451		10.1074/jbc.M109.002089	http://dx.doi.org/10.1074/jbc.M109.002089			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19372223	Green Published, hybrid			2022-12-27	WOS:000266730900041
J	Cai, CX; Weisleder, N; Ko, JK; Komazaki, S; Sunada, Y; Nishi, M; Takeshima, H; Ma, JJ				Cai, Chuanxi; Weisleder, Noah; Ko, Jae-Kyun; Komazaki, Shinji; Sunada, Yoshihide; Nishi, Miyuki; Takeshima, Hiroshi; Ma, Jianjie			Membrane Repair Defects in Muscular Dystrophy Are Linked to Altered Interaction between MG53, Caveolin-3, and Dysferlin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUTANT CAVEOLIN-3; SKELETAL-MUSCLE; T-TUBULE; OVEREXPRESSION; TRAFFICKING; MUTATIONS; APOPTOSIS; LIGAND; DAMAGE; HEART	Defective membrane repair can contribute to the progression of muscular dystrophy. Although mutations in caveolin-3 (Cav3) and dysferlin are linked to muscular dystrophy in human patients, the molecular mechanism underlying the functional interplay between Cav3 and dysferlin in membrane repair of muscle physiology and disease has not been fully resolved. We recently discovered that mitsugumin 53 (MG53), a muscle-specific TRIM (Tri-partite motif) family protein (TRIM72), contributes to intracellular vesicle trafficking and is an essential component of the membrane repair machinery in striated muscle. Here we show that MG53 interacts with dysferlin and Cav3 to regulate membrane repair in skeletal muscle. MG53 mediates active trafficking of intracellular vesicles to the sarcolemma and is required for movement of dysferlin to sites of cell injury during repair patch formation. Mutations in Cav3 (P104L, R26Q) that cause retention of Cav3 in Golgi apparatus result in aberrant localization of MG53 and dysferlin in a dominant-negative fashion, leading to defective membrane repair. Our data reveal that a molecular complex formed by MG53, dysferlin, and Cav3 is essential for repair of muscle membrane damage and also provide a therapeutic target for treatment of muscular and cardiovascular diseases that are linked to compromised membrane repair.	[Cai, Chuanxi; Weisleder, Noah; Ko, Jae-Kyun; Ma, Jianjie] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Phys & Biophys, Piscataway, NJ 08854 USA; [Ma, Jianjie] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Med, Piscataway, NJ 08854 USA; [Komazaki, Shinji] Saitama Med Sch, Dept Anat, Saitama 3500495, Japan; [Sunada, Yoshihide] Kawasaki Med Sch, Dept Internal Med, Kurashiki, Okayama 7010192, Japan; [Nishi, Miyuki; Takeshima, Hiroshi] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Biol Chem, Kyoto 6068501, Japan	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Saitama Medical University; Kawasaki Medical School; Kyoto University	Ma, JJ (corresponding author), Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Phys & Biophys, 675 Hoes La, Piscataway, NJ 08854 USA.	maj2@umdnj.edu	Cai, Chuanxi/AAW-1488-2020; Weisleder, Noah L/A-7098-2013	Weisleder, Noah L/0000-0002-2619-8022; Weisleder, Noah/0000-0003-2710-3088; Takeshima, Hiroshi/0000-0003-4525-3725	National Institutes of Health [RO1-HL069000, RO1-AG028856, K99/R00-AR054793]; Ministry of Education, Science, Sports and Culture of Japan; American Heart Association; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL069000] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K99AR054793, R00AR054793] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028856] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education, Science, Sports and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-HL069000 and RO1-AG028856 ( to J.M. and H. T.) and National Institutes of Health K99 Award K99/R00-AR054793 ( to N.W.). This work was also supported by grants from the Ministry of Education, Science, Sports and Culture of Japan ( to H. T.) and the American Heart Association ( to C. C.).	Bansal D, 2004, TRENDS CELL BIOL, V14, P206, DOI 10.1016/j.tcb.2004.03.001; Bansal D, 2003, NATURE, V423, P168, DOI 10.1038/nature01573; Cai CX, 2009, J BIOL CHEM, V284, P3314, DOI 10.1074/jbc.M808866200; Cai CX, 2009, NAT CELL BIOL, V11, P56, DOI 10.1038/ncb1812; Date T, 2003, J MOL CELL CARDIOL, V35, P811, DOI 10.1016/S0022-2828(03)00139-1; Fee DB, 2004, MUSCLE NERVE, V30, P375, DOI 10.1002/mus.20092; Galbiati F, 2000, P NATL ACAD SCI USA, V97, P9689, DOI 10.1073/pnas.160249097; Galbiati F, 2001, J BIOL CHEM, V276, P21425, DOI 10.1074/jbc.M100828200; Galbiati F, 1999, J BIOL CHEM, V274, P25632, DOI 10.1074/jbc.274.36.25632; Galbiati F, 2001, TRENDS MOL MED, V7, P435, DOI 10.1016/S1471-4914(01)02105-0; Glover L, 2007, TRAFFIC, V8, P785, DOI 10.1111/j.1600-0854.2007.00573.x; Guglieri M, 2008, CURR OPIN NEUROL, V21, P576, DOI 10.1097/WCO.0b013e32830efdc2; Hagiwara Y, 2000, HUM MOL GENET, V9, P3047, DOI 10.1093/hmg/9.20.3047; Han R, 2007, CURR OPIN CELL BIOL, V19, P409, DOI 10.1016/j.ceb.2007.07.001; Han R, 2007, J CLIN INVEST, V117, P1805, DOI 10.1172/JCI30848; Hernandez-Deviez DJ, 2008, J BIOL CHEM, V283, P6476, DOI 10.1074/jbc.M708776200; Hernandez-Deviez DJ, 2006, HUM MOL GENET, V15, P129, DOI 10.1093/hmg/ddi434; Klinge L, 2007, FASEB J, V21, P1768, DOI 10.1096/fj.06-7659com; Ko JK, 2005, AM J PHYSIOL-CELL PH, V288, pC1273, DOI 10.1152/ajpcell.00517.2004; McNally EM, 1998, HUM MOL GENET, V7, P871, DOI 10.1093/hmg/7.5.871; McNeil AK, 2006, J BIOL CHEM, V281, P35202, DOI 10.1074/jbc.M606406200; McNeil PL, 2005, NAT REV MOL CELL BIO, V6, P499, DOI 10.1038/nrm1665; Minetti C, 1998, NAT GENET, V18, P365, DOI 10.1038/ng0498-365; Miyake K, 1995, J CELL BIOL, V131, P1737, DOI 10.1083/jcb.131.6.1737; Nishi M, 1999, J CELL BIOL, V147, P1473, DOI 10.1083/jcb.147.7.1473; Ohsawa Y, 2004, HUM MOL GENET, V13, P151, DOI 10.1093/hmg/ddh014; Pouvreau S, 2007, P NATL ACAD SCI USA, V104, P5235, DOI 10.1073/pnas.0700748104; Setsuta K, 2004, CIRC J, V68, P747, DOI 10.1253/circj.68.747; Smythe GM, 2003, J CELL SCI, V116, P4739, DOI 10.1242/jcs.00806; STEINHARDT RA, 1994, SCIENCE, V263, P390, DOI 10.1126/science.7904084; Sunada Y, 2001, HUM MOL GENET, V10, P173, DOI 10.1093/hmg/10.3.173; Towler MC, 2004, TRAFFIC, V5, P129, DOI 10.1111/j.1600-0854.2003.00164.x; Weisleder N, 2006, J CELL BIOL, V174, P639, DOI 10.1083/jcb.200604166; Yeh CH, 2006, SHOCK, V26, P262, DOI 10.1097/01.shk.0000225863.56714.96	34	194	207	3	25	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15894	15902		10.1074/jbc.M109.009589	http://dx.doi.org/10.1074/jbc.M109.009589			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19380584	hybrid, Green Published			2022-12-27	WOS:000266501000057
J	Foley, DA; Swartzentruber, KG; Colley, KJ				Foley, Deirdre A.; Swartzentruber, Kristin G.; Colley, Karen J.			Identification of Sequences in the Polysialyltransferases ST8Sia II and ST8Sia IV That Are Required for the Protein-specific Polysialylation of the Neural Cell Adhesion Molecule, NCAM	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEVELOPMENTALLY-REGULATED MEMBER; POLYSIALIC ACID SYNTHESIS; AMINO-ACIDS; DIFFERENTIAL BIOSYNTHESIS; LINKED OLIGOSACCHARIDES; RECOGNITION DOMAIN; BRAIN DEVELOPMENT; ALPHA-HELIX; WILMS TUMOR; RAT-BRAIN	The polysialyltransferases ST8Sia II and ST8Sia IV polysialylate the glycans of a small subset of mammalian proteins. Their most abundant substrate is the neural cell adhesion molecule (NCAM). An acidic surface patch and a novel alpha-helix in the first fibronectin type III repeat of NCAM are required for the polysialylation of N-glycans on the adjacent immunoglobulin domain. Inspection of ST8SiaIV sequences revealed two conserved polybasic regions that might interact with the NCAM acidic patch or the growing polysialic acid chain. One is the previously identified polysialyltransferase domain (Nakata, D., Zhang, L., and Troy, F. A. (2006) Glycoconj. J. 23, 423-436). The second is a 35-amino acid polybasic region that contains seven basic residues and is equidistant from the large sialyl motif in both polysialyltransferases. We replaced these basic residues to evaluate their role in enzyme autopolysialylation and NCAM-specific polysialylation. We found that replacement of Arg(276)/Arg(277) or Arg(265) in the polysialyltransferase domain of ST8Sia IV decreased both NCAM polysialylation and autopolysialylation in parallel, suggesting that these residues are important for catalytic activity. In contrast, replacing Arg(82)/Arg(93) in ST8Sia IV with alanine substantially decreased NCAM-specific polysialylation while only partially impacting autopolysialylation, suggesting that these residues may be particularly important for NCAM polysialylation. Two conserved negatively charged residues, Glu(92) and Asp(94), surround Arg(93). Replacement of these residues with alanine largely inactivated ST8Sia IV, whereas reversing these residues enhanced enzyme autopolysialylation but significantly reduced NCAM polysialylation. In sum, we have identified selected amino acids in this conserved polysialyltransferase polybasic region that are critical for the protein-specific polysialylation of NCAM.	[Foley, Deirdre A.; Swartzentruber, Kristin G.; Colley, Karen J.] Univ Illinois, Dept Biochem & Mol Genet, Coll Med, Chicago, IL 60607 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Colley, KJ (corresponding author), Univ Illinois, Dept Biochem & Mol Genet, Coll Med, 900 S Ashland Ave,M-C 669, Chicago, IL 60607 USA.	karenc@uic.edu			National Institutes of Health [RO1 GM63843]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063843] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 GM63843 ( to K. J. C.).	Angata K, 2000, J BIOL CHEM, V275, P18594, DOI 10.1074/jbc.M910204199; Angata K, 2004, J BIOL CHEM, V279, P25883, DOI 10.1074/jbc.M401562200; Angata K, 1997, J BIOL CHEM, V272, P7182, DOI 10.1074/jbc.272.11.7182; BARANSKI TJ, 1991, J BIOL CHEM, V266, P23365; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; BONNER WM, 1974, EUR J BIOCHEM, V46, P83, DOI 10.1111/j.1432-1033.1974.tb03599.x; Close BE, 2001, GLYCOBIOLOGY, V11, P997, DOI 10.1093/glycob/11.11.997; Close BE, 2003, J BIOL CHEM, V278, P30796, DOI 10.1074/jbc.M305390200; Close BE, 2000, J BIOL CHEM, V275, P4484, DOI 10.1074/jbc.275.6.4484; Close BE, 1998, J BIOL CHEM, V273, P34586, DOI 10.1074/jbc.273.51.34586; CUNNINGHAM BA, 1987, SCIENCE, V236, P799, DOI 10.1126/science.3576199; Curreli S, 2007, J BIOL CHEM, V282, P30346, DOI 10.1074/jbc.M702965200; DATTA AK, 1995, J BIOL CHEM, V270, P1497, DOI 10.1074/jbc.270.4.1497; Datta AK, 1998, J BIOL CHEM, V273, P9608, DOI 10.1074/jbc.273.16.9608; DRICKAMER K, 1993, GLYCOBIOLOGY, V3, P2, DOI 10.1093/glycob/3.1.2; ECKHARDT M, 1995, NATURE, V373, P715, DOI 10.1038/373715a0; FINNE J, 1983, BIOCHEM BIOPH RES CO, V112, P482, DOI 10.1016/0006-291X(83)91490-0; Geremia RA, 1997, GLYCOBIOLOGY, V7, pR5; Glaser F, 2001, PROTEINS, V43, P89, DOI 10.1002/1097-0134(20010501)43:2<89::AID-PROT1021>3.3.CO;2-8; Gluer S, 1998, J PEDIATR SURG, V33, P1516, DOI 10.1016/S0022-3468(98)90488-2; Hildebrandt H, 1998, CANCER RES, V58, P779; Hildebrandt H, 1998, J NEUROCHEM, V71, P2339; JAMES WM, 1987, BIOCHEM BIOPH RES CO, V148, P817, DOI 10.1016/0006-291X(87)90949-1; JANIN J, 1988, J MOL BIOL, V204, P155, DOI 10.1016/0022-2836(88)90606-7; Jeanneau C, 2004, J BIOL CHEM, V279, P13461, DOI 10.1074/jbc.M311764200; Johnson CP, 2005, J BIOL CHEM, V280, P137, DOI 10.1074/jbc.M410216200; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kapitonov D, 1999, GLYCOCONJUGATE J, V16, P337, DOI 10.1023/A:1007091926413; Kapitonov D, 1999, GLYCOBIOLOGY, V9, P961, DOI 10.1093/glycob/9.10.961; Kiss JZ, 2001, BRAIN RES REV, V36, P175, DOI 10.1016/S0165-0173(01)00093-5; Kitazume-Kawaguchi S, 2001, J BIOL CHEM, V276, P15696, DOI 10.1074/jbc.M010371200; KOJIMA N, 1995, FEBS LETT, V360, P1, DOI 10.1016/0014-5793(95)00059-I; KOMMINOTH P, 1991, AM J PATHOL, V139, P297; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; LIVINGSTON BD, 1993, J BIOL CHEM, V268, P11504; LIVINGSTON BD, 1988, J BIOL CHEM, V263, P9443; Ma BY, 2003, P NATL ACAD SCI USA, V100, P5772, DOI 10.1073/pnas.1030237100; Meiler J, 2003, P NATL ACAD SCI USA, V100, P12105, DOI 10.1073/pnas.1831973100; Mendiratta SS, 2006, J BIOL CHEM, V281, P36052, DOI 10.1074/jbc.M608073200; Mendiratta SS, 2005, J BIOL CHEM, V280, P32340, DOI 10.1074/jbc.M506217200; MENGELING BJ, 1995, P NATL ACAD SCI USA, V92, P502, DOI 10.1073/pnas.92.2.502; Miller E, 2008, J BIOL CHEM, V283, P1985, DOI 10.1074/jbc.M708160200; Muhlenhoff M, 1996, EMBO J, V15, P6943, DOI 10.1002/j.1460-2075.1996.tb01086.x; Nakata D, 2006, GLYCOCONJUGATE J, V23, P423, DOI 10.1007/s10719-006-6356-5; NAKAYAMA J, 1995, P NATL ACAD SCI USA, V92, P7031, DOI 10.1073/pnas.92.15.7031; NELSON RW, 1995, J BIOL CHEM, V270, P17171, DOI 10.1074/jbc.270.29.17171; Nishikawa A, 1997, J BIOL CHEM, V272, P19408, DOI 10.1074/jbc.272.31.19408; Oltmann-Norden I, 2008, J BIOL CHEM, V283, P1463, DOI 10.1074/jbc.M708463200; Ong E, 1998, GLYCOBIOLOGY, V8, P415, DOI 10.1093/glycob/8.4.415; PELKONEN S, 1989, J VIROL, V63, P4409, DOI 10.1128/JVI.63.10.4409-4416.1989; Phillips GR, 1997, DEV BRAIN RES, V102, P143, DOI 10.1016/S0165-3806(97)00069-2; ROTH J, 1988, AM J PATHOL, V133, P227; ROTH J, 1988, P NATL ACAD SCI USA, V85, P2999, DOI 10.1073/pnas.85.9.2999; ROTHBARD JB, 1982, J BIOL CHEM, V257, P1064; Sato C, 2000, J BIOL CHEM, V275, P15422, DOI 10.1074/jbc.275.20.15422; SCHEIDEGGER EP, 1995, J BIOL CHEM, V270, P22685, DOI 10.1074/jbc.270.39.22685; Sevigny MB, 1998, GLYCOBIOLOGY, V8, P857, DOI 10.1093/glycob/8.9.857; Steenbergen SM, 2006, J BACTERIOL, V188, P6195, DOI 10.1128/JB.00466-06; Steet R, 2005, J BIOL CHEM, V280, P33318, DOI 10.1074/jbc.M505994200; Suzuki M, 2005, GLYCOBIOLOGY, V15, P887, DOI 10.1093/glycob/cwi071; Tanaka F, 2000, CANCER RES, V60, P3072; Weinhold B, 2005, J BIOL CHEM, V280, P42971, DOI 10.1074/jbc.M511097200; Yabe U, 2003, J BIOL CHEM, V278, P13875, DOI 10.1074/jbc.M300458200; YANG PF, 1992, J CELL BIOL, V116, P1487, DOI 10.1083/jcb.116.6.1487; YANG PF, 1994, J BIOL CHEM, V269, P23039; ZUBER C, 1992, J BIOL CHEM, V267, P9965	66	42	42	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15505	15516		10.1074/jbc.M809696200	http://dx.doi.org/10.1074/jbc.M809696200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19336400	Green Published, hybrid			2022-12-27	WOS:000266501000019
J	Kulkarni, MM; McMaster, WR; Kamysz, W; McGwire, BS				Kulkarni, Manjusha M.; McMaster, W. Robert; Kamysz, Wojciech; McGwire, Bradford S.			Antimicrobial Peptide-induced Apoptotic Death of Leishmania Results from Calcium-dependent, Caspase-independent Mitochondrial Toxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROGRAMMED CELL-DEATH; ANTI-INFLAMMATORY AGENT; MELITTIN HYBRID PEPTIDE; DONOVANI PROMASTIGOTES; ENDOPLASMIC-RETICULUM; FLUFENAMIC ACID; PROTOZOAN; PARASITE; CYTOTOXICITY; AMASTIGOTES	alpha- and theta-defensin-, magainin-, and cathelicidin-type antimicrobial peptides (AMPs) can kill the pathogenic protozoan Leishmania. Comparative studies of a panel of AMPs have defined two distinct groups: those that induce nonapoptotic (Class I) and apoptotic (Class II) parasite killing based on their differential ability to induce phosphatidyl serine exposure, loss of mitochondrial membrane potential and decreased ATP production, induction of caspase-3/7 and -12 activity, and DNA degradation. Class II AMPs cause rapid influx of the vital stain SYTOX and an increase in intracellular Ca2+, whereas Class I AMPs cause a slow accumulation of SYTOX and do not affect intracellular Ca2+ levels. Inhibitors of cysteine or caspase proteases diminished fast influx of SYTOX through the surface membrane and DNA degradation but do not ablate the annexin V staining or the induction of apoptosis by Class II AMPs. This suggests that the changes in surface permeability in AMP-mediated apoptosis are related to the downstream events of intracellular cysteine/caspase activation or the loss of ATP. The activation of caspase-12-like activity was Ca2+-dependent, and inhibitors of voltage-gated and nonspecific Ca2+ channels diminished this activity. Flufenamic acid, a nonspecific Ca2+ inhibitor, completely ablated AMP-induced mitochondrial dysfunction and cell death, indicating the importance of dysregulation of Ca2+ in antimicrobial peptide-induced apoptosis.	[McGwire, Bradford S.] Ohio State Univ, Div Infect Dis, Ctr Microbial Interface Biol, Med Ctr, Columbus, OH 43210 USA; [McMaster, W. Robert] Univ British Columbia, Dept Med Genet, Vancouver, BC V6H 3N1, Canada; [Kamysz, Wojciech] Med Univ Gdansk, Fac Pharm, PL-80416 Gdansk, Poland	University System of Ohio; Ohio State University; University of British Columbia; Fahrenheit Universities; Medical University Gdansk	McGwire, BS (corresponding author), Ohio State Univ, Div Infect Dis, Ctr Microbial Interface Biol, Med Ctr, Biomed Res Tower,Rm 1012,460 W 12th Ave, Columbus, OH 43210 USA.	Brad.McGwire@osumc.edu		Kamysz, Wojciech/0000-0001-5335-3043	Ohio State University; American Heart Association; Canadian Institutes of Health [7399]	Ohio State University(Ohio State University); American Heart Association(American Heart Association); Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR))	This work was supported, in part, by the funding from the Ohio State University, American Heart Association Beginning Grant in-Aid and Scientist Development Grant awards (to B. S. M.), and Canadian Institutes of Health Grant MOP 7399 (to W. R. M.).	Arnoult D, 2002, CELL DEATH DIFFER, V9, P65, DOI 10.1038/sj.cdd.4400951; Bellm L, 2000, EXPERT OPIN INV DRUG, V9, P1731, DOI 10.1517/13543784.9.8.1731; BoseDasgupta S, 2008, CELL DEATH DIFFER, V15, P1629, DOI 10.1038/cdd.2008.85; Chen CY, 2001, CELL GROWTH DIFFER, V12, P297; Chicharro C, 2001, ANTIMICROB AGENTS CH, V45, P2441, DOI 10.1128/AAC.45.9.2441-2449.2001; Das M, 2001, J CELL SCI, V114, P2461; Diaz-Achirica P, 1998, BIOCHEM J, V330, P453, DOI 10.1042/bj3300453; Eichler T, 2006, TOXICOL SCI, V90, P392, DOI 10.1093/toxsci/kfj106; Ge YG, 1999, ANTIMICROB AGENTS CH, V43, P782, DOI 10.1128/AAC.43.4.782; Holzmuller P, 2002, INFECT IMMUN, V70, P3727, DOI 10.1128/IAI.70.7.3727-3735.2002; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Jordani MC, 2000, MOL CELL BIOCHEM, V210, P153, DOI 10.1023/A:1007185825101; Joshi PB, 2002, MOL BIOCHEM PARASIT, V120, P33, DOI 10.1016/S0166-6851(01)00432-7; KIDERLEN AF, 1990, J IMMUNOL METHODS, V127, P11, DOI 10.1016/0022-1759(90)90334-R; Kulkarni MM, 2006, MOL MICROBIOL, V62, P1484, DOI 10.1111/j.1365-2958.2006.05459.x; Lee N, 2007, EUKARYOT CELL, V6, P1745, DOI 10.1128/EC.00123-07; MCDOUGALL P, 1983, BIOCHEM PHARMACOL, V32, P2595, DOI 10.1016/0006-2952(83)90024-2; MCDOUGALL P, 1988, BIOCHEM PHARMACOL, V37, P1327, DOI 10.1016/0006-2952(88)90790-3; McGwire BS, 2003, J INFECT DIS, V188, P146, DOI 10.1086/375747; Moreno SNJ, 2003, CURR OPIN MICROBIOL, V6, P359, DOI 10.1016/S1369-5274(03)00091-2; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Paris C, 2004, ANTIMICROB AGENTS CH, V48, P852, DOI 10.1128/AAC.48.3.852-859.2004; Sen N, 2004, J BIOL CHEM, V279, P52366, DOI 10.1074/jbc.M406705200; Sen N, 2004, CELL DEATH DIFFER, V11, P924, DOI 10.1038/sj.cdd.4401435; Sudhandiran G, 2003, J BIOL CHEM, V278, P25120, DOI 10.1074/jbc.M301975200; Van Zandbergen G, 2007, AUTOIMMUNITY, V40, P349, DOI 10.1080/08916930701356960; van Zandbergen G, 2006, P NATL ACAD SCI USA, V103, P13837, DOI 10.1073/pnas.0600843103; Yang L, 2000, BIOPHYS J, V79, P2002, DOI 10.1016/S0006-3495(00)76448-4; Zangger H, 2002, CELL DEATH DIFFER, V9, P1126, DOI 10.1038/sj.cdd.4401071; Zong WX, 2003, J CELL BIOL, V162, P59, DOI 10.1083/jcb.200302084	30	68	73	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15496	15504		10.1074/jbc.M809079200	http://dx.doi.org/10.1074/jbc.M809079200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19357081	Green Published, hybrid			2022-12-27	WOS:000266501000018
J	Levinger, L; Hopkinson, A; Desetty, R; Wilson, C				Levinger, Louis; Hopkinson, Angela; Desetty, Rohini; Wilson, Christopher			Effect of Changes in the Flexible Arm on tRNase Z Processing Kinetics	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CANCER SUSCEPTIBILITY GENE; POLYADENYLATION FACTOR CPSF-73; TRANSFER-RNA; SUBSTRATE RECOGNITION; THERMOTOGA-MARITIMA; ZINC PHOSPHODIESTERASE; CRYSTAL-STRUCTURE; CLEAVAGE SITE; Z CATALYSIS; CCA	tRNAs are transcribed as precursors and processed in a series of reactions culminating in aminoacylation and translation. Central to tRNA maturation, the 3' end trailer can be endonucleolytically removed by tRNase Z. A flexible arm (FA) extruded from the body of tRNase Z consists of a structured alpha alpha beta beta hand that binds the elbow of pre-tRNA. Deleting the FA hand causes an almost 100-fold increase in K-m with little change in k(cat), establishing its contribution to substrate recognition/binding. Remarkably, a 40-residue Ala scan through the FA hand reveals a conserved leucine at the ascending stalk/hand boundary that causes practically the same increase in K-m as the hand deletion, thus nearly eliminating its ability to bind substrate. K-m also increases with substitutions in the GP(alpha 4-alpha 5) loop and at other conserved residues in the FA hand predicted to contact substrate based on the co-crystal structure. Substitutions that reduce k(cat) are clustered in the beta 10-beta 11 loop.	[Levinger, Louis; Hopkinson, Angela; Desetty, Rohini; Wilson, Christopher] CUNY York Coll, Dept Biol, Jamaica, NY 11451 USA	City University of New York (CUNY) System; York College NY (CUNY)	Levinger, L (corresponding author), 94-20 Guy R Brewer Blvd, Jamaica, NY 11451 USA.	louie@york.cuny.edu			National Institutes of Health [S06GM08153, R15CA120072, SC3GM084764]; Professional Staff Congress-City University of New York; NATIONAL CANCER INSTITUTE [R15CA120072] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC3GM084764, S06GM008153] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Professional Staff Congress-City University of New York; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants S06GM08153, R15CA120072, and SC3GM084764. This work was also supported by grants from the Professional Staff Congress-City University of New York.	AEBI M, 1990, J BIOL CHEM, V265, P16216; Chen Y, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-12; de la Sierra-Gallay IL, 2006, NAT STRUCT MOL BIOL, V13, P376, DOI 10.1038/nsmb1066; de la Sierra-Gallay IL, 2005, NATURE, V433, P657, DOI 10.1038/nature03284; DeLano W.L, PYMOL MOL GRAPHICS S; Dominski Z, 2005, CELL, V123, P37, DOI 10.1016/j.cell.2005.08.002; Dominski Z, 2007, CRIT REV BIOCHEM MOL, V42, P67, DOI 10.1080/10409230701279118; Dubrovsky EB, 2004, NUCLEIC ACIDS RES, V32, P255, DOI 10.1093/nar/gkh182; Fechter P, 1998, FEBS LETT, V436, P99, DOI 10.1016/S0014-5793(98)01096-5; Hoelzle A, 2008, RNA, V14, P928, DOI 10.1261/rna.933208; Hopkinson A, 2008, RNA BIOL, V5, P104, DOI 10.4161/rna.5.2.6086; Ishii R, 2005, J BIOL CHEM, V280, P14138, DOI 10.1074/jbc.M500355200; Ishii R, 2007, ACTA CRYSTALLOGR F, V63, P637, DOI 10.1107/S1744309107033623; Karkashon S, 2007, BIOCHEMISTRY-US, V46, P9380, DOI 10.1021/bi700578v; Korver W, 2003, INT J CANCER, V104, P283, DOI 10.1002/ijc.10945; Kostelecky B, 2006, J BACTERIOL, V188, P1607, DOI 10.1128/JB.188.4.1607-1614.2006; Levinger L, 1998, J BIOL CHEM, V273, P1015, DOI 10.1074/jbc.273.2.1015; Mandel CR, 2006, NATURE, V444, P953, DOI 10.1038/nature05363; MCCLAIN WH, 1987, SCIENCE, V238, P527, DOI 10.1126/science.2443980; Minagawa A, 2004, J BIOL CHEM, V279, P15688, DOI 10.1074/jbc.M313951200; Minagawa A, 2008, J MOL BIOL, V381, P289, DOI 10.1016/j.jmb.2008.05.016; Mohan A, 1999, RNA, V5, P245, DOI 10.1017/S1355838299981256; Nashimoto M, 1997, NUCLEIC ACIDS RES, V25, P1148, DOI 10.1093/nar/25.6.1148; Pellegrini O, 2003, EMBO J, V22, P4534, DOI 10.1093/emboj/cdg435; Redko Y, 2007, NAT REV MICROBIOL, V5, P278, DOI 10.1038/nrmicro1622; Schiffer S, 2003, BIOL CHEM, V384, P333, DOI 10.1515/BC.2003.039; Schiffer S, 2002, EMBO J, V21, P2769, DOI 10.1093/emboj/21.11.2769; Schilling O, 2005, J BIOL CHEM, V280, P17857, DOI 10.1074/jbc.M500591200; Shi PY, 1998, RNA, V4, P276; Shibata HS, 2005, J BIOL CHEM, V280, P22326, DOI 10.1074/jbc.M502048200; Smith MM, 2004, DEV BIOL, V266, P151, DOI 10.1016/j.ydbio.2003.10.016; Spath B, 2005, J BIOL CHEM, V280, P35440, DOI 10.1074/jbc.M506418200; Takaku H, 2004, NUCLEIC ACIDS RES, V32, P4429, DOI 10.1093/nar/gkh774; Takaku H, 2003, NUCLEIC ACIDS RES, V31, P2272, DOI 10.1093/nar/gkg337; Tavtigian SV, 2001, NAT GENET, V27, P172, DOI 10.1038/84808; Vogel A, 2004, BIOCHEMISTRY-US, V43, P10379, DOI 10.1021/bi049703+; Yan H, 2006, J BIOL CHEM, V281, P3926, DOI 10.1074/jbc.M509822200; Zareen N, 2005, J MOL BIOL, V350, P189, DOI 10.1016/j.jmb.2005.04.073; Zareen N, 2006, RNA, V12, P1104, DOI 10.1261/rna.4206	39	7	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15685	15691		10.1074/jbc.M900745200	http://dx.doi.org/10.1074/jbc.M900745200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19351879	Green Published, hybrid			2022-12-27	WOS:000266501000037
J	Mittelstadt, PR; Yamaguchi, H; Appella, E; Ashwell, JD				Mittelstadt, Paul R.; Yamaguchi, Hiroshi; Appella, Ettore; Ashwell, Jonathan D.			T Cell Receptor-mediated Activation of p38 alpha by Mono-phosphorylation of the Activation Loop Results in Altered Substrate Specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STAT4 SERINE PHOSPHORYLATION; ATF2 TRANSCRIPTION FACTOR; P38 MAP KINASE; PROTEIN-KINASE; DUAL PHOSPHORYLATION; ACTIVE MUTANTS; IN-VIVO; GAMMA; EXPRESSION; MECHANISM	p38 MAPKs are typically activated by upstream MAPK kinases that phosphorylate a Thr-X-Tyr motif in the activation loop. An exception is the T cell antigen receptor signaling pathway, which bypasses the MAPK cascade and activates p38 alpha and p38 beta by phosphorylation of Tyr-323 and subsequent autophosphorylation of the activation loop. Here we show that, unlike the classic MAPK cascade, the alternative pathway results primarily in mono-phosphorylation of the activation loop residue Thr180. Recombinant mono-phosphorylated and dual phosphorylated p38 alpha differed widely with regard to activity and substrate preference. Altered substrate specificity was reproduced in T cells in which p38 was activated by the alternative or classical MAPK pathways. These findings suggest that T cells have evolved a mechanism to utilize p38 in a specialized manner independent of and distinct from the classical p38 MAPK signaling cascade.	[Mittelstadt, Paul R.; Ashwell, Jonathan D.] NCI, Lab Immune Cell Biol, NIH, Bethesda, MD 20892 USA; [Yamaguchi, Hiroshi; Appella, Ettore] NCI, Cell Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ashwell, JD (corresponding author), NCI, Lab Immune Cell Biol, NIH, Rm 3002,37 Convent Dr, Bethesda, MD 20892 USA.	jda@mail.nih.gov			National Institutes of Health; NATIONAL CANCER INSTITUTE [Z01BC005599, Z01BC010774, ZIABC005599, ZIABC010774] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the National Institutes of Health NCI Intramural Research Program, Center for Cancer Research.	Askari N, 2009, BIOCHEMISTRY-US, V48, P2497, DOI 10.1021/bi900024v; Bell M, 2001, J BIOL CHEM, V276, P25351, DOI 10.1074/jbc.M101818200; Bellon S, 1999, STRUCTURE, V7, P1057, DOI 10.1016/S0969-2126(99)80173-7; Berenson LS, 2006, J IMMUNOL, V176, P4616, DOI 10.4049/jimmunol.176.8.4616; Blaeser F, 2000, J BIOL CHEM, V275, P197, DOI 10.1074/jbc.275.1.197; Blagosklonny MV, 2001, LEUKEMIA, V15, P869, DOI 10.1038/sj.leu.2402134; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; De Chiara G, 2006, J BIOL CHEM, V281, P21353, DOI 10.1074/jbc.M511052200; Diskin R, 2004, J BIOL CHEM, V279, P47040, DOI 10.1074/jbc.M404595200; Diskin R, 2007, J MOL BIOL, V365, P66, DOI 10.1016/j.jmb.2006.08.043; Engelberg D, 2004, SEMIN CANCER BIOL, V14, P271, DOI 10.1016/j.semcancer.2004.04.006; Farley N, 2006, MOL CELL BIOL, V26, P2118, DOI 10.1128/MCB.26.6.2118-2129.2006; Fuchs SY, 2000, J BIOL CHEM, V275, P12560, DOI 10.1074/jbc.275.17.12560; GRONOSTAJSKI RM, 1985, J BIOL CHEM, V260, P3344; Hale KK, 1999, J IMMUNOL, V162, P4246; JIRMANOVA L, 2008, BLOOD; Kyriakis JM, 2001, PHYSIOL REV, V81, P807, DOI 10.1152/physrev.2001.81.2.807; Lee JC, 2000, IMMUNOPHARMACOLOGY, V47, P185, DOI 10.1016/S0162-3109(00)00206-X; Li ZJ, 1996, BIOCHEM BIOPH RES CO, V228, P334, DOI 10.1006/bbrc.1996.1662; Lu BF, 2004, NAT IMMUNOL, V5, P38, DOI 10.1038/ni1020; Lukas SM, 2004, BIOCHEMISTRY-US, V43, P9950, DOI 10.1021/bi049508v; Maayan Inbal, 2008, V20, P171, DOI 10.1007/4735_2007_0249; Marinissen MJ, 1999, MOL CELL BIOL, V19, P4289; Merritt C, 2000, MOL CELL BIOL, V20, P936, DOI 10.1128/MCB.20.3.936-946.2000; Morinobu A, 2002, P NATL ACAD SCI USA, V99, P12281, DOI 10.1073/pnas.182618999; Muir TW, 2003, ANNU REV BIOCHEM, V72, P249, DOI 10.1146/annurev.biochem.72.121801.161900; Park WR, 2004, INT IMMUNOL, V16, P295, DOI 10.1093/intimm/dxh034; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Penix LA, 1996, J BIOL CHEM, V271, P31964, DOI 10.1074/jbc.271.50.31964; RAINGEAUD J, 1995, J BIOL CHEM, V270, P7420, DOI 10.1074/jbc.270.13.7420; Rincon M, 2000, FREE RADICAL BIO MED, V28, P1328, DOI 10.1016/S0891-5849(00)00219-7; Round JL, 2007, NAT IMMUNOL, V8, P154, DOI 10.1038/ni1422; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Rudd CE, 2005, NAT IMMUNOL, V6, P368, DOI 10.1038/ni0405-368; Salmon RA, 1997, J IMMUNOL, V159, P5309; Salvador JM, 2005, NAT IMMUNOL, V6, P396, DOI 10.1038/ni1176; Salvador JM, 2005, NAT IMMUNOL, V6, P390, DOI 10.1038/ni1177; Sours KM, 2008, J MOL BIOL, V379, P1075, DOI 10.1016/j.jmb.2008.04.044; Visconti R, 2000, BLOOD, V96, P1844, DOI 10.1182/blood.V96.5.1844.h8001844_1844_1852; Waas WF, 2001, J BIOL CHEM, V276, P5676, DOI 10.1074/jbc.M008787200; Yang JF, 2001, NAT IMMUNOL, V2, P157, DOI 10.1038/84264; Zhang YY, 2008, J BIOL CHEM, V283, P26591, DOI 10.1074/jbc.M801703200; Zhao M, 1999, MOL CELL BIOL, V19, P21; Zhou B, 2002, J BIOL CHEM, V277, P13889, DOI 10.1074/jbc.M200377200	44	41	44	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15469	15474		10.1074/jbc.M901004200	http://dx.doi.org/10.1074/jbc.M901004200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19324872	Green Published, hybrid			2022-12-27	WOS:000266501000015
J	Ooga, T; Ohashi, Y; Kuramitsu, S; Koyama, Y; Tomita, M; Soga, T; Masui, R				Ooga, Takushi; Ohashi, Yoshiaki; Kuramitsu, Seiki; Koyama, Yoshinori; Tomita, Masaru; Soga, Tomoyoshi; Masui, Ryoji			Degradation of ppGpp by Nudix Pyrophosphatase Modulates the Transition of Growth Phase in the Bacterium Thermus thermophilus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTROPHORESIS-MASS-SPECTROMETRY; SPOT GENE-PRODUCT; ESCHERICHIA-COLI; STRINGENT RESPONSE; BACILLUS-SUBTILIS; GUANOSINE 5'-DIPHOSPHATE-3'-MONOPHOSPHATE; CELL-DIVISION; HYDROLASE; (P)PPGPP; PROTEIN	A major bacterial alarmone, guanosine 3', 5'-bispyrophosphate (ppGpp), controls cellular growth under conditions of nutritional starvation. For most bacteria, intracellular ppGpp levels are tightly controlled by the synthesis/degradation cycle of RelA and SpoT activities. This study shows a novel ppGpp regulatory protein governing the cellular growth of Thermus thermophilus, Ndx8, a member of the Nudix pyrophosphatase family that degrades ppGpp to yield guanosine 3', 5'-bisphosphate. The ndx8-null mutant strain exhibited early stage growth arrest accompanied by the stationary phase-specific morphologies and global transcriptional modulation under nutritionally defined conditions. Several possible substrate compounds of Ndx8, which specifically accumulated in the ndx8 mutant cells, were identified by employing a capillary electrophoresis time-of-flight mass spectrometry-based metabolomics approach. Among them, the hydrolytic activity of Ndx8 for ppGpp was significant not only in vitro but also in vivo. Finally, the elimination of ppGpp synthetic activity suppressed the observed phenotype of the ndx8 mutation, suggesting that the function of Ndx8 as a growth regulator is involved in ppGpp accumulation, which is thought to act as a trigger of the growth phase transition. These results suggest a novel mechanism of ppGpp-mediated growth control by the functional relay between Ndx8 and SpoT activity as ppGpp scavengers.	[Ohashi, Yoshiaki; Tomita, Masaru; Soga, Tomoyoshi] Human Metabolome Technol Inc, Yamagata 9970052, Japan; [Ooga, Takushi; Kuramitsu, Seiki; Masui, Ryoji] Osaka Univ, Grad Sch Sci, Dept Biol Sci, Osaka 5600043, Japan; [Ohashi, Yoshiaki; Tomita, Masaru; Soga, Tomoyoshi] Keio Univ, Inst Adv Biosci, Yamagata 9970052, Japan; [Kuramitsu, Seiki; Masui, Ryoji] RIKEN, SPring Ctr 8, Harima Inst, Mikazuki, Hyogo 6795148, Japan; [Koyama, Yoshinori] Natl Inst Adv Ind Sci & Technol, Inst Biol Resources & Funct, Tsukuba, Ibaraki 3058566, Japan	Osaka University; Keio University; RIKEN; National Institute of Advanced Industrial Science & Technology (AIST)	Ohashi, Y (corresponding author), Human Metabolome Technol Inc, Yamagata 9970052, Japan.	ohashi@humanmetabolome.com; rmasui@bio.sci.osaka-u.ac.jp	Soga, Tomoyoshi/B-8105-2014	Soga, Tomoyoshi/0000-0001-9502-2509	RIKEN Structural Genomics/Proteomics Initiative; National Project on Protein Structural and Functional Analyses, Ministry of Education, Culture, Sports, Science and Technology of Japan; Yamagata Prefecture and Tsuruoka City; Japan Society for the Promotion of Science for Young Scientists [19-601]	RIKEN Structural Genomics/Proteomics Initiative; National Project on Protein Structural and Functional Analyses, Ministry of Education, Culture, Sports, Science and Technology of Japan; Yamagata Prefecture and Tsuruoka City; Japan Society for the Promotion of Science for Young Scientists(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by the RIKEN Structural Genomics/Proteomics Initiative, the National Project on Protein Structural and Functional Analyses, Ministry of Education, Culture, Sports, Science and Technology of Japan, a grant from Yamagata Prefecture and Tsuruoka City, and Japan Society for the Promotion of Science for Young Scientists Research Fellowship 19-601 ( to T. O.).	AKINYANJU J, 1979, FEBS LETT, V107, P173, DOI 10.1016/0014-5793(79)80489-5; Alsaker KV, 2005, J BACTERIOL, V187, P7103, DOI 10.1128/JB.187.20.7103-7118.2005; AMES BN, 1960, J BIOL CHEM, V235, P769; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bessman MJ, 1996, J BIOL CHEM, V271, P25059, DOI 10.1074/jbc.271.41.25059; Braeken K, 2006, TRENDS MICROBIOL, V14, P45, DOI 10.1016/j.tim.2005.11.006; Cartwright JL, 2000, J BIOL CHEM, V275, P32925, DOI 10.1074/jbc.M005015200; Cashel M., 1996, ESCHERICHIA COLI SAL, P1458; Chang DE, 2002, MOL MICROBIOL, V45, P289, DOI 10.1046/j.1365-2958.2002.03001.x; COCHRAN JW, 1974, J BIOL CHEM, V249, P353; Crosse AM, 2000, LETT APPL MICROBIOL, V31, P332, DOI 10.1046/j.1472-765x.2000.00822.x; DAI K, 1991, J BACTERIOL, V173, P3500, DOI 10.1128/jb.173.11.3500-3506.1991; DEBOER HA, 1977, FEBS LETT, V79, P19, DOI 10.1016/0014-5793(77)80341-4; Dunn CA, 1999, J BIOL CHEM, V274, P32318, DOI 10.1074/jbc.274.45.32318; Eymann C, 2002, J BACTERIOL, V184, P2500, DOI 10.1128/JB.184.9.2500-2520.2002; Fisher David I., 2004, BMC Biochemistry, V5, P7, DOI 10.1186/1471-2091-5-7; GALLANT J, 1976, CELL, V7, P75, DOI 10.1016/0092-8674(76)90257-9; GENTRY DR, 1993, J BACTERIOL, V175, P7982, DOI 10.1128/JB.175.24.7982-7989.1993; Hale CA, 1997, CELL, V88, P175, DOI 10.1016/S0092-8674(00)81838-3; Hashimoto Y, 2001, FEBS LETT, V506, P231, DOI 10.1016/S0014-5793(01)02926-X; HEINEMEYER EA, 1978, EUR J BIOCHEM, V89, P125, DOI 10.1111/j.1432-1033.1978.tb20904.x; Hogg T, 2004, CELL, V117, P57, DOI 10.1016/S0092-8674(04)00260-0; JOHNSON GS, 1979, J BIOL CHEM, V254, P5483; Kasai K, 2006, J BACTERIOL, V188, P7111, DOI 10.1128/JB.00574-06; Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100; Larsen N, 2006, APPL ENVIRON MICROB, V72, P1173, DOI 10.1128/AEM.72.2.1173-1179.2006; Legler PM, 2000, BIOCHEMISTRY-US, V39, P8603, DOI 10.1021/bi000537p; Lemos JA, 2007, MOL MICROBIOL, V65, P1568, DOI 10.1111/j.1365-2958.2007.05897.x; Letek M, 2007, INT MICROBIOL, V10, P271, DOI 10.2436/20.1501.01.36; Magnusson LU, 2005, TRENDS MICROBIOL, V13, P236, DOI 10.1016/j.tim.2005.03.008; MAKI H, 1992, NATURE, V355, P273, DOI 10.1038/355273a0; Maksel D, 2001, BIOCHEM J, V357, P399, DOI 10.1042/0264-6021:3570399; McLennan AG, 2006, CELL MOL LIFE SCI, V63, P123, DOI 10.1007/s00018-005-5386-7; Murphy H, 2003, METHOD ENZYMOL, V371, P596; Murray KD, 1996, J MOL BIOL, V259, P41; Nanamiya H, 2008, MOL MICROBIOL, V67, P291, DOI 10.1111/j.1365-2958.2007.06018.x; NISHINO T, 1979, J BACTERIOL, V140, P671, DOI 10.1128/JB.140.2.671-679.1979; OHandley SF, 1996, J BIOL CHEM, V271, P24649, DOI 10.1074/jbc.271.40.24649; Ohashi Y, 2008, MOL BIOSYST, V4, P135, DOI 10.1039/b714176a; Ojha AK, 2000, INFECT IMMUN, V68, P4084, DOI 10.1128/IAI.68.7.4084-4091.2000; PAO CC, 1979, J BIOL CHEM, V254, P688; PAO CC, 1980, J BIOL CHEM, V255, P1830; PAO CC, 1981, BIOCHIM BIOPHYS ACTA, V677, P358, DOI 10.1016/0304-4165(81)90247-6; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; Raskin DM, 2007, P NATL ACAD SCI USA, V104, P4636, DOI 10.1073/pnas.0611650104; SALES M, 1982, MOL GEN GENET, V186, P263, DOI 10.1007/BF00331860; SARUBBI E, 1988, MOL GEN GENET, V213, P214, DOI 10.1007/BF00339584; SEYFZADEH M, 1993, P NATL ACAD SCI USA, V90, P11004, DOI 10.1073/pnas.90.23.11004; Shinkai A, 2007, J BACTERIOL, V189, P3891, DOI 10.1128/JB.01739-06; Soga T, 2003, J PROTEOME RES, V2, P488, DOI 10.1021/pr034020m; Soga T, 2007, J CHROMATOGR A, V1159, P125, DOI 10.1016/j.chroma.2007.05.054; SOMERVILLE CR, 1979, MOL GEN GENET, V169, P315, DOI 10.1007/BF00382277; TANAKA T, 1981, J BIOCHEM-TOKYO, V89, P677, DOI 10.1093/oxfordjournals.jbchem.a133245; Traxler MF, 2006, P NATL ACAD SCI USA, V103, P2374, DOI 10.1073/pnas.0510995103; Wang ZR, 2002, P NATL ACAD SCI USA, V99, P12663, DOI 10.1073/pnas.192445599; XIAO H, 1991, J BIOL CHEM, V266, P5980; Xu WL, 2000, BIOCHEM BIOPH RES CO, V273, P753, DOI 10.1006/bbrc.2000.2999	57	49	50	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15549	15556		10.1074/jbc.M900582200	http://dx.doi.org/10.1074/jbc.M900582200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19346251	hybrid, Green Published			2022-12-27	WOS:000266501000023
J	Wang, YC; Hu, XB; He, F; Feng, F; Wang, L; Li, W; Zhang, P; Li, D; Jia, ZS; Liang, YM; Han, H				Wang, Yao-Chun; Hu, Xing-Bin; He, Fei; Feng, Fan; Wang, Lin; Li, Wei; Zhang, Ping; Li, Duan; Jia, Zhan-Sheng; Liang, Ying-Min; Han, Hua			Lipopolysaccharide-induced Maturation of Bone Marrow-derived Dendritic Cells Is Regulated by Notch Signaling through the Up-regulation of CXCR4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMATOPOIETIC PROGENITOR CELLS; TRANSCRIPTION FACTOR; LINEAGE DECISION; DIFFERENTIATION; LIGAND; MONOCYTES; PRECURSORS; DELTA-1; RBP-J-KAPPA/SU(H); MACROPHAGES	Dendritic cells (DCs) are professional antigen presenting cells to initiate immune response against pathogens, but mechanisms controlling the maturation of DCs are unclear. Here we report that, in the absence of recombination signal binding protein-J kappa (RBP-J, the transcription factor mediating Notch signaling), lipopolysaccharide-stimulated monocyte-derived DCs are arrested at a developmental stage with few dendrites, low major histocompatibility complex II (MHC II) expression, and reduced motility and antigen presentation ability. RBP-J null DCs had lower expression of CXCR4. Transduction with a CXCR4-expressing lentivirus rescued developmental arrest of RBP-J-deficient DCs. Activation of Notch signaling in DCs up-regulated CXCR4 expression and increased the outgrowth of dendrites and the expression of MHC II. These effects were abrogated by a CXCR4 inhibitor. Therefore, Notch signaling is essential for DCs to transit from a dendrite(low)MHC IIlow immature state into a dendrite(high)MHC IIhigh mature state, during the lipopolysaccharide-induced DC maturation, most likely through the up-regulation of CXCR4.	[Liang, Ying-Min; Han, Hua] Fourth Mil Med Univ, Tangdu Hosp, Dept Hematol, Xian 710038, Peoples R China; [Wang, Yao-Chun; Hu, Xing-Bin; He, Fei; Feng, Fan; Wang, Lin; Li, Wei; Zhang, Ping; Li, Duan; Jia, Zhan-Sheng; Han, Hua] Fourth Mil Med Univ, Tangdu Hosp, Dept Med Genet & Dev Biol, State Key Lab Canc Biol, Xian 710038, Peoples R China	Air Force Military Medical University; Air Force Military Medical University	Liang, YM (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Hematol, Xian 710038, Peoples R China.	liangym@fmmu.edu.cn; huahan@fmmu.edu.cn	Hu, XB/U-8501-2019	han, hua/0000-0002-1872-9700	National Natural Science Foundation [30600544, 30830067, 30801050, 30800454]; Ministry of Science and Technology of China [2006AA02A111, 2009CB521706, 2007AA02Z441]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China)	This work was supported by the National Natural Science Foundation ( Grants 30600544, 30830067, 30801050, and 30800454) and the Ministry of Science and Technology of China ( Grants 2006AA02A111, 2009CB521706, and 2007AA02Z441).	Ardavin C, 2001, TRENDS IMMUNOL, V22, P691, DOI 10.1016/S1471-4906(01)02059-2; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; BHARDWAJ N, 1992, J EXP MED, V175, P267, DOI 10.1084/jem.175.1.267; Caton ML, 2007, J EXP MED, V204, P1653, DOI 10.1084/jem.20062648; Cheng PY, 2007, BLOOD, V109, P507, DOI 10.1182/blood-2006-05-025601; Cheng PY, 2003, BLOOD, V102, P3980, DOI 10.1182/blood-2003-04-1034; Cheng PY, 2001, J IMMUNOL, V167, P4458, DOI 10.4049/jimmunol.167.8.4458; Diao J, 2004, J IMMUNOL, V173, P1826, DOI 10.4049/jimmunol.173.3.1826; Dontje W, 2006, BLOOD, V107, P2446, DOI 10.1182/blood-2005-05-2090; Fogg DK, 2006, SCIENCE, V311, P83, DOI 10.1126/science.1117729; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Honjo T, 1996, GENES CELLS, V1, P1, DOI 10.1046/j.1365-2443.1996.10010.x; INABA K, 1992, J EXP MED, V176, P1693, DOI 10.1084/jem.176.6.1693; Ingulli E, 1997, J EXP MED, V185, P2133, DOI 10.1084/jem.185.12.2133; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Kabashima K, 2007, AM J PATHOL, V171, P1249, DOI 10.2353/ajpath.2007.070225; Kabashima K, 2007, BIOCHEM BIOPH RES CO, V361, P1012, DOI 10.1016/j.bbrc.2007.07.128; Kohara H, 2007, BLOOD, V110, P4153, DOI 10.1182/blood-2007-04-084210; Leon B, 2005, SEMIN IMMUNOL, V17, P313, DOI 10.1016/j.smim.2005.05.013; Leon B, 2004, BLOOD, V103, P2668, DOI 10.1182/blood-2003-01-0286; MACATONIA SE, 1986, IMMUNOLOGY, V59, P509; Moll H, 2003, CELL MICROBIOL, V5, P493, DOI 10.1046/j.1462-5822.2003.00291.x; Ohishi K, 2000, BLOOD, V95, P2847, DOI 10.1182/blood.V95.9.2847.009k19_2847_2854; Ohishi K, 2001, BLOOD, V98, P1402, DOI 10.1182/blood.V98.5.1402; Olivier A, 2006, BLOOD, V107, P2694, DOI 10.1182/blood-2005-03-0970; Randolph GJ, 1998, SCIENCE, V282, P480, DOI 10.1126/science.282.5388.480; Randolph GJ, 2008, ANNU REV IMMUNOL, V26, P293, DOI 10.1146/annurev.immunol.26.021607.090254; Sallusto F, 1998, EUR J IMMUNOL, V28, P2760, DOI 10.1002/(SICI)1521-4141(199809)28:09<2760::AID-IMMU2760>3.0.CO;2-N; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Shi ZX, 2008, PROTEIN EXPRES PURIF, V59, P242, DOI 10.1016/j.pep.2008.02.004; Tamura K, 1995, CURR BIOL, V5, P1416, DOI 10.1016/S0960-9822(95)00279-X; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011; Weijzen S, 2002, J IMMUNOL, V169, P4273, DOI 10.4049/jimmunol.169.8.4273; Williams CK, 2008, CANCER RES, V68, P1889, DOI 10.1158/0008-5472.CAN-07-2181; Winzler C, 1997, J EXP MED, V185, P317, DOI 10.1084/jem.185.2.317	36	44	47	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15993	16003		10.1074/jbc.M901144200	http://dx.doi.org/10.1074/jbc.M901144200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19357083	Green Published, hybrid			2022-12-27	WOS:000266501000065
J	Zhu, JZ; Wu, XZ; Goel, S; Gowda, NM; Kumar, S; Krishnegowda, G; Mishra, G; Weinberg, R; Li, G; Gaestel, M; Muta, T; Gowda, DC				Zhu, Jianzhong; Wu, Xianzhu; Goel, Suchi; Gowda, Nagaraj M.; Kumar, Sanjeev; Krishnegowda, Gowdahalli; Mishra, Gourav; Weinberg, Rebecca; Li, Guangfu; Gaestel, Matthias; Muta, Tatsushi; Gowda, D. Channe			MAPK-activated Protein Kinase 2 Differentially Regulates Plasmodium falciparum Glycosylphosphatidylinositol-induced Production of Tumor Necrosis Factor-alpha and Interleukin-12 in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B-ZETA; MESSENGER-RNA STABILITY; GENE-EXPRESSION; TNF-ALPHA; RICH ELEMENT; PROINFLAMMATORY RESPONSES; INNATE IMMUNITY; NITRIC-OXIDE; MALARIA; INDUCTION	Proinflammatory responses induced by Plasmodium falciparum glycosylphosphatidylinositols (GPIs) are thought to be involved in malaria pathogenesis. In this study, we investigated the role of MAPK-activated protein kinase 2 (MK2) in the regulation of tumor necrosis factor-alpha(TNF-alpha) and interleukin (IL)12, two of the major inflammatory cytokines produced by macrophages stimulated with GPIs. We show that MK2 differentially regulates the GPI-induced production of TNF-alpha and IL-12. Although TNF-alpha production was markedly decreased, IL-12 expression was increased by 2-3-fold in GPI-stimulated MK2(-/-) macrophages compared with wild type (WT) cells. MK2(-/-) macrophages produced markedly decreased levels of TNF-alpha than WT macrophages mainly because of lower mRNA stability and translation. In the case of IL-12, mRNA was substantially higher in MK2(-/-) macrophages than WT. This enhanced production is due to increased NF-kappa B binding to the gene promoter, a markedly lower level expression of the transcriptional repressor factor c-Maf, and a decreased binding of GAP-12 to the gene promoter in MK2(-/-) macrophages. Thus, our data demonstrate for the first time the role of MK2 in the transcriptional regulation of IL-12. Using the protein kinase inhibitors SB203580 and U0126, we also show that the ERK and p38 pathways regulate TNF-alpha and IL-12 production, and that both inhibitors can reduce phosphorylation of MK2 in response to GPIs and other toll-like receptor ligands. These results may have important implications for developing therapeutics for malaria and other infectious diseases.	[Zhu, Jianzhong; Wu, Xianzhu; Goel, Suchi; Gowda, Nagaraj M.; Kumar, Sanjeev; Krishnegowda, Gowdahalli; Mishra, Gourav; Weinberg, Rebecca; Li, Guangfu; Gowda, D. Channe] Penn State Univ, Coll Med, Dept Biochem & Mol Biol, Hershey, PA 17033 USA; [Gaestel, Matthias] Hannover Med Sch, Inst Biochem, D-30625 Hannover, Germany; [Muta, Tatsushi] Tohoku Univ, Grad Sch Life Sci, Lab Cell Recognit & Response, Sendai, Miyagi 9808578, Japan	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Hannover Medical School; Tohoku University	Gowda, DC (corresponding author), Penn State Univ, Coll Med, Dept Biochem & Mol Biol, 500 Univ Dr, Hershey, PA 17033 USA.	gowda@psu.edu	Gaestel, Matthias/A-6560-2013	Gaestel, Matthias/0000-0002-4944-4652; GOWDA, KRISHNE/0000-0002-6042-0520; Kumar, Sanjeev/0000-0002-4454-9914; Li, Guangfu/0000-0002-9817-568X	National Institutes of Health [AI41139]; NIAID; Pennsylvania Department of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041139] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Pennsylvania Department of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI41139 from NIAID. This work was also supported by the Pennsylvania Department of Health.	Amarante-Paffaro A, 2004, REPRODUCTION, V128, P207, DOI 10.1530/rep.1.00214; Ariyasinghe A, 2006, J PARASITOL, V92, P531, DOI 10.1645/GE-551R1.1; Artavanis-Tsakonas K, 2003, CLIN EXP IMMUNOL, V133, P145, DOI 10.1046/j.1365-2249.2003.02174.x; Becker C, 2001, J IMMUNOL, V167, P2608, DOI 10.4049/jimmunol.167.5.2608; BIRON CA, 1995, CURR OPIN IMMUNOL, V7, P485, DOI 10.1016/0952-7915(95)80093-X; Cao SJ, 2002, J IMMUNOL, V169, P5715, DOI 10.4049/jimmunol.169.10.5715; COT S, 1994, J INFECT DIS, V169, P1417, DOI 10.1093/infdis/169.6.1417; Coxon PY, 2003, CELL SIGNAL, V15, P993, DOI 10.1016/S0898-6568(03)00074-3; Dimopoulos G, 2001, CURR OPIN IMMUNOL, V13, P79, DOI 10.1016/S0952-7915(00)00186-2; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; Frevel MAE, 2003, MOL CELL BIOL, V23, P425, DOI 10.1128/MCB.23.2.425-436.2003; Gaestel M, 2006, NAT REV MOL CELL BIO, V7, P120, DOI 10.1038/nrm1834; Gasque P, 2004, MOL IMMUNOL, V41, P1089, DOI 10.1016/j.molimm.2004.06.011; Hitti E, 2006, MOL CELL BIOL, V26, P2399, DOI 10.1128/MCB.26.6.2399-2407.2006; Kang YJ, 2008, J IMMUNOL, V180, P5075, DOI 10.4049/jimmunol.180.7.5075; KARUNAWEERA ND, 1992, P NATL ACAD SCI USA, V89, P3200, DOI 10.1073/pnas.89.8.3200; Kotlyarov A, 1999, NAT CELL BIOL, V1, P94, DOI 10.1038/10061; Kotlyarov A, 2002, BIOCHEM SOC T, V30, P959, DOI 10.1042/BST0300959; Kotlyarov A, 2002, MOL CELL BIOL, V22, P4827, DOI 10.1128/MCB.22.13.4827-4835.2002; Krishnegowda G, 2005, J BIOL CHEM, V280, P8606, DOI 10.1074/jbc.M413541200; Lehner MD, 2002, J IMMUNOL, V168, P4667, DOI 10.4049/jimmunol.168.9.4667; Lukas SM, 2004, BIOCHEMISTRY-US, V43, P9950, DOI 10.1021/bi049508v; Malaguarnera L, 2002, LANCET INFECT DIS, V2, P472, DOI 10.1016/S1473-3099(02)00344-4; Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a; Muta T, 2006, VITAM HORM, V74, P301, DOI 10.1016/S0083-6729(06)74012-2; Naik RS, 2003, J BIOL CHEM, V278, P2036, DOI 10.1074/jbc.M208976200; Naik RS, 2000, J EXP MED, V192, P1563, DOI 10.1084/jem.192.11.1563; Neininger A, 2002, J BIOL CHEM, V277, P3065, DOI 10.1074/jbc.C100685200; Ramos-Payan R, 2003, SCAND J IMMUNOL, V57, P439, DOI 10.1046/j.1365-3083.2003.01250.x; Rousseau S, 2008, J CELL SCI, V121, P149, DOI 10.1242/jcs.018671; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; Sandler H, 2008, BIOCHEM SOC T, V36, P491, DOI 10.1042/BST0360491; Sanjabi S, 2000, P NATL ACAD SCI USA, V97, P12705, DOI 10.1073/pnas.230436397; SCHOFIELD L, 1993, J EXP MED, V177, P145, DOI 10.1084/jem.177.1.145; SCHOFIELD L, 1993, ANN TROP MED PARASIT, V87, P617, DOI 10.1080/00034983.1993.11812820; SHERMAN IW, 1998, MALARIA PARASITE BIO, P1; Snow RW, 1999, B WORLD HEALTH ORGAN, V77, P624; Stevenson MM, 2004, NAT REV IMMUNOL, V4, P169, DOI 10.1038/nri1311; STOKOE D, 1992, EMBO J, V11, P3985, DOI 10.1002/j.1460-2075.1992.tb05492.x; Su Z, 2000, INFECT IMMUN, V68, P4399, DOI 10.1128/IAI.68.8.4399-4406.2000; Sugimoto K, 2004, J CLIN INVEST, V114, P857, DOI 10.1172/JCI200420014; Trinh DV, 2008, J MOL BIOL, V379, P122, DOI 10.1016/j.jmb.2008.03.060; Yamamoto M, 2004, NATURE, V430, P218, DOI 10.1038/nature02738; Yamazaki S, 2005, J BIOL CHEM, V280, P1678, DOI 10.1074/jbc.M409983200; Zhang T, 2002, BIOCHEM SOC T, V30, P952, DOI 10.1042/BST0300952; Zhu JZ, 2005, J BIOL CHEM, V280, P8617, DOI 10.1074/jbc.M413539200	46	31	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15750	15761		10.1074/jbc.M901111200	http://dx.doi.org/10.1074/jbc.M901111200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19359247	Green Published, hybrid			2022-12-27	WOS:000266501000044
J	Dangi, B; Obeng, M; Nauroth, JM; Teymourlouei, M; Needham, M; Raman, K; Arterburn, LM				Dangi, Bindi; Obeng, Marcus; Nauroth, Julie M.; Teymourlouei, Mah; Needham, Micah; Raman, Krishna; Arterburn, Linda M.			Biogenic Synthesis, Purification, and Chemical Characterization of Anti-inflammatory Resolvins Derived from Docosapentaenoic Acid (DPAn-6)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDROXY FATTY-ACIDS; DOCOSAHEXAENOIC ACID; LIPOXYGENASE PATHWAY; DOSE-RESPONSE; LIPOXINS; BRAIN; MEDIATORS; INFLAMMATION; PROTECTS; INHIBITION	Enzymatically oxygenated derivatives of the omega-3 fatty acids cis-4,7,10,13,16,19-docosahexaenoic acid (DHA) and cis-5,8,11,14,17-eicosapentaenoic acid, known as resolvins, have potent inflammation resolution activity (Serhan, C. N., Clish, C. B., Brannon, J., Colgan, S. P., Chiang, N., and Gronert, K. (2000) J. Exp. Med. 192, 1197-1204; Hong, S., Gronert, K., Devchand, P. R., Moussignac, R., and Serhan, C. N. (2003) J. Biol. Chem. 278, 14677-14687). Our objective was to determine whether similar derivatives are enzymatically synthesized from other C-22 fatty acids and whether these molecules possess inflammation resolution properties. The reaction of DHA, DPAn-3, and DPAn-6 with 5-, 12-, and 15-lipoxygenases produced oxylipins, which were identified and characterized by liquid chromatography coupled with tandem mass-spectrometry. DPAn-6 and DPAn-3 proved to be good substrates for 15-lipoxygenase. 15-Lipoxygenase proved to be the most efficient enzyme of the three tested for conversion of long chain polyunsaturated fatty acids to corresponding oxylipins. Since DPAn-6 is a major component of Martek DHA-S (TM) oil, we focused our attention on reaction products obtained from the DPAn-6 and 15-lipoxygenase reaction. (17S)-hydroxy-DPAn-6 and (10,17S)-dihydroxy-DPAn-6 were the main products of this reaction. These compounds were purified by preparatory high performance liquid chromatography techniques and further characterized by NMR, UV spectrophotometry, and tandem mass spectrometry. We tested both compounds in two animal models of acute inflammation and demonstrated that both compounds are potent anti-inflammatory agents that are active on local intravenous as well as oral administration. These oxygenated DPAn-6 compounds can thus be categorized as a new class of DPAn-6-derived resolvins.	[Dangi, Bindi; Obeng, Marcus; Nauroth, Julie M.; Teymourlouei, Mah; Needham, Micah; Raman, Krishna; Arterburn, Linda M.] Martek Biosci Corp, Columbia, MD 21045 USA		Dangi, B (corresponding author), Martek Biosci Corp, 6480 Dobbin Rd, Columbia, MD 21045 USA.	bdangi@martek.com						Akiba S, 2000, BIOL PHARM BULL, V23, P1293, DOI 10.1248/bpb.23.1293; Arita M, 2005, P NATL ACAD SCI USA, V102, P7671, DOI 10.1073/pnas.0409271102; Arterburn LM, 2006, AM J CLIN NUTR, V83, p1467S, DOI 10.1093/ajcn/83.6.1467S; AVELDANO MI, 1983, J BIOL CHEM, V258, P9339; Bayer M, 2005, J CHROMATOGR B, V819, P323, DOI 10.1016/j.jchromb.2005.02.008; Bazan NG, 2005, BRAIN PATHOL, V15, P159; Berry H, 1997, FEBS LETT, V408, P324, DOI 10.1016/S0014-5793(97)00453-5; Bonnans C, 2004, ALLERGY, V59, P1027, DOI 10.1111/j.1398-9995.2004.00617.x; Burdge GC, 2002, BRIT J NUTR, V88, P411, DOI 10.1079/BJN2002689; Butovich IA, 2006, J LIPID RES, V47, P854, DOI 10.1194/jlr.D500042-JLR200; Butovich IA, 2005, LIPIDS, V40, P249, DOI 10.1007/s11745-005-1379-z; Butovich IA, 2006, J LIPID RES, V47, P2462, DOI 10.1194/jlr.M600280-JLR200; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; CAREAGA MM, 1984, J BIOL CHEM, V259, P4413; Conolly RB, 2004, TOXICOL SCI, V77, P151, DOI 10.1093/toxsci/kfh007; EDWARDS JCW, 1981, J PATHOL, V134, P147, DOI 10.1002/path.1711340205; Farooqui AA, 2007, J NEUROCHEM, V101, P577, DOI 10.1111/j.1471-4159.2006.04371.x; GARDNER HW, 1991, BIOCHIM BIOPHYS ACTA, V1084, P221, DOI 10.1016/0005-2760(91)90063-N; Gilroy DW, 2004, NAT REV DRUG DISCOV, V3, P401, DOI 10.1038/nrd1383; Green KN, 2007, J NEUROSCI, V27, P4385, DOI 10.1523/JNEUROSCI.0055-07.2007; Greiner RS, 2003, LIPIDS, V38, P431, DOI 10.1007/s11745-003-1080-2; Guilford WJ, 2005, PROSTAG LEUKOTR ESS, V73, P245, DOI 10.1016/j.plefa.2005.05.012; HAMBERG M, 1967, J BIOL CHEM, V242, P5329; Hasturk H, 2006, FASEB J, V20, P401, DOI 10.1096/fj.05-4724fje; Hong S, 2003, J BIOL CHEM, V278, P14677, DOI 10.1074/jbc.M300218200; Hong S, 2007, J AM SOC MASS SPECTR, V18, P128, DOI 10.1016/j.jasms.2006.09.002; Kieran NE, 2004, KIDNEY INT, V65, P1145, DOI 10.1111/j.1523-1755.2004.00487.x; Kohn MC, 2002, J MOL ENDOCRINOL, V29, DOI 10.1677/jme.0.0290113; KUHN H, 1987, ANAL BIOCHEM, V160, P24, DOI 10.1016/0003-2697(87)90609-9; Kuhn H, 2002, PROSTAG OTH LIPID M, V68-9, P263, DOI 10.1016/S0090-6980(02)00035-7; Levy BD, 2005, PROSTAG LEUKOTR ESS, V73, P231, DOI 10.1016/j.plefa.2005.05.010; Levy BD, 2003, ADV EXP MED BIOL, V525, P19; Lipinski CA, 1997, ADV DRUG DELIVER REV, V23, P3, DOI 10.1016/S0169-409X(96)00423-1; Lipinski CA, 2000, J PHARMACOL TOX MET, V44, P235, DOI 10.1016/S1056-8719(00)00107-6; Maderna P, 2000, AM J PHYSIOL-CELL PH, V279, pC945, DOI 10.1152/ajpcell.2000.279.4.C945; Marcheselli VL, 2003, J BIOL CHEM, V278, P43807, DOI 10.1074/jbc.M305841200; Moriguchi T, 2004, J LIPID RES, V45, P1437, DOI 10.1194/jlr.M400087-JLR200; Moriguchi T, 2001, J LIPID RES, V42, P419; Mukherjee PK, 2004, P NATL ACAD SCI USA, V101, P8491, DOI 10.1073/pnas.0402531101; Murphy MG, 1999, LIPIDS, V34, P115, DOI 10.1007/s11745-999-0344-1; Murphy MG, 1997, MOL CELL BIOCHEM, V177, P257, DOI 10.1023/A:1006871524271; Namani T, 2007, COLLOID SURFACE B, V54, P118, DOI 10.1016/j.colsurfb.2006.05.022; Phillis JW, 2006, BRAIN RES REV, V52, P201, DOI 10.1016/j.brainresrev.2006.02.002; PIAZZA GJ, 1996, LIPOXYGENASE LIPOXYG, P1; SAMUELSSON B, 1987, SCIENCE, V237, P1171, DOI 10.1126/science.2820055; Sangster J., 1997, OCTANOL WATER PARTIT; SCHILSTRA MJ, 1994, LIPIDS, V29, P225, DOI 10.1007/BF02536325; SCHILSTRA MJ, 1993, BIOCHEMISTRY-US, V32, P7686, DOI 10.1021/bi00081a012; Schneider C, 2000, ANAL BIOCHEM, V287, P186, DOI 10.1006/abio.2000.4847; Serhan Charles N, 2006, Anesthesiol Clin, V24, P341, DOI 10.1016/j.atc.2006.01.003; Serhan CN, 2006, J IMMUNOL, V176, P1848, DOI 10.4049/jimmunol.176.3.1848; Serhan CN, 2005, CURR OPIN CLIN NUTR, V8, P115, DOI 10.1097/00075197-200503000-00003; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Serhan CN, 2002, PROSTAG OTH LIPID M, V68-9, P433, DOI 10.1016/S0090-6980(02)00047-3; SERHAN CN, 1984, P NATL ACAD SCI-BIOL, V81, P5335, DOI 10.1073/pnas.81.17.5335; Serhan CN, 2000, J EXP MED, V192, P1197, DOI 10.1084/jem.192.8.1197; SHIMIZU T, 1990, METHOD ENZYMOL, V187, P296; Stark KD, 2007, LIPIDS HEALTH DIS, V6, DOI 10.1186/1476-511X-6-13; Svensson CI, 2007, J EXP MED, V204, P245, DOI 10.1084/jem.20061826; Tsuji M, 2003, PROSTAG LEUKOTR ESS, V68, P337, DOI 10.1016/S0952-3278(03)00025-5; Viswanadhan VN, 2002, CURR OPIN DRUG DISC, V5, P400; WINTER CA, 1962, P SOC EXP BIOL MED, V111, P544	62	56	67	1	9	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					14744	14759		10.1074/jbc.M809014200	http://dx.doi.org/10.1074/jbc.M809014200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19324874	hybrid, Green Published			2022-12-27	WOS:000266288200010
J	Vanhoorelbeke, K; De Meyer, SF; Pareyn, I; Melchior, C; Plancon, S; Margue, C; Pradier, O; Fondu, P; Kieffer, N; Springer, TA; Deckmyn, H				Vanhoorelbeke, Karen; De Meyer, Simon F.; Pareyn, Inge; Melchior, Chantal; Plancon, Sebastien; Margue, Christiane; Pradier, Olivier; Fondu, Pierre; Kieffer, Nelly; Springer, Timothy A.; Deckmyn, Hans			The Novel S527F Mutation in the Integrin beta 3 Chain Induces a High Affinity alpha IIb beta 3 Receptor by Hindering Adoption of the Bent Conformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISULFIDE BOND DISRUPTION; CYSTEINE-RICH REPEAT; CRYSTAL-STRUCTURE; EXTRACELLULAR SEGMENT; STRUCTURAL BASIS; POINT MUTATION; ACTIVATION; LIGAND; DOMAIN; ALPHA(IIB)BETA(3)	Three heterozygous mutations were identified in the genes encoding platelet integrin receptor alpha IIb beta 3 in a patient with an ill defined platelet disorder: one in the beta 3 gene (S527F) and two in the alpha IIb gene (R512W and L841M). Five stable Chinese hamster ovary cell lines were constructed expressing recombinant alpha IIb beta 3 receptors bearing the individual R512W, L841M, or S527F mutation; both the R512W and L841M mutations; or all three mutations. All receptors were expressed on the cell surface, and mutations R512W and L841M had no effect on integrin function. Interestingly, the beta 3 S527F mutation produced a constitutively active receptor. Indeed, both fibrinogen and the ligand-mimetic antibody PAC-1 bound to non-activated alpha IIb beta 3 receptors carrying the S527F mutation, indicating that the conformation of this receptor was altered and corresponded to the high affinity ligand binding state. In addition, the conformational change induced by S527F was evident from basal anti-ligand-induced binding site antibody binding to the receptor. A molecular model bearing this mutation was constructed based on the crystal structure of alpha IIb beta 3 and revealed that the S527F mutation, situated in the third integrin epidermal growth factor-like (I-EGF3) domain, hindered the alpha IIb beta 3 receptor from adopting a wild type-like bent conformation. Movement of I-EGF3 into a cleft in the bent conformation may be hampered both by steric hindrance between Phe(527) in beta 3 and the calf-1 domain in alpha IIb and by decreased flexibility between I-EGF2 and I-EGF3.	[Vanhoorelbeke, Karen; De Meyer, Simon F.; Pareyn, Inge; Deckmyn, Hans] Katholieke Univ Leuven, Lab Thrombosis Res, Interdisciplinary Res Ctr, B-8500 Kortrijk, Belgium; [Melchior, Chantal; Plancon, Sebastien; Margue, Christiane; Kieffer, Nelly] Univ Luxembourg, Lab Biol & Physiol Integree, CNRS, GDRE ITI, L-1511 Luxembourg, Luxembourg; [Fondu, Pierre] Univ Libre Bruxelles, Ctr Hosp Univ Brugmann, B-1050 Brussels, Belgium; [Pradier, Olivier] Univ Libre Bruxelles, Hop Erasme, B-1050 Brussels, Belgium; [Springer, Timothy A.] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA	KU Leuven; University of Luxembourg; Universite Libre de Bruxelles; Universite Libre de Bruxelles; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School	Vanhoorelbeke, K (corresponding author), Katholieke Univ Leuven, Lab Thrombosis Res, Interdisciplinary Res Ctr, Campus Kortrijk,E Sabbelaan 53, B-8500 Kortrijk, Belgium.	Karen.Vanhoorelbeke@kuleuven-kortrijk.be	Deckmyn, Hans/L-9434-2015; Deckmyn, Hans/N-8932-2019	Deckmyn, Hans/0000-0003-3952-5501; Deckmyn, Hans/0000-0003-3952-5501; Vanhoorelbeke, Karen/0000-0003-2288-8277; De Meyer, Simon/0000-0002-1807-5882	National Institutes of Health [HL48675]; Katholieke Universiteit Leuven [GOA/2004/09]; European Union-RTN [HPRN-CT-2002-00253]; "Fonds voor Wetenschappelijk Onderzoek Vlaanderen" Belgium	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Katholieke Universiteit Leuven(KU Leuven); European Union-RTN(European Commission); "Fonds voor Wetenschappelijk Onderzoek Vlaanderen" Belgium(FWO)	This work was supported, in whole or in part, by National Institutes of Health Grant HL48675. This work was also supported by Katholieke Universiteit Leuven Grant GOA/2004/09 and European Union-RTN Grant HPRN-CT-2002-00253.; Postdoctoral Fellow supported by the "Fonds voor Wetenschappelijk Onderzoek Vlaanderen" Belgium.	Beglova N, 2002, NAT STRUCT BIOL, V9, P282, DOI 10.1038/nsb779; Chen P, 2001, J BIOL CHEM, V276, P38628, DOI 10.1074/jbc.M105737200; FRELINGER AL, 1990, J BIOL CHEM, V265, P6346; FRELINGER AL, 1991, J BIOL CHEM, V266, P17106; Ghevaert C, 2008, BLOOD, V111, P3407, DOI 10.1182/blood-2007-09-112615; Kamata T, 2004, BIOCHEM J, V378, P1079, DOI 10.1042/BJ20031701; Kashiwagi H, 1999, BLOOD, V93, P2559, DOI 10.1182/blood.V93.8.2559.408k12_2559_2568; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Ma YQ, 2007, J THROMB HAEMOST, V5, P1345, DOI 10.1111/j.1538-7836.2007.02537.x; Mor-Cohen R, 2007, THROMB HAEMOSTASIS, V98, P1257, DOI 10.1160/TH07-04-0248; Mor-Cohen R, 2008, J BIOL CHEM, V283, P19235, DOI 10.1074/jbc.M802399200; Morel-Kopp MC, 2001, THROMB HAEMOSTASIS, V86, P1425; Plancon S, 2001, BIOCHEM J, V357, P529, DOI 10.1042/0264-6021:3570529; Ruiz C, 2001, BLOOD, V98, P2432, DOI 10.1182/blood.V98.8.2432; Schaffner-Reckinger E, 1998, J BIOL CHEM, V273, P12623, DOI 10.1074/jbc.273.20.12623; Shattil SJ, 2004, BLOOD, V104, P1606, DOI 10.1182/blood-2004-04-1257; SHATTIL SJ, 1985, J BIOL CHEM, V260, P1107; Shi ML, 2007, J BIOL CHEM, V282, P30198, DOI 10.1074/jbc.M701670200; Shi ML, 2005, J BIOL CHEM, V280, P30586, DOI 10.1074/jbc.M502525200; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018; ZUCKER MB, 1984, THROMB HAEMOSTASIS, V51, P119	24	17	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					14914	14920		10.1074/jbc.M809167200	http://dx.doi.org/10.1074/jbc.M809167200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19329429	Green Published, hybrid			2022-12-27	WOS:000266288200027
J	Bonini, MG; Gabel, SA; Ranguelova, K; Stadler, K; DeRose, EF; London, RE; Mason, RP				Bonini, Marcelo G.; Gabel, Scott A.; Ranguelova, Kalina; Stadler, Krisztian; DeRose, Eugene F.; London, Robert E.; Mason, Ronald P.			Direct Magnetic Resonance Evidence for Peroxymonocarbonate Involvement in the Cu,Zn-Superoxide Dismutase Peroxidase Catalytic Cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; ZINC SUPEROXIDE-DISMUTASE; CARBONATE-RADICAL-ANION; HYDROGEN-PEROXIDE; HYDROPEROXIDE ANION; NITROGEN-DIOXIDE; AQUEOUS-SOLUTION; ALPHA-SYNUCLEIN; MOTOR-NEURONS; HUMAN COPPER	Cu,Zn-superoxide dismutase (SOD1) is a copper- and zinc-dependent enzyme. The main function of SOD1 is believed to be the scavenging and detoxification of superoxide radicals. Nevertheless, the last 30 years have seen a rapid accumulation of evidence indicating that SOD1 may also act as a peroxidase, an alternative function that was implicated in the onset and progression of familial amyotrophic lateral sclerosis. Although SOD1 peroxidase activity and its dependence on carbon dioxide have been well described, the molecular basis of the SOD1 peroxidase cycle remains obscure, because none of the proposed catalytic intermediates have so far been identified. In view of recent observations, we hypothesized that the SOD1 peroxidase cycle relies on two steps: 1) reduction of SOD-Cu(II) by hydrogen peroxide followed by 2) oxidation of SOD-Cu(I) by peroxy-monocarbonate, the product of the spontaneous reaction of bicarbonate with hydrogen peroxide, to produce SOD-Cu(II) and carbonate radical anion. This hypothesis has been investigated through electron paramagnetic resonance and nuclear magnetic resonance to provide direct evidence for a peroxycarbonate-driven, SOD1-catalyzed carbonate radical production. The results gathered herein indicate that peroxymonocarbonate (HOOCO2-) is a key intermediate in the SOD1 peroxidase cycle and identify this species as the precursor of carbonate radical anions.	[Bonini, Marcelo G.; Ranguelova, Kalina; Stadler, Krisztian; Mason, Ronald P.] NIEHS, Pharmacol Lab, Natl Inst Hlth, Res Triangle Pk, NC 27709 USA; [Gabel, Scott A.; DeRose, Eugene F.; London, Robert E.] NIEHS, Struct Biol Lab, Natl Inst Hlth, Res Triangle Pk, NC 27709 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Bonini, MG (corresponding author), NIEHS, Pharmacol Lab, Natl Inst Hlth, MD F0-02,POB 12233, Res Triangle Pk, NC 27709 USA.	bonini@niehs.nih.gov	London, Robert E/F-7990-2019; Mason, Ronald P/G-5967-2019; Stadler, Krisztian/N-1992-2017	London, Robert E/0000-0001-9108-8463; Mason, Ronald P/0000-0002-1859-9109; 	National Institutes of Health; NIEHS; Intramural Research Program; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES050139, Z01ES050110, Z01ES050139, ZIAES050110] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Intramural Research Program; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by the National Institutes of Health, NIEHS, Intramural Research Program.	Andrekopoulos C, 2004, BIOCHEM J, V378, P435, DOI 10.1042/BJ20031466; Augusto O, 2002, FREE RADICAL BIO MED, V32, P841, DOI 10.1016/S0891-5849(02)00786-4; BECKMAN JS, 1993, NATURE, V364, P584, DOI 10.1038/364584a0; Bennett DA, 2001, INORG CHEM, V40, P2996, DOI 10.1021/ic000910h; BIELSKI BHJ, 1985, J PHYS CHEM REF DATA, V14, P1041, DOI 10.1063/1.555739; BLECH DM, 1983, ARCH BIOCHEM BIOPHYS, V224, P579, DOI 10.1016/0003-9861(83)90245-X; Boillee S, 2006, SCIENCE, V312, P1389, DOI 10.1126/science.1123511; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; BOLANN BJ, 1992, BIOCHIM BIOPHYS ACTA, V1156, P27, DOI 10.1016/0304-4165(92)90091-8; Bonini MG, 2004, J BIOL CHEM, V279, P51836, DOI 10.1074/jbc.M406929200; Bonini MG, 2004, BIOCHEMISTRY-US, V43, P344, DOI 10.1021/bi035606p; BORS W, 1991, FREE RADICAL RES COM, V12-3, P411, DOI 10.3109/10715769109145811; BUXTON GV, 1988, J PHYS CHEM REF DATA, V17, P513, DOI 10.1063/1.555805; CHEN S, 1973, J PHYS CHEM-US, V77, P111; Dean J.A., 1979, LANGES HDB CHEM, Vtwelth, P5; Durham HD, 1997, J NEUROPATH EXP NEUR, V56, P523, DOI 10.1097/00005072-199705000-00008; Elam JS, 2003, J BIOL CHEM, V278, P21032, DOI 10.1074/jbc.M300484200; FERRAUDI G, 1993, J PHYS CHEM-US, V97, P11929, DOI 10.1021/j100148a014; FUCHS HJR, 1983, BIOCHEM BIOPH RES CO, V116, P1107, DOI 10.1016/S0006-291X(83)80256-3; Goss SPA, 1999, J BIOL CHEM, V274, P28233, DOI 10.1074/jbc.274.40.28233; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Hall ED, 1998, J NEUROSCI RES, V53, P66, DOI 10.1002/(SICI)1097-4547(19980701)53:1<66::AID-JNR7>3.3.CO;2-K; Hayward LJ, 2002, J BIOL CHEM, V277, P15923, DOI 10.1074/jbc.M112087200; Hensley K, 2006, ANTIOXID REDOX SIGN, V8, P2075, DOI 10.1089/ars.2006.8.2075; HODGSON EK, 1973, BIOCHEM BIOPH RES CO, V54, P270, DOI 10.1016/0006-291X(73)90918-2; Hough MA, 2004, P NATL ACAD SCI USA, V101, P5976, DOI 10.1073/pnas.0305143101; Jewett SL, 2000, BIOCHEM BIOPH RES CO, V274, P57, DOI 10.1006/bbrc.2000.3092; Karunakaran C, 2004, J BIOL CHEM, V279, P32534, DOI 10.1074/jbc.M314272200; Leinweber B, 2004, FREE RADICAL BIO MED, V36, P911, DOI 10.1016/j.freeradbiomed.2003.12.021; Liochev SI, 2002, J BIOL CHEM, V277, P34674, DOI 10.1074/jbc.M204726200; Liochev SI, 2004, P NATL ACAD SCI USA, V101, P743, DOI 10.1073/pnas.0307635100; Liochev SI, 2004, ARCH BIOCHEM BIOPHYS, V421, P255, DOI 10.1016/j.abb.2003.11.015; Liochev SI, 2007, FREE RADICAL BIO MED, V42, P1465, DOI 10.1016/j.freeradbiomed.2007.02.015; Lynch SM, 2004, BIOCHEMISTRY-US, V43, P16525, DOI 10.1021/bi048831v; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Medinas DB, 2007, IUBMB LIFE, V59, P255, DOI 10.1080/15216540701230511; MEDINAS DB, 2009, CHEM RES TO IN PRESS; Mendes P, 1997, TRENDS BIOCHEM SCI, V22, P361, DOI 10.1016/S0968-0004(97)01103-1; MENDES P, 1993, COMPUT APPL BIOSCI, V9, P563; Okado-Matsumoto A, 2001, J BIOL CHEM, V276, P38388, DOI 10.1074/jbc.M105395200; Potter SZ, 2003, J BIOL INORG CHEM, V8, P373, DOI 10.1007/s00775-003-0447-6; RABANI J, 1973, J PHYS CHEM-US, V77, P1169, DOI 10.1021/j100628a018; Ramirez DC, 2005, FREE RADICAL BIO MED, V38, P201, DOI 10.1016/j.freeradbiomed.2004.10.008; Ramirez DC, 2005, J BIOL CHEM, V280, P27402, DOI 10.1074/jbc.M504241200; Richardson DE, 2003, FREE RADICAL BIO MED, V35, P1538, DOI 10.1016/j.freeradbiomed.2003.08.019; Roberts BR, 2007, J MOL BIOL, V373, P877, DOI 10.1016/j.jmb.2007.07.043; Roe JA, 2002, FREE RADICAL BIO MED, V32, P169, DOI 10.1016/S0891-5849(01)00778-X; Singh RJ, 1998, P NATL ACAD SCI USA, V95, P6675, DOI 10.1073/pnas.95.12.6675; Stathopulos PB, 2003, P NATL ACAD SCI USA, V100, P7021, DOI 10.1073/pnas.1237797100; Trindade DF, 2006, CHEM RES TOXICOL, V19, P1475, DOI 10.1021/tx060146x; Yao HR, 2003, J AM CHEM SOC, V125, P6211, DOI 10.1021/ja0274756; YIM MB, 1990, P NATL ACAD SCI USA, V87, P5006, DOI 10.1073/pnas.87.13.5006; Yim MB, 1996, P NATL ACAD SCI USA, V93, P5709, DOI 10.1073/pnas.93.12.5709; Zhang H, 2000, J BIOL CHEM, V275, P14038, DOI 10.1074/jbc.275.19.14038; Zhang H, 2004, FREE RADICAL BIO MED, V36, P1355, DOI 10.1016/j.freeradbiomed.2004.02.038	55	21	24	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14618	14627		10.1074/jbc.M804644200	http://dx.doi.org/10.1074/jbc.M804644200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19286663	Green Published, hybrid			2022-12-27	WOS:000266286100067
J	Covian, R; Trumpower, BL				Covian, Raul; Trumpower, Bernard L.			The Rate-limiting Step in the Cytochrome bc(1) Complex (Ubiquinol-Cytochrome c Oxidoreductase) Is Not Changed by Inhibition of Cytochrome b-dependent Deprotonation IMPLICATIONS FOR THE MECHANISM OF UBIQUINOL OXIDATION AT CENTER P OF THE bc(1) COMPLEX	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IRON-SULFUR PROTEIN; SUPEROXIDE-PRODUCTION; ELECTRON-TRANSFER; QUINOL OXIDATION; Q(O) SITE; Q-CYCLE; SACCHAROMYCES-CEREVISIAE; MITOCHONDRIAL; BINDING; SOLUBILIZATION	Quinol oxidation at center P of the cytochrome bc(1) complex involves bifurcated electron transfer to the Rieske iron-sulfur protein and cytochrome b. It is unknown whether both electrons are transferred from the same domain close to the Rieske protein, or if an unstable semiquinone anion intermediate diffuses rapidly to the vicinity of the b(L) heme. We have determined the pre-steady state rate and activation energy (E-a) for quinol oxidation in purified yeast bc(1) complexes harboring either a Y185F mutation in the Rieske protein, which decreases the redox potential of the FeS cluster, or a E272Q cytochrome b mutation, which eliminates the proton acceptor in cytochrome b. The rate of the bifurcated reaction in the E272Q mutant (< 10% of the wild type) was even lower than that of the Y185F enzyme (similar to 20% of the wild type). However, the E272Q enzyme showed the same E-a (61 kJ mol(-1)) with respect to the wild type (62 kJ mol(-1)), in contrast with the Y185F mutation, which increased Ea to 73 kJ mol(-1). The rate and E-a of the slow reaction of quinol with oxygen that are observed after cytochrome b is reduced were unaffected by the E272Q substitution, whereas the Y185F mutation modified only its rate. The Y185F/E272Q double mutation resulted in a synergistic decrease in the rate of quinol oxidation (0.7% of the wild type). These results are inconsistent with a sequential "movable semiquinone" mechanism but are consistent with a model in which both electrons are transferred simultaneously from the same domain in center P.	[Covian, Raul; Trumpower, Bernard L.] Dartmouth Med Sch, Dept Biochem, Hanover, NH 03755 USA	Dartmouth College	Trumpower, BL (corresponding author), Dartmouth Med Sch, Dept Biochem, 7200 Vail, Hanover, NH 03755 USA.	Trumpower@Dartmouth.edu			National Institutes of Health Research [GM 20379]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM020379, R01GM020379] Funding Source: NIH RePORTER	National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Research Grant GM 20379.	BERDEN JA, 1970, BIOCHIM BIOPHYS ACTA, V216, P237, DOI 10.1016/0005-2728(70)90215-X; Berry EA, 2003, FEBS LETT, V555, P13, DOI 10.1016/S0014-5793(03)01099-8; Cape JL, 2005, J AM CHEM SOC, V127, P4208, DOI 10.1021/ja043955g; Cape JL, 2007, P NATL ACAD SCI USA, V104, P7887, DOI 10.1073/pnas.0702621104; Covian R, 2004, J BIOL CHEM, V279, P15040, DOI 10.1074/jbc.M400193200; Covian R, 2007, J BIOL CHEM, V282, P22289, DOI 10.1074/jbc.M702132200; Crofts AR, 2006, BBA-BIOENERGETICS, V1757, P1019, DOI 10.1016/j.bbabio.2006.02.009; Crofts AR, 1999, BIOCHEMISTRY-US, V38, P15807, DOI 10.1021/bi990962m; CROFTS AR, 1989, PHOTOSYNTH RES, V22, P69, DOI 10.1007/BF00114768; Denke E, 1998, J BIOL CHEM, V273, P9085, DOI 10.1074/jbc.273.15.9085; Drose S, 2008, J BIOL CHEM, V283, P21649, DOI 10.1074/jbc.M803236200; Esser L, 2006, P NATL ACAD SCI USA, V103, P13045, DOI 10.1073/pnas.0601149103; Forquer I, 2006, J BIOL CHEM, V281, P38459, DOI 10.1074/jbc.M605119200; Gutierrez-Cirlos EB, 2002, J BIOL CHEM, V277, P1195, DOI 10.1074/jbc.M109097200; HELENIUS A, 1975, BIOCHIM BIOPHYS ACTA, V415, P29, DOI 10.1016/0304-4157(75)90016-7; HUMPHREYS KJ, 1968, J PHARM SCI-US, V57, P79, DOI 10.1002/jps.2600570115; Hunte C, 2000, STRUCTURE, V8, P669, DOI 10.1016/S0969-2126(00)00152-0; Kessl JJ, 2007, BBA-BIOENERGETICS, V1767, P319, DOI 10.1016/j.bbabio.2007.02.014; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Link TA, 1997, FEBS LETT, V412, P257, DOI 10.1016/S0014-5793(97)00772-2; LJUNGDAHL P O, 1987, Biochimica et Biophysica Acta, V891, P227, DOI 10.1016/0005-2728(87)90218-0; Margoliash E, 1967, METHOD ENZYMOL, V10, P339; MITCHELL P, 1976, J THEOR BIOL, V62, P327, DOI 10.1016/0022-5193(76)90124-7; Muller F, 2002, BIOCHEMISTRY-US, V41, P7866, DOI 10.1021/bi025581e; Osyczka A, 2004, NATURE, V427, P607, DOI 10.1038/nature02242; Palsdottir H, 2003, J BIOL CHEM, V278, P31303, DOI 10.1074/jbc.M302195200; Rich PR, 2004, BBA-BIOENERGETICS, V1658, P165, DOI 10.1016/j.bbabio.2004.04.021; RICH PR, 1984, BIOCHIM BIOPHYS ACTA, V768, P53, DOI 10.1016/0304-4173(84)90007-7; Seddiki N, 2008, BIOCHEMISTRY-US, V47, P2357, DOI 10.1021/bi701905a; Snyder C, 1998, BBA-BIOENERGETICS, V1365, P125, DOI 10.1016/S0005-2728(98)00052-8; TRUMPOWER BL, 1979, J BIOL CHEM, V254, P8697; TRUMPOWER BL, 1994, ANNU REV BIOCHEM, V63, P675, DOI 10.1146/annurev.bi.63.070194.003331; VONJAGOW G, 1986, METHOD ENZYMOL, V126, P253; Wenz T, 2006, BIOCHEMISTRY-US, V45, P9042, DOI 10.1021/bi060280g; YU CA, 1972, J BIOL CHEM, V247, P1012; Zhang HB, 2007, BBA-BIOENERGETICS, V1767, P883, DOI 10.1016/j.bbabio.2007.04.004; Zhu J, 2007, P NATL ACAD SCI USA, V104, P4864, DOI 10.1073/pnas.0607812104	37	12	12	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14359	14367		10.1074/jbc.M109.000596	http://dx.doi.org/10.1074/jbc.M109.000596			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19325183	Green Published, hybrid			2022-12-27	WOS:000266286100042
J	Irie, N; Takada, Y; Watanabe, Y; Matsuzaki, Y; Naruse, C; Asano, M; Iwakura, Y; Suda, T; Matsuo, K				Irie, Naoko; Takada, Yasunari; Watanabe, Yoshihiko; Matsuzaki, Yumi; Naruse, Chie; Asano, Masahide; Iwakura, Yoichiro; Suda, Toshio; Matsuo, Koichi			Bidirectional Signaling through EphrinA2-EphA2 Enhances Osteoclastogenesis and Suppresses Osteoblastogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHOLIPASE-C-GAMMA; GENE-EXPRESSION; STIMULATING-FACTOR; BONE HOMEOSTASIS; KEY REGULATOR; ACTIVATION; FOS; DIFFERENTIATION; PROTEINS; CLEAVAGE	Bone is remodeled constantly throughout life by bone-resorbing osteoclasts and bone-forming osteoblasts. To maintain bone volume and quality, differentiation of osteoclasts and osteoblasts is tightly regulated through communication between and within these two cell lineages. Previously we reported that cell-cell interaction mediated by ephrinB2 ligand on osteoclasts and EphB4 receptor on osteoblasts generates bidirectional anti-osteoclastogenic and pro-osteoblastogenic signals into respective cells and presumably facilitates transition from bone resorption to bone formation. Here we show that bidirectional ephrinA2-EphA2 signaling regulates bone remodeling at the initiation phase. EphrinA2 expression was rapidly induced by receptor activator of NF-kappa B ligand in osteoclast precursors; this was dependent on the transcription factor c-Fos but independent of the c-Fos target gene product NFATc1. Receptor EphA2 was expressed in osteoclast precursors and osteoblasts. Overexpression experiments revealed that both ephrinA2 and EphA2 in osteoclast precursors enhanced differentiation of multinucleated osteoclasts and that phospholipase C gamma 2 may mediate ephrinA2 reverse signaling. Moreover, ephrinA2 on osteoclasts was cleaved by metalloproteinases, and ephrinA2 released in the culture medium enhanced osteoclastogenesis. Interestingly, differentiation of osteoblasts lacking EphA2 was enhanced along with alkaline phosphatase, Runx2, and Osterix expression, indicating that EphA2 on osteoblasts generates anti-osteoblastogenic signals presumably by up-regulating RhoA activity. Therefore, ephrinA2-EphA2 interaction facilitates the initiation phase of bone remodeling by enhancing osteoclast differentiation and suppressing osteoblast differentiation.	[Irie, Naoko; Takada, Yasunari; Watanabe, Yoshihiko; Matsuo, Koichi] Keio Univ, Sch Med, Dept Microbiol & Immunol, Tokyo 1608582, Japan; [Irie, Naoko; Watanabe, Yoshihiko; Suda, Toshio] Keio Univ, Sch Med, Sakaguchi Lab Dev Biol, Tokyo 1608582, Japan; [Matsuzaki, Yumi] Keio Univ, Sch Med, Dept Physiol, Tokyo 1608582, Japan; [Naruse, Chie; Asano, Masahide] Kanazawa Univ, Adv Sci Res Ctr, Div Transgen Anim Sci, Kanazawa, Ishikawa 9208640, Japan; [Iwakura, Yoichiro] Univ Tokyo, Inst Med Sci, Ctr Med Expt, Tokyo 1088639, Japan	Keio University; Keio University; Keio University; Kanazawa University; University of Tokyo	Matsuo, K (corresponding author), 35 Shinanomachi,Shinjuku Ku, Tokyo 1608582, Japan.	matsuo@sc.itc.keio.ac.jp	Suda, Toshio/H-6761-2013; Matsuo, Koichi/K-5695-2012; Iwakura, Yoichiro/E-5457-2011	Suda, Toshio/0000-0001-7540-1771; Matsuo, Koichi/0000-0002-1490-8955; Iwakura, Yoichiro/0000-0002-9934-5775; Matsuzaki, Yumi/0000-0002-3729-2997	Keio University;  [20-5884]	Keio University; 	This work was supported by Grant-in-aid for Japan Society for the Promotion of Science Fellows 20-5884, by a Keio University grant-in-aid for Encouragement of Young Medical Scientists, The 21st Century COE Program at Keio University, and by Medical School Faculty and Alumni Grants of the Keio University Medical Science Fund, Tokyo.	Allan EH, 2008, J BONE MINER RES, V23, P1170, DOI 10.1359/JBMR.080324; Arvanitis D, 2008, GENE DEV, V22, P416, DOI 10.1101/gad.1630408; Asagiri M, 2005, J EXP MED, V202, P1261, DOI 10.1084/jem.20051150; Bakiri L, 2007, BONE, V40, P867, DOI 10.1016/j.bone.2006.11.005; Carter N, 2002, NAT CELL BIOL, V4, P565, DOI 10.1038/ncb823; Chen YB, 2008, J BIOL CHEM, V283, P29593, DOI 10.1074/jbc.M802493200; Choi SJ, 2001, J BONE MINER RES, V16, P814, DOI 10.1359/jbmr.2001.16.5.814; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Hattori M, 2000, SCIENCE, V289, P1360, DOI 10.1126/science.289.5483.1360; Holmberg J, 2005, GENE DEV, V19, P462, DOI 10.1101/gad.326905; Ishida N, 2002, J BIOL CHEM, V277, P41147, DOI 10.1074/jbc.M205063200; Janes PW, 2005, CELL, V123, P291, DOI 10.1016/j.cell.2005.08.014; Karsenty G, 2002, DEV CELL, V2, P389, DOI 10.1016/S1534-5807(02)00157-0; Kuroda C, 2008, BIOCHEM BIOPH RES CO, V374, P22, DOI 10.1016/j.bbrc.2008.06.089; Kuroda Y, 2008, P NATL ACAD SCI USA, V105, P8643, DOI 10.1073/pnas.0800642105; Mao DL, 2006, J CLIN INVEST, V116, P2869, DOI 10.1172/JCI28775; Marquardt T, 2005, CELL, V121, P127, DOI 10.1016/j.cell.2005.01.020; Matsuo K, 2004, J BIOL CHEM, V279, P26475, DOI 10.1074/jbc.M313973200; Matsuo K, 2008, ARCH BIOCHEM BIOPHYS, V473, P201, DOI 10.1016/j.abb.2008.03.027; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Nakamura I, 2001, J CELL BIOL, V152, P361, DOI 10.1083/jcb.152.2.361; Naruse-Nakajima C, 2001, MECH DEVELOP, V102, P95, DOI 10.1016/S0925-4773(01)00290-8; Nishiwaki T, 2006, J BONE MINER RES, V21, P596, DOI 10.1359/JBMR.051216; Pasquale EB, 2008, CELL, V133, P38, DOI 10.1016/j.cell.2008.03.011; SELANDER K, 1994, CALCIFIED TISSUE INT, V55, P368, DOI 10.1007/BF00299317; Suzuki KGN, 2007, J CELL BIOL, V177, P731, DOI 10.1083/jcb.200609175; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Tanaka M, 2005, J BIOL CHEM, V280, P42375, DOI 10.1074/jbc.M503786200; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Verrier S, 2004, BONE, V35, P34, DOI 10.1016/j.bone.2003.12.029; Zhao C, 2006, CELL METAB, V4, P111, DOI 10.1016/j.cmet.2006.05.012; Zhou L, 2007, J NEUROSCI, V27, P5127, DOI 10.1523/JNEUROSCI.1170-07.2007	32	131	148	3	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14637	14644		10.1074/jbc.M807598200	http://dx.doi.org/10.1074/jbc.M807598200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19299512	hybrid, Green Published			2022-12-27	WOS:000266286100069
J	Dagda, RK; Cherra, SJ; Kulich, SM; Tandon, A; Park, D; Chu, CT				Dagda, Ruben K.; Cherra, Salvatore J., III; Kulich, Scott M.; Tandon, Anurag; Park, David; Chu, Charleen T.			Loss of PINK1 Function Promotes Mitophagy through Effects on Oxidative Stress and Mitochondrial Fission	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; PARKINSONS-DISEASE; CELL-DEATH; RECESSIVE PARKINSONISM; DOPAMINERGIC-NEURONS; ALZHEIMERS-DISEASE; MAMMALIAN-CELLS; SH-SY5Y CELLS; AUTOPHAGY; MUTATIONS	Mitochondrial dysregulation is strongly implicated in Parkinson disease. Mutations in PTEN-induced kinase 1 (PINK1) are associated with familial parkinsonism and neuropsychiatric disorders. Although overexpressed PINK1 is neuroprotective, less is known about neuronal responses to loss of PINK1 function. We found that stable knockdown of PINK1 induced mitochondrial fragmentation and autophagy in SH-SY5Y cells, which was reversed by the reintroduction of an RNA interference (RNAi)-resistant plasmid for PINK1. Moreover, stable or transient overexpression of wild-type PINK1 increased mitochondrial interconnectivity and suppressed toxin-induced autophagy/mitophagy. Mitochondrial oxidant production played an essential role in triggering mitochondrial fragmentation and autophagy in PINK1 shRNA lines. Autophagy/mitophagy served a protective role in limiting cell death, and overexpressing Parkin further enhanced this protective mitophagic response. The dominant negative Drp1 mutant inhibited both fission and mitophagy in PINK1-deficient cells. Interestingly, RNAi knockdown of autophagy proteins Atg7 and LC3/Atg8 also decreased mitochondrial fragmentation without affecting oxidative stress, suggesting active involvement of autophagy in morphologic remodeling of mitochondria for clearance. To summarize, loss of PINK1 function elicits oxidative stress and mitochondrial turnover coordinated by the autophagic and fission/fusion machineries. Furthermore, PINK1 and Parkin may cooperate through different mechanisms to maintain mitochondrial homeostasis.	[Dagda, Ruben K.; Cherra, Salvatore J., III; Kulich, Scott M.; Chu, Charleen T.] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15213 USA; [Chu, Charleen T.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA 15213 USA; [Kulich, Scott M.] Vet Affairs Pittsburgh Healthcare Syst, Pittsburgh, PA 15240 USA; [Tandon, Anurag] Univ Toronto, Ctr Res Neurodegenerat Dis, Toronto, ON M55 3H2, Canada; [Park, David] Univ Ottawa, Neurosci Grp, Ottawa Hlth Res Inst, Ottawa, ON K1H 8M5, Canada	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Pittsburgh Healthcare System; University of Toronto; University of Ottawa; Ottawa Hospital Research Institute	Chu, CT (corresponding author), Univ Pittsburgh, Dept Pathol, 200 Lothrop St, Pittsburgh, PA 15261 USA.	ctc4@pitt.edu	Chu, Charleen T/B-1601-2008	Chu, Charleen T/0000-0002-5052-8271; Dagda, Ruben/0000-0002-9946-9591; Park, David/0000-0002-4490-3784	National Institutes of Health [AG026389, DC009120, NS053777, F32 AG030821]; Pittsburgh Foundation, Emmerling Fund; American Parkinson Disease Association; Veterans Administration Advanced Career Development Award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS053777] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [F32AG030821, R01AG026389] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [K18DC009120] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pittsburgh Foundation, Emmerling Fund; American Parkinson Disease Association; Veterans Administration Advanced Career Development Award; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grants AG026389, DC009120, and NS053777 ( to C. T. C.). This work was also supported by grants from the Pittsburgh Foundation, Emmerling Fund ( to C. T. C.), the American Parkinson Disease Association ( to S. M. K.), and a Veterans Administration Advanced Career Development Award ( to S. M. K.).; Supported in part by National Institutes of Health Grant F32 AG030821.	Abeliovich A, 2006, J NEUROCHEM, V99, P1062, DOI 10.1111/j.1471-4159.2006.04102.x; Beilina A, 2005, P NATL ACAD SCI USA, V102, P5703, DOI 10.1073/pnas.0500617102; Betarbet R, 2002, BRAIN PATHOL, V12, P499; Bove Jordi, 2005, NeuroRx, V2, P484, DOI 10.1602/neurorx.2.3.484; Chang CR, 2007, J BIOL CHEM, V282, P21583, DOI 10.1074/jbc.C700083200; Cherra SJ, 2008, FUTUR NEUROL, V3, P309, DOI 10.2217/14796708.3.3.309; Chu CT, 2007, AUTOPHAGY, V3, P663, DOI 10.4161/auto.4625; Chu CT, 2009, METHOD ENZYMOL, V453, P217, DOI 10.1016/S0076-6879(08)04011-1; Clark IE, 2006, NATURE, V441, P1162, DOI 10.1038/nature04779; Cribbs JT, 2007, EMBO REP, V8, P939, DOI 10.1038/sj.embor.7401062; Dagda RK, 2008, AUTOPHAGY, V4, P770, DOI 10.4161/auto.6458; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; Deng H, 2005, BIOCHEM BIOPH RES CO, V337, P1133, DOI 10.1016/j.bbrc.2005.09.178; Exner N, 2007, J NEUROSCI, V27, P12413, DOI 10.1523/JNEUROSCI.0719-07.2007; Gautier CA, 2008, P NATL ACAD SCI USA, V105, P11364, DOI 10.1073/pnas.0802076105; Gomez-Lazaro M, 2008, FREE RADICAL BIO MED, V44, P1960, DOI 10.1016/j.freeradbiomed.2008.03.009; Haque ME, 2008, P NATL ACAD SCI USA, V105, P1716, DOI 10.1073/pnas.0705363105; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Hirai K, 2001, J NEUROSCI, V21, P3017, DOI 10.1523/JNEUROSCI.21-09-03017.2001; Hoepken HH, 2007, NEUROBIOL DIS, V25, P401, DOI 10.1016/j.nbd.2006.10.007; Jennings JJ, 2006, J BIOL CHEM, V281, P39041, DOI 10.1074/jbc.M607982200; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Karbowski M, 2002, J CELL BIOL, V159, P931, DOI 10.1083/jcb.200209124; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Komatsu M, 2007, P NATL ACAD SCI USA, V104, P14489, DOI 10.1073/pnas.0701311104; Kulich SM, 2007, FREE RADICAL BIO MED, V43, P372, DOI 10.1016/j.freeradbiomed.2007.04.028; Larsen KE, 2002, HISTOL HISTOPATHOL, V17, P897, DOI 10.14670/HH-17.897; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Patel MN, 2003, AGING CELL, V2, P219, DOI 10.1046/j.1474-9728.2003.00055.x; Petit A, 2005, J BIOL CHEM, V280, P34025, DOI 10.1074/jbc.M505143200; Plowey ED, 2008, J NEUROCHEM, V105, P1048, DOI 10.1111/j.1471-4159.2008.05217.x; Plun-Favreau H, 2007, NAT CELL BIOL, V9, P1243, DOI 10.1038/ncb1644; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Pridgeon JW, 2007, PLOS BIOL, V5, P1494, DOI 10.1371/journal.pbio.0050172; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Rideout HJ, 2004, INT J BIOCHEM CELL B, V36, P2551, DOI 10.1016/j.biocel.2004.05.008; Rodriguez-Enriquez S, 2006, AUTOPHAGY, V2, P39, DOI 10.4161/auto.2229; Silvestri L, 2005, HUM MOL GENET, V14, P3477, DOI 10.1093/hmg/ddi377; Sim CH, 2006, HUM MOL GENET, V15, P3251, DOI 10.1093/hmg/ddl398; Smirnova E, 2001, MOL BIOL CELL, V12, P2245, DOI 10.1091/mbc.12.8.2245; Tolkovsky AM, 2002, BIOCHIMIE, V84, P233, DOI 10.1016/S0300-9084(02)01371-8; Trimmer PA, 2000, EXP NEUROL, V162, P37, DOI 10.1006/exnr.2000.7333; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Valente EM, 2004, ANN NEUROL, V56, P336, DOI 10.1002/ana.20256; Wang DL, 2006, P NATL ACAD SCI USA, V103, P13520, DOI 10.1073/pnas.0604661103; Wang HL, 2007, NEUROBIOL DIS, V28, P216, DOI 10.1016/j.nbd.2007.07.010; Wood-Kaczmar A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002455; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yang Y, 2007, EUR J NEUROSCI, V26, P2979, DOI 10.1111/j.1460-9568.2007.05914.x; Yang YF, 2008, P NATL ACAD SCI USA, V105, P7070, DOI 10.1073/pnas.0711845105; Yang YF, 2006, P NATL ACAD SCI USA, V103, P10793, DOI 10.1073/pnas.0602493103; Zhang Y, 2007, AUTOPHAGY, V3, P337, DOI 10.4161/auto.4127; Zhou C, 2008, P NATL ACAD SCI USA, V105, P12022, DOI 10.1073/pnas.0802814105; Zhu JH, 2003, BRAIN PATHOL, V13, P473; Zhu JH, 2007, AM J PATHOL, V170, P75, DOI 10.2353/ajpath.2007.060524	60	716	729	0	95	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13843	13855		10.1074/jbc.M808515200	http://dx.doi.org/10.1074/jbc.M808515200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19279012	hybrid, Green Published			2022-12-27	WOS:000265877300061
J	Cho, HY; Cho, HJ; Kim, YM; Oh, JI; Kang, BS				Cho, Ha Yeon; Cho, Hyo Je; Kim, Young Min; Oh, Jeong Il; Kang, Beom Sik			Structural Insight into the Heme-based Redox Sensing by DosS from Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYGEN SENSOR; 2-COMPONENT SYSTEM; CRYSTAL-STRUCTURE; HYPOXIC RESPONSE; GAF DOMAINS; DEVS; BINDING; PROTEIN; MECHANISM; KINASES	Mycobacterium tuberculosis is thought to undergo transformation into its non-replicating persistence state under the influence of hypoxia or nitric oxide (NO). This transformation is thought to be mediated via two sensor histidine kinases, DosS and DosT, each of which contains two GAF domains that are responsible for detecting oxygen tension. In this study we determined the crystal structures of the first GAF domain (GAF-A) of DosS, which shows an interaction with a heme. A b-type heme was embedded in a hydrophobic cavity of the GAF-A domain and was roughly perpendicular to the beta-sheet of the GAF domain. The heme iron was liganded by His-149 at the proximal heme axial position. The iron, in the oxidized form, was six-coordinated with a water molecule at the distal position. Upon reduction, the iron, in ferrous form, was five-coordinated, and when the GAF domain was exposed to atmospheric O-2, the ferrous form was oxidized to generate the Met form rather than a ferrous O-2-bound form. Because the heme is isolated inside the GAF domain, its accessibility is restricted. However, a defined hydrogen bond network found at the heme site could accelerate the electron transferability and would explain why DosS was unable to bind O-2. Flavin nucleotides were shown to reduce the heme iron of DosS while NADH was unable to do so. These results suggest that DosS is a redox sensor and detects hypoxic conditions by its reduction.	[Cho, Ha Yeon; Cho, Hyo Je; Kang, Beom Sik] Kyungpook Natl Univ, Sch Life Sci & Biotechnol, Taegu 702701, South Korea; [Oh, Jeong Il] Pusan Natl Univ, Dept Microbiol, Pusan 609735, South Korea; [Kim, Young Min] Yonsei Univ, Dept Biol, Seoul 120749, South Korea	Kyungpook National University; Pusan National University; Yonsei University	Kang, BS (corresponding author), 1370 Sangyeok Dong, Taegu 702701, South Korea.	bskang2@knu.ac.kr			21C Frontier Microbial Genomics and Application Center Program; Ministry of Education Science, and Technology, Republic of Korea	21C Frontier Microbial Genomics and Application Center Program(Ministry of Education, Science & Technology (MEST), Republic of Korea); Ministry of Education Science, and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by the 21C Frontier Microbial Genomics and Application Center Program, Ministry of Education Science, and Technology, Republic of Korea.	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Dasgupta N, 2000, TUBERCLE LUNG DIS, V80, P141, DOI 10.1054/tuld.2000.0240; Delgado-Nixon VM, 2000, BIOCHEMISTRY-US, V39, P2685, DOI 10.1021/bi991911s; Ely Fernanda, 2008, BMC Biochemistry, V9, P13, DOI 10.1186/1471-2091-9-13; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gilles-Gonzalez MA, 2005, J INORG BIOCHEM, V99, P1, DOI 10.1016/j.jinorgbio.2004.11.006; Gong WM, 1998, P NATL ACAD SCI USA, V95, P15177, DOI 10.1073/pnas.95.26.15177; Ioanoviciu A, 2007, BIOCHEMISTRY-US, V46, P4250, DOI 10.1021/bi602422p; Kumar A, 2008, J BIOL CHEM, V283, P18032, DOI 10.1074/jbc.M802274200; Kumar A, 2007, P NATL ACAD SCI USA, V104, P11568, DOI 10.1073/pnas.0705054104; Lanzilotta WN, 2000, NAT STRUCT BIOL, V7, P876; Lee JM, 2008, J BACTERIOL, V190, P6795, DOI 10.1128/JB.00401-08; Martinez SE, 2005, P NATL ACAD SCI USA, V102, P3082, DOI 10.1073/pnas.0409913102; Martinez SE, 2002, P NATL ACAD SCI USA, V99, P13260, DOI 10.1073/pnas.192374899; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Parrish NM, 1998, TRENDS MICROBIOL, V6, P107, DOI 10.1016/S0966-842X(98)01216-5; Pellicena P, 2004, P NATL ACAD SCI USA, V101, P12854, DOI 10.1073/pnas.0405188101; Podust LM, 2008, BIOCHEMISTRY-US, V47, P12523, DOI 10.1021/bi8012356; Roberts DM, 2004, J BIOL CHEM, V279, P23082, DOI 10.1074/jbc.M401230200; Sardiwal S, 2005, J MOL BIOL, V353, P929, DOI 10.1016/j.jmb.2005.09.011; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Sherman DR, 2001, P NATL ACAD SCI USA, V98, P7534, DOI 10.1073/pnas.121172498; Shiloh MU, 2008, CELL HOST MICROBE, V3, P323, DOI 10.1016/j.chom.2008.03.007; Smulevich G, 1999, J BIOL INORG CHEM, V4, P39, DOI 10.1007/s007750050287; Sousa EHS, 2007, PROTEIN SCI, V16, P1708, DOI 10.1110/ps.072897707; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072; Voskuil MI, 2003, J EXP MED, V198, P705, DOI 10.1084/jem.20030205; Wayne LG, 2001, ANNU REV MICROBIOL, V55, P139, DOI 10.1146/annurev.micro.55.1.139; Yukl ET, 2007, BIOCHEMISTRY-US, V46, P9728, DOI 10.1021/bi7008695; Zhang W, 2003, STRUCTURE, V11, P1097, DOI 10.1016/S0969-2126(03)00169-2	34	80	82	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					13057	13067		10.1074/jbc.M808905200	http://dx.doi.org/10.1074/jbc.M808905200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19276084	hybrid, Green Published			2022-12-27	WOS:000265688300053
J	Allen, JM; Zamurs, L; Brachvogel, B; Schlotzer-Schrehardt, U; Hansen, U; Lamande, SR; Rowley, L; Fitzgerald, J; Bateman, JF				Allen, Justin M.; Zamurs, Laura; Brachvogel, Bent; Schloetzer-Schrehardt, Ursula; Hansen, Uwe; Lamande, Shireen R.; Rowley, Lynn; Fitzgerald, Jamie; Bateman, John F.			Mice Lacking the Extracellular Matrix Protein WARP Develop Normally but Have Compromised Peripheral Nerve Structure and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHONDROCYTE PERICELLULAR MATRIX; BASEMENT-MEMBRANES; ARTICULAR-CARTILAGE; COLLAGEN-VI; EXPRESSION; COMPONENT; CHAINS; FRAS1; CELLS; SKIN	WARP is a recently identified extracellular matrix molecule with restricted expression in permanent cartilages and a distinct subset of basement membranes in peripheral nerves, muscle, and the central nervous system vasculature. WARP interacts with perlecan, and we also demonstrate here that WARP binds type VI collagen, suggesting a function in bridging connective tissue structures. To understand the in vivo function of WARP, we generated a WARP-deficient mouse strain. WARP-null mice were healthy, viable, and fertile with no overt abnormalities. Motor function and behavioral testing demonstrated that WARP-null mice exhibited a significantly delayed response to acute painful stimulus and impaired fine motor coordination, although general motor function was not affected, suggesting compromised peripheral nerve function. Immunostaining of WARP-interacting ligands demonstrated that the collagen VI microfibrillar matrix was severely reduced and mislocalized in peripheral nerves of WARP-null mice. Further ultrastructural analysis revealed reduced fibrillar collagen deposition within the peripheral nerve extracellular matrix and abnormal partial fusing of adjacent Schwann cell basement membranes, suggesting an important function for WARP in stabilizing the association of the collagenous interstitial matrix with the Schwann cell basement membrane. In contrast, other WARP-deficient tissues such as articular cartilage, intervertebral discs, and skeletal muscle showed no detectable abnormalities, and basement membranes formed normally. Our data demonstrate that although WARP is not essential for basement membrane formation or musculoskeletal development, it has critical roles in the structure and function of peripheral nerves.	[Allen, Justin M.; Zamurs, Laura; Brachvogel, Bent; Lamande, Shireen R.; Rowley, Lynn; Fitzgerald, Jamie; Bateman, John F.] Univ Melbourne, Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia; [Bateman, John F.] Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia; [Brachvogel, Bent] Univ Cologne, Fac Med, Ctr Biochem, D-50931 Cologne, Germany; [Schloetzer-Schrehardt, Ursula] Univ Erlangen Nurnberg, Dept Ophthalmol, D-91054 Erlangen, Germany; [Fitzgerald, Jamie] Oregon Hlth & Sci Univ, Dept Orthopaed & Rehabil, Portland, OR 97239 USA; [Hansen, Uwe] Univ Hosp Muenster, Inst Physiol Chem & Pathobiochem, D-48149 Munster, Germany	Murdoch Children's Research Institute; Royal Children's Hospital Melbourne; University of Melbourne; University of Melbourne; University of Cologne; University of Erlangen Nuremberg; Oregon Health & Science University; University of Munster	Bateman, JF (corresponding author), Univ Melbourne, Royal Childrens Hosp, Murdoch Childrens Res Inst, Parkville, Vic 3052, Australia.	john.bateman@mcri.edu.au		Lamande, Shireen/0000-0003-2938-2711; Bateman, John/0000-0001-8542-0730; Brachvogel, Bent/0000-0002-3923-0554	National Health and Medical Research Council of Australia; Muscular Dystrophy Association [4076]; Murdoch Children's Research Institute; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR055957] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Muscular Dystrophy Association(Muscular Dystrophy Association); Murdoch Children's Research Institute; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants from the National Health and Medical Research Council of Australia, Muscular Dystrophy Association Grant 4076, and the Murdoch Children's Research Institute.	Allen JM, 2006, J BIOL CHEM, V281, P7341, DOI 10.1074/jbc.M513746200; Allen JM, 2008, MATRIX BIOL, V27, P295, DOI 10.1016/j.matbio.2008.01.005; Aszodi A, 2006, ANNU REV CELL DEV BI, V22, P591, DOI 10.1146/annurev.cellbio.22.010305.104258; Brachvogel B, 2005, DEVELOPMENT, V132, P2657, DOI 10.1242/dev.01846; Erickson AC, 2000, J HISTOCHEM CYTOCHEM, V48, P1291, DOI 10.1177/002215540004801001; Fitzgerald J, 2003, FEBS LETT, V552, P91, DOI 10.1016/S0014-5793(03)00968-2; Fitzgerald J, 2002, FEBS LETT, V517, P61, DOI 10.1016/S0014-5793(02)02579-6; Gregory KE, 2001, J BONE MINER RES, V16, P2005, DOI 10.1359/jbmr.2001.16.11.2005; Guilak F, 2006, ANN NY ACAD SCI, V1068, P498, DOI 10.1196/annals.1346.011; Hallmann R, 2005, PHYSIOL REV, V85, P979, DOI 10.1152/physrev.00014.2004; KEENE DR, 1988, J CELL BIOL, V107, P1995, DOI 10.1083/jcb.107.5.1995; Keene DR, 1998, J HISTOCHEM CYTOCHEM, V46, P215, DOI 10.1177/002215549804600210; Kuo HJ, 1997, J BIOL CHEM, V272, P26522, DOI 10.1074/jbc.272.42.26522; Kvist AJ, 2008, MATRIX BIOL, V27, P22, DOI 10.1016/j.matbio.2007.07.007; Lampe AK, 2005, J MED GENET, V42, P673, DOI 10.1136/jmg.2002.002311; LeBleu VS, 2007, EXP BIOL MED, V232, P1121, DOI 10.3181/0703-MR-72; Lee HK, 2007, J NEUROCHEM, V102, P686, DOI 10.1111/j.1471-4159.2007.04580.x; Poole CA, 1997, J ANAT, V191, P1, DOI 10.1046/j.1469-7580.1997.19110001.x; Sambrook J., 2001, MOL CLONING LAB MANU, Vthird edition; Takamiya K, 2004, NAT GENET, V36, P172, DOI 10.1038/ng1292; TILLET E, 1994, EUR J BIOCHEM, V221, P177, DOI 10.1111/j.1432-1033.1994.tb18727.x; VONDERMARK H, 1984, EUR J BIOCHEM, V142, P493; Vrontou S, 2003, NAT GENET, V34, P209, DOI 10.1038/ng1168; Wallquist W, 2002, J COMP NEUROL, V454, P284, DOI 10.1002/cne.10434; Whittaker CA, 2002, MOL BIOL CELL, V13, P3369, DOI 10.1091/mbc.E02-05-0259; Wiberg C, 2002, J BIOL CHEM, V277, P49120, DOI 10.1074/jbc.M206891200; Yurchenco PD, 2004, MATRIX BIOL, V22, P521, DOI 10.1016/j.matbio.2003.10.006	27	28	30	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12020	12030		10.1074/jbc.M806968200	http://dx.doi.org/10.1074/jbc.M806968200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19279005	Green Published, hybrid			2022-12-27	WOS:000265494600034
J	Moroy, G; Martin, E; Dejaegere, A; Stote, RH				Moroy, Gautier; Martin, Elyette; Dejaegere, Annick; Stote, Roland H.			Molecular Basis for Bcl-2 Homology 3 Domain Recognition in the Bcl-2 Protein Family IDENTIFICATION OF CONSERVED HOT SPOT INTERACTIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FREE-ENERGY DECOMPOSITION; PEPTIDE COMPLEX; ANTISENSE BCL-2; BH3-ONLY PROTEINS; BINDING-ENERGY; FORCE-FIELDS; BH4 DOMAIN; CLUSTAL-W; DYNAMICS; SENSITIVITY	The proteins of the Bcl-2 family are important regulators of apoptosis, or programmed cell death. These proteins regulate this fundamental biological process via the formation of heterodimers involving both pro- and anti-apoptotic family members. Disruption of the balance between anti- and pro- apoptotic Bcl-2 proteins is the cause of numerous pathologies. Bcl-xl, an anti- apoptotic protein of this family, is known to form heterodimers with multiple pro- apoptotic proteins, such as Bad, Bim, Bak, and Bid. To elucidate the molecular basis of this recognition process, we used molecular dynamics simulations coupled with the Molecular Mechanics/Poisson-Boltzmann Surface Area approach to identify the amino acids that make significant energetic contributions to the binding free energy of four complexes formed between Bcl-xl and pro- apoptotic Bcl-2 homology 3 peptides. A fifth protein-peptide complex composed of another anti- apoptotic protein, Bcl-w, in complex with the peptide from Bim was also studied. The results identified amino acids of both the anti- apoptotic proteins as well as the Bcl-2 homology 3 (BH3) domains of the pro- apoptotic proteins that make strong, recurrent interactions in the protein complexes. The calculations show that the two anti- apoptotic proteins, Bcl-xl and Bcl-w, share a similar recognition mechanism. Our results provide insight into the molecular basis for the promiscuous nature of this molecular recognition process by members of the Bcl-2 protein family. These amino acids could be targeted in the design of new mimetics that serve as scaffolds for dew antitumoral molecules.	[Martin, Elyette; Dejaegere, Annick; Stote, Roland H.] Univ Strasbourg, Dept Biol & Genom Struct, CNRS INSERM ULP, UMR 7104,IGBMC, F-67404 Illkirch Graffenstaden, France; [Moroy, Gautier; Martin, Elyette; Stote, Roland H.] Univ Strasbourg, UMR 7177, Inst Chim, Mol Biophys Lab, F-67000 Strasbourg, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Stote, RH (corresponding author), Univ Strasbourg, Dept Biol & Genom Struct, CNRS INSERM ULP, UMR 7104,IGBMC, F-67404 Illkirch Graffenstaden, France.	rstote@igbmc.fr	Moroy, Gautier/AAT-1608-2020	Moroy, Gautier/0000-0002-8973-0477	Universite de Strasbourg; CNRS; INSERM; Agence Nationale de la Recherche	Universite de Strasbourg; CNRS(Centre National de la Recherche Scientifique (CNRS)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by the Universite de Strasbourg, CNRS, INSERM, and the Agence Nationale de la Recherche.	Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Browning C, 2007, J BIOL CHEM, V282, P32924, DOI 10.1074/jbc.M705559200; BRUNGER AT, 1988, PROTEINS, V4, P148, DOI 10.1002/prot.340040208; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Cheng EHY, 1996, NATURE, V379, P554, DOI 10.1038/379554a0; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; CRUZREYES J, 1995, GENE, V158, P171, DOI 10.1016/0378-1119(95)00159-4; DAVIS ME, 1991, COMPUT PHYS COMMUN, V62, P187, DOI 10.1016/0010-4655(91)90094-2; Denisov AY, 2006, BIOCHEMISTRY-US, V45, P2250, DOI 10.1021/bi052332s; Doshi JM, 2006, J MED CHEM, V49, P7731, DOI 10.1021/jm060968r; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Gohlke H, 2003, J MOL BIOL, V330, P891, DOI 10.1016/S0022-2836(03)00610-7; Gouda H, 2003, BIOPOLYMERS, V68, P16, DOI 10.1002/bip.10270; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Guvench Olgun, 2008, V443, P63, DOI 10.1007/978-1-59745-177-2_4; Hendsch ZS, 1999, PROTEIN SCI, V8, P1381, DOI 10.1110/ps.8.7.1381; HONIG B, 1995, SCIENCE, V268, P1144, DOI 10.1126/science.7761829; Hopkins AL, 2004, DRUG DISCOV TODAY, V9, P430, DOI 10.1016/S1359-6446(04)03069-7; Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2; Huang DCS, 1998, EMBO J, V17, P1029, DOI 10.1093/emboj/17.4.1029; IORGENSEN WL, 1983, J CHEM PHYS, V79, P926; Kim R, 2004, CANCER-AM CANCER SOC, V101, P2177, DOI 10.1002/cncr.20636; Kim R, 2005, CANCER-AM CANCER SOC, V103, P2199, DOI 10.1002/cncr.21029; Kirkin V, 2004, BBA-MOL CELL RES, V1644, P229, DOI 10.1016/j.bbamcr.2003.08.009; Kollman PA, 2000, ACCOUNTS CHEM RES, V33, P889, DOI 10.1021/ar000033j; Kortemme T, 2002, P NATL ACAD SCI USA, V99, P14116, DOI 10.1073/pnas.202485799; Kuntz ID, 1999, P NATL ACAD SCI USA, V96, P9997, DOI 10.1073/pnas.96.18.9997; Lafont V, 2007, PROTEINS, V67, P418, DOI 10.1002/prot.21259; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu XQ, 2003, IMMUNITY, V19, P341, DOI 10.1016/S1074-7613(03)00234-6; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Neria E, 1996, J CHEM PHYS, V105, P1902, DOI 10.1063/1.472061; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Petros AM, 2000, PROTEIN SCI, V9, P2528, DOI 10.1017/S096183680000331X; Reed JC, 2000, AM J PATHOL, V157, P1415, DOI 10.1016/S0002-9440(10)64779-7; Reynolds CH, 2008, J MED CHEM, V51, P2432, DOI 10.1021/jm701255b; Reynolds CH, 2007, BIOORG MED CHEM LETT, V17, P4258, DOI 10.1016/j.bmcl.2007.05.038; Rueda M, 2007, P NATL ACAD SCI USA, V104, P796, DOI 10.1073/pnas.0605534104; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sadowsky JD, 2007, J AM CHEM SOC, V129, P139, DOI 10.1021/ja0662523; Sadowsky JD, 2005, J AM CHEM SOC, V127, P11966, DOI 10.1021/ja053678t; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SATO T, 1994, P NATL ACAD SCI USA, V91, P9238, DOI 10.1073/pnas.91.20.9238; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; Schaefer M, 1998, ADV PROTEIN CHEM, V51, P1; SEDLAK TW, 1995, P NATL ACAD SCI USA, V92, P7834, DOI 10.1073/pnas.92.17.7834; Sorenson CM, 2004, J BIOL CHEM, V279, P11368, DOI 10.1074/jbc.M310079200; Spiegel M.R., 1975, SCHAUMS OUTLINE SERI; STEINBACH PJ, 1994, J COMPUT CHEM, V15, P667, DOI 10.1002/jcc.540150702; Tanabe K, 2003, INT J ONCOL, V22, P875; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; van Delft MF, 2006, CELL RES, V16, P203, DOI 10.1038/sj.cr.7310028; Vorobjev YN, 1998, PROTEINS, V32, P399, DOI 10.1002/(SICI)1097-0134(19980901)32:4<399::AID-PROT1>3.0.CO;2-C; Walensky LD, 2004, SCIENCE, V305, P1466, DOI 10.1126/science.1099191; Walensky LD, 2006, MOL CELL, V24, P199, DOI 10.1016/j.molcel.2006.08.020; Willis S, 2003, J CELL SCI, V116, P4053, DOI 10.1242/jcs.00754; Wilson JW, 2000, BRIT J CANCER, V82, P178, DOI 10.1054/bjoc.1999.0897; Wilson-Annan J, 2003, J CELL BIOL, V162, P877, DOI 10.1083/jcb.200302144; Zeeh JC, 2006, J BIOL CHEM, V281, P11805, DOI 10.1074/jbc.M600149200; Zhang L, 2007, DRUG RESIST UPDATE, V10, P207, DOI 10.1016/j.drup.2007.08.002; Zoete V, 2007, PROTEINS, V67, P1026, DOI 10.1002/prot.21395	64	25	25	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17499	17511		10.1074/jbc.M805542200	http://dx.doi.org/10.1074/jbc.M805542200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19293158	hybrid, Green Published			2022-12-27	WOS:000267202500016
J	Hosokawa, N; Kamiya, Y; Kamiya, D; Kato, K; Nagata, K				Hosokawa, Nobuko; Kamiya, Yukiko; Kamiya, Daiki; Kato, Koichi; Nagata, Kazuhiro			Human OS-9, a Lectin Required for Glycoprotein Endoplasmic Reticulum-associated Degradation, Recognizes Mannose-trimmed N-Glycans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER-ASSOCIATED DEGRADATION; UBIQUITIN LIGASE COMPLEX; QUALITY-CONTROL; MISFOLDED GLYCOPROTEINS; SECRETORY PATHWAY; IDENTIFIES YOS9P; PROTEIN; DISLOCATION; HOMOLOG; ALPHA-1-ANTITRYPSIN	In the endoplasmic reticulum (ER), lectins and processing enzymes are involved in quality control of newly synthesized proteins for productive folding as well as in the ER-associated degradation (ERAD) of misfolded proteins. ER quality control requires the recognition and modification of the N-linked oligosaccharides attached to glycoproteins. Mannose trimming from the N-glycans plays an important role in targeting of misfolded glycoproteins for ERAD. Recently, two mammalian lectins, OS-9 and XTP3-B, which contain mannose 6-phosphate receptor homology domains, were reported to be involved in ER quality control. Here, we examined the requirement for human OS-9 (hOS-9) lectin activity in degradation of the glycosylated ERAD substrate NHK, a genetic variant of alpha 1-antitrypsin. Using frontal affinity chromatography, we demonstrated that the recombinant hOS-9 mannose 6-phosphate receptor homology domain specifically binds N-glycans lacking the terminal mannose from the C branch in vitro. To examine the specificity of OS-9 recognition of N-glycans in vivo, we modified the oligosaccharide structures on NHK by overexpressing ER alpha 1,2-mannosidase I or EDEM3 and examined the effect of these modifications on NHK degradation in combination with small interfering RNA-mediated knockdown of hOS-9. The ability of hOS-9 to enhance glycoprotein ERAD depended on the N-glycan structures on NHK, consistent with the frontal affinity chromatography results. Thus, we propose a model for mannose trimming and the requirement for hOS-9 lectin activity in glycoprotein ERAD in which N-glycans lacking the terminal mannose from the C branch are recognized by hOS-9 and targeted for degradation.	[Hosokawa, Nobuko; Nagata, Kazuhiro] Kyoto Univ, Inst Frontier Med Sci, Dept Mol & Cellular Biol, Kyoto 6068397, Japan; [Kamiya, Yukiko; Kato, Koichi] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan; [Kamiya, Yukiko; Kamiya, Daiki; Kato, Koichi] Nagaya City Univ, Grad Sch Pharmaceut Sci, Nagoya, Aichi 4678063, Japan; [Kato, Koichi] Ochanomizu Univ, Glycosci Inst, Tokyo 1128610, Japan	Kyoto University; National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); Nagoya City University; Ochanomizu University	Hosokawa, N (corresponding author), 53 Kawahara Cho,Sakyo Ku, Kyoto 6068397, Japan.	nobuko@frontier.kyoto-u.ac.jp; kkatonmr@ims.ac.jp		Kato, Koichi/0000-0001-7187-9612; Kamiya, Yukiko/0000-0001-7582-3886	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Uehara Memorial Foundation; Grants-in-Aid for Scientific Research [20107004, 19GS0314] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to N. H., K. K., and K. N.) and a grant from the Uehara Memorial Foundation (to N. H.).	Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; Avezov E, 2008, MOL BIOL CELL, V19, P216, DOI 10.1091/mbc.E07-05-0505; Bernasconi R, 2008, J BIOL CHEM, V283, P16446, DOI 10.1074/jbc.M802272200; Bhamidipati A, 2005, MOL CELL, V19, P741, DOI 10.1016/j.molcel.2005.07.027; Buschhorn BA, 2004, FEBS LETT, V577, P422, DOI 10.1016/j.febslet.2004.10.039; Cabral CM, 2001, TRENDS BIOCHEM SCI, V26, P619, DOI 10.1016/S0968-0004(01)01942-9; Caramelo JJ, 2008, J BIOL CHEM, V283, P10221, DOI 10.1074/jbc.R700048200; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; Gauss R, 2006, NAT CELL BIOL, V8, P849, DOI 10.1038/ncb1445; HAMMOND C, 1994, J CELL BIOL, V126, P41, DOI 10.1083/jcb.126.1.41; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Herscovics A, 2002, GLYCOBIOLOGY, V12, p14G; Herscovics A, 2001, BIOCHIMIE, V83, P757, DOI 10.1016/S0300-9084(01)01319-0; Hirao K, 2006, J BIOL CHEM, V281, P9650, DOI 10.1074/jbc.M512191200; Hosokawa N, 2003, J BIOL CHEM, V278, P26287, DOI 10.1074/jbc.M303395200; Hosokawa N, 2001, EMBO REP, V2, P415, DOI 10.1093/embo-reports/kve084; Hosokawa N, 2008, J BIOL CHEM, V283, P20914, DOI 10.1074/jbc.M709336200; Hosokawa N, 2007, BIOCHEM BIOPH RES CO, V362, P626, DOI 10.1016/j.bbrc.2007.08.057; Jakob CA, 1998, J CELL BIOL, V142, P1223, DOI 10.1083/jcb.142.5.1223; Kamiya Y, 2005, J BIOL CHEM, V280, P37178, DOI 10.1074/jbc.M505757200; Kamiya Y, 2008, J BIOL CHEM, V283, P1857, DOI 10.1074/jbc.M709384200; Kanehara K, 2007, SEMIN CELL DEV BIOL, V18, P743, DOI 10.1016/j.semcdb.2007.09.007; KASAI K, 1986, J CHROMATOGR, V376, P33, DOI 10.1016/S0378-4347(00)80822-1; Kim W, 2005, MOL CELL, V19, P753, DOI 10.1016/j.molcel.2005.08.010; Lederkremer GZ, 2005, TRENDS BIOCHEM SCI, V30, P297, DOI 10.1016/j.tibs.2005.04.010; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Liu Y, 1999, J BIOL CHEM, V274, P5861, DOI 10.1074/jbc.274.9.5861; Mast SW, 2005, GLYCOBIOLOGY, V15, P421, DOI 10.1093/glycob/cwi014; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Mueller B, 2008, P NATL ACAD SCI USA, V105, P12325, DOI 10.1073/pnas.0805371105; Mueller B, 2006, J CELL BIOL, V175, P261, DOI 10.1083/jcb.200605196; Munro S, 2001, CURR BIOL, V11, pR499, DOI 10.1016/S0960-9822(01)00302-5; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Raasi S, 2007, SEMIN CELL DEV BIOL, V18, P780, DOI 10.1016/j.semcdb.2007.09.008; Szathmary R, 2005, MOL CELL, V19, P765, DOI 10.1016/j.molcel.2005.08.015; van Anken E, 2005, CRIT REV BIOCHEM MOL, V40, P191, DOI 10.1080/10409230591008161	38	156	157	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					17061	17068		10.1074/jbc.M809725200	http://dx.doi.org/10.1074/jbc.M809725200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19346256	Green Published, hybrid			2022-12-27	WOS:000266962400044
J	Xu, YJ; Kelly, TJ				Xu, Yong-jie; Kelly, Thomas J.			Autoinhibition and Autoactivation of the DNA Replication Checkpoint Kinase Cds1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHK2 PROTEIN-KINASE; FORKHEAD-ASSOCIATED DOMAIN; FISSION YEAST; S-PHASE; DAMAGE CHECKPOINT; PHOSPHORYLATION; ACTIVATION; MRC1; AUTOPHOSPHORYLATION; OLIGOMERIZATION	Cds1 is the ortholog of Chk2 and the major effector of the DNA replication checkpoint in Schizosaccharomyces pombe. Previous studies have shown that Cds1 is activated by a two-stage mechanism. In the priming stage, the sensor kinase Rad3 and the mediator Mrc1 function to phosphorylate a threonine residue, Thr(11), in the SQ/TQ domain of Cds1. In the autoactivation stage, primed Cds1 molecules dimerize via intermolecular interactions between the phosphorylated Thr(11) in one Cds1 and the forkhead-associated domain of the other. Dimerization activates Cds1, probably by promoting autophosphorylation. To define the mechanisms for the autoactivation of primed Cds1 and the regulation of this process, we carried out genetic and biochemical studies to identify phosphorylatable residues required for checkpoint activation. Our data indicate that dimerization of Cds1 promotes trans-autophosphorylation of a number of residues in the catalytic domain, but phosphorylation of a highly conserved threonine residue (Thr(328)) in the activation loop is the only covalent modification required for kinase activation in vitro and in vivo. Autophosphorylation of Thr(328) and kinase activation in unprimed, monomeric Cds1 are strongly inhibited by the C-terminal 27-amino acid tail of the enzyme. This autoinhibitory effect may play an important role in preventing spontaneous activation of the replication checkpoint during normal cell cycles. The two-stage activation pathway and the autoinhibition mechanism, which are probably shared by other members of the Chk2 family, provide sensitivity, specificity, and noise immunity, properties required for the replication checkpoint.	[Xu, Yong-jie] Wright State Univ, Sch Med, Dept Biochem & Mol Biol, Dayton, OH 45435 USA	University System of Ohio; Wright State University Dayton	Xu, YJ (corresponding author), 148 Diggs,3640 Col Glenn Hwy, Dayton, OH 45435 USA.	yong-jie.xu@wright.edu; tkelly@mskcc.org						Ahn J, 2004, DNA REPAIR, V3, P1039, DOI 10.1016/j.dnarep.2004.03.033; Ahn J, 2002, J BIOL CHEM, V277, P48418, DOI 10.1074/jbc.M208321200; Ahn JY, 2002, J BIOL CHEM, V277, P19389, DOI 10.1074/jbc.M200822200; Alcasabas AA, 2001, NAT CELL BIOL, V3, P958, DOI 10.1038/ncb1101-958; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Boddy MN, 1998, SCIENCE, V280, P909, DOI 10.1126/science.280.5365.909; Boddy MN, 2001, CURR BIOL, V11, pR953, DOI 10.1016/S0960-9822(01)00572-3; Campbell David G, 2002, J Biomol Tech, V13, P119; Chen P, 2000, CELL, V100, P681, DOI 10.1016/S0092-8674(00)80704-7; Furuya K, 2003, J CELL SCI, V116, P3847, DOI 10.1242/jcs.00790; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Guo ZJ, 2000, GENE DEV, V14, P2745, DOI 10.1101/gad.842500; Huse M, 2001, MOL CELL, V8, P671, DOI 10.1016/S1097-2765(01)00332-X; JEFFREY PD, 1995, NATURE, V376, P313, DOI 10.1038/376313a0; Johnson DA, 2001, CHEM REV, V101, P2243, DOI 10.1021/cr000226k; Johnson LN, 2001, CHEM REV, V101, P2209, DOI 10.1021/cr000225s; Kass EM, 2007, J BIOL CHEM, V282, P30311, DOI 10.1074/jbc.M704642200; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Lee CH, 2001, J BIOL CHEM, V276, P30537, DOI 10.1074/jbc.M104414200; Li J, 2008, J BIOL CHEM, V283, P36019, DOI 10.1074/jbc.M804075200; Lindsay HD, 1998, GENE DEV, V12, P382, DOI 10.1101/gad.12.3.382; Liu QH, 2000, GENE DEV, V14, P1448; Lopez-Girona A, 2001, P NATL ACAD SCI USA, V98, P11289, DOI 10.1073/pnas.191557598; Lovly CM, 2008, MOL CELL BIOL, V28, P5874, DOI 10.1128/MCB.00821-08; MEISENHELDER JT, 1999, CURRENT PROTOCOLS MO; MORENO S, 1991, METHOD ENZYMOL, V194, P795; MURAKAMI H, 1995, NATURE, V374, P817, DOI 10.1038/374817a0; Nakamura TM, 2004, MOL CELL BIOL, V24, P6215, DOI 10.1128/MCB.24.14.6215-6230.2004; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Nyberg KA, 2002, ANNU REV GENET, V36, P617, DOI 10.1146/annurev.genet.36.060402.113540; Oliver AW, 2007, TRENDS BIOCHEM SCI, V32, P351, DOI 10.1016/j.tibs.2007.06.004; Oliver AW, 2006, EMBO J, V25, P3179, DOI 10.1038/sj.emboj.7601209; Osborn AJ, 2003, GENE DEV, V17, P1755, DOI 10.1101/gad.1098303; Osborn AJ, 2002, TRENDS CELL BIOL, V12, P509, DOI 10.1016/S0962-8924(02)02380-2; Saka Y, 1997, GENE DEV, V11, P3387, DOI 10.1101/gad.11.24.3387; Schwarz JK, 2003, MOL CANCER RES, V1, P598; Seo GJ, 2003, BIOCHEM BIOPH RES CO, V304, P339, DOI 10.1016/S0006-291X(03)00589-8; Sweeney FD, 2005, CURR BIOL, V15, P1364, DOI 10.1016/j.cub.2005.06.063; Tanaka K, 2004, J BIOL CHEM, V279, P32079, DOI 10.1074/jbc.M404834200; Tanaka K, 2001, NAT CELL BIOL, V3, P966, DOI 10.1038/ncb1101-966; Tanaka K, 2001, MOL CELL BIOL, V21, P3398, DOI 10.1128/MCB.21.10.3398-3404.2001; Usui T, 2007, P NATL ACAD SCI USA, V104, P2797, DOI 10.1073/pnas.0611259104; Wu XL, 2003, J BIOL CHEM, V278, P36163, DOI 10.1074/jbc.M303795200; Xu XZ, 2002, MOL CELL BIOL, V22, P4419, DOI 10.1128/MCB.22.12.4419-4432.2002; Xu YJ, 2006, GENE DEV, V20, P990, DOI 10.1101/gad.1406706; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhao H, 2003, MOL CELL BIOL, V23, P8395, DOI 10.1128/MCB.23.22.8395-8403.2003; Zou L, 2007, GENE DEV, V21, P879, DOI 10.1101/gad.1550307	49	16	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					16016	16027		10.1074/jbc.M900785200	http://dx.doi.org/10.1074/jbc.M900785200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19357077	Green Published, hybrid			2022-12-27	WOS:000266501000067
J	Green, LA; Liu, Y; He, JJ				Green, Linden A.; Liu, Ying; He, Johnny J.			Inhibition of HIV-1 Infection and Replication by Enhancing Viral Incorporation of Innate Anti-HIV-1 Protein A3G A NON-PATHOGENIC Nef MUTANT-BASED ANTI-HIV STRATEGY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CELL-SURFACE CD4; DOWN-REGULATION; TYPE-1 NEF; RHESUS MACAQUES; ENZYME APOBEC3G; VIF PROTEIN; PARTICLES; ACTIVATION; IDENTIFICATION	APOBEC3G (A3G) is a cellular protein that has been identified as an innate anti-human immunodeficiency virus type 1 (HIV-1) factor. One of the major functions of HIV-1 virion infectivity protein (Vif) protein is to target A3G for ubiquitination/proteasome-mediated degradation and, as a result, evade the host innate defense mechanism. Thus, we wished to devise a strategy to restore the anti-HIV activity of A3G by actively targeting it into HIV-1 virions and countering HIV-1 Vif-targeted degradation. In the current study we performed a series of proof-of-concept experiments for this strategy using as a delivery vehicle of A3G, a derivate of non-pathogenic Nef mutant Nef7 that is capable of being efficiently incorporated into HIV-1 virions. We demonstrate that the Nef7. A3G fusion protein retains several important properties of Nef7; that is, the higher virion incorporation efficiency, no PAK-2 (p21-activated kinase 2) activation, and no CD4 and major histocompatibility complex I down-regulation. Meanwhile, we show that virion incorporated Nef7. A3G possesses the anti-HIV infectivity function of A3G. Moreover, we show that virus-like particle-mediated inverse fusion delivery of Nef7. A3G into HIV-infected CD4+ T lymphocytes leads to potent inhibition of HIV-1 replication in these cells. Taken together, these results indicate that Nef7. A3G can effectively restrict HIV infection and replication by restoring the virion incorporation of A3G, even in the presence of Vif.	[He, Johnny J.] Indiana Univ, Sch Med, Ctr AIDS Res, Indianapolis, IN 46202 USA; [Green, Linden A.; Liu, Ying; He, Johnny J.] Indiana Univ, Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA; [He, Johnny J.] Indiana Univ, Sch Med, Walther Oncol Ctr, Indianapolis, IN 46202 USA; [He, Johnny J.] Walther Canc Inst, Indianapolis, IN 46206 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Walther Cancer Institute; Walther Cancer Institute	He, JJ (corresponding author), Indiana Univ, Sch Med, Ctr AIDS Res, R2 302,950 W Walnut St, Indianapolis, IN 46202 USA.	jjhe@iupui.edu			National Institutes of Health [R01NS039804, R21DA022986, R21DA025487]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA025487, R21DA022986] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants R01NS039804, R21DA022986, and R21DA025487 (to J. J. H.).	Agopian K, 2006, J VIROL, V80, P3050, DOI 10.1128/JVI.80.6.3050-3061.2006; Aguiar RS, 2008, J BIOL CHEM, V283, P2518, DOI 10.1074/jbc.M706436200; Ao ZJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001995; Chazal N, 2001, J VIROL, V75, P4014, DOI 10.1128/JVI.75.8.4014-4018.2001; Crotti A, 2006, J VIROL, V80, P10663, DOI 10.1128/JVI.02621-05; Cullen BR, 1998, CELL, V93, P685, DOI 10.1016/S0092-8674(00)81431-2; D'Aloja P, 1998, J VIROL, V72, P4308; D'Aloja P, 2001, J GEN VIROL, V82, P2735, DOI 10.1099/0022-1317-82-11-2735; DERONDE A, 1992, VIROLOGY, V188, P391, DOI 10.1016/0042-6822(92)90772-H; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Endres MJ, 1997, SCIENCE, V278, P1462, DOI 10.1126/science.278.5342.1462; Fenard D, 2005, J IMMUNOL, V175, P6050, DOI 10.4049/jimmunol.175.9.6050; Giese SI, 2006, VIROLOGY, V355, P175, DOI 10.1016/j.virol.2006.07.003; Harris RS, 2003, CELL, V113, P803, DOI 10.1016/S0092-8674(03)00423-9; He JL, 1997, NATURE, V385, P645, DOI 10.1038/385645a0; HE JL, 1995, J VIROL, V69, P4587, DOI 10.1128/JVI.69.7.4587-4592.1995; Hua J, 1997, J VIROL, V71, P6742, DOI 10.1128/JVI.71.9.6742-6748.1997; Hua J, 1997, VIROLOGY, V231, P231, DOI 10.1006/viro.1997.8517; Huthoff H, 2007, J VIROL, V81, P3807, DOI 10.1128/JVI.02795-06; JAMIESON BD, 1994, J VIROL, V68, P3478, DOI 10.1128/JVI.68.6.3478-3485.1994; KESTLER HW, 1991, CELL, V65, P651, DOI 10.1016/0092-8674(91)90097-I; Khan IH, 1998, J VIROL, V72, P5820, DOI 10.1128/JVI.72.7.5820-5830.1998; LEWIS P, 1992, EMBO J, V11, P3053, DOI 10.1002/j.1460-2075.1992.tb05376.x; Lubben NB, 2007, MOL BIOL CELL, V18, P3351, DOI 10.1091/mbc.E07-03-0218; Mangino G, 2007, J VIROL, V81, P2777, DOI 10.1128/JVI.01640-06; Mariani R, 1996, J VIROL, V70, P7752, DOI 10.1128/JVI.70.11.7752-7764.1996; Marin M, 2003, NAT MED, V9, P1398, DOI 10.1038/nm946; Mehle A, 2004, GENE DEV, V18, P2861, DOI 10.1101/gad.1249904; Miyagij E, 2007, J VIROL, V81, P13346, DOI 10.1128/JVI.01361-07; Peretti S, 2006, VIROLOGY, V345, P115, DOI 10.1016/j.virol.2005.09.054; Peretti S, 2005, MOL THER, V12, P1185, DOI 10.1016/j.ymthe.2005.06.474; Qi ML, 2008, VIROLOGY, V373, P287, DOI 10.1016/j.virol.2007.12.001; Roeth JF, 2006, MICROBIOL MOL BIOL R, V70, P548, DOI 10.1128/MMBR.00042-05; Sawai ET, 1996, CURR BIOL, V6, P1519, DOI 10.1016/S0960-9822(96)00757-9; Schumacher AJ, 2008, J VIROL, V82, P2652, DOI 10.1128/JVI.02391-07; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Simon JHM, 1998, NAT MED, V4, P1397, DOI 10.1038/3987; Singh SP, 2001, VIROLOGY, V283, P78, DOI 10.1006/viro.2001.0849; Swigut T, 2001, EMBO J, V20, P1593, DOI 10.1093/emboj/20.7.1593; Trible RP, 2006, J BIOL CHEM, V281, P27029, DOI 10.1074/jbc.M601128200; Venzke S, 2006, J VIROL, V80, P11141, DOI 10.1128/JVI.01556-06; Wei BL, 2005, J VIROL, V79, P14976, DOI 10.1128/JVI.79.23.14976-14980.2005; Welker R, 1998, J VIROL, V72, P8833, DOI 10.1128/JVI.72.11.8833-8840.1998; Williams M, 2005, J VIROL, V79, P632, DOI 10.1128/JVI.79.1.632-636.2005; Wolf D, 2008, VIROLOGY, V370, P45, DOI 10.1016/j.virol.2007.08.015; Zhang L, 2008, VIROLOGY, V370, P113, DOI 10.1016/j.virol.2007.08.027	47	17	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13363	13372		10.1074/jbc.M806631200	http://dx.doi.org/10.1074/jbc.M806631200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19324886	Green Published, hybrid			2022-12-27	WOS:000265877300012
J	Tatham, AL; Crabtree, MJ; Warrick, N; Cai, SJ; Alp, NJ; Channon, KM				Tatham, Amy L.; Crabtree, Mark J.; Warrick, Nicholas; Cai, Shijie; Alp, Nicholas J.; Channon, Keith M.			GTP Cyclohydrolase I Expression, Protein, and Activity Determine Intracellular Tetrahydrobiopterin Levels, Independent of GTP Cyclohydrolase Feedback Regulatory Protein Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; VASCULAR ENDOTHELIAL-CELLS; NITRIC-OXIDE PRODUCTION; HYDROGEN-PEROXIDE; SMOOTH-MUSCLE; HPH-1 MOUSE; LPS; HYPERPHENYLALANINEMIA; METABOLISM; INDUCTION	GTP cyclohydrolase I (GTPCH) is a key enzyme in the synthesis of tetrahydrobiopterin (BH4), a required cofactor for nitric-oxide synthases and aromatic amino acid hydroxylases. Alterations of GTPCH activity and BH4 availability play an important role in human disease. GTPCH expression is regulated by inflammatory stimuli, in association with reduced expression of GTP cyclohydrolase feedback regulatory protein (GFRP). However, the relative importance of GTPCH expression versus GTPCH activity and the role of GFRP in relation to BH4 bioavailability remain uncertain. We investigated these relationships in a cell line with tet-regulated GTPCH expression and in the hph-1 mouse model of GTPCH deficiency. Doxycycline exposure resulted in a dose-dependent decrease in GTPCH protein and activity, with a strong correlation between GTPCH expression and BH4 levels (r(2) = 0.85, p < 0.0001). These changes in GTPCH and BH4 had no effect on GFRP expression or protein levels. GFRP overexpression and knockdown in tet-GCH cells did not alter GTPCH activity or BH4 levels, and GTPCH-specific knockdown in sEnd. 1 endothelial cells had no effect on GFRP protein. In mouse liver we observed a graded reduction of GTPCH expression, protein, and activity, from wild type, heterozygote, to homozygote littermates, with a striking linear correlation between GTPCH expression and BH4 levels (r(2) = 0.82, p < 0.0001). Neither GFRP expression nor protein differed between wild type, heterozygote, nor homozygote mice, despite the substantial differences in BH4. We suggest that GTPCH expression is the primary regulator of BH4 levels, and changes in GTPCH or BH4 are not necessarily accompanied by changes in GFRP expression.	[Tatham, Amy L.; Crabtree, Mark J.; Warrick, Nicholas; Cai, Shijie; Alp, Nicholas J.; Channon, Keith M.] Univ Oxford, John Radcliffe Hosp, Dept Cardiovasc Med, Oxford OX3 9DU, England	University of Oxford	Channon, KM (corresponding author), Univ Oxford, John Radcliffe Hosp, Dept Cardiovasc Med, Oxford OX3 9DU, England.	keith.channon@cardiov.ox.ac.uk		channon, keith/0000-0002-1043-4342; Crabtree, Mark/0000-0003-3298-2697	British Heart Foundation [RG/07/003/23133] Funding Source: Medline	British Heart Foundation(British Heart Foundation)		Cai S, 2002, CARDIOVASC RES, V55, P838, DOI 10.1016/S0008-6363(02)00460-1; Gesierich A, 2003, BASIC RES CARDIOL, V98, P69, DOI 10.1007/s00395-003-0394-y; GROSS SS, 1993, ADV EXP MED BIOL, V338, P295; HARADA T, 1993, SCIENCE, V260, P1507, DOI 10.1126/science.8502995; HATTORI Y, 1993, BIOCHEM BIOPH RES CO, V195, P435, DOI 10.1006/bbrc.1993.2062; HEALES S, 1989, J CHROMATOGR-BIOMED, V494, P77, DOI 10.1016/S0378-4347(00)82658-4; Hesslinger C, 1998, J BIOL CHEM, V273, P21616, DOI 10.1074/jbc.273.34.21616; HOWELLS DW, 1986, J CHROMATOGR, V381, P285, DOI 10.1016/S0378-4347(00)83594-X; Ishii M, 2005, J PHARMACOL SCI, V97, P299, DOI 10.1254/jphs.SC0040146; Kalivendi S, 2005, FREE RADICAL BIO MED, V38, P481, DOI 10.1016/j.freeradbiomed.2004.11.004; Katusic ZS, 1998, ARTERIOSCL THROM VAS, V18, P27, DOI 10.1161/01.ATV.18.1.27; Khoo JP, 2004, MOL GENET METAB, V82, P251, DOI 10.1016/j.ymgme.2004.04.006; MCDONALD JD, 1988, PEDIATR RES, V23, P63, DOI 10.1203/00006450-198801000-00014; Milstien S, 1996, J BIOL CHEM, V271, P19743, DOI 10.1074/jbc.271.33.19743; NAKAYAMA DK, 1994, AM J PHYSIOL, V266, pL455, DOI 10.1152/ajplung.1994.266.4.L455; Nandi M, 2008, VASC MED, V13, P29, DOI 10.1177/1358863X07085916; PONZONE A, 1993, CLIN CHIM ACTA, V216, P63, DOI 10.1016/0009-8981(93)90139-U; Shimizu S, 2003, FREE RADICAL BIO MED, V34, P1343, DOI 10.1016/S0891-5849(03)00172-2; Walter R, 1998, IMMUNOL LETT, V60, P13, DOI 10.1016/S0165-2478(97)00123-5; Werner ER, 2002, J BIOL CHEM, V277, P10129, DOI 10.1074/jbc.M107326200; Werner-Felmayer G, 1996, METHODS NITRIC OXIDE, P271; WILLIAMS RL, 1989, CELL, V57, P1053, DOI 10.1016/0092-8674(89)90343-7; Yoneyama T, 1998, J BIOL CHEM, V273, P20102, DOI 10.1074/jbc.273.32.20102	23	43	43	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13660	13668		10.1074/jbc.M807959200	http://dx.doi.org/10.1074/jbc.M807959200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19286659	Green Published, hybrid			2022-12-27	WOS:000265877300043
J	Yu, LY; Min, W; He, Y; Qin, LF; Zhang, HF; Bennett, AM; Chen, H				Yu, Luyang; Min, Wang; He, Yun; Qin, Lingfeng; Zhang, Haifeng; Bennett, Anton M.; Chen, Hong			JAK2 and SHP2 Reciprocally Regulate Tyrosine Phosphorylation and Stability of Proapoptotic Protein ASK1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; FLUID SHEAR-STRESS; ASK1-MEDIATED APOPTOSIS; ENDOTHELIAL-CELLS; INDEPENDENT MANNER; INHIBITOR 14-3-3; FAMILY-MEMBERS; KINASE 1; ACTIVATION; DISSOCIATION	Previously we have shown that tyrosine 718 of ASK1 when phosphorylated is critical for SOCS1 binding and SOCS1-mediated degradation of ASK1. However, the kinase and phosphatase responsible for phosphorylation and dephosphorylation of ASK1 at Tyr-718 are unknown. In this study, we identified JAK2 and SHP2 as a Tyr-718-specific kinase and phosphatase, respectively. Interferon-gamma (IFN-gamma) induced degradation of ASK1 in normal but not in SOCS1-KO endothelial cells (EC). IFN-gamma-induced tyrosine phosphorylation of ASK1 at Tyr-718 was blocked by a JAK2-specific inhibitor. IFN-gamma enhanced the association between JAK2 and ASK1, and the ASK1-JAK2 complex was labile and was stabilized by the proteasomal inhibitor MG132. Furthermore, JAK2, but not JAK1, directly bound to and phosphorylated ASK1 at Tyr-718, leading to an enhanced association of ASK1 with SOCS1 and subsequent ASK1 degradation. Next, we showed that overexpression of the SH2-containing protein-tyrosine phosphatase-2 (SHP2) augmented, whereas a phosphatase-inactive mutant of SHP2 inhibited, TNF-induced ASK1 dephosphorylation. SHP2 associated with ASK1 in response to tumor necrosis factor in EC. An SHP-2 substrate-trapping mutant formed a complex with tyrosine-phosphorylated ASK1, suggesting that ASK1 is a direct SHP2 substrate. Moreover, SHP2 wild type, but not a catalytically inactive mutant, dissociated SOCS1 from ASK1. IFN-gamma-induced ASK1 Tyr(P)-718 was enhanced in mouse EC deficient in SHP2 (SHP2-KO). In contrast, tumor necrosis factor-induced dephosphorylation of ASK1 at Tyr(P)-718 and activation of ASK1-JNK signaling, as well as EC apoptosis, are significantly reduced in SHP2-KO EC. Our data suggest that JAK2-SOCS1 and SHP2 reciprocally regulate ASK1 phosphorylation and stability in response to cytokines.	[Yu, Luyang; Min, Wang; He, Yun; Qin, Lingfeng; Zhang, Haifeng] Yale Univ, Sch Med, Interdept Program Vasc Biol & Therapeut, Dept Pathol, New Haven, CT 06520 USA; [Min, Wang] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, Guangzhou 510060, Guangdong, Peoples R China; [Bennett, Anton M.] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA; [Chen, Hong] Oklahoma Med Res Fdn, Oklahoma City, OK 73104 USA	Yale University; Sun Yat Sen University; Yale University; Oklahoma Medical Research Foundation	Min, W (corresponding author), Yale Univ, Sch Med, Interdept Program Vasc Biol & Transplantat, 10 Amistad St, New Haven, CT 06520 USA.	wang.min@yale.edu	qin, lingfeng/D-9242-2012	Yu, Luyang/0000-0002-1301-6285; Bennett, Anton/0000-0001-5187-7599	National Institutes of Health [P01HL070295-6, R01 HL-65978-9, AR46504]; National Nature Science Foundation of China [30828032]; American Heart Association [0835544N]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL065978, P01HL070295] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR046504] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants P01HL070295-6 and R01 HL-65978-9 and AR46504 (to A. M. B.). This work was also supported by National Nature Science Foundation of China Grant 30828032 (to W. M.) and Scientific Development Grant 0835544N from the American Heart Association (to H. C.).	Ali S, 2003, J BIOL CHEM, V278, P52021, DOI 10.1074/jbc.M306758200; Berk BC, 2002, DRUG NEWS PERSPECT, V15, P133, DOI 10.1358/dnp.2002.15.3.704684; Bunkoczi G, 2007, STRUCTURE, V15, P1215, DOI 10.1016/j.str.2007.08.011; De Souza D, 2002, BIOCHEMISTRY-US, V41, P9229, DOI 10.1021/bi0259507; Fornaro M, 2006, J CELL BIOL, V175, P87, DOI 10.1083/jcb.200602029; Fujii K, 2004, ONCOGENE, V23, P5099, DOI 10.1038/sj.onc.1207668; He Y, 2006, J BIOL CHEM, V281, P5559, DOI 10.1074/jbc.M512338200; Ichijo H, 1999, ONCOGENE, V18, P6087, DOI 10.1038/sj.onc.1203129; Izumi Y, 2003, CIRCULATION, V108, P2812, DOI 10.1161/01.CIR.0000096486.01652.FC; Izumiya Y, 2003, CIRC RES, V93, P874, DOI 10.1161/01.RES.0000100665.67510.F5; Kim AH, 2001, MOL CELL BIOL, V21, P893, DOI 10.1128/MCB.21.3.893-901.2001; Kontaridis MI, 2004, MOL CELL BIOL, V24, P5340, DOI 10.1128/MCB.24.12.5340-5352.2004; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Liu YM, 2002, CIRC RES, V90, P1259, DOI 10.1161/01.RES.0000022160.64355.62; Liu YM, 2001, J CLIN INVEST, V107, P917, DOI 10.1172/JCI11947; Marine JC, 1999, CELL, V98, P609, DOI 10.1016/S0092-8674(00)80048-3; Matsuzawa A, 2002, ANTIOXID REDOX SIGN, V4, P415, DOI 10.1089/15230860260196218; Min W, 2008, CIRC RES, V102, P840, DOI 10.1161/CIRCRESAHA.107.168153; Morita K, 2001, EMBO J, V20, P6028, DOI 10.1093/emboj/20.21.6028; Surapisitchat J, 2001, P NATL ACAD SCI USA, V98, P6476, DOI 10.1073/pnas.101134098; Tamura S, 2006, CANCER SCI, V97, P563, DOI 10.1111/j.1349-7006.2006.00219.x; Tiganis T, 2007, BIOCHEM J, V402, P1, DOI 10.1042/BJ20061548; Tobiume K, 2002, J CELL PHYSIOL, V191, P95, DOI 10.1002/jcp.10080; Wang CY, 1998, SCIENCE, V281, P1680, DOI 10.1126/science.281.5383.1680; Xu D, 2008, FRONT BIOSCI-LANDMRK, V13, P4925, DOI 10.2741/3051; Yamawaki H, 2005, J CLIN INVEST, V115, P733, DOI 10.1172/JCI200523001; Zhang HF, 2008, J CLIN INVEST, V118, P3904, DOI 10.1172/JCI36168; Zhang HF, 2004, J BIOL CHEM, V279, P44955, DOI 10.1074/jbc.M407617200; Zhang LX, 1999, P NATL ACAD SCI USA, V96, P8511, DOI 10.1073/pnas.96.15.8511; Zhang R, 2004, CIRC RES, V94, P1483, DOI 10.1161/01.RES.0000130525.37646.a7; Zhang R, 2005, ONCOGENE, V24, P3954, DOI 10.1038/sj.onc.1208548; Zhang R, 2003, J CLIN INVEST, V111, P1933, DOI 10.1172/JCI200317790; Zhang W, 2005, J BIOL CHEM, V280, P19036, DOI 10.1074/jbc.M414674200	33	20	22	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13481	13488		10.1074/jbc.M809740200	http://dx.doi.org/10.1074/jbc.M809740200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19287004	Green Published, hybrid			2022-12-27	WOS:000265877300024
J	Chang, DK; Chiu, CY; Kuo, SY; Lin, WC; Lo, A; Wang, YP; Li, PC; Wu, HC				Chang, De-Kuan; Chiu, Chien-Yu; Kuo, Szu-Yao; Lin, Wei-Chuan; Lo, Albert; Wang, Yi-Ping; Li, Pi-Chun; Wu, Han-Chung			Antiangiogenic Targeting Liposomes Increase Therapeutic Efficacy for Solid Tumors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTERSTITIAL HYPERTENSION; MACROMOLECULAR THERAPEUTICS; ANTI-HER2 IMMUNOLIPOSOMES; CHEMOTHERAPEUTIC-AGENTS; DOXORUBICIN DOXIL; DRUG-DELIVERY; GROWTH-FACTOR; HUMAN BREAST; PHASE-I; CANCER	It is known that solid tumors recruit new blood vessels to support tumor growth, but the molecular diversity of receptors in tumor angiogenic vessels might also be used clinically to develop better targeted therapy. In vivo phage display was used to identify peptides that specifically target tumor blood vessels. Several novel peptides were identified as being able to recognize tumor vasculature but not normal blood vessels in severe combined immunodeficiency (SCID) mice bearing human tumors. These tumor-homing peptides also bound to blood vessels in surgical specimens of various human cancers. The peptide-linked liposomes containing fluorescent substance were capable of translocating across the plasma membrane through endocytosis. With the conjugation of peptides and liposomal doxorubicin, the targeted drug delivery systems enhanced the therapeutic efficacy of the chemotherapeutic agent against human cancer xenografts by decreasing tumor angiogenesis and increasing cancer cell apoptosis. Furthermore, the peptide-mediated targeting liposomes improved the pharmacokinetics and pharmacodynamics of the drug they delivered compared with nontargeting liposomes or free drugs. Our results indicate that the tumor-homing peptides can be used specifically target tumor vasculature and have the potential to improve the systemic treatment of patients with solid tumors.	[Chang, De-Kuan; Chiu, Chien-Yu; Kuo, Szu-Yao; Lin, Wei-Chuan; Lo, Albert; Wang, Yi-Ping; Li, Pi-Chun; Wu, Han-Chung] Acad Sinica, Inst Cellular & Organism Biol, Taipei 115, Taiwan	Academia Sinica - Taiwan	Wu, HC (corresponding author), 128 Acad Rd,Sect 2, Taipei 11529, Taiwan.	hcw0928@gate.sinica.edu.tw	Wu, Han-Chung/B-1209-2011	Wu, Han-Chung/0000-0002-5185-1169; Wang, Yi-Ping/0000-0001-9574-2194	Academia Sinica and National Science Council Taiwan [NSC97-2323-B-001-002, NSC97-3111-B-001-004]	Academia Sinica and National Science Council Taiwan	This work was supported by Academia Sinica and National Science Council (Taiwan) Grants NSC97-2323-B-001-002 and NSC97-3111-B-001-004 (to H.-C. W.).	Al-Batran SE, 2006, BRIT J CANCER, V94, P1615, DOI 10.1038/sj.bjc.6603158; Allen TM, 2004, SCIENCE, V303, P1818, DOI 10.1126/science.1095833; ALLEN TM, 1991, BIOCHIM BIOPHYS ACTA, V1066, P29, DOI 10.1016/0005-2736(91)90246-5; Arap W, 1998, SCIENCE, V279, P377, DOI 10.1126/science.279.5349.377; Barry MA, 1996, NAT MED, V2, P299, DOI 10.1038/nm0396-299; Bellamy WT, 2001, BLOOD, V97, P1427, DOI 10.1182/blood.V97.5.1427; Bosslet K, 1998, CANCER RES, V58, P1195; BOUCHER Y, 1990, CANCER RES, V50, P4478; BOUCHER Y, 1991, CANCER RES, V51, P6691; Brigger I, 2002, ADV DRUG DELIVER REV, V54, P631, DOI 10.1016/S0169-409X(02)00044-3; Chang DK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004171; Chen YC, 2007, CLIN VACCINE IMMUNOL, V14, P404, DOI 10.1128/CVI.00249-06; Colbern GT, 1999, J LIPOSOME RES, V9, P523, DOI 10.3109/08982109909035551; Drummond DC, 1999, PHARMACOL REV, V51, P691; Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330; FOLGORI A, 1994, EMBO J, V13, P2236, DOI 10.1002/j.1460-2075.1994.tb06501.x; GABIZON A, 1994, CANCER RES, V54, P987; Gabrilovich D, 1998, BLOOD, V92, P4150, DOI 10.1182/blood.V92.11.4150.423k45_4150_4166; GUTMANN R, 1992, CANCER RES, V52, P1993; Hashizume H, 2000, AM J PATHOL, V156, P1363, DOI 10.1016/S0002-9440(10)65006-7; Heldin CH, 2004, NAT REV CANCER, V4, P806, DOI 10.1038/nrc1456; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; JAIN RK, 1987, CANCER RES, V47, P3039; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Kirpotin D, 1997, BIOCHEMISTRY-US, V36, P66, DOI 10.1021/bi962148u; Laginha KM, 2005, CLIN CANCER RES, V11, P6944, DOI 10.1158/1078-0432.CCR-05-0343; Lee TY, 2007, CANCER RES, V67, P10958, DOI 10.1158/0008-5472.CAN-07-2233; Lee TY, 2004, CANCER RES, V64, P8002, DOI 10.1158/0008-5472.CAN-04-1948; LESS JR, 1992, CANCER RES, V52, P6371; Liu IJ, 2004, J INFECT DIS, V190, P797, DOI 10.1086/422753; Lo A, 2008, MOL CANCER THER, V7, P579, DOI 10.1158/1535-7163.MCT-07-2359; Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5; Marina NM, 2002, CLIN CANCER RES, V8, P413; MATSUMURA Y, 1986, CANCER RES, V46, P6387; Matsumura Y, 2004, ANN ONCOL, V15, P517, DOI 10.1093/annonc/mdh092; Mayer LD, 1997, J PHARMACOL EXP THER, V280, P1406; Muggia F, 2001, EUR J CANCER, V37, pS15; PAPAHADJOPOULOS D, 1991, P NATL ACAD SCI USA, V88, P11460, DOI 10.1073/pnas.88.24.11460; Park JW, 2002, CLIN CANCER RES, V8, P1172; Pastorino F, 2003, CANCER RES, V63, P86; Safra T, 2000, ANN ONCOL, V11, P1029, DOI 10.1023/A:1008365716693; SCOTT JK, 1990, SCIENCE, V249, P386, DOI 10.1126/science.1696028; SENIOR J, 1991, BIOCHIM BIOPHYS ACTA, V1062, P77, DOI 10.1016/0005-2736(91)90337-8; SPETH PAJ, 1988, CLIN PHARMACOKINET, V15, P15, DOI 10.2165/00003088-198815010-00002; VAAGE J, 1994, CANCER, V73, P1478, DOI 10.1002/1097-0142(19940301)73:5<1478::AID-CNCR2820730526>3.0.CO;2-1; Vasey PA, 1999, CLIN CANCER RES, V5, P83; Verheul HMW, 2007, NAT REV CANCER, V7, P475, DOI 10.1038/nrc2152; Wu H, 2006, J CANC MOL, V2, P57; Wu HC, 2003, J GEN VIROL, V84, P2771, DOI 10.1099/vir.0.19228-0; Wu  HC, 2008, J CANC MOL, V4, P37	50	84	88	0	27	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12905	12916		10.1074/jbc.M900280200	http://dx.doi.org/10.1074/jbc.M900280200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19276080	hybrid, Green Published			2022-12-27	WOS:000265688300036
J	Courtney, HS; Li, Y; Twal, WO; Argraves, WS				Courtney, Harry S.; Li, Yi; Twal, Waleed O.; Argraves, W. Scott			Serum Opacity Factor Is a Streptococcal Receptor for the Extracellular Matrix Protein Fibulin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-A STREPTOCOCCI; FIBRONECTIN-BINDING PROTEIN; SURFACE PROTEIN; PYOGENES; FIBRINOGEN; VIRULENCE; DOMAIN; MECHANISMS; ADHESION; INVASION	The adhesion of bacteria to host tissues is often mediated by interactions with extracellular matrices. Herein, we report on the interactions of the group A streptococcus, Streptococcus pyogenes, with the extracellular matrix protein fibulin-1. S. pyogenes bound purified fibulin-1 in a dose-dependent manner. Genetic ablation of serum opacity factor (SOF), a virulence determinant of S. pyogenes, reduced binding by similar to 50%, and a recombinant peptide of SOF inhibited binding of fibulin-1 to streptococci by similar to 45%. Fibulin-1 bound to purified SOF2 in a dose-dependent manner with high affinity (K-d = 1.6 nM). The fibulin-1-binding domain was localized to amino acid residues 457-806 of SOF2, whereas the fibronectin-binding domain is contained within residues 807-931 of SOF2, indicating that these two domains are separate and distinct. Fibulin-1 bound to recombinant SOF from M types 2, 4, 28, and 75 of S. pyogenes, indicating that the fibulin-1-binding domain is likely conserved among SOF from different serotypes. Mixed binding experiments suggested that gelatin, fibronectin, fibulin-1, and SOF form a quaternary molecular complex that enhanced the binding of fibulin-1. These data indicate that S. pyogenes can interact with fibulin-1 and that SOF is a major streptococcal receptor for fibulin-1 but not the only receptor. Such interactions with fibulin-1 may be involved in the adhesion of S. pyogenes to extracellular matrices of the host.	[Courtney, Harry S.] Vet Adm Med Ctr, Res Serv 151, Memphis, TN 38104 USA; [Courtney, Harry S.; Li, Yi] Univ Tennessee, Hlth Sci Ctr, Dept Med, Memphis, TN 38104 USA; [Twal, Waleed O.; Argraves, W. Scott] Med Univ S Carolina, Dept Cell Biol, Charleston, SC 29425 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; University of Tennessee System; University of Tennessee Health Science Center; Medical University of South Carolina	Courtney, HS (corresponding author), Vet Adm Med Ctr, Res Serv 151, 1030 Jefferson Ave, Memphis, TN 38104 USA.	hcourtney@utmem.edu			National Institutes of Health [HL095067]; Department of Veterans Affairs; American Heart Association [0755346U]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL095067] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL095067 (to W. S. A.). This work was also supported by the Department of Veterans Affairs (to H. S. C.) and American Heart Association Grant 0755346U (to W. S. A.).	Argraves WS, 2003, EMBO REP, V4, P1127, DOI 10.1038/sj.embor.7400033; ARGRAVES WS, 1990, J CELL BIOL, V111, P3155, DOI 10.1083/jcb.111.6.3155; Bergkvist M, 2003, J BIOMED MATER RES A, V64A, P349, DOI 10.1002/jbm.a.10423; Carlsson F, 2005, MOL MICROBIOL, V56, P28, DOI 10.1111/j.1365-2958.2005.04527.x; Chu Mon-Li, 2004, Birth Defects Res C Embryo Today, V72, P25, DOI 10.1002/bdrc.20003; Cooley MA, 2008, DEV BIOL, V319, P336, DOI 10.1016/j.ydbio.2008.04.029; Courtney HS, 2006, J BIOL CHEM, V281, P5515, DOI 10.1074/jbc.M512538200; Courtney HS, 2006, MOL MICROBIOL, V59, P936, DOI 10.1111/j.1365-2958.2005.04977.x; Courtney HS, 1999, MOL MICROBIOL, V32, P89, DOI 10.1046/j.1365-2958.1999.01328.x; Courtney HS, 2002, ANN MED, V34, P77, DOI 10.1080/07853890252953464; COURTNEY HS, 1994, INFECT IMMUN, V62, P3937, DOI 10.1128/IAI.62.9.3937-3946.1994; Courtney HS, 1996, INFECT IMMUN, V64, P2415, DOI 10.1128/IAI.64.7.2415-2419.1996; COURTNEY HS, 2004, BACTERIAL INVASION H, P239; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; DEVEGA S, 2009, CMLS CELL M IN PRESS; ENGVALL E, 1977, INT J CANCER, V20, P1, DOI 10.1002/ijc.2910200102; Gillard BK, 2007, BIOCHEMISTRY-US, V46, P12968, DOI 10.1021/bi701525w; Gillen CM, 2008, J BIOL CHEM, V283, P6359, DOI 10.1074/jbc.M706739200; GODYNA S, 1995, MATRIX BIOL, V14, P467, DOI 10.1016/0945-053X(95)90004-7; Han M, 2009, BIOCHEMISTRY-US, V48, P1481, DOI 10.1021/bi802287q; Karuri NW, 2009, J BIOL CHEM, V284, P3445, DOI 10.1074/jbc.M805025200; Kim S, 2001, J CLIN MICROBIOL, V39, P1316, DOI 10.1128/JCM.39.4.1316-1318.2001; Kreikemeyer B, 2004, INT J MED MICROBIOL, V294, P177, DOI 10.1016/j.ijmm.2004.06.017; Kreikemeyer B, 1999, FEMS MICROBIOL LETT, V178, P305, DOI 10.1016/S0378-1097(99)00373-0; Muriel JM, 2005, DEVELOPMENT, V132, P4223, DOI 10.1242/dev.02007; Oehmcke S, 2004, INFECT IMMUN, V72, P4302, DOI 10.1128/IAI.72.7.4302-4308.2004; Podbielski A, 1996, MOL MICROBIOL, V19, P429, DOI 10.1046/j.1365-2958.1996.377910.x; Pownall HJ, 2008, CHEM PHYS LIPIDS, V156, P45, DOI 10.1016/j.chemphyslip.2008.09.001; PRENTKI P, 1984, GENE, V29, P303, DOI 10.1016/0378-1119(84)90059-3; RAKONJAC JV, 1995, INFECT IMMUN, V63, P622, DOI 10.1128/IAI.63.2.622-631.1995; Rivas JM, 2004, CURR OPIN DRUG DISC, V7, P223; Timmer AM, 2006, MOL MICROBIOL, V62, P15, DOI 10.1111/j.1365-2958.2006.05337.x; Timpl R, 2003, NAT REV MOL CELL BIO, V4, P479, DOI 10.1038/nrm1130; TRAN H, 1995, J BIOL CHEM, V270, P19458, DOI 10.1074/jbc.270.33.19458	34	14	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12966	12971		10.1074/jbc.M901143200	http://dx.doi.org/10.1074/jbc.M901143200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19276078	Green Published, hybrid			2022-12-27	WOS:000265688300043
J	Domazet, I; Holleran, BJ; Martin, SS; Lavigne, P; Leduc, R; Escher, E; Guillemette, G				Domazet, Ivana; Holleran, Brian J.; Martin, Stephane S.; Lavigne, Pierre; Leduc, Richard; Escher, Emanuel; Guillemette, Gaetan			The Second Transmembrane Domain of the Human Type 1 Angiotensin II Receptor Participates in the Formation of the Ligand Binding Pocket and Undergoes Integral Pivoting Movement during the Process of Receptor Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; CYSTEINE ACCESSIBILITY METHOD; MEMBRANE-SPANNING SEGMENT; HUMAN AT(1) RECEPTOR; CONSTITUTIVE ACTIVATION; CRYSTAL-STRUCTURE; CONFORMATIONAL-CHANGES; CONTACT POINTS; SITE CREVICE; MECHANISM	The octapeptide hormone angiotensin II (AngII) exerts a wide variety of cardiovascular effects through the activation of the angiotensin II type-1 (AT1) receptor, which belongs to the G protein-coupled receptor superfamily. Like other G protein-coupled receptors, the AT1 receptor possesses seven transmembrane domains that provide structural support for the formation of the ligand-binding pocket. In order to identify those residues in the second transmembrane domain (TMD2) that contribute to the formation of the binding pocket of the AT1 receptor, we used the substituted cysteine accessibility method. All of the residues within the Leu-70 to Trp-94 region were mutated one at a time to a cysteine, and, after expression in COS-7 cells, the mutant receptors were treated with the sulfhydryl-specific alkylating agent methanethiosulfonate-ethylammonium (MTSEA). MTSEA reacts selectively with water-accessible, free sulfhydryl groups of endogenous or introduced point mutation cysteines. If a cysteine is found in the binding pocket, the covalent modification will affect the binding kinetics of the ligand. MTSEA substantially decreased the binding affinity of D74C-AT1, L81C-AT1, A85C-AT1, T88C-AT1, and A89C-AT1 mutant receptors, which suggests that these residues orient themselves within the water-accessible binding pocket of the AT1 receptor. Interestingly, this pattern of acquired MTSEA sensitivity was altered for TMD2 reporter cysteines engineered in a constitutively active N111G-AT1 receptor background. Indeed, mutant D74C-N111G-AT1 became insensitive to MTSEA, whereas mutant L81C-N111G-AT1 lost some sensitivity and mutant V86C-N111G-AT1 became sensitive to MTSEA. Our results suggest that constitutive activation of the AT1 receptor causes TMD2 to pivot, bringing the top of TMD2 closer to the binding pocket and pushing the bottom of TMD2 away from the binding pocket.	[Domazet, Ivana; Holleran, Brian J.; Martin, Stephane S.; Lavigne, Pierre; Leduc, Richard; Escher, Emanuel; Guillemette, Gaetan] Univ Sherbrooke, Fac Med & Hlth Sci, Dept Pharmacol, Sherbrooke, PQ J1H 5N4, Canada	University of Sherbrooke	Guillemette, G (corresponding author), Univ Sherbrooke, Fac Med, Dept Pharmacol, 3001 12th Ave N, Sherbrooke, PQ J1H 5N4, Canada.	Gaetan.Guillemette@USherbrooke.ca		Escher, Emanuel/0000-0001-6601-987X	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research. This article was submitted to fulfill the requirements of a Ph.D. thesis for I. D. at the Universite de Sherbrooke.	AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; BALDWIN JM, 1993, EMBO J, V12, P1693, DOI 10.1002/j.1460-2075.1993.tb05814.x; BALLA T, 1986, P NATL ACAD SCI USA, V83, P9323, DOI 10.1073/pnas.83.24.9323; Balmforth AJ, 1997, J BIOL CHEM, V272, P4245, DOI 10.1074/jbc.272.7.4245; Boucard AA, 2000, BIOCHEMISTRY-US, V39, P9662, DOI 10.1021/bi000597v; Boucard AA, 2003, J BIOL CHEM, V278, P36628, DOI 10.1074/jbc.M305952200; Burnier M, 2001, CIRCULATION, V103, P904, DOI 10.1161/01.CIR.103.6.904; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; de Gasparo M, 2000, PHARMACOL REV, V52, P415; Dunham TD, 1999, J BIOL CHEM, V274, P1683, DOI 10.1074/jbc.274.3.1683; Feng YH, 1998, BIOCHEMISTRY-US, V37, P15791, DOI 10.1021/bi980863t; FRAKER PJ, 1978, BIOCHEM BIOPH RES CO, V80, P849, DOI 10.1016/0006-291X(78)91322-0; Gether U, 1998, J BIOL CHEM, V273, P17979, DOI 10.1074/jbc.273.29.17979; Ghanouni P, 2001, P NATL ACAD SCI USA, V98, P5997, DOI 10.1073/pnas.101126198; Groblewski T, 1997, J BIOL CHEM, V272, P1822, DOI 10.1074/jbc.272.3.1822; GUILLEMETTE G, 1983, BIOCHEMISTRY-US, V22, P5591, DOI 10.1021/bi00293a021; Hildebrand PW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004382; Inoue Y, 1997, J HYPERTENS, V15, P703, DOI 10.1097/00004872-199715070-00001; Javitch JA, 2002, METHOD ENZYMOL, V343, P137; Javitch JA, 1999, BIOCHEMISTRY-US, V38, P7961, DOI 10.1021/bi9905314; JAVITCH JA, 1994, P NATL ACAD SCI USA, V91, P10355, DOI 10.1073/pnas.91.22.10355; JOSEPH MP, 1995, J PROTEIN CHEM, V14, P381, DOI 10.1007/BF01886795; KOJIMA I, 1984, J BIOL CHEM, V259, P4448; Lanctot PM, 1999, BIOCHEMISTRY-US, V38, P8621, DOI 10.1021/bi9830516; Laporte SA, 1999, MOL ENDOCRINOL, V13, P578, DOI 10.1210/me.13.4.578; Martin SS, 2004, J BIOL CHEM, V279, P51415, DOI 10.1074/jbc.M407965200; Martin SS, 2007, MOL PHARMACOL, V72, P182, DOI 10.1124/mol.106.033670; Matthews EE, 2006, CELL, V127, P447, DOI 10.1016/j.cell.2006.10.016; Miura S, 2002, J BIOL CHEM, V277, P24299, DOI 10.1074/jbc.M202743200; Miura S, 2003, HYPERTENS RES, V26, P937, DOI 10.1291/hypres.26.937; Murakami M, 2008, NATURE, V453, P363, DOI 10.1038/nature06925; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Perodin J, 2002, BIOCHEMISTRY-US, V41, P14348, DOI 10.1021/bi0258602; Proulx CD, 2008, MOL PHARMACOL, V74, P552, DOI 10.1124/mol.108.045054; Seifert R, 2002, N-S ARCH PHARMACOL, V366, P381, DOI 10.1007/s00210-002-0588-0	36	15	19	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					11922	11929		10.1074/jbc.M808113200	http://dx.doi.org/10.1074/jbc.M808113200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19276075	Green Published, hybrid			2022-12-27	WOS:000265494600024
J	Watanabe, H; Matsumaru, H; Ooishi, A; Feng, YW; Odahara, T; Suto, K; Honda, S				Watanabe, Hideki; Matsumaru, Hiroyuki; Ooishi, Ayako; Feng, YanWen; Odahara, Takayuki; Suto, Kyoko; Honda, Shinya			Optimizing pH Response of Affinity between Protein G and IgG Fc HOW ELECTROSTATIC MODULATIONS AFFECT PROTEIN-PROTEIN INTERACTIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHEROMONE-BINDING; DOMAIN; MECHANISM; SWITCH; THERMODYNAMICS; CONFORMATION; DEPENDENCE; PROGRAM; DESIGN; B1	Protein-protein interaction in response to environmental conditions enables sophisticated biological and biotechnological processes. Aiming toward the rational design of a pH-sensitive protein-protein interaction, we engineered pH-sensitive mutants of streptococcal protein G B1, a binder to the IgG constant region. We systematically introduced histidine residues into the binding interface to cause electrostatic repulsion on the basis of a rigid body model. Exquisite pH sensitivity of this interaction was confirmed by surface plasmon resonance and affinity chromatography employing a clinically used human IgG. The pH-sensitive mechanism of the interaction was analyzed and evaluated from kinetic, thermodynamic, and structural viewpoints. Histidine-mediated electrostatic repulsion resulted in significant loss of exothermic heat of the binding that decreased the affinity only at acidic conditions, thereby improving the pH sensitivity. The reduced binding energy was partly recovered by "enthalpy-entropy compensation." Crystal structures of the designed mutants confirmed the validity of the rigid body model on which the effective electrostatic repulsion was based. Moreover, our data suggested that the entropy gain involved exclusion of water molecules solvated in a space formed by the introduced histidine and adjacent tryptophan residue. Our findings concerning the mechanism of histidine-introduced interactions will provide a guideline for the rational design of pH-sensitive protein-protein recognition.	[Watanabe, Hideki; Matsumaru, Hiroyuki; Ooishi, Ayako; Feng, YanWen; Odahara, Takayuki; Suto, Kyoko; Honda, Shinya] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058566, Japan	National Institute of Advanced Industrial Science & Technology (AIST)	Honda, S (corresponding author), Cent 6, Tsukuba, Ibaraki 3058566, Japan.	s.honda@aist.go.jp	Odahara, Takayuki/L-6943-2018; Watanabe, Hideki/M-2711-2018; Honda, Shinya/K-6894-2016; Ooishi, Ayako/L-8654-2018	Watanabe, Hideki/0000-0002-9561-4077; Honda, Shinya/0000-0002-7878-3944; Ooishi, Ayako/0000-0003-4062-868X	NEDO (New Energy and Industrial Technology Development Organization of Japan)	NEDO (New Energy and Industrial Technology Development Organization of Japan)(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported in part by the grant program "Development of New Functional Antibody Technologies" from NEDO (New Energy and Industrial Technology Development Organization of Japan).	Asayama S, 2008, MOL PHARM, V5, P162, DOI 10.1021/mp7001076; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Broz P, 2006, NANO LETT, V6, P2349, DOI 10.1021/nl0619305; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Dincbas-Renqvist V, 2004, J AM CHEM SOC, V126, P11220, DOI 10.1021/ja047727y; DUNITZ JD, 1995, CHEM BIOL, V2, P709, DOI 10.1016/1074-5521(95)90097-7; Ejima D, 2007, PROTEINS, V66, P954, DOI 10.1002/prot.21243; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FAHNESTOCK SR, 1986, J BACTERIOL, V167, P870, DOI 10.1128/jb.167.3.870-880.1986; Garlatti V, 2007, J BIOL CHEM, V282, P35814, DOI 10.1074/jbc.M705741200; Gulich S, 2000, J BIOTECHNOL, V76, P233, DOI 10.1016/S0168-1656(99)00197-2; HOFMANN K, 1980, P NATL ACAD SCI-BIOL, V77, P4666, DOI 10.1073/pnas.77.8.4666; Hom RA, 2007, J MOL BIOL, V373, P412, DOI 10.1016/j.jmb.2007.08.016; Honda S, 2004, STRUCTURE, V12, P1507, DOI 10.1016/j.str.2004.05.022; Honda S, 1999, BIOCHEMISTRY-US, V38, P1203, DOI 10.1021/bi982271g; Honda S, 2000, J MOL BIOL, V295, P269, DOI 10.1006/jmbi.1999.3346; Horst R, 2001, P NATL ACAD SCI USA, V98, P14374, DOI 10.1073/pnas.251532998; Joachimiak LA, 2006, J MOL BIOL, V361, P195, DOI 10.1016/j.jmb.2006.05.022; Kortemme T, 2004, NAT STRUCT MOL BIOL, V11, P371, DOI 10.1038/nsmb749; Leach JL, 1996, J IMMUNOL, V157, P3317; Leal WS, 2005, P NATL ACAD SCI USA, V102, P5386, DOI 10.1073/pnas.0501447102; Lee D, 2006, MOL CELL, V22, P423, DOI 10.1016/j.molcel.2006.04.011; Linder M, 1999, FEBS LETT, V447, P13, DOI 10.1016/S0014-5793(99)00253-7; Martin WL, 2001, MOL CELL, V7, P867, DOI 10.1016/S1097-2765(01)00230-1; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nordlund HR, 2003, FEBS LETT, V555, P449, DOI 10.1016/S0014-5793(03)01302-4; Olson LJ, 2008, J BIOL CHEM, V283, P10124, DOI 10.1074/jbc.M708994200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Qiao SW, 2008, P NATL ACAD SCI USA, V105, P9337, DOI 10.1073/pnas.0801717105; Sammond DW, 2007, J MOL BIOL, V371, P1392, DOI 10.1016/j.jmb.2007.05.096; Sloan DJ, 1999, PROTEIN SCI, V8, P1643, DOI 10.1110/ps.8.8.1643; Sprague ER, 2006, PLOS BIOL, V4, P975, DOI 10.1371/journal.pbio.0040148; Sprague ER, 2004, J BIOL CHEM, V279, P14184, DOI 10.1074/jbc.M313281200; Stevens MM, 2004, LANGMUIR, V20, P7747, DOI 10.1021/la030440e; Tsodikov OV, 2002, J COMPUT CHEM, V23, P600, DOI 10.1002/jcc.10061; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Welfle K, 1999, BBA-PROTEIN STRUCT M, V1431, P120, DOI 10.1016/S0167-4838(99)00046-1; Zubkov S, 2005, J MOL BIOL, V354, P1081, DOI 10.1016/j.jmb.2005.10.015	38	40	66	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12373	12383		10.1074/jbc.M809236200	http://dx.doi.org/10.1074/jbc.M809236200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19269963	hybrid, Green Published			2022-12-27	WOS:000265494600068
J	Stengel, KR; Thangavel, C; Solomon, DA; Angus, SP; Zheng, Y; Knudsen, ES				Stengel, Kristy R.; Thangavel, Chellappagounder; Solomon, David A.; Angus, Steve P.; Zheng, Yi; Knudsen, Erik S.			Retinoblastoma/p107/p130 Pocket Proteins PROTEIN DYNAMICS AND INTERACTIONS WITH TARGET GENE PROMOTERS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE CONTROL; TUMOR-SUPPRESSOR; LIVING CELLS; TRANSCRIPTION FACTOR; FAMILY PROTEINS; RB FUNCTION; IN-VIVO; S-PHASE; E2F; REPRESSION	The retinoblastoma (RB) tumor suppressor and its family members, p107 and p130, function by repressing E2F transcription factor activity to limit the expression of genes required for cell cycle progression. Traditionally, it is thought that the RB family proteins repress E2F target gene expression through complexing with E2F at gene promoters. However, whereas chromatin immunoprecipitation experiments have demonstrated p107 and p130 at E2F-responsive promoters, RB chromatin association has not been reliably observed. Here we used green fluorescent protein-tagged proteins to rigorously explore the mechanism of RB-mediated transcriptional repression relative to its p107 and p130 family members. The use of live cell fluorescent imaging demonstrated that RB, p107, and p130 exhibit similar nuclear dynamics. Although these findings suggest a similar engagement with nuclear structures, chromatin immunoprecipitation approaches with multiple independent antibodies failed to detect the association of RB with target gene promoters. However, by employing antibodies directed against green fluorescent protein, we could utilize the same antibody to assess RB, p107, and p130 engagement. This approach demonstrated RB association with target gene promoters in a fashion analogous to p107 and p130. Extension of this technology demonstrated that direct RB phosphorylation disrupts promoter association to regulate transcription. Thus, RB is associated with promoters in a manner similar to p107/p130 and that association is modulated by phosphorylation during cell cycle progression.	[Thangavel, Chellappagounder; Knudsen, Erik S.] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA; [Stengel, Kristy R.; Zheng, Yi] Cincinnati Childrens Hosp, Med Ctr, Cincinnati, OH 45267 USA; [Angus, Steve P.] Duke Univ, Durham, NC 27710 USA; [Solomon, David A.] Georgetown Univ, Washington, DC 20007 USA	Jefferson University; Cincinnati Children's Hospital Medical Center; Duke University; Georgetown University	Knudsen, ES (corresponding author), Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA.	eknudsen@kimmelcancercenter.org	Zheng, Yi/J-7235-2015	Zheng, Yi/0000-0001-7089-6074; Stengel, Kristy/0000-0002-8330-5744; Angus, Steven/0000-0002-7655-657X				Angus SP, 2003, MOL CELL BIOL, V23, P8172, DOI 10.1128/MCB.23.22.8172-8188.2003; Balciunaite E, 2005, MOL CELL BIOL, V25, P8166, DOI 10.1128/MCB.25.18.8166-8178.2005; Blais A, 2007, CURR OPIN CELL BIOL, V19, P658, DOI 10.1016/j.ceb.2007.10.003; Cam H, 2004, MOL CELL, V16, P399, DOI 10.1016/j.molcel.2004.09.037; CAO L, 1992, NATURE, V355, P176, DOI 10.1038/355176a0; CHELLAPPAN SP, 1991, CELL, V65, P1053, DOI 10.1016/0092-8674(91)90557-F; Cobrinik D, 2005, ONCOGENE, V24, P2796, DOI 10.1038/sj.onc.1208619; COBRINIK D, 1993, GENE DEV, V7, P2392, DOI 10.1101/gad.7.12a.2392; David G, 2008, P NATL ACAD SCI USA, V105, P4168, DOI 10.1073/pnas.0710285105; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Frolov MV, 2004, J CELL SCI, V117, P2173, DOI 10.1242/jcs.01227; Gunawardena RW, 2007, J BIOL CHEM, V282, P20116, DOI 10.1074/jbc.M701406200; Harbour JW, 2000, NAT CELL BIOL, V2, pE65, DOI 10.1038/35008695; Hurford RK, 1997, GENE DEV, V11, P1447, DOI 10.1101/gad.11.11.1447; Iaquinta PJ, 2007, CURR OPIN CELL BIOL, V19, P649, DOI 10.1016/j.ceb.2007.10.006; KATO J, 1993, GENE DEV, V7, P331; Knudsen ES, 1997, MOL CELL BIOL, V17, P5771, DOI 10.1128/MCB.17.10.5771; Lai A, 2001, MOL CELL BIOL, V21, P2918, DOI 10.1128/MCB.21.8.2918-2932.2001; Leonhardt H, 2000, J CELL BIOL, V149, P271, DOI 10.1083/jcb.149.2.271; Link KA, 2008, CANCER RES, V68, P4551, DOI 10.1158/0008-5472.CAN-07-6392; Litovchick L, 2007, MOL CELL, V26, P539, DOI 10.1016/j.molcel.2007.04.015; Markey MP, 2007, ONCOGENE, V26, P6307, DOI 10.1038/sj.onc.1210450; Markey MP, 2002, CANCER RES, V62, P6587; Pilkinton M, 2007, ONCOGENE, V26, P7535, DOI 10.1038/sj.onc.1210562; Rayman JB, 2002, GENE DEV, V16, P933, DOI 10.1101/gad.969202; Schmit F, 2007, CELL CYCLE, V6, P1903, DOI 10.4161/cc.6.15.4512; Siddiqui H, 2003, MOL CELL BIOL, V23, P7719, DOI 10.1128/MCB.23.21.7719-7731.2003; Stevaux O, 2002, CURR OPIN CELL BIOL, V14, P684, DOI 10.1016/S0955-0674(02)00388-5; Strobeck MW, 2000, P NATL ACAD SCI USA, V97, P7748, DOI 10.1073/pnas.97.14.7748; Takahashi Y, 2000, GENE DEV, V14, P804; Tonnetti L, 2008, CANCER RES, V68, P5648, DOI 10.1158/0008-5472.CAN-07-5850; Vandromme M, 2008, MOL CANCER RES, V6, P418, DOI 10.1158/1541-7786.MCR-07-0381; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Wells J, 2000, MOL CELL BIOL, V20, P5797, DOI 10.1128/MCB.20.16.5797-5807.2000; Wells J, 2003, ONCOGENE, V22, P1445, DOI 10.1038/sj.onc.1206264; Young AP, 2004, ONCOGENE, V23, P2587, DOI 10.1038/sj.onc.1207330; Zhang HS, 2000, CELL, V101, P79, DOI 10.1016/S0092-8674(00)80625-X	37	29	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19265	19271		10.1074/jbc.M808740200	http://dx.doi.org/10.1074/jbc.M808740200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19279001	hybrid, Green Published			2022-12-27	WOS:000267908300017
J	Zakharova, MY; Kuznetsov, NA; Dubiley, SA; Kozyr, AV; Fedorova, OS; Chudakov, DM; Knorre, DG; Shemyakin, IG; Gabibov, AG; Kolesnikov, AV				Zakharova, Maria Yu.; Kuznetsov, Nikita A.; Dubiley, Svetlana A.; Kozyr, Arina V.; Fedorova, Olga S.; Chudakov, Dmitry M.; Knorre, Dmitry G.; Shemyakin, Igor G.; Gabibov, Alexander G.; Kolesnikov, Alexander V.			Substrate Recognition of Anthrax Lethal Factor Examined by Combinatorial and Pre-steady-state Kinetic Approaches	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; KINASE-KINASE; ACTIVE-SITE; MECHANISM; INACTIVATION; GLYCOSYLASE; PROTEOLYSIS; PROTEASE; FAMILY	Lethal factor (LF), a zinc-dependent protease of high specificity produced by Bacillus anthracis, is the effector component of the binary toxin that causes death in anthrax. New therapeutics targeting the toxin are required to reduce systemic anthrax-related fatalities. In particular, new insights into the LF catalytic mechanism will be useful for the development of LF inhibitors. We evaluated the minimal length required for formation of bona fide LF substrates using substrate phage display. Phage-based selection yielded a substrate that is cleaved seven times more efficiently by LF than the peptide targeted in the protein kinase MKK6. Site-directed mutagenesis within the metal-binding site in the LF active center and within phage-selected substrates revealed a complex pattern of LF-substrate interactions. The elementary steps of LF-mediated proteolysis were resolved by the stopped-flow technique. Pre-steady-state kinetics of LF proteolysis followed a four-step mechanism as follows: initial substrate binding, rearrangement of the enzyme-substrate complex, a rate-limiting cleavage step, and product release. Examination of LF interactions with metal ions revealed an unexpected activation of the protease by Ca2+ and Mn2+. Based on the available structural and kinetic data, we propose a model for LF-substrate interaction. Resolution of the kinetic and structural parameters governing LF activity may be exploited to design new LF inhibitors.	[Zakharova, Maria Yu.; Dubiley, Svetlana A.; Kozyr, Arina V.; Chudakov, Dmitry M.; Gabibov, Alexander G.; Kolesnikov, Alexander V.] Russian Acad Sci, MM Shemyakin & Yu A Ovchinnikov Inst Bioorgan Che, Moscow 117997, Russia; [Kuznetsov, Nikita A.; Fedorova, Olga S.; Knorre, Dmitry G.] Russian Acad Sci, Inst Chem Biol & Fundamental Med, Siberian Branch, Novosibirsk 630090, Russia; [Shemyakin, Igor G.] State Res Ctr Appl Microbiol & Biotechnol, Obolensk 142279, Moscow Region, Russia	Russian Academy of Sciences; Pushchino Scientific Center for Biological Research (PSCBI) of the Russian Academy of Sciences; Institute of Bioorganic Chemistry of the Russian Academy of Sciences; Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences	Kolesnikov, AV (corresponding author), Inst Bioorgan Chem, Miklukho Maklaya 16-10,117997 GSP,V-437, Moscow, Russia.	koleso@ibch.ru	Fedorova, Olga/ABE-6637-2020; Knorre, Dmitriy/G-4250-2013; Dubiley, Svetlana/AAU-2812-2021; Kuznetsov, Nikita/CAA-3889-2022; Chudakov, Dmitriy M/G-7741-2014; Fedorova, Olga S./E-1291-2013; Kuznetsov, Nikita A/F-3245-2011; Kuznetsov, Nikita/AFU-9897-2022; Kolesnikov, Alexander V/O-1840-2016	Fedorova, Olga/0000-0002-4001-7187; Kuznetsov, Nikita/0000-0002-4016-198X; Chudakov, Dmitriy M/0000-0003-0430-790X; Fedorova, Olga S./0000-0002-4001-7187; Kuznetsov, Nikita A/0000-0002-4016-198X; Kuznetsov, Nikita/0000-0002-4016-198X; 	United States Civilian Research & Development Foundation [2496]; NATO [SfP 980870]; Russian Ministry of Science [02.512.11.2007, 02.512.11.2208]	United States Civilian Research & Development Foundation; NATO(NATO (North Atlantic Treaty Organisation)); Russian Ministry of Science	This work was supported by United States Civilian Research & Development Foundation Grant 2496, NATO Grant SfP 980870, and the Russian Ministry of Science Grants 02.512.11.2007 and 02.512.11.2208.	Allerberger F, 2002, LANCET, V359, P711, DOI 10.1016/S0140-6736(02)07793-0; CHEVRIER B, 1994, STRUCTURE, V2, P283, DOI 10.1016/S0969-2126(00)00030-7; Chopra AP, 2003, J BIOL CHEM, V278, P9402, DOI 10.1074/jbc.M211262200; Cummings RT, 2002, P NATL ACAD SCI USA, V99, P6603, DOI 10.1073/pnas.062171599; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Hammond SE, 1998, INFECT IMMUN, V66, P2374, DOI 10.1128/IAI.66.5.2374-2378.1998; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; HOLLAND DR, 1995, PROTEIN SCI, V4, P1955, DOI 10.1002/pro.5560041001; Huang C Y, 1979, Methods Enzymol, V63, P54; Jernigan DB, 2002, EMERG INFECT DIS, V8, P1019, DOI 10.3201/eid0810.020353; KOCHI SK, 1994, FEMS MICROBIOL LETT, V124, P343, DOI 10.1111/j.1574-6968.1994.tb07306.x; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; Kuznetsov NA, 2007, J BIOL CHEM, V282, P1029, DOI 10.1074/jbc.M605788200; Kuznetsov NA, 2007, BIOCHEMISTRY-US, V46, P424, DOI 10.1021/bi060787r; Liang XD, 2004, J BIOL CHEM, V279, P52473, DOI 10.1074/jbc.M409105200; LOBB RR, 1980, BIOCHEMISTRY-US, V19, P5297, DOI 10.1021/bi00564a023; Mock M, 2001, ANNU REV MICROBIOL, V55, P647, DOI 10.1146/annurev.micro.55.1.647; Mock WL, 1996, BIOCHEMISTRY-US, V35, P7369, DOI 10.1021/bi952827p; Nakajima K, 1997, NUCLEIC ACIDS RES, V25, P2231, DOI 10.1093/nar/25.11.2231; *NOV, 1997, PET SYST MAN, V4, P49; NUSSEY SS, 2001, ENDOCRINOLOGY INTEGR, P173; Pannifer AD, 2001, NATURE, V414, P229, DOI 10.1038/n35101998; Rellos P, 2007, J BIOL CHEM, V282, P6833, DOI 10.1074/jbc.M609721200; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Scott WRP, 2000, STRUCTURE, V8, P1259, DOI 10.1016/S0969-2126(00)00537-2; SMITH MM, 1995, J BIOL CHEM, V270, P6440, DOI 10.1074/jbc.270.12.6440; Souslova EA, 2006, MICROSC RES TECHNIQ, V69, P207, DOI 10.1002/jemt.20278; Tonello F, 2003, J BIOL CHEM, V278, P40075, DOI 10.1074/jbc.M306466200; Tonello F, 2002, NATURE, V418, P386, DOI 10.1038/418386a; Turk BE, 2004, NAT STRUCT MOL BIOL, V11, P60, DOI 10.1038/nsmb708; Vitale G, 2000, BIOCHEM J, V352, P739, DOI 10.1042/0264-6021:3520739; Young JAT, 2007, ANNU REV BIOCHEM, V76, P243, DOI 10.1146/annurev.biochem.75.103004.142728	32	17	18	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					17902	17913		10.1074/jbc.M807510200	http://dx.doi.org/10.1074/jbc.M807510200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19359249	hybrid, Green Published			2022-12-27	WOS:000267712400002
J	Hilgenberg, LGW; Pham, B; Ortega, M; Walid, S; Kemmerly, T; O'Dowd, DK; Smith, MA				Hilgenberg, Lutz G. W.; Pham, Bryan; Ortega, Maria; Walid, Saif; Kemmerly, Thomas; O'Dowd, Diane K.; Smith, Martin A.			Agrin Regulation of alpha 3 Sodium-Potassium ATPase Activity Modulates Cardiac Myocyte Contraction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORTICAL-NEURONS; MONOCLONAL-ANTIBODIES; NA,K-ATPASE ALPHA; INTRACELLULAR NA+; SUBUNIT ISOFORMS; TYROSINE KINASES; PUMP FUNCTION; RAT; RECEPTOR; EXPRESSION	Drugs that inhibit Na, K-ATPases, such as digoxin and ouabain, alter cardiac myocyte contractility. We recently demonstrated that agrin, a protein first identified at the vertebrate neuromuscular junction, binds to and regulates the activity of alpha 3 subunit-containing isoforms of the Na, K-ATPase in the mammalian brain. Both agrin and the alpha 3 Na, K-ATPase are expressed in heart, but their potential for interaction and effect on cardiac myocyte function was unknown. Here we show that agrin binds to the alpha 3 subunit of the Na, K-ATPase in cardiac myocyte membranes, inducing tyrosine phosphorylation and inhibiting activity of the pump. Agrin also triggers a rapid increase in cytoplasmic Na+ in cardiac myocytes, suggesting a role in cardiac myocyte function. Consistent with this hypothesis, spontaneous contraction frequencies of cultured cardiac myocytes prepared from mice in which agrin expression is blocked by mutation of the Agrn gene are significantly higher than in the wild type. The Agrn mutant phenotype is rescued by acute treatment with recombinant agrin. Furthermore, exposure of wild type myocytes to an agrin antagonist phenocopies the Agrn mutation. These data demonstrate that the basal frequency of myocyte contraction depends on endogenous agrin-alpha 3 Na, K-ATPase interaction and suggest that agrin modulation of the alpha 3 Na, K-ATPase is important in regulating heart function.	[Smith, Martin A.] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92697 USA; [Ortega, Maria; Kemmerly, Thomas; O'Dowd, Diane K.] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92697 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Smith, MA (corresponding author), Univ Calif Irvine, Dept Anat & Neurobiol, Joan Irvine Smith Hall,Rm 110, Irvine, CA 92697 USA.	masmith@uci.edu			National Institutes of Health [NS33213, NS27501]; American Heart Association Western States Affiliate; Howard Hughes Medical Institute (HHMI); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS027501, R01NS027501, R29NS027501, R01NS033213] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Western States Affiliate(American Heart Association); Howard Hughes Medical Institute (HHMI)(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants NS33213 (to M. A. S.) and NS27501 (to D. K. O'D.). This work was also supported by a grant-in-aid from the American Heart Association Western States Affiliate (to M. A. S.) and a Howard Hughes Medical Institute (HHMI) professor's grant (to D. K. O'D.).	Arystarkhova E, 1996, J BIOL CHEM, V271, P23407, DOI 10.1074/jbc.271.38.23407; Bers DM, 2003, CARDIOVASC RES, V57, P897, DOI 10.1016/S0008-6363(02)00656-9; BIROC SL, 1993, DEV BRAIN RES, V75, P119, DOI 10.1016/0165-3806(93)90071-H; Blaustein MP, 1998, CLIN EXP HYPERTENS, V20, P691, DOI 10.3109/10641969809053247; Bossuyt J, 2006, J BIOL CHEM, V281, P32765, DOI 10.1074/jbc.M606254200; Bozulic LD, 2005, INVEST OPHTH VIS SCI, V46, P618, DOI 10.1167/iovs.04-0809; Burgess RW, 2000, J CELL BIOL, V151, P41, DOI 10.1083/jcb.151.1.41; Cheusova T, 2006, J NEUROCHEM, V99, P450, DOI 10.1111/j.1471-4159.2006.04086.x; Crambert G, 2002, P NATL ACAD SCI USA, V99, P11476, DOI 10.1073/pnas.182267299; Despa S, 2005, CIRC RES, V97, P252, DOI 10.1161/01.RES.0000176532.97731.e5; Dostanic I, 2003, J BIOL CHEM, V278, P53026, DOI 10.1074/jbc.M308547200; Fuller W, 2004, FASEB J, V18, P197, DOI 10.1096/fj.03-0213fje; GESEMANN M, 1995, J CELL BIOL, V128, P625, DOI 10.1083/jcb.128.4.625; Glitsch HG, 2001, PHYSIOL REV, V81, P1791, DOI 10.1152/physrev.2001.81.4.1791; GODFREY EW, 1988, J CELL BIOL, V106, P1263, DOI 10.1083/jcb.106.4.1263; GOTTLIEB SS, 1992, CIRCULATION, V86, P420, DOI 10.1161/01.CIR.86.2.420; HALLAQ H, 1990, P NATL ACAD SCI USA, V87, P7834, DOI 10.1073/pnas.87.20.7834; HALLAQ H, 1989, J PHARMACOL EXP THER, V248, P716; Han F, 2006, CIRC RES, V99, P1376, DOI 10.1161/01.RES.0000251667.73461.fb; Harada K, 2006, J PHYSIOL SCI, V56, P113, DOI 10.2170/physiolsci.RP001905; Hilgenberg LGW, 2006, CELL, V125, P359, DOI 10.1016/j.cell.2006.01.052; Hilgenberg LGW, 1999, J NEUROSCI, V19, P7384, DOI 10.1523/JNEUROSCI.19-17-07384.1999; Hilgenberg LGW, 2004, J NEUROBIOL, V61, P289, DOI 10.1002/neu.20049; HOCH W, 1993, NEURON, V11, P479, DOI 10.1016/0896-6273(93)90152-H; Hoover CL, 2003, J CELL BIOL, V161, P923, DOI 10.1083/jcb.200301013; James PF, 1999, MOL CELL, V3, P555, DOI 10.1016/S1097-2765(00)80349-4; Jia LG, 2005, AM J PHYSIOL-HEART C, V288, pH1982, DOI 10.1152/ajpheart.00142.2004; Juhaszova M, 1997, ANN NY ACAD SCI, V834, P524, DOI 10.1111/j.1749-6632.1997.tb52310.x; Kaplan JH, 2002, ANNU REV BIOCHEM, V71, P511, DOI 10.1146/annurev.biochem.71.102201.141218; LEVI AJ, 1994, PROG BIOPHYS MOL BIO, V62, P1, DOI 10.1016/0079-6107(94)90005-1; LUCCHESI PA, 1991, J BIOL CHEM, V266, P9327; Martin AO, 2005, J CELL BIOL, V169, P503, DOI 10.1083/jcb.200411054; Mitcheson JS, 1998, CARDIOVASC RES, V39, P280, DOI 10.1016/S0008-6363(98)00128-X; Ngo ST, 2007, INT J BIOCHEM CELL B, V39, P863, DOI 10.1016/j.biocel.2006.10.012; Pierre SV, 2006, CELL BIOCHEM BIOPHYS, V46, P303, DOI 10.1385/CBB:46:3:303; Quintas LEM, 2007, EUR J PHARMACOL, V565, P151, DOI 10.1016/j.ejphar.2007.03.017; Reif R, 2007, FASEB J, V21, P3468, DOI 10.1096/fj.07-8800com; Rhee MS, 2004, AM J PHYSIOL-CELL PH, V287, pC1229, DOI 10.1152/ajpcell.00111.2004; SCHENK DB, 1983, P NATL ACAD SCI-BIOL, V80, P5281, DOI 10.1073/pnas.80.17.5281; Schoner W, 2002, EUR J BIOCHEM, V269, P2440, DOI 10.1046/j.1432-1033.2002.02911.x; Smith MA, 2002, NEUROREPORT, V13, P1485, DOI 10.1097/00001756-200208270-00001; SWEADNER KJ, 1989, BIOCHIM BIOPHYS ACTA, V988, P185, DOI 10.1016/0304-4157(89)90019-1; Thompson CB, 1996, J BIOL CHEM, V271, P32653, DOI 10.1074/jbc.271.51.32653; Verdonck F, 2003, J MOL CELL CARDIOL, V35, P5, DOI 10.1016/S0022-2828(02)00280-8; Wang JN, 1996, J CLIN INVEST, V98, P1650, DOI 10.1172/JCI118960; Wang XQ, 2005, J NEUROCHEM, V93, P1515, DOI 10.1111/j.1471-4159.2005.03147.x; Zahler R, 1996, CIRC RES, V78, P870, DOI 10.1161/01.RES.78.5.870	47	18	21	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					16956	16965		10.1074/jbc.M806855200	http://dx.doi.org/10.1074/jbc.M806855200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19376779	hybrid, Green Published			2022-12-27	WOS:000266962400033
J	Podzelinska, K; He, SM; Wathier, M; Yakunin, A; Proudfoot, M; Hove-Jensen, B; Zechel, DL; Jia, ZC				Podzelinska, Kateryna; He, Shu-Mei; Wathier, Matthew; Yakunin, Alexander; Proudfoot, Michael; Hove-Jensen, Bjarne; Zechel, David L.; Jia, Zongchao			Structure of PhnP, a Phosphodiesterase of the Carbon-Phosphorus Lyase Pathway for Phosphonate Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINUCLEAR ZINC PHOSPHODIESTERASE; METALLO-BETA-LACTAMASES; TRNASE-Z CATALYSIS; ESCHERICHIA-COLI; PYRROLOQUINOLINE QUINONE; STRINGENT RESPONSE; GLYOXALASE-II; TRANSFER-RNA; CRYSTAL-STRUCTURE; Z-ENZYMES	Carbon-phosphorus lyase is a multienzyme system encoded by the phn operon that enables bacteria to metabolize organophosphonates when the preferred nutrient, inorganic phosphate, is scarce. One of the enzymes encoded by this operon, PhnP, is predicted by sequence homology to be a metal-dependent hydrolase of the beta-lactamase superfamily. Screening with a wide array of hydrolytically sensitive substrates indicated that PhnP is an enzyme with phosphodiesterase activity, having the greatest specificity toward bis(p-nitrophenyl) phosphate and 2',3'-cyclic nucleotides. No activity was observed toward RNA. The metal ion dependence of PhnP with bis(p-nitrophenyl) phosphate as substrate revealed a distinct preference for Mn2+ and Ni2+ for catalysis, whereas Zn2+ afforded poor activity. The three-dimensional structure of PhnP was solved by x-ray crystallography to 1.4 angstrom resolution. The overall fold of PhnP is very similar to that of the tRNase Z endonucleases but lacks the long exosite module used by these enzymes to bind their tRNA substrates. The active site of PhnP contains what are probably two Mn2+ ions surrounded by an array of active site residues that are identical to those observed in the tRNase Z enzymes. A second, remote Zn2+ binding site is also observed, composed of a set of cysteine and histidine residues that are strictly conserved in the PhnP family. This second metal ion site appears to stabilize a structural motif.	[Podzelinska, Kateryna; Zechel, David L.; Jia, Zongchao] Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada; [He, Shu-Mei; Wathier, Matthew] Queens Univ, Dept Chem, Kingston, ON K7L 3N6, Canada; [Yakunin, Alexander; Proudfoot, Michael] Univ Toronto, Banting & Best Dept Med Res, Toronto, ON M5G 1L6, Canada; [Hove-Jensen, Bjarne] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark	Queens University - Canada; Queens University - Canada; University of Toronto; University of Copenhagen	Zechel, DL (corresponding author), Queens Univ, Dept Biochem, Kingston, ON K7L 3N6, Canada.	dlzechel@chem.queensu.ca; jia@post.queensu.ca	Yakunin, Alexander/J-1519-2014	Yakunin, Alexander/0000-0003-0813-6490; Zechel, David/0000-0002-1570-599X	Natural Sciences and Engineering Research Council of Canada (NSERC); Canadian Institute for Health Research	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported in part by grants from the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Canadian Institute for Health Research.	Adams MA, 2008, J BACTERIOL, V190, P1072, DOI 10.1128/JB.01274-07; ANDERSEN PS, 1995, J BACTERIOL, V177, P2008, DOI 10.1128/jb.177.8.2008-2013.1995; Aravind L, 1999, In Silico Biol, V1, P69; BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8; BOCHNER BR, 1982, J BIOL CHEM, V257, P9759; Campos-Bermudez VA, 2007, BIOCHEMISTRY-US, V46, P11069, DOI 10.1021/bi7007245; Cheary R.W., 1996, PROGRAMS XFIT FOURYA; Crisp J, 2007, BIOCHEMISTRY-US, V46, P10664, DOI 10.1021/bi700707u; Crowder MW, 2006, ACCOUNTS CHEM RES, V39, P721, DOI 10.1021/ar0400241; de la Sierra-Gallay IL, 2006, NAT STRUCT MOL BIOL, V13, P376, DOI 10.1038/nsmb1066; de la Sierra-Gallay IL, 2005, NATURE, V433, P657, DOI 10.1038/nature03284; Errey JC, 2006, BIOCHEMISTRY-US, V45, P3033, DOI 10.1021/bi052297p; Garrity JD, 2004, J BIOL CHEM, V279, P920, DOI 10.1074/jbc.M309852200; Hogg T, 2004, CELL, V117, P57, DOI 10.1016/S0092-8674(04)00260-0; Hou ZL, 1999, J BIOL CHEM, V274, P17505, DOI 10.1074/jbc.274.25.17505; Hove-Jensen B, 2003, J BACTERIOL, V185, P2793, DOI 10.1128/JB.185.9.2793-2801.2003; HOVEJENSEN B, 1988, J BACTERIOL, V170, P1148, DOI 10.1128/jb.170.3.1148-1152.1988; Hu ZX, 2008, BIOCHEMISTRY-US, V47, P7947, DOI 10.1021/bi8004768; Huang JL, 2005, J MOL EVOL, V61, P682, DOI 10.1007/s00239-004-0349-4; Karkashon S, 2007, BIOCHEMISTRY-US, V46, P9380, DOI 10.1021/bi700578v; Kehres DG, 2003, FEMS MICROBIOL REV, V27, P263, DOI 10.1016/S0168-6445(03)00052-4; Kostelecky B, 2006, J BACTERIOL, V188, P1607, DOI 10.1128/JB.188.4.1607-1614.2006; Kuznetsova E, 2005, FEMS MICROBIOL REV, V29, P263, DOI 10.1016/j.femsre.2004.12.006; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Llarrull LI, 2007, J BIOL CHEM, V282, P18276, DOI 10.1074/jbc.M700742200; Magnusson OT, 2004, P NATL ACAD SCI USA, V101, P7913, DOI 10.1073/pnas.0402640101; Mazumder R, 2002, NUCLEIC ACIDS RES, V30, P5229, DOI 10.1093/nar/gkf645; METCALF WW, 1993, J BACTERIOL, V175, P3430, DOI 10.1128/jb.175.11.3430-3442.1993; Minagawa A, 2006, NUCLEIC ACIDS RES, V34, P3811, DOI 10.1093/nar/gkl517; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Patzer SI, 2001, J BACTERIOL, V183, P4806, DOI 10.1128/JB.183.16.4806-4813.2001; Podzelinska K, 2008, ACTA CRYSTALLOGR F, V64, P554, DOI 10.1107/S1744309108014656; Quinn JP, 2007, ENVIRON MICROBIOL, V9, P2392, DOI 10.1111/j.1462-2920.2007.01397.x; Rao NN, 1998, J BACTERIOL, V180, P2186, DOI 10.1128/JB.180.8.2186-2193.1998; Redko Y, 2007, NAT REV MICROBIOL, V5, P278, DOI 10.1038/nrmicro1622; Rizk SS, 2006, PROTEIN SCI, V15, P1745, DOI 10.1110/ps.062135206; Schilling O, 2005, BIOCHEM J, V385, P145, DOI 10.1042/BJ20040773; Schilling O, 2003, BIOCHEMISTRY-US, V42, P11777, DOI 10.1021/bi034672o; Shibata HS, 2006, BIOCHEMISTRY-US, V45, P5486, DOI 10.1021/bi051972s; SILVER S, 1970, J BACTERIOL, V104, P1299, DOI 10.1128/JB.104.3.1299-1306.1970; Spath B, 2007, CELL MOL LIFE SCI, V64, P2404, DOI 10.1007/s00018-007-7160-5; Spath B, 2008, ARCH MICROBIOL, V190, P301, DOI 10.1007/s00203-008-0368-4; Spath B, 2007, BIOCHEMISTRY-US, V46, P14742, DOI 10.1021/bi7010459; SPIRA B, 1995, J BACTERIOL, V177, P4053, DOI 10.1128/jb.177.14.4053-4058.1995; Toyama H, 1998, MICROBIOL-UK, V144, P183, DOI 10.1099/00221287-144-1-183; VELTEROP JS, 1995, J BACTERIOL, V177, P5088, DOI 10.1128/jb.177.17.5088-5098.1995; Vogel A, 2004, BIOCHEMISTRY-US, V43, P10379, DOI 10.1021/bi049703+; Vogel A, 2002, J BIOL CHEM, V277, P29078, DOI 10.1074/jbc.M112047200; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Yakovleva GM, 1998, APPL MICROBIOL BIOT, V49, P573, DOI 10.1007/s002530051215; Yakunin AF, 2004, J BIOL CHEM, V279, P36819, DOI 10.1074/jbc.M405120200	53	29	31	2	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					17216	17226		10.1074/jbc.M808392200	http://dx.doi.org/10.1074/jbc.M808392200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19366688	Green Published, hybrid			2022-12-27	WOS:000266962400059
J	Pongratz, RL; Kibbey, RG; Kirkpatrick, CL; Zhao, XJ; Pontoglio, M; Yaniv, M; Wollheim, CB; Shulman, GI; Cline, GW				Pongratz, Rebecca L.; Kibbey, Richard G.; Kirkpatrick, Clare L.; Zhao, Xiaojian; Pontoglio, Marco; Yaniv, Moshe; Wollheim, Claes B.; Shulman, Gerald I.; Cline, Gary W.			Mitochondrial Dysfunction Contributes to Impaired Insulin Secretion in INS-1 Cells with Dominant-negative Mutations of HNF-1 alpha and in HNF-1 alpha-deficient Islets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATOCYTE NUCLEAR FACTOR-1-ALPHA; PANCREATIC BETA-CELLS; MAGNETIC-RESONANCE; MALIC ENZYME; ISOLATED RAT; PROTON LEAK; EXPRESSION; METABOLISM; GLUCOSE; GENE	Maturity Onset Diabetes of the Young-type 3 (MODY-3) has been linked to mutations in the transcription factor hepatic nuclear factor (HNF)-1 alpha, resulting in deficiency in glucose-stimulated insulin secretion. In INS-1 cells overexpressing doxycycline-inducible HNF-1 alpha dominant-negative (DN-) gene mutations, and islets from Hnf-1 alpha knock-out mice, insulin secretion was impaired in response to glucose (15 mM) and other nutrient secretagogues. Decreased rates of insulin secretion in response to glutamine plus leucine and to methyl pyruvate, but not potassium depolarization, indicate defects specific to mitochondrial metabolism. To identify the biochemical mechanisms responsible for impaired insulin secretion, we used P-31 NMR measured mitochondrial ATP synthesis (distinct from glycolytic ATP synthesis) together with oxygen consumption measurements to determine the efficiency of mitochondrial oxidative phosphorylation. Mitochondrial uncoupling was significantly higher in DN-HNF-1 alpha cells, such that rates of ATP synthesis were decreased by approximately one-half in response to the secretagogues glucose, glutamine plus leucine, or pyruvate. In addition to closure of the ATP-sensitive K+ channels with mitochondrial ATP synthesis, mitochondrial production of second messengers through increased anaplerotic flux has been shown to be critical for coupling metabolism to insulin secretion. C-13-Isotopomer analysis and tandem mass spectrometry measurement of Krebs cycle intermediates revealed a negative impact of DN-HNF-1 alpha and Hnf-1 alpha knock-out on mitochondrial second messenger production with glucose but not amino acids. Taken together, these results indicate that, in addition to reduced glycolytic flux, uncoupling of mitochondrial oxidative phosphorylation contributes to impaired nutrient-stimulated insulin secretion with either mutations or loss of HNF-1 alpha.	[Pongratz, Rebecca L.; Kibbey, Richard G.; Zhao, Xiaojian; Shulman, Gerald I.; Cline, Gary W.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA; [Shulman, Gerald I.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA; [Shulman, Gerald I.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; [Kirkpatrick, Clare L.; Wollheim, Claes B.] Univ Geneva, Dept Cell Physiol & Metab, CH-1211 Geneva 4, Switzerland; [Pontoglio, Marco; Yaniv, Moshe] Inst Pasteur, CNRS, Dept Dev Biol, Unite Rech Associee 1644, F-75724 Paris, France	Yale University; Yale University; Howard Hughes Medical Institute; Yale University; University of Geneva; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Cline, GW (corresponding author), Yale Univ, Sch Med, Dept Internal Med, POB 208020, New Haven, CT 06520 USA.	gary.cline@yale.edu	Kirkpatrick, Clare L/M-1890-2018; Shulman, Gerald I./P-7176-2019	Kirkpatrick, Clare L/0000-0001-8564-8559; Shulman, Gerald I./0000-0003-1529-5668	National Institutes of Health [R01 DK-071071]; EuroDia [LSHM-CT-2006-518153]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK059635, K08DK080142, R01DK071071, R01DK040936] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EuroDia; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 DK-071071 from USPHS (to G. W. C.). This work was also supported by EuroDia Grant LSHM-CT-2006-518153, a European Community-funded project under Framework Program 6 (to C. B. W.).	Abad MFC, 2004, J BIOL CHEM, V279, P11521, DOI 10.1074/jbc.M306766200; Affourtit C, 2006, BIOCHEM J, V393, P151, DOI 10.1042/BJ20051280; BUKOWIECKI L, 1979, BIOCHIM BIOPHYS ACTA, V583, P370, DOI 10.1016/0304-4165(79)90461-6; CAMPBELLBURK SL, 1987, BIOCHEMISTRY-US, V26, P7493, DOI 10.1021/bi00397a044; Cline GW, 2004, J BIOL CHEM, V279, P44370, DOI 10.1074/jbc.M311842200; Cline GW, 2001, J BIOL CHEM, V276, P20240, DOI 10.1074/jbc.M102540200; COHEN SM, 1978, NATURE, V273, P554, DOI 10.1038/273554a0; David G, 1999, J NEUROSCI, V19, P7495, DOI 10.1523/JNEUROSCI.19-17-07495.1999; Drew B, 2003, AM J PHYSIOL-REG I, V285, pR1259, DOI 10.1152/ajpregu.00264.2003; Du F, 2007, MAGN RESON MED, V57, P103, DOI 10.1002/mrm.21107; Dukes ID, 1998, J BIOL CHEM, V273, P24457, DOI 10.1074/jbc.273.38.24457; FAJANS SS, 1989, DIABETES METAB REV, V5, P579, DOI 10.1002/dmr.5610050705; GADIAN DG, 1979, BIOL APPLICATIONS MA, P463; Hagenfeldt-Johansson KA, 2001, ENDOCRINOLOGY, V142, P5311, DOI 10.1210/en.142.12.5311; Krauss S, 2003, J CLIN INVEST, V112, P1831, DOI 10.1172/JCI200319774; Krauss S, 2002, P NATL ACAD SCI USA, V99, P118, DOI 10.1073/pnas.012410699; MacDonald MJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1, DOI 10.1152/ajpendo.00218.2004; MACDONALD MJ, 1992, HORM METAB RES, V24, P158, DOI 10.1055/s-2007-1003284; MACDONALD MJ, 1985, DIABETES, V34, P246, DOI 10.2337/diabetes.34.3.246; MALLOY CR, 1990, AM J PHYSIOL, V259, pH987, DOI 10.1152/ajpheart.1990.259.3.H987; Papas KK, 1998, AM J PHYSIOL-ENDOC M, V275, pE1100, DOI 10.1152/ajpendo.1998.275.6.E1100; Papas KK, 2007, BIOTECHNOL BIOENG, V98, P1071, DOI 10.1002/bit.21486; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; PETROFF OAC, 1985, NEUROLOGY, V35, P781, DOI 10.1212/WNL.35.6.781; Pongratz RL, 2007, J BIOL CHEM, V282, P200, DOI 10.1074/jbc.M602954200; Pontoglio M, 1998, J CLIN INVEST, V101, P2215, DOI 10.1172/JCI2548; Schuit F, 1997, J BIOL CHEM, V272, P18572, DOI 10.1074/jbc.272.30.18572; Shih DQ, 2001, DIABETES, V50, P2472, DOI 10.2337/diabetes.50.11.2472; Simpson NE, 2006, DIABETOLOGIA, V49, P1338, DOI 10.1007/s00125-006-0216-5; TELLER JK, 1992, J BIOL CHEM, V267, P10423; Thomas H, 2002, BIOL CHEM, V383, P1691, DOI 10.1515/BC.2002.190; Wang HY, 1998, EMBO J, V17, P6701, DOI 10.1093/emboj/17.22.6701; Wang HY, 2000, EMBO J, V19, P4257, DOI 10.1093/emboj/19.16.4257; Wiederkehr A, 2009, EMBO J, V28, P417, DOI 10.1038/emboj.2008.302; Yamagata K, 2002, DIABETES, V51, P114, DOI 10.2337/diabetes.51.1.114; Yamagata K, 1996, NATURE, V384, P455, DOI 10.1038/384455a0; Zawalich WS, 2004, J ENDOCRINOL, V183, P309, DOI 10.1677/joe.1.05832	37	27	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					16808	16821		10.1074/jbc.M807723200	http://dx.doi.org/10.1074/jbc.M807723200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19376774	hybrid, Green Published			2022-12-27	WOS:000266962400017
J	Osterhage, JL; Friedman, KL				Osterhage, Jennifer L.; Friedman, Katherine L.			Chromosome End Maintenance by Telomerase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							TEMPLATE BOUNDARY DEFINITION; YEAST TELOMERASE; REVERSE-TRANSCRIPTASE; CATALYTIC SUBUNIT; SACCHAROMYCES-CEREVISIAE; TETRAHYMENA TELOMERASE; DYSKERATOSIS-CONGENITA; TERMINAL TRANSFERASE; EST3 PROTEIN; OB-FOLD	Telomeres, protein-DNA complexes at the ends of eukaryotic linear chromosomes, are essential for genome stability. The accumulation of chromosomal abnormalities in the absence of proper telomere function is implicated in human aging and cancer. Repetitive telomeric sequences are maintained by telomerase, a ribonucleoprotein complex containing a reverse transcriptase subunit, a template RNA, and accessory components. Telomere elongation is regulated at multiple levels, including assembly of the telomerase holoenzyme, recruitment of telomerase to the chromosome terminus, and telomere accessibility. This minireview provides an overview of telomerase structure, function, and regulation and the role of telomerase in human disease.	[Friedman, Katherine L.] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; [Osterhage, Jennifer L.] Hanover Coll, Dept Biol, Hanover, IN 47243 USA	Vanderbilt University	Friedman, KL (corresponding author), Vanderbilt Univ, Dept Biol Sci, 221 Kirkland Hall, Nashville, TN 37235 USA.	katherine.friedman@vanderbilt.edu						Aisner DL, 2002, CURR OPIN GENET DEV, V12, P80, DOI 10.1016/S0959-437X(01)00268-4; Armbruster BN, 2004, MOL CELL BIOL, V24, P3552, DOI 10.1128/MCB.24.8.3552-3561.2004; Aubert G, 2008, PHYSIOL REV, V88, P557, DOI 10.1152/physrev.00026.2007; Autexier C, 2006, ANNU REV BIOCHEM, V75, P493, DOI 10.1146/annurev.biochem.75.103004.142412; Azzalin CM, 2008, CELL CYCLE, V7, P1161, DOI 10.4161/cc.7.9.5836; Bianchi A, 2008, MOL CELL, V31, P153, DOI 10.1016/j.molcel.2008.06.013; Blackburn EH, 2006, NAT MED, V12, P1133, DOI 10.1038/nm1006-1133; Cairney CJ, 2008, BIOCHIMIE, V90, P13, DOI 10.1016/j.biochi.2007.07.025; Cesare AJ, 2008, MECH AGEING DEV, V129, P99, DOI 10.1016/j.mad.2007.11.006; Chen JL, 2003, GENE DEV, V17, P2747, DOI 10.1101/gad.1140303; Collins K, 2008, MECH AGEING DEV, V129, P91, DOI 10.1016/j.mad.2007.10.008; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Finkel T, 2007, NATURE, V448, P767, DOI 10.1038/nature05985; Gillis AJ, 2008, NATURE, V455, P633, DOI 10.1038/nature07283; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; GREIDER CW, 1987, CELL, V51, P887, DOI 10.1016/0092-8674(87)90576-9; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Hemann MT, 2001, CELL, V107, P67, DOI 10.1016/S0092-8674(01)00504-9; Hughes TR, 2000, CURR BIOL, V10, P809, DOI 10.1016/S0960-9822(00)00562-5; Jacobs SA, 2006, NAT STRUCT MOL BIOL, V13, P218, DOI 10.1038/nsmb1054; Lai CK, 2002, GENE DEV, V16, P415, DOI 10.1101/gad.962602; Lee J, 2008, NAT STRUCT MOL BIOL, V15, P990, DOI 10.1038/nsmb.1472; Lendvay TS, 1996, GENETICS, V144, P1399; Li S, 2009, CELL, V136, P50, DOI 10.1016/j.cell.2008.11.027; Lingner J, 1996, P NATL ACAD SCI USA, V93, P10712, DOI 10.1073/pnas.93.20.10712; Lingner J, 1997, P NATL ACAD SCI USA, V94, P11190, DOI 10.1073/pnas.94.21.11190; Lingner J, 1997, SCIENCE, V276, P561, DOI 10.1126/science.276.5312.561; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; Marcand S, 1997, SCIENCE, V275, P986, DOI 10.1126/science.275.5302.986; Muller H., 1938, COLLECT NET, V13, P182; Nakamura TM, 1997, SCIENCE, V277, P955, DOI 10.1126/science.277.5328.955; OLOVNIKOV AM, 1973, J THEOR BIOL, V41, P181, DOI 10.1016/0022-5193(73)90198-7; Pennock E, 2001, CELL, V104, P387, DOI 10.1016/S0092-8674(01)00226-4; Reichenbach P, 2003, CURR BIOL, V13, P568, DOI 10.1016/S0960-9822(03)00173-8; Riha K, 2003, CHROMOSOME RES, V11, P263, DOI 10.1023/A:1022892010878; Sabourin M, 2008, TRENDS CELL BIOL, V18, P337, DOI 10.1016/j.tcb.2008.04.004; Seto AG, 2002, GENE DEV, V16, P2800, DOI 10.1101/gad.1029302; Seto AG, 1999, NATURE, V401, P177, DOI 10.1038/43694; Sfeir AJ, 2005, CELL CYCLE, V4, P1467, DOI 10.4161/cc.4.11.2161; Shay JW, 2008, BRIT J CANCER, V98, P677, DOI 10.1038/sj.bjc.6604209; Shay JW, 2006, NAT REV DRUG DISCOV, V5, P577, DOI 10.1038/nrd2081; Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049; Snow BE, 2003, CURR BIOL, V13, P698, DOI 10.1016/S0960-9822(03)00210-0; Taggart AKP, 2002, SCIENCE, V297, P1023, DOI 10.1126/science.1074968; Teixeira MT, 2004, CELL, V117, P323, DOI 10.1016/S0092-8674(04)00334-4; Theimer CA, 2006, CURR OPIN STRUC BIOL, V16, P307, DOI 10.1016/j.sbi.2006.05.005; Tomlinson RL, 2006, MOL BIOL CELL, V17, P955, DOI 10.1091/mbc.E05-09-0903; Tseng SF, 2006, NUCLEIC ACIDS RES, V34, P6327, DOI 10.1093/nar/gkl786; Tzfati Y, 2000, SCIENCE, V288, P863, DOI 10.1126/science.288.5467.863; Venteicher AS, 2008, CELL, V132, P945, DOI 10.1016/j.cell.2008.01.019; Vulliamy T, 2008, P NATL ACAD SCI USA, V105, P8073, DOI 10.1073/pnas.0800042105; Walne AJ, 2007, HUM MOL GENET, V16, P1619, DOI 10.1093/hmg/ddm111; WATSON JD, 1972, NATURE-NEW BIOL, V239, P197, DOI 10.1038/newbio239197a0; Wei C, 2003, CELL MOL LIFE SCI, V60, P2283, DOI 10.1007/s00018-003-3244-z; WELLINGER RJ, 1993, CELL, V72, P51, DOI 10.1016/0092-8674(93)90049-V; Yu EY, 2008, NAT STRUCT MOL BIOL, V15, P985, DOI 10.1038/nsmb.1471	56	72	79	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16061	16065		10.1074/jbc.R900011200	http://dx.doi.org/10.1074/jbc.R900011200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19286666	hybrid, Green Published			2022-12-27	WOS:000266730900001
J	Roda-Navarro, P; Reyburn, HT				Roda-Navarro, Pedro; Reyburn, Hugh T.			The Traffic of the NKG2D/Dap10 Receptor Complex during Natural Killer (NK) Cell Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOLOGICAL SYNAPSE; CUTTING EDGE; TUMOR-CELLS; T-CELLS; SECRETORY LYSOSOMES; SURFACE EXPRESSION; DOWN-REGULATION; IMMUNE SYNAPSE; LYMPHOCYTES-T; FAS LIGAND	NKG2D is an important activating receptor for triggering the NK cell cytotoxic activity, although chronic engagement of specific ligands by NKG2D is also known to provoke decreased cell surface expression of the receptor and compromised NK cell function. We have studied the dynamics of surface NKG2D expression and how exposure to the specific ligand major histocompatibility complex class I chain-related molecule B (MICB) affects receptor traffic and fate. While in the NKL cell line and "resting" NK cells NKG2D was found principally at the cell surface, in activated primary NK cells an intracellular pool of receptor could also be found recycling to the plasma membrane. Exposure of NK cells to targets expressing MICB resulted in degradation of similar to 50% of total NKG2D protein and lysosomal degradation of the DAP10 adaptor molecule. Consistent with these observations, confocal microscopy experiments demonstrated that DAP10 trafficked to secretory lysosomes in both transfected NKL cells and in activated primary NK cells upon interaction with MICB-expressing target cells. Interestingly, polarization to the synapse of secretory lysosomes containing DAP10 was also observed. The implications of the intracellular traffic of the NKG2D/DAP10 receptor complex for NK cell activation are discussed. We propose that the rapid degradation of NKG2D/DAP10 observed coincident with recruitment of the receptor to the cytotoxic immune synapse may explain the loss of NKG2D receptor expression after chronic exposure to NKG2D ligands.	[Roda-Navarro, Pedro; Reyburn, Hugh T.] Univ Cambridge, Dept Pathol, Div Immunol, Cambridge CB2 1QP, England	University of Cambridge	Reyburn, HT (corresponding author), CSIC, Ctr Nacl Biotecnol, Darwin 3,Campus Cantoblanco, E-28049 Madrid, Spain.	htreyburn@cnb.csic.es	Reyburn, Hugh T/B-4338-2009	Reyburn, Hugh T/0000-0003-2855-1595	Leukaemia Research Fund; Spanish Ministry of Education and Science; MRC [G9800943] Funding Source: UKRI; Medical Research Council [G9800943] Funding Source: researchfish	Leukaemia Research Fund; Spanish Ministry of Education and Science(Spanish Government); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by the Leukaemia Research Fund.; Supported by a fellowship from the Spanish Ministry of Education and Science.	Augugliaro R, 2003, EUR J IMMUNOL, V33, P1235, DOI 10.1002/eji.200323896; Batista A, 2004, J IMMUNOL, V172, P6709, DOI 10.4049/jimmunol.172.11.6709; Bauer S, 1999, SCIENCE, V285, P727, DOI 10.1126/science.285.5428.727; Blott EJ, 2002, NAT REV MOL CELL BIO, V3, P122, DOI 10.1038/nrm732; Bossi G, 1999, NAT MED, V5, P90, DOI 10.1038/4779; BURKHARDT JK, 1990, J CELL BIOL, V111, P2327, DOI 10.1083/jcb.111.6.2327; Coudert JD, 2005, BLOOD, V106, P1711, DOI 10.1182/blood-2005-03-0918; Das V, 2004, IMMUNITY, V20, P577, DOI 10.1016/S1074-7613(04)00106-2; Giurisato E, 2007, MOL CELL BIOL, V27, P8583, DOI 10.1128/MCB.01477-07; Gonzalez S, 2006, CURR TOP MICROBIOL, V298, P121; Groh V, 2002, NATURE, V419, P734, DOI 10.1038/nature01112; Horng T, 2007, NAT IMMUNOL, V8, P1345, DOI 10.1038/ni1524; KLAUSNER RD, 1983, J BIOL CHEM, V258, P4715; LIPPINCOTTSCHWARTZ J, 1991, J CELL BIOL, V112, P567, DOI 10.1083/jcb.112.4.567; Liu HY, 2000, IMMUNITY, V13, P665, DOI 10.1016/S1074-7613(00)00066-2; Lucas M, 2007, IMMUNITY, V26, P503, DOI 10.1016/j.immuni.2007.03.006; Maasho K, 2005, J IMMUNOL, V174, P4480, DOI 10.4049/jimmunol.174.8.4480; MANDERS EMM, 1992, J CELL SCI, V103, P857; Nichols BJ, 2001, J CELL BIOL, V153, P529, DOI 10.1083/jcb.153.3.529; Ogasawara K, 2003, IMMUNITY, V18, P41, DOI 10.1016/S1074-7613(02)00505-8; Oppenheim DE, 2005, NAT IMMUNOL, V6, P928, DOI 10.1038/ni1239; PERUSSIA B, 1987, NAT IMMUN CELL GROW, V6, P171; PETERS PJ, 1990, IMMUNOL TODAY, V11, P28; PETERS PJ, 1989, EUR J IMMUNOL, V19, P1469, DOI 10.1002/eji.1830190819; Roberts AI, 2001, J IMMUNOL, V167, P5527, DOI 10.4049/jimmunol.167.10.5527; Roda-Navarro P, 2007, FASEB J, V21, P1636, DOI 10.1096/fj.06-7488rev; Roda-Navarro P, 2006, P NATL ACAD SCI USA, V103, P11258, DOI 10.1073/pnas.0600721103; Salih HR, 2006, HUM IMMUNOL, V67, P188, DOI 10.1016/j.humimm.2006.02.008; Salih HR, 2003, BLOOD, V102, P1389, DOI 10.1182/blood-2003-01-0019; Salih HR, 2002, J IMMUNOL, V169, P4098, DOI 10.4049/jimmunol.169.8.4098; Sivori S, 1997, J EXP MED, V186, P1129, DOI 10.1084/jem.186.7.1129; Skepper JN, 2000, J MICROSC-OXFORD, V199, P1, DOI 10.1046/j.1365-2818.2000.00704.x; Stinchcombe JC, 2007, ANNU REV CELL DEV BI, V23, P495, DOI 10.1146/annurev.cellbio.23.090506.123521; Upshaw JL, 2006, NAT IMMUNOL, V7, P524, DOI 10.1038/ni1325; Vitale M, 1998, J EXP MED, V187, P2065, DOI 10.1084/jem.187.12.2065; Waldhauer I, 2006, CANCER RES, V66, P2520, DOI 10.1158/0008-5472.CAN-05-2520; Wiemann K, 2005, J IMMUNOL, V175, P720, DOI 10.4049/jimmunol.175.2.720; Wu J, 1999, SCIENCE, V285, P730, DOI 10.1126/science.285.5428.730; Zuccato E, 2007, J CELL SCI, V120, P191, DOI 10.1242/jcs.03315	39	31	33	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16463	16472		10.1074/jbc.M808561200	http://dx.doi.org/10.1074/jbc.M808561200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19329438	Green Published, hybrid			2022-12-27	WOS:000266730900043
J	Li, ZY; Hassan, MQ; Jafferji, M; Aqeilan, RI; Garzon, R; Croce, CM; van Wijnen, AJ; Stein, JL; Stein, GS; Lian, JB				Li, Zhaoyong; Hassan, Mohammad Q.; Jafferji, Mohammed; Aqeilan, Rami I.; Garzon, Ramiro; Croce, Carlo M.; van Wijnen, Andre J.; Stein, Janet L.; Stein, Gary S.; Lian, Jane B.			Biological Functions of miR-29b Contribute to Positive Regulation of Osteoblast Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO; OSTEOGENIC DIFFERENTIATION; HISTONE DEACETYLASE-4; MESSENGER-RNAS; ACTIVIN-A; TGF-BETA; COLLAGEN; MICRORNA; EXPRESSION; RUNX2	Bone tissue arises from mesenchymal cells induced into the osteoblast lineage by essential transcription factors and signaling cascades. MicroRNAs regulate biological processes by binding to mRNA 3'-untranslated region (UTR) sequences to attenuate protein synthesis. Here we performed microRNA profiling and identified miRs that are up-regulated through stages of osteoblast differentiation. Among these are the miR-29, miR-let-7, and miR-26 families that target many collagens and extracellular matrix proteins. We find that miR-29b supports osteoblast differentiation through several mechanisms. miR-29b decreased and anti-miR-29b increased activity of COL1A1, COL5A3, and COL4A2 3'-UTR sequences in reporter assays, as well as endogenous gene expression. These results support a mechanism for regulating collagen protein accumulation during the mineralization stage when miR-29b reaches peak levels. We propose that this mechanism prevents fibrosis and facilitates mineral deposition. Our studies further demonstrate that miR-29b promotes osteogenesis by directly down regulating known inhibitors of osteoblast differentiation, HDAC4, TGF beta 3, ACVR2A, CTNNBIP1, and DUSP2 proteins through binding to target 3'-UTR sequences in their mRNAs. Thus, miR-29b is a key regulator of development of the osteoblast phenotype by targeting anti-osteogenic factors and modulating bone extracellular matrix proteins.	[Li, Zhaoyong; Hassan, Mohammad Q.; Jafferji, Mohammed; van Wijnen, Andre J.; Stein, Janet L.; Stein, Gary S.; Lian, Jane B.] Univ Massachusetts, Sch Med, Dept Cell Biol & Canc Ctr, Worcester, MA 01655 USA; [Aqeilan, Rami I.; Garzon, Ramiro; Croce, Carlo M.] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Aqeilan, Rami I.; Garzon, Ramiro; Croce, Carlo M.] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA	University of Massachusetts System; University of Massachusetts Worcester; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University	Lian, JB (corresponding author), Univ Massachusetts, Sch Med, Dept Cell Biol & Canc Ctr, 55 Lake Ave N, Worcester, MA 01655 USA.	jane.lian@umassmed.edu	van Wijnen, Andre J./AAG-3578-2019; Young, Richard A/F-6495-2012; Hassan, Mohammad/GZA-7507-2022; Aqeilan, Rami/R-4443-2016; Garzon, Ramiro/E-3104-2011; Aqeilan, Rami/AAT-7785-2020; Li, zhao-yong/N-4288-2013	van Wijnen, Andre J./0000-0002-4458-0946; Young, Richard A/0000-0001-8855-8647; Hassan, Mohammad/0000-0002-1712-0004; Aqeilan, Rami/0000-0002-6034-023X; Li, zhaoyong/0000-0002-1502-4027	National Institutes of Health [AR039588, R37 DE012528]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049069, R01AR039588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R37DE012528] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant AR039588 (to G. S. S.) and R37 DE012528 (to J.B.L.).	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031; Bandyopadhyay A, 2006, PLOS GENET, V2, P2116, DOI 10.1371/journal.pgen.0020216; Banerjee C, 1997, J CELL BIOCHEM, V66, P1, DOI 10.1002/(SICI)1097-4644(19970701)66:1<1::AID-JCB1>3.0.CO;2-V; Beaudoing E, 2001, GENOME RES, V11, P1520, DOI 10.1101/gr.190501; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Bodine PVN, 2006, REV ENDOCR METAB DIS, V7, P33, DOI 10.1007/s11154-006-9002-4; BRENNER RE, 1993, EUR J PEDIATR, V152, P505, DOI 10.1007/BF01955060; Burger C, 2008, BIOPHYS J, V95, P1985, DOI 10.1529/biophysj.107.128355; Caunt CJ, 2008, J BIOL CHEM, V283, P6241, DOI 10.1074/jbc.M706624200; Choi JY, 1996, J CELL BIOCHEM, V61, P609, DOI 10.1002/(SICI)1097-4644(19960616)61:4<609::AID-JCB15>3.3.CO;2-Q; Croce CM, 2008, NEW ENGL J MED, V358, P502, DOI 10.1056/NEJMra072367; Daniels DL, 2002, MOL CELL, V10, P573, DOI 10.1016/S1097-2765(02)00631-7; Deng ZL, 2008, FRONT BIOSCI-LANDMRK, V13, P2001, DOI 10.2741/2819; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Eijken M, 2007, FASEB J, V21, P2949, DOI 10.1096/fj.07-8080com; Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; FRANCESCHI RT, 1994, J BONE MINER RES, V9, P843; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Ge CX, 2007, J CELL BIOL, V176, P709, DOI 10.1083/jcb.200610046; GERSTENFELD LC, 1993, J BONE MINER RES, V8, P1031; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; GLIMCHER MJ, 1989, ANAT REC, V224, P139, DOI 10.1002/ar.1092240205; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Hassan MQ, 2006, J BIOL CHEM, V281, P40515, DOI 10.1074/jbc.M604508200; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Ikenoue T, 1999, J CELL BIOCHEM, V75, P206, DOI 10.1002/(SICI)1097-4644(19991101)75:2<206::AID-JCB3>3.3.CO;2-K; Jeon EJ, 2006, J BIOL CHEM, V281, P16502, DOI 10.1074/jbc.M512494200; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Kang JS, 2005, EMBO J, V24, P2543, DOI 10.1038/sj.emboj.7600729; Kobayashi T, 2008, P NATL ACAD SCI USA, V105, P1949, DOI 10.1073/pnas.0707900105; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Komori T, 2006, J CELL BIOCHEM, V99, P1233, DOI 10.1002/jcb.20958; Levy JB, 1996, ENDOCRINOLOGY, V137, P1159, DOI 10.1210/en.137.4.1159; Li Z, 2008, P NATL ACAD SCI USA, V105, P13906, DOI 10.1073/pnas.0804438105; Lian JB, 2006, REV ENDOCR METAB DIS, V7, P1, DOI 10.1007/s11154-006-9001-5; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu CG, 2004, P NATL ACAD SCI USA, V101, P9740, DOI 10.1073/pnas.0403293101; Luzi E, 2008, J BONE MINER RES, V23, P287, DOI 10.1359/JBMR.071011; LYNCH MP, 1995, EXP CELL RES, V216, P35, DOI 10.1006/excr.1995.1005; Ma L, 2008, CELL CYCLE, V7, P570, DOI 10.4161/cc.7.5.5547; Maeda S, 2004, EMBO J, V23, P552, DOI 10.1038/sj.emboj.7600067; Mott JL, 2007, ONCOGENE, V26, P6133, DOI 10.1038/sj.onc.1210436; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/s0092-8674(01)00622-5; Natalizio BJ, 2002, J BIOL CHEM, V277, P42733, DOI 10.1074/jbc.M208070200; OWEN TA, 1990, J CELL PHYSIOL, V143, P420, DOI 10.1002/jcp.1041430304; Park SY, 2008, NAT STRUCT MOL BIOL, V15, P224, DOI 10.1038/nsmb0308-224; Pekarsky Y, 2006, CANCER RES, V66, P11590, DOI 10.1158/0008-5472.CAN-06-3613; QUARLES LD, 1992, J BONE MINER RES, V7, P683; Raucci A, 2008, J CELL PHYSIOL, V215, P442, DOI 10.1002/jcp.21323; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Sarathchandra P, 2000, J PATHOL, V192, P385; Sengupta S, 2008, P NATL ACAD SCI USA, V105, P5874, DOI 10.1073/pnas.0801130105; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Stein GS, 2008, J CELL BIOCHEM, V104, P2016, DOI 10.1002/jcb.21813; Stewart TL, 2005, CALCIFIED TISSUE INT, V77, P113, DOI 10.1007/s00223-004-0188-8; SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191; Tuddenham L, 2006, FEBS LETT, V580, P4214, DOI 10.1016/j.febslet.2006.06.080; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Wenstrup RJ, 2006, J BIOL CHEM, V281, P12888, DOI 10.1074/jbc.M511528200; Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103; Zhao M, 2003, J BIOL CHEM, V278, P27939, DOI 10.1074/jbc.M304132200; Zhao Y, 2007, TRENDS BIOCHEM SCI, V32, P189, DOI 10.1016/j.tibs.2007.02.006	65	458	498	0	66	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15676	15684		10.1074/jbc.M809787200	http://dx.doi.org/10.1074/jbc.M809787200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19342382	Green Published, hybrid			2022-12-27	WOS:000266501000036
J	Satpathy, M; Shao, MH; Emerson, R; Donner, DB; Matei, D				Satpathy, Minati; Shao, Minghai; Emerson, Robert; Donner, David B.; Matei, Daniela			Tissue Transglutaminase Regulates Matrix Metalloproteinase-2 in Ovarian Cancer by Modulating cAMP-response Element-binding Protein Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR CREB; MATRIX-METALLOPROTEINASE-9 MMP-9; PHOSPHORYLATED CREB; SIGNALING PATHWAY; GENE-EXPRESSION; ACTIVATION; CELLS; KINASE; PROGRESSION; CHEMOSENSITIVITY	Tissue transglutaminase 2 (TG2) is overexpressed in epithelial ovarian cancer (EOC) and promotes intraperitoneal metastasis. How TG2 facilitates the spread of EOC is unknown. Here, we show that TG2 regulates the expression and function of matrix metalloproteinase-2 (MMP-2), a critical mediator of tissue invasiveness. TG2 knockdown down-regulates MMP-2 protein and mRNA expression in SKOV3, IGROV-1, MDA-MB436, and PC-3 cancer cells. TG2 knockdown or inhibition of TG2 activity using KCC009 decreases MMP-2 gelatinase activity in cancer cells. MMP-2expression and function are regulated by TG2 at transcriptional level, as demonstrated by quantitative PCR and reporter assays. We used bioinformatics and chromatin immunoprecipitation to identify a CREB binding site in the MMP-2 promoter. Binding of CREB to the MMP-2 promoter was diminished in cells that expressed decreased TG2 levels. TG2 knockdown decreased CREB phosphorylation, and CREB knockdown decreased MMP-2 expression. The effect of TG2 on CREB-activity and MMP-2 transcription is mediated by TG2-dependent degradation of protein phosphatase 2 (PP2A-alpha). We show that PP2A-alpha complexes with and is targeted for degradation by TG2. In addition to their related in vitro expression levels, TG2 and MMP-2 expression were significantly correlated in vivo, as shown by concordant immunostaining in peritoneal xenografts and in human ovarian tumors. The capacity of TG2 to regulate MMP-2 expression in vitro and in vivo identifies a mechanism that may facilitate tissue invasion and the spread of EOC. The demonstration that TG2 induced degradation of PP2A-alpha activates CREB, and thereby increases MMP-2 transcription, provides novel mechanistic insight into the prometastatic function of TG2.	[Matei, Daniela] Indiana Univ, Sch Med, Div Hematol Oncol, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Satpathy, Minati; Shao, Minghai; Matei, Daniela] Indiana Univ, Dept Med, Indianapolis, IN 46202 USA; [Emerson, Robert] Indiana Univ, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA; [Matei, Daniela] Indiana Univ, Dept Obstet & Gynecol, Indianapolis, IN 46202 USA; [Matei, Daniela] Indiana Univ, Simon Canc Ctr, Indianapolis, IN 46202 USA; [Matei, Daniela] Indiana Univ, Sch Med, Richard L Roudebush Vet Affairs Med Ctr, Indianapolis, IN 46202 USA; [Donner, David B.] Univ Calif San Francisco, Dept Surg, San Francisco, CA 94143 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; University of California System; University of California San Francisco	Matei, D (corresponding author), Indiana Univ, Sch Med, Div Hematol Oncol, Dept Biochem & Mol Biol, 535 Barnhill Dr,Route 473, Indianapolis, IN 46202 USA.	dmatei@iupui.edu		Matei, Daniela/0000-0003-2169-5035	United States Department of Veterans Affairs	United States Department of Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the United States Department of Veterans Affairs through a Veterans Affairs Merit Award ( to D. M.).	ALBERTS AS, 1994, MOL CELL BIOL, V14, P4398, DOI 10.1128/MCB.14.7.4398; Belkin AM, 2004, BIOCHEMISTRY-US, V43, P11760, DOI 10.1021/bi049266z; Belkin AM, 2001, J BIOL CHEM, V276, P18415, DOI 10.1074/jbc.M010135200; Benbow U, 1997, MATRIX BIOL, V15, P519, DOI 10.1016/S0945-053X(97)90026-3; Bergers G, 2000, NAT CELL BIOL, V2, P737, DOI 10.1038/35036374; Cha-Molstad H, 2004, P NATL ACAD SCI USA, V101, P13572, DOI 10.1073/pnas.0405587101; Choi K, 2005, CHEM BIOL, V12, P469, DOI 10.1016/j.chembiol.2005.02.007; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Davidson B., 2002, Arkhiv Patologii, V64, P47; Du KY, 1998, J BIOL CHEM, V273, P32377, DOI 10.1074/jbc.273.49.32377; Fesus L, 2002, TRENDS BIOCHEM SCI, V27, P534, DOI 10.1016/S0968-0004(02)02182-5; Gustin JA, 2004, AM J PHYSIOL-CELL PH, V286, pC547, DOI 10.1152/ajpcell.00332.2002; Hanahan Douglas, 2003, Cancer Research, V63, P3005; HIMELSTEIN BP, 1994, INVAS METAST, V14, P246; Huang H, 2001, J BIOL CHEM, V276, P38830, DOI 10.1074/jbc.M103632200; Impey S, 2004, CELL, V119, P1041, DOI 10.1016/j.cell.2004.10.032; Iordanov M, 1997, EMBO J, V16, P1009, DOI 10.1093/emboj/16.5.1009; Kenny HA, 2008, J CLIN INVEST, V118, P1367, DOI 10.1172/JCI33775; Kuo LY, 2006, J CELL PHYSIOL, V207, P729, DOI 10.1002/jcp.20616; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; Lohi J, 2000, GENE, V242, P75, DOI 10.1016/S0378-1119(99)00549-1; Mann AP, 2006, CANCER RES, V66, P8788, DOI 10.1158/0008-5472.CAN-06-1457; Matei D, 2002, ONCOGENE, V21, P6289, DOI 10.1038/sj.onc.1205785; Melnikova VO, 2006, J BIOL CHEM, V281, P2911, DOI 10.1074/jbc.M508683200; Moran A, 2005, ONCOL REP, V13, P115; Overall CM, 2002, NAT REV CANCER, V2, P657, DOI 10.1038/nrc884; Perigny M, 2008, AM J CLIN PATHOL, V129, P226, DOI 10.1309/49LA9XCBGWJ8F2KM; PINCUS JH, 1968, ARCH BIOCHEM BIOPHYS, V126, P44, DOI 10.1016/0003-9861(68)90557-2; Qin HW, 1999, J BIOL CHEM, V274, P29130, DOI 10.1074/jbc.274.41.29130; Satpathy N, 2007, CANCER RES, V67, P7194, DOI 10.1158/0008-5472.CAN-07-0307; Schmalfeldt B, 2001, CLIN CANCER RES, V7, P2396; Sillanpaa S, 2007, GYNECOL ONCOL, V104, P296, DOI 10.1016/j.ygyno.2006.09.004; Smolarz Beata, 2003, Pol J Pathol, V54, P233; Stadlmann S, 2003, EUR J CANCER, V39, P2499, DOI 10.1016/j.ejca.2003.08.011; Szyllol K, 2002, J EXP CLIN CANC RES, V21, P357; Tucholski J, 2003, J BIOL CHEM, V278, P26838, DOI 10.1074/jbc.M303683200; Tucholski J, 2001, NEUROSCIENCE, V102, P481, DOI 10.1016/S0306-4522(00)00482-6; Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546; Verma A, 2008, CLIN CANCER RES, V14, P1997, DOI 10.1158/1078-0432.CCR-07-1533; WADZINSKI BE, 1993, MOL CELL BIOL, V13, P2822, DOI 10.1128/MCB.13.5.2822; Westerlund A, 1997, GYNECOL ONCOL, V67, P76, DOI 10.1006/gyno.1997.4808; Yuan L, 2005, MOL CANCER THER, V4, P1293, DOI 10.1158/1535-7163.MCT-04-0328; Zakany R, 2002, EXP CELL RES, V275, P1, DOI 10.1006/excr.2002.5487; Zhao J, 2008, J NEUROSCI RES, V86, P2733, DOI 10.1002/jnr.21712	44	52	57	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15390	15399		10.1074/jbc.M808331200	http://dx.doi.org/10.1074/jbc.M808331200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19324884	hybrid, Green Published			2022-12-27	WOS:000266501000006
J	Scolari, S; Engel, S; Krebs, N; Plazzo, AP; De Almeida, RFM; Prieto, M; Veit, M; Herrmann, A				Scolari, Silvia; Engel, Stephanie; Krebs, Nils; Plazzo, Anna Pia; De Almeida, Rodrigo F. M.; Prieto, Manuel; Veit, Michael; Herrmann, Andreas			Lateral Distribution of the Transmembrane Domain of Influenza Virus Hemagglutinin Revealed by Time-resolved Fluorescence Imaging	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; GPI-ANCHORED PROTEINS; LIPID RAFT MICRODOMAINS; LIVING CELL-MEMBRANES; FRET MICROSCOPY; MATRIX PROTEIN; LIVE CELLS; TRANSPORT; SURFACE; GLYCOPROTEINS	Influenza virus hemagglutinin (HA) has been suggested to be enriched in liquid-ordered lipid domains named rafts, which represent an important step in virus assembly. We employed Forster resonance energy transfer (FRET) via fluorescence lifetime imaging microscopy to study the interaction of the cytoplasmic and transmembrane domain (TMD) of HA with a glycosylphosphatidylinositol (GPI)-anchored peptide, an established marker for rafts in the exoplasmic leaflet of living mammalian plasma membranes. Cyan fluorescent protein (CFP) was fused to GPI, whereas the HA sequence was tagged with yellow fluorescent protein (YFP) on its exoplasmic site (TMD-HA-YFP), avoiding any interference of fluorescent proteins with the proposed role of the cytoplasmic domain in lateral organization of HA. Constructs were expressed in Chinese hamster ovary cells (CHO-K1) for which cholesterol-sensitive lipid nanodomains and their dimension in the plasma membrane have been described (Sharma, P., Varma, R., Sarasij, R. C., Ira, Gousset, K., Krishnamoorthy, G., Rao, M., and Mayor, S. (2004) Cell 116, 577-589). Upon transfection in CHO-K1 cells, TMD-HA-YFP is partially expressed as a dimer. Only dimers are targeted to the plasma membrane. Clustering of TMD-HA-YFP with GPI-CFP was observed and shown to be reduced upon cholesterol depletion, a treatment known to disrupt rafts. No indication for association of TMD-HA-YFP with GPI-CFP was found when palmitoylation, an important determinant of raft targeting, was suppressed. Clustering of TMD-HA-YFP and GPI-CFP was also observed in purified plasma membrane suspensions by homoFRET. We concluded that the palmitoylated TMD-HA alone is sufficient to recruit HA to cholesterol-sensitive nanodomains. The corresponding construct of the spike protein E2 of Semliki Forest virus did not partition preferentially in such domains.	[Scolari, Silvia; Krebs, Nils; Plazzo, Anna Pia; Herrmann, Andreas] Humboldt Univ, Dept Biol Mol Biophys, D-10115 Berlin, Germany; [Engel, Stephanie; Veit, Michael] Free Univ Berlin, Fac Med Vet, Dept Immunol, D-12249 Berlin, Germany; [Engel, Stephanie; Veit, Michael] Free Univ Berlin, Fac Med Vet, Dept Mol Biol, D-12249 Berlin, Germany; [De Almeida, Rodrigo F. M.] Univ Lisbon, Fac Ciencias, Ctr Quim & Bioquim Mol & Neural Biophys, P-1749016 Lisbon, Portugal; [Prieto, Manuel] Inst Super Tecn, Ctr Quim Fis Mol, P-1049001 Lisbon, Portugal	Humboldt University of Berlin; Free University of Berlin; Free University of Berlin; Universidade de Lisboa; Universidade de Lisboa; Instituto Superior Tecnico	Herrmann, A (corresponding author), Humboldt Univ, Dept Biol, Invalidenstr 43, D-10115 Berlin, Germany.	andreas.herrmann@rz.hu-berlin.de	Veit, Michael/G-6492-2010; Prieto, Manuel/N-4448-2013; de Almeida, Rodrigo/D-8629-2012	Prieto, Manuel/0000-0003-3012-6598; de Almeida, Rodrigo/0000-0002-9748-7083; Veit, Michael/0000-0002-7638-1829	Deutsche Forschungsgemeinschaft [SPP 1175, SFB 740, TP C3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by the Deutsche Forschungsgemeinschaft (DFG) (SPP 1175 and SFB 740, TP C3) (to A. H. and M. V.).	Baudin F, 2001, VIROLOGY, V281, P102, DOI 10.1006/viro.2000.0804; Borst JW, 2005, J FLUORESC, V15, P153, DOI 10.1007/s10895-005-2523-5; Briggs JAG, 2003, J GEN VIROL, V84, P757, DOI 10.1099/vir.0.18779-0; Brown DA, 2000, J BIOL CHEM, V275, P17221, DOI 10.1074/jbc.R000005200; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Chang DK, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-2; COPELAND CS, 1986, J CELL BIOL, V103, P1179, DOI 10.1083/jcb.103.4.1179; de Almeida RFM, 2005, J MOL BIOL, V346, P1109, DOI 10.1016/j.jmb.2004.12.026; De Almeida RFM, 2006, MOL MEMBR BIOL, V23, P305, DOI 10.1080/09687860600703613; DOMS RW, 1993, VIROLOGY, V193, P545, DOI 10.1006/viro.1993.1164; Enami M, 1996, J VIROL, V70, P6653, DOI 10.1128/JVI.70.10.6653-6657.1996; Gautier I, 2001, BIOPHYS J, V80, P3000, DOI 10.1016/S0006-3495(01)76265-0; Gomez-Puertas P, 2000, J VIROL, V74, P11538, DOI 10.1128/JVI.74.24.11538-11547.2000; Grailhe R, 2006, CHEMPHYSCHEM, V7, P1442, DOI 10.1002/cphc.200600057; Hancock JF, 2006, NAT REV MOL CELL BIO, V7, P456, DOI 10.1038/nrm1925; Heerklotz H, 2002, BIOPHYS J, V83, P2693, DOI 10.1016/S0006-3495(02)75278-8; Hess ST, 2007, P NATL ACAD SCI USA, V104, P17370, DOI 10.1073/pnas.0708066104; Hess ST, 2005, J CELL BIOL, V169, P965, DOI 10.1083/jcb.200412058; Hofman EG, 2008, J CELL SCI, V121, P2519, DOI 10.1242/jcs.028753; Keller P, 2001, NAT CELL BIOL, V3, P140, DOI 10.1038/35055042; Kenworthy AK, 2000, MOL BIOL CELL, V11, P1645, DOI 10.1091/mbc.11.5.1645; Kenworthy AK, 1998, J CELL BIOL, V142, P69, DOI 10.1083/jcb.142.1.69; Lackowicz JR, 2006, PRINCIPLES FLUORESCE; Leser GP, 2005, VIROLOGY, V342, P215, DOI 10.1016/j.virol.2005.09.049; Lin SS, 1998, J CELL BIOL, V142, P51, DOI 10.1083/jcb.142.1.51; Lu YE, 2000, J VIROL, V74, P7708, DOI 10.1128/JVI.74.17.7708-7719.2000; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Patterson GH, 2000, ANAL BIOCHEM, V284, P438, DOI 10.1006/abio.2000.4708; Scheiffele P, 1997, EMBO J, V16, P5501, DOI 10.1093/emboj/16.18.5501; Scheiffele P, 1999, J BIOL CHEM, V274, P2038, DOI 10.1074/jbc.274.4.2038; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Silvius JR, 2006, MOL MEMBR BIOL, V23, P5, DOI 10.1080/09687860500473002; Takeda M, 2003, P NATL ACAD SCI USA, V100, P14610, DOI 10.1073/pnas.2235620100; Tall RD, 2003, TRAFFIC, V4, P838, DOI 10.1046/j.1398-9219.2003.0138.x; TANAKA F, 1979, PHOTOCHEM PHOTOBIOL, V29, P1091, DOI 10.1111/j.1751-1097.1979.tb07825.x; Tatulian SA, 2000, BIOCHEMISTRY-US, V39, P496, DOI 10.1021/bi991594p; VEIT M, 1991, J VIROL, V65, P2491, DOI 10.1128/JVI.65.5.2491-2500.1991; WHITE J, 1982, NATURE, V300, P658, DOI 10.1038/300658a0; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhang J, 2000, J VIROL, V74, P4634, DOI 10.1128/JVI.74.10.4634-4644.2000	40	63	63	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15708	15716		10.1074/jbc.M900437200	http://dx.doi.org/10.1074/jbc.M900437200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19349276	Green Published, hybrid			2022-12-27	WOS:000266501000040
J	Toivanen, PI; Nieminen, T; Viitanen, L; Alitalo, A; Roschier, M; Jauhiainen, S; Markkanen, JE; Laitinen, OH; Airenne, TT; Salminen, TA; Johnson, MS; Airenne, KJ; Yla-Herttuala, S				Toivanen, Pyry I.; Nieminen, Tiina; Viitanen, Lenita; Alitalo, Annamari; Roschier, Miia; Jauhiainen, Suvi; Markkanen, Johanna E.; Laitinen, Olli H.; Airenne, Tomi T.; Salminen, Tiina A.; Johnson, Mark S.; Airenne, Kari J.; Yla-Herttuala, Seppo			Novel Vascular Endothelial Growth Factor D Variants with Increased Biological Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; VEGF-D; GENE-TRANSFER; RECEPTOR SPECIFICITY; ANGSTROM RESOLUTION; SIGNAL-TRANSDUCTION; TYROSINE KINASES; ORF VIRUS; BINDING; ANGIOGENESIS	Members of the vascular endothelial growth factor (VEGF) family play a pivotal role in angiogenesis and lymphangiogenesis. They are potential therapeutics to induce blood vessel formation in myocardium and skeletal muscle, when normal blood flow is compromised. Most members of the VEGF/platelet derived growth factor protein superfamily exist as covalently bound antiparallel dimers. However, the mature form of VEGF-D (VEGF-D-Delta N Delta C) is predominantly a non-covalent dimer even though the cysteine residues (Cys-44 and Cys-53) forming the intersubunit disulfide bridges in the other members of the VEGF family are also conserved in VEGF-D. Moreover, VEGF-D bears an additional cysteine residue (Cys-25) at the subunit interface. Guided by our model of VEGF-D-Delta N Delta C, the cysteines at the subunit interface were mutated to study the effect of these residues on the structural and functional properties of VEGF-D-Delta N Delta C. The conserved cysteines Cys-44 and Cys-53 were found to be essential for the function of VEGF-D-Delta N Delta C. More importantly, the substitution of the Cys-25 at the dimer interface by various amino acids improved the activity of the recombinant VEGF-D-Delta N Delta C and increased the dimer to monomer ratio. Specifically, substitutions to hydrophobic amino acids Ile, Leu, and Val, equivalent to those found in other VEGFs, most favorably affected the activity of the recombinant VEGF-D-Delta N Delta C. The increased activity of these mutants was mainly due to stabilization of the protein. This study enables us to better understand the structural determinants controlling the biological activity of VEGF-D. The novel variants of VEGF-D-Delta N Delta C described here are potential agents for therapeutic applications, where induction of vascular formation is required.	[Yla-Herttuala, Seppo] Univ Kuopio, AI Virtanen Inst Mol Sci, Dept Biotechnol & Mol Med, FI-70211 Kuopio, Finland; [Toivanen, Pyry I.; Nieminen, Tiina] Ark Therapeut Oyj, FI-70210 Kuopio, Finland; [Viitanen, Lenita; Airenne, Tomi T.; Salminen, Tiina A.; Johnson, Mark S.] Abo Akad Univ, Dept Biochem & Pharm, FI-20520 Turku, Finland	University of Eastern Finland; Abo Akademi University	Yla-Herttuala, S (corresponding author), Univ Kuopio, AI Virtanen Inst Mol Sci, Dept Biotechnol & Mol Med, POB 1627, FI-70211 Kuopio, Finland.	seppo.ylaherttuala@uku.fi	Salminen, Tiina A/G-7492-2019; Salminen, Tiina A./AAM-5443-2021; Laitinen, Olli H/A-6618-2016	Salminen, Tiina A/0000-0002-4135-8020; Salminen, Tiina A./0000-0002-4135-8020; Laitinen, Olli H/0000-0002-3751-9952; Yla-Herttuala, Seppo/0000-0001-7593-2708; Jauhiainen, Suvi/0000-0002-0630-8175	Ark Therapeutics Group Plc.; Academy of Finland; ISB (National Graduate School in Informational and Structural Biology); Foundation of Abo Akademi; Sigrid Juselius Foundation; Leducq Foundation; Joe, Pentti, and Tor Borg Memorial Fund; Finnish Cultural Foundation; Magnus Ehrnrooth Foundation	Ark Therapeutics Group Plc.; Academy of Finland(Academy of Finland); ISB (National Graduate School in Informational and Structural Biology); Foundation of Abo Akademi; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Leducq Foundation(Leducq Foundation); Joe, Pentti, and Tor Borg Memorial Fund; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Magnus Ehrnrooth Foundation	This work was supported by Ark Therapeutics Group Plc., the Academy of Finland, the ISB (National Graduate School in Informational and Structural Biology), the Foundation of Abo Akademi ( Centre of Excellence in Cell Stress), the Sigrid Juselius Foundation, the Leducq Foundation, the Joe, Pentti, and Tor Borg Memorial Fund, the Finnish Cultural Foundation, and the Magnus Ehrnrooth Foundation.	Achen MG, 2000, EUR J BIOCHEM, V267, P2505, DOI 10.1046/j.1432-1327.2000.01257.x; Achen MG, 1998, P NATL ACAD SCI USA, V95, P548, DOI 10.1073/pnas.95.2.548; Airenne KJ, 2000, GENE THER, V7, P1499, DOI 10.1038/sj.gt.3301269; Airenne KJ, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng102; ANISIMOV A, 2009, CIRC RES IN PRESS; Annex BH, 2005, CARDIOVASC RES, V65, P649, DOI 10.1016/j.cardiores.2004.09.004; BARTON GJ, 1993, PROTEIN ENG, V6, P37, DOI 10.1093/protein/6.1.37; Bhardwaj S, 2003, HUM GENE THER, V14, P1451, DOI 10.1089/104303403769211664; Bjork A, 2003, J MOL BIOL, V334, P811, DOI 10.1016/j.jmb.2003.10.006; Byrne AM, 2005, J CELL MOL MED, V9, P777, DOI 10.1111/j.1582-4934.2005.tb00379.x; Christinger HW, 2004, J BIOL CHEM, V279, P10382, DOI 10.1074/jbc.M313237200; Culajay JF, 2000, BIOCHEMISTRY-US, V39, P7153, DOI 10.1021/bi9927742; DeLano W.L, PYMOL MOL GRAPHICS S; Fuh G, 1998, J BIOL CHEM, V273, P11197, DOI 10.1074/jbc.273.18.11197; Hagihara Y, 2007, J BIOL CHEM, V282, P36489, DOI 10.1074/jbc.M707078200; Holmes DIR, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-209; Iyer S, 2001, J BIOL CHEM, V276, P12153, DOI 10.1074/jbc.M008055200; Iyer S, 2006, J MOL BIOL, V359, P76, DOI 10.1016/j.jmb.2006.03.002; Jia HY, 2004, J BIOL CHEM, V279, P36148, DOI 10.1074/jbc.M401538200; Joukov V, 1997, EMBO J, V16, P3898, DOI 10.1093/emboj/16.13.3898; Joukov V, 1998, J BIOL CHEM, V273, P6599, DOI 10.1074/jbc.273.12.6599; Karpanen T, 2006, FASEB J, V20, P1462, DOI 10.1096/fj.05-5646com; Laitinen OH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni042; Lehtonen JV, 2004, J COMPUT AID MOL DES, V18, P401, DOI 10.1007/s10822-004-3752-4; LYTTLE DJ, 1994, J VIROL, V68, P84, DOI 10.1128/JVI.68.1.84-92.1994; MAJUMDER K, 1992, GENE, V110, P89, DOI 10.1016/0378-1119(92)90448-X; McColl BK, 2007, FASEB J, V21, P1088, DOI 10.1096/fj.06-7060com; MILES AA, 1952, J PHYSIOL-LONDON, V118, P228, DOI 10.1113/jphysiol.1952.sp004789; Muller YA, 1997, STRUCTURE, V5, P1325, DOI 10.1016/S0969-2126(97)00284-0; MURRAYRUST J, 1993, STRUCTURE, V1, P153, DOI 10.1016/0969-2126(93)90029-G; Nagano N, 1999, FEBS LETT, V458, P69, DOI 10.1016/S0014-5793(99)01122-9; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; PAJUSOLA K, 1994, ONCOGENE, V9, P3545; Pieren M, 2006, J BIOL CHEM, V281, P19578, DOI 10.1074/jbc.M601842200; Rissanen TT, 2003, CIRC RES, V92, P1098, DOI 10.1161/01.RES.0000073584.46059.E3; Rissanen TT, 2002, FASEB J, V16, P100, DOI 10.1096/fj.02-0377fje; Rutanen J, 2003, CARDIOVASC RES, V59, P971, DOI 10.1016/S0008-6363(03)00518-2; Rutanen J, 2004, CIRCULATION, V109, P1029, DOI 10.1161/01.CIR.0000115519.03688.A2; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Shibuya M, 2006, EXP CELL RES, V312, P549, DOI 10.1016/j.yexcr.2005.11.012; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Stacker SA, 1999, J BIOL CHEM, V274, P32127, DOI 10.1074/jbc.274.45.32127; Stacker SA, 1999, J BIOL CHEM, V274, P34884, DOI 10.1074/jbc.274.49.34884; Suto K, 2005, J BIOL CHEM, V280, P2126, DOI 10.1074/jbc.M411395200; Suzuki Y, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni103; Tammela T, 2005, CARDIOVASC RES, V65, P550, DOI 10.1016/j.cardiores.2004.12.002; Tarsitano M, 2006, FASEB J, V20, P227, DOI 10.1096/fj.05-4147com; TERMAN BI, 1992, BIOCHEM BIOPH RES CO, V187, P1579, DOI 10.1016/0006-291X(92)90483-2; TISCHER E, 1991, J BIOL CHEM, V266, P11947; Vajanto I, 2002, J GENE MED, V4, P371, DOI 10.1002/jgm.287; Vlahakis NE, 2005, J BIOL CHEM, V280, P4544, DOI 10.1074/jbc.M412816200; WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988; Eswar Narayanan, 2007, Curr Protoc Protein Sci, VChapter 2, DOI [10.1002/cpbi.3, 10.1002/cpps.20, 10.1002/0471250953.bi0506s15, 10.1002/0471140864.ps0209s50]; Wiesmann C, 1997, CELL, V91, P695, DOI 10.1016/S0092-8674(00)80456-0; Yamazaki Y, 2003, J BIOL CHEM, V278, P51985, DOI 10.1074/jbc.C300454200; Yla-Herttuala S, 2003, NAT MED, V9, P694, DOI 10.1038/nm0603-694	56	24	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					16037	16048		10.1074/jbc.M109.001123	http://dx.doi.org/10.1074/jbc.M109.001123			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19366703	hybrid, Green Published			2022-12-27	WOS:000266501000069
J	Kou, R; Sartoretto, J; Michel, T				Kou, Ruqin; Sartoretto, Juliano; Michel, Thomas			Regulation of Rac1 by Simvastatin in Endothelial Cells DIFFERENTIAL ROLES OF AMP-ACTIVATED PROTEIN KINASE AND CALMODULIN-DEPENDENT KINASE KINASE-beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; VASODILATOR-STIMULATED PHOSPHOPROTEIN; STATIN-MEDIATED INHIBITION; GENE-EXPRESSION; PHOSPHORYLATION; IDENTIFICATION; TRANSLOCATION; MECHANISMS; THROMBIN; SITE	These studies explore the connections between simvastatin, Rac1, and AMP-activated protein kinase (AMPK) pathways in cultured vascular endothelial cells and in arterial preparations isolated from statin-treated mice. In addition to their prominent effects on lipoprotein metabolism, statins can regulate the small GTPase Rac1, and may also affect the phosphorylation of the ubiquitous AMPK. We explored pathways of statin-modulated Rac1 and AMPK activation both in arterial preparations from statin-treated mice as well as in cultured endothelial cells. We treated adult mice with simvastatin daily for 2 weeks and then harvested and analyzed arterial preparations. Simvastatin treatment of mice led to a significant increase in AMPK and LKB1 phosphorylation and to a decrease in protein kinase A activity relative to control animals, associated with a marked increase in Rac1 activation. Exposure of bovine aortic endothelial cells to simvastatin for 24 h strikingly increased GTP-bound Rac1 and led to increased phosphorylation of AMPK as well as the AMPK kinase LKB1. These responses to simvastatin were blocked by mevalonate or geranylgeranyl pyrophosphate but not by farnesyl pyrophosphate. Small interfering RNA (siRNA)mediated knockdown of AMPK abrogated simvastatin-induced Rac1 activation and LKB1 phosphorylation. Importantly, siRNA-mediated knockdown of the key AMPK kinase, calcium/calmodulin-dependent protein kinase kinase beta, completely blocked simvastatin-induced endothelial cell migration and also abrogated statin-promoted phosphorylation of AMPK and LKB1, as did pharmacological inhibition with the specific calcium/calmodulin-dependent protein kinase beta, inhibitor STO-609. Moreover, siRNA-mediated knockdown of Rac1 completely blocked simvastatin-induced LKB1 phosphorylation, but without affecting simvastatin-induced AMPK phosphorylation. These findings establish a key role for simvastatin in activation of a novel Rac1-dependent signaling pathway in the vascular wall.	[Kou, Ruqin; Sartoretto, Juliano; Michel, Thomas] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Cardiovasc, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School	Michel, T (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Cardiovasc, Thorn Bldg,Rm 1210A,75 Francis St, Boston, MA 02115 USA.	thomas_michel@harvard.edu		sartoretto, juliano/0000-0002-0355-5541	National Institutes of Health [HL46457, HL48743, GM36259]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R29HL046457, R01HL046457, P01HL048743] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036259, R37GM036259] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL46457, HL48743, and GM36259.	Abid MR, 2001, FASEB J, V15, P2548, DOI 10.1096/fj.01-0338fje; Alessi DR, 2006, ANNU REV BIOCHEM, V75, P137, DOI 10.1146/annurev.biochem.75.103004.142702; Brandes RP, 2005, CIRC RES, V96, P927, DOI 10.1161/01.RES.0000168040.70096.2a; Chen ZP, 1999, FEBS LETT, V443, P285, DOI 10.1016/S0014-5793(98)01705-0; Choi HC, 2008, J BIOL CHEM, V283, P20186, DOI 10.1074/jbc.M803020200; Comerford KM, 2002, FASEB J, V16, P583, DOI 10.1096/fj.01-0739fje; Cordle A, 2005, J BIOL CHEM, V280, P34202, DOI 10.1074/jbc.M505268200; Davare MA, 2004, J BIOL CHEM, V279, P52191, DOI 10.1074/jbc.M409873200; DerMardirossian C, 2004, MOL CELL, V15, P117, DOI 10.1016/j.molcel.2004.05.019; Di-Poi N, 2001, BIOCHEMISTRY-US, V40, P10014, DOI 10.1021/bi010289c; Fisslthaler B, 2007, CIRC RES, V100, pE12, DOI 10.1161/01.RES.0000257747.74358.1c; Fleming I, 2003, THROMB HAEMOSTASIS, V90, P863, DOI 10.1160/TH03-04-0228; Fogarty S, 2009, J BIOL CHEM, V284, P77, DOI 10.1074/jbc.M806152200; Gabriel M, 2006, J BIOMAT SCI-POLYM E, V17, P567, DOI 10.1163/156856206776986288; Gonzalez E, 2006, J BIOL CHEM, V281, P3210, DOI 10.1074/jbc.M510434200; Halcox JPJ, 2004, CIRCULATION, V109, P42, DOI 10.1161/01.CIR.0000129500.29229.92; Harbeck B, 2000, J BIOL CHEM, V275, P30817, DOI 10.1074/jbc.M005066200; Hardie DG, 1997, EUR J BIOCHEM, V246, P259, DOI 10.1111/j.1432-1033.1997.00259.x; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hernandez-Perera O, 2000, CIRC RES, V87, P616, DOI 10.1161/01.RES.87.7.616; Jacobson JR, 2004, AM J RESP CELL MOL, V30, P662, DOI 10.1165/rcmb.2003-0267OC; Jain MK, 2005, NAT REV DRUG DISCOV, V4, P977, DOI 10.1038/nrd1901; Jensen TE, 2007, AM J PHYSIOL-ENDOC M, V292, pE1308, DOI 10.1152/ajpendo.00456.2006; Jorgensen SB, 2008, FRONT BIOSCI-LANDMRK, V13, P5589; Kou RQ, 2002, BIOCHEMISTRY-US, V41, P4982, DOI 10.1021/bi016017r; Kou RQ, 2007, J BIOL CHEM, V282, P32719, DOI 10.1074/jbc.M706815200; Krause M, 2003, ANNU REV CELL DEV BI, V19, P541, DOI 10.1146/annurev.cellbio.19.050103.103356; Levine YC, 2007, J BIOL CHEM, V282, P20351, DOI 10.1074/jbc.M702182200; Lian LY, 2000, STRUCT FOLD DES, V8, P47, DOI 10.1016/S0969-2126(00)00080-0; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Matsushita M, 1999, J BIOL CHEM, V274, P10086, DOI 10.1074/jbc.274.15.10086; MICHEL T, 1993, P NATL ACAD SCI USA, V90, P6252, DOI 10.1073/pnas.90.13.6252; MONCADA S, 1993, NEW ENGL J MED, V329, P2002; Ohkawara H, 2005, J BIOL CHEM, V280, P10182, DOI 10.1074/jbc.M409547200; Price LS, 2003, J BIOL CHEM, V278, P39413, DOI 10.1074/jbc.M302083200; Sapkota GP, 2002, BIOCHEM J, V362, P481, DOI 10.1042/0264-6021:3620481; Sawada N, 2008, CIRC RES, V103, P360, DOI 10.1161/CIRCRESAHA.108.178897; Sun W, 2006, CIRCULATION, V114, P2655, DOI 10.1161/CIRCULATIONAHA.106.630194; Thors B, 2004, FEBS LETT, V573, P175, DOI 10.1016/j.febslet.2004.07.078; Xenos ES, 2005, ANN VASC SURG, V19, P386, DOI 10.1007/s10016-005-0011-7; Zou MH, 2002, J BIOL CHEM, V277, P32552, DOI 10.1074/jbc.M204512200	41	59	60	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					14734	14743		10.1074/jbc.M808664200	http://dx.doi.org/10.1074/jbc.M808664200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19332549	Green Published, hybrid			2022-12-27	WOS:000266288200009
J	Nagy, P; Kettle, AJ; Winterbourn, CC				Nagy, Peter; Kettle, Anthony J.; Winterbourn, Christine C.			Superoxide-mediated Formation of Tyrosine Hydroperoxides and Methionine Sulfoxide in Peptides through Radical Addition and Intramolecular Oxygen Transfer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIGH-DENSITY-LIPOPROTEINS; APOLIPOPROTEINS AI; ELECTRON-TRANSFER; SINGLET OXYGEN; H-BOND; OXIDATION; ACID; GENERATION; TRYPTOPHAN; REDUCTION	The chemistry underlying superoxide toxicity is not fully understood. A potential mechanism for superoxide-mediated injury involves addition to tyrosyl radicals, to give peptide or protein hydroperoxides. The rate constant for the reaction of tyrosyl radicals with superoxide is higher than for dimerization, but the efficiency of superoxide addition to peptides depends on the position of the Tyr residue. We have examined the requirements for superoxide addition and structurally characterized the products for a range of tyrosyl peptides exposed to a peroxidase/O-2(radical anion) system. These included enkephalins as examples of the numerous proteins and physiological peptides with N-terminal tyrosines. The importance of amino groups in promoting hydroperoxide formation and effect of methionine residues on the reaction were investigated. When tyrosine was N-terminal, the major products were hydroperoxides that had undergone cyclization through conjugate addition of the terminal amine. With non-N-terminal tyrosine, electron transfer from O-2(radical anion) to the peptide radical prevailed. Peptides containing methionine revealed a novel and efficient intramolecular oxygen transfer mechanism from an initial tyrosine hydroperoxide to give a dioxygenated derivative with one oxygen on the tyrosine and the other forming methionine sulfoxide. Exogenous amines promoted hydroperoxide formation on tyrosyl peptides lacking a terminal amine, without forming an adduct. These findings, plus the high hydroperoxide yields with N-terminal tyrosine, can be explained by a mechanism in which hydrogen bonding of O-2(radical anion) to the amine increases is oxidizing potential and alters its reactivity. If this amine effect occurred more generally, it could increase the biological reactivity of O-2(radical anion) and have major implications.	[Nagy, Peter; Kettle, Anthony J.; Winterbourn, Christine C.] Univ Otago, Dept Pathol, Christchurch 8140, New Zealand	University of Otago	Winterbourn, CC (corresponding author), Univ Otago, Dept Pathol, 2 Ricarton Ave,POB 4345, Christchurch 8140, New Zealand.	christine.winterbourn@otago.ac.nz	Nagy, Peter/C-6768-2008; Kettle, Anthony J/A-8520-2008	Nagy, Peter/0000-0003-3393-235X; Kettle, Anthony J/0000-0002-8218-7766	Marsden Fund; Health Research Council of New Zealand	Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Health Research Council of New Zealand(Health Research Council of New Zealand)	This work was supported by the Marsden Fund and the Health Research Council of New Zealand and used equipment provided by the National Research Centre for Growth and Development.	Beal MF, 2002, FREE RADICAL BIO MED, V32, P797, DOI 10.1016/S0891-5849(02)00780-3; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; BOBROWSKI K, 1990, INT J RADIAT BIOL, V57, P919, DOI 10.1080/09553009014551041; BRUICE TC, 1976, ANNU REV BIOCHEM, V45, P331, DOI 10.1146/annurev.bi.45.070176.001555; d'Alessandro N, 2000, J CHEM SOC PERK T 2, P1862, DOI 10.1039/b003346o; Davies MJ, 2005, BBA-PROTEINS PROTEOM, V1703, P93, DOI 10.1016/j.bbapap.2004.08.007; Dean RT, 1997, BIOCHEM J, V324, P1; Field SA, 2008, CHEM RES TOXICOL, V21, P1923, DOI 10.1021/tx8001687; Garner B, 1998, J BIOL CHEM, V273, P6080, DOI 10.1074/jbc.273.11.6080; Garner B, 1998, J BIOL CHEM, V273, P6088, DOI 10.1074/jbc.273.11.6088; GARRISON WM, 1987, CHEM REV, V87, P381, DOI 10.1021/cr00078a006; GIESEG SP, 1993, BIOCHEMISTRY-US, V32, P4780, DOI 10.1021/bi00069a012; HEINECKE JW, 1993, J CLIN INVEST, V91, P2866, DOI 10.1172/JCI116531; Imlay JA, 2008, ANNU REV BIOCHEM, V77, P755, DOI 10.1146/annurev.biochem.77.061606.161055; Jiang XY, 1996, J MASS SPECTROM, V31, P1309, DOI 10.1002/(SICI)1096-9888(199611)31:11<1309::AID-JMS423>3.0.CO;2-R; JIN FM, 1993, J CHEM SOC PERK T 2, P1583, DOI 10.1039/p29930001583; JONSSON M, 1993, J PHYS CHEM-US, V97, P8229, DOI 10.1021/j100133a018; Liochev SI, 1999, IUBMB LIFE, V48, P157, DOI 10.1080/152165499307161; Miyamoto S, 2006, P NATL ACAD SCI USA, V103, P293, DOI 10.1073/pnas.0508170103; Moskovitz J, 1998, P NATL ACAD SCI USA, V95, P14071, DOI 10.1073/pnas.95.24.14071; Mozziconacci O, 2007, FREE RADICAL BIO MED, V43, P229, DOI 10.1016/j.freeradbiomed.2007.04.006; Ohkubo K, 2006, J PHYS CHEM A, V110, P11613, DOI 10.1021/jp064115m; PICHORNER H, 1995, ARCH BIOCHEM BIOPHYS, V323, P429, DOI 10.1006/abbi.1995.0064; PRUTZ WA, 1982, BIOCHIM BIOPHYS ACTA, V705, P139, DOI 10.1016/0167-4838(82)90172-8; SAITO I, 1975, J AM CHEM SOC, V97, P5272, DOI 10.1021/ja00851a042; Souza JM, 2008, FREE RADICAL BIO MED, V45, P357, DOI 10.1016/j.freeradbiomed.2008.04.010; Stadtman ER, 2003, AMINO ACIDS, V25, P207, DOI 10.1007/s00726-003-0011-2; Stubbe J, 1998, CHEM REV, V98, P705, DOI 10.1021/cr9400875; Villamena FA, 2007, J AM CHEM SOC, V129, P8177, DOI 10.1021/ja0702622; Winterbourn CC, 1997, ARCH BIOCHEM BIOPHYS, V338, P15, DOI 10.1006/abbi.1996.9773; Winterbourn CC, 2004, BIOCHEM J, V381, P241, DOI 10.1042/BJ20040259; Winterbourn CC, 2003, BIOCHEM BIOPH RES CO, V305, P729, DOI 10.1016/S0006-291X(03)00810-6; Winterbourn CC, 2008, NAT CHEM BIOL, V4, P278, DOI 10.1038/nchembio.85; WOLFF SP, 1994, METHOD ENZYMOL, V233, P182; Wright A, 2002, PHOTOCHEM PHOTOBIOL, V76, P35, DOI 10.1562/0031-8655(2002)076<0035:SOMPOE>2.0.CO;2; Zhang H, 2009, ARCH BIOCHEM BIOPHYS, V484, P134, DOI 10.1016/j.abb.2008.11.018	36	40	43	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					14723	14733		10.1074/jbc.M809396200	http://dx.doi.org/10.1074/jbc.M809396200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19297319	Green Published, hybrid			2022-12-27	WOS:000266288200008
J	Hernandez, A; Mate, MJ; Sanchez-Diaz, PC; Romero, A; Rojo, F; Martinez, JL				Hernandez, Alvaro; Mate, Maria J.; Sanchez-Diaz, Patricia C.; Romero, Antonio; Rojo, Fernando; Martinez, Jose L.			Structural and Functional Analysis of SmeT, the Repressor of the Stenotrophomonas maltophilia Multidrug Efflux Pump SmeDEF	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURES; RECOMBINANT PROTEINS; TETR FAMILY; BINDING; RESISTANCE; EXPRESSION; COMPLEX; MODEL; OVEREXPRESSION; VISUALIZATION	Stenotrophomonas maltophilia is an opportunistic pathogen characterized for its intrinsic low susceptibility to several antibiotics. Part of this low susceptibility relies on the expression of chromosomally encoded multidrug efflux pumps, with SmeDEF being the most relevant antibiotic resistance efflux pump so far studied in this bacterial species. Expression of smeDEF is down-regulated by the SmeT repressor, encoded upstream smeDEF, in its complementary DNA strand. In the present article we present the crystal structure of SmeT and analyze its interactions with its cognate operator. Like other members of the TetR family of transcriptional repressors, SmeT behaves as a dimer and presents some common structural features with other TetR proteins like TtgR, QacR, and TetR. Differing from other TetR proteins for which the structure is available, SmeT turned out to have two extensions at the N and C termini that might be relevant for its function. Besides, SmeT presents the smallest binding pocket so far described in the TetR family of transcriptional repressors, which may correlate with a specific type and range of effectors. In vitro studies revealed that SmeT binds to a 28-bp pseudopalindromic region, forming two complexes. This operator region was found to overlap the promoters of smeT and smeDEF. This finding is consistent with a role for SmeT simultaneously down-regulating smeT and smeDEF transcription, likely by steric hindrance on RNA polymerase binding to DNA.	[Hernandez, Alvaro; Sanchez-Diaz, Patricia C.; Rojo, Fernando; Martinez, Jose L.] CSIC, Ctr Nacl Biotecnol, Darwin 3, Madrid 28049, Spain; [Martinez, Jose L.] CIBERESP, Madrid 28049, Spain; [Mate, Maria J.; Romero, Antonio] CSIC, Ctr Invest Biol, E-28040 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Martinez, JL (corresponding author), CSIC, Ctr Nacl Biotecnol, Darwin 3, Madrid 28049, Spain.	maria.mate@afmb.univ-mrs.fr; jlmtnez@cnb.csic.es	Romero, Antonio/K-5754-2014; Rojo, Fernando/A-7038-2008; Martinez, Jose L/C-4100-2008; Martinez, Jose L/A-4725-2013	Romero, Antonio/0000-0002-6990-6973; Rojo, Fernando/0000-0003-1848-7745; Martinez, Jose L/0000-0001-8813-7607	Spanish Ministry of Science and Innovation [BIO2005-04278, BFU2005-05055, BFU2006-00767/BMC, BIO-2008-00090]; European Union [LSHM-CT-2005-518152, LSHM-CT-2005018705]; Spanish Ministry of Health [REIPIRD06/0008]; MRC [G0500367] Funding Source: UKRI; Medical Research Council [G0500367] Funding Source: researchfish	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Union(European Commission); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Grants BIO2005-04278, BFU2005-05055, BFU2006-00767/BMC, and BIO-2008-00090 from the Spanish Ministry of Science and Innovation, LSHM-CT-2005-518152 and LSHM-CT-2005018705 from the European Union, and REIPIRD06/0008 from the Spanish Ministry of Health.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Alguel Y, 2007, J MOL BIOL, V369, P829, DOI 10.1016/j.jmb.2007.03.062; Alonso A, 2000, ANTIMICROB AGENTS CH, V44, P3079, DOI 10.1128/AAC.44.11.3079-3086.2000; Alonso A, 2004, J ANTIMICROB CHEMOTH, V53, P432, DOI 10.1093/jac/dkh074; Alonso A, 1997, ANTIMICROB AGENTS CH, V41, P1140, DOI 10.1128/AAC.41.5.1140; Alonso A, 2001, ANTIMICROB AGENTS CH, V45, P1879, DOI 10.1128/AAC.45.6.1879-1881.2001; [Anonymous], 2000, WHO REP INF DIS; ATLAS RM, 1993, HDB MICROBIOLOGICAL, P492; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Brady GP, 2000, J COMPUT AID MOL DES, V14, P383, DOI 10.1023/A:1008124202956; Brooks BE, 2007, J AM CHEM SOC, V129, P8389, DOI 10.1021/ja072576v; Chong SR, 1998, NUCLEIC ACIDS RES, V26, P5109, DOI 10.1093/nar/26.22.5109; Chong SR, 1997, GENE, V192, P271, DOI 10.1016/S0378-1119(97)00105-4; Crossman LC, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-r74; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L, PYMOL MOL GRAPHICS S; Dover LG, 2004, J MOL BIOL, V340, P1095, DOI 10.1016/j.jmb.2004.06.003; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engohang-Ndong J, 2004, MOL MICROBIOL, V51, P175, DOI 10.1046/j.1365-2958.2003.03809.x; Grkovic S, 2002, MICROBIOL MOL BIOL R, V66, P671, DOI 10.1128/MMBR.66.4.671-701.2002; HILLEN W, 1994, ANNU REV MICROBIOL, V48, P345, DOI 10.1146/annurev.mi.48.100194.002021; HINRICHS W, 1994, SCIENCE, V264, P418, DOI 10.1126/science.8153629; Huang BD, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-19; Jeng WY, 2008, NUCLEIC ACIDS RES, V36, P1567, DOI 10.1093/nar/gkm1176; Kamionka A, 2004, NUCLEIC ACIDS RES, V32, P842, DOI 10.1093/nar/gkh200; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Li XZ, 2004, DRUGS, V64, P159, DOI 10.2165/00003495-200464020-00004; Linares JF, 2005, J BACTERIOL, V187, P1384, DOI 10.1128/JB.187.4.1384-1391.2005; Martinez JL, 2009, FEMS MICROBIOL REV, V33, P44, DOI 10.1111/j.1574-6976.2008.00142.x; Martinez JL, 2009, FEMS MICROBIOL REV, V33, P430, DOI 10.1111/j.1574-6976.2008.00157.x; Merritt EA, 1999, ACTA CRYSTALLOGR D, V55, P1109, DOI 10.1107/S0907444999003789; Moretti S, 2007, NUCLEIC ACIDS RES, V35, pW645, DOI 10.1093/nar/gkm333; Murray DS, 2004, J BIOL CHEM, V279, P14365, DOI 10.1074/jbc.M313870200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Orth P, 2000, NAT STRUCT BIOL, V7, P215; Orth P, 1998, J MOL BIOL, V279, P439, DOI 10.1006/jmbi.1998.1775; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Pape T, 2004, J APPL CRYSTALLOGR, V37, P843, DOI 10.1107/S0021889804018047; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Peters KM, 2008, BIOCHEMISTRY-US, V47, P8122, DOI 10.1021/bi8008246; Petrek M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-316; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Piddock LJV, 2006, CLIN MICROBIOL REV, V19, P382, DOI 10.1128/CMR.19.2.382-402.2006; Poole K, 2005, J ANTIMICROB CHEMOTH, V56, P20, DOI 10.1093/jac/dki171; Ramos JL, 2005, MICROBIOL MOL BIOL R, V69, P326, DOI 10.1128/MMBR.69.2.326-356.2005; Reichheld SE, 2006, J MOL BIOL, V361, P382, DOI 10.1016/j.jmb.2006.06.035; Resch M, 2008, NUCLEIC ACIDS RES, V36, P4390, DOI 10.1093/nar/gkn400; Rockwell NC, 2007, BMC BIOINFORMATICS, V8, P1, DOI 10.1186/1471-2105-8-123; ROJO F, 1995, NUCLEIC ACIDS RES, V23, P3181, DOI 10.1093/nar/23.16.3181; Sanchez P, 2002, J ANTIMICROB CHEMOTH, V50, P657, DOI 10.1093/jac/dkf185; Sanchez P, 2002, ANTIMICROB AGENTS CH, V46, P3386, DOI 10.1128/AAC.46.11.3386-3393.2002; Sanchez P, 2005, ANTIMICROB AGENTS CH, V49, P781, DOI 10.1128/AAC.49.2.781-782.2005; Sanchez P, 2004, ANTIMICROB AGENTS CH, V48, P2274, DOI 10.1128/AAC.48.6.2274-2276.2004; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Schumacher MA, 2002, EMBO J, V21, P1210, DOI 10.1093/emboj/21.5.1210; Schumacher MA, 2001, SCIENCE, V294, P2158, DOI 10.1126/science.1066020; Sheldrick GM, 2002, Z KRISTALLOGR, V217, P644, DOI 10.1524/zkri.217.12.644.20662; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P1688, DOI 10.1107/S0907444903015142; Vila J, 2008, CURR DRUG TARGETS, V9, P797, DOI 10.2174/138945008785747806; Willems AR, 2008, J MOL BIOL, V376, P1377, DOI 10.1016/j.jmb.2007.12.061; Zhang L, 2001, ANTIMICROB AGENTS CH, V45, P3497, DOI 10.1128/AAC.45.12.3497-3503.2001	66	39	41	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14428	14438		10.1074/jbc.M809221200	http://dx.doi.org/10.1074/jbc.M809221200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19324881	Green Published, hybrid			2022-12-27	WOS:000266286100049
J	Tremblay, CS; Huard, CC; Huang, FF; Habi, O; Bourdages, V; Levesque, G; Carreau, M				Tremblay, Cedric S.; Huard, Caroline C.; Huang, Feng-Fei; Habi, Ouassila; Bourdages, Valerie; Levesque, Georges; Carreau, Madeleine			The Fanconi Anemia Core Complex Acts as a Transcriptional Co-regulator in Hairy Enhancer of Split 1 Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEINS FANCA; DNA-REPAIR; POSITIONAL CLONING; NUCLEAR-COMPLEX; HELICASE BRIP1; GENE; NOTCH; PATHWAY; COMPLEMENTATION; CELLS	Mutations in one of the 13 Fanconi anemia (FA) genes cause a progressive bone marrow failure disorder associated with developmental abnormalities and a predisposition to cancer. Although FA has been defined as a DNA repair disease based on the hypersensitivity of patient cells to DNA cross-linking agents, FA patients develop various developmental defects such as skeletal abnormalities, microphthalmia, and endocrine abnormalities that may be linked to transcriptional defects. Recently, we reported that the FA core complex interacts with the transcriptional repressor Hairy Enhancer of Split 1 (HES1) suggesting that the core complex plays a role in transcription. Here we show that the FA core complex contributes to transcriptional regulation of HES1-responsive genes, including HES1 and the cyclin-dependent kinase inhibitor p21cip1/waf1. Chromatin immunoprecipitation studies show that the FA core complex interacts with the HES1 promoter but not the p21cip1/waf1 promoter. Furthermore, we show that the FA core complex interferes with HES1 binding to the co-repressor transducin-like-Enhancer of Split, suggesting that the core complex affects transcription both directly and indirectly. Taken together these data suggest a novel function of the FA core complex in transcriptional regulation.	[Tremblay, Cedric S.; Huard, Caroline C.; Huang, Feng-Fei; Habi, Ouassila; Bourdages, Valerie; Levesque, Georges; Carreau, Madeleine] Univ Laval, CHU Laval, Quebec City, PQ G1V 4G2, Canada; [Carreau, Madeleine] Univ Laval, Dept Pediat, Quebec City, PQ G1V 4G2, Canada; [Levesque, Georges] Univ Laval, Dept Med Biol, Quebec City, PQ G1V 4G2, Canada	Laval University; Laval University; Laval University	Carreau, M (corresponding author), Univ Laval, CHU Laval, 2705 Boul Laurier,RC-9800, Quebec City, PQ G1V 4G2, Canada.	Madeleine.Carreau@crchul.ulaval.ca		Huard, Caroline/0000-0001-9646-0500; Carreau, Madeleine/0000-0002-0582-6114	Sickkids Foundation/Institute for Human Development; Child and Youth Health of the Canadian Institutes of Health Research [XG 05-014R]; Roche Foundation for Anemia Research and the Canadian Blood Services; Fonds de la Recherche en Sante du Quebec Senior; La Fondation de la Recherche sur les Maladies Infantiles; FRSQ	Sickkids Foundation/Institute for Human Development; Child and Youth Health of the Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Roche Foundation for Anemia Research and the Canadian Blood Services; Fonds de la Recherche en Sante du Quebec Senior; La Fondation de la Recherche sur les Maladies Infantiles; FRSQ(Fonds de la Recherche en Sante du Quebec)	This work was supported by grants from the Sickkids Foundation/Institute for Human Development, Child and Youth Health of the Canadian Institutes of Health Research (CIHR, Grant XG 05-014R: Role of Fanconi anemia proteins in development), the Roche Foundation for Anemia Research and the Canadian Blood Services, and Fonds de la Recherche en Sante du Quebec Senior Investigator Awards (to G. L. and M. C.). Additional support was provided by training awards from La Fondation de la Recherche sur les Maladies Infantiles (to C. S. T.), the CIHR (to C. H.), and the FRSQ (to C. S. T.).	Apostolou S, 1996, NAT GENET, V14, P324, DOI 10.1038/ng1196-324; Baia G, 2008, NEOPLASIA, V10, P604, DOI 10.1593/neo.08356; Bray S, 2001, CURR BIOL, V11, pR217, DOI 10.1016/S0960-9822(01)00109-9; Bridge WL, 2005, NAT GENET, V37, P953, DOI 10.1038/ng1627; Brodeur I, 2004, J BIOL CHEM, V279, P4713, DOI 10.1074/jbc.M301291200; Carreau M, 1999, EXP HEMATOL, V27, P1667, DOI 10.1016/S0301-472X(99)00102-2; Castella P, 2000, MOL CELL BIOL, V20, P6170, DOI 10.1128/MCB.20.16.6170-6183.2000; Compe E, 2007, NAT NEUROSCI, V10, P1414, DOI 10.1038/nn1990; de Winter JP, 2000, NAT GENET, V24, P15, DOI 10.1038/71626; de Winter JP, 1998, NAT GENET, V20, P281, DOI 10.1038/3093; de Winter JP, 2000, AM J HUM GENET, V67, P1306, DOI 10.1016/S0002-9297(07)62959-0; de Winter JP, 2000, HUM MOL GENET, V9, P2665, DOI 10.1093/hmg/9.18.2665; Dokal I, 2000, BEST PRACT RES CL HA, V13, P407, DOI 10.1053/beha.2000.0085; Dorsman JC, 2007, CELL ONCOL, V29, P211; Fagerlie SR, 2001, BLOOD, V97, P3017, DOI 10.1182/blood.V97.10.3017; Ganem NJ, 2007, CURR OPIN GENET DEV, V17, P157, DOI 10.1016/j.gde.2007.02.011; Garcia-Higuera I, 2000, BLOOD, V96, P3224, DOI 10.1182/blood.V96.9.3224.h8003224_3224_3230; Garcia-Higuera I, 1999, MOL CELL BIOL, V19, P4866; Giri N, 2007, J CLIN ENDOCR METAB, V92, P2624, DOI 10.1210/jc.2007-0135; Godin C, 2003, NEUROREPORT, V14, P1613, DOI 10.1097/00001756-200308260-00014; Gratton MO, 2003, MOL CELL BIOL, V23, P6922, DOI 10.1128/MCB.23.19.6922-6935.2003; Grbavec D, 1996, BIOCHEM BIOPH RES CO, V223, P701, DOI 10.1006/bbrc.1996.0959; Haneline LS, 1999, BLOOD, V94, P1; Hebert SS, 2003, NEUROBIOL DIS, V13, P238, DOI 10.1016/S0969-9961(03)00035-4; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Jhas S, 2006, J NEUROSCI, V26, P11061, DOI 10.1523/JNEUROSCI.1358-06.2006; Ju BG, 2004, CELL, V119, P815, DOI 10.1016/j.cell.2004.11.017; Kageyama R, 2007, DEVELOPMENT, V134, P1243, DOI 10.1242/dev.000786; Kawamata S, 2002, ONCOGENE, V21, P3855, DOI 10.1038/sj.onc.1205487; Keriel A, 2002, CELL, V109, P125, DOI 10.1016/S0092-8674(02)00692-X; King IN, 2006, BIOCHEM BIOPH RES CO, V345, P446, DOI 10.1016/j.bbrc.2006.04.097; Kruyt FAE, 1999, J BIOL CHEM, V274, P34212, DOI 10.1074/jbc.274.48.34212; Levitus M, 2005, NAT GENET, V37, P934, DOI 10.1038/ng1625; Levran O, 2005, NAT GENET, V37, P931, DOI 10.1038/ng1624; LoTenFoe JR, 1996, NAT GENET, V14, P320, DOI 10.1038/ng1196-320; Martys-Zage JL, 2000, J MOL NEUROSCI, V15, P189, DOI 10.1385/JMN:15:3:189; McLarrent FW, 2001, J BIOL CHEM, V276, P1578, DOI 10.1074/jbc.M007629200; Medhurst AL, 2001, HUM MOL GENET, V10, P423, DOI 10.1093/hmg/10.4.423; Meetei AR, 2005, NAT GENET, V37, P958, DOI 10.1038/ng1626; Meetei AR, 2003, NAT GENET, V35, P165, DOI 10.1038/ng1241; Meetei AR, 2004, NAT GENET, V36, P1219, DOI 10.1038/ng1458; Mosedale G, 2005, NAT STRUCT MOL BIOL, V12, P763, DOI 10.1038/nsmb981; Ohtsuka T, 1999, EMBO J, V18, P2196, DOI 10.1093/emboj/18.8.2196; PAROUSH Z, 1994, CELL, V79, P805, DOI 10.1016/0092-8674(94)90070-1; Pouliot F, 2002, J ENDOCRINOL, V172, P187, DOI 10.1677/joe.0.1720187; Prabhu S, 1997, MOL CELL BIOL, V17, P5888, DOI 10.1128/MCB.17.10.5888; Pursglove SE, 2005, INT J BIOCHEM CELL B, V37, P2472, DOI 10.1016/j.biocel.2005.06.013; Reid S, 2007, NAT GENET, V39, P162, DOI 10.1038/ng1947; Sang LY, 2008, SCIENCE, V321, P1095, DOI 10.1126/science.1155998; Sims AE, 2007, NAT STRUCT MOL BIOL, V14, P564, DOI 10.1038/nsmb1252; Smogorzewska A, 2007, CELL, V129, P289, DOI 10.1016/j.cell.2007.03.009; STRATHDEE CA, 1992, NATURE, V356, P763, DOI 10.1038/356763a0; TAKEBAYASHI K, 1994, J BIOL CHEM, V269, P5150; Timmers C, 2001, MOL CELL, V7, P241, DOI 10.1016/S1097-2765(01)00172-1; Tremblay CS, 2008, BLOOD, V112, P2062, DOI 10.1182/blood-2008-04-152710; Waisfisz Q, 1999, P NATL ACAD SCI USA, V96, P10320, DOI 10.1073/pnas.96.18.10320; Wajnrajch MP, 2001, PEDIATRICS, V107, P744, DOI 10.1542/peds.107.4.744; Xia B, 2007, NAT GENET, V39, P159, DOI 10.1038/ng1942; Xue YT, 2008, HUM MOL GENET, V17, P1641, DOI 10.1093/hmg/ddn054	60	16	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13384	13395		10.1074/jbc.M807921200	http://dx.doi.org/10.1074/jbc.M807921200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19321451	hybrid, Green Published			2022-12-27	WOS:000265877300014
J	Lee, J; Moir, RD; Willis, IM				Lee, JaeHoon; Moir, Robyn D.; Willis, Ian M.			Regulation of RNA Polymerase III Transcription Involves SCH9-dependent and SCH9-independent Branches of the Target of Rapamycin (TOR) Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; SACCHAROMYCES-CEREVISIAE; PHOSPHORYLATION SITES; NUCLEAR-LOCALIZATION; NEGATIVE REGULATOR; MASS-SPECTROMETRY; MAF1; SCH9; REPRESSION; GENES	Maf1 is a conserved repressor of transcription that functions at the downstream end of multiple nutrient and stress signaling pathways. How these different signaling pathways converge on Maf1 is not known. Previous work in yeast indicates that protein kinase A (PKA) regulates RNA polymerase (pol) III transcription, in part, by phosphorylating multiple sites in Maf1. Here we present additional evidence for this view and show that a parallel nutrient and stress-sensing pathway involving Sch9, an homologous kinase to metazoan S6 kinase, targets Maf1 at a subset of PKA sites. Using ATP analog-sensitive alleles of PKA and Sch9, we find that these two kinases account for the bulk of the phosphorylation on consensus PKA sites in Maf1. Deletion of Sch9 reduces RNA pol III transcription in a Maf1-dependent manner, yet the cells remain susceptible to further repression by rapamycin and other treatments. Because the rapamycin-sensitive kinase activity of the TORC1 complex is necessary for Sch9 function in vivo and in vitro, our results show that transcriptional regulation of RNA pol III and the coordinate control of ribosomal protein genes can be achieved by Sch9-dependent and -independent branches of the target of rapamycin (TOR) signaling pathway.	[Lee, JaeHoon; Moir, Robyn D.; Willis, Ian M.] Albert Einstein Coll Med, Dept Biochem, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Willis, IM (corresponding author), Albert Einstein Coll Med, Dept Biochem, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	willis@aecom.yu.edu		Willis, Ian/0000-0001-6599-2395	National Institutes of Health [GM42728]; Albert Einstein College of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042728] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Albert Einstein College of Medicine; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM42728. This work was also supported by funds from the Albert Einstein College of Medicine.	Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; Chi A, 2007, P NATL ACAD SCI USA, V104, P2193, DOI 10.1073/pnas.0607084104; Ciesla M, 2007, MOL CELL BIOL, V27, P7693, DOI 10.1128/MCB.01051-07; De Virgilio C, 2006, ONCOGENE, V25, P6392, DOI 10.1038/sj.onc.1209884; Desai N, 2005, J BIOL CHEM, V280, P6455, DOI 10.1074/jbc.M412375200; Goodfellow SJ, 2008, J MOL BIOL, V378, P481, DOI 10.1016/j.jmb.2008.02.060; Gregan J, 2007, NAT PROTOC, V2, P2996, DOI 10.1038/nprot.2007.447; Johnson SS, 2007, MOL CELL, V26, P367, DOI 10.1016/j.molcel.2007.03.021; Li H, 2006, NATURE, V442, P1058, DOI 10.1038/nature05020; Li X, 2007, J PROTEOME RES, V6, P1190, DOI 10.1021/pr060559j; Moir RD, 2006, P NATL ACAD SCI USA, V103, P15044, DOI 10.1073/pnas.0607129103; Oficjalska-Pham D, 2006, MOL CELL, V22, P623, DOI 10.1016/j.molcel.2006.04.008; Pascual-Ahuir A, 2007, EMBO J, V26, P3098, DOI 10.1038/sj.emboj.7601756; Pokholok DK, 2006, SCIENCE, V313, P533, DOI 10.1126/science.1127677; Reina JH, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000134; Roberts DN, 2006, MOL CELL, V22, P633, DOI 10.1016/j.molcel.2006.04.009; Shou WY, 2002, METHOD ENZYMOL, V351, P279; Smets B, 2008, FEMS YEAST RES, V8, P1276, DOI 10.1111/j.1567-1364.2008.00432.x; Towpik J, 2008, J BIOL CHEM, V283, P17168, DOI 10.1074/jbc.M709157200; Upadhya R, 2002, MOL CELL, V10, P1489, DOI 10.1016/S1097-2765(02)00787-6; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; Willis IM, 2007, TRENDS BIOCHEM SCI, V32, P51, DOI 10.1016/j.tibs.2006.12.001; Yorimitsu T, 2007, MOL BIOL CELL, V18, P4180, DOI 10.1091/mbc.E07-05-0485; Zaman S, 2008, ANNU REV GENET, V42, P27, DOI 10.1146/annurev.genet.41.110306.130206	24	90	93	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12604	12608		10.1074/jbc.C900020200	http://dx.doi.org/10.1074/jbc.C900020200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19299514	hybrid, Green Published			2022-12-27	WOS:000265688300004
J	Salgado, MT; Nagababu, E; Rifkind, JM				Salgado, Maria T.; Nagababu, Enika; Rifkind, Joseph M.			Quantification of Intermediates Formed during the Reduction of Nitrite by Deoxyhemoglobin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-NITROSOHEMOGLOBIN; HUMAN CIRCULATION; VASCULAR CONTROL; RED-CELL; OXIDE; HEMOGLOBIN; MECHANISM; BLOOD; NO; NITROSYLATION	Nitric oxide (NO) plays a crucial role in human physiology by regulating vascular tone and blood flow. The short life-span of NO in blood requires a mechanism to retain NO bioactivity in the circulation. Recent studies have suggested a mechanism involving the reduction of nitrite back to NO by deoxyhemoglobin in RBCs. A role for RBCs in transporting NO must, however, bypass the scavenging of NO in RBCs by hemoglobin. To understand how the nitrite reaction can deliver bioactive NO to the vasculature, we have studied the intermediates formed during the reaction. A reliable measure of the total concentration of heme-associated nitrite/NO intermediates formed was provided by combining filtration to measure free nitrite by chemiluminescence and electron paramagnetic resonance to measure the final product Hb(II)NO. By modifying the chemiluminescence method used to detect NO, we have been able to identify two intermediates: 1) a heme-associated nitrite complex that is released as NO in acid solution in the presence of ascorbate and 2) an intermediate that releases NO at neutral pH in the presence of ferricyanide when reacted with an Fe(III) ligand like azide. This species designated as "Hb(II)NO+reversible arrow Hb(III)NO" has properties of both isomeric forms resulting in a slower NO dissociation rate and much higher stability than Hb(III)NO, but provides a potential source for bioactive NO, which can be released from the RBC. This detailed analysis of the nitrite reaction with deoxyHb provides important insights into the mechanism for nitrite induced vasodilation by RBCs.	[Salgado, Maria T.; Nagababu, Enika; Rifkind, Joseph M.] NIA, Mol Dynam Sect, Natl Inst Hlth, Baltimore, MD 21224 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Rifkind, JM (corresponding author), 251 Bayview Blvd,Rm 05B129, Baltimore, MD 21224 USA.	rifkindj@mail.nih.gov			National Institutes of Health NIA Intramural Research Program; NATIONAL INSTITUTE ON AGING [ZIAAG000433, Z01AG000433] Funding Source: NIH RePORTER	National Institutes of Health NIA Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by the National Institutes of Health NIA Intramural Research Program.	ADDISON AW, 1986, BIOCHEMISTRY-US, V25, P4104, DOI 10.1021/bi00362a018; Angelo M, 2006, P NATL ACAD SCI USA, V103, P8366, DOI 10.1073/pnas.0600942103; Brittain T, 2000, J INORG BIOCHEM, V81, P99, DOI 10.1016/S0162-0134(00)00116-1; Cosby K, 2003, NAT MED, V9, P1498, DOI 10.1038/nm954; Dejam A, 2005, BLOOD, V106, P734, DOI 10.1182/blood-2005-02-0567; DOYLE MP, 1981, J BIOL CHEM, V256, P2393; Gautier C, 2006, BIOCHEM BIOPH RES CO, V341, P816, DOI 10.1016/j.bbrc.2006.01.031; Gladwin MT, 2002, J BIOL CHEM, V277, P27818, DOI 10.1074/jbc.M203236200; Gladwin MT, 2000, P NATL ACAD SCI USA, V97, P9943, DOI 10.1073/pnas.180155397; Hoshino M, 1996, J AM CHEM SOC, V118, P5702, DOI 10.1021/ja953311w; Huang KT, 2005, J BIOL CHEM, V280, P31126, DOI 10.1074/jbc.M501496200; Ignarro LJ, 1999, J CARDIOVASC PHARM, V34, P879, DOI 10.1097/00005344-199912000-00016; Jia L, 1996, NATURE, V380, P221, DOI 10.1038/380221a0; Kehmeier ES, 2008, FREE RADICAL BIO MED, V44, P1945, DOI 10.1016/j.freeradbiomed.2008.02.014; Kim-Shapiro DB, 2005, J INORG BIOCHEM, V99, P237, DOI 10.1016/j.jinorgbio.2004.10.034; Lissi E, 1998, FREE RADICAL BIO MED, V24, P1535, DOI 10.1016/S0891-5849(98)00004-5; Liu XP, 1998, J BIOL CHEM, V273, P18709, DOI 10.1074/jbc.273.30.18709; Luchsinger BP, 2003, P NATL ACAD SCI USA, V100, P461, DOI 10.1073/pnas.0233287100; Luchsinger BP, 2005, J INORG BIOCHEM, V99, P912, DOI 10.1016/j.jinorgbio.2004.12.010; Lundberg JO, 2005, ARTERIOSCL THROM VAS, V25, P915, DOI 10.1161/01.ATV.0000161048.72004.c2; McMahon TJ, 2002, NAT MED, V8, P711, DOI 10.1038/nm718; Nagababu E, 2003, J BIOL CHEM, V278, P46349, DOI 10.1074/jbc.M307572200; NAGABABU E, 2008, 15 INT C OX BIND SEN, pP27; Nagababu E, 2006, NITRIC OXIDE-BIOL CH, V15, P20, DOI 10.1016/j.niox.2006.01.012; Nagababu E, 2007, BIOCHEMISTRY-US, V46, P11650, DOI 10.1021/bi700364e; Nagababu E, 2007, FREE RADICAL BIO MED, V42, P1146, DOI 10.1016/j.freeradbiomed.2006.12.029; Pawloski JR, 2001, NATURE, V409, P622, DOI 10.1038/35054560; Rifkind JM, 2007, BIOPHYS J, p383A; Rifkind JM, 2006, ANTIOXID REDOX SIGN, V8, P1193, DOI 10.1089/ars.2006.8.1193; SHARMA VS, 1987, BIOCHEMISTRY-US, V26, P3837, DOI 10.1021/bi00387a015; WANG Y, 1960, J AM CHEM SOC, V118, P3972	31	38	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12710	12718		10.1074/jbc.M808647200	http://dx.doi.org/10.1074/jbc.M808647200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19270306	hybrid, Green Published			2022-12-27	WOS:000265688300015
J	Li, GD; Chiara, DC; Cohen, JB; Olsen, RW				Li, Guo-Dong; Chiara, David C.; Cohen, Jonathan B.; Olsen, Richard W.			Neurosteroids Allosterically Modulate Binding of the Anesthetic Etomidate to gamma-Aminobutyric Acid Type A Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; GABA(A) RECEPTOR; SITES; SUBUNIT; IDENTIFICATION; PHARMACOLOGY; MECHANISMS; MUTATIONS; PROPOFOL; DISTINCT	Photoaffinity labeling of gamma-aminobutyric acid type A (GABA(A))-receptors (GABA(A)R) with an etomidate analog and mutational analyses of direct activation of GABA(A)R by neurosteroids have each led to the proposal that these structurally distinct general anesthetics bind to sites in GABA(A)Rs in the transmembrane domain at the interface between the beta and alpha subunits. We tested whether the two ligand binding sites might overlap by examining whether neuroactive steroids inhibited etomidate analog photolabeling. We previously identified (Li, G. D., Chiara, D. C., Sawyer, G. W., Husain, S. S., Olsen, R. W., and Cohen, J. B. (2006) J. Neurosci. 26, 11599 - 11605) azietomidate photolabeling of GABA(A)R alpha 1Met-236 and beta Met-286 (in alpha M1 and beta M3). Positioning these two photolabeled amino acids in a single type of binding site at the interface of beta and alpha subunits (two copies per pentamer) is consistent with a GABA(A)R homology model based upon the structure of the nicotinic acetylcholine receptor and with recent alpha M1 to beta M3 cross-linking data. Biologically active neurosteroids enhance rather than inhibit azietomidate photolabeling, as assayed at the level of GABA(A)R subunits on analytical SDS-PAGE, and protein microsequencing establishes that the GABA(A)R-modulating neurosteroids do not inhibit photolabeling of GABA(A)R alpha 1Met-236 or beta Met-286 but enhance labeling of alpha 1Met-236. Thus modulatory steroids do not bind at the same site as etomidate, and neither of the amino acids identified as neurosteroid activation determinants (Hosie, A. M., Wilkins, M. E., da Silva, H. M., and Smart, T. G. (2006) Nature 444, 486 - 489) are located at the subunit interface defined by our etomidate site model.	[Li, Guo-Dong; Olsen, Richard W.] Univ Calif Los Angeles, Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Chiara, David C.; Cohen, Jonathan B.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Harvard University; Harvard Medical School	Li, GD (corresponding author), Univ Calif Los Angeles, Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.	guodongli@mednet.ucla.edu; ROlsen@mednet.ucla.edu			National Institutes of Health [GM58448]; Harvard Medical School; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM058448] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Harvard Medical School; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM58448 (to R.W.O., J.B.C., and Keith W. Miller). This work was also supported by an award to Harvard Medical School from the Howard Hughes Biomedical Research Support Program for Medical School.	Akk G, 2008, MOL PHARMACOL, V74, P614, DOI 10.1124/mol.108.048520; Akk G, 2007, PHARMACOL THERAPEUT, V116, P35, DOI 10.1016/j.pharmthera.2007.03.004; Bali M, 2004, MOL PHARMACOL, V65, P68, DOI 10.1124/mol.65.1.68; Bali M, 2009, J NEUROSCI, V29, P3083, DOI 10.1523/JNEUROSCI.6090-08.2009; Belelli D, 1997, P NATL ACAD SCI USA, V94, P11031, DOI 10.1073/pnas.94.20.11031; Belelli D, 2005, NAT REV NEUROSCI, V6, P565, DOI 10.1038/nrn1703; Ernst M, 2005, MOL PHARMACOL, V68, P1291, DOI 10.1124/mol.105.015982; Franks NP, 2008, NAT REV NEUROSCI, V9, P370, DOI 10.1038/nrn2372; Hanchar HJ, 2005, NAT NEUROSCI, V8, P339, DOI 10.1038/nn1398; Hemmings HC, 2005, TRENDS PHARMACOL SCI, V26, P503, DOI 10.1016/j.tips.2005.08.006; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hosie AM, 2006, NATURE, V444, P486, DOI 10.1038/nature05324; Jansen M, 2006, J NEUROSCI, V26, P4492, DOI 10.1523/JNEUROSCI.0224-06.2006; Jurd R, 2002, FASEB J, V16, P250, DOI 10.1096/fj.02-0611fje; KOTZYBAHIBERT F, 1995, ANGEW CHEM INT EDIT, V34, P1296, DOI 10.1002/anie.199512961; Krasowski MD, 1998, MOL PHARMACOL, V53, P530, DOI 10.1124/mol.53.3.530; Li GD, 2006, J NEUROSCI, V26, P11599, DOI 10.1523/JNEUROSCI.3467-06.2006; Liao M, 2005, ANESTH ANALG, V101, P131, DOI 10.1213/01.ANE.0000153011.64764.6F; MCCLELLAND RA, 2004, REACTIVE INTERMEDIAT, P3; Mihic SJ, 1997, NATURE, V389, P385, DOI 10.1038/38738; Olsen RW, 2008, PHARMACOL REV, V60, P243, DOI 10.1124/pr.108.00505; Reynolds DS, 2003, J NEUROSCI, V23, P8608; Rusch D, 2004, J BIOL CHEM, V279, P20982, DOI 10.1074/jbc.M400472200; Siegwart R, 2002, J NEUROCHEM, V80, P140, DOI 10.1046/j.0022-3042.2001.00682.x; Stewart D, 2008, MOL PHARMACOL, V74, P1687, DOI 10.1124/mol.108.050500; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Vodovozova EL, 2007, BIOCHEMISTRY-MOSCOW+, V72, P1, DOI 10.1134/S0006297907010014; Yamakura T, 2001, ANNU REV PHARMACOL, V41, P23, DOI 10.1146/annurev.pharmtox.41.1.23; Ziebell MR, 2004, J BIOL CHEM, V279, P17640, DOI 10.1074/jbc.M313886200	29	54	57	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					11771	11775		10.1074/jbc.C900016200	http://dx.doi.org/10.1074/jbc.C900016200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19282280	hybrid, Green Published			2022-12-27	WOS:000265494600008
J	Liao, HI; Olson, CA; Hwang, SM; Deng, HY; Wong, E; Baric, RS; Roberts, RW; Sun, R				Liao, Hsiang-I.; Olson, C. Anders; Hwang, Seungmin; Deng, Hongyu; Wong, Elaine; Baric, Ralph S.; Roberts, Richard W.; Sun, Ren			mRNA Display Design of Fibronectin-based Intrabodies That Detect and Inhibit Severe Acute Respiratory Syndrome Coronavirus Nucleocapsid Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANKYRIN REPEAT PROTEINS; SARS CORONAVIRUS; SELF-ASSOCIATION; TERMINAL DOMAIN; III DOMAIN; BINDING; SELECTION; ANTIBODIES; THERAPEUTICS; RECOGNITION	The nucleocapsid (N) protein of severe acute respiratory syndrome (SARS) coronavirus plays important roles in both viral replication and modulation of host cell processes. New ligands that target the N protein may thus provide tools to track the protein inside cells, detect interaction hot spots on the protein surface, and discover sites that could be used to develop new anti-SARS therapies. Using mRNA display selection and directed evolution, we designed novel antibody-like protein affinity reagents that target SARS N protein with high affinity and selectivity. Our libraries were based on an 88-residue variant of the 10th fibronectin type III domain from human fibronectin (10Fn3). This selection resulted in eight independent 10Fn3 intrabodies, two that require the N-terminal domain for binding and six that recognize the C terminus, one with K-d = 1.7 nM. 10Fn3 intrabodies are well expressed in mammalian cells and are relocalized by N in SARS-infected cells. Seven of the selected intrabodies tested do not perturb cellular function when expressed singly in vivo and inhibit virus replication from 11- to 5900-fold when expressed in cells prior to infection. Targeting two sites on SARS-N simultaneously using two distinct 10Fn3s results in synergistic inhibition of virus replication.	[Liao, Hsiang-I.; Hwang, Seungmin; Deng, Hongyu; Wong, Elaine; Sun, Ren] Univ Calif Los Angeles, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Sun, Ren] Univ Calif Los Angeles, Calif Nano Syst Inst, Los Angeles, CA 90095 USA; [Olson, C. Anders] CALTECH, Pasadena, CA 91125 USA; [Baric, Ralph S.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC 27599 USA; [Roberts, Richard W.] Univ So Calif, Dept Chem Chem Engn & Biol, Los Angeles, CA 90089 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; California Institute of Technology; University of North Carolina; University of North Carolina Chapel Hill; University of Southern California	Sun, R (corresponding author), Univ Calif Los Angeles, Dept Mol & Med Pharmacol, 650 Charles E Young Dr S,CHS 23-120, Los Angeles, CA 90095 USA.	rsun@mednet.ucla.edu		Hwang, Seungmin/0000-0003-0846-5462	National Institutes of Health [RO1 GM60416]; Burroughs Wellcome Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060416] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 GM60416 (to R. W. R.). This work was also supported by a microbial pathogenesis training grant from Burroughs Wellcome Fund.	Amstutz P, 2005, J BIOL CHEM, V280, P24715, DOI 10.1074/jbc.M501746200; Cardinale A, 2003, EUR J BIOCHEM, V270, P3389, DOI 10.1046/j.1432-1033.2003.03722.x; Cardinale A, 2001, EUR J BIOCHEM, V268, P268, DOI 10.1046/j.1432-1033.2001.01876.x; CARLSON JR, 1988, MOL CELL BIOL, V8, P2638, DOI 10.1128/MCB.8.6.2638; Carter PJ, 2006, NAT REV IMMUNOL, V6, P343, DOI 10.1038/nri1837; Chakrabarti P, 2002, PROTEINS, V47, P334, DOI 10.1002/prot.10085; Chang CK, 2006, J BIOMED SCI, V13, P59, DOI 10.1007/s11373-005-9035-9; Chen CY, 2007, J MOL BIOL, V368, P1075, DOI 10.1016/j.jmb.2007.02.069; Enjuanes L, 2006, ANNU REV MICROBIOL, V60, P211, DOI 10.1146/annurev.micro.60.080805.142157; Hosse RJ, 2006, PROTEIN SCI, V15, P14, DOI 10.1110/ps.051817606; Ja WW, 2005, J BIOL CHEM, V280, P32057, DOI 10.1074/jbc.C500319200; Kawe M, 2006, J BIOL CHEM, V281, P40252, DOI 10.1074/jbc.M602506200; Koide A, 1998, J MOL BIOL, V284, P1141, DOI 10.1006/jmbi.1998.2238; Lipovsek D, 2004, J IMMUNOL METHODS, V290, P51, DOI 10.1016/j.jim.2004.04.008; Liu RH, 2000, METHOD ENZYMOL, V318, P268; Luo HB, 2006, BIOCHEMISTRY-US, V45, P11827, DOI 10.1021/bi0609319; Maynard J, 2000, ANNU REV BIOMED ENG, V2, P339, DOI 10.1146/annurev.bioeng.2.1.339; MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783; Nizak C, 2003, SCIENCE, V300, P984, DOI 10.1126/science.1083911; Olson CA, 2008, ACS CHEM BIOL, V3, P480, DOI 10.1021/cb800069c; Olson CA, 2007, PROTEIN SCI, V16, P476, DOI 10.1110/ps.062498407; Rajpal A, 2001, J BIOL CHEM, V276, P33139, DOI 10.1074/jbc.M101332200; Roberts RS, 2006, ADV EXP MED BIOL, V581, P597; Roberts RW, 1997, P NATL ACAD SCI USA, V94, P12297, DOI 10.1073/pnas.94.23.12297; Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952; Saikatendu KS, 2007, J VIROL, V81, P3913, DOI 10.1128/JVI.02236-06; Satija N, 2007, ANN NY ACAD SCI, V1102, P26, DOI 10.1196/annals.1408.002; Stocks M, 2005, CURR OPIN CHEM BIOL, V9, P359, DOI 10.1016/j.cbpa.2005.06.003; Surjit M, 2004, BIOCHEM BIOPH RES CO, V317, P1030, DOI 10.1016/j.bbrc.2004.03.154; Vascotto F, 2004, J GEN VIROL, V85, P3285, DOI 10.1099/vir.0.80075-0; Visintin M, 1999, P NATL ACAD SCI USA, V96, P11723, DOI 10.1073/pnas.96.21.11723; Yount B, 2003, P NATL ACAD SCI USA, V100, P12995, DOI 10.1073/pnas.1735582100; Yu IM, 2005, J BIOL CHEM, V280, P23280, DOI 10.1074/jbc.M501015200	33	34	36	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17512	17520		10.1074/jbc.M901547200	http://dx.doi.org/10.1074/jbc.M901547200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19364769	hybrid, Green Published, Green Accepted			2022-12-27	WOS:000267202500017
J	Muniyappa, H; Song, SW; Mathews, CK; Das, KC				Muniyappa, Harish; Song, Shiwei; Mathews, Christopher K.; Das, Kumuda C.			Reactive Oxygen Species-independent Oxidation of Thioredoxin in Hypoxia INACTIVATION OF RIBONUCLEOTIDE REDUCTASE AND REDOX-MEDIATED CHECKPOINT CONTROL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANGANESE SUPEROXIDE-DISMUTASE; BREAST-CANCER CELLS; GENE-EXPRESSION; TUMOR HYPOXIA; ATAXIA-TELANGIECTASIA; REPLICATION ARREST; DRUG-RESISTANCE; CYTOSOLIC NADPH; NITRIC-OXIDE; SOLID TUMORS	We have investigated the role of cellular redox state on the regulation of cell cycle in hypoxia and shown that whereas cells expressing mutant thioredoxin (Trx) or a normal level of Trx undergo increased apoptosis, cells overexpressing Trx are protected against apoptosis. We show that hypoxia activates p53 and Chk1/Chk2 proteins in cells expressing normal or mutant Trx but not in cells overexpressing Trx. We also show that the activity of ribonucleotide reductase decreases in hypoxia in cells expressing redox-inactive Trx. Although hypoxia has been shown to induce reactive oxygen species (ROS) generation in the mitochondria resulting in enhanced p53 expression, our data demonstrate that hypoxia-induced p53 expression and phosphorylation are independent of ROS. Furthermore, hypoxia induces oxidation of Trx, and this oxidation is potentiated in the presence of 6-aminonicotinamide, an inhibitor of glucose-6-phosphate dehydrogenase. Taken together our study shows that Trx redox state is modulated in hypoxia independent of ROS and is a critical determinant of cell cycle regulation.	[Muniyappa, Harish; Das, Kumuda C.] Univ Arkansas Med Sci, Dept Pathol, Little Rock, AR 72205 USA; [Song, Shiwei; Mathews, Christopher K.] Oregon State Univ, Dept Biochem & Biophys, Corvallis, OR 97331 USA	University of Arkansas System; University of Arkansas Medical Sciences; Oregon State University	Das, KC (corresponding author), 4301 W Markham,Slot 845, Little Rock, AR 72205 USA.	kdas@uams.edu	Das, Kumuda/A-7662-2012		National Institutes of Health [R01 HL071558]; University of Arkansas for Medical Science Research Council; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL071558] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Arkansas for Medical Science Research Council; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 HL071558. This work was also supported by the University of Arkansas for Medical Science Research Council (to K. C. D.).	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; Avval FZ, 2009, J BIOL CHEM, V284, P8233, DOI 10.1074/jbc.M809338200; Bilodeau JF, 2000, EXP CELL RES, V256, P347, DOI 10.1006/excr.2000.4844; Blancher C, 1998, CANCER METAST REV, V17, P187, DOI 10.1023/A:1006002419244; Brown JM, 1999, CANCER RES, V59, P5863; Brown JM, 2000, MOL MED TODAY, V6, P157, DOI 10.1016/S1357-4310(00)01677-4; Brown JM, 1998, CANCER RES, V58, P1408; Cash TP, 2007, FREE RADICAL BIO MED, V43, P1219, DOI 10.1016/j.freeradbiomed.2007.07.001; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chandel NS, 2000, ONCOGENE, V19, P3840, DOI 10.1038/sj.onc.1203727; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chi JT, 2006, PLOS MED, V3, P395, DOI 10.1371/journal.pmed.0030047; Danielsen T, 1998, BRIT J CANCER, V78, P1547, DOI 10.1038/bjc.1998.722; Das KC, 1998, J IMMUNOL METHODS, V211, P9, DOI 10.1016/S0022-1759(97)00163-4; Das KC, 1997, AM J RESP CELL MOL, V17, P713, DOI 10.1165/ajrcmb.17.6.2809; Das KC, 1999, AM J PHYSIOL-LUNG C, V276, pL530, DOI 10.1152/ajplung.1999.276.3.L530; Das KC, 2004, AM J PHYSIOL-LUNG C, V286, pL87, DOI 10.1152/ajplung.00203.2002; Das KC, 2001, J BIOL CHEM, V276, P4662, DOI 10.1074/jbc.M006206200; Day BJ, 1995, J PHARMACOL EXP THER, V275, P1227; Doege K, 2005, BLOOD, V106, P2311, DOI 10.1182/blood-2005-03-1138; FAULKNER KM, 1994, J BIOL CHEM, V269, P23471; Gallegos A, 1996, CANCER RES, V56, P5765; Giaccia AJ, 2004, GENE DEV, V18, P2183, DOI 10.1101/gad.1243304; Gibson SL, 2005, CANCER RES, V65, P10734, DOI 10.1158/0008-5472.CAN-05-1160; Green SL, 1998, CANCER J SCI AM, V4, P218; Gupte SA, 2006, AM J PHYSIOL-HEART C, V290, pH2228, DOI 10.1152/ajpheart.00615.2005; Hagen T, 2003, SCIENCE, V302, P1975, DOI 10.1126/science.1088805; Hammond EM, 2005, BIOCHEM BIOPH RES CO, V331, P718, DOI 10.1016/j.bbrc.2005.03.154; Hammond EM, 2004, DNA REPAIR, V3, P1117, DOI 10.1016/j.dnarep.2004.03.035; Hammond EM, 2003, MUTAT RES-FUND MOL M, V532, P205, DOI 10.1016/j.mrfmmm.2003.08.017; Hammond EM, 2003, J BIOL CHEM, V278, P12207, DOI 10.1074/jbc.M212360200; Hammond EM, 2002, MOL CELL BIOL, V22, P1834, DOI 10.1128/MCB.22.6.1834-1843.2002; Hockel M, 2001, SEMIN ONCOL, V28, P36, DOI 10.1016/S0093-7754(01)90211-8; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; HOLMGREN A, 1995, METHOD ENZYMOL, V252, P199; Kolberg M, 2004, BBA-PROTEINS PROTEOM, V1699, P1, DOI 10.1016/j.bbapap.2004.02.007; Krtolica A, 1999, BRIT J CANCER, V80, P1875, DOI 10.1038/sj.bjc.6690615; Lambert AJ, 2008, BBA-BIOENERGETICS, V1777, P397, DOI 10.1016/j.bbabio.2008.03.005; Li JJ, 1998, CARCINOGENESIS, V19, P833, DOI 10.1093/carcin/19.5.833; Metzen E, 2003, MOL BIOL CELL, V14, P3470, DOI 10.1091/mbc.e02-12-0791; OBLONG JE, 1994, J BIOL CHEM, V269, P11714; Park WH, 2007, J CELL BIOCHEM, V102, P98, DOI 10.1002/jcb.21280; Plummer ER, 2006, CURR OPIN PHARMACOL, V6, P364, DOI 10.1016/j.coph.2006.02.004; Ravi D, 2005, J BIOL CHEM, V280, P40084, DOI 10.1074/jbc.M507192200; Rotman G, 1997, BIOESSAYS, V19, P911, DOI 10.1002/bies.950191011; Rundle NT, 2001, J BIOL CHEM, V276, P48231, DOI 10.1074/jbc.M103990200; Saito S, 2002, J BIOL CHEM, V277, P12491, DOI 10.1074/jbc.C200093200; Shieh SY, 1999, EMBO J, V18, P1815, DOI 10.1093/emboj/18.7.1815; SLABAUGH MB, 1984, J VIROL, V52, P507, DOI 10.1128/JVI.52.2.507-514.1984; Soldani C, 2002, APOPTOSIS, V7, P321, DOI 10.1023/A:1016119328968; Srinivas V, 2001, J BIOL CHEM, V276, P21995, DOI 10.1074/jbc.C100177200; STCLAIR DK, 1991, CANCER RES, V51, P939; TEICHER BA, 1994, CANCER METAST REV, V13, P139, DOI 10.1007/BF00689633; Tomida A, 1999, ANTI-CANCER DRUG DES, V14, P169; VAUPEL P, 1991, CANCER RES, V51, P3316; Webster L, 1998, BRIT J CANCER, V77, P227, DOI 10.1038/bjc.1998.38; White CW, 2006, FREE RADICAL BIO MED, V40, P923, DOI 10.1016/j.freeradbiomed.2005.12.008; Wolin MS, 2005, AM J PHYSIOL-LUNG C, V289, pL159, DOI 10.1152/ajplung.00060.2005; Xue LJ, 2006, CANCER RES, V66, P1900, DOI 10.1158/0008-5472.CAN-05-2656	60	23	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					17069	17081		10.1074/jbc.M109.008557	http://dx.doi.org/10.1074/jbc.M109.008557			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19369702	Green Published, hybrid			2022-12-27	WOS:000266962400045
J	Podoly, E; Shalev, DE; Shenhar-Tsarfaty, S; Bennett, ER; Ben Assayag, E; Wilgus, H; Livnah, O; Soreq, H				Podoly, Erez; Shalev, Deborah E.; Shenhar-Tsarfaty, Shani; Bennett, Estelle R.; Ben Assayag, Einor; Wilgus, Harvey; Livnah, Oded; Soreq, Hermona			The Butyrylcholinesterase K Variant Confers Structurally Derived Risks for Alzheimer Pathology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECOMBINANT HUMAN BUTYRYLCHOLINESTERASE; AMYLOID BETA-PROTEIN; FORMATION IN-VITRO; CASCADE HYPOTHESIS; MOLECULAR-FORMS; SENILE PLAQUES; DISEASE; ACETYLCHOLINESTERASE; BRAIN; CHOLINESTERASES	The K variant of butyrylcholinesterase (BChE-K, 20% incidence) is a long debated risk factor for Alzheimer disease ( AD). The A539T substitution in BChE-K is located at the C terminus, which is essential both for BChE tetramerization and for its capacity to attenuate beta-amyloid (A beta) fibril formation. Here, we report that BChE-K is inherently unstable as compared with the "usual" BChE (BChE-U), resulting in reduced hydrolytic activity and predicting prolonged acetylcholine maintenance and protection from AD. A synthetic peptide derived from the C terminus of BChE-K (BSP-K), which displayed impaired intermolecular interactions, was less potent in suppressing A beta oligomerization than its BSP-U counterpart. Correspondingly, highly purified recombinant human rBChE-U monomers suppressed beta-amyloid fibril formation less effectively than dimers, which also protected cultured neuroblastoma cells from A beta neurotoxicity. Dual activity structurally derived changes due to the A539T substitution can thus account for both neuroprotective characteristics caused by sustained acetylcholine levels and elevated AD risk due to inefficient interference with amyloidogenic processes.	[Soreq, Hermona] Hebrew Univ Jerusalem, Dept Biol Chem, Alexander Silberman Life Sci Inst, IL-91904 Jerusalem, Israel; [Podoly, Erez; Shalev, Deborah E.; Livnah, Oded] Hebrew Univ Jerusalem, Wolfson Ctr Appl Struct Biol, IL-91904 Jerusalem, Israel; [Shenhar-Tsarfaty, Shani; Ben Assayag, Einor] Tel Aviv Univ, Sackler Fac Med, Sourasky Med Ctr, Dept Neurol, IL-69978 Tel Aviv, Israel; [Wilgus, Harvey] PharmAthene Canada Inc, Montreal, PQ H4S 2C8, Canada	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center	Soreq, H (corresponding author), Hebrew Univ Jerusalem, Dept Biol Chem, Alexander Silberman Life Sci Inst, Safra Campus, IL-91904 Jerusalem, Israel.	soreq@cc.huji.ac.il	Shalev, Deborah E/AAY-2873-2021; Bennett, Estelle R/A-5067-2017	Shenhar-Tsarfaty, Shani/0000-0002-8268-1799; Soreq, Hermona/0000-0002-0955-526X	Hurwitz Fund	Hurwitz Fund	This work was supported by a grant from the Hurwitz Fund ( to H. S.).	Altamirano CV, 1999, CHEM-BIOL INTERACT, V119, P53, DOI 10.1016/S0009-2797(99)00013-7; ARENDT T, 1992, NEUROCHEM INT, V21, P381, DOI 10.1016/0197-0186(92)90189-X; ARPAGAUS M, 1990, BIOCHEMISTRY-US, V29, P124, DOI 10.1021/bi00453a015; Babbes ARH, 2008, BIOCHEMISTRY-US, V47, P6969, DOI 10.1021/bi800636q; Baden EM, 2008, J BIOL CHEM, V283, P15853, DOI 10.1074/jbc.M705347200; BARTELS CF, 1992, AM J HUM GENET, V50, P1086; Ben Assayag E, 2006, THROMB HAEMOSTASIS, V95, P428, DOI 10.1160/THOS-08-0578; Bergmeyer H.U., 1963, METHOD ENZYMAT AN, P736; Berson A, 2008, BRAIN, V131, P109, DOI 10.1093/brain/awm276; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Blong RM, 1997, BIOCHEM J, V327, P747, DOI 10.1042/bj3270747; Bon S, 2003, NEUROCHEM RES, V28, P523, DOI 10.1023/A:1022821306722; Bush AI, 2008, NEUROTHERAPEUTICS, V5, P421, DOI 10.1016/j.nurt.2008.05.001; CARSON KA, 1991, BRAIN RES, V540, P204, DOI 10.1016/0006-8993(91)90508-S; CHOU PY, 1974, BIOCHEMISTRY-US, V13, P222, DOI 10.1021/bi00699a002; Dahlgren KN, 2002, J BIOL CHEM, V277, P32046, DOI 10.1074/jbc.M201750200; Demuro A, 2005, J BIOL CHEM, V280, P17294, DOI 10.1074/jbc.M500997200; Diamant S, 2006, P NATL ACAD SCI USA, V103, P8628, DOI 10.1073/pnas.0602922103; Dvir H, 2004, EMBO J, V23, P4394, DOI 10.1038/sj.emboj.7600425; EDWARDS JA, 1983, BIOCHIM BIOPHYS ACTA, V742, P509, DOI 10.1016/0167-4838(83)90268-6; Fancy DA, 1999, P NATL ACAD SCI USA, V96, P6020, DOI 10.1073/pnas.96.11.6020; Gatke MR, 2002, SCAND J CLIN LAB INV, V62, P375, DOI 10.1080/00365510260296537; Ghebremedhin E, 2002, NEUROSCI LETT, V320, P25, DOI 10.1016/S0304-3940(02)00014-9; Glabe C, 2001, J MOL NEUROSCI, V17, P137, DOI 10.1385/JMN:17:2:137; GomezRamos P, 1997, MOL CHEM NEUROPATHOL, V30, P161, DOI 10.1007/BF02815095; Guillozet AL, 1997, ANN NEUROL, V42, P909, DOI 10.1002/ana.410420613; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Heise H, 2008, J MOL BIOL, V380, P444, DOI 10.1016/j.jmb.2008.05.026; Holmes C, 2005, J NEUROL NEUROSUR PS, V76, P640, DOI 10.1136/jnnp.2004.039321; Huang YJ, 2007, P NATL ACAD SCI USA, V104, P13603, DOI 10.1073/pnas.0702756104; KARNOVSKY MJ, 1964, J HISTOCHEM CYTOCHEM, V12, P219, DOI 10.1177/12.3.219; Klein WL, 2004, NEUROBIOL AGING, V25, P569, DOI 10.1016/j.neurobiolaging.2004.02.010; LANSBURY PT, 1992, BIOCHEMISTRY-US, V31, P6865, DOI 10.1021/bi00145a001; Lee HG, 2004, ANN NY ACAD SCI, V1019, P1, DOI 10.1196/annals.1297.001; Li H, 2008, BIOCHEM J, V411, P425, DOI 10.1042/BJ20071551; Lomakin A, 1996, P NATL ACAD SCI USA, V93, P1125, DOI 10.1073/pnas.93.3.1125; Lopez OL, 2002, J NEUROL NEUROSUR PS, V72, P310, DOI 10.1136/jnnp.72.3.310; Mancuso M, 2007, ANTIOXID REDOX SIGN, V9, P1631, DOI 10.1089/ars.2007.1761; MORAN MA, 1993, ACTA NEUROPATHOL, V85, P362, DOI 10.1007/BF00334445; Ngamelue MN, 2007, ACTA CRYSTALLOGR F, V63, P723, DOI 10.1107/S1744309107037335; Nicolet Y, 2003, J BIOL CHEM, V278, P41141, DOI 10.1074/jbc.M210241200; O'Brien KK, 2003, PHARMACOGENETICS, V13, P231, DOI 10.1097/00008571-200304000-00008; Ofek K, 2007, J MOL MED, V85, P1239, DOI 10.1007/s00109-007-0226-x; Perrier AL, 2002, NEURON, V33, P275, DOI 10.1016/S0896-6273(01)00584-0; PERRY EK, 1978, NEUROPATH APPL NEURO, V4, P273, DOI 10.1111/j.1365-2990.1978.tb00545.x; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; Podoly E, 2008, NEURODEGENER DIS, V5, P232, DOI 10.1159/000113711; Pratico D, 2008, ANN NY ACAD SCI, V1147, P70, DOI 10.1196/annals.1427.010; Shen J, 2007, P NATL ACAD SCI USA, V104, P403, DOI 10.1073/pnas.0608332104; Soto P, 2007, BIOPHYS J, V93, P3015, DOI 10.1529/biophysj.107.112086; Tidow H, 2007, P NATL ACAD SCI USA, V104, P12324, DOI 10.1073/pnas.0705069104; Wagner R, 1996, J MAGN RESON SER A, V123, P119, DOI 10.1006/jmra.1996.0222; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; WRIGHT CI, 1993, ANN NEUROL, V34, P373, DOI 10.1002/ana.410340312; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Zhu XW, 2004, LANCET NEUROL, V3, P219, DOI 10.1016/S1474-4422(04)00707-0	56	76	76	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					17170	17179		10.1074/jbc.M109.004952	http://dx.doi.org/10.1074/jbc.M109.004952			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19383604	hybrid, Green Published			2022-12-27	WOS:000266962400055
J	Krishnan, N; Jeong, DG; Jung, SK; Ryu, SE; Xiao, A; Allis, CD; Kim, SJ; Tonks, NK				Krishnan, Navasona; Jeong, Dae Gwin; Jung, Suk-Kyeong; Ryu, Seong Eon; Xiao, Andrew; Allis, C. David; Kim, Seung Jun; Tonks, Nicholas K.			Dephosphorylation of the C-terminal Tyrosyl Residue of the DNA Damage-related Histone H2A.X Is Mediated by the Protein Phosphatase Eyes Absent	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-H2AX; CANCER; RECOGNITION; MECHANISM; CHROMATIN; DYNAMICS	In mammalian cells, the DNA damage-related histone H2A variant H2A. X is characterized by a C-terminal tyrosyl residue, Tyr-142, which is phosphorylated by an atypical kinase, WSTF. The phosphorylation status of Tyr-142 in H2A. X has been shown to be an important regulator of the DNA damage response by controlling the formation of gamma H2A.X foci, which are platforms for recruiting molecules involved in DNA damage repair and signaling. In this work, we present evidence to support the identification of the Eyes Absent (EYA) phosphatases, protein-tyrosine phosphatases of the haloacid dehalogenase superfamily, as being responsible for dephosphorylating the C-terminal tyrosyl residue of histone H2A. X. We demonstrate that EYA2 and EYA3 displayed specificity for Tyr-142 of H2A. X in assays in vitro. Suppression of eya3 by RNA interference resulted in elevated basal phosphorylation and inhibited DNA damage-induced dephosphorylation of Tyr-142 of H2A. X in vivo. This study provides the first indication of a physiological substrate for the EYA phosphatases and suggests a novel role for these enzymes in regulation of the DNA damage response.	[Jeong, Dae Gwin; Jung, Suk-Kyeong; Ryu, Seong Eon; Kim, Seung Jun] Korea Res Inst Biosci & Biotechnol, Med Prote Res Ctr, Taejon 305333, South Korea; [Krishnan, Navasona; Tonks, Nicholas K.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA; [Xiao, Andrew; Allis, C. David] Rockefeller Univ, Lab Chromatin Biol, New York, NY 10065 USA	Korea Research Institute of Bioscience & Biotechnology (KRIBB); Cold Spring Harbor Laboratory; Rockefeller University	Kim, SJ (corresponding author), Korea Res Inst Biosci & Biotechnol, Med Prote Res Ctr, 52 Eoeun Dong, Taejon 305333, South Korea.	ksj@kribb.re.kr; tonks@cshl.edu	Kim, Seung Jun/N-5248-2019	Kim, Seung Jun/0000-0002-6913-6358	National Institutes of Health [CA53840, GM40922]; Cold Spring Harbor Laboratory Cancer Center [P30-CA45508]; Korea Research Institute of Bioscience & Biotechnology Research Initiative Program; NATIONAL CANCER INSTITUTE [P30CA045508, R01CA053840, R37CA053840] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM040922] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cold Spring Harbor Laboratory Cancer Center; Korea Research Institute of Bioscience & Biotechnology Research Initiative Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA53840 (to N. K. T.) and GM40922 (to C. D. A.) and Cold Spring Harbor Laboratory Cancer Center Support Grant P30-CA45508. This work was also supported by a grant from the Korea Research Institute of Bioscience & Biotechnology Research Initiative Program (to S. J. K.).	Barford D, 1998, ANNU REV BIOPH BIOM, V27, P133, DOI 10.1146/annurev.biophys.27.1.133; Barr AJ, 2009, CELL, V136, P352, DOI 10.1016/j.cell.2008.11.038; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Burroughs AM, 2006, J MOL BIOL, V361, P1003, DOI 10.1016/j.jmb.2006.06.049; Chowdhury D, 2005, MOL CELL, V20, P801, DOI 10.1016/j.molcel.2005.10.003; Downs JA, 2007, NATURE, V447, P951, DOI 10.1038/nature05980; Ghosh A, 2008, MOL CELL, V32, P478, DOI 10.1016/j.molcel.2008.09.021; Gohla A, 2005, NAT CELL BIOL, V7, P21, DOI 10.1038/ncb1201; Jenic J, 2007, ANNU REV BIOCHEM, V76, P513, DOI 10.1146/annurev.biochem.76.052705.164916; Kim YJ, 2007, P NATL ACAD SCI USA, V104, P6596, DOI 10.1073/pnas.0702099104; Kimura H, 2006, J CELL BIOL, V175, P389, DOI 10.1083/jcb.200608001; Kinner A, 2008, NUCLEIC ACIDS RES, V36, P5678, DOI 10.1093/nar/gkn550; Kriebel M, 2007, DEV DYNAM, V236, P1526, DOI 10.1002/dvdy.21170; Li X, 2003, NATURE, V426, P247, DOI 10.1038/nature02083; Lukong KE, 2003, BBA-REV CANCER, V1653, P73, DOI 10.1016/j.bbcan.2003.09.001; Nakada S, 2008, EMBO REP, V9, P1019, DOI 10.1038/embor.2008.162; Rayapureddi JP, 2006, FEBS LETT, V580, P3853, DOI 10.1016/j.febslet.2006.06.009; Rayapureddi JP, 2003, NATURE, V426, P295, DOI 10.1038/nature02093; Reichenberger KJ, 2005, CANCER RES, V65, P2668, DOI 10.1158/0008-5472.CAN-04-4286; Sarmiento M, 2000, BIOCHEMISTRY-US, V39, P8171, DOI 10.1021/bi000319w; Shechter D, 2007, NAT PROTOC, V2, P1445, DOI 10.1038/nprot.2007.202; Tonks NK, 2006, NAT REV MOL CELL BIO, V7, P833, DOI 10.1038/nrm2039; Tootle TL, 2003, NATURE, V426, P299, DOI 10.1038/nature02097; Xiao A, 2009, NATURE, V457, P57, DOI 10.1038/nature07668; Xu PX, 1999, NAT GENET, V23, P113, DOI 10.1038/12722; Zhang L, 2005, CANCER RES, V65, P925; ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E	27	104	112	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16066	16070		10.1074/jbc.C900032200	http://dx.doi.org/10.1074/jbc.C900032200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19351884	Green Published, hybrid			2022-12-27	WOS:000266730900002
J	Xing, J; Jayasundar, JJ; Ouyang, YX; Dong, WJ				Xing, Jun; Jayasundar, Jayant J.; Ouyang, Yexin; Dong, Wen-Ji			Forster Resonance Energy Transfer Structural Kinetic Studies of Cardiac Thin Filament Deactivation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TROPONIN-I; INHIBITORY REGION; CROSS-BRIDGE; CONFORMATIONAL TRANSITIONS; MYOSIN SUBFRAGMENT-1; MUSCLE; CA2+; CALCIUM; COMPLEX; ACTIN	Cardiac thin filament deactivation is initiated by Ca2+ dissociation from troponin C (cTnC), followed by multiple structural changes of thin filament proteins. These structural transitions are the molecular basis underlying the thin filament regulation of cardiac relaxation, but the detailed mechanism remains elusive. In this study Forster resonance energy transfer (FRET) was used to investigate the dynamics and kinetics of the Ca2+-induced conformational changes of the cardiac thin filaments, specifically the closing of the cTnC N-domain, the cTnC-cTnI (troponin I) interaction, and the cTnI-actin interaction. The cTnC N-domain conformational change was examined by monitoring FRET between a donor (AEDANS) attached to one cysteine residue and an acceptor (DDPM) attached the other cysteine of the mutant cTnC(L13C/N51C). The cTnC-cTnI interaction was investigated by monitoring the distance changes from residue 89 of cTnC to residues 151 and 167 of cTnI, respectively. The cTnI-actin interaction was investigated by monitoring the distance changes from residues 151 and 167 of cTnI to residue 374 of actin. FRET Ca2+ titrations and stopped-flow kinetic measurements show that different thin filament structural transitions have different Ca2+ sensitivities and Ca2+ dissociation-induced kinetics. The observed structural transitions involving the regulatory region and the mobile domain of cTnI occurred at fast kinetic rates, whereas the kinetics of the structural transitions involving the cTnI inhibitory region was slow. Our results suggest that the thin filament deactivation upon Ca2+ dissociation is a two-step process. One step involves rapid binding of the mobile domain of cTnI to actin, which is kinetically coupled with the conformational change of the N-domain of cTnC and the dissociation of the regulatory region of cTnI from cTnC. The other step involves switching the inhibitory region of cTnI from interacting with cTnC to interacting with actin. The latter processes may play a key role in regulating cross-bridge kinetics.	[Jayasundar, Jayant J.; Ouyang, Yexin; Dong, Wen-Ji] Washington State Univ, Sch Chem Engn & Bioengn, Pullman, WA 99164 USA; [Dong, Wen-Ji] Washington State Univ, Dept Vet & Comparat Anat, Pullman, WA 99164 USA; [Xing, Jun] Univ Alabama Birmingham, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA	Washington State University; Washington State University; University of Alabama System; University of Alabama Birmingham	Dong, WJ (corresponding author), Washington State Univ, Sch Chem Engn & Bioengn, Pullman, WA 99164 USA.	wdong@vetmed.wsu.edu	Dong, Wenji/A-8579-2011	Jayasundar, Jayant James/0000-0001-9963-9629	National Institutes of Health [HL80186]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080186] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL80186 (to W.-J.D.).	Bevington PR., 2002, DATA REDUCTION ERROR; CHEUNG HC, 1991, BIOCHEMISTRY-US, V30, P5238, DOI 10.1021/bi00235a018; de Tombe PP, 2007, AM J PHYSIOL-REG I, V292, pR1129, DOI 10.1152/ajpregu.00630.2006; Dong WJ, 2008, J BIOL CHEM, V283, P3424, DOI 10.1074/jbc.M703822200; Dong WJ, 2007, BIOCHEMISTRY-US, V46, P9752, DOI 10.1021/bi700574n; Dong WJ, 2006, ARCH BIOCHEM BIOPHYS, V456, P135, DOI 10.1016/j.abb.2006.08.007; Dong WJ, 2003, J BIOL CHEM, V278, P42394, DOI 10.1074/jbc.M304858200; Dong WJ, 1999, J BIOL CHEM, V274, P31382, DOI 10.1074/jbc.274.44.31382; Dong WJ, 2003, J BIOL CHEM, V278, P8686, DOI 10.1074/jbc.M212886200; Dong WJ, 2001, J MOL BIOL, V314, P51, DOI 10.1006/jmbi.2001.5118; EBASHI S, 1969, Quarterly Reviews of Biophysics, V2, P351; FARAH CS, 1995, FASEB J, V9, P755, DOI 10.1096/fasebj.9.9.7601340; Gomes AV, 2004, ANN NY ACAD SCI, V1015, P214, DOI 10.1196/annals.1302.018; GORDON AM, 1987, J GEN PHYSIOL, V90, P321, DOI 10.1085/jgp.90.3.321; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; GUTH K, 1987, J BIOL CHEM, V262, P13627; HANNON JD, 1992, CIRC RES, V71, P984, DOI 10.1161/01.RES.71.4.984; Hoffman RMB, 2006, J MOL BIOL, V361, P625, DOI 10.1016/j.jmb.2006.06.031; Kobayashi T, 2005, ANNU REV PHYSIOL, V67, P39, DOI 10.1146/annurev.physiol.67.040403.114025; Kobayashi T, 2000, BIOCHEMISTRY-US, V39, P86, DOI 10.1021/bi991903b; LEHMAN W, 1994, NATURE, V368, P65, DOI 10.1038/368065a0; Li MX, 2004, J MUSCLE RES CELL M, V25, P559, DOI 10.1007/s10974-004-5879-2; Li MX, 1999, BIOCHEMISTRY-US, V38, P8289, DOI 10.1021/bi9901679; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693, DOI 10.1016/S0006-3495(93)81110-X; Murakami K, 2005, J MOL BIOL, V352, P178, DOI 10.1016/j.jmb.2005.06.067; Palmer S, 1998, CIRC RES, V83, P179, DOI 10.1161/01.RES.83.2.179; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Regnier M, 2004, BIOPHYS J, V87, P1815, DOI 10.1529/biophysj.103.039123; Robinson JM, 2004, J MOL BIOL, V340, P295, DOI 10.1016/j.jmb.2004.04.046; SMILLIE LB, 1982, METHOD ENZYMOL, V85, P234; Solzin J, 2007, BIOPHYS J, V93, P3917, DOI 10.1529/biophysj.107.111146; Stehle R, 2002, BIOPHYS J, V83, P2152, DOI 10.1016/S0006-3495(02)73975-1; Stehle R, 2002, BASIC RES CARDIOL S1, V97, pI127, DOI DOI 10.1007/S003950200041; Stehle R, 2007, AM J PHYSIOL-REG I, V292, pR1125, DOI 10.1152/ajpregu.00841.2006; TAO T, 1990, SCIENCE, V247, P1339, DOI 10.1126/science.2138356; Tripet B, 1997, J MOL BIOL, V271, P728, DOI 10.1006/jmbi.1997.1200; WANG CK, 1986, J MOL BIOL, V191, P509, DOI 10.1016/0022-2836(86)90145-2; XING J, 1994, ARCH BIOCHEM BIOPHYS, V313, P229, DOI 10.1006/abbi.1994.1381; Xing J, 2008, BIOCHEMISTRY-US, V47, P13383, DOI 10.1021/bi801492x	39	24	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16432	16441		10.1074/jbc.M808075200	http://dx.doi.org/10.1074/jbc.M808075200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19369252	Green Published, hybrid			2022-12-27	WOS:000266730900040
J	McKinstry, WJ; Polekhina, G; Diefenbach-Jagger, H; Ho, PWM; Sato, K; Onuma, E; Gillespie, MT; Martin, TJ; Parker, MW				McKinstry, William J.; Polekhina, Galina; Diefenbach-Jagger, Hannelore; Ho, Patricia W. M.; Sato, Koh; Onuma, Etsuro; Gillespie, Matthew T.; Martin, T. John; Parker, Michael W.			Structural Basis for Antibody Discrimination between Two Hormones That Recognize the Parathyroid Hormone Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMANIZED MONOCLONAL-ANTIBODY; HUMORAL HYPERCALCEMIA; BONE METASTASIS; PROTEIN PTHRP; PEPTIDE; BINDING; LOCALIZATION; INVOLVEMENT; SELECTIVITY; FRAGMENT	Parathyroid hormone-related protein (PTHrP) plays a vital role in the embryonic development of the skeleton and other tissues. When it is produced in excess by cancers it can cause hypercalcemia, and its local production by breast cancer cells has been implicated in the pathogenesis of bone metastasis formation in that disease. Antibodies have been developed that neutralize the action of PTHrP through its receptor, parathyroid hormone receptor 1, without influencing parathyroid hormone action through the same receptor. Such neutralizing antibodies against PTHrP are therapeutically effective in animal models of the humoral hypercalcemia of malignancy and of bone metastasis formation. We have determined the crystal structure of the complex between PTHrP (residues 1-108) and a neutralizing monoclonal anti-PTHrP antibody that reveals the only point of contact is an alpha-helical structure extending from residues 14-29. Another striking feature is that the same residues that interact with the antibody also interact with parathyroid hormone receptor 1, showing that the antibody and the receptor binding site on the hormone closely overlap. The structure explains how the antibody discriminates between the two hormones and provides information that could be used in the development of novel agonists and antagonists of their common receptor.	[McKinstry, William J.; Polekhina, Galina; Parker, Michael W.] St Vincents Inst Med Res, Biota Struct Biol Lab, Fitzroy, Vic 3065, Australia; [Diefenbach-Jagger, Hannelore; Ho, Patricia W. M.; Gillespie, Matthew T.; Martin, T. John] St Vincents Inst Med Res, Bone Cell Biol Lab, Fitzroy, Vic 3065, Australia; [Sato, Koh; Onuma, Etsuro] Chugai Pharmaceut Co Ltd, Pharmaceut Res Lab, Shizuoka 4128513, Japan; [McKinstry, William J.; Gillespie, Matthew T.; Martin, T. John] Univ Melbourne, St Vincents Hosp, Dept Med, Fitzroy, Vic 3065, Australia; [Parker, Michael W.] Univ Melbourne, Dept Biochem & Mol Biol, Bio21 Mol Sci & Biotechnol Inst, Parkville, Vic 3010, Australia	St. Vincent's Institute of Medical Research; St. Vincent's Institute of Medical Research; Chugai Pharmaceutical Co., Ltd.; Roche Holding; St Vincent's Hospital Melbourne; University of Melbourne; University of Melbourne	Parker, MW (corresponding author), St Vincents Inst Med Res, Biota Struct Biol Lab, 9 Princes St, Fitzroy, Vic 3065, Australia.	mparker@svi.edu.au	Parker, Michael W/F-9069-2013; McKinstry, William J/D-2612-2013	Parker, Michael W/0000-0002-3101-1138; McKinstry, William J/0000-0001-9668-9364; Gillespie, Matthew/0000-0001-6543-8909	Cancer Council of Victoria; National Health and Medical Research Council of Australia; Australian Cancer Research Foundation Rational Drug Discovery Facility; Commonwealth of Australia; United States Department of Energy, Basic Energy Sciences, Office of Energy Research	Cancer Council of Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Cancer Research Foundation Rational Drug Discovery Facility; Commonwealth of Australia(Australian Government); United States Department of Energy, Basic Energy Sciences, Office of Energy Research(United States Department of Energy (DOE))	This work was supported in part by grants from the Cancer Council of Victoria and National Health and Medical Research Council of Australia with infrastructural support from the Australian Cancer Research Foundation Rational Drug Discovery Facility. This work, including use of the BioCARS sector, was also supported by the Australian Synchrotron Research Program, which is funded by the Commonwealth of Australia. Use of the Advanced Photon Source was supported by the United States Department of Energy, Basic Energy Sciences, Office of Energy Research.	Bakre MM, 2002, NAT MED, V8, P995, DOI 10.1038/nm753; BARDEN JA, 1989, EUR J BIOCHEM, V184, P379, DOI 10.1111/j.1432-1033.1989.tb15030.x; Barden JA, 1997, J BIOL CHEM, V272, P29572, DOI 10.1074/jbc.272.47.29572; Bergwitz C, 1996, J BIOL CHEM, V271, P26469, DOI 10.1074/jbc.271.43.26469; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen ZG, 2000, BIOCHEMISTRY-US, V39, P12766, DOI 10.1021/bi000882e; Clemens TL, 2001, BRIT J PHARMACOL, V134, P1113, DOI 10.1038/sj.bjp.0704378; Dean T, 2006, MOL ENDOCRINOL, V20, P931, DOI 10.1210/me.2005-0349; Dean T, 2008, MOL ENDOCRINOL, V22, P156, DOI 10.1210/me.2007-0274; Gardella TJ, 2001, TRENDS ENDOCRIN MET, V12, P210, DOI 10.1016/S1043-2760(01)00409-X; Gardella TJ, 1996, J BIOL CHEM, V271, P19888, DOI 10.1074/jbc.271.33.19888; GARDELLA TJ, 1993, ENDOCRINOLOGY, V132, P2024, DOI 10.1210/en.132.5.2024; GARDELLA TJ, 1995, J BIOL CHEM, V270, P6584, DOI 10.1074/jbc.270.12.6584; Gensure RC, 2001, J BIOL CHEM, V276, P28650, DOI 10.1074/jbc.M100717200; Guise T A, 1996, Curr Opin Nephrol Hypertens, V5, P307, DOI 10.1097/00041552-199607000-00004; Guise TA, 1996, J CLIN INVEST, V98, P1544, DOI 10.1172/JCI118947; HAMMONDS RG, 1989, J BIOL CHEM, V264, P14806; Henderson MA, 2006, CANCER RES, V66, P2250, DOI 10.1158/0008-5472.CAN-05-2814; Iguchi H, 2001, INT J CANCER, V94, P24, DOI 10.1002/ijc.1425; Jin L, 2000, J BIOL CHEM, V275, P27238; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; KUKREJA SC, 1990, ENDOCRINOLOGY, V127, P305, DOI 10.1210/endo-127-1-305; KUKREJA SC, 1988, J CLIN INVEST, V82, P1798, DOI 10.1172/JCI113794; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; LAWRENCE MC, 2000, J APPL CRYSTALLOGR, V33, P990; Mannstadt M, 1999, AM J PHYSIOL-RENAL, V277, pF665, DOI 10.1152/ajprenal.1999.277.5.F665; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; MOSELEY JM, 1995, CRIT REV CL LAB SCI, V32, P299, DOI 10.3109/10408369509084687; MOSELEY JM, 1987, P NATL ACAD SCI USA, V84, P5048, DOI 10.1073/pnas.84.14.5048; NAVAZA J, 1994, ACTA CRYSTALLOGR A, V50, P157, DOI 10.1107/S0108767393007597; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Onuma E, 2005, INT J CANCER, V116, P471, DOI 10.1002/ijc.21038; Onuma E, 2004, ANTICANCER RES, V24, P2665; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pellegrini M, 1998, J BIOL CHEM, V273, P10420, DOI 10.1074/jbc.273.17.10420; Pioszak AA, 2008, P NATL ACAD SCI USA, V105, P5034, DOI 10.1073/pnas.0801027105; POWELL GJ, 1991, CANCER RES, V51, P3059; Saito H, 2005, ANTICANCER RES, V25, P3817; SATO K, 1993, J BONE MINER RES, V8, P849; Shimizu M, 2001, ENDOCRINOLOGY, V142, P3068, DOI 10.1210/en.142.7.3068; Suda N, 1996, J CELL PHYSIOL, V166, P94, DOI 10.1002/(SICI)1097-4652(199601)166:1<94::AID-JCP11>3.0.CO;2-P; SUVA LJ, 1987, SCIENCE, V237, P893, DOI 10.1126/science.3616618; Yoneda Toshiyuki, 2000, Cancer, V88, P2979, DOI 10.1002/1097-0142(20000615)88:12+<2979::AID-CNCR13>3.0.CO;2-U	45	11	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15557	15563		10.1074/jbc.M900044200	http://dx.doi.org/10.1074/jbc.M900044200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19346515	hybrid, Green Published			2022-12-27	WOS:000266501000024
J	Hardin, JW; Reyes, FE; Batey, RT				Hardin, John W.; Reyes, Francis E.; Batey, Robert T.			Analysis of a Critical Interaction within the Archaeal Box C/D Small Ribonucleoprotein Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL NUCLEOLAR RNA; GUIDED NUCLEOTIDE MODIFICATION; DOMINANT RETINITIS-PIGMENTOSA; RIBOSE METHYLATION; CRYSTAL-STRUCTURE; MOLECULAR-BASIS; SOLUBLE-RNA; PROTEIN; BINDING; L7AE	In archaea and eukarya, box C/D ribonucleoprotein (RNP) complexes are responsible for 2'-O-methylation of tRNAs and rRNAs. The archaeal box C/D small RNP complex requires a small RNA component (sRNA) possessing Watson-Crick complementarity to the target RNA along with three proteins: L7Ae, Nop5p, and fibrillarin. Transfer of a methyl group from S-adenosylmethionine to the target RNA is performed by fibrillarin, which by itself has no affinity for the sRNA-target duplex. Instead, it is targeted to the site of methylation through association with Nop5p, which in turn binds to the L7Ae-sRNA complex. To understand how Nop5p serves as a bridge between the targeting and catalytic functions of the box C/D small RNP complex, we have employed alanine scanning to evaluate the interaction between the Pyrococcus horikoshii Nop5p domain and an L7Ae box C/D RNA complex. From these data, we were able to construct an isolated RNA-binding domain (Nop-RBD) that folds correctly as demonstrated by x-ray crystallography and binds to the L7Ae box C/D RNA complex with near wild type affinity. These data demonstrate that the Nop-RBD is an autonomously folding and functional module important for protein assembly in a number of complexes centered on the L7Ae-kinkturn RNP.	[Hardin, John W.; Reyes, Francis E.; Batey, Robert T.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Batey, RT (corresponding author), Univ Colorado, Dept Chem & Biochem, Campus Box 215, Boulder, CO 80309 USA.	robert.batey@colorado.edu	Batey, Robert/A-8265-2009	Batey, Robert/0000-0002-1384-6625	National Institutes of Health [GM08953]; University of Colorado, Boulder	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Colorado, Boulder	This work was supported, in whole or in part, by National Institutes of Health Grant GM08953 (to R.T.B.). This work was also supported by a graduate research training grant (to F.E.R.) through the University of Colorado, Boulder.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Aittaleb M, 2004, J BIOL CHEM, V279, P41822, DOI 10.1074/jbc.M406209200; Aittaleb M, 2003, NAT STRUCT BIOL, V10, P256, DOI 10.1038/nsb905; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; Clouet-d'Orval B, 2005, BIOCHIMIE, V87, P889, DOI 10.1016/j.biochi.2005.02.004; CUNNINGHAM PR, 1991, BIOCHIMIE, V73, P789, DOI 10.1016/0300-9084(91)90058-9; Decatur WA, 2003, J BIOL CHEM, V278, P695, DOI 10.1074/jbc.R200023200; Decatur WA, 2002, TRENDS BIOCHEM SCI, V27, P344, DOI 10.1016/S0968-0004(02)02109-6; Deng L, 2004, BIOCHEM BIOPH RES CO, V315, P726, DOI 10.1016/j.bbrc.2004.01.114; Dennis PP, 2001, MOL MICROBIOL, V40, P509, DOI 10.1046/j.1365-2958.2001.02381.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gaspin C, 2000, J MOL BIOL, V297, P895, DOI 10.1006/jmbi.2000.3593; Gautier T, 1997, MOL CELL BIOL, V17, P7088, DOI 10.1128/MCB.17.12.7088; Gibrat JF, 1996, CURR OPIN STRUC BIOL, V6, P377, DOI 10.1016/S0959-440X(96)80058-3; Grosjean H., 1998, MODIFICATION EDITING, DOI [10.1128/9781555818296, DOI 10.1128/9781555818296]; Hamma T, 2004, STRUCTURE, V12, P893, DOI 10.1016/S0969-2126(04)00096-6; Hardin JW, 2006, NUCLEIC ACIDS RES, V34, P5039, DOI 10.1093/nar/gkl644; Helm M, 2006, NUCLEIC ACIDS RES, V34, P721, DOI 10.1093/nar/gkj471; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; Holm L, 1996, METHOD ENZYMOL, V266, P653; Kiss T, 2001, EMBO J, V20, P3617, DOI 10.1093/emboj/20.14.3617; KissLaszlo Z, 1996, CELL, V85, P1077, DOI 10.1016/S0092-8674(00)81308-2; Kuhn JF, 2002, NUCLEIC ACIDS RES, V30, P931, DOI 10.1093/nar/30.4.931; Lafontaine DLJ, 1999, RNA, V5, P455, DOI 10.1017/S135583829998192X; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Liu S, 2007, SCIENCE, V316, P115, DOI 10.1126/science.1137924; MADEJ T, 1995, PROTEINS, V23, P356, DOI 10.1002/prot.340230309; Makarova OV, 2002, EMBO J, V21, P1148, DOI 10.1093/emboj/21.5.1148; Mitchell JR, 1999, MOL CELL BIOL, V19, P567; Moore T, 2004, STRUCTURE, V12, P807, DOI 10.1016/j.str.2004.02.033; Newman DR, 2000, RNA, V6, P861, DOI 10.1017/S1355838200992446; Nolivos S, 2005, NUCLEIC ACIDS RES, V33, P6507, DOI 10.1093/nar/gki962; Nottrott S, 2002, EMBO J, V21, P5527, DOI 10.1093/emboj/cdf544; Omer AD, 2003, MOL MICROBIOL, V48, P617, DOI 10.1046/j.1365-2958.2003.03483.x; Omer AD, 2002, P NATL ACAD SCI USA, V99, P5289, DOI 10.1073/pnas.082101999; Oruganti S, 2007, J MOL BIOL, V371, P1141, DOI 10.1016/j.jmb.2007.06.029; Padilla JE, 2003, ACTA CRYSTALLOGR D, V59, P1124, DOI 10.1107/S0907444903007947; Peculis BA, 1997, MOL CELL BIOL, V17, P3702, DOI 10.1128/MCB.17.7.3702; Rana TM, 2007, NAT REV MOL CELL BIO, V8, P23, DOI 10.1038/nrm2085; Reichow SL, 2007, NUCLEIC ACIDS RES, V35, P1452, DOI 10.1093/nar/gkl1172; Rozenski J, 1999, NUCLEIC ACIDS RES, V27, P196, DOI 10.1093/nar/27.1.196; Rozhdestvensky TS, 2003, NUCLEIC ACIDS RES, V31, P869, DOI 10.1093/nar/gkg175; Schultz A, 2006, MOL CELL BIOL, V26, P5146, DOI 10.1128/MCB.02374-05; Sirum-Connolly K, 1995, Nucleic Acids Symp Ser, P73; SIRUMCONNOLLY K, 1993, SCIENCE, V262, P1886, DOI 10.1126/science.8266080; Smith CM, 1997, CELL, V89, P669, DOI 10.1016/S0092-8674(00)80247-0; Sprinzl M, 1998, NUCLEIC ACIDS RES, V26, P148, DOI 10.1093/nar/26.1.148; Suryadi J, 2005, BIOCHEMISTRY-US, V44, P9657, DOI 10.1021/bi050568q; Szewczak LBW, 2005, RNA, V11, P1407, DOI 10.1261/rna.2830905; Tran E, 2005, RNA, V11, P285, DOI 10.1261/rna.7223405; Tran EJ, 2003, EMBO J, V22, P3930, DOI 10.1093/emboj/cdg368; TYCOWSKI KT, 1994, SCIENCE, V266, P1558, DOI 10.1126/science.7985025; Tycowski KT, 1996, P NATL ACAD SCI USA, V93, P14480, DOI 10.1073/pnas.93.25.14480; Verheggen C, 2001, EMBO J, V20, P5480, DOI 10.1093/emboj/20.19.5480; Vithana EN, 2001, MOL CELL, V8, P375, DOI 10.1016/S1097-2765(01)00305-7; Wang HM, 2000, EMBO J, V19, P317, DOI 10.1093/emboj/19.3.317; Watkins NJ, 2002, MOL CELL BIOL, V22, P8342, DOI 10.1128/MCB.22.23.8342-8352.2002; Zhang XX, 2006, RNA, V12, P1092, DOI 10.1261/rna.2230106; Zheng L, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh110; Ziesche SM, 2004, MOL MICROBIOL, V54, P980, DOI 10.1111/j.1365-2958.2004.04319.x	62	4	4	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					15317	15324		10.1074/jbc.M901368200	http://dx.doi.org/10.1074/jbc.M901368200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19336398	hybrid, Green Published			2022-12-27	WOS:000266288200066
J	Sankar, N; Kadeppagari, RK; Thimmapaya, B				Sankar, Natesan; Kadeppagari, Ravi-Kumar; Thimmapaya, Bayar			c-Myc-induced Aberrant DNA Synthesis and Activation of DNA Damage Response in p300 Knockdown Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DORMANT ORIGINS; EXCESS MCM2-7; G(1) EXIT; REPLICATION; CYCLE; ATM; APOPTOSIS; PROTEINS; TUMORIGENESIS; ACETYLATION	We previously showed that in quiescent cells, p300/CBP (CREB-binding protein) family coactivators repress c-myc and prevent premature induction of DNA synthesis. p300/CBP-depleted cells exit G(1) early and continue to accumulate in S phase but do not progress into G(2)/M, and eventually they die of apoptosis. Here, we show that the S-phase arrest in these cells is because of an intra-S-phase block. The inappropriate DNA synthesis that occurs as a result of forced expression of c-myc leads to the activation of the DNA damage response as evidenced by the phosphorylation of several checkpoint related proteins and the formation of foci containing gamma-H2AX. The activation of checkpoint response is related to the induction of c-myc, as the phosphorylation of checkpoint proteins can be reversed when cells are treated with a c-Myc inhibitor or when Myc synthesis is blocked by short hairpin RNA. Using the DNA fiber assay, we show that in p300-depleted cells initiation of replication occurs from multiple replication origins. Chromatin loading of the Cdc45 protein also indicates increased origin activity in p300 knockdown cells. Immunofluorescence experiments indicate that c-Myc colocalizes with replication foci, consistent with the recently reported direct role of c-Myc in the initiation of DNA synthesis. Thus, the inappropriate S-phase entry of p300 down-regulated cells is likely to be because of c-Myc-induced deregulated replication origin activity, which results in replicative stress, activation of a DNA damage response, and S-phase arrest. Our results point to an important role for p300 in maintaining genomic integrity by negatively regulating c-myc.	[Sankar, Natesan; Kadeppagari, Ravi-Kumar; Thimmapaya, Bayar] Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Thimmapaya, B (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Microbiol Immunol, Olson 8-452, Chicago, IL 60611 USA.	b-thimmapaya@northwestern.edu	KADEPPAGARI, RAVI KUMAR/C-1682-2015; Natesan, Sankar/C-9866-2015	KADEPPAGARI, RAVI KUMAR/0000-0003-0576-9508; 	National Institutes of Health [CA74403]; NATIONAL CANCER INSTITUTE [R01CA074403] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA74403 (USPHS).	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; AMATI B, 1994, CURR OPIN GENET DEV, V4, P102, DOI 10.1016/0959-437X(94)90098-1; Aparicio OM, 1999, P NATL ACAD SCI USA, V96, P9130, DOI 10.1073/pnas.96.16.9130; Baluchamy S, 2007, ONCOGENE, V26, P781, DOI 10.1038/sj.onc.1209825; Baluchamy S, 2003, P NATL ACAD SCI USA, V100, P9524, DOI 10.1073/pnas.1633700100; Bartkova J, 2006, NATURE, V444, P633, DOI 10.1038/nature05268; Conti C, 2007, CELL CYCLE, V6, P2760, DOI 10.4161/cc.6.22.4932; Dang CV, 1999, MOL CELL BIOL, V19, P1; Di Micco R, 2006, NATURE, V444, P638, DOI 10.1038/nature05327; Dominguez-Sola D, 2007, NATURE, V448, P445, DOI 10.1038/nature05953; Ekholm-Reed S, 2004, J CELL BIOL, V165, P789, DOI 10.1083/jcb.200404092; Felsher DW, 1999, P NATL ACAD SCI USA, V96, P3940, DOI 10.1073/pnas.96.7.3940; Ge XQ, 2007, GENE DEV, V21, P3331, DOI 10.1101/gad.457807; Goodman RH, 2000, GENE DEV, V14, P1553; Grossman SR, 1998, MOL CELL, V2, P405, DOI 10.1016/S1097-2765(00)80140-9; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Hasan S, 2002, MOL CELL, V10, P1213, DOI 10.1016/S1097-2765(02)00745-1; Hasan S, 2001, MOL CELL, V7, P1221, DOI 10.1016/S1097-2765(01)00272-6; Hasan S, 2001, NATURE, V410, P387, DOI 10.1038/35066610; Ibarra A, 2008, P NATL ACAD SCI USA, V105, P8956, DOI 10.1073/pnas.0803978105; Iyer NG, 2007, ONCOGENE, V26, P21, DOI 10.1038/sj.onc.1209771; Jaspers Nicolaas G J, 2006, Methods Mol Biol, V314, P51; Kastan MB, 2000, NAT REV MOL CELL BIO, V1, P179, DOI 10.1038/35043058; Kolli S, 2001, P NATL ACAD SCI USA, V98, P4646, DOI 10.1073/pnas.081141998; Liao Y, 2007, ADV EXP MED BIOL, V608, P144; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Mendez J, 2000, MOL CELL BIOL, V20, P8602, DOI 10.1128/MCB.20.22.8602-8612.2000; Merrick CJ, 2004, J BIOL CHEM, V279, P20067, DOI 10.1074/jbc.M400022200; Meyer N, 2006, SEMIN CANCER BIOL, V16, P275, DOI 10.1016/j.semcancer.2006.07.011; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Oliver FJ, 1998, J BIOL CHEM, V273, P33533, DOI 10.1074/jbc.273.50.33533; Pusapati RV, 2006, P NATL ACAD SCI USA, V103, P1446, DOI 10.1073/pnas.0507367103; Rajabi HN, 2005, J BIOL CHEM, V280, P361, DOI 10.1074/jbc.M408633200; Saha P, 1998, J BIOL CHEM, V273, P18205, DOI 10.1074/jbc.273.29.18205; Sankar N, 2008, ONCOGENE, V27, P5717, DOI 10.1038/onc.2008.181; Shiloh Y, 2006, TRENDS BIOCHEM SCI, V31, P402, DOI 10.1016/j.tibs.2006.05.004; Singhal G, 2008, VIROLOGY, V377, P227, DOI 10.1016/j.virol.2008.04.042; SOULE HD, 1990, CANCER RES, V50, P6075; Stauffer D, 2007, J BIOL CHEM, V282, P9678, DOI 10.1074/jbc.M609261200; Syljuasen RG, 2005, MOL CELL BIOL, V25, P3553, DOI 10.1128/MCB.25.9.3553-3562.2005; Tini M, 2002, MOL CELL, V9, P265, DOI 10.1016/S1097-2765(02)00453-7; Turnell AS, 2006, BRIT J CANCER, V95, P555, DOI 10.1038/sj.bjc.6603304; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Woodward AM, 2006, J CELL BIOL, V173, P673, DOI 10.1083/jcb.200602108; Yin XY, 2003, ONCOGENE, V22, P6151, DOI 10.1038/sj.onc.1206641	45	26	26	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					15193	15205		10.1074/jbc.M900776200	http://dx.doi.org/10.1074/jbc.M900776200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19332536	Green Published, hybrid			2022-12-27	WOS:000266288200054
J	Sato, T; Mihara, K				Sato, Takashi; Mihara, Katsuyoshi			Topogenesis of Mammalian Oxa1, a Component of the Mitochondrial Inner Membrane Protein Export Machinery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINI; INSERTION; IMPORT; YIDC; COMPLEX; MATRIX; TRANSLOCASE; DEPENDENCE; MUTATIONS; INTERACTS	Oxa1 is a mitochondrial inner membrane protein with a predicted five-transmembrane segment (TM1 similar to 5) topology in which the N terminus and a hydrophilic loop, L2, are exposed to the intermembrane space and the C-terminal region and two loops, L1 and L3, are exposed to the matrix. Oxa1 mediates the insertion of mitochondrial DNA-encoded subunits of respiratory complexes and several nuclear DNA-encoded proteins into the inner membrane from the matrix. Compared with yeast Oxa1, little is known about the import and function of mammalian Oxa1. Here, we investigated the topogenesis of Oxa1 in HeLa cells using systematic deletion or mutation constructs and found that (i) the N-terminal 64-residue segment formed a presequence, and its deletion directed the mature protein to the endoplasmic reticulum, indicating that the presequence arrests cotranslational activation of the potential endoplasmic reticulum-targeting signal within mature Oxa1, (ii) systematic deletion of Oxa1 TM segments revealed that the presence of all five TMs is essential for efficient membrane integration, (iii) the species-conserved hexapeptide (GLPWWG) located near the N terminus of TM1 was essential for export of the N-terminal segment and L2 into the intermembrane space from the matrix, i. e. for correct topogenesis of Oxa1, and (iv) GLPWWG placed near the N terminus of TM2 or TM3 in the reporter construct also supported its membrane integration in the Nout-Cin orientation. Together, these results demonstrated that topogenesis of Oxa1 is a cooperative event of all five TMs, and GLPWWG followed immediately by TM1 is essential for correct Oxa1 topogenesis.	[Sato, Takashi; Mihara, Katsuyoshi] Kyushu Univ, Grad Sch Med Sci, Dept Mol Biol, Fukuoka 812, Japan	Kyushu University	Mihara, K (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Mol Biol, Fukuoka 812, Japan.	mihara@cell.med.kyushu-u.ac.jp			Ministry of Education, Science, and Culture of Japan; Human Frontier Science Program; Core Research from Evolutional Science and Technology; Takeda Science Foundation	Ministry of Education, Science, and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Human Frontier Science Program(Human Frontier Science Program); Core Research from Evolutional Science and Technology(Core Research for Evolutional Science and Technology (CREST)); Takeda Science Foundation(Takeda Science Foundation (TSF))	This work was supported by grants from the Ministry of Education, Science, and Culture of Japan, Human Frontier Science Program, Core Research from Evolutional Science and Technology, and Takeda Science Foundation.	Beck K, 2001, EMBO REP, V2, P709, DOI 10.1093/embo-reports/kve154; BONNEFOY N, 1994, J MOL BIOL, V239, P201, DOI 10.1006/jmbi.1994.1363; He SC, 1997, MOL BIOL CELL, V8, P1449, DOI 10.1091/mbc.8.8.1449; Hell K, 1998, P NATL ACAD SCI USA, V95, P2250, DOI 10.1073/pnas.95.5.2250; Hell K, 1997, FEBS LETT, V418, P367, DOI 10.1016/S0014-5793(97)01412-9; Hell K, 2001, EMBO J, V20, P1281, DOI 10.1093/emboj/20.6.1281; Herrmann JM, 2003, IUBMB LIFE, V55, P219, DOI 10.1080/1521654031000123349; Herrmann JM, 2004, J BIOL CHEM, V279, P2507, DOI 10.1074/jbc.M310468200; Herrmann JM, 1997, EMBO J, V16, P2217, DOI 10.1093/emboj/16.9.2217; HERRMANN JM, 1995, J BIOL CHEM, V270, P27079, DOI 10.1074/jbc.270.45.27079; Ishihara N, 1998, J BIOCHEM-TOKYO, V123, P722; Jia LX, 2007, MOL BIOL CELL, V18, P1897, DOI 10.1091/mbc.E06-10-0925; Jia LX, 2003, EMBO J, V22, P6438, DOI 10.1093/emboj/cdg624; Kanaji S, 2000, J CELL BIOL, V151, P277, DOI 10.1083/jcb.151.2.277; Lemaire C, 2004, J BIOL CHEM, V279, P47464, DOI 10.1074/jbc.M404861200; Miyazaki E, 2005, MOL BIOL CELL, V16, P1788, DOI 10.1091/mbc.e04-08-0707; Nagamori S, 2004, J CELL BIOL, V165, P53, DOI 10.1083/jcb.200402067; Ott M, 2006, EMBO J, V25, P1603, DOI 10.1038/sj.emboj.7601070; Rehling P, 2004, NAT REV MOL CELL BIO, V5, P519, DOI 10.1038/nrm1426; Reif S, 2005, J MOL BIOL, V354, P520, DOI 10.1016/j.jmb.2005.09.054; Rojo EE, 1999, J BIOL CHEM, V274, P19617, DOI 10.1074/jbc.274.28.19617; Samuelson JC, 2000, NATURE, V406, P637, DOI 10.1038/35020586; Serek J, 2004, EMBO J, V23, P294, DOI 10.1038/sj.emboj.7600063; Stuart RA, 2002, BBA-MOL CELL RES, V1592, P79, DOI 10.1016/S0167-4889(02)00266-5; Szyrach G, 2003, EMBO J, V22, P6448, DOI 10.1093/emboj/cdg623; VESTWEBER D, 1988, EMBO J, V7, P1147, DOI 10.1002/j.1460-2075.1988.tb02924.x	26	13	14	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					14819	14827		10.1074/jbc.M809520200	http://dx.doi.org/10.1074/jbc.M809520200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19349278	Green Published, hybrid			2022-12-27	WOS:000266288200017
J	Sheikh, IA; Singh, AK; Singh, N; Sinha, M; Singh, SB; Bhushan, A; Kaur, P; Srinivasan, A; Sharma, S; Singh, TP				Sheikh, Ishfaq Ahmed; Singh, Amit Kumar; Singh, Nagendra; Sinha, Mau; Singh, S. Baskar; Bhushan, Asha; Kaur, Punit; Srinivasan, Alagiri; Sharma, Sujata; Singh, Tej P.			Structural Evidence of Substrate Specificity in Mammalian Peroxidases STRUCTURE OF THE THIOCYANATE COMPLEX WITH LACTOPEROXIDASE AND ITS INTERACTIONS AT 2.4 angstrom RESOLUTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN MYELOPEROXIDASE; CRYSTAL-STRUCTURE; BOVINE LACTOPEROXIDASE; EOSINOPHIL PEROXIDASE; MOLECULAR-MECHANISM; ACID IONIZATION; BINDING; HEME; SYSTEM; WATER	The crystal structure of the complex of lactoperoxidase (LPO) with its physiological substrate thiocyanate (SCN-) has been determined at 2.4 angstrom resolution. It revealed that the SCN- ion is bound to LPO in the distal heme cavity. The observed orientation of the SCN- ion shows that the sulfur atom is closer to the heme iron than the nitrogen atom. The nitrogen atom of SCN- forms a hydrogen bond with a water (Wat) molecule at position 6'. This water molecule is stabilized by two hydrogen bonds with Gln(423) N-epsilon 2 and Phe(422) oxygen. In contrast, the placement of the SCN- ion in the structure of myeloperoxidase (MPO) occurs with an opposite orientation, in which the nitrogen atom is closer to the heme iron than the sulfur atom. The site corresponding to the positions of Gln(423), Phe(422) oxygen, and Wat(6') in LPO is occupied primarily by the side chain of Phe(407) in MPO due to an entirely different conformation of the loop corresponding to the segment Arg(418)-Phe(431) of LPO. This arrangement in MPO does not favor a similar orientation of the SCN- ion. The orientation of the catalytic product OSCN- as reported in the structure of LPO center dot OSCN- is similar to the orientation of SCN- in the structure of LPO center dot SCN-. Similarly, in the structure of LPO center dot SCN-center dot CN-, in which CN- binds at Wat(1), the position and orientation of the SCN- ion are also identical to that observed in the structure of LPO center dot SCN.	[Sheikh, Ishfaq Ahmed; Singh, Amit Kumar; Singh, Nagendra; Sinha, Mau; Singh, S. Baskar; Bhushan, Asha; Kaur, Punit; Srinivasan, Alagiri; Sharma, Sujata; Singh, Tej P.] All India Inst Med Sci, Dept Biophys, New Delhi 110029, India	All India Institute of Medical Sciences (AIIMS) New Delhi	Singh, TP (corresponding author), All India Inst Med Sci, Dept Biophys, New Delhi 110029, India.	tpsingh.aiims@gmail.com	Sheikh, Ishfaq A/H-9611-2012	Singh, Nagendra/0000-0003-0419-0684; SINHA, MAU/0000-0003-3011-9160	Department of Science and Technology, New Delhi; University Grants Commission, New Delhi; Council of Scientific and Industrial Research, New Delhi	Department of Science and Technology, New Delhi(Department of Science & Technology (India)); University Grants Commission, New Delhi(University Grants Commission, India); Council of Scientific and Industrial Research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported in part by the Department of Science and Technology, New Delhi.; Supported by a fellowship from the University Grants Commission, New Delhi.; Supported by a fellowship from the Council of Scientific and Industrial Research, New Delhi.	Ando K, 1999, J PHYS CHEM A, V103, P10398, DOI 10.1021/jp992481i; Ando K, 1997, J PHYS CHEM B, V101, P10464, DOI 10.1021/jp970173j; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAKKENIST ARJ, 1980, BIOCHIM BIOPHYS ACTA, V613, P337, DOI 10.1016/0005-2744(80)90088-1; Blair-Johnson M, 2001, BIOCHEMISTRY-US, V40, P13990, DOI 10.1021/bi0111808; Ciaccio C, 2004, BIOPHYS J, V86, P448, DOI 10.1016/S0006-3495(04)74121-1; CRULL GB, 1993, J INORG BIOCHEM, V50, P181, DOI 10.1016/0162-0134(93)80024-4; DePillis GD, 1997, J BIOL CHEM, V272, P8857; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FENNA R, 1995, ARCH BIOCHEM BIOPHYS, V316, P653, DOI 10.1006/abbi.1995.1086; Fiedler TJ, 2000, J BIOL CHEM, V275, P11964, DOI 10.1074/jbc.275.16.11964; Furtmuller PG, 2004, JPN J INFECT DIS, V57, pS30; Geissler PL, 2001, SCIENCE, V291, P2121, DOI 10.1126/science.1056991; GOLDSTEIN F, 1950, J BIOL CHEM, V187, P523; HOOGENDOORN H, 1977, CARIES RES, V11, P77, DOI 10.1159/000260252; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Klebanoff SJ, 1999, P ASSOC AM PHYSICIAN, V111, P383, DOI 10.1111/paa.1999.111.5.383; KLEBANOFF SJ, 1970, SCIENCE, V169, P1095, DOI 10.1126/science.169.3950.1095; Kooter IM, 1997, J BIOL INORG CHEM, V2, P191, DOI 10.1007/s007750050124; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MODI S, 1990, INDIAN J CHEM A, V29, P301; MODI S, 1989, BIOCHEMISTRY-US, V28, P4689, DOI 10.1021/bi00437a027; Mohammed OF, 2005, SCIENCE, V310, P83, DOI 10.1126/science.1117756; Mowat CG, 2004, NAT STRUCT MOL BIOL, V11, P1023, DOI 10.1038/nsmb827; MURSHUDOV GN, 1997, PROTEIN CRYSTALLOGR, V33, P31; NICHOL AW, 1987, BIOCHEM J, V247, P147, DOI 10.1042/bj2470147; ORAM JD, 1996, BIOCHEM J, V100, P382; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ruf J, 2006, ARCH BIOCHEM BIOPHYS, V445, P269, DOI 10.1016/j.abb.2005.06.023; SHINDLER JS, 1975, BIOCHEM BIOPH RES CO, V67, P1307, DOI 10.1016/0006-291X(75)90169-2; Singh AK, 2009, BIOPHYS J, V96, P646, DOI 10.1016/j.bpj.2008.09.019; Singh AK, 2008, J MOL BIOL, V376, P1060, DOI 10.1016/j.jmb.2007.12.012; Tahboub YR, 2005, J BIOL CHEM, V280, P26129, DOI 10.1074/jbc.M503027200; Tanaka T, 2003, BIOSCI BIOTECH BIOCH, V67, P2254, DOI 10.1271/bbb.67.2254; TAYLOR KL, 1992, J BIOL CHEM, V267, P25282; Thomsen AR, 2000, ARCH BIOCHEM BIOPHYS, V379, P147, DOI 10.1006/abbi.2000.1866; Wang JG, 2006, ARCH BIOCHEM BIOPHYS, V445, P256, DOI 10.1016/j.abb.2005.10.008; WOLFSON LM, 1993, J FOOD PROTECT, V56, P887, DOI 10.4315/0362-028X-56.10.887; ZGLICZYNSKI JM, 1977, P SOC EXP BIOL MED, V154, P418	39	45	47	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					14849	14856		10.1074/jbc.M807644200	http://dx.doi.org/10.1074/jbc.M807644200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19339248	Green Published, hybrid			2022-12-27	WOS:000266288200020
J	Kim, J; Wong, PKY				Kim, Jeesun; Wong, Paul K. Y.			Oxidative Stress Is Linked to ERK1/2-p16 Signaling-mediated Growth Defect in ATM-deficient Astrocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL SELF-RENEWAL; ATAXIA-TELANGIECTASIA; CYCLE CONTROL; INK4A LOCUS; CANCER; MUTANT; GENE; NEURODEGENERATION; APOPTOSIS; NEURONS	The gene that encodes the ATM protein kinase is mutated in ataxia-telangiectasia (A-T). One of the prominent features of A-T is progressive neurodegeneration. We have previously reported that primary astrocytes isolated from Atm(-/-) mice grow slowly and die earlier than control cells in culture. However, the mechanisms for this remain unclear. We show here that intrinsic elevated intracellular levels of reactive oxygen species (ROS) are associated with the senescence-like growth defect of Atm(-/-) astrocytes. This condition is accompanied by constitutively higher levels of ERK1/2 phosphorylation and p16(Ink4a) in Atm(-/-) astrocytes. We also observe that ROS-induced up-regulation of p16(Ink4a) occurs correlatively with ERK1/2-dependent down-regulation and subsequent dissociation from chromatin of Bmi-1. Furthermore, both mitogen-activated protein kinase (MAPK)/ERK inhibitor PD98059 and antioxidant N-acetyl-L-cysteine restored normal proliferation of Atm(-/-) astrocytes. These results suggest that ATM is required for normal astrocyte growth through its ability to stabilize intracellular redox status and that the inability to control ROS is the molecular basis of limited cell growth of Atm(-/-) astrocytes. This defect may be mediated by a mechanism involving ERK1/2 activation and Bmi-1 derepression of p16Ink4a. These data identify new potential targets for therapeutic intervention in A-T neurodegeneration.	[Wong, Paul K. Y.] Univ Texas MD Anderson Canc Ctr, Sci Pk Res Div, Dept Carcinogenesis, Smithville, TX 78957 USA	University of Texas System; UTMD Anderson Cancer Center	Wong, PKY (corresponding author), Univ Texas MD Anderson Canc Ctr, Sci Pk Res Div, Dept Carcinogenesis, 1808 Pk Rd,1C,POB 389, Smithville, TX 78957 USA.	pkwong@mdanderson.org			M. D. Anderson Cancer Center; Longevity Foundation; Ataxia-telanglectasia (A-T) Children's Project	M. D. Anderson Cancer Center; Longevity Foundation; Ataxia-telanglectasia (A-T) Children's Project	This work was supported by a fellowship from the Odyssey Program of M. D. Anderson Cancer Center (to J.K.) and by funds from the Longevity Foundation and Ataxia-telanglectasia (A-T) Children's Project.	Barlow C, 1996, CELL, V86, P159, DOI 10.1016/S0092-8674(00)80086-0; Bartov O, 2006, BRAIN RES, V1069, P198, DOI 10.1016/j.brainres.2005.10.079; Barzilai A, 2004, DNA REPAIR, V3, P1109, DOI 10.1016/j.dnarep.2004.03.002; Benhar M, 2002, EMBO REP, V3, P420, DOI 10.1093/embo-reports/kvf094; Biswas S, 2006, BIOCHEM PHARMACOL, V71, P551, DOI 10.1016/j.bcp.2005.10.044; Browne SE, 2004, FREE RADICAL BIO MED, V36, P938, DOI 10.1016/j.freeradbiomed.2004.01.003; Bruggeman SWM, 2005, GENE DEV, V19, P1438, DOI 10.1101/gad.1299305; Burgoyne JR, 2007, SCIENCE, V317, P1393, DOI 10.1126/science.1144318; Campese VM, 2004, AM J PHYSIOL-HEART C, V287, pH695, DOI 10.1152/ajpheart.00619.2003; Chen P, 2003, J NEUROSCI, V23, P11453; Collado M, 2007, CELL, V130, P223, DOI 10.1016/j.cell.2007.07.003; Crawford T O, 1998, Semin Pediatr Neurol, V5, P287, DOI 10.1016/S1071-9091(98)80007-7; Gamaley IA, 1999, INT REV CYTOL, V188, P203; Gosink EC, 1999, CANCER RES, V59, P5294; Gottfried C, 2002, MECH AGEING DEV, V123, P1333, DOI 10.1016/S0047-6374(02)00069-6; Gueven N, 2006, FREE RADICAL BIO MED, V41, P992, DOI 10.1016/j.freeradbiomed.2006.06.018; HYSLOP PA, 1995, BRAIN RES, V671, P181, DOI 10.1016/0006-8993(94)01291-O; Ivanchuk SM, 2001, J NEURO-ONCOL, V51, P219, DOI 10.1023/A:1010632309113; Jiang YH, 2006, J VIROL, V80, P4557, DOI 10.1128/JVI.80.9.4557-4569.2006; Jorgensen TJ, 1996, INT J RADIAT BIOL, V69, P527, DOI 10.1080/095530096145535; Kamsler A, 2001, CANCER RES, V61, P1849; Lee Y, 2001, J NEUROSCI, V21, P6687, DOI 10.1523/JNEUROSCI.21-17-06687.2001; Leutner S, 2005, PHARMACOPSYCHIATRY, V38, P312, DOI 10.1055/s-2005-916186; Lin YC, 1997, J NEUROVIROL, V3, P28, DOI 10.3109/13550289709015790; Liu N, 2005, LAB INVEST, V85, P1471, DOI 10.1038/labinvest.3700354; Lloyd Alison C, 2006, J Biol, V5, P13, DOI 10.1186/jbiol46; Lucius R, 1996, BRAIN RES, V743, P56, DOI 10.1016/S0006-8993(96)01029-3; Maragakis NJ, 2006, NAT CLIN PRACT NEURO, V2, P679, DOI 10.1038/ncpneuro0355; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Moors M, 2007, TOXICOL APPL PHARM, V221, P57, DOI 10.1016/j.taap.2007.02.018; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; Otani N, 2006, J CLIN NEUROSCI, V13, P934, DOI 10.1016/j.jocn.2005.10.018; Pardal R, 2005, COLD SH Q B, V70, P177, DOI 10.1101/sqb.2005.70.057; Pardo AC, 2006, EXP NEUROL, V201, P120, DOI 10.1016/j.expneurol.2006.03.028; Quelle DE, 1997, P NATL ACAD SCI USA, V94, P669, DOI 10.1073/pnas.94.2.669; Reichenbach J, 2002, ANTIOXID REDOX SIGN, V4, P465, DOI 10.1089/15230860260196254; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Rotman G, 1997, CANCER SURV, V29, P285; SAVITSKY K, 1995, SCIENCE, V268, P1749, DOI 10.1126/science.7792600; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; SHIKOVA E, 1993, J VIROL, V67, P1137, DOI 10.1128/JVI.67.3.1137-1147.1993; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Shiloh Y, 1996, J CLIN IMMUNOL, V16, P254, DOI 10.1007/BF01541389; Takuma K, 2004, PROG NEUROBIOL, V72, P111, DOI 10.1016/j.pneurobio.2004.02.001; Vargas MR, 2008, J NEUROSCI, V28, P13574, DOI 10.1523/JNEUROSCI.4099-08.2008; Voncken JW, 1999, J CELL SCI, V112, P4627; Vonlanthen S, 2001, BRIT J CANCER, V84, P1372, DOI 10.1054/bjoc.2001.1791; Wang XF, 2000, J NEUROCHEM, V74, P1434, DOI 10.1046/j.1471-4159.2000.0741434.x; Watters DJ, 2003, REDOX REP, V8, P23, DOI 10.1179/135100003125001206; Wong P. K. Y., 1997, EOS-Rivista di Immunologia ed Immunofarmacologia, V17, P30; Yan MS, 2006, FREE RADICAL BIO MED, V41, P640, DOI 10.1016/j.freeradbiomed.2006.05.008; Yang Y, 2005, J NEUROSCI, V25, P2522, DOI 10.1523/JNEUROSCI.4946-04.2005; YU BP, 1994, PHYSIOL REV, V74, P139, DOI 10.1152/physrev.1994.74.1.139	54	60	63	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14396	14404		10.1074/jbc.M808116200	http://dx.doi.org/10.1074/jbc.M808116200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19321450	Green Published, hybrid			2022-12-27	WOS:000266286100046
J	Maga, G; van Loon, B; Crespan, E; Villani, G; Hubscher, U				Maga, Giovanni; van Loon, Barbara; Crespan, Emmanuele; Villani, Giuseppe; Huebscher, Ulrich			The Block of DNA Polymerase delta Strand Displacement Activity by an Abasic Site Can Be Rescued by the Concerted Action of DNA Polymerase beta and Flap Endonuclease 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL NUCLEAR ANTIGEN; REPLICATION PROTEIN-A; LAMBDA; BYPASS; REPAIR	Abasic (AP) sites are very frequent and dangerous DNA lesions. Their ability to block the advancement of a replication fork has been always viewed as a consequence of their inhibitory effect on the DNA synthetic activity of replicative DNA polymerases (DNA pols). Here we show that AP sites can also affect the strand displacement activity of the lagging strand DNA pol delta, thus preventing proper Okazaki fragment maturation. This block can be overcome through a polymerase switch, involving the combined physical and functional interaction of DNA pol beta and Flap endonuclease 1. Our data identify a previously unnoticed deleterious effect of the AP site lesion on normal cell metabolism and suggest the existence of a novel repair pathway that might be important in preventing replication fork stalling.	[Maga, Giovanni] CNR, IGM, Inst Mol Genet, I-27100 Pavia, Italy; [van Loon, Barbara; Huebscher, Ulrich] Univ Zurich Irchel, Inst Vet Biochem & Mol Biol, CH-8057 Zurich, Switzerland; [Villani, Giuseppe] Univ Toulouse 3, CNRS, Inst Pharmacol & Biol Struct, F-31077 Toulouse, France	Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica Molecolare (IGM-CNR); University of Zurich; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS)	Maga, G (corresponding author), CNR, IGM, Inst Mol Genet, Via Abbiategrasso 207, I-27100 Pavia, Italy.	maga@igm.cnr.it	Maga, Giovanni/C-5409-2009; van Loon, Barbara/E-6771-2014; Crespan, Emmanuele/F-3899-2018	Maga, Giovanni/0000-0001-8092-1552; van Loon, Barbara/0000-0002-7597-207X; Crespan, Emmanuele/0000-0003-0597-6929	Italiana per la Ricerca sul Cancro-AIRC Investigator Grant	Italiana per la Ricerca sul Cancro-AIRC Investigator Grant(Fondazione AIRC per la ricerca sul cancro)	Supported by an Associazione Italiana per la Ricerca sul Cancro-AIRC Investigator Grant. To whom correspondence should be addressed: Institute of Molecular Genetics IGM-CNR, via Abbiategrasso 207, I-27100 Pavia, Italy.	Bae SH, 2000, J BIOL CHEM, V275, P38022, DOI 10.1074/jbc.M006513200; Beard WA, 2006, METHOD ENZYMOL, V408, P91, DOI 10.1016/S0076-6879(06)08007-4; Blanca G, 2004, BIOCHEMISTRY-US, V43, P11605, DOI 10.1021/bi049050x; Cordeiro-Stone M, 2002, MUTAT RES-FUND MOL M, V510, P91, DOI 10.1016/S0027-5107(02)00255-5; CordeiroStone M, 1997, J BIOL CHEM, V272, P13945, DOI 10.1074/jbc.272.21.13945; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Higuchi K, 2003, GENES CELLS, V8, P437, DOI 10.1046/j.1365-2443.2003.00646.x; Jonsson ZO, 1998, EMBO J, V17, P2412, DOI 10.1093/emboj/17.8.2412; Kedar PS, 2002, J BIOL CHEM, V277, P31115, DOI 10.1074/jbc.M201497200; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Liu Y, 2005, J BIOL CHEM, V280, P3665, DOI 10.1074/jbc.M412922200; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Maga G, 2002, J BIOL CHEM, V277, P48434, DOI 10.1074/jbc.M206889200; Maga G, 2001, P NATL ACAD SCI USA, V98, P14298, DOI 10.1073/pnas.251193198; Maga G, 2007, NATURE, V447, P606, DOI 10.1038/nature05843; Maga G, 2008, P NATL ACAD SCI USA, V105, P20689, DOI 10.1073/pnas.0811241106; McElhinny SAN, 2008, MOL CELL, V30, P137, DOI 10.1016/j.molcel.2008.02.022; MEZZINA M, 1988, J VIROL, V62, P4249, DOI 10.1128/JVI.62.11.4249-4258.1988; Mozzherin DJ, 1997, P NATL ACAD SCI USA, V94, P6126, DOI 10.1073/pnas.94.12.6126; Nikolaishvili-Feinberg N, 2001, BIOCHEMISTRY-US, V40, P15215, DOI 10.1021/bi011474t; Pascucci B, 1999, J BIOL CHEM, V274, P33696, DOI 10.1074/jbc.274.47.33696; Podust VN, 2002, J BIOL CHEM, V277, P3894, DOI 10.1074/jbc.M109684200; Rossi ML, 2006, J BIOL CHEM, V281, P26051, DOI 10.1074/jbc.M604805200; Shibutani S, 1997, J BIOL CHEM, V272, P13916, DOI 10.1074/jbc.272.21.13916; Stucki M, 2001, J BIOL CHEM, V276, P7843, DOI 10.1074/jbc.M008829200; Stucki M, 1998, ONCOGENE, V17, P835, DOI 10.1038/sj.onc.1202001	26	20	20	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14267	14275		10.1074/jbc.M900759200	http://dx.doi.org/10.1074/jbc.M900759200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19329428	Green Published, hybrid, Green Accepted			2022-12-27	WOS:000266286100033
J	Grimm, C; Jors, S; Heller, S				Grimm, Christian; Joers, Simone; Heller, Stefan			Life and Death of Sensory Hair Cells Expressing Constitutively Active TRPML3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VARITINT-WADDLER VA; DEAFWADDLER MICE; DEAFNESS; MUTATIONS; MOUSE; CA2+; INCREASES; PHENOTYPE; RECEPTOR; BUNDLES	The varitint-waddler mutation A419P renders TRPML3 constitutively active, resulting in cationic overload, particularly in sustained influx of Ca2+. TRPML3 is expressed by inner ear sensory hair cells, and we were intrigued by the fact that hair cells are able to cope with expressing the TRPML3(A419P) isoform for weeks before they ultimately die. We hypothesized that the survival of varitint-waddler hair cells is linked to their ability to deal with Ca2+ loads due to the abundance of plasma membrane calcium ATPases (PMCAs). Here, we show that PMCA2 significantly reduced [Ca2+](i) increase and apoptosis in HEK293 cells expressing TRPML3(A419P). The deaf-waddler isoform of PMCA2, operating at 30% efficacy, showed a significantly decreased ability to rescue the Ca2+ loading of cells expressing TRPML3(A419P). When we combined mice heterozygous for the varitint-waddler mutant allele with mice heterozygous for the deaf-waddler mutant allele, we found severe hair bundle defects as well as increased hair cell loss compared with mice heterozygous for each mutant allele alone. Furthermore, 3-week-old double mutant mice lacked auditory brainstem responses, which were present in their respective littermates containing single mutant alleles. Likewise, heterozygous double mutant mice exhibited severe circling behavior, which was not observed in mice heterozygous for TRPML3(A419P) or PMCA2(G283S) alone. Our results provide a molecular rationale for the delayed hair cell loss in varitint-waddler mice. They also show that hair cells are able to survive for weeks with sustained Ca2+ loading, which implies that Ca2+ loading is an unlikely primary cause of hair cell death in ototoxic stress situations.	Stanford Univ, Sch Med, Dept Otolaryngol Head & Neck Surg, Stanford, CA 94305 USA; Stanford Univ, Sch Med, Dept Mol & Cellular Physiol, Stanford, CA 94305 USA	Stanford University; Stanford University	Heller, S (corresponding author), Stanford Univ, Sch Med, Dept Otolaryngol, 801 Welch Rd, Stanford, CA 94305 USA.	hellers@stanford.edu	Grimm, Christian/ABF-9121-2020	Grimm, Christian/0000-0002-0177-5559	National Institutes of Health [DC04563]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004563] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported, in whole or in part, by National Institutes of Health Grant DC04563.	Cable J, 1998, HEARING RES, V123, P125, DOI 10.1016/S0378-5955(98)00107-5; De Luisi A, 2003, J CELL SCI, V116, P1527, DOI 10.1242/jcs.00368; Di Palma F, 2002, P NATL ACAD SCI USA, V99, P14994, DOI 10.1073/pnas.222425399; Dumont RA, 2001, J NEUROSCI, V21, P5066, DOI 10.1523/JNEUROSCI.21-14-05066.2001; Duncan RK, 2000, J COMP PHYSIOL A, V186, P1095, DOI 10.1007/s003590000164; Edmonds B, 2000, NAT NEUROSCI, V3, P786, DOI 10.1038/77687; Fridberger A, 1998, P NATL ACAD SCI USA, V95, P7127, DOI 10.1073/pnas.95.12.7127; Grimm C, 2007, P NATL ACAD SCI USA, V104, P19583, DOI 10.1073/pnas.0709846104; Heller S, 2002, JARO, V3, P488, DOI 10.1007/s10162-002-2050-x; Hill JK, 2006, J NEUROSCI, V26, P6172, DOI 10.1523/JNEUROSCI.0447-06.2006; Kim HJ, 2003, JARO-J ASSOC RES OTO, V4, P83, DOI 10.1007/s10162-002-3011-0; Kim HJ, 2008, EMBO J, V27, P1197, DOI 10.1038/emboj.2008.56; Kim HJ, 2007, J BIOL CHEM, V282, P36138, DOI 10.1074/jbc.C700190200; McCullough BJ, 2004, HEARING RES, V195, P90, DOI 10.1016/j.heares.2004.05.003; Nagata K, 2008, P NATL ACAD SCI USA, V105, P353, DOI 10.1073/pnas.0707963105; Penheiter AR, 2001, HEARING RES, V162, P19, DOI 10.1016/S0378-5955(01)00356-2; Street VA, 1998, NAT GENET, V19, P390, DOI 10.1038/1284; van Aken AFJ, 2008, J PHYSIOL-LONDON, V586, P5403, DOI 10.1113/jphysiol.2008.156992; Xu HX, 2007, P NATL ACAD SCI USA, V104, P18321, DOI 10.1073/pnas.0709096104; Yamoah EN, 1998, J NEUROSCI, V18, P610	20	19	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13823	13831		10.1074/jbc.M809045200	http://dx.doi.org/10.1074/jbc.M809045200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19299509	hybrid, Green Published			2022-12-27	WOS:000265877300059
J	Harrington, JM; Howell, S; Hajduk, SL				Harrington, John M.; Howell, Sawyer; Hajduk, Stephen L.			Membrane Permeabilization by Trypanosome Lytic Factor, a Cytolytic Human High Density Lipoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAPTOGLOBIN-RELATED PROTEIN; APOLIPOPROTEIN-L GENE; NORMAL HUMAN-SERUM; A-I; PHOSPHOLIPID-MEMBRANES; BRUCEI; HEMOGLOBIN; PLASMA; LYSIS; IDENTIFICATION	Trypanosome lytic factor (TLF) is a subclass of human high density lipoprotein (HDL) that mediates an innate immune killing of certain mammalian trypanosomes, most notably Trypanosoma brucei brucei, the causative agent of a wasting disease in cattle. Mechanistically, killing is initiated in the lysosome of the target trypanosome where the acidic pH facilitates a membrane-disrupting activity by TLF. Here we utilize a model liposome system to characterize the membrane binding and permeabilizing activity of TLF and its protein constituents, haptoglobin-related protein (Hpr), apolipoprotein L-1 (apoL-1), and apolipoprotein A-1 (apoA-1). We show that TLF efficiently binds and permeabilizes unilamellar liposomes at lysosomal pH, whereas non-lytic human HDL exhibits inefficient permeabilizing activity. Purified, delipidated Hpr and apoL-1 both efficiently permeabilize lipid bilayers at low pH. Trypanosome lytic factor, apoL-1, and apoA-1 exhibit specificity for anionic membranes, whereas Hpr permeabilizes both anionic and zwitterionic membranes. Analysis of the relative particle sizes of susceptible liposomes reveals distinctly different membrane-active behavior for native TLF and the delipidated protein components. We propose that lysosomal membrane damage in TLF-susceptible trypanosomes is initiated by the stable association of the TLF particle with the lysosomal membrane and that this is a property unique to this subclass of human HDL.	[Harrington, John M.; Howell, Sawyer; Hajduk, Stephen L.] Univ Georgia, Dept Biochem & Mol Biol, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Hajduk, SL (corresponding author), 120 Green St,B129 Life Sci Bldg, Athens, GA 30602 USA.	shajduk@bmb.uga.edu			National Institutes of Health [AI39033]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI039033, R21AI039033] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI39033 (to S. L. H.).	Andra J, 2003, DEV COMP IMMUNOL, V27, P291, DOI 10.1016/S0145-305X(02)00106-4; BAUMBERGER C, 1991, PATHOBIOLOGY, V59, P378, DOI 10.1159/000163681; Bishop JR, 2001, MOL BIOCHEM PARASIT, V118, P33, DOI 10.1016/S0166-6851(01)00361-9; Bolanos-Garcia VM, 2003, PROG BIOPHYS MOL BIO, V83, P47, DOI 10.1016/S0079-6107(03)00028-2; Drain J, 2001, J BIOL CHEM, V276, P30254, DOI 10.1074/jbc.M010198200; Duchateau PN, 2001, J LIPID RES, V42, P620; Fedders H, 2008, BIOCHEM J, V416, P65, DOI 10.1042/BJ20080398; Fukuda M, 2007, J LIPID RES, V48, P882, DOI 10.1194/jlr.M600495-JLR200; HAGER KM, 1994, J CELL BIOL, V126, P155, DOI 10.1083/jcb.126.1.155; HAJDUK SL, 1989, J BIOL CHEM, V264, P5210; HAJDUK SL, 1992, PARASITOL TODAY, V8, P95, DOI 10.1016/0169-4758(92)90247-Y; Harrington JM, 2008, BIOCHEM J, V413, P305, DOI 10.1042/BJ20071357; Hristova K, 1999, J MOL BIOL, V290, P99, DOI 10.1006/jmbi.1999.2840; Kolter T, 2005, ANNU REV CELL DEV BI, V21, P81, DOI 10.1146/annurev.cellbio.21.122303.120013; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; LEVINE DM, 1993, P NATL ACAD SCI USA, V90, P12040, DOI 10.1073/pnas.90.24.12040; LORENZ P, 1994, T ROY SOC TROP MED H, V88, P487, DOI 10.1016/0035-9203(94)90443-X; MAEDA N, 1985, J BIOL CHEM, V260, P6698; Martinez D, 2006, J IMMUNOL, V176, P1163, DOI 10.4049/jimmunol.176.2.1163; Massey JB, 2008, BBA-MOL CELL BIOL L, V1781, P245, DOI 10.1016/j.bbalip.2008.03.003; Matsuzaki K, 2009, BBA-BIOMEMBRANES, V1788, P1687, DOI 10.1016/j.bbamem.2008.09.013; MCEVOY SM, 1988, J BIOL CHEM, V263, P15740; Molina-Portela MP, 2008, J EXP MED, V205, P1721, DOI 10.1084/jem.20071463; Molina-Portela MD, 2005, MOL BIOCHEM PARASIT, V144, P218, DOI 10.1016/j.molbiopara.2005.08.018; Monajemi H, 2002, GENOMICS, V79, P539, DOI 10.1006/geno.2002.6729; Nielsen MJ, 2006, BLOOD, V108, P2846, DOI 10.1182/blood-2006-05-022327; Oli MW, 2006, EUKARYOT CELL, V5, P132, DOI 10.1128/EC.5.1.132-139.2006; Page NM, 2001, GENOMICS, V74, P71, DOI 10.1006/geno.2001.6534; Perez-Morga D, 2005, SCIENCE, V309, P469, DOI 10.1126/science.1114566; RIFKIN MR, 1978, P NATL ACAD SCI USA, V75, P3450, DOI 10.1073/pnas.75.7.3450; RODRIGUEZPARIS JM, 1993, J BIOL CHEM, V268, P9110; Samanovic M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000276; SEGREST JP, 1992, J LIPID RES, V33, P141; Shiflett AM, 2005, J BIOL CHEM, V280, P32578, DOI 10.1074/jbc.M503510200; SMITH AB, 1995, SCIENCE, V268, P284, DOI 10.1126/science.7716520; TALL AR, 1977, NATURE, V265, P163, DOI 10.1038/265163a0; Thaveeratitham P, 2007, J ENDOTOXIN RES, V13, P58, DOI 10.1177/0968051907078611; Thuduppathy GR, 2006, BIOCHEMISTRY-US, V45, P14533, DOI 10.1021/bi0616652; ULEVITCH RJ, 1981, J CLIN INVEST, V67, P827, DOI 10.1172/JCI110100; ULEVITCH RJ, 1979, J CLIN INVEST, V64, P1516, DOI 10.1172/JCI109610; Vaisar T, 2007, J CLIN INVEST, V117, P746, DOI 10.1172/JCI26206; Vanhamme L, 2003, NATURE, V422, P83, DOI 10.1038/nature01461; Vanhollebeke B, 2006, CELL MOL LIFE SCI, V63, P1937, DOI 10.1007/s00018-006-6091-x; Vanhollebeke B, 2008, SCIENCE, V320, P677, DOI 10.1126/science.1156296; Vanhollebeke B, 2007, J EUKARYOT MICROBIOL, V54, P448, DOI 10.1111/j.1550-7408.2007.00285.x; VANZWIETEN R, 1981, J CLIN INVEST, V68, P310, DOI 10.1172/JCI110250; Widener J, 2007, PLOS PATHOG, V3, P1250, DOI 10.1371/journal.ppat.0030129; Winkelmann J, 2006, MOL BIOCHEM PARASIT, V147, P85, DOI 10.1016/j.molbiopara.2006.01.010; WRIGHT J, 1986, J CLIN INVEST, V77, P782, DOI 10.1172/JCI112375; Zhang J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000282	50	32	35	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13505	13512		10.1074/jbc.M900151200	http://dx.doi.org/10.1074/jbc.M900151200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19324878	Green Published, hybrid			2022-12-27	WOS:000265877300027
J	Kuang, E; Wu, FY; Zhu, FX				Kuang, Ersheng; Wu, Fayi; Zhu, Fanxiu			Mechanism of Sustained Activation of Ribosomal S6 Kinase (RSK) and ERK by Kaposi Sarcoma-associated Herpesvirus ORF45 MULTIPROTEIN COMPLEXES RETAIN ACTIVE PHOSPHORYLATED ERK AND RSK AND PROTECT THEM FROM DEPHOSPHORYLATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-REGULATED KINASE; HUMAN CYTOMEGALOVIRUS-INFECTION; CANCER-CELL-PROLIFERATION; MAP KINASE; IN-VIVO; DOCKING SITE; PATHWAY; SPECIFICITY; INHIBITION; IDENTIFICATION	As obligate intracellular parasites, viruses exploit diverse cellular signaling machineries, including the mitogen-activated protein-kinase pathway, during their infections. We have demonstrated previously that the open reading frame 45 (ORF45) of Kaposi sarcoma-associated herpesvirus interacts with p90 ribosomal S6 kinases (RSKs) and strongly stimulates their kinase activities (Kuang, E., Tang, Q., Maul, G. G., and Zhu, F. (2008) J. Virol. 82, 1838-1850). Here, we define the mechanism by which ORF45 activates RSKs. We demonstrated that binding of ORF45 to RSK increases the association of extracellular signal-regulated kinase (ERK) with RSK, such that ORF45, RSK, and ERK formed high molecular mass protein complexes. We further demonstrated that the complexes shielded active pERK and pRSK from dephosphorylation. As a result, the complex-associated RSK and ERK were activated and sustained at high levels. Finally, we provide evidence that this mechanism contributes to the sustained activation of ERK and RSK in Kaposi sarcoma-associated herpesvirus lytic replication.	[Kuang, Ersheng; Wu, Fayi; Zhu, Fanxiu] Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University	Zhu, FX (corresponding author), Florida State Univ, Dept Biol Sci, Tallahassee, FL 32306 USA.	fzhu@bio.fsu.edu			National Institutes of Health [R01DE016680]; Bankhead-Coley bridge grant; Florida State University set-up funds; a planning grant; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016680] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bankhead-Coley bridge grant; Florida State University set-up funds; a planning grant; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DE016680. This work was also supported by a Bankhead-Coley bridge grant, Florida State University set-up funds, and a planning grant ( to F. Z.).	Abada R, 2008, J VIROL, V82, P2230, DOI 10.1128/JVI.02285-07; Andrade AA, 2004, BIOCHEM J, V381, P437, DOI 10.1042/BJ20031375; Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Blanco-Aparicio C, 1999, J CELL BIOL, V147, P1129, DOI 10.1083/jcb.147.6.1129; Cai YY, 2007, J VIROL, V81, P446, DOI 10.1128/JVI.01705-06; Carriere A, 2008, FRONT BIOSCI-LANDMRK, V13, P4258, DOI 10.2741/3003; CHANG Y, 1994, SCIENCE, V266, P1865, DOI 10.1126/science.7997879; Chen Z, 2001, CHEM REV, V101, P2449, DOI 10.1021/cr000241p; Clark DE, 2005, CANCER RES, V65, P3108; Cohen A, 2006, J GEN VIROL, V87, P795, DOI 10.1099/vir.0.81619-0; Cohen MS, 2005, SCIENCE, V308, P1318, DOI 10.1126/science1108367; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; Cuadrado A, 2007, CANCER CELL, V12, P187, DOI 10.1016/j.ccr.2007.08.017; Dufresne SD, 2001, MOL CELL BIOL, V21, P81, DOI 10.1128/MCB.21.1.81-87.2001; Ford PW, 2006, J GEN VIROL, V87, P1139, DOI 10.1099/vir.0.81628-0; GANEM D, 2007, FIELDS VIROLOGY, P2847; Gavin AC, 1999, CURR BIOL, V9, P281, DOI 10.1016/S0960-9822(99)80120-1; Hauge C, 2006, J CELL SCI, V119, P3021, DOI 10.1242/jcs.02950; Jacque JM, 1998, EMBO J, V17, P2607, DOI 10.1093/emboj/17.9.2607; Jeffrey KL, 2007, NAT REV DRUG DISCOV, V6, P391, DOI 10.1038/nrd2289; Johnson RA, 2000, J VIROL, V74, P1158, DOI 10.1128/JVI.74.3.1158-1167.2000; Kang SM, 2007, CANCER CELL, V12, P201, DOI 10.1016/j.ccr.2007.08.003; Kim MJ, 2006, EMBO J, V25, P3056, DOI 10.1038/sj.emboj.7601180; Kong XY, 2004, FEBS LETT, V559, P33, DOI 10.1016/S0014-5793(04)00002-X; Kuang E, 2008, J VIROL, V82, P1838, DOI 10.1128/JVI.02119-07; Liu YS, 2007, NAT REV IMMUNOL, V7, P202, DOI 10.1038/nri2035; Luo HL, 2002, J VIROL, V76, P3365, DOI 10.1128/JVI.76.7.3365-3373.2002; MANSOUR SJ, 1994, SCIENCE, V265, P966, DOI 10.1126/science.8052857; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Meriin AB, 1999, MOL CELL BIOL, V19, P2547; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Nijhara R, 2001, J VIROL, V75, P10348, DOI 10.1128/JVI.75.21.10348-10358.2001; Pan HY, 2006, J VIROL, V80, P5371, DOI 10.1128/JVI.02299-05; Pleschka S, 2001, NAT CELL BIOL, V3, P301, DOI 10.1038/35060098; Raman M, 2007, ONCOGENE, V26, P3100, DOI 10.1038/sj.onc.1210392; Rodems SM, 1998, J VIROL, V72, P9173, DOI 10.1128/JVI.72.11.9173-9180.1998; Roux PP, 2003, MOL CELL BIOL, V23, P4796, DOI 10.1128/MCB.23.14.4796-4804.2003; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Rozen R, 2008, J VIROL, V82, P4742, DOI 10.1128/JVI.02745-07; Sadagopan S, 2007, J VIROL, V81, P3949, DOI 10.1128/JVI.02333-06; Sapkota GP, 2007, BIOCHEM J, V401, P29, DOI 10.1042/BJ20061088; Sharma-Walia N, 2005, J VIROL, V79, P10308, DOI 10.1128/JVI.79.16.10308-10329.2005; Smith JA, 1999, J BIOL CHEM, V274, P2893, DOI 10.1074/jbc.274.5.2893; Smith JA, 2005, CANCER RES, V65, P1027; SONTAG E, 1993, CELL, V75, P887, DOI 10.1016/0092-8674(93)90533-V; Trivier E, 1996, NATURE, V384, P567, DOI 10.1038/384567a0; Uetz P, 2006, SCIENCE, V311, P239, DOI 10.1126/science.1116804; Vaidyanathan H, 2007, P NATL ACAD SCI USA, V104, P19837, DOI 10.1073/pnas.0704514104; Wang PY, 2003, EMBO J, V22, P2658, DOI 10.1093/emboj/cdg255; Xie JP, 2008, VIROLOGY, V371, P139, DOI 10.1016/j.virol.2007.09.040; Xie JP, 2005, J VIROL, V79, P15027, DOI 10.1128/JVI.79.24.15027-15037.2005; Yang XY, 1999, J VIROL, V73, P3460, DOI 10.1128/JVI.73.4.3460-3466.1999; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; Zhou B, 2002, J BIOL CHEM, V277, P31818, DOI 10.1074/jbc.M203969200; Zhu FX, 2006, J VIROL, V80, P12187, DOI 10.1128/JVI.01275-06; Zhu FX, 2005, J VIROL, V79, P800, DOI 10.1128/JVI.79.2.800-811.2005; Zhu FX, 2003, J VIROL, V77, P4221, DOI 10.1128/JVI.77.7.4221-4230.2003; Zhu FX, 1999, J VIROL, V73, P5556, DOI 10.1128/JVI.73.7.5556-5567.1999; Zhu FX, 2002, P NATL ACAD SCI USA, V99, P5573, DOI 10.1073/pnas.082420599	60	40	41	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13958	13968		10.1074/jbc.M900025200	http://dx.doi.org/10.1074/jbc.M900025200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19304659	Green Published, hybrid			2022-12-27	WOS:000265877300071
J	Lilla, JN; Joshi, RV; Craik, CS; Werb, Z				Lilla, Jennifer N.; Joshi, Ravi V.; Craik, Charles S.; Werb, Zena			Active Plasma Kallikrein Localizes to Mast Cells and Regulates Epithelial Cell Apoptosis, Adipocyte Differentiation, and Stromal Remodeling during Mammary Gland Involution	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIPEPTIDYL PEPTIDASE-I; PLASMINOGEN ACTIVATION; CONTACT ACTIVATION; PREKALLIKREIN GENE; EXPRESSION; KININOGEN; SYSTEM; TRANSCRIPTION; ADIPOGENESIS; INHIBITION	The plasminogen cascade of serine proteases directs both development and tumorigenesis in the mammary gland. Plasminogen can be activated to plasmin by urokinase-type plasminogen activator (uPA), tissue-type plasminogen activator (tPA), and plasma kallikrein (PKal). The dominant plasminogen activator for mammary involution is PKal, a serine protease that participates in the contact activation system of blood coagulation. We observed that the prekallikrein gene (Klkb1) is expressed highly in the mammary gland during stromal remodeling periods including puberty and postlactational involution. We used a variant of ecotin (ecotin-PKal), a macromolecular inhibitor of serine proteases engineered to be highly specific for active PKal, to demonstrate that inhibition of PKal with ecotin-PKal delays alveolar apoptosis, adipocyte replenishment, and stromal remodeling in the involuting mammary gland, producing a phenotype resembling that resulting from plasminogen deficiency. Using biotinylated ecotin-PKal, we localized active PKal to connective tissue-type mast cells in the mammary gland. Taken together, these results implicate PKal as an effector of the plasminogen cascade during mammary development.	[Lilla, Jennifer N.; Werb, Zena] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Joshi, Ravi V.; Craik, Charles S.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Werb, Z (corresponding author), Univ Calif San Francisco, Dept Anat, HSW 1323, San Francisco, CA 94143 USA.	zena.werb@ucsf.edu			National Institutes of Health [CA057621]; NCI [CA072006]; Department of Defense DOD-CMDRP Breast Cancer Research Program [W81XW-05-0272]; NATIONAL CANCER INSTITUTE [P01CA072006, R01CA057621] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Department of Defense DOD-CMDRP Breast Cancer Research Program(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA057621 and CA072006 from the NCI. This work was also supported by a Predoctoral Fellowship from the Department of Defense DOD-CMDRP Breast Cancer Research Program (W81XW-05-0272) ( to J. N. L.).	Alexander CM, 2001, J CELL BIOL, V152, P693, DOI 10.1083/jcb.152.4.693; BAUMGARTEN CR, 1986, J IMMUNOL, V137, P977; Cerf ME, 2000, METAB BRAIN DIS, V15, P315, DOI 10.1023/A:1011179426420; CIECHANOWICZ A, 1993, BIOCHEM BIOPH RES CO, V197, P1370, DOI 10.1006/bbrc.1993.2628; Dano K, 2005, THROMB HAEMOSTASIS, V93, P676, DOI 10.1160/TH05-01-0054; DUTTLINGER R, 1993, DEVELOPMENT, V118, P705; Eggers CT, 2001, J MOL BIOL, V308, P975, DOI 10.1006/jmbi.2001.4754; ICHINOSE A, 1984, FEBS LETT, V175, P412, DOI 10.1016/0014-5793(84)80779-6; Jamieson T, 2005, NAT IMMUNOL, V6, P403, DOI 10.1038/ni1182; JUNQUEIRA LCU, 1979, HISTOCHEM J, V11, P447, DOI 10.1007/BF01002772; Leers MPG, 1999, J PATHOL, V187, P567, DOI 10.1002/(SICI)1096-9896(199904)187:5<567::AID-PATH288>3.0.CO;2-J; Lima AR, 2008, BIOL CHEM, V389, P1487, DOI 10.1515/BC.2008.166; Lund LR, 2006, EMBO J, V25, P2686, DOI 10.1038/sj.emboj.7601173; Lund LR, 1996, DEVELOPMENT, V122, P181; Lund LR, 2000, DEVELOPMENT, V127, P4481; Mandrup S, 1997, J BIOL CHEM, V272, P5367, DOI 10.1074/jbc.272.9.5367; MCINTYRE JA, 1981, INT ARCH ALLER A IMM, V66, P244, DOI 10.1159/000232827; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; MILES LA, 1983, THROMB RES, V29, P407, DOI 10.1016/0049-3848(83)90244-X; MOLONEY WC, 1960, J HISTOCHEM CYTOCHEM, V8, P200, DOI 10.1177/8.3.200; Motta G, 1998, BLOOD, V91, P516, DOI 10.1182/blood.V91.2.516.516_516_528; Neth P, 2005, BIOL CHEM, V386, P101, DOI 10.1515/BC.2005.013; Neth P, 2001, THROMB HAEMOSTASIS, V85, P1043, DOI 10.1055/s-0037-1615961; Pham CTN, 1999, P NATL ACAD SCI USA, V96, P8627, DOI 10.1073/pnas.96.15.8627; RAZIN E, 1984, J IMMUNOL, V132, P1479; Rojkjaer R, 1999, IMMUNOPHARMACOLOGY, V43, P109, DOI 10.1016/S0162-3109(99)00069-7; Schmaier AH, 2007, J THROMB HAEMOST, V5, P2323, DOI 10.1111/j.1538-7836.2007.02770.x; Schmaier AH, 1999, THROMB HAEMOSTASIS, V82, P226; Selvarajan S, 2001, NAT CELL BIOL, V3, P267, DOI 10.1038/35060059; SMAS CM, 1995, BIOCHEM J, V309, P697, DOI 10.1042/bj3090697; SPIEGELMAN BM, 1983, CELL, V35, P657, DOI 10.1016/0092-8674(83)90098-3; Stoop AA, 2003, NAT BIOTECHNOL, V21, P1063, DOI 10.1038/nbt860; STRANGE R, 1992, DEVELOPMENT, V115, P49; Wolters PJ, 2001, J BIOL CHEM, V276, P18551, DOI 10.1074/jbc.M100223200; Yang SQ, 1998, J MOL BIOL, V279, P1001, DOI 10.1006/jmbi.1998.1749	35	36	42	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13792	13803		10.1074/jbc.M900508200	http://dx.doi.org/10.1074/jbc.M900508200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19297327	hybrid, Green Published			2022-12-27	WOS:000265877300056
J	Niture, SK; Jaiswal, AK				Niture, Suryakant K.; Jaiswal, Anil K.			RETRACTED: Prothymosin-alpha Mediates Nuclear Import of the INrf2/Cul3 center dot Rbx1 Complex to Degrade Nuclear Nrf2 (Publication with Expression of Concern. See vol. 191, pg. 1199, 2016) (Retracted article. See vol. 292, pg. 2049, 2017)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Retracted Publication							PROTEIN-KINASE-C; KEAP1; ACTIVATION; STRESS; PHOSPHORYLATION; EXPRESSION; EXPORT; INRF2; INDUCTION; ADAPTER	Nrf2-mediated coordinated induction of a battery of defensive genes is a critical mechanism in cellular protection and survival. INrf2 (Keap1), an inhibitor of Nrf2, functions as an adaptor for Cul3 center dot Rbx1-mediated degradation of Nrf2. A majority of the INrf2/Cul3 center dot Rbx1 complex is localized in the cytosol that degrades cytosolic Nrf2. However, 10-15% of INrf2 is also localized inside the nucleus. INrf2 does not contain a defined nuclear import signal, and the mechanism of nuclear import and its function inside the nucleus remain obscure. Present studies demonstrate that the DGR region of INrf2 is required for nuclear import of INrf2. Studies also demonstrate that Cul3 and Rbx1 are also imported inside the nucleus in complex with INrf2. Interestingly, Nrf2 and prothymosin-alpha both bind to the DGR region of INrf2. However, it is prothymosin-alpha and not Nrf2 that mediates nuclear import of INrf2/Cul3 center dot Rbx1 complex. Antioxidant treatment increases nuclear import of INrf2/Cul3 center dot Rbx1 complex. The INrf2/Cul3 center dot Rbx1 complex inside the nucleus exchanges prothymosin-alpha with Nrf2, resulting in degradation of Nrf2. These results led to the conclusion that prothymosin-alpha-mediated nuclear import of INrf2/Cul3 center dot Rbx1 complex leads to ubiquitination and degradation of Nrf2 inside the nucleus presumably to regulate nuclear level of Nrf2 and rapidly switch off the activation of Nrf2 downstream gene expression.	[Niture, Suryakant K.; Jaiswal, Anil K.] Univ Maryland, Sch Med, Dept Pharmacol & Expt Therapeut, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore	Jaiswal, AK (corresponding author), Univ Maryland, Sch Med, Dept Pharmacol & Expt Therapeut, 655 W Baltimore St, Baltimore, MD 21201 USA.	ajaiswal@som.umaryland.edu		Niture, Suryakant/0000-0003-0613-9399	National Institutes of Health (NIEHS) [RO1 ES012265]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012265] Funding Source: NIH RePORTER	National Institutes of Health (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 ES012265 (NIEHS).	Bloom DA, 2003, J BIOL CHEM, V278, P44675, DOI 10.1074/jbc.M307633200; Dhakshinamoorthy S, 2001, ONCOGENE, V20, P3906, DOI 10.1038/sj.onc.1204506; Dhakshinamoorthy S, 2000, CURR TOP CELL REGUL, V36, P201; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Itoh K, 1999, GENE DEV, V13, P76, DOI 10.1101/gad.13.1.76; Jain AK, 2007, J BIOL CHEM, V282, P16502, DOI 10.1074/jbc.M611336200; Jain AK, 2006, J BIOL CHEM, V281, P12132, DOI 10.1074/jbc.M511198200; Jaiswal AK, 2004, FREE RADICAL BIO MED, V36, P1199, DOI 10.1016/j.freeradbiomed.2004.02.074; Kang MI, 2004, P NATL ACAD SCI USA, V101, P2046, DOI 10.1073/pnas.0308347100; Karapetian RN, 2005, MOL CELL BIOL, V25, P1089, DOI 10.1128/MCB.25.3.1089-1099.2005; Kobayashi A, 2004, MOL CELL BIOL, V24, P7130, DOI 10.1128/MCB.24.16.7130-7139.2004; Kobayashi M, 2006, ADV ENZYME REGUL, V46, P113, DOI 10.1016/j.advenzreg.2006.01.007; Kwak MK, 2003, J BIOL CHEM, V278, P8135, DOI 10.1074/jbc.M211898200; Lee OH, 2007, J BIOL CHEM, V282, P36412, DOI 10.1074/jbc.M706517200; Padmanabhan B, 2006, MOL CELL, V21, P689, DOI 10.1016/j.molcel.2006.01.013; Singh A, 2006, PLOS MED, V3, P1865, DOI 10.1371/journal.pmed.0030420; Tan KP, 2007, MOL PHARMACOL, V72, P1380, DOI 10.1124/mol.107.039370; Velichkova M, 2005, MOL CELL BIOL, V25, P4501, DOI 10.1128/MCB.25.11.4501-4513.2005; Wakabayashi N, 2004, P NATL ACAD SCI USA, V101, P2040, DOI 10.1073/pnas.0307301101; Wakabayashi N, 2003, NAT GENET, V35, P238, DOI 10.1038/ng1248; Zhang DD, 2003, MOL CELL BIOL, V23, P8137, DOI 10.1128/MCB.23.22.8137-8151.2003; Zhang DD, 2004, MOL CELL BIOL, V24, P10941, DOI 10.1128/MCB.24.24.10941-10953.2004	22	57	62	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13856	13868		10.1074/jbc.M808084200	http://dx.doi.org/10.1074/jbc.M808084200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19279002	Green Published, hybrid			2022-12-27	WOS:000265877300062
J	Zhai, XH; Malakhova, ML; Pike, HM; Benson, LM; Bergen, HR; Sugar, IP; Malinina, L; Patel, DJ; Brown, RE				Zhai, Xiuhong; Malakhova, Margarita L.; Pike, Helen M.; Benson, Linda M.; Bergen, H. Robert, III; Sugar, Istvan P.; Malinina, Lucy; Patel, Dinshaw J.; Brown, Rhoderick E.			Glycolipid Acquisition by Human Glycolipid Transfer Protein Dramatically Alters Intrinsic Tryptophan Fluorescence INSIGHTS INTO GLYCOLIPID BINDING AFFINITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSBILAYER DISTRIBUTION; STRUCTURAL BASIS; SITES; GLYCOSPHINGOLIPIDS; MODEL; SUGAR; GALACTOSYLCERAMIDE; GLUCOSYLCERAMIDE; IDENTIFICATION; SPHINGOMYELIN	Glycolipid transfer proteins (GLTPs) are small, soluble proteins that selectively accelerate the intermembrane transfer of glycolipids. The GLTP fold is conformationally unique among lipid binding/transfer proteins and serves as the prototype and founding member of the new GLTP superfamily. In the present study, changes in human GLTP tryptophan fluorescence, induced by membrane vesicles containing glycolipid, are shown to reflect glycolipid binding when vesicle concentrations are low. Characterization of the glycolipid-induced "signature response," i.e. similar to 40% decrease in Trp intensity and similar to 12-nm blue shift in emission wavelength maximum, involved various modes of glycolipid presentation, i.e. microinjection/dilution of lipid-ethanol solutions or phosphatidylcholine vesicles, prepared by sonication or extrusion and containing embedded glycolipids. High resolution x-ray structures of apo- and holo-GLTP indicate that major conformational alterations are not responsible for the glycolipid-induced GLTP signature response. Instead, glycolipid binding alters the local environment of Trp-96, which accounts for similar to 70% of total emission intensity of three Trp residues in GLTP and provides a stacking platform that aids formation of a hydrogen bond network with the ceramide-linked sugar of the glycolipid head group. The changes in Trp signal were used to quantitatively assess human GLTP binding affinity for various lipids including glycolipids containing different sugar headgroups and homogenous acyl chains. The presence of the glycolipid acyl chain and at least one sugar were essential for achieving a low-to-submicromolar dissociation constant that was only slightly altered by increased sugar headgroup complexity.	[Malinina, Lucy] CICbioGUNE, Struct Biol, Derio 48160, Spain; [Zhai, Xiuhong; Malakhova, Margarita L.; Pike, Helen M.; Brown, Rhoderick E.] Univ Minnesota, Hormel Inst, Austin, MN 55912 USA; [Benson, Linda M.; Bergen, H. Robert, III] Mayo Clin, Coll Med, Mayo Prote Res Ctr, Rochester, MN 55905 USA; [Patel, Dinshaw J.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Sugar, Istvan P.] Mt Sinai Sch Med, Dept Neurol, New York, NY 10029 USA	University of Minnesota System; Mayo Clinic; Memorial Sloan Kettering Cancer Center; Icahn School of Medicine at Mount Sinai	Malinina, L (corresponding author), CICbioGUNE, Struct Biol, Parque Tecnol Vizcaya Ed 800, Derio 48160, Spain.	lucy@cicbiogune.es; pateld@mskcc.org; reb@umn.edu	Malinina, Lucy/B-8161-2013; Sugar, Istvan/AAU-4351-2020	Brown, Rhoderick/0000-0002-7337-3604; Malinina, Lucy/0000-0001-7973-1831	National Institutes of Health [CA121493, GM45928]; United States Public Health Service and NCI; Abby Rockefeller Mauze Trust; Dewitt Wallace Fund; Maloris Foundation; Mayo Foundation; Medical Educationand Research; The Hormel Foundation.; NATIONAL CANCER INSTITUTE [R01CA121493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045928] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Public Health Service and NCI; Abby Rockefeller Mauze Trust; Dewitt Wallace Fund; Maloris Foundation; Mayo Foundation; Medical Educationand Research; The Hormel Foundation.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA121493 and GM45928 from the United States Public Health Service and NCI. This work was also supported by grants from the Abby Rockefeller Mauze Trust and the Dewitt Wallace Fund, the Maloris Foundation, the Mayo Foundation for Medical Educationand Research, and The Hormel Foundation.	Airenne TT, 2006, J MOL BIOL, V355, P224, DOI 10.1016/j.jmb.2005.10.031; BARTLETT GR, 1959, J BIOL CHEM, V234, P468; Bektas M, 2003, GLYCOCONJUGATE J, V20, P39, DOI 10.1023/B:GLYC.0000016741.88476.8b; Berg OG, 2001, CHEM REV, V101, P2613, DOI 10.1021/cr990139w; Brown RE, 2007, BBA-MOL CELL BIOL L, V1771, P746, DOI 10.1016/j.bbalip.2007.01.011; Cho WH, 2005, ANNU REV BIOPH BIOM, V34, P119, DOI 10.1146/annurev.biophys.33.110502.133337; Cho W, 2006, BBA-MOL CELL BIOL L, V1761, P803, DOI 10.1016/j.bbalip.2006.08.012; Chowdary TK, 2007, BIOCHEM J, V401, P437, DOI 10.1042/BJ20061046; Christiaens B, 2002, EUR J BIOCHEM, V269, P2918, DOI 10.1046/j.1432-1033.2002.02963.x; Corti M, 2007, CURR OPIN COLLOID IN, V12, P148, DOI 10.1016/j.cocis.2007.05.002; D'Angelo G, 2007, NATURE, V449, P62, DOI 10.1038/nature06097; Gouaze-Andersson V, 2006, BBA-BIOMEMBRANES, V1758, P2096, DOI 10.1016/j.bbamem.2006.08.012; Halter D, 2007, J CELL BIOL, V179, P101, DOI 10.1083/jcb.200704091; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hurley JH, 2006, BBA-MOL CELL BIOL L, V1761, P805, DOI 10.1016/j.bbalip.2006.02.020; Jones S, 1997, J MOL BIOL, V272, P121, DOI 10.1006/jmbi.1997.1234; Jones S, 1997, J MOL BIOL, V272, P133, DOI 10.1006/jmbi.1997.1233; JOSEPH M, 1995, J BIOL CHEM, V270, P16749, DOI 10.1074/jbc.270.28.16749; Ladokhin AS, 2000, ANAL BIOCHEM, V285, P235, DOI 10.1006/abio.2000.4773; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Li XM, 2004, BIOCHEMISTRY-US, V43, P10285, DOI 10.1021/bi0495432; Madera M, 2004, NUCLEIC ACIDS RES, V32, pD235, DOI 10.1093/nar/gkh117; Malakhova ML, 2005, J BIOL CHEM, V280, P26312, DOI 10.1074/jbc.M500481200; Malewicz B, 2005, BIOPHYS J, V88, P2670, DOI 10.1529/biophysj.104.057059; Malinina L, 2004, NATURE, V430, P1048, DOI 10.1038/nature02856; Malinina L, 2006, PLOS BIOL, V4, P1996, DOI 10.1371/journal.pbio.0040362; Mattjus P, 2002, J BIOL CHEM, V277, P19476, DOI 10.1074/jbc.M201305200; Morales A, 2004, GLYCOCONJUGATE J, V20, P579; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Nylund M, 2007, LANGMUIR, V23, P11726, DOI 10.1021/la701927u; Persson D, 2004, BIOCHEMISTRY-US, V43, P11045, DOI 10.1021/bi036054d; PRINETTI A, 2009, BIOCHIM BIOPHYS ACTA, V1778, P184; Rao CS, 2005, BIOPHYS J, V89, P4017, DOI 10.1529/biophysj.105.070631; Rao CS, 2004, BIOCHEMISTRY-US, V43, P13805, DOI 10.1021/bi0492197; Sabourdy F, 2008, BBA-MOL CELL BIOL L, V1781, P145, DOI 10.1016/j.bbalip.2008.01.004; Schnaar RL, 2004, ARCH BIOCHEM BIOPHYS, V426, P163, DOI 10.1016/j.abb.2004.02.019; Sillence DJ, 2000, J LIPID RES, V41, P1252; SIXMA TK, 1992, NATURE, V355, P561, DOI 10.1038/355561a0; Smaby JM, 1996, BIOCHEMISTRY-US, V35, P5696, DOI 10.1021/bi953057k; Soisson SM, 1997, J MOL BIOL, V273, P226, DOI 10.1006/jmbi.1997.1314; Sujatha MS, 2004, PROTEINS, V55, P44, DOI 10.1002/prot.10612; Sujatha MS, 2004, PROTEIN SCI, V13, P2502, DOI 10.1110/ps.04812804; Sykora J, 2005, CHEM PHYS LIPIDS, V135, P213, DOI 10.1016/j.chemphyslip.2005.03.003; Vazquez-Ibar JL, 2003, P NATL ACAD SCI USA, V100, P12706, DOI 10.1073/pnas.1835645100; Viard M, 2003, GLYCOCONJUGATE J, V20, P213, DOI 10.1023/B:GLYC.0000024253.48791.d9; VYAS NK, 1988, SCIENCE, V242, P1290, DOI 10.1126/science.3057628; Weis WI, 1996, ANNU REV BIOCHEM, V65, P441, DOI 10.1146/annurev.bi.65.070196.002301; West G, 2008, FEBS J, V275, P3421, DOI 10.1111/j.1742-4658.2008.06498.x; West G, 2006, BBA-BIOMEMBRANES, V1758, P1732, DOI 10.1016/j.bbamem.2006.06.020; Yu ZW, 1998, BIOCHEMISTRY-US, V37, P1540, DOI 10.1021/bi971010o; Zhai XH, 2006, BIOPHYS J, V91, P2490, DOI 10.1529/biophysj.106.084921; Zolotnitsky G, 2004, P NATL ACAD SCI USA, V101, P11275, DOI 10.1073/pnas.0404311101; Zou XQ, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-72	53	28	28	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13620	13628		10.1074/jbc.M809089200	http://dx.doi.org/10.1074/jbc.M809089200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19270338	Green Published, hybrid			2022-12-27	WOS:000265877300039
J	Kampf, M; Absmanner, B; Schwarz, M; Lehle, L				Kaempf, Michael; Absmanner, Birgit; Schwarz, Markus; Lehle, Ludwig			Biochemical Characterization and Membrane Topology of Alg2 from Saccharomyces cerevisiae as a Bifunctional alpha 1,3-and 1,6-Mannosyltransferase Involved in Lipid-linked Oligosaccharide Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAMSTER OVARY CELLS; FUNGUS RHIZOMUCOR-PUSILLUS; YEAST MUTANTS DEFICIENT; 2 ACTIVE-SITES; ENDOPLASMIC-RETICULUM; ESCHERICHIA-COLI; MOLECULAR-CLONING; PROTEIN TOPOLOGY; OLIGOSACCHARYLTRANSFERASE COMPLEX; TRANSMEMBRANE TOPOLOGY	N-Linked glycosylation involves the ordered, stepwise synthesis of the unique lipid-linked oligosaccharide precursor Glc(3)Man(9) GlcNAc(2)-PP-Dol on the endoplasmic reticulum (ER), catalyzed by a series of glycosyltransferases. Here we characterize Alg2 as a bifunctional enzyme that is required for both the transfer of the alpha 1,3- and the alpha 1,6-mannose-linked residue from GDP-mannose to Man(1)GlcNAc(2)-PP-Dol forming the Man(3)GlcNAc(2)-PP-Dol intermediate on the cytosolic side of the ER. Alg2 has a calculated mass of 58 kDa and is predicted to contain four transmembrane-spanning helices, two at the N-terminus and two at the C terminus. Contradictory to topology predictions, we prove that only the two N-terminal domains ful-fill this criterion, whereas the C-terminal hydrophobic sequences contribute to ER localization in a nontransmembrane manner. Surprisingly, none of the four domains is essential for transferase activity because truncated Alg2 variants can exert their function as long as Alg2 is associated with the ER by either its N- or C-terminal hydrophobic regions. By site-directed mutagenesis we demonstrate that an EX7E motif, conserved in a variety of glycosyltransferases, is not important for Alg2 function in vivo and in vitro. Instead, we identify a conserved lysine residue, Lys(230), as being essential for activity, which could be involved in the binding of the phosphate of the glycosyl donor.	[Kaempf, Michael; Absmanner, Birgit; Schwarz, Markus; Lehle, Ludwig] Univ Regensburg, Lehrstuhl Zellbiol & Pflanzenphysiol, D-93053 Regensburg, Germany	University of Regensburg	Lehle, L (corresponding author), Univ Regensburg, Lehrstuhl Zellbiol & Pflanzenphysiol, Univ Str 31, D-93053 Regensburg, Germany.	ludwig.lehle@biologie.uni-regensburg.de			Deutsche Forschungsgemeinschaft; Korber-Stiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Korber-Stiftung	This work was supported by grants from the Deutsche Forschungsgemeinschaft and the Korber-Stiftung.	Abdian PL, 2000, J BIOL CHEM, V275, P40568, DOI 10.1074/jbc.M007496200; BECK PJ, 1990, SOMAT CELL MOLEC GEN, V16, P539, DOI 10.1007/BF01233094; Bickel T, 2005, J BIOL CHEM, V280, P34500, DOI 10.1074/jbc.M506358200; Blobel G, 2000, CHEMBIOCHEM, V1, P87; BLOBEL G, 1980, P NATL ACAD SCI-BIOL, V77, P1496, DOI 10.1073/pnas.77.3.1496; Bourne Y, 2001, CURR OPIN STRUC BIOL, V11, P593, DOI 10.1016/S0959-440X(00)00253-0; Bracey MH, 2002, SCIENCE, V298, P1793, DOI 10.1126/science.1076535; Breton C, 2006, GLYCOBIOLOGY, V16, p29R, DOI 10.1093/glycob/cwj016; Burda P, 1999, BBA-GEN SUBJECTS, V1426, P239, DOI 10.1016/S0304-4165(98)00127-5; Burda P, 1999, GLYCOBIOLOGY, V9, P617, DOI 10.1093/glycob/9.6.617; Campbell JA, 1997, BIOCHEM J, V326, P929, DOI 10.1042/bj3260929u; CHAPMAN A, 1979, J BIOL CHEM, V254, P243; Cid E, 2000, J BIOL CHEM, V275, P33614, DOI 10.1074/jbc.M005358200; Coutinho PM, 2003, J MOL BIOL, V328, P307, DOI 10.1016/S0022-2836(03)00307-3; Frank CG, 2005, GLYCOBIOLOGY, V15, P1156, DOI 10.1093/glycob/cwj002; Glover KJ, 2005, P NATL ACAD SCI USA, V102, P14255, DOI 10.1073/pnas.0507311102; Griffiths G, 1998, J BIOL CHEM, V273, P11752, DOI 10.1074/jbc.273.19.11752; Hall CW, 1997, J CELL BIOCHEM, V67, P201, DOI 10.1002/(SICI)1097-4644(19971101)67:2<201::AID-JCB5>3.3.CO;2-Q; HEIFETZ A, 1977, J BIOL CHEM, V252, P3057; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Helenius J, 2002, NATURE, V415, P447, DOI 10.1038/415447a; HUFFAKER TC, 1982, J BIOL CHEM, V257, P3203; HUFFAKER TC, 1983, P NATL ACAD SCI-BIOL, V80, P7466, DOI 10.1073/pnas.80.24.7466; Hwang HY, 2003, NATURE, V423, P439, DOI 10.1038/nature01634; Igura M, 2008, EMBO J, V27, P234, DOI 10.1038/sj.emboj.7601940; Jing W, 2000, GLYCOBIOLOGY, V10, P883, DOI 10.1093/glycob/10.9.883; Jing W, 2003, GLYCOBIOLOGY, V13, P661, DOI 10.1093/glycob/cwg085; Kapitonov D, 1999, GLYCOBIOLOGY, V9, P961, DOI 10.1093/glycob/9.10.961; KEAN EL, 1983, BIOCHIM BIOPHYS ACTA, V750, P268, DOI 10.1016/0005-2760(83)90028-0; Kean EL, 1999, J BIOL CHEM, V274, P34072, DOI 10.1074/jbc.274.48.34072; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; Kim H, 2003, P NATL ACAD SCI USA, V100, P7460, DOI 10.1073/pnas.1332735100; Knauer R, 1999, BBA-GEN SUBJECTS, V1426, P259, DOI 10.1016/S0304-4165(98)00128-7; Knauer R, 1999, J BIOL CHEM, V274, P17249, DOI 10.1074/jbc.274.24.17249; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Kostova Z, 2003, EUR J BIOCHEM, V270, P4507, DOI 10.1046/j.1432-1033.2003.03844.x; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Lehle L, 2006, ANGEW CHEM INT EDIT, V45, P6802, DOI 10.1002/anie.200601645; Ninomiya T, 2002, J BIOL CHEM, V277, P21567, DOI 10.1074/jbc.M201719200; O'Reilly MK, 2006, BIOCHEMISTRY-US, V45, P9593, DOI 10.1021/bi060878o; Partridge AW, 2003, J BIOL CHEM, V278, P22056, DOI 10.1074/jbc.M210685200; PICOT D, 1994, NATURE, V367, P243, DOI 10.1038/367243a0; Qasba PK, 2005, TRENDS BIOCHEM SCI, V30, P53, DOI 10.1016/j.tibs.2004.11.005; Ramakrishnan B, 2002, J BIOL CHEM, V277, P20833, DOI 10.1074/jbc.M111183200; RUNGE KW, 1984, J BIOL CHEM, V259, P412; RUNGE KW, 1986, J BIOL CHEM, V261, P5582; Sanyal S, 2008, BIOCHEMISTRY-US, V47, P7937, DOI 10.1021/bi800723n; SENGSTAG C, 1990, MOL CELL BIOL, V10, P672, DOI 10.1128/MCB.10.2.672; SHARMA CB, 1982, EUR J BIOCHEM, V126, P319; Sharma CB, 2001, BIOL CHEM, V382, P321, DOI 10.1515/BC.2001.039; SILBERSTEIN S, 1995, J CELL BIOL, V131, P371, DOI 10.1083/jcb.131.2.371; Stolz J, 1998, FEBS LETT, V440, P213, DOI 10.1016/S0014-5793(98)01454-9; Strahl-Bolsinger S, 1999, J BIOL CHEM, V274, P9068, DOI 10.1074/jbc.274.13.9068; Takeuchi K, 1999, GLYCOBIOLOGY, V9, P1287, DOI 10.1093/glycob/9.12.1287; Thiel C, 2003, J BIOL CHEM, V278, P22498, DOI 10.1074/jbc.M302850200; Upreti RK, 2003, PROTEOMICS, V3, P363, DOI 10.1002/pmic.200390052; van der Wel H, 2002, J BIOL CHEM, V277, P46527, DOI 10.1074/jbc.M208824200; VIJAY IK, 1982, EUR J BIOCHEM, V126, P167, DOI 10.1111/j.1432-1033.1982.tb06762.x; von Heijne G, 2006, NAT REV MOL CELL BIO, V7, P909, DOI 10.1038/nrm2063; Wacker M, 2002, SCIENCE, V298, P1790, DOI 10.1126/science.298.5599.1790; Weerapana E, 2006, GLYCOBIOLOGY, V16, p91R, DOI 10.1093/glycob/cwj099; Wilkinson BM, 1996, J BIOL CHEM, V271, P25590, DOI 10.1074/jbc.271.41.25590; Yada T, 2003, J BIOL CHEM, V278, P39711, DOI 10.1074/jbc.M304421200; Yada T, 2003, J BIOL CHEM, V278, P30235, DOI 10.1074/jbc.M303657200; Yamazaki H, 1998, GENE, V221, P179, DOI 10.1016/S0378-1119(98)00456-9; Yan AX, 2005, J BIOL CHEM, V280, P3121, DOI 10.1074/jbc.R400036200; Zakharov SD, 2002, BIOCHIMIE, V84, P465, DOI 10.1016/S0300-9084(02)01453-0; ZENG Y, 1991, ANAL BIOCHEM, V193, P266, DOI 10.1016/0003-2697(91)90020-T; Zhang J, 2006, P NATL ACAD SCI USA, V103, P16212, DOI 10.1073/pnas.0604567103	69	26	27	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					11900	11912		10.1074/jbc.M806416200	http://dx.doi.org/10.1074/jbc.M806416200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19282279	hybrid, Green Published			2022-12-27	WOS:000265494600022
J	Hoffman, DL; Brookes, PS				Hoffman, David L.; Brookes, Paul S.			Oxygen Sensitivity of Mitochondrial Reactive Oxygen Species Generation Depends on Metabolic Conditions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-TRANSPORT-CHAIN; CYTOCHROME BC(1) COMPLEX; SUPEROXIDE-PRODUCTION; HYDROGEN-PEROXIDE; HEART-MITOCHONDRIA; HYPOXIA; CELL; GENTAMICIN; GRADIENTS; NEPHROTOXICITY	The mitochondrial generation of reactive oxygen species (ROS) plays a central role in many cell signaling pathways, but debate still surrounds its regulation by factors, such as substrate availability, [O-2] and metabolic state. Previously, we showed that in isolated mitochondria respiring on succinate, ROS generation was a hyperbolic function of [O-2]. In the current study, we used a wide variety of substrates and inhibitors to probe the O-2 sensitivity of mitochondrial ROS generation under different metabolic conditions. From such data, the apparent K-m for O-2 of putative ROS-generating sites within mitochondria was estimated as follows: 0.2, 0.9, 2.0, and 5.0 mu M O-2 for the complex I flavin site, complex I electron backflow, complex IIIQ(O) site, and electron transfer flavoprotein quinone oxidoreductase of beta-oxidation, respectively. Differential effects of respiratory inhibitors on ROS generation were also observed at varying [O-2]. Based on these data, we hypothesize that at physiological [O-2], complex I is a significant source of ROS, whereas the electron transfer flavoprotein quinone oxidoreductase may only contribute to ROS generation at very high [O-2]. Furthermore, we suggest that previous discrepancies in the assignment of effects of inhibitors on ROS may be due to differences in experimental [O-2]. Finally, the data set (see supplemental material) may be useful in the mathematical modeling of mitochondrial metabolism.	[Brookes, Paul S.] Univ Rochester, Med Ctr, Dept Anesthesiol, Rochester, NY 14642 USA; [Hoffman, David L.] Univ Rochester, Med Ctr, Dept Biochem, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Brookes, PS (corresponding author), Univ Rochester, Med Ctr, Dept Anesthesiol, Box 604,601 Elmwood Ave, Rochester, NY 14642 USA.	paul_brookes@urmc.rochester.edu		Hoffman, David/0000-0002-8661-3291; Brookes, Paul/0000-0002-8639-8413				Acker H, 2005, PHILOS T R SOC B, V360, P2201, DOI 10.1098/rstb.2005.1760; Adam-Vizi V, 2006, TRENDS PHARMACOL SCI, V27, P639, DOI 10.1016/j.tips.2006.10.005; AW TY, 1987, AM J PHYSIOL, V253, pF440, DOI 10.1152/ajprenal.1987.253.3.F440; Barja G, 1998, ANN NY ACAD SCI, V854, P224, DOI 10.1111/j.1749-6632.1998.tb09905.x; Bayir H, 2008, CRIT CARE, V12, DOI 10.1186/cc6779; Bell EL, 2007, J CELL BIOL, V177, P1029, DOI 10.1083/jcb.200609074; BOVERIS A, 1973, BIOCHEM J, V134, P707, DOI 10.1042/bj1340707; BOVERIS A, 1976, BIOCHEM J, V156, P435, DOI 10.1042/bj1560435; Brookes PS, 2003, J BIOL CHEM, V278, P31603, DOI 10.1074/jbc.M211784200; Brookes PS, 2004, AM J PHYSIOL-CELL PH, V287, pC817, DOI 10.1152/ajpcell.00139.2004; Byun HO, 2008, J CELL BIOCHEM, V104, P1747, DOI 10.1002/jcb.21741; Campian JL, 2004, J BIOL CHEM, V279, P46580, DOI 10.1074/jbc.M406685200; Carre JE, 2008, BBA-BIOENERGETICS, V1777, P763, DOI 10.1016/j.bbabio.2008.04.024; CHANCE B, 1965, J GEN PHYSIOL, V49, P163, DOI 10.1085/jgp.49.1.163; Chandel NS, 2000, J BIOL CHEM, V275, P25130, DOI 10.1074/jbc.M001914200; Chandel NS, 1998, P NATL ACAD SCI USA, V95, P11715, DOI 10.1073/pnas.95.20.11715; Chen Q, 2003, J BIOL CHEM, V278, P36027, DOI 10.1074/jbc.M304854200; Chen Q, 2008, AM J PHYSIOL-CELL PH, V294, pC460, DOI 10.1152/ajpcell.00211.2007; Chen YQ, 2007, J CELL SCI, V120, P4155, DOI 10.1242/jcs.011163; COLE RP, 1982, J APPL PHYSIOL, V53, P1116, DOI 10.1152/jappl.1982.53.5.1116; DULON D, 1988, ACTA OTO-LARYNGOL, V106, P219, DOI 10.3109/00016488809106429; Forquer I, 2006, J BIOL CHEM, V281, P38459, DOI 10.1074/jbc.M605119200; Gnaiger E, 1998, BBA-BIOENERGETICS, V1365, P249, DOI 10.1016/S0005-2728(98)00076-0; Gnaiger E, 2007, MITOCHONDRIAL PATHWA; Goldman D, 2006, AM J PHYSIOL-HEART C, V290, pH2277, DOI 10.1152/ajpheart.00547.2005; Guzy RD, 2006, EXP PHYSIOL, V91, P807, DOI 10.1113/expphysiol.2006.033506; Hoffman DL, 2007, AM J PHYSIOL-HEART C, V292, pH101, DOI 10.1152/ajpheart.00699.2006; Johnson DT, 2007, AM J PHYSIOL-CELL PH, V292, pC698, DOI 10.1152/ajpcell.00109.2006; JONES DP, 1986, AM J PHYSIOL, V250, pC663, DOI 10.1152/ajpcell.1986.250.5.C663; Klimova T, 2008, CELL DEATH DIFFER, V15, P660, DOI 10.1038/sj.cdd.4402307; KROON AM, 1983, PHARM WEEKBLAD, V5, P81, DOI 10.1007/BF01960982; Lambert AJ, 2004, J BIOL CHEM, V279, P39414, DOI 10.1074/jbc.M406576200; MAIRBAURL H, 2005, MIP 2005 4 MIT PHYS, P26; Matsumoto A, 2005, MAGN RESON MED, V54, P1530, DOI 10.1002/mrm.20714; Michelakis ED, 2002, CIRC RES, V90, P1307, DOI 10.1161/01.RES.0000024689.07590.C2; Muller FL, 2003, BIOCHEMISTRY-US, V42, P6493, DOI 10.1021/bi0342160; Muller FL, 2008, BIOCHEM J, V409, P491, DOI 10.1042/BJ20071162; *NAT RES COUNC, 1996, NIH PUBL, V8623; PARDEE AB, 1949, J BIOL CHEM, V178, P241; Rengasamy A, 1996, J PHARMACOL EXP THER, V276, P30; Schroedl C, 2002, AM J PHYSIOL-LUNG C, V283, pL922, DOI 10.1152/ajplung.00014.2002; Schuerholz T, 2008, MINERVA ANESTESIOL, V74, P183; Sperl W, 1997, MOL CELL BIOCHEM, V174, P71, DOI 10.1023/A:1006880529195; St-Pierre J, 2002, J BIOL CHEM, V277, P44784, DOI 10.1074/jbc.M207217200; Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025; Sun H, 2003, ARCH BIOCHEM BIOPHYS, V419, P198, DOI 10.1016/j.abb.2003.08.028; Takahashi E, 1998, AM J PHYSIOL-HEART C, V275, pH225, DOI 10.1152/ajpheart.1998.275.1.H225; Tsai AG, 2003, PHYSIOL REV, V83, P933, DOI 10.1152/physrev.00034.2002; TURRENS JF, 1980, BIOCHEM J, V191, P421, DOI 10.1042/bj1910421; WALKER PD, 1987, AM J PHYSIOL, V253, pC495, DOI 10.1152/ajpcell.1987.253.4.C495; Walker PD, 1999, RENAL FAILURE, V21, P433, DOI 10.3109/08860229909085109; Wang QS, 2007, FREE RADICAL BIO MED, V42, P642, DOI 10.1016/j.freeradbiomed.2006.12.008; Wojtovich AP, 2008, BBA-BIOENERGETICS, V1777, P882, DOI 10.1016/j.bbabio.2008.03.025	53	131	135	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16236	16245		10.1074/jbc.M809512200	http://dx.doi.org/10.1074/jbc.M809512200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19366681	Green Published, hybrid			2022-12-27	WOS:000266730900021
J	Jiang, M; Xu, XL; Wang, YH; Toyoda, F; Liu, XS; Zhang, M; Robinson, RB; Tseng, GN				Jiang, Min; Xu, Xulin; Wang, Yuhong; Toyoda, Futoshi; Liu, Xian-Sheng; Zhang, Mei; Robinson, Richard B.; Tseng, Gea-Ny			Dynamic Partnership between KCNQ1 and KCNE1 and Influence on Cardiac I-Ks Current Amplitude by KCNE2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-QT SYNDROME; FAMILIAL ATRIAL-FIBRILLATION; K+ CHANNEL COMPLEXES; OF-FUNCTION MUTATION; POTASSIUM CHANNEL; BETA-SUBUNITS; MINK; EXPRESSION; PORE; MODULATION	Cardiac slow delayed rectifier (I-Ks) channel is composed of KCNQ1 (pore-forming) and KCNE1 (auxiliary) subunits. Although KCNE1 is an obligate I-Ks component that confers the uniquely slow gating kinetics, KCNE2 is also expressed in human heart. In vitro experiments suggest that KCNE2 can associate with the KCNQ1-KCNE1 complex to suppress the current amplitude without altering the slow gating kinetics. Our goal here is to test the role of KCNE2 in cardiac I-Ks channel function. Pulse-chase experiments in COS-7 cells show that there is a KCNE1 turnover in the KCNQ1-KCNE1 complex, supporting the possibility that KCNE1 in the I-Ks channel complex can be substituted by KCNE2 when the latter is available. Biotinylation experiments in COS-7 cells show that although KCNE1 relies on KCNQ1 coassembly for more efficient cell surface expression, KCNE2 can independently traffic to the cell surface, thus becoming available for substituting KCNE1 in the I-Ks channel complex. Injecting vesicles carrying KCNE1 or KCNE2 into KCNQ1-expressing oocytes leads to KCNQ1 modulation in the same manner as KCNQ1 + KCNEx (where x = 1 or 2) cRNA coinjection. Thus, free KCNEx peptides delivered to the cell membrane can associate with existing KCNQ1 channels to modulate their function. Finally, adenovirus-mediated KCNE2 expression in adult guinea pig ventricular myocytes exhibited colocalization with native KCNQ1 protein and reduces the native I-Ks current density. We propose that in cardiac myocytes the I-Ks current amplitude is under dynamic control by the availability of KCNE2 subunits in the cell membrane.	[Jiang, Min; Xu, Xulin; Wang, Yuhong; Liu, Xian-Sheng; Zhang, Mei; Tseng, Gea-Ny] Virginia Commonwealth Univ, Dept Physiol & Biophys, Richmond, VA 23298 USA; [Toyoda, Futoshi] Shiga Univ Med Sci, Dept Physiol, Shiga 5202192, Japan; [Robinson, Richard B.] Columbia Univ, Dept Pharmacol, New York, NY 10032 USA; [Robinson, Richard B.] Columbia Univ, Ctr Mol Therapeut, New York, NY 10032 USA	Virginia Commonwealth University; Shiga University of Medical Science; Columbia University; Columbia University	Tseng, GN (corresponding author), Virginia Commonwealth Univ, Dept Physiol & Biophys, 1101 E Marshall St, Richmond, VA 23298 USA.	gtseng@vcu.edu			National Institutes of Health [HL-46451, HL-28958]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL046451, R01HL107294, P01HL028958] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-46451 (to G.-N.T.) and HL-28958.	Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Bendahhou S, 2005, CARDIOVASC RES, V67, P529, DOI 10.1016/j.cardiores.2005.02.014; Chandrasekhar KD, 2006, J BIOL CHEM, V281, P40015, DOI 10.1074/jbc.M604398200; Chen HJ, 2003, NEURON, V40, P15, DOI 10.1016/S0896-6273(03)00570-1; Chen YH, 2003, SCIENCE, V299, P251, DOI 10.1126/science.1077771; Delpon E, 2008, CIRC-ARRHYTHMIA ELEC, V1, P209, DOI 10.1161/CIRCEP.107.748103; ELLINGSEN O, 1993, AM J PHYSIOL, V265, pH747, DOI 10.1152/ajpheart.1993.265.2.H747; Gaborit N, 2005, CIRCULATION, V112, P471, DOI 10.1161/CIRCULATIONAHA.104.506857; Ghosh S, 2006, CIRC RES, V98, P1048, DOI 10.1161/01.RES.0000218863.44140.f2; Haitin Y, 2008, J PHYSIOL-LONDON, V586, P1803, DOI 10.1113/jphysiol.2007.149187; Hong K, 2005, CARDIOVASC RES, V68, P433, DOI 10.1016/j.cardiores.2005.06.023; Jiang M, 2000, CARDIOVASC RES, V48, P34, DOI 10.1016/S0008-6363(00)00159-0; Jiang M, 2004, CIRCULATION, V109, P1783, DOI 10.1161/01.CIR.0000124225.43852.50; Jost N, 2005, CIRCULATION, V112, P1392, DOI 10.1161/CIRCULATIONAHA.105.550111; Kang CB, 2008, BIOCHEMISTRY-US, V47, P7999, DOI 10.1021/bi800875q; Kurokawa J, 2001, J GEN PHYSIOL, V117, P43, DOI 10.1085/jgp.117.1.43; Liu XS, 2007, J MEMBRANE BIOL, V216, P117, DOI 10.1007/s00232-007-9047-7; Liu XS, 2007, AM J PHYSIOL-HEART C, V292, pH560, DOI 10.1152/ajpheart.00616.2006; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Lundquist AL, 2006, GENOMICS, V87, P119, DOI 10.1016/j.ygeno.2005.09.004; Lundquist Andrew L, 2005, J Mol Cell Cardiol, V38, P277, DOI 10.1016/j.yjmcc.2004.11.012; Manderfield LJ, 2008, FEBS J, V275, P1336, DOI 10.1111/j.1742-4658.2008.06294.x; MARSAL J, 1995, P NATL ACAD SCI USA, V92, P5224, DOI 10.1073/pnas.92.11.5224; Marx SO, 2002, SCIENCE, V295, P496, DOI 10.1126/science.1066843; McCrossan ZA, 2004, NEUROPHARMACOLOGY, V47, P787, DOI 10.1016/j.neuropharm.2004.06.018; Melman YF, 2004, NEURON, V42, P927, DOI 10.1016/j.neuron.2004.06.001; Morin TJ, 2008, P NATL ACAD SCI USA, V105, P1478, DOI 10.1073/pnas.0710366105; Morin TJ, 2007, ACS CHEM BIOL, V2, P469, DOI 10.1021/cb700089s; Nakahira K, 1996, J BIOL CHEM, V271, P7084, DOI 10.1074/jbc.271.12.7084; Nakajo K, 2007, J GEN PHYSIOL, V130, P269, DOI 10.1085/jgp.200709805; Panaghie G, 2006, J PHYSIOL-LONDON, V570, P455, DOI 10.1113/jphysiol.2005.100644; Poulsen AN, 2007, BIOCHEM BIOPH RES CO, V363, P133, DOI 10.1016/j.bbrc.2007.08.146; Qu JH, 2004, J BIOL CHEM, V279, P43497, DOI 10.1074/jbc.M405018200; Radicke S, 2006, CARDIOVASC RES, V71, P695, DOI 10.1016/j.cardiores.2006.06.017; Rocheleau JM, 2008, J GEN PHYSIOL, V131, P59, DOI 10.1085/jgp.200709816; Rocheleau JM, 2006, J GEN PHYSIOL, V128, P721, DOI 10.1085/jgp.200609657; Ruan YF, 2008, CIRC-ARRHYTHMIA ELEC, V1, P290, DOI 10.1161/CIRCEP.108.795617; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; SCHREIBMAYER W, 1994, PFLUG ARCH EUR J PHY, V426, P453, DOI 10.1007/BF00388310; Seebohm G, 2006, BIOPHYS J, V90, P2235, DOI 10.1529/biophysj.105.067165; Seebohm G, 2007, CIRC RES, V100, P686, DOI 10.1161/01.RES.0000260250.83824.8f; Sesti F, 1998, J GEN PHYSIOL, V112, P651, DOI 10.1085/jgp.112.6.651; Shamgar L, 2006, CIRC RES, V98, P1055, DOI 10.1161/01.RES.0000218979.40770.69; Splawski I, 2000, CIRCULATION, V102, P1178, DOI 10.1161/01.CIR.102.10.1178; Tapper AR, 2000, J GEN PHYSIOL, V116, P379, DOI 10.1085/jgp.116.3.379; Tapper AR, 2001, J BIOL CHEM, V276, P38249; Tian CL, 2007, BIOCHEMISTRY-US, V46, P11459, DOI 10.1021/bi700705j; Tinel N, 2000, EMBO J, V19, P6326, DOI 10.1093/emboj/19.23.6326; Tseng GN, 2007, HEART RHYTHM, V4, P1542, DOI 10.1016/j.hrthm.2007.08.014; Um SY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000933; Wang HY, 2007, NAT NEUROSCI, V10, P32, DOI 10.1038/nn1822; Wang KW, 1996, NEURON, V16, P571, DOI 10.1016/S0896-6273(00)80076-8; Wang Y, 2007, BIOPHYS J, V93, P3083, DOI 10.1529/biophysj.107.110320; Wiener R, 2008, J BIOL CHEM, V283, P5815, DOI 10.1074/jbc.M707541200; Wu DM, 2006, HEART RHYTHM, V3, P1469, DOI 10.1016/j.hrthm.2006.08.019; Xu XL, 2008, J GEN PHYSIOL, V131, P589, DOI 10.1085/jgp.200809976; Yang YQ, 2004, AM J HUM GENET, V75, P899, DOI 10.1086/425342; Yang YS, 1998, J GEN PHYSIOL, V112, P665, DOI 10.1085/jgp.112.6.665; Zhang M, 2001, CIRC RES, V88, P1012, DOI 10.1161/hh1001.090839	61	47	49	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16452	16462		10.1074/jbc.M808262200	http://dx.doi.org/10.1074/jbc.M808262200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19372218	Green Published, hybrid			2022-12-27	WOS:000266730900042
J	Farias, GG; Alfaro, IE; Cerpa, W; Grabowski, CP; Godoy, JA; Bonansco, C; Inestrosa, NC				Farias, Ginny G.; Alfaro, Ivan E.; Cerpa, Waldo; Grabowski, Catalina P.; Godoy, Juan A.; Bonansco, Christian; Inestrosa, Nibaldo C.			Wnt-5a/JNK Signaling Promotes the Clustering of PSD-95 in Hippocampal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POSTSYNAPTIC DENSITY-95; WNT; SYNAPSE; PROTEINS; PATHWAY; COLOCALIZATION; TRANSMISSION; ACCUMULATION; MECHANISMS; INHIBITOR	During the formation of synapses, specific regions of pre- and postsynaptic cells associate to form a single functional transmission unit. In this process, synaptogenic factors are necessary to modulate pre- and postsynaptic differentiation. In mammals, different Wnt ligands operate through canonical and non-canonical Wnt pathways, and their precise functions to coordinate synapse structure and function in the mature central nervous system are still largely unknown. Here, we studied the effect of different Wnt ligands on postsynaptic organization. We found that Wnt-5a induces short term changes in the clustering of PSD-95, without affecting its total levels. Wnt-5a promotes the recruitment of PSD-95 from a diffuse dendritic cytoplasmic pool to form new PSD-95 clusters in dendritic spines. Moreover, Wnt-5a acting as a non-canonical ligand regulates PSD-95 distribution through a JNK-dependent signaling pathway, as demonstrated by using the TAT-TI-JIP peptide in mature hippocampal neurons. Finally, using adult rat hippocampal slices, we found that Wnt-5a modulates glutamatergic synaptic transmission through a postsynaptic mechanism. Our studies indicate that the Wnt-5a/JNK pathway modulates the postsynaptic region of mammalian synapse directing the clustering and distribution of the physiologically relevant scaffold protein, PSD-95.	[Farias, Ginny G.; Alfaro, Ivan E.; Cerpa, Waldo; Grabowski, Catalina P.; Godoy, Juan A.; Inestrosa, Nibaldo C.] Pontificia Univ Catolica Chile, Fac Ciencias Biol, Inst Milenio,Ctr Regulac Celular & Patol Joaquin, Ctr Envejecimiento & Regenerac, Santiago, Chile; [Cerpa, Waldo; Bonansco, Christian] Univ Valparaiso, Fac Ciencias, Dept Fisiol, Ctr Neurobiol & Plast Desarrollo, Valparaiso, Chile	Pontificia Universidad Catolica de Chile; Universidad de Valparaiso	Inestrosa, NC (corresponding author), Pontificia Univ Catolica Chile, Fac Ciencias Biol, Inst Milenio,Ctr Regulac Celular & Patol Joaquin, Ctr Envejecimiento & Regenerac, Alameda 340,POB 8331150, Santiago, Chile.	ninestrosa@bio.puc.cl	Godoy, Juan A/F-5398-2018; Cerpa, Waldo/GSI-5204-2022	Godoy, Juan A/0000-0001-9920-6698; Cerpa, Waldo/0000-0001-7344-0144	Fondo de Financiamiento de Centros de Excelencia en Investigacion; Comision Nacional de Investigacion Cientifica y Tecnologica; Millennium Institute; Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) [1061074]; DIPUV [CID/1/2006]; FONDECYT	Fondo de Financiamiento de Centros de Excelencia en Investigacion; Comision Nacional de Investigacion Cientifica y Tecnologica; Millennium Institute(Takeda Pharmaceutical Company Ltd); Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); DIPUV; FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	This work was supported by Fondo de Financiamiento de Centros de Excelencia en Investigacion, Comision Nacional de Investigacion Cientifica y Tecnologica, and the Millennium Institute ( to N.C.I.); Fondo Nacional de Desarrollo Cientifico y Tecnologico (FONDECYT) Grant 1061074 and DIPUV Grant CID/1/2006 ( to C. B.); and predoctoral fellowships from FONDECYT ( to G. G. F., I. E. A., W. C., and C. P. G.).	Ahmad-Annuar A, 2006, J CELL BIOL, V174, P127, DOI 10.1083/jcb.200511054; Almeida CG, 2005, NEUROBIOL DIS, V20, P187, DOI 10.1016/j.nbd.2005.02.008; Alvarez VA, 2007, ANNU REV NEUROSCI, V30, P79, DOI 10.1146/annurev.neuro.30.051606.094222; Ataman B, 2008, NEURON, V57, P705, DOI 10.1016/j.neuron.2008.01.026; Beaumont V, 2007, MOL CELL NEUROSCI, V35, P513, DOI 10.1016/j.mcn.2007.03.004; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bourne JN, 2008, ANNU REV NEUROSCI, V31, P47, DOI 10.1146/annurev.neuro.31.060407.125646; Bresler T, 2001, MOL CELL NEUROSCI, V18, P149, DOI 10.1006/mcne.2001.1012; Cerpa W, 2008, J BIOL CHEM, V283, P5918, DOI 10.1074/jbc.M705943200; Chen JY, 2006, J BIOL CHEM, V281, P11910, DOI 10.1074/jbc.M511920200; Ciani L, 2005, NAT REV NEUROSCI, V6, P351, DOI 10.1038/nrn1665; Cleary JP, 2005, NAT NEUROSCI, V8, P79, DOI 10.1038/nn1372; De Ferrari GV, 2000, BRAIN RES REV, V33, P1, DOI 10.1016/S0165-0173(00)00021-7; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; Farias GG, 2007, J NEUROSCI, V27, P5313, DOI 10.1523/JNEUROSCI.3934-06.2007; Fox MA, 2006, J NEUROCHEM, V97, P1215, DOI 10.1111/j.1471-4159.2006.03834.x; Fuentealba RA, 2004, BRAIN RES REV, V47, P275, DOI 10.1016/j.brainresrev.2004.07.018; Gerrow K, 2006, NEURON, V49, P547, DOI 10.1016/j.neuron.2006.01.015; Glynn MW, 2006, NAT PROTOC, V1, P1287, DOI 10.1038/nprot.2006.220; Goda Y, 2003, NEURON, V40, P243, DOI 10.1016/S0896-6273(03)00608-1; Gordon MD, 2006, J BIOL CHEM, V281, P22429, DOI 10.1074/jbc.R600015200; Guan QH, 2006, NEUROSCIENCE, V139, P609, DOI 10.1016/j.neuroscience.2005.11.067; Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3; Inestrosa NC, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-9; Kennedy MJ, 2006, ANNU REV NEUROSCI, V29, P325, DOI 10.1146/annurev.neuro.29.051605.112808; Kennedy MB, 2005, NAT REV NEUROSCI, V6, P423, DOI 10.1038/nrn1685; Kim MJ, 2007, NEURON, V56, P488, DOI 10.1016/j.neuron.2007.09.007; Kuriu T, 2006, J NEUROSCI, V26, P7693, DOI 10.1523/JNEUROSCI.0522-06.2006; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; Li Z, 2003, NAT REV MOL CELL BIO, V4, P833, DOI 10.1038/nrm1242; Lie DC, 2005, NATURE, V437, P1370, DOI 10.1038/nature04108; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; McAllister AM, 2007, ANNU REV NEUROSCI, V30, P425, DOI 10.1146/annurev.neuro.29.051605.112830; McGee AW, 2001, J NEUROSCI, V21, P3085, DOI 10.1523/JNEUROSCI.21-09-03085.2001; Miech C, 2008, J NEUROSCI, V28, P10875, DOI 10.1523/JNEUROSCI.0164-08.2008; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Montcouquiol M, 2006, ANNU REV NEUROSCI, V29, P363, DOI 10.1146/annurev.neuro.29.051605.112933; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Patapoutian A, 2000, CURR OPIN NEUROBIOL, V10, P392, DOI 10.1016/S0959-4388(00)00100-8; Petralia RS, 2005, MOL CELL NEUROSCI, V29, P436, DOI 10.1016/j.mcn.2005.03.013; Rattner A, 1997, P NATL ACAD SCI USA, V94, P2859, DOI 10.1073/pnas.94.7.2859; Roselli F, 2005, J NEUROSCI, V25, P11061, DOI 10.1523/JNEUROSCI.3034-05.2005; Rosso SB, 2005, NAT NEUROSCI, V8, P34, DOI 10.1038/nn1374; Safholm A, 2006, J BIOL CHEM, V281, P2740, DOI 10.1074/jbc.M508386200; Salinas PC, 2008, ANNU REV NEUROSCI, V31, P339, DOI 10.1146/annurev.neuro.31.060407.125649; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shimogori T, 2004, J COMP NEUROL, V473, P496, DOI 10.1002/cne.20135; Speese SD, 2007, TRENDS NEUROSCI, V30, P268, DOI 10.1016/j.tins.2007.04.003; Stein V, 2003, J NEUROSCI, V23, P5503; Tang SJ, 2007, SYNAPSE, V61, P866, DOI 10.1002/syn.20434; Waites CL, 2005, ANNU REV NEUROSCI, V28, P251, DOI 10.1146/annurev.neuro.27.070203.144336; Zhang Y, 2006, CHEM BIOL, V13, P1001, DOI 10.1016/j.chembiol.2006.07.010	54	160	166	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15857	15866		10.1074/jbc.M808986200	http://dx.doi.org/10.1074/jbc.M808986200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19332546	Green Published, hybrid			2022-12-27	WOS:000266501000054
J	Keogh, MR; Courtney, PD; Kinney, AJ; Dewey, RE				Keogh, Matthew R.; Courtney, Polly D.; Kinney, Anthony J.; Dewey, Ralph E.			Functional Characterization of Phospholipid N-Methyltransferases from Arabidopsis and Soybean	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLETHANOLAMINE METHYLATION PATHWAY; PHOSPHATIDYLCHOLINE SYNTHESIS; SACCHAROMYCES-CEREVISIAE; INOSITOL SYNTHESIS; YEAST; CHOLINE; GENE; BIOSYNTHESIS; LEAVES; DNA	Phospholipid N-methyltransferase (PLMT) enzymes catalyze the S-adenosylmethionine-dependent methylation of ethanolamine-containing phospholipids to produce the abundant membrane lipid phosphatidylcholine (PtdCho). In mammals and yeast, PLMT activities are required for the de novo synthesis of the choline headgroup found in PtdCho. PLMT enzyme activities have also been reported in plants, yet their roles in PtdCho biosynthesis are less clear because most plants can produce the choline headgroup entirely via soluble substrates, initiated by the methylation of free ethanolamine-phosphate. To gain further insights into the function of PLMT enzymes in plants, we isolated PLMT cDNAs from Arabidopsis and soybean (Glycine max) based upon primary amino acid sequence homology to the rat PLMT, phosphatidylethanolamine N-methyltransferase. Using a heterologous yeast expression system, it was shown that plant PLMTs methylate phosphatidylmonomethylethanolamine and phosphatidyldimethylethanolamine but cannot utilize phosphatidylethanolamine as a substrate. Identification of an Arabidopsis line containing a knock-out dissociator transposon insertion within the single copy AtPLMT gene allowed us to investigate the consequences of loss of PLMT function. Although the accumulation of the PLMT substrates phosphatidylmonomethylethanolamine and phosphatidyldimethylethanolamine was considerably elevated in the atplmt knock-out line, PtdCho levels remained normal, and no obvious differences were observed in plant morphology or development under standard growth conditions. However, because the metabolic routes through which PtdCho is synthesized in plants vary greatly among differing species, it is predicted that the degree with which PtdCho synthesis is dependent upon PLMT activities will also vary widely throughout the plant kingdom.	[Courtney, Polly D.; Dewey, Ralph E.] N Carolina State Univ, Dept Crop Sci, Raleigh, NC 27695 USA; [Keogh, Matthew R.] N Carolina State Univ, Dept Plant Biol, Raleigh, NC 27695 USA; [Kinney, Anthony J.] DuPont Co Inc, Expt Stn, Crop Genet Res, Wilmington, DE 19880 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; DuPont	Keogh, MR (corresponding author), N Carolina State Univ, Dept Crop Sci, Campus Box 8009, Raleigh, NC 27695 USA.	ralph_dewey@ncsu.edu		Dewey, Ralph/0000-0003-1924-3777	National Science Foundation [9513582]; United States Department of Agriculture Cooperative State Research, Education, and Extension Service [2001-52101-11507]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016475] Funding Source: NIH RePORTER; Direct For Biological Sciences [0920663] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture Cooperative State Research, Education, and Extension Service(United States Department of Agriculture (USDA)National Institute of Food and Agriculture); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by National Science Foundation Grant IBN-9513582 and the Initiative for Future Agriculture and Food Systems Grant 2001-52101-11507 from the United States Department of Agriculture Cooperative State Research, Education, and Extension Service.	Bates PD, 2007, J BIOL CHEM, V282, P31206, DOI 10.1074/jbc.M705447200; BECKER DM, 1991, P NATL ACAD SCI USA, V88, P1968, DOI 10.1073/pnas.88.5.1968; Bolognese CP, 2000, PLANT PHYSIOL, V124, P1800, DOI 10.1104/pp.124.4.1800; Boumann HA, 2004, J BIOL CHEM, V279, P40314, DOI 10.1074/jbc.M406517200; BROWSE J, 1986, BIOCHEM J, V235, P25, DOI 10.1042/bj2350025; CARMAN GM, 1989, ANNU REV BIOCHEM, V58, P635, DOI 10.1146/annurev.biochem.58.1.635; Cruz-Ramirez A, 2004, PLANT CELL, V16, P2020, DOI 10.1105/tpc.103.018648; DATKO AH, 1988, PLANT PHYSIOL, V88, P854, DOI 10.1104/pp.88.3.854; DATKO AH, 1988, PLANT PHYSIOL, V88, P1338, DOI 10.1104/pp.88.4.1338; DeLong CJ, 1999, J BIOL CHEM, V274, P29683, DOI 10.1074/jbc.274.42.29683; DEWEY RE, 1994, PLANT CELL, V6, P1495, DOI 10.1105/tpc.6.10.1495; EDWARDS K, 1991, NUCLEIC ACIDS RES, V19, P1349, DOI 10.1093/nar/19.6.1349; GAYNOR PM, 1991, BIOCHIM BIOPHYS ACTA, V1090, P326, DOI 10.1016/0167-4781(91)90197-T; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Goode JH, 1999, PLANT PHYSIOL BIOCH, V37, P445, DOI 10.1016/S0981-9428(99)80049-7; Guthrie C, 1991, GUIDE YEAST GENETICS; HANSON AD, 1982, PLANT PHYSIOL, V70, P1191, DOI 10.1104/pp.70.4.1191; HITZ WD, 1981, PLANT PHYSIOL, V68, P814, DOI 10.1104/pp.68.4.814; Kanipes MI, 1997, BBA-LIPID LIPID MET, V1348, P134, DOI 10.1016/S0005-2760(97)00121-5; Kinney Anthony J., 1993, P259; KODAKI T, 1987, J BIOL CHEM, V262, P15428; MARSHALL MO, 1973, FEBS LETT, V31, P199, DOI 10.1016/0014-5793(73)80102-4; Martienssen RA, 1998, P NATL ACAD SCI USA, V95, P2021, DOI 10.1073/pnas.95.5.2021; MCGRAW P, 1989, GENETICS, V122, P317; McNeil SD, 2000, PLANT PHYSIOL, V123, P371, DOI 10.1104/pp.123.1.371; Meijer HJG, 2003, ANNU REV PLANT BIOL, V54, P265, DOI 10.1146/annurev.arplant.54.031902.134748; Mou ZL, 2002, PLANT CELL, V14, P2031, DOI 10.1105/tpc.001701; MUDD SH, 1986, PLANT PHYSIOL, V82, P126, DOI 10.1104/pp.82.1.126; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nuccio ML, 2000, J BIOL CHEM, V275, P14095, DOI 10.1074/jbc.275.19.14095; RIDGWAY ND, 1987, J BIOL CHEM, V262, P17231; Rontein D, 2002, METAB ENG, V4, P49, DOI 10.1006/mben.2001.0208; Sambrook J., 2001, MOL CLONING LAB MANU; Shields DJ, 2003, J BIOL CHEM, V278, P35826, DOI 10.1074/jbc.M306308200; SIKORSKI RS, 1989, GENETICS, V122, P19; SUMMERS EF, 1988, GENETICS, V120, P909; Tang GQ, 2005, PLANT J, V44, P433, DOI 10.1111/j.1365-313X.2005.02535.x; VANCE DE, 1996, BIOCH LIPIDS LIPOPRO, P153; WANG XM, 1990, PLANT PHYSIOL, V93, P250, DOI 10.1104/pp.93.1.250; Watkins SM, 2003, J NUTR, V133, P3386, DOI 10.1093/jn/133.11.3386; Welti R, 2002, J BIOL CHEM, V277, P31994, DOI 10.1074/jbc.M205375200; WILLIAMS M, 1994, BIOCHEM J, V304, P463, DOI 10.1042/bj3040463; Zeisel SH, 2007, IUBMB LIFE, V59, P380, DOI 10.1080/15216540701468954; Zhu XN, 2003, BIOCHEM J, V370, P987, DOI 10.1042/BJ20021523	44	37	40	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15439	15447		10.1074/jbc.M109.005991	http://dx.doi.org/10.1074/jbc.M109.005991			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19366698	hybrid, Green Published			2022-12-27	WOS:000266501000012
J	Rawlinson, SM; Pryor, MJ; Wright, PJ; Jans, DA				Rawlinson, Stephen M.; Pryor, Melinda J.; Wright, Peter J.; Jans, David A.			CRM1-mediated Nuclear Export of Dengue Virus RNA Polymerase NS5 Modulates Interleukin-8 Induction and Virus Production	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORE PROTEIN; IN-VITRO; LOCALIZATION SEQUENCE; IMPORTIN BETA-1; VIRAL HELICASE; CK2 SITE; SIGNALS; TRANSPORT; IDENTIFICATION; REPLICATION	Although all established functions of dengue virus NS5 (nonstructural protein 5) occur in the cytoplasm, its nuclear localization, mediated by dual nuclear localization sequences, is essential for virus replication. Here, we have determined the mechanism by which NS5 can localize in the cytoplasm to perform its role in replication, establishing for the first time that it is able to be exported from the nucleus by the exportin CRM1 and hence can shuttle between the nucleus and cytoplasm. We define the nuclear export sequence responsible to be residues 327-343 and confirm interaction of NS5 and CRM1 by pull-down assay. Significantly, greater nuclear accumulation of NS5 during infection due to CRM1 inhibition coincided with altered kinetics of virus production and decreased induction of the antiviral chemokine interleukin-8. This is the first report of a nuclear export sequence within NS5 for any member of the Flavivirus genus; because of its high conservation within the genus, it may represent a target for the treatment of diseases caused by several medically important flaviviruses.	[Rawlinson, Stephen M.; Pryor, Melinda J.; Jans, David A.] Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia; [Wright, Peter J.] Monash Univ, Dept Microbiol, Clayton, Vic 3800, Australia	Monash University; Monash University	Jans, DA (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton, Vic 3800, Australia.	david.jans@med.monash.edu.au		Rawlinson, Stephen/0000-0003-2602-7650; Jans, David/0000-0001-5115-4745	National Health and Medical Research Council Fellowship (Australia) [384109]	National Health and Medical Research Council Fellowship (Australia)(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by National Health and Medical Research Council Fellowship 384109 (Australia).	Ackermann M, 2001, J BIOL CHEM, V276, P39926, DOI 10.1074/jbc.M104248200; Alvisi G, 2008, BBA-PROTEINS PROTEOM, V1784, P213, DOI 10.1016/j.bbapap.2007.08.021; BARTHOLOMEUSZ AI, 1993, ARCH VIROL, V128, P111, DOI 10.1007/BF01309792; Begitt A, 2000, P NATL ACAD SCI USA, V97, P10418, DOI 10.1073/pnas.190318397; Brooks AJ, 2002, J BIOL CHEM, V277, P36399, DOI 10.1074/jbc.M204977200; BULICH R, 1992, J GEN VIROL, V73, P2999, DOI 10.1099/0022-1317-73-11-2999; CHU PWG, 1992, ARCH VIROL, V125, P177, DOI 10.1007/BF01309636; Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; Fornerod M, 1997, CELL, V90, P1051, DOI 10.1016/S0092-8674(00)80371-2; Forwood JK, 1999, BIOCHEM BIOPH RES CO, V257, P731, DOI 10.1006/bbrc.1999.0370; Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3; Ghildyal R, 2005, BIOCHEMISTRY-US, V44, P12887, DOI 10.1021/bi050701e; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Gualano RC, 1998, J GEN VIROL, V79, P437, DOI 10.1099/0022-1317-79-3-437; Gubler DJ, 2002, ARCH MED RES, V33, P330, DOI 10.1016/S0188-4409(02)00378-8; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Hubner S, 1997, J BIOL CHEM, V272, P17191, DOI 10.1074/jbc.272.27.17191; Johansson M, 2001, J GEN VIROL, V82, P735, DOI 10.1099/0022-1317-82-4-735; KAPOOR M, 1995, J BIOL CHEM, V270, P19100, DOI 10.1074/jbc.270.32.19100; Koo BCA, 2006, J VIROL, V80, P7885, DOI 10.1128/JVI.00519-06; KOONIN EV, 1991, J GEN VIROL, V72, P2197, DOI 10.1099/0022-1317-72-9-2197; KOONIN EV, 1993, J GEN VIROL, V74, P733, DOI 10.1099/0022-1317-74-4-733; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Kudo N, 1998, EXP CELL RES, V242, P540, DOI 10.1006/excr.1998.4136; Kutay U, 2005, TRENDS CELL BIOL, V15, P121, DOI 10.1016/j.tcb.2005.01.005; la Cour T, 2004, PROTEIN ENG DES SEL, V17, P527, DOI 10.1093/protein/gzh062; la Cour T, 2003, NUCLEIC ACIDS RES, V31, P393, DOI 10.1093/nar/gkg101; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lindenbach B.D., 2001, FLAVIVIRIDAE VIRUSES; Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001; MacKenzie JM, 2001, J VIROL, V75, P10787, DOI 10.1128/JVI.75.22.10787-10799.2001; MAKINO Y, 1989, J GEN VIROL, V70, P1417, DOI 10.1099/0022-1317-70-6-1417; Medin CL, 2005, J VIROL, V79, P11053, DOI 10.1128/JVI.79.17.11053-11061.2005; Mosammaparast N, 2004, TRENDS CELL BIOL, V14, P547, DOI 10.1016/j.tcb.2004.09.004; Moseley GW, 2007, BIOCHEMISTRY-US, V46, P12053, DOI 10.1021/bi700521m; Murai N, 2003, J BIOL CHEM, V278, P44791, DOI 10.1074/jbc.M308059200; NISHI K, 1994, J BIOL CHEM, V269, P6320; Poon IH, 2005, CANCER RES, V65, P7059, DOI 10.1158/0008-5472.CAN-05-1370; Poon IKH, 2005, TRAFFIC, V6, P173, DOI 10.1111/j.1600-0854.2005.00268.x; Pryor MJ, 2007, TRAFFIC, V8, P795, DOI 10.1111/j.1600-0854.2007.00579.x; Pryor MJ, 2001, AM J TROP MED HYG, V65, P427, DOI 10.4269/ajtmh.2001.65.427; Remick DG, 2005, CRIT CARE MED, V33, pS466, DOI 10.1097/01.CCM.0000186783.34908.18; Scheifele LZ, 2005, J VIROL, V79, P8732, DOI 10.1128/JVI.79.14.8732-8741.2005; Sherman MP, 2001, J VIROL, V75, P1522, DOI 10.1128/JVI.75.3.1522-1532.2001; Strunze S, 2005, MOL BIOL CELL, V16, P2999, DOI 10.1091/mbc.E05-02-0121; TADANO M, 1989, J GEN VIROL, V70, P1409, DOI 10.1099/0022-1317-70-6-1409; Tan BH, 1996, VIROLOGY, V216, P317, DOI 10.1006/viro.1996.0067; Uchil PD, 2003, VIROLOGY, V307, P358, DOI 10.1016/S0042-6822(02)00130-7; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Xiao CY, 1997, J BIOL CHEM, V272, P22191, DOI 10.1074/jbc.272.35.22191	51	87	118	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15589	15597		10.1074/jbc.M808271200	http://dx.doi.org/10.1074/jbc.M808271200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19297323	hybrid, Green Published			2022-12-27	WOS:000266501000027
J	Shiraiwa, Y; Ikushiro, H; Hayashi, H				Shiraiwa, Yuka; Ikushiro, Hiroko; Hayashi, Hideyuki			Multifunctional Role of His(159) in the Catalytic Reaction of Serine Palmitoyltransferase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PYRIDOXAL-5'-PHOSPHATE-DEPENDENT ENZYMES; 8-AMINO-7-OXONONANOATE SYNTHASE; CRYSTAL-STRUCTURE; COA; BIOSYNTHESIS; VITAMIN-B-6; MECHANISMS; EVOLUTION	Serine palmitoyltransferase (SPT) belongs to the fold type I family of the pyridoxal 5'-phosphate (PLP)-dependent enzyme and forms 3-ketodihydrosphingosine (KDS) from L-serine and palmitoyl-CoA. Like other alpha-oxamine synthase subfamily enzymes, SPT is different from most of the fold type I enzymes in that its re face of the PLP-Lys aldimine is occupied by a His residue (His(159)) instead of an aromatic amino acid residue. His(159) was changed into alanine or aromatic amino acid residues to examine its role during catalysis. All mutant SPTs formed the PLP-L-serine aldimine with dissociation constants several 10-fold higher than that of the wild type SPT and catalyzed the abortive transamination of L-serine. These results indicate that His(159) is not only the anchoring site for L-serine but regulates the alpha-deprotonation of L-serine by fixing the conformation of the PLP-L-serine aldimine to prevent unwanted side reactions. Only H159A SPT retained activity and showed a prominent 505-nm absorption band of the quinonoid species during catalysis. Global analysis of the time-resolved spectra suggested the presence of the two quinonoid intermediates, the first formed from the PLP-L-serine aldimine and the second from the PLP-KDS aldimine. Accumulation of these quinonoid intermediates indicated that His(159) promotes both the Claisen-type condensation as an acid catalyst and the protonation at C alpha of the second quinonoid to form the PLP-KDS aldimine. These results, combined with the previous model building study (Ikushiro, H., Fujii, S., Shiraiwa, Y., and Hayashi, H. (2008) J. Biol. Chem. 283, 7542-7553), lead us to propose a novel mechanism, in which His(159) plays multiple roles by exploiting the stereochemistry of Dunathan's conjecture.	[Shiraiwa, Yuka; Ikushiro, Hiroko; Hayashi, Hideyuki] Osaka Med Coll, Dept Biochem, Takatsuki, Osaka 5698686, Japan	Osaka Medical College	Ikushiro, H (corresponding author), 2-7 Daigakumachi, Takatsuki, Osaka 5698686, Japan.	ikushiro@art.osaka-med.ac.jp; hayashi@art.osaka-med.ac.jp			Japan Society for the Promotion of Science [21570120, 21570149]; Osaka Medical Research Foundation for Incurable Diseases	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Osaka Medical Research Foundation for Incurable Diseases	This work was supported in part by Grants-in-Aid for Scientific Research 21570120 (to H. H.) and 21570149 (to H. I.) from the Japan Society for the Promotion of Science and a grant from the Osaka Medical Research Foundation for Incurable Diseases (to H. I.).	Alexeev D, 1998, J MOL BIOL, V284, P401, DOI 10.1006/jmbi.1998.2086; Astner I, 2005, EMBO J, V24, P3166, DOI 10.1038/sj.emboj.7600792; Eliot AC, 2004, ANNU REV BIOCHEM, V73, P383, DOI 10.1146/annurev.biochem.73.011303.074021; HADENER A, 1990, BIOCHEM J, V271, P487; Hanada K, 2003, BBA-MOL CELL BIOL L, V1632, P16, DOI 10.1016/S1388-1981(03)00059-3; HAYASHI H, 1995, J BIOCHEM-TOKYO, V118, P463, DOI 10.1093/oxfordjournals.jbchem.a124931; HAYASHI H, 1993, BIOCHEMISTRY-US, V32, P812, DOI 10.1021/bi00054a011; Hunter GA, 1999, BIOCHEMISTRY-US, V38, P3711, DOI 10.1021/bi982390w; Hunter GA, 2007, J BIOL CHEM, V282, P23025, DOI 10.1074/jbc.M609330200; Ikushiro H, 2004, BIOCHEMISTRY-US, V43, P1082, DOI 10.1021/bi035706v; Ikushiro H, 2001, J BIOL CHEM, V276, P18249, DOI 10.1074/jbc.M101550200; Ikushiro H, 2008, J BIOL CHEM, V283, P7542, DOI 10.1074/jbc.M706874200; Mehta PK, 2000, ADV ENZYMOL RAMB, V74, P129; ONUFFER JJ, 1994, PROTEIN ENG, V7, P413, DOI 10.1093/protein/7.3.413; Salzmann D, 2000, BIOCHEM BIOPH RES CO, V270, P576, DOI 10.1006/bbrc.2000.2460; Schmidt A, 2001, BIOCHEMISTRY-US, V40, P5151, DOI 10.1021/bi002204y; Schneider G, 2000, STRUCT FOLD DES, V8, pR1, DOI 10.1016/S0969-2126(00)00085-X; Valls F, 2001, J AGR FOOD CHEM, V49, P38, DOI 10.1021/jf0003202; Webster SP, 2000, BIOCHEMISTRY-US, V39, P516, DOI 10.1021/bi991620j; Yard BA, 2007, J MOL BIOL, V370, P870, DOI 10.1016/j.jmb.2007.04.086	20	14	16	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15487	15495		10.1074/jbc.M808916200	http://dx.doi.org/10.1074/jbc.M808916200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19346561	Green Published, hybrid			2022-12-27	WOS:000266501000017
J	Kurella, VB; Richard, JM; Parke, CL; LeCour, LF; Bellamy, HD; Worthylake, DK				Kurella, Vinodh B.; Richard, Jessica M.; Parke, Courtney L.; LeCour, Louis F., Jr.; Bellamy, Henry D.; Worthylake, David K.			Crystal Structure of the GTPase-activating Protein-related Domain from IQGAP1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IDENTIFICATION; COMPLEX; BINDING; RASGAP; ALIGNMENT; CDC42; GAP; OVEREXPRESSION; STIMULATION; ASSOCIATION	IQGAP1 is a 190-kDa molecular scaffold containing several domains required for interaction with numerous proteins. One domain is homologous to Ras GTPase-activating protein (GAP) domains. However, instead of accelerating hydrolysis of bound GTP on Ras IQGAP1, using its GAP-related domain (GRD) binds to Cdc42 and Rac1 and stabilizes their GTP-bound states. We report here the crystal structure of the isolated IQGAP1 GRD. Despite low sequence conservation, the overall structure of the GRD is very similar to the GAP domains from p120 RasGAP, neurofibromin, and SynGAP. However, instead of the catalytic "arginine finger" seen in functional Ras GAPs, the GRD has a conserved threonine residue. GRD residues 1099-1129 have no structural equivalent in RasGAP and are seen to form an extension at one end of the molecule. Because the sequence of these residues is highly conserved, this region likely confers a functionality particular to IQGAP family GRDs. We have used isothermal titration calorimetry to demonstrate that the isolated GRD binds to active Cdc42. Assuming a mode of interaction similar to that displayed in the Ras-RasGAP complex, we created an energy-minimized model of Cdc42 center dot GTP bound to the GRD. Residues of the GRD that contact Cdc42 map to the surface of the GRD that displays the highest level of sequence conservation. The model indicates that steric clash between threonine 1046 with the phosphate-binding loop and other subtle changes would likely disrupt the proper geometry required for GTP hydrolysis.	[Worthylake, David K.] Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, New Orleans, LA 70112 USA; [Bellamy, Henry D.] Louisiana State Univ, Ctr Adv Microstruct & Devices, Baton Rouge, LA 70806 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University	Worthylake, DK (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, 1901 Perdido St, New Orleans, LA 70112 USA.	dworth@lsuhsc.edu						Ahmadian MR, 1996, J BIOL CHEM, V271, P16409, DOI 10.1074/jbc.271.27.16409; Ahmadian MR, 1999, P NATL ACAD SCI USA, V96, P7065, DOI 10.1073/pnas.96.12.7065; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Barrett T, 1997, NATURE, V385, P458, DOI 10.1038/385458a0; Bax B, 1998, NATURE, V392, P447, DOI 10.1038/33040; BROWNBRIDGE GG, 1993, J BIOL CHEM, V268, P10914; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Dong PX, 2006, CANCER LETT, V243, P120, DOI 10.1016/j.canlet.2005.11.024; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; GIDEON P, 1992, MOL CELL BIOL, V12, P2050, DOI 10.1128/MCB.12.5.2050; Hart MJ, 1996, EMBO J, V15, P2997, DOI 10.1002/j.1460-2075.1996.tb00663.x; Jadeski L, 2008, J BIOL CHEM, V283, P1008, DOI 10.1074/jbc.M708466200; JOHN J, 1990, BIOCHEMISTRY-US, V29, P6058, DOI 10.1021/bi00477a025; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Ko N, 2007, MOL BIOL CELL, V18, P5139, DOI 10.1091/mbc.E07-05-0509; Kuroda S, 1998, SCIENCE, V281, P832, DOI 10.1126/science.281.5378.832; LEVITT M, 1988, J MOL BIOL, V201, P751, DOI 10.1016/0022-2836(88)90471-8; Maegley KA, 1996, P NATL ACAD SCI USA, V93, P8160, DOI 10.1073/pnas.93.16.8160; Mataraza JM, 2003, J BIOL CHEM, V278, P41237, DOI 10.1074/jbc.M304838200; Mataraza JM, 2003, BIOCHEM BIOPH RES CO, V305, P315, DOI 10.1016/S0006-291X(03)00759-9; Mbele GO, 2002, J BIOL CHEM, V277, P49998, DOI 10.1074/jbc.M205363200; Morris LE, 2005, GENE CHROMOSOME CANC, V42, P280, DOI 10.1002/gcc.20150; Musacchio A, 1996, P NATL ACAD SCI USA, V93, P14373, DOI 10.1073/pnas.93.25.14373; Nabeshima K, 2002, CANCER LETT, V176, P101, DOI 10.1016/S0304-3835(01)00742-X; NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407; Owen D, 2008, J BIOL CHEM, V283, P1692, DOI 10.1074/jbc.M707257200; Pena V, 2008, EMBO REP, V9, P350, DOI 10.1038/embor.2008.20; Rittinger K, 1997, NATURE, V389, P758, DOI 10.1038/39651; Rittinger K, 1997, NATURE, V388, P693, DOI 10.1038/41805; Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333; Scheffzek K, 1996, NATURE, V384, P591, DOI 10.1038/384591a0; Scheffzek K, 1998, EMBO J, V17, P4313, DOI 10.1093/emboj/17.15.4313; Scheffzek K, 2005, CELL MOL LIFE SCI, V62, P3014, DOI 10.1007/s00018-005-5136-x; Schmidt VA, 2008, MOL CELL BIOL, V28, P1489, DOI 10.1128/MCB.01090-07; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; SKINNER RH, 1991, J BIOL CHEM, V266, P14163; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Sun WY, 2004, CANCER LETT, V212, P83, DOI 10.1016/j.canlet.2004.03.023; Swart-Mataraza JM, 2002, J BIOL CHEM, V277, P24753, DOI 10.1074/jbc.M111165200; Weissbach L, 1998, BIOCHEM BIOPH RES CO, V251, P269, DOI 10.1006/bbrc.1998.9371; WEISSBACH L, 1994, J BIOL CHEM, V269, P20517	46	43	44	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					14857	14865		10.1074/jbc.M808974200	http://dx.doi.org/10.1074/jbc.M808974200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19321438	Green Published, hybrid			2022-12-27	WOS:000266288200021
J	Nishimichi, N; Higashikawa, F; Kinoh, HH; Tateishi, Y; Matsuda, H; Yokosaki, Y				Nishimichi, Norihisa; Higashikawa, Fumiko; Kinoh, Hiromi H.; Tateishi, Yoshiko; Matsuda, Haruo; Yokosaki, Yasuyuki			Polymeric Osteopontin Employs Integrin alpha 9 beta 1 as a Receptor and Attracts Neutrophils by Presenting a de Novo Binding Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TISSUE TRANSGLUTAMINASE; FACTOR-XIII; III REPEAT; CELL; ALPHA(9)BETA(1); TENASCIN; INFILTRATION; INFLAMMATION; SUBSTRATE; MIGRATION	Osteopontin (OPN) is a cytokine and ligand for multiple members of the integrin family. OPN undergoes the in vivo polymerization catalyzed by cross-linking enzyme transglutaminase 2, which consequently increases the bioactivity through enhanced interaction with integrins. The integrin alpha 9 beta 1, highly expressed on neutrophils, binds to the sequence SVVYGLR only after intact OPN is cleaved by thrombin. The SVVYGLR sequence appears to be cryptic in intact OPN because alpha 9 beta 1 does not recognize intact OPN. Because transglutaminase 2-catalyzed polymers change their physical and chemical properties, we hypothesized that the SVVYGLR site might also be exposed on polymeric OPN. As expected, alpha 9 beta 1 turned into a receptor for polymeric OPN, a result obtained by cell adhesion and migration assays with alpha 9-transfected cells and by detection of direct binding of recombinant soluble alpha 9 beta 1 with colorimetry and surface plasmon resonance analysis. Because the N-terminal fragment of thrombincleaved OPN, a ligand for alpha 9 beta 1, has been reported to attract neutrophils, we next examined migration of neutrophils to polymeric OPN using time-lapse microscopy. Polymeric OPN showed potent neutrophil chemotactic activity, which was clearly inhibited by anti-alpha 9 beta 1 antibody. Unexpectedly, mutagenesis studies showed that alpha 9 beta 1 bound to polymeric OPN independently of the SVVYGLR sequence, and further, SVVYGLR sequence of polymeric OPN was cryptic because SVVYGLR-specific antibody did not recognize polymeric OPN. These results demonstrate that polymerization of OPN generates a novel alpha 9 beta 1-binding site and that the interaction of this site with the alpha 9 beta 1 integrin is critical to the neutrophil chemotaxis induced by polymeric OPN.	[Higashikawa, Fumiko; Kinoh, Hiromi H.; Yokosaki, Yasuyuki] Hiroshima Univ, Biomed Res Unit, Cell Matrix Frontier Lab, Minami Ku, Hiroshima 7348551, Japan; Hiroshima Univ, Grad Sch Biosphere Sci, Dept Biochem & Appl Mol Biosci, Immunobiol Lab, Higashihiroshima 7398528, Japan; [Yokosaki, Yasuyuki] Hiroshima Univ, Hlth Adm Ctr, Higashihiroshima 7398521, Japan	Hiroshima University; Hiroshima University; Immuno-Biological Laboratories Co. Ltd.; Hiroshima University	Yokosaki, Y (corresponding author), Hiroshima Univ, Biomed Res Unit, Cell Matrix Frontier Lab, Minami Ku, Biomed Res Bldg 216,1-2-3 Kasumi, Hiroshima 7348551, Japan.	yokosaki@hiroshima-u.ac.jp			Japan New Energy and Industrial Technology Development Organization; Tsuchiya Memorial Medical Foundation	Japan New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); Tsuchiya Memorial Medical Foundation	This work was supported by a grant from the Japan New Energy and Industrial Technology Development Organization (to N. N., Y. T., H. M., and Y. Y., new functional antibody technologies) and by a grant from the Tsuchiya Memorial Medical Foundation (to Y. Y.).	Agnihotri R, 2001, J BIOL CHEM, V276, P28261, DOI 10.1074/jbc.M103608200; Apte UM, 2005, TOXICOL APPL PHARM, V207, P25, DOI 10.1016/j.taap.2004.12.018; Banerjee A, 2006, J PATHOL, V208, P473, DOI 10.1002/path.1917; Carrigan SO, 2007, J LEUKOCYTE BIOL, V82, P1575, DOI 10.1189/jlb.0806528; Denhardt DT, 2001, J CLIN INVEST, V107, P1055, DOI 10.1172/JCI12980; Diao HY, 2004, IMMUNITY, V21, P539, DOI 10.1016/j.immuni.2004.08.012; Higashikawa F, 2007, FEBS LETT, V581, P2697, DOI 10.1016/j.febslet.2007.05.018; Kaartinen MT, 2007, J HISTOCHEM CYTOCHEM, V55, P375, DOI 10.1369/jhc.6A7087.2006; Kaartinen MT, 2002, J BONE MINER RES, V17, P2161, DOI 10.1359/jbmr.2002.17.12.2161; Koh A, 2007, IMMUNOLOGY, V122, P466, DOI 10.1111/j.1365-2567.2007.02682.x; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; McAllister SS, 2008, CELL, V133, P994, DOI 10.1016/j.cell.2008.04.045; Nitta N, 2007, J IMMUNOL METHODS, V320, P155, DOI 10.1016/j.jim.2006.12.010; PRINCE CW, 1991, BIOCHEM BIOPH RES CO, V177, P1205, DOI 10.1016/0006-291X(91)90669-X; Sato Y, 2008, ATHEROSCLEROSIS, V200, P303, DOI 10.1016/j.atherosclerosis.2008.02.001; Scatena M, 2007, ARTERIOSCL THROM VAS, V27, P2302, DOI 10.1161/ATVBAHA.107.144824; SENGER DR, 1994, MOL BIOL CELL, V5, P565, DOI 10.1091/mbc.5.5.565; Smith LL, 1996, J BIOL CHEM, V271, P28485, DOI 10.1074/jbc.271.45.28485; Takahashi H, 2000, J BIOL CHEM, V275, P23589, DOI 10.1074/jbc.M003526200; Taooka Y, 1999, J CELL BIOL, V145, P413, DOI 10.1083/jcb.145.2.413; Wang A, 1996, AM J RESP CELL MOL, V15, P664, DOI 10.1165/ajrcmb.15.5.8918373; Yokosaki Y, 2005, MATRIX BIOL, V24, P418, DOI 10.1016/j.matbio.2005.05.005; YOKOSAKI Y, 1994, J BIOL CHEM, V269, P26691; Yokosaki Y, 1996, J BIOL CHEM, V271, P24144, DOI 10.1074/jbc.271.39.24144; Yokosaki Y, 1998, J BIOL CHEM, V273, P11423, DOI 10.1074/jbc.273.19.11423; Yokosaki Y, 1999, J BIOL CHEM, V274, P36328, DOI 10.1074/jbc.274.51.36328; Zemskov EA, 2006, FRONT BIOSCI-LANDMRK, V11, P1057, DOI 10.2741/1863	27	40	41	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					14769	14776		10.1074/jbc.M901515200	http://dx.doi.org/10.1074/jbc.M901515200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19346516	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000266288200012
J	Partch, CL; Card, PB; Amezcua, CA; Gardner, KH				Partch, Carrie L.; Card, Paul B.; Amezcua, Carlos A.; Gardner, Kevin H.			Molecular Basis of Coiled Coil Coactivator Recruitment by the Aryl Hydrocarbon Receptor Nuclear Translocator (ARNT)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAS-B DOMAIN; STRUCTURAL BASIS; GENE-EXPRESSION; CHEMICAL-SHIFT; DNA-BINDING; HYPOXIA; PROTEIN; DIOXIN; MOTIF; HETERODIMERIZATION	The aryl hydrocarbon receptor nuclear translocator ( ARNT) serves as the obligate heterodimeric partner for bHLH-PAS proteins involved in sensing and coordinating transcriptional responses to xenobiotics, hypoxia, and developmental pathways. Although its C-terminal transactivation domain is dispensable for transcriptional activation in vivo, ARNT has recently been shown to use its N-terminal bHLH and/or PAS domains to interact with several transcriptional coactivators that are required for transcriptional initiation after xenobiotic or hypoxic cues. Here we show that ARNT uses a single PAS domain to interact with two coiled coil coactivators, TRIP230 and CoCoA. Both coactivators interact with the same interface on the ARNT PAS-B domain, located on the opposite side of the domain used to associate with the analogous PAS domain on its heterodimeric bHLH-PAS partner HIF-2 alpha. Using NMR and biochemical studies, we identified the ARNT-interacting motif of one coactivator, TRIP230 as an LXXLL-like nuclear receptor box. Mutation of this motif and proximal sequences disrupts the interaction with ARNT PAS-B. Identification of this ARNT-coactivator interface illustrates how ARNT PAS-B is used to form critical interactions with both bHLH-PAS partners and coactivators that are required for transcriptional responses.	Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Gardner, Kevin H.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Gardner, KH (corresponding author), 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Kevin.Gardner@utsouthwestern.edu	Gardner, Kevin H./K-7802-2012; Gardner, Kevin/K-5493-2019	Gardner, Kevin H./0000-0002-8671-2556; 	National Institutes of Health [GM081875];  [CA130441]; NATIONAL CANCER INSTITUTE [F32CA130441] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081875] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM081875 (to K.H.G.) and CA130441 (to C.L.P.).	Andersson P, 2002, P NATL ACAD SCI USA, V99, P9990, DOI 10.1073/pnas.152706299; Beischlag TV, 2004, J BIOL CHEM, V279, P54620, DOI 10.1074/jbc.M410456200; Blommel PG, 2007, PROTEIN EXPRES PURIF, V55, P53, DOI 10.1016/j.pep.2007.04.013; Card PB, 2005, J MOL BIOL, V353, P664, DOI 10.1016/j.jmb.2005.08.043; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P533, DOI 10.1016/B978-012164491-8/50009-9; Chang CY, 1999, MOL CELL BIOL, V19, P8226; Chang KH, 1997, P NATL ACAD SCI USA, V94, P9040, DOI 10.1073/pnas.94.17.9040; Chapman-Smith A, 2006, J BIOL CHEM, V281, P12535, DOI 10.1074/jbc.M512145200; Chapman-Smith A, 2004, J BIOL CHEM, V279, P5353, DOI 10.1074/jbc.M310041200; Chen YH, 2005, MOL CELL BIOL, V25, P5965, DOI 10.1128/MCB.25.14.5965-5972.2005; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Crews ST, 1999, CURR OPIN GENET DEV, V9, P580, DOI 10.1016/S0959-437X(99)00003-9; Dayan F, 2006, CANCER RES, V66, P3688, DOI 10.1158/0008-5472.CAN-05-4564; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Erbel PJA, 2003, P NATL ACAD SCI USA, V100, P15504, DOI 10.1073/pnas.2533374100; Farmer BT, 1996, NAT STRUCT BIOL, V3, P995, DOI 10.1038/nsb1296-995; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; GRADDIS TJ, 1993, BIOCHEMISTRY-US, V32, P12664, DOI 10.1021/bi00210a015; Gu J, 2001, J BIOL CHEM, V276, P3550, DOI 10.1074/jbc.M009522200; Harper SM, 2003, SCIENCE, V301, P1541, DOI 10.1126/science.1086810; Heery DM, 1997, NATURE, V387, P733, DOI 10.1038/42750; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kewley RJ, 2004, INT J BIOCHEM CELL B, V36, P189, DOI 10.1016/S1357-2725(03)00211-5; Kim JH, 2004, J BIOL CHEM, V279, P49842, DOI 10.1074/jbc.M408535200; Kim JH, 2003, MOL CELL, V12, P1537, DOI 10.1016/S1097-2765(03)00450-7; Ko HSP, 1996, MOL CELL BIOL, V16, P430; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li H, 1996, J BIOL CHEM, V271, P21262, DOI 10.1074/jbc.271.35.21262; Lodrini M, 2008, NUCLEIC ACIDS RES, V36, P1847, DOI 10.1093/nar/gkn029; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; MA Q, 1995, J BIOL CHEM, V270, P12697, DOI 10.1074/jbc.270.21.12697; Marr MT, 2006, GENE DEV, V20, P1458, DOI 10.1101/gad.1418806; Maxwell PH, 1997, P NATL ACAD SCI USA, V94, P8104, DOI 10.1073/pnas.94.15.8104; McKenna NJ, 1998, P NATL ACAD SCI USA, V95, P11697, DOI 10.1073/pnas.95.20.11697; PASCAL SM, 1994, J MAGN RESON SER B, V103, P197, DOI 10.1006/jmrb.1994.1031; Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680; Razeto A, 2004, J MOL BIOL, V336, P319, DOI 10.1016/j.jmb.2003.12.057; Sadek CM, 2000, MECH DEVELOP, V97, P13, DOI 10.1016/S0925-4773(00)00415-9; Savkur RS, 2004, J PEPT RES, V63, P207, DOI 10.1111/j.1399-3011.2004.00126.x; Scheuermann TH, 2009, P NATL ACAD SCI USA, V106, P450, DOI 10.1073/pnas.0808092106; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Suzuki T, 2003, MOL CELL BIOL, V23, P238, DOI 10.1128/MCB.23.1.238-249.2003; Taylor BL, 1999, MICROBIOL MOL BIOL R, V63, P479, DOI 10.1128/MMBR.63.2.479-506.1999; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Yang JS, 2005, J BIOL CHEM, V280, P36047, DOI 10.1074/jbc.M501755200; Zelzer E, 1997, GENE DEV, V11, P2079, DOI 10.1101/gad.11.16.2079; Zwijsen RML, 1998, GENE DEV, V12, P3488, DOI 10.1101/gad.12.22.3488	49	27	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					15184	15192		10.1074/jbc.M808479200	http://dx.doi.org/10.1074/jbc.M808479200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19324882	Green Published, hybrid			2022-12-27	WOS:000266288200053
J	Resman, N; Vasl, J; Oblak, A; Pristovsek, P; Gioannini, TL; Weiss, JP; Jerala, R				Resman, Nusa; Vasl, Jozica; Oblak, Alja; Pristovsek, Primoz; Gioannini, Theresa L.; Weiss, Jerrold P.; Jerala, Roman			Essential Roles of Hydrophobic Residues in Both MD-2 and Toll-like Receptor 4 in Activation by Endotoxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRANDED-RNA; LIPID-IVA; LIPOPOLYSACCHARIDE RESPONSIVENESS; SIGNAL-TRANSDUCTION; TLR4-MD-2 COMPLEX; CRYSTAL-STRUCTURE; NMR SYSTEM; BINDING; TLR4; LPS	Gram-negative bacterial endotoxin (i.e. lipopolysaccharide (LPS)) is one of the most potent stimulants of the innate immune system, recognized by the TLR4.MD-2 complex. Direct binding to MD-2 of LPS and LPS analogues that act as TLR4 agonists or antagonists is well established, but the role of MD-2 and TLR4 in receptor activation is much less clear. We have identified residues within the hairpin of MD-2 between strands five and six that, although not contacting acyl chains of tetraacylated lipid IVa (a TLR4 antagonist), influence activation of TLR4 by hexaacylated lipid A. We show that hydrophobic residues at positions 82, 85, and 87 of MD-2 are essential both for transfer of endotoxin from CD14 to monomeric MD-2 and for TLR4 activation. We also identified a pair of conserved hydrophobic residues (Phe-440 and Phe-463) in leucine-rich repeats 16 and 17 of the TLR4 ectodomain, which are essential for activation of TLR4 by LPS. F440A or F463A mutants of TLR4 were inactive, whereas the F440W mutant retained full activity. Charge reversal of neighboring cationic groups in the TLR4 ectodomain (Lys-388 and Lys-435), in contrast, did not affect cell activation. Our mutagenesis studies are consistent with a molecular model in which Val-82, Met-85, and Leu-87 in MD-2 and distal portions of a secondary acyl chain of hexaacylated lipid A that do not fit into the hydrophobic binding pocket of MD-2 form a hydrophobic surface that interacts with Phe-440 and Phe-463 on a neighboring TLR4.MD-2.LPS complex, driving TLR4 activation.	[Resman, Nusa; Vasl, Jozica; Oblak, Alja; Pristovsek, Primoz; Jerala, Roman] Univ Ljubljana, Dept Biotechnol, Natl Inst Chem, Ljubljana 1000, Slovenia; [Jerala, Roman] Univ Ljubljana, Fac Chem & Chem Technol, Ljubljana 1000, Slovenia; [Gioannini, Theresa L.; Weiss, Jerrold P.] Univ Iowa, Inflammat Program, Dept Microbiol, Iowa City, IA 52242 USA; [Weiss, Jerrold P.] Univ Iowa, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Gioannini, Theresa L.] Vet Affairs Med Ctr, Iowa City, IA 52246 USA	National Institute of Chemistry - Slovenia; University of Ljubljana; University of Ljubljana; University of Iowa; University of Iowa; US Department of Veterans Affairs; Veterans Health Administration (VHA); Iowa City VA Health Care System	Jerala, R (corresponding author), Univ Ljubljana, Dept Biotechnol, Natl Inst Chem, Hajdrihova 19, Ljubljana 1000, Slovenia.	roman.jerala@ki.si	Jerala, Roman/H-9850-2015	Jerala, Roman/0000-0002-6337-5251; Pristovsek, Primoz/0000-0002-2304-1791; Weiss, Jerrold/0000-0003-1476-4485	National Institutes of Health [AI05732]; Slovenian research agency; Slovenian-United States of America; Veterans Affairs; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI059372] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Slovenian research agency(Slovenian Research Agency - Slovenia); Slovenian-United States of America; Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI05732 (NIAID, to J.W.). This work was also supported by grants from the Slovenian research agency, a bilateral Slovenian-United States of America collaborative grant, and by Veterans Affairs (to T. L. G.).	Akashi S, 2001, INT IMMUNOL, V13, P1595, DOI 10.1093/intimm/13.12.1595; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Gangloff M, 2004, TRENDS BIOCHEM SCI, V29, P294, DOI 10.1016/j.tibs.2004.04.008; Giardina PC, 2001, J BIOL CHEM, V276, P5883, DOI 10.1074/jbc.M009273200; Gioannini TL, 2007, J BIOL CHEM, V282, P7877, DOI 10.1074/jbc.M605031200; Gioannini TL, 2004, P NATL ACAD SCI USA, V101, P4186, DOI 10.1073/pnas.0306906101; Gruber A, 2004, J BIOL CHEM, V279, P28475, DOI 10.1074/jbc.M400993200; Hajjar AM, 2002, NAT IMMUNOL, V3, P354, DOI 10.1038/ni777; Jerala R, 2007, INT J MED MICROBIOL, V297, P353, DOI 10.1016/j.ijmm.2007.04.001; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kawasaki K, 2003, J IMMUNOL, V170, P413, DOI 10.4049/jimmunol.170.1.413; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Kobayashi M, 2006, J IMMUNOL, V176, P6211, DOI 10.4049/jimmunol.176.10.6211; Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; MEDZHITOV R, 1997, NATURE, V388, P397; Miyake K, 2004, SEMIN IMMUNOL, V16, P11, DOI 10.1016/j.smim.2003.10.007; Muroi M, 2006, J BIOL CHEM, V281, P5484, DOI 10.1074/jbc.M509193200; Nishitani C, 2006, J BIOL CHEM, V281, P38322, DOI 10.1074/jbc.M606904200; Nishitania C, 2005, BIOCHEM BIOPH RES CO, V328, P586, DOI 10.1016/j.bbrc.2005.01.021; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Palsson-McDermott EM, 2004, IMMUNOLOGY, V113, P153, DOI 10.1111/j.1365-2567.2004.01976.x; Park BS, 2009, NATURE IN PRESS; Pirher N, 2008, NAT STRUCT MOL BIOL, V15, P761, DOI 10.1038/nsmb.1453; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Prohinar P, 2007, J BIOL CHEM, V282, P1010, DOI 10.1074/jbc.M609400200; Rallabhandi P, 2006, J IMMUNOL, V177, P322, DOI 10.4049/jimmunol.177.1.322; Re F, 2003, J IMMUNOL, V171, P5272, DOI 10.4049/jimmunol.171.10.5272; Resman N, 2008, FEBS LETT, V582, P3929, DOI 10.1016/j.febslet.2008.10.037; Saitoh S, 2004, INT IMMUNOL, V16, P961, DOI 10.1093/intimm/dxh097; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Stover AG, 2004, J BIOL CHEM, V279, P4440, DOI 10.1074/jbc.M310760200; Tanamoto K, 2000, J IMMUNOL, V164, P3149, DOI 10.4049/jimmunol.164.6.3149; Teghanemt A, 2005, J IMMUNOL, V175, P4669, DOI 10.4049/jimmunol.175.7.4669; Teghanemt A, 2008, J BIOL CHEM, V283, P1257, DOI 10.1074/jbc.M705994200; Vasl J, 2008, J IMMUNOL, V180, P6107, DOI 10.4049/jimmunol.180.9.6107; Viriyakosol S, 2001, J BIOL CHEM, V276, P38044; Visintin A, 2003, J BIOL CHEM, V278, P48313, DOI 10.1074/jbc.M306802200; Walsh C, 2008, J IMMUNOL, V181, P1245, DOI 10.4049/jimmunol.181.2.1245; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311	43	86	96	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					15052	15060		10.1074/jbc.M901429200	http://dx.doi.org/10.1074/jbc.M901429200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19321453	Green Published, hybrid			2022-12-27	WOS:000266288200041
J	Ogawa, C; Usui, K; Ito, F; Itoh, M; Hayashizaki, Y; Suzuki, H				Ogawa, Chihiro; Usui, Kengo; Ito, Fuyu; Itoh, Masayoshi; Hayashizaki, Yoshihide; Suzuki, Harukazu			Role of Survival Motor Neuron Complex Components in Small Nuclear Ribonucleoprotein Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINAL MUSCULAR-ATROPHY; SMN COMPLEX; IN-VITRO; U SNRNPS; PROTEIN; IDENTIFICATION; GENE; BIOGENESIS; EXPRESSION; GEMIN8	Survival motor neuron (SMN) complex is essential for the biogenesis of the small nuclear ribonucleoprotein (snRNP) complex, although the complete role of each SMN complex component for the snRNP synthesis is largely unclear. We have identified an interaction between the two components Gemin2-Gemin7 using the mammalian two-hybrid system. In vitro stability assay revealed that the known SMN-Gemin7 interaction becomes stable in the presence of Gemin2 possibly via the identified Gemin2-Gemin7 interaction. Gemin7 knockdown revealed a decrease in snRNP assembly activity and a decrease in SmE protein, a component of snRNP, in the SMN complex, which was consistent with a previous discussion that the Gemin6-Gemin7 heterodimer may serve as a surrogate for the SmD3-SmB particle in forming a subcore, the intermediate complex for snRNP. Interestingly, we found that Unrip, but not Gemin8, can remove Gemin7 from the stable SMN-Gemin2-Gemin7 ternary complex. In an in vitro snRNP assembly assay using the Unrip knockdown and the untreated cell lysates, we revealed that there was a decrease in Gemin7 and increase in SmB/B' in the SMN complex observed in untreated cells during the assay, suggesting that the Gemin6-Gemin7 heterodimer in the subcore is exchanged by the SmD3-SmB particle to form snRNP. Surprisingly, these changes were not observed in the assay using the Unrip knockdown cell extracts, indicating the importance of Unrip in the formation of snRNP likely via removal of the Gemin6-Gemin7 from the SMN complex. Taken together, these results indicate that snRNP is synthesized by harmonization of the SMN complex components.	[Ogawa, Chihiro; Usui, Kengo; Ito, Fuyu; Itoh, Masayoshi; Hayashizaki, Yoshihide; Suzuki, Harukazu] RIKEN, Yokohama Inst, RIKEN Om Sci Ctr OSC, Tsurumi Ku, Kanagawa 2300045, Japan; [Usui, Kengo; Ito, Fuyu] Japan Sci & Technol Agcy, CREST, Kawaguchi, Saitama, Japan	RIKEN; Japan Science & Technology Agency (JST)	Suzuki, H (corresponding author), RIKEN, Yokohama Inst, RIKEN Om Sci Ctr OSC, Tsurumi Ku, 1-7-22 Suehiro Cho, Kanagawa 2300045, Japan.	rgscerg@gsc.riken.jp	Hayashizaki, Yoshihide/N-6590-2015; Itoh, Masayoshi/N-5363-2015; Suzuki, Harukazu/N-9553-2015; Usui, Kengo/A-7203-2016	Itoh, Masayoshi/0000-0002-1772-318X; Suzuki, Harukazu/0000-0002-8087-0836; 	CREST (Core Research for Evolutional Science and Technology) of the Japan Science and Technology Corporation (JST); Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government	CREST (Core Research for Evolutional Science and Technology) of the Japan Science and Technology Corporation (JST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from CREST (Core Research for Evolutional Science and Technology) of the Japan Science and Technology Corporation (JST) (to Y. H.) and a research grant for the RIKEN Omics Science Center from the Ministry of Education, Culture, Sports, Science and Technology of the Japanese Government (to Y. H.).	Baccon J, 2002, J BIOL CHEM, V277, P31957, DOI 10.1074/jbc.M203478200; Carissimi C, 2006, J BIOL CHEM, V281, P8126, DOI 10.1074/jbc.M512243200; Carissimi C, 2005, FEBS LETT, V579, P2348, DOI 10.1016/j.febslet.2005.03.034; Carissimi C, 2006, J BIOL CHEM, V281, P37009, DOI 10.1074/jbc.M607505200; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Chari A, 2008, CELL, V135, P497, DOI 10.1016/j.cell.2008.09.020; Feng WQ, 2005, HUM MOL GENET, V14, P1605, DOI 10.1093/hmg/ddi168; Grimmler M, 2005, HUM MOL GENET, V14, P3099, DOI 10.1093/hmg/ddi343; Gubitz AK, 2004, EXP CELL RES, V296, P51, DOI 10.1016/j.yexcr.2004.03.022; Jablonka S, 2002, P NATL ACAD SCI USA, V99, P10126, DOI 10.1073/pnas.152318699; LEFEBVRE S, 1995, CELL, V80, P155, DOI 10.1016/0092-8674(95)90460-3; Liu Q, 1997, CELL, V90, P1013, DOI 10.1016/S0092-8674(00)80367-0; Liu Q, 1996, EMBO J, V15, P3555, DOI 10.1002/j.1460-2075.1996.tb00725.x; Ma YL, 2005, STRUCTURE, V13, P883, DOI 10.1016/j.str.2005.03.014; Matera AG, 1998, AM J HUM GENET, V63, P317, DOI 10.1086/301992; Meister G, 2002, TRENDS CELL BIOL, V12, P472, DOI 10.1016/S0962-8924(02)02371-1; Narayanan U, 2004, MOL CELL, V16, P223, DOI 10.1016/j.molcel.2004.09.024; Ogawa C, 2007, J BIOL CHEM, V282, P11122, DOI 10.1074/jbc.M609297200; Otter S, 2007, J BIOL CHEM, V282, P5825, DOI 10.1074/jbc.M608528200; Paushkin S, 2002, CURR OPIN CELL BIOL, V14, P305, DOI 10.1016/S0955-0674(02)00332-0; Raker VA, 1996, EMBO J, V15, P2256, DOI 10.1002/j.1460-2075.1996.tb00579.x; Shpargel KB, 2005, P NATL ACAD SCI USA, V102, P17372, DOI 10.1073/pnas.0508947102; Suzuki H, 2001, GENOME RES, V11, P1758, DOI 10.1101/gr.180101; Suzuki H, 2004, BIOTECHNIQUES, V37, P918, DOI 10.2144/04376BM06; Will CL, 2001, CURR OPIN CELL BIOL, V13, P290, DOI 10.1016/S0955-0674(00)00211-8; Yong J, 2004, MOL CELL BIOL, V24, P2747, DOI 10.1128/MCB.24.7.2747-2756.2004; Yong JS, 2002, EMBO J, V21, P1188, DOI 10.1093/emboj/21.5.1188; ZERRES K, 1995, ARCH NEUROL-CHICAGO, V52, P518, DOI 10.1001/archneur.1995.00540290108025	28	21	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14609	14617		10.1074/jbc.M809031200	http://dx.doi.org/10.1074/jbc.M809031200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19321448	Green Published, hybrid			2022-12-27	WOS:000266286100066
J	Venkatachalam, K; Venkatesan, B; Valente, AJ; Melby, PC; Nandish, S; Reusch, JEB; Clark, RA; Chandrasekar, B				Venkatachalam, Kaliyamurthi; Venkatesan, Balachandar; Valente, Anthony J.; Melby, Peter C.; Nandish, Sailesh; Reusch, Jane E. B.; Clark, Robert A.; Chandrasekar, Bysani			WISP1, a Pro-mitogenic, Pro-survival Factor, Mediates Tumor Necrosis Factor-alpha (TNF-alpha)-stimulated Cardiac Fibroblast Proliferation but Inhibits TNF-alpha-induced Cardiomyocyte Death	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEIN; NF-KAPPA-B; TISSUE GROWTH-FACTOR; MYOCARDIAL-INFARCTION; INFLAMMATORY CYTOKINES; CREB PHOSPHORYLATION; SIGNAL-TRANSDUCTION; ACTIVATED PROTEIN; FACTOR-BETA; EXPRESSION	WNT1-inducible signaling pathway protein-1 (WISP1), a member of the CYR61/CTGF/Nov family of growth factors, can mediate cell growth, transformation, and survival. Previously we demonstrated that WISP1 is up-regulated in post-infarct heart, stimulates cardiac fibroblast proliferation, and is induced by the proinflammatory cytokine tumor necrosis factor-alpha (TNF-alpha). Here we investigated (i) the localization of TNF-alpha and WISP1 in post-infarct heart, (ii) the mechanism of TNF-alpha-mediated WISP1 induction in primary human cardiac fibroblasts (CF), (iii) the role of WISP1 in TNF-alpha-mediated CF proliferation and collagen production, and (iv) the effects of WISP1 on TNF-alpha-mediated cardiomyocyte death. TNF-alpha and WISP1 expressions were increased in the border zones and non-ischemic remote regions of the post-ischemic heart. In CF, TNF-alpha potently induced WISP1 expression in cyclic AMP response element-binding protein (CREB)-dependent manner. TNF-alpha induced CREB phosphorylation in vitro and DNA binding and reporter gene activities in vivo. TNF-alpha induced CREB activation via ERK1/2, and inhibition of ERK1/2 and CREB blunted TNF-alpha-mediated WISP1 induction. Most importantly, WISP1 knockdown attenuated TNF-alpha stimulated collagen production and CF proliferation. Furthermore, WISP1 attenuated TNF-alpha-mediated cardiomyocyte death, thus demonstrating pro-mitogenic and pro-survival effects for WISP1 in myocardial constituent cells. Our results suggest that a TNF-alpha/WISP1 signaling pathway may contribute to post-infarct cardiac remodeling, a condition characterized by fibrosis and progressive cardiomyocyte loss.	[Valente, Anthony J.; Melby, Peter C.; Nandish, Sailesh; Clark, Robert A.; Chandrasekar, Bysani] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Venkatachalam, Kaliyamurthi; Venkatesan, Balachandar; Melby, Peter C.; Clark, Robert A.; Chandrasekar, Bysani] S Texas Vet Hlth Care Syst, Dept Vet Affairs, San Antonio, TX 78229 USA; [Reusch, Jane E. B.] Univ Colorado, Hlth Sci Ctr, Dept Med, Div Endocrinol Metab & Diabet, Aurora, CO 80110 USA; [Reusch, Jane E. B.] Denver Vet Affairs Med Ctr, Vet Affairs Res Serv, Denver, CO 80220 USA	University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital; University of Colorado System; University of Colorado Anschutz Medical Campus; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver	Chandrasekar, B (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	chandraseka@uthscsa.edu	Clark, Robert/Q-6764-2019	Clark, Robert/0000-0002-4892-3619; Reusch, Jane/0000-0001-8620-1003	Research Service of the Department of Veterans Affairs	Research Service of the Department of Veterans Affairs(US Department of Veterans Affairs)	This work was supported in part by the Research Service of the Department of Veterans Affairs.	Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Anker SD, 2004, HEART, V90, P464, DOI 10.1136/hrt.2002.007005; Banerjee I, 2006, ANN NY ACAD SCI, V1080, P76, DOI 10.1196/annals.1380.007; Baudino TA, 2006, AM J PHYSIOL-HEART C, V291, pH1015, DOI 10.1152/ajpheart.00023.2006; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Bradley JR, 2008, J PATHOL, V214, P149, DOI 10.1002/path.2287; Chandrasekar B, 2005, J BIOL CHEM, V280, P4553, DOI 10.1074/jbc.M411787200; Chandrasekar B, 1998, BBA-MOL BASIS DIS, V1406, P91, DOI 10.1016/S0925-4439(97)00062-8; Chandrasekar B, 1999, CIRCULATION, V99, P427, DOI 10.1161/01.CIR.99.3.427; Chandrasekar B, 2008, J BIOL CHEM, V283, P4200, DOI 10.1074/jbc.M708142200; Chandrasekar B, 2006, J BIOL CHEM, V281, P15099, DOI 10.1074/jbc.M600200200; Chen CC, 2007, EMBO J, V26, P1257, DOI 10.1038/sj.emboj.7601596; Chen CC, 2009, INT J BIOCHEM CELL B, V41, P771, DOI 10.1016/j.biocel.2008.07.025; Chen GQ, 2002, SCIENCE, V296, P1634, DOI 10.1126/science.1071924; Clerk A, 1999, J MOL CELL CARDIOL, V31, P2087, DOI 10.1006/jmcc.1999.1040; Colston JT, 2007, AM J PHYSIOL-HEART C, V293, pH1839, DOI 10.1152/ajpheart.00428.2007; Colston JT, 2004, BIOCHEM BIOPH RES CO, V316, P256, DOI 10.1016/j.bbrc.2004.02.042; Colston JT, 2002, J BIOL CHEM, V277, P23477, DOI 10.1074/jbc.M108676200; Cortez DM, 2007, AM J PHYSIOL-HEART C, V293, pH3356, DOI 10.1152/ajpheart.00928.2007; Council NR, 1996, GUIDE CARE USE LAB A; Dhingra S, 2007, AM J PHYSIOL-HEART C, V293, pH3524, DOI 10.1152/ajpheart.00919.2007; Diwan A, 2004, CIRCULATION, V109, P262, DOI 10.1161/01.CIR.0000109642.27985.FA; Frangogiannis NG, 2002, CARDIOVASC RES, V53, P31, DOI 10.1016/S0008-6363(01)00434-5; Funakoshi Y, 2002, J BIOL CHEM, V277, P18710, DOI 10.1074/jbc.M110430200; GONZALEZ GA, 1991, MOL CELL BIOL, V11, P1306, DOI 10.1128/MCB.11.3.1306; Gustin JA, 2004, AM J PHYSIOL-CELL PH, V286, pC547, DOI 10.1152/ajpcell.00332.2002; Haudek SB, 2007, J CLIN INVEST, V117, P2692, DOI 10.1172/JCI29134; Hirschl MM, 1996, EUR HEART J, V17, P1852; Inkson CA, 2008, J CELL BIOCHEM, V104, P1865, DOI 10.1002/jcb.21754; Irwin MW, 1999, CIRCULATION, V99, P1492, DOI 10.1161/01.CIR.99.11.1492; Jacobs M, 1999, J MOL CELL CARDIOL, V31, P1949, DOI 10.1006/jmcc.1999.1007; Jiang LP, 2008, CHEM-BIOL INTERACT, V171, P348, DOI 10.1016/j.cbi.2007.11.013; JUNQUEIRA LCU, 1979, ANAL BIOCHEM, V94, P96, DOI 10.1016/0003-2697(79)90795-4; Kurrelmeyer K, 1998, CLIN CARDIOL, V21, P14, DOI 10.1002/clc.4960211304; Kurrelmeyer KM, 2000, P NATL ACAD SCI USA, V97, P5456, DOI 10.1073/pnas.070036297; Lee EO, 2004, J NEUROIMMUNOL, V155, P21, DOI 10.1016/j.jneuroim.2004.05.012; Leicht M, 2000, CARDIOVASC RES, V48, P274, DOI 10.1016/S0008-6363(00)00170-X; Liu FC, 1996, NEURON, V17, P1133, DOI 10.1016/S0896-6273(00)80245-7; Liu XQ, 2006, MOL PHARMACOL, V70, P1992, DOI 10.1124/mol.106.028951; Martinez-Velazquez M, 2007, CELL SIGNAL, V19, P1212, DOI 10.1016/j.cellsig.2007.01.001; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Mehrhof FB, 2001, CIRCULATION, V104, P2088, DOI 10.1161/hc4201.097133; Mori T, 1999, J CELL PHYSIOL, V181, P153, DOI 10.1002/(SICI)1097-4652(199910)181:1<153::AID-JCP16>3.0.CO;2-K; Munoz V, 2008, J PHYSIOL-LONDON, V586, P2423, DOI 10.1113/jphysiol.2008.153387; Nakano M, 1998, CIRCULATION, V97, P1392, DOI 10.1161/01.CIR.97.14.1392; Nian M, 2004, CIRC RES, V94, P1543, DOI 10.1161/01.RES.0000130526.20854.fa; Ono H, 2004, ARTERIOSCL THROM VAS, V24, P1634, DOI 10.1161/01.ATV.0000138052.86051.0d; Patel DN, 2007, J BIOL CHEM, V282, P27229, DOI 10.1074/jbc.M703250200; PFEFFER MA, 1990, CIRCULATION, V81, P1161, DOI 10.1161/01.CIR.81.4.1161; Porter KE, 2004, CARDIOVASC RES, V64, P507, DOI 10.1016/j.cardiores.2004.07.020; Powell DW, 1999, AM J PHYSIOL-CELL PH, V277, pC1, DOI 10.1152/ajpcell.1999.277.1.C1; Pugazhenthi S, 2000, J BIOL CHEM, V275, P10761, DOI 10.1074/jbc.275.15.10761; Reddy VS, 2008, J CELL PHYSIOL, V215, P697, DOI 10.1002/jcp.21348; Sarkar SA, 2007, DIABETOLOGIA, V50, P1649, DOI 10.1007/s00125-007-0707-z; SassoneCorsi P, 1995, ANNU REV CELL DEV BI, V11, P355, DOI 10.1146/annurev.cellbio.11.1.355; Seternes OM, 1999, MOL ENDOCRINOL, V13, P1071, DOI 10.1210/me.13.7.1071; Shi-Wen X, 2008, CYTOKINE GROWTH F R, V19, P133, DOI 10.1016/j.cytogfr.2008.01.002; Su F, 2002, GENE DEV, V16, P46, DOI 10.1101/gad.942902; Sun Y, 2009, CARDIOVASC RES, V81, P482, DOI 10.1093/cvr/cvn333; Tiyyagura SR, 2006, MT SINAI J MED, V73, P840; VADDI K, 1994, CIRCULATION, V90, P694, DOI 10.1161/01.CIR.90.2.694; Venkatachalam K, 2008, AM J PHYSIOL-HEART C, V294, pH2078, DOI 10.1152/ajpheart.01363.2007; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Xu LF, 2000, GENE DEV, V14, P585; Yeger H, 2007, J CELL COMMUN SIGNAL, V1, P159, DOI 10.1007/s12079-008-0022-6; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0	66	90	94	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14414	14427		10.1074/jbc.M809757200	http://dx.doi.org/10.1074/jbc.M809757200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19339243	hybrid, Green Published			2022-12-27	WOS:000266286100048
J	Kleinschmidt, MA; Wagner, TU; Liedtke, D; Spahr, S; Samans, B; Gaubatz, S				Kleinschmidt, Markus A.; Wagner, Toni U.; Liedtke, Daniel; Spahr, Susi; Samans, Birgit; Gaubatz, Stefan			lin9 Is Required for Mitosis and Cell Survival during Early Zebrafish Development	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							B-MYB; REPRESSOR COMPLEX; PROTEIN; GENES; CYCLE; TRANSCRIPTION; EXPRESSION; IDENTIFICATION; PROLIFERATION; CYTOKINESIS	LIN9 has been described as a regulator of G(1)/S and G(2)/M progression of the cell cycle in invertebrates and human cell lines. To elucidate the in vivo function of LIN9 during vertebrate development, we took advantage of the teleost zebrafish (Danio rerio). By means of antisense morpholinos we show here that Lin9-depleted embryonic cells accumulate in mitosis. Flow cytometry and confocal microscopy data demonstrate that the delay in mitotic progression is followed by apoptosis, which strongly manifests in the developing central nervous system. In accordance with these findings, we identified a cohort of Lin9-regulated genes required for different mitotic processes, including mitotic entry, metaphase/anaphase transition, and cytokinesis. Our data establish LIN9 as an essential regulator of mitosis in vertebrate development.	[Kleinschmidt, Markus A.; Wagner, Toni U.; Liedtke, Daniel; Spahr, Susi; Gaubatz, Stefan] Univ Wurzburg, Dept Physiol Chem 1, Bioctr, D-97074 Wurzburg, Germany; [Samans, Birgit] Univ Marburg, Inst Mol Biol & Tumor Res, D-35032 Marburg, Germany	University of Wurzburg; Philipps University Marburg	Gaubatz, S (corresponding author), Univ Wurzburg, Dept Physiol Chem 1, Bioctr, D-97074 Wurzburg, Germany.	stefan.gaubatz@biozentrum.uni-wuerzburg.de	Wagner, Toni/A-5387-2011; Pillay, Nischalan/F-9536-2012; Liedtke, Daniel/A-7804-2010	Liedtke, Daniel/0000-0003-0934-7169; Gaubatz, Stefan/0000-0001-8751-4191	Deutsche Forschungsgemeinschaft [TR 17]; European Union [018673]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union(European Commission)	This work was supported by Deutsche Forschungsgemeinschaft Grant TR 17 (to S. G. and D. L.) and a European Union grant (Plurigenes FP6 project 018673) (to T. W.).	Abaza A, 2003, J BIOL CHEM, V278, P27844, DOI 10.1074/jbc.M304522200; Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; Coelho PA, 2008, PLOS BIOL, V6, P1758, DOI 10.1371/journal.pbio.0060207; Cole LK, 2001, DEV BIOL, V240, P123, DOI 10.1006/dbio.2001.0432; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; Georlette D, 2007, GENE DEV, V21, P2880, DOI 10.1101/gad.1600107; Harrison MM, 2006, P NATL ACAD SCI USA, V103, P16782, DOI 10.1073/pnas.0608461103; Herpin A, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-99; Holt LJ, 2008, NATURE, V454, P353, DOI 10.1038/nature07050; Hwang LH, 1998, SCIENCE, V279, P1041, DOI 10.1126/science.279.5353.1041; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kleinschmidt MA, 2008, NUCLEIC ACIDS RES, V36, P3202, DOI 10.1093/nar/gkn166; Korenjak M, 2004, CELL, V119, P181, DOI 10.1016/j.cell.2004.09.034; Laoukili J, 2005, NAT CELL BIOL, V7, P126, DOI 10.1038/ncb1217; Lewis PW, 2004, GENE DEV, V18, P2929, DOI 10.1101/gad.1255204; Li L, 2007, CELL SIGNAL, V19, P2046, DOI 10.1016/j.cellsig.2007.05.017; Litovchick L, 2007, MOL CELL, V26, P539, DOI 10.1016/j.molcel.2007.04.015; Liu XQ, 2004, J CELL SCI, V117, P3233, DOI 10.1242/jcs.01173; Mueller T, 2003, DEV BRAIN RES, V140, P137, DOI 10.1016/S0165-3806(02)00583-7; Osterloh L, 2007, EMBO J, V26, P144, DOI 10.1038/sj.emboj.7601478; Pelegri F, 2003, DEV DYNAM, V228, P535, DOI 10.1002/dvdy.10390; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pilkinton M, 2007, ONCOGENE, V26, P7535, DOI 10.1038/sj.onc.1210562; Pilkinton M, 2007, J BIOL CHEM, V282, P168, DOI 10.1074/jbc.M609924200; Raemaekers T, 2003, J CELL BIOL, V162, P1017, DOI 10.1083/jcb.200302129; Sandoval R, 2006, EXP CELL RES, V312, P2465, DOI 10.1016/j.yexcr.2006.04.002; Schmit F, 2007, CELL CYCLE, V6, P1903, DOI 10.4161/cc.6.15.4512; Schneider L, 2007, J BIOL CHEM, V282, P29273, DOI 10.1074/jbc.M704151200; Shepard JL, 2005, P NATL ACAD SCI USA, V102, P13194, DOI 10.1073/pnas.0506583102; Summers MK, 2008, MOL CELL, V31, P544, DOI 10.1016/j.molcel.2008.07.014; Tanaka Y, 1999, J BIOL CHEM, V274, P28067, DOI 10.1074/jbc.274.40.28067; Tarasov KV, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002478; Wagner TU, 2009, STEM CELLS DEV, V18, P151, DOI 10.1089/scd.2007.0262; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Whitehead CM, 1998, J CELL SCI, V111, P2551; Wullimann MF, 2000, ANAT EMBRYOL, V202, P385, DOI 10.1007/s004290000115; Zhu CJ, 2005, BIOCHEM J, V389, P373, DOI 10.1042/BJ20050097; Zhu CJ, 2005, MOL BIOL CELL, V16, P3187, DOI 10.1091/mbc.E05-02-0167; Zhu WC, 2004, EMBO J, V23, P4615, DOI 10.1038/sj.emboj.7600459	39	8	8	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					13119	13127		10.1074/jbc.M809635200	http://dx.doi.org/10.1074/jbc.M809635200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19278998	Green Published, hybrid			2022-12-27	WOS:000265688300059
J	Mitchell, DA; Lee, SW; Pence, MA; Markley, AL; Limm, JD; Nizet, V; Dixon, JE				Mitchell, Douglas A.; Lee, Shaun W.; Pence, Morgan A.; Markley, Andrew L.; Limm, Joyce D.; Nizet, Victor; Dixon, Jack E.			Structural and Functional Dissection of the Heterocyclic Peptide Cytotoxin Streptolysin S	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OXYGEN-STABLE HEMOLYSINS; ANTIBIOTIC MICROCIN B17; PROMOTES SECONDARY METABOLISM; DNA-GYRASE INHIBITOR; MUTATIONAL ANALYSIS; CHEMICAL-SUBSTANCE; NISIN BIOSYNTHESIS; MATURATION PATHWAY; GENE-CLUSTER; STREPTOCOCCUS	The human pathogen Streptococcus pyogenes secretes a highly cytolytic toxin known as streptolysin S (SLS). SLS is a key virulence determinant and responsible for the beta-hemolytic phenotype of these bacteria. Despite over a century of research, the chemical structure of SLS remains unknown. Recent experiments have revealed that SLS is generated from an inactive precursor peptide that undergoes extensive post-translational modification to an active form. In this work, we address outstanding questions regarding the SLS biosynthetic process, elucidating the features of substrate recognition and sites of post-translational modification to the SLS precursor peptide. Further, we exploit these findings to guide the design of artificial cytolytic toxins that are recognized by the SLS biosynthetic enzymes and others that are intrinsically cytolytic. This new structural information has ramifications for future antimicrobial therapies.	[Dixon, Jack E.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Mitchell, Douglas A.; Lee, Shaun W.; Dixon, Jack E.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Mitchell, Douglas A.; Lee, Shaun W.; Dixon, Jack E.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Mitchell, Douglas A.; Lee, Shaun W.; Markley, Andrew L.; Limm, Joyce D.; Dixon, Jack E.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Pence, Morgan A.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Nizet, Victor] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, La Jolla, CA 92093 USA; [Nizet, Victor] Univ Calif San Diego, Div Pharmacol & Drug Discovery, La Jolla, CA 92093 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Dixon, JE (corresponding author), Howard Hughes Med Inst, 4000 Jones Bridge Rd, Chevy Chase, MD 20815 USA.	jedixon@ucsd.edu	Nizet, Victor/AAF-3190-2019; Mitchell, Doug/B-6349-2012; Pence, Morgan A./N-1620-2019; Mitchell, Douglas/C-4400-2011	Mitchell, Doug/0000-0002-9564-0953; Pence, Morgan A./0000-0003-0239-0228; Nizet, Victor/0000-0003-3847-0422	National Institutes of Health; Walther Cancer Institute, the Ellison Foundation; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [T32CA121938] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077780] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Walther Cancer Institute, the Ellison Foundation(Lawrence Ellison Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by a National Institutes of Health grant. This work was also supported by grants from the Walther Cancer Institute, the Ellison Foundation, and the Howard Hughes Medical Institute (to J.E.D.).	BERNHEIM.AW, 1967, J BACTERIOL, V93, P2024, DOI 10.1128/JB.93.6.2024-2025.1967; BERNHEIM.AW, 1965, J BACTERIOL, V89, P1387, DOI 10.1128/JB.89.5.1387-1392.1965; BERNHEIMER AW, 1949, J EXP MED, V90, P373, DOI 10.1084/jem.90.5.373; BERNHEIMER AW, 1950, J EXP MED, V92, P129, DOI 10.1084/jem.92.2.129; Betschel SD, 1998, INFECT IMMUN, V66, P1671, DOI 10.1128/IAI.66.4.1671-1679.1998; Cotter PD, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000144; Datta V, 2005, MOL MICROBIOL, V56, P681, DOI 10.1111/j.1365-2958.2005.04583.x; DEVOS WM, 1995, MOL MICROBIOL, V17, P427, DOI 10.1111/j.1365-2958.1995.mmi_17030427.x; Donia MS, 2008, NAT CHEM BIOL, V4, P341, DOI 10.1038/nchembio.84; Fuller JD, 2002, INFECT IMMUN, V70, P5730, DOI 10.1128/IAI.70.10.5730-5739.2002; GINSBURG I, 1963, J EXP MED, V118, P905, DOI 10.1084/jem.118.6.905; GINSBURG I, 1965, J EXP MED, V121, P633, DOI 10.1084/jem.121.4.633; HRYNIEWICZ W, 1977, INFECT IMMUN, V16, P730, DOI 10.1128/IAI.16.3.730-733.1977; Humar D, 2002, LANCET, V359, P124, DOI 10.1016/S0140-6736(02)07371-3; Igarashi Y, 2001, J ANTIBIOT, V54, P1045, DOI 10.7164/antibiotics.54.1045; Kelleher NL, 1999, BIOCHEMISTRY-US, V38, P15623, DOI 10.1021/bi9913698; KOYAMA J, 1963, J BIOCHEM-TOKYO, V53, P147, DOI 10.1093/oxfordjournals.jbchem.a127670; KOYAMA J, 1963, J BIOCHEM-TOKYO, V54, P146; KOYAMA J, 1963, J BIOCHEM-TOKYO, V56, P355; Lee SW, 2008, P NATL ACAD SCI USA, V105, P5879, DOI 10.1073/pnas.0801338105; Li B, 2006, SCIENCE, V311, P1464, DOI 10.1126/science.1121422; Li YM, 1996, SCIENCE, V274, P1188, DOI 10.1126/science.274.5290.1188; Locke JB, 2007, DIS AQUAT ORGAN, V76, P17, DOI 10.3354/dao076017; Madison LL, 1997, MOL MICROBIOL, V23, P161, DOI 10.1046/j.1365-2958.1997.2041565.x; Marmorek A., 1895, ANN I PASTEUR, V9, P593; Milne JC, 1999, BIOCHEMISTRY-US, V38, P4768, DOI 10.1021/bi982975q; Nizet V, 2002, TRENDS MICROBIOL, V10, P575, DOI 10.1016/S0966-842X(02)02473-3; Nizet V, 2000, INFECT IMMUN, V68, P4245, DOI 10.1128/IAI.68.7.4245-4254.2000; OFEK I, 1972, INFECT IMMUN, V6, P459, DOI 10.1128/IAI.6.4.459-464.1972; Okeley NM, 2003, BIOCHEMISTRY-US, V42, P13613, DOI 10.1021/bi0354942; Onaka H, 2001, J ANTIBIOT, V54, P1036, DOI 10.7164/antibiotics.54.1036; ROBINSON JJ, 1951, J IMMUNOL, V66, P661; Roy RS, 1999, CHEM BIOL, V6, P789, DOI 10.1016/S1074-5521(99)80126-4; Roy RS, 1999, NAT PROD REP, V16, P249, DOI 10.1039/a806930a; Roy RS, 1998, CHEM BIOL, V5, P217, DOI 10.1016/S1074-5521(98)90635-4; Schmidt EW, 2005, P NATL ACAD SCI USA, V102, P7315, DOI 10.1073/pnas.0501424102; WILLIAMS AB, 1993, CANCER LETT, V71, P97, DOI 10.1016/0304-3835(93)90103-G; YORGEY P, 1993, MOL MICROBIOL, V9, P897, DOI 10.1111/j.1365-2958.1993.tb01747.x; YORGEY P, 1994, P NATL ACAD SCI USA, V91, P4519, DOI 10.1073/pnas.91.10.4519	39	61	64	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					13004	13012		10.1074/jbc.M900802200	http://dx.doi.org/10.1074/jbc.M900802200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19286651	hybrid, Green Published			2022-12-27	WOS:000265688300048
J	Domenzain-Reyna, C; Hernandez, D; Miquel-Serra, L; Docampo, MJ; Badenas, C; Fabra, A; Bassols, A				Domenzain-Reyna, Clelia; Hernandez, Daniel; Miquel-Serra, Laia; Jose Docampo, Maria; Badenas, Celia; Fabra, Angels; Bassols, Anna			Structure and Regulation of the Versican Promoter THE VERSICAN PROMOTER IS REGULATED BY AP-1 AND TCF TRANSCRIPTION FACTORS IN INVASIVE HUMAN MELANOMA CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-MELANOMA; BREAST-CANCER; UP-REGULATION; G3 DOMAIN; DIFFERENTIAL EXPRESSION; CHONDROITIN SULFATE; ISOFORM EXPRESSION; BRAF MUTATIONS; CELL-ADHESION; GROWTH-FACTOR	Versican is a large chondroitin sulfate proteoglycan of the extracellular matrix that is involved in a variety of cellular processes. We showed previously that versican, which is overexpressed in cutaneous melanomas as well as in premalignant lesions, contributes to melanoma progression, favoring the detachment of cells and the metastatic dissemination. Here, we investigated the transcriptional regulation of the versican promoter in melanoma cell lines with different levels of biological aggressiveness and stages of differentiation. We show that versican promoter up-regulation accounts for the differential expression levels of mRNA and protein detected in the invasive SK-mel-131 human melanoma cells. The activity of the versican promoter increased 5-fold in these cells in comparison with that measured in non-invasive MeWo melanoma cells. Several transcriptional regulatory elements were identified in the proximal promoter, including AP-1, Sp1, AP-2, and two TCF-4 sites. We show that promoter activation is mediated by the ERK/MAPK and JNK signaling pathways acting on the AP-1 site, suggesting that BRAF mutation present in SK-mel-131 cells impinge upon the up-regulation of the versican gene through signaling elicited by the ERK/MAPK pathway. This is the first time the AP-1 transcription factor family has been shown to be related to the regulation of versican expression. Furthermore, deletion of the TCF-4 binding sites caused a 60% decrease in the promoter activity in SK-mel-131 cells. These results showing that AP-1 and TCF-4 binding sites are the main regulatory regions directing versican production provide new insights into versican promoter regulation during melanoma progression.	[Domenzain-Reyna, Clelia; Hernandez, Daniel; Miquel-Serra, Laia; Jose Docampo, Maria; Bassols, Anna] Univ Autonoma Barcelona, Dept Bioquim & Biol Mol, Fac Vet, Cerdanyola Del Valles 08193, Spain; [Badenas, Celia] Hosp Barcelona, Unitat Genet, Barcelona 08036, Spain; [Fabra, Angels] Inst Invest Biomed Bellvitge IDIBEL, Lhospitalet De Llobregat 08907, Spain	Autonomous University of Barcelona; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL)	Bassols, A (corresponding author), Edifici 5, Cerdanyola Del Valles 08193, Spain.	anna.bassols@uab.cat	Bassols, Anna/K-7961-2014; Badenas, Celia/ABH-5480-2020; Docampo, María José/A-4957-2009	Bassols, Anna/0000-0003-4213-2274; Badenas, Celia/0000-0002-0621-0477; Miquel Serra, Laia/0000-0001-8382-3341; Docampo, Maria Jose/0000-0003-1242-222X; Domenzain, Clelia/0000-0002-3080-6799	Ministerio de Educacion y Ciencia [SAF2003-08750]; Ministerio de Sanidad y Consumo [FIS-PI-06194]; Generalitat de Catalunya [2005SGR00542]; FEDER program of the European Union	Ministerio de Educacion y Ciencia(Spanish Government); Ministerio de Sanidad y Consumo(Instituto de Salud Carlos III); Generalitat de Catalunya(Generalitat de Catalunya); FEDER program of the European Union(European Commission)	This work was supported by Grants SAF2003-08750 from the Ministerio de Educacion y Ciencia (to A. B.), FIS-PI-06194 from the Ministerio de Sanidad y Consumo (to A.F.), and 2005SGR00542 from the Generalitat de Catalunya (to A. B.). This work was also supported in part by the FEDER program of the European Union.	Briggs J, 2002, ONCOGENE, V21, P7077, DOI 10.1038/sj.onc.1205857; Chen DH, 2003, CANCER RES, V63, P6626; Chudnovsky Y, 2005, J CLIN INVEST, V115, P813, DOI 10.1172/JCI200524808; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; den Dunnen JT, 2000, HUM MUTAT, V15, P7; Ding QQ, 2005, MOL CELL, V19, P159, DOI 10.1016/j.molcel.2005.06.009; Docampo MJ, 2007, AM J VET RES, V68, P1376, DOI 10.2460/ajvr.68.12.1376; Domenzain C, 2003, BBA-MOL CELL RES, V1642, P107, DOI 10.1016/S0167-4889(03)00104-6; Dorsky RI, 1998, NATURE, V396, P370, DOI 10.1038/24620; Dunn KJ, 2000, P NATL ACAD SCI USA, V97, P10050, DOI 10.1073/pnas.97.18.10050; Dutt S, 2006, J BIOL CHEM, V281, P12123, DOI 10.1074/jbc.M510834200; Goodwin A. M., 2002, Angiogenesis, V5, P1, DOI 10.1023/A:1021563510866; Gorden A, 2003, CANCER RES, V63, P3955; Govindarajan B, 2003, J BIOL CHEM, V278, P9790, DOI 10.1074/jbc.M212929200; Haluska FG, 2006, CLIN CANCER RES, V12, p2301S, DOI 10.1158/1078-0432.CCR-05-2518; HOUGHTON AN, 1987, J EXP MED, V165, P812, DOI 10.1084/jem.165.3.812; Hsu MY, 2002, DIFFERENTIATION, V70, P522, DOI 10.1046/j.1432-0436.2002.700906.x; Jorda M, 2005, J CELL SCI, V118, P3371, DOI 10.1242/jcs.02465; Kim D, 2007, ONCOGENE, V26, P4571, DOI 10.1038/sj.onc.1210230; Kodama J, 2007, ANN ONCOL, V18, P269, DOI 10.1093/annonc/mdl370; Koyama H, 2007, AM J PATHOL, V170, P1086, DOI 10.2353/ajpath.2007.060793; LaPierre DP, 2007, CANCER RES, V67, P4742, DOI 10.1158/0008-5472.CAN-06-3610; Lee JT, 2007, J CELL BIOCHEM, V101, P862, DOI 10.1002/jcb.21204; Lemire JM, 2002, J CELL PHYSIOL, V190, P38, DOI 10.1002/jcp.10043; Lopez-Bergami P, 2007, CANCER CELL, V11, P447, DOI 10.1016/j.ccr.2007.03.009; Maldonado JL, 2003, J NATL CANCER I, V95, P1878, DOI 10.1093/jnci/djg123; Miquel-Serra L, 2006, LAB INVEST, V86, P889, DOI 10.1038/labinvest.3700449; NASO MF, 1994, J BIOL CHEM, V269, P32999; Nyormoi O, 2003, CLIN EXP METASTAS, V20, P251, DOI 10.1023/A:1022991302172; Ozanne BW, 2007, ONCOGENE, V26, P1, DOI 10.1038/sj.onc.1209759; Paulus W, 1996, J NEUROPATH EXP NEUR, V55, P528, DOI 10.1097/00005072-199605000-00005; Rahmani M, 2006, CAN J PHYSIOL PHARM, V84, P77, DOI 10.1139/Y05-154; Rahmani M, 2005, J BIOL CHEM, V280, P13019, DOI 10.1074/jbc.M411766200; Read JT, 2007, J BIOL CHEM, V282, P31954, DOI 10.1074/jbc.M702099200; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Ricciardelli C, 2002, CLIN CANCER RES, V8, P1054; Ricciardelli C, 2007, J BIOL CHEM, V282, P10814, DOI 10.1074/jbc.M606991200; Sakko AJ, 2003, CANCER RES, V63, P4786; SCHONHERR E, 1991, J BIOL CHEM, V266, P17640; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Serra M, 2005, INT J CANCER, V114, P879, DOI 10.1002/ijc.20813; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Sheng W, 2006, MOL BIOL CELL, V17, P2009, DOI 10.1091/mbc.E05-10-0951; Tellez C, 2003, J BIOL CHEM, V278, P46632, DOI 10.1074/jbc.M309159200; Theocharis AD, 2006, ADV PHARMACOL, V53, P281, DOI 10.1016/S1054-3589(05)53013-8; Theocharis AD, 2002, BBA-MOL BASIS DIS, V1588, P165, DOI 10.1016/S0925-4439(02)00161-8; Touab M, 2003, AM J CLIN PATHOL, V119, P587, DOI 10.1309/ME25J1G5E57LM3; Touab M, 2002, AM J PATHOL, V160, P549, DOI 10.1016/S0002-9440(10)64874-2; Tsao H, 2004, J INVEST DERMATOL, V122, P337, DOI 10.1046/j.0022-202X.2004.22243.x; Vogt PK, 2001, ONCOGENE, V20, P2365, DOI 10.1038/sj.onc.1204443; Widlund HR, 2002, J CELL BIOL, V158, P1079, DOI 10.1083/jcb.200202049; Wight TN, 2008, FRONT BIOSCI, V13, P4933, DOI 10.2741/3052; Wight TN, 2002, CURR OPIN CELL BIOL, V14, P617, DOI 10.1016/S0955-0674(02)00375-7; Willert Jennifer, 2002, BMC Dev Biol, V2, P8, DOI 10.1186/1471-213X-2-8; Williams DR, 2005, BIOCHEM BIOPH RES CO, V334, P960, DOI 10.1016/j.bbrc.2005.06.189; Wu YJ, 2004, MOL BIOL CELL, V15, P2093, DOI 10.1091/mbc.E03-09-0667; Yan CH, 2007, J CELL PHYSIOL, V211, P19, DOI 10.1002/jcp.20948; Yang BL, 1999, J CELL BIOCHEM, V72, P210, DOI 10.1002/(SICI)1097-4644(19990201)72:2<210::AID-JCB5>3.0.CO;2-E; Yee AJ, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1751; Zhang Y, 1998, J BIOL CHEM, V273, P21342, DOI 10.1074/jbc.273.33.21342; Zheng PS, 2004, FASEB J, V18, P754, DOI 10.1096/fj.03-0545fje; Zizola CF, 2007, MATRIX BIOL, V26, P419, DOI 10.1016/j.matbio.2007.04.002	62	22	23	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12306	12317		10.1074/jbc.M807108200	http://dx.doi.org/10.1074/jbc.M807108200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19269971	Green Published, hybrid			2022-12-27	WOS:000265494600062
J	Glozak, MA; Seto, E				Glozak, Michele A.; Seto, Edward			Acetylation/Deacetylation Modulates the Stability of DNA Replication Licensing Factor Cdt1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HISTONE DEACETYLASE FAMILY; S-PHASE; GEMININ BINDING; ORIGIN ACTIVITY; ACETYLATION; ACETYLTRANSFERASE; DEGRADATION; CHROMATIN; PROTEIN; CELLS	Proper expression of the replication licensing factor Cdt1 is primarily regulated post-translationally by ubiquitylation and proteasome degradation. In a screen to identify novel non-histone targets of histone deacetylases (HDACs), we found Cdt1 as a binding partner for HDAC11. Cdt1 associates specifically and directly with HDAC11. We show that Cdt1 undergoes acetylation and is reversibly deacetylated by HDAC11. In vitro, Cdt1 can be acetylated at its N terminus by the lysine acetyltransferases KAT2B and KAT3B. Acetylation protects Cdt1 from ubiquitylation and subsequent proteasomal degradation. These results extend the list of non-histone acetylated proteins to include a critical DNA replication factor and provide an additional level of complexity to the regulation of Cdt1.	[Glozak, Michele A.; Seto, Edward] H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, Tampa, FL 33612 USA	H Lee Moffitt Cancer Center & Research Institute	Seto, E (corresponding author), H Lee Moffitt Canc Ctr & Res Inst, Dept Mol Oncol, SRB 23011,12902 Magnolia Dr, Tampa, FL 33612 USA.	ed.seto@moffitt.org			National Institutes of Health [CA109699]; American Heart Association [0755298B]; Kaul Foundation; NATIONAL CANCER INSTITUTE [R01CA109699] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Kaul Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA109699 (to E. S.). This work was also supported by American Heart Association Grant 0755298B and the Kaul Foundation (to E. S.).	Aggarwal BD, 2004, NATURE, V430, P372, DOI 10.1038/nature02694; Arias EE, 2006, NAT CELL BIOL, V8, P84, DOI 10.1038/ncb1346; Balasubramanyam K, 2004, J BIOL CHEM, V279, P51163, DOI 10.1074/jbc.M409024200; Ballabeni A, 2004, EMBO J, V23, P3122, DOI 10.1038/sj.emboj.7600314; Gao L, 2002, J BIOL CHEM, V277, P25748, DOI 10.1074/jbc.M111871200; Gaughan L, 2005, NUCLEIC ACIDS RES, V33, P13, DOI 10.1093/nar/gki141; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Gregoretti IV, 2004, J MOL BIOL, V338, P17, DOI 10.1016/j.jmb.2004.02.006; Iizuka M, 1999, J BIOL CHEM, V274, P23027, DOI 10.1074/jbc.274.33.23027; Kemp MG, 2005, NUCLEIC ACIDS RES, V33, P325, DOI 10.1093/nar/gki177; Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200; Li XH, 2003, J BIOL CHEM, V278, P30854, DOI 10.1074/jbc.C300251200; Liu HD, 2008, J NEUROSCI RES, V86, P537, DOI 10.1002/jnr.21521; Lutzmann M, 2006, EMBO J, V25, P5764, DOI 10.1038/sj.emboj.7601436; Machida YJ, 2005, CELL, V123, P13, DOI 10.1016/j.cell.2005.09.019; Martinez-Balbas MA, 2000, EMBO J, V19, P662, DOI 10.1093/emboj/19.4.662; Miotto B, 2008, GENE DEV, V22, P2633, DOI 10.1101/gad.1674108; Nishitani H, 2006, EMBO J, V25, P1126, DOI 10.1038/sj.emboj.7601002; Nishitani H, 2004, J BIOL CHEM, V279, P30807, DOI 10.1074/jbc.M312644200; Patel JH, 2004, MOL CELL BIOL, V24, P10826, DOI 10.1128/MCB.24.24.10826-10834.2004; Polesskaya A, 2001, J BIOL CHEM, V276, P44502, DOI 10.1074/jbc.M106501200; Saxena S, 2004, MOL CELL, V15, P245, DOI 10.1016/j.molcel.2004.06.045; Senga T, 2006, J BIOL CHEM, V281, P6246, DOI 10.1074/jbc.M512705200; Sugimoto N, 2004, J BIOL CHEM, V279, P19691, DOI 10.1074/jbc.M313175200; Takeda DY, 2005, J BIOL CHEM, V280, P23416, DOI 10.1074/jbc.M501208200; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Thompson PR, 2001, J BIOL CHEM, V276, P33721, DOI 10.1074/jbc.M104736200; Villagra A, 2009, NAT IMMUNOL, V10, P92, DOI 10.1038/ni.1673; Wohlschlegel JA, 2000, SCIENCE, V290, P2309, DOI 10.1126/science.290.5500.2309; Zeng L, 2008, STRUCTURE, V16, P643, DOI 10.1016/j.str.2008.01.010	30	54	55	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	APR 24	2009	284	17					11446	11453		10.1074/jbc.M809394200	http://dx.doi.org/10.1074/jbc.M809394200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NP	19276081	hybrid, Green Published			2022-12-27	WOS:000265494500049
J	Koodathingal, P; Jaffe, NE; Kraut, DA; Prakash, S; Fishbain, S; Herman, C; Matouschek, A				Koodathingal, Prakash; Jaffe, Neil E.; Kraut, Daniel A.; Prakash, Sumit; Fishbain, Susan; Herman, Christophe; Matouschek, Andreas			ATP-dependent Proteases Differ Substantially in Their Ability to Unfold Globular Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ESCHERICHIA-COLI LON; YEAST SACCHAROMYCES-CEREVISIAE; FTSH-MEDIATED PROTEOLYSIS; CLPXP DEGRADATION MACHINE; HEAT-SHOCK-PROTEIN; AAA PLUS PROTEASE; END RULE PATHWAY; 26 S PROTEASOME; DIHYDROFOLATE-REDUCTASE; SUBSTRATE-RECOGNITION	ATP-dependent proteases control the concentrations of hundreds of regulatory proteins and remove damaged or misfolded proteins from cells. They select their substrates primarily by recognizing sequence motifs or covalent modifications. Once a substrate is bound to the protease, it has to be unfolded and translocated into the proteolytic chamber to be degraded. Some proteases appear to be promiscuous, degrading substrates with poorly defined targeting signals, which suggests that selectivity may be controlled at additional levels. Here we compare the abilities of representatives from all classes of ATP-dependent proteases to unfold a model substrate protein and find that the unfolding abilities range over more than 2 orders of magnitude. We propose that these differences in unfolding abilities contribute to the fates of substrate proteins and may act as a further layer of selectivity during protein destruction.	[Koodathingal, Prakash; Jaffe, Neil E.; Kraut, Daniel A.; Prakash, Sumit; Fishbain, Susan; Matouschek, Andreas] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA; [Koodathingal, Prakash; Jaffe, Neil E.; Kraut, Daniel A.; Prakash, Sumit; Fishbain, Susan; Matouschek, Andreas] Northwestern Univ, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Herman, Christophe] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	Northwestern University; Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Baylor College of Medicine	Matouschek, A (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, 2205 Tech Dr, Evanston, IL 60208 USA.	matouschek@northwestern.edu	Prakash, Sumit/B-2679-2009; Matouschek, Andreas/L-9379-2013	Prakash, Sumit/0000-0002-0608-3420; Matouschek, Andreas/0000-0001-6016-2341; Kraut, Daniel/0000-0002-4428-5832	National Science Foundation [MCB 426913]; National Institutes of Health [R01GM64003]; Gillson Longenbaugh Foundation; Robert H. Lurie Comprehensive Cancer Center at Northwestern; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063004] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Gillson Longenbaugh Foundation; Robert H. Lurie Comprehensive Cancer Center at Northwestern; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Science Foundation Grant MCB 426913 and by National Institutes of Health Grant R01GM64003. This work was also supported by The Gillson Longenbaugh Foundation, the Robert H. Lurie Comprehensive Cancer Center at Northwestern	Asahara Y, 2000, J BIOCHEM, V127, P931, DOI 10.1093/oxfordjournals.jbchem.a022689; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Benaroudj N, 2003, MOL CELL, V11, P69, DOI 10.1016/S1097-2765(02)00775-X; Benaroudj N, 2000, NAT CELL BIOL, V2, P833, DOI 10.1038/35041081; BESSMAN MJ, 1963, METHOD ENZYMOL, V6, P166, DOI 10.1016/0076-6879(63)06160-7; Bolon DN, 2004, MOL CELL, V13, P443, DOI 10.1016/S1097-2765(04)00027-9; Bota DA, 2002, NAT CELL BIOL, V4, P674, DOI 10.1038/ncb836; Burton RE, 2005, NAT STRUCT MOL BIOL, V12, P245, DOI 10.1038/nsmb898; Burton RE, 2003, PROTEIN SCI, V12, P893, DOI 10.1110/ps.0237603; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; Chiba S, 2000, EMBO REP, V1, P47, DOI 10.1093/embo-reports/kvd005; Choy JS, 2007, J BACTERIOL, V189, P6564, DOI 10.1128/JB.00860-07; Dougan DA, 2003, MOL CELL, V12, P373, DOI 10.1016/j.molcel.2003.08.012; Dougan DA, 2002, MOL CELL, V9, P673, DOI 10.1016/S1097-2765(02)00485-9; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; ENDO T, 1988, EMBO J, V7, P1153, DOI 10.1002/j.1460-2075.1988.tb02925.x; Erbse A, 2006, NATURE, V439, P753, DOI 10.1038/nature04412; Flynn JM, 2003, MOL CELL, V11, P671, DOI 10.1016/S1097-2765(03)00060-1; Forster A, 2003, EMBO J, V22, P4356, DOI 10.1093/emboj/cdg436; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Gonciarz-Swiatek M, 1999, J BIOL CHEM, V274, P13999, DOI 10.1074/jbc.274.20.13999; Gottesman S, 2003, ANNU REV CELL DEV BI, V19, P565, DOI 10.1146/annurev.cellbio.19.110701.153228; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Gottesman S, 1997, GENE DEV, V11, P815, DOI 10.1101/gad.11.7.815; Gottesman S, 1996, ANNU REV GENET, V30, P465, DOI 10.1146/annurev.genet.30.1.465; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Gur E, 2008, P NATL ACAD SCI USA, V105, P16113, DOI 10.1073/pnas.0808802105; HARTLEY RW, 1989, TRENDS BIOCHEM SCI, V14, P450, DOI 10.1016/0968-0004(89)90104-7; HARTLEY RW, 1975, BIOCHEMISTRY-US, V14, P2367, DOI 10.1021/bi00682a015; Herman C, 1998, GENE DEV, V12, P1348, DOI 10.1101/gad.12.9.1348; Herman C, 2003, MOL CELL, V11, P659, DOI 10.1016/S1097-2765(03)00068-6; HERMAN C, 1995, P NATL ACAD SCI USA, V92, P3516, DOI 10.1073/pnas.92.8.3516; Hinnerwisch J, 2005, CELL, V121, P1029, DOI 10.1016/j.cell.2005.04.012; Hoffman L, 1996, J BIOL CHEM, V271, P32538, DOI 10.1074/jbc.271.51.32538; Hori O, 2002, J CELL BIOL, V157, P1151, DOI 10.1083/jcb.200108103; Hoskins JR, 2002, P NATL ACAD SCI USA, V99, P11037, DOI 10.1073/pnas.172378899; Hoskins JR, 2000, J BIOL CHEM, V275, P35361, DOI 10.1074/jbc.M006288200; Huang SH, 1999, NAT STRUCT BIOL, V6, P1132; Ishii Y, 2000, J BIOCHEM-TOKYO, V127, P837, DOI 10.1093/oxfordjournals.jbchem.a022677; Ishikawa T, 2001, P NATL ACAD SCI USA, V98, P4328, DOI 10.1073/pnas.081543698; Iwakura M, 2000, NAT STRUCT BIOL, V7, P580, DOI 10.1038/76811; Jelinsky SA, 2000, MOL CELL BIOL, V20, P8157, DOI 10.1128/MCB.20.21.8157-8167.2000; Jenal U, 2003, CURR OPIN MICROBIOL, V6, P163, DOI 10.1016/S1369-5274(03)00029-8; JOHNSTON JA, 1995, J BIOL CHEM, V270, P8172, DOI 10.1074/jbc.270.14.8172; Joshi SA, 2004, NAT STRUCT MOL BIOL, V11, P404, DOI 10.1038/nsmb752; Jubete Y, 1996, J BIOL CHEM, V271, P30798, DOI 10.1074/jbc.271.48.30798; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; Kenniston JA, 2003, CELL, V114, P511, DOI 10.1016/S0092-8674(03)00612-3; Kenniston JA, 2005, P NATL ACAD SCI USA, V102, P1390, DOI 10.1073/pnas.0409634102; Kenniston JA, 2004, J STRUCT BIOL, V146, P130, DOI 10.1016/j.jsb.2003.10.023; KIHARA A, 1995, P NATL ACAD SCI USA, V92, P4532, DOI 10.1073/pnas.92.10.4532; Kihara A, 1999, EMBO J, V18, P2970, DOI 10.1093/emboj/18.11.2970; Kim YI, 2000, MOL CELL, V5, P639, DOI 10.1016/S1097-2765(00)80243-9; Kobiler O, 2004, J STRUCT BIOL, V146, P72, DOI 10.1016/j.jsb.2003.10.021; Kuroda A, 2001, SCIENCE, V293, P705, DOI 10.1126/science.1061315; Kwon AR, 2004, J STRUCT BIOL, V146, P141, DOI 10.1016/j.jsb.2003.11.003; Lee C, 2001, MOL CELL, V7, P627, DOI 10.1016/S1097-2765(01)00209-X; Levchenko I, 2000, SCIENCE, V289, P2354, DOI 10.1126/science.289.5488.2354; LopezHernandez E, 1996, FOLD DES, V1, P43, DOI 10.1016/S1359-0278(96)00011-9; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P1147, DOI 10.1038/nsmb.1503; Martin A, 2008, MOL CELL, V29, P441, DOI 10.1016/j.molcel.2008.02.002; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P139, DOI 10.1038/nsmb.1380; Matouschek A, 1997, EMBO J, V16, P6727, DOI 10.1093/emboj/16.22.6727; MAURIZI MR, 1994, METHOD ENZYMOL, V244, P314; Mogk A, 2004, J STRUCT BIOL, V146, P90, DOI 10.1016/j.jsb.2003.10.009; MUROFF I, 1990, EMBO J, V9, P2765, DOI 10.1002/j.1460-2075.1990.tb07464.x; Navon A, 2001, MOL CELL, V8, P1339, DOI 10.1016/S1097-2765(01)00407-5; Okuno T, 2006, GENES CELLS, V11, P261, DOI 10.1111/j.1365-2443.2006.00940.x; Ondrovicova G, 2005, J BIOL CHEM, V280, P25103, DOI 10.1074/jbc.M502796200; PHILLIPS TA, 1984, J BACTERIOL, V159, P283, DOI 10.1128/JB.159.1.283-287.1984; Prakash S, 2004, NAT STRUCT MOL BIOL, V11, P830, DOI 10.1038/nsmb814; Prakash S, 2009, NAT CHEM BIOL, V5, P29, DOI 10.1038/nchembio.130; Rajagopalan PTR, 2002, P NATL ACAD SCI USA, V99, P13481, DOI 10.1073/pnas.172501499; Reid BG, 2001, P NATL ACAD SCI USA, V98, P3768, DOI 10.1073/pnas.071043698; Rep M, 1996, SCIENCE, V274, P103, DOI 10.1126/science.274.5284.103; ROOD JI, 1980, GENE, V8, P255, DOI 10.1016/0378-1119(80)90003-7; Rosen R, 2002, FEMS MICROBIOL LETT, V207, P9, DOI 10.1111/j.1574-6968.2002.tb11020.x; Saeki Y, 2005, METHOD ENZYMOL, V399, P215, DOI 10.1016/S0076-6879(05)99014-9; Sato T, 2005, P NATL ACAD SCI USA, V102, P17999, DOI 10.1073/pnas.0504495102; Savel'ev AS, 1998, J BIOL CHEM, V273, P20596, DOI 10.1074/jbc.273.32.20596; SEIFRIED SE, 1988, J BIOL CHEM, V263, P13511; Seong IS, 1999, FEBS LETT, V456, P211, DOI 10.1016/S0014-5793(99)00935-7; Siddiqui SM, 2004, GENE DEV, V18, P369, DOI 10.1101/gad.1170304; Sim KL, 2002, MOL CELL PROTEOMICS, V1, P983, DOI 10.1074/mcp.M200032-MCP200; Singh SK, 2000, P NATL ACAD SCI USA, V97, P8898, DOI 10.1073/pnas.97.16.8898; Singh SK, 1999, BIOCHEMISTRY-US, V38, P14906, DOI 10.1021/bi991615f; Smith CK, 1999, P NATL ACAD SCI USA, V96, P6678, DOI 10.1073/pnas.96.12.6678; SUZUKI CK, 1994, SCIENCE, V264, P273, DOI 10.1126/science.8146662; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Tian L, 2005, NAT STRUCT MOL BIOL, V12, P1045, DOI 10.1038/nsmb1018; TOMOYASU T, 1995, EMBO J, V14, P2551, DOI 10.1002/j.1460-2075.1995.tb07253.x; Tomoyasu T, 2001, MOL MICROBIOL, V40, P397, DOI 10.1046/j.1365-2958.2001.02383.x; Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072; van Dijl JM, 1998, P NATL ACAD SCI USA, V95, P10584, DOI 10.1073/pnas.95.18.10584; van Dyck L, 1998, GENE DEV, V12, P1515, DOI 10.1101/gad.12.10.1515; Van Dyck L, 1999, CELL MOL LIFE SCI, V56, P825, DOI 10.1007/s000180050029; VANDYCK L, 1994, J BIOL CHEM, V269, P238; Vineyard D, 2006, BIOCHEMISTRY-US, V45, P4602, DOI 10.1021/bi052377t; Vineyard D, 2005, BIOCHEMISTRY-US, V44, P1671, DOI 10.1021/bi048618z; von Janowsky B, 2005, BIOL CHEM, V386, P1307, DOI 10.1515/BC.2005.149; WAGNER I, 1994, EMBO J, V13, P5135, DOI 10.1002/j.1460-2075.1994.tb06843.x; Wah DA, 2002, CHEM BIOL, V9, P1237, DOI 10.1016/S1074-5521(02)00268-5; Weber-Ban EU, 1999, NATURE, V401, P90, DOI 10.1038/43481; WEISSBRUMMER B, 1982, CELL, V29, P527, DOI 10.1016/0092-8674(82)90169-6; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; Wilcox AJ, 2005, P NATL ACAD SCI USA, V102, P15435, DOI 10.1073/pnas.0507324102; Wu WF, 1999, J BACTERIOL, V181, P3681, DOI 10.1128/JB.181.12.3681-3687.1999; Yoo SJ, 1996, BIOCHEM BIOPH RES CO, V229, P531, DOI 10.1006/bbrc.1996.1838; Zwickl P, 2000, CURR OPIN STRUC BIOL, V10, P242, DOI 10.1016/S0959-440X(00)00075-0; Zwickl P, 1999, J BIOL CHEM, V274, P26008, DOI 10.1074/jbc.274.37.26008; ZWICKL P, 1992, BIOCHEMISTRY-US, V31, P964, DOI 10.1021/bi00119a004	112	58	58	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18674	18684		10.1074/jbc.M900783200	http://dx.doi.org/10.1074/jbc.M900783200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19383601	hybrid, Green Published			2022-12-27	WOS:000267711500016
J	Jeon, BN; Choi, WI; Yu, MY; Yoon, AR; Kim, MH; Yun, CO; Hur, MW				Jeon, Bu-Nam; Choi, Won-Il; Yu, Mi-Young; Yoon, A-Rum; Kim, Myung-Hwa; Yun, Chae-Ok; Hur, Man-Wook			ZBTB2, a Novel Master Regulator of the p53 Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN INTERACTION MOTIF; ACUTE PROMYELOCYTIC LEUKEMIA; DNA-BINDING DOMAIN; POZ-DOMAIN; HISTONE DEACETYLASE; FINGER PROTEIN; TRANSCRIPTION; GENE; REPRESSION; SP1	We found that ZBTB2, a POK family transcription factor, is a potent repressor of the ARF-HDM2-p53-p21 pathway important in cell cycle regulation. ZBTB2 repressed transcription of the ARF, p53, and p21 genes, but activated the HDM2 gene. In particular, ZBTB2 repressed transcription of the p21 gene by acting on the two distal p53 binding elements and the proximal Sp1 binding GC-box 5/6 elements. ZBTB2 directly interacted with Sp1 via its POZ domain and zinc fingers, which was important in the repression of transcription activation by Sp1. ZBTB2 and Sp1 competed with each other in binding to the GC-box 5/6 elements and the two p53 binding elements. ZBTB2 directly interacted with p53 via its zinc fingers, inhibiting p53 binding and repressing transcription activation by p53. The POZ domain, required for transcription repression, interacted with corepressors such as BCoR, NCoR, and SMRT. The interactions deacetylated histones Ac-H3 and -H4 at the proximal promoter. Although ectopic ZBTB2 stimulated cell proliferation, knockdown of ZBTB2 expression decreased cell proliferation and DNA synthesis. Overall, our data suggest that ZBTB2 is a potential proto-oncogenic master control gene of the p53 pathway and, in particular, is a potent transcription repressor of the cell cycle arrest gene p21 by inhibiting p53 and Sp1.	[Yoon, A-Rum; Yun, Chae-Ok] Yonsei Univ, Sch Med, Inst Canc Res, Seoul 120752, South Korea; [Jeon, Bu-Nam; Choi, Won-Il; Yu, Mi-Young; Kim, Myung-Hwa; Hur, Man-Wook] Inst Genet Sci, Dept Biochem & Mol Biol, Brain Korea Project Med Sci 21, Seoul 120752, South Korea	Yonsei University	Yun, CO (corresponding author), Yonsei Univ, Sch Med, Inst Canc Res, 134 ShinChon Dong, Seoul 120752, South Korea.	chaeok@yuhs.ac; mwhur2@yuhs.ac	Yun, Chae-Ok/P-3698-2015	CHOI, WONIL/0000-0002-4837-0436; Yun, Chae-Ok/0000-0002-9466-4531; Hur, Man-Wook/0000-0002-3416-1334	National Research Laboratory Research [ROA-2003-000-10318-0, M10416130002-04N1613-00210, R15-2004-024-02001-0]; Medical Research Center; Korean Science and Engineering Foundation of the Korean Ministry of Science and Technology [R13-2002-054-05002-0]; Korean Ministry for Health, Welfare and Family Affairs [00001561]	National Research Laboratory Research(Korea Science and Engineering Foundation); Medical Research Center; Korean Science and Engineering Foundation of the Korean Ministry of Science and Technology(Korea Science and Engineering Foundation); Korean Ministry for Health, Welfare and Family Affairs	This work was supported by National Research Laboratory Research Grants ROA-2003-000-10318-0 (to M.-W. H.) and M10416130002-04N1613-00210 and R15-2004-024-02001-0 (to C.-O. Y.), Medical Research Center Grant R13-2002-054-05002-0 (to M.-W. H.) from the Korean Science and Engineering Foundation of the Korean Ministry of Science and Technology, and Grant 00001561 (to M.-W. H.) from the National R& D Program for Cancer Control, Korean Ministry for Health, Welfare and Family Affairs.	ALBAGLI O, 1995, CELL GROWTH DIFFER, V6, P1193; Aravind L, 1999, J MOL BIOL, V285, P1353, DOI 10.1006/jmbi.1998.2394; BARDWELL VJ, 1994, GENE DEV, V8, P1664, DOI 10.1101/gad.8.14.1664; Barna M, 2000, NAT GENET, V25, P166, DOI 10.1038/76014; Chang CC, 1996, P NATL ACAD SCI USA, V93, P6947, DOI 10.1073/pnas.93.14.6947; Chen WY, 2004, CANCER CELL, V6, P387, DOI 10.1016/j.ccr.2004.08.030; CHEN Z, 1993, EMBO J, V12, P1161, DOI 10.1002/j.1460-2075.1993.tb05757.x; Choi WI, 2008, J BIOL CHEM, V283, P29341, DOI 10.1074/jbc.M802477200; Costoya JA, 2004, NAT GENET, V36, P653, DOI 10.1038/ng1367; Deltour S, 1999, P NATL ACAD SCI USA, V96, P14831, DOI 10.1073/pnas.96.26.14831; Dhordain P, 1997, P NATL ACAD SCI USA, V94, P10762, DOI 10.1073/pnas.94.20.10762; Dong S, 1996, P NATL ACAD SCI USA, V93, P3624, DOI 10.1073/pnas.93.8.3624; EL DW, 1993, CELL, V75, P817; ELDEIRY WS, 1994, CANCER RES, V54, P1169; FARKAS G, 1994, NATURE, V371, P806, DOI 10.1038/371806a0; Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Huynh KD, 2000, GENE DEV, V14, P1810; Jeon BN, 2008, J BIOL CHEM, V283, P33199, DOI 10.1074/jbc.M802935200; Kaczynski J, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-206; KADONAGA JT, 1987, CELL, V51, P1079, DOI 10.1016/0092-8674(87)90594-0; KERCKAERT JP, 1993, NAT GENET, V5, P66, DOI 10.1038/ng0993-66; KOONIN EV, 1992, TRENDS BIOCHEM SCI, V17, P213, DOI 10.1016/0968-0004(92)90379-N; Koutsodontis G, 2001, J BIOL CHEM, V276, P29116, DOI 10.1074/jbc.M104130200; Lee JA, 2005, J BIOL CHEM, V280, P28061, DOI 10.1074/jbc.M414134200; Lin RJ, 1998, NATURE, V391, P811, DOI 10.1038/35895; Maeda T, 2005, NATURE, V433, P278, DOI 10.1038/nature03203; Nagy L, 1997, CELL, V89, P373, DOI 10.1016/S0092-8674(00)80218-4; Niculescu AB, 1998, MOL CELL BIOL, V18, P629, DOI 10.1128/MCB.18.1.629; Ogryzko VV, 1997, MOL CELL BIOL, V17, P4877, DOI 10.1128/MCB.17.8.4877; Phan RT, 2005, NAT IMMUNOL, V6, P1054, DOI 10.1038/ni1245; Sun GP, 2005, NAT IMMUNOL, V6, P373, DOI 10.1038/ni1183; Toledo F, 2006, NAT REV CANCER, V6, P909, DOI 10.1038/nrc2012; Yamochi T, 1999, ONCOGENE, V18, P487, DOI 10.1038/sj.onc.1202334	34	47	49	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					17935	17946		10.1074/jbc.M809559200	http://dx.doi.org/10.1074/jbc.M809559200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19380588	Green Published, hybrid			2022-12-27	WOS:000267712400005
J	Lahiri, S; Park, H; Laviad, EL; Lu, XQ; Bittman, R; Futerman, AH				Lahiri, Sujoy; Park, Hyejung; Laviad, Elad L.; Lu, Xuequan; Bittman, Robert; Futerman, Anthony H.			Ceramide Synthesis Is Modulated by the Sphingosine Analog FTY720 via a Mixture of Uncompetitive and Noncompetitive Inhibition in an Acyl-CoA Chain Length-dependent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNOSUPPRESSIVE AGENT FTY720; IMMUNOMODULATORY DRUG FTY720; LONGEVITY ASSURANCE GENE-1; SUBSTRATE-SPECIFICITY; 1-PHOSPHATE; CELLS; GROWTH; PHOSPHORYLATION; FINGOLIMOD; RECEPTORS	FTY720, a sphingosine analog, is in clinical trials as an immunomodulator. The biological effects of FTY720 are believed to occur after its metabolism to FTY720 phosphate. However, very little is known about whether FTY720 can interact with and modulate the activity of other enzymes of sphingolipid metabolism. We examined the ability of FTY720 to modulate de novo ceramide synthesis. In mammals, ceramide is synthesized by a family of six ceramide synthases, each of which utilizes a restricted subset of acyl-CoAs. We show that FTY720 inhibits ceramide synthase activity in vitro by noncompetitive inhibition toward acyl-CoA and uncompetitive inhibition toward sphinganine; surprisingly, the efficacy of inhibition depends on the acyl-CoA chain length. In cultured cells, FTY720 has a more complex effect, with ceramide synthesis inhibited at high (500 nM to 5 mu M) but not low (<200 nM) sphinganine concentrations, consistent with FTY720 acting as an uncompetitive inhibitor toward sphinganine. Finally, electrospray ionization-tandem mass spectrometry demonstrated, unexpectedly, elevated levels of ceramide, sphingomyelin, and hexosylceramides after incubation with FTY720. Our data suggest a novel mechanism by which FTY720 might mediate some of its biological effects, which may be of mechanistic significance for understanding its mode of action.	[Lahiri, Sujoy; Laviad, Elad L.; Futerman, Anthony H.] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel; [Park, Hyejung] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Park, Hyejung] Georgia Inst Technol, Petit Inst Bioengn & Biosci, Atlanta, GA 30332 USA; [Lu, Xuequan; Bittman, Robert] CUNY Queens Coll, Dept Chem & Biochem, Flushing, NY 11367 USA	Weizmann Institute of Science; University System of Georgia; Georgia Institute of Technology; University System of Georgia; Georgia Institute of Technology; City University of New York (CUNY) System; Queens College NY (CUNY)	Futerman, AH (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	tony.futerman@weizmann.ac.il		Futerman, Anthony/0000-0003-0013-0115	National Institutes of Health [GM076217, HL-083187]; Israel Science Foundation [1404/07]; Minerva Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R24HL083187] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076217] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Israel Science Foundation(Israel Science Foundation); Minerva Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM076217 (to A. M. and A. H. F.), and HL-083187 ( to R. B.). This work was also supported by Israel Science Foundation Grant 1404/07 and by funds from the Minerva Foundation (to A. H. F.).	Alderton F, 2001, BRIT J PHARMACOL, V134, P6, DOI 10.1038/sj.bjp.0704278; Azuma H, 2002, CANCER RES, V62, P1410; Bandhuvula P, 2005, J BIOL CHEM, V280, P33697, DOI 10.1074/jbc.C500294200; Berdyshev EV, 2009, J BIOL CHEM, V284, P5467, DOI 10.1074/jbc.M805186200; Billich A, 2003, J BIOL CHEM, V278, P47408, DOI 10.1074/jbc.M307687200; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Brown BA, 2007, ANN PHARMACOTHER, V41, P1660, DOI 10.1345/aph.1G424; Chiba K, 2006, CELL MOL IMMUNOL, V3, P11; Cornish-Bowden A., 1995, FUNDAMENTALS ENZYME; FOLCHPI J, 1957, J BIOL CHEM, V226, P496; HIRSCHBERG K, 1993, BIOCHEM J, V290, P751, DOI 10.1042/bj2900751; Horga Alejandro, 2008, Expert Rev Neurother, V8, P699, DOI 10.1586/14737175.8.5.699; Kharel Y, 2005, J BIOL CHEM, V280, P36865, DOI 10.1074/jbc.M506293200; Kihara A, 2008, BBA-MOL CELL BIOL L, V1781, P496, DOI 10.1016/j.bbalip.2008.05.003; Koybasi S, 2004, J BIOL CHEM, V279, P44311, DOI 10.1074/jbc.M406920200; Lahiri S, 2005, J BIOL CHEM, V280, P33735, DOI 10.1074/jbc.M506485200; Lahiri S, 2007, FEBS LETT, V581, P5289, DOI 10.1016/j.febslet.2007.10.018; Laviad EL, 2008, J BIOL CHEM, V283, P5677, DOI 10.1074/jbc.M707386200; Lu XQ, 2009, J ORG CHEM, V74, P3192, DOI 10.1021/jo900023u; Mandala S, 2002, SCIENCE, V296, P346, DOI 10.1126/science.1070238; Mansoor M, 2008, REV RECENT CLIN TRIA, V3, P62, DOI 10.2174/157488708783330486; Matsuoka Y, 2003, BRIT J PHARMACOL, V138, P1303, DOI 10.1038/sj.bjp.0705182; Meno-Tetang GML, 2006, DRUG METAB DISPOS, V34, P1480, DOI 10.1124/dmd.105.009001; Merrill AH, 1996, TRENDS CELL BIOL, V6, P218, DOI 10.1016/0962-8924(96)10021-0; Merrill AH, 2005, METHODS, V36, P207, DOI 10.1016/j.ymeth.2005.01.009; Miron VE, 2008, AM J PATHOL, V173, P1143, DOI 10.2353/ajpath.2008.080478; Mizutani Y, 2006, BIOCHEM J, V398, P531, DOI 10.1042/BJ20060379; Nagaoka Y, 2008, BIOL PHARM BULL, V31, P1177, DOI 10.1248/bpb.31.1177; Neviani P, 2007, J CLIN INVEST, V117, P2408, DOI 10.1172/JCI31095; Payne SG, 2007, BLOOD, V109, P1077, DOI 10.1182/blood-2006-03-011437; Pettus BJ, 2004, J BIOL CHEM, V279, P11320, DOI 10.1074/jbc.M309262200; Pinschewer DD, 2000, J IMMUNOL, V164, P5761, DOI 10.4049/jimmunol.164.11.5761; Riebeling C, 2003, J BIOL CHEM, V278, P43452, DOI 10.1074/jbc.M307104200; Sanchez AM, 2008, EUR J PHARMACOL, V584, P237, DOI 10.1016/j.ejphar.2008.02.011; Sanchez T, 2003, J BIOL CHEM, V278, P47281, DOI 10.1074/jbc.M306896200; Segel IH., 1993, ENZYME KINETICS BEHA; SULLARDS MC, 2001, SCIENCESS STKE, V67; Venkataraman K, 2002, J BIOL CHEM, V277, P35642, DOI 10.1074/jbc.M205211200; Yagi H, 2000, EUR J IMMUNOL, V30, P1435, DOI 10.1002/(SICI)1521-4141(200005)30:5<1435::AID-IMMU1435>3.0.CO;2-O; Yopp AC, 2006, CLIN TRANSPLANT, V20, P788, DOI 10.1111/j.1399-0012.2006.00570.x; Zemann B, 2006, BLOOD, V107, P1454, DOI 10.1182/blood-2005-07-2628; Zhang Z, 2007, MINI-REV MED CHEM, V7, P845	43	99	104	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16090	16098		10.1074/jbc.M807438200	http://dx.doi.org/10.1074/jbc.M807438200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19357080	hybrid, Green Published			2022-12-27	WOS:000266730900005
J	Tsunekawa, K; Shijuku, T; Hayashimoto, M; Kojima, Y; Onai, K; Morishita, M; Ishiura, M; Kuroda, T; Nakamura, T; Kobayashi, H; Sato, M; Toyooka, K; Matsuoka, K; Omata, T; Uozumi, N				Tsunekawa, Kenta; Shijuku, Toshiaki; Hayashimoto, Mitsuo; Kojima, Yoichi; Onai, Kiyoshi; Morishita, Megumi; Ishiura, Masahiro; Kuroda, Teruo; Nakamura, Tatsunosuke; Kobayashi, Hiroshi; Sato, Mayuko; Toyooka, Kiminori; Matsuoka, Ken; Omata, Tatsuo; Uozumi, Nobuyuki			Identification and Characterization of the Na+/H+ Antiporter Nhas3 from the Thylakoid Membrane of Synechocystis sp PCC 6803	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SP STRAIN PCC-6803; ESCHERICHIA-COLI; CIRCADIAN-RHYTHMS; ION HOMEOSTASIS; REAL-TIME; FUNCTIONAL EXPRESSION; ARABIDOPSIS-THALIANA; SYNECHOCOCCUS SP; PHOTOSYSTEM-II; SALT STRESS	Na+/H+ antiporters influence proton or sodium motive force across the membrane. Synechocystis sp. PCC 6803 has six genes encoding Na+/H+ antiporters, nhaS1-5 and sll0556. In this study, the function of NhaS3 was examined. NhaS3 was essential for growth of Synechocystis, and loss of nhaS3 was not complemented by expression of the Escherichia coli Na+/H+ antiporter NhaA. Membrane fractionation followed by immunoblotting as well as immunogold labeling revealed that NhaS3 was localized in the thylakoid membrane of Synechocystis. NhaS3 was shown to be functional over a pH range from pH 6.5 to 9.0 when expressed in E. coli. A reduction in the copy number of nhaS3 in the Synechocystis genome rendered the cells more sensitive to high Na+ concentrations. NhaS3 had no K+/H+ exchange activity itself but enhanced K+ uptake from the medium when expressed in an E. coli potassium uptake mutant. Expression of nhaS3 increased after shifting from low CO2 to high CO2 conditions. Expression of nhaS3 was also found to be controlled by the circadian rhythm. Gene expression peaked at the beginning of subjective night. This coincided with the time of the lowest rate of CO2 consumption caused by the ceasing of O-2-evolving photosynthesis. This is the first report of a Na+/H+ antiporter localized in thylakoid membrane. Our results suggested a role of NhaS3 in the maintenance of ion homeostasis of H+, Na+, and K+ in supporting the conversion of photosynthetic products and in the supply of energy in the dark.	[Shijuku, Toshiaki; Hayashimoto, Mitsuo; Uozumi, Nobuyuki] Tohoku Univ, Dept Biomol Engn, Grad Sch Engn, Sendai, Miyagi 9808579, Japan; [Tsunekawa, Kenta; Omata, Tatsuo] Nagoya Univ, Lab Mol Plant Physiol, Grad Sch Bioagr Sci, Nagoya, Aichi 4648601, Japan; [Kojima, Yoichi] Shizuoka Univ, Dept Environm & Forest Resources Sci, Fac Agr, Shizuoka 4228529, Japan; [Onai, Kiyoshi; Morishita, Megumi; Ishiura, Masahiro] Nagoya Univ, Ctr Gene Res, Nagoya, Aichi 4648602, Japan; [Kuroda, Teruo] Okayama Univ, Dept Genome Appl Microbiol, Grad Sch Med Dent & Pharmaceut Sci, Okayama 7008530, Japan; [Nakamura, Tatsunosuke] Niigata Univ Pharm & Appl Life Sci, Dept Microbiol, Niigata 9502081, Japan; [Kobayashi, Hiroshi] Chiba Univ, Grad Sch Pharmaceut Sci, Chiba 2608675, Japan; [Sato, Mayuko; Toyooka, Kiminori] RIKEN Plant Sci Ctr, Yokohama, Kanagawa 2300045, Japan; [Matsuoka, Ken] Kyushu Univ, Lab Plant Nutr, Fac Agr, Fukuoka 8128581, Japan	Tohoku University; Nagoya University; Shizuoka University; Nagoya University; Okayama University; Niigata University; Chiba University; RIKEN; Kyushu University	Uozumi, N (corresponding author), Tohoku Univ, Dept Biomol Engn, Grad Sch Engn, Aobayama 6-6-07, Sendai, Miyagi 9808579, Japan.	uozumi@biophy.che.tohoku.ac.jp	Matsuoka, Ken/E-3215-2010; Uozumi, Nobuyuki/AAG-3252-2019; Toyooka, Kiminori/B-5027-2011	Onai, Kiyoshi/0000-0001-9062-2548; Matsuoka, Ken/0000-0001-7229-7294; Uozumi, Nobuyuki/0000-0003-4268-1126	MEXT [17078005, 20-08103]; JSPS	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by Grants-in-aid for Scientific Research 17078005 and 20-08103 (to N. U.) from MEXT and JSPS.	Allakhverdiev SI, 2000, PLANT PHYSIOL, V123, P1047, DOI 10.1104/pp.123.3.1047; Allakhverdiev SI, 1999, P NATL ACAD SCI USA, V96, P5862, DOI 10.1073/pnas.96.10.5862; Apse MP, 2003, PLANT J, V36, P229, DOI 10.1046/j.1365-313X.2003.01871.x; Apse MP, 1999, SCIENCE, V285, P1256, DOI 10.1126/science.285.5431.1256; Berry S, 2003, FEBS LETT, V548, P53, DOI 10.1016/S0014-5793(03)00729-4; BUURMAN ET, 1995, J BIOL CHEM, V270, P6678, DOI 10.1074/jbc.270.12.6678; Elanskaya IV, 2002, BIOCHEMISTRY-MOSCOW+, V67, P432, DOI 10.1023/A:1015281906254; GOLDBERG EB, 1987, P NATL ACAD SCI USA, V84, P2615, DOI 10.1073/pnas.84.9.2615; Golden SS, 1997, ANNU REV PLANT PHYS, V48, P327, DOI 10.1146/annurev.arplant.48.1.327; Hamada A, 2001, PLANT PHYSIOL, V125, P437, DOI 10.1104/pp.125.1.437; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Inaba M, 2001, J BACTERIOL, V183, P1376, DOI 10.1128/JB.183.4.1376-1384.2001; Inoue H, 1999, FEBS LETT, V443, P11, DOI 10.1016/S0014-5793(98)01652-4; JAGENDORF AT, 1966, P NATL ACAD SCI USA, V55, P170, DOI 10.1073/pnas.55.1.170; KAPLAN A, 1989, PLANT PHYSIOL, V89, P1220, DOI 10.1104/pp.89.4.1220; KARPEL R, 1988, J BIOL CHEM, V263, P10408; Katoh H, 2001, J BACTERIOL, V183, P2779, DOI 10.1128/JB.183.9.2779-2784.2001; Kucho K, 2005, GENES GENET SYST, V80, P19, DOI 10.1266/ggs.80.19; Kucho K, 2005, J BACTERIOL, V187, P2190, DOI 10.1128/JB.187.6.2190-2199.2005; KURODA T, 1994, J BIOCHEM-TOKYO, V116, P1030, DOI 10.1093/oxfordjournals.jbchem.a124624; Matsuda N, 2004, J BIOL CHEM, V279, P54952, DOI 10.1074/jbc.M407268200; Mikkat S, 2000, PLANT CELL ENVIRON, V23, P549, DOI 10.1046/j.1365-3040.2000.00565.x; MILLER AG, 1984, J BACTERIOL, V159, P100, DOI 10.1128/JB.159.1.100-106.1984; MITSUI A, 1986, NATURE, V323, P720, DOI 10.1038/323720a0; Norling B, 1998, FEBS LETT, V436, P189, DOI 10.1016/S0014-5793(98)01123-5; Nowaczyk MM, 2006, PLANT CELL, V18, P3121, DOI 10.1105/tpc.106.042671; Ohkawa H, 2000, J BACTERIOL, V182, P2591, DOI 10.1128/JB.182.9.2591-2596.2000; OHYAMA T, 1994, J BACTERIOL, V176, P4311, DOI 10.1128/jb.176.14.4311-4315.1994; Okamoto K, 2005, PLANT CELL ENVIRON, V28, P1305, DOI 10.1111/j.1365-3040.2005.01377.x; Okamoto K, 2005, ANAL BIOCHEM, V340, P193, DOI 10.1016/j.ab.2004.11.007; OMATA T, 1995, PLANT CELL PHYSIOL, V36, P207, DOI 10.1093/oxfordjournals.pcp.a078751; Onai M, 2004, J BACTERIOL, V186, P4972, DOI 10.1128/JB.186.15.4972-4977.2004; PADAN E, 1994, BBA-BIOENERGETICS, V1187, P206, DOI 10.1016/0005-2728(94)90112-0; PADAN E, 1994, BBA-BIOENERGETICS, V1185, P129, DOI 10.1016/0005-2728(94)90204-6; RIPPKA R, 1979, J GEN MICROBIOL, V111, P1, DOI 10.1099/00221287-111-1-1; Schonknecht G, 1995, P NATL ACAD SCI USA, V92, P12185, DOI 10.1073/pnas.92.26.12185; Serrano R, 2001, CURR OPIN CELL BIOL, V13, P399, DOI 10.1016/S0955-0674(00)00227-1; Shi HZ, 2002, PLANT CELL, V14, P465, DOI 10.1105/tpc.010371; Shibata M, 2002, J BIOL CHEM, V277, P18658, DOI 10.1074/jbc.M112468200; Shijuku T, 2002, BBA-BIOENERGETICS, V1556, P142, DOI 10.1016/S0005-2728(02)00345-6; Shijuku T, 2001, BBA-BIOENERGETICS, V1506, P212, DOI 10.1016/S0005-2728(01)00215-8; Song CP, 2004, P NATL ACAD SCI USA, V101, P10211, DOI 10.1073/pnas.0403709101; Stumpe S, 1997, ARCH MICROBIOL, V167, P126, DOI 10.1007/s002030050425; Sze H, 2004, PLANT PHYSIOL, V136, P2532, DOI 10.1104/pp.104.046003; Toyooka K, 2006, AUTOPHAGY, V2, P96, DOI 10.4161/auto.2.2.2366; Uozumi N, 1998, P NATL ACAD SCI USA, V95, P9773, DOI 10.1073/pnas.95.17.9773; Venema K, 2003, J BIOL CHEM, V278, P22453, DOI 10.1074/jbc.M210794200; Yamaguchi T, 2003, P NATL ACAD SCI USA, V100, P12510, DOI 10.1073/pnas.2034966100; Zhang HX, 2001, NAT BIOTECHNOL, V19, P765, DOI 10.1038/90824; Zhang PP, 2004, PLANT CELL, V16, P3326, DOI 10.1105/tpc.104.026526; ZHAO JD, 1988, ARCH BIOCHEM BIOPHYS, V264, P657, DOI 10.1016/0003-9861(88)90332-3	51	47	49	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16513	16521		10.1074/jbc.M109.001875	http://dx.doi.org/10.1074/jbc.M109.001875			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19372598	Green Published, hybrid			2022-12-27	WOS:000266730900048
J	Loane, DJ; Stoica, BA; Pajoohesh-Ganji, A; Byrnes, KR; Faden, AI				Loane, David J.; Stoica, Bogdan A.; Pajoohesh-Ganji, Ahdeah; Byrnes, Kimberly R.; Faden, Alan I.			Activation of Metabotropic Glutamate Receptor 5 Modulates Microglial Reactivity and Neurotoxicity by Inhibiting NADPH Oxidase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRAUMATIC NEURONAL INJURY; KINASE-C-DELTA; NITRIC-OXIDE; IN-VITRO; DOPAMINERGIC-NEURONS; CELL-DEATH; P47(PHOX) PHOSPHORYLATION; NEUROPROTECTIVE ACTIVITY; SUPEROXIDE-PRODUCTION; INTERFERON-GAMMA	Microglial-related factors have been implicated in the signaling cascades that contribute to neuronal cell death in various neurodegenerative disorders. Thus, strategies that reduce microglial activation and associated neurotoxicity may have therapeutic benefit. Group II and III metabotropic glutamate receptors (mGluRs) are expressed in microglia and can modulate microglial activity in primary cell cultures. We demonstrate that the group I receptor member mGluR5 is highly expressed in primary microglial cultures and the BV2 microglial cell line. Activation of mGluR5 using the selective agonist (RS)-2-chloro-5-hydroxyphenylglycine (CHPG) significantly attenuates microglial activation in response to lipopolysaccharide and interferon-gamma, as indicated by a reduction in the expression of inducible nitric-oxide synthase, production of nitric oxide and tumor necrosis factor-alpha, and intracellular generation of reactive oxygen species. In addition, microglial-induced neurotoxicity is also markedly reduced by CHPG treatment. The anti-inflammatory effects of CHPG are mediated by the mGluR5 receptor, because either a selective mGluR5 antagonist or small interference RNA knockdown attenuated the actions of this drug. CHPG blocked the lipopolysaccharide-induced increase in expression and enzymatic activity of NADPH oxidase. Moreover, the protective effects of CHPG were significantly reduced when the NADPH oxidase subunits p22(phox) or gp91(phox) were knocked down by small interference RNA. These data suggest that mGluR5 represents a novel target for modulating microglial dependent neuroinflammation, and may have therapeutic relevance for neurological disorders that exhibit microglial-mediated neurodegeneration.	[Loane, David J.; Stoica, Bogdan A.; Pajoohesh-Ganji, Ahdeah; Byrnes, Kimberly R.; Faden, Alan I.] Georgetown Univ, Med Ctr, Dept Neurosci, Washington, DC 20057 USA	Georgetown University	Loane, DJ (corresponding author), Georgetown Univ, Med Ctr, Dept Neurosci, 3970 Reservoir Rd NW, Washington, DC 20057 USA.	djl42@georgetown.edu	STOICA, BOGDAN/H-9782-2013; Loane, David/ABD-5177-2021	STOICA, BOGDAN/0000-0002-2501-6434; Loane, David/0000-0003-0393-3503; Byrnes, Kimberly/0000-0002-7501-7734	National Institutes of Health [R01 5R01NS037313-08]; NINDS; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS037313] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 5R01NS037313-08 from NINDS.	Allen JW, 2000, CELL DEATH DIFFER, V7, P470, DOI 10.1038/sj.cdd.4400678; Bal-Price A, 2001, J NEUROSCI, V21, P6480; Bao WL, 2001, BRAIN RES, V922, P173, DOI 10.1016/S0006-8993(01)03062-1; Bey EA, 2004, J IMMUNOL, V173, P5730, DOI 10.4049/jimmunol.173.9.5730; Biber K, 1999, J NEUROCHEM, V72, P1671, DOI 10.1046/j.1471-4159.1999.721671.x; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Block ML, 2004, FASEB J, V18, P1618, DOI 10.1096/fj.04-1945fje; Byrnes KR, 2009, ANN NEUROL, V66, P63, DOI 10.1002/ana.21673; Byrnes KR, 2009, NEUROTHERAPEUTICS, V6, P94, DOI 10.1016/j.nurt.2008.10.038; Byrnes KR, 2006, GLIA, V53, P420, DOI 10.1002/glia.20295; Cheret C, 2008, J NEUROSCI, V28, P12039, DOI 10.1523/JNEUROSCI.3568-08.2008; Choi SH, 2005, J NEUROSCI, V25, P4082, DOI 10.1523/JNEUROSCI.4306-04.2005; Corti C, 2007, J NEUROSCI, V27, P8297, DOI 10.1523/JNEUROSCI.1889-07.2007; Cross AR, 2004, BBA-BIOENERGETICS, V1657, P1, DOI 10.1016/j.bbabio.2004.03.008; D'Antoni S, 2008, NEUROCHEM RES, V33, P2436, DOI 10.1007/s11064-008-9694-9; Faden AI, 2001, EXP NEUROL, V167, P435, DOI 10.1006/exnr.2000.7577; Faden AI, 1997, J NEUROTRAUM, V14, P885, DOI 10.1089/neu.1997.14.885; Fei Z, 2006, J CLIN NEUROSCI, V13, P1023, DOI 10.1016/j.jocn.2005.11.042; Fernandes DC, 2007, AM J PHYSIOL-CELL PH, V292, pC413, DOI 10.1152/ajpcell.00188.2006; Gao HM, 2003, FASEB J, V17, DOI 10.1096/fj.03-0109fje; Gao HM, 2003, J NEUROSCI, V23, P6181; Gao HM, 2008, TRENDS IMMUNOL, V29, P357, DOI 10.1016/j.it.2008.05.002; Geurts JJG, 2003, BRAIN, V126, P1755, DOI 10.1093/brain/awg179; Gibbons HM, 2006, BRAIN RES, V1084, P1, DOI 10.1016/j.brainres.2006.02.032; Golde S, 2002, J NEUROCHEM, V82, P269, DOI 10.1046/j.1471-4159.2002.00973.x; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; He Y, 2003, J NEUROCHEM, V86, P1338, DOI 10.1046/j.1471-4159.2003.01938.x; Iravani MM, 2002, NEUROSCIENCE, V110, P49, DOI 10.1016/S0306-4522(01)00562-0; Lea PM, 2006, CNS DRUG REV, V12, P149, DOI 10.1111/j.1527-3458.2006.00149.x; Lea PM, 2005, BRIT J PHARMACOL, V145, P527, DOI 10.1038/sj.bjp.0706219; Li JM, 2005, MOL CELL BIOL, V25, P2320, DOI 10.1128/MCB.25.6.2320-2330.2005; Li JR, 2005, P NATL ACAD SCI USA, V102, P9936, DOI 10.1073/pnas.0502552102; Mander P, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-20; McNaught KSP, 1998, J NEUROCHEM, V70, P1541; Mount MP, 2007, J NEUROSCI, V27, P3328, DOI 10.1523/JNEUROSCI.5321-06.2007; Movsesyan VA, 2006, J NEUROTRAUM, V23, P117, DOI 10.1089/neu.2006.23.117; Movsesyan VA, 2004, J NEUROCHEM, V89, P1528, DOI 10.1111/j.1471-4159.2004.02451.x; Pacheco R, 2004, J BIOL CHEM, V279, P33352, DOI 10.1074/jbc.M401761200; Patel M, 2005, J NEUROCHEM, V92, P123, DOI 10.1111/j.1471-4159.2004.02838.x; Pawate S, 2004, J NEUROSCI RES, V77, P540, DOI 10.1002/jnr.20180; Pinteaux-Jones F, 2008, J NEUROCHEM, V106, P442, DOI 10.1111/j.1471-4159.2008.05426.x; Qian L, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-23; Qin LY, 2004, J BIOL CHEM, V279, P1415, DOI 10.1074/jbc.M307657200; Qin LY, 2002, J NEUROCHEM, V83, P973, DOI 10.1046/j.1471-4159.2002.01210.x; Schools GP, 1999, J NEUROSCI RES, V58, P533, DOI 10.1002/(SICI)1097-4547(19991115)58:4<533::AID-JNR6>3.0.CO;2-G; Szydlowska K, 2007, EUR J PHARMACOL, V554, P18, DOI 10.1016/j.ejphar.2006.09.061; Taylor DL, 2002, J NEUROCHEM, V82, P1179, DOI 10.1046/j.1471-4159.2002.01062.x; Taylor DL, 2005, J NEUROSCI, V25, P2952, DOI 10.1523/JNEUROSCI.4456-04.2005; Taylor DL, 2003, J NEUROSCI, V23, P2150; Wu XF, 2005, ANTIOXID REDOX SIGN, V7, P654, DOI 10.1089/ars.2005.7.654; Zhang D, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-21; Zhang W, 2007, GLIA, V55, P1178, DOI 10.1002/glia.20532; Zhao XR, 2001, J NEUROSCI RES, V64, P121, DOI 10.1002/jnr.1059; Zhao XX, 2005, J LEUKOCYTE BIOL, V77, P414, DOI 10.1189/jlb.0504284; Zou JY, 2005, BRAIN RES, V1034, P11, DOI 10.1016/j.brainres.2004.11.014	55	88	92	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15629	15639		10.1074/jbc.M806139200	http://dx.doi.org/10.1074/jbc.M806139200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19364772	Green Published, hybrid			2022-12-27	WOS:000266501000031
J	Matsuda, S; Matsuda, Y; D'Adamio, L				Matsuda, Shuji; Matsuda, Yukiko; D'Adamio, Luciano			BRI3 Inhibits Amyloid Precursor Protein Processing in a Mechanistically Distinct Manner from Its Homologue Dementia Gene BRI2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATED INTRAMEMBRANE PROTEOLYSIS; GAMMA-SECRETASE; INTRACELLULAR DOMAIN; ALZHEIMERS-DISEASE; A-BETA; APP; PRESENILIN; NOTCH; TRANSCRIPTION; EXPRESSION	Alzheimer disease (AD) is characterized by senile plaques, which are mainly composed of beta amyloid (A beta) peptides. A beta is cleaved off from amyloid precursor protein (APP) with consecutive proteolytic processing: beta-secretase, followed by gamma-secretase. Here, we show that BRI3, a member of the BRI gene family that includes the familial British and Danish dementia gene BRI2, interacts with APP and serves as an endogenous negative regulator of A beta production. BRI3 colocalizes with APP along neuritis in differentiated N2a cells; endogenous BRI3-APP complexes are readily detectable in mouse brain extract; reducing endogenous BRI3 levels by RNA interference results in increased A beta secretion. BRI3 resembles BRI2, because BRI3 overexpression reduces both alpha-and beta-APP cleavage. We propose that BRI3 inhibits the various processing of APP by blocking the access of alpha-and beta-secretases to APP. However, unlike BRI2, the binding of BRI3 to the beta-secretase cleaved APP C-terminal fragment is negligible and BRI3 does not cause the massive accumulation of this APP fragment, suggesting that, unlike BRI2, BRI3 is a poor gamma-cleavage inhibitor. Competitive inhibition of APP processing by BRI3 may provide a new approach to AD therapy and prevention.	[Matsuda, Shuji; Matsuda, Yukiko; D'Adamio, Luciano] Yeshiva Univ Albert Einstein Coll Med, Dept Microbiol & Immunol, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	D'Adamio, L (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Microbiol & Immunol, 1300 Morris Pk Ave, Bronx, NY 10461 USA.	ldadamio@aecom.yu.edu		D'Adamio, Luciano/0000-0002-9820-4882; D'Adamio, Luciano/0000-0002-2204-9441	National Institutes of Health [RO1 AG22024, RO1 AG21588, R21 AG027139]; NIA; Alzheimer's Association [IIRG-05-14511]; NATIONAL INSTITUTE ON AGING [R21AG027139, R01AG022024, R01AG021588] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Alzheimer's Association(Alzheimer's Association); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 AG22024, RO1 AG21588, and R21 AG027139 from the NIA. This work was also supported by Alzheimer's Association Grant IIRG-05-14511 to L. D.).	Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; BRETELER MMB, 1992, EPIDEMIOL REV, V14, P59, DOI 10.1093/oxfordjournals.epirev.a036092; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Checler F, 2007, CURR ALZHEIMER RES, V4, P423, DOI 10.2174/156720507781788945; Chyung JH, 2005, J BIOL CHEM, V280, P4383, DOI 10.1074/jbc.M409272200; Cupers P, 2001, J NEUROCHEM, V78, P1168, DOI 10.1046/j.1471-4159.2001.00516.x; Deleersnijder W, 1996, J BIOL CHEM, V271, P19475, DOI 10.1074/jbc.271.32.19475; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; Evin G, 2006, CNS DRUGS, V20, P351, DOI 10.2165/00023210-200620050-00002; Fotinopoulou A, 2005, J BIOL CHEM, V280, P30768, DOI 10.1074/jbc.C500231200; Giliberto L, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-12; Hamid R, 2007, J NEUROCHEM, V102, P1264, DOI 10.1111/j.1471-4159.2007.04627.x; Kaether C, 2006, TRAFFIC, V7, P408, DOI 10.1111/j.1600-0854.2006.00396.x; Kim HS, 2003, FASEB J, V17, P1951, DOI 10.1096/fj.03-0106fje; Kim JS, 2008, J NEUROSCI, V28, P6030, DOI 10.1523/JNEUROSCI.0891-08.2008; KOO EH, 1990, P NATL ACAD SCI USA, V87, P1561, DOI 10.1073/pnas.87.4.1561; Leissring MA, 2002, P NATL ACAD SCI USA, V99, P4697, DOI 10.1073/pnas.072033799; Li QM, 2004, J BIOL CHEM, V279, P10542, DOI 10.1074/jbc.M310001200; Liu Q, 2007, NEURON, V56, P66, DOI 10.1016/j.neuron.2007.08.008; Madeira A, 2005, FASEB J, V19, P1905, DOI 10.1096/fj.05-3839fje; Martin L, 2008, J BIOL CHEM, V283, P1644, DOI 10.1074/jbc.M706661200; Matsuda S, 2005, J BIOL CHEM, V280, P28912, DOI 10.1074/jbc.C500217200; Matsuda S, 2001, J NEUROSCI, V21, P6597; Matsuda S, 2008, J NEUROSCI, V28, P8668, DOI 10.1523/JNEUROSCI.2094-08.2008; Pardossi-Piquard R, 2005, NEURON, V46, P541, DOI 10.1016/j.neuron.2005.04.008; Passer Brent, 2000, Journal of Alzheimer's Disease, V2, P289; Roncarati R, 2002, P NATL ACAD SCI USA, V99, P7102, DOI 10.1073/pnas.102192599; Sanchez-Pulido L, 2002, TRENDS BIOCHEM SCI, V27, P329, DOI 10.1016/S0968-0004(02)02134-5; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Scheinfeld MH, 2002, J BIOL CHEM, V277, P44195, DOI 10.1074/jbc.M208110200; Scheinfeld MH, 2002, J BIOL CHEM, V277, P3767, DOI 10.1074/jbc.M108357200; Scheinfeld MH, 2003, P NATL ACAD SCI USA, V100, P1729, DOI 10.1073/pnas.0437908100; Selkoe D, 2003, ANNU REV NEUROSCI, V26, P565, DOI 10.1146/annurev.neuro.26.041002.131334; Selkoe DJ, 2002, ANNU REV GENOM HUM G, V3, P67, DOI 10.1146/annurev.genom.3.022502.103022; Shen J, 2007, P NATL ACAD SCI USA, V104, P403, DOI 10.1073/pnas.0608332104; Sisodia SS, 2002, NAT REV NEUROSCI, V3, P281, DOI 10.1038/nrn785; Stamer K, 2002, J CELL BIOL, V156, P1051, DOI 10.1083/jcb.200108057; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vidal R, 2000, P NATL ACAD SCI USA, V97, P4920, DOI 10.1073/pnas.080076097; Vidal R, 1999, NATURE, V399, P776; Vidal R, 2001, GENE, V266, P95, DOI 10.1016/S0378-1119(01)00374-2; von Rotz RC, 2004, J CELL SCI, V117, P4435, DOI 10.1242/jcs.01323; Wickham L, 2005, J NEUROCHEM, V92, P93, DOI 10.1111/j.1471-4159.2004.02840.x; Zazzeroni F, 2003, BLOOD, V102, P3270, DOI 10.1182/blood-2003-03-0689	44	39	45	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15815	15825		10.1074/jbc.M109.006403	http://dx.doi.org/10.1074/jbc.M109.006403			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19366692	hybrid, Green Published			2022-12-27	WOS:000266501000050
J	Andersen, KM; Madsen, L; Prag, S; Johnsen, AH; Semple, CA; Hendil, KB; Hartmann-Petersen, R				Andersen, Katrine M.; Madsen, Louise; Prag, Soren; Johnsen, Anders H.; Semple, Colin A.; Hendil, Klavs B.; Hartmann-Petersen, Rasmus			Thioredoxin Txnl1/TRP32 Is a Redox-active Cofactor of the 26 S Proteasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAENORHABDITIS-ELEGANS; MOLECULAR-CLONING; PROTEIN; IDENTIFICATION; PURIFICATION; DEGRADATION; EXPRESSION; SITE; RECOGNITION; PROTEOMICS	The 26 S proteasome is a large proteolytic machine, which degrades most intracellular proteins. We found that thioredoxin, Txnl1/TRP32, binds to Rpn11, a subunit of the regulatory complex of the human 26 S proteasome. Txnl1 is abundant, metabolically stable, and widely expressed and is present in the cytoplasm and nucleus. Txnl1 has thioredoxin activity with a redox potential of about -250 mV. Mutant Txnl1 with one active site cysteine replaced by serine formed disulfide bonds to eEF1A1, a substrate-recruiting factor of the 26 S proteasome. eEF1A1 is therefore a likely physiological substrate. In response to knockdown of Txnl1, ubiquitin-protein conjugates were moderately stabilized. Hence, Txnl1 is the first example of a direct connection between protein reduction and proteolysis, two major intracellular protein quality control mechanisms.	[Hartmann-Petersen, Rasmus] Univ Copenhagen, Dept Biol, DK-2100 Copenhagen, Denmark; [Prag, Soren] Univ Lisbon, Fac Med, Inst Mol Med, P-1649028 Lisbon, Portugal; [Johnsen, Anders H.] Copenhagen Univ Hosp, Dept Clin Biochem, DK-2100 Copenhagen, Denmark; [Semple, Colin A.] MRC, Human Genet Unit, Edinburgh EH4 2XU, Midlothian, Scotland	University of Copenhagen; Universidade de Lisboa; University of Copenhagen; University of Edinburgh	Hartmann-Petersen, R (corresponding author), Univ Copenhagen, Dept Biol, Univ Pk 13, DK-2100 Copenhagen, Denmark.	rhpetersen@bio.ku.dk	Hartmann-Petersen, Rasmus/K-4434-2014; Semple, Colin A M/A-5613-2009	Hartmann-Petersen, Rasmus/0000-0002-4155-7791; Semple, Colin A M/0000-0003-1765-4118	Danish Research Academy, Lundbeck Foundation; Novo Nordisk Foundation, and Carlsberg Foundation	Danish Research Academy, Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Foundation, and Carlsberg Foundation(Novo Nordisk Foundation)	This work was supported by grants from the Danish Research Academy, Lundbeck Foundation, Novo Nordisk Foundation, and Carlsberg Foundation (to R.H.-P.).	Ambroggio XI, 2004, PLOS BIOL, V2, P113, DOI 10.1371/journal.pbio.0020002; Balmer Y, 2003, P NATL ACAD SCI USA, V100, P370, DOI 10.1073/pnas.232703799; Braun BC, 1999, NAT CELL BIOL, V1, P221, DOI 10.1038/12043; Brodegger T, 2004, BIOL CHEM, V385, P1185, DOI 10.1515/BC.2004.153; Brooks P, 2000, BIOCHEM J, V346, P155, DOI 10.1042/0264-6021:3460155; Chen L, 2005, CANCER RES, V65, P5599, DOI 10.1158/0008-5472.CAN-05-0201; Chuang SM, 2005, MOL CELL BIOL, V25, P403, DOI 10.1128/MCB.25.1.403-413.2005; Davy A, 2001, EMBO REP, V2, P821, DOI 10.1093/embo-reports/kve184; Dawson S, 2002, J BIOL CHEM, V277, P10893, DOI 10.1074/jbc.M107313200; Demasi M, 2003, J BIOL CHEM, V278, P679, DOI 10.1074/jbc.M209282200; Felberbaum-Corti M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001144; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; GONEN H, 1994, P NATL ACAD SCI USA, V91, P7648, DOI 10.1073/pnas.91.16.7648; Grune T, 2004, INT J BIOCHEM CELL B, V36, P2519, DOI 10.1016/j.biocel.2004.04.020; Guerrero C, 2008, P NATL ACAD SCI USA, V105, P13333, DOI 10.1073/pnas.0801870105; Hartmann-Petersen R, 2003, TRENDS BIOCHEM SCI, V28, P26, DOI 10.1016/S0968-0004(02)00002-6; Haugstetter J, 2005, J BIOL CHEM, V280, P8371, DOI 10.1074/jbc.M413924200; Hendil KB, 2005, METHOD ENZYMOL, V398, P439, DOI 10.1016/S0076-6879(05)98036-1; Hendil KB, 2004, CURR PROTEIN PEPT SC, V5, P135, DOI 10.2174/1389203043379747; Hirota K, 1997, P NATL ACAD SCI USA, V94, P3633, DOI 10.1073/pnas.94.8.3633; HOFFMAN L, 1992, J BIOL CHEM, V267, P22362; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; HOUGH R, 1987, J BIOL CHEM, V262, P8303; Ishii T, 2005, BIOCHEMISTRY-US, V44, P13893, DOI 10.1021/bi051336u; Jimenez A, 2006, FEBS LETT, V580, P960, DOI 10.1016/j.febslet.2006.01.025; Jimenez A, 2007, YEAST, V24, P481, DOI 10.1002/yea.1483; Jorgensen JP, 2006, J MOL BIOL, V360, P1043, DOI 10.1016/j.jmb.2006.06.011; KE B, 1957, BIOCHIM BIOPHYS ACTA, V25, P650, DOI 10.1016/0006-3002(57)90544-9; Kouwen TRHM, 2008, J MOL BIOL, V379, P520, DOI 10.1016/j.jmb.2008.03.077; KRAUSE G, 1991, J BIOL CHEM, V266, P9494; Landino LM, 2004, FREE RADICAL BIO MED, V36, P497, DOI 10.1016/j.freeradbiomed.2003.11.026; Lee KK, 1998, J BIOL CHEM, V273, P19160, DOI 10.1074/jbc.273.30.19160; Leggett DS, 2002, MOL CELL, V10, P495, DOI 10.1016/S1097-2765(02)00638-X; Liu CW, 2002, J BIOL CHEM, V277, P26815, DOI 10.1074/jbc.M201782200; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lukash TO, 2004, INT J BIOCHEM CELL B, V36, P1341, DOI 10.1016/j.biocel.2003.11.009; Lundgren J, 2005, MOL CELL BIOL, V25, P4662, DOI 10.1128/MCB.25.11.4662-4675.2005; Lyngholm JM, 2001, ALLERGY, V56, P21; MA CP, 1992, J BIOL CHEM, V267, P10515; Madsen L, 2008, INT J BIOCHEM CELL B, V40, P2927, DOI 10.1016/j.biocel.2008.06.008; Malki A, 2002, BIOCHEM BIOPH RES CO, V296, P749, DOI 10.1016/S0006-291X(02)00935-X; Meiners S, 2003, J BIOL CHEM, V278, P21517, DOI 10.1074/jbc.M301032200; Menendez-Benito V, 2005, HUM MOL GENET, V14, P2787, DOI 10.1093/hmg/ddi312; Miranda-Vizuete A, 1998, BIOCHEM BIOPH RES CO, V243, P284, DOI 10.1006/bbrc.1997.8003; Motohashi K, 2001, P NATL ACAD SCI USA, V98, P11224, DOI 10.1073/pnas.191282098; ROST J, 1964, NATURE, V201, P185, DOI 10.1038/201185a0; RUBARTELLI A, 1992, J BIOL CHEM, V267, P24161; SLOT LA, 1987, SCAND J CLIN LAB INV, V47, P393; Sone T, 2004, J BIOL CHEM, V279, P28807, DOI 10.1074/jbc.M403165200; Strickland E, 2000, J BIOL CHEM, V275, P5565, DOI 10.1074/jbc.275.8.5565; Tanahashi N, 2000, J BIOL CHEM, V275, P14336, DOI 10.1074/jbc.275.19.14336; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Urano F, 2002, J CELL BIOL, V158, P639, DOI 10.1083/jcb.200203086; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Vignols F, 2003, J BIOL CHEM, V278, P4516, DOI 10.1074/jbc.M210080200; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Wang XR, 2008, MOL CELL PROTEOMICS, V7, P46, DOI 10.1074/mcp.M700261-MCP200; Wiseman RL, 2009, J BIOL CHEM, V284, P15233, DOI 10.1074/jbc.M109.002121; Wong JH, 2003, FEBS LETT, V547, P151, DOI 10.1016/S0014-5793(03)00696-3; Xie YM, 2001, P NATL ACAD SCI USA, V98, P3056, DOI 10.1073/pnas.071022298; Yamazaki D, 2004, PLANT CELL PHYSIOL, V45, P18, DOI 10.1093/pcp/pch019; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071	62	60	64	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					15246	15254		10.1074/jbc.M900016200	http://dx.doi.org/10.1074/jbc.M900016200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19349277	Green Published, hybrid			2022-12-27	WOS:000266288200059
J	Deffieu, M; Bhatia-Kissova, I; Salin, B; Galinier, A; Manon, S; Camougrand, N				Deffieu, Maika; Bhatia-Kissova, Ingrid; Salin, Benedicte; Galinier, Anne; Manon, Stephen; Camougrand, Nadine			Glutathione Participates in the Regulation of Mitophagy in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-GLUTAMYL-TRANSPEPTIDASE; PROGRAMMED CELL-DEATH; SACCHAROMYCES-CEREVISIAE; OXIDATIVE STRESS; MITOCHONDRIAL AUTOPHAGY; AMINO-ACID; NITROGEN-SOURCE; DEGRADATION; STARVATION; GROWTH	Theantioxidant N-acetyl-L-cysteine prevented the autophagy-dependent delivery of mitochondria to the vacuoles, as examined by fluorescence microscopy of mitochondria-targeted green fluorescent protein, transmission electron microscopy, and Western blot analysis of mitochondrial proteins. The effect of N-acetyl-L-cysteine was specific to mitochondrial autophagy (mitophagy). Indeed, autophagy-dependent activation of alkaline phosphatase and the presence of hallmarks of non-selective microautophagy were not altered by N-acetyl-L-cysteine. The effect of N-acetyl-L-cysteine was not related to its scavenging properties, but rather to its fueling effect of the glutathione pool. As a matter of fact, the decrease of the glutathione pool induced by chemical or genetical manipulation did stimulate mitophagy but not general autophagy. Conversely, the addition of a cell-permeable form of glutathione inhibited mitophagy. Inhibition of glutathione synthesis had no effect in the strain Delta uth1, which is deficient in selective mitochondrial degradation. These data show that mitophagy can be regulated independently of general autophagy, and that its implementation may depend on the cellular redox status.	[Camougrand, Nadine] Univ Bordeaux 2, CNRS, Inst Biochim & Genet Cellulaires, UMR 5095, F-33077 Bordeaux, France; [Bhatia-Kissova, Ingrid] Comenius Univ, Dept Biochem, Bratislava 84215, Slovakia; [Salin, Benedicte] Univ Bordeaux 2, Serv Commun Microscopie, F-33076 Bordeaux, France; [Galinier, Anne] Univ Toulouse 3, CNRS, UMR 5018, CHU Rangueil,TSA 50032,IFR 31, F-31059 Toulouse 9, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux; Comenius University Bratislava; UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CHU de Toulouse; Universite de Toulouse; Universite Toulouse III - Paul Sabatier	Camougrand, N (corresponding author), Univ Bordeaux 2, CNRS, Inst Biochim & Genet Cellulaires, UMR 5095, 1 Rue Camille St Saens, F-33077 Bordeaux, France.	n.camougrand@ibgc.cnrs.fr	Manon, Stéphen/C-7088-2017; Bhatia, Ingrid/H-7016-2016	Manon, Stephen/0000-0002-5792-1084; Galinier, Anne/0000-0003-2454-5681	CNRS; Universite de Bordeaux 2; Conseil Regional d'Aquitaine [UMR 5095]; Association pour la Recherche contre le Cancer [3812]; Slovak Ministry of Education [VEGA1/0264/08]; Science and Technology Assistance Agency [APVV-0024-07]; Egide ECO-NET [10187VF]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite de Bordeaux 2; Conseil Regional d'Aquitaine(Region Nouvelle-Aquitaine); Association pour la Recherche contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Slovak Ministry of Education; Science and Technology Assistance Agency; Egide ECO-NET	This work was supported in part by grants from the CNRS, the Universite de Bordeaux 2, the Conseil Regional d'Aquitaine (to UMR 5095), and Association pour la Recherche contre le Cancer Grant 3812 (to S. M.), Slovak Ministry of Education Contract VEGA1/0264/08 and Science and Technology Assistance Agency Contract APVV-0024-07 (to I. B.-K.). The France/Slovakia collaboration was supported by Egide ECO-NET 10187VF (to S. M.).	AMY PS, 1983, APPL ENVIRON MICROB, V45, P1041, DOI 10.1128/AEM.45.3.1041-1048.1983; ARUOMA OI, 1989, FREE RADICAL BIO MED, V6, P593, DOI 10.1016/0891-5849(89)90066-X; Camougrand N, 2003, MOL MICROBIOL, V47, P495, DOI 10.1046/j.1365-2958.2003.03311.x; Carmel-Harel O, 2000, ANNU REV MICROBIOL, V54, P439, DOI 10.1146/annurev.micro.54.1.439; Gomes DS, 2002, BBA-GEN SUBJECTS, V1573, P21, DOI 10.1016/S0304-4165(02)00324-0; Grant CM, 2001, MOL MICROBIOL, V39, P533, DOI 10.1046/j.1365-2958.2001.02283.x; Grant CM, 1997, MOL BIOL CELL, V8, P1699, DOI 10.1091/mbc.8.9.1699; Grant CM, 1996, CURR GENET, V29, P511, DOI 10.1007/BF02426954; Griffith OW, 1999, FREE RADICAL BIO MED, V27, P922, DOI 10.1016/S0891-5849(99)00176-8; Hamasaki M, 2005, TRAFFIC, V6, P56, DOI 10.1111/j.1600-0854.2004.00245.x; Hammarqvist F, 2005, CLIN NUTR, V24, P236, DOI 10.1016/j.clnu.2004.10.004; Huang WP, 2002, CELL STRUCT FUNCT, V27, P409, DOI 10.1247/csf.27.409; Jazwinski SM, 2005, MECH AGEING DEV, V126, P243, DOI 10.1016/j.mad.2004.08.016; Kanki T, 2008, J BIOL CHEM, V283, P32386, DOI 10.1074/jbc.M802403200; Kiel JAKW, 2003, FEBS LETT, V549, P1, DOI 10.1016/S0014-5793(03)00794-4; Kiffin R, 2006, ANTIOXID REDOX SIGN, V8, P152, DOI 10.1089/ars.2006.8.152; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; Kissova I, 2004, J BIOL CHEM, V279, P39068, DOI 10.1074/jbc.M406960200; Kissova I, 2007, AUTOPHAGY, V3, P329, DOI 10.4161/auto.4034; Kissova I, 2006, FREE RADICAL BIO MED, V41, P1655, DOI 10.1016/j.freeradbiomed.2006.08.012; KLINGENBERG M, 1985, METHOD ENZYMAT AN, V7, P251; Kraft C, 2008, NAT CELL BIOL, V10, P602, DOI 10.1038/ncb1723; Kundu M, 2005, CELL DEATH DIFFER, V12, P1484, DOI 10.1038/sj.cdd.4401780; Lemasters JJ, 2005, REJUV RES, V8, P3, DOI 10.1089/rej.2005.8.3; Lenaz G, 2002, ANN NY ACAD SCI, V959, P199, DOI 10.1111/j.1749-6632.2002.tb02094.x; Mehdi K, 1997, MICROBIOL-UK, V143, P1885, DOI 10.1099/00221287-143-6-1885; Melnyk S, 1999, J NUTR BIOCHEM, V10, P490, DOI 10.1016/S0955-2863(99)00033-9; MOAT AG, 1969, J BACTERIOL, V98, P573, DOI 10.1128/JB.98.2.573-578.1969; Nair U, 2005, J BIOL CHEM, V280, P41785, DOI 10.1074/jbc.R500016200; NODA T, 1995, BIOCHEM BIOPH RES CO, V210, P126, DOI 10.1006/bbrc.1995.1636; Nowikovsky K, 2007, CELL DEATH DIFFER, V14, P1647, DOI 10.1038/sj.cdd.4402167; OHTAKE Y, 1990, AGR BIOL CHEM TOKYO, V54, P3145, DOI 10.1080/00021369.1990.10870487; Okamoto K, 1998, J CELL BIOL, V142, P613, DOI 10.1083/jcb.142.3.613; Pan XZ, 2000, MOL BIOL CELL, V11, P2445, DOI 10.1091/mbc.11.7.2445; Penninckx MJ, 2002, FEMS YEAST RES, V2, P295, DOI 10.1111/j.1567-1364.2002.tb00098.x; Priault M, 2005, CELL DEATH DIFFER, V12, P1613, DOI 10.1038/sj.cdd.4401697; Reggiori F, 2005, CURR OPIN CELL BIOL, V17, P415, DOI 10.1016/j.ceb.2005.06.007; Richie JP, 2004, NUTRITION, V20, P800, DOI 10.1016/j.nut.2004.05.009; Roberts P, 2003, MOL BIOL CELL, V14, P129, DOI 10.1091/mbc.E02-08-0483; Rodriguez-Enriquez S, 2004, INT J BIOCHEM CELL B, V36, P2463, DOI 10.1016/j.biocel.2004.04.009; Rodriguez-Enriquez S, 2006, AUTOPHAGY, V2, P39, DOI 10.4161/auto.2229; Rosado CJ, 2008, AUTOPHAGY, V4, P205, DOI 10.4161/auto.5331; Sakai Y, 1998, J CELL BIOL, V141, P625, DOI 10.1083/jcb.141.3.625; Sanz A, 2006, ANTIOXID REDOX SIGN, V8, P582, DOI 10.1089/ars.2006.8.582; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Scherz-Shouval R, 2007, EMBO J, V26, P1749, DOI 10.1038/sj.emboj.7601623; SJODIN K, 1989, BIOCHEM PHARMACOL, V38, P3981, DOI 10.1016/0006-2952(89)90677-1; Springael JY, 2003, BIOCHEM J, V371, P589, DOI 10.1042/BJ20021893; Tal R, 2007, J BIOL CHEM, V282, P5617, DOI 10.1074/jbc.M605940200; TATEISHI N, 1977, J NUTR, V107, P51, DOI 10.1093/jn/107.1.51; Terman Alexei, 2006, Molecular Aspects of Medicine, V27, P471, DOI 10.1016/j.mam.2006.08.006; Tolkovsky AM, 2002, BIOCHIMIE, V84, P233, DOI 10.1016/S0300-9084(02)01371-8; Turrens JF, 2003, J PHYSIOL-LONDON, V552, P335, DOI 10.1113/jphysiol.2003.049478; Ullmann P, 1996, EUR J BIOCHEM, V236, P662, DOI 10.1111/j.1432-1033.1996.00662.x; VOGT BL, 1993, BIOCHEM PHARMACOL, V46, P257, DOI 10.1016/0006-2952(93)90412-P; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; WATSON TG, 1976, J GEN MICROBIOL, V96, P263, DOI 10.1099/00221287-96-2-263; WELLNER VP, 1984, P NATL ACAD SCI-BIOL, V81, P4732, DOI 10.1073/pnas.81.15.4732; Xue L, 2001, CURR BIOL, V11, P361, DOI 10.1016/S0960-9822(01)00100-2; Xue LZ, 1999, MOL CELL NEUROSCI, V14, P180, DOI 10.1006/mcne.1999.0780; Yu BP, 2006, MECH AGEING DEV, V127, P436, DOI 10.1016/j.mad.2006.01.023; Yu L, 2006, P NATL ACAD SCI USA, V103, P4952, DOI 10.1073/pnas.0511288103	62	85	91	3	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					14828	14837		10.1074/jbc.M109.005181	http://dx.doi.org/10.1074/jbc.M109.005181			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19366696	Green Published, hybrid			2022-12-27	WOS:000266288200018
J	Paul, DM; Morris, EP; Kensler, RW; Squire, JM				Paul, Danielle M.; Morris, Edward P.; Kensler, Robert W.; Squire, John M.			Structure and Orientation of Troponin in the Thin Filament	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-PARTICLE ANALYSIS; 3-DIMENSIONAL RECONSTRUCTION; ELECTRON-MICROSCOPY; MUSCLE-CONTRACTION; ACTIN-FILAMENT; ATOMIC MODEL; F-ACTIN; SKELETAL-MUSCLE; CO-CRYSTALS; TROPOMYOSIN	The troponin complex on the thin filament plays a crucial role in the regulation of muscle contraction. However, the precise location of troponin relative to actin and tropomyosin remains uncertain. We have developed a method of reconstructing thin filaments using single particle analysis that does not impose the helical symmetry of actin and is independent of a starting model. We present a single particle three-dimensional reconstruction of the thin filament. Atomic models of the F-actin filament were fitted into the electron density maps and troponin and tropomyosin located. The structure provides evidence that the globular head region of troponin labels the two strands of actin with a 27.5-angstrom axial stagger. The density attributed to troponin appears tapered with the widest point toward the barbed end. This leads us to interpret the polarity of the troponin complex in the thin filament as reversed with respect to the widely accepted model.	[Paul, Danielle M.; Morris, Edward P.] Chester Beatty Labs, Inst Canc Res, London SW3 6JB, England; [Kensler, Robert W.] Univ Puerto Rico, Dept Anat, Sch Med, San Juan, PR 00936 USA; [Squire, John M.] Univ Bristol, Dept Physiol & Pharmacol, Bristol BS8 1TD, Avon, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Bristol	Morris, EP (corresponding author), Chester Beatty Labs, Inst Canc Res, 237 Fulham Rd, London SW3 6JB, England.	edward.morris@icr.ac.uk		Squire, John/0000-0001-5731-253X; Squire, John/0000-0001-6656-7390; Morris, Edward/0000-0003-3544-0041	National Institutes of Health Minorities Basic Research [S06 GM08224]; Research Centers in Minority Institutions Award [G12RR-03051]; BHF [13962, 23480]; Wellcome Trust [066418]; European MYORES Network on Muscle Development; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003051] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [S06GM008224] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007600] Funding Source: NIH RePORTER	National Institutes of Health Minorities Basic Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Centers in Minority Institutions Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); BHF(British Heart Foundation); Wellcome Trust(Wellcome TrustEuropean Commission); European MYORES Network on Muscle Development; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported, in whole or in part, by National Institutes of Health Minorities Basic Research Support Grant S06 GM08224 (to R. W. K.) and a Research Centers in Minority Institutions Award G12RR-03051 from the NCRR. This work was also supported by a BHF studentship (13962, to D. P.), a BHF Project Grant 23480 (to E. P. M. and J.M.S.), a Wellcome Trust Grant 066418 (to E. P. M.), and the European MYORES Network on Muscle Development (to J.M.S.).	Al-Khayat HA, 2006, J STRUCT BIOL, V155, P202, DOI 10.1016/j.jsb.2006.01.014; Beckmann R, 1997, SCIENCE, V278, P2123, DOI 10.1126/science.278.5346.2123; Bottcher B, 1997, NATURE, V386, P88, DOI 10.1038/386088a0; BREMER A, 1994, J MOL BIOL, V242, P683, DOI 10.1006/jmbi.1994.1617; Brown JH, 2005, ADV PROTEIN CHEM, V71, P121, DOI 10.1016/S0065-3233(04)71004-9; Burgess S, 2004, J MOL BIOL, V341, P1161, DOI 10.1016/j.jmb.2004.06.077; CabralLilly D, 1997, BIOPHYS J, V73, P1763, DOI 10.1016/S0006-3495(97)78206-7; CARR HJ, 1988, J MUSCLE RES CELL M, V9, P384, DOI 10.1007/BF01774065; CROWTHER RA, 1970, PROC R SOC LON SER-A, V317, P319, DOI 10.1098/rspa.1970.0119; Crowther RA, 1996, J STRUCT BIOL, V116, P9, DOI 10.1006/jsbi.1996.0003; DeLano W.L, PYMOL MOL GRAPHICS S; EBASHI S, 1972, NATURE, V240, P217, DOI 10.1038/240217a0; EBASHI S, 1972, COLD SPRING HARB SYM, V37, P215; Egelman EH, 2000, ULTRAMICROSCOPY, V85, P225, DOI 10.1016/S0304-3991(00)00062-0; EGELMAN EH, 1992, BIOPHYS J, V63, P1299, DOI 10.1016/S0006-3495(92)81716-2; FLICKER PF, 1982, J MOL BIOL, V162, P495, DOI 10.1016/0022-2836(82)90540-X; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Frank J, 1998, BIOPHYS J, V74, P589, DOI 10.1016/S0006-3495(98)77817-8; Galinska-Rakoczy A, 2008, J MOL BIOL, V379, P929, DOI 10.1016/j.jmb.2008.04.062; Gomes AV, 2004, MOL CELL BIOCHEM, V263, P115, DOI 10.1023/B:MCBI.0000041853.20588.a0; GONCHAROV AB, 1988, ULTRAMICROSCOPY, V25, P317, DOI 10.1016/0304-3991(88)90006-X; GREASER ML, 1973, J BIOL CHEM, V248, P2125; Greenfield NJ, 2002, BIOPHYS J, V82, P2580, DOI 10.1016/S0006-3495(02)75600-2; GREGORIO CC, 1995, NATURE, V377, P83, DOI 10.1038/377083a0; HARAUZ G, 1986, OPTIK, V73, P146; HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0; KENSLER RW, 1989, J CELL SCI, V94, P391; KOCSIS E, 1991, J STRUCT BIOL, V107, P6, DOI 10.1016/1047-8477(91)90025-R; LEHMAN W, 1994, NATURE, V368, P65, DOI 10.1038/368065a0; LEHMAN W, 1995, J MOL BIOL, V251, P191, DOI 10.1006/jmbi.1995.0425; Liu J, 2004, J STRUCT BIOL, V147, P268, DOI 10.1016/j.jsb.2004.03.008; MAK AS, 1981, J MOL BIOL, V149, P541, DOI 10.1016/0022-2836(81)90486-1; MENDELSON RA, 1994, J MOL BIOL, V240, P138, DOI 10.1006/jmbi.1994.1428; MOORE PB, 1970, J MOL BIOL, V50, P279, DOI 10.1016/0022-2836(70)90192-0; Mouche F, 2003, J STRUCT BIOL, V144, P301, DOI 10.1016/j.jsb.2003.09.001; Narita A, 2001, J MOL BIOL, V308, P241, DOI 10.1006/jmbi.2001.4598; Navaza J, 2002, ACTA CRYSTALLOGR D, V58, P1820, DOI 10.1107/S0907444902013707; OHTSUKI I, 1979, J BIOCHEM, V86, P491, DOI 10.1093/oxfordjournals.jbchem.a132549; OHTSUKI I, 1988, J BIOCHEM-TOKYO, V103, P913, DOI 10.1093/oxfordjournals.jbchem.a122387; OHTSUKI I, 1974, J BIOCHEM-TOKYO, V75, P753, DOI 10.1093/oxfordjournals.jbchem.a130448; Oliveira DM, 2000, J BIOL CHEM, V275, P27513; Patwardhan A, 2004, J MOL BIOL, V344, P707, DOI 10.1016/j.jmb.2004.09.068; Paul D, 2004, J STRUCT BIOL, V148, P236, DOI 10.1016/j.jsb.2004.05.004; PEARLSTONE JR, 1982, J BIOL CHEM, V257, P587; Pirani A, 2006, J MOL BIOL, V357, P707, DOI 10.1016/j.jmb.2005.12.050; Pirani A, 2005, J MOL BIOL, V346, P761, DOI 10.1016/j.jmb.2004.12.013; RADERMACHER M, 1988, J ELECTRON MICR TECH, V9, P359, DOI 10.1002/jemt.1060090405; RADERMACHER M, 1994, ULTRAMICROSCOPY, V53, P121, DOI 10.1016/0304-3991(94)90003-5; Squire JM, 1998, FASEB J, V12, P761, DOI 10.1096/fasebj.12.10.761; STOKES DL, 1987, J CELL BIOL, V104, P1005, DOI 10.1083/jcb.104.4.1005; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; van Heel M, 2005, J STRUCT BIOL, V151, P250, DOI 10.1016/j.jsb.2005.05.009; van Heel M, 2000, Q REV BIOPHYS, V33, P307, DOI 10.1017/S0033583500003644; VANHEEL M, 1984, ULTRAMICROSCOPY, V13, P165, DOI 10.1016/0304-3991(84)90066-4; VANHEEL M, 1987, ULTRAMICROSCOPY, V21, P111, DOI 10.1016/0304-3991(87)90078-7; VANHEEL M, 1989, OPTIK, V82, P114; Vinogradova MV, 2005, P NATL ACAD SCI USA, V102, P5038, DOI 10.1073/pnas.0408882102; Whitby FG, 2000, PROTEINS, V38, P49; WHITE SP, 1987, NATURE, V325, P826, DOI 10.1038/325826a0; Woodhead JL, 2005, NATURE, V436, P1195, DOI 10.1038/nature03920; Wriggers W, 1999, J STRUCT BIOL, V125, P185, DOI 10.1006/jsbi.1998.4080	61	22	23	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					15007	15015		10.1074/jbc.M808615200	http://dx.doi.org/10.1074/jbc.M808615200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19321455	hybrid, Green Published			2022-12-27	WOS:000266288200037
J	Bourbon-Freie, A; Dub, RE; Xiao, XJ; Lowe, ME				Bourbon-Freie, Angela; Dub, Rachel E.; Xiao, Xunjun; Lowe, Mark E.			Trp-107 and Trp-253 Account for the Increased Steady State Fluorescence That Accompanies the Conformational Change in Human Pancreatic Triglyceride Lipase Induced by Tetrahydrolipstatin and Bile Salt	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACID SUBSTITUTION MATRICES; MIXED MICELLES; INTERFACIAL ACTIVATION; ENERGY-TRANSFER; YEAST-CELLS; COMPLEX; PROCOLIPASE; DOMAIN; PURIFICATION; TRANSITION	The conformation of a surface loop, the lid, controls activity of pancreatic triglyceride lipase (PTL) by moving from a position that sterically hinders substrate access to the active site into a new conformation that opens and configures the active site. Movement of the lid is accompanied by a large change in steady state tryptophan fluorescence. Although a change in the microenvironment of Trp-253, a lid residue, could account for the increased fluorescence, the mechanism and tryptophan residues have not been identified. To identify the tryptophan residues responsible for the increased fluorescence and to gain insight into the mechanism of lid opening and the structure of PTL in aqueous solution, we examined the effects of mutating individual tryptophan residues to tyrosine, alanine, or phenylalanine on lipase activity and steady state fluorescence. Substitution of tryptophans 86, 107, 253, and 403 reduced activity against tributyrin with the largest effects caused by substituting Trp-86 and Trp-107. Trp-107 and Trp-253 fluorescence accounts for the increased fluorescence emissions of PTL that is stimulated by tetrahydrolipstatin and sodium taurodeoxycholate. The largest contribution is from Trp-107. Contrary to the prediction from the crystal structure of PTL, Trp-107 is likely exposed to solvent. Both tetrahydrolipstatin and sodium taurodeoxycholate are required to produce the increased fluorescence in PTL. Alone, neither is sufficient. Colipase does not significantly influence the conformational changes leading to increased emission fluorescence. Thus, Trp-107 and Trp-253 contribute to the change in steady state fluorescence that is triggered by mixed micelles of inhibitor and bile salt. Furthermore, the results suggest that the conformation of PTL in solution differs significantly from the conformation in crystals.	[Dub, Rachel E.; Xiao, Xunjun; Lowe, Mark E.] UPMC, Childrens Hosp Pittsburgh, Dept Pediat, Pittsburgh, PA 15213 USA; [Bourbon-Freie, Angela] Washington Univ, Sch Med, Dept Neurosurg, St Louis, MO 63110 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Washington University (WUSTL)	Lowe, ME (corresponding author), UPMC, Childrens Hosp Pittsburgh, Dept Pediat, 3705 5th Ave, Pittsburgh, PA 15213 USA.	mark.lowe@chp.edu		Xiao, Xunjun/0000-0001-5930-4664	National Institutes of Health [HD33060]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD033060] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported, in whole or in part, by National Institutes of Health Grant HD33060.	Ayvazian L, 1998, J BIOL CHEM, V273, P33604, DOI 10.1074/jbc.273.50.33604; Belle V, 2007, BIOCHEMISTRY-US, V46, P2205, DOI 10.1021/bi0616089; Bezzine S, 1998, BIOCHEMISTRY-US, V37, P11846, DOI 10.1021/bi973136r; BORDO D, 1991, J MOL BIOL, V217, P721, DOI 10.1016/0022-2836(91)90528-E; BRUSTEIN EA, 1973, PHOTOCHEM PHOTOBIOL, V18, P263, DOI DOI 10.1016/S1567-5394(01)00170-0; Chahinian H, 2002, BIOCHEMISTRY-US, V41, P13725, DOI 10.1021/bi0257944; Cordle RA, 1998, PROTEIN EXPRES PURIF, V13, P30, DOI 10.1006/prep.1998.0873; Crandall WV, 2001, J BIOL CHEM, V276, P12505, DOI 10.1074/jbc.M009986200; CUDREY C, 1993, BIOCHEMISTRY-US, V32, P13800, DOI 10.1021/bi00213a008; EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P547, DOI 10.1021/bi00854a024; EFTINK MR, 1976, BIOCHEMISTRY-US, V15, P672, DOI 10.1021/bi00648a035; EFTINK MR, 1981, ANAL BIOCHEM, V114, P199, DOI 10.1016/0003-2697(81)90474-7; EGLOFF MP, 1995, BIOCHEMISTRY-US, V34, P2751, DOI 10.1021/bi00009a003; Freie AB, 2006, J BIOL CHEM, V281, P7793, DOI 10.1074/jbc.M512984200; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Henikoff S, 2000, ADV PROTEIN CHEM, V54, P73, DOI 10.1016/S0065-3233(00)54003-0; Hermoso J, 1997, EMBO J, V16, P5531, DOI 10.1093/emboj/16.18.5531; Hermoso J, 1996, J BIOL CHEM, V271, P18007, DOI 10.1074/jbc.271.30.18007; Holmquist M, 2000, CURR PROTEIN PEPT SC, V1, P209, DOI 10.2174/1389203003381405; JULTILA A, 2000, BIOPHYS J, V78, P1634; Lakowicz J. R, 1999, PRINCIPLES FLUORESCE, P446; Lowe ME, 2002, J LIPID RES, V43, P2007, DOI 10.1194/jlr.R200012-JLR200; Lowe ME, 1997, J BIOL CHEM, V272, P9; LUTHIPENG Q, 1992, EUR J BIOCHEM, V205, P383, DOI 10.1111/j.1432-1033.1992.tb16791.x; Miled N, 2000, BBA-PROTEIN STRUCT M, V1476, P165, DOI 10.1016/S0167-4838(99)00288-5; OLLIS DL, 1992, PROTEIN ENG, V5, P197, DOI 10.1093/protein/5.3.197; Pignol D, 2000, J BIOL CHEM, V275, P4220, DOI 10.1074/jbc.275.6.4220; Ramos P, 2003, BIOCHEMISTRY-US, V42, P12488, DOI 10.1021/bi034900e; ROUARD M, 1978, BIOCHIM BIOPHYS ACTA, V530, P227, DOI 10.1016/0005-2760(78)90008-5; Roussel A, 1998, J BIOL CHEM, V273, P32121, DOI 10.1074/jbc.273.48.32121; Roussel A, 1998, PROTEINS, V32, P523; Sambrook J., 2001, MOL CLONING LAB MANU; VANTILBEURGH H, 1993, NATURE, V362, P814, DOI 10.1038/362814a0; VANTILBEURGH H, 1993, J MOL BIOL, V229, P552, DOI 10.1006/jmbi.1993.1054; Verger R, 1997, TRENDS BIOTECHNOL, V15, P32, DOI 10.1016/S0167-7799(96)10064-0; WEBER G, 1960, BIOCHEM J, V75, P335, DOI 10.1042/bj0750335; WINKLER FK, 1990, NATURE, V343, P771, DOI 10.1038/343771a0; Yang YQ, 2000, J LIPID RES, V41, P48; Yang YQ, 1998, PROTEIN EXPRES PURIF, V13, P36, DOI 10.1006/prep.1998.0874; Yapoudjian S, 2002, EUR J BIOCHEM, V269, P1613, DOI 10.1046/j.1432-1327.2002.02786.x	40	7	7	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14157	14164		10.1074/jbc.M901154200	http://dx.doi.org/10.1074/jbc.M901154200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19346257	Green Published, hybrid			2022-12-27	WOS:000266286100022
J	Kataoka, K; Sugiyama, R; Hirota, S; Inoue, M; Urata, K; Minagawa, Y; Seo, D; Sakurai, T				Kataoka, Kunishige; Sugiyama, Ryosuke; Hirota, Shun; Inoue, Megumi; Urata, Kanae; Minagawa, Yoichi; Seo, Daisuke; Sakurai, Takeshi			Four-electron Reduction of Dioxygen by a Multicopper Oxidase, CueO, and Roles of Asp(112) and Glu(506) Located Adjacent to the Trinuclear Copper Center	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; PEROXIDE INTERMEDIATE; BILIRUBIN-OXIDASE; CUPROUS OXIDASE; PROTON DONOR; BINDING; LACCASE; O-2; HOMEOSTASIS	The mechanism of the four-electron reduction of dioxygen by a multicopper oxidase, CueO, was studied based on reactions of single and double mutants with Cys(500), a type I copper ligand, and the noncoordinating Asp(112) and Glu(506), which form hydrogen bonds with the trinuclear copper center directly and indirectly via a water molecule. The reaction of C500S containing a vacant type I copper center produced intermediate I in an EPR-silent peroxide-bound form. The formation of intermediate I from C500S/D112N was restricted due to a reduction in the affinity of the trinuclear copper center for dioxygen. The state of intermediate I was realized to be the resting form of C500S/E506Q and C500S of the truncated mutant Delta alpha 5-7CueO, in which the 50 amino acids covering the substrate-binding site were removed. Reactions of the recombinant CueO and E506Q afforded intermediate II, a fully oxidized form different from the resting one, with a very broad EPR signal, g < 2, detectable only at cryogenic temperatures and unsaturated with high power microwaves. The lifetime of intermediate II was prolonged by the mutation at Glu(506) involved in the donation of protons. The structure of intermediates I and II and the mechanism of the four-electron reduction of dioxygen driven by Asp(112) and Glu(506) are discussed.	[Kataoka, Kunishige; Sugiyama, Ryosuke; Inoue, Megumi; Urata, Kanae; Minagawa, Yoichi; Seo, Daisuke; Sakurai, Takeshi] Kanazawa Univ, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan; [Hirota, Shun] Nara Inst Sci & Technol, Grad Sch Mat Sci, Nara 6300192, Japan	Kanazawa University; Nara Institute of Science & Technology	Sakurai, T (corresponding author), Kanazawa Univ, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan.	ts0513@kenroku.kanazawa-u.ac.jp	SEO, Daisuke/L-3520-2015; Sakurai, Takeshi/C-3335-2015; Hirota, Shun/AAD-2651-2021; KATAOKA, Kunishige/J-8457-2015	SEO, Daisuke/0000-0001-9596-6569; Sakurai, Takeshi/0000-0002-7989-8882; Hirota, Shun/0000-0003-3227-8376; 	Ministry of Education, Culture, Sports, Science and Technology of Japan [19350081]; NEDO; Mandom Corp; Toyota Motor Corp	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NEDO(New Energy and Industrial Technology Development Organization (NEDO)); Mandom Corp; Toyota Motor Corp	This work was supported by Grant-in-aid for Scientific Research 19350081 from the Ministry of Education, Culture, Sports, Science and Technology of Japan (to T. S.), NEDO, Mandom Corp., and Toyota Motor Corp.	Augustine AJ, 2007, J AM CHEM SOC, V129, P13118, DOI 10.1021/ja073905m; BENTO I, 2005, J CHEM SOC DA, P3507; Bento I, 2007, ACTA CRYSTALLOGR D, V63, P240, DOI 10.1107/S090744490604947X; Durao P, 2006, J BIOL INORG CHEM, V11, P514, DOI 10.1007/s00775-006-0102-0; Garavaglia S, 2004, J MOL BIOL, V342, P1519, DOI 10.1016/j.jmb.2004.07.100; Grass G, 2004, J BACTERIOL, V186, P5826, DOI 10.1128/JB.186.17.5826-5833.2004; Hakulinen N, 2006, BIOCHEM BIOPH RES CO, V350, P929, DOI 10.1016/j.bbrc.2006.09.144; Huang HW, 1999, J BIOL CHEM, V274, P32718, DOI 10.1074/jbc.274.46.32718; Kataoka K, 2005, BIOCHEMISTRY-US, V44, P7004, DOI 10.1021/bi0476836; Kataoka K, 2007, J MOL BIOL, V373, P141, DOI 10.1016/j.jmb.2007.07.041; KATO JI, 1988, J BACTERIOL, V170, P3967, DOI 10.1128/jb.170.9.3967-3977.1988; Kurose S, 2007, CHEM LETT, V36, P232, DOI 10.1246/cl.2007.232; Lee SK, 2002, J AM CHEM SOC, V124, P6180, DOI 10.1021/ja0114052; Lewis EA, 2004, CHEM REV, V104, P1047, DOI 10.1021/cr020633r; MAGNUS KA, 1994, PROTEINS, V19, P302, DOI 10.1002/prot.340190405; MESSERSCHMIDT A, 1992, J MOL BIOL, V224, P179, DOI 10.1016/0022-2836(92)90583-6; Messerschmidt A., 1997, MULTICOPPER OXIDASES; Miura Y, 2009, FUEL CELLS, V9, P70, DOI 10.1002/fuce.200800027; Miura Y, 2007, CHEM LETT, V36, P132, DOI 10.1246/cl.2007.132; Nitta K, 2002, J INORG BIOCHEM, V91, P125, DOI 10.1016/S0162-0134(02)00440-3; Outten FW, 2001, J BIOL CHEM, V276, P30670, DOI 10.1074/jbc.M104122200; Palmer AE, 2002, BIOCHEMISTRY-US, V41, P6438, DOI 10.1021/bi011979j; Quintanar L, 2005, BIOCHEMISTRY-US, V44, P6081, DOI 10.1021/bi047379c; Rensing C, 2003, FEMS MICROBIOL REV, V27, P197, DOI 10.1016/S0168-6445(03)00049-4; Roberts SA, 2002, P NATL ACAD SCI USA, V99, P2766, DOI 10.1073/pnas.052710499; Sakurai T, 2007, CELL MOL LIFE SCI, V64, P2642, DOI 10.1007/s00018-007-7183-y; Sakurai T, 2007, CHEM REC, V7, P220, DOI 10.1002/tcr.20125; Shin W, 1996, J AM CHEM SOC, V118, P3202, DOI 10.1021/ja953621e; Singh SK, 2004, J BACTERIOL, V186, P7815, DOI 10.1128/JB.186.22.7815-7817.2004; Solomon EI, 2001, ANGEW CHEM INT EDIT, V40, P4570, DOI 10.1002/1521-3773(20011217)40:24<4570::AID-ANIE4570>3.0.CO;2-4; Taylor AB, 2005, P NATL ACAD SCI USA, V102, P15459, DOI 10.1073/pnas.0506227102; Tsujimura S, 2008, ELECTROCHIM ACTA, V53, P5716, DOI 10.1016/j.electacta.2008.03.037; Ueki Y, 2006, FEBS LETT, V580, P4069, DOI 10.1016/j.febslet.2006.06.049; Yoon JJ, 2007, J AM CHEM SOC, V129, P13127, DOI 10.1021/ja073947a; Zoppellaro G, 2001, J BIOCHEM-TOKYO, V129, P949, DOI 10.1093/oxfordjournals.jbchem.a002942	35	61	62	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14405	14413		10.1074/jbc.M808468200	http://dx.doi.org/10.1074/jbc.M808468200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19297322	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000266286100047
J	Wang, GH; Krishnamurthy, K; Umapathy, NS; Verin, AD; Bieberich, E				Wang, Guanghu; Krishnamurthy, Kannan; Umapathy, Nagavedi S.; Verin, Alexander D.; Bieberich, Erhard			The Carboxyl-terminal Domain of Atypical Protein Kinase C zeta Binds to Ceramide and Regulates Junction Formation in Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							E-CADHERIN; PKC-LAMBDA; NEURONAL MIGRATION; ADHERENS JUNCTIONS; CANCER-CELLS; STEM-CELLS; APOPTOSIS; POLARITY; MOUSE; COMPLEX	Atypical protein kinase Cs (PKCs) (aPKC zeta and lambda/iota) have emerged as important binding partners for ceramide, a membrane-resident cell signaling lipid that is involved in the regulation of apoptosis as well as cell polarity. Using ceramide overlay assays with proteolytic fragments of PKC zeta and vesicle binding assays with ectopically expressed protein, we show that a protein fragment comprising the carboxyl-terminal 20-kDa sequence of PKC zeta (C20 zeta, amino acids 405-592) bound to C16:0 ceramide. This sequence is not identical to the C1 domain (amino acids 131-180), which has been suggested to serve as a potential ceramide binding domain. Using immunocytochemistry, we found that a C20 zeta protein fragment ectopically expressed in two epithelial cell types (neural progenitors and Madin-Darby canine kidney cells) co-distributed with ceramide. Stable expression of C20 zeta-EGFP in Madin-Darby canine kidney cells disrupted the formation of adherens and tight junctions and impaired the epithelium integrity by reducing transepithelial electrical resistance. Disruption of cell adhesion and loss of transepithelial electrical resistance was prevented by incubation with C16: 0 ceramide. Our results show, for the first time, that there is a novel ceramide binding domain (C20 zeta) in the carboxyl terminus of aPKC. Our results also show that the interaction of ceramide with this binding domain is essential for cell-to-cell contacts in epithelia. Therefore, ceramide interaction with the C20 zeta binding domain is a potential mechanism by which ceramide and aPKC regulate the formation of junctional complexes in epithelial cells.	[Wang, Guanghu; Krishnamurthy, Kannan; Bieberich, Erhard] Med Coll Georgia, Inst Mol Med & Genet, Program Dev Neurobiol, Sch Med, Augusta, GA 30912 USA; [Umapathy, Nagavedi S.; Verin, Alexander D.] Med Coll Georgia, Sch Med, Vasc Biol Ctr, Augusta, GA 30912 USA	University System of Georgia; Augusta University; University System of Georgia; Augusta University	Bieberich, E (corresponding author), 1120 15th St,Rm CB-2803, Augusta, GA 30912 USA.	ebieberich@mcg.edu			National Institutes of Health [R01NS046835]; March of Dimes [6FY08-322]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046835] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01NS046835. This work was also supported by March of Dimes Grant 6FY08-322.	AKIMOTO K, 1994, J BIOL CHEM, V269, P12677; Akimoto K, 1996, EMBO J, V15, P788, DOI 10.1002/j.1460-2075.1996.tb00414.x; Bieberich E, 2000, J BIOL CHEM, V275, P177, DOI 10.1074/jbc.275.1.177; Bieberich E, 2003, J CELL BIOL, V162, P469, DOI 10.1083/jcb.200212067; Bieberich E, 2004, J CELL BIOL, V167, P723, DOI 10.1083/jcb.200405144; Bieberich E, 2002, CANCER LETT, V181, P55, DOI 10.1016/S0304-3835(02)00049-6; Birukova AA, 2004, J CELL PHYSIOL, V201, P55, DOI 10.1002/jcp.20055; Bourbon NA, 2000, J BIOL CHEM, V275, P35617, DOI 10.1074/jbc.M007346200; DiazMeco MT, 1996, CELL, V86, P777, DOI 10.1016/S0092-8674(00)80152-X; DLUGOSZ AA, 1992, MOL CARCINOGEN, V5, P286, DOI 10.1002/mc.2940050409; Etienne-Manneville S, 2005, J CELL BIOL, V170, P895, DOI 10.1083/jcb.200412172; Etienne-Manneville S, 2003, CURR OPIN CELL BIOL, V15, P67, DOI 10.1016/S0955-0674(02)00005-4; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Etienne-Manneville S, 2001, CELL, V106, P489, DOI 10.1016/S0092-8674(01)00471-8; Fox TE, 2007, J BIOL CHEM, V282, P12450, DOI 10.1074/jbc.M700082200; Frutos S, 1999, J BIOL CHEM, V274, P10765, DOI 10.1074/jbc.274.16.10765; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Galadari S, 1998, BIOCHEMISTRY-US, V37, P11232, DOI 10.1021/bi980911+; Guizzetti M, 2000, BIOCHEM PHARMACOL, V60, P1457, DOI 10.1016/S0006-2952(00)00468-8; Hannun YA, 2002, J BIOL CHEM, V277, P25847, DOI 10.1074/jbc.R200008200; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hatten ME, 2002, SCIENCE, V297, P1660, DOI 10.1126/science.1074572; Heinrich M, 2004, CELL DEATH DIFFER, V11, P550, DOI 10.1038/sj.cdd.4401382; Horne-Badovinac S, 2001, CURR BIOL, V11, P1492, DOI 10.1016/S0960-9822(01)00458-4; Imai F, 2006, DEVELOPMENT, V133, P1735, DOI 10.1242/dev.02330; Kitchens KM, 2005, ADV DRUG DELIVER REV, V57, P2163, DOI 10.1016/j.addr.2005.09.013; Koike C, 2005, J NEUROSCI, V25, P10290, DOI 10.1523/JNEUROSCI.3657-05.2005; Kojima Y, 2008, HUM PATHOL, V39, P824, DOI 10.1016/j.humpath.2007.11.001; Krishnamurthy K, 2007, J BIOL CHEM, V282, P3379, DOI 10.1074/jbc.M607779200; Krishnamurthy K, 2007, J LIPID RES, V48, P968, DOI 10.1194/jlr.D600043-JLR200; Le TL, 1999, J CELL BIOL, V146, P219, DOI 10.1083/jcb.146.1.219; Muller T, 2002, EXP CELL RES, V280, P119, DOI 10.1006/excr.2002.5630; Ohno S, 2001, CURR OPIN CELL BIOL, V13, P641, DOI 10.1016/S0955-0674(00)00264-7; Palacios F, 2005, MOL CELL BIOL, V25, P389, DOI 10.1128/MCB.25.1.389-402.2005; Regala RP, 2008, CANCER RES, V68, P5888, DOI 10.1158/0008-5472.CAN-08-0438; RODRIGUEZBOULAN E, 1989, SCIENCE, V245, P718, DOI 10.1126/science.2672330; Shen Y, 2008, J BIOL CHEM, V283, P5127, DOI 10.1074/jbc.M703300200; Solecki DJ, 2004, NAT NEUROSCI, V7, P1195, DOI 10.1038/nn1332; Soloff RS, 2004, J IMMUNOL, V173, P3250, DOI 10.4049/jimmunol.173.5.3250; Suzuki A, 2003, J BIOCHEM, V133, P9, DOI 10.1093/jb/mvg018; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Suzuki A, 2002, J CELL SCI, V115, P3565, DOI 10.1242/jcs.00032; van Blitterswijk WJ, 1998, BIOCHEM J, V331, P679; Wang GH, 2005, J BIOL CHEM, V280, P26415, DOI 10.1074/jbc.M501492200; Wang G, 2008, J NEUROCHEM, V106, P718, DOI 10.1111/j.1471-4159.2008.05451.x; Wooten MW, 1999, CELL DEATH DIFFER, V6, P753, DOI 10.1038/sj.cdd.4400548; Yap AS, 1997, ANNU REV CELL DEV BI, V13, P119, DOI 10.1146/annurev.cellbio.13.1.119; Zhang X, 2007, NAT CELL BIOL, V9, P743, DOI 10.1038/ncb1603; Zhang YH, 1997, CELL, V89, P63, DOI 10.1016/S0092-8674(00)80183-X	49	36	37	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14469	14475		10.1074/jbc.M808909200	http://dx.doi.org/10.1074/jbc.M808909200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19304661	Green Published, hybrid			2022-12-27	WOS:000266286100053
J	Kurada, BRVVSN; Li, LC; Mulherkar, N; Subramanian, M; Prasad, KV; Prabhakar, BS				Kurada, Bapi Raju V. V. S. N.; Li, Liang Cheng; Mulherkar, Nirupama; Subramanian, Mahesh; Prasad, Kanteti V.; Prabhakar, Bellur S.			MADD, a Splice Variant of IG20, Is Indispensable for MAPK Activation and Protection against Apoptosis upon Tumor Necrosis Factor-alpha Treatment	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GDP/GTP EXCHANGE PROTEIN; TRAIL-INDUCED APOPTOSIS; DEATH DOMAIN PROTEIN; TNF RECEPTOR-I; NF-KAPPA-B; SIGNAL-TRANSDUCTION; NEOPLASTIC-CELLS; DENN-SV; CANCER; KINASE	We investigated the physiological role of endogenous MAPK-activating death domain-containing protein (MADD), a splice variant of the IG20 gene, that can interact with TNFR1 in tumor necrosis factor-alpha (TNF alpha)-induced activation of NF-kappa B, MAPK, ERK1/2, JNK, and p38. Using exon-specific short hairpin RNAs expressing lentiviruses, we knocked down the expression of all IG20 splice variants or MADD, which is overexpressed in cancer cells. Abrogation of MADD expression rendered cells highly susceptible to TNF alpha-induced apoptosis in the absence of cycloheximide. It also resulted in a dramatic loss in TNF alpha-induced activation of MAPK without any apparent effect on NF-kappa B activation. This observation was substantiated by an accompanying loss in the activation of p90RSK, a key downstream target of MAPK, whereas the NF-kappa B-regulated interleukin 6 levels remained unaffected. Endogenous MADD knockdown, however, did not affect epidermal growth factor-induced MAPK activation thereby demonstrating the specific requirement of MADD for TNF receptor-mediated MAPK activation. Re-expression of short hairpin RNA-resistant MADD in the absence of endogenous IG20 expression rescued the cells from TNF alpha-induced apoptosis. The requirement for MADD was highly specific for TNF alpha-induced activation of MAPK but not the related JNK and p38 kinases. Loss of MADD expression resulted in reduced Grb2 and Sos1/2 recruitment to the TNFR1 complex and decreased Ras and MEKK1/2 activation. These results demonstrate the essential role of MADD in protecting cancer cells from TNF alpha-induced apoptosis by specifically activating MAPKs through Grb2 and Sos1/2 recruitment, and its potential as a novel cancer therapeutic target.	[Kurada, Bapi Raju V. V. S. N.; Li, Liang Cheng; Mulherkar, Nirupama; Subramanian, Mahesh; Prasad, Kanteti V.; Prabhakar, Bellur S.] Univ Illinois, Coll Med, Dept Microbiol & Immunol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Prabhakar, BS (corresponding author), Univ Illinois, Coll Med, Dept Microbiol & Immunol, Rm E-705,835 S Wolcott Ave M-C 790, Chicago, IL 60612 USA.	bprabhak@uic.edu			National Institutes of Health [R01 CA107506]; NATIONAL CANCER INSTITUTE [R01CA107506] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA107506 (to B. S. P.).	Al-Zoubi AM, 2001, J BIOL CHEM, V276, P47202, DOI 10.1074/jbc.M104835200; Bachmann R, 1999, AM J PATHOL, V154, P1417, DOI 10.1016/S0002-9440(10)65395-3; BARKER PE, 1984, P NATL ACAD SCI-BIOL, V81, P5826, DOI 10.1073/pnas.81.18.5826; Ben-Baruch A, 2003, BREAST CANCER RES, V5, P31, DOI 10.1186/bcr554; Boutros T, 2008, PHARMACOL REV, V60, P261, DOI 10.1124/pr.107.00106; Brown TL, 1998, CURR BIOL, V8, pR191; BUDAY L, 1993, CELL, V73, P611, DOI 10.1016/0092-8674(93)90146-H; Chen CL, 2000, MOL CELL BIOL, V20, P2687, DOI 10.1128/MCB.20.8.2687-2695.2000; Chow VTK, 1998, GENOME, V41, P543, DOI 10.1139/gen-41-4-543; Chow VTK, 1996, DNA SEQUENCE, V6, P263, DOI 10.3109/10425179609020873; Collesi C, 1996, MOL CELL BIOL, V16, P5518; Coppola T, 2002, BIOCHEM J, V362, P273, DOI 10.1042/0264-6021:3620273; Del Villar K, 2004, P NATL ACAD SCI USA, V101, P4210, DOI 10.1073/pnas.0307349101; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Efimova E, 2003, CANCER RES, V63, P8768; Efimova EV, 2004, ONCOGENE, V23, P1076, DOI 10.1038/sj.onc.1207210; Frodin M, 1999, MOL CELL ENDOCRINOL, V151, P65, DOI 10.1016/S0303-7207(99)00061-1; Goeddel DV, 1999, CHEST, V116, p69S, DOI 10.1378/chest.116.suppl_1.69S; Hildt E, 1999, J EXP MED, V189, P1707, DOI 10.1084/jem.189.11.1707; Hoshino R, 1999, ONCOGENE, V18, P813, DOI 10.1038/sj.onc.1202367; JANKNECHT R, 1993, EMBO J, V12, P5097, DOI 10.1002/j.1460-2075.1993.tb06204.x; Kalnina Z, 2005, GENE CHROMOSOME CANC, V42, P342, DOI 10.1002/gcc.20156; Li LC, 2008, CANCER RES, V68, P7352, DOI 10.1158/0008-5472.CAN-07-6311; Lim KM, 2002, MOL CARCINOGEN, V35, P110, DOI 10.1002/mc.10082; MCCORMICK F, 1994, CURR OPIN GENET DEV, V4, P71, DOI 10.1016/0959-437X(94)90093-0; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Mulherkar N, 2006, ONCOGENE, V25, P6252, DOI 10.1038/sj.onc.1209650; Mulherkar N, 2007, J BIOL CHEM, V282, P11715, DOI 10.1074/jbc.M701085200; Nagata S, 1999, ANNU REV GENET, V33, P29, DOI 10.1146/annurev.genet.33.1.29; Niwa S, 2008, NAT CELL BIOL, V10, P1269, DOI 10.1038/ncb1785; Ostrowski J, 2000, BRIT J CANCER, V82, P1041; Ramaswamy M, 2004, ONCOGENE, V23, P6083, DOI 10.1038/sj.onc.1207804; SASAOKA T, 1994, J BIOL CHEM, V269, P32621; Schievella AR, 1997, J BIOL CHEM, V272, P12069, DOI 10.1074/jbc.272.18.12069; SUBRAMANIAN M, 2009, J CLIN ENDO IN PRESS; Tanaka M, 2001, MOL BIOL CELL, V12, P1421, DOI 10.1091/mbc.12.5.1421; Venables JP, 2006, BIOESSAYS, V28, P378, DOI 10.1002/bies.20390; Wada M, 1997, J BIOL CHEM, V272, P3875, DOI 10.1074/jbc.272.7.3875; Xiao CW, 2002, BIOL REPROD, V67, P436, DOI 10.1095/biolreprod67.2.436; Yamaguchi K, 2002, P NATL ACAD SCI USA, V99, P14536, DOI 10.1073/pnas.212511399; Yang Y, 2007, EUR J PHARMACOL, V576, P26, DOI 10.1016/j.ejphar.2007.07.067; Zhang Y, 1998, P NATL ACAD SCI USA, V95, P2586, DOI 10.1073/pnas.95.5.2586; ZHANG YH, 1994, P NATL ACAD SCI USA, V91, P2225, DOI 10.1073/pnas.91.6.2225; Zhou T, 1996, J IMMUNOL, V156, P2661	46	34	38	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13533	13541		10.1074/jbc.M808554200	http://dx.doi.org/10.1074/jbc.M808554200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19289468	Green Published, hybrid			2022-12-27	WOS:000265877300030
J	Park, E; Lee, MS; Baik, SM; Cho, EB; Son, GH; Seong, JY; Lee, KH; Kim, K				Park, Eonyoung; Lee, Mi Sun; Baik, Sun Mi; Cho, Eun Bee; Son, Gi Hoon; Seong, Jae Young; Lee, Kun Ho; Kim, Kyungjin			Nova-1 Mediates Glucocorticoid-induced Inhibition of Pre-mRNA Splicing of Gonadotropin-releasing Hormone Transcripts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEIN; 1ST INTRON; FEMALE REPRODUCTION; LHRH NEURONS; STRESS; GNRH; PITUITARY; ENHANCER; REPRESSION; RECEPTOR	Glucocorticoid (GC) is known to affect the reproductive system by suppressing the gonadotropin-releasing hormone (GnRH) gene expression in the hypothalamus. However, the mechanism of this effect is poorly understood. We show here that the GC-induced reduction of GnRH mRNA is due to attenuation of a post-transcriptional process i.e. splicing of intron A. Treatment of dexamethasone (DEX), a synthetic GC, lowered GnRH mRNA transcripts and was accompanied by reduced excision of the first intron (intron A) from the GnRH pre-mRNA both in vitro and in vivo. While seeking to identify the splicing factors involved in GC-inhibited GnRH pre-mRNA splicing, we found that DEX down-regulated neuro-oncological ventral antigen-1 (Nova-1) mRNA and protein and that knockdown of Nova-1 reduced intron A excision from GnRH pre-mRNA. Nova-1 overexpression reversed the DEX-induced reduction of intron A excision. Nova-1 appears to promote intron A excision by binding to the distal region of exon 1 of the GnRH pre-mRNA. Taken together, our findings indicate that the intron A excision by Nova-1 is a target of GC for down-regulation of GnRH gene expression, and more importantly, we characterized Nova-1, a brain-enriched splicing regulator responsible for GnRH pre-mRNA splicing.	[Park, Eonyoung; Lee, Mi Sun; Baik, Sun Mi; Cho, Eun Bee; Son, Gi Hoon; Lee, Kun Ho; Kim, Kyungjin] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea; [Seong, Jae Young] Korea Univ, Coll Med, Lab G Protein Coupled Receptors, Seoul 136705, South Korea	Seoul National University (SNU); Korea University; Korea University Medicine (KU Medicine)	Kim, K (corresponding author), Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea.	kyungjin@snu.ac.kr	Seong, Jae Young/A-5794-2012	Seong, Jae Young/0000-0002-3312-6924	Ministry of Science and Technology, Republic of Korea	Ministry of Science and Technology, Republic of Korea(Ministry of Science & Technology (MOST), Republic of Korea)	This work was supported by a grant from the Brain Research Center of the 21st Century Frontier Research Program in Neuroscience funded by the Ministry of Science and Technology, Republic of Korea.	AHIMA RS, 1992, NEUROENDOCRINOLOGY, V56, P845, DOI 10.1159/000126315; Breen KM, 2004, ENDOCRINOLOGY, V145, P692, DOI 10.1210/en.2003-1114; Buckanovich RJ, 1996, J NEUROSCI, V16, P1114; Chan RCC, 1997, MOL CELL BIOL, V17, P4667, DOI 10.1128/MCB.17.8.4667; Chandran UR, 1996, J BIOL CHEM, V271, P20412, DOI 10.1074/jbc.271.34.20412; CHANDRAN UR, 1994, ENDOCRINOLOGY, V134, P1467, DOI 10.1210/en.134.3.1467; CHATTERTON RT, 1990, INT J FERTIL, V35, P8; Chou MY, 1999, MOL CELL BIOL, V19, P69; Dobson H, 2003, REPRODUCTION, V125, P151, DOI 10.1530/rep.0.1250151; Dobson H, 2000, ANIM REPROD SCI, V60, P743, DOI 10.1016/S0378-4320(00)00080-4; Dredge BK, 2003, MOL CELL BIOL, V23, P4687, DOI 10.1128/MCB.23.13.4687-4700.2003; Ferin M, 1999, J CLIN ENDOCR METAB, V84, P1768, DOI 10.1210/jc.84.6.1768; Genazzani Alessandro D, 2005, Pediatr Endocrinol Rev, V2, P661; Gore AC, 2006, MOL CELL ENDOCRINOL, V256, P40, DOI 10.1016/j.mce.2006.06.002; HANDA RJ, 1994, HORM BEHAV, V28, P464, DOI 10.1006/hbeh.1994.1044; Jensen KB, 2000, P NATL ACAD SCI USA, V97, P5740, DOI 10.1073/pnas.090553997; Jensen KB, 2000, NEURON, V25, P359, DOI 10.1016/S0896-6273(00)80900-9; KOSAKI A, 1993, J BIOL CHEM, V268, P21990; KRAINER AR, 1985, CELL, V42, P725, DOI 10.1016/0092-8674(85)90269-7; Lai GJ, 2006, ENDOCRINOLOGY, V147, P3961, DOI 10.1210/en.2005-1551; Li Q, 2007, NAT REV NEUROSCI, V8, P819, DOI 10.1038/nrn2237; Mastorakos George, 2006, Pediatr Endocrinol Rev, V3 Suppl 1, P172; MCEWEN BS, 1994, ANN NY ACAD SCI, V743, P1, DOI 10.1111/j.1749-6632.1994.tb55784.x; Min HS, 1997, GENE DEV, V11, P1023, DOI 10.1101/gad.11.8.1023; Nijholt I, 2004, MOL PSYCHIATR, V9, P174, DOI 10.1038/sj.mp.4001446; Park E, 2006, J BIOL CHEM, V281, P401, DOI 10.1074/jbc.M505814200; RIVIER JE, 1986, J MED CHEM, V29, P1846, DOI 10.1021/jm00160a008; Seong JY, 1999, MOL ENDOCRINOL, V13, P1882, DOI 10.1210/me.13.11.1882; Seong JY, 2002, MOL ENDOCRINOL, V16, P2426, DOI 10.1210/me.2001-0297; Seong JY, 2001, ENDOCRINOLOGY, V142, P4454, DOI 10.1210/en.142.10.4454; Son GH, 2003, J BIOL CHEM, V278, P18037, DOI 10.1074/jbc.M209850200; Tanebe K, 2000, J NEUROENDOCRINOL, V12, P13; Ule J, 2005, NAT GENET, V37, P844, DOI 10.1038/ng1610; Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095; Ule J, 2006, NATURE, V444, P580, DOI 10.1038/nature05304; WRAY S, 1988, PEPTIDES, V9, P1151, DOI 10.1016/0196-9781(88)90103-9; Zhang WQ, 2002, RNA, V8, P671, DOI 10.1017/S1355838202027036; Zhen SJ, 1997, J BIOL CHEM, V272, P12620, DOI 10.1074/jbc.272.19.12620	38	9	9	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12792	12800		10.1074/jbc.M807386200	http://dx.doi.org/10.1074/jbc.M807386200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19282286	Green Published, hybrid			2022-12-27	WOS:000265688300024
J	Lam, BYH; Zhang, WT; Enticknap, N; Haggis, E; Cader, MZ; Chawla, S				Lam, Brian Yee Hong; Zhang, Wenting; Enticknap, Nicola; Haggis, Eleanor; Cader, M. Zaeem; Chawla, Sangeeta			Inverse Regulation of Plasticity-related Immediate Early Genes by Calcineurin in Hippocampal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; SENSITIVE COINCIDENCE DETECTOR; SERUM RESPONSE ELEMENT; C-FOS; SYNAPTIC PLASTICITY; TRANSCRIPTION FACTORS; CALCIUM-CHANNELS; CORTICAL-NEURONS; RAT HIPPOCAMPUS; TERNARY COMPLEX	In the mammalian hippocampus, changes in the expression of immediate early genes (IEGs) is thought to contribute to long term plastic changes in neurons brought about by learning tasks and high frequency stimulation of synapses. The phosphatase calcineurin has emerged as an important negative regulator of hippocampus-dependent learning and long term potentiation. Here we investigated the possibility that the constraining action of calcineurin on hippocampal plasticity is mediated in part by regulation of gene expression through negative control of transcription factors, such as cAMP-response element (CRE)-binding protein (CREB). We assessed the effect of calcineurin inhibitors on CREB activation by neuronal activity and show that calcineurin activity is in fact required for CREB-mediated gene expression. However, inhibition of calcineurin had disparate effects on the transcriptional induction of CREB-dependent IEGs. We find that the IEG c-fos is unaffected by suppression of calcineurin activity, the plasticity-related genes Egr1/Zif268 and Egr2/Krox-20 are up-regulated, and genes encoding the orphan nuclear hormone receptors Nor1 and Nur77 are down-regulated. We further show that the up-regulation of particular IEGs is probably due to the presence of serum response elements (SREs) in their promoters, because SRE-mediated gene expression is enhanced by calcineurin blockers. Moreover, expression of the c-fos gene, which is unaffected by calcineurin inhibitors, could be down-regulated by mutating the SRE. Conversely, SRE-mediated c-fos induction in the absence of a functional CRE was enhanced by calcineurin inhibitors. Our experiments thus implicate calcineurin as a negative regulator of SRE-dependent neuronal genes.	[Lam, Brian Yee Hong; Zhang, Wenting; Enticknap, Nicola; Haggis, Eleanor; Cader, M. Zaeem; Chawla, Sangeeta] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England	University of Cambridge	Chawla, S (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England.	sc10008@cam.ac.uk	Lam, Brian YH/AAH-5749-2021	Lam, Brian YH/0000-0002-3638-9025; Cader, Mohammed Zaeem/0000-0002-4121-748X	Biotechnology and Biological Sciences Research Council; Royal Society; Biotechnology and Biological Sciences Research Council [JF20603] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Royal Society(Royal Society of London); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council and the Royal Society.	ALEXANDRE C, 1991, ONCOGENE, V6, P1851; Baumgartel K, 2008, NAT NEUROSCI, V11, P572, DOI 10.1038/nn.2113; Belfield JL, 2006, J BIOL CHEM, V281, P27724, DOI 10.1074/jbc.M601485200; Bito H, 1996, CELL, V87, P1203, DOI 10.1016/S0092-8674(00)81816-4; Blaeser F, 2000, J BIOL CHEM, V275, P197, DOI 10.1074/jbc.275.1.197; Calella AM, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-4; COLE AJ, 1989, NATURE, V340, P474, DOI 10.1038/340474a0; DRAGUNOW M, 1987, NEUROSCI LETT, V82, P157, DOI 10.1016/0304-3940(87)90121-2; Fass DM, 2003, J BIOL CHEM, V278, P43014, DOI 10.1074/jbc.M305905200; French PJ, 2001, EUR J NEUROSCI, V14, P2037, DOI 10.1046/j.0953-816x.2001.01818.x; Garcia-Rodriguez C, 2000, EUR J IMMUNOL, V30, P2432, DOI 10.1002/1521-4141(2000)30:8<2432::AID-IMMU2432>3.0.CO;2-F; Genazzani AA, 1999, P NATL ACAD SCI USA, V96, P5797, DOI 10.1073/pnas.96.10.5797; Graef IA, 1999, NATURE, V401, P703, DOI 10.1038/44378; Guerini D, 2000, J BIOL CHEM, V275, P3706, DOI 10.1074/jbc.275.5.3706; Guzowski JF, 2001, J NEUROSCI, V21, P5089, DOI 10.1523/JNEUROSCI.21-14-05089.2001; Guzowski JF, 2000, J NEUROSCI, V20, P3993; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 1999, NEURON, V22, P789, DOI 10.1016/S0896-6273(00)80737-0; JANKNECHT R, 1993, EMBO J, V12, P5097, DOI 10.1002/j.1460-2075.1993.tb06204.x; Kawashima T, 2009, P NATL ACAD SCI USA, V106, P316, DOI 10.1073/pnas.0806518106; Kingsbury TJ, 2007, J NEUROCHEM, V103, P761, DOI 10.1111/j.1471-4159.2007.04801.x; Kovacs KA, 2007, P NATL ACAD SCI USA, V104, P4700, DOI 10.1073/pnas.0607524104; Kramer D, 2003, MOL CELL NEUROSCI, V23, P325, DOI 10.1016/S1044-7431(03)00057-5; Lam BYH, 2007, NEUROSCI LETT, V427, P153, DOI 10.1016/j.neulet.2007.09.030; Lanahan A, 1998, NEUROBIOL LEARN MEM, V70, P37, DOI 10.1006/nlme.1998.3836; Lavaur J, 2007, J NEUROSCI, V27, P14448, DOI 10.1523/JNEUROSCI.2279-07.2007; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Malleret G, 2001, CELL, V104, P675, DOI 10.1016/S0092-8674(01)00264-1; Mansuy IM, 2003, BIOCHEM BIOPH RES CO, V311, P1195, DOI 10.1016/j.bbrc.2003.10.046; Mao ZX, 1999, J BIOL CHEM, V274, P31102, DOI 10.1074/jbc.274.43.31102; METZ R, 1991, GENE DEV, V5, P1754, DOI 10.1101/gad.5.10.1754; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Ramanan N, 2005, NAT NEUROSCI, V8, P759, DOI 10.1038/nn1462; Screaton RA, 2004, CELL, V119, P61, DOI 10.1016/j.cell.2004.09.015; Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513; SHAW PE, 1989, CELL, V56, P563, DOI 10.1016/0092-8674(89)90579-5; Sugimoto T, 1997, J BIOL CHEM, V272, P29415, DOI 10.1074/jbc.272.47.29415; Sun W, 2007, J NEUROCHEM, V100, P269, DOI 10.1111/j.1471-4159.2006.04214.x; Tian JM, 1999, J BIOL CHEM, V274, P15173, DOI 10.1074/jbc.274.21.15173; TREISMAN R, 1987, EMBO J, V6, P2711, DOI 10.1002/j.1460-2075.1987.tb02564.x; TREISMAN R, 1995, EMBO J, V14, P4905, DOI 10.1002/j.1460-2075.1995.tb00173.x; Waltereit R, 2001, J NEUROSCI, V21, P5484, DOI 10.1523/JNEUROSCI.21-15-05484.2001; WILLIAMS J, 1995, MOL BRAIN RES, V28, P87, DOI 10.1016/0169-328X(94)00187-J; Wilson HL, 2001, MOL CELL ENDOCRINOL, V181, P27, DOI 10.1016/S0303-7207(01)00540-8; Winder DG, 2001, NAT REV NEUROSCI, V2, P461, DOI 10.1038/35081514; Zeng HK, 2001, CELL, V107, P617, DOI 10.1016/S0092-8674(01)00585-2; Zhang SJ, 2007, NEURON, V53, P549, DOI 10.1016/j.neuron.2007.01.025; Zhou Y, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000016	49	26	27	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12562	12571		10.1074/jbc.M901121200	http://dx.doi.org/10.1074/jbc.M901121200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19270309	Green Published, hybrid			2022-12-27	WOS:000265494600085
J	Raaijmakers, HCA; Versteegh, JE; Uitdehaag, JCM				Raaijmakers, Hans C. A.; Versteegh, Judith E.; Uitdehaag, Joost C. M.			The X-ray Structure of RU486 Bound to the Progesterone Receptor in a Destabilized Agonistic Conformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGAND-BINDING DOMAIN; IN-VITRO; CRYSTAL-STRUCTURES; ESTROGEN-RECEPTOR; B ISOFORMS; CHO-CELLS; MIFEPRISTONE; ANTAGONISM; MECHANISM; (ANTI)PROGESTAGENS	Here we describe the 1.95 angstrom structure of the clinically used antiprogestin RU486 (mifepristone) in complex with the progesterone receptor (PR). The structure was obtained by taking a crystal of the PR ligand binding domain containing the agonist norethindrone and soaking it in a solution containing the antagonist RU486 for extended times. Clear ligand exchange could be observed in one copy of the PR ligand binding domain dimer in the crystal. RU486 binds while PR is in an agonistic conformation without displacing helix 12. Although this is probably because of the constraints of the crystal lattice, it demonstrates that helix 12 displacement is not a prerequisite for RU486 binding. Interestingly, B-factor analysis clearly shows that helix 12 becomes more flexible after RU486 binding, suggesting that RU486, being a model antagonist, does not induce one fixed conformation of helix 12 but changes its positional equilibrium. This conclusion is confirmed by comparing the structures of RU486 bound to PR and RU486 bound to the glucocorticoid receptor.	[Versteegh, Judith E.; Uitdehaag, Joost C. M.] Schering Plough Res Inst, Dept Mol Pharmacol & DMPK, NL-5340 BH Oss, Netherlands; [Raaijmakers, Hans C. A.] Schering Plough Res Inst, Dept Mol Design & Informat, NL-5340 BH Oss, Netherlands	Merck & Company; Merck & Company	Uitdehaag, JCM (corresponding author), Schering Plough Res Inst, Dept Mol Pharmacol & DMPK, Rm RH2121,POB 20, NL-5340 BH Oss, Netherlands.	joost.uitdehaag@spcorp.com		raaijmakers, hans/0000-0002-2567-7363				ALLAN GF, 1992, J BIOL CHEM, V267, P19513; Allen FH, 2002, ACTA CRYSTALLOGR B, V58, P380, DOI 10.1107/S0108768102003890; Attardi BJ, 2004, J STEROID BIOCHEM, V88, P277, DOI 10.1016/j.jsbmb.2003.12.004; BENHAMOU B, 1992, SCIENCE, V255, P206, DOI 10.1126/science.1372753; BRANDEN C, 1991, INTRO PROTEIN STRUCT, P13; Cadepond F, 1997, ANNU REV MED, V48, P129; COPELAND RA, 2000, ENZYMES, P285; Dijkema R, 1998, J STEROID BIOCHEM, V64, P147, DOI 10.1016/S0960-0760(97)00160-X; Greschik I, 2003, CURR TOP MED CHEM, V3, P1573, DOI 10.2174/1568026033451736; Hassell AM, 2007, ACTA CRYSTALLOGR D, V63, P72, DOI 10.1107/S0907444906047020; Honer C, 2003, MOL PHARMACOL, V63, P1012, DOI 10.1124/mol.63.5.1012; Jones DG, 2005, BIOORG MED CHEM LETT, V15, P3203, DOI 10.1016/j.bmcl.2005.05.001; Kauppi B, 2003, J BIOL CHEM, V278, P22748, DOI 10.1074/jbc.M212711200; KLOOSTERBOER HJ, 1995, ANN NY ACAD SCI, V761, P192, DOI 10.1111/j.1749-6632.1995.tb31379.x; Kong EH, 2003, BIOCHEM SOC T, V31, P56, DOI 10.1042/BST0310056; Leonhardt SA, 2002, EXP BIOL MED, V227, P969, DOI 10.1177/153537020222701104; Letz M, 1999, BBA-PROTEIN STRUCT M, V1429, P391, DOI 10.1016/S0167-4838(98)00249-0; Madauss KP, 2007, MOL ENDOCRINOL, V21, P1066, DOI 10.1210/me.2006-0524; Madauss KP, 2004, J MED CHEM, V47, P3381, DOI 10.1021/jm030640n; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nakabayashi M, 2008, J MED CHEM, V51, P5320, DOI 10.1021/jm8004477; Nettles KW, 2008, NAT CHEM BIOL, V4, P241, DOI 10.1038/nchembio.76; Palmer S, 2000, J STEROID BIOCHEM, V75, P33, DOI 10.1016/S0960-0760(00)00134-5; Poole AJ, 2006, SCIENCE, V314, P1467, DOI 10.1126/science.1130471; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; PRECIGOUX G, 1975, ACTA CRYSTALLOGR B, V31, P1527, DOI 10.1107/S0567740875005638; Pullen MA, 2006, STEROIDS, V71, P792, DOI 10.1016/j.steroids.2006.05.009; REISCH J, 1994, ARCH PHARM, V327, P809; SADOWSKI J, 1993, CHEM REV, V93, P2567, DOI 10.1021/cr00023a012; Schoonen WGEJ, 1998, J STEROID BIOCHEM, V64, P157, DOI 10.1016/S0960-0760(97)00161-1; Schoonen WGEJ, 2000, J STEROID BIOCHEM, V74, P109, DOI 10.1016/S0960-0760(00)00094-7; VANGEERESTEIN VJ, 1987, ACTA CRYSTALLOGR C, V43, P2398, DOI 10.1107/S0108270187087626; VEGETO E, 1992, CELL, V69, P703, DOI 10.1016/0092-8674(92)90234-4; Vellieux FMD, 1997, J APPL CRYSTALLOGR, V30, P396, DOI 10.1107/S0021889896012551; WEHLE H, 1995, STEROIDS, V60, P368, DOI 10.1016/0039-128X(94)00067-M; Williams SP, 1998, NATURE, V393, P392, DOI 10.1038/30775; Winneker RC, 2008, STEROIDS, V73, P689, DOI 10.1016/j.steroids.2008.03.005	37	53	54	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19572	19579		10.1074/jbc.M109.007872	http://dx.doi.org/10.1074/jbc.M109.007872			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19372222	Green Published, hybrid			2022-12-27	WOS:000267908300049
J	Magnone, M; Bruzzone, S; Guida, L; Damonte, G; Millo, E; Scarft, S; Usai, C; Sturla, L; Palombo, D; De Flora, A; Zocchi, E				Magnone, Mirko; Bruzzone, Santina; Guida, Lucrezia; Damonte, Gianluca; Millo, Enrico; Scarft, Sonia; Usai, Cesare; Sturla, Laura; Palombo, Domenico; De Flora, Antonio; Zocchi, Elena			Abscisic Acid Released by Human Monocytes Activates Monocytes and Vascular Smooth Muscle Cell Responses Involved in Atherogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-ADP-RIBOSE; CHEMOATTRACTANT PROTEIN-1 GENE; NF-KAPPA-B; INOSITOL 1,4,5-TRISPHOSPHATE RECEPTOR; C-DEPENDENT PROCESSES; POLYMORPHONUCLEAR NEUTROPHILS; HUMAN GRANULOCYTES; EXPRESSION; ATHEROSCLEROSIS; PROLIFERATION	Abscisic acid (ABA) is a phytohormone recently identified as a new endogenous pro-inflammatory hormone in human granulocytes. Here we report the functional activation of human monocytes and vascular smooth muscle cells by ABA. Incubation of monocytes with ABA evokes an intracellular Ca2+ rise through the second messenger cyclic ADP-ribose, leading to NF-kappa B activation and consequent increase of cyclooxygenase-2 expression and prostaglandin E-2 production and enhanced release of MCP-1 (monocyte chemoattractant protein-1) and of metalloprotease-9, all events reportedly involved in atherogenesis. Moreover, monocytes release ABA when exposed to thrombin-activated platelets, a condition occurring at the injured vascular endothelium; monocyte-derived ABA behaves as an autocrine and paracrine pro-inflammatory hormone-stimulating monocyte migration and MCP-1 release, as well as vascular smooth muscle cells migration and proliferation. These results, and the presence of ABA in human arterial plaques at a 10-fold higher concentration compared with normal arterial tissue, identify ABA as a new signal molecule involved in the development of atherosclerosis and suggest a possible new target for anti-atherosclerotic therapy.	[Magnone, Mirko; Bruzzone, Santina; Guida, Lucrezia; Damonte, Gianluca; Millo, Enrico; Scarft, Sonia; Sturla, Laura; De Flora, Antonio; Zocchi, Elena] Univ Genoa, Biochem Sect, Dept Expt Med, I-16132 Genoa, Italy; [Bruzzone, Santina; Scarft, Sonia; Zocchi, Elena] Adv Biotechnol Ctr, I-16132 Genoa, Italy; [Usai, Cesare] CNR, Inst Biophys, I-16149 Genoa, Italy; [Palombo, Domenico] San Martino Hosp, Vasc & Endovasc Surg Unit, I-16132 Genoa, Italy	University of Genoa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); University of Genoa; IRCCS AOU San Martino IST	Zocchi, E (corresponding author), Univ Genoa, Biochem Sect, Dept Expt Med, Viale Benedetto 15 1, I-16132 Genoa, Italy.	ezocchi@unige.it	Bruzzone, Santina/A-4264-2015; Millo, Enrico/K-3218-2018; Scarfi, Sonia/AAJ-2387-2020	Bruzzone, Santina/0000-0003-2034-3716; Millo, Enrico/0000-0002-4019-0051; Scarfi, Sonia/0000-0002-7079-6919; Usai, Cesare/0000-0001-8863-7759	Regione Liguria; Italian Ministry for University and Research; University of Genova; Fondazione CARIGE	Regione Liguria(Regione Liguria); Italian Ministry for University and Research(Ministry of Education, Universities and Research (MIUR)); University of Genova; Fondazione CARIGE(Fondazione Carige)	This work was supported in part by grants from Regione Liguria, Italian Ministry for University and Research, University of Genova, and Fondazione CARIGE.	ABEDI H, 1995, CARDIOVASC RES, V30, P544, DOI 10.1016/0008-6363(95)00092-5; BLEASDALE JE, 1990, J PHARMACOL EXP THER, V255, P756; Bobryshev YV, 2006, MICRON, V37, P208, DOI 10.1016/j.micron.2005.10.007; Bruzzone S, 2006, BIOCHEM J, V393, P697, DOI 10.1042/BJ20051302; Bruzzone S, 2008, J BIOL CHEM, V283, P32188, DOI 10.1074/jbc.M802603200; Bruzzone S, 2007, P NATL ACAD SCI USA, V104, P5759, DOI 10.1073/pnas.0609379104; Chazov EI, 2007, CAN J PHYSIOL PHARM, V85, P332, DOI 10.1139/Y07-008; Cui YH, 2002, J IMMUNOL, V168, P434, DOI 10.4049/jimmunol.168.1.434; De Simone R, 2007, J NEUROIMMUNOL, V190, P53, DOI 10.1016/j.jneuroim.2007.07.020; De Smet P, 1999, CELL CALCIUM, V26, P9; Fujiwara Nagatoshi, 2005, Current Drug Targets - Inflammation and Allergy, V4, P281, DOI 10.2174/1568010054022024; Gafni J, 1997, NEURON, V19, P723, DOI 10.1016/S0896-6273(00)80384-0; Gawaz M, 2005, J CLIN INVEST, V115, P3378, DOI 10.1172/JCI27196; Gosling J, 1999, J CLIN INVEST, V103, P773, DOI 10.1172/JCI5624; Graeff R, 2002, BIOCHEM J, V361, P379, DOI 10.1042/bj3610379; GRAEFF RM, 1994, J BIOL CHEM, V269, P30260; Gross S, 2007, J EXP MED, V204, P311, DOI 10.1084/jem.20061617; Guida L, 2002, J BIOL CHEM, V277, P47097, DOI 10.1074/jbc.M207793200; Guri AJ, 2008, J NUTR BIOCHEM, V19, P216, DOI 10.1016/j.jnutbio.2007.02.010; Guri AJ, 2007, CLIN NUTR, V26, P107, DOI 10.1016/j.clnu.2006.07.008; Han B, 2000, AM J PHYSIOL-CELL PH, V278, pC344, DOI 10.1152/ajpcell.2000.278.2.C344; Hwang D, 1997, BIOCHEM PHARMACOL, V54, P87, DOI 10.1016/S0006-2952(97)00154-8; Idzko M, 2002, BLOOD, V100, P925, DOI 10.1182/blood.V100.3.925; Imhof A, 2008, DIABETES VASC DIS RE, V5, P48, DOI 10.3132/dvdr.2008.009; Kim MP, 2007, ATHEROSCLEROSIS, V193, P366, DOI 10.1016/j.atherosclerosis.2006.06.029; Kobori M, 2004, CELL DEATH DIFFER, V11, P123, DOI 10.1038/sj.cdd.4401325; LEE HC, 2002, CYCLIC ADP RIBOSE NA; LEONCINI G, 1990, EUR J HAEMATOL, V44, P115; Lutgens E, 2005, CIRCULATION, V111, P3443, DOI 10.1161/CIRCULATIONAHA.104.510073; Martineau I, 2004, BIOMATERIALS, V25, P4489, DOI 10.1016/j.biomaterials.2003.11.013; Nambara E, 2005, ANNU REV PLANT BIOL, V56, P165, DOI 10.1146/annurev.arplant.56.032604.144046; Newby AC, 2006, CARDIOVASC RES, V69, P614, DOI 10.1016/j.cardiores.2005.08.002; Ogawa K, 2004, BIOCHEM J, V381, P413, DOI 10.1042/BJ20040058; Ohtani K, 2004, GENE THER, V11, P1273, DOI 10.1038/sj.gt.3302288; Puce S, 2004, J BIOL CHEM, V279, P39783, DOI 10.1074/jbc.M405348200; Ross R, 1999, AM HEART J, V138, pS419, DOI 10.1016/S0002-8703(99)70266-8; Scarfi S, 2007, FEBS J, V274, P60, DOI 10.1111/j.1742-4658.2006.05564.x; Selzman CH, 2002, AM J PHYSIOL-HEART C, V283, pH1455, DOI 10.1152/ajpheart.00188.2002; SMITH RJ, 1990, J PHARMACOL EXP THER, V253, P688; Soler C, 2001, FASEB J, V15, P1979, DOI 10.1096/fj.01-0022com; Sussmann M, 2004, CIRC RES, V94, P592, DOI 10.1161/01.RES.0000119169.87429.A0; Takeshita H, 1999, J VIROL, V73, P5548, DOI 10.1128/JVI.73.7.5548-5555.1999; UEDA A, 1994, J IMMUNOL, V153, P2052; Verstraete M, 1996, HAEMOSTASIS, V26, P70; WALSETH TF, 1993, BIOCHIM BIOPHYS ACTA, V1178, P235, DOI 10.1016/0167-4889(93)90199-Y; Weber C, 2005, CIRC RES, V96, P612, DOI 10.1161/01.RES.0000160077.17427.57; Willis A I, 2004, Vasc Endovascular Surg, V38, P11, DOI 10.1177/153857440403800102; Yamazaki D, 2003, PLANT J, V35, P129, DOI 10.1046/j.1365-313X.2003.01782.x; Zilber MT, 2000, P NATL ACAD SCI USA, V97, P2840, DOI 10.1073/pnas.050583197; Zocchi E, 1998, J BIOL CHEM, V273, P8017, DOI 10.1074/jbc.273.14.8017; Zocchi E, 2003, J CELL SCI, V116, P629, DOI 10.1242/jcs.00277	51	63	67	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17808	17818		10.1074/jbc.M809546200	http://dx.doi.org/10.1074/jbc.M809546200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19332545	hybrid, Green Published			2022-12-27	WOS:000267202500046
J	Ohana, E; Hoch, E; Keasar, C; Kambe, T; Yifrach, O; Hershfinkel, M; Sekler, I				Ohana, Ehud; Hoch, Eitan; Keasar, Chen; Kambe, Taiho; Yifrach, Ofer; Hershfinkel, Michal; Sekler, Israel			Identification of the Zn2+ Binding Site and Mode of Operation of a Mammalian Zn2+ Transporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN ZINC TRANSPORTER; SECRETORY PATHWAY; ALKALINE-PHOSPHATASES; SENSING RECEPTOR; VERTEBRATE CELLS; METAL-BINDING; MOUSE-BRAIN; PH; MECHANISM; MEMBRANE	Vesicular zinc transporters (ZnTs) play a critical role in regulating Zn2+ homeostasis in various cellular compartments and are linked to major diseases ranging from Alzheimer disease to diabetes. Despite their importance, the intracellular localization of ZnTs poses a major challenge for establishing the mechanisms by which they function and the identity of their ion binding sites. Here, we combine fluorescence-based functional analysis and structural modeling aimed at elucidating these functional aspects. Expression of ZnT5 was followed by both accelerated removal of Zn2+ from the cytoplasm and its increased vesicular sequestration. Further, activity of this zinc transport was coupled to alkalinization of the trans-Golgi network. Finally, structural modeling of ZnT5, based on the x-ray structure of the bacterial metal transporter YiiP, identified four residues that can potentially form the zinc binding site on ZnT5. Consistent with this model, replacement of these residues, Asp(599) and His(451), with alanine was sufficient to block Zn2+ transport. These findings indicate, for the first time, that Zn2+ transport mediated by a mammalian ZnT is catalyzed by H+/Zn2+ exchange and identify the zinc binding site of ZnT proteins essential for zinc transport.	[Sekler, Israel] Ben Gurion Univ Negev, Fac Hlth Sci, Dept Physiol, IL-84105 Beer Sheva, Israel; [Keasar, Chen] Ben Gurion Univ Negev, Dept Comp Sci, IL-84105 Beer Sheva, Israel; [Yifrach, Ofer] Ben Gurion Univ Negev, Dept Life Sci, IL-84105 Beer Sheva, Israel; [Hershfinkel, Michal] Ben Gurion Univ Negev, Dept Morphol, IL-84105 Beer Sheva, Israel; [Kambe, Taiho] Kyoto Univ, Grad Sch Biostudies, Div Integrated Life Sci, Kyoto 6068502, Japan	Ben Gurion University; Ben Gurion University; Ben Gurion University; Ben Gurion University; Kyoto University	Sekler, I (corresponding author), Ben Gurion Univ Negev, Fac Hlth Sci, Dept Physiol, POB 653, IL-84105 Beer Sheva, Israel.	sekler@bgu.ac.il	YIFRACH, Ofer/F-1480-2012; Ohana, Ehud/ABB-3060-2020; Hershfinkel, Michal/F-1548-2012; Keasar, Chen/J-8413-2012; KEASAR, CHEN/HGB-9794-2022; ohana, ehud/C-3077-2014	Hershfinkel, Michal/0000-0003-1652-1989; Keasar, Chen/0000-0003-0994-1520; Ohana, Ehud/0000-0001-8598-4042	Israel Science Foundation (ISF) [985/05]; German-Israel Foundation [917-119.1/2006]; ISF [450/03]	Israel Science Foundation (ISF)(Israel Science Foundation); German-Israel Foundation(German-Israeli Foundation for Scientific Research and Development); ISF(Israel Science Foundation)	This work was supported in part by Israel Science Foundation (ISF) Grant 985/05 (to I.S.), German-Israel Foundation Grant 917-119.1/2006 (to I.S.), and ISF Grant 450/03 (to M.H.).	ATAR D, 1995, J BIOL CHEM, V270, P2473, DOI 10.1074/jbc.270.6.2473; Azriel-Tamir H, 2004, J BIOL CHEM, V279, P51804, DOI 10.1074/jbc.M406581200; Burdette SC, 2001, J AM CHEM SOC, V123, P7831, DOI 10.1021/ja010059l; Canzoniero LMT, 1997, NEUROBIOL DIS, V4, P275, DOI 10.1006/nbdi.1997.0160; Chao Y, 2004, J BIOL CHEM, V279, P12043, DOI 10.1074/jbc.M313510200; Chao Y, 2004, J BIOL CHEM, V279, P17173, DOI 10.1074/jbc.M400208200; Dunn MF, 2005, BIOMETALS, V18, P295, DOI 10.1007/s10534-005-3685-y; Ellis CD, 2005, J BIOL CHEM, V280, P28811, DOI 10.1074/jbc.M505500200; Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124; Hershfinkel M, 2001, P NATL ACAD SCI USA, V98, P11749, DOI 10.1073/pnas.201193398; Huang LP, 2002, J BIOL CHEM, V277, P26389, DOI 10.1074/jbc.M200462200; Huang LP, 1997, NAT GENET, V17, P292, DOI 10.1038/ng1197-292; Inoue K, 2002, HUM MOL GENET, V11, P1775, DOI 10.1093/hmg/11.15.1775; Ishihara K, 2006, J BIOL CHEM, V281, P17743, DOI 10.1074/jbc.M602470200; Jackson KA, 2007, J BIOL CHEM, V282, P10423, DOI 10.1074/jbc.M610535200; Jordan BA, 2001, P NATL ACAD SCI USA, V98, P343, DOI 10.1073/pnas.011384898; Kalisman N, 2005, BIOINFORMATICS, V21, P3931, DOI 10.1093/bioinformatics/bti630; Kambe T, 2002, J BIOL CHEM, V277, P19049, DOI 10.1074/jbc.M200910200; Kawachi M, 2008, J BIOL CHEM, V283, P8374, DOI 10.1074/jbc.M707646200; Lee JY, 2002, P NATL ACAD SCI USA, V99, P7705, DOI 10.1073/pnas.092034699; Levi V, 2002, BIOPHYS J, V82, P437, DOI 10.1016/S0006-3495(02)75408-8; Love R, 2005, BRAIN RES, V1061, P1, DOI 10.1016/j.brainres.2005.08.018; Lu M, 2007, SCIENCE, V317, P1746, DOI 10.1126/science.1143748; MacDiarmid CW, 2002, J BIOL CHEM, V277, P39187, DOI 10.1074/jbc.M205052200; Machen TE, 2003, AM J PHYSIOL-CELL PH, V285, pC205, DOI 10.1152/ajpcell.00008.2003; Mao XQ, 2007, J BIOL CHEM, V282, P6992, DOI 10.1074/jbc.M610552200; MARKWELL MAK, 1978, ANAL BIOCHEM, V87, P206, DOI 10.1016/0003-2697(78)90586-9; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Montanini B, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-107; Nitzan YB, 2002, DEV BRAIN RES, V137, P149, DOI 10.1016/S0165-3806(02)00437-6; Obara K, 2005, P NATL ACAD SCI USA, V102, P14489, DOI 10.1073/pnas.0506222102; Ohana E, 2004, J BIOL CHEM, V279, P4278, DOI 10.1074/jbc.M309229200; Ramsey IS, 2006, NATURE, V440, P1213, DOI 10.1038/nature04700; Schapiro FB, 2000, J BIOL CHEM, V275, P21025, DOI 10.1074/jbc.M002386200; Sekler I, 2002, J COMP NEUROL, V447, P201, DOI 10.1002/cne.10224; SEKLER I, 1995, J BIOL CHEM, V270, P28751, DOI 10.1074/jbc.270.48.28751; Sekler I, 2007, MOL MED, V13, P337, DOI 10.2119/2007-00037.Sekler; Sensi SL, 2006, BIOGERONTOLOGY, V7, P367, DOI 10.1007/s10522-006-9051-9; Seve M, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-32; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Stiernet P, 2006, J BIOL CHEM, V281, P22142, DOI 10.1074/jbc.M513224200; Suzuki T, 2005, J BIOL CHEM, V280, P637, DOI 10.1074/jbc.M411247200; Suzuki T, 2005, J BIOL CHEM, V280, P30956, DOI 10.1074/jbc.M506902200; Valentine RA, 2007, J BIOL CHEM, V282, P14389, DOI 10.1074/jbc.M701752200; VALLEE BL, 1993, PHYSIOL REV, V73, P79, DOI 10.2466/pr0.1993.73.1.79; Wei YN, 2006, J BIOL CHEM, V281, P23492, DOI 10.1074/jbc.M602254200; Wei YN, 2005, J BIOL CHEM, V280, P33716, DOI 10.1074/jbc.M506107200	47	135	137	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17677	17686		10.1074/jbc.M109.007203	http://dx.doi.org/10.1074/jbc.M109.007203			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19366695	Green Published, hybrid			2022-12-27	WOS:000267202500034
J	Li, XJ; Serwanski, DR; Miralles, CP; Nagata, K; De Blas, AL				Li, Xuejing; Serwanski, David R.; Miralles, Celia P.; Nagata, Koh-ichi; De Blas, Angel L.			Septin 11 Is Present in GABAergic Synapses and Plays a Functional Role in the Cytoarchitecture of Neurons and GABAergic Synaptic Connectivity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINOBUTYRIC ACID(A) RECEPTOR; GABA-A RECEPTOR; MAMMALIAN SEPTIN; IMMUNOCYTOCHEMICAL LOCALIZATION; POSTSYNAPTIC DENSITIES; STRUCTURAL INSIGHTS; SPLICE VARIANT; SUBUNIT; PROTEIN; BRAIN	Mass spectrometry and immunoblot analysis of a rat brain fraction enriched in type-II postsynaptic densities and postsynaptic GABAergic markers showed enrichment in the protein septin 11. Septin 11 is expressed throughout the brain, being particularly high in the spiny branchlets of the Purkinje cells in the molecular layer of cerebellum and in the olfactory bulb. Immunofluorescence of cultured hippocampal neurons showed that 54 +/- 4% of the GABAergic synapses and 25 +/- 2% of the glutamatergic synapses had colocalizing septin 11 clusters. Similar colocalization numbers were found in the molecular layer of cerebellar sections. In cultured hippocampal neurons, septin 11 clusters were frequently present at the base of dendritic protrusions and at the bifurcation points of the dendritic branches. Electron microscopy immunocytochemistry of the rat brain cerebellum revealed the accumulation of septin 11 at the neck of dendritic spines, at the bifurcation of dendritic branches, and at some GABAergic synapses. Knocking down septin 11 in cultured hippocampal neurons with septin 11 small hairpin RNAs showed (i) reduced dendritic arborization; (ii) decreased density and increased length of dendritic protrusions; and (iii) decreased GABAergic synaptic contacts that these neurons receive. The results indicate that septin 11 plays important roles in the cytoarchitecture of neurons, including dendritic arborization and dendritic spines, and that septin 11 also plays a role in GABAergic synaptic connectivity.	[Li, Xuejing; Serwanski, David R.; Miralles, Celia P.; De Blas, Angel L.] Univ Connecticut, Dept Physiol & Neurobiol, Storrs, CT 06269 USA; [Nagata, Koh-ichi] Aichi Human Serv Ctr, Inst Dev Res, Dept Mol Neurobiol, Aichi 4800392, Japan	University of Connecticut	De Blas, AL (corresponding author), Univ Connecticut, Dept Physiol & Neurobiol, 75 N Eagleville Rd,U-3156, Storrs, CT 06269 USA.	angel.deblas@uconn.edu			National Institutes of Health; NINDS [NS38752, NS39287]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038752, R01NS039287] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health, NINDS, Grants NS38752 and NS39287.	Amin ND, 2008, J NEUROSCI, V28, P3631, DOI 10.1523/JNEUROSCI.0453-08.2008; Barral Y, 2000, MOL CELL, V5, P841, DOI 10.1016/S1097-2765(00)80324-X; Barral Y, 2008, CURR OPIN CELL BIOL, V20, P12, DOI 10.1016/j.ceb.2007.12.001; Beites CL, 2005, BIOCHEM J, V385, P347, DOI 10.1042/BJ20041090; Beites CL, 1999, NAT NEUROSCI, V2, P434, DOI 10.1038/8100; Blaser S, 2006, J PATHOL, V210, P103, DOI 10.1002/path.2013; Caltagarone J, 1998, NEUROREPORT, V9, P2907, DOI 10.1097/00001756-199808240-00042; CARLIN RK, 1980, J CELL BIOL, V86, P831, DOI 10.1083/jcb.86.3.831; Chandra D, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-30; Charych EI, 2004, J BIOL CHEM, V279, P38978, DOI 10.1074/jbc.M405786200; Charych EI, 2004, J NEUROCHEM, V90, P173, DOI 10.1111/j.1471-4159.2004.02481.x; Christie SB, 2006, MOL CELL NEUROSCI, V31, P1, DOI 10.1016/j.mcn.2005.08.014; Christie SB, 2003, J COMP NEUROL, V456, P361, DOI 10.1002/cne.10535; Christie SB, 2002, NEUROREPORT, V13, P2355, DOI 10.1097/00001756-200212030-00037; Christie SB, 2002, PROG BRAIN RES, V136, P157; Christie SB, 2002, J NEUROSCI, V22, P684, DOI 10.1523/JNEUROSCI.22-03-00684.2002; COTMAN CW, 1974, J CELL BIOL, V63, P441, DOI 10.1083/jcb.63.2.441; DEBLAS AL, 1983, ANAL BIOCHEM, V133, P214, DOI 10.1016/0003-2697(83)90245-2; DEBLAS AL, 1984, J NEUROSCI, V4, P265; DEBLAS AL, 1988, J NEUROSCI, V8, P602; Dent J, 2002, P NATL ACAD SCI USA, V99, P3064, DOI 10.1073/pnas.052715199; Fang C, 2006, J NEUROSCI, V26, P12758, DOI 10.1523/JNEUROSCI.4214-06.2006; Fritschy JM, 2006, J NEUROSCI, V26, P3245, DOI 10.1523/JNEUROSCI.5118-05.2006; Fujishima K, 2007, J NEUROCHEM, V102, P77, DOI 10.1111/j.1471-4159.2007.04478.x; GOSLIN K, 1998, CULTURING NERVE CELL; Hanai N, 2004, FEBS LETT, V568, P83, DOI 10.1016/j.febslet.2004.05.030; Homanics GE, 1999, NEUROPHARMACOLOGY, V38, P253, DOI 10.1016/S0028-3908(98)00177-4; Hsu SC, 1998, NEURON, V20, P1111, DOI 10.1016/S0896-6273(00)80493-6; Ihara M, 2007, NEURON, V53, P519, DOI 10.1016/j.neuron.2007.01.019; Ito H, 2005, ONCOGENE, V24, P7064, DOI 10.1038/sj.onc.1208862; Joo E, 2005, TRAFFIC, V6, P626, DOI 10.1111/j.1600-0854.2005.00305.x; Kartmann B, 2001, J CELL SCI, V114, P839; Kawasaki BT, 1997, J NEUROSCI RES, V49, P381, DOI 10.1002/(SICI)1097-4547(19970801)49:3<381::AID-JNR13>3.0.CO;2-2; Kinoshita A, 2000, J COMP NEUROL, V428, P223, DOI 10.1002/1096-9861(20001211)428:2<223::AID-CNE3>3.0.CO;2-M; Kinoshita A, 1998, AM J PATHOL, V153, P1551, DOI 10.1016/S0002-9440(10)65743-4; Kinoshita M, 2006, CURR OPIN CELL BIOL, V18, P54, DOI 10.1016/j.ceb.2005.12.005; Kinoshita M, 2003, J BIOCHEM, V134, P491, DOI 10.1093/jb/mvg182; Kremer BE, 2005, MOL BIOL CELL, V16, P4648, DOI 10.1091/mbc.E05-03-0267; Kremer BE, 2007, CELL, V130, P837, DOI 10.1016/j.cell.2007.06.053; Kuhlenbaumer G, 2005, NAT GENET, V37, P1044, DOI 10.1038/ng1649; Li RW, 2005, J COMP NEUROL, V488, P11, DOI 10.1002/cne.20566; Li RW, 2005, J NEUROCHEM, V95, P756, DOI 10.1111/j.1471-4159.2005.03426.x; Li X, 2007, J NEUROCHEM, V102, P1329, DOI 10.1111/j.1471-4159.2007.04635.x; Longtine MS, 2003, TRENDS CELL BIOL, V13, P403, DOI 10.1016/S0962-8924(03)00151-X; Lukoyanova N, 2008, J MOL BIOL, V376, P1, DOI 10.1016/j.jmb.2007.11.029; Miralles CP, 1999, J COMP NEUROL, V413, P535; MORENO JI, 1994, J COMP NEUROL, V350, P260, DOI 10.1002/cne.903500209; Nagata K, 2004, J BIOL CHEM, V279, P55895, DOI 10.1074/jbc.M406153200; Nusser Z, 1998, J NEUROSCI, V18, P1693; Ono R, 2005, MOL CELL BIOL, V25, P10965, DOI 10.1128/MCB.25.24.10965-10978.2005; Peng XR, 2002, MOL CELL BIOL, V22, P378, DOI 10.1128/MCB.22.1.378-387.2002; Riquelme R, 2002, J NEUROSCI, V22, P10720; Rodal AA, 2005, MOL BIOL CELL, V16, P372, DOI 10.1091/mbc.e04-08-0734; Serwanski DR, 2006, J COMP NEUROL, V499, P458, DOI 10.1002/cne.21115; SHOLL DA, 1953, J ANAT, V87, P387; Sirajuddin M, 2007, NATURE, V449, P311, DOI 10.1038/nature06052; Son JH, 2005, J NEUROCHEM, V94, P1040, DOI 10.1111/j.1471-4159.2005.03257.x; Sudo K, 2007, HUM MUTAT, V28, P1005, DOI 10.1002/humu.20554; Tada T, 2007, CURR BIOL, V17, P1752, DOI 10.1016/j.cub.2007.09.039; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Vrabioiu AM, 2006, NATURE, V443, P466, DOI 10.1038/nature05109; Walikonis RS, 2000, J NEUROSCI, V20, P4069; Xie YL, 2007, CURR BIOL, V17, P1746, DOI 10.1016/j.cub.2007.08.042; Xue J, 2004, J NEUROCHEM, V91, P579, DOI 10.1111/j.1471-4159.2004.02755.x; Yu JY, 2002, P NATL ACAD SCI USA, V99, P6047, DOI 10.1073/pnas.092143499; Yu W, 2007, MOL CELL NEUROSCI, V36, P484, DOI 10.1016/j.mcn.2007.08.008	66	42	45	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					17253	17265		10.1074/jbc.M109.008870	http://dx.doi.org/10.1074/jbc.M109.008870			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19380581	Green Published, hybrid			2022-12-27	WOS:000266962400062
J	Bunda, S; Wang, YT; Mitts, TF; Liu, P; Arab, S; Arabkhari, M; Hinek, A				Bunda, Severa; Wang, Yanting; Mitts, Thomas F.; Liu, Peter; Arab, Sara; Arabkhari, Majid; Hinek, Aleksander			Aldosterone Stimulates Elastogenesis in Cardiac Fibroblasts via Mineralocorticoid Receptor-independent Action Involving the Consecutive Activation of G alpha(13), c-Src, the Insulin-like Growth Factor-I Receptor, and Phosphatidylinositol 3-Kinase/Akt	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTORS; CONGESTIVE-HEART-FAILURE; COLLAGEN GENE-EXPRESSION; ANGIOTENSIN-II; AUTOPHOSPHORYLATION SITES; REGULATES TRANSCRIPTION; ESTROGEN-RECEPTOR; BINDING PROTEIN; KINASE-ACTIVITY; ELASTIN GENE	We previously demonstrated that aldosterone, which stimulates collagen production through the mineralocorticoid receptor (MR)-dependent pathway, also induces elastogenesis via a parallel MR-independent mechanism involving insulin-like growth factor-I receptor (IGF-IR) signaling. The present study provides a more detailed explanation of this signaling pathway. Our data demonstrate that small interfering RNA-driven elimination of MR in cardiac fibroblasts does not inhibit aldosterone-induced IGF-IR phosphorylation and subsequent increase in elastin production. These results exclude the involvement of the MR in aldosterone-induced increases in elastin production. Results of further experiments aimed at identifying the upstream signaling component(s) that might be activated by aldosterone also eliminate the putative involvement of pertussis toxin-sensitive G alpha(i) proteins, which have previously been shown to be responsible for some MR-independent effects of aldosterone. Instead, we found that small interfering RNA-dependent elimination of another heterotrimeric G protein, G alpha(13), eliminates aldosterone-induced elastogenesis. We further demonstrate that aldosterone first engages G alpha(13) and then promotes its transient interaction with c-Src, which constitutes a prerequisite step for aldosterone-dependent activation of the IGF-IR and propagation of consecutive downstream elastogenic signaling involving phosphatidylinositol 3-kinase/Akt. In summary, the data we present reveal new details of an MR-independent cellular signaling pathway through which aldosterone stimulates elastogenesis in human cardiac fibroblasts.	[Bunda, Severa; Wang, Yanting; Mitts, Thomas F.; Arabkhari, Majid; Hinek, Aleksander] Univ Toronto, Hosp Sick Children, Dept Lab Med & Pathobiol, Physiol & Expt Med Program, Toronto, ON M5G 1X8, Canada; [Liu, Peter; Hinek, Aleksander] Univ Toronto, Heart & Stroke Richard Lewar Ctr Excellence, Toronto, ON M5G 1X8, Canada; [Liu, Peter; Arab, Sara] Univ Hlth Network, Toronto Gen Hosp, Toronto, ON M5G 1X8, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Hinek, A (corresponding author), Univ Toronto, Hosp Sick Children, Dept Lab Med & Pathobiol, Physiol & Expt Med Program, 555 Univ Ave, Toronto, ON M5G 1X8, Canada.	alek.hinek@sickkids.ca	Hinek, Aleksander/V-8790-2019		Canadian Institute of Health Research [PG 13920]; Heart and Stroke Foundation of Ontario [NA 5435, NA 4381]; Career Investigator Award [CI 4198]	Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Career Investigator Award	This work was supported by the Canadian Institute of Health Research through Grant PG 13920, by the Heart and Stroke Foundation of Ontario through Grants NA 5435 and NA 4381, and by Career Investigator Award CI 4198 (to A.H.).	Adarichev VA, 2003, AM J PHYSIOL-CELL PH, V285, pC922, DOI 10.1152/ajpcell.00115.2003; ALESSI DR, 1995, J BIOL CHEM, V270, P27489, DOI 10.1074/jbc.270.46.27489; ANDO A, 1992, J BIOL CHEM, V267, P12788; Arima S, 2006, STEROIDS, V71, P281, DOI 10.1016/j.steroids.2005.09.013; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Bohmer S, 2006, BIOL CHEM, V387, P917, DOI 10.1515/BC.2006.116; BRILLA CG, 1993, AM J CARDIOL, V71, pA12, DOI 10.1016/0002-9149(93)90239-9; Bunda S, 2007, AM J PATHOL, V171, P809, DOI 10.2353/ajpath.2007.070101; Chai WX, 2005, HYPERTENSION, V46, P701, DOI 10.1161/01.HYP.0000182661.98259.4f; CHRIST M, 1994, MOL CELL ENDOCRINOL, V99, pR31, DOI 10.1016/0303-7207(94)90027-2; Coles JG, 2005, J THORAC CARDIOV SUR, V129, P1128, DOI 10.1016/j.jtcvs.2004.11.055; Conn KJ, 1996, J BIOL CHEM, V271, P28853, DOI 10.1074/jbc.271.46.28853; Connell JMC, 2005, J ENDOCRINOL, V186, P1, DOI 10.1677/joe.1.06017; Dib K, 2001, J IMMUNOL, V166, P6311, DOI 10.4049/jimmunol.166.10.6311; Dikic I, 1996, NATURE, V383, P547, DOI 10.1038/383547a0; EISEN C, 1994, CELL MOL BIOL, V40, P351; ERLANGER BF, 1957, J BIOL CHEM, V228, P713; Filardo EJ, 2008, STEROIDS, V73, P870, DOI 10.1016/j.steroids.2007.12.025; Filardo EJ, 2000, MOL ENDOCRINOL, V14, P1649, DOI 10.1210/me.14.10.1649; Filardo EJ, 2002, MOL ENDOCRINOL, V16, P70, DOI 10.1210/me.16.1.70; Gekle M, 1998, J PHYSIOL-LONDON, V511, P255, DOI 10.1111/j.1469-7793.1998.255bi.x; Gustafsson AB, 2000, MOL PHARMACOL, V58, P1470, DOI 10.1124/mol.58.6.1470; Hafizi S, 1998, CIRCULATION, V98, P2553, DOI 10.1161/01.CIR.98.23.2553; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Haseroth K, 1999, BIOCHEM BIOPH RES CO, V266, P257, DOI 10.1006/bbrc.1999.1771; HINEK A, 1993, J BIOL CHEM, V268, P1405; HINEK A, 1994, J CELL BIOL, V126, P563, DOI 10.1083/jcb.126.2.563; HINEK A, 1993, J CLIN INVEST, V91, P1198, DOI 10.1172/JCI116280; Jennings DL, 2005, PHARMACOTHERAPY, V25, P1126, DOI 10.1592/phco.2005.25.8.1126; JENSEN DE, 1995, J BIOL CHEM, V270, P6555, DOI 10.1074/jbc.270.12.6555; JI H, 1994, J BIOL CHEM, V269, P16533; Jiang XY, 2007, ACTA CARDIOL, V62, P429, DOI 10.2143/AC.62.5.2023404; Jiang YX, 1996, J BIOL CHEM, V271, P160, DOI 10.1074/jbc.271.1.160; Karni R, 2003, FEBS LETT, V537, P47, DOI 10.1016/S0014-5793(03)00069-3; Kim M, 2006, BIOCHEM BIOPH RES CO, V339, P271, DOI 10.1016/j.bbrc.2005.11.014; Kim S, 2006, BLOOD, V107, P947, DOI 10.1182/blood-2005-07-3040; Klages B, 1999, J CELL BIOL, V144, P745, DOI 10.1083/jcb.144.4.745; Krumins AM, 2006, J BIOL CHEM, V281, P10250, DOI 10.1074/jbc.M511551200; Kuang PP, 2007, AM J PHYSIOL-LUNG C, V292, pL944, DOI 10.1152/ajplung.00184.2006; Kurose H, 2003, LIFE SCI, V74, P155, DOI 10.1016/j.lfs.2003.09.003; Le Moellic C, 2004, J AM SOC NEPHROL, V15, P1145; LEROITH D, 1995, ENDOCR REV, V16, P143, DOI 10.1210/er.16.2.143; Li JZ, 1996, BLOOD, V88, P417, DOI 10.1182/blood.V88.2.417.bloodjournal882417; Li L, 2003, CRIT REV ORAL BIOL M, V14, P100, DOI 10.1177/154411130301400204; LIU DL, 1993, J VIROL, V67, P6835, DOI 10.1128/JVI.67.11.6835-6840.1993; Losel RM, 2008, FRONT NEUROENDOCRIN, V29, P258, DOI 10.1016/j.yfrne.2007.09.002; Mazak I, 2004, CIRCULATION, V109, P2792, DOI 10.1161/01.CIR.0000131860.80444.AB; MEYER C, 1995, EUR J BIOCHEM, V229, P736, DOI 10.1111/j.1432-1033.1995.tb20521.x; Mihailidou AS, 2006, STEROIDS, V71, P277, DOI 10.1016/j.steroids.2005.09.017; Minuz P, 2006, BIOCHEM J, V400, P127, DOI 10.1042/BJ20061015; Mita MM, 2003, CANCER BIOL THER, V2, pS169; Nagai Y, 2005, HYPERTENSION, V46, P1039, DOI 10.1161/01.HYP.0000174593.88899.68; NAKAMURA I, 1995, FEBS LETT, V361, P79, DOI 10.1016/0014-5793(95)00153-Z; Nishida M, 2007, J BIOL CHEM, V282, P23117, DOI 10.1074/jbc.M611780200; Peterson JE, 1996, J BIOL CHEM, V271, P31562, DOI 10.1074/jbc.271.49.31562; Pitt B, 2003, NEW ENGL J MED, V348, P1309, DOI 10.1056/NEJMoa030207; Pitt B, 1999, NEW ENGL J MED, V341, P709, DOI 10.1056/NEJM199909023411001; Rodems SM, 1998, J VIROL, V72, P9173, DOI 10.1128/JVI.72.11.9173-9180.1998; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V331, P1, DOI 10.1016/j.bbrc.2005.03.012; Shi CS, 2000, J BIOL CHEM, V275, P24470, DOI 10.1074/jbc.M908449199; Simoncini T, 2006, MOL ENDOCRINOL, V20, P1756, DOI 10.1210/me.2005-0259; Uehata M, 1997, NATURE, V389, P990, DOI 10.1038/40187; Urbach V, 2001, J PHYSIOL-LONDON, V537, P267, DOI 10.1111/j.1469-7793.2001.0267k.x; WEBER KT, 1991, CIRCULATION, V83, P1849, DOI 10.1161/01.CIR.83.6.1849; WEHLING M, 1992, MOL CELL ENDOCRINOL, V90, pC5, DOI 10.1016/0303-7207(92)90092-K; WIDDOP RE, 1993, AM J PHYSIOL, V265, pH226, DOI 10.1152/ajpheart.1993.265.1.H226; WILDLING L, 2009, PFLUGERS AR IN PRESS; WOLFE BL, 1993, J BIOL CHEM, V268, P12418; Xiao F, 2004, HYPERTENSION, V44, P340, DOI 10.1161/01.HYP.0000140771.21243.ed; Yamaguchi Y, 2003, J BIOL CHEM, V278, P14936, DOI 10.1074/jbc.M301409200; Yanazume T, 2002, J BIOL CHEM, V277, P8618, DOI 10.1074/jbc.M107924200; YANO H, 1993, J BIOL CHEM, V268, P25846; YOUNG M, 1994, J CLIN INVEST, V93, P2578, DOI 10.1172/JCI117269; Zannad F, 2000, CIRCULATION, V102, P2700, DOI 10.1161/01.CIR.102.22.2700; Zannad F, 2001, HYPERTENSION, V38, P1227, DOI 10.1161/hy1101.099484; Zhou GP, 1996, MOL CELL BIOCHEM, V154, P171, DOI 10.1007/BF00226785; Zhu Y, 2003, P NATL ACAD SCI USA, V100, P2231, DOI 10.1073/pnas.0336132100; Zhu Y, 2003, P NATL ACAD SCI USA, V100, P2237, DOI 10.1073/pnas.0436133100	78	43	48	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16633	16647		10.1074/jbc.M109.008748	http://dx.doi.org/10.1074/jbc.M109.008748			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19372600	Green Published, hybrid			2022-12-27	WOS:000266730900059
J	Olsson, M; Tang, KW; Persson, C; Wilhelmsson, LM; Billeter, M; Elias, P				Olsson, Monica; Tang, Ka-Wei; Persson, Cecilia; Wilhelmsson, L. Marcus; Billeter, Martin; Elias, Per			Stepwise Evolution of the Herpes Simplex Virus Origin Binding Protein and Origin of Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CERCOPITHECINE HERPESVIRUS-1 GENOME; TYPE-1 DNA-REPLICATION; SEQUENCE REQUIREMENTS; PRIMATE HERPESVIRUSES; GENETIC ARRANGEMENT; VIRAL ORIGIN; UL9; DOMAIN; ICP8; ORIS	The herpes simplex virus replicon consists of cis-acting sequences, oriS and oriL, and the origin binding protein (OBP) encoded by the UL9 gene. Here we identify essential structural features in the initiator protein OBP and the replicator sequence oriS, and we relate the appearance of these motifs to the evolutionary history of the alphaherpesvirus replicon. Our results reveal two conserved sequence elements in herpes simplex virus type 1, OBP; the RVKNL motif, common to and specific for all alphaherpesviruses, is required for DNA binding, and the WPXXXGAXXFXXL motif, found in a subset of alphaherpesviruses, is required for specific binding to the single strand DNA-binding protein ICP8. A 121-amino acid minimal DNA binding domain containing conserved residues is not soluble and does not bind DNA. Additional sequences present 220 amino acids upstream from the RVKNL motif are needed for solubility and function. We also examine the binding sites for OBP in origins of DNA replication and how they are arranged. NMR and DNA melting experiments demonstrate that origin sequences derived from many, but not all, alphaherpesviruses can adopt stable boxI/boxIII hairpin conformations. Our results reveal a stepwise evolutionary history of the herpes simplex virus replicon and suggest that replicon divergence contributed to the formation of major branches of the herpesvirus family.	[Olsson, Monica; Tang, Ka-Wei; Elias, Per] Univ Gothenburg, Inst Biomed, Dept Med Biochem & Cell Biol, Sahlgrenska Acad, S-40530 Gothenburg, Sweden; [Persson, Cecilia] Univ Gothenburg, Swedish NMR Ctr, S-40530 Gothenburg, Sweden; [Wilhelmsson, L. Marcus] Chalmers, Dept Chem & Biol Engn Phys Chem, S-41296 Gothenburg, Sweden; [Billeter, Martin] Univ Gothenburg, Dept Chem, Biophys Grp, S-40530 Gothenburg, Sweden	University of Gothenburg; University of Gothenburg; Chalmers University of Technology; University of Gothenburg	Elias, P (corresponding author), Univ Gothenburg, Inst Biomed, Dept Med Biochem & Cell Biol, Sahlgrenska Acad, Box 440, S-40530 Gothenburg, Sweden.	per.elias@medkem.gu.es	Wilhelmsson, Marcus/A-9165-2008; Billeter, Martin/A-8293-2010	Wilhelmsson, Marcus/0000-0002-2193-6639; Tang, Ka-Wei/0000-0003-1189-5092	Swedish Cancer Foundation; The Swedish Research Council; Sahlgrenska University Hospital Lakarutbildningsavtal	Swedish Cancer Foundation; The Swedish Research Council(Swedish Research Council); Sahlgrenska University Hospital Lakarutbildningsavtal	This work was supported by grants from the Swedish Cancer Foundation, The Swedish Research Council, and the Sahlgrenska University Hospital Lakarutbildningsavtal.	ARBUCKLE MI, 1993, J GEN VIROL, V74, P1349, DOI 10.1099/0022-1317-74-7-1349; Aslani A, 2000, J BIOL CHEM, V275, P5880, DOI 10.1074/jbc.275.8.5880; Aslani A, 2002, J BIOL CHEM, V277, P41204, DOI 10.1074/jbc.M208270200; Aslani A, 2001, P NATL ACAD SCI USA, V98, P7194, DOI 10.1073/pnas.121177198; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; BLUMEL J, 1995, J GEN VIROL, V76, P3119, DOI 10.1099/0022-1317-76-12-3119; BOEHMER PE, 1994, J BIOL CHEM, V269, P29329; BOEHMER PE, 1993, P NATL ACAD SCI USA, V90, P8444, DOI 10.1073/pnas.90.18.8444; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; CHEN D, 1995, J VIROL, V69, P4515, DOI 10.1128/JVI.69.7.4515-4518.1995; Davison AJ, 2009, ARCH VIROL, V154, P171, DOI 10.1007/s00705-008-0278-4; DEB S, 1991, J VIROL, V65, P2829, DOI 10.1128/JVI.65.6.2829-2838.1991; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dykes C, 1997, J GEN VIROL, V78, P1125, DOI 10.1099/0022-1317-78-5-1125; ELIAS P, 1986, P NATL ACAD SCI USA, V83, P6322, DOI 10.1073/pnas.83.17.6322; ELIAS P, 1990, J BIOL CHEM, V265, P17167; Falkenberg M, 2000, P NATL ACAD SCI USA, V97, P3896, DOI 10.1073/pnas.97.8.3896; Guntert Peter, 2004, Methods Mol Biol, V278, P353; GUSTAFSSON CM, 1995, J BIOL CHEM, V270, P19028, DOI 10.1074/jbc.270.32.19028; Hammarsten O, 1997, NUCLEIC ACIDS RES, V25, P1753, DOI 10.1093/nar/25.9.1753; HAZUDA DJ, 1991, J BIOL CHEM, V266, P24621; Herbst L, 2004, CURR BIOL, V14, pR697, DOI 10.1016/j.cub.2004.08.040; HERNANDEZ TR, 1991, J VIROL, V65, P1649, DOI 10.1128/JVI.65.3.1649-1652.1991; KNIPE DM, 2007, FIELDS VIROLOGY, P2479; Krug LT, 2001, VIROLOGY, V288, P145, DOI 10.1006/viro.2001.1066; Krug LT, 2001, J VIROL, V75, P3925, DOI 10.1128/JVI.75.8.3925-3936.2001; Lehman IR, 1999, J BIOL CHEM, V274, P28059, DOI 10.1074/jbc.274.40.28059; Macao B, 2004, J BIOL CHEM, V279, P29211, DOI 10.1074/jbc.M400371200; Makhov AM, 2003, P NATL ACAD SCI USA, V100, P898, DOI 10.1073/pnas.0237171100; MARKY LA, 1987, BIOPOLYMERS, V26, P1601, DOI 10.1002/bip.360260911; MARTIN DW, 1991, J VIROL, V65, P4359, DOI 10.1128/JVI.65.8.4359-4369.1991; MARTIN DW, 1994, VIROLOGY, V198, P71, DOI 10.1006/viro.1994.1009; Muylaert I, 2007, J BIOL CHEM, V282, P10865, DOI 10.1074/jbc.M611834200; Ohsawa K, 2003, ARCH VIROL, V148, P989, DOI 10.1007/s00705-003-0011-2; Ohsawa K, 2002, J VIROL, V76, P1516, DOI 10.1128/JVI.76.3.1516-1520.2002; Perelygina L, 2003, J VIROL, V77, P6167, DOI 10.1128/JVI.77.11.6167-6177.2003; PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855; SCHEFFLE.IE, 1968, J MOL BIOL, V36, P291, DOI 10.1016/0022-2836(68)90156-3; Schildgen O, 2005, J VIROL, V79, P7273, DOI 10.1128/JVI.79.11.7273-7278.2005; Simonsson S, 1998, J BIOL CHEM, V273, P24633, DOI 10.1074/jbc.273.38.24633; Stacy BA, 2008, VET MICROBIOL, V126, P63, DOI 10.1016/j.vetmic.2007.07.002; STOW ND, 1986, J GEN VIROL, V67, P1613, DOI 10.1099/0022-1317-67-8-1613; STOW ND, 1990, VIROLOGY, V177, P570, DOI 10.1016/0042-6822(90)90522-S; Stow ND, 1998, VIROLOGY, V240, P183, DOI 10.1006/viro.1997.8910; Strang BL, 2005, J VIROL, V79, P12487, DOI 10.1128/JVI.79.19.12487-12494.2005; Thureen DR, 2006, J VIROL, V80, P7863, DOI 10.1128/JVI.00134-06; WEIR HM, 1989, NUCLEIC ACIDS RES, V17, P1409, DOI 10.1093/nar/17.4.1409; WEIR HM, 1990, J GEN VIROL, V71, P1379, DOI 10.1099/0022-1317-71-6-1379; XODO LE, 1988, BIOCHEMISTRY-US, V27, P6321, DOI 10.1021/bi00417a018	49	16	16	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16246	16255		10.1074/jbc.M807551200	http://dx.doi.org/10.1074/jbc.M807551200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19351883	hybrid, Green Published			2022-12-27	WOS:000266730900022
J	Jerga, A; Rock, CO				Jerga, Agoston; Rock, Charles O.			Acyl-Acyl Carrier Protein Regulates Transcription of Fatty Acid Biosynthetic Genes via the FabT Repressor in Streptococcus pneumoniae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; FACTOR FADR; LIPID BIOSYNTHESIS; STRUCTURAL BASIS; BINDING; COENZYME; METABOLISM; INHIBITION; MECHANISM; BACTERIA	Long-chain acyl-acyl carrier proteins (acyl-ACP) are established biochemical regulators of bacterial type II fatty acid synthases due to their ability to feedback-inhibit the early steps in the biosynthetic pathway. In Streptococcus pneumoniae, the expression of the fatty acid synthase (fab) genes is controlled by a helix-turn-helix transcriptional repressor called FabT. A screen of pathway intermediates identified acyl-ACP as a ligand that increased the affinity of FabT for DNA. FabT bound to a wide range of acyl-ACP chain lengths in the absence of DNA, but only the long-chain acyl-ACPs increase the affinity of FabT for DNA. FabT affinity for DNA increased with increasing acyl-ACP chain length with cis-vaccenoyl-ACP being the most effective ligand. Thus, FabT is a new ACP-interacting partner that acts as a transcriptional rheostat to fine tune the expression of the fab genes based on the demand for fatty acids.	[Jerga, Agoston; Rock, Charles O.] St Jude Childrens Res Hosp, Dept Infect Dis, Memphis, TN 38105 USA	St Jude Children's Research Hospital	Rock, CO (corresponding author), St Jude Childrens Res Hosp, Dept Infect Dis, 262 Danny Thomas Pl, Memphis, TN 38105 USA.	charles.rock@stjude.org			National Institutes of Health [GM34496]; Cancer Center (CORE) Support Grant [CA21765]; American Lebanese Syrian Associated Charities; NATIONAL CANCER INSTITUTE [P30CA021765] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034496, R37GM034496] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center (CORE) Support Grant; American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM34496, Cancer Center (CORE) Support Grant CA21765, and the American Lebanese Syrian Associated Charities.	ALBERTS AW, 1972, J BIOL CHEM, V247, P3190; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; Campbell JW, 2001, J BACTERIOL, V183, P5982, DOI 10.1128/JB.183.20.5982-5990.2001; Cronan JE, 1997, J BACTERIOL, V179, P1819, DOI 10.1128/jb.179.5.1819-1823.1997; CRONAN JE, 2008, ESCHERICHIA COLI SAL; Davis MS, 2001, J BACTERIOL, V183, P1499, DOI 10.1128/JB.183.4.1499-1503.2001; DiRusso CC, 1998, J BIOL CHEM, V273, P33652, DOI 10.1074/jbc.273.50.33652; DIRUSSO CC, 1992, J BIOL CHEM, V267, P8685; DIRUSSO CC, 1985, J BACTERIOL, V161, P583, DOI 10.1128/JB.161.2.583-588.1985; Heath RJ, 2000, NATURE, V406, P145, DOI 10.1038/35018162; Heath RJ, 1996, J BIOL CHEM, V271, P10996, DOI 10.1074/jbc.271.18.10996; Heath RJ, 1999, J BIOL CHEM, V274, P11110, DOI 10.1074/jbc.274.16.11110; HELMKAMP GM, 1968, J BIOL CHEM, V243, P3229; HENRY MF, 1992, CELL, V70, P671, DOI 10.1016/0092-8674(92)90435-F; HENRY MF, 1991, J MOL BIOL, V222, P843, DOI 10.1016/0022-2836(91)90574-P; JACKOWSKI S, 1983, J BIOL CHEM, V258, P5186; Jerga A, 2009, J BIOL CHEM, V284, P7246, DOI 10.1074/jbc.M805962200; Lazar GA, 2006, P NATL ACAD SCI USA, V103, P4005, DOI 10.1073/pnas.0508123103; Lishanski A, 2000, Nucleic Acids Res, V28, pE42, DOI 10.1093/nar/28.9.e42; Lu YJ, 2006, MOL CELL, V23, P765, DOI 10.1016/j.molcel.2006.06.030; Lu YJ, 2006, MOL MICROBIOL, V59, P551, DOI 10.1111/j.1365-2958.2005.04951.x; Marrakchi H, 2002, J BIOL CHEM, V277, P44809, DOI 10.1074/jbc.M208920200; McCue LA, 2001, NUCLEIC ACIDS RES, V29, P774, DOI 10.1093/nar/29.3.774; OVERATH P, 1969, EUR J BIOCHEM, V7, P559; RAMAN N, 1995, J BIOL CHEM, V270, P1092, DOI 10.1074/jbc.270.3.1092; ROCK CO, 1979, J BIOL CHEM, V254, P7123; Rock CO, 2002, BIOCHEM BIOPH RES CO, V292, P1155, DOI 10.1006/bbrc.2001.2022; Schujman GE, 2005, CURR OPIN MICROBIOL, V8, P149, DOI 10.1016/j.mib.2005.02.003; Schujman GE, 2003, DEV CELL, V4, P663, DOI 10.1016/S1534-5807(03)00123-0; Schujman GE, 2008, MOL MICROBIOL, V68, P987, DOI 10.1111/j.1365-2958.2008.06202.x; Schujman GE, 2006, EMBO J, V25, P4074, DOI 10.1038/sj.emboj.7601284; ULLMAN EF, 1994, P NATL ACAD SCI USA, V91, P5426, DOI 10.1073/pnas.91.12.5426; van Aalten DMF, 2000, EMBO J, V19, P5167, DOI 10.1093/emboj/19.19.5167; van Aalten DMF, 2001, EMBO J, V20, P2041, DOI 10.1093/emboj/20.8.2041; Xu YB, 2001, J BIOL CHEM, V276, P17373, DOI 10.1074/jbc.M100195200; Zhang YM, 2002, J BIOL CHEM, V277, P15558, DOI 10.1074/jbc.M201399200; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839; Zhang YM, 2007, MOL MICROBIOL, V66, P622, DOI 10.1111/j.1365-2958.2007.05934.x; Zhang YM, 2009, J LIPID RES, V50, pS115, DOI 10.1194/jlr.R800046-JLR200	39	46	47	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15364	15368		10.1074/jbc.C109.002410	http://dx.doi.org/10.1074/jbc.C109.002410			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19376778	hybrid, Green Published			2022-12-27	WOS:000266501000004
J	Lehtinen, MJ; Rops, AL; Isenman, DE; van der Vlag, J; Jokiranta, TS				Lehtinen, Markus J.; Rops, Angelique L.; Isenman, David E.; van der Vlag, Johan; Jokiranta, T. Sakari			Mutations of Factor H Impair Regulation of Surface-bound C3b by Three Mechanisms in Atypical Hemolytic Uremic Syndrome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPLEMENT FACTOR-H; HEPARIN-BINDING DOMAIN; SHORT CONSENSUS REPEAT; ENDOTHELIAL-CELLS; PROTEIN BETA-1H; 3RD COMPONENT; FACTOR H-1; FACTOR-B; RECOGNITION; SITE	Atypical hemolytic uremic syndrome (aHUS) is a thrombotic microangiopathy associated with mutations in complement proteins, most frequently in the main plasma alternative pathway regulator factorH(FH). The hotspot for the FH mutations is in domains 19-20 (FH19-20) that are indispensable for FH activity on C3b bound covalently to host cells. In aHUS, down-regulation of cell-bound C3b by FH is impaired, but it is not clear whether this is due to an altered FH binding to surface-bound C3b or to cell surface structures. To explore the molecular pathogenesis of aHUS we tested binding of 14 FH19-20 point mutants to C3b and its C3d fragment, mouse glomerular endothelial cells (mGEnC-1), and heparin. The cell binding correlated well, but not fully, with heparin binding and the cell binding site was overlapping but distinct from the C3b/C3d binding site that was shown to extend to domain 19. Our results show that aHUS-associated FH19-20 mutants have different combinations of three primary defects: impaired binding to C3b/C3d, impaired binding to the mGEnC-1 cells/heparin, and, as a novel observation, an enhanced mGEnC-1 cell or heparin binding. We propose a model of the molecular pathogenesis of aHUS where all three mechanisms lead eventually to impaired control of C3b on the endothelial cell surfaces. Based on the results with the aHUS patient mutants and the overlap in FH19-20 binding sites for mGEnC-1/heparin and C3b/C3d we conclude that binding of FH19-20 to C3b/C3d is essential for target discrimination by the alternative pathway.	[Lehtinen, Markus J.; Jokiranta, T. Sakari] Univ Helsinki, Dept Bacteriol & Immunol, Haartman Inst, FIN-00290 Helsinki, Finland; [Rops, Angelique L.; van der Vlag, Johan] Radboud Univ Nijmegen, Med Ctr, Div Nephrol, Nijmegen Ctr Mol Life Sci,Nephrol Res Lab, NL-6500 HB Nijmegen, Netherlands; [Isenman, David E.] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Helsinki; Radboud University Nijmegen; University of Toronto	Lehtinen, MJ (corresponding author), Univ Helsinki, POB 21,Haartmaninkatu 3, FIN-00014 Helsinki, Finland.	markus.j.lehtinen@helsinki.fi	Van der Vlag, Johan/E-4636-2010; Jokiranta, T. Sakari/F-1906-2011	Van der Vlag, Johan/0000-0001-7843-5918; 	Academy of Finland Projects [201506, 202529]; Sigrid Juselius Foundation; Dutch Kidney Foundation [C05.2152]; Helsinki University Central Hospital Funds	Academy of Finland Projects(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Dutch Kidney Foundation; Helsinki University Central Hospital Funds	This work was supported in part by the Academy of Finland Projects 201506 and 202529, The Sigrid Juselius Foundation, Dutch Kidney Foundation Grant C05.2152, and The Helsinki University Central Hospital Funds.	Blackmore TK, 1996, J IMMUNOL, V157, P5422; Blackmore TK, 1998, J IMMUNOL, V160, P3342; Cheng ZZ, 2006, MOL IMMUNOL, V43, P972, DOI 10.1016/j.molimm.2005.05.011; de Jorge EG, 2007, P NATL ACAD SCI USA, V104, P240, DOI 10.1073/pnas.0603420103; Ferreira VP, 2006, J IMMUNOL, V177, P6308, DOI 10.4049/jimmunol.177.9.6308; Fremeaux-Bacchi V, 2004, J MED GENET, V41, DOI 10.1136/jmg.2004.019083; Fremeaux-Bacchi V, 2008, BLOOD, V112, P4948, DOI 10.1182/blood-2008-01-133702; GORDON DL, 1995, J IMMUNOL, V155, P348; HARRISON RA, 1980, MOL IMMUNOL, V17, P219, DOI 10.1016/0161-5890(80)90074-7; HARRISON RA, 1980, MOL IMMUNOL, V17, P9, DOI 10.1016/0161-5890(80)90119-4; Hellwage J, 2002, J IMMUNOL, V169, P6935, DOI 10.4049/jimmunol.169.12.6935; Herbert AP, 2006, J BIOL CHEM, V281, P16512, DOI 10.1074/jbc.M513611200; Jarva H, 1999, J IMMUNOL, V163, P3957; Jokiranta TS, 2006, EMBO J, V25, P1784, DOI 10.1038/sj.emboj.7601052; Jokiranta TS, 2000, J BIOL CHEM, V275, P27657; Jokiranta TS, 2005, AM J PATHOL, V167, P1173, DOI 10.1016/S0002-9440(10)61205-9; Jozsi M, 2006, J AM SOC NEPHROL, V17, P170, DOI 10.1681/ASN.2005080868; KAVANAGH D, 2006, BR MED B, V5, P5; KOISTINEN V, 1989, COMPLEMENT INFLAMMAT, V6, P270, DOI 10.1159/000463102; LAW SK, 1977, P NATL ACAD SCI USA, V74, P2701, DOI 10.1073/pnas.74.7.2701; LESAVRE PH, 1978, J EXP MED, V148, P1498, DOI 10.1084/jem.148.6.1498; Manuelian T, 2003, J CLIN INVEST, V111, P1181, DOI 10.1172/JCI200316651; MULLOY B, 1993, BIOCHEM J, V293, P849, DOI 10.1042/bj2930849; Nagar B, 1998, SCIENCE, V280, P1277, DOI 10.1126/science.280.5367.1277; Noris M, 2003, LANCET, V362, P1542, DOI 10.1016/S0140-6736(03)14742-3; Ormsby RJ, 2006, MOL IMMUNOL, V43, P1624, DOI 10.1016/j.molimm.2005.09.012; PANGBURN MK, 1991, J BIOL CHEM, V266, P16847; PANGBURN MK, 1977, J EXP MED, V146, P257, DOI 10.1084/jem.146.1.257; PANGBURN MK, 1978, P NATL ACAD SCI USA, V75, P2416, DOI 10.1073/pnas.75.5.2416; PANGBURN MK, 1981, J EXP MED, V154, P856, DOI 10.1084/jem.154.3.856; Perez-Caballero D, 2001, AM J HUM GENET, V68, P478, DOI 10.1086/318201; Pickering MC, 2007, J EXP MED, V204, P1249, DOI 10.1084/jem.20070301; Richards A, 2003, P NATL ACAD SCI USA, V100, P12966, DOI 10.1073/pnas.2135497100; Richards A, 2001, AM J HUM GENET, V68, P485, DOI 10.1086/318203; Rops AL, 2008, KIDNEY INT, V73, P52, DOI 10.1038/sj.ki.5002573; Rops AL, 2004, KIDNEY INT, V66, P2193, DOI 10.1111/j.1523-1755.2004.66009.x; RUDDY S, 1969, J IMMUNOL, V102, P533; Ruggenenti P, 2001, KIDNEY INT, V60, P831, DOI 10.1046/j.1523-1755.2001.060003831.x; Sanchez-Corral P, 2002, AM J HUM GENET, V71, P1285, DOI 10.1086/344515; Schmidt CQ, 2008, J IMMUNOL, V181, P2610, DOI 10.4049/jimmunol.181.4.2610; SEYA T, 1986, J EXP MED, V163, P837, DOI 10.1084/jem.163.4.837; Vaziri-Sani F, 2006, KIDNEY INT, V69, P981, DOI 10.1038/sj.ki.5000155; Warwicker P, 1998, KIDNEY INT, V53, P836, DOI 10.1111/j.1523-1755.1998.00824.x; WEILER JM, 1976, P NATL ACAD SCI USA, V73, P3268, DOI 10.1073/pnas.73.9.3268; WHALEY K, 1976, J EXP MED, V144, P1147, DOI 10.1084/jem.144.5.1147	45	83	83	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15650	15658		10.1074/jbc.M900814200	http://dx.doi.org/10.1074/jbc.M900814200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19351878	Green Published, hybrid			2022-12-27	WOS:000266501000033
J	Suel, KE; Chook, YM				Sueel, Katherine E.; Chook, Yuh Min			Kap104p Imports the PY-NLS-containing Transcription Factor Tfg2p into the Nucleus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; TATA-BINDING PROTEIN; SACCHAROMYCES-CEREVISIAE; NUCLEOCYTOPLASMIC TRANSPORT; LOCALIZATION SIGNALS; CRYSTALLOGRAPHIC ANALYSIS; PREINITIATION COMPLEX; INITIATION COMPLEX; KARYOPHERIN ALPHA; STRUCTURAL BASIS	A previous bioinformatics study identified a putative PY-NLS in the yeast transcription factor Tfg2p (Suel, K. E., Gu, H., and Chook, Y. M. (2008) PLoS Biol. 6, e137). In this study, we validate Tfg2p as a Kap104p substrate and examine the energetic organization of its PY-NLS. The Tfg2p PY-NLS can target a heterologous protein into the cell nucleus through interactions with Kap104p. Surprisingly, full-length Tfg2p is still localized to the nucleus of Kap104p temperature-sensitive cells and, similarly, Tfg2p with a mutated PY-NLS is nuclear in wild-type cells. Other Karyopherin beta s (Kap beta s) such as Kap108p and Kap120p also bind Tfg2p and may import it into the nucleus. More importantly, we demonstrate that Tfg2p is retained in the nucleus through DNA binding. Mutations of DNA binding residues relieve nuclear retention and unmask the role of Kap104p in Tfg2p nuclear import. More generally, steady-state localization of a nuclear protein is dictated by its nuclear import and export activities as well as its interactions in the nucleus and the cytoplasm.	[Sueel, Katherine E.; Chook, Yuh Min] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Chook, YM (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Pharmacol, 6001 Forest Pk, Dallas, TX 75390 USA.	yuhmin.chook@utsouthwestern.edu	Chook, Yuh Min/AAA-9549-2019		National Institutes of Health [R01-GM069909, 5-T32-GM008297]; Welch Foundation [1-1532]; University of Texas; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069909, T32GM008297] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); University of Texas; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-GM069909 and 5-T32-GM008297. This work was also supported by Welch Foundation Grant 1-1532 and the University of Texas Southwestern Endowed Scholars Program.	Aitchison JD, 1996, SCIENCE, V274, P624, DOI 10.1126/science.274.5287.624; Albertini M, 1998, J CELL BIOL, V143, P1447, DOI 10.1083/jcb.143.6.1447; Bertolotti A, 1998, MOL CELL BIOL, V18, P1489, DOI 10.1128/MCB.18.3.1489; Brachmann CB, 1998, YEAST, V14, P115; Cardoso MC, 1999, J CELL BIOL, V147, P25, DOI 10.1083/jcb.147.1.25; Catimel B, 2001, J BIOL CHEM, V276, P34189, DOI 10.1074/jbc.M103531200; Chen HT, 2007, NAT STRUCT MOL BIOL, V14, P696, DOI 10.1038/nsmb1272; Chook YM, 2001, CURR OPIN STRUC BIOL, V11, P703, DOI 10.1016/S0959-440X(01)00264-0; Chung WH, 2003, MOL CELL, V12, P1003, DOI 10.1016/S1097-2765(03)00387-3; Conti E, 1998, CELL, V94, P193, DOI 10.1016/S0092-8674(00)81419-1; Conti E, 2000, STRUCTURE, V8, P329, DOI 10.1016/S0969-2126(00)00107-6; Conti E, 2001, CURR OPIN CELL BIOL, V13, P310, DOI 10.1016/S0955-0674(00)00213-1; Damelin M, 2002, METHOD ENZYMOL, V351, P587; Fontes MRM, 2003, J BIOL CHEM, V278, P27981, DOI 10.1074/jbc.M303275200; Fontes MRM, 2000, J MOL BIOL, V297, P1183, DOI 10.1006/jmbi.2000.3642; Freire-Picos MA, 2005, NUCLEIC ACIDS RES, V33, P5045, DOI 10.1093/nar/gki825; Fried H, 2003, CELL MOL LIFE SCI, V60, P1659, DOI 10.1007/s00018-003-3070-3; Gaiser F, 2000, J MOL BIOL, V302, P1119, DOI 10.1006/jmbi.2000.4110; Ghazy MA, 2004, MOL CELL BIOL, V24, P10975, DOI 10.1128/MCB.24.24.10975-10985.2004; Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607; Groft CM, 1998, P NATL ACAD SCI USA, V95, P9117, DOI 10.1073/pnas.95.16.9117; HENRY NL, 1994, GENE DEV, V8, P2868, DOI 10.1101/gad.8.23.2868; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hodel MR, 2001, J BIOL CHEM, V276, P1317, DOI 10.1074/jbc.M008522200; Hodges JL, 2005, MOL BIOL CELL, V16, P3200, DOI 10.1091/mbc.E04-11-0990; KALDERON D, 1984, NATURE, V311, P33, DOI 10.1038/311033a0; Khaperskyy DA, 2008, MOL CELL BIOL, V28, P3757, DOI 10.1128/MCB.02272-07; Lange A, 2008, J BIOL CHEM, V283, P12926, DOI 10.1074/jbc.M800898200; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Lee BJ, 2006, CELL, V126, P543, DOI 10.1016/j.cell.2006.05.049; Lee DCY, 1999, J BIOL CHEM, V274, P29031, DOI 10.1074/jbc.274.41.29031; Leslie DM, 2004, MOL CELL BIOL, V24, P8487, DOI 10.1128/MCB.24.19.8487-8503.2004; Makhnevych T, 2003, CELL, V115, P813, DOI 10.1016/S0092-8674(03)00986-3; Morehouse H, 1999, P NATL ACAD SCI USA, V96, P12542, DOI 10.1073/pnas.96.22.12542; Mosammaparast N, 2002, J BIOL CHEM, V277, P862, DOI 10.1074/jbc.M106845200; Mosammaparast N, 2004, TRENDS CELL BIOL, V14, P547, DOI 10.1016/j.tcb.2004.09.004; Mosammaparast N, 2002, EMBO J, V21, P6527, DOI 10.1093/emboj/cdf647; Mosammaparast N, 2001, J CELL BIOL, V153, P251, DOI 10.1083/jcb.153.2.251; Pemberton LF, 1999, J CELL BIOL, V145, P1407, DOI 10.1083/jcb.145.7.1407; Rout MP, 1997, CELL, V89, P715, DOI 10.1016/S0092-8674(00)80254-8; SIKORSKI RS, 1989, GENETICS, V122, P19; Siomi MC, 1998, MOL CELL BIOL, V18, P4141, DOI 10.1128/MCB.18.7.4141; Suel KE, 2008, PLOS BIOL, V6, P1253, DOI 10.1371/journal.pbio.0060137; TAN SY, 1995, P NATL ACAD SCI USA, V92, P6042, DOI 10.1073/pnas.92.13.6042; Titov AA, 1999, J CELL BIOL, V147, P235, DOI 10.1083/jcb.147.2.235; Truant R, 1998, MOL CELL BIOL, V18, P1449, DOI 10.1128/MCB.18.3.1449; Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5; Yoshida K, 2001, J CELL BIOL, V152, P729, DOI 10.1083/jcb.152.4.729; Ziegler E. C., 2005, SCI STKE, pre6, DOI DOI 10.1126/STKE.2842005RE6	49	22	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15416	15424		10.1074/jbc.M809384200	http://dx.doi.org/10.1074/jbc.M809384200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19366694	Green Published, hybrid			2022-12-27	WOS:000266501000009
J	Hristova, VA; Beasley, SA; Rylett, RJ; Shaw, GS				Hristova, Ventzislava A.; Beasley, Steven A.; Rylett, R. Jane; Shaw, Gary S.			Identification of a Novel Zn2+-binding Domain in the Autosomal Recessive Juvenile Parkinson-related E3 Ligase Parkin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-PROTEIN LIGASE; EARLY-ONSET PARKINSONISM; DISEASE GENE-PRODUCT; POINT MUTATIONS; COMPARATIVE GENOMICS; S-NITROSYLATION; RBR FAMILY; RING; FINGER; DEGRADATION	Missense mutations in park2, encoding the parkin protein, account for similar to 50% of autosomal recessive juvenile Parkinson disease (ARJP) cases. Parkin belongs to the family of RBR (RING-between-RING) E3 ligases involved in the ubiquitin-mediated degradation and trafficking of proteins such as Pael-R and synphillin-1. The proposed architecture of parkin, based largely on sequence similarity studies, consists of N-terminal ubiquitin-like and C-terminal RBR domains. These domains are separated by a similar to 160-residue unique parkin sequence having no recognizable domain structure. We used limited proteolysis experiments on bacterially expressed and purified parkin to identify a new domain (RING0) within the unique parkin domain sequence. RING0 comprises two distinct, conserved cysteine-rich clusters between Cys(150)-Cys(169) and Cys(196)-His(215) consisting of CX2-3CX11CX2C and CX4-6CX10-16-CX2(H/C) motifs. The positions of the cysteine/histidine residues in this region bear similarity to parkin RING1 and RING2 domains, as well as other E3 ligase RING domains. However, in parkin a 26-residue linker region separates the motifs, which is not typical of other RING domain structures. Further, the RING0 domain includes all but one of the known ARJP mutation sites between the ubiquitin-like and RBR regions of parkin. Using electrospray ionization mass spectrometry and inductively coupled plasma-atomic emission spectrometry analysis, we determined that the RING0, RING1, IBR, and RING2 domains each bind two Zn2+ ions, the first observation of an E3 ligase with the ability to bind eight metal ions. Removal of the zinc from parkin causes near complete unfolding of the protein, an observation that rationalizes cysteine-based ARJP mutations found throughout parkin, including RING0 (C212Y) that form cellular inclusions and/or are defective for ubiquitination likely because of poor zinc binding and misfolding. The identification of the RING0 domain in parkin provides a new overall domain structure for the protein that will be important in assessing the roles of ARJP mutations and designing experiments aimed at understanding the disease.	[Hristova, Ventzislava A.; Beasley, Steven A.; Shaw, Gary S.] Univ Western Ontario, Dept Biochem, London, ON N6A 5C1, Canada; [Rylett, R. Jane] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON N6A 5C1, Canada; [Hristova, Ventzislava A.; Rylett, R. Jane] Robarts Res Lab, Mol Brain Res Grp, London, ON N6A 5K8, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Shaw, GS (corresponding author), Univ Western Ontario, Dept Biochem, London, ON N6A 5C1, Canada.	gshaw1@uwo.ca	Rylett, Rebecca Jane/K-3597-2013; Shaw, Gary S./C-7656-2009; Beasley, Steven/B-8106-2019	Rylett, Rebecca Jane/0000-0002-9158-9599; Shaw, Gary S./0000-0002-4685-9625; Beasley, Steven/0000-0002-8702-5651	Canadian Institutes of Health Research; Canada Research Chairs Program; Ontario Graduate and Parkinson's Society of Canada Graduate Scholarships	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Research Chairs Program(Canada Research Chairs); Ontario Graduate and Parkinson's Society of Canada Graduate Scholarships	This work was supported by research grants from the Canadian Institutes of Health Research (to G. S. S. and R.J.R.) and the Canada Research Chairs Program (to G. S. S.) and by Ontario Graduate and Parkinson's Society of Canada Graduate Scholarships (to V. A. H.).	Abbas N, 1999, HUM MOL GENET, V8, P567, DOI 10.1093/hmg/8.4.567; Ardley HC, 2001, J BIOL CHEM, V276, P19640, DOI 10.1074/jbc.M011028200; Beasley SA, 2007, P NATL ACAD SCI USA, V104, P3095, DOI 10.1073/pnas.0610548104; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Capili AD, 2004, J MOL BIOL, V340, P1117, DOI 10.1016/j.jmb.2004.05.035; Choi P, 2003, MOL BRAIN RES, V117, P179, DOI 10.1016/S0169-328X(03)00318-8; Chung KKK, 2004, SCIENCE, V304, P1328, DOI 10.1126/science.1093891; Doss-Pepe EW, 2005, J BIOL CHEM, V280, P16619, DOI 10.1074/jbc.M413591200; Fallon L, 2006, NAT CELL BIOL, V8, P834, DOI 10.1038/ncb1441; Foroud T, 2003, NEUROLOGY, V60, P796, DOI 10.1212/01.WNL.0000049470.00180.07; Gu WJ, 2003, NEUROBIOL DIS, V14, P357, DOI 10.1016/j.nbd.2003.08.011; Hampe C, 2006, HUM MOL GENET, V15, P2059, DOI 10.1093/hmg/ddl131; Hattori N, 1998, BIOCHEM BIOPH RES CO, V249, P754, DOI 10.1006/bbrc.1998.9134; Hedrich K, 2002, NEUROLOGY, V58, P1239, DOI 10.1212/WNL.58.8.1239; Henn IH, 2005, J NEUROCHEM, V92, P114, DOI 10.1111/j.1471-4159.2004.02854.x; Hennig J, 2008, J MOL BIOL, V377, P431, DOI 10.1016/j.jmb.2008.01.005; Huynh DP, 2003, HUM MOL GENET, V12, P2587, DOI 10.1093/hmg/ddg269; Imai Y, 2000, J BIOL CHEM, V275, P35661, DOI 10.1074/jbc.C000447200; Imai Y, 2002, MOL CELL, V10, P55, DOI 10.1016/S1097-2765(02)00583-X; Jiang HB, 2004, J BIOL CHEM, V279, P54380, DOI 10.1074/jbc.M409282200; Joch M, 2007, MOL BIOL CELL, V18, P3105, DOI 10.1091/mbc.E05-11-1027; Kalia SK, 2004, NEURON, V44, P931, DOI 10.1016/j.neuron.2004.11.026; Kirisako T, 2006, EMBO J, V25, P4877, DOI 10.1038/sj.emboj.7601360; Kitada T, 1998, NATURE, V392, P605, DOI 10.1038/33416; Lim KL, 2005, J NEUROSCI, V25, P2002, DOI 10.1523/JNEUROSCI.4474-04.2005; Lohmann E, 2003, ANN NEUROL, V54, P176, DOI 10.1002/ana.10613; Lucas JI, 2006, J MOL BIOL, V357, P9, DOI 10.1016/j.jmb.2005.12.068; Lucking CB, 2000, NEW ENGL J MED, V342, P1560, DOI 10.1056/NEJM200005253422103; Marin I, 2004, PHYSIOL GENOMICS, V17, P253, DOI 10.1152/physiolgenomics.00226.2003; Marin I, 2002, MOL BIOL EVOL, V19, P2039, DOI 10.1093/oxfordjournals.molbev.a004029; Matthews JM, 2002, IUBMB LIFE, V54, P351, DOI 10.1080/15216540216035; Morett E, 1999, TRENDS BIOCHEM SCI, V24, P229, DOI 10.1016/S0968-0004(99)01381-X; Moynihan TP, 1999, J BIOL CHEM, V274, P30963, DOI 10.1074/jbc.274.43.30963; Niwa J, 2001, BIOCHEM BIOPH RES CO, V281, P706, DOI 10.1006/bbrc.2001.4414; Periquet M, 2003, BRAIN, V126, P1271, DOI 10.1093/brain/awg136; Periquet M, 2001, AM J HUM GENET, V68, P617, DOI 10.1086/318791; Pineda-Trujillo NL, 2001, NEUROSCI LETT, V298, P87, DOI 10.1016/S0304-3940(00)01733-X; Rankin CA, 2001, J BIOMED SCI, V8, P421; Ren Y, 2003, J NEUROSCI, V23, P3316; Roehm PC, 1997, BIOCHEMISTRY-US, V36, P10240, DOI 10.1021/bi970863d; Safadi SS, 2007, BIOCHEMISTRY-US, V46, P14162, DOI 10.1021/bi7016969; Sakata E, 2003, EMBO REP, V4, P301, DOI 10.1038/sj.embor.embor764; Sato S, 2006, EMBO J, V25, P211, DOI 10.1038/sj.emboj.7600774; Satoh J, 1999, NEUROREPORT, V10, P2735, DOI 10.1097/00001756-199909090-00008; Shimura H, 2000, NAT GENET, V25, P302, DOI 10.1038/77060; Shyu WC, 2005, PARKINSONISM RELAT D, V11, P173, DOI 10.1016/j.parkreldis.2004.12.004; Sriram SR, 2005, HUM MOL GENET, V14, P2571, DOI 10.1093/hmg/ddi292; Tashiro M, 2003, J BIOMOL NMR, V25, P153, DOI 10.1023/A:1022254432039; Tsai YC, 2003, J BIOL CHEM, V278, P22044, DOI 10.1074/jbc.M212235200; Um JW, 2006, J NEUROSCI RES, V84, P1543, DOI 10.1002/jnr.21041; Um JW, 2006, J BIOL CHEM, V281, P3595, DOI 10.1074/jbc.M504994200; Upadhya SC, 2003, TRENDS BIOCHEM SCI, V28, P280, DOI 10.1016/S0968-0004(03)00092-6; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; von Coelln R, 2004, CELL TISSUE RES, V318, P175, DOI 10.1007/s00441-004-0924-4; Wang C, 2005, J NEUROCHEM, V93, P422, DOI 10.1111/j.1471-4159.2005.03023.x; West A, 2002, AM J MED GENET, V114, P584, DOI 10.1002/ajmg.10525; Wong ESP, 2007, J BIOL CHEM, V282, P12310, DOI 10.1074/jbc.M609466200; Yamanaka K, 2003, NAT CELL BIOL, V5, P336, DOI 10.1038/ncb952; Yao DD, 2004, P NATL ACAD SCI USA, V101, P10810, DOI 10.1073/pnas.0404161101; Zhang Y, 2000, P NATL ACAD SCI USA, V97, P13354, DOI 10.1073/pnas.240347797; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	61	97	102	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					14978	14986		10.1074/jbc.M808700200	http://dx.doi.org/10.1074/jbc.M808700200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19339245	hybrid, Green Published			2022-12-27	WOS:000266288200034
J	Rock, JR; O'Neal, WK; Gabriel, SE; Randell, SH; Harfe, BD; Boucher, RC; Grubb, BR				Rock, Jason R.; O'Neal, Wanda K.; Gabriel, Sherif E.; Randell, Scott H.; Harfe, Brian D.; Boucher, Richard C.; Grubb, Barbara R.			Transmembrane Protein 16A (TMEM16A) Is a Ca2+-regulated Cl- Secretory Channel in Mouse Airways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SURFACE LIQUID VOLUME; SMOOTH-MUSCLE-CELLS; CYSTIC-FIBROSIS; CHLORIDE CONDUCTANCE; EXTRACELLULAR ATP; ION-TRANSPORT; CALCIUM; CFTR; MICE; REGULATOR	For almost two decades, it has been postulated that calcium-activated Cl- channels (CaCCs) play a role in airway epithelial Cl- secretion, but until recently, the molecular identity of the airway CaCC(s) was unknown. Recent studies have unequivocally identified TMEM16A as a glandular epithelial CaCC. We have studied the airway bioelectrics of neonatal mice homozygous for a null allele of Tmem16a (Tmem16a(-/-)) to investigate the role of this channel in Cl- secretion in airway surface epithelium. When compared with wild-type tracheas, the Tmem16a(-/-) tracheas exhibited a >60% reduction in purinoceptor (UTP)-regulated CaCC activity. Other members of the Tmem16 gene family, including Tmem16f and Tmem16k, were also detected by reverse transcription-PCR in neonatal tracheal epithelium, suggesting that other family members could be considered as contributing to the small residual UTP response. TMEM16A, however, appeared to contribute little to unstimulated Cl- secretion, whereas studies with cystic fibrosis transmembrane conductance regulator (CFTR)-deficient mice and wild-type littermates revealed that unstimulated Cl- secretion reflected similar to 50% CFTR activity and similar to 50% non-Tmem16a activity. Interestingly, the tracheas of both the Tmem16a(-/-) and the CFTR-/- mice exhibited similar congenital cartilaginous defects that may reflect acommon Cl- secretory defect mediated by the molecularly distinct Cl- channels. Importantly, the residual CaCC activity in Tmem16a(-/-) mice appeared inadequate for normal airway hydration because Tmem16a(-/-) tracheas exhibited significant, neonatal, lumenal mucusaccumulation. Our data suggest that TMEM16A CaCC-mediated Cl- secretion appears to be necessary for normal airway surface liquid homeostasis.	[O'Neal, Wanda K.; Gabriel, Sherif E.; Randell, Scott H.; Boucher, Richard C.; Grubb, Barbara R.] Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC 27599 USA; Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27708 USA; [Harfe, Brian D.] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA	University of North Carolina; University of North Carolina Chapel Hill; Duke University; State University System of Florida; University of Florida	Grubb, BR (corresponding author), Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, 7011 Thurston Bowles Bldg,CB 7248, Chapel Hill, NC 27599 USA.	bgrubb@med.unc.edu			National Institutes of Health [P30 Dk065988, P01-HL034322]; SCCOR NIH [5 P50 HL084934]; Cystic Fibrosis Foundation [CFF R0 26-CR037]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL034322, P50HL084934] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK065988] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); SCCOR NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants P30 Dk065988, P01-HL034322, and SCCOR NIH 5 P50 HL084934. This work was also supported by RDP Grant CFF R0 26-CR037 from the Cystic Fibrosis Foundation.	Angermann JE, 2006, J GEN PHYSIOL, V128, P73, DOI 10.1085/jgp.200609507; Barro-Soria R, 2008, BBA-MOL CELL RES, V1783, P1993, DOI 10.1016/j.bbamcr.2008.06.016; Bonvin E, 2008, J PHYSIOL-LONDON, V586, P3231, DOI 10.1113/jphysiol.2008.150763; Caputo A, 2008, SCIENCE, V322, P590, DOI 10.1126/science.1163518; CLARKE LL, 1994, P NATL ACAD SCI USA, V91, P479, DOI 10.1073/pnas.91.2.479; Grubb Barbara R, 2002, Methods Mol Med, V70, P525; GRUBB BR, 1994, AM J PHYSIOL, V267, pC293, DOI 10.1152/ajpcell.1994.267.1.C293; GRUBB BR, 2007, PEDIATR PULM, V30, P280; KNOWLES MR, 1991, NEW ENGL J MED, V325, P533, DOI 10.1056/NEJM199108223250802; Kunzelmann K, 2007, PFLUG ARCH EUR J PHY, V454, P879, DOI 10.1007/s00424-007-0245-z; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; MASON SJ, 1991, BRIT J PHARMACOL, V103, P1649, DOI 10.1111/j.1476-5381.1991.tb09842.x; Matthews HR, 2003, CURR OPIN NEUROBIOL, V13, P469, DOI 10.1016/S0959-4388(03)00097-7; Rock JR, 2008, DEV BIOL, V321, P141, DOI 10.1016/j.ydbio.2008.06.009; Schroeder BC, 2008, CELL, V134, P1019, DOI 10.1016/j.cell.2008.09.003; STUTTS MJ, 1995, SCIENCE, V269, P847, DOI 10.1126/science.7543698; STUTTS MJ, 1992, P NATL ACAD SCI USA, V89, P1621, DOI 10.1073/pnas.89.5.1621; Tarran R, 2006, ANNU REV PHYSIOL, V68, P543, DOI 10.1146/annurev.physiol.68.072304.112754; Tarran R, 2002, J GEN PHYSIOL, V120, P407, DOI 10.1085/jgp.20028599; Vandebrouck C, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-113; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313	21	199	204	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258			J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					14875	14880		10.1074/jbc.C109.000869	http://dx.doi.org/10.1074/jbc.C109.000869			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19363029	Green Published, hybrid			2022-12-27	WOS:000266288200023
J	Li, GY; Zhang, YL; Inouye, M; Ikura, M				Li, Guang-Yao; Zhang, Yonglong; Inouye, Masayori; Ikura, Mitsuhiko			Inhibitory Mechanism of Escherichia coli RelE-RelB Toxin-Antitoxin Module Involves a Helix Displacement Near an mRNA Interferase Active Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TORSION ANGLE DYNAMICS; CHEMICAL-SHIFT; PROTEIN; SYSTEM; PLASMID; COMPLEX; DECAY; 30S	In Escherichia coli, RelE toxin participates in growth arrest and cell death by inducing mRNA degradation at the ribosomal A-site under stress conditions. The NMR structures of a mutant of E. coli RelE toxin, RelE(R81A/R83A), with reduced toxicity and its complex with an inhibitory peptide from RelB antitoxin, RelBC (Lys(47)-Leu(79)), have been determined. In the free RelE(R81A/R83A) structure, helix alpha 4 at the C terminus adopts a closed conformation contacting with the beta-sheet core and adjacent loops. In the RelE(R81A/R83A)-RelB(C) complex, helix alpha 3* of RelBC displaces alpha 4 of RelE(R81A/R83A) from the binding site on the beta-sheet core. This helix replacement results in neutralization of a conserved positively charged cluster of RelE by acidic residues from alpha 3* of RelB. The released helix alpha 4 becomes unfolded, adopting an open conformation with increased mobility. The displacement of alpha 4 disrupts the geometry of critical residues, including Arg(81) and Tyr(87), in a putative active site of RelE toxin. Our structures indicate that RelB counteracts the toxic activity of RelE by displacing alpha 4 helix from the catalytically competent position found in the free RelE structure.	[Li, Guang-Yao; Ikura, Mitsuhiko] Univ Toronto, Div Signaling Biol, Ontario Canc Inst, Toronto, ON M5G 1L7, Canada; [Li, Guang-Yao; Ikura, Mitsuhiko] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 1L7, Canada; [Zhang, Yonglong; Inouye, Masayori] Robert Wood Johnson Med Sch, Dept Biochem, Piscataway, NJ 08854 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; Rutgers State University New Brunswick; Rutgers State University Medical Center	Ikura, M (corresponding author), MaRS Toronto Med Discovery Tower,Rm 4-804,101 C, Toronto, ON M5G 1L7, Canada.	mikura@uhnres.utoronto.ca			National Institutes of Health [RO1GM081567]; Canadian Institutes of Health Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081567] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1GM081567 (to M. Inouye). This work was also supported by a grant from Canadian Institutes of Health Research (to M. Ikura) and a Canadian Institutes of Health Research operating grant.	Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-12-r81; Aoki H, 2002, ANTIMICROB AGENTS CH, V46, P1080, DOI 10.1128/AAC.46.4.1080-1085.2002; Bahassi EM, 1999, J BIOL CHEM, V274, P10936, DOI 10.1074/jbc.274.16.10936; BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Christensen SK, 2003, MOL MICROBIOL, V48, P1389, DOI 10.1046/j.1365-2958.2003.03512.x; Condon C, 2006, MOL MICROBIOL, V61, P573, DOI 10.1111/j.1365-2958.2006.05270.x; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Engelberg-Kulka H, 1999, ANNU REV MICROBIOL, V53, P43, DOI 10.1146/annurev.micro.53.1.43; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Gerdes K, 2000, MOL MICROBIOL, V37, P455, DOI 10.1046/j.1365-2958.2000.01975.x; Gerdes K, 1997, Genet Eng (N Y), V19, P49; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Johnson Bruce A, 2004, Methods Mol Biol, V278, P313; Kamada K, 2005, MOL CELL, V19, P497, DOI 10.1016/j.molcel.2005.07.004; Kanelis V, 2001, IUBMB LIFE, V52, P291, DOI 10.1080/152165401317291147; Lewis K, 2008, CURR TOP MICROBIOL, V322, P107; Li GY, 2008, J MOL BIOL, V380, P107, DOI 10.1016/j.jmb.2008.04.039; Liu M, 2008, P NATL ACAD SCI USA, V105, P5885, DOI 10.1073/pnas.0711949105; Mal TK, 2004, J MOL BIOL, V339, P681, DOI 10.1016/j.jmb.2004.04.020; Moll I, 2002, BIOCHEM BIOPH RES CO, V297, P1021, DOI 10.1016/S0006-291X(02)02333-1; ORENGO CA, 1993, STRUCTURE, V1, P105, DOI 10.1016/0969-2126(93)90026-D; Pedersen K, 2002, MOL MICROBIOL, V45, P501, DOI 10.1046/j.1365-2958.2002.03027.x; Pedersen K, 2003, CELL, V112, P131, DOI 10.1016/S0092-8674(02)01248-5; Sevcik J, 2002, ACTA CRYSTALLOGR D, V58, P1307, DOI 10.1107/S0907444902010090; Suzuki M, 2005, MOL CELL, V18, P253, DOI 10.1016/j.molcel.2005.03.011; Takagi H, 2005, NAT STRUCT MOL BIOL, V12, P327, DOI 10.1038/nsmb911; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Yajima S, 2006, NUCLEIC ACIDS RES, V34, P6074, DOI 10.1093/nar/gkl729; Yamaguchi Y, 2009, PROG MOL BIOL TRANSL, V85, P467, DOI 10.1016/S0079-6603(08)00812-X; Zhang YL, 2003, MOL CELL, V12, P913, DOI 10.1016/S1097-2765(03)00402-7; Zhang Y, 2009, J BIOL CHEM, V284, P6627, DOI 10.1074/jbc.M808779200; Zwahlen C, 1997, J AM CHEM SOC, V119, P6711, DOI 10.1021/ja970224q	36	57	62	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14628	14636		10.1074/jbc.M809656200	http://dx.doi.org/10.1074/jbc.M809656200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19297318	hybrid, Green Published			2022-12-27	WOS:000266286100068
J	Simon, N; Scholz, SM; Moreira, CK; Templeton, TJ; Kuehn, A; Dude, MA; Pradel, G				Simon, Nina; Scholz, Sabrina M.; Moreira, Cristina K.; Templeton, Thomas J.; Kuehn, Andrea; Dude, Marie-Adrienne; Pradel, Gabriele			Sexual Stage Adhesion Proteins Form Multi-protein Complexes in the Malaria Parasite Plasmodium falciparum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL-CHARACTERIZATION; DEAFNESS DISORDER; XANTHURENIC ACID; TRANSMISSION; EXPRESSION; DOMAIN; MOSQUITO; GENE; RECEPTOR; BINDING	The sexual phase of the malaria parasite Plasmodium falciparum is accompanied by the coordinated expression of stage-specific adhesive proteins. Among these are six secreted proteins with multiple adhesion domains, termed P. falciparum LCCL domain-containing protein (PfCCp) proteins, which are expressed in the parasitophorous vacuole of the differentiating gametocytes and which are later associated with macrogametes. Although the majority of the PfCCp proteins are implicated in parasite development in the mosquito vector, their functions remain unknown. In the present study we investigated the molecular interactions between the PfCCp proteins during gametocyte development and emergence. Using five different gene-disruptant parasite lines, we show that the lack of one PfCCp protein leads to the loss of other PfCCp family members. Co-immunoprecipitation assays on gametocyte lysates revealed formation of complexes involving all PfCCp proteins, and affinity chromatography co-elution binding assays with recombinant PfCCp domains further indicated direct binding between distinct adhesion domains. PfCCp-coated latex beads bind to newly formed macrogametes but not to gametocytes or older macrogametes 6 or 24 h post-activation. In view of these data, we propose that the PfCCp proteins form multi-protein complexes that are exposed during gametogenesis, thereby mediating cell contacts of macrogametes.	[Simon, Nina; Scholz, Sabrina M.; Kuehn, Andrea; Dude, Marie-Adrienne; Pradel, Gabriele] Univ Wurzburg, Res Ctr Infect Dis, D-97070 Wurzburg, Germany; [Moreira, Cristina K.; Templeton, Thomas J.] Weill Cornell Med Coll, Dept Microbiol & Immunol, New York, NY 10021 USA	University of Wurzburg; Cornell University	Pradel, G (corresponding author), Univ Wurzburg, Res Ctr Infect Dis, Rontgenring 11, D-97070 Wurzburg, Germany.	gabriele.pradel@mail.uni-wuerzburg.de			National Institutes of Health [RO1 A1054580-01A1]; Deutsche Forschungsgemeinschaft [SFB479]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 A1054580-01A1 (to T.J.T.). This work was also supported by an Emmy Noether grant and an SFB479 grant from the Deutsche Forschungsgemeinschaft (to G. P.).	Aruffo A, 1997, IMMUNOL TODAY, V18, P498, DOI 10.1016/S0167-5699(97)01130-4; Billker O, 1998, NATURE, V392, P289, DOI 10.1038/32667; Carter V, 2008, MOL MICROBIOL, V68, P1560, DOI 10.1111/j.1365-2958.2008.06254.x; Claudianos C, 2002, MOL MICROBIOL, V45, P1473, DOI 10.1046/j.1365-2958.2002.03118.x; Deitsch KW, 2001, NUCLEIC ACIDS RES, V29, P850, DOI 10.1093/nar/29.3.850; Delrieu I, 2002, MOL BIOCHEM PARASIT, V121, P11, DOI 10.1016/S0166-6851(02)00016-6; Dessens JT, 2004, TRENDS PARASITOL, V20, P102, DOI 10.1016/j.pt.2004.01.002; Dorin-Semblat D, 2007, MOL MICROBIOL, V65, P1170, DOI 10.1111/j.1365-2958.2007.05859.x; Duraisingh MT, 2002, INT J PARASITOL, V32, P81, DOI 10.1016/S0020-7519(01)00345-9; Eksi S, 2006, MOL MICROBIOL, V61, P991, DOI 10.1111/j.1365-2958.2006.05284.x; Elomaa O, 1998, J BIOL CHEM, V273, P4530, DOI 10.1074/jbc.273.8.4530; Garcia GE, 1998, J BIOL CHEM, V273, P12003, DOI 10.1074/jbc.273.20.12003; GOLDBERGER G, 1987, J BIOL CHEM, V262, P10065; Ifediba T, 1981, NATURE, V294, P364, DOI 10.1038/294364a0; KAPLAN F, 1999, AM J PHYSIOL, V276, P1027; Kariuki MM, 1998, AM J TROP MED HYG, V59, P505, DOI 10.4269/ajtmh.1998.59.505; Koshiba T, 2003, J BIOL CHEM, V278, P7573, DOI 10.1074/jbc.M211154200; KUMAR N, 1992, MOL BIOCHEM PARASIT, V53, P113, DOI 10.1016/0166-6851(92)90013-A; KUMAR N, 1987, PARASITE IMMUNOL, V9, P321, DOI 10.1111/j.1365-3024.1987.tb00511.x; Lasonder E, 2002, NATURE, V419, P537, DOI 10.1038/nature01111; Lavazec C, 2009, MOL BIOCHEM PARASIT, V163, P1, DOI 10.1016/j.molbiopara.2008.09.002; Liepinsh E, 2001, EMBO J, V20, P5347, DOI 10.1093/emboj/20.19.5347; Liu YJ, 2008, GENE DEV, V22, P1051, DOI 10.1101/gad.1656508; MUTA T, 1991, J BIOL CHEM, V266, P6554; Pradel G, 2007, PARASITOLOGY, V134, P1911, DOI 10.1017/S0031182007003381; Pradel G, 2006, EXP PARASITOL, V112, P263, DOI 10.1016/j.exppara.2005.11.010; Pradel G, 2004, J EXP MED, V199, P1533, DOI 10.1084/jem.20031274; Raine JD, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030030; RESNICK D, 1994, TRENDS BIOCHEM SCI, V19, P5, DOI 10.1016/0968-0004(94)90165-1; Robertson NG, 1997, GENOMICS, V46, P345, DOI 10.1006/geno.1997.5067; Saul A, 2007, CURR OPIN INFECT DIS, V20, P476, DOI 10.1097/QCO.0b013e3282a95e12; Scholz SM, 2008, INT J PARASITOL, V38, P327, DOI 10.1016/j.ijpara.2007.08.009; Sidhu ABS, 2005, MOL MICROBIOL, V57, P913, DOI 10.1111/j.1365-2958.2005.04729.x; Templeton TJ, 1997, MOL BIOCHEM PARASIT, V90, P359, DOI 10.1016/S0166-6851(97)00164-3; Templeton TJ, 2004, GENOME RES, V14, P1686, DOI 10.1101/gr.2615304; Trexler M, 2000, EUR J BIOCHEM, V267, P5751, DOI 10.1046/j.1432-1327.2000.01641.x; Trueman HE, 2004, J PARASITOL, V90, P1062, DOI 10.1645/GE-3368; WHITNEY GS, 1995, J BIOL CHEM, V270, P18187, DOI 10.1074/jbc.270.31.18187; YU Q, 1990, NUCLEIC ACIDS RES, V18, P5296, DOI 10.1093/nar/18.17.5296	39	53	53	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14537	14546		10.1074/jbc.M808472200	http://dx.doi.org/10.1074/jbc.M808472200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19304662	Green Published, hybrid			2022-12-27	WOS:000266286100060
J	Hanoulle, X; Badillo, A; Wieruszeski, JM; Verdegem, D; Landrieu, I; Bartenschlager, R; Penin, F; Lippens, G				Hanoulle, Xavier; Badillo, Aurelie; Wieruszeski, Jean-Michel; Verdegem, Dries; Landrieu, Isabelle; Bartenschlager, Ralf; Penin, Francois; Lippens, Guy			Hepatitis C Virus NS5A Protein Is a Substrate for the Peptidyl-prolyl cis/trans Isomerase Activity of Cyclophilins A and B	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS; NONSTRUCTURAL PROTEIN; CYCLOSPORINE-A; BINDING-PROTEIN; REPLICATION; SENSITIVITY; RESISTANCE; CATALYSIS; DOMAIN; IDENTIFICATION	We report here a biochemical and structural characterization of domain 2 of the nonstructural 5A protein (NS5A) from the JFH1 Hepatitis C virus strain and its interactions with cyclophilins A and B (CypA and CypB). Gel filtration chromatography, circular dichroism spectroscopy, and finally NMR spectroscopy all indicate the natively unfolded nature of this NS5A-D2 domain. Because mutations in this domain have been linked to cyclosporin A resistance, we used NMR spectroscopy to investigate potential interactions between NS5A-D2 and cellular CypA and CypB. We observed a direct molecular interaction between NS5A-D2 and both cyclophilins. The interaction surface on the cyclophilins corresponds to their active site, whereas on NS5A-D2, it proved to be distributed over the many proline residues of the domain. NMR heteronuclear exchange spectroscopy yielded direct evidence that many proline residues in NS5A-D2 form a valid substrate for the enzymatic peptidyl-prolyl cis/trans isomerase (PPIase) activity of CypA and CypB.	[Hanoulle, Xavier; Wieruszeski, Jean-Michel; Verdegem, Dries; Landrieu, Isabelle; Lippens, Guy] Univ Sci & Technol Lille, CNRS, IFR 147, Unite Glycobiol Struct & Fonctionnelle,UMR 8576, F-59655 Villeneuve Dascq, France; [Badillo, Aurelie; Penin, Francois] Univ Lyon, Inst Biol & Chim Prot, UMR 5086, CNRS,IFR 128, F-69397 Lyon, France; [Bartenschlager, Ralf] Heidelberg Univ, Dept Mol Virol, D-69120 Heidelberg, Germany	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Ruprecht Karls University Heidelberg	Lippens, G (corresponding author), Univ Sci & Technol Lille, CNRS, IFR 147, Unite Glycobiol Struct & Fonctionnelle,UMR 8576, F-59655 Villeneuve Dascq, France.	guy.lippens@univ-lille1.fr	HANOULLE, Xavier/HHN-4815-2022; Hanoulle, Xavier/AAK-7236-2021; Landrieu, Isabelle/AAF-8495-2019; Bartenschlager, Ralf/L-2582-2015	Hanoulle, Xavier/0000-0002-3755-2680; Landrieu, Isabelle/0000-0002-4883-2637; Bartenschlager, Ralf/0000-0001-5601-9307; Lippens, Guy/0000-0002-8236-0901	French Centre National de la Recherche Scientifique (CNRS); Universities of Lille and Lyon; French National Agency for Research on AIDS; European Commission	French Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Universities of Lille and Lyon; French National Agency for Research on AIDS(ANRS); European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the French Centre National de la Recherche Scientifique (CNRS) and the Universities of Lille and Lyon and by grants from the French National Agency for Research on AIDS and Viral Hepatitis and the European Commission (VIRGIL Network of Excellence on Antiviral Drug Resistance).	Appel N, 2006, J BIOL CHEM, V281, P9833, DOI 10.1074/jbc.R500026200; Appel N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000035; Barik S, 2006, CELL MOL LIFE SCI, V63, P2889, DOI 10.1007/s00018-006-6215-3; BERGSMA DJ, 1991, J BIOL CHEM, V266, P23204; Bosco DA, 2004, BIOCHEMISTRY-US, V43, P6110, DOI 10.1021/bi049841z; Bosco DA, 2002, P NATL ACAD SCI USA, V99, P5247, DOI 10.1073/pnas.082100499; Brass V, 2002, J BIOL CHEM, V277, P8130, DOI 10.1074/jbc.M111289200; Brazin KN, 2002, P NATL ACAD SCI USA, V99, P1899, DOI 10.1073/pnas.042529199; Buck M, 1998, Q REV BIOPHYS, V31, P297, DOI 10.1017/S003358359800345X; Bukovsky AA, 1997, P NATL ACAD SCI USA, V94, P10943, DOI 10.1073/pnas.94.20.10943; CHEN YH, 1974, BIOCHEMISTRY-US, V13, P3350, DOI 10.1021/bi00713a027; Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6; Combet C, 2007, NUCLEIC ACIDS RES, V35, pD363, DOI 10.1093/nar/gkl970; CORTAY JC, 1994, J BIOL CHEM, V269, P14885; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; FARROW NA, 1994, J BIOMOL NMR, V4, P727, DOI 10.1007/BF00404280; Fernandes F, 2007, HEPATOLOGY, V46, P1026, DOI 10.1002/hep.21809; Fischer G, 1998, FEBS LETT, V426, P17, DOI 10.1016/S0014-5793(98)00242-7; Flisiak R, 2008, HEPATOLOGY, V47, P817, DOI 10.1002/hep.22131; Golovanov AP, 2007, J AM CHEM SOC, V129, P6528, DOI 10.1021/ja070505q; Grzesiek S, 1997, PROTEIN SCI, V6, P1248, DOI 10.1002/pro.5560060613; Gunasekaran K, 2003, TRENDS BIOCHEM SCI, V28, P81, DOI 10.1016/S0968-0004(03)00003-3; HANDSCHUMACHER RE, 1984, SCIENCE, V226, P544, DOI 10.1126/science.6238408; Hanoulle X, 2007, J BIOL CHEM, V282, P34148, DOI 10.1074/jbc.M706353200; HARRISON RK, 1990, BIOCHEMISTRY-US, V29, P3813, DOI 10.1021/bi00468a001; Huang LY, 2005, J BIOL CHEM, V280, P36417, DOI 10.1074/jbc.M508175200; Huang LY, 2004, PROTEIN EXPRES PURIF, V37, P144, DOI 10.1016/j.pep.2004.05.005; Ishii N, 2006, J VIROL, V80, P4510, DOI 10.1128/JVI.80.9.4510-4520.2006; Kaplan J.I., 1980, NMR CHEM EXCHANGING; Kern D, 2005, METHOD ENZYMOL, V394, P507, DOI 10.1016/S0076-6879(05)94021-4; KERN D, 1993, FEBS LETT, V323, P198, DOI 10.1016/0014-5793(93)81338-Z; KIELISZEWSKI MJ, 1990, PLANT PHYSIOL, V92, P316, DOI 10.1104/pp.92.2.316; Liang Y, 2007, BIOCHEMISTRY-US, V46, P11550, DOI 10.1021/bi700776e; Liang Y, 2006, MOL CELLS, V22, P13; LIU J, 1991, CELL, V66, P807, DOI 10.1016/0092-8674(91)90124-H; Lohmann V, 1999, SCIENCE, V285, P110, DOI 10.1126/science.285.5424.110; LUBAN J, 1993, CELL, V73, P1067, DOI 10.1016/0092-8674(93)90637-6; Luban J, 2007, J VIROL, V81, P1054, DOI 10.1128/JVI.01519-06; Macdonald A, 2004, J GEN VIROL, V85, P2485, DOI 10.1099/vir.0.80204-0; MIKOL V, 1994, P NATL ACAD SCI USA, V91, P5183, DOI 10.1073/pnas.91.11.5183; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Nakagawa M, 2005, GASTROENTEROLOGY, V129, P1031, DOI 10.1053/j.gastro.2005.06.031; Nakagawa M, 2004, BIOCHEM BIOPH RES CO, V313, P42, DOI 10.1016/j.bbrc.2003.11.080; *NIH, 2002, HEPATOLOGY S1, V36, pS2; Ottiger M, 1997, J MOL BIOL, V272, P64, DOI 10.1006/jmbi.1997.1220; Penin F, 2004, J BIOL CHEM, V279, P40835, DOI 10.1074/jbc.M404761200; Penin F, 2004, HEPATOLOGY, V39, P5, DOI 10.1002/hep.20032; Pietschmann T, 2006, P NATL ACAD SCI USA, V103, P7408, DOI 10.1073/pnas.0504877103; Robida JM, 2007, J VIROL, V81, P5829, DOI 10.1128/JVI.02524-06; SCHREIBER SL, 1991, SCIENCE, V251, P283, DOI 10.1126/science.1702904; Simmonds P, 2005, HEPATOLOGY, V42, P962, DOI 10.1002/hep.20819; Sokolskaja E, 2006, J VIROL, V80, P2855, DOI 10.1128/JVI.80.6.2855-2862.2006; Tanabe Y, 2004, J INFECT DIS, V189, P1129, DOI 10.1086/382595; Tellinghuisen TL, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000032; Tellinghuisen TL, 2008, J VIROL, V82, P1073, DOI 10.1128/JVI.00328-07; Tellinghuisen TL, 2007, J VIROL, V81, P8853, DOI 10.1128/JVI.00753-07; Tellinghuisen TL, 2005, NATURE, V435, P374, DOI 10.1038/nature03580; Tellinghuisen TL, 2004, J BIOL CHEM, V279, P48576, DOI 10.1074/jbc.M407787200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Verdegem D, 2008, J BIOMOL NMR, V42, P11, DOI 10.1007/s10858-008-9262-2; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Watashi K, 2003, HEPATOLOGY, V38, P1282, DOI 10.1053/jhep.2003.50449; Watashi K, 2005, MOL CELL, V19, P111, DOI 10.1016/j.molcel.2005.05.014; Watashi K, 2007, DRUG TARGET INSIGHT, V2, P9; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Yang F, 2008, J VIROL, V82, P5269, DOI 10.1128/JVI.02614-07; Yoo SH, 1997, J MOL BIOL, V269, P780, DOI 10.1006/jmbi.1997.1051; Zhao YD, 1996, BIOCHEMISTRY-US, V35, P7356, DOI 10.1021/bi9602775; Zhao YD, 1996, BIOCHEMISTRY-US, V35, P7362, DOI 10.1021/bi960278x; Zhong J, 2005, P NATL ACAD SCI USA, V102, P9294, DOI 10.1073/pnas.0503596102	71	131	144	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13589	13601		10.1074/jbc.M809244200	http://dx.doi.org/10.1074/jbc.M809244200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19297321	Green Published, hybrid			2022-12-27	WOS:000265877300036
J	Uvarov, P; Ludwig, A; Markkanen, M; Soni, S; Hubner, CA; Rivera, C; Airaksinen, MS				Uvarov, Pavel; Ludwig, Anastasia; Markkanen, Marika; Soni, Shetal; Hubner, Christian A.; Rivera, Claudio; Airaksinen, Matti S.			Coexpression and Heteromerization of Two Neuronal K-Cl Cotransporter Isoforms in Neonatal Brain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATION-CHLORIDE COTRANSPORTERS; INHIBITORY NEUROTRANSMISSION; MEMBRANE-PROTEINS; KCC2; EXPRESSION; NKCC1; DISRUPTION; KINASE	The neuron-specific K-Cl cotransporter KCC2 maintains the low intracellular chloride concentration required for the fast hyperpolarizing actions of inhibitory neurotransmitters. The KCC2 gene codes for two isoforms, KCC2a and KCC2b, which differ in their N termini. The relative expression and cellular distribution of the two KCC2 protein isoforms are unknown. Here, we characterize an antibody against the KCC2a isoform and show that a previously described antibody against KCC2 is specific for the KCC2b isoform (Hubner, C. A., Stein, V., Hermans-Borgmeyer, I., Meyer, T., Ballanyi, K., and Jentsch, T. J. (2001) Neuron 30, 515-524). Immunostaining of dissociated hippocampal cultures confirms that both KCC2 isoforms are neuron-specific. Immunoblot analysis indicates that KCC2b is the major KCC2 isoform in the adult brain, whereas in the neonatal mouse central nervous system, half of total KCC2 protein is KCC2a. At this stage, the two KCC2 isoforms are largely colocalized and show similar patterns of distribution in the brain. When coexpressed in HEK293 cells, KCC2a and KCC2b proteins form heteromeric complexes. Moreover, the two isoforms can be coimmunoprecipitated from the neonatal brain, suggesting the presence of endogenous KCC2a-KCC2b heteromers. Consistent with this, native gel analysis shows that a substantial part of endogenous KCC2 isoforms in the neonatal brain constitute dimers.	[Uvarov, Pavel; Markkanen, Marika; Airaksinen, Matti S.] Univ Helsinki, Ctr Neurosci, FIN-00014 Helsinki, Finland; [Ludwig, Anastasia; Soni, Shetal; Rivera, Claudio] Univ Helsinki, Inst Biotechnol, FIN-00014 Helsinki, Finland; [Hubner, Christian A.] Univ Jena, Dept Clin Chem, D-07747 Jena, Germany	University of Helsinki; University of Helsinki; Friedrich Schiller University of Jena	Uvarov, P (corresponding author), Univ Helsinki, Ctr Neurosci, Viikinkaari 4, FIN-00014 Helsinki, Finland.	pavel.uvarov@helsinki.fi; matti.airaksinen@helsinki.fi	Ludwig, Anastasia/N-1837-2016; Hübner, Christian/A-2950-2017; Rivera, Claudio/ABE-2499-2021; Uvarov, Pavel/AGR-2614-2022	Ludwig, Anastasia/0000-0003-4849-8074; Hübner, Christian/0000-0002-1030-4943; Rivera, Claudio/0000-0003-2462-6561; Uvarov, Pavel/0000-0001-8439-6150; Airaksinen, Matti/0000-0002-7199-4984; Soni, Shetal/0000-0003-1006-8511	Academy of Finland; University of Helsinki; Sigrid Juselius Foundation	Academy of Finland(Academy of Finland); University of Helsinki; Sigrid Juselius Foundation(Sigrid Juselius Foundation)	This work was supported by grants from the Academy of Finland, the University of Helsinki, and the Sigrid Juselius Foundation (to M. S. A. and C. R.).	Balakrishnan V, 2003, J NEUROSCI, V23, P4134; Blaesse P, 2006, J NEUROSCI, V26, P10407, DOI 10.1523/JNEUROSCI.3257-06.2006; Blaesse P, 2009, NEURON, V61, P820, DOI 10.1016/j.neuron.2009.03.003; Cai C, 2002, J BIOL CHEM, V277, P31484, DOI 10.1074/jbc.M204354200; Casula S, 2001, J BIOL CHEM, V276, P41870, DOI 10.1074/jbc.M107155200; Dowd BFX, 2003, J BIOL CHEM, V278, P27347, DOI 10.1074/jbc.M301899200; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; Goslin K., 1998, CULTURING NERVE CELL, P339; Hubner CA, 2001, NEURON, V30, P515, DOI 10.1016/S0896-6273(01)00297-5; Khirug S, 2005, EUR J NEUROSCI, V21, P899, DOI 10.1111/j.1460-9568.2005.03886.x; Li H, 2002, EUR J NEUROSCI, V16, P2358, DOI 10.1046/j.1460-9568.2002.02419.x; Lu J, 1999, J NEUROBIOL, V39, P558, DOI 10.1002/(SICI)1097-4695(19990615)39:4<558::AID-NEU9>3.0.CO;2-5; Ludwig A, 2003, EUR J NEUROSCI, V18, P3199, DOI 10.1111/j.1460-9568.2003.03069.x; Moore-Hoon ML, 2000, BIOCHEMISTRY-US, V39, P3718, DOI 10.1021/bi992301v; Parvin MN, 2007, BIOCHEMISTRY-US, V46, P9630, DOI 10.1021/bi700881a; Payne JA, 1996, J BIOL CHEM, V271, P16245, DOI 10.1074/jbc.271.27.16245; Pedersen M, 2008, J BIOL CHEM, V283, P2663, DOI 10.1074/jbc.M708194200; Ramjeesingh M, 1999, BIOCHEM J, V342, P119, DOI 10.1042/0264-6021:3420119; Sagne C, 1996, BIOCHEM J, V316, P825, DOI 10.1042/bj3160825; Simard CF, 2007, J BIOL CHEM, V282, P18083, DOI 10.1074/jbc.M607811200; Stein V, 2004, J COMP NEUROL, V468, P57, DOI 10.1002/cne.10983; Tornberg J, 2005, EUR J NEUROSCI, V21, P1327, DOI 10.1111/j.1460-9568.2005.03959.x; Toth ZE, 2007, J HISTOCHEM CYTOCHEM, V55, P545, DOI 10.1369/jhc.6A7134.2007; Ushiro H, 1998, ARCH BIOCHEM BIOPHYS, V355, P233, DOI 10.1006/abbi.1998.0736; Uvarov P, 2007, J BIOL CHEM, V282, P30570, DOI 10.1074/jbc.M705095200; Williams JR, 1999, J BIOL CHEM, V274, P12656, DOI 10.1074/jbc.274.18.12656; Woo NS, 2002, HIPPOCAMPUS, V12, P258, DOI 10.1002/hipo.10014; Zhang LL, 2006, J COMP NEUROL, V499, P132, DOI 10.1002/cne.21100	28	60	62	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13696	13704		10.1074/jbc.M807366200	http://dx.doi.org/10.1074/jbc.M807366200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19307176	hybrid, Green Published			2022-12-27	WOS:000265877300047
J	Bauer, PO; Wong, HK; Oyama, F; Goswami, A; Okuno, M; Kino, Y; Miyazaki, H; Nukina, N				Bauer, Peter O.; Wong, Hon Kit; Oyama, Fumitaka; Goswami, Anand; Okuno, Misako; Kino, Yoshihiro; Miyazaki, Haruko; Nukina, Nobuyuki			Inhibition of Rho Kinases Enhances the Degradation of Mutant Huntingtin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-PROTEASOME SYSTEM; NEURONAL INTRANUCLEAR INCLUSIONS; EXPANDED POLYGLUTAMINE; BINDING-PROTEIN; CASPASE ACTIVATION; CELL-DEATH; DISEASE; AUTOPHAGY; PHOSPHORYLATION; EXPRESSION	Huntington disease (HD) is a fatal hereditary neurodegenerative disease caused by an expansion of the polyglutamine (polyQ) stretch in huntingtin (htt). Whereas the pathological significance of the expanded polyQ has been clearly established and a tremendous effort to develop therapeutic tools for HD has been exerted, there is yet no effective cure. Whereas many molecules able to reduce the polyQ accumulation and aggregation have been identified, including several Rho kinase (ROCK) inhibitors, it remains very important to determine the mechanism of action of the potential drugs. ROCK inhibitors, including Y-27632 were reported to decrease aggregation of htt and androgen receptor (AR) through ROCK1 and protein kinase C-related protein kinase-2 (PRK-2). A downstream effector of ROCK1, actin-binding factor profilin, was shown to inhibit the mutant htt aggregation but not AR by direct interaction. We found that the anti-aggregation effect of ROCK inhibitors was not limited to the mutant htt and AR and that Y-27632 was also able to reduce the aggregation of ataxin-3 and atrophin-1 with expanded polyQ. These results suggested that in addition to the mechanism reported for htt and AR, there might also be other common mediators involved in the reduced aggregation of different polyQ proteins. In this study, we show that Y-27632 not only reduced the mutant htt aggregation by enhancing its degradation, but surprisingly was able to activate the main cellular degradation pathways, proteasome, and macroautophagy. We also show that this unique effect was mediated by ROCK1 and ROCK2.	[Bauer, Peter O.; Wong, Hon Kit; Oyama, Fumitaka; Goswami, Anand; Okuno, Misako; Kino, Yoshihiro; Miyazaki, Haruko; Nukina, Nobuyuki] RIKEN, Brain Sci Inst, Lab Struct Neuropathol, Wako, Saitama 3510198, Japan	RIKEN	Nukina, N (corresponding author), RIKEN, Brain Sci Inst, Lab Struct Neuropathol, 2-1 Hirosawa, Wako, Saitama 3510198, Japan.	nukina@brain.riken.jp	Oyama, Fumitaka/Q-4268-2019; Nukina, Nobuyuki/GPP-6265-2022; Bauer, Peter O./AAD-6502-2022; Wong, Hon-Kit/G-3944-2014	Oyama, Fumitaka/0000-0002-1095-8306; Bauer, Peter O./0000-0003-2811-1354; Wong, Hon-Kit/0000-0003-0049-8454	Ministry of Education, Culture, Sport, Science, and Technology of Japan [17025044]; Ministry of Health, Welfare and Labor of Japan; JSPS (Japan Society for the Promotion of Science)	Ministry of Education, Culture, Sport, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Welfare and Labor of Japan(Ministry of Health, Labour and Welfare, Japan); JSPS (Japan Society for the Promotion of Science)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a Grant-in-Aid for Scientific Research on Priority Areas (Research on Pathomechanisms of Brain Disorders) from the Ministry of Education, Culture, Sport, Science, and Technology of Japan (17025044) and by a Grant-in-Aid for the Research on Measures for Intractable Diseases from the Ministry of Health, Welfare and Labor of Japan. This work was also supported in part by a grant from the JSPS (Japan Society for the Promotion of Science).	Arimura N, 2000, J BIOL CHEM, V275, P23973, DOI 10.1074/jbc.M001032200; Arimura N, 2004, J NEUROBIOL, V58, P34, DOI 10.1002/neu.10269; Asanuma K, 2003, FASEB J, V17, P1165, DOI 10.1096/fj.02-0580fje; Beal MF, 2005, ANN NEUROL, V58, P495, DOI 10.1002/ana.20624; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; Bennett EJ, 2005, MOL CELL, V17, P351, DOI 10.1016/j.molcel.2004.12.021; Brown ME, 2004, J NEUROBIOL, V58, P118, DOI 10.1002/neu.10285; Davies JE, 2007, BMC BIOCHEM, V8, DOI 10.1186/1471-2091-8-S1-S2; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Degtyarev M, 2008, J CELL BIOL, V183, P101, DOI 10.1083/jcb.200801099; Denker SP, 2000, MOL CELL, V6, P1425, DOI 10.1016/S1097-2765(00)00139-8; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Doi H, 2004, FEBS LETT, V571, P171, DOI 10.1016/j.febslet.2004.06.077; Evert BO, 2000, CELL TISSUE RES, V301, P189, DOI 10.1007/s004410000228; Hosokawa N, 2006, FEBS LETT, V580, P2623, DOI 10.1016/j.febslet.2006.04.008; Ishizaki T, 1996, EMBO J, V15, P1885, DOI 10.1002/j.1460-2075.1996.tb00539.x; Jana NR, 2001, HUM MOL GENET, V10, P1049, DOI 10.1093/hmg/10.10.1049; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kegel KB, 2002, J BIOL CHEM, V277, P7466, DOI 10.1074/jbc.M103946200; Khan LA, 2006, J NEUROCHEM, V98, P576, DOI 10.1111/j.1471-4159.2006.03895.x; Kotliarova S, 2005, J NEUROCHEM, V93, P641, DOI 10.1111/j.1471-4159.2005.03035.x; Kuo PL, 2006, MOL CANCER THER, V5, P3209, DOI 10.1158/1535-7163.MCT-06-0478; Landles C, 2004, EMBO REP, V5, P958, DOI 10.1038/sj.embor.7400250; Leavitt BR, 2006, J NEUROCHEM, V96, P1121, DOI 10.1111/j.1471-4159.2005.03605.x; Lee WCM, 2004, P NATL ACAD SCI USA, V101, P3224, DOI 10.1073/pnas.0400243101; LEUNG T, 1995, J BIOL CHEM, V270, P29051, DOI 10.1074/jbc.270.49.29051; Li H, 2000, NAT GENET, V25, P385, DOI 10.1038/78054; Li Z, 2005, NAT CELL BIOL, V7, P399, DOI 10.1038/ncb1236; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Machida Y, 2006, BIOCHEM BIOPH RES CO, V343, P190, DOI 10.1016/j.bbrc.2006.02.141; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; Monastyrska I, 2008, MOL BIOL CELL, V19, P1962, DOI 10.1091/mbc.E07-09-0892; Myers Richard H, 2004, NeuroRx, V1, P255, DOI 10.1602/neurorx.1.2.255; Nagaoka U, 2004, J NEUROCHEM, V91, P57, DOI 10.1111/j.1471-4159.2004.02692.x; Nishimura Y, 2000, CELL TISSUE RES, V301, P341, DOI 10.1007/s004410000243; Nucifora FC, 2001, SCIENCE, V291, P2423, DOI 10.1126/science.1056784; Ohashi K, 2000, J BIOL CHEM, V275, P3577, DOI 10.1074/jbc.275.5.3577; Orr HT, 2007, ANNU REV NEUROSCI, V30, P575, DOI 10.1146/annurev.neuro.29.051605.113042; Oyama F, 2004, J BIOL CHEM, V279, P27272, DOI 10.1074/jbc.M401634200; Pedrini S, 2005, PLOS MED, V2, P69, DOI 10.1371/journal.pmed.0020018; Peters MF, 1999, NEUROSCI LETT, V275, P129, DOI 10.1016/S0304-3940(99)00758-2; Pollitt SK, 2003, NEURON, V40, P685, DOI 10.1016/S0896-6273(03)00697-4; Qin WP, 2006, J BIOL CHEM, V281, P21745, DOI 10.1074/jbc.M602909200; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Ross CA, 2004, TRENDS CELL BIOL, V14, P703, DOI 10.1016/j.tcb.2004.10.006; Ross CA, 2002, NEURON, V35, P819, DOI 10.1016/S0896-6273(02)00872-3; Sarkar S, 2008, HUM MOL GENET, V17, P170, DOI 10.1093/hmg/ddm294; Satoh SI, 2008, BRAIN RES, V1193, P102, DOI 10.1016/j.brainres.2007.11.050; Scott RW, 2007, J MOL MED, V85, P555, DOI 10.1007/s00109-007-0165-6; Shao JY, 2008, MOL CELL BIOL, V28, P5196, DOI 10.1128/MCB.00079-08; Shao J, 2008, FEBS LETT, V582, P1637, DOI 10.1016/j.febslet.2008.04.009; Steffan JS, 2000, P NATL ACAD SCI USA, V97, P6763, DOI 10.1073/pnas.100110097; Sumi T, 2001, J BIOL CHEM, V276, P670, DOI 10.1074/jbc.M007074200; Tadokoro K, 2005, J HUM GENET, V50, P382, DOI 10.1007/s10038-005-0261-9; Usdin MT, 1999, HUM MOL GENET, V8, P839, DOI 10.1093/hmg/8.5.839; Wang GH, 2000, HUM MOL GENET, V9, P1795, DOI 10.1093/hmg/9.12.1795; Wang GH, 1999, NEUROREPORT, V10, P2435, DOI 10.1097/00001756-199908200-00001; Wong HK, 2008, HUM MOL GENET, V17, P3223, DOI 10.1093/hmg/ddn218; Yamanaka T, 2008, EMBO J, V27, P827, DOI 10.1038/emboj.2008.23; Zemskov EA, 2003, J NEUROCHEM, V87, P395, DOI 10.1046/j.1471-4159.2003.02002.x; Zeng M, 2008, CELL SIGNAL, V20, P659, DOI 10.1016/j.cellsig.2007.11.015; Zhang LH, 2007, P NATL ACAD SCI USA, V104, P19023, DOI 10.1073/pnas.0709695104; Zhou Y, 2003, SCIENCE, V302, P1215, DOI 10.1126/science.1090154	64	74	78	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					13153	13164		10.1074/jbc.M809229200	http://dx.doi.org/10.1074/jbc.M809229200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19278999	Green Published, hybrid			2022-12-27	WOS:000265688300062
J	Boshuizen, RS; Schulz, V; Morbin, M; Mazzoleni, G; Meloen, RH; Langedijk, JPM				Boshuizen, Ronald S.; Schulz, Veronica; Morbin, Michela; Mazzoleni, Giulia; Meloen, Rob H.; Langedijk, Johannes P. M.			Heterologous Stacking of Prion Protein Peptides Reveals Structural Details of Fibrils and Facilitates Complete Inhibition of Fibril Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PARALLEL BETA-HELICES; AMYLOID FIBRILS; RESIDUES; SEQUENCE; SCRAPIE; DISEASE; FORM; NEURODEGENERATION; NEUROTOXICITY; DYNAMICS	Fibrils play an important role in the pathogenesis of amyloidosis; however, the underlying mechanisms of the growth process and the structural details of fibrils are poorly understood. Crucial in the fibril formation of prion proteins is the stacking of PrP monomers. We previously proposed that the structure of the prion protein fibril may be similar as a parallel left-handed beta-helix. The beta-helix is composed of spiraling rungs of parallel beta-strands, and in the PrP model residues 105-143 of each PrP monomer can contribute two beta-helical rungs to the growing fibril. Here we report data to support this model. We show that two cyclized human PrP peptides corresponding to residues 105-124 and 125-143, based on two single rungs of the left-handed beta-helical core of the human PrPSc fibril, show spontaneous cooperative fibril growth in vitro by heterologous stacking. Because the structural model must have predictive value, peptides were designed based on the structure rules of the left-handed beta-helical fold that could stack with prion protein peptides to stimulate or to block fibril growth. The stimulator peptide was designed as an optimal left-handed beta-helical fold that can serve as a template for fibril growth initiation. The inhibiting peptide was designed to bind to the exposed rung but frustrate the propagation of the fibril growth. The single inhibitory peptide hardly shows inhibition, but the combination of the inhibitory with the stimulatory peptide showed complete inhibition of the fibril growth of peptide huPrP-(106-126). Moreover, the unique strategy based on stimulatory and inhibitory peptides seems a powerful new approach to study amyloidogenic fibril structures in general and could prove useful for the development of therapeutics.	[Boshuizen, Ronald S.; Schulz, Veronica; Meloen, Rob H.; Langedijk, Johannes P. M.] Pepscan Therapeut BV, NL-8243 RC AB Lelystad, Netherlands; [Morbin, Michela; Mazzoleni, Giulia] Carattere Sci Inst Neurol Carlo Besta, Fdn Ist Di Ricovero & Cura, I-20133 Milan, Italy; [Meloen, Rob H.] Univ Utrecht, Acad Biomed Ctr, Utrecht, Netherlands	Pepscan Therapeutics B.V.; IRCCS Istituto Neurologico Besta; Utrecht University	Boshuizen, RS (corresponding author), Pepscan Therapeut BV, Zuidersluisweg 2, NL-8243 RC AB Lelystad, Netherlands.	r.boshuizen@pepscan.com		Morbin, Michela/0000-0001-8034-3123				Abalos GC, 2008, J BIOL CHEM, V283, P34021, DOI 10.1074/jbc.M804475200; Boshuizen RS, 2007, AMYLOID, V14, P205, DOI 10.1080/13506120701464628; BRUCE ME, 1989, NEUROSCI LETT, V102, P1, DOI 10.1016/0304-3940(89)90298-X; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Choi JH, 2008, PROTEINS, V73, P150, DOI 10.1002/prot.22051; FIELDS C G, 1991, Peptide Research, V4, P95; FORLONI G, 1993, NATURE, V362, P543, DOI 10.1038/362543a0; GEYSEN HM, 1984, P NATL ACAD SCI-BIOL, V81, P3998, DOI 10.1073/pnas.81.13.3998; Govaerts C, 2004, P NATL ACAD SCI USA, V101, P8342, DOI 10.1073/pnas.0402254101; Gray F, 1999, J NEUROPATH EXP NEUR, V58, P321, DOI 10.1097/00005072-199904000-00002; Haik S, 2000, NEUROBIOL DIS, V7, P644, DOI 10.1006/nbdi.2000.0316; Helmus JJ, 2008, P NATL ACAD SCI USA, V105, P6284, DOI 10.1073/pnas.0711716105; Iengar P, 2006, STRUCTURE, V14, P529, DOI 10.1016/j.str.2005.11.021; Kaneko K, 2000, J MOL BIOL, V295, P997, DOI 10.1006/jmbi.1999.3386; Langedijk JPM, 2006, J MOL BIOL, V360, P907, DOI 10.1016/j.jmb.2006.05.042; Laws DD, 2001, P NATL ACAD SCI USA, V98, P11686, DOI 10.1073/pnas.201404298; Lim KH, 2006, SOLID STATE NUCL MAG, V29, P183, DOI 10.1016/j.ssnmr.2005.09.017; Luhrs T, 2005, P NATL ACAD SCI USA, V102, P17342, DOI 10.1073/pnas.0506723102; Luhrs TT, 2006, J MOL BIOL, V357, P833, DOI 10.1016/j.jmb.2006.01.016; Novitskaya V, 2006, J BIOL CHEM, V281, P13828, DOI 10.1074/jbc.M511174200; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; PAULING L, 1951, P NATL ACAD SCI USA, V37, P729, DOI 10.1073/pnas.37.11.729; Peretz D, 1997, J MOL BIOL, V273, P614, DOI 10.1006/jmbi.1997.1328; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; RAETZ CRH, 1995, SCIENCE, V270, P997, DOI 10.1126/science.270.5238.997; Salmona M, 1999, BIOCHEM J, V342, P207, DOI 10.1042/0264-6021:3420207; Salmona M, 2003, J BIOL CHEM, V278, P48146, DOI 10.1074/jbc.M307295200; Stork M, 2005, BIOPHYS J, V88, P2442, DOI 10.1529/biophysj.104.052415; Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348; TAGLIAVINI F, 1993, P NATL ACAD SCI USA, V90, P9678, DOI 10.1073/pnas.90.20.9678; TAGLIAVINI F, 1994, CELL, V79, P695, DOI 10.1016/0092-8674(94)90554-1; Timmerman P, 2005, CHEMBIOCHEM, V6, P821, DOI 10.1002/cbic.200400374; Tsai HH, 2006, STRUCTURE, V14, P1059, DOI 10.1016/j.str.2006.03.015; Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839	34	4	4	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12809	12820		10.1074/jbc.M809151200	http://dx.doi.org/10.1074/jbc.M809151200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19304665	Green Published, hybrid			2022-12-27	WOS:000265688300026
J	Ramirez, OA; Vidal, RL; Tello, JA; Vargas, KJ; Kindler, S; Haertel, S; Couve, A				Ramirez, Omar A.; Vidal, Rene L.; Tello, Judith A.; Vargas, Karina J.; Kindler, Stefan; Haertel, Steffen; Couve, Andres			Dendritic Assembly of Heteromeric gamma-Aminobutyric Acid Type B Receptor Subunits in Hippocampal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETERODIMERIC GABA(B) RECEPTOR; DEPENDENT PROTEIN-KINASE; ENDOPLASMIC-RETICULUM; SUBCELLULAR-LOCALIZATION; TRAFFICKING; ACTIVATION; TRANSPORT; CELLS; PHOSPHORYLATION; OLIGOMERIZATION	Understanding the mechanisms that control synaptic efficacy through the availability of neurotransmitter receptors depends on uncovering their specific intracellular trafficking routes. gamma-Aminobutyric acid type B (GABA(B)) receptors (GABA(B)Rs) are obligatory heteromers present at dendritic excitatory and inhibitory postsynaptic sites. It is unknown whether synthesis and assembly of GABA(B)Rs occur in the somatic endoplasmic reticulum (ER) followed by vesicular transport to dendrites or whether somatic synthesis is followed by independent transport of the subunits for assembly and ER export throughout the somatodendritic compartment. To discriminate between these possibilities we studied the association of GABA(B)R subunits in dendrites of hippocampal neurons combining live fluorescence microscopy, biochemistry, quantitative colocalization, and bimolecular fluorescent complementation. We demonstrate that GABA(B)R subunits are segregated and differentially mobile in dendritic intracellular compartments and that a high proportion of non-associated intracellular subunits exist in the brain. Assembled heteromers are preferentially located at the plasma membrane, but blockade of ER exit results in their intracellular accumulation in the cell body and dendrites. We propose that GABA(B)R subunits assemble in the ER and are exported from the ER throughout the neuron prior to insertion at the plasmamembrane. Our results are consistent with a bulk flow of segregated subunits through the ER and rule out a post-Golgi vesicular transport of preassembled GABA(B)Rs.	[Couve, Andres] Univ Chile, Fac Med, Inst Ciencias Biomed ICBM, Programa Fisiol & Biofis, Santiago 8380000, Chile; [Kindler, Stefan] Univ Klinikum Hamburg Eppendorf, Inst Humangenet, D-20246 Hamburg, Germany; [Vidal, Rene L.; Vargas, Karina J.] Univ Austral Chile, Valdivia 5090000, Chile	Universidad de Chile; University of Hamburg; University Medical Center Hamburg-Eppendorf; Universidad Austral de Chile	Couve, A (corresponding author), Univ Chile, Fac Med, Inst Ciencias Biomed ICBM, Programa Fisiol & Biofis, Independencia 1027, Santiago 8380000, Chile.	andres@neuro.med.uchile.cl	Vidal, Rene Luis/S-7154-2019; Härtel, Steffen/AAA-2336-2020; couve, andres/I-2249-2013	Härtel, Steffen/0000-0002-8913-1757; couve, andres/0000-0003-4216-8672	Mejoramiento de la Calidad y Equidad de la Educacio n Superior (MECESUP); Comisio n Nacional de Investigacio n Cientifica y Tecnologica (CONICYT); Fondo Nacional de Desanollo Cientifico y Tecnologico (FONDECYT) [1060890]; FONDECYT [1071001]; Iniciativa Cientifico Milenio (ICM) [P07-048-F]; Human Frontiers Science Program Organization (HFSPO) [ST00105/2005-C]; Deutsche Forschungsgemeinschaft Forschergruppe 885;  [Ki488/2-6];  [KR 1321/4-1]	Mejoramiento de la Calidad y Equidad de la Educacio n Superior (MECESUP); Comisio n Nacional de Investigacio n Cientifica y Tecnologica (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Fondo Nacional de Desanollo Cientifico y Tecnologico (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Iniciativa Cientifico Milenio (ICM); Human Frontiers Science Program Organization (HFSPO)(Human Frontier Science Program); Deutsche Forschungsgemeinschaft Forschergruppe 885(German Research Foundation (DFG)); ; 	Supported by Mejoramiento de la Calidad y Equidad de la Educacio n Superior (MECESUP).; 2 Supported by Comisio n Nacional de Investigacio n Cientifica y Tecnologica (CONICYT).; 3 Supported by Grants Ki488/2-6 and KR 1321/4-1.; 4 Supported by Fondo Nacional de Desanollo Cientifico y Tecnologico (FONDECYT) Grant 1060890.; 5 Supported by FONDECYT Grant 1071001, Iniciativa Cientifico Milenio (ICM) Grant P07-048-F, Human Frontiers Science Program Organization (HFSPO) Grant ST00105/2005-C, and Deutsche Forschungsgemeinschaft Forschergruppe 885.	Aridor M, 2004, J NEUROSCI, V24, P3770, DOI 10.1523/JNEUROSCI.4775-03.2004; Balasubramanian S, 2004, J BIOL CHEM, V279, P18840, DOI 10.1074/jbc.M313470200; Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003; Bettler B, 2006, PHARMACOL THERAPEUT, V110, P533, DOI 10.1016/j.pharmthera.2006.03.006; Blichenberg A, 1999, J NEUROSCI, V19, P8818, DOI 10.1523/JNEUROSCI.19-20-08818.1999; Brock C, 2005, MOL BIOL CELL, V16, P5572, DOI 10.1091/mbc.E05-05-0400; Calver AR, 2001, J NEUROSCI, V21, P1203; Clem RL, 2006, NEURON, V49, P663, DOI 10.1016/j.neuron.2006.01.019; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Correa SAL, 2004, NEUROPHARMACOLOGY, V47, P475, DOI 10.1016/j.neuropharm.2004.04.021; COSTES SV, BIOPHYS J, V86, P3993; Cousins MS, 2002, DRUG ALCOHOL DEPEN, V65, P209, DOI 10.1016/S0376-8716(01)00163-6; Couve A, 2004, BIOCHEM PHARMACOL, V68, P1527, DOI 10.1016/j.bcp.2004.06.036; Couve A, 1998, J BIOL CHEM, V273, P26361, DOI 10.1074/jbc.273.41.26361; Couve A, 2002, NAT NEUROSCI, V5, P415, DOI 10.1038/nn833; Couve A, 2001, MOL CELL NEUROSCI, V17, P317, DOI 10.1006/mcne.2000.0938; Duthey B, 2002, J BIOL CHEM, V277, P3236, DOI 10.1074/jbc.M108900200; Espinosa A, 2009, J BIOL CHEM, V284, P2568, DOI 10.1074/jbc.M804249200; Fairfax BP, 2004, J BIOL CHEM, V279, P12565, DOI 10.1074/jbc.M311389200; Filippov AK, 2000, J NEUROSCI, V20, P2867; Gatti G, 2001, J CELL BIOL, V154, P525, DOI 10.1083/jcb.200103002; Gonchar Y, 2001, J COMP NEUROL, V431, P182, DOI 10.1002/1096-9861(20010305)431:2<182::AID-CNE1064>3.0.CO;2-K; Goslin K., 1991, CULTURING NERVE CELL, P251; Hanus C, 2008, TRAFFIC, V9, P1437, DOI 10.1111/j.1600-0854.2008.00775.x; Horton AC, 2003, J NEUROSCI, V23, P6188; Inoue A, 2003, CURR OPIN NEUROBIOL, V13, P332, DOI 10.1016/S0959-4388(03)00077-1; Jiang M, 2006, NAT PROTOC, V1, P695, DOI 10.1038/nprot.2006.86; Kaupmann K, 1998, NATURE, V396, P683, DOI 10.1038/25360; Kennedy MJ, 2006, ANNU REV NEUROSCI, V29, P325, DOI 10.1146/annurev.neuro.29.051605.112808; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; Kulik A, 2003, J NEUROSCI, V23, P11026; Kuramoto N, 2007, NEURON, V53, P233, DOI 10.1016/j.neuron.2006.12.015; Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X; Moss SJ, 2001, NAT REV NEUROSCI, V2, P240, DOI 10.1038/35067500; Perestenko PV, 2003, J BIOL CHEM, V278, P43525, DOI 10.1074/jbc.M306206200; Petersen OH, 2001, TRENDS NEUROSCI, V24, P271, DOI 10.1016/S0166-2236(00)01787-2; Pin JP, 2004, BIOCHEM PHARMACOL, V68, P1565, DOI 10.1016/j.bcp.2004.06.035; Restituito S, 2005, MOL CELL NEUROSCI, V28, P747, DOI 10.1016/j.mcn.2004.12.006; Robbins MJ, 2001, J NEUROSCI, V21, P8043, DOI 10.1523/JNEUROSCI.21-20-08043.2001; Rubio ME, 1999, J NEUROSCI, V19, P5549; Sakaba T, 2003, NATURE, V424, P775, DOI 10.1038/nature01859; SEGUCHI T, 1992, J BIOL CHEM, V267, P11626; Towers S, 2000, EUR J NEUROSCI, V12, P3201, DOI 10.1046/j.1460-9568.2000.00237.x; Vargas KJ, 2008, J BIOL CHEM, V283, P24641, DOI 10.1074/jbc.M802419200; Vidal RL, 2007, MOL CELL NEUROSCI, V35, P501, DOI 10.1016/j.mcn.2007.04.008; Vigot R, 2006, NEURON, V50, P589, DOI 10.1016/j.neuron.2006.04.014; Villemure JF, 2005, BIOCHEM J, V388, P47, DOI 10.1042/BJ20041435; Ward TH, 2001, J CELL BIOL, V155, P557, DOI 10.1083/jcb.200107045	48	32	33	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					13077	13085		10.1074/jbc.M900575200	http://dx.doi.org/10.1074/jbc.M900575200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19276079	Green Published, hybrid			2022-12-27	WOS:000265688300055
J	Platanias, LC				Platanias, Leonidas C.			Biological Responses to Arsenic Compounds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ACUTE PROMYELOCYTIC LEUKEMIA; TRIOXIDE-INDUCED APOPTOSIS; MULTIPLE-MYELOMA CELLS; PROTEIN-KINASE PATHWAY; DRINKING-WATER; INDUCED CYTOTOXICITY; SIGNAL-TRANSDUCTION; CELLULAR-RESPONSES; CASPASE ACTIVATION; MAMMALIAN TARGET	Arsenic is a metalloid that generates various biological effects on cells and tissues. Depending on the specific tissue exposed and the time and degree of exposure, diverse responses can be observed. In humans, prolonged and/or high dose exposure to arsenic can have a variety of outcomes, including the development of malignancies, severe gastrointestinal toxicities, diabetes, cardiac arrhythmias, and death. On the other hand, one arsenic derivative, arsenic trioxide (As2O3), has important antitumor properties. This agent is a potent inducer of antileukemic responses, and it is now approved by the Food and Drug Administration for the treatment of acute promyelocytic leukemia in humans. The promise and therapeutic potential of arsenic and its various derivatives have been exploited for hundreds of years. Remarkably, research focused on the potential use of arsenic compounds in the treatment of human diseases remains highly promising, and it is an area of active investigation. An emerging approach of interest and therapeutic potential involves efforts to target and block cellular pathways activated in a negative feedback manner during treatment of cells with As2O3. Such an approach may ultimately provide the means to selectively enhance the suppressive effects of this agent on malignant cells and render normally resistant tumors sensitive to its antineoplastic properties.	[Platanias, Leonidas C.] Northwestern Univ, Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA; [Platanias, Leonidas C.] Northwestern Univ, Sch Med, Div Hematol Oncol, Chicago, IL 60611 USA; [Platanias, Leonidas C.] Jesse Brown Vet Affairs Med Ctr, Chicago, IL 60612 USA	Ann & Robert H. Lurie Children's Hospital of Chicago; Northwestern University; Robert H. Lurie Comprehensive Cancer Center; Northwestern University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Platanias, LC (corresponding author), Northwestern Univ, Sch Med, Robert H Lurie Comprehens Canc Ctr, Chicago, IL 60611 USA.	l-platanias@northwestern.edu						Akao Y, 1998, BRIT J HAEMATOL, V102, P1055, DOI 10.1046/j.1365-2141.1998.00869.x; Altman JK, 2008, J BIOL CHEM, V283, P1992, DOI 10.1074/jbc.M705227200; Amran D, 2007, BBA-MOL CELL RES, V1773, P1653, DOI 10.1016/j.bbamcr.2007.06.003; Baastrup R, 2008, ENVIRON HEALTH PERSP, V116, P231, DOI 10.1289/ehp.10623; Benbrahim-Tallaa L, 2008, ENVIRON HEALTH PERSP, V116, P158, DOI 10.1289/ehp.10423; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Bjornsti MA, 2004, NAT REV CANCER, V4, P335, DOI 10.1038/nrc1362; Celik I, 2008, ENVIRON RES, V108, P48, DOI 10.1016/j.envres.2008.04.001; Chen CJ, 2007, TOXICOL APPL PHARM, V222, P298, DOI 10.1016/j.taap.2006.12.032; Chen GQ, 1996, BLOOD, V88, P1052; Cheng HYY, 2004, ONCOGENE, V23, P3603, DOI 10.1038/sj.onc.1207466; CHIOU HY, 1995, CANCER RES, V55, P1296; Davison K, 2004, BLOOD, V103, P3496, DOI 10.1182/blood-2003-05-1412; Dilda PJ, 2007, CANCER TREAT REV, V33, P542, DOI 10.1016/j.ctrv.2007.05.001; Dolniak B, 2008, J BIOL CHEM, V283, P12034, DOI 10.1074/jbc.M708816200; Douer D, 2005, J CLIN ONCOL, V23, P2396, DOI 10.1200/JCO.2005.10.217; Gartenhaus RB, 2002, CLIN CANCER RES, V8, P566; Giafis N, 2006, CANCER RES, V66, P6763, DOI 10.1158/0008-5472.CAN-05-3699; Grad JM, 2001, BLOOD, V98, P805, DOI 10.1182/blood.V98.3.805; Ishitsuka K, 2002, LEUKEMIA LYMPHOMA, V43, P1107, DOI 10.1080/10428190290021461; Ito K, 2008, NATURE, V453, P1072, DOI 10.1038/nature07016; Ivanov VN, 2004, J BIOL CHEM, V279, P22747, DOI 10.1074/jbc.M314131200; Kannan-Thulasiraman P, 2006, J BIOL CHEM, V281, P22446, DOI 10.1074/jbc.M603111200; Kapahi P, 2000, J BIOL CHEM, V275, P36062, DOI 10.1074/jbc.M007204200; Kapaj S, 2006, J ENVIRON SCI HEAL A, V41, P2399, DOI 10.1080/10934520600873571; Kim EH, 2008, CANCER RES, V68, P266, DOI 10.1158/0008-5472.CAN-07-2444; Kumagai Y, 2007, ANNU REV PHARMACOL, V47, P243, DOI 10.1146/annurev.pharmtox.47.120505.105144; Li LN, 2008, J CELL PHYSIOL, V217, P486, DOI 10.1002/jcp.21523; Li XQ, 2004, CANCER INVEST, V22, P389, DOI 10.1081/CNV-200029068; Litzow MR, 2008, EXPERT OPIN PHARMACO, V9, P1773, DOI [10.1517/14656566.9.10.1773, 10.1517/14656566.9.10.1773 ]; Liu J, 2008, TOXICOL SCI, V105, P24, DOI 10.1093/toxsci/kfn120; Lunghi P, 2008, BLOOD, V112, P2450, DOI 10.1182/blood-2007-10-114348; Lunghi P, 2006, BLOOD, V107, P4549, DOI 10.1182/blood-2005-07-2829; McCafferty-Grad J, 2003, MOL CANCER THER, V2, P1155; Miller WH, 2002, CANCER RES, V62, P3893; Millman A, 2008, PEDIATRICS, V122, P620, DOI 10.1542/peds.2007-3143; Morales AA, 2008, BLOOD, V111, P5152, DOI 10.1182/blood-2007-10-116889; Nasr R, 2008, NAT MED, V14, P1333, DOI 10.1038/nm.1891; Nordstrom DK, 2002, SCIENCE, V296, P2143, DOI 10.1126/science.1072375; Park WH, 2003, BIOCHEM BIOPH RES CO, V300, P230, DOI 10.1016/S0006-291X(02)02831-0; Puccetti E, 2000, CANCER RES, V60, P3409; Radosavljevic V, 2008, J ENVIRON HEALTH, V71, P40; Roboz GJ, 2008, CANCER-AM CANCER SOC, V113, P2504, DOI 10.1002/cncr.23855; Sanz MA, 2009, BLOOD, V113, P1875, DOI 10.1182/blood-2008-04-150250; Schiller GJ, 2006, J CLIN ONCOL, V24, P2456, DOI 10.1200/JCO.2005.03.7903; Shackelford D, 2006, CANCER RES, V66, P11360, DOI 10.1158/0008-5472.CAN-06-1774; Shen ZX, 2004, P NATL ACAD SCI USA, V101, P5328, DOI 10.1073/pnas.0400053101; Smedley PL, 2002, APPL GEOCHEM, V17, P517, DOI 10.1016/S0883-2927(02)00018-5; SMITH AH, 1992, ENVIRON HEALTH PERSP, V97, P259, DOI 10.2307/3431362; Tallman MS, 2002, BLOOD, V99, P759, DOI 10.1182/blood.V99.3.759; TSUDA T, 1995, AM J EPIDEMIOL, V141, P198, DOI 10.1093/oxfordjournals.aje.a117421; Tun-Kyi A, 2008, ANN ONCOL, V19, P1488, DOI 10.1093/annonc/mdn056; Vahter M, 2008, BASIC CLIN PHARMACOL, V102, P204, DOI 10.1111/j.1742-7843.2007.00168.x; Verma A, 2002, J BIOL CHEM, V277, P44988, DOI 10.1074/jbc.M207176200; Wen JG, 2008, BRIT J HAEMATOL, V140, P169, DOI 10.1111/j.1365-2141.2007.06895.x; Wetzler M, 2007, CLIN CANCER RES, V13, P2261, DOI 10.1158/1078-0432.CCR-06-2468; Wetzler M, 2006, CLIN CANCER RES, V12, P6817, DOI 10.1158/1078-0432.CCR-06-1354; Yang CH, 1999, BRIT J CANCER, V81, P796, DOI 10.1038/sj.bjc.6690766; Yang CY, 2008, J TOXICOL ENV HEAL A, V71, P1559, DOI 10.1080/15287390802392065; Yoon P, 2006, MOL CANCER THER, V5, P2815, DOI 10.1158/1535-7163.MCT-06-0263; Zhang QY, 2009, P NATL ACAD SCI USA, V106, P3378, DOI 10.1073/pnas.0813142106; Zheng YH, 2005, ONCOGENE, V24, P3339, DOI 10.1038/sj.onc.1208484	62	112	118	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18583	18587		10.1074/jbc.R900003200	http://dx.doi.org/10.1074/jbc.R900003200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19363033	Green Published, hybrid			2022-12-27	WOS:000267711500006
J	Schnitger, AKD; Yassine, H; Kafatos, FC; Osta, MA				Schnitger, Anna K. D.; Yassine, Hassan; Kafatos, Fotis C.; Osta, Mike A.			Two C-type Lectins Cooperate to Defend Anopheles gambiae against Gram-negative Bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPOPOLYSACCHARIDE-BINDING PROTEIN; MANDUCA-SEXTA; TOBACCO HORNWORM; BOMBYX-MORI; RECOGNITION; HEMOLYMPH; INSECT; MELANIZATION; IMMULECTIN-2; GENES	C-type lectins (CTLs) are a family of proteins that share a common structural motif, the carbohydrate recognition domain, and may act as receptors in pathogen recognition. Indeed, some vertebrate CTLs, particularly the collectins, are unequivocally implicated in the innate immune response to certain microbes. Although studies in insects and other invertebrates have described CTL activation of effector immune responses in vitro, the contribution of these CTLs to immune defenses in vivo is still poorly understood. Here we report that two CTLs, CTL4 and CTLMA2, which were shown previously to inhibit Plasmodium berghei ookinete melanization in the malaria vector Anopheles gambiae, are transcriptionally induced by bacterial challenge. Using in vivo reverse genetic analysis, we show that both CTLs are required for the clearance of Escherichia coli, but not Staphylococcus aureus, from adult female mosquitoes. Silencing either CTL dramatically reduces mosquito survival to Gram-negative but not to Gram-positive bacterial infections, suggesting a role in defense against Gram-negative bacteria. Furthermore, molecular characterization reveals that both CTLs are secreted into the mosquito hemolymph mainly in the form of a disulfide-linked heterodimer. This association explains the similar roles of these CTLs in bacterial defense as well as in the melanization response to P. berghei ookinetes. Apparently, CTL4 and CTLMA2 serve pleiotropic functions in the innate immune response of A. gambiae.	[Kafatos, Fotis C.] Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, London SW7 2AZ, England; [Yassine, Hassan; Osta, Mike A.] Amer Univ Beirut, Fac Arts & Sci, Dept Biol, Beirut 11072020, Lebanon	Imperial College London; American University of Beirut	Kafatos, FC (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Cell & Mol Biol, Exhibit Rd, London SW7 2AZ, England.	f.kafatos@imperial.ac.uk; mo07@aub.edu.lb			National Institutes of Health [2PO1AI044220-06A1]; Wellcome Trust Programme [GR077229/Z/05/Z]; American University of Beirut Research Board [DDF111030988140]; Lebanese National Center for Scientific Research [111030522369]; European Commission [LSHP-CT-2004-503578]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI044220] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust Programme(Wellcome Trust); American University of Beirut Research Board; Lebanese National Center for Scientific Research; European Commission(European CommissionEuropean Commission Joint Research Centre); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Project Grant 2PO1AI044220-06A1 from NIAID. This work was also supported by The Wellcome Trust Programme Grant GR077229/Z/05/Z, the American University of Beirut Research Board Grant DDF111030988140, Lebanese National Center for Scientific Research Grant 111030522369, and is part of the activities of the BioMalPar Network of Excellence supported by European Commission Grant LSHP-CT-2004-503578 under "Life Sciences, Genomics and Biotechnology for Health" in the European Commission 6th Framework Programme.	Blandin S, 2004, CELL, V116, P661, DOI 10.1016/S0092-8674(04)00173-4; Blandin S, 2002, EMBO REP, V3, P852, DOI 10.1093/embo-reports/kvf180; Christophides GK, 2002, SCIENCE, V298, P159, DOI 10.1126/science.1077136; Danielli A, 2000, P NATL ACAD SCI USA, V97, P7136, DOI 10.1073/pnas.97.13.7136; De Masi F, 2005, PROTEOMICS, V5, P4070, DOI 10.1002/pmic.200401279; Dimopoulos G, 2002, P NATL ACAD SCI USA, V99, P8814, DOI 10.1073/pnas.092274999; Drickamer K, 2002, BIOCHEM SOC SYMP, V69, P59; DRICKAMER K, 1993, ANNU REV CELL BIOL, V9, P237, DOI 10.1146/annurev.cb.09.110193.001321; Eleftherianos I, 2006, DEV COMP IMMUNOL, V30, P1099, DOI 10.1016/j.dci.2006.02.008; Holmskov U, 2003, ANNU REV IMMUNOL, V21, P547, DOI 10.1146/annurev.immunol.21.120601.140954; JOMORI T, 1992, FEBS LETT, V296, P283, DOI 10.1016/0014-5793(92)80305-Z; Koizumi N, 1999, FEBS LETT, V443, P139, DOI 10.1016/S0014-5793(98)01701-3; Koizumi N, 1997, EUR J BIOCHEM, V248, P217, DOI 10.1111/j.1432-1033.1997.t01-1-00217.x; Koizumi N, 1999, J INSECT PHYSIOL, V45, P853, DOI 10.1016/S0022-1910(99)00069-4; KUHLMAN M, 1989, J EXP MED, V169, P1733, DOI 10.1084/jem.169.5.1733; LeVine AM, 2000, J IMMUNOL, V165, P3934, DOI 10.4049/jimmunol.165.7.3934; Lindh JM, 2005, APPL ENVIRON MICROB, V71, P7217, DOI 10.1128/AEM.71.11.7217-7223.2005; Matsushita M, 1996, RES IMMUNOL, V147, P115, DOI 10.1016/0923-2494(96)87185-9; Michel K, 2006, P NATL ACAD SCI USA, V103, P16858, DOI 10.1073/pnas.0608033103; Muller HM, 1999, J BIOL CHEM, V274, P11727, DOI 10.1074/jbc.274.17.11727; Osta MA, 2004, SCIENCE, V303, P2030, DOI 10.1126/science.1091789; SALAZAR CE, 1993, NUCLEIC ACIDS RES, V21, P4147, DOI 10.1093/nar/21.17.4147; Schnitger AKD, 2007, J BIOL CHEM, V282, P21884, DOI 10.1074/jbc.M701635200; Schulenburg H, 2008, IMMUNOBIOLOGY, V213, P237, DOI 10.1016/j.imbio.2007.12.004; SCHWEINLE JE, 1989, J CLIN INVEST, V84, P1821, DOI 10.1172/JCI114367; Shi L, 2004, J EXP MED, V199, P1379, DOI 10.1084/jem.20032207; Shin SW, 2000, FEBS LETT, V467, P70, DOI 10.1016/S0014-5793(00)01127-3; Tanji T, 2006, BIOCHEM J, V396, P127, DOI 10.1042/BJ20051921; Volz J, 2006, CELL MICROBIOL, V8, P1392, DOI 10.1111/j.1462-5822.2006.00718.x; Watanabe A, 2006, J IMMUNOL, V177, P4594, DOI 10.4049/jimmunol.177.7.4594; WEIS WI, 1991, SCIENCE, V254, P1608, DOI 10.1126/science.1721241; WEIS WI, 1992, NATURE, V360, P127, DOI 10.1038/360127a0; Wilson R, 1999, J IMMUNOL, V162, P1590; Yu XQ, 2006, INSECT MOL BIOL, V15, P119, DOI 10.1111/j.1365-2583.2006.00618.x; Yu XQ, 2005, INSECT BIOCHEM MOLEC, V35, P285, DOI 10.1016/j.ibmb.2005.01.004; Yu XQ, 2004, DEV COMP IMMUNOL, V28, P891, DOI 10.1016/j.dci.2004.02.005; Yu XQ, 2003, DEV COMP IMMUNOL, V27, P189, DOI 10.1016/S0145-305X(02)00099-X; Yu XQ, 1999, INSECT BIOCHEM MOLEC, V29, P585, DOI 10.1016/S0965-1748(99)00036-3; Yu XQ, 2000, J BIOL CHEM, V275, P37373, DOI 10.1074/jbc.M003021200; Zirwes RF, 1997, P NATL ACAD SCI USA, V94, P11387, DOI 10.1073/pnas.94.21.11387	41	80	87	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17616	17624		10.1074/jbc.M808298200	http://dx.doi.org/10.1074/jbc.M808298200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19380589	Green Published, hybrid			2022-12-27	WOS:000267202500027
J	Anwar, A; Leong, KM; Ng, ML; Chu, JJH; Garcia-Blanco, MA				Anwar, Azlinda; Leong, K. M.; Ng, Mary L.; Chu, Justin J. H.; Garcia-Blanco, Mariano A.			The Polypyrimidine Tract-binding Protein Is Required for Efficient Dengue Virus Propagation and Associates with the Viral Replication Machinery	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATITIS-C VIRUS; TRANS-ACTING FACTORS; NUCLEAR-LOCALIZATION; INTERNAL INITIATION; GENE-EXPRESSION; RNA-SYNTHESIS; 3'-UNTRANSLATED REGION; HCV REPLICATION; HOST FACTORS; STRAND RNA	The polypyrimidine tract-binding protein (PTB) functions primarily as an IRES trans-acting factor in the propagation of hepatitis C virus and picornaviruses. PTB interacts with secondary structures within the 3'- and 5'-untranslated regions of these viral genomes to mediate efficient IRES-mediated viral translation. PTB has also been reported to bind to the untranslated region of the single-stranded RNA dengue virus (DENV), suggesting a similar function for PTB in flaviviruses. Indeed small interfering RNA-mediated PTB knockdown inhibited the production of infectious DENV, and this inhibition was specific to PTB knockdown and not due to a nonspecific anti-viral state. In fact, PTB depletion did not inhibit the production infectious yellow fever virus, another flavivirus. Nevertheless, whereas PTB knockdown led to a significant decrease in the accumulation of DENV viral RNAs, it did not impair translation. Moreover, PTB was shown to interact with the DENV nonstructural 4A protein, a known component of the viral replication complex, and with the DENV genome during infection. These data suggest that PTB interacts with the replication complex of DENV and is acting at the level of viral RNA replication.	[Ng, Mary L.; Chu, Justin J. H.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, Singapore 117597, Singapore; [Anwar, Azlinda; Leong, K. M.; Garcia-Blanco, Mariano A.] Duke Natl Univ Singapore, Grad Sch Med, Program Emerging Infect Dis, Singapore 169547, Singapore; [Garcia-Blanco, Mariano A.] Duke Univ, Med Ctr, Durham, NC 27710 USA	National University of Singapore; National University of Singapore; Duke University	Chu, JJH (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Microbiol, 8 Med Dr, Singapore 117597, Singapore.	miccjh@nus.edu.sg; garci001@mc.duke.edu	Chu, Justin Jang Hann/ABA-8297-2021; Kim, Seongman/N-6910-2014	Chu, Justin Jang Hann/0000-0002-1673-6819	Agency for Science, Technology and Research of Singapore; Singapore Ministry of Health [R-913-200-002-304]; National University of Singapore [R-182-000-117-112]; National Medical Research Council (Singapore) [NMRC/NIG/0012/2007]	Agency for Science, Technology and Research of Singapore(Agency for Science Technology & Research (A*STAR)); Singapore Ministry of Health(Ministry of Health-Singapore); National University of Singapore(National University of Singapore); National Medical Research Council (Singapore)(National Medical Research Council, SingaporeUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Agency for Science, Technology and Research of Singapore and Singapore Ministry of Health Award R-913-200-002-304 (to M. A. G.-B.) and National University of Singapore Grant R-182-000-117-112 and National Medical Research Council (Singapore) Grant NMRC/NIG/0012/2007 (to J.J.H.C.).	Ahlquist P, 2003, J VIROL, V77, P8181, DOI 10.1128/JVI.77.15.8181-8186.2003; Aizaki H, 2006, J BIOMED SCI, V13, P469, DOI 10.1007/s11373-006-9088-4; Alvarez DE, 2005, VIROLOGY, V339, P200, DOI 10.1016/j.virol.2005.06.009; Anwar A, 2006, ANAL BIOCHEM, V352, P120, DOI 10.1016/j.ab.2006.01.046; Anwar A, 2005, VIROLOGY, V332, P66, DOI 10.1016/j.virol.2004.11.022; Auweter SD, 2008, CELL MOL LIFE SCI, V65, P516, DOI 10.1007/s00018-007-7378-2; Back SH, 2002, J VIROL, V76, P2529, DOI 10.1128/JVI.76.5.2529-2542.2002; BEHRENS SE, 2006, MOL BIOL FLAVIVIRUS, P101; Brinton MA, 2001, ANN NY ACAD SCI, V951, P207; Chang KS, 2006, VIRUS RES, V115, P1, DOI 10.1016/j.virusres.2005.06.012; Choi KS, 2002, VIROLOGY, V303, P58, DOI 10.1006/viro.2002.1675; Clyde K, 2006, J VIROL, V80, P11418, DOI 10.1128/JVI.01257-06; De Nova-Ocampo M, 2002, VIROLOGY, V295, P337, DOI 10.1006/viro.2002.1407; Domitrovich AM, 2005, VIROLOGY, V335, P72, DOI 10.1016/j.virol.2005.02.009; Edgil D, 2006, J VIROL, V80, P2976, DOI 10.1128/JVI.80.6.2976-2986.2006; Florez PM, 2005, J VIROL, V79, P6172, DOI 10.1128/JVI.79.10.6172-6179.2005; Gama-Carvalho M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-11-r113; GARCIABLANCO MA, 1989, GENE DEV, V3, P1874, DOI 10.1101/gad.3.12a.1874; Gould E., 1985, VIROLOGY PRACTICAL A, P43; Gritsun TS, 2007, VIROLOGY, V366, P8, DOI 10.1016/j.virol.2007.04.011; Gritsun TS, 2007, VIROLOGY, V358, P258, DOI 10.1016/j.virol.2006.09.033; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; Hiscox JA, 2007, NAT REV MICROBIOL, V5, P119, DOI 10.1038/nrmicro1597; Huang PY, 1999, J VIROL, V73, P9110, DOI 10.1128/JVI.73.11.9110-9116.1999; Hunt SL, 1999, RNA, V5, P344, DOI 10.1017/S1355838299981414; Jang SK, 2006, VIRUS RES, V119, P2, DOI 10.1016/j.virusres.2005.11.003; Kamath RV, 2001, MOL BIOL CELL, V12, P3808, DOI 10.1091/mbc.12.12.3808; Kaminski A, 1998, RNA, V4, P626, DOI 10.1017/S1355838298971898; KAPOOR M, 1995, J BIOL CHEM, V270, P19100, DOI 10.1074/jbc.270.32.19100; Karakasiliotis I, 2006, J GEN VIROL, V87, P3339, DOI 10.1099/vir.0.82153-0; Kim SM, 2006, VIRUS RES, V115, P131, DOI 10.1016/j.virusres.2005.07.013; Li HP, 1999, J VIROL, V73, P772, DOI 10.1128/JVI.73.1.772-777.1999; Lindenbach B., 2011, FIELDS VIROLOGY, V5th ed., P1101; Lindenbach BD, 2007, J VIROL, V81, P8905, DOI 10.1128/JVI.00937-07; Marianneau P, 1998, J INFECT DIS, V178, P1270, DOI 10.1086/314466; Martinez-Salas E, 2008, J GEN VIROL, V89, P611, DOI 10.1099/vir.0.83426-0; Niranjanakumari S, 2002, METHODS, V26, P182, DOI 10.1016/S1046-2023(02)00021-X; Pryor MJ, 2007, TRAFFIC, V8, P795, DOI 10.1111/j.1600-0854.2007.00579.x; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Randall G, 2007, P NATL ACAD SCI USA, V104, P12884, DOI 10.1073/pnas.0704894104; Pulido MR, 2007, VIROLOGY, V364, P466, DOI 10.1016/j.virol.2007.03.013; Sangiambut S, 2008, J GEN VIROL, V89, P1254, DOI 10.1099/vir.0.83264-0; Song YT, 2005, RNA, V11, P1809, DOI 10.1261/rna.7430405; Spellman R, 2006, TRENDS BIOCHEM SCI, V31, P73, DOI 10.1016/j.tibs.2005.12.003; Spellman R, 2007, MOL CELL, V27, P420, DOI 10.1016/j.molcel.2007.06.016; Spriggs KA, 2005, CELL DEATH DIFFER, V12, P585, DOI 10.1038/sj.cdd.4401642; Stoneley M, 2004, ONCOGENE, V23, P3200, DOI 10.1038/sj.onc.1207551; Thurner C, 2004, J GEN VIROL, V85, P1113, DOI 10.1099/vir.0.19462-0; Tischendorf JJW, 2004, ARCH VIROL, V149, P1955, DOI 10.1007/s00705-004-0341-8; TOLLERVEY D, 1993, CELL, V72, P443, DOI 10.1016/0092-8674(93)90120-F; Uchil PD, 2006, J VIROL, V80, P5451, DOI 10.1128/JVI.01982-05; Wagner EJ, 2002, MOL CELL, V10, P943, DOI 10.1016/S1097-2765(02)00645-7; Westaway EG, 2003, ADV VIRUS RES, V59, P99, DOI 10.1016/S0065-3527(03)59004-2; Westaway EG, 1997, VIROLOGY, V234, P31, DOI 10.1006/viro.1997.8629; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0; Wollerton MC, 2004, MOL CELL, V13, P91, DOI 10.1016/S1097-2765(03)00502-1; WU BF, 1996, J BIOL CHEM, V271, P4201; Yi MY, 2000, J VIROL, V74, P6459, DOI 10.1128/JVI.74.14.6459-6468.2000	58	45	46	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					17021	17029		10.1074/jbc.M109.006239	http://dx.doi.org/10.1074/jbc.M109.006239			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19380576	hybrid, Green Published			2022-12-27	WOS:000266962400040
J	Nigro, J; Wang, AM; Mukhopadhyay, D; Lauer, M; Midura, RJ; Sackstein, R; Hascall, VC				Nigro, Julie; Wang, Aimin; Mukhopadhyay, Durba; Lauer, Mark; Midura, Ronald J.; Sackstein, Robert; Hascall, Vincent C.			Regulation of Heparan Sulfate and Chondroitin Sulfate Glycosaminoglycan Biosynthesis by 4-Fluoro-glucosamine in Murine Airway Smooth Muscle Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-D-XYLOSIDE; PROTEOGLYCANS; INHIBITION	The importance of the pathological changes in proteoglycans has driven the need to study and design novel chemical tools to control proteoglycan synthesis. Accordingly, we tested the fluorinated analogue of glucosamine (4-fluoro-N-acetyl-glucosamine (4-F-GlcNAc)) on the synthesis of heparan sulfate (HS) and chondroitin sulfate (CS) by murine airway smooth muscle (ASM) cells in the presence of radiolabeled metabolic precursors. Secreted and cell-associated CS and HS were assessed for changes in size by Superose 6 chromatography. Treatment of ASM cells with 4-F-GlcNAc (100 mu M) reduced the quantity (by 64.1-76.6%) and decreased the size of HS/CS glycosaminoglycans associated with the cell layer (K-av shifted from 0.30 to 0.45). The quantity of CS secreted into the medium decreased by 65.7-73.0%, and the size showed a K-av shift from 0.30 to 0.50. Treatment of ASM cells with 45 mu M and 179 mu M 4-F-GlcNAc in the presence of a stimulator of CS synthesis, 4-methylumbelliferyl-beta-D-xyloside, reduced the amount of the xyloside-CS chains by 65.4 and 87.0%, respectively. The size of xyloside-CS chains synthesized in the presence of 4-F-GlcNAc were only slightly larger than those with xyloside treatment alone (K-av of 0.55 compared with that of 0.6). The effects of 4-F-GlcNAc to inhibit CS synthesis were not observed with equimolar concentrations of glucosamine. We propose that 4-F-GlcNAc inhibits CS synthesis by inhibiting 4-epimerization of UDP-GlcNAc to UDP-GalNAc, thereby depleting one of the substrates required, whereas HS elongation is inhibited by truncation when the nonreducing terminus of the growing chain is capped with 4-F-GlcNAc.	[Hascall, Vincent C.] Cleveland Clin, Dept Biomed Engn, Cleveland Clin Fdn, Lerner Res Inst, Cleveland, OH 44195 USA; [Sackstein, Robert] Harvard Univ, Sch Med, Brigham Womens Hosp, Dept Dermatol, Boston, MA 02115 USA; [Sackstein, Robert] Harvard Univ, Sch Med, Brigham Womens Hosp, Dept Med, Boston, MA 02115 USA; [Nigro, Julie] Commonwealth Sci & Ind Res Org Mol & Hlth Technol, Clayton, Vic 3168, Australia	Cleveland Clinic Foundation; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Hascall, VC (corresponding author), Cleveland Clin, Dept Biomed Engn, Cleveland Clin Fdn, Lerner Res Inst, ND20, Cleveland, OH 44195 USA.	hascalv@ccf.org			National Institutes of Health [P11 HL081064, HL073714, CA121335]; NATIONAL CANCER INSTITUTE [R01CA121335] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073714, P01HL081064] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants P11 HL081064, HL073714 (to R. S.), and CA121335 (to R. S.).	Berkin A, 2000, CARBOHYD RES, V326, P250, DOI 10.1016/S0008-6215(00)00049-5; BERNACKI RJ, 1977, J SUPRAMOL STR CELL, V7, P235, DOI 10.1002/jss.400070208; BLUMENKR.N, 1973, ANAL BIOCHEM, V54, P484, DOI 10.1016/0003-2697(73)90377-1; CONTRERAS A, 1978, J ANTIBIOT, V31, P598, DOI 10.7164/antibiotics.31.598; Dimitroff CJ, 2003, J CLIN INVEST, V112, P1008, DOI 10.1172/JCI200319220; Feng F, 2004, ORG BIOMOL CHEM, V2, P1617, DOI 10.1039/b402860k; Johnson PRA, 2000, AM J RESP CRIT CARE, V162, P2145, DOI 10.1164/ajrccm.162.6.9909111; Kisilevsky R, 2002, J MOL NEUROSCI, V19, P45, DOI 10.1007/s12031-002-0009-3; LOHMANDER S, 1979, ARCH BIOCHEM BIOPHYS, V192, P148, DOI 10.1016/0003-9861(79)90080-8; Morgenstern DA, 2002, PROG BRAIN RES, V137, P313; Nakashima Y, 2008, CARDIOVASC RES, V79, P14, DOI 10.1093/cvr/cvn099; POTTERPERIGO S, 1992, ARCH BIOCHEM BIOPHYS, V297, P101, DOI 10.1016/0003-9861(92)90646-E; Roberts C R, 1998, Can Respir J, V5, P48; SHARMA M, 1990, CARBOHYD RES, V198, P205, DOI 10.1016/0008-6215(90)84293-4; TSUCHIYA T, 1990, CHEM DEV FLUORINATED, P91; Uldry M, 2002, FEBS LETT, V524, P199, DOI 10.1016/S0014-5793(02)03058-2; Whitelock JM, 2008, BIOCHEMISTRY-US, V47, P11174, DOI 10.1021/bi8013938	17	26	26	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					16832	16839		10.1074/jbc.M109.002956	http://dx.doi.org/10.1074/jbc.M109.002956			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19346253	Green Published, hybrid			2022-12-27	WOS:000266962400019
J	Williams, JR; Khandoga, AL; Goyal, P; Fells, JI; Perygin, DH; Siess, W; Parrill, AL; Tigyi, G; Fujiwara, Y				Williams, Jesica R.; Khandoga, Anna L.; Goyal, Pankaj; Fells, James I.; Perygin, Donna H.; Siess, Wolfgang; Parrill, Abby L.; Tigyi, Gabor; Fujiwara, Yuko			Unique Ligand Selectivity of the GPR92/LPA(5) Lysophosphatidate Receptor Indicates Role in Human Platelet Activation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; DIFFERENTIATION GENE FAMILY; CYCLIC PHOSPHATIDIC-ACID; LOW-DENSITY-LIPOPROTEIN; SPHINGOSINE 1-PHOSPHATE; N-ARACHIDONYLGLYCINE; ENDOGENOUS LIGANDS; ORPHAN GPCR; IDENTIFICATION; AGGREGATION	Lysophosphatidic acid (LPA) is a ligand for LPA(1-3) of the endothelial differentiation gene family G-protein-coupled receptors, and LPA(4-8) is related to the purinergic family G-protein-coupled receptor. Because the structure-activity relationship (SAR) of GPR92/LPA(5) is limited and whether LPA is its preferred endogenous ligand has been questioned in the literature, in this study we applied a combination of computational and experimental site-directed mutagenesis of LPA(5) residues predicted to interact with the headgroup of LPA. Four residues involved in ligand recognition in LPA(5) were identified as follows: R2.60N mutant abolished receptor activation, whereas H4.64E, R6.62A, and R7.32A greatly reduced receptor activation. We also investigated the SAR of LPA5 using LPA analogs and other non-lysophospholipid ligands. SAR revealed that the rank order of agonists is alkyl glycerol phosphate > LPA > farnesyl phosphates >> N-arachidonoylglycine. These results confirm LPA(5) to be a bona fide lysophospholipid receptor. We also evaluated several compounds with previously established selectivity for the endothelial differentiation gene receptors and found several that are LPA(5) agonists. A pharmacophore model of LPA(5) binding requirements was developed for in silico screening, which identified two non-lipid LPA(5) antagonists. Because LPA(5) transcripts are abundant in human platelets, we tested its antagonists on platelet activation and found that these non-lipid LPA(5) antagonists inhibit platelet activation. The present results suggest that selective inhibition of LPA(5) may provide a basis for future anti-thrombotic therapies.	[Tigyi, Gabor; Fujiwara, Yuko] Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA; [Williams, Jesica R.; Fells, James I.; Perygin, Donna H.; Parrill, Abby L.] Univ Memphis, Dept Chem, Memphis, TN 38152 USA; [Williams, Jesica R.; Fells, James I.; Perygin, Donna H.; Parrill, Abby L.] Univ Memphis, Computat Res Mat Inst, Memphis, TN 38152 USA; [Khandoga, Anna L.; Goyal, Pankaj; Siess, Wolfgang] Univ Munich, Fac Med, Inst Prevent Cardiovasc Dis, D-80336 Munich, Germany	University of Tennessee System; University of Tennessee Health Science Center; University of Memphis; University of Memphis; University of Munich	Fujiwara, Y (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Physiol, 894 Union Ave, Memphis, TN 38163 USA.	yuko@physio1.utmem.edu	Goyal, Pankaj/C-3567-2012; Siess, Wolfgang/A-6430-2009	Siess, Wolfgang/0000-0003-0698-6416; Parrill, Abby/0000-0003-1658-8497	National Institutes of Health [CA92160, HL79004, HL084007]; NCI; American Heart Association [0625325B, 0715125B]; Graduate Program of the Bavarian Eliteforderungsgesetz Deutsche Forschungsgemeinschaft [Si 274/9-3]; NATIONAL CANCER INSTITUTE [R01CA092160] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079004, R01HL084007] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080405] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Heart Association(American Heart Association); Graduate Program of the Bavarian Eliteforderungsgesetz Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant CA92160 from NCI and National Institutes of Health Grants HL79004 ( to G. T.) and HL084007 ( to A. L. P.). This work was also supported by American Heart Association Grants 0625325B ( to Y. F.) and 0715125B ( to J. F.) and Graduate Program of the Bavarian Eliteforderungsgesetz Deutsche Forschungsgemeinschaft Grant Si 274/9-3 ( to A. L. K.).	Amisten S, 2008, THROMB RES, V122, P47, DOI 10.1016/j.thromres.2007.08.014; Baker DL, 2006, J BIOL CHEM, V281, P22786, DOI 10.1074/jbc.M512486200; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Bandoh K, 1999, J BIOL CHEM, V274, P27776, DOI 10.1074/jbc.274.39.27776; Bond SD, 1999, J COMPUT PHYS, V151, P114, DOI 10.1006/jcph.1998.6171; Burstein SH, 2002, BIOCHEM PHARMACOL, V64, P1147, DOI 10.1016/S0006-2952(02)01301-1; Durgam GG, 2006, BIOORG MED CHEM LETT, V16, P633, DOI 10.1016/j.bmcl.2005.10.031; Fang XJ, 2002, BBA-MOL CELL BIOL L, V1582, P257, DOI 10.1016/S1388-1981(02)00179-8; Fells JI, 2008, BIOORGAN MED CHEM, V16, P6207, DOI 10.1016/j.bmc.2008.04.035; Fischer DJ, 1998, MOL PHARMACOL, V54, P979, DOI 10.1124/mol.54.6.979; Fujiwara Y, 2005, J BIOL CHEM, V280, P35038, DOI 10.1074/jbc.M504351200; GERLACH E, 1963, BIOCHEM Z, V337, P477; Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI 10.1002/(SICI)1096-987X(199604)17:5/6<616::AID-JCC5>3.0.CO;2-X; Haseruck N, 2004, BLOOD, V103, P2585, DOI 10.1182/blood-2003-04-1127; Holdsworth G, 2005, GENE, V350, P59, DOI 10.1016/j.gene.2005.01.016; Inagaki Y, 2005, BIOCHEM J, V389, P187, DOI 10.1042/BJ20050046; Jin JG, 1998, P NATL ACAD SCI USA, V95, P8070, DOI 10.1073/pnas.95.14.8070; Keularts IMLW, 2000, J BIOL CHEM, V275, P1763, DOI 10.1074/jbc.275.3.1763; Khandoga AL, 2008, PLATELETS, V19, P415, DOI 10.1080/09537100802220468; Kobilka BK, 2007, BBA-BIOMEMBRANES, V1768, P794, DOI 10.1016/j.bbamem.2006.10.021; Kotarsky K, 2006, J PHARMACOL EXP THER, V318, P619, DOI 10.1124/jpet.105.098848; Lee CW, 2006, J BIOL CHEM, V281, P23589, DOI 10.1074/jbc.M603670200; Liliom K, 2006, BBA-MOL CELL BIOL L, V1761, P1506, DOI 10.1016/j.bbalip.2006.09.012; Maschberger P, 2000, J BIOL CHEM, V275, P19159, DOI 10.1074/jbc.M910257199; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Murakami M, 2008, BIOCHEM BIOPH RES CO, V371, P707, DOI 10.1016/j.bbrc.2008.04.145; Naor MM, 2007, J MOL GRAPH MODEL, V26, P519, DOI 10.1016/j.jmgm.2007.03.004; NEGRESCU EV, 1995, J BIOL CHEM, V270, P1057, DOI 10.1074/jbc.270.3.1057; Oh DY, 2008, J BIOL CHEM, V283, P21054, DOI 10.1074/jbc.M708908200; Pamuklar Z, 2008, ARTERIOSCL THROM VAS, V28, P555, DOI 10.1161/ATVBAHA.107.151837; Panetti TS, 2001, PROSTAG OTH LIPID M, V64, P93, DOI 10.1016/S0090-6980(01)00102-2; Parrill AL, 2008, BBA-MOL CELL BIOL L, V1781, P540, DOI 10.1016/j.bbalip.2008.04.011; Parrill AL, 2005, BIOCHEM SOC T, V33, P1366, DOI 10.1042/BST0331366; Parrill AL, 2000, J BIOL CHEM, V275, P39379, DOI 10.1074/jbc.M007680200; Pasternack SM, 2008, NAT GENET, V40, P329, DOI 10.1038/ng.84; Pulcinelli FM, 1999, FEBS LETT, V460, P37, DOI 10.1016/S0014-5793(99)01313-7; Retzer M, 2000, CELL SIGNAL, V12, P645, DOI 10.1016/S0898-6568(00)00108-X; Rother E, 2003, CIRCULATION, V108, P741, DOI 10.1161/01.CIR.0000083715.37658.C4; Sardar VM, 2002, BBA-MOL CELL BIOL L, V1582, P309, DOI 10.1016/S1388-1981(02)00185-3; Siess W, 1999, P NATL ACAD SCI USA, V96, P6931, DOI 10.1073/pnas.96.12.6931; Siess W, 2004, J CELL BIOCHEM, V92, P1086, DOI 10.1002/jcb.20108; SIMON MF, 1982, BIOCHEM BIOPH RES CO, V108, P1743, DOI 10.1016/S0006-291X(82)80113-7; Szkopinska A, 2005, ACTA BIOCHIM POL, V52, P45; Tabata KI, 2007, BIOCHEM BIOPH RES CO, V363, P861, DOI 10.1016/j.bbrc.2007.09.063; Tigyi G, 2001, PROSTAG OTH LIPID M, V64, P47, DOI 10.1016/S0090-6980(01)00107-1; Uchiyama A, 2007, BBA-MOL CELL BIOL L, V1771, P103, DOI 10.1016/j.bbalip.2006.10.001; Valentine WJ, 2008, J BIOL CHEM, V283, P12175, DOI 10.1074/jbc.M708847200; Wang DA, 2001, J BIOL CHEM, V276, P49213, DOI 10.1074/jbc.M107301200; Weiner JA, 1999, P NATL ACAD SCI USA, V96, P5233, DOI 10.1073/pnas.96.9.5233	49	109	114	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					17304	17319		10.1074/jbc.M109.003194	http://dx.doi.org/10.1074/jbc.M109.003194			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19366702	Green Published, hybrid			2022-12-27	WOS:000266962400066
J	Howlett, AC; Gray, AJ; Hunter, JM; Willardson, BM				Howlett, Alyson C.; Gray, Amy J.; Hunter, Jesse M.; Willardson, Barry M.			Role of Molecular Chaperones in G Protein beta 5/Regulator of G Protein Signaling Dimer Assembly and G Protein beta gamma Dimer Specificity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSDUCIN-LIKE PROTEIN; GTPASE-ACCELERATING PROTEIN; CRYSTAL-STRUCTURE; RGS PROTEINS; SUBUNIT; COMPLEX; RHODOPSIN; TRAFFICKING; ACTIVATION; REGULATORS	The G protein beta gamma subunit dimer (G beta gamma) and the G beta 5/regulator of G protein signaling (RGS) dimer play fundamental roles in propagating and regulating G protein pathways, respectively. How these complexes form dimers when the individual subunits are unstable is a question that has remained unaddressed for many years. In the case of G beta gamma, recent studies have shown that phosducin-like protein 1 (PhLP1) works as a co-chaperone with the cytosolic chaperonin complex (CCT) to fold G beta and mediate its interaction with G gamma. However, it is not known what fraction of the many G beta gamma combinations is assembled this way or whether chaperones influence the specificity of G beta gamma dimer formation. Moreover, the mechanism of G beta 5-RGS assembly has yet to be assessed experimentally. The current study was undertaken to directly address these issues. The data show that PhLP1 plays a vital role in the assembly of G gamma 2 with all four G beta 1-4 subunits and in the assembly of G gamma 2 with all twelve G gamma subunits, without affecting the specificity of the G beta gamma interactions. The results also show that G beta 5-RGS7 assembly is dependent on CCT and PhLP1, but the apparent mechanism is different from that of G beta gamma. PhLP1 seems to stabilize the interaction of G beta 5 with CCT until G beta 5 is folded, after which it is released to allow G beta 5 to interact with RGS7. These findings point to a general role for PhLP1 in the assembly of all G beta gamma combinations and suggest a CCT-dependent mechanism for G beta 5-RGS7 assembly that utilizes the co-chaperone activity of PhLP1 in a unique way.	[Howlett, Alyson C.; Gray, Amy J.; Hunter, Jesse M.; Willardson, Barry M.] Brigham Young Univ, Dept Chem & Biochem, Provo, UT 84602 USA	Brigham Young University	Willardson, BM (corresponding author), Brigham Young Univ, Dept Chem & Biochem, C-100 BNSN, Provo, UT 84602 USA.	barry_willardson@byu.edu		Willardson, Barry/0000-0002-8503-2268	National Institutes of Health [GM078550, EY012287]; NATIONAL EYE INSTITUTE [R01EY012287] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078550] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM078550 and EY012287 (to B. M. W.).	Cabrera-Vera TM, 2003, ENDOCR REV, V24, P765, DOI 10.1210/er.2000-0026; Carter Michael D, 2004, J Biomol Tech, V15, P257; Cheever ML, 2008, NAT STRUCT MOL BIOL, V15, P155, DOI 10.1038/nsmb.1377; Chen CK, 2000, NATURE, V403, P557, DOI 10.1038/35000601; Dingus J, 2005, BIOCHEMISTRY-US, V44, P11882, DOI 10.1021/bi0504254; Downes GB, 1999, GENOMICS, V62, P544, DOI 10.1006/geno.1999.5992; Dupre DJ, 2007, J BIOL CHEM, V282, P13703, DOI 10.1074/jbc.M608846200; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; Fletcher JE, 1998, J BIOL CHEM, V273, P636, DOI 10.1074/jbc.273.1.636; Gaudet R, 1996, CELL, V87, P577, DOI 10.1016/S0092-8674(00)81376-8; Gautam N, 1998, CELL SIGNAL, V10, P447, DOI 10.1016/S0898-6568(98)00006-0; Grantham J, 2006, EXP CELL RES, V312, P2309, DOI 10.1016/j.yexcr.2006.03.028; He W, 2000, J BIOL CHEM, V275, P37093, DOI 10.1074/jbc.M006982200; Hu G, 2002, P NATL ACAD SCI USA, V99, P9755, DOI 10.1073/pnas.152094799; Humrich J, 2005, J BIOL CHEM, V280, P20042, DOI 10.1074/jbc.M409233200; Jones MB, 2004, MOL INTERV, V4, P200, DOI 10.1124/mi.4.4.4; Jones MB, 1999, ANAL BIOCHEM, V268, P126, DOI 10.1006/abio.1998.3064; KISSELEV O, 1993, J BIOL CHEM, V268, P24519; Knol JC, 2005, MOL CELL BIOL, V25, P8393, DOI 10.1128/MCB.25.18.8393-8400.2005; Kubota S, 2006, P NATL ACAD SCI USA, V103, P8360, DOI 10.1073/pnas.0600195103; Kunisawa J, 2003, MOL CELL, V12, P565, DOI 10.1016/j.molcel.2003.08.009; Li J, 2004, J MOL BIOL, V343, P1409, DOI 10.1016/j.jmb.2004.08.090; Lukov GL, 2006, J BIOL CHEM, V281, P22261, DOI 10.1074/jbc.M601590200; Lukov GL, 2005, EMBO J, V24, P1965, DOI 10.1038/sj.emboj.7600673; Marrari Y, 2007, BIOCHEMISTRY-US, V46, P7665, DOI 10.1021/bi700338m; Martemyanov KA, 2005, J BIOL CHEM, V280, P5133, DOI 10.1074/jbc.C400596200; Martin-Benito J, 2004, P NATL ACAD SCI USA, V101, P17410, DOI 10.1073/pnas.0405070101; McLaughlin JN, 2002, P NATL ACAD SCI USA, V99, P7962, DOI 10.1073/pnas.112075699; McLaughlin JN, 2002, J BIOL CHEM, V277, P34885, DOI 10.1074/jbc.M205583200; Myung CS, 2006, MOL PHARMACOL, V69, P877, DOI 10.1124/mol.105.018994; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Ray K, 1996, TRENDS CARDIOVAS MED, V6, P115, DOI 10.1016/1050-1738(96)00021-7; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Robishaw JD, 2004, CURR OPIN CELL BIOL, V16, P206, DOI 10.1016/j.ceb.2004.02.007; Ross EM, 2000, ANNU REV BIOCHEM, V69, P795, DOI 10.1146/annurev.biochem.69.1.795; Savage JR, 2000, J BIOL CHEM, V275, P30399, DOI 10.1074/jbc.M005120200; Thulin CD, 1999, MOL VIS, V5, pU13; Valpuesta JM, 2002, FEBS LETT, V529, P11, DOI 10.1016/S0014-5793(02)03180-0; WATSON AJ, 1994, J BIOL CHEM, V269, P22150; Wells CA, 2006, J BIOL CHEM, V281, P20221, DOI 10.1074/jbc.M602409200; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Willars GB, 2006, SEMIN CELL DEV BIOL, V17, P363, DOI 10.1016/j.semcdb.2006.03.005; Witherow DS, 2003, RECEPTOR CHANNEL, V9, P205, DOI 10.1080/10606820390203848	43	21	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16386	16399		10.1074/jbc.M900800200	http://dx.doi.org/10.1074/jbc.M900800200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19376773	Green Published, hybrid			2022-12-27	WOS:000266730900036
J	Kim, JR; Kee, HJ; Kim, JY; Joung, H; Nam, KI; Eom, GH; Choe, N; Kim, HS; Kim, JC; Kook, H; Seo, SB; Kook, H				Kim, Ju-Ryoung; Kee, Hae Jin; Kim, Ji-Young; Joung, Hosouk; Nam, Kwang-Il; Eom, Gwang Hyeon; Choe, Nakwon; Kim, Hyung-Suk; Kim, Jeong Chul; Kook, Hoon; Seo, Sang Beom; Kook, Hyun			Enhancer of Polycomb1 Acts on Serum Response Factor to Regulate Skeletal Muscle Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GENE-EXPRESSION; TRANSCRIPTION FACTOR; PROTEIN; TIP60; COMPLEX; CELLS; MYOD; ACTIVATION; CHROMATIN; PROMOTER	Skeletal muscle differentiation is well regulated by a series of transcription factors. We reported previously that enhancer of polycomb1 (Epc1), a chromatin protein, can modulate skeletal muscle differentiation, although the mechanisms of this action have yet to be defined. Here we report that Epc1 recruits both serum response factor (SRF) and p300 to induce skeletal muscle differentiation. Epc1 interacted physically with SRF. Transfection of Epc1 to myoblast cells potentiated the SRF-induced expression of skeletal muscle-specific genes as well as multinucleation. Proximal CArG box in the skeletal alpha-actin promoter was responsible for the synergistic activation of the promoter-luciferase. Epc1 knockdown caused a decrease in the acetylation of histones associated with serum response element (SRE) of the skeletal alpha-actin promoter. The Epc1.SRF complex bound to the SRE, and the knockdown of Epc1 resulted in a decrease in SRF binding to the skeletal alpha-actin promoter. Epc1 recruited histone acetyltransferase activity, which was potentiated by cotransfection with p300 but abolished by si-p300. Epc1 directly bound to p300 in myoblast cells. Epc1(+/-) mice showed distortion of skeletal alpha-actin, and the isolated myoblasts from the mice had impaired muscle differentiation. These results suggest that Epc1 is required for skeletal muscle differentiation by recruiting both SRF and p300 to the SRE of muscle-specific gene promoters.	[Kim, Ju-Ryoung; Kee, Hae Jin; Eom, Gwang Hyeon; Choe, Nakwon; Kook, Hyun] Chonnam Natl Univ, Dept Pharmacol, Sch Med, Kwangju 501746, South Korea; [Kim, Ju-Ryoung; Kee, Hae Jin; Joung, Hosouk; Eom, Gwang Hyeon; Choe, Nakwon; Kook, Hyun] Chonnam Natl Univ, Med Res Ctr Gene Regulat, Sch Med, Kwangju 501746, South Korea; [Nam, Kwang-Il] Chonnam Natl Univ, Dept Anat, Sch Med, Kwangju 501746, South Korea; [Kim, Hyung-Suk] Chonnam Natl Univ, Dept Forens Med, Sch Med, Kwangju 501746, South Korea; [Kee, Hae Jin; Joung, Hosouk; Nam, Kwang-Il; Kim, Hyung-Suk; Kook, Hoon; Kook, Hyun] Chonnam Natl Univ, Ctr Biomed Human Resources BK 21, Sch Med, Kwangju 501746, South Korea; [Kim, Jeong Chul] Chonnam Natl Univ Hosp, Dept Surg, Kwangju 501746, South Korea; [Kook, Hoon] Chonnam Natl Univ Hosp, Dept Pediat, Kwangju 501746, South Korea; [Kim, Ji-Young; Seo, Sang Beom] Chung Ang Univ, Coll Nat Sci, Dept Life Sci, Seoul 156745, South Korea	Chonnam National University; Chonnam National University; Chonnam National University; Chonnam National University; Chonnam National University; Chonnam National University; Chonnam National University Hospital; Chonnam National University; Chonnam National University Hospital; Chung Ang University	Kook, H (corresponding author), Chonnam Natl Univ, Dept Pharmacol, Sch Med, Kwangju 501746, South Korea.	kookhyun@chonnam.ac.kr	Kee, Hae Jin/ABC-9979-2021; Kook, Hyun/AAR-5405-2021; Nam, Kwang Il/C-4580-2019	Kook, Hyun/0000-0002-0740-1806; Nam, Kwang Il/0000-0001-5380-6815; Kee, Hae Jin/0000-0002-9774-4828	Korea Research Foundation [KRF-2007-313-E00126]; Ministry of Education, Science, and Technology [M10648000081-08N4800-08110]; Korean Government [KRF-2008-532-E00003]; Heart Research Center of Chonnam National University Hospital [A084869]	Korea Research Foundation(National Research Foundation of Korea); Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korean Government(Korean Government); Heart Research Center of Chonnam National University Hospital	This work was supported in part by Korea Research Foundation Grant KRF-2007-313-E00126.; Supported by Research Program for New Drug Target Discovery Grant M10648000081-08N4800-08110 from the Ministry of Education, Science, and Technology and by Korea Research Foundation Grant KRF-2008-532-E00003 funded by the Korean Government.; Supported by Grant A084869 from the Heart Research Center of Chonnam National University Hospital.	Arnold HH, 1998, CURR OPIN GENET DEV, V8, P539, DOI 10.1016/S0959-437X(98)80008-7; Attwooll C, 2005, J BIOL CHEM, V280, P1199, DOI 10.1074/jbc.M412509200; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Boudreault AA, 2003, GENE DEV, V17, P1415, DOI 10.1101/gad.1056603; Buckingham M, 2001, CURR OPIN GENET DEV, V11, P440, DOI 10.1016/S0959-437X(00)00215-X; Carnac G, 1998, MOL BIOL CELL, V9, P1891, DOI 10.1091/mbc.9.7.1891; Carson JA, 1998, AM J PHYSIOL-CELL PH, V275, pC1438, DOI 10.1152/ajpcell.1998.275.6.C1438; Chan HM, 2001, J CELL SCI, V114, P2363; Chang PS, 2001, J BIOL CHEM, V276, P17206, DOI 10.1074/jbc.M010983200; Croissant JD, 1996, DEV BIOL, V177, P250, DOI 10.1006/dbio.1996.0160; Doyon Y, 2004, MOL CELL BIOL, V24, P1884, DOI 10.1128/MCB.24.5.1884-1896.2004; Eckner R, 1996, GENE DEV, V10, P2478, DOI 10.1101/gad.10.19.2478; EDMONDSON DG, 1993, J BIOL CHEM, V268, P755; Fluck M, 2000, BIOCHEM BIOPH RES CO, V270, P488, DOI 10.1006/bbrc.2000.2457; Fu J, 2007, J BIOL CHEM, V282, P12410, DOI 10.1074/jbc.M608748200; Gupta M, 2007, CAN J PHYSIOL PHARM, V85, P349, DOI 10.1139/Y07-009; Ikura T, 2000, CELL, V102, P463, DOI 10.1016/S0092-8674(00)00051-9; Kee HJ, 2007, J BIOL CHEM, V282, P7700, DOI 10.1074/jbc.M611198200; Kim MS, 2006, J BIOL CHEM, V281, P15082, DOI 10.1074/jbc.M513593200; L'honore A, 2003, MOL BIOL CELL, V14, P2151, DOI 10.1091/mbc.e02-07-0451; Legube G, 2003, EMBO REP, V4, P944, DOI 10.1038/sj.embor.embor941; Li SJ, 2005, P NATL ACAD SCI USA, V102, P1082, DOI 10.1073/pnas.0409103102; Lim W, 2004, PHYSIOL GENOMICS, V18, P79, DOI 10.1152/physiolgenomics.00148.2003; Lough JW, 2002, DEV DYNAM, V223, P419, DOI 10.1002/dvdy.10058; Marsh DR, 1998, J MUSCLE RES CELL M, V19, P897, DOI 10.1023/A:1005485400448; McAllister D, 2002, GENE, V289, P169, DOI 10.1016/S0378-1119(02)00546-2; McKinsey TA, 2001, CURR OPIN GENET DEV, V11, P497, DOI 10.1016/S0959-437X(00)00224-0; Miano JM, 2003, J MOL CELL CARDIOL, V35, P577, DOI 10.1016/S0022-2828(03)00110-X; Miano JM, 2007, AM J PHYSIOL-CELL PH, V292, pC70, DOI 10.1152/ajpcell.00386.2006; Niu Z, 2005, J BIOL CHEM, V280, P32531, DOI 10.1074/jbc.M501372200; NORMAN C, 1988, CELL, V55, P989, DOI 10.1016/0092-8674(88)90244-9; Roth JF, 2003, EMBO J, V22, P5186, DOI 10.1093/emboj/cdg473; Sapountzi V, 2006, INT J BIOCHEM CELL B, V38, P1496, DOI 10.1016/j.biocel.2006.03.003; Sartorelli V, 1997, MOL CELL BIOL, V17, P1010, DOI 10.1128/MCB.17.2.1010; Seo SB, 2001, CELL, V104, P119, DOI 10.1016/S0092-8674(01)00196-9; Shimono Y, 2000, J BIOL CHEM, V275, P39411, DOI 10.1074/jbc.M006585200; Stankunas K, 1998, DEVELOPMENT, V125, P4055; Stewart AFR, 1998, CIRC RES, V83, P43, DOI 10.1161/01.RES.83.1.43; Wang DZ, 2001, CELL, V105, P851, DOI 10.1016/S0092-8674(01)00404-4; Wang SX, 2005, J BIOL CHEM, V280, P6204, DOI 10.1074/jbc.M409506200; Weinhold B, 2000, EMBO J, V19, P5835, DOI 10.1093/emboj/19.21.5835	42	28	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16308	16316		10.1074/jbc.M807725200	http://dx.doi.org/10.1074/jbc.M807725200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19359245	Green Published, hybrid			2022-12-27	WOS:000266730900028
J	Mushinski, JF; Nguyen, P; Stevens, LM; Khanna, C; Lee, S; Chung, EJ; Lee, MJ; Kim, YS; Linehan, WM; Horisberger, MA; Trepel, JB				Mushinski, J. Frederic; Nguyen, PhuongMai; Stevens, Lisa M.; Khanna, Chand; Lee, Sunmin; Chung, Eun Joo; Lee, Min-Jung; Kim, Yeong Sang; Linehan, W. Marston; Horisberger, Michel A.; Trepel, Jane B.			Inhibition of Tumor Cell Motility by the Interferon-inducible GTPase MxA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN PROSTATE-CANCER; GENE-EXPRESSION; ANTIVIRAL ACTIVITY; CARCINOMA-CELLS; DYNAMIN FAMILY; MESSENGER-RNA; PROTEIN MXA; METASTASIS; GROWTH; INVOLVEMENT	To identify pathways controlling prostate cancer metastasis we performed differential display analysis of the human prostate carcinoma cell line PC-3 and its highly metastatic derivative PC-3M. This revealed that a 78-kDa interferon-inducible GTPase, MxA, was expressed in PC-3 but not in PC-3M cells. The gene encoding MxA, MX1, is located in the region of chromosome 21 deleted as a consequence of fusion of TMPRSS2 and ERG, which has been associated with aggressive, invasive prostate cancer. Stable exogenous MxA expression inhibited in vitro motility and invasiveness of PC-3M cells. In vivo exogenous MxA expression decreased the number of hepatic metastases following intrasplenic injection. Exogenous MxA also reduced motility and invasiveness of highly metastatic LOX melanoma cells. A mutation in MxA that inactivated its GTPase reversed inhibition of motility and invasion in both tumor cell lines. Co-immunoprecipitation studies demonstrated that MxA associated with tubulin, but the GTPase-inactivating mutation blocked this association. Because MxA is a highly inducible gene, an MxA-targeted drug discovery screen was initiated by placing the MxA promoter upstream of a luciferase reporter. Examination of the NCI diversity set of small molecules revealed three hits that activated the promoter. In PC-3M cells, these drugs induced MxA protein and inhibited motility. These data demonstrate that MxA inhibits tumor cell motility and invasion, and that MxA expression can be induced by small molecules, potentially offering a new approach to the prevention and treatment of metastasis.	[Nguyen, PhuongMai; Lee, Sunmin; Chung, Eun Joo; Lee, Min-Jung; Kim, Yeong Sang; Trepel, Jane B.] NCI, NIH, Med Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA; NCI, NIH, Lab Canc Biol & Genet, Ctr Canc Res, Bethesda, MD 20892 USA; [Khanna, Chand] NCI, NIH, Pediat Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Linehan, W. Marston] NCI, NIH, Urol Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA; [Horisberger, Michel A.] Aivogen AG, CH-4052 Basel, Switzerland	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Trepel, JB (corresponding author), NCI, NIH, Med Oncol Branch, Ctr Canc Res, Bldg 10,Rm 12N230,10 Ctr Dr, Bethesda, MD 20892 USA.	trepel@helix.nih.gov			National Institutes of Health NCI Intramural Program; NATIONAL CANCER INSTITUTE [Z01BC011028, ZIABC011024, ZIABC011028, ZICSC006743, Z01SC006743, ZIABC010566, Z01BC011024, Z01BC010566] Funding Source: NIH RePORTER	National Institutes of Health NCI Intramural Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by the National Institutes of Health NCI Intramural Program.	Abal M, 2002, J CELL BIOL, V159, P731, DOI 10.1083/jcb.200207076; Accola MA, 2002, J BIOL CHEM, V277, P21829, DOI 10.1074/jbc.M201641200; AlMasri AN, 1997, J CLIN PATHOL-MOL PA, V50, P9, DOI 10.1136/mp.50.1.9; Amara N, 2001, CANCER RES, V61, P4660; Argani P, 2001, CANCER RES, V61, P4320; Attard G, 2008, ONCOGENE, V27, P253, DOI 10.1038/sj.onc.1210640; Ballestrem C, 2000, MOL BIOL CELL, V11, P2999, DOI 10.1091/mbc.11.9.2999; BANG YJ, 1994, P NATL ACAD SCI USA, V91, P5330, DOI 10.1073/pnas.91.12.5330; BROUTYBOYE D, 1980, SCIENCE, V208, P516, DOI 10.1126/science.6154315; Cascinelli N, 2001, LANCET, V358, P866, DOI 10.1016/S0140-6736(01)06068-8; Chinnaiyan AM, 2008, NEOPLASIA, V10, P177, DOI 10.1593/neo.07822; Choi YH, 1997, J BIOL CHEM, V272, P28479, DOI 10.1074/jbc.272.45.28479; Danino D, 2001, CURR OPIN CELL BIOL, V13, P454, DOI 10.1016/S0955-0674(00)00236-2; Dolle L, 2006, CURR CANCER DRUG TAR, V6, P729, DOI 10.2174/156800906779010263; Dong ZY, 1999, CANCER RES, V59, P872; FODSTAD O, 1988, INT J CANCER, V41, P442, DOI 10.1002/ijc.2910410322; FORT P, 1985, NUCLEIC ACIDS RES, V13, P1431, DOI 10.1093/nar/13.5.1431; GOETSCHY JF, 1989, J VIROL, V63, P2616, DOI 10.1128/JVI.63.6.2616-2622.1989; Haller O, 2002, TRAFFIC, V3, P710, DOI 10.1034/j.1600-0854.2002.31003.x; Haller O, 2007, MICROBES INFECT, V9, P1636, DOI 10.1016/j.micinf.2007.09.010; Han HJ, 2008, NATURE, V452, P187, DOI 10.1038/nature06781; HARTWIG JH, 1992, J CELL BIOL, V118, P1421, DOI 10.1083/jcb.118.6.1421; HORISBERGER MA, 1992, J VIROL, V66, P4705, DOI 10.1128/JVI.66.8.4705-4709.1992; HORISBERGER MA, 1990, J VIROL, V64, P1171, DOI 10.1128/JVI.64.3.1171-1181.1990; HORISBERGER MA, 1995, AM J RESP CRIT CARE, V152, pS67, DOI 10.1164/ajrccm/152.4_Pt_2.S67; HORISBERGER MA, 1987, J INTERFERON RES, V7, P331, DOI 10.1089/jir.1987.7.331; Jatiani SS, 2004, BIOCHEM BIOPH RES CO, V323, P541, DOI 10.1016/j.bbrc.2004.08.134; Jonasch E, 2001, ONCOLOGIST, V6, P34, DOI 10.1634/theoncologist.6-1-34; Kauffman EC, 2003, J UROLOGY, V169, P1122, DOI 10.1097/01.ju.0000051580.89109.4b; Kawamoto S, 2004, EXP HEMATOL, V32, P797, DOI 10.1016/j.exphem.2004.06.008; Khanna C, 2000, CLIN EXP METASTAS, V18, P261, DOI 10.1023/A:1006767007547; Kochs G, 2002, J BIOL CHEM, V277, P14172, DOI 10.1074/jbc.M200244200; Kotenko SV, 2003, NAT IMMUNOL, V4, P69, DOI 10.1038/ni875; KOZLOWSKI JM, 1984, CANCER RES, V44, P3522; Kuratsukuri K, 2000, UROL ONCOL, V5, P265, DOI 10.1016/S1078-1439(00)00086-7; LAFONT F, 1994, NATURE, V372, P801; Lee SJ, 1998, J BIOL CHEM, V273, P10618, DOI 10.1074/jbc.273.17.10618; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; Magdalena J, 2003, J CELL SCI, V116, P743, DOI 10.1242/jcs.00288; Nagano K, 2004, ONCOGENE, V23, P1693, DOI 10.1038/sj.onc.1207297; Nanus D M, 2000, Curr Oncol Rep, V2, P417, DOI 10.1007/s11912-000-0061-5; Oh WK, 1999, J CLIN ONCOL, V17, P3664, DOI 10.1200/JCO.1999.17.11.3664; Pastore RD, 2001, CANCER INVEST, V19, P281, DOI 10.1081/CNV-100102556; Ponten A, 1997, J VIROL, V71, P2591, DOI 10.1128/JVI.71.4.2591-2599.1997; Ratner S, 1997, J IMMUNOL, V159, P1063; Reiter RE, 1998, P NATL ACAD SCI USA, V95, P1735, DOI 10.1073/pnas.95.4.1735; ROERS A, 1994, J INFECT DIS, V169, P807, DOI 10.1093/infdis/169.4.807; Ronni T, 1998, J INTERF CYTOK RES, V18, P773, DOI 10.1089/jir.1998.18.773; Saffran DC, 2001, P NATL ACAD SCI USA, V98, P2658, DOI 10.1073/pnas.051624698; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Scherf U, 2000, NAT GENET, V24, P236, DOI 10.1038/73439; Schulz WA, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-14; Shou JY, 2002, P NATL ACAD SCI USA, V99, P2830, DOI 10.1073/pnas.052705299; Singh D, 2002, CANCER CELL, V1, P203, DOI 10.1016/S1535-6108(02)00030-2; Tazi-Ahnini R, 2000, HUM GENET, V106, P639, DOI 10.1007/s004390050037; Waterman-Storer CM, 1999, NAT CELL BIOL, V1, P45, DOI 10.1038/9018; Wittmann T, 2001, J CELL SCI, V114, P3795; YAMADA T, 1994, NEUROSCI LETT, V181, P61, DOI 10.1016/0304-3940(94)90560-6; Yang RM, 1998, J UROLOGY, V159, P941, DOI 10.1016/S0022-5347(01)63776-5	59	38	40	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					15206	15214		10.1074/jbc.M806324200	http://dx.doi.org/10.1074/jbc.M806324200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19297326	Green Published, hybrid			2022-12-27	WOS:000266288200055
J	Hui, XY; Zhu, WD; Wang, Y; Lam, KSL; Zhang, JL; Wu, DH; Kraegen, EW; Li, YX; Xu, AM				Hui, Xiaoyan; Zhu, Weidong; Wang, Yu; Lam, Karen S. L.; Zhang, Jialiang; Wu, Donghai; Kraegen, Edward W.; Li, Yixue; Xu, Aimin			Major Urinary Protein-1 Increases Energy Expenditure and Improves Glucose Intolerance through Enhancing Mitochondrial Function in Skeletal Muscle of Diabetic Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONSERVED LYSINE RESIDUES; INSULIN-RESISTANCE; COLLAGENOUS DOMAIN; METABOLIC SYNDROME; GENE-EXPRESSION; POTENTIAL ROLE; FEMALE MICE; LIVER; ADIPONECTIN; DYSFUNCTION	Major urinary protein-1 (MUP-1) is a low molecular weight secreted protein produced predominantly from the liver. Structurally it belongs to the lipocalin family, which carries small hydrophobic ligands such as pheromones. However, the physiological functions of MUP-1 remain poorly understood. Here we provide evidence demonstrating that MUP-1 is an important player in regulating energy expenditure and metabolism in mice. Both microarray and real-time PCR analysis demonstrated that the MUP-1 mRNA abundance in the liver of db/db obese mice was reduced by similar to 30-fold compared with their lean littermates, whereas this change was partially reversed by treatment with the insulin-sensitizing drug rosiglitazone. In both dietary and genetic obese mice, the circulating concentrations of MUP-1 were markedly decreased compared with the lean controls. Chronic elevation of circulating MUP-1 in db/db mice, using an osmotic pump-based protein delivery system, increased energy expenditure and locomotor activity, raised core body temperature, and decreased glucose intolerance as well as insulin resistance. At the molecular level, MUP-1-mediated improvement in metabolic profiles was accompanied by increased expression of genes involved in mitochondrial biogenesis, elevated mitochondrial oxidative capacity, decreased triglyceride accumulation, and enhanced insulin-evoked Akt signaling in skeletal muscle but not in liver. Altogether, these findings raise the possibility that MUP-1 deficiency might contribute to the metabolic dysregulation in obese/diabetic mice, and suggest that the beneficial metabolic effects of MUP-1 are attributed in part to its ability in increasing mitochondrial function in skeletal muscle.	[Zhu, Weidong; Lam, Karen S. L.; Zhang, Jialiang; Xu, Aimin] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Zhu, Weidong; Wang, Yu; Lam, Karen S. L.; Zhang, Jialiang; Xu, Aimin] Univ Hong Kong, Res Ctr Heart Brain Hormone & Healthy Aging, Hong Kong, Hong Kong, Peoples R China; [Wang, Yu; Xu, Aimin] Univ Hong Kong, Dept Pharmacol & Pharm, Hong Kong, Hong Kong, Peoples R China; [Hui, Xiaoyan; Li, Yixue] Chinese Acad Sci, Grad Sch, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai 200031, Peoples R China; [Wu, Donghai] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangzhou 510663, Guangdong, Peoples R China; [Kraegen, Edward W.] Univ New S Wales, Garvan Inst Med Res, Sydney, NSW 2010, Australia; [Kraegen, Edward W.] Univ New S Wales, Sch Med Sci, Sydney, NSW 2010, Australia	University of Hong Kong; University of Hong Kong; University of Hong Kong; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Garvan Institute of Medical Research; University of New South Wales Sydney; University of New South Wales Sydney	Xu, AM (corresponding author), Univ Hong Kong, Dept Med, L8-40,New Lab Block,21 Sassoon Rd, Hong Kong, Hong Kong, Peoples R China.	amxu@hkucc.hku.hk	HUI, Xiaoyan Hannah/M-5175-2019; Xu, Aimin/D-3291-2013	HUI, Xiaoyan Hannah/0000-0002-7525-5812; Xu, Aimin/0000-0002-0668-033X; wang, yu/0000-0001-8697-2940	Hong Kong Research Council General Research scheme [HKU778007M]; University of Hong Kong; Major State Basic Research Development Program [2006CB910700]	Hong Kong Research Council General Research scheme; University of Hong Kong(University of Hong Kong); Major State Basic Research Development Program(National Basic Research Program of China)	This work was funded by Grant HKU778007M from the Hong Kong Research Council General Research scheme (to Y.W.), a seeding fund for basic research and an Outstanding Young Researcher Award from the University of Hong Kong (to A.X.), and Major State Basic Research Development Program Grant 2006CB910700 (to Y.L.).	Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bhattacharjee A, 1998, TOXICOL APPL PHARM, V150, P186, DOI 10.1006/taap.1998.8392; Bradbury MW, 2006, AM J PHYSIOL-GASTR L, V290, pG194, DOI 10.1152/ajpgi.00413.2005; Brennan PA, 1999, NEUROSCIENCE, V90, P1463, DOI 10.1016/S0306-4522(98)00556-9; Chamero P, 2007, NATURE, V450, P899, DOI 10.1038/nature05997; Chen C, 2003, NAT BIOTECHNOL, V21, P294, DOI 10.1038/nbt795; Flower DR, 2000, BBA-PROTEIN STRUCT M, V1482, P9, DOI 10.1016/S0167-4838(00)00148-5; Fritsche L, 2008, CURR MED CHEM, V15, P1316, DOI 10.2174/092986708784534956; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Gervois P, 2004, J BIOL CHEM, V279, P16154, DOI 10.1074/jbc.M400346200; Holland WL, 2007, NUTR REV, V65, pS39, DOI 10.1301/nr.2007.jun.S39-S46; Hoo Ruby Lc, 2008, Expert Rev Endocrinol Metab, V3, P29, DOI 10.1586/17446651.3.1.29; Itani SI, 2002, DIABETES, V51, P2005, DOI 10.2337/diabetes.51.7.2005; Kharitonenkov A, 2005, J CLIN INVEST, V115, P1627, DOI 10.1172/JCI23606; Kim JA, 2008, CIRC RES, V102, P401, DOI 10.1161/CIRCRESAHA.107.165472; Kraegen EW, 2008, P NATL ACAD SCI USA, V105, P7627, DOI 10.1073/pnas.0803901105; Kumar KG, 2008, CELL METAB, V8, P468, DOI 10.1016/j.cmet.2008.10.011; Lara-Castro C, 2008, ENDOCRIN METAB CLIN, V37, P841, DOI 10.1016/j.ecl.2008.09.002; Lautt WW, 1999, CAN J PHYSIOL PHARM, V77, P553, DOI 10.1139/cjpp-77-8-553; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; MARCHLEWSKAKOJ A, 1981, J REPROD FERTIL, V61, P221, DOI 10.1530/jrf.0.0610221; MCINTOSH I, 1989, MOL CELL BIOL, V9, P2202, DOI 10.1128/MCB.9.5.2202; MUCIGNATCARETTA C, 1995, J PHYSIOL-LONDON, V486, P517, DOI 10.1113/jphysiol.1995.sp020830; Nisoli E, 2007, CIRC RES, V100, P795, DOI 10.1161/01.RES.0000259591.97107.6c; Oike Y, 2005, NAT MED, V11, P400, DOI 10.1038/nm1214; Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Polonsky KS, 2006, NEW ENGL J MED, V354, P2596, DOI 10.1056/NEJMe068091; Reitman ML, 2007, CELL METAB, V5, P405, DOI 10.1016/j.cmet.2007.05.010; Sreekumar R, 2002, DIABETES, V51, P1913, DOI 10.2337/diabetes.51.6.1913; Wang W, 2007, ASAIO J, V53, P41, DOI 10.1097/01.mat.0000247960.90841.80; Wang Y, 2002, J BIOL CHEM, V277, P19521, DOI 10.1074/jbc.M200601200; Wang Y, 2007, MOL ENDOCRINOL, V21, P972, DOI 10.1210/me.2006-0249; Wang Y, 2006, J BIOL CHEM, V281, P16391, DOI 10.1074/jbc.M513907200; Xie HS, 1996, AM J PHYSIOL-ENDOC M, V270, pE858, DOI 10.1152/ajpendo.1996.270.5.E858; Xu A, 2007, CIRCULATION, V115, P1537, DOI 10.1161/CIRCULATIONAHA.106.647503; Xu AM, 2009, ENDOCRINOLOGY, V150, P625, DOI 10.1210/en.2008-0999; Xu AM, 2005, P NATL ACAD SCI USA, V102, P6086, DOI 10.1073/pnas.0408452102; Yang Q, 2005, NATURE, V436, P356, DOI 10.1038/nature03711; Zhang X, 2008, DIABETES, V57, P1246, DOI 10.2337/db07-1476; Zhou MY, 2008, HEPATOLOGY, V48, P1087, DOI 10.1002/hep.22444	42	91	94	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14050	14057		10.1074/jbc.M109.001107	http://dx.doi.org/10.1074/jbc.M109.001107			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19336396	Green Published, hybrid			2022-12-27	WOS:000266286100011
J	Xu, J; Liao, L; Qin, J; Xu, JM; Liu, D; Songyang, Z				Xu, Jun; Liao, Lan; Qin, Jun; Xu, Jianming; Liu, Dan; Songyang, Zhou			Identification of Flightless-I as a Substrate of the Cytokine-independent Survival Kinase CISK	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; FORKHEAD TRANSCRIPTION FACTOR; UBIQUITIN LIGASE NEDD4-2; SERINE-THREONINE KINASE; PROTEIN-KINASE; ESTROGEN-RECEPTOR; TARGETED DISRUPTION; HAIR FOLLICLE; MAMMARY-GLAND; BREAST-CANCER	Phosphatidylinositol (PI) 3-kinase mediates multiple pathways that regulate many aspects of the cell including metabolism, survival, migration, and proliferation. Both Akt and cytokine-independent survival kinase (CISK)/SGK3 are known AGC family protein kinases that function downstream of PI 3-kinase. Although the Akt signaling pathway has been studied extensively, the specific signaling cascades that are modulated by CISK remain to be elucidated. To understand CISK function, we affinity-purified the CISK protein complex and identified Flightless-I (FLII) as a novel downstream target of CISK. Here we show that FLII is an in vivo substrate of CISK that functions downstream of PI 3-kinase. CISK can associate with FLII and phosphorylate FLII at residues Ser(436) and Thr(818). FLII has been shown to act as a co-activator for nuclear hormone receptors such as estrogen receptor (ER). We demonstrate here that CISK can enhance ER transcription, which is dependent on its kinase activity, and mutation of CISK phosphorylation sites on FLII attenuates its activity as an ER co-activator. Furthermore, FLII knockdown by RNA interference renders 32D cells more sensitive to interleukin-3 withdrawal-induced apoptosis, suggesting that FLII itself is also a survival factor. These findings support the model that CISK phosphorylates FLII and activates nuclear receptor transcription and suggest a new cell survival signaling pathway mediated by PI 3-kinase and CISK.	[Xu, Jun; Qin, Jun; Liu, Dan; Songyang, Zhou] Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Liao, Lan; Qin, Jun; Xu, Jianming] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine	Songyang, Z (corresponding author), Baylor Coll Med, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA.	songyang@bcm.tmc.edu			National Institutes of Health [CA84208, GM069572, CA119689]; Welch Foundation; NATIONAL CANCER INSTITUTE [R01CA084208, R01CA119689] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069572] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA84208 and GM069572 (to Z.S.) and CA119689 (to J.M.X.). This work was also supported by funds from the Welch Foundation (to Z.S.).	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Alonso L, 2005, J CELL BIOL, V170, P559, DOI 10.1083/jcb.200504131; Archer SK, 2004, BIOCHEM SOC T, V32, P940, DOI 10.1042/BST0320940; Baltaev R, 2005, PFLUG ARCH EUR J PHY, V450, P26, DOI 10.1007/s00424-004-1369-z; BELLACOSA A, 1991, SCIENCE, V254, P274, DOI 10.1126/science.1833819; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; CAMPBELL HD, 1993, P NATL ACAD SCI USA, V90, P11386, DOI 10.1073/pnas.90.23.11386; Campbell HD, 2002, MOL CELL BIOL, V22, P3518, DOI 10.1128/MCB.22.10.3518-3526.2002; Campbell HD, 1997, GENOMICS, V42, P46, DOI 10.1006/geno.1997.4709; Campbell RA, 2001, J BIOL CHEM, V276, P9817, DOI 10.1074/jbc.M010840200; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Carracedo A, 2008, ONCOGENE, V27, P5527, DOI 10.1038/onc.2008.247; Castagnetta L, 2004, ANN NY ACAD SCI, V1028, P233, DOI 10.1196/annals.1321.028; Chang HW, 1997, SCIENCE, V276, P1848, DOI 10.1126/science.276.5320.1848; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Davy DA, 2001, J CELL SCI, V114, P549; DEL PL, 1997, SCIENCE, V278, P687; Deng CX, 2000, ONCOGENE, V19, P1059, DOI 10.1038/sj.onc.1203269; Dieter M, 2004, OBES RES, V12, P862, DOI 10.1038/oby.2004.104; ECKHART W, 1979, CELL, V18, P925, DOI 10.1016/0092-8674(79)90205-8; Embark HM, 2004, KIDNEY INT, V66, P1918, DOI 10.1111/j.1523-1755.2004.00966.x; Evan GI, 2001, NATURE, V411, P342, DOI 10.1038/35077213; Franke TF, 2003, ONCOGENE, V22, P8983, DOI 10.1038/sj.onc.1207115; Grahammer F, 2006, AM J PHYSIOL-REG I, V290, pR945, DOI 10.1152/ajpregu.00484.2005; Green DR, 2003, IMMUNOL REV, V193, P5, DOI 10.1034/j.1600-065X.2003.00045.x; Herynk MH, 2007, ADV EXP MED BIOL, V608, P130; Kane LP, 1999, CURR BIOL, V9, P601, DOI 10.1016/S0960-9822(99)80265-6; Kobayashi T, 1999, BIOCHEM J, V344, P189, DOI 10.1042/0264-6021:3440189; Komada M, 2005, J BIOCHEM, V137, P1, DOI 10.1093/jb/mvi001; Kucharova Silvia, 2002, Endocr Regul, V36, P37; Lang UE, 2006, BEHAV BRAIN RES, V167, P75, DOI 10.1016/j.bbr.2005.08.017; Lawlor MA, 2001, J CELL SCI, V114, P2903; Lee YH, 2006, NUCLEIC ACIDS RES, V34, P5052, DOI 10.1093/nar/gkl652; Li JY, 2008, J CELL BIOL, V181, P321, DOI 10.1083/jcb.200711082; Li QT, 2007, MOL CELL BIOL, V27, P8073, DOI 10.1128/MCB.00451-07; Liang J, 2008, NAT CELL BIOL, V10, P731, DOI 10.1038/ncb1736; Liu D, 2000, CURR BIOL, V10, P1233, DOI 10.1016/S0960-9822(00)00733-8; Lonard DM, 2007, MOL CELL, V27, P691, DOI 10.1016/j.molcel.2007.08.012; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; McCormick JA, 2004, MOL BIOL CELL, V15, P4278, DOI 10.1091/mbc.E04-01-0027; McDonnell DP, 2002, SCIENCE, V296, P1642, DOI 10.1126/science.1071884; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Musgrove EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002987; Mussi P, 2006, P NATL ACAD SCI USA, V103, P16716, DOI 10.1073/pnas.0607768103; Nagata S, 1997, CELL, V88, P355, DOI 10.1016/S0092-8674(00)81874-7; Ozes ON, 1999, NATURE, V401, P82; Peri A, 2005, J ENDOCRINOL INVEST, V28, P285, DOI 10.1007/BF03345387; Romashkova JA, 1999, NATURE, V401, P86, DOI 10.1038/43474; Sandu C, 2005, PFLUG ARCH EUR J PHY, V451, P437, DOI 10.1007/s00424-005-1474-7; Slagsvold T, 2006, EMBO J, V25, P3738, DOI 10.1038/sj.emboj.7601267; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Stoica GE, 2003, MOL ENDOCRINOL, V17, P818, DOI 10.1210/me.2002-0330; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Syed F, 2005, BIOCHEM BIOPH RES CO, V328, P688, DOI 10.1016/j.bbrc.2004.11.097; Tessier M, 2006, J CELL BIOCHEM, V98, P1391, DOI 10.1002/jcb.20894; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; THREADGILL DW, 1995, SCIENCE, V269, P230, DOI 10.1126/science.7618084; Toker A, 2006, CANCER RES, V66, P3963, DOI 10.1158/0008-5472.CAN-06-0743; WANG TTY, 1995, CANCER RES, V55, P2487; Wyllie AH, 1997, EUR J CELL BIOL, V73, P189; Xing JZ, 2005, CHEM RES TOXICOL, V18, P154, DOI 10.1021/tx049721s; Xing Y, 2004, J BIOL CHEM, V279, P30662, DOI 10.1074/jbc.M404107200; Xu J, 2002, J BIOL CHEM, V277, P35561, DOI 10.1074/jbc.M203805200; Xu JS, 2001, J CELL BIOL, V154, P1069, DOI 10.1083/jcb.200103111	66	18	25	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14377	14385		10.1074/jbc.M807770200	http://dx.doi.org/10.1074/jbc.M807770200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19293151	Green Published, hybrid			2022-12-27	WOS:000266286100044
J	Senthivinayagam, S; Mishra, P; Paramasivam, SK; Yallapragada, S; Chatterjee, M; Wong, L; Rana, A; Rana, B				Senthivinayagam, Subramanian; Mishra, Prajna; Paramasivam, Suresh Kanna; Yallapragada, Srinivas; Chatterjee, Malay; Wong, Lucas; Rana, Ajay; Rana, Basabi			Caspase-mediated Cleavage of beta-Catenin Precedes Drug-induced Apoptosis in Resistant Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRAIL-INDUCED APOPTOSIS; RECEPTOR-GAMMA ACTIVATION; SENSITIZES TUMOR-CELLS; HUMAN COLON-CANCER; COLORECTAL-CANCER; IN-VITRO; HEPATOCELLULAR CARCINOMAS; DEATH RECEPTORS; GENE-EXPRESSION; TARGETING DEATH	A delicate balance between cell death and survival pathways maintains normal physiology, which is altered in many cancers, shifting the balance toward increased survival. Several studies have established a close connection between the Wnt/beta-catenin pathway and tumorigenesis, aberrant activation of which might contribute toward increased cancer cell growth and survival. Extensive research is underway to identify therapeutic agents that can induce apoptosis specifically in cancer cells with minimal collateral damage to normal cells. Although tumor necrosis factor-related apoptosis-inducing ligand( TRAIL) can induce apoptosis specifically in tumor cells, many cancer cells develop resistance, which can be overcome by combinatorial treatment with other agents: for example, peroxisome proliferator-activated receptor gamma (PPAR gamma) ligands. To identify the molecular target mediating combinatorial drug-induced apoptosis, we focused on beta-catenin, a protein implicated in oncogenesis. Our results show that co-treatment of TRAIL-resistant cancer cells with TRAIL and the PPAR gamma ligand troglitazone leads to a reduction of beta-catenin expression, coinciding with maximal apoptosis. Modulation of beta-catenin levels via ectopic overexpression or small interference RNA-mediated gene silencing modulates drug-induced apoptosis, indicating involvement of beta-catenin in regulating this pathway. More in-depth studies indicated a post-translational mechanism, independent of glycogen synthase kinase-3 beta activity regulating beta-catenin expression following combinatorial drug treatment. Furthermore, TRAIL- and troglitazone-induced apoptosis was preceded by a cleavage of beta-catenin, which was complete in a fully apoptotic population, and was mediated by caspases-3 and -8. These results demonstrate beta-catenin as a promising new target of drug-induced apoptosis, which can be targeted to sensitize apoptosis-resistant cancer cells.	[Senthivinayagam, Subramanian; Mishra, Prajna; Paramasivam, Suresh Kanna; Rana, Basabi] Loyola Univ, Dept Med, Div Gastroenterol Hepatol & Nutr, Maywood, IL 60153 USA; [Rana, Ajay; Rana, Basabi] Loyola Univ, Dept Pharmacol & Expt Therapeut, Maywood, IL 60153 USA; [Yallapragada, Srinivas] Texas A&M Univ, Hlth Sci Ctr, Dept Internal Med, Coll Med, Temple, TX 76504 USA; [Rana, Ajay; Rana, Basabi] Hines Vet Affairs Med Ctr, Hines, IL 60141 USA; [Chatterjee, Malay] Jadavpur Univ, Dept Pharmaceut Technol, Div Biochem, Kolkata 700032, India; [Wong, Lucas] Scott & White Hosp, Div Hematol Oncol, Temple, TX 76504 USA	Loyola University Chicago; Loyola University Chicago; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; Jadavpur University	Rana, B (corresponding author), Loyola Univ Chicago, Bldg 101,Rm 2729,2160 S 1st Ave, Maywood, IL 60153 USA.	brana@lumc.edu	Senthivinayagam, Subramanian/E-3141-2012; Rana, Ajay/ABE-3739-2020	Senthivinayagam, Subramanian/0000-0001-8796-3640; Rana, Ajay/0000-0003-0951-2566; Mishra, Prajna/0000-0002-1906-0244	National Institutes of Health [CA121221, GM55835]; Veterans Affairs Merit and VISN 17; Susan Komen Breast Cancer Foundation; Veterans Affairs Merit award; NATIONAL CANCER INSTITUTE [R21CA121221] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055835] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit and VISN 17(US Department of Veterans Affairs); Susan Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); Veterans Affairs Merit award(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA121221 (to B. R.) and GM55835 (to A. R.). This work was also supported by Veterans Affairs Merit and VISN 17 awards (to B. R.), the Susan Komen Breast Cancer Foundation, and a Veterans Affairs Merit award (to A. R.).	Abe K, 2007, NEURON, V53, P387, DOI 10.1016/j.neuron.2007.01.016; Ashkenazi A, 1999, J CLIN INVEST, V104, P155, DOI 10.1172/JCI6926; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Ashkenazi A, 2002, NAT REV CANCER, V2, P420, DOI 10.1038/nrc821; Barthwal MK, 2003, J BIOL CHEM, V278, P3897, DOI 10.1074/jbc.M211598200; Bienz M, 2000, CELL, V103, P311, DOI 10.1016/S0092-8674(00)00122-7; Bonavida B, 1999, INT J ONCOL, V15, P793; Chinnaiyan AM, 2000, P NATL ACAD SCI USA, V97, P1754, DOI 10.1073/pnas.030545097; de La Coste A, 1998, P NATL ACAD SCI USA, V95, P8847; Dihlmann S, 2005, CARCINOGENESIS, V26, P1503, DOI 10.1093/carcin/bgi120; Emery JG, 1998, J BIOL CHEM, V273, P14363, DOI 10.1074/jbc.273.23.14363; Fesik SW, 2005, NAT REV CANCER, V5, P876, DOI 10.1038/nrc1736; Fukuda K, 1999, INT J BIOCHEM CELL B, V31, P519, DOI 10.1016/S1357-2725(98)00119-8; Fulda S, 2004, CANCER RES, V64, P337, DOI 10.1158/0008-5472.CAN-03-1656; Gao JJ, 2005, P NATL ACAD SCI USA, V102, P17207, DOI 10.1073/pnas.0506893102; Goke R, 2000, CELL IMMUNOL, V201, P77, DOI 10.1006/cimm.2000.1650; He Q, 2002, ONCOGENE, V21, P6032, DOI 10.1038/sj.onc.1205897; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Hyer ML, 2005, CANCER RES, V65, P4799, DOI 10.1158/0008-5472.CAN-04-3319; Keane MM, 1999, CANCER RES, V59, P734; Kelley SK, 2004, CURR OPIN PHARMACOL, V4, P333, DOI 10.1016/j.coph.2004.02.006; Kim Y, 2002, J BIOL CHEM, V277, P22320, DOI 10.1074/jbc.M202458200; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kliewer SA, 1997, P NATL ACAD SCI USA, V94, P4318, DOI 10.1073/pnas.94.9.4318; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; LeBlanc H, 2002, NAT MED, V8, P274, DOI 10.1038/nm0302-274; Ling YH, 2001, MOL PHARMACOL, V59, P593, DOI 10.1124/mol.59.3.593; Lu ML, 2005, J BIOL CHEM, V280, P6742, DOI 10.1074/jbc.M411519200; Matsuzawa S, 2001, MOL CELL, V7, P915, DOI 10.1016/S1097-2765(01)00242-8; Miyoshi Y, 1998, CANCER RES, V58, P2524; Nayak TK, 2007, NUCL MED BIOL, V34, P185, DOI 10.1016/j.nucmedbio.2006.11.006; Rubinfeld B, 1996, SCIENCE, V272, P1023, DOI 10.1126/science.272.5264.1023; Sarraf P, 1998, NAT MED, V4, P1046, DOI 10.1038/2030; Schultze K, 2006, APOPTOSIS, V11, P1503, DOI 10.1007/s10495-006-8896-3; Sharma C, 2004, J BIOL CHEM, V279, P35583, DOI 10.1074/jbc.M403143200; Sharma C, 2004, J BIOL CHEM, V279, P16927, DOI 10.1074/jbc.M309045200; Sprick MR, 2000, IMMUNITY, V12, P599, DOI 10.1016/S1074-7613(00)80211-3; Steinhusen U, 2000, J BIOL CHEM, V275, P16345, DOI 10.1074/jbc.M001458200; SUREAU C, 1992, J VIROL, V66, P1241, DOI 10.1128/JVI.66.2.1241-1245.1992; Tan XP, 2008, HEPATOLOGY, V47, P1667, DOI 10.1002/hep.22225; Teitz T, 2000, NAT MED, V6, P529, DOI 10.1038/75007; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Van Nhieu JT, 1999, AM J PATHOL, V155, P703, DOI 10.1016/S0002-9440(10)65168-1; Verma UN, 2003, CLIN CANCER RES, V9, P1291; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wang HY, 2005, CANCER RES, V65, P8604, DOI 10.1158/0008-5472.CAN-05-1169; Wang L, 2001, P NATL ACAD SCI USA, V98, P13884, DOI 10.1073/pnas.241358198; Xiao JH, 2003, J BIOL CHEM, V278, P29954, DOI 10.1074/jbc.M304761200; Xie HM, 2005, J IMMUNOL, V175, P7981, DOI 10.4049/jimmunol.175.12.7981; Yamanaka T, 2000, HEPATOLOGY, V32, P482, DOI 10.1053/jhep.2000.16266; Yu J, 2006, HEPATOLOGY, V43, P134, DOI 10.1002/hep.20994; Zeng G, 2007, NEOPLASIA, V9, P951, DOI 10.1593/neo.07469; Zou W, 2007, CANCER BIOL THER, V6, P99, DOI 10.4161/cbt.6.1.3555	53	25	27	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13577	13588		10.1074/jbc.M900248200	http://dx.doi.org/10.1074/jbc.M900248200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19289465	hybrid, Green Published			2022-12-27	WOS:000265877300035
J	Kamata, Y; Taniguchi, A; Yamamoto, M; Nomura, J; Ishihara, K; Takahara, H; Hibino, T; Takeda, A				Kamata, Yayoi; Taniguchi, Aya; Yamamoto, Mami; Nomura, Junko; Ishihara, Kazuhiko; Takahara, Hidenari; Hibino, Toshihiko; Takeda, Atsushi			Neutral Cysteine Protease Bleomycin Hydrolase Is Essential for the Breakdown of Deiminated Filaggrin into Amino Acids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PEPTIDYLARGININE DEIMINASE; IMMUNOHISTOCHEMICAL LOCALIZATION; TERMINAL DIFFERENTIATION; PROTEOLYTIC CLEAVAGE; HUMAN PROFILAGGRIN; STRATUM-CORNEUM; MULTIPLE ROLES; ENVELOPE; SKIN; CALCIUM	Filaggrin is a component of the cornified cell envelope and the precursor of free amino acids acting as a natural moisturizing factor in the stratum corneum. Deimination is critical for the degradation of filaggrin into free amino acids. In this study, we tried to identify the enzyme(s) responsible for the cleavage of deiminated filaggrin in vitro. First, we investigated citrulline aminopeptidase activity in the extract of newborn rat epidermis by double layer fluorescent zymography and detected strong activity at neutral pH. Monitoring the citrulline-releasing activity, we purified an enzyme of 280 kDa, comprised of six identical subunits of 48 kDa. The NH2 terminus of representative tryptic peptides perfectly matched the sequence of rat bleomycin hydrolase (BH). The enzyme released various amino acids except Pro from beta-naphthylamide derivatives and hydrolyzed citrulline-beta-naphthylamide most effectively. Thus, to break down deiminated filaggrin, another protease would be required. Among proteases tested, calpain I degraded the deiminated filaggrin effectively into many peptides of different mass on the matrix-assisted laser desorption/ionization-time of flight mass spectrum. We confirmed that various amino acids including citrulline were released by BH from those peptides. On the other hand, caspase 14 degraded deiminated filaggrin into a few peptides of limited mass. Immunohistochemical analysis of normal human skin revealed co-localization of BH and filaggrin in the granular layer. Collectively, our results suggest that BH is essential for the synthesis of natural moisturizing factors and that calpain I would play a role as an upstream protease in the degradation of filaggrin.	[Kamata, Yayoi; Taniguchi, Aya; Takeda, Atsushi] Sagami Womens Univ, Grad Sch Nutr Sci, Biochem Lab, Kanagawa 2288533, Japan; [Kamata, Yayoi; Ishihara, Kazuhiko] Kitasato Univ, Grad Sch Med Sci, Dept Biochem, Kanagawa 2288555, Japan; [Yamamoto, Mami; Nomura, Junko; Hibino, Toshihiko] Shiseido Res Ctr, Kanagawa 2388643, Japan; [Takahara, Hidenari] Ibaraki Univ, Sch Agr, Dept Appl Biol Resource Sci, Ami, Ibaraki 30003, Japan	Kitasato University; Shiseido Company, Limited; Ibaraki University	Takeda, A (corresponding author), Sagami Womens Univ, Grad Sch Nutr Sci, Biochem Lab, Kanagawa 2288533, Japan.	takeda.a.ns@star.sagami-wu.ac.jp	Perry, George/A-8611-2009	Perry, George/0000-0002-6547-0172; Takahara, Hidenari/0000-0003-2373-8588	Sagami Women's University	Sagami Women's University	This work was supported by research grants from Sagami Women's University.	BERTI PJ, 1995, J MOL BIOL, V246, P273, DOI 10.1006/jmbi.1994.0083; BIKLE DD, 1993, ENDOCR REV, V14, P3, DOI 10.1210/er.14.1.3; Chavanas S, 2006, J DERMATOL SCI, V44, P63, DOI 10.1016/j.jdermsci.2006.07.004; CLAR EJ, 1981, INT J COSMETIC SCI, V3, P101, DOI 10.1111/j.1467-2494.1981.tb00275.x; DALE BA, 1985, ANN NY ACAD SCI, V455, P330, DOI 10.1111/j.1749-6632.1985.tb50420.x; Denecker G, 2008, J CELL BIOL, V180, P451, DOI 10.1083/jcb.200709098; Denecker G, 2007, NAT CELL BIOL, V9, P666, DOI 10.1038/ncb1597; ECKERT RL, 1989, ENVIRON HEALTH PERSP, V80, P109, DOI 10.2307/3430736; ECKERT RL, 1993, J INVEST DERMATOL, V100, P613, DOI 10.1111/1523-1747.ep12472288; Elias PM, 1998, J INVEST DERMATOL, V110, P399, DOI 10.1046/j.1523-1747.1998.00151.x; HARDING CR, 1983, J MOL BIOL, V170, P651, DOI 10.1016/S0022-2836(83)80126-0; HOHL D, 1991, J BIOL CHEM, V266, P6626; JOSHUATOR L, 2004, HDB PROTEOLYTIC ENZY, P1197; Kajiya A, 2006, PROTEIN PEPTIDE LETT, V13, P119, DOI 10.2174/092986606775101562; Kamata Y, 2007, J BIOCHEM, V141, P69, DOI 10.1093/jb/mvm005; Kanno T, 2000, J INVEST DERMATOL, V115, P813, DOI 10.1046/j.1523-1747.2000.00131.x; Katunuma N, 2005, ANAL BIOCHEM, V347, P208, DOI 10.1016/j.ab.2005.09.024; Koldamova RP, 1998, MOL PHARMACOL, V54, P954, DOI 10.1124/mol.54.6.954; Koldamova RP, 1999, BIOCHEMISTRY-US, V38, P7111, DOI 10.1021/bi990135l; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEE SC, 1993, J BIOL CHEM, V268, P12164; Lefterov IM, 2000, FASEB J, V14, P1837, DOI 10.1096/fj.99-0938com; Leyvraz C, 2005, J CELL BIOL, V170, P487, DOI 10.1083/jcb.200501038; List K, 2003, J CELL BIOL, V163, P901, DOI 10.1083/jcb.200304161; McGrath JA, 2008, TRENDS MOL MED, V14, P20, DOI 10.1016/j.molmed.2007.10.006; Mechin MC, 2005, CELL MOL LIFE SCI, V62, P1984, DOI 10.1007/s00018-005-5196-y; Niemer I, 1997, CURR GENET, V32, P41, DOI 10.1007/s002940050246; OHSUGI I, 1995, ARCH BIOCHEM BIOPHYS, V317, P62, DOI 10.1006/abbi.1995.1136; Pearton DJ, 2001, EXP DERMATOL, V10, P193, DOI 10.1034/j.1600-0625.2001.010003193.x; Presland RB, 1997, J INVEST DERMATOL, V108, P170, DOI 10.1111/1523-1747.ep12333356; Presland RB, 2000, J INVEST DERMATOL, V115, P1072, DOI 10.1046/j.1523-1747.2000.00178.x; Rawlings A.V., 2004, DERMATOL THER S1, V17, P43, DOI [10.1111/j.1396-0296.2004.04s1005.x, DOI 10.1111/J.1396-0296.2004.04S1005.X]; RAWLINGS AV, 1994, J INVEST DERMATOL, V103, P731, DOI 10.1111/1523-1747.ep12398620; RESING KA, 1989, J BIOL CHEM, V264, P1837; RESING KA, 1993, J BIOL CHEM, V268, P25139; RESING KA, 1995, J BIOL CHEM, V270, P28193; Schwartz DR, 1999, P NATL ACAD SCI USA, V96, P4680, DOI 10.1073/pnas.96.8.4680; SCOTT IR, 1982, BIOCHIM BIOPHYS ACTA, V719, P110, DOI 10.1016/0304-4165(82)90314-2; SCOTT IR, 1986, DEV BIOL, V115, P84, DOI 10.1016/0012-1606(86)90230-7; Senshu T, 1996, BIOCHEM BIOPH RES CO, V225, P712, DOI 10.1006/bbrc.1996.1240; STEINERT PM, 1995, J BIOL CHEM, V270, P17702, DOI 10.1074/jbc.270.30.17702; Stoltze L, 2000, NAT IMMUNOL, V1, P413, DOI 10.1038/80852; Takahashi M, 1996, ARCH BIOCHEM BIOPHYS, V329, P123, DOI 10.1006/abbi.1996.0199; Takeda A, 1999, ARCH DERMATOL RES, V291, P238, DOI 10.1007/s004030050400; Takeda A, 1996, J BIOCHEM-TOKYO, V119, P29; Takeda A, 1996, J BIOCHEM-TOKYO, V120, P353; Tamura N, 1998, CELL, V95, P637, DOI 10.1016/S0092-8674(00)81634-7; Tarcsa E, 1996, J BIOL CHEM, V271, P30709, DOI 10.1074/jbc.271.48.30709; Trianse S., 1974, COSMET PERFUM, V89, P57; Verdier-Sevrain Sylvie, 2007, J Cosmet Dermatol, V6, P75, DOI 10.1111/j.1473-2165.2007.00300.x; Vossenaar ER, 2003, BIOESSAYS, V25, P1106, DOI 10.1002/bies.10357; Watt FM, 1989, CURR OPIN CELL BIOL, V1, P1107, DOI 10.1016/S0955-0674(89)80058-4; WIEDOW O, 1990, J BIOL CHEM, V265, P14791; Yamazaki M, 1997, BIOCHEM BIOPH RES CO, V235, P652, DOI 10.1006/bbrc.1997.6809; Zimny J, 2006, J BIOL CHEM, V281, P22485, DOI 10.1074/jbc.M603656200	55	112	117	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12829	12836		10.1074/jbc.M807908200	http://dx.doi.org/10.1074/jbc.M807908200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19286660	Green Published, hybrid			2022-12-27	WOS:000265688300028
J	Panchal, RG; Ulrich, RL; Bradfute, SB; Lane, D; Ruthel, G; Kenny, TA; Iversen, PL; Anderson, AO; Gussio, R; Raschke, WC; Bavari, S				Panchal, Rekha G.; Ulrich, Ricky L.; Bradfute, Steven B.; Lane, Douglas; Ruthel, Gordon; Kenny, Tara A.; Iversen, Patrick L.; Anderson, Arthur O.; Gussio, Rick; Raschke, William C.; Bavari, Sina			Reduced Expression of CD45 Protein-tyrosine Phosphatase Provides Protection against Anthrax Pathogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; LETHAL TOXIN; MACROPHAGES; INHIBITORS; KINASE; INTERNALIZATION; EXPLOITATION; REGULATOR; INFECTION; APOPTOSIS	The modulation of cellular processes by small molecule inhibitors, gene inactivation, or targeted knockdown strategies combined with phenotypic screens are powerful approaches to delineate complex cellular pathways and to identify key players involved in disease pathogenesis. Using chemical genetic screening, we tested a library of known phosphatase inhibitors and identified several compounds that protected Bacillus anthracis infected macrophages from cell death. The most potent compound was assayed against a panel of sixteen different phosphatases of which CD45 was found to be most sensitive to inhibition. Testing of a known CD45 inhibitor and antisense phosphorodiamidate morpholino oligomers targeting CD45 also protected B. anthracis-infected macrophages from cell death. However, reduced CD45 expression did not protect anthrax lethal toxin ( LT) treated macrophages, suggesting that the pathogen and independently added LT may signal through distinct pathways. Subsequent, in vivo studies with both gene-targeted knockdown of CD45 and genetically engineered mice expressing reduced levels of CD45 resulted in protection of mice after infection with the virulent Ames B. anthracis. Intermediate levels of CD45 expression were critical for the protection, as mice expressing normal levels of CD45 or disrupted CD45 phosphatase activity or no CD45 all succumbed to this pathogen. Mechanism-based studies suggest that the protection provided by reduced CD45 levels results from regulated immune cell homeostasis that may diminish the impact of apoptosis during the infection. To date, this is the first report demonstrating that reduced levels of host phosphatase CD45 modulate anthrax pathogenesis.	[Panchal, Rekha G.; Ulrich, Ricky L.; Bradfute, Steven B.; Ruthel, Gordon; Anderson, Arthur O.; Bavari, Sina] USA, Med Res Inst Infect Dis, Ft Detrick, MD 21702 USA; [Lane, Douglas; Kenny, Tara A.] NCI, NIH, Target Struct Based Drug Discovery Grp, SAIC Frederick Inc, Frederick, MD 21702 USA; [Iversen, Patrick L.] AVI BioPharma Inc, Corvallis, OR 97333 USA; [Gussio, Rick] NCI, NIH, Target Struct Based Drug Discovery Grp, Informat Technol Branch,Dev Therapeut Program, Frederick, MD 21702 USA; [Raschke, William C.] Sidney Kimmel Canc Ctr, San Diego, CA 92121 USA; [Raschke, William C.] Virogenics Inc, Del Mar, CA 92014 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Panchal, RG (corresponding author), USA, Med Res Inst Infect Dis, 1425 Porter St, Ft Detrick, MD 21702 USA.	rekha.panchal@amedd.army.mil; sina.bavari@amedd.army.mil	Iversen, Patrick L/D-8854-2019; Bavari, Sina/L-3642-2019; Ruthel, Gordon/GYU-9133-2022; Iversen, Patrick L./L-5454-2019; Panchal, Rekha/None	Iversen, Patrick L/0000-0003-0106-9790; Bavari, Sina/0000-0001-8424-5635; Iversen, Patrick L./0000-0003-0106-9790; Panchal, Rekha/0000-0001-8621-9078	National Institutes of Health [N01-CO-12400, R43 A1055102]; Defense Threat Reduction Agency; NIAID; Developmental Therapeutics Program; Division of Cancer Treatment and Diagnosis of the NCI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Developmental Therapeutics Program; Division of Cancer Treatment and Diagnosis of the NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics)	This work was supported, in whole or in part, by National Institutes of Health Grant N01-CO-12400, by the Defense Threat Reduction Agency (to S. B. and R. G. P.), the NIAID, National Institutes of Health Grant R43 A1055102 (to W. C. R.), and by the Developmental Therapeutics Program in the Division of Cancer Treatment and Diagnosis of the NCI, National Institutes of Health.	Agrawal A, 2004, CELL MOL LIFE SCI, V61, P2859, DOI 10.1007/s00018-004-4251-4; Alexander DR, 2000, SEMIN IMMUNOL, V12, P349, DOI 10.1006/smim.2000.0218; Alonso A, 2004, CELL, V117, P699, DOI 10.1016/j.cell.2004.05.018; Andersen JN, 2004, FASEB J, V18, P8, DOI 10.1096/fj.02-1212rev; Bashat S, 2006, P NATL ACAD SCI USA, V103, P13509, DOI 10.1073/pnas.0509870103; BERGER SA, 1994, J EXP MED, V180, P471, DOI 10.1084/jem.180.2.471; Bhavsar AP, 2007, NATURE, V449, P827, DOI 10.1038/nature06247; Bialy L, 2005, ANGEW CHEM INT EDIT, V44, P3814, DOI 10.1002/anie.200461517; Black DS, 2000, CELL MICROBIOL, V2, P401, DOI 10.1046/j.1462-5822.2000.00061.x; Bottini N, 2002, ARCH IMMUNOL THER EX, V50, P95; Boyden ED, 2006, NAT GENET, V38, P240, DOI 10.1038/ng1724; Brossier F, 2000, INFECT IMMUN, V68, P1781, DOI 10.1128/IAI.68.4.1781-1786.2000; Cote CK, 2004, MICROB PATHOGENESIS, V37, P169, DOI 10.1016/j.micpath.2004.06.013; Crawford MA, 2009, INFECT IMMUN, V77, P1664, DOI 10.1128/IAI.01208-08; DESAI DM, 1994, EMBO J, V13, P4002, DOI 10.1002/j.1460-2075.1994.tb06716.x; Ducruet AP, 2005, ANNU REV PHARMACOL, V45, P725, DOI 10.1146/annurev.pharmtox.45.120403.100040; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Finlay BB, 1997, SCIENCE, V276, P718, DOI 10.1126/science.276.5313.718; FRIEDLANDER AM, 1993, INFECT IMMUN, V61, P245, DOI 10.1128/IAI.61.1.245-252.1993; Gao HL, 2000, EXP HEMATOL, V28, P1062, DOI 10.1016/S0301-472X(00)00513-0; Glomski IJ, 2007, J IMMUNOL, V178, P2646, DOI 10.4049/jimmunol.178.5.2646; Hermiston ML, 2003, ANNU REV IMMUNOL, V21, P107, DOI 10.1146/annurev.immunol.21.120601.140946; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Huntington ND, 2005, J EXP MED, V201, P1421, DOI 10.1084/jem.20042294; Kang TJ, 2008, EUR J IMMUNOL, V38, P1574, DOI 10.1002/eji.200838141; Kim SO, 2003, J BIOL CHEM, V278, P7413, DOI 10.1074/jbc.M209279200; Lazo JS, 2003, ONCOL RES, V13, P347; Lazo JS, 2002, MOL PHARMACOL, V61, P720, DOI 10.1124/mol.61.4.720; Li XL, 2008, P NATL ACAD SCI USA, V105, P20816, DOI 10.1073/pnas.0807265105; Lyons CR, 2004, INFECT IMMUN, V72, P4801, DOI 10.1128/IAI.72.8.4801-4809.2004; McNeill L, 2007, IMMUNITY, V27, P425, DOI 10.1016/j.immuni.2007.07.015; Montoya M, 2006, EUR J IMMUNOL, V36, P2150, DOI 10.1002/eji.200535304; Moulton HM, 2004, BIOCONJUGATE CHEM, V15, P290, DOI 10.1021/bc034221g; Muehlbauer SM, 2007, CELL CYCLE, V6, P758, DOI 10.4161/cc.6.6.3991; Nandan D, 2000, J LEUKOCYTE BIOL, V67, P464, DOI 10.1002/jlb.67.4.464; Panchal RG, 2007, CHEM BIOL, V14, P245, DOI 10.1016/j.chembiol.2007.01.007; Park JM, 2002, SCIENCE, V297, P2048, DOI 10.1126/science.1073163; Pei ZH, 2004, CURR PHARM DESIGN, V10, P3481, DOI 10.2174/1381612043382954; Pellizzari R, 1999, FEBS LETT, V462, P199, DOI 10.1016/S0014-5793(99)01502-1; Pickering AK, 2004, INFECT IMMUN, V72, P6382, DOI 10.1128/IAI.72.11.6382-6389.2004; Piercy J, 2006, IMMUNOLOGY, V118, P250, DOI 10.1111/j.1365-2567.2006.02363.x; Ribot WJ, 2006, INFECT IMMUN, V74, P5029, DOI 10.1128/IAI.00275-06; Ryan PL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001817; SHEN F, 1995, J IMMUNOL, V154, P644; SINGH Y, 1989, J BIOL CHEM, V264, P11099; Summerton J, 1997, ANTISENSE NUCLEIC A, V7, P187, DOI 10.1089/oli.1.1997.7.187; Tang GQ, 1999, INFECT IMMUN, V67, P3055, DOI 10.1128/IAI.67.6.3055-3060.1999; Tautz L, 2006, EXPERT OPIN THER TAR, V10, P157, DOI 10.1517/14728222.10.1.157; Thomas ML, 1999, IMMUNOL TODAY, V20, P406, DOI 10.1016/S0167-5699(99)01506-6; Umezawa K, 2003, PHARMACOL THERAPEUT, V99, P15, DOI 10.1016/S0163-7258(03)00050-0; Urbanek RA, 2001, J MED CHEM, V44, P1777, DOI 10.1021/jm000447i; Virts EL, 2003, BLOOD, V101, P849, DOI 10.1182/blood-2002-07-1969; Virts EL, 2001, J BIOL CHEM, V276, P19913, DOI 10.1074/jbc.M100448200; Walberg K, 2008, J INTERF CYTOK RES, V28, P597, DOI 10.1089/jir.2007.0143; Wei W, 2006, CELL, V124, P1141, DOI 10.1016/j.cell.2005.12.045; Zamoyska R, 2007, IMMUNITY, V27, P421, DOI 10.1016/j.immuni.2007.08.009	56	22	22	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12874	12885		10.1074/jbc.M809633200	http://dx.doi.org/10.1074/jbc.M809633200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19269962	Green Published, hybrid			2022-12-27	WOS:000265688300033
J	Ermak, G; Hench, KJ; Chang, KT; Sachdev, S; Davies, KJA				Ermak, Gennady; Hench, Karl J.; Chang, Kevin T.; Sachdev, Sean; Davies, Kelvin J. A.			Regulator of Calcineurin (RCAN1-1L) Is Deficient in Huntington Disease and Protective against Mutant Huntingtin Toxicity in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SYNDROME CRITICAL REGION; DOWN-SYNDROME; DSCR1 ADAPT78; INHIBITS CALCINEURIN; OXIDATIVE STRESS; ST14A CELLS; PHOSPHORYLATION; PROTEIN; EXPRESSION; CALCIUM	Our work suggests an important new link between the RCAN1 gene and Huntington disease. Huntington disease is caused by expansion of glutamine repeats in the huntingtin protein. How the huntingtin protein with expanded polyglutamines (mutant huntingtin) causes the disease is still unclear, but phosphorylation of huntingtin appears to be protective. Increased huntingtin phosphorylation can be produced either by inhibition of the phosphatase calcineurin or by activation of the Akt kinase. The RCAN1 gene encodes regulators of calcineurin, and we now demonstrate, for the first time, that RCAN1-1L is depressed in Huntington disease. We also show that RCAN1-1L overexpression can protect against mutant huntingtin toxicity in an ST14A cell culture model of Huntington disease and that increased phosphorylation of huntingtin via calcineurin inhibition, rather than via Akt induction or activation, is the likely mechanism by which RCAN1-1L may be protective against mutant huntingtin. These findings suggest that RCAN1-1L "deficiency" may actually play a role in the etiology of Huntington disease. In addition, our results allow for the possibility that controlled overexpression of RCAN1-1L in the striatal region of the brain might be a viable avenue for therapeutic intervention in Huntington disease patients (and perhaps other polyglutamine expansion disorders).	[Davies, Kelvin J. A.] Univ So Calif, Ethel Percy Andrus Gerontol Ctr, Los Angeles, CA 90089 USA; Univ So Calif, Div Mol & Computat Biol, Los Angeles, CA 90089 USA	University of Southern California; University of Southern California	Davies, KJA (corresponding author), Univ So Calif, Ethel Percy Andrus Gerontol Ctr, 3715 McClintock Ave, Los Angeles, CA 90089 USA.	kelvin@usc.edu		Davies, Kelvin/0000-0001-7790-3003	CHDI Foundation, Inc.; NINDS; National Institutes of Health; National Institute of Mental Health; National Multiple Sclerosis Society; Department of Veterans Affairs	CHDI Foundation, Inc.; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Department of Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the CHDI Foundation, Inc. All tissue specimens were obtained from the Human Brain and Spinal Fluid Resource Center of the Veterans Affairs West Los Angeles Healthcare Center, which is supported by NINDS, National Institutes of Health, the National Institute of Mental Health, the National Multiple Sclerosis Society, and the Department of Veterans Affairs.	Cao X, 2002, BIOCHEM J, V367, P459, DOI 10.1042/BJ20011797; Cattaneo E, 1998, J NEUROSCI RES, V53, P223, DOI 10.1002/(SICI)1097-4547(19980715)53:2<223::AID-JNR11>3.0.CO;2-7; Chang KT, 2005, NAT NEUROSCI, V8, P1577, DOI 10.1038/nn1564; Davies KJA, 2007, FASEB J, V21, P3023, DOI 10.1096/fj.06-7246com; Ehrlich ME, 2001, EXP NEUROL, V167, P215, DOI 10.1006/exnr.2000.7551; Ermak G, 2002, FASEB J, V16, DOI 10.1096/fj.01-0846com; Ermak G, 2004, FASEB J, V18, P62, DOI 10.1096/fj.03-0451com; Ermak G, 2006, FEBS J, V273, P2100, DOI 10.1111/j.1742-4658.2006.05217.x; Ermak G, 2002, MOL IMMUNOL, V38, P713, DOI 10.1016/S0161-5890(01)00108-0; Ermak G, 2001, J BIOL CHEM, V276, P38787, DOI 10.1074/jbc.M102829200; Fuentes JJ, 2000, HUM MOL GENET, V9, P1681, DOI 10.1093/hmg/9.11.1681; Genesca L, 2003, BIOCHEM J, V374, P567, DOI 10.1042/BJ20030267; Gorlach J, 2000, EMBO J, V19, P3618, DOI 10.1093/emboj/19.14.3618; Hilioti Z, 2004, GENE DEV, V18, P35, DOI 10.1101/gad.1159204; Hoeffer CA, 2007, J NEUROSCI, V27, P13161, DOI 10.1523/JNEUROSCI.3974-07.2007; Humbert S, 2002, DEV CELL, V2, P831, DOI 10.1016/S1534-5807(02)00188-0; Kingsbury TJ, 2000, GENE DEV, V14, P1595; Kovtun IV, 2007, NATURE, V447, P447, DOI 10.1038/nature05778; Pardo R, 2006, J NEUROSCI, V26, P1635, DOI 10.1523/JNEUROSCI.3706-05.2006; Rigamonti D, 2000, J NEUROSCI, V20, P3705, DOI 10.1523/JNEUROSCI.20-10-03705.2000; Rothermel B, 2000, J BIOL CHEM, V275, P8719, DOI 10.1074/jbc.275.12.8719; Vega RB, 2003, P NATL ACAD SCI USA, V100, P669, DOI 10.1073/pnas.0237225100	22	39	39	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					11845	11853		10.1074/jbc.M900639200	http://dx.doi.org/10.1074/jbc.M900639200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19270310	Green Published, hybrid			2022-12-27	WOS:000265494600016
J	Dunstan, MS; Hang, PC; Zelinskaya, NV; Honek, JF; Conn, GL				Dunstan, Mark S.; Hang, Pei C.; Zelinskaya, Natalia V.; Honek, John F.; Conn, Graeme L.			Structure of the Thiostrepton Resistance Methyltransferase center dot S-Adenosyl-L-methionine Complex and Its Interaction with Ribosomal RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; X-RAY; PROTEIN; SITE; ANTIBIOTICS; METHYLATION; MECHANISM; MUTANTS; REVEALS; FOLD	The x-ray crystal structure of the thiostrepton resistance RNA methyltransferase (Tsr)center dot S-adenosyl-L-methionine (AdoMet) complex was determined at 2.45-angstrom resolution. Tsr is definitively confirmed as a Class IV methyltransferase of the SpoU family with an N-terminal "L30-like" putative target recognition domain. The structure and our in vitro analysis of the interaction of Tsr with its target domain from 23 S ribosomal RNA (rRNA) demonstrate that the active biological unit is a Tsr homodimer. In vitro methylation assays show that Tsr activity is optimal against a 29-nucleotide hairpin rRNA though the full 58-nucleotide L11-binding domain and intact 23 S rRNA are also effective substrates. Molecular docking experiments predict that Tsr center dot rRNA binding is dictated entirely by the sequence and structure of the rRNA hairpin containing the A1067 target nucleotide and is most likely driven primarily by large complementary electrostatic surfaces. One L30-like domain is predicted to bind the target loop and the other is near an internal loop more distant from the target site where a nucleotide change (U1061 to A) also decreases methylation by Tsr. Furthermore, a predicted interaction with this internal loop by Tsr amino acid Phe-88 was confirmed by mutagenesis and RNA binding experiments. We therefore propose that Tsr achieves its absolute target specificity using the N-terminal domains of each monomer in combination to recognize the two distinct structural elements of the target rRNA hairpin such that both Tsr subunits contribute directly to the positioning of the target nucleotide on the enzyme.	[Zelinskaya, Natalia V.; Conn, Graeme L.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; [Dunstan, Mark S.] Univ Manchester, Fac Life Sci, Manchester Interdisciplinary Bioctr, Manchester M1 7DN, Lancs, England; [Hang, Pei C.; Honek, John F.] Univ Waterloo, Dept Chem, Waterloo, ON N2L 3G1, Canada	Emory University; University of Manchester; University of Waterloo	Conn, GL (corresponding author), Emory Univ, Sch Med, Dept Biochem, 1510 Clifton Rd NE, Atlanta, GA 30322 USA.	gconn@emory.edu	Dunstan, Mark/B-8934-2013	Conn, Graeme/0000-0002-2419-380X; Honek, John/0000-0002-4035-4538; Dunstan, Mark/0000-0002-9416-5505	The Wellcome Trust [79242]; National Sciences and Engineering Council (Canada)	The Wellcome Trust(Wellcome TrustEuropean Commission); National Sciences and Engineering Council (Canada)	This work was supported by The Wellcome Trust (Grant 79242 to G. L. C.) and National Sciences and Engineering Council (Canada) (to J. F. H.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ahn HJ, 2003, EMBO J, V22, P2593, DOI 10.1093/emboj/cdg269; Anantharaman V, 2002, NUCLEIC ACIDS RES, V30, P1427, DOI 10.1093/nar/30.7.1427; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BECHTHOLD A, 1994, EUR J BIOCHEM, V224, P431, DOI 10.1111/j.1432-1033.1994.00431.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cameron DM, 2004, NUCLEIC ACIDS RES, V32, P3220, DOI 10.1093/nar/gkh644; Chao JA, 2004, STRUCTURE, V12, P1165, DOI 10.1016/j.str.2004.04.023; Clouet-d'Orval B, 2005, BIOCHIMIE, V87, P889, DOI 10.1016/j.biochi.2005.02.004; Conn GL, 1998, BIOCHEMISTRY-US, V37, P11980, DOI 10.1021/bi980825+; Conn GL, 1999, SCIENCE, V284, P1171, DOI 10.1126/science.284.5417.1171; Conn GL, 2009, DNA RNA MODIFICATION; COWLAN K, 1994, JOINT CCP4 ESF EACBM, V31, P34; CUNDLIFFE E, 1989, ANNU REV MICROBIOL, V43, P207, DOI 10.1146/annurev.micro.43.1.207; Decatur WA, 2002, TRENDS BIOCHEM SCI, V27, P344, DOI 10.1016/S0968-0004(02)02109-6; Doi Y, 2007, CLIN INFECT DIS, V45, P88, DOI 10.1086/518605; Dunstan MS, 2005, CHEM BIOL, V12, P201, DOI 10.1016/j.chembiol.2004.11.019; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ferre-D'Amare AR, 2003, CURR OPIN STRUC BIOL, V13, P49, DOI 10.1016/S0959-440X(02)00002-7; Gaynor M, 2003, CURR TOP MED CHEM, V3, P949, DOI 10.2174/1568026033452159; Goodman CD, 2007, MOL BIOCHEM PARASIT, V152, P181, DOI 10.1016/j.molbiopara.2007.01.005; Gustafsson C, 1996, NUCLEIC ACIDS RES, V24, P3756, DOI 10.1093/nar/24.19.3756; Gustilo EM, 2008, CURR OPIN MICROBIOL, V11, P134, DOI 10.1016/j.mib.2008.02.003; Harms JM, 2008, MOL CELL, V30, P26, DOI 10.1016/j.molcel.2008.01.009; He Y, 2007, ACTA CRYSTALLOGR D, V63, P793, DOI 10.1107/S0907444907023451; HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; Liao ZY, 2006, MOL PHARMACOL, V70, P366, DOI 10.1124/mol.105.021865; LONG KS, 2009, DNA RNA MODIFICATION; Mao HY, 1999, NAT STRUCT BIOL, V6, P1139; Michel G, 2002, STRUCTURE, V10, P1303, DOI 10.1016/S0969-2126(02)00852-3; Mosbacher TG, 2005, J MOL BIOL, V345, P535, DOI 10.1016/j.jmb.2004.10.051; Poehlsgaard J, 2005, NAT REV MICROBIOL, V3, P870, DOI 10.1038/nrmicro1265; Rozenski J, 1999, NUCLEIC ACIDS RES, V27, P196, DOI 10.1093/nar/27.1.196; Schubert HL, 2003, TRENDS BIOCHEM SCI, V28, P329, DOI 10.1016/S0968-0004(03)00090-2; Taylor AB, 2008, NUCLEIC ACIDS RES, V36, P1542, DOI 10.1093/nar/gkm1172; Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036; THOMPSON J, 1982, J BIOL CHEM, V257, P7915; Tkaczuk KL, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-73; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Walker SC, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng082; Watanabe K, 2005, J BIOL CHEM, V280, P10368, DOI 10.1074/jbc.M411209200; WIENEN B, 1979, J BIOL CHEM, V254, P8031; Wimberly BT, 1999, CELL, V97, P491, DOI 10.1016/S0092-8674(00)80759-X; Xu Z, 2008, NAT STRUCT MOL BIOL, V15, P534, DOI 10.1038/nsmb.1408	45	24	26	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					17013	17020		10.1074/jbc.M901618200	http://dx.doi.org/10.1074/jbc.M901618200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19369248	hybrid, Green Published			2022-12-27	WOS:000266962400039
J	Slugoski, MD; Smith, KM; Ng, AML; Yao, SYM; Karpinski, E; Cass, CE; Baldwin, SA; Young, JD				Slugoski, Melissa D.; Smith, Kyla M.; Ng, Amy M. L.; Yao, Sylvia Y. M.; Karpinski, Edward; Cass, Carol E.; Baldwin, Stephen A.; Young, James D.			Conserved Glutamate Residues Glu-343 and Glu-519 Provide Mechanistic Insights into Cation/Nucleoside Cotransport by Human Concentrative Nucleoside Transporter hCNT3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; FUNCTIONAL-CHARACTERIZATION; NA+/PROLINE TRANSPORTER; MOLECULAR-CLONING; CRYSTAL-STRUCTURE; LACTOSE PERMEASE; ACIDIC RESIDUES; CNT FAMILY; NA+; BINDING	Human concentrative nucleoside transporter 3 (hCNT3) utilizes electrochemical gradients of both Na+ and H+ to accumulate pyrimidine and purine nucleosides within cells. We have employed radioisotope flux and electrophysiological techniques in combination with site-directed mutagenesis and heterologous expression in Xenopus oocytes to identify two conserved pore-lining glutamate residues (Glu-343 and Glu-519) with essential roles in hCNT3 Na+/nucleoside and H+/nucleoside cotransport. Mutation of Glu-343 and Glu-519 to aspartate, glutamine, and cysteine severely compromised hCNT3 transport function, and changes included altered nucleoside and cation activation kinetics (all mutants), loss or impairment of H+ dependence (all mutants), shift in Na+ : nucleoside stoichiometry from 2:1 to 1:1 (E519C), complete loss of catalytic activity (E519Q) and, similar to the corresponding mutant in Na+-specific hCNT1, uncoupled Na+ currents (E343Q). Consistent with close-proximity integration of cation/solute-binding sites within a common cation/permeant translocation pore, mutation of Glu-343 and Glu-519 also altered hCNT3 nucleoside transport selectivity. Both residues were accessible to the external medium and inhibited by p-chloromercuribenzene sulfonate when converted to cysteine.	[Slugoski, Melissa D.; Smith, Kyla M.; Ng, Amy M. L.; Yao, Sylvia Y. M.; Karpinski, Edward; Young, James D.] Univ Alberta, Dept Physiol, Membrane Prot Res Grp, Edmonton, AB T6G 2H7, Canada; [Cass, Carol E.] Univ Alberta, Dept Oncol, Membrane Prot Res Grp, Edmonton, AB T6G 2H7, Canada; [Cass, Carol E.] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada; [Baldwin, Stephen A.] Univ Leeds, Inst Membrane & Syst Biol, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England	University of Alberta; University of Alberta; University of Alberta; University of Leeds	Young, JD (corresponding author), Univ Alberta, Dept Physiol, Membrane Prot Res Grp, 7-55 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.	james.young@ualberta.ca			National Cancer Institute of Canada; Canadian Cancer Society; Alberta Cancer Board	National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Canadian Cancer Society(Canadian Cancer Society (CCS)); Alberta Cancer Board	This work was supported in part by the National Cancer Institute of Canada with funds from the Canadian Cancer Society and the Alberta Cancer Board.	Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Baldwin SA, 2004, PFLUG ARCH EUR J PHY, V447, P735, DOI 10.1007/s00424-003-1103-2; CASS CE, 1995, DRUG TRANSPORT ANTIM, P403; Chen NH, 2004, J BIOL CHEM, V279, P5508, DOI 10.1074/jbc.M306294200; Damaraju VL, 2007, AM J PHYSIOL-RENAL, V293, pF200, DOI 10.1152/ajprenal.00007.2007; Damaraju VL, 2003, ONCOGENE, V22, P7524, DOI 10.1038/sj.onc.1206952; DASCAL N, 1987, CRIT REV BIOCHEM MOL, V22, P317, DOI 10.3109/10409238709086960; Errasti-Murugarren E, 2008, MOL PHARMACOL, V73, P379, DOI 10.1124/mol.107.041848; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; FRANCO PJ, 1994, J BIOL CHEM, V269, P7379; Gray JH, 2004, PFLUG ARCH EUR J PHY, V447, P728, DOI 10.1007/s00424-003-1107-y; Grewer C, 2003, J BIOL CHEM, V278, P2585, DOI 10.1074/jbc.M207956200; Griffith DA, 1999, BIOCHEMISTRY-US, V38, P7524, DOI 10.1021/bi990076b; Griffith DA, 1996, BBA-REV BIOMEMBRANES, V1286, P153, DOI 10.1016/S0304-4157(96)00008-1; Hamilton SR, 2001, J BIOL CHEM, V276, P27981, DOI 10.1074/jbc.M100518200; Hilgemann DW, 1999, J GEN PHYSIOL, V114, P459, DOI 10.1085/jgp.114.3.459; Hunte C, 2005, NATURE, V435, P1197, DOI 10.1038/nature03692; Kaback HR, 2005, CR BIOL, V328, P557, DOI 10.1016/j.crvi.2005.03.008; Karlin A, 1997, P NATL ACAD SCI USA, V94, P5508, DOI 10.1073/pnas.94.11.5508; King AE, 2006, TRENDS PHARMACOL SCI, V27, P416, DOI 10.1016/j.tips.2006.06.004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Latini S, 2001, J NEUROCHEM, V79, P463, DOI 10.1046/j.1471-4159.2001.00607.x; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Lin F, 1996, BIOPHYS J, V71, P3126, DOI 10.1016/S0006-3495(96)79506-1; Loewen SK, 1999, J BIOL CHEM, V274, P24475, DOI 10.1074/jbc.274.35.24475; Loewen SK, 2004, MOL MEMBR BIOL, V21, P1, DOI 10.1080/0968768031000140836; Loewen SK, 2003, YEAST, V20, P661, DOI 10.1002/yea.1000; Lu CC, 1999, J GEN PHYSIOL, V114, P445, DOI 10.1085/jgp.114.3.445; Noel J, 2003, BIOCHEMISTRY-US, V42, P15361, DOI 10.1021/bi035296a; Pastor-Anglada M, 2007, J PHYSIOL BIOCHEM, V63, P97, DOI 10.1007/BF03174089; Pirch T, 2002, J BIOL CHEM, V277, P8790, DOI 10.1074/jbc.M111008200; POURCHER T, 1993, J BIOL CHEM, V268, P3209; Quick M, 1998, BIOCHEMISTRY-US, V37, P13800, DOI 10.1021/bi980562j; Quick M, 1997, BIOCHEMISTRY-US, V36, P4631, DOI 10.1021/bi963063w; Quick M, 2001, J BIOL CHEM, V276, P1728, DOI 10.1074/jbc.M005521200; Ritzel MWL, 1998, MOL MEMBR BIOL, V15, P203; Ritzel MWL, 1997, AM J PHYSIOL-CELL PH, V272, pC707, DOI 10.1152/ajpcell.1997.272.2.C707; Ritzel MWL, 2001, J BIOL CHEM, V276, P2914, DOI 10.1074/jbc.M007746200; Screpanti E, 2007, J STRUCT BIOL, V159, P261, DOI 10.1016/j.jsb.2007.01.011; Slugoski MD, 2008, J BIOL CHEM, V283, P24922, DOI 10.1074/jbc.M801793200; Slugoski MD, 2008, J BIOL CHEM, V283, P8496, DOI 10.1074/jbc.M710433200; Slugoski MD, 2007, BIOCHEMISTRY-US, V46, P1684, DOI 10.1021/bi061692s; Slugoski MD, 2009, J BIOL CHEM, V284, P17281, DOI 10.1074/jbc.M109.009704; Smith FM, 2007, MOL MEMBR BIOL, V24, P53, DOI 10.1080/09687860600942534; Smith KM, 2005, J BIOL CHEM, V280, P25436, DOI 10.1074/jbc.M409454200; Smith KM, 2004, J PHYSIOL-LONDON, V558, P807, DOI 10.1113/jphysiol.2004.068189; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Xiao GQ, 2001, MOL PHARMACOL, V59, P339, DOI 10.1124/mol.59.2.339; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yao SY, 2002, AM J PHYSIOL-CELL PH, V283, pC155, DOI 10.1152/ajpcell.00587.2001; Yao SYM, 2007, J BIOL CHEM, V282, P30607, DOI 10.1074/jbc.M703285200; Yao SYM, 2000, PRACT APPROACH SER, P47; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Young JD, 2008, XENOBIOTICA, V38, P995, DOI [10.1080/00498250801927427, 10.1080/00498250801927427 ]; Young JD, 2001, CURR TOP MEMBR, V50, P329; Zhang J, 2006, BIOCHEM J, V394, P389, DOI 10.1042/BJ20051476	56	15	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					17266	17280		10.1074/jbc.M109.009613	http://dx.doi.org/10.1074/jbc.M109.009613			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19380587	Green Published, hybrid			2022-12-27	WOS:000266962400063
J	Kotorashvili, A; Russo, SJ; Mulugeta, S; Guttentag, S; Beers, MF				Kotorashvili, Adam; Russo, Scott J.; Mulugeta, Surafel; Guttentag, Susan; Beers, Michael F.			Anterograde Transport of Surfactant Protein C Proprotein to Distal Processing Compartments Requires PPDY-mediated Association with Nedd4 Ubiquitin Ligases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL NA+ CHANNEL; INTERSTITIAL LUNG-DISEASE; RAT TYPE-II; PULMONARY SURFACTANT; TERMINAL PROPEPTIDE; AGGRESOME FORMATION; RNA INTERFERENCE; WW DOMAINS; CELLS; GENE	Biosynthesis of surfactant protein C (SP-C) by alveolar type 2 cells requires proteolytic processing of a 21-kDa propeptide (proSP-C-21) in post-Golgi compartments to yield a 3.7-kDa mature form. Scanning alanine mutagenesis, binding assays, and co-immunoprecipitation were used to characterize the proSP-C targeting domain. Delivery of proSP-C-21 to distal processing organelles is dependent upon the NH2-terminal cytoplasmic SP-C propeptide, which contains a conserved PPDY motif. In A549 cells, transfection of EGFP/proSP-C-21 constructs containing polyalanine substitution for Glu(11)-Thr(18), (PPDY16)-P-13, or P-14, Y-16 produced endoplasmic reticulum retention of the fusion proteins. Protein-protein interactions of proSP-C with known WW domains were screened using a solid-phase array that revealed binding of the proSP-C NH2 terminus to several WW domains found in the Nedd4 family of E3 ligases. Specificity of the interaction was confirmed by co-immunoprecipitation of proSP-C and Nedd4 or Nedd4-2 in epithelial cell lines. By Western blotting and reverse transcription-PCR, both forms were detected in primary human type 2 cells. Knockdown of Nedd4-2 by small interference RNA transfection of cultured human type 2 cells blocked processing of S-35-labeled proSP-C-21. Mutagenesis of potential acceptor sites for ubiquitination in the cytosolic domain of proSP-C (Lys(6), Lys(34), or both) failed to inhibit trafficking of EGFP/proSP-C-21. These results indicate that PPDY-mediated interaction with Nedd4 E3-ligases is required for trafficking of proSP-C. We speculate that the Nedd4/proSP-C tandem is part of a larger protein complex containing a ubiquitinated component that further directs its transport.	[Beers, Michael F.] Univ Penn, Sch Med, Div Pulm & Crit Care, Surfactant Biol Labs,Dept Med, Philadelphia, PA 19104 USA; [Guttentag, Susan] Childrens Hosp Philadelphia, Dept Pediat, Div Neonatol, Philadelphia, PA 19104 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Beers, MF (corresponding author), Univ Penn, Sch Med, Div Pulm & Crit Care, Surfactant Biol Labs,Dept Med, H410F Hill Pavil,380 S Univ Ave, Philadelphia, PA 19104 USA.	mfbeers@mail.med.upenn.edu	Russo, Scott/R-7107-2019; Guttentag, Susan/ABE-7405-2020; Guttentag, Susan H/D-8705-2013	Russo, Scott/0000-0002-6470-1805; Guttentag, Susan/0000-0003-4420-5879; Guttentag, Susan H/0000-0003-4420-5879	National Institutes of Health [HL-19737, HL-059959, HL090732]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090732, R01HL059959, P01HL019737, R56HL059959] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-19737 (to M.F.B.), HL-059959 (to S.G.), and HL090732 (to S.M.).	Akinbi HT, 1997, J BIOL CHEM, V272, P9640; Beers MF, 1995, AM J PHYSIOL-LUNG C, V269, pL744, DOI 10.1152/ajplung.1995.269.6.L744; Beers MF, 2005, ANNU REV PHYSIOL, V67, P663, DOI 10.1146/annurev.physiol.67.040403.101937; Beers MF, 1998, J BIOL CHEM, V273, P15287, DOI 10.1074/jbc.273.24.15287; Beers MF, 1996, J BIOL CHEM, V271, P14361, DOI 10.1074/jbc.271.24.14361; BEERS MF, 1994, J BIOL CHEM, V269, P20318; Bortnick AE, 2003, AM J PHYSIOL-LUNG C, V285, pL869, DOI 10.1152/ajplung.00077.2003; Brasch F, 2004, EUR RESPIR J, V24, P30, DOI 10.1183/09031936.04.00000104; Brasch F, 2002, AM J RESP CELL MOL, V26, P659, DOI 10.1165/ajrcmb.26.6.4744; Cao XR, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1160940; Conkright JJ, 2001, J BIOL CHEM, V276, P14658, DOI 10.1074/jbc.M011770200; FISHER JH, 1989, BIOCHIM BIOPHYS ACTA, V995, P225, DOI 10.1016/0167-4838(89)90040-X; Fotia AB, 2006, INT J BIOCHEM CELL B, V38, P472, DOI 10.1016/j.biocel.2005.11.006; Gerson KD, 2008, J BIOL CHEM, V283, P10330, DOI 10.1074/jbc.M707516200; GLASSER SW, 1990, J BIOL CHEM, V265, P21986; GLASSER SW, 1988, J BIOL CHEM, V263, P10326; Glasser SW, 2003, J BIOL CHEM, V278, P14291, DOI 10.1074/jbc.M210909200; Glasser SW, 2001, P NATL ACAD SCI USA, V98, P6366, DOI 10.1073/pnas.101500298; GLASSER SW, 1988, J BIOL CHEM, V263, P9; Gonzales LW, 2002, AM J PHYSIOL-LUNG C, V283, pL940, DOI 10.1152/ajplung.00127.2002; Guttentag SH, 2005, AM J RESP CELL MOL, V33, P14, DOI 10.1165/rcmb.2004-0293OC; Henry PC, 2003, J BIOL CHEM, V278, P20019, DOI 10.1074/jbc.M211153200; Huang X, 2000, NAT STRUCT BIOL, V7, P634, DOI 10.1038/77923; Ing B, 2007, MOL CELL BIOL, V27, P481, DOI 10.1128/MCB.00463-06; Johnson AL, 2001, AM J RESP CELL MOL, V24, P253, DOI 10.1165/ajrcmb.24.3.4312; Kabore AF, 2001, J CELL SCI, V114, P293; Kabra R, 2008, J BIOL CHEM, V283, P6033, DOI 10.1074/jbc.M708555200; Kay BK, 2000, FASEB J, V14, P231, DOI 10.1096/fasebj.14.2.231; KUMAR S, 2008, P AUSTR PHYSL SOC, V39; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li TB, 2007, AM J PHYSIOL-LUNG C, V293, pL1069, DOI 10.1152/ajplung.00151.2007; Malbert-Colas L, 2003, PFLUG ARCH EUR J PHY, V447, P35, DOI 10.1007/s00424-003-1152-6; MOORE KJ, 1992, GENOMICS, V12, P388, DOI 10.1016/0888-7543(92)90389-A; Mulugeta S, 2005, AM J RESP CELL MOL, V32, P521, DOI 10.1165/rcmb.2005-0009OC; Mulugeta S, 2003, J BIOL CHEM, V278, P47979, DOI 10.1074/jbc.M308210200; Myat A, 2002, NEURON, V35, P447, DOI 10.1016/S0896-6273(02)00795-X; Nogee LM, 2002, CHEST, V121, p20S, DOI 10.1378/chest.121.3_suppl.20S; Pak Y, 2006, J CELL BIOL, V175, P631, DOI 10.1083/jcb.200603001; Russo SJ, 1999, AM J PHYSIOL-LUNG C, V277, pL1034, DOI 10.1152/ajplung.1999.277.5.L1034; Shenoy SK, 2008, J BIOL CHEM, V283, P22166, DOI 10.1074/jbc.M709668200; Shi PP, 2008, AM J PHYSIOL-RENAL, V295, pF462, DOI 10.1152/ajprenal.90300.2008; Shi W, 2004, AM J PHYSIOL-LUNG C, V286, pL293, DOI 10.1152/ajplung.00228.2003; Snyder PM, 2004, J BIOL CHEM, V279, P5042, DOI 10.1074/jbc.M312477200; Snyder PM, 2002, J BIOL CHEM, V277, P5, DOI 10.1074/jbc.C100623200; Snyder PM, 2001, J BIOL CHEM, V276, P28321, DOI 10.1074/jbc.M011487200; Solarin KO, 1997, PEDIATR RES, V42, P356, DOI 10.1203/00006450-199709000-00017; Staub O, 1996, EMBO J, V15, P2371, DOI 10.1002/j.1460-2075.1996.tb00593.x; Staub O, 2006, PHYSIOL REV, V86, P669, DOI 10.1152/physrev.00020.2005; Stevens PA, 2005, PEDIATR RES, V57, P89, DOI 10.1203/01.PDR.0000147567.02473.5A; Sudol M, 2000, CELL, V103, P1001, DOI 10.1016/S0092-8674(00)00203-8; VOORHOUT WF, 1993, MICROSC RES TECHNIQ, V26, P366, DOI 10.1002/jemt.1070260504; Vorbroker DK, 1995, AM J PHYSIOL-LUNG C, V269, pL727, DOI 10.1152/ajplung.1995.269.6.L727; Wang WJ, 2003, J CELL SCI, V116, P683, DOI 10.1242/jcs.00267; Wang WJ, 2002, J BIOL CHEM, V277, P19929, DOI 10.1074/jbc.M201537200; WARR RG, 1987, P NATL ACAD SCI USA, V84, P7915, DOI 10.1073/pnas.84.22.7915; Zhou RF, 2007, J BIOL CHEM, V282, P20207, DOI 10.1074/jbc.M611329200	56	16	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16667	16678		10.1074/jbc.M109.002816	http://dx.doi.org/10.1074/jbc.M109.002816			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19366705	hybrid, Green Published			2022-12-27	WOS:000266730900062
J	Kim, YS; Kim, NH; Yeom, SJ; Kim, SW; Oh, DK				Kim, Yeong-Su; Kim, Nam-Hee; Yeom, Soo-Jin; Kim, Seon-Won; Oh, Deok-Kun			In Vitro Characterization of a Recombinant Blh Protein from an Uncultured Marine Bacterium as a beta-Carotene 15,15 '-Dioxygenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VITAMIN-A; ENZYMATIC CONVERSION; DIPHOSPHATE SYNTHASE; MOLECULAR-CLONING; GENOME SEQUENCE; EXPRESSION; GENE; IDENTIFICATION; PATTERN; BACTERIORHODOPSIN	Codon optimization was used to synthesize the blh gene from the uncultured marine bacterium 66A03 for expression in Escherichia coli. The expressed enzyme cleaved beta-carotene at its central double bond (15,15') to yield two molecules of all-trans-retinal. The molecular mass of the native purified enzyme was similar to 64 kDa as a dimer of 32-kDa subunits. The K-m, k(cat), and k(cat)/K-m values for beta-carotene as substrate were 37 mu M, 3.6 min(-1), and 97 mM(-1) min(-1), respectively. The enzyme exhibited the highest activity for beta-carotene, followed by beta-cryptoxanthin, beta-apo-4'-carotenal, alpha-carotene, and gamma-carotene in decreasing order, but not for beta-apo-8'-carotenal, beta-apo-12'-carotenal, lutein, zeaxanthin, or lycopene, suggesting that the presence of one unsubstituted beta-ionone ring in a substrate with a molecular weight greater than C-35 seems to be essential for enzyme activity. The oxygen atom of retinal originated not from water but from molecular oxygen, suggesting that the enzyme was beta-carotene 15,15'-dioxygenase. Although the Blh protein and beta-carotene 15,15'-monooxygenases catalyzed the same biochemical reaction, the Blh protein was unrelated to the mammalian beta-carotene 15,15'-monooxygenases as assessed by their different properties, including DNA and amino acid sequences, molecular weight, form of association, reaction mechanism, kinetic properties, and substrate specificity. This is the first report of in vitro characterization of a bacterial beta-carotene-cleaving enzyme.	[Kim, Yeong-Su; Kim, Nam-Hee; Yeom, Soo-Jin; Oh, Deok-Kun] Konkuk Univ, Dept Biosci & Biotechnol, Seoul 143701, South Korea; [Kim, Seon-Won] Gyeongsang Natl Univ, Environm Biotechnol Natl Care Res Ctr, Div Appl Life Sci BK21, Jinju 660701, South Korea; [Kim, Seon-Won] Gyeongsang Natl Univ, Plant Mol Biol & Biotechnol Res Ctr, Jinju 660701, South Korea	Konkuk University; Gyeongsang National University; Gyeongsang National University	Oh, DK (corresponding author), Konkuk Univ, Dept Biosci & Biotechnol, 1 Hwayang Dong, Seoul 143701, South Korea.	deokkun@konkuk.ac.kr	Yeom, Soojin/AAE-3558-2022	Kim, Yeong-Su/0000-0002-9831-2883; Yeom, Soo-Jin/0000-0001-7307-237X				Baliga NS, 2004, GENOME RES, V14, P2221, DOI 10.1101/gr.2700304; Borowski T, 2008, CHEM-EUR J, V14, P2264, DOI 10.1002/chem.200701344; Boulanger A, 2003, FASEB J, V17, P1304, DOI 10.1096/fj.02-0690fje; Bower MJ, 1997, J MOL BIOL, V267, P1268, DOI 10.1006/jmbi.1997.0926; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Burgess-Brown NA, 2008, PROTEIN EXPRES PURIF, V59, P94, DOI 10.1016/j.pep.2008.01.008; Ding YX, 2008, BIOSCI BIOTECH BIOCH, V72, P1571, DOI 10.1271/bbb.80067; During A, 1996, ANAL BIOCHEM, V241, P199, DOI 10.1006/abio.1996.0400; During A, 2004, ARCH BIOCHEM BIOPHYS, V430, P77, DOI 10.1016/j.abb.2004.03.024; EHRENSHAFT M, 1994, APPL ENVIRON MICROB, V60, P2766, DOI 10.1128/AEM.60.8.2766-2771.1994; FIDGE NH, 1969, BIOCHEM J, V114, P689, DOI 10.1042/bj1140689; Galperin MY, 1998, GENOME RES, V8, P779, DOI 10.1101/gr.8.8.779; GLOVER J, 1960, VITAM HORM, V18, P371; GOODMAN DS, 1967, J BIOL CHEM, V242, P3543; GOODMAN DS, 1966, J BIOL CHEM, V241, P1929; Grolier P, 1997, ARCH BIOCHEM BIOPHYS, V348, P233, DOI 10.1006/abbi.1997.0388; Gustafsson C, 2004, TRENDS BIOTECHNOL, V22, P346, DOI 10.1016/j.tibtech.2004.04.006; Iwata-Reuyl D, 2003, BIOCHEMISTRY-US, V42, P3359, DOI 10.1021/bi0206614; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kim YS, 2007, APPL MICROBIOL BIOT, V76, P1339, DOI 10.1007/s00253-007-1118-2; Kloer DP, 2005, SCIENCE, V308, P267, DOI 10.1126/science.1108965; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LAKSHMAN.MR, 1972, J LIPID RES, V13, P477; Lampert JM, 2003, DEVELOPMENT, V130, P2173, DOI 10.1242/dev.00437; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leuenberger M. G., 2001, ANGEW CHEM, V113, P2683; Leuenberger MG, 2001, ANGEW CHEM INT EDIT, V40, P2614, DOI 10.1002/1521-3773(20010716)40:14<2613::AID-ANIE2613>3.0.CO;2-Z; Lindqvist A, 2002, J BIOL CHEM, V277, P23942, DOI 10.1074/jbc.M202756200; Martinez A, 2007, P NATL ACAD SCI USA, V104, P5590, DOI 10.1073/pnas.0611470104; McCarren J, 2007, ENVIRON MICROBIOL, V9, P846, DOI 10.1111/j.1462-2920.2006.01203.x; Mongodin EF, 2005, P NATL ACAD SCI USA, V102, P18147, DOI 10.1073/pnas.0509073102; Nagao A, 1996, ARCH BIOCHEM BIOPHYS, V328, P57, DOI 10.1006/abbi.1996.0142; Ng WV, 2000, P NATL ACAD SCI USA, V97, P12176, DOI 10.1073/pnas.190337797; Paik J, 2001, J BIOL CHEM, V276, P32160, DOI 10.1074/jbc.M010086200; Pan XC, 2008, DNA SEQUENCE, V19, P98, DOI 10.1080/10425170701446509; Peck RF, 2001, J BIOL CHEM, V276, P5739, DOI 10.1074/jbc.M009492200; Pfeiffer F, 2008, GENOMICS, V91, P335, DOI 10.1016/j.ygeno.2008.01.001; Poliakov E, 2005, J BIOL CHEM, V280, P29217, DOI 10.1074/jbc.M500409200; Ramos A, 2008, APPL MICROBIOL BIOT, V79, P819, DOI 10.1007/s00253-008-1492-4; Redmond TM, 2001, J BIOL CHEM, V276, P6560, DOI 10.1074/jbc.M009030200; Sabehi G, 2005, PLOS BIOL, V3, P1409, DOI 10.1371/journal.pbio.0030273; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Scherzinger D, 2008, MOL MICROBIOL, V69, P231, DOI 10.1111/j.1365-2958.2008.06282.x; SHAND RF, 1994, J BACTERIOL, V176, P1655, DOI 10.1128/jb.176.6.1655-1660.1994; Takaya A, 2003, BBA-GENE STRUCT EXPR, V1625, P214, DOI 10.1016/S0167-4781(02)00602-4; von Lintig J, 2000, J BIOL CHEM, V275, P11915, DOI 10.1074/jbc.275.16.11915; von Lintig J, 2001, ARCH BIOCHEM BIOPHYS, V385, P47, DOI 10.1006/abbi.2000.2096; WOLF G, 1995, NUTR REV, V53, P134, DOI 10.1111/j.1753-4887.1995.tb01537.x; Wyss A, 2000, BIOCHEM BIOPH RES CO, V271, P334, DOI 10.1006/bbrc.2000.2619; Wyss A, 2001, BIOCHEM J, V354, P521, DOI 10.1042/0264-6021:3540521; Yan WM, 2001, GENOMICS, V72, P193, DOI 10.1006/geno.2000.6476; Yang CF, 1996, J BACTERIOL, V178, P840, DOI 10.1128/jb.178.3.840-845.1996	52	28	31	0	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15781	15793		10.1074/jbc.M109.002618	http://dx.doi.org/10.1074/jbc.M109.002618			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19366683	hybrid, Green Published			2022-12-27	WOS:000266501000047
J	Chaptal, V; Ottolia, M; Mercado-Besserer, G; Nicoll, DA; Philipson, KD; Abramson, J				Chaptal, Vincent; Ottolia, Michela; Mercado-Besserer, Gabriel; Nicoll, Debora A.; Philipson, Kenneth D.; Abramson, Jeff			Structure and Functional Analysis of a Ca2+ Sensor Mutant of the Na+/Ca2+ Exchanger	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA+-CA2+ EXCHANGER; NCX1; MODEL	The mammalian Na+/Ca2+ exchanger, NCX1.1, serves as the main mechanism for Ca2+ efflux across the sarcolemma following cardiac contraction. In addition to transporting Ca2+, NCX1.1 activity is also strongly regulated by Ca2+ binding to two intracellular regulatory domains, CBD1 and CBD2. The structures of both of these domains have been solved by NMR spectroscopy and x-ray crystallography, greatly enhancing our understanding of Ca2+ regulation. Nevertheless, the mechanisms by which Ca2+ regulates the exchanger remain incompletely understood. The initial NMR study showed that the first regulatory domain, CBD1, unfolds in the absence of regulatory Ca2+. It was further demonstrated that a mutation of an acidic residue involved in Ca2+ binding, E454K, prevents this structural unfolding. A contradictory result was recently obtained in a second NMR study in which Ca2+ removal merely triggered local rearrangements of CBD1. To address this issue, we solved the crystal structure of the E454K-CBD1 mutant and performed electrophysiological analyses of the full-length exchanger with mutations at position 454. We show that the lysine substitution replaces the Ca2+ ion at position 1 of the CBD1 Ca2+ binding site and participates in a charge compensation mechanism. Electrophysiological analyses show that mutations of residue Glu-454 have no impact on Ca2+ regulation of NCX1.1. Together, structural and mutational analyses indicate that only two of the four Ca2+ ions that bind to CBD1 are important for regulating exchanger activity.	[Chaptal, Vincent; Ottolia, Michela; Mercado-Besserer, Gabriel; Nicoll, Debora A.; Philipson, Kenneth D.; Abramson, Jeff] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA; [Ottolia, Michela; Nicoll, Debora A.; Philipson, Kenneth D.] Univ Calif Los Angeles, David Geffen Sch Med, Cardiovasc Res Labs, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Philipson, KD (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA.	kphilipson@mednet.ucla.edu; jabramson@mednet.ucla.edu		chaptal, vincent/0000-0003-2603-0294	National Institutes of Health [GM07844, HL49101]; American Heart Association [0630258N]; Human Frontier Science Program (HFSP) [RGY0069]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049101] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078844] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Human Frontier Science Program (HFSP)(Human Frontier Science Program); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM07844 (to J.A.) and Grant HL49101 (to K. D. P.). This work was also supported by American Heart Association Grant 0630258N and Human Frontier Science Program (HFSP) Grant RGY0069 (to J.A.).	Bers DM, 2002, NATURE, V415, P198, DOI 10.1038/415198a; Boyman L, 2009, J BIOL CHEM, V284, P6185, DOI 10.1074/jbc.M809012200; del Monte F, 2008, HEART FAIL REV, V13, P151, DOI 10.1007/s10741-007-9071-9; Dyck C, 1999, J GEN PHYSIOL, V114, P701, DOI 10.1085/jgp.114.5.701; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Hilge M, 2006, MOL CELL, V22, P15, DOI 10.1016/j.molcel.2006.03.008; Hilgemann DW, 1998, METHOD ENZYMOL, V293, P267; Johnson E, 2008, J MOL BIOL, V377, P945, DOI 10.1016/j.jmb.2008.01.046; MATSUOKA S, 1995, J GEN PHYSIOL, V105, P403, DOI 10.1085/jgp.105.3.403; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MERCADOBESSERER G, 2007, P NATL ACAD SCI USA, V104, P18467; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nicoll DA, 1999, J BIOL CHEM, V274, P910, DOI 10.1074/jbc.274.2.910; Nicoll DA, 2007, ANN NY ACAD SCI, V1099, P1, DOI 10.1196/annals.1387.014; Nicoll DA, 2006, J BIOL CHEM, V281, P21577, DOI 10.1074/jbc.C600117200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patton C, 2004, CELL CALCIUM, V35, P427, DOI 10.1016/j.ceca.2003.10.006; Schwarz EM, 1997, P NATL ACAD SCI USA, V94, P10249, DOI 10.1073/pnas.94.19.10249	18	24	25	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					14688	14692		10.1074/jbc.C900037200	http://dx.doi.org/10.1074/jbc.C900037200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19332552	Green Published, hybrid			2022-12-27	WOS:000266288200004
J	Liu, CC; Pearson, C; Bu, GJ				Liu, Chia-Chen; Pearson, Chelsea; Bu, Guojun			Cooperative Folding and Ligand-binding Properties of LRP6 beta-Propeller Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-RELATED PROTEIN-6; LDL-RECEPTOR; MOLECULAR CHAPERONE; TUMOR-GROWTH; BONE-MASS; FAMILY; MESD; DENSITY; DICKKOPF-1; MUTATION	Wnt/beta-catenin signaling controls cell growth during development, and its misregulation in adults can cause human diseases. LRP6, the essential co-receptor for the Wnt pathway, consists of four beta-propeller domains flanked by epidermal growth factor repeats in its extracellular region. To understand the maturation and ligand-binding properties of individual BP domains, we generated soluble receptor consisting of individual BPs, as well as combinations of these domains. We show that BP1, BP2, and BP4 each can be folded and secreted, and their secretion was enhanced by co-expression of Mesd, a molecular chaperone essential for LRP6 folding and maturation. BP3 is not secreted when expressed on its own or in combination with BP2 or BP1 and 2 (BP12); however, folding and secretion of BP3 is vastly enhanced when expressed together with BP4. Similar cooperative folding and maturation was observed between BP1 and BP2. These results suggest that BP1 forms a functional folding unit with BP2, whereas BP3 folds together with BP4. Using these BP constructs, we also found that BP12 and BP34 constitute independent ligand-binding domains capable of binding Wnt3a, Dkk1, and Mesd. The ability of Mesd to block the binding of both Wnt3a and Dkk1 to LRP6 enables this specialized chaperone to function as a Wnt signaling modulator. Together, our studies reveal unique properties of the LRP6 BP domains and provide novel tools to understand LRP6 function in ligand binding and Wnt signaling. Our results also support the development of soluble LRP6 receptors and Mesd as potential therapeutic molecules that target Wnt signaling.	[Bu, Guojun] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	Bu, GJ (corresponding author), Washington Univ, Sch Med, Dept Pediat, Campus Box 8208,660 S Euclid Ave, St Louis, MO 63110 USA.	bu@wustl.edu			National Institutes of Health [CA100520]; Midwest Regional Center for Excellence in Emerging infections Diseases; NATIONAL CANCER INSTITUTE [R01CA100520] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Midwest Regional Center for Excellence in Emerging infections Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA100520. This work was also supported by a grant from the Midwest Regional Center for Excellence in Emerging infections Diseases (to G. B.).	Bafico A, 2001, NAT CELL BIOL, V3, P683, DOI 10.1038/35083081; Bafico A, 1998, ONCOGENE, V16, P2819, DOI 10.1038/sj.onc.1201797; Bafico A, 2004, CANCER CELL, V6, P497, DOI 10.1016/j.ccr.2004.09.032; Beglova N, 2004, MOL CELL, V16, P281, DOI 10.1016/j.molcel.2004.09.038; Boyden LM, 2002, NEW ENGL J MED, V346, P1513, DOI 10.1056/NEJMoa013444; Brown SD, 1998, BIOCHEM BIOPH RES CO, V248, P879, DOI 10.1006/bbrc.1998.9061; Bu GJ, 1996, J BIOL CHEM, V271, P22218, DOI 10.1074/jbc.271.36.22218; Bu GJ, 2001, INT REV CYTOL, V209, P79; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Culi J, 2004, EMBO J, V23, P1372, DOI 10.1038/sj.emboj.7600132; DeAlmeida VI, 2007, CANCER RES, V67, P5371, DOI 10.1158/0008-5472.CAN-07-0266; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; He X, 2004, DEVELOPMENT, V131, P1663, DOI 10.1242/dev.01117; Hsieh JC, 2003, CELL, V112, P355, DOI 10.1016/S0092-8674(03)00045-X; Jeon H, 2001, NAT STRUCT BIOL, V8, P499, DOI 10.1038/88556; Koduri V, 2007, BIOCHEMISTRY-US, V46, P6570, DOI 10.1021/bi700049g; Koehler Christian, 2006, Journal of Structural and Functional Genomics, V7, P131, DOI 10.1007/s10969-007-9016-5; Kubota T, 2008, J BONE MINER RES, V23, P1661, DOI 10.1359/JBMR.080512; Kuhnert F, 2004, P NATL ACAD SCI USA, V101, P266, DOI 10.1073/pnas.2536800100; Lal A, 2005, MOL CELL PROBE, V19, P385, DOI 10.1016/j.mcp.2005.06.007; Li YH, 2005, J CELL SCI, V118, P5305, DOI 10.1242/jcs.02651; Li Yonghe, 2005, Future Oncol, V1, P673, DOI 10.2217/14796694.1.5.673; Li YH, 2006, FEBS LETT, V580, P5423, DOI 10.1016/j.febslet.2006.09.011; Li YS, 2000, J BIOL CHEM, V275, P37187, DOI 10.1074/jbc.M000490200; Lustig B, 2003, J CANCER RES CLIN, V129, P199, DOI 10.1007/s00432-003-0431-0; MacDonald BT, 2004, DEVELOPMENT, V131, P2543, DOI 10.1242/dev.01126; Mani A, 2007, SCIENCE, V315, P1278, DOI 10.1126/science.1136370; Mao BY, 2001, NATURE, V411, P321, DOI 10.1038/35077108; Mao BY, 2002, NATURE, V417, P664, DOI 10.1038/nature756; Niehrs C, 2006, ONCOGENE, V25, P7469, DOI 10.1038/sj.onc.1210054; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Semenov MV, 2008, J BIOL CHEM, V283, P21427, DOI 10.1074/jbc.M800014200; Semenov MV, 2001, CURR BIOL, V11, P951, DOI 10.1016/S0960-9822(01)00290-1; SINGH I, 1990, EMBO J, V9, P631, DOI 10.1002/j.1460-2075.1990.tb08155.x; Tian E, 2003, NEW ENGL J MED, V349, P2483, DOI 10.1056/NEJMoa030847; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; You L, 2004, CANCER RES, V64, P5385, DOI 10.1158/0008-5472.CAN-04-1227; Zhang YH, 2004, MOL CELL BIOL, V24, P4677, DOI 10.1128/MCB.24.11.4677-4684.2004; Zi XL, 2005, CANCER RES, V65, P9762, DOI 10.1158/0008-5472.CAN-05-0103	41	25	27	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					15299	15307		10.1074/jbc.M807285200	http://dx.doi.org/10.1074/jbc.M807285200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19339249	Green Published, hybrid			2022-12-27	WOS:000266288200064
J	Tian, J; Li, X; Liang, M; Liu, LJ; Xie, JX; Ye, QQ; Kometiani, P; Tillekeratne, M; Jin, RM; Xie, ZJ				Tian, Jiang; Li, Xin; Liang, Man; Liu, Lijun; Xie, Joe X.; Ye, Qiqi; Kometiani, Peter; Tillekeratne, Manoranjani; Jin, Runming; Xie, Zijian			Changes in Sodium Pump Expression Dictate the Effects of Ouabain on Cell Growth	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMALEMMAL NA/K-ATPASE; HUMAN SKELETAL-MUSCLE; CARDIAC-GLYCOSIDES; NA+/K+-ATPASE; BREAST-CANCER; LLC-PK1 CELLS; CARDIOTONIC STEROIDS; MESSENGER-RNA; BETA-SUBUNIT; NA,K-ATPASE	Here we show that ouabain-induced cell growth regulation is intrinsically coupled to changes in the cellular amount of Na/K-ATPase via the phosphoinositide 3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) pathway. Ouabain increases the endocytosis and degradation of Na/K-ATPase in LLC-PK1, human breast (BT20), and prostate (DU145) cancer cells. However, ouabain stimulates the PI3K/Akt/mTOR pathway and consequently up-regulates the expression of Na/K-ATPase in LLC-PK1 but not BT20 and DU145 cells. This up-regulation is sufficient to replete the plasma membrane pool of Na/K-ATPase and to stimulate cell proliferation in LLC-PK1 cells. On the other hand, ouabain causes a gradual depletion of Na/K-ATPase and an increased expression of cell cycle inhibitor p21(cip), which consequently inhibits cell proliferation in BT20 and DU145 cells. Consistently, we observe that small interfering RNA-mediated knockdown of Na/K-ATPase is sufficient to induce the expression of p21cip and slow the proliferation of LLC-PK1 cells. Moreover, this knockdown converts the growth stimulatory effect of ouabain to growth inhibition in LLC-PK1 cells. Mechanistically, both Src and caveolin-1 are required for ouabain-induced activation of Akt and up-regulation of Na/K-ATPase. Furthermore, inhibition of the PI3K/Akt/mTOR pathway by rapamycin completely blocks ouabain-induced expression of Na/K-ATPase and converts ouabain-induced growth stimulation to growth inhibition in LLC-PK1 cells. Taken together, we conclude that changes in the expression of Na/K-ATPase dictate the growth regulatory effects of ouabain on cells.	[Tian, Jiang; Liang, Man; Liu, Lijun; Xie, Joe X.; Ye, Qiqi; Kometiani, Peter; Tillekeratne, Manoranjani; Xie, Zijian] Univ Toledo, Dept Physiol & Pharmacol, Coll Med, Toledo, OH 43614 USA; [Li, Xin; Jin, Runming] Huazhong Univ Sci & Technol, Dept Pediat, Union Hosp, Wuhan 430074, Hubei, Peoples R China	University System of Ohio; University of Toledo; Huazhong University of Science & Technology	Xie, ZJ (corresponding author), 3000 Arlington Ave, Toledo, OH 43614 USA.	zi-jian.xie@utoledo.edu			National Institutes of Health [HL-36573, HL-67963, GM 78565]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067963, P01HL036573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078565] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-36573, HL-67963, and GM 78565.	ANDERSON RGW, 1993, P NATL ACAD SCI USA, V90, P10909, DOI 10.1073/pnas.90.23.10909; Aydemir-Koksoy A, 2001, J BIOL CHEM, V276, P46605, DOI 10.1074/jbc.M106178200; Bagrov AY, 1996, CARDIOVASC RES, V31, P296; BAKER PF, 1972, J PHYSIOL-LONDON, V224, P441, DOI 10.1113/jphysiol.1972.sp009904; Cai HP, 2008, AM J PHYSIOL-CELL PH, V294, pC555, DOI 10.1152/ajpcell.00475.2007; Cai T, 2008, J CELL BIOL, V182, P1153, DOI 10.1083/jcb.200712022; CAYANIS E, 1992, J MEMBRANE BIOL, V125, P163; Chueh SC, 2001, J UROLOGY, V166, P347, DOI 10.1016/S0022-5347(05)66157-5; Cohen AW, 2003, AM J PHYSIOL-CELL PH, V285, pC222, DOI 10.1152/ajpcell.00006.2003; Cook J S, 1985, Soc Gen Physiol Ser, V39, P3; Dmitrieva RI, 2003, J BIOL CHEM, V278, P28160, DOI 10.1074/jbc.M303768200; Elkareh J, 2007, HYPERTENSION, V49, P215, DOI 10.1161/01.HYP.0000252409.36927.05; Ferrandi M, 2004, J BIOL CHEM, V279, P33306, DOI 10.1074/jbc.M402187200; Haas A, 2002, J BIOL CHEM, V277, P18694, DOI 10.1074/jbc.M111357200; Haas M, 2000, J BIOL CHEM, V275, P27832; HAMLYN JM, 1991, P NATL ACAD SCI USA, V88, P6259, DOI 10.1073/pnas.88.14.6259; Haux J, 1999, MED HYPOTHESES, V53, P543, DOI 10.1054/mehy.1999.0985; Huang YT, 2004, BIOCHEM PHARMACOL, V67, P727, DOI 10.1016/j.bcp.2003.10.013; Inge LJ, 2008, HISTOL HISTOPATHOL, V23, P459, DOI 10.14670/HH-23.459; JING YK, 1994, JPN J CANCER RES, V85, P645, DOI 10.1111/j.1349-7006.1994.tb02408.x; KAPLAN JG, 1978, ANNU REV PHYSIOL, V40, P19, DOI 10.1146/annurev.ph.40.030178.000315; Khundmiri SJ, 2006, AM J PHYSIOL-CELL PH, V291, pC1247, DOI 10.1152/ajpcell.00593.2005; Kometiani P, 2005, MOL PHARMACOL, V67, P929, DOI 10.1124/mol.104.007302; KONSKI AA, 1991, INT J RADIAT ONCOL, V21, P1033; Kotova O, 2006, J BIOL CHEM, V281, P20085, DOI 10.1074/jbc.M601577200; LESCALEMATYS L, 1990, J BIOL CHEM, V265, P17935; Li ZC, 2009, PFLUG ARCH EUR J PHY, V457, P635, DOI 10.1007/s00424-008-0470-0; LIANG M, 2006, J BIOL CHEM; Liang M, 2007, J BIOL CHEM, V282, P10585, DOI 10.1074/jbc.M609181200; Liang M, 2006, J BIOL CHEM, V281, P19709, DOI 10.1074/jbc.M512240200; LINGREL JB, 1990, PROG NUCLEIC ACID RE, V38, P37; Liu J, 2004, KIDNEY INT, V66, P227, DOI 10.1111/j.1523-1755.2004.00723.x; Liu JA, 2005, KIDNEY INT, V67, P1844, DOI 10.1111/j.1523-1755.2005.00283.x; Liu LJ, 2007, AM J PHYSIOL-CELL PH, V293, pC1489, DOI 10.1152/ajpcell.00158.2007; Liu LJ, 2004, AM J PHYSIOL-HEART C, V287, pH2173, DOI 10.1152/ajpheart.00352.2004; Maeshima A, 2002, KIDNEY INT, V62, P446, DOI 10.1046/j.1523-1755.2002.00463.x; McConkey DJ, 2000, CANCER RES, V60, P3807; Mijatovic T, 2007, BBA-REV CANCER, V1776, P32, DOI 10.1016/j.bbcan.2007.06.002; Murata Y, 1996, JPN J PHARMACOL, V72, P347, DOI 10.1254/jjp.72.347; Murphy KT, 2004, J PHYSIOL-LONDON, V556, P507, DOI 10.1113/jphysiol.2003.054981; Newman RA, 2008, MOL INTERV, V8, P36, DOI 10.1124/mi.8.1.8; Newman RA, 2006, J EXP THER ONCOL, V5, P167; Nguyen ANT, 2007, J AM SOC NEPHROL, V18, P46, DOI 10.1681/ASN.2006010086; Podar K, 2003, J BIOL CHEM, V278, P5794, DOI 10.1074/jbc.M208636200; Pollack L R, 1982, Prog Clin Biol Res, V91, P71; POLLACK LR, 1981, AM J PHYSIOL, V241, pC173, DOI 10.1152/ajpcell.1981.241.5.C173; POLLACK LR, 1981, J CELL PHYSIOL, V106, P85, DOI 10.1002/jcp.1041060110; QIN X, 1994, AM J HYPERTENS, V7, P96, DOI 10.1093/ajh/7.1.96; Rajasekaran SA, 2001, MOL BIOL CELL, V12, P279, DOI 10.1091/mbc.12.2.279; Rajasekaran SA, 1999, J UROLOGY, V162, P574, DOI 10.1016/S0022-5347(05)68629-6; Schoner W, 2008, NAT MED, V14, P16, DOI 10.1038/nm0108-16; SKOU JC, 1965, PHYSIOL REV, V45, P596, DOI 10.1152/physrev.1965.45.3.596; Stenkvist B, 1999, ONCOL REP, V6, P493; STENKVIST B, 1979, LANCET, V1, P563; STENKVIST B, 1982, NEW ENGL J MED, V306, P484; STENKVIST B, 1980, ANAL QUANT CYTOL, V2, P49; Taguchi K, 2007, NEUROSCI LETT, V413, P42, DOI 10.1016/j.neulet.2006.11.061; Tian J, 2006, MOL BIOL CELL, V17, P317, DOI 10.1091/mbc.E05-08-0735; Wang HJ, 2004, J BIOL CHEM, V279, P17250, DOI 10.1074/jbc.M313239200; Watabe M, 1998, ONCOGENE, V16, P779, DOI 10.1038/sj.onc.1201592; Xie Zijian, 2003, Mol Interv, V3, P157, DOI 10.1124/mi.3.3.157; Ye M, 2004, J STEROID BIOCHEM, V91, P87, DOI 10.1016/j.jsbmb.2004.01.010; Yeh JY, 2001, J UROLOGY, V166, P1937, DOI 10.1016/S0022-5347(05)65724-2; Zhou XM, 2001, BIOCHEM BIOPH RES CO, V285, P46, DOI 10.1006/bbrc.2001.5126	64	101	108	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					14921	14929		10.1074/jbc.M808355200	http://dx.doi.org/10.1074/jbc.M808355200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19329430	hybrid, Green Published			2022-12-27	WOS:000266288200028
J	Sato, Y; Uemura, T; Morimitsu, K; Sato-Nishiuchi, R; Manabe, R; Takagi, J; Yamada, M; Sekiguchi, K				Sato, Yuya; Uemura, Toshihiko; Morimitsu, Keisuke; Sato-Nishiuchi, Ryoko; Manabe, Ri-ichiroh; Takagi, Junichi; Yamada, Masashi; Sekiguchi, Kiyotoshi			Molecular Basis of the Recognition of Nephronectin by Integrin alpha 8 beta 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-DIRECTED MUTAGENESIS; LIGAND-BINDING SPECIFICITIES; STRUCTURAL BASIS; KIDNEY MORPHOGENESIS; PROTEIN NEPHRONECTIN; BASEMENT-MEMBRANE; HUMAN FIBRONECTIN; ADHESIVE FUNCTION; EMBRYONIC KIDNEY; LAMININ ISOFORMS	Integrin alpha 8 beta 1 interacts with a variety of Arg-Gly-Asp (RGD)-containing ligands in the extracellular matrix. Here, we examined the binding activities of alpha 8 beta 1 integrin toward a panel of RGD-containing ligands. Integrin alpha 8 beta 1 bound specifically to nephronectin with an apparent dissociation constant of 0.28 +/- 0.01 nM, but showed only marginal affinities for fibronectin and other RGD-containing ligands. The high-affinity binding to alpha 8 beta 1 integrin was fully reproduced with a recombinant nephronectin fragment derived from the RGD-containing central "linker" segment. A series of deletion mutants of the recombinant fragment identified the LFEIFEIER sequence on the C-terminal side of the RGD motif as an auxiliary site required for high-affinity binding to alpha 8 beta 1 integrin. Alanine scanning mutagenesis within the LFEIFEIER sequence defined the EIE sequence as a critical motif ensuring the high-affinity integrin-ligand interaction. Although a synthetic LFEIFEIER peptide failed to inhibit the binding of alpha 8 beta 1 integrin to nephronectin, a longer peptide containing both the RGD motif and the LFEIFEIER sequence was strongly inhibitory, and was similar to 2,000-fold more potent than a peptide containing only the RGD motif. Furthermore, trans-complementation assays using recombinant fragments containing either the RGD motif or LFEIFEIER sequence revealed a clear synergism in the binding to alpha 8 beta 1 integrin. Taken together, these results indicate that the specific high-affinity binding of nephronectin to alpha 8 beta 1 integrin is achieved by bipartite interaction of the integrin with the RGD motif and LFEIFEIER sequence, with the latter serving as a synergy site that greatly potentiates the RGD-driven integrin-ligand interaction but has only marginal activity to secure the interaction by itself.	[Sato, Yuya; Uemura, Toshihiko; Morimitsu, Keisuke; Sato-Nishiuchi, Ryoko; Manabe, Ri-ichiroh; Takagi, Junichi; Yamada, Masashi; Sekiguchi, Kiyotoshi] Osaka Univ, Inst Prot Res, Suita, Osaka 5650871, Japan	Osaka University	Sekiguchi, K (corresponding author), Osaka Univ, Inst Prot Res, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan.	sekiguch@protein.osaka-u.ac.jp			New Energy and Industrial Technology Development Organization of Japan [17082005, 20370046, 06001294-0]	New Energy and Industrial Technology Development Organization of Japan(New Energy and Industrial Technology Development Organization (NEDO))	This work was supported in part by Grants-in-aid for Scientific Research 17082005 and 20370046 (to K. S.) and Research Contract 06001294-0 with the New Energy and Industrial Technology Development Organization of Japan.	AKIYAMA SK, 1985, J BIOL CHEM, V260, P402; AKIYAMA Y, 1998, GEN INF SER WORKSH G, V9, P131; AOTA S, 1994, J BIOL CHEM, V269, P24756; BOSSY B, 1991, EMBO J, V10, P2375, DOI 10.1002/j.1460-2075.1991.tb07776.x; Brandenberger R, 2001, J CELL BIOL, V154, P447, DOI 10.1083/jcb.200103069; Denda S, 1998, MOL BIOL CELL, V9, P1425, DOI 10.1091/mbc.9.6.1425; DiCara D, 2007, J BIOL CHEM, V282, P9657, DOI 10.1074/jbc.M610461200; EKBLOM P, 1981, J CELL BIOL, V91, P1, DOI 10.1083/jcb.91.1.1; Evans AL, 2000, NAT GENET, V24, P424, DOI 10.1038/74286; Gu JG, 2001, J BIOL CHEM, V276, P27090, DOI 10.1074/jbc.M102284200; Hansen JE, 1998, GLYCOCONJUGATE J, V15, P115, DOI 10.1023/A:1006960004440; Humphries JD, 2000, J BIOL CHEM, V275, P20337, DOI 10.1074/jbc.M000568200; Humphries MJ, 2003, CURR OPIN STRUC BIOL, V13, P236, DOI 10.1016/S0959-440X(03)00035-6; HYNES RO, 1992, CELL, V69, P11, DOI 10.1016/0092-8674(92)90115-S; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ido H, 2007, J BIOL CHEM, V282, P11144, DOI 10.1074/jbc.M609402200; Kamata T, 2001, J BIOL CHEM, V276, P44275, DOI 10.1074/jbc.M107021200; Kiyozumi D, 2005, EXP CELL RES, V306, P9, DOI 10.1016/j.yexcr.2005.01.020; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Linton JM, 2007, DEVELOPMENT, V134, P2501, DOI 10.1242/dev.005033; Lu M, 2002, J CELL SCI, V115, P4641, DOI 10.1242/jcs.00145; Manabe R, 1997, J CELL BIOL, V139, P295, DOI 10.1083/jcb.139.1.295; Manabe RI, 2008, P NATL ACAD SCI USA, V105, P12849, DOI 10.1073/pnas.0803640105; Morimura N, 2001, J BIOL CHEM, V276, P42172, DOI 10.1074/jbc.M103216200; Mould AP, 2000, J BIOL CHEM, V275, P20324, DOI 10.1074/jbc.M000572200; Mould AP, 2003, J BIOL CHEM, V278, P39993, DOI 10.1074/jbc.M304627200; Muller U, 1997, CELL, V88, P603, DOI 10.1016/S0092-8674(00)81903-0; MULLER U, 1995, MOL BIOL CELL, V6, P433; Nishiuchi R, 2006, MATRIX BIOL, V25, P189, DOI 10.1016/j.matbio.2005.12.001; Nishiuchi R, 2003, J BIOCHEM, V134, P497, DOI 10.1093/jb/mvg185; OBARA M, 1988, CELL, V53, P649, DOI 10.1016/0092-8674(88)90580-6; Osada A, 2005, EXP CELL RES, V303, P148, DOI 10.1016/j.yexcr.2004.04.053; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; Redick SD, 2000, J CELL BIOL, V149, P521, DOI 10.1083/jcb.149.2.521; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Scherberich A, 2005, ONCOGENE, V24, P1525, DOI 10.1038/sj.onc.1208342; Scherberich A, 2004, J CELL SCI, V117, P571, DOI 10.1242/jcs.00867; SCHNAPP LM, 1995, J BIOL CHEM, V270, P23196, DOI 10.1074/jbc.270.39.23196; SEKIGUCHI K, 1983, J BIOL CHEM, V258, P4359; Takagi J, 2004, BIOCHEM SOC T, V32, P403, DOI 10.1042/BST0320403; Takagi J, 2002, CELL, V110, P599, DOI 10.1016/S0092-8674(02)00935-2; Takagi J, 2001, NAT STRUCT BIOL, V8, P412, DOI 10.1038/87569; Takagi J, 2007, CURR OPIN CELL BIOL, V19, P557, DOI 10.1016/j.ceb.2007.09.002; von der Mark H, 2007, J MOL BIOL, V371, P1188, DOI 10.1016/j.jmb.2007.05.074; Wagner TE, 2003, J HISTOCHEM CYTOCHEM, V51, P1307, DOI 10.1177/002215540305101008; Xiao T, 2004, NATURE, V432, P59, DOI 10.1038/nature02976; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; YATOHGO T, 1988, CELL STRUCT FUNCT, V13, P281, DOI 10.1247/csf1975.13.281	48	51	54	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14524	14536		10.1074/jbc.M900200200	http://dx.doi.org/10.1074/jbc.M900200200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19342381	hybrid, Green Published			2022-12-27	WOS:000266286100059
J	Takaku, M; Machida, S; Hosoya, N; Nakayama, S; Takizawa, Y; Sakane, I; Shibata, T; Miyagawa, K; Kurumizaka, H				Takaku, Motoki; Machida, Shinichi; Hosoya, Noriko; Nakayama, Shugo; Takizawa, Yoshimasa; Sakane, Isao; Shibata, Takehiko; Miyagawa, Kiyoshi; Kurumizaka, Hitoshi			Recombination Activator Function of the Novel RAD51-and RAD51B-binding Protein, Human EVL	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STRAND BREAK REPAIR; HUMAN RAD52 PROTEIN; HOMOLOGOUS RECOMBINATION; DNA-REPAIR; EXCHANGE ACTIVITY; COMPLEX-FORMATION; VERTEBRATE CELLS; BINDING PROTEIN; USTILAGO-MAYDIS; MOUSE GENES	The RAD51 protein is a central player in homologous recombinational repair. The RAD51B protein is one of five RAD51 paralogs that function in the homologous recombinational repair pathway in higher eukaryotes. In the present study, we found that the human EVL (Ena/Vasp-like) protein, which is suggested to be involved in actin-remodeling processes, unexpectedly binds to the RAD51 and RAD51B proteins and stimulates the RAD51-mediated homologous pairing and strand exchange. The EVL knockdown cells impaired RAD51 assembly onto damaged DNA after ionizing radiation or mitomycin C treatment. The EVL protein alone promotes single-stranded DNA annealing, and the recombination activities of the EVL protein are further enhanced by the RAD51B protein. The expression of the EVL protein is not ubiquitous, but it is significantly expressed in breast cancer-derived MCF7 cells. These results suggest that the EVL protein is a novel recombination factor that may be required for repairing specific DNA lesions, and that may cause tumor malignancy by its inappropriate expression.	[Takaku, Motoki; Machida, Shinichi; Nakayama, Shugo; Takizawa, Yoshimasa; Sakane, Isao; Kurumizaka, Hitoshi] Waseda Univ, Inst Adv Sci & Med Care, Grad Sch Adv Sci & Engn & Consolidated Res, Struct Biol Lab,Shinjuku Ku, Tokyo 1628480, Japan; [Hosoya, Noriko; Miyagawa, Kiyoshi] Univ Tokyo, Grad Sch Med, Ctr Dis Biol & Integrat Med, Lab Mol Radiol,Bunkyo ku, Tokyo 1130033, Japan; [Shibata, Takehiko] RIKEN, Adv Sci Inst, Wako, Saitama 3510198, Japan	Waseda University; University of Tokyo; RIKEN	Kurumizaka, H (corresponding author), Waseda Univ, Inst Adv Sci & Med Care, Grad Sch Adv Sci & Engn & Consolidated Res, Struct Biol Lab,Shinjuku Ku, 2-2 Wakamatsu Cho, Tokyo 1628480, Japan.	kurumizaka@waseda.jp	Takaku, Motoki/AAT-7972-2020; Hosoya, Noriko/AAA-1447-2022; Takizawa, Yoshimasa/G-2956-2015	Takaku, Motoki/0000-0002-8652-2541; Hosoya, Noriko/0000-0002-1418-0677; Takizawa, Yoshimasa/0000-0002-6265-4830; Kurumizaka, Hitoshi/0000-0001-7412-3722	Ministry of Education, Culture, Sports, Science, and Technology, Japan; Grants-in-Aid for Scientific Research [21310034] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Agarwal S, 2006, DNA REPAIR, V5, P1075, DOI 10.1016/j.dnarep.2006.05.029; Albala JS, 1997, GENOMICS, V46, P476, DOI 10.1006/geno.1997.5062; Baumann P, 1996, CELL, V87, P757, DOI 10.1016/S0092-8674(00)81394-X; Benson FE, 1998, NATURE, V391, P401, DOI 10.1038/34937; Bleuyard JY, 2005, PLANT J, V41, P533, DOI 10.1111/j.1365-313X.2004.02318.x; Cartwright R, 1998, NUCLEIC ACIDS RES, V26, P1653, DOI 10.1093/nar/26.7.1653; Date O, 2006, CANCER RES, V66, P6018, DOI 10.1158/0008-5472.CAN-05-2803; Davies AA, 2001, MOL CELL, V7, P273, DOI 10.1016/S1097-2765(01)00175-7; Davies OR, 2007, NAT STRUCT MOL BIOL, V14, P475, DOI 10.1038/nsmb1251; Esashi F, 2005, NATURE, V434, P598, DOI 10.1038/nature03404; Esashi F, 2007, NAT STRUCT MOL BIOL, V14, P468, DOI 10.1038/nsmb1245; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Fujimori A, 2001, EMBO J, V20, P5513, DOI 10.1093/emboj/20.19.5513; Galkin VE, 2005, P NATL ACAD SCI USA, V102, P8537, DOI 10.1073/pnas.0407266102; Golub EI, 1997, NUCLEIC ACIDS RES, V25, P4106, DOI 10.1093/nar/25.20.4106; Gupta RC, 1997, P NATL ACAD SCI USA, V94, P463, DOI 10.1073/pnas.94.2.463; Hatanaka A, 2005, MOL CELL BIOL, V25, P1124, DOI 10.1128/MCB.25.3.1124-1134.2005; HENRICKSEN LA, 1994, J BIOL CHEM, V269, P11121; Hu LD, 2008, ONCOL REP, V19, P1015; Ishida T, 2008, GENES CELLS, V13, P91, DOI 10.1111/j.1365-2443.2007.01143.x; Kagawa W, 2001, J BIOL CHEM, V276, P35201, DOI 10.1074/jbc.M104938200; Kagawa W, 2008, J BIOL CHEM, V283, P24264, DOI 10.1074/jbc.M802204200; Kinebuchi T, 2004, MOL CELL, V14, P363, DOI 10.1016/S1097-2765(04)00218-7; Kovalenko OV, 1997, NUCLEIC ACIDS RES, V25, P4946, DOI 10.1093/nar/25.24.4946; Kurumizaka H, 1999, J MOL BIOL, V291, P537, DOI 10.1006/jmbi.1999.2950; Kwiatkowski AV, 2003, TRENDS CELL BIOL, V13, P386, DOI 10.1016/S0962-8924(03)00130-2; Lio YC, 2003, J BIOL CHEM, V278, P2469, DOI 10.1074/jbc.M211038200; Maeshima K, 1996, GENES CELLS, V1, P1057, DOI 10.1046/j.1365-2443.1996.d01-224.x; Masson JY, 2001, GENE DEV, V15, P3296, DOI 10.1101/gad.947001; Mazina OM, 2004, J BIOL CHEM, V279, P52042, DOI 10.1074/jbc.M410244200; Mazloum N, 2008, P NATL ACAD SCI USA, V105, P524, DOI 10.1073/pnas.0707031105; Mazloum N, 2007, BIOCHEMISTRY-US, V46, P7163, DOI 10.1021/bi700399m; Mcllwraith MJ, 2008, MOL CELL, V29, P510, DOI 10.1016/j.molcel.2007.11.037; Modesti M, 2007, MOL CELL, V28, P468, DOI 10.1016/j.molcel.2007.08.025; Mortensen UH, 1996, P NATL ACAD SCI USA, V93, P10729, DOI 10.1073/pnas.93.20.10729; New JH, 1998, NATURE, V391, P407, DOI 10.1038/34950; Ohta S, 1997, BIOCHEM BIOPH RES CO, V237, P307, DOI 10.1006/bbrc.1997.7113; Osakabe K, 2005, PLANT MOL BIOL, V57, P819, DOI 10.1007/s11103-005-2187-1; Pellegrini L, 2002, NATURE, V420, P287, DOI 10.1038/nature01230; Petalcorin MIR, 2007, P NATL ACAD SCI USA, V104, P8299, DOI [10.1073/pnas.0702805104, 10.1073/pnas.0702808104]; Reddy G, 1997, MUTAT RES-FUND MOL M, V377, P53, DOI 10.1016/S0027-5107(97)00057-2; Rice MC, 1997, P NATL ACAD SCI USA, V94, P7417, DOI 10.1073/pnas.94.14.7417; Schild D, 2000, J BIOL CHEM, V275, P16443, DOI 10.1074/jbc.M001473200; Shen ZY, 1996, J BIOL CHEM, V271, P148, DOI 10.1074/jbc.271.1.148; Shinohara A, 1998, NATURE, V391, P404, DOI 10.1038/34943; SHIVJI MK, NUCL ACIDS RES, V34, P4000; Sigurdsson S, 2002, J BIOL CHEM, V277, P42790, DOI 10.1074/jbc.M208004200; Sigurdsson S, 2001, GENE DEV, V15, P3308, DOI 10.1101/gad.935501; Sugiyama T, 1998, P NATL ACAD SCI USA, V95, P6049, DOI 10.1073/pnas.95.11.6049; Sung P, 2003, J BIOL CHEM, V278, P42729, DOI 10.1074/jbc.R300027200; SUNG P, 1994, SCIENCE, V265, P1241, DOI 10.1126/science.8066464; Sung P, 1997, J BIOL CHEM, V272, P28194, DOI 10.1074/jbc.272.45.28194; Sung P, 2006, NAT REV MOL CELL BIO, V7, P739, DOI 10.1038/nrm2008; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Takata M, 2000, MOL CELL BIOL, V20, P6476, DOI 10.1128/MCB.20.17.6476-6482.2000; Tanaka K, 2000, J BIOL CHEM, V275, P26316, DOI 10.1074/jbc.M910306199; Weinstock DM, 2006, DNA REPAIR, V5, P1065, DOI 10.1016/j.dnarep.2006.05.028; Wesoly J, 2006, MOL CELL BIOL, V26, P976, DOI 10.1128/MCB.26.3.976-989.2006; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Wiese C, 2007, MOL CELL, V28, P482, DOI 10.1016/j.molcel.2007.08.027; Wyman C, 2006, ANNU REV GENET, V40, P363, DOI 10.1146/annurev.genet.40.110405.090451; Yamaguchi-Iwai Y, 1998, MOL CELL BIOL, V18, P6430, DOI 10.1128/MCB.18.11.6430; Yang HJ, 2002, SCIENCE, V297, P1837, DOI 10.1126/science.297.5588.1837; Yokoyama H, 2004, NUCLEIC ACIDS RES, V32, P2556, DOI 10.1093/nar/gkh578; Yokoyama H, 2003, J BIOL CHEM, V278, P2767, DOI 10.1074/jbc.M210899200; Yonetani Y, 2005, NUCLEIC ACIDS RES, V33, P4544, DOI 10.1093/nar/gki766	66	16	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14326	14336		10.1074/jbc.M807715200	http://dx.doi.org/10.1074/jbc.M807715200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19329439	Green Published, hybrid			2022-12-27	WOS:000266286100039
J	Aimanianda, V; Clavaud, C; Simenel, C; Fontaine, T; Delepierre, M; Latge, JP				Aimanianda, Vishukumar; Clavaud, Cecile; Simenel, Catherine; Fontaine, Thierry; Delepierre, Muriel; Latge, Jean-Paul			Cell Wall beta-(1,6)-Glucan of Saccharomyces cerevisiae STRUCTURAL CHARACTERIZATION AND IN SITU SYNTHESIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-1,6-GLUCAN SYNTHESIS; CANDIDA-ALBICANS; GENE ENCODES; MEMBRANE-PROTEIN; GLUCAN SYNTHESIS; OSMOTIC SHOCK; BETA-GLUCANS; YEAST; GROWTH; SPECTROSCOPY	Despite its essential role in the yeast cell wall, the exact composition of the beta-(1,6)-glucan component is not well characterized. While solubilizing the cell wall alkali-insoluble fraction from a wild type strain of Saccharomyces cerevisiae using a recombinant beta-(1,3)-glucanase followed by chromatographic characterization of the digest on an anion exchange column, we observed a soluble polymer that eluted at the end of the solvent gradient run. Further characterization indicated this soluble polymer to have a molecular mass of similar to 38 kDa and could be hydrolyzed only by beta-(1,6)-glucanase. Gas chromatography-mass spectrometry and NMR(H-1 and C-13) analyses confirmed it to be a beta-(1,6)-glucan polymer with, on average, branching at every fifth residue with one or two beta-(1,3)-linked glucose units in the side chain. This polymer peak was significantly reduced in the corresponding digests from mutants of the kre genes (kre9 and kre5) that are known to play a crucial role in the beta-(1,6)glucan biosynthesis. In the current study, we have developed a biochemical assay wherein incubation of UDP-[C-14] glucose with permeabilized S. cerevisiae yeasts resulted in the synthesis of a polymer chemically identical to the branched beta-(1,6)-glucan isolated from the cell wall. Using this assay, parameters essential for beta-(1,6)-glucan synthetic activity were defined.	[Aimanianda, Vishukumar; Clavaud, Cecile; Fontaine, Thierry; Latge, Jean-Paul] Inst Pasteur, CNRS, URA 2185, Unite Aspergillus, F-75724 Paris 15, France; [Simenel, Catherine; Delepierre, Muriel] Inst Pasteur, CNRS, URA 2185, Unite Resonance Magnet Nucl Biomol, F-75724 Paris 15, France	Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Latge, JP (corresponding author), Inst Pasteur, CNRS, URA 2185, Unite Aspergillus, 25-28 Rue Dr Roux, F-75724 Paris 15, France.	jplatge@pasteur.fr	Fontaine, Thierry/F-8227-2011; Aimanianda, Vishukumar/E-9204-2011; Fontaine, thierry/Q-2201-2018; Latge, Jean Paul/C-9846-2014	Aimanianda, Vishukumar/0000-0001-5813-7497; Fontaine, thierry/0000-0002-8184-789X; 	European Union [LSHB CT 2004-511952]	European Union(European Commission)	This work was supported in part by European Union STREP Fungwall Grant LSHB CT 2004-511952.	BATRA KK, 1969, CARBOHYD RES, V9, P221, DOI 10.1016/S0008-6215(00)82137-0; BOCK K, 1974, J CHEM SOC PERK T 2, P293, DOI 10.1039/p29740000293; BROWN JL, 1993, MOL CELL BIOL, V13, P6346, DOI 10.1128/MCB.13.10.6346; Cabib E, 2008, J BIOL CHEM, V283, P29859, DOI 10.1074/jbc.M804274200; Chelico L, 2003, MYCOLOGIA, V95, P976, DOI 10.2307/3762025; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Crotti LB, 2001, ANAL BIOCHEM, V292, P8, DOI 10.1006/abio.2001.5051; DELACRUZ J, 1995, J BACTERIOL, V177, P1864, DOI 10.1128/jb.177.7.1864-1871.1995; Dijkgraaf GJP, 1996, YEAST, V12, P683, DOI 10.1002/(SICI)1097-0061(19960615)12:7<683::AID-YEA959>3.0.CO;2-8; Feldmesser M, 2000, J INFECT DIS, V182, P1791, DOI 10.1086/317614; FELIX H, 1982, ANAL BIOCHEM, V120, P211, DOI 10.1016/0003-2697(82)90340-2; FONTAINE T, 1991, ANAL BIOCHEM, V199, P154, DOI 10.1016/0003-2697(91)90083-6; Fontaine T, 2000, J BIOL CHEM, V275, P27594; GOLDSTEIN I. J., 1965, METHOD CARBOHYD CHEM, V5, P361; GRIESINGER C, 1988, J AM CHEM SOC, V110, P7870, DOI 10.1021/ja00231a044; Herrero AB, 2004, EUKARYOT CELL, V3, P1423, DOI 10.1128/EC.3.6.1423-1432.2004; Humbel BM, 2001, YEAST, V18, P433, DOI 10.1002/yea.694; Iorio E, 2008, CARBOHYD RES, V343, P1050, DOI 10.1016/j.carres.2008.02.020; KANG MS, 1986, P NATL ACAD SCI USA, V83, P5808, DOI 10.1073/pnas.83.16.5808; KAPTEYN JC, 1995, J BACTERIOL, V177, P3788, DOI 10.1128/jb.177.13.3788-3792.1995; Kapteyn JC, 1996, GLYCOBIOLOGY, V6, P337, DOI 10.1093/glycob/6.3.337; Kapteyn JC, 1999, BBA-GEN SUBJECTS, V1426, P373, DOI 10.1016/S0304-4165(98)00137-8; Klis FM, 2006, YEAST, V23, P185, DOI 10.1002/yea.1349; Klis FM, 2002, FEMS MICROBIOL REV, V26, P239, DOI 10.1016/S0168-6445(02)00087-6; Kollar R, 1997, J BIOL CHEM, V272, P17762, DOI 10.1074/jbc.272.28.17762; Lequette Y, 2007, MICROBIOL-SGM, V153, P3255, DOI 10.1099/mic.0.2007/008953-0; Lesage G, 2006, MICROBIOL MOL BIOL R, V70, P317, DOI 10.1128/MMBR.00038-05; Levinson JN, 2002, YEAST, V19, P1243, DOI 10.1002/yea.908; Llull D, 2001, J BIOL CHEM, V276, P21053, DOI 10.1074/jbc.M010287200; LOPEZROMERO E, 1977, BIOCHIM BIOPHYS ACTA, V500, P372, DOI 10.1016/0304-4165(77)90028-9; Lussier M, 1998, P NATL ACAD SCI USA, V95, P9825, DOI 10.1073/pnas.95.17.9825; MACURA S, 1981, J MAGN RESON, V43, P259, DOI 10.1016/0022-2364(81)90037-8; Magnelli P, 2002, ANAL BIOCHEM, V301, P136, DOI 10.1006/abio.2001.5473; MANNERS DJ, 1973, BIOCHEM J, V135, P31, DOI 10.1042/bj1350031; MEADEN P, 1990, MOL CELL BIOL, V10, P3013, DOI 10.1128/MCB.10.6.3013; Mio T, 1997, J BACTERIOL, V179, P2363, DOI 10.1128/jb.179.7.2363-2372.1997; Montijn RC, 1999, J BACTERIOL, V181, P7414, DOI 10.1128/JB.181.24.7414-7420.1999; Mrsa V, 1997, YEAST, V13, P1145; Mukerjea R, 1996, CARBOHYD RES, V292, P11; Nagahashi S, 1998, J BACTERIOL, V180, P5020, DOI 10.1128/JB.180.19.5020-5029.1998; PARENTE JP, 1985, CARBOHYD RES, V141, P41, DOI 10.1016/S0008-6215(00)90753-5; Portela P, 2006, BIOCHEM J, V396, P117, DOI 10.1042/BJ20051642; RANCE M, 1983, BIOCHEM BIOPH RES CO, V117, P479, DOI 10.1016/0006-291X(83)91225-1; ROEMER T, 1994, J CELL BIOL, V127, P567, DOI 10.1083/jcb.127.2.567; ROEMER T, 1991, P NATL ACAD SCI USA, V88, P11295, DOI 10.1073/pnas.88.24.11295; Rubio MC, 2006, ENZYME MICROB TECH, V39, P601, DOI 10.1016/j.enzmictec.2005.11.011; SAWARDEKAR JS, 1967, ANAL CHEM, V37, P1602; Schmid F, 2006, CARBOHYD RES, V341, P365, DOI 10.1016/j.carres.2005.10.013; Sestak S, 2001, ANAL BIOCHEM, V292, P34; Shahinian S, 2000, MOL MICROBIOL, V35, P477, DOI 10.1046/j.1365-2958.2000.01713.x; Stevens DA, 2006, ANTIMICROB AGENTS CH, V50, P3160, DOI 10.1128/AAC.00563-06; TEHEESEN S, 1994, EUR J BIOCHEM, V224, P71, DOI 10.1111/j.1432-1033.1994.tb19996.x; Vink E, 2004, YEAST, V21, P1121, DOI 10.1002/yea.1156; WAGNER G, 1983, J MAGN RESON, V55, P151, DOI 10.1016/0022-2364(83)90284-6; WILLKER W, 1993, MAGN RESON CHEM, V31, P287, DOI 10.1002/mrc.1260310315; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Zverlov VV, 1997, MICROBIOL-SGM, V143, P3537, DOI 10.1099/00221287-143-11-3537	58	87	90	3	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13401	13412		10.1074/jbc.M807667200	http://dx.doi.org/10.1074/jbc.M807667200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19279004	hybrid, Green Published			2022-12-27	WOS:000265877300016
J	Han, D; Qureshi, HY; Lu, YF; Paudel, HK				Han, Dong; Qureshi, Hamid Y.; Lu, Yifan; Paudel, Hemant K.			Familial FTDP-17 Missense Mutations Inhibit Microtubule Assembly-promoting Activity of Tau by Increasing Phosphorylation at Ser(202) in Vitro	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; GLYCOGEN-SYNTHASE KINASE-3-BETA; CDC2-LIKE PROTEIN-KINASE; CYCLIN-DEPENDENT PROTEIN-KINASE-5; ALZHEIMERS-DISEASE; FRONTOTEMPORAL DEMENTIA; ABNORMAL PHOSPHORYLATION; MASS-SPECTROMETRY; BRAIN; PATHOLOGY	In Alzheimer disease (AD), frontotemporal dementia and parkinsonism linked to chromosome 17 (FTDP-17) and other tauopathies, tau accumulates and forms paired helical filaments (PHFs) in the brain. Tau isolated from PHFs is phosphorylated at a number of sites, migrates as similar to 60-, 64-, and 68-kDa bands on SDS-gel, and does not promote microtubule assembly. Upon dephosphorylation, the PHF-tau migrates as similar to 50-60-kDa bands on SDS-gels in a manner similar to tau that is isolated from normal brain and promotes microtubule assembly. The site(s) that inhibits microtubule assembly-promoting activity when phosphorylated in the diseased brain is not known. In this study, when tau was phosphorylated by Cdk5 in vitro, its mobility shifted from similar to 60-kDa bands to similar to 64- and 68-kDa bands in a time-dependent manner. This mobility shift correlated with phosphorylation at Ser(202), and Ser(202) phosphorylation inhibited tau microtubule-assembly promoting activity. When several tau point mutants were analyzed, G272V, P301L, V337M, and R406W mutations associated with FTDP-17, but not nonspecific mutations S214A and S262A, promoted Ser(202) phosphorylation and mobility shift to a similar to 68-kDa band. Furthermore, Ser(202) phosphorylation inhibited the microtubule assembly-promoting activity of FTDP-17 mutants more than of WT. Our data indicate that FTDP-17 missense mutations, by promoting phosphorylation at Ser(202), inhibit the microtubule assembly-promoting activity of tau in vitro, suggesting that Ser(202) phosphorylation plays a major role in the development of NFT pathology in AD and related tauopathies.	[Han, Dong; Qureshi, Hamid Y.; Lu, Yifan; Paudel, Hemant K.] Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Bloomfield Ctr Res Aging, Montreal, PQ H3T 1E2, Canada; [Paudel, Hemant K.] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H3T 1E2, Canada	Lady Davis Institute; McGill University; McGill University	Paudel, HK (corresponding author), Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Bloomfield Ctr Res Aging, 3755 Cote Ste Catherine, Montreal, PQ H3T 1E2, Canada.	hemant.paudel@mcgill.ca			Canadian Institute for Health Research; Alzheimer Society of Canada; National Science and Engineering Research Council of Canada	Canadian Institute for Health Research(Canadian Institutes of Health Research (CIHR)); Alzheimer Society of Canada; National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by grants from the Canadian Institute for Health Research, the Alzheimer Society of Canada, and the National Science and Engineering Research Council of Canada.	Agarwal-Mawal A, 2001, J BIOL CHEM, V276, P23712, DOI 10.1074/jbc.M010002200; ALONSO AD, 1994, P NATL ACAD SCI USA, V91, P5562, DOI 10.1073/pnas.91.12.5562; Alonso AD, 2004, J BIOL CHEM, V279, P34873, DOI 10.1074/jbc.M405131200; Arima K, 2000, NEUROLOGY, V54, P1787, DOI 10.1212/WNL.54.9.1787; Avila J, 2004, PHYSIOL REV, V84, P361, DOI 10.1152/physrev.00024.2003; BIERNAT J, 1993, NEURON, V11, P153, DOI 10.1016/0896-6273(93)90279-Z; BRAAK E, 1994, ACTA NEUROPATHOL, V87, P554, DOI 10.1007/s004010050124; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; BRAMBLETT GT, 1993, NEURON, V10, P1089, DOI 10.1016/0896-6273(93)90057-X; Bronner IF, 2005, BRAIN, V128, P2645, DOI 10.1093/brain/awh591; Clark LN, 1998, P NATL ACAD SCI USA, V95, P13103, DOI 10.1073/pnas.95.22.13103; Connell JW, 2001, FEBS LETT, V493, P40, DOI 10.1016/S0014-5793(01)02267-0; Crowther RA, 2000, J STRUCT BIOL, V130, P271, DOI 10.1006/jsbi.2000.4270; FLAMENT S, 1990, ACTA NEUROPATHOL, V80, P212, DOI 10.1007/BF00308927; FLAMENT S, 1989, FEBS LETT, V247, P213, DOI 10.1016/0014-5793(89)81337-7; GELFAND VI, 1991, ANNU REV CELL BIOL, V7, P93, DOI 10.1146/annurev.cb.07.110191.000521; GOEDERT M, 1995, NEUROSCI LETT, V189, P167, DOI 10.1016/0304-3940(95)11484-E; GOEDERT M, 1992, NEURON, V8, P159, DOI 10.1016/0896-6273(92)90117-V; GOEDERT M, 1993, P NATL ACAD SCI USA, V90, P5066, DOI 10.1073/pnas.90.11.5066; GREENBERG SG, 1990, P NATL ACAD SCI USA, V87, P5827, DOI 10.1073/pnas.87.15.5827; GUSTKE N, 1994, BIOCHEMISTRY-US, V33, P9511, DOI 10.1021/bi00198a017; Hanger DP, 1998, J NEUROCHEM, V71, P2465; Hasegawa M, 1998, FEBS LETT, V437, P207, DOI 10.1016/S0014-5793(98)01217-4; Hashiguchi M, 2000, J BIOL CHEM, V275, P25247, DOI 10.1074/jbc.M003738200; Hong M, 1998, SCIENCE, V282, P1914, DOI 10.1126/science.282.5395.1914; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Iqbal K, 2005, BBA-MOL BASIS DIS, V1739, P198, DOI 10.1016/j.bbadis.2004.09.008; Jicha GA, 1999, J NEUROSCI, V19, P7486, DOI 10.1523/JNEUROSCI.19-17-07486.1999; Krishnamurthy PK, 2004, J BIOL CHEM, V279, P7893, DOI 10.1074/jbc.M311203200; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Li T, 2006, BIOCHEMISTRY-US, V45, P3134, DOI 10.1021/bi051635j; Li T, 2006, BIOCHEMISTRY-US, V45, P3125, DOI 10.1021/bi051634r; Li T, 2007, J BIOL CHEM, V282, P6619, DOI 10.1074/jbc.M606347200; Lu PJ, 1999, NATURE, V399, P784; Mack TGA, 2001, NEUROSCIENCE, V108, P701, DOI 10.1016/S0306-4522(01)00434-1; Matsumura N, 1999, AM J PATHOL, V154, P1649, DOI 10.1016/S0002-9440(10)65420-X; Mesulam M, 2004, ANN NEUROL, V55, P815, DOI 10.1002/ana.20100; MORISHIMAKAWASHIMA M, 1995, J BIOL CHEM, V270, P823, DOI 10.1074/jbc.270.2.823; Paudel HK, 1997, J BIOL CHEM, V272, P28328, DOI 10.1074/jbc.272.45.28328; PAUDEL HK, 1993, J BIOL CHEM, V268, P23512; Perez M, 2000, J NEUROCHEM, V74, P2583, DOI 10.1046/j.1471-4159.2000.0742583.x; Sahara N, 2000, J NEUROSCI RES, V60, P380, DOI 10.1002/(SICI)1097-4547(20000501)60:3<380::AID-JNR13>3.0.CO;2-5; SCOTT CW, 1993, J BIOL CHEM, V268, P1166; Sobue K, 2000, J BIOL CHEM, V275, P16673, DOI 10.1074/jbc.M000784200; Spillantini MG, 1996, ACTA NEUROPATHOL, V92, P42, DOI 10.1007/s004010050487; Spillantini MG, 1998, AM J PATHOL, V153, P1359, DOI 10.1016/S0002-9440(10)65721-5; STEINER B, 1990, EMBO J, V9, P3539, DOI 10.1002/j.1460-2075.1990.tb07563.x; Sun W, 2002, J BIOL CHEM, V277, P11933, DOI 10.1074/jbc.M107182200; van Swieten JC, 1999, ANN NEUROL, V46, P617, DOI 10.1002/1531-8249(199910)46:4<617::AID-ANA10>3.0.CO;2-I; Vogelsberg-Ragaglia V, 2000, MOL BIOL CELL, V11, P4093, DOI 10.1091/mbc.11.12.4093; Yang LS, 1997, J NEUROCHEM, V69, P1548; Yuan ZF, 2004, J BIOL CHEM, V279, P26105, DOI 10.1074/jbc.M308298200	53	35	37	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13422	13433		10.1074/jbc.M901095200	http://dx.doi.org/10.1074/jbc.M901095200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19304664	Green Published, hybrid			2022-12-27	WOS:000265877300018
J	Chernov, AV; Sounni, NE; Remacle, AG; Strongin, AY				Chernov, Andrei V.; Sounni, Nor Eddine; Remacle, Albert G.; Strongin, Alex Y.			Epigenetic Control of the Invasion-promoting MT1-MMP/MMP-2/TIMP-2 Axis in Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYPE-1 MATRIX-METALLOPROTEINASE; EMBRYONIC STEM-CELLS; INTEGRIN ALPHA(V) SUBUNIT; BREAST-CARCINOMA CELLS; HISTONE H3; DEVELOPMENTAL REGULATORS; LYSINE-9 METHYLATION; TISSUE INHIBITOR; GENE-EXPRESSION; MEMBRANE	Membrane type-1 matrix metalloproteinase (MT1-MMP) is an activator of soluble MMP-2. The activity of both MMPs is regulated by their physiological inhibitor TIMP-2. An MT1-MMP/MMP-2/TIMP-2 axis plays a key role in the invasive behavior of many cell types. Despite its importance, epigenetic control of this pro-invasive axis is insufficiently studied, and, as a result, its modification in a rational and clinically beneficial manner is exceedingly difficult. Therefore, we performed an epigenetic analysis of the MT1-MMP, MMP-2, and TIMP-2 gene promoters in highly migratory glioblastoma cells and in low migratory breast carcinoma MCF-7 cells. We determined, for the first time, that the epigenetic control leading to the transcriptional silencing of both MMPs includes hypermethylation of the corresponding CpG regions and histone H3 lysine-27 trimethylation (H3K27me3). In turn, undermethylation of the CpG islands and low levels of histone H3 lysine-27 trimethylation are features of transcriptionally active MT1-MMP and MMP-2 genes in invasive cancer cells. Additional histone modifications we have analyzed, including H3ac and H3K4me2, are present in both transcriptionally active and inactive promoters of both MMPs. Histone H3 lysine-4 trimethylation is likely to play no significant role in regulating MT1-MMP and MMP-2. The pattern of epigenetic regulation of TIMP-2 was clearly distinct from that of MMPs and included the coordinated methylation and demethylation of the two CpG regions in the promoter. Our results suggest that the epigenetic control plays an important role in both the balanced regulation of the MT1-MMP/MMP-2/TIMP-2 axis and the invasive behavior in cancer cells.	[Chernov, Andrei V.; Sounni, Nor Eddine; Remacle, Albert G.; Strongin, Alex Y.] Burnham Inst Med Res, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Strongin, AY (corresponding author), Burnham Inst Med Res, La Jolla, CA 92037 USA.	strongin@burnham.org	Strongin, Alex/R-6609-2019; Chernov, Andrei/I-1623-2019; Sounni, Nor Eddine/AAY-8766-2021	Strongin, Alex/0000-0003-3765-3016; Chernov, Andrei/0000-0002-3294-5418; Sounni, Nor Eddine/0000-0001-9962-9236	National Institutes of Health [CA83017, CA77470, RR020843]; Susan G. Komen Breast Cancer Foundation [BCTR123106]; NATIONAL CANCER INSTITUTE [R01CA077470, R01CA083017] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [U54RR020843] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Susan G. Komen Breast Cancer Foundation(Susan G. Komen Breast Cancer Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grants CA83017, CA77470, and RR020843. This work was also supported by Susan G. Komen Breast Cancer Foundation Grant BCTR123106 (to A. Y. S.).	Atkinson SJ, 2006, BIOCHEM J, V398, P15, DOI 10.1042/BJ20060243; Azuara V, 2006, NAT CELL BIOL, V8, P532, DOI 10.1038/ncb1403; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2002, P NATL ACAD SCI USA, V99, P8695, DOI 10.1073/pnas.082249499; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Chicoine E, 2002, BIOCHEM BIOPH RES CO, V297, P765, DOI 10.1016/S0006-291X(02)02283-0; Clark IA, 2008, INT J BIOCHEM CELL B, V40, P1362, DOI 10.1016/j.biocel.2007.12.006; Clark IM, 2007, FRONT BIOSCI, V12, P528, DOI 10.2741/2079; Curtin M, 2003, CURR MED CHEM, V10, P2373, DOI 10.2174/0929867033456576; Deryugina EI, 1997, J CELL SCI, V110, P2473; Deryugina EI, 2002, J BIOL CHEM, V277, P9749, DOI 10.1074/jbc.M110269200; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; El-Aziz SHA, 2007, CANCER SCI, V98, P1330, DOI 10.1111/j.1349-7006.2007.00547.x; Friedl P, 2008, CANCER RES, V68, P7247, DOI 10.1158/0008-5472.CAN-08-0784; Fry CJ, 2001, CURR BIOL, V11, pR185, DOI 10.1016/S0960-9822(01)00090-2; Golubkov VS, 2005, J BIOL CHEM, V280, P42237, DOI 10.1074/jbc.M510139200; Holmbeck K, 1999, CELL, V99, P81, DOI 10.1016/S0092-8674(00)80064-1; Itoh T, 1997, J BIOL CHEM, V272, P22389, DOI 10.1074/jbc.272.36.22389; Itoh Y, 2006, IUBMB LIFE, V58, P589, DOI 10.1080/15216540600962818; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Murphy G, 1999, APMIS, V107, P38, DOI 10.1111/j.1699-0463.1999.tb01524.x; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Noel A, 2004, J CLIN PATHOL, V57, P577, DOI 10.1136/jcp.2003.014472; Oh J, 2004, ONCOGENE, V23, P5041, DOI 10.1038/sj.onc.1207688; Ohlsson R, 2001, TRENDS GENET, V17, P520, DOI 10.1016/S0168-9525(01)02366-6; Osenkowski P, 2004, J CELL PHYSIOL, V200, P2, DOI 10.1002/jcp.20064; Peters AHFM, 2002, NAT GENET, V30, P77, DOI 10.1038/ng789; Pulukuri SM, 2007, ONCOGENE, V26, P5229, DOI 10.1038/sj.onc.1210329; Ratnikov BI, 2002, J BIOL CHEM, V277, P7377, DOI 10.1074/jbc.M109580200; Roach HI, 2005, ARTHRITIS RHEUM-US, V52, P3110, DOI 10.1002/art.21300; Rozanov DV, 2001, J BIOL CHEM, V276, P25705, DOI 10.1074/jbc.M007921200; Rozen S, 2000, Methods Mol Biol, V132, P365; Seidah NG, 2008, INT J BIOCHEM CELL B, V40, P1111, DOI 10.1016/j.biocel.2008.01.030; Sounni NE, 2004, J BIOL CHEM, V279, P13564, DOI 10.1074/jbc.M307688200; Strongin AY, 2006, CANCER METAST REV, V25, P87, DOI 10.1007/s10555-006-7892-y; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; Swigut T, 2007, CELL, V131, P29, DOI 10.1016/j.cell.2007.09.026; Turner BM, 2005, NAT STRUCT MOL BIOL, V12, P110, DOI 10.1038/nsmb0205-110; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004	45	90	95	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12727	12734		10.1074/jbc.M900273200	http://dx.doi.org/10.1074/jbc.M900273200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19286653	Green Published, hybrid			2022-12-27	WOS:000265688300017
J	LaChapelle, S; Tweten, RK; Hotze, EM				LaChapelle, Stephanie; Tweten, Rodney K.; Hotze, Eileen M.			Intermedilysin-Receptor Interactions during Assembly of the Pore Complex ASSEMBLY INTERMEDIATES INCREASE HOST CELL SUSCEPTIBILITY TO COMPLEMENT-MEDIATED LYSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHOLESTEROL-DEPENDENT CYTOLYSIN; STREPTOCOCCUS-INTERMEDIUS; PERFRINGOLYSIN-O; CONFORMATIONAL-CHANGES; HUMAN CD59; MEMBRANE; TOXIN; BINDING; C5B-9; MECHANISM	Intermedilysin (ILY) is an unusual member of the family of cholesterol-dependent cytolysins because it binds to human CD59 (hCD59) rather than directly to cholesterol-rich membranes. Binding of ILY to hCD59 initiates a series of conformational changes within the toxin that result in the conversion of the soluble monomer into an oligomeric membrane-embedded pore complex. In this study the association of ILY with its membrane receptor has been examined throughout the assembly and formation of the pore complex. Using ILY mutants trapped at various stages of pore assembly, we show ILY remains engaged with hCD59 throughout the assembly of the prepore oligomer, but it disengages from the receptor upon the conversion to the pore complex. We further show that the assembly intermediates increase the sensitivity of the host cell to lysis by its complement membrane attack complex, apparently by blocking the hCD59-binding site for complement proteins C8 alpha and C9.	[LaChapelle, Stephanie; Tweten, Rodney K.; Hotze, Eileen M.] Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, Oklahoma City, OK 73104 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center	Hotze, EM (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Microbiol & Immunol, 940 Stanton L Young Blvd,BMSB 1053, Oklahoma City, OK 73190 USA.	eileen-hotze@ouhsc.edu			National Institutes of Health [P20 RR015564-08, AI063444]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015564] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063444] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants P20 RR015564-08 (to E. M. H.) and AI063444 (to R. K. T.) from NIAID.	BOULNOIS GJ, 1992, J GEN MICROBIOL, V138, P249, DOI 10.1099/00221287-138-2-249; Bricker AL, 2002, MOL MICROBIOL, V44, P257, DOI 10.1046/j.1365-2958.2002.02876.x; Brooke JS, 1998, BIOCHEM BIOPH RES CO, V248, P297, DOI 10.1006/bbrc.1998.8953; Czajkowsky DM, 2004, EMBO J, V23, P3206, DOI 10.1038/sj.emboj.7600350; Farkas I, 2002, J PHYSIOL-LONDON, V539, P537, DOI 10.1113/jphysiol.2001.013381; Gelber SE, 2008, J BACTERIOL, V190, P3896, DOI 10.1128/JB.01965-07; Ghiran I, 2003, J BIOL CHEM, V278, P21024, DOI 10.1074/jbc.M302306200; Giddings KS, 2004, NAT STRUCT MOL BIOL, V11, P1173, DOI 10.1038/nsmb862; Giddings KS, 2003, P NATL ACAD SCI USA, V100, P11315, DOI 10.1073/pnas.2033520100; HAMILTON KK, 1990, BLOOD, V76, P2572; Heuck AP, 2000, MOL CELL, V6, P1233, DOI 10.1016/S1097-2765(00)00119-2; Heuck AP, 2001, BIOCHEMISTRY-US, V40, P9065, DOI 10.1021/bi0155394; Hotze E, 2002, PERSPECTIVES IN MOLECULAR TOXINOLOGY, P23; Hotze EM, 2001, J BIOL CHEM, V276, P8261, DOI 10.1074/jbc.M009865200; Huang YX, 2005, J BIOL CHEM, V280, P34073, DOI 10.1074/jbc.M504922200; Kimberley FC, 2007, MOL IMMUNOL, V44, P73, DOI 10.1016/j.molimm.2006.06.019; Macey MG, 2001, INFECT IMMUN, V69, P6102, DOI 10.1128/IAI.69.10.6102-6109.2001; Nagamune H, 1996, INFECT IMMUN, V64, P3093, DOI 10.1128/IAI.64.8.3093-3100.1996; Nagamune H, 2000, J CLIN MICROBIOL, V38, P220; Nichols BJ, 2001, J CELL BIOL, V153, P529, DOI 10.1083/jcb.153.3.529; Otabor I, 2004, MOL IMMUNOL, V41, P185, DOI 10.1016/j.molimm.2004.03.029; Pecharki D, 2008, ORAL MICROBIOL IMMUN, V23, P79, DOI 10.1111/j.1399-302X.2007.00395.x; Polekhina G, 2005, P NATL ACAD SCI USA, V102, P600, DOI 10.1073/pnas.0403229101; PORTNOY DA, 1988, J EXP MED, V167, P1459, DOI 10.1084/jem.167.4.1459; Rainey GJA, 2005, P NATL ACAD SCI USA, V102, P13278, DOI 10.1073/pnas.0505865102; Ramachandran R, 2004, NAT STRUCT MOL BIOL, V11, P697, DOI 10.1038/nsmb793; Ramachandran R, 2002, NAT STRUCT BIOL, V9, P823, DOI 10.1038/nsb855; ROLLINS SA, 1990, J IMMUNOL, V144, P3478; ROLLINS SA, 1991, J IMMUNOL, V146, P2345; Rossjohn J, 1997, CELL, V89, P685, DOI 10.1016/S0092-8674(00)80251-2; Shepard LA, 1998, BIOCHEMISTRY-US, V37, P14563, DOI 10.1021/bi981452f; Soltani CE, 2007, P NATL ACAD SCI USA, V104, P20226, DOI 10.1073/pnas.0708104105; Soltani CE, 2007, J BIOL CHEM, V282, P15709, DOI 10.1074/jbc.M701173200; Tilley SJ, 2005, CELL, V121, P247, DOI 10.1016/j.cell.2005.02.033; Waheed AA, 2001, P NATL ACAD SCI USA, V98, P4926, DOI 10.1073/pnas.091090798; ZHAO J, 1991, J BIOL CHEM, V266, P13418	36	37	39	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12719	12726		10.1074/jbc.M900772200	http://dx.doi.org/10.1074/jbc.M900772200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19293153	Green Published, hybrid			2022-12-27	WOS:000265688300016
J	Holdensen, AN; Andersen, JP				Holdensen, Anne Nyholm; Andersen, Jens Peter			The Length of the A-M3 Linker Is a Crucial Determinant of the Rate of the Ca2+ Transport Cycle of Sarcoplasmic Reticulum Ca2+-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL CONSEQUENCES; STRUCTURAL BASIS; CALCIUM-TRANSPORT; DOMAIN; CA-2+-ATPASE; SITE; DEPHOSPHORYLATION; GLUTAMATE-183; EFFICIENCY; MUTATIONS	Ion translocation by the sarcoplasmic reticulum Ca2+-ATPase depends on large movements of the A-domain, but the driving forces have yet to be defined. The A-domain is connected to the ion-binding membranous part of the protein through linker regions. We have determined the functional consequences of changing the length of the linker between the A-domain and transmembrane helix M3 ("A-M3 linker") by insertion and deletion mutagenesis at two sites. It was feasible to insert as many as 41 residues (polyglycine and glycine-proline loops) in the flexible region of the linker without loss of the ability to react with Ca2+ and ATP and to form the phosphorylated Ca(2)E1P intermediate, but the rate of the energy-transducing conformational transition to E2P was reduced by >80%. Insertion of a smaller number of residues gave effects gradually increasing with the length of the insertion. Deletion of two residues at the same site, but not replacement with glycine, gave a similar reduction as the longest insertion. Insertion of one or three residues in another part of the A-M3 linker that forms an alpha-helix ("A3 helix") in E2/E2P conformations had even more profound effects on the ability of the enzyme to form E2P. These results demonstrate the importance of the length of the A-M3 linker and of the position and integrity of the A3 helix for stabilization of E2P and suggest that, during the normal enzyme cycle, strain of the A-M3 linker could contribute to destabilize the Ca(2)E1P state and thereby to drive the transition to E2P.	[Holdensen, Anne Nyholm; Andersen, Jens Peter] Aarhus Univ, Dept Physiol & Biophys, Ctr Membrane Pumps Cells & Dis PUMPKIN, Danish Natl Res Fdn, DK-8000 Aarhus C, Denmark	Aarhus University; Danmarks Grundforskningsfond	Andersen, JP (corresponding author), Aarhus Univ, Dept Physiol & Biophys, Ctr Membrane Pumps Cells & Dis PUMPKIN, Danish Natl Res Fdn, Bldg 1180,Ole Worms Alle 6, DK-8000 Aarhus C, Denmark.	jpa@fi.au.dk		Andersen, Jens Peter/0000-0003-0654-4300	Danish Medical Research Council; Novo Nordisk Foundation; Lundbeck Foundation; Danish National Research Foundation-PUMPKIN	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Lundbeck Foundation(Lundbeckfonden); Danish National Research Foundation-PUMPKIN(Danmarks Grundforskningsfond)	This work was supported in part by grants from the Danish Medical Research Council, the Novo Nordisk Foundation (Denmark), the Lundbeck Foundation (Denmark) ( to A. N. H.), and the Danish National Research Foundation- PUMPKIN.	Andersen JP, 2001, J BIOL CHEM, V276, P23312, DOI 10.1074/jbc.M102384200; ANDERSEN JP, 1989, J BIOL CHEM, V264, P21018; Anthonisen AN, 2006, J BIOL CHEM, V281, P31572, DOI 10.1074/jbc.M605194200; BAGINSKI ES, 1967, CLIN CHEM, V13, P326; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Clausen JD, 2006, J BIOL CHEM, V281, P9471, DOI 10.1074/jbc.M512371200; Clausen JD, 2004, J BIOL CHEM, V279, P54426, DOI 10.1074/jbc.M410204200; Clausen JD, 2004, P NATL ACAD SCI USA, V101, P2776, DOI 10.1073/pnas.0400122101; Daiho T, 2007, J BIOL CHEM, V282, P34429, DOI 10.1074/jbc.M707665200; DEMEIS L, 1980, BIOCHEMISTRY-US, V19, P4252, DOI 10.1021/bi00559a017; DEMEIS L, 1979, ANNU REV BIOCHEM, V48, P275; FALCHETTO R, 1992, PROTEIN SCI, V1, P1613, DOI 10.1002/pro.5560011209; FORGE V, 1993, J BIOL CHEM, V268, P10953; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; HASSELBACH W, 1963, BIOCHEM Z, V339, P94; JORGENSEN PL, 1988, J MEMBRANE BIOL, V103, P95, DOI 10.1007/BF01870942; KAUFMAN RJ, 1989, MOL CELL BIOL, V9, P946, DOI 10.1128/MCB.9.3.946; MARUYAMA K, 1988, P NATL ACAD SCI USA, V85, P3314, DOI 10.1073/pnas.85.10.3314; Moller JV, 2002, J BIOL CHEM, V277, P38647, DOI 10.1074/jbc.M204603200; Olesen C, 2004, SCIENCE, V306, P2251, DOI 10.1126/science.1106289; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Schack VR, 2008, J BIOL CHEM, V283, P27982, DOI 10.1074/jbc.M803506200; Sorensen T, 1997, J BIOL CHEM, V272, P30244, DOI 10.1074/jbc.272.48.30244; Sorensen TLM, 2000, J BIOL CHEM, V275, P5400, DOI 10.1074/jbc.275.8.5400; Strehler EE, 2001, PHYSIOL REV, V81, P21, DOI 10.1152/physrev.2001.81.1.21; Toyoshima C, 2004, ANNU REV BIOCHEM, V73, P269, DOI 10.1146/annurev.biochem.73.011303.073700; Toyoshima C, 2004, NATURE, V432, P361, DOI 10.1038/nature02981; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; TOYOSHIMA C, 2009, BIOCH BIOPH IN PRESS; VILSEN B, 1991, J BIOL CHEM, V266, P16157; VILSEN B, 1989, J BIOL CHEM, V264, P21024; WEBER K, 1969, J BIOL CHEM, V244, P4406	32	18	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12258	12265		10.1074/jbc.M900977200	http://dx.doi.org/10.1074/jbc.M900977200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19278994	Green Published, hybrid			2022-12-27	WOS:000265494600057
J	Butcher, AJ; Torrecilla, I; Young, KW; Kong, KC; Mistry, SC; Bottrill, AR; Tobin, AB				Butcher, Adrian J.; Torrecilla, Ignacio; Young, Kenneth W.; Kong, Kok Choi; Mistry, Sharad C.; Bottrill, Andrew R.; Tobin, Andrew B.			N-Methyl-D-aspartate Receptors Mediate the Phosphorylation and Desensitization of Muscarinic Receptors in Cerebellar Granule Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; PROTEIN-KINASE-C; SH-SY5Y NEUROBLASTOMA-CELLS; INOSITOL 1,4,5-TRISPHOSPHATE; COUPLED RECEPTORS; RAPID DESENSITIZATION; SYNAPTIC PLASTICITY; NMDA RECEPTORS; CA1 REGION; HIPPOCAMPUS	Changes in synaptic strength mediated by ionotropic glutamate N-methyl-D-asparate (NMDA) receptors is generally considered to be the molecular mechanism underlying memory and learning. NMDA receptors themselves are subject to regulation through signaling pathways that are activated by G-proteincoupled receptors (GPCRs). In this study we investigate the ability of NMDA receptors to regulate the signaling of GPCRs by focusing on the G(q/11)-coupled M-3-muscarinic receptor expressed endogenously in mouse cerebellar granule neurons. We show that NMDA receptor activation results in the phosphorylation and desensitization of M-3-muscarinic receptors through a mechanism dependent on NMDA-mediated calcium influx and the activity of calcium-calmodulin-dependent protein kinase II. Our study reveals a complex pattern of regulation where GPCRs (M-3-muscarinic) and NMDA receptors can feedback on each other in a process that is likely to influence the threshold value of signaling networks involved in synaptic plasticity.	[Butcher, Adrian J.; Torrecilla, Ignacio; Kong, Kok Choi; Tobin, Andrew B.] Univ Leicester, Dept Cell Physiol & Pharmacol, Leicester LE1 9HN, Leics, England; [Mistry, Sharad C.; Bottrill, Andrew R.] Univ Leicester, Prot & Nucle Acid Chem Lab, Leicester LE1 9HN, Leics, England; [Young, Kenneth W.] MRC, Toxicol Unit, Leicester LE1 9HN, Leics, England	University of Leicester; University of Leicester; University of Leicester	Tobin, AB (corresponding author), Univ Leicester, Dept Cell Physiol & Pharmacol, Hodgkin Bldg,Lancaster Rd, Leicester LE1 9HN, Leics, England.	tba@le.ac.uk	Bottrill, Andrew/ABD-1459-2021; Bottrill, Andrew/C-6367-2013	Bottrill, Andrew/0000-0002-5182-3643; Bottrill, Andrew/0000-0002-5182-3643; Torrecilla, Ignacio/0000-0003-4283-0283	Wellcome Trust [047600]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work is supported by Wellcome Trust Grant 047600.	Abel T, 1997, CELL, V88, P615, DOI 10.1016/S0092-8674(00)81904-2; Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; Auerbach JM, 1996, J PHYSIOL-LONDON, V492, P479, DOI 10.1113/jphysiol.1996.sp021323; BASHIR ZI, 1993, EUR J PHARMACOL, V239, P265, DOI 10.1016/0014-2999(93)91009-C; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; BORTOLOTTO ZA, 1994, NATURE, V368, P740, DOI 10.1038/368740a0; Budd DC, 2001, J BIOL CHEM, V276, P4581, DOI 10.1074/jbc.M008827200; Budd DC, 2000, J BIOL CHEM, V275, P19667, DOI 10.1074/jbc.M000492200; DeBock F, 2003, EUR J NEUROSCI, V17, P1411, DOI 10.1046/j.1460-9568.2003.02544.x; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; Grishin AA, 2005, NEUROPHARMACOLOGY, V49, P328, DOI 10.1016/j.neuropharm.2005.03.019; Hirose K, 1999, SCIENCE, V284, P1527, DOI 10.1126/science.284.5419.1527; Huang YQ, 2001, NEURON, V29, P485, DOI 10.1016/S0896-6273(01)00220-3; Kemp N, 2001, PROG NEUROBIOL, V65, P339, DOI 10.1016/S0301-0082(01)00013-2; Leist M, 1997, MOL MED, V3, P750, DOI 10.1007/BF03401713; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Lu WY, 1999, NAT NEUROSCI, V2, P331, DOI 10.1038/7243; Macdonald DS, 2005, J NEUROSCI, V25, P11374, DOI 10.1523/JNEUROSCI.3871-05.2005; MacDonald JF, 2007, BBA-BIOMEMBRANES, V1768, P941, DOI 10.1016/j.bbamem.2006.12.006; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; McCutchen E, 2006, J NEUROPHYSIOL, V96, P3114, DOI 10.1152/jn.00144.2006; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Nahorski SR, 2003, TRENDS NEUROSCI, V26, P444, DOI 10.1016/S0166-2236(03)00178-4; Nash MS, 2002, J BIOL CHEM, V277, P35947, DOI 10.1074/jbc.M205622200; Nguyen PV, 2001, TRENDS NEUROSCI, V24, P314, DOI 10.1016/S0166-2236(00)01872-5; Okabe S, 2007, MOL CELL NEUROSCI, V34, P503, DOI 10.1016/j.mcn.2007.01.006; Okubo Y, 2001, NEURON, V32, P113, DOI 10.1016/S0896-6273(01)00464-0; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Semba K, 1997, J NEUROCHEM, V69, P1066; Sheng M, 2002, SCIENCE, V298, P776, DOI 10.1126/science.1075333; Shinoe T, 2005, J NEUROSCI, V25, P11194, DOI 10.1523/JNEUROSCI.2338-05.2005; TOBIN AB, 1993, J BIOL CHEM, V268, P9817; TOBIN AB, 1993, FEBS LETT, V335, P353, DOI 10.1016/0014-5793(93)80418-T; TOBIN AB, 1992, MOL PHARMACOL, V42, P1042; Tobin AB, 2008, TRENDS PHARMACOL SCI, V29, P413, DOI 10.1016/j.tips.2008.05.006; Torrecilla I, 2007, J CELL BIOL, V177, P127, DOI 10.1083/jcb.200610018; Tsuga H, 1998, J PHARMACOL EXP THER, V284, P1218; van Koppen CJ, 2003, PHARMACOL THERAPEUT, V98, P197, DOI 10.1016/S0163-7258(03)00032-9; Vanhoose AM, 2003, J NEUROSCI, V23, P5827; Watabe AM, 2000, J NEUROSCI, V20, P5924, DOI 10.1523/JNEUROSCI.20-16-05924.2000; Watkins JC, 2006, BRIT J PHARMACOL, V147, pS100, DOI 10.1038/sj.bjp.0706444; Willets JM, 2002, J BIOL CHEM, V277, P15523, DOI 10.1074/jbc.M111217200; WOJCIKIEWICZ RJH, 1994, J NEUROCHEM, V63, P177; Xiong ZG, 1998, MOL PHARMACOL, V54, P1055, DOI 10.1124/mol.54.6.1055; Young KW, 2003, J BIOL CHEM, V278, P20753, DOI 10.1074/jbc.M211555200; Young KW, 2004, J NEUROCHEM, V89, P1537, DOI 10.1111/j.1471-4159.2004.02458.x	47	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					17147	17156		10.1074/jbc.M901031200	http://dx.doi.org/10.1074/jbc.M901031200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19332541	hybrid, Green Published			2022-12-27	WOS:000266962400053
J	Cork, AJ; Jergic, S; Hammerschmidt, S; Kobe, B; Pancholi, V; Benesch, JLP; Robinson, CV; Dixon, NE; Aquilina, JA; Walker, MJ				Cork, Amanda J.; Jergic, Slobodan; Hammerschmidt, Sven; Kobe, Bostjan; Pancholi, Vijay; Benesch, Justin L. P.; Robinson, Carol V.; Dixon, Nicholas E.; Aquilina, J. Andrew; Walker, Mark J.			Defining the Structural Basis of Human Plasminogen Binding by Streptococcal Surface Enolase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROUP-A STREPTOCOCCI; PROTEIN SECONDARY STRUCTURE; CIRCULAR-DICHROISM SPECTRA; MASS-SPECTROMETRY; ALPHA-ENOLASE; ANGSTROM RESOLUTION; MACROMOLECULAR ASSEMBLIES; HISTIDINE-RESIDUES; CRYSTAL-STRUCTURE; ACTIVATION	The flesh-eating bacterium group A Streptococcus ( GAS) binds and activates human plasminogen, promoting invasive disease. Streptococcal surface enolase (SEN), a glycolytic pathway enzyme, is an identified plasminogen receptor of GAS. Here we used mass spectrometry ( MS) to confirm that GAS SEN is octameric, thereby validating in silico modeling based on the crystal structure of Streptococcus pneumoniae alpha-enolase. Site-directed mutagenesis of surface-located lysine residues (SENK252+255A, SENK304A, SENK334A, SENK344E, SENK435L, and SEN Delta 434- 435) was used to examine their roles in maintaining structural integrity, enzymatic function, and plasminogen binding. Structural integrity of the GAS SEN octamer was retained for all mutants except SENK344E, as determined by circular dichroism spectroscopy and MS. However, ion mobility MS revealed distinct differences in the stability of several mutant octamers in comparison with wild type. Enzymatic analysis indicated that SENK344E had lost alpha-enolase activity, which was also reduced in SENK334A and SEN Delta 434-435. Surface plasmon resonance demonstrated that the capacity to bind human plasminogen was abolished in SENK252+255A, SENK435L, and SEN Delta 434-435. The lysine residues at positions 252, 255, 434, and 435 therefore play a concerted role in plasminogen acquisition. This study demonstrates the ability of combining in silico structural modeling with ion mobility-MS validation for undertaking functional studies on complex protein structures.	[Aquilina, J. Andrew; Walker, Mark J.] Univ Wollongong, Sch Biol Sci, Wollongong, NSW 2522, Australia; [Jergic, Slobodan; Dixon, Nicholas E.] Univ Wollongong, Sch Chem, Wollongong, NSW 2522, Australia; [Hammerschmidt, Sven] Ernst Moritz Arndt Univ Greifswald, Inst Genet & Funct Genom, Dept Genet Microorganisms, D-17487 Greifswald, Germany; [Kobe, Bostjan] Univ Queensland, Sch Mol & Microbial Sci, Brisbane, Qld 4072, Australia; [Kobe, Bostjan] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Pancholi, Vijay] Ohio State Univ, Dept Pathol, Columbus, OH 43210 USA; [Benesch, Justin L. P.; Robinson, Carol V.] Univ Cambridge, Dept Chem, Cambridge CB2 1TN, England	University of Wollongong; University of Wollongong; Ernst Moritz Arndt Universitat Greifswald; University of Queensland; University of Queensland; University System of Ohio; Ohio State University; University of Cambridge	Walker, MJ (corresponding author), Univ Wollongong, Sch Biol Sci, Northfields Ave, Wollongong, NSW 2522, Australia.	mwalker@uow.edu.au	Aquilina, J. Andrew/A-5366-2013; Pancholi, Vijay/E-3810-2011; Dixon, Nicholas E/A-1226-2008; Aquilina, John Andrew/AGF-4013-2022; Hammerschmidt, Sven/G-2598-2010; Cork, Amanda/C-3830-2012; Kobe, Bostjan/D-1292-2009; Walker, Mark J./F-6940-2011	Dixon, Nicholas E/0000-0002-5958-6945; Hammerschmidt, Sven/0000-0002-6382-6681; Cork, Amanda/0000-0003-2207-6877; Kobe, Bostjan/0000-0001-9413-9166; Walker, Mark/0000-0001-7423-2769; Benesch, Justin/0000-0002-1507-3742; robinson, carol/0000-0001-7829-5505				Abad MC, 2002, J MOL BIOL, V318, P1009, DOI 10.1016/S0022-2836(02)00211-5; Benesch JL, 2006, CURR OPIN STRUC BIOL, V16, P245, DOI 10.1016/j.sbi.2006.03.009; Benesch JLP, 2003, ANAL CHEM, V75, P2208, DOI 10.1021/ac034132x; Benesch JLP, 2007, CHEM REV, V107, P3544, DOI 10.1021/cr068289b; Benesch JLP, 2006, CHEM BIOL, V13, P597, DOI 10.1016/j.chembiol.2006.04.006; Benesch JLP, 2009, ANAL CHEM, V81, P1270, DOI 10.1021/ac801950u; Benesch JLP, 2009, J AM SOC MASS SPECTR, V20, P341, DOI 10.1016/j.jasms.2008.11.014; BERGE A, 1993, J BIOL CHEM, V268, P25417; Bergmann S, 2003, MOL MICROBIOL, V49, P411, DOI 10.1046/j.1365-2958.2003.03557.x; Bergmann S, 2007, THROMB HAEMOSTASIS, V98, P512, DOI 10.1160/TH07-02-0117; Boel G, 2004, J MOL BIOL, V337, P485, DOI 10.1016/j.jmb.2003.12.082; Byrne B, 2002, CURR OPIN STRUC BIOL, V12, P239, DOI 10.1016/S0959-440X(02)00316-0; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Carapetis JR, 1999, EPIDEMIOL INFECT, V122, P59, DOI 10.1017/S0950268898001952; Cole J. N., 2006, MOL BIOL STREPTOCOCC, P359; Cole JN, 2005, INFECT IMMUN, V73, P3137, DOI 10.1128/IAI.73.5.3137-3146.2005; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; D'Costa SS, 1998, MICROB PATHOGENESIS, V24, P341, DOI 10.1006/mpat.1998.0207; DANO K, 1985, ADV CANCER RES, V44, P139, DOI 10.1016/S0065-230X(08)60028-7; Derbise A, 2004, INFECT IMMUN, V72, P94, DOI 10.1128/IAI.72.1.94-105.2004; Ehinger S, 2004, J MOL BIOL, V343, P997, DOI 10.1016/j.jmb.2004.08.088; Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543; Geiger JH, 2004, J THROMB HAEMOST, V2, P23, DOI 10.1111/j.1538-7836.2004.00544.x; GILES K, 2008, 56 ASMS C MASS SPECT; Hernandez H, 2006, EMBO REP, V7, P605, DOI 10.1038/sj.embor.7400702; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Jordan P, 2001, NATURE, V411, P909, DOI 10.1038/35082000; KAPUR V, 1995, MOL MICROBIOL, V16, P509, DOI 10.1111/j.1365-2958.1995.tb02415.x; KUUSELA P, 1992, INFECT IMMUN, V60, P196, DOI 10.1128/IAI.60.1.196-201.1992; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; LOTTENBERG R, 1992, J BACTERIOL, V174, P5204, DOI 10.1128/JB.174.16.5204-5210.1992; Madhusudhan M.S., 2007, CURR PROTOC PROTEIN, V2; McArthur JD, 2008, FASEB J, V22, P3146, DOI 10.1096/fj.08-109348; McKay FC, 2004, INFECT IMMUN, V72, P364, DOI 10.1128/IAI.72.1.364-370.2004; Mesleh MF, 1996, J PHYS CHEM-US, V100, P16082, DOI 10.1021/jp961623v; Morris AM, 2008, FEBS J, V275, P5885, DOI 10.1111/j.1742-4658.2008.06719.x; Pancholi V, 1998, J BIOL CHEM, V273, P14503, DOI 10.1074/jbc.273.23.14503; Pancholi V, 2003, INT J MED MICROBIOL, V293, P391, DOI 10.1078/1438-4221-00283; PANCHOLI V, 1992, J EXP MED, V176, P415, DOI 10.1084/jem.176.2.415; Pancholi V, 2001, CELL MOL LIFE SCI, V58, P902, DOI 10.1007/PL00000910; Parry MAA, 2000, TRENDS BIOCHEM SCI, V25, P53, DOI 10.1016/S0968-0004(99)01521-2; PONTING CP, 1992, BLOOD COAGUL FIBRIN, V3, P605, DOI 10.1097/00001721-199210000-00012; Pringle SD, 2007, INT J MASS SPECTROM, V261, P1, DOI 10.1016/j.ijms.2006.07.021; REDDY KNN, 1972, J BIOL CHEM, V247, P1683; Riekel C, 2005, CURR OPIN STRUC BIOL, V15, P556, DOI 10.1016/j.sbi.2005.08.013; Ruotolo BT, 2008, NAT PROTOC, V3, P1139, DOI 10.1038/nprot.2008.78; Ruotolo BT, 2005, SCIENCE, V310, P1658, DOI 10.1126/science.1120177; SAKSELA O, 1988, ANNU REV CELL BIOL, V4, P93, DOI 10.1146/annurev.cb.04.110188.000521; Sanderson-Smith M, 2006, J BIOL CHEM, V281, P3217, DOI 10.1074/jbc.M508758200; Sanderson-Smith ML, 2008, FASEB J, V22, P2715, DOI 10.1096/fj.07-105643; Sanderson-Smith ML, 2007, J BACTERIOL, V189, P1435, DOI 10.1128/JB.01218-06; Sanderson-Smith ML, 2006, J BIOL CHEM, V281, P25965, DOI 10.1074/jbc.M603846200; Schuwirth BS, 2005, SCIENCE, V310, P827, DOI 10.1126/science.1117230; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Sun HM, 2004, SCIENCE, V305, P1283, DOI 10.1126/science.1101245; Tart AH, 2007, TRENDS MICROBIOL, V15, P318, DOI 10.1016/j.tim.2007.05.001; Walker MJ, 2007, NAT MED, V13, P981, DOI 10.1038/nm1612; Walker MJ, 2005, TRENDS MICROBIOL, V13, P308, DOI 10.1016/j.tim.2005.05.006; WANG H, 1995, J INFECT DIS, V171, P85, DOI 10.1093/infdis/171.1.85; Winram SB, 1998, MICROBIOL-SGM, V144, P2025, DOI 10.1099/00221287-144-8-2025; Wold F., 1971, ENZYMES, P499; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	62	54	56	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					17129	17137		10.1074/jbc.M109.004317	http://dx.doi.org/10.1074/jbc.M109.004317			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19363026	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000266962400051
J	Dhar, SK; St Clair, DK				Dhar, Sanjit Kumar; St Clair, Daret K.			Nucleophosmin Blocks Mitochondrial Localization of p53 and Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR PROTEIN; MANGANESE SUPEROXIDE-DISMUTASE; P53-DEPENDENT APOPTOSIS; P53-INDUCED APOPTOSIS; BCL-2 FAMILY; DNA-DAMAGE; CELL-DEATH; GENE; ACTIVATION; EXPRESSION	Activation of p53 is an important mechanism in apoptosis. However, whether the presence of p53 in mitochondria plays an important role in p53-mediated apoptosis is unclear. Here, we demonstrate that overexpression of NPM (nucleophosmin) significantly suppresses 12-O-tetradecanoylphorbol 13-acetate (TPA)-mediated apoptosis, in part, by blocking the mitochondrial localization of p53. Within 1 h following TPA treatment of skin epithelial (JB6) cells, p53 accumulated in mitochondria. Expression of NPM enhances p53 levels in the nucleus but reduces p53 levels in mitochondria, as detected by immunocytochemistry and Western blot analysis. The suppressive effect of NPM on p53 mitochondrial localization is also observed in TPA-treated primary epithelial cells and in JB6 cells treated with doxorubicin. NPM enhances the expression of p53 target gene p21 and bax. However, the increase in Bax level in the absence of p53 in mitochondria did not lead to an increase in TPA-induced apoptosis, suggesting that the presence of p53 in mitochondria is important. Suppression of NPM by NPM small interfering RNA leads to an increase of p53 levels in mitochondria and apoptosis. Furthermore, suppression of NPM in tumor cells with a high constitutive level of NPM results in p53 translocation to mitochondria and enhances TPA-mediated apoptosis. The results demonstrate the effect of NPM on p53 localization in mitochondria and apoptosis. Together, the data indicate that the presence of p53 in mitochondria plays an important role in stress-induced apoptosis and suggest that NPM may protect cells from apoptosis by reducing the mitochondrial level of p53.	[Dhar, Sanjit Kumar; St Clair, Daret K.] Univ Kentucky, Grad Ctr Toxicol, Lexington, KY 40536 USA	University of Kentucky	St Clair, DK (corresponding author), Univ Kentucky, Grad Ctr Toxicol, Lexington, KY 40536 USA.	DSTCL00@uky.edu			National Institutes of Health [CA 49797, CA 73599]; NATIONAL CANCER INSTITUTE [R29CA049797, R01CA073599, R01CA049797] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA 49797 and CA 73599 (to D. K. S. C.).	BAKHSHI A, 1985, CELL, V41, P899, DOI 10.1016/S0092-8674(85)80070-2; Baptiste N, 2004, CELL, V116, P487, DOI 10.1016/S0092-8674(04)00164-3; Bates S, 1999, CELL MOL LIFE SCI, V55, P28, DOI 10.1007/s000180050267; Bernardi R, 2004, NAT CELL BIOL, V6, P665, DOI 10.1038/ncb1147; Bertwistle D, 2004, MOL CELL BIOL, V24, P985, DOI 10.1128/MCB.24.3.985-996.2004; Brugarolas J, 1999, P NATL ACAD SCI USA, V96, P1002, DOI 10.1073/pnas.96.3.1002; CAELLES C, 1994, NATURE, V370, P220, DOI 10.1038/370220a0; Chen JJ, 2008, J IMMUNOL, V180, P8030, DOI 10.4049/jimmunol.180.12.8030; Chen XB, 1996, GENE DEV, V10, P2438, DOI 10.1101/gad.10.19.2438; COLBURN NH, 1979, NATURE, V281, P589, DOI 10.1038/281589a0; Colombo E, 2005, MOL CELL BIOL, V25, P8874, DOI 10.1128/MCB.25.20.8874-8886.2005; Colombo E, 2002, NAT CELL BIOL, V4, P529, DOI 10.1038/ncb814; Dhar SK, 2006, J BIOL CHEM, V281, P21698, DOI 10.1074/jbc.M601083200; Dhar SK, 2004, J BIOL CHEM, V279, P28209, DOI 10.1074/jbc.M403553200; Erster S, 2004, MOL CELL BIOL, V24, P6728, DOI 10.1128/MCB.24.15.6728-6741.2004; HAUPT Y, 1995, GENE DEV, V9, P2170, DOI 10.1101/gad.9.17.2170; Higuchi Y, 1998, BIOCHEM BIOPH RES CO, V248, P597, DOI 10.1006/bbrc.1998.8978; Hsu CY, 1998, ONCOGENE, V16, P915, DOI 10.1038/sj.onc.1201615; Itahana K, 2003, MOL CELL, V12, P1151, DOI 10.1016/S1097-2765(03)00431-3; Kondo T, 1997, ONCOGENE, V15, P1275, DOI 10.1038/sj.onc.1201286; Korgaonkar C, 2005, MOL CELL BIOL, V25, P1258, DOI 10.1128/MCB.25.4.1258-1271.2005; Kurki S, 2004, CANCER CELL, V5, P465, DOI 10.1016/S1535-6108(04)00110-2; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li J, 2005, LEUKEMIA RES, V29, P1415, DOI 10.1016/j.leukres.2005.05.005; Li J, 2004, J BIOL CHEM, V279, P41275, DOI 10.1074/jbc.C400297200; Li PF, 1999, EMBO J, V18, P6027, DOI 10.1093/emboj/18.21.6027; Liu B, 2008, FREE RADICAL BIO MED, V44, P1529, DOI 10.1016/j.freeradbiomed.2008.01.011; Lohrum MAE, 1999, CELL DEATH DIFFER, V6, P1162, DOI 10.1038/sj.cdd.4400625; Louria-Hayon I, 2003, J BIOL CHEM, V278, P33134, DOI 10.1074/jbc.M301264200; Marchenko ND, 2007, EMBO J, V26, P923, DOI 10.1038/sj.emboj.7601560; Marchenko ND, 2000, J BIOL CHEM, V275, P16202, DOI 10.1074/jbc.275.21.16202; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; MIYASHITA T, 1995, CELL, V80, P293; Nozawa Y, 1996, J PATHOL, V178, P48; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; Ohtsuka T, 2004, NAT CELL BIOL, V6, P121, DOI 10.1038/ncb1087; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; Prives C, 1999, J PATHOL, V187, P112; Reed JC, 1998, BBA-BIOENERGETICS, V1366, P127, DOI 10.1016/S0005-2728(98)00108-X; Ryan KM, 2001, CURR OPIN CELL BIOL, V13, P332, DOI 10.1016/S0955-0674(00)00216-7; Sakaguchi K, 1997, BIOCHEMISTRY-US, V36, P10117, DOI 10.1021/bi970759w; Schuler M, 2001, BIOCHEM SOC T, V29, P684, DOI 10.1042/0300-5127:0290684; Shields LBE, 1997, J SOC GYNECOL INVEST, V4, P298, DOI 10.1016/S1071-5576(97)00068-3; Subong ENP, 1999, PROSTATE, V39, P298; TANAKA M, 1992, CANCER RES, V52, P3372; TSUJIMOTO Y, 1986, P NATL ACAD SCI USA, V83, P5214, DOI 10.1073/pnas.83.14.5214; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wu MH, 2002, J BIOL CHEM, V277, P48234, DOI 10.1074/jbc.M206550200; Zhao YF, 2005, CANCER RES, V65, P3745, DOI 10.1158/0008-5472.CAN-04-3835	50	49	51	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16409	16418		10.1074/jbc.M109.005736	http://dx.doi.org/10.1074/jbc.M109.005736			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19366707	Green Published, hybrid			2022-12-27	WOS:000266730900038
J	Hinton, A; Sennoune, SR; Bond, S; Fang, M; Reuveni, M; Sahagian, GG; Jay, D; Martinez-Zaguilan, R; Forgac, M				Hinton, Ayana; Sennoune, Souad R.; Bond, Sarah; Fang, Min; Reuveni, Moshe; Sahagian, G. Gary; Jay, Daniel; Martinez-Zaguilan, Raul; Forgac, Michael			Function of a Subunit Isoforms of the V-ATPase in pH Homeostasis and in Vitro Invasion of MDA-MB231 Human Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACUOLAR H+-ATPASE; PROTON-TRANSLOCATING ATPASE; PLASMA-MEMBRANE; A3 ISOFORM; OSTEOCLAST DIFFERENTIATION; CYSTEINE CATHEPSINS; MOLECULAR-CLONING; VIVO DISSOCIATION; INTRACELLULAR PH; DRUG-RESISTANCE	It has previously been shown that highly invasive MDA-MB231 human breast cancer cells express vacuolar proton-translocating ATPase (V-ATPases) at the cell surface, whereas the poorly invasive MCF7 cell line does not. Bafilomycin, a specific V-ATPase inhibitor, reduces the in vitro invasion of MB231 cells but not MCF7 cells. Targeting of V-ATPases to different cellular membranes is controlled by isoforms of subunit a. mRNA levels for a subunit isoforms were measured in MB231 and MCF7 cells using quantitative reverse transcription-PCR. The results show that although all four isoforms are detectable in both cell types, levels of a3 and a4 are much higher in MB231 than in MCF7 cells. Isoform-specific small interfering RNAs (siRNA) were employed to selectively reduce mRNA levels for each isoform in MB231 cells. V-ATPase function was assessed using the fluorescent indicators SNARF-1 and pyranine to monitor the pH of the cytosol and endosomal/lysosomal compartments, respectively. Cytosolic pH was decreased only on knockdown of a3, whereas endosome/lysosome pH was increased on knockdown of a1, a2, and a3. Treatment of cells with siRNA to a4 did not affect either cytosolic or endosome/lysosome pH. Measurement of invasion using an in vitro transwell assay revealed that siRNAs to both a3 and a4 significantly inhibited invasion of MB231 cells. Immunofluorescence staining of MB231 cells for V-ATPase distribution revealed extensive intracellular staining, with plasma membrane staining observed in similar to 18% of cells. Knockdown of a4 had the greatest effect on plasma membrane staining, leading to a 32% reduction. These results suggest that the a4 isoform may be responsible for targeting V-ATPases to the plasma membrane of MB231 cells and that cell surface V-ATPases play a significant role in invasion. However, other V-ATPases affecting the pH of the cytosol and intracellular compartments, particularly those containing a3, are also involved in invasion.	[Hinton, Ayana; Bond, Sarah; Fang, Min; Sahagian, G. Gary; Jay, Daniel; Forgac, Michael] Tufts Univ, Dept Physiol, Sch Med, Boston, MA 02111 USA; [Sennoune, Souad R.; Martinez-Zaguilan, Raul] Texas Tech Univ, Dept Cell Physiol & Mol Biophys, Lubbock, TX 79430 USA; [Reuveni, Moshe] ARO Volcani Ctr, Dept Ornamental Hort, IL-50250 Bet Dagan, Israel	Tufts University; Texas Tech University System; Texas Tech University; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH	Forgac, M (corresponding author), Tufts Univ, Dept Physiol, Sch Med, 136 Harrison Ave, Boston, MA 02111 USA.	michael.forgac@tufts.edu			National Institutes of Health [GM34478]; National Institutes of Health Ruth L. Kirschstein Institutional Research Training Grant [T32DK007542]; National Institutes of Health Training in Education and Critical Research Skills Grant [K12GM074869]; American Heart Association [SD 0435197N, GIA 0855168]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007542] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034478, R37GM034478, K12GM074869] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Ruth L. Kirschstein Institutional Research Training Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Training in Education and Critical Research Skills Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM34478 (to M. F.), post-doctoral support (to A. H.) and pre-doctoral support (to S. B.) from National Institutes of Health Ruth L. Kirschstein Institutional Research Training Grant T32DK007542, and post-doctoral support (to A. H.) from National Institutes of Health Training in Education and Critical Research Skills Grant K12GM074869. This work was also supported by American Heart Association Grants SD 0435197N (to S. R. S.) and GIA 0855168 (to R. M. Z.).	Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Frattini A, 2000, NAT GENET, V25, P343, DOI 10.1038/77131; Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050; GILLIES RJ, 1991, J BIOL CHEM, V266, P1551; Gocheva V, 2007, CELL CYCLE, V6, P60, DOI 10.4161/cc.6.1.3669; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hu YW, 2005, FEBS LETT, V579, P4937, DOI 10.1016/j.febslet.2005.07.078; Hurtado-Lorenzo A, 2006, NAT CELL BIOL, V8, P124, DOI 10.1038/ncb1348; Joyce JA, 2004, CELL CYCLE, V3, P1516, DOI 10.4161/cc.3.12.1289; Kawasaki-Nishi S, 2001, J BIOL CHEM, V276, P47411, DOI 10.1074/jbc.M108310200; Kubota S, 2000, BIOCHEM BIOPH RES CO, V278, P390, DOI 10.1006/bbrc.2000.3802; Lu YD, 2005, CANCER RES, V65, P6843, DOI 10.1158/0008-5472.CAN-04-3822; MANOLSON MF, 1994, J BIOL CHEM, V269, P14064; Martinez-Zaguilan R, 1999, BIOCHEM PHARMACOL, V57, P1037, DOI 10.1016/S0006-2952(99)00022-2; MARTINEZZAGUILAN R, 1991, AM J PHYSIOL, V260, pC297, DOI 10.1152/ajpcell.1991.260.2.C297; Morel N, 2003, J CELL SCI, V116, P4751, DOI 10.1242/jcs.00791; Murakami T, 2001, INT J CANCER, V93, P869, DOI 10.1002/ijc.1418; Nishi T, 2000, J BIOL CHEM, V275, P6824, DOI 10.1074/jbc.275.10.6824; Ohta T, 1996, BRIT J CANCER, V73, P1511, DOI 10.1038/bjc.1996.285; Oka T, 2001, J BIOL CHEM, V276, P40050, DOI 10.1074/jbc.M106488200; Pantel K, 2004, NAT REV CANCER, V4, P448, DOI 10.1038/nrc1370; Philippe JM, 2002, GLIA, V37, P365, DOI 10.1002/glia.10041; Pietrement C, 2006, BIOL REPROD, V74, P185, DOI 10.1095/biolreprod.105.043752; Raghunand N, 1999, BIOCHEM PHARMACOL, V57, P1047, DOI 10.1016/S0006-2952(99)00021-0; Rojas JD, 2006, AM J PHYSIOL-HEART C, V291, pH1147, DOI 10.1152/ajpheart.00166.2006; Sennoune SR, 2004, AM J PHYSIOL-CELL PH, V286, pC1443, DOI 10.1152/ajpcell.00407.2003; Sennoune SR, 2004, CELL BIOCHEM BIOPHYS, V40, P185, DOI 10.1385/CBB:40:2:185; Smith AN, 2001, J BIOL CHEM, V276, P42382, DOI 10.1074/jbc.M107267200; Smith AN, 2000, NAT GENET, V26, P71, DOI 10.1038/79208; Sun-Wada GH, 2006, J CELL SCI, V119, P4531, DOI 10.1242/jcs.03234; Torigoe T, 2002, J BIOL CHEM, V277, P36534, DOI 10.1074/jbc.M202605200; Toyomura T, 2000, J BIOL CHEM, V275, P8760, DOI 10.1074/jbc.275.12.8760; Toyomura T, 2003, J BIOL CHEM, V278, P22023, DOI 10.1074/jbc.M302436200; Wang Y, 2008, J BIOL CHEM, V283, P20696, DOI 10.1074/jbc.M803258200	34	153	157	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16400	16408		10.1074/jbc.M901201200	http://dx.doi.org/10.1074/jbc.M901201200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19366680	hybrid, Green Published			2022-12-27	WOS:000266730900037
J	Ma, TH; Wang, Z; Guo, YQ; Pei, DQ				Ma, Tianhua; Wang, Zhe; Guo, Yunqian; Pei, Duanqing			The C-terminal Pentapeptide of Nanog Tryptophan Repeat Domain Interacts with Nac1 and Regulates Stem Cell Proliferation but Not Pluripotency	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SUSTAINING FACTOR; SELF-RENEWAL; MOUSE; TRANSCRIPTION; EXPRESSION; NETWORK; PROTEIN; IDENTIFICATION; GENERATION; CLONING	Overexpression of Nanog in mouse embryonic stem (ES) cells has been shown to abrogate the requirement of leukemia inhibitory factor for self-renewal in culture. Little is known about the molecular mechanism of Nanog function. Here we describe the role of the tryptophan repeat (WR) domain, one of the two transactivators at its C terminus, in regulating stem cell proliferation as well as pluripotency. We first created a supertransactivator, W2W3x10, by duplicating repeats W2W3 10 times and discovered that it can functionally substitute for wild type WR at sustaining pluripotency, albeit with a significantly slower cell cycle, phenocopying Nanog(9W) with the C-terminal pentapeptide (WNAAP) of WR deleted. ES cells carrying both W2W3x10 and Nanog(9W) have a longer G(1) phase, a shorter S phase in cell cycle distribution and progression analysis, and a lower level of pAkt(Ser(473)) compared with wild type Nanog, suggesting that both mutants impact the cell cycle machinery via the phosphatidylinositol 3-kinase/Akt pathway. Both mutants remain competent in dimerizing with Nanog but cannot form a complex with Nac1 efficiently, suggesting that WNAAP may be involved in Nac1 binding. By tagging Gal4DBD with WNAAP, we demonstrated that this pentapeptide is sufficient to confer Nac1 binding. Furthermore, we can rescue W2W3x10 by placing WNAAP at the corresponding locations. Finally, we found that Nanog and Nac1 synergistically up-regulate ERas expression and promote the proliferation of ES cells. These results suggest that Nanog interacts with Nac1 through WNAAP to regulate the cell cycle of ES cells via the ERas/phosphatidylinositol 3-kinase/Akt pathway, but not pluripotency, thus decoupling cell cycle control from pluripotency.	[Ma, Tianhua; Wang, Zhe; Guo, Yunqian; Pei, Duanqing] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, S China Inst Stem Cell Biol & Regenerat Med, Stem Cell & Canc Biol Grp,Key Lab Regenerat Biol, Guangzhou 510663, Guangdong, Peoples R China; [Ma, Tianhua; Wang, Zhe; Guo, Yunqian] Tsinghua Univ, Lab Stem Cell Biol, Sch Med, Dept Biol Sci & Biotechnol,Inst Biomed, Beijing 100084, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Tsinghua University	Pei, DQ (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, S China Inst Stem Cell Biol & Regenerat Med, Stem Cell & Canc Biol Grp,Key Lab Regenerat Biol, Guangzhou 510663, Guangdong, Peoples R China.	pei_duanqing@gibh.ac.cn	Guo, Yunqian/L-4716-2013; zhou, xingru/G-4442-2012		National Natural Science Foundation of China [30725012, 30630039]; Chinese Academy of Sciences [KSCX2-YW-R-48]; Guangzhou Science and Technology [2006A50104002]; Ministry of Science and Technology 973 Grants [2006CB701504, 2006CB943600, 2007CB948002, 2007CB947804, 2009CB941000]; National High Technology Project 863 Grant [2005AA210930]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Guangzhou Science and Technology; Ministry of Science and Technology 973 Grants(National Basic Research Program of China); National High Technology Project 863 Grant(National High Technology Research and Development Program of China)	This work was supported by National Natural Science Foundation of China Grants 30725012 and 30630039; Chinese Academy of Sciences Grant KSCX2-YW-R-48; Guangzhou Science and Technology Grant 2006A50104002; Ministry of Science and Technology 973 Grants 2006CB701504, 2006CB943600, 2007CB948002, 2007CB947804, and 2009CB941000; and National High Technology Project 863 Grant 2005AA210930.	Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Hart AH, 2004, DEV DYNAM, V230, P187, DOI 10.1002/dvdy.20034; Jirmanova L, 2002, ONCOGENE, V21, P5515, DOI 10.1038/sj.onc.1205728; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Mackler SA, 2003, NEUROSCIENCE, V121, P355, DOI 10.1016/S0306-4522(03)00376-2; Mackler SA, 2000, J NEUROSCI, V20, P6210, DOI 10.1523/JNEUROSCI.20-16-06210.2000; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Mullin NP, 2008, BIOCHEM J, V411, P227, DOI 10.1042/BJ20080134; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Pan GJ, 2005, J BIOL CHEM, V280, P1401, DOI 10.1074/jbc.M407847200; Pan GJ, 2003, CELL RES, V13, P499, DOI 10.1038/sj.cr.7290193; Pan GJ, 2006, FASEB J, V20, P1730, DOI 10.1096/fj.05-5543fje; Takahashi K, 2003, NATURE, V423, P541, DOI 10.1038/nature01646; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wang J, 2008, P NATL ACAD SCI USA, V105, P6326, DOI 10.1073/pnas.0802288105; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wang Z, 2008, J BIOL CHEM, V283, P4480, DOI 10.1074/jbc.M706009200; Yamanaka S, 2007, CELL STEM CELL, V1, P39, DOI 10.1016/j.stem.2007.05.012; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	25	20	20	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16071	16081		10.1074/jbc.M109.005041	http://dx.doi.org/10.1074/jbc.M109.005041			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19366700	Green Published, hybrid			2022-12-27	WOS:000266730900003
J	Pardossi-Piquard, R; Yang, SP; Kanemoto, S; Gu, Y; Chen, FS; Bohm, C; Sevalle, J; Li, T; Wong, PC; Checler, F; Schmitt-Ulms, G; St George-Hyslop, P; Fraser, PE				Pardossi-Piquard, Raphaelle; Yang, Seung-Pil; Kanemoto, Soshi; Gu, Yongjun; Chen, Fusheng; Boehm, Christopher; Sevalle, Jean; Li, Tong; Wong, Philip C.; Checler, Frederic; Schmitt-Ulms, Gerold; St. George-Hyslop, Peter; Fraser, Paul E.			APH1 Polar Transmembrane Residues Regulate the Assembly and Activity of Presenilin Complexes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-SECRETASE COMPLEXES; ALZHEIMERS-DISEASE; MISSENSE MUTATIONS; BETA-APP; INTRAMEMBRANE PROTEOLYSIS; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; NICASTRIN; MEMBRANE; PROTEIN	Complexes involved in the gamma/epsilon-secretase-regulated intramembranous proteolysis of substrates such as the amyloid-beta precursor protein are composed primarily of presenilin (PS1 or PS2), nicastrin, anterior pharynx defective-1 (APH1), and PEN2. The presenilin aspartyl residues form the catalytic site, and similar potentially functional polar transmembrane residues in APH1 have been identified. Substitution of charged (E84A, R87A) or polar (Q83A) residues in TM3 had no effect on complex assembly or activity. In contrast, changes to either of two highly conserved histidines (H171A, H197A) located in TM5 and TM6 negatively affected PS1 cleavage and altered binding to other secretase components, resulting in decreased amyloid generating activity. Charge replacement with His-to-Lys substitutions rescued nicastrin maturation and PS1 endoproteolysis leading to assembly of the formation of structurally normal but proteolytically inactive gamma-secretase complexes. Substitution with a negatively charged side chain (His-to-Asp) or altering the structural location of the histidines also disrupted gamma-secretase binding and abolished functionality of APH1. These results suggest that the conserved transmembrane histidine residues contribute to APH1 function and can affect presenilin catalytic activity.	[Fraser, Paul E.] Univ Toronto, Ctr Res Neurodegenerat Dis, Toronto, ON M5S 3H2, Canada; [Sevalle, Jean; Checler, Frederic] CNRS, Inst Pharmacol Mol & Cellulaire, Equipe Labellisee Fdn Rech Med, F-06560 Valbonne, France; [Sevalle, Jean; Checler, Frederic] CNRS, Inst NeuroMed Mol, Equipe Labellisee Fdn Rech Med, F-06560 Valbonne, France; [Li, Tong; Wong, Philip C.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Li, Tong; Wong, Philip C.] Johns Hopkins Univ, Sch Med, Dept Pathol, Baltimore, MD 21205 USA; [Schmitt-Ulms, Gerold] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5G 1L5, Canada; [St. George-Hyslop, Peter] Univ Hlth Network, Toronto Western Hosp Res Inst, Dept Med, Div Neurol, Toronto, ON M5T 2S8, Canada; [St. George-Hyslop, Peter] Univ Cambridge, Dept Clin Neurosci, Cambridge CB2 OXY, England; [Fraser, Paul E.] Univ Toronto, Dept Med Biophys, Toronto, ON M5G 2M9, Canada	University of Toronto; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); Johns Hopkins University; Johns Hopkins University; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Cambridge; University of Toronto	Fraser, PE (corresponding author), Univ Toronto, Ctr Res Neurodegenerat Dis, 6 Queens Pk Crescent W, Toronto, ON M5S 3H2, Canada.	paul.fraser@utoronto.ca	Checler, Frederic/C-1241-2009; Pardossi-Piquard, Raphaëlle/D-6263-2012; Pardossi-Piquard, Raphaëlle/ABA-4472-2021	Checler, Frederic/0000-0003-2098-1750; Pardossi-Piquard, Raphaëlle/0000-0001-5292-4414; Yang, Seung-Pil/0000-0003-3980-7103; St George-Hyslop, Peter/0000-0003-0796-7209	Canadian Institutes of Health Research; Howard Hughes Medical Institute; Alzheimer Society of Ontario; Ontario Research and Development Challenge Fund; Canada Foundation for Innovation; Weston and Garfield Foundation; Fondation pour la Recherche Medicale; Conseil General des Alpes Maritimes; France Alzheimer Association; Wellcome Trust; National Institutes of Health [R01 NS45150, P01 NS047308]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS047308, R01NS045150] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Alzheimer Society of Ontario; Ontario Research and Development Challenge Fund(General Electric); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Weston and Garfield Foundation; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Conseil General des Alpes Maritimes(Region Provence-Alpes-Cote d'Azur); France Alzheimer Association; Wellcome Trust(Wellcome TrustEuropean Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by grants from the Canadian Institutes of Health Research, Howard Hughes Medical Institute, Alzheimer Society of Ontario, The Ontario Research and Development Challenge Fund and the Canada Foundation for Innovation, the Weston and Garfield Foundation, and Fondation pour la Recherche Medicale and the Conseil General des Alpes Maritimes.; Funded by France Alzheimer Association.; Supported by the Wellcome Trust.; Development of the knockout mice was supported by National Institutes of Health Grants R01 NS45150 and P01 NS047308 (NINDS).	Ben-Shem A, 2007, P NATL ACAD SCI USA, V104, P462, DOI 10.1073/pnas.0609773104; Brokx SJ, 2005, BIOCHEMISTRY-US, V44, P10339, DOI 10.1021/bi050621a; Call ME, 2002, CELL, V111, P967, DOI 10.1016/S0092-8674(02)01194-7; Capell A, 1998, J BIOL CHEM, V273, P3205, DOI 10.1074/jbc.273.6.3205; Checler F, 2001, J NEUROCHEM, V76, P1621, DOI 10.1046/j.1471-4159.2001.00244.x; Chen FS, 2006, NATURE, V440, P1208, DOI 10.1038/nature04667; Chen FS, 2001, NAT CELL BIOL, V3, P751, DOI 10.1038/35087069; Choma C, 2000, NAT STRUCT BIOL, V7, P161; Cotten JF, 1999, J BIOL CHEM, V274, P5429, DOI 10.1074/jbc.274.9.5429; Courville P, 2008, J BIOL CHEM, V283, P9651, DOI 10.1074/jbc.M709906200; da Costa CA, 2006, J NEUROSCI, V26, P6377, DOI 10.1523/JNEUROSCI.0651-06.2006; DE SB, 1999, NATURE, V398, P518; De Strooper B, 1998, NATURE, V391, P387, DOI 10.1038/34910; Dolcini V, 2008, BIOCHEM BIOPH RES CO, V371, P69, DOI 10.1016/j.bbrc.2008.03.151; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; Evin G, 2006, CNS DRUGS, V20, P351, DOI 10.2165/00023210-200620050-00002; Fortna RR, 2004, J BIOL CHEM, V279, P3685, DOI 10.1074/jbc.M310505200; Francis R, 2002, DEV CELL, V3, P85, DOI 10.1016/S1534-5807(02)00189-2; Franco PJ, 2001, BBA-BIOMEMBRANES, V1510, P231, DOI 10.1016/S0005-2736(00)00353-9; Freeman M, 2004, NAT REV MOL CELL BIO, V5, P188, DOI 10.1038/nrm1334; Goutte C, 2002, P NATL ACAD SCI USA, V99, P775, DOI 10.1073/pnas.022523499; Gu YJ, 2004, J BIOL CHEM, V279, P31329, DOI 10.1074/jbc.M401548200; Gu YJ, 2003, J BIOL CHEM, V278, P7374, DOI 10.1074/jbc.M209499200; Guo ZY, 2005, J BIOL CHEM, V280, P37814, DOI 10.1074/jbc.M508384200; Gupta SK, 1998, J BIOL CHEM, V273, P4282, DOI 10.1074/jbc.273.7.4282; Hu J, 2006, P NATL ACAD SCI USA, V103, P6865, DOI 10.1073/pnas.0601944103; Hunte C, 2000, STRUCTURE, V8, P669, DOI 10.1016/S0969-2126(00)00152-0; Kaether C, 2007, EMBO REP, V8, P743, DOI 10.1038/sj.embor.7401027; Kim SH, 2005, J BIOL CHEM, V280, P41953, DOI 10.1074/jbc.M509070200; Kim SH, 2001, J BIOL CHEM, V276, P43343, DOI 10.1074/jbc.M108245200; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; Kulkarni AA, 2007, PHARM RES-DORDR, V24, P66, DOI 10.1007/s11095-006-9119-x; Lee SF, 2002, J BIOL CHEM, V277, P45013, DOI 10.1074/jbc.M208164200; Lee SF, 2004, J BIOL CHEM, V279, P4144, DOI 10.1074/jbc.M309745200; Louvi A, 2006, NAT REV NEUROSCI, V7, P93, DOI 10.1038/nrn1847; Ma GJ, 2005, J NEUROSCI, V25, P192, DOI 10.1523/JNEUROSCI.3814-04.2005; Ma ZM, 2006, J GEN PHYSIOL, V127, P309, DOI 10.1085/jgp.200509421; Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739; Pardossi-Piquard R, 2005, NEURON, V46, P541, DOI 10.1016/j.neuron.2005.04.008; Partridge AW, 2004, PROTEINS, V54, P648, DOI 10.1002/prot.10611; ROGAEV EI, 1995, NATURE, V376, P775, DOI 10.1038/376775a0; Rogaeva E, 2006, J ALZHEIMERS DIS, V9, P381; Sato C, 2006, J NEUROSCI, V26, P12081, DOI 10.1523/JNEUROSCI.3614-06.2006; Serneels L, 2005, P NATL ACAD SCI USA, V102, P1719, DOI 10.1073/pnas.0408901102; Shah S, 2005, CELL, V122, P435, DOI 10.1016/j.cell.2005.05.022; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Shirotani K, 2004, J BIOL CHEM, V279, P41340, DOI 10.1074/jbc.M405768200; Shirotani K, 2004, J NEUROCHEM, V89, P1520, DOI 10.1111/j.1471-4159.2004.02447.x; Spasic D, 2008, J CELL SCI, V121, P413, DOI 10.1242/jcs.015255; Spasic D, 2007, J CELL BIOL, V176, P629, DOI 10.1083/jcb.200609180; Stojanovic A, 2004, J BIOL CHEM, V279, P35932, DOI 10.1074/jbc.M403821200; Stouffer AL, 2008, NATURE, V451, P596, DOI 10.1038/nature06528; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Thinakaran G, 1996, NEURON, V17, P181, DOI 10.1016/S0896-6273(00)80291-3; Tolia A, 2006, J BIOL CHEM, V281, P27633, DOI 10.1074/jbc.M604997200; Wang YC, 2007, P NATL ACAD SCI USA, V104, P2098, DOI 10.1073/pnas.0611080104; Wang YC, 2006, NATURE, V444, P179, DOI 10.1038/nature05255; Weihofen A, 2002, SCIENCE, V296, P2215, DOI 10.1126/science.1070925; Wolfe MS, 1998, J MED CHEM, V41, P6, DOI 10.1021/jm970621b; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077; Yu G, 2000, NATURE, V407, P48, DOI 10.1038/35024009; Yu G, 1998, J BIOL CHEM, V273, P16470, DOI 10.1074/jbc.273.26.16470; Zhang ML, 2005, J BIOL CHEM, V280, P26169, DOI 10.1074/jbc.M502102200; Zhou FX, 2000, NAT STRUCT BIOL, V7, P154	64	29	30	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16298	16307		10.1074/jbc.M109.000067	http://dx.doi.org/10.1074/jbc.M109.000067			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19369254	hybrid, Green Published			2022-12-27	WOS:000266730900027
J	Suarez, J; Ranguelova, K; Schelvis, JPM; Magliozzo, RS				Suarez, Javier; Ranguelova, Kalina; Schelvis, Johannes P. M.; Magliozzo, Richard S.			Antibiotic Resistance in Mycobacterium tuberculosis PEROXIDASE INTERMEDIATE BYPASS CAUSES POOR ISONIAZID ACTIVATION BY THE S315G MUTANT OF M-TUBERCULOSIS CATALASE-PEROXIDASE (KatG)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CATALASE-PEROXIDASE KATG; SITE-DIRECTED MUTAGENESIS; ISONIAZID ACTIVATION; HYDROGEN-PEROXIDE; S315T MUTANT; NUCLEOTIDE-SEQUENCE; CRYSTAL-STRUCTURE; ACTIVE-SITE; INHA; OVEREXPRESSION	KatG (catalase-peroxidase) in Mycobacterium tuberculosis is responsible for activation of isoniazid (INH), a pro-drug used to treat tuberculosis infections. Resistance to INH is a global health problem most often associated with mutations in the katG gene. The origin of INH resistance caused by the KatG[S315G] mutant enzyme is examined here. Overexpressed KatG[ S315G] was characterized by optical, EPR, and resonance Raman spectroscopy and by studies of the INH activation mechanism in vitro. Catalase activity and peroxidase activity with artificial substrates were moderately reduced (50 and 35%, respectively), whereas the rates of formation of oxyferryl heme:po rphyrin pi-cation radical and the decay of heme intermediates were similar to 2- fold faster in KatG[S315G] compared with WT enzyme. The INH binding affinity for the resting enzyme was unchanged, whereas INH activation, measured by the rate of formation of an acyl-nicotinamide adenine dinucleotide adduct considered to be a bactericidal molecule, was reduced by 30% compared with WT KatG. INH resistance is suggested to arise from a redirection of catalytic intermediates into nonproductive reactions that interfere with oxidation of INH. In the resting mutant enzyme, a rapid evolution of 5-c heme to 6-c species occurred in contrast with the behavior of WT KatG and KatG[S315T] and consistent with greater flexibility at the heme edge in the absence of the hydroxyl of residue 315. Insights into the effects of mutations at residue 315 on enzyme structure, peroxidation kinetics, and specific interactions with INH are presented.	[Suarez, Javier; Ranguelova, Kalina; Magliozzo, Richard S.] CUNY Brooklyn Coll, Dept Chem, Brooklyn, NY 11210 USA; [Suarez, Javier; Ranguelova, Kalina; Magliozzo, Richard S.] CUNY, Grad Ctr, Dept Biochem, New York, NY 11216 USA; [Schelvis, Johannes P. M.] NYU, Dept Chem, New York, NY 10003 USA	City University of New York (CUNY) System; Brooklyn College (CUNY); City University of New York (CUNY) System; New York University	Magliozzo, RS (corresponding author), CUNY Brooklyn Coll, Dept Chem, 2900 Bedford Ave, Brooklyn, NY 11210 USA.	rmagliozzo@brooklyn.cuny.edu			National Institutes of Health [AI060014]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI060014, R01AI060014] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI060014 ( to R. S. M.) from NIAID.	Argyrou A, 2006, NAT STRUCT MOL BIOL, V13, P408, DOI 10.1038/nsmb1089; Argyrou A, 2006, BIOCHEMISTRY-US, V45, P13947, DOI 10.1021/bi061874m; Bertrand T, 2004, J BIOL CHEM, V279, P38991, DOI 10.1074/jbc.M402382200; Broussy S, 2005, ORG BIOMOL CHEM, V3, P670, DOI 10.1039/b417698g; Cardoso RF, 2004, ANTIMICROB AGENTS CH, V48, P3373, DOI 10.1128/AAC.48.9.3373-3381.2004; Chouchane S, 2003, J BIOL CHEM, V278, P8154, DOI 10.1074/jbc.M208256200; Chouchane S, 2000, BIOCHEMISTRY-US, V39, P9975, DOI 10.1021/bi0005815; Chouchane S, 2002, J BIOL CHEM, V277, P42633, DOI 10.1074/jbc.M207916200; Dalla Costa ER, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-39; Engleder M, 2000, BIOCHIMIE, V82, P211, DOI 10.1016/S0300-9084(00)00204-2; Gandhi NR, 2006, LANCET, V368, P1575, DOI 10.1016/S0140-6736(06)69573-1; Gegia M, 2008, ANTIMICROB AGENTS CH, V52, P725, DOI 10.1128/AAC.01124-07; Ghiladi RA, 2005, J AM CHEM SOC, V127, P13428, DOI 10.1021/ja054366t; GIROTTO S, 2004, THESIS GRADUATE CTR; Hazbon MH, 2006, ANTIMICROB AGENTS CH, V50, P2640, DOI 10.1128/AAC.00112-06; Hutchison DCS, 2003, RESP MED, V97, P65, DOI 10.1053/rmed.2002.1412; Ivancich A, 2003, J AM CHEM SOC, V125, P14093, DOI 10.1021/ja035582+; Jakopitsch C, 2007, BIOCHEMISTRY-US, V46, P1183, DOI 10.1021/bi062266+; Johnsson K, 1997, J BIOL CHEM, V272, P2834, DOI 10.1074/jbc.272.5.2834; JOHNSSON K, 1995, J AM CHEM SOC, V117, P5009, DOI 10.1021/ja00122a038; Kapetanaki S, 2003, BIOCHEMISTRY-US, V42, P3835, DOI 10.1021/bi026992y; Kapetanaki SM, 2007, J INORG BIOCHEM, V101, P422, DOI 10.1016/j.jinorgbio.2006.11.004; KELMAN DJ, 1992, FREE RADICAL RES COM, V16, P27, DOI 10.3109/10715769209049156; KELMAN DJ, 1994, J BIOL CHEM, V269, P7458; KOCHI A, 1991, TUBERCLE, V72, P1, DOI 10.1016/0041-3879(91)90017-M; Larsen MH, 2002, MOL MICROBIOL, V46, P453, DOI 10.1046/j.1365-2958.2002.03162.x; Lei BF, 2000, J BIOL CHEM, V275, P2520, DOI 10.1074/jbc.275.4.2520; LOEWEN PC, 1990, MOL GEN GENET, V224, P147, DOI 10.1007/BF00259461; MARCINKEVICIENE JA, 1995, J BIOL CHEM, V270, P22290, DOI 10.1074/jbc.270.38.22290; Marttila HJ, 2008, INT J TUBERC LUNG D, V12, P338; Metcalfe C, 2008, J BIOL CHEM, V283, P6193, DOI 10.1074/jbc.M707412200; Morlock GP, 2003, ANTIMICROB AGENTS CH, V47, P3799, DOI 10.1128/AAC.47.12.3799-3805.2003; Nagy JM, 1997, J BIOL CHEM, V272, P31265, DOI 10.1074/jbc.272.50.31265; Ng VH, 2004, MOL MICROBIOL, V52, P1291, DOI 10.1111/j.1365-2958.2004.04078.x; Parsons LA, 2005, ANTIMICROB AGENTS CH, V49, P2218, DOI 10.1128/AAC.49.6.2218-2225.2005; Phyu S, 2003, EMERG INFECT DIS, V9, P274; QUEMARD A, 1995, BIOCHEMISTRY-US, V34, P8235, DOI 10.1021/bi00026a004; Ranguelova K, 2008, BIOCHEMISTRY-US, V47, P12583, DOI 10.1021/bi801511u; Ranguelova K, 2007, J BIOL CHEM, V282, P6255, DOI 10.1074/jbc.M607309200; ROBITZEK EH, 1952, AM REV TUBERC PULM, V65, P402; Rouse DA, 1996, MOL MICROBIOL, V22, P583, DOI 10.1046/j.1365-2958.1996.00133.x; Rozwarski DA, 1998, SCIENCE, V279, P98, DOI 10.1126/science.279.5347.98; Saint-Joanis B, 1999, BIOCHEM J, V338, P753, DOI 10.1042/0264-6021:3380753; SEPKOWITZ KA, 1995, CLIN INFECT DIS, V20, P232, DOI 10.1093/clinids/20.2.232; Sepkowitz KA, 2001, EMERG INFECT DIS, V7, P259, DOI 10.3201/eid0702.010222; SINHA BK, 1983, J BIOL CHEM, V258, P796; Svistunenko DA, 2001, BBA-PROTEIN STRUCT M, V1546, P365, DOI 10.1016/S0167-4838(01)00157-1; Timmins GS, 2006, MOL MICROBIOL, V62, P1220, DOI 10.1111/j.1365-2958.2006.05467.x; WELINDER KG, 1991, BIOCHIM BIOPHYS ACTA, V1080, P215; Wengenack NL, 1997, J INFECT DIS, V176, P722, DOI 10.1086/514096; Wengenack NL, 1998, BIOCHEMISTRY-US, V37, P15825, DOI 10.1021/bi982023k; Wengenack NL, 2001, BIOCHEMISTRY-US, V40, P8990, DOI 10.1021/bi002614m; Yu SW, 2003, J BIOL CHEM, V278, P14769, DOI 10.1074/jbc.M300326200; Yu SW, 2002, PROTEIN SCI, V11, P58, DOI 10.1110/ps.ps.09902; Zhao XB, 2006, BIOCHEMISTRY-US, V45, P4131, DOI 10.1021/bi051967o; Zhao XB, 2007, BIOCHEMISTRY-US, V46, P3161, DOI 10.1021/bi062218p; 2007, MORTAL WKLY REP, V56, P250	57	18	19	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16146	16155		10.1074/jbc.M109.005546	http://dx.doi.org/10.1074/jbc.M109.005546			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19363028	Green Published, hybrid			2022-12-27	WOS:000266730900011
J	Wang, CM; Qi, RZ; Li, N; Wang, ZX; An, HZ; Zhang, QH; Yu, YZ; Cao, XT				Wang, Chunmei; Qi, Runzi; Li, Nan; Wang, Zhengxin; An, Huazhang; Zhang, Qinghua; Yu, Yizhi; Cao, Xuetao			Notch1 Signaling Sensitizes Tumor Necrosis Factor-related Apoptosis-inducing Ligand-induced Apoptosis in Human Hepatocellular Carcinoma Cells by Inhibiting Akt/Hdm2-mediated p53 Degradation and Up-regulating p53-dependent DR5 Expression (Publication with Expression of Concern. See vol. 295, pg. 8881, 2020) (Withdrawn Publication. See vol. 296, 2021) (Withdrawn Publication. See vol. 296, 2021)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article; Withdrawn Publication							TRAIL-INDUCED APOPTOSIS; CANCER-CELLS; HEPATOMA-CELLS; I INTERFERON; CYCLE ARREST; DEATH; ACTIVATION; RESISTANCE; RECEPTORS; GENE	Notch signaling plays a critical role in regulating cell proliferation, differentiation, and apoptosis. Our previous study showed that overexpression of Notch1 could inhibit human hepatocellular carcinoma (HCC) cell growth by arresting the cell cycle and inducing apoptosis. HCC cells are resistant to apoptotic induction by tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), so new therapeutic approaches have been explored to sensitize HCC cells to TRAIL-induced apoptosis. We are wondering whether and how Notch1 signaling can enhance the sensitivity of HCC cells to TRAIL-induced apoptosis. In this study, we found that overexpression of ICN, the constitutive activated form of Notch1, up-regulated p53 protein expression in HCC cells by inhibiting proteasome degradation. p53 up-regulation was further observed in human primary hepatocellular carcinoma cells after activation of Notch signaling. Inhibition of the Akt/Hdm2 pathway by Notch1 signaling was responsible for the suppression of p53 proteasomal degradation, thus contributing to the Notch1 signaling-mediated up-regulation of p53 expression. Accordingly, Notch1 signaling could make HCC cells more sensitive to TRAIL-induced apoptosis, whereas Notch1 signaling lost the synergistic promotion of TRAIL-induced apoptosis in p53-silenced HepG2 HCC cells and p53-defective Hep3B HCC cells. The data suggest that enhancement of TRAIL-induced apoptosis by Notch1 signaling is dependent upon p53 up-regulation. Furthermore, Notch1 signaling could enhance DR5 expression in a p53-dependent manner. Taken together, Notch1 signaling sensitizes TRAIL-induced apoptosis in HCC cells by inhibiting Akt/Hdm2-mediated p53 degradation and up-regulating p53-dependent DR5 expression. Thus, our results suggest that activation of Notch1 signaling may be a promising approach to improve the therapeutic efficacy of TRAIL-resistant HCC.	[Wang, Zhengxin; An, Huazhang; Zhang, Qinghua; Yu, Yizhi] Changzheng Hosp, Dept Surg, Shanghai 200003, Peoples R China; [Wang, Chunmei; Qi, Runzi; Li, Nan; Cao, Xuetao] Second Mil Med Univ, Natl Key Lab Med Immunol, Shanghai 200433, Peoples R China; [Wang, Chunmei; Qi, Runzi; Li, Nan; Cao, Xuetao] Second Mil Med Univ, Inst Immunol, Shanghai 200433, Peoples R China	Naval Medical University; Naval Medical University; Naval Medical University	Yu, YZ (corresponding author), Changzheng Hosp, Dept Surg, Shanghai 200003, Peoples R China.	cjcb@sh163.net; caoxt@public3.sta.net.cn	yu, yizhi/ADP-7854-2022		National Natural Science Foundation of China [30400523, 30721091, 30801009]; National Key Basic Research Program of China [2004CB518807, 2007CB512403]; National 115 Specific Grants for Hepatitis B and Liver Cancer [2008ZX10002-023]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Program of China(National Basic Research Program of China); National 115 Specific Grants for Hepatitis B and Liver Cancer	This work was supported by National Natural Science Foundation of China Grants 30400523, 30721091, and 30801009; National Key Basic Research Program of China Grants 2004CB518807 and 2007CB512403; and National 115 Specific Grants for Hepatitis B and Liver Cancer 2008ZX10002-023.	An HZ, 2008, NAT IMMUNOL, V9, P542, DOI 10.1038/ni.1604; Armeanu S, 2003, CANCER RES, V63, P2369; Baldi A, 2004, BIOL CELL, V96, P303, DOI 10.1016/j.biolcel.2004.01.005; Beverly LJ, 2005, CANCER RES, V65, P7159, DOI 10.1158/0008-5472.CAN-05-1664; Boehme KA, 2008, P NATL ACAD SCI USA, V105, P7785, DOI 10.1073/pnas.0703423105; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Carter BZ, 2008, BLOOD, V111, P3742, DOI 10.1182/blood-2007-05-091504; Croquelois A, 2005, HEPATOLOGY, V41, P487, DOI 10.1002/hep.20571; de Almodovar CR, 2004, J BIOL CHEM, V279, P4093, DOI 10.1074/jbc.M311243200; Fuchs SY, 1998, P NATL ACAD SCI USA, V95, P10541, DOI 10.1073/pnas.95.18.10541; Ganten TM, 2004, CELL DEATH DIFFER, V11, pS86, DOI 10.1038/sj.cdd.4401437; Huang J, 2008, J PHARMACOL SCI, V107, P370, DOI 10.1254/jphs.08044FP; Ichikawa K, 2001, NAT MED, V7, P954, DOI 10.1038/91000; Jin ZY, 2004, J BIOL CHEM, V279, P35829, DOI 10.1074/jbc.M405538200; Kelley SK, 2004, CURR OPIN PHARMACOL, V4, P333, DOI 10.1016/j.coph.2004.02.006; Kohler C, 2004, HEPATOLOGY, V39, P1056, DOI 10.1002/hep.20156; Lai EC, 2004, DEVELOPMENT, V131, P965, DOI 10.1242/dev.01074; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; LeBlanc HN, 2003, CELL DEATH DIFFER, V10, P66, DOI 10.1038/sj.cdd.4401187; Liu XG, 2005, CANCER RES, V65, P9169, DOI 10.1158/0008-5472.CAN-05-0939; Liu XG, 2008, BLOOD, V112, P4961, DOI 10.1182/blood-2008-03-144022; Meng RD, 2001, EXP CELL RES, V262, P154, DOI 10.1006/excr.2000.5073; Momand J, 2000, GENE, V242, P15, DOI 10.1016/S0378-1119(99)00487-4; Oikonomou E, 2007, BRIT J CANCER, V97, P73, DOI 10.1038/sj.bjc.6603835; Qi RZ, 2003, CANCER RES, V63, P8323; Shankar E, 2008, ONCOGENE, V27, P3957, DOI 10.1038/onc.2008.39; Sheikh MS, 2000, LEUKEMIA, V14, P1509, DOI 10.1038/sj.leu.2401865; Shigeno M, 2003, ONCOGENE, V22, P1653, DOI 10.1038/sj.onc.1206139; Shin EC, 2002, EXP MOL MED, V34, P114, DOI 10.1038/emm.2002.17; Sriuranpong V, 2001, CANCER RES, V61, P3200; Takimoto R, 2000, ONCOGENE, V19, P1735, DOI 10.1038/sj.onc.1203489; Talora C, 2005, EXP CELL RES, V305, P343, DOI 10.1016/j.yexcr.2005.01.015; Tan-Pertel HT, 2000, J IMMUNOL, V165, P4428, DOI 10.4049/jimmunol.165.8.4428; Vousden KH, 2000, CELL, V103, P691, DOI 10.1016/S0092-8674(00)00171-9; Yagita H, 2004, CANCER SCI, V95, P777, DOI 10.1111/j.1349-7006.2004.tb02181.x; Yamamoto T, 2004, CLIN CANCER RES, V10, P7884, DOI 10.1158/1078-0432.CCR-04-0794; Yang XD, 2004, DEV BIOL, V269, P81, DOI 10.1016/j.ydbio.2004.01.014; Yoeli-Lerner M, 2005, MOL CELL, V20, P539, DOI 10.1016/j.molcel.2005.10.033; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973; Zhou J, 2008, MOL CANCER THER, V7, P2170, DOI 10.1158/1535-7163.MCT-08-0071	40	78	87	0	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16183	16190		10.1074/jbc.M109.002105	http://dx.doi.org/10.1074/jbc.M109.002105			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19376776	Green Published, hybrid			2022-12-27	WOS:000266730900015
J	Macri, V; Nazzari, H; McDonald, E; Accili, EA				Macri, Vincenzo; Nazzari, Hamed; McDonald, Evan; Accili, Eric A.			Alanine Scanning of the S6 Segment Reveals a Unique and cAMP-sensitive Association between the Pore and Voltage-dependent Opening in HCN Channels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED CATION CHANNEL; NUCLEOTIDE-GATED CHANNELS; RABBIT SA NODE; PACEMAKER CHANNELS; POTASSIUM CHANNEL; SENSING MECHANISM; K+ CHANNEL; BINDING; MODEL; IDENTIFICATION	Hyperpolarization-activated cyclic nucleotide-modulated (HCN) channels resemble Shaker K+ channels in structure and function. In both, changes in membrane voltage produce directionally similar movement of positively charged residues in the voltage sensor to alter the pore structure at the intracellular side and gate ion flow. However, HCNs open when hyperpolarized, whereas Shaker opens when depolarized. Thus, electromechanical coupling between the voltage sensor and gate is opposite. A key determinant of this coupling is the intrinsic stability of the pore. In Shaker, an alanine/valine scan of residues across the pore, by single point mutation, showed that most mutations made the channel easier to open and steepened the response of the channel to changes in voltage. Because most mutations likely destabilize protein packing, the Shaker pore is most stable when closed, and the voltage sensor works to open it. In HCN channels, the pore energetics and vector of work by the voltage sensor are unknown. Accordingly, we performed a 22-residue alanine/valine scan of the distal pore of the HCN2 isoform and show that the effects of mutations on channel opening and on the steepness of the response of the channel to voltage are mixed and smaller than those in Shaker. These data imply that the stabilities of the open and closed pore are similar, the voltage sensor must apply force to close the pore, and the interactions between the pore and voltage sensor are weak. Moreover, cAMP binding to the channel heightens the effects of the mutations, indicating stronger interactions between the pore and voltage sensor, and tips the energetic balance toward a more stable open state.	[Macri, Vincenzo; Nazzari, Hamed; McDonald, Evan; Accili, Eric A.] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada	University of British Columbia	Accili, EA (corresponding author), Univ British Columbia, Dept Cellular & Physiol Sci, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	eaaccili@interchange.ubc.ca		Macri, Vincenzo/0000-0003-3463-2877	Heart and Stroke Foundation of British Columbia the Yukon	Heart and Stroke Foundation of British Columbia the Yukon	This work was supported in part by grants from the Heart and Stroke Foundation of British Columbia & the Yukon (to E. A. A.).	Altomare C, 2001, J GEN PHYSIOL, V117, P519, DOI 10.1085/jgp.117.6.519; Barbuti A, 1999, J PHYSIOL-LONDON, V520, P737, DOI 10.1111/j.1469-7793.1999.00737.x; Bell DC, 2004, J GEN PHYSIOL, V123, P5, DOI 10.1085/jgp.200308918; BRUENINGWRIGHT A, 2008, BIOPHYS J, V94, P119; Chen J, 2000, J BIOL CHEM, V275, P36465, DOI 10.1074/jbc.M007034200; Chen J, 2001, P NATL ACAD SCI USA, V98, P11277, DOI 10.1073/pnas.201250598; Chen S, 2007, J GEN PHYSIOL, V129, P175, DOI 10.1085/jgp.200609585; Cheng L, 2007, J PHARMACOL EXP THER, V322, P931, DOI 10.1124/jpet.107.121467; Craven KB, 2004, J GEN PHYSIOL, V124, P663, DOI 10.1085/jgp.200409178; Decher N, 2004, J BIOL CHEM, V279, P13859, DOI 10.1074/jbc.M313704200; DiFrancesco D, 1999, J PHYSIOL-LONDON, V515, P367, DOI 10.1111/j.1469-7793.1999.367ac.x; DIFRANCESCO D, 1991, NATURE, V351, P145, DOI 10.1038/351145a0; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Gauss R, 1998, NATURE, V393, P583, DOI 10.1038/31248; Giorgetti A, 2005, BIOPHYS J, V89, P932, DOI 10.1529/biophysj.104.045286; Hackos DH, 2002, J GEN PHYSIOL, V119, P521, DOI 10.1085/jgp.20028569; Ishii TM, 1999, J BIOL CHEM, V274, P12835, DOI 10.1074/jbc.274.18.12835; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Macri V, 2004, J BIOL CHEM, V279, P16832, DOI 10.1074/jbc.M400518200; Macri V, 2002, J BIOL CHEM, V277, P35939, DOI 10.1074/jbc.M203485200; Mannikko R, 2002, NATURE, V419, P837, DOI 10.1038/nature01038; Much B, 2003, J BIOL CHEM, V278, P43781, DOI 10.1074/jbc.M306958200; Nazzari H, 2008, AM J PHYSIOL-CELL PH, V295, pC642, DOI 10.1152/ajpcell.00062.2008; Proenza C, 2006, J GEN PHYSIOL, V127, P183, DOI 10.1085/jgp.200509389; Proenza C, 2002, J BIOL CHEM, V277, P5101, DOI 10.1074/jbc.M106974200; Rothberg BS, 2003, J GEN PHYSIOL, V122, P501, DOI 10.1085/jgp.200308928; Rothberg BS, 2002, J GEN PHYSIOL, V119, P83, DOI 10.1085/jgp.119.1.83; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Schoppa NE, 1998, J GEN PHYSIOL, V111, P313, DOI 10.1085/jgp.111.2.313; Shin KS, 2004, NEURON, V41, P737, DOI 10.1016/S0896-6273(04)00083-2; Shin KS, 2001, J GEN PHYSIOL, V117, P91, DOI 10.1085/jgp.117.2.91; Vemana S, 2004, J GEN PHYSIOL, V123, P21, DOI 10.1085/jgp.200308916; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Yifrach O, 2002, CELL, V111, P231, DOI 10.1016/S0092-8674(02)01013-9; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P321, DOI 10.1085/jgp.103.2.321; Zhou L, 2007, STRUCTURE, V15, P655, DOI 10.1016/j.str.2007.04.012	38	5	5	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15659	15667		10.1074/jbc.M809164200	http://dx.doi.org/10.1074/jbc.M809164200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19269964	Green Published, hybrid			2022-12-27	WOS:000266501000034
J	Fila, T; Trazzi, S; Crochemore, C; Bartesaghi, R; Ciani, E				Fila, Tatiana; Trazzi, Stefania; Crochemore, Christophe; Bartesaghi, Renata; Ciani, Elisabetta			Lot1 Is a Key Element of the Pituitary Adenylate Cyclase-activating Polypeptide (PACAP)/Cyclic AMP Pathway That Negatively Regulates Neuronal Precursor Proliferation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; ZINC-FINGER PROTEIN; CEREBELLAR GRANULE CELLS; TUMOR-SUPPRESSOR GENE; ADRENAL PHEOCHROMOCYTOMA CELLS; RECEPTOR MESSENGER-RNAS; POSITIVE FEEDBACK LOOP; PACAP BINDING-SITES; PC12 CELLS; NEURITE OUTGROWTH	The tumor suppressor gene Lot1 is highly expressed during brain development. During cerebellar development, Lot1 is expressed by proliferating granule cells with a time course matching the expression of the pituitary adenylate cyclase-activating polypeptide (PACAP) receptor, a neuropeptide receptor that plays an important role in the regulation of granule cell proliferation/survival. Although it has become clear that Lot1 is a negative regulator of cell division in tumor cells, its role in neuronal proliferation is not understood. We previously demonstrated that in cerebellar granule cells Lot1 expression is regulated by the PACAP/cAMP system. The aim of this study was to investigate the role played by Lot1 in neuron proliferation/survival and to identify the molecular mechanisms underlying its actions. Using a Lot1-inducible expression system, we found that in PC12 cells Lot1 negatively regulates proliferation and favors differentiation by up-regulating the expression of the PACAP receptor. In cerebellar granule cells in culture, an increase in Lot1 expression was paralleled by inhibition of proliferation and up-regulation of the PACAP receptor, which in turn positively regulated Lot1 expression. Silencing of Lot1 leads to an increase in granule cell proliferation and a reduction in survival. Confirming the in vitro results, in vivo experiments showed that PACAP induced an increase in Lot1 expression that was paralleled by inhibition of cerebellar granule cell proliferation. These data show that Lot1 is a key element of the PACAP/cAMP pathway that negatively regulates neuronal precursor proliferation. The existence of a PACAP receptor/Lot1-positive feedback loop may powerfully regulate neural proliferation during critical phases of cerebellar development.	[Fila, Tatiana; Trazzi, Stefania; Bartesaghi, Renata; Ciani, Elisabetta] Univ Bologna, Dept Human & Gen Physiol, I-40126 Bologna, Italy; [Crochemore, Christophe] Univ Bologna, Dept Biol, I-40126 Bologna, Italy	University of Bologna; University of Bologna	Ciani, E (corresponding author), Univ Bologna, Dept Human & Gen Physiol, Piazza Porta San Donato 2, I-40126 Bologna, Italy.	elisabetta.ciani@unibo.it	Ciani, Elisabetta/AAL-6462-2020	ciani, elisabetta/0000-0003-3130-5168; Trazzi, Stefania/0000-0003-2623-2769	University of Bologna	University of Bologna	This work was supported by the University of Bologna through funding for basic research (to E.C.).	Abdollahi A, 1997, CANCER RES, V57, P2029; Abdollahi A, 1999, ONCOGENE, V18, P6477, DOI 10.1038/sj.onc.1203067; Abdollahi A, 1997, ONCOGENE, V14, P1973, DOI 10.1038/sj.onc.1201034; Alam S, 2005, DEV DYNAM, V234, P772, DOI 10.1002/dvdy.20577; Allais A, 2007, EUR J NEUROSCI, V25, P2604, DOI 10.1111/j.1460-9568.2007.05535.x; Altman J., 1982, CEREBELLUM NEW VISTA, V47, P8; Arima T, 2005, NUCLEIC ACIDS RES, V33, P2650, DOI 10.1093/nar/gki555; Arimura A, 1998, JPN J PHYSIOL, V48, P301, DOI 10.2170/jjphysiol.48.301; Barrett AL, 2008, DEV BIOL, V317, P234, DOI 10.1016/j.ydbio.2008.02.025; BASILLE M, 1993, NEUROSCIENCE, V57, P329, DOI 10.1016/0306-4522(93)90066-O; Basille M, 2000, J COMP NEUROL, V425, P495; Basille M, 2000, ANN NY ACAD SCI, V921, P304; Basille M, 2006, REGUL PEPTIDES, V137, P27, DOI 10.1016/j.regpep.2006.03.010; Bilanges B, 1999, ONCOGENE, V18, P3979, DOI 10.1038/sj.onc.1202933; Bilanges B, 2001, ONCOGENE, V20, P1246, DOI 10.1038/sj.onc.1204237; Botia B, 2007, PEPTIDES, V28, P1746, DOI 10.1016/j.peptides.2007.04.013; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Carey RG, 2002, J NEUROSCI, V22, P1583, DOI 10.1523/JNEUROSCI.22-05-01583.2002; Cavallaro S, 1996, MOL PHARMACOL, V50, P60; Cheng AW, 2003, DEV BIOL, V258, P319, DOI 10.1016/S0012-1606(03)00120-9; Ciani E, 1999, MOL BRAIN RES, V69, P290, DOI 10.1016/S0169-328X(99)00116-3; Ciani E, 2003, DEV BRAIN RES, V142, P193, DOI 10.1016/S0165-3806(03)00092-0; Ciani E, 2002, J BIOL CHEM, V277, P49896, DOI 10.1074/jbc.M206177200; Ciani E, 1995, J MOL NEUROSCI, V6, P131, DOI 10.1007/BF02736772; Colitti CV, 1998, ONCOGENE, V16, P555, DOI 10.1038/sj.onc.1201523; Conconi MT, 2006, INT REV CYTOL, V249, P1, DOI 10.1016/S0074-7696(06)49001-X; Contestabile A, 2005, J BIOL CHEM, V280, P33541, DOI 10.1074/jbc.M413323200; Contestabile A, 2009, BRAIN PATHOL, V19, P224, DOI 10.1111/j.1750-3639.2008.00168.x; DEUTSCH PJ, 1992, J BIOL CHEM, V267, P5108; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; Dicicco-Bloom E, 1998, ANN NY ACAD SCI, V865, P274, DOI 10.1111/j.1749-6632.1998.tb11188.x; Falluel-Morel A, 2008, J MOL NEUROSCI, V36, P8, DOI 10.1007/s12031-008-9111-5; Foehr ED, 2000, J NEUROSCI, V20, P7556; Godard T, 1999, CYTOMETRY, V36, P117, DOI 10.1002/(SICI)1097-0320(19990601)36:2<117::AID-CYTO5>3.0.CO;2-#; Gonzalez BJ, 1997, NEUROSCIENCE, V78, P419, DOI 10.1016/S0306-4522(96)00617-3; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; GUNNING PW, 1981, J CELL BIOL, V89, P240, DOI 10.1083/jcb.89.2.240; Hansen TVO, 2000, J NEUROCHEM, V75, P1870, DOI 10.1046/j.1471-4159.2000.0751870.x; Hashimoto H, 2000, J NEUROCHEM, V74, P501, DOI 10.1046/j.1471-4159.2000.740501.x; Hauge C, 2006, J CELL SCI, V119, P3021, DOI 10.1242/jcs.02950; HERNANDEZ A, 1995, PEPTIDES, V16, P927, DOI 10.1016/0196-9781(95)00059-S; Hoffmann A, 1998, ANN NY ACAD SCI, V865, P49, DOI 10.1111/j.1749-6632.1998.tb11162.x; JANKNECHT R, 1995, CARCINOGENESIS, V16, P443, DOI 10.1093/carcin/16.3.443; Kas K, 1998, J BIOL CHEM, V273, P23026, DOI 10.1074/jbc.273.36.23026; Kiermayer S, 2005, MOL BIOL CELL, V16, P5639, DOI 10.1091/mbc.E05-05-0432; Lazarovici P, 1998, MOL PHARMACOL, V54, P547, DOI 10.1124/mol.54.3.547; Lelievre V, 2008, DEV BIOL, V313, P359, DOI 10.1016/j.ydbio.2007.10.031; Lemeta S, 2006, HUM PATHOL, V37, P749, DOI 10.1016/j.humpath.2006.02.002; Li Y, 2006, GENE DEV, V20, P2793, DOI 10.1101/gad.1466306; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu NR, 1997, P NATL ACAD SCI USA, V94, P3357, DOI 10.1073/pnas.94.7.3357; Ma L, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-11; McCulloch DA, 2002, BIOCHEM SOC T, V30, P441, DOI 10.1042/bst0300441; Ng YP, 2003, J BIOL CHEM, V278, P38731, DOI 10.1074/jbc.M304623200; Nicot A, 2002, J NEUROSCI, V22, P9244; Nielsen HS, 1998, NEUROREPORT, V9, P2639, DOI 10.1097/00001756-199808030-00039; NOWAKOWSKI RS, 1989, J NEUROCYTOL, V18, P311, DOI 10.1007/BF01190834; Pagotto U, 2000, CANCER RES, V60, P6794; Pennuto M, 2002, MOL BIOL CELL, V13, P2706, DOI 10.1091/mbc.E02-01-0036; Piras G, 2000, MOL CELL BIOL, V20, P3308, DOI 10.1128/MCB.20.9.3308-3315.2000; Ravni A, 2008, MOL PHARMACOL, V73, P1688, DOI 10.1124/mol.107.044792; Riccio A, 1997, SCIENCE, V277, P1097, DOI 10.1126/science.277.5329.1097; Shi GX, 2006, MOL CELL BIOL, V26, P9136, DOI 10.1128/MCB.00332-06; Singhal S, 2003, CANCER BIOL THER, V2, P291, DOI 10.4161/cbt.2.3.399; Skoglosa Y, 1999, NEUROSCI LETT, V265, P207, DOI 10.1016/S0304-3940(99)00250-5; Smith RJ, 2002, GENE, V292, P101, DOI 10.1016/S0378-1119(02)00666-2; Somogyvari-Vigh A, 2004, CURR PHARM DESIGN, V10, P2861, DOI 10.2174/1381612043383548; Spengler D, 1997, EMBO J, V16, P2814, DOI 10.1093/emboj/16.10.2814; Stork PJS, 2003, TRENDS BIOCHEM SCI, V28, P267, DOI 10.1016/S0968-0004(03)00087-2; Suh JH, 2001, NAT NEUROSCI, V4, P123, DOI 10.1038/83936; TISCHLER AS, 1978, LAB INVEST, V39, P77; Tsuda T, 2004, DEV DYNAM, V229, P340, DOI 10.1002/dvdy.10439; Valente T, 2005, DEV DYNAM, V233, P667, DOI 10.1002/dvdy.20373; Valente T, 2001, MECH DEVELOP, V108, P207, DOI 10.1016/S0925-4773(01)00492-0; Varrault A, 1998, P NATL ACAD SCI USA, V95, P8835, DOI 10.1073/pnas.95.15.8835; Vaudry D, 2000, P NATL ACAD SCI USA, V97, P13390, DOI 10.1073/pnas.97.24.13390; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Vaudry D, 1999, P NATL ACAD SCI USA, V96, P9415, DOI 10.1073/pnas.96.16.9415; Vaudry D, 2002, ANN NY ACAD SCI, V971, P491, DOI 10.1111/j.1749-6632.2002.tb04513.x; Vaudry D, 2000, ANN NY ACAD SCI, V921, P293; Vaudry D, 1998, ANN NY ACAD SCI, V865, P92, DOI 10.1111/j.1749-6632.1998.tb11167.x; WHITMARSH AJ, 1995, SCIENCE, V269, P403, DOI 10.1126/science.7618106; Ye WZ, 2009, DEV NEUROBIOL, V69, P1, DOI 10.1002/dneu.20680	83	16	16	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					15325	15338		10.1074/jbc.M109.002329	http://dx.doi.org/10.1074/jbc.M109.002329			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19346254	Green Published, hybrid			2022-12-27	WOS:000266288200067
J	Garza, RM; Sato, BK; Hampton, RY				Garza, Renee M.; Sato, Brian K.; Hampton, Randolph Y.			In Vitro Analysis of Hrd1p-mediated Retrotranslocation of Its Multispanning Membrane Substrate 3-Hydroxy-3-methylglutaryl (HMG)-CoA Reductase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER-ASSOCIATED DEGRADATION; ENDOPLASMIC-RETICULUM MEMBRANE; HMG-COA REDUCTASE; UBIQUITIN-PROTEASOME PATHWAY; PROTEIN-DEGRADATION; MISFOLDED PROTEINS; QUALITY-CONTROL; REGULATED DEGRADATION; RETRO-TRANSLOCATION; STEROL REGULATION	Endoplasmic reticulum (ER)-associated degradation (ERAD) is responsible for the ubiquitin-mediated destruction of both misfolded and normal ER-resident proteins. ERAD substrates must be moved from the ER to the cytoplasm for ubiquitination and proteasomal destruction by a process called retrotranslocation. Many aspects of retrotranslocation are poorly understood, including its generality, the cellular components required, the energetics, and the mechanism of transfer through the ER membrane. To address these questions, we have developed an in vitro assay, using the 8-transmembrane span ER-resident Hmg2p isozyme of HMG-CoA reductase fused to GFP, which undergoes regulated ERAD mediated by the Hrd1p ubiquitin ligase. We have now directly demonstrated in vitro retrotranslocation of full-length, ubiquitinated Hmg2p-GFP to the aqueous phase. Hrd1p was rate-limiting for Hmg2p-GFP retrotranslocation, which required ATP, the AAA-ATPase Cdc48p, and its receptor Ubx2p. In addition, the adaptors Dsk2p and Rad23p, normally implicated in later parts of the pathway, were required. Hmg2p-GFP retrotranslocation did not depend on any of the proposed ER channel candidates. To examine the role of the Hrd1p transmembrane domain as a retrotranslocon, we devised a self-ubiquitinating polytopic substrate (Hmg1-Hrd1p) that undergoes ERAD in the absence of Hrd1p. In vitro retrotranslocation of full-length Hmg1-Hrd1p occurred in the absence of the Hrd1p transmembrane domain, indicating that it did not serve a required channel function. These studies directly demonstrate polytopic membrane protein retrotranslocation during ERAD and delineate avenues for mechanistic understanding of this general process.	[Garza, Renee M.; Sato, Brian K.; Hampton, Randolph Y.] Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, La Jolla, CA 92093 USA	University of California System; University of California San Diego	Hampton, RY (corresponding author), Univ Calif San Diego, Div Biol Sci, Sect Cell & Dev Biol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	rhampton@ucsd.edu			National Institutes of Health [5 R01 DK051996-15]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051996] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant 5 R01 DK051996-15 (to R.Y.H.) with an additional Minority Supplement (to R.M.G.).	Ahner A, 2004, TRENDS CELL BIOL, V14, P474, DOI 10.1016/j.tcb.2004.07.013; Amano T, 2003, GENE DEV, V17, P2436, DOI 10.1101/gad.1096603; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Bays NW, 2001, MOL BIOL CELL, V12, P4114, DOI 10.1091/mbc.12.12.4114; Bazirgan OA, 2006, J BIOL CHEM, V281, P38989, DOI 10.1074/jbc.M608174200; Berke SJS, 2003, CURR OPIN GENET DEV, V13, P253, DOI 10.1016/S0959-437X(03)00053-4; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; CHENG SH, 1990, CELL, V63, P827, DOI 10.1016/0092-8674(90)90148-8; Cronin SR, 2000, J CELL BIOL, V148, P915, DOI 10.1083/jcb.148.5.915; DeLaBarre B, 2006, MOL CELL, V22, P451, DOI 10.1016/j.molcel.2006.03.036; Denic V, 2006, CELL, V126, P349, DOI 10.1016/j.cell.2006.05.045; Flierman D, 2003, J BIOL CHEM, V278, P34774, DOI 10.1074/jbc.M303360200; Flury I, 2005, EMBO J, V24, P3917, DOI 10.1038/sj.emboj.7600855; Gardner R, 1998, MOL BIOL CELL, V9, P2611, DOI 10.1091/mbc.9.9.2611; Gardner RG, 2001, MOL CELL BIOL, V21, P4276, DOI 10.1128/MCB.21.13.4276-4291.2001; Gardner RG, 2000, J CELL BIOL, V151, P69, DOI 10.1083/jcb.151.1.69; Gardner RG, 1999, EMBO J, V18, P5994, DOI 10.1093/emboj/18.21.5994; Gauss R, 2006, EMBO J, V25, P1827, DOI 10.1038/sj.emboj.7601088; Gauss R, 2006, NAT CELL BIOL, V8, P849, DOI 10.1038/ncb1445; Hampton RY, 2002, ANNU REV CELL DEV BI, V18, P345, DOI 10.1146/annurev.cellbio.18.032002.131219; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; HAMPTON RY, 1994, J CELL BIOL, V125, P299, DOI 10.1083/jcb.125.2.299; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; Hitchcock AL, 2001, MOL BIOL CELL, V12, P3226, DOI 10.1091/mbc.12.10.3226; Ito K, 2005, ANNU REV MICROBIOL, V59, P211, DOI 10.1146/annurev.micro.59.030804.121316; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; JOHNSTON NL, 1991, BIOCHEMISTRY-US, V30, P7514, DOI 10.1021/bi00244a021; Kang Y, 2006, J MOL BIOL, V356, P1027, DOI 10.1016/j.jmb.2005.12.001; Kopito Ron R., 1999, Physiological Reviews, V79, pS167; Kreft SG, 2006, J BIOL CHEM, V281, P4646, DOI 10.1074/jbc.M512215200; Lilley BN, 2005, P NATL ACAD SCI USA, V102, P14296, DOI 10.1073/pnas.0505014102; Lilley BN, 2004, NATURE, V429, P834, DOI 10.1038/nature02592; Medicherla B, 2004, EMBO REP, V5, P692, DOI 10.1038/sj.embor.7400164; Nakatsukasa K, 2008, CELL, V132, P101, DOI 10.1016/j.cell.2007.11.023; Neuber O, 2005, NAT CELL BIOL, V7, P993, DOI 10.1038/ncb1298; Nishikawa S, 2001, J CELL BIOL, V153, P1061, DOI 10.1083/jcb.153.5.1061; Plemper RK, 1997, NATURE, V388, P891, DOI 10.1038/42276; Plemper RK, 1999, J CELL SCI, V112, P4123; Plemper RK, 1999, MOL BIOL REP, V26, P125, DOI 10.1023/A:1006913215484; Ploegh HL, 2007, NATURE, V448, P435, DOI 10.1038/nature06004; Rao H, 2002, J BIOL CHEM, V277, P11691, DOI 10.1074/jbc.M200245200; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Rumpf S, 2006, MOL CELL, V21, P261, DOI 10.1016/j.molcel.2005.12.014; Ryu KY, 2006, ANAL BIOCHEM, V353, P153, DOI 10.1016/j.ab.2006.03.038; Sato BK, 2006, YEAST, V23, P1053, DOI 10.1002/yea.1407; Schuberth C, 2005, NAT CELL BIOL, V7, P999, DOI 10.1038/ncb1299; Scott DC, 2008, J CELL BIOL, V181, P1095, DOI 10.1083/jcb.200804053; Shang F, 2005, J BIOL CHEM, V280, P20365, DOI 10.1074/jbc.M414356200; Shearer AG, 2004, J BIOL CHEM, V279, P188, DOI 10.1074/jbc.M307734200; Song BL, 2005, CELL METAB, V1, P179, DOI 10.1016/j.cmet.2005.01.001; Spang A, 1998, J CELL BIOL, V143, P589, DOI 10.1083/jcb.143.3.589; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Thrower JS, 2000, EMBO J, V19, P94, DOI 10.1093/emboj/19.1.94; Walden H, 2003, NATURE, V422, P330, DOI 10.1038/nature01456; Wiertz EJHJ, 1996, NATURE, V384, P432, DOI 10.1038/384432a0; Wilkinson CRM, 2001, NAT CELL BIOL, V3, P939, DOI 10.1038/ncb1001-939; Wilson JD, 2006, TRAFFIC, V7, P1213, DOI 10.1111/j.1600-0854.2006.00460.x; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102; Ye YH, 2004, NATURE, V429, P841, DOI 10.1038/nature02656; Ye YH, 2006, J STRUCT BIOL, V156, P29, DOI 10.1016/j.jsb.2006.01.005	63	64	64	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					14710	14722		10.1074/jbc.M809607200	http://dx.doi.org/10.1074/jbc.M809607200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19324879	hybrid, Green Published			2022-12-27	WOS:000266288200007
J	Satapathy, AK; Crampton, DJ; Beauchamp, BB; Richardson, CC				Satapathy, Ajit K.; Crampton, Donald J.; Beauchamp, Benjamin B.; Richardson, Charles C.			Promiscuous Usage of Nucleotides by the DNA Helicase of Bacteriophage T7 DETERMINANTS OF NUCLEOTIDE SPECIFICITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; GENE 4 PROTEIN; DEOXYRIBONUCLEIC-ACID; CRYSTAL-STRUCTURE; HEXAMERIC HELICASES; REPLICATION FORK; PRIMASE; BINDING; HYDROLYSIS; POLYMERASE	The multifunctional protein encoded by gene 4 of bacteriophage T7 (gp4) provides both helicase and primase activity at the replication fork. T7 DNA helicase preferentially utilizes dTTP to unwind duplex DNA in vitro but also hydrolyzes other nucleotides, some of which do not support helicase activity. Very little is known regarding the architecture of the nucleotide binding site in determining nucleotide specificity. Crystal structures of the T7 helicase domain with bound dATP or dTTP identified Arg-363 and Arg-504 as potential determinants of the specificity for dATP and dTTP. Arg-363 is in close proximity to the sugar of the bound dATP, whereas Arg-504 makes a hydrogen bridge with the base of bound dTTP. T7 helicase has a serine at position 319, whereas bacterial helicases that use rATP have a threonine in the comparable position. Therefore, in the present study we have examined the role of these residues (Arg-363, Arg-504, and Ser-319) in determining nucleotide specificity. Our results show that Arg-363 is responsible for dATP, dCTP, and dGTP hydrolysis, whereas Arg-504 and Ser-319 confer dTTP specificity. Helicase-R504A hydrolyzes dCTP far better than wild-type helicase, and the hydrolysis of dCTP fuels unwinding of DNA. Substitution of threonine for serine 319 reduces the rate of hydrolysis of dTTP without affecting the rate of dATP hydrolysis. We propose that different nucleotides bind to the nucleotide binding site of T7 helicase by an induced fit mechanism. We also present evidence that T7 helicase uses the energy derived from the hydrolysis of dATP in addition to dTTP for mediating DNA unwinding.	[Satapathy, Ajit K.; Crampton, Donald J.; Beauchamp, Benjamin B.; Richardson, Charles C.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Richardson, CC (corresponding author), Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, 240 Longwood Ave,Bldg C2,Rm 219, Boston, MA 02115 USA.	ccr@hms.harvard.edu			National Institutes of Health [GM54397]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM054397] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM54397 (to C. C. R.).	Crampton DJ, 2006, MOL CELL, V21, P165, DOI 10.1016/j.molcel.2005.11.027; Crampton DJ, 2004, P NATL ACAD SCI USA, V101, P4373, DOI 10.1073/pnas.0400968101; Crampton DJ, 2006, J MOL BIOL, V360, P667, DOI 10.1016/j.jmb.2006.05.037; EGELMAN EH, 1995, P NATL ACAD SCI USA, V92, P3869, DOI 10.1073/pnas.92.9.3869; Enemark EJ, 2006, NATURE, V442, P270, DOI 10.1038/nature04943; Frick DN, 2001, ANNU REV BIOCHEM, V70, P39, DOI 10.1146/annurev.biochem.70.1.39; Hamdan SM, 2007, MOL CELL, V27, P539, DOI 10.1016/j.molcel.2007.06.020; Hingorani MM, 1996, BIOCHEMISTRY-US, V35, P2218, DOI 10.1021/bi9521497; Kim DE, 2002, J MOL BIOL, V321, P807, DOI 10.1016/S0022-2836(02)00733-7; KOLODNER R, 1977, P NATL ACAD SCI USA, V74, P1525, DOI 10.1073/pnas.74.4.1525; LECHNER RL, 1983, J BIOL CHEM, V258, P1185; Lee SJ, 2008, P NATL ACAD SCI USA, V105, P8908, DOI 10.1073/pnas.0802732105; Lee SJ, 2001, J BIOL CHEM, V276, P49419, DOI 10.1074/jbc.M108443200; Liao JC, 2005, J MOL BIOL, V350, P452, DOI 10.1016/j.jmb.2005.04.051; Lohman TM, 1996, ANNU REV BIOCHEM, V65, P169, DOI 10.1146/annurev.bi.65.070196.001125; MATHEWS CK, 1972, J BIOL CHEM, V247, P7430; MATSON SW, 1985, J BIOL CHEM, V260, P2281; MATSON SW, 1990, ANNU REV BIOCHEM, V59, P289, DOI 10.1146/annurev.bi.59.070190.001445; MATSON SW, 1983, J BIOL CHEM, V258, P4017; MATSON SW, 1983, J BIOL CHEM, V258, P4009; MENDELMAN LV, 1992, P NATL ACAD SCI USA, V89, P10638, DOI 10.1073/pnas.89.22.10638; MENDELMAN LV, 1993, J BIOL CHEM, V268, P27208; Moreau MJ, 2007, MOL CELL, V28, P304, DOI 10.1016/j.molcel.2007.08.013; NOTARNICOLA SM, 1995, J BIOL CHEM, V270, P20215, DOI 10.1074/jbc.270.34.20215; PATEL SS, 1992, J BIOL CHEM, V267, P15013; Patel SS, 2000, ANNU REV BIOCHEM, V69, P651, DOI 10.1146/annurev.biochem.69.1.651; Sawaya MR, 1999, CELL, V99, P167, DOI 10.1016/S0092-8674(00)81648-7; Singleton MR, 2000, CELL, V101, P589, DOI 10.1016/S0092-8674(00)80871-5; Subramanya HS, 1996, NATURE, V384, P379, DOI 10.1038/384379a0; TABOR S, 1981, P NATL ACAD SCI-BIOL, V78, P205, DOI 10.1073/pnas.78.1.205; VENKATESAN M, 1982, J BIOL CHEM, V257, P2426; Washington MT, 1996, J BIOL CHEM, V271, P26825, DOI 10.1074/jbc.271.43.26825	32	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14286	14295		10.1074/jbc.M900557200	http://dx.doi.org/10.1074/jbc.M900557200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19297330	Green Published, hybrid			2022-12-27	WOS:000266286100035
J	Zhu, YWT; Hu, LP; Qi, C; Zhu, YJ				Zhu, Yiwei Tony; Hu, Liping; Qi, Chao; Zhu, Yi-Jun			PRIP Promotes Tumor Formation through Enhancing Serum-responsive Factor-mediated FOS Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-INTERACTING PROTEIN; ACTIVATING PROTEIN-1; MOLECULAR-CLONING; COACTIVATOR PRIP; NUCLEAR-FACTOR; IDENTIFICATION; MODULATOR; RAP250; GROWTH; DOMAIN	PRIP (peroxisome proliferator-activator receptor interacting protein) is a nuclear receptor coactivator required for mammary gland development. To understand the function of PRIP in breast tumorigenesis, we established a mammary tumor cell line with the PRIPLoxp/Loxp genotype. By knocking out the PRIP gene in the tumor cell line, we demonstrated that PRIP deficiency led to inhibited tumor formation without affecting tumor cell proliferation. The PRIP deficiency was associated with decreased cell invasion and migration capabilities. We found that PRIP deficiency substantially reduced FOS gene expression. A chromatin immunoprecipitation assay revealed that PRIP was recruited to the FOS promoter. In addition, we demonstrated that PRIP also directly up-regulated the FOS gene expression in human breast cancer cells. Promoter analysis showed that PRIP acted through serum-responsive factor to regulate FOS gene expression. Finally, by re-expressing the FOS gene, we confirmed that the inhibited tumor formation of PRIP-deficient tumor cells was due to reduced expression of the FOS gene.	[Zhu, Yiwei Tony; Hu, Liping; Qi, Chao; Zhu, Yi-Jun] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA	Northwestern University; Feinberg School of Medicine	Zhu, YJ (corresponding author), Northwestern Univ, Dept Pathol, Feinberg Sch Med, 303 E Chicago Ave, Chicago, IL 60611 USA.	y-zhu2@northwestern.edu			National Institutes of Health [CA 88898]; NATIONAL CANCER INSTITUTE [R01CA088898] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA 88898 (to Y. J. Z.).	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Antonson P, 2003, MOL CELL BIOL, V23, P1260, DOI 10.1128/MCB.23.4.1260-1268.2003; Caira F, 2000, J BIOL CHEM, V275, P5308, DOI 10.1074/jbc.275.8.5308; Chai J, 2002, J PHYSIOL PHARMACOL, V53, P147; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Chow JC, 2005, ANNU REV GENOM HUM G, V6, P69, DOI 10.1146/annurev.genom.6.080604.162350; Eferl R, 2003, NAT REV CANCER, V3, P859, DOI 10.1038/nrc1209; Goo YH, 2003, MOL CELL BIOL, V23, P140, DOI 10.1128/MCB.23.1.140-149.2003; Heard E, 2006, GENE DEV, V20, P1848, DOI 10.1101/gad.1422906; Hong SH, 2007, P NATL ACAD SCI USA, V104, P18439, DOI 10.1073/pnas.0707292104; Issaeva I, 2007, MOL CELL BIOL, V27, P1889, DOI 10.1128/MCB.01506-06; Iwasaki T, 2001, J BIOL CHEM, V276, P33375, DOI 10.1074/jbc.M101517200; Jung DJ, 2002, J BIOL CHEM, V277, P1229, DOI 10.1074/jbc.M110417200; Karin M, 1997, CURR OPIN CELL BIOL, V9, P240, DOI 10.1016/S0955-0674(97)80068-3; Ko L, 2000, P NATL ACAD SCI USA, V97, P6212, DOI 10.1073/pnas.97.11.6212; Kuang SQ, 2002, J BIOL CHEM, V277, P45356, DOI 10.1074/jbc.C200509200; Lee SK, 2000, MOL ENDOCRINOL, V14, P915, DOI 10.1210/me.14.6.915; Lee SK, 1999, J BIOL CHEM, V274, P34283, DOI 10.1074/jbc.274.48.34283; Mahajan MA, 2000, MOL CELL BIOL, V20, P5048, DOI 10.1128/MCB.20.14.5048-5063.2000; Marzluff WF, 2005, CURR OPIN CELL BIOL, V17, P274, DOI 10.1016/j.ceb.2005.04.010; Miano JM, 2007, AM J PHYSIOL-CELL PH, V292, pC70, DOI 10.1152/ajpcell.00386.2006; Posern G, 2006, TRENDS CELL BIOL, V16, P588, DOI 10.1016/j.tcb.2006.09.008; Qi C, 2004, J BIOL CHEM, V279, P33696, DOI 10.1074/jbc.M401266200; ROSKAM WG, 1979, NUCLEIC ACIDS RES, V7, P305, DOI 10.1093/nar/7.2.305; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Sng JCG, 2004, BIOL PHARM BULL, V27, P606, DOI 10.1248/bpb.27.606; YANG J, 1980, P NATL ACAD SCI-BIOL, V77, P2088, DOI 10.1073/pnas.77.4.2088; Zhu YJ, 2000, J BIOL CHEM, V275, P13510, DOI 10.1074/jbc.275.18.13510; Zhu YJ, 2003, J BIOL CHEM, V278, P1986, DOI 10.1074/jbc.C200634200; Zhu YJ, 2001, P NATL ACAD SCI USA, V98, P10380, DOI 10.1073/pnas.181347498	30	7	8	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14485	14492		10.1074/jbc.M900935200	http://dx.doi.org/10.1074/jbc.M900935200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19329434	hybrid, Green Published			2022-12-27	WOS:000266286100055
J	Garscha, U; Oliw, EH				Garscha, Ulrike; Oliw, Ernst H.			Leucine/Valine Residues Direct Oxygenation of Linoleic Acid by (10R)- and (8R)-Dioxygenases EXPRESSION AND SITE-DIRECTED MUTAGENESIS OF (10R)-DIOXYGENASE WITH EPOXYALCOHOL SYNTHASE ACTIVITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPEROXIDE-H SYNTHASE-1; CYCLOOXYGENASE ACTIVE-SITE; TANDEM MASS-SPECTROMETRY; ARACHIDONIC-ACID; ASPERGILLUS-NIDULANS; DIOL SYNTHASE; LIQUID-CHROMATOGRAPHY; STEREOCHEMISTRY; PRODUCTS; REARRANGEMENT	Linoleate (10R)-dioxygenase (10R-DOX) of Aspergillus fumigatus was cloned and expressed in insect cells. Recombinant 10R-DOX oxidized 18:2n-6 to (10R)-hydroperoxy8(E), 12(Z)-octadecadienoic acid (10R-HPODE; similar to 90%), (8R)-hydroperoxylinoleic acid (8R-HPODE; similar to 10%), and small amounts of 12S(13R)-epoxy-(10R)-hydroxy-(8E)-octadecenoic acid. We investigated the oxygenation of 18: 2n-6 at C-10 and C-8 by site-directed mutagenesis of 10R-DOX and 7,8-linoleate diol synthase (7,8-LDS), which forms similar to 98% 8R-HPODE and similar to 2% 10R-HPODE. The 10R-DOX and 7,8-LDS sequences differ in homologous positions of the presumed dioxygenation sites (Leu-384/Val-330 and Val-388/Leu-334, respectively) and at the distal site of the heme (Leu-306/Val-256). Leu-384/Val-330 influenced oxygenation, as L384V and L384A of 10R-DOX elevated the biosynthesis of 8-HPODE to 22 and 54%, respectively, as measured by liquid chromatography-tandem mass spectrometry analysis. The stereospecificity was also decreased, as L384A formed the R and S isomers of 10-HPODE and 8-HPODE in a 3: 2 ratio. Residues in this position also influenced oxygenation by 7,8-LDS, as its V330L mutant augmented the formation of 10R-HPODE 3-fold. Replacement of Val-388 in 10R-DOX with leucine and phenylalanine increased the formation of 8R-HPODE to 16 and 36%, respectively, whereas L334V of 7,8-LDS was inactive. Mutation of Leu-306 with valine or alanine had little influence on the epoxyalcohol synthase activity. Our results suggest that Leu-384 and Val-388 of 10R-DOX control oxygenation of 18: 2n-6 at C-10 and C-8, respectively. The two homologous positions of prostaglandin H synthase-1, Val-349 and Ser-353, are also critical for the position and stereospecificity of the cyclooxygenase reaction.	[Oliw, Ernst H.] Uppsala Univ, Uppsala Biomed Ctr, Dept Pharmaceut Biosci, Div Biochem Pharmacol, SE-75124 Uppsala, Sweden	Uppsala University	Oliw, EH (corresponding author), Uppsala Univ, Uppsala Biomed Ctr, Dept Pharmaceut Biosci, Div Biochem Pharmacol, POB 591, SE-75124 Uppsala, Sweden.	Ernst.Oliw@farmbio.uu.se	; Garscha, Ulrike/G-3559-2018	Oliw, Ernst/0000-0002-7986-8130; Garscha, Ulrike/0000-0002-3645-7833	VR Medicine [03X-06523]; FORMAS [222-2005-1733]; Knut and Alice Wallenberg Foundation [2004.0123]	VR Medicine; FORMAS(Swedish Research Council Formas); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	This work was supported by VR Medicine Grant 03X-06523, FORMAS Grant 222-2005-1733, and by Knut and Alice Wallenberg Foundation Grant 2004.0123.	Akakabe Y, 2005, BIOSCI BIOTECH BIOCH, V69, P1539, DOI 10.1271/bbb.69.1539; BRASH AR, 1995, ARCH BIOCHEM BIOPHYS, V321, P485, DOI 10.1006/abbi.1995.1421; Bylund J, 1998, ANAL BIOCHEM, V265, P55, DOI 10.1006/abio.1998.2897; Cristea M, 2005, ARCH BIOCHEM BIOPHYS, V434, P201, DOI 10.1016/j.abb.2004.10.026; Cristea M, 2003, LIPIDS, V38, P1275, DOI 10.1007/s11745-003-1189-3; Cristea N, 2007, J LIPID RES, V48, P890, DOI 10.1194/jlr.M600505-JLR200; Dagenais TRT, 2008, INFECT IMMUN, V76, P3214, DOI 10.1128/IAI.00009-08; Daiyasu H, 2000, J MOL EVOL, V51, P433, DOI 10.1007/s002390010106; Garavito RM, 2002, PROSTAG OTH LIPID M, V68-9, P129; Garscha U, 2008, FEBS LETT, V582, P3547, DOI 10.1016/j.febslet.2008.09.031; Garscha U, 2008, BIOCHEM BIOPH RES CO, V373, P579, DOI 10.1016/j.bbrc.2008.06.060; Garscha U, 2007, J BIOL CHEM, V282, P34707, DOI 10.1074/jbc.M705366200; Garscha U, 2007, ANAL BIOCHEM, V367, P238, DOI 10.1016/j.ab.2007.04.045; Hamberg M, 2005, BIOCHEM BIOPH RES CO, V338, P169, DOI 10.1016/j.bbrc.2005.08.117; Harman CA, 2004, J BIOL CHEM, V279, P42929, DOI 10.1074/jbc.M403013200; Hornsten L, 1999, J BIOL CHEM, V274, P28219, DOI 10.1074/jbc.274.40.28219; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kiefer JR, 2000, NATURE, V405, P97, DOI 10.1038/35011103; Koeduka T, 2002, J BIOL CHEM, V277, P22648, DOI 10.1074/jbc.M110420200; Koszelak-Rosenblum M, 2008, J BIOL CHEM, V283, P24962, DOI 10.1074/jbc.M804358200; Kurumbail RG, 1996, NATURE, V384, P644, DOI 10.1038/384644a0; Liu JY, 2007, J BIOL CHEM, V282, P18233, DOI 10.1074/jbc.M701235200; Malkowski MG, 2000, SCIENCE, V289, P1933, DOI 10.1126/science.289.5486.1933; Malkowski MG, 2001, J BIOL CHEM, V276, P37547, DOI 10.1074/jbc.M105982200; Marnett LJ, 1999, J BIOL CHEM, V274, P22903, DOI 10.1074/jbc.274.33.22903; Milne GL, 2008, J BIOL CHEM, V283, P15533, DOI 10.1074/jbc.R700047200; Murphy RC, 2005, ANAL BIOCHEM, V346, P1, DOI 10.1016/j.ab.2005.04.042; Nemcovic M, 2008, FEMS MICROBIOL LETT, V284, P231, DOI 10.1111/j.1574-6968.2008.01202.x; Noverr MC, 2002, INFECT IMMUN, V70, P400, DOI 10.1128/IAI.70.1.400-402.2002; Oliw EH, 2006, ANAL BIOCHEM, V354, P111, DOI 10.1016/j.ab.2006.04.010; OLIW EH, 1983, J CHROMATOGR, V275, P245, DOI 10.1016/S0378-4347(00)84372-8; Schneider C, 2000, J BIOL CHEM, V275, P4743, DOI 10.1074/jbc.275.7.4743; Schneider C, 2002, J BIOL CHEM, V277, P478, DOI 10.1074/jbc.M107471200; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; Su C, 1996, J BIOL CHEM, V271, P14112, DOI 10.1074/jbc.271.24.14112; Thuresson ED, 2000, J BIOL CHEM, V275, P8501, DOI 10.1074/jbc.275.12.8501; Thuresson ED, 2001, J BIOL CHEM, V276, P10347, DOI 10.1074/jbc.M009377200; TSAI AL, 1994, J BIOL CHEM, V269, P5085; Tsitsigiannis D, 2004, EUKARYOT CELL, V3, P1398, DOI 10.1128/EC.3.6.1398-1411.2004; Tsitsigiannis DI, 2006, MOL MICROBIOL, V59, P882, DOI 10.1111/j.1365-2958.2005.05000.x; Tsitsigiannis DI, 2005, INFECT IMMUN, V73, P4548, DOI 10.1128/IAI.73.8.4548-4559.2005; Tsitsigiannis DI, 2004, J BIOL CHEM, V279, P11344, DOI 10.1074/jbc.M310840200; Tsitsigiannis DI, 2007, TRENDS MICROBIOL, V15, P109, DOI 10.1016/j.tim.2007.01.005; Valmsen K, 2004, EUR J BIOCHEM, V271, P3533, DOI 10.1111/j.0014-2956.2004.04289.x; WURZENBERGER M, 1984, BIOCHIM BIOPHYS ACTA, V794, P18, DOI 10.1016/0005-2760(84)90292-3	45	30	32	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13755	13765		10.1074/jbc.M808665200	http://dx.doi.org/10.1074/jbc.M808665200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19289462	Green Published, hybrid			2022-12-27	WOS:000265877300053
J	Macdonald-Obermann, JL; Pike, LJ				Macdonald-Obermann, Jennifer L.; Pike, Linda J.			The Intracellular Juxtamembrane Domain of the Epidermal Growth Factor (EGF) Receptor Is Responsible for the Allosteric Regulation of EGF Binding	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE DOMAIN; EXTRACELLULAR DOMAIN; SIGNAL-TRANSDUCTION; CRYSTAL-STRUCTURE; AFFINITY; DIMERIZATION; ACTIVATION; SURFACE; PHOSPHORYLATION; REGION	We have previously shown that the binding of epidermal growth factor (EGF) to its receptor can best be described by a model that involves negative cooperativity in an aggregating system (Macdonald, J. L., and Pike, L. J. (2008) Proc. Natl. Acad. Sci. U. S. A. 105, 112-117). However, despite the fact that biochemical analyses indicate that EGF induces dimerization of its receptor, the binding data provided no evidence for positive linkage between EGF binding and dimer assembly. By analyzing the binding of EGF to a number of receptor mutants, we now report that in naive, unphosphorylated EGF receptors, ligand binding is positively linked to receptor dimerization but the linkage is abolished upon autophosphorylation of the receptor. Both phosphorylated and unphosphorylated EGF receptors exhibit negative cooperativity, indicating that mechanistically, cooperativity is distinct from the phenomenon of linkage. Nonetheless, both the positive linkage and the negative cooperativity observed in EGF binding require the presence of the intracellular juxtamembrane domain. This indicates the existence of inside-out signaling in the EGF receptor system. The intracellular juxtamembrane domain has previously been shown to be required for the activation of the EGF receptor tyrosine kinase (Thiel, K. W., and Carpenter, G. (2007) Proc. Natl. Acad. Sci. U. S. A. 104, 19238-19243). Our experiments expand the role of this domain to include the allosteric control of ligand binding by the extracellular domain.	[Macdonald-Obermann, Jennifer L.; Pike, Linda J.] Washington Univ, Sch Med, Dept Biochem & Mol Biophys, St Louis, MO 63110 USA	Washington University (WUSTL)	Pike, LJ (corresponding author), 660 So Euclid Ave,Box 8231, St Louis, MO 63110 USA.	pike@biochem.wustl.edu			National Institutes of Health [R01GM064491, R01GM082824]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM082824, R01GM064491] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM064491 and R01GM082824 (to L. J. P.).	Aifa S, 2006, PROTEINS, V62, P1036, DOI 10.1002/prot.20780; Aifa S, 2005, EXP CELL RES, V302, P108, DOI 10.1016/j.yexcr.2004.08.032; CADENA DL, 1994, J BIOL CHEM, V269, P260; CHEN WS, 1989, CELL, V59, P33, DOI 10.1016/0092-8674(89)90867-2; Clayton AHA, 2005, J BIOL CHEM, V280, P30392, DOI 10.1074/jbc.M504770200; COCHET C, 1988, J BIOL CHEM, V263, P3290; DORAN DM, 1980, J IMMUNOL METHODS, V39, P155, DOI 10.1016/0022-1759(80)90304-X; DOWNWARD J, 1984, NATURE, V311, P483, DOI 10.1038/311483a0; Ferguson KM, 2003, MOL CELL, V11, P507, DOI 10.1016/S1097-2765(03)00047-9; Garrett TPJ, 2002, CELL, V110, P763, DOI 10.1016/S0092-8674(02)00940-6; HANKS SK, 1991, METHOD ENZYMOL, V200, P38; HSUAN JJ, 1989, BIOCHEM J, V262, P659, DOI 10.1042/bj2620659; KING AC, 1982, J BIOL CHEM, V257, P3053; Lee NY, 2006, PROTEIN SCI, V15, P1142, DOI 10.1110/ps.052045306; Lee NY, 2005, PROTEIN SCI, V14, P2793, DOI 10.1110/ps.051630305; Liu P, 2007, BIOPHYS J, V93, P684, DOI 10.1529/biophysj.106.102087; Macdonald J, 2006, BBA-MOL CELL RES, V1763, P870, DOI 10.1016/j.bbamcr.2006.05.002; Macdonald JL, 2008, P NATL ACAD SCI USA, V105, P112, DOI 10.1073/pnas.0707080105; Macdonald-Obermann JL, 2009, BIOCHEMISTRY-US, V48, P2505, DOI 10.1021/bi802249x; MAGUN BE, 1980, J BIOL CHEM, V255, P6373; MARGOLIS B, 1990, EMBO J, V9, P4375, DOI 10.1002/j.1460-2075.1990.tb07887.x; Mattoon D, 2004, P NATL ACAD SCI USA, V101, P923, DOI 10.1073/pnas.0307286101; McLaughlin S, 2005, J GEN PHYSIOL, V126, P41, DOI 10.1085/jgp.200509274; Ogiso H, 2002, CELL, V110, P775, DOI 10.1016/S0092-8674(02)00963-7; REES AR, 1984, EMBO J, V3, P1843, DOI 10.1002/j.1460-2075.1984.tb02057.x; Saffarian S, 2007, BIOPHYS J, V93, P1021, DOI 10.1529/biophysj.107.105494; SHOYAB M, 1979, NATURE, V279, P387, DOI 10.1038/279387a0; Thiel KW, 2007, P NATL ACAD SCI USA, V104, P19238, DOI 10.1073/pnas.0703854104; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; Walker F, 2004, J BIOL CHEM, V279, P22387, DOI 10.1074/jbc.M401244200; WELLS A, 1990, SCIENCE, V247, P962, DOI 10.1126/science.2305263; Wong I, 1995, METHOD ENZYMOL, V259, P95; Wyman J., 1990, BINDING LINKAGE FUNC, P203; Yang KS, 2009, J BIOL CHEM, V284, P7474, DOI 10.1074/jbc.M808041200; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1443, DOI 10.1021/bi00379a035; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	36	66	67	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13570	13576		10.1074/jbc.M109.001487	http://dx.doi.org/10.1074/jbc.M109.001487			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19336395	hybrid, Green Published			2022-12-27	WOS:000265877300034
J	Klockner, C; Schneider, M; Lutz, S; Jani, D; Kressler, D; Stewart, M; Hurt, E; Kohler, A				Kloeckner, Christoph; Schneider, Maren; Lutz, Sheila; Jani, Divyang; Kressler, Dieter; Stewart, Murray; Hurt, Ed; Koehler, Alwin			Mutational Uncoupling of the Role of Sus1 in Nuclear Pore Complex Targeting of an mRNA Export Complex and Histone H2B Deubiquitination	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL ACTIVATION; IN-VIVO; SAGA; ASSOCIATION; GENES; ACETYLTRANSFERASE; UBP8; UBIQUITYLATION; ELONGATION; DEUBIQUITYLATION	Sus1 is an evolutionary conserved protein that functions both in transcription and mRNA export and has been proposed to contribute to coupling these processes in yeast. Sus1 mediates its different roles as a component of both the histone H2B deubiquitinating module (Sus1-Sgf11-Ubp8-Sgf73) of the SAGA (Spt-Ada-Gcn5 acetyltransferase) transcriptional co-activator and the mRNA export complex, TREX-2 (Sus1-Sac3-Thp1-Cdc31). We have dissected the different functions of Sus1 with respect to its partitioning in transcription and export complexes using a mutational approach. Here we show that the sus1-10 (E18A, S19A, and G20A) and sus1-12 (V73A and D75A) alleles of Sus1 can be dissociated from TREX-2 while leaving its interaction with SAGA largely intact. Conversely, the binding to both TREX-2 and SAGA was impaired in the sus1-11 allele (G37A and W38A),in which two highly conserved residues were mutated. In vitro experiments demonstrated that dissociation of mutant Sus1 from its partners is caused by a reduced affinity toward the TREX-2 subunit, Sac3, and the SAGA factor, Sgf11, respectively. Consistent with the biochemical data, these sus1 mutant alleles showed differential genetic relationships with SAGA and mRNA export mutants. In vivo, all three sus1 mutants were impaired in targeting TREX-2 (i.e. Sac3) to the nuclear pore complexes and exhibited nuclear mRNA export defects. This study has implications for how Sus1, in combination with distinct interaction partners, can regulate diverse aspects of gene expression.	[Kloeckner, Christoph; Schneider, Maren; Lutz, Sheila; Kressler, Dieter; Hurt, Ed; Koehler, Alwin] Heidelberg Univ, Biochem Zentrum, D-69120 Heidelberg, Germany; [Jani, Divyang; Stewart, Murray] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	Ruprecht Karls University Heidelberg; MRC Laboratory Molecular Biology	Hurt, E (corresponding author), Heidelberg Univ, Biochem Zentrum, Neuenheimer Feld 328, D-69120 Heidelberg, Germany.	ed.hurt@bzh.uni-heidelberg.de	Kressler, Dieter/C-2218-2012; Ed Hurt, Dr./AAE-8874-2019	Ed Hurt, Dr./0000-0002-4535-8255; Kressler, Dieter/0000-0003-4855-3563; Lutz, Sheila/0000-0002-6729-4598	MRC [MC_U105178939] Funding Source: UKRI; Medical Research Council [MC_U105178939] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abruzzi KC, 2006, EMBO J, V25, P4253, DOI 10.1038/sj.emboj.7601305; Akhtar A, 2007, NAT REV GENET, V8, P507, DOI 10.1038/nrg2122; Bauer A, 1996, J CELL SCI, V109, P1575; Brickner JH, 2004, PLOS BIOL, V2, P1843, DOI 10.1371/journal.pbio.0020342; Brown CR, 2007, CURR OPIN GENET DEV, V17, P100, DOI 10.1016/j.gde.2007.02.005; Cabal GG, 2006, NATURE, V441, P770, DOI 10.1038/nature04752; Casolari JM, 2004, CELL, V117, P427, DOI 10.1016/S0092-8674(04)00448-9; Chekanova JA, 2008, RNA, V14, P66, DOI 10.1261/rna.764108; Daniel JA, 2004, J BIOL CHEM, V279, P1867, DOI 10.1074/jbc.C300494200; Daniel JA, 2007, MUTAT RES-FUND MOL M, V618, P135, DOI 10.1016/j.mrfmmm.2006.09.008; Dieppois G, 2006, MOL CELL BIOL, V26, P7858, DOI 10.1128/MCB.00870-06; Fischer T, 2004, NAT CELL BIOL, V6, P840, DOI 10.1038/ncb1163; Fischer T, 2002, EMBO J, V21, P5843, DOI 10.1093/emboj/cdf590; Fleming AB, 2008, MOL CELL, V31, P57, DOI 10.1016/j.molcel.2008.04.025; Gonzalez-Aguilera C, 2008, MOL BIOL CELL, V19, P4310, DOI 10.1091/mbc.E08-04-0355; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Henry KW, 2003, GENE DEV, V17, P2648, DOI 10.1101/gad.1144003; Iglesias N, 2008, FEBS LETT, V582, P1987, DOI 10.1016/j.febslet.2008.03.038; Ingvarsdottir K, 2005, MOL CELL BIOL, V25, P1162, DOI 10.1128/MCB.25.3.1162-1172.2005; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; Jones AL, 2000, P NATL ACAD SCI USA, V97, P3224, DOI 10.1073/pnas.050432997; Kao CF, 2003, METHODS, V31, P59, DOI 10.1016/S1046-2023(03)00088-4; Kohler A, 2008, NAT CELL BIOL, V10, P707, DOI 10.1038/ncb1733; Kohler A, 2007, NAT REV MOL CELL BIO, V8, P761, DOI 10.1038/nrm2255; Kohler A, 2006, MOL BIOL CELL, V17, P4228, DOI 10.1091/mbc.E06-02-0098; Kressler D, 2008, J CELL BIOL, V181, P935, DOI 10.1083/jcb.200801181; Kurshakova MM, 2007, EMBO J, V26, P4956, DOI 10.1038/sj.emboj.7601901; Kuwahara K, 2001, P NATL ACAD SCI USA, V98, P10279, DOI 10.1073/pnas.181335698; Larschan E, 2001, GENE DEV, V15, P1946, DOI 10.1101/gad.911501; Lee KK, 2005, MOL CELL BIOL, V25, P1173, DOI 10.1128/MCB.25.3.1173-1182.2005; Lei EP, 2003, MOL BIOL CELL, V14, P836, DOI 10.1091/mbc.E02-08-0520; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Luna R, 2008, CHROMOSOMA, V117, P319, DOI 10.1007/s00412-008-0158-4; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; McMahon SJ, 2005, P NATL ACAD SCI USA, V102, P8478, DOI 10.1073/pnas.0503493102; Nissan TA, 2002, EMBO J, V21, P5539, DOI 10.1093/emboj/cdf547; Pascual-Garcia P, 2008, GENE DEV, V22, P2811, DOI 10.1101/gad.483308; Pavri R, 2006, CELL, V125, P703, DOI 10.1016/j.cell.2006.04.029; Resendes KK, 2008, MOL CELL BIOL, V28, P1755, DOI 10.1128/MCB.01697-07; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Rodriguez-Navarro S, 2004, CELL, V116, P75, DOI 10.1016/S0092-8674(03)01025-0; Segref A, 1997, EMBO J, V16, P3256, DOI 10.1093/emboj/16.11.3256; Shukla A, 2006, MOL CELL BIOL, V26, P3339, DOI 10.1128/MCB.26.9.3339-3352.2006; Taddei A, 2006, NATURE, V441, P774, DOI 10.1038/nature04845; Takei Y, 2001, EMBO REP, V2, P119, DOI 10.1093/embo-reports/kve026; Weake VM, 2008, MOL CELL, V29, P653, DOI 10.1016/j.molcel.2008.02.014; Weake VM, 2008, EMBO J, V27, P394, DOI 10.1038/sj.emboj.7601966; WERTMAN KF, 1992, GENETICS, V132, P337; Wilmes GM, 2008, MOL CELL, V32, P735, DOI 10.1016/j.molcel.2008.11.012; Wyce A, 2007, MOL CELL, V27, P275, DOI 10.1016/j.molcel.2007.01.035; Yoshida M, 2007, GENES CELLS, V12, P1205, DOI 10.1111/j.1365-2443.2007.01119.x; Zhang XY, 2008, MOL CELL, V29, P102, DOI 10.1016/j.molcel.2007.12.015; Zhao Y, 2008, MOL CELL, V29, P92, DOI 10.1016/j.molcel.2007.12.011	53	20	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12049	12056		10.1074/jbc.M900502200	http://dx.doi.org/10.1074/jbc.M900502200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19269973	Green Published, hybrid			2022-12-27	WOS:000265494600037
J	Sesma, JI; Esther, CR; Kreda, SM; Jones, L; O'Neal, W; Nishihara, S; Nicholas, RA; Lazarowski, ER				Sesma, Juliana I.; Esther, Charles R., Jr.; Kreda, Silvia M.; Jones, Lisa; O'Neal, Wanda; Nishihara, Shoko; Nicholas, Robert A.; Lazarowski, Eduardo R.			Endoplasmic Reticulum/Golgi Nucleotide Sugar Transporters Contribute to the Cellular Release of UDP-sugar Signaling Molecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-COUPLED RECEPTOR; AIRWAY EPITHELIAL-CELLS; ATP RELEASE; P2Y(14) RECEPTOR; ADENOSINE-TRIPHOSPHATE; FUNCTIONAL EXPRESSION; INTRACELLULAR CALCIUM; PURINERGIC RECEPTORS; FRINGE CONNECTION; GOLGI-APPARATUS	Extracellular UDP-sugars promote cellular responses by interacting with widely distributed P2Y(14) receptors, but the mechanisms by which these molecules are released from cells are poorly understood. Given the active role of UDP-sugars in glycosylation reactions within the secretory pathway, we hypothesized that UDP-sugar release includes an exocytotic component. This hypothesis was tested by assessing the contribution of endoplasmic reticulum (ER)/Golgi-resident UDPGlcNAc transporters to the cellular release of their cognate substrates. A sensitive and highly selective assay for UDP-GlcNAc mass was developed using purified AGX2, an isoenzyme of human UDP-GlcNAc pyrophosphorylase. Robust constitutive release of UDP-GlcNAc was observed in yeast as well as in well differentiated human airway epithelial cells. The human UDPGlcNAc transporter HFRC1 was overexpressed in human bronchial epithelial cells and was shown to localize in the Golgi and to enhance the surface expression of N-acetylglucosamine-rich glycans. HFRC1-overexpressing cells also displayed increased constitutive and hypotonic stress-stimulated release of UDPGlcNAc. Yeast mutants lacking Yea4 (the ER UDP-GlcNAc transporter endogenously expressed in Saccharomyces cerevisiae) showed reduced UDP-GlcNAc release. Yea4-deficient cells complemented with Yea4 showed UDP-GlcNAc release rates at levels similar to or higher than wild type cells. Our results illustrate that ER/Golgi lumen constitutes a significant source of extracellular UDP-sugars and therefore plays a critical role in nucleotide sugar-promoted cell signaling.	[Lazarowski, Eduardo R.] Univ N Carolina, Dept Med, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC 27599 USA; [Esther, Charles R., Jr.] Univ N Carolina, Dept Pediat, Chapel Hill, NC 27599 USA; [Nicholas, Robert A.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Nishihara, Shoko] Soka Univ, Fac Engn, Dept Bioinformat, Tokyo, Japan	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Soka University	Lazarowski, ER (corresponding author), Univ N Carolina, Dept Med, Cyst Fibrosis Pulm Res & Treatment Ctr, 7017 Thurston Bowles Bldg,CB 7248, Chapel Hill, NC 27599 USA.	eduardo_lazarowski@med.unc.edu		Nishihara, Shoko/0000-0002-1668-2603	National Institutes of Health [P01-HL034322]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL034322] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant P01-HL034322.	Abbracchio MP, 2003, TRENDS PHARMACOL SCI, V24, P52, DOI 10.1016/S0165-6147(02)00038-X; Berninsone PM, 2000, CURR OPIN STRUC BIOL, V10, P542, DOI 10.1016/S0959-440X(00)00128-7; Bianco F, 2005, BRAIN RES REV, V48, P144, DOI 10.1016/j.brainresrev.2004.12.004; Bodin P, 2001, J CARDIOVASC PHARM, V38, P900, DOI 10.1097/00005344-200112000-00012; Boudreault F, 2004, J PHYSIOL-LONDON, V561, P499, DOI 10.1113/jphysiol.2004.072306; Boudreault F, 2004, J MICROSC-OXFORD, V215, P302, DOI 10.1111/j.0022-2720.2004.01378.x; Burnstock G, 2006, BRIT J PHARMACOL, V147, pS172, DOI 10.1038/sj.bjp.0706429; Burnstock G, 2000, J PHARMACOL EXP THER, V295, P862; Chambers JK, 2000, J BIOL CHEM, V275, P10767, DOI 10.1074/jbc.275.15.10767; CLAIRMONT CA, 1992, J BIOL CHEM, V267, P3983; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; Dinter A, 1998, HISTOCHEM CELL BIOL, V109, P571, DOI 10.1007/s004180050256; Esther CR, 2008, EUR RESPIR J, V31, P949, DOI 10.1183/09031936.00089807; Esther CR, 2008, BIOCHEMISTRY-US, V47, P9269, DOI 10.1021/bi800855k; Fumagalli M, 2003, GLIA, V43, P218, DOI 10.1002/glia.10248; Gatof D, 2004, AM J PHYSIOL-GASTR L, V286, pG538, DOI 10.1152/ajpgi.00355.2003; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Groulx N, 2006, J MEMBRANE BIOL, V214, P43, DOI 10.1007/s00232-006-0080-8; GUILLEN E, 1995, BIOCHEMISTRY-US, V34, P5472, DOI 10.1021/bi00016a018; Guyot A, 2002, J PHYSIOL-LONDON, V545, P199, DOI 10.1113/jphysiol.2002.030148; Hirschberg CB, 1998, ANNU REV BIOCHEM, V67, P49, DOI 10.1146/annurev.biochem.67.1.49; Ishida N, 2005, GENOMICS, V85, P106, DOI 10.1016/j.ygeno.2004.09.010; Ishida N, 2004, PFLUG ARCH EUR J PHY, V447, P768, DOI 10.1007/s00424-003-1093-0; Johnson LG, 1998, J VIROL, V72, P8861, DOI 10.1128/JVI.72.11.8861-8872.1998; Jokela TA, 2008, J BIOL CHEM, V283, P7666, DOI 10.1074/jbc.M706001200; Joseph SM, 2004, BRIT J PHARMACOL, V142, P1002, DOI 10.1038/sj.bjp.0705865; Kreda SM, 2008, BRIT J PHARMACOL, V153, P1528, DOI 10.1038/sj.bjp.0707692; Kreda SM, 2007, J PHYSIOL-LONDON, V584, P245, DOI 10.1113/jphysiol.2007.139840; Kreda SM, 2000, NAT BIOTECHNOL, V18, P635, DOI 10.1038/76479; Lazarowski ER, 2004, J BIOL CHEM, V279, P36855, DOI 10.1074/jbc.M405367200; Lazarowski ER, 1999, BRIT J PHARMACOL, V127, P1272, DOI 10.1038/sj.bjp.0702654; Lazarowski ER, 2000, J BIOL CHEM, V275, P31061, DOI 10.1074/jbc.M003255200; Lazarowski ER, 2003, MOL PHARMACOL, V64, P785, DOI 10.1124/mol.64.4.785; Lazarowski ER, 2003, MOL PHARMACOL, V63, P1190, DOI 10.1124/mol.63.5.1190; Lee BC, 2003, GENE DEV, V17, P1592, DOI 10.1101/gad.1071503; Maroto R, 2001, J BIOL CHEM, V276, P23867, DOI 10.1074/jbc.M101500200; MENGINLECREULX D, 1994, J BACTERIOL, V176, P5788, DOI 10.1128/JB.176.18.5788-5795.1994; Moore DJ, 2003, MOL BRAIN RES, V118, P10, DOI 10.1016/S0169-328X(03)00330-9; Muller T, 2005, AM J RESP CELL MOL, V33, P601, DOI 10.1165/rcmb.2005-0181OC; Okada SF, 2006, J BIOL CHEM, V281, P22992, DOI 10.1074/jbc.M603019200; Peneff C, 2001, EMBO J, V20, P6191, DOI 10.1093/emboj/20.22.6191; PEREZ M, 1986, J BIOL CHEM, V261, P6822; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rabina J, 2001, GLYCOCONJUGATE J, V18, P799, DOI 10.1023/A:1021107602535; Roy SK, 2000, J BIOL CHEM, V275, P13580, DOI 10.1074/jbc.275.18.13580; Sabirov Ravshan Z, 2005, Purinergic Signal, V1, P311, DOI 10.1007/s11302-005-1557-0; Scrivens M, 2005, BRIT J PHARMACOL, V146, P435, DOI 10.1038/sj.bjp.0706322; Scrivens M, 2006, EUR J PHARMACOL, V543, P166, DOI 10.1016/j.ejphar.2006.05.037; Selva EM, 2001, NAT CELL BIOL, V3, P809, DOI 10.1038/ncb0901-809; Shin A, 2008, BLOOD, V111, P3062, DOI 10.1182/blood-2007-02-071910; Shinotsuka C, 2002, J BIOL CHEM, V277, P9468, DOI 10.1074/jbc.M112427200; Skelton L, 2003, J IMMUNOL, V171, P1941, DOI 10.4049/jimmunol.171.4.1941; Suda T, 2004, J BIOL CHEM, V279, P26469, DOI 10.1074/jbc.M311353200; Tatur S, 2008, PURINERG SIGNAL, V4, P139, DOI 10.1007/s11302-007-9059-x; Turnock DC, 2007, EUKARYOT CELL, V6, P1450, DOI 10.1128/EC.00175-07; van der Wijk T, 2003, J BIOL CHEM, V278, P40020, DOI 10.1074/jbc.M307603200; Wang-Gillam A, 1998, J BIOL CHEM, V273, P27055, DOI 10.1074/jbc.273.42.27055; Yi SMP, 2001, GENE THER, V8, P1826, DOI 10.1038/sj.gt.3301598; Zhong XT, 2003, J BIOL CHEM, V278, P33436, DOI 10.1074/jbc.M305785200	59	51	53	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12572	12583		10.1074/jbc.M806759200	http://dx.doi.org/10.1074/jbc.M806759200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19276090	Green Published, hybrid			2022-12-27	WOS:000265494600086
J	Ono, RN; Sengle, G; Charbonneau, NL; Carlberg, V; Bachinger, HP; Sasaki, T; Lee-Arteaga, S; Zilberberg, L; Rifkin, DB; Ramirez, F; Chu, ML; Sakai, LY				Ono, Robert N.; Sengle, Gerhard; Charbonneau, Noe L.; Carlberg, Valerie; Bachinger, Hans Peter; Sasaki, Takako; Lee-Arteaga, Sui; Zilberberg, Lior; Rifkin, Daniel B.; Ramirez, Francesco; Chu, Mon-Li; Sakai, Lynn Y.			Latent Transforming Growth Factor beta-binding Proteins and Fibulins Compete for Fibrillin-1 and Exhibit Exquisite Specificities in Binding Sites	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICROFIBRIL-ASSOCIATED GLYCOPROTEIN-1; TGF-BETA; EXTRACELLULAR-MATRIX; IN-VIVO; DEVELOPMENTAL EXPRESSION; TISSUE LOCALIZATION; TERNARY COMPLEX; MARFAN-SYNDROME; INTERACTS; LTBP-1	Latent transforming growth factor (TGF) beta-binding proteins (LTBPs) interact with fibrillin-1. This interaction is important for proper sequestration and extracellular control of TGF beta. Surface plasmon resonance interaction studies show that residues within the first hybrid domain (Hyb1) of fibrillin-1 contribute to interactions with LTBP-1 and LTBP-4. Modulation of binding affinities by fibrillin-1 polypeptides in which residues in the third epidermal growth factor-like domain (EGF3) are mutated demonstrates that the binding sites for LTBP-1 and LTBP-4 are different and suggests that EGF3 may also contribute residues to the binding site for LTBP-4. In addition, fibulin-2, fibulin-4, and fibulin-5 bind to residues contained within EGF3/Hyb1, but mutated polypeptides again indicate differences in their binding sites in fibrillin-1. Results demonstrate that these protein-protein interactions exhibit "exquisite specificities," a phrase commonly used to describe monoclonal antibody interactions. Despite these differences, interactions between LTBP-1 and fibrillin-1 compete for interactions between fibrillin-1 and these fibulins. All of these proteins have been immunolocalized to microfibrils. However, in fibrillin-1 (Fbn1) null fibroblast cultures, LTBP-1 and LTBP-4 are not incorporated into microfibrils. In contrast, in fibulin-2 (Fbln2) null or fibulin-4 (Fbln4) null cultures, fibrillin-1, LTBP-1, and LTBP-4 are incorporated into microfibrils. These data show for the first time that fibrillin-1, but not fibulin-2 or fibulin-4, is required for appropriate matrix assembly of LTBPs. These studies also suggest that the fibulins may affect matrix sequestration of LTBPs, because in vitro interactions between these proteins are competitive.	[Sengle, Gerhard; Carlberg, Valerie; Bachinger, Hans Peter; Sasaki, Takako; Sakai, Lynn Y.] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA; [Ono, Robert N.; Charbonneau, Noe L.; Bachinger, Hans Peter; Sakai, Lynn Y.] Oregon Hlth & Sci Univ, Shriners Hosp Children, Portland, OR 97239 USA; [Lee-Arteaga, Sui; Ramirez, Francesco] Mt Sinai Sch Med, Dept Pharmacol & Syst Therapeut, New York, NY 10029 USA; [Zilberberg, Lior; Rifkin, Daniel B.] NYU, Langone Med Ctr, Dept Cell Biol, New York, NY 10016 USA; [Chu, Mon-Li] Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, Philadelphia, PA 19107 USA	Oregon Health & Science University; Oregon Health & Science University; Icahn School of Medicine at Mount Sinai; New York University; NYU Langone Medical Center; Jefferson University	Sakai, LY (corresponding author), 3101 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	lys@shcc.org			National Institutes of Health [P01 AR049698]; Shriners Hospitals for Children; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR049698] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Shriners Hospitals for Children; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant P01 AR049698 (to F. R., D. B. R., and L. Y. S.). This work was also supported a grant from the Shriners Hospitals for Children (to H. P. B. and L. Y. S.).	Arteaga-Solis E, 2001, J CELL BIOL, V154, P275, DOI 10.1083/jcb.200105046; Carta L, 2006, J BIOL CHEM, V281, P8016, DOI 10.1074/jbc.M511599200; Charbonneau NL, 2003, J BIOL CHEM, V278, P2740, DOI 10.1074/jbc.M209201200; Charbonneau Noe L, 2004, Birth Defects Res C Embryo Today, V72, P37, DOI 10.1002/bdrc.20000; Cohn RD, 2007, NAT MED, V13, P204, DOI 10.1038/nm1536; Comeglio P, 2002, BRIT J OPHTHALMOL, V86, P1359, DOI 10.1136/bjo.86.12.1359; CORSON GM, 1993, GENOMICS, V17, P476, DOI 10.1006/geno.1993.1350; Dallas SL, 2000, J BONE MINER RES, V15, P68, DOI 10.1359/jbmr.2000.15.1.68; DALLAS SL, 1995, J CELL BIOL, V131, P539, DOI 10.1083/jcb.131.2.539; El-Hallous E, 2007, J BIOL CHEM, V282, P8935, DOI 10.1074/jbc.M608204200; Fontana L, 2005, FASEB J, V19, P1798, DOI 10.1096/fj.05-4134com; GIBSON MA, 1986, J BIOL CHEM, V261, P1429; Giltay R, 1999, MATRIX BIOL, V18, P469, DOI 10.1016/S0945-053X(99)00038-4; Gregory KE, 2005, J BIOL CHEM, V280, P27970, DOI 10.1074/jbc.M504270200; Habashi JP, 2006, SCIENCE, V312, P117, DOI 10.1126/science.1124287; Hanssen E, 2004, J BIOL CHEM, V279, P29185, DOI 10.1074/jbc.M313672200; Hirai M, 2007, EMBO J, V26, P3283, DOI 10.1038/sj.emboj.7601768; Hirani R, 2007, MATRIX BIOL, V26, P213, DOI 10.1016/j.matbio.2006.12.006; Isogai Z, 2002, J BIOL CHEM, V277, P4565, DOI 10.1074/jbc.M110583200; Isogai Z, 2003, J BIOL CHEM, V278, P2750, DOI 10.1074/jbc.M209256200; Keene DR, 1997, J HISTOCHEM CYTOCHEM, V45, P1069, DOI 10.1177/002215549704500805; Kobayashi N, 2007, J BIOL CHEM, V282, P11805, DOI 10.1074/jbc.M611029200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McLaughlin PJ, 2006, MOL CELL BIOL, V26, P1700, DOI 10.1128/MCB.26.5.1700-1709.2006; Nakamura T, 2002, NATURE, V415, P171, DOI 10.1038/415171a; Neptune ER, 2003, NAT GENET, V33, P407, DOI 10.1038/ng1116; Reinboth B, 2002, J BIOL CHEM, V277, P3950, DOI 10.1074/jbc.M109540200; Reinhardt DP, 1996, J BIOL CHEM, V271, P19489, DOI 10.1074/jbc.271.32.19489; Rifkin DB, 2005, J BIOL CHEM, V280, P7409, DOI 10.1074/jbc.R400029200; SAKAI LY, 1986, J CELL BIOL, V103, P2499, DOI 10.1083/jcb.103.6.2499; SASAKI T, 1995, J MOL BIOL, V254, P892, DOI 10.1006/jmbi.1995.0664; SENGLE G, 2008, PRIMER METABOLIC BON, P27; Sengle G, 2008, J BIOL CHEM, V283, P13874, DOI 10.1074/jbc.M707820200; Sicot FX, 2008, MOL CELL BIOL, V28, P1061, DOI 10.1128/MCB.01876-07; Taipale J, 1996, J HISTOCHEM CYTOCHEM, V44, P875, DOI 10.1177/44.8.8756760; Tiedemann K, 2005, J BIOL CHEM, V280, P11404, DOI 10.1074/jbc.M409882200; Trask BC, 2000, MOL BIOL CELL, V11, P1499, DOI 10.1091/mbc.11.5.1499; Unsold C, 2001, J CELL SCI, V114, P187; Weinbaum JS, 2008, J BIOL CHEM, V283, P25533, DOI 10.1074/jbc.M709962200; Wuttke M, 2001, J BIOL CHEM, V276, P36839, DOI 10.1074/jbc.M105689200; Yanagisawa H, 2002, NATURE, V415, P168, DOI 10.1038/415168a; ZHANG H, 1995, J CELL BIOL, V129, P1165, DOI 10.1083/jcb.129.4.1165	42	125	127	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					16872	16881		10.1074/jbc.M809348200	http://dx.doi.org/10.1074/jbc.M809348200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19349279	hybrid, Green Published			2022-12-27	WOS:000266962400023
J	Hatipoglu, OF; Hirohata, S; Cilek, MZ; Ogawa, H; Miyoshi, T; Obika, M; Demircan, K; Shinohata, R; Kusachi, S; Ninomiya, Y				Hatipoglu, Omer F.; Hirohata, Satoshi; Cilek, M. Zeynel; Ogawa, Hiroko; Miyoshi, Toru; Obika, Masanari; Demircan, Kadir; Shinohata, Ryoko; Kusachi, Shozo; Ninomiya, Yoshifumi			ADAMTS1 Is a Unique Hypoxic Early Response Gene Expressed by Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OUMS-27 CHONDROSARCOMA CELLS; MYOCARDIAL-INFARCTION; INDUCIBLE FACTOR-1; HUMAN CHONDROCYTES; IN-VITRO; MATRIX; METALLOPROTEINASES; INTERLEUKIN-1-BETA; ACTIVATION; INDUCTION	ADAMTS1 (a disintegrin and metalloproteinase with thrombospondin motifs 1) is a member of the matrix metalloproteinase family. We have previously reported that ADAMTS1 was strongly expressed in myocardial infarction. In this study, we investigated whether hypoxia induced ADAMTS1 and investigated its regulatory mechanism. In hypoxia, the expression level of ADAMTS1 mRNA and protein rapidly increased in endothelial cells, but not in other cell types. Interestingly, the induction of ADAMTS1 by hypoxia was transient, whereas vascular endothelial growth factor induction by hypoxia in human umbilical vein endothelial cells (HUVEC) increased in a time-dependent manner. CoCl2, a transition metal that mimics hypoxia, induced ADAMTS1 in HUVEC. The phosphatidylinositol 3-kinase inhibitor LY294002 dose-dependently inhibited the increase of ADAMTS1 mRNA expression in hypoxia. We characterized the promoter region of ADAMTS1, and the secreted luciferase assay system demonstrated that hypoxia induced luciferase secretion in the culture medium 4.6-fold in HUVEC. In the promoter region of ADAMTS1, we found at least three putative hypoxia-inducible factor (HIF) binding sites, and the chromatin immunoprecipitation assay revealed HIF-1 binding to HIF binding sites in the promoter region of ADAMTS1 under hypoxia. Recombinant ADAMTS1 protein promoted the migration of HUVEC under hypoxic conditions. In summary, we found that ADAMTS1 is transiently induced by hypoxia in endothelial cells, and its transcription is mediated by HIF-1 binding. Our data indicate that ADAMTS1 is a novel acute hypoxia-inducible gene.	[Hatipoglu, Omer F.; Hirohata, Satoshi; Cilek, M. Zeynel; Ogawa, Hiroko; Miyoshi, Toru; Obika, Masanari; Demircan, Kadir; Ninomiya, Yoshifumi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Mol Biol & Biochem, Okayama 7008558, Japan; [Shinohata, Ryoko; Kusachi, Shozo] Okayama Univ, Dept Med Technol, Grad Sch Hlth Sci, Okayama 7008558, Japan	Okayama University; Okayama University	Hirohata, S (corresponding author), 2-5-1 Shikata Cho, Okayama 7008558, Japan.	hirohas@cc.okayama-u.ac.jp	Kusachi, Shozo/B-1779-2011; Cilek, Mehmet Zeynel/F-1143-2016; SHINOHATA, Ryoko/B-1793-2011; Hatipoglu, Omer Faruk/J-6706-2019	Cilek, Mehmet Zeynel/0000-0002-0808-2691; SHINOHATA, Ryoko/0000-0003-1144-083X; Hatipoglu, Omer Faruk/0000-0002-1012-001X	Japan Society for the Promotion of Science [19659142, 20390399]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a grant-in-aid for scientific research from the Japan Society for the Promotion of Science (Grants 19659142 and 20390399 (to S. H.)).	Bevitt DJ, 2003, BBA-GENE STRUCT EXPR, V1626, P83, DOI 10.1016/S0167-4781(03)00047-2; CORY AH, 1991, CANCER COMMUN, V3, P207, DOI 10.3727/095535491820873191; Cross AK, 2006, BRAIN RES, V1088, P19, DOI 10.1016/j.brainres.2006.02.136; Demircan K, 2005, ARTHRITIS RHEUM-US, V52, P1451, DOI 10.1002/art.21010; Demircan K, 2009, HEAD NECK-J SCI SPEC, V31, P793, DOI 10.1002/hed.21045; Faller DV, 1999, CLIN EXP PHARMACOL P, V26, P74, DOI 10.1046/j.1440-1681.1999.02992.x; Fischer S, 2004, J CELL PHYSIOL, V198, P359, DOI 10.1002/jcp.10417; Flannery CR, 1999, MATRIX BIOL, V18, P225, DOI 10.1016/S0945-053X(99)00024-4; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Glasson SS, 2005, NATURE, V434, P644, DOI 10.1038/nature03369; Hatipoglu OF, 2009, ACTA MED OKAYAMA, V63, P79; Hirohata S, 2002, J BIOL CHEM, V277, P12182, DOI 10.1074/jbc.M109665200; Jonnsson-Rylander AC, 2005, ARTERIOSCL THROM VAS, V25, P180, DOI 10.1161/01.ATV.0000150045.27127.37; Kalinski T, 2007, HUM PATHOL, V38, P86, DOI 10.1016/j.humpath.2006.06.012; Kapitsinou PP, 2008, CELL DEATH DIFFER, V15, P650, DOI 10.1038/sj.cdd.4402313; Krampert M, 2005, J BIOL CHEM, V280, P23844, DOI 10.1074/jbc.M412212200; Kuno K, 1997, J BIOL CHEM, V272, P556, DOI 10.1074/jbc.272.1.556; Miyoshi T, 2006, FASEB J, V20, P1904, DOI 10.1096/fj.05-5565fje; Nakamura K, 2004, J BIOCHEM, V136, P439, DOI 10.1093/jb/mvh138; Ng YH, 2006, HUM REPROD, V21, P1990, DOI 10.1093/humrep/del108; Petersen EJ, 2008, ATHEROSCLEROSIS, V198, P301, DOI 10.1016/j.atherosclerosis.2007.10.015; Porter S, 2005, BIOCHEM J, V386, P15, DOI 10.1042/BJ20040424; Russell DL, 2003, J BIOL CHEM, V278, P42330, DOI 10.1074/jbc.M300519200; Sabatine MS, 2008, ARTERIOSCL THROM VAS, V28, P562, DOI 10.1161/ATVBAHA.107.156653; Secchiero P, 2008, BLOOD, V111, P1287, DOI 10.1182/blood-2007-05-092031; Semenza GL, 1998, CURR OPIN GENET DEV, V8, P588, DOI 10.1016/S0959-437X(98)80016-6; Sezaki S, 2005, EXP BIOL MED, V230, P621; Stanton H, 2005, NATURE, V434, P648, DOI 10.1038/nature03417; Toeda K, 2005, MOL CELL BIOCHEM, V280, P47, DOI 10.1007/s11010-005-8051-4; Torres-Collado AX, 2006, J BIOL CHEM, V281, P17827, DOI 10.1074/jbc.M513465200; Tortorella MD, 1999, SCIENCE, V284, P1664, DOI 10.1126/science.284.5420.1664; Vazquez F, 1999, J BIOL CHEM, V274, P23349, DOI 10.1074/jbc.274.33.23349; Wang G L, 1996, Curr Opin Hematol, V3, P156; Wiesener MS, 2003, ANN MED, V35, P183, DOI 10.1080/0785389031000458233; Yamawaki H, 2009, GLYCOBIOLOGY, V19, P83, DOI 10.1093/glycob/cwn109; Yaykasli KO, 2009, MOL CELL BIOCHEM, V323, P69, DOI 10.1007/s11010-008-9965-4	36	53	53	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16325	16333		10.1074/jbc.M109.001313	http://dx.doi.org/10.1074/jbc.M109.001313			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19349275	Green Published, hybrid			2022-12-27	WOS:000266730900030
J	Hu, XB; Kang, S; Chen, XY; Shoemaker, CB; Jin, MM				Hu, Xuebo; Kang, Sungkwon; Chen, Xiaoyue; Shoemaker, Charles B.; Jin, Moonsoo M.			Yeast Surface Two-hybrid for Quantitative in Vivo Detection of Protein-Protein Interactions via the Secretory Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GREEN FLUORESCENT PROTEIN; SACCHAROMYCES-CEREVISIAE; LIVING CELLS; ANTIBODY; AFFINITY; DISPLAY; COMPLEMENTATION; EXPRESSION; EVOLUTION; SEQUENCES	A quantitative in vivo method for detecting protein-protein interactions will enhance our understanding of protein interaction networks and facilitate affinity maturation as well as designing new interaction pairs. We have developed a novel platform, dubbed "yeast surface two-hybrid (YS2H)," to enable a quantitative measurement of pairwise protein interactions via the secretory pathway by expressing one protein (bait) anchored to the cell wall and the other (prey) in soluble form. In YS2H, the prey is released either outside of the cells or remains on the cell surface by virtue of its binding to the bait. The strength of their interaction is measured by antibody binding to the epitope tag appended to the prey or direct readout of split green fluorescence protein (GFP) complementation. When two alpha-helices forming coiled coils were expressed as a pair of prey and bait, the amount of the prey in complex with the bait progressively decreased as the affinity changes from 100 pM to 10 mu M. With GFP complementation assay, we were able to discriminate a 6-log difference in binding affinities in the range of 100 pM to 100 mu M. The affinity estimated from the level of antibody binding to fusion tags was in good agreement with that measured in solution using a surface plasmon resonance technique. In contrast, the level of GFP complementation linearly increased with the on-rate of coiled coil interactions, likely because of the irreversible nature of GFP reconstitution. Furthermore, we demonstrate the use of YS2H in exploring the nature of antigen recognition by antibodies and activation allostery in integrins and in isolating heavy chain-only antibodies against botulinum neurotoxin.	[Hu, Xuebo; Kang, Sungkwon; Chen, Xiaoyue; Jin, Moonsoo M.] Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA; [Shoemaker, Charles B.] Tufts Cummings Sch Vet Med, Dept Biomed Sci, North Grafton, MA 01536 USA	Cornell University	Jin, MM (corresponding author), Cornell Univ, Dept Biomed Engn, Ithaca, NY 14853 USA.	mj227@cornell.edu	Jin, Moonsoo/D-6128-2011		National Institutes of Health [NO1-AI30050]; American Heart Association; Northeast Biodefense Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R29AI030050] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Northeast Biodefense Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant NO1-AI30050 (to C. B. S.). This work was also supported by an American Heart Association Scientist Development grant (to M. M. J.) and a Northeast Biodefense Center grant (to M. M. J.).	Arnon SS, 2001, JAMA-J AM MED ASSOC, V285, P1059, DOI 10.1001/jama.285.8.1059; Boder ET, 1997, NAT BIOTECHNOL, V15, P553, DOI 10.1038/nbt0697-553; Boder ET, 2005, BIOTECHNOL BIOENG, V92, P485, DOI 10.1002/bit.20616; Colby DW, 2004, METHOD ENZYMOL, V388, P348; De Crescenzo G, 2003, BIOCHEMISTRY-US, V42, P1754, DOI 10.1021/bi0268450; Dranginis AM, 2007, MICROBIOL MOL BIOL R, V71, P282, DOI 10.1128/MMBR.00037-06; EGELMITANI M, 1988, GENE, V73, P113, DOI 10.1016/0378-1119(88)90317-4; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Ghosh I, 2000, J AM CHEM SOC, V122, P5658, DOI 10.1021/ja994421w; Gietz RD, 2007, NAT PROTOC, V2, P38, DOI 10.1038/nprot.2007.15; Hagihara Y, 2002, P NATL ACAD SCI USA, V99, P6619, DOI 10.1073/pnas.102172099; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Hanes J, 1997, P NATL ACAD SCI USA, V94, P4937, DOI 10.1073/pnas.94.10.4937; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Huang LL, 2006, J LEUKOCYTE BIOL, V80, P905, DOI 10.1189/jlb.1105649; Jeong KJ, 2007, P NATL ACAD SCI USA, V104, P8247, DOI 10.1073/pnas.0702650104; Jin M, 2006, P NATL ACAD SCI USA, V103, P5758, DOI 10.1073/pnas.0601164103; Jin M, 2004, STRUCTURE, V12, P2137, DOI 10.1016/j.str.2004.10.005; JOHNSTON M, 1984, MOL CELL BIOL, V4, P1440, DOI 10.1128/MCB.4.8.1440; Krebber C, 1997, J MOL BIOL, V268, P607, DOI 10.1006/jmbi.1997.0981; Maass DR, 2007, J IMMUNOL METHODS, V324, P13, DOI 10.1016/j.jim.2007.04.008; Magliery TJ, 2005, J AM CHEM SOC, V127, P146, DOI 10.1021/ja046699g; Nyfeler B, 2005, P NATL ACAD SCI USA, V102, P6350, DOI 10.1073/pnas.0501976102; Remy Ingrid, 2004, Methods Mol Biol, V261, P411; SANCHEZMADRID F, 1982, P NATL ACAD SCI-BIOL, V79, P7489, DOI 10.1073/pnas.79.23.7489; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Shimaoka M, 2006, P NATL ACAD SCI USA, V103, P13991, DOI 10.1073/pnas.0605716103; SMITH GP, 1985, SCIENCE, V228, P1315, DOI 10.1126/science.4001944; Stagljar I, 2002, TRENDS BIOCHEM SCI, V27, P559, DOI 10.1016/S0968-0004(02)02197-7; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; van den Beucken T, 2003, FEBS LETT, V546, P288, DOI 10.1016/S0014-5793(03)00602-1	31	22	23	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16369	16376		10.1074/jbc.M109.001743	http://dx.doi.org/10.1074/jbc.M109.001743			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19369257	hybrid, Green Published			2022-12-27	WOS:000266730900034
J	Liu, JX; Hu, B; Wang, Y; Gui, JF; Xiao, WH				Liu, Jing-Xia; Hu, Bo; Wang, Yang; Gui, Jian-Fang; Xiao, Wuhan			Zebrafish eaf1 and eaf2/u19 Mediate Effective Convergence and Extension Movements through the Maintenance of wnt11 and wnt5 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL MOVEMENTS; EMBRYONIC-DEVELOPMENT; AXIS FORMATION; FACTOR-2 EAF2; GASTRULATION; ELL; PROTEIN; ROLES; GENE; MLL	Studies have attributed several functions to the Eaf family, including tumor suppression and eye development. Given the potential association between cancer and development, we set forth to explore Eaf1 and Eaf2/U19 activity in vertebrate embryogenesis, using zebrafish. In situ hybridization revealed similar eaf1 and eaf2/u19 expression patterns. Morpholino-mediated knockdown of either eaf1 or eaf2/u19 expression produced similar morphological changes that could be reversed by ectopic expression of target or reciprocal-target mRNA. However, combination of Eaf1 and Eaf2/U19 (Eafs)-morpholinos increased the severity of defects, suggesting that Eaf1 and Eaf2/U19 only share some functional redundancy. The Eafs knockdown phenotype resembled that of embryos with defects in convergence and extension movements. Indeed, knockdown caused expression pattern changes for convergence and extension movement markers, whereas cell tracing experiments using kaeda mRNA showed a correlation between Eafs knockdown and cell migration defects. Cardiac and pancreatic differentiation markers revealed that Eafs knockdown also disrupted midline convergence of heart and pancreatic organ precursors. Noncanonical Wnt signaling plays a key role in both convergence and extension movements and midline convergence of organ precursors. We found that Eaf1 and Eaf2/U19 maintained expression levels of wnt11 and wnt5. Moreover, wnt11 or wnt5 mRNA partially rescued the convergence and extension movement defects occurring in eafs morphants. Wnt11 and Wnt5 converge on rhoA, so not surprisingly, rhoA mRNA more effectively rescued defects than either wnt11 or wnt5 mRNA alone. However, the ectopic expression of wnt11 and wnt5 did not affect eaf1 and eaf2/u19 expression. These data indicate that eaf1 and eaf2/u19 act upstream of noncanonical Wnt signaling to mediate convergence and extension movements.	[Liu, Jing-Xia; Hu, Bo; Xiao, Wuhan] Chinese Acad Sci, Key Lab Biodivers & Conservat Aquat Organisms, Wuhan 430072, Peoples R China; [Wang, Yang; Gui, Jian-Fang] Chinese Acad Sci, Inst Hydrobiol, State Key Lab Fresh Water Ecol & Biotechnol, Wuhan 430072, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Hydrobiology, CAS	Xiao, WH (corresponding author), Chinese Acad Sci, Key Lab Biodivers & Conservat Aquat Organisms, Wuhan 430072, Peoples R China.	w-xiao@ihb.ac.cn	Xiao, Wuhan/GLU-7352-2022; hu, bo/ABC-3810-2021	hu, bo/0000-0001-5656-9632	National Natural Science Foundation of China (NSFC) [30700440, 20890113]; Chinese Academy of Sciences [KSCX2-YW-N-020];  [2004CB117404];  [2007CB815705];  [2006CB504100]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); ; ; 	Supported by National Natural Science Foundation of China (NSFC) (Youth Foundation) Grant 30700440 and Grant 20890113.; Supported by "973" Grants 2004CB117404, 2007CB815705, and 2006CB504100; NSFC Grant 30671037; and Chinese Academy of Sciences Grant KSCX2-YW-N-020. To whom correspondence should be addressed.	Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Correa RG, 2005, CURR BIOL, V15, P1291, DOI 10.1016/j.cub.2005.06.023; Hammond KL, 2003, DEVELOPMENT, V130, P1403, DOI 10.1242/dev.00360; Heisenberg CP, 2000, NATURE, V405, P76, DOI 10.1038/35011068; Jessen JR, 2002, NAT CELL BIOL, V4, P610, DOI 10.1038/ncb828; Jopling C, 2005, EMBO REP, V6, P426, DOI 10.1038/sj.embor.7400386; Jopling C, 2007, PLOS GENET, V3, P2468, DOI 10.1371/journal.pgen.0030225; Jopling C, 2007, MECH DEVELOP, V124, P129, DOI 10.1016/j.mod.2006.10.003; KELLER R, 1992, DEVELOPMENT, P81; Kilian B, 2003, MECH DEVELOP, V120, P467, DOI 10.1016/S0925-4773(03)00004-2; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kong SE, 2005, P NATL ACAD SCI USA, V102, P10094, DOI 10.1073/pnas.0503017102; Langheinrich U, 2002, CURR BIOL, V12, P2023, DOI 10.1016/S0960-9822(02)01319-2; Lee H, 2002, DEV CELL, V2, P607, DOI 10.1016/S1534-5807(02)00166-1; Li M, 2003, DEV DYNAM, V228, P273, DOI 10.1002/dvdy.10367; Luo RT, 2001, MOL CELL BIOL, V21, P5678, DOI 10.1128/MCB.21.16.5678-5687.2001; Matsui T, 2005, GENE DEV, V19, P164, DOI 10.1101/gad.1253605; Maurus D, 2005, EMBO J, V24, P1181, DOI 10.1038/sj.emboj.7600603; Mitani K, 2000, BIOCHEM BIOPH RES CO, V279, P563, DOI 10.1006/bbrc.2000.3970; Miyasaka KY, 2007, P NATL ACAD SCI USA, V104, P11274, DOI 10.1073/pnas.0702000104; Myers DC, 2002, TRENDS GENET, V18, P447, DOI 10.1016/S0168-9525(02)02725-7; Ober EA, 2004, EMBO REP, V5, P78, DOI 10.1038/sj.embor.7400047; Reiter JF, 2001, DEVELOPMENT, V128, P125; Shilatifard A, 1996, SCIENCE, V271, P1873, DOI 10.1126/science.271.5257.1873; Simone F, 2003, BLOOD, V101, P2355, DOI 10.1182/blood-2002-06-1664; Simone F, 2001, BLOOD, V98, P201, DOI 10.1182/blood.V98.1.201; Stainier DYR, 2001, NAT REV GENET, V2, P39, DOI 10.1038/35047564; Tao QH, 2005, CELL, V120, P857, DOI 10.1016/j.cell.2005.01.013; THIRMAN MJ, 1994, P NATL ACAD SCI USA, V91, P12110, DOI 10.1073/pnas.91.25.12110; Topczewski J, 2001, DEV CELL, V1, P251, DOI 10.1016/S1534-5807(01)00005-3; Wallingford JB, 2002, DEV CELL, V2, P695, DOI 10.1016/S1534-5807(02)00197-1; Wang Z, 1997, P NATL ACAD SCI USA, V94, P12999, DOI 10.1073/pnas.94.24.12999; Westerfield M, 1999, TRENDS GENET, V15, P248, DOI 10.1016/S0168-9525(99)01741-2; Westfall TA, 2003, J CELL BIOL, V162, P889, DOI 10.1083/jcb.200303107; Wunnenberg-Stapleton K, 1999, DEVELOPMENT, V126, P5339; Xiao W, 2008, ONCOGENE, V27, P1536, DOI 10.1038/sj.onc.1210786; Xiao WH, 2003, CANCER RES, V63, P4698; Xiao WH, 2009, CANCER RES, V69, P2599, DOI 10.1158/0008-5472.CAN-08-2595; Yamashita S, 2002, DEV CELL, V2, P363, DOI 10.1016/S1534-5807(02)00126-0; Yang ZG, 2001, DEV BIOL, V231, P138, DOI 10.1006/dbio.2000.0139; Zhu SZ, 2006, CELL SIGNAL, V18, P359, DOI 10.1016/j.cellsig.2005.05.019	41	38	40	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16679	16692		10.1074/jbc.M109.009654	http://dx.doi.org/10.1074/jbc.M109.009654			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19380582	hybrid, Green Published			2022-12-27	WOS:000266730900063
J	Prats, C; Helge, JW; Nordby, P; Qvortrup, K; Ploug, T; Dela, F; Wojtaszewski, JFP				Prats, Clara; Helge, Jorn W.; Nordby, Pernille; Qvortrup, Klaus; Ploug, Thorkil; Dela, Flemming; Wojtaszewski, Jorgen F. P.			Dual Regulation of Muscle Glycogen Synthase during Exercise by Activation and Compartmentalization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RABBIT SKELETAL-MUSCLE; NUCLEAR-MAGNETIC-RESONANCE; POLYCYSTIC-OVARY-SYNDROME; CASEIN KINASE-II; PROTEIN-KINASE; SARCOPLASMIC-RETICULUM; INSULIN ACTIVATION; INCREASED RISK; PHOSPHORYLATION; GLUCOSE	Glycogen synthase (GS) is considered the rate-limiting enzyme in glycogenesis but still today there is a lack of understanding on its regulation. We have previously shown phosphorylation-dependent GS intracellular redistribution at the start of glycogen re-synthesis in rabbit skeletal muscle (Prats, C., Cadefau, J. A., Cusso, R., Qvortrup, K., Nielsen, J. N., Wojtaszewki, J. F., Wojtaszewki, J. F., Hardie, D. G., Stewart, G., Hansen, B. F., and Ploug, T. (2005) J. Biol. Chem. 280, 23165-23172). In the present study we investigate the regulation of human muscle GS activity by glycogen, exercise, and insulin. Using immunocytochemistry we investigate the existence and relevance of GS intracellular compartmentalization during exercise and during glycogen re-synthesis. The results show that GS intrinsic activity is strongly dependent on glycogen levels and that such regulation involves associated dephosphorylation at sites 2 + 2a, 3a, and 3a + 3b. Furthermore, we report the existence of several glycogen metabolism regulatory mechanisms based on GS intracellular compartmentalization. After exhausting exercise, epinephrine-induced protein kinase A activation leads to GS site 1b phosphorylation targeting the enzyme to intramyofibrillar glycogen particles, which are preferentially used during muscle contraction. On the other hand, when phosphorylated at sites 2 + 2a, GS is preferentially associated with subsarcolemmal and intermyofibrillar glycogen particles. Finally, we verify the existence in human vastus lateralis muscle of the previously reported mechanism of glycogen metabolism regulation in rabbit tibialis anterior muscle. After overnight low muscle glycogen level and/or in response to exhausting exercise-induced glycogenolysis, GS is associated with spherical structures at the I-band of sarcomeres.	[Prats, Clara; Helge, Jorn W.; Nordby, Pernille; Qvortrup, Klaus; Ploug, Thorkil; Dela, Flemming] Univ Copenhagen, Dept Biomed Sci, Ctr Healthy Ageing, Copenhagen Muscle Res Ctr, DK-2200 Copenhagen N, Denmark; [Wojtaszewski, Jorgen F. P.] Univ Copenhagen, Inst Exercise & Sport Sci, Mol Physiol Grp, DK-2200 Copenhagen N, Denmark	University of Copenhagen; University of Copenhagen	Prats, C (corresponding author), Blegdamsvej 3, DK-2200 Copenhagen N, Denmark.	cprats@mfi.ku.dk	Prats, Clara/F-5993-2014; Wojtaszewski, Jørgen FP/P-6583-2014; Dela, Flemming/B-3239-2008; Helge, Jørn Wulff/I-7096-2012; Dela, Flemming/AAU-1691-2021	Prats, Clara/0000-0001-6465-3068; Wojtaszewski, Jørgen FP/0000-0001-9785-6830; Dela, Flemming/0000-0001-9970-9535; Helge, Jørn Wulff/0000-0001-9724-5423; Dela, Flemming/0000-0001-9970-9535; Ploug, Thorkil/0000-0002-5375-6595; Qvortrup, Klaus/0000-0001-8811-0260; Nordby, Pernille/0000-0002-3934-6952; wojtaszewski, jorgen/0000-0001-8185-3408	Copenhagen Muscle Research Centre; Novo Nordisk Research Foundation; Danish Diabetes Association; Lundbeck Foundation; Velux Foundation; Foundation of 1870; Direktor Jacob and Olga Madsens Foundation; Aase and Ejnar Danielsens foundation; European Commission [LSHM-CT-2004-005272]; Danish Medical Research Council	Copenhagen Muscle Research Centre; Novo Nordisk Research Foundation(Novo Nordisk Foundation); Danish Diabetes Association; Lundbeck Foundation(Lundbeckfonden); Velux Foundation(Velux Fonden); Foundation of 1870; Direktor Jacob and Olga Madsens Foundation; Aase and Ejnar Danielsens foundation; European Commission(European CommissionEuropean Commission Joint Research Centre); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported in part by The Copenhagen Muscle Research Centre, the Novo Nordisk Research Foundation, The Danish Diabetes Association, the Lundbeck Foundation, the Velux Foundation, the Foundation of 1870, Direktor Jacob and Olga Madsens Foundation, Aase and Ejnar Danielsens foundation, and an Integrated Project (Grant LSHM-CT-2004-005272) funded by the European Commission and The Danish Medical Research Council.	ANDERSEN P, 1985, J APPL PHYSIOL, V59, P1647, DOI 10.1152/jappl.1985.59.5.1647; Aschenbach WG, 2001, J BIOL CHEM, V276, P39959, DOI 10.1074/jbc.M105518200; BERGSTROM J, 1962, SCAND J CLIN LAB INV, V14, P1; BOGARDUS C, 1984, J CLIN INVEST, V73, P1185, DOI 10.1172/JCI111304; CARLING D, 1989, BIOCHIM BIOPHYS ACTA, V1012, P81, DOI 10.1016/0167-4889(89)90014-1; Cohen P, 1997, FEBS LETT, V410, P3, DOI 10.1016/S0014-5793(97)00490-0; DAMSBO P, 1991, DIABETOLOGIA, V34, P239, DOI 10.1007/BF00405082; DANFORTH WH, 1965, J BIOL CHEM, V240, P588; DAWSON DJ, 1969, AUST J BIOL SCI, V22, P247, DOI 10.1071/BI9690247; DEPAOLIROACH AA, 1983, J BIOL CHEM, V258, P702; ERIKSSON J, 1989, NEW ENGL J MED, V321, P337, DOI 10.1056/NEJM198908103210601; FernandezNovell JM, 1997, BIOCHEM J, V321, P227, DOI 10.1042/bj3210227; Ferrer JC, 1997, FEBS LETT, V415, P249, DOI 10.1016/S0014-5793(97)01136-8; FIOL CJ, 1987, J BIOL CHEM, V262, P14042; FLOTOW H, 1989, J BIOL CHEM, V264, P9126; FLOTOW H, 1990, J BIOL CHEM, V265, P14264; FRIDEN J, 1989, ACTA PHYSIOL SCAND, V135, P381, DOI 10.1111/j.1748-1716.1989.tb08591.x; Glintborg D, 2008, J CLIN ENDOCR METAB, V93, P3618, DOI 10.1210/jc.2008-0760; GOLDSTEIN MA, 1985, J MUSCLE RES CELL M, V6, P177, DOI 10.1007/BF00713059; Hojlund K, 2003, DIABETES, V52, P1393, DOI 10.2337/diabetes.52.6.1393; Hojlund K, 2008, DIABETES, V57, P357, DOI 10.2337/db07-0706; Hojlund K, 2006, CURR DIABETES REV, V2, P375, DOI 10.2174/1573399810602040375; HUANG TS, 1977, BIOCHEM BIOPH RES CO, V75, P643, DOI 10.1016/0006-291X(77)91521-2; Jorgensen SB, 2004, DIABETES, V53, P3074, DOI 10.2337/diabetes.53.12.3074; Lai YC, 2007, AM J PHYSIOL-ENDOC M, V293, pE1622, DOI 10.1152/ajpendo.00113.2007; Marchand I, 2002, J APPL PHYSIOL, V93, P1598, DOI 10.1152/japplphysiol.00585.2001; McBride A, 2009, CELL METAB, V9, P23, DOI 10.1016/j.cmet.2008.11.008; MEYER F, 1970, J BIOL CHEM, V245, P6642; Nielsen JN, 2001, J PHYSIOL-LONDON, V531, P757, DOI 10.1111/j.1469-7793.2001.0757h.x; Parker GJ, 2003, J BIOL CHEM, V278, P10022, DOI 10.1074/jbc.M207787200; PICTON C, 1982, FEBS LETT, V150, P191, DOI 10.1016/0014-5793(82)81332-X; Ploug T, 1998, J CELL BIOL, V142, P1429, DOI 10.1083/jcb.142.6.1429; Prats C, 2005, J BIOL CHEM, V280, P23165, DOI 10.1074/jbc.M502713200; Prats C, 2002, BBA-GEN SUBJECTS, V1573, P68, DOI 10.1016/S0304-4165(02)00332-X; Roach Peter J., 1998, Journal of Basic and Clinical Physiology and Pharmacology, V9, P139; ROACH PJ, 1978, J CYCLIC NUCL PROT, V4, P245; ROACH PJ, 1990, FASEB J, V4, P2961, DOI 10.1096/fasebj.4.12.2168324; ROACH PJ, 1991, J BIOL CHEM, V266, P14139; Roden M, 2001, RECENT PROG HORM RES, V56, P219, DOI 10.1210/rp.56.1.219; Rybicka KK, 1996, TISSUE CELL, V28, P253, DOI 10.1016/S0040-8166(96)80013-9; SCHALINJANTTI C, 1992, DIABETES, V41, P598, DOI 10.2337/diabetes.41.5.598; SHULMAN GI, 1990, NEW ENGL J MED, V322, P223, DOI 10.1056/NEJM199001253220403; SJOSTROM M, 1982, HISTOCHEMISTRY, V76, P425, DOI 10.1007/BF00489899; SKURAT AV, 1994, J BIOL CHEM, V269, P25534; STEFANINI M, 1967, NATURE, V216, P173, DOI 10.1038/216173a0; VAAG A, 1992, J CLIN INVEST, V89, P782, DOI 10.1172/JCI115656; VILLARPALASI C, 1991, BIOCHIM BIOPHYS ACTA, V1095, P261, DOI 10.1016/0167-4889(91)90109-B; VILLARPALASI C, 1995, BBA-GEN SUBJECTS, V1244, P203, DOI 10.1016/0304-4165(95)00006-W; WANSON JC, 1968, J CELL BIOL, V38, P130, DOI 10.1083/jcb.38.1.130; WANSON JC, 1972, J CELL BIOL, V54, P206, DOI 10.1083/jcb.54.2.206; Wojtaszewski JFP, 2002, DIABETES, V51, P284, DOI 10.2337/diabetes.51.2.284	51	63	66	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15692	15700		10.1074/jbc.M900845200	http://dx.doi.org/10.1074/jbc.M900845200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19339242	hybrid, Green Published			2022-12-27	WOS:000266501000038
J	Nakamura, S; Takamura, T; Matsuzawa-Nagata, N; Takayama, H; Misu, H; Noda, H; Nabemoto, S; Kurita, S; Ota, T; Ando, H; Miyamoto, K; Kaneko, S				Nakamura, Seiji; Takamura, Toshinari; Matsuzawa-Nagata, Naoto; Takayama, Hiroaki; Misu, Hirofumi; Noda, Hiroyo; Nabemoto, Satoko; Kurita, Seiichiro; Ota, Tsuguhito; Ando, Hitoshi; Miyamoto, Ken-ichi; Kaneko, Shuichi			Palmitate Induces Insulin Resistance in H4IIEC3 Hepatocytes through Reactive Oxygen Species Produced by Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; SATURATED FATTY-ACIDS; INCREASED OXIDATIVE STRESS; SKELETAL-MUSCLE CELLS; SIGNAL-TRANSDUCTION; JNK PATHWAY; LIVER; CERAMIDE; OBESITY; KINASE	Visceral adiposity in obesity causes excessive free fatty acid (FFA) flux into the liver via the portal vein and may cause fatty liver disease and hepatic insulin resistance. However, because animal models of insulin resistance induced by lipid infusion or a high fat diet are complex and may be accompanied by alterations not restricted to the liver, it is difficult to determine the contribution of FFAs to hepatic insulin resistance. Therefore, we treated H4IIEC3 cells, a rat hepatocyte cell line, with a monounsaturated fatty acid (oleate) and a saturated fatty acid (palmitate) to investigate the direct and initial effects of FFAs on hepatocytes. We show that palmitate, but not oleate, inhibited insulin-stimulated tyrosine phosphorylation of insulin receptor substrate 2 and serine phosphorylation of Akt, through c-Jun NH2-terminal kinase (JNK) activation. Among the well established stimuli for JNK activation, reactive oxygen species (ROS) played a causal role in palmitate-induced JNK activation. In addition, etomoxir, an inhibitor of carnitine palmitoyltransferase-1, which is the rate-limiting enzyme in mitochondrial fatty acid beta-oxidation, as well as inhibitors of the mitochondrial respiratory chain complex (thenoyltrifluoroacetone and carbonyl cyanide m-chlorophenylhydrazone) decreased palmitate-induced ROS production. Together, our findings in hepatocytes indicate that palmitate inhibited insulin signal transduction through JNK activation and that accelerated beta-oxidation of palmitate caused excess electron flux in the mitochondrial respiratory chain, resulting in increased ROS generation. Thus, mitochondria-derived ROS induced by palmitate may be major contributors to JNK activation and cellular insulin resistance.	[Nakamura, Seiji; Takamura, Toshinari; Takayama, Hiroaki; Misu, Hirofumi; Noda, Hiroyo; Nabemoto, Satoko; Kurita, Seiichiro; Ota, Tsuguhito; Ando, Hitoshi; Kaneko, Shuichi] Kanazawa Univ, Grad Sch Med Sci, Dept Dis Control & Homeostasis, Kanazawa, Ishikawa 9208641, Japan; [Matsuzawa-Nagata, Naoto; Miyamoto, Ken-ichi] Kanazawa Univ Hosp, Dept Med Informat, Kanazawa, Ishikawa 9208641, Japan	Kanazawa University; Kanazawa University	Takamura, T (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Dept Dis Control & Homeostasis, Kanazawa, Ishikawa 9208641, Japan.	ttakamura@m-kanazawa.jp	Takayama, Hiroaki/C-4694-2015; ANDO, Hitoshi/O-8199-2016; Nagata, Naoto/C-8498-2009; NAGATA, Naoto/D-9261-2012	Takayama, Hiroaki/0000-0003-4792-3868; ANDO, Hitoshi/0000-0001-6179-9993; NAGATA, Naoto/0000-0002-2389-2334	Ministry of Education, Culture, Sports, Science, and Technology of Japan	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by grants-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Boden G, 2005, DIABETES, V54, P3458, DOI 10.2337/diabetes.54.12.3458; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Bruce CR, 2007, NAT MED, V13, P1137, DOI 10.1038/nm1007-1137; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Carlsson C, 1999, ENDOCRINOLOGY, V140, P3422, DOI 10.1210/en.140.8.3422; Chavez JA, 2003, ARCH BIOCHEM BIOPHYS, V419, P101, DOI 10.1016/j.abb.2003.08.020; Chavez JA, 2003, J BIOL CHEM, V278, P10297, DOI 10.1074/jbc.M212307200; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; De Minicis S, 2006, GASTROENTEROLOGY, V131, P272, DOI 10.1053/j.gastro.2006.05.048; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Evans JL, 2002, ENDOCR REV, V23, P599, DOI 10.1210/er.2001-0039; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI21625, 10.1172/JCI20042162S]; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Ide T, 2004, NAT CELL BIOL, V6, P351, DOI 10.1038/ncb1111; Kaneto H, 2004, DRUG NEWS PERSPECT, V17, P447, DOI 10.1358/dnp.2004.17.7.863704; Karaskov E, 2006, ENDOCRINOLOGY, V147, P3398, DOI 10.1210/en.2005-1494; Kim JK, 2001, P NATL ACAD SCI USA, V98, P7522, DOI 10.1073/pnas.121164498; Matsuzawa N, 2007, HEPATOLOGY, V46, P1392, DOI 10.1002/hep.21874; Matsuzawa-Nagata N, 2008, METABOLISM, V57, P1071, DOI 10.1016/j.metabol.2008.03.010; Miller TA, 2005, BIOCHEM BIOPH RES CO, V336, P309, DOI 10.1016/j.bbrc.2005.08.088; Nakatani Y, 2005, J BIOL CHEM, V280, P847, DOI 10.1074/jbc.M411860200; Nakatani Y, 2004, J BIOL CHEM, V279, P45803, DOI 10.1074/jbc.M406963200; Nguyen MTA, 2005, J BIOL CHEM, V280, P35361, DOI 10.1074/jbc.M504611200; Nishikawa T, 2000, NATURE, V404, P787, DOI 10.1038/35008121; OSMUNDSEN H, 1991, BIOCHIM BIOPHYS ACTA, V1085, P141, DOI 10.1016/0005-2760(91)90089-Z; Ota T, 2007, GASTROENTEROLOGY, V132, P282, DOI 10.1053/j.gastro.2006.10.014; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Powell DJ, 2004, BIOCHEM J, V382, P619, DOI 10.1042/BJ20040139; Sakurai M, 2007, J GASTROENTEROL, V42, P312, DOI 10.1007/s00535-006-1948; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Schmitz-Peiffer C, 1999, J BIOL CHEM, V274, P24202, DOI 10.1074/jbc.274.34.24202; Solinas G, 2006, P NATL ACAD SCI USA, V103, P16454, DOI 10.1073/pnas.0607626103; TURINSKY J, 1990, J BIOL CHEM, V265, P16880	38	315	325	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					14809	14818		10.1074/jbc.M901488200	http://dx.doi.org/10.1074/jbc.M901488200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19332540	hybrid, Green Published, Green Submitted			2022-12-27	WOS:000266288200016
J	Gong, R; Vu, BK; Feng, Y; Prieto, DA; Dyba, MA; Walsh, JD; Prabakaran, P; Veenstra, TD; Tarasov, SG; Ishima, R; Dimitrov, DS				Gong, Rui; Vu, Bang K.; Feng, Yang; Prieto, DaRue A.; Dyba, Marzena A.; Walsh, Joseph D.; Prabakaran, Ponraj; Veenstra, Timothy D.; Tarasov, Sergey G.; Ishima, Rieko; Dimitrov, Dimiter S.			Engineered Human Antibody Constant Domains with Increased Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING-PROTEINS; DISULFIDE BOND; CRYSTAL-STRUCTURE; VARIABLE DOMAINS; NMR; STABILIZATION; RECOGNITION; SENSITIVITY; SCAFFOLDS; FRAGMENTS	The immunoglobulin (Ig) constant CH2 domain is critical for antibody effector functions. Isolated CH2 domains are promising as scaffolds for construction of libraries containing diverse binders that could also confer some effector functions. However, previous work has shown that an isolated murine CH2 domain is relatively unstable to thermally induced unfolding. To explore unfolding mechanisms of isolated human CH2 and increase its stability gamma 1 CH2 was cloned and a panel of cysteine mutants was constructed. Human gamma 1 CH2 unfolded at a higher temperature (T-m = 54.1 degrees C, as measured by circular dichroism) than that previously reported for a mouse CH2 (41 degrees C). One mutant (m01) was remarkably stable (T-m = 73.8 degrees C). Similar results were obtained by differential scanning calorimetry. This mutant was also significantly more stable than the wild-type CH2 against urea induced unfolding (50% unfolding at urea concentration of 6.8 M versus 4.2 M). The m01 was highly soluble and monomeric. The existence of the second disulfide bond in m01 and its correct position were demonstrated by mass spectrometry and nuclear magnetic resonance spectroscopy, respectively. The loops were on average more flexible than the framework in both CH2 and m01, and the overall secondary structure was not affected by the additional disulfide bond. These data suggest that a human CH2 domain is relatively stable to unfolding at physiological temperature, and that both CH2 and the highly stable mutant m01 are promising new scaffolds for the development of therapeutics against human diseases.	[Gong, Rui; Vu, Bang K.; Feng, Yang; Prabakaran, Ponraj; Dimitrov, Dimiter S.] NCI Frederick, Prot Interact Grp, CCRNP, CCR,NIH, Frederick, MD 21702 USA; [Tarasov, Sergey G.] NCI Frederick, Struct Biophys Lab, NIH, Frederick, MD 21702 USA; [Prieto, DaRue A.; Veenstra, Timothy D.] NCI Frederick, Lab Prote & Analyt Technol, SAIC Frederick Inc, Frederick, MD 21702 USA; [Dyba, Marzena A.] NCI Frederick, Struct Biophys Lab, SAIC Frederick Inc, Frederick, MD 21702 USA; [Walsh, Joseph D.; Ishima, Rieko] Univ Pittsburgh, Sch Med, Dept Biol Struct, Pittsburgh, PA 15260 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Science Applications International Corporation (SAIC); SAIC-Frederick; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Dimitrov, DS (corresponding author), NCI Frederick, Prot Interact Grp, CCRNP, CCR,NIH, Bldg 469,Rm 150B, Frederick, MD 21702 USA.	dimitrov@ncifcrf.gov	Ponraj, Prabakaran/D-6325-2011	Ponraj, Prabakaran/0000-0002-4049-4813	National Institutes of Health; NCI [N01-CO-12400]; Center for Cancer Research Intramural Research Program; Gates Foundation; NATIONAL CANCER INSTITUTE [ZICBC010965, ZIABC010701, ZIABC011155] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research Intramural Research Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Gates Foundation(Bill & Melinda Gates Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants from the Intramural AIDS Targeted Antiviral Program (IATAP), the NIAID Intramural Biodefense Program, the NCI, Center for Cancer Research Intramural Research Program (to D. S. D.) and Contract N01-CO-12400 from the NCI. This work was also supported by the Gates Foundation.	Binz HK, 2005, NAT BIOTECHNOL, V23, P1257, DOI 10.1038/nbt1127; Dani VS, 2003, PROTEIN ENG, V16, P187, DOI 10.1093/proeng/gzg024; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dimitrov DS, 2009, MABS, V1, P26, DOI 10.4161/mabs.1.1.7480; Feige MJ, 2004, J MOL BIOL, V344, P107, DOI 10.1016/j.jmb.2004.09.033; Gong QG, 2007, J BIOMOL NMR, V37, P147, DOI 10.1007/s10858-006-9125-7; GRZESIEK S, 1993, J AM CHEM SOC, V115, P12593, DOI 10.1021/ja00079a052; Hagihara Y, 2007, J BIOL CHEM, V282, P36489, DOI 10.1074/jbc.M707078200; Hey T, 2005, TRENDS BIOTECHNOL, V23, P514, DOI 10.1016/j.tibtech.2005.07.007; Holliger P, 2005, NAT BIOTECHNOL, V23, P1126, DOI 10.1038/nbt1142; Holt LJ, 2003, TRENDS BIOTECHNOL, V21, P484, DOI 10.1016/j.tibtech.2003.08.007; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; KAY LE, 1990, J MAGN RESON, V89, P496, DOI 10.1016/0022-2364(90)90333-5; Koenig BW, 2003, J BIOMOL NMR, V26, P193, DOI 10.1023/A:1023887412387; Kolmar H, 2008, FEBS J, V275, P2667, DOI 10.1111/j.1742-4658.2008.06437.x; Masse JE, 2005, J MAGN RESON, V174, P133, DOI 10.1016/j.jmr.2005.01.017; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; Muyldermans S, 2001, TRENDS BIOCHEM SCI, V26, P230, DOI 10.1016/S0968-0004(01)01790-X; Nygren PA, 2004, J IMMUNOL METHODS, V290, P3, DOI 10.1016/j.jim.2004.04.006; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Pellequer JL, 2006, PROTEINS, V65, P192, DOI 10.1002/prot.21059; Prabakaran P, 2008, ACTA CRYSTALLOGR D, V64, P1062, DOI 10.1107/S0907444908025274; Saerens D, 2008, J MOL BIOL, V377, P478, DOI 10.1016/j.jmb.2008.01.022; Saerens D, 2008, CURR OPIN PHARMACOL, V8, P600, DOI 10.1016/j.coph.2008.07.006; Saphire EO, 2001, SCIENCE, V293, P1155, DOI 10.1126/science.1061692; Sharma D, 2000, J BIOMOL NMR, V18, P165, DOI 10.1023/A:1008398416292; Skerra A, 2007, CURR OPIN BIOTECH, V18, P295, DOI 10.1016/j.copbio.2007.04.010; Stanfield RL, 2004, SCIENCE, V305, P1770, DOI 10.1126/science.1101148; WARD ES, 1989, NATURE, V341, P544, DOI 10.1038/341544a0	29	80	96	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14203	14210		10.1074/jbc.M900769200	http://dx.doi.org/10.1074/jbc.M900769200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19307178	Green Published, hybrid			2022-12-27	WOS:000266286100026
J	Heinrich, B; Zhang, ZY; Raitskin, O; Hiller, M; Benderska, N; Hartmann, AM; Bracco, L; Elliott, D; Ben-Ari, S; Soreq, H; Sperling, J; Sperling, R; Stamm, S				Heinrich, Bettina; Zhang, Zhaiyi; Raitskin, Oleg; Hiller, Michael; Benderska, Natalya; Hartmann, Annette M.; Bracco, Laurent; Elliott, David; Ben-Ari, Shani; Soreq, Hermona; Sperling, Joseph; Sperling, Ruth; Stamm, Stefan			Heterogeneous Nuclear Ribonucleoprotein G Regulates Splice Site Selection by Binding to CC(A/C)-rich Regions in Pre-mRNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HNRNP-G; ELECTRON-MICROSCOPY; CARCINOMA-CELLS; INRNP PARTICLES; TAU EXON-10; SR PROTEINS; PHOSPHORYLATION; HTRA2-BETA-1; EXPRESSION; TRA2-BETA	Almost every protein-coding gene undergoes pre-mRNA splicing, and the majority of these pre-mRNAs are alternatively spliced. Alternative exon usage is regulated by the transient formation of protein complexes on the pre-mRNA that typically contain heterogeneous nuclear ribonucleoproteins (hnRNPs). Here we characterize hnRNP G, a member of the hnRNP class of proteins. We show that hnRNP G is a nuclear protein that is expressed in different concentrations in various tissues and that interacts with other splicing regulatory proteins. hnRNP G is part of the supraspliceosome, where it regulates alternative splice site selection in a concentration-dependent manner. Its action on alternative exons can occur without a functional RNA-recognition motif by binding to other splicing regulatory proteins. The RNA-recognition motif of hnRNP G binds to a loose consensus sequence containing a CC(A/C) motif, and hnRNP G preferentially regulates alternative exons where this motif is clustered in close proximity. The X-chromosomally encoded hnRNP G regulates different RNAs than its Y-chromosomal paralogue RNA-binding motif protein, Y-linked (RBMY), suggesting that differences in alternative splicing, evoked by the sex-specific expression of hnRNP G and RBMY, could contribute to molecular sex differences in mammals.	[Heinrich, Bettina; Zhang, Zhaiyi; Benderska, Natalya; Hartmann, Annette M.; Stamm, Stefan] Univ Erlangen Nurnberg, Inst Biochem, D-91054 Erlangen, Germany; [Raitskin, Oleg; Ben-Ari, Shani; Soreq, Hermona; Sperling, Ruth] Hebrew Univ Jerusalem, IL-91904 Jerusalem, Israel; [Hiller, Michael] Univ Freiburg, Bioinformat Grp, Inst Comp Sci, D-79110 Freiburg, Germany; [Bracco, Laurent] ExonHit Therapeut, Exonhit, F-75013 Paris, France; [Sperling, Joseph] Weizmann Inst Sci, IL-76100 Rehovot, Israel; [Elliott, David] Newcastle Univ, Int Ctr Life, Inst Human Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Zhang, Zhaiyi; Stamm, Stefan] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA	University of Erlangen Nuremberg; Hebrew University of Jerusalem; University of Freiburg; Weizmann Institute of Science; Newcastle University - UK; University of Kentucky	Stamm, S (corresponding author), B283 Biomed Biol Sci Res Bldg,741 S Limestone, Lexington, KY 40536 USA.	stefan@stamms-lab.net	Hartmann, Annette/AAS-6331-2021	Soreq, Hermona/0000-0002-0955-526X	National Institutes of Health [GM079549, P20 RR020171, R21HD056195-01]; German Research Council; Families of SMA, EURASNET; Bundesministerium fur Bildung und Forschung; Weizmann Institute of Science; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD056195] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR020171] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079549] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Council(German Research Foundation (DFG)); Families of SMA, EURASNET; Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Weizmann Institute of Science; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM079549 (to R. S. and J.S.), P20 RR020171, and R21HD056195-01 (to S. S.). This work was also supported by the German Research Council, the Families of SMA, EURASNET, the Bundesministerium fur Bildung und Forschung, and a grant from the Helen and Milton Kimmelman Center for Biomolecular Structure and Assembly at the Weizmann Institute of Science (to J.S.).	Azubel M, 2004, MOL CELL, V15, P833, DOI 10.1016/j.molcel.2004.07.022; Azubel M, 2006, J MOL BIOL, V356, P955, DOI 10.1016/j.jmb.2005.11.078; BAKER BS, 1989, NATURE, V340, P521, DOI 10.1038/340521a0; Beil B, 1997, DNA CELL BIOL, V16, P679, DOI 10.1089/dna.1997.16.679; Blaustein M, 2005, NAT STRUCT MOL BIOL, V12, P1037, DOI 10.1038/nsmb1020; Chen TP, 1999, MOL BIOL CELL, V10, P3015, DOI 10.1091/mbc.10.9.3015; Cohen-Krausz S, 2007, J MOL BIOL, V368, P319, DOI 10.1016/j.jmb.2007.01.090; Elliott DJ, 2004, INT J ANDROL, V27, P328, DOI 10.1111/j.1365-2605.2004.00496.x; Fehlbaum P, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni047; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Guil S, 2006, MOL CELL BIOL, V26, P5744, DOI 10.1128/MCB.00224-06; Harfmann AM, 1999, MOL BIOL CELL, V10, P3909, DOI 10.1091/mbc.10.11.3909; Hartmann AM, 2001, MOL CELL NEUROSCI, V18, P80, DOI 10.1006/mcne.2001.1000; Hiller M, 2007, PLOS GENET, V3, P2147, DOI 10.1371/journal.pgen.0030204; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Hofmann Y, 2000, P NATL ACAD SCI USA, V97, P9618, DOI 10.1073/pnas.160181697; Hofmann Y, 2002, HUM MOL GENET, V11, P2037, DOI 10.1093/hmg/11.17.2037; Jiang ZH, 2003, J BIOL CHEM, V278, P18997, DOI 10.1074/jbc.M301800200; Jurica MS, 2003, MOL CELL, V12, P5, DOI 10.1016/S1097-2765(03)00270-3; Lalli E, 2003, J CELL SCI, V116, P441, DOI 10.1242/jcs.00249; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Lorson CL, 1999, P NATL ACAD SCI USA, V96, P6307, DOI 10.1073/pnas.96.11.6307; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; MIRIAMI E, 1995, J MOL BIOL, V246, P254, DOI 10.1006/jmbi.1994.0081; MIRIAMI E, 1994, NUCLEIC ACIDS RES, V22, P3084, DOI 10.1093/nar/22.15.3084; Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443; Muller S, 1998, J MOL BIOL, V283, P383, DOI 10.1006/jmbi.1998.2078; Nadano D, 2001, BIOCHEMISTRY-US, V40, P15184, DOI 10.1021/bi0108397; Nasim MT, 2003, HUM MOL GENET, V12, P1337, DOI 10.1093/hmg/ddg136; Nayler O, 2000, J CELL BIOL, V150, P949, DOI 10.1083/jcb.150.5.949; Novoyatleva T, 2008, HUM MOL GENET, V17, P52, DOI 10.1093/hmg/ddm284; Raitskin O, 2002, J STRUCT BIOL, V140, P123, DOI 10.1016/S1047-8477(02)00541-5; Raitskin O, 2001, P NATL ACAD SCI USA, V98, P6571, DOI 10.1073/pnas.111153798; Sambrook J., 2001, MOL CLONING LAB MANU; Sergeant KA, 2007, J CELL SCI, V120, P309, DOI 10.1242/jcs.03344; Shin KH, 2006, CLIN CANCER RES, V12, P3222, DOI 10.1158/1078-0432.CCR-05-2656; Skrisovska L, 2007, EMBO REP, V8, P372, DOI 10.1038/sj.embor.7400910; SOULARD M, 1991, EXP CELL RES, V193, P59, DOI 10.1016/0014-4827(91)90538-6; SOULARD M, 1993, NUCLEIC ACIDS RES, V21, P4210, DOI 10.1093/nar/21.18.4210; SPANN P, 1989, P NATL ACAD SCI USA, V86, P466, DOI 10.1073/pnas.86.2.466; Sperling J, 2008, STRUCTURE, V16, P1605, DOI 10.1016/j.str.2008.08.011; SPERLING R, 1985, MOL CELL BIOL, V5, P569, DOI 10.1128/MCB.5.3.569; Stamm S, 1999, MOL BRAIN RES, V64, P108, DOI 10.1016/S0169-328X(98)00313-1; Stamm S, 2005, GENE, V344, P1, DOI 10.1016/j.gene.2004.10.022; Stamm S, 2008, J BIOL CHEM, V283, P1223, DOI 10.1074/jbc.R700034200; Stoilov P, 2004, HUM MOL GENET, V13, P509, DOI 10.1093/hmg/ddh051; Stoss O, 1999, BRAIN RES PROTOC, V4, P383, DOI 10.1016/S1385-299X(99)00043-4; Stoss O, 2004, MOL CELL NEUROSCI, V27, P8, DOI 10.1016/j.mcn.2004.04.011; Venables JP, 2000, HUM MOL GENET, V9, P685, DOI 10.1093/hmg/9.5.685; Wang JN, 2004, J NEUROCHEM, V88, P1078, DOI 10.1046/j.1471-4159.2003.02232.x; Yitzhaki S, 1996, P NATL ACAD SCI USA, V93, P8830, DOI 10.1073/pnas.93.17.8830	51	67	78	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14303	14315		10.1074/jbc.M901026200	http://dx.doi.org/10.1074/jbc.M901026200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19282290	hybrid, Green Published			2022-12-27	WOS:000266286100037
J	Lehmann, M; Milev, MP; Abrahamyan, L; Yao, XJ; Pante, N; Mouland, AJ				Lehmann, Martin; Milev, Miroslav P.; Abrahamyan, Levon; Yao, Xiao-Jian; Pante, Nelly; Mouland, Andrew J.			Intracellular Transport of Human Immunodeficiency Virus Type 1 Genomic RNA and Viral Production Are Dependent on Dynein Motor Function and Late Endosome Positioning	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIV-1 AUXILIARY PROTEINS; MEMBRANE-BINDING; PLASMA-MEMBRANE; NUCLEAR EXPORT; NUCLEOCAPSID PROTEIN; GAG MULTIMERIZATION; CYTOPLASMIC DYNEIN; QUALITY-CONTROL; RILP INTERACTS; MATRIX PROTEIN	Our earlier work indicated that the human immunodeficiency virus type 1 (HIV-1) genomic RNA (vRNA) is trafficked to the microtubule-organizing center (MTOC) when heterogeneous nuclear ribonucleoprotein A2/B1 is depleted from cells. Also, Rab7-interacting lysosomal protein promoted dynein motor complex, late endosome and vRNA clustering at the MTOC suggesting that the dynein motor and late endosomes were involved in vRNA trafficking. To investigate the role of the dynein motor in vRNA trafficking, dynein motor function was disrupted by small interference RNA-mediated depletion of the dynein heavy chain or by p50/dynamitin overexpression. These treatments led to a marked relocalization of vRNA and viral structural protein Gag to the cell periphery with late endosomes and a several-fold increase in HIV-1 production. In contrast, rerouting vRNA to the MTOC reduced virus production. vRNA localization depended on Gag membrane association as shown using both myristoylation and Gag nucleocapsid domain proviral mutants. Furthermore, the cytoplasmic localization of vRNA and Gag was not attributable to intracellular or internalized endocytosed virus particles. Our results demonstrate that dynein motor function is important for regulating Gag and vRNA egress on endosomal membranes in the cytoplasm to directly impact on viral production.	[Lehmann, Martin; Milev, Miroslav P.; Abrahamyan, Levon; Mouland, Andrew J.] Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, RNA Trafficking Lab HIV 1, Montreal, PQ H3T 1E2, Canada; [Milev, Miroslav P.; Mouland, Andrew J.] McGill Univ, Dept Med, Montreal, PQ H3A 2B4, Canada; [Yao, Xiao-Jian] Univ Manitoba, Dept Med Microbiol, Winnipeg, MB R3E 0J9, Canada; [Pante, Nelly] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada	Lady Davis Institute; McGill University; McGill University; University of Manitoba; University of British Columbia	Mouland, AJ (corresponding author), Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, 3755 Cote Ste Catherine Rd, Montreal, PQ H3T 1E2, Canada.	andrew.mouland@mcgill.ca	Pante, Nelly/GVR-8478-2022; Abrahamyan, Levon/E-1982-2013	Abrahamyan, Levon/0000-0002-0849-0134; Milev, Miroslav/0000-0002-3354-1634; Yao, Xiaojian/0000-0002-5022-1309	Canadian Institutes of Health Research (CIHR) [MOP-56794, MOP-38111]; Canadian Foundation for Innovation [6848]	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation(Canada Foundation for Innovation)	This work was supported in part by the Canadian Institutes of Health Research (CIHR) (Grants MOP-56794 and MOP-38111) and the Canadian Foundation for Innovation (Grant 6848) (to A.J.M.).	Ajamian L, 2008, RNA, V14, P914, DOI 10.1261/rna.829208; Alroy I, 2005, P NATL ACAD SCI USA, V102, P1478, DOI 10.1073/pnas.0408717102; Anderson EC, 2006, J VIROL, V80, P10478, DOI 10.1128/JVI.02596-05; Ao ZJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001995; Bananis E, 2004, MOL BIOL CELL, V15, P3688, DOI 10.1091/mbc.E04-04-0278; Basyuk E, 2005, J MOL BIOL, V354, P330, DOI 10.1016/j.jmb.2005.09.071; Basyuk E, 2003, DEV CELL, V5, P161, DOI 10.1016/S1534-5807(03)00188-6; Benmerah A, 1999, J CELL SCI, V112, P1303; Beriault V, 2004, J BIOL CHEM, V279, P44141, DOI 10.1074/jbc.M404691200; BERKOWITZ RD, 1995, J VIROL, V69, P6445, DOI 10.1128/JVI.69.10.6445-6456.1995; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Brown CL, 2005, TRAFFIC, V6, P1114, DOI 10.1111/j.1600-0854.2005.00347.x; Burkhardt JK, 1997, J CELL BIOL, V139, P469, DOI 10.1083/jcb.139.2.469; Butsch M, 2002, J VIROL, V76, P3089, DOI 10.1128/jvi.76.7.3089-3094.2002; Cantalupo G, 2001, EMBO J, V20, P683, DOI 10.1093/emboj/20.4.683; Carson JH, 2005, BIOL CELL, V97, P51; Carson JH, 2001, CURR OPIN NEUROBIOL, V11, P558, DOI 10.1016/S0959-4388(00)00249-X; Chatel-Chaix L, 2004, MOL CELL BIOL, V24, P2637, DOI 10.1128/MCB.24.7.2637-2648.2004; Chatel-Chaix L, 2007, J VIROL, V81, P6216, DOI 10.1128/JVI.00284-07; CHESEBRO B, 1992, J VIROL, V66, P6547, DOI 10.1128/JVI.66.11.6547-6554.1992; Cimarelli A, 1999, J VIROL, V73, P5388, DOI 10.1128/JVI.73.7.5388-5401.1999; Cochrane AW, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-18; Cohen RS, 2005, BIOL CELL, V97, P5; Cullen BR, 1998, CELL, V93, P685, DOI 10.1016/S0092-8674(00)81431-2; Darlix JL, 2007, ADV PHARMACOL, V55, P299, DOI 10.1016/S1054-3589(07)55009-X; Denek M, 2007, J CELL BIOL, V177, P329, DOI 10.1083/jcb.200609050; Dohner K, 2005, TRENDS MICROBIOL, V13, P320, DOI 10.1016/j.tim.2005.05.010; Dugre-Brisson S, 2005, NUCLEIC ACIDS RES, V33, P4797, DOI 10.1093/nar/gki794; Dupont S, 1999, NATURE, V402, P681, DOI 10.1038/45272; Ferrandon D, 1997, EMBO J, V16, P1751, DOI 10.1093/emboj/16.7.1751; GORELICK RJ, 1993, J VIROL, V67, P4027, DOI 10.1128/JVI.67.7.4027-4036.1993; Grigorov B, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-54; Harada A, 1998, J CELL BIOL, V141, P51, DOI 10.1083/jcb.141.1.51; Harila K, 2006, J VIROL, V80, P3765, DOI 10.1128/JVI.80.8.3765-3772.2006; He Y, 2005, J CELL BIOL, V168, P697, DOI 10.1083/jcb.200407191; Hilleren P, 2001, NATURE, V413, P538, DOI 10.1038/35097110; Hofmann W, 2001, J CELL BIOL, V152, P895, DOI 10.1083/jcb.152.5.895; Hope TJ, 1999, ARCH BIOCHEM BIOPHYS, V365, P186, DOI 10.1006/abbi.1999.1207; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Hunyady L, 2002, J CELL BIOL, V157, P1211, DOI 10.1083/jcb.200111013; Irion U, 2007, NATURE, V445, P554, DOI 10.1038/nature05503; Johansson M, 2007, J CELL BIOL, V176, P459, DOI 10.1083/jcb.200606077; Jordens I, 2001, CURR BIOL, V11, P1680, DOI 10.1016/S0960-9822(01)00531-0; Kafaie J, 2008, VIROLOGY, V375, P592, DOI 10.1016/j.virol.2008.02.001; Kjems J, 2000, Adv Pharmacol, V48, P251; Klein KC, 2007, AIDS REV, V9, P150; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Kural C, 2005, SCIENCE, V308, P1469, DOI 10.1126/science.1108408; Lee YM, 1998, J VIROL, V72, P9061, DOI 10.1128/JVI.72.11.9061-9068.1998; Levesque K, 2006, TRAFFIC, V7, P1177, DOI 10.1111/j.1600-0854.2006.00461.x; Li H, 2007, J VIROL, V81, P12899, DOI 10.1128/JVI.01280-07; Li L, 2005, CELL RES, V15, P923, DOI 10.1038/sj.cr.7290370; LODGE R, 1994, J VIROL, V68, P4857, DOI 10.1128/JVI.68.8.4857-4861.1994; Luby-Phelps K, 2000, INT REV CYTOL, V192, P189; Ma J, 2008, VIROLOGY, V375, P253, DOI 10.1016/j.virol.2008.01.025; Ma S, 2002, J CELL SCI, V115, P1453; MALIM MH, 1989, NATURE, V338, P254, DOI 10.1038/338254a0; Martinez NW, 2008, J VIROL, V82, P9937, DOI 10.1128/JVI.00819-08; McDonald D, 2002, J CELL BIOL, V159, P441, DOI 10.1083/jcb.200203150; Mizuno N, 2004, EMBO J, V23, P2459, DOI 10.1038/sj.emboj.7600240; Mouland AJ, 2000, J VIROL, V74, P5441, DOI 10.1128/JVI.74.12.5441-5451.2000; Mouland AJ, 2002, VIROLOGY, V292, P321, DOI 10.1006/viro.2001.1261; Mouland AJ, 2001, MOL CELL BIOL, V21, P2133, DOI 10.1128/MCB.21.6.2133-2143.2001; MOULAND AJ, 2003, CURR GENOMICS, V4, P196; Murray JL, 2005, J VIROL, V79, P11742, DOI 10.1128/JVI.79.18.11742-11751.2005; Naghavi MH, 2007, CURR OPIN IMMUNOL, V19, P402, DOI 10.1016/j.coi.2007.07.003; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Neil Stuart J. D., 2006, PLoS Pathogens, V2, DOI 10.1371/jounral.ppat.0020039; Nydegger S, 2003, TRAFFIC, V4, P902, DOI 10.1046/j.1600-0854.2003.00145.x; Ono A, 2005, J VIROL, V79, P14131, DOI 10.1128/JVI.79.22.14131-14140.2005; Ono A, 2004, P NATL ACAD SCI USA, V101, P14889, DOI 10.1073/pnas.0405596101; Ono A, 1999, J VIROL, V73, P4136, DOI 10.1128/JVI.73.5.4136-4144.1999; Ono A, 2000, J VIROL, V74, P2855, DOI 10.1128/JVI.74.6.2855-2866.2000; Paillart JC, 1999, J VIROL, V73, P2604, DOI 10.1128/JVI.73.4.2604-2612.1999; Pelchen-Matthews A, 2003, J CELL BIOL, V162, P443, DOI 10.1083/jcb.200304008; Perlman M, 2006, TRAFFIC, V7, P731, DOI 10.1111/j.1398-9219.2006.00428.x; Petit C, 2003, J CELL SCI, V116, P3433, DOI 10.1242/jcs.00613; Poole E, 2005, TRAFFIC, V6, P741, DOI 10.1111/j.1600-0854.2005.00312.x; Progida C, 2006, BIOCHEM BIOPH RES CO, V347, P1074, DOI 10.1016/j.bbrc.2006.07.007; PURCELL DFJ, 1993, J VIROL, V67, P6365, DOI 10.1128/JVI.67.11.6365-6378.1993; Resh MD, 2005, AIDS REV, V7, P84; Resh MD, 2004, P NATL ACAD SCI USA, V101, P417, DOI 10.1073/pnas.0308043101; Sanchez-Velar N, 2004, GENE DEV, V18, P23, DOI 10.1101/gad.1149704; Sandefur S, 1998, J VIROL, V72, P2723, DOI 10.1128/JVI.72.4.2723-2732.1998; Schliwa M, 2003, NATURE, V422, P759, DOI 10.1038/nature01601; Schrader M, 2000, J CELL SCI, V113, P3663; Schroer TA, 2004, ANNU REV CELL DEV BI, V20, P759, DOI 10.1146/annurev.cellbio.20.012103.094623; Seelamgari A, 2004, FRONT BIOSCI-LANDMRK, V9, P2388, DOI 10.2741/1403; Shav-Tal Y, 2005, J CELL SCI, V118, P4077, DOI 10.1242/jcs.02543; Sheftel AD, 2007, BLOOD, V110, P125, DOI 10.1182/blood-2007-01-068148; Varthakavi V, 2006, TRAFFIC, V7, P298, DOI 10.1111/j.1600-0854.2005.00380.x; von Schwedler UK, 2003, CELL, V114, P701, DOI 10.1016/S0092-8674(03)00714-1; Wang TL, 2006, BIOCHEM BIOPH RES CO, V350, P413, DOI 10.1016/j.bbrc.2006.09.064; Yu Z, 2005, P NATL ACAD SCI USA, V102, P4027, DOI 10.1073/pnas.0408889102; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	95	59	60	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14572	14585		10.1074/jbc.M808531200	http://dx.doi.org/10.1074/jbc.M808531200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19286658	Green Published, hybrid			2022-12-27	WOS:000266286100063
J	Waak, J; Weber, SS; Gorner, K; Schall, C; Ichijo, H; Stehle, T; Kahle, PJ				Waak, Jens; Weber, Stephanie S.; Goerner, Karin; Schall, Christoph; Ichijo, Hidenori; Stehle, Thilo; Kahle, Philipp J.			Oxidizable Residues Mediating Protein Stability and Cytoprotective Interaction of DJ-1 with Apoptosis Signal-regulating Kinase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ONSET PARKINSONS-DISEASE; DEATH-ASSOCIATED PROTEIN; CYSTEINE-SULFINIC ACID; CELL-DEATH; OXIDATIVE STRESS; CRYSTAL-STRUCTURE; ANTIOXIDATIVE STRESS; ALPHA-SYNUCLEIN; MUTATIONS; DAXX	Parkinson disease (PD)-associated genomic deletions and the destabilizing L166P point mutation lead to loss of the cytoprotective DJ-1 protein. The effects of other PD-associated point mutations are less clear. Here we demonstrate that the M26I mutation reduces DJ-1 expression, particularly in a null background (knockout mouse embryonic fibroblasts). Thus, homozygous M26I mutation causes loss of DJ-1 protein. To determine the cellular consequences, we measured suppression of apoptosis signal-regulating kinase 1 (ASK1) and cytotoxicity for [M26I] DJ-1, and systematically all other DJ-1 methionine and cysteine mutants. C106A mutation of the central redox site specifically abolished binding to ASK1 and the cytoprotective activity of DJ-1. DJ-1 was apparently recruited into the ASK1 signalosome via Cys-106-linked mixed disulfides. The designed higher order oxidation mimicking [C106DD]DJ-1 non-covalently bound to ASK1 even in the absence of hydrogen peroxide and conferred partial cytoprotection. Interestingly, mutations of peripheral redox sites (C46A and C53A) and M26I also led to constitutive ASK1 binding. Cytoprotective [wt] DJ-1 bound to the ASK1 N terminus (which is known to bind another negative regulator, thioredoxin 1), whereas [M26I] DJ-1 bound to aberrant C-terminal site(s). Consequently, the peripheral cysteine mutants retained cytoprotective activity, whereas the PD-associated mutant [M26I] DJ-1 failed to suppress ASK1 activity and nuclear export of the death domain-associated protein Daxx and did not promote cytoprotection. Thus, cytoprotective binding of DJ-1 to ASK1 depends on the central redox-sensitive Cys-106 and may be modulated by peripheral cysteine residues. We suggest that impairments in oxidative conformation changes of DJ-1 might contribute to PD neurodegeneration.	[Waak, Jens; Weber, Stephanie S.; Kahle, Philipp J.] Univ Clin Tubingen, Dept Neurodegenerat, Hertie Inst Clin Brain Res, Lab Funct Neurogenet, D-72076 Tubingen, Germany; [Goerner, Karin; Kahle, Philipp J.] Univ Munich, Dept Metab Biochem, D-80336 Munich, Germany; [Goerner, Karin] Advalytix Prod, Bio Business Div, Olympus Life Sci Res Europe, D-81377 Munich, Germany; [Schall, Christoph; Stehle, Thilo] Univ Tubingen, Interfac Inst Biochem, D-72076 Tubingen, Germany; [Ichijo, Hidenori] Univ Tokyo, Grad Sch Pharmaceut Sci, Lab Cell Signaling, Tokyo 1130033, Japan; [Stehle, Thilo] Vanderbilt Univ, Sch Med, Dept Pediat, Nashville, TN 37232 USA	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; University of Munich; Olympus Corporation; Eberhard Karls University of Tubingen; University of Tokyo; Vanderbilt University	Kahle, PJ (corresponding author), Univ Clin Tubingen, Dept Neurodegenerat, Hertie Inst Clin Brain Res, Lab Funct Neurogenet, Otfried Muller Str 27, D-72076 Tubingen, Germany.	Philipp.Kahle@Uni-Tuebingen.de		Ichijo, Hidenori/0000-0002-5005-6438	German National Genome Research Network [01GS0466]; Deutsche Forschungsgemeinschaft [SFB596 A12]; Novartis Pharma Ltd; Hertie Foundation	German National Genome Research Network; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Novartis Pharma Ltd; Hertie Foundation	This work was supported by the German National Genome Research Network (NGFN-2 Grant 01GS0466), the Deutsche Forschungsgemeinschaft (Program Project Grant SFB596 A12), a collaborative research contract with Novartis Pharma Ltd., and the Hertie Foundation.	Abdallah J, 2007, J BACTERIOL, V189, P9140, DOI 10.1128/JB.01208-07; Abeliovich A, 2006, J NEUROCHEM, V99, P1062, DOI 10.1111/j.1471-4159.2006.04102.x; Abou-Sleiman PM, 2003, ANN NEUROL, V54, P283, DOI 10.1002/ana.10675; Abou-Sleiman PM, 2004, CELL TISSUE RES, V318, P185, DOI 10.1007/s00441-004-0922-6; Bandopadhyay R, 2004, BRAIN, V127, P420, DOI 10.1093/brain/awh054; Baulac S, 2004, MOL CELL NEUROSCI, V27, P236, DOI 10.1016/j.mcn.2004.06.014; Blackinton J, 2005, MOL BRAIN RES, V134, P76, DOI 10.1016/j.molbrainres.2004.09.004; Blackinton J, 2009, J BIOL CHEM, V284, P6476, DOI 10.1074/jbc.M806599200; Bonifati V, 2003, SCIENCE, V299, P256, DOI 10.1126/science.1077209; Bretaud S, 2007, J NEUROCHEM, V100, P1626, DOI 10.1111/j.1471-4159.2006.04291.x; Canet-Aviles RM, 2004, P NATL ACAD SCI USA, V101, P9103, DOI 10.1073/pnas.0402959101; Choi J, 2006, J BIOL CHEM, V281, P10816, DOI 10.1074/jbc.M509079200; Gorner K, 2007, J BIOL CHEM, V282, P13680, DOI 10.1074/jbc.M609821200; Gorner K, 2004, J BIOL CHEM, V279, P6943, DOI 10.1074/jbc.M309204200; Hering R, 2004, HUM MUTAT, V24, P321, DOI 10.1002/humu.20089; Herrera FE, 2007, J BIOL CHEM, V282, P24905, DOI 10.1074/jbc.M701013200; Honbou K, 2003, J BIOL CHEM, V278, P31380, DOI 10.1074/jbc.M305878200; Hulleman JD, 2007, BIOCHEMISTRY-US, V46, P5776, DOI 10.1021/bi7001778; Ito G, 2006, BIOCHEM BIOPH RES CO, V339, P667, DOI 10.1016/j.bbrc.2005.11.058; Junn E, 2005, P NATL ACAD SCI USA, V102, P9691, DOI 10.1073/pnas.0409635102; Karunakaran S, 2007, FASEB J, V21, P2226, DOI 10.1096/fj.06-7580com; Kim RH, 2005, P NATL ACAD SCI USA, V102, P5215, DOI 10.1073/pnas.0501282102; Kinumi T, 2004, BIOCHEM BIOPH RES CO, V317, P722, DOI 10.1016/j.bbrc.2004.03.110; Ko YG, 2001, J BIOL CHEM, V276, P39103, DOI 10.1074/jbc.M105928200; Lakshminarasimhan M, 2008, BIOCHEMISTRY-US, V47, P1381, DOI 10.1021/bi701189c; LIU F, 2008, J NEUROCHEM; Macedo MG, 2003, HUM MOL GENET, V12, P2807, DOI 10.1093/hmg/ddg304; Malgieri G, 2008, PROTEIN SCI, V17, P855, DOI 10.1110/ps.073411608; Martinat C, 2004, PLOS BIOL, V2, P1754, DOI 10.1371/journal.pbio.0020327; Meulener M, 2005, CURR BIOL, V15, P1572, DOI 10.1016/j.cub.2005.07.064; Meulener MC, 2006, P NATL ACAD SCI USA, V103, P12517, DOI 10.1073/pnas.0601891103; Miller DW, 2003, J BIOL CHEM, V278, P36588, DOI 10.1074/jbc.M304272200; Mo JS, 2008, CELL DEATH DIFFER, V15, P1030, DOI 10.1038/cdd.2008.26; Moore DJ, 2003, J NEUROCHEM, V87, P1558, DOI 10.1111/j.1471-4159.2003.02265.x; Nadeau PJ, 2007, MOL BIOL CELL, V18, P3903, DOI 10.1091/mbc.E07-05-0491; Neumann M, 2004, ACTA NEUROPATHOL, V107, P489, DOI 10.1007/s00401-004-0834-2; Noguchi T, 2005, J BIOL CHEM, V280, P37033, DOI 10.1074/jbc.M506771200; Olzmann JA, 2004, J BIOL CHEM, V279, P8506, DOI 10.1074/jbc.M311017200; Saitoh M, 1998, EMBO J, V17, P2596, DOI 10.1093/emboj/17.9.2596; Salomoni P, 2006, TRENDS CELL BIOL, V16, P97, DOI 10.1016/j.tcb.2005.12.002; Shendelman S, 2004, PLOS BIOL, V2, P1764, DOI 10.1371/journal.pbio.0020362; Song JJ, 2003, J BIOL CHEM, V278, P47245, DOI 10.1074/jbc.M213201200; Taira T, 2004, EMBO REP, V5, P213, DOI 10.1038/sj.embor.7400074; Takahashi-Niki K, 2004, BIOCHEM BIOPH RES CO, V320, P389, DOI 10.1016/j.bbrc.2004.05.187; Tao X, 2003, J BIOL CHEM, V278, P31372, DOI 10.1074/jbc.M304221200; Ved R, 2005, J BIOL CHEM, V280, P42655, DOI 10.1074/jbc.M505910200; Wilson MA, 2003, P NATL ACAD SCI USA, V100, P9256, DOI 10.1073/pnas.1133288100; Witt AC, 2008, BIOCHEMISTRY-US, V47, P7430, DOI 10.1021/bi800282d; Xu J, 2005, HUM MOL GENET, V14, P1231, DOI 10.1093/hmg/ddi134; Yang YF, 2005, P NATL ACAD SCI USA, V102, P13670, DOI 10.1073/pnas.0504610102; Zhou WB, 2006, J MOL BIOL, V356, P1036, DOI 10.1016/j.jmb.2005.12.030	51	113	117	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14245	14257		10.1074/jbc.M806902200	http://dx.doi.org/10.1074/jbc.M806902200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19293155	hybrid, Green Published			2022-12-27	WOS:000266286100031
J	Zhang, ZR; Perrett, S				Zhang, Zai-Rong; Perrett, Sarah			Novel Glutaredoxin Activity of the Yeast Prion Protein Ure2 Reveals a Native-like Dimer within Fibrils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTATHIONE S-TRANSFERASES; HEAVY-METAL ION; SACCHAROMYCES-CEREVISIAE; DISULFIDE-ISOMERASE; ESCHERICHIA-COLI; OMEGA CLASS; IN-VITRO; THIOLTRANSFERASE GLUTAREDOXIN; MONOTHIOL GLUTAREDOXINS; INSULIN DISULFIDES	Ure2 is the protein determinant of the Saccharomyces cerevisiae prion [URE3]. Ure2 has structural similarity to glutathione transferases, protects cells against heavy metal and oxidant toxicity in vivo, and shows glutathione-dependent peroxidase activity in vitro. Here we report that Ure2 (which has no cysteine residues) also shows thiol-disulfide oxidoreductase activity similar to that of glutaredoxin enzymes. This demonstrates that disulfide reductase activity can be independent of the classical glutaredoxin CXXC/CXXS motif or indeed an intrinsic catalytic cysteine residue. The kinetics of the glutaredoxin activity of Ure2 showed positive cooperativity for the substrate glutathione in both the soluble native state and in amyloid-like fibrils, indicating native-like dimeric structure within Ure2 fibrils. Characterization of the glutaredoxin activity of Ure2 sheds light on its ability to protect yeast from heavy metal ion and oxidant toxicity and suggests a role in reversible protein glutathionylation signal transduction. Observation of allosteric enzyme behavior within amyloid-like Ure2 fibrils not only provides insight into the molecular structure of the fibrils but also has implications for the mechanism of [URE3] prion formation.	[Zhang, Zai-Rong; Perrett, Sarah] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China; [Zhang, Zai-Rong] Chinese Acad Sci, Grad Univ, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Perrett, S (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, 15 Datun Rd, Beijing 100101, Peoples R China.	sarah.perrett@iname.com	Zhang, Zairong/G-1030-2013; Perrett, Sarah/AAS-9483-2020	Perrett, Sarah/0000-0003-0137-0997; ZHANG, ZAIRONG/0000-0001-9768-0548	National Natural Science Foundation of China [30620130109, 30670428, 30870482]; Chinese Ministry of Science and Technology [2006CB500703, 2006CB910903]; Chinese Academy of Sciences [KSCX2-YW-R-119]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by National Natural Science Foundation of China Grants 30620130109, 30670428, and 30870482; Chinese Ministry of Science and Technology Grants 2006CB500703 and 2006CB910903; and Chinese Academy of Sciences Grant KSCX2-YW-R-119.	Bai M, 2004, J BIOL CHEM, V279, P50025, DOI 10.1074/jbc.M406612200; Baxa U, 2003, J BIOL CHEM, V278, P43717, DOI 10.1074/jbc.M306004200; Baxa U, 2002, P NATL ACAD SCI USA, V99, P5253, DOI 10.1073/pnas.082097899; Board PG, 2000, J BIOL CHEM, V275, P24798, DOI 10.1074/jbc.M001706200; Bousset L, 2001, BIOCHEMISTRY-US, V40, P13564, DOI 10.1021/bi011007b; Bousset L, 2002, EMBO J, V21, P2903, DOI 10.1093/emboj/cdf303; Bousset L, 2001, STRUCTURE, V9, P39, DOI 10.1016/S0969-2126(00)00553-0; Caccuri AM, 2002, J BIOL CHEM, V277, P18777, DOI 10.1074/jbc.M201137200; Chrestensen CA, 2000, J BIOL CHEM, V275, P26556, DOI 10.1074/jbc.M004097200; Collinson EJ, 2003, J BIOL CHEM, V278, P22492, DOI 10.1074/jbc.M301387200; Collinson EJ, 2002, J BIOL CHEM, V277, P16712, DOI 10.1074/jbc.M111686200; Discola KF, 2009, J MOL BIOL, V385, P889, DOI 10.1016/j.jmb.2008.10.055; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Fay N, 2005, J BIOL CHEM, V280, P37149, DOI 10.1074/jbc.M506917200; Fernandes AP, 2004, ANTIOXID REDOX SIGN, V6, P63, DOI 10.1089/152308604771978354; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; Garcera A, 2006, BIOCHEM J, V398, P187, DOI 10.1042/BJ20060034; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Herrero E, 2007, CELL MOL LIFE SCI, V64, P1518, DOI 10.1007/s00018-007-6554-8; HOLMGREN A, 1979, J BIOL CHEM, V254, P9627; HOLMGREN A, 1976, P NATL ACAD SCI USA, V73, P2275, DOI 10.1073/pnas.73.7.2275; HOLMGREN A, 1995, METHOD ENZYMOL, V252, P283; Jung CH, 1996, ARCH BIOCHEM BIOPHYS, V335, P61, DOI 10.1006/abbi.1996.0482; Kajava AV, 2004, P NATL ACAD SCI USA, V101, P7885, DOI 10.1073/pnas.0402427101; Lillig CH, 2003, J BIOL CHEM, V278, P22325, DOI 10.1074/jbc.M302304200; Lillig CH, 2008, BBA-GEN SUBJECTS, V1780, P1304, DOI 10.1016/j.bbagen.2008.06.003; MARTIN JL, 1995, STRUCTURE, V3, P245, DOI 10.1016/S0969-2126(01)00154-X; Mesecke N, 2008, MOL BIOL CELL, V19, P2673, DOI 10.1091/mbc.E07-09-0896; Mesecke N, 2008, BIOCHEMISTRY-US, V47, P1452, DOI 10.1021/bi7017865; Peltoniemi MJ, 2006, J BIOL CHEM, V281, P33107, DOI 10.1074/jbc.M605602200; Perrett S, 1999, J MOL BIOL, V290, P331, DOI 10.1006/jmbi.1999.2872; Rai R, 2005, YEAST, V22, P343, DOI 10.1002/yea.1215; Rai R, 2003, J BIOL CHEM, V278, P12826, DOI 10.1074/jbc.M212186200; Sheehan D, 2001, BIOCHEM J, V360, P1, DOI 10.1042/0264-6021:3600001; Speransky VV, 2001, J CELL BIOL, V153, P1327, DOI 10.1083/jcb.153.6.1327; Taylor KL, 1999, SCIENCE, V283, P1339, DOI 10.1126/science.283.5406.1339; Wang XY, 2009, BIOCHEM J, V417, P55, DOI 10.1042/BJ20071702; WANG ZX, 1994, ANAL BIOCHEM, V216, P15, DOI 10.1006/abio.1994.1002; WELLS WW, 1995, METHOD ENZYMOL, V252, P30; WELLS WW, 1990, J BIOL CHEM, V265, P15361; Whitbread AK, 2005, METHOD ENZYMOL, V401, P78, DOI 10.1016/S0076-6879(05)01005-0; Yu J, 2008, PROTEINS, V72, P1077, DOI 10.1002/prot.22096; Zaffagnini M, 2008, J BIOL CHEM, V283, P8868, DOI 10.1074/jbc.M709567200; Zhang ZR, 2008, J MOL BIOL, V384, P641, DOI 10.1016/j.jmb.2008.09.047; Zhao Z, 2003, J BIOL CHEM, V278, P43292, DOI 10.1074/jbc.M306945200	45	31	32	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14058	14067		10.1074/jbc.M901189200	http://dx.doi.org/10.1074/jbc.M901189200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19321443	Green Published, hybrid			2022-12-27	WOS:000266286100012
J	Zhu, YJ; Wu, YJ; Kim, JI; Wang, ZM; Daaka, Y; Nie, ZZ				Zhu, Yunjuan; Wu, Yuanjun; Kim, Jae I.; Wang, Zhimin; Daaka, Yehia; Nie, Zhongzhen			Arf GTPase-activating Protein AGAP2 Regulates Focal Adhesion Kinase Activity and Focal Adhesion Remodeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIN CYTOSKELETON; CELL-MIGRATION; HUMAN CANCERS; PIKE-A; ASAP1; INVASION; GAPS; DYNAMICS; REGION; MOTILE	Focal adhesions are specialized sites of cell attachment to the extracellular matrix where integrin receptors link extracellular matrix to the actin cytoskeleton, and they are constantly remodeled during cell migration. Focal adhesion kinase (FAK) is an important regulator of focal adhesion remodeling. AGAP2 is an Arf GTPase-activating protein that regulates endosomal trafficking and is overexpressed in different human cancers. Here we examined the regulation of the FAK activity and the focal adhesion remodeling by AGAP2. Our results show that FAK binds the pleckstrin homology domain of AGAP2, and the binding is independent of FAK activation following epidermal growth factor receptor stimulation. Overexpression of AGAP2 augments the activity of FAK, and concordantly, the knockdown of AGAP2 expression with RNA interference attenuates the FAK activity stimulated by epidermal growth factor or platelet-derived growth factor receptors. AGAP2 is localized to the focal adhesions, and its overexpression results in dissolution of the focal adhesions, whereas knockdown of its expression stabilizes them. The AGAP2-induced dissolution of the focal adhesions is independent of its GTPase-activating protein activity but may involve its N-terminal G protein-like domain. Our results indicate that AGAP2 regulates the FAK activity and the focal adhesion disassembly during cell migration.	[Zhu, Yunjuan; Wu, Yuanjun; Kim, Jae I.; Wang, Zhimin; Daaka, Yehia; Nie, Zhongzhen] Med Coll Georgia, Dept Pathol, Augusta, GA 30912 USA	University System of Georgia; Augusta University	Nie, ZZ (corresponding author), Med Coll Georgia, Dept Pathol, 1410 Laney Walker Blvd,CN-3112, Augusta, GA 30912 USA.	znie@mcg.edu		Kim, Jae/0000-0003-1668-3910	National Institutes of Health [CA129155, CA131988]; Department of Pathology at the Medical College of Georgia; NATIONAL CANCER INSTITUTE [R21CA131988, R01CA129155] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Pathology at the Medical College of Georgia; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA129155 and CA131988 (to Y. D.). This work was also supported by start-up funds from the Department of Pathology at the Medical College of Georgia (to Z. N.).	Ahn JY, 2004, P NATL ACAD SCI USA, V101, P6993, DOI 10.1073/pnas.0400921101; Ahn JY, 2004, J BIOL CHEM, V279, P16441, DOI 10.1074/jbc.M312175200; Broussard JA, 2008, CURR OPIN CELL BIOL, V20, P85, DOI 10.1016/j.ceb.2007.10.009; Carragher NO, 2004, TRENDS CELL BIOL, V14, P241, DOI 10.1016/j.tcb.2004.03.011; Che MM, 2005, CELL SIGNAL, V17, P1276, DOI 10.1016/j.cellsig.2005.01.007; Cohen LA, 2005, CURR CANCER DRUG TAR, V5, P629, DOI 10.2174/156800905774932798; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Donaldson JG, 2005, BIOCHEM SOC T, V33, P639, DOI 10.1042/BST0330639; Ehlers JP, 2005, CLIN CANCER RES, V11, P3609, DOI 10.1158/1078-0432.CCR-04-1941; Elkahloun AG, 1997, GENOMICS, V42, P295, DOI 10.1006/geno.1997.4727; Ha VL, 2008, J BIOL CHEM, V283, P14915, DOI 10.1074/jbc.M709717200; Ilic Dusko, 1995, Nature (London), V377, P539, DOI 10.1038/377539a0; Kam JL, 2000, J BIOL CHEM, V275, P9653, DOI 10.1074/jbc.275.13.9653; Lin D, 2008, CANCER RES, V68, P4352, DOI 10.1158/0008-5472.CAN-07-5237; Liu X, 2007, ONCOGENE, V26, P4918, DOI 10.1038/sj.onc.1210290; Liu YH, 2005, J BIOL CHEM, V280, P8884, DOI 10.1074/jbc.M412200200; Liu YH, 2002, MOL BIOL CELL, V13, P2147, DOI 10.1091/mbc.E02-01-0018; Lo SH, 2006, DEV BIOL, V294, P280, DOI 10.1016/j.ydbio.2006.03.029; McLean GW, 2005, NAT REV CANCER, V5, P505, DOI 10.1038/nrc1647; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Miura K, 2002, MOL CELL, V9, P109, DOI 10.1016/S1097-2765(02)00428-8; Nie ZZ, 2006, J CELL SCI, V119, P1203, DOI 10.1242/jcs.02924; Nie ZZ, 2005, J CELL SCI, V118, P3555, DOI 10.1242/jcs.02486; Okabe H, 2004, INT J ONCOL, V24, P43; Randazzo PA, 2000, P NATL ACAD SCI USA, V97, P4011, DOI 10.1073/pnas.070552297; Randazzo PA, 2004, CELL SIGNAL, V16, P401, DOI 10.1016/j.cellsig.2003.09.012; Randazzo PA, 2007, BIOL CELL, V99, P583, DOI 10.1042/BC20070034; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Sastry SK, 2000, EXP CELL RES, V261, P25, DOI 10.1006/excr.2000.5043; Schlaepfer DD, 2004, BBA-MOL CELL RES, V1692, P77, DOI 10.1016/j.bbamcr.2004.04.008; Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007; Yoon HY, 2006, J CELL SCI, V119, P4650, DOI 10.1242/jcs.03237	33	29	30	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13489	13496		10.1074/jbc.M900469200	http://dx.doi.org/10.1074/jbc.M900469200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19318351	Green Published, hybrid			2022-12-27	WOS:000265877300025
J	Erales, J; Lignon, S; Gontero, B				Erales, Jenny; Lignon, Sabrina; Gontero, Brigitte			CP12 from Chlamydomonas reinhardtii, a Permanent Specific "Chaperone-like" Protein of Glyceraldehyde-3-phosphate Dehydrogenase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRINSICALLY UNSTRUCTURED PROTEINS; CALVIN CYCLE ACTIVITY; FRESH-WATER DIATOM; D-GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE; REDOX-SWITCH; SUPRAMOLECULAR COMPLEX; ASTERIONELLA-FORMOSA; THERMAL AGGREGATION; STRUCTURAL DISORDER; LIGHT REGULATION	Anew role is reported for CP12, a highly unfolded and flexible protein, mainly known for its redox function with A(4) glyceraldehyde-3-phosphate dehydrogenase (GAPDH). Both reduced and oxidized CP12 can prevent the in vitro thermal inactivation and aggregation of GAPDH from Chlamydomonas reinhardtii. This mechanism is thus not redox-dependent. The protection is specific to CP12, because other proteins, such as bovine serum albumin, thioredoxin, and a general chaperone, Hsp33, do not fully prevent denaturation of GAPDH. Furthermore, CP12 acts as a specific chaperone, since it does not protect other proteins, such as catalase, alcohol dehydrogenase, or lysozyme. The interaction between CP12 and GAPDH is necessary to prevent the aggregation and inactivation, since the mutant C66S that does not form any complex with GAPDH cannot accomplish this protection. Unlike the C66S mutant, the C23S mutant that lacks the N-terminal bridge is partially able to protect and to slow down the inactivation and aggregation. Tryptic digestion coupled to mass spectrometry confirmed that the S-loop of GAPDH is the interaction site with CP12. Thus, CP12 not only has a redox function but also behaves as a specific "chaperone-like protein" for GAPDH, although a stable and not transitory interaction is observed. This new function of CP12 may explain why it is also present in complexes involving A(2)B(2) GAPDHs that possess a regulatory C-terminal extension (GapB subunit) and therefore do not require CP12 to be redox-regulated.	[Erales, Jenny; Gontero, Brigitte] CNRS, Lab Enzymol Complexes Supramol, UPR 9036, F-13402 Marseille 20, France; [Lignon, Sabrina] CNRS, Inst Microbiol Mediterranee, IFR88, F-13402 Marseille 20, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS)	Gontero, B (corresponding author), CNRS, Lab Enzymol Complexes Supramol, UPR 9036, 31 Chemin J Aiguier, F-13402 Marseille 20, France.	bmeunier@ifr88.cnrs-mrs.fr			French Ministry of Research (fellowship from the Universite Pierre et Marie Curie, Paris VI, France)	French Ministry of Research (fellowship from the Universite Pierre et Marie Curie, Paris VI, France)(Ministry of Research, France)	Supported by Ph.D. funding from the French Ministry of Research (fellowship from the Universite Pierre et Marie Curie, Paris VI, France).	Baalmann E, 1996, PLANT MOL BIOL, V32, P505, DOI 10.1007/BF00019102; Bhattacharyya J, 1999, J BIOL CHEM, V274, P15505, DOI 10.1074/jbc.274.22.15505; Boggetto N, 2007, J PHYCOL, V43, P1227, DOI 10.1111/j.1529-8817.2007.00409.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRINKMANN H, 1989, PLANT MOL BIOL, V13, P81, DOI 10.1007/BF00027337; Bukau B, 2000, CELL, V101, P119, DOI 10.1016/S0092-8674(00)80806-5; Caldas T, 2006, BIOCHEM BIOPH RES CO, V343, P780, DOI 10.1016/j.bbrc.2006.03.028; CERFF R, 1979, J BIOL CHEM, V254, P6094; Clark JI, 1996, P NATL ACAD SCI USA, V93, P15185, DOI 10.1073/pnas.93.26.15185; Csizmok V, 2007, CURR PROTEIN PEPT SC, V8, P173, DOI 10.2174/138920307780363479; Cumming RC, 2005, FASEB J, V19, P2060, DOI 10.1096/fj.05-4195fje; Delobel A, 2005, RAPID COMMUN MASS SP, V19, P3379, DOI 10.1002/rcm.2192; Dosztanyi Zsuzsanna, 2008, V426, P103, DOI 10.1007/978-1-60327-058-8_6; Dunker AK, 2007, STRUCTURE, V15, P1026, DOI 10.1016/j.str.2007.08.001; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Ehrnsperger M, 1997, EMBO J, V16, P221, DOI 10.1093/emboj/16.2.221; Erales J, 2008, FEBS J, V275, P1248, DOI 10.1111/j.1742-4658.2008.06284.x; Erales J, 2009, BIOCHEM J, V419, P75, DOI 10.1042/BJ20082004; Erales J, 2008, J PHYCOL, V44, P1455, DOI 10.1111/j.1529-8817.2008.00600.x; Fermani S, 2007, P NATL ACAD SCI USA, V104, P11109, DOI 10.1073/pnas.0611636104; Fermani S, 2001, J MOL BIOL, V314, P527, DOI 10.1006/jmbi.2001.5172; Gardebien F, 2006, J MOL GRAPH MODEL, V25, P186, DOI 10.1016/j.jmgm.2005.12.003; Graciet E, 2004, EUR J BIOCHEM, V271, P4737, DOI 10.1111/j.1432-1033.2004.04437.x; Graciet E, 2004, J EXP BOT, V55, P1245, DOI 10.1093/jxb/erh107; Graciet E, 2003, BIOCHEMISTRY-US, V42, P8163, DOI 10.1021/bi034474x; Graciet E, 2003, EUR J BIOCHEM, V270, P129, DOI 10.1046/j.1432-1033.2003.03372.x; Guha S, 1998, J BIOL CHEM, V273, P30077, DOI 10.1074/jbc.273.46.30077; Habeeb A F, 1972, Methods Enzymol, V25, P457, DOI 10.1016/S0076-6879(72)25041-8; Hegyi H, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000017; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; Huang GC, 2000, PROTEIN SCI, V9, P1254, DOI 10.1110/ps.9.6.1254; Iakoucheva LM, 2002, J MOL BIOL, V323, P573, DOI 10.1016/S0022-2836(02)00969-5; Ilbert M, 2007, NAT STRUCT MOL BIOL, V14, P556, DOI 10.1038/nsmb1244; Jakob U, 1999, CELL, V96, P341, DOI 10.1016/S0092-8674(00)80547-4; Jakob U, 2000, J BIOL CHEM, V275, P38302, DOI 10.1074/jbc.M005957200; Jeffery CJ, 1999, TRENDS BIOCHEM SCI, V24, P8, DOI 10.1016/S0968-0004(98)01335-8; Kim TD, 2002, BIOCHEMISTRY-US, V41, P13782, DOI 10.1021/bi026284c; Kovacs D, 2008, PLANT PHYSIOL, V147, P381, DOI 10.1104/pp.108.118208; Kramer G, 2004, J BACTERIOL, V186, P3777, DOI 10.1128/JB.186.12.3777-3784.2004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lebreton S, 2006, FEBS J, V273, P3358, DOI 10.1111/j.1742-4658.2006.05342.x; Lee GJ, 1997, EMBO J, V16, P659, DOI 10.1093/emboj/16.3.659; Li AD, 1997, PLANT PHYSIOL, V115, P1201, DOI 10.1104/pp.115.3.1201; LIANG SJ, 1990, BIOCHIM BIOPHYS ACTA, V1038, P240, DOI 10.1016/0167-4838(90)90211-W; LIN YZ, 1990, BIOCHIM BIOPHYS ACTA, V1038, P247, DOI 10.1016/0167-4838(90)90212-X; Manna T, 2001, J BIOL CHEM, V276, P39742, DOI 10.1074/jbc.M104061200; Markossian KA, 2008, BBA-PROTEINS PROTEOM, V1784, P1286, DOI 10.1016/j.bbapap.2008.04.030; Markossian KA, 2006, BIOCHEMISTRY-US, V45, P13375, DOI 10.1021/bi0610707; Marri L, 2005, PLANT PHYSIOL, V139, P1433, DOI 10.1104/pp.105.068445; Marri L, 2008, J BIOL CHEM, V283, P1831, DOI 10.1074/jbc.M705650200; Oesterhelt C, 2007, PLANT CELL PHYSIOL, V48, P1359, DOI 10.1093/pcp/pcm108; Pohlmeyer K, 1996, PLANT MOL BIOL, V32, P969, DOI 10.1007/BF00020493; Potters G, 2002, PLANT PHYSIOL BIOCH, V40, P537, DOI 10.1016/S0981-9428(02)01414-6; Robbens S, 2007, J MOL EVOL, V64, P601, DOI 10.1007/s00239-006-0159-y; Scagliarini S, 1998, J EXP BOT, V49, P1307, DOI 10.1093/jexbot/49.325.1307; Scheibe R, 2002, EUR J BIOCHEM, V269, P5617, DOI 10.1046/j.1432-1033.2002.03269.x; Sickmeier M, 2007, NUCLEIC ACIDS RES, V35, pD786, DOI 10.1093/nar/gkl893; Sparla F, 2005, PLANT PHYSIOL, V138, P2210, DOI 10.1104/pp.105.062117; Sparla F, 2002, J BIOL CHEM, V277, P44946, DOI 10.1074/jbc.M206873200; Sriram G, 2005, AM J HUM GENET, V76, P911, DOI 10.1086/430799; Tamoi M, 2005, PLANT J, V42, P504, DOI 10.1111/j.1365-313X.2005.02391.x; Tompa P, 2004, FASEB J, V18, P1169, DOI 10.1096/fj.04-1584rev; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072; Trost P, 2006, PHOTOSYNTH RES, V89, P263, DOI 10.1007/s11120-006-9099-z; Uversky VN, 2002, EUR J BIOCHEM, V269, P2, DOI 10.1046/j.0014-2956.2001.02649.x; Wedel N, 1997, P NATL ACAD SCI USA, V94, P10479, DOI 10.1073/pnas.94.19.10479; Wedel N, 1998, P NATL ACAD SCI USA, V95, P9699, DOI 10.1073/pnas.95.16.9699; Wickner S, 1999, SCIENCE, V286, P1888, DOI 10.1126/science.286.5446.1888; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Yoon MK, 2006, PROTEINS, V65, P856, DOI 10.1002/prot.21089; Zhang XF, 2005, INT J BIOCHEM CELL B, V37, P1232, DOI 10.1016/j.biocel.2004.12.004	73	35	35	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12735	12744		10.1074/jbc.M808254200	http://dx.doi.org/10.1074/jbc.M808254200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19287002	Green Published, hybrid			2022-12-27	WOS:000265688300018
J	Hatzios, SK; Schelle, MW; Holsclaw, CM; Behrens, CR; Botyanszki, Z; Lin, FL; Carlson, BL; Kumar, P; Leary, JA; Bertozzi, CR				Hatzios, Stavroula K.; Schelle, Michael W.; Holsclaw, Cynthia M.; Behrens, Christopher R.; Botyanszki, Zsofia; Lin, Fiona L.; Carlson, Brian L.; Kumar, Pawan; Leary, Julie A.; Bertozzi, Carolyn R.			PapA3 Is an Acyltransferase Required for Polyacyltrehalose Biosynthesis in Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKAGE POSITION DETERMINATION; SULFOLIPID-1 BIOSYNTHESIS; GENE-EXPRESSION; VIRULENCE; ACYLTREHALOSES; ANTIGENS; MMPL8; ACIDS	Mycobacterium tuberculosis possesses an unusual cell wall that is replete with virulence-enhancing lipids. One cell wall molecule unique to pathogenic M. tuberculosis is polyacyltrehalose (PAT), a pentaacylated, trehalose-based glycolipid. Little is known about the biosynthesis of PAT, although its biosynthetic gene cluster has been identified and found to resemble that of the better studied M. tuberculosis cell wall component sulfolipid-1. In this study, we sought to elucidate the function of papA3, a gene from the PAT locus encoding a putative acyltransferase. To determine whether PapA3 participates in PAT assembly, we expressed the protein heterologously and evaluated its acyltransferase activity in vitro. The purified enzyme catalyzed the sequential esterification of trehalose with two palmitoyl groups, generating a diacylated product similar to the 2,3-diacyltrehalose glycolipids of M. tuberculosis. Notably, PapA3 was selective for trehalose; no activity was observed with other structurally related disaccharides. Disruption of the papA3 gene from M. tuberculosis resulted in the loss of PAT from bacterial lipid extracts. Complementation of the mutant strain restored PAT production, demonstrating that PapA3 is essential for the biosynthesis of this glycolipid in vivo. Furthermore, we determined that the PAT biosynthetic machinery has no cross-talk with that for sulfolipid-1 despite their related structures.	[Hatzios, Stavroula K.; Schelle, Michael W.; Behrens, Christopher R.; Botyanszki, Zsofia; Lin, Fiona L.; Kumar, Pawan; Bertozzi, Carolyn R.] Univ Calif Berkeley, Dept Chem, Berkeley, CA 94720 USA; [Carlson, Brian L.; Bertozzi, Carolyn R.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Hatzios, Stavroula K.; Schelle, Michael W.; Botyanszki, Zsofia; Lin, Fiona L.; Carlson, Brian L.; Kumar, Pawan; Bertozzi, Carolyn R.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Holsclaw, Cynthia M.; Leary, Julie A.] Univ Calif Davis, Sect Mol & Cell Biol, Davis, CA 95616 USA; [Leary, Julie A.] Univ Calif Davis, Dept Chem, Davis, CA 95616 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Davis; University of California System; University of California Davis	Bertozzi, CR (corresponding author), Univ Calif Berkeley, Dept Chem, B84 Hildebrand Hall, Berkeley, CA 94720 USA.	crb@berkeley.edu		Hatzios, Stavroula/0000-0001-8658-8949	National Institutes of Health [AI51622]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI051622, R01AI051622] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant AI51622 (to C. R. B.).	Bhatt K, 2007, MICROBIOL-SGM, V153, P513, DOI 10.1099/mic.0.2006/003103-0; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Chesne-Seck ML, 2008, J BACTERIOL, V190, P1329, DOI 10.1128/JB.01465-07; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Converse SE, 2003, P NATL ACAD SCI USA, V100, P6121, DOI 10.1073/pnas.1030024100; DAFFE M, 1988, EUR J BIOCHEM, V172, P579, DOI 10.1111/j.1432-1033.1988.tb13928.x; Domenech P, 2005, INFECT IMMUN, V73, P3492, DOI 10.1128/IAI.73.6.3492-3501.2005; Domenech P, 2004, J BIOL CHEM, V279, P21257, DOI 10.1074/jbc.M400324200; Dubey VS, 2002, MOL MICROBIOL, V45, P1451, DOI 10.1046/j.1365-2958.2002.03119.x; Ferreras JA, 2008, CHEM BIOL, V15, P51, DOI 10.1016/j.chembiol.2007.11.010; Glickman MS, 2000, MOL CELL, V5, P717, DOI 10.1016/S1097-2765(00)80250-6; Hampshire T, 2004, TUBERCULOSIS, V84, P228, DOI 10.1016/j.tube.2003.12.010; HOFMEISTER GE, 1991, J AM CHEM SOC, V113, P5964, DOI 10.1021/ja00016a007; Jain M, 2005, PLOS PATHOG, V1, P12, DOI 10.1371/journal.ppat.0010002; KALUZNY MA, 1985, J LIPID RES, V26, P135; Kumar P, 2007, P NATL ACAD SCI USA, V104, P11221, DOI 10.1073/pnas.0611649104; LANGSTON S, 1994, HELV CHIM ACTA, V77, P2341, DOI 10.1002/hlca.19940770821; Minnikin DE, 2002, CHEM BIOL, V9, P545, DOI 10.1016/S1074-5521(02)00142-4; Mougous JD, 2004, NAT STRUCT MOL BIOL, V11, P721, DOI 10.1038/nsmb802; Onwueme KC, 2004, P NATL ACAD SCI USA, V101, P4608, DOI 10.1073/pnas.0306928101; Rohde KH, 2007, CELL HOST MICROBE, V2, P352, DOI 10.1016/j.chom.2007.09.006; Rousseau C, 2003, CELL MICROBIOL, V5, P405, DOI 10.1046/j.1462-5822.2003.00289.x; Schelle MW, 2006, CHEMBIOCHEM, V7, P1516, DOI 10.1002/cbic.200600224; Six DA, 2008, BIOCHEMISTRY-US, V47, P8623, DOI 10.1021/bi800873n; STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; WALLACE PA, 1994, J CHEM SOC CHEM COMM, P329, DOI 10.1039/c39940000329; WALLACE PA, 1994, CARBOHYD RES, V263, P43, DOI 10.1016/0008-6215(94)00164-2; ZHOU ZR, 1990, J ORG CHEM, V55, P5444, DOI 10.1021/jo00307a011	29	53	58	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12745	12751		10.1074/jbc.M809088200	http://dx.doi.org/10.1074/jbc.M809088200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19276083	hybrid, Green Published			2022-12-27	WOS:000265688300019
J	Shanklin, J; Guy, JE; Mishra, G; Lindqvist, Y				Shanklin, John; Guy, Jodie E.; Mishra, Girish; Lindqvist, Ylva			Desaturases: Emerging Models for Understanding Functional Diversification of Diiron-containing Enzymes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ACYL-CARRIER-PROTEIN; STEAROYL-COA DESATURASE; FATTY-ACID DESATURASES; ALKANE OMEGA-HYDROXYLASE; CRYSTAL-STRUCTURE; RICINUS-COMMUNIS; OLEATE 12-HYDROXYLASE; ACP DESATURASE; IDENTIFICATION; SPECIFICITY	Desaturases and related enzymes perform O-2-dependent dehydrogenations initiated at unactivated C-H groups with the use of a diiron active site. Determination of the long-sought oxidized desaturase crystal structure facilitated structural comparison of the active sites of disparate diiron enzymes. Experiments on the castor desaturase are discussed that provide experimental support for a hypothesized ancestral oxidase enzyme in the context of the evolution of the diiron enzyme diverse functionality. We also summarize recent analysis of a castor mutant desaturase that provides valuable insights into the relationship of proposed substrate-binding modes with respect to a range of catalytic outcomes.	[Shanklin, John; Mishra, Girish] Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA; [Guy, Jodie E.; Lindqvist, Ylva] Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden	United States Department of Energy (DOE); Brookhaven National Laboratory; Karolinska Institutet	Shanklin, J (corresponding author), Brookhaven Natl Lab, Dept Biol, Upton, NY 11973 USA.	shanklin@bnl.gov	Lindqvist, Ylva/F-9009-2010	Lindqvist, Ylva/0000-0003-3162-8661; Shanklin, John/0000-0002-6774-8043; Guy, Jodie/0000-0003-0331-0699				Badami RC, 1980, PROG LIPID RES, V19, P119; BLOCH K, 1969, ACCOUNTS CHEM RES, V2, P193, DOI 10.1021/ar50019a001; Broadwater JA, 2002, J BIOL CHEM, V277, P15613, DOI 10.1074/jbc.M200231200; Broadwater JA, 1998, FETT-LIPID, V100, P103; Broadwater JA, 2000, J INORG BIOCHEM, V78, P7, DOI 10.1016/S0162-0134(99)00199-3; Broun P, 1998, PLANT J, V13, P201, DOI 10.1046/j.1365-313X.1998.00023.x; Broun P, 1998, SCIENCE, V282, P1315, DOI 10.1126/science.282.5392.1315; Buist PH, 2007, NAT PROD REP, V24, P1110, DOI 10.1039/b508584p; BUIST PH, 1992, J AM CHEM SOC, V114, P5073, DOI 10.1021/ja00039a018; Buist PH, 2004, NAT PROD REP, V21, P249, DOI 10.1039/b302094k; Cahoon EB, 1997, P NATL ACAD SCI USA, V94, P4872, DOI 10.1073/pnas.94.10.4872; Cahoon EB, 2004, J BIOL CHEM, V279, P12495, DOI 10.1074/jbc.M314329200; Damude HG, 2006, P NATL ACAD SCI USA, V103, P9446, DOI 10.1073/pnas.0511079103; Dyer JM, 2002, PLANT PHYSIOL, V130, P2027, DOI 10.1104/pp.102.010835; Engeseth N, 1996, PLANTA, V198, P238, DOI 10.1007/BF00206249; Fosdike WLJ, 2005, FEBS J, V272, P2661, DOI 10.1111/j.1742-4658.2005.04675.x; Fox BG, 2004, ACCOUNTS CHEM RES, V37, P421, DOI 10.1021/ar030186h; FOX BG, 1993, P NATL ACAD SCI USA, V90, P2486, DOI 10.1073/pnas.90.6.2486; Gomes CM, 2001, CHEMBIOCHEM, V2, P583, DOI 10.1002/1439-7633(20010803)2:7/8<583::AID-CBIC583>3.0.CO;2-5; Gomez FE, 2003, BIOCHEM BIOPH RES CO, V300, P316; Goren MA, 2008, PROTEIN EXPRES PURIF, V62, P171, DOI 10.1016/j.pep.2008.08.002; Guy JE, 2007, J BIOL CHEM, V282, P19863, DOI 10.1074/jbc.M702520200; Guy JE, 2006, P NATL ACAD SCI USA, V103, P17220, DOI 10.1073/pnas.0607165103; Haas JA, 1999, BIOCHEMISTRY-US, V38, P12833, DOI 10.1021/bi991318a; Heilmann I, 2004, PLANT PHYSIOL, V136, P4237, DOI 10.1104/pp.104.052951; Jin S, 2002, J AM CHEM SOC, V124, P9845, DOI 10.1021/ja026587u; JOHNSON AR, 1967, NATURE, V214, P1244, DOI 10.1038/2141244a0; Lee M, 1998, SCIENCE, V280, P915, DOI 10.1126/science.280.5365.915; Lindqvist Y, 1996, EMBO J, V15, P4081, DOI 10.1002/j.1460-2075.1996.tb00783.x; Lindqvist Y., 2001, DELTA 9 STEAROYL ACY; Millar AA, 2000, TRENDS PLANT SCI, V5, P95, DOI 10.1016/S1360-1385(00)01566-1; Moche M, 2003, J BIOL CHEM, V278, P25072, DOI 10.1074/jbc.M301662200; Reipa V, 2004, CHEM COMMUN, P2406, DOI 10.1039/b409595b; ROSENZWEIG AC, 1993, NATURE, V366, P537, DOI 10.1038/366537a0; Sazinsky MH, 2006, ACCOUNTS CHEM RES, V39, P558, DOI 10.1021/ar030204v; Serra M, 2007, P NATL ACAD SCI USA, V104, P16444, DOI 10.1073/pnas.0705385104; SHANKLIN J, 1991, P NATL ACAD SCI USA, V88, P2510, DOI 10.1073/pnas.88.6.2510; Shanklin J, 1998, ANNU REV PLANT PHYS, V49, P611, DOI 10.1146/annurev.arplant.49.1.611; Shanklin J, 2003, FEBS LETT, V545, P188, DOI 10.1016/S0014-5793(03)00529-5; SHANKLIN J, 1994, BIOCHEMISTRY-US, V33, P12787, DOI 10.1021/bi00209a009; Shanklin J, 1997, P NATL ACAD SCI USA, V94, P2981, DOI 10.1073/pnas.94.7.2981; SHANKLIN J, 2007, ACYL ACP DESATURASE; Soulard P, 2008, ANAL CHIM ACTA, V627, P105, DOI 10.1016/j.aca.2008.04.017; STUKEY JE, 1990, J BIOL CHEM, V265, P20144; Van De Loo Frank J., 1993, P91; VANDELOO FJ, 1995, P NATL ACAD SCI USA, V92, P6743, DOI 10.1073/pnas.92.15.6743; Wallar BJ, 1996, CHEM REV, V96, P2625, DOI 10.1021/cr9500489; Whittle E, 2005, J BIOL CHEM, V280, P28169, DOI 10.1074/jbc.M504205200; Whittle E, 2001, J BIOL CHEM, V276, P21500, DOI 10.1074/jbc.M102129200; Whittle EJ, 2008, P NATL ACAD SCI USA, V105, P14738, DOI 10.1073/pnas.0805645105; Yoon SG, 2004, J AM CHEM SOC, V126, P16692, DOI 10.1021/ja044489y	51	136	142	0	47	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18559	18563		10.1074/jbc.R900009200	http://dx.doi.org/10.1074/jbc.R900009200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19363032	Green Published, hybrid			2022-12-27	WOS:000267711500002
J	Winter, JM; Moore, BS				Winter, Jaclyn M.; Moore, Bradley S.			Exploring the Chemistry and Biology of Vanadium-dependent Haloperoxidases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							FUNGUS CURVULARIA-INAEQUALIS; CONTAINING ENZYME CHLOROPEROXIDASE; ALGAE CORALLINA-OFFICINALIS; MARINE NATURAL-PRODUCTS; ACTIVE-SITE MUTANTS; X-RAY-STRUCTURE; HETEROLOGOUS EXPRESSION; CATALYTIC MECHANISMS; LAMINARIA-DIGITATA; CRYSTAL-STRUCTURE	Nature has developed an exquisite array of methods to introduce halogen atoms into organic compounds. Most of these enzymes are oxidative and require either hydrogen peroxide or molecular oxygen as a cosubstrate to generate a reactive halogen atom for catalysis. Vanadium-dependent haloperoxidases contain a vanadate prosthetic group and utilize hydrogen peroxide to oxidize a halide ion into a reactive electrophilic intermediate. These metalloenzymes have a large distribution in nature, where they are present in macroalgae, fungi, and bacteria, but have been exclusively characterized in eukaryotes. In this mini-review, we highlight the chemistry and biology of vanadium-dependent haloperoxidases from fungi and marine algae and the emergence of new bacterial members that extend the biological function of these poorly understood halogenating enzymes.	[Winter, Jaclyn M.; Moore, Bradley S.] Univ Calif San Diego, Ctr Marine Biotechnol & Biomed, Scripps Inst Oceanog, San Diego, CA 92093 USA; [Moore, Bradley S.] Univ Calif San Diego, Skaggs Sch Pharm & Pharmaceut Sci, San Diego, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; University of California System; University of California San Diego	Moore, BS (corresponding author), Univ Calif San Diego, Ctr Marine Biotechnol & Biomed, Scripps Inst Oceanog, San Diego, CA 92093 USA.	bsmoore@ucsd.edu		Winter, Jaclyn/0000-0001-6273-5377; Moore, Bradley/0000-0002-4652-1253	National Institutes of Health [AI52445, GM067550]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM067550] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AI52445 (to B. S. M.) and by Ruth L. Kirschstein National Research Service Award GM067550 from the National Institutes of Health Training Program in Marine Biotechnology at the Scripps Institution of Oceanography (to J. M. W.). This is the fourth article of five in the second Thematic Minireview Series on Metals in Biology. This minireview will be reprinted in the 2009 Minireview Compendium, which will be available in January, 2010.	Andersson M, 1997, J ORG CHEM, V62, P8455, DOI 10.1021/jo9712456; Barnett P, 1998, J BIOL CHEM, V273, P23381, DOI 10.1074/jbc.273.36.23381; Betancourt DA, 2008, APPL ENVIRON MICROB, V74, P3471, DOI 10.1128/AEM.02694-07; Butler A, 2004, NAT PROD REP, V21, P180, DOI 10.1039/b302337k; Butler A, 2001, HANDBOOK ON METALLOPROTEINS, P153; Carter JN, 2002, J INORG BIOCHEM, V91, P59, DOI 10.1016/S0162-0134(02)00400-2; Carter-Franklin JN, 2004, J AM CHEM SOC, V126, P15060, DOI 10.1021/ja047925p; Chen XP, 2008, ACTA BIOCH BIOPH SIN, V40, P183, DOI 10.1111/j.1745-7270.2008.00390.x; Colin C, 2003, J BIOL CHEM, V278, P23545, DOI 10.1074/jbc.M300247200; Cosse A, 2009, NEW PHYTOL, V182, P239, DOI 10.1111/j.1469-8137.2008.02745.x; Coupe EE, 2007, PROTEIN EXPRES PURIF, V52, P265, DOI 10.1016/j.pep.2006.08.010; Crans DC, 2004, CHEM REV, V104, P849, DOI 10.1021/cr020607t; de Macedo-Ribeiro S, 2008, BIOCHEMISTRY-US, V47, P929, DOI 10.1021/bi7018628; DEBOER E, 1986, BIOCHIM BIOPHYS ACTA, V872, P104, DOI 10.1016/0167-4838(86)90153-6; DEBOER E, 1987, BIOTECHNOL BIOENG, V30, P607, DOI 10.1002/bit.260300504; Eady RR, 2003, COORDIN CHEM REV, V237, P23, DOI 10.1016/S0010-8545(02)00248-5; FENICAL W, 1975, J PHYCOL, V11, P245, DOI 10.1111/j.0022-3646.1975.00245.x; Gribble GW, 2004, AM SCI, V92, P342, DOI 10.1511/2004.4.342; Hasan Z, 2006, J BIOL CHEM, V281, P9738, DOI 10.1074/jbc.M512166200; Hemrika W, 1999, J BIOL CHEM, V274, P23820, DOI 10.1074/jbc.274.34.23820; Hemrika W, 1997, P NATL ACAD SCI USA, V94, P2145, DOI 10.1073/pnas.94.6.2145; HEWSON WD, 1980, J PHYCOL, V16, P340; HUNTERCEVERA JC, 1986, MICROBIAL ECOL, V12, P121, DOI 10.1007/BF02153227; Isupov MN, 2000, J MOL BIOL, V299, P1035, DOI 10.1006/jmbi.2000.3806; ITOH N, 1988, EUR J BIOCHEM, V172, P477, DOI 10.1111/j.1432-1033.1988.tb13913.x; ITOH N, 1985, BIOCHEM BIOPH RES CO, V131, P428, DOI 10.1016/0006-291X(85)91820-0; Kladi Maria, 2004, Phytochemistry Reviews, V3, P337, DOI 10.1007/s11101-004-4155-9; Littlechild J, 2002, J MOL RECOGNIT, V15, P291, DOI 10.1002/jmr.590; LIU TNE, 1987, BIOCHEM BIOPH RES CO, V142, P329; Macedo-Ribeiro S, 1999, J BIOL INORG CHEM, V4, P209, DOI 10.1007/s007750050306; Martinez VM, 2008, J AM CHEM SOC, V130, P13192, DOI 10.1021/ja804606m; Messerschmidt A, 1997, BIOL CHEM, V378, P309, DOI 10.1515/bchm.1997.378.3-4.309; Messerschmidt A, 1996, P NATL ACAD SCI USA, V93, P392, DOI 10.1073/pnas.93.1.392; Ohshiro T, 2004, PROTEIN SCI, V13, P1566, DOI 10.1110/ps.03496004; Ohshiro T, 1999, PHYTOCHEMISTRY, V52, P1211, DOI 10.1016/S0031-9422(99)00404-5; PLAT H, 1987, BIOCHEM J, V248, P277, DOI 10.1042/bj2480277; Pooransingh-Margolis N, 2006, J AM CHEM SOC, V128, P5190, DOI 10.1021/ja060480f; Raugei S, 2006, J PHYS CHEM B, V110, P3747, DOI 10.1021/jp054901b; REHDER D, 1991, ANGEW CHEM INT EDIT, V30, P148, DOI 10.1002/anie.199101481; Renirie R, 2000, J BIOL CHEM, V275, P11650, DOI 10.1074/jbc.275.16.11650; SHEFFIELD DJ, 1993, PHYTOCHEMISTRY, V32, P21; Shimonishi M, 1998, FEBS LETT, V428, P105, DOI 10.1016/S0014-5793(98)00500-6; SOEDJAK HS, 1990, INORG CHEM, V29, P5015, DOI 10.1021/ic00350a003; Tanaka N, 2002, EUR J BIOCHEM, V269, P2162, DOI 10.1046/j.1432-1033.2002.02871.x; ten Brink HB, 2000, J INORG BIOCHEM, V80, P91, DOI 10.1016/S0162-0134(00)00044-1; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vaillancourt FH, 2006, CHEM REV, V106, P3364, DOI 10.1021/cr050313i; VANSCHIJNDEL JWPM, 1993, BIOCHIM BIOPHYS ACTA, V1161, P249, DOI 10.1016/0167-4838(93)90221-C; VITLER H, 1984, PHYTOCHEMISTRY, V23, P387; Wever R., 2001, HDB METALLOPROTEINS, P1417; Weyand M, 1999, J MOL BIOL, V293, P595, DOI 10.1006/jmbi.1999.3179; Winter JM, 2007, J BIOL CHEM, V282, P16362, DOI 10.1074/jbc.M611046200; Winter JM, 2009, ANGEW CHEM INT EDIT, V48, P767, DOI 10.1002/anie.200805140; YAMADA H, 1985, AGR BIOL CHEM TOKYO, V49, P2961, DOI 10.1080/00021369.1985.10867194; Zhang Y, 2008, J INORG BIOCHEM, V102, P1684, DOI 10.1016/j.jinorgbio.2008.04.006; Zhao Y, 2006, J INTEGR PLANT BIOL, V48, P745, DOI 10.1111/j.1744-7909.2006.00271.x	56	151	153	3	63	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18577	18581		10.1074/jbc.R109.001602	http://dx.doi.org/10.1074/jbc.R109.001602			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19363038	hybrid, Green Published			2022-12-27	WOS:000267711500005
J	Percherancier, Y; Germain-Desprez, D; Galisson, F; Mascle, XH; Dianoux, L; Estephan, P; Chelbi-Alix, MK; Aubry, M				Percherancier, Yann; Germain-Desprez, Delphine; Galisson, Frederic; Mascle, Xavier H.; Dianoux, Laurent; Estephan, Patricia; Chelbi-Alix, Mounira K.; Aubry, Muriel			Role of SUMO in RNF4-mediated Promyelocytic Leukemia Protein (PML) Degradation SUMOYLATION OF PML AND PHOSPHO-SWITCH CONTROL OF ITS SUMO BINDING DOMAIN DISSECTED IN LIVING CELLS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; NUCLEAR-BODY FORMATION; LIVING CELLS; UBIQUITIN LIGASE; TRANSFER BRET; RNF4; DYNAMICS; BODIES; ALPHA; RECRUITMENT	Promyelocytic leukemia protein (PML) is a tumor suppressor acting as the organizer of subnuclear structures called PML nuclear bodies (NBs). Both covalent modification of PML by the small ubiquitin-like modifier (SUMO) and non-covalent binding of SUMO to the PML SUMO binding domain (SBD) are necessary for PML NB formation and maturation. PML sumoylation and proteasome-dependent degradation induced by the E3 ubiquitin ligase, RNF4, are enhanced by the acute promyelocytic leukemia therapeutic agent, arsenic trioxide (As2O3). Here, we established a novel bioluminescence resonance energy transfer (BRET) assay to dissect and monitor PML/SUMO interactions dynamically in living cells upon addition of therapeutic agents. Using this sensitive and quantitative SUMO BRET assay that distinguishes PML sumoylation from SBD-mediated PML/SUMO non-covalent interactions, we probed the respective roles of covalent and non-covalent PML/SUMO interactions in PML degradation and interaction with RNF4. We found that, although dispensable for As2O3-enhanced PML sumoylation and RNF4 interaction, PML SBD core sequence was required for As2O3- and RNF4-induced PML degradation. As confirmed with a phosphomimetic mutant, phosphorylation of a stretch of serine residues, contained within PML SBD was needed for PML interaction with SUMO-modified protein partners and thus for NB maturation. However, mutation of these serine residues did not impair As2O3- and RNF4-induced PML degradation, contrasting with the known role of these phosphoserine residues for casein kinase 2-promoted PML degradation. Altogether, these data suggest a model whereby sumoylation- and SBD-dependent PML oligomerization within NBs is sufficient for RNF4-mediated PML degradation and does not require the phosphorylation-dependent association of PML with other sumoylated partners.	[Percherancier, Yann; Galisson, Frederic; Dianoux, Laurent; Chelbi-Alix, Mounira K.] Inst Andre Lwoff, CNRS, FRE2937, F-94801 Villejuif, France; [Germain-Desprez, Delphine; Mascle, Xavier H.; Estephan, Patricia; Aubry, Muriel] Univ Montreal, Dept Biochim, Montreal, PQ H3C 3J7, Canada	Centre National de la Recherche Scientifique (CNRS); Universite de Montreal	Chelbi-Alix, MK (corresponding author), 7 Rue Guy Moquet, F-94801 Villejuif, France.	mchelbi@vjf.cnrs.fr; muriel.aubry@umontreal.ca		percherancier, yann/0000-0002-2410-5806	Natural Sciences and Engineering Research Council of Canada; Association pour la Recherche sur le Cancer; Ligue Nationale Contre le Cancer	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer)	This work was supported in part by a grant from Natural Sciences and Engineering Research Council of Canada (to M.A.), the Association pour la Recherche sur le Cancer, and the Ligue Nationale Contre le Cancer (to M.K. C.-A.).	Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; Ayaydin F, 2004, MOL BIOL CELL, V15, P5208, DOI 10.1091/mbc.E04-07-0589; Bernardi R, 2007, NAT REV MOL CELL BIO, V8, P1006, DOI 10.1038/nrm2277; DETHE H, 1990, NATURE, V347, P558, DOI 10.1038/347558a0; Duprez E, 1999, J CELL SCI, V112, P381; Germain-Desprez D, 2003, J BIOL CHEM, V278, P22367, DOI 10.1074/jbc.M302234200; Hamdan FF, 2005, J BIOMOL SCREEN, V10, P463, DOI 10.1177/1087057105275344; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hecker CM, 2006, J BIOL CHEM, V281, P16117, DOI 10.1074/jbc.M512757200; Kaiser FJ, 2003, J BIOL CHEM, V278, P38780, DOI 10.1074/jbc.M306259200; Kamitani T, 1998, J BIOL CHEM, V273, P26675, DOI 10.1074/jbc.273.41.26675; Lafarga M, 2002, MOL BIOL CELL, V13, P2771, DOI 10.1091/mbc.E02-03-0122; Lallemand-Breitenbach V, 2001, J EXP MED, V193, P1361, DOI 10.1084/jem.193.12.1361; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Mascle XH, 2007, J BIOL CHEM, V282, P10190, DOI 10.1074/jbc.M611429200; Mukhopadhyay D, 2006, J CELL BIOL, V174, P939, DOI 10.1083/jcb.200510103; Negorev D, 2001, ONCOGENE, V20, P7234, DOI 10.1038/sj.onc.1204764; Percherancier Y, 2005, J BIOL CHEM, V280, P9895, DOI 10.1074/jbc.M411151200; Perroy J, 2004, NAT METHODS, V1, P203, DOI 10.1038/NMETH722; Petrie K, 2008, NAT CELL BIOL, V10, P507, DOI 10.1038/ncb0508-507; Salomoni P, 2002, CELL, V108, P165, DOI 10.1016/S0092-8674(02)00626-8; Scaglioni PP, 2006, CELL, V126, P269, DOI 10.1016/j.cell.2006.05.041; Seeler JS, 2001, ONCOGENE, V20, P7243, DOI 10.1038/sj.onc.1204758; Shen TH, 2006, MOL CELL, V24, P331, DOI 10.1016/j.molcel.2006.09.013; Stehmeier P, 2009, MOL CELL, V33, P400, DOI 10.1016/j.molcel.2009.01.013; Sun H, 2007, EMBO J, V26, P4102, DOI 10.1038/sj.emboj.7601839; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Weidtkamp-Peters S, 2008, J CELL SCI, V121, P2731, DOI 10.1242/jcs.031922; Xu Y, 1999, P NATL ACAD SCI USA, V96, P151, DOI 10.1073/pnas.96.1.151; Yang XJ, 2006, MOL CELL, V23, P779, DOI 10.1016/j.molcel.2006.08.009; Zennou V, 2000, CELL, V101, P173, DOI 10.1016/S0092-8674(00)80828-4; Zhu J, 1997, P NATL ACAD SCI USA, V94, P3978, DOI 10.1073/pnas.94.8.3978	32	47	51	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16595	16608		10.1074/jbc.M109.006387	http://dx.doi.org/10.1074/jbc.M109.006387			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19380586	Green Published, hybrid			2022-12-27	WOS:000266730900056
J	Qu, ZQ; Cheng, W; Cui, YY; Cui, YY; Zheng, J				Qu, Zhiqiang; Cheng, Wei; Cui, Yuanyuan; Cui, Yuanyuan; Zheng, Jie			Human Disease-causing Mutations Disrupt an N-C-terminal Interaction and Channel Function of Bestrophin 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEOTIDE-GATED CHANNELS; CHLORIDE CHANNEL; RETINAL DEGENERATION; MOUSE BESTROPHIN-2; CA2+ CHANNELS; CELLS; MEMBRANE; FAMILY; ELECTRORETINOGRAM; PRODUCT	Mutations in the human bestrophin 1 (hBest1) chloride channel cause Best vitelliform macular dystrophy. Although mutations in its transmembrane domains were found to alter biophysical properties of the channel, the mechanism for disease-causing mutations in its N and C termini remains elusive. We hypothesized that these mutations lead to channel dysfunction through disruption of an N-C-terminal interaction. Here, we present data demonstrating that hBest1 N and C termini indeed interact both in vivo and in vitro. In addition, using a spectrum-based fluorescence resonance energy transfer method, we showed that functional hBest1 channels in the plasma membrane were multimers. Disease-causing mutations in the N terminus (R19C, R25C, and K30C) and the C terminus (G299E, D301N, and D312N) caused channel dysfunction and disruption of the N-C interaction. Consistent with the functional and biochemical results, mutants D301N and D312N clearly reduced fluorescence resonance energy transfer signal, indicating that the N-C interaction was indeed perturbed. These results suggest that hBest1 functions as a multimer in the plasma membrane, and disruption of the N-C interaction by mutations leads to hBest1 channel dysfunction.	[Qu, Zhiqiang; Cui, Yuanyuan] Emory Univ, Dept Cell Biol, Sch Med, Atlanta, GA 30322 USA; [Cheng, Wei; Cui, Yuanyuan; Zheng, Jie] Univ Calif Davis, Dept Physiol & Membrane Biol, Sch Med, Davis, CA 95616 USA; [Qu, Zhiqiang] Qingdao Univ, Dept Physiol, Sch Med, Qingdao 266071, Shandong, Peoples R China	Emory University; University of California System; University of California Davis; Qingdao University	Qu, ZQ (corresponding author), Emory Univ, Dept Cell Biol, Sch Med, 615 Michael St,535 Whitehead Bldg, Atlanta, GA 30322 USA.	zqu@emory.edu	cheng, wei/F-2135-2011; Cui, Yuanyuan/G-1899-2015; Cui, Yuanyuan/G-1787-2017	Cui, Yuanyuan/0000-0002-1455-5643	National Institutes of Health [REY016754A, GM60448, EY014852]; American Federation of Aging; Qingdao University; American Heart Association [0665201Y]; National Center for Research Resources [C06-RR-12088-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR012088] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R21EY016754, R01EY014852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060448] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Federation of Aging; Qingdao University; American Heart Association(American Heart Association); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant REY016754A (to J. Z.), GM60448, and EY014852. This work was also supported by an American Federation of Aging Research Award and a Qingdao University Faculty Grant (to Z. Q.), American Heart Association Grant 0665201Y (to J. Z.), and Research Facilities Improvement Program Grant C06-RR-12088-01 from the National Center for Research Resources.	Brady JD, 2006, P NATL ACAD SCI USA, V103, P15635, DOI 10.1073/pnas.0603344103; Bykova EA, 2006, NAT STRUCT MOL BIOL, V13, P1115, DOI 10.1038/nsmb1176; Cheng W, 2007, J GEN PHYSIOL, V129, P191, DOI 10.1085/jgp.200709731; Chien LT, 2006, J GEN PHYSIOL, V128, P247, DOI 10.1085/jgp.200609581; Gallemore RP, 1997, PROG RETIN EYE RES, V16, P509, DOI 10.1016/S1350-9462(96)00037-7; Hartzell C, 2005, PHYSIOLOGY, V20, P292, DOI 10.1152/physiol.00021.2005; Hartzell HC, 2008, PHYSIOL REV, V88, P639, DOI 10.1152/physrev.00022.2007; Marmorstein AD, 2000, P NATL ACAD SCI USA, V97, P12758, DOI 10.1073/pnas.220402097; Marmorstein AD, 2007, EXP EYE RES, V85, P423, DOI 10.1016/j.exer.2006.03.021; Marmorstein LY, 2006, J GEN PHYSIOL, V127, P577, DOI 10.1085/jgp.200509473; NEHER E, 1992, SCIENCE, V256, P498, DOI 10.1126/science.1373906; Pifferi S, 2006, P NATL ACAD SCI USA, V103, P12929, DOI 10.1073/pnas.0604505103; Qiang Z, 2007, J BIOL CHEM, V282, P17460, DOI 10.1074/jbc.M701043200; Qu ZQ, 2008, AM J PHYSIOL-CELL PH, V294, pC1371, DOI 10.1152/ajpcell.00398.2007; Qu ZQ, 2006, J NEUROSCI, V26, P5411, DOI 10.1523/JNEUROSCI.5500-05.2006; Qu ZQ, 2004, J GEN PHYSIOL, V124, P371, DOI 10.1085/jgp.200409108; Qu ZQ, 2004, J GEN PHYSIOL, V123, P327, DOI 10.1085/jgp.200409031; Qu ZQ, 2003, J BIOL CHEM, V278, P49563, DOI 10.1074/jbc.M308414200; Qu ZQ, 2000, J BIOL CHEM, V275, P31573, DOI 10.1074/jbc.M003473200; Rosenthal R, 2005, FASEB J, V19, P178, DOI 10.1096/fj.05-4495fje; SORIA RB, 2006, J BIOL CHEM, V281, P17460; Stanton JB, 2006, BBA-BIOMEMBRANES, V1758, P241, DOI 10.1016/j.bbamem.2006.01.024; Sun H, 2002, P NATL ACAD SCI USA, V99, P4008, DOI 10.1073/pnas.052692999; Takanishi CL, 2006, BRAIN RES, V1091, P132, DOI 10.1016/j.brainres.2006.01.119; Tsunenari T, 2003, J BIOL CHEM, V278, P41114, DOI 10.1074/jbc.M306150200; Tsunenari T, 2006, J GEN PHYSIOL, V127, P749, DOI 10.1085/jgp.200609527; Varnum MD, 1997, SCIENCE, V278, P110, DOI 10.1126/science.278.5335.110; WAJIMA R, 1993, OPHTHALMOLOGICA, V207, P174, DOI 10.1159/000310429; Xiao Q, 2008, J GEN PHYSIOL, V132, P681, DOI 10.1085/jgp.200810056; Yu K, 2008, J NEUROSCI, V28, P5660, DOI 10.1523/JNEUROSCI.0065-08.2008; Yu K, 2007, INVEST OPHTH VIS SCI, V48, P4694, DOI 10.1167/iovs.07-0301; Zheng J, 2000, NEURON, V28, P369, DOI 10.1016/S0896-6273(00)00117-3; Zheng J, 2003, J NEUROSCI, V23, P8167	33	20	20	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16473	16481		10.1074/jbc.M109.002246	http://dx.doi.org/10.1074/jbc.M109.002246			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19372599	Green Published, hybrid			2022-12-27	WOS:000266730900044
J	Kim, T; Kim, K; Lee, SH; So, HS; Lee, J; Kim, N; Choi, Y				Kim, Taesoo; Kim, Kabsun; Lee, Seoung Hoon; So, Hong-Seob; Lee, Junwon; Kim, Nacksung; Choi, Yongwon			Identification of LRRc17 as a Negative Regulator of Receptor Activator of NF-kappa B Ligand (RANKL)-induced Osteoclast Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NECROSIS-FACTOR RECEPTOR; NUCLEAR-FACTOR; T-CELLS; OSTEOPROTEGERIN; PROTEIN; RANKL; CYTOKINE; TRANCE; NFATC1; KINASE	Osteoblasts are the primary cells responsible for bone formation. They also support osteoclast formation from bone marrow precursors in response to osteotropic factors by inducing receptor activator of NF-kappa B ligand (RANKL) expression and down-regulating osteoprotegerin (OPG) production. In addition to the RANKL-RANK-OPG signaling axis, other factors produced by osteoblasts/stromal cells are involved in osteoclastogenesis. Here, we describe the identification and characterization of leucine-rich repeat-containing 17 (LRRc17), a member of the LRR superfamily that acts as a negative regulator of RANKL-induced osteoclast differentiation. Osteoblasts showed high levels of LRRc17 expression, which was down-regulated in response to the pro-osteoclastogenic factor 1,25-dihydroxyvitamin D-3. Recombinant LRRc17 protein inhibited RANKL-induced osteoclast differentiation from bone marrow precursors, whereas it did not affect the differentiation or activation of macrophages and dendritic cells. These results suggest that among the cell types derived from common myeloid precursors, LRRc17 specifically regulates osteoclasts. Further analysis revealed that LRRc17 attenuated RANKL-induced expression of NFATc1 by blocking phospholipase C-gamma signaling, which, in turn, inhibited RANKL-mediated osteoclast differentiation. Taken together, our results demonstrated a novel inhibitory activity of LRRc17 in RANKL-induced osteoclastogenesis.	[Kim, Kabsun; Kim, Nacksung] Chonnam Natl Univ, Sch Med, Med Res Ctr Gene Regulat, Natl Res Lab Regulat Bone Metab & Dis, Kwangju 501746, South Korea; [Kim, Taesoo; Lee, Seoung Hoon; Choi, Yongwon] Univ Penn, Sch Med, Dept Pathol, Philadelphia, PA 19104 USA; [Kim, Taesoo; Lee, Seoung Hoon; Choi, Yongwon] Univ Penn, Sch Med, Dept Lab Med, Philadelphia, PA 19104 USA; [Lee, Seoung Hoon] Wonkwang Univ, Sch Dent, Dept Oral Microbiol & Immunol, Iksan 570749, South Korea; [So, Hong-Seob] Wonkwang Univ, Sch Med, Vestibulocochlear Syst Res Ctr, Iksan 570749, Jeonbuk, South Korea; [So, Hong-Seob] Wonkwang Univ, Sch Med, Dept Microbiol, Iksan 570749, Jeonbuk, South Korea; [Lee, Junwon] Pai Chai Univ, Dept Life Sci & Genet Engn, Taejon 302725, South Korea	Chonnam National University; University of Pennsylvania; University of Pennsylvania; Wonkwang University; Wonkwang University; Wonkwang University; Pai Chai University	Kim, N (corresponding author), Chonnam Natl Univ, Sch Med, Med Res Ctr Gene Regulat, Natl Res Lab Regulat Bone Metab & Dis, Hak Dong 5, Kwangju 501746, South Korea.	nacksung@chonnam.ac.kr; ychoi3@mail.med.upenn.edu			National Institutes of Health [AR053843]; Korean government (MEST) [R0A-2007-000-20025-0]; Medical Research Center for Gene Regulation at Chonnam National University [R13-2002013-03001-0]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053843] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Medical Research Center for Gene Regulation at Chonnam National University; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AR053843 (to Y.C.) through the NIAMS. This work was also supported in part by the Korea Science and Engineering Foundation National Research Laboratory Program grant funded by the Korean government (MEST) (Grant R0A-2007-000-20025-0) (to N.K.) and Grant R13-2002013-03001-0 from the Korea Science and Engineering foundation through the Medical Research Center for Gene Regulation at Chonnam National University.	Ameye L, 2002, GLYCOBIOLOGY, V12, p107R, DOI 10.1093/glycob/cwf065; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Clark HF, 2003, GENOME RES, V13, P2265, DOI 10.1101/gr.1293003; Curtiss NP, 2005, GENOMICS, V85, P600, DOI 10.1016/j.ygeno.2005.01.013; Hirotani H, 2004, J BIOL CHEM, V279, P13984, DOI 10.1074/jbc.M213067200; Kearns AE, 2008, ENDOCR REV, V29, P155, DOI 10.1210/er.2007-0014; Kim D, 1996, BBA-GENE STRUCT EXPR, V1309, P183, DOI 10.1016/S0167-4781(96)00158-3; Kim K, 2005, J BIOL CHEM, V280, P35209, DOI 10.1074/jbc.M505815200; Kim K, 2007, J IMMUNOL, V178, P5588, DOI 10.4049/jimmunol.178.9.5588; Kim K, 2007, BLOOD, V109, P3253, DOI 10.1182/blood-2006-09-048249; Kim N, 2002, J EXP MED, V195, P201, DOI 10.1084/jem.20011681; Koga T, 2004, NATURE, V428, P758, DOI 10.1038/nature02444; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lee J, 2006, BLOOD, V107, P2686, DOI 10.1182/blood-2005-07-2798; Lee ZH, 2003, BIOCHEM BIOPH RES CO, V305, P211, DOI 10.1016/S0006-291X(03)00695-8; Mocsai A, 2004, P NATL ACAD SCI USA, V101, P6158, DOI 10.1073/pnas.0401602101; Simonet WS, 1997, CELL, V89, P309, DOI 10.1016/S0092-8674(00)80209-3; Suda T, 1997, METHOD ENZYMOL, V282, P223; Suda T, 1999, ENDOCR REV, V20, P345, DOI 10.1210/er.20.3.345; Takami M, 2002, J IMMUNOL, V169, P1516, DOI 10.4049/jimmunol.169.3.1516; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2005, J MOL MED, V83, P170, DOI 10.1007/s00109-004-0612-6; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Theoleyre S, 2004, CYTOKINE GROWTH F R, V15, P457, DOI 10.1016/j.cytogfr.2004.06.004; Waddington R. J., 2003, European Cells & Materials, V6, P12; Walsh MC, 2006, ANNU REV IMMUNOL, V24, P33, DOI 10.1146/annurev.immunol.24.021605.090646; Wong BR, 1997, J BIOL CHEM, V272, P25190, DOI 10.1074/jbc.272.40.25190; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597	29	29	31	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					15308	15316		10.1074/jbc.M807722200	http://dx.doi.org/10.1074/jbc.M807722200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19336404	Green Published, hybrid			2022-12-27	WOS:000266288200065
J	Kumar, S; Kostin, S; Flacke, JP; Reusch, HP; Ladilov, Y				Kumar, Sanjeev; Kostin, Sawa; Flacke, Jan-Paul; Reusch, H. Peter; Ladilov, Yury			Soluble Adenylyl Cyclase Controls Mitochondria-dependent Apoptosis in Coronary Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN PHOSPHATASE 2A; PERMEABILITY TRANSITION; CARDIAC MYOCYTES; CYCLIC-AMP; PH; ACTIVATION; BAX; HOMEOSTASIS; INHIBITION; ISCHEMIA	The cAMP signaling pathway plays an essential role in modulating the apoptotic response to various stress stimuli. Until now, it was attributed exclusively to the activity of the G-protein-responsive transmembrane adenylyl cyclase. In addition to transmembrane AC, mammalian cells possess a second source of cAMP, the ubiquitously expressed soluble adenylyl cyclase (sAC). However, the role of this cyclase in apoptosis was unknown. A mitochondrial localization of this cyclase has recently been demonstrated, which led us to the hypothesis that sAC may play a role in apoptosis through modulation of mitochondria-dependent apoptosis. To prove this hypothesis, apoptosis was induced by simulated in vitro ischemia or by acidosis, which is an important component of ischemia. Suppression of sAC activity with the selective inhibitor KH7 or sAC knockdown by small interfering RNA transfection abolished endothelial apoptosis. Furthermore, pharmacological inhibition or knockdown of protein kinase A, an important cAMP target, demonstrated a significant anti-apoptotic effect. Analysis of the underlying mechanisms revealed (i) the translocation of sAC to mitochondria under acidic stress and (ii) activation of the mitochondrial pathway of apoptosis, i. e. cytochrome c release and caspase-9 cleavage. sAC inhibition or knockdown abolished the activation of the mitochondrial pathway of apoptosis. Analysis of mitochondrial co-localization of Bcl-2 family proteins demonstrated sAC- and protein kinase A-dependent translocation of Bax to mitochondria. Taken together, these results suggest the important role of sAC in modulating the mitochondria-dependent pathway of apoptosis in endothelial cells.	[Ladilov, Yury] Ruhr Univ Bochum, Klin Pharmakol Abt, D-44801 Bochum, Germany; [Kostin, Sawa] Max Planck Inst Heart & Lung Res, D-61231 Bad Nauheim, Germany	Ruhr University Bochum; Max Planck Society	Ladilov, Y (corresponding author), Ruhr Univ Bochum, Klin Pharmakol Abt, Univ Str 150, D-44801 Bochum, Germany.	yury.ladilov@ruhr-uni-bochum.de	Ladilov, Yury/AAD-3547-2021; Kumar, Sanjeev/P-8547-2014; Ladilov, Yury/AAN-2603-2020	Kumar, Sanjeev/0000-0003-0562-2645; 	Deutsche Forschungsgemeinschaft [LA 1159/6-1]; Ruhr-Universitat Bochum [F620-08]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ruhr-Universitat Bochum	This work was supported by Grant LA 1159/6-1 from the Deutsche Forschungsgemeinschaft and by Forum Grant F620-08 from the Ruhr-Universitat Bochum.	Ando H, 1999, AM J PHYSIOL-HEART C, V276, pH1755, DOI 10.1152/ajpheart.1999.276.5.H1755; Aoyama K, 2005, J CEREBR BLOOD F MET, V25, P358, DOI 10.1038/sj.jcbfm.9600043; Arokium H, 2007, J BIOL CHEM, V282, P35104, DOI 10.1074/jbc.M704891200; Bombeli T, 1997, BLOOD, V89, P2429, DOI 10.1182/blood.V89.7.2429; Buck J, 1999, P NATL ACAD SCI USA, V96, P79, DOI 10.1073/pnas.96.1.79; Chen JW, 2004, CIRC RES, V94, P370, DOI 10.1161/01.RES.0000113782.07824.BE; Chen YQ, 2000, SCIENCE, V289, P625, DOI 10.1126/science.289.5479.625; D'Arcangelo D, 2000, CIRC RES, V86, P312, DOI 10.1161/01.RES.86.3.312; Desaubry L, 1996, J BIOL CHEM, V271, P2380, DOI 10.1074/jbc.271.5.2380; Er E, 2006, BBA-BIOENERGETICS, V1757, P1301, DOI 10.1016/j.bbabio.2006.05.032; Geng WD, 2005, AM J PHYSIOL-CELL PH, V288, pC1305, DOI 10.1152/ajpcell.00584.2004; GOTTLIEB RA, 1995, P NATL ACAD SCI USA, V92, P5965, DOI 10.1073/pnas.92.13.5965; Han H, 2005, J EXP MED, V202, P353, DOI 10.1084/jem.20050778; Hess KC, 2005, DEV CELL, V9, P249, DOI 10.1016/j.devcel.2005.06.007; Khabbaz KR, 2008, J THORAC CARDIOV SUR, V135, P139, DOI 10.1016/j.jtcvs.2007.07.035; Kumar S, 2007, J CELL MOL MED, V11, P798, DOI 10.1111/j.1582-4934.2007.00053.x; Kumar S, 2007, CARDIOVASC RES, V73, P172, DOI 10.1016/j.cardiores.2006.09.018; Kwak HJ, 2008, CELL SIGNAL, V20, P803, DOI 10.1016/j.cellsig.2007.12.011; Ladilov Y, 2000, CARDIOVASC RES, V47, P394, DOI 10.1016/S0008-6363(00)00108-5; Lagadic-Gossmann D, 2004, CELL DEATH DIFFER, V11, P953, DOI 10.1038/sj.cdd.4401466; Leone V, 2007, AM J PHYSIOL-GASTR L, V293, pG673, DOI 10.1152/ajpgi.00584.2006; Lou LG, 2002, J BIOL CHEM, V277, P32799, DOI 10.1074/jbc.M201491200; Moon EY, 2003, BLOOD, V101, P4122, DOI 10.1182/blood-2002-10-3208; Piper HM, 1990, CELL CULTURE TECHNIQ, P158; RUBIN CS, 1994, BBA-MOL CELL RES, V1224, P467; Rudolph JA, 2004, J BIOL CHEM, V279, P14828, DOI 10.1074/jbc.M310289200; Sayner SL, 2006, CIRC RES, V98, P675, DOI 10.1161/01.RES.0000209516.84815.3e; Scarabelli TM, 2002, CIRC RES, V90, P745, DOI 10.1161/01.RES.0000015224.07870.9A; SCOTT JD, 1990, J BIOL CHEM, V265, P21561; SIMMEN HP, 1993, AM J SURG, V166, P24, DOI 10.1016/S0002-9610(05)80576-8; Smith PG, 2005, BLOOD, V105, P308, DOI 10.1182/blood-2004-01-0240; Tafani M, 2002, J BIOL CHEM, V277, P49569, DOI 10.1074/jbc.M208915200; TANNOCK IF, 1989, CANCER RES, V49, P4373; Terminella C, 2002, AM J PHYSIOL-LUNG C, V283, pL1291, DOI 10.1152/ajplung.00246.2001; Thatte HS, 2004, ANN THORAC SURG, V77, P1376, DOI 10.1016/j.athoracsur.2003.07.047; Vander Heiden MG, 1999, NAT CELL BIOL, V1, pE209, DOI 10.1038/70237; VanderHeiden MG, 1997, CELL, V91, P627, DOI 10.1016/S0092-8674(00)80450-X; Webster KA, 1999, J CLIN INVEST, V104, P239; Weiss JN, 2003, CIRC RES, V93, P292, DOI 10.1161/01.RES.0000087542.26971.D4; Werner N, 2006, ARTERIOSCL THROM VAS, V26, P112, DOI 10.1161/01.ATV.0000191634.13057.15; Xin MG, 2006, J BIOL CHEM, V281, P18859, DOI 10.1074/jbc.M512543200; Young JJ, 2008, J NEUROSCI RES, V86, P118, DOI 10.1002/jnr.21458; YU HJ, 1995, FEBS LETT, V374, P89; Zhang LZ, 2004, J BIOL CHEM, V279, P20858, DOI 10.1074/jbc.M310643200; Zippin JH, 2002, FASEB J, V16, P82, DOI 10.1096/fj.02-0598fje	46	70	74	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					14760	14768		10.1074/jbc.M900925200	http://dx.doi.org/10.1074/jbc.M900925200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19336406	Green Published, hybrid			2022-12-27	WOS:000266288200011
J	Dixon, RM; Mellor, JR; Hanley, JG				Dixon, Rebecca M.; Mellor, Jack R.; Hanley, Jonathan G.			PICK1-mediated Glutamate Receptor Subunit 2 (GluR2) Trafficking Contributes to Cell Death in Oxygen/Glucose-deprived Hippocampal Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CA2+-PERMEABLE AMPA RECEPTORS; GLOBAL-ISCHEMIA; SYNAPTIC PLASTICITY; CA2+ PERMEABILITY; DOWN-REGULATION; PICK1; EXPRESSION; CALCIUM; BLOCKADE	Oxygen and glucose deprivation (OGD) induces delayed cell death in hippocampal CA1 neurons via Ca2+/Zn2+-permeable, GluR2-lacking AMPA receptors (AMPARs). Following OGD, synaptic AMPAR currents in hippocampal neurons show marked inward rectification and increased sensitivity to channel blockers selective for GluR2-lacking AMPARs. This occurs via two mechanisms: a delayed down-regulation of GluR2 mRNA expression and a rapid internalization of GluR2-containing AMPARs during the OGD insult, which are replaced by GluR2-lacking receptors. The mechanisms that underlie this rapid change in subunit composition are unknown. Here, we demonstrate that this trafficking event shares features in common with events that mediate long term depression and long term potentiation and is initiated by the activation of N-methyl-D-aspartic acid receptors. Using biochemical and electrophysiological approaches, we show that peptides that interfere with PICK1 PDZ domain interactions block the OGD-induced switch in subunit composition, implicating PICK1 in restricting GluR2 from synapses during OGD. Furthermore, we show that GluR2-lacking AMPARs that arise at synapses during OGD as a result of PICK1 PDZ interactions are involved in OGD-induced delayed cell death. This work demonstrates that PICK1 plays a crucial role in the response to OGD that results in altered synaptic transmission and neuronal death and has implications for our understanding of the molecular mechanisms that underlie cell death during stroke.	[Dixon, Rebecca M.; Mellor, Jack R.; Hanley, Jonathan G.] Univ Bristol, Dept Anat, Ctr Synapt Plast, MRC, Bristol BS8 1TD, Avon, England	University of Bristol	Hanley, JG (corresponding author), Univ Bristol, Dept Anat, Ctr Synapt Plast, MRC, Univ Walk, Bristol BS8 1TD, Avon, England.	jon.hanley@bristol.ac.uk	MELLOR, Jack/B-4548-2019	MELLOR, Jack/0000-0002-7706-8105; Hanley, Jonathan/0000-0003-1704-4707	The Wellcome Trust; Medical Research Council; European Neuroscience Institutes Network (ENI-NET); Medical Research Council [G120/838, G0601841B] Funding Source: researchfish; MRC [G120/838] Funding Source: UKRI	The Wellcome Trust(Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Neuroscience Institutes Network (ENI-NET); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work was funded by grants from The Wellcome Trust, the Medical Research Council, and European Neuroscience Institutes Network (ENI-NET).	Adesnik H, 2007, J NEUROSCI, V27, P4598, DOI 10.1523/JNEUROSCI.0325-07.2007; Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; CHOI DW, 1995, TRENDS NEUROSCI, V18, P58; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Cull-Candy S, 2006, CURR OPIN NEUROBIOL, V16, P288, DOI 10.1016/j.conb.2006.05.012; Daw MI, 2000, NEURON, V28, P873, DOI 10.1016/S0896-6273(00)00160-4; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; Dingledine R, 1999, PHARMACOL REV, V51, P7; Gardner SM, 2005, NEURON, V45, P903, DOI 10.1016/j.neuron.2005.02.026; Gorter JA, 1997, J NEUROSCI, V17, P6179; Greger IH, 2007, CURR OPIN NEUROBIOL, V17, P289, DOI 10.1016/j.conb.2007.04.007; Grooms SY, 2000, P NATL ACAD SCI USA, V97, P3631, DOI 10.1073/pnas.050586497; Hanley JG, 2005, EMBO J, V24, P3266, DOI 10.1038/sj.emboj.7600801; Hanley JG, 2002, NEURON, V34, P53, DOI 10.1016/S0896-6273(02)00638-4; Hanley JG, 2008, PHARMACOL THERAPEUT, V118, P152, DOI 10.1016/j.pharmthera.2008.02.002; Ho MTW, 2007, J NEUROSCI, V27, P11651, DOI 10.1523/JNEUROSCI.2671-07.2007; HOLLMANN M, 1991, SCIENCE, V252, P851, DOI 10.1126/science.1709304; Isaac JTR, 2007, NEURON, V54, P859, DOI 10.1016/j.neuron.2007.06.001; Iwakura Y, 2001, J BIOL CHEM, V276, P40025, DOI 10.1074/jbc.M103125200; Kim CH, 2001, P NATL ACAD SCI USA, V98, P11725, DOI 10.1073/pnas.211132798; KIRINO T, 1982, BRAIN RES, V239, P57, DOI 10.1016/0006-8993(82)90833-2; Liu BS, 2006, J NEUROSCI, V26, P5309, DOI 10.1523/JNEUROSCI.0567-06.2006; Liu SH, 2004, NEURON, V43, P43, DOI 10.1016/j.neuron.2004.06.017; Liu SJ, 2007, TRENDS NEUROSCI, V30, P126, DOI 10.1016/j.tins.2007.01.006; Liu SQJ, 2005, NAT NEUROSCI, V8, P768, DOI 10.1038/nn1468; Noh KM, 2005, P NATL ACAD SCI USA, V102, P12230, DOI 10.1073/pnas.0505408102; PellegriniGiampietro DE, 1997, TRENDS NEUROSCI, V20, P464, DOI 10.1016/S0166-2236(97)01100-4; PELLEGRINIGIAMPIETRO DE, 1992, P NATL ACAD SCI USA, V89, P10499, DOI 10.1073/pnas.89.21.10499; Plant K, 2006, NAT NEUROSCI, V9, P602, DOI 10.1038/nn1678; PULSINELLI WA, 1982, ANN NEUROL, V11, P491, DOI 10.1002/ana.410110509; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Tanaka H, 2000, BRAIN RES, V886, P190, DOI 10.1016/S0006-8993(00)02951-6; Terashima A, 2004, J NEUROSCI, V24, P5381, DOI 10.1523/JNEUROSCI.4378-03.2004; Terashima A, 2008, NEURON, V57, P872, DOI 10.1016/j.neuron.2008.01.028; TSUBOKAWA H, 1995, J NEUROPHYSIOL, V74, P218, DOI 10.1152/jn.1995.74.1.218; Yin HZ, 2002, J NEUROSCI, V22, P1273, DOI 10.1523/JNEUROSCI.22-04-01273.2002; Ying HS, 1997, J NEUROSCI, V17, P9536	37	55	58	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14230	14235		10.1074/jbc.M901203200	http://dx.doi.org/10.1074/jbc.M901203200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19321442	Green Published, hybrid			2022-12-27	WOS:000266286100029
J	Saita, S; Shirane, M; Natume, T; Iemura, S; Nakayama, KI				Saita, Shotaro; Shirane, Michiko; Natume, Tohru; Iemura, Shun-ichiro; Nakayama, Keiichi I.			Promotion of Neurite Extension by Protrudin Requires Its Interaction with Vesicle-associated Membrane Protein-associated Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; LIPID-BINDING PROTEINS; ENDOPLASMIC-RETICULUM; FFAT MOTIF; VAP; TRAFFICKING; MUTATION; FKBP38; VAMP; IMMUNOPHILINS	Protrudin is a protein that contains a Rab11-binding domain and a FYVE (lipid-binding) domain and that functions to promote neurite formation through interaction with the GDP-bound form of Rab11. Protrudin also contains a short sequence motif designated FFAT (two phenylalanines in an acidic tract), which in other proteins has been shown to mediate binding to vesicle-associated membrane protein-associated protein (VAP). We now show that protrudin associates and colocalizes with VAP-A, an isoform of VAP expressed in the endoplasmic reticulum. Both the interaction between protrudin and VAP-A as well as the induction of process formation by protrudin were markedly inhibited by mutation of the FFAT motif. Furthermore, depletion of VAP-A by RNA interference resulted in mislocalization of protrudin as well as in inhibition of neurite outgrowth induced by nerve growth factor in rat pheochromocytoma PC12 cells. These defects resulting from depletion of endogenous rat VAP-A in PC12 cells were corrected by forced expression of (RNA interference-resistant) human VAP-A but not by VAP-A mutants that have lost the ability to interact with protrudin. These results suggest that VAP-A is an important regulator both of the subcellular localization of protrudin and of its ability to stimulate neurite outgrowth.	[Saita, Shotaro; Shirane, Michiko; Nakayama, Keiichi I.] Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, Fukuoka 8128582, Japan; [Saita, Shotaro; Shirane, Michiko; Nakayama, Keiichi I.] Japan Sci & Technol Corp, CREST, Kawaguchi, Saitama 3320012, Japan; [Natume, Tohru; Iemura, Shun-ichiro] Natl Inst Adv Ind Sci, Kohtoh Ku, Tokyo 1350064, Japan	Kyushu University; Japan Science & Technology Agency (JST); National Institute of Advanced Industrial Science & Technology (AIST)	Nakayama, KI (corresponding author), Kyushu Univ, Med Inst Bioregulat, Dept Mol & Cellular Biol, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	nakayak1@bioreg.kyushu-u.ac.jp	Natsume, Tohru/M-7627-2018	Natsume, Tohru/0000-0002-1510-2582; Saita, Shotaro/0000-0002-7406-8361; Shirane, Michiko/0000-0002-8297-9245	Grants-in-Aid for Scientific Research [20670003] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Amarilio R, 2005, J BIOL CHEM, V280, P5934, DOI 10.1074/jbc.M409566200; Barik S, 2006, CELL MOL LIFE SCI, V63, P2889, DOI 10.1007/s00018-006-6215-3; Davies TH, 2005, INT J BIOCHEM CELL B, V37, P42, DOI 10.1016/j.biocel.2004.03.013; Favaloro V, 2008, J CELL SCI, V121, P1832, DOI 10.1242/jcs.020321; Foster LJ, 2000, AM J PHYSIOL-CELL PH, V279, pC877, DOI 10.1152/ajpcell.2000.279.4.C877; FREEDMAN RB, 1994, TRENDS BIOCHEM SCI, V19, P331, DOI 10.1016/0968-0004(94)90072-8; Gillooly DJ, 2001, BIOCHEM J, V355, P249, DOI 10.1042/0264-6021:3550249; Hamilton GS, 1998, J MED CHEM, V41, P5119, DOI 10.1021/jm980307x; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Kagiwada S, 1998, J BACTERIOL, V180, P1700, DOI 10.1128/JB.180.7.1700-1708.1998; Kaiser SE, 2005, STRUCTURE, V13, P1035, DOI 10.1016/j.str.2005.04.010; Kanekura K, 2006, J BIOL CHEM, V281, P30223, DOI 10.1074/jbc.M605049200; Kawano M, 2006, J BIOL CHEM, V281, P30279, DOI 10.1074/jbc.M605032200; Lapierre LA, 1999, J CELL SCI, V112, P3723; Loewen CJR, 2005, J BIOL CHEM, V280, P14097, DOI 10.1074/jbc.M500147200; Loewen CJR, 2003, EMBO J, V22, P2025, DOI 10.1093/emboj/cdg201; Mannan AU, 2006, AM J HUM GENET, V79, P351, DOI 10.1086/504927; Mitne-Neto M, 2007, PROTEIN EXPRES PURIF, V55, P139, DOI 10.1016/j.pep.2007.04.007; Nakagawa T, 2007, GENES CELLS, V12, P709, DOI 10.1111/j.1365-2443.2007.01086.x; Natsume T, 2002, ANAL CHEM, V74, P4725, DOI 10.1021/ac020018n; Nishimura AL, 2004, AM J HUM GENET, V75, P822, DOI 10.1086/425287; Nishimura Y, 1999, BIOCHEM BIOPH RES CO, V254, P21, DOI 10.1006/bbrc.1998.9876; Pelham HRB, 1996, CELL STRUCT FUNCT, V21, P413, DOI 10.1247/csf.21.413; Pennetta G, 2002, NEURON, V35, P291, DOI 10.1016/S0896-6273(02)00769-9; Salinas S, 2007, J NEUROSCI RES, V85, P2778, DOI 10.1002/jnr.21238; Shirane M, 2003, NAT CELL BIOL, V5, P28, DOI 10.1038/ncb894; Shirane M, 2008, GENES CELLS, V13, P635, DOI 10.1111/j.1365-2443.2008.01194.x; Shirane M, 2006, SCIENCE, V314, P818, DOI 10.1126/science.1134027; Skehel PA, 2000, P NATL ACAD SCI USA, V97, P1101, DOI 10.1073/pnas.97.3.1101; Soussan L, 1999, J CELL BIOL, V146, P301, DOI 10.1083/jcb.146.2.301; Takenawa T, 2006, IUBMB LIFE, V58, P296, DOI 10.1080/15216540600732039; Teuling E, 2007, J NEUROSCI, V27, P9801, DOI 10.1523/JNEUROSCI.2661-07.2007; Weir ML, 1998, BIOCHEM J, V333, P247, DOI 10.1042/bj3330247; Wyles JP, 2002, J BIOL CHEM, V277, P29908, DOI 10.1074/jbc.M201191200; Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055	35	68	73	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13766	13777		10.1074/jbc.M807938200	http://dx.doi.org/10.1074/jbc.M807938200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19289470	hybrid, Green Published			2022-12-27	WOS:000265877300054
J	Shigemoto, T; Kageyama, M; Hirai, R; Zheng, JP; Yoneyama, M; Fujita, T				Shigemoto, Taeko; Kageyama, Maiko; Hirai, Reiko; Zheng, JiPing; Yoneyama, Mitsutoshi; Fujita, Takashi			Identification of Loss of Function Mutations in Human Genes Encoding RIG-I and MDA5 IMPLICATIONS FOR RESISTANCE TO TYPE I DIABETES	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIVIRAL RESPONSES; INNATE IMMUNITY; RNA; RECOGNITION; HELICASE; MECHANISM; DOMAIN; ACID; LGP2	Retinoic acid-inducible gene I (RIG-I) and melanoma differentiation-associated gene 5 (MDA5) are essential for detecting viral RNA and triggering antiviral responses, including production of type I interferon. We analyzed the phenotype of non-synonymous mutants of human RIG-I and MDA5 reported in databases by functional complementation in cell cultures. Of seven missense mutations of RIG-I, S183I, which occurs within the second caspase recruitment domain repeat, inactivated this domain and conferred a dominant inhibitory function. Of 10 mutants of MDA5, two exhibited loss of function. A nonsense mutation, E627*, resulted in deletion of the C-terminal region and double-stranded RNA (dsRNA) binding activity. Another loss of function mutation, I923V, which occurs within the C-terminal domain, did not affect dsRNA binding activity, suggesting a novel and essential role for this residue in the signaling. Remarkably, these mutations are implicated in resistance to type I diabetes. However, the A946T mutation of MDA5, which has been implicated in type I diabetes by previous genetic analyses, affected neither dsRNA binding nor IFN gene activation. These results provide new insights into the structure-function relationship of RIG-I-like receptors as well as into human RIG-I-like receptor polymorphisms, antiviral innate immunity, and autoimmune diseases.	[Shigemoto, Taeko; Kageyama, Maiko; Hirai, Reiko; Zheng, JiPing; Yoneyama, Mitsutoshi; Fujita, Takashi] Kyoto Univ, Mol Genet Lab, Inst Virus Res, Kyoto 6068507, Japan; [Shigemoto, Taeko; Kageyama, Maiko; Yoneyama, Mitsutoshi; Fujita, Takashi] Kyoto Univ, Grad Sch Biostudies, Mol Cell Biol Lab, Kyoto 6068507, Japan; [Yoneyama, Mitsutoshi] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	Kyoto University; Kyoto University; Japan Science & Technology Agency (JST)	Fujita, T (corresponding author), Kyoto Univ, Mol Genet Lab, Inst Virus Res, Kyoto 6068507, Japan.	tfujita@virus.kyoto-u.ac.jp	Yoneyama, Mitsutoshi/D-8244-2017	Yoneyama, Mitsutoshi/0000-0001-9512-0408; zheng, ji ping/0000-0002-7393-8054	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Science and Technology Agency; Mochida Memorial Foundation for Medical Pharmaceutical Research; Nippon Boehringer Ingelheim	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Mochida Memorial Foundation for Medical Pharmaceutical Research; Nippon Boehringer Ingelheim(Boehringer Ingelheim)	This work was supported by grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan, Japan Science and Technology Agency, The Mochida Memorial Foundation for Medical Pharmaceutical Research, and Nippon Boehringer Ingelheim.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Li XJ, 2009, J BIOL CHEM, V284, P13881, DOI 10.1074/jbc.M900818200; NEJENTSEV S, 2009, SCIENCE         0305, DOI DOI 10.1126/SCIENCE.1167728; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2008, IMMUNITY, V29, P178, DOI 10.1016/j.immuni.2008.07.009	17	116	118	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13348	13354		10.1074/jbc.M809449200	http://dx.doi.org/10.1074/jbc.M809449200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19324880	Green Published, hybrid			2022-12-27	WOS:000265877300010
J	Sudhaharan, T; Liu, P; Foo, YH; Bu, WY; Lim, KB; Wohland, T; Ahmed, S				Sudhaharan, Thankiah; Liu, Ping; Foo, Yong Hwee; Bu, Wenyu; Lim, Kim Buay; Wohland, Thorsten; Ahmed, Sohail			Determination of in Vivo Dissociation Constant, K-D, of Cdc42-Effector Complexes in Live Mammalian Cells Using Single Wavelength Fluorescence Cross-correlation Spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIVING CELLS; RHO-GTPASES; PROTEINS; CDC42; BIOLOGY; BINDING; ACTIN	The RhoGTPase Cdc42 coordinates cell morphogenesis, cell cycle, and cell polarity decisions downstream of membrane-bound receptors through distinct effector pathways. Cdc42-effector protein interactions represent important elements of cell signaling pathways that regulate cell biology in systems as diverse as yeast and humans. To derive mechanistic insights into cell signaling pathways, it is vital that we generate quantitative data from in vivo systems. We need to be able to measure parameters such as protein concentrations, rates of diffusion, and dissociation constants (K-D) of protein-protein interactions in vivo. Here we show how single wavelength fluorescence cross-correlation spectroscopy in combination with Forster resonance energy transfer analysis can be used to determine K-D of Cdc42-effector interactions in live mammalian cells. Constructs encoding green fluorescent protein or monomeric red fluorescent protein fusion proteins of Cdc42, an effector domain (CRIB), and two effectors, neural Wiskott-Aldrich syndrome protein (N-WASP) and insulin receptor substrate protein (IRSp53), were expressed as pairs in Chinese hamster ovary cells, and concentrations of free protein as well as complexed protein were determined. The measured K-D for Cdc42V12-N-WASP, Cdc42V12-CRIB, and Cdc42V12-IRSp53 was 27, 250, and 391 nM, respectively. The determination of K-D for Cdc42-effector interactions opens the way to describe cell signaling pathways quantitatively in vivo in mammalian cells.	[Sudhaharan, Thankiah; Foo, Yong Hwee; Bu, Wenyu; Lim, Kim Buay; Ahmed, Sohail] Inst Med Biol, Singapore 138665, Singapore; [Liu, Ping; Foo, Yong Hwee; Wohland, Thorsten] Natl Univ Singapore, Dept Chem, Singapore 117543, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); National University of Singapore	Ahmed, S (corresponding author), Inst Med Biol, 8A Biomed Grove, Singapore 138665, Singapore.	sohail.ahmed@imb.a-star.edu.sg	Wohland, Thorsten/H-8285-2012; WOHLAND, THORSTEN/R-6404-2019	Wohland, Thorsten/0000-0002-0148-4321; Foo, Yong Hwee/0000-0003-2337-469X	Singapore Bioimaging Consortium [SBIC 003/2005]	Singapore Bioimaging Consortium(Agency for Science Technology & Research (A*STAR))	This work was supported by Singapore Bioimaging Consortium Grant SBIC 003/2005.	Bacia K, 2006, NAT METHODS, V3, P83, DOI 10.1038/NMETH822; Bacia K, 2002, BIOPHYS J, V83, P1184, DOI 10.1016/S0006-3495(02)75242-9; Briddon SJ, 2007, TRENDS PHARMACOL SCI, V28, P637, DOI 10.1016/j.tips.2007.09.008; BURBELO PD, 1995, J BIOL CHEM, V270, P29071, DOI 10.1074/jbc.270.49.29071; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Clayton AHA, 2005, J BIOL CHEM, V280, P30392, DOI 10.1074/jbc.M504770200; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; GOLDMAN R, 2005, LIVE CELL IMAGING LA; Govind S, 2001, J CELL BIOL, V152, P579, DOI 10.1083/jcb.152.3.579; HART MJ, 1991, NATURE, V354, P311, DOI 10.1038/354311a0; Hein R, 1996, CURR BIOL, V6, P178, DOI 10.1016/S0960-9822(02)00450-5; Herrick-Davis K, 2006, J BIOL CHEM, V281, P27109, DOI 10.1074/jbc.M604390200; Hillesheim LN, 2006, BIOPHYS J, V91, P4273, DOI 10.1529/biophysj.106.085845; Hwang LC, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1862614; Hwang LC, 2006, BIOPHYS J, V91, P715, DOI 10.1529/biophysj.105.074120; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jahnz M, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni060; Lim KB, 2008, J BIOL CHEM, V283, P20454, DOI 10.1074/jbc.M710185200; Liu P, 2008, TRENDS ENDOCRIN MET, V19, P181, DOI 10.1016/j.tem.2008.02.004; Liu P, 2007, BIOPHYS J, V93, P684, DOI 10.1529/biophysj.106.102087; Maeder CI, 2007, NAT CELL BIOL, V9, P1319, DOI 10.1038/ncb1652; MAGDE D, 1974, BIOPOLYMERS, V13, P29, DOI 10.1002/bip.1974.360130103; Nevins AK, 2005, J BIOL CHEM, V280, P1944, DOI 10.1074/jbc.M409528200; Owen D, 2000, BIOCHEMISTRY-US, V39, P1243, DOI 10.1021/bi991567z; Peter M, 2005, BIOPHYS J, V88, P1224, DOI 10.1529/biophysj.104.050153; Slaughter BD, 2007, P NATL ACAD SCI USA, V104, P20320, DOI 10.1073/pnas.0710336105; Zhang SF, 2004, CELL, V119, P137, DOI 10.1016/j.cell.2004.09.012	28	45	46	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13602	13609		10.1074/jbc.M900894200	http://dx.doi.org/10.1074/jbc.M900894200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19293156	hybrid, Green Published			2022-12-27	WOS:000265877300037
J	Frost, B; Jacks, RL; Diamond, MI				Frost, Bess; Jacks, Rachel L.; Diamond, Marc I.			Propagation of Tau Misfolding from the Outside to the Inside of a Cell	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PAIRED HELICAL FILAMENTS; ALZHEIMERS-DISEASE; NEURONAL CELLS; NEUROFIBRILLARY DEGENERATION; FRONTOTEMPORAL DEMENTIA; EXTRACELLULAR TAU; MAMMALIAN-CELLS; PROTEIN; TAUOPATHIES; ASSOCIATION	Tauopathies are neurodegenerative diseases characterized by aggregation of the microtubule-associated protein Tau in neurons and glia. Although Tau is normally considered an intracellular protein, Tau aggregates are observed in the extracellular space, and Tau peptide is readily detected in the cerebrospinal fluid of patients. Tau aggregation occurs in many diseases, including Alzheimer disease and frontotemporal dementia. Tau pathology begins in discrete, disease-specific regions but eventually involves much larger areas of the brain. It is unknown how this propagation of Tau misfolding occurs. We hypothesize that extracellular Tau aggregates can transmit a misfolded state from the outside to the inside of a cell, similar to prions. Here we show that extracellular Tau aggregates, but not monomer, are taken up by cultured cells. Internalized Tau aggregates displace tubulin, co-localize with dextran, a marker of fluid-phase endocytosis, and induce fibrillization of intracellular full-length Tau. These intracellular fibrils are competent to seed fibril formation of recombinant Tau monomer in vitro. Finally, we observed that newly aggregated intracellular Tau transfers between co-cultured cells. Our data indicate that Tau aggregates can propagate a fibrillar, misfolded state from the outside to the inside of a cell. This may have important implications for understanding how protein misfolding spreads through the brains of tauopathy patients, and it is potentially relevant to myriad neurodegenerative diseases associated with protein misfolding.	[Frost, Bess; Jacks, Rachel L.; Diamond, Marc I.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Diamond, Marc I.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Frost, Bess; Jacks, Rachel L.; Diamond, Marc I.] Univ Calif San Francisco, Program Biomed Sci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Diamond, MI (corresponding author), GH-S572B 600 16th St, San Francisco, CA 94143 USA.	marc.diamond@ucsf.edu		Frost, Bess/0000-0002-1212-8138	NINDS NIH HHS [R01 NS50284-03] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS050284] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; Arnold SE, 1991, CEREB CORTEX, V1, P103, DOI 10.1093/cercor/1.1.103; Asuni AA, 2007, J NEUROSCI, V27, P9115, DOI 10.1523/JNEUROSCI.2361-07.2007; Braak H, 1997, NEUROBIOL AGING, V18, P351, DOI 10.1016/S0197-4580(97)00056-0; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Delacourte A, 2005, FOLIA NEUROPATHOL, V43, P244; Delacourte A, 1999, NEUROLOGY, V52, P1158, DOI 10.1212/WNL.52.6.1158; DePace AH, 2002, NAT STRUCT BIOL, V9, P389, DOI 10.1038/nsb786; ENDOH R, 1993, BRAIN RES, V601, P164, DOI 10.1016/0006-8993(93)91707-Y; Fevrier B, 2004, P NATL ACAD SCI USA, V101, P9683, DOI 10.1073/pnas.0308413101; Friedhoff P, 1998, P NATL ACAD SCI USA, V95, P15712, DOI 10.1073/pnas.95.26.15712; Frost B, 2009, J BIOL CHEM, V284, P3546, DOI 10.1074/jbc.M805627200; GOEDERT M, 1990, EMBO J, V9, P4225, DOI 10.1002/j.1460-2075.1990.tb07870.x; Gomez-Ramos A, 2008, MOL CELL NEUROSCI, V37, P673, DOI 10.1016/j.mcn.2007.12.010; Gomez-Ramos A, 2006, FEBS LETT, V580, P4842, DOI 10.1016/j.febslet.2006.07.078; GREENBERG SG, 1990, P NATL ACAD SCI USA, V87, P5827, DOI 10.1073/pnas.87.15.5827; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Kanu N, 2002, CURR BIOL, V12, P523, DOI 10.1016/S0960-9822(02)00722-4; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; King ME, 2006, J CELL BIOL, V175, P541, DOI 10.1083/jcb.200605187; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Liu W, 2004, NEUROLOGY, V62, P742, DOI 10.1212/01.WNL.0000113729.77161.C9; Magalhaes AC, 2005, J NEUROSCI, V25, P5207, DOI 10.1523/JNEUROSCI.0653-05.2005; Poorkaj P, 1998, ANN NEUROL, V43, P815, DOI 10.1002/ana.410430617; Ren PH, 2009, NAT CELL BIOL, V11, P219, DOI 10.1038/ncb1830; RYDER EF, 1990, J NEUROBIOL, V21, P356, DOI 10.1002/neu.480210209; Sergeant N, 1999, J NEUROCHEM, V72, P1243, DOI 10.1046/j.1471-4159.1999.0721243.x; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P7737, DOI 10.1073/pnas.95.13.7737; TRINCZEK B, 1995, MOL BIOL CELL, V6, P1887, DOI 10.1091/mbc.6.12.1887; VANDERMEEREN M, 1993, J NEUROCHEM, V61, P1828, DOI 10.1111/j.1471-4159.1993.tb09823.x; WEINGARTEN MD, 1975, P NATL ACAD SCI USA, V72, P1858, DOI 10.1073/pnas.72.5.1858; Yang W, 2002, HUM MOL GENET, V11, P2905, DOI 10.1093/hmg/11.23.2905	32	817	851	2	135	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12845	12852		10.1074/jbc.M808759200	http://dx.doi.org/10.1074/jbc.M808759200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19282288	Green Published, hybrid			2022-12-27	WOS:000265688300030
J	Zhang, YQ; Rosado, LAR; Moon, SY; Zhang, BL				Zhang, Yaqin; Rosado, Leslie A. Rivera; Moon, Sun Young; Zhang, Baolin			Silencing of D4-GDI Inhibits Growth and Invasive Behavior in MDA-MB-231 Cells by Activation of Rac-dependent p38 and JNK Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; GDP-DISSOCIATION INHIBITOR; N-TERMINAL KINASE; DRUG-INDUCED APOPTOSIS; GTP-BINDING PROTEINS; HUMAN LYMPHOMA-CELLS; RHO-GTPASES; EPITHELIAL-CELLS; GENE-EXPRESSION; OVARIAN-CARCINOMA	The Rho GDP dissociation inhibitor D4-GDI is overexpressed in some human breast cancer cell lines (Zhang, Y., and Zhang, B. (2006) Cancer Res. 66, 5592-5598). Here, we show that silencing of D4-GDI by RNA interference abrogates tumor growth and lung metastasis of otherwise highly invasive MDA-MB-231 breast cancer cells. Under anchorage-independent culture conditions, D4-GDI-depleted cells undergo rapid apoptosis (anoikis), which is known to hinder metastasis. We also found that D4-GDI associates with Rac1 and Rac3 in breast cancer cells, but not with other Rho GTPases tested (Cdc42, RhoA, RhoC, and TC10). Silencing of D4-GDI results in constitutive Rac1 activation and translocation from the cytosol to cellular membrane compartments and in sustained activation of p38 and JNK kinases. Rac1 blockade inhibits p38/JNK kinase activities and the spontaneous anoikis of D4-GDI knockdown cells. These results suggest that D4-GDI regulates cell function by interacting primarily with Rac GTPases and may play an integral role in breast cancer tumorigenesis. D4-GDI could prove to be a potential new target for therapeutic intervention.	[Zhang, Yaqin; Rosado, Leslie A. Rivera; Moon, Sun Young; Zhang, Baolin] US FDA, Ctr Drug Evaluat & Res, Off Biotechnol, Div Therapeut Prot, Bethesda, MD 20892 USA	US Food & Drug Administration (FDA)	Zhang, BL (corresponding author), US FDA, Ctr Drug Evaluat & Res, Off Biotechnol, Div Therapeut Prot, Bldg 29A,Rm 2A01,HFD-122,29 Lincoln Dr, Bethesda, MD 20892 USA.	Baolin.zhang@fda.hhs.gov						Baugher PJ, 2005, BREAST CANCER RES, V7, pR965, DOI 10.1186/bcr1329; Benitah SA, 2004, BBA-REV CANCER, V1705, P121, DOI 10.1016/j.bbcan.2004.10.002; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Brenner B, 1997, J BIOL CHEM, V272, P22173, DOI 10.1074/jbc.272.35.22173; Chan AY, 2005, ONCOGENE, V24, P7821, DOI 10.1038/sj.onc.1208909; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Cheng TL, 2004, EXP CELL RES, V295, P497, DOI 10.1016/j.yexcr.2004.02.002; Coniglio SJ, 2001, J BIOL CHEM, V276, P28113, DOI 10.1074/jbc.M102299200; Coopman PJP, 2000, NATURE, V406, P742, DOI 10.1038/35021086; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; Dransart E, 2005, J BIOL CHEM, V280, P4674, DOI 10.1074/jbc.M409741200; Eifel P, 2001, JNCI-J NATL CANCER I, V93, P979; Ellenbroek SIJ, 2007, CLIN EXP METASTAS, V24, P657, DOI 10.1007/s10585-007-9119-1; Embade N, 2000, MOL BIOL CELL, V11, P4347, DOI 10.1091/mbc.11.12.4347; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Gildea JJ, 2002, CANCER RES, V62, P6418; Han HJ, 2008, NATURE, V452, P187, DOI 10.1038/nature06781; Harrington AW, 2002, J NEUROSCI, V22, P156, DOI 10.1523/JNEUROSCI.22-01-00156.2002; Hordijk PL, 1997, SCIENCE, V278, P1464, DOI 10.1126/science.278.5342.1464; Hu LD, 2007, ONCOL REP, V17, P1383; Hwang SY, 2006, INT J CANCER, V118, P2056, DOI 10.1002/ijc.21574; Jiang P, 2008, CANCER RES, V68, P1310, DOI 10.1158/0008-5472.CAN-07-5111; Jiang WG, 2003, CLIN CANCER RES, V9, P6432; Jin S, 2006, AM J PHYSIOL-GASTR L, V291, pG1137, DOI 10.1152/ajpgi.00031.2006; Kallergi G, 2007, CELL PHYSIOL BIOCHEM, V20, P977, DOI 10.1159/000110458; Lee JC, 1999, PHARMACOL THERAPEUT, V82, P389, DOI 10.1016/S0163-7258(99)00008-X; LELIAS JM, 1993, P NATL ACAD SCI USA, V90, P1479, DOI 10.1073/pnas.90.4.1479; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Ma L, 2007, BRIT J HAEMATOL, V139, P217, DOI 10.1111/j.1365-2141.2007.06782.x; Mansouri A, 2003, J BIOL CHEM, V278, P19245, DOI 10.1074/jbc.M208134200; Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111; MICHIELS F, 1995, NATURE, V375, P338, DOI 10.1038/375338a0; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Mira JP, 2000, P NATL ACAD SCI USA, V97, P185, DOI 10.1073/pnas.97.1.185; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Ota T, 2004, MOL CARCINOGEN, V39, P206, DOI 10.1002/mc.20006; Ota T, 2006, CLIN EXP METASTAS, V23, P323, DOI 10.1007/s10585-006-9041-y; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Ridley AJ, 2004, BREAST CANCER RES TR, V84, P13, DOI 10.1023/B:BREA.0000018423.47497.c6; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; SCHERLE P, 1993, P NATL ACAD SCI USA, V90, P7568, DOI 10.1073/pnas.90.16.7568; Schunke D, 2007, CANCER RES, V67, P10694, DOI 10.1158/0008-5472.CAN-07-1621; Sun D, 2006, DRUG RESIST UPDATE, V9, P274, DOI 10.1016/j.drup.2006.12.001; Tang Y, 2008, FRONT BIOSCI-LANDMRK, V13, P759, DOI 10.2741/2718; Tapper J, 2001, CANCER GENET CYTOGEN, V128, P1, DOI 10.1016/S0165-4608(01)00386-7; Theodorescu D, 2004, CLIN CANCER RES, V10, P3800, DOI 10.1158/1078-0432.CCR-03-0653; Thorat MA, 2007, LANCET, V369, P1428, DOI 10.1016/S0140-6736(07)60663-1; Valentijn AJ, 2004, BIOCHEM SOC T, V32, P421, DOI 10.1042/BST0320421; van Golen KL, 2000, CANCER RES, V60, P5832; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Yagita H, 2004, CANCER SCI, V95, P777, DOI 10.1111/j.1349-7006.2004.tb02181.x; Zhang BL, 2006, DRUG RESIST UPDATE, V9, P134, DOI 10.1016/j.drup.2006.06.001; Zhang BL, 2005, CANCER RES, V65, P6054, DOI 10.1158/0008-5472.CAN-05-0175; Zhang BL, 2004, MOL CELL BIOL, V24, P6205, DOI 10.1128/MCB.24.14.6205-6214.2004; Zhang BL, 2003, MOL CELL BIOL, V23, P5716, DOI 10.1128/MCB.23.16.5716-5725.2003; Zhang YQ, 2006, CANCER RES, V66, P5592, DOI 10.1158/0008-5472.CAN-05-4004; Zhu ZY, 2001, CANCER RES, V61, P1707; Zugasti O, 2001, MOL CELL BIOL, V21, P6706, DOI 10.1128/MCB.21.19.6706-6717.2001; Zuo YF, 2006, BIOCHEM BIOPH RES CO, V351, P361, DOI 10.1016/j.bbrc.2006.10.043	60	48	53	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12956	12965		10.1074/jbc.M807845200	http://dx.doi.org/10.1074/jbc.M807845200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19269969	Green Published, hybrid			2022-12-27	WOS:000265688300042
J	Lin, HM; Lee, JH; Yadav, H; Kamaraju, AK; Liu, E; Duan, ZG; Vieira, A; Kim, SJ; Collins, H; Matschinsky, F; Harlan, DM; Roberts, AB; Rane, SG				Lin, Huei-Min; Lee, Ji-Hyeon; Yadav, Hariom; Kamaraju, Anil K.; Liu, Eric; Duan Zhigang; Vieira, Anthony; Kim, Seong-Jin; Collins, Heather; Matschinsky, Franz; Harlan, David M.; Roberts, Anita B.; Rane, Sushil G.			Transforming Growth Factor-beta/Smad3 Signaling Regulates Insulin Gene Transcription and Pancreatic Islet beta-Cell Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMAD BINDING-ELEMENT; TGF-BETA; TARGETED DISRUPTION; EXOCRINE PANCREAS; RECEPTOR; SECRETION; PROMOTER; REPRESSION; EXPRESSION; ACTIVIN	Pancreatic islet beta-cell dysfunction is a signature feature of Type 2 diabetes pathogenesis. Consequently, knowledge of signals that regulate beta-cell function is of immense clinical relevance. Transforming growth factor (TGF)-beta signaling plays a critical role in pancreatic development although the role of this pathway in the adult pancreas is obscure. Here, we define an important role of the TGF-beta pathway in regulation of insulin gene transcription and beta-cell function. We identify insulin as a TGF-beta target gene and show that the TGF-beta signaling effector Smad3 occupies the insulin gene promoter and represses insulin gene transcription. In contrast, Smad3 small interfering RNAs relieve insulin transcriptional repression and enhance insulin levels. Transduction of adenoviral Smad3 into primary human and non-human primate islets suppresses insulin content, whereas, dominant-negative Smad3 enhances insulin levels. Consistent with this, Smad3-deficient mice exhibit moderate hyperinsulinemia and mild hypoglycemia. Moreover, Smad3 deficiency results in improved glucose tolerance and enhanced glucose-stimulated insulin secretion in vivo. In ex vivo perifusion assays, Smad3-deficient islets exhibit improved glucose-stimulated insulin release. Interestingly, Smad3-deficient islets harbor an activated insulin-receptor signaling pathway and TGF-beta signaling regulates expression of genes involved in beta-cell function. Together, these studies emphasize TGF-beta/Smad3 signaling as an important regulator of insulin gene transcription and beta-cell function and suggest that components of the TGF-beta signaling pathway may be dysregulated in diabetes.	[Lin, Huei-Min; Lee, Ji-Hyeon; Yadav, Hariom; Kamaraju, Anil K.; Liu, Eric; Duan Zhigang; Harlan, David M.; Rane, Sushil G.] NIDDK, Diabet Branch, Bethesda, MD 20892 USA; [Vieira, Anthony; Roberts, Anita B.] NCI, Lab Cell Regulat & Carcinogenesis, NIH, Bethesda, MD 20892 USA; [Kim, Seong-Jin] Gachon Univ Med & Sci, Lee Gil Ya Canc & Diabet Inst, Songdo 406840, Incheon, South Korea; [Collins, Heather; Matschinsky, Franz] Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Gachon University; University of Pennsylvania	Rane, SG (corresponding author), CRC, 5-5940,10 Ctr Dr, Bethesda, MD 20892 USA.	ranes@mail.nih.gov	Yadav, Hariom/I-2455-2018	Yadav, Hariom/0000-0003-4504-1597	National Institutes of Health Intramural Program; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK055106, ZIADK055105, ZIADK062002, Z01DK062002, Z01DK055106] Funding Source: NIH RePORTER	National Institutes of Health Intramural Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Program.	Araki K, 2003, ONCOGENE, V22, P7632, DOI 10.1038/sj.onc.1206840; Attisano L, 2002, SCIENCE, V296, P1646, DOI 10.1126/science.1071809; Bertolino P, 2008, P NATL ACAD SCI USA, V105, P7246, DOI 10.1073/pnas.0801285105; Bindra RS, 2006, CANCER BIOL THER, V5, P1400, DOI 10.4161/cbt.5.10.3454; Bottinger EP, 1997, EMBO J, V16, P2621, DOI 10.1093/emboj/16.10.2621; Bratanova-Tochkova TK, 2002, DIABETES, V51, pS83, DOI 10.2337/diabetes.51.2007.S83; Brissova M, 2005, J HISTOCHEM CYTOCHEM, V53, P1087, DOI 10.1369/jhc.5C6684.2005; Campbell SC, 1999, FEBS LETT, V463, P53, DOI 10.1016/S0014-5793(99)01584-7; Chipuk JE, 2002, J BIOL CHEM, V277, P1240, DOI 10.1074/jbc.M108855200; COLLINS H, 1992, J BIOL CHEM, V267, P1357; Datto MB, 1999, MOL CELL BIOL, V19, P2495; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Docherty HM, 2005, BIOCHEM J, V389, P813, DOI 10.1042/BJ20041891; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Frederick JP, 2004, MOL CELL BIOL, V24, P2546, DOI 10.1128/MCB.24.6.2546-2559.2004; Gannon M, 2007, CELL METAB, V5, P157, DOI 10.1016/j.cmet.2007.02.003; Georgia S, 2004, J CLIN INVEST, V114, P963, DOI 10.1172/JCI200422098; Goulley J, 2007, CELL METAB, V5, P207, DOI 10.1016/j.cmet.2007.01.009; Hay CW, 2006, DIABETES, V55, P3201, DOI 10.2337/db06-0788; Herman MA, 2006, J CLIN INVEST, V116, P1767, DOI 10.1172/JCI29027; Hirshberg B, 2003, DIABETES CARE, V26, P3288, DOI 10.2337/diacare.26.12.3288; Inman GJ, 2002, MOL CELL, V10, P283, DOI 10.1016/S1097-2765(02)00585-3; Johnson K, 1999, J BIOL CHEM, V274, P20709, DOI 10.1074/jbc.274.29.20709; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kim SK, 2001, GENE DEV, V15, P111, DOI 10.1101/gad.859401; Kim SK, 2002, CURR OPIN GENET DEV, V12, P540, DOI 10.1016/S0959-437X(02)00338-6; Kitamura T, 2003, ANNU REV PHYSIOL, V65, P313, DOI 10.1146/annurev.physiol.65.092101.142540; Lee DK, 2002, J BIOL CHEM, V277, P38557, DOI 10.1074/jbc.M206786200; LEE MS, 1995, AM J PATHOL, V147, P42; Liu F, 1997, GENE DEV, V11, P3157, DOI 10.1101/gad.11.23.3157; Lu M, 1997, J BIOL CHEM, V272, P28349, DOI 10.1074/jbc.272.45.28349; Massague J, 2000, NAT REV MOL CELL BIO, V1, P169, DOI 10.1038/35043051; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Nagarajan RP, 1999, J BIOL CHEM, V274, P33412, DOI 10.1074/jbc.274.47.33412; Nakao A, 1997, EMBO J, V16, P5353, DOI 10.1093/emboj/16.17.5353; Ohneda K, 2000, SEMIN CELL DEV BIOL, V11, P227, DOI 10.1006/scdb.2000.0171; Rane SG, 2000, FRONT BIOSCI, V5, pD1, DOI 10.2741/Rane; Rane SG, 2006, CYTOKINE GROWTH F R, V17, P107, DOI 10.1016/j.cytogfr.2005.09.003; Rane SG, 1999, NAT GENET, V22, P44, DOI 10.1038/8751; Roberts AB, 2003, P NATL ACAD SCI USA, V100, P8621, DOI 10.1073/pnas.1633291100; Safina A, 2007, ONCOGENE, V26, P2407, DOI 10.1038/sj.onc.1210046; SEKINE N, 1994, DIABETES RES CLIN PR, V26, P7, DOI 10.1016/0168-8227(94)90133-3; SJOHOLM A, 1991, AM J PHYSIOL, V260, pC1046, DOI 10.1152/ajpcell.1991.260.5.C1046; Smart NG, 2006, PLOS BIOL, V4, P200, DOI 10.1371/journal.pbio.0040039; Tulachan SS, 2007, DEV BIOL, V305, P508, DOI 10.1016/j.ydbio.2007.02.033; Weir GC, 2004, DIABETES, V53, pS16, DOI 10.2337/diabetes.53.suppl_3.S16; WRANA JL, 1994, NATURE, V370, P341, DOI 10.1038/370341a0; Yakar S, 2001, DIABETES, V50, P1110, DOI 10.2337/diabetes.50.5.1110; YAMANAKA Y, 1993, DIABETES, V42, P746, DOI 10.2337/diabetes.42.5.746; Yamaoka T, 1998, J CLIN INVEST, V102, P294, DOI 10.1172/JCI2769; Yang X, 1999, EMBO J, V18, P1280, DOI 10.1093/emboj/18.5.1280; Zhang YQ, 2004, DIABETES, V53, P2024, DOI 10.2337/diabetes.53.8.2024	54	115	129	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12246	12257		10.1074/jbc.M805379200	http://dx.doi.org/10.1074/jbc.M805379200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19265200	hybrid, Green Published			2022-12-27	WOS:000265494600056
J	Pratt, AJ; MacRae, IJ				Pratt, Ashley J.; MacRae, Ian J.			The RNA-induced Silencing Complex: A Versatile Gene-silencing Machine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							MICRORNA-DEPENDENT LOCALIZATION; TARGETED MESSENGER-RNAS; HUMAN RISC; C-ELEGANS; GENOME REARRANGEMENT; CRYSTAL-STRUCTURE; ENZYME COMPLEX; ARGONAUTE; DROSOPHILA; INTERFERENCE	RNA interference is a powerful mechanism of gene silencing that underlies many aspects of eukaryotic biology. On the molecular level, RNA interference is mediated by a family of ribonucleoprotein complexes called RNA-induced silencing complexes (RISCs), which can be programmed to target virtually any nucleic acid sequence for silencing. The ability of RISC to locate target RNAs has been co-opted by evolution many times to generate a broad spectrum of gene-silencing pathways. Here, we review the fundamental biochemical and biophysical properties of RISC that facilitate gene targeting and describe the various mechanisms of gene silencing known to exploit RISC activity.	[Pratt, Ashley J.; MacRae, Ian J.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	Scripps Research Institute	MacRae, IJ (corresponding author), Scripps Res Inst, Dept Mol Biol, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA.	macrae@scripps.edu	MacRae, Ian/CAF-5564-2022; Pratt, Ashley/A-1754-2012	Pratt, Ashley/0000-0002-9702-8805	National Institutes of Health [1RO1GM086701]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086701] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by Grant 1RO1GM086701 from the National Institutes of Health. To whom correspondence should be addressed. E-mail:macrae@ scripps.edu.	Ameres SL, 2007, CELL, V130, P101, DOI 10.1016/j.cell.2007.04.037; Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Batista PJ, 2008, MOL CELL, V31, P67, DOI 10.1016/j.molcel.2008.06.002; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Bohmert K, 1998, EMBO J, V17, P170, DOI 10.1093/emboj/17.1.170; Brennecke J, 2008, SCIENCE, V322, P1387, DOI 10.1126/science.1165171; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Eulalio A, 2008, NAT STRUCT MOL BIOL, V15, P346, DOI 10.1038/nsmb.1405; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Forstemann K, 2007, CELL, V130, P287, DOI 10.1016/j.cell.2007.05.056; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Haley B, 2004, NAT STRUCT MOL BIOL, V11, P599, DOI 10.1038/nsmb780; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hock J, 2007, EMBO REP, V8, P1052, DOI 10.1038/sj.embor.7401088; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Iwasaki S, 2009, MOL CELL, V34, P58, DOI 10.1016/j.molcel.2009.02.010; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Landthaler M, 2008, RNA, V14, P2580, DOI 10.1261/rna.1351608; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Leung AKL, 2006, P NATL ACAD SCI USA, V103, P18125, DOI 10.1073/pnas.0608845103; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Mochizuki K, 2004, CURR OPIN GENET DEV, V14, P181, DOI 10.1016/j.gde.2004.01.004; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702; Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; Qi HH, 2008, NATURE, V455, P421, DOI 10.1038/nature07186; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514; Tolia NH, 2007, NAT CHEM BIOL, V3, P36, DOI 10.1038/nchembio848; Vasudevan S, 2007, CELL, V128, P1105, DOI 10.1016/j.cell.2007.01.038; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wang YL, 2008, NATURE, V456, P209, DOI 10.1038/nature07315; Wang YL, 2008, NATURE, V456, P921, DOI 10.1038/nature07666; Yigit E, 2006, CELL, V127, P747, DOI 10.1016/j.cell.2006.09.033; Yin H, 2007, NATURE, V450, P304, DOI 10.1038/nature06263; Yuan YR, 2005, MOL CELL, V19, P405, DOI 10.1016/j.molcel.2005.07.011; Zeng Y, 2008, BIOCHEM J, V413, P429, DOI 10.1042/BJ20080599	47	322	335	0	51	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					17897	17901		10.1074/jbc.R900012200	http://dx.doi.org/10.1074/jbc.R900012200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19342379	hybrid, Green Published			2022-12-27	WOS:000267712400001
J	Chatterji, U; Bobardt, M; Selvarajah, S; Yang, F; Tang, HL; Sakamoto, N; Vuagniaux, G; Parkinson, T; Gallay, P				Chatterji, Udayan; Bobardt, Michael; Selvarajah, Suganya; Yang, Feng; Tang, Hengli; Sakamoto, Noayo; Vuagniaux, Gregoire; Parkinson, Tanya; Gallay, Philippe			The Isomerase Active Site of Cyclophilin A Is Critical for Hepatitis C Virus Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CIS-TRANS ISOMERASE; CYCLOSPORINE-A; HOMOLOG NINAA; TYPE-1; INFECTION; PROTEIN; BINDING; RESISTANCE; INHIBITORS; THERAPY	Cyclosporine A and nonimmunosuppressive cyclophilin (Cyp) inhibitors such as Debio 025, NIM811, and SCY-635 block hepatitis C virus (HCV) replication in vitro. This effect was recently confirmed in HCV-infected patients where Debio 025 treatment dramatically decreased HCV viral load, suggesting that Cyps inhibitors represent a novel class of anti-HCV agents. However, it remains unclear how these compounds control HCV replication. Recent studies suggest that Cyps are important for HCV replication. However, a profound disagreement currently exists as to the respective roles of Cyp members in HCV replication. In this study, we analyzed the respective contribution of Cyp members to HCV replication by specifically knocking down their expression by both transient and stable small RNA interference. Only the CypA knockdown drastically decreased HCV replication. The re-expression of an exogenous CypA escape protein, which contains escape mutations at the small RNA interference recognition site, restored HCV replication, demonstrating the specificity for the CypA requirement. We then mutated residues that reside in the hydrophobic pocket of CypA where proline-containing peptide substrates and cyclosporine A bind and that are vital for the enzymatic or the hydrophobic pocket binding activity of CypA. Remarkably, these CypA mutants fail to restore HCV replication, suggesting for the first time that HCV exploits either the isomerase or the chaperone activity of CypA to replicate in hepatocytes and that CypA is the principal mediator of the Cyp inhibitor anti-HCV activity. Moreover, we demonstrated that the HCV NS5B polymerase associates with CypA via its enzymatic pocket. The study of the roles of Cyps in HCV replication should lead to the identification of new targets for the development of alternate anti-HCV therapies.	[Gallay, Philippe] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Yang, Feng; Tang, Hengli] Florida State Univ, Tallahassee, FL 32306 USA; [Sakamoto, Noayo] Tokyo Med & Dent Univ, Tokyo 1138519, Japan; [Parkinson, Tanya] Pfizer Ltd, Sandwich CT13 9NJ, Kent, England; [Vuagniaux, Gregoire] Debiopharm, CH-1002 Lausanne, Switzerland	Scripps Research Institute; State University System of Florida; Florida State University; Tokyo Medical & Dental University (TMDU); Pfizer; Debiopharm	Gallay, P (corresponding author), Scripps Res Inst, Dept Immunol & Microbial Sci, IMM 9,10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	gallay@scripps.edu	Tang, Hengli/F-2085-2014; Sakamoto, Naoya/G-2734-2012	Sakamoto, Naoya/0000-0003-0061-059X				Akiyama H, 1997, BONE MARROW TRANSPL, V20, P993, DOI 10.1038/sj.bmt.1700996; BANG H, 1991, BIOMED BIOCHIM ACTA, V50, pS137; Bieniasz PD, 2004, NAT IMMUNOL, V5, P1109, DOI 10.1038/ni1125; Braaten D, 2001, EMBO J, V20, P1300, DOI 10.1093/emboj/20.6.1300; Braaten D, 1996, J VIROL, V70, P3551, DOI 10.1128/JVI.70.6.3551-3560.1996; Braaten D, 1997, J VIROL, V71, P2107, DOI 10.1128/JVI.71.3.2107-2113.1997; Coelmont L, 2009, ANTIMICROB AGENTS CH, V53, P967, DOI 10.1128/AAC.00939-08; COLLEY NJ, 1991, CELL, V67, P255, DOI 10.1016/0092-8674(91)90177-Z; Cullen BR, 2003, NAT MED, V9, P1112, DOI 10.1038/nm0903-1112; Eckert B, 2005, NAT STRUCT MOL BIOL, V12, P619, DOI 10.1038/nsmb946; Fernandes F, 2007, HEPATOLOGY, V46, P1026, DOI 10.1002/hep.21809; FISCHER G, 1989, NATURE, V337, P476, DOI 10.1038/337476a0; Fischer G, 2006, MOL MICROBIOL, V61, P1388, DOI 10.1111/j.1365-2958.2006.05349.x; Flisiak R, 2008, HEPATOLOGY, V47, P817, DOI 10.1002/hep.22131; Flisiak R, 2007, EXPERT OPIN INV DRUG, V16, P1345, DOI 10.1517/13543784.16.9.1345; FRANKE EK, 1994, NATURE, V372, P359, DOI 10.1038/372359a0; Goto K, 2006, BIOCHEM BIOPH RES CO, V343, P879, DOI 10.1016/j.bbrc.2006.03.059; GOTO K, 2008, 14 INT S HEP C VIR G, pP235; HANDSCHUMACHER RE, 1984, SCIENCE, V226, P544, DOI 10.1126/science.6238408; Hayashi N, 2006, J GASTROENTEROL, V41, P17, DOI 10.1007/s00535-005-1740-7; HOPKINS S, 2008, 59 ANN M AM ASS STUD; HUBNER D, 1991, FEBS LETT, V284, P79, DOI 10.1016/0014-5793(91)80766-V; Inoue K, 2005, TRANSPLANT P, V37, P1233, DOI 10.1016/j.transproceed.2004.11.041; Inoue K, 2003, J GASTROENTEROL, V38, P567, DOI 10.1007/s00535-002-1104-5; Ishii N, 2006, J VIROL, V80, P4510, DOI 10.1128/JVI.80.9.4510-4520.2006; Kao CL, 2001, J CLIN MICROBIOL, V39, P3672, DOI 10.1128/JCM.39.10.3672-3677.2001; Kapadia SB, 2003, P NATL ACAD SCI USA, V100, P2014, DOI 10.1073/pnas.252783999; KAUL A, 2008, 15 INT S HEP C VIR R; LANG K, 1987, NATURE, V329, P268, DOI 10.1038/329268a0; Liu SK, 2004, NUCLEIC ACIDS RES, V32, P3752, DOI 10.1093/nar/gkh715; LUBAN J, 1993, CELL, V73, P1067, DOI 10.1016/0092-8674(93)90637-6; Luban J, 2007, J VIROL, V81, P1054, DOI 10.1128/JVI.01519-06; Ma S, 2006, ANTIMICROB AGENTS CH, V50, P2976, DOI 10.1128/AAC.00310-06; Martin NC, 2006, J VIROL METHODS, V134, P74, DOI 10.1016/j.jviromet.2005.12.002; Mathy JE, 2008, ANTIMICROB AGENTS CH, V52, P3267, DOI 10.1128/AAC.00498-08; Nakagawa M, 2004, BIOCHEM BIOPH RES CO, V313, P42, DOI 10.1016/j.bbrc.2003.11.080; Paeshuyse J, 2006, HEPATOLOGY, V43, P761, DOI 10.1002/hep.21102; Pawlotsky JM, 2006, HEPATOLOGY, V43, pS207, DOI 10.1002/hep.21064; Robida JM, 2007, J VIROL, V81, P5829, DOI 10.1128/JVI.02524-06; Saphire ACS, 1999, EMBO J, V18, P6771, DOI 10.1093/emboj/18.23.6771; Schiene C, 2000, CURR OPIN STRUC BIOL, V10, P40, DOI 10.1016/S0959-440X(99)00046-9; Shin EC, 2005, HEPATOLOGY, V42, p245A; Sokolskaja E, 2004, J VIROL, V78, P12800, DOI 10.1128/JVI.78.23.12800-12808.2004; STAMNES MA, 1991, CELL, V65, P219, DOI 10.1016/0092-8674(91)90156-S; THALI M, 1994, NATURE, V372, P363, DOI 10.1038/372363a0; Towers GJ, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-40; Wang P, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-226; Watashi K, 2003, HEPATOLOGY, V38, P1282, DOI 10.1053/jhep.2003.50449; Watashi K, 2005, MOL CELL, V19, P111, DOI 10.1016/j.molcel.2005.05.014; WEIDMANN B, 2008, 15 INT S HEP C VIR R; Yang F, 2008, J VIROL, V82, P5269, DOI 10.1128/JVI.02614-07; ZYDOWSKY LD, 1992, PROTEIN SCI, V1, P1092, DOI 10.1002/pro.5560010903	52	155	171	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					16998	17005		10.1074/jbc.M109.007625	http://dx.doi.org/10.1074/jbc.M109.007625			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19380579	Green Published			2022-12-27	WOS:000266962400037
J	Balakrishnan, L; Brandt, PD; Lindsey-Boltz, LA; Sancar, A; Bambara, RA				Balakrishnan, Lata; Brandt, Patrick D.; Lindsey-Boltz, Laura A.; Sancar, Aziz; Bambara, Robert A.			Long Patch Base Excision Repair Proceeds via Coordinated Stimulation of the Multienzyme DNA Repair Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAD9-RAD1-HUS1 CHECKPOINT COMPLEX; POLYMERASE-BETA; FLAP ENDONUCLEASE-1; LIGASE-I; APURINIC/APYRIMIDINIC ENDONUCLEASE-1; FISSION YEAST; CLAMP; SUBSTRATE; PROTEINS; CLEAVAGE	Base excision repair, a major repair pathway in mammalian cells, is responsible for correcting DNA base damage and maintaining genomic integrity. Recent reports show that the Rad9-Rad1-Hus1 complex (9-1-1) stimulates enzymes proposed to perform a long patch-base excision repair sub-pathway (LP-BER), including DNA glycosylases, apurinic/apyrimidinic endonuclease 1 (APE1), DNA polymerase beta (pol beta), flap endonuclease 1 (FEN1), and DNA ligase I (LigI). However, 9-1-1 was found to produce minimal stimulation of FEN1 and LigI in the context of a complete reconstitution of LP-BER. We show here that pol beta is a robust stimulator of FEN1 and a moderate stimulator of LigI. Apparently, there is a maximum possible stimulation of these two proteins such that after responding to pol beta or another protein in the repair complex, only a small additional response to 9-1-1 is allowed. The 9-1-1 sliding clamp structure must serve primarily to coordinate enzyme actions rather than enhancing rate. Significantly, stimulation by the polymerase involves interaction of primer terminus-bound pol beta with FEN1 and LigI. This observation provides compelling evidence that the proposed LP-BER pathway is actually employed in cells. Moreover, this pathway has been proposed to function by sequential enzyme actions in a "hit and run" mechanism. Our results imply that this mechanism is still carried out, but in the context of a multienzyme complex that remains structurally intact during the repair process.	[Bambara, Robert A.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Lindsey-Boltz, Laura A.; Sancar, Aziz] Univ N Carolina, Sch Med, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	University of Rochester; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Bambara, RA (corresponding author), Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, 601 Elmwood Ave,Box 712, Rochester, NY 14642 USA.	Robert_bambara@urmc.rochester.edu	Lindsey-Boltz, Laura/A-3121-2010	Lindsey-Boltz, Laura/0000-0001-6493-8194	National Institutes of Health [GM024441, GM032833]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032833, R01GM024441] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant GM024441 (to R.A.B.), with additional support from Grant GM032833 (to A.S.).	Beard WA, 1995, METHOD ENZYMOL, V262, P98; Bermudez VP, 2003, P NATL ACAD SCI USA, V100, P1633, DOI 10.1073/pnas.0437927100; Bornarth CJ, 1999, BIOCHEMISTRY-US, V38, P13347, DOI 10.1021/bi991321u; Burtelow MA, 2000, J BIOL CHEM, V275, P26343, DOI 10.1074/jbc.M001244200; CASASFINET JR, 1991, J BIOL CHEM, V266, P19618; Chang DY, 2005, J BIOL CHEM, V280, P408, DOI 10.1074/jbc.M406800200; Dahm K, 2002, ONCOGENE, V21, P7710, DOI 10.1038/sj.onc.1205872; Ellison V, 2003, PLOS BIOL, V1, P231, DOI 10.1371/journal.pbio.0000033; Friedrich-Heineken F, 2005, J MOL BIOL, V353, P980, DOI 10.1016/j.jmb.2005.09.018; Gembka A, 2007, NUCLEIC ACIDS RES, V35, P2596, DOI 10.1093/nar/gkl1139; Guan X, 2007, NUCLEIC ACIDS RES, V35, P6207, DOI 10.1093/nar/gkm678; HARRINGTON JJ, 1995, J BIOL CHEM, V270, P4503, DOI 10.1074/jbc.270.9.4503; HARRINGTON JJ, 1994, EMBO J, V13, P1235, DOI 10.1002/j.1460-2075.1994.tb06373.x; Henricksen LA, 2000, J BIOL CHEM, V275, P16420, DOI 10.1074/jbc.M909635199; Jaiswal AS, 2002, ONCOGENE, V21, P5912, DOI 10.1038/sj.onc.1205789; Kao KI, 2002, J BIOL CHEM, V277, P14379, DOI 10.1074/jbc.M110662200; Klungland A, 1997, EMBO J, V16, P3341, DOI 10.1093/emboj/16.11.3341; KUMAR A, 1990, BIOCHEMISTRY-US, V29, P7156, DOI 10.1021/bi00483a002; Lindsey-Boltz LA, 2001, P NATL ACAD SCI USA, V98, P11236, DOI 10.1073/pnas.201373498; Liu Y, 2005, J BIOL CHEM, V280, P3665, DOI 10.1074/jbc.M412922200; MATSUMOTO Y, 1995, SCIENCE, V269, P699, DOI 10.1126/science.7624801; Meister P, 2003, NUCLEIC ACIDS RES, V31, P5064, DOI 10.1093/nar/gkg719; Memisoglu A, 2000, MUTAT RES-FUND MOL M, V451, P39, DOI 10.1016/S0027-5107(00)00039-7; Menge KL, 1995, BIOCHEMISTRY-US, V34, P15934, DOI 10.1021/bi00049a008; MURANTE RS, 1994, J BIOL CHEM, V269, P1191; Murante RS, 1995, J BIOL CHEM, V270, P30377, DOI 10.1074/jbc.270.51.30377; Petermann E, 2003, DNA REPAIR, V2, P1101, DOI 10.1016/S1568-7864(03)00117-4; Piersen CE, 1996, J BIOL CHEM, V271, P17811, DOI 10.1074/jbc.271.30.17811; Prasad R, 2000, J BIOL CHEM, V275, P4460, DOI 10.1074/jbc.275.6.4460; Prasad R, 1996, J BIOL CHEM, V271, P16000, DOI 10.1074/jbc.271.27.16000; Rajendran S, 1998, J BIOL CHEM, V273, P31021, DOI 10.1074/jbc.273.47.31021; Ranalli TA, 2002, J BIOL CHEM, V277, P41715, DOI 10.1074/jbc.M207207200; REIN DC, 1990, EUKARYOTIC NUCLEUS M, V1, P95; Sattler U, 2003, EMBO REP, V4, P363, DOI 10.1038/sj.embor.embor796; Scharer OD, 2001, BIOESSAYS, V23, P270, DOI 10.1002/1521-1878(200103)23:3<270::AID-BIES1037>3.0.CO;2-J; Shi GL, 2006, BIOCHEM J, V400, P53, DOI 10.1042/BJ20060774; Smirnova E, 2005, BIOCHEM J, V389, P13, DOI 10.1042/BJ20050211; Sobol RW, 1996, NATURE, V379, P183, DOI 10.1038/379183a0; Sung JS, 2006, FEBS J, V273, P1620, DOI 10.1111/j.1742-4658.2006.05192.x; Tom S, 2001, J BIOL CHEM, V276, P48781, DOI 10.1074/jbc.M109626200; Tom S, 2000, J BIOL CHEM, V275, P10498, DOI 10.1074/jbc.275.14.10498; Toueille M, 2004, NUCLEIC ACIDS RES, V32, P3316, DOI 10.1093/nar/gkh652; Wang WS, 2006, J BIOL CHEM, V281, P20865, DOI 10.1074/jbc.M602289200; Wang WS, 2004, P NATL ACAD SCI USA, V101, P16762, DOI 10.1073/pnas.0407686101; Wilson DM, 2001, MUTAT RES-DNA REPAIR, V485, P283, DOI 10.1016/S0921-8777(01)00063-5; Wilson SH, 1998, MUTAT RES-DNA REPAIR, V407, P203, DOI 10.1016/S0921-8777(98)00002-0; WU WM, 1995, J BIOL CHEM, V270, P325, DOI 10.1074/jbc.270.1.263; Zou L, 2002, GENE DEV, V16, P198, DOI 10.1101/gad.950302; Zou L, 2003, P NATL ACAD SCI USA, V100, P13827, DOI 10.1073/pnas.2336100100	49	41	42	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					15158	15172		10.1074/jbc.M109.000505	http://dx.doi.org/10.1074/jbc.M109.000505			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19329425	hybrid, Green Published			2022-12-27	WOS:000266288200051
J	Bhattacharyya, S; Keirsey, J; Russell, B; Kavecansky, J; Lillard-Wetherell, K; Tahmaseb, K; Turchi, JJ; Groden, J				Bhattacharyya, Saumitri; Keirsey, Jeremy; Russell, Beatriz; Kavecansky, Juraj; Lillard-Wetherell, Kate; Tahmaseb, Kambiz; Turchi, John J.; Groden, Joanna			Telomerase-associated Protein 1, HSP90, and Topoisomerase II alpha Associate Directly with the BLM Helicase in Immortalized Cells Using ALT and Modulate Its Helicase Activity Using Telomeric DNA Substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WERNERS-SYNDROME GENES; REPLICATION FORK; BLOOMS; SGS1; MAINTENANCE; TRF2; RECOMBINATION; INTERACTS; RAD50/MRE11/NBS1; INSTABILITY	The BLM helicase associates with the telomere structural proteins TRF1 and TRF2 in immortalized cells using the alternative lengthening of telomere (ALT) pathways. This work focuses on identifying protein partners of BLM in cells using ALT. Mass spectrometry and immunoprecipitation techniques have identified three proteins that bind directly to BLM and TRF2 in ALT cells: telomerase-associated protein 1 (TEP1), heat shock protein 90 (HSP90), and topoisomerase II alpha (TOPOII alpha). BLM predominantly co-localizes with these proteins in foci actively synthesizing DNA during late S and G(2)/M phases of the cell cycle when ALT is thought to occur. Immunoprecipitation studies also indicate that only HSP90 and TOPOII alpha are components of a specific complex containing BLM, TRF1, and TRF2 but that this complex does not include TEP1. TEP1, TOPOII alpha, and HSP90 interact directly with BLM in vitro and modulate its helicase activity on telomere-like DNA substrates but not on non-telomeric substrates. Initial studies suggest that knockdown of BLM in ALT cells reduces average telomere length but does not do so in cells using telomerase.	[Bhattacharyya, Saumitri; Keirsey, Jeremy; Russell, Beatriz; Kavecansky, Juraj; Groden, Joanna] Ohio State Univ, Coll Med, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Lillard-Wetherell, Kate] Univ Cincinnati, Dept Mol Genet Biochem & Microbiol, Howard Hughes Med Inst, Coll Med, Cincinnati, OH 43267 USA; [Tahmaseb, Kambiz] Wright State Univ, Dept Biochem & Mol Biol, Sch Med, Dayton, OH 45435 USA; [Turchi, John J.] Indiana Univ, Dept Biochem & Mol Biol, Sch Med, Indianapolis, IN 46220 USA; [Turchi, John J.] Indiana Univ, Dept Med, Sch Med, Indianapolis, IN 46220 USA	University System of Ohio; Ohio State University; Howard Hughes Medical Institute; University System of Ohio; University of Cincinnati; University System of Ohio; Wright State University Dayton; Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis	Groden, J (corresponding author), 460 W 12th Ave,986 Biomed Res Tower, Columbus, OH 43210 USA.	groden.2@osu.edu	Turchi, John J/B-5807-2015	Turchi, John J/0000-0001-5375-2992	National Institutes of Health [CA-117898]; Bloom's Syndrome Foundation; NATIONAL CANCER INSTITUTE [R01CA117898] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bloom's Syndrome Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA-117898. This work was also supported by The Bloom's Syndrome Foundation.	BRYAN TM, 1995, EMBO J, V14, P4240, DOI 10.1002/j.1460-2075.1995.tb00098.x; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; DELANGE T, 1992, EMBO J, V11, P717, DOI 10.1002/j.1460-2075.1992.tb05104.x; Dunham MA, 2000, NAT GENET, V26, P447, DOI 10.1038/82586; Dutertre S, 2000, ONCOGENE, V19, P2731, DOI 10.1038/sj.onc.1203595; Forsythe HL, 2001, J BIOL CHEM, V276, P15571, DOI 10.1074/jbc.C100055200; Franchitto A, 2002, J CELL BIOL, V157, P19, DOI 10.1083/jcb.200110009; GERMAN J, 1995, DERMATOL CLIN, V13, P7, DOI 10.1016/S0733-8635(18)30101-3; GERMAN J, 1966, ANN GENET-PARIS, V9, pG143; Grobelny JV, 2000, J CELL SCI, V113, P4577; Harrington L, 1997, SCIENCE, V275, P973, DOI 10.1126/science.275.5302.973; Holt SE, 1999, GENE DEV, V13, P817, DOI 10.1101/gad.13.7.817; Igel H, 1998, RNA, V4, P1; Johnson FB, 2000, CANCER RES, V60, P1162; Karow JK, 2000, P NATL ACAD SCI USA, V97, P6504, DOI 10.1073/pnas.100448097; Kickhoefer VA, 1999, J BIOL CHEM, V274, P32712, DOI 10.1074/jbc.274.46.32712; Laine JP, 2003, CANCER RES, V63, P7136; Li JL, 2001, BIOCHEMISTRY-US, V40, P15194, DOI 10.1021/bi011067h; Lillard-Wetherell K, 2005, CANCER RES, V65, P5520, DOI 10.1158/0008-5472.CAN-05-0632; Lillard-Wetherell K, 2004, HUM MOL GENET, V13, P1919, DOI 10.1093/hmg/ddh193; Liu Y, 2000, MOL CELL BIOL, V20, P8178, DOI 10.1128/MCB.20.21.8178-8184.2000; LUNDBLAD V, 1993, CELL, V73, P347, DOI 10.1016/0092-8674(93)90234-H; Mohaghegh P, 2001, NUCLEIC ACIDS RES, V29, P2843, DOI 10.1093/nar/29.13.2843; Myung K, 2001, NAT GENET, V27, P113, DOI 10.1038/83673; Ohki R, 2004, NUCLEIC ACIDS RES, V32, P1627, DOI 10.1093/nar/gkh309; Opresko PL, 2005, J BIOL CHEM, V280, P32069, DOI 10.1074/jbc.M505211200; Opresko PL, 2002, J BIOL CHEM, V277, P41110, DOI 10.1074/jbc.M205396200; Shor E, 2002, GENETICS, V162, P647; Stavropoulos DJ, 2002, HUM MOL GENET, V11, P3135, DOI 10.1093/hmg/11.25.3135; Temime-Smaali N, 2008, EMBO J, V27, P1513, DOI 10.1038/emboj.2008.74; Ui A, 2005, DNA REPAIR, V4, P191, DOI 10.1016/j.dnarep.2004.09.002; Ui A, 2001, MOL GENET GENOMICS, V265, P837, DOI 10.1007/s004380100479; Wang JC, 1996, ANNU REV BIOCHEM, V65, P635, DOI 10.1146/annurev.bi.65.070196.003223; Watt PM, 1996, GENETICS, V144, P935; Wu GK, 2000, J BIOL CHEM, V275, P30618, DOI 10.1074/jbc.C000390200; Wu L, 2000, J BIOL CHEM, V275, P9636, DOI 10.1074/jbc.275.13.9636; Yamagata K, 1998, P NATL ACAD SCI USA, V95, P8733, DOI 10.1073/pnas.95.15.8733; Yeager TR, 1999, CANCER RES, V59, P4175; Yoon HJ, 1998, BBA-GENE STRUCT EXPR, V1395, P110, DOI 10.1016/S0167-4781(97)00139-5; Zhu XD, 2000, NAT GENET, V25, P347, DOI 10.1038/77139	40	43	46	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					14966	14977		10.1074/jbc.M900195200	http://dx.doi.org/10.1074/jbc.M900195200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19329795	Green Published, hybrid			2022-12-27	WOS:000266288200033
J	Hernandez, A; Jiang, XY; Cubero, B; Nieto, PM; Bressan, RA; Hasegawa, PM; Pardo, JM				Hernandez, Agustin; Jiang, Xingyu; Cubero, Beatriz; Nieto, Pedro M.; Bressan, Ray A.; Hasegawa, Paul M.; Pardo, Jose M.			Mutants of the Arabidopsis thaliana Cation/H+ Antiporter AtNHX1 Conferring Increased Salt Tolerance in Yeast THE ENDOSOME/PREVACUOLAR COMPARTMENT IS A TARGET FOR SALT TOXICITY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-MEMBRANE ATPASE; NA+/H+ EXCHANGER; SACCHAROMYCES-CEREVISIAE; POTASSIUM UPTAKE; ION HOMEOSTASIS; TOPOLOGY MODEL; PH; PROTEIN; GOLGI; VACUOLE	Mutants of the plant cation/H+ antiporter AtNHX1 that confer greater halotolerance were generated by random mutagenesis and selected in yeast by phenotypic complementation. The amino acid substitutions that were selected were conservative and occurred in the second half of the membrane-associated N terminus. AtNHX1 complemented the lack of endogenous ScNHX1 in endosomal protein trafficking assays. Growth enhancement on hygromycin B and vanadate media agreed with a generally improved endosomal/prevacuolar function of the mutated proteins. In vivo measurements by P-31 NMR revealed that wild-type and mutant AtNHX1 transporters did not affect cytosolic or vacuolar pH. Surprisingly, when yeast cells were challenged with lithium, a tracer for sodium, the main effect of the mutations in AtNHX1 was a reduction in the amount of compartmentalized lithium. When purified and reconstituted into proteoliposomes or assayed in intact vacuoles isolated from yeast cells, a representative mutant transporter (V318I) showed a greater cation discrimination favoring potassium transport over that of sodium or lithium. Together, our data suggest that the endosome/prevacuolar compartment is a target for salt toxicity. Poisoning by toxic cations in the endosome/prevacuolar compartment is detrimental for cell functions, but it can be alleviated by improving the discrimination of transported alkali cations by the resident cation/H+ antiporter.	[Hernandez, Agustin; Jiang, Xingyu; Cubero, Beatriz; Pardo, Jose M.] CSIC, Inst Recursos Nat & Agrobiol, IRNASE, Seville 41012, Spain; [Nieto, Pedro M.] CSIC, IIQ, Seville 41092, Spain; [Bressan, Ray A.; Hasegawa, Paul M.] Purdue Univ, Ctr Plant Environm Stress Physiol, W Lafayette, IN 47907 USA	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Recursos Naturales y Agrobiologia de Sevilla (IRNAS); Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-USE - Instituto de Investigaciones Quimicas (IIQ); Purdue University System; Purdue University; Purdue University West Lafayette Campus	Pardo, JM (corresponding author), CSIC, Inst Recursos Nat & Agrobiol, IRNASE, Avda Reina Mercedes 10, Seville 41012, Spain.	pardo@cica.es	Pardo, Jose M/AAB-5866-2022; Hernandez, Agustin/E-4544-2010; Nieto, Pedro M/B-7869-2008; Pardo, Jose M./B-4652-2009	Pardo, Jose M/0000-0003-4510-8624; Hernandez, Agustin/0000-0002-7884-8023; Nieto, Pedro M/0000-0002-4074-9011; Pardo, Jose M./0000-0003-4510-8624; Bressan, Ray/0000-0002-8754-606X	Ministry of Science and Innovation in Spain [BFU2006-06968]	Ministry of Science and Innovation in Spain(Ministry of Science and Innovation, Spain (MICINN))	This work was supported by Ministry of Science and Innovation in Spain Grant BFU2006-06968.	Apse MP, 1999, SCIENCE, V285, P1256, DOI 10.1126/science.285.5431.1256; Bachert C, 2001, MOL BIOL CELL, V12, P3152, DOI 10.1091/mbc.12.10.3152; Bell-Parikh LC, 2001, J BIOL CHEM, V276, P29854, DOI 10.1074/jbc.M103936200; Bowers K, 2000, MOL BIOL CELL, V11, P4277, DOI 10.1091/mbc.11.12.4277; Brett CL, 2005, MOL BIOL CELL, V16, P1396, DOI 10.1091/mbc.E04-11-0999; Brett CL, 2002, AM J PHYSIOL-CELL PH, V282, pC1031, DOI 10.1152/ajpcell.00420.2001; Bryant NJ, 1998, J CELL BIOL, V142, P651, DOI 10.1083/jcb.142.3.651; Bryant NJ, 1998, MICROBIOL MOL BIOL R, V62, P230, DOI 10.1128/MMBR.62.1.230-247.1998; Cagnac O, 2007, J BIOL CHEM, V282, P24284, DOI 10.1074/jbc.M703116200; Carmelo V, 1997, BBA-BIOMEMBRANES, V1325, P63, DOI 10.1016/S0005-2736(96)00245-3; Conibear E, 1998, BBA-MOL CELL RES, V1404, P211, DOI 10.1016/S0167-4889(98)00058-5; D'Souza S, 1998, J BIOL CHEM, V273, P2035, DOI 10.1074/jbc.273.4.2035; Darley CP, 2000, BIOCHEM J, V351, P241, DOI 10.1042/0264-6021:3510241; Gaxiola RA, 1999, P NATL ACAD SCI USA, V96, P1480, DOI 10.1073/pnas.96.4.1480; Gietz RD, 2002, METHOD ENZYMOL, V350, P87; GILLIES R J, 1992, Cellular Physiology and Biochemistry, V2, P159, DOI 10.1159/000154638; Hernandez A, 1998, BIOINFORMATICS, V14, P227, DOI 10.1093/bioinformatics/14.2.227; JIA ZP, 1992, EMBO J, V11, P1631, DOI 10.1002/j.1460-2075.1992.tb05209.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Loukin SH, 1997, EMBO J, V16, P4817, DOI 10.1093/emboj/16.16.4817; Madrid R, 1998, J BIOL CHEM, V273, P14838, DOI 10.1074/jbc.273.24.14838; MCCUSKER JH, 1987, MOL CELL BIOL, V7, P4082, DOI 10.1128/MCB.7.11.4082; MENDOZA I, 1994, J BIOL CHEM, V269, P8792; Miseta A, 1999, J BIOL CHEM, V274, P5939, DOI 10.1074/jbc.274.9.5939; Mukherjee S, 2006, BIOCHEM J, V398, P97, DOI 10.1042/BJ20060388; MURGUIA JR, 1995, SCIENCE, V267, P232; Murtazina R, 2001, EUR J BIOCHEM, V268, P4674, DOI 10.1046/j.1432-1327.2001.02391.x; Nakamura N, 2005, J BIOL CHEM, V280, P1561, DOI 10.1074/jbc.M410041200; Nass R, 1997, J BIOL CHEM, V272, P26145, DOI 10.1074/jbc.272.42.26145; Nass R, 1998, J BIOL CHEM, V273, P21054, DOI 10.1074/jbc.273.33.21054; Navarre C, 2000, EMBO J, V19, P2515, DOI 10.1093/emboj/19.11.2515; Numata M, 2001, J BIOL CHEM, V276, P17387, DOI 10.1074/jbc.M101319200; Padan E, 2001, BBA-BIOENERGETICS, V1505, P144, DOI 10.1016/S0005-2728(00)00284-X; Pardo JM, 2006, J EXP BOT, V57, P1181, DOI 10.1093/jxb/erj114; Pelham HRB, 1996, CELL STRUCT FUNCT, V21, P413, DOI 10.1247/csf.21.413; Rodriguez-Rosales MP, 2008, NEW PHYTOL, V179, P366, DOI 10.1111/j.1469-8137.2008.02461.x; Piper RC, 2001, TRAFFIC, V2, P612, DOI 10.1034/j.1600-0854.2001.20904.x; Pouyssegur J, 2001, Novartis Found Symp, V240, P186; Quintero FJ, 2000, FEBS LETT, V471, P224, DOI 10.1016/S0014-5793(00)01412-5; RAYMOND CK, 1992, MOL BIOL CELL, V3, P1389, DOI 10.1091/mbc.3.12.1389; Ritter M, 2001, CELL PHYSIOL BIOCHEM, V11, P1, DOI 10.1159/000047787; ROBERTS CJ, 1991, METHOD ENZYMOL, V194, P644; Rockwell NC, 2002, J BIOL CHEM, V277, P17531, DOI 10.1074/jbc.M111909200; RODRIGUEZNAVARRO A, 1984, J BACTERIOL, V159, P940; Roos W, 1997, J BIOL CHEM, V272, P15849, DOI 10.1074/jbc.272.25.15849; RUBIO F, 1995, SCIENCE, V270, P1660, DOI 10.1126/science.270.5242.1660; Sato Y, 2005, J BIOCHEM, V138, P425, DOI 10.1093/jb/mvi132; Schapiro FB, 2000, J BIOL CHEM, V275, P21025, DOI 10.1074/jbc.M002386200; Shaw JD, 2001, EXP CELL RES, V271, P1, DOI 10.1006/excr.2001.5373; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Sychrova H, 1999, FEMS MICROBIOL LETT, V171, P167, DOI 10.1111/j.1574-6968.1999.tb13428.x; Venema K, 2003, J BIOL CHEM, V278, P22453, DOI 10.1074/jbc.M210794200; Venema K, 2002, J BIOL CHEM, V277, P2413, DOI 10.1074/jbc.M105043200; WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310; Wakabayashi S, 2000, J BIOL CHEM, V275, P7942, DOI 10.1074/jbc.275.11.7942; Warringer J, 2003, P NATL ACAD SCI USA, V100, P15724, DOI 10.1073/pnas.2435976100; Yadav J, 2007, MOL BIOL CELL, V18, P1480, DOI 10.1091/mbc.E06-11-1049; Yamaguchi T, 2005, P NATL ACAD SCI USA, V102, P16107, DOI 10.1073/pnas.0504437102; Yamaguchi T, 2003, P NATL ACAD SCI USA, V100, P12510, DOI 10.1073/pnas.2034966100; Yokoi S, 2002, PLANT J, V30, P529, DOI 10.1046/j.1365-313X.2002.01309.x; Yoshida S, 2000, MOL GEN GENET, V263, P877, DOI 10.1007/s004380000255; Zegers MMP, 1998, BIOCHEM J, V336, P257, DOI 10.1042/bj3360257; Zizak M, 2000, BIOCHEMISTRY-US, V39, P8102, DOI 10.1021/bi000870t	63	62	64	2	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14276	14285		10.1074/jbc.M806203200	http://dx.doi.org/10.1074/jbc.M806203200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19307188	Green Published, hybrid			2022-12-27	WOS:000266286100034
J	Hua, QX; Xu, B; Huang, K; Hu, SQ; Nakagawa, S; Jia, WH; Wang, S; Whittaker, J; Katsoyannis, PG; Weiss, MA				Hua, Qing-xin; Xu, Bin; Huang, Kun; Hu, Shi-Quan; Nakagawa, Satoe; Jia, Wenhua; Wang, Shuhua; Whittaker, Jonathan; Katsoyannis, Panayotis G.; Weiss, Michael A.			Enhancing the Activity of a Protein by Stereospecific Unfolding CONFORMATIONAL LIFE CYCLE OF INSULIN AND ITS EVOLUTIONARY ORIGINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIABETES-ASSOCIATED MUTATIONS; RECEPTOR-BINDING SURFACE; SINGLE-CHAIN INSULIN; MUTANT HUMAN INSULIN; PHOTO-CROSS-LINKING; B-CHAIN; A-CHAIN; CHIRAL MUTAGENESIS; STRUCTURAL SWITCH; CRYSTAL-STRUCTURE	A central tenet of molecular biology holds that the function of a protein is mediated by its structure. An inactive ground-state conformation may nonetheless be enjoined by the interplay of competing biological constraints. A model is provided by insulin, well characterized at atomic resolution by x-ray crystallography. Here, we demonstrate that the activity of the hormone is enhanced by stereospecific unfolding of a conserved structural element. A bifunctional beta-strand mediates both self-assembly (within beta-cell storage vesicles) and receptor binding (in the bloodstream). This strand is anchored by an invariant side chain (Phe(B24)); its substitution by Ala leads to an unstable but native-like analog of low activity. Substitution by D-Ala is equally destabilizing, and yet the protein diastereomer exhibits enhanced activity with segmental unfolding of the beta-strand. Corresponding photoactivable derivatives (containing L- or D-para-azido-Phe) cross-link to the insulin receptor with higher D-specific efficiency. Aberrant exposure of hydrophobic surfaces in the analogs is associated with accelerated fibrillation, a form of aggregation-coupled misfolding associated with cellular toxicity. Conservation of Phe(B24), enforced by its dual role in native self-assembly and induced fit, thus highlights the implicit role of misfolding as an evolutionary constraint. Whereas classical crystal structures of insulin depict its storage form, signaling requires engagement of a detachable arm at an extended receptor interface. Because this active conformation resembles an amyloidogenic intermediate, we envisage that induced fit and self-assembly represent complementary molecular adaptations to potential proteotoxicity. The cryptic threat of misfolding poses a universal constraint in the evolution of polypeptide sequences.	[Hua, Qing-xin; Xu, Bin; Huang, Kun; Hu, Shi-Quan; Jia, Wenhua; Wang, Shuhua; Whittaker, Jonathan; Weiss, Michael A.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Nakagawa, Satoe] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Katsoyannis, Panayotis G.] Mt Sinai Sch Med, Dept Pharmacol & Biol Chem, New York, NY 10029 USA	Case Western Reserve University; University of Chicago; Icahn School of Medicine at Mount Sinai	Weiss, MA (corresponding author), Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA.	michael.weiss@case.edu	Huang, Kun/H-4427-2012	Xu, Bin/0000-0002-0490-9540	National Institutes of Health [DK040949, DK069764]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069764, R01DK040949] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK040949 and DK069764 (to M.A.W.). This is a contribution from the Cleveland Center for Membrane and Structural Biology.	Ahmad A, 2003, BIOCHEMISTRY-US, V42, P11404, DOI 10.1021/bi034868o; ASSOIAN RK, 1982, P NATL ACAD SCI-BIOL, V79, P5147, DOI 10.1073/pnas.79.17.5147; BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; Bang D, 2004, ANGEW CHEM INT EDIT, V43, P2534, DOI 10.1002/anie.200353540; BENTLEY G, 1976, NATURE, V261, P166, DOI 10.1038/261166a0; Brange J, 1997, J PHARM SCI, V86, P517, DOI 10.1021/js960297s; Brange J, 1997, PROTEINS, V27, P507, DOI 10.1002/(SICI)1097-0134(199704)27:4<507::AID-PROT4>3.3.CO;2-H; BREMS DN, 1992, PROTEIN ENG, V5, P527, DOI 10.1093/protein/5.6.527; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; CASARETTO M, 1987, BIOL CHEM H-S, V368, P709, DOI 10.1515/bchm3.1987.368.1.709; COSMATOS A, 1979, INT J PEPT PROT RES, V14, P457; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; DEREWENDA U, 1989, NATURE, V338, P594, DOI 10.1038/338594a0; DEREWENDA U, 1991, J MOL BIOL, V220, P425, DOI 10.1016/0022-2836(91)90022-X; Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; FISCHER WH, 1985, BIOL CHEM H-S, V366, P521, DOI 10.1515/bchm3.1985.366.1.521; Hua QX, 2008, J BIOL CHEM, V283, P14703, DOI 10.1074/jbc.M800313200; Hua QX, 2006, J BIOL CHEM, V281, P28131, DOI 10.1074/jbc.M602616200; Hua QX, 2006, J BIOL CHEM, V281, P24900, DOI 10.1074/jbc.M602691200; Hua QX, 2006, J BIOL CHEM, V281, P24889, DOI 10.1074/jbc.M602617200; HUA QX, 1993, P NATL ACAD SCI USA, V90, P582, DOI 10.1073/pnas.90.2.582; Hua QX, 2004, J BIOL CHEM, V279, P21449, DOI 10.1074/jbc.M314141200; Hua QX, 1998, J MOL BIOL, V277, P103, DOI 10.1006/jmbi.1997.1574; HUA QX, 1995, NAT STRUCT BIOL, V2, P129, DOI 10.1038/nsb0295-129; Hua QX, 2002, BIOCHEMISTRY-US, V41, P14700, DOI 10.1021/bi0202981; Hua QX, 2002, J BIOL CHEM, V277, P43443, DOI 10.1074/jbc.M206107200; Hua QX, 1996, J MOL BIOL, V264, P390, DOI 10.1006/jmbi.1996.0648; HUA QX, 1991, NATURE, V354, P238, DOI 10.1038/354238a0; Hua QX, 2001, BIOCHEMISTRY-US, V40, P12299, DOI 10.1021/bi011021o; Huang K, 2005, J BIOL CHEM, V280, P42345, DOI 10.1074/jbc.M507110200; Huang K, 2004, J MOL BIOL, V341, P529, DOI 10.1016/j.jmb.2004.05.023; Huang K, 2007, J BIOL CHEM, V282, P35337, DOI 10.1074/jbc.M705996200; Huang YD, 2001, SCI CHINA SER C, V44, P593, DOI 10.1007/BF02879353; Jacoby E, 1996, J MOL BIOL, V258, P136, DOI 10.1006/jmbi.1996.0239; KAARSHOLM NC, 1993, BIOCHEMISTRY-US, V32, P10773, DOI 10.1021/bi00091a031; KATSOYANNIS PG, 1966, SCIENCE, V154, P1509, DOI 10.1126/science.154.3756.1509; Keyhanfar M, 2007, BIOCHEM J, V401, P269, DOI 10.1042/BJ20060890; KOBAYASHI M, 1989, DIABETES RES CLIN PR, V7, P25, DOI 10.1016/0168-8227(89)90040-5; KOBAYASHI M, 1984, BIOCHEM BIOPH RES CO, V119, P49, DOI 10.1016/0006-291X(84)91616-4; KOBAYASHI M, 1982, BIOCHEM BIOPH RES CO, V107, P329, DOI 10.1016/0006-291X(82)91708-9; KRISTENSEN C, 1995, BIOCHEM J, V305, P981, DOI 10.1042/bj3050981; Kurapkat G, 1999, PROTEIN SCI, V8, P499; KUROSE T, 1994, J BIOL CHEM, V269, P29190; LIANG DC, 1994, BIOPHYS CHEM, V50, P63, DOI 10.1016/0301-4622(94)85020-8; Ludvigsen S, 1998, J MOL BIOL, V279, P1, DOI 10.1006/jmbi.1998.1801; MARKUSSEN J, 1985, INT J PEPT PROT RES, V26, P70; MARKUSSEN J, 1987, PEPTIDES 1986, P189, DOI DOI 10.1002/BIT.260460206; MIRMIRA RG, 1991, J BIOL CHEM, V266, P1428; MIRMIRA RG, 1989, J BIOL CHEM, V264, P6349; Nakagawa SH, 2006, J BIOL CHEM, V281, P22386, DOI 10.1074/jbc.M603547200; Nakagawa SH, 2005, BIOCHEMISTRY-US, V44, P4984, DOI 10.1021/bi048025o; NAKAGAWA SH, 1992, BIOCHEMISTRY-US, V31, P3204, DOI 10.1021/bi00127a023; Nakagawa SH, 2000, BIOCHEMISTRY-US, V39, P15826, DOI 10.1021/bi001802+; NANJO K, 1986, J CLIN INVEST, V77, P514, DOI 10.1172/JCI112331; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P8397, DOI 10.1021/bi0105983; NISHI M, 1990, MOL ENDOCRINOL, V4, P1192, DOI 10.1210/mend-4-8-1192; Olsen HB, 1996, BIOCHEMISTRY-US, V35, P8836, DOI 10.1021/bi960292+; PULLEN RA, 1976, NATURE, V259, P369, DOI 10.1038/259369a0; Qiao ZS, 2001, BIOCHEMISTRY-US, V40, P2662, DOI 10.1021/bi001613r; SCHWARTZ GP, 1987, P NATL ACAD SCI USA, V84, P6408, DOI 10.1073/pnas.84.18.6408; SHOELSON SE, 1992, BIOCHEMISTRY-US, V31, P1757, DOI 10.1021/bi00121a025; Smith GD, 2003, ACTA CRYSTALLOGR D, V59, P474, DOI 10.1107/S0907444902023685; Sohma Y, 2008, ANGEW CHEM INT EDIT, V47, P1102, DOI 10.1002/anie.200703521; Sosnick TR, 2000, METHOD ENZYMOL, V317, P393; STEINER DF, 1990, DIABETES CARE, V13, P600, DOI 10.2337/diacare.13.6.600; TANG JG, 1990, BIOCHEM J, V268, P429, DOI 10.1042/bj2680429; Wan ZL, 2005, BIOCHEMISTRY-US, V44, P5000, DOI 10.1021/bi047585k; Wan ZL, 2003, BIOCHEMISTRY-US, V42, P12770, DOI 10.1021/bi034430o; WAUGH DF, 1946, J AM CHEM SOC, V68, P247, DOI 10.1021/ja01206a030; WAUGH DF, 1953, J AM CHEM SOC, V75, P2592, DOI 10.1021/ja01107a013; Weiss MA, 2002, BIOCHEMISTRY-US, V41, P809, DOI 10.1021/bi011839+; Weiss MA, 2001, J BIOL CHEM, V276, P40018, DOI 10.1074/jbc.M104634200; WEISS MA, 1991, BIOCHEMISTRY-US, V30, P7373, DOI 10.1021/bi00244a004; Xu B, 2004, BIOCHEMISTRY-US, V43, P8356, DOI 10.1021/bi0497796; Xu B, 2004, DIABETES, V53, P1599, DOI 10.2337/diabetes.53.6.1599; Xu B, 2002, J MOL BIOL, V316, P435, DOI 10.1006/jmbi.2001.5377; Xu B, 2009, J BIOL CHEM, V284, P14597, DOI 10.1074/jbc.M900087200	79	37	38	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14586	14596		10.1074/jbc.M900085200	http://dx.doi.org/10.1074/jbc.M900085200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19321436	Green Published, hybrid			2022-12-27	WOS:000266286100064
J	Kaur, H; Kumar, C; Junot, C; Toledano, MB; Bachhawat, AK				Kaur, Hardeep; Kumar, Chitranshu; Junot, Christophe; Toledano, Michel B.; Bachhawat, Anand K.			Dug1p Is a Cys-Gly Peptidase of the gamma-Glutamyl Cycle of Saccharomyces cerevisiae and Represents a Novel Family of Cys-Gly Peptidases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI K-12; SCHIZOSACCHAROMYCES-POMBE; GLUTATHIONE TRANSPORTER; LEUCYL AMINOPEPTIDASE; RENAL DIPEPTIDASE; PURIFICATION; CYSTEINYLGLYCINE; IDENTIFICATION; TRANSPEPTIDASE; DEGRADATION	GSH metabolism in yeast is carried out by the gamma-glutamyl cycle as well as by the DUG complex. One of the last steps in the gamma-glutamyl cycle is the cleavage of Cys-Gly by a peptidase to the constitutent amino acids. Saccharomyces cerevisiae extracts carry Cys-Gly dipeptidase activity, but the corresponding gene has not yet been identified. We describe the isolation and characterization of a novel Cys-Gly dipeptidase, encoded by the DUG1 gene. Dug1p had previously been identified as part of the Dug1p-Dug2p-Dug3p complex that operates as an alternate GSH degradation pathway and has also been suggested to function as a possible di- or tripeptidase based on genetic studies. We show here that Dug1p is a homodimer that can also function in a Dug2-Dug3-independent manner as a dipeptidase with high specificity for Cys-Gly and no activity toward tri- or tetrapeptides in vitro. This activity requires zinc or manganese ions. Yeast cells lacking Dug1p (dug1 Delta) accumulate Cys-Gly. Unlike all other Cys-Gly peptidases, which are members of the metallopeptidase M17, M19, or M1 families, Dug1p is the first to belong to the M20A family. We also show that the Dug1p Schizosaccharomyces pombe orthologue functions as the exclusive Cys-Gly peptidase in this organism. The human orthologue CNDP2 also displays Cys-Gly peptidase activity, as seen by complementation of the dug1 Delta mutant and by biochemical characterization, which revealed a high substrate specificity and affinity for Cys-Gly. The results indicate that the Dug1p family represents a novel class of Cys-Gly dipeptidases.	[Kaur, Hardeep; Bachhawat, Anand K.] Inst Microbial Technol, Chandigarh 160036, India; [Kumar, Chitranshu; Toledano, Michel B.] CEA Saclay, Lab Stress Oxydants & Cancers, F-91191 Gif Sur Yvette, France; [Junot, Christophe] CEA, Serv Pharmacol & Immunoanal, DSV, iBiTec S,SPI, F-91191 Gif Sur Yvette, France	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); CEA; UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Saclay	Bachhawat, AK (corresponding author), Inst Microbial Technol, Sector 39-A, Chandigarh 160036, India.	anand@imtech.res.in	Junot, Christophe/AAG-2251-2020		Department of Science and Technology, Government of India; Department of Biotechnology, Government of India	Department of Science and Technology, Government of India(Department of Science & Technology (India)); Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India)	Supported by grant-in-aid projects from the Department of Science and Technology, Government of India, and the Department of Biotechnology, Government of India. To whom correspondence should be addressed.	ADACHI H, 1989, J BIOCHEM-TOKYO, V105, P957, DOI 10.1093/oxfordjournals.jbchem.a122787; Alfa C, 1993, EXPT FISSION YEAST L; Bourbouloux A, 2000, J BIOL CHEM, V275, P13259, DOI 10.1074/jbc.275.18.13259; CAMPBELL BJ, 1984, J BIOL CHEM, V259, P4586; Cappiello M, 2004, BIOCHEM J, V378, P35, DOI 10.1042/BJ20031336; Chaudhuri B, 1997, GENETICS, V145, P75; Chu LR, 2008, J BIOL CHEM, V283, P19351, DOI 10.1074/jbc.M801034200; Del Bello B, 1999, FASEB J, V13, P69; Dominici S, 1999, FREE RADICAL BIO MED, V27, P623, DOI 10.1016/S0891-5849(99)00111-2; Dringen R, 2001, J NEUROSCI RES, V66, P1003, DOI 10.1002/jnr.10042; Enoiu M, 2000, FREE RADICAL BIO MED, V29, P825, DOI 10.1016/S0891-5849(00)00370-1; FAHEY RC, 1987, J MOL EVOL, V25, P81, DOI 10.1007/BF02100044; FERGUSON KA, 1964, METABOLISM, V13, P985, DOI 10.1016/S0026-0495(64)80018-4; Fujita Y, 2004, BIOSCI BIOTECH BIOCH, V68, P306, DOI 10.1271/bbb.68.306; GAITONDE MK, 1967, BIOCHEM J, V104, P627, DOI 10.1042/bj1040627; Ganguli D, 2007, GENETICS, V175, P1137, DOI 10.1534/genetics.106.066944; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; JASPERS CJ, 1985, PHYTOCHEMISTRY, V24, P703; Josch C, 2003, BIOL CHEM, V384, P213, DOI 10.1515/BC.2003.023; KOZAK EM, 1982, J BIOL CHEM, V257, P6322; Kumada HO, 2007, BIOSCI BIOTECH BIOCH, V71, P3102, DOI 10.1271/bbb.70443; Kumar C, 2003, FEMS MICROBIOL LETT, V219, P187, DOI 10.1016/S0378-1097(03)00059-4; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lafaye A, 2005, J BIOL CHEM, V280, P24723, DOI 10.1074/JBC.M502285200; Madalinski G, 2008, ANAL CHEM, V80, P3291, DOI 10.1021/ac7024915; MCINTYRE T, 1982, J BIOL CHEM, V257, P1915; MEISTER A, 1983, ANNU REV BIOCHEM, V52, P711, DOI 10.1146/annurev.bi.52.070183.003431; OLSON CK, 1950, J BIOL CHEM, V186, P731; Otani H, 2005, J BIOCHEM, V137, P167, DOI 10.1093/jb/mvi016; Paolicchi A, 2002, BIOCHEM PHARMACOL, V64, P1027, DOI 10.1016/S0006-2952(02)01173-5; Penninckx MJ, 2002, FEMS YEAST RES, V2, P295, DOI 10.1111/j.1567-1364.2002.tb00098.x; Rawlings ND, 2006, NUCLEIC ACIDS RES, V34, pD270, DOI 10.1093/nar/gkj089; SHERWOOD RF, 1985, EUR J BIOCHEM, V148, P447, DOI 10.1111/j.1432-1033.1985.tb08860.x; Srikanth CV, 2005, CURR GENET, V47, P345, DOI 10.1007/s00294-005-0571-7; Suzuki H, 2001, J BACTERIOL, V183, P1489, DOI 10.1128/JB.183.4.1489-1490.2001; Suzuki H, 2001, BIOSCI BIOTECH BIOCH, V65, P1549, DOI 10.1271/bbb.65.1549; Teufel M, 2003, J BIOL CHEM, V278, P6521, DOI 10.1074/jbc.M209764200; Thakur A, 2008, FEMS YEAST RES, V8, P916, DOI 10.1111/j.1567-1364.2008.00423.x	38	58	64	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14493	14502		10.1074/jbc.M808952200	http://dx.doi.org/10.1074/jbc.M808952200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19346245	Green Published, hybrid			2022-12-27	WOS:000266286100056
J	Wang, ZH; Treder, K; Miller, WA				Wang, Zhaohui; Treder, Krzysztof; Miller, W. Allen			Structure of a Viral Cap-independent Translation Element That Functions via High Affinity Binding to the eIF4E Subunit of eIF4F	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TOBACCO NECROSIS VIRUS; INITIATION-FACTOR 4E; MESSENGER-RNA-CAP; SELECTIVE 2'-HYDROXYL ACYLATION; SINGLE NUCLEOTIDE RESOLUTION; PRIMER EXTENSION SHAPE; YEAST 2-HYBRID SYSTEM; ENATION MOSAIC-VIRUS; FACTOR ISO 4E; 3'-UNTRANSLATED REGION	RNAs of many positive strand RNA viruses lack a 5' cap structure and instead rely on cap-independent translation elements (CITEs) to facilitate efficient translation initiation. The mechanisms by which these RNAs recruit ribosomes are poorly understood, and for many viruses the CITE is unknown. Here we identify the first CITE of an umbravirus in the 3'-untranslated region of pea enation mosaic virus RNA 2. Chemical and enzymatic probing of the similar to 100-nucleotide PEMV RNA 2 CITE (PTE), and mutagenesis revealed that it forms a long, bulged helix that branches into two short stem-loops, with a possible pseudoknot interaction between a C-rich bulge at the branch point and a G-rich bulge in the main helix. The PTE inhibited translation in trans, and addition of eIF4F, but not eIFiso4F, restored translation. Filter binding assays revealed that the PTE binds eIF4F and its eIF4E subunit with high affinity. Tight binding required an intact cap-binding pocket in eIF4E. Among many PTE mutants, there was a strong correlation between PTE-eIF4E binding affinity and ability to stimulate cap-independent translation. We conclude that the PTE recruits eIF4F by binding eIF4E. The PTE represents a different class of translation enhancer element, as defined by its structure and ability to bind eIF4E in the absence of an m(7)G cap.	[Wang, Zhaohui; Treder, Krzysztof; Miller, W. Allen] Iowa State Univ, Dept Plant Pathol, Ames, IA 50011 USA; [Miller, W. Allen] Iowa State Univ, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA	Iowa State University; Iowa State University	Miller, WA (corresponding author), Iowa State Univ, Dept Plant Pathol, 351 Bessey Hall, Ames, IA 50011 USA.	wamiller@iastate.edu	Wang, Zhaohui/E-8139-2013; Treder, Krzysztof/L-3856-2014	Treder, Krzysztof/0000-0002-8764-0574	National Institutes of Health [2R01 GM067104]; Hatch Act and State of Iowa funds [3608]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067104] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hatch Act and State of Iowa funds; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant 2R01 GM067104. This is journal paper of the Iowa Agriculture and Home Economics Experiment Station, Ames, IA, Project No. 3608 was supported by Hatch Act and State of Iowa funds.	ALLEN ML, 1992, J BIOL CHEM, V267, P23232; Amrani N, 2008, NATURE, V453, P1276, DOI 10.1038/nature06974; Barry JK, 2002, P NATL ACAD SCI USA, V99, P11133, DOI 10.1073/pnas.162223099; Beauchemin C, 2007, J VIROL, V81, P775, DOI 10.1128/JVI.01277-06; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Browning KS, 2004, BIOCHEM SOC T, V32, P589, DOI 10.1042/BST0320589; Browning KS, 1996, PLANT MOL BIOL, V32, P107, DOI 10.1007/BF00039380; Charron C, 2008, PLANT J, V54, P56, DOI 10.1111/j.1365-313X.2008.03407.x; Demler SA, 1997, J GEN VIROL, V78, P511, DOI 10.1099/0022-1317-78-3-511; DEMLER SA, 1993, J GEN VIROL, V74, P1, DOI 10.1099/0022-1317-74-1-1; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; Fabian MR, 2006, RNA, V12, P1304, DOI 10.1261/rna.69506; Fabian MR, 2004, J BIOL CHEM, V279, P28862, DOI 10.1074/jbc.M401272200; Gallie DR, 2002, NUCLEIC ACIDS RES, V30, P3401, DOI 10.1093/nar/gkf457; Gallie DR, 2001, J BIOL CHEM, V276, P36951, DOI 10.1074/jbc.M103869200; Gazo BM, 2004, J BIOL CHEM, V279, P13584, DOI 10.1074/jbc.M311361200; German-Retana S, 2008, J VIROL, V82, P7601, DOI 10.1128/JVI.00209-08; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; GOSS DJ, 1990, BIOCHEMISTRY-US, V29, P5008, DOI 10.1021/bi00473a002; Gross JD, 2003, CELL, V115, P739, DOI 10.1016/S0092-8674(03)00975-9; Guo L, 2001, MOL CELL, V7, P1103, DOI 10.1016/S1097-2765(01)00252-0; Guo L, 2000, RNA, V6, P1808, DOI 10.1017/S1355838200001539; Hentze MW, 2007, TRANSLATIONAL CONTRO, P269; Jan E, 2006, VIRUS RES, V119, P16, DOI 10.1016/j.virusres.2005.10.011; JEFFREY SB, 2006, FEBS LETT, V580, P2591; Karetnikov A, 2007, J GEN VIROL, V88, P286, DOI 10.1099/vir.0.82307-0; Khan MA, 2008, J BIOL CHEM, V283, P1340, DOI 10.1074/jbc.M703356200; KOZAK M, 1991, J BIOL CHEM, V266, P19867; Lellis AD, 2002, CURR BIOL, V12, P1046, DOI 10.1016/S0960-9822(02)00898-9; Leonard S, 2000, J VIROL, V74, P7730, DOI 10.1128/JVI.74.17.7730-7737.2000; Marcotrigiano J, 1997, CELL, V89, P951, DOI 10.1016/S0092-8674(00)80280-9; Mayberry LK, 2007, METHOD ENZYMOL, V430, P397, DOI 10.1016/S0076-6879(07)30015-3; Merino EJ, 2005, J AM CHEM SOC, V127, P4223, DOI 10.1021/ja043822v; Meulewaeter F, 1998, RNA, V4, P1347, DOI 10.1017/S135583829898092X; Miller WA, 2007, BIOCHEM SOC T, V35, P1629, DOI 10.1042/BST0351629; Miller WA, 2006, ANNU REV PHYTOPATHOL, V44, P447, DOI 10.1146/annurev.phyto.44.070505.143353; MILLER WA, 2009, RECODING EX IN PRESS; Mizumoto H, 2003, J VIROL, V77, P12113, DOI 10.1128/JVI.77.22.12113-12121.2003; Mochizuki K, 2005, RNA, V11, P77, DOI 10.1261/rna.7108205; Monzingo AF, 2007, PLANT PHYSIOL, V143, P1504, DOI 10.1104/pp.106.093146; Morino S, 1996, EUR J BIOCHEM, V239, P597, DOI 10.1111/j.1432-1033.1996.0597u.x; Niedzwiecka A, 2002, J MOL BIOL, V319, P615, DOI 10.1016/S0022-2836(02)00328-5; Niepel M, 1999, FEBS LETT, V462, P79, DOI 10.1016/S0014-5793(99)01514-8; Nieto C, 2006, PLANT J, V48, P452, DOI 10.1111/j.1365-313X.2006.02885.x; Pestova TV, 2002, GENE DEV, V16, P2906, DOI 10.1101/gad.1020902; Pestova TV, 2001, P NATL ACAD SCI USA, V98, P7029, DOI 10.1073/pnas.111145798; Pestova TV, 2007, TRANSLATIONAL CONTRO, V4, P87; Kneller ELP, 2006, VIRUS RES, V119, P63, DOI 10.1016/j.virusres.2005.10.010; Qu F, 2000, J VIROL, V74, P1085, DOI 10.1128/JVI.74.3.1085-1093.2000; RAKOTONDRAFARA AM, 2007, CURRENT PROTOCOLS MI; Rakotondrafara AM, 2006, RNA, V12, P1893, DOI 10.1261/rna.115606; Ray S, 2006, J BIOL CHEM, V281, P35826, DOI 10.1074/jbc.M605762200; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; Robaglia C, 2006, TRENDS PLANT SCI, V11, P40, DOI 10.1016/j.tplants.2005.11.004; Rutkowska-Wlodarczyk I, 2008, BIOCHEMISTRY-US, V47, P2710, DOI 10.1021/bi701168z; Schaad MC, 2000, VIROLOGY, V273, P300, DOI 10.1006/viro.2000.0416; Scheets K, 2006, VIROLOGY, V350, P171, DOI 10.1016/j.virol.2006.02.004; Shen RZ, 2004, J VIROL, V78, P4655, DOI 10.1128/JVI.78.9.4655-4664.2004; Sonenberg N, 2003, CURR OPIN STRUC BIOL, V13, P56, DOI 10.1016/S0959-440X(03)00009-5; Stupina VA, 2008, RNA, V14, P2379, DOI 10.1261/rna.1227808; Taliansky ME, 2003, J GEN VIROL, V84, P1951, DOI 10.1099/vir.0.19219-0; TIMMER RT, 1993, J BIOL CHEM, V268, P9504; Tomoo K, 2003, J MOL BIOL, V328, P365, DOI 10.1016/S0022-2836(03)00314-0; Tomoo K, 2002, BIOCHEM J, V362, P539, DOI 10.1042/0264-6021:3620539; Treder K, 2008, RNA, V14, P134, DOI 10.1261/rna.777308; Truniger V, 2008, PLANT J, V56, P716, DOI 10.1111/j.1365-313X.2008.03630.x; Van Lipzig R, 2002, RNA, V8, P229, DOI 10.1017/S1355838202018071; von der Haar T, 2004, NAT STRUCT MOL BIOL, V11, P503, DOI 10.1038/nsmb779; WANG SP, 1995, J BIOL CHEM, V270, P13446, DOI 10.1074/jbc.270.22.13446; Wang SP, 1997, EMBO J, V16, P4107, DOI 10.1093/emboj/16.13.4107; Wells SE, 1998, MOL CELL, V2, P135, DOI 10.1016/S1097-2765(00)80122-7; Wilkinson KA, 2006, NAT PROTOC, V1, P1610, DOI 10.1038/nprot.2006.249; Wittmann S, 1997, VIROLOGY, V234, P84, DOI 10.1006/viro.1997.8634; WONG I, 1993, P NATL ACAD SCI USA, V90, P5428, DOI 10.1073/pnas.90.12.5428; Zeenko V, 2005, J BIOL CHEM, V280, P26813, DOI 10.1074/jbc.M503576200; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	76	60	63	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14189	14202		10.1074/jbc.M808841200	http://dx.doi.org/10.1074/jbc.M808841200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19276085	hybrid, Green Published			2022-12-27	WOS:000266286100025
J	Diab, H; Ohira, M; Liu, ML; Cobb, E; Kane, PM				Diab, Heba; Ohira, Masashi; Liu, Mali; Cobb, Ester; Kane, Patricia M.			Subunit Interactions and Requirements for Inhibition of the Yeast V-1-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACUOLAR H+-ATPASE; N-TERMINAL DOMAIN; V-ATPASE; REGULATORY PROTEIN; CRYSTAL-STRUCTURE; PERIPHERAL STALK; STATOR; F-1-ATPASE; COMPLEX; VMA13P	Disassembly of the yeast V-ATPase into cytosolic V-1 and membrane V-0 sectors inactivates MgATPase activity of the V-1-ATPase. This inactivation requires the V-1 H subunit (Parra, K. J., Keenan, K. L., and Kane, P. M. (2000) J. Biol. Chem. 275, 21761-21767), but its mechanism is not fully understood. The H subunit has two domains. Interactions of each domain with V-1 and V-0 subunits were identified by two-hybrid assay. The B subunit of the V-1 catalytic headgroup interacted with the H sub unit N-terminal domain (H-NT), and the C-terminal domain (H-CT) interacted with V-1 subunits B, E (peripheral stalk), and D (central stalk), and the cytosolic N-terminal domain of V-0 subunit Vph1p. V-1-ATPase complexes from yeast expressing H-NT are partially inhibited, exhibiting 26% the MgATPase activity of complexes with no H subunit. The H-CT domain does not copurify with V-1 when expressed in yeast, but the bacterially expressed and purified H-CT domain inhibits MgATPase activity in V-1 lacking H almost as well as the full-length H subunit. Binding of full-length H subunit to V-1 was more stable than binding of either H-NT or H-CT, suggesting that both domains contribute to binding and inhibition. Intact H and H-CT can bind to the expressed N-terminal domain of Vph1p, but this fragment of Vph1p does not bind to V-1 complexes containing subunit H. We propose that upon disassembly, the H subunit undergoes a conformational change that inhibits V-1-ATPase activity and precludes V-0 interactions.	[Diab, Heba; Ohira, Masashi; Liu, Mali; Cobb, Ester; Kane, Patricia M.] SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Kane, PM (corresponding author), SUNY Upstate Med Univ, Dept Biochem & Mol Biol, Syracuse, NY 13210 USA.	kanepm@upstate.edu			National Institutes of Health [R01-GM50322]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM050322] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM50322 ( to P. M. K.).	Bai C, 1997, METHOD ENZYMOL, V283, P141; Beyenbach KW, 2006, J EXP BIOL, V209, P577, DOI 10.1242/jeb.02014; Breton S, 2007, AM J PHYSIOL-RENAL, V292, pF1, DOI 10.1152/ajprenal.00340.2006; Cabezon E, 2003, NAT STRUCT BIOL, V10, P744, DOI 10.1038/nsb966; Cross RL, 2000, BBA-BIOENERGETICS, V1458, P270, DOI 10.1016/S0005-2728(00)00079-7; Curtis KK, 2002, J BIOL CHEM, V277, P2716, DOI 10.1074/jbc.M107777200; Dickson VK, 2006, EMBO J, V25, P2911, DOI 10.1038/sj.emboj.7601177; Drory O, 2004, EMBO REP, V5, P1148, DOI 10.1038/sj.embor.7400294; ELBLE R, 1992, BIOTECHNIQUES, V13, P18; Fethiere J, 2005, BIOCHEMISTRY-US, V44, P15906, DOI 10.1021/bi051762f; Flannery AR, 2008, J BIOL CHEM, V283, P29099, DOI 10.1074/jbc.M803280200; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Gledhill JR, 2007, P NATL ACAD SCI USA, V104, P15671, DOI 10.1073/pnas.0707326104; Gledhill JR, 2005, BIOCHEM J, V386, P591, DOI 10.1042/BJ20041513; Graf R, 1996, J BIOL CHEM, V271, P20908, DOI 10.1074/jbc.271.34.20908; Hirata T, 2003, J BIOL CHEM, V278, P23714, DOI 10.1074/jbc.M302756200; Huss M, 2007, FEBS LETT, V581, P5566, DOI 10.1016/j.febslet.2007.11.004; Imamizu H, 2003, P NATL ACAD SCI USA, V100, P5461, DOI 10.1073/pnas.0835746100; James P, 1996, GENETICS, V144, P1425; Jefferies KC, 2008, J BIOL CHEM, V283, P4512, DOI 10.1074/jbc.M707144200; Kane PA, 2006, MICROBIOL MOL BIOL R, V70, P177, DOI 10.1128/MMBR.70.1.177-191.2006; Kane PM, 2003, J BIOENERG BIOMEMBR, V35, P313, DOI 10.1023/A:1025724814656; KANE PM, 1992, J BIOL CHEM, V267, P447; Kitagawa N, 2008, J BIOL CHEM, V283, P3329, DOI 10.1074/jbc.M707924200; Landolt-Marticorena C, 2000, J BIOL CHEM, V275, P15449, DOI 10.1074/jbc.M000207200; Li SC, 2009, BBA-MOL CELL RES, V1793, P650, DOI 10.1016/j.bbamcr.2008.08.003; Liu ML, 2005, J BIOL CHEM, V280, P36978, DOI 10.1074/jbc.M505296200; Lolkema JS, 2003, J BIOENERG BIOMEMBR, V35, P323, DOI 10.1023/A:1025776831494; LOTSCHER HR, 1984, BIOCHEMISTRY-US, V23, P4128, DOI 10.1021/bi00313a018; Lu M, 2004, J BIOL CHEM, V279, P8732, DOI 10.1074/jbc.M303871200; Lu M, 2002, J BIOL CHEM, V277, P38409, DOI 10.1074/jbc.M203521200; Makyio H, 2005, EMBO J, V24, P3974, DOI 10.1038/sj.emboj.7600859; Nelson N, 1999, PHYSIOL REV, V79, P361, DOI 10.1152/physrev.1999.79.2.361; Ohira M, 2006, J BIOL CHEM, V281, P22752, DOI 10.1074/jbc.M601441200; Parra KJ, 2000, J BIOL CHEM, V275, P21761, DOI 10.1074/jbc.M002305200; Qi J, 2008, J BIOL CHEM, V283, P19274, DOI 10.1074/jbc.M802442200; Rizzo JM, 2007, J BIOL CHEM, V282, P8521, DOI 10.1074/jbc.M607092200; Sagermann M, 2001, P NATL ACAD SCI USA, V98, P7134, DOI 10.1073/pnas.131192798; Smardon AM, 2007, J BIOL CHEM, V282, P26185, DOI 10.1074/jbc.M703627200; Tucker WC, 2004, J BIOL CHEM, V279, P47415, DOI 10.1074/jbc.C400269200; Venzke D, 2005, J MOL BIOL, V349, P659, DOI 10.1016/j.jmb.2005.04.033; Voss M, 2007, J BIOL CHEM, V282, P33735, DOI 10.1074/jbc.M703368200; Walker JE, 2006, BBA-BIOENERGETICS, V1757, P286, DOI 10.1016/j.bbabio.2006.01.001; Wilkens S, 2004, J BIOL CHEM, V279, P41942, DOI 10.1074/jbc.M407821200; Zhang ZY, 2006, FEBS LETT, V580, P2006, DOI 10.1016/j.febslet.2006.03.001; Zhang ZY, 2003, J BIOL CHEM, V278, P47299, DOI 10.1074/jbc.M309445200	46	40	41	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13316	13325		10.1074/jbc.M900475200	http://dx.doi.org/10.1074/jbc.M900475200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19299516	hybrid, Green Published			2022-12-27	WOS:000265877300007
J	Lee, JH; Kim, HN; Yang, D; Jung, K; Kim, HM; Kim, HH; Ha, H; Lee, ZH				Lee, Jong-Ho; Kim, Ha-Neui; Yang, Daum; Jung, Kyoungsuk; Kim, Hyun-Man; Kim, Hong-Hee; Ha, Hyunil; Lee, Zang Hee			Trolox Prevents Osteoclastogenesis by Suppressing RANKL Expression and Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; NECROSIS-FACTOR-ALPHA; LACKING C-FOS; BONE-RESORPTION; RECEPTOR ACTIVATOR; MICE LACKING; CRUCIAL ROLE; OSTEOPROTEGERIN LIGAND; OXIDATIVE STRESS; GENE-EXPRESSION	Excessive receptor activator of NF-kappa B ligand (RANKL) signaling causes enhanced osteoclast formation and bone resorption. Thus, down-regulation of RANKL expression or its downstream signals may be a therapeutic approach to the treatment of pathological bone loss. In this study, we investigated the effects of Trolox, a water-soluble vitamin E analogue, on osteoclastogenesis and RANKL signaling. Trolox potently inhibited interleukin-1-induced osteoclast formation in bone marrow cell-osteoblast coculture by abrogating RANKL induction in osteoblasts. This RANKL reduction was attributed to the reduced production of prostaglandin E-2 via a down-regulation of cyclooxygenase-2 activity. We also found that Trolox inhibited osteoclast formation from bone marrow macrophages induced by macrophage colony-stimulating factor plus RANKL in a reversible manner. Trolox was effective only when present during the early stage of culture, which implies that it targets early osteoclast precursors. Pretreatment with Trolox did not affect RANKL-induced early signaling pathways, including MAPKs, NF-kappa B, and Akt. We found that Trolox down-regulated the induction by RANKL of c-Fos protein by suppressing its translation. Ectopic overexpression of c-Fos rescued the inhibition of osteoclastogenesis by Trolox in bone marrow macrophages. Trolox also suppressed interleukin-1-induced osteoclast formation and bone loss in mouse calvarial bone. Taken together, our findings indicate that Trolox prevents osteoclast formation and bone loss by inhibiting both RANKL induction in osteoblasts and c-Fos expression in osteoclast precursors.	[Lee, Jong-Ho; Kim, Ha-Neui; Yang, Daum; Jung, Kyoungsuk; Kim, Hyun-Man; Kim, Hong-Hee; Ha, Hyunil; Lee, Zang Hee] Seoul Natl Univ, Dept Cell & Dev Biol, Sch Dent, Dent Res Inst, Seoul 110749, South Korea	Seoul National University (SNU)	Ha, H (corresponding author), Seoul Natl Univ, Dept Cell & Dev Biol, Sch Dent, Dent Res Inst, 28 Yeongon Dong, Seoul 110749, South Korea.	hyunil74@hotmail.com; zang1959@snu.ac.kr			21st Century Frontier R D Program; Korea Science and Engineering Foundation Science Research Center; Korean Ministry of Education, Science, and Technology	21st Century Frontier R D Program(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Science and Engineering Foundation Science Research Center(Korea Science and Engineering Foundation); Korean Ministry of Education, Science, and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by a grant from the Center for Biological Modulators of the 21st Century Frontier R & D Program and the Korea Science and Engineering Foundation Science Research Center through Bone Metabolism Research Center, the Korean Ministry of Education, Science, and Technology.	Abramson SB, 2002, RHEUMATOLOGY, V41, P972, DOI 10.1093/rheumatology/41.9.972; Besselink GAJ, 2003, VOX SANG, V85, P25, DOI 10.1046/j.1423-0410.2003.00318.x; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Darnay BG, 1998, J BIOL CHEM, V273, P20551, DOI 10.1074/jbc.273.32.20551; Darnay BG, 1999, J BIOL CHEM, V274, P7724, DOI 10.1074/jbc.274.12.7724; David JP, 2002, J CELL SCI, V115, P4317, DOI 10.1242/jcs.00082; Diaz Z, 2005, BLOOD, V105, P1237, DOI 10.1182/blood-200405-1772; Eum HA, 2004, BRIT J PHARMACOL, V142, P35, DOI 10.1038/sj.bjp.0705758; Franzoso G, 1997, GENE DEV, V11, P3482, DOI 10.1101/gad.11.24.3482; GRIGORIADIS AE, 1994, SCIENCE, V266, P443, DOI 10.1126/science.7939685; Ha H, 2003, J BIOL CHEM, V278, P18573, DOI 10.1074/jbc.M212626200; Ha H, 2006, J IMMUNOL, V176, P111, DOI 10.4049/jimmunol.176.1.111; Ha H, 2004, EXP CELL RES, V301, P119, DOI 10.1016/j.yexcr.2004.07.035; Hofbauer LC, 1999, BONE, V25, P255, DOI 10.1016/S8756-3282(99)00162-3; Iotsova V, 1997, NAT MED, V3, P1285, DOI 10.1038/nm1197-1285; Ito Y, 2005, BONE, V37, P842, DOI 10.1016/j.bone.2005.04.030; Kudo O, 2003, BONE, V32, P1, DOI 10.1016/S8756-3282(02)00915-8; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lean JM, 2003, J CLIN INVEST, V112, P915, DOI 10.1172/JCI200318859; Lee NK, 2005, BLOOD, V106, P852, DOI 10.1182/blood-2004-09-3662; Lee SE, 2002, BONE, V30, P71, DOI 10.1016/S8756-3282(01)00657-3; Lee SE, 2001, J BIOL CHEM, V276, P49343, DOI 10.1074/jbc.M103642200; Lorenzo JA, 1998, ENDOCRINOLOGY, V139, P3022, DOI 10.1210/en.139.6.3022; Matsuo K, 2004, J BIOL CHEM, V279, P26475, DOI 10.1074/jbc.M313973200; Miyaura C, 2003, J EXP MED, V197, P1303, DOI 10.1084/jem.20030015; Murakami M, 2000, J BIOL CHEM, V275, P32783, DOI 10.1074/jbc.M003505200; Ouedraogo GD, 2003, PHOTOCHEM PHOTOBIOL, V77, P192, DOI 10.1562/0031-8655(2003)077<0192:SROSET>2.0.CO;2; Quintanilla RA, 2005, J BIOL CHEM, V280, P11615, DOI 10.1074/jbc.M411936200; Suda T, 1997, J BONE MINER RES, V12, P869, DOI 10.1359/jbmr.1997.12.6.869; Sugatani T, 2005, J BIOL CHEM, V280, P3583, DOI 10.1074/jbc.M410480200; Takasu H, 2006, J CLIN INVEST, V116, P528, DOI 10.1172/JCI24742; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takayanagi H, 2002, NATURE, V416, P744, DOI 10.1038/416744a; TANAKA S, 1993, J CLIN INVEST, V91, P257, DOI 10.1172/JCI116179; Teitelbaum SL, 2003, NAT REV GENET, V4, P638, DOI 10.1038/nrg1122; Teitelbaum SL, 2004, J CLIN INVEST, V114, P463, DOI 10.1172/JCI200422644; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; WANG ZQ, 1992, NATURE, V360, P741, DOI 10.1038/360741a0; Wei S, 2002, J BIOL CHEM, V277, P6622, DOI 10.1074/jbc.M104957200; Xiao T, 2003, J TOXICOL ENV HEAL A, V66, P469, DOI 10.1080/15287390306449; Yamashita T, 2007, J BIOL CHEM, V282, P18245, DOI 10.1074/jbc.M610701200; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; Zwerina J, 2005, FASEB J, V19, P2011, DOI 10.1096/fj.05-4278fje	43	52	54	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13725	13734		10.1074/jbc.M806941200	http://dx.doi.org/10.1074/jbc.M806941200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19299513	hybrid, Green Published			2022-12-27	WOS:000265877300050
J	Saitoh, A; Shin, HW; Yamada, A; Waguri, S; Nakayama, K				Saitoh, Akina; Shin, Hye-Won; Yamada, Akane; Waguri, Satoshi; Nakayama, Kazuhisa			Three Homologous ArfGAPs Participate in Coat Protein I-mediated Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEIN; NUCLEOTIDE EXCHANGE FACTOR; COPI VESICLES; GOLGI MEMBRANES; ARF GAPS; COMPLEX; LOCALIZATION; HYDROLYSIS; CARGO; BIG2	ArfGAP1 is a prototype of GTPase-activating proteins for ADP-ribosylation factors (ARFs) and has been proposed to be involved in retrograde transport from the Golgi apparatus to the endoplasmic reticulum (ER) by regulating the uncoating of coat protein I (COPI)-coated vesicles. Depletion of ArfGAP1 by RNA interference, however, causes neither a discernible phenotypic change in the COPI localization nor a change in the Golgi-to-ER retrograde transport. Therefore, we also examined ArfGAP2 and ArfGAP3, closely related homologues of ArfGAP1. Cells in which ArfGAP1, ArfGAP2, and ArfGAP3 are simultaneously knocked down show an increase in the GTP-bound ARF level. Furthermore, in these cells proteins resident in or cycling through the cis-Golgi, including ERGIC-53, beta-COP, and GM130, accumulate in the ER-Golgi intermediate compartment, and Golgi-to-ER retrograde transport is blocked. The phenotypes observed in the triple ArfGAP knockdown cells are similar to those seen in beta-COP-depleted cells. Both the triple ArfGAP- and beta-COP-depleted cells accumulate characteristic vacuolar structures that are visible under electron microscope. Furthermore, COPI is concentrated at rims of the vacuolar structures in the ArfGAP-depleted cells. On the basis of these observations, we conclude that ArfGAP1, ArfGAP2, and ArfGAP3 have overlapping roles in regulating COPI function in Golgi-to-ER retrograde transport.	[Saitoh, Akina; Shin, Hye-Won; Nakayama, Kazuhisa] Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan; [Shin, Hye-Won] Kyoto Univ, Career Path Promot Unit Young Life Sci, Sakyo Ku, Kyoto 6068501, Japan; [Yamada, Akane; Waguri, Satoshi] Fukushima Med Univ, Sch Med, Dept Anat & Histol, Fukushima 9601295, Japan	Kyoto University; Kyoto University; Fukushima Medical University	Nakayama, K (corresponding author), Kyoto Univ, Grad Sch Pharmaceut Sci, Sakyo Ku, Kyoto 6068501, Japan.	kazunaka@pharm.kyoto-u.ac.jp	Nakayama, Kazuhisa/ABF-2924-2020; Shin, Hye-Won/P-5398-2018	Shin, Hye-Won/0000-0002-9138-9554; Nakayama, Kazuhisa/0000-0001-7701-7183	Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japan Society for Promotion of Science; Targeted Proteins Research Program; International Young Scientists Career Development Organization ( ICDO) of Kyoto University; Uehara Memorial Foundation; NOVARTIS Foundation ( Japan) for the Promotion of Science; Hayashi Memorial Foundation for Female Natural Scientists	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Targeted Proteins Research Program(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); International Young Scientists Career Development Organization ( ICDO) of Kyoto University; Uehara Memorial Foundation(Uehara Memorial Foundation); NOVARTIS Foundation ( Japan) for the Promotion of Science(Novartis); Hayashi Memorial Foundation for Female Natural Scientists(Hayashi Memorial Foundation for Female Natural Scientists)	This work was supported in part by grants from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, the Japan Society for Promotion of Science, the Targeted Proteins Research Program, the International Young Scientists Career Development Organization ( ICDO) of Kyoto University, the Uehara Memorial Foundation, the NOVARTIS Foundation ( Japan) for the Promotion of Science, and the Hayashi Memorial Foundation for Female Natural Scientists.	Aoe T, 1997, EMBO J, V16, P7305, DOI 10.1093/emboj/16.24.7305; Appenzeller-Herzog C, 2006, J CELL SCI, V119, P2173, DOI 10.1242/jcs.03019; Bigay J, 2005, EMBO J, V24, P2244, DOI 10.1038/sj.emboj.7600714; Bigay J, 2003, NATURE, V426, P563, DOI 10.1038/nature02108; Cole NB, 1996, MOL BIOL CELL, V7, P631, DOI 10.1091/mbc.7.4.631; Coleman R Edward, 1998, Clin Positron Imaging, V1, P15, DOI 10.1016/S1095-0397(97)00004-6; CUKIERMAN E, 1995, SCIENCE, V270, P1999, DOI 10.1126/science.270.5244.1999; Donaldson JG, 2005, BBA-MOL CELL RES, V1744, P364, DOI 10.1016/j.bbamcr.2005.03.001; Frigerio G, 2007, TRAFFIC, V8, P1644, DOI 10.1111/j.1600-0854.2007.00631.x; Futatsumori M, 2000, J BIOCHEM-TOKYO, V128, P793, DOI 10.1093/oxfordjournals.jbchem.a022817; Gillingham AK, 2007, ANNU REV CELL DEV BI, V23, P579, DOI 10.1146/annurev.cellbio.23.090506.123209; Gleeson PA, 1996, J CELL SCI, V109, P2811; Goldberg J, 1999, CELL, V96, P893, DOI 10.1016/S0092-8674(00)80598-X; Guo YS, 2008, MOL BIOL CELL, V19, P2830, DOI 10.1091/mbc.E07-12-1236; Ishizaki R, 2006, GENES CELLS, V11, P949, DOI 10.1111/j.1365-2443.2006.00991.x; Kahn RA, 2008, J CELL BIOL, V182, P1039, DOI 10.1083/jcb.200806041; Kasai K, 1999, J BIOCHEM, V125, P780, DOI 10.1093/oxfordjournals.jbchem.a022349; Kliouchnikov L, 2009, MOL BIOL CELL, V20, P859, DOI 10.1091/mbc.E08-10-1010; Lanoix J, 1999, EMBO J, V18, P4935, DOI 10.1093/emboj/18.18.4935; Lanoix J, 2001, J CELL BIOL, V155, P1199, DOI 10.1083/jcb.200108017; Lee SY, 2005, J CELL BIOL, V168, P281, DOI 10.1083/jcb.200404008; Lewis SM, 2004, MOL BIOL CELL, V15, P4064, DOI 10.1091/mbc.e04-04-0316; Liu W, 2005, J CELL BIOL, V168, P1053, DOI 10.1083/jcb.200410142; Liu XQ, 2001, FEBS LETT, V490, P79, DOI 10.1016/S0014-5793(01)02134-2; Majoul I, 2001, DEV CELL, V1, P139, DOI 10.1016/S1534-5807(01)00004-1; Moelleken J, 2007, P NATL ACAD SCI USA, V104, P4425, DOI 10.1073/pnas.0611360104; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Natsume W, 2006, MOL BIOL CELL, V17, P2592, DOI 10.1091/mbc.E05-10-0909; Nickel W, 1998, J CELL SCI, V111, P3081; Nickel W, 1998, HISTOCHEM CELL BIOL, V109, P477, DOI 10.1007/s004180050249; Nie ZZ, 2006, J CELL SCI, V119, P1203, DOI 10.1242/jcs.02924; Nie ZZ, 2005, J CELL SCI, V118, P3555, DOI 10.1242/jcs.02486; Pepperkok R, 2000, J CELL SCI, V113, P135; Poon PP, 1999, EMBO J, V18, P555, DOI 10.1093/emboj/18.3.555; Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001; Reinhard C, 2003, P NATL ACAD SCI USA, V100, P8253, DOI 10.1073/pnas.1432391100; Santy LC, 2001, J CELL BIOL, V154, P599, DOI 10.1083/jcb.200104019; SCHWEIZER A, 1988, J CELL BIOL, V107, P1643, DOI 10.1083/jcb.107.5.1643; Shin HW, 2005, METHOD ENZYMOL, V404, P206, DOI 10.1016/S0076-6879(05)04020-6; Shin HW, 2005, J CELL SCI, V118, P4039, DOI 10.1242/jcs.02524; Shin HW, 2004, J BIOCHEM, V136, P761, DOI 10.1093/jb/mvh185; Shin HW, 2004, MOL BIOL CELL, V15, P5283, DOI 10.1091/mbc.E04-05-0388; Sohda M, 2007, TRAFFIC, V8, P270, DOI 10.1111/j.1600-0854.2006.00530.x; Styers ML, 2008, AM J PHYSIOL-CELL PH, V294, pC1485, DOI 10.1152/ajpcell.00010.2008; Szafer E, 2001, J BIOL CHEM, V276, P47834, DOI 10.1074/jbc.M106000200; Takatsu H, 2002, BIOCHEM J, V365, P369, DOI 10.1042/BJ20020428; TANIGAWA G, 1993, J CELL BIOL, V123, P1365, DOI 10.1083/jcb.123.6.1365; TEAL SB, 1994, J BIOL CHEM, V269, P3135; Waguri S, 2003, MOL BIOL CELL, V14, P142, DOI 10.1091/mbc.E02-06-0338; Waguri S, 1999, ARCH HISTOL CYTOL, V62, P423, DOI 10.1679/aohc.62.423; Watson PJ, 2004, TRAFFIC, V5, P79, DOI 10.1111/j.1600-0854.2004.00158.x; Wegmann D, 2004, MOL CELL BIOL, V24, P1070, DOI 10.1128/MCB.24.3.1070-1080.2004; Weimer C, 2008, J CELL BIOL, V183, P725, DOI 10.1083/jcb.200806140; Yahara N, 2006, J CELL SCI, V119, P2604, DOI 10.1242/jcs.02997; Yang JS, 2005, EMBO J, V24, P4133, DOI 10.1038/sj.emboj.7600873; Yang JS, 2002, J CELL BIOL, V159, P69, DOI 10.1083/jcb.200206015; Yoshimura S, 2004, J BIOCHEM, V135, P201, DOI 10.1093/jb/mvh024; Zhang CG, 2000, GENOMICS, V63, P400, DOI 10.1006/geno.1999.6095	58	24	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13948	13957		10.1074/jbc.M900749200	http://dx.doi.org/10.1074/jbc.M900749200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19299515	Green Published, hybrid			2022-12-27	WOS:000265877300070
J	Zhang, H; Liu, CY; Zha, ZY; Zhao, B; Yao, J; Zhao, SM; Xiong, Y; Lei, QY; Guan, KL				Zhang, Heng; Liu, Chen-Ying; Zha, Zheng-Yu; Zhao, Bin; Yao, Jun; Zhao, Shimin; Xiong, Yue; Lei, Qun-Ying; Guan, Kun-Liang			TEAD Transcription Factors Mediate the Function of TAZ in Cell Growth and Epithelial-Mesenchymal Transition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR; BREAST-CANCER; FACTOR CTGF; PROLIFERATION; TUMORIGENESIS; COACTIVATOR; EXPRESSION; APOPTOSIS; PROMOTES	The TAZ transcription co-activator has been shown to promote cell proliferation and to induce epithelial-mesenchymal transition. Recently we have demonstrated that TAZ is phosphorylated and inhibited by the Hippo tumor suppressor pathway, which is altered in human cancer. The mechanism of TAZ-mediated transcription is unclear. We demonstrate here that TEAD is a key downstream transcription factor mediating the function of TAZ. Disruption of TEAD-TAZ binding or silencing of TEAD expression blocked the function of TAZ to promote cell proliferation and to induce epithelial-mesenchymal transition, demonstrating TEAD as a key downstream effector of TAZ. We also identified CTGF, a gene that regulates cell adhesion, proliferation, and migration, as a direct target of TAZ and TEAD. Our study establishes a functional partnership between TAZ and TEAD under negative regulation by the Hippo signaling pathway.	[Zhang, Heng; Liu, Chen-Ying; Zha, Zheng-Yu; Yao, Jun; Zhao, Shimin; Xiong, Yue; Lei, Qun-Ying; Guan, Kun-Liang] Fudan Univ, Inst Biomed Sci, Mol & Cell Biol Lab, Shanghai 200032, Peoples R China; [Zhang, Heng; Liu, Chen-Ying; Zhao, Shimin] Fudan Univ, Sch Life Sci, Shanghai 200032, Peoples R China; [Lei, Qun-Ying; Guan, Kun-Liang] Fudan Univ, Sch Med, Dept Biol Chem, Shanghai 200032, Peoples R China; [Zhao, Bin; Guan, Kun-Liang] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Zhao, Bin; Guan, Kun-Liang] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Xiong, Yue] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	Fudan University; Fudan University; Fudan University; University of California System; University of California San Diego; University of California System; University of California San Diego; University of North Carolina; University of North Carolina Chapel Hill	Lei, QY (corresponding author), Fudan Univ, Inst Biomed Sci, Mol & Cell Biol Lab, Shanghai 200032, Peoples R China.	qlei@fudan.edu.cn; kuguan@ucsd.edu	Guan, Kun-Liang/ADK-7088-2022; Lei, Qun-Ying/J-1390-2017	Lei, Qun-Ying/0000-0002-8547-8518; zha, zhengyu/0000-0002-8619-3661; Liu, Chen-Ying/0000-0002-8930-6182	National Institutes of Health [RO1CA65572, RO1CA132809]; Chinese Ministry of Education, National High Technology Research and Development Program of China [2004BA711A18, 2006AA02A308]; State Key Development Program for Basic Research of China [2006CB806700, 2009CB918401]; National Natural Science Foundation of China [30600112, 30871255]; Shanghai Key Project [06JC14086]; Pufa Talent [07pj14011]; Shanghai Leading Academic Discipline [B110]; University of Michigan; NATIONAL CANCER INSTITUTE [R01CA065572, R01CA132809] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Chinese Ministry of Education, National High Technology Research and Development Program of China(Ministry of Education, China); State Key Development Program for Basic Research of China(State Key Development Program for Basic Research of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Key Project; Pufa Talent; Shanghai Leading Academic Discipline(Shanghai Leading Academic Discipline Project); University of Michigan(University of Michigan System); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health grants RO1CA65572 and RO1CA132809 (to Y. X. and K.-L. G.). This work was also supported by 985 Program from the Chinese Ministry of Education, National High Technology Research and Development Program of China Grants 2004BA711A18 and 2006AA02A308, State Key Development Program for Basic Research of China Grants 2006CB806700 and 2009CB918401, National Natural Science Foundation of China Grants 30600112 and 30871255, Shanghai Key Project Grant 06JC14086, Pufa Talent Grant 07pj14011, Shanghai Leading Academic Discipline Project, project number B110, and a University of Michigan Rackham predoctoral fellowship (to B. Z.).	Chan SW, 2008, CANCER RES, V68, P2592, DOI 10.1158/0008-5472.CAN-07-2696; Chu CY, 2008, J BIOMED SCI, V15, P675, DOI 10.1007/s11373-008-9264-9; Dornhofer N, 2006, CANCER RES, V66, P5816, DOI 10.1158/0008-5472.CAN-06-0081; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Hinestrosa MC, 2007, NAT REV CANCER, V7, P309, DOI 10.1038/nrc2113; Hong JH, 2006, CELL CYCLE, V5, P176, DOI 10.4161/cc.5.2.2362; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Hossain Z, 2007, P NATL ACAD SCI USA, V104, P1631, DOI 10.1073/pnas.0605266104; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Lai ZC, 2005, CELL, V120, P675, DOI 10.1016/j.cell.2004.12.036; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Makita R, 2008, AM J PHYSIOL-RENAL, V294, pF542, DOI 10.1152/ajprenal.00201.2007; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; McClatchey AI, 2005, GENE DEV, V19, P2265, DOI 10.1101/gad.1335605; Murakami M, 2006, BIOCHEM BIOPH RES CO, V339, P533, DOI 10.1016/j.bbrc.2005.10.214; Murakami M, 2005, P NATL ACAD SCI USA, V102, P18034, DOI 10.1073/pnas.0509109102; Park KS, 2004, J BIOL CHEM, V279, P17384, DOI 10.1074/jbc.M312569200; Rybak JN, 2005, NAT METHODS, V2, P291, DOI 10.1038/NMETH745; Sala-Torra O, 2007, BLOOD, V109, P3080, DOI 10.1182/blood-2006-06-031096; Tapon N, 2002, CELL, V110, P467, DOI 10.1016/S0092-8674(02)00824-3; Varelas X, 2008, NAT CELL BIOL, V10, P837, DOI 10.1038/ncb1748; Wang G, 2005, MOL CELL, V17, P683, DOI 10.1016/j.molcel.2005.02.010; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408	23	387	404	0	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13355	13362		10.1074/jbc.M900843200	http://dx.doi.org/10.1074/jbc.M900843200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19324877	hybrid, Green Published			2022-12-27	WOS:000265877300011
J	Funakoshi-Tago, M; Tago, K; Sumi, K; Abe, M; Aizu-Yokota, E; Oshio, T; Sonoda, Y; Kasahara, T				Funakoshi-Tago, Megumi; Tago, Kenji; Sumi, Kazuya; Abe, Miyuki; Aizu-Yokota, Eriko; Oshio, Tomoyuki; Sonoda, Yoshiko; Kasahara, Tadashi			The Acute Lymphoblastic Leukemia-associated JAK2 L611S Mutant Induces Tumorigenesis in Nude Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYROSINE KINASE; PSEUDOKINASE DOMAIN; POLYCYTHEMIA-VERA; INDUCED APOPTOSIS; GENE-EXPRESSION; CELL-DEATH; LINKED IAP; BCL-X; ACTIVATION; RECEPTOR	JAK2 plays important roles in the regulation of a variety of cellular processes including cell migration, proliferation, and protection from apoptosis. Recently the L611S point mutation in JAK2 has been identified in a child with acute lymphoblastic leukemia. Here we analyzed the mechanism by which JAK2 exhibits its oncogenicity. In BaF3 murine hematopoietic cells, L611S mutant increased the expression of antiapoptotic proteins including X chromosome-linked inhibitor of apoptosis protein, inhibitor of apoptosis protein, and Bcl-XL. We also showed that JAK2 L611S mutant protects BaF3 cells from cytokine withdrawal-induced apoptotic cell death and leads to cytokine-independent cell growth. Furthermore BaF3 cells expressing JAK2 L611S mutant gained the ability to induce tumorigenesis in nude mice. The L611S mutant also exhibited malignancy, including prompt invasion and spreading into various organs, leading to rapid lethality of the mice. Finally we showed that a specific JAK2 inhibitor, AG490, potently inhibited cytokine-independent cell growth induced by JAK2 L611S mutant via the induction of apoptotic cell death. In addition, treatment with AG490 significantly inhibited the JAK2 L611S mutant-induced tumorigenesis in nude mice. Thus, our results both in vitro and in vivo strongly suggest that L611S mutant of JAK2 harbors potent oncogenic activity, and this probably requires the antiapoptotic signaling pathway.	[Funakoshi-Tago, Megumi; Sumi, Kazuya; Abe, Miyuki; Aizu-Yokota, Eriko; Oshio, Tomoyuki; Sonoda, Yoshiko; Kasahara, Tadashi] Keio Univ, Dept Biochem, Fac Pharm, Minato Ku, Tokyo 1058512, Japan; [Tago, Kenji] Nara Inst Sci & Technol, Grad Sch Biol Sci, Dept Cell Biol, Nara 6300101, Japan	Keio University; Nara Institute of Science & Technology	Funakoshi-Tago, M (corresponding author), Keio Univ, Dept Biochem, Fac Pharm, Minato Ku, 1-5-30 Shibakoen, Tokyo 1058512, Japan.	tago-mg@pha.keio.ac.jp	Aizu-Yokota, Eriko/AAH-1318-2020		Ministry of Education, Culture, Sports, Science and Technology [G19790071]; Research Foundation for Pharmaceutical Sciences; Hi-Tech Research Center Project for Private Universities in Japan	Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Research Foundation for Pharmaceutical Sciences; Hi-Tech Research Center Project for Private Universities in Japan	This work was supported in part by Ministry of Education, Culture, Sports, Science and Technology Grant G19790071 and grants from the Research Foundation for Pharmaceutical Sciences and the Hi-Tech Research Center Project for Private Universities in Japan.	Baker SJ, 2007, ONCOGENE, V26, P6724, DOI 10.1038/sj.onc.1210757; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Danilkovitch-Miagkova A, 2002, J CLIN INVEST, V109, P863; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Feldman GM, 1997, BLOOD, V90, P1768, DOI 10.1182/blood.V90.5.1768; Feng J, 1997, MOL CELL BIOL, V17, P2497, DOI 10.1128/MCB.17.5.2497; Fidler IJ, 2002, SEMIN CANCER BIOL, V12, P89, DOI 10.1006/scbi.2001.0416; Funakoshi-Tago M, 2003, J BIOL CHEM, V278, P29359, DOI 10.1074/jbc.M213115200; Funakoshi-Tago M, 2008, BIOCHEM PHARMACOL, V76, P1681, DOI 10.1016/j.bcp.2008.09.012; Funakoshi-Tago M, 2008, MOL CELL BIOL, V28, P1792, DOI 10.1128/MCB.01447-07; GOTTSCHALK AR, 1994, P NATL ACAD SCI USA, V91, P7350, DOI 10.1073/pnas.91.15.7350; Grant S, 2008, J CLIN INVEST, V118, P3003, DOI 10.1172/JCI36898; Ihle JN, 2007, CURR OPIN GENET DEV, V17, P8, DOI 10.1016/j.gde.2006.12.009; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Khoshnan A, 2000, J IMMUNOL, V165, P1743, DOI 10.4049/jimmunol.165.4.1743; Kinkade CW, 2008, J CLIN INVEST, V118, P3051, DOI 10.1172/JCI34764; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Kratz CP, 2006, LEUKEMIA, V20, P381, DOI 10.1038/sj.leu.2404060; Lacronique V, 1997, SCIENCE, V278, P1309, DOI 10.1126/science.278.5341.1309; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Lindauer K, 2001, PROTEIN ENG, V14, P27, DOI 10.1093/protein/14.1.27; Meydan N, 1996, NATURE, V379, P645, DOI 10.1038/379645a0; O'Sullivan LA, 2007, MOL IMMUNOL, V44, P2497, DOI 10.1016/j.molimm.2006.11.025; Onishi M, 1998, MOL CELL BIOL, V18, P3871, DOI 10.1128/MCB.18.7.3871; Roy N, 1997, EMBO J, V16, P6914, DOI 10.1093/emboj/16.23.6914; Saharinen P, 2003, MOL BIOL CELL, V14, P1448, DOI 10.1091/mbc.E02-06-0342; Saharinen P, 2002, J BIOL CHEM, V277, P47954, DOI 10.1074/jbc.M205156200; Schindler C, 2007, J BIOL CHEM, V282, P20059, DOI 10.1074/jbc.R700016200; Stehlik C, 1998, J EXP MED, V188, P211, DOI 10.1084/jem.188.1.211; You MJ, 1997, MOL CELL BIOL, V17, P7328, DOI 10.1128/MCB.17.12.7328	32	20	21	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12680	12690		10.1074/jbc.M808879200	http://dx.doi.org/10.1074/jbc.M808879200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19289461	Green Published, hybrid			2022-12-27	WOS:000265688300012
J	Meyer, PA; Ye, P; Suh, MH; Zhang, M; Fu, J				Meyer, Peter A.; Ye, Ping; Suh, Man-Hee; Zhang, Mincheng; Fu, Jianhua			Structure of the 12-Subunit RNA Polymerase II Refined with the Aid of Anomalous Diffraction Data	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELONGATION COMPLEX; MOLECULAR-BASIS; TRANSCRIPTION; INITIATION; RESOLUTION; ARCHITECTURE; TEMPERATURE; SUBUNIT; RPB4; DNA	RNApolymerase II (Pol II) is the central enzyme of eukaryotic gene expression machinery. Complete definition of the three-dimensional structure of Pol II is essential for understanding the mechanisms that regulate transcription via protein-protein interactions within the Pol II apparatus. To date a series of Pol II-related crystal structures have been reported. However, certain peptide regions, including several that are implicated to interact with regulatory factors, remain obscure. Here we describe conformations for two such regions that are close to the Pol II surface and assume seemingly flexible loop structures. One is located in the TFIIF-interacting Protrusion domain, whereas the other is in the TFIIE-interacting Clamp domain. This structural definition was aided by the application of an advanced crystallographic refinement approach that utilizes the single anomalous diffraction (SAD) from zinc ions bound intrinsically in Pol II. The SAD-based strategy allowed the 12-subunit Pol II model to be fully refined up to 3.8 A with excellent stereochemical properties, demonstrating the effectiveness of the SAD approach for the refinement of large structures at low-tomoderate resolutions. Our results also define additional components of the free Pol II, including the functionally critical Fork Loop-1 and Fork Loop-2 elements. As such, this refined Pol II model provides the most complete structural reference for future analyses of complex structures formed between Pol II and its regulatory factors.	[Meyer, Peter A.; Ye, Ping; Suh, Man-Hee; Zhang, Mincheng; Fu, Jianhua] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Meyer, Peter A.; Suh, Man-Hee] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14853 USA	Medical College of Wisconsin; Cornell University	Fu, J (corresponding author), Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA.	jfu@mcw.edu			National Institutes of Health [GM064651]; American Cancer Society [IRG-01-231-01]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR001646] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM064651] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM064651 (to J.F.). This work was also supported by American Cancer Society Grant IRG-01-231-01 (to J.F.).	Armache KJ, 2005, J BIOL CHEM, V280, P7131, DOI 10.1074/jbc.M413038200; Armache KJ, 2003, P NATL ACAD SCI USA, V100, P6964, DOI 10.1073/pnas.1030608100; Arrahams JP, 2003, METHOD ENZYMOL, V374, P163; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Ban N, 1998, CELL, V93, P1105, DOI 10.1016/S0092-8674(00)81455-5; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Brueckner F, 2008, NAT STRUCT MOL BIOL, V15, P811, DOI 10.1038/nsmb.1458; Brueckner F, 2007, SCIENCE, V315, P859, DOI 10.1126/science.1135400; Bushnell DA, 2003, P NATL ACAD SCI USA, V100, P6969, DOI 10.1073/pnas.1130601100; Chen B, 2005, STRUCTURE, V13, P197, DOI 10.1016/j.str.2004.12.004; Chen HT, 2007, NAT STRUCT MOL BIOL, V14, P696, DOI 10.1038/nsmb1272; Cramer P, 2000, SCIENCE, V288, P640, DOI 10.1126/science.288.5466.640; Cramer Patrick, 2001, Science (Washington D C), V292, P1863, DOI 10.1126/science.1059493; DeLaBarre B, 2003, NAT STRUCT BIOL, V10, P856, DOI 10.1038/nsb972; DeLaBarre B, 2006, ACTA CRYSTALLOGR D, V62, P923, DOI 10.1107/S0907444906012650; EDWARDS AM, 1991, J BIOL CHEM, V266, P71; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; EYCK LFT, 2001, INT TABLES CRYSTALLO, P369; Fu JH, 1999, CELL, V98, P799, DOI 10.1016/S0092-8674(00)81514-7; Gnatt AL, 2001, SCIENCE, V292, P1876, DOI 10.1126/science.1059495; Guo F, 2004, MOL CELL, V16, P351, DOI 10.1016/S1097-2765(04)00592-1; HENDRICKSON WA, 1985, METHOD ENZYMOL, V115, P252; HOWLIN B, 1989, ACTA CRYSTALLOGR A, V45, P851, DOI 10.1107/S0108767389009177; Jeronimo C, 2004, MOL CELL BIOL, V24, P7043, DOI 10.1128/MCB.24.16.7043-7058.2004; Kazmirski SL, 2004, P NATL ACAD SCI USA, V101, P16750, DOI 10.1073/pnas.0407904101; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Kornberg RD, 2007, P NATL ACAD SCI USA, V104, P12955, DOI 10.1073/pnas.0704138104; Lehmann E, 2007, NATURE, V450, P445, DOI 10.1038/nature06290; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Meyer PA, 2006, STRUCTURE, V14, P973, DOI 10.1016/j.str.2006.04.003; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Pannu NS, 2004, ACTA CRYSTALLOGR D, V60, P22, DOI 10.1107/S0907444903020808; Roeder RG, 1996, TRENDS BIOCHEM SCI, V21, P327, DOI 10.1016/0968-0004(96)10050-5; Rosenheck S, 1998, J BACTERIOL, V180, P6187; SCHOMAKER V, 1968, ACTA CRYSTALL B-STRU, VB 24, P63, DOI 10.1107/S0567740868001718; Skubak P, 2005, ACTA CRYSTALLOGR D, V61, P1626, DOI 10.1107/S0907444905032233; Skubak P, 2004, ACTA CRYSTALLOGR D, V60, P2196, DOI 10.1107/S0907444904019079; Trinh V, 2006, MICROBIOL MOL BIOL R, V70, P12, DOI 10.1128/MMBR.70.1.12-36.2006; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; Westover KD, 2004, CELL, V119, P481, DOI 10.1016/j.cell.2004.10.016; Westover KD, 2004, SCIENCE, V303, P1014, DOI 10.1126/science.1090839; WOYCHIK NA, 1989, MOL CELL BIOL, V9, P2854, DOI 10.1128/MCB.9.7.2854; Woychik NA, 2002, CELL, V108, P453, DOI 10.1016/S0092-8674(02)00646-3	45	16	16	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12933	12939		10.1074/jbc.M809199200	http://dx.doi.org/10.1074/jbc.M809199200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19289466	hybrid, Green Published			2022-12-27	WOS:000265688300039
J	Sakoh-Nakatogawa, M; Nishikawa, S; Endo, T				Sakoh-Nakatogawa, Machiko; Nishikawa, Shuh-ichi; Endo, Toshiya			Roles of Protein-disulfide Isomerase-mediated Disulfide Bond Formation of Yeast Mnl1p in Endoplasmic Reticulum-associated Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER-ASSOCIATED DEGRADATION; MANNOSIDASE-LIKE PROTEIN; SACCHAROMYCES-CEREVISIAE; MISFOLDED GLYCOPROTEINS; MOLECULAR CHAPERONES; QUALITY-CONTROL; SIGNAL; RETROTRANSLOCATION; MUTATIONS; CALNEXIN	The endoplasmic reticulum (ER) has a strict protein quality control system. Misfolded proteins generated in the ER are degraded by the ER-associated degradation (ERAD). Yeast Mnl1p consists of an N-terminal mannosidase homology domain and a less conserved C-terminal domain and facilitates the ERAD of glycoproteins. We found that Mnl1p is an ER luminal protein with a cleavable signal sequence and stably interacts with a protein-disulfide isomerase (PDI). Analyses of a series of Mnl1p mutants revealed that interactions between the C-terminal domain of Mnl1p and PDI, which include an intermolecular disulfide bond, are essential for subsequent introduction of a disulfide bond into the mannosidase homology domain of Mnl1p by PDI. This disulfide bond is essential for the ERAD activity of Mnl1p and in turn stabilizes the prolonged association of PDI with Mnl1p. Close interdependence between Mnl1p and PDI suggests that these two proteins form a functional unit in the ERAD pathway.	[Sakoh-Nakatogawa, Machiko; Nishikawa, Shuh-ichi; Endo, Toshiya] Nagoya Univ, Grad Sch Sci, Dept Chem, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Nagoya University	Endo, T (corresponding author), Nagoya Univ, Grad Sch Sci, Dept Chem, Chikusa Ku, Nagoya, Aichi 4648602, Japan.	endo@biochem.chem.nagoya-u.ac.jp						Anelli T, 2008, EMBO J, V27, P315, DOI 10.1038/sj.emboj.7601974; Apperizeller-Herzog C, 2008, BBA-MOL CELL RES, V1783, P535, DOI 10.1016/j.bbamcr.2007.11.010; Bhamidipati A, 2005, MOL CELL, V19, P741, DOI 10.1016/j.molcel.2005.07.027; BOHNI PC, 1988, J CELL BIOL, V106, P1035, DOI 10.1083/jcb.106.4.1035; Buck TM, 2007, SEMIN CELL DEV BIOL, V18, P751, DOI 10.1016/j.semcdb.2007.09.001; Clerc S, 2009, J CELL BIOL, V184, P159, DOI 10.1083/jcb.200809198; CREIGHTON TE, 1995, TRENDS BIOTECHNOL, V13, P18, DOI 10.1016/S0167-7799(00)88896-4; Frand AR, 1999, MOL CELL, V4, P469, DOI 10.1016/S1097-2765(00)80198-7; Gilbert HF, 1997, J BIOL CHEM, V272, P29399, DOI 10.1074/jbc.272.47.29399; Gillece P, 1999, J CELL BIOL, V147, P1443, DOI 10.1083/jcb.147.7.1443; Hirao K, 2006, J BIOL CHEM, V281, P9650, DOI 10.1074/jbc.M512191200; Holst B, 1997, J CELL BIOL, V138, P1229, DOI 10.1083/jcb.138.6.1229; Hosokawa N, 2001, EMBO REP, V2, P415, DOI 10.1093/embo-reports/kve084; Jakob CA, 1998, J CELL BIOL, V142, P1223, DOI 10.1083/jcb.142.5.1223; Jakob CA, 2001, EMBO REP, V2, P423; Kim W, 2005, MOL CELL, V19, P753, DOI 10.1016/j.molcel.2005.08.010; KITADA K, 1995, GENE, V165, P203, DOI 10.1016/0378-1119(95)00552-H; Klappa P, 1997, EUR J BIOCHEM, V248, P37, DOI 10.1111/j.1432-1033.1997.t01-1-00037.x; KOIVU J, 1987, J BIOL CHEM, V262, P6447; Kulp MS, 2006, J BIOL CHEM, V281, P876, DOI 10.1074/jbc.M511764200; LAMANTIA ML, 1993, CELL, V74, P899, DOI 10.1016/0092-8674(93)90469-7; McCracken AA, 1996, J CELL BIOL, V132, P291, DOI 10.1083/jcb.132.3.291; Molinari M, 1999, NATURE, V402, P90, DOI 10.1038/47062; Nakatsukasa K, 2001, J BIOL CHEM, V276, P8635, DOI 10.1074/jbc.C100023200; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Nishikawa S, 2001, J CELL BIOL, V153, P1061, DOI 10.1083/jcb.153.5.1061; Nishikawa S, 1997, J BIOL CHEM, V272, P12889, DOI 10.1074/jbc.272.20.12889; Norgaard P, 2001, J CELL BIOL, V152, P553, DOI 10.1083/jcb.152.3.553; Oda Y, 2003, SCIENCE, V299, P1394, DOI 10.1126/science.1079181; Olivari S, 2006, BIOCHEM BIOPH RES CO, V349, P1278, DOI 10.1016/j.bbrc.2006.08.186; QADOTA H, 1992, YEAST, V8, P735, DOI 10.1002/yea.320080906; Quan EM, 2008, MOL CELL, V32, P870, DOI 10.1016/j.molcel.2008.11.017; ROBINSON JS, 1988, MOL CELL BIOL, V8, P4936, DOI 10.1128/MCB.8.11.4936; Sevier CS, 2006, ANTIOXID REDOX SIGN, V8, P797, DOI 10.1089/ars.2006.8.797; SIKORSKI RS, 1989, GENETICS, V122, P19; Szathmary R, 2005, MOL CELL, V19, P765, DOI 10.1016/j.molcel.2005.08.015; Tsai M, 2002, J CELL BIOL, V159, P207, DOI 10.1083/jcb.200207120; Ushioda R, 2008, SCIENCE, V321, P569, DOI 10.1126/science.1159293; Wearsch PA, 2008, CURR OPIN CELL BIOL, V20, P624, DOI 10.1016/j.ceb.2008.09.005; YAFFE MP, P NATL ACAD SCI US, V81, P4819; Yoshihisa T, 2003, MOL BIOL CELL, V14, P3266, DOI 10.1091/mbc.E02-11-0757	41	49	49	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					11815	11825		10.1074/jbc.M900813200	http://dx.doi.org/10.1074/jbc.M900813200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19279007	hybrid, Green Published			2022-12-27	WOS:000265494600013
J	Graham, AI; Hunt, S; Stokes, SL; Bramall, N; Bunch, J; Cox, AG; McLeod, CW; Poole, RK				Graham, Alison I.; Hunt, Stuart; Stokes, Sarah L.; Bramall, Neil; Bunch, Josephine; Cox, Alan G.; McLeod, Cameron W.; Poole, Robert K.			Severe Zinc Depletion of Escherichia coli ROLES FOR HIGH AFFINITY ZINC BINDING BY ZinT, ZINC TRANSPORT AND ZINC-INDEPENDENT PROTEINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPONSIVE REGULATOR ZUR; TRANSCRIPTIONAL RESPONSE; UPTAKE SYSTEM; BACILLUS-SUBTILIS; SACCHAROMYCES-CEREVISIAE; STREPTOMYCES-COELICOLOR; RIBOSOMAL-PROTEINS; ARRAY TECHNOLOGY; GENE-EXPRESSION; METAL-BINDING	Zinc ions play indispensable roles in biological chemistry. However, bacteria have an impressive ability to acquire Zn2+ from the environment, making it exceptionally difficult to achieve Zn2+ deficiency, and so a comprehensive understanding of the importance of Zn2+ has not been attained. Reduction of the Zn2+ content of Escherichia coli growth medium to 60 nM or less is reported here for the first time, without recourse to chelators of poor specificity. Cells grown in Zn2+-deficient medium had a reduced growth rate and contained up to five times less cellular Zn2+. To understand global responses to Zn2+ deficiency, microarray analysis was conducted of cells grown under Zn2+-replete and Zn2+-depleted conditions in chemostat cultures. Nine genes were up-regulated more than 2-fold (p<0.05) in cells from Zn2+-deficient chemostats, including zinT (yodA). zinT is shown to be regulated by Zur ( zinc uptake regulator). A mutant lacking zinT displayed a growth defect and a 3-fold lowered cellular Zn2+ level under Zn2+ limitation. The purified ZinT protein possessed a single, high affinity metal-binding site that can accommodate Zn2+ or Cd2+. A further up-regulated gene, ykgM, is believed to encode a non-Zn2+ finger-containing paralogue of the Zn2+ finger ribosomal protein L31. The gene encoding the periplasmic Zn2+- binding protein znuA showed increased expression. During both batch and chemostat growth, cells "found" more Zn2+ than was originally added to the culture, presumably because of leaching from the culture vessel. Zn2+ elimination is shown to be a more precise method of depleting Zn2+ than by using the chelator N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine.	[Graham, Alison I.; Hunt, Stuart; Poole, Robert K.] Univ Sheffield, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; [Stokes, Sarah L.; Bramall, Neil; Bunch, Josephine; Cox, Alan G.; McLeod, Cameron W.] Univ Sheffield, Ctr Analyt Sci, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield; University of Sheffield	Poole, RK (corresponding author), Univ Sheffield, Dept Mol Biol & Biotechnol, Western Bank, Sheffield S10 2TN, S Yorkshire, England.	r.poole@sheffield.ac.uk		Bunch, Josephine/0000-0002-4257-1296	Biotechnology and Biological Sciences Research Council, UK; Biotechnology and Biological Sciences Research Council [BB/C509831/1] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council, UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by the Biotechnology and Biological Sciences Research Council, UK.	Akanuma G, 2006, J BACTERIOL, V188, P2715, DOI 10.1128/JB.188.7.2715-2720.2006; Ammendola S, 2007, INFECT IMMUN, V75, P5867, DOI 10.1128/IAI.00559-07; Andreini C, 2006, J PROTEOME RES, V5, P3173, DOI 10.1021/pr0603699; [Anonymous], 1975, PRINCIPLES MICROBIAL; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Beard SJ, 1997, MOL MICROBIOL, V25, P883, DOI 10.1111/j.1365-2958.1997.mmi518.x; Berducci G, 2004, FEBS LETT, V569, P289, DOI 10.1016/j.febslet.2004.06.008; Berg JM, 1996, SCIENCE, V271, P1081, DOI 10.1126/science.271.5252.1081; Birch RM, 2003, PROTEOMICS, V3, P764, DOI 10.1002/pmic.200300397; Blencowe DK, 2003, FEMS MICROBIOL REV, V27, P291, DOI 10.1016/S0168-6445(03)00041-X; Brocklehurst KR, 2000, MICROBIOL-UK, V146, P2277, DOI 10.1099/00221287-146-9-2277; Cai F, 2006, INFECT IMMUN, V74, P5617, DOI 10.1128/IAI.00552-06; Cherny RA, 2001, NEURON, V30, P665, DOI 10.1016/S0896-6273(01)00317-8; CICCOGNANI DT, 1992, FEMS MICROBIOL LETT, V94, P1; Da Silva J. F., 2001, BIOL CHEM ELEMENTS I; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; David G, 2003, J BIOL CHEM, V278, P43728, DOI 10.1074/jbc.M304484200; David G, 2002, ACTA CRYSTALLOGR D, V58, P1243, DOI 10.1107/S0907444902008326; Davis LM, 2009, J BACTERIOL, V191, P1631, DOI 10.1128/JB.01394-08; de Seny D, 2001, J BIOL CHEM, V276, P45065, DOI 10.1074/jbc.M106447200; Fekkes P, 1999, BIOCHEMISTRY-US, V38, P5111, DOI 10.1021/bi982818r; Ferenci T, 2008, ADV MICROB PHYSIOL, V53, P169, DOI 10.1016/S0065-2911(07)53003-1; Ferianc P, 1998, MICROBIOL-UK, V144, P1045, DOI 10.1099/00221287-144-4-1045; GARLAND PB, 1962, NATURE, V196, P987, DOI 10.1038/196987a0; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Hantke K, 2005, CURR OPIN MICROBIOL, V8, P196, DOI 10.1016/j.mib.2005.02.001; Hayes A, 2002, METHODS, V26, P281, DOI 10.1016/S1046-2023(02)00032-4; Hoskisson PA, 2005, MICROBIOL-SGM, V151, P3153, DOI 10.1099/mic.0.27924-0; HUGHES MN, 1991, J GEN MICROBIOL, V137, P725, DOI 10.1099/00221287-137-4-725; Jackson KA, 2007, J BIOL CHEM, V282, P10423, DOI 10.1074/jbc.M610535200; Kadokura H, 2004, SCIENCE, V303, P534, DOI 10.1126/science.1091724; Kannan G, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-37; Kay Alan R, 2004, BMC Physiol, V4, P4, DOI 10.1186/1472-6793-4-4; Kershaw CJ, 2007, BIOCHEM BIOPH RES CO, V364, P66, DOI 10.1016/j.bbrc.2007.09.094; Kershaw CJ, 2005, MICROBIOL-SGM, V151, P1187, DOI 10.1099/mic.0.27650-0; KOCH AL, 1961, BIOCHIM BIOPHYS ACTA, V51, P429, DOI 10.1016/0006-3002(61)90599-6; KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5; LaurentWinter C, 1997, EUR J BIOCHEM, V244, P767, DOI 10.1111/j.1432-1033.1997.00767.x; Lee LJ, 2005, J BACTERIOL, V187, P1124, DOI 10.1128/JB.187.3.1124-1134.2005; LIN PS, 1983, CANCER RES, V43, P1049; Makarova K. S., 2001, GENOME BIOL, V2, P14; Moore CM, 2005, MOL MICROBIOL, V57, P27, DOI 10.1111/j.1365-2958.2005.04642.x; MUKHERJEE G, 1995, J INORG BIOCHEM, V59, P827, DOI 10.1016/0162-0134(94)00082-L; Nanamiya H, 2004, MOL MICROBIOL, V52, P273, DOI 10.1111/j.1365-2958.2003.03972.x; Neidhardt FC, 1990, PHYSL BACTERIAL CELL, P418; Notley-McRobb L, 1999, ENVIRON MICROBIOL, V1, P45, DOI 10.1046/j.1462-2920.1999.00003.x; Outten CE, 2001, SCIENCE, V292, P2488, DOI 10.1126/science.1060331; Owen GA, 2007, J BACTERIOL, V189, P4078, DOI 10.1128/JB.01901-06; Panina EM, 2003, P NATL ACAD SCI USA, V100, P9912, DOI 10.1073/pnas.1733691100; Patzer SI, 2000, J BIOL CHEM, V275, P24321, DOI 10.1074/jbc.M001775200; Patzer SI, 1998, MOL MICROBIOL, V28, P1199, DOI 10.1046/j.1365-2958.1998.00883.x; Piper MDW, 2002, J BIOL CHEM, V277, P37001, DOI 10.1074/jbc.M204490200; Puskarova A, 2002, MICROBIOL-SGM, V148, P3801, DOI 10.1099/00221287-148-12-3801; Scott C, 2000, FEMS MICROBIOL LETT, V192, P85, DOI 10.1111/j.1574-6968.2000.tb09363.x; Sebat JL, 2001, APPL ENVIRON MICROB, V67, P3934, DOI 10.1128/AEM.67.9.3934-3942.2001; Shin JH, 2007, J BACTERIOL, V189, P4070, DOI 10.1128/JB.01851-06; Sigdel TK, 2006, J BACTERIOL, V188, P6709, DOI 10.1128/JB.00680-06; SIMONS TJB, 1993, J BIOCHEM BIOPH METH, V27, P25, DOI 10.1016/0165-022X(93)90065-V; Stojnev T, 2007, CURR MICROBIOL, V55, P99, DOI 10.1007/s00284-006-0516-5; Wang AY, 2005, J BACTERIOL, V187, P3259, DOI 10.1128/JB.187.9.3259-3266.2005; Yamamoto K, 2005, J BACTERIOL, V187, P6333, DOI 10.1128/JB.187.18.6333-6340.2005; Yamamoto K, 2005, MOL MICROBIOL, V56, P215, DOI 10.1111/j.1365-2958.2005.04532.x; Yatsunyk LA, 2008, J BIOL INORG CHEM, V13, P271, DOI 10.1007/s00775-007-0320-0	63	107	113	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18377	18389		10.1074/jbc.M109.001503	http://dx.doi.org/10.1074/jbc.M109.001503			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19377097	Green Published, hybrid, Green Accepted			2022-12-27	WOS:000267712400050
J	Shuman, S				Shuman, Stewart			DNA Ligases: Progress and Prospects	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							MYCOBACTERIUM-TUBERCULOSIS; CRYSTAL-STRUCTURE; RNA LIGASE-1; LIGATION; MECHANISM; IDENTIFICATION; SPECIFICITY; REPAIR	DNA ligases seal 5'-PO4 and 3'-OH polynucleotide ends via three nucleotidyl transfer steps involving ligase-adenylate and DNA-adenylate intermediates. DNA ligases are essential guardians of genomic integrity, and ligase dysfunction underlies human genetic disease syndromes. Crystal structures of DNA ligases bound to nucleotide and nucleic acid substrates have illuminated how ligase reaction chemistry is catalyzed, how ligases recognize damaged DNA ends, and how protein domain movements and active-site remodeling are used to choreograph the end-joining pathway. Although a shared feature of DNA ligases is their envelopment of the nicked duplex as a C-shaped protein clamp, they accomplish this feat by using remarkably different accessory structural modules and domain topologies. As structural, biochemical, and phylogenetic insights coalesce, we can expect advances on several fronts, including (i) pharmacological targeting of ligases for antibacterial and anticancer therapies and (ii) the discovery and design of new strand-sealing enzymes with unique substrate specificities.	Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Shuman, S (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA.	s-shuman@ski.mskcc.org						Ahel I, 2006, NATURE, V443, P713, DOI 10.1038/nature05164; Blondal T, 2005, NUCLEIC ACIDS RES, V33, P135, DOI 10.1093/nar/gki149; Brotz-Oesterhelt H, 2003, J BIOL CHEM, V278, P39435, DOI 10.1074/jbc.M306479200; Bullard DR, 2006, BIOCHEM J, V398, P135, DOI 10.1042/BJ20060313; Chen B, 2009, FEBS J, V276, P807, DOI 10.1111/j.1742-4658.2008.06825.x; Chen X, 2008, CANCER RES, V68, P3169, DOI 10.1158/0008-5472.CAN-07-6636; Ellenberger T, 2008, ANNU REV BIOCHEM, V77, P313, DOI 10.1146/annurev.biochem.77.061306.123941; Gajiwala KS, 2004, STRUCTURE, V12, P1449, DOI 10.1016/j.str.2004.05.017; Hakansson K, 1997, CELL, V89, P545, DOI 10.1016/S0092-8674(00)80236-6; Keppetipola N, 2005, J BACTERIOL, V187, P6902, DOI 10.1128/JB.187.20.6902-6908.2005; Knight ZA, 2007, CELL, V128, P425, DOI 10.1016/j.cell.2007.01.021; LEHMAN IR, 1974, SCIENCE, V186, P790; Martins A, 2004, J BIOL CHEM, V279, P50654, DOI 10.1074/jbc.M407657200; Meier TI, 2008, FEBS J, V275, P5258, DOI 10.1111/j.1742-4658.2008.06652.x; Miesel L, 2007, ANAL BIOCHEM, V366, P9, DOI 10.1016/j.ab.2007.03.028; Nair PA, 2007, NAT STRUCT MOL BIOL, V14, P770, DOI 10.1038/nsmb1266; Nandakumar J, 2004, MOL CELL, V16, P211, DOI 10.1016/j.molcel.2004.09.022; Nandakumar J, 2007, MOL CELL, V26, P257, DOI 10.1016/j.molcel.2007.02.026; Nishida H, 2006, J MOL BIOL, V360, P956, DOI 10.1016/j.jmb.2006.05.062; Odell M, 2000, MOL CELL, V6, P1183, DOI 10.1016/S1097-2765(00)00115-5; Pascal JM, 2004, NATURE, V432, P473, DOI 10.1038/nature03082; Pascal JM, 2006, MOL CELL, V24, P279, DOI 10.1016/j.molcel.2006.08.015; Sekiguchi J, 1997, BIOCHEMISTRY-US, V36, P9073, DOI 10.1021/bi970705m; Shuman S, 2004, CURR OPIN STRUC BIOL, V14, P757, DOI 10.1016/j.sbi.2004.10.006; Shuman S, 2007, NAT REV MICROBIOL, V5, P852, DOI 10.1038/nrmicro1768; SRISKANDA V, 2002, J BIOL CHEM, V277, P9685; Srivastava SK, 2007, PROTEINS, V69, P97, DOI 10.1002/prot.21457; Srivastava SK, 2005, NUCLEIC ACIDS RES, V33, P7090, DOI 10.1093/nar/gki1006; Subramanya HS, 1996, CELL, V85, P607, DOI 10.1016/S0092-8674(00)81260-X; Sun Y, 2008, ENVIRON MICROBIOL, V10, P3212, DOI 10.1111/j.1462-2920.2008.01710.x; Tomkinson AE, 2006, CHEM REV, V106, P687, DOI 10.1021/cr040498d; Wang LK, 2007, RNA, V13, P1235, DOI 10.1261/rna.591807; Zhu H, 2008, J BIOL CHEM, V283, P8331, DOI 10.1074/jbc.M705476200	33	117	134	2	50	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17365	17369		10.1074/jbc.R900017200	http://dx.doi.org/10.1074/jbc.R900017200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19329793	Green Published, hybrid			2022-12-27	WOS:000267202500002
J	Takahasi, K; Kumeta, H; Tsuduki, N; Narita, R; Shigemoto, T; Hirai, R; Yoneyama, M; Horiuchi, M; Ogura, K; Fujita, T; Inagaki, F				Takahasi, Kiyohiro; Kumeta, Hiroyuki; Tsuduki, Natsuko; Narita, Ryo; Shigemoto, Taeko; Hirai, Reiko; Yoneyama, Mitsutoshi; Horiuchi, Masataka; Ogura, Kenji; Fujita, Takashi; Inagaki, Fuyuhiko			Solution Structures of Cytosolic RNA Sensor MDA5 and LGP2 C-terminal Domains IDENTIFICATION OF THE RNA RECOGNITION LOOP IN RIG-I-LIKE RECEPTORS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TORSION ANGLE DYNAMICS; DOUBLE-STRANDED-RNA; ANTIVIRAL RESPONSES; INNATE IMMUNITY; REGULATORY DOMAIN; ADAPTER PROTEIN; HELICASE; MECHANISM; VIRUSES; DYANA	The RIG-I like receptor (RLR) comprises three homologues: RIG-I (retinoic acid-inducible gene I), MDA5(melanoma differentiation-associated gene 5), and LGP2 (laboratory of genetics and physiology 2). Each RLR senses different viral infections by recognizing replicating viral RNA in the cytoplasm. The RLR contains a conserved C-terminal domain (CTD), which is responsible for the binding specificity to the viral RNAs, including double-stranded RNA (dsRNA) and 5'-triphosphated single-stranded RNA (5'ppp-ssRNA). Here, the solution structures of the MDA5 and LGP2 CTD domains were solved by NMR and compared with those of RIG-I CTD. The CTD domains each have a similar fold and a similar basic surface but there is the distinct structural feature of a RNA binding loop; The LGP2 and RIG-I CTD domains have a large basic surface, one bank of which is formed by the RNA binding loop. MDA5 also has a large basic surface that is extensively flat due to open conformation of the RNA binding loop. The NMR chemical shift perturbation study showed that dsRNA and 5'ppp-ssRNA are bound to the basic surface of LGP2 CTD, whereas dsRNA is bound to the basic surface of MDA5 CTD but much more weakly, indicating that the conformation of the RNA binding loop is responsible for the sensitivity to dsRNA and 5'ppp-ssRNA. Mutation study of the basic surface and the RNA binding loop supports the conclusion from the structure studies. Thus, the CTD is responsible for the binding affinity to the viral RNAs.	[Takahasi, Kiyohiro; Kumeta, Hiroyuki; Tsuduki, Natsuko; Horiuchi, Masataka; Ogura, Kenji; Inagaki, Fuyuhiko] Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Biol Struct, Kita Ku, Sapporo, Hokkaido 0010021, Japan; [Narita, Ryo; Shigemoto, Taeko; Hirai, Reiko; Yoneyama, Mitsutoshi; Fujita, Takashi] Kyoto Univ, Inst Virus Res, Mol Genet Lab, Kyoto 6068507, Japan; [Narita, Ryo; Shigemoto, Taeko; Hirai, Reiko; Yoneyama, Mitsutoshi; Fujita, Takashi] Kyoto Univ, Grad Sch Biostudies, Mol Cell Biol Lab, Kyoto 6068507, Japan; [Yoneyama, Mitsutoshi] Japan Sci & Technol Agcy, PRESTO, Saitama 3320012, Japan	Hokkaido University; Kyoto University; Kyoto University; Japan Science & Technology Agency (JST)	Inagaki, F (corresponding author), Hokkaido Univ, Grad Sch Pharmaceut Sci, Dept Biol Struct, Kita Ku, N-21,W-11, Sapporo, Hokkaido 0010021, Japan.	finagaki@pharm.hokudai.ac.jp	Yoneyama, Mitsutoshi/D-8244-2017; Horiuchi, Masataka/D-5491-2012	Yoneyama, Mitsutoshi/0000-0001-9512-0408; Kumeta, Hiroyuki/0000-0003-3713-2122	Japanese Ministry of Education, Culture, Sports, Science, and Technology; Uehara Memorial Foundation; Nippon Boehringer Ingelheim Co., Ltd	Japanese Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Uehara Memorial Foundation(Uehara Memorial Foundation); Nippon Boehringer Ingelheim Co., Ltd(Boehringer Ingelheim)	This work was supported by grants-in-aid (Tokutei-ryoiki (Matrix of Infection Phenomena), Kiban (S)) and National Projects on Targeted Proteins Research Program from the Japanese Ministry of Education, Culture, Sports, Science, and Technology, by a Research Grant of the Uehara Memorial Foundation, and by Nippon Boehringer Ingelheim Co., Ltd.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Guntert P, 1997, J MOL BIOL, V273, P283, DOI 10.1006/jmbi.1997.1284; Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; LI X, 2009, J BIOL CHEM; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pippig DA, 2009, NUCLEIC ACIDS RES, V37, P2014, DOI 10.1093/nar/gkp059; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Venkataraman T, 2007, J IMMUNOL, V178, P6444, DOI 10.4049/jimmunol.178.10.6444; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2008, IMMUNITY, V29, P178, DOI 10.1016/j.immuni.2008.07.009	24	157	168	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17465	17474		10.1074/jbc.M109.007179	http://dx.doi.org/10.1074/jbc.M109.007179			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19380577	Green Published, hybrid			2022-12-27	WOS:000267202500013
J	Tralau, T; Lafite, P; Levy, C; Combe, JP; Scrutton, NS; Leys, D				Tralau, Tewes; Lafite, Pierre; Levy, Colin; Combe, John P.; Scrutton, Nigel S.; Leys, David			An Internal Reaction Chamber in Dimethylglycine Oxidase Provides Efficient Protection from Exposure to Toxic Formaldehyde	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-METHYLTRYPTOPHAN OXIDASE; SARCOSINE DEHYDROGENASE; ENZYMATIC-PROPERTIES; SUBSTRATE; TETRAHYDROFOLATE; DETOXIFICATION; DISSIMILATION; MITOCHONDRIA; PROTEINS; ENZYMES	We report a synthetic biology approach to demonstrate substrate channeling in an unusual bifunctional flavoprotein dimethylglycine oxidase. The catabolism of dimethylglycine through methyl group oxidation can potentially liberate toxic formaldehyde, a problem common to many amine oxidases and dehydrogenases. Using a novel synthetic in vivo reporter system for cellular formaldehyde, we found that the oxidation of dimethylglycine is coupled to the synthesis of 5,10-methylenetetrahydrofolate through an unusual substrate channeling mechanism. We also showed that uncoupling of the active sites could be achieved by mutagenesis or deletion of the 5,10-methylenetetrahydrofolate synthase site and that this leads to accumulation of intracellular formaldehyde. Channeling occurs by non-biased diffusion of the labile intermediate through a large solvent cavity connecting both active sites. This central "reaction chamber" is created by a modular protein architecture that appears primitive when compared with the sophisticated design of other paradigm substrate-channeling enzymes. The evolutionary origins of the latter were likely similar to dimethylglycine oxidase. This work demonstrates the utility of synthetic biology approaches to the study of enzyme mechanisms in vivo and points to novel channeling mechanisms that protect the cell milieu from potentially toxic reaction products.	[Tralau, Tewes; Lafite, Pierre; Levy, Colin; Combe, John P.; Scrutton, Nigel S.; Leys, David] Univ Manchester, Fac Life Sci, Manchester Interdisciplinary Bioctr, Manchester M1 7DN, Lancs, England	University of Manchester	Leys, D (corresponding author), Univ Manchester, Fac Life Sci, Manchester Interdisciplinary Bioctr, 131 Princess St, Manchester M1 7DN, Lancs, England.	david.leys@manchester.ac.uk	Lafite, Pierre/F-6806-2011	Lafite, Pierre/0000-0003-1637-4966; Tralau, Tewes/0000-0002-7857-4237; Levy, Colin/0000-0002-9724-310X	Biotechnology and Biological Sciences Research Council (BBSRC) [BBE0170101]; Biotechnology and Biological Sciences Research Council [BB/D01963X/1, BB/E017010/1] Funding Source: researchfish; BBSRC [BB/D01963X/1, BB/E017010/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council (BBSRC) Grant BBE0170101.	An SG, 2008, SCIENCE, V320, P103, DOI 10.1126/science.1152241; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; BARAK AJ, 1983, LIFE SCI, V32, P771, DOI 10.1016/0024-3205(83)90311-9; Basran J, 2002, BIOCHEMISTRY-US, V41, P4733, DOI 10.1021/bi025519h; Basran J, 2006, BIOCHEMISTRY-US, V45, P11151, DOI 10.1021/bi061094d; Bosetti C, 2008, ANN ONCOL, V19, P29, DOI 10.1093/annonc/mdm202; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Crameri A, 1996, NAT BIOTECHNOL, V14, P315, DOI 10.1038/nbt0396-315; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Douce R, 2001, TRENDS PLANT SCI, V6, P167, DOI 10.1016/S1360-1385(01)01892-1; Duine JA, 1999, BIOFACTORS, V10, P201, DOI 10.1002/biof.5520100217; Dunn MF, 2008, TRENDS BIOCHEM SCI, V33, P254, DOI 10.1016/j.tibs.2008.04.008; ELDIN S, 1995, J AM CHEM SOC, V117, P6631, DOI 10.1021/ja00129a043; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gabdoulline RR, 1997, BIOPHYS J, V72, P1917, DOI 10.1016/S0006-3495(97)78838-6; Gonzalez CF, 2006, J BIOL CHEM, V281, P14514, DOI 10.1074/jbc.M600996200; Graham JWA, 2007, PLANT CELL, V19, P3723, DOI 10.1105/tpc.107.053371; Hall NE, 1998, J PHYS CHEM A, V102, P4930, DOI 10.1021/jp9810825; Herring CD, 2004, J BACTERIOL, V186, P6714, DOI 10.1128/JB.186.20.6714-6720.2004; Holden HM, 1999, CELL MOL LIFE SCI, V56, P507, DOI 10.1007/s000180050448; Huang XY, 2001, ANNU REV BIOCHEM, V70, P149, DOI 10.1146/annurev.biochem.70.1.149; Ilari A, 2008, PROTEINS, V71, P2065, DOI 10.1002/prot.21898; Jakalian A, 2002, J COMPUT CHEM, V23, P1623, DOI 10.1002/jcc.10128; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Khanna P, 2001, BIOCHEMISTRY-US, V40, P1441, DOI 10.1021/bi0024411; Levovich I, 2008, CANCER CHEMOTH PHARM, V62, P471, DOI 10.1007/s00280-007-0627-0; Leys D, 2003, EMBO J, V22, P4038, DOI 10.1093/emboj/cdg395; MACKENZIE CG, 1958, J BIOL CHEM, V232, P417; Maden BEH, 2000, BIOCHEM J, V350, P609, DOI 10.1042/0264-6021:3500609; Manjasetty BA, 2003, P NATL ACAD SCI USA, V100, P6992, DOI 10.1073/pnas.1236794100; Meskys R, 2001, EUR J BIOCHEM, V268, P3390, DOI 10.1046/j.1432-1327.2001.02239.x; Mouilleron S, 2007, CURR OPIN STRUC BIOL, V17, P653, DOI 10.1016/j.sbi.2007.09.003; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Myers RS, 2003, BIOCHEMISTRY-US, V42, P7013, DOI 10.1021/bi034314l; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; PORTER DH, 1985, ARCH BIOCHEM BIOPHYS, V243, P396, DOI 10.1016/0003-9861(85)90516-8; Raushel FM, 2003, ACCOUNTS CHEM RES, V36, P539, DOI 10.1021/ar020047k; Sambrook J, 1989, MOL CLONING LAB MANU, V3; Schagger H, 2000, EMBO J, V19, P1777, DOI 10.1093/emboj/19.8.1777; Schirch V, 2005, CURR OPIN CHEM BIOL, V9, P482, DOI 10.1016/j.cbpa.2005.08.017; Scrutton NS, 2004, NAT PROD REP, V21, P722, DOI 10.1039/b306788m; Scrutton NS, 2005, BIOCHEM SOC T, V33, P776, DOI 10.1042/BST0330776; THURNHEER T, 1986, J GEN MICROBIOL, V132, P1215; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Weeks A, 2006, CURR OPIN CHEM BIOL, V10, P465, DOI 10.1016/j.cbpa.2006.08.008; WITTWER AJ, 1981, J BIOL CHEM, V256, P4109; Yurimoto H, 2005, CHEM REC, V5, P367, DOI 10.1002/tcr.20056	48	20	22	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17826	17834		10.1074/jbc.M109.006262	http://dx.doi.org/10.1074/jbc.M109.006262			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19369258	hybrid, Green Published			2022-12-27	WOS:000267202500048
J	Porte, S; Valencia, E; Yakovtseva, EA; Borras, E; Shafqat, N; Debreczeny, JE; Pike, ACW; Oppermann, U; Farres, J; Fita, I; Pares, X				Porte, Sergio; Valencia, Eva; Yakovtseva, Evgenia A.; Borras, Emma; Shafqat, Naeem; Debreczeny, Judit E.; Pike, Ashley C. W.; Oppermann, Udo; Farres, Jaume; Fita, Ignacio; Pares, Xavier			Three-dimensional Structure and Enzymatic Function of Proapoptotic Human p53-inducible Quinone Oxidoreductase PIG3	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZETA-CRYSTALLIN; ALCOHOL-DEHYDROGENASE; THIOESTER REDUCTASE; TUMOR-SUPPRESSOR; GUINEA-PIG; BINDING; PROTEIN; NADPH; IDENTIFICATION; SEQUENCE	Tumor suppressor p53 regulates the expression of p53-induced genes ( PIG) that trigger apoptosis. PIG3 or TP53I3 is the only known member of the medium chain dehydrogenase/reductase superfamily induced by p53 and is used as a proapoptotic marker. Although the participation of PIG3 in the apoptotic pathway is proven, the protein and its mechanism of action were never characterized. We analyzed human PIG3 enzymatic function and found NADPH-dependent reductase activity with ortho-quinones, which is consistent with the classification of PIG3 in the quinone oxidoreductase family. However, the activity is much lower than that of zeta-crystallin, a better known quinone oxidoreductase. In addition, we report the crystallographic structure of PIG3, which allowed the identification of substrate- and cofactor-binding sites, with residues fully conserved from bacteria to human. Tyr-59 in zeta-crystallin (Tyr-51 in PIG3) was suggested to participate in the catalysis of quinone reduction. However, kinetics of Tyr/Phe and Tyr/Ala mutants of both enzymes demonstrated that the active site Tyr is not catalytic but may participate in substrate binding, consistent with a mechanism based on propinquity effects. It has been proposed that PIG3 contribution to apoptosis would be through oxidative stress generation. We found that in vitro activity and in vivo overexpression of PIG3 accumulate reactive oxygen species. Accordingly, an inactive PIG3 mutant (S151V) did not produce reactive oxygen species in cells, indicating that enzymatically active protein is necessary for this function. This supports that PIG3 action is through oxidative stress produced by its enzymatic activity and provides essential knowledge for eventual control of apoptosis.	[Porte, Sergio; Yakovtseva, Evgenia A.; Borras, Emma; Farres, Jaume; Pares, Xavier] Univ Autonoma Barcelona, Fac Biosci, Dept Biochem & Mol Biol, E-08193 Barcelona, Spain; [Valencia, Eva; Fita, Ignacio] CSIC, IBMB, Inst Mol Biol, E-08028 Barcelona, Spain; [Valencia, Eva; Fita, Ignacio] IRB Barcelona, Barcelona 08028, Spain; [Shafqat, Naeem; Debreczeny, Judit E.; Pike, Ashley C. W.; Oppermann, Udo] Univ Oxford, Struct Genom Consortium, Oxford OX3 7DQ, England; [Oppermann, Udo] Botnar Res Ctr, Oxford Biomed Res Unit, Oxford OX3 7LD, England	Autonomous University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Biologia Molecular de Barcelona (IBMB); Barcelona Institute of Science & Technology; Institute for Research in Biomedicine - IRB Barcelona; University of Oxford; University of Oxford	Pares, X (corresponding author), Univ Autonoma Barcelona, Fac Biosci, Dept Biochem & Mol Biol, E-08193 Barcelona, Spain.	xavier.pares@uab.es	Fita, Ignasi/R-4515-2019; Farrés, Jaume/F-8648-2016; Pares, Xavier/K-8228-2017	Fita, Ignasi/0000-0002-7521-2679; Farrés, Jaume/0000-0001-9069-3987; Pares, Xavier/0000-0002-5071-9465; Shafqat, Sheikh Naeem/0000-0002-1468-4082	Spanish Direccion General de Investigacion [BFU2005-02621, BFU2008-02945/BMC, BFU2005-08686C02-01]; Generalitat de Catalunya [2005 SGR 00112]; Canadian Institutes for Health Research [1097737]; Canadian Foundation for Innovation, Genome Canada; Ontario Genomics Institute,	Spanish Direccion General de Investigacion(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Foundation for Innovation, Genome Canada(Genome CanadaCanada Foundation for Innovation); Ontario Genomics Institute,	This work was supported by Spanish Direccion General de Investigacion Grants BFU2005-02621, BFU2008-02945/BMC, and BFU2005-08686C02-01 and the Generalitat de Catalunya Grant 2005 SGR 00112. The Structural Genomics Consortium is a registered charity ( number 1097737) and receives funds from the Canadian Institutes for Health Research, the Canadian Foundation for Innovation, Genome Canada, through the Ontario Genomics Institute, GlaxoSmithKline, Karolinska Institutet, the Knut and Alice Wallenberg Foundation, the Ontario Innovation Trust, the Ontario Ministry for Research and Innovation, Merck, the Novartis Research Foundation, the Swedish Agency for Innovation Systems, the Swedish Foundation for Strategic Research, and the Wellcome Trust.	Airenne TT, 2003, J MOL BIOL, V327, P47, DOI 10.1016/S0022-2836(03)00038-X; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BAKER PJ, 1992, J MOL BIOL, V228, P662, DOI 10.1016/0022-2836(92)90848-E; Bergamaschi D, 2004, MOL CELL BIOL, V24, P1341, DOI 10.1128/MCB.24.3.1341-1350.2004; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Campomenosi P, 2001, ONCOGENE, V20, P3573, DOI 10.1038/sj.onc.1204468; Carugo O, 1997, PROTEINS, V28, P10, DOI 10.1002/(SICI)1097-0134(199705)28:1<10::AID-PROT2>3.3.CO;2-R; Chen ZJ, 2008, J MOL BIOL, V379, P830, DOI 10.1016/j.jmb.2008.04.041; Contente A, 2003, CANCER RES, V63, P1756; Contente A, 2002, NAT GENET, V30, P315, DOI 10.1038/ng836; Delia D, 1997, CARCINOGENESIS, V18, P943, DOI 10.1093/carcin/18.5.943; Edwards KJ, 1996, ARCH BIOCHEM BIOPHYS, V328, P173, DOI 10.1006/abbi.1996.0158; Fernandez MR, 2007, CELL MOL LIFE SCI, V64, P1419, DOI 10.1007/s00018-007-7091-1; Flatt PM, 2000, CANCER LETT, V156, P63, DOI 10.1016/S0304-3835(00)00441-9; FUJII Y, 1990, J BIOL CHEM, V265, P9914; Gallego O, 2006, BIOCHEM J, V399, P101, DOI 10.1042/BJ20051988; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95; HIROMI K, 1980, ANAL BIOCHEM, V101, P421, DOI 10.1016/0003-2697(80)90208-0; Hori T, 2004, J BIOL CHEM, V279, P22615, DOI 10.1074/jbc.M312655200; HUANG QL, 1987, CURR EYE RES, V6, P725, DOI 10.3109/02713688709034836; Ibrahim H, 2008, KIDNEY INT, V73, P11, DOI 10.1038/sj.ki.5002581; Ito M, 2006, JPN J CLIN ONCOL, V36, P116, DOI 10.1093/jjco/hyi225; Johnson TM, 1996, P NATL ACAD SCI USA, V93, P11848, DOI 10.1073/pnas.93.21.11848; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Jornvall H, 2008, CELL MOL LIFE SCI, V65, P3875, DOI 10.1007/s00018-008-8586-0; Kavanagh K, 2008, CELL MOL LIFE SCI, V65, P3895, DOI 10.1007/s00018-008-8588-y; Kim IK, 2008, J MOL BIOL, V379, P372, DOI 10.1016/j.jmb.2008.04.003; Kranthi BV, 2006, NUCLEIC ACIDS RES, V34, P4060, DOI 10.1093/nar/gkl577; LEVINE AJ, 1991, NATURE, V351, P453, DOI 10.1038/351453a0; Liang XQ, 2004, FEBS LETT, V569, P94, DOI 10.1016/j.febslet.2004.05.057; MA Q, 1992, J BIOL CHEM, V267, P22298; MacFarlane M, 2004, EMBO REP, V5, P674, DOI 10.1038/sj.embor.7400191; Mano J, 2002, PLANT CELL PHYSIOL, V43, P1445, DOI 10.1093/pcp/pcf187; Mano J, 2000, EUR J BIOCHEM, V267, P3661, DOI 10.1046/j.1432-1327.2000.01398.x; Maruyama A, 2003, MICROBIOL-SGM, V149, P389, DOI 10.1099/mic.0.25796-0; Moll UM, 2004, MOL CANCER RES, V2, P371; Naumann U, 2006, CANCER GENE THER, V13, P469, DOI 10.1038/sj.cgt.7700917; Nomdedeu JF, 2008, LEUKEMIA RES, V32, P186, DOI 10.1016/j.leukres.2007.01.023; Oppermann U, 2007, ANNU REV PHARMACOL, V47, P293, DOI 10.1146/annurev.pharmtox.47.120505.105316; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Polyak K, 1997, NATURE, V389, P300, DOI 10.1038/38525; RAO PV, 1992, J BIOL CHEM, V267, P96; Rao PV, 1997, BIOCHEMISTRY-US, V36, P5353, DOI 10.1021/bi9622985; Riveros-Rosas H, 2003, EUR J BIOCHEM, V270, P3309, DOI 10.1046/j.1432-1033.2003.03704.x; Rosell A, 2003, J MOL BIOL, V330, P75, DOI 10.1016/S0022-2836(03)00431-5; Rossman M.G., 1975, ENZYMES, V11, P61, DOI 10.1016/S1874-6047(08)60210-3; ROYALL JA, 1993, ARCH BIOCHEM BIOPHYS, V302, P348, DOI 10.1006/abbi.1993.1222; Sablina AA, 2005, NAT MED, V11, P1306, DOI 10.1038/nm1320; Schlegel BP, 1998, BIOCHEMISTRY-US, V37, P11003, DOI 10.1021/bi980475r; STINSON RA, 1973, BIOCHEM J, V131, P719, DOI 10.1042/bj1310719; Tanaka T, 2007, CELL, V130, P638, DOI 10.1016/j.cell.2007.08.001; Tang A, 2001, J BIOL CHEM, V276, P21375, DOI 10.1074/jbc.M101941200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; Valencia E, 2004, J MOL BIOL, V341, P1049, DOI 10.1016/j.jmb.2004.06.037; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; YOKOMIZO T, 1993, J BIOL CHEM, V268, P18128; Yokomizo T, 1996, J BIOL CHEM, V271, P2844, DOI 10.1074/jbc.271.5.2844; Youn B, 2006, J BIOL CHEM, V281, P40076, DOI 10.1074/jbc.M605900200; Zhang Q, 2008, FOOD CHEM TOXICOL, V46, P2042, DOI 10.1016/j.fct.2008.01.049	61	42	48	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					17194	17205		10.1074/jbc.M109.001800	http://dx.doi.org/10.1074/jbc.M109.001800			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19349281	hybrid, Green Published			2022-12-27	WOS:000266962400057
J	Dittmer, PJ; Miranda, JG; Gorski, JA; Palmer, AE				Dittmer, Philip J.; Miranda, Jose G.; Gorski, Jessica A.; Palmer, Amy E.			Genetically Encoded Sensors to Elucidate Spatial Distribution of Cellular Zinc	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; FLUORESCENT PROTEIN; MITOCHONDRIAL DYSFUNCTION; DYNAMIC-RANGE; NITRIC-OXIDE; METALLOTHIONEIN; INDICATORS; CA2+; ZN2+; NEUROBIOLOGY	Transition metals are essential enzyme cofactors that are required for a wide range of cellular processes. Paradoxically, whereas metal ions are essential for numerous cellular processes, they are also toxic. Therefore cells must tightly regulate metal accumulation, transport, distribution, and export. Improved tools to interrogate metal ion availability and spatial distribution within living cells would greatly advance our understanding of cellular metal homeostasis. In this work, we present genetically encoded sensors for Zn2+ based on the principle of fluorescence resonance energy transfer. We also develop methodology to calibrate the probes within the cellular environment. To identify both sources of and sinks for Zn2+, these sensors are genetically targeted to specific locations within the cell, including cytosol, plasma membrane, and mitochondria. Localized probes reveal that mitochondria contain an elevated pool of Zn2+ under resting conditions that can be released into the cytosol upon glutamate stimulation of hippocampal neurons. We also observed that Zn2+ is taken up into mitochondria following glutamate/Zn2+ treatment and that there is heterogeneity in both the magnitude and kinetics of the response. Our results suggest that mitochondria serve as a source of and a sink for Zn2+ signals under different cellular conditions.	[Dittmer, Philip J.; Miranda, Jose G.; Palmer, Amy E.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Gorski, Jessica A.] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder	Palmer, AE (corresponding author), Univ Colorado, Dept Chem & Biochem, UCB 215, Boulder, CO 80309 USA.	Amy.Palmer@Colorado.edu	Miranda, Jose/HCI-6099-2022	Dittmer, Philip/0000-0002-5681-1502	National Institutes of Health [T32 GM-065103, GM084027]; University of Colorado; Whitehall Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM065103, R01GM084027] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Colorado; Whitehall Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants T32 GM-065103 (to P. J. D.) and GM084027 (to A. E. P.). This work was also supported by the University of Colorado and a Whitehall Foundation beginning grant-in-aid.	BANKER G, 1998, CULTURING NERVE CELL; Bossy-Wetzel E, 2004, NEURON, V41, P351, DOI 10.1016/S0896-6273(04)00015-7; Bozym RA, 2006, ACS CHEM BIOL, V1, P103, DOI 10.1021/cb500043a; Eide DJ, 2006, BBA-MOL CELL RES, V1763, P711, DOI 10.1016/j.bbamcr.2006.03.005; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; ElrodErickson M, 1996, STRUCTURE, V4, P1171, DOI 10.1016/S0969-2126(96)00125-6; Evers TH, 2007, J MOL BIOL, V374, P411, DOI 10.1016/j.jmb.2007.09.021; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hires SA, 2008, P NATL ACAD SCI USA, V105, P4411, DOI 10.1073/pnas.0712008105; Hong SH, 2003, P NATL ACAD SCI USA, V100, P2255, DOI 10.1073/pnas.0438005100; KAO JPY, 1994, METHOD CELL BIOL, V40, P155; KRONCKE KD, 1994, BIOCHEM BIOPH RES CO, V200, P1105, DOI 10.1006/bbrc.1994.1564; Malaiyandi LM, 2005, J NEUROCHEM, V93, P1242, DOI 10.1111/j.1471-4159.2005.03116.x; MARET W, 1995, NEUROCHEM INT, V27, P111, DOI 10.1016/0197-0186(94)00173-R; MARET W, 1994, P NATL ACAD SCI USA, V91, P237, DOI 10.1073/pnas.91.1.237; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Miyawaki A, 1999, P NATL ACAD SCI USA, V96, P2135, DOI 10.1073/pnas.96.5.2135; Miyawaki A, 2000, METHOD ENZYMOL, V327, P472, DOI 10.1016/S0076-6879(00)27297-2; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Nolan EM, 2006, J AM CHEM SOC, V128, P15517, DOI 10.1021/ja065759a; Palmer AE, 2006, CHEM BIOL, V13, P521, DOI 10.1016/j.chembiol.2006.03.007; Qiao W, 2006, P NATL ACAD SCI USA, V103, P8674, DOI 10.1073/pnas.0600928103; Que EL, 2008, CHEM REV, V108, P1517, DOI 10.1021/cr078203u; Rae TD, 1999, SCIENCE, V284, P805, DOI 10.1126/science.284.5415.805; Sensi SL, 2000, EUR J NEUROSCI, V12, P3813, DOI 10.1046/j.1460-9568.2000.00277.x; Sensi SL, 2003, P NATL ACAD SCI USA, V100, P6157, DOI 10.1073/pnas.1031598100; Suhy DA, 1999, J BIOL CHEM, V274, P9183, DOI 10.1074/jbc.274.14.9183; van Dongen EMWM, 2007, J AM CHEM SOC, V129, P3494, DOI 10.1021/ja069105d; Walkup GK, 2000, J AM CHEM SOC, V122, P5644, DOI 10.1021/ja000868p; Walkup GK, 1996, J AM CHEM SOC, V118, P3053, DOI 10.1021/ja9538501; Wilkinson Keith D, 2004, Methods Mol Biol, V261, P15; Zhang J, 2007, MOL BIOSYST, V3, P759, DOI 10.1039/b706628g	34	170	172	0	33	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16289	16297		10.1074/jbc.M900501200	http://dx.doi.org/10.1074/jbc.M900501200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19363034	Green Published, hybrid			2022-12-27	WOS:000266730900026
J	Shi, XM; Shao, CH; Zhang, X; Zambonelli, C; Redfield, AG; Head, JF; Seaton, BA; Roberts, MF				Shi, Xiaomeng; Shao, Chenghua; Zhang, Xin; Zambonelli, Carlo; Redfield, Alfred G.; Head, James F.; Seaton, Barbara A.; Roberts, Mary F.			Modulation of Bacillus thuringiensis Phosphatidylinositol-specific Phospholipase C Activity by Mutations in the Putative Dimerization Interface	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FIELD-CYCLING NMR; CIRCULAR-DICHROISM SPECTRA; ANGLE NEUTRON-SCATTERING; MEMBRANE-PROTEINS; PHOSPHODIESTERASE ACTIVITY; TRYPTOPHAN RESIDUES; ACTIVATION; BINDING; PHOSPHATIDYLCHOLINE; DYNAMICS	Cleavage of phosphatidylinositol (PI) to inositol 1,2-(cyclic)phosphate (cIP) and cIP hydrolysis to inositol 1-phosphate by Bacillus thuringiensis phosphatidylinositol-specific phospholipase C are activated by the enzyme binding to phosphatidylcholine (PC) surfaces. Part of this reflects improved binding of the protein to interfaces. However, crystallographic analysis of an interfacially impaired phosphatidylinositol-specific phospholipase (W47A/W242A) suggested protein dimerization might occur on the membrane. In the W47A/W242A dimer, four tyrosine residues from one monomer interact with the same tyrosine cluster of the other, forming a tight dimer interface close to the membrane binding regions. We have constructed mutant proteins in which two or more of these tyrosine residues have been replaced with serine. Phospholipid binding and enzymatic activity of these mutants have been examined to assess the importance of these residues to enzyme function. Replacing two tyrosines had small effects on enzyme activity. However, removal of three or four tyrosine residues weakened PC binding and reduced PI cleavage by the enzyme as well as PC activation of cIP hydrolysis. Crystal structures of Y247S/Y251S in the absence and presence of myo-inositol as well as Y246S/Y247S/Y248S/Y251S indicate that both mutant proteins crystallized as monomers, were very similar to one another, and had no change in the active site region. Kinetic assays, lipid binding, and structural results indicate that either (i) a specific PC binding site, critical for vesicle activities and cIP activation, has been impaired, or (ii) the reduced dimerization potential for Y246S/Y247S/ Y248S and Y246S/Y247S/Y248S/Y251S is responsible for their reduced catalytic activity in all assay systems.	[Shi, Xiaomeng; Zhang, Xin; Zambonelli, Carlo; Roberts, Mary F.] Boston Coll, Dept Chem, Merkert Chem Ctr, Chestnut Hill, MA 02467 USA; [Shao, Chenghua; Head, James F.; Seaton, Barbara A.] Boston Univ, Sch Med, Dept Physiol & Biophys, Boston, MA 02118 USA; [Redfield, Alfred G.] Brandeis Univ, Dept Biochem, Waltham, MA 02454 USA	Boston College; Boston University; Brandeis University	Roberts, MF (corresponding author), Boston Coll, Dept Chem, Merkert Chem Ctr, Chestnut Hill, MA 02467 USA.	mary.roberts@bc.edu		Head, James/0000-0002-6226-4146; Seaton, Barbara/0000-0003-4654-7709; Zhang, Xin/0000-0003-3023-664X	National Institutes of Health [GM60418]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060418] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM60418 (to M.F.R.).	ANDRADE MA, 1993, PROTEIN ENG, V6, P383, DOI 10.1093/protein/6.4.383; Barrall GA, 1996, J CHEM PHYS, V104, P509, DOI 10.1063/1.470847; Berg OG, 2004, BIOCHEMISTRY-US, V43, P2080, DOI 10.1021/bi035063j; BIAN JR, 1992, J COLLOID INTERF SCI, V153, P420, DOI 10.1016/0021-9797(92)90333-H; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DeLano W.L, PYMOL MOL GRAPHICS S; Feng JW, 2003, J BIOL CHEM, V278, P24651, DOI 10.1074/jbc.M301207200; Feng JW, 2002, J BIOL CHEM, V277, P19867, DOI 10.1074/jbc.M200938200; Gelb MH, 2000, BBA-MOL CELL BIOL L, V1488, P20, DOI 10.1016/S1388-1981(00)00106-2; Ghosh AK, 1997, BIOCHEMISTRY-US, V36, P14291, DOI 10.1021/bi971933j; Han SK, 1999, J BIOL CHEM, V274, P11881, DOI 10.1074/jbc.274.17.11881; Heinz DW, 1998, J MOL BIOL, V275, P635, DOI 10.1006/jmbi.1997.1490; HEINZ DW, 1995, EMBO J, V14, P3855, DOI 10.1002/j.1460-2075.1995.tb00057.x; HERZFELD J, 1978, BIOCHEMISTRY-US, V17, P2711, DOI 10.1021/bi00607a003; Hong HD, 2007, J AM CHEM SOC, V129, P8320, DOI 10.1021/ja068849o; JAIN MK, 1989, BIOCHIM BIOPHYS ACTA, V1002, P127, DOI 10.1016/0005-2760(89)90281-6; Jones T. A., 1992, MANUAL; Kissinger CR, 1999, ACTA CRYSTALLOGR D, V55, P484, DOI 10.1107/S0907444998012517; Klauda JB, 2008, BIOPHYS J, V94, P3074, DOI 10.1529/biophysj.107.121806; LIN TL, 1986, J AM CHEM SOC, V108, P3499, DOI 10.1021/ja00272a055; LIN TL, 1987, J PHYS CHEM-US, V91, P406, DOI 10.1021/j100286a031; LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Qian XQ, 1998, BIOCHEMISTRY-US, V37, P6513, DOI 10.1021/bi972650u; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Roberts MF, 2004, P NATL ACAD SCI USA, V101, P17066, DOI 10.1073/pnas.0407565101; Roberts MF, 2004, J AM CHEM SOC, V126, P13765, DOI 10.1021/ja046658k; Roberts MF, 2004, BIOCHEMISTRY-US, V43, P3637, DOI 10.1021/bi035979q; Safferling M, 2003, BIOCHEMISTRY-US, V42, P13969, DOI 10.1021/bi035173q; Santos JSD, 2000, BIOCHEMISTRY-US, V39, P14065, DOI 10.1021/bi000659h; SCHIFFER M, 1992, PROTEIN ENG, V5, P213, DOI 10.1093/protein/5.3.213; Shao CH, 2007, J BIOL CHEM, V282, P9228, DOI 10.1074/jbc.M610918200; Toker A, 2002, CELL MOL LIFE SCI, V59, P761, DOI 10.1007/s00018-002-8465-z; Tsou LK, 2002, J AM CHEM SOC, V124, P14917, DOI 10.1021/ja026721a; VOLWERK JJ, 1990, BIOCHEMISTRY-US, V29, P8056, DOI 10.1021/bi00487a010; Wallace BA, 1999, ADV EXP MED BIOL, V467, P789; Wehbi H, 2003, BIOCHEMISTRY-US, V42, P9374, DOI 10.1021/bi034195+; Wehbi H, 2003, BBA-BIOMEMBRANES, V1613, P15, DOI 10.1016/S0005-2736(03)00134-2; Wu YQ, 1997, BIOCHEMISTRY-US, V36, P8514, DOI 10.1021/bi970560j; Zhang X, 2004, J BIOL CHEM, V279, P20490, DOI 10.1074/jbc.M401016200; Zhou C, 1997, BIOCHEMISTRY-US, V36, P347, DOI 10.1021/bi960601w; Zhou C, 1997, BIOCHEMISTRY-US, V36, P10089, DOI 10.1021/bi970846o; Zhou C, 1998, BIOCHEMISTRY-US, V37, P16430, DOI 10.1021/bi980601r; [No title captured]	45	14	14	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15607	15618		10.1074/jbc.M901601200	http://dx.doi.org/10.1074/jbc.M901601200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19369255	Green Published, hybrid			2022-12-27	WOS:000266501000029
J	Gill, MB; Vivithanaporn, P; Swanson, GT				Gill, Martin B.; Vivithanaporn, Pornpun; Swanson, Geoffrey T.			Glutamate Binding and Conformational Flexibility of Ligand-binding Domains Are Critical Early Determinants of Efficient Kainate Receptor Biogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RETICULUM QUALITY-CONTROL; D-ASPARTATE RECEPTOR; ENDOPLASMIC-RETICULUM; PHARMACOLOGICAL CHAPERONES; SYNAPTIC-TRANSMISSION; AMPA; TRAFFICKING; EXPRESSION; DESENSITIZATION; CHECKPOINT	Intracellular glutamate binding within the endoplasmic reticulum (ER) is thought to be necessary for plasma membrane expression of ionotropic glutamate receptors. Here we determined the importance of glutamate binding to folding and assembly of soluble ligand-binding domains (LBDs), as well as full-length receptors, by comparing the secretion of a soluble GluR6-S1S2 protein versus the plasma membrane localization of GluR6 kainate receptors following mutagenesis of the LBD. The mutations were designed to either eliminate glutamate binding, thereby trapping the bilobate LBD in an "open" conformation, or "lock" the LBD in a closed conformation with an engineered interdomain disulfide bridge. Analysis of plasma membrane localization, medium secretion of soluble LBD proteins, and measures of folding efficiency suggested that loss of glutamate binding affinity significantly impacted subunit protein folding and assembly. In contrast, receptors with conformationally restricted LBDs also exhibited decreased PM expression and altered oligomeric receptor assembly but did not exhibit any deficits in subunit folding. Secretion of the closed LBD protein was enhanced compared with wild-type GluR6-S1S2. Our results suggest that glutamate acts as a chaperone molecule for appropriate folding of nascent receptors and that relaxation of LBDs from fully closed states during oligomerization represents a critical transition that necessarily engages other determinants within receptor dimers. Glutamate receptor LBDs therefore must access multiple conformations for efficient biogenesis.	[Gill, Martin B.; Swanson, Geoffrey T.] Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA; [Vivithanaporn, Pornpun] Mahidol Univ, Fac Sci, Dept Pharmacol, Bangkok 10400, Thailand; [Vivithanaporn, Pornpun] Univ Alberta, Dept Neurol, Edmonton, AB T6G 2S2, Canada	Northwestern University; Feinberg School of Medicine; Mahidol University; University of Alberta	Swanson, GT (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol & Biol Chem, Searle 7-443,303 E Chicago Ave, Chicago, IL 60611 USA.	gtswanson@northwestern.edu						Atlason PT, 2007, J BIOL CHEM, V282, P25299, DOI 10.1074/jbc.M702778200; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Blanke ML, 2008, J BIOL CHEM, V283, P21519, DOI 10.1074/jbc.M709190200; Coleman SK, 2009, J NEUROSCI, V29, P303, DOI 10.1523/JNEUROSCI.3953-08.2009; Fleck MW, 2006, NEUROSCIENTIST, V12, P232, DOI 10.1177/1073858405283828; Fleck MW, 2003, J NEUROSCI, V23, P1219; Greger IH, 2007, TRENDS NEUROSCI, V30, P407, DOI 10.1016/j.tins.2007.06.005; Greger IH, 2007, CURR OPIN NEUROBIOL, V17, P289, DOI 10.1016/j.conb.2007.04.007; Greger IH, 2006, NEURON, V51, P85, DOI 10.1016/j.neuron.2006.05.020; Grunwald ME, 2003, NEUROPHARMACOLOGY, V45, P768, DOI 10.1016/S0028-3908(03)00274-0; Hirbec H, 2003, NEURON, V37, P625, DOI 10.1016/S0896-6273(02)01191-1; Kenny AV, 2009, J BIOL CHEM, V284, P324, DOI 10.1074/jbc.M804023200; Luscher C, 1999, NEURON, V24, P649, DOI 10.1016/S0896-6273(00)81119-8; Luthi A, 1999, NEURON, V24, P389, DOI 10.1016/S0896-6273(00)80852-1; Madden DR, 2000, EUR J BIOCHEM, V267, P4281; Mah SJ, 2005, J NEUROSCI, V25, P2215, DOI 10.1523/JNEUROSCI.4573-04.2005; Matsuda S, 2004, EUR J NEUROSCI, V19, P1683, DOI 10.1111/j.1460-9568.2004.03307.x; Mayer ML, 2005, NEURON, V45, P539, DOI 10.1016/j.neuron.2005.01.031; Morello JP, 2000, TRENDS PHARMACOL SCI, V21, P466, DOI 10.1016/S0165-6147(00)01575-3; Park YY, 2006, NEURON, V49, P95, DOI 10.1016/j.neuron.2005.11.035; Penn AC, 2008, EMBO J, V27, P3056, DOI 10.1038/emboj.2008.222; Petaja-Repo UE, 2002, EMBO J, V21, P1628, DOI 10.1093/emboj/21.7.1628; Pinheiro P, 2006, CELL TISSUE RES, V326, P457, DOI 10.1007/s00441-006-0265-6; Priel A, 2006, NEURON, V52, P1037, DOI 10.1016/j.neuron.2006.12.006; Schiffer HH, 1997, NEURON, V19, P1141, DOI 10.1016/S0896-6273(00)80404-3; Selkirk JV, 2002, J NEUROCHEM, V80, P346, DOI 10.1046/j.0022-3042.2001.00704.x; Snapp E.L., 2003, CURRENT PROTOCOLS CE; Valluru L, 2005, J BIOL CHEM, V280, P6085, DOI 10.1074/jbc.M411549200; Vazhappilly R, 2002, NEUROSCI LETT, V318, P153, DOI 10.1016/S0304-3940(01)02482-X; Vivithanaporn P, 2007, J NEUROSCI, V27, P10423, DOI 10.1523/JNEUROSCI.2674-07.2007; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62	31	24	24	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14503	14512		10.1074/jbc.M900510200	http://dx.doi.org/10.1074/jbc.M900510200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19342380	Green Published, hybrid			2022-12-27	WOS:000266286100057
J	Maruyama, Y; Ogura, T; Mio, K; Kato, K; Kaneko, T; Kiyonaka, S; Mori, Y; Sato, C				Maruyama, Yuusuke; Ogura, Toshihiko; Mio, Kazuhiro; Kato, Kenta; Kaneko, Takeshi; Kiyonaka, Shigeki; Mori, Yasuo; Sato, Chikara			Tetrameric Orai1 Is a Teardrop-shaped Molecule with a Long, Tapered Cytoplasmic Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUTOMATIC PARTICLE PICKUP; OPERATED CA2+ ENTRY; CRAC CHANNEL; PLASMA-MEMBRANE; 3-DIMENSIONAL RECONSTRUCTION; ENDOPLASMIC-RETICULUM; STORE DEPLETION; CALCIUM-CHANNEL; CATION CHANNEL; NEURAL-NETWORK	The Ca2+ release-activated Ca2+ channel is a principal regulator of intracellular Ca2+ rise, which conducts various biological functions, including immune responses. This channel, involved in store-operated Ca2+ influx, is believed to be composed of at least two major components. Orai1 has a putative channel pore and locates in the plasma membrane, and STIM1 is a sensor for luminal Ca2+ store depletion in the endoplasmic reticulum membrane. Here we have purified the FLAG-fused Orai1 protein, determined its tetrameric stoichiometry, and reconstructed its three-dimensional structure at 21-angstrom resolution from 3681 automatically selected particle images, taken with an electron microscope. This first structural depiction of a member of the Orai family shows an elongated teardrop-shape 150 angstrom in height and 95 angstrom in width. Antibody decoration and volume estimation from the amino acid sequence indicate that the widest transmembrane domain is located between the round extracellular domain and the tapered cytoplasmic domain. The cytoplasmic length of 100 angstrom is sufficient for direct association with STIM1. Orifices close to the extracellular and intracellular membrane surfaces of Orai1 seem to connect outside the molecule to large internal cavities.	[Sato, Chikara] AIST, Neurosci Res Inst, Tsukuba, Ibaraki 3058568, Japan; [Mio, Kazuhiro; Sato, Chikara] Natl Inst Adv Ind Sci & Technol, Biomed Informat Res Ctr, Tsukuba, Ibaraki 3058568, Japan; [Ogura, Toshihiko] Japan Sci & Technol Agcy, Precursory Res Embryon Sci & Technol, Kawaguchi, Saitama 3320012, Japan; [Kato, Kenta; Kaneko, Takeshi; Kiyonaka, Shigeki; Mori, Yasuo] Kyoto Univ, Grad Sch Engn, Dept Synthet Chem & Biol Chem, Kyoto 6158510, Japan	National Institute of Advanced Industrial Science & Technology (AIST); National Institute of Advanced Industrial Science & Technology (AIST); Japan Science & Technology Agency (JST); Kyoto University	Sato, C (corresponding author), AIST, Neurosci Res Inst, Umezono 1-1-4, Tsukuba, Ibaraki 3058568, Japan.	ti-sato@aist.go.jp	Mio, Kazuhiro/L-7488-2018; Kiyonaka, Shigeki/AAM-7303-2021; Sato, Chikara/M-7183-2016; Ogura, Toshihiko/M-4089-2018	Mio, Kazuhiro/0000-0002-1655-8231; Sato, Chikara/0000-0001-5543-4496; 	Japan New Energy and Industrial Technology Development Organization; Precursory Research for Embryonic Science and Technology of the Japan Science Agency; National Institute of Advanced Industrial Science and Technology (AIST); Grants-in-Aid for Scientific Research [20249015] Funding Source: KAKEN	Japan New Energy and Industrial Technology Development Organization(New Energy and Industrial Technology Development Organization (NEDO)); Precursory Research for Embryonic Science and Technology of the Japan Science Agency; National Institute of Advanced Industrial Science and Technology (AIST); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Science Research on Priority Areas, Structure of Biological Macromolecular Assemblies, by a grant from the Japan New Energy and Industrial Technology Development Organization (to C. S.), by a grant from Precursory Research for Embryonic Science and Technology of the Japan Science Agency (to T. O.), and by grants from the National Institute of Advanced Industrial Science and Technology (AIST).	Baba Y, 2006, P NATL ACAD SCI USA, V103, P16704, DOI 10.1073/pnas.0608358103; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Chang WC, 2008, J BIOL CHEM, V283, P4622, DOI 10.1074/jbc.M705002200; Cheng KT, 2008, J BIOL CHEM, V283, P12935, DOI 10.1074/jbc.C800008200; Feske S, 2001, NAT IMMUNOL, V2, P316, DOI 10.1038/86318; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Franck J., 2006, 3 DIMENSIONAL ELECT, P91; Gross SA, 2007, J BIOL CHEM, V282, P19375, DOI 10.1074/jbc.M701962200; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; Hara Y, 2002, MOL CELL, V9, P163, DOI 10.1016/S1097-2765(01)00438-5; HARAUZ G, 1986, OPTIK, V73, P146; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Inoue R, 2001, CIRC RES, V88, P325, DOI 10.1161/01.RES.88.3.325; Ji W, 2008, P NATL ACAD SCI USA, V105, P13668, DOI 10.1073/pnas.0806499105; Li ZZ, 2007, J BIOL CHEM, V282, P29448, DOI 10.1074/jbc.M703573200; Liao Y, 2007, P NATL ACAD SCI USA, V104, P4682, DOI 10.1073/pnas.0611692104; Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055; Luik RM, 2008, NATURE, V454, P538, DOI 10.1038/nature07065; Luik RM, 2006, J CELL BIOL, V174, P815, DOI 10.1083/jcb.200604015; Maruyama Y, 2007, J BIOL CHEM, V282, P36961, DOI 10.1074/jbc.M705694200; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Mignen O, 2008, J PHYSIOL-LONDON, V586, P419, DOI 10.1113/jphysiol.2007.147249; Mio K, 2008, J BIOL CHEM, V283, P30300, DOI 10.1074/jbc.M803185200; Mio K, 2007, J MOL BIOL, V367, P373, DOI 10.1016/j.jmb.2006.12.043; Mori Y, 2002, J EXP MED, V195, P673, DOI 10.1084/jem.20011758; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Ogura T, 2003, J STRUCT BIOL, V143, P185, DOI 10.1016/j.jsb.2003.08.005; Ogura T, 2004, J STRUCT BIOL, V145, P63, DOI 10.1016/S1047-8477(03)00139-4; Ogura T, 2004, J STRUCT BIOL, V146, P344, DOI 10.1016/j.jsb.2004.01.007; Ogura T, 2001, J STRUCT BIOL, V136, P227, DOI 10.1006/jsbi.2002.4442; Ogura T, 2006, J STRUCT BIOL, V156, P371, DOI 10.1016/j.jsb.2006.05.016; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; PARTISETI M, 1994, J BIOL CHEM, V269, P32327; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; PENCZEK P, 1992, ULTRAMICROSCOPY, V40, P33, DOI 10.1016/0304-3991(92)90233-A; PENCZEK PA, 1994, ULTRAMICROSCOPY, V53, P251, DOI 10.1016/0304-3991(94)90038-8; Penna A, 2008, NATURE, V456, P116, DOI 10.1038/nature07338; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; Sato C, 2004, J MOL BIOL, V336, P155, DOI 10.1016/j.jmb.2003.11.024; Sato C, 2001, NATURE, V409, P1047, DOI 10.1038/35059098; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; van Heel M, 2000, Q REV BIOPHYS, V33, P307, DOI 10.1017/S0033583500003644; vanHeel M, 1996, J STRUCT BIOL, V116, P17, DOI 10.1006/jsbi.1996.0004; Varnai P, 2007, J BIOL CHEM, V282, P29678, DOI 10.1074/jbc.M704339200; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Vig M, 2006, CURR BIOL, V16, P2073, DOI 10.1016/j.cub.2006.08.085; Williams RT, 2001, BIOCHEM J, V357, P673, DOI 10.1042/0264-6021:3570673; Wu MM, 2006, J CELL BIOL, V174, P803, DOI 10.1083/jcb.200604014; Xu PY, 2006, BIOCHEM BIOPH RES CO, V350, P969, DOI 10.1016/j.bbrc.2006.09.134; Yazawa M, 2007, NATURE, V448, P78, DOI 10.1038/nature05928; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Zhang SL, 2006, P NATL ACAD SCI USA, V103, P9357, DOI 10.1073/pnas.0603161103; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; ZWEIFACH A, 1993, P NATL ACAD SCI USA, V90, P6295, DOI 10.1073/pnas.90.13.6295	56	65	67	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13676	13685		10.1074/jbc.M900812200	http://dx.doi.org/10.1074/jbc.M900812200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19289460	Green Published, hybrid			2022-12-27	WOS:000265877300045
J	Seo, JH; Lim, JC; Lee, DY; Kim, KS; Piszczek, G; Nam, HW; Kim, YS; Ahn, T; Yun, CH; Kim, K; Chock, PB; Chae, HZ				Seo, Jae Ho; Lim, Jung Chae; Lee, Duck-Yeon; Kim, Kyung Seok; Piszczek, Grzegorz; Nam, Hyung Wook; Kim, Yu Sam; Ahn, Taeho; Yun, Chul-Ho; Kim, Kanghwa; Chock, P. Boon; Chae, Ho Zoon			Novel Protective Mechanism against Irreversible Hyperoxidation of Peroxiredoxin N-alpha-TERMINAL ACETYLATION OF HUMAN PEROXIREDOXIN II	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYSTEINE-SULFINIC ACID; ACTIVE-SITE CYSTEINE; THIOL-SPECIFIC ANTIOXIDANT; OXIDATIVE STRESS; MAMMALIAN PEROXIREDOXIN; 2-CYS PEROXIREDOXIN; HYDROGEN-PEROXIDE; IN-VIVO; DIFFERENTIAL EXPRESSION; REDUCE PEROXIDES	Peroxiredoxins (Prxs) are a group of peroxidases containing a cysteine thiol at their catalytic site. During peroxidase catalysis, the catalytic cysteine, referred to as the peroxidatic cysteine (C-P), cycles between thiol (C-P-SH) and disulfide (-S-S-) states via a sulfenic (C-P-SOH) intermediate. Hyperoxidation of the CP thiol to its sulfinic (C-P-SO2H) derivative has been shown to be reversible, but its sulfonic (C-P-SO3H) derivative is irreversible. Our comparative study of hyperoxidation and regeneration of Prx I and Prx II in HeLa cells revealed that Prx II is more susceptible than Prx I to hyperoxidation and that the majority of the hyperoxidized Prx II formation is reversible. However, the hyperoxidized Prx I showed much less reversibility because of the formation of its irreversible sulfonic derivative, as verified with C-P-SO3H-specific antiserum. In an attempt to identify the multiple hyperoxidized spots of the Prx I on two-dimensional PAGE analysis, an N-acetylated Prx I was identified as part of the total Prx I using anti-acetylated Lys antibody. Using peptidyl-Asp metalloendopeptidase (EC 3.4.24.33) peptide fingerprints, we found that N-alpha-terminal acetylation (N-alpha-Ac) occurred exclusively on Prx II after demethionylation. N-alpha-Ac of Prx II blocks Prx II from irreversible hyperoxidation without altering its affinity for hydrogen peroxide. A comparative study of non-N-alpha-acetylated and N-alpha-terminal acetylated Prx II revealed that N-alpha-Ac of Prx II induces a significant shift in the circular dichroism spectrum and elevation of T-m from 59.6 to 70.9 degrees C. These findings suggest that the structural maintenance of Prx II by N-alpha-Ac may be responsible for preventing its hyperoxidation to form C-P-SO3H.	[Lee, Duck-Yeon; Piszczek, Grzegorz; Chock, P. Boon; Chae, Ho Zoon] NHLBI, Biochem Lab, NIH, Bethesda, MD 20892 USA; [Seo, Jae Ho; Lim, Jung Chae; Kim, Kyung Seok; Yun, Chul-Ho] Chonnam Natl Univ, Sch Biol Sci & Technol, Kwangju 500757, South Korea; [Kim, Kanghwa] Chonnam Natl Univ, Dept Food & Nutr, Kwangju 500757, South Korea; [Kim, Kanghwa] Chonnam Natl Univ, Coll Vet Med, Kwangju 500757, South Korea; [Ahn, Taeho] Chonnam Natl Univ, Dept Biochem, Kwangju 500757, South Korea; [Nam, Hyung Wook; Kim, Yu Sam] Yonsei Univ, Res Ctr, Prot Network, Coll Sci,Dept Biochem, Seoul 120749, South Korea	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Chonnam National University; Chonnam National University; Chonnam National University; Chonnam National University; Yonsei University	Chae, HZ (corresponding author), NHLBI, Biochem Lab, NIH, Bldg 3, Bethesda, MD 20892 USA.	hzchae@chonnam.ac.kr	Piszczek, Grzegorz/GYU-2029-2022	Yun, Chul-Ho/0000-0003-2685-2968	Korea Research Foundation [KRF2005-070-C00081]; Chonnam National University [CNU-2008-1005]; Korea Science and Engineering Foundation [R01-2008-000-2107202008]; Ministry of Education, Science and Technology of Korea; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL000338, Z01HL000202, ZIAHL000202, ZICHL006028] Funding Source: NIH RePORTER	Korea Research Foundation(National Research Foundation of Korea); Chonnam National University; Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); Ministry of Education, Science and Technology of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was authored, in whole or in part, by National Institutes of Health staff. This work was supported by Korea Research Foundation Grant KRF2005-070-C00081, Chonnam National University Grant CNU-2008-1005, Korea Science and Engineering Foundation Grant R01-2008-000-2107202008 (to H. Z. C.), and Second Stage BK21 Project from the Ministry of Education, Science and Technology of Korea.	Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Bradshaw RA, 1998, TRENDS BIOCHEM SCI, V23, P263, DOI 10.1016/S0968-0004(98)01227-4; Bryk R, 2000, NATURE, V407, P211, DOI 10.1038/35025109; Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569; CHAE HZ, 1994, P NATL ACAD SCI USA, V91, P7017, DOI 10.1073/pnas.91.15.7017; Chae HZ, 1999, DIABETES RES CLIN PR, V45, P101, DOI 10.1016/S0168-8227(99)00037-6; Chae HZ, 1999, METHOD ENZYMOL, V300, P219; Chang TS, 2004, J BIOL CHEM, V279, P50994, DOI 10.1074/jbc.M409482200; Chevallet M, 2003, J BIOL CHEM, V278, P37146, DOI 10.1074/jbc.M305161200; Choi MH, 2005, NATURE, V435, P347, DOI 10.1038/nature03587; Egler RA, 2005, ONCOGENE, V24, P8038, DOI 10.1038/sj.onc.1208821; Hofmann B, 2002, BIOL CHEM, V383, P347, DOI 10.1515/BC.2002.040; Jang HH, 2004, CELL, V117, P625, DOI 10.1016/j.cell.2004.05.002; Joensson Thomas J., 2007, V44, P115; Jonsson TJ, 2008, NATURE, V451, P98, DOI 10.1038/nature06415; Jung H, 2001, J BIOL CHEM, V276, P15504, DOI 10.1074/jbc.M009620200; Kang SW, 1998, J BIOL CHEM, V273, P6297, DOI 10.1074/jbc.273.11.6297; Karplus P. Andrew, 2007, V44, P41; Kim SY, 2008, FEBS LETT, V582, P1913, DOI 10.1016/j.febslet.2008.05.015; Kraus LM, 2001, KIDNEY INT, V59, pS102, DOI 10.1046/j.1523-1755.2001.59780102.x; Lapko VN, 2001, PROTEIN SCI, V10, P1130, DOI 10.1110/ps.40901; Lee K, 2002, BIOCHEM BIOPH RES CO, V296, P337, DOI 10.1016/S0006-291X(02)00801-X; Lee TH, 2003, BLOOD, V101, P5033, DOI 10.1182/blood-2002-08-2548; Lee WS, 2007, J BIOL CHEM, V282, P22011, DOI 10.1074/jbc.M610330200; Lim JC, 2008, J BIOL CHEM, V283, P28873, DOI 10.1074/jbc.M804087200; LUTHMAN M, 1982, BIOCHEMISTRY-US, V21, P6628, DOI 10.1021/bi00269a003; Matsumura T, 2008, J BIOL CHEM, V283, P284, DOI 10.1074/jbc.M705753200; McCarthy J, 2003, J PROTEOME RES, V2, P239, DOI 10.1021/pr025564b; Mitsumoto A, 2001, FREE RADICAL BIO MED, V30, P625, DOI 10.1016/S0891-5849(00)00503-7; MONNOT M, 1987, J BIOL CHEM, V262, P2502; Moon JC, 2005, J BIOL CHEM, V280, P28775, DOI 10.1074/jbc.M505362200; Mu ZM, 2002, J BIOL CHEM, V277, P43175, DOI 10.1074/jbc.M206066200; Neumann CA, 2003, NATURE, V424, P561, DOI 10.1038/nature01819; Neumann CA, 2007, CURR OPIN PHARMACOL, V7, P375, DOI 10.1016/j.coph.2007.04.007; OGAWA K, 1994, EUR J BIOCHEM, V222, P659, DOI 10.1111/j.1432-1033.1994.tb18910.x; Ogusucu R, 2007, FREE RADICAL BIO MED, V42, P326, DOI 10.1016/j.freeradbiomed.2006.10.042; Ok E, 2005, KIDNEY INT, V68, P173, DOI 10.1111/j.1523-1755.2005.00391.x; Park SY, 2007, CANCER RES, V67, P9294, DOI 10.1158/0008-5472.CAN-07-0651; Parmigiani RB, 2008, P NATL ACAD SCI USA, V105, P9633, DOI 10.1073/pnas.0803749105; Peskin AV, 2007, J BIOL CHEM, V282, P11885, DOI 10.1074/jbc.M700339200; Polevoda B, 2000, J BIOL CHEM, V275, P36479, DOI 10.1074/jbc.R000023200; Poole Leslie B., 2007, V44, P61; Rabilloud T, 2002, J BIOL CHEM, V277, P19396, DOI 10.1074/jbc.M106585200; Rhee SG, 2007, KIDNEY INT, V72, pS3, DOI 10.1038/sj.ki.5002380; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Rhee SG, 2001, IUBMB LIFE, V52, P35, DOI 10.1080/15216540252774748; Sarafian TA, 1999, J NEUROSCI RES, V56, P206, DOI 10.1002/(SICI)1097-4547(19990415)56:2<206::AID-JNR1>3.0.CO;2-X; Schroder E, 2000, STRUCTURE, V8, P605, DOI 10.1016/S0969-2126(00)00147-7; Stark G R, 1972, Methods Enzymol, V25, P579, DOI 10.1016/S0076-6879(72)25057-1; Taggart C, 2000, J BIOL CHEM, V275, P27258; Trujillo M, 2008, METHOD ENZYMOL, V441, P173, DOI 10.1016/S0076-6879(08)01210-X; Trujillo Madia, 2007, V44, P83; Wagner E, 2002, BIOCHEM J, V366, P777, DOI 10.1042/BJ20020525; Wen ST, 1997, GENE DEV, V11, P2456, DOI 10.1101/gad.11.19.2456; Woo HA, 2003, J BIOL CHEM, V278, P47361, DOI 10.1074/jbc.C300428200; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Wood ZA, 2003, TRENDS BIOCHEM SCI, V28, P32, DOI 10.1016/S0968-0004(02)00003-8; Xiao NZ, 2005, FEBS J, V272, P3929, DOI 10.1111/j.1742-4658.2005.04809.x; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200	60	38	38	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13455	13465		10.1074/jbc.M900641200	http://dx.doi.org/10.1074/jbc.M900641200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19286652	Green Published, hybrid			2022-12-27	WOS:000265877300021
J	Sinnett-Smith, J; Jacamo, R; Kui, R; Wang, YZM; Young, SH; Rey, O; Waldron, RT; Rozengurt, E				Sinnett-Smith, James; Jacamo, Rodrigo; Kui, Robert; Wang, YunZu M.; Young, Steven H.; Rey, Osvaldo; Waldron, Richard T.; Rozengurt, Enrique			Protein Kinase D Mediates Mitogenic Signaling by G(q)-coupled Receptors through Protein Kinase C-independent Regulation of Activation Loop Ser(744) and Ser(748) Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; POTENTIATES DNA-SYNTHESIS; GROWTH-FACTOR RECEPTOR; D PKD ACTIVATION; TYROSINE PHOSPHORYLATION; LYSOPHOSPHATIDIC ACID; RAPIDLY STIMULATE; SWISS 3T3-CELLS; MAJOR SUBSTRATE; BOMBESIN FAMILY	Rapid protein kinase D(PKD) activation and phosphorylation via protein kinase C(PKC) have been extensively documented in many cell types cells stimulated by multiple stimuli. In contrast, little is known about the role and mechanism(s) of a recently identified sustained phase of PKD activation in response to G protein-coupled receptor agonists. To elucidate the role of biphasic PKD activation, we used Swiss 3T3 cells because PKD expression in these cells potently enhanced duration of ERK activation and DNA synthesis in response to G(q)-coupled receptor agonists. Cell treatment with the preferential PKC inhibitors GF109203X or Go6983 profoundly inhibited PKD activation induced by bombesin stimulation for < 15 min but did not prevent PKD catalytic activation induced by bombesin stimulation for longer times (> 60 min). The existence of sequential PKC-dependent and PKC-independent PKD activation was demonstrated in 3T3 cells stimulated with various concentrations of bombesin (0.3-10 nM) or with vasopressin, a different G(q)-coupled receptor agonist. To gain insight into the mechanisms involved, we determined the phosphorylation state of the activation loop residues Ser(744) and Ser(748). Transphosphorylation targeted Ser(744), whereas autophosphorylation was the predominant mechanism for Ser(748) in cells stimulated with G(q)-coupled receptor agonists. We next determined which phase of PKD activation is responsible for promoting enhanced ERK activation and DNA synthesis in response to G(q)-coupled receptor agonists. We show, for the first time, that the PKC-independent phase of PKD activation mediates prolonged ERK signaling and progression to DNA synthesis in response to bombesin or vasopressin through a pathway that requires epidermal growth factor receptor-tyrosine kinase activity. Thus, our results identify a novel mechanism of G(q)-coupled receptor-induced mitogenesis mediated by sustained PKD activation through a PKC-independent pathway.	Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Digest Dis,CURE, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Digest Dis Res Ctr, Los Angeles, CA 90095 USA; Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Rozengurt, E (corresponding author), Univ Calif Los Angeles, Sch Med, Dept Med, 900 Vet Ave,Warren Hall,Rm 11-124, Los Angeles, CA 90095 USA.	erozengurt@mednet.ucla.edu	Waldron, Richard Taliesin/ABF-2773-2020	Waldron, Richard Taliesin/0000-0003-3151-6002; Rey, Osvaldo/0000-0003-1575-9864	National Institutes of Health [R0-1 DK 55003, R0-1 DK56930, P30 DK41301]; NATIONAL CANCER INSTITUTE [K22CA128883] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK056930, R21DK071783, P30DK041301, R01DK055003] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R0-1 DK 55003, R0-1 DK56930, and P30 DK41301 (to E. R.).	Brandlin I, 2002, J BIOL CHEM, V277, P6490, DOI 10.1074/jbc.M106083200; Bridges AJ, 1996, J MED CHEM, V39, P267, DOI 10.1021/jm9503613; BROOKS SF, 1992, J BIOL CHEM, V267, P14212; BROOKS SF, 1991, EMBO J, V10, P2497, DOI 10.1002/j.1460-2075.1991.tb07789.x; Chiu T, 2002, AM J PHYSIOL-CELL PH, V282, pC434, DOI 10.1152/ajpcell.00240.2001; Chiu T, 2001, AM J PHYSIOL-CELL PH, V280, pC929, DOI 10.1152/ajpcell.2001.280.4.C929; Chiu T, 2001, FEBS LETT, V489, P101, DOI 10.1016/S0014-5793(01)02076-2; Chiu TT, 2007, AM J PHYSIOL-CELL PH, V292, pC767, DOI 10.1152/ajpcell.00308.2006; Dalby KN, 1998, J BIOL CHEM, V273, P1496, DOI 10.1074/jbc.273.3.1496; Frodin M, 1999, MOL CELL ENDOCRINOL, V151, P65, DOI 10.1016/S0303-7207(99)00061-1; Geiges D, 1997, BIOCHEM PHARMACOL, V53, P865, DOI 10.1016/S0006-2952(96)00885-4; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; Gschwind A, 2001, ONCOGENE, V20, P1594, DOI 10.1038/sj.onc.1204192; Guha S, 2002, CANCER RES, V62, P1632; Hunger-Glaser I, 2003, J BIOL CHEM, V278, P22631, DOI 10.1074/jbc.M210876200; Iglesias T, 1999, FEBS LETT, V454, P53, DOI 10.1016/S0014-5793(99)00772-3; Iglesias T, 1998, J BIOL CHEM, V273, P410, DOI 10.1074/jbc.273.1.410; Iglesias T, 1998, J BIOL CHEM, V273, P27662, DOI 10.1074/jbc.273.42.27662; Jacamo R, 2008, J BIOL CHEM, V283, P12877, DOI 10.1074/jbc.M800442200; LEVITZKI A, 1995, SCIENCE, V267, P1782, DOI 10.1126/science.7892601; Liljedahl M, 2001, CELL, V104, P409, DOI 10.1016/S0092-8674(01)00228-8; Matthews SA, 2006, MOL CELL BIOL, V26, P1569, DOI 10.1128/MCB.26.4.1569-1577.2006; Matthews SA, 1997, J BIOL CHEM, V272, P20245, DOI 10.1074/jbc.272.32.20245; Matthews SA, 1999, J BIOL CHEM, V274, P26543, DOI 10.1074/jbc.274.37.26543; Mihailovic T, 2004, CANCER RES, V64, P8939, DOI 10.1158/0008-5472.CAN-04-0981; Needham LK, 1998, J BIOL CHEM, V273, P14626, DOI 10.1074/jbc.273.23.14626; Paolucci L, 2000, AM J PHYSIOL-CELL PH, V278, pC33, DOI 10.1152/ajpcell.2000.278.1.C33; Poulin B, 2005, P NATL ACAD SCI USA, V102, P4276, DOI 10.1073/pnas.0409590102; Prigozhina NL, 2004, CURR BIOL, V14, P88, DOI 10.1016/j.cub.2004.01.003; Rey O, 2004, J BIOL CHEM, V279, P34361, DOI 10.1074/jbc.M403265200; ROZENGURT E, 1983, P NATL ACAD SCI-BIOL, V80, P7244, DOI 10.1073/pnas.80.23.7244; Rozengurt E, 2002, TRENDS ENDOCRIN MET, V13, P128, DOI 10.1016/S1043-2760(01)00544-6; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Rozengurt E, 1998, J CELL PHYSIOL, V177, P507, DOI 10.1002/(SICI)1097-4652(199812)177:4<507::AID-JCP2>3.0.CO;2-K; ROZENGURT E, 1986, SCIENCE, V234, P161, DOI 10.1126/science.3018928; Rozengurt E, 2007, J CELL PHYSIOL, V213, P589, DOI 10.1002/jcp.21246; Santiskulvong C, 2001, AM J PHYSIOL-CELL PH, V281, pC886, DOI 10.1152/ajpcell.2001.281.3.C886; Schafer B, 2004, ONCOGENE, V23, P991, DOI 10.1038/sj.onc.1207278; Seufferlein T, 1996, MOL BIOL CELL, V7, P1865, DOI 10.1091/mbc.7.12.1865; Sinnett-Smith J, 2004, J BIOL CHEM, V279, P16883, DOI 10.1074/jbc.M313225200; Sinnett-Smith J, 2007, J CELL PHYSIOL, V211, P781, DOI 10.1002/jcp.20984; SINNETTSMITH J, 1993, J BIOL CHEM, V268, P14261; Storz P, 2003, EMBO J, V22, P109, DOI 10.1093/emboj/cdg009; TOULLEC D, 1991, J BIOL CHEM, V266, P15771; VANLINT J, 1995, J BIOL CHEM, V270, P1455, DOI 10.1074/jbc.270.3.1455; Waldron RT, 2001, J BIOL CHEM, V276, P32606, DOI 10.1074/jbc.M101648200; Waldron RT, 2003, J BIOL CHEM, V278, P154, DOI 10.1074/jbc.M208075200; Wang Y, 2002, MOL CELL BIOL, V22, P916, DOI 10.1128/MCB.22.3.916-926.2001; Young LH, 2005, CARDIOVASC DRUG REV, V23, P255; Yuan JZ, 2003, J BIOL CHEM, V278, P4882, DOI 10.1074/jbc.M211175200; Yuan JZ, 2000, J BIOL CHEM, V275, P2157, DOI 10.1074/jbc.275.3.2157; Yuan JZ, 2001, J BIOL CHEM, V276, P38619, DOI 10.1074/jbc.M105530200; ZACHARY I, 1985, P NATL ACAD SCI USA, V82, P7616, DOI 10.1073/pnas.82.22.7616; ZACHARY I, 1987, J BIOL CHEM, V262, P3947; Zhao Y, 1996, J BIOL CHEM, V271, P29773, DOI 10.1074/jbc.271.47.29773; Zhukova E, 2001, J CELL PHYSIOL, V189, P291, DOI 10.1002/jcp.10018; Zhukova E, 2001, J BIOL CHEM, V276, P40298, DOI 10.1074/jbc.M106512200; Zugaza JL, 1996, EMBO J, V15, P6220, DOI 10.1002/j.1460-2075.1996.tb01012.x; Zugaza JL, 1997, J BIOL CHEM, V272, P23952, DOI 10.1074/jbc.272.38.23952	59	52	55	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13434	13445		10.1074/jbc.M806554200	http://dx.doi.org/10.1074/jbc.M806554200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19289471	hybrid, Green Published			2022-12-27	WOS:000265877300019
J	Watanabe, H; Smith, MJ; Heilig, E; Beglopoulos, V; Kelleher, RJ; Shen, J				Watanabe, Hirotaka; Smith, Miriam J.; Heilig, Elizabeth; Beglopoulos, Vassilios; Kelleher, Raymond J., III; Shen, Jie			Indirect Regulation of Presenilins in CREB-mediated Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING PROTEIN; ALZHEIMERS-DISEASE; PROTEOLYTIC RELEASE; GAMMA-SECRETASE; STEM-CELLS; EXPRESSION; ERK; PHOSPHORYLATION; PATHWAY; KINASE	Presenilins are essential for synaptic function, memory formation, and neuronal survival. Previously, we reported that expression of cAMP response element-binding protein (CREB) target genes is reduced in the cerebral cortex of presenilin (PS) conditional double knock-out (cDKO) mice. To determine whether the reduced expression of the CREB target genes in these mutant mice is due to loss of presenilin directly or secondary to the impaired neuronal activity, we established a sensitive luciferase reporter system to assess direct transcriptional regulation in cultured cells. We first used immortalized PS-deficient mouse embryonic fibroblasts (MEFs), and found that both CREB-mediated transcription and Notch-mediated HES1 transcription are decreased. However, the ubiquitin-C promoter-mediated transcription is also reduced, and among these three reporters, transfection of exogenous PS1 can rescue only the Notch-mediated HES1 transcription. Further Northern analysis revealed transcriptional alterations of Creb, ubiquitin-C, and other housekeeping genes in PS-deficient MEFs, indicating transcriptional dysregulation in these cells. We then used the Cre/loxP system to develop a postnatal PS-deficient cortical neuronal culture. Surprisingly, in these PS-null neurons, CREB-mediated transcription is not significantly decreased, and levels of total and phosphorylated CREB proteins are unchanged as well. Notch-mediated HES1 transcription is markedly reduced, and this reduction can be rescued by exogenous PS1. Together, our findings suggest that CREB-mediated transcription is regulated indirectly by PS in the adult cerebral cortex, and that attenuation of CREB target gene expression in PS cDKO mice is likely due to reduced neuronal activity in these mutant brains.	[Watanabe, Hirotaka; Smith, Miriam J.; Beglopoulos, Vassilios; Shen, Jie] Brigham & Womens Hosp, Ctr Neurol Dis, Boston, MA 02115 USA; [Heilig, Elizabeth; Kelleher, Raymond J., III] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital	Shen, J (corresponding author), Harvard New Res Bldg,Rm 636E,77 Ave Louis Pasteur, Boston, MA 02115 USA.	jshen@rics.bwh.harvard.edu	Smith, Miriam/J-4001-2015; Watanabe, Hirotaka/GZA-8002-2022; Shen, Jie/GXH-9449-2022	Smith, Miriam/0000-0002-3184-0817; 	National Institutes of Health [NS41783]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS041783] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS41783 (to J. S.).	BAKER RT, 1989, AM J HUM GENET, V44, P534; Baki L, 2008, J NEUROSCI, V28, P483, DOI 10.1523/JNEUROSCI.4067-07.2008; Barnes NY, 2008, J NEUROCHEM, V104, P1637, DOI 10.1111/j.1471-4159.2007.05102.x; Beglopoulos V, 2006, TRENDS PHARMACOL SCI, V27, P33, DOI 10.1016/j.tips.2005.11.010; Beglopoulos V, 2004, J BIOL CHEM, V279, P46907, DOI 10.1074/jbc.M409544200; Dehvari N, 2008, NEUROSCI LETT, V436, P77, DOI 10.1016/j.neulet.2008.02.063; Dolmetsch RE, 2001, SCIENCE, V294, P333, DOI 10.1126/science.1063395; FINCH JS, 1992, CELL GROWTH DIFFER, V3, P269; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Handler M, 2000, DEVELOPMENT, V127, P2593; Herreman A, 2000, NAT CELL BIOL, V2, P461, DOI 10.1038/35017105; Ho A, 2006, J NEUROSCI, V26, P13089, DOI 10.1523/JNEUROSCI.2855-06.2006; Hutton M, 1997, HUM MOL GENET, V6, P1639, DOI 10.1093/hmg/6.10.1639; Impey S, 1998, NAT NEUROSCI, V1, P595, DOI 10.1038/2830; Impey S, 1996, NEURON, V16, P973, DOI 10.1016/S0896-6273(00)80120-8; JARRIAULT S, 1995, NATURE, V377, P355, DOI 10.1038/377355a0; Johannessen M, 2004, CELL SIGNAL, V16, P1211, DOI 10.1016/j.cellsig.2004.05.001; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Kang DE, 2005, J BIOL CHEM, V280, P31537, DOI 10.1074/jbc.M500833200; Kavalali ET, 1999, P NATL ACAD SCI USA, V96, P12893, DOI 10.1073/pnas.96.22.12893; Kida S, 2002, NAT NEUROSCI, V5, P348, DOI 10.1038/nn819; Kim DJ, 2004, J BIOL CHEM, V279, P23719, DOI 10.1074/jbc.M312063200; Kim MY, 2005, BIOCHEM BIOPH RES CO, V332, P609, DOI 10.1016/j.bbrc.2005.05.001; Kim WY, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-2; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; Laudon H, 2005, J BIOL CHEM, V280, P35352, DOI 10.1074/jbc.M507217200; Liang ZH, 2007, J NEUROCHEM, V103, P2462, DOI 10.1111/j.1471-4159.2007.04942.x; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Mantamadiotis T, 2002, NAT GENET, V31, P47, DOI 10.1038/ng882; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Mitsuda N, 2001, J BIOL CHEM, V276, P9688, DOI 10.1074/jbc.M006153200; Oh YS, 2005, BIOCHEMISTRY-US, V44, P11821, DOI 10.1021/bi0509494; Periz G, 2004, J NEUROSCI RES, V77, P309, DOI 10.1002/jnr.20203; Saura CA, 2004, NEURON, V42, P23, DOI 10.1016/S0896-6273(04)00182-5; Schorpp M, 1996, NUCLEIC ACIDS RES, V24, P1787, DOI 10.1093/nar/24.9.1787; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Shen J, 1997, CELL, V89, P629, DOI 10.1016/S0092-8674(00)80244-5; Shen J, 2007, P NATL ACAD SCI USA, V104, P403, DOI 10.1073/pnas.0608332104; Sindreu CB, 2007, NEURON, V53, P79, DOI 10.1016/j.neuron.2006.11.024; Song WH, 1999, P NATL ACAD SCI USA, V96, P6959, DOI 10.1073/pnas.96.12.6959; Steiner H, 1999, J BIOL CHEM, V274, P28669, DOI 10.1074/jbc.274.40.28669; Vitolo OV, 2002, P NATL ACAD SCI USA, V99, P13217, DOI 10.1073/pnas.172504199; Wines-Samuelson M, 2005, NEUROSCIENTIST, V11, P441, DOI 10.1177/1073858405278922; Yamamoto-Sasaki M, 1999, BRAIN RES, V824, P300, DOI 10.1016/S0006-8993(99)01220-2	45	25	26	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13705	13713		10.1074/jbc.M809168200	http://dx.doi.org/10.1074/jbc.M809168200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19289467	Green Published, Green Accepted, hybrid			2022-12-27	WOS:000265877300048
J	Yamamoto, T; Ryan, RO				Yamamoto, Taichi; Ryan, Robert O.			Domain Swapping Reveals That Low Density Lipoprotein (LDL) Type A Repeat Order Affects Ligand Binding to the LDL Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGION; PH	The low density lipoprotein receptor (LDLR) plays a key role in plasma cholesterol homeostasis by binding and internalizing lipoprotein ligands. Studies have revealed that one or more of the seven LDL type A repeats (LA1-LA7) in the receptor are responsible for apolipoprotein binding. In the present study, protein engineering was performed to swap or replace key LA repeats in a recombinant soluble LDLR (sLDLR). Although wild type sLDLR showed strong ligand binding activity, an sLDLR variant in which LA repeat 5 was replaced by a second copy of LA repeat 2 showed low binding activity. Likewise, a variant wherein LA repeats 2 and 5 were swapped displayed low binding activity. At the same time, substitution of LA repeat 2 with a second a copy of repeat 5 resulted in a receptor with ligand binding activity similar to wild type LDLR. When binding assays were conducted with human low density lipoprotein as ligand, LA repeat order was a less important determinant of binding activity. Taken together, the data indicate that the sequential order of LA repeats plays a key role in ligand binding properties of LDLR.	[Yamamoto, Taichi; Ryan, Robert O.] Childrens Hosp Oakland, Res Inst, Ctr Prevent Obes Cardiovasc Dis & Diabet, Oakland, CA 94609 USA	Children's Hospital Oakland Research Institute; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland	Ryan, RO (corresponding author), Childrens Hosp Oakland, Res Inst, Ctr Prevent Obes Cardiovasc Dis & Diabet, 5700 Martin Luther King Jr Way, Oakland, CA 94609 USA.	rryan@chori.org			National Institutes of Health [HL 64159]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL064159, R01HL064159] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL 64159 (to R. O. R.).	Bajari TM, 2005, METHODS, V36, P109, DOI 10.1016/j.ymeth.2004.11.007; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; DALY NL, 1995, P NATL ACAD SCI USA, V92, P6334, DOI 10.1073/pnas.92.14.6334; DAVIS CG, 1987, NATURE, V326, P760, DOI 10.1038/326760a0; ESSER V, 1988, J BIOL CHEM, V263, P13282; Fass D, 1997, NATURE, V388, P691, DOI 10.1038/41798; Fisher C, 2004, BIOCHEMISTRY-US, V43, P1037, DOI 10.1021/bi035529y; GOLDSTEIN JL, 1985, ANNU REV CELL BIOL, V1, P1, DOI 10.1146/annurev.cb.01.110185.000245; Horton JD, 2009, J LIPID RES, V50, pS172, DOI 10.1194/jlr.R800091-JLR200; Kiss RS, 2003, J BIOL CHEM, V278, P21952, DOI 10.1074/jbc.M302676200; Kong WJ, 2006, J MOL MED, V84, P29, DOI 10.1007/s00109-005-0717-6; LEHRMAN MA, 1985, CELL, V41, P735, DOI 10.1016/S0092-8674(85)80054-4; Rudenko G, 2003, CURR OPIN STRUC BIOL, V13, P683, DOI 10.1016/j.sbi.2003.10.001; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; RUSSELL DW, 1989, J BIOL CHEM, V264, P21682; Yamamoto T, 2008, BIOCHEMISTRY-US, V47, P11647, DOI 10.1021/bi801117t; Yamamoto T, 2006, BBA-MOL CELL BIOL L, V1761, P1100, DOI 10.1016/j.bbalip.2006.07.006; Yamamoto T, 2006, J LIPID RES, V47, P1091, DOI 10.1194/jlr.D600001-JLR200; Zhao ZZ, 2008, J BIOL CHEM, V283, P26528, DOI 10.1074/jbc.M804624200	19	8	8	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13396	13400		10.1074/jbc.M900194200	http://dx.doi.org/10.1074/jbc.M900194200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19329437	hybrid, Green Published			2022-12-27	WOS:000265877300015
J	Kimbrel, EA; Kung, AL				Kimbrel, Erin A.; Kung, Andrew L.			The F-box Protein beta-TrCp1/Fbw1a Interacts with p300 to Enhance beta-Catenin Transcriptional Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN LIGASE RECEPTOR; COLORECTAL-CANCER CELLS; CREB-BINDING PROTEIN; GENE-EXPRESSION; DEPENDENT DEGRADATION; MOLECULAR-MECHANISMS; COACTIVATOR P300; COLON-CARCINOMA; MESSENGER-RNA; ACTIVATION	Hyperactivated beta-catenin is a commonly found molecular abnormality in colon cancer, and its nuclear accumulation is thought to promote the expression of genes associated with cellular proliferation and transformation. The p300 transcriptional co-activator binds to beta-catenin and facilitates transcription by recruiting chromatin remodeling complexes and general transcriptional apparatus. We have found that beta-TrCp1/Fbw1a, a member of the Skp1/Cullin/Rbx1/F-box E3 ubiquitin ligase complex, binds directly to p300 and co-localizes with it to beta-catenin target gene promoters. Our data show that Fbw1a, which normally targets beta-catenin for degradation, works together with p300 to enhance the transcriptional activity of beta-catenin, whereas other F-box/WD40 proteins do not. Fbw1a also cooperates with p300 to co-activate transcription by SMAD3, another Fbw1a ubiquitylation target, but not p53 or HIF-1 alpha, which are substrates for other ubiquitin ligase complexes. These results suggest that, although Fbw1a is part of a negative feedback loop for controlling beta-catenin levels in normal cells, its overexpression and binding to p300 may contribute to hyperactivated beta-catenin transcriptional activity in colon cancer cells.	[Kung, Andrew L.] Childrens Hosp, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School	Kung, AL (corresponding author), Childrens Hosp, Dana Farber Canc Inst, Dept Pediat Oncol, 44 Binney St, Boston, MA 02115 USA.	andrew_kung@dfci.harvard.edu	Kung, Andrew/AAL-2384-2020; Kung, Andrew L/AEU-0826-2022	Kung, Andrew L/0000-0002-9091-488X	Dana-Farber Cancer Institute Pediatric Oncology Department	Dana-Farber Cancer Institute Pediatric Oncology Department	This work was supported by an Abraham fellowship through the Dana-Farber Cancer Institute Pediatric Oncology Department and an Aid for Cancer Research fellowship (to E. A. K.).	Allende-Vega N, 2007, ONCOGENE, V26, P4234, DOI 10.1038/sj.onc.1210209; Auld KL, 2006, MOL CELL, V21, P861, DOI 10.1016/j.molcel.2006.02.020; Ayton PM, 2001, ONCOGENE, V20, P5695, DOI 10.1038/sj.onc.1204639; Bai L, 2007, FEBS LETT, V581, P5904, DOI 10.1016/j.febslet.2007.11.072; Bordonaro M, 2004, NUCLEIC ACIDS RES, V32, P2660, DOI 10.1093/nar/gkh596; Brower CS, 2002, P NATL ACAD SCI USA, V99, P10353, DOI 10.1073/pnas.162424199; Chen X, 2008, ACTA BIOCH BIOPH SIN, V40, P577, DOI 10.1111/j.1745-7270.2008.00440.x; Chen YH, 2007, NUCLEIC ACIDS RES, V35, P2084, DOI 10.1093/nar/gkm095; Chen YH, 2007, EXP PHYSIOL, V92, P99, DOI 10.1113/expphysiol.2006.036079; Chiaur DS, 2000, CYTOGENET CELL GENET, V88, P255, DOI 10.1159/000015532; Chung KKK, 2004, SCIENCE, V304, P1328, DOI 10.1126/science.1093891; De Guzman RN, 2004, J BIOL CHEM, V279, P3042, DOI 10.1074/jbc.M310348200; De Guzman RN, 2000, J MOL BIOL, V303, P243, DOI 10.1006/jmbi.2000.4141; Dornan D, 2003, MOL CELL BIOL, V23, P8846, DOI 10.1128/MCB.23.23.8846-8861.2003; Ferdous A, 2007, GENE DEV, V21, P112, DOI 10.1101/gad.1493207; Fodde R, 2001, NAT REV CANCER, V1, P55, DOI 10.1038/35094067; Fousteri M, 2008, CELL RES, V18, P73, DOI 10.1038/cr.2008.6; Fuchs SY, 2004, ONCOGENE, V23, P2028, DOI 10.1038/sj.onc.1207389; Fukuchi M, 2001, MOL BIOL CELL, V12, P1431, DOI 10.1091/mbc.12.5.1431; Goodman RH, 2000, GENE DEV, V14, P1553; Hecht A, 2000, EMBO J, V19, P1839, DOI 10.1093/emboj/19.8.1839; Huibregtse JM, 1997, P NATL ACAD SCI USA, V94, P3656, DOI 10.1073/pnas.94.8.3656; Ishihama K, 2007, J CLIN PATHOL, V60, P1205, DOI 10.1136/jcp.2005.029165; Jenster G, 1997, P NATL ACAD SCI USA, V94, P7879, DOI 10.1073/pnas.94.15.7879; Kamei Y, 1996, CELL, V85, P403, DOI 10.1016/S0092-8674(00)81118-6; Kang ZG, 2002, J BIOL CHEM, V277, P48366, DOI 10.1074/jbc.M209074200; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; Kitagawa M, 2008, MOL CELL, V29, P217, DOI 10.1016/j.molcel.2007.11.036; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Krubasik D, 2006, BRIT J CANCER, V94, P1326, DOI 10.1038/sj.bjc.6603101; Kung AL, 2004, CANCER CELL, V6, P33, DOI 10.1016/j.ccr.2004.06.009; Kung AL, 2000, GENE DEV, V14, P272; KWOK RPS, 1994, NATURE, V370, P223, DOI 10.1038/370223a0; Lassot I, 2001, MOL CELL BIOL, V21, P2192, DOI 10.1128/MCB.21.6.2192-2202.2001; Latres E, 1999, ONCOGENE, V18, P849, DOI 10.1038/sj.onc.1202653; Levy L, 2004, MOL CELL BIOL, V24, P3404, DOI 10.1128/MCB.24.8.3404-3414.2004; Li J, 2008, NAT CELL BIOL, V10, P160, DOI 10.1038/ncb1684; Li Q, 2002, MOL ENDOCRINOL, V16, P2819, DOI 10.1210/me.2002-0154; Lipford JR, 2005, NATURE, V438, P113, DOI 10.1038/nature04098; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Livengood JA, 2002, J BIOL CHEM, V277, P9054, DOI 10.1074/jbc.M108870200; Logan IR, 2004, J BIOL CHEM, V279, P11696, DOI 10.1074/jbc.M312712200; Matsuda S, 2004, J BIOL CHEM, V279, P14055, DOI 10.1074/jbc.M310188200; Min JH, 2002, SCIENCE, V296, P1886, DOI 10.1126/science.1073440; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Muraoka M, 1996, ONCOGENE, V12, P1565; Muratani M, 2005, CELL, V120, P887, DOI 10.1016/j.cell.2004.12.025; Noubissi FK, 2006, NATURE, V441, P898, DOI 10.1038/nature04839; Novak A, 1999, CELL MOL LIFE SCI, V56, P523, DOI 10.1007/s000180050449; Ougolkov A, 2004, JNCI-J NATL CANCER I, V96, P1161, DOI 10.1093/jnci/djh219; Picard N, 2008, MOL ENDOCRINOL, V22, P317, DOI 10.1210/me.2007-0281; Poizat C, 2005, MOL CELL BIOL, V25, P2673, DOI 10.1128/MCB.25.7.2673-2687.2005; Poizat C, 2000, MOL CELL BIOL, V20, P8643, DOI 10.1128/MCB.20.23.8643-8654.2000; Rape M, 2004, BBA-MOL CELL RES, V1695, P209, DOI 10.1016/j.bbamcr.2004.09.022; Rebel VI, 2002, P NATL ACAD SCI USA, V99, P14789, DOI 10.1073/pnas.232568499; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Sanchez-Molina S, 2006, BIOCHEM J, V398, P215, DOI 10.1042/BJ20060052; Shirogane T, 2005, J BIOL CHEM, V280, P26863, DOI 10.1074/jbc.M502862200; Spiegelman VS, 2000, MOL CELL, V5, P877, DOI 10.1016/S1097-2765(00)80327-5; Tanaka K, 2004, BBA-MOL CELL RES, V1695, P235, DOI 10.1016/j.bbamcr.2004.09.026; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Teufel DP, 2007, P NATL ACAD SCI USA, V104, P7009, DOI 10.1073/pnas.0702010104; Turnell AS, 2006, BRIT J CANCER, V95, P555, DOI 10.1038/sj.bjc.6603304; Turnell AS, 2005, NATURE, V438, P690, DOI 10.1038/nature04151; van de Wetering M, 2002, CELL, V111, P241, DOI 10.1016/S0092-8674(02)01014-0; van Noort M, 2002, J BIOL CHEM, V277, P17901, DOI 10.1074/jbc.M111635200; Verma S, 2004, MOL CELL BIOL, V24, P8716, DOI 10.1128/MCB.24.19.8716-8726.2004; von der Lehr N, 2003, MOL CELL, V11, P1189, DOI 10.1016/S1097-2765(03)00193-X; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Yang XJ, 2004, NUCLEIC ACIDS RES, V32, P959, DOI 10.1093/nar/gkh252; Yochum GS, 2007, J BIOL CHEM, V282, P871, DOI 10.1074/jbc.M609391200	71	13	13	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					13033	13044		10.1074/jbc.M901248200	http://dx.doi.org/10.1074/jbc.M901248200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19297328	hybrid, Green Published			2022-12-27	WOS:000265688300051
J	Sugiyama, T; Levy, BD; Michel, T				Sugiyama, Toru; Levy, Bruce D.; Michel, Thomas			Tetrahydrobiopterin Recycling, a Key Determinant of Endothelial Nitric-oxide Synthase-dependent Signaling Pathways in Cultured Vascular Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MESSENGER-RNA; GROWTH-FACTOR; PHOSPHORYLATION; SUPEROXIDE; PROTEIN; BIOSYNTHESIS; DYSFUNCTION; ACTIVATION; EXPRESSION; AKT	Tetrahydrobiopterin (BH4) is a key redox-active cofactor in endothelial isoform of NO synthase (eNOS) catalysis and is an important determinant of NO-dependent signaling pathways. BH4 oxidation is observed in vascular cells in the setting of the oxidative stress associated with diabetes. However, the relative roles of de novo BH4 synthesis and BH4 redox recycling in the regulation of eNOS bioactivity remain incompletely defined. We used small interference RNA (siRNA)-mediated "knock-down" GTP cyclohydrolase-1 (GTPCH1), the rate-limiting enzyme in BH4 biosynthesis, and dihydrofolate reductase (DHFR), an enzyme-recycling oxidized BH4 (7,8-dihydrobiopterin (BH2)), and studied the effects on eNOS regulation and biopterin metabolism in cultured aortic endothelial cells. Knockdown of either DHFR or GTPCH1 attenuated vascular endothelial growth factor (VEGF)-induced eNOS activity and NO production; these effects were recovered by supplementation with BH4. In contrast, supplementation with BH2 abolished VEGF-induced NO production. DHFR but not GTPCH1 knockdown increased reactive oxygen species (ROS) production. The increase in ROS production seen with siRNA-mediated DHFR knockdown was abolished either by simultaneous siRNA-mediated knockdown of eNOS or by supplementing with BH4. In contrast, addition of BH2 increased ROS production; this effect of BH2 was blocked by BH4 supplementation. DHFR but not GTPCH1 knockdown inhibited VEGF-induced dephosphorylation of eNOS at the inhibitory site serine 116; these effects were recovered by supplementation with BH4. These studies demonstrate a striking contrast in the pattern of eNOS regulation seen by the selective modulation of BH4 salvage/reduction versus de novo BH4 synthetic pathways. Our findings suggest that the depletion of BH4 is not sufficient to perturb NO signaling, but rather that concentration of intracellular BH2, as well as the relative concentrations of BH4 and BH2, together play a determining role in the redox regulation of eNOS-modulated endothelial responses.	[Sugiyama, Toru; Michel, Thomas] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Cardiovasc,Dept Med, Boston, MA 02115 USA; [Levy, Bruce D.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Pulm,Dept Med, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Michel, T (corresponding author), Harvard Univ, Sch Med, Brigham & Womens Hosp, Div Cardiovasc,Dept Med, 75 Francis St,Thorn Bldg,Rm 1210A, Boston, MA 02115 USA.	thomas_michel@harvard.edu			National Institutes of Health [HL46457, HL48743, GM36259, HL090927, AI068084, HL068669]; American Heart Association postdoctoral fellowship; uehara Memorial Foundation postdoctoral fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL090927, R01HL068669, R29HL046457, P01HL048743, R01HL046457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI068084, R01AI068084] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM036259, R01GM036259] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association postdoctoral fellowship(American Heart Association); uehara Memorial Foundation postdoctoral fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL46457, HL48743, and GM36259 (to T. M.) and Grants HL090927, AI068084, and HL068669 (to B. D. L.). This work was also supported by an American Heart Association postdoctoral fellowship and a uehara Memorial Foundation postdoctoral fellowship (to T. S.).	Arnal JF, 1999, CELL MOL LIFE SCI, V55, P1078, DOI 10.1007/s000180050358; BOGDAN C, 1995, FEBS LETT, V363, P69, DOI 10.1016/0014-5793(95)00284-G; Cai S, 2002, CARDIOVASC RES, V55, P838, DOI 10.1016/S0008-6363(02)00460-1; Channon KM, 2004, TRENDS CARDIOVAS MED, V14, P323, DOI 10.1016/j.tcm.2004.10.003; Cosentino F, 1999, CARDIOVASC RES, V43, P274, DOI 10.1016/S0008-6363(99)00134-0; Crabtree MJ, 2008, AM J PHYSIOL-HEART C, V294, pH1530, DOI 10.1152/ajpheart.00823.2007; Crabtree MJ, 2009, J BIOL CHEM, V284, P1136, DOI 10.1074/jbc.M805403200; Dimmeler S, 1999, NATURE, V399, P601, DOI 10.1038/21224; Dudzinski DM, 2006, ANNU REV PHARMACOL, V46, P235, DOI 10.1146/annurev.pharmtox.44.101802.121844; Fleming I, 2003, AM J PHYSIOL-REG I, V284, pR1, DOI 10.1152/ajpregu.00323.2002; FUKUSHIMA T, 1980, ANAL BIOCHEM, V102, P176, DOI 10.1016/0003-2697(80)90336-X; Fulton D, 1999, NATURE, V399, P597, DOI 10.1038/21218; Gonzalez E, 2002, J BIOL CHEM, V277, P39554, DOI 10.1074/jbc.M207299200; Gorren ACF, 2000, BIOCHEMISTRY-US, V39, P11763, DOI 10.1021/bi0007775; Harris MB, 2001, J BIOL CHEM, V276, P16587, DOI 10.1074/jbc.M100229200; Hasegawa H, 2005, MOL GENET METAB, V86, pS2, DOI 10.1016/j.ymgme.2005.09.002; He H, 1999, J BIOL CHEM, V274, P25130, DOI 10.1074/jbc.274.35.25130; Heller R, 2006, EUR J CLIN PHARMACOL, V62, P21, DOI 10.1007/s00228-005-0009-7; Hemmens B, 2000, J BIOL CHEM, V275, P35786, DOI 10.1074/jbc.M005976200; Ishii M, 1997, LIFE SCI, V61, P739, DOI 10.1016/S0024-3205(97)00538-9; Katusic ZS, 2001, AM J PHYSIOL-HEART C, V281, pH981, DOI 10.1152/ajpheart.2001.281.3.H981; Kolodziejski PJ, 2003, P NATL ACAD SCI USA, V100, P14263, DOI 10.1073/pnas.2435290100; Kou RQ, 2002, J BIOL CHEM, V277, P29669, DOI 10.1074/jbc.M204519200; Kou RQ, 2007, J BIOL CHEM, V282, P32719, DOI 10.1074/jbc.M706815200; Landmesser U, 2003, J CLIN INVEST, V111, P1201, DOI 10.1172/JCI200314172; Levy BD, 2005, AM J RESP CRIT CARE, V172, P824, DOI 10.1164/rccm.200410-1413OC; Loscalzo J, 2001, CIRC RES, V88, P756, DOI 10.1161/hh0801.089861; LOSCALZO J, 1995, PROG CARDIOVASC DIS, V38, P87, DOI 10.1016/S0033-0620(05)80001-5; Meininger CJ, 2000, BIOCHEM J, V349, P353, DOI 10.1042/0264-6021:3490353; Michel T, 1997, J CLIN INVEST, V100, P2146, DOI 10.1172/JCI119750; MICHEL T, 1993, P NATL ACAD SCI USA, V90, P6252, DOI 10.1073/pnas.90.13.6252; Michell BJ, 1999, CURR BIOL, V9, P845, DOI 10.1016/S0960-9822(99)80371-6; Moat SJ, 2006, EUR J PHARMACOL, V530, P250, DOI 10.1016/j.ejphar.2005.11.047; Moens AL, 2006, ARTERIOSCL THROM VAS, V26, P2439, DOI 10.1161/01.ATV.0000243924.00970.cb; Raman CS, 1998, CELL, V95, P939, DOI 10.1016/S0092-8674(00)81718-3; Rinaldi M, 2007, VET IMMUNOL IMMUNOP, V115, P107, DOI 10.1016/j.vetimm.2006.09.009; Shaul PW, 2002, ANNU REV PHYSIOL, V64, P749, DOI 10.1146/annurev.physiol.64.081501.155952; Shaul PW, 2003, J PHYSIOL-LONDON, V547, P21, DOI 10.1113/jphysiol.2002.031534; Stuehr D, 2001, J BIOL CHEM, V276, P14533, DOI 10.1074/jbc.R100011200; Stuehr DJ, 1999, BBA-BIOENERGETICS, V1411, P217, DOI 10.1016/S0005-2728(99)00016-X; Tai NW, 2004, BIOCHEM J, V378, P999, DOI 10.1042/BJ20031396; THORNY B, 2000, BIOCHEM J, V347, P1; TZENG E, 1995, P NATL ACAD SCI USA, V92, P11771, DOI 10.1073/pnas.92.25.11771; Vasquez-Vivar J, 1998, P NATL ACAD SCI USA, V95, P9220, DOI 10.1073/pnas.95.16.9220; Vasquez-Vivar J, 2002, BIOCHEM J, V362, P733, DOI 10.1042/0264-6021:3620733; Werner-Felmayer G, 2002, CURR DRUG METAB, V3, P159, DOI 10.2174/1389200024605073; Wever RMF, 1997, BIOCHEM BIOPH RES CO, V237, P340, DOI 10.1006/bbrc.1997.7069	47	76	78	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12691	12700		10.1074/jbc.M809295200	http://dx.doi.org/10.1074/jbc.M809295200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19286667	Green Published, hybrid			2022-12-27	WOS:000265688300013
J	Guengerich, FP				Guengerich, F. Peter			Thematic Minireview Series: Metals in Biology	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Editorial Material								Metals have important roles in biochemistry ranging from essential to toxic. This prologue introduces the second of the Thematic Minireview Series on Metals in Biology, which includes minireviews on five metals: iron, zinc, nickel, vanadium, and arsenic. Three of the minireviews are focused on the roles of the metals in enzymes ( iron, nickel, and vanadium). Zinc deficiency is discussed in another, and the arsenic minireview deals with the toxic and some potentially useful applications of the biological effects.	[Guengerich, F. Peter] Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA; [Guengerich, F. Peter] Vanderbilt Univ, Ctr Mol Toxicol, Sch Med, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University	Guengerich, FP (corresponding author), Vanderbilt Univ, Dept Biochem, Sch Med, Nashville, TN 37232 USA.	f.guengerich@vanderbilt.edu							0	15	15	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18557	18557		10.1074/jbc.M109.003863	http://dx.doi.org/10.1074/jbc.M109.003863			1	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19363036	Green Published, hybrid			2022-12-27	WOS:000267711500001
J	Hurd, PJ; Bannister, AJ; Halls, K; Dawson, MA; Vermeulen, M; Olsen, JV; Ismail, H; Somers, J; Mann, M; Owen-Hughes, T; Gout, I; Kouzarides, T				Hurd, Paul J.; Bannister, Andrew J.; Halls, Karen; Dawson, Mark A.; Vermeulen, Michiel; Olsen, Jesper V.; Ismail, Heba; Somers, Joanna; Mann, Matthias; Owen-Hughes, Tom; Gout, Ivan; Kouzarides, Tony			Phosphorylation of Histone H3 Thr-45 Is Linked to Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE C-DELTA; NEUTROPHIL APOPTOSIS; LEUKEMIA-CELLS; LYSINE 9; ACTIVATION; RECOGNITION; METHYLATION; TRAP; SITE; HL60	Numerous post-translational modifications have been identified in histones. Most of these occur within the histone tails, but a few have been identified within the histone core sequences. Histone core post-translational modifications have the potential to directly modulate nucleosome structure and consequently DNA accessibility. Here, we identify threonine 45 of histone H3 (H3T45) as a site of phosphorylation in vivo. We find that phosphorylation of H3T45 (H3T45ph) increases dramatically in apoptotic cells, around the time of DNA nicking. To further explore this connection, we analyzed human neutrophil cells because they are short-lived cells that undergo apoptosis in vivo. Freshly isolated neutrophils contain very little H3T45ph, whereas cells cultured for 20 h possess significant amounts; the kinetics of H3T45ph induction closely parallel those of caspase-3 activation. Cytokine inhibition of neutrophil apoptosis leads to reduced levels of H3T45ph. We identify protein kinase C-delta as the kinase responsible for H3T45ph in vitro and in vivo. Given the nucleosomal position of H3T45, we postulate that H3T45ph induces structural change within the nucleosome to facilitate DNA nicking and/or fragmentation.	[Hurd, Paul J.; Bannister, Andrew J.; Halls, Karen; Dawson, Mark A.; Kouzarides, Tony] Univ Cambridge, Wellcome Trust & Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; [Hurd, Paul J.; Bannister, Andrew J.; Halls, Karen; Dawson, Mark A.; Kouzarides, Tony] Univ Cambridge, Dept Pathol, Cambridge CB2 1QN, England; [Dawson, Mark A.] Univ Cambridge, Cambridge Inst Med Res, Dept Haematol, Cambridge CB2 OXY, England; [Vermeulen, Michiel; Olsen, Jesper V.; Mann, Matthias] Max Planck Inst Biochem, Dept Prote & Signal Transduct, D-82152 Martinsried, Germany; [Ismail, Heba; Gout, Ivan] UCL, Dept Struct & Mol Biol, London WC1E 6BT, England; [Somers, Joanna; Owen-Hughes, Tom] Univ Dundee, Dept Biochem, Wellcome Trust Bioctr, Div Gene Regulat & Express, Dundee DD1 5EH, Scotland	University of Cambridge; University of Cambridge; University of Cambridge; Max Planck Society; University of London; University College London; University of Dundee	Kouzarides, T (corresponding author), Univ Cambridge, Wellcome Trust & Canc Res UK Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	tk106@mole.bio.cam.ac.uk	Olsen, Jesper/ABH-4638-2020; Dawson, Mark A/B-9317-2017; Vermeulen, Michiel/C-8883-2013; Mann, Matthias/A-3454-2013	Olsen, Jesper/0000-0002-4747-4938; Dawson, Mark A/0000-0002-5464-5029; Vermeulen, Michiel/0000-0003-0836-6894; Mann, Matthias/0000-0003-1292-4799; Hurd, Paul/0000-0003-1112-9347; Kouzarides, Tony/0000-0002-8918-4162; Bannister, Andrew/0000-0002-6312-4436; Owen-Hughes, Tom/0000-0002-0618-8185	Cancer Research UK; European Union	Cancer Research UK(Cancer Research UK); European Union(European Commission)	This work was supported by grants from Cancer Research UK and the 6th Research Framework Programme of the European Union (EPIgenetic TReatment Of Neoplastic disease (Epitron) and Small Modulators of Gene Activation and Repression by Targeting Epigenetic Regulators (SMARTER)) (to T. K.). We declare competing financial interests; T. K. is a director of Abcam Ltd.	Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bannister AJ, 2004, METHOD ENZYMOL, V376, P269; Choi MR, 2007, APOPTOSIS, V12, P2025, DOI 10.1007/s10495-007-0121-5; Clayton AL, 2000, EMBO J, V19, P3714, DOI 10.1093/emboj/19.14.3714; COLLINS SJ, 1978, P NATL ACAD SCI USA, V75, P2458, DOI 10.1073/pnas.75.5.2458; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Ferreira H, 2007, MOL CELL BIOL, V27, P4037, DOI 10.1128/MCB.02229-06; Fischle W, 2003, CURR OPIN CELL BIOL, V15, P172, DOI 10.1016/S0955-0674(03)00013-9; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Hughes PJ, 2001, BIOCHEM J, V355, P361, DOI 10.1042/0264-6021:3550361; Khwaja A, 1999, BLOOD, V94, P291, DOI 10.1182/blood.V94.1.291.413k10_291_301; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Larsen MR, 2005, MOL CELL PROTEOMICS, V4, P873, DOI 10.1074/mcp.T500007-MCP200; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Luo HBR, 2008, AM J HEMATOL, V83, P288, DOI 10.1002/ajh.21078; MacDonald N, 2005, MOL CELL, V20, P199, DOI 10.1016/j.molcel.2005.08.032; Olins AL, 2001, EXP CELL RES, V268, P115, DOI 10.1006/excr.2001.5269; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Pongracz J, 1999, J BIOL CHEM, V274, P37329, DOI 10.1074/jbc.274.52.37329; Rea S, 2000, NATURE, V406, P593, DOI 10.1038/35020506; Reyland ME, 2007, BIOCHEM SOC T, V35, P1001, DOI 10.1042/BST0351001; Schroeder MJ, 2004, ANAL CHEM, V76, P3590, DOI 10.1021/ac0497104; Simon HU, 2003, IMMUNOL REV, V193, P101, DOI 10.1034/j.1600-065X.2003.00038.x; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Thomson S, 2001, MOL CELL, V8, P1231, DOI 10.1016/S1097-2765(01)00404-X; Wallace JA, 2007, CURR OPIN GENET DEV, V17, P400, DOI 10.1016/j.gde.2007.08.005	27	81	83	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16575	16583		10.1074/jbc.M109.005421	http://dx.doi.org/10.1074/jbc.M109.005421			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19363025	hybrid, Green Published			2022-12-27	WOS:000266730900054
J	Saggu, M; Zebger, I; Ludwig, M; Lenz, O; Friedrich, B; Hildebrandt, P; Lendzian, F				Saggu, Miguel; Zebger, Ingo; Ludwig, Marcus; Lenz, Oliver; Friedrich, Baerbel; Hildebrandt, Peter; Lendzian, Friedhelm			Spectroscopic Insights into the Oxygen-tolerant Membrane-associated [NiFe] Hydrogenase of Ralstonia eutropha H16	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VULGARIS MIYAZAKI-F; IRON-SULFUR CLUSTER; DESULFOVIBRIO-GIGAS HYDROGENASE; DENSITY-FUNCTIONAL THEORY; NAD-REDUCING HYDROGENASE; ELECTRON-SPIN-RESONANCE; SINGLE-CRYSTAL EPR; LOW-LEVEL H-2; ACTIVE-SITE; CHROMATIUM-VINOSUM	This study provides the first spectroscopic characterization of the membrane-bound oxygen-tolerant [NiFe] hydrogenase (MBH) from Ralstonia eutropha H16 in its natural environment, the cytoplasmic membrane. The H-2-converting MBH is composed of a large subunit, harboring the [NiFe] active site, and a small subunit, capable in coordinating one [3Fe4S] and two [4Fe4S] clusters. The hydrogenase dimer is electronically connected to a membrane-integral cytochrome b. EPR and Fourier transform infrared spectroscopy revealed a strong similarity of the MBH active site with known [NiFe] centers from strictly anaerobic hydrogenases. Most redox states characteristic for anaerobic [NiFe] hydrogenases were identified except for one remarkable difference. The formation of the oxygen-inhibited Ni-u-A state was never observed. Furthermore, EPR data showed the presence of an additional paramagnetic center at high redox potential (+ 290 mV), which couples magnetically to the [3Fe4S] center and indicates a structural and/or redox modification at or near the proximal [4Fe4S] cluster. Additionally, significant differences regarding the magnetic coupling between the Ni-a-C state and [4Fe4S] clusters were observed in the reduced form of the MBH. The spectroscopic properties are discussed with regard to the unusual oxygen tolerance of this hydrogenase and in comparison with those of the solubilized, dimeric form of the MBH.	[Saggu, Miguel; Zebger, Ingo; Hildebrandt, Peter; Lendzian, Friedhelm] Tech Univ Berlin, Inst Chem, D-10623 Berlin, Germany; [Ludwig, Marcus; Lenz, Oliver; Friedrich, Baerbel] Humboldt Univ, Dept Microbiol, Inst Biol, D-10115 Berlin, Germany	Technical University of Berlin; Humboldt University of Berlin	Zebger, I (corresponding author), Tech Univ Berlin, Inst Chem, PC14,Str 17 Juni 135, D-10623 Berlin, Germany.	ingo.zebger@tu-berlin.de; f.lendzian@tu-berlin.de	Hildebrandt, Peter/J-5658-2014; Lenz, Oliver/N-5130-2019; Saggu, Miguel/B-1224-2009; Lenz, Oliver/C-1582-2019	Hildebrandt, Peter/0000-0003-1030-5900; Lenz, Oliver/0000-0003-4550-5128; Lenz, Oliver/0000-0003-4550-5128	Deutsche Forschungsgemeinschaft [SFB 498 TP C1, TP C9]; Cluster of Excellence "Unifying Concepts in Catalysis,"; Federal Ministry of Education and Research ["Bio-H2"]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cluster of Excellence "Unifying Concepts in Catalysis,"(German Research Foundation (DFG)); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	This work was supported by Deutsche Forschungsgemeinschaft Grants SFB 498 TP C1, TP C9 and by Cluster of Excellence "Unifying Concepts in Catalysis," and by the Federal Ministry of Education and Research (BMBF, project "Bio-H2").	ADAMS MWW, 1990, BIOCHIM BIOPHYS ACTA, V1020, P115, DOI 10.1016/0005-2728(90)90044-5; Agrawal AG, 2006, J PHYS CHEM B, V110, P8142, DOI 10.1021/jp0573902; ALBRACHT SPJ, 1983, BIOCHIM BIOPHYS ACTA, V724, P309, DOI 10.1016/0005-2728(83)90089-0; ALBRACHT SPJ, 1994, BBA-BIOENERGETICS, V1188, P167, DOI 10.1016/0005-2728(94)90036-1; ALBRACHT SPJ, 1984, BIOCHIM BIOPHYS ACTA, V766, P245, DOI 10.1016/0005-2728(84)90238-X; ALBRACHT SPJ, 1982, BIOCHIM BIOPHYS ACTA, V681, P330, DOI 10.1016/0005-2728(82)90041-X; Aragno M., 1992, The prokaryotes: a handbook on the biology of bacteria: ecophysiology, isolation, identification, applications, vol. 1., P344; BAGLEY KA, 1995, BIOCHEMISTRY-US, V34, P5527, DOI 10.1021/bi00016a026; Bernhard M, 1997, EUR J BIOCHEM, V248, P179, DOI 10.1111/j.1432-1033.1997.00179.x; Bleijlevens B, 2004, J BIOL INORG CHEM, V9, P743, DOI 10.1007/s00775-004-0570-z; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brecht M, 2003, J AM CHEM SOC, V125, P13075, DOI 10.1021/ja036624x; Brugna-Guiral M, 2003, EXTREMOPHILES, V7, P145, DOI 10.1007/s00792-002-0306-3; Buhrke T, 2005, J BIOL CHEM, V280, P23791, DOI 10.1074/jbc.M503260200; Buhrke T, 2005, J BIOL CHEM, V280, P19488, DOI 10.1074/jbc.M500601200; Burgdorf T, 2005, J AM CHEM SOC, V127, P576, DOI 10.1021/ja0461926; CAMMACK R, 1986, BIOCHIMIE, V68, P85, DOI 10.1016/S0300-9084(86)81072-0; Cammack R., 2001, HYDROGEN FUEL LEARNI; COREMANS JMCC, 1992, BIOCHIM BIOPHYS ACTA, V1119, P157, DOI 10.1016/0167-4838(92)90386-R; De Lacey AL, 2007, CHEM REV, V107, P4304, DOI 10.1021/cr0501947; deLacey AL, 1997, J AM CHEM SOC, V119, P7181, DOI 10.1021/ja963802w; Dole F, 1996, BIOCHEMISTRY-US, V35, P16399, DOI 10.1021/bi961662x; Duche O, 2005, FEBS J, V272, P3899, DOI 10.1111/j.1742-4658.2005.04806.x; FERNANDEZ VM, 1985, BIOCHIM BIOPHYS ACTA, V832, P69, DOI 10.1016/0167-4838(85)90175-X; Fichtner C, 2003, PHYS CHEM CHEM PHYS, V5, P5507, DOI 10.1039/b310205j; Fichtner C, 2006, BIOCHEMISTRY-US, V45, P9706, DOI 10.1021/bi0602462; Foerster S, 2005, J BIOL INORG CHEM, V10, P51, DOI 10.1007/s00775-004-0613-5; Foerster S, 2003, J AM CHEM SOC, V125, P83, DOI 10.1021/ja027522u; FRIEDRICH B, 1993, ANNU REV MICROBIOL, V47, P351, DOI 10.1146/annurev.mi.47.100193.002031; Garcin E, 1999, STRUCT FOLD DES, V7, P557, DOI 10.1016/S0969-2126(99)80072-0; Happe RP, 2000, FEBS LETT, V466, P259, DOI 10.1016/S0014-5793(99)01799-8; Higuchi Y, 1997, STRUCTURE, V5, P1671, DOI 10.1016/S0969-2126(97)00313-4; Ihara M, 2006, PHOTOCHEM PHOTOBIOL, V82, P676, DOI 10.1562/2006-01-16-RA-778; KNUTTEL K, 1994, B POL ACAD SCI-CHEM, V42, P495; KORTLUKE C, 1992, J BACTERIOL, V174, P6277; Kurkin S, 2004, BIOCHEMISTRY-US, V43, P6820, DOI 10.1021/bi049854c; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lamle SE, 2004, J AM CHEM SOC, V126, P14899, DOI 10.1021/ja047939v; Lenz O, 2005, J BACTERIOL, V187, P6590, DOI 10.1128/JB.187.18.6590-6595.2005; Lubitz W, 2007, CHEM REV, V107, P4331, DOI 10.1021/cr050186q; Ludwig M, 2009, J BIOL CHEM, V284, P465, DOI 10.1074/jbc.M803676200; Nicolet Y, 1999, STRUCTURE, V7, P13, DOI 10.1016/S0969-2126(99)80005-7; Ogata H, 2005, STRUCTURE, V13, P1635, DOI 10.1016/j.str.2005.07.018; Peters JW, 1998, SCIENCE, V282, P1853, DOI 10.1126/science.282.5395.1853; Pierik AJ, 1999, J BIOL CHEM, V274, P3331, DOI 10.1074/jbc.274.6.3331; Pilak O, 2006, J MOL BIOL, V358, P798, DOI 10.1016/j.jmb.2006.02.035; PODZUWEIT HG, 1987, BIOCHIM BIOPHYS ACTA, V905, P435, DOI 10.1016/0005-2736(87)90473-1; Rousset M, 1998, P NATL ACAD SCI USA, V95, P11625, DOI 10.1073/pnas.95.20.11625; SCHINK B, 1979, BIOCHIM BIOPHYS ACTA, V567, P315, DOI 10.1016/0005-2744(79)90117-7; SCHNEIDER K, 1983, BIOCHIM BIOPHYS ACTA, V748, P353, DOI 10.1016/0167-4838(83)90179-6; Schroder O, 2007, J BIOL INORG CHEM, V12, P212, DOI 10.1007/s00775-006-0185-7; Schubert T, 2007, MOL MICROBIOL, V66, P453, DOI 10.1111/j.1365-2958.2007.05933.x; Schwartz E, 1998, J BACTERIOL, V180, P3197, DOI 10.1128/JB.180.12.3197-3204.1998; STESMANS A, 1989, REV SCI INSTRUM, V60, P2949, DOI 10.1063/1.1140633; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; SURERUS KK, 1994, BIOCHEMISTRY-US, V33, P4980, DOI 10.1021/bi00182a029; Trofanchuk O, 2000, J BIOL INORG CHEM, V5, P36, DOI 10.1007/PL00010654; Van der Linden E, 2004, J BIOL INORG CHEM, V9, P616, DOI 10.1007/s00775-004-0555-y; van Gastel M, 2006, J BIOL INORG CHEM, V11, P41, DOI 10.1007/s00775-005-0048-7; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Vincent KA, 2005, J AM CHEM SOC, V127, P18179, DOI 10.1021/ja055160v; Vincent KA, 2005, P NATL ACAD SCI USA, V102, P16951, DOI 10.1073/pnas.0504499102; Vincent KA, 2006, CHEM COMMUN, P5033, DOI 10.1039/b614272a; Volbeda A, 2005, J BIOL INORG CHEM, V10, P239, DOI 10.1007/s00775-005-0632-x; VOLBEDA A, 1995, NATURE, V373, P580, DOI 10.1038/373580a0; Volbeda A, 1996, J AM CHEM SOC, V118, P12989, DOI 10.1021/ja962270g; WITHOLT B, 1976, ANAL BIOCHEM, V74, P160, DOI 10.1016/0003-2697(76)90320-1	67	83	84	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16264	16276		10.1074/jbc.M805690200	http://dx.doi.org/10.1074/jbc.M805690200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19304663	Green Published, hybrid			2022-12-27	WOS:000266730900024
J	Darwanto, A; Theruvathu, JA; Sowers, JL; Rogstad, DK; Pascal, T; Goddard, WA; Sowers, LC				Darwanto, Agus; Theruvathu, Jacob A.; Sowers, James L.; Rogstad, Daniel K.; Pascal, Tod; Goddard, William A., III; Sowers, Lawrence C.			Mechanisms of Base Selection by Human Single-stranded Selective Monofunctional Uracil-DNA Glycosylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN 5-FORMYLURACIL-DNA GLYCOSYLASE; DENSITY-FUNCTIONAL THEORY; SOLVATION FREE-ENERGIES; PRINCIPLES CALCULATION; BASIS-SETS; SMUG1; OLIGONUCLEOTIDES; IDENTIFICATION; 5-CARBOXY-2'-DEOXYURIDINE; SPECIFICITY	hSMUG1 (human single-stranded selective monofunctional uracil-DNA glyscosylase) is one of three glycosylases encoded within a small region of human chromosome 12. Those three glycosylases, UNG (uracil-DNA glycosylase), TDG (thymine-DNA glyscosylase), and hSMUG1, have in common the capacity to remove uracil from DNA. However, these glycosylases also repair other lesions and have distinct substrate preferences, indicating that they have potentially redundant but not overlapping physiological roles. The mechanisms by which these glycosylases locate and selectively remove target lesions are not well understood. In addition to uracil, hSMUG1 has been shown to remove some oxidized pyrimidines, suggesting a role in the repair of DNA oxidation damage. In this paper, we describe experiments in which a series of oligonucleotides containing purine and pyrimidine analogs have been used to probe mechanisms by which hSMUG1 distinguishes potential substrates. Our results indicate that the preference of hSMUG1 for mispaired uracil over uracil paired with adenine is best explained by the reduced stability of a duplex containing a mispair, consistent with previous reports with Escherichia coli mispaired uracil-DNA glycosylase. We have also extended the substrate range of hSMUG1 to include 5-carboxyuracil, the last in the series of damage products from thymine methyl group oxidation. The properties used by hSMUG1 to select damaged pyrimidines include the size and free energy of solvation of the 5-substituent but not electronic inductive properties. The observed distinct mechanisms of base selection demonstrated for members of the uracil glycosylase family help explain how considerable diversity in chemical lesion repair can be achieved.	[Darwanto, Agus; Theruvathu, Jacob A.; Sowers, James L.; Rogstad, Daniel K.; Sowers, Lawrence C.] Loma Linda Univ, Sch Med, Dept Basic Sci, Loma Linda, CA 92350 USA; [Pascal, Tod; Goddard, William A., III; Sowers, Lawrence C.] CALTECH, Dept Chem, Pasadena, CA 91125 USA	Loma Linda University; California Institute of Technology	Sowers, LC (corresponding author), 11021 Campus St,Rm 101, Loma Linda, CA 92350 USA.	lsowers@llu.edu			National Institutes of Health [CA112293]; NATIONAL CANCER INSTITUTE [R01CA112293] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA112293.	Akbari M, 2004, NUCLEIC ACIDS RES, V32, P5486, DOI 10.1093/nar/gkh872; ALCANTARA R, 1965, PHOTOCHEM PHOTOBIOL, V4, P473; Barrett TE, 1998, CELL, V92, P117, DOI 10.1016/S0092-8674(00)80904-6; Bennett MT, 2006, J AM CHEM SOC, V128, P12510, DOI 10.1021/ja0634829; BETHOD T, 1997, J PHOTOCHEM PHOTOBIO, V104, P97; Boorstein RJ, 2001, J BIOL CHEM, V276, P41991, DOI 10.1074/jbc.M106953200; Bryantsev VS, 2007, J PHYS CHEM A, V111, P4422, DOI 10.1021/jp071040t; Cerny J, 2005, PHYS CHEM CHEM PHYS, V7, P1624, DOI 10.1039/b502769c; CLOUGH DW, 1978, ANTIMICROB AGENTS CH, V14, P126, DOI 10.1128/AAC.14.1.126; Cui ZF, 2008, ANAL BIOCHEM, V379, P196, DOI 10.1016/j.ab.2008.04.031; Cybulski SM, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1829044; Di Noia JM, 2007, J EXP MED, V204, P3209, DOI 10.1084/jem.20071768; Di Noia JM, 2006, EMBO J, V25, P585, DOI 10.1038/sj.emboj.7600939; DUNNING TH, 1989, J CHEM PHYS, V90, P1007, DOI 10.1063/1.456153; Fujimoto J, 1997, CHEM RES TOXICOL, V10, P1254, DOI 10.1021/tx970102b; Gait M. J, 1984, OLIGONUCLEOTIDE SYNT; Guerniou V, 2003, NUCLEOS NUCLEOT NUCL, V22, P1073, DOI 10.1081/NCN-120022739; HANSCH C, 1973, J MED CHEM, V16, P1207, DOI 10.1021/jm00269a003; Haushalter KA, 1999, CURR BIOL, V9, P174, DOI 10.1016/S0960-9822(99)80087-6; HOBZA P, 1995, J COMPUT CHEM, V16, P1315, DOI 10.1002/jcc.540161102; Jang YH, 2001, J PHYS CHEM A, V105, P274, DOI 10.1021/jp994432b; Kavli B, 2007, DNA REPAIR, V6, P505, DOI 10.1016/j.dnarep.2006.10.014; Kelly CP, 2006, J PHYS CHEM A, V110, P2493, DOI 10.1021/jp055336f; KENDALL RA, 1992, J CHEM PHYS, V96, P6796, DOI 10.1063/1.462569; Krokan HE, 2002, ONCOGENE, V21, P8935, DOI 10.1038/sj.onc.1205996; Krokan HE, 2001, PROG NUCLEIC ACID RE, V68, P365; La Francois CJ, 2000, CHEM RES TOXICOL, V13, P462, DOI 10.1021/tx990209u; Liu PF, 2008, J BIOL CHEM, V283, P8829, DOI 10.1074/jbc.M707174200; Marten B, 1996, J PHYS CHEM-US, V100, P11775, DOI 10.1021/jp953087x; Masaoka A, 2003, BIOCHEMISTRY-US, V42, P5003, DOI 10.1021/bi0273213; Matsubara M, 2004, NUCLEIC ACIDS RES, V32, P5291, DOI 10.1093/nar/gkh859; Matsubara M, 2003, BIOCHEMISTRY-US, V42, P4993, DOI 10.1021/bi027322v; MATSUDAIRA P, 1990, METHOD ENZYMOL, V182, P602; Mendes CLD, 2006, J PHYS CHEM A, V110, P4034, DOI 10.1021/jp053520v; Morgan MT, 2007, J BIOL CHEM, V282, P27578, DOI 10.1074/jbc.M704253200; Neddermann P, 1996, J BIOL CHEM, V271, P12767, DOI 10.1074/jbc.271.22.12767; Nilsen H, 2000, MOL CELL, V5, P1059, DOI 10.1016/S1097-2765(00)80271-3; Nilsen H, 2001, EMBO J, V20, P4278, DOI 10.1093/emboj/20.15.4278; Pearl LH, 2000, MUTAT RES-DNA REPAIR, V460, P165, DOI 10.1016/S0921-8777(00)00025-2; PEREZJORDA JM, 1995, CHEM PHYS LETT, V233, P134, DOI 10.1016/0009-2614(94)01402-H; Privat E, 1996, CHEM RES TOXICOL, V9, P745, DOI 10.1021/tx950182o; Rao JS, 2006, INT J QUANTUM CHEM, V106, P1217, DOI 10.1002/qua.20862; Rogstad DK, 2004, BIOCHEMISTRY-US, V43, P5688, DOI 10.1021/bi030247j; SantaLucia J, 1996, BIOCHEMISTRY-US, V35, P3555, DOI 10.1021/bi951907q; SibghatUllah, 1996, BIOCHEMISTRY-US, V35, P12926, DOI 10.1021/bi961022u; SLUPPHAUG G, 1995, BIOCHEMISTRY-US, V34, P128, DOI 10.1021/bi00001a016; Sousa MML, 2007, MOL ASPECTS MED, V28, P276, DOI 10.1016/j.mam.2007.04.006; SOWERS LC, 1987, MUTAT RES, V177, P201, DOI 10.1016/0027-5107(87)90003-0; SOWERS LC, 1993, J ORG CHEM, V58, P1664, DOI 10.1021/jo00059a011; Sugiyama H, 1996, TETRAHEDRON LETT, V37, P9067, DOI 10.1016/S0040-4039(96)02130-2; TANNOR DJ, 1994, J AM CHEM SOC, V116, P11875, DOI 10.1021/ja00105a030; Waters TR, 1998, J BIOL CHEM, V273, P20007, DOI 10.1074/jbc.273.32.20007; Wibley JEA, 2003, MOL CELL, V11, P1647, DOI 10.1016/S1097-2765(03)00235-1; Zhao Y, 2005, J CHEM THEORY COMPUT, V1, P415, DOI 10.1021/ct049851d; Zhao Y, 2008, J PHYS CHEM C, V112, P4061, DOI 10.1021/jp710918f; Zhao Y, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2370993; Zielenkiewicz W, 2003, THERMOCHIM ACTA, V405, P155, DOI 10.1016/S0040-6031(03)00128-X	57	34	34	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15835	15846		10.1074/jbc.M807846200	http://dx.doi.org/10.1074/jbc.M807846200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19324873	Green Published, hybrid			2022-12-27	WOS:000266501000052
J	Masuyama, N; Kuronita, T; Tanaka, R; Muto, T; Hirota, Y; Takigawa, A; Fujita, H; Aso, Y; Amano, J; Tanaka, Y				Masuyama, Naoko; Kuronita, Toshio; Tanaka, Rika; Muto, Tomonori; Hirota, Yuko; Takigawa, Azusa; Fujita, Hideaki; Aso, Yoshinori; Amano, Jun; Tanaka, Yoshitaka			HM1.24 Is Internalized from Lipid Rafts by Clathrin-mediated Endocytosis through Interaction with alpha-Adaptin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE-MYELOMA CELLS; GPI-ANCHORED PROTEINS; FACTOR-II RECEPTOR; MOLECULAR-CLONING; MEMBRANE-PROTEIN; SORTING SIGNALS; BINDING SITE; COATED PITS; HIV-1 VPU; DISTINCT	HM1.24/Bst2/CD317 is a protein highly expressed in multiple myeloma cells and has unique topology with two membrane anchor domains, an NH2-terminal transmembrane domain and a glycosylphosphatidylinositol attached to the COOH terminus. We show here that human HM1.24 is localized not only on the cell surface but also in the trans-Golgi network and/or recycling endosomes, where it resides in detergent-resistant microdomains, lipid rafts. In contrast to other glycosylphosphatidylinositol-anchored proteins, HM1.24 was internalized from lipid rafts on the cell surface by clathrin-mediated endocytosis. Interestingly, a non-canonical tyrosine-based motif, which contains two tyrosine residues, Tyr-6 and Tyr-8, present in the NH2-terminal cytoplasmic tail, was essential for endocytosis through interaction with an alpha-adaptin, but not mu 2-subunit, of the AP-2 complex. Indeed, an appendage domain of alpha-adaptin was identified as a protein interacting with the cytoplasmic tail of HM1.24. Furthermore, overexpression of the appendage domain of alpha-adaptin in cells depleted of alpha-adaptin could rescue the clathrin-mediated endocytosis of HM1.24 but not of the transferrin receptor. Taken together, our findings suggest that clathrin-dependent endocytosis of human HM1.24 from the cell surface lipid rafts is mediated by direct interaction with alpha-adaptin.	[Masuyama, Naoko; Kuronita, Toshio; Tanaka, Rika; Muto, Tomonori; Hirota, Yuko; Takigawa, Azusa; Fujita, Hideaki; Tanaka, Yoshitaka] Kyushu Univ, Grad Sch Pharmaceut Sci, Div Pharmaceut Cell Biol, Fukuoka 8128582, Japan; [Aso, Yoshinori; Amano, Jun] Chugai Pharmaceut Co Ltd, Fuji Gotemba Res Labs, Gotemba, Shizuoka 4128513, Japan	Kyushu University; Chugai Pharmaceutical Co., Ltd.; Roche Holding	Tanaka, Y (corresponding author), Kyushu Univ, Grad Sch Pharmaceut Sci, Div Pharmaceut Cell Biol, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	tanakay@bioc.phar.kyushu-u.ac.jp		Fujita, Hideaki/0000-0002-4105-4430	Ministry of Education, Culture, Sports, Sciences and Technology of Japan	Ministry of Education, Culture, Sports, Sciences and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant-in-aid from the Ministry of Education, Culture, Sports, Sciences and Technology of Japan.	Abrami L, 2006, J CELL BIOL, V172, P309, DOI 10.1083/jcb.200507067; Abrami L, 2003, J CELL BIOL, V160, P321, DOI 10.1083/jcb.200211018; Benmerah A, 1996, J BIOL CHEM, V271, P12111, DOI 10.1074/jbc.271.20.12111; Benmerah A, 1998, J CELL BIOL, V140, P1055, DOI 10.1083/jcb.140.5.1055; Benmerah A, 2000, J BIOL CHEM, V275, P3288, DOI 10.1074/jbc.275.5.3288; Blasius AL, 2006, J IMMUNOL, V177, P3260, DOI 10.4049/jimmunol.177.5.3260; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Brugger B, 2006, P NATL ACAD SCI USA, V103, P2641, DOI 10.1073/pnas.0511136103; CANFIELD WM, 1991, J BIOL CHEM, V266, P5682; Capurso G, 2006, ENDOCR-RELAT CANCER, V13, P541, DOI 10.1677/erc.1.01153; Dell'Angelica EC, 1998, SCIENCE, V280, P431, DOI 10.1126/science.280.5362.431; Di Guglielmo GM, 2003, NAT CELL BIOL, V5, P410, DOI 10.1038/ncb975; Fessart D, 2007, J CELL SCI, V120, P1723, DOI 10.1242/jcs.03444; GOTO T, 1994, BLOOD, V84, P1922; Grutzmann R, 2005, ONCOGENE, V24, P5079, DOI 10.1038/sj.onc.1208696; Guha A, 2003, J CELL SCI, V116, P3373, DOI 10.1242/jcs.00637; Hinrichsen L, 2003, J BIOL CHEM, V278, P45160, DOI 10.1074/jbc.M307290200; Hirosako K, 2004, BIOCHEM BIOPH RES CO, V316, P845, DOI 10.1016/j.bbrc.2004.02.119; Hirota Y, 2007, BIOCHEM BIOPH RES CO, V364, P40, DOI 10.1016/j.bbrc.2007.09.089; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; ISHIKAWA J, 1995, GENOMICS, V26, P527, DOI 10.1016/0888-7543(95)80171-H; Janvier K, 2005, MOL BIOL CELL, V16, P4231, DOI 10.1091/mbc.E05-03-0213; Johannessen LE, 2006, MOL CELL BIOL, V26, P389, DOI 10.1128/MCB.26.2.389-401.2006; Kupzig S, 2003, TRAFFIC, V4, P694, DOI 10.1034/j.1600-0854.2003.00129.x; Kuronita T, 2005, TRAFFIC, V6, P895, DOI 10.1111/j.1600-0854.2005.00325.x; Kuronita T, 2002, J CELL SCI, V115, P4117, DOI 10.1242/jcs.00075; LARKIN JM, 1983, CELL, V33, P273, DOI 10.1016/0092-8674(83)90356-2; Li XY, 2007, MOL BIOL CELL, V18, P1261, DOI 10.1091/mbc.E06-03-0236; Mayor S, 2004, NAT REV MOL CELL BIO, V5, P110, DOI 10.1038/nrm1309; Meyer C, 2000, EMBO J, V19, P2193, DOI 10.1093/emboj/19.10.2193; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; MURATA M, 1995, P NATL ACAD SCI USA, V92, P10339, DOI 10.1073/pnas.92.22.10339; Naslavsky N, 2004, MOL BIOL CELL, V15, P3542, DOI 10.1091/mbc.E04-02-0151; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Nichols B, 2003, J CELL SCI, V116, P4707, DOI 10.1242/jcs.00840; Nichols BJ, 2002, NAT CELL BIOL, V4, P374, DOI 10.1038/ncb787; Ohno H, 1998, J BIOL CHEM, V273, P25915, DOI 10.1074/jbc.273.40.25915; Ohtomo T, 1999, BIOCHEM BIOPH RES CO, V258, P583, DOI 10.1006/bbrc.1999.0683; Ono K, 1999, MOL IMMUNOL, V36, P387, DOI 10.1016/S0161-5890(99)00029-2; Owen DJ, 1999, CELL, V97, P805, DOI 10.1016/S0092-8674(00)80791-6; Ozaki S, 1997, BLOOD, V90, P3179, DOI 10.1182/blood.V90.8.3179; Peden AA, 2002, J CELL BIOL, V156, P327, DOI 10.1083/jcb.200107140; Pelkmans L, 2002, TRAFFIC, V3, P311, DOI 10.1034/j.1600-0854.2002.30501.x; Praefcke GJK, 2004, EMBO J, V23, P4371, DOI 10.1038/sj.emboj.7600445; Rapoport I, 1998, EMBO J, V17, P2148, DOI 10.1093/emboj/17.8.2148; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Rollason R, 2007, J CELL SCI, V120, P3850, DOI 10.1242/jcs.003343; ROTHBERG KG, 1992, CELL, V68, P673, DOI 10.1016/0092-8674(92)90143-Z; Sabharanjak S, 2002, DEV CELL, V2, P411, DOI 10.1016/S1534-5807(02)00145-4; Schmid EM, 2007, NATURE, V448, P883, DOI 10.1038/nature06031; Schmid EM, 2006, PLOS BIOL, V4, P1532, DOI 10.1371/journal.pbio.0040262; Shih W, 1995, J BIOL CHEM, V270, P31083, DOI 10.1074/jbc.270.52.31083; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; Stoddart A, 2005, MOL BIOL CELL, V16, P2339, DOI 10.1091/mbc.e05-01-0025; Stoddart A, 2002, IMMUNITY, V17, P451, DOI 10.1016/S1074-7613(02)00416-8; Subtil A, 1999, P NATL ACAD SCI USA, V96, P6775, DOI 10.1073/pnas.96.12.6775; Sunaga N, 2004, CANCER RES, V64, P4277, DOI 10.1158/0008-5472.CAN-03-3941; Taylor DR, 2005, J CELL SCI, V118, P5141, DOI 10.1242/jcs.02627; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001; Van Damme N, 2008, CELL MICROBIOL, V10, P1040, DOI 10.1111/j.1462-5822.2007.01101.x; van Deurs B, 2003, TRENDS CELL BIOL, V13, P92, DOI 10.1016/S0962-8924(02)00039-9; Vidal-Laliena M, 2005, CELL IMMUNOL, V236, P6, DOI 10.1016/j.cellimm.2005.08.002; Volonte D, 1999, J BIOL CHEM, V274, P12702, DOI 10.1074/jbc.274.18.12702; Walter-Yohrling J, 2003, CANCER RES, V63, P8939; Yao DY, 2002, MOL BIOL CELL, V13, P4001, DOI 10.1091/mbc.02-07-0104	65	117	118	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15927	15941		10.1074/jbc.M109.005124	http://dx.doi.org/10.1074/jbc.M109.005124			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19359243	hybrid, Green Published			2022-12-27	WOS:000266501000060
J	Brognard, J; Niederst, M; Reyes, G; Warfel, N; Newton, AC				Brognard, John; Niederst, Matthew; Reyes, Gloria; Warfel, Noel; Newton, Alexandra C.			Common Polymorphism in the Phosphatase PHLPP2 Results in Reduced Regulation of Akt and Protein Kinase C	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; RICTOR-MTOR COMPLEX; BREAST-CANCER CELLS; CELLULAR-SURVIVAL; TUMOR-SUPPRESSOR; PROSTATE-CANCER; IN-VIVO; PHOSPHORYLATION; ACTIVATION; ESTROGEN	PHLPP2 (PH domain leucine-rich repeat protein phosphatase 2) terminates Akt and protein kinase C (PKC) activity by specifically dephosphorylating these kinases at a key regulatory site, the hydrophobic motif (Ser-473 in Akt1). Here we identify a polymorphism that results in an amino acid change from a Leu to Ser at codon 1016 in the phosphatase domain of PHLPP2, which reduces phosphatase activity toward Akt both in vitro and in cells, in turn resulting in reduced apoptosis. Depletion of endogenous PHLPP2 variants in breast cancer cells revealed the Ser-1016 variant is less functional toward both Akt and PKC. In pair-matched high grade breast cancer samples we observed retention of only the Ser allele from heterozygous patients (identical results were observed in a pair-matched normal and tumor cell line). Thus, we have identified a functional polymorphism that impairs the activity of PHLPP2 and correlates with elevated Akt phosphorylation and increased PKC levels.	Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Brognard, John; Niederst, Matthew; Warfel, Noel] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego	Newton, AC (corresponding author), 9500 Gilman Dr, La Jolla, CA 92093 USA.	anewton@ucsd.edu	Brognard, John/T-5099-2019	Brognard, John/0000-0002-9243-6615; Warfel, Noel/0000-0001-6410-9011	National Institutes of Health [GM067946]; Department of Defense Breast Cancer Research Program Predoctoral [BC043239]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752, R01GM067946] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Breast Cancer Research Program Predoctoral(United States Department of Defense); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM067946 (to A.C.N.). This work was also supported by Department of Defense Breast Cancer Research Program Predoctoral Grant BC043239 to J.B.), awarded and administered by the U.S. Army Medical Research Acquisition Activity, Fort Detrick, MD.	Andjelkovic M, 1996, P NATL ACAD SCI USA, V93, P5699, DOI 10.1073/pnas.93.12.5699; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Brognard J, 2001, CANCER RES, V61, P3986; Brognard J, 2008, TRENDS ENDOCRIN MET, V19, P223, DOI 10.1016/j.tem.2008.04.001; Brognard J, 2007, MOL CELL, V25, P917, DOI 10.1016/j.molcel.2007.02.017; Calleja V, 2007, PLOS BIOL, V5, P780, DOI 10.1371/journal.pbio.0050095; Callen DF, 2002, CANCER GENET CYTOGEN, V133, P76, DOI 10.1016/S0165-4608(01)00565-9; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Driouch K, 1997, GENE CHROMOSOME CANC, V19, P185, DOI 10.1002/(SICI)1098-2264(199707)19:3<185::AID-GCC8>3.0.CO;2-U; Faridi J, 2003, CLIN CANCER RES, V9, P2933; Freudenreich CH, 2007, FRONT BIOSCI-LANDMRK, V12, P4911, DOI 10.2741/2437; Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001; Gao T, 2008, J BIOL CHEM, V283, P6300, DOI 10.1074/jbc.M707319200; Gao TY, 2005, MOL CELL, V18, P13, DOI 10.1016/j.molcel.2005.03.008; Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Konecny GE, 2006, CANCER RES, V66, P1630, DOI 10.1158/0008-5472.CAN-05-1182; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liang J, 2002, NAT MED, V8, P1153, DOI 10.1038/nm761; Liu W, 2007, FRONT BIOSCI-LANDMRK, V12, P4011, DOI 10.2741/2367; Mackay HJ, 2007, NAT REV CANCER, V7, P554, DOI 10.1038/nrc2168; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Mendoza MC, 2007, MOL CELL, V25, P798, DOI 10.1016/j.molcel.2007.03.007; Nakatani K, 1999, J BIOL CHEM, V274, P21528, DOI 10.1074/jbc.274.31.21528; Nicholson KM, 2003, BREAST CANCER RES TR, V81, P117, DOI 10.1023/A:1025765215765; Perren A, 1999, AM J PATHOL, V155, P1253, DOI 10.1016/S0002-9440(10)65227-3; Rakha EA, 2006, GENE CHROMOSOME CANC, V45, P527, DOI 10.1002/gcc.20318; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; SIEGEL PM, 1994, MOL CELL BIOL, V14, P7068, DOI 10.1128/MCB.14.11.7068; SLAMON DJ, 1989, SCIENCE, V244, P707, DOI 10.1126/science.2470152; Sun M, 2001, CANCER RES, V61, P5985; Viglietto G, 2002, NAT MED, V8, P1136, DOI 10.1038/nm762	35	34	35	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					15215	15223		10.1074/jbc.M901468200	http://dx.doi.org/10.1074/jbc.M901468200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19324870	Green Published, hybrid			2022-12-27	WOS:000266288200056
J	Kandegedara, A; Thiyagarajan, S; Kondapalli, KC; Stemmler, TL; Rosen, BP				Kandegedara, Ashoka; Thiyagarajan, Saravanamuthu; Kondapalli, Kalyan C.; Stemmler, Timothy L.; Rosen, Barry P.			Role of Bound Zn(II) in the CadC Cd(II)/Pb(II)/Zn(II)-responsive Repressor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AUREUS PI258 CADC; CADMIUM RESISTANCE; BINDING-SITES; CRYSTAL-STRUCTURE; PROTEIN; CD(II); PB(II); SMTB	The Staphylococcus aureus plasmid pI258 cadCA operon encodes a P-type ATPase, CadA, that confers resistance to Cd(II)/Pb(II)/Zn(II). Expression is regulated by CadC, a homodimeric repressor that dissociates from the cad operator/promoter upon binding of Cd(II), Pb(II), or Zn(II). CadC is a member of the ArsR/SmtB family of metalloregulatory proteins. The crystal structure of CadC shows two types of metal binding sites, termed Site 1 and Site 2, and the homodimer has two of each. Site 1 is the physiological inducer binding site. The two Site 2 metal binding sites are formed at the dimerization interface. Site 2 is not regulatory in CadC but is regulatory in the homologue SmtB. Here the role of each site was investigated by mutagenesis. Both sites bind either Cd(II) or Zn(II). However, Site 1 has higher affinity for Cd(II) over Zn(II), and Site 2 prefers Zn(II) over Cd(II). Site 2 is not required for either derepression or dimerization. The crystal structure of the wild type with bound Zn(II) and of a mutant lacking Site 2 was compared with the SmtB structure with and without bound Zn(II). We propose that an arginine residue allows for Zn(II) regulation in SmtB and, conversely, a glycine results in a lack of regulation by Zn(II) in CadC. We propose that a glycine residue was ancestral whether the repressor binds Zn(II) at a Site 2 like CadC or has no Site 2 like the paralogous ArsR and implies that acquisition of regulatory ability in SmtB was a more recent evolutionary event.	[Rosen, Barry P.] Florida Int Univ, Coll Med, Dept Cellular Biol & Pharmacol, Miami, FL 33199 USA; [Kandegedara, Ashoka; Thiyagarajan, Saravanamuthu; Kondapalli, Kalyan C.; Stemmler, Timothy L.; Rosen, Barry P.] Wayne State Univ, Dept Biochem & Mol Biol, Sch Med, Detroit, MI 48201 USA	State University System of Florida; Florida International University; Wayne State University	Rosen, BP (corresponding author), Florida Int Univ, Coll Med, Dept Cellular Biol & Pharmacol, 11200 SW 8th St,HLS 2 693, Miami, FL 33199 USA.	brosen@fiu.edu	Kondapalli, Kalyan C/N-8097-2019; S, Thiyagarajan/AAU-3934-2021	Thiyagarajan, Saravanamuthu/0000-0001-6960-2729; Rosen, Barry P./0000-0002-5230-4271	National Institutes of Health [AI043428, DK068139]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043428] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK068139] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants AI043428 (to B. P. R.) and DK068139 (to T. L. S.).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bhattacharjee H, 2007, MOL MICROBIOLOGY HEA, P371, DOI [10.1007/7171_2006_086, DOI 10.1007/7171_2006_086]; Busenlehner LS, 2003, FEMS MICROBIOL REV, V27, P131, DOI 10.1016/S0168-6445(03)00054-8; Busenlehner LS, 2002, J MOL BIOL, V319, P685, DOI 10.1016/S0022-2836(02)00299-1; Busenlehner LS, 2001, BIOCHEMISTRY-US, V40, P4426, DOI 10.1021/bi010006g; Cook WJ, 1998, J MOL BIOL, V275, P337, DOI 10.1006/jmbi.1997.1443; CORBISIER P, 1993, FEMS MICROBIOL LETT, V110, P231, DOI 10.1111/j.1574-6968.1993.tb06325.x; Eicken C, 2003, J MOL BIOL, V333, P683, DOI 10.1016/j.jmb.2003.09.007; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; ENDO G, 1995, J BACTERIOL, V177, P4437, DOI 10.1128/jb.177.15.4437-4441.1995; GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7; Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238; MARTELL AE, 1977, OTHER ORGANIC LIGAND, P168; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mukhopadhyay R, 2002, FEMS MICROBIOL REV, V26, P311, DOI 10.1016/S0168-6445(02)00112-2; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NUCIFORA G, 1989, P NATL ACAD SCI USA, V86, P3544, DOI 10.1073/pnas.86.10.3544; Ordonez E, 2008, J BIOL CHEM, V283, P25706, DOI 10.1074/jbc.M803209200; Sun Y, 2001, J BIOL CHEM, V276, P14955, DOI 10.1074/jbc.M010595200; Teichert F, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-425; Turner JS, 1996, NUCLEIC ACIDS RES, V24, P3714, DOI 10.1093/nar/24.19.3714; Wang B, 2003, J BIOL CHEM, V278, P20225, DOI 10.1074/jbc.M300459200; Wong MD, 2002, J BIOL CHEM, V277, P40930, DOI 10.1074/jbc.M206536200; Ye J, 2005, J BACTERIOL, V187, P4214, DOI 10.1128/JB.187.12.4214-4221.2005	24	17	19	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					14958	14965		10.1074/jbc.M809179200	http://dx.doi.org/10.1074/jbc.M809179200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19286656	Green Published, hybrid			2022-12-27	WOS:000266288200032
J	Martino, MEB; Olsen, JC; Fulcher, NB; Wolfgang, MC; O'Neal, WK; Ribeiro, CMP				Martino, Mary E. B.; Olsen, John C.; Fulcher, Nanette B.; Wolfgang, Matthew C.; O'Neal, Wanda K.; Ribeiro, Carla M. P.			Airway Epithelial Inflammation-induced Endoplasmic Reticulum Ca2+ Store Expansion Is Mediated by X-box Binding Protein-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLASMA-CELL DIFFERENTIATION; UNFOLDED PROTEIN; ER STRESS; MEMBRANE BIOGENESIS; MOUSE MODEL; XBP1; IRE1; COORDINATION	Inflamed cystic fibrosis (CF) human bronchial epithelia (HBE), or normal HBE exposed to supernatant from mucopurulent material (SMM) from CF airways, exhibit endoplasmic reticulum (ER)/Ca2+ store expansion and amplified Ca2+-mediated inflammation. HBE inflammation triggers an unfolded protein response (UPR) coupled to mRNA splicing of X-box binding protein-1 (XBP-1). Because spliced XBP-1 (XBP-1s) promotes ER expansion in other cellular models, we hypothesized that XBP-1s is responsible for the ER/Ca2+ store expansion in inflamed HBE. XBP-1s was increased in freshly isolated infected/inflamed CF in comparison with normal HBE. The link between airway epithelial inflammation, XBP-1s, and ER/Ca2+ store expansion was then addressed in murine airways challenged with phosphate-buffered saline or Pseudomonas aeruginosa. P. aeruginosa-challenged mice exhibited airway epithelial ER/Ca2+ store expansion, which correlated with airway inflammation. P. aeruginosa-induced airway inflammation triggered XBP-1s in ER stress-activated indicator (ERAI) mice. To evaluate the functional role of XBP-1s in airway inflammation linked to ER/Ca2+ store expansion, control, XBP-1s, or dominant negative XBP- 1 (DN-XBP-1) stably expressing 16HBE14o(-) cell lines were used. Studies with cells transfected with an unfolded protein response element (UPRE) luciferase reporter plasmid confirmed that the UPRE was activated or inhibited by expression of XBP-1s or DN-XBP-1, respectively. Expression of XBP-1s induced ER/Ca2+ store expansion and potentiated bradykinin-increased interleukin (IL)-8 secretion, whereas expression of DN-XBP-1 inhibited bradykinin-dependent IL-8 secretion. In addition, expression of DN-XBP-1 blunted SMM-induced ER/Ca2+ store expansion and SMM-induced IL-8 secretion. These findings suggest that, in inflamed HBE, XBP-1s is responsible for the ER/Ca2+ store expansion that confers amplification of Ca2+-dependent inflammatory responses.	[Martino, Mary E. B.; Olsen, John C.; Fulcher, Nanette B.; Wolfgang, Matthew C.; O'Neal, Wanda K.; Ribeiro, Carla M. P.] Univ N Carolina, Cyst Fibrosis Pulm Res & Treatment Ctr, Chapel Hill, NC 27599 USA; [Olsen, John C.; O'Neal, Wanda K.; Ribeiro, Carla M. P.] Univ N Carolina, Dept Med, Chapel Hill, NC 27599 USA; [Wolfgang, Matthew C.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Ribeiro, CMP (corresponding author), CB 7248,7013 Thurston Bowles Bldg, Chapel Hill, NC 27599 USA.	carla_ribeiro@med.unc.edu	Ribeiro, Carla Maria P/A-6955-2009		Cystic Fibrosis Foundation [RIBEIR07G0]	Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation)	This work was supported by Cystic Fibrosis Foundation Grant RIBEIR07G0 (to C. M. P. R.).	Bartoszewski R, 2008, AM J RESP CELL MOL, V39, P448, DOI 10.1165/rcmb.2008-0065OC; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Cox JS, 1997, MOL BIOL CELL, V8, P1805, DOI 10.1091/mbc.8.9.1805; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; Credle JJ, 2005, P NATL ACAD SCI USA, V102, P18773, DOI 10.1073/pnas.0509487102; Hybiske K, 2007, AM J PHYSIOL-LUNG C, V293, pL1250, DOI 10.1152/ajplung.00231.2007; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Iwawaki T, 2004, NAT MED, V10, P98, DOI 10.1038/nm970; Johnson LG, 1998, J VIROL, V72, P8861, DOI 10.1128/JVI.72.11.8861-8872.1998; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; Kaufman RJ, 2002, NAT REV MOL CELL BIO, V3, P411, DOI 10.1038/nrm829; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Lee AH, 2005, EMBO J, V24, P4368, DOI 10.1038/sj.emboj.7600903; Lee AS, 2001, TRENDS BIOCHEM SCI, V26, P504, DOI 10.1016/S0968-0004(01)01908-9; Mall M, 2004, NAT MED, V10, P487, DOI 10.1038/nm1028; Mori K, 2000, CELL, V101, P451, DOI 10.1016/S0092-8674(00)80855-7; Nanua S, 2006, BIOCHEM BIOPH RES CO, V343, P135, DOI 10.1016/j.bbrc.2006.02.137; Paradiso AM, 2001, J GEN PHYSIOL, V117, P53, DOI 10.1085/jgp.117.1.53; Patil C, 2001, CURR OPIN CELL BIOL, V13, P349, DOI 10.1016/S0955-0674(00)00219-2; Pedrosa CM, 2001, CILIA AND MUCUS: FROM DEVELOPMENT TO RESPIRATORY DEFENSE, P303; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Ribeiro CMP, 2005, J BIOL CHEM, V280, P10202, DOI 10.1074/jbc.M410317200; Ribeiro CMP, 2005, J BIOL CHEM, V280, P17798, DOI 10.1074/jbc.M410618200; Ron D, 2004, J CELL BIOL, V167, P23, DOI 10.1083/jcb.200408117; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010; Smith RS, 2004, INFECT IMMUN, V72, P1677, DOI 10.1128/IAI.72.3.1677-1684.2004; Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Urano F, 2000, J CELL SCI, V113, P3697; WIEST DL, 1990, J CELL BIOL, V110, P1501, DOI 10.1083/jcb.110.5.1501; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang KZ, 2004, J BIOL CHEM, V279, P25935, DOI 10.1074/jbc.R400008200	35	62	64	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					14904	14913		10.1074/jbc.M809180200	http://dx.doi.org/10.1074/jbc.M809180200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19321437	hybrid, Green Published			2022-12-27	WOS:000266288200026
J	Namkung, Y; Dipace, C; Javitch, JA; Sibley, DR				Namkung, Yoon; Dipace, Concetta; Javitch, Jonathan A.; Sibley, David R.			G Protein-coupled Receptor Kinase-mediated Phosphorylation Regulates Post-endocytic Trafficking of the D-2 Dopamine Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AGONIST-INDUCED DESENSITIZATION; HAMSTER OVARY CELLS; D2 RECEPTORS; ADENYLATE-CYCLASE; ARRESTIN BINDING; BETA-ARRESTINS; INTERNALIZATION; SENSITIZATION; ISOFORMS; RESPONSIVENESS	We investigated the role of G protein-coupled receptor kinase (GRK)-mediated phosphorylation in agonist-induced desensitization, arrestin association, endocytosis, and intracellular trafficking of the D-2 dopamine receptor (DAR). Agonist activation of D-2 DARs results in rapid and sustained receptor phosphorylation that is solely mediated by GRKs. A survey of GRKs revealed that only GRK2 or GRK3 promotes D-2 DAR phosphorylation. Mutational analyses resulted in the identification of eight serine/threonine residues within the third cytoplasmic loop of the receptor that are phosphorylated by GRK2/3. Simultaneous mutation of these eight residues results in a receptor construct, GRK(-), that is completely devoid of agonist-promoted GRK-mediated receptor phosphorylation. We found that both wild-type (WT) and GRK(-) receptors underwent a similar degree of agonist-induced desensitization as assessed using [S-35]GTP gamma S binding assays. Similarly, both receptor constructs internalized to the same extent in response to agonist treatment. Furthermore, using bioluminescence resonance energy transfer assays to directly assess receptor association with arrestin3, we found no differences between the WT and GRK(-) receptors. Thus, phosphorylation is not required for arrestin-receptor association or agonist-induced desensitization or internalization. In contrast, when we examined recycling of the D-2 DARs to the cell surface, subsequent to agonist-induced endocytosis, the GRK(-) construct exhibited less recycling in comparison with the WT receptor. This impairment appears to be due to a greater propensity of the GRK(-) receptors to down-regulate once internalized. In contrast, if the receptor is highly phosphorylated, then receptor recycling is promoted. These results reveal a novel role for GRK-mediated phosphorylation in regulating the post-endocytic trafficking of a G protein-coupled receptor.	[Namkung, Yoon; Sibley, David R.] NINDS, Mol Neuropharmacol Sect, NIH, Bethesda, MD 20892 USA; [Dipace, Concetta; Javitch, Jonathan A.] Columbia Univ, Coll Phys & Surg, Ctr Mol Recognit, New York, NY 10032 USA; [Dipace, Concetta; Javitch, Jonathan A.] Columbia Univ, Coll Phys & Surg, Dept Psychiat, New York, NY 10032 USA; [Dipace, Concetta; Javitch, Jonathan A.] Columbia Univ, Coll Phys & Surg, Dept Pharmacol, New York, NY 10032 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Columbia University; Columbia University; Columbia University	Sibley, DR (corresponding author), NINDS, Mol Neuropharmacol Sect, NIH, 5625 Fishers Ln,Rm 4S-04,MSC 9405, Bethesda, MD 20892 USA.	sibley@helix.nih.gov	Sibley, David/AAC-3591-2019	Javitch, Jonathan/0000-0001-7395-2967	NINDS; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH054137] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS002263] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K05DA022413] Funding Source: NIH RePORTER	NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	work was supported, in whole or in part, by a National Institutes of Health grant from NINDS (Intramural Research Program).	AGUI T, 1988, J BIOCHEM-TOKYO, V103, P436, DOI 10.1093/oxfordjournals.jbchem.a122288; Bartlett SE, 2005, P NATL ACAD SCI USA, V102, P11521, DOI 10.1073/pnas.0502418102; BARTON AC, 1991, MOL PHARMACOL, V39, P650; BATES MD, 1991, MOL PHARMACOL, V39, P55; Cho DI, 2006, BIOCHEM BIOPH RES CO, V350, P634, DOI 10.1016/j.bbrc.2006.09.090; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Ferguson SSG, 1996, CAN J PHYSIOL PHARM, V74, P1095, DOI 10.1139/y96-124; Ferguson SSG, 2007, TRENDS PHARMACOL SCI, V28, P173, DOI 10.1016/j.tips.2007.02.008; Gainetdinov RR, 2003, NEURON, V38, P291, DOI 10.1016/S0896-6273(03)00192-2; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Galliera E, 2004, J BIOL CHEM, V279, P25590, DOI 10.1074/jbc.M400363200; Gardner B, 1996, BRIT J PHARMACOL, V118, P1544, DOI 10.1111/j.1476-5381.1996.tb15572.x; Gurevich VV, 2006, PHARMACOL THERAPEUT, V110, P465, DOI 10.1016/j.pharmthera.2005.09.008; Hanyaloglu AC, 2005, EMBO J, V24, P2265, DOI 10.1038/sj.emboj.7600688; Hanyaloglu AC, 2008, ANNU REV PHARMACOL, V48, P537, DOI 10.1146/annurev.pharmtox.48.113006.094830; Ito K, 1999, EUR J BIOCHEM, V260, P112, DOI 10.1046/j.1432-1327.1999.00125.x; Itokawa M, 1996, MOL PHARMACOL, V49, P560; Iwata K, 1999, EUR J BIOCHEM, V263, P596, DOI 10.1046/j.1432-1327.1999.00549.x; Iwata K, 2005, J BIOL CHEM, V280, P2197, DOI 10.1074/jbc.M408834200; Kabbani N, 2004, CELL SIGNAL, V16, P497, DOI 10.1016/j.cellsig.2003.09.011; Kapur S, 2001, BIOL PSYCHIAT, V50, P873, DOI 10.1016/S0006-3223(01)01251-3; Kim KM, 2001, J BIOL CHEM, V276, P37409, DOI 10.1074/jbc.M106728200; Kim OJ, 2008, J RECEPT SIG TRANSD, V28, P453, DOI [10.1080/10799890802379410, 10.1080/10799890802379410 ]; Kim OJ, 2008, J NEUROCHEM, V106, P83, DOI 10.1111/j.1471-4159.2008.05348.x; Klewe IV, 2008, NEUROPHARMACOLOGY, V54, P1215, DOI 10.1016/j.neuropharm.2008.03.015; Lan HX, 2009, MOL PHARMACOL, V75, P113, DOI 10.1124/mol.108.050534; Lan HX, 2009, MOL PHARMACOL, V75, P19, DOI 10.1124/mol.108.050542; Loening AM, 2006, PROTEIN ENG DES SEL, V19, P391, DOI 10.1093/protein/gzl023; Macey TA, 2004, MOL PHARMACOL, V66, P1635, DOI 10.1124/mol.104.001495; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Marion S, 2006, J BIOL CHEM, V281, P2932, DOI 10.1074/jbc.M508074200; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Moore CAC, 2007, ANNU REV PHYSIOL, V69, P451, DOI 10.1146/annurev.physiol.69.022405.154712; Morris SJ, 2007, EUR J PHARMACOL, V577, P44, DOI 10.1016/j.ejphar.2007.08.027; Mukherjee S, 2002, J BIOL CHEM, V277, P17916, DOI 10.1074/jbc.M110479200; Namkung Y, 2004, J BIOL CHEM, V279, P49533, DOI 10.1074/jbc.M408319200; Neve KA, 2006, MOL PHARMACOL, V69, P673, DOI 10.1124/mol.105.021535; Neve KA, 2004, J RECEPT SIG TRANSD, V24, P165, DOI 10.1081/LRST-200029981; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Premont RT, 2007, ANNU REV PHYSIOL, V69, P511, DOI 10.1146/annurev.physiol.69.022405.154731; Rankin ML, 2006, MOL PHARMACOL, V69, P759, DOI 10.1124/mol.105.019901; Seeman P, 2007, SYNAPSE, V61, P1013, DOI 10.1002/syn.20453; Shukla AK, 2008, P NATL ACAD SCI USA, V105, P9988, DOI 10.1073/pnas.0804246105; SIBLEY DR, 1992, TRENDS PHARMACOL SCI, V13, P61, DOI 10.1016/0165-6147(92)90025-2; SIBLEY DR, 1997, DOPAMINE RECEPTORS, P383; Skinbjerg M, 2009, SYNAPSE, V63, P621, DOI 10.1002/syn.20636; Tandon R, 2008, SCHIZOPHR RES, V100, P4, DOI 10.1016/j.schres.2008.01.022; Thompson D, 2007, J BIOL CHEM, V282, P29178, DOI 10.1074/jbc.M704014200; Vickery RG, 1999, J CELL BIOL, V144, P31, DOI 10.1083/jcb.144.1.31; Wang FF, 2008, MOL ENDOCRINOL, V22, P1881, DOI 10.1210/me.2007-0496; Watts VJ, 1996, MOL PHARMACOL, V50, P966; Watts VJ, 2005, PHARMACOL THERAPEUT, V106, P405, DOI 10.1016/j.pharmthera.2004.12.005; Whistler JL, 2002, SCIENCE, V297, P615, DOI 10.1126/science.1073308; ZHANG LJ, 1994, MOL PHARMACOL, V45, P878	55	73	78	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					15038	15051		10.1074/jbc.M900388200	http://dx.doi.org/10.1074/jbc.M900388200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19332542	Green Published, hybrid			2022-12-27	WOS:000266288200040
J	Ordonez, E; Van Belle, K; Roos, G; De Galan, S; Letek, M; Gil, JA; Wyns, L; Mateos, LM; Messens, J				Ordonez, Efren; Van Belle, Karolien; Roos, Goedele; De Galan, Sandra; Letek, Michal; Gil, Jose A.; Wyns, Lode; Mateos, Luis M.; Messens, Joris			Arsenate Reductase, Mycothiol, and Mycoredoxin Concert Thiol/Disulfide Exchange	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORYNEBACTERIUM-GLUTAMICUM ATCC-13032; AUREUS PLASMID PI258; STAPHYLOCOCCUS-AUREUS; ESCHERICHIA-COLI; DISULFIDE OXIDOREDUCTASE; LEISHMANIA-MAJOR; HYDROGEN DONOR; ARSENITE; THIOL; GLUTATHIONE	We identified the first enzymes that use mycothiol and mycoredoxin in a thiol/disulfide redox cascade. The enzymes are two arsenate reductases from Corynebacterium glutamicum (Cg ArsC1 and Cg ArsC2), which play a key role in the defense against arsenate. In vivo knockouts showed that the genes for Cg_ArsC1 and Cg_ArsC2 and those of the enzymes of the mycothiol biosynthesis pathway confer arsenate resistance. With steady-state kinetics, arsenite analysis, and theoretical reactivity analysis, we unraveled the catalytic mechanism for the reduction of arsenate to arsenite in C. glutamicum. The active site thiolate in Cg_ArsCs facilitates adduct formation between arsenate and mycothiol. Mycoredoxin, a redox enzyme for which the function was never shown before, reduces the thiol-arseno bond and forms arsenite and a mycothiol-mycoredoxin mixed disulfide. A second molecule of mycothiol recycles mycoredoxin and forms mycothione that, in its turn, is reduced by the NADPH-dependent mycothione reductase. Cg_ArsCs show a low specificity constant of similar to 5 M-1 s(-1), typically for a thiol/disulfide cascade with nucleophiles on three different molecules. With the in vitro reconstitution of this novel electron transfer pathway, we have paved the way for the study of redox mechanisms in actinobacteria.	[Ordonez, Efren; Letek, Michal; Gil, Jose A.; Mateos, Luis M.] Univ Leon, Dept Mol Biol, Area Microbiol, E-24071 Leon, Spain; [Van Belle, Karolien; Roos, Goedele; Messens, Joris] Brussels Ctr Redox Biol, B-1050 Brussels, Belgium; [Van Belle, Karolien; Roos, Goedele; Wyns, Lode; Messens, Joris] Vrije Univ Brussels, Dept Mol & Cellular Interact, Vlaams Inst Biotechnol, B-1050 Brussels, Belgium; [Van Belle, Karolien; Roos, Goedele; Wyns, Lode; Messens, Joris] Vrije Univ Brussels, Dept Struct Biol Brussels, B-1050 Brussels, Belgium; [De Galan, Sandra] Vrije Univ Brussels, Dept Analyt Chem, B-1050 Brussels, Belgium; [Roos, Goedele] Vrije Univ Brussels, Dept Gen Chem, B-1050 Brussels, Belgium	Universidad de Leon; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; Vrije Universiteit Brussel; Vrije Universiteit Brussel; Vrije Universiteit Brussel	Mateos, LM (corresponding author), Univ Leon, Dept Mol Biol, Area Microbiol, E-24071 Leon, Spain.	luis.mateos@unileon.es; joris.messens@vib-vub.be	Letek, Michal/K-3903-2019; Gil, José A./L-1800-2019; Messens, Joris/AAH-3008-2020; Gil, Jose A./C-3902-2009; MATEOS DELGADO, LUIS MARIANO/ABB-8848-2021; Letek, Michal/AAH-4292-2019; Letek, Michal/C-6345-2008	Letek, Michal/0000-0002-9509-5174; Gil, José A./0000-0002-5069-2637; Messens, Joris/0000-0002-2128-8264; Gil, Jose A./0000-0002-5069-2637; MATEOS DELGADO, LUIS MARIANO/0000-0001-7763-582X; Letek, Michal/0000-0002-9509-5174	Vlaams Instituut voor Biotechnologie (VIB); Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO); Onderzoeksraad of the Vrije Universiteit Brussel; Science and Technology Ministry from Spain [BIO2008-00519, BIO2005-02723]	Vlaams Instituut voor Biotechnologie (VIB); Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO)(FWO); Onderzoeksraad of the Vrije Universiteit Brussel; Science and Technology Ministry from Spain	This work was supported by the Vlaams Instituut voor Biotechnologie (VIB), the Fonds voor Wetenschappelijk Onderzoek Vlaanderen (FWO), the Onderzoeksraad of the Vrije Universiteit Brussel, and Science and Technology Ministry from Spain Grants BIO2008-00519 and BIO2005-02723.	Achour AR, 2007, RES MICROBIOL, V158, P128, DOI 10.1016/j.resmic.2006.11.006; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Bennett MS, 2001, P NATL ACAD SCI USA, V98, P13577, DOI 10.1073/pnas.241397198; Bunik V, 1999, PROTEIN SCI, V8, P65; Bzymek KP, 2007, J BACTERIOL, V189, P6796, DOI 10.1128/JB.00644-07; delCardayre SB, 1998, J BIOL CHEM, V273, P5752, DOI 10.1074/jbc.273.10.5752; Demel S, 2004, PROTEIN SCI, V13, P2330, DOI 10.1110/ps.04787204; den Hengst CD, 2008, BBA-GEN SUBJECTS, V1780, P1201, DOI 10.1016/j.bbagen.2008.01.008; Duan GL, 2007, NEW PHYTOL, V174, P311, DOI 10.1111/j.1469-8137.2007.02009.x; FAHEY RC, 1978, J BACTERIOL, V133, P1126, DOI 10.1128/JB.133.3.1126-1129.1978; Feng J, 2006, J BIOL CHEM, V281, P10778, DOI 10.1074/jbc.M513192200; Frisch M. J., 2019, GAUSSIAN 16 REVISION; GLADYSHEVA TB, 1994, BIOCHEMISTRY-US, V33, P7288, DOI 10.1021/bi00189a033; GRAVINA SA, 1993, BIOCHEMISTRY-US, V32, P3368, DOI 10.1021/bi00064a021; Healy SM, 1999, BIOL TRACE ELEM RES, V68, P249, DOI 10.1007/BF02783907; HOLMGREN A, 1976, P NATL ACAD SCI USA, V73, P2275, DOI 10.1073/pnas.73.7.2275; Ikeda M, 2003, APPL MICROBIOL BIOT, V62, P99, DOI 10.1007/s00253-003-1328-1; JI GY, 1992, P NATL ACAD SCI USA, V89, P9474, DOI 10.1073/pnas.89.20.9474; JI GY, 1994, BIOCHEMISTRY-US, V33, P7294, DOI 10.1021/bi00189a034; Kalinowski J, 2003, J BIOTECHNOL, V104, P5, DOI 10.1016/S0168-1656(03)00154-8; Latinwo LM, 1998, BIOCHEM BIOPH RES CO, V242, P67, DOI 10.1006/bbrc.1997.7911; Li XK, 2007, J BACTERIOL, V189, P3705, DOI 10.1128/JB.01913-06; Martin P, 2001, STRUCTURE, V9, P1071, DOI 10.1016/S0969-2126(01)00672-4; Mateos LM, 2006, INT MICROBIOL, V9, P207; Mennucci B, 1997, J CHEM PHYS, V106, P5151, DOI 10.1063/1.473558; Messens J, 2002, P NATL ACAD SCI USA, V99, P8506, DOI 10.1073/pnas.132142799; Messens J, 2002, J BIOL INORG CHEM, V7, P146, DOI 10.1007/s007750100282; Messens J, 1999, BIOCHEMISTRY-US, V38, P16857, DOI 10.1021/bi9911841; Messens J, 2006, J MOL BIOL, V362, P1, DOI 10.1016/j.jmb.2006.07.002; MissetSmits M, 1997, FEBS LETT, V409, P221, DOI 10.1016/S0014-5793(97)00510-3; Mukhopadhyay R, 2000, J BIOL CHEM, V275, P21149, DOI 10.1074/jbc.M910401199; Mukhopadhyay R, 1998, FEMS MICROBIOL LETT, V168, P127, DOI 10.1016/S0378-1097(98)00430-3; Mukhopadhyay R, 2002, FEMS MICROBIOL REV, V26, P311, DOI 10.1016/S0168-6445(02)00112-2; Mukhopadhyay R, 2009, J MOL BIOL, V386, P1229, DOI 10.1016/j.jmb.2008.07.056; Newton GL, 2008, MICROBIOL MOL BIOL R, V72, P471, DOI 10.1128/MMBR.00008-08; Newton GL, 2002, ARCH MICROBIOL, V178, P388, DOI 10.1007/s00203-002-0469-4; Newton GL, 1996, J BACTERIOL, V178, P1990, DOI 10.1128/jb.178.7.1990-1995.1996; NEWTON GL, 1993, J BACTERIOL, V175, P2734, DOI 10.1128/JB.175.9.2734-2742.1993; Newton GL, 2000, BIOCHEMISTRY-US, V39, P10739, DOI 10.1021/bi000356n; Ordonez E, 2005, APPL ENVIRON MICROB, V71, P6206, DOI 10.1128/AEM.71.10.6206-6215.2005; Ordonez E, 2008, J BIOL CHEM, V283, P25706, DOI 10.1074/jbc.M803209200; Pearson RG., 1997, CHEM HARDNESS PLACE; Rawat M, 2007, FEMS MICROBIOL REV, V31, P278, DOI 10.1111/j.1574-6976.2006.00062.x; Roos G, 2006, CHEMBIOCHEM, V7, P981, DOI 10.1002/cbic.200500507; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Shi J, 1999, J BIOL CHEM, V274, P36039, DOI 10.1074/jbc.274.51.36039; Silver S, 1996, GENE, V179, P9, DOI 10.1016/S0378-1119(96)00323-X; SPIES HSC, 1994, EUR J BIOCHEM, V224, P203, DOI 10.1111/j.1432-1033.1994.tb20013.x; Stehr M, 2004, PROTEINS, V55, P613, DOI 10.1002/prot.20126; Vogt RN, 2003, BIOCHEM J, V374, P657, DOI 10.1042/BJ20030642; Wang R, 2007, J BIOL CHEM, V282, P16288, DOI 10.1074/jbc.M610347200; Yang YW, 1998, BIOCHEMISTRY-US, V37, P17145, DOI 10.1021/bi9806504; Zegers I, 2001, NAT STRUCT BIOL, V8, P843, DOI 10.1038/nsb1001-843; Zhou Y, 2004, J BIOL CHEM, V279, P37445, DOI 10.1074/jbc.M404383200	55	75	79	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					15107	15116		10.1074/jbc.M900877200	http://dx.doi.org/10.1074/jbc.M900877200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19286650	Green Published, hybrid			2022-12-27	WOS:000266288200046
J	Cedzich, A; Huttenlocher, F; Kuhn, BM; Pfannstiel, J; Gabler, L; Stintzi, A; Schaller, A				Cedzich, Anna; Huttenlocher, Franziska; Kuhn, Benjamin M.; Pfannstiel, Jens; Gabler, Leszek; Stintzi, Annick; Schaller, Andreas			The Protease-associated Domain and C-terminal Extension Are Required for Zymogen Processing, Sorting within the Secretory Pathway, and Activity of Tomato Subtilase 3 (SlSBT3)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROPROTEIN CONVERTASE PC5A; SUBTILISIN-LIKE PROTEASE; SERINE-PROTEASE; SUBSTRATE-SPECIFICITY; CLEAVAGE SPECIFICITY; ARABIDOPSIS-THALIANA; CELLULAR TRAFFICKING; CUTTING EDGE; PLANT-CELLS; FURIN	A transgenic plant cell suspension culture was established as a versatile and efficient expression system for the subtilase SlSBT3 from tomato. The recombinant protease was purified to homogeneity from culture supernatants by fractionated ammonium sulfate precipitation, batch adsorption to cation exchange material, and anion exchange chromatography. Purified SlSBT3 was identified as a 79-kDa glycoprotein with both complex and paucimannosidic type glycan chains at Asn(177), Asn(203), Asn(376), Asn(697), and Asn(745). SlSBT3 was found to be a very stable enzyme, being fully active at 60 degrees C and showing highest activity at alkaline conditions with a maximum between pH 7.5 and 8.0. Substrate specificity of SlSBT3 was analyzed in detail, revealing a preference for Gln and Lys in the P-1 and P-2 positions of oligopeptide substrates, respectively. Similar to bacterial, yeast, and mammalian subtilases, SlSBT3 is synthesized as a preproenzyme, and processing of the prodomain in the endoplasmic reticulum is a prerequisite for passage through the secretory pathway. SlSBT3 S538A and S538C active site mutants accumulated intracellularly as unprocessed zymogens, indicating that prodomain cleavage occurs autocatalytically. The wild-type SlSBT3 protein failed to cleave the prodomain of the S538A mutant in trans, demonstrating that zymogen maturation is an intramolecular process. Distinguishing features of plant as compared with mammalian subtilases include the insertion of a large protease-associated domain between the His and Ser residues of the catalytic triad and the C-terminal extension to the catalytic domain. Both features were found to be required for SlSBT3 activity and, consequently, for prodomain processing and secretion.	[Cedzich, Anna; Huttenlocher, Franziska; Kuhn, Benjamin M.; Gabler, Leszek; Stintzi, Annick; Schaller, Andreas] Univ Hohenheim, Inst Plant Physiol & Biotechnol, D-70593 Stuttgart, Germany; [Pfannstiel, Jens] Univ Hohenheim, Life Sci Ctr, D-70593 Stuttgart, Germany; [Pfannstiel, Jens] Univ Hohenheim, Inst Physiol, Dept Biosci, D-70593 Stuttgart, Germany	University Hohenheim; University Hohenheim; University Hohenheim	Schaller, A (corresponding author), Univ Hohenheim, Inst Plant Physiol & Biotechnol, D-70593 Stuttgart, Germany.	schaller@uni-hohenheim.de	Schaller, Andreas/AAC-1940-2020	Schaller, Andreas/0000-0001-6872-9576; Stintzi, Annick/0000-0002-6479-8184	Deutsche Forschungsgemeinschaft [SCHA591/2]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grant SCHA591/2 (to A.S.).	Anderson ED, 2002, J BIOL CHEM, V277, P12879, DOI 10.1074/jbc.M108740200; Berger D, 2000, GENE DEV, V14, P1119; Book AJ, 2005, PLANT PHYSIOL, V138, P1046, DOI 10.1104/pp.104.057406; Boyd PM, 2002, BBA-PROTEIN STRUCT M, V1596, P269, DOI 10.1016/S0167-4838(02)00228-5; BRUINENBERG PG, 1994, BIOCHEM J, V302, P957, DOI 10.1042/bj3020957; Coffeen WC, 2004, PLANT CELL, V16, P857, DOI 10.1105/tpc.017947; CREEMERS JWM, 1993, J BIOL CHEM, V268, P21826; DE B, 1996, J CELL BIOL, V135, P1261; Dodson G, 1998, TRENDS BIOCHEM SCI, V23, P347, DOI 10.1016/S0968-0004(98)01254-7; ELLIS KJ, 1982, METHOD ENZYMOL, V87, P405; FELIX G, 1995, PLANT J, V7, P381, DOI 10.1046/j.1365-313X.1995.7030381.x; Fitchette-Laine AC, 1997, PLANT J, V12, P1411, DOI 10.1046/j.1365-313x.1997.12061411.x; GLEAVE AP, 1992, PLANT MOL BIOL, V20, P1203, DOI 10.1007/BF00028910; Gupta Ramneek, 2002, Pac Symp Biocomput, P310; Hamilton CM, 1996, P NATL ACAD SCI USA, V93, P9975, DOI 10.1073/pnas.93.18.9975; Hamilton JMU, 2003, BIOCHEM J, V370, P57, DOI 10.1042/BJ20021125; Henrich S, 2005, J MOL BIOL, V345, P211, DOI 10.1016/j.jmb.2004.10.050; Huet Y, 2008, BIOL CHEM, V389, P91, DOI 10.1515/BC.2008.006; Janzik I, 2000, J BIOL CHEM, V275, P5193, DOI 10.1074/jbc.275.7.5193; KLEIN TM, 1988, BIO-TECHNOL, V6, P559, DOI 10.1038/nbt0588-559; Kruger J, 2002, SCIENCE, V296, P744, DOI 10.1126/science.1069288; Lawrence CM, 1999, SCIENCE, V286, P779, DOI 10.1126/science.286.5440.779; Lerouge P, 1998, PLANT MOL BIOL, V38, P31, DOI 10.1023/A:1006012005654; LI YY, 1994, J BIOL CHEM, V269, P4169; Lineberry NB, 2008, J IMMUNOL, V181, P1622, DOI 10.4049/jimmunol.181.3.1622; Liu JX, 2007, PLANT CELL, V19, P4111, DOI 10.1105/tpc.106.050021; Liu JX, 2007, PLANT J, V51, P897, DOI 10.1111/j.1365-313X.2007.03195.x; Luo XM, 2001, TRENDS BIOCHEM SCI, V26, P147, DOI 10.1016/S0968-0004(00)01768-0; Lusson J, 1997, BIOCHEM J, V326, P737, DOI 10.1042/bj3260737; Mahon P, 2000, PROTEIN SCI, V9, P1930, DOI 10.1110/ps.9.10.1930; Matsubayashi Y, 2006, ANNU REV PLANT BIOL, V57, P649, DOI 10.1146/annurev.arplant.56.032604.144204; Mayer G, 2008, J BIOL CHEM, V283, P2373, DOI 10.1074/jbc.M708763200; Meichtry J, 1999, PLANT MOL BIOL, V39, P749, DOI 10.1023/A:1006193414434; Muller L, 2000, PROG NUCLEIC ACID RE, V63, P69, DOI 10.1016/S0079-6603(08)60720-5; NEBES VL, 1991, J BIOL CHEM, V266, P22851; Nilsson I, 2000, J BIOL CHEM, V275, P17338, DOI 10.1074/jbc.M002317200; Nour N, 2003, J BIOL CHEM, V278, P2886, DOI 10.1074/jbc.M208009200; Patel AK, 2007, J AGR FOOD CHEM, V55, P5809, DOI 10.1021/jf063700h; PIETRZAK M, 1986, NUCLEIC ACIDS RES, V14, P5857, DOI 10.1093/nar/14.14.5857; POWER SD, 1986, P NATL ACAD SCI USA, V83, P3096, DOI 10.1073/pnas.83.10.3096; Rautengarten C, 2005, PLOS COMPUT BIOL, V1, P297, DOI 10.1371/journal.pcbi.0010040; Rautengarten C, 2008, PLANT J, V54, P466, DOI 10.1111/j.1365-313X.2008.03437.x; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Rovere C, 1999, J BIOL CHEM, V274, P12461, DOI 10.1074/jbc.274.18.12461; RUDENSKAYA GN, 1995, PLANTA, V196, P174, DOI 10.1007/BF00193231; Ryan CA, 2003, P NATL ACAD SCI USA, V100, P14577, DOI 10.1073/pnas.1934788100; Sakai J, 1998, MOL CELL, V2, P505, DOI 10.1016/S1097-2765(00)80150-1; Schaller A, 2004, PLANTA, V220, P183, DOI 10.1007/s00425-004-1407-2; SCHECHTER I, 1967, BIOCHEM BIOPH RES CO, V27, P157, DOI 10.1016/S0006-291X(67)80055-X; Schnorf Martin, 1991, Transgenic Research, V1, P23, DOI 10.1007/BF02512993; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Seidah NG, 2006, BIOL CHEM, V387, P871, DOI 10.1515/BC.2006.110; Seidah NG, 1999, P NATL ACAD SCI USA, V96, P1321, DOI 10.1073/pnas.96.4.1321; Siezen RJ, 1997, PROTEIN SCI, V6, P501; Srivastava R, 2008, PLANT J, V56, P219, DOI 10.1111/j.1365-313X.2008.03598.x; Steiner DF, 1998, CURR OPIN CHEM BIOL, V2, P31, DOI 10.1016/S1367-5931(98)80033-1; Strasser R, 2007, PLANT PHYSIOL, V145, P5, DOI 10.1104/pp.107.101162; Tanaka H, 2001, DEVELOPMENT, V128, P4681; Terp N, 2000, J PLANT PHYSIOL, V156, P468, DOI 10.1016/S0176-1617(00)80161-3; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Tornero P, 1996, P NATL ACAD SCI USA, V93, P6332, DOI 10.1073/pnas.93.13.6332; TRIMBLE RB, 1987, METHOD ENZYMOL, V138, P763; Tripathi LP, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-200; VEY M, 1994, J CELL BIOL, V127, P1829, DOI 10.1083/jcb.127.6.1829; Voinnet O, 2003, PLANT J, V33, P949, DOI 10.1046/j.1365-313X.2003.01676.x; von Groll U, 2002, PLANT CELL, V14, P1527, DOI 10.1105/tpc.001016; YAMAGATA H, 1994, J BIOL CHEM, V269, P32725; Yonezawa H, 2000, BIOSCI BIOTECH BIOCH, V64, P2104, DOI 10.1271/bbb.64.2104	68	51	53	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14068	14078		10.1074/jbc.M900370200	http://dx.doi.org/10.1074/jbc.M900370200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19332543	hybrid, Green Published			2022-12-27	WOS:000266286100013
J	Jeong, BC; Lee, YS; Park, YY; Bae, IH; Kim, DK; Koo, SH; Choi, HR; Kim, SH; Franceschi, RT; Koh, JT; Choi, HS				Jeong, Byung-Chul; Lee, Yong-Soo; Park, Yun-Yong; Bae, In-Ho; Kim, Don-Kyu; Koo, Seung-Hoi; Choi, Hong-Ran; Kim, Sun-Hun; Franceschi, Renny T.; Koh, Jeong-Tae; Choi, Hueng-Sik			The Orphan Nuclear Receptor Estrogen Receptor-related Receptor gamma Negatively Regulates BMP2-induced Osteoblast Differentiation and Bone Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORMATION IN-VITRO; ALPHA ERR-ALPHA; GENE-EXPRESSION; TRANSCRIPTIONAL COACTIVATOR; MORPHOGENETIC PROTEIN-2; OSTEOCALCIN GENE; CELL-LINE; RUNX2; INTERACTS; PROMOTER	Estrogen receptor-related receptor gamma(ERR gamma/ERR3/NR3B3) is a member of the orphan nuclear receptor with important functions in development and homeostasis. Recently it has been reported that ERR alpha is involved in osteoblast differentiation and bone formation. In the present study we examined the role of ERR gamma in osteoblast differentiation. Here, we showed that ERR gamma is expressed in osteoblast progenitors and primary osteoblasts, and its expression is increased temporarily by BMP2. Overexpression of ERR gamma reduced BMP2-induced alkaline phosphatase activity and osteocalcin production as well as calcified nodule formation, whereas inhibition of ERR gamma expression significantly enhanced BMP2-induced osteogenic differentiation and mineralization, suggesting that endogenous ERR gamma plays an important role in osteoblast differentiation. In addition, ERR gamma significantly repressed Runx2 transactivity on osteocalcin and bone sialoprotein promoters. We also observed that ERR gamma physically interacts with Runx2 in vitro and in vivo and competes with p300 to repress Runx2 transactivity. Notably, intramuscular injection of ERR gamma strongly inhibited BMP2-induced ectopic bone formation in a dose-dependent manner. Taken together, these results suggest that ERR gamma is a novel negative regulator of osteoblast differentiation and bone formation via its regulation of Runx2 transactivity.	[Koh, Jeong-Tae] Chonnam Natl Univ, Sch Dent, Dept Pharmacol & Dent Therapeut, Dent Sci Res Inst, Kwangju 500757, South Korea; [Lee, Yong-Soo; Park, Yun-Yong; Kim, Don-Kyu; Choi, Hueng-Sik] Chonnam Natl Univ, Sch Biol Sci & Technol, Hormone Res Ctr, Kwangju 500757, South Korea; [Koo, Seung-Hoi] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon 440746, Gyeonggi Do, South Korea; [Franceschi, Renny T.] Univ Michigan, Sch Dent, Dept Periodont & Oral Med, Ann Arbor, MI 48109 USA	Chonnam National University; Chonnam National University; Sungkyunkwan University (SKKU); University of Michigan System; University of Michigan	Koh, JT (corresponding author), Chonnam Natl Univ, Sch Dent, Dept Pharmacol & Dent Therapeut, Dent Sci Res Inst, Kwangju 500757, South Korea.	jtkoh@chonnam.ac.kr; hsc@chonnam.ac.kr	Koo, Seung-Hoi/E-2763-2015; Lee, Yong-Soo/AAI-7059-2020	Koo, Seung-Hoi/0000-0001-8769-2879; 	National Research Laboratory [M1-05004705J-4710]; Korean Government Ministry of Education and Human Resource Development [KRF-2007-313-E00469]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE013386] Funding Source: NIH RePORTER	National Research Laboratory(Korea Science and Engineering Foundation); Korean Government Ministry of Education and Human Resource Development(Ministry of Education & Human Resources Development (MOEHRD), Republic of KoreaKorean Government); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by National Research Laboratory Grant M1-05004705J-4710 (to H.-S.C.) and the Korea Research Foundation Grant, funded in part by Korean Government Ministry of Education and Human Resource Development Grant KRF-2007-313-E00469 (to J.-T.K.).	Bonnelye E, 2002, J BONE MINER RES, V17, P1392, DOI 10.1359/jbmr.2002.17.8.1392; Bonnelye E, 2001, J CELL BIOL, V153, P971, DOI 10.1083/jcb.153.5.971; Chen D, 1998, J CELL BIOL, V142, P295, DOI 10.1083/jcb.142.1.295; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Ducy P, 2000, DEV DYNAM, V219, P461, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1074>3.0.CO;2-C; Giguere V, 2002, TRENDS ENDOCRIN MET, V13, P220, DOI 10.1016/S1043-2760(02)00592-1; Hruska KA, 2005, CIRC RES, V97, P105, DOI 10.1161/01.RES.00000175571.53833.6c; Huppunen J, 2004, MOL CELL ENDOCRINOL, V219, P151, DOI 10.1016/j.mce.2004.01.002; Javed A, 2000, J CELL SCI, V113, P2221; Koh JT, 2008, J DENT RES, V87, P845, DOI 10.1177/154405910808700906; Koh JT, 2006, MOL THER, V14, P684, DOI 10.1016/j.ymthe.2006.05.021; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Lammi J, 2004, MOL ENDOCRINOL, V18, P1546, DOI 10.1210/me.2003-0247; Lee KS, 2000, MOL CELL BIOL, V20, P8783, DOI 10.1128/MCB.20.23.8783-8792.2000; Lee MK, 2006, J CELL BIOCHEM, V99, P986, DOI 10.1002/jcb.20990; Makita N, 2008, GENE, V413, P8, DOI 10.1016/j.gene.2007.12.025; McLarren KW, 2000, J BIOL CHEM, V275, P530, DOI 10.1074/jbc.275.1.530; Miyama K, 1999, DEV BIOL, V208, P123, DOI 10.1006/dbio.1998.9197; Mundy G, 1999, SCIENCE, V286, P1946, DOI 10.1126/science.286.5446.1946; Olsen BR, 2000, ANNU REV CELL DEV BI, V16, P191, DOI 10.1146/annurev.cellbio.16.1.191; Park YY, 2005, NUCLEIC ACIDS RES, V33, P6756, DOI 10.1093/nar/gki976; Phimphilai M, 2006, J BONE MINER RES, V21, P637, DOI 10.1359/JBMR.060109; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Puleo DA, 1997, J CELL PHYSIOL, V173, P93, DOI 10.1002/(SICI)1097-4652(199710)173:1<93::AID-JCP11>3.0.CO;2-O; Roca H, 2005, J BIOL CHEM, V280, P30845, DOI 10.1074/jbc.M503942200; Sanyal S, 2002, J BIOL CHEM, V277, P1739, DOI 10.1074/jbc.M106140200; Schroeder TM, 2004, J BIOL CHEM, V279, P41998, DOI 10.1074/jbc.M403702200; Shafritz AB, 1998, CLIN ORTHOP RELAT R, P46; Sierra J, 2003, MOL CELL BIOL, V23, P3339, DOI 10.1128/MCB.23.9.3339-3351.2003; Thomas DM, 2001, MOL CELL, V8, P303, DOI 10.1016/S1097-2765(01)00327-6; Westendorf JJ, 2002, MOL CELL BIOL, V22, P7982, DOI 10.1128/MCB.22.22.7982-7992.2002; WOZNEY JM, 1988, SCIENCE, V242, P1528, DOI 10.1126/science.3201241; Yagi R, 1999, EMBO J, V18, P2551, DOI 10.1093/emboj/18.9.2551; Yoshida CA, 2002, NAT GENET, V32, P633, DOI 10.1038/ng1015; Yoshida Y, 2000, CELL, V103, P1085, DOI 10.1016/S0092-8674(00)00211-7; Zirngibl RA, 2008, J MOL ENDOCRINOL, V40, P61, DOI 10.1677/JME-07-0114	36	39	40	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14211	14218		10.1074/jbc.M808345200	http://dx.doi.org/10.1074/jbc.M808345200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19324883	hybrid, Green Published			2022-12-27	WOS:000266286100027
J	Topping, RP; Wilkinson, JC; Scarpinato, KD				Topping, Ryan P.; Wilkinson, John C.; Scarpinato, Karin Drotschmann			Mismatch Repair Protein Deficiency Compromises Cisplatin-induced Apoptotic Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-DAMAGE; MICROSATELLITE INSTABILITY; METHYLATING AGENTS; CASPASE ACTIVATION; G(2) CHECKPOINT; OVARIAN-CANCER; MUTS HOMOLOGS; TUMOR-CELLS; RESISTANCE; EXPRESSION	Mismatch repair (MMR) proteins participate in cytotoxicity induced by certain DNA damage-inducing agents, including cisplatin (cis-diamminedichloroplatinum(II), CDDP), a cancer chemotherapeutic drug utilized clinically to treat a variety of malignancies. MMR proteins have been demonstrated to bind to CDDP-DNA adducts and initiate MMR protein-dependent cell death in cells treated with CDDP; however, the molecular events underlying this death remain unclear. As MMR proteins have been suggested to be important in clinical responses to CDDP, a clear understanding of MMR protein-dependent, CDDP-induced cell death is critical. In this report, we demonstrate MMR protein-dependent relocalization of cytochrome c to the cytoplasm and cleavage of caspase-9, caspase-3, and poly(ADP-ribose) polymerase upon treatment of cells with CDDP. Chemical inhibition of caspases specifically attenuates CDDP/MMR protein-dependent cytotoxicity, suggesting that a caspase-dependent signaling mechanism is required for the execution of this cell death. p53 protein levels were up-regulated independently of MMR protein status, suggesting that p53 is not a mediator of MMR-dependent, CDDP-induced death. This work is the first indication of a required signaling mechanism in CDDP-induced, MMR protein-dependent cytotoxicity, which can be uncoupled from other CDDP response pathways, and defines a critical contribution of MMR proteins to the control of cell death.	[Topping, Ryan P.; Scarpinato, Karin Drotschmann] Wake Forest Univ, Bowman Gray Sch Med, Dept Canc Biol, Winston Salem, NC 27157 USA; [Wilkinson, John C.] Wake Forest Univ, Bowman Gray Sch Med, Dept Biochem, Winston Salem, NC 27157 USA; [Scarpinato, Karin Drotschmann] Wake Forest Univ, Bowman Gray Sch Med, Ctr Comprehens Canc, Winston Salem, NC 27157 USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center	Scarpinato, KD (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Canc Biol, Med Ctr Blvd, Winston Salem, NC 27157 USA.	kscarpin@wfubmc.edu			National Institutes of Health [CA101829]; Comprehensive Cancer Center at Wake Forest University School of Medicine; Dept. of Defense Prostate Cancer Research Program [W81XWH-08-1-0045]; NATIONAL CANCER INSTITUTE [R01CA101829] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Comprehensive Cancer Center at Wake Forest University School of Medicine; Dept. of Defense Prostate Cancer Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA101829 from NCI (to K. D. S.). This work was also supported by the Comprehensive Cancer Center at Wake Forest University School of Medicine and a "Golfers against Cancer" grant (to K. D. S.) and by Grant W81XWH-08-1-0045 from the Dept. of Defense Prostate Cancer Research Program (to J.C.W.).	Aebi S, 1997, CLIN CANCER RES, V3, P1763; Avdievich E, 2008, P NATL ACAD SCI USA, V105, P4247, DOI 10.1073/pnas.0800276105; Bhalla KN, 2003, ONCOGENE, V22, P9075, DOI 10.1038/sj.onc.1207233; Boatright KM, 2003, MOL CELL, V11, P529, DOI 10.1016/S1097-2765(03)00051-0; Cain K, 1999, J BIOL CHEM, V274, P22686, DOI 10.1074/jbc.274.32.22686; Clodfelter JE, 2005, NUCLEIC ACIDS RES, V33, P3323, DOI 10.1093/nar/gki646; Cryns V, 1998, GENE DEV, V12, P1551, DOI 10.1101/gad.12.11.1551; Drotschmann K, 2004, DNA REPAIR, V3, P729, DOI 10.1016/j.dnarep.2004.02.011; Duckett DR, 1996, P NATL ACAD SCI USA, V93, P6443, DOI 10.1073/pnas.93.13.6443; Fink D, 1996, CANCER RES, V56, P4881; Gong JG, 1999, NATURE, V399, P806; Hickman MJ, 2004, MOL CELL, V14, P105, DOI 10.1016/S1097-2765(04)00162-5; Hirose Y, 2003, MOL CELL BIOL, V23, P8306, DOI 10.1128/MCB.23.22.8306-8315.2003; Hou YZ, 2007, J BIOL CHEM, V282, P9279, DOI 10.1074/jbc.M608523200; Kishi K, 2003, CLIN CANCER RES, V9, P4368; KOI M, 1994, CANCER RES, V54, P4308; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Li LS, 2008, J BIOL CHEM, V283, P21394, DOI 10.1074/jbc.M709954200; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Lin DP, 2004, CANCER RES, V64, P517, DOI 10.1158/0008-5472.CAN-03-2957; Mayer F, 2002, CANCER RES, V62, P2758; Nehme A, 1997, CANCER RES, V57, P3253; Pani E, 2007, CELL CYCLE, V6, P1796, DOI 10.4161/cc.6.14.4472; Papouli E, 2004, CANCER RES, V64, P3391, DOI 10.1158/0008-5472.CAN-04-0513; Peltomaki P, 2003, J CLIN ONCOL, V21, P1174, DOI 10.1200/JCO.2003.04.060; Reed JC, 1998, ONCOGENE, V17, P3225, DOI 10.1038/sj.onc.1202591; Risinger JI, 1996, NAT GENET, V14, P102, DOI 10.1038/ng0996-102; Salsbury FR, 2006, NUCLEIC ACIDS RES, V34, P2173, DOI 10.1093/nar/gkl238; Samimi G, 2000, CLIN CANCER RES, V6, P1415; Sartorius UA, 2002, INT J CANCER, V97, P584, DOI 10.1002/ijc.10096; Scartozzi M, 2006, LUNG CANCER, V53, P103, DOI 10.1016/j.lungcan.2006.03.008; Sedletska Y, 2007, J MOL BIOL, V369, P27, DOI 10.1016/j.jmb.2007.02.048; Stojic L, 2004, DNA REPAIR, V3, P1091, DOI 10.1016/j.dnarep.2004.06.006; Stojic L, 2004, GENE DEV, V18, P1331, DOI 10.1101/gad.294404; Tai YT, 1998, J CLIN ONCOL, V16, P2583, DOI 10.1200/JCO.1998.16.8.2583; Umar A, 1998, GENETICS, V148, P1637; Umar A, 1997, CANCER RES, V57, P3949; Vaisman A, 1998, CANCER RES, V58, P3579; Velasco A, 2008, INT J CANCER, V122, P1774, DOI 10.1002/ijc.23291; Williams J, 2005, GYNECOL ONCOL, V96, P287, DOI 10.1016/j.ygyno.2004.10.026; Yang GZ, 2004, CANCER CELL, V6, P139, DOI 10.1016/j.ccr.2004.06.024; Youn CK, 2005, NAT CELL BIOL, V7, P137, DOI 10.1038/ncb1215	42	52	56	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14029	14039		10.1074/jbc.M809303200	http://dx.doi.org/10.1074/jbc.M809303200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19286655	hybrid, Green Published			2022-12-27	WOS:000266286100009
J	Boumechache, M; Masin, M; Edwardson, JM; Gorecki, DC; Murrell-Lagnado, R				Boumechache, Miyyada; Masin, Marianela; Edwardson, J. Michael; Gorecki, Dariusz C.; Murrell-Lagnado, Ruth			Analysis of Assembly and Trafficking of Native P2X4 and P2X7 Receptor Complexes in Rodent Immune Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							P2X(4) RECEPTORS; PORE PROPERTIES; SUBUNITS; CHANNEL; ACTIVATION; TRIMERS; STATE; FORM	P2X4 and P2X7 are the predominant P2X receptor subtypes expressed in immune cells. Having previously shown a structural and functional interaction between the two recombinant receptors, our aims here were to identify the preferred assembly pathway of the endogenous receptors in macrophage-like cells and to investigate the trafficking of these receptors between the plasma membrane and intracellular sites. We exploited the difference in size between the two subunits, and we used a combination of cross-linkers and blue native-PAGE analysis to investigate the subunit composition of complexes present in primary cultures of rat microglia and macrophages from wild type and P2X7(-/-) mice. Our results indicate that the preferred assembly pathway for both receptors is the formation of homotrimers. Homotrimers of P2X7 were able to co-immunoprecipitate with P2X4, suggesting that an interaction occurs between rather than within receptor complexes. In both macrophages and microglia, P2X7 receptors were predominantly at the cell surface, whereas P2X4 receptors were predominantly intracellular. There were clear cell type-dependent differences in the extent to which P2X4 receptors trafficked to and from the surface; trafficking was much more dynamic in microglia than in the macrophages, and further activation of cultured microglia with relatively short (3-h) incubations with lipopolysaccharide caused an similar to 4-fold increase in the fraction of receptors at the surface with only a 1.2-fold increase in total expression. The redistribution of intracellular receptors is thus an efficient means of enhancing the functional expression of P2X4 at the plasma membrane of microglia.	[Boumechache, Miyyada; Masin, Marianela; Edwardson, J. Michael; Murrell-Lagnado, Ruth] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England; [Gorecki, Dariusz C.] Univ Portsmouth, Sch Pharm & Biomed Sci, Portsmouth PO1 2DT, Hants, England	University of Cambridge; University of Portsmouth	Murrell-Lagnado, R (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Ct Rd, Cambridge CB2 1PD, England.	rdm1003@cam.ac.uk		Gorecki, Dariusz/0000-0003-3584-1654; Murrell-Lagnado, Ruth/0000-0003-2743-7977	Biotechnology and Biological Sciences Research Council [BB/F001320/1]; Interreg IV; BBSRC [BB/F001320/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Interreg IV; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by Biotechnology and Biological Sciences Research Council Grant BB/F001320/1 (to R. M.- L.) and the Interreg IV (AdMiN) (to D. C. G.).	Aschrafi A, 2004, J MOL BIOL, V342, P333, DOI 10.1016/j.jmb.2004.06.092; Barrera NP, 2005, J BIOL CHEM, V280, P10759, DOI 10.1074/jbc.M412265200; Cheewatrakoolpong B, 2005, BIOCHEM BIOPH RES CO, V332, P17, DOI 10.1016/j.bbrc.2005.04.087; Chessell IP, 2005, PAIN, V114, P386, DOI 10.1016/j.pain.2005.01.002; Ding SH, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-17; Fairbairn IP, 2001, J IMMUNOL, V167, P3300, DOI 10.4049/jimmunol.167.6.3300; Fujiwara Y, 2004, J PHYSIOL-LONDON, V558, P31, DOI 10.1113/jphysiol.2004.064568; Guo C, 2007, MOL PHARMACOL, V72, P1447, DOI 10.1124/mol.107.035980; Khakh BS, 2006, NATURE, V442, P527, DOI 10.1038/nature04886; Khakh BS, 2000, NATURE, V406, P405, DOI 10.1038/35019066; Kuehnel MP, 2009, J CELL SCI, V122, P499, DOI 10.1242/jcs.034199; Labasi JM, 2002, J IMMUNOL, V168, P6436, DOI 10.4049/jimmunol.168.12.6436; Lalo U, 2008, J NEUROSCI, V28, P5473, DOI 10.1523/JNEUROSCI.1149-08.2008; Lehnardt S, 2003, P NATL ACAD SCI USA, V100, P8514, DOI 10.1073/pnas.1432609100; LEWIS C, 1995, NATURE, V377, P432, DOI 10.1038/377432a0; Ma WY, 2006, J PHYSIOL-LONDON, V571, P503, DOI 10.1113/jphysiol.2005.103408; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Murrell-Lagnado RD, 2008, MOL MEMBR BIOL, V25, P321, DOI 10.1080/09687680802050385; Nicke A, 1998, EMBO J, V17, P3016, DOI 10.1093/emboj/17.11.3016; Nicke A, 2008, BIOCHEM BIOPH RES CO, V377, P803, DOI 10.1016/j.bbrc.2008.10.042; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Qureshi OS, 2007, J CELL SCI, V120, P3838, DOI 10.1242/jcs.010348; Raouf R, 2007, NEUROPHARMACOLOGY, V53, P496, DOI 10.1016/j.neuropharm.2007.06.010; Surprenant A, 2009, ANNU REV PHYSIOL, V71, P333, DOI 10.1146/annurev.physiol.70.113006.100630; Tsuda M, 2003, NATURE, V424, P778, DOI 10.1038/nature01786	26	98	99	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13446	13454		10.1074/jbc.M901255200	http://dx.doi.org/10.1074/jbc.M901255200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19304656	hybrid, Green Published			2022-12-27	WOS:000265877300020
J	Crose, LES; Hilder, TL; Sciaky, N; Johnson, GL				Crose, Lisa E. S.; Hilder, Thomas L.; Sciaky, Noah; Johnson, Gary L.			Cerebral Cavernous Malformation 2 Protein Promotes Smad Ubiquitin Regulatory Factor 1-mediated RhoA Degradation in Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIGASE; DOMAIN; GTPASES	Mutation of CCM2 predisposes individuals to cerebral cavernous malformations, vascular abnormalities that cause seizures and hemorrhagic stroke. CCM2 has been proposed to regulate the activity of RhoA for maintenance of vascular integrity. Herein, we define a novel mechanism where the CCM2 phosphotyrosine binding (PTB) domain binds the ubiquitin ligase (E3) Smurf1, controlling RhoA degradation. Brain endothelial cells with knockdown of CCM2 have increased RhoA protein and display impaired directed cell migration. CCM2 binding of Smurf1 increases Smurf1-mediated degradation of RhoA. CCM2 does not significantly alter the catalytic activity of Smurf1, nor is CCM2 a Smurf1 substrate. Rather the CCM2-Smurf1 interaction functions to localize Smurf1 for RhoA degradation. These findings provide a molecular mechanism for the pathogenesis of cerebral cavernous malformations (CCM) resulting from loss of CCM2-mediated localization of Smurf1, which controls RhoA degradation required for maintenance of normal endothelial cell physiology.	[Johnson, Gary L.] Univ N Carolina, Sch Med, Dept Pharmacol, Chapel Hill, NC 27599 USA; Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Johnson, GL (corresponding author), Univ N Carolina, Sch Med, Dept Pharmacol, 4016 Genet Med Bldg,Campus Box 7365, Chapel Hill, NC 27599 USA.	glj@med.unc.edu			NIGMS NIH HHS [R01 GM068820] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068820] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Hilder TL, 2007, J PROTEOME RES, V6, P4343, DOI 10.1021/pr0704276; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Liquori CL, 2003, AM J HUM GENET, V73, P1459, DOI 10.1086/380314; Marchuk DA, 2003, HUM MOL GENET, V12, pR97, DOI 10.1093/hmg/ddg103; Plant PJ, 1997, J BIOL CHEM, V272, P32329, DOI 10.1074/jbc.272.51.32329; Plummer Nicholas W, 2005, Curr Neurol Neurosci Rep, V5, P391, DOI 10.1007/s11910-005-0063-7; Smith MJ, 2006, MOL CELL BIOL, V26, P8461, DOI 10.1128/MCB.01491-06; Uhlik MT, 2003, NAT CELL BIOL, V5, P1104, DOI 10.1038/ncb1071; Wang HR, 2006, METHOD ENZYMOL, V406, P437, DOI 10.1016/S0076-6879(06)06032-0; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Whitehead KJ, 2009, NAT MED, V15, P177, DOI 10.1038/nm.1911; Wojciak-Stothard B, 2002, VASC PHARMACOL, V39, P187, DOI 10.1016/S1537-1891(03)00008-9; Yamashita M, 2005, CELL, V121, P101, DOI 10.1016/j.cell.2005.01.035; Zawistowski JS, 2005, HUM MOL GENET, V14, P2521, DOI 10.1093/hmg/ddi256	14	64	66	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13301	13305		10.1074/jbc.C900009200	http://dx.doi.org/10.1074/jbc.C900009200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19318350	hybrid, Green Published			2022-12-27	WOS:000265877300005
J	Kent, T; Kashkina, E; Anikin, M; Temiakov, D				Kent, Tatyana; Kashkina, Ekaterina; Anikin, Michael; Temiakov, Dmitry			Maintenance of RNA-DNA Hybrid Length in Bacterial RNA Polymerases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION ELONGATION; THERMUS-THERMOPHILUS; STRUCTURAL BASIS; LID ELEMENT; MECHANISM; COMPLEX; CONFORMATIONS; PROCESSIVITY; MISALIGNMENT; TERMINATION	During transcription elongation the nascent RNA remains base-paired to the template strand of the DNA before it is displaced and the two strands of the DNA reanneal, resulting in the formation of a transcription "bubble" of similar to 10 bp. To examine how the length of the RNA-DNA hybrid is maintained, we assembled transcription elongation complexes on synthetic nucleic acid scaffolds that mimic the situation in which transcript displacement is compromised and the polymerase synthesizes an extended hybrid. We found that in such complexes bacterial RNA polymerase exhibit an intrinsic endonucleolytic cleavage activity that restores the hybrid to its normal length. Mutations in the region of the RNA polymerase near the site of RNA-DNA separation result in altered RNA displacement and translocation functions and as a consequence in different patterns of proofreading activities. Our data corroborate structural findings concerning the elements involved in the maintenance of the length of the RNA-DNA hybrid and suggest interplay between polymerase translocation, DNA strand separation, and intrinsic endonucleolytic activity.	[Kent, Tatyana; Kashkina, Ekaterina; Anikin, Michael; Temiakov, Dmitry] Univ Med & Dent New Jersey, Sch Osteopath Med, Dept Cell Biol, Stratford, NJ 08084 USA	Rowan University; Rowan University School of Osteopathic Medicine; Rutgers State University New Brunswick; Rutgers State University Medical Center	Temiakov, D (corresponding author), Univ Med & Dent New Jersey, Sch Osteopath Med, Dept Cell Biol, Stratford, NJ 08084 USA.	d.temiakov@umdnj.edu		KENT, Tatiana/0000-0001-8237-0184	National Institutes of Health [GM38147, GM74252]; University of Medicine and Dentistry of New Jersey Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074252, R01GM038147] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Medicine and Dentistry of New Jersey Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM38147 (to W. T. McAllister) and GM74252 (to D. G. Vassylyev).; This work was also supported by the University of Medicine and Dentistry of New Jersey Foundation (to D. T.).	Artsimovitch I, 2003, J BIOL CHEM, V278, P12344, DOI 10.1074/jbc.M211214200; Bar-Nahum G, 2005, CELL, V120, P183, DOI 10.1016/j.cell.2004.11.045; ERIE DA, 1993, SCIENCE, V262, P867, DOI 10.1126/science.8235608; Gusarov I, 1999, MOL CELL, V3, P495, DOI 10.1016/S1097-2765(00)80477-3; Jiang ML, 2004, MOL CELL, V15, P777, DOI 10.1016/j.molcel.2004.07.019; Kashkina E, 2006, MOL CELL, V24, P257, DOI 10.1016/j.molcel.2006.10.001; Kashkina E, 2006, NUCLEIC ACIDS RES, V34, P4036, DOI 10.1093/nar/gkl559; Kashlev M, 2002, J BIOL CHEM, V277, P14501, DOI 10.1074/jbc.M200215200; Kireeva ML, 2000, J MOL BIOL, V299, P325, DOI 10.1006/jmbi.2000.3755; Korzheva N, 2000, SCIENCE, V289, P619, DOI 10.1126/science.289.5479.619; Korzheva N, 1998, COLD SPRING HARB SYM, V63, P337, DOI 10.1101/sqb.1998.63.337; Korzheva N, 2001, CURR OPIN MICROBIOL, V4, P119, DOI 10.1016/S1369-5274(00)00176-4; Kuznedelov K, 2002, EMBO J, V21, P1369, DOI 10.1093/emboj/21.6.1369; Kyzer S, 2007, J BIOL CHEM, V282, P19020, DOI 10.1074/jbc.M701483200; Laptenko O, 2003, METHOD ENZYMOL, V371, P219; Naryshkina T, 2006, J MOL BIOL, V361, P634, DOI 10.1016/j.jmb.2006.05.034; Pomerantz RT, 2006, MOL CELL, V24, P245, DOI 10.1016/j.molcel.2006.08.014; Sidorenkov I, 1998, MOL CELL, V2, P55, DOI 10.1016/S1097-2765(00)80113-6; Temiakov D, 2002, J BIOL CHEM, V277, P47035, DOI 10.1074/jbc.M208923200; Toulokhonov I, 2006, J MOL BIOL, V361, P644, DOI 10.1016/j.jmb.2006.06.071; Vassylyev DG, 2007, NATURE, V448, P157, DOI 10.1038/nature05932; Vassylyeva MN, 2002, ACTA CRYSTALLOGR D, V58, P1497, DOI 10.1107/S0907444902011770; Westover KD, 2004, SCIENCE, V303, P1014, DOI 10.1126/science.1090839; Zenkin N, 2006, NATURE, V439, P617, DOI 10.1038/nature04337; Zenkin N, 2006, SCIENCE, V313, P518, DOI 10.1126/science.1127422	25	18	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13497	13504		10.1074/jbc.M901898200	http://dx.doi.org/10.1074/jbc.M901898200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19321439	hybrid, Green Published			2022-12-27	WOS:000265877300026
J	Lee, EC; Desai, U; Gololobov, G; Hong, S; Feng, X; Yu, XC; Gay, J; Wilganowski, N; Gao, CH; Du, LL; Chen, J; Hu, Y; Zhao, SR; Kirkpatrick, L; Schneider, M; Zambrowicz, BP; Landes, G; Powell, DR; Sonnenburg, WK				Lee, E-Chiang; Desai, Urvi; Gololobov, Gennady; Hong, Seokjoo; Feng, Xiao; Yu, Xuan-Chuan; Gay, Jason; Wilganowski, Nat; Gao, Cuihua; Du, Ling-Ling; Chen, Joan; Hu, Yi; Zhao, Sharon; Kirkpatrick, Laura; Schneider, Matthias; Zambrowicz, Brian P.; Landes, Greg; Powell, David R.; Sonnenburg, William K.			Identification of a New Functional Domain in Angiopoietin-like 3 (ANGPTL3) and Angiopoietin-like 4 (ANGPTL4) Involved in Binding and Inhibition of Lipoprotein Lipase (LPL)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NONFASTING TRIGLYCERIDES; LIPID-METABOLISM; RISK; PROTEIN-3; TISSUE; LOCI	Angiopoietin-like 3 (ANGPTL3) and angiopoietin-like 4 (ANGPTL4) are secreted proteins that regulate triglyceride (TG) metabolism in part by inhibiting lipoprotein lipase (LPL). Recently, we showed that treatment of wild-type mice with monoclonal antibody (mAb) 14D12, specific for ANGPTL4, recapitulated the Angptl4 knock-out (-/-) mouse phenotype of reduced serum TG levels. In the present study, we mapped the region of mouse ANGPTL4 recognized by mAb 14D12 to amino acids Gln(29)-His(53), which we designate as specific epitope 1 (SE1). The 14D12 mAb prevented binding of ANGPTL4 with LPL, consistent with its ability to neutralize the LPL-inhibitory activity of ANGPTL4. Alignment of all angiopoietin family members revealed that a sequence similar to ANGPTL4 SE1 was present only in ANGPTL3, corresponding to amino acids Glu(32)-His(55). We produced a mouse mAb against this SE1-like region in ANGPTL3. This mAb, designated 5.50.3, inhibited the binding of ANGPTL3 to LPL and neutralized ANGPTL3-mediated inhibition of LPL activity in vitro. Treatment of wild-type as well as hyperlipidemic mice with mAb 5.50.3 resulted in reduced serum TG levels, recapitulating the lipid phenotype found in Angptl3(-/-) mice. These results show that the SE1 region of ANGPTL3 and ANGPTL4 functions as a domain important for binding LPL and inhibiting its activity in vitro and in vivo. Moreover, these results demonstrate that therapeutic antibodies that neutralize ANGPTL4 and ANGPTL3 may be useful for treatment of some forms of hyperlipidemia.	[Lee, E-Chiang; Gololobov, Gennady; Hong, Seokjoo; Feng, Xiao; Gao, Cuihua; Du, Ling-Ling; Chen, Joan; Kirkpatrick, Laura; Zambrowicz, Brian P.; Landes, Greg; Powell, David R.; Sonnenburg, William K.] Lexicon Pharmaceut Inc, Dept Biotherapeut, The Woodlands, TX 77381 USA; [Desai, Urvi; Gay, Jason; Wilganowski, Nat; Schneider, Matthias; Zambrowicz, Brian P.; Powell, David R.] Lexicon Pharmaceut Inc, Dept Pharmaceut Biol, The Woodlands, TX 77381 USA; [Yu, Xuan-Chuan; Zambrowicz, Brian P.] Lexicon Pharmaceut Inc, Dept Pharmaceut Discovery, The Woodlands, TX 77381 USA; [Hu, Yi; Zhao, Sharon; Zambrowicz, Brian P.] Lexicon Pharmaceut Inc, Dept Mol Biol, The Woodlands, TX 77381 USA	Lexicon Pharmaceuticals; Lexicon Pharmaceuticals; Lexicon Pharmaceuticals; Lexicon Pharmaceuticals	Lee, EC (corresponding author), Lexicon Pharmaceut Inc, Dept Biotherapeut, The Woodlands, TX 77381 USA.	elee@lexpharma.com; wsonnenburg@lexpharma.com						Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bansal S, 2007, JAMA-J AM MED ASSOC, V298, P309, DOI 10.1001/jama.298.3.309; Bergo M, 1996, BIOCHEM J, V313, P893, DOI 10.1042/bj3130893; Desai U, 2007, P NATL ACAD SCI USA, V104, P11766, DOI 10.1073/pnas.0705041104; Ge HF, 2005, J LIPID RES, V46, P1484, DOI 10.1194/jlr.M500005-JLR200; Ge HF, 2004, J LIPID RES, V45, P2071, DOI 10.1194/jlr.M400138-JLR200; Goldberg IJ, 2001, FRONT BIOSCI-LANDMRK, V6, pD388, DOI 10.2741/Goldberg; Hatsuda S, 2007, J VASC RES, V44, P61, DOI 10.1159/000098153; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Koishi R, 2002, NAT GENET, V30, P151, DOI 10.1038/ng814; Koster A, 2005, ENDOCRINOLOGY, V146, P4943, DOI 10.1210/en.2005-0476; Merkel M, 2002, J LIPID RES, V43, P1997, DOI 10.1194/jlr.R200015-JLR200; *NAT RES COUNC I L, 1996, GUID CAR US LAB AN; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; Ono M, 2003, J BIOL CHEM, V278, P41804, DOI 10.1074/jbc.M302861200; Panteghini M, 2001, ANN CLIN BIOCHEM, V38, P365, DOI 10.1258/0004563011900876; Preiss-Landl K, 2002, CURR OPIN LIPIDOL, V13, P471, DOI 10.1097/00041433-200210000-00002; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Romeo S, 2009, J CLIN INVEST, V119, P70, DOI 10.1172/JCI37118; Shan L, 2009, J BIOL CHEM, V284, P1419, DOI 10.1074/jbc.M808477200; Shimizugawa T, 2002, J BIOL CHEM, V277, P33742, DOI 10.1074/jbc.M203215200; Sukonina V, 2006, P NATL ACAD SCI USA, V103, P17450, DOI 10.1073/pnas.0604026103; Wattler S, 1999, BIOTECHNIQUES, V26, P1150, DOI 10.2144/99266rr02; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Yoshida K, 2002, J LIPID RES, V43, P1770, DOI 10.1194/jlr.C200010-JLR200; ZILVERSMIT DB, 1995, CLIN CHEM, V41, P153	26	123	141	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13735	13745		10.1074/jbc.M807899200	http://dx.doi.org/10.1074/jbc.M807899200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19318355	Green Published, hybrid			2022-12-27	WOS:000265877300051
J	Forster, ML; Mahn, JJ; Tsai, B				Forster, Michele L.; Mahn, James J.; Tsai, Billy			Generating an Unfoldase from Thioredoxin-like Domains	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-DISULFIDE-ISOMERASE; HUMAN PROLYL 4-HYDROXYLASE; TRIGLYCERIDE TRANSFER PROTEIN; CHOLERA-TOXIN; ENDOPLASMIC-RETICULUM; RETRO-TRANSLOCATION; FUNCTIONAL-PROPERTIES; REDUCED RIBONUCLEASE; CATALYTIC-ACTIVITY; STRUCTURAL DOMAIN	Protein-disulfide isomerase (PDI), an endoplasmic reticulum (ER)-resident protein, is primarily known as a catalyst of oxidative protein folding but also has a protein unfolding activity. We showed previously that PDI unfolds the cholera toxin A1 (CTA1) polypeptide to facilitate the ER-to-cytosol retrotranslocation of the toxin during intoxication. We now provide insight into the mechanism of this unfoldase activity. PDI includes two redox-active (a and a') and two redox-inactive (b and b')thioredoxin-like domains, a linker (x), and a C-terminal domain (c) arranged as abb' xa' c. Using recombinant PDI fragments, we show that binding of CTA1 by the continuous PDIbb' xa' fragment is necessary and sufficient to trigger unfolding. The specific linear arrangement of bb' xa' and the type a domain (a' versus a) C-terminal to bb' x are additional determinants of activity. These data suggest a general mechanism for the unfoldase activity of PDI: the concurrent and specific binding of bb' xa' to particular regions along the CTA1 molecule triggers its unfolding. Furthermore, we show the bb' domains of PDI are indispensable to the unfolding reaction, whereas the function of its a' domain can be substituted partially by the a' domain from ERp57 (abb' xa' c) or ERp72 (ca degrees abb' xa'), PDI-like proteins that do not unfold CTA1 normally. However, the bb' domains of PDI were insufficient to convert full-length ERp57 into an unfoldase because the a domain of ERp57 inhibited toxin binding. Thus, we propose that generating an unfoldase from thioredoxin-like domains requires the bb'(x) domains of PDI followed by an a' domain but not preceded by an inhibitory a domain.	[Forster, Michele L.; Mahn, James J.; Tsai, Billy] Univ Michigan, Dept Cell & Dev Biol, Sch Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Tsai, B (corresponding author), 109 Zina Pitcher Pl,3043 BSRB, Ann Arbor, MI 48109 USA.	btsai@umich.edu						Apperizeller-Herzog C, 2008, BBA-MOL CELL RES, V1783, P535, DOI 10.1016/j.bbamcr.2007.11.010; Bernardi KM, 2008, MOL BIOL CELL, V19, P877, DOI 10.1091/mbc.E07-08-0755; Darby NJ, 1999, FEBS LETT, V448, P167, DOI 10.1016/S0014-5793(99)00374-9; DARBY NJ, 1995, BIOCHEMISTRY-US, V34, P11725, DOI 10.1021/bi00037a009; Darby NJ, 1998, J MOL BIOL, V276, P239, DOI 10.1006/jmbi.1997.1504; Darby NJ, 1996, BIOCHEMISTRY-US, V35, P10517, DOI 10.1021/bi960763s; EDMAN JC, 1985, NATURE, V317, P267, DOI 10.1038/317267a0; Ellgaard L, 2005, EMBO REP, V6, P28, DOI 10.1038/sj.embor.7400311; Ferrari DM, 1999, BIOCHEM J, V339, P1, DOI 10.1042/0264-6021:3390001; Forster ML, 2006, J CELL BIOL, V173, P853, DOI 10.1083/jcb.200602046; Frickel EM, 2004, J BIOL CHEM, V279, P18277, DOI 10.1074/jbc.M314089200; Fujinaga Y, 2003, MOL BIOL CELL, V14, P4783, DOI 10.1091/mbc.E03-06-0354; Gilbert J, 2006, J VIROL, V80, P10868, DOI 10.1128/JVI.01117-06; GIVOL D, 1964, J BIOL CHEM, V239, P3114; GOLDBERGER RF, 1964, J BIOL CHEM, V239, P1406; Hazes B, 1997, BIOCHEMISTRY-US, V36, P11051, DOI 10.1021/bi971383p; JOHN DCA, 1993, EMBO J, V12, P1587, DOI 10.1002/j.1460-2075.1993.tb05803.x; Kemmink J, 1996, BIOCHEMISTRY-US, V35, P7684, DOI 10.1021/bi960335m; Kemmink J, 1997, CURR BIOL, V7, P239, DOI 10.1016/S0960-9822(06)00119-9; Klappa P, 1998, EMBO J, V17, P927, DOI 10.1093/emboj/17.4.927; Koivunen P, 2005, J BIOL CHEM, V280, P5227, DOI 10.1074/jbc.M412480200; Koivunen P, 1999, EMBO J, V18, P65, DOI 10.1093/emboj/18.1.65; Kramer B, 2001, BIOCHEM J, V357, P83, DOI 10.1042/0264-6021:3570083; Kulp MS, 2006, J BIOL CHEM, V281, P876, DOI 10.1074/jbc.M511764200; Lamberg A, 1996, BIOCHEM J, V315, P533, DOI 10.1042/bj3150533; Lencer WI, 2003, TRENDS BIOCHEM SCI, V28, P639, DOI 10.1016/j.tibs.2003.10.002; Lencer WI, 2001, AM J PHYSIOL-GASTR L, V280, pG781, DOI 10.1152/ajpgi.2001.280.5.G781; Li SJ, 2006, J BIOL CHEM, V281, P6581, DOI 10.1074/jbc.M508422200; Maattanen P, 2006, BIOCHEM CELL BIOL, V84, P881, DOI 10.1139/O06-186; MEKALANOS JJ, 1979, J BIOL CHEM, V254, P5855; Molinari M, 2002, J CELL BIOL, V158, P247, DOI 10.1083/jcb.200204122; Nguyen VD, 2008, J MOL BIOL, V383, P1144, DOI 10.1016/j.jmb.2008.08.085; Oliver JD, 1997, SCIENCE, V275, P86, DOI 10.1126/science.275.5296.86; Park B, 2006, CELL, V127, P369, DOI 10.1016/j.cell.2006.08.041; PIHLAJANIEMI T, 1987, EMBO J, V6, P643, DOI 10.1002/j.1460-2075.1987.tb04803.x; Pirneskoski A, 2004, J BIOL CHEM, V279, P10374, DOI 10.1074/jbc.M312193200; Pirneskoski A, 2001, J BIOL CHEM, V276, P11287, DOI 10.1074/jbc.M010656200; Rodighiero C, 2002, EMBO REP, V3, P1222, DOI 10.1093/embo-reports/kvf239; Schelhaas M, 2007, CELL, V131, P516, DOI 10.1016/j.cell.2007.09.038; SONG JL, 1995, EUR J BIOCHEM, V231, P312, DOI 10.1111/j.1432-1033.1995.tb20702.x; Tian G, 2006, CELL, V124, P61, DOI 10.1016/j.cell.2005.10.044; Tian G, 2008, J BIOL CHEM, V283, P33630, DOI 10.1074/jbc.M806026200; Tsai B, 2002, NAT REV MOL CELL BIO, V3, P246, DOI 10.1038/nrm780; Tsai B, 2001, CELL, V104, P937, DOI 10.1016/S0092-8674(01)00289-6; Tsai M, 2002, J CELL BIOL, V159, P207, DOI 10.1083/jcb.200207120; VUORI K, 1992, P NATL ACAD SCI USA, V89, P7467, DOI 10.1073/pnas.89.16.7467; VUORI K, 1992, EMBO J, V11, P4213, DOI 10.1002/j.1460-2075.1992.tb05515.x; Wahlman J, 2007, CELL, V129, P943, DOI 10.1016/j.cell.2007.03.046; WANG CC, 1993, FASEB J, V7, P1515, DOI 10.1096/fasebj.7.15.7903263; Wang L, 2009, J BIOL CHEM, V284, P199, DOI 10.1074/jbc.M806645200; WETTERAU JR, 1990, J BIOL CHEM, V265, P9800; WETTERAU JR, 1991, BIOCHEMISTRY-US, V30, P9728, DOI 10.1021/bi00104a023; Winter J, 2002, J BIOL CHEM, V277, P310, DOI 10.1074/jbc.M107832200; ZHANG RG, 1995, J MOL BIOL, V251, P563, DOI 10.1006/jmbi.1995.0456	54	17	17	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					13045	13056		10.1074/jbc.M808352200	http://dx.doi.org/10.1074/jbc.M808352200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19289469	Green Published, hybrid			2022-12-27	WOS:000265688300052
J	Horiuchi, M; Takeuchi, K; Noda, N; Muroya, N; Suzuki, T; Nakamura, T; Kawamura-Tsuzuku, J; Takahasi, K; Yamamoto, T; Inagaki, F				Horiuchi, Masataka; Takeuchi, Kosei; Noda, Nobuo; Muroya, Nobuyuki; Suzuki, Toru; Nakamura, Takahisa; Kawamura-Tsuzuku, Junko; Takahasi, Kiyohiro; Yamamoto, Tadashi; Inagaki, Fuyuhiko			Structural Basis for the Antiproliferative Activity of the Tob-hCaf1 Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-POLYMERASE-I; MESSENGER-RNA; POLY(A)-BINDING PROTEIN; PC3/BTG/TOB FAMILY; CRYSTAL-STRUCTURE; CCR4-NOT COMPLEX; TOB/BTG1 FAMILY; MICE LACKING; TOB; COMPONENT	The Tob/BTG family is a group of antiproliferative proteins containing two highly homologous regions, Box A and Box B. These proteins all associate with CCR4-associated factor 1 (Caf1), which belongs to the ribonuclease D (RNase D) family of deadenylases and is a component of the CCR4-Not deadenylase complex. Here we determined the crystal structure of the complex of the N-terminal region of Tob and human Caf1 (hCaf1). Tob exhibited a novel fold, whereas hCaf1 most closely resembled the catalytic domain of yeast Pop2 and human poly(A)-specific ribonuclease. Interestingly, the association of hCaf1 was mediated by both Box A and Box B of Tob. Cell growth assays using both wild-type and mutant proteins revealed that deadenylase activity of Caf1 is not critical but complex formation is crucial to cell growth inhibition. Caf1 tethers Tob to the CCR4-Not deadenylase complex, and thereby Tob gathers several factors at its C-terminal region, such as poly(A)-binding proteins, to exert antiproliferative activity.	[Horiuchi, Masataka; Noda, Nobuo; Muroya, Nobuyuki; Takahasi, Kiyohiro; Inagaki, Fuyuhiko] Hokkaido Univ, Dept Biol Struct, Grad Sch Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan; [Takeuchi, Kosei] Niigata Univ, Grad Sch Med & Dent Sci, Div Mol & Cellular Biol, Chuo Ku, Niigata 9518510, Japan; [Suzuki, Toru; Nakamura, Takahisa; Kawamura-Tsuzuku, Junko; Yamamoto, Tadashi] Univ Tokyo, Inst Med Sci, Dept Oncol, Minato Ku, Tokyo 1088639, Japan	Hokkaido University; Niigata University; University of Tokyo	Inagaki, F (corresponding author), Hokkaido Univ, Dept Biol Struct, Grad Sch Pharmaceut Sci, Kita Ku, N12,W6, Sapporo, Hokkaido 0600812, Japan.	finagaki@pharm.hokudai.ac.jp	Takeuchi, Kosei/AAV-3577-2021; Horiuchi, Masataka/D-5491-2012; Noda, Nobuo/P-1397-2015	Takeuchi, Kosei/0000-0001-6397-2243; Noda, Nobuo/0000-0002-6940-8069	Ministry of Education, Culture, Sports, Science, and Technology, Japan;  [15770063]	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	This work was supported by Grant-in-aid for Scientific Research 15770063 and the National Projects on Protein Structural and Functional Analyses and Targeted Proteins Program from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Berthet C, 2004, MOL CELL BIOL, V24, P5808, DOI 10.1128/MCB.24.13.5808-5820.2004; Bianchin C, 2005, RNA, V11, P487, DOI 10.1261/rna.7135305; Bogdan JA, 1998, BIOCHEM J, V336, P471, DOI 10.1042/bj3360471; BRADBURY A, 1991, P NATL ACAD SCI USA, V88, P3353, DOI 10.1073/pnas.88.8.3353; Breyer WA, 2000, NAT STRUCT BIOL, V7, P1125; Buanne P, 2000, GENOMICS, V68, P253, DOI 10.1006/geno.2000.6288; Chen JJ, 2002, EMBO J, V21, P1414, DOI 10.1093/emboj/21.6.1414; Daugeron MC, 2001, NUCLEIC ACIDS RES, V29, P2448, DOI 10.1093/nar/29.12.2448; Denis CL, 2003, PROG NUCLEIC ACID RE, V73, P221, DOI 10.1016/S0079-6603(03)01007-9; DRAPER MP, 1995, MOL CELL BIOL, V15, P3487; ELLIS RE, 1995, GENETICS, V139, P561; Ezzeddine N, 2007, MOL CELL BIOL, V27, P7791, DOI 10.1128/MCB.01254-07; FLETCHER BS, 1991, J BIOL CHEM, V266, P14511; Fukuda M, 1996, J BIOL CHEM, V271, P20024, DOI 10.1074/jbc.271.33.20024; Funakoshi Y, 2007, GENE DEV, V21, P3135, DOI 10.1101/gad.1597707; Goldstrohm AC, 2007, J BIOL CHEM, V282, P109, DOI 10.1074/jbc.M609413200; Guehenneux F, 1997, LEUKEMIA, V11, P370, DOI 10.1038/sj.leu.2400599; Hamdan S, 2002, STRUCTURE, V10, P535, DOI 10.1016/S0969-2126(02)00738-4; Ikematsu N, 1999, ONCOGENE, V18, P7432, DOI 10.1038/sj.onc.1203193; Jonstrup AT, 2007, NUCLEIC ACIDS RES, V35, P3153, DOI 10.1093/nar/gkm178; Kawamura-Tsuzuku J, 2004, ONCOGENE, V23, P6630, DOI 10.1038/sj.onc.1207890; Kiefer JR, 1997, STRUCTURE, V5, P95, DOI 10.1016/S0969-2126(97)00169-X; Lin WJ, 1996, J BIOL CHEM, V271, P15034, DOI 10.1074/jbc.271.25.15034; Maekawa M, 2002, J BIOL CHEM, V277, P37783, DOI 10.1074/jbc.M204506200; Matsuda S, 2001, FEBS LETT, V497, P67, DOI 10.1016/S0014-5793(01)02436-X; Matsuda S, 1996, ONCOGENE, V12, P705; Mauxion F, 2008, EMBO J, V27, P1039, DOI 10.1038/emboj.2008.43; Molin L, 2005, GENE, V358, P73, DOI 10.1016/j.gene.2005.05.023; Morita S, 2000, GENE THER, V7, P1063, DOI 10.1038/sj.gt.3301206; Moser MJ, 1997, NUCLEIC ACIDS RES, V25, P5110, DOI 10.1093/nar/25.24.5110; Nakamura T, 2004, NAT GENET, V36, P528, DOI 10.1038/ng1344; Okochi K, 2005, GENES CELLS, V10, P151, DOI 10.1111/j.1365-2443.2005.00826.x; Onishi M, 1996, EXP HEMATOL, V24, P324; Prevot D, 2001, J BIOL CHEM, V276, P9640, DOI 10.1074/jbc.M008201200; Rouault JP, 1998, J BIOL CHEM, V273, P22563, DOI 10.1074/jbc.273.35.22563; ROUAULT JP, 1992, EMBO J, V11, P1663, DOI 10.1002/j.1460-2075.1992.tb05213.x; Rouault JP, 1996, NAT GENET, V14, P482, DOI 10.1038/ng1296-482; SACHS AB, 1993, CELL, V74, P413, DOI 10.1016/0092-8674(93)80043-E; Sasajima H, 2002, EUR J BIOCHEM, V269, P3596, DOI 10.1046/j.1432-1033.2002.03052.x; Suzuki T, 2002, GENE DEV, V16, P1356, DOI 10.1101/gad.962802; Thore S, 2003, EMBO REP, V4, P1150, DOI 10.1038/sj.embor.7400020; Tirone F, 2001, J CELL PHYSIOL, V187, P155, DOI 10.1002/jcp.1062; Tucker M, 2002, EMBO J, V21, P1427, DOI 10.1093/emboj/21.6.1427; Tucker M, 2001, CELL, V104, P377, DOI 10.1016/S0092-8674(01)00225-2; Tzachanis D, 2001, NAT IMMUNOL, V2, P1174, DOI 10.1038/ni730; Viswanathan P, 2004, J BIOL CHEM, V279, P23988, DOI 10.1074/jbc.M402803200; WEN W, 1995, CELL, V82, P463, DOI 10.1016/0092-8674(95)90435-2; Wu MS, 2005, EMBO J, V24, P4082, DOI 10.1038/sj.emboj.7600869; Yoshida Y, 2000, CELL, V103, P1085, DOI 10.1016/S0092-8674(00)00211-7; Yoshida Y, 1998, ONCOGENE, V16, P2687, DOI 10.1038/sj.onc.1201805; Yoshida Y, 2003, MECH DEVELOP, V120, P629, DOI 10.1016/S0925-4773(03)00020-0; Yoshida Y, 2003, GENE DEV, V17, P1201, DOI 10.1101/gad.1088003; Yoshida Y, 2001, JPN J CANCER RES, V92, P592, DOI 10.1111/j.1349-7006.2001.tb01135.x	53	70	75	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					13244	13255		10.1074/jbc.M809250200	http://dx.doi.org/10.1074/jbc.M809250200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19276069	Green Published, hybrid			2022-12-27	WOS:000265688300071
J	Shanmukhappa, K; Matte, U; Degen, JL; Bezerra, JA				Shanmukhappa, Kumar; Matte, Ursula; Degen, Jay L.; Bezerra, Jorge A.			Plasmin-mediated Proteolysis Is Required for Hepatocyte Growth Factor Activation during Liver Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR SCATTER FACTOR; SERINE-PROTEASE; IN-VITRO; UROKINASE; REGENERATION; RECEPTOR; INJURY; MICE; HGF; HEPSIN	The physiological relevance of the activation of hepatocyte growth factor (Hgf) by the plasminogen (Plg) system of proteases and its contribution to tissue repair are largely undefined. Here, we investigated whether the defective liver repair in mice lacking Plg is due to impaired activation of Hgf. Loss of Plg in vivo suppressed Hgf activation and signaling through its Met tyrosine kinase receptor. Without Plg, hepatocytes were unresponsive to Hgf-induced proliferation and migration, with a more pronounced impairment in hepatocyte movement within the hepatic environment. Most notably, circumventing the defect in proteolytic activation of Hgf by the downstream expression of an activated Met receptor corrected the functional deficits and improved liver repair in Plg-deficient mice. These findings support a fibrinolysis-unrelated role for Plg in modulating cell proliferation and migration by activation of Hgf.	[Shanmukhappa, Kumar; Bezerra, Jorge A.] Cincinnati Childrens Hosp, Med Ctr, Div Pediat Gastroenterol Hepatol & Nutr, Cincinnati, OH 45229 USA; [Degen, Jay L.] Cincinnati Childrens Hosp, Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA; Univ Cincinnati, Coll Med, Cincinnati, OH 45229 USA; [Matte, Ursula] Hosp Clin, BR-90035903 Porto Alegre, RS, Brazil	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Bezerra, JA (corresponding author), Cincinnati Childrens Hosp, Med Ctr, Div Pediat Gastroenterol Hepatol & Nutr, 3333 Burnet Ave, Cincinnati, OH 45229 USA.	jorge.bezerra@cchmc.org	Matte, Ursula/J-4589-2012; Da Silveira Matte umatte, Ursula/U-3912-2019	Da Silveira Matte umatte, Ursula/0000-0003-4977-6662	National Institutes of Health [DK55710, AR049822]; Integrative Morphology Core of the Digestive Health Center [HL085357, DK032512]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085357] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049822] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK055710] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Integrative Morphology Core of the Digestive Health Center; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK55710 (to J.A.B.), AR049822 and HL085357 (to J.L.D.), and DK032512 (Integrative Morphology Core of the Digestive Health Center).	AMICONE L, 1995, GENE, V162, P323, DOI 10.1016/0378-1119(95)00277-D; Bezerra JA, 1999, P NATL ACAD SCI USA, V96, P15143, DOI 10.1073/pnas.96.26.15143; Bezerra JA, 2001, AM J PATHOL, V158, P921, DOI 10.1016/S0002-9440(10)64039-4; Bugge TH, 1996, P NATL ACAD SCI USA, V93, P5899, DOI 10.1073/pnas.93.12.5899; Bugge TH, 1996, CELL, V87, P709, DOI 10.1016/S0092-8674(00)81390-2; Burr AW, 1998, J PATHOL, V185, P298; Currier AR, 2003, AM J PHYSIOL-GASTR L, V284, pG508, DOI 10.1152/ajpgi.00336.2002; GAK E, 1992, FEBS LETT, V311, P17, DOI 10.1016/0014-5793(92)81356-Q; Hattori N, 2004, AM J PATHOL, V164, P1091, DOI 10.1016/S0002-9440(10)63196-3; Herter S, 2005, BIOCHEM J, V390, P125, DOI 10.1042/BJ20041955; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; ISHIKI Y, 1992, HEPATOLOGY, V16, P1227, DOI 10.1016/0270-9139(92)90019-6; Jeffers M, 1996, MOL CELL BIOL, V16, P1115; Kaido T, 1996, BIOCHEM BIOPH RES CO, V218, P1, DOI 10.1006/bbrc.1996.0001; Li ZD, 2007, AM J PHYSIOL-GASTR L, V292, pG639, DOI 10.1152/ajpgi.00292.2006; MARS WM, 1993, AM J PATHOL, V143, P949; MATSUDA Y, 1995, J BIOCHEM-TOKYO, V118, P643, DOI 10.1093/oxfordjournals.jbchem.a124958; Matsumoto K, 1997, CIBA F SYMP, V212, P198; Michalopoulos GK, 1997, SCIENCE, V276, P60, DOI 10.1126/science.276.5309.60; Miyazawa K, 1996, J BIOL CHEM, V271, P3615; Moran P, 2006, J BIOL CHEM, V281, P30439, DOI 10.1074/jbc.M605440200; NALDINI L, 1995, J BIOL CHEM, V270, P603, DOI 10.1074/jbc.270.2.603; NALDINI L, 1992, EMBO J, V11, P4825, DOI 10.1002/j.1460-2075.1992.tb05588.x; Passino MA, 2007, SCIENCE, V315, P1853, DOI 10.1126/science.1137603; PEPPER MS, 1992, J BIOL CHEM, V267, P20493; Ried S, 1999, J BIOL CHEM, V274, P16377, DOI 10.1074/jbc.274.23.16377; Shanmukhappa K, 2005, P NATL ACAD SCI USA, V102, P10182, DOI 10.1073/pnas.0501691102; Shanmukhappa K, 2006, BMC GASTROENTEROL, V6, DOI 10.1186/1471-230X-6-40; Stolz DB, 1997, J CELL PHYSIOL, V170, P57; Webb CP, 2000, CANCER RES, V60, P342; Yu IS, 2000, THROMB HAEMOSTASIS, V84, P865, DOI 10.1055/s-0037-1614129	31	29	32	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12917	12923		10.1074/jbc.M807313200	http://dx.doi.org/10.1074/jbc.M807313200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19286661	hybrid, Green Published			2022-12-27	WOS:000265688300037
J	Venkatakrishnan, P; Nakayasu, ES; Almeida, IC; Miller, RT				Venkatakrishnan, Priya; Nakayasu, Ernesto S.; Almeida, Igor C.; Miller, R. Timothy			Absence of Nitric-oxide Synthase in Sequentially Purified Rat Liver Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AORTIC ENDOTHELIAL-CELLS; RELAXING FACTOR; HYDROGEN-PEROXIDE; ESCHERICHIA-COLI; SKELETAL-MUSCLE; SMOOTH-MUSCLE; L-ARGININE; NO; PEROXYNITRITE; RESPIRATION	Data, both for and against the presence of a mitochondrial nitric-oxide synthase (NOS) isoform, is in the refereed literature. However, irrefutable evidence has not been forthcoming. In light of this controversy, we designed studies to investigate the existence of the putative mitochondrial NOS. Using repeated differential centrifugation followed by Percoll gradient fractionation, ultrapure, never frozen rat liver mitochondria and submitochondrial particles were obtained. Following trypsin digestion and desalting, the mitochondrial samples were analyzed by nano-HPLC-coupled linear ion trap-mass spectrometry. Linear ion trap-mass spectrometry analyses of rat liver mitochondria as well as submitochondrial particles were negative for any peptide from any NOS isoform. However, recombinant neuronal NOS-derived peptides from spiked mitochondrial samples were easily detected, down to 50 fmol on column. The protein calmodulin (CaM), absolutely required for NOS activity, was absent, whereas peptides from CaM-spiked samples were detected. Also, L-[C-14] arginine to L-[C-14] citrulline conversion assays were negative for NOS activity. Finally, Western blot analyses of rat liver mitochondria, using NOS(neuronal or endothelial) and CaM antibodies, were negative for any NOS isoform or CaM. In conclusion, and in light of our present limits of detection, data from carefully conducted, properly controlled experiments for NOS detection, utilizing three independent yet complementary methodologies, independently as well as collectively, refute the claim that a NOS isoform exists within rat liver mitochondria.	[Venkatakrishnan, Priya; Nakayasu, Ernesto S.; Almeida, Igor C.; Miller, R. Timothy] Univ Texas El Paso, Dept Biol Sci, El Paso, TX 79968 USA	University of Texas System; University of Texas El Paso	Miller, RT (corresponding author), 500 W Univ Ave, El Paso, TX 79968 USA.	tmiller2@utep.edu	Nakayasu, Ernesto S./AAJ-8374-2020; Almeida, Igor C./AAF-9409-2019	Nakayasu, Ernesto S./0000-0002-4056-2695; Almeida, Igor C./0000-0002-2443-8213	NIEHS [ES 011982]; NCRR [5G12RR008124]; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR008124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES011982] Funding Source: NIH RePORTER	NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Grant ES 011982 (to R. T. M.) from NIEHS and by Grant 5G12RR008124 from NCRR to the Border Biomedical Research Center, University of Texas, El Paso.	Bates TE, 1996, BIOCHEM BIOPH RES CO, V218, P40, DOI 10.1006/bbrc.1996.0008; BATES TE, 1995, BIOCHEM BIOPH RES CO, V213, P896, DOI 10.1006/bbrc.1995.2213; BOVERIS A, 1975, FEBS LETT, V54, P311, DOI 10.1016/0014-5793(75)80928-8; BOVERIS A, 1972, BIOCHEM J, V128, P617, DOI 10.1042/bj1280617; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brookes PS, 2004, MITOCHONDRION, V3, P187, DOI 10.1016/j.mito.2003.10.001; BROWN GC, 1995, NEUROSCI LETT, V193, P201, DOI 10.1016/0304-3940(95)11703-Y; Brown MR, 2006, J BIOL CHEM, V281, P11658, DOI 10.1074/jbc.M510303200; Cadenas E, 2000, FREE RADICAL RES, V33, P747, DOI 10.1080/10715760000301271; CLEETER MWJ, 1994, FEBS LETT, V345, P50, DOI 10.1016/0014-5793(94)00424-2; DIONISI O, 1975, BIOCHIM BIOPHYS ACTA, V403, P292, DOI 10.1016/0005-2744(75)90059-5; EBEL RE, 1975, FEBS LETT, V55, P198, DOI 10.1016/0014-5793(75)80991-4; Elfering SL, 2002, J BIOL CHEM, V277, P38079, DOI 10.1074/jbc.M205256200; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; FORSTERMANN U, 1991, P NATL ACAD SCI USA, V88, P1788, DOI 10.1073/pnas.88.5.1788; Frandsen U, 1996, BIOCHEM BIOPH RES CO, V227, P88, DOI 10.1006/bbrc.1996.1472; FURCHGOTT RF, 1989, FASEB J, V3, P2007, DOI 10.1096/fasebj.3.9.2545495; Ghafourifar P, 2005, METHOD ENZYMOL, V396, P424, DOI 10.1016/S0076-6879(05)96036-9; Ghafourifar P, 2002, METHOD ENZYMOL, V359, P339; Ghafourifar P, 1997, FEBS LETT, V418, P291, DOI 10.1016/S0014-5793(97)01397-5; Giulivi C, 2003, FREE RADICAL BIO MED, V34, P397, DOI 10.1016/S0891-5849(02)01298-4; Giulivi C, 1998, J BIOL CHEM, V273, P11038, DOI 10.1074/jbc.273.18.11038; HIBBS JB, 1988, BIOCHEM BIOPH RES CO, V157, P87, DOI 10.1016/S0006-291X(88)80015-9; Hotta Y, 1999, EUR J PHARMACOL, V380, P37, DOI 10.1016/S0014-2999(99)00531-2; HUIE RE, 1993, FREE RADICAL RES COM, V18, P195, DOI 10.3109/10715769309145868; IGNARRO LJ, 1988, J PHARMACOL EXP THER, V246, P218; IGNARRO LJ, 1989, FASEB J, V3, P31, DOI 10.1096/fasebj.3.1.2642868; Jachymova M, 2005, P NATL ACAD SCI USA, V102, P15833, DOI 10.1073/pnas.0506522102; Jurado JD, 2007, TOXICON, V49, P339, DOI 10.1016/j.toxicon.2006.10.004; Kanai A, 2004, AM J PHYSIOL-HEART C, V286, pH13, DOI 10.1152/ajpheart.00737.2003; Kanai AJ, 2001, P NATL ACAD SCI USA, V98, P14126, DOI 10.1073/pnas.241380298; Kennedy MC, 1997, J BIOL CHEM, V272, P20340, DOI 10.1074/jbc.272.33.20340; KNOWLES RG, 1989, P NATL ACAD SCI USA, V86, P5159, DOI 10.1073/pnas.86.13.5159; KOBZIK L, 1995, BIOCHEM BIOPH RES CO, V211, P375, DOI 10.1006/bbrc.1995.1824; Lacza Z, 2006, NITRIC OXIDE-BIOL CH, V14, P162, DOI 10.1016/j.niox.2005.05.011; Lacza Z, 2004, J NEUROCHEM, V90, P942, DOI 10.1111/j.1471-4159.2004.02553.x; Lacza Z, 2003, FREE RADICAL BIO MED, V35, P1217, DOI 10.1016/S0891-5849(03)00510-0; Lacza Z, 2001, FREE RADICAL BIO MED, V31, P1609, DOI 10.1016/S0891-5849(01)00754-7; Lopez-Figueroa MO, 2000, BIOCHEM BIOPH RES CO, V272, P129, DOI 10.1006/bbrc.2000.2748; Lopez-Figueroa MO, 2002, METHOD ENZYMOL, V352, P296; MALINSKI T, 1993, BIOCHEM BIOPH RES CO, V193, P1076, DOI 10.1006/bbrc.1993.1735; Martasek P, 1996, BIOCHEM BIOPH RES CO, V219, P359, DOI 10.1006/bbrc.1996.0238; Miller RT, 2002, CHEM RES TOXICOL, V15, P927, DOI 10.1021/tx020016y; Moncada S, 2000, Verh K Acad Geneeskd Belg, V62, P171; MURAD F, 1992, JPN J PHARM S2, V58, P150; NARAYANAN K, 1994, J MED CHEM, V37, P885, DOI 10.1021/jm00033a004; NATHAN C, 1992, FASEB J, V6, P3051, DOI 10.1096/fasebj.6.12.1381691; Nishimura JS, 1999, J BIOL CHEM, V274, P5399, DOI 10.1074/jbc.274.9.5399; PERTOFT H, 1978, ANAL BIOCHEM, V88, P271, DOI 10.1016/0003-2697(78)90419-0; POLLOCK JS, 1991, P NATL ACAD SCI USA, V88, P10480, DOI 10.1073/pnas.88.23.10480; Radi R, 2002, BIOL CHEM, V383, P401, DOI 10.1515/BC.2002.044; RADI R, 1994, ARCH BIOCHEM BIOPHYS, V308, P89, DOI 10.1006/abbi.1994.1013; REINHART PH, 1982, BIOCHEM J, V204, P731, DOI 10.1042/bj2040731; Rodrigues ML, 2008, EUKARYOT CELL, V7, P58, DOI 10.1128/EC.00370-07; ROMAN LJ, 1995, P NATL ACAD SCI USA, V92, P8428, DOI 10.1073/pnas.92.18.8428; Schild L, 2003, FASEB J, V17, P2194, DOI 10.1096/fj.02-1170com; SCHMIDT K, 1994, BIOCHEM J, V301, P645, DOI 10.1042/bj3010645; SHETA EA, 1994, J BIOL CHEM, V269, P15147; SHIN WS, 1992, J BIOL CHEM, V267, P20377; Stone Kathryn L., 1996, P415, DOI 10.1007/978-1-60327-259-9_71; STUEHR DJ, 1992, ADV ENZYMOL RELAT AR, V65, P287; Tatoyan A, 1998, J BIOL CHEM, V273, P11044, DOI 10.1074/jbc.273.18.11044; Tay YMS, 2004, FREE RADICAL RES, V38, P591, DOI 10.1080/10715760410001694008; Thomas DD, 2003, ANTIOXID REDOX SIGN, V5, P307, DOI 10.1089/152308603322110887; Thomas DD, 2001, P NATL ACAD SCI USA, V98, P355, DOI 10.1073/pnas.98.1.355; Zanella B, 2002, BIOCHEM BIOPH RES CO, V290, P1010, DOI 10.1006/bbrc.2001.6284	66	47	48	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 24	2009	284	30					19843	19855		10.1074/jbc.M109.003301	http://dx.doi.org/10.1074/jbc.M109.003301			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	471ZO	19372221	Green Published, hybrid			2022-12-27	WOS:000268097400011
J	Ragsdale, SW				Ragsdale, Stephen W.			Nickel-based Enzyme Systems	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							METHYL-COENZYME-M; CONTAINING SUPEROXIDE-DISMUTASE; WOOD-LJUNGDAHL PATHWAY; ACTIVE-SITE; CRYSTAL-STRUCTURE; CO DEHYDROGENASE; STRUCTURAL BASIS; M REDUCTASE; ACETYL-COA; METHANE	Of the eight known nickel enzymes, all but glyoxylase I catalyze the use and/or production of gases central to the global carbon, nitrogen, and oxygen cycles. Nickel appears to have been selected for its plasticity in coordination and redox chemistry and is able to cycle through three redox states (1 +, 2 +, 3 +) and to catalyze reactions spanning similar to 1.5 V. This minireview focuses on the catalytic mechanisms of nickel enzymes, with an emphasis on the role(s) of the metal center. The metal centers vary from mononuclear to complex metal clusters and catalyze simple hydrolytic to multistep redox reactions.	Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Ragsdale, SW (corresponding author), Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA.	sragsdal@umich.edu			NIGMS NIH HHS [R01 GM039451] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039451] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Barondeau DP, 2004, BIOCHEMISTRY-US, V43, P8038, DOI 10.1021/bi0496081; Bryngelson P. A., 2007, NICKEL ITS SURPRISIN, P417; Ciurli S., 2007, NICKEL ITS SURPRISIN, P241; Darnault C, 2003, NAT STRUCT BIOL, V10, P271, DOI 10.1038/nsb912; Denkhaus E, 2002, CRIT REV ONCOL HEMAT, V42, P35, DOI 10.1016/S1040-8428(01)00214-1; DIXON NE, 1975, J AM CHEM SOC, V97, P4131, DOI 10.1021/ja00847a045; Doukov TI, 2002, SCIENCE, V298, P567, DOI 10.1126/science.1075843; Doukov TI, 2008, BIOCHEMISTRY-US, V47, P3474, DOI 10.1021/bi702386t; Dupont CL, 2008, ENVIRON MICROBIOL, V10, P1831, DOI 10.1111/j.1462-2920.2008.01604.x; Ermler U, 1997, SCIENCE, V278, P1457, DOI 10.1126/science.278.5342.1457; ERNST FD, 2007, NICKEL ITS SURPRISIN, P545; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; FRIDOVICH I, 2008, REDOX BIOCH, P55; Garcin E, 1999, STRUCT FOLD DES, V7, P557, DOI 10.1016/S0969-2126(99)80072-0; Gebler A, 2007, FEBS J, V274, P74, DOI 10.1111/j.1742-4658.2006.05565.x; Goubeaud M, 1997, EUR J BIOCHEM, V243, P110, DOI 10.1111/j.1432-1033.1997.00110.x; Graham D.E., 2007, NICKEL ITS SURPRISIN, P357; Ha SW, 2007, J BIOL CHEM, V282, P10639, DOI 10.1074/jbc.M610641200; Hausinger R.P., 2001, HDB METALLOPROTEINS, P867; He MM, 2000, BIOCHEMISTRY-US, V39, P8719, DOI 10.1021/bi000856g; HOLLIGER C, 1993, J AM CHEM SOC, V115, P5651, DOI 10.1021/ja00066a034; Horng YC, 2001, BIOCHEMISTRY-US, V40, P12875, DOI 10.1021/bi011196y; Jaun B., 2007, NICKEL ITS SURPRISIN, P323; Ju TT, 2006, J MOL BIOL, V363, P823, DOI 10.1016/j.jmb.2006.08.060; Lill SON, 2009, BIOCHEMISTRY-US, V48, P1056, DOI 10.1021/bi801218n; Lubitz W., 2007, NICKEL ITS SURPRISIN, P279; Martin W, 2007, PHILOS T R SOC B, V362, P1887, DOI 10.1098/rstb.2006.1881; Miller AF, 2008, ACCOUNTS CHEM RES, V41, P501, DOI 10.1021/ar700237u; Montet Y, 1997, NAT STRUCT BIOL, V4, P523, DOI 10.1038/nsb0797-523; Nicolet Y, 2000, TRENDS BIOCHEM SCI, V25, P138, DOI 10.1016/S0968-0004(99)01536-4; Nriagu J, 1980, GLOBAL CYCLE NICKEL; Parkin A, 2007, J AM CHEM SOC, V129, P10328, DOI 10.1021/ja073643o; Phillips CM, 2008, BIOCHEMISTRY-US, V47, P1938, DOI 10.1021/bi702006h; Pochapsky TC, 2007, METAL IONS LIFE SCI, P473; QUIROZ S, 2007, NICKEL ITS SURPRISIN, P519; Ragsdale SW, 2008, ANN NY ACAD SCI, V1125, P129, DOI 10.1196/annals.1419.015; Ragsdale SW, 2007, J INORG BIOCHEM, V101, P1657, DOI 10.1016/j.jinorgbio.2007.07.014; Ragsdale SW, 2008, BBA-PROTEINS PROTEOM, V1784, P1873, DOI 10.1016/j.bbapap.2008.08.012; Ragsdale SW, 2003, PORPHYRIN HDB, P205; Rodionov DA, 2006, J BACTERIOL, V188, P317, DOI 10.1128/JB.188.1.317-327.2006; Samuels NM, 2005, BIOCHEMISTRY-US, V44, P14308, DOI 10.1021/bi051176m; Schmidt M, 2008, CHEMBIOCHEM, V9, P2135, DOI 10.1002/cbic.200800017; Seravalli J, 2008, J BIOL CHEM, V283, P8384, DOI 10.1074/jbc.M709470200; SOMERVILLE GA, 2008, REDOX BIOCH, P218; Strous M, 2004, ANNU REV MICROBIOL, V58, P99, DOI 10.1146/annurev.micro.58.030603.123605; Sukdeo N, 2007, NICKEL ITS SURPRISIN, P445; Szilagyi RK, 2004, J AM CHEM SOC, V126, P3018, DOI 10.1021/ja039106v; Vignais PM, 2007, CHEM REV, V107, P4206, DOI 10.1021/cr050196r; Youn HD, 1996, BIOCHEM J, V318, P889, DOI 10.1042/bj3180889; Zelko IN, 2002, FREE RADICAL BIO MED, V33, P337, DOI 10.1016/S0891-5849(02)00905-X	50	230	233	0	73	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18571	18575		10.1074/jbc.R900020200	http://dx.doi.org/10.1074/jbc.R900020200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19363030	Green Published, hybrid			2022-12-27	WOS:000267711500004
J	Guilherme, A; Tesz, GJ; Guntur, KVP; Czech, MP				Guilherme, Adilson; Tesz, Gregory J.; Guntur, Kalyani V. P.; Czech, Michael P.			Tumor Necrosis Factor-alpha Induces Caspase-mediated Cleavage of Peroxisome Proliferator-activated Receptor gamma in Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PPAR-GAMMA; INSULIN-RESISTANCE; 3T3-L1 ADIPOCYTES; ADIPOSE-TISSUE; FATTY-ACIDS; TNF-ALPHA; RXR-ALPHA; EXPRESSION; TRANSCRIPTION; ADIPOGENESIS	The nuclear receptor peroxisome proliferator-activated receptor gamma (PPAR gamma) is a ligand-dependent transcription factor that acts as a primary regulator of adipogenesis and controls adipocyte metabolism and insulin action. Increased expression of tumor necrosis factor (TNF alpha) in adipose tissue of obese subjects potently suppresses the expression of PPAR gamma and attenuates adipocyte functions. Here we show that PPAR gamma is a substrate of caspase-3 and caspase-6 during TNF alpha receptor signaling in adipocytes, and the consequent PPAR gamma cleavage disrupts its nuclear localization. TNF alpha treatment of 3T3-L1 adipocytes decreases full-length PPAR gamma while increasing the level of a 45-kDa immunoreactive PPAR gamma fragment. Specific inhibitors of caspase-3 and caspase-6 attenuate the cleavage of PPAR gamma protein in response to TNF alpha in cultured adipocytes. Incubation of nuclear fractions with recombinant caspase-3 and caspase-6 also generates a 45-kDa PPAR gamma cleavage product. Dispersion of nuclear PPAR gamma to the cytoplasm in response to TNF alpha treatment occurs in parallel with detection of activated caspase-3. We suggest that activation of the caspase cascade by TNF alpha down-regulates PPAR gamma protein and PPAR gamma-mediated metabolic processes in adipose cells.	[Guilherme, Adilson; Tesz, Gregory J.; Guntur, Kalyani V. P.; Czech, Michael P.] Univ Massachusetts, Sch Med, Program Mol Med, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Czech, MP (corresponding author), 373 Plantat St,Suite 100, Worcester, MA 01605 USA.	Michael.Czech@umassmed.edu			National Institutes of Health [DK30898, DK030638]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK030898, R37DK030898] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK30898 and DK030638 (to M. P. C.).	Akiyama TE, 2002, MOL ENDOCRINOL, V16, P707, DOI 10.1210/me.16.4.707; Backes C, 2005, NUCLEIC ACIDS RES, V33, pW208, DOI 10.1093/nar/gki433; Berger J, 2000, MOL CELL ENDOCRINOL, V162, P57, DOI 10.1016/S0303-7207(00)00211-2; Boden G, 1997, DIABETES, V46, P3, DOI 10.2337/diabetes.46.1.3; Budihardjo I, 1999, ANNU REV CELL DEV BI, V15, P269, DOI 10.1146/annurev.cellbio.15.1.269; CHAWLA A, 1994, ENDOCRINOLOGY, V135, P798, DOI 10.1210/en.135.2.798; Chowdhury I, 2008, COMP BIOCHEM PHYS B, V151, P10, DOI 10.1016/j.cbpb.2008.05.010; Christianson JL, 2008, J BIOL CHEM, V283, P2906, DOI 10.1074/jbc.M705656200; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Diradourian C, 2005, BIOCHIMIE, V87, P33, DOI 10.1016/j.biochi.2004.11.010; Farmer SR, 2005, INT J OBESITY, V29, pS13, DOI 10.1038/sj.ijo.0802907; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Floyd ZE, 2002, J BIOL CHEM, V277, P4062, DOI 10.1074/jbc.M108473200; FREIDENBERG GR, 1988, J CLIN INVEST, V82, P1398, DOI 10.1172/JCI113744; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Hauser S, 2000, J BIOL CHEM, V275, P18527, DOI 10.1074/jbc.M001297200; He F, 2008, OBESITY, V16, P1735, DOI 10.1038/oby.2008.269; HOTAMISLIGIL GS, 1994, P NATL ACAD SCI USA, V91, P4854, DOI 10.1073/pnas.91.11.4854; HU ED, 1995, P NATL ACAD SCI USA, V92, P9856, DOI 10.1073/pnas.92.21.9856; Jones JR, 2005, P NATL ACAD SCI USA, V102, P6207, DOI 10.1073/pnas.0306743102; KELLEY DE, 1993, J CLIN INVEST, V92, P91, DOI 10.1172/JCI116603; Kreuz S, 2001, MOL CELL BIOL, V21, P3964, DOI 10.1128/MCB.21.12.3964-3973.2001; Lazar MA, 2005, BIOCHIMIE, V87, P9, DOI 10.1016/j.biochi.2004.10.021; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; MACDOUGALD OA, 1994, J BIOL CHEM, V269, P19041; Medina EA, 2005, ENDOCRINOLOGY, V146, P2726, DOI 10.1210/en.2004-1074; Nisoli E, 2006, CELL DEATH DIFFER, V13, P2154, DOI 10.1038/sj.cdd.4401956; Nordstrom EA, 2005, DIABETES, V54, P1726, DOI 10.2337/diabetes.54.6.1726; Oakes ND, 1997, DIABETES, V46, P2022, DOI 10.2337/diabetes.46.12.2022; Puri V, 2008, ACTA PHYSIOL, V192, P103, DOI 10.1111/j.1748-1716.2007.01786.x; Puri V, 2008, P NATL ACAD SCI USA, V105, P7833, DOI 10.1073/pnas.0802063105; Rosen ED, 2005, PROSTAG LEUKOTR ESS, V73, P31, DOI 10.1016/j.plefa.2005.04.004; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Ruan H, 2002, DIABETES, V51, P1319, DOI 10.2337/diabetes.51.5.1319; Sabatino L, 2005, J BIOL CHEM, V280, P26517, DOI 10.1074/jbc.M502716200; Santomauro ATMG, 1999, DIABETES, V48, P1836, DOI 10.2337/diabetes.48.9.1836; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Shao DL, 1998, NATURE, V396, P377, DOI 10.1038/24634; Sims E A, 1973, Recent Prog Horm Res, V29, P457; Stephens JM, 1997, J BIOL CHEM, V272, P971, DOI 10.1074/jbc.272.2.971; SWICK AG, 1989, NUCLEIC ACIDS RES, V17, P9291, DOI 10.1093/nar/17.22.9291; Tang XQ, 2006, P NATL ACAD SCI USA, V103, P2087, DOI 10.1073/pnas.0507660103; Tang XQ, 2005, J BIOL CHEM, V280, P22523, DOI 10.1074/jbc.M501949200; TONTONOZ P, 1994, NUCLEIC ACIDS RES, V22, P5628, DOI 10.1093/nar/22.25.5628; TONTONOZ P, 1995, MOL CELL BIOL, V15, P351, DOI 10.1128/MCB.15.1.351; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Unger RH, 2002, ANNU REV MED, V53, P319, DOI 10.1146/annurev.med.53.082901.104057; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514; Wilson-Fritch L, 2004, J CLIN INVEST, V114, P1281, DOI 10.1172/JCI200421752; Wilson-Fritch L, 2003, MOL CELL BIOL, V23, P1085, DOI 10.1128/MCB.23.3.1085-1094.2003; Ye JP, 2008, BIOCHEM BIOPH RES CO, V374, P405, DOI 10.1016/j.bbrc.2008.07.068; Zhang B, 1996, MOL ENDOCRINOL, V10, P1457, DOI 10.1210/me.10.11.1457	54	39	42	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					17082	17091		10.1074/jbc.M809042200	http://dx.doi.org/10.1074/jbc.M809042200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19321447	Green Published, hybrid			2022-12-27	WOS:000266962400046
J	Gutman, BL; Niyogi, KK				Gutman, Benjamin L.; Niyogi, Krishna K.			Evidence for Base Excision Repair of Oxidative DNA Damage in Chloroplasts of Arabidopsis thaliana	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI ENDONUCLEASE-VIII; SUBCELLULAR-LOCALIZATION; COMPACTING PROTEIN; SULFITE REDUCTASE; SORTING SIGNALS; GLYCOSYLASE; MUTANTS; HOMOLOG; GENOME; PURIFICATION	Chloroplasts are the sites of photosynthesis in plants, and they contain their own multicopy, requisite genome. Chloroplasts are also major sites for production of reactive oxygen species, which can damage essential components of the chloroplast, including the chloroplast genome. Compared with mitochondria in animals, relatively little is known about the potential to repair oxidative DNA damage in chloroplasts. Here we provide evidence of DNA glycosylase-lyase/endonuclease activity involved in base excision repair of oxidized pyrimidines in chloroplast protein extracts of Arabidopsis thaliana. Three base excision repair components (two endonuclease III homologs and an apurinic/apyrimidinic endonuclease) that might account for this activity were identified by bioinformatics. Transient expression of protein-green fluorescent protein fusions showed that all three are targeted to the chloroplast and co-localized with chloroplast DNA in nucleoids. The glycosylase-lyase/endonuclease activity of one of the endonuclease III homologs, AtNTH2, which had not previously been characterized, was confirmed in vitro. T-DNA insertions in each of these genes were identified, and the physiological and biochemical phenotypes of the single, double, and triple mutants were analyzed. This mutant analysis revealed the presence of a third glycosylase activity and potentially another pathway for repair of oxidative DNA damage in chloroplasts.	[Gutman, Benjamin L.; Niyogi, Krishna K.] Univ Calif Berkeley, Dept Plant & Microbial Sci, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Niyogi, KK (corresponding author), Univ Calif Berkeley, Dept Plant & Microbial Sci, 111 Koshland Hall, Berkeley, CA 94720 USA.	niyogi@nature.berkeley.edu			National Institutes of Health [R01GM071908]; United States Department of Agriculture; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071908] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Agriculture(United States Department of Agriculture (USDA)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM071908 from NIGMS. This work was also supported by the United States Department of Agriculture.	Abdel-Ghany SE, 2005, PLANT CELL, V17, P1233, DOI 10.1105/tpc.104.030452; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; BABIYCHUK E, 1994, P NATL ACAD SCI USA, V91, P3299, DOI 10.1073/pnas.91.8.3299; Bandaru V, 2002, DNA REPAIR, V1, P517, DOI 10.1016/S1568-7864(02)00036-8; Bannai H, 2002, BIOINFORMATICS, V18, P298, DOI 10.1093/bioinformatics/18.2.298; BENSEN RJ, 1987, PLANT PHYSIOL, V84, P1102, DOI 10.1104/pp.84.4.1102; Cadet J, 2000, MUTAT RES-REV MUTAT, V462, P121, DOI 10.1016/S1383-5742(00)00022-3; CERUTTI H, 1992, P NATL ACAD SCI USA, V89, P8068, DOI 10.1073/pnas.89.17.8068; Chi-Ham CL, 2002, PLANT MOL BIOL, V49, P621, DOI 10.1023/A:1015500431421; Chiu WL, 1996, CURR BIOL, V6, P325, DOI 10.1016/S0960-9822(02)00483-9; Cho HS, 2004, PLANT CELL, V16, P2665, DOI 10.1105/tpc.104.024281; Cokol M, 2000, EMBO REP, V1, P411, DOI 10.1093/embo-reports/kvd092; DEMPLE B, 1994, ANNU REV BIOCHEM, V63, P915, DOI 10.1146/annurev.biochem.63.1.915; Dizdaroglu M, 2005, MUTAT RES-FUND MOL M, V591, P45, DOI 10.1016/j.mrfmmm.2005.01.033; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Girard PM, 1997, BIOCHIMIE, V79, P559, DOI 10.1016/S0300-9084(97)82004-4; Hays JB, 2002, DNA REPAIR, V1, P579, DOI 10.1016/S1568-7864(02)00093-9; Hoffman PD, 2004, GENE DEV, V18, P2676, DOI 10.1101/gad.1217204; Huffman JL, 2005, MUTAT RES-FUND MOL M, V577, P55, DOI 10.1016/j.mrfmmm.2005.03.012; Ikeda S, 1998, J BIOL CHEM, V273, P21585, DOI 10.1074/jbc.273.34.21585; Jiang DY, 1997, J BACTERIOL, V179, P3773, DOI 10.1128/jb.179.11.3773-3782.1997; Khakhlova O, 2006, PLANT J, V46, P85, DOI 10.1111/j.1365-313X.2006.02673.x; Kliebenstein DJ, 1998, PLANT PHYSIOL, V118, P637, DOI 10.1104/pp.118.2.637; KLIMYUK VI, 1993, PLANT J, V3, P493, DOI 10.1046/j.1365-313X.1993.t01-26-00999.x; Krokan HE, 1997, BIOCHEM J, V325, P1; Li A, 2002, PLANT CELL, V14, P263, DOI 10.1105/tpc.010258; Murphy TM, 2005, PHYSIOL PLANTARUM, V123, P227, DOI 10.1111/j.1399-3054.2005.00453.x; Murphy TM, 2001, J PHOTOCH PHOTOBIO B, V61, P87, DOI 10.1016/S1011-1344(01)00172-5; Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X; NETRAWALI MS, 1984, ENVIRON EXP BOT, V24, P63, DOI 10.1016/0098-8472(84)90061-3; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Roldan-Arjona T, 2000, PLANT MOL BIOL, V44, P43, DOI 10.1023/A:1006429114451; Saito Y, 1997, J BACTERIOL, V179, P3783, DOI 10.1128/jb.179.11.3783-3785.1997; Sato N, 2001, FEBS LETT, V487, P347, DOI 10.1016/S0014-5793(00)02342-5; Schein AI, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.16.e82; Sessions A, 2002, PLANT CELL, V14, P2985, DOI 10.1105/tpc.004630; Small I, 2004, PROTEOMICS, V4, P1581, DOI 10.1002/pmic.200300776; Stivers JT, 2003, CHEM REV, V103, P2729, DOI 10.1021/cr010219b; Sunderland PA, 2006, PLANT J, V47, P356, DOI 10.1111/j.1365-313X.2006.02791.x; Sung JS, 2006, FEBS J, V273, P1620, DOI 10.1111/j.1742-4658.2006.05192.x; TAIZ L, 1991, PLANT PHYSIOL, P111; Tell G, 2005, ANTIOXID REDOX SIGN, V7, P367, DOI 10.1089/ars.2005.7.367; Weigel D, 2002, ARABIDOPSIS LAB MANU, P217; Yamada K, 2003, SCIENCE, V302, P842, DOI 10.1126/science.1088305	45	42	45	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					17006	17012		10.1074/jbc.M109.008342	http://dx.doi.org/10.1074/jbc.M109.008342			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19372224	hybrid, Green Published			2022-12-27	WOS:000266962400038
J	Li, ZZ; Wang, H; Eyler, CE; Hjeimeiand, AB; Rich, JN				Li, Zhizhong; Wang, Hui; Eyler, Christine E.; Hjeimeiand, Anita B.; Rich, Jeremy N.			Turning Cancer Stem Cells Inside Out: An Exploration of Glioma Stem Cell Signaling Pathways	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							C-MYC; INHIBITS DIFFERENTIATION; VASCULAR NICHE; MOUSE MODEL; EXPRESSION; GROWTH; GLIOBLASTOMA; NOTCH; NEURON; OLIG2	Tumors are complex collections of heterogeneous cells with recruited vasculature, inflammatory cells, and stromal elements. Neoplastic cells frequently display a hierarchy in differentiation status. Recent studies suggest that brain tumors have a limited population of neoplastic cells called cancer stem cells with the capacity for sustained self-renewal and tumor propagation. Brain tumor stem cells contribute to therapeutic resistance and tumor angiogenesis. In this minireview, we summarize recent data regarding critical signaling pathways involved in brain tumor stem cell biology and discuss how targeting these molecules may contribute to the development of novel anti-glioma therapies.	[Li, Zhizhong; Wang, Hui; Eyler, Christine E.] Duke Univ, Med Ctr, Dept Pharmacol & Canc Biol, Durham, NC 27710 USA; [Rich, Jeremy N.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Rich, Jeremy N.] Duke Univ, Med Ctr, Dept Surg, Durham, NC 27710 USA; [Eyler, Christine E.] Duke Univ, Med Ctr, Med Sci Training Program, Durham, NC 27710 USA; [Eyler, Christine E.; Hjeimeiand, Anita B.; Rich, Jeremy N.] Cleveland Clin, Dept Stem Cell Biol & Regenerat Med, Cleveland, OH 44195 USA	Duke University; Duke University; Duke University; Duke University; Cleveland Clinic Foundation		richj@ccf.org	Eyler, Christine E/A-2921-2010; Rich, Jeremy/AAM-1445-2021		National Institutes of Health [CA129958, CA116659, NS054276]; Damon Runyon Cancer Research Foundation; Goldhirsh Foundation; Brain Tumor Society; NATIONAL CANCER INSTITUTE [R01CA129958, R01CA116659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS054276] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation; Goldhirsh Foundation; Brain Tumor Society; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants CA129958, CA116659, and NS054276. This work was also supported by the Damon Runyon Cancer Research Foundation, the Goldhirsh Foundation, and the Brain Tumor Society. This minireview will be reprinted in the 2009 Minireview Compendium, which will be available in January, 2010.	Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Bachoo RM, 2002, CANCER CELL, V1, P269, DOI 10.1016/S1535-6108(02)00046-6; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Bar EE, 2007, STEM CELLS, V25, P2524, DOI 10.1634/stemcells.2007-0166; Batchelor TT, 2007, CANCER CELL, V11, P83, DOI 10.1016/j.ccr.2006.11.021; Bhatia M, 1997, P NATL ACAD SCI USA, V94, P5320, DOI 10.1073/pnas.94.10.5320; Bruggeman SWM, 2007, CANCER CELL, V12, P328, DOI 10.1016/j.ccr.2007.08.032; Calabrese C, 2007, CANCER CELL, V11, P69, DOI 10.1016/j.ccr.2006.11.020; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chiba T, 2008, CANCER RES, V68, P7742, DOI 10.1158/0008-5472.CAN-07-5882; Cho RW, 2008, CURR OPIN GENET DEV, V18, P48, DOI 10.1016/j.gde.2008.01.017; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; Dahmane N, 2001, DEVELOPMENT, V128, P5201; Dirks P, 2007, CANCER CELL, V12, P295, DOI 10.1016/j.ccr.2007.10.003; Du ZH, 2009, GLIA, V57, P724, DOI 10.1002/glia.20800; Eyler CE, 2008, STEM CELLS, V26, P3027, DOI 10.1634/stemcells.2007-1073; Fan X, 2004, CANCER RES, V64, P7787, DOI 10.1158/0008-5472.CAN-04-1446; Fan X, 2006, CANCER RES, V66, P7445, DOI 10.1158/0008-5472.CAN-06-0858; Gaiano N, 2002, ANNU REV NEUROSCI, V25, P471, DOI 10.1146/annurev.neuro.25.030702.130823; Gal H, 2008, BIOCHEM BIOPH RES CO, V376, P86, DOI 10.1016/j.bbrc.2008.08.107; Hallahan AR, 2004, CANCER RES, V64, P7794, DOI 10.1158/0008-5472.CAN-04-1813; Herms JW, 1999, SURG NEUROL, V51, P536, DOI 10.1016/S0090-3019(98)00028-7; Jensen NA, 2003, J BIOL CHEM, V278, P8300, DOI 10.1074/jbc.M211195200; Jordan CT, 2009, CELL STEM CELL, V4, P203, DOI 10.1016/j.stem.2009.02.003; Lee J, 2008, CANCER CELL, V13, P69, DOI 10.1016/j.ccr.2007.12.005; Lee SK, 2005, GENE DEV, V19, P282, DOI 10.1101/gad.1257105; Li L, 2009, NEURO-ONCOLOGY, V11, P9, DOI 10.1215/15228517-2008-081; Ligon KL, 2007, NEURON, V53, P503, DOI 10.1016/j.neuron.2007.01.009; Ligon KL, 2004, J NEUROPATH EXP NEUR, V63, P499, DOI 10.1093/jnen/63.5.499; Llaguno SA, 2009, CANCER CELL, V15, P45, DOI 10.1016/j.ccr.2008.12.006; Lu QR, 2002, CELL, V109, P75, DOI 10.1016/S0092-8674(02)00678-5; Ma S, 2008, ONCOGENE, V27, P1749, DOI 10.1038/sj.onc.1210811; Novitch BG, 2001, NEURON, V31, P773, DOI 10.1016/S0896-6273(01)00407-X; Panchision DM, 2002, CURR OPIN GENET DEV, V12, P478, DOI 10.1016/S0959-437X(02)00329-5; Park Y, 2003, DEV BIOL, V253, P247, DOI 10.1016/S0012-1606(02)00019-2; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Purow BW, 2005, CANCER RES, V65, P2353, DOI 10.1158/0008-5472.CAN-04-1890; Reddi A. Hari, 1997, Cytokine and Growth Factor Reviews, V8, P11, DOI 10.1016/S1359-6101(96)00049-4; Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026; Shih AH, 2006, NEOPLASIA, V8, P1072, DOI 10.1593/neo.06526; Silber J, 2008, BMC MED, V6, DOI 10.1186/1741-7015-6-14; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Soeda A, 2008, J BIOL CHEM, V283, P10958, DOI 10.1074/jbc.M704205200; Solecki DJ, 2001, NEURON, V31, P557, DOI 10.1016/S0896-6273(01)00395-6; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Takebayashi H, 2000, MECH DEVELOP, V99, P143, DOI 10.1016/S0925-4773(00)00466-4; Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025; Vredenburgh JJ, 2007, CLIN CANCER RES, V13, P1253, DOI 10.1158/1078-0432.CCR-06-2309; Wang JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003769; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Zhang XP, 2008, MOL CELL BIOCHEM, V307, P101, DOI 10.1007/s11010-007-9589-0; Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3	54	74	76	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					16705	1609		10.1074/jbc.R900013200	http://dx.doi.org/10.1074/jbc.R900013200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19286664	hybrid, Green Published			2022-12-27	WOS:000266962400004
J	Ludlam, A; Brunzelle, J; Pribyl, T; Xu, XJ; Gatti, DL; Ackerman, SH				Ludlam, Anthony; Brunzelle, Joseph; Pribyl, Thomas; Xu, Xingjue; Gatti, Domenico L.; Ackerman, Sharon H.			Chaperones of F-1-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL F-1-ATPASE; ALPHA-SUBUNIT; BETA-SUBUNIT; YEAST; PROTEIN; IDENTIFICATION; ATP11; ACCUMULATION; F1-ATPASE; FEATURES	Mitochondrial F-1-ATPase contains a hexamer of alternating alpha and beta subunits. The assembly of this structure requires two specialized chaperones, Atp11p and Atp12p, that bind transiently to beta and alpha. In the absence of Atp11p and Atp12p, the hexamer is not formed, and alpha and beta precipitate as large insoluble aggregates. An early model for the mechanism of chaperone-mediated F-1 assembly (Wang, Z. G., Sheluho, D., Gatti, D. L., and Ackerman, S. H. (2000) EMBO J. 19, 1486-1493) hypothesized that the chaperones themselves look very much like the alpha and beta subunits, and proposed an exchange of Atp11p for alpha and of Atp12p for beta; the driving force for the exchange was expected to be a higher affinity of alpha and beta for each other than for the respective chaperone partners. One important feature of this model was the prediction that as long as Atp11p is bound to beta and Atp12p is bound to alpha, the two F-1 subunits cannot interact at either the catalytic site or the noncatalytic site interface. Here we present the structures of Atp11p from Candida glabrata and Atp12p from Paracoccus denitrificans, and we show that some features of the Wang model are correct, namely that binding of the chaperones to alpha and beta prevents further interactions between these F-1 subunits. However, Atp11p and Atp12p do not resemble alpha or beta, and it is instead the F-1 gamma subunit that initiates the release of the chaperones from alpha and beta and their further assembly into the mature complex.	[Ludlam, Anthony; Pribyl, Thomas; Xu, Xingjue; Gatti, Domenico L.; Ackerman, Sharon H.] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA; [Brunzelle, Joseph] Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol & Biol Chem, Life Sci Collaborat Access Team, Chicago, IL 60611 USA	Wayne State University; Northwestern University; Feinberg School of Medicine	Gatti, DL (corresponding author), Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA.	dgatti@med.wayne.edu; sackerm@med.wayne.edu			National Institutes of Health [GM41857, GM69840]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069840] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM41857 ( to S. H. A.) and GM69840 ( to D. L. G.) from USPHS. Author's Choice-Final version full access.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; ACKERMAN SH, 1992, J BIOL CHEM, V267, P7386; ACKERMAN SH, 1990, P NATL ACAD SCI USA, V87, P4986, DOI 10.1073/pnas.87.13.4986; Ackerman Sharon H, 2007, Methods Mol Biol, V372, P363, DOI 10.1007/978-1-59745-365-3_26; Alouf JE, 2003, FOLIA MICROBIOL, V48, P5, DOI 10.1007/BF02931271; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bianchet MA, 1998, P NATL ACAD SCI USA, V95, P11065, DOI 10.1073/pnas.95.19.11065; BOWMAN S, 1991, J BIOL CHEM, V266, P7517; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395; De Meirleir L, 2004, J MED GENET, V41, P120, DOI 10.1136/jmg.2003.012047; DeLano W. L., 2007, PYMOL MOL GRAPHICS S; Gibrat JF, 1996, CURR OPIN STRUC BIOL, V6, P377, DOI 10.1016/S0959-440X(96)80058-3; HILL JE, 1986, YEAST, V2, P163, DOI 10.1002/yea.320020304; Hinton A, 2004, J BIOL CHEM, V279, P9016, DOI 10.1074/jbc.M312631200; Kabaleeswaran V, 2006, EMBO J, V25, P5433, DOI 10.1038/sj.emboj.7601410; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P67, DOI 10.1107/S0021889887009737; Kallhoff V, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-6; Kanekiyo T, 2007, P NATL ACAD SCI USA, V104, P6412, DOI 10.1073/pnas.0701585104; Kawabata T, 2003, NUCLEIC ACIDS RES, V31, P3367, DOI 10.1093/nar/gkg581; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lang BF, 1999, ANNU REV GENET, V33, P351, DOI 10.1146/annurev.genet.33.1.351; Lazo ND, 2005, PROTEIN SCI, V14, P1581, DOI 10.1110/ps.041292205; Lefebvre-Legendre L, 2005, J BIOL CHEM, V280, P18386, DOI 10.1074/jbc.M410789200; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Llopis J, 1998, P NATL ACAD SCI USA, V95, P6803, DOI 10.1073/pnas.95.12.6803; Marchler-Bauer A, 2003, NUCLEIC ACIDS RES, V31, P383, DOI 10.1093/nar/gkg087; Mueller DM, 2004, PROTEIN EXPRES PURIF, V37, P479, DOI 10.1016/j.pep.2004.06.035; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PAUL MF, 1994, J BIOL CHEM, V269, P26158; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; SITKOFF D, 1994, J PHYS CHEM-US, V98, P1978, DOI 10.1021/j100058a043; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Wang ZG, 1998, J BIOL CHEM, V273, P2993, DOI 10.1074/jbc.273.5.2993; Wang ZG, 2000, EMBO J, V19, P1486, DOI 10.1093/emboj/19.7.1486; Wang ZG, 1996, J BIOL CHEM, V271, P4887; Wang ZG, 2000, J BIOL CHEM, V275, P5767, DOI 10.1074/jbc.275.8.5767; WHITE M, 1995, ARCH BIOCHEM BIOPHYS, V319, P299, DOI 10.1006/abbi.1995.1296	42	23	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					17138	17146		10.1074/jbc.M109.002568	http://dx.doi.org/10.1074/jbc.M109.002568			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19383603	hybrid, Green Published			2022-12-27	WOS:000266962400052
J	Arakane, Y; Lomakin, J; Beeman, RW; Muthukrishnan, S; Gehrke, SH; Kanost, MR; Kramer, KJ				Arakane, Yasuyuki; Lomakin, Joseph; Beeman, Richard W.; Muthukrishnan, Subbaratnam; Gehrke, Stevin H.; Kanost, Michael R.; Kramer, Karl J.			Molecular and Functional Analyses of Amino Acid Decarboxylases Involved in Cuticle Tanning in Tribolium castaneum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CHITIN-SYNTHASE GENES; RED FLOUR BEETLE; DOPA DECARBOXYLASE; MANDUCA-SEXTA; BETA-ALANINE; INSECT CUTICLE; ADULT DEVELOPMENT; TOBACCO HORNWORM; SCLEROTIZATION; CATECHOLAMINE	Aspartate 1-decarboxylase (ADC) and 3,4-dihydroxyphenylalanine decarboxylase (DDC) provide beta-alanine and dopamine used in insect cuticle tanning. beta-Alanine is conjugated with dopamine to yield N-beta-alanyldopamine (NBAD), a substrate for the phenol oxidase laccase that catalyzes the synthesis of cuticle protein cross-linking agents and pigment precursors. We identified ADC and DDC genes in the red flour beetle, Tribolium castaneum (Tc), and investigated their functions. TcADC mRNA was most abundant prior to the pupal-adult molt. Injection of TcADC double-stranded (ds) RNA (dsTcADC) into mature larvae resulted in depletion of NBAD in pharate adults, accumulation of dopamine, and abnormally dark pigmentation of the adult cuticle. Injection of beta-alanine, the expected product of ADC, into dsTcADC-treated pupae rescued the pigmentation phenotype, resulting in normal rust-red color. A similar pattern of catechol content consisting of elevated dopamine and depressed NBAD was observed in the genetic black mutants of Tribolium, in which levels of TcADC mRNA were drastically reduced. Furthermore, from the Tribolium black mutant and dsTcADC-injected insects both exhibited similar changes in material properties. Dynamic mechanical analysis of elytral cuticle from beetles with depleted TcADC transcripts revealed diminished cross-linking of cuticular components, further confirming the important role of oxidation products of NBAD as cross-linking agents during cuticle tanning. Injection of dsTcDDC into larvae produced a lethal pupal phenotype, and the resulting grayish pupal cuticle exhibited many small patches of black pigmentation. When dsTcDDC was injected into young pupae, the resulting adults had abnormally dark brown body color, but there was little mortality. Injection of dsTcDDC resulted in more than a 5-fold increase in levels of DOPA, indicating that lack of TcDDC led to accumulation of its substrate, DOPA.	[Arakane, Yasuyuki; Muthukrishnan, Subbaratnam; Kanost, Michael R.; Kramer, Karl J.] Kansas State Univ, Dept Biochem, Manhattan, KS 66506 USA; [Lomakin, Joseph; Gehrke, Stevin H.] Univ Kansas, Dept Chem & Petr Engn, Lawrence, KS 66045 USA; [Beeman, Richard W.; Kramer, Karl J.] USDA ARS, Grain Mkt & Prod Res Ctr, Manhattan, KS 66502 USA	Kansas State University; University of Kansas; United States Department of Agriculture (USDA)	Kanost, MR (corresponding author), Kansas State Univ, Dept Biochem, 141 Chalmers Hall, Manhattan, KS 66506 USA.	kanost@ksu.edu	mo, qin/O-7877-2014; Gehrke, Stevin H/A-5265-2014	Kanost, Michael/0000-0002-6827-0061	National Science Foundation [IOS 0726425]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant IOS 0726425. This is Contribution 08-298-J from the Kansas Agricultural Experiment Station.	ANDERSEN SO, 2005, COMPREHENSIVE MOL IN, V4, P145; Andersen SO, 2007, INSECT BIOCHEM MOLEC, V37, P969, DOI 10.1016/j.ibmb.2007.05.002; Arakane Y, 2005, INSECT MOL BIOL, V14, P453, DOI 10.1111/j.1365-2583.2005.00576.x; Arakane Y, 2005, P NATL ACAD SCI USA, V102, P11337, DOI 10.1073/pnas.0504982102; Arakane Y, 2004, INSECT BIOCHEM MOLEC, V34, P291, DOI 10.1016/j.ibmb.2003.11.004; BEEMAN RW, 1990, J ECON ENTOMOL, V83, P1745, DOI 10.1093/jee/83.5.1745; BLACK BC, 1987, MOL GEN GENET, V209, P306, DOI 10.1007/BF00329658; Ferdig MT, 1996, INSECT MOL BIOL, V5, P119, DOI 10.1111/j.1365-2583.1996.tb00046.x; Ferry J.D, 1980, VISCOELASTIC PROPERT, P33; Gardel ML, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.188102; HALISCAK JP, 1983, J ECON ENTOMOL, V76, P717, DOI 10.1093/jee/76.4.717; HIRUMA K, 1995, DEV BIOL, V169, P195, DOI 10.1006/dbio.1995.1137; Hodgetts RB, 2006, ANNU REV ENTOMOL, V51, P259, DOI 10.1146/annurev.ento.51.110104.151143; HOFFMAN BD, 2005, ARXIVPHYSICS0504051V; HOPKINS TL, 1992, ANNU REV ENTOMOL, V37, P273, DOI 10.1146/annurev.en.37.010192.001421; HOPKINS TL, 1984, INSECT BIOCHEM, V14, P533, DOI 10.1016/0020-1790(84)90008-8; HOPKINS TL, 1982, SCIENCE, V217, P364, DOI 10.1126/science.217.4557.364; Huang CY, 2005, INSECT MOL BIOL, V14, P237, DOI 10.1111/j.1365-2583.2004.00552.x; Koenderink GH, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysLettRev.96.138307; Kong HJ, 2003, MACROMOLECULES, V36, P4582, DOI 10.1021/ma034137w; Kramer KJ, 2001, TETRAHEDRON, V57, P385, DOI 10.1016/S0040-4020(00)00949-2; KRAMER KJ, 1984, INSECT BIOCHEM, V14, P293, DOI 10.1016/0020-1790(84)90063-5; Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150; Lorenzen MD, 2002, GENETICS, V160, P225; MARSH JL, 1986, GENETICS, V112, P249; MENARD KP, 1999, DYNAMIC MECH ANAL PR, P84; MORGAN TD, 1987, INSECT BIOCHEM, V17, P255, DOI 10.1016/0020-1790(87)90066-7; Phillips AM, 2005, GENE, V351, P131, DOI 10.1016/j.gene.2005.03.013; ROSELAND CR, 1987, INSECT BIOCHEM, V17, P21, DOI 10.1016/0020-1790(87)90139-9; SOKOLOFF A, 1977, BIOL TRIBOLIUM, V3, P96; SOKOLOFF ALEXANDER, 1960, JOUR HEREDITY, V51, P131; THOMAS BR, 1989, INSECT BIOCHEM, V19, P611, DOI 10.1016/0020-1790(89)90095-4; Tomoyasu Y, 2004, DEV GENES EVOL, V214, P575, DOI 10.1007/s00427-004-0434-0; UJVARY I, 1987, INSECT BIOCHEM, V17, P389, DOI 10.1016/0020-1790(87)90001-1	34	143	154	6	53	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16584	16594		10.1074/jbc.M901629200	http://dx.doi.org/10.1074/jbc.M901629200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19366687	Green Published, hybrid			2022-12-27	WOS:000266730900055
J	Li, X; Baillie, GS; Houslay, MD				Li, Xiang; Baillie, George S.; Houslay, Miles D.			Mdm2 Directs the Ubiquitination of beta-Arrestin-sequestered cAMP Phosphodiesterase-4D5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-A; SIGNALING SCAFFOLD PROTEINS; INTERACTING MOTIF; BETA(2)-ADRENERGIC RECEPTORS; ROLIPRAM INHIBITION; COUPLED RECEPTORS; BINDING PROTEINS; TERMINAL REGION; ERK ACTIVATION; PDE4D GENE	beta-Arrestin plays a key role in regulating beta(2)-adrenoreceptor signaling by interdicting activation of adenylyl cyclase and selectively sequestering cAMP phosphodiesterase-4D5 (PDE4D5) for delivery of an active cAMP degrading system to the site of cAMP synthesis. Here we show that the beta-agonist, isoprenaline, triggers the rapid and transient ubiquitination of PDE4D5 in primary cardiomyocytes, mouse embryo fibroblasts, and HEK293B2 cells constitutively expressing beta(2)-adrenoceptors. Reconstitution analyses in beta-arrestin1/2 double knockout cells plus small interference RNA knockdown studies indicate that a beta-arrestin-scaffolded pool of the E3-ubiquitin ligase, Mdm2, mediates PDE4D5 ubiquitination. Critical for this is the ubiquitin-interacting motif located in the extreme C terminus of PDE4D5, which is specific to the PDE4D sub-family. In vitro SUMOylation of a PDE4D5 spot-immobilized peptide array, followed by a mutagenesis strategy, showed that PDE4D5 ubiquitination occurs at Lys-48, Lys- 53, and Lys-78, which are located within its isoform-specific N-terminal region, as well as at Lys-140 located within its regulatory UCR1 module. We suggest that mono-ubiquitination at Lys-140 primes PDE4D5 for a subsequent cascade of polyubiquitination occurring within its isoform-specific N-terminal region at Lys-48, Lys-53, and Lys-78. PDE4D5 interacts with a non-ubiquitinated beta-arrestin sub-population that is likely to be protected from Mdm2-mediated ubiquitination due to steric hindrance caused by sequestered PDE4D5. Ubiquitination of PDE4D5 elicits an increase in the fraction of PDE4D5 sequestered by beta-arrestin in cells, thereby contributing to the fidelity of PDE4D5-beta-arrestin interaction, as well as decreasing the fraction of PDE4D5 sequestered by the scaffolding protein, RACK1.	[Li, Xiang; Baillie, George S.; Houslay, Miles D.] Univ Glasgow, Fac Biomed & Life Sci, Glasgow G12 8QQ, Lanark, Scotland	University of Glasgow	Houslay, MD (corresponding author), Univ Glasgow, Fac Biomed & Life Sci, Wolfson & Davidson Bldg, Glasgow G12 8QQ, Lanark, Scotland.	M.Houslay@bio.gla.ac.uk	Houslay, Miles/AAM-5281-2020; Houslay, Miles D/A-6825-2011	Houslay, Miles/0000-0002-3826-8091	Medical Research Council (UK) [G0600765]; European Union [LSHB-CT-2006-037189]; Fondation Leducq [06CVD02]; MRC [G0600765] Funding Source: UKRI; Medical Research Council [G0600765] Funding Source: researchfish	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); Fondation Leducq(Leducq Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Medical Research Council (UK) Grant G0600765 ( to M. D. H. and G. S. B.), by European Union Grant LSHB-CT-2006-037189 ( to M. D. H.), and by the Fondation Leducq Grant 06CVD02 ( to M. D. H. and G. S. B.).	Ariga M, 2004, J IMMUNOL, V173, P7531, DOI 10.4049/jimmunol.173.12.7531; Baillie GS, 2007, BIOCHEM J, V404, P71, DOI 10.1042/BJ20070005; Baillie GS, 2005, FEBS LETT, V579, P3264, DOI 10.1016/j.febslet.2005.03.089; Baillie GS, 2005, CURR OPIN CELL BIOL, V17, P129, DOI 10.1016/j.ceb.2005.01.003; Baillie GS, 2003, P NATL ACAD SCI USA, V100, P940, DOI 10.1073/pnas.262787199; Beard MB, 2000, J BIOL CHEM, V275, P10349, DOI 10.1074/jbc.275.14.10349; Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911; Bolger GB, 2003, J BIOL CHEM, V278, P49230, DOI 10.1074/jbc.M303772200; Bolger GB, 1997, BIOCHEM J, V328, P539; Bolger GB, 2006, BIOCHEM J, V398, P23, DOI 10.1042/BJ20060423; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Bruss MD, 2008, J BIOL CHEM, V283, P22430, DOI 10.1074/jbc.M803306200; Carter S, 2007, NAT CELL BIOL, V9, P428, DOI 10.1038/ncb1562; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Cooper DMF, 2003, BIOCHEM J, V375, P517, DOI 10.1042/BJ20031061; Crook T, 1996, VIROLOGY, V217, P285, DOI 10.1006/viro.1996.0115; DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Dodge KL, 2001, EMBO J, V20, P1921, DOI 10.1093/emboj/20.8.1921; Fisher RD, 2003, J BIOL CHEM, V278, P28976, DOI 10.1074/jbc.M302596200; Fraser IDC, 2000, CURR BIOL, V10, P409, DOI 10.1016/S0960-9822(00)00419-X; Fujiwara K, 2004, J BIOL CHEM, V279, P4760, DOI 10.1074/jbc.M309448200; Gurevich EV, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-236; Haglund K, 2003, TRENDS BIOCHEM SCI, V28, P598, DOI 10.1016/j.tibs.2003.09.005; Hill EV, 2006, CELL SIGNAL, V18, P2056, DOI 10.1016/j.cellsig.2006.07.018; Hirano S, 2006, NAT STRUCT MOL BIOL, V13, P272, DOI 10.1038/nsmb1051; Hoeller D, 2007, MOL CELL, V26, P891, DOI 10.1016/j.molcel.2007.05.014; Hoffmann R, 1998, BIOCHEM J, V333, P139, DOI 10.1042/bj3330139; Hoffmann R, 1999, EMBO J, V18, P893, DOI 10.1093/emboj/18.4.893; Hofmann K, 2001, TRENDS BIOCHEM SCI, V26, P347, DOI 10.1016/S0968-0004(01)01835-7; Houslay MD, 2005, DRUG DISCOV TODAY, V10, P1503, DOI 10.1016/S1359-6446(05)03622-6; Houslay MD, 2003, BIOCHEM J, V370, P1, DOI 10.1042/BJ20021698; HOUSLAY MD, 1985, P NUTR SOC, V44, P157, DOI 10.1079/PNS19850034; Huang Z, 2006, CURR MED CHEM, V13, P3253, DOI 10.2174/092986706778773040; Hurley JH, 2006, BIOCHEM J, V399, P361, DOI 10.1042/BJ20061138; Jin SLC, 2005, J IMMUNOL, V175, P1523, DOI 10.4049/jimmunol.175.3.1523; King RW, 1996, MOL BIOL CELL, V7, P1343, DOI 10.1091/mbc.7.9.1343; Kirkin V, 2007, CURR OPIN CELL BIOL, V19, P199, DOI 10.1016/j.ceb.2007.02.002; Klapisz E, 2002, J BIOL CHEM, V277, P30746, DOI 10.1074/jbc.M203004200; Lefkowitz RJ, 2004, TRENDS PHARMACOL SCI, V25, P413, DOI 10.1016/j.tips.2004.06.006; Lohse MJ, 2003, CIRC RES, V93, P896, DOI 10.1161/01.RES.0000102042.83024.CA; Lynch MJ, 2005, J BIOL CHEM, V280, P33178, DOI 10.1074/jbc.M414316200; Maguire M, 2008, CANCER RES, V68, P3232, DOI 10.1158/0008-5472.CAN-07-5271; Mao Y, 2005, P NATL ACAD SCI USA, V102, P12700, DOI 10.1073/pnas.0506344102; Martin NP, 2003, J BIOL CHEM, V278, P45954, DOI 10.1074/jbc.M308285200; McCahill A, 2005, CELL SIGNAL, V17, P1158, DOI 10.1016/j.cellsig.2005.04.003; McLean AJ, 2000, BRIT J PHARMACOL, V130, P1825, DOI 10.1038/sj.bjp.0703506; McPhee I, 1999, J BIOL CHEM, V274, P11796, DOI 10.1074/jbc.274.17.11796; Millar JK, 2005, SCIENCE, V310, P1187, DOI 10.1126/science.1112915; Miller SLH, 2004, J BIOL CHEM, V279, P33528, DOI 10.1074/jbc.M313097200; Mimnaugh Edward G., 2005, V301, P223; Miranda M, 2007, MOL BIOL CELL, V18, P313, DOI 10.1091/mbc.E06-08-0704; Murdoch H, 2007, J NEUROSCI, V27, P9513, DOI 10.1523/JNEUROSCI.1493-07.2007; Nakayama T, 2007, CURR MED CHEM, V14, P3171, DOI 10.2174/092986707782793871; O'Donnell JM, 2004, TRENDS PHARMACOL SCI, V25, P158, DOI 10.1016/j.tips.2004.01.003; Oakley RH, 2000, J BIOL CHEM, V275, P17201, DOI 10.1074/jbc.M910348199; Oldham CE, 2002, CURR BIOL, V12, P1112, DOI 10.1016/S0960-9822(02)00900-4; Perry SJ, 2002, SCIENCE, V298, P834, DOI 10.1126/science.1074683; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Polo S, 2002, NATURE, V416, P451, DOI 10.1038/416451a; Raiborg C, 2006, TRENDS BIOCHEM SCI, V31, P541, DOI 10.1016/j.tibs.2006.07.009; Reiter E, 2006, TRENDS ENDOCRIN MET, V17, P159, DOI 10.1016/j.tem.2006.03.008; Richter W, 2008, EMBO J, V27, P384, DOI 10.1038/sj.emboj.7601968; Sachs BD, 2007, J CELL BIOL, V177, P1119, DOI 10.1083/jcb.200701040; Salcedo A, 2006, EMBO J, V25, P4752, DOI 10.1038/sj.emboj.7601351; Sette C, 1996, J BIOL CHEM, V271, P16526, DOI 10.1074/jbc.271.28.16526; Shekhtman A, 2002, BIOCHEM BIOPH RES CO, V296, P1222, DOI 10.1016/S0006-291X(02)02006-5; Shenoy SK, 2003, J BIOL CHEM, V278, P14498, DOI 10.1074/jbc.M209626200; Shenoy SK, 2005, J BIOL CHEM, V280, P15315, DOI 10.1074/jbc.M412418200; Shenoy SK, 2001, SCIENCE, V294, P1307, DOI 10.1126/science.1063866; Shenoy SK, 2007, J BIOL CHEM, V282, P29549, DOI 10.1074/jbc.M700852200; Sigismund S, 2004, CURR TOP MICROBIOL, V286, P149; Smith KJ, 2007, CELL SIGNAL, V19, P2612, DOI 10.1016/j.cellsig.2007.08.015; Stefan E, 2007, J AM SOC NEPHROL, V18, P199, DOI 10.1681/ASN.2006020132; Sun LJ, 2004, CURR OPIN CELL BIOL, V16, P119, DOI 10.1016/j.ceb.2004.02.005; Swanson KA, 2003, EMBO J, V22, P4597, DOI 10.1093/emboj/cdg471; Tasken K, 2004, PHYSIOL REV, V84, P137, DOI 10.1152/physrev.00021.2003; Tasken KA, 2001, J BIOL CHEM, V276, P21999, DOI 10.1074/jbc.C000911200; Taylor SS, 2005, BBA-PROTEINS PROTEOM, V1754, P25, DOI 10.1016/j.bbapap.2005.08.024; Terrin A, 2006, J CELL BIOL, V175, P441, DOI 10.1083/jcb.200605050; Tohgo A, 2003, J BIOL CHEM, V278, P6258, DOI 10.1074/jbc.M212231200; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Verde I, 2001, J BIOL CHEM, V276, P11189, DOI 10.1074/jbc.M006546200; Wang QH, 2005, J MOL BIOL, V348, P727, DOI 10.1016/j.jmb.2005.03.007; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Willoughby D, 2007, J BIOL CHEM, V282, P34235, DOI 10.1074/jbc.M706765200; Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527	87	53	57	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16170	16182		10.1074/jbc.M109.008078	http://dx.doi.org/10.1074/jbc.M109.008078			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19372219	Green Published, hybrid			2022-12-27	WOS:000266730900014
J	du Plessis, DJF; Berrelkamp, G; Nouwen, N; Driessen, AJM				du Plessis, David J. F.; Berrelkamp, Greetje; Nouwen, Nico; Driessen, Arnold J. M.			The Lateral Gate of SecYEG Opens during Protein Translocation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BACTERIAL CYTOPLASMIC MEMBRANE; ESCHERICHIA-COLI; CONDUCTING CHANNEL; PREPROTEIN TRANSLOCATION; CROSS-LINKING; CATALYTIC CYCLE; SECA PROTEIN; ATPASE; COMPLEX; OMPT	The SecYEG translocon of Escherichia coli mediates the translocation of preproteins across the cytoplasmic membrane. Here, we have examined the role of the proposed lateral gate of the translocon in translocation. A dual cysteine cross-linking approach allowed the introduction of cross-linker arms of various lengths between adjoining aminoacyl positions of transmembrane segments 2b and 7 of the lateral gate. Oxidation and short spacer linkers that fix the gate in the closed state abolished preprotein translocation, whereas long spacer linkers support translocation. The cross-linking data further suggests that SecYEG lateral gate opening and activation of the SecA ATPase are coupled processes. It is concluded that lateral gate opening is a critical step during SecA-dependent protein translocation.	[du Plessis, David J. F.; Berrelkamp, Greetje; Nouwen, Nico; Driessen, Arnold J. M.] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Mol Microbiol, NL-9751 NN Haren, Netherlands	University of Groningen	Driessen, AJM (corresponding author), Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Mol Microbiol, NL-9751 NN Haren, Netherlands.	a.j.m.driessen@rug.nl	Driessen, Arnold J.M./D-1876-2012	Driessen, Arnold J.M./0000-0001-9258-9104	Netherlands Royal Academy of Sciences (KNAW); NanoNed; Dutch Ministry of Economic Affairs; Netherlands Foundation for Scientific Research, Chemical Sciences	Netherlands Royal Academy of Sciences (KNAW); NanoNed; Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands); Netherlands Foundation for Scientific Research, Chemical Sciences(Netherlands Organization for Scientific Research (NWO))	This work was supported by the Netherlands Royal Academy of Sciences (KNAW), NanoNed, a national nanotechnology program coordinated by the Dutch Ministry of Economic Affairs, and the Netherlands Foundation for Scientific Research, Chemical Sciences.	AKIYAMA Y, 1990, BIOCHEM BIOPH RES CO, V167, P711, DOI 10.1016/0006-291X(90)92083-C; ARKOWITZ RA, 1993, EMBO J, V12, P243, DOI 10.1002/j.1460-2075.1993.tb05650.x; BANEYX F, 1990, J BACTERIOL, V172, P491, DOI 10.1128/JB.172.1.491-494.1990; Bol R, 2007, J BIOL CHEM, V282, P29785, DOI 10.1074/jbc.M702140200; BRUNDAGE L, 1990, CELL, V62, P649, DOI 10.1016/0092-8674(90)90111-Q; CABELLI RJ, 1988, CELL, V55, P683, DOI 10.1016/0092-8674(88)90227-9; CHEN LL, 1991, J BIOL CHEM, V266, P18237; de Keyzer J, 2002, J BIOL CHEM, V277, P46059, DOI 10.1074/jbc.M208449200; DRIESSEN AJM, 1992, EMBO J, V11, P847, DOI 10.1002/j.1460-2075.1992.tb05122.x; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; Economou A, 1995, CELL, V83, P1171, DOI 10.1016/0092-8674(95)90143-4; ECONOMOU A, 1994, CELL, V78, P835, DOI 10.1016/S0092-8674(94)90582-7; Erlandson KJ, 2008, NATURE, V455, P984, DOI 10.1038/nature07439; Fekkes P, 1999, MICROBIOL MOL BIOL R, V63, P161, DOI 10.1128/MMBR.63.1.161-173.1999; Gumbart J, 2007, BIOCHEMISTRY-US, V46, P11147, DOI 10.1021/bi700835d; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HARTL FU, 1990, CELL, V63, P269, DOI 10.1016/0092-8674(90)90160-G; JOLY JC, 1993, EMBO J, V12, P255, DOI 10.1002/j.1460-2075.1993.tb05651.x; KIM JS, 1995, ANAL BIOCHEM, V225, P174, DOI 10.1006/abio.1995.1131; KORADI R, 1996, J MOL GRAPHICS, V14, P32; KOSOWER NS, 1987, METHOD ENZYMOL, V143, P76; KOSOWER NS, 1980, BIOCHIM BIOPHYS ACTA, V622, P201, DOI 10.1016/0005-2795(80)90031-8; Kramer RA, 2000, FEBS LETT, V468, P220, DOI 10.1016/S0014-5793(00)01231-X; LILL R, 1989, EMBO J, V8, P961, DOI 10.1002/j.1460-2075.1989.tb03458.x; Mitra K, 2005, NATURE, V438, P318, DOI 10.1038/nature04133; Mitra K, 2006, FEBS LETT, V580, P3353, DOI 10.1016/j.febslet.2006.05.019; Mitra K, 2006, NAT STRUCT MOL BIOL, V13, P957, DOI 10.1038/nsmb1166; Nomen N, 2007, J MOL BIOL, V372, P422, DOI 10.1016/j.jmb.2007.07.003; Nouwen N, 2001, FEBS LETT, V508, P103, DOI 10.1016/S0014-5793(01)03033-2; Osborne AR, 2007, CELL, V129, P97, DOI 10.1016/j.cell.2007.02.036; Plath K, 2004, MOL BIOL CELL, V15, P1, DOI 10.1091/mbc.E03-06-0390; Pohlschroder M, 1997, CELL, V91, P563, DOI 10.1016/S0092-8674(00)80443-2; RANDALL LL, 1983, CELL, V33, P231, DOI 10.1016/0092-8674(83)90352-5; Scheuring J, 2005, J MOL BIOL, V354, P258, DOI 10.1016/j.jmb.2005.09.058; SCHIEBEL E, 1991, CELL, V64, P927, DOI 10.1016/0092-8674(91)90317-R; Tomkiewicz D, 2006, J BIOL CHEM, V281, P15709, DOI 10.1074/jbc.M600205200; Tsukazaki T, 2008, NATURE, V455, P988, DOI 10.1038/nature07421; van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218; van der Does C, 2003, METHOD ENZYMOL, V372, P86; van der Sluis EO, 2002, FEBS LETT, V527, P159, DOI 10.1016/S0014-5793(02)03202-7; van der Wolk JPW, 1997, EMBO J, V16, P7297, DOI 10.1093/emboj/16.24.7297; Zimmer J, 2008, NATURE, V455, P936, DOI 10.1038/nature07335	42	72	74	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15805	15814		10.1074/jbc.M901855200	http://dx.doi.org/10.1074/jbc.M901855200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19366685	hybrid, Green Published			2022-12-27	WOS:000266501000049
J	Clark, K; Plater, L; Peggie, M; Cohen, P				Clark, Kristopher; Plater, Lorna; Peggie, Mark; Cohen, Philip			Use of the Pharmacological Inhibitor BX795 to Study the Regulation and Physiological Roles of TBK1 and I kappa B Kinase epsilon A DISTINCT UPSTREAM KINASE MEDIATES SER-172 PHOSPHORYLATION AND ACTIVATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IKK-RELATED KINASE; SIGNALING PATHWAY; VIRAL-INFECTION; ANTIVIRAL IMMUNITY; ACTIVATION; PHOSPHORYLATION; INNATE; TRANSCRIPTION; BINDING; TANK	TANK-binding kinase 1 (TBK1) and I kappa B kinase epsilon (IKK epsilon) regulate the production of Type 1 interferons during bacterial and viral infection, but the lack of useful pharmacological inhibitors has hampered progress in identifying additional physiological roles of these protein kinases and how they are regulated. Here we demonstrate that BX795, a potent and relatively specific inhibitor of TBK1 and IKK epsilon, blocked the phosphorylation, nuclear translocation, and transcriptional activity of interferon regulatory factor 3 and, hence, the production of interferon-beta in macrophages stimulated with poly(I: C) or lipopolysaccharide (LPS). In contrast, BX795 had no effect on the canonical NF kappa B signaling pathway. Although BX795 blocked the autophosphorylation of overexpressed TBK1 and IKK epsilon at Ser-172 and, hence, the autoactivation of these protein kinases, it did not inhibit the phosphorylation of endogenous TBK1 and IKK epsilon at Ser-172 in response to LPS, poly(I: C), interleukin-1 alpha (IL-1 alpha), or tumor necrosis factor alpha and actually enhanced the LPS, poly(I: C), and IL-1 alpha-stimulated phosphorylation of this residue. These results demonstrate that the phosphorylation of Ser-172 and the activation of TBK1 and IKK epsilon are catalyzed by a distinct protein kinase(s) in vivo and that TBK1 and IKK epsilon control a feedback loop that limits their activation by LPS, poly(I: C) and IL-1 alpha (but not tumor necrosis factor alpha) to prevent the hyperactivation of these enzymes.	[Clark, Kristopher; Plater, Lorna; Peggie, Mark; Cohen, Philip] Univ Dundee, Sir James Black Ctr, MRC, Prot Phosphorylat Unit,Coll Life Sci, Dundee DD1 5EH, Scotland	University of Dundee	Cohen, P (corresponding author), Univ Dundee, Sir James Black Ctr, MRC, Prot Phosphorylat Unit,Coll Life Sci, Dundee DD1 5EH, Scotland.	p.cohen@dundee.ac.uk			United Kingdom Medical Research Council; AstraZeneca; Boehringer Ingelheim; GlaxoSmithKline; Merck-Serono; Pfizer; MRC [MC_EX_G0800765] Funding Source: UKRI; Medical Research Council [MC_EX_G0800765] Funding Source: researchfish	United Kingdom Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); AstraZeneca(AstraZeneca); Boehringer Ingelheim(Boehringer Ingelheim); GlaxoSmithKline(GlaxoSmithKline); Merck-Serono(Merck & Company); Pfizer(Pfizer); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was supported by the United Kingdom Medical Research Council, AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Merck- Serono, and Pfizer.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Ananieva O, 2008, NAT IMMUNOL, V9, P1028, DOI 10.1038/ni.1644; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Beinke S, 2004, MOL CELL BIOL, V24, P9658, DOI 10.1128/MCB.24.21.9658-9667.2004; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Bonnard M, 2000, EMBO J, V19, P4976, DOI 10.1093/emboj/19.18.4976; Buss H, 2004, J BIOL CHEM, V279, P55633, DOI 10.1074/jbc.M409825200; Clark K, 2006, EMBO J, V25, P290, DOI 10.1038/sj.emboj.7600931; Collins BJ, 2005, J CELL SCI, V118, P5023, DOI 10.1242/jcs.02617; Feldman RI, 2005, J BIOL CHEM, V280, P19867, DOI 10.1074/jbc.M501367200; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fujita F, 2003, MOL CELL BIOL, V23, P7780, DOI 10.1128/MCB.23.21.7780-7793.2003; Harris J, 2006, J IMMUNOL, V177, P2527, DOI 10.4049/jimmunol.177.4.2527; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hemmi H, 2004, J EXP MED, V199, P1641, DOI 10.1084/jem.20040520; Jiang ZF, 2004, P NATL ACAD SCI USA, V101, P3533, DOI 10.1073/pnas.0308496101; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kishore N, 2002, J BIOL CHEM, V277, P13840, DOI 10.1074/jbc.M110474200; Korherr C, 2006, P NATL ACAD SCI USA, V103, P4240, DOI 10.1073/pnas.0511319103; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Mattioli I, 2006, J BIOL CHEM, V281, P6175, DOI 10.1074/jbc.M508045200; McWhirter SM, 2004, P NATL ACAD SCI USA, V101, P233, DOI 10.1073/pnas.2237236100; Morton S, 2008, FEBS LETT, V582, P997, DOI 10.1016/j.febslet.2008.02.047; Perry AK, 2004, J EXP MED, V199, P1651, DOI 10.1084/jem.20040528; Pomerantz JL, 1999, EMBO J, V18, P6694, DOI 10.1093/emboj/18.23.6694; Pullen N, 1998, SCIENCE, V279, P707, DOI 10.1126/science.279.5351.707; Ryzhakov G, 2007, EMBO J, V26, P3180, DOI 10.1038/sj.emboj.7601743; Sato S, 2005, NAT IMMUNOL, V6, P1087, DOI 10.1038/ni1255; Schroder M, 2008, EMBO J, V27, P2147, DOI 10.1038/emboj.2008.143; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Shimada T, 1999, INT IMMUNOL, V11, P1357, DOI 10.1093/intimm/11.8.1357; Soulat D, 2008, EMBO J, V27, P2135, DOI 10.1038/emboj.2008.126; Takeuchi O, 2008, CURR OPIN IMMUNOL, V20, P17, DOI 10.1016/j.coi.2008.01.002; Tenoever BR, 2007, SCIENCE, V315, P1274, DOI 10.1126/science.1136567; Tojima Y, 2000, NATURE, V404, P778, DOI 10.1038/35008109; Waterfield M, 2004, MOL CELL BIOL, V24, P6040, DOI 10.1128/MCB.24.13.6040-6048.2004; Zhong B, 2008, IMMUNITY, V29, P538, DOI 10.1016/j.immuni.2008.09.003; Zhong J, 2004, MOL CELL BIOL, V24, P9165, DOI 10.1128/MCB.24.20.9165-9175.2004; Zhong J, 2007, J BIOL CHEM, V282, P24246, DOI 10.1074/jbc.M703422200	40	269	283	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14136	14146		10.1074/jbc.M109.000414	http://dx.doi.org/10.1074/jbc.M109.000414			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19307177	hybrid, Green Published			2022-12-27	WOS:000266286100020
J	Chakrabarti, P; Kandror, KV				Chakrabarti, Partha; Kandror, Konstantin V.			FoxO1 Controls Insulin-dependent Adipose Triglyceride Lipase (ATGL) Expression and Lipolysis in Adipocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MICE LACKING; METABOLISM; PHOSPHORYLATION; TRANSCRIPTION; ACTIVATION; LONGEVITY; RECEPTOR; PROTEIN; FAMILY; CELLS	FoxO1 represents a central regulator of metabolism in several cell types. Although FoxO1 is abundant in adipocytes, its biological functions in these cells remain largely unknown. We show here that the promotor region of the rate-limiting lipolytic enzyme, adipose triglyceride lipase (ATGL), has two FoxO1-binding sites, and co-transfection with wild type and unphosphorylated FoxO1 mutant activates the expression of luciferase driven by the ATGL promotor. In 3T3-L1 adipocytes, insulin controls nucleo-cytoplasmic shuttling of FoxO1 and regulates its interaction with endogenous ATGL promotors. Knockdown of FoxO1 in 3T3-L1 adipocytes decreases the expression of ATGL and attenuates basal and isoproterenol-stimulated lipolysis. Infection of mouse embryonic fibroblasts with FoxO1-encoding lentivirus increases ATGL expression and renders it sensitive to regulation by insulin. Thus, FoxO1 may play an important role in the regulation of lipolysis in adipocytes by controlling the expression of ATGL.	[Chakrabarti, Partha; Kandror, Konstantin V.] Boston Univ, Sch Med, Dept Biochem, Boston, MA 02118 USA	Boston University	Kandror, KV (corresponding author), Boston Univ, Sch Med, Dept Biochem, K124D,715 Albany St, Boston, MA 02118 USA.	kandror@biochem.bumc.bu.edu		Kandror, Konstantin/0000-0002-8601-9313	National Institutes of Health Research [DK52057, DK56736]; American Diabetes Association; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK052057, R01DK052057, R01DK056736] Funding Source: NIH RePORTER	National Institutes of Health Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Research Grants DK52057 and DK56736 (to K. V. K.). This work was also supported by a research award from the American Diabetes Association (to K. V. K.).	Accili D, 2004, CELL, V117, P421, DOI 10.1016/S0092-8674(04)00452-0; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Brasaemle DL, 2007, J LIPID RES, V48, P2547, DOI 10.1194/jlr.R700014-JLR200; Calnan DR, 2008, ONCOGENE, V27, P2276, DOI 10.1038/onc.2008.21; Choi YH, 2006, J CLIN INVEST, V116, P3240, DOI 10.1172/JCI24867; Czech MP, 2003, P NATL ACAD SCI USA, V100, P11198, DOI 10.1073/pnas.2135308100; Duncan RE, 2007, ANNU REV NUTR, V27, P79, DOI 10.1146/annurev.nutr.27.061406.093734; FRAZE E, 1985, J CLIN ENDOCR METAB, V61, P807, DOI 10.1210/jcem-61-5-807; Gronke S, 2005, CELL METAB, V1, P323, DOI 10.1016/j.cmet.2005.04.003; Gross DN, 2008, ONCOGENE, V27, P2320, DOI 10.1038/onc.2008.25; Haemmerle G, 2006, SCIENCE, V312, P734, DOI 10.1126/science.1123965; Jenkins CM, 2004, J BIOL CHEM, V279, P48968, DOI 10.1074/jbc.M407841200; Kamagate A, 2008, J CLIN INVEST, V118, P2347, DOI [10.1172/JCI32914, 10.1172/JC132914]; Kershaw EE, 2006, DIABETES, V55, P148, DOI 10.2337/diabetes.55.01.06.db05-0982; Kershaw EE, 2007, AM J PHYSIOL-ENDOC M, V293, pE1736, DOI 10.1152/ajpendo.00122.2007; Kim JY, 2006, AM J PHYSIOL-ENDOC M, V291, pE115, DOI 10.1152/ajpendo.00317.2005; Kim MS, 2006, NAT NEUROSCI, V9, P901, DOI 10.1038/nn1731; Kitamura T, 1999, MOL CELL BIOL, V19, P6286; Kralisch S, 2005, MOL CELL ENDOCRINOL, V240, P43, DOI 10.1016/j.mce.2005.06.002; Kurat CF, 2006, J BIOL CHEM, V281, P491, DOI 10.1074/jbc.M508414200; McGarry JD, 2002, DIABETES, V51, P7, DOI 10.2337/diabetes.51.1.7; Miyoshi H, 2007, J BIOL CHEM, V282, P996, DOI 10.1074/jbc.M605770200; Miyoshi H, 2006, J BIOL CHEM, V281, P15837, DOI 10.1074/jbc.M601097200; Nakae J, 2003, DEV CELL, V4, P119, DOI 10.1016/S1534-5807(02)00401-X; Oknianska A, 2007, BIOCHEM BIOPH RES CO, V353, P1080, DOI 10.1016/j.bbrc.2006.12.141; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; Smirnova E, 2006, EMBO REP, V7, P106, DOI 10.1038/sj.embor.7400559; Southgate RJ, 2007, J BIOL CHEM, V282, P21176, DOI 10.1074/jbc.M702039200; Stumvoll M, 2008, LANCET, V371, P2153, DOI 10.1016/S0140-6736(08)60932-0; Vihervaara T, 2008, J MOL BIOL, V376, P1215, DOI 10.1016/j.jmb.2007.12.042; Villena JA, 2004, J BIOL CHEM, V279, P47066, DOI 10.1074/jbc.M403855200; Wang MC, 2008, SCIENCE, V322, P957, DOI 10.1126/science.1162011; Wymann MP, 2008, NAT REV MOL CELL BIO, V9, P162, DOI 10.1038/nrm2335; Xu Z, 2002, J BIOL CHEM, V277, P47972, DOI 10.1074/jbc.C200486200; Zechner R, 2009, J LIPID RES, V50, P3, DOI 10.1194/jlr.R800031-JLR200; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	36	153	159	3	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13296	13300		10.1074/jbc.C800241200	http://dx.doi.org/10.1074/jbc.C800241200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19297333	Green Published, hybrid			2022-12-27	WOS:000265877300004
J	Diering, GH; Church, J; Numata, M				Diering, Graham H.; Church, John; Numata, Masayuki			Secretory Carrier Membrane Protein 2 Regulates Cell-surface Targeting of Brain-enriched Na+/H+ Exchanger NHE5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINOCEREBELLAR ATAXIA TYPE-4; INTRACELLULAR PH; MOLECULAR-CLONING; PLASMA-MEMBRANE; FUNCTIONAL EXPRESSION; MONOCLONAL-ANTIBODIES; CEREBELLAR-ATAXIA; NERVE-TERMINALS; SCAMP1 FUNCTION; SPERM MOTILITY	NHE5 is a brain-enriched Na+/H+ exchanger that dynamically shuttles between the plasma membrane and recycling endosomes, serving as a mechanism that acutely controls the local pH environment. In the current study we show that secretory carrier membrane proteins (SCAMPs), a group of tetraspanning integral membrane proteins that reside in multiple secretory and endocytic organelles, bind to NHE5 and co-localize predominantly in the recycling endosomes. In vitro protein-protein interaction assays revealed that NHE5 directly binds to the N- and C-terminal cytosolic extensions of SCAMP2. Heterologous expression of SCAMP2 but not SCAMP5 increased cell-surface abundance as well as transporter activity of NHE5 across the plasma membrane. Expression of a deletion mutant lacking the SCAMP2-specific N-terminal cytosolic domain, and a mini-gene encoding the N-terminal extension, reduced the transporter activity. Although both Arf6 and Rab11 positively regulate NHE5 cell-surface targeting and NHE5 activity across the plasma membrane, SCAMP2-mediated surface targeting of NHE5 was reversed by dominant-negative Arf6 but not by dominant-negative Rab11. Together, these results suggest that SCAMP2 regulates NHE5 transit through recycling endosomes and promotes its surface targeting in an Arf6-dependent manner.	[Diering, Graham H.; Numata, Masayuki] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada; [Church, John] Univ British Columbia, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	Numata, M (corresponding author), Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z3, Canada.	mnumata@interchange.ubc.ca			Canadian Institutes of Health Research Operating Grants [MOP144919, MOP77616]; Michael Smith Foundation for Health Research ( MSFHR)	Canadian Institutes of Health Research Operating Grants(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research ( MSFHR)(Michael Smith Foundation for Health Research)	This work was supported in part by Canadian Institutes of Health Research Operating Grants MOP144919 ( to M. N.) and MOP77616 ( to J. C.), and by Michael Smith Foundation for Health Research ( MSFHR) establishment grants ( to M. N.).	ARONSON PS, 1982, NATURE, V299, P161, DOI 10.1038/299161a0; Attaphitaya S, 1999, J BIOL CHEM, V274, P4383, DOI 10.1074/jbc.274.7.4383; Attaphitaya S, 2001, AM J PHYSIOL-CELL PH, V281, pC1146, DOI 10.1152/ajpcell.2001.281.4.C1146; Baird NR, 1999, J BIOL CHEM, V274, P4377, DOI 10.1074/jbc.274.7.4377; Balasubramanian N, 2007, NAT CELL BIOL, V9, P1381, DOI 10.1038/ncb1657; Battaglino RA, 2008, BONE, V42, P180, DOI 10.1016/j.bone.2007.09.046; Baxter KA, 1996, J PHYSIOL-LONDON, V493, P457, DOI 10.1113/jphysiol.1996.sp021396; Bell SM, 1999, AM J PHYSIOL-CELL PH, V276, pC788, DOI 10.1152/ajpcell.1999.276.4.C788; BIANCHINI L, 1995, AM J PHYSIOL-CELL PH, V269, pC998, DOI 10.1152/ajpcell.1995.269.4.C998; BOYARSKY G, 1988, AM J PHYSIOL, V255, pC844, DOI 10.1152/ajpcell.1988.255.6.C844; Brett CL, 2005, AM J PHYSIOL-CELL PH, V288, pC223, DOI 10.1152/ajpcell.00360.2004; Castle A, 2005, J CELL SCI, V118, P3769, DOI 10.1242/jcs.02503; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Chen YH, 1998, J NEUROSCI, V18, P2982; Chesler M, 2003, PHYSIOL REV, V83, P1183, DOI 10.1152/physrev.00010.2003; Cox GA, 1997, CELL, V91, P139, DOI 10.1016/S0092-8674(01)80016-7; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Decoursey TE, 2003, PHYSIOL REV, V83, P475, DOI 10.1152/physrev.00028.2002; DeVries SH, 2001, NEURON, V32, P1107, DOI 10.1016/S0896-6273(01)00535-9; Donaldson JG, 2003, J BIOL CHEM, V278, P41573, DOI 10.1074/jbc.R300026200; Edwards RH, 2007, NEURON, V55, P835, DOI 10.1016/j.neuron.2007.09.001; Fernandez-Chacon R, 2000, J NEUROSCI, V20, P7941; Fernandez-Chacon R, 2000, J BIOL CHEM, V275, P12752, DOI 10.1074/jbc.275.17.12752; Fernandez-Chacon R, 1999, J BIOL CHEM, V274, P32551, DOI 10.1074/jbc.274.46.32551; Flanigan K, 1996, AM J HUM GENET, V59, P392; Guo ZH, 2002, J BIOL CHEM, V277, P35357, DOI 10.1074/jbc.M202259200; Hellenbroich Y, 2005, J NEUROL, V252, P1472, DOI 10.1007/s00415-005-0892-y; Hellenbroich Y, 2003, J NEUROL, V250, P668, DOI 10.1007/s00415-003-1052-x; HODGES RS, 1988, J BIOL CHEM, V263, P11768; Hubbard C, 2000, MOL BIOL CELL, V11, P2933, DOI 10.1091/mbc.11.9.2933; Ishikawa K, 2006, NEUROPATHOLOGY, V26, P352, DOI 10.1111/j.1440-1789.2006.00719.x; Jang IS, 2006, J NEUROCHEM, V99, P1224, DOI 10.1111/j.1471-4159.2006.04168.x; Jones MC, 2006, CURR OPIN CELL BIOL, V18, P549, DOI 10.1016/j.ceb.2006.08.003; Koh TW, 2004, NEURON, V43, P193, DOI 10.1016/j.neuron.2004.06.029; KRISHTAL OA, 1987, BRAIN RES, V436, P352, DOI 10.1016/0006-8993(87)91678-7; Lacroix J, 2004, EMBO REP, V5, P91, DOI 10.1038/sj.embor.7400035; Lee SH, 2008, BIOCHEM BIOPH RES CO, V369, P320, DOI 10.1016/j.bbrc.2008.01.168; Lin PJC, 2007, CELL SIGNAL, V19, P978, DOI 10.1016/j.cellsig.2006.11.006; Lin PJC, 2005, J CELL SCI, V118, P1885, DOI 10.1242/jcs.02315; Liu LX, 2005, MOL BIOL CELL, V16, P4463, DOI 10.1091/mbc.E05-03-0231; Liu LX, 2002, MOL BIOL CELL, V13, P4266, DOI 10.1091/mbc.E02-03-0136; MACKENZIE D, 1982, J BIOL CHEM, V257, P7100; Marie B, 2004, NEURON, V43, P207, DOI 10.1016/j.neuron.2004.07.001; Montesinos ML, 2005, BRAIN RES REV, V49, P416, DOI 10.1016/j.brainresrev.2005.06.002; Muller HK, 2006, J BIOL CHEM, V281, P28901, DOI 10.1074/jbc.M602848200; Nagaoka U, 2000, NEUROLOGY, V54, P1971, DOI 10.1212/WNL.54.10.1971; Naslavsky N, 2005, J CELL SCI, V118, P4093, DOI 10.1242/jcs.02595; Naslavsky N, 2004, MOL BIOL CELL, V15, P2410, DOI 10.1091/mbc.E03-10-0733; Onishi I, 2007, CELL SIGNAL, V19, P194, DOI 10.1016/j.cellsig.2006.06.011; OPRIAN DD, 1987, P NATL ACAD SCI USA, V84, P8874, DOI 10.1073/pnas.84.24.8874; Orlowski J, 2004, PFLUG ARCH EUR J PHY, V447, P549, DOI 10.1007/s00424-003-1110-3; Orlowski J, 2007, CURR OPIN CELL BIOL, V19, P483, DOI 10.1016/j.ceb.2007.06.001; OTSU K, 1992, J BIOL CHEM, V267, P8089; Owada K, 2005, NEUROLOGY, V65, P629, DOI 10.1212/01.wnl.0000173065.75680.e2; POLO S, 2003, SCI STKE, pRE17, DOI DOI 10.1126/STKE.2132003RE17; Porcelli AM, 2002, BBA-MOL CELL RES, V1542, P125, DOI 10.1016/S0167-4889(01)00173-2; Powelka AM, 2004, TRAFFIC, V5, P20, DOI 10.1111/j.1600-0854.2004.00150.x; Ren MD, 1998, P NATL ACAD SCI USA, V95, P6187, DOI 10.1073/pnas.95.11.6187; Rocha MA, 2008, J NEUROCHEM, V106, P231, DOI 10.1111/j.1471-4159.2008.05355.x; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; Rose S, 2007, MOL BIOL CELL, V18, P5091, DOI 10.1091/mbc.E07-05-0460; ROTIN D, 1989, AM J PHYSIOL, V257, pC1158, DOI 10.1152/ajpcell.1989.257.6.C1158; SARDET C, 1989, CELL, V56, P271, DOI 10.1016/0092-8674(89)90901-X; Schlierf B, 2000, EXP CELL RES, V259, P257, DOI 10.1006/excr.2000.4947; Shi A, 2007, CURR BIOL, V17, P1913, DOI 10.1016/j.cub.2007.10.045; Sklan EH, 2006, PROG NEUROBIOL, V78, P117, DOI 10.1016/j.pneurobio.2005.12.002; Smith GAM, 1998, J PHYSIOL-LONDON, V512, P487, DOI 10.1111/j.1469-7793.1998.487be.x; Szabo EZ, 2000, J BIOL CHEM, V275, P6302, DOI 10.1074/jbc.275.9.6302; Szabo EZ, 2005, P NATL ACAD SCI USA, V102, P2790, DOI 10.1073/pnas.0407444102; Szaszi K, 2002, J BIOL CHEM, V277, P42623, DOI 10.1074/jbc.M206629200; TRAYNELIS SF, 1990, NATURE, V345, P347, DOI 10.1038/345347a0; Trudeau LE, 1999, J NEUROPHYSIOL, V81, P2627, DOI 10.1152/jn.1999.81.6.2627; Wakabayashi S, 1997, PHYSIOL REV, V77, P51, DOI 10.1152/physrev.1997.77.1.51; Wakabayashi S, 2003, J BIOL CHEM, V278, P11828, DOI 10.1074/jbc.M213243200; Wang D, 2003, NAT CELL BIOL, V5, P1117, DOI 10.1038/ncb1072; Wang W, 2008, TRAFFIC, V9, P742, DOI 10.1111/j.1600-0854.2008.00712.x; Woo AL, 2002, MOL REPROD DEV, V62, P348, DOI 10.1002/mrd.90002	77	24	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13892	13903		10.1074/jbc.M807055200	http://dx.doi.org/10.1074/jbc.M807055200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19276089	Green Published, hybrid			2022-12-27	WOS:000265877300065
J	Rodriguez-Escudero, I; Andres-Pons, A; Pulido, R; Molina, M; Cid, VJ				Rodriguez-Escudero, Isabel; Andres-Pons, Amparo; Pulido, Rafael; Molina, Maria; Cid, Victor J.			Phosphatidylinositol 3-Kinase-dependent Activation of Mammalian Protein Kinase B/Akt in Saccharomyces cerevisiae, an in Vivo Model for the Functional Study of Akt Mutations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLECKSTRIN HOMOLOGY DOMAIN; P110-ALPHA SUBUNIT; CRYSTAL-STRUCTURE; ONCOGENIC PI3K; YEAST; SCH9; INTEGRITY; PHOSPHORYLATION; PATHWAY; COMPLEX	In animal cells, Akt (also called protein kinase B) is activated by stimuli that elevate the level of phosphatidylinositol 3,4,5-trisphosphate and is a major effector for eliciting responses that support cell growth and survival. We have shown previously that co-expression of Akt1 in budding yeast (Saccharomyces cerevisiae) along with hyperactive p110 alpha, the catalytic subunit of mammalian phosphatidylinositol 3-kinase, results in Akt1 relocalization to cellular membranes and activation. In the present study, we show that activation of all three mammalian Akt isoforms by wild-type p110 alpha causes deleterious effects on yeast cell growth. Toxicity of Akt in S. cerevisiae required its catalytic activity, its pleckstrin homology domain, and phosphorylation of its activation loop, but not phosphorylation of its hydrophobic motif. We demonstrate that expression in yeast of the only purported oncogenic allele, Akt1(E17K), leads to enhanced phenotypes. Ala-scanning mutagenesis of the VL1 region within the phosphatidylinositol 3,4,5-trisphosphate-interacting pocket of the Akt1 pleckstrin homology domain revealed that most residues in this region are essential for Akt1 activity. We found that active Akt leads to enhanced signaling through the yeast cell wall integrity pathway. This effect requires the upstream Rho1 activator Rom 2 and involves both phosphorylation of the MAPK Slt2 and expression of its transcriptional targets, thus providing a quantitative reporter system for heterologous Akt activity in vivo. Collectively, our results disclose a heterologous yeast system that allows the functional assessment in vivo of both loss-of-function and tumorigenic Akt alleles.	[Rodriguez-Escudero, Isabel; Molina, Maria; Cid, Victor J.] Univ Complutense Madrid, Fac Farm, Dept Microbiol 2, E-28040 Madrid, Spain; [Andres-Pons, Amparo; Pulido, Rafael] Ctr Invest Principe Felipe, Valencia 46012, Spain	Complutense University of Madrid; Prince Felipe Research Center	Cid, VJ (corresponding author), Univ Complutense Madrid, Fac Farm, Dept Microbiol 2, Pza Ramon & Cajan S-N, E-28040 Madrid, Spain.	vicjcid@farm.ucm.es	Molina, Maria/ABE-7186-2021; JIMENEZ CID, VICTOR/ABC-4858-2021; CID, VICTOR JIMENEZ/I-1240-2015; Rodríguez, Isabel/I-5955-2017	Molina, Maria/0000-0003-0074-3309; JIMENEZ CID, VICTOR/0000-0002-3933-2016; CID, VICTOR JIMENEZ/0000-0002-3933-2016; Rodríguez, Isabel/0000-0002-1792-1143; Andres-Pons, Amparo/0000-0001-5801-4024; Pulido, Rafael/0000-0001-9100-248X	Ministerio Educacion y Ciencia [BIO2007-67299]; Comunidad Autonoma de Madrid [S-SAL-0246-2006, 920628]; Ministerio de Educacion y Ciencia [SAF2006-083139]; Instituto de Salud Carlos III, Spain [ISCIII-RETIC RD06/0020]; Fundacion Mutua Madrilena; Ayuntamiento de Valencia, Spain	Ministerio Educacion y Ciencia(Spanish Government); Comunidad Autonoma de Madrid(Comunidad de Madrid); Ministerio de Educacion y Ciencia(Spanish Government); Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III); Fundacion Mutua Madrilena(Instituto de Salud Carlos III); Ayuntamiento de Valencia, Spain	This work was supported in part by Grant BIO2007-67299 from Ministerio Educacion y Ciencia, Grant S-SAL-0246-2006 and the Programme for Universidad Complutense de Madrid Research Groups (920628) from Comunidad Autonoma de Madrid (to M. M.) and by Grant SAF2006-083139 from Ministerio de Educacion y Ciencia, Grant ISCIII-RETIC RD06/0020 from Instituto de Salud Carlos III, Spain, and Fundacion Mutua Madrilena (to R. P.). 1 Recipient of a predoctoral fellowship from Ayuntamiento de Valencia, Spain.	Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Andres-Pons A, 2007, CANCER RES, V67, P9731, DOI 10.1158/0008-5472.CAN-07-1278; Aoki M, 1998, P NATL ACAD SCI USA, V95, P14950, DOI 10.1073/pnas.95.25.14950; Baraldi E, 1999, STRUCTURE, V7, P449, DOI 10.1016/S0969-2126(99)80057-4; Bellacosa A, 1998, ONCOGENE, V17, P313, DOI 10.1038/sj.onc.1201947; Bellacosa A, 2005, ADV CANCER RES, V94, P29, DOI 10.1016/S0065-230X(05)94002-5; Bermejo C, 2008, MOL BIOL CELL, V19, P1113, DOI 10.1091/mbc.E07-08-0742; Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Bickle M, 1998, EMBO J, V17, P2235, DOI 10.1093/emboj/17.8.2235; Bleeker FE, 2008, ONCOGENE, V27, P5648, DOI 10.1038/onc.2008.170; Brodbeck D, 2001, J BIOL CHEM, V276, P29550, DOI 10.1074/jbc.M104633200; Calleja V, 2007, PLOS BIOL, V5, P780, DOI 10.1371/journal.pbio.0050095; Carpten JD, 2007, NATURE, V448, P439, DOI 10.1038/nature05933; Carson JD, 2008, BIOCHEM J, V409, P519, DOI 10.1042/BJ20070681; Casamayor A, 1999, CURR BIOL, V9, P186, DOI 10.1016/S0960-9822(99)80088-8; Eng C, 2003, HUM MUTAT, V22, P183, DOI 10.1002/humu.10257; Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497; Frech M, 1997, J BIOL CHEM, V272, P8474, DOI 10.1074/jbc.272.13.8474; Garcia R, 2004, J BIOL CHEM, V279, P15183, DOI 10.1074/jbc.M312954200; Hanada M, 2004, BBA-PROTEINS PROTEOM, V1697, P3, DOI 10.1016/j.bbapap.2003.11.009; He L, 2006, J BIOL CHEM, V281, P11126, DOI 10.1074/jbc.M510724200; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Jorgensen P, 2004, GENE DEV, V18, P2491, DOI 10.1101/gad.1228804; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Kumar CC, 2005, ONCOGENE, V24, P7493, DOI 10.1038/sj.onc.1209087; Lietzke SE, 2000, MOL CELL, V6, P385, DOI 10.1016/S1097-2765(00)00038-1; Liu K, 2005, J BIOL CHEM, V280, P22679, DOI 10.1074/jbc.M502972200; Liu ZN, 2006, CELL CYCLE, V5, P675, DOI 10.4161/cc.5.7.2605; Mager WH, 2005, TRENDS PHARMACOL SCI, V26, P265, DOI 10.1016/j.tips.2005.03.004; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Martin H, 2000, J BIOL CHEM, V275, P1511, DOI 10.1074/jbc.275.2.1511; Milburn CC, 2003, BIOCHEM J, V375, P531, DOI 10.1042/BJ20031229; Miled N, 2007, SCIENCE, V317, P239, DOI 10.1126/science.1135394; Park WS, 2008, MOL CELL, V30, P381, DOI 10.1016/j.molcel.2008.04.008; Pascual-Ahuir A, 2007, CELL CYCLE, V6, P2445, DOI 10.4161/cc.6.20.4792; Pedruzzi I, 2003, MOL CELL, V12, P1607, DOI 10.1016/S1097-2765(03)00485-4; Powers T, 2003, CURR TOP MICROBIOL, V279, P39; Rodriguez-Escudero I, 2005, BIOCHEM J, V390, P613, DOI 10.1042/BJ20050574; Rodriguez-Pena JM, 2008, J BIOTECHNOL, V133, P311, DOI 10.1016/j.jbiotec.2007.10.006; Roelants FM, 2004, MICROBIOL-SGM, V150, P3289, DOI 10.1099/mic.0.27286-0; Roosen J, 2005, MOL MICROBIOL, V55, P862, DOI 10.1111/j.1365-2958.2004.04429.x; Samuels Y, 2006, CURR OPIN ONCOL, V18, P77, DOI 10.1097/01.cco.0000198021.99347.b9; Sansal I, 2004, J CLIN ONCOL, V22, P2954, DOI 10.1200/jco.2004.02.141; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Simon JA, 2004, NAT REV CANCER, V4, P481, DOI 10.1038/nrc1372; Sulis ML, 2003, TRENDS CELL BIOL, V13, P478, DOI 10.1016/S0962-8924(03)00175-2; Thomas CC, 2002, CURR BIOL, V12, P1256, DOI 10.1016/S0960-9822(02)00972-7; Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020; WATANABE Y, 1995, MOL CELL BIOL, V15, P5740; Williams MR, 2000, CURR BIOL, V10, P439, DOI 10.1016/S0960-9822(00)00441-3; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; YON J, 1989, NUCLEIC ACIDS RES, V17, P4895, DOI 10.1093/nar/17.12.4895; Zunder ER, 2008, CANCER CELL, V14, P180, DOI 10.1016/j.ccr.2008.06.014	53	14	14	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13373	13383		10.1074/jbc.M807867200	http://dx.doi.org/10.1074/jbc.M807867200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19307184	Green Published, hybrid			2022-12-27	WOS:000265877300013
J	Yu, HT; Yu, MA; Li, CY; Zhan, YQ; Xu, WX; Li, YH; Li, W; Wang, ZD; Ge, CH; Yang, XM				Yu, Hai-Tao; Yu, Miao; Li, Chang-Yan; Zhan, Yi-Qun; Xu, Wang-Xiang; Li, Yong-Hui; Li, Wei; Wang, Zhi-Dong; Ge, Chang-Hui; Yang, Xiao-Ming			Specific Expression and Regulation of Hepassocin in the Liver and Down-regulation of the Correlation of HNF1 alpha with Decreased Levels of Hepassocin in Human Hepatocellular Carcinoma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HYDRODYNAMICS-BASED TRANSFECTION; ENRICHED TRANSCRIPTION FACTORS; NUCLEAR FACTOR; FACTOR-I; ALBUMIN GENE; MOUSE; DNA; REGENERATION; HEPATOCYTES; FIBRINOGEN	Hepassocin (HPS), is a liver-specific gene with mitogenic activity on isolated hepatocytes. It is up-regulated following partial hepatectomy and down-regulated frequently in heptocellular carcinoma (HCC). However, very little is known about the HPS transcription regulation mechanism. In this study, we identified HNF1 alpha (hepatocyte nuclear factor-1 alpha) as an important liver-specific cis-acting element for HPS using in vivo luciferase assays. Deletion of the HNF1 binding site not only led to a complete loss of HPS promoter activity in vivo but also abolished the induction of the HPS promoter by HNF1 alpha. An electrophoretic mobility shift assay demonstrated that HNF1 alpha interacted with the HPS gene promoter in vitro. Chromatin immunoprecipitation showed that HNF1 alpha interacted with HMGB1 and CREB-binding protein, and all of them were recruited to the HPS promoter in vivo. Moreover, HNF1 alpha expression was lower in HCC cell lines and tissues and correlated significantly with the down-regulation of HPS expression. Re-expression of HNF1 alpha in human hepatoma HepG2 cells reinduced HPS expression. In contrast, knockdown of endogenous HNF1 alpha expression by small interfering RNA resulted in a significant reduction of HPS expression. Furthermore, we found that partial hepatectomy and IL-6 significantly induced promoter activity of HPS, depending on STAT3 and HNF1 binding sites in the HPS promoter. These results demonstrate that the HNF1 binding site and HNF1 alpha are critical to liver-specific expression of HPS, and down-regulation or loss of HNF1 alpha causes, at least in part, the transcriptional down-regulation of HPS in HCC.	[Yu, Hai-Tao; Yu, Miao; Li, Chang-Yan; Zhan, Yi-Qun; Xu, Wang-Xiang; Li, Yong-Hui; Li, Wei; Wang, Zhi-Dong; Ge, Chang-Hui; Yang, Xiao-Ming] Beijing Inst Radiat Med, Beijing 100850, Peoples R China; [Yu, Hai-Tao; Yu, Miao; Li, Chang-Yan; Zhan, Yi-Qun; Xu, Wang-Xiang; Li, Yong-Hui; Li, Wei; Wang, Zhi-Dong; Ge, Chang-Hui; Yang, Xiao-Ming] State Key Lab Prote, Beijing 100850, Peoples R China; [Yang, Xiao-Ming] Tianjin Univ, Sch Chem Engn & Technol, Tianjin 300072, Peoples R China	Academy of Military Medical Sciences - China; Tianjin University	Yang, XM (corresponding author), Beijing Inst Radiat Med, 27 Taiping Rd, Beijing 100850, Peoples R China.	xmyang2@nic.bmi.ac.cn	li, tao/B-2402-2008		Special Funds for Major State Basic Research of China [Special Funds for Major State Basic Research of China (2006CB910802]; National Program on Key Basic Research Projects [2004CB518903]	Special Funds for Major State Basic Research of China; National Program on Key Basic Research Projects(National Basic Research Program of China)	This work was partially supported by the Special Funds for Major State Basic Research of China (2006CB910802) and the National Program on Key Basic Research Projects (2004CB518903).	Andre FM, 2006, GENE THER, V13, P1619, DOI 10.1038/sj.gt.3302827; Andrianaivo F, 2004, J GENE MED, V6, P877, DOI 10.1002/jgm.574; BLUMENFELD M, 1991, DEVELOPMENT, V113, P589; Bosserhoff AK, 2003, J BIOL CHEM, V278, P15225, DOI 10.1074/jbc.M212639200; Cereghini S, 1996, FASEB J, V10, P267, DOI 10.1096/fasebj.10.2.8641560; CEREGHINI S, 1988, GENE DEV, V2, P957, DOI 10.1101/gad.2.8.957; CHANG HK, 1989, MOL CELL BIOL, V9, P5189, DOI 10.1128/MCB.9.11.5189; CLAIRMONT A, 1994, CANCER RES, V54, P1319; COSTA RH, 1988, MOL CELL BIOL, V8, P81, DOI 10.1128/MCB.8.1.81; COURTOIS G, 1987, SCIENCE, V238, P688, DOI 10.1126/science.3499668; COURTOIS G, 1988, P NATL ACAD SCI USA, V85, P7937, DOI 10.1073/pnas.85.21.7937; Diehl AM, 1996, FASEB J, V10, P215, DOI 10.1096/fasebj.10.2.8641555; Dohda T, 2004, J BIOCHEM, V136, P313, DOI 10.1093/jb/mvh123; Hara H, 2001, BBA-GENE STRUCT EXPR, V1520, P45, DOI 10.1016/S0167-4781(01)00249-4; Hara H, 2000, BBA-GENE STRUCT EXPR, V1492, P31, DOI 10.1016/S0167-4781(00)00056-7; Hayashi Y, 1999, J CLIN PATHOL-MOL PA, V52, P19; Higgins GM, 1931, ARCH PATHOL, V12, P186; Huston JM, 2006, J EXP MED, V203, P1623, DOI 10.1084/jem.20052362; Institute of Laboratory Animal Research Commission on Life Sciences National Research Council, 1996, GUID CAR US LAB AN, P21; Leu JI, 2001, MOL CELL BIOL, V21, P414, DOI 10.1128/MCB.21.2.414-424.2001; LICHTSTEINER S, 1987, CELL, V51, P963, DOI 10.1016/0092-8674(87)90583-6; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Liu ZL, 2008, BIOCHEM BIOPH RES CO, V365, P729, DOI 10.1016/j.bbrc.2007.11.069; Parrizas M, 2001, MOL CELL BIOL, V21, P3234, DOI 10.1128/MCB.21.9.3234-3243.2001; Pontoglio M, 1996, CELL, V84, P575, DOI 10.1016/S0092-8674(00)81033-8; Rijken DC, 2006, BIOCHEM BIOPH RES CO, V350, P191, DOI 10.1016/j.bbrc.2006.09.018; TSUTSUMI K, 1989, MOL CELL BIOL, V9, P4923, DOI 10.1128/MCB.9.11.4923; van Wering HM, 2002, J BIOL CHEM, V277, P27659, DOI 10.1074/jbc.M203645200; Wardemann H, 2002, J EXP MED, V195, P771, DOI 10.1084/jem.20011140; Yan J, 2004, ONCOGENE, V23, P1939, DOI 10.1038/sj.onc.1207306; Yan J, 2002, CELL RES, V12, P353, DOI 10.1038/sj.cr.7290137; Yang Q, 2002, DIABETES, V51, P1785, DOI 10.2337/diabetes.51.6.1785; Yu M, 2008, NUCLEIC ACIDS RES, V36, P1209, DOI 10.1093/nar/gkm1131; Zheng F, 2003, AM J PATHOL, V162, P1339, DOI 10.1016/S0002-9440(10)63929-6	34	42	48	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13335	13347		10.1074/jbc.M806393200	http://dx.doi.org/10.1074/jbc.M806393200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19304666	hybrid, Green Published			2022-12-27	WOS:000265877300009
J	Lee, J; Wang, XF; Di Jeso, B; Arvan, P				Lee, Jaemin; Wang, Xiaofan; Di Jeso, Bruno; Arvan, Peter			The Cholinesterase-like Domain, Essential in Thyroglobulin Trafficking for Thyroid Hormone Synthesis, Is Required for Protein Dimerization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECOMBINANT HUMAN ACETYLCHOLINESTERASE; INTERSUBUNIT DISULFIDE BONDS; MISSENSE MUTATION G2320R; ENDOPLASMIC-RETICULUM; CONGENITAL GOITER; GOITROUS HYPOTHYROIDISM; TORPEDO-CALIFORNICA; GENE; SECRETION; OLIGOMERIZATION	The carboxyl-terminal cholinesterase-like (ChEL) domain of thyroglobulin (Tg) has been identified as critically important in Tg export from the endoplasmic reticulum. In a number of human kindreds suffering from congenital hypothyroidism, and in the cog congenital goiter mouse and rdw rat dwarf models, thyroid hormone synthesis is inhibited because of mutations in the ChEL domain that block protein export from the endoplasmic reticulum. We hypothesize that Tg forms homodimers through noncovalent interactions involving two predicted alpha-helices in each ChEL domain that are homologous to the dimerization helices of acetylcholinesterase. This has been explored through selective epitope tagging of dimerization partners and by inserting an extra, unpaired Cys residue to create an opportunity for intermolecular disulfide pairing. We show that the ChEL domain is necessary and sufficient for Tg dimerization; specifically, the isolated ChEL domain can dimerize with full-length Tg or with itself. Insertion of an N-linked glycan into the putative upstream dimerization helix inhibits homodimerization of the isolated ChEL domain. However, interestingly, co-expression of upstream Tg domains, either in cis or in trans, overrides the dimerization defect of such a mutant. Thus, although the ChEL domain provides a nidus for Tg dimerization, interactions of upstream Tg regions with the ChEL domain actively stabilizes the Tg dimer complex for intracellular transport.	[Arvan, Peter] Univ Michigan, Sch Med, Div Metab Endocrinol & Diabet, Med Ctr, Ann Arbor, MI 48109 USA; [Lee, Jaemin; Arvan, Peter] Univ Michigan, Med Ctr, Cell & Mol Biol Program, Ann Arbor, MI 48109 USA; [Di Jeso, Bruno] Univ Lecce, Ctr Ecotekne, Lab Patol Gen, Dipartimento Sci & Tecnol Biol Ambientali,Fac Sci, I-73100 Lecce, Italy	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Salento	Arvan, P (corresponding author), Univ Michigan, Sch Med, Div Metab Endocrinol & Diabet, Med Ctr, 5560 MSRB2,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	parvan@umich.edu	Lee, Jaemin/AAP-4875-2021	Lee, Jaemin/0000-0002-0224-7141; di jeso, bruno/0000-0001-8713-5984	National Institutes of Health [DK40344]; Ministero dell'Universita e della Ricerca [PRIN 2006069102_004]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040344, R29DK040344] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministero dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant DK40344 ( to P. A.). This work was also supported in part by the Ministero dell'Universita e della Ricerca PRIN 2006069102_004 (to B. D. J.).	Arvan P, 1997, THYROID, V7, P89, DOI 10.1089/thy.1997.7.89; BERG G, 1980, MOL CELL ENDOCRINOL, V20, P87, DOI 10.1016/0303-7207(80)90096-9; BERG G, 1975, BIOCHIM BIOPHYS ACTA, V386, P422, DOI 10.1016/0005-2795(75)90285-8; BERG JM, 1980, J MED GENET, V17, P144, DOI 10.1136/jmg.17.2.144; BOURNE Y, 1995, CELL, V83, P503, DOI 10.1016/0092-8674(95)90128-0; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Caputo M, 2007, CLIN ENDOCRINOL, V67, P351, DOI 10.1111/j.1365-2265.2007.02889.x; Caron P, 2003, J CLIN ENDOCR METAB, V88, P3546, DOI 10.1210/jc.2002-021744; Di Jeso B, 2005, MOL CELL BIOL, V25, P9793, DOI 10.1128/MCB.25.22.9793-9805.2005; DIJESO B, 2004, THYROID, P77; Dunn AD, 1998, J BIOL CHEM, V273, P25223, DOI 10.1074/jbc.273.39.25223; GOUGH NR, 1995, J NEUROCHEM, V65, P2734; Hishinuma A, 2000, ENDOCRINOLOGY, V141, P4050, DOI 10.1210/en.141.11.4050; Jain RK, 2001, BIOCHEM J, V360, P645, DOI 10.1042/0264-6021:3600645; KEREM A, 1993, J BIOL CHEM, V268, P180; Kim PS, 2008, MOL ENDOCRINOL, V22, P477, DOI 10.1210/me.2007-0183; KIM PS, 1991, J BIOL CHEM, V266, P12412; Kim PS, 2000, MOL ENDOCRINOL, V14, P1944, DOI 10.1210/me.14.12.1944; Kim PS, 1996, J CELL BIOL, V133, P517, DOI 10.1083/jcb.133.3.517; Kim PS, 1998, P NATL ACAD SCI USA, V95, P9909, DOI 10.1073/pnas.95.17.9909; Kitanaka S, 2006, J HUM GENET, V51, P379, DOI 10.1007/s10038-006-0360-2; LAMAS L, 1977, ENDOCRINOLOGY, V100, P1129; Lee J, 2008, J CLIN INVEST, V118, P2950, DOI 10.1172/JCI35164; MARRIQ C, 1991, MOL CELL ENDOCRINOL, V81, P155, DOI 10.1016/0303-7207(91)90214-D; Matakidou A, 2004, CARCINOGENESIS, V25, P369, DOI 10.1093/carcin/bgh027; Morel N, 2001, J BIOL CHEM, V276, P37379, DOI 10.1074/jbc.M103192200; MORI N, 1987, P NATL ACAD SCI USA, V84, P2813, DOI 10.1073/pnas.84.9.2813; Pardo V, 2008, THYROID, V18, P783, DOI 10.1089/thy.2007.0321; Park YN, 2004, J BIOL CHEM, V279, P17085, DOI 10.1074/jbc.M314042200; Reddy PS, 1998, BIOESSAYS, V20, P546, DOI 10.1002/(SICI)1521-1878(199807)20:7<546::AID-BIES5>3.0.CO;2-I; Rivolta CM, 2006, CLIN CHIM ACTA, V374, P8, DOI 10.1016/j.cca.2006.05.043; SCHUMACHER M, 1986, NATURE, V319, P407, DOI 10.1038/319407a0; SEED RANDOLPH W., 1965, SCIENCE, V149, P1380, DOI 10.1126/science.149.3690.1380; SEED RW, 1965, J BIOL CHEM, V240, P764; SUSSMAN JL, 1991, SCIENCE, V253, P872, DOI 10.1126/science.1678899; SWILLENS S, 1986, BIOCHEM BIOPH RES CO, V137, P142, DOI 10.1016/0006-291X(86)91187-3; Taurog A, 1999, BIOCHIMIE, V81, P557, DOI 10.1016/S0300-9084(99)80110-2; Turakulov Ia Kh, 1976, Biokhimiia, V41, P1004; van de Graaf SAR, 2001, J ENDOCRINOL, V170, P307, DOI 10.1677/joe.0.1700307; VELAN B, 1991, J BIOL CHEM, V266, P23977; Veneziani BM, 1999, BIOCHIMIE, V81, P517, DOI 10.1016/S0300-9084(99)80104-7; Vono-Toniolo J, 2005, THYROID, V15, P1021, DOI 10.1089/thy.2005.15.1021; Xiao S, 1996, ARCH BIOCHEM BIOPHYS, V334, P284, DOI 10.1006/abbi.1996.0457	43	36	36	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12752	12761		10.1074/jbc.M806898200	http://dx.doi.org/10.1074/jbc.M806898200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19276074	Green Published, hybrid			2022-12-27	WOS:000265688300020
J	Mohamed, TMA; Oceandy, D; Prehar, S; Alatwi, N; Hegab, Z; Baudoin, FM; Pickard, A; Zaki, AO; Nadif, R; Cartwright, EJ; Neyses, L				Mohamed, Tamer M. A.; Oceandy, Delvac; Prehar, Sukhpal; Alatwi, Nasser; Hegab, Zeinab; Baudoin, Florence M.; Pickard, Adam; Zaki, Aly O.; Nadif, Raja; Cartwright, Elizabeth J.; Neyses, Ludwig			Specific Role of Neuronal Nitric-oxide Synthase when Tethered to the Plasma Membrane Calcium Pump in Regulating the beta-Adrenergic Signal in the Myocardium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MODULATES CARDIAC REPOLARIZATION; TROPONIN-I; CARDIOVASCULAR-SYSTEM; HEART-FAILURE; PHOSPHODIESTERASES; PHOSPHORYLATION; CGMP; OVEREXPRESSION; CONTRACTILITY; ACTIVATION	The cardiac neuronal nitric-oxide synthase (nNOS) has been described as a modulator of cardiac contractility. We have demonstrated previously that isoform 4b of the sarcolemmal calcium pump (PMCA4b) binds to nNOS in the heart and that this complex regulates beta-adrenergic signal transmission in vivo. Here, we investigated whether the nNOS-PMCA4b complex serves as a specific signaling modulator in the heart. PMCA4b transgenic mice (PMCA4b-TG) showed a significant reduction in nNOS and total NOS activities as well as in cGMP levels in the heart compared with their wild type (WT) littermates. In contrast, PMCA4b-TG hearts showed an elevation in cAMP levels compared with the WT. Adult cardiomyocytes isolated from PMCA4b-TG mice demonstrated a 3-fold increase in Ser(16) phospholamban (PLB) phosphorylation as well as Ser(22) and Ser(23) cardiac troponin I (cTnI) phosphorylation at base line compared with the WT. In addition, the relative induction of PLB phosphorylation and cTnI phosphorylation following isoproterenol treatment was severely reduced in PMCA4b-TG myocytes, explaining the blunted physiological response to the beta-adrenergic stimulation. In keeping with the data from the transgenic animals, neonatal rat cardiomyocytes overexpressing PMCA4b showed a significant reduction in nitric oxide and cGMP levels. This was accompanied by an increase in cAMP levels, which led to an increase in both PLB and cTnI phosphorylation at base line. Elevated cAMP levels were likely due to the modulation of cardiac phosphodiesterase, which determined the balance between cGMP and cAMP following PMCA4b overexpression. In conclusion, these results showed that the nNOS-PMCA4b complex regulates contractility via cAMP and phosphorylation of both PLB and cTnI.	[Neyses, Ludwig] Univ Manchester, Dept Cardiol, Manchester M13 9PT, Lancs, England; Cent Manchester NHS Fdn Trust, Biomed Res Ctr, Manchester M13 9PT, Lancs, England	University of Manchester	Neyses, L (corresponding author), Univ Manchester, Dept Cardiol, 1-302 Stopford Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	Ludwig.Neyses@cmft.nhs.uk	Oceandy, Delvac/G-9911-2015; Neyses, Ludwig/AGY-7446-2022	Oceandy, Delvac/0000-0002-6242-6491; Hegab, Zeinab/0000-0001-7381-4425; Prehar, Sukhpal/0000-0002-4334-7931; Cartwright, Elizabeth/0000-0002-6836-7795; Baudoin, Florence/0000-0002-2300-1490; pickard, adam/0000-0001-9757-143X	Medical Research Council Programme [G0500025]; British Heart Foundation Project [PG-05-082]; Manchester Biomedical Research Centre; National Institute for Health Research; MRC [G0500025] Funding Source: UKRI; Medical Research Council [G0500025] Funding Source: researchfish	Medical Research Council Programme(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation Project(British Heart Foundation); Manchester Biomedical Research Centre(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by Medical Research Council Programme Grant G0500025 (to L. N.) and British Heart Foundation Project Grant PG-05-082 (to D. O., E. J. C., and L. N.). This work was also supported by Manchester Biomedical Research Centre, which is funded by the National Institute for Health Research.	Arking DE, 2006, NAT GENET, V38, P644, DOI 10.1038/ng1790; Armesilla AL, 2004, J BIOL CHEM, V279, P31318, DOI 10.1074/jbc.M307557200; Barouch LA, 2002, NATURE, V416, P337, DOI 10.1038/416337a; Bendall JK, 2004, CIRCULATION, V110, P2368, DOI 10.1161/01.CIR.0000145160.04084.AC; Burkard N, 2007, CIRC RES, V100, pE32, DOI 10.1161/01.RES.0000259042.04576.6a; CARAFOLI E, 1991, ANNU REV PHYSIOL, V53, P531, DOI 10.1146/annurev.physiol.53.1.531; Chang KC, 2008, P NATL ACAD SCI USA, V105, P4477, DOI 10.1073/pnas.0709118105; Dawson D, 2005, CIRCULATION, V112, P3729, DOI 10.1161/CIRCULATIONAHA.105.539437; Fischmeister R, 2006, CIRC RES, V99, P816, DOI 10.1161/01.RES.0000246118.98832.04; FUJIMOTO T, 1993, J CELL BIOL, V120, P1147, DOI 10.1083/jcb.120.5.1147; Hammes A, 1998, CIRC RES, V83, P877; Hare JM, 2005, J CLIN INVEST, V115, P509, DOI 10.1172/JCI200524459; Kanai AJ, 2001, P NATL ACAD SCI USA, V98, P14126, DOI 10.1073/pnas.241380298; MERY PF, 1993, J BIOL CHEM, V268, P26286; Mongillo M, 2006, CIRC RES, V98, P226, DOI 10.1161/01.RES.0000200178.34179.93; Murad F, 2006, NEW ENGL J MED, V355, P2003, DOI 10.1056/NEJMsa063904; Oceandy D, 2007, BIOCHEM SOC T, V35, P927, DOI 10.1042/BST0350927; Oceandy D, 2007, CIRCULATION, V115, P483, DOI 10.1161/CIRCULATIONAHA.106.643791; Osadchii OE, 2007, CARDIOVASC DRUG THER, V21, P171, DOI 10.1007/s10557-007-6014-6; Saraiva RM, 2006, CURR OPIN CARDIOL, V21, P221, DOI 10.1097/01.hco.0000221584.56372.dc; Schuh K, 2001, J CELL BIOL, V155, P201, DOI 10.1083/jcb.200104131; Sears CE, 2003, CIRC RES, V92, pE52, DOI 10.1161/01.RES.0000064585.95749.6D; Strehler EE, 2001, PHYSIOL REV, V81, P21, DOI 10.1152/physrev.2001.81.1.21; Surapisitchat J, 2007, CIRC RES, V101, P811, DOI 10.1161/CIRCRESAHA.107.154229; Takimoto E, 2004, CIRC RES, V94, P496, DOI 10.1161/01.RES.0000117307.57798.F5; Tavernier B, 2001, FASEB J, V15, P294, DOI 10.1096/fj.00-0433fje; Ueda K, 2008, P NATL ACAD SCI USA, V105, P9355, DOI 10.1073/pnas.0801294105; Vandsburger MH, 2007, EUR HEART J, V28, P2792, DOI 10.1093/eurheartj/ehm241; WATTANAPERMPOOL J, 1995, J MOL CELL CARDIOL, V27, P1383, DOI 10.1006/jmcc.1995.0131; Williams JC, 2006, J BIOL CHEM, V281, P23341, DOI 10.1074/jbc.M513341200; Xu KY, 2003, J BIOL CHEM, V278, P41798, DOI 10.1074/jbc.M306865200; Yasuda SI, 2007, CIRC RES, V101, P377, DOI 10.1161/CIRCRESAHA.106.145557; Zaccolo M, 2007, CIRC RES, V100, P1569, DOI 10.1161/CIRCRESAHA.106.144501; Zhang YH, 2008, CIRC RES, V102, P242, DOI 10.1161/CIRCRESAHA.107.164798	34	30	30	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12091	12098		10.1074/jbc.M809112200	http://dx.doi.org/10.1074/jbc.M809112200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19278978	Green Published, hybrid			2022-12-27	WOS:000265494600041
J	Corcoran, K; Wang, XL; Lybarger, L				Corcoran, Kathleen; Wang, Xiaoli; Lybarger, Lonnie			Adapter-mediated Substrate Selection for Endoplasmic Reticulum-associated Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; PEPTIDE-LOADING COMPLEX; CLASS-I MOLECULES; SARCOMA-ASSOCIATED HERPESVIRUS; ER-ASSOCIATED DEGRADATION; UBIQUITIN LIGASE COMPLEX; CD8(+) T-CELLS; MISFOLDED GLYCOPROTEINS; IMMUNE EVASION; ANTIGEN PRESENTATION	During endoplasmic reticulum (ER)-associated degradation (ERAD), a relatively small number of ubiquitin ligases (E3) must be capable of ubiquitinating an assortment of substrates diverse in both structure and location (ER lumen, membrane, and/or cytosol). Therefore, mechanisms that operate independently of primary sequence determinants must exist to ensure specificity during this process. Here we provide direct evidence for adapter-mediated substrate recruitment for a virus-encoded ERAD E3 ligase, mK3. Members of an ER membrane protein complex that normally functions during major histocompatibility complex class I biogenesis in the immune system are required for mK3 substrate selection. We demonstrate that heterologous substrates could be ubiquitinated by mK3 if they were recruited by these ER accessory molecules to the proper position relative to the ligase domain of mK3. This mechanism of substrate recruitment by adapter proteins may explain the ability of some E3 ligases, including cellular ERAD E3 ligases, to specifically target the ubiquitination of multiple substrates that are unrelated in sequence.	[Lybarger, Lonnie] Univ Arizona, Dept Cell Biol & Anat, Tucson, AZ 85724 USA; [Corcoran, Kathleen; Lybarger, Lonnie] Univ Arizona, Dept Immunobiol, Tucson, AZ 85724 USA; [Wang, Xiaoli] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO 63110 USA	University of Arizona; University of Arizona; Washington University (WUSTL)	Lybarger, L (corresponding author), Univ Arizona, Dept Cell Biol & Anat, 1501 N Campbell Ave,LSN 444, Tucson, AZ 85724 USA.	lybarger@email.arizona.edu			National Institutes of Health [AI060723, AI19687]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI019687, R01AI060723] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants AI060723 (to L. L.) and AI19687 (to X. W.).	Ballar P, 2007, J BIOL CHEM, V282, P33908, DOI 10.1074/jbc.M704446200; Bartee E, 2004, J VIROL, V78, P1109, DOI 10.1128/JVI.78.3.1109-1120.2004; Bartee E, 2006, PLOS PATHOG, V2, P975, DOI 10.1371/journal.ppat.0020107; Bays NW, 2001, NAT CELL BIOL, V3, P24, DOI 10.1038/35050524; Bhamidipati A, 2005, MOL CELL, V19, P741, DOI 10.1016/j.molcel.2005.07.027; Boname JM, 2004, IMMUNITY, V20, P305, DOI 10.1016/S1074-7613(04)00047-0; Boname JM, 2001, IMMUNITY, V15, P627, DOI 10.1016/S1074-7613(01)00213-8; BRODSKY FM, 1979, EUR J IMMUNOL, V9, P536, DOI 10.1002/eji.1830090709; Cadwell K, 2005, SCIENCE, V309, P127, DOI 10.1126/science.1110340; Cadwell K, 2008, J VIROL, V82, P4184, DOI 10.1128/JVI.02264-07; Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471; Carvalho P, 2006, CELL, V126, P361, DOI 10.1016/j.cell.2006.05.043; Christianson JC, 2008, NAT CELL BIOL, V10, P272, DOI 10.1038/ncb1689; Coscoy L, 2007, NAT REV IMMUNOL, V7, P391, DOI 10.1038/nri2076; DUBRIDGE RB, 1987, MOL CELL BIOL, V7, P379, DOI 10.1128/MCB.7.1.379; Duda DM, 2008, CELL, V134, P995, DOI 10.1016/j.cell.2008.07.022; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Grandea AG, 2000, IMMUNITY, V13, P213, DOI 10.1016/S1074-7613(00)00021-2; Hassink G, 2005, BIOCHEM J, V388, P647, DOI 10.1042/BJ20041241; Hebert DN, 2005, TRENDS CELL BIOL, V15, P364, DOI 10.1016/j.tcb.2005.05.007; Hughes EA, 1997, P NATL ACAD SCI USA, V94, P1896, DOI 10.1073/pnas.94.5.1896; Kim W, 2005, MOL CELL, V19, P753, DOI 10.1016/j.molcel.2005.08.010; Kostova Z, 2007, SEMIN CELL DEV BIOL, V18, P770, DOI 10.1016/j.semcdb.2007.09.002; Lehner PJ, 2004, CURR OPIN IMMUNOL, V16, P82, DOI 10.1016/j.coi.2003.11.012; Lewis JW, 1996, CURR BIOL, V6, P873, DOI 10.1016/S0960-9822(02)00611-5; Lybarger L, 2003, IMMUNITY, V18, P121, DOI 10.1016/S1074-7613(02)00509-5; Margalit A, 2003, INT IMMUNOL, V15, P1379, DOI 10.1093/intimm/dxg136; Matsuki Y, 2007, EMBO J, V26, P846, DOI 10.1038/sj.emboj.7601556; Nakatsukasa K, 2008, TRAFFIC, V9, P861, DOI 10.1111/j.1600-0854.2008.00729.x; Ohmura-Hoshino M, 2006, J BIOCHEM, V140, P147, DOI 10.1093/jb/mvj160; Ohmura-Hoshino M, 2006, J IMMUNOL, V177, P341, DOI 10.4049/jimmunol.177.1.341; Orlicky S, 2003, CELL, V112, P243, DOI 10.1016/S0092-8674(03)00034-5; Papadopoulos M, 2007, J BIOL CHEM, V282, P9401, DOI 10.1074/jbc.M610429200; PeaceBrewer AL, 1996, IMMUNITY, V4, P505, DOI 10.1016/S1074-7613(00)80416-1; Peaper DR, 2008, ANNU REV CELL DEV BI, V24, P343, DOI 10.1146/annurev.cellbio.24.110707.175347; PEDERSEN LO, 1995, EUR J IMMUNOL, V25, P1609, DOI 10.1002/eji.1830250621; Petersen JL, 2005, J IMMUNOL, V174, P962, DOI 10.4049/jimmunol.174.2.962; Plemper RK, 1999, J CELL SCI, V112, P4123; Ravid T, 2006, EMBO J, V25, P533, DOI 10.1038/sj.emboj.7600946; Ravid T, 2008, NAT REV MOL CELL BIO, V9, P679, DOI 10.1038/nrm2468; Sadasivan B, 1996, IMMUNITY, V5, P103, DOI 10.1016/S1074-7613(00)80487-2; Saha A, 2008, MOL CELL, V32, P21, DOI 10.1016/j.molcel.2008.08.021; SCHMIDT W, 1981, IMMUNOGENETICS, V13, P483, DOI 10.1007/BF00343716; Schulman BA, 2000, NATURE, V408, P381, DOI 10.1038/35042620; Stevenson PG, 2000, P NATL ACAD SCI USA, V97, P8455, DOI 10.1073/pnas.150240097; Stevenson PG, 2002, NAT IMMUNOL, V3, P733, DOI 10.1038/ni818; STORKUS WJ, 1993, J IMMUNOTHER, V14, P94, DOI 10.1097/00002371-199308000-00003; Szathmary R, 2005, MOL CELL, V19, P765, DOI 10.1016/j.molcel.2005.08.015; Tan P, 2002, J IMMUNOL, V168, P1950, DOI 10.4049/jimmunol.168.4.1950; Tang X, 2007, CELL, V129, P1165, DOI 10.1016/j.cell.2007.04.042; Van Parijs L, 1999, IMMUNITY, V11, P281, DOI 10.1016/S1074-7613(00)80103-X; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Wang XL, 2007, J CELL BIOL, V177, P613, DOI 10.1083/jcb.200611063; Wang XL, 2006, J BIOL CHEM, V281, P8636, DOI 10.1074/jbc.M513920200; Wang XL, 2005, J VIROL, V79, P4099, DOI 10.1128/JVI.79.7.4099-4108.2005; Wang XL, 2004, J VIROL, V78, P8673, DOI 10.1128/JVI.78.16.8673-8686.2004; Wu G, 2003, MOL CELL, V11, P1445, DOI 10.1016/S1097-2765(03)00234-X; Ye YH, 2005, P NATL ACAD SCI USA, V102, P14132, DOI 10.1073/pnas.0505006102; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x; Yu YYL, 1999, J IMMUNOL, V163, P4427; Yu YYL, 2002, J VIROL, V76, P2796, DOI 10.1128/JVI.76.6.2796-2803.2002; Zheng N, 2002, NATURE, V416, P703, DOI 10.1038/416703a; Zhou PB, 2000, MOL CELL, V6, P751, DOI 10.1016/S1097-2765(00)00074-5	63	4	4	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17475	17487		10.1074/jbc.M808258200	http://dx.doi.org/10.1074/jbc.M808258200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19366690	Green Published, hybrid			2022-12-27	WOS:000267202500014
J	Alberts, SM; Sonntag, C; Schafer, A; Wolf, DH				Alberts, Sven M.; Sonntag, Caroline; Schaefer, Antje; Wolf, Dieter H.			Ubx4 Modulates Cdc48 Activity and Influences Degradation of Misfolded Proteins of the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ER-ASSOCIATED DEGRADATION; UBIQUITIN-PROTEASOME PATHWAY; AAA ATPASE CDC48/P97; SACCHAROMYCES-CEREVISIAE; LUMINAL PROTEIN; QUALITY-CONTROL; MEMBRANE; COMPLEX; YEAST; CHAPERONE	Misfolded proteins of the secretory pathway are recognized in the endoplasmic reticulum (ER), retrotranslocated into the cytoplasm, and degraded by the ubiquitin-proteasome system. Right after retrotranslocation and polyubiquitination, they are extracted from the cytosolic side of the ER membrane through a complex consisting of the AAA ATPase Cdc48 (p97 in mammals), Ufd1, and Npl4. This complex delivers misfolded proteins to the proteasome for final degradation. Extraction, delivery, and processing of ERAD (ER-associated degradation) substrates to the proteasome requires additional cofactors of Cdc48. Here we characterize the UBX domain containing protein Ubx4 (Cui1) as a crucial factor for the degradation of polyubiquitinated proteins via ERAD. Ubx4 modulates the Cdc48-Ufd1Npl4 complex to guarantee its correct function. Mutant variants of Ubx4 lead to defective degradation of misfolded proteins and accumulation of polyubiquitinated proteins bound to Cdc48. We show the requirement of the UBX domain of Ubx4 for its function in ERAD. The observation that Ubx2 and Ubx4 are not found together in one complex with Cdc48 suggests several distinct steps in modulating the activity and localization of Cdc48 in ERAD.	[Alberts, Sven M.; Sonntag, Caroline; Schaefer, Antje; Wolf, Dieter H.] Univ Stuttgart, Inst Biochem, D-70569 Stuttgart, Germany	University of Stuttgart	Wolf, DH (corresponding author), Univ Stuttgart, Inst Biochem, Pfaffenwaldring 55, D-70569 Stuttgart, Germany.	dieter.wolf@ibc.uni-stuttgart.de			European Network of Excellence RUBICON; Deutsche Forschungsgemeinschaft, Bonn	European Network of Excellence RUBICON; Deutsche Forschungsgemeinschaft, Bonn(German Research Foundation (DFG))	This work was supported by the European Network of Excellence RUBICON and the Deutsche Forschungsgemeinschaft, Bonn.	Ahner A, 2004, TRENDS CELL BIOL, V14, P474, DOI 10.1016/j.tcb.2004.07.013; Ausubel FM, 1994, CURRENT PROTOCOLS MO; Bays NW, 2001, MOL BIOL CELL, V12, P4114, DOI 10.1091/mbc.12.12.4114; Beuron F, 2006, EMBO J, V25, P1967, DOI 10.1038/sj.emboj.7601055; Biederer T, 1996, EMBO J, V15, P2069, DOI 10.1002/j.1460-2075.1996.tb00560.x; Bordallo J, 1998, MOL BIOL CELL, V9, P209, DOI 10.1091/mbc.9.1.209; Braun S, 2002, EMBO J, V21, P615, DOI 10.1093/emboj/21.4.615; Bruderer RM, 2004, J BIOL CHEM, V279, P49609, DOI 10.1074/jbc.M408695200; Buchberger A, 2001, J MOL BIOL, V307, P17, DOI 10.1006/jmbi.2000.4462; Buschhorn BA, 2004, FEBS LETT, V577, P422, DOI 10.1016/j.febslet.2004.10.039; Dai RM, 2001, NAT CELL BIOL, V3, P740, DOI 10.1038/35087056; Decottignies A, 2004, YEAST, V21, P127, DOI 10.1002/yea.1071; Gauss R, 2005, YEAST, V22, P1, DOI 10.1002/yea.1187; Ghislain M, 1996, EMBO J, V15, P4884, DOI 10.1002/j.1460-2075.1996.tb00869.x; Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23; Guthrie C, 1991, METHODS ENZYMOLOGY; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; Huyer G, 2004, J BIOL CHEM, V279, P38369, DOI 10.1074/jbc.M402468200; Jarosch E, 2002, NAT CELL BIOL, V4, P134, DOI 10.1038/ncb746; Jentsch S, 2007, TRENDS BIOCHEM SCI, V32, P6, DOI 10.1016/j.tibs.2006.11.005; Knop M, 1996, EMBO J, V15, P753, DOI 10.1002/j.1460-2075.1996.tb00411.x; Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W; Kostova Z, 2003, EMBO J, V22, P2309, DOI 10.1093/emboj/cdg227; LATTERICH M, 1995, CELL, V82, P885, DOI 10.1016/0092-8674(95)90268-6; Medicherla B, 2004, EMBO REP, V5, P692, DOI 10.1038/sj.embor.7400164; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; Meyer HH, 2002, EMBO J, V21, P5645, DOI 10.1093/emboj/cdf579; Neuber O, 2005, NAT CELL BIOL, V7, P993, DOI 10.1038/ncb1298; Pan XW, 2006, CELL, V124, P1069, DOI 10.1016/j.cell.2005.12.036; Pye VE, 2007, P NATL ACAD SCI USA, V104, P467, DOI 10.1073/pnas.0603408104; Raasi S, 2007, SEMIN CELL DEV BIOL, V18, P780, DOI 10.1016/j.semcdb.2007.09.008; Rabinovich E, 2002, MOL CELL BIOL, V22, P626, DOI 10.1128/MCB.22.2.626-634.2002; Rabouille C, 1998, CELL, V92, P603, DOI 10.1016/S0092-8674(00)81128-9; Rape M, 2001, CELL, V107, P667, DOI 10.1016/S0092-8674(01)00595-5; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; SCHAFER A, 2008, UBIQUITIN PROTEASOME, P123; Schuberth C, 2008, CELL MOL LIFE SCI, V65, P2360, DOI 10.1007/s00018-008-8072-8; Schuberth C, 2005, NAT CELL BIOL, V7, P999, DOI 10.1038/ncb1299; Schuberth C, 2004, EMBO REP, V5, P818, DOI 10.1038/sj.embor.7400203; SCHUBERTH C, 2006, THESIS L MAXIMILIANS; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Vashist S, 2004, J CELL BIOL, V165, P41, DOI 10.1083/jcb.200309132; Ye YH, 2001, NATURE, V414, P652, DOI 10.1038/414652a; Ye YH, 2006, J STRUCT BIOL, V156, P29, DOI 10.1016/j.jsb.2006.01.005	45	30	30	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16082	16089		10.1074/jbc.M809282200	http://dx.doi.org/10.1074/jbc.M809282200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19359248	hybrid, Green Published			2022-12-27	WOS:000266730900004
J	Pinkse, MWH; Rijkers, DTS; Dostmann, WR; Heck, AJR				Pinkse, Martijn W. H.; Rijkers, Dirk T. S.; Dostmann, Wolfgang R.; Heck, Albert J. R.			Mode of Action of cGMP-dependent Protein Kinase-specific Inhibitors Probed by Photoaffinity Cross-linking Mass Spectrometry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							I-ALPHA; DISSOCIATION-CONSTANTS; SUBSTRATE-SPECIFICITY; PEPTIDE LIBRARIES; COUPLING REAGENTS; BINDING-SITE; COMPLEXES; PHENYLALANINE; ACTIVATION; MECHANISMS	The inhibitor peptide DT-2 (YGRKKRRQRRRPPLRKKK-KKH) is the most potent and selective inhibitor of the cGMP-dependent protein kinase (PKG) known today. DT-2 is a construct of a PKG tight binding sequence (W45, LRKKKKKH, K-I = 0.8 mu M) and a membrane translocating sequence (DT-6, YGRKKRRQRRRPP, K-I = 1.1 mu M), that combined strongly inhibits PKG catalyzed phosphorylation (K-I = 12.5 nM) with similar to 1000-fold selectivity toward PKG over protein kinase A, the closest relative of PKG. However, the molecular mechanism behind this inhibition is not entirely understood. Using a combination of photoaffinity labeling, stable isotope labeling, and mass spectrometry, we have located the binding sites of PKG-specific substrate and inhibitor peptides. Covalent linkage of a PKG-specific substrate analogue was localized in the catalytic core on residues 356-372, also known as the glycine-rich loop, essential for ATP binding. By analogy, the individual inhibitor peptides W45 and DT-6 were also found to cross-link near the glycine-rich loop, suggesting these are both substrate competitive inhibitors. A bifunctional photoreactive analogue of DT-2 was found to generate dimers of PKG. This cross-linking induced covalent PKG dimerization was not observed for an N-terminal deletion mutant of PKG, which lacks the dimerization domain. In addition, non-covalent mass spectrometry was used to determine binding stoichiometry and binding order of the inhibitor peptides. Dimeric PKG binds two W45 and DT-6 peptides, whereas only one DT-2 molecule was observed to bind to the dimeric PKG. Taken together, these findings imply that (i) the two individual components making up DT-2 are both targeted against the substrate-binding site and (ii) binding of a single DT-2 molecule inactivates both PKG monomers simultaneously, which is an indication that (iii) in cGMP-activated PKG the catalytic centers of both subunits may be in each other's proximity.	[Pinkse, Martijn W. H.; Heck, Albert J. R.] Univ Utrecht, Biomol Mass Spectrometry & Prote Grp, Bijvoet Ctr Biomol Res, NL-3584 CA Utrecht, Netherlands; [Rijkers, Dirk T. S.] Univ Utrecht, Utrecht Inst Pharmaceut Sci, Dept Pharmaceut Sci, Fac Sci, NL-3584 CA Utrecht, Netherlands; [Dostmann, Wolfgang R.] Univ Vermont, Dept Pharmacol, Coll Med, Burlington, VT 05405 USA; [Pinkse, Martijn W. H.] Delft Univ Technol, Dept Biotechnol, NL-2628 BC Delft, Netherlands	Utrecht University; Utrecht University; University of Vermont; Delft University of Technology	Heck, AJR (corresponding author), Sorbonnnelaan 16, NL-3584 CA Utrecht, Netherlands.	a.j.r.heck@uu.nl	Heck, Albert/D-7098-2011	Heck, Albert/0000-0002-2405-4404; Rijkers, Dirk T.S./0000-0002-8874-7576	National Institutes of Health [HL68891]; Netherlands Proteomics Centre; Totman Trust for Medical Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068891] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Proteomics Centre; Totman Trust for Medical Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by National Institutes of Health Grant HL68891 (to W. R. D.). This work was also supported by the Netherlands Proteomics Centre and the Totman Trust for Medical Research.	Adams JA, 2001, CHEM REV, V101, P2271, DOI 10.1021/cr000230w; Alverdi V, 2008, J MOL BIOL, V375, P1380, DOI 10.1016/j.jmb.2007.11.053; Bligh SWA, 2003, J MOL RECOGNIT, V16, P139, DOI 10.1002/jmr.622; Bove PF, 2007, AM J RESP CELL MOL, V36, P138, DOI 10.1165/rcmb.2006-0253SM; Brunner J, 1996, TRENDS CELL BIOL, V6, P154, DOI 10.1016/0962-8924(96)40001-0; CARPINO LA, 1994, J CHEM SOC CHEM COMM, P201, DOI 10.1039/c39940000201; COLBRAN JL, 1992, J BIOL CHEM, V267, P9589; Dey NB, 2005, J CARDIOVASC PHARM, V45, P404, DOI 10.1097/01.fjc.0000157455.38068.12; Dostmann WRG, 2002, PHARMACOL THERAPEUT, V93, P203, DOI 10.1016/S0163-7258(02)00189-4; Dostmann WRG, 1999, PHARMACOL THERAPEUT, V82, P373, DOI 10.1016/S0163-7258(98)00063-1; Dostmann WRG, 2000, P NATL ACAD SCI USA, V97, P14772, DOI 10.1073/pnas.97.26.14772; FIELDS C G, 1991, Peptide Research, V4, P95; Foley KF, 2005, FRONT BIOSCI-LANDMRK, V10, P1302, DOI 10.2741/1620; Francis S H, 1988, Second Messengers Phosphoproteins, V12, P301; FRANCIS SH, 1994, ANNU REV PHYSIOL, V56, P237, DOI 10.1146/annurev.ph.56.030194.001321; Francis SH, 2002, FRONT BIOSCI-LANDMRK, V7, pD580, DOI 10.2741/francis; GLASS DB, 1986, J BIOL CHEM, V261, P2987; GLASS DB, 1979, J BIOL CHEM, V254, P9728; Heck AJR, 2004, MASS SPECTROM REV, V23, P368, DOI 10.1002/mas.10081; HOFMANN F, 1992, BIOCHIM BIOPHYS ACTA, V1135, P51, DOI 10.1016/0167-4889(92)90165-8; Hou YL, 2006, CELL SIGNAL, V18, P882, DOI 10.1016/j.cellsig.2005.07.015; Jahn O, 2004, ANAL BIOANAL CHEM, V378, P1031, DOI 10.1007/s00216-003-2353-8; KAUER JC, 1986, J BIOL CHEM, V261, P695; Kim C, 2005, SCIENCE, V307, P690, DOI 10.1126/science.1104607; Kim C, 2007, CELL, V130, P1032, DOI 10.1016/j.cell.2007.07.018; KNORR R, 1989, TETRAHEDRON LETT, V30, P1927, DOI 10.1016/S0040-4039(00)99616-3; Krieg T, 2005, AM J PHYSIOL-HEART C, V288, pH1976, DOI 10.1152/ajpheart.00883.2004; Lohmann SM, 1997, TRENDS BIOCHEM SCI, V22, P307, DOI 10.1016/S0968-0004(97)01086-4; Loo JA, 1997, MASS SPECTROM REV, V16, P1; Meiring HD, 2002, J SEP SCI, V25, P557, DOI 10.1002/1615-9314(20020601)25:9<557::AID-JSSC557>3.0.CO;2-F; MILLER WT, 1988, P NATL ACAD SCI USA, V85, P5429, DOI 10.1073/pnas.85.15.5429; MITCHELL RD, 1995, BIOCHEMISTRY-US, V34, P528, DOI 10.1021/bi00002a018; NASSAL M, 1984, J AM CHEM SOC, V106, P7540, DOI 10.1021/ja00336a038; Pinkse MWH, 2004, J AM SOC MASS SPECTR, V15, P1392, DOI 10.1016/j.jasms.2004.06.015; Ploug M, 1998, BIOCHEMISTRY-US, V37, P3612, DOI 10.1021/bi972787k; Przybylski M, 1996, ANGEW CHEM INT EDIT, V35, P807; RINK H, 1987, TETRAHEDRON LETT, V28, P3787, DOI 10.1016/S0040-4039(00)96384-6; Rogniaux H, 2001, ANAL BIOCHEM, V291, P48, DOI 10.1006/abio.2000.4975; Samalikova M, 2004, ANAL BIOANAL CHEM, V378, P1112, DOI 10.1007/s00216-003-2339-6; Scholten A, 2008, MASS SPECTROM REV, V27, P331, DOI 10.1002/mas.20166; Sharon M, 2007, ANNU REV BIOCHEM, V76, P167, DOI 10.1146/annurev.biochem.76.061005.090816; Simmons DA, 2002, BIOCHEMISTRY-US, V41, P1906, DOI 10.1021/bi011697j; Tahallah N, 2001, RAPID COMMUN MASS SP, V15, P596, DOI 10.1002/rcm.275; TAKIO K, 1984, BIOCHEMISTRY-US, V23, P4207, DOI 10.1021/bi00313a030; Taylor MS, 2004, MOL PHARMACOL, V65, P1111, DOI 10.1124/mol.65.5.1111; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; TEGGE W, 1995, BIOCHEMISTRY-US, V34, P10569, DOI 10.1021/bi00033a032; TENKORTENAAR PBW, 1986, INT J PEPT PROT RES, V27, P398; THOMAS NE, 1987, BIOCHEMISTRY-US, V26, P4471, DOI 10.1021/bi00388a043; Tjernberg A, 2004, ANAL CHEM, V76, P4325, DOI 10.1021/ac0497914; van Duijn E, 2005, NAT METHODS, V2, P371, DOI 10.1038/nmeth753; Veenstra TD, 1998, J AM SOC MASS SPECTR, V9, P8, DOI 10.1016/S1044-0305(97)00229-8; Weber PJA, 1997, J PEPT RES, V49, P375; Wood JS, 1996, J BIOL CHEM, V271, P174, DOI 10.1074/jbc.271.1.174; Wu J, 2007, SCIENCE, V318, P274, DOI 10.1126/science.1146447; Yan XW, 1996, J BIOL CHEM, V271, P1845, DOI 10.1074/jbc.271.4.1845; Zhu CB, 2005, J BIOL CHEM, V280, P15649, DOI 10.1074/jbc.M410858200	57	13	13	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16354	16368		10.1074/jbc.M808521200	http://dx.doi.org/10.1074/jbc.M808521200			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19369251	Green Published, hybrid			2022-12-27	WOS:000266730900033
J	Pless, SA; Lynch, JW				Pless, Stephan A.; Lynch, Joseph W.			Ligand-specific Conformational Changes in the alpha 1 Glycine Receptor Ligand-binding Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NICOTINIC ACETYLCHOLINE-RECEPTOR; GATED ION-CHANNEL; CYS-LOOP RECEPTORS; GABA(A) RECEPTOR; CRYSTAL-STRUCTURE; AGONIST-BINDING; EXTRACELLULAR DOMAIN; STRYCHNINE BINDING; CHARGED RESIDUES; F-LOOP	Understanding the activation mechanism of Cys loop ion channel receptors is key to understanding their physiological and pharmacological properties under normal and pathological conditions. The ligand-binding domains of these receptors comprise inner and outer beta-sheets and structural studies indicate that channel opening is accompanied by conformational rearrangements in both beta-sheets. In an attempt to resolve ligand-dependent movements in the ligand-binding domain, we employed voltage-clamp fluorometry on alpha 1 glycine receptors to compare changes mediated by the agonist, glycine, and by the antagonist, strychnine. Voltage-clamp fluorometry involves labeling introduced cysteines with environmentally sensitive fluorophores and inferring structural rearrangements from ligand-induced fluorescence changes. In the inner beta-sheet, we labeled residues in loop 2 and in binding domain loops D and E. At each position, strychnine and glycine induced distinct maximal fluorescence responses. The pre-M1 domain responded similarly; at each of four labeled positions glycine produced a strong fluorescence signal, whereas strychnine did not. This suggests that glycine induces conformational changes in the inner beta-sheet and pre-M1 domain that may be important for activation, desensitization, or both. In contrast, most labeled residues in loops C and F yielded fluorescence changes identical in magnitude for glycine and strychnine. A notable exception was H201C in loop C. This labeled residue responded differently to glycine and strychnine, thus underlining the importance of loop C in ligand discrimination. These results provide an important step toward mapping the domains crucial for ligand discrimination in the ligand-binding domain of glycine receptors and possibly other Cys loop receptors.	[Lynch, Joseph W.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia	University of Queensland; University of Queensland	Lynch, JW (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia.	j.lynch@uq.edu.au	Lynch, Joseph/C-8636-2009	Pless, Stephan/0000-0001-6654-114X	Australian Research Council; National Health and Medical Research Council of Australia; University of Queensland	Australian Research Council(Australian Research Council); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); University of Queensland(University of Queensland)	This work was supported by the Australian Research Council and the National Health and Medical Research Council of Australia.; Supported by an International Postgraduate Research Scholarship from the University of Queensland.; Supported by a National Health and Medical Research Council of Australia Senior Research Fellowship.	Absalom NL, 2003, J BIOL CHEM, V278, P50151, DOI 10.1074/jbc.M305357200; BARNARD EA, 1992, TRENDS BIOCHEM SCI, V17, P368, DOI 10.1016/0968-0004(92)90002-Q; Beato M, 2002, J GEN PHYSIOL, V119, P443, DOI 10.1085/jgp.20028530; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bourne Y, 2005, EMBO J, V24, P1512, DOI 10.1038/sj.emboj.7600620; Brejc K, 2001, NATURE, V411, P269, DOI 10.1038/35077011; Celie PHN, 2004, NEURON, V41, P907, DOI 10.1016/S0896-6273(04)00115-1; Celie PHN, 2005, NAT STRUCT MOL BIOL, V12, P582, DOI 10.1038/nsmb951; Chang YC, 2002, NAT NEUROSCI, V5, P1163, DOI 10.1038/nn926; Cheng XL, 2006, PLOS COMPUT BIOL, V2, P1173, DOI 10.1371/journal.pcbi.0020134; Cheng XL, 2006, J MOL BIOL, V355, P310, DOI 10.1016/j.jmb.2005.10.039; Dahan DS, 2004, P NATL ACAD SCI USA, V101, P10195, DOI 10.1073/pnas.0301885101; Gao F, 2005, J BIOL CHEM, V280, P8443, DOI 10.1074/jbc.M412389200; Grudzinska J, 2005, NEURON, V45, P727, DOI 10.1016/j.neuron.2005.01.028; Hansen SB, 2005, EMBO J, V24, P3635, DOI 10.1038/sj.emboj.7600828; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Kash TL, 2004, BIOCHEM SOC T, V32, P540, DOI 10.1042/BST0320540; Kash TL, 2004, NEUROSCI LETT, V371, P230, DOI 10.1016/j.neulet.2004.09.002; Kash TL, 2004, J BIOL CHEM, V279, P4887, DOI 10.1074/jbc.M311441200; Kash TL, 2003, NATURE, V421, P272, DOI 10.1038/nature01280; Khatri A, 2009, BIOPHYS J, V96, P45, DOI 10.1016/j.bpj.2008.09.011; Law RJ, 2005, P NATL ACAD SCI USA, V102, P6813, DOI 10.1073/pnas.0407739102; Le Novere N, 2001, PHILOS T R SOC B, V356, P1121; Lee WY, 2005, NATURE, V438, P243, DOI 10.1038/nature04156; Lester HA, 2004, TRENDS NEUROSCI, V27, P329, DOI 10.1016/j.tins.2004.04.002; Lewis TM, 2003, J PHYSIOL-LONDON, V549, P361, DOI 10.1113/jphysiol.2002.037796; Liu XL, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040019; Mourot A, 2008, J NEUROCHEM, V105, P413, DOI 10.1111/j.1471-4159.2007.05151.x; Mukhtasimova N, 2005, J GEN PHYSIOL, V126, P23, DOI 10.1085/jgp.200509283; Mukhtasimova N, 2007, J NEUROSCI, V27, P4110, DOI 10.1523/JNEUROSCI.0025-07.2007; Muroi Y, 2006, BIOCHEMISTRY-US, V45, P7013, DOI 10.1021/bi060222v; Muroi Y, 2009, BIOPHYS J, V96, P499, DOI 10.1016/j.bpj.2008.09.037; Newell JG, 2003, J BIOL CHEM, V278, P13166, DOI 10.1074/jbc.M211905200; Padgett CL, 2008, J BIOL CHEM, V283, P2702, DOI 10.1074/jbc.M705699200; Pless SA, 2008, J NEUROSCI, V28, P10937, DOI 10.1523/JNEUROSCI.2540-08.2008; Pless SA, 2008, CLIN EXP PHARMACOL P, V35, P1137, DOI 10.1111/j.1440-1681.2008.04954.x; Pless SA, 2007, J BIOL CHEM, V282, P36057, DOI 10.1074/jbc.M706468200; Pless SA, 2009, J NEUROCHEM, V108, P1585, DOI 10.1111/j.1471-4159.2009.05930.x; Purohit P, 2007, J GEN PHYSIOL, V130, P569, DOI 10.1085/jgp.200709858; RAJENDRA S, 1995, EMBO J, V14, P2987, DOI 10.1002/j.1460-2075.1995.tb07301.x; Sala F, 2005, J BIOL CHEM, V280, P6642, DOI 10.1074/jbc.M411048200; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Taly A, 2006, P NATL ACAD SCI USA, V103, P16965, DOI 10.1073/pnas.0607477103; Thompson AJ, 2006, J BIOL CHEM, V281, P16576, DOI 10.1074/jbc.M601265200; Unwin N, 2003, FEBS LETT, V555, P91, DOI 10.1016/S0014-5793(03)01084-6; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Unwin N, 2002, J MOL BIOL, V319, P1165, DOI 10.1016/S0022-2836(02)00381-9; VANDENBERG RJ, 1992, NEURON, V9, P491, DOI 10.1016/0896-6273(92)90186-H; Venkatachalan SP, 2008, P NATL ACAD SCI USA, V105, P13604, DOI 10.1073/pnas.0801854105; Virkki LV, 2006, J BIOL CHEM, V281, P28837, DOI 10.1074/jbc.M603861200; Wagner DA, 2001, J NEUROSCI, V21, P67, DOI 10.1523/JNEUROSCI.21-01-00067.2001; Xiu XN, 2005, J BIOL CHEM, V280, P41655, DOI 10.1074/jbc.M508635200; YOUNG AB, 1974, P NATL ACAD SCI USA, V71, P4002, DOI 10.1073/pnas.71.10.4002; YOUNG AB, 1973, P NATL ACAD SCI USA, V70, P2832, DOI 10.1073/pnas.70.10.2832; Zhang JL, 2009, J PHYSIOL-LONDON, V587, P139, DOI 10.1113/jphysiol.2008.160093	55	54	54	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15847	15856		10.1074/jbc.M809343200	http://dx.doi.org/10.1074/jbc.M809343200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19286654	Green Published, hybrid			2022-12-27	WOS:000266501000053
J	Yuan, W; Xie, JW; Long, CZ; Erdjument-Bromage, H; Ding, XJ; Zheng, Y; Tempst, P; Chen, S; Zhu, B; Reinberg, D				Yuan, Wen; Xie, Jingwei; Long, Chengzu; Erdjument-Bromage, Hediye; Ding, Xiaojun; Zheng, Yong; Tempst, Paul; Chen, She; Zhu, Bing; Reinberg, Danny			Heterogeneous Nuclear Ribonucleoprotein L Is a Subunit of Human KMT3a/Set2 Complex Required for H3 Lys-36 Trimethylation Activity in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA-POLYMERASE-II; HISTONE H3; HNRNP-L; GENE-EXPRESSION; TRANSCRIPTIONAL ELONGATION; SACCHAROMYCES-CEREVISIAE; CHROMATIN MODIFICATIONS; H3K36 METHYLATION; MESSENGER-RNAS; SET2	The presence of histone H3 lysine 36 methylation (H3K36me) correlates with actively transcribed genes. In yeast, histone H3K36me mediated by KMT3 (also known as Set2) recruits a histone deacetylase complex, Rpd3s, to ensure the fidelity of transcription initiation. We report the purification of human KMT3a (also known as HYPB or hSet2) complex and the identification of a novel, higher eukaryotic specific subunit, heterogeneous nuclear ribonucleoprotein L (HnRNP-L). Interestingly, although KMT3a has intrinsic activity in vitro, HnRNP-L is essential in vivo. Moreover, KMT3a generates mono-, di-, and trimethylated products in vitro, but RNA interference against KMT3a or HnRNP-L down-regulates exclusively the H3K36me3 mark in vivo.	[Yuan, Wen; Xie, Jingwei; Long, Chengzu; Ding, Xiaojun; Zheng, Yong; Chen, She; Zhu, Bing] Natl Inst Biol Sci, Beijing 102206, Peoples R China; [Yuan, Wen] China Agr Univ, Coll Biol Sci, State Key Lab Plant Physiol & Biochem, Beijing 100094, Peoples R China; [Xie, Jingwei] Peking Union Med Coll, Grad Program, Beijing 100730, Peoples R China; [Xie, Jingwei] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Erdjument-Bromage, Hediye; Tempst, Paul] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10021 USA; [Zheng, Yong; Zhu, Bing; Reinberg, Danny] NYU, Sch Med, Dept Biochem, Howard Hughes Med Inst, New York, NY 10016 USA	National Institute of Biological Sciences, Beijing; China Agricultural University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; New York University	Zhu, B (corresponding author), Natl Inst Biol Sci, 7 Sci Pk Rd,Zhong Guan Cun Life Sci Pk, Beijing 102206, Peoples R China.	zhubing@nibs.ac.cn; reinbd01@med.nyu.edu	xie, jing/GRY-1689-2022	Erdjument-Bromage, Hediye/0000-0003-0224-3594; Reinberg, Danny/0000-0003-4288-2016; Tempst, Paul/0000-0002-6680-3987; yuan, wen/0000-0003-0029-2544	National Institutes of Health [GM37120]; NCI [P30 CA08748]; Howard Hughes Medical Institute; Chinese Ministry of Science and Technology [2007AA02Z1A6]; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM037120, R37GM037120] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM37120. This work was also supported by the NCI Cancer Center Support Grant P30 CA08748 (to P. T.), by the Howard Hughes Medical Institute (to D. R.), and by the Chinese Ministry of Science and Technology 863 Project 2007AA02Z1A6 (to B. Z.).	Bannister AJ, 2005, J BIOL CHEM, V280, P17732, DOI 10.1074/jbc.M500796200; Bell O, 2008, MOL CELL BIOL, V28, P3401, DOI 10.1128/MCB.00006-08; Bell O, 2007, EMBO J, V26, P4974, DOI 10.1038/sj.emboj.7601926; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Edmunds JW, 2008, EMBO J, V27, P406, DOI 10.1038/sj.emboj.7601967; FIDDES JC, 1980, NATURE, V286, P684, DOI 10.1038/286684a0; FITZGERALD M, 1981, CELL, V24, P251, DOI 10.1016/0092-8674(81)90521-3; Guang SH, 2005, MOL CELL BIOL, V25, P6303, DOI 10.1128/MCB.25.15.6303-6313.2005; Hampsey M, 2003, CELL, V113, P429, DOI 10.1016/S0092-8674(03)00360-X; Hui JY, 2003, NAT STRUCT BIOL, V10, P33, DOI 10.1038/nsb875; Hung LH, 2008, RNA, V14, P284, DOI 10.1261/rna.725208; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kizer KO, 2005, MOL CELL BIOL, V25, P3305, DOI 10.1128/MCB.25.8.3305-3316.2005; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Konarska MM, 2005, GENE DEV, V19, P2255, DOI 10.1101/gad.1363105; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Li B, 2003, J BIOL CHEM, V278, P8897, DOI 10.1074/jbc.M212134200; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li B, 2007, SCIENCE, V316, P1050, DOI 10.1126/science.1139004; Li JX, 2002, J BIOL CHEM, V277, P49383, DOI 10.1074/jbc.M209294200; LIU XD, 1995, GENE DEV, V9, P1766, DOI 10.1101/gad.9.14.1766; Maniatis T, 2002, NATURE, V416, P499, DOI 10.1038/416499a; Margueron R, 2005, CURR OPIN GENET DEV, V15, P163, DOI 10.1016/j.gde.2005.01.005; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Martin DGE, 2006, MOL CELL BIOL, V26, P3018, DOI 10.1128/MCB.26.8.3018-3028.2006; Melton AA, 2007, MOL CELL BIOL, V27, P6972, DOI 10.1128/MCB.00419-07; Orphanides G, 2002, CELL, V108, P439, DOI 10.1016/S0092-8674(02)00655-4; Rayasam GV, 2003, EMBO J, V22, P3153, DOI 10.1093/emboj/cdg288; Rothrock CR, 2005, EMBO J, V24, P2792, DOI 10.1038/sj.emboj.7600745; Santos-Rosa H, 2002, NATURE, V419, P407, DOI 10.1038/nature01080; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Shi XB, 2007, J BIOL CHEM, V282, P2450, DOI 10.1074/jbc.C600286200; Shilatifard A, 2006, ANNU REV BIOCHEM, V75, P243, DOI 10.1146/annurev.biochem.75.103004.142422; Sims RJ, 2007, MOL CELL, V28, P665, DOI 10.1016/j.molcel.2007.11.010; Strahl BD, 2002, MOL CELL BIOL, V22, P1298, DOI 10.1128/MCB.22.5.1298-1306.2002; Sun XJ, 2005, J BIOL CHEM, V280, P35261, DOI 10.1074/jbc.M504012200; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; Weake VM, 2008, MOL CELL, V29, P653, DOI 10.1016/j.molcel.2008.02.014; Xiao TJ, 2003, GENE DEV, V17, P654, DOI 10.1101/gad.1055503; Xu L, 2008, MOL CELL BIOL, V28, P1348, DOI 10.1128/MCB.01607-07; Zhu B, 2005, MOL CELL, V20, P601, DOI 10.1016/j.molcel.2005.09.025; Zhu B, 2005, GENE DEV, V19, P1668, DOI 10.1101/gad.1292105	47	72	77	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15701	15707		10.1074/jbc.M808431200	http://dx.doi.org/10.1074/jbc.M808431200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19332550	Green Published, hybrid			2022-12-27	WOS:000266501000039
J	Chen, YL; Cai, T; Wang, HJ; Li, ZC; Loreaux, E; Lingrel, JB; Xie, ZJ				Chen, Yiliang; Cai, Ting; Wang, Haojie; Li, Zhichuan; Loreaux, Elizabeth; Lingrel, Jerry B.; Xie, Zijian			Regulation of Intracellular Cholesterol Distribution by Na/K-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SIGNAL-TRANSDUCING FUNCTION; ACTIVATED PROTEIN-KINASES; NA+/K+-ATPASE; CARDIAC MYOCYTES; PLASMA-MEMBRANES; CAVEOLAE; RECEPTOR; CELLS; COMPLEX; BINDING	Recent studies have ascribed many non-pumping functions to the Na/K-ATPase. We show here that graded knockdown of cellular Na/K-ATPase alpha 1 subunit produces a parallel decrease in both caveolin-1 and cholesterol in light fractions of LLC-PK1 cell lysates. This observation is further substantiated by imaging analyses, showing redistribution of cholesterol from the plasma membrane to intracellular compartments in the knockdown cells. Moreover, this regulation is confirmed in alpha 1(-/-) mouse liver. Functionally, the knockdown-induced redistribution appears to affect the cholesterol sensing in the endoplasmic reticulum, because it activates the sterol regulatory element-binding protein pathway and increases expression of hydroxym-ethylglutaryl-CoA reductase and low density lipoprotein receptor in the liver. Consistently, we detect a modest increase in hepatic cholesterol as well as a reduction in the plasma cholesterol. Mechanistically, alpha 1(-/-) livers show increases in cellular Src and ERK activity and redistribution of caveolin-1. Although activation of Src is not required in Na/K-ATPase-mediated regulation of cholesterol distribution, the interaction between the Na/K-ATPase and caveolin-1 is important for this regulation. Taken together, our new findings demonstrate a novel function of the Na/K-ATPase in control of the plasma membrane cholesterol distribution. Moreover, the data also suggest that the plasma membrane Na/K-ATPase-caveolin-1 interaction may represent an important sensing mechanism by which the cells regulate the sterol regulatory element-binding protein pathway.	[Xie, Zijian] Univ Toledo, Coll Med, Dept Physiol & Pharmacol, Toledo, OH 43614 USA; [Loreaux, Elizabeth; Lingrel, Jerry B.] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA	University System of Ohio; University of Toledo; University System of Ohio; University of Cincinnati	Xie, ZJ (corresponding author), Univ Toledo, Coll Med, Dept Physiol & Pharmacol, 3000 Arlington Ave, Toledo, OH 43614 USA.	zi-jian.xie@utoledo.edu	Li, Zhichuan/Q-7379-2017	Chen, Yiliang/0000-0001-9786-8305; Edwards, Elizabeth/0000-0002-5983-4654; Edwards, Elizabeth/0000-0003-0770-1179	National Institutes of Health [HL-36573, HL-67963, GM 78565]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067963, P01HL036573] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078565] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants HL-36573, HL-67963, and GM 78565.	Abidi P, 2005, INT J MOL MED, V16, P779; Bist A, 1997, P NATL ACAD SCI USA, V94, P10693, DOI 10.1073/pnas.94.20.10693; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Brown MS, 1999, P NATL ACAD SCI USA, V96, P11041, DOI 10.1073/pnas.96.20.11041; Cai T, 2008, J CELL BIOL, V182, P1153, DOI 10.1083/jcb.200712022; Carozzi AJ, 2000, TRAFFIC, V1, P326, DOI 10.1034/j.1600-0854.2000.010406.x; CHEN M, 1995, BBA-MOL BASIS DIS, V1272, P101, DOI 10.1016/0925-4439(95)00073-D; Chen Y, 2008, J BIOL CHEM, V283, P1128, DOI 10.1074/jbc.M708025200; CORNELIUS F, 1995, BBA-BIOMEMBRANES, V1235, P205, DOI 10.1016/0005-2736(95)80006-2; DELUISE M, 1980, NEW ENGL J MED, V303, P1017, DOI 10.1056/NEJM198010303031801; Djurhuus MS, 2001, J CLIN ENDOCR METAB, V86, P859, DOI 10.1210/jc.86.2.859; Fielding CJ, 2000, BBA-MOL CELL BIOL L, V1529, P210, DOI 10.1016/S1388-1981(00)00150-5; Frank PG, 2006, AM J PHYSIOL-HEART C, V291, pH677, DOI 10.1152/ajpheart.01092.2005; Garver WS, 2007, J CELL BIOCHEM, V101, P498, DOI 10.1002/jcb.21200; GIRAUD F, 1976, NATURE, V264, P646, DOI 10.1038/264646a0; Goldstein JL, 2006, CELL, V124, P35, DOI 10.1016/j.cell.2005.12.022; Haas A, 2002, J BIOL CHEM, V277, P18694, DOI 10.1074/jbc.M111357200; Haas M, 2000, J BIOL CHEM, V275, P27832; Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961; James PF, 1999, MOL CELL, V3, P555, DOI 10.1016/S1097-2765(00)80349-4; Kometiani P, 1998, J BIOL CHEM, V273, P15249, DOI 10.1074/jbc.273.24.15249; Lange Y, 2000, J BIOL CHEM, V275, P17468, DOI 10.1074/jbc.M000875200; Lange Y, 1999, J LIPID RES, V40, P2264; LANGE Y, 1989, J BIOL CHEM, V264, P3786; Li H, 1998, ENDOCRINOLOGY, V139, P4991, DOI 10.1210/en.139.12.4991; Li SN, 1998, TOXICOL APPL PHARM, V151, P377, DOI 10.1006/taap.1998.8471; Liang M, 2007, J BIOL CHEM, V282, P10585, DOI 10.1074/jbc.M609181200; Liang M, 2006, J BIOL CHEM, V281, P19709, DOI 10.1074/jbc.M512240200; LINGREL JB, 1990, PROG NUCLEIC ACID RE, V38, P37; LINGREL JB, 1994, J BIOL CHEM, V269, P19659; Liu LJ, 2003, AM J PHYSIOL-CELL PH, V284, pC1550, DOI 10.1152/ajpcell.00555.2002; MURATA M, 1995, P NATL ACAD SCI USA, V92, P10339, DOI 10.1073/pnas.92.22.10339; NODA K, 1990, DIABETES RES CLIN PR, V8, P177, DOI 10.1016/0168-8227(90)90114-9; Parton RG, 2006, J CELL SCI, V119, P787, DOI 10.1242/jcs.02853; Pelkmans L, 2005, NATURE, V436, P128, DOI 10.1038/nature03866; Pol A, 2001, J CELL BIOL, V152, P1057, DOI 10.1083/jcb.152.5.1057; Puri V, 2003, J BIOL CHEM, V278, P20961, DOI 10.1074/jbc.M300304200; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Sampson LJ, 2004, CIRC RES, V95, P1012, DOI 10.1161/01.RES.0000148634.47095.ab; SKOU JC, 1957, BIOCHIM BIOPHYS ACTA, V23, P394, DOI 10.1016/0006-3002(57)90343-8; Sobo K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000851; Sun YT, 2005, BIOCHEMISTRY-US, V44, P14455, DOI 10.1021/bi0509090; SWEADNER KJ, 1989, BIOCHIM BIOPHYS ACTA, V988, P185, DOI 10.1016/0304-4157(89)90019-1; Tian J, 2006, MOL BIOL CELL, V17, P317, DOI 10.1091/mbc.E05-08-0735; Uittenbogaard A, 2002, J BIOL CHEM, V277, P4925, DOI 10.1074/jbc.M109278200; Uittenbogaard A, 1998, J BIOL CHEM, V273, P6525, DOI 10.1074/jbc.273.11.6525; Wang HJ, 2004, J BIOL CHEM, V279, P17250, DOI 10.1074/jbc.M313239200; Williams TM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-214; Xie ZJ, 2001, CELL MOL BIOL, V47, P383; Xie ZJ, 1999, J BIOL CHEM, V274, P19323, DOI 10.1074/jbc.274.27.19323; YEAGLE PL, 1983, BIOCHIM BIOPHYS ACTA, V727, P39, DOI 10.1016/0005-2736(83)90366-8; Yuan ZK, 2005, MOL BIOL CELL, V16, P4034, DOI 10.1091/mbc.E05-04-0295	52	44	49	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					14881	14890		10.1074/jbc.M109.003574	http://dx.doi.org/10.1074/jbc.M109.003574			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19363037	Green Published, hybrid			2022-12-27	WOS:000266288200024
J	Huang, SH; Zhao, L; Sun, ZP; Li, XZ; Geng, Z; Zhang, KD; Chao, MV; Chen, ZY				Huang, Shu-Hong; Zhao, Ling; Sun, Zong-Peng; Li, Xue-Zhi; Geng, Zhao; Zhang, Kai-Di; Chao, Moses V.; Chen, Zhe-Yu			Essential Role of Hrs in Endocytic Recycling of Full-length TrkB Receptor but Not Its Isoform TrkB.T1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR RECEPTOR; NEUROTROPHIN SIGNAL-TRANSDUCTION; ACTIVITY-DEPENDENT SECRETION; TYROSINE KINASE SUBSTRATE; PROTEIN-COUPLED RECEPTORS; ZINC-FINGER DOMAIN; EARLY ENDOSOMES; MULTIVESICULAR ENDOSOMES; TRUNCATED RECEPTORS; DENDRITIC GROWTH	Brain-derived neurotrophic factor (BDNF) signaling through its receptor, TrkB, modulates survival, differentiation, and synaptic activity of neurons. Both full-length TrkB (TrkB-FL) and its isoform T1 (TrkB.T1) receptors are expressed in neurons; however, whether they follow the same endocytic pathway after BDNF treatment is not known. In this study we report that TrkB-FL and TrkB.T1 receptors traverse divergent endocytic pathways after binding to BDNF. We provide evidence that in neurons TrkB.T1 receptors predominantly recycle back to the cell surface by a "default" mechanism. However, endocytosed TrkB-FL receptors recycle to a lesser extent in a hepatocyte growth factor-regulated tyrosine kinase substrate (Hrs)-dependent manner which relies on its tyrosine kinase activity. The distinct role of Hrs in promoting recycling of internalized TrkB-FL receptors is independent of its ubiquitin-interacting motif. Moreover, Hrs-sensitive TrkB-FL recycling plays a role in BDNF-induced prolonged mitogen-activated protein kinase (MAPK) activation. These observations provide evidence for differential postendocytic sorting of TrkB-FL and TrkB.T1 receptors to alternate intracellular pathways.	[Huang, Shu-Hong; Zhao, Ling; Sun, Zong-Peng; Li, Xue-Zhi; Geng, Zhao; Zhang, Kai-Di; Chen, Zhe-Yu] Shandong Univ, Qilu Hosp, Dept Neurobiol, Key Lab Med Neurobiol,Sch Med, Jinan 250012, Shandong, Peoples R China; [Chen, Zhe-Yu] Shandong Univ, Qilu Hosp, Key Lab Cardiovasc Remodeling & Funct Res, Chinese Minist Educ, Jinan 250012, Shandong, Peoples R China; [Chen, Zhe-Yu] Shandong Univ, Qilu Hosp, Chinese Minist Hlth, Jinan 250012, Shandong, Peoples R China; [Chao, Moses V.] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Chao, Moses V.] NYU, Sch Med, Dept Physiol, New York, NY 10016 USA; [Chao, Moses V.] NYU, Sch Med, Dept Neurosci, New York, NY 10016 USA; [Chao, Moses V.] NYU, Sch Med, Dept Psychiat, New York, NY 10016 USA	Shandong University; Shandong University; Shandong University; New York University; New York University; New York University; New York University	Chen, ZY (corresponding author), Shandong Univ, Dept Neurobiol, Sch Med, 44 Wenhua Xi Rd, Jinan 250012, Shandong, Peoples R China.	zheyuchen@sdu.edu.cn	Li, Xuezhi/ABF-6626-2021; Huang, Shuhong/AAI-4151-2021	Chao, Moses/0000-0002-6969-3744; Li, Xuezhi/0000-0003-1030-9688	Natural Science Foundation of China [30671050, 30725020, 30700258, 90713016]; National 973 Basic Research Program of China [2009CB941403, 2009CB526507]; National High-Tech Research and Development Program of China [2006AA02A406]; Chinese Ministry of Education [707040]; Fok Ying Tong Education Foundation [111044]; China Postdoctoral Science Foundation [20070421083, 200702028, 200801406]; Research Fund for the Doctoral Program of Higher Education of China [200804221070]; National Alliance for Research on Schizophrenia and Depression	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National 973 Basic Research Program of China(National Basic Research Program of China); National High-Tech Research and Development Program of China(National High Technology Research and Development Program of China); Chinese Ministry of Education(Ministry of Education, China); Fok Ying Tong Education Foundation(Fok Ying Tung Education Foundation); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); National Alliance for Research on Schizophrenia and Depression(NARSAD)	This work was supported by Natural Science Foundation of China Grants 30671050, 30725020, 30700258, and 90713016, National 973 Basic Research Program of China Grants 2009CB941403 and 2009CB526507, National High-Tech Research and Development Program of China Grant 2006AA02A406, Cultivation Fund of the Key Science and Technology Innovation Project from Chinese Ministry of Education Grant 707040, Fok Ying Tong Education Foundation Grant 111044, China Postdoctoral Science Foundation Grants 20070421083, 200702028, and 200801406, Research Fund for the Doctoral Program of Higher Education of China Grant 200804221070, and the National Alliance for Research on Schizophrenia and Depression.	Alderson RF, 2000, BRAIN RES, V871, P210, DOI 10.1016/S0006-8993(00)02428-8; ALLENDOERFER KL, 1994, J NEUROSCI, V14, P1795; Arevalo JC, 2006, NEURON, V50, P549, DOI 10.1016/j.neuron.2006.03.044; ARMANINI MP, 1995, EUR J NEUROSCI, V7, P1403, DOI 10.1111/j.1460-9568.1995.tb01132.x; Babst M, 2000, TRAFFIC, V1, P248, DOI 10.1034/j.1600-0854.2000.010307.x; Bache KG, 2003, J BIOL CHEM, V278, P12513, DOI 10.1074/jbc.M210843200; Baxter GT, 1997, J NEUROSCI, V17, P2683; BIFFO S, 1995, DEVELOPMENT, V121, P2461; Bilodeau PS, 2002, NAT CELL BIOL, V4, P534, DOI 10.1038/ncb815; Chao M, 1998, BRAIN RES REV, V26, P295, DOI 10.1016/S0165-0173(97)00036-2; Chao MV, 2003, NAT REV NEUROSCI, V4, P299, DOI 10.1038/nrn1078; Chen ZY, 2004, J NEUROSCI, V24, P4401, DOI 10.1523/JNEUROSCI.0348-04.2004; Chen ZY, 2005, MOL BIOL CELL, V16, P5761, DOI 10.1091/mbc.E05-07-0651; Chin LS, 2001, J BIOL CHEM, V276, P7069, DOI 10.1074/jbc.M004129200; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; Cong M, 2001, J BIOL CHEM, V276, P45145, DOI 10.1074/jbc.M106087200; Dorsey SG, 2006, NEURON, V51, P21, DOI 10.1016/j.neuron.2006.06.009; Eide FF, 1996, J NEUROSCI, V16, P3123; ESCANDON E, 1994, J NEUROSCI, V14, P2054; FRISEN J, 1993, P NATL ACAD SCI USA, V90, P4971, DOI 10.1073/pnas.90.11.4971; Fryer RH, 1997, EXP NEUROL, V148, P616, DOI 10.1006/exnr.1997.6699; Fryer RH, 1996, J COMP NEUROL, V374, P21, DOI 10.1002/(SICI)1096-9861(19961007)374:1<21::AID-CNE2>3.0.CO;2-P; Gage RM, 2001, J BIOL CHEM, V276, P44712, DOI 10.1074/jbc.M107417200; Galet C, 2003, MOL ENDOCRINOL, V17, P411, DOI 10.1210/me.2002-0161; Geetha T, 2005, MOL CELL, V20, P301, DOI 10.1016/j.molcel.2005.09.014; Ginty DD, 2002, CURR OPIN NEUROBIOL, V12, P268, DOI 10.1016/S0959-4388(02)00326-4; Grimes ML, 1997, P NATL ACAD SCI USA, V94, P9909, DOI 10.1073/pnas.94.18.9909; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Haapasalo A, 1999, ONCOGENE, V18, P1285, DOI 10.1038/sj.onc.1202401; Hanyaloglu AC, 2005, EMBO J, V24, P2265, DOI 10.1038/sj.emboj.7600688; Hanyaloglu AC, 2007, J BIOL CHEM, V282, P3095, DOI 10.1074/jbc.M605398200; Hasdemir B, 2007, J BIOL CHEM, V282, P29646, DOI 10.1074/jbc.M702974200; Heerssen HM, 2002, TRENDS NEUROSCI, V25, P160, DOI 10.1016/S0166-2236(02)02144-6; Hislop JN, 2004, J BIOL CHEM, V279, P22522, DOI 10.1074/jbc.M311062200; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Jadhav T, 2008, BIOCHEM BIOPH RES CO, V371, P521, DOI 10.1016/j.bbrc.2008.04.138; Jullien J, 2002, J BIOL CHEM, V277, P38700, DOI 10.1074/jbc.M202348200; Kaplan DR, 2000, CURR OPIN NEUROBIOL, V10, P381, DOI 10.1016/S0959-4388(00)00092-1; KLEIN R, 1990, CELL, V61, P647, DOI 10.1016/0092-8674(90)90476-U; KNUSEL B, 1994, J NEUROSCI, V14, P1542, DOI 10.1523/JNEUROSCI.14-03-01542.1994; KOMADA M, 1995, MOL CELL BIOL, V15, P6213; Komada M, 1997, J BIOL CHEM, V272, P20538, DOI 10.1074/jbc.272.33.20538; Kryl D, 1999, J NEUROSCI, V19, P5823, DOI 10.1523/JNEUROSCI.19-14-05823.1999; Li JG, 2002, J BIOL CHEM, V277, P27545, DOI 10.1074/jbc.M200058200; Marchese A, 2003, DEV CELL, V5, P709, DOI 10.1016/S1534-5807(03)00321-6; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; MIDDLEMAS DS, 1991, MOL CELL BIOL, V11, P143, DOI 10.1128/MCB.11.1.143; Morino C, 2004, EXP CELL RES, V297, P380, DOI 10.1016/j.yexcr.2004.03.038; Ninkina N, 1996, EMBO J, V15, P6385, DOI 10.1002/j.1460-2075.1996.tb01029.x; Pornillos O, 2002, TRENDS CELL BIOL, V12, P569, DOI 10.1016/S0962-8924(02)02402-9; QIU MS, 1992, NEURON, V9, P705, DOI 10.1016/0896-6273(92)90033-A; Raiborg C, 2003, CURR OPIN CELL BIOL, V15, P446, DOI 10.1016/S0955-0674(03)00080-2; Raiborg C, 2001, J CELL SCI, V114, P2255; RUDGE JS, 1994, EUR J NEUROSCI, V6, P693, DOI 10.1111/j.1460-9568.1994.tb00981.x; Santi S, 2006, EMBO J, V25, P4372, DOI 10.1038/sj.emboj.7601303; Saxena S, 2005, MOL CELL NEUROSCI, V28, P571, DOI 10.1016/j.mcn.2004.11.011; Shih SC, 2002, NAT CELL BIOL, V4, P389, DOI 10.1038/ncb790; Sommerfeld MT, 2000, J BIOL CHEM, V275, P8982, DOI 10.1074/jbc.275.12.8982; Spellman DS, 2008, MOL CELL PROTEOMICS, V7, P1067, DOI 10.1074/mcp.M700387-MCP200; Stenmark H, 1996, J BIOL CHEM, V271, P24048, DOI 10.1074/jbc.271.39.24048; Stoilov P, 2002, BIOCHEM BIOPH RES CO, V290, P1054, DOI 10.1006/bbrc.2001.6301; Tanowitz M, 2003, J BIOL CHEM, V278, P45978, DOI 10.1074/jbc.M304504200; Tessarollo L, 1998, CYTOKINE GROWTH F R, V9, P125, DOI 10.1016/S1359-6101(98)00003-3; Vargas GA, 2004, J BIOL CHEM, V279, P37461, DOI 10.1074/jbc.M401034200; WETMORE C, 1995, J COMP NEUROL, V353, P143, DOI 10.1002/cne.903530113; Yacoubian TA, 2000, NAT NEUROSCI, V3, P342, DOI 10.1038/73911; Zheng J, 2008, J BIOL CHEM, V283, P13280, DOI 10.1074/jbc.M709930200	68	44	45	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					15126	15136		10.1074/jbc.M809763200	http://dx.doi.org/10.1074/jbc.M809763200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19351881	Green Published, hybrid			2022-12-27	WOS:000266288200048
J	Manolopoulou, M; Guo, Q; Malito, E; Schilling, AB; Tang, WJ				Manolopoulou, Marika; Guo, Qing; Malito, Enrico; Schilling, Alexander B.; Tang, Wei-Jen			Molecular Basis of Catalytic Chamber-assisted Unfolding and Cleavage of Human Insulin by Human Insulin-degrading Enzyme	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELECTRON-CAPTURE DISSOCIATION; AMYLOID-BETA PEPTIDE; MACROMOLECULAR STRUCTURES; SUBSTRATE RECOGNITION; ALZHEIMERS-DISEASE; MASS-SPECTROMETRY; DISULFIDE BONDS; ALPHA-HELIX; IN-VIVO; RECEPTOR	Insulin is a hormone vital for glucose homeostasis, and insulin-degrading enzyme( (IDE) plays a key role in its clearance. IDE exhibits a remarkable specificity to degrade insulin without breaking the disulfide bonds that hold the insulin A and B chains together. Using Fourier transform ion cyclotron resonance (FTICR) mass spectrometry to obtain high mass accuracy, and electron capture dissociation (ECD) to selectively break the disulfide bonds in gas phase fragmentation, we determined the cleavage sites and composition of human insulin fragments generated by human IDE. Our time-dependent analysis of IDE-digested insulin fragments reveals that IDE is highly processive in its initial cleavage at the middle of both the insulin A and B chains. This ensures that IDE effectively splits insulin into inactive N- and C-terminal halves without breaking the disulfide bonds. To understand the molecular basis of the recognition and unfolding of insulin by IDE, we determined a 2.6- angstrom resolution insulin-bound IDE structure. Our structure reveals that IDE forms an enclosed catalytic chamber that completely engulfs and intimately interacts with a partially unfolded insulin molecule. This structure also highlights how the unique size, shape, charge distribution, and exosite of the IDE catalytic chamber contribute to its high affinity (similar to 100 nM) for insulin. In addition, this structure shows how IDE utilizes the interaction of its exosite with the N terminus of the insulin A chain as well as other properties of the catalytic chamber to guide the unfolding of insulin and allowing for the processive cleavages.	[Manolopoulou, Marika; Guo, Qing; Malito, Enrico; Tang, Wei-Jen] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Schilling, Alexander B.] Univ Illinois, Prote & Informat Serv Facil, Chicago, IL 60612 USA	University of Chicago; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Tang, WJ (corresponding author), Univ Chicago, Ben May Dept Canc Res, 929 E 57th St, Chicago, IL 60637 USA.	wtang@uchicago.edu		Tang, Wei-Jen/0000-0002-8267-8995	National Institutes of Health [GM81539]; American Health Assistance Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081539] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Health Assistance Foundation(BrightFocus Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM81539 (to W.- J. T.). This work was also supported by the American Health Assistance Foundation (to E. M.).	Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baker TA, 2006, TRENDS BIOCHEM SCI, V31, P647, DOI 10.1016/j.tibs.2006.10.006; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chesneau V, 2000, PROTEIN EXPRES PURIF, V19, P91, DOI 10.1006/prep.2000.1217; DAVIES JG, 1988, BIOCHEM J, V249, P209, DOI 10.1042/bj2490209; DeMattos RB, 2002, SCIENCE, V295, P2264, DOI 10.1126/science.1067568; DEREWENDA U, 1989, NATURE, V338, P594, DOI 10.1038/338594a0; DUCKWORTH WC, 1988, J BIOL CHEM, V263, P1826; Duckworth WC, 1998, ENDOCR REV, V19, P608, DOI 10.1210/er.19.5.608; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farris W, 2003, P NATL ACAD SCI USA, V100, P4162, DOI 10.1073/pnas.0230450100; FRANK BH, 1983, J CHROMATOGR, V266, P239, DOI 10.1016/S0021-9673(01)90897-0; Glendorf T, 2008, BIOCHEMISTRY-US, V47, P4743, DOI 10.1021/bi800054z; Grasso G, 2008, BBA-PROTEINS PROTEOM, V1784, P1122, DOI 10.1016/j.bbapap.2008.04.011; Grasso G, 2007, J MASS SPECTROM, V42, P1590, DOI 10.1002/jms.1348; HAMLIN JL, 1974, J BIOL CHEM, V249, P21; Huang K, 2007, J BIOL CHEM, V282, P35337, DOI 10.1074/jbc.M705996200; Im H, 2007, J BIOL CHEM, V282, P25453, DOI 10.1074/jbc.M701590200; Kim M, 2007, J BIOL CHEM, V282, P7825, DOI 10.1074/jbc.M609168200; KLEYWEGT GJ, 1994, ACTA CRYSTALLOGR D, V50, P178, DOI 10.1107/S0907444993011333; Kristensen C, 1997, J BIOL CHEM, V272, P12978, DOI 10.1074/jbc.272.20.12978; Kurochkin IV, 2001, TRENDS BIOCHEM SCI, V26, P421, DOI 10.1016/S0968-0004(01)01876-X; KUROCHKIN IV, 1994, FEBS LETT, V345, P33, DOI 10.1016/0014-5793(94)00387-4; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Leissring MA, 2003, NEURON, V40, P1087, DOI 10.1016/S0896-6273(03)00787-6; Li P, 2006, BIOCHEM BIOPH RES CO, V343, P1032, DOI 10.1016/j.bbrc.2006.03.083; Malito E, 2008, CELL MOL LIFE SCI, V65, P2574, DOI 10.1007/s00018-008-8112-4; Malito E, 2008, BIOCHEMISTRY-US, V47, P12822, DOI 10.1021/bi801192h; Mayer JP, 2007, BIOPOLYMERS, V88, P687, DOI 10.1002/bip.20734; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McKern NM, 2006, NATURE, V443, P218, DOI 10.1038/nature05106; Miller BC, 2003, P NATL ACAD SCI USA, V100, P6221, DOI 10.1073/pnas.1031520100; MIRSKY A, 1949, ARCH BIOCHEM, V20, P1; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840; Olsen HB, 1996, BIOCHEMISTRY-US, V35, P8836, DOI 10.1021/bi960292+; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Page JS, 2004, CURR OPIN BIOTECH, V15, P3, DOI 10.1016/j.copbio.2004.01.002; Potterton E, 2002, ACTA CRYSTALLOGR D, V58, P1955, DOI 10.1107/S0907444902015391; Shen YQ, 2006, NATURE, V443, P870, DOI 10.1038/nature05143; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Tanzi RE, 2005, CELL, V120, P545, DOI 10.1016/j.cell.2005.02.008; Udgaonkar JB, 2008, ANNU REV BIOPHYS, V37, P489, DOI 10.1146/annurev.biophys.37.032807.125920; Uggerud E, 2004, INT J MASS SPECTROM, V234, P45, DOI 10.1016/j.ijms.2004.01.020; Ward CW, 2007, TRENDS BIOCHEM SCI, V32, P129, DOI 10.1016/j.tibs.2007.01.001; Wefing S, 2006, ANAL CHEM, V78, P1235, DOI 10.1021/ac051634x; Xu B, 2002, PROTEIN SCI, V11, P104, DOI 10.1110/ps.ps.32102; Zubarev RA, 1999, J AM CHEM SOC, V121, P2857, DOI 10.1021/ja981948k; Zubarev RA, 2004, CURR OPIN BIOTECH, V15, P12, DOI 10.1016/j.copbio.2003.12.002; Zubarev RA, 1998, J AM CHEM SOC, V120, P3265, DOI 10.1021/ja973478k	50	60	67	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14177	14188		10.1074/jbc.M900068200	http://dx.doi.org/10.1074/jbc.M900068200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19321446	Green Published, hybrid			2022-12-27	WOS:000266286100024
J	Warren, CM; Kobayashi, T; Solaro, RJ				Warren, Chad M.; Kobayashi, Tomoyoshi; Solaro, R. John			Sites of Intra- and Intermolecular Cross-linking of the N-terminal Extension of Troponin I in Human Cardiac Whole Troponin Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERFUSED RABBIT HEART; MASS-SPECTROMETRY; PHOSPHORYLATION; EXPRESSION; RELAXATION; ADRENALINE; ACTIVATION; DEPENDENCE; PROTEINS; BINDING	Our previous studies (Howarth, J.W., Meller, J., Solaro, R.J., Trewhella, J., and Rosevear, P. R. (2007) J. Mol. Biol. 373, 706-722) of the unique N-terminal region of human cardiac troponin I (hcTnI), predicted a possible intramolecular interaction near the basic inhibitory peptide. To explore this possibility, we generated single cysteine mutants (hcTnI-S5C and hcTnI-I19C), which were labeled with the hetero-bifunctional crosslinker benzophenone-4-maleimide. The labeled hcTnI was reconstituted to whole troponin and exposed to UV light to form cross-linked proteins. Reversed-phase high-performance liquid chromatography and SDS-PAGE indicated intra- and intermolecular cross-linking with hcTnC and hcTnT. Moreover, using tandem mass spectrometry and Edman sequencing, specific intramolecular sites of interaction were determined at position Met-154 (I19C mutant) and Met-155 (S5C mutant) of hcTnI and intermolecular interactions at positions Met-47 and Met-80 of hcTnC in all conditions. Even though specific intermolecular cross-linked sites did not differ, the relative abundance of cross-linking was altered. We also measured the Ca2+-dependent ATPase rate of reconstituted thin filament-myosin-S1 preparation regulated by either cross-linked or non-labeled troponin. Ca2+ regulation of the ATPase rate was lost when the Cys-5 hcTnI mutant was cross-linked in the absence of Ca2+, but only partially inhibited with Cys-19 cross-linking in either the presence or absence of Ca2+. This result indicates different functional effects of cross-linking to Met-154 and Met-155, which are located on different sides of the hcTnI switch peptide. Our data provide novel evidence identifying interactions of the hcTnI-N terminus with specific intra- and intermolecular sites.	Univ Illinois, Coll Med, Dept Physiol & Biophys, Chicago, IL 60612 USA; Univ Illinois, Coll Med, Cardiovasc Res Ctr, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Warren, CM (corresponding author), Univ Illinois, Coll Med, Dept Physiol & Biophys MC 901, 835 S Wolcott Ave, Chicago, IL 60612 USA.	cmwarren@uic.edu			National Institutes of Health [PO1 HL 62426, RO1 HL 82923]; The Searle Funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL082923, P01HL062426] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Searle Funds; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants PO1 HL 62426 (Project 1) (to R.J.S.) and RO1 HL 82923 (to T. K.). Use of LTQ-FT and Voyager De Pro was provided by the CBC-UIC research Resources Center Proteomics and Informatics Services Facility, which was established by a grant from The Searle Funds at the Chicago Community Trust to the Chicago Biomedical Consortium. The ABI 4700 was used at the Proteomics Core Facility at the University of Chicago.	Arteaga GM, 2000, J PHYSIOL-LONDON, V526, P541, DOI 10.1111/j.1469-7793.2000.t01-1-00541.x; Baryshnikova OK, 2008, J MOL BIOL, V375, P735, DOI 10.1016/j.jmb.2007.10.062; DORMAN G, 1994, BIOCHEMISTRY-US, V33, P5661, DOI 10.1021/bi00185a001; F'entzke RC, 1999, J PHYSIOL-LONDON, V517, P143, DOI 10.1111/j.1469-7793.1999.0143z.x; FRITZ JD, 1989, ANAL BIOCHEM, V180, P205, DOI 10.1016/0003-2697(89)90116-4; Howarth JW, 2007, J MOL BIOL, V373, P706, DOI 10.1016/j.jmb.2007.08.035; Kobayashi T, 2006, J BIOL CHEM, V281, P13471, DOI 10.1074/jbc.M509561200; Konhilas JP, 2003, J PHYSIOL-LONDON, V547, P951, DOI 10.1113/jphysiol.2002.038117; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Layland J, 2005, FASEB J, V19, P1137, DOI 10.1096/fj.04-2519fje; Leszyk J, 1998, J MUSCLE RES CELL M, V19, P479, DOI 10.1023/A:1005352324741; Li MX, 1999, BIOCHEMISTRY-US, V38, P8289, DOI 10.1021/bi9901679; Luo Y, 2000, J MOL BIOL, V296, P899, DOI 10.1006/jmbi.1999.3495; MOIR AJG, 1980, BIOCHEM J, V185, P505, DOI 10.1042/bj1850505; Parker L, 2008, J MASS SPECTROM, V43, P518, DOI 10.1002/jms.1342; Rarick HM, 1996, J BIOL CHEM, V271, P27039, DOI 10.1074/jbc.271.43.27039; RAY KP, 1976, FEBS LETT, V70, P11, DOI 10.1016/0014-5793(76)80716-8; SCHENK PM, 1995, BIOTECHNIQUES, V19, P196; Solaro RJ, 2008, BIOCHEM BIOPH RES CO, V369, P82, DOI 10.1016/j.bbrc.2007.12.114; SOLARO RJ, 1976, NATURE, V262, P615, DOI 10.1038/262615a0; SWARTZ DR, 1992, J BIOL CHEM, V267, P20497; Takeda S, 2003, NATURE, V424, P35, DOI 10.1038/nature01780; WANG ZY, 1990, J BIOL CHEM, V265, P4953; Ward DG, 2004, BIOCHEMISTRY-US, V43, P4020, DOI 10.1021/bi036128l; Ward DG, 2003, BIOCHEMISTRY-US, V42, P10324, DOI 10.1021/bi034495r; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; Westfall MV, 2007, J MOL CELL CARDIOL, V43, P107, DOI 10.1016/j.yjmcc.2007.05.017; Wolska BM, 2001, J PHYSIOL-LONDON, V536, P863, DOI 10.1111/j.1469-7793.2001.00863.x; Yu ET, 2008, J PROTEOME RES, V7, P4848, DOI 10.1021/pr800443f; Yuan C, 2008, AM J PHYSIOL-HEART C, V295, pH647, DOI 10.1152/ajpheart.00357.2008	30	19	19	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14258	14266		10.1074/jbc.M807621200	http://dx.doi.org/10.1074/jbc.M807621200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19321456	Green Published, hybrid			2022-12-27	WOS:000266286100032
J	De Maria, A; Shi, YR; Kumar, NM; Bassnett, S				De Maria, Alicia; Shi, Yanrong; Kumar, Nalin M.; Bassnett, Steven			Calpain Expression and Activity during Lens Fiber Cell Differentiation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-SUBUNIT GENE; RAT LENS; MOLECULAR-CLONING; MOUSE LENS; EMBRYONIC-DEVELOPMENT; UBIQUITOUS CALPAINS; CATARACT FORMATION; MESSENGER-RNA; SPECTRIN; PROTEOLYSIS	In animal models, the dysregulated activity of calcium-activated proteases, calpains, contributes directly to cataract formation. However, the physiological role of calpains in the healthy lens is not well defined. In this study, we examined the expression pattern of calpains in the mouse lens. Real time PCR and Western blotting data indicated that calpain 1, 2, 3, and 7 were expressed in lens fiber cells. Using controlled lysis, depth-dependent expression profiles for each calpain were obtained. These indicated that, unlike calpain 1, 2, and 7, which were most abundant in cells near the lens surface, calpain 3 expression was strongest in the deep cortical region of the lens. We detected calpain activities in vitro and showed that calpains were active in vivo by microinjecting fluorogenic calpain substrates into cortical fiber cells. To identify endogenous calpain substrates, membrane/cytoskeleton preparations were treated with recombinant calpain, and cleaved products were identified by two-dimensional difference electrophoresis/mass spectrometry. Among the calpain substrates identified by this approach was alpha II-spectrin. An antibody that specifically recognized calpain-cleaved spectrin was used to demonstrate that spectrin is cleaved in vivo, late in fiber cell differentiation, at or about the time that lens organelles are degraded. The generation of the calpain-specific spectrin cleavage product was not observed in lens tissue from calpain 3-null mice, indicating that calpain 3 is uniquely activated during lens fiber differentiation. Our data suggest a role for calpains in the remodeling of the membrane cytoskeleton that occurs with fiber cell maturation.	[De Maria, Alicia; Shi, Yanrong; Bassnett, Steven] Washington Univ, Dept Ophthalmol & Visual Sci, St Louis, MO 63110 USA; [Kumar, Nalin M.] Univ Illinois, Dept Ophthalmol & Visual Sci, Chicago, IL 60612 USA	Washington University (WUSTL); University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Bassnett, S (corresponding author), 660 S Euclid Ave,Campus Box 8096, St Louis, MO 63110 USA.	bassnett@vision.wustl.edu		Bassnett, Steven/0000-0002-8337-2760	National Institutes of Health [P30 NS057105, R01EY09852]; Core Grant for Vision Research [EY02687]; Research to Prevent Blindness [EY01792]; University of Illinois at Chicago; NATIONAL EYE INSTITUTE [P30EY001792, R01EY009852, P30EY002687] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS057105] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Core Grant for Vision Research; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); University of Illinois at Chicago; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant P30 NS057105 (to Washington University). This work was also supported by Grant R01EY09852 (to S. B.), Core Grant for Vision Research EY02687, an unrestricted grant to the Department of Ophthalmology and Visual Sciences from Research to Prevent Blindness (to Washington University), and Core Grant EY01792 to the Department of Ophthalmology of the University of Illinois at Chicago.	Arthur JSC, 2000, MOL CELL BIOL, V20, P4474, DOI 10.1128/MCB.20.12.4474-4481.2000; Azuma M, 1997, EXP EYE RES, V64, P529, DOI 10.1006/exer.1996.0234; BAGCHI M, 1985, EXP EYE RES, V40, P385, DOI 10.1016/0014-4835(85)90151-4; Barnoy S, 2005, BIOCHEM BIOPH RES CO, V332, P697, DOI 10.1016/j.bbrc.2005.05.010; Bassnett S, 2009, EXP EYE RES, V88, P133, DOI 10.1016/j.exer.2008.08.017; Bi X, 1996, NEUROSCIENCE, V73, P903, DOI 10.1016/0306-4522(96)00157-1; Biswas S, 2004, MOL CELL BIOCHEM, V261, P169, DOI 10.1023/B:MCBI.0000028752.89886.43; Biswas S, 2004, TRENDS MOL MED, V10, P78, DOI 10.1016/j.molmed.2003.12.007; Blankenship T, 2007, INVEST OPHTH VIS SCI, V48, P3269, DOI 10.1167/iovs.07-0109; Bredemeyer AJ, 2004, P NATL ACAD SCI USA, V101, P11785, DOI 10.1073/pnas.0402353101; Croall DE, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-6-218; Czogalla A, 2005, CELL MOL LIFE SCI, V62, P1913, DOI 10.1007/s00018-005-5097-0; DAVID LL, 1994, INVEST OPHTH VIS SCI, V35, P785; Dourdin N, 2001, J BIOL CHEM, V276, P48382, DOI 10.1074/jbc.M108893200; Dutt P, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-3; Fukiage C, 1997, BBA-MOL BASIS DIS, V1361, P304, DOI 10.1016/S0925-4439(97)00043-4; Futai E, 2001, BBA-GENE STRUCT EXPR, V1517, P316, DOI 10.1016/S0167-4781(00)00256-6; Glantz SB, 2007, BIOCHEMISTRY-US, V46, P502, DOI 10.1021/bi061504y; GLASER T, 1986, FEBS LETT, V206, P115, DOI 10.1016/0014-5793(86)81351-5; Hanis CL, 1996, NAT GENET, V13, P161, DOI 10.1038/ng0696-161; Hell JW, 1996, P NATL ACAD SCI USA, V93, P3362, DOI 10.1073/pnas.93.8.3362; Herasse M, 1999, MOL CELL BIOL, V19, P4047; Horikawa Y, 2000, NAT GENET, V26, P163, DOI 10.1038/79876; IRELAND M, 1984, EXP EYE RES, V38, P637, DOI 10.1016/0014-4835(84)90182-9; Lee A, 2001, J BIOL CHEM, V276, P20735, DOI 10.1074/jbc.M009723200; Lee HJ, 1998, BIOL CHEM, V379, P175, DOI 10.1515/bchm.1998.379.2.175; Leonard JR, 2002, J NEUROPATH EXP NEUR, V61, P673, DOI 10.1093/jnen/61.8.673; Liu J, 2008, SCI SIGNAL, V1, DOI [10.1126/stke.114re1, 10.1126/scisignal.123tr3]; Liu XL, 2003, J PHARMACOL EXP THER, V304, P63, DOI 10.1124/jpet.102.043406; Ma H, 2005, FEBS LETT, V579, P6745, DOI 10.1016/j.febslet.2005.11.004; Ma H, 1999, EXP EYE RES, V68, P447, DOI 10.1006/exer.1998.0625; Ma H, 2001, J BIOL CHEM, V276, P28525, DOI 10.1074/jbc.M100603200; Ma H, 1998, EXP EYE RES, V67, P221, DOI 10.1006/exer.1998.0515; Ma H, 1998, INVEST OPHTH VIS SCI, V39, P454; MERDES A, 1991, J CELL BIOL, V115, P397, DOI 10.1083/jcb.115.2.397; More MI, 2001, J CELL BIOL, V154, P187, DOI 10.1083/jcb.200104038; Nakajima T, 2001, BBA-GENE STRUCT EXPR, V1519, P55, DOI 10.1016/S0167-4781(01)00212-3; Nakamura Y, 2000, INVEST OPHTH VIS SCI, V41, P1460; NIXON RA, 1994, ANN NY ACAD SCI, V747, P77; PIERSCIONEK B, 1988, CURR EYE RES, V7, P11, DOI 10.3109/02713688809047015; Reed NA, 2003, EXP EYE RES, V76, P433, DOI 10.1016/S0014-4835(02)00336-6; REPASKY EA, 1982, CELL, V29, P821, DOI 10.1016/0092-8674(82)90444-5; Richard I, 2000, J CELL BIOL, V151, P1583, DOI 10.1083/jcb.151.7.1583; ROBERTSLEWIS JM, 1994, J NEUROSCI, V14, P3934; Robertson LJG, 2005, INVEST OPHTH VIS SCI, V46, P4634, DOI 10.1167/iovs.04-1291; Sakamoto-Mizutani K, 2002, EXP EYE RES, V75, P611, DOI 10.1006/exer.2002.2065; SANDILANDS A, 1995, J CELL SCI, V108, P1397; Sato K, 2001, BIOL CHEM, V382, P743, DOI 10.1515/BC.2001.090; SHEARER TR, 1991, INVEST OPHTH VIS SCI, V32, P533; Shestopalov VI, 2003, J CELL SCI, V116, P4191, DOI 10.1242/jcs.00738; Shih M, 2006, EXP EYE RES, V82, P146, DOI 10.1016/j.exer.2005.06.011; Shih M, 2001, CURR EYE RES, V22, P458, DOI 10.1076/ceyr.22.6.458.5483; Singh RB, 2004, MOL CELL BIOCHEM, V263, P241, DOI 10.1023/B:MCBI.0000041865.63445.40; SORIMACHI H, 1989, J BIOL CHEM, V264, P20106; SORIMACHI H, 1993, J BIOL CHEM, V268, P19476; Tamada Y, 2001, CURR EYE RES, V22, P280, DOI 10.1076/ceyr.22.4.280.5505; Tang YJ, 2007, INVEST OPHTH VIS SCI, V48, P2685, DOI 10.1167/iovs.06-0926; Tomimatsu Y, 2002, LIFE SCI, V72, P355, DOI 10.1016/S0024-3205(02)02285-3; TRUSCOTT RJW, 1989, BIOCHEM BIOPH RES CO, V162, P1472, DOI 10.1016/0006-291X(89)90840-1; Ueda Y, 2002, MOL CELL PROTEOMICS, V1, P357, DOI 10.1074/mcp.M200007-MCP200; Vosler PS, 2008, MOL NEUROBIOL, V38, P78, DOI 10.1007/s12035-008-8036-x; Wyatt K, 2008, J BIOL CHEM, V283, P6607, DOI 10.1074/jbc.M709144200; YOSHIDA H, 1985, INVEST OPHTH VIS SCI, V26, P953; Zimmerman UJP, 2000, IUBMB LIFE, V50, P63	64	35	36	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13542	13550		10.1074/jbc.M900561200	http://dx.doi.org/10.1074/jbc.M900561200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19269960	hybrid, Green Published			2022-12-27	WOS:000265877300031
J	Laursen, M; Bublitz, M; Moncoq, K; Olesen, C; Moller, JV; Young, HS; Nissen, P; Morth, JP				Laursen, Mette; Bublitz, Maike; Moncoq, Karine; Olesen, Claus; Moller, Jesper Vuust; Young, Howard S.; Nissen, Poul; Morth, J. Preben			Cyclopiazonic Acid Is Complexed to a Divalent Metal Ion When Bound to the Sarcoplasmic Reticulum Ca2+-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE SEGMENT M1; CRYSTAL-STRUCTURE; CALCIUM-PUMP; ATP-BINDING; K+-ATPASE; INHIBITION; TRANSPORT; DOMAIN; THAPSIGARGIN; CA-2+-ATPASE	We have determined the structure of the sarco(endo) plasmic reticulum Ca2+-ATPase (SERCA) in an E2.P-i-like form stabilized as a complex with MgF42-, an ATP analog, adenosine 5'-(beta,gamma-methylene) triphosphate (AMPPCP), and cyclopiazonic acid (CPA). The structure determined at 2.5 angstrom resolution leads to a significantly revised model of CPA binding when compared with earlier reports. It shows that a divalent metal ion is required for CPA binding through coordination of the tetramic acid moiety at a characteristic kink of the M1 helix found in all P-type ATPase structures, which is expected to be part of the cytoplasmic cation access pathway. Our model is consistent with the biochemical data on CPA function and provides new measures in structure-based drug design targeting Ca2+-ATPases, e. g. from pathogens. We also present an extended structural basis of ATP modulation pinpointing key residues at or near the ATP binding site. A structural comparison to the Na+, K+-ATPase reveals that the Phe(93) side chain occupies the equivalent binding pocket of the CPA site in SERCA, suggesting an important role of this residue in stabilization of the potassium-occluded E2 state of Na+, K+-ATPase.	[Laursen, Mette; Bublitz, Maike; Olesen, Claus; Moller, Jesper Vuust; Nissen, Poul; Morth, J. Preben] Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Dis PUMPKIN, DK-8000 Aarhus C, Denmark; [Laursen, Mette; Bublitz, Maike; Nissen, Poul; Morth, J. Preben] Aarhus Univ, Dept Mol Biol, DK-8000 Aarhus C, Denmark; [Olesen, Claus; Moller, Jesper Vuust] Aarhus Univ, Dept Physiol & Biophys, DK-8000 Aarhus C, Denmark; [Moncoq, Karine; Young, Howard S.] Univ Alberta, Dept Biochem, Edmonton, AB T6G 2H7, Canada; [Moncoq, Karine; Young, Howard S.] Univ Alberta, Natl Inst Nanotechnol, Edmonton, AB T6G 2H7, Canada	Danmarks Grundforskningsfond; Aarhus University; Aarhus University; University of Alberta; National Research Council Canada; University of Alberta	Morth, JP (corresponding author), Danish Natl Res Fdn, Ctr Membrane Pumps Cells & Dis PUMPKIN, Gustav Wieds Vej 10C, DK-8000 Aarhus C, Denmark.	jpm@mb.au.dk	Nissen, Poul/D-5774-2014; Morth, Jens Preben/G-4450-2013; Morth, Jens Preben/AAP-7834-2021	Morth, Jens Preben/0000-0003-4077-0192; Morth, Jens Preben/0000-0003-4077-0192; Bublitz, Maike/0000-0003-3161-418X; Olesen, Claus/0000-0002-0462-1686; Laursen, Mette/0000-0002-6265-2069; Nissen, Poul/0000-0003-0948-6628; Young, Howard/0000-0002-5990-8422	Danish National Research Foundation; Novo Nordisk Foundation; Danish Medical Research Council; Aarhus University Research Foundation; Fabrikant Vilhelm Pedersen og hustrus legat	Danish National Research Foundation(Danmarks Grundforskningsfond); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Aarhus University Research Foundation; Fabrikant Vilhelm Pedersen og hustrus legat	This work was supported by a center of excellence grant from the Danish National Research Foundation and by a Hallas-Moller research stipend from the Novo Nordisk Foundation (to P. N.) and by grants from the Danish Medical Research Council, Aarhus University Research Foundation and Novo Nordisk Foundation and the "Fabrikant Vilhelm Pedersen og hustrus legat" (to J. V. M.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ANDERSEN JP, 1985, J BIOL CHEM, V260, P371; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Berman MC, 2003, BIOCHEMISTRY-US, V42, P3556, DOI 10.1021/bi026071n; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Clausen JD, 2003, J BIOL CHEM, V278, P20245, DOI 10.1074/jbc.M301122200; Clausen JD, 2007, J BIOL CHEM, V282, P20686, DOI 10.1074/jbc.M702365200; Clausen JD, 2008, J BIOL CHEM, V283, P35703, DOI 10.1074/jbc.M806795200; Einholm AP, 2007, J BIOL CHEM, V282, P23854, DOI 10.1074/jbc.M702259200; Einholm AP, 2005, P NATL ACAD SCI USA, V102, P11254, DOI 10.1073/pnas.0501201102; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GALLAGHER RT, 1978, MYCOPATHOLOGIA, V66, P31, DOI 10.1007/BF00683969; GOEGER DE, 1988, BIOCHEM PHARMACOL, V37, P978, DOI 10.1016/0006-2952(88)90195-5; HOLZAPFE.CW, 1968, TETRAHEDRON, V24, P2101, DOI 10.1016/0040-4020(68)88113-X; Hua SM, 2005, J BIOL CHEM, V280, P17579, DOI 10.1074/jbc.M500472200; Jensen AML, 2006, EMBO J, V25, P2305, DOI 10.1038/sj.emboj.7601135; Johnson NA, 2009, ARCH BIOCHEM BIOPHYS, V481, P157, DOI 10.1016/j.abb.2008.11.010; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kato S, 2003, J BIOL CHEM, V278, P9624, DOI 10.1074/jbc.M208861200; Krishna S, 2001, J BIOL CHEM, V276, P10782, DOI 10.1074/jbc.M010554200; LEBRUN MH, 1985, J INORG BIOCHEM, V24, P167, DOI 10.1016/0162-0134(85)85001-7; Ma HL, 1999, BIOCHEMISTRY-US, V38, P15522, DOI 10.1021/bi991523q; MACLENNA.DH, 1970, J BIOL CHEM, V245, P4508; Martinez-Azorin F, 2004, FEBS LETT, V576, P73, DOI 10.1016/j.febslet.2004.08.064; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McIntosh DB, 1996, J BIOL CHEM, V271, P25778, DOI 10.1074/jbc.271.42.25778; Moller JV, 1996, BBA-REV BIOMEMBRANES, V1286, P1, DOI 10.1016/0304-4157(95)00017-8; Moncoq K, 2007, J BIOL CHEM, V282, P9748, DOI 10.1074/jbc.M611653200; Montigny C, 2007, BIOCHEMISTRY-US, V46, P15162, DOI 10.1021/bi701855r; MOORE GA, 1987, FEBS LETT, V224, P331, DOI 10.1016/0014-5793(87)80479-9; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Olesen C, 2007, NATURE, V450, P1036, DOI 10.1038/nature06418; Schobert R, 2008, BIOORGAN MED CHEM, V16, P4203, DOI 10.1016/j.bmc.2008.02.069; SEIDLER NW, 1989, J BIOL CHEM, V264, P17816; Sobolev VS, 2005, J AOAC INT, V88, P1367; Sohoel H, 2006, BIOORGAN MED CHEM, V14, P2810, DOI 10.1016/j.bmc.2005.12.001; Soler F, 1998, BIOCHEMISTRY-US, V37, P4266, DOI 10.1021/bi971455c; Sorensen TLM, 2006, J BIOTECHNOL, V124, P704, DOI 10.1016/j.jbiotec.2006.02.004; Sorensen TLM, 2004, SCIENCE, V304, P1672, DOI 10.1126/science.1099366; Steiner T, 2001, J MOL BIOL, V305, P535, DOI 10.1006/jmbi.2000.4301; STEYN PS, 1976, PHYTOCHEMISTRY, V15, P1977, DOI 10.1016/S0031-9422(00)88860-3; Takahashi M, 2007, P NATL ACAD SCI USA, V104, P5800, DOI 10.1073/pnas.0700979104; Toyoshima C, 2004, NATURE, V430, P529, DOI 10.1038/nature02680; Toyoshima C, 2000, NATURE, V405, P647, DOI 10.1038/35015017; Van Baelen K, 2004, BBA-MOL CELL RES, V1742, P103, DOI 10.1016/j.bbamcr.2004.08.018	45	78	79	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13513	13518		10.1074/jbc.C900031200	http://dx.doi.org/10.1074/jbc.C900031200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19289472	Green Published, hybrid			2022-12-27	WOS:000265877300028
J	Lee, IH; Campbell, CR; Song, SH; Day, ML; Kumar, S; Cook, DI; Dinudom, A				Lee, Il-Ha; Campbell, Craig R.; Song, Sung-Hee; Day, Margot L.; Kumar, Sharad; Cook, David I.; Dinudom, Anuwat			The Activity of the Epithelial Sodium Channels Is Regulated by Caveolin-1 via a Nedd4-2-dependent Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIDDLES-SYNDROME MUTATIONS; SUBUNIT MESSENGER-RNAS; LIPID RAFTS; MEMBRANE CHOLESTEROL; MEDIATED ENDOCYTOSIS; SURFACE EXPRESSION; APICAL MEMBRANE; NA+ TRANSPORT; CLATHRIN; PROTEIN	It has recently been shown that the epithelial Na+ channel (ENaC) is compartmentalized in caveolin-rich lipid rafts and that pharmacological depletion of membrane cholesterol, which disrupts lipid raft formation, decreases the activity of ENaC. Here we show, for the first time, that a signature protein of caveolae, caveolin-1 (Cav-1), down-regulates the activity and membrane surface expression of ENaC. Physical interaction between ENaC and Cav-1 was also confirmed in a coimmuno-precipitation assay. We found that the effect of Cav-1 on ENaC requires the activity of Nedd4-2, a ubiquitin protein ligase of the Nedd4 family, which is known to induce ubiquitination and internalization of ENaC. The effect of Cav-1 on ENaC requires the proline-rich motifs at the C termini of the beta- and gamma-subunits of ENaC, the binding motifs that mediate interaction with Nedd4-2. Taken together, our data suggest that Cav-1 inhibits the activity of ENaC by decreasing expression of ENaC at the cell membrane via a mechanism that involves the promotion of Nedd4-2-dependent internalization of the channel.	[Lee, Il-Ha; Campbell, Craig R.; Song, Sung-Hee; Day, Margot L.; Cook, David I.; Dinudom, Anuwat] Univ Sydney, Discipline Physiol, Bosch Inst, Fac Med, Sydney, NSW 2006, Australia; [Kumar, Sharad] Hanson Inst, Ctr Canc Biol, Adelaide, SA 5000, Australia	University of Sydney; Centre for Cancer Biology; Hanson Institute	Dinudom, A (corresponding author), Univ Sydney, Discipline Physiol, Bosch Inst, Fac Med, Sydney, NSW 2006, Australia.	anuwat@physiol.usyd.edu.au	Kumar, Sharad/AAX-7787-2020; Campbell, Craig R/B-5983-2012	Kumar, Sharad/0000-0001-7126-9814; Campbell, Craig R/0000-0002-0843-7579; Day, Margot/0000-0002-8689-7458	National Health and Medical Research Council of Australia [508086]; Australian Research Council [DP0774320]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work was supported by National Health and Medical Research Council of Australia Grant 508086 and Australian Research Council Grant DP0774320.	Abrami L, 2003, J CELL BIOL, V160, P321, DOI 10.1083/jcb.200211018; Adam RM, 2007, CANCER RES, V67, P6238, DOI 10.1158/0008-5472.CAN-07-0288; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Balut C, 2006, AM J PHYSIOL-CELL PH, V290, pC87, DOI 10.1152/ajpcell.00184.2005; Callera GE, 2007, CURR OPIN NEPHROL HY, V16, P90, DOI 10.1097/MNH.0b013e328040bfbd; Carman CV, 1999, J BIOL CHEM, V274, P8858, DOI 10.1074/jbc.274.13.8858; Cha SK, 2008, AM J PHYSIOL-RENAL, V294, pF1212, DOI 10.1152/ajprenal.00007.2008; Cheng PC, 1999, J EXP MED, V190, P1549, DOI 10.1084/jem.190.11.1549; Cohen AW, 2004, PHYSIOL REV, V84, P1341, DOI 10.1152/physrev.00046.2003; Cuitino L, 2005, TRAFFIC, V6, P820, DOI 10.1111/j.1600-0854.2005.00320.x; de la Rosa DA, 2000, ANNU REV PHYSIOL, V62, P573, DOI 10.1146/annurev.physiol.62.1.573; Deinhardt K, 2006, J CELL BIOL, V174, P459, DOI 10.1083/jcb.200508170; Dinudom A, 2004, P NATL ACAD SCI USA, V101, P11886, DOI 10.1073/pnas.0402178101; DUC C, 1994, J CELL BIOL, V127, P1907, DOI 10.1083/jcb.127.6.1907; Farman N, 1997, AM J PHYSIOL-CELL PH, V272, pC131, DOI 10.1152/ajpcell.1997.272.1.C131; Fecchi K, 2006, FASEB J, V20, P705, DOI 10.1096/fj.05-4661fje; Firsov D, 1996, P NATL ACAD SCI USA, V93, P15370, DOI 10.1073/pnas.93.26.15370; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; Fotia AB, 2002, FASEB J, V16, P70, DOI 10.1096/fj.02-0497fje; Gonzalez MI, 2007, J BIOL CHEM, V282, P29855, DOI 10.1074/jbc.M704738200; Guzzi F, 2001, BIOCHEM J, V355, P323, DOI 10.1042/0264-6021:3550323; Hansen GH, 2005, BIOCHEMISTRY-US, V44, P873, DOI 10.1021/bi047959+; Hanzal-Bayer MF, 2007, FEBS LETT, V581, P2098, DOI 10.1016/j.febslet.2007.03.019; Harvey KF, 2001, J BIOL CHEM, V276, P8597, DOI 10.1074/jbc.C000906200; Hill WG, 2007, J BIOL CHEM, V282, P37402, DOI 10.1074/jbc.M704084200; Hill WG, 2002, J BIOL CHEM, V277, P33541, DOI 10.1074/jbc.C200309200; Hommelgaard AM, 2005, TRAFFIC, V6, P720, DOI 10.1111/j.1600-0854.2005.00314.x; Hummler E, 1999, AM J PHYSIOL-GASTR L, V276, pG567, DOI 10.1152/ajpgi.1999.276.3.G567; Jayanthi LD, 2004, J BIOL CHEM, V279, P19315, DOI 10.1074/jbc.M311172200; Kabra R, 2008, J BIOL CHEM, V283, P6033, DOI 10.1074/jbc.M708555200; Kamynina E, 2001, KIDNEY INT, V60, P466, DOI 10.1046/j.1523-1755.2001.060002466.x; Kunzelmann K, 2000, P NATL ACAD SCI USA, V97, P10282, DOI 10.1073/pnas.160041997; Kurzchalia TV, 1999, CURR OPIN CELL BIOL, V11, P424, DOI 10.1016/S0955-0674(99)80061-1; Kwik J, 2003, P NATL ACAD SCI USA, V100, P13964, DOI 10.1073/pnas.2336102100; Lajoie P, 2007, J CELL MOL MED, V11, P644, DOI 10.1111/j.1582-4934.2007.00083.x; Lee IH, 2008, CLIN EXP PHARMACOL P, V35, P235, DOI 10.1111/j.1440-1681.2007.04844.x; Lee IH, 2007, J BIOL CHEM, V282, P29866, DOI 10.1074/jbc.M701923200; Lipardi C, 1998, J CELL BIOL, V140, P617, DOI 10.1083/jcb.140.3.617; Liu JA, 2005, KIDNEY INT, V67, P1844, DOI 10.1111/j.1523-1755.2005.00283.x; Liu Jiang, 2007, Pathophysiology, V14, P171, DOI 10.1016/j.pathophys.2007.09.008; Lu C, 2007, TRAFFIC, V8, P1246, DOI 10.1111/j.1600-0854.2007.00602.x; Malik B, 2005, AM J PHYSIOL-RENAL, V289, pF107, DOI 10.1152/ajprenal.00179.2002; Martens JR, 2004, TRENDS PHARMACOL SCI, V25, P16, DOI 10.1016/j.tips.2003.11.007; Matalon S, 1999, ANNU REV PHYSIOL, V61, P627, DOI 10.1146/annurev.physiol.61.1.627; Matsushita K, 1996, AM J PHYSIOL-LUNG C, V271, pL332, DOI 10.1152/ajplung.1996.271.2.L332; Parton RG, 2003, TRAFFIC, V4, P724, DOI 10.1034/j.1600-0854.2003.00128.x; Patel HH, 2008, ANNU REV PHARMACOL, V48, P359, DOI 10.1146/annurev.pharmtox.48.121506.124841; Patra SK, 2008, BBA-REV CANCER, V1785, P182, DOI 10.1016/j.bbcan.2007.11.002; Plant PJ, 2000, J CELL BIOL, V149, P1473, DOI 10.1083/jcb.149.7.1473; Prince LS, 1999, AM J PHYSIOL-CELL PH, V276, pC1346, DOI 10.1152/ajpcell.1999.276.6.C1346; Raikwar NS, 2008, AM J PHYSIOL-RENAL, V294, pF1157, DOI 10.1152/ajprenal.00339.2007; Ramminger SJ, 2000, J PHYSIOL-LONDON, V524, P539, DOI 10.1111/j.1469-7793.2000.t01-1-00539.x; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; Rodal SK, 1999, MOL BIOL CELL, V10, P961, DOI 10.1091/mbc.10.4.961; Rollason R, 2007, J CELL SCI, V120, P3850, DOI 10.1242/jcs.003343; Roy S, 1999, NAT CELL BIOL, V1, P98, DOI 10.1038/10067; Salaun C, 2004, TRAFFIC, V5, P255, DOI 10.1111/j.1600-0854.2004.0162.x; Schlegel A, 2001, J BIOL CHEM, V276, P4398, DOI 10.1074/jbc.M005448200; Schlegel A, 1998, CELL SIGNAL, V10, P457, DOI 10.1016/S0898-6568(98)00007-2; Shigematsu S, 2003, J BIOL CHEM, V278, P10683, DOI 10.1074/jbc.M208563200; Shlyonsky VG, 2003, AM J PHYSIOL-RENAL, V284, pF182, DOI 10.1152/ajprenal.00216.2002; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408; SNYDER PM, 1995, CELL, V83, P969, DOI 10.1016/0092-8674(95)90212-0; Stoddart A, 2002, IMMUNITY, V17, P451, DOI 10.1016/S1074-7613(02)00416-8; STOOS BA, 1991, KIDNEY INT, V39, P1168, DOI 10.1038/ki.1991.148; Subtil A, 1999, P NATL ACAD SCI USA, V96, P6775, DOI 10.1073/pnas.96.12.6775; Trouet D, 2001, BIOCHEM BIOPH RES CO, V284, P461, DOI 10.1006/bbrc.2001.4995; Wang XL, 2005, J BIOL CHEM, V280, P11656, DOI 10.1074/jbc.M410987200; Weerth SH, 2007, CELL CALCIUM, V41, P155, DOI 10.1016/j.ceca.2006.06.006; West TA, 2005, CELL PHYSIOL BIOCHEM, V16, P263, DOI 10.1159/000089852; Yuan T, 2007, CELL RES, V17, P772, DOI 10.1038/cr.2007.73; Zabner J, 1998, MOL CELL, V2, P397, DOI 10.1016/S1097-2765(00)80284-1; Zhou RF, 2007, J BIOL CHEM, V282, P20207, DOI 10.1074/jbc.M611329200; ZURZOLO C, 1994, EMBO J, V13, P42, DOI 10.1002/j.1460-2075.1994.tb06233.x	75	40	40	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12663	12669		10.1074/jbc.M809737200	http://dx.doi.org/10.1074/jbc.M809737200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19304660	hybrid, Green Published			2022-12-27	WOS:000265688300010
J	Sato, T; Nakashima, A; Guo, L; Tamanoi, F				Sato, Tatsuhiro; Nakashima, Akio; Guo, Lea; Tamanoi, Fuyuhiko			Specific Activation of mTORC1 by Rheb G-protein in Vitro Involves Enhanced Recruitment of Its Substrate Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUBEROUS SCLEROSIS COMPLEX; SMALL GTPASE-RHEB; MAMMALIAN TARGET; KINASE-ACTIVITY; RAPAMYCIN COMPLEX-1; RAS PROTEINS; CELL-GROWTH; ADENYLATE-CYCLASE; BINDING PARTNER; FISSION YEAST	Rheb G-protein plays critical roles in the TSC/Rheb/mTOR signaling pathway by activating mTORC1. The activation of mTORC1 by Rheb can be faithfully reproduced in vitro by using mTORC1 immunoprecipitated by the use of anti-raptor antibody from mammalian cells starved for nutrients. The low in vitro kinase activity against 4E-BP1 of this mTORC1 preparation is dramatically increased by the addition of recombinant Rheb. On the other hand, the addition of Rheb does not activate mTORC2 immunoprecipitated from mammalian cells by the use of anti-rictor antibody. The activation of mTORC1 is specific to Rheb, because other G-proteins such as KRas, RalA/B, and Cdc42 did not activate mTORC1. Both Rheb1 and Rheb2 activate mTORC1. In addition, the activation is dependent on the presence of bound GTP. We also find that the effector domain of Rheb is required for the mTORC1 activation. FKBP38, a recently proposed mediator of Rheb action, appears not to be involved in the Rheb-dependent activation of mTORC1 in vitro, because the preparation of mTORC1 that is devoid of FKBP38 is still activated by Rheb. The addition of Rheb results in a significant increase of binding of the substrate protein 4E-BP1 to mTORC1. PRAS40, a TOR signaling (TOS) motif-containing protein that competes with the binding of 4EBP1 to mTORC1, inhibits Rheb-induced activation of mTORC1. A preparation of mTORC1 that is devoid of raptor is not activated by Rheb. Rheb does not induce autophosphorylation of mTOR. These results suggest that Rheb induces alteration in the binding of 4E-BP1 with mTORC1 to regulate mTORC1 activation.	[Sato, Tatsuhiro; Nakashima, Akio; Guo, Lea; Tamanoi, Fuyuhiko] Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Inst Mol Biol, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90095 USA	UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Tamanoi, F (corresponding author), Univ Calif Los Angeles, Dept Microbiol Mol Genet & Immunol, Inst Mol Biol, Jonsson Comprehens Canc Ctr, 1602 Mol Sci Bldg, Los Angeles, CA 90095 USA.	fuyut@microbio.ucla.edu			National Institutes of Health [CA41996]; NATIONAL CANCER INSTITUTE [R01CA041996] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA41996.	Alarcon CM, 1999, MOL BIOL CELL, V10, P2531, DOI 10.1091/mbc.10.8.2531; Aspuria PJ, 2004, CELL SIGNAL, V16, P1105, DOI 10.1016/j.cellsig.2004.03.019; Avruch J, 2006, ONCOGENE, V25, P6361, DOI 10.1038/sj.onc.1209882; Bai XC, 2007, SCIENCE, V318, P977, DOI 10.1126/science.1147379; BROEK D, 1985, CELL, V41, P763, DOI 10.1016/S0092-8674(85)80057-X; BROWN EJ, 1995, NATURE, V377, P441, DOI 10.1038/377441a0; Brunn GJ, 1997, J BIOL CHEM, V272, P32547, DOI 10.1074/jbc.272.51.32547; Brunn GJ, 1996, EMBO J, V15, P5256, DOI 10.1002/j.1460-2075.1996.tb00911.x; Castro AF, 2003, J BIOL CHEM, V278, P32493, DOI 10.1074/jbc.C300226200; Clark GJ, 1997, J BIOL CHEM, V272, P10608; Corradetti MN, 2006, ONCOGENE, V25, P6347, DOI 10.1038/sj.onc.1209885; Eguchi S, 2006, GENES CELLS, V11, P757, DOI 10.1111/j.1365-2443.2006.00977.x; Fonseca BD, 2007, J BIOL CHEM, V282, P24514, DOI 10.1074/jbc.M704406200; Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X; GOMEZ M, 1999, TUBEROUS SELEROSIS C; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Huang J, 2008, BIOCHEM J, V412, P179, DOI 10.1042/BJ20080281; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Long XM, 2007, J BIOL CHEM, V282, P18542, DOI 10.1074/jbc.M610736200; Ma DZ, 2008, J BIOL CHEM, V283, P25963, DOI 10.1074/jbc.M802356200; McCormick F, 1996, CURR OPIN BIOTECH, V7, P449, DOI 10.1016/S0958-1669(96)80123-6; Mizuki N, 1996, GENOMICS, V34, P114, DOI 10.1006/geno.1996.0248; Mothe-Satney I, 2000, J BIOL CHEM, V275, P33836, DOI 10.1074/jbc.M006005200; Mothe-Satney I, 2000, MOL CELL BIOL, V20, P3558, DOI 10.1128/MCB.20.10.3558-3567.2000; Narayanan V, 2003, PEDIATR NEUROL, V29, P404, DOI 10.1016/j.pediatrneurol.2003.09.002; Oshiro N, 2004, GENES CELLS, V9, P359, DOI 10.1111/j.1356-9597.2004.00727.x; Oshiro N, 2007, J BIOL CHEM, V282, P20329, DOI 10.1074/jbc.M702636200; Patel PH, 2003, J CELL SCI, V116, P3601, DOI 10.1242/jcs.00661; Proud CG, 2004, BIOCHEM BIOPH RES CO, V313, P429, DOI 10.1016/j.bbrc.2003.07.015; Reiling JH, 2006, ONCOGENE, V25, P6373, DOI 10.1038/sj.onc.1209889; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Saito K, 2005, J BIOCHEM, V137, P423, DOI 10.1093/jb/mvi046; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sato T, 2008, METHOD ENZYMOL, V438, P307, DOI 10.1016/S0076-6879(07)38021-X; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Scrima A, 2008, EMBO J, V27, P1145, DOI 10.1038/emboj.2008.30; Smith EM, 2005, J BIOL CHEM, V280, P18717, DOI 10.1074/jbc.M414499200; Tabancay AP, 2003, J BIOL CHEM, V278, P39921, DOI 10.1074/jbc.M306553200; Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2; Tee AR, 2005, FEBS LETT, V579, P4763, DOI 10.1016/j.febslet.2005.07.054; Thedieck K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001217; TODA T, 1985, CELL, V40, P27, DOI 10.1016/0092-8674(85)90305-8; Urano J, 2005, MOL MICROBIOL, V58, P1074, DOI 10.1111/j.1365-2958.2005.04877.x; Urano J, 2000, J BIOL CHEM, V275, P11198, DOI 10.1074/jbc.275.15.11198; Urano J, 2007, P NATL ACAD SCI USA, V104, P3514, DOI 10.1073/pnas.0608510104; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Wang LF, 2007, J BIOL CHEM, V282, P20036, DOI 10.1074/jbc.M702376200; Wang LF, 2006, J BIOL CHEM, V281, P24293, DOI 10.1074/jbc.M603566200; Wang XM, 2008, J BIOL CHEM, V283, P30482, DOI 10.1074/jbc.M803348200; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yang Q, 2006, P NATL ACAD SCI USA, V103, P6811, DOI 10.1073/pnas.0602282103; Yang WL, 2001, MOL MICROBIOL, V41, P1339, DOI 10.1046/j.1365-2958.2001.02599.x; Yonezawa K, 2004, BIOCHEM BIOPH RES CO, V313, P437, DOI 10.1016/j.bbrc.2003.07.018; Yu YD, 2005, J BIOL CHEM, V280, P17093, DOI 10.1074/jbc.M501253200; Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999	60	141	145	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12783	12791		10.1074/jbc.M809207200	http://dx.doi.org/10.1074/jbc.M809207200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19299511	hybrid, Green Published			2022-12-27	WOS:000265688300023
J	Wang, Y; Li, D; Nurieva, R; Yang, J; Sen, M; Carreno, R; Lu, S; McIntyre, BW; Molldrem, JJ; Legge, GB; Ma, Q				Wang, Yang; Li, Dan; Nurieva, Roza; Yang, Justin; Sen, Mehmet; Carreno, Roberto; Lu, Sijie; McIntyre, Bradley W.; Molldrem, Jeffrey J.; Legge, Glen B.; Ma, Qing			LFA-1 Affinity Regulation Is Necessary for the Activation and Proliferation of Naive T Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VERSUS-HOST-DISEASE; ADHESION MOLECULES; STRUCTURAL BASIS; CONFORMATIONAL REGULATION; CLINICAL-TRIALS; I-DOMAIN; ANTIGEN-1; BINDING; GENERATION; ANTIBODIES	The activation of LFA-1 (lymphocyte function-associated antigen) is a critical event for T cell co-stimulation. The mechanism of LFA-1 activation involves both affinity and avidity regulation, but the role of each in T cell activation remains unclear. We have identified antibodies that recognize and block different affinity states of the mouse LFA-1 I-domain. Monoclonal antibody 2D7 preferentially binds to the low affinity conformation, and this specific binding is abolished when LFA-1 is locked in the high affinity conformation. In contrast, M17/4 can bind both the locked high and low affinity forms of LFA-1. Although both 2D7 and M17/4 are blocking antibodies, 2D7 is significantly less potent than M17/4 in blocking LFA-1-mediated adhesion; thus, blocking high affinity LFA-1 is critical for preventing LFA-1-mediated adhesion. Using these reagents, we investigated whether LFA-1 affinity regulation affects T cell activation. We found that blocking high affinity LFA-1 prevents interleukin-2 production and T cell proliferation, demonstrated by TCR cross-linking and antigen-specific stimulation. Furthermore, there is a differential requirement of high affinity LFA-1 in the activation of CD4(+) and CD8(+) T cells. Although CD4(+) T cell activation depends on both high and low affinity LFA-1, only high affinity LFA-1 provides co-stimulation for CD8(+) T cell activation. Together, our data demonstrated that the I-domain of LFA-1 changes to the high affinity state in primary T cells, and high affinity LFA-1 is critical for facilitating T cell activation. This implicates LFA-1 activation as a novel regulatory mechanism for the modulation of T cell activation and proliferation.	[Wang, Yang; Li, Dan; Yang, Justin; Lu, Sijie; Molldrem, Jeffrey J.; Ma, Qing] Univ Texas MD Anderson Canc Ctr, Sect Transplantat Immunol, Dept Stem Cell Transplantat & Cellular Therapy, Houston, TX 77030 USA; [Nurieva, Roza; McIntyre, Bradley W.] Univ Texas MD Anderson Canc Ctr, Dept Immunol, Houston, TX 77030 USA; [Sen, Mehmet; Carreno, Roberto; Legge, Glen B.] Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Houston System; University of Houston	Ma, Q (corresponding author), Univ Texas MD Anderson Canc Ctr, Sect Transplantat Immunol, Dept Stem Cell Transplantat & Cellular Therapy, Unit 900,1515 Holcombe Blvd, Houston, TX 77030 USA.	qma@mdanderson.org			American Cancer Society [RSG-08-183-01-LIB]	American Cancer Society(American Cancer Society)	This work was supported by American Cancer Society Grant RSG-08-183-01-LIB (to Q.M.).	Anikeeva N, 2005, P NATL ACAD SCI USA, V102, P6437, DOI 10.1073/pnas.0502467102; Aricescu AR, 2007, CURR OPIN CELL BIOL, V19, P543, DOI 10.1016/j.ceb.2007.09.010; Astrof NS, 2006, BIOCHEMISTRY-US, V45, P15020, DOI 10.1021/bi061566o; Bachmann MF, 1997, IMMUNITY, V7, P549, DOI 10.1016/S1074-7613(00)80376-3; Berlin-Rufenach C, 1999, J EXP MED, V189, P1467, DOI 10.1084/jem.189.9.1467; BLAZAR BR, 1995, BLOOD, V85, P2607, DOI 10.1182/blood.V85.9.2607.bloodjournal8592607; BROWER RC, 1994, MOL IMMUNOL, V31, P1285, DOI 10.1016/0161-5890(94)90079-5; Butcher EC, 1996, SCIENCE, V272, P60, DOI 10.1126/science.272.5258.60; Carman CV, 2003, CURR OPIN CELL BIOL, V15, P547, DOI 10.1016/j.ceb.2003.08.003; Carreno R, 2008, J BIOL CHEM, V283, P10642, DOI 10.1074/jbc.M704699200; DEMOTZ S, 1990, SCIENCE, V249, P1028, DOI 10.1126/science.2118680; DIAMOND MS, 1994, CURR BIOL, V4, P506, DOI 10.1016/S0960-9822(00)00111-1; Ding ZM, 1999, J IMMUNOL, V163, P5029; Dustin ML, 2007, CURR OPIN CELL BIOL, V19, P529, DOI 10.1016/j.ceb.2007.08.003; Dustin ML, 2003, ANN NY ACAD SCI, V987, P51, DOI 10.1111/j.1749-6632.2003.tb06032.x; Dustin ML, 2004, NAT IMMUNOL, V5, P363, DOI 10.1038/ni1057; Gadek TR, 2002, SCIENCE, V295, P1086, DOI 10.1126/science.295.5557.1086; Gordon KB, 2003, JAMA-J AM MED ASSOC, V290, P3073, DOI 10.1001/jama.290.23.3073; HARDING CV, 1990, NATURE, V346, P574, DOI 10.1038/346574a0; HARNING R, 1991, TRANSPLANTATION, V52, P842, DOI 10.1097/00007890-199111000-00017; Hogg N, 2002, IMMUNOL REV, V186, P164, DOI 10.1034/j.1600-065X.2002.18614.x; HUANG CC, 1995, J BIOL CHEM, V270, P19008, DOI 10.1074/jbc.270.32.19008; Huppa JB, 2003, NAT REV IMMUNOL, V3, P973, DOI 10.1038/nri1245; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; Hynes RO, 2003, SCIENCE, V300, P755, DOI 10.1126/science.1084854; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; Jenkinson SR, 2005, J IMMUNOL, V174, P3401, DOI 10.4049/jimmunol.174.6.3401; JOHNSTON SC, 1990, J IMMUNOL, V145, P1181; Kallen J, 1999, J MOL BIOL, V292, P1, DOI 10.1006/jmbi.1999.3047; Katagiri K, 2003, NAT IMMUNOL, V4, P741, DOI 10.1038/ni950; Kim M, 2004, J CELL BIOL, V167, P1241, DOI 10.1083/jcb.200404160; Kim M, 2003, SCIENCE, V301, P1720, DOI 10.1126/science.1084174; Kootstra CJ, 1997, CLIN EXP IMMUNOL, V108, P324, DOI 10.1046/j.1365-2249.1997.3641266.x; Krogsgaard M, 2003, SEMIN IMMUNOL, V15, P307, DOI 10.1016/j.smim.2003.09.002; Lebwohl M, 2003, NEW ENGL J MED, V349, P2004, DOI 10.1056/NEJMoa030002; Legge GB, 2002, PROTEINS, V48, P151, DOI 10.1002/prot.10134; Lu CF, 2004, J IMMUNOL, V173, P3972, DOI 10.4049/jimmunol.173.6.3972; Lu CF, 2001, P NATL ACAD SCI USA, V98, P2393, DOI 10.1073/pnas.041618598; Luo BH, 2007, ANNU REV IMMUNOL, V25, P619, DOI 10.1146/annurev.immunol.25.022106.141618; Ma Q, 2002, J BIOL CHEM, V277, P10638, DOI 10.1074/jbc.M112417200; Matthews JB, 2003, AM J TRANSPLANT, V3, P794, DOI 10.1046/j.1600-6135.2003.0154.x; Mueller KL, 2004, J IMMUNOL, V173, P2222, DOI 10.4049/jimmunol.173.4.2222; Nicolls MR, 2006, AM J TRANSPLANT, V6, P27, DOI 10.1111/j.1600-6143.2005.01158.x; Perez OD, 2003, NAT IMMUNOL, V4, P1083, DOI 10.1038/ni984; Purbhoo MA, 2004, NAT IMMUNOL, V5, P524, DOI 10.1038/ni1058; Scheinfeld N, 2006, EXPERT OPIN DRUG SAF, V5, P197, DOI 10.1517/14740338.5.2.197; Schmits R, 1996, J EXP MED, V183, P1415, DOI 10.1084/jem.183.4.1415; Schreiber TH, 2007, BLOOD, V109, P1381, DOI 10.1182/blood-2006-07-032995; Semmrich M, 2005, J EXP MED, V201, P1987, DOI 10.1084/jem.20041850; Shamri R, 2005, NAT IMMUNOL, V6, P497, DOI 10.1038/ni1194; Shimaoka M, 2001, P NATL ACAD SCI USA, V98, P6009, DOI 10.1073/pnas.101130498; Shimaoka M, 2003, NAT REV DRUG DISCOV, V2, P703, DOI 10.1038/nrd1174; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Shimaoka M, 2002, ANNU REV BIOPH BIOM, V31, P485, DOI 10.1146/annurev.biophys.31.101101.140922; SPRINGER TA, 1994, CELL, V76, P301, DOI 10.1016/0092-8674(94)90337-9; VANKOOYK Y, 1994, TRANSPLANT P, V26, P401; Vorup-Jensen T, 2007, BBA-PROTEINS PROTEOM, V1774, P1148, DOI 10.1016/j.bbapap.2007.06.014; Weitz-Schmidt G, 2001, NAT MED, V7, P687, DOI 10.1038/89058; Wooten DK, 1999, J LEUKOCYTE BIOL, V65, P127, DOI 10.1002/jlb.65.1.127; Yang YT, 2004, MOL CELL, V14, P269, DOI 10.1016/S1097-2765(04)00204-7	61	41	41	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12645	12653		10.1074/jbc.M807207200	http://dx.doi.org/10.1074/jbc.M807207200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19297325	Green Published, hybrid			2022-12-27	WOS:000265688300008
J	Brodhun, F; Gobel, C; Hornung, E; Feussner, I				Brodhun, Florian; Goebel, Cornelia; Hornung, Ellen; Feussner, Ivo			Identification of PpoA from Aspergillus nidulans as a Fusion Protein of a Fatty Acid Heme Dioxygenase/Peroxidase and a Cytochrome P450	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNGUS GAEUMANNOMYCES-GRAMINIS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE; HUMAN PROSTACYCLIN SYNTHASE; MONOXIDE-BINDING PIGMENT; ALLENE OXIDE SYNTHASE; LOWER OXYGEN-CONTENT; HYDROPEROXIDE ISOMERASE; CRYSTAL-STRUCTURE; LINOLEIC-ACID; REACTION-KINETICS	The homothallic ascomycete Aspergillus nidulans serves as model organism for filamentous fungi because of its ability to propagate with both asexual and sexual life cycles, and fatty acid-derived substances regulate the balance between both cycles. These so-called psi (precocious sexual inducer) factors are produced by psi factor-producing oxygenases (Ppo enzymes). Bioinformatic analysis predicted the presence of two different heme domains in Ppo proteins: in the N-terminal region, a fatty acid heme dioxygenase/peroxidase domain is predicted, whereas in the C-terminal region, a P450 heme thiolate domain is predicted. To analyze the reaction catalyzed by Ppo enzymes, PpoA was expressed in Escherichia coli as an active enzyme. The protein was purified by 62-fold and identified as a homotetrameric ferric heme protein that metabolizes mono-as well as polyunsaturated C-16 and C-18 fatty acids at pH similar to 7.25. The presence of thiolate-ligated heme was confirmed on the basis of sequence alignments and the appearance of a characteristic 450 nm CO-binding spectrum. Studies on its reaction mechanism revealed that PpoA uses different heme domains to catalyze two separate reactions. Within the heme peroxidase domain, linoleic acid is oxidized to (8R)-hydroperoxyoctadecadienoic acid by abstracting a H-atom from C-8 of the fatty acid, yielding a carbon-centered radical that reacts with molecular dioxygen. In the second reaction step, 8-hydroperoxyoctadecadienoic acid is isomerized within the P450 heme thiolate domain to 5,8-dihydroxyoctadecadienoic acid. We identify PpoA as a bifunctional P450 fusion protein that uses a previously unknown reaction mechanism for forming psi factors.	[Brodhun, Florian; Goebel, Cornelia; Hornung, Ellen; Feussner, Ivo] Univ Gottingen, Albrecht von Haller Inst Plant Sci, Dept Plant Biochem, D-37077 Gottingen, Germany	University of Gottingen	Feussner, I (corresponding author), Univ Gottingen, Albrecht von Haller Inst Plant Sci, Dept Plant Biochem, Justus von Liebig Weg 11, D-37077 Gottingen, Germany.	ifeussn@uni-goettingen.de	Feussner, Ivo/H-9320-2013	Feussner, Ivo/0000-0002-9888-7003	German Research Foundation (IRTG 1422). [IRTG 1422]	German Research Foundation (IRTG 1422).(German Research Foundation (DFG))	This work was supported by the German Research Foundation (IRTG 1422).	Antonini E., 1971, HEMOGLOBIN MYOGLOBIN; BOWERS WS, 1986, SCIENCE, V232, P105, DOI 10.1126/science.232.4746.105; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRODOWSKY ID, 1992, BIOCHIM BIOPHYS ACTA, V1124, P59, DOI 10.1016/0005-2760(92)90126-G; BRODOWSKY ID, 1992, J BIOL CHEM, V267, P14738; BRODOWSKY ID, 1993, BIOCHIM BIOPHYS ACTA, V1168, P68, DOI 10.1016/0005-2760(93)90267-D; Calvo AM, 2002, MICROBIOL MOL BIOL R, V66, P447, DOI 10.1128/MMBR.66.3.447-459.2002; Calvo AM, 2001, J BIOL CHEM, V276, P25766, DOI 10.1074/jbc.M100732200; Calvo AM, 1999, APPL ENVIRON MICROB, V65, P3668; CHAMPE SP, 1989, J BACTERIOL, V171, P3982, DOI 10.1128/jb.171.7.3982-3988.1989; Chiang CW, 2006, J MOL BIOL, V364, P266, DOI 10.1016/j.jmb.2006.09.039; Coon MJ, 2005, ANNU REV PHARMACOL, V45, P1, DOI 10.1146/annurev.pharmtox.45.120403.100030; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Garscha U, 2008, FEBS LETT, V582, P3547, DOI 10.1016/j.febslet.2008.09.031; Garscha U, 2008, BIOCHEM BIOPH RES CO, V373, P579, DOI 10.1016/j.bbrc.2008.06.060; Garscha U, 2007, J BIOL CHEM, V282, P34707, DOI 10.1074/jbc.M705366200; Garscha U, 2007, ANAL BIOCHEM, V367, P238, DOI 10.1016/j.ab.2007.04.045; HAMBERG M, 1994, ARCH BIOCHEM BIOPHYS, V309, P77, DOI 10.1006/abbi.1994.1087; Hoffmann M, 2007, J BIOL CHEM, V282, P26666, DOI 10.1074/jbc.M705068200; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Koeduka T, 2002, J BIOL CHEM, V277, P22648, DOI 10.1074/jbc.M110420200; Koshiishi I, 2006, BIOCHEM J, V395, P303, DOI 10.1042/BJ20051595; Koshiishi I, 2005, J LIPID RES, V46, P2506, DOI 10.1194/jlr.D500006-JLR200; KULMACZ RJ, 1987, PROSTAGLANDINS, V34, P225, DOI 10.1016/0090-6980(87)90246-2; KULMACZ RJ, 1994, J BIOL CHEM, V269, P5527; Kupfer R, 2001, BIOCHEMISTRY-US, V40, P11490, DOI 10.1021/bi010914d; Landino LM, 1997, J BIOL CHEM, V272, P21565, DOI 10.1074/jbc.272.34.21565; LAU SMC, 1993, BIOCHEMISTRY-US, V32, P1945, DOI 10.1021/bi00059a010; Lee DS, 2008, NATURE, V455, P363, DOI 10.1038/nature07307; Liavonchanka A, 2006, J PLANT PHYSIOL, V163, P348, DOI 10.1016/j.jplph.2005.11.006; Lu GQ, 1999, J BIOL CHEM, V274, P16162, DOI 10.1074/jbc.274.23.16162; MAZUR P, 1990, TETRAHEDRON LETT, V31, P3837, DOI 10.1016/S0040-4039(00)97482-3; MAZUR P, 1991, J CHEM SOC CHEM COMM, P1486, DOI 10.1039/c39910001486; OHKI S, 1979, J BIOL CHEM, V254, P829; OMURA T, 1964, J BIOL CHEM, V239, P2379; OMURA T, 1964, J BIOL CHEM, V239, P2370; PICOT D, 1994, NATURE, V367, P243, DOI 10.1038/367243a0; Sanz A, 1998, PLANT CELL, V10, P1523, DOI 10.1105/tpc.10.9.1523; Sasaki M, 2005, APPL ENVIRON MICROB, V71, P8024, DOI 10.1128/AEM.71.12.8024-8030.2005; SHIMOKAWA T, 1990, J BIOL CHEM, V265, P20073; Smith WL, 2000, ANNU REV BIOCHEM, V69, P145, DOI 10.1146/annurev.biochem.69.1.145; SONG WC, 1991, SCIENCE, V253, P781, DOI 10.1126/science.1876834; Su C, 1998, J BIOL CHEM, V273, P20744, DOI 10.1074/jbc.273.33.20744; Su C, 1996, J BIOL CHEM, V271, P14112, DOI 10.1074/jbc.271.24.14112; Takajo T, 2007, J LIPID RES, V48, P1371, DOI 10.1194/jlr.M700055-JLR200; Takajo T, 2007, J LIPID RES, V48, P855, DOI 10.1194/jlr.M600446-JLR200; Thuresson ED, 2001, J BIOL CHEM, V276, P10347, DOI 10.1074/jbc.M009377200; Tsitsigiannis D, 2004, EUKARYOT CELL, V3, P1398, DOI 10.1128/EC.3.6.1398-1411.2004; Tsitsigiannis DI, 2006, MOL MICROBIOL, V59, P882, DOI 10.1111/j.1365-2958.2005.05000.x; Tsitsigiannis DI, 2005, INFECT IMMUN, V73, P4548, DOI 10.1128/IAI.73.8.4548-4559.2005; Tsitsigiannis DI, 2005, MICROBIOL-SGM, V151, P1809, DOI 10.1099/mic.0.27880-0; Tsitsigiannis DI, 2004, J BIOL CHEM, V279, P11344, DOI 10.1074/jbc.M310840200; Tsitsigiannis DI, 2007, TRENDS MICROBIOL, V15, P109, DOI 10.1016/j.tim.2007.01.005; Yano JK, 2000, J BIOL CHEM, V275, P31086, DOI 10.1074/jbc.M004281200; Yeh HC, 2005, BBA-MOL CELL BIOL L, V1738, P121, DOI 10.1016/j.bbalip.2005.11.007	55	73	78	1	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					11792	11805		10.1074/jbc.M809152200	http://dx.doi.org/10.1074/jbc.M809152200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19286665	Green Published, hybrid			2022-12-27	WOS:000265494600011
J	Carapito, R; Imberty, A; Jeltsch, JM; Byrns, SC; Tam, PH; Lowary, TL; Varrot, A; Phalip, V				Carapito, Raphael; Imberty, Anne; Jeltsch, Jean-Marc; Byrns, Simon C.; Tam, Pui-Hang; Lowary, Todd L.; Varrot, Annabelle; Phalip, Vincent			Molecular Basis of Arabinobio-hydrolase Activity in Phytopathogenic Fungi CRYSTAL STRUCTURE AND CATALYTIC MECHANISM OF FUSARIUM GRAMINEARUM GH93 EXO-alpha-L-ARABINANASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALPHA-L-ARABINOFURANOSIDASE; PLANT-CELL-WALL; PENICILLIUM-CHRYSOGENUM EXO-1,5-ALPHA-L-ARABINANASE; ENZYMATIC GLYCOSIDE HYDROLYSIS; FUSARIUM-GRAMINEARUM; CRYSTAL-STRUCTURE; ARABINOXYLAN-ARABINOFURANOHYDROLASE; BACTERIAL SIALIDASES; ARABINANASE 43A; BETA-PROPELLER	The phytopathogenic fungus Fusarium graminearum secretes a very diverse pool of glycoside hydrolases (GHs) aimed at degrading plant cell walls. alpha-L-Arabinanases are essential GHs participating in the complete hydrolysis of hemicellulose, a natural resource for various industrial processes, such as bioethanol or pharmaceuticals production. Arb93A, the exo-1,5-alpha-arabinanase of F. graminearum encoded by the gene fg03054.1, belongs to the GH93 family, for which no structural data exists. The enzyme is highly active (1065 units/mg) and displays a strict substrate specificity for linear alpha-1,5-L-arabinan. Biochemical assays and NMR experiments demonstrated that the enzyme releases alpha-1,5-L-arabinobiose from the nonreducing end of the polysaccharide. We determined the crystal structure of the native enzyme and its complex with alpha-1,5-L-arabinobiose, a degradation product of alpha-Me-1,5-L-arabinotetraose, at 1.85 and 2.05 angstrom resolution, respectively. Arb93A is a monomeric enzyme, which presents the six-bladed beta-propeller fold characteristic of sialidases of clan GHE. The configuration of the bound arabinobiose is consistent with the retaining mechanism proposed for the GH93 family. Catalytic residues were proposed from the structural analysis, and site-directed mutagenesis was used to validate their role. They are significantly different from those observed for GHE sialidases.	[Imberty, Anne; Varrot, Annabelle] Univ Grenoble 1, CERMAV, CNRS, F-38401 Grenoble 09, France; [Carapito, Raphael; Jeltsch, Jean-Marc; Phalip, Vincent] Univ Strasbourg, UMR 7175, Ecole Super Biotechnol Strasbourg, CNRS, F-67412 Illkirch Graffenstaden, France; [Imberty, Anne; Varrot, Annabelle] Inst Chim Mol Grenoble, F-38401 Grenoble 09, France; [Byrns, Simon C.; Tam, Pui-Hang; Lowary, Todd L.] Univ Alberta, Alberta Ingenu Ctr Carbohydrate Sci, Gunning Lemieux Chem Ctr E5 52A, Edmonton, AB T6G 2G2, Canada; [Byrns, Simon C.; Tam, Pui-Hang; Lowary, Todd L.] Univ Alberta, Dept Chem, Gunning Lemieux Chem Ctr E5 52A, Edmonton, AB T6G 2G2, Canada	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Alberta; University of Alberta	Varrot, A (corresponding author), Univ Grenoble 1, CERMAV, CNRS, BP53, F-38401 Grenoble 09, France.	Annabelle.Varrot@cermav.cnrs.fr	Lowary, Todd L/F-9608-2019; Carapito, Raphael/ABG-5061-2020; Carapito, Raphael/O-5317-2016; Imberty, Anne/P-6451-2018	Lowary, Todd L/0000-0002-8331-8211; Carapito, Raphael/0000-0002-7036-442X; Carapito, Raphael/0000-0002-7036-442X; Varrot, Annabelle/0000-0001-6667-8162; Imberty, Anne/0000-0001-6825-9527	CNRS; Universite de Strasbourg	CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite de Strasbourg	This work was supported by CNRS and the Universite de Strasbourg. The atomic coordinates and structure factors (codes 2w5n and 2w5o) have been deposited in the Protein Data Bank, Research Collaboratory for Structural Bioinformatics, Rutgers University, New Brunswick, NJ (http://www.rcsb.org/).	Amaya MF, 2004, STRUCTURE, V12, P775, DOI 10.1016/j.str.2004.02.036; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Brunzelle JS, 2008, ARCH BIOCHEM BIOPHYS, V474, P157, DOI 10.1016/j.abb.2008.03.007; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Carapito R, 2009, BIORESOURCE TECHNOL, V100, P845, DOI 10.1016/j.biortech.2008.07.006; Chavas LMG, 2005, J BIOL CHEM, V280, P469, DOI 10.1074/jbc.M411506200; Copley RR, 2001, PROTEIN SCI, V10, P285, DOI 10.1110/ps.31901; CORFIELD T, 1992, GLYCOBIOLOGY, V2, P509, DOI 10.1093/glycob/2.6.509; CROS S, 1993, CARBOHYD RES, V248, P81, DOI 10.1016/0008-6215(93)84117-O; CROS S, 1994, BIOPOLYMERS, V34, P1433, DOI 10.1002/bip.360341014; Doublie S, 1997, METHOD ENZYMOL, V276, P523, DOI 10.1016/S0076-6879(97)76075-0; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; GASKELL A, 1995, STRUCTURE, V3, P1197, DOI 10.1016/S0969-2126(01)00255-6; Gielkens MMC, 1997, CURR GENET, V31, P22, DOI 10.1007/s002940050172; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Guldener U, 2006, NUCLEIC ACIDS RES, V34, pD456, DOI 10.1093/nar/gkj026; Hatsch D, 2006, BIOCHEM BIOPH RES CO, V345, P959, DOI 10.1016/j.bbrc.2006.04.171; Heightman TD, 1999, ANGEW CHEM INT EDIT, V38, P750, DOI 10.1002/(SICI)1521-3773(19990315)38:6<750::AID-ANIE750>3.0.CO;2-6; Henrissat B, 1998, BIOCHEM SOC T, V26, P153, DOI 10.1042/bst0260153; Hovel K, 2003, EMBO J, V22, P4922, DOI 10.1093/emboj/cdg494; Jawad Z, 2002, STRUCTURE, V10, P447, DOI 10.1016/S0969-2126(02)00750-5; Joe M, 2007, J AM CHEM SOC, V129, P9885, DOI 10.1021/ja072892+; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; KOSHLAND DE, 1953, BIOL REV, V28, P416, DOI 10.1111/j.1469-185X.1953.tb01386.x; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee RC, 2003, J BIOL CHEM, V278, P5377, DOI 10.1074/jbc.M210627200; Mai V, 2000, GENE, V247, P137, DOI 10.1016/S0378-1119(00)00106-2; MargollesClark E, 1996, APPL ENVIRON MICROB, V62, P3840, DOI 10.1128/AEM.62.10.3840-3846.1996; MCCARTER JD, 1994, CURR OPIN STRUC BIOL, V4, P885, DOI 10.1016/0959-440X(94)90271-2; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; MILLER GL, 1959, ANAL CHEM, V31, P426, DOI 10.1021/ac60147a030; Mitchell DB, 1997, MICROBIOL-SGM, V143, P245, DOI 10.1099/00221287-143-1-245; Miyanaga A, 2004, J BIOL CHEM, V279, P44907, DOI 10.1074/jbc.M405390200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Narine AA, 2006, BIOCHEMISTRY-US, V45, P9319, DOI 10.1021/bi0607507; Navaza J, 1997, METHOD ENZYMOL, V276, P581, DOI 10.1016/S0076-6879(97)76079-8; Numan MT, 2006, J IND MICROBIOL BIOT, V33, P247, DOI 10.1007/s10295-005-0072-1; Nurizzo D, 2002, NAT STRUCT BIOL, V9, P665, DOI 10.1038/nsb835; Paes G, 2008, BIOCHEMISTRY-US, V47, P7441, DOI 10.1021/bi800424e; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Phalip V, 2005, CURR GENET, V48, P366, DOI 10.1007/s00294-005-0040-3; Proctor MR, 2005, P NATL ACAD SCI USA, V102, P2697, DOI 10.1073/pnas.0500051102; ROGGENTIN P, 1989, GLYCOCONJUGATE J, V6, P349, DOI 10.1007/BF01047853; Sabini E, 1999, CHEM BIOL, V6, P483, DOI 10.1016/S1074-5521(99)80066-0; Saha BC, 2003, J IND MICROBIOL BIOT, V30, P279, DOI 10.1007/s10295-003-0049-x; Sakamoto T, 2004, BBA-GEN SUBJECTS, V1674, P85, DOI 10.1016/j.bbagen.2004.06.001; Sakamoto T, 2004, FEBS LETT, V560, P199, DOI 10.1016/S0014-5793(04)00106-1; Sakamoto T., 2006, Journal of Applied Glycoscience, V53, P115; Sakamoto T, 2001, APPL ENVIRON MICROB, V67, P3319, DOI 10.1128/AEM.67.7.3319-3321.2001; Taylor EJ, 2006, BIOCHEM J, V395, P31, DOI 10.1042/BJ20051780; Thobhani S, 2003, J AM CHEM SOC, V125, P7154, DOI 10.1021/ja029759w; Vandermarliere E, 2009, BIOCHEM J, V418, P39, DOI 10.1042/BJ20081256; Varghese JN, 1999, STRUCTURE, V7, P179, DOI 10.1016/S0969-2126(99)80024-0; Varrot A, 2000, J MOL BIOL, V297, P819, DOI 10.1006/jmbi.2000.3567; Vocadlo DJ, 2008, CURR OPIN CHEM BIOL, V12, P539, DOI 10.1016/j.cbpa.2008.05.010; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; WARD OP, 1989, CRIT REV BIOTECHNOL, V8, P237, DOI 10.3109/07388558909148194; Yamaguchi A, 2005, J BIOCHEM, V137, P587, DOI 10.1093/jb/mvi078; Yin HF, 2002, J ORG CHEM, V67, P892, DOI 10.1021/jo010910e	60	42	42	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12285	12296		10.1074/jbc.M900439200	http://dx.doi.org/10.1074/jbc.M900439200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19269961	Green Published, hybrid			2022-12-27	WOS:000265494600060
J	Tcherpakov, M; Delaunay, A; Toth, J; Kadoya, T; Petroski, MD; Ronai, ZA				Tcherpakov, Marianna; Delaunay, Agnes; Toth, Julia; Kadoya, Takayuki; Petroski, Matthew D.; Ronai, Ze'ev A.			Regulation of Endoplasmic Reticulum-associated Degradation by RNF5-dependent Ubiquitination of JNK-associated Membrane Protein (JAMP)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RING FINGER PROTEIN; INCLUSION-BODY MYOSITIS; QUALITY-CONTROL; STRESS; ACTIVATION; ERAD; TRANSLOCATION; MOTILITY; PATHWAY; TRAF2	Clearance of misfolded proteins by endoplasmic reticulum (ER)-associated degradation (ERAD) requires concerted activity of chaperones, adaptor proteins, ubiquitin ligases, and proteasomes. RNF5 is a ubiquitin ligase anchored to the ER membrane implicated in ERAD via ubiquitination of misfolded proteins. Among RNF5-associated proteins is JNK-associated membrane protein (JAMP), a 7-transmembrane protein located within the ER membrane that facilitates degradation of misfolded proteins through recruitment of proteasomes and ERAD regulatory components. Here we demonstrate that RNF5 associates with JAMP in the ER membrane. This association results in Ubc13-dependent RNF5-mediated noncanonical ubiquitination of JAMP. This ubiquitination does not alter JAMP stability but rather inhibits its association with Rpt5 and p97. Consequently, clearance of misfolded proteins, such as CFTR Delta 508 and T cell receptor alpha, is less efficient, resulting in their greater accumulation. Significantly, the RNF5 effect on JAMP is seen prior to and after ER stress response, thereby highlighting a novel mechanism to limit ERAD and proteasome assembly at the ER, to the actual ER stress response.	[Tcherpakov, Marianna; Delaunay, Agnes; Toth, Julia; Kadoya, Takayuki; Petroski, Matthew D.; Ronai, Ze'ev A.] Burnham Inst Med Res, Signal Transduct Program, La Jolla, CA 92037 USA	Sanford Burnham Prebys Medical Discovery Institute	Ronai, ZA (corresponding author), Burnham Inst Med Res, Signal Transduct Program, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	ronai@burnham.org	Delaunay-moisan, Agnes/GRX-7749-2022	Delaunay-moisan, Agnes/0000-0003-3105-221X; RONAI, ZEEV/0000-0002-3859-0400	National Institutes of Health Grant [CA097105]; NATIONAL CANCER INSTITUTE [R01CA097105] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA097105 (to Z.R.)	Broday L, 2004, J CELL BIOL, V165, P857, DOI 10.1083/jcb.200401133; Brodsky JL, 2007, BIOCHEM J, V404, P353, DOI 10.1042/BJ20061890; Bromberg KD, 2007, CANCER RES, V67, P8172, DOI 10.1158/0008-5472.CAN-07-0045; Chen ZJJ, 2004, CANCER BIOL THER, V3, P286, DOI 10.4161/cbt.3.3.798; Cox EA, 2004, J CELL SCI, V117, P1885, DOI 10.1242/jcs.01176; DeLaBarre B, 2006, MOL CELL, V22, P451, DOI 10.1016/j.molcel.2006.03.036; Delaunay A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001609; Didier C, 2003, MOL CELL BIOL, V23, P5331, DOI 10.1128/MCB.23.15.5331-5345.2003; Engel WK, 2006, NEUROLOGY, V66, pS20, DOI 10.1212/01.wnl.0000192260.33106.bb; Fang SY, 2001, P NATL ACAD SCI USA, V98, P14422, DOI 10.1073/pnas.251401598; Gomez TS, 2005, NAT IMMUNOL, V6, P261, DOI 10.1038/ni1168; Habelhah H, 2004, EMBO J, V23, P322, DOI 10.1038/sj.emboj.7600044; Habelhah H, 2002, EMBO J, V21, P5756, DOI 10.1093/emboj/cdf576; Hampton RY, 2002, CURR OPIN CELL BIOL, V14, P476, DOI 10.1016/S0955-0674(02)00358-7; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Kadoya T, 2005, MOL CELL BIOL, V25, P8619, DOI 10.1128/MCB.25.19.8619-8630.2005; Kostova Z, 2007, SEMIN CELL DEV BIOL, V18, P770, DOI 10.1016/j.semcdb.2007.09.002; Morito D, 2008, MOL BIOL CELL, V19, P1328, DOI 10.1091/mbc.E07-06-0601; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Nogalska A, 2006, J NEUROCHEM, V96, P1491, DOI 10.1111/j.1471-4159.2006.03668.x; Okuda-Shimizu Y, 2007, MOL CELL, V28, P544, DOI 10.1016/j.molcel.2007.09.012; Osborne AR, 2005, ANNU REV CELL DEV BI, V21, P529, DOI 10.1146/annurev.cellbio.21.012704.133214; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Tcherpakov M, 2008, MOL BIOL CELL, V19, P5019, DOI 10.1091/mbc.E08-08-0839; Tuvia S, 2007, J CELL BIOL, V177, P51, DOI 10.1083/jcb.200611036; Vattemi G, 2004, AM J PATHOL, V164, P1, DOI 10.1016/S0002-9440(10)63089-1; Wojcik C, 2006, MOL BIOL CELL, V17, P4606, DOI 10.1091/mbc.E06-05-0432; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Yamasaki S, 2005, ARTHRITIS RES THER, V7, P181, DOI 10.1186/ar1808; Yamasaki S, 2006, INT J MOL MED, V18, P113; Younger JM, 2006, CELL, V126, P571, DOI 10.1016/j.cell.2006.06.041	31	33	39	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12099	12109		10.1074/jbc.M808222200	http://dx.doi.org/10.1074/jbc.M808222200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19269966	hybrid, Green Published			2022-12-27	WOS:000265494600042
J	daCosta, CJB; Baenziger, JE				daCosta, Corrie J. B.; Baenziger, John E.			A Lipid-dependent Uncoupled Conformation of the Acetylcholine Receptor	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GATED ION-CHANNEL; TORPEDO POSTSYNAPTIC MEMBRANES; X-RAY-STRUCTURE; TRYPTOPHAN SUBSTITUTIONS; TRANSMEMBRANE SEGMENT; BINDING-SITE; CALIFORNICA; LIGAND; M4; MUTATIONS	Lipids influence the ability of Cys-loop receptors to gate open in response to neurotransmitter binding, but the underlying mechanisms are poorly understood. With the nicotinic acetylcholine receptor (nAChR) from Torpedo, current models suggest that lipids modulate the natural equilibrium between resting and desensitized conformations. We show that the lipid-inactivated nAChR is not desensitized, instead it adopts a novel conformation where the allosteric coupling between its neuro-transmitter-binding sites and transmembrane pore is lost. The uncoupling is accompanied by an unmasking of previously buried residues, suggesting weakened association between structurally intact agonist-binding and transmembrane domains. These data combined with the extensive literature on Cys-loop receptor-lipid interactions suggest that the M4 transmembrane helix plays a key role as a lipid-sensor, translating bilayer properties into altered nAChR function.	[daCosta, Corrie J. B.; Baenziger, John E.] Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada	University of Ottawa	daCosta, CJB (corresponding author), Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada.	corrie@dacosta.net; jebaenz@uottawa.ca		Baenziger, John/0000-0002-2888-5328	Canadian Institutes of Health Research; Canadian Graduate Scholarship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian Graduate Scholarship	This work was supported by the Canadian Institutes of Health Research and a Canadian Graduate Scholarship (to C. J. B. D.).	Arias HR, 2003, BIOCHEMISTRY-US, V42, P7358, DOI 10.1021/bi034052n; Baenziger JE, 2000, J BIOL CHEM, V275, P777, DOI 10.1074/jbc.275.2.777; Baenziger JE, 2008, MOL PHARMACOL, V73, P880, DOI 10.1124/mol.107.039008; Barrantes FJ, 2004, BRAIN RES REV, V47, P71, DOI 10.1016/j.brainresrev.2004.06.008; Bertrand D, 2007, BIOCHEM PHARMACOL, V74, P1155, DOI 10.1016/j.bcp.2007.07.011; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Bouzat C, 1998, MOL PHARMACOL, V54, P146, DOI 10.1124/mol.54.1.146; BOYD ND, 1980, BIOCHEMISTRY-US, V19, P5344, DOI 10.1021/bi00564a031; BOYD ND, 1980, BIOCHEMISTRY-US, V19, P5353, DOI 10.1021/bi00564a032; Brannigan G, 2008, P NATL ACAD SCI USA, V105, P14418, DOI 10.1073/pnas.0803029105; CRIADO M, 1984, J BIOL CHEM, V259, P9188; daCosta C.J.B., 2006, THESIS U OTTAWA OTTA; daCosta CJB, 2005, BIOPHYS J, V88, P1755, DOI 10.1529/biophysj.104.052944; daCosta CJB, 2002, J BIOL CHEM, V277, P201, DOI 10.1074/jbc.M108341200; EPSTEIN M, 1978, J BIOL CHEM, V253, P6660; FONG TM, 1986, BIOCHEMISTRY-US, V25, P830, DOI 10.1021/bi00352a015; Hamouda AK, 2006, BIOCHEMISTRY-US, V45, P4327, DOI 10.1021/bi052281z; HEIDMANN T, 1980, EUR J BIOCHEM, V110, P35, DOI 10.1111/j.1432-1033.1980.tb04839.x; HERZ JM, 1987, J BIOL CHEM, V262, P7238; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Hosie AM, 2006, NATURE, V444, P486, DOI 10.1038/nature05324; Katz EJ, 1997, TOXICOL APPL PHARM, V146, P227, DOI 10.1006/taap.1997.8201; KRODEL EK, 1979, MOL PHARMACOL, V15, P294; Lasalde JA, 1996, BIOCHEMISTRY-US, V35, P14139, DOI 10.1021/bi961583l; LEE YH, 1994, BIOPHYS J, V66, P646, DOI 10.1016/S0006-3495(94)80838-0; LI L, 1992, BIOPHYS J, V62, P61, DOI 10.1016/S0006-3495(92)81779-4; MCCARTHY MP, 1992, J BIOL CHEM, V267, P7655; METHOT N, 1995, BIOCHEMISTRY-US, V34, P15142, DOI 10.1021/bi00046a021; Mitra A, 2004, STRUCTURE, V12, P1909, DOI 10.1016/j.str.2004.08.004; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Pagan OR, 2001, BIOCHEMISTRY-US, V40, P11121, DOI 10.1021/bi0112255; Paradiso K, 2001, J NEUROSCI, V21, P6561, DOI 10.1523/JNEUROSCI.21-17-06561.2001; Rankin SE, 1997, BIOPHYS J, V73, P2446, DOI 10.1016/S0006-3495(97)78273-0; Ridder A, 2005, J MOL BIOL, V354, P894, DOI 10.1016/j.jmb.2005.09.084; Ryan SE, 2002, J BIOL CHEM, V277, P10420, DOI 10.1074/jbc.M107412200; Ryan SE, 2001, J BIOL CHEM, V276, P4796, DOI 10.1074/jbc.M007063200; Ryan SE, 1999, MOL PHARMACOL, V55, P348, DOI 10.1124/mol.55.2.348; Shen XM, 2006, ANN NEUROL, V60, P128, DOI 10.1002/ana.20861; Sine SM, 2006, NATURE, V440, P448, DOI 10.1038/nature04708; Tamamizu S, 2000, BIOCHEMISTRY-US, V39, P4666, DOI 10.1021/bi992835w; TOBIMATSU T, 1987, FEBS LETT, V222, P56, DOI 10.1016/0014-5793(87)80191-6; Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031; Young GT, 2008, P NATL ACAD SCI USA, V105, P14686, DOI 10.1073/pnas.0804372105	44	82	82	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17819	17825		10.1074/jbc.M900030200	http://dx.doi.org/10.1074/jbc.M900030200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19357079	Green Published, hybrid			2022-12-27	WOS:000267202500047
J	Huang, CC; Yoshino-Koh, K; Tesmer, JJG				Huang, Chih-chin; Yoshino-Koh, Kae; Tesmer, John J. G.			A Surface of the Kinase Domain Critical for the Allosteric Activation of G Protein-coupled Receptor Kinases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE SEQUENCE ALIGNMENT; G-BETA-GAMMA; RHODOPSIN KINASE; BETA(2)-ADRENERGIC RECEPTOR; MOTIF PHOSPHORYLATION; CRYSTAL-STRUCTURE; TERMINAL TAIL; MECHANISM; IDENTIFICATION; COMPLEX	G protein-coupled receptor ( GPCR) kinases (GRKs) phosphorylate activated GPCRs and initiate their desensitization. Many prior studies suggest that activated GPCRs dock to an allosteric site on the GRKs and thereby stimulate kinase activity. The extreme N-terminal region of GRKs is clearly involved in this process, but its role is not understood. Using our recent structure of bovine GRK1 as a guide, we generated mutants of solvent-exposed residues in the GRK1 kinase domain that are conserved among GRKs but not in the extended protein kinase A, G, and C family and evaluated their catalytic activity. Mutation of select residues in strands beta 1 and beta 3 of the kinase small lobe, alpha D of the kinase large lobe, and the protein kinase A, G, and C kinase C-tail greatly impaired receptor phosphorylation. The most dramatic effect was observed for mutation of an invariant arginine on the beta 1-strand (similar to 1000-fold decrease in k(cat)/K-m). These residues form a continuous surface that is uniquely available in GRKs for protein-protein interactions. Surprisingly, these mutants, as well as a 19-amino acid N-terminal truncation of GRK1, also show decreased catalytic efficiency for peptide substrates, although to a lesser extent than for receptor phosphorylation. Our data suggest that the N-terminal region and the newly identified surface interact and stabilize the closed, active conformation of the kinase domain. Receptor binding is proposed to promote this interaction, thereby enhancing GRK activity.	[Huang, Chih-chin; Yoshino-Koh, Kae; Tesmer, John J. G.] Univ Michigan, Dept Pharmacol, Inst Life Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Tesmer, JJG (corresponding author), 210 Washtenaw Ave, Ann Arbor, MI 48109 USA.	johntesmer@umich.edu		Tesmer, John/0000-0003-1125-3727	National Institutes of Health [HL086865, HL071818]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086865, R01HL071818] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL086865 and HL071818 (to J.J.G.T.).	Armon A, 2001, J MOL BIOL, V307, P447, DOI 10.1006/jmbi.2000.4474; Batkin M, 2000, BIOCHEMISTRY-US, V39, P5366, DOI 10.1021/bi000153z; CHEN CK, 1995, J BIOL CHEM, V270, P18060, DOI 10.1074/jbc.270.30.18060; CHEN CY, 1993, J BIOL CHEM, V268, P7825; DebBurman SK, 1996, J BIOL CHEM, V271, P22552, DOI 10.1074/jbc.271.37.22552; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; FERGUSON SSG, 1995, J BIOL CHEM, V270, P24782, DOI 10.1074/jbc.270.42.24782; Gold MG, 2006, CURR OPIN STRUC BIOL, V16, P693, DOI 10.1016/j.sbi.2006.10.006; Goldsmith EJ, 2007, CHEM REV, V107, P5065, DOI 10.1021/cr068221w; Hauge C, 2007, EMBO J, V26, P2251, DOI 10.1038/sj.emboj.7601682; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Kannan N, 2007, P NATL ACAD SCI USA, V104, P1272, DOI 10.1073/pnas.0610251104; KIM CM, 1993, J BIOL CHEM, V268, P15412; KIM CM, 1993, RECEPTOR, V3, P39; Krasel C, 2008, J BIOL CHEM, V283, P31840, DOI 10.1074/jbc.M806086200; Krupnick JG, 1998, ANNU REV PHARMACOL, V38, P289, DOI 10.1146/annurev.pharmtox.38.1.289; KUNAPULI P, 1994, J BIOL CHEM, V269, P1099; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; Lodowski DT, 2006, J BIOL CHEM, V281, P16785, DOI 10.1074/jbc.M601327200; Lodowski DT, 2003, SCIENCE, V300, P1256, DOI 10.1126/science.1082348; Lodowski DT, 2005, BIOCHEMISTRY-US, V44, P6958, DOI 10.1021/bi050119q; Madhusudan, 2002, NAT STRUCT BIOL, V9, P273, DOI 10.1038/nsb780; McCarthy NEM, 2002, BIOCHEM J, V363, P359, DOI 10.1042/0264-6021:3630359; Metaye T, 2005, CELL SIGNAL, V17, P917, DOI 10.1016/j.cellsig.2005.01.002; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Noble B, 2003, J BIOL CHEM, V278, P47466, DOI 10.1074/jbc.M308257200; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; ONORATO JJ, 1991, BIOCHEMISTRY-US, V30, P5118, DOI 10.1021/bi00235a002; PALCZEWSKI K, 1991, J BIOL CHEM, V266, P12949; PALCZEWSKI K, 1993, J BIOL CHEM, V268, P6004; PALCZEWSKI K, 1988, BIOCHEMISTRY-US, V27, P2306, DOI 10.1021/bi00407a010; PALCZEWSKI K, 1991, TRENDS BIOCHEM SCI, V16, P387, DOI 10.1016/0968-0004(91)90157-Q; PAPERMASTER DS, 1982, METHOD ENZYMOL, V81, P240; Pellicena P, 2006, CURR OPIN STRUC BIOL, V16, P702, DOI 10.1016/j.sbi.2006.10.007; Pitcher JA, 1996, J BIOL CHEM, V271, P24907, DOI 10.1074/jbc.271.40.24907; Pitcher JA, 1998, ANNU REV BIOCHEM, V67, P653, DOI 10.1146/annurev.biochem.67.1.653; Seibold A, 2000, MOL PHARMACOL, V58, P1162, DOI 10.1124/mol.58.5.1162; Singh P, 2008, J BIOL CHEM, V283, P14053, DOI 10.1074/jbc.M708974200; Smith CM, 1997, TRENDS BIOCHEM SCI, V22, P444, DOI 10.1016/S0968-0004(97)01131-6; STERNEMARR R, 2009, BIOCHEMISTR IN PRESS; Tesmer VM, 2005, SCIENCE, V310, P1686, DOI 10.1126/science.1118890; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tran TM, 2007, BIOCHEMISTRY-US, V46, P14438, DOI 10.1021/bi700922h; Vaughan DJ, 2006, J BIOL CHEM, V281, P7684, DOI 10.1074/jbc.M500328200; Whalen EJ, 2007, CELL, V129, P511, DOI 10.1016/j.cell.2007.02.046; Xu ZB, 2004, J BIOL CHEM, V279, P50401, DOI 10.1074/jbc.M409216200; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; Yang J, 2002, MOL CELL, V9, P1227, DOI 10.1016/S1097-2765(02)00550-6; Yu QM, 1999, J NEUROCHEM, V73, P1222, DOI 10.1046/j.1471-4159.1999.0731222.x	49	52	54	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					17206	17215		10.1074/jbc.M809544200	http://dx.doi.org/10.1074/jbc.M809544200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19364770	Green Published, hybrid			2022-12-27	WOS:000266962400058
J	Mi, LX; Gan, NQ; Cheema, A; Dakshanamurthy, S; Wang, XT; Yang, DCH; Chung, FL				Mi, Lixin; Gan, Nanqin; Cheema, Amrita; Dakshanamurthy, Sivanesan; Wang, Xiantao; Yang, David C. H.; Chung, Fung-Lung			Cancer Preventive Isothiocyanates Induce Selective Degradation of Cellular alpha- and beta-Tubulins by Proteasomes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHENETHYL ISOTHIOCYANATE; GROWTH ARREST; APOPTOSIS; CELLS; SULFORAPHANE; PROTEINS; BINDING; MECHANISMS; MICROTUBULES; AUTOPHAGY	Although it is conceivable that cancer preventive isothiocyanates (ITCs), a family of compounds in cruciferous vegetables, induce cell cycle arrest and apoptosis through a mechanism involving oxidative stress, our study shows that binding to cellular proteins correlates with their potencies of apoptosis induction. More recently, we showed that ITCs bind selectively to tubulins. The differential binding affinities toward tubulin among benzyl isothiocyanate, phenethyl isothiocyanate, and sulforaphane correlate well with their potencies of inducing tubulin conformation changes, microtubule depolymerization, and eventual cell cycle arrest and apoptosis in human lung cancer A549 cells. These results support that tubulin binding by ITCs is an early event for cell growth inhibition. Here we demonstrate that ITCs can selectively induce degradation of both alpha- and beta-tubulins in a variety of human cancer cell lines in a dose- and time-dependent manner. The onset of degradation, a rapid and irreversible process, is initiated by tubulin aggregation, and the degradation is proteasome-dependent. Results indicate that the degradation is triggered by ITC binding to tubulin and is irrelevant to oxidative stress. This is the first report that tubulin, a stable and abundant cytoskeleton protein required for cell cycle progression, can be selectively degraded by a small molecule.	[Mi, Lixin; Gan, Nanqin; Cheema, Amrita; Dakshanamurthy, Sivanesan; Wang, Xiantao] Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20057 USA; [Yang, David C. H.; Chung, Fung-Lung] Georgetown Univ, Dept Chem, Washington, DC 20057 USA	Georgetown University; Georgetown University	Mi, LX (corresponding author), Georgetown Univ, Lombardi Comprehens Canc Ctr, Dept Oncol, 3800 Reservoir Rd,LL 129,Box 571465, Washington, DC 20057 USA.	lm293@georgetown.edu; flc6@georgetown.edu	Dakshanamurthy, Sivanesan/CAF-4258-2022; Yang, David/A-7294-2009	Dakshanamurthy, Sivanesan/0000-0003-3681-4121; 	National Institutes of Health; NCI [CA100853]; NATIONAL CANCER INSTITUTE [R01CA100853] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA100853 from NCI.	Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; BENZEEV A, 1979, CELL, V17, P319, DOI 10.1016/0092-8674(79)90157-0; Chen YR, 1998, J BIOL CHEM, V273, P1769, DOI 10.1074/jbc.273.3.1769; Chiao JW, 2002, INT J ONCOL, V20, P631; CLEVELAND DW, 1983, NATURE, V305, P738, DOI 10.1038/305738a0; CLEVELAND DW, 1981, CELL, V25, P537, DOI 10.1016/0092-8674(81)90072-6; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Downing KH, 1999, CELL STRUCT FUNCT, V24, P269; Ferrington DA, 2001, J BIOL CHEM, V276, P937, DOI 10.1074/jbc.M005356200; Garcia-Mata R, 2002, TRAFFIC, V3, P388, DOI 10.1034/j.1600-0854.2002.30602.x; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; HARTWELL LH, 1994, SCIENCE, V266, P1821, DOI 10.1126/science.7997877; Herman-Antosiewicz A, 2006, CANCER RES, V66, P5828, DOI 10.1158/0008-5472.CAN-06-0139; Iwata A, 2005, J BIOL CHEM, V280, P40282, DOI 10.1074/jbc.M508786200; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Lengauer C, 1998, NATURE, V396, P643, DOI 10.1038/25292; Liu Y, 2007, CANCER RES, V67, P10207, DOI 10.1158/0008-5472.CAN-07-2574; Mi LX, 2008, J BIOL CHEM, V283, P22136, DOI 10.1074/jbc.M802330200; Mi LX, 2007, CANCER RES, V67, P6409, DOI 10.1158/0008-5472.CAN-07-0340; Nogales E, 2000, ANNU REV BIOCHEM, V69, P277, DOI 10.1146/annurev.biochem.69.1.277; NOGALES E, 1995, NATURE, V375, P424, DOI 10.1038/375424a0; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Pierce A, 2008, MOL CELL PROTEOMICS, V7, P853, DOI 10.1074/mcp.M700251-MCP200; Salmeen A, 2005, ANTIOXID REDOX SIGN, V7, P560, DOI 10.1089/ars.2005.7.560; Sherman MY, 2001, NEURON, V29, P15, DOI 10.1016/S0896-6273(01)00177-5; Shringarpure R, 2003, J BIOL CHEM, V278, P311, DOI 10.1074/jbc.M206279200; Singh SV, 2005, J BIOL CHEM, V280, P19911, DOI 10.1074/jbc.M412443200; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; White E, 1996, GENE DEV, V10, P1, DOI 10.1101/gad.10.1.1; *WHO, 2004, IARC HDB CANC PREV, V9, P43; Xiao D, 2005, MOL CARCINOGEN, V43, P130, DOI 10.1002/mc.20099; Xirodimas D, 2001, ONCOGENE, V20, P4972, DOI 10.1038/sj.onc.1204656; Yang YL, 2007, CANCER RES, V67, P9472, DOI 10.1158/0008-5472.CAN-07-0568; Yang YM, 2005, CANCER RES, V65, P8538, DOI 10.1158/0008-5472.CAN-05-0236; Zhang YS, 2005, FREE RADICAL BIO MED, V38, P70, DOI 10.1016/j.freeradbiomed.2004.09.033; Zhang YS, 1998, CANCER RES, V58, P4632	36	95	96	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					17039	17051		10.1074/jbc.M901789200	http://dx.doi.org/10.1074/jbc.M901789200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19339240	Green Published, hybrid			2022-12-27	WOS:000266962400042
J	Hong, KU; Kim, HJ; Kim, HS; Seong, YS; Hong, KM; Bae, CD; Park, J				Hong, Kyung Uk; Kim, Hyun-Jun; Kim, Hyo-Sil; Seong, Yeon-Sun; Hong, Kyeong-Man; Bae, Chang-Dae; Park, Joobae			Cdk1-Cyclin B1-mediated Phosphorylation of Tumor-associated Microtubule-associated Protein/Cytoskeleton-associated Protein 2 in Mitosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							XENOPUS EGG EXTRACTS; CYTOSKELETON-ASSOCIATED PROTEIN; DEPENDENT KINASE CDK1; MITOTIC SPINDLE; CELL-CYCLE; M-PHASE; CDC2 KINASE; HELA-CELLS; IN-VIVO; DYNAMICS	During mitosis, establishment of structurally and functionally sound bipolar spindles is necessary for maintaining the fidelity of chromosome segregation. Tumor-associated microtubule-associated protein (TMAP), also known as cytoskeleton-associated protein 2 (CKAP2), is a mitotic spindle-associated protein whose level is frequently up-regulated in various malignancies. Previous reports have suggested that TMAP is a potential regulator of mitotic spindle assembly and dynamics and that it is required for chromosome segregation to occur properly. So far, there have been no reports on how its mitosis-related functions are regulated. Here, we report that TMAP is hyper-phosphorylated at the C terminus specifically during mitosis. At least four different residues (Thr-578, Thr-596, Thr-622, and Ser-627) were responsible for the mitosis-specific phosphorylation of TMAP. Among these, Thr-622 was specifically phosphorylated by Cdk1-cyclin B1 both in vitro and in vivo. Interestingly, compared with the wild type, a phosphorylation-deficient mutant form of TMAP, in which Thr-622 had been replaced with an alanine (T622A), induced a significant increase in the frequency of metaphase cells with abnormal bipolar spindles, which often displayed disorganized, asymmetrical, or narrow and elongated morphologies. Formation of these abnormal bipolar spindles subsequently resulted in misalignment of metaphase chromosomes and ultimately caused a delay in the entry into anaphase. Moreover, such defects resulting from the T622A mutation were associated with a decrease in the rate of protein turnover at spindle microtubules. These findings suggest that Cdk1-cyclin B1-mediated phosphorylation of TMAP is important for and contributes to proper regulation of microtubule dynamics and establishment of functional bipolar spindles during mitosis.	[Hong, Kyung Uk; Kim, Hyun-Jun; Kim, Hyo-Sil; Bae, Chang-Dae; Park, Joobae] Sungkyunkwan Univ, Dept Mol Cell Biol, Sch Med, Suwon 440769, South Korea; [Hong, Kyung Uk; Kim, Hyun-Jun; Kim, Hyo-Sil; Bae, Chang-Dae; Park, Joobae] Sungkyunkwan Univ, Samsung Biomed Res Inst, Sch Med, Suwon 440769, South Korea; [Seong, Yeon-Sun] Dankook Univ, Dept Biochem, Coll Med, Cheonan 330714, Chungnam, South Korea; [Hong, Kyeong-Man] Natl Canc Ctr, Res Inst, Goyang Si 410769, South Korea	Sungkyunkwan University (SKKU); Sungkyunkwan University (SKKU); Dankook University; National Cancer Center - Korea (NCC)	Bae, CD (corresponding author), Sungkyunkwan Univ, Dept Mol Cell Biol, Sch Med, 300 Chunchundong, Suwon 440746, South Korea.	cdbae@med.skku.ac.kr; jbpark@med.skku.ac.kr	Hong, Kyung Uk/G-7145-2011; SEONG, YEON-SUN/B-2485-2016	Hong, Kyung Uk/0000-0001-6700-9470; SEONG, YEON-SUN/0000-0002-4743-8048	Ministry of Health and Welfare, Republic of Korea [0720370]	Ministry of Health and Welfare, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea)	This work was supported by the National R&D Program for Cancer Control, Ministry of Health and Welfare, Republic of Korea (Grant 0720370).	Bae CD, 2003, J CANCER RES CLIN, V129, P621, DOI 10.1007/s00432-003-0484-0; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bharadwaj R, 2004, ONCOGENE, V23, P2016, DOI 10.1038/sj.onc.1207374; Blangy A, 1995, CELL, V83, P1159, DOI 10.1016/0092-8674(95)90142-6; Cassimeris L, 2002, CURR OPIN CELL BIOL, V14, P18, DOI 10.1016/S0955-0674(01)00289-7; Cha HJ, 2007, J BIOL CHEM, V282, P22984, DOI 10.1074/jbc.M700735200; Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105; Draviam VM, 2006, EMBO J, V25, P2814, DOI 10.1038/sj.emboj.7601168; Eichmuller S, 2001, P NATL ACAD SCI USA, V98, P629, DOI 10.1073/pnas.021386498; Fourest-Lieuvin A, 2006, MOL BIOL CELL, V17, P1041, DOI 10.1091/mbc.E05-07-0621; Gadde S, 2004, CURR BIOL, V14, pR797, DOI 10.1016/j.cub.2004.09.021; Gergely F, 2003, GENE DEV, V17, P336, DOI 10.1101/gad.245603; Guadagno TM, 1998, SCIENCE, V282, P1312, DOI 10.1126/science.282.5392.1312; Hong KU, 2008, EXP MOL MED, V40, P377, DOI 10.3858/emm.2008.40.4.377; Hong KU, 2007, MOL CELL BIOL, V27, P3667, DOI 10.1128/MCB.01386-06; Hong KU, 2009, CELL CYCLE, V8, P314, DOI 10.4161/cc.8.2.7597; Jeon SM, 2006, BIOCHEM BIOPH RES CO, V348, P222, DOI 10.1016/j.bbrc.2006.07.046; Jin Y, 2004, CANCER SCI, V95, P815, DOI 10.1111/j.1349-7006.2004.tb02187.x; Kimura K, 2001, J BIOL CHEM, V276, P5417, DOI 10.1074/jbc.C000873200; Kline-Smith SL, 2004, MOL CELL, V15, P317, DOI 10.1016/j.molcel.2004.07.012; LIEUVIN A, 1994, J CELL BIOL, V124, P985, DOI 10.1083/jcb.124.6.985; Logarinho E, 2008, CELL CYCLE, V7, P1763, DOI 10.4161/cc.7.12.6180; Maouche-Chretien L, 1998, ONCOGENE, V17, P1245, DOI 10.1038/sj.onc.1202048; Meraldi P, 2001, J CELL SCI, V114, P3749; Mishima M, 2004, NATURE, V430, P908, DOI 10.1038/nature02767; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; North BJ, 2007, J BIOL CHEM, V282, P19546, DOI 10.1074/jbc.M702990200; Nousiainen M, 2006, P NATL ACAD SCI USA, V103, P5391, DOI 10.1073/pnas.0507066103; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; Ohsugi M, 2003, EMBO J, V22, P2091, DOI 10.1093/emboj/cdg208; Ookata K, 1997, BIOCHEMISTRY-US, V36, P15873, DOI 10.1021/bi971251w; OOKATA K, 1995, J CELL BIOL, V128, P849, DOI 10.1083/jcb.128.5.849; PETER M, 1990, CELL, V61, P591, DOI 10.1016/0092-8674(90)90471-P; Raemaekers T, 2003, J CELL BIOL, V162, P1017, DOI 10.1083/jcb.200302129; Rudner AD, 2000, J CELL BIOL, V149, P1377, DOI 10.1083/jcb.149.7.1377; SAXTON WM, 1984, J CELL BIOL, V99, P2175, DOI 10.1083/jcb.99.6.2175; Tsuchihara K, 2005, CANCER RES, V65, P6685, DOI 10.1158/0008-5472.CAN-04-4223; Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062; Ubersax JA, 2007, NAT REV MOL CELL BIO, V8, P530, DOI 10.1038/nrm2203; Vasquez RJ, 1999, CELL MOTIL CYTOSKEL, V43, P310, DOI 10.1002/(SICI)1097-0169(1999)43:4<310::AID-CM4>3.3.CO;2-A; VERDE F, 1992, J CELL BIOL, V118, P1097, DOI 10.1083/jcb.118.5.1097; VERDE F, 1990, NATURE, V343, P233, DOI 10.1038/343233a0; Wakefield JG, 2003, J CELL SCI, V116, P637, DOI 10.1242/jcs.00273; Whitfield ML, 2002, MOL BIOL CELL, V13, P1977, DOI 10.1091/mbc.02-02-0030; Wong J, 2008, MOL BIOL CELL, V19, P2083, DOI 10.1091/mbc.E07-10-1088; Yu LR, 2007, J PROTEOME RES, V6, P4150, DOI 10.1021/pr070152u; Zhai Y, 1996, J CELL BIOL, V135, P201, DOI 10.1083/jcb.135.1.201; ZHOU SY, 1994, CURR BIOL, V4, P973, DOI 10.1016/S0960-9822(00)00221-9	49	15	17	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16501	16512		10.1074/jbc.M900257200	http://dx.doi.org/10.1074/jbc.M900257200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19369249	hybrid, Green Published			2022-12-27	WOS:000266730900047
J	Pu, MM; Fang, XM; Redfield, AG; Gershenson, A; Roberts, MF				Pu, Mingming; Fang, Xiaomin; Redfield, Alfred G.; Gershenson, Anne; Roberts, Mary F.			Correlation of Vesicle Binding and Phospholipid Dynamics with Phospholipase C Activity INSIGHTS INTO PHOSPHATIDYLCHOLINE ACTIVATION AND SURFACE DILUTION INHIBITION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENCE CORRELATION SPECTROSCOPY; FIELD-CYCLING NMR; INTERFACIAL BINDING; BACILLUS-CEREUS; INHALATION ANTHRAX; SIZE-DISTRIBUTION; MURINE MODEL; COMPLEX; THURINGIENSIS; SIMULATION	The enzymatic activity of the peripheral membrane protein, phosphatidylinositol-specific phospholipase C (PI-PLC), is increased by nonsubstrate phospholipids with the extent of enhancement tuned by the membrane lipid composition. For Bacillus thuringiensis PI-PLC, a small amount of phosphatidylcholine (PC) activates the enzyme toward its substrate PI; above 0.5 mol fraction PC (X-PC), enzyme activity decreases substantially. To provide a molecular basis for this PC-dependent behavior, we used fluorescence correlation spectroscopy to explore enzyme binding to multicomponent lipid vesicles composed of PC and anionic phospholipids (that bind to the active site as substrate analogues) and high resolution field cycling P-31 NMR methods to estimate internal correlation times (tau(c)) of phospholipid headgroup motions. PI-PLC binds poorly to pure anionic phospholipid vesicles, but 0.1 X-PC significantly enhances binding, increases PI-PLC activity, and slows nanosecond rotational/wobbling motions of both phospholipid headgroups, as indicated by increased tau(c). PI-PLC activity and phospholipid tau(c) are constant between 0.1 and 0.5 X-PC. Above this PC content, PI-PLC has little additional effect on the substrate analogue but further slows the PC tau(c), a motional change that correlates with the onset of reduced enzyme activity. For PC-rich bilayers, these changes, together with the reduced order parameter and enhanced lateral diffusion of the substrate analogue in the presence of PI-PLC, imply that at high X-PC, kinetic inhibition of PI-PLC results from intravesicle sequestration of the enzyme from the bulk of the substrate. Both methodologies provide a detailed view of protein-lipid interactions and can be readily adapted for other peripheral membrane proteins.	[Roberts, Mary F.] Boston Coll, Merkert Chem Ctr, Chestnut Hill, MA 02467 USA; [Fang, Xiaomin; Redfield, Alfred G.; Gershenson, Anne] Brandeis Univ, Waltham, MA 02454 USA	Boston College; Brandeis University	Roberts, MF (corresponding author), Boston Coll, Merkert Chem Ctr, Chestnut Hill, MA 02467 USA.	mary.roberts@bc.edu	Pu, Mingming/F-6760-2012	Gershenson, Anne/0000-0003-3124-9610	National Institutes of Health [GM60418, GM77974]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM060418, R01GM077974] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM60418 (to M. F. R.) and GM77974 (to A. G. R.).	Berg OG, 2001, CHEM REV, V101, P2613, DOI 10.1021/cr990139w; CARMAN GM, 1995, J BIOL CHEM, V270, P18711, DOI 10.1074/jbc.270.32.18711; Downes CP, 2005, TRENDS CELL BIOL, V15, P259, DOI 10.1016/j.tcb.2005.03.008; ELSON EL, 1974, BIOPOLYMERS, V13, P1, DOI 10.1002/bip.1974.360130102; Feng JW, 2003, J BIOL CHEM, V278, P24651, DOI 10.1074/jbc.M301207200; Feng JW, 2002, J BIOL CHEM, V277, P19867, DOI 10.1074/jbc.M200938200; Ghelardi E, 2007, MICROBES INFECT, V9, P591, DOI 10.1016/j.micinf.2007.02.001; Goni FM, 2000, BIOSCIENCE REP, V20, P443, DOI 10.1023/A:1010450702670; Guo S, 2008, BIOCHEMISTRY-US, V47, P4201, DOI 10.1021/bi702269u; Heffernan BJ, 2007, FEMS MICROBIOL LETT, V271, P98, DOI 10.1111/j.1574-6968.2007.00713.x; Heffernan BJ, 2006, INFECT IMMUN, V74, P3756, DOI 10.1128/IAI.00307-06; HEINZ DW, 1995, EMBO J, V14, P3855, DOI 10.1002/j.1460-2075.1995.tb00057.x; Klauda JB, 2008, BIOPHYS J, V94, P3074, DOI 10.1529/biophysj.107.121806; Liu L, 2006, BIOCHEMISTRY-US, V45, P10865, DOI 10.1021/bi0609568; MAGDE D, 1974, BIOPOLYMERS, V13, P29, DOI 10.1002/bip.1974.360130103; Maulucci G, 2005, BIOPHYS J, V88, P3545, DOI 10.1529/biophysj.104.048876; Mulgrew-Nesbitt A, 2006, BBA-MOL CELL BIOL L, V1761, P812, DOI 10.1016/j.bbalip.2006.07.002; Paulick MG, 2008, BIOCHEMISTRY-US, V47, P6991, DOI 10.1021/bi8006324; Qian XQ, 1998, BIOCHEMISTRY-US, V37, P6513, DOI 10.1021/bi972650u; Rhee SG, 2001, ANNU REV BIOCHEM, V70, P281, DOI 10.1146/annurev.biochem.70.1.281; Rhoades E, 2006, BIOPHYS J, V90, P4692, DOI 10.1529/biophysj.105.079251; Roberts MF, 2004, P NATL ACAD SCI USA, V101, P17066, DOI 10.1073/pnas.0407565101; Roberts MF, 2004, J AM CHEM SOC, V126, P13765, DOI 10.1021/ja046658k; Roberts MF, 2004, BIOCHEMISTRY-US, V43, P3637, DOI 10.1021/bi035979q; Rusu L, 2004, BIOPHYS J, V87, P1044, DOI 10.1529/biophysj.104.039958; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shao CH, 2007, J BIOL CHEM, V282, P9228, DOI 10.1074/jbc.M610918200; SWAIRJO MA, 1994, BBA-BIOMEMBRANES, V1191, P354, DOI 10.1016/0005-2736(94)90186-4; Takakuwa Y, 1999, BIOPHYS CHEM, V82, P149, DOI 10.1016/S0301-4622(99)00114-3; Thompson N. L., 1991, TOPICS FLUORESCENCE, V1, P337; VOLWERK JJ, 1994, BIOCHEMISTRY-US, V33, P3464, DOI 10.1021/bi00178a002; VOLWERK JJ, 1990, BIOCHEMISTRY-US, V29, P8056, DOI 10.1021/bi00487a010; Wehbi H, 2003, BIOCHEMISTRY-US, V42, P9374, DOI 10.1021/bi034195+; Zenewicz LA, 2005, J IMMUNOL, V174, P8011, DOI 10.4049/jimmunol.174.12.8011; ZHANG MY, 1993, INFECT IMMUN, V61, P4947, DOI 10.1128/IAI.61.12.4947-4954.1993; Zhou C, 1997, BIOCHEMISTRY-US, V36, P347, DOI 10.1021/bi960601w; Zhou C, 1997, BIOCHEMISTRY-US, V36, P10089, DOI 10.1021/bi970846o; Zhou C, 1998, BIOCHEMISTRY-US, V37, P16430, DOI 10.1021/bi980601r	38	25	25	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16099	16107		10.1074/jbc.M809600200	http://dx.doi.org/10.1074/jbc.M809600200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19336401	hybrid, Green Published			2022-12-27	WOS:000266730900006
J	Bayir, H; Kapralov, AA; Jiang, JF; Huang, ZT; Tyurina, YY; Tyurin, VA; Zhao, Q; Belikova, NA; Vlasova, II; Maeda, A; Zhu, JH; Na, HM; Mastroberardino, PG; Sparvero, LJ; Amoscato, AA; Chu, CT; Greenamyre, JT; Kagan, VE				Bayir, Huelya; Kapralov, Alexandr A.; Jiang, Janfei; Huang, Zhentai; Tyurina, Yulia Y.; Tyurin, Vladimir A.; Zhao, Qing; Belikova, Natalia A.; Vlasova, Irina I.; Maeda, Akihiro; Zhu, Jianhui; Na, Hye-Mee; Mastroberardino, Pier-Giorgio; Sparvero, Louis J.; Amoscato, Andrew A.; Chu, Charleen T.; Greenamyre, John T.; Kagan, Valerian E.			Peroxidase Mechanism of Lipid-dependent Cross-linking of Synuclein with Cytochrome c PROTECTION AGAINST APOPTOSIS VERSUS DELAYED OXIDATIVE STRESS IN PARKINSON DISEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MUTANT ALPHA-SYNUCLEIN; WILD-TYPE; NEURONAL CELLS; LEWY BODIES; AGGREGATION; MICE; CARDIOLIPIN; RESONANCE; NEURODEGENERATION; 6-HYDROXYDOPAMINE	Damage of presynaptic mitochondria could result in release of proapoptotic factors that threaten the integrity of the entire neuron. We discovered that alpha-synuclein (Syn) forms a triple complex with anionic lipids ( such as cardiolipin) and cytochrome c, which exerts a peroxidase activity. The latter catalyzes covalent hetero-oligomerization of Syn with cytochrome c into high molecular weight aggregates. Syn is a preferred substrate of this reaction and is oxidized more readily than cardiolipin, dopamine, and other phenolic substrates. Co-localization of Syn with cytochrome c was detected in aggregates formed upon proapoptotic stimulation of SH-SY5Y and HeLa cells and in dopaminergic substantia nigra neurons of rotenone-treated rats. Syn-cardiolipin exerted protection against cytochrome c-induced caspase-3 activation in a cell-free system, particularly in the presence of H2O2. Direct delivery of Syn into mouse embryonic cells conferred resistance to proapoptotic caspase-3 activation. Conversely, small interfering RNA depletion of Syn in HeLa cells made them more sensitive to dopamine-induced apoptosis. In human Parkinson disease substantia nigra neurons, two-thirds of co-localized Syn-cytochrome c complexes occurred in Lewy neurites. Taken together, these results indicate that Syn may prevent execution of apoptosis in neurons through covalent hetero-oligomerization of cytochrome c. This immediate protective function of Syn is associated with the formation of the peroxidase complex representing a source of oxidative stress and postponed damage.	[Bayir, Huelya; Kapralov, Alexandr A.; Jiang, Janfei; Huang, Zhentai; Tyurina, Yulia Y.; Tyurin, Vladimir A.; Zhao, Qing; Belikova, Natalia A.; Vlasova, Irina I.; Maeda, Akihiro; Kagan, Valerian E.] Univ Pittsburgh, Ctr Free Rad & Antioxidant Hlth, Pittsburgh, PA 15219 USA; [Bayir, Huelya] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA 15219 USA; [Bayir, Huelya; Kapralov, Alexandr A.; Jiang, Janfei; Huang, Zhentai; Tyurina, Yulia Y.; Tyurin, Vladimir A.; Zhao, Qing; Belikova, Natalia A.; Vlasova, Irina I.; Maeda, Akihiro] Univ Pittsburgh, Dept Environm & Occupat Hlth, Pittsburgh, PA 15219 USA; [Zhu, Jianhui; Chu, Charleen T.] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA 15219 USA; [Na, Hye-Mee; Mastroberardino, Pier-Giorgio; Greenamyre, John T.] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15219 USA; [Na, Hye-Mee; Sparvero, Louis J.; Amoscato, Andrew A.] Univ Pittsburgh, Dept Surg, Pittsburgh, PA 15219 USA; [Mastroberardino, Pier-Giorgio; Greenamyre, John T.] Univ Pittsburgh, Pittsburgh Inst Neurodegenerat Dis, Pittsburgh, PA 15219 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Bayir, H (corresponding author), CCM Off, 3705 5th Ave, Pittsburgh, PA 15213 USA.	bayihx@ccm.upmc.edu; kagan@pitt.edu	Greenamyre, J. Timothy/B-4049-2011; Mastroberardino, Pier/D-5623-2009; Maeda, Akihiro/K-5190-2015; Huang, Zhentai/C-6926-2012; Chu, Charleen T/B-1601-2008	Huang, Zhentai/0000-0002-8102-464X; Chu, Charleen T/0000-0002-5052-8271; Tyurin, Vladimir/0000-0002-3474-1697; Greenamyre, J. Timothy/0000-0003-3468-7878; Amoscato, Andrew/0000-0002-1340-9150; Kapralov, Oleksandr/0000-0002-3006-916X; Tyurina, Yulia/0000-0003-0287-2091; Kagan, Valerian E./0000-0002-7245-1885; MASTROBERARDINO, PIER GIORGIO/0000-0003-2364-4258	National Institutes of Health [U19 AIO68021, NS061817, HD057587, AG026389, ES012068]; Pennsylvania Department of Health [SAP 4100027294]; Picower Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R21HD057587] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI068021] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [U54ES012068] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061817, P01NS059806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG026389, P50AG005133] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pennsylvania Department of Health; Picower Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants U19 AIO68021, NS061817, HD057587, AG026389, and ES012068 (NIEHS). This work was also supported by Pennsylvania Department of Health Grant SAP 4100027294 and The Picower Foundation.	Abou-Sleiman PM, 2006, NAT REV NEUROSCI, V7, P207, DOI 10.1038/nrn1868; Alakoskela JM, 2006, BIOCHEMISTRY-US, V45, P13447, DOI 10.1021/bi0611107; Anglade P, 1997, HISTOL HISTOPATHOL, V12, P603; Baba M, 1998, AM J PATHOL, V152, P879; Bayir H, 2006, BBA-BIOENERGETICS, V1757, P648, DOI 10.1016/j.bbabio.2006.03.002; Betarbet R, 2000, NAT NEUROSCI, V3, P1301, DOI 10.1038/81834; Betarbet R, 2002, BRAIN PATHOL, V12, P499; Borisenko GG, 2008, BIOCHEMISTRY-US, V47, P13699, DOI 10.1021/bi801507s; Burkitt M, 2004, BIOCHEM SOC SYMP, V71, P97; Callio J, 2005, J BIOL CHEM, V280, P18536, DOI 10.1074/jbc.M413224200; CASTNER TG, 1959, PHYS REV, V115, P1506, DOI 10.1103/PhysRev.115.1506; Chen YR, 2004, J BIOL CHEM, V279, P18054, DOI 10.1074/jbc.M307706200; Chu CT, 2006, J NEUROPATH EXP NEUR, V65, P423, DOI 10.1097/01.jnen.0000229233.75253.be; Chu CT, 2005, J NEUROCHEM, V94, P1685, DOI 10.1111/j.1471-4159.2005.03329.x; Conway KA, 2001, SCIENCE, V294, P1346, DOI 10.1126/science.1063522; da Costa CA, 2000, J BIOL CHEM, V275, P24065, DOI 10.1074/jbc.M002413200; da Costa CA, 2002, J BIOL CHEM, V277, P50980, DOI 10.1074/jbc.M207825200; Dauer W, 2003, NEURON, V39, P889, DOI 10.1016/S0896-6273(03)00568-3; Dickson DW, 2001, CURR OPIN NEUROL, V14, P423, DOI 10.1097/00019052-200108000-00001; Eliezer D, 2001, J MOL BIOL, V307, P1061, DOI 10.1006/jmbi.2001.4538; Ellis CE, 2005, MOL CELL BIOL, V25, P10190, DOI 10.1128/MCB.25.22.10190-10201.2005; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fornai F, 2005, P NATL ACAD SCI USA, V102, P3413, DOI 10.1073/pnas.0409713102; Giannakis E, 2008, BBA-BIOMEMBRANES, V1778, P1112, DOI 10.1016/j.bbamem.2008.01.012; Giasson BI, 2000, SCIENCE, V290, P985, DOI 10.1126/science.290.5493.985; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Greenamyre JT, 2004, SCIENCE, V304, P1120, DOI 10.1126/science.1098966; Hashimoto M, 1999, J BIOL CHEM, V274, P28849, DOI 10.1074/jbc.274.41.28849; Horbinski C, 2005, FREE RADICAL BIO MED, V38, P2, DOI 10.1016/j.freeradbiomed.2004.09.030; Hsu LJ, 2000, AM J PATHOL, V157, P401, DOI 10.1016/S0002-9440(10)64553-1; Irizarry MC, 1998, J NEUROPATH EXP NEUR, V57, P334, DOI 10.1097/00005072-199804000-00005; Iwata A, 2001, J BIOL CHEM, V276, P45320, DOI 10.1074/jbc.M103736200; Jiang JF, 2004, LIPIDS, V39, P1133, DOI 10.1007/s11745-004-1340-1; Kagan VE, 2005, NAT CHEM BIOL, V1, P223, DOI 10.1038/nchembio727; Kahle PJ, 2000, J NEUROSCI, V20, P6365, DOI 10.1523/JNEUROSCI.20-17-06365.2000; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kaul S, 2005, MOL BRAIN RES, V139, P137, DOI 10.1016/j.molbrainres.2005.05.022; Kenworthy AK, 2001, METHODS, V24, P289, DOI 10.1006/meth.2001.1189; Klivenyi P, 2006, NEUROBIOL DIS, V21, P541, DOI 10.1016/j.nbd.2005.08.018; LASSMANN G, 1991, J BIOL CHEM, V266, P20045; Lee M, 2001, J NEUROCHEM, V76, P998, DOI 10.1046/j.1471-4159.2001.00149.x; Lee SJ, 2003, ANTIOXID REDOX SIGN, V5, P337, DOI 10.1089/152308603322110904; Leng Y, 2006, J NEUROSCI, V26, P7502, DOI 10.1523/JNEUROSCI.0096-06.2006; Li K, 2000, CELL, V101, P389, DOI 10.1016/S0092-8674(00)80849-1; Lim J, 2008, NATURE, V452, P713, DOI 10.1038/nature06731; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; Machida Y, 2005, BIOCHEM BIOPH RES CO, V332, P233, DOI 10.1016/j.bbrc.2005.04.124; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Matsuoka Y, 2001, NEUROBIOL DIS, V8, P535, DOI 10.1006/nbdi.2001.0392; Mattson MP, 2000, BRAIN PATHOL, V10, P300, DOI 10.1111/j.1750-3639.2000.tb00264.x; McKeith IG, 2005, NEUROLOGY, V65, P1863, DOI 10.1212/01.wnl.0000187889.17253.b1; Monti B, 2007, J NEUROCHEM, V103, P518, DOI 10.1111/j.1471-4159.2007.04778.x; Norris EH, 2005, ANTIOXID REDOX SIGN, V7, P673; Olteanu A, 2004, PROTEIN SCI, V13, P2852, DOI 10.1110/ps.04947204; PETIT JM, 1992, EUR J BIOCHEM, V209, P267, DOI 10.1111/j.1432-1033.1992.tb17285.x; Purring-Koch C, 2000, P NATL ACAD SCI USA, V97, P11928, DOI 10.1073/pnas.220416197; Qian SY, 2002, BIOCHEM J, V363, P281, DOI 10.1042/0264-6021:3630281; RADI R, 1991, ARCH BIOCHEM BIOPHYS, V288, P118, DOI 10.1016/0003-9861(91)90172-F; Ramirez DC, 2005, J BIOL CHEM, V280, P27402, DOI 10.1074/jbc.M504241200; Seo JH, 2002, FASEB J, V16, P1826, DOI 10.1096/fj.02-0041fje; Sherer TB, 2002, J NEUROSCI, V22, P7006; Shults CW, 2006, P NATL ACAD SCI USA, V103, P1661, DOI 10.1073/pnas.0509567103; Smith DP, 2008, BIOCHEMISTRY-US, V47, P1425, DOI 10.1021/bi701522m; Smith WW, 2005, HUM MOL GENET, V14, P3801, DOI 10.1093/hmg/ddi396; Souza JM, 2000, J BIOL CHEM, V275, P18344, DOI 10.1074/jbc.M000206200; Swerdlow RH, 1998, ANN NEUROL, V44, P873, DOI 10.1002/ana.410440605; Tyurin VA, 2008, METHOD ENZYMOL, V442, P375, DOI [10.1017/S0076-6879(08)01419-5, 10.1016/S0076-6879(08)01419-5]; Tyurina YY, 2006, MOL PHARMACOL, V70, P706, DOI 10.1124/mol.106.022731; Vlasova II, 2006, J BIOL CHEM, V281, P14554, DOI 10.1074/jbc.M509507200; Winklhofer KF, 2008, EMBO J, V27, P336, DOI 10.1038/sj.emboj.7601930; Xu J, 2002, NAT MED, V8, P600, DOI 10.1038/nm0602-600; Zhu JH, 2003, BRAIN PATHOL, V13, P473; Zhu M, 2003, J BIOL CHEM, V278, P40186, DOI 10.1074/jbc.M305326200	73	85	87	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15951	15969		10.1074/jbc.M900418200	http://dx.doi.org/10.1074/jbc.M900418200			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19351880	Green Published, hybrid			2022-12-27	WOS:000266501000062
J	Jia, J; Maccarana, M; Zhang, X; Bespalov, M; Lindahl, U; Li, JP				Jia, Juan; Maccarana, Marco; Zhang, Xiao; Bespalov, Maxim; Lindahl, Ulf; Li, Jin-Ping			Lack of L-Iduronic Acid in Heparan Sulfate Affects Interaction with Growth Factors and Cell Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEONATAL LETHALITY; CRYSTAL-STRUCTURE; BINDING-SITES; PROTEOGLYCANS; MICE; BIOSYNTHESIS; C5-EPIMERASE; FGF; GLYCOSAMINOGLYCANS; OLIGOSACCHARIDES	HSEPI (glucuronyl C5-epimerase) catalyzes the conversion of D-glucuronic acid to L-iduronic acid in heparan sulfate (HS) biosynthesis. Disruption of the Hsepi gene in mice yielded a lethal phenotype with selective organ defects but had remarkably little effect on other organ systems. We have approached the underlying mechanisms by examining the course and effects of FGF2 signaling in a mouse embryonic fibroblast (MEF) cell line derived from the Hsepi(-/-) mouse. The HS produced by these cells is devoid of L-iduronic acid residues but shows up-regulated N- and 6-O-sulfation compared with wild type (WT) MEF HS. In medium fortified with 10% fetal calf serum, the Hsepi(-/-) MEFs proliferated and migrated similarly to WT cells. Under starvation conditions, both cell types showed attenuated proliferation and migration that could be restored by the addition of FGF2 to WT cells, whereas Hsepi(-/-) cells were resistant. Moreover, ERK phosphorylation following FGF2 stimulation was delayed in Hsepi(-/-) compared with WT cells. Assessment of HS-growth factor interaction by nitrocellulose filter trapping revealed a strikingly aberrant binding property of FGF2 and glia-derived neurotropic factor to Hsepi(-/-) but not to WT HS. glia-derived neurotropic factor has a key role in kidney development, defective in Hsepi(-/-) mice. By contrast, Hsepi(-/-) and WT HS interacted similarly and in conventional mode with FGF10. These findings correlate defective function of growth factors with their mode of HS interaction and may help explain the partly modest organ phenotypes observed after genetic ablation of selected enzymes in HS biosynthesis.	[Jia, Juan; Lindahl, Ulf; Li, Jin-Ping] Uppsala Univ, Biomed Ctr, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden; [Maccarana, Marco] Lund Univ, Dept Expt Med Sci, BMC D12, SE-22184 Lund, Sweden; [Zhang, Xiao] Uppsala Univ, Dept Publ Hlth & Caring Sci, Rudbeck Lab, S-75185 Uppsala, Sweden; [Bespalov, Maxim] Univ Helsinki, Inst Biotechnol, FIN-00014 Helsinki, Finland	Uppsala University; Lund University; Uppsala University; University of Helsinki	Li, JP (corresponding author), Uppsala Univ, Biomed Ctr, Dept Med Biochem & Microbiol, Box 582, SE-75123 Uppsala, Sweden.	Jin-Ping.Li@imbim.uu.se	Bespalov, Maxim/O-2817-2016; maccarana, marco/AAB-4764-2021	Bespalov, Maxim/0000-0002-8754-5753; Maccarana, Marco/0000-0003-3549-8921	Swedish Research Council [32X-15023, 2007-5985, K2009-67X-21128-01-3]; Polysackaridforskning AB (Uppsala, Sweden)	Swedish Research Council(Swedish Research CouncilEuropean Commission); Polysackaridforskning AB (Uppsala, Sweden)	This work was supported by the Swedish Research Council (32X-15023, 2007-5985; K2009-67X-21128-01-3) and Polysackaridforskning AB (Uppsala, Sweden).	ABBONDANZO SJ, 1993, METHOD ENZYMOL, V225, P803; Abramsson A, 2007, GENE DEV, V21, P316, DOI 10.1101/gad.398207; Ashikari-Hada S, 2004, J BIOL CHEM, V279, P12346, DOI 10.1074/jbc.M313523200; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bullock SL, 1998, GENE DEV, V12, P1894, DOI 10.1101/gad.12.12.1894; Casu B, 2001, ADV CARBOHYD CHEM BI, V57, P159, DOI 10.1016/S0065-2318(01)57017-1; Catlow KR, 2008, J BIOL CHEM, V283, P5235, DOI 10.1074/jbc.M706589200; Delehedde M, 2000, J BIOL CHEM, V275, P33905, DOI 10.1074/jbc.M005949200; Esko JD, 2002, ANNU REV BIOCHEM, V71, P435, DOI 10.1146/annurev.biochem.71.110601.135458; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Feyzi E, 1998, J BIOL CHEM, V273, P13395, DOI 10.1074/jbc.273.22.13395; Forsberg E, 1999, NATURE, V400, P773, DOI 10.1038/23488; Galvis MLE, 2007, NAT CHEM BIOL, V3, P773, DOI 10.1038/nchembio.2007.41; Goodger SJ, 2008, J BIOL CHEM, V283, P13001, DOI 10.1074/jbc.M704531200; GUIMOND S, 1993, J BIOL CHEM, V268, P23906; HOOK GER, 1982, J BIOL CHEM, V257, P9211; Inatani M, 2003, SCIENCE, V302, P1044, DOI 10.1126/science.1090497; Jastrebova N, 2006, J BIOL CHEM, V281, P26884, DOI 10.1074/jbc.M600806200; JAT PS, 1986, MOL CELL BIOL, V6, P1204, DOI 10.1128/MCB.6.4.1204; Kreuger J, 2005, BIOCHEM J, V389, P145, DOI 10.1042/BJ20042129; Kreuger J, 2003, METHOD ENZYMOL, V363, P327; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Lauder RM, 2000, GLYCOBIOLOGY, V10, P393, DOI 10.1093/glycob/10.4.393; Ledin J, 2004, J BIOL CHEM, V279, P42732, DOI 10.1074/jbc.M405382200; Li JP, 2003, J BIOL CHEM, V278, P28363, DOI 10.1074/jbc.C300219200; Li JP, 2001, J BIOL CHEM, V276, P20069, DOI 10.1074/jbc.M011783200; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; Lin XH, 1999, DEVELOPMENT, V126, P3715; Maccarana M, 2006, J BIOL CHEM, V281, P11560, DOI 10.1074/jbc.M513373200; Merry CLR, 2001, J BIOL CHEM, V276, P35429, DOI 10.1074/jbc.M100379200; Patel VN, 2008, J BIOL CHEM, V283, P9308, DOI 10.1074/jbc.M709995200; Pellegrini L, 2000, NATURE, V407, P1029, DOI 10.1038/35039551; Ringvall M, 2000, J BIOL CHEM, V275, P25926, DOI 10.1074/jbc.C000359200; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; SHIVELY JE, 1976, BIOCHEMISTRY-US, V15, P3932, DOI 10.1021/bi00663a005; Sugaya N, 2008, J BIOL CHEM, V283, P10366, DOI 10.1074/jbc.M705948200; Tour E, 2005, DEVELOPMENT, V132, P5271, DOI 10.1242/dev.02138	37	51	54	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15942	15950		10.1074/jbc.M809577200	http://dx.doi.org/10.1074/jbc.M809577200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19336402	hybrid, Green Published			2022-12-27	WOS:000266501000061
J	Kotaka, M; Kong, R; Qureshi, I; Ho, QS; Sun, HH; Liew, CW; Goh, LP; Cheung, P; Mu, YG; Lescar, J; Liang, ZX				Kotaka, Masayo; Kong, Rong; Qureshi, Insaf; Ho, Qin Shi; Sun, Huihua; Liew, Chong Wai; Goh, Lan Pei; Cheung, Peter; Mu, Yuguang; Lescar, Julien; Liang, Zhao-Xun			Structure and Catalytic Mechanism of the Thioesterase CalE7 in Enediyne Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							II THIOESTERASE; GENE-CLUSTER; 4-HYDROXYBENZOYL-COA THIOESTERASE; SUBSTRATE-SPECIFICITY; FUNCTIONAL-ANALYSIS; CRYSTAL-STRUCTURE; DOMAIN; DEHYDROGENASE; SUPERFAMILY; COMPLEXES	The biosynthesis of the enediyne moiety of the antitumor natural product calicheamicin involves an iterative polyketide synthase (CalE8) and other ancillary enzymes. In the proposed mechanism for the early stage of 10-membered enediyne biosynthesis, CalE8 produces a carbonyl-conjugated polyene with the assistance of a putative thioesterase (CalE7). We have determined the x-ray crystal structure of CalE7 and found that the subunit adopts a hotdog fold with an elongated and kinked substrate-binding channel embedded between two subunits. The 1.75-angstrom crystal structure revealed that CalE7 does not contain a critical catalytic residue (Glu or Asp) conserved in other hotdog fold thioesterases. Based on biochemical and site-directed mutagenesis studies, we proposed a catalytic mechanism in which the conserved Arg(37) plays a crucial role in the hydrolysis of the thioester bond, and that Tyr(29) and a hydrogen-bonded water network assist the decarboxylation of the beta-ketocarboxylic acid intermediate. Moreover, computational docking suggested that the substrate-binding channel binds a polyene substrate that contains a single cis double bond at the C4/C5 position, raising the possibility that the C4=C5 double bond in the enediyne moiety could be generated by the iterative polyketide synthase. Together, the results revealed a hotdog fold thioesterase distinct from the common type I and type II thioesterases associated with polyketide biosynthesis and provided interesting insight into the enediyne biosynthetic mechanism.	[Kotaka, Masayo; Kong, Rong; Qureshi, Insaf; Ho, Qin Shi; Sun, Huihua; Liew, Chong Wai; Goh, Lan Pei; Cheung, Peter; Mu, Yuguang; Lescar, Julien; Liang, Zhao-Xun] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore	Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Lescar, J (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.	julien@ntu.edu.sg; zxliang@ntu.edu.sg	Liang, Zhao-Xun/A-2191-2011; Qureshi, Insaf Ahmed/W-1957-2019; Mu, Yuguang/A-9558-2010; Kotaka, Masayo/C-4483-2009	Qureshi, Insaf Ahmed/0000-0001-7720-7067; Kotaka, Masayo/0000-0001-9692-3843; Liang, Zhao-Xun/0000-0002-3128-1330; Sun, Huihua/0000-0002-0538-7553	Ministry of Education of Singapore through the Academic Research Council [RG60/06]; Biomedical Research Council [06/1/22/19/447, 05/1/22/19/405]	Ministry of Education of Singapore through the Academic Research Council(Ministry of Education, Singapore); Biomedical Research Council(Agency for Science Technology & Research (A*STAR))	This work was supported by the Ministry of Education of Singapore through the Academic Research Council (Grant RG60/06 to Z.-X.L.). The laboratory of J.L. is supported by Biomedical Research Council Grants 06/1/22/19/447 and 05/1/22/19/405.	Ahlert J, 2002, SCIENCE, V297, P1173, DOI 10.1126/science.1072105; Akey DL, 2006, NAT CHEM BIOL, V2, P537, DOI 10.1038/nchembio824; Ames BD, 2008, P NATL ACAD SCI USA, V105, P5349, DOI 10.1073/pnas.0709223105; Angelini A, 2008, PROTEINS, V72, P1212, DOI 10.1002/prot.22014; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Benning MM, 1998, J BIOL CHEM, V273, P33572, DOI 10.1074/jbc.273.50.33572; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chen DQ, 2009, BIOCHEMISTRY-US, V48, P511, DOI 10.1021/bi802207t; Cheng ZJ, 2006, BIOCHEM BIOPH RES CO, V349, P172, DOI 10.1016/j.bbrc.2006.08.025; Dillon SC, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-109; Fedoy AE, 2007, J MOL BIOL, V372, P130, DOI 10.1016/j.jmb.2007.06.040; Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430; Gachotte D, 1998, P NATL ACAD SCI USA, V95, P13794, DOI 10.1073/pnas.95.23.13794; Gao Q, 2008, FEMS MICROBIOL LETT, V282, P105, DOI 10.1111/j.1574-6968.2008.01112.x; Gigant B, 1997, P NATL ACAD SCI USA, V94, P7857, DOI 10.1073/pnas.94.15.7857; Guo ZF, 2009, BIOCHEMISTRY-US, V48, P1712, DOI 10.1021/bi802165x; Heathcole ML, 2001, CHEM BIOL, V8, P207, DOI 10.1016/S1074-5521(01)00002-3; Holm L, 1997, NUCLEIC ACIDS RES, V25, P231, DOI 10.1093/nar/25.1.231; Hu ZH, 2003, MICROBIOL-SGM, V149, P2213, DOI 10.1099/mic.0.26015-0; Itoh T, 2007, BIOCHEMISTRY-US, V46, P8181, DOI 10.1021/bi700190p; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760; Keegan RM, 2007, ACTA CRYSTALLOGR D, V63, P447, DOI 10.1107/S0907444907002661; Kim BS, 2002, J BIOL CHEM, V277, P48028, DOI 10.1074/jbc.M207770200; Koglin A, 2008, NATURE, V454, P907, DOI 10.1038/nature07161; Kong R, 2008, J AM CHEM SOC, V130, P8142, DOI 10.1021/ja8019643; Kotowska M, 2002, MICROBIOL-SGM, V148, P1777, DOI 10.1099/00221287-148-6-1777; Kunishima N, 2005, J MOL BIOL, V352, P212, DOI 10.1016/j.jmb.2005.07.008; LAM KS, 1993, J AM CHEM SOC, V115, P12340, DOI 10.1021/ja00079a014; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leduc D, 2007, J BACTERIOL, V189, P7112, DOI 10.1128/JB.00755-07; Linne U, 2004, EUR J BIOCHEM, V271, P1536, DOI 10.1111/j.1432-1033.2004.04063.x; Liu W, 2005, CHEM BIOL, V12, P293, DOI 10.1016/j.chembiol.2004.12.013; Liu W, 2002, SCIENCE, V297, P1170, DOI 10.1126/science.1072110; Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7; Murugan E, 2008, FEBS LETT, V582, P1097, DOI 10.1016/j.febslet.2008.02.061; NICOLAOU KC, 1993, P NATL ACAD SCI USA, V90, P5881, DOI 10.1073/pnas.90.13.5881; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Salas JJ, 2002, ARCH BIOCHEM BIOPHYS, V403, P25, DOI 10.1016/S0003-9861(02)00017-6; Shen B, 2003, CURR MED CHEM, V10, P2317, DOI 10.2174/0929867033456701; Thoden JB, 2003, J BIOL CHEM, V278, P43709, DOI 10.1074/jbc.M308198200; Thoden JB, 2002, J BIOL CHEM, V277, P27468, DOI 10.1074/jbc.M203904200; Thorson JS, 1999, BIOORG CHEM, V27, P172, DOI 10.1006/bioo.1998.1122; TOKIWA Y, 1992, J AM CHEM SOC, V114, P4107, DOI 10.1021/ja00037a011; Trauger JW, 2000, NATURE, V407, P215, DOI 10.1038/35025116; Van Lanen SG, 2007, J AM CHEM SOC, V129, P13082, DOI 10.1021/ja073275o; Wang F, 2007, CHEM BIOL, V14, P543, DOI 10.1016/j.chembiol.2007.04.005; Willis MA, 2008, BIOCHEMISTRY-US, V47, P2797, DOI 10.1021/bi702336d; Zazopoulos E, 2003, NAT BIOTECHNOL, V21, P187, DOI 10.1038/nbt784; Zhang J, 2008, P NATL ACAD SCI USA, V105, P1460, DOI 10.1073/pnas.0711625105	50	36	36	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15739	15749		10.1074/jbc.M809669200	http://dx.doi.org/10.1074/jbc.M809669200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19357082	Green Published, hybrid			2022-12-27	WOS:000266501000043
J	Scutt, PJ; Chu, MLH; Sloane, DA; Cherry, M; Bignell, CR; Williams, DH; Eyers, PA				Scutt, Paul J.; Chu, Matthew L. H.; Sloane, Dominic A.; Cherry, Mike; Bignell, Colin R.; Williams, David H.; Eyers, Patrick A.			Discovery and Exploitation of Inhibitor-resistant Aurora and Polo Kinase Mutants for the Analysis of Mitotic Networks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SMALL-MOLECULE INHIBITOR; GROWTH IN-VIVO; DRUG-RESISTANT; ABL KINASE; B KINASE; CENTRIOLE DUPLICATION; SELECTIVE INHIBITOR; STRUCTURAL BASIS; TYROSINE KINASE; A ACTIVATION	The Aurora and Polo-like kinases are central components of mitotic signaling pathways, and recent evidence suggests that substantial cross-talk exists between Aurora A and Plk1. In addition to their validation as novel anticancer agents, small molecule kinase inhibitors are increasingly important tools to help dissect clinically relevant protein phosphorylation networks. However, one major problem associated with kinase inhibitors is their promiscuity toward "off-target" members of the kinome, which makes interpretation of data obtained from complex cellular systems challenging. Additionally, the emergence of inhibitor resistance in patients makes it clear that an understanding of resistance mechanisms is essential to inform drug design. In this study, we exploited structural knowledge of the binding modes of VX-680, an Aurora kinase inhibitor, and BI 2536, a Polo-like kinase inhibitor, to design and evaluate drug-resistant kinase mutants. Using inducible stable human cell lines, we authenticated mitotic targets for both compounds and demonstrated that Aurora A mutants exhibit differential cellular sensitivity toward the inhibitors VX-680 and MLN8054. In addition, we validated Aurora B as an important anti-proliferative target for VX-680 in model human cancer cells. Finally, this chemical genetic approach allowed us to prove that Aurora A activation loop phosphorylation is controlled by a Plk1-mediated pathway in human cells.	[Sloane, Dominic A.; Eyers, Patrick A.] Univ Sheffield, Yorkshire Canc Res Inst Canc Studies, Sheffield S10 2RX, S Yorkshire, England; [Scutt, Paul J.] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England; [Chu, Matthew L. H.] Univ Manchester, Sch Pharm & Pharmaceut Sci, Manchester M13 9PT, Lancs, England; [Cherry, Mike] Accelrys, Cambridge CB4 0WN, England; [Bignell, Colin R.] ImmunoBiol Ltd, Cambridge CB22 3AT, England; [Williams, David H.] Summit Plc, Abingdon OX14 4RY, Oxon, England	University of Sheffield; University of Manchester; University of Manchester; BIOVIA	Eyers, PA (corresponding author), Univ Sheffield, Yorkshire Canc Res Inst Canc Studies, Sheffield S10 2RX, S Yorkshire, England.	p.eyers@sheffield.ac.uk			Cancer Research UK [A7778]; MRC [G120/1030] Funding Source: UKRI; Medical Research Council [G120/1030] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Recipient of a Medical Research Council career development fellowship and supported by Project Grant A7778 from Cancer Research UK.	Azam M, 2003, CELL, V112, P831, DOI 10.1016/S0092-8674(03)00190-9; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bamborough P, 2008, J MED CHEM, V51, P7898, DOI 10.1021/jm8011036; Bayliss R, 2003, MOL CELL, V12, P851, DOI 10.1016/S1097-2765(03)00392-7; Bettencourt-Dias M, 2005, CURR BIOL, V15, P2199, DOI 10.1016/j.cub.2005.11.042; Blencke S, 2004, CHEM BIOL, V11, P691, DOI 10.1016/j.chembiol.2004.02.029; Carpinelli P, 2008, ADV EXP MED BIOL, V610, P54, DOI 10.1007/978-0-387-73898-7_5; Carter TA, 2005, P NATL ACAD SCI USA, V102, P11011, DOI 10.1073/pnas.0504952102; Chan EHY, 2008, CHROMOSOMA, V117, P457, DOI 10.1007/s00412-008-0165-5; Cheetham GMT, 2007, CANCER LETT, V251, P323, DOI 10.1016/j.canlet.2006.12.004; Cohen P, 2009, CURR OPIN CELL BIOL, V21, P317, DOI 10.1016/j.ceb.2009.01.015; De Luca M, 2006, CELL CYCLE, V5, P296; DeLano WL, 2005, DRUG DISCOV TODAY, V10, P213, DOI 10.1016/S1359-6446(04)03363-X; Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091; Dreier MR, 2009, EXP CELL RES, V315, P1085, DOI 10.1016/j.yexcr.2009.02.008; Druker BJ, 2008, BLOOD, V112, P4808, DOI 10.1182/blood-2008-07-077958; Eyers PA, 2003, CURR BIOL, V13, P691, DOI 10.1016/S0960-9822(03)00166-0; Eyers PA, 1999, FEBS LETT, V451, P191, DOI 10.1016/S0014-5793(99)00552-9; Eyers PA, 1998, CHEM BIOL, V5, P321, DOI 10.1016/S1074-5521(98)90170-3; Eyers PA, 2004, J BIOL CHEM, V279, P9008, DOI 10.1074/jbc.M312424200; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Giles FJ, 2007, BLOOD, V109, P500, DOI 10.1182/blood-2006-05-025049; Girdler F, 2008, CHEM BIOL, V15, P552, DOI 10.1016/j.chembiol.2008.04.013; Girdler F, 2006, J CELL SCI, V119, P3664, DOI 10.1242/jcs.03145; Guo J, 2009, PHARMACOGENOMICS J, V9, P90, DOI 10.1038/tpj.2008.20; Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320; Hanisch A, 2006, MOL BIOL CELL, V17, P448, DOI 10.1091/mbc.E05-08-0801; Harrington EA, 2004, NAT MED, V10, P262, DOI 10.1038/nm1003; Heron NM, 2006, BIOORG MED CHEM LETT, V16, P1320, DOI 10.1016/j.bmcl.2005.11.053; Howard S, 2009, J MED CHEM, V52, P379, DOI 10.1021/jm800984v; Jaeschke A, 2006, MOL CELL, V23, P899, DOI 10.1016/j.molcel.2006.07.028; Johnson EF, 2007, BIOCHEMISTRY-US, V46, P9551, DOI 10.1021/bi7008745; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Knight ZA, 2005, CHEM BIOL, V12, P621, DOI 10.1016/j.chembiol.2005.04.011; Kothe M, 2007, CHEM BIOL DRUG DES, V70, P540, DOI 10.1111/j.1747-0285.2007.00594.x; Krug M, 2008, MINI-REV MED CHEM, V8, P1312, DOI 10.2174/138955708786369591; Lane HA, 1996, J CELL BIOL, V135, P1701, DOI 10.1083/jcb.135.6.1701; Lansing TJ, 2007, MOL CANCER THER, V6, P450, DOI 10.1158/1535-7163.MCT-06-0543; Lenart P, 2007, CURR BIOL, V17, P304, DOI 10.1016/j.cub.2006.12.046; Lin YG, 2008, CLIN CANCER RES, V14, P5437, DOI 10.1158/1078-0432.CCR-07-4922; Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185; Malumbres M, 2007, CURR OPIN GENET DEV, V17, P60, DOI 10.1016/j.gde.2006.12.008; Manfredi MG, 2007, P NATL ACAD SCI USA, V104, P4106, DOI 10.1073/pnas.0608798104; Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096; O'Keefe SJ, 2007, J BIOL CHEM, V282, P34663, DOI 10.1074/jbc.M704236200; Plyte S, 2007, CURR BIOL, V17, pR280, DOI 10.1016/j.cub.2007.02.018; Qian YW, 1999, MOL CELL BIOL, V19, P8625; Santamaria A, 2007, MOL BIOL CELL, V18, P4024, DOI 10.1091/mbc.E07-05-0517; Saurin AT, 2008, NAT CELL BIOL, V10, P891, DOI 10.1038/ncb1749; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Seki A, 2008, SCIENCE, V320, P1655, DOI 10.1126/science.1157425; Sessa F, 2005, MOL CELL, V18, P379, DOI 10.1016/j.molcel.2005.03.031; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Steegmaier M, 2007, CURR BIOL, V17, P316, DOI 10.1016/j.cub.2006.12.037; Taylor S, 2008, CURR OPIN CELL BIOL, V20, P77, DOI 10.1016/j.ceb.2007.11.008; Terada Y, 1998, EMBO J, V17, P667, DOI 10.1093/emboj/17.3.667; Tyler RK, 2007, CELL CYCLE, V6, P2846, DOI 10.4161/cc.6.22.4940; Wilkinson RW, 2007, CLIN CANCER RES, V13, P3682, DOI 10.1158/1078-0432.CCR-06-2979; Young MA, 2006, CANCER RES, V66, P1007, DOI 10.1158/0008-5472.CAN-05-2788; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559; Zhao BG, 2008, PROTEIN SCI, V17, P1791, DOI 10.1110/ps.036590.108; Zunder ER, 2008, CANCER CELL, V14, P180, DOI 10.1016/j.ccr.2008.06.014	63	61	61	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15880	15893		10.1074/jbc.M109.005694	http://dx.doi.org/10.1074/jbc.M109.005694			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19359241	Green Published, hybrid			2022-12-27	WOS:000266501000056
J	Takahashi, T; Inoue-Kashino, N; Ozawa, S; Takahashi, Y; Kashino, Y; Satoh, K				Takahashi, Takeshi; Inoue-Kashino, Natsuko; Ozawa, Shin-ichiro; Takahashi, Yuichiro; Kashino, Yasuhiro; Satoh, Kazuhiko			Photosystem II Complex in Vivo Is a Monomer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE-PROTEIN COMPLEXES; SYNECHOCYSTIS SP PCC-6803; CYANOBACTERIUM SYNECHOCOCCUS SP; CYTOCHROME B(6)F COMPLEX; BLUE-GREEN-ALGA; RED ALGA; CYANIDIUM-CALDARIUM; REACTION CENTERS; LIGHT-INTENSITY; ENERGY-TRANSFER	Photosystem II (PS II) complexes are membrane protein complexes that are composed of >20 distinct subunit proteins. Similar to many other membrane protein complexes, two PS II complexes are believed to form a homo-dimer whose molecular mass is similar to 650 kDa. Contrary to this well known concept, we propose that the functional form of PS II in vivo is a monomer, based on the following observations. Deprivation of lipids caused the conversion of PS II from a monomeric form to a dimeric form. Only a monomeric PS II was detected in solubilized cyanobacterial and red algal thylakoids using blue-native polyacrylamide gel electrophoresis. Furthermore, energy transfer between PS II units, which was observed in the purified dimeric PS II, was not detected in vivo. Our proposal will lead to a re-evaluation of many crystallographic models of membrane protein complexes in terms of their oligomerization status.	[Takahashi, Takeshi; Inoue-Kashino, Natsuko; Kashino, Yasuhiro; Satoh, Kazuhiko] Hyogo Med Univ, Grad Sch Life Sci, Kamigori, Hyogo 6781297, Japan; [Inoue-Kashino, Natsuko; Ozawa, Shin-ichiro; Takahashi, Yuichiro] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan	University of Hyogo; Okayama University	Kashino, Y (corresponding author), Hyogo Med Univ, Grad Sch Life Sci, 3-2-1 Kohto, Kamigori, Hyogo 6781297, Japan.	kashino@sci.u-hyogo.ac.jp	Takahashi, Yuichiro/B-2062-2011; Ozawa, Shin-Ichiro/O-7408-2015	Takahashi, Yuichiro/0000-0001-6410-0447; Ozawa, Shin-Ichiro/0000-0001-7698-5350	MEXT [20051021, 18GS0318]; Hyogo Science and Technology Association [20I107]; MEXT; Japan Science Society [17-166, 19-440]	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Hyogo Science and Technology Association; MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science Society	This work was supported by MEXT (Grant 20051021 to Y. K. and Grant 18GS0318 to Y. T.), from Hyogo Science and Technology Association (Grant 20I107 to Y. K.), GCOE Program from MEXT (to K. S.), and by Sasakawa Scientific Research Grants from The Japan Science Society (17-166 to T. T. and 19-440 to N.I.-K.).	ALLEN MM, 1968, J PHYCOL, V4, P1, DOI 10.1111/j.1529-8817.1968.tb04667.x; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Aro EM, 2005, J EXP BOT, V56, P347, DOI 10.1093/jxb/eri041; BERTHOLD DA, 1981, FEBS LETT, V134, P231, DOI 10.1016/0014-5793(81)80608-4; Bricker TM, 1998, BBA-BIOENERGETICS, V1409, P50, DOI 10.1016/S0005-2728(98)00148-0; CUNNINGHAM FX, 1989, PLANT PHYSIOL, V91, P1179, DOI 10.1104/pp.91.3.1179; DINER BA, 1979, PLANT PHYSIOL, V63, P20, DOI 10.1104/pp.63.1.20; Dobakova M, 2007, PLANT PHYSIOL, V145, P1681, DOI 10.1104/pp.107.107805; DYER DL, 1961, SCIENCE, V134, P616, DOI 10.1126/science.134.3479.616; ENAMI I, 1975, PLANT CELL PHYSIOL, V16, P211; Ferreira KN, 2004, SCIENCE, V303, P1831, DOI 10.1126/science.1093087; FORK DC, 1983, PHOTOCHEM PHOTOBIOL, V37, P421, DOI 10.1111/j.1751-1097.1983.tb04495.x; Furuya Ken, 1998, Journal of Oceanography, V54, P199, DOI 10.1007/BF02751695; GIDDINGS TH, 1983, PLANT PHYSIOL, V71, P409, DOI 10.1104/pp.71.2.409; GIDDINGS TH, 1979, BIOCHIM BIOPHYS ACTA, V546, P373, DOI 10.1016/0005-2728(79)90074-4; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Hankamer B, 1997, ANNU REV PLANT PHYS, V48, P641, DOI 10.1146/annurev.arplant.48.1.641; Herranen M, 2004, PLANT PHYSIOL, V134, P470, DOI 10.1104/pp.103.032326; HIRANO M, 1980, Photosynthesis Research, V1, P149, DOI 10.1007/BF00020594; HOLZENBURG A, 1993, NATURE, V363, P470, DOI 10.1038/363470a0; HUANG D, 1994, BIOCHEMISTRY-US, V33, P4401, DOI 10.1021/bi00180a038; Inoue-Kashino N, 2005, BIOCHEMISTRY-US, V44, P12214, DOI 10.1021/bi047539k; Iwai M, 2004, PLANT CELL PHYSIOL, V45, P1809, DOI 10.1093/pcp/pch207; Iwai M, 2008, PLANT CELL, V20, P2177, DOI 10.1105/tpc.108.059352; JENNINGS RC, 1980, FEBS LETT, V117, P332, DOI 10.1016/0014-5793(80)80974-4; JOLIOT A, 1964, CR HEBD ACAD SCI, V258, P4622; Kamiya N, 2003, P NATL ACAD SCI USA, V100, P98, DOI 10.1073/pnas.0135651100; Kashino Y, 2003, J CHROMATOGR B, V797, P191, DOI 10.1016/S1570-0232(03)00428-8; Kashino Y, 2002, BIOCHEMISTRY-US, V41, P8004, DOI 10.1021/bi026012+; KASHINO Y, 1990, PLANT CELL PHYSIOL, V31, P479; Kashino Y, 2001, ELECTROPHORESIS, V22, P1004, DOI 10.1002/1522-2683()22:6<1004::AID-ELPS1004>3.0.CO;2-Y; Kashino Y, 2007, J CHROMATOGR B, V849, P282, DOI 10.1016/j.jchromb.2006.10.067; Kashino Yasuhiro, 2003, Phycological Research, V51, P168, DOI 10.1111/j.1440-1835.2003.tb00184.x; Kashino Yasuhiro, 1992, P163; Komenda J, 2004, J BIOL CHEM, V279, P48620, DOI 10.1074/jbc.M405725200; Kuhl H, 2000, J BIOL CHEM, V275, P20652, DOI 10.1074/jbc.M001321200; KURAHOTTA M, 1986, ARCH BIOCHEM BIOPHYS, V249, P1, DOI 10.1016/0003-9861(86)90553-9; Kurisu G, 2003, SCIENCE, V302, P1009, DOI 10.1126/science.1090165; KURSAR TA, 1983, PLANT PHYSIOL, V72, P409, DOI 10.1104/pp.72.2.409; LEY AC, 1984, PLANT PHYSIOL, V74, P451, DOI 10.1104/pp.74.2.451; Loll B, 2005, NATURE, V438, P1040, DOI 10.1038/nature04224; Loll B, 2007, BBA-BIOENERGETICS, V1767, P509, DOI 10.1016/j.bbabio.2006.12.009; LYON MK, 1993, J STRUCT BIOL, V110, P133, DOI 10.1006/jsbi.1993.1014; Matsuzaki M, 2004, NATURE, V428, P653, DOI 10.1038/nature02398; MELIS A, 1979, PHOTOCHEM PHOTOBIOL, V29, P373, DOI 10.1111/j.1751-1097.1979.tb07061.x; MELIS A, 1976, PHOTOCHEM PHOTOBIOL, V23, P343, DOI 10.1111/j.1751-1097.1976.tb07259.x; MORSCHEL E, 1987, PLANTA, V172, P145, DOI 10.1007/BF00394582; Murata N., 1986, Light emission by plants and bacteria, P137; Nixon PJ, 2005, J EXP BOT, V56, P357, DOI 10.1093/jxb/eri021; OHKI K, 1987, PLANT CELL PHYSIOL, V28, P1219; Ohnishi N, 2007, J BIOL CHEM, V282, P7107, DOI 10.1074/jbc.M606763200; PORRA RJ, 1989, BIOCHIM BIOPHYS ACTA, V975, P384, DOI 10.1016/S0005-2728(89)80347-0; Renger G, 2008, PHOTOSYNTH RES, V98, P53, DOI 10.1007/s11120-008-9345-7; Roose JL, 2008, J BIOL CHEM, V283, P4044, DOI 10.1074/jbc.M708960200; Sakurai I, 2007, PLANT PHYSIOL, V145, P1361, DOI 10.1104/pp.107.106781; SATOH K, 1983, BIOCHIM BIOPHYS ACTA, V722, P190, DOI 10.1016/0005-2728(83)90173-1; SATOH K, 1983, PLANT PHYSIOL, V71, P673, DOI 10.1104/pp.71.3.673; SATOH K, 1995, PLANT CELL PHYSIOL, V36, P597; SCHAGGER H, 1994, ANAL BIOCHEM, V217, P220, DOI 10.1006/abio.1994.1112; SCHAGGER H, 2002, MEMBRANE PROTEIN PUR, P105; Simpson D. J., 1996, OXYGENIC PHOTOSYNTHE, P493; Siraki AG, 2004, TOXICOL SCI, V81, P148, DOI 10.1093/toxsci/kfh182; Stroebel D, 2003, NATURE, V426, P413, DOI 10.1038/nature02155; THIELEN APGM, 1981, BIOCHIM BIOPHYS ACTA, V637, P439, DOI 10.1016/0005-2728(81)90049-9; TSUKIHARA T, 1995, SCIENCE, V269, P1069, DOI 10.1126/science.7652554; VARGAS C, 1993, ANAL BIOCHEM, V209, P323, DOI 10.1006/abio.1993.1127; WOLLMAN FA, 1979, PLANT PHYSIOL, V63, P375, DOI 10.1104/pp.63.2.375; Zouni A, 2001, NATURE, V409, P739, DOI 10.1038/35055589	68	51	52	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15598	15606		10.1074/jbc.M109.000372	http://dx.doi.org/10.1074/jbc.M109.000372			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19351885	hybrid, Green Published			2022-12-27	WOS:000266501000028
J	Kaysser, L; Lutsch, L; Siebenberg, S; Wemakor, E; Kammerer, B; Gust, B				Kaysser, Leonard; Lutsch, Liane; Siebenberg, Stefanie; Wemakor, Emmanuel; Kammerer, Bernd; Gust, Bertolt			Identification and Manipulation of the Caprazamycin Gene Cluster Lead to New Simplified Liponucleoside Antibiotics and Give Insights into the Biosynthetic Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACETYLMURAMYL-PENTAPEPTIDE TRANSLOCASE; BACTERIAL PEPTIDOGLYCAN SYNTHESIS; ANTITUMOR POLYKETIDE ELLORAMYCIN; RIBOFURANOSYL NUCLEOSIDE MOIETY; STREPTOMYCES SP; SACCHAROPOLYSPORA-SPINOSA; HETEROLOGOUS EXPRESSION; ESCHERICHIA-COLI; FLEXIBLE GLYCOSYLTRANSFERASE; STRUCTURE ELUCIDATION	Caprazamycins are potent anti-mycobacterial liponucleoside antibiotics isolated from Streptomyces sp. MK730-62F2 and belong to the translocase I inhibitor family. Their complex structure is derived from 5'-(beta-O-aminoribosyl)-glycyluridine and comprises a unique N-methyldiazepanone ring. The biosynthetic gene cluster has been identified, cloned, and sequenced, representing the first gene cluster of a translocase I inhibitor. Sequence analysis revealed the presence of 23 open reading frames putatively involved in export, resistance, regulation, and biosynthesis of the caprazamycins. Heterologous expression of the gene cluster in Streptomyces coelicolor M512 led to the production of non-glycosylated bioactive caprazamycin derivatives. A set of gene deletions validated the boundaries of the cluster and inactivation of cpz21 resulted in the accumulation of novel simplified liponucleoside antibiotics that lack the 3-methylglutaryl moiety. Therefore, Cpz21 is assigned to act as an acyltransferase in caprazamycin biosynthesis. In vivo and in silico analysis of the caprazamycin biosynthetic gene cluster allows a first proposal of the biosynthetic pathway and provides insights into the biosynthesis of related uridyl-antibiotics.	[Kaysser, Leonard; Lutsch, Liane; Siebenberg, Stefanie; Wemakor, Emmanuel; Gust, Bertolt] Univ Tubingen, Inst Pharmazeut, D-72076 Tubingen, Germany; [Siebenberg, Stefanie; Kammerer, Bernd] Univ Tubingen, Inst Pharmakol & Toxikol, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Gust, B (corresponding author), Univ Tubingen, Inst Pharmazeut, Morgenstelle 8, D-72076 Tubingen, Germany.	bertolt.gust@uni-tuebingen.de	Kaysser, Leonard/Q-2091-2019	Kaysser, Leonard/0000-0002-3943-993X	European Commission [IP005224]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported European Commission Grant IP005224 ActinoGEN.	Akoh CC, 2004, PROG LIPID RES, V43, P534, DOI 10.1016/j.plipres.2004.09.002; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Basnet DB, 2006, MOL CELLS, V22, P154; BIBB MJ, 1984, GENE, V30, P157, DOI 10.1016/0378-1119(84)90116-1; Blanco G, 2001, CHEM BIOL, V8, P253, DOI 10.1016/S1074-5521(01)00010-2; Brandish PE, 1996, ANTIMICROB AGENTS CH, V40, P1640, DOI 10.1128/AAC.40.7.1640; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Choi SS, 2007, MICROBIOL-SGM, V153, P1095, DOI 10.1099/mic.0.2006/003194-0; Dairi T, 2005, J ANTIBIOT, V58, P227, DOI 10.1038/ja.2005.27; Dini C, 2005, CURR TOP MED CHEM, V5, P1221, DOI 10.2174/156802605774463042; Dini C, 2001, BIOORG MED CHEM LETT, V11, P533, DOI 10.1016/S0960-894X(00)00714-9; Dini C, 2001, BIOORG MED CHEM LETT, V11, P529, DOI 10.1016/S0960-894X(00)00715-0; Doumith M, 2000, MOL GEN GENET, V264, P477, DOI 10.1007/s004380000329; Eustaquio AS, 2005, APPL ENVIRON MICROB, V71, P2452, DOI 10.1128/AEM.71.5.2452-2459.2005; Flett F, 1997, FEMS MICROBIOL LETT, V155, P223, DOI 10.1111/j.1574-6968.1997.tb13882.x; Gallegos MT, 1997, MICROBIOL MOL BIOL R, V61, P393, DOI 10.1128/.61.4.393-410.1997; Gao QJ, 2006, CHEM BIOL, V13, P733, DOI 10.1016/j.chembiol.2006.05.009; Gullon S, 2006, APPL ENVIRON MICROB, V72, P4172, DOI 10.1128/AEM.00734-06; Gunsior M, 2004, CHEM BIOL, V11, P927, DOI 10.1016/j.chembiol.2004.04.012; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Gust B, 2004, ADV APPL MICROBIOL, V54, P107, DOI 10.1016/S0065-2164(04)54004-2; Hirano S, 2005, ANGEW CHEM INT EDIT, V44, P1854, DOI 10.1002/anie.200462439; Hirano S, 2008, J ORG CHEM, V73, P569, DOI 10.1021/jo702264e; Holmquist M, 2000, CURR PROTEIN PEPT SC, V1, P209, DOI 10.2174/1389203003381405; Huang FL, 2006, CHEM BIOL, V13, P475, DOI 10.1016/j.chembiol.2006.02.014; Igarahi M, 2003, J ANTIBIOT, V56, P580, DOI 10.7164/antibiotics.56.580; Igarashi M, 2005, J ANTIBIOT, V58, P327, DOI 10.1038/ja.2005.41; Igarashi M., 2002, 42 INT C ANT AG CHEM, P232; ISONO K, 1985, J ANTIBIOT, V38, P1617, DOI 10.7164/antibiotics.38.1617; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; Kagami S, 2003, J ANTIBIOT, V56, P552, DOI 10.7164/antibiotics.56.552; Kapp U, 2008, ACTA CRYSTALLOGR F, V64, P479, DOI 10.1107/S1744309108011822; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kimura K, 2003, NAT PROD REP, V20, P252, DOI 10.1039/b202149h; Kimura K, 1998, J ANTIBIOT, V51, P647, DOI 10.7164/antibiotics.51.647; Kimura K, 1998, J ANTIBIOT, V51, P1099, DOI 10.7164/antibiotics.51.1099; Kudo F, 2007, BIOORGAN MED CHEM, V15, P4360, DOI 10.1016/j.bmc.2007.04.040; Li WL, 2008, J BIOL CHEM, V283, P28607, DOI 10.1074/jbc.M804279200; Luzhetskyy A, 2007, CHEMBIOCHEM, V8, P599, DOI 10.1002/cbic.200600529; MACNEIL DJ, 1988, J BACTERIOL, V170, P5607, DOI 10.1128/jb.170.12.5607-5612.1988; Madduri K, 2001, J BACTERIOL, V183, P5632, DOI 10.1128/JB.183.19.5632-5638.2001; Makart S, 2007, J BIOTECHNOL, V130, P402, DOI 10.1016/j.jbiotec.2007.05.008; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; McDonald LA, 2002, J AM CHEM SOC, V124, P10260, DOI 10.1021/ja017748h; OCHI K, 1989, Patent No. 4950605; Ohnuki T, 2003, J ANTIBIOT, V56, P268, DOI 10.7164/antibiotics.56.268; Patallo EP, 2001, J BIOL CHEM, V276, P18765, DOI 10.1074/jbc.M101225200; Price NPJ, 2007, J ANTIBIOT, V60, P485, DOI 10.1038/ja.2007.62; Ramos A, 2008, MICROBIOL-SGM, V154, P781, DOI 10.1099/mic.0.2007/014035-0; Reeve AM, 1998, J BIOL CHEM, V273, P30695, DOI 10.1074/jbc.273.46.30695; RODRIGUEZ AM, 1993, MOL MICROBIOL, V8, P571; Sambrook J., 1989, MOL CLONING LAB MANU, V1, P21, DOI DOI 10.51-10.67; Sinha SC, 2001, CURR OPIN STRUC BIOL, V11, P733, DOI 10.1016/S0959-440X(01)00274-3; STENFLO J, 1989, P NATL ACAD SCI USA, V86, P444, DOI 10.1073/pnas.86.2.444; STRUVE WG, 1966, BIOCHEMISTRY-US, V5, P82, DOI 10.1021/bi00865a012; TAKEUCHI T, 2002, Patent No. 6780616; Tsvetanova BC, 2002, J BIOL CHEM, V277, P35289, DOI 10.1074/jbc.M201345200; UBUKATA M, 1992, J ORG CHEM, V57, P6392, DOI 10.1021/jo00050a009; Waldron C, 2000, ANTON LEEUW INT J G, V78, P385, DOI 10.1023/A:1010289901631; Waldron C, 2001, CHEM BIOL, V8, P487, DOI 10.1016/S1074-5521(01)00029-1; Weitnauer G, 2001, CHEM BIOL, V8, P569, DOI 10.1016/S1074-5521(01)00040-0; Wu XM, 2009, CHEMBIOCHEM, V10, P304, DOI 10.1002/cbic.200800527	62	84	85	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					14987	14996		10.1074/jbc.M901258200	http://dx.doi.org/10.1074/jbc.M901258200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19351877	hybrid, Green Published			2022-12-27	WOS:000266288200035
J	E, SY; Lai, YJ; Tsukahara, R; Chen, CS; Fujiwara, Y; Yue, JM; Yu, JH; Guo, H; Kihara, A; Tigyi, G; Lin, FT				E, Shuyu; Lai, Yun-Ju; Tsukahara, Ryoko; Chen, Chen-Shan; Fujiwara, Yuko; Yue, Junming; Yu, Jei-Hwa; Guo, Huazhang; Kihara, Akio; Tigyi, Gabor; Lin, Fang-Tsyr			Lysophosphatidic Acid 2 Receptor-mediated Supramolecular Complex Formation Regulates Its Antiapoptotic Effect	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED CELL-MIGRATION; COLON-CANCER CELLS; PROTEIN INTERACTIONS; LPA(2) RECEPTOR; DOWN-REGULATION; PDZ DOMAIN; PHOSPHORYLATION; ACTIVATION; SPECIFICITY; ASSOCIATION	The G protein-coupled lysophosphatidic acid 2 (LPA(2)) receptor elicits prosurvival responses to prevent and rescue cells from apoptosis. However, G protein-coupled signals are not sufficient for the full protective effect of LPA(2). LPA(2) differs from other LPA receptor subtypes in the C-terminal tail, where it contains a zinc finger-binding motif for the interactions with LIM domain-containing TRIP6 and proapoptotic Siva-1, and a PDZ-binding motif through which it complexes with the NHERF2 scaffold protein. In this report, we identify a unique CXXC motif of LPA(2) responsible for the binding to TRIP6 and Siva-1, and demonstrate that disruption of these macromolecular complexes or knockdown of TRIP6 or NHERF2 expression attenuates LPA(2)-mediated protection from chemotherapeutic agent-induced apoptosis. In contrast, knockdown of Siva-1 expression enhances this effect. Furthermore, a PDZ-mediated direct interaction between TRIP6 and NHERF2 facilitates their interaction with LPA(2). Together, these results suggest that in addition to G protein-activated signals, the cooperation embedded in the LPA(2)-TRIP6-NHERF2 ternary complex provides a novel ligand-dependent signal amplification mechanism that is required for LPA(2)-mediated full activation of antiapoptotic signaling.	[E, Shuyu; Tsukahara, Ryoko; Fujiwara, Yuko; Yue, Junming; Guo, Huazhang; Tigyi, Gabor] Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA; [Lai, Yun-Ju; Chen, Chen-Shan; Lin, Fang-Tsyr] Univ Alabama, Dept Cell Biol, Birmingham, AL 35294 USA; [Yu, Jei-Hwa] Univ Alabama, Dept Biochem & Mol Genet, Birmingham, AL 35294 USA; [Kihara, Akio] Hokkaido Univ, Fac Pharmaceut Sci, Lab Biomembrane & Biofunct Chem, Kita Ku, Sapporo, Hokkaido 0600812, Japan	University of Tennessee System; University of Tennessee Health Science Center; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Hokkaido University	Tigyi, G (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA.	gtigyi@physio1.utmem.edu; flin@uab.edu	KIHARA, AKIO/A-3802-2012; e, s/GWU-7511-2022	KIHARA, AKIO/0000-0001-5889-0788; 	National Institutes of Health [CA92160, AI 080405, CA100848]; Marsha Rivkin Center for Ovarian Cancer Research; NATIONAL CANCER INSTITUTE [R01CA100848, R01CA092160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080405] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marsha Rivkin Center for Ovarian Cancer Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grants CA92160 (to G. T.), AI 080405 (to G. T.), and CA100848 (to F. L.). This work was also supported by a grant from the Marsha Rivkin Center for Ovarian Cancer Research (to F. L.). G. T. is a founder of RxBio Inc. and a member of the scientific advisory board.	Bach I, 2000, MECH DEVELOP, V91, P5, DOI 10.1016/S0925-4773(99)00314-7; Chun J, 2002, BIOCHEM BIOPH RES CO, V298, P207, DOI 10.1016/S0006-291X(02)02428-2; Deng W, 2007, GASTROENTEROLOGY, V132, P1834, DOI 10.1053/j.gastro.2007.03.038; Fortin A, 2004, J BIOL CHEM, V279, P28706, DOI 10.1074/jbc.M400376200; Hur EM, 2002, CELL SIGNAL, V14, P397, DOI 10.1016/S0898-6568(01)00258-3; Lai YJ, 2005, MOL CELL BIOL, V25, P5859, DOI 10.1128/MCB.25.14.5859-5868.2005; Lau AG, 2001, BIOCHEMISTRY-US, V40, P8572, DOI 10.1021/bi0103516; Li CY, 2005, J EXP MED, V202, P975, DOI 10.1084/jem.20050421; Lin FT, 2008, BBA-MOL CELL BIOL L, V1781, P558, DOI 10.1016/j.bbalip.2008.04.013; Lin FT, 2007, J BIOL CHEM, V282, P37759, DOI 10.1074/jbc.M705025200; Longva KE, 2005, INT J CANCER, V116, P359, DOI 10.1002/ijc.21015; Maudsley S, 2005, J PHARMACOL EXP THER, V314, P485, DOI 10.1124/jpet.105.083121; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Moolenaar WH, 2004, BIOESSAYS, V26, P870, DOI 10.1002/bies.20081; Oh YS, 2004, MOL CELL BIOL, V24, P5069, DOI 10.1128/MCB.24.11.5069-5079.2004; Parrill AL, 2008, BBA-MOL CELL BIOL L, V1781, P540, DOI 10.1016/j.bbalip.2008.04.011; Pasternack SM, 2008, NAT GENET, V40, P329, DOI 10.1038/ng.84; Qanbar R, 2003, PHARMACOL THERAPEUT, V97, P1, DOI 10.1016/S0163-7258(02)00300-5; Radeff-Huang J, 2004, J CELL BIOCHEM, V92, P949, DOI 10.1002/jcb.20094; Rusovici R, 2007, BBA-GEN SUBJECTS, V1770, P1194, DOI 10.1016/j.bbagen.2007.04.008; Tabata KI, 2007, BIOCHEM BIOPH RES CO, V363, P861, DOI 10.1016/j.bbrc.2007.09.063; Takahashi Y, 2006, EMBO J, V25, P910, DOI 10.1038/sj.emboj.7600979; Wan J, 2007, NAT PROTOC, V2, P1573, DOI 10.1038/nprot.2007.225; Wang HQ, 2005, ONCOGENE, V24, P3574, DOI 10.1038/sj.onc.1208463; Wu Y, 2000, J BIOL CHEM, V275, P21477, DOI 10.1074/jbc.M909741199; Xu J, 2004, J BIOL CHEM, V279, P10459, DOI 10.1074/jbc.M311891200; Yamada T, 2005, J BIOL CHEM, V280, P19358, DOI 10.1074/jbc.M414561200; Yun CC, 2005, AM J PHYSIOL-CELL PH, V289, pC2, DOI 10.1152/ajpcell.00610.2004; Zhang HC, 2007, CELL SIGNAL, V19, P261, DOI 10.1016/j.cellsig.2006.06.008	29	50	53	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14558	14571		10.1074/jbc.M900185200	http://dx.doi.org/10.1074/jbc.M900185200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19293149	Green Published, hybrid			2022-12-27	WOS:000266286100062
J	Fu, W; Ma, QP; Chen, L; Li, PF; Zhang, M; Ramamoorthy, S; Nawaz, Z; Shimojima, T; Wang, HB; Yang, YH; Shen, Z; Zhang, YT; Zhang, XH; Nicosia, SV; Zhang, YP; Pledger, JW; Chen, JD; Bai, WL				Fu, Wei; Ma, Qiuping; Chen, Lei; Li, Pengfei; Zhang, Mu; Ramamoorthy, Sivapriya; Nawaz, Zafar; Shimojima, Tsukasa; Wang, Hengbin; Yang, Yonghua; Shen, Zheng; Zhang, Yingtao; Zhang, Xiaohong; Nicosia, Santo V.; Zhang, Yanping; Pledger, Jack W.; Chen, Jiandong; Bai, Wenlong			MDM2 Acts Downstream of p53 as an E3 Ligase to Promote FOXO Ubiquitination and Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FORKHEAD TRANSCRIPTION FACTOR; ANDROGEN RECEPTOR; TUMOR-SUPPRESSOR; OXIDATIVE-STRESS; PROSTATE-CANCER; PROTEASOMAL DEGRADATION; DOWN-REGULATION; DNA-DAMAGE; CELL-DEATH; LIFE-SPAN	Members of the FOXO (forkhead O) class of transcription factors are tumor suppressors that also control aging and organismal life span. MammalianFOXOdegradation is proteasomemediated, although the ubiquitin E3 ligase for FOXO factors remains to be defined. We show that MDM2 binds to FOXO1 and FOXO3A and promotes their ubiquitination and degradation, a process apparently dependent on FOXO phosphorylation at AKT sites and the E3 ligase activity of MDM2. Binding of MDM2 to FOXO occurs through the region of MDM2 that directs its cellular trafficking and the forkhead box of FOXO1. MDM2 promotes the ubiquitination of FOXO1 in a cell-free system, and its knockdown by small interfering RNA causes accumulation of endogenous FOXO3A protein in cells and enhances the expression of FOXO target genes. In cells stably expressing a temperature-sensitive p53 mutant, activation of p53 by shifting to permissive temperatures leads to MDM2 induction and degradation of endogenous FOXO3A. These data suggest that MDM2 acts as an ubiquitin E3 ligase, downstream of p53, to regulate the degradation of mammalian FOXO factors.	[Fu, Wei; Ma, Qiuping; Chen, Lei; Li, Pengfei; Zhang, Mu; Yang, Yonghua; Shen, Zheng; Zhang, Yingtao; Zhang, Xiaohong; Nicosia, Santo V.; Bai, Wenlong] Univ S Florida, Coll Med, Dept Pathol, Tampa, FL 33612 USA; [Fu, Wei; Ma, Qiuping; Chen, Lei; Li, Pengfei; Zhang, Mu; Yang, Yonghua; Shen, Zheng; Zhang, Yingtao; Zhang, Xiaohong; Nicosia, Santo V.; Bai, Wenlong] Univ S Florida, Coll Med, Dept Cell Biol, Tampa, FL 33612 USA; [Zhang, Xiaohong; Bai, Wenlong] H Lee Moffitt Canc Ctr & Res Inst, Program Mol Oncol, Tampa, FL 33612 USA; [Nicosia, Santo V.; Pledger, Jack W.; Chen, Jiandong] H Lee Moffitt Canc Ctr & Res Inst, Program Expt Therapeut, Tampa, FL 33612 USA; [Ramamoorthy, Sivapriya; Nawaz, Zafar; Pledger, Jack W.; Chen, Jiandong] Univ Miami, Sch Med, Dept Biochem & Mol Biol, Miami, FL 33136 USA; [Shimojima, Tsukasa; Wang, Hengbin] Univ Alabama, Dept Biochem & Mol Genet, Birmingham, AL 35233 USA; [Zhang, Yanping] Univ N Carolina, Dept Radiat Oncol, Chapel Hill, NC 27514 USA	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; H Lee Moffitt Cancer Center & Research Institute; H Lee Moffitt Cancer Center & Research Institute; University of Miami; University of Alabama System; University of Alabama Birmingham; University of North Carolina; University of North Carolina Chapel Hill	Bai, WL (corresponding author), Univ S Florida, Coll Med, Dept Pathol & Cell Biol, 12901 Bruce B Downs Blvd,MDC 11, Tampa, FL 33612 USA.	wbai@health.usf.edu	高, 雨莉/HGU-8187-2022; Bai, Wenlong/A-8977-2013	Bai, Wenlong/0000-0002-9536-0556; Fu, Wei/0000-0003-0506-5594; Wang, Hengbin/0000-0003-2414-0609	National Institutes of Health [CA93666, CA111334]; Department of Defense Prostate Cancer [DAMD17-021-0140]; American Heart Association Predoctoral Fellowship [0315115B]; NATIONAL CANCER INSTITUTE [R01CA127770, R01CA093666, R01CA100302] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Prostate Cancer(United States Department of Defense); American Heart Association Predoctoral Fellowship(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants CA93666 (to W. B.) and CA111334 (to W. B.). This work was also supported by Department of Defense Prostate Cancer Grant DAMD17-021-0140 (to W. B.) and American Heart Association Predoctoral Fellowship 0315115B (to W. F.).	Aoki M, 2004, P NATL ACAD SCI USA, V101, P13613, DOI 10.1073/pnas.0405454101; Barthel A, 2005, TRENDS ENDOCRIN MET, V16, P183, DOI 10.1016/j.tem.2005.03.010; Brenkman AB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002819; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Carter ME, 2007, CURR BIOL, V17, pR113, DOI 10.1016/j.cub.2007.01.008; Catzavelos C, 1997, NAT MED, V3, P227, DOI 10.1038/nm0297-227; CHEN JD, 1995, MOL MED, V1, P142, DOI 10.1007/BF03401562; CHEN JD, 1993, MOL CELL BIOL, V13, P4107, DOI 10.1128/MCB.13.7.4107; Chen LH, 1997, J BIOL CHEM, V272, P22966, DOI 10.1074/jbc.272.36.22966; Daujat S, 2001, TRENDS GENET, V17, P459, DOI 10.1016/S0168-9525(01)02369-1; Dong XY, 2006, CANCER RES, V66, P6998, DOI 10.1158/0008-5472.CAN-06-0411; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Feng JH, 2004, J BIOL CHEM, V279, P35510, DOI 10.1074/jbc.M404936200; Freedman DA, 1999, CANCER RES, V59, P1; Frescas D, 2005, J BIOL CHEM, V280, P20589, DOI 10.1074/jbc.M412357200; Ganguli G, 2003, MOL CANCER RES, V1, P1027; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Hu MCT, 2004, CELL, V117, P225, DOI 10.1016/S0092-8674(04)00302-2; Huang H, 2005, P NATL ACAD SCI USA, V102, P1649, DOI 10.1073/pnas.0406789102; Huang HJ, 2006, SCIENCE, V314, P294, DOI 10.1126/science.1130512; Jin SK, 2001, J CELL SCI, V114, P4139; Kajihara T, 2006, MOL ENDOCRINOL, V20, P2444, DOI 10.1210/me.2006-0118; Katoh M, 2004, INT J ONCOL, V25, P1495; Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002; Kim HK, 2005, J GERONTOL A-BIOL, V60, P4, DOI 10.1093/gerona/60.1.4; Kitamura YI, 2005, CELL METAB, V2, P153, DOI 10.1016/j.cmet.2005.08.004; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Li PF, 2003, MOL CELL BIOL, V23, P104, DOI 10.1128/MCB.23.1.104-118.2003; Li PF, 2001, J BIOL CHEM, V276, P20444, DOI 10.1074/jbc.M010226200; Lin HK, 2002, EMBO J, V21, P4037, DOI 10.1093/emboj/cdf406; LUNA RMD, 1995, NATURE, V378, P203; Macri E, 1998, CANCER METAST REV, V17, P337, DOI 10.1023/A:1006133620914; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; Matsuzaki H, 2005, P NATL ACAD SCI USA, V102, P11278, DOI 10.1073/pnas.0502738102; McMasters KM, 1996, ONCOGENE, V13, P1731; Medema RH, 2000, NATURE, V404, P782, DOI 10.1038/35008115; Miyauchi H, 2004, EMBO J, V23, P212, DOI 10.1038/sj.emboj.7600045; Modur V, 2002, J BIOL CHEM, V277, P47928, DOI 10.1074/jbc.M207509200; Nakamura N, 2000, MOL CELL BIOL, V20, P8969, DOI 10.1128/MCB.20.23.8969-8982.2000; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Peng YH, 2001, J BIOL CHEM, V276, P40583, DOI 10.1074/jbc.M102817200; Perrot V, 2005, MOL ENDOCRINOL, V19, P2283, DOI 10.1210/me.2004-0292; Plas DR, 2003, J BIOL CHEM, V278, P12361, DOI 10.1074/jbc.M213069200; Pochampally R, 1999, J BIOL CHEM, V274, P15271, DOI 10.1074/jbc.274.21.15271; Rena G, 2002, EMBO J, V21, P2263, DOI 10.1093/emboj/21.9.2263; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Schmidt M, 2002, MOL CELL BIOL, V22, P7842, DOI 10.1128/MCB.22.22.7842-7852.2002; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; van der Horst A, 2006, NAT CELL BIOL, V8, P1064, DOI 10.1038/ncb1469; Wang CG, 2005, EMBO J, V24, P3279, DOI 10.1038/sj.emboj.7600791; Yang JY, 2008, NAT CELL BIOL, V10, P138, DOI 10.1038/ncb1676; Yang YH, 2005, EMBO J, V24, P1021, DOI 10.1038/sj.emboj.7600570; You H, 2004, P NATL ACAD SCI USA, V101, P14057, DOI 10.1073/pnas.0406286101; You H, 2006, P NATL ACAD SCI USA, V103, P9051, DOI 10.1073/pnas.0600889103; Yu ZK, 2000, ONCOGENE, V19, P5892, DOI 10.1038/sj.onc.1203980; Zhou BHP, 2001, NAT CELL BIOL, V3, P973, DOI 10.1038/ncb1101-973	60	140	144	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					13987	14000		10.1074/jbc.M901758200	http://dx.doi.org/10.1074/jbc.M901758200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19321440	Green Published, hybrid			2022-12-27	WOS:000266286100005
J	Thangasamy, A; Rogge, J; Ammanamanchi, S				Thangasamy, Amalraj; Rogge, Jessica; Ammanamanchi, Sudhakar			Recepteur d'Origine Nantais Tyrosine Kinase Is a Direct Target of Hypoxia-inducible Factor-1 alpha-mediated Invasion of Breast Carcinoma Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-I; MEDIATED INVASION; CANCER; RON; EXPRESSION; OVEREXPRESSION; METASTASIS; PROGNOSIS; PATHWAY; MODEL	Hypoxia-inducible factor-1 alpha (HIF-1 alpha) overexpression was shown to be associated with invasion and metastasis of tumors and tumor cell lines. The identification of molecular targets that contribute to HIF-1 alpha-mediated invasion is under intensive investigation. We have analyzed the role of recepteur d'origine nantais (RON), a tyrosine kinase receptor for macrophage-stimulating protein (MSP) that plays a role in breast cancer cell invasion as one of the molecular targets of HIF-1 alpha. Analysis of a panel of breast cancer cell lines indicated a correlation between HIF-1 alpha and RON expression. Treatment of HIF-1 alpha-and RON-positive breast cancer cells with HIF-1 alpha inhibitor, echinomycin, led to the inhibition of HIF-1 alpha activity and RON expression. We have identified HIF-1 alpha binding site on the RON promoter. Chromatin immunoprecipitation analysis and site-directed mutagenesis of the RON promoter confirmed the binding of HIF-1 alpha to RON promoter. HIF-1 alpha inhibitor-, echinomycin-, or short hairpin RNA-mediated selective knockdown of HIF-1 alpha or HIF-1 alpha target RON tyrosine kinase abrogated RON gene expression, and the RON ligand macrophage-stimulating protein mediated invasion of breast cancer cells. Consequently, the data presented herein demonstrated RON as a novel molecular target of HIF-1 alpha and suggest a potential therapeutic role for HIF-1 alpha or RON tyrosine kinase inhibitors in the blockade of RON tyrosine kinase-mediated invasion of carcinoma cells.	[Thangasamy, Amalraj; Rogge, Jessica; Ammanamanchi, Sudhakar] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Hematol & Med Oncol, San Antonio, TX 78229 USA; [Ammanamanchi, Sudhakar] Univ Texas Hlth Sci Ctr San Antonio, Canc Therapy & Res Ctr, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio; Cancer Therapy & Research Center; University of Texas System; University of Texas Health San Antonio	Ammanamanchi, S (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Hematol & Med Oncol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	ammanamanchi@uthscsa.edu			National Institutes of Health [P30 CA54174]; NCl; NATIONAL CANCER INSTITUTE [P30CA054174] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCl; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant P30 CA54174 from the NCl.	Bos R, 2003, CANCER, V97, P1573, DOI 10.1002/cncr.11246; Bos R, 2001, JNCI-J NATL CANCER I, V93, P309, DOI 10.1093/jnci/93.4.309; Dales JP, 2005, INT J CANCER, V116, P734, DOI 10.1002/ijc.20984; Danilkovitch-Miagkova A, 2001, MOL CELL BIOL, V21, P5857, DOI 10.1128/MCB.21.17.5857-5868.2001; DELGATTO F, 1995, BBA-GENE STRUCT EXPR, V1263, P93, DOI 10.1016/0167-4781(95)00082-R; Fukuda R, 2002, J BIOL CHEM, V277, P38205, DOI 10.1074/jbc.M203781200; Gruber G, 2004, BREAST CANCER RES, V6, pR191, DOI 10.1186/bcr775; Hiraga T, 2007, CANCER RES, V67, P4157, DOI 10.1158/0008-5472.CAN-06-2355; Kimbro KS, 2006, ENDOCR-RELAT CANCER, V13, P739, DOI 10.1677/erc.1.00728; Kong DH, 2005, CANCER RES, V65, P9047, DOI 10.1158/0008-5472.CAN-05-1235; Kronblad A, 2006, INT J CANCER, V118, P2609, DOI 10.1002/ijc.21676; Lee WY, 2005, CLIN CANCER RES, V11, P2222, DOI 10.1158/1078-0432.CCR-04-1761; Leonis Mike A, 2007, Future Oncol, V3, P441, DOI 10.2217/14796694.3.4.441; Liao D, 2007, CANCER RES, V67, P563, DOI 10.1158/0008-5472.CAN-06-2701; Narasimhan M, 2008, CANCER RES, V68, P5185, DOI 10.1158/0008-5472.CAN-07-6883; Thangasamy A, 2008, J BIOL CHEM, V283, P5335, DOI 10.1074/jbc.M706957200; Vleugel MM, 2005, J CLIN PATHOL, V58, P172, DOI 10.1136/jcp.2004.019885; Wang MH, 2007, J PATHOL, V213, P402, DOI 10.1002/path.2245; Welm AL, 2007, P NATL ACAD SCI USA, V104, P7570, DOI 10.1073/pnas.0702095104; Yamamoto Y, 2008, BREAST CANCER RES TR, V110, P465, DOI 10.1007/s10549-007-9742-1; Zhong H, 2000, CANCER RES, V60, P1541; Zinser GM, 2006, CANCER RES, V66, P11967, DOI 10.1158/0008-5472.CAN-06-2473	22	38	40	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14001	14010		10.1074/jbc.M809320200	http://dx.doi.org/10.1074/jbc.M809320200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19307182	Green Published, hybrid			2022-12-27	WOS:000266286100006
J	Xu, B; Huang, K; Chu, YC; Hu, SQ; Nakagawa, S; Wang, SH; Wang, RY; Whittaker, J; Katsoyannis, PG; Weiss, MA				Xu, Bin; Huang, Kun; Chu, Ying-Chi; Hu, Shi-Quan; Nakagawa, Satoe; Wang, Shuhua; Wang, Run-Ying; Whittaker, Jonathan; Katsoyannis, Panayotis G.; Weiss, Michael A.			Decoding the Cryptic Active Conformation of a Protein by Synthetic Photoscanning INSULIN INSERTS A DETACHABLE ARM BETWEEN RECEPTOR DOMAINS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DIABETES-ASSOCIATED MUTATIONS; ALANINE-SCANNING MUTAGENESIS; PHOTO-CROSS-LINKING; CHAIN ALPHA-HELIX; B-CHAIN; CRYSTAL-STRUCTURE; BINDING-SITE; BIOLOGICAL-ACTIVITY; CHIRAL MUTAGENESIS; NEGATIVE COOPERATIVITY	Proteins evolve in a fitness landscape encompassing a complex network of biological constraints. Because of the interrelation of folding, function, and regulation, the ground-state structure of a protein may be inactive. A model is provided by insulin, a vertebrate hormone central to the control of metabolism. Whereas native assembly mediates storage within pancreatic beta-cells, the active conformation of insulin and its mode of receptor binding remain elusive. Here, functional surfaces of insulin were probed by photocross-linking of an extensive set of azido derivatives constructed by chemical synthesis. Contacts are circumferential, suggesting that insulin is encaged within its receptor. Mapping of photoproducts to the hormone-binding domains of the insulin receptor demonstrated alternating contacts by the B-chain beta-strand (residues B24-B28). Whereas even-numbered probes (at positions B24 and B26) contact the N-terminal L1 domain of the alpha-subunit, odd-numbered probes (at positions B25 and B27) contact its C-terminal insert domain. This alternation corresponds to the canonical structure of a beta-strand (wherein successive residues project in opposite directions) and so suggests that the B-chain inserts between receptor domains. Detachment of a receptor-binding arm enables photo engagement of surfaces otherwise hidden in the free hormone. The arm and associated surfaces contain sites also required for nascent folding and self-assembly of storage hexamers. The marked compression of structural information within a short polypeptide sequence rationalizes the diversity of diabetes-associated mutations in the insulin gene. Our studies demonstrate that photo-scanning mutagenesis can decode the active conformation of a protein and so illuminate cryptic constraints underlying its evolution.	[Xu, Bin; Huang, Kun; Hu, Shi-Quan; Wang, Shuhua; Whittaker, Jonathan; Weiss, Michael A.] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Chu, Ying-Chi; Wang, Run-Ying; Katsoyannis, Panayotis G.] Mt Sinai Sch Med, Dept Pharmacol & Biol Chem, New York, NY 10029 USA; [Nakagawa, Satoe] Univ Chicago, Dept Med, Chicago, IL 60637 USA	Case Western Reserve University; Icahn School of Medicine at Mount Sinai; University of Chicago	Weiss, MA (corresponding author), Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA.	michael.weiss@case.edu	Huang, Kun/H-4427-2012	Xu, Bin/0000-0002-0490-9540	National Institutes of Health [DK065980, DK56673, DK040949, DK069764]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK069764, R01DK056673, R56DK065980, R01DK040949, R01DK065980] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK065980 (to J.W.), DK56673 (to P.G.K.), and DK040949 and DK069764 (to M.A.W.).	ANDERSEN AS, 1992, J BIOL CHEM, V267, P13681; BAKER EN, 1988, PHILOS T ROY SOC B, V319, P369, DOI 10.1098/rstb.1988.0058; BENTLEY G, 1976, NATURE, V261, P166, DOI 10.1038/261166a0; BLUNDELL TL, 1971, NATURE, V231, P506, DOI 10.1038/231506a0; BLUNDELL TL, 1972, DIABETES, V21, P492, DOI 10.2337/diab.21.2.S492; BRADER ML, 1991, TRENDS BIOCHEM SCI, V16, P341; CARROLL RJ, 1988, P NATL ACAD SCI USA, V85, P8943, DOI 10.1073/pnas.85.23.8943; Chan SJ, 2007, J BIOL CHEM, V282, P13754, DOI 10.1074/jbc.M700724200; CLACKSON T, 1995, SCIENCE, V267, P383, DOI 10.1126/science.7529940; Colombo C, 2008, J CLIN INVEST, V118, P2148, DOI 10.1172/JCI33777; CUNNINGHAM BC, 1993, J MOL BIOL, V234, P554, DOI 10.1006/jmbi.1993.1611; CUNNINGHAM BC, 1991, SCIENCE, V254, P821, DOI 10.1126/science.1948064; De Meyts P, 2004, BIOESSAYS, V26, P1351, DOI 10.1002/bies.20151; De Meyts P, 2002, NAT REV DRUG DISCOV, V1, P769, DOI 10.1038/nrd917; De Meyts P, 2008, TRENDS BIOCHEM SCI, V33, P376, DOI 10.1016/j.tibs.2008.06.003; DEMEYTS P, 1994, DIABETOLOGIA, V37, pS135, DOI 10.1007/BF00400837; DEREWENDA U, 1989, NATURE, V338, P594, DOI 10.1038/338594a0; DEREWENDA U, 1991, J MOL BIOL, V220, P425, DOI 10.1016/0022-2836(91)90022-X; Dodson G, 1998, CURR OPIN STRUC BIOL, V8, P189, DOI 10.1016/S0959-440X(98)80037-7; EBERLE AN, 1985, METHOD ENZYMOL, V109, P129; Edghill EL, 2008, DIABETES, V57, P1034, DOI 10.2337/db07-1405; FABRY M, 1992, J BIOL CHEM, V267, P8950; Glendorf T, 2008, BIOCHEMISTRY-US, V47, P4743, DOI 10.1021/bi800054z; HU SQ, 1993, BIOCHEMISTRY-US, V32, P2631, DOI 10.1021/bi00061a022; Hua QX, 2006, J BIOL CHEM, V281, P24900, DOI 10.1074/jbc.M602691200; Hua QX, 2006, J BIOL CHEM, V281, P24889, DOI 10.1074/jbc.M602617200; Hua QX, 2009, J BIOL CHEM, V284, P14586, DOI 10.1074/jbc.M900085200; HUA QX, 1993, BIOCHEMISTRY-US, V32, P1433, DOI 10.1021/bi00057a006; HUA QX, 1995, NAT STRUCT BIOL, V2, P129, DOI 10.1038/nsb0295-129; Hua QX, 1996, J MOL BIOL, V264, P390, DOI 10.1006/jmbi.1996.0648; HUA QX, 1991, NATURE, V354, P238, DOI 10.1038/354238a0; Huang K, 2004, J MOL BIOL, V341, P529, DOI 10.1016/j.jmb.2004.05.023; Huang K, 2007, J BIOL CHEM, V282, P35337, DOI 10.1074/jbc.M705996200; Huang YD, 2001, SCI CHINA SER C, V44, P593, DOI 10.1007/BF02879353; KITAGAWA K, 1984, BIOCHEMISTRY-US, V23, P1405, DOI 10.1021/bi00302a011; KJELDSEN T, 1991, P NATL ACAD SCI USA, V88, P4404, DOI 10.1073/pnas.88.10.4404; KOBAYASHI M, 1982, BIOCHEM BIOPH RES CO, V107, P329, DOI 10.1016/0006-291X(82)91708-9; KOBAYASHI M, 1986, BIOCHEM BIOPH RES CO, V137, P250, DOI 10.1016/0006-291X(86)91203-9; Kristensen C, 1997, J BIOL CHEM, V272, P12978, DOI 10.1074/jbc.272.20.12978; Kurapkat G, 1999, PROTEIN SCI, V8, P499; KUROSE T, 1994, J BIOL CHEM, V269, P29190; LENZ V, 1991, BIOL CHEM H-S, V372, P495, DOI 10.1515/bchm3.1991.372.2.495; LIANG DC, 1994, BIOPHYS CHEM, V50, P63, DOI 10.1016/0301-4622(94)85020-8; MARKUSSEN J, 1985, INT J PEPT PROT RES, V26, P70; McKern NM, 2006, NATURE, V443, P218, DOI 10.1038/nature05106; MIRMIRA RG, 1991, J BIOL CHEM, V266, P1428; MIRMIRA RG, 1989, J BIOL CHEM, V264, P6349; Molven A, 2008, DIABETES, V57, P1131, DOI 10.2337/db07-1467; Mynarcik DC, 1996, J BIOL CHEM, V271, P2439, DOI 10.1074/jbc.271.5.2439; Nakagawa SH, 2006, J BIOL CHEM, V281, P22386, DOI 10.1074/jbc.M603547200; Nakagawa SH, 2005, BIOCHEMISTRY-US, V44, P4984, DOI 10.1021/bi048025o; NAKAGAWA SH, 1992, BIOCHEMISTRY-US, V31, P3204, DOI 10.1021/bi00127a023; NAKAGAWA SH, 1989, J BIOL CHEM, V264, P272; NAKAGAWA SH, 1991, J BIOL CHEM, V266, P11502; Olsen HB, 1996, BIOCHEMISTRY-US, V35, P8836, DOI 10.1021/bi960292+; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; *PEK INS STRUCT GR, 1971, PEKING REV, V40, P11; PULLEN RA, 1976, NATURE, V259, P369, DOI 10.1038/259369a0; SCHAFFER L, 1994, EUR J BIOCHEM, V221, P1127, DOI 10.1111/j.1432-1033.1994.tb18833.x; SCHUMACHER R, 1993, J BIOL CHEM, V268, P1087; SCHWARTZ G, 1978, BIOCHEMISTRY-US, V17, P4550, DOI 10.1021/bi00614a029; SCHWARTZ GP, 1987, P NATL ACAD SCI USA, V84, P6408, DOI 10.1073/pnas.84.18.6408; SCHWARTZ GP, 1989, P NATL ACAD SCI USA, V86, P458, DOI 10.1073/pnas.86.2.458; SHOELSON S, 1983, NATURE, V302, P540, DOI 10.1038/302540a0; Sparrow LG, 2008, PROTEINS, V71, P426, DOI 10.1002/prot.21768; STEINER DF, 1988, HORM METAB RES, V20, P443, DOI 10.1055/s-2007-1010855; STEINER DF, 1990, DIABETES CARE, V13, P600, DOI 10.2337/diacare.13.6.600; Stoy J, 2007, P NATL ACAD SCI USA, V104, P15040, DOI 10.1073/pnas.0707291104; WAN Z, 1988, SCI CHINA SER B, V31, P1426; Wan ZL, 2008, J BIOL CHEM, V283, P21198, DOI 10.1074/jbc.M800235200; Wan ZL, 2005, BIOCHEMISTRY-US, V44, P5000, DOI 10.1021/bi047585k; Wan ZL, 2004, BIOCHEMISTRY-US, V43, P16119, DOI 10.1021/bi048223f; Ward C, 2008, ACTA PHYSIOL, V192, P3, DOI 10.1111/j.1748-1716.2007.01781.x; WEDEKIND F, 1989, BIOL CHEM H-S, V370, P251, DOI 10.1515/bchm3.1989.370.1.251; Weiss MA, 2001, J BIOL CHEM, V276, P40018, DOI 10.1074/jbc.M104634200; WEISS MA, 1991, BIOCHEMISTRY-US, V30, P7373, DOI 10.1021/bi00244a004; Whittaker J, 2002, J BIOL CHEM, V277, P47380, DOI 10.1074/jbc.M208371200; Whittaker L, 2008, BIOCHEMISTRY-US, V47, P12900, DOI 10.1021/bi801693h; WILLIAMS PF, 1995, J BIOL CHEM, V270, P3012, DOI 10.1074/jbc.270.7.3012; Xu B, 2004, BIOCHEMISTRY-US, V43, P8356, DOI 10.1021/bi0497796; Xu B, 2004, DIABETES, V53, P1599, DOI 10.2337/diabetes.53.6.1599; Xu B, 2002, J MOL BIOL, V316, P435, DOI 10.1006/jmbi.2001.5377; YIP CC, 1988, BIOCHEM BIOPH RES CO, V157, P321, DOI 10.1016/S0006-291X(88)80050-0; Zakova L, 2004, BIOCHEMISTRY-US, V43, P2323, DOI 10.1021/bi036001w	84	34	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14597	14608		10.1074/jbc.M900087200	http://dx.doi.org/10.1074/jbc.M900087200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19321435	Green Published, hybrid			2022-12-27	WOS:000266286100065
J	Snyder, M; Huang, XY; Zhang, JJ				Snyder, Marylynn; Huang, Xin-Yun; Zhang, J. Jillian			The Minichromosome Maintenance Proteins 2-7 (MCM2-7) Are Necessary for RNA Polymerase II (Pol II)-mediated Transcription	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-REPLICATION; SACCHAROMYCES-CEREVISIAE; HELICASE ACTIVITY; HUMAN-CELLS; IFN-GAMMA; COMPLEXES; ORIGINS; ACTIVATION; CHROMATIN; MCM5	The MCM2-7 (minichromosome maintenance) proteins are a family of evolutionarily highly conserved proteins. They are essential for DNA replication in yeast and are considered to function as DNA helicases. However, it has long been shown that there is an overabundance of the MCM2-7 proteins when compared with the number of DNA replication origins in chromatin. It has been suggested that the MCM2-7 proteins may function in other biological processes that require the unwinding of the DNA helix. In this report, we show that RNA polymerase II (Pol II)-mediated transcription is dependent on MCM5 and MCM2 proteins. Furthermore, the MCM2-7 proteins are co-localized with RNA Pol II on chromatins of constitutively transcribing genes, and MCM5 is required for transcription elongation of RNA Pol II. Finally, we demonstrate that the integrity of the MCM2-7 hexamer complex and the DNA helicase domain in MCM5 are essential for the process of transcription.	[Snyder, Marylynn; Huang, Xin-Yun; Zhang, J. Jillian] Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, New York, NY 10065 USA	Cornell University	Zhang, JJ (corresponding author), Cornell Univ, Weill Med Coll, Dept Physiol & Biophys, 1300 York Ave, New York, NY 10065 USA.	jjz2002@med.cornell.edu			National Institutes of Health [GM61652]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061652] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM61652 (to J. J. Z.).	Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; Ausubel F.A., 1997, CURRENT PROTOCOLS MO, DOI DOI 10.1.4; Bochman ML, 2008, MOL CELL BIOL, V28, P5865, DOI 10.1128/MCB.00161-08; Bochman ML, 2008, MOL CELL, V31, P287, DOI 10.1016/j.molcel.2008.05.020; CRISSMAN HA, 1973, J CELL BIOL, V59, P766, DOI 10.1083/jcb.59.3.766; DaFonseca CJ, 2001, P NATL ACAD SCI USA, V98, P3034, DOI 10.1073/pnas.061487598; Donovan S, 1997, P NATL ACAD SCI USA, V94, P5611, DOI 10.1073/pnas.94.11.5611; Eisen A, 1998, BIOESSAYS, V20, P634, DOI 10.1002/(SICI)1521-1878(199808)20:8<634::AID-BIES6>3.0.CO;2-I; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; Ge XQ, 2007, GENE DEV, V21, P3331, DOI 10.1101/gad.457807; GUZDER SN, 1994, NATURE, V369, P578, DOI 10.1038/369578a0; Holland L, 2002, EUR J BIOCHEM, V269, P5192, DOI 10.1046/j.1432-1033.2002.03224.x; Holthoff HP, 1998, J BIOL CHEM, V273, P7320, DOI 10.1074/jbc.273.13.7320; Ibarra A, 2008, P NATL ACAD SCI USA, V105, P8956, DOI 10.1073/pnas.0803978105; Ishimi Y, 1997, J BIOL CHEM, V272, P24508, DOI 10.1074/jbc.272.39.24508; Kanter DM, 2008, J BIOL CHEM, V283, P31172, DOI 10.1074/jbc.M804686200; Labib K, 2000, SCIENCE, V288, P1643, DOI 10.1126/science.288.5471.1643; Lee JK, 2000, J BIOL CHEM, V275, P18871, DOI 10.1074/jbc.M001118200; Lei M, 1996, MOL CELL BIOL, V16, P5081; Moreland RJ, 1999, J BIOL CHEM, V274, P22127, DOI 10.1074/jbc.274.32.22127; Newlon CS, 1997, CELL, V91, P717, DOI 10.1016/S0092-8674(00)80459-6; Raghuraman MK, 2001, SCIENCE, V294, P115, DOI 10.1126/science.294.5540.115; Sato M, 2000, J MOL BIOL, V300, P421, DOI 10.1006/jmbi.2000.3865; Shin JH, 2006, J BIOL CHEM, V281, P26914, DOI 10.1074/jbc.M605518200; Snyder M, 2005, P NATL ACAD SCI USA, V102, P14539, DOI 10.1073/pnas.0507479102; Tanaka TU, 1997, CELL, V90, P649, DOI 10.1016/S0092-8674(00)80526-7; Thommes P, 1997, EMBO J, V16, P3312, DOI 10.1093/emboj/16.11.3312; Tsuyama T, 2005, NUCLEIC ACIDS RES, V33, P765, DOI 10.1093/nar/gki226; Tye BK, 2000, J BIOL CHEM, V275, P34833, DOI 10.1074/jbc.R000018200; Tye BK, 1999, ANNU REV BIOCHEM, V68, P649, DOI 10.1146/annurev.biochem.68.1.649; Wyrick JJ, 2001, SCIENCE, V294, P2357, DOI 10.1126/science.1066101; Yabuta N, 2003, GENES CELLS, V8, P413, DOI 10.1046/j.1365-2443.2003.00645.x; Yang E, 2002, J BIOL CHEM, V277, P13455, DOI 10.1074/jbc.M112038200; Yankulov K, 1999, MOL CELL BIOL, V19, P6154; Zhang JJ, 1998, EMBO J, V17, P6963, DOI 10.1093/emboj/17.23.6963	35	30	33	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13466	13472		10.1074/jbc.M809471200	http://dx.doi.org/10.1074/jbc.M809471200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19318354	hybrid, Green Published			2022-12-27	WOS:000265877300022
J	Turu, G; Varnai, P; Gyombolai, P; Szidonya, L; Bagdy, G; Kunos, G; Hunyady, L				Turu, Gabor; Varnai, Peter; Gyombolai, Pal; Szidonya, Laszlo; Bagdy, Gyoergy; Kunos, George; Hunyady, Laszlo			Paracrine Transactivation of the CB1 Cannabinoid Receptor by AT(1) Angiotensin and Other G(q/11) Protein-coupled Receptors	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BETA-ARRESTIN BINDING; ENDOGENOUS CANNABINOIDS; ENDOCANNABINOID SYSTEM; ACTIVATION; 2-ARACHIDONOYLGLYCEROL; PHOSPHORYLATION; PHARMACOLOGY; PATHWAYS; RELEASE; SIGNAL	Intracellular signaling systems of G protein-coupled receptors are well established, but their role in paracrine regulation of adjacent cells is generally considered as a tissue-specific mechanism. We have shown previously that AT(1) receptor (AT(1)R) stimulation leads to diacylglycerol lipase-mediated transactivation of co-expressed CB(1)Rs in Chinese hamster ovary cells. In the present study we detected a paracrine effect of the endocannabinoid release from Chinese hamster ovary, COS7, and HEK293 cells during the stimulation of AT(1) angiotensin receptors by determining CB1 cannabinoid receptor activity with bioluminescence resonance energy transfer-based sensors of G protein activation expressed in separate cells. The angiotensin II-induced, paracrine activation of CB1 receptors was visualized by detecting translocation of green fluorescent protein-tagged beta-arrestin2. Mass spectrometry analyses have demonstrated angiotensin II-induced stimulation of 2-arachidonoylglycerol production, whereas no increase of anandamide levels was observed. Stimulation of G(q/11)-coupled M-1, M-3, M-5 muscarinic, V1 vasopressin, alpha(1a) adrenergic, B2 bradykinin receptors, but not G(i/o)-coupled M-2 and M-4 muscarinic receptors, also led to paracrine transactivation of CB1 receptors. These data suggest that, in addition to their retrograde neurotransmitter role, endocannabinoids have much broader paracrine mediator functions during activation of G(q/11)-coupled receptors.	[Hunyady, Laszlo] Semmelweis Univ, Dept Physiol, Fac Med, H-1444 Budapest, Hungary; [Bagdy, Gyoergy] Semmelweis Univ, Fac Pharm, Dept Pharmacodynam, H-1444 Budapest, Hungary; [Hunyady, Laszlo] Semmelweis Univ, Lab Neurobiochem & Mol Physiol, H-1444 Budapest, Hungary; [Bagdy, Gyoergy] Semmelweis Univ, Grp Neuropsychopharmacol, H-1444 Budapest, Hungary; [Bagdy, Gyoergy] Hungarian Acad Sci, Budapest, Hungary; [Szidonya, Laszlo; Kunos, George] NIAAA, Lab Psychol Studies, Bethesda, MD 20892 USA	Semmelweis University; Semmelweis University; Semmelweis University; Semmelweis University; Hungarian Academy of Sciences; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)	Hunyady, L (corresponding author), Semmelweis Univ, Dept Physiol, Fac Med, POB 259, H-1444 Budapest, Hungary.	Hunyady@eok.sote.hu	Szidonya, Laszlo/A-2271-2010; Bagdy, György/O-3893-2017	Bagdy, György/0000-0001-8141-3410; Gyombolai, Pal/0000-0001-7117-6351; Turu, Gabor/0000-0002-4421-3812	Hungarian Scientific Research Fund [NK-072661, NF-68563, M-045341, T-034606]; Agency for Research Fund Management and Research Exploitation, Hungary [NKFP1-010/2005]; Hungarian Ministry of Public Health [ETT 447/2006, 460/2006]; EC [LSHM-CT-2004-503474]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [Z01AA000350, ZIAAA000350] Funding Source: NIH RePORTER	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Agency for Research Fund Management and Research Exploitation, Hungary; Hungarian Ministry of Public Health; EC(European CommissionEuropean Commission Joint Research Centre); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by grants from the Hungarian Scientific Research Fund (OTKA Grants NK-072661, NF-68563, M-045341 and T-034606), the Anyos Jedlik program by the Agency for Research Fund Management and Research Exploitation, Hungary (Grants NKFP1-010/2005), the Hungarian Ministry of Public Health (Grants ETT 447/2006 and 460/2006) and the EC (Grant LSHM-CT-2004-503474).	Azpiazu I, 2004, J BIOL CHEM, V279, P27709, DOI 10.1074/jbc.M403712200; Barak LS, 1997, J BIOL CHEM, V272, P27497, DOI 10.1074/jbc.272.44.27497; Barak LS, 2001, P NATL ACAD SCI USA, V98, P93, DOI 10.1073/pnas.011303698; Basavarajappa BS, 2007, PROTEIN PEPTIDE LETT, V14, P237, DOI 10.2174/092986607780090829; Bennett TA, 2000, J BIOL CHEM, V275, P24590, DOI 10.1074/jbc.C000314200; Berghuis P, 2007, SCIENCE, V316, P1212, DOI 10.1126/science.1137406; Bisogno T, 2003, J CELL BIOL, V163, P463, DOI 10.1083/jcb.200305129; Bisogno T, 1997, BIOCHEM J, V322, P671, DOI 10.1042/bj3220671; Bockaert J, 1999, EMBO J, V18, P1723, DOI 10.1093/emboj/18.7.1723; Brown AJ, 2007, BRIT J PHARMACOL, V152, P567, DOI 10.1038/sj.bjp.0707481; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; DeWire SM, 2007, ANNU REV PHYSIOL, V69, P483, DOI 10.1146/annurev.physiol.69.022405.154749; Ferguson Stephen S. G., 2003, V237, P121; Fredriksson R, 2005, ANN NY ACAD SCI, V1040, P89, DOI 10.1196/annals.1327.011; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Gaborik Z, 2003, ENDOCRINOLOGY, V144, P2220, DOI 10.1210/en.2002-0135; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Hanus L, 2001, P NATL ACAD SCI USA, V98, P3662, DOI 10.1073/pnas.061029898; Harkany T, 2007, TRENDS PHARMACOL SCI, V28, P83, DOI 10.1016/j.tips.2006.12.004; Hashimotodani Y, 2005, NEURON, V45, P257, DOI 10.1016/j.neuron.2005.01.004; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Hunyady L, 2006, MOL ENDOCRINOL, V20, P953, DOI 10.1210/me.2004-0536; Huttenrauch F, 2002, J BIOL CHEM, V277, P30769, DOI 10.1074/jbc.M204033200; Jacoby E, 2006, CHEMMEDCHEM, V1, P760, DOI 10.1002/cmdc.200600134; Jeong WI, 2008, CELL METAB, V7, P227, DOI 10.1016/j.cmet.2007.12.007; Kim J, 2002, J NEUROSCI, V22, P10182; Kogan Natalya M, 2007, Dialogues Clin Neurosci, V9, P413; Kunos G, 2007, AM J MED, V120, P24; Lagane B, 2005, MOL PHARMACOL, V67, P1966, DOI 10.1124/mol.104.009779; Lefkowitz RJ, 2004, TRENDS PHARMACOL SCI, V25, P413, DOI 10.1016/j.tips.2004.06.006; Leterrier C, 2004, J BIOL CHEM, V279, P36013, DOI 10.1074/jbc.M403990200; Luttrell Louis M., 2006, V332, P3; Maejima T, 2001, NEURON, V31, P463, DOI 10.1016/S0896-6273(01)00375-0; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; McDonald NA, 2007, MOL PHARMACOL, V71, P976, DOI 10.1124/mol.106.029348; Mechoulam R, 2005, P NATL ACAD SCI USA, V102, P17541, DOI 10.1073/pnas.0508644102; Mhaouty-Kodja S, 1999, MOL PHARMACOL, V55, P339, DOI 10.1124/mol.55.2.339; MUNRO S, 1993, NATURE, V365, P61, DOI 10.1038/365061a0; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Pacher P, 2005, HANDB EXP PHARMACOL, V168, P599; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Ryberg E, 2007, BRIT J PHARMACOL, V152, P1092, DOI 10.1038/sj.bjp.0707460; SAVARESE TM, 1992, BIOCHEM J, V283, P1; SHENOY SK, 2005, SCI STKE, pCM14; Spat A, 2004, PHYSIOL REV, V84, P489, DOI 10.1152/physrev.00030.2003; Stella N, 1997, NATURE, V388, P773, DOI 10.1038/42015; Sugiura T, 2006, PROG LIPID RES, V45, P405, DOI 10.1016/j.plipres.2006.03.003; Turu G, 2006, FEBS LETT, V580, P41, DOI 10.1016/j.febslet.2005.11.044; Turu G, 2007, J BIOL CHEM, V282, P7753, DOI 10.1074/jbc.C600318200; Tyndall JDA, 2005, MED CHEM, V1, P405, DOI 10.2174/1573406054368675; Wang L, 2003, P NATL ACAD SCI USA, V100, P1393, DOI 10.1073/pnas.0336351100; Wei HJ, 2003, P NATL ACAD SCI USA, V100, P10782, DOI 10.1073/pnas.1834556100; Wilson RI, 2001, NEURON, V31, P453, DOI 10.1016/S0896-6273(01)00372-5	53	51	52	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					16914	16921		10.1074/jbc.M109.003681	http://dx.doi.org/10.1074/jbc.M109.003681			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19357084	Green Published, Green Submitted, hybrid			2022-12-27	WOS:000266962400028
J	Grandy, D; Shan, JF; Zhang, XX; Rao, S; Akunuru, S; Li, HY; Zhang, YH; Alpatov, I; Zhang, XA; Lang, RA; Shi, DL; Zheng, JJ				Grandy, David; Shan, Jufang; Zhang, Xinxin; Rao, Sujata; Akunuru, Shailaja; Li, Hongyan; Zhang, Yanhui; Alpatov, Ivan; Zhang, Xin A.; Lang, Richard A.; Shi, De-Li; Zheng, Jie J.			Discovery and Characterization of a Small Molecule Inhibitor of the PDZ Domain of Dishevelled	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-LIGAND INTERACTIONS; EMPIRICAL SCORING FUNCTION; PROGRAMMED CELL-DEATH; WNT PATHWAY; HUMAN COUNTERPART; UP-REGULATION; BINDING; EXPRESSION; PROSTATE; POLARITY	Dishevelled (Dvl) is an essential protein in the Wnt signaling pathways; it uses its PDZ domain to transduce the Wnt signals from the membrane receptor Frizzled to downstream components. Here, we report identifying a drug-like small molecule compound through structure-based ligand screening and NMR spectroscopy and show the compound to interact at low micromolar affinity with the PDZ domain of Dvl. In a Xenopus testing system, the compound could permeate the cell membrane and block the Wnt signaling pathways. In addition, the compound inhibited Wnt signaling and reduced the levels of apoptosis in the hyaloid vessels of eye. Moreover, this compound also suppressed the growth of prostate cancer PC-3 cells. These biological effects suggest that by blocking the PDZ domain of Dvl, the compound identified in our studies effectively inhibits the Wnt signaling and thus provides a useful tool for studies dissecting the Wnt signaling pathways.	[Grandy, David; Shan, Jufang; Zhang, Xinxin; Zheng, Jie J.] St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA; [Zhang, Yanhui; Alpatov, Ivan; Zhang, Xin A.] Univ Tennessee, Hlth Sci Ctr, Dept Med, Memphis, TN 38163 USA; [Zheng, Jie J.] Univ Tennessee, Hlth Sci Ctr, Dept Mol Sci, Memphis, TN 38163 USA; [Shan, Jufang] Univ Tennessee, Hlth Sci Ctr, Interdisciplinary Grad Program, Memphis, TN 38163 USA; [Rao, Sujata; Akunuru, Shailaja; Lang, Richard A.] Childrens Hosp Res Fdn, Dept Ophthalmol, Cincinnati, OH 45229 USA; [Rao, Sujata; Akunuru, Shailaja; Lang, Richard A.] Childrens Hosp Res Fdn, Div Dev Biol, Cincinnati, OH 45229 USA; [Li, Hongyan; Shi, De-Li] Univ Paris 06, Dev Biol Lab, CNRS, UMR 7622, F-75005 Paris, France	St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite	Zheng, JJ (corresponding author), St Jude Childrens Res Hosp, Dept Biol Struct, 332 N Lauderdale St, Memphis, TN 38105 USA.	jie.zheng@stjude.org	Li, HY/G-3987-2010; zhang, xinxin/E-8629-2012; Shi, De-Li/AAG-1807-2021; Lang, Richard/E-5578-2011	Zhang, Yanhui/0000-0001-8277-8008; Zheng, Jie/0000-0001-6524-6800; Lang, Richard/0000-0002-5212-254X	National Institutes of Health [R01GM081492]; American Lebanese Syrian Associated Charities; Ligue National Contre le Cancer; Association pour la Recherche sur le Cancer; NATIONAL CANCER INSTITUTE [R25CA023944] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081492] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Lebanese Syrian Associated Charities(American Lebanese Syrian Associated Charities (ALSAC)); Ligue National Contre le Cancer(Ligue nationale contre le cancer); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01GM081492. This work was also supported, in whole or in part, by the American Lebanese Syrian Associated Charities and grants from the Ligue National Contre le Cancer and the Association pour la Recherche sur le Cancer.	Axelrod JD, 2001, GENE DEV, V15, P1182; Axelrod JD, 1998, GENE DEV, V12, P2610, DOI 10.1101/gad.12.16.2610; Barker N, 2006, NAT REV DRUG DISCOV, V5, P997, DOI 10.1038/nrd2154; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; BOHM HJ, 1992, J COMPUT AID MOL DES, V6, P61, DOI 10.1007/bf00124387; BOHM HJ, 1994, J COMPUT AID MOL DES, V8, P243, DOI 10.1007/BF00126743; Boutros M, 1998, CELL, V94, P109, DOI 10.1016/S0092-8674(00)81226-X; Brannon M, 1997, GENE DEV, V11, P2359, DOI 10.1101/gad.11.18.2359; Bui TD, 1997, BIOCHEM BIOPH RES CO, V239, P510, DOI 10.1006/bbrc.1997.7500; Cheyette BNR, 2002, DEV CELL, V2, P449, DOI 10.1016/S1534-5807(02)00140-5; Dann CE, 2001, NATURE, V412, P86, DOI 10.1038/35083601; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Eldridge MD, 1997, J COMPUT AID MOL DES, V11, P425, DOI 10.1023/A:1007996124545; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Giles RH, 2003, BBA-REV CANCER, V1653, P1, DOI 10.1016/S0304-419X(03)00005-2; GODDARD TD, 1998, SPARKY 3 0; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; KLEBE G, 1994, J COMPUT AID MOL DES, V8, P583, DOI 10.1007/BF00123667; Kramer B, 1999, PROTEINS, V37, P228, DOI 10.1002/(SICI)1097-0134(19991101)37:2<228::AID-PROT8>3.0.CO;2-8; KUNTZ ID, 1982, J MOL BIOL, V161, P269, DOI 10.1016/0022-2836(82)90153-X; Leach AR, 2006, J MED CHEM, V49, P5851, DOI 10.1021/jm060999m; Lee HJ, 2009, BIOORGAN MED CHEM, V17, P1701, DOI 10.1016/j.bmc.2008.12.060; Lobov IB, 2005, NATURE, V437, P417, DOI 10.1038/nature03928; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; London TBC, 2004, BIOCHEM BIOPH RES CO, V322, P326, DOI 10.1016/j.bbrc.2004.07.113; Mizutani K, 2005, TUMORI J, V91, P546, DOI 10.1177/030089160509100616; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Muegge I, 1999, J MED CHEM, V42, P791, DOI 10.1021/jm980536j; Nagahata T, 2003, CANCER SCI, V94, P515, DOI 10.1111/j.1349-7006.2003.tb01475.x; Rothbacher U, 2000, EMBO J, V19, P1010, DOI 10.1093/emboj/19.5.1010; Shan JF, 2005, BIOCHEMISTRY-US, V44, P15495, DOI 10.1021/bi0512602; Shan JF, 2009, J COMPUT AID MOL DES, V23, P37, DOI 10.1007/s10822-008-9236-1; Shimizu H, 1997, CELL GROWTH DIFFER, V8, P1349; Shoichet BK, 2004, NATURE, V432, P862, DOI 10.1038/nature03197; Uematsu K, 2003, ONCOGENE, V22, P7218, DOI 10.1038/sj.onc.1206817; Uematsu K, 2003, CANCER RES, V63, P4547; Umbhauer M, 2000, EMBO J, V19, P4944, DOI 10.1093/emboj/19.18.4944; Wallingford JB, 2005, DEVELOPMENT, V132, P4421, DOI 10.1242/dev.02068; Wissmann C, 2003, J PATHOL, V201, P204, DOI 10.1002/path.1449; Wong HC, 2003, MOL CELL, V12, P1251, DOI 10.1016/S1097-2765(03)00427-1; Wong HC, 2000, NAT STRUCT BIOL, V7, P1178; Wuthrich K, 2000, NAT STRUCT BIOL, V7, P188, DOI 10.1038/73278; Xu Q, 2004, CELL, V116, P883, DOI 10.1016/S0092-8674(04)00216-8; Zhang XA, 2001, MOL BIOL CELL, V12, P351, DOI 10.1091/mbc.12.2.351; Zi XL, 2005, CANCER RES, V65, P9762, DOI 10.1158/0008-5472.CAN-05-0103	45	151	155	0	19	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16256	16263		10.1074/jbc.M109.009647	http://dx.doi.org/10.1074/jbc.M109.009647			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19383605	Green Published, hybrid			2022-12-27	WOS:000266730900023
J	Hoosdally, SJ; Andress, EJ; Wooding, C; Martin, CA; Linton, KJ				Hoosdally, Sarah J.; Andress, Edward J.; Wooding, Carol; Martin, Catherine A.; Linton, Kenneth J.			The Human Scavenger Receptor CD36 GLYCOSYLATION STATUS AND ITS ROLE IN TRAFFICKING AND FUNCTION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							N-LINKED OLIGOSACCHARIDES; MEMBRANE-PROTEIN; FATTY-ACIDS; SR-BI; GLYCOPROTEIN; EXPRESSION; BINDING; IDENTIFICATION; CLONING; DIFFERENTIATION	Human CD36 is a class B scavenger receptor expressed in a variety of cell types such as macrophage and adipocytes. This plasma membrane glycoprotein has a wide range of ligands including oxidized low density lipoprotein and long chain fatty acids which involves the receptor in diseases such as atherosclerosis and insulin resistance. CD36 is heavily modified post-translationally by N-linked glycosylation, and 10 putative glycosylation sites situated in the large extracellular loop of the protein have been identified; however, their utilization and role in the folding and function of the protein have not been characterized. Using mass spectrometry on purified and peptide N-glycosidase F-deglycosylated CD36 and also by comparing the electrophoretic mobility of different glycosylation site mutants, we have determined that 9 of the 10 sites can be modified by glycosylation. Flow cytometric analysis of the different glycosylation mutants expressed in mammalian cells established that glycosylation is necessary for trafficking to the plasma membrane. Minimally glycosylated mutants that supported trafficking were identified and indicated the importance of carboxyl-terminal sites Asn-247, Asn-321, and Asn-417. However, unlike SRBI, no individual site was found to be essential for proper trafficking of CD36. Surprisingly, these minimally glycosylated mutants appear to be predominantly core-glycosylated, indicating that mature glycosylation is not necessary for surface expression in mammalian cells. The data also show that neither the nature nor the pattern of glycosylation is relevant to binding of modified low density lipoprotein.	[Linton, Kenneth J.] Queen Mary Univ London, Barts & London Sch Med & Dent, Inst Cell & Mol Sci, London E1 2AT, England; [Hoosdally, Sarah J.; Andress, Edward J.; Wooding, Carol; Martin, Catherine A.; Linton, Kenneth J.] Univ London Imperial Coll Sci Technol & Med, MRC, Ctr Clin Sci, London W12 0NN, England	University of London; Queen Mary University London; Imperial College London	Linton, KJ (corresponding author), Queen Mary Univ London, Barts & London Sch Med & Dent, Inst Cell & Mol Sci, 4 Newark St, London E1 2AT, England.	kenneth.linton@ic.ac.uk		Martin, Catherine/0000-0001-7088-3441	Medical Research Council UK; British Heart Foundation [PG/03/044/15328]; Medical Research Council [MC_U120088463] Funding Source: researchfish; MRC [MC_U120088463] Funding Source: UKRI	Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council UK and also by British Heart Foundation Project Grant PG/03/044/15328 ( to C. A. M. and K. J. L.).	ABUMRAD NA, 1993, J BIOL CHEM, V268, P17665; ACTON SL, 1994, J BIOL CHEM, V269, P21003; Aitman TJ, 1999, NAT GENET, V21, P76, DOI 10.1038/5013; ALESSIO M, 1991, CELL IMMUNOL, V137, P487, DOI 10.1016/0008-8749(91)90096-T; ASCH AS, 1993, SCIENCE, V262, P1436, DOI 10.1126/science.7504322; Berglund L, 1996, BBA-GENE STRUCT EXPR, V1309, P63, DOI 10.1016/S0167-4781(96)00143-1; CALVO D, 1993, J BIOL CHEM, V268, P18929; Dixon PH, 2000, HUM MOL GENET, V9, P1209, DOI 10.1093/hmg/9.8.1209; ENDEMANN G, 1993, J BIOL CHEM, V268, P11811; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; Franc NC, 1996, IMMUNITY, V4, P431, DOI 10.1016/S1074-7613(00)80410-0; Freeze HH, 2006, NAT REV GENET, V7, P537, DOI 10.1038/nrg1894; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; GREENWALT DE, 1990, BIOCHEMISTRY-US, V29, P7054, DOI 10.1021/bi00482a015; GREENWALT DE, 1992, BLOOD, V80, P1105; Gruarin P, 2000, BIOCHEM BIOPH RES CO, V275, P446, DOI 10.1006/bbrc.2000.3333; HARMON CM, 1993, J MEMBRANE BIOL, V133, P43; HART K, 1993, J MOL BIOL, V234, P249, DOI 10.1006/jmbi.1993.1580; Hebert DN, 1997, J CELL BIOL, V139, P613, DOI 10.1083/jcb.139.3.613; HELENIUS A, 1994, MOL BIOL CELL, V5, P253, DOI 10.1091/mbc.5.3.253; HSIEH P, 1984, J BIOL CHEM, V259, P2375; Hwang EH, 1998, J NUCL MED, V39, P1681; Jarvis DL, 2003, VIROLOGY, V310, P1, DOI 10.1016/S0042-6822(03)00120-X; Klinkenberg LG, 2006, EUKARYOT CELL, V5, P1007, DOI 10.1128/EC.00045-06; Koonen DPY, 2007, CIRCULATION, V116, P2139, DOI 10.1161/CIRCULATIONAHA.107.712901; Kulkarni KA, 2004, PROTEINS, V56, P821, DOI 10.1002/prot.20168; Love-Gregory L, 2008, HUM MOL GENET, V17, P1695, DOI 10.1093/hmg/ddn060; Ma XW, 2004, HUM MOL GENET, V13, P2197, DOI 10.1093/hmg/ddh233; Martin CA, 2007, PROTEIN SCI, V16, P2531, DOI 10.1110/ps.073007207; Mitra N, 2006, TRENDS BIOCHEM SCI, V31, P156, DOI 10.1016/j.tibs.2006.01.003; Nufer O, 2002, J CELL SCI, V115, P619; OConnor SE, 1996, CHEM BIOL, V3, P803, DOI 10.1016/S1074-5521(96)90064-2; OQUENDO P, 1989, CELL, V58, P95, DOI 10.1016/0092-8674(89)90406-6; PEARCE SFA, 1994, BLOOD, V84, P384; Peterman Scott M, 2005, J Biomol Tech, V16, P112; Rasmussen JT, 1998, EUR J BIOCHEM, V257, P488, DOI 10.1046/j.1432-1327.1998.2570488.x; Rutella S, 1997, EUR J HISTOCHEM, V41, P53; SCHINKEL AH, 1993, J BIOL CHEM, V268, P7474; Serghides L, 2003, TRENDS PARASITOL, V19, P461, DOI 10.1016/j.pt.2003.08.006; TANDON NN, 1989, J BIOL CHEM, V264, P7576; Tao NB, 1996, J BIOL CHEM, V271, P22315, DOI 10.1074/jbc.271.37.22315; Trombetta ES, 1998, CURR OPIN STRUC BIOL, V8, P587, DOI 10.1016/S0959-440X(98)80148-6; VEGA MA, 1991, J BIOL CHEM, V266, P16818; Vinals M, 2003, J BIOL CHEM, V278, P5325, DOI 10.1074/jbc.M211073200; Yamashita S, 2007, MOL CELL BIOCHEM, V299, P19, DOI 10.1007/s11010-005-9031-4; Zhou FF, 2005, MOL PHARMACOL, V67, P868, DOI 10.1124/mol.104.007583	46	76	79	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16277	16288		10.1074/jbc.M109.007849	http://dx.doi.org/10.1074/jbc.M109.007849			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19369259	Green Published, hybrid			2022-12-27	WOS:000266730900025
J	Ding, HL; Ryder, JW; Stull, JT; Kamm, KE				Ding, Hai-Lei; Ryder, Jeffrey W.; Stull, James T.; Kamm, Kristine E.			Signaling Processes for Initiating Smooth Muscle Contraction upon Neural Stimulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYOSIN LIGHT-CHAIN; URINARY-BLADDER; PROTEIN-KINASE; CA2+ SENSITIVITY; RHO-KINASE; PHOSPHORYLATION; ACTIVATION; PAXILLIN; PHOSPHATASE; CALMODULIN	Relationships among biochemical signaling processes involved in Ca2+/calmodulin (CaM)-dependent phosphorylation of smooth muscle myosin regulatory light chain (RLC) by myosin light chain kinase (MLCK) were determined. A genetically-encoded biosensor MLCK for measuring Ca2+-dependent CaM binding and activation was expressed in smooth muscles of transgenic mice. We performed real-time evaluations of the relationships among [Ca2+](i), MLCK activation, and contraction in urinary bladder smooth muscle strips neurally stimulated for 3 s. Latencies for the onset of [Ca2+](i) and kinase activation were 55 +/- 8 and 65 +/- 6 ms, respectively. Both increased with RLC phosphorylation at 100 ms, whereas force latency was 109 +/- 3 ms. [Ca2+](i), kinase activation, and RLC phosphorylation responses were maximal by 1.2 s, whereas force increased more slowly to a maximal value at 3 s. A delayed temporal response between RLC phosphorylation and force is probably due to mechanical effects associated with elastic elements in the tissue. MLCK activation partially declined at 3 s of stimulation with no change in [Ca2+](i) and also declined more rapidly than [Ca2+](i) during relaxation. The apparent desensitization of MLCK to Ca2+ activation appears to be due to phosphorylation in its calmodulin binding segment. Phosphorylation of two myosin light chain phosphatase regulatory proteins (MYPT1 and CPI-17) or a protein implicated in strengthening membrane adhesion complexes for force transmission (paxillin) did not change during force development. Thus, neural stimulation leads to rapid increases in [Ca2+](i), MLCK activation, and RLC phosphorylation in phasic smooth muscle, showing a tightly coupled Ca2+ signaling complex as an elementary mechanism initiating contraction.	[Ding, Hai-Lei; Ryder, Jeffrey W.; Stull, James T.; Kamm, Kristine E.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas	Kamm, KE (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA.	kristine.kamm@utsouthwestern.edu			National Institutes of Health [HL26043]; Moss Heart Fund; Fouad A. and Val Imm Bashour Distinguished Chair in Physiology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL026043, R37HL026043] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Moss Heart Fund; Fouad A. and Val Imm Bashour Distinguished Chair in Physiology; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL26043. This work was also supported by the Moss Heart Fund and the Fouad A. and Val Imm Bashour Distinguished Chair in Physiology ( to J. T. S.).	Agbulut O, 2007, J BIOL CHEM, V282, P10465, DOI 10.1074/jbc.M610418200; AKSOY MO, 1983, AM J PHYSIOL, V245, pC255, DOI 10.1152/ajpcell.1983.245.3.C255; BOWMAN BF, 1992, J BIOL CHEM, V267, P5346; Chen Q, 2005, J UROLOGY, V174, P370, DOI 10.1097/01.ju.0000161210.17365.cc; Deng JT, 2001, J BIOL CHEM, V276, P16365, DOI 10.1074/jbc.M011634200; Ekman M, 2006, EUR J PHARMACOL, V532, P99, DOI 10.1016/j.ejphar.2005.11.010; Geguchadze R, 2004, FEBS LETT, V557, P121, DOI 10.1016/S0014-5793(03)01456-X; Gomez-Pinilla PJ, 2008, J PINEAL RES, V44, P416, DOI 10.1111/j.1600-079X.2007.00544.x; Gunst SJ, 2003, RESP PHYSIOL NEUROBI, V137, P151, DOI 10.1016/S1569-9048(03)00144-7; Gunst SJ, 2008, AM J PHYSIOL-CELL PH, V295, pC576, DOI 10.1152/ajpcell.00253.2008; He WQ, 2008, GASTROENTEROLOGY, V135, P610, DOI 10.1053/j.gastro.2008.05.032; Heppner TJ, 2005, J PHYSIOL-LONDON, V564, P201, DOI 10.1113/jphysiol.2004.077826; Hirano K, 2003, MOL CELL BIOCHEM, V248, P105, DOI 10.1023/A:1024180101032; Horman S, 2008, J BIOL CHEM, V283, P18505, DOI 10.1074/jbc.M802053200; Ihara E, 2007, AM J PHYSIOL-GASTR L, V293, pG699, DOI 10.1152/ajpgi.00214.2007; Ihara E, 2007, CAN J PHYSIOL PHARM, V85, P79, DOI 10.1139/Y06-103; Isotani E, 2004, P NATL ACAD SCI USA, V101, P6279, DOI 10.1073/pnas.0308742101; Ito M, 2004, MOL CELL BIOCHEM, V259, P197, DOI 10.1023/B:MCBI.0000021373.14288.00; Ji GJ, 2004, J BIOL CHEM, V279, P21461, DOI 10.1074/jbc.M401084200; JOHNSON JD, 1981, J BIOL CHEM, V256, P2194; KAMM KE, 1985, AM J PHYSIOL, V249, pC238, DOI 10.1152/ajpcell.1985.249.3.C238; KAMM KE, 1989, J BIOL CHEM, V264, P21223; KAMM KE, 1985, ANNU REV PHARMACOL, V25, P593, DOI 10.1146/annurev.pharmtox.25.1.593; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; KENNEY RE, 1990, J BIOL CHEM, V265, P8642; Kitazawa T, 2000, J BIOL CHEM, V275, P9897, DOI 10.1074/jbc.275.14.9897; Mehta D, 1998, AM J PHYSIOL-CELL PH, V274, pC741, DOI 10.1152/ajpcell.1998.274.3.C741; Meng E, 2008, NEUROUROL URODYNAM, V27, P79, DOI 10.1002/nau.20456; Mizuno Y, 2008, AM J PHYSIOL-CELL PH, V295, pC358, DOI 10.1152/ajpcell.90645.2007; Murthy KS, 2006, ANNU REV PHYSIOL, V68, P345, DOI 10.1146/annurev.physiol.68.040504.094707; Pandita RK, 2000, J UROLOGY, V164, P1385, DOI 10.1016/S0022-5347(05)67204-7; PERSECHINI A, 1986, J BIOL CHEM, V261, P6293; Rembold CM, 2007, AM J PHYSIOL-CELL PH, V293, pC993, DOI 10.1152/ajpcell.00090.2007; Ryder JW, 2007, J BIOL CHEM, V282, P20447, DOI 10.1074/jbc.M702927200; Saez AO, 2004, AM J PHYSIOL-CELL PH, V286, pC433, DOI 10.1152/ajpcell.00030.2003; Silinsky EM, 1996, J PHYSIOL-LONDON, V492, P815, DOI 10.1113/jphysiol.1996.sp021348; Somlyo AP, 2000, J PHYSIOL-LONDON, V522, P177, DOI 10.1111/j.1469-7793.2000.t01-2-00177.x; Somlyo AP, 2003, PHYSIOL REV, V83, P1325, DOI 10.1152/physrev.00023.2003; STULL JT, 1990, J BIOL CHEM, V265, P16683; STULL JT, 1993, MOL CELL BIOCHEM, V128, P229, DOI 10.1007/BF01076774; STULL JT, 1986, ENZYMES, P113; TANSEY MG, 1992, J BIOL CHEM, V267, P12511; TANSEY MG, 1994, J BIOL CHEM, V269, P9912; THOMPSON CI, 1980, AM J PHYSIOL, V238, pH389, DOI 10.1152/ajpheart.1980.238.3.H389; TOROK K, 1994, BIOCHEMISTRY-US, V33, P12807, DOI 10.1021/bi00209a012; Turner CE, 2000, NAT CELL BIOL, V2, pE231, DOI 10.1038/35046659; Wang ZL, 1996, AM J PHYSIOL-CELL PH, V271, pC1594, DOI 10.1152/ajpcell.1996.271.5.C1594; Wegener JW, 2004, FASEB J, V18, P1159, DOI 10.1096/fj.04-1516fje; Werner ME, 2007, AM J PHYSIOL-REG I, V292, pR616, DOI 10.1152/ajpregu.00036.2006; Wibberley A, 2003, BRIT J PHARMACOL, V138, P757, DOI 10.1038/sj.bjp.0705109; ZIMMERMANN B, 1995, J BIOL CHEM, V270, P23966, DOI 10.1074/jbc.270.41.23966	51	50	50	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15541	15548		10.1074/jbc.M900888200	http://dx.doi.org/10.1074/jbc.M900888200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19349274	Green Published, hybrid			2022-12-27	WOS:000266501000022
J	Hatanaka, H; Omura, F; Kodama, Y; Ashikari, T				Hatanaka, Haruyo; Omura, Fumihiko; Kodama, Yukiko; Ashikari, Toshihiko			Gly-46 and His-50 of Yeast Maltose Transporter Mal21p Are Essential for Its Resistance against Glucose-induced Degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMINO-ACID PERMEASE; TERMINAL CYTOPLASMIC DOMAIN; UBIQUITIN-PROTEIN LIGASE; PLASMA-MEMBRANE PROTEINS; PEST-LIKE SEQUENCE; SACCHAROMYCES-CEREVISIAE; CATABOLITE INACTIVATION; INDUCED PROTEOLYSIS; ENDOCYTIC PATHWAY; INTERNALIZATION	The maltose transporter gene is situated at the MAL locus, which consists of genes for a transporter, maltase, and transcriptional activator. Five unlinked MAL loci (MAL1, MAL2, MAL3, MAL4, and MAL6) constitute a gene family in Saccharomyces cerevisiae. The expression of the maltose transporter is induced by maltose and repressed by glucose. The activity of the maltose transporter is also regulated post-translationally; Mal61p is rapidly internalized from the plasma membrane and degraded by ubiquitin-mediated proteolysis in the presence of glucose. We found that S. cerevisiae strain ATCC20598 harboring MAL21 could grow in maltose supplemented with a non-assimilable glucose analogue, 2-deoxyglucose, whereas strain ATCC96955 harboring MAL61 and strain CB11 with MAL31 and AGT1 could not. These observations implied a Mal21p-specific resistance against glucose-induced degradation. Mal21p found in ATCC20598 has 10 amino acids, including Gly-46 and His-50, that are inconsistent with the corresponding residues in Mal61p. The half-life of Mal21p for glucose-induced degradation was 118 min when expressed using the constitutive TPI1 promoter, which was significantly longer than that of Mal61p (25 min). Studies with mutant cells that are defective in endocytosis or the ubiquitination process indicated that Mal21p was less ubiquitinated than Mal61p, suggesting that Mal21p remains on the plasma membrane because of poor susceptibility to ubiquitination. Mutational studies revealed that both residues Gly-46 and His-50 in Mal21p are essential for the full resistance of maltose transporters against glucose-induced degradation.	[Hatanaka, Haruyo; Omura, Fumihiko; Kodama, Yukiko] Suntory Res Ctr, Osaka 6188503, Japan	Suntory Holdings Ltd	Hatanaka, H (corresponding author), 1-1-1 Wakayamadai, Shimamoto, Osaka 6188503, Japan.	Haruyo_Hatanaka@suntory.co.jp						Brondijk THC, 1998, J BIOL CHEM, V273, P15352, DOI 10.1074/jbc.273.25.15352; Brondijk THC, 2001, ARCH MICROBIOL, V176, P96; CHENG Q, 1989, GENETICS, V123, P477; CLAIBORNE VC, 1998, PROG NUCL ACID RES M, V59, P95; Day RE, 2002, YEAST, V19, P1015, DOI 10.1002/yea.894; DEGRYSE E, 1995, YEAST, V11, P629, DOI 10.1002/yea.320110704; Dupre S, 2001, MOL CELL BIOL, V21, P4482, DOI 10.1128/MCB.21.14.4482-4494.2001; ENTIAN KD, 1990, J GEN MICROBIOL, V136, P855, DOI 10.1099/00221287-136-5-855; Gadura N, 2006, GENETICS, V172, P1427, DOI 10.1534/genetics.105.051698; Gadura N, 2006, CURR GENET, V50, P101, DOI 10.1007/s00294-006-0080-3; HAN EK, 1995, MOL MICROBIOL, V17, P1093, DOI 10.1111/j.1365-2958.1995.mmi_17061093.x; HEIN C, 1995, MOL MICROBIOL, V18, P77, DOI 10.1111/j.1365-2958.1995.mmi_18010077.x; Hein C, 1997, MOL MICROBIOL, V24, P607, DOI 10.1046/j.1365-2958.1997.3771735.x; Hicke L, 1997, FASEB J, V11, P1215, DOI 10.1096/fasebj.11.14.9409540; Hicke L, 1998, J CELL BIOL, V141, P349, DOI 10.1083/jcb.141.2.349; HU Z, 1995, CURR GENET, V28, P258, DOI 10.1007/BF00309785; Hu Z, 1999, CURR GENET, V36, P1, DOI 10.1007/s002940050466; Jespersen L, 1999, APPL ENVIRON MICROB, V65, P450; Kodama Y, 2001, APPL ENVIRON MICROB, V67, P3455, DOI 10.1128/AEM.67.8.3455-3462.2001; LEVINE J, 1992, CURR GENET, V22, P181, DOI 10.1007/BF00351724; Lucero P, 1997, FEMS MICROBIOL LETT, V147, P273, DOI 10.1016/S0378-1097(96)00538-1; Madrid R, 2001, EMBO J, V20, P7008, DOI 10.1093/emboj/20.24.7008; Maeta K, 2005, FEMS MICROBIOL LETT, V243, P87, DOI 10.1016/j.femsle.2004.11.046; Maeta K, 2005, J BIOL CHEM, V280, P253, DOI 10.1074/jbc.M408061200; Marchal C, 1998, MOL CELL BIOL, V18, P314, DOI 10.1128/MCB.18.1.314; Medintz I, 2000, BIOCHEMISTRY-US, V39, P4518, DOI 10.1021/bi992455a; Medintz I, 1998, J BIOL CHEM, V273, P34454, DOI 10.1074/jbc.273.51.34454; Medintz I, 1996, J BACTERIOL, V178, P2245, DOI 10.1128/jb.178.8.2245-2254.1996; MORTIMER RK, 1986, GENETICS, V113, P35; NAUMOV GI, 1994, GENETICS, V136, P803; NI B, 1990, MOL CELL BIOL, V10, P3797, DOI 10.1128/MCB.10.7.3797; NISHIKAWA K, 1983, BIOCHIM BIOPHYS ACTA, V748, P285, DOI 10.1016/0167-4838(83)90306-0; Omura F, 2001, FEMS MICROBIOL LETT, V194, P207, DOI 10.1016/S0378-1097(00)00532-2; Omura F, 2001, BIOCHEM BIOPH RES CO, V287, P1045, DOI 10.1006/bbrc.2001.5697; POSTMA E, 1990, YEAST, V6, P149, DOI 10.1002/yea.320060209; Ramasamy R, 2006, CELL, V124, P258, DOI 10.1016/j.cell.2006.01.002; RATHS S, 1993, J CELL BIOL, V120, P55, DOI 10.1083/jcb.120.1.55; Rekha Nambudiry, 2003, BMC Struct Biol, V3, P4, DOI 10.1186/1472-6807-3-4; RIBALLO E, 1995, J BACTERIOL, V177, P5622, DOI 10.1128/jb.177.19.5622-5627.1995; ROSE MD, 1987, GENE, V60, P237, DOI 10.1016/0378-1119(87)90232-0; ROSE MD, 1990, METHODS YEAST GENETI, P179; Stolk M, 2005, BIOCHEM J, V386, P281, DOI 10.1042/BJ20041571; Vidgren V, 2005, APPL ENVIRON MICROB, V71, P7846, DOI 10.1128/AEM.71.12.7846-7857.2005; Wang GL, 2001, MOL CELL BIOL, V21, P3564, DOI 10.1128/MCB.21.10.3564-3575.2001; Wang JF, 1997, J BIOL CHEM, V272, P4613, DOI 10.1074/jbc.272.7.4613; Wesp A, 1997, MOL BIOL CELL, V8, P2291, DOI 10.1091/mbc.8.11.2291; YAO B, 1994, MOL GEN GENET, V243, P622, DOI 10.1007/BF00279571	47	11	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15448	15457		10.1074/jbc.M808151200	http://dx.doi.org/10.1074/jbc.M808151200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19359240	hybrid, Green Published			2022-12-27	WOS:000266501000013
J	Liu, ZM; Adams, HC; Whitehead, IP				Liu, Zhuoming; Adams, Homer C., III; Whitehead, Ian P.			The Rho-specific Guanine Nucleotide Exchange Factor Dbs Regulates Breast Cancer Cell Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; MEDIATED TYROSINE PHOSPHORYLATION; BINDING PROTEIN; SIGNALING COMPLEX; UP-REGULATION; V-CRK; SRC; GROWTH; DOMAIN; ACTIVATION	Dbs is a Rho-specific guanine nucleotide exchange factor (RhoGEF) that regulates neurotrophin-3-induced cell migration in Schwann cells. Here we report that Dbs regulates cell motility in tumor-derived, human breast epithelial cells through activation of Cdc42 and Rac1. Cdc42 and Rac1 are activated in T47D cells that stably express onco- or proto-Dbs, and activation is dependent upon growth of the cells on collagen I. Transient suppression of expression of Cdc42 or Rac1 by small interfering RNAs attenuates Dbs-enhanced motility. Both onco- and proto-Dbs-enhanced motility correlates with an increase in tyrosine phosphorylation of focal adhesion kinase on Tyr-397 and p130(Cas) on Tyr-410 and an increase in the abundance of the Crk.p130(Cas) complex. Suppression of expression of Cdc42 or its effector, Ack1, reduces tyrosine phosphorylation of focal adhesion kinase and p130(Cas) and disrupts the Crk.p130(Cas) complex. We further determined that suppression of expression of Cdc42, Ack1, p130(Cas), or Crk reduces Rac1 activation and cell motility in Dbs-expressing cells to a level comparable with that in vector cells. Therefore, a cascade of activation of Cdc42 and Rac1 by Dbs through the Cdc42 effector Ack1 and the Crk.p130(Cas) complex is established. Suppression of the expression of endogenous Dbs reduces cell motility in both T47D cells and MDA-MB-231 cells, which correlates with the down-regulation of Cdc42 activity. This suggests that Dbs activates Cdc42 in these two human breast cancer cell lines and that the normal function of Dbs may be required to support cell movement.	Univ Med & Dent New Jersey, Dept Microbiol & Mol Genet, Newark, NJ 07101 USA; Univ Med & Dent New Jersey, Univ Hosp Canc Ctr, New Jersey Med Sch, Newark, NJ 07101 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Whitehead, IP (corresponding author), Canc Ctr H Level, 205 S Orange Ave, Newark, NJ 07101 USA.	whiteip@umdnj.edu	Liu, Zhuoming/I-6950-2013	Liu, Zhuoming/0000-0002-8466-3199	National Institutes of Health (NCI, to the United States Public Health Service) [CA97066]; American Cancer Society Research Scholar [RGS-04-199-01]; NATIONAL CANCER INSTITUTE [R01CA097066] Funding Source: NIH RePORTER	National Institutes of Health (NCI, to the United States Public Health Service)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Cancer Society Research Scholar(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA97066 (NCI, to the United States Public Health Service). This work was also supported by American Cancer Society Research Scholar Grant RGS-04-199-01 (to I. P. W.).	Alowami S, 2003, BREAST CANCER RES, V5, pR129, DOI 10.1186/bcr622; BIRGE RB, 1993, MOL CELL BIOL, V13, P4648, DOI 10.1128/MCB.13.8.4648; Brown JL, 1997, GENE DEV, V11, P2972, DOI 10.1101/gad.11.22.2972; Cheng L, 2004, J BIOL CHEM, V279, P12786, DOI 10.1074/jbc.M313099200; Chodniewicz D, 2004, BBA-MOL CELL RES, V1692, P63, DOI 10.1016/j.bbamcr.2004.03.006; CHUANG TH, 1995, P NATL ACAD SCI USA, V92, P10282, DOI 10.1073/pnas.92.22.10282; GOTOH T, 1995, MOL CELL BIOL, V15, P6746; Hamasaki K, 1996, BIOCHEM BIOPH RES CO, V222, P338, DOI 10.1006/bbrc.1996.0745; Hasegawa H, 1996, MOL CELL BIOL, V16, P1770; HORII Y, 1994, EMBO J, V13, P4776, DOI 10.1002/j.1460-2075.1994.tb06803.x; Keely PJ, 1997, NATURE, V390, P632, DOI 10.1038/37656; KEELY PJ, 1995, J CELL SCI, V108, P595; Keely PJ, 2001, METHODS ENZYMOL, V333, P256; KEYDAR I, 1979, EUR J CANCER, V15, P659, DOI 10.1016/0014-2964(79)90139-7; Kiyokawa E, 1998, GENE DEV, V12, P3331, DOI 10.1101/gad.12.21.3331; Klemke RL, 1998, J CELL BIOL, V140, P961, DOI 10.1083/jcb.140.4.961; KMIECIK TE, 1987, CELL, V49, P65, DOI 10.1016/0092-8674(87)90756-2; KNUDSEN BS, 1994, J BIOL CHEM, V269, P32781; Kostenko EV, 2005, J BIOL CHEM, V280, P2807, DOI 10.1074/jbc.M411139200; KOZMA R, 1995, MOL CELL BIOL, V15, P1942; Liu ZM, 2006, J BIOL CHEM, V281, P16043, DOI 10.1074/jbc.M601823200; MANSER E, 1993, NATURE, V363, P364, DOI 10.1038/363364a0; MATSUDA M, 1992, MOL CELL BIOL, V12, P3482, DOI 10.1128/MCB.12.8.3482; McSherry EA, 2007, CELL MOL LIFE SCI, V64, P3201, DOI 10.1007/s00018-007-7388-0; Minard ME, 2005, ONCOGENE, V24, P2568, DOI 10.1038/sj.onc.1208503; Modzelewska K, 2006, J BIOL CHEM, V281, P37527, DOI 10.1074/jbc.M604342200; Nakamoto T, 1996, J BIOL CHEM, V271, P8959, DOI 10.1074/jbc.271.15.8959; Nobes CD, 2000, METHOD ENZYMOL, V325, P441; NOBES CD, 1995, BIOCHEM SOC T, V23, P456, DOI 10.1042/bst0230456; Olabisi OO, 2006, CANCER RES, V66, P6250, DOI 10.1158/0008-5472.CAN-06-0536; RIDLEY AJ, 1992, CELL, V70, P401, DOI 10.1016/0092-8674(92)90164-8; RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; ROSEN MK, 1995, NATURE, V374, P477, DOI 10.1038/374477a0; Rossman KL, 2005, NAT REV MOL CELL BIO, V6, P167, DOI 10.1038/nrm1587; ROWLEY JD, 1973, NATURE, V243, P290, DOI 10.1038/243290a0; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; SAKAI R, 1994, EMBO J, V13, P3748, DOI 10.1002/j.1460-2075.1994.tb06684.x; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Schlaepfer DD, 1997, MOL CELL BIOL, V17, P1702, DOI 10.1128/MCB.17.3.1702; Shen F, 2007, MOL BIOL CELL, V18, P732, DOI 10.1091/mbc.E06-02-0142; Shin NY, 2004, J BIOL CHEM, V279, P38331, DOI 10.1074/jbc.M404675200; Shintani Y, 2008, J CELL BIOL, V180, P1277, DOI 10.1083/jcb.200708137; Shintani Y, 2008, AM J RESP CELL MOL, V38, P95, DOI 10.1165/rcmb.2007-0071OC; Shintani Y, 2006, MOL BIOL CELL, V17, P2963, DOI 10.1091/mbc.E05-12-1123; Shintani Y, 2006, CANCER RES, V66, P11745, DOI 10.1158/0008-5472.CAN-06-2322; Tachibana K, 1997, J BIOL CHEM, V272, P29083, DOI 10.1074/jbc.272.46.29083; TANAKA S, 1994, P NATL ACAD SCI USA, V91, P3443, DOI 10.1073/pnas.91.8.3443; Tolnai S., 1975, TCA MANUAL, V1, P37, DOI DOI 10.1007/BF00914435; Ueki K, 1998, FEBS LETT, V432, P197, DOI 10.1016/S0014-5793(98)00862-X; van der Horst EH, 2005, P NATL ACAD SCI USA, V102, P15901, DOI 10.1073/pnas.0508014102; Vuori K, 1996, MOL CELL BIOL, V16, P2606; WHITEHEAD I, 1995, ONCOGENE, V10, P713; Whitehead IP, 1997, BBA-REV CANCER, V1332, pF1, DOI 10.1016/S0304-419X(96)00040-6; Whitehead LP, 1999, MOL CELL BIOL, V19, P7759; Worthylake RA, 2001, J CELL BIOL, V154, P147, DOI 10.1083/jcb.200103048; Worthylake RA, 2003, J BIOL CHEM, V278, P13578, DOI 10.1074/jbc.M211584200; Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007; Yamauchi J, 2005, P NATL ACAD SCI USA, V102, P14889, DOI 10.1073/pnas.0507125102; Yamauchi J, 2005, P NATL ACAD SCI USA, V102, P5198, DOI 10.1073/pnas.0501160102; Yang WN, 1997, J BIOL CHEM, V272, P24819, DOI 10.1074/jbc.272.40.24819; Zeisberg M, 2001, AM J PATHOL, V159, P1313, DOI 10.1016/S0002-9440(10)62518-7	62	32	33	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15771	15780		10.1074/jbc.M901853200	http://dx.doi.org/10.1074/jbc.M901853200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19366686	Green Published, hybrid			2022-12-27	WOS:000266501000046
J	Vakonakis, I; Staunton, D; Ellis, IR; Sarkies, P; Flanagan, A; Schor, AM; Schor, SL; Campbell, ID				Vakonakis, Ioannis; Staunton, David; Ellis, Ian R.; Sarkies, Peter; Flanagan, Aleksandra; Schor, Ana M.; Schor, Seth L.; Campbell, Iain D.			Motogenic Sites in Human Fibronectin Are Masked by Long Range Interactions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MIGRATION-STIMULATING FACTOR; HUMAN-PLASMA FIBRONECTIN; GELATIN-BINDING DOMAIN; CRYSTAL-STRUCTURES; FRAGMENT; CONFORMATION; MODULES; SUPERFIBRONECTIN; TRANSGLUTAMINASE; IDENTIFICATION	Fibronectin (FN) is a large extracellular matrix glycoprotein important for development and wound healing in vertebrates. Recent work has focused on the ability of FN fragments and embryonic or tumorigenic splicing variants to stimulate fibroblast migration into collagen gels. This activity has been localized to specific sites and is not exhibited by full-length FN. Here we show that an N-terminal FN fragment, spanning the migration stimulation sites and including the first three type III FN domains, also lacks this activity. A screen for interdomain interactions by solution-state NMR spectroscopy revealed specific contacts between the Fn N terminus and two of the type III domains. A single amino acid substitution, R222A, disrupts the strongest interaction, between domains (4-5)FnI and (3)FnIII, and restores motogenic activity to the FN N-terminal fragment. Anastellin, which promotes fibril formation, destabilizes 3FnIII and disrupts the observed (4-5)FnI-(3)FnIII interaction. We discuss these findings in the context of the control of cellular activity through exposure of masked sites.	[Vakonakis, Ioannis; Staunton, David; Sarkies, Peter; Flanagan, Aleksandra; Campbell, Iain D.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Ellis, Ian R.; Schor, Ana M.; Schor, Seth L.] Univ Dundee, Unit Cell & Mol Biol, Dundee DD1 4HR, Scotland	University of Oxford; University of Dundee	Vakonakis, I (corresponding author), Univ Oxford, Dept Biochem, S Parks Rd, Oxford OX1 3QU, England.	ioannis.vakonakis@bioch.ox.ac.uk	Ellis, Ian/AAM-9833-2021	Sarkies, Peter/0000-0003-0279-6199; Ellis, Ian/0000-0001-8035-6012	Marie Curie Fellowships program; Royal Society; Trinity College, Oxford, UK	Marie Curie Fellowships program(European Commission); Royal Society(Royal Society of London); Trinity College, Oxford, UK	Recipient of support from the Marie Curie Fellowships program, the Royal Society, and Trinity College, Oxford, UK.	Akimov SS, 2001, J CELL SCI, V114, P2989; ALEXANDER SS, 1979, J BIOL CHEM, V254, P1501; Altroff H, 2004, J BIOL CHEM, V279, P55995, DOI 10.1074/jbc.M406976200; Aricescu AR, 2006, ACTA CRYSTALLOGR D, V62, P1243, DOI 10.1107/S0907444906029799; Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688; Bingham RJ, 2008, P NATL ACAD SCI USA, V105, P12254, DOI 10.1073/pnas.0803556105; Briknarova K, 2003, J MOL BIOL, V332, P205, DOI 10.1016/S0022-2836(03)00890-8; Copie V, 1998, J MOL BIOL, V277, P663; Erat MC, 2009, P NATL ACAD SCI USA, V106, P4195, DOI 10.1073/pnas.0812516106; HOCKING DC, 1994, J BIOL CHEM, V269, P19183; Houard X, 2005, INT J CANCER, V116, P378, DOI 10.1002/ijc.21053; Ingham KC, 2004, J BIOL CHEM, V279, P28132, DOI 10.1074/jbc.M312785200; Ingham KC, 1997, J BIOL CHEM, V272, P1718, DOI 10.1074/jbc.272.3.1718; Ingham KC, 2002, ARCH BIOCHEM BIOPHYS, V407, P217, DOI 10.1016/S0003-9861(02)00454-X; INGHAM KC, 1988, J BIOL CHEM, V263, P4624; Karuri NW, 2009, J BIOL CHEM, V284, P3445, DOI 10.1074/jbc.M805025200; LAI CS, 1993, J MOL BIOL, V230, P625, DOI 10.1006/jmbi.1993.1174; Leahy DJ, 1996, CELL, V84, P155, DOI 10.1016/S0092-8674(00)81002-8; LITVINOVICH SV, 1995, J MOL BIOL, V248, P611, DOI 10.1006/jmbi.1995.0246; Liu XY, 2003, MATRIX BIOL, V22, P393, DOI 10.1016/S0945-053X(03)00071-4; Millard CJ, 2007, J BIOL CHEM, V282, P35530, DOI 10.1074/jbc.M707532200; MORLA A, 1992, J CELL BIOL, V118, P421, DOI 10.1083/jcb.118.2.421; MORLA A, 1994, NATURE, V367, P193, DOI 10.1038/367193a0; Mott JD, 2004, CURR OPIN CELL BIOL, V16, P558, DOI 10.1016/j.ceb.2004.07.010; Nelea V, 2008, PROTEIN J, V27, P223, DOI 10.1007/s10930-008-9128-1; Ohashi T, 2005, J BIOL CHEM, V280, P39143, DOI 10.1074/jbc.M509082200; Ozeri V, 1996, EMBO J, V15, P989, DOI 10.1002/j.1460-2075.1996.tb00435.x; Pelta J, 2000, BIOCHEMISTRY-US, V39, P5146, DOI 10.1021/bi992770x; Pickford AR, 2001, EMBO J, V20, P1519, DOI 10.1093/emboj/20.7.1519; RADEK JT, 1993, P NATL ACAD SCI USA, V90, P3152, DOI 10.1073/pnas.90.8.3152; Rudino-Pinera E, 2007, J MOL BIOL, V368, P833, DOI 10.1016/j.jmb.2007.02.061; Schor SL, 2003, CANCER RES, V63, P8827; Schor SL, 1999, J CELL SCI, V112, P3879; SCHOR SL, 1988, J CELL SCI, V90, P391; SCHOR SL, 1980, J CELL SCI, V41, P159; Schor SL, 1996, J CELL SCI, V109, P2581; Schreiber G, 2002, CURR OPIN STRUC BIOL, V12, P41, DOI 10.1016/S0959-440X(02)00287-7; SJOBERG B, 1987, ARCH BIOCHEM BIOPHYS, V255, P347, DOI 10.1016/0003-9861(87)90402-4; Spitzfaden C, 1997, J MOL BIOL, V265, P565, DOI 10.1006/jmbi.1996.0736; Talay SR, 2000, CELL MICROBIOL, V2, P521, DOI 10.1046/j.1462-5822.2000.00076.x; Tomasini-Johansson BR, 2006, MATRIX BIOL, V25, P282, DOI 10.1016/j.matbio.2006.02.002; UGAROVA TP, 1995, BIOCHEMISTRY-US, V34, P4457, DOI 10.1021/bi00013a039; Vakonakis I, 2008, STRUCTURE, V16, P944, DOI 10.1016/j.str.2008.02.020; Vakonakis I, 2007, EMBO J, V26, P2575, DOI 10.1038/sj.emboj.7601694; Vakonakis L, 2007, CURR OPIN CELL BIOL, V19, P578, DOI 10.1016/j.ceb.2007.09.005; VUILLARD L, 1990, EUR J BIOCHEM, V191, P333, DOI 10.1111/j.1432-1033.1990.tb19127.x; WOLFF C, 1988, BIOCHEMISTRY-US, V27, P3483, DOI 10.1021/bi00409a053; Xu JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004113; Zaman MH, 2007, ANN BIOMED ENG, V35, P91, DOI 10.1007/s10439-006-9205-6; Zhao QS, 2001, EXP CELL RES, V268, P211, DOI 10.1006/excr.2001.5291	50	44	44	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15668	15675		10.1074/jbc.M109.003673	http://dx.doi.org/10.1074/jbc.M109.003673			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19366708	hybrid, Green Published			2022-12-27	WOS:000266501000035
J	Yang, HS; Kim, E; Lee, S; Park, HJ; Cooper, DS; Rajbhandari, I; Choi, I				Yang, Han Soo; Kim, Eunjin; Lee, Soojung; Park, Hae Jeong; Cooper, Deborah S.; Rajbhandari, Ira; Choi, Inyeong			Mutation of Aspartate 555 of the Sodium/Bicarbonate Transporter SLC4A4/NBCe1 Induces Chloride Transport	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SODIUM-BICARBONATE COTRANSPORTER; ELECTROGENIC NA+-HCO3-COTRANSPORTER; ERYTHROCYTE ANION-EXCHANGER; NA/HCO3 COTRANSPORTER; TUBULAR-ACIDOSIS; XENOPUS OOCYTES; RAT-KIDNEY; PROTEIN; AE1; HCO3	To understand the mechanism for ion transport through the sodium/bicarbonate transporter SLC4A4 (NBCe1), we examined amino acid residues, within transmembrane domains, that are conserved among electrogenic Na/HCO3 transporters but are substituted with residues at the corresponding site of all electroneutral Na/HCO3 transporters. Point mutants were constructed and expressed in Xenopus oocytes to assess function using two-electrode voltage clamp. Among the mutants, D555E (charge-conserved substitution of the aspartate at position 555 with a glutamate) produced decreasing HCO3- currents at more positive membrane voltages. Immunohistochemistry showed D555E protein expression in oocyte membranes. D555E induced Na/HCO3-dependent pH recovery from a CO2-induced acidification. Current-voltage relationships revealed that D555E produced an outwardly rectifying current in the nominally CO2/HCO3--free solution that was abolished by Cl- removal from the bath. In the presence of CO2/HCO3-, however, the outward current produced by D555E decreased only slightly after Cl- removal. Starting from a Cl--free condition, D555E produced dose-dependent outward currents in response to a series of chloride additions. The D555E-mediated chloride current decreased by 70% in the presence of CO2/HCO3-. The substitution of Asp(555) with an asparagine also produced a Cl- current. Anion selectivity experiments revealed that D555E was broadly permissive to other anions including NO3-. Fluorescence measurements of chloride transport were done with human embryonic kidney HEK 293 cells expressing NBCe1 and D555E. A marked increase in chloride transport was detected in cells expressing D555E. We conclude that Asp(555) plays a role in HCO3- selectivity.	[Yang, Han Soo; Kim, Eunjin; Lee, Soojung; Park, Hae Jeong; Cooper, Deborah S.; Rajbhandari, Ira; Choi, Inyeong] Emory Univ, Dept Physiol, Sch Med, Atlanta, GA 30322 USA	Emory University	Choi, I (corresponding author), Emory Univ, Dept Physiol, Sch Med, 615 Michael St, Atlanta, GA 30322 USA.	ichoi@emory.edu	Park, Hae Jeong/ABF-3130-2020; choi, inyeong/AAM-4826-2021		National Institutes of Health [GM078502]; National Kidney Foundation Young Investigator; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078502] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Kidney Foundation Young Investigator; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM078502. This work was also supported by a National Kidney Foundation Young Investigator Grant ( to I. C.).	Abuladze N, 2005, J PHYSIOL-LONDON, V565, P717, DOI 10.1113/jphysiol.2005.084988; Alper SL, 2006, EXP PHYSIOL, V91, P153, DOI 10.1113/expphysiol.2005.031765; Bernardo AA, 2006, SEMIN NEPHROL, V26, P352, DOI 10.1016/j.semnephrol.2006.07.008; Bevensee MO, 2000, AM J PHYSIOL-CELL PH, V278, pC1200, DOI 10.1152/ajpcell.2000.278.6.C1200; Boron WF, 1997, WIEN KLIN WOCHENSCHR, V109, P445; Boron WF, 1989, REGULATION ACID BASE, P33; Burnham CE, 1997, J BIOL CHEM, V272, P19111, DOI 10.1074/jbc.272.31.19111; CABANTCHIK ZI, 1974, J MEMBRANE BIOL, V15, P207, DOI 10.1007/BF01870088; Chang MH, 2008, J BIOL CHEM, V283, P18402, DOI 10.1074/jbc.M709819200; CHAO AC, 1989, BIOPHYS J, V56, P1071, DOI 10.1016/S0006-3495(89)82755-9; Choi I, 1997, FEBS LETT, V405, P133, DOI 10.1016/S0014-5793(97)00155-5; Choi I, 1999, AM J PHYSIOL-CELL PH, V276, pC576, DOI 10.1152/ajpcell.1999.276.3.C576; Choi I, 2000, NATURE, V405, P571, DOI 10.1038/35014615; Choi I, 2007, J PHYSIOL-LONDON, V578, P131, DOI 10.1113/jphysiol.2006.114959; CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x; Dinour D, 2004, J BIOL CHEM, V279, P52238, DOI 10.1074/jbc.M406591200; Fujinaga J, 1999, J BIOL CHEM, V274, P6626, DOI 10.1074/jbc.274.10.6626; Gawenis LR, 2007, J BIOL CHEM, V282, P9042, DOI 10.1074/jbc.M607041200; Grichtchenko II, 2000, J GEN PHYSIOL, V115, P533, DOI 10.1085/jgp.115.5.533; Kao LY, 2008, J BIOL CHEM, V283, P26782, DOI 10.1074/jbc.M804006200; Kuma H, 2002, BIOCHEMISTRY-US, V41, P3380, DOI 10.1021/bi015879p; Lauger P., 1991, ELECTROGENIC ION PUM, P61; Li HC, 2005, AM J PHYSIOL-RENAL, V289, pF61, DOI 10.1152/ajprenal.00032.2005; Lu J, 2006, J BIOL CHEM, V281, P19241, DOI 10.1074/jbc.M602181200; McAlear SD, 2006, J BIOL CHEM, V281, P32417, DOI 10.1074/jbc.M607253200; McAlear SD, 2006, J GEN PHYSIOL, V127, P639, DOI 10.1085/jgp.200609520; OKUBO K, 1994, J BIOL CHEM, V269, P1918; Perry C, 2006, AM J PHYSIOL-RENAL, V290, pF417, DOI 10.1152/ajprenal.00395.2004; Popov M, 1999, BIOCHEM J, V339, P269, DOI 10.1042/0264-6021:3390269; Pushkin A, 2006, AM J PHYSIOL-RENAL, V290, pF580, DOI 10.1152/ajprenal.00252.2005; Qu ZQ, 2000, J GEN PHYSIOL, V116, P825, DOI 10.1085/jgp.116.6.825; Romero MF, 2004, PFLUG ARCH EUR J PHY, V447, P495, DOI 10.1007/s00424-003-1180-2; Sciortino CM, 1999, AM J PHYSIOL-RENAL, V277, pF611, DOI 10.1152/ajprenal.1999.277.4.F611; Shirakabe K, 2006, P NATL ACAD SCI USA, V103, P9542, DOI 10.1073/pnas.0602250103; SOLEIMANI M, 1987, J CLIN INVEST, V79, P1276, DOI 10.1172/JCI112948; Tang XB, 1998, J BIOL CHEM, V273, P22545, DOI 10.1074/jbc.273.35.22545; Weber WM, 1999, J MEMBRANE BIOL, V170, P1, DOI 10.1007/s002329900532; Zhu QS, 2004, J BIOL CHEM, V279, P23565, DOI 10.1074/jbc.M401380200; Zhu QS, 2009, J BIOL CHEM, V284, P8909, DOI 10.1074/jbc.M806674200	39	25	25	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15970	15979		10.1074/jbc.M109.001438	http://dx.doi.org/10.1074/jbc.M109.001438			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19336397	hybrid, Green Published			2022-12-27	WOS:000266501000063
J	Abe, Y; Yoon, SO; Kubota, K; Mendoza, MC; Gygi, SP; Blenis, J				Abe, Yuki; Yoon, Sang-Oh; Kubota, Kazuishi; Mendoza, Michelle C.; Gygi, Steven P.; Blenis, John			p90 Ribosomal S6 Kinase and p70 Ribosomal S6 Kinase Link Phosphorylation of the Eukaryotic Chaperonin Containing TCP-1 to Growth Factor, Insulin, and Nutrient Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-SUPPRESSOR COMPLEX; IN-VIVO; MOLECULAR CHAPERONES; CYTOPLASMIC CHAPERONIN; PROTEIN-SYNTHESIS; NASCENT CHAIN; AKT SUBSTRATE; IDENTIFICATION; RSK; ACTIN	Chaperonin containing TCP-1 (CCT) is a large multisubunit complex that mediates protein folding in eukaryotic cells. CCT participates in the folding of newly synthesized polypeptides, including actin, tubulin, and several cell cycle regulators; therefore, CCT plays an important role in cytoskeletal organization and cell division. Here we identify the chaperonin CCT as a novel physiological substrate for p90 ribosomal S6 kinase (RSK) and p70 ribosomal S6 kinase (S6K). RSK phosphorylates the beta subunit of CCT in response to tumor promoters or growth factors that activate the Ras-mitogen-activated protein kinase (MAPK) pathway. CCT beta Ser-260 was identified as the RSK site by mass spectrometry and confirmed by site-directed mutagenesis. RSK-dependent Ser-260 phosphorylation was sensitive to the MEK inhibitor UO126 and the RSK inhibitor BID-1870. Insulin weakly activates RSK but strongly activates the phosphoinositide 3-kinase (PI3K)-mammalian target of rapamycin (mTOR) pathway and utilizes S6K to regulate CCT beta phosphorylation. Thus, the Ras-MAPK and PI3K-mTOR pathways converge on CCT beta Ser-260 phosphorylation in response to multiple agonists in various mammalian cells. We also show that RNA interference-mediated knockdown of endogenous CCT beta causes impaired cell proliferation that can be rescued with ectopically expressed murine CCT beta wild-type or phosphomimetic mutant S260D, but not the phosphorylation-deficient mutant S260A. Although the molecular mechanism of CCT beta regulation remains unclear, our findings demonstrate a link between oncogene and growth factor signaling and chaperonin CCT-mediated cellular activities.	[Abe, Yuki; Yoon, Sang-Oh; Kubota, Kazuishi; Mendoza, Michelle C.; Gygi, Steven P.; Blenis, John] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Blenis, J (corresponding author), 240 Longwood Ave, Boston, MA 02115 USA.	john_blenis@hms.harvard.edu			National Institutes of Health [R37CA046595, RO1GM051405, HG3456]; NATIONAL CANCER INSTITUTE [R37CA046595] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051405] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R37CA046595 (to J.B.), RO1GM051405 (to J.B.), and HG3456 (to S. P. G.).	Anjum R, 2005, CURR BIOL, V15, P1762, DOI 10.1016/j.cub.2005.08.050; Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Archibald JM, 2001, J STRUCT BIOL, V135, P157, DOI 10.1006/jsbi.2001.4353; Avruch J, 2005, CURR OPIN CLIN NUTR, V8, P67, DOI 10.1097/00075197-200501000-00010; Beausoleil SA, 2006, NAT BIOTECHNOL, V24, P1285, DOI 10.1038/nbt1240; Behrends C, 2006, MOL CELL, V23, P887, DOI 10.1016/j.molcel.2006.08.017; Booth CR, 2008, NAT STRUCT MOL BIOL, V15, P746, DOI 10.1038/nsmb.1436; Carriere A, 2008, CURR BIOL, V18, P1269, DOI 10.1016/j.cub.2008.07.078; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; CHEN XY, 1994, P NATL ACAD SCI USA, V91, P9111, DOI 10.1073/pnas.91.19.9111; Coghlin C, 2006, J PATHOL, V210, P351, DOI 10.1002/path.2056; Cuellar J, 2008, NAT STRUCT MOL BIOL, V15, P858, DOI 10.1038/nsmb.1464; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; ENG JK, 1994, J AM SOC MASS SPECTR, V5, P976, DOI 10.1016/1044-0305(94)80016-2; Feldman DE, 1999, MOL CELL, V4, P1051, DOI 10.1016/S1097-2765(00)80233-6; Frodin M, 1999, MOL CELL ENDOCRINOL, V151, P65, DOI 10.1016/S0303-7207(99)00061-1; FRYDMAN J, 1994, NATURE, V370, P111, DOI 10.1038/370111a0; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; GAO YJ, 1992, CELL, V69, P1043, DOI 10.1016/0092-8674(92)90622-J; Gharahdaghi F, 1999, ELECTROPHORESIS, V20, P601, DOI 10.1002/(SICI)1522-2683(19990301)20:3<601::AID-ELPS601>3.0.CO;2-6; Grantham J, 2006, EXP CELL RES, V312, P2309, DOI 10.1016/j.yexcr.2006.03.028; GROVE JR, 1993, BIOCHEMISTRY-US, V32, P7727, DOI 10.1021/bi00081a018; Haas W, 2006, MOL CELL PROTEOMICS, V5, P1326, DOI 10.1074/mcp.M500339-MCP200; Hansen WJ, 1999, J CELL BIOL, V145, P265, DOI 10.1083/jcb.145.2.265; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Hers I, 2006, J BIOL CHEM, V281, P4762, DOI 10.1074/jbc.M511008200; HOFFMAN M, 2003, Patent No. 03020722; Holland EC, 2004, ONCOGENE, V23, P3138, DOI 10.1038/sj.onc.1207590; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; Jiang ZY, 2005, J BIOL CHEM, V280, P21622, DOI 10.1074/jbc.m414464200; Kane S, 2002, J BIOL CHEM, V277, P22115, DOI 10.1074/jbc.C200198200; Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721; Klumpp M, 1997, CELL, V91, P263, DOI 10.1016/S0092-8674(00)80408-0; Konishi H, 2007, J BIOL CHEM, V282, P23491, DOI 10.1074/jbc.M611703200; Kovacina KS, 2003, J BIOL CHEM, V278, P10189, DOI 10.1074/jbc.M210837200; LEWIS VA, 1992, NATURE, V358, P249, DOI 10.1038/358249a0; Liu XQ, 2005, MOL CELL BIOL, V25, P4993, DOI 10.1128/MCB.25.12.4993-5010.2005; Ma X, 2008, BBA-PROTEINS PROTEOM, V1784, P882, DOI 10.1016/j.bbapap.2008.02.008; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Martin KA, 2001, J BIOL CHEM, V276, P7884, DOI 10.1074/jbc.M006969200; Martin-Benito J, 2002, EMBO J, V21, P6377, DOI 10.1093/emboj/cdf640; Melville MW, 2003, MOL CELL BIOL, V23, P3141, DOI 10.1128/MCB.23.9.3141-3151.2003; Miller EJ, 2006, PROTEIN SCI, V15, P1522, DOI 10.1110/ps.052001606; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Raught B, 2004, EMBO J, V23, P1761, DOI 10.1038/sj.emboj.7600193; Reissmann S, 2007, NAT STRUCT MOL BIOL, V14, P432, DOI 10.1038/nsmb1236; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Roux PP, 2004, P NATL ACAD SCI USA, V101, P13489, DOI 10.1073/pnas.0405659101; Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003; Sapkota GP, 2007, BIOCHEM J, V401, P29, DOI 10.1042/BJ20061088; Shahbazian D, 2006, EMBO J, V25, P2781, DOI 10.1038/sj.emboj.7601166; SHAULIAN E, 1992, MOL CELL BIOL, V12, P5581, DOI 10.1128/MCB.12.12.5581; STERNLICHT H, 1993, P NATL ACAD SCI USA, V90, P9422, DOI 10.1073/pnas.90.20.9422; Szpikowska BK, 1998, PROTEIN SCI, V7, P1524, DOI 10.1002/pro.5560070705; Tam S, 2006, NAT CELL BIOL, V8, P1155, DOI 10.1038/ncb1477; Thulasiraman V, 1999, EMBO J, V18, P85, DOI 10.1093/emboj/18.1.85; URSIC D, 1994, MOL BIOL CELL, V5, P1065, DOI 10.1091/mbc.5.10.1065; Valpuesta JM, 2002, FEBS LETT, V529, P11, DOI 10.1016/S0014-5793(02)03180-0; Won KA, 1998, MOL CELL BIOL, V18, P7584, DOI 10.1128/MCB.18.12.7584; Yam AY, 2008, NAT STRUCT MOL BIOL, V15, P1255, DOI 10.1038/nsmb.1515; Zhao YG, 2001, J BIOL CHEM, V276, P32822, DOI 10.1074/jbc.M105562200	62	67	68	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					14939	14948		10.1074/jbc.M900097200	http://dx.doi.org/10.1074/jbc.M900097200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19332537	Green Published, hybrid			2022-12-27	WOS:000266288200030
J	Marty, NJ; Rajalingam, D; Kight, AD; Lewis, NE; Fologea, D; Kumar, TKS; Henry, RL; Goforth, RL				Marty, Naomi J.; Rajalingam, Dakshinamurthy; Kight, Alicia D.; Lewis, Nathaniel E.; Fologea, Daniel; Kumar, Thallapuranam Krishnaswamy Suresh; Henry, Ralph L.; Goforth, Robyn L.			The Membrane-binding Motif of the Chloroplast Signal Recognition Particle Receptor (cpFtsY) Regulates GTPase Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SRP-RECEPTOR; CIRCULAR-DICHROISM; THYLAKOID MEMBRANE; PROTEIN-TRANSPORT; FTSY; DOMAIN; RNA; PHENYLALANINE; POLYPEPTIDE; TRANSLOCASE	The chloroplast signal recognition particle (cpSRP) and its receptor (cpFtsY) function in thylakoid biogenesis to target integral membrane proteins to thylakoids. Unlike cytosolic SRP receptors in eukaryotes, cpFtsY partitions between thylakoid membranes and the soluble stroma. Based on sequence alignments, a membrane-binding motif identified in Escherichia coli FtsY appears to be conserved in cpFtsY, yet whether the proposed motif is responsible for the membrane-binding function of cpFtsY has yet to be shown experimentally. Our studies show that a small N-terminal region in cpFtsY stabilizes a membrane interaction critical to cpFtsY function in cpSRP-dependent protein targeting. This membrane-binding motif is both necessary and sufficient to direct cpFtsY and fused passenger proteins to thylakoids. Our results demonstrate that the cpFtsY membrane-binding motif may be functionally replaced by the corresponding region from E. coli, confirming that the membrane-binding motif is conserved among organellar and prokaryotic homologs. Furthermore, the capacity of cpFtsY for lipid binding correlates with liposome-induced GTP hydrolysis stimulation. Mutations that debilitate the membrane-binding motif in cpFtsY result in higher rates of GTP hydrolysis, suggesting that negative regulation is provided by the intact membrane-binding region in the absence of a bilayer. Furthermore, NMR and CD structural studies of the N-terminal region and the analogous region in the E. coli SRP receptor revealed a conformational change in secondary structure that takes place upon lipid binding. These studies suggest that the cpFtsY membrane-binding motif plays a critical role in the intramolecular communication that regulates cpSRP receptor functions at the membrane.	[Marty, Naomi J.; Kight, Alicia D.; Lewis, Nathaniel E.; Fologea, Daniel; Henry, Ralph L.; Goforth, Robyn L.] Univ Arkansas, Dept Biol Sci, Fayetteville, AR 72701 USA; [Rajalingam, Dakshinamurthy; Kumar, Thallapuranam Krishnaswamy Suresh] Univ Arkansas, Dept Chem & Biochem, Fayetteville, AR 72701 USA	University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas System; University of Arkansas Fayetteville	Goforth, RL (corresponding author), Univ Arkansas, Dept Biol Sci, SCEN 601, Fayetteville, AR 72701 USA.	Robyn.Goforth@uark.edu	KUMAR, P. SURESH/AAT-8951-2020; Kumar, Dr Suresh/HHZ-2615-2022; Kumar, Suresh Thallapuranam/R-5606-2016	KUMAR, P. SURESH/0000-0003-3222-2604; Kumar, Dr Suresh/0000-0002-2539-6553; Kumar, Suresh Thallapuranam/0000-0001-7262-1373	National Institutes of Health [P20RR15569]; Department of Energy [DE-FG02-01ER15161]; Arkansas Bioscience Institute; National Science Foundation [0139570]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015569] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy(United States Department of Energy (DOE)); Arkansas Bioscience Institute; National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant P20RR15569 (to R. L. G. and T. K. S. K.) from the Centers of Biomedical Research Excellence Program of the National Center for Research Resources. This work was also supported by Department of Energy Grant DE-FG02-01ER15161 (to R. L. H., T. K. S. K., and R. L. G.), the Arkansas Bioscience Institute, and the National Science Foundation GK-12 Outreach funded by National Science Foundation Grant 0139570.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Angelini S, 2006, J CELL BIOL, V174, P715, DOI 10.1083/jcb.200606093; ARNON DI, 1949, PLANT PHYSIOL, V24, P15; Asakura Y, 2004, PLANT CELL, V16, P201, DOI 10.1105/tpc.014787; Bahari L, 2007, J BIOL CHEM, V282, P32168, DOI 10.1074/jbc.M705429200; Bradshaw N, 2009, SCIENCE, V323, P127, DOI 10.1126/science.1165971; BUSH CA, 1978, BIOCHEMISTRY-US, V17, P4951, DOI 10.1021/bi00616a015; CARNEY J, 2006, CURR PROTOCOLS PROTE; Chandrasekar S, 2008, J MOL BIOL, V375, P425, DOI 10.1016/j.jmb.2007.09.061; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Clamp M, 2004, BIOINFORMATICS, V20, P426, DOI 10.1093/bioinformatics/btg430; CLINE K, 1993, EMBO J, V12, P4105, DOI 10.1002/j.1460-2075.1993.tb06094.x; CLINE K, 1989, J BIOL CHEM, V264, P14225; CONNOLLY T, 1993, J CELL BIOL, V123, P799, DOI 10.1083/jcb.123.4.799; Dabney-Smith C, 2006, J BIOL CHEM, V281, P5476, DOI 10.1074/jbc.M512453200; de Leeuw E, 2000, EMBO J, V19, P531, DOI 10.1093/emboj/19.4.531; DOUCE R, 1996, ADV PHOTOSYNTH, V4, P69; Egea PF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003619; Egea PF, 2004, NATURE, V427, P215, DOI 10.1038/nature02250; Eitan A, 2004, J BACTERIOL, V186, P2492, DOI 10.1128/JB.186.8.2492-2494.2004; Focia PJ, 2004, SCIENCE, V303, P373, DOI 10.1126/science.1090827; Gawronski-Salerno J, 2007, PROTEINS, V66, P984, DOI 10.1002/prot.21200; GODDARD TD, 1997, SPARKY3; Goforth RL, 2004, J BIOL CHEM, V279, P43077, DOI 10.1074/jbc.M401600200; Henry R, 2007, ENZYMES, V25, P493, DOI 10.1016/S1874-6047(07)25019-X; HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4; Jaru-Ampornpan P, 2007, MOL BIOL CELL, V18, P2636, DOI 10.1091/mbc.E07-01-0037; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; Koradi R, 1996, J MOL GRAPHICS, V14, P29; Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2; Moore M, 2003, J CELL BIOL, V162, P1245, DOI 10.1083/jcb.200307067; Neher SB, 2008, NAT STRUCT MOL BIOL, V15, P916, DOI 10.1038/nsmb.1467; Parlitz R, 2007, J BIOL CHEM, V282, P32176, DOI 10.1074/jbc.M705430200; Pool MR, 2005, MOL MEMBR BIOL, V22, P3, DOI 10.1080/09687860400026348; Samuelsson T, 1999, NUCLEIC ACIDS RES, V27, P169, DOI 10.1093/nar/27.1.169; Sreerama N, 1999, BIOCHEMISTRY-US, V38, P10814, DOI 10.1021/bi990516z; Stengel KF, 2007, FEBS LETT, V581, P5671, DOI 10.1016/j.febslet.2007.11.024; Tzvetkova-Chevolleau T, 2007, PLANT CELL, V19, P1635, DOI 10.1105/tpc.106.048959; Valent QA, 1998, EMBO J, V17, P2504, DOI 10.1093/emboj/17.9.2504; VIGUERA AR, 1995, BIOCHEMISTRY-US, V34, P8771, DOI 10.1021/bi00027a028; Wang YJ, 1997, J BIOMOL NMR, V10, P373, DOI 10.1023/A:1018315729609; Wuthrich K, 1986, NMR PROTEINS NUCL AC; Yuan J, 2002, J BIOL CHEM, V277, P32400, DOI 10.1074/jbc.M206192200; Zelazny A, 1997, P NATL ACAD SCI USA, V94, P6025, DOI 10.1073/pnas.94.12.6025	44	20	21	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					14891	14903		10.1074/jbc.M900775200	http://dx.doi.org/10.1074/jbc.M900775200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19293157	Green Published, hybrid			2022-12-27	WOS:000266288200025
J	Lee, SB; Ou, DSC; Lee, CF; Juan, LJ				Lee, Sung-Bau; Ou, Derick S-C.; Lee, Chung-Fan; Juan, Li-Jung			Gene-specific Transcriptional Activation Mediated by the p150 Subunit of the Chromatin Assembly Factor 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-REPLICATION; S-PHASE; HUMAN CYTOMEGALOVIRUS; CELL-DIVISION; MOUSE CELLS; FACTOR-I; PROTEIN; CAF-1; YEAST; INHERITANCE	Chromatin assembly factor 1 contains three subunits, p150, p60, and p48. It is essential for coupling nucleosome assembly to newly synthesized DNA. Whether chromatin assembly factor 1 subunits have functions beyond escorting histones, which depends on the complex formation of p150 and p60, has been an issue of great interest. This study reveals a novel role of p150, but not p60, in gene-specific transcriptional activation. We found that p150 transcriptionally activated an essential viral promoter, the major immediate early promoter (MIEP) of the human cytomegalovirus, independently of p60. Knocking down p150 decreased the MIEP function in both transfected and virally infected cells. The chromatin immunoprecipitation analysis and the in vitro protein-DNA binding assay demonstrated that p150 used its KER domain to associate with the MIEP from -593 to -574 bp. The N-terminal 244 residues were also found essential for p150-mediated MIEP activation, likely through recruiting the acetyltransferase p300 to acetylate local histones. Domain swapping experiments further showed that the KER and the N terminus of p150 acted as an independent DNA binding and transcriptional activation domain, respectively. Because p60 did not seem involved in the reaction, together these results indicate for the first time that p150 directly activates transcription, independently of its histone deposition function.	[Lee, Sung-Bau; Ou, Derick S-C.; Lee, Chung-Fan; Juan, Li-Jung] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Lee, Sung-Bau] Natl Def Med Ctr, Grad Inst Life Sci, Taipei 114, Taiwan; [Lee, Sung-Bau; Lee, Chung-Fan] Natl Hlth Res Inst, Inst Canc Res, Zhunan Town 350, Miaoli County, Taiwan; [Ou, Derick S-C.] Natl Tsing Hua Univ, Inst Biotechnol, Dept Life Sci, Hsinchu 300, Taiwan; [Lee, Chung-Fan] Natl Taiwan Univ, Coll Med, Inst Mol Med, Taipei 100, Taiwan	Academia Sinica - Taiwan; National Defense Medical Center; National Health Research Institutes - Taiwan; National Tsing Hua University; National Taiwan University	Juan, LJ (corresponding author), Acad Sinica, Genom Res Ctr, 128 Acad Rd,Sec 2, Taipei 115, Taiwan.	ljjuan@gate.sinica.edu.tw	Juan, Li-Jung/H-6631-2015; Lee, Sung-Bau/AAJ-5176-2021	Lee, Sung-Bau/0000-0002-8628-8687; Ou, Shi-Chen/0000-0002-9129-9030	Genomics Research Center; National Health Research Institutes	Genomics Research Center; National Health Research Institutes(National Health Research Institutes, JapanNational Health Research Institutes - Taiwan)	This work was supported by grants from the Genomics Research Center and the National Health Research Institutes ( to L.-J.J.).	Banks GC, 1999, J BIOL CHEM, V274, P16536, DOI 10.1074/jbc.274.23.16536; Belizario JE, 2008, CURR PROTEIN PEPT SC, V9, P210, DOI 10.2174/138920308784534023; Compagnone NA, 2000, MOL ENDOCRINOL, V14, P875, DOI 10.1210/me.14.6.875; Enomoto S, 1998, GENE DEV, V12, P219, DOI 10.1101/gad.12.2.219; Hoek M, 2003, P NATL ACAD SCI USA, V100, P12183, DOI 10.1073/pnas.1635158100; Hsu CH, 2004, EMBO J, V23, P2269, DOI 10.1038/sj.emboj.7600239; Huang CF, 2000, J BIOL CHEM, V275, P12313, DOI 10.1074/jbc.275.16.12313; Huang SB, 2007, EMBO J, V26, P2274, DOI 10.1038/sj.emboj.7601670; Jones MH, 2000, GENOMICS, V63, P40, DOI 10.1006/geno.1999.6071; KAUFMAN PD, 1995, CELL, V81, P1105, DOI 10.1016/S0092-8674(05)80015-7; Kitagawa H, 2003, CELL, V113, P905, DOI 10.1016/S0092-8674(03)00436-7; Marheineke K, 1998, J BIOL CHEM, V273, P15279, DOI 10.1074/jbc.273.24.15279; Moggs JG, 2000, MOL CELL BIOL, V20, P1206, DOI 10.1128/MCB.20.4.1206-1218.2000; Monson EK, 1997, P NATL ACAD SCI USA, V94, P13081, DOI 10.1073/pnas.94.24.13081; Murzina N, 1999, MOL CELL, V4, P529, DOI 10.1016/S1097-2765(00)80204-X; Nabatiyan A, 2004, MOL CELL BIOL, V24, P2853, DOI 10.1128/MCB.24.7.2853-2862.2004; Park YJ, 2006, BIOCHEM CELL BIOL, V84, P549, DOI 10.1139/O06-088; Parthun MR, 1996, CELL, V87, P85, DOI 10.1016/S0092-8674(00)81325-2; QIAN YW, 1993, NATURE, V364, P648, DOI 10.1038/364648a0; Quivy JP, 2008, NAT STRUCT MOL BIOL, V15, P972, DOI 10.1038/nsmb.1470; Quivy JP, 2004, EMBO J, V23, P3516, DOI 10.1038/sj.emboj.7600362; Ramirez-Parra E, 2007, TRENDS PLANT SCI, V12, P570, DOI 10.1016/j.tplants.2007.10.002; Reese BE, 2003, MOL CELL BIOL, V23, P3226, DOI 10.1128/MCB.23.9.3226-3236.2003; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Schonrock N, 2006, J BIOL CHEM, V281, P9560, DOI 10.1074/jbc.M513426200; Shibahara K, 1999, CELL, V96, P575, DOI 10.1016/S0092-8674(00)80661-3; SPAETE RR, 1987, P NATL ACAD SCI USA, V84, P7213, DOI 10.1073/pnas.84.20.7213; Takami Y, 2007, MOL BIOL CELL, V18, P129, DOI 10.1091/mbc.E06-05-0426; Verreault A, 1996, CELL, V87, P95, DOI 10.1016/S0092-8674(00)81326-4; Ye XF, 2003, MOL CELL, V11, P341, DOI 10.1016/S1097-2765(03)00037-6; Zabaronick SR, 2005, MOL CELL BIOL, V25, P652, DOI 10.1128/MCB.25.2.652-660.2005	32	11	12	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14040	14049		10.1074/jbc.M901833200	http://dx.doi.org/10.1074/jbc.M901833200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19324875	Green Published, hybrid			2022-12-27	WOS:000266286100010
J	Thompson, BR; Mazurkiewicz-Munoz, AM; Suttles, J; Carter-Su, C; Bernlohr, DA				Thompson, Brian R.; Mazurkiewicz-Munoz, Anna M.; Suttles, Jill; Carter-Su, Christin; Bernlohr, David A.			Interaction of Adipocyte Fatty Acid-binding Protein (AFABP) and JAK2 AFABP/aP2 AS A REGULATOR OF JAK2 SIGNALING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HORMONE-SENSITIVE LIPASE; LIPID-BINDING; APOLIPOPROTEIN-E; AP2; INTERLEUKIN-6; CYTOKINE; SOCS3; ATHEROSCLEROSIS; MACROPHAGES; ACTIVATION	Adipocyte fatty acid-binding protein (AFABP/aP2) facilitates the intracellular solubilization and trafficking of lipids within the aqueous environment of the cell. Studies in the AFABP/aP2 knock-out mouse suggest that the protein may have roles in cellular processes broader than lipid transport. We present herein the finding that AFABP/aP2 interacts with JAK2 in a fatty acid-dependent manner. This interaction was established using yeast two-hybrid analysis, co-immunoprecipitation from adipose tissue, and 3T3-L1 adipocytes as well as in 293 cells overexpressing JAK2 and AFABP/aP2. Mutational analysis of AFABP/aP2 (R126L/Y128F) revealed that fatty acid binding activity is necessary for the interaction and that Asp18 of the helix-turn-helix motif forms a component of the interaction domain. Mutational analysis of JAK2 (Y1007F/Y1008F) revealed that AFABP/aP2 associates with the basal unphosphorylated form of the protein. Interleukin-6, but not interleukin-10, stimulated phosphorylation of STAT3, and induction of SOCS3 mRNA expression were potentiated in a time-and dose-dependent manner in macrophage cell lines derived from AFABP/aP2-EFABP/mal1 double knock-out mice relative to cells from wild type animals. These results suggest that ligand-bound AFABP/aP2 binds to and attenuates JAK2 signaling and establishes a new role for AFABP/aP2 as a fatty acid sensor affecting cellular metabolism via protein-protein interactions.	[Thompson, Brian R.; Bernlohr, David A.] Univ Minnesota Twin Cities, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Mazurkiewicz-Munoz, Anna M.; Carter-Su, Christin] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Suttles, Jill] Univ Louisville, Sch Med, Dept Microbiol & Immunol, Louisville, KY 40292 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Michigan System; University of Michigan; University of Louisville	Bernlohr, DA (corresponding author), Univ Minnesota Twin Cities, Dept Biochem Mol Biol & Biophys, 6-155 Jackson Hall,321 Church St SE, Minneapolis, MN 55455 USA.	Bernl001@umn.edu			National Institutes of Health [DK053189, R01 AI048850, DK34171]; Minnesota Obesity Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI048850] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK034171, R01DK053189, R01DK034171, R56DK053189] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Minnesota Obesity Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK053189 (to D. A. B.), R01 AI048850 (to J. S.), and NIH DK34171 (to C. C.- S.). This work was also supported by the Minnesota Obesity Center.	Argetsinger LS, 2004, MOL CELL BIOL, V24, P4955, DOI 10.1128/MCB.24.11.4955-4967.2004; Baar RA, 2005, AM J PHYSIOL-ENDOC M, V288, pE187, DOI 10.1152/ajpendo.00256.2004; BLASI E, 1985, NATURE, V318, P667, DOI 10.1038/318667a0; Boord JB, 2004, CIRCULATION, V110, P1492, DOI 10.1161/01.CIR.0000141735.13202.B6; Boord JB, 2002, ARTERIOSCL THROM VAS, V22, P1686, DOI 10.1161/01.ATV.0000033090.81345.E6; Clemons-Miller AR, 2000, IMMUNOBIOLOGY, V202, P477, DOI 10.1016/S0171-2985(00)80105-9; Coe NR, 1999, J LIPID RES, V40, P967; Croker BA, 2003, NAT IMMUNOL, V4, P540, DOI 10.1038/ni931; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Feng J, 1997, MOL CELL BIOL, V17, P2497, DOI 10.1128/MCB.17.5.2497; Fischer P, 2004, BIOCHEM J, V378, P449, DOI 10.1042/BJ20030893; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Grundy SM, 2008, ARTERIOSCL THROM VAS, V28, P629, DOI 10.1161/ATVBAHA.107.151092; Heinrich PC, 1998, BIOCHEM J, V334, P297, DOI 10.1042/bj3340297; Herrington J, 2000, ONCOGENE, V19, P2585, DOI 10.1038/sj.onc.1203526; Hertzel AV, 2006, AM J PHYSIOL-ENDOC M, V290, pE814, DOI 10.1152/ajpendo.00465.2005; Hertzel AV, 2002, J LIPID RES, V43, P2105, DOI 10.1194/jlr.M200227-JLR200; Hertzel AV, 2000, TRENDS ENDOCRIN MET, V11, P175; Hotamisligil GS, 1996, SCIENCE, V274, P1377, DOI 10.1126/science.274.5291.1377; Jenkins-Kruchten AE, 2003, J BIOL CHEM, V278, P47636, DOI 10.1074/jbc.M307680200; Kleemann R, 2008, CARDIOVASC RES, V79, P360, DOI 10.1093/cvr/cvn120; Lang R, 2003, NAT IMMUNOL, V4, P546, DOI 10.1038/ni932; LiCata VJ, 1998, PROTEINS, V33, P577, DOI 10.1002/(SICI)1097-0134(19981201)33:4<577::AID-PROT10>3.0.CO;2-2; Madan M, 2008, ATHEROSCLEROSIS, V197, P504, DOI 10.1016/j.atherosclerosis.2007.02.023; Maeda K, 2005, CELL METAB, V1, P107, DOI 10.1016/j.cmet.2004.12.008; Makowski L, 2005, J BIOL CHEM, V280, P12888, DOI 10.1074/jbc.M413788200; Makowski L, 2001, NAT MED, V7, P699, DOI 10.1038/89076; Matsuda T, 2004, BIOCHEM BIOPH RES CO, V325, P586, DOI 10.1016/j.bbrc.2004.10.071; NARAZAKI M, 1994, P NATL ACAD SCI USA, V91, P2285, DOI 10.1073/pnas.91.6.2285; Niemand C, 2003, J IMMUNOL, V170, P3263, DOI 10.4049/jimmunol.170.6.3263; Reynolds JM, 2007, J IMMUNOL, V179, P313, DOI 10.4049/jimmunol.179.1.313; Rui LY, 1997, MOL CELL BIOL, V17, P6633, DOI 10.1128/MCB.17.11.6633; Schieffer B, 2004, CIRCULATION, V110, P3493, DOI 10.1161/01.CIR.0000148135.08582.97; SHA RS, 1993, J BIOL CHEM, V268, P7885; Shen WJ, 1999, P NATL ACAD SCI USA, V96, P5528, DOI 10.1073/pnas.96.10.5528; Shen WJ, 2001, J BIOL CHEM, V276, P49443, DOI 10.1074/jbc.M104095200; Smith AJ, 2004, J BIOL CHEM, V279, P52399, DOI 10.1074/jbc.M410301200; Smith AJ, 2007, J BIOL CHEM, V282, P32424, DOI 10.1074/jbc.M703730200; Smith AJ, 2008, J BIOL CHEM, V283, P33536, DOI 10.1074/jbc.M806732200; Starr R, 1997, NATURE, V387, P917, DOI 10.1038/43206; XU ZH, 1993, J BIOL CHEM, V268, P7874; Yasukawa H, 2003, NAT IMMUNOL, V4, P551, DOI 10.1038/ni938	42	36	41	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13473	13480		10.1074/jbc.M900075200	http://dx.doi.org/10.1074/jbc.M900075200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19318353	hybrid, Green Published			2022-12-27	WOS:000265877300023
J	Bertini, I; Fragai, M; Luchinat, C; Melikian, M; Mylonas, E; Sarti, N; Svergun, DI				Bertini, Ivano; Fragai, Marco; Luchinat, Claudio; Melikian, Maxime; Mylonas, Efstratios; Sarti, Niko; Svergun, Dmitri I.			Interdomain Flexibility in Full-length Matrix Metalloproteinase-1 (MMP-1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-TERMINAL DOMAIN; NEUTROPHIL COLLAGENASE; CRYSTAL-STRUCTURE; CATALYTIC DOMAIN; SUBSTRATE-SPECIFICITY; SURFACE ACCESSIBILITY; ACTIVATION MECHANISM; TISSUE INHIBITORS; PEPTIDE MODELS; NMR RELAXATION	The presence of extensive reciprocal conformational freedom between the catalytic and the hemopexin-like domains of fulllength matrix metalloproteinase-1 (MMP-1) is demonstrated by NMR and small angle x-ray scattering experiments. This finding is discussed in relation to the essentiality of the hemopexin-like domain for the collagenolytic activity of MMP-1. The conformational freedom experienced by the present system, having the shortest linker between the two domains, when compared with similar findings on MMP-12 and MMP-9 having longer and the longest linker within the family, respectively, suggests this type of conformational freedom to be a general property of all MMPs.	[Bertini, Ivano; Fragai, Marco; Luchinat, Claudio; Melikian, Maxime; Sarti, Niko] Univ Florence, Magnet Resonance Ctr, I-50019 Sesto Fiorentino, Italy; [Bertini, Ivano; Sarti, Niko] Univ Florence, Dept Chem, I-50019 Sesto Fiorentino, Italy; [Fragai, Marco; Luchinat, Claudio] Univ Florence, Dept Agr Biotechnol, I-50144 Florence, Italy; [Mylonas, Efstratios; Svergun, Dmitri I.] Hamburg Outstn, European Mol Biol Lab, D-22603 Hamburg, Germany; [Svergun, Dmitri I.] Russian Acad Sci, Inst Crystallog, Moscow 117333, Russia	University of Florence; University of Florence; University of Florence; European Molecular Biology Laboratory (EMBL); Russian Academy of Sciences; FSRC Crystallography & Photonics RAS	Bertini, I (corresponding author), Via L Sacconi 6, I-50019 Sesto Fiorentino, Italy.	ivanobertini@cerm.unifi.it	Mylonas, Efstratios/AAC-4948-2022; Fragai, Marco/K-4732-2015	Fragai, Marco/0000-0002-8440-1690; Melikian, Maxime/0000-0003-4846-1749; Svergun, Dmitri/0000-0003-0830-5696; Luchinat, Claudio/0000-0003-2271-8921; Mylonas, Efstratios/0000-0003-4476-3010	European Commission [MEST-CT-2004-504391]; SFMET [201640]; SPINE2-COMPLEXES [031220]; Nano4Drugs [LSHB-CT-2005019102]; Ministero dell'Istruzione, dell'Universita` e della Ricerca [2005039878, RBLA032ZM7, RBIP06LSS2]; Ente Cassa di Risparmio di Firenze	European Commission(European CommissionEuropean Commission Joint Research Centre); SFMET; SPINE2-COMPLEXES; Nano4Drugs; Ministero dell'Istruzione, dell'Universita` e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Ente Cassa di Risparmio di Firenze(Fondazione Cassa Risparmio Firenze)	This work was supported by grants from the European Commission (Projects MEST-CT-2004-504391, SFMET Number 201640, SPINE2-COMPLEXES Number 031220, and Nano4Drugs Number LSHB-CT-2005019102), the Ministero dell'Istruzione, dell'Universita` e della Ricerca (PRIN 2005, Protocollo Number 2005039878, Protocollo RBLA032ZM7, Protocollo RBIP06LSS2), and the Ente Cassa di Risparmio di Firenze.	Aime S, 2002, J BIOL INORG CHEM, V7, P617, DOI 10.1007/s00775-002-0340-8; Andreini C, 2004, J PROTEOME RES, V3, P21, DOI 10.1021/pr0340476; Arumugam S, 1998, BIOCHEMISTRY-US, V37, P9650, DOI 10.1021/bi980128h; Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n; Bernini A, 2008, BIOPHYS CHEM, V137, P71, DOI 10.1016/j.bpc.2008.07.003; Bertini I, 2004, ANGEW CHEM INT EDIT, V43, P2254, DOI 10.1002/anie.200353453; Bertini I, 2003, ANGEW CHEM INT EDIT, V42, P2673, DOI 10.1002/anie.200350957; Bertini I, 2005, P NATL ACAD SCI USA, V102, P5334, DOI 10.1073/pnas.0407106102; Bertini I, 2008, J AM CHEM SOC, V130, P7011, DOI 10.1021/ja710491y; Bertini I, 2006, ANGEW CHEM INT EDIT, V45, P7952, DOI 10.1002/anie.200603100; Bhaskaran R, 2008, J BIOL CHEM, V283, P21779, DOI 10.1074/jbc.M709966200; Bode W, 2003, BIOL CHEM, V384, P863, DOI 10.1515/BC.2003.097; BODE W, 1994, EMBO J, V13, P1263, DOI 10.1002/j.1460-2075.1994.tb06378.x; Brinckerhoff CE, 2002, NAT REV MOL CELL BIO, V3, P207, DOI 10.1038/nrm763; Cha J, 1997, BIOCHEMISTRY-US, V36, P16019, DOI 10.1021/bi972223g; Chung LD, 2004, EMBO J, V23, P3020, DOI 10.1038/sj.emboj.7600318; CLARK IM, 1989, BIOCHEM J, V263, P201, DOI 10.1042/bj2630201; de la Torre JG, 2000, J MAGN RESON, V147, P138, DOI 10.1006/jmre.2000.2170; ESPOSITO G, 1992, J MOL BIOL, V224, P659, DOI 10.1016/0022-2836(92)90551-T; Gall AL, 2001, J MOL BIOL, V307, P577, DOI 10.1006/jmbi.2001.4493; Gioia M, 2002, J BIOL CHEM, V277, P23123, DOI 10.1074/jbc.M110873200; Gioia M, 2007, J MOL BIOL, V368, P1101, DOI 10.1016/j.jmb.2007.02.076; Grzesiek S, 1996, NAT STRUCT BIOL, V3, P340, DOI 10.1038/nsb0496-340; Guinier A., 1939, ANN PHYS-NEW YORK, V11, P161, DOI DOI 10.1051/ANPHYS/193911120161; Impagliazzo A, 2004, J AM CHEM SOC, V126, P5658, DOI 10.1021/ja049619h; Iyer S, 2006, J MOL BIOL, V362, P78, DOI 10.1016/j.jmb.2006.06.079; Jarvet J, 2007, J BIOMOL NMR, V39, P63, DOI 10.1007/s10858-007-9176-4; Jozic D, 2005, J BIOL CHEM, V280, P9578, DOI 10.1074/jbc.M411084200; KAY LE, 1992, J MAGN RESON, V97, P359, DOI 10.1016/0022-2364(92)90320-7; Keller R., 2004, COMPUTER AIDED RESON, V1; Knauper V, 1997, J BIOL CHEM, V272, P7608, DOI 10.1074/jbc.272.12.7608; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Lauer-Fields JL, 2000, J BIOL CHEM, V275, P13282, DOI 10.1074/jbc.275.18.13282; Lauer-Fields JL, 2002, BIOPOLYMERS, V66, P19, DOI 10.1002/bip.10201; LI J, 1995, STRUCTURE, V3, P541, DOI 10.1016/S0969-2126(01)00188-5; Massova I, 1998, FASEB J, V12, P1075, DOI 10.1096/fasebj.12.12.1075; Minond D, 2004, BIOCHEMISTRY-US, V43, P11474, DOI 10.1021/bi048938i; Morgunova E, 1999, SCIENCE, V284, P1667, DOI 10.1126/science.284.5420.1667; MURPHY G, 1992, J BIOL CHEM, V267, P9612; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Nagase H, 1999, J BIOL CHEM, V274, P21491, DOI 10.1074/jbc.274.31.21491; Nanga RPR, 2008, BIOCHEMISTRY-US, V47, P12689, DOI 10.1021/bi8014357; Nesi A, 2007, CHEMBIOCHEM, V8, P1367, DOI 10.1002/cbic.200700055; Ottl J, 2000, CHEM BIOL, V7, P119, DOI 10.1016/S1074-5521(00)00077-6; Overall CM, 2007, STRUCTURE, V15, P1159, DOI 10.1016/j.str.2007.10.001; Overall CM, 2002, MOL BIOTECHNOL, V22, P51, DOI 10.1385/MB:22:1:051; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; PENG JW, 1994, METHOD ENZYMOL, V239, P563; Pintacuda G, 2002, J AM CHEM SOC, V124, P372, DOI 10.1021/ja016985h; Respondek M, 2007, J AM CHEM SOC, V129, P5228, DOI 10.1021/ja069004f; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; Rosenblum G, 2007, J AM CHEM SOC, V129, P13566, DOI 10.1021/ja073941l; Rosenblum G, 2007, STRUCTURE, V15, P1227, DOI 10.1016/j.str.2007.07.019; Saffarian S, 2004, SCIENCE, V306, P108, DOI 10.1126/science.1099179; Scarselli M, 1998, EUR J BIOCHEM, V254, P313, DOI 10.1046/j.1432-1327.1998.2540313.x; Scarselli M, 1999, J BIOMOL NMR, V15, P125, DOI 10.1023/A:1008319507565; Spiga O, 2002, FEBS LETT, V511, P33, DOI 10.1016/S0014-5793(01)03274-4; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Tam EM, 2004, J BIOL CHEM, V279, P43336, DOI 10.1074/jbc.M407186200; Tam EM, 2002, J BIOL CHEM, V277, P39005, DOI 10.1074/jbc.M206874200; Van den Steen PE, 2006, J BIOL CHEM, V281, P18626, DOI 10.1074/jbc.M512308200; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Wang TZ, 2005, J AM CHEM SOC, V127, P828, DOI 10.1021/ja045743p; Yuan T, 1999, J BIOL CHEM, V274, P8411, DOI 10.1074/jbc.274.13.8411	66	64	64	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12821	12828		10.1074/jbc.M809627200	http://dx.doi.org/10.1074/jbc.M809627200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19282283	Green Published, hybrid			2022-12-27	WOS:000265688300027
J	Deck, KM; Vasanthakumar, A; Anderson, SA; Goforth, JB; Kennedy, MC; Antholine, WE; Eisenstein, RS				Deck, Kathryn M.; Vasanthakumar, Aparna; Anderson, Sheila A.; Goforth, Jeremy B.; Kennedy, M. Claire; Antholine, William E.; Eisenstein, Richard S.			Evidence That Phosphorylation of Iron Regulatory Protein 1 at Serine 138 Destabilizes the [4Fe-4S] Cluster in Cytosolic Aconitase by Enhancing 4Fe-3Fe Cycling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELEMENT-BINDING-PROTEIN; FE-S CLUSTER; NITRIC-OXIDE; SULFUR CLUSTER; RNA-BINDING; BEEF-LIVER; HOMEOSTASIS; PEROXYNITRITE; SUPEROXIDE; ACTIVATION	Iron-sulfur cluster-dependent interconversion of iron regulatory protein 1 (IRP1) between its RNA binding and cytosolic aconitase (c-acon) forms controls vertebrate iron homeostasis. Cluster removal from c-acon is thought to include oxidative demetallation as a required step, but little else is understood about the process of conversion to IRP1. In comparison with c-acon(WT), Ser(138) phosphomimetic mutants of c-acon contain an unstable [4Fe-4S] cluster and were used as tools to further define the pathway(s) of iron-sulfur cluster disassembly. Under anaerobic conditions cluster insertion into purified IRP1(S138E) and cluster loss on treatment with NO regulated aconitase and RNA binding activity over a similar range as observed for IRP1(WT). However, activation of RNA binding of c-acon(S138E) was an order of magnitude more sensitive to NO than for c-acon(WT). Consistent with this, an altered set point between RNA-binding and aconitase forms was observed for IRP1(S138E) when expressed in HEK cells. Active c-acon(S138E) could only accumulate under hypoxic conditions, suggesting enhanced cluster disassembly in normoxia. Cluster disassembly mechanisms were further probed by determining the impact of iron chelation on acon activity. Unexpectedly EDTA rapidly inhibited c-acon(S138E) activity without affecting c-acon(WT). Additional chelator experiments suggested that cluster loss can be initiated in c-acon(S138E) through a spontaneous nonoxidative demetallation process. Taken together, our results support a model wherein Ser(138) phosphorylation sensitizes IRP1/c-acon to decreased iron availability by allowing the [4Fe-4S](2+) cluster to cycle with [3Fe-4S](0) in the absence of cluster perturbants, indicating that regulation can be initiated merely by changes in iron availability.	[Deck, Kathryn M.; Vasanthakumar, Aparna; Anderson, Sheila A.; Goforth, Jeremy B.; Eisenstein, Richard S.] Univ Wisconsin, Dept Nutr Sci, Madison, WI 53706 USA; [Kennedy, M. Claire] Med Coll Wisconsin, Dept Biochem, Milwaukee, WI 53226 USA; [Antholine, William E.] Med Coll Wisconsin, Dept Biophys, Natl Biomed Esr Ctr, Milwaukee, WI 53226 USA	University of Wisconsin System; University of Wisconsin Madison; Medical College of Wisconsin; Medical College of Wisconsin	Eisenstein, RS (corresponding author), Univ Wisconsin, Dept Nutr Sci, 1415 Linden Dr, Madison, WI 53706 USA.	eisenste@nutrisci.wisc.edu			National Institutes of Health [DK 66600]; National Biomedical ESR Center [EB001980]; United States Department of Agriculture Cooperative States Research Education and Extension Service [2006-35200-16604]; University of Wisconsin-Madison Hatch [4885]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB001980] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007665, R01DK066600, R56DK066600] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Biomedical ESR Center; United States Department of Agriculture Cooperative States Research Education and Extension Service; University of Wisconsin-Madison Hatch; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by National Institutes of Health Grants DK 66600 (to R. S. E.) and National Biomedical ESR Center Grant EB001980. This work was also supported by United States Department of Agriculture Cooperative States Research Education and Extension Service Grant 2006-35200-16604 and University of Wisconsin-Madison Hatch Project 4885 (to R. S. E.).	BARTON HA, 1990, J BIOL CHEM, V265, P7000; BASILION JP, 1994, ARCH BIOCHEM BIOPHYS, V311, P517, DOI 10.1006/abbi.1994.1270; Beckman JS, 1996, AM J PHYSIOL-CELL PH, V271, pC1424; Beinert H, 1996, CHEM REV, V96, P2335, DOI 10.1021/cr950040z; Bouton C, 1999, CELL MOL LIFE SCI, V55, P1043, DOI 10.1007/s000180050355; BOUTON C, 2003, SCI STKE, pPE17; Brown NM, 2002, J BIOL CHEM, V277, P7246, DOI 10.1074/jbc.M110282200; Brown NM, 1998, P NATL ACAD SCI USA, V95, P15235, DOI 10.1073/pnas.95.26.15235; Cairo G, 2002, BIOCHEMISTRY-US, V41, P7435, DOI 10.1021/bi025756k; Chen OS, 1997, J NUTR, V127, P238, DOI 10.1093/jn/127.2.238; Clarke SL, 2006, EMBO J, V25, P544, DOI 10.1038/sj.emboj.7600954; Cooper CE, 1999, BBA-BIOENERGETICS, V1411, P290, DOI 10.1016/S0005-2728(99)00021-3; DRAPIER JC, 1993, EMBO J, V12, P3643, DOI 10.1002/j.1460-2075.1993.tb06038.x; Eisenstein RS, 1997, CH MICROBIOL SER, P157; EMPTAGE MH, 1983, J BIOL CHEM, V258, P1106; Fillebeen C, 2003, MOL CELL BIOL, V23, P6973, DOI 10.1128/MCB.23.19.6973-6981.2003; Gardner PR, 1997, BIOSCIENCE REP, V17, P33, DOI 10.1023/A:1027383100936; GARDNER PR, 1995, J BIOL CHEM, V270, P13399, DOI 10.1074/jbc.270.22.13399; GUO B, 1995, J BIOL CHEM, V270, P21645, DOI 10.1074/jbc.270.37.21645; HAILE DJ, 1992, P NATL ACAD SCI USA, V89, P7536, DOI 10.1073/pnas.89.16.7536; HAILE DJ, 1992, P NATL ACAD SCI USA, V89, P11735, DOI 10.1073/pnas.89.24.11735; Hanson ES, 1999, J BIOL CHEM, V274, P5047, DOI 10.1074/jbc.274.8.5047; Hanson ES, 1998, J BIOL CHEM, V273, P7588, DOI 10.1074/jbc.273.13.7588; HENSON CP, 1967, J BIOL CHEM, V242, P3833; HENTZE MW, 1989, SCIENCE, V244, P357, DOI 10.1126/science.2711187; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Imlay JA, 2006, MOL MICROBIOL, V59, P1073, DOI 10.1111/j.1365-2958.2006.05028.x; Jordan PA, 1999, BIOCHEM J, V344, P739, DOI 10.1042/0264-6021:3440739; Kennedy MC, 1997, J BIOL CHEM, V272, P20340, DOI 10.1074/jbc.272.33.20340; KENNEDY MC, 1992, P NATL ACAD SCI USA, V89, P11730, DOI 10.1073/pnas.89.24.11730; KENNEDY MC, 1983, J BIOL CHEM, V258, P1098; Kiley PJ, 2003, CURR OPIN MICROBIOL, V6, P181, DOI 10.1016/S1369-5274(03)00039-0; Meyron-Holtz EG, 2004, SCIENCE, V306, P2087, DOI 10.1126/science.1103786; Meyron-Holtz EG, 2004, EMBO J, V23, P386, DOI 10.1038/sj.emboj.7600041; Muckenthaler MU, 2008, ANNU REV NUTR, V28, P197, DOI 10.1146/annurev.nutr.28.061807.155521; PRESS WH, 1986, NUMERICAL RECIPES AR; Rouault T A, 1996, EXS, V77, P183; Rouault TA, 1996, TRENDS BIOCHEM SCI, V21, P174, DOI 10.1016/0968-0004(96)10024-4; Rouault TA, 2006, NAT CHEM BIOL, V2, P406, DOI 10.1038/nchembio807; SAMANIEGO F, 1994, J BIOL CHEM, V269, P30904; Schalinske KL, 1997, BIOCHEMISTRY-US, V36, P3950, DOI 10.1021/bi9624447; Schalinske KL, 1996, J BIOL CHEM, V271, P7168, DOI 10.1074/jbc.271.12.7168; Schneider BD, 2003, BLOOD, V102, P3404, DOI 10.1182/blood-2003-02-0433; Shaw GC, 2006, NATURE, V440, P96, DOI 10.1038/nature04512; Soum E, 2003, BIOCHEMISTRY-US, V42, P7648, DOI 10.1021/bi030041i; Soum E, 2003, J BIOL INORG CHEM, V8, P226, DOI 10.1007/s00775-002-0412-9; Tacchini L, 1999, J BIOL CHEM, V274, P24142, DOI 10.1074/jbc.274.34.24142; Tarpey MM, 2001, CIRC RES, V89, P224, DOI 10.1161/hh1501.094365; Varghese S, 2003, J BACTERIOL, V185, P221, DOI 10.1128/JB.185.1.221-230.2003; Walden WE, 2002, P NATL ACAD SCI USA, V99, P4138, DOI 10.1073/pnas.082108799; Wallander ML, 2006, BBA-MOL CELL RES, V1763, P668, DOI 10.1016/j.bbamcr.2006.05.004; WEISS G, 1993, EMBO J, V12, P3651, DOI 10.1002/j.1460-2075.1993.tb06039.x	52	23	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12701	12709		10.1074/jbc.M807717200	http://dx.doi.org/10.1074/jbc.M807717200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19269970	hybrid, Green Published			2022-12-27	WOS:000265688300014
J	Galli, C; Fu, Q; Wang, WF; Olsen, BR; Manolagas, SC; Jilka, RL; O'Brien, CA				Galli, Carlo; Fu, Qiang; Wang, WenFang; Olsen, Bjorn R.; Manolagas, Stavros C.; Jilka, Robert L.; O'Brien, Charles A.			Commitment to the Osteoblast Lineage Is Not Required for RANKL Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B LIGAND; OSTEOCLAST-DIFFERENTIATION-FACTOR; DISTANT TRANSCRIPTIONAL ENHANCER; INCREASED BONE-FORMATION; GROWTH-FACTOR-BETA; RECEPTOR ACTIVATOR; MESSENGER-RNA; OSTEOPROTEGERIN EXPRESSION; MEDIATED DEGRADATION; TARGETED DELETION	Differentiation of bone-resorbing osteoclasts from hematopoietic precursors depends upon expression of the cytokine receptor activator of NF kappa B ligand (RANKL) by fibroblastic stromal cells, which some evidence suggests are of the osteoblast lineage. We have shown previously that hormonal-responsiveness of the murine RANKL gene is mediated in part by a distal enhancer that binds Runx2, a transcription factor required for commitment to the osteoblast lineage, supporting the idea that osteoclast-supporting stromal cells may be osteoblasts or their progenitors. However, in this study we demonstrate that parathyroid hormone (PTH) stimulation of RANKL in mice is not affected by a significant reduction in the number of osteoblasts. Consistent with this, neither Runx2, nor Cbfb, a binding partner essential for Runx activity, are required for basal or PTH-stimulated RANKL expression in fibroblastic stromal cell models. Nonetheless, RANKL responsiveness to PTH was elevated in cultured calvaria cells expressing high levels of osterix, another transcription factor required for osteoblast differentiation, and this was associated with elevated PTH receptor expression. The responsiveness of RANKL to 1,25-dihydroxyvitamin D-3 was not elevated in the osterix-expressing cells. Together, these results suggest that commitment to the osteoblast lineage is not a requirement for RANKL gene transcription in fibroblastic stromal cells but may enhance responsiveness of this gene to specific hormones via control of their receptors.	[Galli, Carlo; Fu, Qiang; Manolagas, Stavros C.; Jilka, Robert L.; O'Brien, Charles A.] Univ Arkansas Med Sci, Ctr Osteoporosis & Metab Bone Dis, Little Rock, AR 72205 USA; [Galli, Carlo; Fu, Qiang; Manolagas, Stavros C.; Jilka, Robert L.; O'Brien, Charles A.] Cent Arkansas Vet Healthcare Syst, Little Rock, AR 72205 USA; [Wang, WenFang; Olsen, Bjorn R.] Harvard Univ, Sch Dent Med, Dept Dev Biol, Boston, MA 02115 USA; [Olsen, Bjorn R.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	University of Arkansas System; University of Arkansas Medical Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System; Harvard University; Harvard School of Dental Medicine; Harvard University; Harvard Medical School	O'Brien, CA (corresponding author), Univ Arkansas Med Sci, Ctr Osteoporosis & Metab Bone Dis, 4301 W Markham St,MS 587, Little Rock, AR 72205 USA.	caobrien@uams.edu	Galli, Carlo/D-4728-2014; O'Brien, Charles A./AAL-5078-2020	Galli, Carlo/0000-0001-7476-7181; 	National Institutes of Health [R01 AR049794, P01 AG13918]; University of Parma; UAMS Tobacco Settlement Funds; Veterans Affairs Merit Reviews; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049794] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG013918] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Parma; UAMS Tobacco Settlement Funds; Veterans Affairs Merit Reviews(US Department of Veterans Affairs); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 AR049794 (to C.A.O.) and P01 AG13918 (to S. C. M.). This work was also supported by an institutional award from the University of Parma (to C. G.), UAMS Tobacco Settlement Funds, and by Veterans Affairs Merit Reviews (to S. C. M. and R.L.J.).	Akune T, 2004, J CLIN INVEST, V113, P846, DOI 10.1172/JCI200419900; Bellido T, 2003, J BIOL CHEM, V278, P50259, DOI 10.1074/jbc.M307444200; Bilic-Curcic I, 2005, GENESIS, V43, P87, DOI 10.1002/gene.20156; BONEWALD LF, 1990, CLIN ORTHOP RELAT R, P261; Collin-Osdoby P, 2001, J BIOL CHEM, V276, P20659, DOI 10.1074/jbc.M010153200; Corral DA, 1998, P NATL ACAD SCI USA, V95, P13835, DOI 10.1073/pnas.95.23.13835; Eghbali-Fatourechi G, 2003, J CLIN INVEST, V111, P1221, DOI 10.1172/JCI200317215; Eriksen EF, 2007, J BONE MINER RES, V22, P1, DOI 10.1359/JBMR.060910; Fu Q, 2002, J BIOL CHEM, V277, P48868, DOI 10.1074/jbc.M208494200; Fu Q, 2006, MOL CELL BIOL, V26, P6453, DOI 10.1128/MCB.00356-06; Galli C, 2008, ENDOCRINOLOGY, V149, P146, DOI 10.1210/en.2007-0734; Gao YH, 1998, BIOCHEM BIOPH RES CO, V252, P697, DOI 10.1006/bbrc.1998.9643; Geoffroy V, 2002, MOL CELL BIOL, V22, P6222, DOI 10.1128/MCB.22.17.6222-6233.2002; Gori F, 2000, ENDOCRINOLOGY, V141, P4768, DOI 10.1210/endo.141.12.7840; Hikita A, 2006, J BIOL CHEM, V281, P36846, DOI 10.1074/jbc.M606656200; Huang G, 2001, EMBO J, V20, P723, DOI 10.1093/emboj/20.4.723; Huang JC, 2004, J BONE MINER RES, V19, P235, DOI 10.1359/JBMR.0301226; Ikeda T, 2001, J BONE MINER RES, V16, P1416, DOI 10.1359/jbmr.2001.16.8.1416; Ishida A, 2002, J BIOL CHEM, V277, P26217, DOI 10.1074/jbc.M111093200; Jilka RL, 2009, BONE, V44, P275, DOI 10.1016/j.bone.2008.10.037; Jochum W, 2000, NAT MED, V6, P980, DOI 10.1038/79676; Kartsogiannis V, 1999, BONE, V25, P525, DOI 10.1016/S8756-3282(99)00214-8; Kearns AE, 2008, ENDOCR REV, V29, P155, DOI 10.1210/er.2007-0014; Keating A, 2006, CURR OPIN HEMATOL, V13, P419, DOI 10.1097/01.moh.0000245697.54887.6f; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Kong YY, 1999, NATURE, V397, P315, DOI 10.1038/16852; Kundu M, 2002, NAT GENET, V32, P639, DOI 10.1038/ng1050; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Li XD, 2008, J BONE MINER RES, V23, P860, DOI 10.1359/JBMR.080216; Lien CY, 2007, STEM CELLS, V25, P1462, DOI 10.1634/stemcells.2006-0391; Lin SC, 1997, J CLIN INVEST, V100, P1980, DOI 10.1172/JCI119729; Liu WG, 2001, J CELL BIOL, V155, P157, DOI 10.1083/jcb.200105052; MAJESKA RJ, 1982, CALCIFIED TISSUE INT, V34, P59, DOI 10.1007/BF02411210; Mak KK, 2008, DEV CELL, V14, P674, DOI 10.1016/j.devcel.2008.02.003; Manolagas SC, 2000, ENDOCR REV, V21, P115, DOI 10.1210/er.21.2.115; MANOLAGAS SC, 1996, PRINCIPLES BONE BIOL; Miao DS, 2004, ENDOCRINOLOGY, V145, P2046, DOI 10.1210/en.2003-1097; Miller J, 2002, NAT GENET, V32, P645, DOI 10.1038/ng1049; Mori K, 2006, J CELL BIOCHEM, V98, P1629, DOI 10.1002/jcb.20891; Nagy A., 2003, MANIPULATING MOUSE E; Notoya M, 2004, BIOCHEM BIOPH RES CO, V324, P655, DOI 10.1016/j.bbrc.2004.09.101; O'Brien CA, 2002, BONE, V30, P453, DOI 10.1016/S8756-3282(01)00692-5; OBrien CA, 1997, J BIOL CHEM, V272, P15003, DOI 10.1074/jbc.272.23.15003; Ominsky MS, 2008, J BONE MINER RES, V23, P672, DOI 10.1359/JBMR.080109; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Parfitt AM, 2002, BONE, V30, P5, DOI 10.1016/S8756-3282(01)00642-1; Quinn JMW, 2000, J BONE MINER RES, V15, P1459, DOI 10.1359/jbmr.2000.15.8.1459; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Sabatakos G, 2000, NAT MED, V6, P985, DOI 10.1038/79683; Silvestrini G, 2005, J MOL HISTOL, V36, P59, DOI 10.1007/s10735-004-3839-1; TAKAHASHI N, 1988, ENDOCRINOLOGY, V123, P2600, DOI 10.1210/endo-123-5-2600; Tang YY, 2000, FEBS LETT, V470, P167, DOI 10.1016/S0014-5793(00)01312-0; Tat SK, 2008, BONE, V43, P284, DOI 10.1016/j.bone.2008.04.006; Tozum TF, 2004, CALCIFIED TISSUE INT, V75, P60, DOI 10.1007/s00223-004-0119-8; UDAGAWA N, 1989, ENDOCRINOLOGY, V125, P1805, DOI 10.1210/endo-125-4-1805; Ueno Y, 2003, J CELL BIOCHEM, V90, P267, DOI 10.1002/jcb.10623; Usui M, 2008, J BONE MINER RES, V23, P314, DOI 10.1359/JBMR.071025; Walsh MC, 2006, ANNU REV IMMUNOL, V24, P33, DOI 10.1146/annurev.immunol.24.021605.090646; Yasuda H, 1998, P NATL ACAD SCI USA, V95, P3597, DOI 10.1073/pnas.95.7.3597; You LD, 2008, BONE, V42, P172, DOI 10.1016/j.bone.2007.09.047; Zhao S, 2002, J BONE MINER RES, V17, P2068, DOI 10.1359/jbmr.2002.17.11.2068	61	37	40	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12654	12662		10.1074/jbc.M806628200	http://dx.doi.org/10.1074/jbc.M806628200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19279010	Green Published, hybrid			2022-12-27	WOS:000265688300009
J	He, XQ; Ma, Q				He, Xiaoqing; Ma, Qiang			Induction of Metallothionein I by Arsenic via Metal-activated Transcription Factor 1 CRITICAL ROLE OF C-TERMINAL CYSTEINE RESIDUES IN ARSENIC SENSING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESPONSIVE TRANSCRIPTION; FACTOR MTF-1; ZINC FINGERS; SIGNAL-TRANSDUCTION; OXIDATIVE STRESS; GENE-EXPRESSION; NAD(P)H-QUINONE OXIDOREDUCTASE; HEAVY-METALS; MOUSE; PROTECTION	Metal-activated transcription factor 1 (MTF1) mediates the induction of metallothioneins I and II by zinc and stress signals. The mechanism of MTF1 activation has not been well understood. We analyzed the interaction between arsenic (As3+) and MTF1 for Mt1 induction. As3+ potently induces Mt1 mRNA expression in mouse hepa1c1c7 cells. Induction is dependent upon functional MTF1 as induction is lost in Mtf1 knockout cells but is restored upon reconstitution with Mtf1; moreover, As3+ induces the binding of MTF1 to the metal response elements of endogenous Mt1. Induction is not affected by modulating zinc concentrations but is markedly enhanced by cycloheximide. Phenylarsine oxide (PAO), which covalently binds to vicinal protein cysteine thiol groups, induces Mt1 with a magnitude of higher potency than that of As3+. PAO affinity beads effectively pulls down the carboxyl half of MTF1 (MTF1(321-675)) by binding to a cluster of five cysteine residues near the terminus. Preincubation with As3+, Cd2+, Co2+, Ni2+, Ag+, Hg2+, and Bi3+ blocks pulldown ofMTF1(321-675) by PAO beads in vitro and in vivo, indicating that binding of the metal inducers to the same C-terminal cysteine cluster as PAO occurs. Deletion of the C-terminal cysteine cluster or mutation of the cysteine residues abolishes or markedly reduces the transcription activation activity of MTF1 and the ability of MTF1 to restore Mt1 induction in Mtf1 knockout cells. The findings demonstrate a critical role of the C-terminal cysteine cluster of MTF1 in arsenic sensing and gene transcription via arsenic-cysteine thiol interaction.	[He, Xiaoqing; Ma, Qiang] NIOSH, Receptor Biol Lab, Toxicol & Mol Biol Branch, Hlth Effects Lab,Ctr Dis Control & Prevent, Morgantown, WV 26505 USA; [Ma, Qiang] W Virginia Univ, Sch Med, Dept Biochem, Morgantown, WV 26505 USA	Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); West Virginia University	Ma, Q (corresponding author), NIOSH, Receptor Biol Lab, Toxicol & Mol Biol Branch, Hlth Effects Lab,Ctr Dis Control & Prevent, 1095 Willowdale Rd, Morgantown, WV 26505 USA.	qam1@cdc.gov	Ebenso, Eno E./D-2585-2011; ma, qiang/HCI-1013-2022; EBENSO, ENO/AAB-6762-2022	Ebenso, Eno E./0000-0002-0411-9258; EBENSO, ENO/0000-0002-0411-9258				Adams TK, 2002, ENVIRON HEALTH PERSP, V110, P813, DOI 10.1289/ehp.02110s5813; Aitken Alastair, 1996, P487, DOI 10.1007/978-1-60327-259-9_82; Andrews GK, 2001, BIOMETALS, V14, P223, DOI 10.1023/A:1012932712483; Andrews GK, 2000, BIOCHEM PHARMACOL, V59, P95, DOI 10.1016/S0006-2952(99)00301-9; Balamurugan K, 2004, BIOL CHEM, V385, P597, DOI 10.1515/BC.2004.074; Balamurugan K, 2007, EMBO J, V26, P1035, DOI 10.1038/sj.emboj.7601543; Bi YY, 2004, BIOCHEM J, V380, P695, DOI 10.1042/BJ20031677; Bi YY, 2006, J BIOCHEM MOL TOXIC, V20, P57, DOI 10.1002/jbt.20116; Bianco NR, 2005, BIOCHEM J, V385, P279, DOI 10.1042/BJ20040959; BRUGNERA E, 1994, NUCLEIC ACIDS RES, V22, P3167, DOI 10.1093/nar/22.15.3167; Chappell WR, 1997, ENVIRON HEALTH PERSP, V105, P1060, DOI 10.1289/ehp.971051060; Chen XH, 2004, J BIOL CHEM, V279, P4515, DOI 10.1074/jbc.M308924200; Duker AA, 2005, ENVIRON INT, V31, P631, DOI 10.1016/j.envint.2004.10.020; Giedroc DP, 2001, ANTIOXID REDOX SIGN, V3, P577, DOI 10.1089/15230860152542943; Giedroc DP, 2001, J BIOL CHEM, V276, P42322, DOI 10.1074/jbc.M106517200; Golub MS, 1998, J TOXICOL ENV HEAL B, V1, P199, DOI 10.1080/10937409809524552; GOMEZCAMINERO A, 2001, ENVIRON HEALTH CRIT, V224, P1; Gunes C, 1998, EMBO J, V17, P2846, DOI 10.1093/emboj/17.10.2846; He XQ, 2008, CHEM RES TOXICOL, V21, P1375, DOI 10.1021/tx800019a; He XQ, 2007, TOXICOL SCI, V98, P298, DOI 10.1093/toxsci/kfm081; He XQ, 2006, J BIOL CHEM, V281, P23620, DOI 10.1074/jbc.M604120200; Jiang HM, 2003, J BIOL CHEM, V278, P30394, DOI 10.1074/jbc.M303598200; Klaassen CD, 1999, ANNU REV PHARMACOL, V39, P267, DOI 10.1146/annurev.pharmtox.39.1.267; LaRochelle O, 2001, J BIOL CHEM, V276, P41879, DOI 10.1074/jbc.M108313200; LEONARD A, 1980, MUTAT RES, V75, P49, DOI 10.1016/0165-1110(80)90027-5; Li Y, 2006, MOL CELL BIOL, V26, P5580, DOI 10.1128/MCB.00471-06; Lichtlen P, 2001, BIOESSAYS, V23, P1010, DOI 10.1002/bies.1146; Liu J, 2008, CASARETT DOULLS TOXI, P931; Ma Q, 2004, BIOCHEM J, V377, P205, DOI 10.1042/BJ20031123; Ma Q, 2008, CHEM RES TOXICOL, V21, P1651, DOI 10.1021/tx800156s; MASTERS BA, 1994, P NATL ACAD SCI USA, V91, P584, DOI 10.1073/pnas.91.2.584; Mastin JP, 2005, CARDIOVASC TOXICOL, V5, P91, DOI 10.1385/CT:5:2:091; Maur AAD, 1999, BIOL CHEM, V380, P175, DOI 10.1515/BC.1999.026; MICHALSKA AE, 1993, P NATL ACAD SCI USA, V90, P8088, DOI 10.1073/pnas.90.17.8088; Nishikimi A, 2001, BIOCHEM J, V356, P621, DOI 10.1042/0264-6021:3560621; PALMITER RD, 1994, P NATL ACAD SCI USA, V91, P1219, DOI 10.1073/pnas.91.4.1219; Palmiter RD, 2004, P NATL ACAD SCI USA, V101, P4918, DOI 10.1073/pnas.0401022101; Palmiter RD, 1998, P NATL ACAD SCI USA, V95, P8428, DOI 10.1073/pnas.95.15.8428; Potter BM, 2005, J BIOL CHEM, V280, P28529, DOI 10.1074/jbc.M505217200; RADTKE F, 1993, EMBO J, V12, P1355, DOI 10.1002/j.1460-2075.1993.tb05780.x; RADTKE F, 1995, NUCLEIC ACIDS RES, V23, P2277, DOI 10.1093/nar/23.12.2277; SARKAR B, 1983, BIOL ASPECTS METALS, P1; Saydam N, 2002, J BIOL CHEM, V277, P20438, DOI 10.1074/jbc.M110631200; Saydam N, 2003, J BIOL CHEM, V278, P31879, DOI 10.1074/jbc.M302138200; Selvaraj A, 2005, GENE DEV, V19, P891, DOI 10.1101/gad.1301805; STUART GW, 1985, NATURE, V317, P828, DOI 10.1038/317828a0; Tamura Y, 2005, ONCOGENE, V24, P399, DOI 10.1038/sj.onc.1208197; TAYLOR PR, 1989, BRIT J IND MED, V46, P881; Tseng CH, 2005, J ENVIRON SCI HEAL C, V23, P55, DOI 10.1081/GNC-200051860; Wang Y, 2004, FASEB J, V18, P1071, DOI 10.1096/fj.03-1282com; Wang ZY, 2008, BLOOD, V111, P2505, DOI 10.1182/blood-2007-07-102798; WESTIN G, 1988, EMBO J, V7, P3763, DOI 10.1002/j.1460-2075.1988.tb03260.x; Zhang B, 2003, MOL CELL BIOL, V23, P8471, DOI 10.1128/MCB.23.23.8471-8485.2003	53	45	45	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12609	12621		10.1074/jbc.M901204200	http://dx.doi.org/10.1074/jbc.M901204200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19276070	Green Published, hybrid			2022-12-27	WOS:000265688300005
J	Pakotiprapha, D; Liu, Y; Verdine, GL; Jeruzalmi, D				Pakotiprapha, Danaya; Liu, Yi; Verdine, Gregory L.; Jeruzalmi, David			A Structural Model for the Damage-sensing Complex in Bacterial Nucleotide Excision Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; (A)BC EXCINUCLEASE; LIGHT-SCATTERING; COUPLING FACTOR; ACTIVE-SITE; NMR SYSTEM; 5 INCISION; UVRB; DNA; BINDING	Nucleotide excision repair is distinguished from other DNA repair pathways by its ability to process a wide range of structurally unrelated DNA lesions. In bacteria, damage recognition is achieved by the UvrA.UvrB ensemble. Here, we report the structure of the complex between the interaction domains of UvrA and UvrB. These domains are necessary and sufficient for full-length UvrA and UvrB to associate and thereby form the DNA damage-sensing complex of bacterial nucleotide excision repair. The crystal structure and accompanying biochemical analyses suggest a model for the complete damage-sensing complex.	[Pakotiprapha, Danaya; Liu, Yi; Verdine, Gregory L.; Jeruzalmi, David] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Pakotiprapha, Danaya; Verdine, Gregory L.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Verdine, Gregory L.] Dana Farber Canc Inst, Program Canc Chem Biol, Boston, MA 02115 USA	Harvard University; Harvard University; Harvard University; Dana-Farber Cancer Institute	Verdine, GL (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	gregory_verdine@harvard.edu; dj@mcb.harvard.edu	Pakotiprapha, Danaya/B-1032-2013	Pakotiprapha, Danaya/0000-0002-5017-8283	National Institutes of Health [CA100742]; National Center for Research Resources [RR-15301]; National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA100742] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported, in whole or in part, by National Institutes of Health Grant CA100742 (to G. L. V.). This work was also supported by Award RR-15301 from the National Center for Research Resources at the National Institutes of Health.	Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; BERTRANDBURGGRAF E, 1991, J MOL BIOL, V219, P27, DOI 10.1016/0022-2836(91)90854-Y; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Deaconescu AM, 2006, CELL, V124, P507, DOI 10.1016/j.cell.2005.11.045; Delagoutte E, 2002, J MOL BIOL, V320, P73, DOI 10.1016/S0022-2836(02)00401-1; DellaVecchia MJ, 2004, J BIOL CHEM, V279, P45245, DOI 10.1074/jbc.M408659200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Folta-Stogniew Ewa, 2006, V328, P97; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; HSU DS, 1995, J BIOL CHEM, V270, P8319, DOI 10.1074/jbc.270.14.8319; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; LIN JJ, 1992, J BIOL CHEM, V267, P17693; LIN JJ, 1992, J BIOL CHEM, V267, P17688; Malta E, 2007, BIOCHEMISTRY-US, V46, P9080, DOI 10.1021/bi7002235; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MELLON I, 1989, NATURE, V342, P95, DOI 10.1038/342095a0; Moolenaar GF, 2000, J BIOL CHEM, V275, P8044, DOI 10.1074/jbc.275.11.8044; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; ORREN DK, 1992, J BIOL CHEM, V267, P780; ORREN DK, 1989, P NATL ACAD SCI USA, V86, P5237, DOI 10.1073/pnas.86.14.5237; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pakotiprapha D, 2008, MOL CELL, V29, P122, DOI 10.1016/j.molcel.2007.10.026; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; SELBY CP, 1993, SCIENCE, V260, P53, DOI 10.1126/science.8465200; SELBY CP, 1995, J BIOL CHEM, V270, P4882, DOI 10.1074/jbc.270.9.4882; SELBY CP, 1991, P NATL ACAD SCI USA, V88, P11574, DOI 10.1073/pnas.88.24.11574; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Truglio JJ, 2006, NAT STRUCT MOL BIOL, V13, P360, DOI 10.1038/nsmb1072; Truglio JJ, 2006, CHEM REV, V106, P233, DOI 10.1021/cr040471u; Truglio JJ, 2004, EMBO J, V23, P2498, DOI 10.1038/sj.emboj.7600263; Verhoeven EEA, 2000, J BIOL CHEM, V275, P5120, DOI 10.1074/jbc.275.7.5120; Verhoeven EEA, 2002, EMBO J, V21, P4196, DOI 10.1093/emboj/cdf396; WYATT PJ, 1991, BIOCHEM SOC T, V19, P485, DOI 10.1042/bst0190485	34	40	40	2	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12837	12844		10.1074/jbc.M900571200	http://dx.doi.org/10.1074/jbc.M900571200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19287003	Green Published, hybrid			2022-12-27	WOS:000265688300029
J	Sun, W; Shahinas, D; Bonvin, J; Hou, WJ; Kimber, MS; Turnbull, J; Christendat, D				Sun, Warren; Shahinas, Dea; Bonvin, Julie; Hou, Wenjuan; Kimber, Matthew S.; Turnbull, Joanne; Christendat, Dinesh			The Crystal Structure of Aquifex aeolicus Prephenate Dehydrogenase Reveals the Mode of Tyrosine Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TYRA PROTEIN FAMILY; ESCHERICHIA-COLI; AROGENATE DEHYDROGENASE; BIOCHEMICAL-CHARACTERIZATION; ARABIDOPSIS-THALIANA; BIOSYNTHESIS; REFINEMENT; PATHWAY; SYNECHOCYSTIS; PURIFICATION	TyrA proteins belong to a family of dehydrogenases that are dedicated to L-tyrosine biosynthesis. The three TyrA subclasses are distinguished by their substrate specificities, namely the prephenate dehydrogenases, the arogenate dehydrogenases, and the cyclohexadienyl dehydrogenases, which utilize prephenate, L-arogenate, or both substrates, respectively. The molecular mechanism responsible for TyrA substrate selectivity and regulation is unknown. To further our understanding of TyrA-catalyzed reactions, we have determined the crystal structures of Aquifex aeolicus prephenate dehydrogenase bound with NAD(+) plus either 4-hydroxyphenylpyuvate, 4-hydroxyphenylpropionate, or L-tyrosine and have used these structures as guides to target active site residues for site-directed mutagenesis. From a combination of mutational and structural analyses, we have demonstrated that His-147 and Arg-250 are key catalytic and binding groups, respectively, and Ser-126 participates in both catalysis and substrate binding through the ligand 4-hydroxyl group. The crystal structure revealed that tyrosine, a known inhibitor, binds directly to the active site of the enzyme and not to an allosteric site. The most interesting finding though, is that mutating His-217 relieved the inhibitory effect of tyrosine on A. aeolicus prephenate dehydrogenase. The identification of a tyrosine-insensitive mutant provides a novel avenue for designing an unregulated enzyme for application in metabolic engineering.	[Sun, Warren; Shahinas, Dea; Christendat, Dinesh] Univ Toronto, Dept Cell & Syst Biol, Toronto, ON M5S 3G5, Canada; [Bonvin, Julie; Hou, Wenjuan; Turnbull, Joanne] Concordia Univ, Dept Chem & Biochem, Montreal, PQ H4B 1R6, Canada; [Kimber, Matthew S.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada	University of Toronto; Concordia University - Canada; University of Guelph	Christendat, D (corresponding author), Univ Toronto, Dept Cell & Syst Biol, 25 Harbord St, Toronto, ON M5S 3G5, Canada.	dinesh.christendat@utoronto.ca	Kimber, Matthew/Q-8144-2019	Kimber, Matthew/0000-0001-9454-5586	Natural Sciences and Engineering Research Council of Canada; United States Dept. of Energy; Office of Energy Research [W-31-109-ENG-38]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); United States Dept. of Energy; Office of Energy Research	This work was supported in part by research grants from the Natural Sciences and Engineering Research Council of Canada (to D.C. and J.T.). Use of the Argonne National Laboratory Structural Biology Center beamlines at the Advanced Photon Source was supported by the United States Dept. of Energy, Office of Energy Research, under Contract W-31-109-ENG-38.	BONNER C, 1987, METHOD ENZYMOL, V142, P488; BONNER C, 1987, METHOD ENZYMOL, V142, P479; Bonner CA, 2004, BIOCHEM J, V382, P279, DOI 10.1042/BJ20031809; Bonner CA, 2008, MICROBIOL MOL BIOL R, V72, P13, DOI 10.1128/MMBR.00026-07; Bonvin J, 2006, PROTEIN SCI, V15, P1417, DOI 10.1110/ps.051942206; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CHAMPNEY WS, 1970, J BIOL CHEM, V245, P3763; Chipman DM, 2001, CURR OPIN STRUC BIOL, V11, P694, DOI 10.1016/S0959-440X(01)00272-X; Christendat D, 1998, BIOCHEMISTRY-US, V37, P15703, DOI 10.1021/bi981412b; Christendat D, 1999, BIOCHEMISTRY-US, V38, P4782, DOI 10.1021/bi982673o; Cleland W W, 1979, Methods Enzymol, V63, P103; COBBETT CS, 1987, J BACTERIOL, V169, P2500, DOI 10.1128/jb.169.6.2500-2506.1987; DeLano W.L, PYMOL MOL GRAPHICS S; DEWICK PM, 1984, NAT PROD REP, V1, P451, DOI 10.1039/np9840100451; Duzinski P K, 1976, Prep Biochem, V6, P113; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Facchini PJ, 2000, PHYTOCHEMISTRY, V54, P121, DOI 10.1016/S0031-9422(00)00050-9; FAZEL AM, 1979, J BACTERIOL, V138, P805, DOI 10.1128/JB.138.3.805-815.1979; FAZEL AM, 1980, P NATL ACAD SCI-BIOL, V77, P1270, DOI 10.1073/pnas.77.3.1270; JENSEN RA, 1975, J MOL EVOL, V4, P249, DOI 10.1007/BF01732984; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kleywegt GJ, 2007, ACTA CRYSTALLOGR D, V63, P94, DOI [10.1107/S0907444906022657, 10.1107/S907444906022657]; Legrand P, 2006, STRUCTURE, V14, P767, DOI 10.1016/j.str.2006.01.006; LINDBLAD B, 1977, J BIOL CHEM, V252, P5073; Meganathan R, 2001, FEMS MICROBIOL LETT, V203, P131, DOI 10.1016/S0378-1097(01)00330-5; Meganathan R, 2001, VITAM HORM, V61, P173; Memelink J, 2004, NAT BIOTECHNOL, V22, P1526, DOI 10.1038/nbt1204-1526; Mobley EM, 1999, GENE, V240, P115, DOI 10.1016/S0378-1119(99)00423-0; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rinaldi AC, 1998, EUR J BIOCHEM, V251, P91, DOI 10.1046/j.1432-1327.1998.2510091.x; Rippert P, 2002, EUR J BIOCHEM, V269, P4753, DOI 10.1046/j.1432-1033.2002.03172.x; SAMPATHKUMAR P, 1982, BIOCHIM BIOPHYS ACTA, V702, P212, DOI 10.1016/0167-4838(82)90505-2; Song J, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-13; Sun W, 2006, J BIOL CHEM, V281, P12919, DOI 10.1074/jbc.M511986200; Taylor LP, 2005, CURR OPIN PLANT BIOL, V8, P317, DOI 10.1016/j.pbi.2005.03.005; TURNBULL J, 1991, BIOCHEMISTRY-US, V30, P7783, DOI 10.1021/bi00245a017; TURNBULL J, 1991, BIOCHEMISTRY-US, V30, P7777, DOI 10.1021/bi00245a016; Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2; XIA T, 1993, J MOL EVOL, V36, P107, DOI 10.1007/BF00166246; Xie G, 2000, COMP BIOCHEM PHYS C, V125, P65, DOI 10.1016/S0742-8413(99)00090-0	42	17	17	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					13223	13232		10.1074/jbc.M806272200	http://dx.doi.org/10.1074/jbc.M806272200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19279014	hybrid, Green Published			2022-12-27	WOS:000265688300069
J	Anishkin, A; Sukharev, S				Anishkin, Andriy; Sukharev, Sergei			State-stabilizing Interactions in Bacterial Mechanosensitive Channel Gating and Adaptation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							ESCHERICHIA-COLI MSCS; LARGE-CONDUCTANCE; TRANSMEMBRANE HELIX; MOLECULAR-DYNAMICS; MECHANISM; MEMBRANE; TRANSITION; PRESSURE; TENSION; RESIDUE	We outline several principles that we believe define the gating of two bacterial mechanosensitive channels, MscL and MscS. Serving as turgor regulators in bacteria and other walled cells, these molecules are tangible models for studying conformational transitions in membrane proteins driven directly by membrane tension. MscL, a compact pentamer, reversibly opens a gigantic 30-angstrom pore at near-lytic tensions. MscS, a heptameric complex, exhibits transient activation of a smaller pore at moderate tensions, thereby entering a tension-insensitive inactivated state. By comparing the structures and predicted transitions in these channels, we concluded that opening is commonly achieved through tilting and outward motion of the porelining helices, which is kinetically limited by hydration of the pore. The intricate adaptive behavior in MscS appears to depend on specific interhelical associations and the flexibility of the pore-lining helices. We discuss physical factors that may direct the transitions and stabilize main functional states in these channels.	[Anishkin, Andriy; Sukharev, Sergei] Univ Maryland, Dept Biol, College Pk, MD 20742 USA	University System of Maryland; University of Maryland College Park	Sukharev, S (corresponding author), Univ Maryland, Dept Biol, College Pk, MD 20742 USA.	sukharev@umd.edu		Sukharev, Sergei/0000-0002-4807-9665	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075225] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM075225, GM075225] Funding Source: Medline; NINDS NIH HHS [NS03931405A] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Akitake B, 2005, J GEN PHYSIOL, V125, P143, DOI 10.1085/jgp.200409198; Akitake B, 2007, NAT STRUCT MOL BIOL, V14, P1141, DOI 10.1038/nsmb1341; Anishkin A, 2005, J GEN PHYSIOL, V125, P155, DOI 10.1085/jgp.200409118; Anishkin A, 2005, CURR OPIN NEUROBIOL, V15, P397, DOI 10.1016/j.conb.2005.06.002; Anishkin A, 2004, BIOPHYS J, V86, P2883, DOI 10.1016/S0006-3495(04)74340-4; Anishkin A, 2003, J GEN PHYSIOL, V121, P227, DOI 10.1085/jgp.20028768; Anishkin A, 2008, J GEN PHYSIOL, V132, P67, DOI 10.1085/jgp.200810000; Anishkin A, 2008, BIOPHYS J, V94, P1252, DOI 10.1529/biophysj.107.110171; Bartlett JL, 2004, P NATL ACAD SCI USA, V101, P10161, DOI 10.1073/pnas.0402040101; Bass RB, 2002, SCIENCE, V298, P1582, DOI 10.1126/science.1077945; Beckstein O, 2003, P NATL ACAD SCI USA, V100, P7063, DOI 10.1073/pnas.1136844100; Belyy V, 2009, BIOPHYS J, V96, p256A, DOI 10.1016/j.bpj.2008.12.1265; Betanzos M, 2002, NAT STRUCT BIOL, V9, P704, DOI 10.1038/nsb828; Blount P, 1999, Methods Enzymol, V294, P458; Chang G, 1998, SCIENCE, V282, P2220, DOI 10.1126/science.282.5397.2220; Chiang CS, 2004, BIOPHYS J, V86, P2846, DOI 10.1016/S0006-3495(04)74337-4; Cui C, 1996, J MEMBRANE BIOL, V150, P143, DOI 10.1007/s002329900039; Edwards MD, 2005, NAT STRUCT MOL BIOL, V12, P113, DOI 10.1038/nsmb895; Edwards MD, 2004, CURR OPIN MICROBIOL, V7, P163, DOI 10.1016/j.mib.2004.02.006; Gullingsrud J, 2004, BIOPHYS J, V86, P3496, DOI 10.1529/biophysj.103.034322; Gullingsrud J, 2003, BIOPHYS J, V85, P2087, DOI 10.1016/S0006-3495(03)74637-2; Levina N, 1999, EMBO J, V18, P1730, DOI 10.1093/emboj/18.7.1730; Lindahl E, 2000, J CHEM PHYS, V113, P3882, DOI 10.1063/1.1287423; Markin VS, 2004, PHYS BIOL, V1, P110, DOI 10.1088/1478-3967/1/2/007; Melnyk RA, 2004, J BIOL CHEM, V279, P16591, DOI 10.1074/jbc.M313936200; Miller S, 2003, EMBO J, V22, P36, DOI 10.1093/emboj/cdg011; Moe P, 2005, BIOCHEMISTRY-US, V44, P12239, DOI 10.1021/bi0509649; Nomura T, 2008, BIOPHYS J, V94, P1638, DOI 10.1529/biophysj.107.114785; Norman C, 2005, EUR BIOPHYS J BIOPHY, V34, P396, DOI 10.1007/s00249-005-0475-y; Ou XR, 1998, P NATL ACAD SCI USA, V95, P11471, DOI 10.1073/pnas.95.19.11471; Perozo E, 2003, CURR OPIN STRUC BIOL, V13, P432, DOI 10.1016/S0959-440X(03)00106-4; Perozo E, 2002, NAT STRUCT BIOL, V9, P696, DOI 10.1038/nsb827; Perozo E, 2002, NATURE, V418, P942, DOI 10.1038/nature00992; Sotomayor M, 2006, BIOPHYS J, V90, P3496, DOI 10.1529/biophysj.105.080069; Sotomayor M, 2004, BIOPHYS J, V87, P3050, DOI 10.1529/biophysj.104.046045; Sotomayor M, 2007, BIOPHYS J, V92, P886, DOI 10.1529/biophysj.106.095232; Spronk SA, 2006, BIOPHYS J, V90, P3555, DOI 10.1529/biophysj.105.080432; Steinbacher S, 2007, CURR TOP MEMBR, V58, P1, DOI 10.1016/S1063-5823(06)58001-9; Sukharev S, 2002, BIOPHYS J, V83, P290, DOI 10.1016/S0006-3495(02)75169-2; Sukharev S, 2001, BIOPHYS J, V81, P917, DOI 10.1016/S0006-3495(01)75751-7; Sukharev S, 2001, NATURE, V409, P720, DOI 10.1038/35055559; Sukharev SI, 1999, J GEN PHYSIOL, V113, P525, DOI 10.1085/jgp.113.4.525; SUKHAREV SI, 1994, NATURE, V368, P265, DOI 10.1038/368265a0; van den Bogaart G, 2007, BIOPHYS J, V92, P1233, DOI 10.1529/biophysj.106.088708; Vasquez V, 2008, SCIENCE, V321, P1210, DOI 10.1126/science.1159674; Vasquez V, 2008, J MOL BIOL, V378, P55, DOI 10.1016/j.jmb.2007.10.086; Wang WJ, 2008, SCIENCE, V321, P1179, DOI 10.1126/science.1159262; Wiggins P, 2005, BIOPHYS J, V88, P880, DOI 10.1529/biophysj.104.047431; Wood JM, 2001, COMP BIOCHEM PHYS A, V130, P437, DOI 10.1016/S1095-6433(01)00442-1; Yoshimura K, 1999, BIOPHYS J, V77, P1960, DOI 10.1016/S0006-3495(99)77037-2	50	19	19	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 17	2009	284	29					19153	19157		10.1074/jbc.R109.009357	http://dx.doi.org/10.1074/jbc.R109.009357			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	469OE	19383606	hybrid, Green Published			2022-12-27	WOS:000267908300001
J	Schmidt-Glenewinkel, H; Reinz, E; Eils, R; Brady, NR				Schmidt-Glenewinkel, Hannah; Reinz, Eileen; Eils, Roland; Brady, Nathan R.			Systems Biological Analysis of Epidermal Growth Factor Receptor Internalization Dynamics for Altered Receptor Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EGF-RECEPTOR; SIGNAL-TRANSDUCTION; MEDIATED ENDOCYTOSIS; ERBB RECEPTORS; BREAST-CANCER; LIVING CELLS; TYROSINE KINASES; FLOW-CYTOMETRY; ACTIVATION; PROTEIN	Epidermal growth factor (EGF) receptor ( EGFR) overexpression is a hallmark of many cancers. EGFR endocytosis is a critical step in signal attenuation, raising the question of how receptor expression levels affect the internalization process. Here we combined quantitative experimental and mathematical modeling approaches to investigate the role of the EGFR expression level on the rate of receptor internalization. Using tetramethyl-rhodamine-labeled EGF, we established assays for quantifying EGF-triggered EGFR internalization by both high resolution confocal microscopy and flow cytometry. We determined that the flow cytometry approach was more sensitive for examining large populations of cells. Mathematical modeling was used to investigate the relationship between EGF internalization kinetics, EGFR expression, and internalization machinery. We predicted that the standard parameter used to assess internalization kinetics, the temporal evolution r(t) of the ratio of internalized versus surface-located ligand.receptor complexes, does not describe a straight line, as proposed previously. Instead, a convex or concave curve occurs depending on whether initial receptor numbers or internalization adaptors are limiting the uptake reaction, respectively. To test model predictions, we measured EGF-EGFR binding and internalization in cells expressing different levels of green fluorescent protein-EGFR. As expected, surface binding of rhodamine-labeled EGF increased with green fluorescent protein-EGFR expression level. Unexpectedly, internalization of ligand.receptor complexes increased linearly with increasing receptor expression level, suggesting that receptors and not internalization adaptors were limiting the uptake in our experimental model. Finally, determining the ratio of internalized versus surface-located ligand.receptor complexes for this cell line confirmed that	[Eils, Roland] Univ Heidelberg, German Canc Res Ctr, Div Theoret Bioinformat, D-69120 Heidelberg, Germany; [Reinz, Eileen] Univ Heidelberg, German Canc Res Ctr, Infect & Canc Res Program, D-69120 Heidelberg, Germany; [Eils, Roland] Univ Heidelberg, Inst Pharm & Mol Biotechnol & Bioquant, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg	Eils, R (corresponding author), Univ Heidelberg, German Canc Res Ctr, Div Theoret Bioinformat, D-69120 Heidelberg, Germany.	r.eils@dkfz.de	Eils, Roland/B-6121-2009; Brady, Nathan/H-2452-2013	Eils, Roland/0000-0002-0034-4036; Brady, Nathan/0000-0002-1901-5996	Initiative and Networking Fund of the Helmholtz Association	Initiative and Networking Fund of the Helmholtz Association	This work was supported in part by SBCancer within the Helmholtz Alliance on Systems Biology funded by the Initiative and Networking Fund of the Helmholtz Association.	Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Baulida J, 1996, J BIOL CHEM, V271, P5251; Bremm A, 2008, CANCER RES, V68, P707, DOI 10.1158/0008-5472.CAN-07-1588; Ceresa BP, 2000, CURR OPIN CELL BIOL, V12, P204, DOI 10.1016/S0955-0674(99)00077-0; Citri A, 2006, NAT REV MOL CELL BIO, V7, P505, DOI 10.1038/nrm1962; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; de Bruin K, 2007, MOL THER, V15, P1297, DOI 10.1038/sj.mt.6300176; Haglund K, 2003, NAT CELL BIOL, V5, P461, DOI 10.1038/ncb983; Herbst RS, 2004, INT J RADIAT ONCOL, V59, P21, DOI 10.1016/j.ijrobp.2003.11.041; Huang F, 2007, P NATL ACAD SCI USA, V104, P16904, DOI 10.1073/pnas.0707416104; Jarvella S, 2006, NEUROPATH APPL NEURO, V32, P441, DOI 10.1111/j.1365-2990.2006.00758.x; Kapoor V, 2007, NAT METHODS, V4, P678, DOI 10.1038/nmeth0907-678; Karunagaran D, 1996, EMBO J, V15, P254, DOI 10.1002/j.1460-2075.1996.tb00356.x; Kazazic M, 2006, TRAFFIC, V7, P1518, DOI 10.1111/j.1600-0854.2006.00487.x; Kholodenko BN, 2007, NAT CELL BIOL, V9, P247, DOI 10.1038/ncb0307-247; Layfield LJ, 2006, APPL IMMUNOHISTO M M, V14, P91, DOI 10.1097/01.pai.0000159772.73775.2e; Lenferink AEG, 1998, EMBO J, V17, P3385, DOI 10.1093/emboj/17.12.3385; Lidke DS, 2004, NAT BIOTECHNOL, V22, P198, DOI 10.1038/nbt929; LUND KA, 1990, J BIOL CHEM, V265, P15713; Markevich NI, 2004, J CELL BIOL, V164, P353, DOI 10.1083/jcb.200308060; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; Offterdinger M, 2008, TRAFFIC, V9, P147, DOI 10.1111/j.1600-0854.2007.00665.x; OPRESKO LK, 1987, J BIOL CHEM, V262, P4109; Orth JD, 2006, CANCER RES, V66, P3603, DOI 10.1158/0008-5472.CAN-05-2916; Ozcan F, 2006, P NATL ACAD SCI USA, V103, P5735, DOI 10.1073/pnas.0601469103; Pelkmans L, 2005, NATURE, V436, P128, DOI 10.1038/nature03866; Revillion F, 1998, EUR J CANCER, V34, P791, DOI 10.1016/S0959-8049(97)10157-5; Sako Y, 2000, NAT CELL BIOL, V2, P168, DOI 10.1038/35004044; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Schmidt-Glenewinkel H, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-32; Schoeberl B, 2002, NAT BIOTECHNOL, V20, P370, DOI 10.1038/nbt0402-370; Schulze WX, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100012; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Slamon DJ, 2001, NEW ENGL J MED, V344, P783, DOI 10.1056/NEJM200103153441101; Soubeyran P, 2002, NATURE, V416, P183, DOI 10.1038/416183a; Telford W, 2005, CYTOM PART A, V68A, P36, DOI 10.1002/cyto.a.20182; Teramura Y, 2006, EMBO J, V25, P4215, DOI 10.1038/sj.emboj.7601308; Tse GMK, 2009, BREAST CANCER RES TR, V114, P441, DOI 10.1007/s10549-008-0030-5; Vieira AV, 1996, SCIENCE, V274, P2086, DOI 10.1126/science.274.5295.2086; Wang Q, 2005, EMBO REP, V6, P942, DOI 10.1038/sj.embor.7400491; Wang XQ, 2007, CANCER RES, V67, P9986, DOI 10.1158/0008-5472.CAN-07-1300; Waterman H, 1998, J BIOL CHEM, V273, P13819, DOI 10.1074/jbc.273.22.13819; Waterman H, 2001, FEBS LETT, V490, P142, DOI 10.1016/S0014-5793(01)02117-2; WELLS A, 1990, SCIENCE, V247, P962, DOI 10.1126/science.2305263; WILEY HS, 1988, J CELL BIOL, V107, P801, DOI 10.1083/jcb.107.2.801; WILEY HS, 1982, J BIOL CHEM, V257, P4222; Wiley HS, 2003, EXP CELL RES, V284, P78, DOI 10.1016/S0014-4827(03)00002-8; Wiley HS, 2003, TRENDS CELL BIOL, V13, P43; Zwang Y, 2006, EMBO J, V25, P4195, DOI 10.1038/sj.emboj.7601297	52	13	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					17243	17252		10.1074/jbc.M809586200	http://dx.doi.org/10.1074/jbc.M809586200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19297331	Green Published, hybrid			2022-12-27	WOS:000266962400061
J	Wang, JT; Sengupta, P; Guo, YJ; Golebiewska, U; Scarlata, S				Wang, Jingting; Sengupta, Parijat; Guo, Yuanjian; Golebiewska, Urszula; Scarlata, Suzanne			Evidence for a Second, High Affinity G beta gamma Binding Site on G alpha(i1)(GDP) Subunits	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HETEROTRIMERIC G-PROTEINS; PHOSPHOLIPASE-C-BETA; GUANINE-NUCLEOTIDE-BINDING; LIVING CELLS; ADENYLYL-CYCLASE; TRANSMEMBRANE SIGNALS; COUPLED-RECEPTOR; ACTIVATION; MEMBRANE; STIMULATION	It is well known that G alpha(i1)(GDP) binds strongly to G beta gamma subunits to form the G alpha(i1)(GDP)-G beta gamma heterotrimer, and that activation to G alpha(i1)(GTP) results in conformational changes that reduces its affinity for G beta gamma subunits. Previous studies of G protein subunit interactions have used stoichiometric amounts of the proteins. Here, we have found that G alpha(i1)(GDP) can bind a second G beta gamma subunit with an affinity only 10-fold weaker than the primary site and close to the affinity between activated G alpha(i1) and G beta gamma subunits. Also, we find that phospholipase C beta 2, an effector of G beta gamma, does not compete with the second binding site implying that effectors can be bound to the G alpha(i1)(GDP)-(G beta gamma)2 complex. Biophysical measurements and molecular docking studies suggest that this second site is distant from the primary one. A synthetic peptide having a sequence identical to the putative second binding site on G alpha(i1) competes with binding of the second G beta gamma subunit. Injection of this peptide into cultured cells expressing eYFP-G alpha(i1)(GDP) and eCFP-G beta gamma reduces the overall association of the subunits suggesting this site is operative in cells. We propose that this second binding site serves to promote and stabilize G protein subunit interactions in the presence of competing cellular proteins.	[Wang, Jingting; Sengupta, Parijat; Guo, Yuanjian; Golebiewska, Urszula; Scarlata, Suzanne] SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Scarlata, S (corresponding author), SUNY Stony Brook, Dept Physiol & Biophys, Stony Brook, NY 11794 USA.	Suzanne.Scarlata@sunysb.edu			National Institutes of Health [GM53132]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM053132] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM53132.	ALBERTS B, 1994, MOL BIOL CELL, P734; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; Birnbaumer L, 2007, BBA-BIOMEMBRANES, V1768, P772, DOI 10.1016/j.bbamem.2006.12.002; Buck E, 2002, J BIOL CHEM, V277, P49707, DOI 10.1074/jbc.M205553200; Buck E, 1999, SCIENCE, V283, P1332, DOI 10.1126/science.283.5406.1332; Bunemann M, 2003, P NATL ACAD SCI USA, V100, P16077, DOI 10.1073/pnas.2536719100; Cabrera-Vera TM, 2003, ENDOCR REV, V24, P765, DOI 10.1210/er.2000-0026; Chen Y, 1999, BIOPHYS J, V77, P553, DOI 10.1016/S0006-3495(99)76912-2; Chidiac P, 1999, BIOCHEM PHARMACOL, V58, P39, DOI 10.1016/S0006-2952(99)00080-5; Diel S, 2006, J BIOL CHEM, V281, P288, DOI 10.1074/jbc.M511045200; Digby GJ, 2006, P NATL ACAD SCI USA, V103, P17789, DOI 10.1073/pnas.0607116103; Dowal L, 2006, J BIOL CHEM, V281, P23999, DOI 10.1074/jbc.M512330200; Drin G, 2007, CELL SIGNAL, V19, P1383, DOI 10.1016/j.cellsig.2007.04.006; Drin G, 2006, BIOCHEMISTRY-US, V45, P5712, DOI 10.1021/bi052317n; Edidin M, 2003, ANNU REV BIOPH BIOM, V32, P257, DOI 10.1146/annurev.biophys.32.110601.142439; EXTON JH, 1994, ANNU REV PHYSIOL, V56, P349; Exton JH, 1997, EUR J BIOCHEM, V243, P10, DOI 10.1111/j.1432-1033.1997.t01-1-00010.x; Golebiewska U, 2008, BIOPHYS J, V95, P2575, DOI 10.1529/biophysj.108.129353; Hildebrandt JD, 1997, BIOCHEM PHARMACOL, V54, P325, DOI 10.1016/S0006-2952(97)00269-4; Hughes TE, 2001, J BIOL CHEM, V276, P4227, DOI 10.1074/jbc.M007608200; Hynes TR, 2004, J BIOL CHEM, V279, P44101, DOI 10.1074/jbc.M405151200; Janetopoulos C, 2001, SCIENCE, V291, P2408, DOI 10.1126/science.1055835; Li Y, 1998, J BIOL CHEM, V273, P16265, DOI 10.1074/jbc.273.26.16265; Lodowski DT, 2003, SCIENCE, V300, P1256, DOI 10.1126/science.1082348; Medkova M, 2002, BIOCHEMISTRY-US, V41, P9962, DOI 10.1021/bi0255726; Murray D, 2001, J BIOL CHEM, V276, P45153, DOI 10.1074/jbc.M101784200; NEER EJ, 1994, PROTEIN SCI, V3, P3; NEER EJ, 1995, CELL, V80, P249, DOI 10.1016/0092-8674(95)90407-7; Nobles M, 2005, P NATL ACAD SCI USA, V102, P18706, DOI 10.1073/pnas.0504778102; Panchenko MP, 1998, J BIOL CHEM, V273, P28298, DOI 10.1074/jbc.273.43.28298; Philip F, 2007, J BIOL CHEM, V282, P19203, DOI 10.1074/jbc.M701558200; Rebecchi MJ, 2000, PHYSIOL REV, V80, P1291, DOI 10.1152/physrev.2000.80.4.1291; Runnels LW, 1999, BIOCHEMISTRY-US, V38, P1488, DOI 10.1021/bi9821519; Runnels LW, 1998, BIOCHEMISTRY-US, V37, P15563, DOI 10.1021/bi9811258; Sarvazyan NA, 2002, BIOCHEMISTRY-US, V41, P12858, DOI 10.1021/bi026212l; Schwille P, 2001, CELL BIOCHEM BIOPHYS, V34, P383, DOI 10.1385/CBB:34:3:383; Skiba NP, 1996, J BIOL CHEM, V271, P413, DOI 10.1074/jbc.271.1.413; Suh PG, 2008, BMB REP, V41, P415, DOI 10.5483/BMBRep.2008.41.6.415; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; Tesmer JJG, 1997, CELL, V89, P251, DOI 10.1016/S0092-8674(00)80204-4; VANDERMEER W, 1994, RESONANCE ENERGY TRA, P148; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Wang JT, 2009, J MOL BIOL, V387, P92, DOI 10.1016/j.jmb.2009.01.051; WEDEGAERTNER PB, 1995, J BIOL CHEM, V270, P503, DOI 10.1074/jbc.270.2.503	44	8	8	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					16906	16913		10.1074/jbc.M109.006585	http://dx.doi.org/10.1074/jbc.M109.006585			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19369247	hybrid, Green Published			2022-12-27	WOS:000266962400027
J	Ren, J; Hascall, VC; Wang, AM				Ren, Juan; Hascall, Vincent C.; Wang, Aimin			Cyclin D3 Mediates Synthesis of a Hyaluronan Matrix That Is Adhesive for Monocytes in Mesangial Cells Stimulated to Divide in Hyperglycemic Medium	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; SMOOTH-MUSCLE-CELLS; ADIPOCYTE DIFFERENTIATION; ENDOPLASMIC-RETICULUM; DIABETIC-NEPHROPATHY; DEPENDENT KINASES; C/EBP-ALPHA; GLUCOSE; GROWTH; PROLIFERATION	Serum-starved, growth-arrested, near confluent rat mesangial cell cultures were stimulated to divide in medium with low (5.6 mM) or high (25.6 mM) glucose. In high glucose cultures Western blots showed large increases in cyclin D3 and CCAAT/enhancer-binding protein alpha (C/EBP alpha) at 48-72 h, concurrent with the production of a monocyte-adhesive hyaluronan matrix, whereas low glucose and mannitol osmotic control cultures did not. Cyclin D3 small interfering RNA inhibited both the synthesis of this matrix and the up-regulation of C/EBP alpha in cultures exposed to high glucose, indicating that cyclin D3 is a key mediator in regulating responses of dividing mesangial cells to hyperglycemia. A complex with cyclin D3, cyclin-dependent kinase 4, and C/EBP alpha was observed at 48-72 h in the hyperglycemic cultures, and cyclin D3 and C/EBP alpha were spatially co-localized in coalesced perinuclear honeycomb-like structures with embedded hyaluronan. Furthermore, microtubule-associated protein 1 light chain 3, a marker for autophagy, colocalizes with these structures. These results suggest that cyclin D3 is a central coordinator that controls the organization of a complex set of proteins that regulate autophagy, formation of the monocyte-adhesive hyaluronan matrix, and C/EBP alpha-mediated lipogenesis. Abnormal deposits of hyaluronan, cyclin D3, and C/EBP alpha were present in glomeruli of kidney sections from hyperglycemic rats 4 weeks after streptozotocin treatment, indicating that similar processes likely occur in vivo. Mesangial cell cultures treated with poly(I:C) or tunicamycin in normal glucose media synthesized monocyte-adhesive hyaluronan matrices but with concurrent down-regulation of cyclin D3. This indicates that the cyclin D3 mechanism is induced by hyperglycemia and is distinct from those involved in these cell stress responses.	[Wang, Aimin] Cleveland Clin, Dept Biomed Engn, Lerner Res Inst, Cleveland, OH 44195 USA	Cleveland Clinic Foundation	Wang, AM (corresponding author), Cleveland Clin, Dept Biomed Engn, Lerner Res Inst, ND20, Cleveland, OH 44195 USA.	wanga@ccf.org			National Institutes of Health [R01 DK62934, 1P30 AR-050953]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR050953] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK062934] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK62934 (to A. W.) and 1P30 AR-050953.	Bartkova J, 1998, ONCOGENE, V17, P1027, DOI 10.1038/sj.onc.1202016; Blain SW, 2008, CELL CYCLE, V7, P892, DOI 10.4161/cc.7.7.5637; Bloom J, 2007, NAT REV MOL CELL BIO, V8, P149, DOI 10.1038/nrm2105; Bourguignon LYW, 2007, J BIOL CHEM, V282, P19426, DOI 10.1074/jbc.M610054200; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Calabro A, 2000, GLYCOBIOLOGY, V10, P273, DOI 10.1093/glycob/10.3.273; Calabro A, 2000, GLYCOBIOLOGY, V10, P283, DOI 10.1093/glycob/10.3.283; CALVO JC, 1993, ARCH BIOCHEM BIOPHYS, V302, P468, DOI 10.1006/abbi.1993.1241; Cenciarelli C, 1999, MOL CELL BIOL, V19, P5203; COSIO FG, 1995, J AM SOC NEPHROL, V5, P1600; de la Motte CA, 2003, AM J PATHOL, V163, P121, DOI 10.1016/S0002-9440(10)63636-X; de la Motte CA, 1999, J BIOL CHEM, V274, P30747, DOI 10.1074/jbc.274.43.30747; de la Serna IL, 2001, J BIOL CHEM, V276, P41486, DOI 10.1074/jbc.M107281200; Doglioni C, 1998, J PATHOL, V185, P159, DOI 10.1002/(SICI)1096-9896(199806)185:2<159::AID-PATH73>3.0.CO;2-0; Erikstrup C, 2001, EUR J ENDOCRINOL, V145, P193, DOI 10.1530/eje.0.1450193; Evanko SP, 1999, J HISTOCHEM CYTOCHEM, V47, P1331, DOI 10.1177/002215549904701013; Fujimoto M, 2005, BBA-MOL CELL RES, V1745, P38, DOI 10.1016/j.bbamcr.2004.12.007; Garcia-Mata R, 2002, TRAFFIC, V3, P388, DOI 10.1034/j.1600-0854.2002.30602.x; Hascall VC, 2004, BBA-GEN SUBJECTS, V1673, P3, DOI 10.1016/j.bbagen.2004.02.013; HAYASHI JN, 1991, VIRCHOWS ARCH B, V60, P245, DOI 10.1007/BF02899553; HEGELE RG, 1989, CLIN INVEST MED, V12, P181; Jones S, 2001, KIDNEY INT, V59, P1739, DOI 10.1046/j.1523-1755.2001.0590051739.x; Lauer ME, 2007, J BIOL CHEM, V282, P843, DOI 10.1074/jbc.M608823200; MACDOUGALD OA, 1995, ANNU REV BIOCHEM, V64, P345, DOI 10.1146/annurev.bi.64.070195.002021; Majors AK, 2003, J BIOL CHEM, V278, P47223, DOI 10.1074/jbc.M304871200; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; MENE P, 1989, PHYSIOL REV, V69, P1347, DOI 10.1152/physrev.1989.69.4.1347; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/bj20020508; Reichert M, 1999, ONCOGENE, V18, P459, DOI 10.1038/sj.onc.1202308; Rickheim DG, 2002, HEPATOLOGY, V36, P30, DOI 10.1053/jhep.2002.33996; Rosen ED, 2005, PROSTAG LEUKOTR ESS, V73, P31, DOI 10.1016/j.plefa.2005.04.004; Sakaki K, 2008, AUTOPHAGY, V4, P841, DOI 10.4161/auto.6607; Sakaki K, 2008, J BIOL CHEM, V283, P15370, DOI 10.1074/jbc.M710209200; SIMONSON MS, 1990, METHOD ENZYMOL, V187, P544; Takeda M, 2001, METABOLISM, V50, P789, DOI 10.1053/meta.2001.24207; TEMPLETON DM, 1990, J BIOL CHEM, V265, P21764; TOOLE BP, 2000, PROTEOGLYCANS STRUCT, P61; Wang AM, 2004, J BIOL CHEM, V279, P10279, DOI 10.1074/jbc.M312045200; Wang AM, 1996, KIDNEY INT, V49, P437, DOI 10.1038/ki.1996.63; WANG AM, 1994, J CELL PHYSIOL, V159, P295, DOI 10.1002/jcp.1041590213; Wang GL, 2006, MOL CELL BIOL, V26, P2570, DOI 10.1128/MCB.26.7.2570-2582.2006; Wang GL, 2008, EXP CELL RES, V314, P1626, DOI 10.1016/j.yexcr.2008.01.028; Weigel PH, 1997, J BIOL CHEM, V272, P13997, DOI 10.1074/jbc.272.22.13997; Wolf G, 1999, KIDNEY INT, V56, P393, DOI 10.1046/j.1523-1755.1999.00590.x; Wolf G, 2001, AM J PATHOL, V158, P1091, DOI 10.1016/S0002-9440(10)64056-4; Xia L, 2008, AM J PHYSIOL-RENAL, V295, pF1705, DOI 10.1152/ajprenal.00043.2008; Yang JQ, 2005, J BIOL CHEM, V280, P38689, DOI 10.1074/jbc.M503486200; Young B., 1992, Journal of the American Society of Nephrology, V3, P770; YOUNG BA, 1995, KIDNEY INT, V47, P935, DOI 10.1038/ki.1995.139; Zheng XL, 2007, DIABETOLOGIA, V50, P881, DOI 10.1007/s00125-006-0543-6	50	32	33	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16621	16632		10.1074/jbc.M806430200	http://dx.doi.org/10.1074/jbc.M806430200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19276076	Green Published, hybrid			2022-12-27	WOS:000266730900058
J	Derrien, B; Majeran, W; Wollman, FA; Vallon, O				Derrien, Benoit; Majeran, Wojciech; Wollman, Francis-Andre; Vallon, Olivier			Multistep Processing of an Insertion Sequence in an Essential Subunit of the Chloroplast ClpP Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; CHLAMYDOMONAS-REINHARDTII; MESOSTIGMA-VIRIDE; GENOME SEQUENCE; DNA-SEQUENCE; PROTEASE; PROTEINS; GENE; TRANSFORMATION; ARCHITECTURE	In Chlamydomonas reinhardtii, the clpP1 chloroplast gene encoding one of the catalytic subunits of the ClpP protease complex contains a large in-frame insertion sequence (IS1). Based on the Escherichia coli ClpP structure, IS1 is predicted to protrude at the apical surface of the complex, likely influencing the interaction of the catalytic core with ClpC/HSP100 chaperones. Immunoblotting with an anti-ClpP1 antibody detected two immunoreactive forms of ClpP1: ClpP1(H) (59 kDa) and ClpP1(L) (25 kDa). It has been proposed that IS1 is a new type of protein intron (different from inteins). By studying transformants harboring mutations at the predicted borders of IS1 and tags at the C terminus of ClpP1 (tandem affinity purification tag, His tag, Strep.Tag) or within the IS1 sequence (3-hemagglutinin tag), we show that IS1 is not a protein intron and that ClpP1(L) results from endoproteolytic cleavage inside IS1. Processing sites have been identified in the middle of IS1 and near its C terminus. The sites can be mutated without abolishing processing.	[Derrien, Benoit; Wollman, Francis-Andre; Vallon, Olivier] Univ Paris 06, IBPC, UMR7141, CNRS, F-75005 Paris, France; [Majeran, Wojciech] Cornell Univ, Dept Plant Biol, Ithaca, NY 14853 USA	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Cornell University	Vallon, O (corresponding author), Univ Paris 06, IBPC, UMR7141, CNRS, 13 Rue Pierre & Marie Curie, F-75005 Paris, France.	ovallon@ibpc.fr	VALLON, Olivier/AAM-7737-2021		CNRS [UMR7141]; Universite Pierre et Marie Curie-Paris	CNRS(Centre National de la Recherche Scientifique (CNRS)); Universite Pierre et Marie Curie-Paris	This work was supported by CNRS UMR7141 and the Universite Pierre et Marie Curie-Paris 6.	Belanger AS, 2006, MOL GENET GENOMICS, V276, P464, DOI 10.1007/s00438-006-0156-2; BOYNTON JE, 1988, SCIENCE, V240, P1534, DOI 10.1126/science.2897716; Brouard JS, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-290; de Cambiaire JC, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-213; de Cambiaire JC, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-37; GOLDSCHMIDTCLERMONT M, 1991, NUCLEIC ACIDS RES, V19, P4083, DOI 10.1093/nar/19.15.4083; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; GOTTESMAN S, 1993, J BIOL CHEM, V268, P22618; Harris EH, 1989, CHLAMYDOMONAS SOURCE, P25, DOI [DOI 10.1016/B978-0-12-326880-8.50007-9, DOI 10.1126/SCIENCE.246.4936.1503-A]; Higuchi R, 1990, PCR PROTOCOLS GUIDE, P177; Hoskins JR, 2000, J BIOL CHEM, V275, P35361, DOI 10.1074/jbc.M006288200; HUANG CZ, 1994, MOL GEN GENET, V244, P151, DOI 10.1007/BF00283516; Kim YI, 2000, MOL CELL, V5, P639, DOI 10.1016/S1097-2765(00)80243-9; KURAS R, 1994, EMBO J, V13, P1019, DOI 10.1002/j.1460-2075.1994.tb06350.x; Kuroda H, 2003, NATURE, V425, P86, DOI 10.1038/nature01909; Lemieux C, 2000, NATURE, V403, P649, DOI 10.1038/35001059; Lemieux C, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-2; Majeran W, 2005, FEBS J, V272, P5558, DOI 10.1111/j.1742-4658.2005.04951.x; Majeran W, 2000, PLANT CELL, V12, P137; MAURIZI MR, 1990, J BIOL CHEM, V265, P12536; Ortega J, 2004, J STRUCT BIOL, V146, P217, DOI 10.1016/j.jsb.2003.11.023; Peltier JB, 2004, J BIOL CHEM, V279, P4768, DOI 10.1074/jbc.M309212200; Perler FB, 2005, IUBMB LIFE, V57, P469, DOI 10.1080/15216540500163343; Perler FB, 2002, NUCLEIC ACIDS RES, V30, P383, DOI 10.1093/nar/30.1.383; PICCIONI RG, 1981, EUR J BIOCHEM, V117, P93; Pombert JF, 2006, BMC BIOL, V4, DOI 10.1186/1741-7007-4-3; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Shikanai T, 2001, PLANT CELL PHYSIOL, V42, P264, DOI 10.1093/pcp/pce031; Singh SK, 2000, P NATL ACAD SCI USA, V97, P8898, DOI 10.1073/pnas.97.16.8898; Sjogren LLE, 2006, PLANT CELL, V18, P2635, DOI 10.1105/tpc.106.044594; Stanne TM, 2007, J BIOL CHEM, V282, P14394, DOI 10.1074/jbc.M700275200; THOMPSON MW, 1994, J BIOL CHEM, V269, P18201; THOMPSON MW, 1994, J BIOL CHEM, V269, P18209; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Turmel M, 2008, J PHYCOL, V44, P739, DOI 10.1111/j.1529-8817.2008.00510.x; Wang SL, 1997, J BIOL CHEM, V272, P11869, DOI 10.1074/jbc.272.18.11869; Werner R, 1998, PLANT MOL BIOL REP, V16, P295, DOI 10.1023/A:1007583508766	39	11	11	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15408	15415		10.1074/jbc.M109.002733	http://dx.doi.org/10.1074/jbc.M109.002733			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19346247	Green Published, hybrid			2022-12-27	WOS:000266501000008
J	Vosper, JMD; McDowell, GS; Hindley, CJ; Fiore-Heriche, CS; Kucerova, R; Horan, I; Philpott, A				Vosper, Jonathan M. D.; McDowell, Gary S.; Hindley, Christopher J.; Fiore-Heriche, Christelle S.; Kucerova, Romana; Horan, Ian; Philpott, Anna			Ubiquitylation on Canonical and Non-canonical Sites Targets the Transcription Factor Neurogenin for Ubiquitin-mediated Proteolysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NH2-TERMINAL ACETYLATION; DEGRADATION; STABILITY; PROTEINS; MYOD; REQUIRES; NUCLEAR; PATHWAY	Polyubiquitylation targets multiple proteins for degradation by the proteasome. Typically, the first ubiquitin is linked to lysine residues in the substrate for degradation via an isopeptide bond, although rarely ubiquitin linkage to the N-terminal residue has also been observed. We have recently shown that Neurogenin (NGN), a basic helix-loop-helix transcription factor that plays a central role in regulating neuronal differentiation, is degraded by ubiquitin-mediated proteolysis. We have taken a biochemical and mutagenesis approach to investigate sites of ubiquitylation of NGN, initially using extracts of eggs from the frog Xenopus laevis as a source of ubiquitylation and degradation components. NGN can be targeted for destruction by ubiquitylation via lysines or the N terminus. However, we see that a modified NGN, where canonical lysine ubiquitylation and N-terminally linked ubiquitylation are prevented, is nevertheless ubiquitylated and degraded by the proteasome. We show that polyubiquitin chains covalently attach to non-canonical cysteine residues in NGN, and these non-canonical linkages alone are capable of targeting NGN protein for destruction. Importantly, canonical and non-canonical ubiquitylation occurs simultaneously in the native protein and may differ in importance for driving degradation in interphase and mitosis. We conclude that native NGN is ubiquitylated on multiple canonical and non-canonical sites by cellular ubiquitin ligases, and all types of linkage can contribute to protein turnover.	[Vosper, Jonathan M. D.; McDowell, Gary S.; Hindley, Christopher J.; Fiore-Heriche, Christelle S.; Kucerova, Romana; Horan, Ian; Philpott, Anna] Univ Cambridge, Addenbrookes Hosp, Dept Oncol, Hutchison Med Res Council MRC,Res Ctr, Cambridge CB2 0XZ, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Philpott, A (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Oncol, Hutchison Med Res Council MRC,Res Ctr, Cambridge CB2 0XZ, England.	ap113@cam.ac.uk	McDowell, Gary/H-3382-2019	McDowell, Gary/0000-0002-9470-3799; Philpott, Anna/0000-0003-3789-2463	MRC [GO500101, G0700758]; Biotechnology and Biological Sciences Research Council [BB/C 004108/1]; Medical Research Council [G0700758, G0800784B, G0800784, G0300723] Funding Source: researchfish; MRC [G0300723, G0800784] Funding Source: UKRI	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by training awards from the MRC (to J. V. and G. M.), MRC Grants GO500101 (to C. F.- H.) and G0700758 (R. K.), and Biotechnology and Biological Sciences Research Council Grant BB/C 004108/1.	Breitschopf K, 1998, EMBO J, V17, P5964, DOI 10.1093/emboj/17.20.5964; BUTT TR, 1988, J BIOL CHEM, V263, P16364; Cadwell K, 2005, SCIENCE, V309, P127, DOI 10.1126/science.1110340; Carvalho AF, 2007, J BIOL CHEM, V282, P31267, DOI 10.1074/jbc.M706325200; CHAU V, 1989, SCIENCE, V243, P1576, DOI 10.1126/science.2538923; Ciechanover A, 2004, TRENDS CELL BIOL, V14, P103, DOI 10.1016/j.tcb.2004.01.004; Ciechanover Aaron, 2005, V301, P255; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; HERSHKO A, 1991, J BIOL CHEM, V266, P16376; Hoyt MA, 2004, CELL MOL LIFE SCI, V61, P1596, DOI 10.1007/s00018-004-4133-9; Kuo ML, 2004, GENE DEV, V18, P1862, DOI 10.1101/gad.1213904; Lindon C, 2000, MOL CELL BIOL, V20, P8923, DOI 10.1128/MCB.20.23.8923-8932.2000; Lingbeck JM, 2003, J BIOL CHEM, V278, P1817, DOI 10.1074/jbc.M208815200; Meinnel T, 2005, BIOCHIMIE, V87, P701, DOI 10.1016/j.biochi.2005.03.011; MURRAY AW, 1989, NATURE, V339, P275, DOI 10.1038/339275a0; PALMITER RD, 1977, J BIOL CHEM, V252, P8781; Passmore LA, 2004, BIOCHEM J, V379, P513, DOI 10.1042/BJ20040198; Polevoda B, 2003, J MOL BIOL, V325, P595, DOI 10.1016/S0022-2836(02)01269-X; Pollice A, 2008, FEBS LETT, V582, P3257, DOI 10.1016/j.febslet.2008.09.026; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Ravid T, 2007, NAT CELL BIOL, V9, P422, DOI 10.1038/ncb1558; Rodway H, 2004, ONCOGENE, V23, P6186, DOI 10.1038/sj.onc.1207854; RUBENSTEIN P, 1981, J BIOL CHEM, V256, P8149; Sadeh R, 2008, P NATL ACAD SCI USA, V105, P15690, DOI 10.1073/pnas.0808373105; Salic A, 2000, MOL CELL, V5, P523, DOI 10.1016/S1097-2765(00)80446-3; Sun Y, 2001, CELL, V104, P365, DOI 10.1016/S0092-8674(01)00224-0; Tait SWG, 2007, J CELL BIOL, V179, P1453, DOI 10.1083/jcb.200707063; Tintignac LA, 2005, J BIOL CHEM, V280, P2847, DOI 10.1074/jbc.M411346200; Vosper JMD, 2007, BIOCHEM J, V407, P277, DOI 10.1042/BJ20070064; Williams C, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M702038200	30	52	52	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15458	15468		10.1074/jbc.M809366200	http://dx.doi.org/10.1074/jbc.M809366200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19336407	Green Published, hybrid			2022-12-27	WOS:000266501000014
J	Gralle, M; Botelho, MG; Wouters, FS				Gralle, Matthias; Botelho, Michelle Gralle; Wouters, Fred S.			Neuroprotective Secreted Amyloid Precursor Protein Acts by Disrupting Amyloid Precursor Protein Dimers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMAGING MOLECULAR-INTERACTIONS; FAMILIAL ALZHEIMERS-DISEASE; CELL-SURFACE PROTEINS; EXTRACELLULAR DOMAIN; ALPHA-SECRETASE; BETA-SECRETASE; FULL-LENGTH; HIPPOCAMPAL-NEURONS; FLUORESCENT PROTEIN; CYTOPLASMIC DOMAIN	The amyloid precursor protein (APP) is implied both in cell growth and differentiation and in neurodegenerative processes in Alzheimer disease. Regulated proteolysis of APP generates biologically active fragments such as the neuroprotective secreted ectodomain sAPP alpha and the neurotoxic beta-amyloid peptide. Furthermore, it has been suggested that the intact transmembrane APP plays a signaling role, which might be important for both normal synaptic plasticity and neuronal dysfunction in dementia. To understand APP signaling, we tracked single molecules of APP using quantum dots and quantitated APP homodimerization using fluorescence lifetime imaging microscopy for the detection of Forster resonance energy transfer in living neuroblastoma cells. Using selective labeling with synthetic fluorophores, we show that the dimerization of APP is considerably higher at the plasma membrane than in intracellular membranes. Heparan sulfate significantly contributes to the almost complete dimerization of APP at the plasma membrane. Importantly, this technique for the first time structurally defines the initiation of APP signaling by binding of a relevant physiological extracellular ligand; our results indicate APP as receptor for neuroprotective sAPP alpha, as sAPP alpha binding disrupts APP dimers, and this disruption of APP dimers by sAPP alpha is necessary for the protection of neuroblastoma cells against starvation-induced cell death. Only cells expressing reversibly dimerized wild-type, but not covalently dimerized mutant APP are protected by sAPP alpha. These findings suggest a potentially beneficial effect of increasing sAPP alpha production or disrupting APP dimers for neuronal survival.	[Gralle, Matthias; Wouters, Fred S.] Univ Gottingen, Lab Mol & Cellular Syst, Dept Neurophysiol & Sensory Physiol, D-37073 Gottingen, Germany; [Botelho, Michelle Gralle] Max Planck Inst Biophys Chem, Lab Cellular Dynam, D-37070 Gottingen, Germany	University of Gottingen; Max Planck Society	Gralle, M (corresponding author), Max Planck Inst Evolutionary Anthropol, Dept Mol Genet, Deutsch Pl 6, D-04103 Leipzig, Germany.	matthias.gralle@eva.mpg.de	Gralle, Matthias/B-9005-2014; Caarls, Michelle Botelho/T-7976-2019		German Federal Ministry for Education and Research (Bundesministerium fur Bildung und Forschung); European Neuroscience Institute Gottinge	German Federal Ministry for Education and Research (Bundesministerium fur Bildung und Forschung)(Federal Ministry of Education & Research (BMBF)); European Neuroscience Institute Gottinge	This work was supported by the German Federal Ministry for Education and Research (Bundesministerium fur Bildung und Forschung) for the project "FLI-Cam" in the Biophotonik III program and from the European Neuroscience Institute Gottinge.	BARGER SW, 1995, BIOCHEM J, V311, P45, DOI 10.1042/bj3110045; Bell KFS, 2008, NEUROBIOL AGING, V29, P554, DOI 10.1016/j.neurobiolaging.2006.11.004; Bouron A, 2004, EUR J NEUROSCI, V20, P2071, DOI 10.1111/j.1460-9568.2004.03680.x; CAPORASO GL, 1992, P NATL ACAD SCI USA, V89, P3055, DOI 10.1073/pnas.89.7.3055; Chen CD, 2006, J NEUROCHEM, V97, P30, DOI 10.1111/j.1471-4159.2006.03705.x; Devi L, 2006, J NEUROSCI, V26, P9057, DOI 10.1523/JNEUROSCI.1469-06.2006; Dulubova I, 2004, BIOCHEMISTRY-US, V43, P9583, DOI 10.1021/bi049041o; Esposito A, 2005, BIOPHYS J, V89, P4286, DOI 10.1529/biophysj.104.053397; Esposito A, 2006, J BIOMED OPT, V11, DOI 10.1117/1.2208999; Ganesan S, 2006, P NATL ACAD SCI USA, V103, P4089, DOI 10.1073/pnas.0509922103; George N, 2004, J AM CHEM SOC, V126, P8896, DOI 10.1021/ja048396s; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; Gong YS, 2003, P NATL ACAD SCI USA, V100, P10417, DOI 10.1073/pnas.1834302100; Gorman PM, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-17; Gralle M, 2006, J MOL BIOL, V357, P493, DOI 10.1016/j.jmb.2005.12.053; Gralle M, 2002, BIOPHYS J, V83, P3513, DOI 10.1016/S0006-3495(02)75351-4; Gralle M, 2007, PROG NEUROBIOL, V82, P11, DOI 10.1016/j.pneurobio.2007.02.001; HAASS C, 1995, J CELL BIOL, V128, P537, DOI 10.1083/jcb.128.4.537; HAGEN GM, 2007, P SPIE, V6441; Hashimoto Y, 2003, J PHARMACOL EXP THER, V306, P889, DOI 10.1124/jpet.103.051383; Heber S, 2000, J NEUROSCI, V20, P7951; Herms J, 2004, EMBO J, V23, P4106, DOI 10.1038/sj.emboj.7600390; Hoffmann J, 1999, J HISTOCHEM CYTOCHEM, V47, P373, DOI 10.1177/002215549904700311; Hoyer S, 2000, EXP GERONTOL, V35, P1363, DOI 10.1016/S0531-5565(00)00156-X; Jares-Erijman EA, 2006, CURR OPIN CHEM BIOL, V10, P409, DOI 10.1016/j.cbpa.2006.08.021; Jung SS, 1999, NEUROBIOL AGING, V20, P249, DOI 10.1016/S0197-4580(99)00051-2; Jung SS, 1996, J NEUROSCI RES, V46, P336, DOI 10.1002/(SICI)1097-4547(19961101)46:3<336::AID-JNR7>3.3.CO;2-L; Kaden D, 2008, J BIOL CHEM, V283, P7271, DOI 10.1074/jbc.M708046200; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Kienlen-Campard P, 2008, J BIOL CHEM, V283, P7733, DOI 10.1074/jbc.M707142200; KOO EH, 1994, J BIOL CHEM, V269, P17386; Kroenke CD, 1997, BIOCHEMISTRY-US, V36, P8145, DOI 10.1021/bi9705669; Lacor PN, 2004, J NEUROSCI, V24, P10191, DOI 10.1523/JNEUROSCI.3432-04.2004; LANNFELT L, 1995, NAT MED, V1, P829, DOI 10.1038/nm0895-829; Leyssen M, 2005, EMBO J, V24, P2944, DOI 10.1038/sj.emboj.7600757; Lidke Diane S, 2007, Methods Mol Biol, V374, P69; Lidke DS, 2005, J CELL BIOL, V170, P619, DOI 10.1083/jcb.200503140; Lidke DS, 2003, BIOCHEM SOC T, V31, P1020; Lidke KA, 2005, OPT EXPRESS, V13, P7052, DOI 10.1364/OPEX.13.007052; Ma QH, 2008, NAT CELL BIOL, V10, P283, DOI 10.1038/ncb1690; MATTSON MP, 1993, NEURON, V10, P243, DOI 10.1016/0896-6273(93)90315-I; Mbebi C, 2002, J BIOL CHEM, V277, P20979, DOI 10.1074/jbc.M107948200; Meyer BH, 2006, FEBS LETT, V580, P1654, DOI 10.1016/j.febslet.2006.02.007; Meziane H, 1998, P NATL ACAD SCI USA, V95, P12683, DOI 10.1073/pnas.95.21.12683; MOYA KL, 1994, DEV BIOL, V161, P597, DOI 10.1006/dbio.1994.1055; Munter LM, 2007, EMBO J, V26, P1702, DOI 10.1038/sj.emboj.7601616; NINOMIYA H, 1994, J NEUROCHEM, V63, P495; Park JH, 2006, J NEUROSCI, V26, P1386, DOI 10.1523/JNEUROSCI.3291-05.2006; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Postina R, 2008, CURR ALZHEIMER RES, V5, P179, DOI 10.2174/156720508783954668; Priller C, 2006, J NEUROSCI, V26, P7212, DOI 10.1523/JNEUROSCI.1450-06.2006; QIU WQ, 1995, J NEUROSCI, V15, P2157, DOI 10.1523/JNEUROSCI.15-03-02157.1995; Rohn TT, 2000, J NEUROCHEM, V74, P2331, DOI 10.1046/j.1471-4159.2000.0742331.x; Rossjohn J, 1999, NAT STRUCT BIOL, V6, P327; Rovelet-Lecrux A, 2006, NAT GENET, V38, P24, DOI 10.1038/ng1718; Sato T, 2009, P NATL ACAD SCI USA, V106, P1421, DOI 10.1073/pnas.0812261106; Scheuermann S, 2001, J BIOL CHEM, V276, P33923, DOI 10.1074/jbc.M105410200; Schneider A, 2008, J NEUROSCI, V28, P2874, DOI 10.1523/JNEUROSCI.5345-07.2008; SCHUBERT D, 1993, BRAIN RES, V629, P275, DOI 10.1016/0006-8993(93)91331-L; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; Sennvik K, 2000, NEUROSCI LETT, V278, P169, DOI 10.1016/S0304-3940(99)00929-5; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Skovronsky DM, 2000, J BIOL CHEM, V275, P2568, DOI 10.1074/jbc.275.4.2568; Soba P, 2005, EMBO J, V24, P3624, DOI 10.1038/sj.emboj.7600824; Stein TD, 2004, J NEUROSCI, V24, P7707, DOI 10.1523/JNEUROSCI.2211-04.2004; Storey E, 1999, EUR J NEUROSCI, V11, P1779, DOI 10.1046/j.1460-9568.1999.00599.x; Sudo H, 2000, MOL CELL NEUROSCI, V16, P708, DOI 10.1006/mcne.2000.0910; Sudo H, 2001, BIOCHEM BIOPH RES CO, V282, P548, DOI 10.1006/bbrc.2001.4604; Tikkanen R, 2002, BIOL CHEM, V383, P1855, DOI 10.1515/BC.2002.209; Wang P, 2005, J NEUROSCI, V25, P1219, DOI 10.1523/JNEUROSCI.4660-04.2005; Wang YC, 2004, MOL CELL, V15, P343, DOI 10.1016/j.molcel.2004.06.037; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; Young-Pearse TL, 2007, J NEUROSCI, V27, P14459, DOI 10.1523/JNEUROSCI.4701-07.2007; Young-Pearse TL, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-15; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539	75	110	114	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					15016	15025		10.1074/jbc.M808755200	http://dx.doi.org/10.1074/jbc.M808755200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19336403	Green Published, hybrid			2022-12-27	WOS:000266288200038
J	Hoegy, F; Lee, XY; Noel, S; Rognan, D; Mislin, GLA; Reimmann, C; Schalk, IJ				Hoegy, Francoise; Lee, Xiaoyun; Noel, Sabrina; Rognan, Didier; Mislin, Gaetan L. A.; Reimmann, Cornelia; Schalk, Isabelle J.			Stereospecificity of the Siderophore Pyochelin Outer Membrane Transporters in Fluorescent Pseudomonads	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI; FERRIC ENTEROBACTIN; FERRIPYOCHELIN RECEPTOR; COORDINATION CHEMISTRY; AERUGINOSA REQUIRES; OPTICAL ANTIPODE; IRON UPTAKE; BINDING; ACID; TONB	Pyochelin (Pch) and enantio-pyochelin (EPch) are enantiomer siderophores that are produced by Pseudomonas aeruginosa and Pseudomonas fluorescens, respectively, under iron limitation. Pch promotes growth of P. aeruginosa when iron is scarce, and EPch carries out the same biological function in P. fluorescens. However, the two siderophores are unable to promote growth in the heterologous species, indicating that siderophore-mediated iron uptake is highly stereospecific. In the present work, using binding and iron uptake assays, we found that FptA, the Fe-Pch outer membrane transporter of P. aeruginosa, recognized (K-d = 2.5 +/- 1.1 nM) and transported Fe-Pch but did not interact with Fe-EPch. Likewise, FetA, the Fe-EPch receptor of P. fluorescens, was specific for Fe-EPch (K-d = 3.7 +/- 2.1 nM) but did not bind and transport Fe-Pch. Growth promotion experiments performed under iron-limiting conditions confirmed that FptA and FetA are highly specific for Pch and EPch, respectively. When fptA and fetA along with adjacent transport genes involved in siderophore uptake were swapped between the two bacterial species, P. aeruginosa became able to utilize Fe-EPch as an iron source, and P. fluorescens was able to grow with Fe-Pch. Docking experiments using the FptA structure and binding assays showed that the stereospecificity of Pch recognition by FptA was mostly due to the configuration of the siderophore chiral centers C4 '' and C2 '' and was only weakly dependent on the configuration of the C4' carbon atom. Together, these findings increase our understanding of the stereospecific interaction between Pch and its outer membrane receptor FptA.	[Hoegy, Francoise; Noel, Sabrina; Mislin, Gaetan L. A.; Schalk, Isabelle J.] Univ Strasbourg, ESBS, CNRS, F-67413 Strasbourg, France; [Lee, Xiaoyun; Reimmann, Cornelia] Univ Lausanne, Dept Microbiol Fondamentale, Quartier UNIL Sorge, CH-1015 Lausanne, Switzerland; [Rognan, Didier] Univ Strasbourg, Dept Pharmacochim Commun Cellulaire, CNRS, Fac Pharm 74, F-67401 Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Lausanne; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Schalk, IJ (corresponding author), Univ Strasbourg, ESBS, CNRS, FRE3211,Blvd Sebastien Brant,BP 10412, F-67413 Strasbourg, France.	schalk@esbs.u-strasbg.fr	Rognan, Didier/B-9939-2014		CNRS; Vaincre la Mucoviscidose; Agence Nationale de Recherche [ANR-05-JCJC-0181-01]; Swiss National Science Foundation [31-113955/1]	CNRS(Centre National de la Recherche Scientifique (CNRS)); Vaincre la Mucoviscidose; Agence Nationale de Recherche(French National Research Agency (ANR)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the CNRS, the association Vaincre la Mucoviscidose (French Association against Cystic Fibrosis), Agence Nationale de Recherche Grant ANR-05-JCJC-0181-01, and Swiss National Science Foundation for Scientific Research Project 31-113955/1).	ANKENBAUER RG, 1994, J BACTERIOL, V176, P307, DOI 10.1128/JB.176.2.307-319.1994; ANKENBAUER RG, 1988, J BACTERIOL, V170, P5344, DOI 10.1128/jb.170.11.5344-5351.1988; Barnard TJ, 2001, MOL MICROBIOL, V41, P527, DOI 10.1046/j.1365-2958.2001.02473.x; BERGERON RJ, 1985, J BIOL CHEM, V260, P7936; Bergeron RJ, 2001, J MED CHEM, V44, P2469, DOI 10.1021/jm010019s; Blumer C, 1999, P NATL ACAD SCI USA, V96, P14073, DOI 10.1073/pnas.96.24.14073; Braun V, 2003, FRONT BIOSCI-LANDMRK, V8, pS1409, DOI 10.2741/1232; Castignetti D, 1997, CURR MICROBIOL, V34, P250, DOI 10.1007/s002849900178; Cobessi D, 2005, J MOL BIOL, V352, P893, DOI 10.1016/j.jmb.2005.08.004; COX CD, 1980, J BACTERIOL, V142, P581, DOI 10.1128/JB.142.2.581-587.1980; COX CD, 1981, P NATL ACAD SCI-BIOL, V78, P4256, DOI 10.1073/pnas.78.7.4256; Crosa JH, 2002, MICROBIOL MOL BIOL R, V66, P223, DOI 10.1128/MMBR.66.2.223-249.2002; Darling P, 1998, INFECT IMMUN, V66, P874, DOI 10.1128/IAI.66.2.874-877.1998; DEMANGE P, 1990, BIOL MET, V3, P155; DRECHSEL H, 1992, BIOMETALS, V5, P141, DOI 10.1007/BF01061320; ECKER DJ, 1986, J BACTERIOL, V167, P666, DOI 10.1128/jb.167.2.666-673.1986; FARINHA MA, 1990, FEMS MICROBIOL LETT, V70, P221, DOI 10.1016/S0378-1097(05)80043-6; Greenwald J, 2007, J BIOL CHEM, V282, P2987, DOI 10.1074/jbc.M609238200; HEINRICHS DE, 1993, J BACTERIOL, V175, P5882, DOI 10.1128/JB.175.18.5882-5889.1993; Higgs PI, 2002, MOL MICROBIOL, V44, P271, DOI 10.1046/j.1365-2958.2002.02880.x; Hoegy FO, 2005, J BIOL CHEM, V280, P20222, DOI 10.1074/jbc.M500776200; KADNER RJ, 1995, J BACTERIOL, V177, P4829, DOI 10.1128/jb.177.17.4829-4835.1995; KEEL C, 1989, PHYTOPATHOLOGY, V79, P584, DOI 10.1094/Phyto-79-584; Klumpp C, 2005, BIOORG MED CHEM LETT, V15, P1721, DOI 10.1016/j.bmcl.2005.01.034; Laville J, 1998, J BACTERIOL, V180, P3187, DOI 10.1128/JB.180.12.3187-3196.1998; LIU PV, 1978, INFECT IMMUN, V22, P878, DOI 10.1128/IAI.22.3.878-890.1978; Maurhofer M, 1998, PHYTOPATHOLOGY, V88, P678, DOI 10.1094/PHYTO.1998.88.7.678; Michel L, 2005, MOL MICROBIOL, V58, P495, DOI 10.1111/j.1365-2958.2005.04837.x; Michel L, 2007, MICROBIOL-SGM, V153, P1508, DOI 10.1099/mic.0.2006/002915-0; Mislin GLA, 2006, J MOL BIOL, V357, P1437, DOI 10.1016/j.jmb.2006.01.080; Mossialos D, 2007, FUTURE MICROBIOL, V2, P387, DOI 10.2217/17460913.2.4.387; MULLER G, 1985, J BIOL CHEM, V260, P3921; Munzinger M, 1999, BIOMETALS, V12, P189, DOI 10.1023/A:1009259118034; NEILANDS JB, 1981, J BIOL CHEM, V256, P3831; Newton SMC, 1999, MOL MICROBIOL, V32, P1153, DOI 10.1046/j.1365-2958.1999.01424.x; Phoebe CH, 2001, J ANTIBIOT, V54, P56; Postle K, 2003, MOL MICROBIOL, V49, P869, DOI 10.1046/j.1365-2958.2003.03629.x; Reimmann C, 1998, MICROBIOL-UK, V144, P3135, DOI 10.1099/00221287-144-11-3135; Reimmann C, 2001, J BACTERIOL, V183, P813, DOI 10.1128/JB.183.3.813-820.2001; RINEHART KL, 1995, J ORG CHEM, V60, P2786, DOI 10.1021/jo00114a029; Sambrook J., 2001, MOL CLONING LAB MANU; Schalk IJ, 2001, MOL MICROBIOL, V39, P351, DOI 10.1046/j.1365-2958.2001.02207.x; Schlegel K, 2004, BIOMETALS, V17, P409, DOI 10.1023/B:BIOM.0000029437.42633.73; SCHNIDER U, 1995, J BACTERIOL, V177, P5387, DOI 10.1128/jb.177.18.5387-5392.1995; Serino L, 1997, J BACTERIOL, V179, P248, DOI 10.1128/jb.179.1.248-257.1997; SOKOL PA, 1986, J CLIN MICROBIOL, V23, P560, DOI 10.1128/JCM.23.3.560-562.1986; STANISICH VA, 1972, GENET RES, V19, P91, DOI 10.1017/S0016672300014294; Takase H, 2000, INFECT IMMUN, V68, P1834, DOI 10.1128/IAI.68.4.1834-1839.2000; Tseng CF, 2006, J BIOL INORG CHEM, V11, P419, DOI 10.1007/s00775-006-0088-7; Verdonk ML, 2003, PROTEINS, V52, P609, DOI 10.1002/prot.10465; VOISARD C, 1994, MOLECULAR ECOLOGY OF RHIZOSPHERE MICROORGANISMS, P67, DOI 10.1002/9783527615810.ch6; Wiener MC, 2005, CURR OPIN STRUC BIOL, V15, P394, DOI 10.1016/j.sbi.2005.07.001; WINKELMANN G, 1979, FEBS LETT, V97, P43, DOI 10.1016/0014-5793(79)80048-4; WINKELMANN G, 1981, FEMS MICROBIOL LETT, V11, P237, DOI 10.1016/0378-1097(81)90068-9; YE RW, 1995, J BACTERIOL, V177, P3606, DOI 10.1128/jb.177.12.3606-3609.1995; Youard ZA, 2007, J BIOL CHEM, V282, P35546, DOI 10.1074/jbc.M707039200; Zamri A, 2000, TETRAHEDRON, V56, P249, DOI 10.1016/S0040-4020(99)00946-1	57	45	45	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					14949	14957		10.1074/jbc.M900606200	http://dx.doi.org/10.1074/jbc.M900606200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19297329	Green Published, hybrid			2022-12-27	WOS:000266288200031
J	Perreault, A; Gascon, S; D'Amours, A; Aletta, JM; Bachand, F				Perreault, Audrey; Gascon, Suzanne; D'Amours, Annie; Aletta, John M.; Bachand, Francois			A Methyltransferase-independent Function for Rmt3 in Ribosomal Subunit Homeostasis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SET DOMAIN METHYLTRANSFERASE; PROTEIN ARGININE METHYLTRANSFERASES; MASS-SPECTROMETRIC ANALYSIS; RNA-POLYMERASE-II; FISSION YEAST; SACCHAROMYCES-CEREVISIAE; POLY(A)-BINDING PROTEIN; DROSOPHILA-MELANOGASTER; ENVIRONMENTAL-CHANGES; PRE-40S SUBUNITS	Schizosaccharomyces pombe Rmt3 is a member of the protein-arginine methyltransferase (PRMT) family and is the homolog of human PRMT3. We previously characterized Rmt3 as a ribosomal protein methyltransferase based on the identification of the 40 S Rps2 (ribosomal protein S2) as a substrate of Rmt3. RMT3-null cells produce nonmethylated Rps2 and show mis-regulation of the 40 S/60 S ribosomal subunit ratio due to a small subunit deficit. For this study, we have generated a series of RMT3 alleles that express various amino acid substitutions to characterize the functional domains of Rmt3 in Rps2 binding, Rps2 arginine methylation, and small ribosomal subunit production. Notably, catalytically inactive versions of Rmt3 restored the ribosomal subunit imbalance detected in RMT3-null cells. Consistent with a methyltransferase-independent function for Rmt3 in small ribosomal subunit production, the expression of an Rps2 variant in which the identified methylarginine residues were substituted with lysines showed normal levels of 40 S subunit. Importantly, substitutions within the zinc finger domain of Rmt3 that abolished Rps2 binding did not rescue the 40 S ribosomal subunit deficit of RMT3-null cells. Our findings suggest that the Rmt3-Rps2 interaction, rather than Rps2 methylation, is important for the function of Rmt3 in the regulation of small ribosomal subunit production.	[Perreault, Audrey; Gascon, Suzanne; D'Amours, Annie; Bachand, Francois] Univ Sherbrooke, Dept Biochem, RNA Grp, Sherbrooke, PQ J1H 5N4, Canada; [Aletta, John M.] CH3 BioSyst LLC, New York State Ctr Excellence Bioinformat & Life, Buffalo, NY 14228 USA	University of Sherbrooke	Bachand, F (corresponding author), Univ Sherbrooke, Dept Biochem, RNA Grp, 5E Etage 3001,12E Av Nord, Sherbrooke, PQ J1H 5N4, Canada.	f.bachand@usherbrooke.ca			Canadian Institutes for Health Research (CIHR) [MOP-171704]	Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	This work was supported by Canadian Institutes for Health Research (CIHR) Grant MOP-171704 (to F. B.).	Amsterdam A, 2004, PLOS BIOL, V2, P690, DOI 10.1371/journal.pbio.0020139; Bachand F, 2006, MOL CELL BIOL, V26, P1731, DOI 10.1128/MCB.26.5.1731-1742.2006; Bachand F, 2004, EMBO J, V23, P2641, DOI 10.1038/sj.emboj.7600265; Bachand F, 2007, EUKARYOT CELL, V6, P889, DOI 10.1128/EC.00099-07; Bedford MT, 2007, J CELL SCI, V120, P4243, DOI 10.1242/jcs.019885; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Brahms H, 2001, RNA, V7, P1531, DOI 10.1017/S135583820101442X; BURD CG, 1994, SCIENCE, V265, P615, DOI 10.1126/science.8036511; Causton HC, 2001, MOL BIOL CELL, V12, P323, DOI 10.1091/mbc.12.2.323; CHANG FN, 1976, ARCH BIOCHEM BIOPHYS, V172, P627, DOI 10.1016/0003-9861(76)90117-X; Chen DR, 2003, MOL BIOL CELL, V14, P214, DOI 10.1091/mbc.E02-08-0499; Cheng DH, 2007, MOL CELL, V25, P71, DOI 10.1016/j.molcel.2006.11.019; Cheung N, 2007, NAT CELL BIOL, V9, P1208, DOI 10.1038/ncb1642; Choesmel V, 2008, HUM MOL GENET, V17, P1253, DOI 10.1093/hmg/ddn015; CRAMTON SE, 1994, GENETICS, V137, P1039; Duan P, 2007, J IMMUNOL METHODS, V320, P132, DOI 10.1016/j.jim.2007.01.006; Ebert BL, 2008, NATURE, V451, P335, DOI 10.1038/nature06494; Frankel A, 2000, J BIOL CHEM, V275, P32974, DOI 10.1074/jbc.M006445200; Friesen WJ, 2001, MOL CELL, V7, P1111, DOI 10.1016/S1097-2765(01)00244-1; Gary JD, 1998, PROG NUCLEIC ACID RE, V61, P65, DOI 10.1016/S0079-6603(08)60825-9; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Godin KS, 2007, RNA BIOL, V4, P69, DOI 10.4161/rna.4.2.4869; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; KEENEY JB, 1994, GENETICS, V136, P849; KILEDJIAN M, 1992, EMBO J, V11, P2655, DOI 10.1002/j.1460-2075.1992.tb05331.x; Komili S, 2007, CELL, V131, P557, DOI 10.1016/j.cell.2007.08.037; KRUISWIJK T, 1978, BIOCHEM J, V175, P221, DOI 10.1042/bj1750221; Kwak YT, 2003, MOL CELL, V11, P1055, DOI 10.1016/S1097-2765(03)00101-1; Lam YW, 2007, CURR BIOL, V17, P749, DOI 10.1016/j.cub.2007.03.064; Lambertsson A, 1998, ADV GENET, V38, P69, DOI 10.1016/S0065-2660(08)60142-X; Lee J, 2002, EMBO REP, V3, P268, DOI 10.1093/embo-reports/kvf052; Lee SW, 2002, P NATL ACAD SCI USA, V99, P5942, DOI 10.1073/pnas.082119899; LHOEST J, 1984, EUR J BIOCHEM, V141, P585, DOI 10.1111/j.1432-1033.1984.tb08233.x; Liang XH, 2007, MOL CELL, V28, P965, DOI 10.1016/j.molcel.2007.10.012; Liu MF, 2004, RNA, V10, P1713, DOI 10.1261/rna.7820104; Louie DF, 1996, J BIOL CHEM, V271, P28189, DOI 10.1074/jbc.271.45.28189; Marygold SJ, 2005, GENETICS, V169, P683, DOI 10.1534/genetics.104.034124; Marygold SJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r216; NAJBAUER J, 1993, J BIOL CHEM, V268, P10501; Odintsova TI, 2003, J PROTEIN CHEM, V22, P249, DOI 10.1023/A:1025068419698; Oliver ER, 2004, DEVELOPMENT, V131, P3907, DOI 10.1242/dev.01268; Pal S, 2007, J CELL PHYSIOL, V213, P306, DOI 10.1002/jcp.21180; Perreault A, 2008, NUCLEIC ACIDS RES, V36, P6132, DOI 10.1093/nar/gkn625; Perreault A, 2007, J BIOL CHEM, V282, P7552, DOI 10.1074/jbc.M610512200; Polevoda B, 2007, MOL MICROBIOL, V65, P590, DOI 10.1111/j.1365-2958.2007.05831.x; Porras-Yakushi TR, 2007, J BIOL CHEM, V282, P12368, DOI 10.1074/jbc.M611896200; Porras-Yakushi TR, 2006, J BIOL CHEM, V281, P35835, DOI 10.1074/jbc.M606578200; Porras-Yakushi TR, 2005, J BIOL CHEM, V280, P34590, DOI 10.1074/jbc.M507672200; RAMAGOPAL S, 1991, BIOCHEM CELL BIOL, V69, P263, DOI 10.1139/o91-040; Rappsilber J, 2003, ANAL CHEM, V75, P3107, DOI 10.1021/ac026283q; Rother S, 2007, GENE DEV, V21, P1409, DOI 10.1101/gad.428407; Rosado IV, 2007, NUCLEIC ACIDS RES, V35, P4203, DOI 10.1093/nar/gkm388; Roy-Chaudhuri B, 2008, MOL MICROBIOL, V68, P1547, DOI 10.1111/j.1365-2958.2008.06252.x; Sadaie M, 2008, J BIOL CHEM, V283, P7185, DOI 10.1074/jbc.M709429200; Smith JJ, 1999, J BIOL CHEM, V274, P13229, DOI 10.1074/jbc.274.19.13229; STEWART MJ, 1993, MOL CELL BIOL, V13, P2524, DOI 10.1128/MCB.13.4.2524; Sulic S, 2005, GENE DEV, V19, P3070, DOI 10.1101/gad.359305; SUZUKI K, 1991, J BIOL CHEM, V266, P20007; Swiercz R, 2005, BIOCHEM J, V386, P85, DOI 10.1042/BJ20041466; Swiercz R, 2007, J BIOL CHEM, V282, P16917, DOI 10.1074/jbc.M609778200; Torok I, 1999, MOL CELL BIOL, V19, P2308; Torres-Padilla ME, 2007, NATURE, V445, P214, DOI 10.1038/nature05458; Volarevic S, 2000, SCIENCE, V288, P2045, DOI 10.1126/science.288.5473.2045; WATSON KL, 1992, P NATL ACAD SCI USA, V89, P11302, DOI 10.1073/pnas.89.23.11302; White J, 2008, MOL CELL BIOL, V28, P3151, DOI 10.1128/MCB.01674-07; Wysocka J, 2006, FRONT BIOSCI-LANDMRK, V11, P344, DOI 10.2741/1802; Xirodimas DP, 2008, EMBO REP, V9, P280, DOI 10.1038/embor.2008.10; Yu MC, 2004, GENE DEV, V18, P2024, DOI 10.1101/gad.1223204; Yu YH, 2005, PROTEIN SCI, V14, P1438, DOI 10.1110/ps.041293005; Zhang X, 2003, STRUCTURE, V11, P509, DOI 10.1016/S0969-2126(03)00071-6; Zhang X, 2000, EMBO J, V19, P3509, DOI 10.1093/emboj/19.14.3509; Zhao X, 2008, GENE DEV, V22, P640, DOI 10.1101/gad.1632608	72	23	24	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					15026	15037		10.1074/jbc.M109.004812	http://dx.doi.org/10.1074/jbc.M109.004812			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19359250	Green Published, hybrid			2022-12-27	WOS:000266288200039
J	Stuart, SA; Wang, JYJ				Stuart, Scott A.; Wang, Jean Y. J.			Ionizing Radiation Induces ATM-independent Degradation of p21(Cip1) in Transformed Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIN-DEPENDENT KINASES; DNA-DAMAGE; UBIQUITIN LIGASE; NUCLEAR ANTIGEN; ATAXIA-TELANGIECTASIA; PROTEIN-KINASES; UV-IRRADIATION; IN-VIVO; S-PHASE; PCNA	The cyclin-dependent kinase inhibitor p21(Cip1) plays an important role in the cellular response to DNA damage. In normal cells, genotoxic stress activates the ATM-p53 pathway that up-regulates the expression of p21(Cip1) leading to cell cycle arrest. However, we have found that in several neoplastic cell lines, ionizing radiation (IR) induces ubiquitin-dependent degradation of p21(Cip1). This process is independent of the ATM pathway as it occurs in immortalized A-T fibroblasts. Knockdown of Skp2, an F-box protein capable of regulating the normal turnover of p21(Cip1), does not prevent the IR-induced degradation. Instead, this process requires the Cul4-DDB1(Cdt2) E3 ligase as knockdown of either DDB1 or Cdt2 rescues p21(Cip1) degradation after IR. Mutating the proliferating cell nuclear antigen-binding site of p21(Cip1) also prevents its IR-induced degradation suggesting that the p21(Cip1)-proliferating cell nuclear antigen interaction is critical for this event. Although ectopic expression of a nondegradable p21(Cip1) did not by itself affect the clonogenic survival of HEK293 cells after IR, the degradation of p21(Cip1) and other targets of the Cul4-DDB1(Cdt2) E3 ligase may collectively contribute to the survival of neoplastic cells after ionizing radiation.	[Stuart, Scott A.; Wang, Jean Y. J.] Univ Calif San Diego, Biomed Sci Grad Program, Sch Med, La Jolla, CA 92093 USA; [Wang, Jean Y. J.] Univ Calif San Diego, Div Hematol Oncol, Sch Med, Dept Med, La Jolla, CA 92093 USA; [Wang, Jean Y. J.] Univ Calif San Diego, Moores Canc Ctr, Sch Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Wang, JYJ (corresponding author), 3855 Hlth Sci Dr,MC 0820, La Jolla, CA 92122 USA.	jywang@ucsd.edu			National Institutes of Health [CA43054, CA067754]; NATIONAL CANCER INSTITUTE [R37CA043054, T32CA067754, R01CA043054] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA43054 (to J.Y.J.W.). Supported in part by National Institutes of Health Training Grant CA067754.	Abbas T, 2008, GENE DEV, V22, P2496, DOI 10.1101/gad.1676108; Ahuja D, 2005, ONCOGENE, V24, P7729, DOI 10.1038/sj.onc.1209046; Arias EE, 2006, NAT CELL BIOL, V8, P84, DOI 10.1038/ncb1346; Balajee AS, 2001, NUCLEIC ACIDS RES, V29, P1341, DOI 10.1093/nar/29.6.1341; Bendjennat M, 2003, CELL, V114, P599, DOI 10.1016/j.cell.2003.08.001; Bloom J, 2003, CELL, V115, P71, DOI 10.1016/S0092-8674(03)00755-4; Cang Y, 2007, P NATL ACAD SCI USA, V104, P2733, DOI 10.1073/pnas.0611311104; CHEN JJ, 1995, NATURE, V374, P386, DOI 10.1038/374386a0; Chen XY, 2004, MOL CELL, V16, P839, DOI 10.1016/j.molcel.2004.11.011; DENG CX, 1995, CELL, V82, P675, DOI 10.1016/0092-8674(95)90039-X; DI LEONARDO A, 1994, GENE DEV, V8, P2540, DOI 10.1101/gad.8.21.2540; DULIC V, 1994, CELL, V76, P1013, DOI 10.1016/0092-8674(94)90379-4; EL DW, 1993, CELL, V75, P817; Gervais JLM, 1998, J BIOL CHEM, V273, P19207, DOI 10.1074/jbc.273.30.19207; GU Y, 1993, NATURE, V366, P707, DOI 10.1038/366707a0; Gulbis JM, 1996, CELL, V87, P297, DOI 10.1016/S0092-8674(00)81347-1; Guterman A, 2004, J BIOL CHEM, V279, P1729, DOI 10.1074/jbc.M307050200; HARPER JW, 1993, CELL, V75, P805; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Higa LAA, 2003, NAT CELL BIOL, V5, P1008, DOI 10.1038/ncb1061; Higa LA, 2006, CELL CYCLE, V5, P1675, DOI 10.4161/cc.5.15.3149; Hu J, 2006, J BIOL CHEM, V281, P3753, DOI 10.1074/jbc.C500464200; Hu J, 2004, NAT CELL BIOL, V6, P1003, DOI 10.1038/ncb1172; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; KASTAN MB, 1992, CELL, V71, P587, DOI 10.1016/0092-8674(92)90593-2; KASTAN MB, 1991, CANCER RES, V51, P6304; Kim Y, 2008, GENE DEV, V22, P2507, DOI 10.1101/gad.1703708; KROSS J, 1982, BIOCHEMISTRY-US, V21, P4310, DOI 10.1021/bi00261a021; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Meng LH, 1999, P NATL ACAD SCI USA, V96, P10403, DOI 10.1073/pnas.96.18.10403; Miura M, 1996, RADIAT RES, V145, P75, DOI 10.2307/3579198; Nishitani H, 2008, J BIOL CHEM, V283, P29045, DOI 10.1074/jbc.M806045200; NODA A, 1994, EXP CELL RES, V211, P90, DOI 10.1006/excr.1994.1063; O'Connell BC, 2007, CURR OPIN CELL BIOL, V19, P206, DOI 10.1016/j.ceb.2007.02.014; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Prives C, 2008, CELL CYCLE, V7, P3840, DOI 10.4161/cc.7.24.7243; Sarkaria JN, 1998, CANCER RES, V58, P4375; Sheaff RJ, 2000, MOL CELL, V5, P403, DOI 10.1016/S1097-2765(00)80435-9; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; Wang W, 2005, BIOCHEMISTRY-US, V44, P14553, DOI 10.1021/bi051071j; XIONG Y, 1992, CELL, V71, P505, DOI 10.1016/0092-8674(92)90518-H; XIONG Y, 1993, NATURE, V366, P701, DOI 10.1038/366701a0; Yu ZK, 1998, P NATL ACAD SCI USA, V95, P11324, DOI 10.1073/pnas.95.19.11324	46	25	27	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					15061	15070		10.1074/jbc.M808810200	http://dx.doi.org/10.1074/jbc.M808810200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19332548	hybrid, Green Published			2022-12-27	WOS:000266288200042
J	Beuria, TK; Mullapudi, S; Mileykovskaya, E; Sadasivam, M; Dowhan, W; Margolin, W				Beuria, Tushar K.; Mullapudi, Srinivas; Mileykovskaya, Eugenia; Sadasivam, Mahalakshmi; Dowhan, William; Margolin, William			Adenine Nucleotide-dependent Regulation of Assembly of Bacterial Tubulin-like FtsZ by a Hypermorph of Bacterial Actin-like FtsA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-DIVISION PROTEIN; ESCHERICHIA-COLI FTSZ; MEMBRANE TARGETING SEQUENCE; Z-RING; BACILLUS-SUBTILIS; FILAMENT TURNOVER; SEPTAL RING; IN-VITRO; DYNAMICS; ZIPA	Cytokinesis in bacteria depends upon the contractile Z ring, which is composed of dynamic polymers of the tubulin homolog FtsZ as well as other membrane-associated proteins such as FtsA, a homolog of actin that is required for membrane attachment of the Z ring and its subsequent constriction. Here we show that a previously characterized hypermorphic mutant FtsA (FtsA*) partially disassembled FtsZ polymers in vitro. This effect was strictly dependent on ATP or ADP binding to FtsA* and occurred at sub-stoichiometric levels relative to FtsZ, similar to cellular levels. Nucleotide-bound FtsA* did not affect FtsZ GTPase activity or the critical concentration for FtsZ assembly but was able to disassemble preformed FtsZ polymers, suggesting that FtsA* acts on FtsZ polymers. Microscopic examination of the inhibited FtsZ polymers revealed a transition from long, straight polymers and polymer bundles to mainly short, curved protofilaments. These results indicate that a bacterial actin, when activated by adenine nucleotides, can modify the length distribution of bacterial tubulin polymers, analogous to the effects of actin-depolymerizing factor/cofilin on F-actin.	[Beuria, Tushar K.; Sadasivam, Mahalakshmi; Margolin, William] Univ Texas Houston, Sch Med, Dept Microbiol & Mol Genet, Houston, TX 77030 USA; [Mullapudi, Srinivas; Mileykovskaya, Eugenia; Dowhan, William] Univ Texas Houston, Sch Med, Dept Biochem & Mol Biol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Margolin, W (corresponding author), Univ Texas Houston, Sch Med, Dept Microbiol & Mol Genet, 6431 Fannin St, Houston, TX 77030 USA.	William.Margolin@uth.tmc.edu		Mileykovskaya, Eugenia/0000-0002-8775-4467	National Institutes of Health [R01-GM61074, R37-GM20478]; John S. Dunn research foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM020478, R01GM061074] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); John S. Dunn research foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-GM61074 (to W.M.) and R37-GM20478 (to W.D.). This work was also supported by a grant from the John S. Dunn research foundation (to W.D.).	Addinall SG, 1996, MOL MICROBIOL, V22, P231, DOI 10.1046/j.1365-2958.1996.00100.x; Addinall SG, 1996, J BACTERIOL, V178, P3877, DOI 10.1128/jb.178.13.3877-3884.1996; Anderson DE, 2004, J BACTERIOL, V186, P5775, DOI 10.1128/JB.186.17.5775-5781.2004; Andrianantoandro E, 2006, MOL CELL, V24, P13, DOI 10.1016/j.molcel.2006.08.006; Bernard CS, 2007, MOL MICROBIOL, V64, P1289, DOI 10.1111/j.1365-2958.2007.05738.x; Beuria TK, 2005, BIOCHEMISTRY-US, V44, P16584, DOI 10.1021/bi050767+; BI E, 1991, NATURE, V354, P161, DOI 10.1038/354161a0; BORK P, 1992, P NATL ACAD SCI USA, V89, P7290, DOI 10.1073/pnas.89.16.7290; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Chen YD, 2005, J BIOL CHEM, V280, P22549, DOI 10.1074/jbc.M500895200; Chung KM, 2007, J BIOL CHEM, V282, P14891, DOI 10.1074/jbc.M605177200; Corbin BD, 2004, J BACTERIOL, V186, P7736, DOI 10.1128/JB.186.22.7736-7744.2004; DAI K, 1992, J BACTERIOL, V174, P6145, DOI 10.1128/JB.174.19.6145-6151.1992; Dajkovic A, 2008, CURR BIOL, V18, P235, DOI 10.1016/j.cub.2008.01.042; DEWAR SJ, 1992, J BACTERIOL, V174, P6314, DOI 10.1128/JB.174.19.6314-6316.1992; Din N, 1998, MOL MICROBIOL, V27, P1051, DOI 10.1046/j.1365-2958.1998.00752.x; Erickson HP, 1996, P NATL ACAD SCI USA, V93, P519, DOI 10.1073/pnas.93.1.519; Feucht A, 2001, MOL MICROBIOL, V40, P115, DOI 10.1046/j.1365-2958.2001.02356.x; Geissler B, 2005, MOL MICROBIOL, V58, P596, DOI 10.1111/j.1365-2958.2005.04858.x; Geissler B, 2003, P NATL ACAD SCI USA, V100, P4197, DOI 10.1073/pnas.0635003100; Geissler B, 2007, MICROBIOL-SGM, V153, P814, DOI 10.1099/mic.0.2006/001834-0; Goehring NW, 2007, J BACTERIOL, V189, P633, DOI 10.1128/JB.00991-06; Haeusser DP, 2004, MOL MICROBIOL, V52, P801, DOI 10.1111/j.1365-2958.2004.04016.x; Hale CA, 2000, J BACTERIOL, V182, P5153, DOI 10.1128/JB.182.18.5153-5166.2000; Hale CA, 1997, CELL, V88, P175, DOI 10.1016/S0092-8674(00)81838-3; Hu ZL, 1999, P NATL ACAD SCI USA, V96, P14819, DOI 10.1073/pnas.96.26.14819; Jensen SO, 2005, J BACTERIOL, V187, P6536, DOI 10.1128/JB.187.18.6536-6544.2005; Lara B, 2005, MOL MICROBIOL, V55, P699, DOI 10.1111/j.1365-2958.2004.04432.x; Li Z, 2007, EMBO J, V26, P4694, DOI 10.1038/sj.emboj.7601895; Ma XL, 1999, J BACTERIOL, V181, P7531, DOI 10.1128/JB.181.24.7531-7544.1999; Ma XL, 1996, P NATL ACAD SCI USA, V93, P12998, DOI 10.1073/pnas.93.23.12998; Margolin W, 2005, NAT REV MOL CELL BIO, V6, P862, DOI 10.1038/nrm1745; Michie KA, 2006, ANNU REV BIOCHEM, V75, P467, DOI 10.1146/annurev.biochem.75.103004.142452; Mingorance J, 2005, J BIOL CHEM, V280, P20909, DOI 10.1074/jbc.M503059200; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Mosyak L, 2000, EMBO J, V19, P3179, DOI 10.1093/emboj/19.13.3179; Mukherjee A, 1999, J BACTERIOL, V181, P823, DOI 10.1128/JB.181.3.823-832.1999; Mukherjee A, 1998, EMBO J, V17, P462, DOI 10.1093/emboj/17.2.462; Niu LL, 2008, BIOPHYS J, V95, P2009, DOI 10.1529/biophysj.108.128751; Pichoff S, 2005, MOL MICROBIOL, V55, P1722, DOI 10.1111/j.1365-2958.2005.04522.x; Pichoff S, 2007, MOL MICROBIOL, V64, P1129, DOI 10.1111/j.1365-2958.2007.05735.x; RayChaudhuri D, 1999, EMBO J, V18, P2372, DOI 10.1093/emboj/18.9.2372; Redick SD, 2005, J BACTERIOL, V187, P2727, DOI 10.1128/JB.187.8.2727-2736.2005; Rico AI, 2004, MOL MICROBIOL, V53, P1359, DOI 10.1111/j.1365-2958.2004.04245.x; Rueda S, 2003, J BACTERIOL, V185, P3344, DOI 10.1128/JB.185.11.3344-3351.2003; SANCHEZ M, 1994, EMBO J, V13, P4919, DOI 10.1002/j.1460-2075.1994.tb06819.x; Scheffers DJ, 2008, FEBS LETT, V582, P2601, DOI 10.1016/j.febslet.2008.06.038; Shiomi D, 2008, MOL MICROBIOL, V67, P558, DOI 10.1111/j.1365-2958.2007.06085.x; Shiomi D, 2007, MOL MICROBIOL, V66, P1396, DOI 10.1111/j.1365-2958.2007.05998.x; Srinivasan R, 2008, GENE DEV, V22, P1741, DOI 10.1101/gad.1660908; Stricker J, 2002, P NATL ACAD SCI USA, V99, P3171, DOI 10.1073/pnas.052595099; Sun Q, 1998, J BACTERIOL, V180, P2050, DOI 10.1128/JB.180.8.2050-2056.1998; Thanedar S, 2004, CURR BIOL, V14, P1167, DOI 10.1016/j.cub.2004.06.048; van den Ent F, 2000, EMBO J, V19, P5300, DOI 10.1093/emboj/19.20.5300; Wang XD, 1997, J BACTERIOL, V179, P5551, DOI 10.1128/jb.179.17.5551-5559.1997; Weart RB, 2005, MOL MICROBIOL, V57, P238, DOI 10.1111/j.1365-2958.2005.04673.x; Weiss DS, 2004, MOL MICROBIOL, V54, P588, DOI 10.1111/j.1365-2958.2004.04283.x; Yan K, 2000, BIOCHEM BIOPH RES CO, V270, P387, DOI 10.1006/bbrc.2000.2439; Yim L, 2000, J BACTERIOL, V182, P6366, DOI 10.1128/JB.182.22.6366-6373.2000; Yu XC, 1997, EMBO J, V16, P5455, DOI 10.1093/emboj/16.17.5455	61	48	48	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14079	14086		10.1074/jbc.M808872200	http://dx.doi.org/10.1074/jbc.M808872200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19297332	hybrid, Green Published			2022-12-27	WOS:000266286100014
J	Liu, HY; Yehuda-Shnaidman, E; Hong, T; Han, JM; Pi, JB; Liu, ZQ; Cao, WH				Liu, Hui-Yu; Yehuda-Shnaidman, Einav; Hong, Tao; Han, Jianmin; Pi, Jingbo; Liu, Zhenqi; Cao, Wenhong			Prolonged Exposure to Insulin Suppresses Mitochondrial Production in Primary Hepatocytes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; HUMAN SKELETAL-MUSCLE; GENE-EXPRESSION; ADIPOSE-TISSUE; HEPATIC GLUCONEOGENESIS; PYRUVATE-DEHYDROGENASE; METABOLIC SYNDROME; SIGNALING PATHWAY; OXIDATIVE STRESS; AMINO-ACIDS	Insulin is the central regulator of metabolism and is necessary for storing energy as fat efficiently. Mitochondria are primary sites of energy consumption of most cells. Increased plasma insulin level and mitochondrial dysfunction are features of insulin resistance. The exact role of insulin in regulation of mitochondrial production and function remains unestablished. In this study, we observed that mitochondrial production in liver and skeletal muscle gastrocnemius was increased in mice with insulin deficiency (streptozotocin-induced type 1 diabetes). In contrast, prolonged exposure (24 h) of isolated hepatocytes to insulin decreased mitochondrial mass, mitochondrial DNA (mtDNA), intracellular ATP content, and cellular O-2 consumption. Transcript levels of genes associated with mitochondrial production and beta oxidation were decreased, whereas those of lipogenic genes were increased by the prolonged exposure to insulin. Insulin-induced changes in mtDNA, mitochondrial mass, intracellular ATP content, and transcripts of mitochondrion-associated genes were prevented by blockade of Akt activation with the phosphatidylinositol 3-kinase inhibitor LY294002. Conversely, levels of mtDNA, intracellular ATP content, and expression of mitochondrion-associated genes were decreased by overexpression of the constitutively active Akt. Finally, insulin suppression of mtDNA, ATP production, and expression of mitochondrion-related genes was largely prevented by inhibition of cyclic nucleotide phosphodiesterase with isobutylmethylxanthine. Together, our results show prolonged exposure of isolated hepatocytes to insulin suppresses mitochondrial production and function through the classical Akt-dependent insulin signaling pathway.	[Cao, Wenhong] Duke Univ, Med Ctr, Dept Internal Med Endocrinol, Durham, NC 27705 USA; [Liu, Hui-Yu; Yehuda-Shnaidman, Einav; Hong, Tao; Han, Jianmin; Pi, Jingbo; Cao, Wenhong] Hamner Inst Hlth Sci, Res Triangle Pk, NC 27709 USA; [Liu, Zhenqi] Univ Virginia, Med Sci Ctr, Dept Med Endocrinol, Charlottesville, VA 22908 USA	Duke University; The Hamner Institutes for Health Sciences; University of Virginia	Cao, WH (corresponding author), Duke Univ, Med Ctr, Dept Internal Med Endocrinol, Durham, NC 27705 USA.	wcao@thehamner.org	PI, JINGBO/GWC-2514-2022	PI, JINGBO/0000-0003-0227-8041	National Institutes of Health [R01DK076039]; Investigator Development Fund from the Hamner Institutes for Health Sciences; American Heart Association [SDG-0530244N]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK076039] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Investigator Development Fund from the Hamner Institutes for Health Sciences; American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R01DK076039 (to W. C.). This work was also supported by the Investigator Development Fund from the Hamner Institutes for Health Sciences (to W. C.) and American Heart Association Grant SDG-0530244N (to W. C.).	Accili D, 2004, DIABETES, V53, P1633, DOI 10.2337/diabetes.53.7.1633; Al-Regaiey KA, 2005, ENDOCRINOLOGY, V146, P851, DOI 10.1210/en.2004-1120; BEATTIE DS, 1967, J BIOL CHEM, V242, P4584; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Burns JM, 2007, NEUROLOGY, V69, P1094, DOI 10.1212/01.wnl.0000276952.91704.af; Cao WH, 2005, J BIOL CHEM, V280, P42731, DOI 10.1074/jbc.M506223200; Civitarese AE, 2007, PLOS MED, V4, P485, DOI 10.1371/journal.pmed.0040076; Cole GM, 2007, EXP GERONTOL, V42, P10, DOI 10.1016/j.exger.2006.08.009; Collins QF, 2007, J BIOL CHEM, V282, P30143, DOI 10.1074/jbc.M702390200; Collins QF, 2006, J BIOL CHEM, V281, P24336, DOI 10.1074/jbc.M602177200; Crowell JA, 2007, MOL CANCER THER, V6, P2139, DOI 10.1158/1535-7163.MCT-07-0120; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; DANFORD HG, 1956, J CLIN INVEST, V35, P1205, DOI 10.1172/JCI103375; Garcia-Roves P, 2007, P NATL ACAD SCI USA, V104, P10709, DOI 10.1073/pnas.0704024104; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Houstis N, 2006, NATURE, V440, P944, DOI 10.1038/nature04634; Huang X, 1999, DIABETES, V48, P1508, DOI 10.2337/diabetes.48.8.1508; Katic M, 2007, AGING CELL, V6, P827, DOI 10.1111/j.1474-9726.2007.00346.x; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; KONES RJ, 1975, CARDIOLOGY, V60, P280, DOI 10.1159/000169727; Kumashiro N, 2008, DIABETES, V57, P2083, DOI 10.2337/db08-0144; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Larsson NG, 1998, NAT GENET, V18, P231, DOI 10.1038/ng0398-231; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861; Lin Y, 2005, J BIOL CHEM, V280, P4617, DOI 10.1074/jbc.M411863200; Liu HY, 2008, J BIOL CHEM, V283, P30642, DOI 10.1074/jbc.M803698200; Liu HY, 2008, J BIOL CHEM, V283, P12056, DOI 10.1074/jbc.M801033200; Liu HY, 2007, J BIOL CHEM, V282, P14205, DOI 10.1074/jbc.M609701200; Matthias A, 2000, J BIOL CHEM, V275, P25073, DOI 10.1074/jbc.M000547200; Meijer AJ, 2003, J NUTR, V133, p2057S, DOI 10.1093/jn/133.6.2057S; MENZIES RA, 1972, J NEUROCHEM, V19, P1671, DOI 10.1111/j.1471-4159.1972.tb06212.x; MENZIES RA, 1971, J BIOL CHEM, V246, P2425; Moreira PI, 2007, J NEUROL SCI, V257, P206, DOI 10.1016/j.jns.2007.01.017; MUKHERJEE C, 1975, BIOCHEM J, V148, P229, DOI 10.1042/bj1480229; Nishino Naonobu, 2007, Kobe J Med Sci, V53, P99; Nisoli E, 2008, AM J CARDIOL, V101, p22E, DOI 10.1016/j.amjcard.2008.02.077; Palmeira CM, 2007, TOXICOL APPL PHARM, V225, P214, DOI 10.1016/j.taap.2007.07.015; Pendergrass W, 2004, CYTOM PART A, V61A, P162, DOI 10.1002/cyto.a.20033; Petersen KF, 2005, PLOS MED, V2, P879, DOI 10.1371/journal.pmed.0020233; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Pospisilik JA, 2007, CELL, V131, P476, DOI 10.1016/j.cell.2007.08.047; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2; Roche TE, 2007, CELL MOL LIFE SCI, V64, P830, DOI 10.1007/s00018-007-6380-z; Southgate RJ, 2005, FASEB J, V19, P2072, DOI 10.1096/fj.05-3993fje; Stump CS, 2003, P NATL ACAD SCI USA, V100, P7996, DOI 10.1073/pnas.1332551100; Sugden M. C., 2002, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V2, P151, DOI 10.2174/1568008023340785; Tanaka T, 2003, P NATL ACAD SCI USA, V100, P15924, DOI 10.1073/pnas.0306981100; Turko IV, 2003, J BIOL CHEM, V278, P35844, DOI 10.1074/jbc.M303139200; Wallace DC, 2005, ANNU REV GENET, V39, P359, DOI 10.1146/annurev.genet.39.110304.095751; Wang MY, 2008, P NATL ACAD SCI USA, V105, P6139, DOI 10.1073/pnas.0801981105; Wijkander J, 1998, ENDOCRINOLOGY, V139, P219, DOI 10.1210/en.139.1.219; Xiong Y, 2007, J BIOL CHEM, V282, P4975, DOI 10.1074/jbc.M606742200; Yin XM, 2008, HEPATOLOGY, V47, P1773, DOI 10.1002/hep.22146	56	47	48	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14087	14095		10.1074/jbc.M807992200	http://dx.doi.org/10.1074/jbc.M807992200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19336408	Green Published, hybrid			2022-12-27	WOS:000266286100015
J	Bynagari, YS; Nagy, B; Tuluc, F; Bhavaraju, K; Kim, S; Vijayan, KV; Kunapuli, SP				Bynagari, Yamini S.; Nagy, Bela, Jr.; Tuluc, Florin; Bhavaraju, Kamala; Kim, Soochong; Vijayan, K. Vinod; Kunapuli, Satya P.			Mechanism of Activation and Functional Role of Protein Kinase C eta in Human Platelets	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADP RECEPTORS; INTEGRIN ALPHA(IIB)BETA(3); P2Y(12) RECEPTOR; TYROSINE KINASE; MOLECULAR-BASIS; DOWN-REGULATION; PATHWAYS; GENERATION; ISOFORM; EPSILON	The novel class of protein kinase C (nPKC) isoform eta is expressed in platelets, but not much is known about its activation and function. In this study, we investigated the mechanism of activation and functional implications of nPKC eta using pharmacological and gene knock-out approaches. nPKC eta was phosphorylated (at Thr-512) in a time-and concentration-dependent manner by 2MeSADP. Pretreatment of platelets with MRS-2179, a P2Y(1) receptor antagonist, or YM-254890, a G(q) blocker, abolished 2MeSADP-induced phosphorylation of nPKC eta. Similarly, ADP failed to activate nPKC eta in platelets isolated from P2Y(1) and G(q) knock-out mice. However, pretreatment of platelets with P2Y(12) receptor antagonist, AR-C69331MX did not interfere with ADP-induced nPKC eta phosphorylation. In addition, when platelets were activated with 2MeSADP under stirring conditions, although nPKC eta was phosphorylated within 30 s by ADP receptors, it was also dephosphorylated by activated integrin alpha(II)b beta(3) mediated outside-in signaling. Moreover, in the presence of SC-57101, alpha(II)b beta(3) receptor antagonist, nPKC eta dephosphorylation was inhibited. Furthermore, in murine platelets lacking PP1C gamma, a catalytic subunit of serine/threonine phosphatase, alpha(II)b beta(3) failed to dephosphorylate n PKC eta. Thus, we conclude that ADP activates nPKC eta via P2Y(1) receptor and is subsequently dephosphorylated by PP1 gamma phosphatase activated by alpha(II)b beta(3) integrin. In addition, pretreatment of platelets with eta-RACK antagonistic peptides, a specific inhibitor of nPKC eta, inhibited ADP-induced thromboxane generation. However, these peptides had no affect on ADP-induced aggregation when thromboxane generation was blocked. In summary, nPKC eta positively regulates agonist-induced thromboxane generation with no effects on platelet aggregation.	[Bynagari, Yamini S.; Nagy, Bela, Jr.; Tuluc, Florin; Bhavaraju, Kamala; Kim, Soochong; Kunapuli, Satya P.] Temple Univ, Sch Med, Dept Physiol, Philadelphia, PA 19140 USA; [Kunapuli, Satya P.] Temple Univ, Sch Med, Dept Pharmacol, Philadelphia, PA 19140 USA; [Kunapuli, Satya P.] Temple Univ, Sch Med, Sol Sherry Thrombosis Res Ctr, Philadelphia, PA 19140 USA; [Vijayan, K. Vinod] Baylor Coll Med, Dept Med, Houston, TX 77030 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Baylor College of Medicine	Kunapuli, SP (corresponding author), Temple Univ, Sch Med, Dept Physiol, 3420 N Broad St, Philadelphia, PA 19140 USA.	spk@temple.edu	Tuluc, Petronel/C-2527-2011		National Institutes of Health [HL81322, HL93231, HL80444, HL60683]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081613, R01HL080444, R01HL060683, R01HL081322] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants HL81322, HL93231, HL80444, and HL60683.	Baurand A, 2001, EUR J PHARMACOL, V412, P213, DOI 10.1016/S0014-2999(01)00733-6; Brandlin I, 2002, J BIOL CHEM, V277, P6490, DOI 10.1074/jbc.M106083200; Brass LF, 1999, J CLIN INVEST, V104, P1663, DOI 10.1172/JCI8944; BRASS LP, 1993, ADV EXP MED BIOL, V344, P17; CHARI R, 2009, ARTERIOSCLE IN PRESS; Crosby D, 2003, J BIOL CHEM, V278, P24533, DOI 10.1074/jbc.M301847200; Crosby D, 2002, J BIOL CHEM, V277, P9958, DOI 10.1074/jbc.M108965200; Csukai M, 1997, J BIOL CHEM, V272, P29200, DOI 10.1074/jbc.272.46.29200; Dangelmaier C, 2000, EUR J BIOCHEM, V267, P2283, DOI 10.1046/j.1432-1327.2000.01235.x; Dangelmaier CA, 2005, BLOOD, V105, P3918, DOI 10.1182/blood-2004-09-3689; Daniel JL, 1998, J BIOL CHEM, V273, P2024, DOI 10.1074/jbc.273.4.2024; Dorsam RT, 2005, BLOOD, V105, P2749, DOI 10.1182/blood-2004-07-2821; Dorsam RT, 2004, J CLIN INVEST, V113, P340, DOI 10.1172/JCI200420986; Fabre JE, 1999, NAT MED, V5, P1199, DOI 10.1038/13522; Garcia A, 2007, BIOCHEM J, V404, P299, DOI 10.1042/BJ20061584; GOODE NT, 1995, J BIOL CHEM, V270, P2669, DOI 10.1074/jbc.270.6.2669; GUSHIKEN FC, 2007, BLOOD, V110, pA135; Gushiken FC, 2008, J BIOL CHEM, V283, P12862, DOI 10.1074/jbc.M708804200; Inagaki K, 2003, CIRCULATION, V108, P869, DOI 10.1161/01.CIR.0000081943.93653.73; Jin JG, 2002, BLOOD, V99, P193, DOI 10.1182/blood.V99.1.193; Jin JG, 1998, P NATL ACAD SCI USA, V95, P8070, DOI 10.1073/pnas.95.14.8070; Jin JG, 1998, J BIOL CHEM, V273, P2030, DOI 10.1074/jbc.273.4.2030; Joseph EK, 2007, PAIN, V132, P67, DOI 10.1016/j.pain.2007.01.027; Kawasaki T, 2003, THROMB HAEMOSTASIS, V90, P406, DOI 10.1160/TH03-02-0115; Kim S, 2006, BLOOD, V107, P947, DOI 10.1182/blood-2005-07-3040; Kim S, 2004, J BIOL CHEM, V279, P4186, DOI 10.1074/jbc.M306162200; Kunapuli Satva P, 2002, ScientificWorldJournal, V2, P424; Lee HW, 1997, MOL PHARMACOL, V51, P439; Leon C, 1999, J CLIN INVEST, V104, P1731, DOI 10.1172/JCI8399; Liedtke CM, 2005, J BIOL CHEM, V280, P25491, DOI 10.1074/jbc.M504473200; Lum H, 2001, AM J PHYSIOL-LUNG C, V281, pL546, DOI 10.1152/ajplung.2001.281.3.L546; Mills DCB, 1996, THROMB HAEMOSTASIS, V76, P835; MOCHLYROSEN D, 1991, J BIOL CHEM, V266, P14866; Murugappan S, 2004, J BIOL CHEM, V279, P2360, DOI 10.1074/jbc.M306960200; Nagy B, 2009, BLOOD, V113, P2557, DOI 10.1182/blood-2008-07-169268; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; Newton AC, 2003, BIOCHEM J, V370, P361, DOI 10.1042/BJ20021626; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; Offermanns S, 2000, BIOL CHEM, V381, P389, DOI 10.1515/BC.2000.051; Offermanns S, 1997, P NATL ACAD SCI USA, V94, P14089, DOI 10.1073/pnas.94.25.14089; PARKER PJ, 1995, BIOCHEM SOC T, V23, P153, DOI 10.1042/bst0230153; Quinton TM, 2002, BIOCHEM J, V368, P535, DOI 10.1042/BJ20020226; RON D, 1995, J BIOL CHEM, V270, P24180, DOI 10.1074/jbc.270.41.24180; RON D, 1994, P NATL ACAD SCI USA, V91, P839, DOI 10.1073/pnas.91.3.839; Schror K, 1997, SEMIN THROMB HEMOST, V23, P349, DOI 10.1055/s-2007-996108; Shankar H, 2006, J THROMB HAEMOST, V4, P638, DOI 10.1111/j.1538-7836.2006.01789.x; Shattil SJ, 2004, BLOOD, V104, P1606, DOI 10.1182/blood-2004-04-1257; Shattil SJ, 1998, BLOOD, V91, P2645, DOI 10.1182/blood.V91.8.2645.2645_2645_2657; Soriani A, 2006, J THROMB HAEMOST, V4, P648, DOI 10.1111/j.1538-7836.2006.01806.x; Taniguchi M, 2004, BIOORGAN MED CHEM, V12, P3125, DOI 10.1016/j.bmc.2004.04.006; Uht RM, 2007, ONCOGENE, V26, P2885, DOI 10.1038/sj.onc.1210090; Varmuza S, 1999, DEV BIOL, V205, P98, DOI 10.1006/dbio.1998.9100; Vijayan KV, 2004, J BIOL CHEM, V279, P33039, DOI 10.1074/jbc.C400239200; Vijayan KV, 2005, J BIOL CHEM, V280, P21756, DOI 10.1074/jbc.M500872200; Yang X, 1997, THROMB RES, V88, P317, DOI 10.1016/S0049-3848(97)00261-2	55	25	26	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13413	13421		10.1074/jbc.M808970200	http://dx.doi.org/10.1074/jbc.M808970200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19286657	Green Published, hybrid			2022-12-27	WOS:000265877300017
J	Lu, RJ; Li, Y; Zhang, YW; Chen, YJ; Shields, AD; Winder, DG; Angelotti, T; Jiao, K; Limbird, LE; Zhou, Y; Wang, Q				Lu, Roujian; Li, Yong; Zhang, Youwen; Chen, Yunjia; Shields, Angela D.; Winder, Danny G.; Angelotti, Timothy; Jiao, Kai; Limbird, Lee E.; Zhou, Yi; Wang, Qin			Epitope-tagged Receptor Knock-in Mice Reveal That Differential Desensitization of alpha(2)-Adrenergic Responses Is because of Ligand-selective Internalization	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MU-OPIOID RECEPTOR; PROTEIN-COUPLED RECEPTORS; AGONIST-SPECIFIC REGULATION; BETA-ADRENERGIC-RECEPTORS; HUMAN ASTROCYTOMA-CELLS; ALPHA(2A)-ADRENERGIC RECEPTOR; SYMPATHETIC NEURONS; 7-TRANSMEMBRANE RECEPTORS; ADENYLATE-CYCLASE; BETA-2-ADRENERGIC RECEPTOR	Although ligand-selective regulation of G protein-coupled receptor-mediated signaling and trafficking are well documented, little is known about whether ligand-selective effects occur on endogenous receptors or whether such effects modify the signaling response in physiologically relevant cells. Using a gene targeting approach, we generated a knock-in mouse line, in which N-terminal hemagglutinin epitope-tagged alpha(2)A-adrenergic receptor (AR) expression was driven by the endogenous mouse alpha(2A)AR gene locus. Exploiting this mouse line, we evaluated alpha(2A)AR trafficking and alpha(2A)AR-mediated inhibition of Ca2+ currents in native sympathetic neurons in response to clonidine and guanfacine, two drugs used for treatment of hypertension, attention deficit and hyperactivity disorder, and enhancement of analgesia through actions on the alpha(2A)AR subtype. We discovered a more rapid desensitization of Ca2+ current suppression by clonidine than guanfacine, which paralleled a more marked receptor phosphorylation and endocytosis of alpha(2A)AR evoked by clonidine than by guanfacine. Clonidine-induced alpha(2A)AR desensitization, but not receptor phosphorylation, was attenuated by blockade of endocytosis with concanavalin A, indicating a critical role for internalization of alpha(2A)AR in desensitization to this ligand. Our data on endogenous receptor-mediated signaling and trafficking in native cells reveal not only differential regulation of G protein- coupled receptor endocytosis by different ligands, but also a differential contribution of receptor endocytosis to signaling desensitization. Taken together, our data suggest that these HA-alpha(2A)AR knock-in mice will serve as an important model in developing ligands to favor endocytosis or nonendocytosis of receptors, depending on the target cell and pathophysiology being addressed.	[Lu, Roujian; Zhang, Youwen; Chen, Yunjia; Wang, Qin] Univ Alabama Birmingham, Dept Physiol & Biophys, Birmingham, AL 35294 USA; [Li, Yong; Wang, Qin] Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA; [Jiao, Kai] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA; [Li, Yong] Shanghai Jiao Tong Univ, Dept Neurobiol, Sch Med, Shanghai 200025, Peoples R China; [Shields, Angela D.; Winder, Danny G.] Vanderbilt Univ, Dept Mol Physiol, Nashville, TN 37232 USA; [Angelotti, Timothy] Stanford Univ, Dept Anesthesia, CCM, Stanford, CA 94305 USA; [Limbird, Lee E.] Meharry Med Coll, Dept Biomed Sci, Nashville, TN 37208 USA; [Zhou, Yi] Florida State Univ, Dept Biomed Sci, Tallahassee, FL 32306 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Shanghai Jiao Tong University; Vanderbilt University; Stanford University; Meharry Medical College; State University System of Florida; Florida State University	Wang, Q (corresponding author), 958 MCLM,1918 Univ Blvd, Birmingham, AL 35294 USA.	qinwang@uab.edu	Angelotti, Timothy/AAD-3714-2022; Winder, Danny G./H-4857-2013; Li, Yong/ABB-5588-2021	Angelotti, Timothy/0000-0002-0100-2011; Wang, Qin/0000-0002-1079-5914; Jiao, Kai/0000-0002-5415-9020	National Institutes of Health [DK43852, HL25182, MH079075, MH081917, NS050355]; American Heart Association [0630103N, 0635497N]; NINDS [KO8 Grant NS050654]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL025182] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH079075, R01MH081917] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS050654, R01NS050355] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants DK43852 and HL25182 (to L. E. L.), MH079075 (to Q. W.), MH081917 (to Q.W.), and NS050355 (to Y.Z.). This work was also supported by American Heart Association Awards 0630103N (to Q. W.) and 0635497N (to Y.Z.).; Supported by National Institutes of Health KO8 Grant NS050654 from NINDS.	Abbadie C, 2001, NEUROREPORT, V12, P3069, DOI 10.1097/00001756-200110080-00017; Alvarez VA, 2002, J NEUROSCI, V22, P5769; Arttamangkul S, 2006, J NEUROSCI, V26, P4118, DOI 10.1523/JNEUROSCI.0303-06.2006; Banaschewski T, 2004, EUR CHILD ADOLES PSY, V13, P102, DOI 10.1007/s00787-004-1010-x; Bhatnagar A, 2001, J BIOL CHEM, V276, P8269, DOI 10.1074/jbc.M006968200; Bisello A, 2004, MOL ENDOCRINOL, V18, P1486, DOI 10.1210/me.2003-0487; Bisello A, 2002, J BIOL CHEM, V277, P38524, DOI 10.1074/jbc.M202544200; Bohn LM, 2000, NATURE, V408, P720, DOI 10.1038/35047086; Borgland SL, 2003, J BIOL CHEM, V278, P18776, DOI 10.1074/jbc.M300525200; Boudin H, 2000, J NEUROSCI, V20, P5932, DOI 10.1523/JNEUROSCI.20-16-05932.2000; Brady AE, 2005, MOL PHARMACOL, V67, P1690, DOI 10.1124/mol.104.005215; Brum PC, 2006, NEUROPHARMACOLOGY, V51, P397, DOI 10.1016/j.neuropharm.2006.03.032; Bushell T, 2002, MOL PHARMACOL, V61, P55, DOI 10.1124/mol.61.1.55; CARCHMAN SH, 1987, J CLIN PHARMACOL, V27, P762, DOI 10.1002/j.1552-4604.1987.tb02993.x; Chan F, 2004, P NATL ACAD SCI USA, V101, P9109, DOI 10.1073/pnas.0403149101; CHENG K, 2001, ADV ABNORMAL PSYCHOL, P507; Cormack JR, 2005, J CLIN NEUROSCI, V12, P375, DOI 10.1016/j.jocn.2004.06.008; Debic HH, 2005, J NEUROSCI, V25, P7847, DOI 10.1523/JNEUROSCI.5045-04.2005; DiversePierluissi M, 1996, NEURON, V16, P579, DOI 10.1016/S0896-6273(00)80077-X; Drake MT, 2008, J BIOL CHEM, V283, P5669, DOI 10.1074/jbc.M708118200; ELMSLIE KS, 1990, NEURON, V5, P75, DOI 10.1016/0896-6273(90)90035-E; Ferguson SSG, 2001, PHARMACOL REV, V53, P1; Gainetdinov RR, 2004, ANNU REV NEUROSCI, V27, P107, DOI 10.1146/annurev.neuro.27.070203.144206; Guthrie CR, 2005, J PHARMACOL EXP THER, V313, P1003, DOI 10.1124/jpet.104.081919; Hanley NRS, 2002, J PHARMACOL EXP THER, V300, P468, DOI 10.1124/jpet.300.2.468; Hein L, 1999, ANN NY ACAD SCI, V881, P265, DOI 10.1111/j.1749-6632.1999.tb09368.x; HERTEL C, 1985, J BIOL CHEM, V260, P2547; Ikeda SR, 1999, ADV SEC MESS PHOSPH, V33, P131; Jasper JR, 1998, BIOCHEM PHARMACOL, V55, P1035, DOI 10.1016/S0006-2952(97)00631-X; Jeong SW, 2000, P NATL ACAD SCI USA, V97, P907, DOI 10.1073/pnas.97.2.907; Kable JW, 2000, J PHARMACOL EXP THER, V293, P1; KEEFER JR, 1993, J BIOL CHEM, V268, P11340; Kenakin T, 2004, TRENDS PHARMACOL SCI, V25, P186, DOI 10.1016/j.tips.2004.02.012; KENAKIN T, 2007, TRENDS PHARMACOL SCI, V16, P232; Koch T, 2005, MOL PHARMACOL, V67, P280, DOI 10.1124/mol.104.004994; Kohout TA, 2003, MOL PHARMACOL, V63, P9, DOI 10.1124/mol.63.1.9; Lakhlani PP, 1997, P NATL ACAD SCI USA, V94, P9950, DOI 10.1073/pnas.94.18.9950; Li JG, 2003, J PHARMACOL EXP THER, V305, P531, DOI 10.1124/jpet.102.045559; Li Y, 2006, NEURON, V51, P755, DOI 10.1016/j.neuron.2006.08.014; Liao D, 2007, MOL CELL NEUROSCI, V35, P456, DOI 10.1016/j.mcn.2007.04.007; LIMBIRD LE, 1988, FASEB J, V2, P2686, DOI 10.1096/fasebj.2.11.2840317; LOHSE MJ, 1990, J BIOL CHEM, V265, P3202; MacDonald E, 1997, TRENDS PHARMACOL SCI, V18, P211; MacMillan LB, 1996, SCIENCE, V273, P801, DOI 10.1126/science.273.5276.801; MANINTVELD AJ, 1997, ANTIHYPERTENSIVE DRU, P427; Marie N, 2003, J BIOL CHEM, V278, P22795, DOI 10.1074/jbc.M300084200; Minnis JG, 2003, NEUROSCIENCE, V119, P33, DOI 10.1016/S0306-4522(03)00135-0; Oates J. A., 2001, GOODMAN GILMANS PHAR, V10, P871; Olli-Lahdesmaki T, 2003, EUR J CELL BIOL, V82, P231, DOI 10.1078/0171-9335-00311; Perez DM, 2005, PHARMACOL REV, V57, P147, DOI 10.1124/pr.57.2.2; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Pierce KL, 2001, NAT REV NEUROSCI, V2, P727, DOI 10.1038/35094577; Ryman-Rasmussen JP, 2005, MOL PHARMACOL, V68, P1039, DOI 10.1124/mol.105.012153; Scahill L, 1999, J Child Adolesc Psychiatr Nurs, V12, P168, DOI 10.1111/j.1744-6171.1999.tb00065.x; Scherrer G, 2006, P NATL ACAD SCI USA, V103, P9691, DOI 10.1073/pnas.0603359103; Schlag BD, 2004, J PHARMACOL EXP THER, V310, P865, DOI 10.1124/jpet.104.067306; Schramm NL, 1999, J BIOL CHEM, V274, P24935, DOI 10.1074/jbc.274.35.24935; Schwenk F, 1995, NUCLEIC ACIDS RES, V23, P5080, DOI 10.1093/nar/23.24.5080; Shukla AK, 2008, P NATL ACAD SCI USA, V105, P9988, DOI 10.1073/pnas.0804246105; Sica Domenic A, 2007, J Clin Hypertens (Greenwich), V9, P399, DOI 10.1111/j.1524-6175.2007.07161.x; SU YF, 1979, J BIOL CHEM, V254, P38; SURPRENANT A, 1992, SCIENCE, V257, P977, DOI 10.1126/science.1354394; Tan CM, 2002, P NATL ACAD SCI USA, V99, P12471, DOI 10.1073/pnas.122368499; Trafton JA, 2000, J NEUROSCI, V20, P8578; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Velazquez B, 2000, MOL CELL BIOCHEM, V206, P75, DOI 10.1023/A:1007091127392; VIDOVIC M, 1994, MOL BRAIN RES, V22, P49, DOI 10.1016/0169-328X(94)90031-0; Violin JD, 2007, TRENDS PHARMACOL SCI, V28, P416, DOI 10.1016/j.tips.2007.06.006; von Zastrow M, 2007, CURR OPIN CELL BIOL, V19, P436, DOI 10.1016/j.ceb.2007.04.021; Wang Q, 2004, SCIENCE, V304, P1940, DOI 10.1126/science.1098274; Wang Q, 2002, J BIOL CHEM, V277, P50589, DOI 10.1074/jbc.M208503200; Wang RX, 1997, MOL PHARMACOL, V52, P1071, DOI 10.1124/mol.52.6.1071; Wang YL, 2003, J PHARMACOL EXP THER, V307, P1127, DOI 10.1124/jpet.103.055814; Whistler JL, 1999, NEURON, V23, P737, DOI 10.1016/S0896-6273(01)80032-5; Whistler JL, 1998, P NATL ACAD SCI USA, V95, P9914, DOI 10.1073/pnas.95.17.9914; Xiang Y, 2002, J BIOL CHEM, V277, P33783, DOI 10.1074/jbc.M204136200; Xu JM, 2008, J BIOL CHEM, V283, P14516, DOI 10.1074/jbc.M710340200; YAMAUCHI A, 1973, J ANAT, V114, P271; Zhang J, 1998, P NATL ACAD SCI USA, V95, P7157, DOI 10.1073/pnas.95.12.7157; Zhang J, 1999, J RECEPT SIGNAL TR R, V19, P301, DOI 10.3109/10799899909036653	80	27	32	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					13233	13243		10.1074/jbc.M807535200	http://dx.doi.org/10.1074/jbc.M807535200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19276088	Green Published, hybrid			2022-12-27	WOS:000265688300070
J	Morales, AA; Gutman, D; Cejas, PJ; Lee, KP; Boise, LH				Morales, Alejo A.; Gutman, Delia; Cejas, Pedro J.; Lee, Kelvin P.; Boise, Lawrence H.			Reactive Oxygen Species Are Not Required for an Arsenic Trioxide-induced Antioxidant Response or Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE-MYELOMA CELLS; TRANSCRIPTION FACTOR NRF2; HEME OXYGENASE-1; MOLECULAR-MECHANISMS; UP-REGULATION; GENE-EXPRESSION; CANCER-CELLS; INTRACELLULAR GLUTATHIONE; IMMUNOMODULATORY AGENT; SIGNAL-TRANSDUCTION	Arsenicals are both environmental carcinogens as well as therapeutic agents for the treatment of trypanosomiasis and more recently cancer. Arsenic trioxide (ATO) has been successfully used for the treatment of acute promyelocytic leukemia (APL) and has activity in multiple myeloma (MM). While signaling events associated with carcinogenesis have been well studied, it still remains to be determined which of these events are involved in anti-cancer signaling. To better define this response, gene expression profiling following ATO treatment of four MM cell lines was performed. The pattern was consistent with a strong antioxidative response, particularly of genes activated by Nrf2. While Nrf2 is expressed constitutively at the mRNA level, the protein is not detected in untreated cells. Consistent with inactivation of Keap1, Nrf2 protein is stabilized and present in the nucleus within 6 h of ATO treatment. Despite the activation of this antioxidative response, ROS may not be important in ATO-induced death. Inhibition of ATO-induced ROS with butylated hydroxyanisole (BHA) does not affect Nrf2 activation or cell death. Moreover, silencing Nrf2 had no effect on ATO-induced apoptosis. Together these data suggest that ROS is not important in the induction of the antioxidative response or cellular death by ATO.	[Morales, Alejo A.; Gutman, Delia; Cejas, Pedro J.; Boise, Lawrence H.] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA; [Morales, Alejo A.; Gutman, Delia; Cejas, Pedro J.; Boise, Lawrence H.] Univ Miami, Miller Sch Med, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA; [Lee, Kelvin P.] Roswell Pk Canc Inst, Dept Immunol, Buffalo, NY 14263 USA; [Lee, Kelvin P.] Roswell Pk Canc Inst, Dept Med, Buffalo, NY 14263 USA	University of Miami; University of Miami; Roswell Park Cancer Institute; Roswell Park Cancer Institute	Boise, LH (corresponding author), 1600 NW 10th Ave,RMSB,Rm 3153, Miami, FL 33136 USA.	lboise@med.miami.edu	Boise, Lawrence/AAD-2314-2019	Boise, Lawrence/0000-0001-9436-8815	National Institutes of Health [R01 CA129968, CA97243, CA127910]; Multiple Myeloma Foundation; NATIONAL CANCER INSTITUTE [R01CA129968, R01CA127910, R01CA097243] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Multiple Myeloma Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 CA129968, CA97243, and CA127910. This work was also supported by a Senior Research Award from the Multiple Myeloma Foundation.	Abraham NG, 2007, CURR GENE THER, V7, P89, DOI 10.2174/156652307780363134; Alam J, 2007, AM J RESP CELL MOL, V36, P166, DOI 10.1165/rcmb.2006-0340TR; ALBORES A, 1992, CHEM-BIOL INTERACT, V85, P127, DOI 10.1016/0009-2797(92)90057-R; Bahlis NJ, 2002, CLIN CANCER RES, V8, P3658; Baranano DE, 2002, P NATL ACAD SCI USA, V99, P16093, DOI 10.1073/pnas.252626999; Berenson JR, 2006, CLIN LYMPHOMA MYELOM, V7, P192, DOI 10.3816/CLM.2006.n.058; Bonati A, 2006, CURR PHARM BIOTECHNO, V7, P397, DOI 10.2174/138920106779116829; Brouard S, 2000, J EXP MED, V192, P1015, DOI 10.1084/jem.192.7.1015; Calderwood SK, 2006, TRENDS BIOCHEM SCI, V31, P164, DOI 10.1016/j.tibs.2006.01.006; Chen CY, 2005, BIOCHEM BIOPH RES CO, V331, P993, DOI 10.1016/j.bbrc.2005.03.237; Chen D, 2006, CANCER RES, V66, P11416, DOI 10.1158/0008-5472.CAN-06-0409; Circu ML, 2009, BIOCHEM PHARMACOL, V77, P76, DOI 10.1016/j.bcp.2008.09.011; Dai J, 1999, BLOOD, V93, P268, DOI 10.1182/blood.V93.1.268.401a21_268_277; Devling TWP, 2005, P NATL ACAD SCI USA, V102, P7280, DOI 10.1073/pnas.0501475102; Dilda PJ, 2007, CANCER TREAT REV, V33, P542, DOI 10.1016/j.ctrv.2007.05.001; Fang J, 2004, APOPTOSIS, V9, P27, DOI 10.1023/B:APPT.0000012119.83734.4e; Ferrandiz ML, 2008, CURR PHARM DESIGN, V14, P473, DOI 10.2174/138161208783597399; Fujita H, 2008, BRAIN RES, V1206, P1, DOI 10.1016/j.brainres.2008.01.081; Gallagher RE, 2001, LEUKEMIA RES, V25, P237, DOI 10.1016/S0145-2126(00)00144-2; Gao XQ, 2004, P NATL ACAD SCI USA, V101, P10446, DOI 10.1073/pnas.0403886101; GOUILL S, 2005, ONCOGENE, V24, P8076; Grad JM, 2001, BLOOD, V98, P805, DOI 10.1182/blood.V98.3.805; Harada H, 2008, FREE RADICAL RES, V42, P297, DOI 10.1080/10715760801975735; Hayashi T, 2002, MOL CANCER THER, V1, P851; Hu XM, 2006, MOL CELL BIOL, V26, P940, DOI 10.1128/MCB.26.3.940-954.2006; Hu XM, 2003, CANCER CHEMOTH PHARM, V52, P47, DOI 10.1007/s00280-003-0629-5; Huang HC, 2002, J BIOL CHEM, V277, P42769, DOI 10.1074/jbc.M206911200; Hussein MA, 2001, MED ONCOL, V18, P239, DOI 10.1385/MO:18:4:239; Itoh K, 1997, BIOCHEM BIOPH RES CO, V236, P313, DOI 10.1006/bbrc.1997.6943; Kajiguchi T, 2006, CANCER SCI, V97, P540, DOI 10.1111/j.1349-7006.2006.00199.x; Kalmadi SR, 2006, ACTA HAEMATOL-BASEL, V116, P1, DOI 10.1159/000092341; Kannan-Thulasiraman P, 2006, J BIOL CHEM, V281, P22446, DOI 10.1074/jbc.M603111200; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kobayashi A, 2006, MOL CELL BIOL, V26, P221, DOI 10.1128/MCB.26.1.221-229.2006; Kobayashi M, 2005, ANTIOXID REDOX SIGN, V7, P385, DOI 10.1089/ars.2005.7.385; Krause C, 2008, ANTICANCER RES, V28, P2585; Kumagai Y, 2007, ANNU REV PHARMACOL, V47, P243, DOI 10.1146/annurev.pharmtox.47.120505.105144; Kwak MK, 2003, J BIOL CHEM, V278, P8135, DOI 10.1074/jbc.M211898200; Lee JS, 2005, CANCER LETT, V224, P171, DOI 10.1016/j.canlet.2004.09.042; Liu Q, 2003, BLOOD, V101, P4078, DOI 10.1182/blood-2002-10-3231; Liu ZM, 2004, ONCOGENE, V23, P503, DOI 10.1038/sj.onc.1207173; Lo SC, 2006, J BIOL CHEM, V281, P37893, DOI 10.1074/jbc.M606539200; Ma Q, 2004, BIOCHEM J, V377, P205, DOI 10.1042/BJ20031123; Ma Q, 2006, AM J PATHOL, V168, P1960, DOI 10.2353/ajpath.2006.051113; Martin D, 2004, J BIOL CHEM, V279, P8919, DOI 10.1074/jbc.M309660200; McCafferty-Grad J, 2003, MOL CANCER THER, V2, P1155; Miller WH, 2002, CANCER RES, V62, P3893; Min JY, 2006, J NEURAL TRANSM, V113, P1821, DOI 10.1007/s00702-006-0500-z; Morales AA, 2008, BLOOD, V111, P5152, DOI 10.1182/blood-2007-10-116889; Munshi NC, 2002, LEUKEMIA, V16, P1835, DOI 10.1038/sj.leu.2402599; Ngu TT, 2006, J AM CHEM SOC, V128, P12473, DOI 10.1021/ja062914c; Nguyen T, 2004, FREE RADICAL BIO MED, V37, P433, DOI 10.1016/j.freeradbiomed.2004.04.033; Nowis D, 2006, ONCOGENE, V25, P3365, DOI 10.1038/sj.onc.1209378; Park WH, 2000, CANCER RES, V60, P3065; Ramos-Gomez M, 2001, P NATL ACAD SCI USA, V98, P3410, DOI 10.1073/pnas.051618798; Rousselot P, 2004, LEUKEMIA, V18, P1518, DOI 10.1038/sj.leu.2403424; Ryter SW, 2002, ANTIOXID REDOX SIGN, V4, P625, DOI 10.1089/15230860260220120; Sasaki T, 2005, VIRCHOWS ARCH, V446, P525, DOI 10.1007/s00428-005-1247-x; Sato K, 2001, J IMMUNOL, V166, P4185, DOI 10.4049/jimmunol.166.6.4185; Shen ZY, 2003, INT J MOL MED, V11, P479; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Toyama M, 2002, J BIOCHEM, V132, P217, DOI 10.1093/oxfordjournals.jbchem.a003213; Volm M, 2002, BRIT J CANCER, V87, P251, DOI 10.1038/sj.bjc.6600463; Wang ZY, 2008, BLOOD, V111, P2505, DOI 10.1182/blood-2007-07-102798; Woo SH, 2004, INT J CANCER, V112, P596, DOI 10.1002/ijc.20433; Yamamoto N, 2007, J BIOL CHEM, V282, P4364, DOI 10.1074/jbc.M603712200; Yan W, 2007, BIOCHEM BIOPH RES CO, V355, P1038, DOI 10.1016/j.bbrc.2007.02.064; Zhou P, 2005, BRIT J HAEMATOL, V128, P636, DOI 10.1111/j.1365-2141.2005.05369.x	68	35	38	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12886	12895		10.1074/jbc.M806546200	http://dx.doi.org/10.1074/jbc.M806546200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19279006	Green Published, hybrid			2022-12-27	WOS:000265688300034
J	Wu, TJ; Chiang, YH; Lin, YC; Tsai, CR; Yu, TY; Sung, MT; Lee, YHW; Lin, JJ				Wu, Tzung-Ju; Chiang, Yi-Hsuan; Lin, Yi-Chien; Tsai, Chang-Ru; Yu, Tai-Yuan; Sung, Ming-Ta; Lee, Yan-Hwa Wu; Lin, Jing-Jer			Sequential Loading of Saccharomyces cerevisiae Ku and Cdc13p to Telomeres	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING PROTEIN; STRAND BREAK REPAIR; SINGLE-STRAND; YEAST KU; IN-VIVO; RIF PROTEINS; SIR PROTEINS; MAINTENANCE; MECHANISM; LENGTH	Ku is a heterodimeric protein involved in nonhomologous end-joining of the DNA double-stranded break repair pathway. It binds to the double-stranded DNA ends and then activates a series of repair enzymes that join the broken DNA. In addition to its function in DNA repair, the yeast Saccharomyces cerevisiae Ku (Yku) is also a component of telomere protein-DNA complexes that affect telomere function. The yeast telomeres are composed of duplex C1-3(A/T)G(1-3) telomeric DNA repeats plus single-stranded TG(1-3) telomeric DNA tails. Here we show that Yku is capable of binding to a tailed-duplex DNA formed by telomeric DNA that mimics the structure of telomeres. Addition of Cdc13p, a single-stranded telomeric DNA-binding protein, to the Yku-DNA complex enables the formation of a ternary complex with Cdc13p binding to the single-stranded tail of the DNA substrate. Because pre-loading of Cdc13p to the single-stranded telomeric tail inhibits the binding of Yku, the results suggested that loading of Yku and Cdc13p to telomeres is sequential. Through generating a double-stranded break near telomeric DNA sequences, we found that Ku protein appears to bind to the de novo synthesized telomeres earlier than that of Cdc13p in vivo. Thus, our results indicated that Yku interacts directly with telomeres and that sequential loading of Yku followed by Cdc13p to telomeres is required for both proteins to form a ternary complex on telomeres. Our results also offer a mechanism that the binding of Cdc13p to telomeres might prevent Yku from initiating DNA double-stranded break repair pathway on telomeres.	[Lin, Yi-Chien; Lee, Yan-Hwa Wu] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan; [Wu, Tzung-Ju; Chiang, Yi-Hsuan; Lin, Yi-Chien; Tsai, Chang-Ru; Yu, Tai-Yuan; Sung, Ming-Ta; Lin, Jing-Jer] Natl Yang Ming Univ, Inst Biopharmaceut Sci, Taipei 112, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University	Lee, YHW (corresponding author), Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan.	yhwulee@ym.edu.tw; jjlin@ym.edu.tw	Lin, Jing-Jer/G-8068-2015	Lee Wu, Yan-Hwa/0000-0001-7299-7354; LIN, JING-JER/0000-0001-8250-7398	National Science Council, Taiwan [97-2311-B-010-005-MY3, 97-3112-B-010-013]; National Health Research Institute [NHRI-EX97-9625SI]	National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institute(National Health Research Institutes - Taiwan)	This work was supported by National Science Council, Taiwan, Grants 97-2311-B-010-005-MY3 and 97-3112-B-010-013 and National Health Research Institute Grant NHRI-EX97-9625SI.	Anderson EM, 2002, NUCLEIC ACIDS RES, V30, P4305, DOI 10.1093/nar/gkf554; Bianchi A, 1999, J BIOL CHEM, V274, P21223, DOI 10.1074/jbc.274.30.21223; BLACKBURN EH, 1990, J BIOL CHEM, V265, P5919; Blackburn EH, 2006, NAT MED, V12, P1133, DOI 10.1038/nm1006-1133; Boulton SJ, 1996, NUCLEIC ACIDS RES, V24, P4639, DOI 10.1093/nar/24.23.4639; Boulton SJ, 1998, EMBO J, V17, P1819, DOI 10.1093/emboj/17.6.1819; Bourns BD, 1998, MOL CELL BIOL, V18, P5600, DOI 10.1128/MCB.18.9.5600; Cosgrove AJ, 2002, GENE DEV, V16, P2485, DOI 10.1101/gad.231602; di Fagagna FD, 2001, CURR BIOL, V11, P1192, DOI 10.1016/S0960-9822(01)00328-1; Diede SJ, 2001, CURR BIOL, V11, P1336, DOI 10.1016/S0960-9822(01)00400-6; Diede SJ, 1999, CELL, V99, P723, DOI 10.1016/S0092-8674(00)81670-0; FALZON M, 1993, J BIOL CHEM, V268, P10546; Ferreira MG, 2004, MOL CELL, V13, P7, DOI 10.1016/S1097-2765(03)00531-8; Fisher TS, 2004, NAT STRUCT MOL BIOL, V11, P1198, DOI 10.1038/nsmb854; Gravel S, 1998, SCIENCE, V280, P741, DOI 10.1126/science.280.5364.741; Hsu HL, 1999, P NATL ACAD SCI USA, V96, P12454, DOI 10.1073/pnas.96.22.12454; Laroche T, 1998, CURR BIOL, V8, P653, DOI 10.1016/S0960-9822(98)70252-0; Larrivee M, 2004, GENE DEV, V18, P1391, DOI 10.1101/gad.1199404; Lieber MR, 2003, NAT REV MOL CELL BIO, V4, P712, DOI 10.1038/nrm1202; Lin JJ, 1996, P NATL ACAD SCI USA, V93, P13760, DOI 10.1073/pnas.93.24.13760; Lin YC, 2001, J BIOL CHEM, V276, P24588, DOI 10.1074/jbc.M101642200; Lin YC, 2007, BIOCHEM J, V403, P289, DOI 10.1042/BJ20061698; Martin SG, 1999, CELL, V97, P621, DOI 10.1016/S0092-8674(00)80773-4; MIMORI T, 1986, J BIOL CHEM, V261, P375; Mishra K, 1999, CURR BIOL, V9, P1123, DOI 10.1016/S0960-9822(99)80483-7; Mitton-Fry RM, 2002, SCIENCE, V296, P145, DOI 10.1126/science.1068799; Miyoshi T, 2003, J BIOL CHEM, V278, P1924, DOI 10.1074/jbc.M208813200; Nugent CI, 1998, CURR BIOL, V8, P657, DOI 10.1016/S0960-9822(98)70253-2; Nugent CI, 1996, SCIENCE, V274, P249, DOI 10.1126/science.274.5285.249; O'Driscoll M, 2006, NAT REV GENET, V7, P45, DOI 10.1038/nrg1746; ONO M, 1994, NUCLEIC ACIDS RES, V22, P3918, DOI 10.1093/nar/22.19.3918; PAILLARD S, 1991, NUCLEIC ACIDS RES, V19, P5619, DOI 10.1093/nar/19.20.5619; Pang TL, 2003, J BIOL CHEM, V278, P9318, DOI 10.1074/jbc.M208347200; Peterson SE, 2001, NAT GENET, V27, P64, DOI 10.1038/83778; Porter SE, 1996, NUCLEIC ACIDS RES, V24, P582, DOI 10.1093/nar/24.4.582; RATHMELL WK, 1994, MOL CELL BIOL, V14, P4741, DOI 10.1128/MCB.14.7.4741; Roy R, 2004, J BIOL CHEM, V279, P86, DOI 10.1074/jbc.M306841200; Stellwagen AE, 2003, GENE DEV, V17, P1; Taggart AKP, 2002, SCIENCE, V297, P1023, DOI 10.1126/science.1074968; Tsukamoto Y, 1997, NATURE, V388, P900, DOI 10.1038/42288; Walker JR, 2001, NATURE, V412, P607, DOI 10.1038/35088000	41	7	7	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12801	12808		10.1074/jbc.M809131200	http://dx.doi.org/10.1074/jbc.M809131200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19276071	Green Published, hybrid			2022-12-27	WOS:000265688300025
J	Jaskolski, F; Mayo-Martin, B; Jane, D; Henley, JM				Jaskolski, Frederic; Mayo-Martin, Belen; Jane, David; Henley, Jeremy M.			Dynamin-dependent Membrane Drift Recruits AMPA Receptors to Dendritic Spines	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; HIPPOCAMPAL-NEURONS; LATERAL MOVEMENTS; ENDOCYTIC ZONES; NMDA RECEPTORS; SYNAPSES; DIFFUSION; TRAFFICKING; PROTEINS	The surface expression and localization of AMPA receptors (AMPARs) at dendritic spines are tightly controlled to regulate synaptic transmission. Here we show that de novo exocytosis of the GluR2 AMPAR subunit occurs at the dendritic shaft and that new AMPARs diffuse into spines by lateral diffusion in the membrane. However, membrane topology restricts this lateral diffusion. We therefore investigated which mechanisms recruit AMPARs to spines from the shaft and demonstrated that inhibition of dynamin GTPase activity reduced lateral diffusion of membrane-anchored green fluorescent protein and super-ecliptic pHluorin (SEP)-GluR2 into spines. In addition, the activation of synaptic N-methyl-D-aspartate (NMDA) receptors enhanced lateral diffusion of SEP-GluR2 and increased the number of endogenous AMPARs in spines. The NMDA-invoked effects were prevented by dynamin inhibition, suggesting that activity-dependent dynamin-mediated endocytosis within spines generates a net inward membrane drift that overrides lateral diffusion barriers to enhance membrane protein delivery into spines. These results provide a novel mechanistic explanation of how AMPARs and other membrane proteins are recruited to spines by synaptic activity.	[Jaskolski, Frederic; Henley, Jeremy M.] Univ Bristol, Sch Med Sci, Dept Anat, MRC Ctr Synapt Plast, Bristol BS8 1TD, Avon, England; [Mayo-Martin, Belen; Jane, David] Univ Bristol, Sch Med Sci, Dept Physiol & Pharmacol, Med Res Council Ctr Synapt Plast, Bristol BS8 1TD, Avon, England	University of Bristol; University of Bristol	Henley, JM (corresponding author), Univ Bristol, Sch Med Sci, Dept Anat, MRC Ctr Synapt Plast, Bristol BS8 1TD, Avon, England.	J.M.Henley@bristol.ac.uk		Henley, Jeremy/0000-0003-3589-8335	Medical Research Council (MRC); Wellcome Trust; European Union; Medical Research Council [G0601812, G0601810] Funding Source: researchfish; MRC [G0601812, G0601810] Funding Source: UKRI	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); European Union(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council (MRC), the Wellcome Trust, and the European Union (GRIPPANT and ENI-NET grants).	AIZENBUD BM, 1982, BIOPHYS J, V38, P287, DOI 10.1016/S0006-3495(82)84560-8; Ashby MC, 2004, J NEUROSCI, V24, P5172, DOI 10.1523/JNEUROSCI.1042-04.2004; Ashby MC, 2004, TRENDS NEUROSCI, V27, P257, DOI 10.1016/j.tins.2004.03.010; Ashby MC, 2006, J NEUROSCI, V26, P7046, DOI 10.1523/JNEUROSCI.1235-06.2006; AXELROD D, 1976, BIOPHYS J, V16, P1055, DOI 10.1016/S0006-3495(76)85755-4; Bats C, 2007, NEURON, V53, P719, DOI 10.1016/j.neuron.2007.01.030; Blanpied TA, 2002, NEURON, V36, P435, DOI 10.1016/S0896-6273(02)00979-0; Bloodgood BL, 2005, SCIENCE, V310, P866, DOI 10.1126/science.1114816; Borgdorff AJ, 2002, NATURE, V417, P649, DOI 10.1038/nature00780; Cooney JR, 2002, J NEUROSCI, V22, P2215, DOI 10.1523/JNEUROSCI.22-06-02215.2002; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; DUDEK SM, 1993, J NEUROSCI, V13, P2910; Ehlers MD, 2007, NEURON, V55, P686, DOI 10.1016/j.neuron.2007.08.009; Feder TJ, 1996, BIOPHYS J, V70, P2767, DOI 10.1016/S0006-3495(96)79846-6; Gerges NZ, 2006, EMBO J, V25, P1623, DOI 10.1038/sj.emboj.7601065; Gray NW, 2003, CURR BIOL, V13, P510, DOI 10.1016/S0960-9822(03)00136-2; Groc L, 2006, TRENDS NEUROSCI, V29, P132, DOI 10.1016/j.tins.2006.01.005; Groc L, 2004, NAT NEUROSCI, V7, P695, DOI 10.1038/nn1270; Harris KM, 2003, PHILOS T R SOC B, V358, P745, DOI 10.1098/rstb.2002.1254; HARRIS KM, 1992, J NEUROSCI, V12, P2685; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; Henley J, 2001, BIOCHEM SOC T, V29, P485, DOI 10.1042/BST0290485; Henley JM, 2003, NEUROSCI RES, V45, P243, DOI 10.1016/S0168-0102(02)00229-8; Holcman D, 2006, BIOPHYS J, V91, P2405, DOI 10.1529/biophysj.106.081935; Kim EJ, 2004, NAT REV NEUROSCI, V5, P771, DOI 10.1038/nrn1517; Kruchten AE, 2006, J CELL SCI, V119, P1683, DOI 10.1242/jcs.02963; Leaney JL, 2002, J BIOL CHEM, V277, P28803, DOI 10.1074/jbc.M204683200; Lu J, 2007, NEURON, V55, P874, DOI 10.1016/j.neuron.2007.06.041; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Malenka RC, 2003, ANN NY ACAD SCI, V1003, P1, DOI 10.1196/annals.1300.001; Matsuzaki M, 2001, NAT NEUROSCI, V4, P1086, DOI 10.1038/nn736; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; McNiven MA, 2000, J CELL BIOL, V151, P187, DOI 10.1083/jcb.151.1.187; Moriyoshi K, 1996, NEURON, V16, P255, DOI 10.1016/S0896-6273(00)80044-6; Neves G, 2008, NAT REV NEUROSCI, V9, P65, DOI 10.1038/nrn2303; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Park M, 2006, NEURON, V52, P817, DOI 10.1016/j.neuron.2006.09.040; Passafaro M, 2001, NAT NEUROSCI, V4, P917, DOI 10.1038/nn0901-917; Perestenko PV, 2003, J BIOL CHEM, V278, P43525, DOI 10.1074/jbc.M306206200; Pickard L, 2001, NEUROPHARMACOLOGY, V41, P700, DOI 10.1016/S0028-3908(01)00127-7; Racz B, 2004, NAT NEUROSCI, V7, P917, DOI 10.1038/nn1303; Richards DA, 2004, J PHYSIOL-LONDON, V558, P503, DOI 10.1113/jphysiol.2004.062091; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Sbalzarini IF, 2006, BIOPHYS J, V90, P878, DOI 10.1529/biophysj.105.073809; Shepherd JD, 2007, ANNU REV CELL DEV BI, V23, P613, DOI 10.1146/annurev.cellbio.23.090506.123516; Shi SH, 2001, CELL, V105, P331, DOI 10.1016/S0092-8674(01)00321-X; Tamkun MM, 2007, J CELL SCI, V120, P2413, DOI 10.1242/jcs.007351; Tanaka J, 2005, J NEUROSCI, V25, P799, DOI 10.1523/JNEUROSCI.4256-04.2005; Tardin C, 2003, EMBO J, V22, P4656, DOI 10.1093/emboj/cdg463; Yudowski GA, 2007, J NEUROSCI, V27, P11112, DOI 10.1523/JNEUROSCI.2465-07.2007	50	51	51	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12491	12503		10.1074/jbc.M808401200	http://dx.doi.org/10.1074/jbc.M808401200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19269965	Green Published, hybrid			2022-12-27	WOS:000265494600078
J	Lee, DH; Shi, JJ; Jeoung, NH; Kim, MS; Zabolotny, JM; Lee, SW; White, MF; Wei, L; Kim, YB				Lee, Dae Ho; Shi, Jianjian; Jeoung, Nam Ho; Kim, Min Seon; Zabolotny, Janice M.; Lee, Sam W.; White, Morris F.; Wei, Lei; Kim, Young-Bum			Targeted Disruption of ROCK1 Causes Insulin Resistance in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BINDING PROTEIN RHO; SERINE/THREONINE KINASE; PATHWAY; GTPASE; GLUT4; PHOSPHORYLATION; TRANSLOCATION; CYTOSKELETON; ADIPOCYTES; ACTIVATION	Insulin signaling is essential for normal glucose homeostasis. Rho-kinase (ROCK) isoforms have been shown to participate in insulin signaling and glucose metabolism in cultured cell lines. To investigate the physiological role of ROCK1 in the regulation of whole body glucose homeostasis and insulin sensitivity in vivo, we studied mice with global disruption of ROCK1. Here we show that, at 16 - 18 weeks of age, ROCK1-deficient mice exhibited insulin resistance, as revealed by the failure of blood glucose levels to decrease after insulin injection. However, glucose tolerance was normal in the absence of ROCK1. These effects were independent of changes in adiposity. Interestingly, ROCK1 gene ablation caused a significant increase in glucose-induced insulin secretion, leading to hyperinsulinemia. To determine the mechanism(s) by which deletion of ROCK1 causes insulin resistance, we measured the ability of insulin to activate phosphatidylinositol 3-kinase and multiple distal pathways in skeletal muscle. Insulin-stimulated phosphatidylinositol 3-kinase activity associated with IRS-1 or phospho-tyrosine was also reduced similar to 40% without any alteration in tyrosine phosphorylation of insulin receptor in skeletal muscle. Concurrently, serine phosphorylation of IRS-1 at serine 632/635, which is phosphorylated by ROCK in vitro, was also impaired in these mice. Insulin-induced phosphorylation of Akt, AS160, S6K, and S6 was also decreased in skeletal muscle. These data suggest that ROCK1 deficiency causes systemic insulin resistance by impairing insulin signaling in skeletal muscle. Thus, our results identify ROCK1 as a novel regulator of glucose homeostasis and insulin sensitivity in vivo, which could lead to new treatment approaches for obesity and type 2 diabetes.	[Shi, Jianjian; Wei, Lei] Indiana Univ, Sch Med, Wells Ctr Pediat Res, Riley Heart Res Ctr,Dept Pediat, Indianapolis, IN 46202 USA; [Lee, Dae Ho; Zabolotny, Janice M.; Kim, Young-Bum] Beth Israel Deaconess Med Ctr, Div Endocrinol Diabet & Metab, Boston, MA 02215 USA; [Lee, Dae Ho; Zabolotny, Janice M.; Kim, Young-Bum] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Jeoung, Nam Ho] Indiana Univ, Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Jeoung, Nam Ho] Richard L Roudebush Vet Affairs Med Ctr, Indianapolis, IN 46202 USA; [Kim, Min Seon] Univ Ulsan, Coll Med, Asan Inst Life Sci, Dept Internal Med, Seoul 138736, South Korea; [Lee, Sam W.] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA 02129 USA; [Lee, Sam W.] Harvard Univ, Sch Med, Charlestown, MA 02129 USA; [White, Morris F.] Childrens Hosp, Div Endocrinol, Howard Hughes Med Inst, Boston, MA 02115 USA; [White, Morris F.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Indiana University System; Indiana University-Purdue University Indianapolis; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Indiana University System; Indiana University-Purdue University Indianapolis; US Department of Veterans Affairs; Veterans Health Administration (VHA); Richard L. Roudebush VA Medical Center; University of Ulsan; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School	Wei, L (corresponding author), Indiana Univ, Sch Med, Wells Ctr Pediat Res, Riley Heart Res Ctr,Dept Pediat, 1044 W Walnut St,R4-370, Indianapolis, IN 46202 USA.	lewei@iupui.edu; ykim2@bidmc.harvard.edu		Jeoung, Nam Ho/0000-0002-7584-3761	National Institutes of Health [DK43051, DK38712, CA127247, HL072897, HL085098]; American Diabetes Association [7-05-PPG-02, 1-09-RA-87]; Showalter Trust [89829]; Korean Ministry of Health and Welfare Grant [A06-2363]; Korea Science and Engineering Foundation [R-01-2006-000-108060-0]; NATIONAL CANCER INSTITUTE [R01CA127247] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072897, P01HL085098] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038712, R37DK043051, R55DK038712, R01DK043051, R29DK038712] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); Showalter Trust; Korean Ministry of Health and Welfare Grant; Korea Science and Engineering Foundation(Korea Science and Engineering Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK43051 (to Y.B.K.), DK38712 (to M. F. W.), CA127247 (to S. W. L.), and HL072897 and HL085098 (to L. W.). This work was also supported by American Diabetes Association Grants 7-05-PPG-02 and 1-09-RA-87 (to Y.B.K.), Showalter Trust Grant 89829 (to J.S.), Korean Ministry of Health and Welfare Grant A06-2363 (to M. S. K.), and Korea Science and Engineering Foundation Grant R-01-2006-000-108060-0 (to M. S. K.).	Chappell J, 2000, J BIOL CHEM, V275, P31792, DOI 10.1074/jbc.M004798200; CHEATHAM B, 1994, MOL CELL BIOL, V14, P4902, DOI 10.1128/MCB.14.7.4902; DeFronzo RA, 1997, DIABETES REV, V5, P177; Furukawa N, 2005, CELL METAB, V2, P119, DOI 10.1016/j.cmet.2005.06.011; HAMMAR E, 2009, ENDOCRINOLO IN PRESS; HARA K, 1994, P NATL ACAD SCI USA, V91, P7415, DOI 10.1073/pnas.91.16.7415; Hu E, 2005, EXPERT OPIN THER TAR, V9, P715, DOI 10.1517/14728222.9.4.715; Hu Erding, 2003, Curr Opin Investig Drugs, V4, P1065; Ishizaki T, 1996, EMBO J, V15, P1885, DOI 10.1002/j.1460-2075.1996.tb00539.x; Jiang ZY, 2003, P NATL ACAD SCI USA, V100, P7569, DOI 10.1073/pnas.1332633100; Kahn BB, 1998, CELL, V92, P593, DOI 10.1016/S0092-8674(00)81125-3; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Kanda T, 2005, FASEB J, V19, P169, DOI 10.1096/fj.05-4197fje; Kim YB, 2002, J BIOL CHEM, V277, P32915, DOI 10.1074/jbc.M204710200; Kobayashi K, 2004, J NEUROSCI, V24, P3480, DOI 10.1523/JNEUROSCI.0295-04.2004; Kolavennu V, 2008, DIABETES, V57, P714, DOI 10.2337/db07-1241; LEUNG T, 1995, J BIOL CHEM, V270, P29051, DOI 10.1074/jbc.270.49.29051; Matsui T, 1996, EMBO J, V15, P2208, DOI 10.1002/j.1460-2075.1996.tb00574.x; Nakagawa O, 1996, FEBS LETT, V392, P189, DOI 10.1016/0014-5793(96)00811-3; Nakamura Y, 2006, BIOCHEM BIOPH RES CO, V350, P68, DOI 10.1016/j.bbrc.2006.08.192; *NIH, 1996, NIH PUBL, V85; Omata W, 2000, BIOCHEM J, V346, P321, DOI 10.1042/0264-6021:3460321; Ozes ON, 2001, P NATL ACAD SCI USA, V98, P4640, DOI 10.1073/pnas.051042298; Patki V, 2001, MOL BIOL CELL, V12, P129, DOI 10.1091/mbc.12.1.129; Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128; Sano H, 2003, J BIOL CHEM, V278, P14599, DOI 10.1074/jbc.C300063200; Shirai H, 2007, CURR OPIN NEPHROL HY, V16, P111, DOI 10.1097/MNH.0b013e3280148e4f; Tsakiridis T, 1999, MICROSC RES TECHNIQ, V47, P79, DOI 10.1002/(SICI)1097-0029(19991015)47:2<79::AID-JEMT1>3.0.CO;2-S; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; White MF, 2002, AM J PHYSIOL-ENDOC M, V283, pE413, DOI 10.1152/ajpendo.00514.2001; Zhang YM, 2006, FASEB J, V20, P916, DOI 10.1096/fj.05-5129com; Zick Y, 2001, TRENDS CELL BIOL, V11, P437, DOI 10.1016/S0962-8924(01)02129-8	34	98	105	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					11776	11780		10.1074/jbc.C900014200	http://dx.doi.org/10.1074/jbc.C900014200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19276091	Green Published, hybrid			2022-12-27	WOS:000265494600009
J	Ryan, RM; Compton, ELR; Mindell, JA				Ryan, Renae M.; Compton, Emma L. R.; Mindell, Joseph A.			Functional Characterization of a Na+-dependent Aspartate Transporter from Pyrococcus horikoshii	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NEURONAL GLUTAMATE TRANSPORTER; SCANNING MUTAGENESIS REVEALS; CHLORIDE PERMEATION PATHWAY; RAT-BRAIN; REENTRANT LOOP; SUBSTRATE-BINDING; ACID TRANSPORTER; ACTIVE-TRANSPORT; ION FLUXES; RECONSTITUTION	Excitatory amino acid transporters (EAATs) are crucial in maintaining extracellular levels of glutamate, the most abundant excitatory neurotransmitter, below toxic levels. The recent three-dimensional crystal structure of Glt(Ph), an archaeal homolog of the EAATs, provides elegant structural details of this family of proteins, yet we know little about the mechanism of the bacterial transporter. Conflicting reports in the literature have described Glt(Ph) as an aspartate transporter driven by Na+ or a glutamate transporter driven by either Na+ or H+. Here we use purified protein reconstituted into liposomes to thoroughly characterize the ion and substrate dependence of the Glt(Ph) transport. We confirm that Glt(Ph) is a Na+-dependent transporter that is highly selective for aspartate over other amino acids, and we show that transport is coupled to at least two Na+ ions. In contrast to the EAATs, transport via Glt(Ph) is independent of H+ and K+. We propose a kinetic model of transport in which at least two Na+ ions are coupled to the cotransport of each aspartate molecule by Glt(Ph), and where an ion-and substrate-free transporter reorients to complete the transport cycle.	[Ryan, Renae M.; Compton, Emma L. R.; Mindell, Joseph A.] NINDS, Membrane Transport Biophys Unit, Porter Neurosci Ctr, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Mindell, JA (corresponding author), 35 Convent Dr,Bldg 35,MSC 3701, Bethesda, MD 20892 USA.	mindellj@ninds.nih.gov	Mindell, Joseph/P-4461-2017; Ryan, Renae/AAC-3540-2021	Mindell, Joseph/0000-0002-6952-8247; Ryan, Renae/0000-0002-8680-4610; Compton-Daw, Emma/0000-0002-3832-7194	National Institutes of Health; Australian National Health and Medical Research Council [358779]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003014, Z01NS003014] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole, or in part, by a National Institutes of Health grant from NINDS Intramural Program. This work was also supported by Australian National Health and Medical Research Council C. J. Martin Postdoctoral Fellowship 358779 (to R. M. R.).	Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Bendahan A, 2000, J BIOL CHEM, V275, P37436, DOI 10.1074/jbc.M006536200; Billups B, 1996, J NEUROSCI, V16, P6722; Borre L, 2002, J BIOL CHEM, V277, P13501, DOI 10.1074/jbc.M110861200; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; DANBOLT NC, 1990, BIOCHEMISTRY-US, V29, P6734, DOI 10.1021/bi00480a025; FAIRMAN WA, 1995, NATURE, V375, P599, DOI 10.1038/375599a0; FERSHT A, 1985, ENZYME STRUCTURE MEC, P101; Gaillard I, 1996, BIOCHEMISTRY-US, V35, P6150, DOI 10.1021/bi953005v; Graves AR, 2008, NATURE, V453, P788, DOI 10.1038/nature06907; Grewer C, 2005, BIOCHEMISTRY-US, V44, P11913, DOI 10.1021/bi050987n; Grewer C, 2003, J BIOL CHEM, V278, P2585, DOI 10.1074/jbc.M207956200; Grunewald M, 2002, J BIOL CHEM, V277, P26074, DOI 10.1074/jbc.M202248200; Grunewald M, 1998, NEURON, V21, P623, DOI 10.1016/S0896-6273(00)80572-3; Grunewald M, 2000, J BIOL CHEM, V275, P9684, DOI 10.1074/jbc.275.13.9684; KANNER BI, 1978, BIOCHEMISTRY-US, V17, P3949, DOI 10.1021/bi00612a011; KANNER BI, 1978, FEBS LETT, V94, P245, DOI 10.1016/0014-5793(78)80947-8; Kavanaugh MP, 1997, J BIOL CHEM, V272, P1703, DOI 10.1074/jbc.272.3.1703; Koch HP, 2005, J NEUROSCI, V25, P1730, DOI 10.1523/JNEUROSCI.4138-04.2005; Leighton BH, 2002, J BIOL CHEM, V277, P29847, DOI 10.1074/jbc.M202508200; Raunser S, 2006, BIOCHEMISTRY-US, V45, P12796, DOI 10.1021/bi061008+; RIGAUD JL, 1995, BBA-BIOENERGETICS, V1231, P223, DOI 10.1016/0005-2728(95)00091-V; Ryan RM, 2007, NAT STRUCT MOL BIOL, V14, P365, DOI 10.1038/nsmb1230; Ryan RM, 2004, J BIOL CHEM, V279, P20742, DOI 10.1074/jbc.M304433200; Ryan RM, 2002, J BIOL CHEM, V277, P13494, DOI 10.1074/jbc.M109970200; Seal RP, 1998, NEURON, V21, P1487, DOI 10.1016/S0896-6273(00)80666-2; Slotboom DJ, 1999, MICROBIOL MOL BIOL R, V63, P293, DOI 10.1128/MMBR.63.2.293-307.1999; Slotboom DJ, 1999, P NATL ACAD SCI USA, V96, P14282, DOI 10.1073/pnas.96.25.14282; Slotboom DJ, 2001, J BIOL CHEM, V276, P10775, DOI 10.1074/jbc.M011064200; VANDENBERG RJ, 1995, J BIOL CHEM, V270, P17668, DOI 10.1074/jbc.270.30.17668; WADICHE JI, 1995, NEURON, V14, P1019, DOI 10.1016/0896-6273(95)90340-2; Wadiche JI, 1998, J NEUROSCI, V18, P7650; WADICHE JI, 1995, NEURON, V15, P721, DOI 10.1016/0896-6273(95)90159-0; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Zerangue N, 1996, NATURE, V383, P634, DOI 10.1038/383634a0	36	86	87	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17540	17548		10.1074/jbc.M109.005926	http://dx.doi.org/10.1074/jbc.M109.005926			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19380583	hybrid, Green Published			2022-12-27	WOS:000267202500020
J	Manna, T; Thrower, DA; Honnappa, S; Steinmetz, MO; Wilson, L				Manna, Tapas; Thrower, Douglas A.; Honnappa, Srinivas; Steinmetz, Michel O.; Wilson, Leslie			Regulation of Microtubule Dynamic Instability in Vitro by Differentially Phosphorylated Stathmin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT PROTEIN-KINASE; INTRACELLULAR PH; ONCOPROTEIN 18; MULTISITE PHOSPHORYLATION; DESTABILIZING ACTIVITY; PHOSPHOPROTEIN FAMILY; TUBULIN; OP18/STATHMIN; COMPLEX; CELLS	Stathmin is an important regulator of microtubule polymerization and dynamics. When unphosphorylated it destabilizes microtubules in two ways, by reducing the microtubule polymer mass through sequestration of soluble tubulin into an assembly-incompetent T2S complex (two alpha:beta tubulin dimers per molecule of stathmin), and by increasing the switching frequency (catastrophe frequency) from growth to shortening at plus and minus ends by binding directly to the microtubules. Phosphorylation of stathmin on one or more of its four serine residues (Ser(16), Ser(25), Ser(38), and Ser(63)) reduces its microtubule-destabilizing activity. However, the effects of phosphorylation of the individual serine residues of stathmin on microtubule dynamic instability have not been investigated systematically. Here we analyzed the effects of stathmin singly phosphorylated at Ser(16) or Ser(63), and doubly phosphorylated at Ser(25) and Ser(38), on its ability to modulate microtubule dynamic instability at steady-state in vitro. Phosphorylation at either Ser(16) or Ser(63) strongly reduced or abolished the ability of stathmin to bind to and sequester soluble tubulin and its ability to act as a catastrophe factor by directly binding to the microtubules. In contrast, double phosphorylation of Ser(25) and Ser(38) did not affect the binding of stathmin to tubulin or microtubules or its catastrophe-promoting activity. Our results indicate that the effects of stathmin on dynamic instability are strongly but differently attenuated by phosphorylation at Ser(16) and Ser(63) and support the hypothesis that selective targeting by Ser(16)-specific or Ser(63)-specific kinases provides complimentary mechanisms for regulating microtubule function.	[Manna, Tapas; Thrower, Douglas A.; Wilson, Leslie] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Manna, Tapas; Thrower, Douglas A.; Wilson, Leslie] Univ Calif Santa Barbara, Neurosci Res Inst, Santa Barbara, CA 93106 USA; [Honnappa, Srinivas; Steinmetz, Michel O.] Paul Scherrer Inst, CH-5232 Villigen, Switzerland	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute	Wilson, L (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.	wilson@lifesci.ucsb.edu	Steinmetz, Michel O/AAA-3349-2022	Steinmetz, Michel O/0000-0001-6157-3687; Manna, Tapas/0000-0002-2213-6246	National Institutes of Health [NS13560]; USPHS; Swiss National Science Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS013560] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); USPHS(United States Department of Health & Human ServicesUnited States Public Health Service); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS13560 (to L.W.) from the USPHS. This work was also supported by the Swiss National Science Foundation (to M. O. S.).	Amayed P, 2002, J BIOL CHEM, V277, P22718, DOI 10.1074/jbc.M111605200; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; BERETTA L, 1993, J BIOL CHEM, V268, P20076; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRATTSAND G, 1994, EUR J BIOCHEM, V220, P359, DOI 10.1111/j.1432-1033.1994.tb18632.x; BUCKLER KJ, 1990, PFLUG ARCH EUR J PHY, V417, P234, DOI 10.1007/BF00370705; Cassimeris L, 2002, CURR OPIN CELL BIOL, V14, P18, DOI 10.1016/S0955-0674(01)00289-7; CHAILLET JR, 1986, P NATL ACAD SCI USA, V83, P522, DOI 10.1073/pnas.83.2.522; Curmi PA, 1997, J BIOL CHEM, V272, P25029, DOI 10.1074/jbc.272.40.25029; Curmi PA, 1999, CELL STRUCT FUNCT, V24, P345; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Desai A, 1999, CELL, V96, P69, DOI 10.1016/S0092-8674(00)80960-5; Gavet O, 1998, J CELL SCI, V111, P3333; GERBOTH GD, 1993, AM J PHYSIOL, V264, pL448, DOI 10.1152/ajplung.1993.264.5.L448; Gigant B, 2005, NATURE, V435, P519, DOI 10.1038/nature03566; Gradin HM, 1998, J CELL BIOL, V140, P131, DOI 10.1083/jcb.140.1.131; Holmfeldt P, 2006, MOL BIOL CELL, V17, P2921, DOI 10.1091/mbc.e06-02-0165; Honnappa S, 2003, J BIOL CHEM, V278, P38926, DOI 10.1074/jbc.M305546200; Honnappa S, 2006, J BIOL CHEM, V281, P16078, DOI 10.1074/jbc.M513524200; Horwitz SB, 1997, J BIOL CHEM, V272, P8129, DOI 10.1074/jbc.272.13.8129; Howell B, 1999, MOL BIOL CELL, V10, P105, DOI 10.1091/mbc.10.1.105; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; Jourdain I, 2004, BIOCHEM J, V378, P877, DOI 10.1042/BJ20031413; Jourdain L, 1997, BIOCHEMISTRY-US, V36, P10817, DOI 10.1021/bi971491b; Kuntziger T, 2001, J BIOL CHEM, V276, P22979, DOI 10.1074/jbc.M101466200; LARSSON N, 1995, J BIOL CHEM, V270, P14175, DOI 10.1074/jbc.270.23.14175; Larsson N, 1997, MOL CELL BIOL, V17, P5530, DOI 10.1128/MCB.17.9.5530; Leem CH, 1999, J PHYSIOL-LONDON, V517, P159, DOI 10.1111/j.1469-7793.1999.0159z.x; Malinowska Iwona, 2002, Med Sci Monit, V8, pCR441; Manna T, 2006, J BIOL CHEM, V281, P2071, DOI 10.1074/jbc.M510661200; Manna T, 2007, BIOCHEMISTRY-US, V46, P3543, DOI 10.1021/bi061819d; MARKLUND U, 1993, J BIOL CHEM, V268, P15039; Marklund U, 1996, EMBO J, V15, P5290, DOI 10.1002/j.1460-2075.1996.tb00914.x; MARKLUND U, 1993, J BIOL CHEM, V268, P25671; MITCHISON TJ, 1989, J CELL BIOL, V109, P637, DOI 10.1083/jcb.109.2.637; Muller DR, 2001, ANAL CHEM, V73, P1927, DOI 10.1021/ac001379a; Muller-Borer BJ, 1998, AM J PHYSIOL-HEART C, V275, pH1937, DOI 10.1152/ajpheart.1998.275.6.H1937; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Ray A, 2007, CANCER RES, V67, P3767, DOI 10.1158/0008-5472.CAN-06-3065; Rodionov V, 1999, P NATL ACAD SCI USA, V96, P115, DOI 10.1073/pnas.96.1.115; Rogers GC, 2005, J CELL SCI, V118, P1105, DOI 10.1242/jcs.02284; Rogers GC, 2004, NATURE, V427, P364, DOI 10.1038/nature02256; Rubin CI, 2004, J CELL BIOCHEM, V93, P242, DOI 10.1002/jcb.20187; SAWIN KE, 1991, J CELL BIOL, V112, P941, DOI 10.1083/jcb.112.5.941; SCHUBART UK, 1992, DIFFERENTIATION, V51, P21, DOI 10.1111/j.1432-0436.1992.tb00676.x; SEKSEK O, 1991, ANAL BIOCHEM, V193, P49, DOI 10.1016/0003-2697(91)90042-R; SOBEL A, 1991, TRENDS BIOCHEM SCI, V16, P301, DOI 10.1016/0968-0004(91)90123-D; Srivastava A, 1997, ANAL BIOCHEM, V249, P140, DOI 10.1006/abio.1997.2164; Steinmetz MO, 2007, J STRUCT BIOL, V158, P137, DOI 10.1016/j.jsb.2006.07.018; Steinmetz MO, 2000, EMBO J, V19, P572, DOI 10.1093/emboj/19.4.572; Steinmetz MO, 2001, EMBO REP, V2, P505, DOI 10.1093/embo-reports/kve105; Stewart AK, 1999, J PHYSIOL-LONDON, V516, P209, DOI 10.1111/j.1469-7793.1999.209aa.x; Trzaskawka E, 2000, EUR J ORAL SCI, V108, P54, DOI 10.1034/j.1600-0722.2000.00670.x; Vorobjev IA, 1997, J CELL SCI, V110, P2635; Vorobjev IA, 1999, J CELL SCI, V112, P2277; Wilson L, 1999, CELL STRUCT FUNCT, V24, P329, DOI 10.1247/csf.24.329; Wittmann T, 2004, J BIOL CHEM, V279, P6196, DOI 10.1074/jbc.M307261200; Wong P, 2002, BRIT J CANCER, V87, P238, DOI 10.1038/sj.bjc.6600424	58	63	67	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15640	15649		10.1074/jbc.M900343200	http://dx.doi.org/10.1074/jbc.M900343200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19359244	hybrid, Green Published			2022-12-27	WOS:000266501000032
J	Thibault, J; Faudry, E; Ebel, C; Attree, I; Elsen, S				Thibault, Julie; Faudry, Eric; Ebel, Christine; Attree, Ina; Elsen, Sylvie			Anti-activator ExsD Forms a 1:1 Complex with ExsA to Inhibit Transcription of Type III Secretion Operons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTERICA SEROVAR TYPHIMURIUM; PSEUDOMONAS-AERUGINOSA; CYSTIC-FIBROSIS; EXOENZYME-S; REGULATORY PROTEIN; SHIGELLA-FLEXNERI; DNA-BINDING; SYSTEM; EXPRESSION; GENES	The ExsA protein is a Pseudomonas aeruginosa transcriptional regulator of the AraC/XylS family that is responsible for activating the type III secretion system operons upon host cell contact. Its activity is known to be controlled in vivo through interaction with its negative regulator ExsD. Using a heterologous expression system, we demonstrated that ExsD is sufficient to inhibit the transcriptional activity of ExsA. Gel shift assays with ExsA- and ExsD-containing cytosolic extracts revealed that ExsD does not block DNA target sites but affects the DNA binding activity of the transcriptional activator. The ExsA- ExsD complex was purified after coproduction of the two partners in Escherichia coli. Size exclusion chromatography and ultracentrifugation analysis revealed a homogeneous complex with a 1:1 ratio. When in interaction with ExsD, ExsA is not able to bind to its specific target any longer, as evidenced by gel shift assays. Size exclusion chromatography further showed a partial dissociation of the complex in the presence of a specific DNA sequence. A model of the molecular inhibitory role of ExsD toward ExsA is proposed, in which, under noninducing conditions, the anti-activator ExsD sequesters ExsA and hinders its binding to DNA sites, preventing the transcription of type III secretion genes.	[Thibault, Julie; Faudry, Eric; Attree, Ina; Elsen, Sylvie] Commissariat Energie Atom, LBBSI, iRTSV, F-38054 Grenoble 09, France; [Thibault, Julie; Faudry, Eric; Attree, Ina; Elsen, Sylvie] CNRS, UMR 5092, F-38054 Grenoble, France; [Thibault, Julie; Faudry, Eric; Ebel, Christine; Attree, Ina; Elsen, Sylvie] Univ Grenoble 1, F-38000 Grenoble, France; [Ebel, Christine] Commissariat Energie Atom, Inst Biol Struct, Lab Mol Biophys, F-38027 Grenoble, France; [Ebel, Christine] CNRS, UMR 5075, F-38027 Grenoble, France	CEA; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA	Elsen, S (corresponding author), Commissariat Energie Atom, LBBSI, iRTSV, 17 Rue Martyrs, F-38054 Grenoble 09, France.	sylvie.elsen@cea.fr	Faudry, Eric/I-9154-2014	Faudry, Eric/0000-0001-9958-6029; Elsen, Sylvie/0000-0003-4611-4719; Ebel, Christine/0000-0002-6912-500X; Attree, Ina/0000-0002-2580-764X	CNRS; Commissariat a l'Energie Atomique; Universite Joseph Fourier; Region Rhone-Alpes	CNRS(Centre National de la Recherche Scientifique (CNRS)); Commissariat a l'Energie Atomique(French Atomic Energy Commission); Universite Joseph Fourier; Region Rhone-Alpes(Region Auvergne-Rhone-Alpes)	This work was supported in part by institutional grants from the CNRS, Commissariat a l'Energie Atomique, and Universite Joseph Fourier and a grant from Region Rhone-Alpes (Cluster 10 Infectiologie).	Banwart B, 2002, J INFECT DIS, V185, P269, DOI 10.1086/338197; Baxter MA, 2003, INFECT IMMUN, V71, P1295, DOI 10.1128/IAI.71.3.1295-1305.2003; BODEY GP, 1983, REV INFECT DIS, V5, P279; Brutinel ED, 2008, CURR OPIN MICROBIOL, V11, P128, DOI 10.1016/j.mib.2008.02.010; Brutinel ED, 2008, MOL MICROBIOL, V68, P657, DOI 10.1111/j.1365-2958.2008.06179.x; Chen GZ, 2004, MOL MICROBIOL, V52, P1641, DOI 10.1111/j.1365-2958.2004.04110.x; Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526; Dacheux D, 2001, INFECT IMMUN, V69, P538, DOI 10.1128/IAI.69.1.538-542.2001; Darwin KH, 2001, EMBO J, V20, P1850, DOI 10.1093/emboj/20.8.1850; Dasgupta N, 2004, MOL MICROBIOL, V53, P297, DOI 10.1111/j.1365-2958.2004.04128.x; Dasgupta N, 2001, J BACTERIOL, V183, P6636, DOI 10.1128/JB.183.22.6636-6644.2001; Dominguez-Cuevas P, 2008, J BACTERIOL, V190, P3118, DOI 10.1128/JB.01784-07; Ebel C., 2007, PROTEIN STRUCTURES M, P229; Egan SM, 2002, J BACTERIOL, V184, P5529, DOI 10.1128/JB.184.20.5529-5532.2002; Engel J, 2009, CURR OPIN MICROBIOL, V12, P61, DOI 10.1016/j.mib.2008.12.007; Furukawa S, 2006, J BACTERIOL, V188, P1211, DOI 10.1128/JB.188.4.1211-1217.2006; Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272; Goodman AL, 2004, DEV CELL, V7, P745, DOI 10.1016/j.devcel.2004.08.020; Ha UH, 2004, MOL MICROBIOL, V54, P307, DOI 10.1111/j.1365-2958.2004.04282.x; HOVEY AK, 1995, J BACTERIOL, V177, P4427, DOI 10.1128/jb.177.15.4427-4436.1995; Kipnis E, 2006, MED MALADIES INFECT, V36, P78, DOI 10.1016/j.medmal.2005.10.007; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; Lykken GL, 2006, J BACTERIOL, V188, P6832, DOI 10.1128/JB.00884-06; Martin RG, 2001, CURR OPIN MICROBIOL, V4, P132, DOI 10.1016/S1369-5274(00)00178-8; Mavris M, 2002, MOL MICROBIOL, V43, P1543, DOI 10.1046/j.1365-2958.2002.02836.x; McCaw ML, 2002, MOL MICROBIOL, V46, P1123, DOI 10.1046/j.1365-2958.2002.03228.x; Miller J. H, 1972, EXPT MOL GENETICS; Parsot C, 2005, MOL MICROBIOL, V56, P1627, DOI 10.1111/j.1365-2958.2005.04645.x; Pilonieta MC, 2008, J BACTERIOL, V190, P2249, DOI 10.1128/JB.01824-07; Plano GV, 2004, MOL MICROBIOL, V54, P287, DOI 10.1111/j.1365-2958.2004.04306.x; Qin YP, 2007, J BIOL CHEM, V282, P19979, DOI 10.1074/jbc.M703332200; Rietsch A, 2005, P NATL ACAD SCI USA, V102, P8006, DOI 10.1073/pnas.0503005102; Schleif R, 2003, BIOESSAYS, V25, P274, DOI 10.1002/bies.10237; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; TOUSSAINT B, 1993, BIOCHEM BIOPH RES CO, V196, P416, DOI 10.1006/bbrc.1993.2265; Urbanowski ML, 2005, P NATL ACAD SCI USA, V102, P9930, DOI 10.1073/pnas.0504405102; Yahr TL, 2006, MOL MICROBIOL, V62, P631, DOI 10.1111/j.1365-2958.2006.05412.x; YAHR TL, 1995, J BACTERIOL, V177, P1169, DOI 10.1128/jb.177.5.1169-1178.1995; Yamamoto S, 2006, J BACTERIOL, V188, P6703, DOI 10.1128/JB.00799-06; Yang J, 2008, MOL MICROBIOL, V68, P314, DOI 10.1111/j.1365-2958.2008.06171.x; Zheng ZD, 2007, J BIOL CHEM, V282, P6136, DOI 10.1074/jbc.M611664200; Zhou XH, 2008, MOL MICROBIOL, V69, P747, DOI 10.1111/j.1365-2958.2008.06326.x	43	43	45	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15762	15770		10.1074/jbc.M109.003533	http://dx.doi.org/10.1074/jbc.M109.003533			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19369699	hybrid, Green Published			2022-12-27	WOS:000266501000045
J	Goult, BT; Bate, N; Anthis, NJ; Wegener, KL; Gingras, AR; Patel, B; Barsukov, IL; Campbell, ID; Roberts, GCK; Critchley, DR				Goult, Benjamin T.; Bate, Neil; Anthis, Nicholas J.; Wegener, Kate L.; Gingras, Alexandre R.; Patel, Bipin; Barsukov, Igor L.; Campbell, Iain D.; Roberts, Gordon C. K.; Critchley, David R.			The Structure of an Interdomain Complex That Regulates Talin Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL PHOSPHATE KINASE; VINCULIN-BINDING-SITE; INTEGRIN ACTIVATION; PHOSPHORYLATION SITES; MOUSE DEVELOPMENT; FOCAL ADHESIONS; CHEMICAL-SHIFT; IN-VIVO; DOMAIN; ROD	Talin is a large flexible rod-shaped protein that activates the integrin family of cell adhesion molecules and couples them to cytoskeletal actin. It exists in both globular and extended conformations, and an intramolecular interaction between the N-terminal F3 FERM subdomain and the C-terminal part of the talin rod contributes to an autoinhibited form of the molecule. Here, we report the solution structure of the primary F3 binding domain within the C-terminal region of the talin rod and use intermolecular nuclear Overhauser effects to determine the structure of the complex. The rod domain (residues 1655-1822) is an amphipathic five-helix bundle; Tyr- 377 of F3 docks into a hydrophobic pocket at one end of the bundle, whereas a basic loop in F3 (residues 316-326) interacts with a cluster of acidic residues in the middle of helix 4. Mutation of Glu-1770 abolishes binding. The rod domain competes with beta 3-integrin tails for binding to F3, and the structure of the complex suggests that the rod is also likely to sterically inhibit binding of the FERM domain to the membrane.	[Goult, Benjamin T.; Bate, Neil; Gingras, Alexandre R.; Patel, Bipin; Roberts, Gordon C. K.; Critchley, David R.] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England; [Anthis, Nicholas J.; Wegener, Kate L.; Campbell, Iain D.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England; [Barsukov, Igor L.] Univ Liverpool, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England	University of Leicester; University of Oxford; University of Liverpool	Critchley, DR (corresponding author), Univ Leicester, Dept Biochem, Lancaster Rd, Leicester LE1 9HN, Leics, England.	drc@le.ac.uk	Gingras, Alexandre R/E-1867-2011; Goult, Benjamin T/B-3127-2009; Wegener, Kate/E-5077-2010	Gingras, Alexandre R/0000-0002-5373-0176; Goult, Benjamin T/0000-0002-3438-2807; Wegener, Kate/0000-0002-1562-6060; Anthis, Nicholas/0000-0002-1881-450X	National Institutes of Health [U54 GM64346]; Wellcome Trust; Cancer Research UK; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM064346] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant U54 GM64346 through the Cell Migration Consortium. This work was also supported by grants from the Wellcome Trust and Cancer Research UK.	Ayed A, 2001, NAT STRUCT BIOL, V8, P756, DOI 10.1038/nsb0901-756; Barsukov IL, 2003, J BIOL CHEM, V278, P31202, DOI 10.1074/jbc.M303850200; Baxter NJ, 1998, J MOL BIOL, V284, P1625, DOI 10.1006/jmbi.1998.2265; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bos JL, 2005, CURR OPIN CELL BIOL, V17, P123, DOI 10.1016/j.ceb.2005.02.009; Bouaouina M, 2008, J BIOL CHEM, V283, P6118, DOI 10.1074/jbc.M709527200; Bretscher A, 2000, ANNU REV CELL DEV BI, V16, P113, DOI 10.1146/annurev.cellbio.16.1.113; Calderwood DA, 2004, J CELL SCI, V117, P657, DOI 10.1242/jcs.01014; Chen NT, 2005, BIOCHEM BIOPH RES CO, V337, P670, DOI 10.1016/j.bbrc.2005.09.100; Conti FJ, 2008, DEVELOPMENT, V135, P2043, DOI 10.1242/dev.015818; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Cram EJ, 2003, J CELL SCI, V116, P3871, DOI 10.1242/jcs.00705; de Pereda JM, 2005, J BIOL CHEM, V280, P8381, DOI 10.1074/jbc.M413180200; De Vries SJ, 2007, PROTEINS, V69, P726, DOI 10.1002/prot.21723; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano WL, 2004, PYMOL MOL GRAPHICS S; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Fillingham I, 2005, STRUCTURE, V13, P65, DOI 10.1016/j.str.2004.11.006; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Gingras AR, 2008, EMBO J, V27, P458, DOI 10.1038/sj.emboj.7601965; Gingras AR, 2009, J BIOL CHEM, V284, P8857, DOI 10.1074/jbc.M805937200; Gingras AR, 2006, BIOCHEMISTRY-US, V45, P1805, DOI 10.1021/bi052136l; Gingras AR, 2005, J BIOL CHEM, V280, P37217, DOI 10.1074/jbc.M508060200; Goksoy E, 2008, MOL CELL, V31, P124, DOI 10.1016/j.molcel.2008.06.011; Han JW, 2006, CURR BIOL, V16, P1796, DOI 10.1016/j.cub.2006.08.035; Hemmings L, 1996, J CELL SCI, V109, P2715; Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432; Lee HS, 2009, J BIOL CHEM, V284, P5119, DOI 10.1074/jbc.M807117200; Ling K, 2003, J CELL BIOL, V163, P1339, DOI 10.1083/jcb.200310067; Ling K, 2002, NATURE, V420, P89, DOI 10.1038/nature01082; Linge JP, 2001, METHOD ENZYMOL, V339, P71, DOI 10.1016/S0076-6879(01)39310-2; Martel V, 2001, J BIOL CHEM, V276, P21217, DOI 10.1074/jbc.M102373200; MOLONY L, 1987, J BIOL CHEM, V262, P7790; Monkley SJ, 2000, DEV DYNAM, V219, P560, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1079>3.0.CO;2-Y; Nieswandt B, 2007, J EXP MED, V204, P3113, DOI 10.1084/jem.20071827; Oxley CL, 2008, J BIOL CHEM, V283, P5420, DOI 10.1074/jbc.M709435200; Papagrigoriou E, 2004, EMBO J, V23, P2942, DOI 10.1038/sj.emboj.7600285; Petrich BG, 2007, J EXP MED, V204, P3103, DOI 10.1084/jem.20071800; Ratnikov B, 2005, J CELL SCI, V118, P4921, DOI 10.1242/jcs.02682; Smith SJ, 2007, BIOCHEMISTRY-US, V46, P10886, DOI 10.1021/bi700637a; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Tanentzapf G, 2006, J CELL SCI, V119, P1632, DOI 10.1242/jcs.02859; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang YF, 2008, J CLIN INVEST, V118, P812, DOI 10.1172/JCI34239; Wegener KL, 2008, MOL MEMBR BIOL, V25, P376, DOI 10.1080/09687680802269886; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; ZHANG X, 2008, NAT CELL BIOL	48	94	98	1	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					15097	15106		10.1074/jbc.M900078200	http://dx.doi.org/10.1074/jbc.M900078200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19297334	Green Published, hybrid			2022-12-27	WOS:000266288200045
J	Nott, SL; Huang, YF; Li, XD; Fluharty, BR; Qiu, X; Welshons, WV; Yeh, S; Muyan, M				Nott, Stephanie L.; Huang, Yanfang; Li, Xiaodong; Fluharty, Brian R.; Qiu, Xing; Welshons, Wade V.; Yeh, ShuYuan; Muyan, Mesut			Genomic Responses from the Estrogen-responsive Element-dependent Signaling Pathway Mediated by Estrogen Receptor alpha Are Required to Elicit Cellular Alterations	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BREAST-CANCER CELLS; DNA-BINDING DOMAIN; HYALURONAN SYNTHASE-2 GENE; PLASMINOGEN-ACTIVATOR; ER-ALPHA; MESSENGER-RNA; TARGET GENES; TRANSCRIPTIONAL RESPONSES; ESTRADIOL REGULATION; RETINOIC ACID	Estrogen (E2) signaling is conveyed by the transcription factors estrogen receptor (ER) alpha and beta. ERs modulate the expression of genes involved in cellular proliferation, motility, and death. The regulation of transcription by E2-ER alpha through binding to estrogen-responsive elements (EREs) in DNA constitutes the ERE-dependent signaling pathway. E2-ER alpha also modulates gene expression by interacting with transregulators bound to cognate DNA-regulatory elements, and this regulation is referred to as the ERE-independent signaling pathway. The relative importance of the ERE-independent pathway in E2-ER alpha signaling is unclear. To address this issue, we engineered an ERE-binding defective ER alpha mutant (ER alpha(EBD)) by changing residues in an alpha-helix of the protein involved in DNA binding to render the receptor functional only through the ERE-independent signaling pathway. Using recombinant adenovirus-infected ER-negative MDA-MB-231 cells derived from a breast adenocarcinoma, we found that E2-ER alpha(EBD) modulated the expression of a subset of ER alpha-responsive genes identified by microarrays and verified by quantitative PCR. However, E2-ER alpha(EBD) did not affect cell cycle progression, cellular growth, death, or motility in contrast to E2-ER alpha. ER alpha(EBD) in the presence of E2 was also ineffective in inducing phenotypic alterations in ER-negative U-2OS cells derived from an osteosarcoma. E2-ER alpha, on the other hand, effectively repressed growth in this cell line. Our findings suggest that genomic responses from the ERE-dependent signaling pathway are required for E2-ER alpha to induce alterations in cellular responses.	[Nott, Stephanie L.; Huang, Yanfang; Li, Xiaodong; Fluharty, Brian R.; Muyan, Mesut] Univ Rochester, Sch Med, Dept Biochem & Biophys, Rochester, NY 14642 USA; [Qiu, Xing] Univ Rochester, Sch Med, Dept Biostat & Computat Biol, Rochester, NY 14642 USA; [Yeh, ShuYuan] Univ Rochester, Sch Med, Dept Urol, Rochester, NY 14642 USA; [Muyan, Mesut] Univ Rochester, Sch Med, Dept Obstet & Gynecol, Rochester, NY 14642 USA; [Welshons, Wade V.] Univ Missouri, Dept Biomed Sci, Columbia, MO 65211 USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Missouri System; University of Missouri Columbia	Muyan, M (corresponding author), 601 Elmwood Ave,Box 712, Rochester, NY 14642 USA.	mesut_muyan@urmc.rochester.edu	Muyan, Mesut/AAZ-4888-2020	Muyan, Mesut/0000-0003-3058-6228	NCI [CA113682]; Susan G. Komen Foundation; University of Rochester Clinical and Translational Science Institute; NATIONAL CANCER INSTITUTE [R01CA113682] Funding Source: NIH RePORTER	NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Susan G. Komen Foundation(Susan G. Komen Breast Cancer Foundation); University of Rochester Clinical and Translational Science Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA113682 from the NCI (to M.M.). This work was also supported by grants from the Susan G. Komen Foundation (to M.M.) and the University of Rochester Clinical and Translational Science Institute (to M.M.).	AUGEREAU P, 1994, MOL ENDOCRINOL, V8, P693, DOI 10.1210/me.8.6.693; Bai YL, 2003, MOL ENDOCRINOL, V17, P589, DOI 10.1210/me.2002-0351; BATES SE, 1988, MOL ENDOCRINOL, V2, P543, DOI 10.1210/mend-2-6-543; BERRY M, 1989, P NATL ACAD SCI USA, V86, P1218, DOI 10.1073/pnas.86.4.1218; Bjornstrom L, 2005, MOL ENDOCRINOL, V19, P833, DOI 10.1210/me.2004-0486; Bjornstrom L, 2002, J BIOL CHEM, V277, P48479, DOI 10.1074/jbc.C200570200; Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645; BUTLER WB, 1979, BIOCHEM BIOPH RES CO, V90, P1328, DOI 10.1016/0006-291X(79)91181-1; Chang EC, 2006, ENDOCRINOLOGY, V147, P4831, DOI 10.1210/en.2006-0563; Christian CA, 2008, ENDOCRINOLOGY, V149, P5328, DOI 10.1210/en.2008-0520; Costa M, 1998, EUR J BIOCHEM, V258, P123, DOI 10.1046/j.1432-1327.1998.2580123.x; COUSIN E, 1991, NUCLEIC ACIDS RES, V19, P3881, DOI 10.1093/nar/19.14.3881; Dai MH, 2007, BIOINFORMATICS, V23, P2185, DOI 10.1093/bioinformatics/btm297; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Davis AJ, 2000, GEN COMP ENDOCR, V119, P308, DOI 10.1006/gcen.2000.7522; DeNardo DG, 2007, MOL CELL ENDOCRINOL, V277, P13, DOI 10.1016/j.mce.2007.07.006; DeNardo DG, 2005, MOL ENDOCRINOL, V19, P362, DOI 10.1210/me.2004-0267; Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987; Dzau VJ, 2002, CIRC RES, V90, P1234, DOI 10.1161/01.RES.0000025209.24283.73; ElAshry D, 1996, J STEROID BIOCHEM, V59, P261, DOI 10.1016/S0960-0760(96)00118-5; Ferreira MC, 2008, J MOL HISTOL, V39, P535, DOI 10.1007/s10735-008-9194-x; Fowler AM, 2004, FASEB J, V18, P81, DOI 10.1096/fj.03-0038com; Frasor J, 2003, ENDOCRINOLOGY, V144, P4562, DOI 10.1210/en.2003-0567; GARCIA M, 1992, P NATL ACAD SCI USA, V89, P11538, DOI 10.1073/pnas.89.23.11538; Gautier L, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-111; Glidewell-Kenney C, 2008, ENDOCRINOLOGY, V149, P4168, DOI 10.1210/en.2007-1807; Gorczyca W, 1998, METH MOL B, V91, P217; Gotte M, 2006, CANCER RES, V66, P10233, DOI 10.1158/0008-5472.CAN-06-1464; Hall JM, 2001, J BIOL CHEM, V276, P36869, DOI 10.1074/jbc.R100029200; Hammes SR, 2007, ENDOCR REV, V28, P726, DOI 10.1210/er.2007-0022; Harbig J, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni027; Huang J, 2005, MOL ENDOCRINOL, V19, P2696, DOI 10.1210/me.2005-0120; Huang J, 2004, MOL CELL ENDOCRINOL, V218, P65, DOI 10.1016/j.mce.2003.12.005; Huang S, 2005, GLOBAL NETW, V5, P379, DOI 10.1111/j.1471-0374.2005.00125.x; Irigoyen JP, 1999, CELL MOL LIFE SCI, V56, P104, DOI 10.1007/PL00000615; Jakacka M, 2001, J BIOL CHEM, V276, P13615, DOI 10.1074/jbc.M008384200; Jakacka M, 2002, MOL ENDOCRINOL, V16, P2188, DOI 10.1210/me.2001-0174; JIANG SY, 1992, JNCI-J NATL CANCER I, V84, P580, DOI 10.1093/jnci/84.8.580; KIAN TM, 2004, MOL BIOL CELL, V15, P1262; King KL, 1998, ANNU REV PHYSIOL, V60, P601, DOI 10.1146/annurev.physiol.60.1.601; Klebanov L, 2006, COMPUT STAT DATA AN, V50, P3619, DOI 10.1016/j.csda.2005.08.005; Klinge CM, 2001, NUCLEIC ACIDS RES, V29, P2905, DOI 10.1093/nar/29.14.2905; Kushner PJ, 2000, J STEROID BIOCHEM, V74, P311, DOI 10.1016/S0960-0760(00)00108-4; Laufs S, 2006, CELL CYCLE, V5, P1760; Lazennec G, 1999, MOL CELL ENDOCRINOL, V149, P93, DOI 10.1016/S0303-7207(98)00254-8; Levenson AS, 1998, BRIT J CANCER, V78, P88, DOI 10.1038/bjc.1998.447; Li XD, 2004, MOL CELL BIOL, V24, P7681, DOI 10.1128/MCB.24.17.7681-7694.2004; Li XD, 2008, J MOL ENDOCRINOL, V40, P211, DOI 10.1677/JME-07-0156; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LUISI BF, 1994, VITAM HORM, V49, P1; MADER S, 1993, NUCLEIC ACIDS RES, V21, P1125, DOI 10.1093/nar/21.5.1125; MADER S, 1989, NATURE, V338, P271, DOI 10.1038/338271a0; Mao C, 2008, J BIOL CHEM, V283, P12819, DOI 10.1074/jbc.M709936200; Margueron R, 2003, J ENDOCRINOL, V179, P41, DOI 10.1677/joe.0.1790041; Monroe DG, 2003, J CELL BIOCHEM, V90, P315, DOI 10.1002/jcb.10633; Monslow J, 2006, J BIOL CHEM, V281, P18043, DOI 10.1074/jbc.M510467200; Mosselman S, 1996, FEBS LETT, V392, P49, DOI 10.1016/0014-5793(96)00782-X; Murakami Y, 2005, J REPROD DEVELOP, V51, P639, DOI 10.1262/jrd.17029; Muyan M, 2001, MOL CELL ENDOCRINOL, V182, P249, DOI 10.1016/S0303-7207(01)00493-2; Nguyen D, 2007, NUCLEIC ACIDS RES, V35, P3465, DOI 10.1093/nar/gkm241; Norris JD, 1996, MOL ENDOCRINOL, V10, P1605, DOI 10.1210/mend.10.12.8961270; Oesterreich S, 2001, CANCER RES, V61, P5771; Renier M A, 1998, Eur J Contracept Reprod Health Care, V3, P129; Saavalainen K, 2005, J BIOL CHEM, V280, P14636, DOI 10.1074/jbc.M500206200; Safe S, 2001, VITAM HORM, V62, P231, DOI 10.1016/S0083-6729(01)62006-5; SCHWABE JWR, 1993, CELL, V75, P567, DOI 10.1016/0092-8674(93)90390-C; SCHWABE JWR, 1995, STRUCTURE, V3, P201, DOI 10.1016/S0969-2126(01)00150-2; Soulez M, 2001, J MOL ENDOCRINOL, V27, P259, DOI 10.1677/jme.0.0270259; Stossi F, 2004, ENDOCRINOLOGY, V145, P3473, DOI 10.1210/en.2003-1682; Sun GL, 1998, MOL ENDOCRINOL, V12, P882, DOI 10.1210/me.12.6.882; TAKAHASHI T, 1994, CELL GROWTH DIFFER, V5, P919; Wang LH, 2004, NAT MED, V10, P40, DOI 10.1038/nm969; Wang LH, 2003, CANCER RES, V63, P2046; Wang LH, 2006, CANCER CELL, V10, P487, DOI 10.1016/j.ccr.2006.09.015; WEBB P, 1995, MOL ENDOCRINOL, V9, P443, DOI 10.1210/me.9.4.443; WESTFALL PH, 1993, RESAMPLING BASED MUL, P36; Yi P, 2002, MOL ENDOCRINOL, V16, P674, DOI 10.1210/me.16.4.674; Yi P, 2002, MOL ENDOCRINOL, V16, P1810, DOI 10.1210/me.2001-0323	78	19	21	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					15277	15288		10.1074/jbc.M900365200	http://dx.doi.org/10.1074/jbc.M900365200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19321454	Green Published, hybrid			2022-12-27	WOS:000266288200062
J	Geng, Y; Hoke, A; Delpire, E				Geng, Yang; Hoke, Ahmet; Delpire, Eric			The Ste20 Kinases Ste20-related Proline-Alanine-rich Kinase and Oxidative-stress Response 1 Regulate NKCC1 Function in Sensory Neurons	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INTRACELLULAR CHLORIDE REGULATION; NA-K-2CL COTRANSPORTER; NA+-K+-2CL(-) COTRANSPORTER; SPAK; OSR1; PHOSPHORYLATION; HYPERALGESIA; ACTIVATION; CLONING; GROWTH	NKCC1 is highly expressed in dorsal root ganglion neurons, where it is involved in gating sensory information. In a recent study, it was shown that peripheral nerve injury results in increased NKCC1 activity, not due to an increase in cotransporter expression, but to increased phosphorylation of the cotransporter (Pieraut, S., Matha, V., Sar, C., Hubert, T., Mechaly, I., Hilaire, C., Mersel, M., Delpire, E., Valmier, J., and Scamps, F. (2007) J. Neurosci. 27, 6751-6759). Our laboratory has also identified two Ste20-like kinases that bind and phosphorylate NKCC1: Ste20-related proline-alanine-rich kinase (SPAK) and oxidative-stress response 1 (OSR1). In this study, we show that both kinases are expressed at similar expression levels in spinal cord and dorsal root ganglion neurons, and that both kinases participate equally in the regulation of NKCC1. Using a novel fluorescence method to assay NKCC1 activity in single cells, we show a 50% reduction in NKCC1 activity in DRG neurons isolated from SPAK knockout mice, indicating that another kinase, e. g. OSR1, is present to phosphorylate and activate the cotransporter. Using a nociceptive dorsal root ganglion sensory neuronal cell line, which expresses the same cation-chloride cotransporters and kinases as native DRG neurons, and gene silencing via short hairpin RNA, we demonstrate a direct relationship between kinase expression and cotransporter activity. We show that inactivation of either kinase significantly affects NKCC1 activity, whereas inactivation of both kinases results in an additive effect. In summary, our study demonstrates redundancy of kinases in the regulation of NKCC1 in dorsal root ganglion neurons.	[Geng, Yang; Delpire, Eric] Vanderbilt Univ, Med Ctr, Grad Program Neurosci, Nashville, TN 37232 USA; [Geng, Yang; Delpire, Eric] Vanderbilt Univ, Med Ctr, Dept Anesthesiol, Nashville, TN 37232 USA; [Hoke, Ahmet] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21287 USA	Vanderbilt University; Vanderbilt University; Johns Hopkins University	Delpire, E (corresponding author), Dept Anesthesiol, T-4202 MCN 1161 21st Ave, S Nashville, TN 37232 USA.	eric.delpire@vanderbilt.edu		Hoke, Ahmet/0000-0003-1215-3373	National Institutes of Health [GM074771, NS53658]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074771] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS053658] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM074771 and NS53658 (to E. D.).	Akai S, 2007, J BIOL CHEM, V282, P23996, DOI 10.1074/jbc.M702819200; ALVAREZLEEFMANS FJ, 1988, J PHYSIOL-LONDON, V406, P225, DOI 10.1113/jphysiol.1988.sp017378; Chen W, 2004, J BIOL CHEM, V279, P11129, DOI 10.1074/jbc.M313562200; Chen WR, 2007, J PERIPHER NERV SYST, V12, P121, DOI 10.1111/j.1529-8027.2007.00131.x; Dai PG, 2006, J BIOL CHEM, V281, P927, DOI 10.1074/jbc.M507360200; Delpire E, 2009, P NATL ACAD SCI USA, V106, P5383, DOI 10.1073/pnas.0812756106; Dowd BFX, 2003, J BIOL CHEM, V278, P27347, DOI 10.1074/jbc.M301899200; Gagnon KBE, 2006, MOL CELL BIOL, V26, P689, DOI 10.1128/MCB.26.2.689-698.2006; Gagnon KBE, 2006, AM J PHYSIOL-CELL PH, V290, pC134, DOI 10.1152/ajpcell.00037.2005; Gagnon KBE, 2007, CELL PHYSIOL BIOCHEM, V20, P131, DOI 10.1159/000104161; Granados-Soto V, 2005, PAIN, V114, P231, DOI 10.1016/j.pain.2004.12.023; Johnston AM, 2000, ONCOGENE, V19, P4290, DOI 10.1038/sj.onc.1203784; LABOSKY PA, 1994, DEVELOPMENT, V120, P3197; Laird JMA, 2004, NEUROSCI LETT, V361, P200, DOI 10.1016/j.neulet.2003.12.015; Moriguchi T, 2005, J BIOL CHEM, V280, P42685, DOI 10.1074/jbc.M510042200; Piechotta K, 2003, J BIOL CHEM, V278, P52848, DOI 10.1074/jbc.M309436200; Piechotta K, 2002, J BIOL CHEM, V277, P50812, DOI 10.1074/jbc.M208108200; Pieraut S, 2007, J NEUROSCI, V27, P6751, DOI 10.1523/JNEUROSCI.1337-07.2007; Price TJ, 2005, CURR TOP MED CHEM, V5, P547, DOI 10.2174/1568026054367629; Rocha-Gonzalez HI, 2008, J NEUROPHYSIOL, V100, P169, DOI 10.1152/jn.01007.2007; Sung KW, 2000, J NEUROSCI, V20, P7531; Tamari M, 1999, J HUM GENET, V44, P116, DOI 10.1007/s100380050121; Ushiro H, 1998, ARCH BIOCHEM BIOPHYS, V355, P233, DOI 10.1006/abbi.1998.0736; Vitari AC, 2006, BIOCHEM J, V397, P223, DOI 10.1042/BJ20060220; Weaver CD, 2004, J BIOMOL SCREEN, V9, P671, DOI 10.1177/1087057104268749; Willis WD, 1999, EXP BRAIN RES, V124, P395, DOI 10.1007/s002210050637; Yan Y, 2007, BBA-GENE STRUCT EXPR, V1769, P106, DOI 10.1016/j.bbaexp.2007.01.003; Zeng Y, 2003, RNA, V9, P112, DOI 10.1261/rna.2780503; Zhou HX, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni061	29	53	54	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14020	14028		10.1074/jbc.M900142200	http://dx.doi.org/10.1074/jbc.M900142200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19307180	hybrid, Green Published			2022-12-27	WOS:000266286100008
J	Bhattacharya, R; Cabral, F				Bhattacharya, Rajat; Cabral, Fernando			Molecular Basis for Class V beta-Tubulin Effects on Microtubule Assembly and Paclitaxel Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HAMSTER OVARY CELLS; CONFER RESISTANCE; C-TERMINUS; CAENORHABDITIS-ELEGANS; ANTIMITOTIC DRUGS; ALPHA-TUBULIN; ISOTYPES; EXPRESSION; MUTATIONS; MECHANISMS	Vertebrates produce at least seven distinct beta-tubulin isotypes that coassemble into all cellular microtubules. The functional differences among these tubulin isoforms are largely unknown, but recent studies indicate that tubulin composition can affect microtubule properties and cellular microtubule-dependent behavior. One of the isotypes whose incorporation causes the largest change in microtubule assembly is beta 5-tubulin. Overexpression of this isotype can almost completely destroy the microtubule network, yet it appears to be required in smaller amounts for normal mitotic progression. Moderate levels of overexpression can also confer paclitaxel resistance. Experiments using chimeric constructs and site-directed mutagenesis now indicate that the hypervariable C-terminal region of beta 5 plays no role in these phenotypes. Instead, we demonstrate that two residues found in beta 5 (Ser-239 and Ser-365) are each sufficient to inhibit microtubule assembly and confer paclitaxel resistance when introduced into beta 1-tubulin; yet the single mutation of residue Ser-239 in beta 5 eliminates its ability to confer these phenotypes. Despite the high degree of conservation among beta-tubulin isotypes, mutations affecting residue 365 demonstrate that amino acid substitutions can be context sensitive; i.e. an amino acid change in one isotype will not necessarily produce the same phenotype when introduced into a different isotype. Modeling studies indicate that residue Cys-239 of beta 1-tubulin is close to a highly conserved Cys-354 residue suggesting the possibility that disulfide formation could play a significant role in the stability of microtubules formed with beta 1-but not with beta 5-tubulin.	[Bhattacharya, Rajat; Cabral, Fernando] Univ Texas Houston, Sch Med, Dept Integrat Biol & Pharmacol, Houston, TX 77030 USA	University of Texas System; University of Texas Health Science Center Houston	Cabral, F (corresponding author), Univ Texas Houston, Sch Med, Dept Integrat Biol & Pharmacol, 6431 Fannin St, Houston, TX 77030 USA.	fernando.r.cabral@uth.tmc.edu		Bhattacharya, Rajat/0000-0001-5693-6754	National Institutes of Health [CA85935]; National Science Foundation [0516080]; NATIONAL CANCER INSTITUTE [R01CA085935] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA85935 (to F. C.). This work was also supported by National Science Foundation Grant 0516080 (to F. C.).	ABRAHAM I, 1983, J CELL BIOL, V97, P1055, DOI 10.1083/jcb.97.4.1055; AHMAD S, 1991, BIOCHIM BIOPHYS ACTA, V1090, P252, DOI 10.1016/0167-4781(91)90112-Y; BARLOW S, 1994, J CELL BIOL, V126, P1017, DOI 10.1083/jcb.126.4.1017; Bhattacharya R, 2004, MOL BIOL CELL, V15, P3123, DOI 10.1091/mbc.E04-01-0060; Bhattacharya R, 2008, CELL MOTIL CYTOSKEL, V65, P708, DOI 10.1002/cm.20292; Blade K, 1999, J CELL SCI, V112, P2213; BOND JF, 1986, CELL, V44, P461, DOI 10.1016/0092-8674(86)90467-8; Britto PJ, 2005, BIOCHEM J, V389, P549, DOI 10.1042/BJ20042118; Burkhart CA, 2001, BBA-REV CANCER, V1471, pO1, DOI 10.1016/S0304-419X(00)00022-6; CABRAL F, 1991, PHARMACOL THERAPEUT, V52, P159, DOI 10.1016/0163-7258(91)90006-8; CABRAL F, 1980, CELL, V20, P29, DOI 10.1016/0092-8674(80)90231-7; Cabral F., 2000, DRUG RESIST UPDATE, V3, P1; Cabral Fernando, 2008, P337, DOI 10.1007/978-1-59745-336-3_14; CABRAL FR, 1986, ANN NY ACAD SCI, V466, P745, DOI 10.1111/j.1749-6632.1986.tb38456.x; Chaudhuri AR, 2001, BIOCHEMISTRY-US, V40, P8834, DOI 10.1021/bi0101603; DEAVEN LL, 1973, CHROMOSOMA, V41, P129, DOI 10.1007/BF00319690; Ganguly A, 2008, CELL CYCLE, V7, P3187, DOI 10.4161/cc.7.20.6814; Gonzalez-Garay ML, 1999, J BIOL CHEM, V274, P23875, DOI 10.1074/jbc.274.34.23875; Gupta ML, 2002, MOL BIOL CELL, V13, P2919, DOI 10.1091/mbc.E02-01-0003; Hari M, 2003, CELL MOTIL CYTOSKEL, V56, P45, DOI 10.1002/cm.10132; Hari M, 2003, MOL CANCER THER, V2, P597; HOYLE HD, 1990, J CELL BIOL, V111, P1009, DOI 10.1083/jcb.111.3.1009; Jordan MA, 1998, CURR OPIN CELL BIOL, V10, P123, DOI 10.1016/S0955-0674(98)80095-1; KUNG AL, 1990, P NATL ACAD SCI USA, V87, P9553, DOI 10.1073/pnas.87.24.9553; LEWIS SA, 1987, CELL, V49, P539, DOI 10.1016/0092-8674(87)90456-9; LOPATA MA, 1987, J CELL BIOL, V105, P1707, DOI 10.1083/jcb.105.4.1707; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; Lu CG, 2004, MOL BIOL CELL, V15, P142, DOI 10.1091/mbc.E03-06-0418; Luduena RF, 1998, INT REV CYTOL, V178, P207; LUDUENA RF, 1993, MOL BIOL CELL, V4, P445, DOI 10.1091/mbc.4.5.445; MARYA PK, 1994, J CELL SCI, V107, P339; MINOTTI AM, 1991, J BIOL CHEM, V266, P3987; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Moores CA, 2002, MOL CELL, V9, P903, DOI 10.1016/S1097-2765(02)00503-8; Niederstrasser H, 2002, J MOL BIOL, V316, P817, DOI 10.1006/jmbi.2001.5360; Orr GA, 2003, ONCOGENE, V22, P7280, DOI 10.1038/sj.onc.1206934; Popodi EM, 2008, CELL MOTIL CYTOSKEL, V65, P216, DOI 10.1002/cm.20256; PUCK TT, 1958, J EXP MED, V108, P945, DOI 10.1084/jem.108.6.945; Ravelli RBG, 2004, NATURE, V428, P198, DOI 10.1038/nature02393; Rudner AD, 1996, CURR OPIN CELL BIOL, V8, P773, DOI 10.1016/S0955-0674(96)80077-9; SAVAGE C, 1989, GENE DEV, V3, P870, DOI 10.1101/gad.3.6.870; SAWADA T, 1989, J BIOL CHEM, V264, P3013; SERRANO L, 1984, BIOCHEMISTRY-US, V23, P4675, DOI 10.1021/bi00315a024; SIMINOVITCH L, 1976, CELL, V7, P1, DOI 10.1016/0092-8674(76)90249-X; STEMME S, 1985, BRAIN RES, V359, P140, DOI 10.1016/0006-8993(85)91421-0; SULLIVAN KF, 1986, MOL CELL BIOL, V6, P4409, DOI 10.1128/MCB.6.12.4409; SULLIVAN KF, 1988, ANNU REV CELL BIOL, V4, P687, DOI 10.1146/annurev.cb.04.110188.003351; THEODORAKIS NG, 1992, MOL CELL BIOL, V12, P791, DOI 10.1128/MCB.12.2.791; Thorn KS, 2000, J CELL BIOL, V151, P1093, DOI 10.1083/jcb.151.5.1093; Vent J, 2005, J CELL SCI, V118, P4333, DOI 10.1242/jcs.02550; Wang YQ, 2006, BIOCHEMISTRY-US, V45, P185, DOI 10.1021/bi051207d; Wang ZH, 2000, BIOPHYS J, V78, P1955, DOI 10.1016/S0006-3495(00)76743-9; White SR, 2007, J CELL BIOL, V176, P995, DOI 10.1083/jcb.200610072; Yang HL, 2007, J BIOL CHEM, V282, P27058, DOI 10.1074/jbc.M704101200; Yin SH, 2007, MOL CANCER THER, V6, P2798, DOI 10.1158/1535-7163.MCT-06-0791	55	30	31	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					13023	13032		10.1074/jbc.M900167200	http://dx.doi.org/10.1074/jbc.M900167200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19282281	Green Published, hybrid			2022-12-27	WOS:000265688300050
J	Varrin-Doyer, M; Vincent, P; Cavagna, S; Auvergnon, N; Noraz, N; Rogemond, V; Honnorat, J; Moradi-Ameli, M; Giraudon, P				Varrin-Doyer, Michel; Vincent, Peggy; Cavagna, Sylvie; Auvergnon, Nathalie; Noraz, Nelly; Rogemond, Veronique; Honnorat, Jerome; Moradi-Ameli, Mahnaz; Giraudon, Pascale			Phosphorylation of Collapsin Response Mediator Protein 2 on Tyr-479 Regulates CXCL12-induced T Lymphocyte Migration	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MULTIPLE-SCLEROSIS; SIGNALING PATHWAYS; NEURITE OUTGROWTH; GROWTH CONE; CRMP-2; BRAIN; EXPRESSION; CXCL12; CELLS; DISORDERS	In the central nervous system, collapsin response mediator protein 2 (CRMP2) is a transducer protein that supports the semaphorin-induced guidance of axons toward their cognate target. However, we previously showed that CRMP2 is also expressed in immune cells and plays a crucial role in T lymphocyte migration. Here we further investigated the molecular mechanisms underlying CRMP2 function in chemokine-directed T-cell motility. Examining Jurkat T-cells treated with the chemokine CXCL12, we found that 1) CXCL12 induces a dynamic re-localization of CRMP2 to uropod, the flexible structure of migrating lymphocyte, and increases its binding to the cytoskeletal protein vimentin; 2) CXCL12 decreases phosphorylation of the glycogen synthase kinase-3 beta-targeted residues CRMP2-Thr-509/514; and 3) tyrosine Tyr-479 is a new phosphorylation CRMP2 residue and a target for the Src-family kinase Yes. Moreover, phospho-Tyr-479 increased under CXCL12 signaling while phospho-Thr-509/514 decreased. The functional importance of this tyrosine phosphorylation was demonstrated by Y479F mutation that strongly reduced CXCL12-mediated T-cell polarization and motility as tested in a transmigration model and on neural tissue. We propose that differential phosphorylation by glycogen synthase kinase-3 beta and Yes modulates the contribution of CRMP2 to cytoskeletal reorganization during chemokine-directed T-cell migration. In addition to providing a novel mechanism for T lymphocyte motility, our findings reveal CRMP2 as a transducer of chemokine signaling.	[Giraudon, Pascale] Univ Lyon 1, INSERM, Dept Neurooncol & Neuroinflammat, Fac Med R Laennec,U842, F-69372 Lyon, France; Univ Lyon 1, UMR S842, F-69372 Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Giraudon, P (corresponding author), Univ Lyon 1, INSERM, Dept Neurooncol & Neuroinflammat, Fac Med R Laennec,U842, Rue Guillaume Paradin, F-69372 Lyon, France.	pascale.giraudon@inserm.fr	noraz, nelly/H-9477-2017; Rogemond, Veronique/J-4824-2017; Honnorat, jerome/G-6394-2017	noraz, nelly/0000-0003-4076-9773; Rogemond, Veronique/0000-0003-2098-920X; Honnorat, jerome/0000-0002-4721-5952	French Agency of Research on Multiple Sclerosis; INSERM; Agence Nationale de la Recherche	French Agency of Research on Multiple Sclerosis; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by grants and fellowships from the French Agency of Research on Multiple Sclerosis, INSERM, and Agence Nationale de la Recherche.	Arimura N, 2005, MOL CELL BIOL, V25, P9973, DOI 10.1128/MCB.25.22.9973-9984.2005; Bleul CC, 1996, J EXP MED, V184, P1101, DOI 10.1084/jem.184.3.1101; Brown MJ, 2001, J IMMUNOL, V166, P6640, DOI 10.4049/jimmunol.166.11.6640; Buttner B, 2005, BIOCHEMISTRY-US, V44, P6938, DOI 10.1021/bi050066c; Calderon TM, 2006, J NEUROIMMUNOL, V177, P27, DOI 10.1016/j.jneuroim.2006.05.003; Charrier E, 2003, MOL NEUROBIOL, V28, P51, DOI 10.1385/MN:28:1:51; Cole AR, 2008, J BIOL CHEM, V283, P18227, DOI 10.1074/jbc.M801645200; Cole AR, 2006, J BIOL CHEM, V281, P16591, DOI 10.1074/jbc.M513344200; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Fukata Y, 2002, NAT CELL BIOL, V4, P583, DOI 10.1038/ncb825; GOSHIMA Y, 1995, NATURE, V376, P509, DOI 10.1038/376509a0; Gu YJ, 2000, J BIOL CHEM, V275, P17917, DOI 10.1074/jbc.C000179200; Inagaki N, 2001, NAT NEUROSCI, V4, P781, DOI 10.1038/90476; Kawano Y, 2005, MOL CELL BIOL, V25, P9920, DOI 10.1128/MCB.25.22.9920-9935.2005; Krummel MF, 2006, NAT IMMUNOL, V7, P1143, DOI 10.1038/ni1404; Lataillade JJ, 2004, EUR CYTOKINE NETW, V15, P177; Li MZ, 2008, PROG NEUROBIOL, V84, P116, DOI 10.1016/j.pneurobio.2007.11.003; Lieberam I, 2005, NEURON, V47, P667, DOI 10.1016/j.neuron.2005.08.011; Martinez JC, 1999, NAT STRUCT BIOL, V6, P1010; McCandless EE, 2008, AM J PATHOL, V172, P799, DOI 10.2353/ajpath.2008.070918; Mellado M, 2001, EMBO J, V20, P2497, DOI 10.1093/emboj/20.10.2497; Mimura F, 2006, J BIOL CHEM, V281, P15970, DOI 10.1074/jbc.M510934200; Nishimura T, 2003, NAT CELL BIOL, V5, P819, DOI 10.1038/ncb1039; Patrussi L, 2008, IMMUNOL LETT, V115, P75, DOI 10.1016/j.imlet.2007.10.012; Quinn CC, 2003, J NEUROSCI, V23, P2815; Rogemond V, 2008, J BIOL CHEM, V283, P14751, DOI 10.1074/jbc.M708480200; Rosslenbroich V, 2005, EXP CELL RES, V310, P434, DOI 10.1016/j.yexcr.2005.08.005; Rot A, 2004, ANNU REV IMMUNOL, V22, P891, DOI 10.1146/annurev.immunol.22.012703.104543; Rubin JB, 2003, P NATL ACAD SCI USA, V100, P13513, DOI 10.1073/pnas.2235846100; Serrador JM, 1999, TRENDS CELL BIOL, V9, P228, DOI 10.1016/S0962-8924(99)01553-6; Stenmark P, 2007, J NEUROCHEM, V101, P906, DOI 10.1111/j.1471-4159.2006.04401.x; Tahimic CGT, 2006, BIOCHEM BIOPH RES CO, V340, P1244, DOI 10.1016/j.bbrc.2005.12.132; Uchida Y, 2005, GENES CELLS, V10, P165, DOI 10.1111/j.1365-2443.2005.00827.x; Vicente-Manzanares M, 2005, BLOOD, V105, P3026, DOI 10.1182/blood-2004-07-2925; Vicente-Manzanares Miguel, 2004, Methods Mol Biol, V239, P53; Vincent P, 2005, J IMMUNOL, V175, P7650, DOI 10.4049/jimmunol.175.11.7650; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Vuaillat C, 2008, J NEUROIMMUNOL, V193, P38, DOI 10.1016/j.jneuroim.2007.09.033; Werdich Xiang Q., 2005, Angiogenesis, V8, P315; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Yoshimura T, 2006, ANN NY ACAD SCI, V1086, P116, DOI 10.1196/annals.1377.013	41	38	44	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					13265	13276		10.1074/jbc.M807664200	http://dx.doi.org/10.1074/jbc.M807664200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19276087	hybrid, Green Published, Green Submitted			2022-12-27	WOS:000265688300073
J	Sato, Y; Isaji, T; Tajiri, M; Yoshida-Yamamoto, S; Yoshinaka, T; Somehara, T; Fukuda, T; Wada, Y; Gu, JG				Sato, Yuya; Isaji, Tomoya; Tajiri, Michiko; Yoshida-Yamamoto, Shumi; Yoshinaka, Tsuyoshi; Somehara, Toshiaki; Fukuda, Tomohiko; Wada, Yoshinao; Gu, Jianguo			An N-Glycosylation Site on the beta-Propeller Domain of the Integrin alpha 5 Subunit Plays Key Roles in Both Its Function and Site-specific Modification by beta 1,4-N-Acetylglucosaminyltransferase III	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-MIGRATION; ACETYLGLUCOSAMINYLTRANSFERASE-III; LIGAND-BINDING; STRUCTURAL DETERMINANTS; ALTERED GLYCOSYLATION; EXTRACELLULAR SEGMENT; PROTEIN GLYCOSYLATION; FIBRONECTIN RECEPTOR; MESODERMAL DEFECTS; CRYSTAL-STRUCTURE	Recently we reported that N-glycans on the beta-propeller domain of the integrin alpha 5 subunit (S-3,4,5) are essential for alpha 5 beta 1 heterodimerization, expression, and cell adhesion. Herein to further investigate which N-glycosylation site is the most important for the biological function and regulation, we characterized the S-3,4,5 mutants in detail. We found that site-4 is a key site that can be specifically modified by N-acetylglucosaminyltransferase III (GnT-III). The introduction of bisecting GlcNAc into the S-3,4,5 mutant catalyzed by GnT-III decreased cell adhesion and migration on fibronectin, whereas overexpression of N-acetylglucosaminyltransferase V (GnT-V) promoted cell migration. The phenomenon is similar to previous observations that the functions of the wild-type alpha 5 subunit were positively and negatively regulated by GnT-V and GnT-III, respectively, suggesting that the alpha 5 subunit could be duplicated by the S-3,4,5 mutant. Interestingly GnT-III specifically modified the S-4,5 mutant but not the S-3,5 mutant. This result was confirmed by erythroagglutinating phytohemagglutinin lectin blot analysis. The reduction in cell adhesion was consistently observed in the S-4,5 mutant but not in the S-3,5 mutant cells. Furthermore mutation of site-4 alone resulted in a substantial decrease in erythroagglutinating phytohemagglutinin lectin staining and suppression of cell spread induced by GnT-III compared with that of either the site-3 single mutant or wild-type alpha 5. These results, taken together, strongly suggest that N-glycosylation of site-4 on the alpha 5 subunit is the most important site for its biological functions. To our knowledge, this is the first demonstration that site-specific modification of N-glycans by a glycosyltransferase results in functional regulation.	[Sato, Yuya; Isaji, Tomoya; Fukuda, Tomohiko; Gu, Jianguo] Tohoku Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Regulatory Glycobiol, Aoba Ku, Sendai, Miyagi 9818558, Japan; [Tajiri, Michiko; Yoshida-Yamamoto, Shumi; Wada, Yoshinao] Osaka Med Ctr, Dept Mol Med, Osaka 5941101, Japan; [Tajiri, Michiko; Yoshida-Yamamoto, Shumi; Wada, Yoshinao] Res Inst Maternal & Child Hlth, Osaka 5941101, Japan; [Yoshinaka, Tsuyoshi; Somehara, Toshiaki] Wako Pure Chem Ind Ltd, Lab Chem Div, Chuo Ku, Osaka 5408605, Japan	Tohoku Medical & Pharmaceutical University; Osaka Medical Center for Cancer & Cardiovascular Diseases	Gu, JG (corresponding author), Tohoku Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Regulatory Glycobiol, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, Japan.	jgu@tohoku-pharm.ac.jp	Isaji, Tomoya/ABC-9285-2021; Gu, Jianguo/ABC-9257-2020		Core Research for Evolutional Science and Technology; Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science; Takeda Science Foundation, Japan	Core Research for Evolutional Science and Technology(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation, Japan(Takeda Science Foundation (TSF))	This work was supported in part by Core Research for Evolutional Science and Technology; the Japan Science and Technology Agency; the "Academic Frontier" Project for Private Universities from the Ministry of Education, Culture, Sports, Science and Technology of Japan; the core to core program (Japan Society for the Promotion of Science); and Takeda Science Foundation, Japan.	AKIYAMA SK, 1989, J BIOL CHEM, V264, P18011; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Bellis SL, 2004, BBA-BIOMEMBRANES, V1663, P52, DOI 10.1016/j.bbamem.2004.03.012; CUMMINGS RD, 1982, J BIOL CHEM, V257, P1230; DENNIS J, 1982, NATURE, V300, P274, DOI 10.1038/300274a0; DWEK RA, 1995, BIOCHEM SOC T, V23, P1; Endo T, 2006, METHOD ENZYMOL, V417, P137, DOI 10.1016/S0076-6879(06)17011-1; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; Goh KL, 1997, DEVELOPMENT, V124, P4309; Gu JG, 2004, GLYCOCONJUGATE J, V21, P9, DOI 10.1023/B:GLYC.0000043741.47559.30; Guo HB, 2002, CANCER RES, V62, P6837; Hoffmeister KM, 2003, SCIENCE, V301, P1531, DOI 10.1126/science.1085322; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Isaji T, 2004, J BIOL CHEM, V279, P19747, DOI 10.1074/jbc.M311627200; Isaji T, 2006, J BIOL CHEM, V281, P33258, DOI 10.1074/jbc.M607771200; Josefsson EC, 2005, J BIOL CHEM, V280, P18025, DOI 10.1074/jbc.M501178200; Ju TZ, 2005, NATURE, V437, P1252, DOI 10.1038/4371252a; Ju TZ, 2002, P NATL ACAD SCI USA, V99, P16613, DOI 10.1073/pnas.262438199; KAWANO T, 1993, INT J CANCER, V53, P91, DOI 10.1002/ijc.2910530118; Koyota S, 2001, J BIOL CHEM, V276, P32867, DOI 10.1074/jbc.M102371200; Liu YM, 2008, PROTEINS, V73, P989, DOI 10.1002/prot.22126; Manya H, 2004, P NATL ACAD SCI USA, V101, P500, DOI 10.1073/pnas.0307228101; Manya H, 2007, J BIOL CHEM, V282, P20200, DOI 10.1074/jbc.M702369200; Mould AP, 2000, J BIOL CHEM, V275, P20324, DOI 10.1074/jbc.M000572200; Mould AP, 2003, J BIOL CHEM, V278, P39993, DOI 10.1074/jbc.M304627200; Nadanaka S, 2001, J BIOL CHEM, V276, P33657, DOI 10.1074/jbc.M011100200; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Pretzlaff RK, 2000, CELL ADHES COMMUN, V7, P491, DOI 10.3109/15419060009040306; Sasai K, 2003, J BIOL CHEM, V278, P25295, DOI 10.1074/jbc.M301913200; Saxon E, 2001, ANNU REV CELL DEV BI, V17, P1, DOI 10.1146/annurev.cellbio.17.1.1; SCHREINER CL, 1989, J CELL BIOL, V109, P3157, DOI 10.1083/jcb.109.6.3157; Seales EC, 2005, CANCER RES, V65, P4645, DOI 10.1158/0008-5472.CAN-04-3117; Seales EC, 2003, ONCOGENE, V22, P7137, DOI 10.1038/sj.onc.1206834; Semel AC, 2002, J BIOL CHEM, V277, P32830, DOI 10.1074/jbc.M202493200; Shaikh FM, 2008, EXP CELL RES, V314, P2941, DOI 10.1016/j.yexcr.2008.07.021; Solly K, 2004, ASSAY DRUG DEV TECHN, V2, P363, DOI 10.1089/adt.2004.2.363; WATT FM, 1994, CURR BIOL, V4, P270, DOI 10.1016/S0960-9822(00)00063-4; Xiong JP, 2001, SCIENCE, V294, P339, DOI 10.1126/science.1064535; Xiong JP, 2002, SCIENCE, V296, P151, DOI 10.1126/science.1069040; YAMASHITA K, 1987, J BIOL CHEM, V262, P1602; YAMASHITA K, 1983, J BIOL CHEM, V258, P4753; YANG JT, 1993, DEVELOPMENT, V119, P1093; Zhao YY, 2006, J BIOL CHEM, V281, P32122, DOI 10.1074/jbc.M607274200; ZHENG MZ, 1994, J BIOL CHEM, V269, P12325	44	42	45	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					11873	11881		10.1074/jbc.M807660200	http://dx.doi.org/10.1074/jbc.M807660200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19276077	Green Published, hybrid			2022-12-27	WOS:000265494600019
J	Shaffer, JF; Kensler, RW; Harris, SP				Shaffer, Justin F.; Kensler, Robert W.; Harris, Samantha P.			The Myosin-binding Protein C Motif Binds to F-actin in a Phosphorylation-sensitive Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE-A PHOSPHORYLATION; RABBIT SKELETAL-MUSCLE; VITRO MOTILITY ASSAY; HYPERTROPHIC CARDIOMYOPATHY; MYBP-C; REGULATORY DOMAIN; CARDIAC-FUNCTION; STRIATED-MUSCLE; THIN-FILAMENTS; CONTRACTION	Cardiac myosin-binding protein C (cMyBP-C) is a regulatory protein expressed in cardiac sarcomeres that is known to interact with myosin, titin, and actin. cMyBP-C modulates actomyosin interactions in a phosphorylation-dependent way, but it is unclear whether interactions with myosin, titin, or actin are required for these effects. Here we show using cosedimentation binding assays, that the 4 N-terminal domains of murine cMyBP-C (i. e. C0-C1-m-C2) bind to F-actin with a dissociation constant (K-d) of similar to 10 mu M and a molar binding ratio (B-max) near 1.0, indicating 1: 1 (mol/mol) binding to actin. Electron microscopy and light scattering analyses show that these domains cross-link F-actin filaments, implying multiple sites of interaction with actin. Phosphorylation of the MyBP-C regulatory motif, or m-domain, reduced binding to actin (reduced Bmax) and eliminated actin cross-linking. These results suggest that the N terminus of cMyBP-C interacts with F-actin through multiple distinct binding sites and that binding at one or more sites is reduced by phosphorylation. Reversible interactions with actin could contribute to effects of cMyBP-C to increase crossbridge cycling.	[Shaffer, Justin F.; Harris, Samantha P.] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; [Shaffer, Justin F.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Kensler, Robert W.] Univ Puerto Rico, Sch Med, San Juan, PR 00936 USA	University of California System; University of California Davis; University of Washington; University of Washington Seattle; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus	Harris, SP (corresponding author), 196 Briggs Hall,1 Shields Ave, Davis, CA 95616 USA.	samharris@ucdavis.edu			National Institutes of Health [SC1HL096017, HL080367]; National Science Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [SC1HL096017, R01HL080367] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants SC1HL096017 (to R. W. K.) and HL080367 (to S. P. H.). This work was also supported by a National Science Foundation Graduate Research Fellowship (to J. F. S.).	Ababou A, 2007, J BIOL CHEM, V282, P9204, DOI 10.1074/jbc.M610899200; Ababou A, 2008, J MOL BIOL, V384, P615, DOI 10.1016/j.jmb.2008.09.065; BENNETT P, 1986, J MUSCLE RES CELL M, V7, P550, DOI 10.1007/BF01753571; Brown LJ, 2002, P NATL ACAD SCI USA, V99, P12765, DOI 10.1073/pnas.202477399; Calaghan SC, 2000, J PHYSIOL-LONDON, V528, P151, DOI 10.1111/j.1469-7793.2000.00151.x; Colson BA, 2008, CIRC RES, V103, P244, DOI 10.1161/CIRCRESAHA.108.178996; Dhandapany PS, 2009, NAT GENET, V41, P187, DOI 10.1038/ng.309; FRITZ JD, 1989, ANAL BIOCHEM, V180, P205, DOI 10.1016/0003-2697(89)90116-4; Galinska-Rakoczy A, 2008, J MOL BIOL, V379, P929, DOI 10.1016/j.jmb.2008.04.062; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Gruen M, 1999, FEBS LETT, V453, P254, DOI 10.1016/S0014-5793(99)00727-9; Gruen M, 1999, J MOL BIOL, V286, P933, DOI 10.1006/jmbi.1998.2522; Harris SP, 2002, CIRC RES, V90, P594, DOI 10.1161/01.RES.0000012222.70819.64; HOFMANN PA, 1991, J PHYSIOL-LONDON, V439, P701, DOI 10.1113/jphysiol.1991.sp018689; ISHIKAWA M, 1983, J BIOCHEM-TOKYO, V94, P1209, DOI 10.1093/oxfordjournals.jbchem.a134466; Jeffries CM, 2008, J MOL BIOL, V377, P1186, DOI 10.1016/j.jmb.2008.01.080; KORN ED, 1982, PHYSIOL REV, V62, P672, DOI 10.1152/physrev.1982.62.2.672; Korte FS, 2003, CIRC RES, V93, P752, DOI 10.1161/01.RES.0000096363.85588.9A; Kulikovskaya I, 2003, J GEN PHYSIOL, V122, P761, DOI 10.1085/jgp.200308941; Kunst G, 2000, CIRC RES, V86, P51, DOI 10.1161/01.RES.86.1.51; LEHMAN W, 1994, NATURE, V368, P65, DOI 10.1038/368065a0; Luther PK, 2008, J MOL BIOL, V384, P60, DOI 10.1016/j.jmb.2008.09.013; MARGOSSIAN SS, 1985, J BIOL CHEM, V260, P3747; MARGOSSIAN SS, 1982, METHOD ENZYMOL, V85, P55; MCKILLOP DFA, 1993, BIOPHYS J, V65, P693, DOI 10.1016/S0006-3495(93)81110-X; MOOS C, 1978, J MOL BIOL, V124, P571, DOI 10.1016/0022-2836(78)90172-9; Moss RL, 2004, CIRC RES, V94, P1290, DOI 10.1161/01.RES.0000127125.61647.4F; Nagayama T, 2007, CIRCULATION, V116, P2399, DOI 10.1161/CIRCULATIONAHA.107.706523; Palmer BM, 2004, CIRC RES, V94, P1249, DOI 10.1161/01.RES.0000126898.95550.31; PARDEE JD, 1982, METHOD ENZYMOL, V85, P164; Pirani A, 2006, J MOL BIOL, V357, P707, DOI 10.1016/j.jmb.2005.12.050; Razumova MV, 2006, J BIOL CHEM, V281, P35846, DOI 10.1074/jbc.M606949200; Razumova MV, 2008, J GEN PHYSIOL, V132, P575, DOI 10.1085/jgp.200810013; Richard P, 2003, CIRCULATION, V107, P2227, DOI 10.1161/01.CIR.0000066323.15244.54; Saber W, 2008, J MOL CELL CARDIOL, V44, P1053, DOI 10.1016/j.yjmcc.2008.03.012; Sadayappan S, 2006, P NATL ACAD SCI USA, V103, P16918, DOI 10.1073/pnas.0607069103; Shaffer JF, 2007, FEBS LETT, V581, P1501, DOI 10.1016/j.febslet.2007.03.007; Spiess M, 1999, J STRUCT BIOL, V126, P98, DOI 10.1006/jsbi.1999.4111; Squire JM, 2003, J MOL BIOL, V331, P713, DOI 10.1016/S0022-2836(03)00781-2; Stelzer JE, 2007, CIRC RES, V101, P503, DOI 10.1161/CIRCRESAHA.107.153650; Stelzer JE, 2006, BIOPHYS J, V90, P4119, DOI 10.1529/biophysj.105.078147; Tong CW, 2008, CIRC RES, V103, P974, DOI 10.1161/CIRCRESAHA.108.177683; Whitten AE, 2008, P NATL ACAD SCI USA, V105, P18360, DOI 10.1073/pnas.0808903105; Wilkinson Keith D, 2004, Methods Mol Biol, V261, P15; YAMAMOTO K, 1986, FEBS LETT, V208, P123, DOI 10.1016/0014-5793(86)81545-9	46	155	155	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12318	12327		10.1074/jbc.M808850200	http://dx.doi.org/10.1074/jbc.M808850200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19269976	hybrid, Green Published			2022-12-27	WOS:000265494600063
J	Medalia, N; Beer, A; Zwickl, P; Mihalache, O; Beck, M; Medalia, O; Navon, A				Medalia, Noa; Beer, Avital; Zwickl, Peter; Mihalache, Oana; Beck, Martin; Medalia, Ohad; Navon, Ami			Architecture and Molecular Mechanism of PAN, the Archaeal Proteasome Regulatory ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							20S PROTEASOME; DEPENDENT PROTEASE; ESCHERICHIA-COLI; 26S PROTEASOME; SUBSTRATE-BINDING; COMPLEX STRUCTURE; STRUCTURAL BASIS; GROEL; DEGRADATION; PROTEINS	In Archaea, an hexameric ATPase complex termed PAN promotes proteins unfolding and translocation into the 20 S proteasome. PAN is highly homologous to the six ATPases of the eukaryotic 19 S proteasome regulatory complex. Thus, insight into the mechanism of PAN function may reveal a general mode of action mutual to the eukaryotic 19 S proteasome regulatory complex. In this study we generated a three-dimensional model of PAN from tomographic reconstruction of negatively stained particles. Surprisingly, this reconstruction indicated that the hexameric complex assumes a two-ring structure enclosing a large cavity. Assessment of distinct three-dimensional functional states of PAN in the presence of adenosine 5'-O-(thiotriphosphate) and ADP and in the absence of nucleotides outlined a possible mechanism linking nucleotide binding and hydrolysis to substrate recognition, unfolding, and translocation. A novel feature of the ATPase complex revealed in this study is a gate controlling the "exit port" of the regulatory complex and, presumably, translocation into the 20 S proteasome. Based on our structural and biochemical findings, we propose a possible model in which substrate binding and unfolding are linked to structural transitions driven by nucleotide binding and hydrolysis, whereas translocation into the proteasome only depends upon the presence of an unfolded substrate and binding but not hydrolysis of nucleotide.	[Medalia, Noa; Beer, Avital; Navon, Ami] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Medalia, Noa; Medalia, Ohad] Ben Gurion Univ Negev, Dept Life Sci, IL-84195 Beer Sheva, Israel; [Medalia, Noa; Medalia, Ohad] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84195 Beer Sheva, Israel; [Zwickl, Peter; Mihalache, Oana; Medalia, Ohad] Max Planck Inst Biochem, Dept Mol Struct Biol, D-82152 Martinsried, Germany; [Beck, Martin] Swiss Fed Inst Technol, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland	Weizmann Institute of Science; Ben Gurion University; Ben Gurion University; Max Planck Society; ETH Zurich	Navon, A (corresponding author), Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel.	ami.navon@weizmann.ac.il	Beck, Martin/B-5589-2011	Beck, Martin/0000-0002-7397-1321; Medalia, Ohad/0000-0003-0994-2937	Israeli Science Foundation [ISF 802/04, ISF 794/02]; German Minerva Foundation [780040]; German-Israeli Foundation for Scientific Research and Development [GIF I-845-210.9/2004]; Rolando Uziel	Israeli Science Foundation(Israel Science Foundation); German Minerva Foundation; German-Israeli Foundation for Scientific Research and Development(German-Israeli Foundation for Scientific Research and Development); Rolando Uziel	This work was supported in part by the Israeli Science Foundation Grants ISF 802/04 (to A.N.) and ISF 794/02 (to O.M.), German Minerva Foundation Grant 780040 (to A.N.), German-Israeli Foundation for Scientific Research and Development Grant GIF I-845-210.9/2004), and a special donation from Rolando Uziel (to A.N.).	Akopian TN, 1997, J BIOL CHEM, V272, P1791, DOI 10.1074/jbc.272.3.1791; Arighi CN, 1998, BIOCHEMISTRY-US, V37, P16802, DOI 10.1021/bi981827x; Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0; Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808; Benaroudj N, 2003, MOL CELL, V11, P69, DOI 10.1016/S1097-2765(02)00775-X; Benaroudj N, 2000, NAT CELL BIOL, V2, P833, DOI 10.1038/35041081; Bochtler M, 2000, NATURE, V403, P800, DOI 10.1038/35001629; Braun BC, 1999, NAT CELL BIOL, V1, P221, DOI 10.1038/12043; Coux O, 1996, ANNU REV BIOCHEM, V65, P801, DOI 10.1146/annurev.bi.65.070196.004101; DeLaBarre B, 2005, J MOL BIOL, V347, P437, DOI 10.1016/j.jmb.2005.01.060; Dreveny I, 2004, EMBO J, V23, P1030, DOI 10.1038/sj.emboj.7600139; Forster A, 2005, MOL CELL, V18, P589, DOI 10.1016/j.molcel.2005.04.016; Forster F, 2005, P NATL ACAD SCI USA, V102, P4729, DOI 10.1073/pnas.0409178102; Gerega A, 2005, J BIOL CHEM, V280, P42856, DOI 10.1074/jbc.M510592200; Glickman MH, 1998, MOL CELL BIOL, V18, P3149, DOI 10.1128/MCB.18.6.3149; Golbik R, 1998, J MOL BIOL, V276, P505, DOI 10.1006/jmbi.1997.1538; Gottesman S, 1997, CELL, V91, P435, DOI 10.1016/S0092-8674(00)80428-6; Groll M, 2000, NAT STRUCT BIOL, V7, P1062, DOI 10.1038/80992; Groll M, 1997, NATURE, V386, P463, DOI 10.1038/386463a0; Harauz G, 1996, J STRUCT BIOL, V116, P290, DOI 10.1006/jsbi.1996.0044; Hartmann-Petersen R, 2001, ARCH BIOCHEM BIOPHYS, V386, P89, DOI 10.1006/abbi.2000.2178; Hendil KB, 2002, J MOL BIOL, V315, P627, DOI 10.1006/jmbi.2001.5285; Holzl H, 2000, J CELL BIOL, V150, P119, DOI 10.1083/jcb.150.1.119; Ishikawa T, 2004, J STRUCT BIOL, V146, P180, DOI 10.1016/j.jsb.2003.11.018; Kenniston JA, 2003, CELL, V114, P511, DOI 10.1016/S0092-8674(03)00612-3; Kisselev AF, 1998, J BIOL CHEM, V273, P1982, DOI 10.1074/jbc.273.4.1982; Kohler A, 2001, MOL CELL, V7, P1143, DOI 10.1016/S1097-2765(01)00274-X; Kusmierczyk AR, 2000, J BIOL CHEM, V275, P33504, DOI 10.1074/jbc.M006256200; Larsen CN, 1997, CELL, V91, P431, DOI 10.1016/S0092-8674(00)80427-4; Lee C, 2001, MOL CELL, V7, P627, DOI 10.1016/S1097-2765(01)00209-X; LOWE J, 1995, SCIENCE, V268, P533, DOI 10.1126/science.7725097; Martin A, 2005, NATURE, V437, P1115, DOI 10.1038/nature04031; Matouschek A, 2003, CURR OPIN STRUC BIOL, V13, P98, DOI 10.1016/S0959-440X(03)00010-1; Medalia N, 2006, J STRUCT BIOL, V156, P84, DOI 10.1016/j.jsb.2006.03.015; Navon A, 2001, MOL CELL, V8, P1339, DOI 10.1016/S1097-2765(01)00407-5; Nickell S, 2005, J STRUCT BIOL, V149, P227, DOI 10.1016/j.jsb.2004.10.006; Nickell S, 2007, BIOCHEM BIOPH RES CO, V353, P115, DOI 10.1016/j.bbrc.2006.11.141; Ortega J, 2000, MOL CELL, V6, P1515, DOI 10.1016/S1097-2765(00)00148-9; Pak M, 1997, P NATL ACAD SCI USA, V94, P4901, DOI 10.1073/pnas.94.10.4901; Rabl J, 2008, MOL CELL, V30, P360, DOI 10.1016/j.molcel.2008.03.004; Raha T, 1999, BIOCHEMISTRY-US, V38, P2110, DOI 10.1021/bi980734c; Ranson NA, 2006, NAT STRUCT MOL BIOL, V13, P147, DOI 10.1038/nsmb1046; Ranson NA, 2001, CELL, V107, P869, DOI 10.1016/S0092-8674(01)00617-1; Rohrwild M, 1996, P NATL ACAD SCI USA, V93, P5808, DOI 10.1073/pnas.93.12.5808; Rohrwild M, 1997, NAT STRUCT BIOL, V4, P133, DOI 10.1038/nsb0297-133; Schug ZT, 2008, J BIOL CHEM, V283, P2939, DOI [10.1074/jbc.M706645200, 10.1074/jbc.M802716200]; Smith DM, 2005, MOL CELL, V20, P687, DOI 10.1016/j.molcel.2005.10.019; Smoot AL, 2001, BIOCHEMISTRY-US, V40, P4484, DOI 10.1021/bi001822b; Song HK, 2000, P NATL ACAD SCI USA, V97, P14103, DOI 10.1073/pnas.250491797; Sousa MC, 2000, CELL, V103, P633, DOI 10.1016/S0092-8674(00)00166-5; Strickland E, 2000, J BIOL CHEM, V275, P5565, DOI 10.1074/jbc.275.8.5565; Tang G, 2007, J STRUCT BIOL, V157, P38, DOI 10.1016/j.jsb.2006.05.009; Voges D, 1999, ANNU REV BIOCHEM, V68, P1015, DOI 10.1146/annurev.biochem.68.1.1015; Walz J, 1998, J STRUCT BIOL, V121, P19, DOI 10.1006/jsbi.1998.3958; Weber-Ban EU, 1999, NATURE, V401, P90, DOI 10.1038/43481; Whitby FG, 2000, NATURE, V408, P115, DOI 10.1038/35040607; White SR, 2007, TRAFFIC, V8, P1657, DOI 10.1111/j.1600-0854.2007.00642.x; Wolf S, 1998, J MOL BIOL, V277, P13, DOI 10.1006/jmbi.1997.1589; Zwickl P, 1999, J BIOL CHEM, V274, P26008, DOI 10.1074/jbc.274.37.26008; Zwickl P, 2002, ADV PROTEIN CHEM, V59, P187	60	14	14	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 21	2009	284	34					22952	22960		10.1074/jbc.M809643200	http://dx.doi.org/10.1074/jbc.M809643200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	483KG	19363223	Green Published, hybrid			2022-12-27	WOS:000268963100048
J	Bains, J; Leon, R; Boulanger, MJ				Bains, Jasleen; Leon, Rafael; Boulanger, Martin J.			Structural and Biophysical Characterization of BoxC from Burkholderia xenovorans LB400 A NOVEL RING-CLEAVING ENZYME IN THE CROTONASE SUPERFAMILY	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AEROBIC BENZOATE METABOLISM; 1.8 ANGSTROM RESOLUTION; COA CATABOLIC PATHWAY; CRYSTAL-STRUCTURE; COENZYME-A; AZOARCUS-EVANSII; DELTA(3)-DELTA(2)-ENOYL-COA ISOMERASE; RHODOPSEUDOMONAS-PALUSTRIS; AROMATIC-COMPOUNDS; CLEAVAGE ENZYME	The mineralization of aromatic compounds by microorganisms relies on a structurally and functionally diverse group of ring-cleaving enzymes. The recently discovered benzoate oxidation pathway in Burkholderia xenovorans LB400 encodes a novel such ring-cleaving enzyme, termed BoxC, that catalyzes the conversion of 2,3-dihydro-2,3-dihydroxybenzoyl-CoA to 3,4-dehydroadipyl-CoA without the requirement for molecular oxygen. Sequence analysis indicates that BoxC is a highly divergent member of the crotonase superfamily and nearly double the size of the average superfamily member. The structure of BoxC determined to 1.5 angstrom resolution reveals an intriguing structural demarcation. A highly divergent region in the C terminus probably serves as a structural scaffold for the conserved N terminus that encompasses the active site and, in conjunction with a conserved C-terminal helix, mediates dimer formation. Isothermal titration calorimetry and molecular docking simulations contribute to a detailed view of the active site, resulting in a compelling mechanistic model where a pair of conserved glutamate residues (Glu146 and Glu168) work in tandem to deprotonate the dihydroxylated ring substrate, leading to cleavage. A final deformylation step incorporating a water molecule and Cys(111) as a general base completes the formation of 3,4-dehydroadipyl-CoA product. Overall, this study establishes the basis for BoxC as one of the most divergent members of the crotonase superfamily and provides the first structural insight into the mechanism of this novel class of ring-cleaving enzymes.	[Bains, Jasleen; Boulanger, Martin J.] Univ Victoria, Dept Biochem & Microbiol, Victoria, BC V8W 3P6, Canada; [Leon, Rafael] Univ Victoria, Dept Chem, Victoria, BC V8W 3P6, Canada	University of Victoria; University of Victoria	Boulanger, MJ (corresponding author), Univ Victoria, Dept Biochem & Microbiol, POB 3055 STN CSC, Victoria, BC V8W 3P6, Canada.	mboulang@uvic.ca	León, Rafael/A-6997-2012; León, Rafael/AAE-4139-2019	León, Rafael/0000-0003-4017-5756; León, Rafael/0000-0003-4017-5756	Natural Sciences and Engineering Research Council of Canada; University of Victoria	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Victoria	This work was supported by a research grant from the Natural Sciences and Engineering Research Council of Canada (to M. J. B.).; Supported by a University of Victoria graduate award.	Babbitt PC, 1997, J BIOL CHEM, V272, P30591, DOI 10.1074/jbc.272.49.30591; Bains J, 2008, J MOL BIOL, V379, P597, DOI 10.1016/j.jmb.2008.04.031; Bains J, 2008, ACTA CRYSTALLOGR F, V64, P422, DOI 10.1107/S1744309108010919; Bains J, 2007, J MOL BIOL, V373, P965, DOI 10.1016/j.jmb.2007.08.008; Bennett JP, 2007, BIOCHEMISTRY-US, V46, P137, DOI 10.1021/bi061900g; Benning MM, 1996, BIOCHEMISTRY-US, V35, P8103, DOI 10.1021/bi960768p; Benning MM, 2000, BIOCHEMISTRY-US, V39, P4630, DOI 10.1021/bi9928896; Bugg TDH, 2003, TETRAHEDRON, V59, P7075, DOI 10.1016/S0040-4020(03)00944-X; CONNOLLY ML, 1983, SCIENCE, V221, P709, DOI 10.1126/science.6879170; DeLano W.L, PYMOL MOL GRAPHICS S; Denef VJ, 2006, APPL ENVIRON MICROB, V72, P585, DOI 10.1128/AEM.72.1.585-595.2006; Denef VJ, 2005, J BACTERIOL, V187, P7996, DOI 10.1128/JB.187.23.7996-8005.2005; Denef VJ, 2004, APPL ENVIRON MICROB, V70, P4961, DOI 10.1128/AEM.70.8.4961-4970.2004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Engel CK, 1996, EMBO J, V15, P5135, DOI 10.1002/j.1460-2075.1996.tb00897.x; EVANS WC, 1977, NATURE, V270, P17, DOI 10.1038/270017a0; EVANS WC, 1988, ANNU REV MICROBIOL, V42, P289, DOI 10.1146/annurev.mi.42.100188.001445; Frisch M.J., 2009, GAUSSIAN 09 LINUX VE; Gerber PR, 1998, J COMPUT AID MOL DES, V12, P37, DOI 10.1023/A:1007902804814; GERBER PR, 1995, J COMPUT AID MOL DES, V9, P251, DOI 10.1007/BF00124456; Gerlt JA, 2001, ANNU REV BIOCHEM, V70, P209, DOI 10.1146/annurev.biochem.70.1.209; Gescher J, 2006, J BACTERIOL, V188, P2919, DOI 10.1128/JB.188.8.2919-2927.2006; Gescher J, 2005, MOL MICROBIOL, V56, P1586, DOI 10.1111/j.1365-2958.2005.04637.x; Gescher J, 2002, J BACTERIOL, V184, P6301, DOI 10.1128/JB.184.22.6301-6315.2002; Gibson J, 2002, ANNU REV MICROBIOL, V56, P345, DOI 10.1146/annurev.micro.56.012302.160749; Hall PR, 2003, EMBO J, V22, P2334, DOI 10.1093/emboj/cdg244; Hamed RB, 2008, CELL MOL LIFE SCI, V65, P2507, DOI 10.1007/s00018-008-8082-6; HARWOOD CS, 1986, J BACTERIOL, V165, P504, DOI 10.1128/jb.165.2.504-509.1986; Harwood CS, 1996, ANNU REV MICROBIOL, V50, P553, DOI 10.1146/annurev.micro.50.1.553; Kurimoto K, 2001, STRUCTURE, V9, P1253, DOI 10.1016/S0969-2126(01)00686-4; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leonard PM, 2006, ACTA CRYSTALLOGR D, V62, P1494, DOI 10.1107/S0907444906039199; Leonard PM, 2004, J BIOL CHEM, V279, P31312, DOI 10.1074/jbc.M403514200; Modis Y, 1998, STRUCTURE, V6, P957, DOI 10.1016/S0969-2126(98)00098-7; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Mursula AM, 2001, J MOL BIOL, V309, P845, DOI 10.1006/jmbi.2001.4671; Partanen ST, 2004, J MOL BIOL, V342, P1197, DOI 10.1016/j.jmb.2004.07.039; Pelletier DA, 1998, J BACTERIOL, V180, P2330, DOI 10.1128/JB.180.9.2330-2336.1998; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pflugrath JW, 1999, ACTA CRYSTALLOGR D, V55, P1718, DOI 10.1107/S090744499900935X; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sleeman MC, 2005, J BIOL CHEM, V280, P34956, DOI 10.1074/jbc.M507196200; Stanier R Y, 1973, Adv Microb Physiol, V9, P89; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thomsen R, 2006, J MED CHEM, V49, P3315, DOI 10.1021/jm051197e; Truglio JJ, 2003, J BIOL CHEM, V278, P42352, DOI 10.1074/jbc.M307399200; Ulaganathan V, 2007, ACTA CRYSTALLOGR F, V63, P908, DOI 10.1107/S1744309107047720; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Wendt KS, 2003, EMBO J, V22, P3493, DOI 10.1093/emboj/cdg358; Whittingham JL, 2003, J BIOL CHEM, V278, P1744, DOI 10.1074/jbc.M211188200; Widboom PF, 2007, NATURE, V447, P342, DOI 10.1038/nature05702; Zaar A, 2004, MOL MICROBIOL, V54, P223, DOI 10.1111/j.1365-2958.2004.04263.x; Zhang HL, 2003, SCIENCE, V299, P2064, DOI 10.1126/science.1081366	54	10	11	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16377	16385		10.1074/jbc.M900226200	http://dx.doi.org/10.1074/jbc.M900226200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19369256	Green Published, hybrid			2022-12-27	WOS:000266730900035
J	Ortiz, D; Sanchez, MA; Koch, HP; Larsson, HP; Landfear, SM				Ortiz, Diana; Sanchez, Marco A.; Koch, Hans P.; Larsson, H. Peter; Landfear, Scott M.			An Acid-activated Nucleobase Transporter from Leishmania major	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FUNCTIONAL-CHARACTERIZATION; DEFICIENT MUTANT; CLONING; GENE; PH; EXPRESSION; DONOVANI; RESCUE; FAMILY	Parasitic protozoa are unable to synthesize purines de novo and must import preformed purine nucleobases or nucleosides from their hosts. Leishmania major expresses two purine nucleobase transporters, LmaNT3 and LmaNT4. Previous studies revealed that at neutral pH, LmaNT3 is a broad specificity, high affinity nucleobase transporter, whereas LmaNT4 mediates the uptake of only adenine. Because LmaNT4 is required for optimal viability of the amastigote stage of the parasite that lives within acidified phagolysomal vesicles of mammalian macrophages, the function of this permease was examined under acidic pH conditions. At acidic pH, LmaNT4 acquires the ability to transport adenine, hypoxanthine, guanine, and xanthine with Km values in the micromolar range, indicating that this transporter is activated at low pH. Thus, LmaNT4 is an acid-activated purine nucleobase transporter that functions optimally under the physiological conditions the parasite is exposed to in the macrophage phagolysosome. In contrast, LmaNT3 functions optimally at neutral pH. Two-electrode voltage clamp experiments performed on LmaNT3 and LmaNT4 expressed in Xenopus oocytes revealed substrate-induced inward directed currents at acidic pH, and application of substrates induced acidification of the oocyte cytosol. These observations imply that LmaNT3 and LmaNT4 are nucleobase/proton symporters.	[Ortiz, Diana; Sanchez, Marco A.; Landfear, Scott M.] Oregon Hlth & Sci Univ, Dept Mol Microbiol & Immunol, Portland, OR 97239 USA; [Koch, Hans P.; Larsson, H. Peter] Oregon Hlth & Sci Univ, Inst Neurosci, Portland, OR 97239 USA	Oregon Health & Science University; Oregon Health & Science University	Landfear, SM (corresponding author), OR Hlth & Sci Univ, Dept Mol Microbiol & Immunol, 3181 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.	landfear@ohsu.edu		Landfear, Scott/0000-0002-1643-6664	National Institutes of Health [AI44138, NS051169]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044138] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051169] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants AI44138 ( to S. M. L.) and NS051169 ( to H. P. L.).	ANTOINE JC, 1990, INFECT IMMUN, V58, P779, DOI 10.1128/IAI.58.3.779-787.1990; ARRIZA JL, 1993, J BIOL CHEM, V268, P15329; Baldwin SA, 2005, J BIOL CHEM, V280, P15880, DOI 10.1074/jbc.M414337200; Barnes K, 2006, CIRC RES, V99, P510, DOI 10.1161/01.RES.0000238359.18495.42; Carter NS, 2000, J BIOL CHEM, V275, P20935, DOI 10.1074/jbc.M002418200; CARTER NS, 2003, MOL MED PARASITOLOGY, P197; Gontijo NF, 1998, EXP PARASITOL, V90, P212, DOI 10.1006/expr.1998.4336; Herwaldt BL, 1999, LANCET, V354, P1191, DOI 10.1016/S0140-6736(98)10178-2; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; MARTINEZ S, 1992, NEW ENGL J MED, V326, P741, DOI 10.1056/NEJM199203123261105; Motulsky H., 1999, ANAL DATA GRAPHPAD P; Ortiz D, 2007, MOL MICROBIOL, V64, P1228, DOI 10.1111/j.1365-2958.2007.05730.x; Sanchez MA, 2004, MOL MEMBR BIOL, V21, P11, DOI 10.1080/0968768031000140845; Stein A, 2003, J BIOL CHEM, V278, P35127, DOI 10.1074/jbc.M306188200; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; ULLMAN B, 1984, PHARM RES-DORDR, P194, DOI 10.1023/A:1016365128531; Vasudevan G, 1998, P NATL ACAD SCI USA, V95, P9873, DOI 10.1073/pnas.95.17.9873	17	21	21	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16164	16169		10.1074/jbc.M109.006718	http://dx.doi.org/10.1074/jbc.M109.006718			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19366701	hybrid, Green Published			2022-12-27	WOS:000266730900013
J	Hsu, LJ; Schultz, L; Hong, QY; Van Moer, K; Heath, J; Li, MY; Lai, FJ; Lin, SR; Lee, MH; Lo, CP; Lin, YS; Chen, ST; Chang, NS				Hsu, Li-Jin; Schultz, Lori; Hong, Qunying; Van Moer, Kris; Heath, John; Li, Meng-Yen; Lai, Feng-Jie; Lin, Sing-Ru; Lee, Ming-Hui; Lo, Cheng-Peng; Lin, Yee-Shin; Chen, Shur-Tzu; Chang, Nan-Shan			Transforming Growth Factor beta 1 Signaling via Interaction with Cell Surface Hyal-2 and Recruitment of WWOX/WOX1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOMAIN-CONTAINING OXIDOREDUCTASE; WWOX TUMOR-SUPPRESSOR; NECROSIS-FACTOR CYTOTOXICITY; IN-VITRO; TYROSINE-33 PHOSPHORYLATION; NUCLEAR TRANSLOCATION; PHYSICALLY INTERACTS; BCL-2 EXPRESSION; PROSTATE-CANCER; POTENTIAL ROLE	Transforming growth factor beta(TGF-beta) initiates multiple signal pathways and activates many downstream kinases. Here, we determined that TGF-beta 1 bound cell surface hyaluronidase Hyal-2 on microvilli in type II TGF-beta receptor-deficient HCT116 cells, as determined by immunoelectron microscopy. This binding resulted in recruitment of proapoptotic WOX1 ( also named WWOX or FOR) and formation of Hyal-2 center dot WOX1 complexes for relocation to the nuclei. TGF-beta 1 strengthened the binding of the catalytic domain of Hyal-2 with the N-terminal Tyr-33-phosphorylated WW domain of WOX1, as determined by time lapse fluorescence resonance energy transfer analysis in live cells, co-immunoprecipitation, and yeast two-hybrid domain/domain mapping. In promoter activation assay, ectopic WOX1 or Hyal-2 alone increased the promoter activity driven by Smad. In combination, WOX1 and Hyal-2 dramatically enhanced the promoter activation (8-9-fold increases), which subsequently led to cell death (> 95% of promoter-activated cells). TGF-beta 1 supports L929 fibroblast growth. In contrast, transiently overexpressed WOX1 and Hyal-2 sensitized L929 to TGF-beta 1-induced apoptosis. Together, TGF-beta 1 invokes a novel signaling by engaging cell surface Hyal-2 and recruiting WOX1 for regulating the activation of Smad-driven promoter, thereby controlling cell growth and death.	[Lin, Sing-Ru; Lee, Ming-Hui; Chang, Nan-Shan] Natl Cheng Kung Univ, Coll Med, Inst Mol Med, Tainan 70101, Taiwan; [Hsu, Li-Jin; Lin, Yee-Shin] Natl Cheng Kung Univ, Coll Med, Dept Microbiol & Immunol, Tainan 70101, Taiwan; [Hsu, Li-Jin; Lin, Yee-Shin; Chang, Nan-Shan] Natl Cheng Kung Univ, Coll Med, Ctr Gene Regulat & Signal Transduct Res, Tainan 70101, Taiwan; [Li, Meng-Yen; Lo, Cheng-Peng; Chen, Shur-Tzu] Natl Cheng Kung Univ, Coll Med, Dept Cell Biol & Anat, Tainan 70101, Taiwan; [Lai, Feng-Jie] Natl Cheng Kung Univ, Coll Med, Dept Dermatol, Tainan 70101, Taiwan; [Hsu, Li-Jin; Schultz, Lori; Hong, Qunying; Van Moer, Kris; Heath, John; Chang, Nan-Shan] Guthrie Res Inst, Lab Mol Immunol, Sayre, PA 18840 USA; [Chang, Nan-Shan] SUNY Upstate Med Univ, Dept Neurosci & Physiol, Syracuse, NY 13210 USA	National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center	Chang, NS (corresponding author), Natl Cheng Kung Univ, Coll Med, Inst Mol Med, Tainan 70101, Taiwan.	wox1world@gmail.com	Hsu, Li-Jin/G-7822-2011		American Heart Association; Department of Defense [DAMD17-03-1-0736, W81XWH-08-1-0682]; Guthrie Foundation for Education and Research; National Science Council, Taiwan [NSC96-2320-B-006-014, 96-2628-B-006-041-MY3, 96-2628-B-006-045-MY3]; National Health Research Institute, Taiwan [NHRI-EX97-9704BI]; National Cheng Kung University Landmark [C0167, R026]	American Heart Association(American Heart Association); Department of Defense(United States Department of Defense); Guthrie Foundation for Education and Research; National Science Council, Taiwan(Ministry of Science and Technology, Taiwan); National Health Research Institute, Taiwan(National Health Research Institutes - Taiwan); National Cheng Kung University Landmark	This research was supported in part by the American Heart Association, Department of Defense Grants DAMD17-03-1-0736 and W81XWH-08-1-0682, the Guthrie Foundation for Education and Research, the National Science Council, Taiwan Grants NSC96-2320-B-006-014, 96-2628-B-006-041-MY3, and 96-2628-B-006-045-MY3), the National Health Research Institute, Taiwan Grant NHRI-EX97-9704BI), and the National Cheng Kung University Landmark Projects C0167 and R026 ( to N.S.C.).	Aqeilan RI, 2008, J BIOL CHEM, V283, P21629, DOI 10.1074/jbc.M800855200; Aqeilan RI, 2007, J CELL PHYSIOL, V212, P307, DOI 10.1002/jcp.21099; Aqeilan RI, 2007, P NATL ACAD SCI USA, V104, P3949, DOI 10.1073/pnas.0609783104; Aqeilan RI, 2009, ENDOCRINOLOGY, V150, P1530, DOI 10.1210/en.2008-1087; Aqeilan RI, 2005, CANCER RES, V65, P6764, DOI 10.1158/0008-5472.CAN-05-1150; Aqeilan RI, 2004, P NATL ACAD SCI USA, V101, P4401, DOI 10.1073/pnas.0400805101; Aqeilan RI, 2004, CANCER RES, V64, P8256, DOI 10.1158/0008-5472.CAN-04-2055; Aqeilian RI, 2007, CANCER RES, V67, P9330, DOI 10.1158/0008-5472.CAN-07-2147; Atfi A, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.126pe33; Bachman KE, 2005, CURR OPIN ONCOL, V17, P49, DOI 10.1097/01.cco.0000143682.45316.ae; Bednarek AK, 2001, CANCER RES, V61, P8068; Bourguignon LYW, 2002, J BIOL CHEM, V277, P39703, DOI 10.1074/jbc.M204320200; Cattaruzza S, 2005, MATRIX BIOL, V24, P400, DOI 10.1016/j.matbio.2005.06.005; Chang NS, 2007, TRENDS MOL MED, V13, P12, DOI 10.1016/j.molmed.2006.11.006; Chang NS, 1998, INT J MOL MED, V2, P653; Chang NS, 2005, J BIOL CHEM, V280, P43100, DOI 10.1074/jbc.M505590200; Chang NS, 2005, ONCOGENE, V24, P714, DOI 10.1038/sj.onc.1208124; Chang NS, 2003, J BIOL CHEM, V278, P9195, DOI 10.1074/jbc.M208373200; Chang NS, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-8; Chang NS, 2002, J BIOL CHEM, V277, P10323, DOI 10.1074/jbc.M106607200; Chang NS, 2001, J BIOL CHEM, V276, P3361, DOI 10.1074/jbc.M007140200; Chen ST, 2005, NEUROSCIENCE, V130, P397, DOI 10.1016/j.neuroscience.2004.07.054; Chen ST, 2004, NEUROSCIENCE, V124, P831, DOI 10.1016/j.neuroscience.2003.12.036; Chuang JI, 2001, J CHEM NEUROANAT, V21, P215, DOI 10.1016/S0891-0618(01)00109-0; Cordenonsi M, 2003, CELL, V113, P301, DOI 10.1016/S0092-8674(03)00308-8; Driouch K, 2002, ONCOGENE, V21, P1832, DOI 10.1038/sj.onc.1205273; Fabbri M, 2005, P NATL ACAD SCI USA, V102, P15611, DOI 10.1073/pnas.0505485102; Guler G, 2004, CANCER, V100, P1605, DOI 10.1002/cncr.20137; Hong QY, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-50; Hsu LJ, 2008, CELL SIGNAL, V20, P1303, DOI 10.1016/j.cellsig.2008.02.018; Ilsley JL, 2002, CELL SIGNAL, V14, P183, DOI 10.1016/S0898-6568(01)00236-4; Ito T, 2004, AM J PATHOL, V164, P1979, DOI 10.1016/S0002-9440(10)63758-3; Jiang W, 1997, BIOCHEMISTRY-US, V36, P14786, DOI 10.1021/bi9717892; Jin CJ, 2006, BIOCHEM BIOPH RES CO, V341, P784, DOI 10.1016/j.bbrc.2006.01.023; Lai FJ, 2005, CLIN CANCER RES, V11, P5769, DOI 10.1158/1078-0432.CCR-04-2274; Lepperdinger G, 1998, J BIOL CHEM, V273, P22466, DOI 10.1074/jbc.273.35.22466; Lo CP, 2008, EUR J NEUROSCI, V27, P1634, DOI 10.1111/j.1460-9568.2008.06139.x; Lokeshwar VB, 2005, CANCER RES, V65, P7782, DOI 10.1158/0008-5472.CAN-05-1022; Ludes-Meyers JH, 2007, GENE CHROMOSOME CANC, V46, P1129, DOI 10.1002/gcc.20497; Mahajan NP, 2005, CANCER RES, V65, P10514, DOI 10.1158/0008-5472.CAN-05-1127; Muraoka-Cook RS, 2005, CLIN CANCER RES, V11, p937S; Okada T, 2007, TRENDS CELL BIOL, V17, P222, DOI 10.1016/j.tcb.2007.03.006; Pluciennik E, 2006, EJSO-EUR J SURG ONC, V32, P153, DOI 10.1016/j.ejso.2005.11.002; Qin HR, 2007, MOL CANCER RES, V5, P957, DOI 10.1158/1541-7786.MCR-07-0211; Qin HR, 2006, CANCER RES, V66, P6477, DOI 10.1158/0008-5472.CAN-06-0956; Rai SK, 2001, P NATL ACAD SCI USA, V98, P4443, DOI 10.1073/pnas.071572898; Ried K, 2000, HUM MOL GENET, V9, P1651, DOI 10.1093/hmg/9.11.1651; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Schultz L, 2004, DNA CELL BIOL, V23, P67, DOI 10.1089/104454904322745943; Smith DI, 2007, SEMIN CANCER BIOL, V17, P31, DOI 10.1016/j.semcancer.2006.10.003; SUDOL M, 1995, FEBS LETT, V369, P67, DOI 10.1016/0014-5793(95)00550-S; Sze CI, 2004, J BIOL CHEM, V279, P30498, DOI 10.1074/jbc.M401399200; Udabage L, 2005, EXP CELL RES, V310, P205, DOI 10.1016/j.yexcr.2005.07.026; Wang J, 2004, J BIOL CHEM, V279, P40237, DOI 10.1074/jbc.M401665200; Watanabe A, 2003, CANCER RES, V63, P8629	55	61	67	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					16049	16059		10.1074/jbc.M806688200	http://dx.doi.org/10.1074/jbc.M806688200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19366691	Green Published, hybrid			2022-12-27	WOS:000266501000070
J	Nencioni, L; De Chiara, G; Sgarbanti, R; Amatore, D; Aquilano, K; Marcocci, ME; Serafino, A; Torcia, M; Cozzolino, F; Ciriolo, MR; Garaci, E; Palamara, AT				Nencioni, Lucia; De Chiara, Giovanna; Sgarbanti, Rossella; Amatore, Donatella; Aquilano, Katia; Marcocci, Maria E.; Serafino, Annalucia; Torcia, Maria; Cozzolino, Federico; Ciriolo, Maria R.; Garaci, Enrico; Palamara, Anna T.			Bcl-2 Expression and p38MAPK Activity in Cells Infected with Influenza A Virus IMPACT ON VIRALLY INDUCED APOPTOSIS AND VIRAL REPLICATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATED PROTEIN-KINASE; NUCLEAR EXPORT; AVIAN INFLUENZA; P38 MAPK; M1 PROTEIN; PHOSPHORYLATION; NUCLEOPROTEIN; INHIBITION; PATHWAY; DEATH	Previous reports have shown that various steps in the influenza A virus life cycle are impaired in cells expressing the antiapoptotic protein Bcl-2 (Bcl-2(+) cells). We demonstrated a direct link between Bcl-2 and the reduced nuclear export of viral ribonucleoprotein (vRNP) complexes in these cells. However, despite its negative impact on viral replication, Bcl-2 did not prevent host cells from undergoing virally triggered apoptosis. The protein's reduced antiapoptotic capacity was related to phosphorylation of its threonine 56 and serine 87 residues by virally activated p38MAPK. In infected Bcl-2(+) cells, activated p38MAPK was found predominantly in the cytoplasm, colocalized with Bcl-2, and both Bcl-2 phosphorylation and virally induced apoptosis were diminished by specific inhibition of p38MAPK activity. In contrast, in Bcl-2-negative (Bcl-2(-)) cells, which are fully permissive to viral infection, p38MAPK activity was predominantly nuclear, and its inhibition decreased vRNP traffic, phosphorylation of viral nucleoprotein, and virus titers in cell supernatants, suggesting that this kinase also contributes to the regulation of vRNP export and viral replication. This could explain why in Bcl-2(+) cells, where p38MAPK is active in the cytoplasm, phosphorylating Bcl-2, influenza viral replication is substantially reduced, whereas apoptosis proceeds at rates similar to those observed in Bcl-2(+) cells. Our findings suggest that the impact of p38MAPK on the influenza virus life cycle and the apoptotic response of host cells to infection depends on whether or not the cells express Bcl-2, highlighting the possibility that the pathological effects of the virus are partly determined by the cell type it targets.	[Nencioni, Lucia; Sgarbanti, Rossella; Amatore, Donatella; Marcocci, Maria E.; Palamara, Anna T.] Univ Roma La Sapienza, Dept Publ Hlth Sci, I-00185 Rome, Italy; [Palamara, Anna T.] Univ Roma La Sapienza, Ist Pasteur Fdn Cenci Bolognetti, I-00185 Rome, Italy; [De Chiara, Giovanna] Ist Super Sanita, Dept Cell Biol & Neurosci, I-00161 Rome, Italy; [Aquilano, Katia; Ciriolo, Maria R.] Univ Roma Tor Vergata, Dept Biol, I-00133 Rome, Italy; [Garaci, Enrico] Univ Roma Tor Vergata, Dept Expt Med & Biochem Sci, I-00133 Rome, Italy; [Serafino, Annalucia] CNR, Inst Neurobiol & Mol Med, I-00133 Rome, Italy; [Torcia, Maria; Cozzolino, Federico] Univ Florence, Dept Clin Physiopathol, I-50139 Florence, Italy; [Ciriolo, Maria R.; Palamara, Anna T.] Hosp & Hlth Care S Raffaele, Sci Inst Res, I-00100 Rome, Italy	Sapienza University Rome; Fondazione Cenci Bolognetti; Sapienza University Rome; Istituto Superiore di Sanita (ISS); University of Rome Tor Vergata; University of Rome Tor Vergata; Consiglio Nazionale delle Ricerche (CNR); University of Florence; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	Palamara, AT (corresponding author), Univ Roma La Sapienza, Dept Publ Hlth Sci, P le Aldo Moro 5, I-00185 Rome, Italy.	annateresa.palamara@uniroma1.it	Ciriolo, Maria Rosa/K-6572-2016; Serafino, Annalucia/AAC-1719-2019; Torcia, Maria Gabriella G/K-1840-2018; Elena, Marcocci Maria/I-9550-2014; AQUILANO, KATIA/K-8888-2016; Nencioni, Lucia/K-5988-2016; De Chiara, Giovanna/AAJ-7843-2021; GARACI, ENRICO/AAB-3349-2021; Sgarbanti, Rossella/D-8797-2011	Serafino, Annalucia/0000-0002-1142-4752; Torcia, Maria Gabriella G/0000-0003-4740-4646; Elena, Marcocci Maria/0000-0003-4751-4263; AQUILANO, KATIA/0000-0002-5905-9870; Nencioni, Lucia/0000-0003-4427-4823; De Chiara, Giovanna/0000-0002-2219-6097; AMATORE, DONATELLA/0000-0001-5701-9683; Ciriolo, Maria Rosa/0000-0002-7863-9029; Sgarbanti, Rossella/0000-0002-8028-0027; PALAMARA, ANNA TERESA/0000-0001-8330-4381; Cozzolino, Federico/0000-0002-2800-640X	Italian Ministry of Instruction, University and Research Special Project [FIRB RBIP067F9E, Reti FIRB RBPR05NWWC_006]; Progetto Ateneo	Italian Ministry of Instruction, University and Research Special Project; Progetto Ateneo	This work was supported in part by Italian Ministry of Instruction, University and Research Special Project "Fund for Investments on Basic Research" Grants FIRB RBIP067F9E and Reti FIRB RBPR05NWWC_006) and a grant from Progetto Ateneo.	Akarsu H, 2003, EMBO J, V22, P4646, DOI 10.1093/emboj/cdg449; Aquilano K, 2006, FASEB J, V20, P1683, DOI 10.1096/fj.05-5225fje; Blagosklonny MV, 2001, LEUKEMIA, V15, P869, DOI 10.1038/sj.leu.2402134; Boulo S, 2007, VIRUS RES, V124, P12, DOI 10.1016/j.virusres.2006.09.013; Bui M, 2000, J VIROL, V74, P1781, DOI 10.1128/JVI.74.4.1781-1786.2000; Bui M, 2002, VIRUS RES, V84, P37, DOI 10.1016/S0168-1702(01)00413-0; Bullido R, 2000, J GEN VIROL, V81, P135, DOI 10.1099/0022-1317-81-1-135; Cros JF, 2003, VIRUS RES, V95, P3, DOI 10.1016/S0168-1702(03)00159-X; De Chiara G, 2006, J BIOL CHEM, V281, P21353, DOI 10.1074/jbc.M511052200; DeSilva DR, 1998, J IMMUNOL, V160, P4175; Elton D, 2001, J VIROL, V75, P408, DOI 10.1128/JVI.75.1.408-419.2001; FIELDS BN, 2007, VIROLOGY, V2, P1647; Fremont L, 2000, LIFE SCI, V66, P663, DOI 10.1016/S0024-3205(99)00410-5; Galluzzi L, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000018; GARLAND LG, 1987, TRENDS PHARMACOL SCI, V8, P334, DOI 10.1016/0165-6147(87)90138-6; GAUSH CR, 1968, APPL MICROBIOL, V16, P588, DOI 10.1128/AEM.16.4.588-594.1968; GOMPEL A, 1994, AM J PATHOL, V144, P1195; HALDAR S, 1995, P NATL ACAD SCI USA, V92, P4507, DOI 10.1073/pnas.92.10.4507; Harris JF, 2005, AM J RESP CRIT CARE, V171, P764, DOI 10.1164/rccm.200408-1108OC; HINSHAW VS, 1994, J VIROL, V68, P3667, DOI 10.1128/JVI.68.6.3667-3673.1994; Hirayama E, 2004, J VIROL, V78, P1263, DOI 10.1128/JVI.78.3.1263-1270.2004; HOCKENBERY DM, 1991, P NATL ACAD SCI USA, V88, P6961, DOI 10.1073/pnas.88.16.6961; KISTNER O, 1989, J GEN VIROL, V70, P2421, DOI 10.1099/0022-1317-70-9-2421; Kristensson K, 2006, BRAIN RES BULL, V68, P406, DOI 10.1016/j.brainresbull.2005.11.022; Kujime K, 2000, J IMMUNOL, V164, P3222, DOI 10.4049/jimmunol.164.6.3222; Lee DCW, 2005, J VIROL, V79, P10147, DOI 10.1128/JVI.79.16.10147-10154.2005; Lee JC, 1999, PHARMACOL THERAPEUT, V82, P389, DOI 10.1016/S0163-7258(99)00008-X; LEVINE B, 1993, NATURE, V361, P739, DOI 10.1038/361739a0; Ludwig S, 2006, CELL MICROBIOL, V8, P375, DOI 10.1111/j.1462-5822.2005.00678.x; Ludwig S, 2003, TRENDS MOL MED, V9, P46, DOI 10.1016/S1471-4914(02)00010-2; MAHY BWJ, 1991, VIROLOGY PRACTICAL A, P119; Maines TR, 2005, J VIROL, V79, P11788, DOI 10.1128/JVI.79.18.11788-11800.2005; Maruoka S, 2003, BIOCHEM BIOPH RES CO, V307, P870, DOI 10.1016/S0006-291X(03)01283-X; Nencioni L, 2003, FASEB J, V17, P758, DOI 10.1096/fj.02-0508fje; Neumann G, 1997, J VIROL, V71, P9690, DOI 10.1128/JVI.71.12.9690-9700.1997; Neumann G, 2000, EMBO J, V19, P6751, DOI 10.1093/emboj/19.24.6751; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; O'Neill RE, 1998, EMBO J, V17, P288, DOI 10.1093/emboj/17.1.288; Olsen CW, 1996, J VIROL, V70, P663, DOI 10.1128/JVI.70.1.663-666.1996; Palamara AT, 2005, J INFECT DIS, V191, P1719, DOI 10.1086/429694; Pica F, 2000, ANTIMICROB AGENTS CH, V44, P200, DOI 10.1128/AAC.44.1.200-204.2000; Pleschka S, 2001, NAT CELL BIOL, V3, P301, DOI 10.1038/35060098; Portela A, 2002, J GEN VIROL, V83, P723, DOI 10.1099/0022-1317-83-4-723; REED JC, 1994, J CELL BIOL, V124, P1, DOI 10.1083/jcb.124.1.1; Rosini P, 2000, BIOCHEM BIOPH RES CO, V278, P753, DOI 10.1006/bbrc.2000.3871; Shin YK, 2007, J VIROL, V81, P12730, DOI 10.1128/JVI.01427-07; Tanaka H, 2003, VET MICROBIOL, V95, P1, DOI 10.1016/S0378-1135(03)00132-9; Tesfaigzi J, 1998, AM J RESP CELL MOL, V18, P794, DOI 10.1165/ajrcmb.18.6.3036; Tibbles LA, 1999, CELL MOL LIFE SCI, V55, P1230, DOI 10.1007/s000180050369; Torcia M, 2001, J BIOL CHEM, V276, P39027, DOI 10.1074/jbc.M102970200; Uchide N, 2007, INTERVIROLOGY, V50, P99, DOI 10.1159/000097396; Whittaker GR, 1998, VIROLOGY, V246, P1, DOI 10.1006/viro.1998.9165; Wurzer WJ, 2003, EMBO J, V22, P2717, DOI 10.1093/emboj/cdg279; Zachos G, 2001, J VIROL, V75, P2710, DOI 10.1128/JVI.75.6.2710-2728.2001	54	74	77	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					16004	16015		10.1074/jbc.M900146200	http://dx.doi.org/10.1074/jbc.M900146200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19336399	hybrid, Green Published			2022-12-27	WOS:000266501000066
J	Maeda, A; Maeda, T; Golczak, M; Chou, S; Desai, A; Hoppel, CL; Matsuyama, S; Palczewski, K				Maeda, Akiko; Maeda, Tadao; Golczak, Marcin; Chou, Steven; Desai, Amar; Hoppel, Charles L.; Matsuyama, Shigemi; Palczewski, Krzysztof			Involvement of All-trans-retinal in Acute Light-induced Retinopathy of Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTORECEPTOR OUTER SEGMENTS; LIPOFUSCIN FLUOROPHORE; INDUCED DEGENERATION; OXIDATIVE STRESS; EPITHELIAL-CELLS; INDUCED DAMAGE; VISUAL CYCLE; GENE ABCR; A2E; DEHYDROGENASE	Exposure to bright light can cause visual dysfunction and retinal photoreceptor damage in humans and experimental animals, but the mechanism(s) remain unclear. We investigated whether the retinoid cycle (i.e. the series of biochemical reactions required for vision through continuous generation of 11-cis-retinal and clearance of all-trans-retinal, respectively) might be involved. Previously, we reported that mice lacking two enzymes responsible for clearing all-trans-retinal, namely photoreceptor-specific ABCA4 (ATP-binding cassette transporter 4) and RDH8 (retinol dehydrogenase 8), manifested retinal abnormalities exacerbated by light and associated with accumulation of diretinoid-pyridinium-ethanolamine (A2E), a condensation product of all-trans-retinal and a surrogate marker for toxic retinoids. Now we show that these mice develop an acute, light-induced retinopathy. However, cross-breeding these animals with lecithin: retinol acyltransferase knock-out mice lacking retinoids within the eye produced progeny that did not exhibit such light-induced retinopathy until gavaged with the artificial chromophore, 9-cis-retinal. No significant ocular accumulation of A2E occurred under these conditions. These results indicate that this acute light-induced retinopathy requires the presence of free all-trans-retinal and not, as generally believed, A2E or other retinoid condensation products. Evidence is presented that the mechanism of toxicity may include plasma membrane permeability and mitochondrial poisoning that lead to caspase activation and mitochondria-associated cell death. These findings further understanding of the mechanisms involved in light-induced retinal degeneration.	[Palczewski, Krzysztof] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA; [Maeda, Tadao] Case Western Reserve Univ, Dept Ophthalmol, Cleveland, OH 44106 USA; [Hoppel, Charles L.; Matsuyama, Shigemi] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Chou, Steven; Matsuyama, Shigemi] Case Western Reserve Univ, Case Comprehens Canc Ctr, Cleveland, OH 44106 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University	Palczewski, K (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	kxp65@case.edu			Case Western Reserve University); NATIONAL EYE INSTITUTE [R01EY009339, R01EY008123, K08EY019031, P30EY011373] Funding Source: NIH RePORTER	Case Western Reserve University); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank Dr. J. Lem for Gnat1<SUP>-/-</SUP> mice; Drs. L. T. Webster and J. von Lintig (Case Western Reserve University) for comments on the manuscript; and Drs. K. Lodowski, S. Shiose, S. Howell, S. Roos, M. Matosky, M. Singer, and H. Matsuyama (Case Western Reserve University) for technical support and advice about some of the procedures employed.	Allikmets R, 1997, NAT GENET, V15, P236, DOI 10.1038/ng0397-236; Allikmets R, 2000, AM J HUM GENET, V67, P487, DOI 10.1086/303018; Allikmets R, 1997, SCIENCE, V277, P1805, DOI 10.1126/science.277.5333.1805; Baehr W, 2003, VISION RES, V43, P2957, DOI 10.1016/j.visres.2003.10.001; Batten ML, 2005, PLOS MED, V2, P1177, DOI 10.1371/journal.pmed.0020333; Batten ML, 2004, J BIOL CHEM, V279, P10422, DOI 10.1074/jbc.M312410200; Ben-Shabat S, 2002, ANGEW CHEM INT EDIT, V41, P814, DOI 10.1002/1521-3773(20020301)41:5<814::AID-ANIE814>3.0.CO;2-2; Ben-Shabat S, 2002, J BIOL CHEM, V277, P7183, DOI 10.1074/jbc.M108981200; Deveraux QL, 1997, NATURE, V388, P300, DOI 10.1038/40901; Estabrook R. W., 1967, METHODS ENZYMOLOGY, V10, P41, DOI DOI 10.1016/0076-6879(67)10010-4; Fan J, 2005, J PHYSIOL-LONDON, V568, P83, DOI 10.1113/jphysiol.2005.091942; Finnemann SC, 2002, P NATL ACAD SCI USA, V99, P3842, DOI 10.1073/pnas.052025899; Fishkin NE, 2005, P NATL ACAD SCI USA, V102, P7091, DOI 10.1073/pnas.0501266102; Fukui H, 2008, TRENDS NEUROSCI, V31, P251, DOI 10.1016/j.tins.2008.02.008; Golczak M, 2005, J BIOL CHEM, V280, P42263, DOI 10.1074/jbc.M509351200; Golczak M, 2005, P NATL ACAD SCI USA, V102, P8162, DOI 10.1073/pnas.0503318102; Gomez JA, 2007, BIOCHEM SOC T, V35, P797, DOI 10.1042/BST0350797; Hao WS, 2002, NAT GENET, V32, P254, DOI 10.1038/ng984; HOFMANN KP, 1992, J BIOL CHEM, V267, P15701; Holownia A, 1999, BRAIN RES, V833, P202, DOI 10.1016/S0006-8993(99)01529-2; HOPPEL CL, 1972, J BIOL CHEM, V247, P832; Jager S, 1996, BIOCHEMISTRY-US, V35, P2901, DOI 10.1021/bi9524068; Kim SR, 2007, P NATL ACAD SCI USA, V104, P19273, DOI 10.1073/pnas.0708714104; Kim SR, 2007, BIOCHEMISTRY-US, V46, P10122, DOI 10.1021/bi7009635; Kim SR, 2008, EXP EYE RES, V86, P975, DOI 10.1016/j.exer.2008.03.016; Kim SR, 2006, EXP EYE RES, V82, P828, DOI 10.1016/j.exer.2005.10.004; Kruman II, 1999, J NEUROCHEM, V72, P529, DOI 10.1046/j.1471-4159.1999.0720529.x; Li Y, 2007, CELL DEATH DIFFER, V14, P2058, DOI 10.1038/sj.cdd.4402219; Maeda A, 2005, J BIOL CHEM, V280, P18822, DOI 10.1074/jbc.M501757200; Maeda A, 2008, J BIOL CHEM, V283, P26684, DOI 10.1074/jbc.M804505200; Maeda A, 2007, P NATL ACAD SCI USA, V104, P19565, DOI 10.1073/pnas.0707477104; Maeda A, 2006, J BIOL CHEM, V281, P37697, DOI 10.1074/jbc.M608375200; Maeda T, 2005, INVEST OPHTH VIS SCI, V46, P4320, DOI 10.1167/iovs.05-0478; Mata NL, 2000, P NATL ACAD SCI USA, V97, P7154, DOI 10.1073/pnas.130110497; McBee JK, 2001, PROG RETIN EYE RES, V20, P469, DOI 10.1016/S1350-9462(01)00002-7; Molday RS, 2007, J BIOENERG BIOMEMBR, V39, P507, DOI 10.1007/s10863-007-9118-6; Nickell S, 2007, J CELL BIOL, V177, P917, DOI 10.1083/jcb.200612010; PALCZEWSKI K, 1994, BIOCHEMISTRY-US, V33, P13741, DOI 10.1021/bi00250a027; Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743; PALMER JW, 1977, J BIOL CHEM, V252, P8731; Rattner A, 2000, J BIOL CHEM, V275, P11034, DOI 10.1074/jbc.275.15.11034; Rohrer B, 2005, INVEST OPHTH VIS SCI, V46, P3876, DOI 10.1167/iovs.05-0533; Siems W, 2002, FASEB J, V16, P1289, DOI 10.1096/fj.01-0765fje; Sparrow JR, 1999, INVEST OPHTH VIS SCI, V40, P2988; Sparrow JR, 2002, INVEST OPHTH VIS SCI, V43, P1222; Sparrow JR, 2000, INVEST OPHTH VIS SCI, V41, P1981; Tawa P, 2001, CELL DEATH DIFFER, V8, P30, DOI 10.1038/sj.cdd.4400769; Thompson DA, 2003, PROG RETIN EYE RES, V22, P683, DOI 10.1016/S1350-9462(03)00051-X; Travis GH, 2007, ANNU REV PHARMACOL, V47, P469, DOI 10.1146/annurev.pharmtox.47.120505.105225; Verdegem PJE, 1997, TETRAHEDRON LETT, V38, P5355, DOI 10.1016/S0040-4039(97)01171-4; Weil M, 1996, J CELL BIOL, V133, P1053, DOI 10.1083/jcb.133.5.1053; Weng J, 1999, CELL, V98, P13, DOI 10.1016/S0092-8674(00)80602-9; Wenzel A, 2001, J NEUROSCI, V21, P53, DOI 10.1523/JNEUROSCI.21-01-00053.2001; Yannuzzi LA, 2004, AM J OPHTHALMOL, V137, P511, DOI 10.1016/j.ajo.2003.12.035; Zhang HB, 2008, J NEUROSCI, V28, P4008, DOI 10.1523/JNEUROSCI.0317-08.2008; Zhou JL, 2006, P NATL ACAD SCI USA, V103, P16182, DOI 10.1073/pnas.0604255103	56	177	189	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					15173	15183		10.1074/jbc.M900322200	http://dx.doi.org/10.1074/jbc.M900322200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19304658	Green Published, hybrid			2022-12-27	WOS:000266288200052
J	Makarava, N; Ostapchenko, VG; Savtchenko, R; Baskakov, IV				Makarava, Natallia; Ostapchenko, Valeriy G.; Savtchenko, Regina; Baskakov, Ilia V.			Conformational Switching within Individual Amyloid Fibrils	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO CONVERSION; PRION PROTEIN; PHYSICAL-PROPERTIES; STRAIN; PRPSC	A key structural component of amyloid fibrils is a highly ordered, crystalline-like cross-beta-sheet core. Conformationally different amyloid structures can be formed within the same amino acid sequence. It is generally assumed that individual fibrils consist of conformationally uniform cross-beta-structures. Using mammalian recombinant prion protein (PrP), we showed that, contrary to common perception, amyloid is capable of accommodating a significant conformational switching within individual fibrils. The conformational switch occurred when the amino acid sequence of a PrP variant used as a precursor substrate in a fibrillation reaction was not compatible with the strain-specific conformation of the fibrillar template. Despite the mismatch in amino acid sequences between the substrate and template, individual fibrils recruited the heterologous PrP variant; however, the fibril elongation proceeded through a conformational adaptation, resulting in a change in amyloid strain within individual fibrils. This study illustrates the high adaptation potential of amyloid structures and suggests that conformational switching within individual fibrils may account for adaptation of amyloid strains to a heterologous substrate. This work proposes a new mechanistic explanation for the phenomenon of strain conversion and illustrates the direction in evolution of amyloid structures. This study also provides a direct illustration that catalytic activity of self-replicating amyloid structures is not ultimately coupled with their templating effect.	[Makarava, Natallia; Ostapchenko, Valeriy G.; Savtchenko, Regina; Baskakov, Ilia V.] Univ Maryland, Ctr Med Biotechnol, Inst Biotechnol, Baltimore, MD 21201 USA; [Baskakov, Ilia V.] Univ Maryland, Dept Biochem & Mol Biol, Baltimore, MD 21201 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore	Baskakov, IV (corresponding author), Univ Maryland, Ctr Med Biotechnol, Inst Biotechnol, 725 W Lombard St, Baltimore, MD 21201 USA.	Baskakov@umbi.umd.edu		Ostapchenko, Valeriy/0000-0002-3629-7702	National Institutes of Health [NS045585]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS045585] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant NS045585 (to I. V. B.).	Baskakov IV, 2007, BBA-MOL BASIS DIS, V1772, P692, DOI 10.1016/j.bbadis.2006.07.007; Bocharova OV, 2005, BIOCHEMISTRY-US, V44, P6776, DOI 10.1021/bi050251q; Bocharova OV, 2005, PROTEIN SCI, V14, P1222, DOI 10.1110/ps.041186605; Bocharova OV, 2005, J MOL BIOL, V346, P645, DOI 10.1016/j.jmb.2004.11.068; Breydo L, 2005, BIOCHEMISTRY-US, V44, P15534, DOI 10.1021/bi051369+; BRUCE ME, 1987, J GEN VIROL, V68, P79, DOI 10.1099/0022-1317-68-1-79; Capobianco R, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030031; Castilla J, 2008, CELL, V134, P757, DOI 10.1016/j.cell.2008.07.030; Chien P, 2004, ANNU REV BIOCHEM, V73, P617, DOI 10.1146/annurev.biochem.72.121801.161837; Derkatch IL, 2004, P NATL ACAD SCI USA, V101, P12934, DOI 10.1073/pnas.0404968101; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; Diaz-Avalos R, 2003, J MOL BIOL, V330, P1165, DOI 10.1016/S0022-2836(03)00659-4; Dobson CM, 1999, TRENDS BIOCHEM SCI, V24, P329, DOI 10.1016/S0968-0004(99)01445-0; Makarava N, 2008, J BIOL CHEM, V283, P15988, DOI 10.1074/jbc.M800562200; Makarava N, 2007, J BIOL CHEM, V282, P36704, DOI 10.1074/jbc.M704926200; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Novitskaya V, 2006, J BIOL CHEM, V281, P15536, DOI 10.1074/jbc.M601349200; O'Nuallain B, 2004, J BIOL CHEM, V279, P17490, DOI 10.1074/jbc.M311300200; Ostapchenko VG, 2008, J MOL BIOL, V383, P1210, DOI 10.1016/j.jmb.2008.08.073; Peretz D, 2002, NEURON, V34, P921, DOI 10.1016/S0896-6273(02)00726-2; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; Tanaka M, 2004, NATURE, V428, P323, DOI 10.1038/nature02392; Tycko R, 2006, Q REV BIOPHYS, V39, P1, DOI 10.1017/S0033583506004173; Yan JM, 2007, AM J PATHOL, V171, P172, DOI 10.2353/ajpath.2007.060576	24	51	51	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14386	14395		10.1074/jbc.M900533200	http://dx.doi.org/10.1074/jbc.M900533200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19329794	hybrid, Green Published			2022-12-27	WOS:000266286100045
J	Li, XJ; Ranjith-Kumar, CT; Brooks, MT; Dharmaiah, S; Herr, AB; Kao, C; Li, PW				Li, Xiaojun; Ranjith-Kumar, C. T.; Brooks, Monica T.; Dharmaiah, S.; Herr, Andrew B.; Kao, Cheng; Li, Pingwei			The RIG-I-like Receptor LGP2 Recognizes the Termini of Double-stranded RNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANTIVIRAL INNATE IMMUNITY; TOLL-LIKE-RECEPTORS; INDUCIBLE GENE-I; STRUCTURAL BASIS; HELICASE LGP2; RESPONSES; ACID; MECHANISM; VIRUSES; DOMAIN	The RIG-I-like receptors (RLRs), RIG-I and MDA5, recognize single-stranded RNA with 5' triphosphates and double-stranded RNA (dsRNA) to initiate innate antiviral immune responses. LGP2, a homolog of RIG-I and MDA5 that lacks signaling capability, regulates the signaling of the RLRs. To establish the structural basis of dsRNA recognition by the RLRs, we have determined the 2.0-A resolution crystal structure of human LGP2 C-terminal domain bound to an 8-bp dsRNA. Two LGP2 C-terminal domain molecules bind to the termini of dsRNA with minimal contacts between the protein molecules. Gel filtration chromatography and analytical ultracentrifugation demonstrated that LGP2 binds blunt-ended dsRNA of different lengths, forming complexes with 2: 1 stoichiometry. dsRNA with protruding termini bind LGP2 and RIG-I weakly and do not stimulate the activation of RIG-I efficiently in cells. Surprisingly, full-length LGP2 containing mutations that abolish dsRNA binding retained the ability to inhibit RIG-I signaling.	[Li, Xiaojun; Li, Pingwei] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Ranjith-Kumar, C. T.; Dharmaiah, S.; Kao, Cheng] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Ranjith-Kumar, C. T.; Dharmaiah, S.; Kao, Cheng] Indiana Univ, Multidisciplinary Biochem Program, Bloomington, IN 47405 USA; [Brooks, Monica T.; Herr, Andrew B.] Univ Cincinnati, Coll Med, Dept Mol Genet Biochem & Microbiol, Cincinnati, OH 45267 USA	Texas A&M University System; Texas A&M University College Station; Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; University System of Ohio; University of Cincinnati	Li, PW (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	pingwei@tamu.edu	Dharmaiah, Srisathiyanarayanan/B-2887-2009; Li, Xiaojun/J-4460-2012; Herr, Andrew/R-3049-2019; Kumar CT, Ranjith/J-5701-2016	Li, Xiaojun/0000-0001-8528-8258; Herr, Andrew/0000-0002-3598-3399; Dharmaiah, Srisathiyanarayanan/0000-0001-7630-3962	National Institutes of Health [1RO1AI073335]; Robert Welch Foundation [A-1687]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073335] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant 1RO1AI073335 ( to C. K.). This work was also supported by Robert Welch Foundation Grant A-1687 ( to P. L.).	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Jones TA, 1997, METHOD ENZYMOL, V277, P173, DOI 10.1016/S0076-6879(97)77012-5; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Komuro A, 2006, J VIROL, V80, P12332, DOI 10.1128/JVI.01325-06; Komuro A, 2008, CYTOKINE, V43, P350, DOI 10.1016/j.cyto.2008.07.011; LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648; Li PW, 2007, NAT STRUCT MOL BIOL, V14, P381, DOI 10.1038/nsmb1234; Liu L, 2008, SCIENCE, V320, P379, DOI 10.1126/science.1155406; Malathi K, 2007, NATURE, V448, P816, DOI 10.1038/nature06042; Marques JT, 2006, NAT BIOTECHNOL, V24, P559, DOI 10.1038/nbt1205; Murali A, 2008, J BIOL CHEM, V283, P15825, DOI 10.1074/jbc.M800542200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pippig DA, 2009, NUCLEIC ACIDS RES, V37, P2014, DOI 10.1093/nar/gkp059; Ranjith-Kumar CT, 2009, J BIOL CHEM, V284, P1155, DOI 10.1074/jbc.M806219200; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; Takeuchi O, 2008, CURR OPIN IMMUNOL, V20, P17, DOI 10.1016/j.coi.2008.01.002; Thompson AJ, 2007, IMMUNOL CELL BIOL, V85, P435, DOI 10.1038/sj.icb.7100100; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2008, IMMUNITY, V29, P178, DOI 10.1016/j.immuni.2008.07.009; Yoneyama M, 2007, J BIOL CHEM, V282, P15315, DOI 10.1074/jbc.R700007200	34	108	118	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13881	13891		10.1074/jbc.M900818200	http://dx.doi.org/10.1074/jbc.M900818200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19278996	Green Published, hybrid			2022-12-27	WOS:000265877300064
J	Stubs, G; Fingerle, V; Wilske, B; Gobel, UB; Zahringer, U; Schumann, RR; Schroder, NWJ				Stuebs, Gunthard; Fingerle, Volker; Wilske, Bettina; Goebel, Ulf B.; Zaehringer, Ulrich; Schumann, Ralf R.; Schroeder, Nicolas W. J.			Acylated Cholesteryl Galactosides Are Specific Antigens of Borrelia Causing Lyme Disease and Frequently Induce Antibodies in Late Stages of Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BURGDORFERI; HELICOBACTER; GLYCOLIPIDS; LIPOPROTEIN; SPIROCHETE; GLUCOSIDE; TREPONEMA; VACCINE; EUROPE; CELLS	Borrelia burgdorferi sensu lato is the causative agent of Lyme disease (LD), an infectious disease occurring in North America, Europe, and Asia in different clinical stages. B. burgdorferi sensu lato encompasses at least 12 species, with B. burgdorferi sensu stricto, B. garinii, and B. afzelii being of highest clinical importance. Immunologic testing for LD as well as recent vaccination strategies exclusively refer to proteinaceous antigens. However, B. burgdorferi sensu stricto exhibits glycolipid antigens, including 6-O-acylated cholesteryl beta-D-galactopyranoside (ACGal), and first the data indicated that this compound may act as an immunogen. Here we investigated whether B. garinii and B. afzelii also possess this antigen, and whether antibodies directed against these compounds are abundant among patients suffering from different stages of LD. Gas-liquid chromatography/mass spectroscopy and NMR spectroscopy showed that both B. garinii and B. afzelii exhibit ACGal in high quantities. In contrast, B. hermsii causing relapsing fever features 6-O-acylated cholesteryl beta-D-glucopyranoside (ACGlc). Sera derived from patients diagnosed for LD contained antibodies against ACGal, with 80% of patients suffering from late stage disease exhibiting this feature. Antibodies reacted with ACGal from all three B. burgdorferi species tested, but not with ACGlc from B. hermsii. These data show that ACGal is present in all clinically important B. burgdorferi species, and that specific antibodies against this compound are frequently found during LD. ACGal may thus be an interesting tool for improving diagnostics as well as for novel vaccination strategies.	[Schroeder, Nicolas W. J.] Charite Med Ctr, Inst Neuropathol, D-10117 Berlin, Germany; [Stuebs, Gunthard; Goebel, Ulf B.; Schumann, Ralf R.] Charite Med Ctr, Inst Microbiol & Hyg, D-10117 Berlin, Germany; [Fingerle, Volker] Bavarian Hlth & Food Safety Author, D-85764 Oberschleissheim, Germany; [Wilske, Bettina] Univ Munich, Max von Pettenkofer Inst Med Microbiol & Hyg, D-80336 Munich, Germany; [Zaehringer, Ulrich] Res Ctr Borstel, Div Immunochem, D-23845 Borstel, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Bavarian Health & Food Safety Authority; University of Munich; Forschungszentrum Borstel	Schroder, NWJ (corresponding author), Charite Med Ctr, Inst Neuropathol, D-10117 Berlin, Germany.	nicolas.schroeder@charite.de		Fingerle, Volker/0000-0002-3835-5646				Bacon R. M., 2007, Morbidity and Mortality Weekly Report, V56, P573; BELISLE JT, 1994, J BACTERIOL, V176, P2151, DOI 10.1128/JB.176.8.2151-2157.1994; Ben-Menachem G, 2003, P NATL ACAD SCI USA, V100, P7913, DOI 10.1073/pnas.1232451100; BURGDORFER W, 1982, SCIENCE, V216, P1317, DOI 10.1126/science.7043737; Dennis David T., 2002, P251, DOI 10.1079/9780851996325.0251; Fingerle V, 2008, INT J MED MICROBIOL, V298, P279, DOI 10.1016/j.ijmm.2007.05.002; Fraser CM, 1997, NATURE, V390, P580, DOI 10.1038/37551; Goettner G, 2005, J CLIN MICROBIOL, V43, P3602, DOI 10.1128/JCM.43.8.3602-3609.2005; Gross DM, 1998, SCIENCE, V281, P703, DOI 10.1126/science.281.5377.703; Haque M, 1996, J BACTERIOL, V178, P2065, DOI 10.1128/jb.178.7.2065-2070.1996; Hauser U, 1998, J CLIN MICROBIOL, V36, P427, DOI 10.1128/JCM.36.2.427-436.1998; HIRAI Y, 1995, J BACTERIOL, V177, P5327, DOI 10.1128/jb.177.18.5327-5333.1995; HONARVAR N, 1994, IMMUNOLOGY, V82, P389; Hossain H, 2001, BIOCHIMIE, V83, P683, DOI 10.1016/S0300-9084(01)01296-2; Hubalek Z, 1997, EUR J EPIDEMIOL, V13, P951, DOI 10.1023/A:1007426304900; Huppertz HI, 1999, EUR J CLIN MICROBIOL, V18, P697, DOI 10.1007/s100960050381; Kinjo Y, 2006, NAT IMMUNOL, V7, P978, DOI 10.1038/ni1380; LIVERMORE BP, 1978, INFECT IMMUN, V20, P215, DOI 10.1128/IAI.20.1.215-220.1978; LIVERMORE BP, 1974, J BACTERIOL, V120, P1268, DOI 10.1128/JB.120.3.1268-1273.1974; Nigrovic LE, 2007, EPIDEMIOL INFECT, V135, P1, DOI 10.1017/S0950268806007096; Ostberg Y, 2007, FEMS MICROBIOL LETT, V272, P22, DOI 10.1111/j.1574-6968.2007.00728.x; RADOLF JD, 1995, INFECT IMMUN, V63, P2154, DOI 10.1128/IAI.63.6.2154-2163.1995; Reed KD, 2002, J CLIN MICROBIOL, V40, P319, DOI 10.1128/JCM.40.2.319-324.2002; Rottem S, 2002, BIOCHEM BIOPH RES CO, V292, P1289, DOI 10.1006/bbrc.2001.2023; Schroder NWJ, 2003, J BIOL CHEM, V278, P15587, DOI 10.1074/jbc.M212829200; SMITH PF, 1971, J BACTERIOL, V108, P986, DOI 10.1128/JB.108.3.986-991.1971; Smith RP, 2002, ANN INTERN MED, V136, P421, DOI 10.7326/0003-4819-136-6-200203190-00005; Stanek G, 2003, LANCET, V362, P1639, DOI 10.1016/S0140-6736(03)14798-8; Steere AC, 2004, J CLIN INVEST, V113, P1093, DOI [10.1172/JCI200421681, 10.1172/JCI21681]; Steere AC, 2003, NEW ENGL J MED, V348, P2472, DOI 10.1056/NEJM200306123482423; Steere AC, 1998, NEW ENGL J MED, V339, P209, DOI 10.1056/NEJM199807233390401; STEERE AC, 1987, ANN INTERN MED, V107, P725, DOI 10.7326/0003-4819-107-5-725; STEIM JM, 1967, BIOCHIM BIOPHYS ACTA, V144, P118, DOI 10.1016/0005-2760(67)90083-5; TAKI T, 1994, ANAL BIOCHEM, V221, P312, DOI 10.1006/abio.1994.1418; Warnecke D, 1999, J BIOL CHEM, V274, P13048, DOI 10.1074/jbc.274.19.13048; Wilske B, 1996, INFECTION, V24, P208, DOI 10.1007/BF01713341; Wilske B, 2007, FEMS IMMUNOL MED MIC, V49, P13, DOI 10.1111/j.1574-695X.2006.00139.x; Wunder C, 2006, NAT MED, V12, P1030, DOI 10.1038/nm1480	38	48	48	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13326	13334		10.1074/jbc.M809575200	http://dx.doi.org/10.1074/jbc.M809575200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19307181	Green Published, hybrid			2022-12-27	WOS:000265877300008
J	Zhu, Y; Bogomolovas, J; Labeit, S; Granzier, H				Zhu, Yi; Bogomolovas, Julius; Labeit, Siegfried; Granzier, Henk			Single Molecule Force Spectroscopy of the Cardiac Titin N2B Element EFFECTS OF THE MOLECULAR CHAPERONE alpha B-CRYSTALLIN WITH DISEASE-CAUSING MUTATIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GIANT PROTEIN TITIN; SPRING ELEMENTS; HEART-MUSCLE; ELASTICITY; MECHANICS; ASSOCIATION; STIFFNESS; MYOCYTES; SEQUENCE; DOMAIN	The small heat shock protein alpha B-crystallin interacts with N2B-Us, a large unique sequence found in the N2B element of cardiac titin. Using single molecule force spectroscopy, we studied the effect of alpha B-crystallin on the N2B-Us and its flanking Ig-like domains. Ig domains from the proximal tandem Ig segment of titin were also studied. The effect of wild type alpha B-crystallin on the single molecule force-extension curve was determined as well as that of mutant alpha B-crystallins harboring the dilated cardiomyopathy missense mutation, R157H, or the desmin-related myopathy mutation, R120G. Results revealed that wild type alpha B-crystallin decreased the persistence length of the N2B-Us (from similar to 0.7 to similar to 0.2 nm) but did not alter its contour length. alpha B-crystallin also increased the unfolding force of the Ig domains that flank the N2B-Us (by 51 +/- 3 piconewtons); the rate constant of unfolding at zero force was estimated to be similar to 17-fold lower in the presence of alpha B-crystallin (1.4 x 10(-4) s(-1) versus 2.4 x 10(-3) s(-1)). We also found that alpha B-crystallin increased the unfolding force of Ig domains from the proximal tandem Ig segment by 28 +/- 6 piconewtons. The effects of alpha B-crystallin were attenuated by the R157H mutation (but were still significant) and were absent when using the R120G mutant. We conclude that alpha B-crystallin protects titin from damage by lowering the persistence length of the N2B-Us and reducing the Ig domain unfolding probability. Our finding that this effect is either attenuated (R157H) or lost (R120G) in disease causing alpha B-crystallin mutations suggests that the interaction between alpha B-crystallin and titin is important for normal heart function.	[Zhu, Yi; Granzier, Henk] Univ Arizona, Dept Mol & Cellular Biol, Sarver Mol Cardiovasc Res Program, Tucson, AZ 85724 USA; [Bogomolovas, Julius; Labeit, Siegfried] Univ Heidelberg, Med Fac Mannheim, D-68167 Mannheim, Germany	University of Arizona; Ruprecht Karls University Heidelberg	Granzier, H (corresponding author), Univ Arizona, Dept Mol & Cellular Biol, Sarver Mol Cardiovasc Res Program, MRB 325,POB 245217, Tucson, AZ 85724 USA.	granzier@email.arizona.edu	Bogomolovas, Julius/AAS-3642-2020; Bogomolovas, Julius/HGD-2595-2022	Bogomolovas, Julius/0000-0001-8344-1909; 	National Institutes of Health [HL62881]; Deutsche Forschungsgemeinschaft [La668/12-1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062881] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant HL62881 ( to H. G.). This work was also supported by Deutsche Forschungsgemeinschaft Grant La668/12-1 ( to S. L.).	Bang ML, 2001, CIRC RES, V89, P1065, DOI 10.1161/hh2301.100981; BHAT SP, 1989, BIOCHEM BIOPH RES CO, V158, P319, DOI 10.1016/S0006-291X(89)80215-3; Bullard B, 2004, J BIOL CHEM, V279, P7917, DOI 10.1074/jbc.M307473200; BUSTAMANTE C, 1994, SCIENCE, V265, P1600; Golenhofen N, 2002, J MOL CELL CARDIOL, V34, P309, DOI 10.1006/jmcc.2001.1513; Granzier H, 1997, BIOPHYS J, V73, P2043, DOI 10.1016/S0006-3495(97)78234-1; Granzier HL, 2004, CIRC RES, V94, P284, DOI 10.1161/01.RES.0000117769.88862.F8; Helmes M, 1999, CIRC RES, V84, P1339, DOI 10.1161/01.RES.84.11.1339; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Horwitz J, 2003, EXP EYE RES, V76, P145, DOI 10.1016/S0014-4835(02)00278-6; Horwitz J, 2000, SEMIN CELL DEV BIOL, V11, P53, DOI 10.1006/scdb.1999.0351; Inagaki N, 2006, BIOCHEM BIOPH RES CO, V342, P379, DOI 10.1016/j.bbrc.2006.01.154; Kellermayer MSZ, 1997, SCIENCE, V276, P1112, DOI 10.1126/science.276.5315.1112; Kruger M, 2009, CIRC RES, V104, P87, DOI 10.1161/CIRCRESAHA.108.184408; Kumarapeli ARK, 2004, J MOL CELL CARDIOL, V37, P1097, DOI 10.1016/j.yjmcc.2004.07.004; Labeit D, 2003, P NATL ACAD SCI USA, V100, P13716, DOI 10.1073/pnas.2235652100; LABEIT S, 1995, SCIENCE, V270, P293, DOI 10.1126/science.270.5234.293; Lange S, 2002, J CELL SCI, V115, P4925, DOI 10.1242/jcs.00181; Leake MC, 2006, J STRUCT BIOL, V155, P263, DOI 10.1016/j.jsb.2006.02.017; Li HB, 2002, NATURE, V418, P998, DOI 10.1038/nature00938; Linke WA, 1998, BIOPHYS J, V75, P2613, DOI 10.1016/S0006-3495(98)77706-9; Lu H, 1998, BIOPHYS J, V75, P662, DOI 10.1016/S0006-3495(98)77556-3; Muhle-Goll C, 2001, J MOL BIOL, V313, P431, DOI 10.1006/jmbi.2001.5017; Radke MH, 2007, P NATL ACAD SCI USA, V104, P3444, DOI 10.1073/pnas.0608543104; ROST B, 1993, J MOL BIOL, V232, P584, DOI 10.1006/jmbi.1993.1413; Sheikh F, 2008, J CLIN INVEST, V118, P3870, DOI 10.1172/JCI34472; Treweek TM, 2005, FEBS J, V272, P711, DOI 10.1111/j.1742-4658.2004.04507.x; Trombitas K, 1999, BIOPHYS J, V77, P3189, DOI 10.1016/S0006-3495(99)77149-3; TROMBITAS K, 1995, CIRC RES, V77, P856, DOI 10.1161/01.RES.77.4.856; Vaughan-Jones RD, 2009, J MOL CELL CARDIOL, V46, P318, DOI 10.1016/j.yjmcc.2008.10.024; Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765; Wang XJ, 2002, J CARD FAIL, V8, pS287, DOI 10.1054/jcaf.2002.129279; Watanabe K, 2002, J STRUCT BIOL, V137, P248, DOI 10.1006/jsbi.2002.4458; Watanabe K, 2002, J BIOL CHEM, V277, P11549, DOI 10.1074/jbc.M200356200; Witt CC, 1998, J STRUCT BIOL, V122, P206, DOI 10.1006/jsbi.1998.3993; Wu YM, 2000, J MOL CELL CARDIOL, V32, P2151, DOI 10.1006/jmcc.2000.1281; Yamasaki R, 2002, CIRC RES, V90, P1181, DOI 10.1161/01.RES.0000021115.24712.99	37	41	42	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13914	13923		10.1074/jbc.M809743200	http://dx.doi.org/10.1074/jbc.M809743200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19282282	Green Published, hybrid			2022-12-27	WOS:000265877300067
J	Norambuena, A; Metz, C; Vicuna, L; Silva, A; Pardo, E; Oyanadel, C; Massardo, L; Gonzalez, A; Soza, A				Norambuena, Andres; Metz, Claudia; Vicuna, Lucas; Silva, Antonia; Pardo, Evelyn; Oyanadel, Claudia; Massardo, Loreto; Gonzalez, Alfonso; Soza, Andrea			Galectin-8 Induces Apoptosis in Jurkat T Cells by Phosphatidic Acid-mediated ERK1/2 Activation Supported by Protein Kinase A Down-regulation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; SYSTEMIC-LUPUS-ERYTHEMATOSUS; PHOSPHOLIPASE-D ACTIVITY; GROWTH-FACTOR RECEPTOR; DEPENDENT KINASE; MAP KINASE; CYTOKINE SECRETION; MAPK/ERK PATHWAY; PLASMA-MEMBRANE; IMMUNE-RESPONSE	Galectins have been implicated in T cell homeostasis playing complementary pro-apoptotic roles. Here we show that galectin-8 (Gal-8) is a potent pro-apoptotic agent in Jurkat T cells inducing a complex phospholipase D/phosphatidic acid signaling pathway that has not been reported for any galectin before. Gal-8 increases phosphatidic signaling, which enhances the activity of both ERK1/2 and type 4 phosphodiesterases (PDE4), with a subsequent decrease in basal protein kinase A activity. Strikingly, rolipram inhibition of PDE4 decreases ERK1/2 activity. Thus Gal-8-induced PDE4 activation releases a negative influence of cAMP/protein kinase A on ERK1/2. The resulting strong ERK1/2 activation leads to expression of the death factor Fas ligand and caspase-mediated apoptosis. Several conditions that decrease ERK1/2 activity also decrease apoptosis, such as anti-Fas ligand blocking antibodies. In addition, experiments with freshly isolated human peripheral blood mononuclear cells, previously stimulated with anti-CD3 and anti-CD28, show that Gal-8 is pro-apoptotic on activated T cells, most likely on a subpopulation of them. Anti-Gal-8 autoantibodies from patients with systemic lupus erythematosus block the apoptotic effect of Gal-8. These results implicate Gal-8 as a novel T cell suppressive factor, which can be counterbalanced by function-blocking autoantibodies in autoimmunity.	[Metz, Claudia; Massardo, Loreto; Gonzalez, Alfonso; Soza, Andrea] Pontificia Univ Catolica Chile, Dept Inmunol Clin & Reumatol, Fac Med, Santiago 6510260, Chile; [Norambuena, Andres; Metz, Claudia; Vicuna, Lucas; Silva, Antonia; Pardo, Evelyn; Oyanadel, Claudia; Gonzalez, Alfonso; Soza, Andrea] Pontificia Univ Catolica Chile, Ctr Regulac Celular & Patol, Fac Ciencias Biol, Santiago 6510260, Chile; [Norambuena, Andres; Metz, Claudia; Vicuna, Lucas; Silva, Antonia; Pardo, Evelyn; Oyanadel, Claudia; Gonzalez, Alfonso; Soza, Andrea] Pontificia Univ Catolica Chile, Ctr Envejecimiento & Regenerac, Fac Ciencias Biol, Santiago 6510260, Chile; [Norambuena, Andres; Metz, Claudia; Vicuna, Lucas; Silva, Antonia; Pardo, Evelyn; Oyanadel, Claudia; Gonzalez, Alfonso; Soza, Andrea] Millenium Inst Fundamental & Appl Biol, Inst Milenio Biol Fundamental & Aplicada, Santiago 7780344, Chile	Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile	Soza, A (corresponding author), Pontificia Univ Catolica Chile, Dept Inmunol Clin & Reumatol, Fac Med, Marcoleta 367, Santiago 6510260, Chile.	amsoza@med.puc.cl	Vicuña, Lucas/AAD-5889-2019; Vicuña, Lucas/AAR-2636-2020; Vicuña, Lucas/O-3075-2015	Vicuña, Lucas/0000-0002-0901-0032; Oyanadel, Claudia/0000-0002-5018-9767; Pardo, Evelyn/0000-0002-2516-5632; Metz, Claudia/0000-0002-5093-3066; Soza, Andrea/0000-0003-3783-5231; Christine, Metz/0000-0002-1013-1691	Fondo Nacional de Desarrollo CientIfico y Tecnologico [1050715]; Fondo Nacional de Areas Prioritarias [13980001]; Financiamiento Basal para Centros Cientificos y Tecnologicos de Excelencia [PFB12/2007]; Ministerio de Planificacion y Cooperacion de Chile	Fondo Nacional de Desarrollo CientIfico y Tecnologico(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Fondo Nacional de Areas Prioritarias; Financiamiento Basal para Centros Cientificos y Tecnologicos de Excelencia(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/BASAL); Ministerio de Planificacion y Cooperacion de Chile	This work was supported by Fondo Nacional de Desarrollo CientIfico y Tecnologico Grant 1050715, Fondo Nacional de Areas Prioritarias Grant 13980001, Financiamiento Basal para Centros Cientificos y Tecnologicos de Excelencia Grant PFB12/2007, and the Millenium Institute for Fundamental and Applied Biology, which is financed in part by the Ministerio de Planificacion y Cooperacion de Chile.	Adams CL, 2004, J IMMUNOL, V173, P1579, DOI 10.4049/jimmunol.173.3.1579; Arbel-Goren R, 2005, J BIOL CHEM, V280, P19105, DOI 10.1074/jbc.M502060200; Arp J, 2003, MOL CELL BIOL, V23, P8042, DOI 10.1128/MCB.23.22.8042-8057.2003; Bacon KB, 1998, J IMMUNOL, V160, P1894; Baumann Sven, 2002, Current Molecular Medicine (Hilversum), V2, P257, DOI 10.2174/1566524024605671; Bi S, 2008, J BIOL CHEM, V283, P12248, DOI 10.1074/jbc.M800523200; Bidon N, 2001, INT J MOL MED, V8, P245; Bidon-Wagner N, 2002, GLYCOCONJUGATE J, V19, P557, DOI 10.1023/B:GLYC.0000014086.38343.98; Cantrell D, 1996, ANNU REV IMMUNOL, V14, P259, DOI 10.1146/annurev.immunol.14.1.259; Carcamo C, 2006, EXP CELL RES, V312, P374, DOI 10.1016/j.yexcr.2005.10.025; Cooper DNW, 1999, GLYCOBIOLOGY, V9, P979, DOI 10.1093/glycob/9.10.979; Dhillon AS, 2002, MOL CELL BIOL, V22, P3237, DOI 10.1128/MCB.22.10.3237-3246.2002; Diaz O, 2005, J IMMUNOL, V175, P8077, DOI 10.4049/jimmunol.175.12.8077; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Du GW, 2004, MOL BIOL CELL, V15, P1024, DOI 10.1091/mbc.E03-09-0673; Dumaz N, 2002, MOL CELL BIOL, V22, P3717, DOI 10.1128/MCB.22.11.3717-3728.2002; Dumont FJ, 1998, J IMMUNOL, V160, P2579; ElBawab S, 1997, EUR J BIOCHEM, V247, P1151, DOI 10.1111/j.1432-1033.1997.01151.x; Essayan DM, 2001, J ALLERGY CLIN IMMUN, V108, P671, DOI 10.1067/mai.2001.119555; Fernandez GC, 2005, GLYCOBIOLOGY, V15, P519, DOI 10.1093/glycob/cwi026; Fournel S, 1996, J IMMUNOL, V157, P4309; Gendron S, 2003, J BIOL CHEM, V278, P48633, DOI 10.1074/jbc.M305169200; Giembycz MA, 1996, BRIT J PHARMACOL, V118, P1945, DOI 10.1111/j.1476-5381.1996.tb15629.x; Grange M, 2000, J BIOL CHEM, V275, P33379, DOI 10.1074/jbc.M006329200; Hadari YR, 2000, J CELL SCI, V113, P2385; HADARI YR, 1995, J BIOL CHEM, V270, P3447, DOI 10.1074/jbc.270.7.3447; Hedges JF, 2005, J IMMUNOL, V174, P6045, DOI 10.4049/jimmunol.174.10.6045; Hermann-Kleiter N, 2006, BLOOD, V107, P4841, DOI 10.1182/blood-2005-10-4044; Holmstrom TH, 2000, EMBO J, V19, P5418, DOI 10.1093/emboj/19.20.5418; Houslay MD, 2003, BIOCHEM J, V370, P1, DOI 10.1042/BJ20021698; Janssen O, 2000, CELL TISSUE RES, V301, P85, DOI 10.1007/s004419900155; Jimenez JL, 2001, J PHARMACOL EXP THER, V299, P753; JU ST, 1995, NATURE, V373, P444, DOI 10.1038/373444a0; KAMMER GM, 1994, J CLIN INVEST, V94, P422, DOI 10.1172/JCI117340; Kanda N, 2001, BIOCHEM PHARMACOL, V62, P495, DOI 10.1016/S0006-2952(01)00688-8; Kawai K, 2004, J ALLERGY CLIN IMMUN, V113, P1211, DOI 10.1016/j.jaci.2004.02.044; KAYAGAKI N, 1995, J EXP MED, V182, P1777, DOI 10.1084/jem.182.6.1777; Kim K, 2003, BBA-MOL CELL RES, V1641, P13, DOI 10.1016/S0167-4889(03)00045-4; Krammer P H, 1999, Adv Immunol, V71, P163; Lahm H, 2003, GLYCOCONJUGATE J, V20, P227, DOI 10.1023/B:GLYC.0000025817.24297.17; Lahmers KK, 2006, J LEUKOCYTE BIOL, V80, P939, DOI 10.1189/jlb.0506353; Leffler H, 2002, GLYCOCONJUGATE J, V19, P433, DOI 10.1023/B:GLYC.0000014072.34840.04; Levy Y, 2001, J BIOL CHEM, V276, P31285, DOI 10.1074/jbc.M100340200; Levy Y, 2003, J BIOL CHEM, V278, P14533, DOI 10.1074/jbc.M207380200; Li LS, 1999, SCIENCE, V283, P848, DOI 10.1126/science.283.5403.848; Li YQ, 1999, IMMUNOLOGY, V96, P524; Liu FT, 2005, NAT REV CANCER, V5, P29, DOI 10.1038/nrc1527; Liu SD, 2008, BLOOD, V112, P120, DOI 10.1182/blood-2007-09-114181; Lu LH, 2007, J BIOCHEM, V141, P157, DOI 10.1093/jb/mvm019; MARCOZ P, 1993, BIOCHIM BIOPHYS ACTA, V1176, P129, DOI 10.1016/0167-4889(93)90187-T; MOLLINEDO F, 1994, J IMMUNOL, V153, P2457; Mor A, 2007, NAT CELL BIOL, V9, P713, DOI 10.1038/ncb1592; Morris AJ, 1997, ANAL BIOCHEM, V252, P1, DOI 10.1006/abio.1997.2299; NIELSEN HV, 1994, J IMMUNOL, V153, P2021; Nishi N, 2003, GLYCOBIOLOGY, V13, P755, DOI 10.1093/glycob/cwg102; Pardo E, 2006, REV MED CHILE, V134, P159; PERILLO NL, 1995, NATURE, V378, P736, DOI 10.1038/378736a0; Perillo NL, 1998, J MOL MED, V76, P402, DOI 10.1007/s001090050232; Peter D, 2007, J IMMUNOL, V178, P4820, DOI 10.4049/jimmunol.178.8.4820; Rabinovich GA, 2007, SCAND J IMMUNOL, V66, P143, DOI 10.1111/j.1365-3083.2007.01986.x; Rabinovich GA, 1999, CELL DEATH DIFFER, V6, P711, DOI 10.1038/sj.cdd.4400535; Ramstad C, 2000, CELL SIGNAL, V12, P557, DOI 10.1016/S0898-6568(00)00097-8; Refaeli Y, 1998, IMMUNITY, V8, P615, DOI 10.1016/S1074-7613(00)80566-X; Rizzo MA, 2000, J BIOL CHEM, V275, P23911, DOI 10.1074/jbc.M001553200; Salazar G, 2002, MOL BIOL CELL, V13, P1677, DOI 10.1091/mbc.01-08-0403; Saxena M, 1999, NAT CELL BIOL, V1, P305, DOI 10.1038/13024; Sebban LE, 2007, J IMMUNOL, V179, P1225, DOI 10.4049/jimmunol.179.2.1225; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; Stillman BN, 2006, J IMMUNOL, V176, P778, DOI 10.4049/jimmunol.176.2.778; Stork PJS, 2002, TRENDS CELL BIOL, V12, P258, DOI 10.1016/S0962-8924(02)02294-8; Stowell SR, 2008, J IMMUNOL, V180, P3091, DOI 10.4049/jimmunol.180.5.3091; Sturm A, 2004, J IMMUNOL, V173, P3825, DOI 10.4049/jimmunol.173.6.3825; Tamir A, 1996, J IMMUNOL, V157, P1514; THOMPSON WJ, 1971, BIOCHEMISTRY-US, V10, P311; TOMIC S, 1995, J BIOL CHEM, V270, P21277, DOI 10.1074/jbc.270.36.21277; Torgersen KM, 2002, CELL SIGNAL, V14, P1, DOI 10.1016/S0898-6568(01)00214-5; Tribulatti MV, 2007, GLYCOBIOLOGY, V17, P1404, DOI 10.1093/glycob/cwm104; van den Brink MRM, 1999, J BIOL CHEM, V274, P11178, DOI 10.1074/jbc.274.16.11178; Vespa GNR, 1999, J IMMUNOL, V162, P799; Wang XM, 2006, PROG LIPID RES, V45, P250, DOI 10.1016/j.plipres.2006.01.005; Whitehurst CE, 1996, J IMMUNOL, V156, P1020; Yang RY, 1996, P NATL ACAD SCI USA, V93, P6737, DOI 10.1073/pnas.93.13.6737; Yang RY, 2003, CELL MOL LIFE SCI, V60, P267, DOI 10.1007/s000180300022; Zavazava N, 1996, NAT MED, V2, P1005, DOI 10.1038/nm0996-1005; Zhu L, 1999, IMMUNOLOGY, V97, P26; Zick Y, 2002, GLYCOCONJUGATE J, V19, P517, DOI 10.1023/B:GLYC.0000014081.55445.af	86	52	54	2	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12670	12679		10.1074/jbc.M808949200	http://dx.doi.org/10.1074/jbc.M808949200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19276072	Green Published, hybrid			2022-12-27	WOS:000265688300011
J	Kim, HS; Lim, IK				Kim, Hong Seok; Lim, In Kyoung			Phosphorylated Extracellular Signal-regulated Protein Kinases 1 and 2 Phosphorylate Sp1 on Serine 59 and Regulate Cellular Senescence via Transcription of p21(Sdi1/Cip1/Waf1)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-DIPLOID FIBROBLASTS; NADPH-OXIDASE ACTIVATION; INDUCED GROWTH ARREST; HUMAN T-CELLS; TYROSINE PHOSPHORYLATION; NUCLEAR ACCUMULATION; CYCLE PROGRESSION; PHOSPHOLIPASE-D; DOWN-REGULATION; RECEPTOR-ALPHA	Expression of p21(Sdi1) downstream of p53 is essential for induction of cellular senescence, although cancer cell senescence can also occur in the p53 null condition. We report herein that senescence-associated phosphorylated extracellular signal-regulated protein kinases 1 and 2 (SA-pErk1/2) enhanced p21(Sdi1) transcription by phosphorylating Sp1 on Ser(59) downstream of protein kinase C (PKC) alpha. Reactive oxygen species (ROS), which was increased in cellular senescence, significantly activated both PKC alpha and PKC beta I. However, PKC alpha, but not PKC beta I, regulated ROS generation and cell proliferation in senescent cells along with activation of cdk2, proven by siRNAs. PKC alpha-siRNA also reduced SA-pErk1/2 expression in old human diploid fibroblast cells, accompanied with changes of senescence phenotypes to young cell-like. Regulation of SA-pErk1/2 was also confirmed by using catalytically active PKC alpha and its DN-mutant construct. These findings strongly suggest a new pathway to regulate senescence phenotypes by ROS via Sp1 phosphorylation between PKC alpha and SA-pErk1/2: employing GST-Sp1 mutants and MEK inhibitor analyses, we found that SA-pErk1/2 regulated Sp1 phosphorylation on the Ser(59) residue in vivo, but not threonine, in cellular senescence, which regulated transcription of p21(Sdi1) expression. In summary, PKC alpha, which was activated in senescent cells by ROS strongly activated Erk1/2, and the SA-pErk1/2 in turn phosphorylated Sp1 on Ser(59). Sp1-enhanced transcription of p21(Sdi1) resulted in regulation of cellular senescence in primary human diploid fibroblast cells.	[Kim, Hong Seok; Lim, In Kyoung] Ajou Univ, Sch Med, Dept Biochem & Mol Biol, Suwon 443721, South Korea	Ajou University	Lim, IK (corresponding author), Ajou Univ, Sch Med, Dept Biochem & Mol Biol, Suwon 443721, South Korea.	iklim@ajou.ac.kr		Lim, In Kyoung/0000-0002-2399-607X	Korea Science and Engineering Foundation [R11-2002-097-08002-0]	Korea Science and Engineering Foundation(Korea Science and Engineering Foundation)	This work was supported by Research Grant R11-2002-097-08002-0( 2008) provided by the Korea Science and Engineering Foundation.	Armstrong SA, 1997, J BIOL CHEM, V272, P13489, DOI 10.1074/jbc.272.21.13489; Besson A, 2000, MOL CELL BIOL, V20, P4580, DOI 10.1128/MCB.20.13.4580-4590.2000; BILEZIKJIAN LM, 1987, MOL ENDOCRINOL, V1, P555, DOI 10.1210/mend-1-8-555; Bonello MR, 2004, J BIOL CHEM, V279, P2377, DOI 10.1074/jbc.M308254200; BRAWN MK, 1995, FREE RADICAL RES, V22, P23, DOI 10.3109/10715769509147525; Cabodi S, 2000, MOL CELL, V6, P1121, DOI 10.1016/S1097-2765(00)00110-6; Chang BD, 2000, P NATL ACAD SCI USA, V97, P4291, DOI 10.1073/pnas.97.8.4291; Chaves MM, 2002, GERONTOLOGY, V48, P354, DOI 10.1159/000065503; Chuang JY, 2008, MOL BIOL CELL, V19, P1139, DOI 10.1091/mbc.E07-09-0881; Chun RF, 1998, J VIROL, V72, P2615, DOI 10.1128/JVI.72.4.2615-2629.1998; CLEMENS MJ, 1992, J CELL SCI, V103, P881; COPPOCK DL, 1992, CELL GROWTH DIFFER, V3, P485; CRISTOFALO VJ, 1993, PHYSIOL REV, V73, P617, DOI 10.1152/physrev.1993.73.3.617; Dangi S, 2006, CELL PROLIFERAT, V39, P261, DOI 10.1111/j.1365-2184.2006.00388.x; De Siervi A, 2004, CANCER RES, V64, P743, DOI 10.1158/0008-5472.CAN-03-2505; DEKKER LV, 1994, TRENDS BIOCHEM SCI, V19, P73, DOI 10.1016/0968-0004(94)90038-8; DOI S, 1994, MOL CARCINOGEN, V11, P197, DOI 10.1002/mc.2940110405; FOJAS DB, 2001, EMBO J, V20, P5737; Fontayne A, 2002, BIOCHEMISTRY-US, V41, P7743, DOI 10.1021/bi011953s; Frey MR, 2000, J CELL BIOL, V151, P763, DOI 10.1083/jcb.151.4.763; Frey MR, 1997, J BIOL CHEM, V272, P9424; GOPALAKRISHNA R, 1989, P NATL ACAD SCI USA, V86, P6758, DOI 10.1073/pnas.86.17.6758; GRUBER JR, 1992, J BIOL CHEM, V267, P13356; Hamada K, 1996, BBA-MOL CELL RES, V1310, P149, DOI 10.1016/0167-4889(95)00148-4; Hatoum A, 2001, CARCINOGENESIS, V22, P1955, DOI 10.1093/carcin/22.12.1955; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Iwahori S, 2008, CELL SIGNAL, V20, P1795, DOI 10.1016/j.cellsig.2008.06.007; Kang HT, 2003, J BIOL CHEM, V278, P51223, DOI 10.1074/jbc.M307332200; Kenessey A, 2006, AM J PHYSIOL-HEART C, V290, pH381, DOI 10.1152/ajpheart.00576.2005; Kim HS, 2003, J BIOL CHEM, V278, P37497, DOI 10.1074/jbc.M211739200; Kim YK, 2006, CELL SIGNAL, V18, P236, DOI 10.1016/j.cellsig.2005.04.008; Kim YK, 2003, ONCOGENE, V22, P6023, DOI 10.1038/sj.onc.1206875; Konishi H, 1997, P NATL ACAD SCI USA, V94, P11233, DOI 10.1073/pnas.94.21.11233; Kwak IH, 2004, CANCER RES, V64, P572, DOI 10.1158/0008-5472.CAN-03-1856; Lim IK, 2000, MECH AGEING DEV, V119, P113, DOI 10.1016/S0047-6374(00)00167-6; Llovet JM, 2008, HEPATOLOGY, V48, P1312, DOI 10.1002/hep.22506; Lu ZM, 1998, MOL CELL BIOL, V18, P839, DOI 10.1128/MCB.18.2.839; Maloney JA, 1998, AM J PHYSIOL-CELL PH, V274, pC974, DOI 10.1152/ajpcell.1998.274.4.C974; Milanini-Mongiat J, 2002, J BIOL CHEM, V277, P20631, DOI 10.1074/jbc.M201753200; Min DS, 1998, J BIOL CHEM, V273, P29986, DOI 10.1074/jbc.273.45.29986; Nakamura S, 2000, MOL CELL BIOL, V20, P9391, DOI 10.1128/MCB.20.24.9391-9398.2000; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; NODA A, 1994, EXP CELL RES, V211, P90, DOI 10.1006/excr.1994.1063; Oliva JL, 2008, J BIOL CHEM, V283, P5466, DOI 10.1074/jbc.M707576200; PALUMBO EJ, 1992, BIOCHEM BIOPH RES CO, V187, P1439, DOI 10.1016/0006-291X(92)90463-U; Salabat MR, 2006, PANCREAS, V33, P148, DOI 10.1097/01.mpa.0000226896.93945.41; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; SASAGURI T, 1993, EXP CELL RES, V208, P311, DOI 10.1006/excr.1993.1251; Schavinsky-Khrapunsky Y, 2003, ONCOGENE, V22, P5315, DOI 10.1038/sj.onc.1206782; Schavinsky-Khrapunsky Y, 2003, BIOCHEM BIOPH RES CO, V304, P696, DOI 10.1016/S0006-291X(03)00650-8; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; SHARMA P, 1991, BIOCHEM BIOPH RES CO, V177, P1033, DOI 10.1016/0006-291X(91)90642-K; Sugibayashi R, 2001, ONCOGENE, V20, P1220, DOI 10.1038/sj.onc.1204206; Tan NY, 2008, CIRC RES, V102, pE38, DOI 10.1161/CIRCRESAHA.107.167395; Thompson LJ, 1996, J BIOL CHEM, V271, P15045, DOI 10.1074/jbc.271.25.15045; Traore K, 2005, LEUKEMIA RES, V29, P863, DOI 10.1016/j.leukres.2004.12.011; Traore K, 2008, J CELL PHYSIOL, V216, P276, DOI 10.1002/jcp.21403; VENABLE ME, 1994, J BIOL CHEM, V269, P26040; Vijayan K, 2004, AM J PHYSIOL-HEART C, V287, pH2777, DOI 10.1152/ajpheart.00171.2004; Wang JF, 2004, J BIOL CHEM, V279, P27088, DOI 10.1074/jbc.M314015200; WATANABE T, 1992, P NATL ACAD SCI USA, V89, P10159, DOI 10.1073/pnas.89.21.10159; WHISLER RL, 1995, ARCH BIOCHEM BIOPHYS, V319, P23, DOI 10.1006/abbi.1995.1263; Zhang Y, 2006, MOL CELL BIOL, V26, P6748, DOI 10.1128/MCB.00560-06; Zheng XL, 2001, J BIOL CHEM, V276, P13822, DOI 10.1074/jbc.M011031200; ZHOU W, 1993, J BIOL CHEM, V268, P23041; Zupanska A, 2007, CELL SIGNAL, V19, P1268, DOI 10.1016/j.cellsig.2007.01.011	66	27	27	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15475	15486		10.1074/jbc.M808734200	http://dx.doi.org/10.1074/jbc.M808734200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19318349	Green Published, hybrid			2022-12-27	WOS:000266501000016
J	Komiyama, T; Coppola, JM; Larsen, MJ; van Dort, ME; Ross, BD; Day, R; Rehemtulla, A; Fuller, RS				Komiyama, Tomoko; Coppola, Julia M.; Larsen, Martha J.; van Dort, Marcian E.; Ross, Brian D.; Day, Robert; Rehemtulla, Alnawaz; Fuller, Robert S.			Inhibition of Furin/Proprotein Convertase-catalyzed Surface and Intracellular Processing by Small Molecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROPROTEIN CONVERTASES; PROTEOLYTIC ACTIVATION; CRYSTAL-STRUCTURE; MATRIX-METALLOPROTEINASE; FURIN INHIBITORS; ANTHRAX TOXIN; D-ARGININE; CLEAVAGE; PROTEIN; GLYCOPROTEIN	Furin is a ubiquitously expressed proprotein convertase (PC) that plays a vital role in numerous disease processes including cancer metastasis, bacterial toxin activation (e. g. anthrax and Pseudomonas), and viral propagation (e. g. avian influenza and human immunodeficiency virus). To identify small molecule inhibitors of furin and related processing enzymes, we performed high-throughput screens of chemical diversity libraries utilizing both enzyme-based and cell-based assays. The screens identified partially overlapping sets of compounds that were further characterized for affinity, mechanism, and efficacy in additional cellular processing assays. Dicoumarols were identified as a class of compounds that inhibited furin non-competitively and reversibly with K-i values in the micromolar range. These compounds inhibited furin/furin-like activity both at the cell surface (protecting against anthrax toxin) and in the secretory pathway (blocking processing of the metastasis factor membrane-type 1 matrix metalloproteinase/MT1-MMP) at concentrations close to K-i values. Compounds tested exhibited distinct patterns of inhibition of other furin-family PCs (rat PACE4, human PC5/6 and human PC7), showing that dicoumarol derivatives might be developed as either generic or selective inhibitors of the PCs. The extensive clinical use, high bioavailability and relatively low toxicity of dicoumarols suggests that the dicoumarol structure will be a good starting point for development of drug-like inhibitors of furin and other PCs that can act both intracellularly and at the cell surface.	[Komiyama, Tomoko; Coppola, Julia M.; Fuller, Robert S.] Univ Michigan, Sch Med, Dept Biol Chem, Ann Arbor, MI 48109 USA; [Coppola, Julia M.; Rehemtulla, Alnawaz] Univ Michigan, Sch Med, Dept Radiat Oncol, Ann Arbor, MI 48109 USA; [van Dort, Marcian E.; Ross, Brian D.] Univ Michigan, Sch Med, Dept Radiol, Ann Arbor, MI 48109 USA; [Larsen, Martha J.] Univ Michigan, Inst Life Sci, Ctr Chem Genom, Ann Arbor, MI 48109 USA; [Day, Robert] Univ Sherbrooke, Fac Med, Sherbrooke, PQ J1H 5N4, Canada	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Sherbrooke	Rehemtulla, A (corresponding author), Univ Michigan, Med Ctr, BSRB Room A528,109 Zina Pitcher Pl, Ann Arbor, MI 48109 USA.	alnawaz@umich.edu; bfuller@umich.edu			National Institutes of Health NCI [P01CA85878, R24CA83099, P50CA093990, GM39697, GM50915]; Canadian Institutes of Health Research grants; NATIONAL CANCER INSTITUTE [P01CA085878, P50CA093990, R24CA083099] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM039697, R01GM050915, R55GM039697] Funding Source: NIH RePORTER	National Institutes of Health NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Canadian Institutes of Health Research grants(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health NCI Grants P01CA85878, R24CA83099, and P50CA093990 ( to A. R. and B. D. R.) and GM39697 and GM50915 ( to R. S. F.). This work was also supported by Canadian Institutes of Health Research grants ( to R. D.).	Abdelmohsen K, 2005, ARCH BIOCHEM BIOPHYS, V434, P241, DOI 10.1016/j.abb.2004.11.002; ANDERSON ED, 1993, J BIOL CHEM, V268, P24887; Arner EC, 2002, CURR OPIN PHARMACOL, V2, P322, DOI 10.1016/S1471-4892(02)00148-0; Asher G, 2006, BIOCHEMISTRY-US, V45, P6372, DOI 10.1021/bi0600087; Basak A, 2001, BIOCHEM J, V353, P537, DOI 10.1042/0264-6021:3530537; Bassi DE, 2005, MOL CARCINOGEN, V44, P151, DOI 10.1002/mc.20134; Beauregard KE, 2000, CELL MICROBIOL, V2, P251, DOI 10.1046/j.1462-5822.2000.00052.x; Bennett BD, 2000, J BIOL CHEM, V275, P37712, DOI 10.1074/jbc.M005339200; Borges F, 2005, CURR MED CHEM, V12, P887, DOI 10.2174/0929867053507315; BRAVO DA, 1994, J BIOL CHEM, V269, P25830; CAO J, 1995, J BIOL CHEM, V270, P801, DOI 10.1074/jbc.270.2.801; Chen GA, 2005, P NATL ACAD SCI USA, V102, P12507, DOI 10.1073/pnas.0500397102; Collier RJ, 2003, ANNU REV CELL DEV BI, V19, P45, DOI 10.1146/annurev.cellbio.19.111301.140655; Coppola J, 2008, NEOPLASIA, V10, P363, DOI 10.1593/neo.08166; Coppola JM, 2007, ANAL BIOCHEM, V364, P19, DOI 10.1016/j.ab.2007.01.013; Dixon M., 1979, ENZYMES, Vthird; Fear G, 2007, PHARMACOL THERAPEUT, V113, P354, DOI 10.1016/j.pharmthera.2006.09.001; Fugere M, 2005, TRENDS PHARMACOL SCI, V26, P294, DOI 10.1016/j.tips.2005.04.006; Fugere M, 2002, J BIOL CHEM, V277, P7648, DOI 10.1074/jbc.M107467200; GARRED O, 1995, J BIOL CHEM, V270, P10817; GORDON VM, 1995, INFECT IMMUN, V63, P82, DOI 10.1128/IAI.63.1.82-87.1995; GUMINSKA M, 1961, J MED PHARMACEUT CH, V3, P583, DOI 10.1021/jm50016a016; HALLENBERGER S, 1992, NATURE, V360, P358, DOI 10.1038/360358a0; Hamstra DA, 1999, HUM GENE THER, V10, P235, DOI 10.1089/10430349950019020; Henrich S, 2003, NAT STRUCT BIOL, V10, P520, DOI 10.1038/nsb941; Holyoak T, 2003, BIOCHEMISTRY-US, V42, P6709, DOI 10.1021/bi034434t; Jean F, 2000, P NATL ACAD SCI USA, V97, P2864, DOI 10.1073/pnas.050504297; Jean F, 1998, P NATL ACAD SCI USA, V95, P7293, DOI 10.1073/pnas.95.13.7293; Jiao GS, 2006, P NATL ACAD SCI USA, V103, P19707, DOI 10.1073/pnas.0606555104; Kacprzak MM, 2004, J BIOL CHEM, V279, P36788, DOI 10.1074/jbc.M400484200; Komiyama T, 2005, ANTIMICROB AGENTS CH, V49, P3875, DOI 10.1128/AAC.49.9.3875-3882.2005; Komiyama T, 2003, P NATL ACAD SCI USA, V100, P8205, DOI 10.1073/pnas.1032865100; Komiyama T, 2000, BIOCHEMISTRY-US, V39, P15156, DOI 10.1021/bi001907c; LOCKNER D, 1979, BRIT J CLIN PHARMACO, V8, P59, DOI 10.1111/j.1365-2125.1979.tb05910.x; Matsuzawa T, 2004, J BIOL CHEM, V279, P2866, DOI 10.1074/jbc.M310340200; McAlister V, 2006, CLIN INVEST MED, V29, P373; Mironov AA, 2004, EUR J CELL BIOL, V83, P263, DOI 10.1078/0171-9335-00377; Moulard M, 2000, BBA-REV BIOMEMBRANES, V1469, P121, DOI 10.1016/S0304-4157(00)00014-9; Richards RM, 2006, P NATL ACAD SCI USA, V103, P1522, DOI 10.1073/pnas.0508815103; Rockwell NC, 2002, CHEM REV, V102, P4525, DOI 10.1021/cr010168i; Roebroek AJM, 2004, J BIOL CHEM, V279, P53442, DOI 10.1074/jbc.M407152200; Roebroek AJM, 1998, DEVELOPMENT, V125, P4863; Rostagno A, 2005, CELL MOL LIFE SCI, V62, P1814, DOI 10.1007/s00018-005-5092-5; Sarac MS, 2004, INFECT IMMUN, V72, P602, DOI 10.1128/IAI.72.1.602-605.2004; Sato H, 2005, CANCER SCI, V96, P212, DOI 10.1111/j.1349-7006.2005.00039.x; Scamuffa N, 2006, FASEB J, V20, P1954, DOI 10.1096/fj.05-5491rev; Schulman S, 1997, NEW ENGL J MED, V336, P393, DOI 10.1056/NEJM199702063360601; Segel I.H, 1993, ENZYME KINETICS; Stadler K, 1997, J VIROL, V71, P8475, DOI 10.1128/JVI.71.11.8475-8481.1997; Stawowy P, 2005, J MOL MED, V83, P865, DOI 10.1007/s00109-005-0723-8; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Volchkov VE, 1998, P NATL ACAD SCI USA, V95, P5762, DOI 10.1073/pnas.95.10.5762; Wallin R, 2004, TRENDS MOL MED, V10, P299, DOI 10.1016/j.molmed.2004.05.003; WATANABE M, 1995, J VIROL, V69, P3206, DOI 10.1128/JVI.69.5.3206-3210.1995; Yana I, 2000, MOL BIOL CELL, V11, P2387, DOI 10.1091/mbc.11.7.2387; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	56	51	53	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15729	15738		10.1074/jbc.M901540200	http://dx.doi.org/10.1074/jbc.M901540200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19332539	Green Published, hybrid			2022-12-27	WOS:000266501000042
J	Feng, HT; Cheng, TS; Steer, JH; Joyce, DA; Pavlos, NJ; Leong, CL; Kular, J; Liu, JZ; Feng, X; Zheng, MH; Xu, JK				Feng, HaoTian; Cheng, Taksum; Steer, James H.; Joyce, David A.; Pavlos, Nathan J.; Leong, ChengLoon; Kular, Jasreen; Liu, Jianzhong; Feng, Xu; Zheng, Ming H.; Xu, Jiake			Myocyte Enhancer Factor 2 and Microphthalmia-associated Transcription Factor Cooperate with NFATc1 to Transactivate the V-ATPase d2 Promoter during RANKL-induced Osteoclastogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KAPPA-B LIGAND; RECEPTOR ACTIVATOR; GENE-EXPRESSION; BONE-RESORPTION; NUCLEAR-FACTOR; DC-STAMP; DIFFERENTIATION; MEF2; OSTEOPETROSIS; SUBUNIT	The V-ATPase d2 protein constitutes an important subunit of the V-ATPase proton pump, which regulates bone homeostasis; however, currently little is known about its transcriptional regulation. Here, in an attempt to understand regulation of the V-ATPase d2 promoter, we identified the presence of NFATc1, microphthalmia-associated transcription factor (MITF)- and myocyte enhancer factor 2 (MEF2)-binding sites within the V-ATPase d2 promoter using complementary bioinformatic analyses, chromatin immunoprecipitation, and electromobility shift assay. Intriguingly, activation of the V-ATPase d2 promoter by NFATc1 was enhanced by either MEF2 or MITF overexpression. By comparison, coexpression of MITF and MEF2 did not further enhance V-ATPase d2 promoter activity above that of expression of MITF alone. Consistent with a role in transcriptional regulation, both NFATc1 and MITF proteins translocated from the cytosol to the nucleus during RANKL-induced osteoclastogenesis, whereas MEF2 persisted in the nucleus of both osteoclasts and their mononuclear precursors. Targeted mutation of the putative NFATc1-,MITF-, or MEF2-binding sites in the V-ATPase d2 promoter impaired its transcriptional activation. Additionally retroviral overexpression of MITF or MEF2 in RAW264.7 cells potentiated RANKL-induced osteoclastogenesis and V-ATPase d2 gene expression. Based on these data, we propose that MEF2 and MITF function cooperatively with NFATc1 to transactivate the V-ATPase d2 promoter during RANKL-induced osteoclastogenesis.	[Feng, HaoTian; Cheng, Taksum; Pavlos, Nathan J.; Leong, ChengLoon; Kular, Jasreen; Zheng, Ming H.; Xu, Jiake] Univ Western Australia, Ctr Orthopaed Res, Sch Surg, Mol Orthopaed Lab, Nedlands, WA 6009, Australia; [Steer, James H.; Joyce, David A.] Univ Western Australia, Pharmacol Unit, Sch Med & Pharmacol, Nedlands, WA 6009, Australia; [Liu, Jianzhong; Feng, Xu] Univ Alabama, Dept Pathol, Birmingham, AL 35294 USA	University of Western Australia; University of Western Australia; University of Alabama System; University of Alabama Birmingham	Xu, JK (corresponding author), Univ Western Australia, QEII Med Ctr, Sch Surg, Mol Orthopaed Lab, 2nd Floor,M Block, Nedlands, WA 6009, Australia.	jiake.xu@uwa.edu.au	Joyce, David/H-5156-2014	Pavlos, Nathan/0000-0001-7003-188X; Xu, Jiake/0000-0003-2021-8309; /0000-0002-2151-3433; Zheng, Minghao/0000-0003-1185-4768	National Health and Medical Research Council of Australia	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by the National Health and Medical Research Council of Australia.	Arnold MA, 2007, DEV CELL, V12, P377, DOI 10.1016/j.devcel.2007.02.004; Beranger GE, 2007, J BONE MINER RES, V22, P975, DOI 10.1359/JBMR.070406; Black BL, 1998, ANNU REV CELL DEV BI, V14, P167, DOI 10.1146/annurev.cellbio.14.1.167; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Crotti TN, 2006, GENE, V372, P92, DOI 10.1016/j.gene.2005.12.012; Feng HT, 2008, J BIOL CHEM, V283, P13194, DOI 10.1074/jbc.M709712200; Forgac M, 1999, J BIOENERG BIOMEMBR, V31, P57, DOI 10.1023/A:1005496530380; Heidenreich KA, 2004, MOL NEUROBIOL, V29, P155, DOI 10.1385/MN:29:2:155; Hirotani H, 2004, J BIOL CHEM, V279, P13984, DOI 10.1074/jbc.M213067200; Kim K, 2005, J BIOL CHEM, V280, P35209, DOI 10.1074/jbc.M505815200; Kim K, 2008, MOL ENDOCRINOL, V22, P176, DOI 10.1210/me.2007-0237; Kornak U, 2000, HUM MOL GENET, V9, P2059, DOI 10.1093/hmg/9.13.2059; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; Li YP, 1999, NAT GENET, V23, P447, DOI 10.1038/70563; Matsumoto M, 2004, J BIOL CHEM, V279, P45969, DOI 10.1074/jbc.M408795200; Meadows NA, 2007, J BIOL CHEM, V282, P1891, DOI 10.1074/jbc.M608572200; Molkentin JD, 1996, MOL CELL BIOL, V16, P2627; Morimoto R, 2006, EMBO J, V25, P4175, DOI 10.1038/sj.emboj.7601317; Motyckova G, 2001, P NATL ACAD SCI USA, V98, P5798, DOI 10.1073/pnas.091479298; Passier R, 2000, J CLIN INVEST, V105, P1395, DOI 10.1172/JCI8551; Stevens TH, 1997, ANNU REV CELL DEV BI, V13, P779, DOI 10.1146/annurev.cellbio.13.1.779; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; van Oort RJ, 2006, CIRCULATION, V114, P298, DOI 10.1161/CIRCULATIONAHA.105.608968; Wang C, 2003, J BONE MINER RES, V18, P2159, DOI 10.1359/jbmr.2003.18.12.2159; Wu H, 2001, EMBO J, V20, P6414, DOI 10.1093/emboj/20.22.6414; Xu J, 2007, HISTOL HISTOPATHOL, V22, P443, DOI 10.14670/HH-22.443; Xu JK, 2000, J BONE MINER RES, V15, P2178, DOI 10.1359/jbmr.2000.15.11.2178; Yagi M, 2007, J BONE MINER RES, V22, P992, DOI 10.1359/JBMR.070401; Yamashita T, 2007, J BIOL CHEM, V282, P18245, DOI 10.1074/jbc.M610701200; Yip KHM, 2005, J BONE MINER RES, V20, P1462, DOI 10.1359/JBMR.050324; Yip KHM, 2004, J BONE MINER RES, V19, P1905, DOI 10.1359/JBMR.040919; Yip KHM, 2006, AM J PATHOL, V169, P503, DOI 10.2353/ajpath.2006.050960	33	80	87	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14667	14676		10.1074/jbc.M901670200	http://dx.doi.org/10.1074/jbc.M901670200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19321441	Green Published, hybrid			2022-12-27	WOS:000266286100072
J	Imamura, Y; Fujigaki, Y; Oomori, Y; Usui, S; Wang, PL				Imamura, Yasuhiro; Fujigaki, Yoshihisa; Oomori, Yuriko; Usui, Syuhei; Wang, Pao-Li			Cooperation of Salivary Protein Histatin 3 with Heat Shock Cognate Protein 70 Relative to the G(1)/S Transition in Human Gingival Fibroblasts	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DEPENDENT-KINASE INHIBITOR; HISTIDINE-RICH PROTEINS; HUMAN-PAROTID SECRETION; CANDIDA-ALBICANS; NUCLEAR EXPORT; IMMUNOSUPPRESSANT DEOXYSPERGUALIN; ANTICANDIDAL ACTIVITY; MOLECULAR CHAPERONES; GROWTH-FACTOR; CELL-CYCLE	Histatins, a family of salivary proteins, have antimicrobial activity. Candida albicans, which is killed by histatins, induces oral candidiasis in individuals with compromised immune systems. Although the functional significance of histatins has been documented, their biological and physiological functions against host cells have not been clarified. In this study, we found that histatin 3, a member of the histatin family, binds to heat shock cognate protein 70 (HSC70). These proteins were co-localized in the cytoplasm and nucleus in human gingival fibroblasts following non-heat and heat shock. Histatin 3 induced stimulation of DNA synthesis and cell survival in human gingival fibroblasts in a dose-dependent manner. This DNA synthesis was found to be dependent on HSC70 by knockdown experiments. The effect of heat shock on DNA synthesis induced by histatin 3 was similar to 2-fold higher than that of non-heat shock. When the histatin 3 uptake into cells was inhibited by monodansylcadaverine or when histatin 3 binding to HSC70 was precluded by 15-deoxyspergualin, DNA synthesis by histatin 3 was similar to 2-fold less than that without monodansylcadaverine or 15-deoxyspergualin. Although HSC70 directly bound to p27(Kip1) (a cyclin-dependent kinase inhibitor), histatin 3 increased the binding between those proteins but not with a peptide capable of binding to HSC70. Moreover histatin 3 prevented ATP-dependent dissociation of HSC70-p27(Kip1). ATP was unable to form a histatin 3-HSC70(D10N)-p27(Kip1) complex (HSC70(D10N) is a mutant attenuating ATPase activity). These findings suggest that histatin 3 may be involved in cell proliferation through the regulation of HSC70 and p27(Kip1) in oral cells.	[Imamura, Yasuhiro; Wang, Pao-Li] Matsumoto Dent Univ, Dept Pharmacol, Nagano 3990781, Japan; [Fujigaki, Yoshihisa] Matsumoto Dent Univ, Dept Community Dent, Nagano 3990781, Japan; [Oomori, Yuriko] Matsumoto Dent Univ, Dept Special Patient & Oral Care, Nagano 3990781, Japan; [Usui, Syuhei] Matsumoto Dent Univ, Dept Periodontol, Nagano 3990781, Japan	Matsumoto Dental University; Matsumoto Dental University; Matsumoto Dental University; Matsumoto Dental University	Wang, PL (corresponding author), Matsumoto Dent Univ, Dept Pharmacol, 1780 Gohbara, Nagano 3990781, Japan.	ohhourei@po.mdu.ac.jp			grant-in-aid for scientific research (C)	grant-in-aid for scientific research (C)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a grant-in-aid for scientific research (C).	BUCHBERGER A, 1995, J BIOL CHEM, V270, P16903, DOI 10.1074/jbc.270.28.16903; CHAPPELL TG, 1986, CELL, V45, P3, DOI 10.1016/0092-8674(86)90532-5; Connor MK, 2003, MOL BIOL CELL, V14, P201, DOI 10.1091/mbc.E02-06-0319; CRAIG EA, 1991, TRENDS BIOCHEM SCI, V16, P135, DOI 10.1016/0968-0004(91)90055-Z; DAVIES PJA, 1980, NATURE, V283, P162, DOI 10.1038/283162a0; DELUCAFLAHERTY C, 1990, CELL, V62, P875, DOI 10.1016/0092-8674(90)90263-E; ELLIS RJ, 1991, ANNU REV BIOCHEM, V60, P321, DOI 10.1146/annurev.bi.60.070191.001541; Fitzgerald DH, 2003, FEMS MICROBIOL LETT, V220, P247, DOI 10.1016/S0378-1097(03)00121-6; Gusman H, 2001, FEBS LETT, V489, P97, DOI 10.1016/S0014-5793(01)02077-4; HUANG SP, 1993, J BIOL CHEM, V268, P2063; IMAMURA T, 1990, SCIENCE, V249, P1567, DOI 10.1126/science.1699274; Imamura Y, 2004, J BIOL CHEM, V279, P26425, DOI 10.1074/jbc.M403685200; Komi A, 1998, EXP CELL RES, V243, P408, DOI 10.1006/excr.1998.4176; Kose S, 2005, J CELL BIOL, V171, P19, DOI 10.1083/jcb.200506074; LAL K, 1992, J ACQ IMMUN DEF SYND, V5, P904; Lamian V, 1996, EXP CELL RES, V228, P84, DOI 10.1006/excr.1996.0302; Lin YZ, 1996, J BIOL CHEM, V271, P5305, DOI 10.1074/jbc.271.10.5305; Lindhe J, 2003, CLIN PERIODONTOLOGY, P19; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; Malicet C, 2006, BIOCHEM BIOPH RES CO, V339, P284, DOI 10.1016/j.bbrc.2005.11.018; MANDELL RB, 1990, J CELL BIOL, V111, P1775, DOI 10.1083/jcb.111.5.1775; MIRALSKI KL, 1989, J CELL BIOL, V108, P413; Montagnoli A, 1999, GENE DEV, V13, P1181, DOI 10.1101/gad.13.9.1181; MURAKAMI Y, 1994, BIOCHEM BIOPH RES CO, V198, P274, DOI 10.1006/bbrc.1994.1038; Murray AW, 2004, CELL, V116, P221, DOI 10.1016/S0092-8674(03)01080-8; NADEAU K, 1994, BIOCHEMISTRY-US, V33, P2561, DOI 10.1021/bi00175a027; NADLER SG, 1992, SCIENCE, V258, P484, DOI 10.1126/science.1411548; Nakamura S, 1999, BIOCHEM BIOPH RES CO, V257, P340, DOI 10.1006/bbrc.1999.0442; Nakayama K, 1998, BIOESSAYS, V20, P1020, DOI 10.1002/(SICI)1521-1878(199812)20:12<1020::AID-BIES8>3.0.CO;2-D; NISHIKATA M, 1991, BIOCHEM BIOPH RES CO, V174, P625, DOI 10.1016/0006-291X(91)91463-M; OPPENHEIM FG, 1988, J BIOL CHEM, V263, P7472; OPPENHEIM FG, 1986, J BIOL CHEM, V261, P1177; Panjwani N, 1999, J IMMUNOL, V163, P1936; PERINPANAYAGAM HER, 1995, J DENT RES, V74, P345, DOI 10.1177/00220345950740011001; POLLOCK JJ, 1984, INFECT IMMUN, V44, P702, DOI 10.1128/IAI.44.3.702-707.1984; POLYAK K, 1994, CELL, V78, P59, DOI 10.1016/0092-8674(94)90572-X; RAJI PA, 1990, J BIOL CHEM, V265, P3898; RAPAPORT E, 1979, P NATL ACAD SCI USA, V76, P1643, DOI 10.1073/pnas.76.4.1643; SABATINI LM, 1989, BIOCHEM BIOPH RES CO, V160, P495, DOI 10.1016/0006-291X(89)92460-1; Sheaff RJ, 1997, GENE DEV, V11, P1464, DOI 10.1101/gad.11.11.1464; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Sullivan CS, 2002, MICROBIOL MOL BIOL R, V66, P179, DOI 10.1128/MMBR.66.2.179-202.2002; Takeda S, 1996, BIOCHEMISTRY-US, V35, P4636, DOI 10.1021/bi952903o; Tenovuo J, 1998, ACTA ODONTOL SCAND, V56, P250, DOI 10.1080/000163598428400; Tomoda K, 1999, NATURE, V398, P160, DOI 10.1038/18230; TOYOSHIMA H, 1994, CELL, V78, P67, DOI 10.1016/0092-8674(94)90573-8; TROXLER RF, 1990, J DENT RES, V69, P2, DOI 10.1177/00220345900690010101; Tsuji S, 2001, J EXP MED, V194, P529, DOI 10.1084/jem.194.4.529; Tsukahara F, 2004, J BIOL CHEM, V279, P8867, DOI 10.1074/jbc.M308848200; Urushitani M, 2004, J NEUROCHEM, V90, P231, DOI 10.1111/j.1471-4159.2004.02486.x; Vlach J, 1997, EMBO J, V16, P5334, DOI 10.1093/emboj/16.17.5334; WANG PL, 2005, DENT JPN, V41, P39; WELCH WJ, 1988, J CELL BIOL, V106, P1117, DOI 10.1083/jcb.106.4.1117; XEUWEI S, 2003, J BIOL CHEM, V278, P28553; XU T, 1991, INFECT IMMUN, V59, P2549, DOI 10.1128/IAI.59.8.2549-2554.1991; XU T, 1990, J DENT RES, V69, P1717, DOI 10.1177/00220345900690110301; Zeise E, 1998, CELL STRESS CHAPERON, V3, P94, DOI 10.1379/1466-1268(1998)003<0094:NTOSPH>2.3.CO;2	57	18	19	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14316	14325		10.1074/jbc.M807278200	http://dx.doi.org/10.1074/jbc.M807278200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19321452	Green Published, hybrid			2022-12-27	WOS:000266286100038
J	Sivashanmugam, A; Wang, JJ				Sivashanmugam, Arun; Wang, Jianjun			A Unified Scheme for Initiation and Conformational Adaptation of Human Apolipoprotein E N-terminal Domain upon Lipoprotein Binding and for Receptor Binding Activity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LDL-RECEPTOR; LIPID-BINDING; EXCHANGEABLE APOLIPOPROTEIN; APOLIPOPHORIN-III; CHEMICAL-SHIFT; PROTEIN; ASSIGNMENT; APOE; CHOLESTEROL; TRANSPORT	We report here a high-resolution NMR structure of the complete receptor-binding domain of human apolipoprotein E3 (apoE3-NT). Similar to the crystal structure of apoE-NT, the NMR structure displayed an elongated four-helix bundle. However, additional unique structural features were also observed. The segments in the N and C termini, which were missing in the crystal structure, formed alpha-helices having extensive tertiary contacts with the bundle, which oriented these short helices at specific positions for receptor binding activity. Several buried hydrophilic residues observed in the bundle were located strategically between helices 1 and 2 and between helices 3 and 4, significantly destabilizing these helix-helix interfaces. In addition, these buried hydrophilic residues formed buried H-bonds, which may play a key role in specific lipid-free helix bundle recovery. A short helix, nHelix C, was fully solvent-exposed and nearly perpendicular to the bundle. This short helix likely plays a critical role in initiating protein-lipid interaction, causing a preferred conformational adaptation of the bundle at the weaker helix-helix interfaces. This produces an open conformation with two lobes of helices, helices 1 and 4 and helices 2 and 3, which may be the competent conformation for receptor binding activity. Thus, the NMR structure suggests a unified scheme for the initiation and helix bundle opening of apoE-NT upon lipoprotein-binding and for receptor binding activity.	[Sivashanmugam, Arun; Wang, Jianjun] Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA	Wayne State University	Wang, JJ (corresponding author), Wayne State Univ, Sch Med, Dept Biochem & Mol Biol, Detroit, MI 48201 USA.	jjwang@med.wayne.edu			National Institutes of Health [RO1 HL074365]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL074365] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1 HL074365 (to J.W.).	BREITER DR, 1991, BIOCHEMISTRY-US, V30, P603, DOI 10.1021/bi00217a002; BRYSON JW, 1995, SCIENCE, V270, P935, DOI 10.1126/science.270.5238.935; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Eghbalnia HR, 2005, J BIOMOL NMR, V32, P71, DOI 10.1007/s10858-005-5705-1; Fan DP, 2003, J BIOL CHEM, V278, P21212, DOI 10.1074/jbc.M208486200; Fisher C, 2006, MOL CELL, V22, P277, DOI 10.1016/j.molcel.2006.02.021; Fisher CA, 1999, J LIPID RES, V40, P93; Fisher CA, 2000, J BIOL CHEM, V275, P33601, DOI 10.1074/jbc.M002643200; Fisher CA, 1997, BIOCHEM CELL BIOL, V75, P45, DOI 10.1139/bcb-75-1-45; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Gupta V, 2006, J BIOL CHEM, V281, P39294, DOI 10.1074/jbc.M608085200; Hatters DM, 2006, TRENDS BIOCHEM SCI, V31, P445, DOI 10.1016/j.tibs.2006.06.008; Hatters DM, 2005, J BIOL CHEM, V280, P26477, DOI 10.1074/jbc.M503910200; HUANG YD, 1994, P NATL ACAD SCI USA, V91, P1834, DOI 10.1073/pnas.91.5.1834; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; LALAZAR A, 1989, J BIOL CHEM, V264, P8447; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lu B, 2000, J BIOL CHEM, V275, P20775, DOI 10.1074/jbc.M003508200; Mahley RW, 2006, J CLIN INVEST, V116, P1226, DOI 10.1172/JCI28632; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; Morrow JA, 2000, J BIOL CHEM, V275, P2576, DOI 10.1074/jbc.275.4.2576; Peters-Libeu CA, 2006, J BIOL CHEM, V281, P1073, DOI 10.1074/jbc.M510851200; Redmond KA, 2006, FEBS J, V273, P558, DOI 10.1111/J.1742-4658.2005.05089.X; Rudenko G, 2003, CURR OPIN STRUC BIOL, V13, P683, DOI 10.1016/j.sbi.2003.10.001; Rudenko G, 2002, SCIENCE, V298, P2353, DOI 10.1126/science.1078124; Ruiz J, 2005, J LIPID RES, V46, P1721, DOI 10.1194/jlr.M500114-JLR200; Segelke BW, 2000, PROTEIN SCI, V9, P886, DOI 10.1110/ps.9.5.886; Wang JJ, 2002, P NATL ACAD SCI USA, V99, P1188, DOI 10.1073/pnas.032565999; WARDELL MR, 1991, J LIPID RES, V32, P521; WEISGRABER KH, 1994, ADV PROTEIN CHEM, V45, P249; Willard L, 2003, NUCLEIC ACIDS RES, V31, P3316, DOI 10.1093/nar/gkg565; WILSON C, 1991, SCIENCE, V252, P1817, DOI 10.1126/science.2063194; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; Xu C, 2005, J BIOMOL NMR, V32, P177, DOI 10.1007/s10858-005-6729-2; Zhang YH, 2007, BIOCHEMISTRY-US, V46, P10722, DOI 10.1021/bi700672v; Zhang YH, 2008, BIOMOL NMR ASSIGN, V2, P207, DOI 10.1007/s12104-008-9122-8; Zheng Y, 2004, J BIOMOL NMR, V30, P423, DOI 10.1007/s10858-004-4345-1	39	38	38	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14657	14666		10.1074/jbc.M901012200	http://dx.doi.org/10.1074/jbc.M901012200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19307174	hybrid, Green Published			2022-12-27	WOS:000266286100071
J	Kaminska, M; Havrylenko, S; Decottignies, P; Le Marechal, P; Negrutskii, B; Mirande, M				Kaminska, Monika; Havrylenko, Svitlana; Decottignies, Paulette; Le Marechal, Pierre; Negrutskii, Boris; Mirande, Marc			Dynamic Organization of Aminoacyl-tRNA Synthetase Complexes in the Cytoplasm of Human Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-PROTEIN INTERACTIONS; ELONGATION FACTOR-I; MACROMOLECULAR COMPLEXES; POLYPEPTIDE COMPONENTS; MAMMALIAN-CELLS; TRANSLATION; LOCALIZATION; RABBIT; SHEEP; ASSOCIATION	The localization in space and in time of proteins within the cytoplasm of eukaryotic cells is a central question of the cellular compartmentalization of metabolic pathways. The assembly of proteins within stable or transient complexes plays an essential role in this process. Here, we examined the subcellular localization of the multi-aminoacyl-tRNA synthetase complex in human cells. The sequestration of its components within the cytoplasm rests on the presence of the eukaryotic-specific polypeptide extensions that characterize the human enzymes, as compared with their prokaryotic counterparts. The cellular mobility of several synthetases, assessed by measuring fluorescence recovery after photobleaching, suggested that they are not freely diffusible within the cytoplasm. Several of these enzymes, isolated by tandem affinity purification, were copurified with ribosomal proteins and actin. The capacity of aminoacyl-tRNA synthetases to interact with polyribosomes and with the actin cytoskeleton impacts their subcellular localization and mobility. Our observations have conceptual implications for understanding how translation machinery is organized in vivo.	[Kaminska, Monika; Havrylenko, Svitlana; Mirande, Marc] CNRS, Lab Enzymol & Biochim Struct, F-91190 Gif Sur Yvette, France; [Havrylenko, Svitlana; Negrutskii, Boris] Inst Mol Biol & Genet, UA-03143 Kiev, Ukraine; [Decottignies, Paulette; Le Marechal, Pierre] Univ Paris 11, CNRS, UMR 8619, Inst Biochim & Biophys Mol & Cellulaire, F-91405 Orsay, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; National Academy of Sciences Ukraine; Institute of Molecular Biology & Genetics of NASU; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Mirande, M (corresponding author), CNRS, Lab Enzymol & Biochim Struct, 1 Ave Terrasse, F-91190 Gif Sur Yvette, France.	Marc.Mirande@lebs.cnrs-gif.fr	Negrutskii, Boris/G-6439-2016	Negrutskii, Boris/0000-0001-5974-1629	CNRS; Association pour la Recherche sur le Cancer; La Ligue; Fondation pour la Recherche Medicale; Bourse du Gouvernement Francais	CNRS(Centre National de la Recherche Scientifique (CNRS)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); La Ligue; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Bourse du Gouvernement Francais	This work was supported by grants from CNRS, the Association pour la Recherche sur le Cancer, and La Ligue.; Recipient of postdoctoral fellowships from the Fondation pour la Recherche Medicale and Association pour la Recherche sur le Cancer. Present address: Institut Pasteur, Unite de Biochimie Structurale et Cellulaire, 25 Rue du Docteur Roux, 75015 Paris, France.; Recipient of a Bourse du Gouvernement Francais.	BARBARESE E, 1995, J CELL SCI, V108, P2781; Barton GM, 2002, P NATL ACAD SCI USA, V99, P14943, DOI 10.1073/pnas.242594499; Beaulande M, 2001, FEBS LETT, V494, P170, DOI 10.1016/S0014-5793(01)02340-7; BEC G, 1989, J BIOL CHEM, V264, P21131; Bouwmeester T, 2004, NAT CELL BIOL, V6, P97, DOI 10.1038/ncb1086; Cahuzac B, 2000, EMBO J, V19, P445, DOI 10.1093/emboj/19.3.445; Corti O, 2003, HUM MOL GENET, V12, P1427, DOI 10.1093/hmg/ddg159; Czaplinski K, 2006, TRENDS BIOCHEM SCI, V31, P687, DOI 10.1016/j.tibs.2006.10.007; DANG CV, 1983, J CELL BIOL, V96, P1138, DOI 10.1083/jcb.96.4.1138; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Gross SR, 2007, MOL CELL BIOL, V27, P1974, DOI 10.1128/MCB.00832-06; Hudder A, 2003, MOL CELL BIOL, V23, P9318, DOI 10.1128/MCB.23.24.9318-9326.2003; Kaminska M, 2001, BIOCHEMISTRY-US, V40, P14309, DOI 10.1021/bi015670b; Kaminska M, 2009, J BIOL CHEM, V284, P6053, DOI 10.1074/jbc.M809636200; KAO J, 1994, J BIOL CHEM, V269, P9774; Kapp LD, 2004, ANNU REV BIOCHEM, V73, P657, DOI 10.1146/annurev.biochem.73.030403.080419; Ko YG, 2001, J BIOL CHEM, V276, P23028, DOI 10.1074/jbc.M101544200; Ko YG, 2000, J CELL BIOL, V149, P567, DOI 10.1083/jcb.149.3.567; Lecuyer E, 2007, CELL, V131, P174, DOI 10.1016/j.cell.2007.08.003; Lee SW, 2004, J CELL SCI, V117, P3725, DOI 10.1242/jcs.01342; Lee YN, 2005, MOL CELL BIOL, V25, P8904, DOI 10.1128/MCB.25.20.8904-8912.2005; LUBYPHELPS K, 1994, CURR OPIN CELL BIOL, V6, P3, DOI 10.1016/0955-0674(94)90109-0; MIRANDE M, 1982, J BIOL CHEM, V257, P1056; MIRANDE M, 1982, J BIOL CHEM, V257, P1049; MIRANDE M, 1985, EXP CELL RES, V156, P91, DOI 10.1016/0014-4827(85)90264-2; MIRANDE M, 2005, AMINOACYL TRNA SYNTH, P298; MOTORIN YA, 1988, FEBS LETT, V238, P262, DOI 10.1016/0014-5793(88)80492-7; Negrutskii BS, 1999, J BIOL CHEM, V274, P4545, DOI 10.1074/jbc.274.8.4545; PAILLIEZ JP, 1984, J BIOL CHEM, V259, P5491; POPENKO VI, 1994, EUR J CELL BIOL, V65, P60; Robinson JC, 2000, J MOL BIOL, V304, P983, DOI 10.1006/jmbi.2000.4242; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Sampath P, 2004, CELL, V119, P195, DOI 10.1016/j.cell.2004.09.030; Sanders J, 1996, J CELL SCI, V109, P1113; Shalak V, 2007, J BIOL CHEM, V282, P10935, DOI 10.1074/jbc.M611737200; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Stapulionis R, 1997, J BIOL CHEM, V272, P24980, DOI 10.1074/jbc.272.40.24980; Tiedge H, 1996, J NEUROSCI, V16, P7171; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; USSERY MA, 1977, EUR J BIOCHEM, V72, P491, DOI 10.1111/j.1432-1033.1977.tb11272.x	40	52	60	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13746	13754		10.1074/jbc.M900480200	http://dx.doi.org/10.1074/jbc.M900480200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19289464	Green Published, hybrid			2022-12-27	WOS:000265877300052
J	Yang, HB; Xiang, J; Wang, ND; Zhao, Y; Hyman, J; Li, S; Jiang, J; Chen, JK; Yang, Z; Lin, S				Yang, Hongbo; Xiang, Jing; Wang, Nengdong; Zhao, Yun; Hyman, Joel; Li, Song; Jiang, Jin; Chen, James K.; Yang, Zhen; Lin, Shuo			Converse Conformational Control of Smoothened Activity by Structurally Related Small Molecules	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEDGEHOG SIGNALING PATHWAY; BASAL-CELL CARCINOMA; SONIC HEDGEHOG; HUMAN HOMOLOG; BRAIN-TUMORS; FLOOR PLATE; MEDULLOBLASTOMA; INHIBITION; PROLIFERATION; CYCLOPAMINE	The seven-pass transmembrane protein Smoothened (Smo) is an essential component of the Hedgehog (Hh) signaling pathway that is critically involved in normal animal development as well as pathological malignancies. In studying Hh-related biological processes, it would be highly desirable if Smo activity could be instantly switched between activation and inhibition. Using Gli1-dependent GFP transgenic zebrafish and in vitro biochemical assays, we identified and characterized two potent Smo inhibitors, SANT74 and 75 (Smoothened antagonist 74 and 75), by screening a small molecule library designed based on the scaffold of Smo agonist SAG. These compounds are structural analogs of SAG with the methyl group substituted by a propyl or allyl group in SANTs. We show that SANTs and SAG exert opposite effects on Smo activity by regulating protein conformation. Our study represents the first demonstration of conformational regulation of Smo by small molecule analogs, and the combinational use of these Smo modulators in a temporal controlled fashion should be useful for studying Hh biology.	[Yang, Hongbo; Xiang, Jing; Yang, Zhen; Lin, Shuo] Peking Univ, Shenzhen Grad Sch, Lab Chem Genom, Shenzhen 518055, Peoples R China; [Yang, Hongbo; Lin, Shuo] Peking Univ, Coll Life Sci, Beijing 100871, Peoples R China; [Xiang, Jing; Wang, Nengdong; Yang, Zhen] Peking Univ, Coll Chem & Mol Engn, Beijing 100871, Peoples R China; [Zhao, Yun] Univ Texas SW Med Ctr Dallas, Dept Dev Biol, Dallas, TX 75390 USA; [Zhao, Yun] Chinese Acad Sci, Inst Biochem & Cell Biol, Shanghai 200031, Peoples R China; [Hyman, Joel; Jiang, Jin; Chen, James K.] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Li, Song] Shenzhen Shengjie Biotech Co Ltd, Shenzhen 518055, Peoples R China; [Lin, Shuo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA	Peking University; University Town of Shenzhen; Peking University; Peking University; University of Texas System; University of Texas Southwestern Medical Center Dallas; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Stanford University; University of California System; University of California Los Angeles	Yang, Z (corresponding author), Peking Univ, Shenzhen Grad Sch, Lab Chem Genom, Shenzhen 518055, Peoples R China.	zyang@pku.edu.cn; shuolin@ucla.edu	Yang, Zhen/J-6306-2015; Chen, James/G-9972-2011	Yang, Zhen/0000-0001-8036-934X; Chen, James/0000-0002-9220-8436	National Science Foundation of China [20325208, 20225318, 20521202, 20672004]; Ministry of Education of China Program 985; Shenzhen Science and Technology Key Laboratory Promotion Fund; Instrumental Analysis Fund of Peking University; Sidney Kimmel Foundation for Cancer Research; Astellas USA Foundation; Brain Tumor Society/ Rachel Molly Markoff Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061269, R01GM067045] Funding Source: NIH RePORTER	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China Program 985; Shenzhen Science and Technology Key Laboratory Promotion Fund; Instrumental Analysis Fund of Peking University; Sidney Kimmel Foundation for Cancer Research; Astellas USA Foundation(Astellas Pharmaceuticals); Brain Tumor Society/ Rachel Molly Markoff Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Science Foundation of China Grants 20325208, 20225318, 20521202, and 20672004, Ministry of Education of China Program 985, the Shenzhen Science and Technology Key Laboratory Promotion Fund, the Instrumental Analysis Fund of Peking University, and funds from the Sidney Kimmel Foundation for Cancer Research (to J.K.C.), the Astellas USA Foundation (to J.K.C.), and the Brain Tumor Society/ Rachel Molly Markoff Foundation (to J.K.C.).	Berman DM, 2002, SCIENCE, V297, P1559, DOI 10.1126/science.1073733; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Chen W, 2004, SCIENCE, V306, P2257, DOI 10.1126/science.1104135; Cooper MK, 1998, SCIENCE, V280, P1603, DOI 10.1126/science.280.5369.1603; Corcoran RB, 2006, P NATL ACAD SCI USA, V103, P8408, DOI 10.1073/pnas.0602852103; Denef N, 2000, CELL, V102, P521, DOI 10.1016/S0092-8674(00)00056-8; Dwyer JR, 2007, J BIOL CHEM, V282, P8959, DOI 10.1074/jbc.M611741200; FISCHER J, 2006, ANALOGUE BASED DRUG, pR31; Frank-Kamenetsky Maria, 2002, J Biol, V1, P10, DOI 10.1186/1475-4924-1-10; Gailani MR, 1996, NAT GENET, V14, P78, DOI 10.1038/ng0996-78; Geng Ling, 2007, Angiogenesis, V10, P259, DOI 10.1007/s10456-007-9078-9; Gering M, 2005, DEV CELL, V8, P389, DOI 10.1016/j.devcel.2005.01.010; Hahn H, 1999, J MOL MED-JMM, V77, P459, DOI 10.1007/s001099900018; Jacob L, 2007, SCIENCE, V318, P66, DOI 10.1126/science.1147314; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Karhadkar SS, 2004, NATURE, V431, P707, DOI 10.1038/nature02962; Lee J, 2007, CHEMBIOCHEM, V8, P1916, DOI 10.1002/cbic.200700403; Lee Y, 2003, CANCER RES, V63, P5428; Nagase M, 2006, MICROVASC RES, V71, P85, DOI 10.1016/j.mvr.2005.11.006; Pepicelli CV, 1998, CURR BIOL, V8, P1083, DOI 10.1016/S0960-9822(98)70446-4; Pola R, 2001, NAT MED, V7, P706, DOI 10.1038/89083; ROELINK H, 1994, CELL, V76, P761, DOI 10.1016/0092-8674(94)90514-2; Rohatgi R, 2007, NAT CELL BIOL, V9, P1005, DOI 10.1038/ncb435; Romer JT, 2004, CANCER CELL, V6, P229, DOI 10.1016/j.ccr.2004.08.019; Sanchez P, 2005, MECH DEVELOP, V122, P223, DOI 10.1016/j.mod.2004.10.002; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Taipale J, 2000, NATURE, V406, P1005, DOI 10.1038/35023008; Tas S, 2004, EUR J DERMATOL, V14, P96; Tostar U, 2006, J PATHOL, V208, P17, DOI 10.1002/path.1882; Wang ND, 2008, J COMB CHEM, V10, P825, DOI 10.1021/cc800025n; Wechsler-Reya R, 2001, ANNU REV NEUROSCI, V24, P385, DOI 10.1146/annurev.neuro.24.1.385; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Williams JA, 2003, P NATL ACAD SCI USA, V100, P4616, DOI 10.1073/pnas.0732813100; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Zhao Y, 2007, NATURE, V450, P252, DOI 10.1038/nature06225	36	49	56	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 31	2009	284	31					20876	20884		10.1074/jbc.M807648200	http://dx.doi.org/10.1074/jbc.M807648200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	474WV	19366682	Green Published, hybrid			2022-12-27	WOS:000268316100051
J	Husain, M; Meggs, LG; Vashistha, H; Simoes, S; Griffiths, KO; Kumar, D; Mikulak, J; Mathieson, PW; Saleem, MA; Del Valle, L; Pina-Oviedo, S; Wang, JY; Seshan, SV; Malhotra, A; Reiss, K; Singhal, PC				Husain, Mohammad; Meggs, Leonard G.; Vashistha, Himanshu; Simoes, Sonia; Griffiths, Kevin O.; Kumar, Dileep; Mikulak, Joanna; Mathieson, Peter W.; Saleem, Moin A.; Del Valle, Luis; Pina-Oviedo, Sergio; Wang, Jin Ying; Seshan, Surya V.; Malhotra, Ashwani; Reiss, Krzysztof; Singhal, Pravin C.			Inhibition of p66ShcA Longevity Gene Rescues Podocytes from HIV-1-induced Oxidative Stress and Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HIV-ASSOCIATED NEPHROPATHY; SMALL INTERFERING RNA; BIOCHEMICAL-MECHANISMS; TRANSCRIPTION FACTORS; BASEMENT-MEMBRANE; TRANSGENIC MICE; CELL APOPTOSIS; EXPRESSION; DELETION; SURVIVAL	Glomerular visceral epithelial cells (podocytes) play a critical role in the pathogenesis of human immunodeficiency virus (HIV)-associated nephropathy. A key question concerns the mechanism(s) by which the HIV-1 genome alters the phenotype of the highly specialized, terminally differentiated podocytes. Here, using an in vitro system of conditionally immortalized differentiated human podocytes (CIDHPs), we document a pivotal role for the p66ShcA protein in HIV-1-induced reactive oxygen species generation and CIDHP apoptosis. CIDHP transfected with truncated HIV-1 construct (NL4-3) exhibit increased reactive oxygen species metabolism, DNA strand breaks, and a 5-fold increase in apoptosis, whereas the opposite was true for NL4-3/CIDHP co-transfected with mu-36p66ShcA (mu-36) dominant negative expression vector or isoform-specific p66-small interfering RNA. Phosphorylation at Ser-36 of the wild type p66ShcA protein, required for p66ShcA redox function and inhibition of the potent stress response regulator Foxo3a, was unchanged in mu-36/NL4-3/CIDHP but increased in NL4-3/CIDHP. Acute knockdown of Foxo3a by small interfering RNA induced a 50% increase in mu-36/NL4-3/CIDHP apoptosis, indicating that Foxo3a-dependent responses promote the survival phenotype in mu-36 cells. We conclude that inhibition of p66ShcA redox activity prevents generation of HIV-1 stress signals and activation of the CIDHP apoptosis program.	[Husain, Mohammad; Kumar, Dileep; Mikulak, Joanna; Singhal, Pravin C.] N Shore Long Isl Jewish Hlth Syst, Div Kidney Dis & Hypertens, Dept Med, New Hyde Pk, NY 11040 USA; [Meggs, Leonard G.; Vashistha, Himanshu; Simoes, Sonia; Griffiths, Kevin O.; Malhotra, Ashwani] Univ Med & Dent New Jersey, New Jersey Med Sch, Div Nephrol & Hypertens, Dept Med, Newark, NJ 07103 USA; [Mathieson, Peter W.; Saleem, Moin A.] Univ Bristol, Childrens Renal Unit, Bristol BS1 5NB, Avon, England; [Del Valle, Luis; Pina-Oviedo, Sergio; Wang, Jin Ying; Reiss, Krzysztof] Temple Univ, Sch Med, Dept Neurosci, Philadelphia, PA 19122 USA; [Seshan, Surya V.] Weil Cornell Med Sch, Dept Surg Pathol, New York, NY 10065 USA	Northwell Health; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of Bristol; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Qatar Foundation (QF); Weill Cornell Medical College Qatar	Singhal, PC (corresponding author), Div Kidney Dis & Hypertens, 100 Community Dr, Great Neck, NY 11021 USA.	singhal@lij.edu	Del Valle, Luis/J-4085-2015; mikulak, joanna/AAB-3070-2022; Oviedo, Sergio Pina/AAV-8814-2021	Del Valle, Luis/0000-0003-3894-9206; mikulak, joanna/0000-0001-8310-9543; Saleem, Moin/0000-0002-9808-4518; Singhal, Pravin/0000-0002-6898-358X; Husain, Mohammad/0000-0003-3876-8181	National Institutes of Health [RO1DA12111, 1RO1 HL072852, 1RO1 DK073793]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072852] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073793] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS043980, R01NS055644] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012111] Funding Source: NIH RePORTER; Medical Research Council [G0800200] Funding Source: researchfish; MRC [G0800200] Funding Source: UKRI	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1DA12111 (to P.C.S.), 1RO1 HL072852 (to A.M.), and 1RO1 DK073793 (to L.G.M.).	Abid R, 2004, ARTERIOSCL THROM VAS, V24, P294, DOI 10.1161/01.ATV.0000110502.10593.06; Barisoni L, 1999, J AM SOC NEPHROL, V10, P51; Barisoni L, 2000, KIDNEY INT, V58, P173, DOI 10.1046/j.1523-1755.2000.00152.x; Bruggeman LA, 1997, J CLIN INVEST, V100, P84, DOI 10.1172/JCI119525; Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001; Camici GG, 2007, P NATL ACAD SCI USA, V104, P5217, DOI 10.1073/pnas.0609656104; Chen JH, 2007, NUCLEIC ACIDS RES, V35, P7417, DOI 10.1093/nar/gkm681; Chintapalli J, 2007, AM J PHYSIOL-RENAL, V292, pF523, DOI 10.1152/ajprenal.00215.2006; Coward RJM, 2007, DIABETES, V56, P1127, DOI 10.2337/db06-0693; Cui M, 2008, J IMMUNOL, V180, P898, DOI 10.4049/jimmunol.180.2.898; DICKIE P, 1991, VIROLOGY, V185, P109, DOI 10.1016/0042-6822(91)90759-5; Furukawa-Hibi Y, 2002, J BIOL CHEM, V277, P26729, DOI 10.1074/jbc.C200256200; GOTTLIEB MS, 1986, MED CLIN N AM, V70, P651, DOI 10.1016/S0025-7125(16)30944-0; Gray F, 2000, J NEUROVIROL, V6, pS38; Hu YY, 2005, MOL BIOL CELL, V16, P3705, DOI 10.1091/mbc.E05-04-0301; Husain M, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000019642.55998.69; Kanmogne GD, 2005, BIOCHEM BIOPH RES CO, V333, P1107, DOI 10.1016/j.bbrc.2005.05.198; Kerjaschki D, 1996, J AM SOC NEPHROL, V7, P2518; Kisielow M, 2002, BIOCHEM J, V363, P1, DOI 10.1042/0264-6021:3630001; Kojima K, 2004, J AM SOC NEPHROL, V15, P2079, DOI 10.1097/01.ASN.0000133531.43177.21; KOPP JB, 1992, P NATL ACAD SCI USA, V89, P1577, DOI 10.1073/pnas.89.5.1577; Kriz W, 1998, KIDNEY INT, V54, P687, DOI 10.1046/j.1523-1755.1998.00044.x; Li JJ, 2007, KIDNEY INT, V72, pS36, DOI 10.1038/sj.ki.5002384; Macho A, 1999, ONCOGENE, V18, P7543, DOI 10.1038/sj.onc.1203095; Marras D, 2002, NAT MED, V8, P522, DOI 10.1038/nm0502-522; Mattson MP, 2005, CELL DEATH DIFFER, V12, P893, DOI 10.1038/sj.cdd.4401577; Menini S, 2006, DIABETES, V55, P1642, DOI 10.2337/db05-1477; Migliaccio E, 1999, NATURE, V402, P309, DOI 10.1038/46311; Monks TJ, 2006, DRUG METAB REV, V38, P755, DOI 10.1080/03602530600959649; Napoli C, 2003, P NATL ACAD SCI USA, V100, P2112, DOI 10.1073/pnas.0336359100; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; Passes JF, 2007, BIOESSAYS, V29, P908, DOI 10.1002/bies.20634; Perry SW, 2005, J IMMUNOL, V174, P4333, DOI 10.4049/jimmunol.174.7.4333; Ravichandran KS, 2001, ONCOGENE, V20, P6322, DOI 10.1038/sj.onc.1204776; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Salih DAM, 2008, CURR OPIN CELL BIOL, V20, P126, DOI 10.1016/j.ceb.2008.02.005; Selliah N, 2001, CELL DEATH DIFFER, V8, P127, DOI 10.1038/sj.cdd.4400822; Wang HY, 2008, J BIOL CHEM, V283, P15845, DOI 10.1074/jbc.M800834200; Wei YH, 1998, P SOC EXP BIOL MED, V217, P53; Yang L, 2006, P NATL ACAD SCI USA, V103, P11479, DOI 10.1073/pnas.0604993103; Zhong JY, 2005, KIDNEY INT, V68, P1048, DOI 10.1111/j.1523-1755.2005.00497.x	41	44	44	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16648	16658		10.1074/jbc.M109.008482	http://dx.doi.org/10.1074/jbc.M109.008482			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19383602	Green Published, hybrid			2022-12-27	WOS:000266730900060
J	Siu, KL; Kok, KH; Ng, MHJ; Poon, VKM; Yuen, KY; Zheng, BJ; Jin, DY				Siu, Kam-Leung; Kok, Kin-Hang; Ng, Ming-Him James; Poon, Vincent K. M.; Yuen, Kwok-Yung; Zheng, Bo-Jian; Jin, Dong-Yan			Severe Acute Respiratory Syndrome Coronavirus M Protein Inhibits Type I Interferon Production by Impeding the Formation of TRAF3 center dot TANK center dot TBK1/IKK epsilon Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INFLUENZA-A-VIRUS; HOST GENE-EXPRESSION; NF-KAPPA-B; MEMBRANE-PROTEIN; RIG-I; ANTIVIRAL RESPONSES; SARS-CORONAVIRUS; NS1 PROTEIN; INNATE IMMUNITY; ACTIVATION	Severe acute respiratory syndrome (SARS) coronavirus is highly pathogenic in humans and evades innate immunity at multiple levels. It has evolved various strategies to counteract the production and action of type I interferons, which mobilize the front-line defense against viral infection. In this study we demonstrate that SARS coronavirus M protein inhibits gene transcription of type I interferons. M protein potently antagonizes the activation of interferon-stimulated response element-dependent transcription by double-stranded RNA, RIG-I, MDA5, TBK1, IKK epsilon, and virus-induced signaling adaptor (VISA) but has no influence on the transcriptional activity of this element when IRF3 or IRF7 is overexpressed. M protein physically associates with RIG-I, TBK1, IKK epsilon, and TRAF3 and likely sequesters some of them in membrane-associated cytoplasmic compartments. Consequently, the expression of M protein prevents the formation of TRAF3 center dot TANK center dot TBK1/IKK epsilon complex and thereby inhibits TBK1/IKK epsilon-dependent activation of IRF3/IRF7 transcription factors. Taken together, our findings reveal a new mechanism by which SARS coronavirus circumvents the production of type I interferons.	[Siu, Kam-Leung; Kok, Kin-Hang; Ng, Ming-Him James; Jin, Dong-Yan] Univ Hong Kong, Dept Biochem, Pokfulam, Hong Kong, Peoples R China; [Poon, Vincent K. M.; Yuen, Kwok-Yung; Zheng, Bo-Jian] Univ Hong Kong, Dept Microbiol, Pokfulam, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Jin, DY (corresponding author), Univ Hong Kong, Dept Biochem, 21 Sassoon Rd, Pokfulam, Hong Kong, Peoples R China.	dyjin@hkucc.hku.hk	Kok, Kin-Hang/C-4184-2009	Yuen, Kwok-yung/0000-0002-2083-1552; Poon, Vincent kwok-man/0000-0002-7737-8912	Research Fund for the Control of Infectious Disease [04050052]; Research Council of Hong Kong Food and Health Bureau	Research Fund for the Control of Infectious Disease; Research Council of Hong Kong Food and Health Bureau	This work was supported by the Research Fund for the Control of Infectious Disease (Project 04050052) from the Research Council of Hong Kong Food and Health Bureau.	Alff PJ, 2008, J VIROL, V82, P9115, DOI 10.1128/JVI.00290-08; Borden EC, 2007, NAT REV DRUG DISCOV, V6, P975, DOI 10.1038/nrd2422; Chan CM, 2007, ARCH BIOCHEM BIOPHYS, V459, P197, DOI 10.1016/j.abb.2007.01.012; Chan CP, 2006, J VIROL, V80, P9279, DOI 10.1128/JVI.00659-06; Cheng VCC, 2007, CLIN MICROBIOL REV, V20, P660, DOI 10.1128/CMR.00023-07; Chin KT, 2007, CANCER RES, V67, P1072, DOI 10.1158/0008-5472.CAN-06-3053; Ching YP, 2006, NAT CELL BIOL, V8, P717, DOI 10.1038/ncb1432; Choy EYW, 2008, J EXP MED, V205, P2551, DOI 10.1084/jem.20072581; Devaraj SG, 2007, J BIOL CHEM, V282, P32208, DOI 10.1074/jbc.M704870200; Doyle SE, 2002, IMMUNITY, V17, P251, DOI 10.1016/S1074-7613(02)00390-4; Fang XN, 2007, J MED VIROL, V79, P1431, DOI 10.1002/jmv.20953; Frieman M, 2008, MICROBIOL MOL BIOL R, V72, P672, DOI 10.1128/MMBR.00015-08; Frieman M, 2007, J VIROL, V81, P9812, DOI 10.1128/JVI.01012-07; Guo BC, 2007, J BIOL CHEM, V282, P11817, DOI 10.1074/jbc.M700017200; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hatakeyama S, 2008, VIROLOGY, V380, P99, DOI 10.1016/j.virol.2008.07.012; He LS, 2006, J BIOL CHEM, V281, P11235, DOI 10.1074/jbc.M508779200; Hiscott J, 2007, J BIOL CHEM, V282, P15325, DOI 10.1074/jbc.R700002200; Hussain S, 2008, J VIROL, V82, P7212, DOI 10.1128/JVI.02406-07; Ishitani T, 2003, EMBO J, V22, P6277, DOI 10.1093/emboj/cdg605; Kamitani W, 2006, P NATL ACAD SCI USA, V103, P12885, DOI 10.1073/pnas.0603144103; Kok KH, 2006, J GEN VIROL, V87, P2639, DOI 10.1099/vir.0.81764-0; Kopecky-Bromberg SA, 2007, J VIROL, V81, P548, DOI 10.1128/JVI.01782-06; LAUDE H, 1992, J VIROL, V66, P743, DOI 10.1128/JVI.66.2.743-749.1992; Li W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001487; Lin RT, 1998, MOL CELL BIOL, V18, P2986, DOI 10.1128/MCB.18.5.2986; Ma HC, 2008, J BIOMED SCI, V15, P301, DOI 10.1007/s11373-008-9235-1; Masters PS, 2006, ADV VIRUS RES, V66, P193, DOI 10.1016/S0065-3527(06)66005-3; Mibayashi M, 2007, J VIROL, V81, P514, DOI 10.1128/JVI.01265-06; Moore CB, 2008, NATURE, V451, P573, DOI 10.1038/nature06501; Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715; Nal B, 2005, J GEN VIROL, V86, P1423, DOI 10.1099/vir.0.80671-0; Narayananj K, 2008, J VIROL, V82, P4471, DOI 10.1128/JVI.02472-07; Netland J, 2007, J VIROL, V81, P11520, DOI 10.1128/JVI.01308-07; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Oganesyan G, 2006, NATURE, V439, P208, DOI 10.1038/nature04374; Oostra M, 2006, J VIROL, V80, P2326, DOI 10.1128/JVI.80.5.2326-2336.2006; Opitz B, 2007, CELL MICROBIOL, V9, P930, DOI 10.1111/j.1462-5822.2006.00841.x; Pacciarini F, 2008, J VIROL, V82, P5137, DOI 10.1128/JVI.00096-08; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Prins KC, 2009, J VIROL, V83, P3069, DOI 10.1128/JVI.01875-08; Randall RE, 2008, J GEN VIROL, V89, P1, DOI 10.1099/vir.0.83391-0; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Schafer SL, 1998, J BIOL CHEM, V273, P2714, DOI 10.1074/jbc.273.5.2714; Schroder M, 2008, EMBO J, V27, P2147, DOI 10.1038/emboj.2008.143; SIU KL, 2009, J GEN VIROL IN PRESS; Siu YL, 2008, J VIROL, V82, P11318, DOI 10.1128/JVI.01052-08; Siu YT, 2008, MOL BIOL CELL, V19, P4750, DOI 10.1091/mbc.E08-04-0369; Siu YT, 2006, J VIROL, V80, P7052, DOI 10.1128/JVI.00103-06; Soulat D, 2008, EMBO J, V27, P2135, DOI 10.1038/emboj.2008.126; Tan YJ, 2007, CELL MICROBIOL, V9, P2552, DOI 10.1111/j.1462-5822.2007.01034.x; Thiel V, 2008, CYTOKINE GROWTH F R, V19, P121, DOI 10.1016/j.cytogfr.2008.01.001; Wathelet MG, 2007, J VIROL, V81, P11620, DOI 10.1128/JVI.00702-07; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2007, J BIOL CHEM, V282, P15315, DOI 10.1074/jbc.R700007200; Zhang LW, 2000, J VIROL, V74, P1061, DOI 10.1128/JVI.74.3.1061-1068.2000; Zust R, 2007, PLOS PATHOG, V3, P1062, DOI 10.1371/journal.ppat.0030109	59	223	240	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16202	16209		10.1074/jbc.M109.008227	http://dx.doi.org/10.1074/jbc.M109.008227			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19380580	Green Published, hybrid			2022-12-27	WOS:000266730900017
J	Dowen, RH; Engel, JL; Shao, F; Ecker, JR; Dixon, JE				Dowen, Robert H.; Engel, James L.; Shao, Feng; Ecker, Joseph R.; Dixon, Jack E.			A Family of Bacterial Cysteine Protease Type III Effectors Utilizes Acylation-dependent and -independent Strategies to Localize to Plasma Membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLANT IMMUNE-SYSTEM; SYRINGAE PV PHASEOLICOLA; DISEASE RESISTANCE GENE; PSEUDOMONAS-SYRINGAE; N-MYRISTOYLATION; INNATE IMMUNITY; TOMATO DC3000; ARABIDOPSIS-THALIANA; SIGNAL-TRANSDUCTION; AVIRULENCE GENES	Bacterial phytopathogens employ a type III secretion system to deliver effector proteins into the plant cell to suppress defense pathways; however, the molecular mechanisms and subcellular localization strategies that drive effector function largely remain a mystery. Here, we demonstrate that the plant plasma membrane is the primary site for subcellular localization of the Pseudomonas syringae effector AvrPphB and five additional cysteine protease family members. AvrPphB and two AvrPphB-like effectors, ORF4 and NopT, autoproteolytically process following delivery into the plant cell to expose embedded sites for fatty acylation. Host-dependent lipidation of these three effectors directs plasma membrane localization and is required for the avirulence activity of AvrPphB. Surprisingly, the AvrPphB-like effectors RipT, HopC1, and HopN1 utilize an acylation-independent mechanism to localize to the cellular plasma membrane. Although some AvrPphB-like effectors employ acylation-independent localization strategies, others hijack the eukaryotic lipidation machinery to ensure plasma membrane localization, illustrating the diverse tactics employed by type III effectors to target specific subcellular compartments.	[Ecker, Joseph R.] Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; [Dowen, Robert H.; Engel, James L.; Shao, Feng; Dixon, Jack E.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Dowen, Robert H.; Engel, James L.; Shao, Feng; Dixon, Jack E.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Dowen, Robert H.; Engel, James L.; Shao, Feng; Dixon, Jack E.] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Dowen, Robert H.] Univ Calif San Diego, Biomed Sci Grad Program, La Jolla, CA 92093 USA; [Dixon, Jack E.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA	Salk Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego	Ecker, JR (corresponding author), Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA.	ecker@salk.edu; jedixon@ucsd.edu	Ecker, Joseph R/B-9144-2008	Ecker, Joseph R/0000-0001-5799-5895	National Institutes of Health [AI060662]; Pharmacology Training [2 T32 GM07752-25]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI060662] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007752] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Pharmacology Training; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AI060662 ( to J.E.D.) and Pharmacology Training Grant 2 T32 GM07752-25 ( to R. H. D.).	Ade J, 2007, P NATL ACAD SCI USA, V104, P2531, DOI 10.1073/pnas.0608779104; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BERTHIAUME L, 1995, J BIOL CHEM, V270, P22399, DOI 10.1074/jbc.270.38.22399; BISGROVE SR, 1994, PLANT CELL, V6, P927, DOI 10.1105/tpc.6.7.927; Bologna G, 2004, PROTEOMICS, V4, P1626, DOI 10.1002/pmic.200300783; Chang JH, 2005, P NATL ACAD SCI USA, V102, P2549, DOI 10.1073/pnas.0409660102; Coaker G, 2005, SCIENCE, V308, P548, DOI 10.1126/science.1108633; Dai WJ, 2008, J BACTERIOL, V190, P5101, DOI 10.1128/JB.00306-08; DELANEY TP, 1994, SCIENCE, V266, P1247, DOI 10.1126/science.266.5188.1247; Deslandes L, 2003, P NATL ACAD SCI USA, V100, P8024, DOI 10.1073/pnas.1230660100; Dodds PN, 2006, P NATL ACAD SCI USA, V103, P8888, DOI 10.1073/pnas.0602577103; Dunphy JT, 1996, J BIOL CHEM, V271, P7154, DOI 10.1074/jbc.271.12.7154; Glover CJ, 1997, J BIOL CHEM, V272, P28680, DOI 10.1074/jbc.272.45.28680; Guttman DS, 2002, SCIENCE, V295, P1722, DOI 10.1126/science.295.5560.1722; Holt BF, 2005, SCIENCE, V309, P929, DOI 10.1126/science.1109977; HUYNH TV, 1989, SCIENCE, V245, P1374, DOI 10.1126/science.2781284; Jamir Y, 2004, PLANT J, V37, P554, DOI 10.1046/j.1365-313X.2003.01982.x; Jia Y, 2000, EMBO J, V19, P4004, DOI 10.1093/emboj/19.15.4004; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Lewis JD, 2008, J BACTERIOL, V190, P2880, DOI 10.1128/JB.01702-07; Lopez-Solanilla E, 2004, MOL MICROBIOL, V54, P353, DOI 10.1111/j.1365-2958.2004.04285.x; Mackey D, 2006, MOL MICROBIOL, V61, P1365, DOI 10.1111/j.1365-2958.2006.05311.x; Maurer-Stroh S, 2004, TRENDS MICROBIOL, V12, P178, DOI 10.1016/j.tim.2004.02.006; Nimchuk Z, 2000, CELL, V101, P353, DOI 10.1016/S0092-8674(00)80846-6; Nimchuk Z, 2003, ANNU REV GENET, V37, P579, DOI 10.1146/annurev.genet.37.110801.142628; Nobuta K, 2007, PLANT PHYSIOL, V144, P1144, DOI [10.1104/pp.107.097691, 10.1104/PP.107.097691]; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; PERRET X, 1991, P NATL ACAD SCI USA, V88, P1923, DOI 10.1073/pnas.88.5.1923; Petnicki-Ocwieja T, 2002, P NATL ACAD SCI USA, V99, P7652, DOI 10.1073/pnas.112183899; Podell S, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-37; Puri N, 1997, MOL PLANT MICROBE IN, V10, P247, DOI 10.1094/MPMI.1997.10.2.247; Resh MD, 1999, BBA-MOL CELL RES, V1451, P1, DOI 10.1016/S0167-4889(99)00075-0; Robert-Seilaniantz A, 2006, MOL PLANT MICROBE IN, V19, P130, DOI 10.1094/MPMI-19-0130; Roine E, 1997, P NATL ACAD SCI USA, V94, P3459, DOI 10.1073/pnas.94.7.3459; Scheel D, 1998, CURR OPIN PLANT BIOL, V1, P305, DOI 10.1016/1369-5266(88)80051-7; Shan LB, 2000, PLANT CELL, V12, P2323, DOI 10.1105/tpc.12.12.2323; Shan LB, 2008, CELL HOST MICROBE, V4, P17, DOI 10.1016/j.chom.2008.05.017; Shao F, 2002, CELL, V109, P575, DOI 10.1016/S0092-8674(02)00766-3; Shao F, 2003, SCIENCE, V301, P1230, DOI 10.1126/science.1085671; SIMONICH MT, 1995, MOL PLANT MICROBE IN, V8, P637, DOI 10.1094/MPMI-8-0637; Song JP, 1996, J BIOL CHEM, V271, P20273, DOI 10.1074/jbc.271.34.20273; Tampakaki AP, 2002, MOL PLANT MICROBE IN, V15, P292, DOI 10.1094/MPMI.2002.15.3.292; Thieme F, 2007, MOL PLANT MICROBE IN, V20, P1250, DOI 10.1094/MPMI-20-10-1250; Tornero P, 2001, PLANT J, V28, P475, DOI 10.1046/j.1365-313X.2001.01136.x; Utsumi T, 2001, J BIOL CHEM, V276, P10505, DOI 10.1074/jbc.M006134200; Wang XL, 2005, DEV CELL, V8, P855, DOI 10.1016/j.devcel.2005.05.001; Warren RF, 1999, GENETICS, V152, P401; Xiang TT, 2008, CURR BIOL, V18, P74, DOI 10.1016/j.cub.2007.12.020; Zha JP, 2000, SCIENCE, V290, P1761, DOI 10.1126/science.290.5497.1761; Zhu MF, 2004, P NATL ACAD SCI USA, V101, P302, DOI 10.1073/pnas.2036536100	50	75	75	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15867	15879		10.1074/jbc.M900519200	http://dx.doi.org/10.1074/jbc.M900519200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19346252	Green Published, hybrid			2022-12-27	WOS:000266501000055
J	MacDougall, DA; Wachten, S; Ciruela, A; Sinz, A; Cooper, DMF				MacDougall, David A.; Wachten, Sebastian; Ciruela, Antonio; Sinz, Andrea; Cooper, Dermot M. F.			Separate Elements within a Single IQ-like Motif in Adenylyl Cyclase Type 8 Impart Ca2+/Calmodulin Binding and Autoinhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAPACITATIVE CA2+ ENTRY; TARGET RECOGNITION; CRYSTAL-STRUCTURE; PEPTIDE COMPLEX; CALCIUM-ENTRY; INTACT-CELLS; CYCLIC-AMP; CALMODULIN; MECHANISMS; CHANNELS	The ubiquitous Ca2+-sensing protein calmodulin (CaM) fulfills its numerous signaling functions through a wide range of modular binding and activation mechanisms. By activating adenylyl cyclases (ACs) 1 and 8, Ca2+ acting via calmodulin impacts on the signaling of the other major cellular second messenger cAMP. In possessing two CaM-binding domains, a 1-5-8-14 motif at the N terminus and an IQ-like motif (IQlm) at the C terminus, AC8 offers particularly sophisticated regulatory possibilities. The IQlm has remained unexplored beyond the suggestion that it bound CaM, and the larger C2b region of which it is part was involved in the relief of autoinhibition of AC8. Here we attempt to distinguish the function of individual residues of the IQlm. From a complementary approach of in vitro and cell population AC activity assays, as well as CaM binding, we propose that the IQlm alone, and not the majority of the C2b, imparts CaM binding and autoinhibitory functions. Moreover, this duality of function is spatially separated and depends on amino acid side-chain character. Accordingly, residues critical for CaM binding are positively charged and clustered toward the C terminus, and those essential for the maintenance of autoinhibition are hydrophobic and more N-terminal. Secondary structure prediction of the IQlm supports this separation, with an ideally placed break in the alpha-helical nature of the sequence. We additionally find that the N and C termini of AC8 interact, which is an association specifically abrogated by fully Ca2+-bound, but not Ca2+-free, CaM. These data support a sophisticated activation mechanism of AC8 by CaM, in which the duality of the IQlm function is critical.	[MacDougall, David A.; Wachten, Sebastian; Ciruela, Antonio; Cooper, Dermot M. F.] Univ Cambridge, Dept Pharmacol, Cambridge CB2 1PD, England; [Sinz, Andrea] Univ Halle Wittenberg, Inst Pharm, D-06120 Halle, Saale, Germany	University of Cambridge; Martin Luther University Halle Wittenberg	Cooper, DMF (corresponding author), Univ Cambridge, Dept Pharmacol, Tennis Court Rd, Cambridge CB2 1PD, England.	dmfc2@cam.ac.uk		MacDougall, David/0000-0003-1811-288X	Wellcome Trust [RG31760]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by Wellcome Trust Grant RG31760.	BABU YS, 1985, NATURE, V315, P37, DOI 10.1038/315037a0; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; BERRIDGE MJ, 1995, BIOCHEM J, V312, P1, DOI 10.1042/bj3120001; Black DJ, 2004, CELL CALCIUM, V35, P415, DOI 10.1016/j.ceca.2003.10.005; Bootman MD, 2001, SEMIN CELL DEV BIOL, V12, P3, DOI 10.1006/scdb.2000.0211; BOYAJIAN CL, 1991, J BIOL CHEM, V266, P4995; BROOKS SPJ, 1992, ANAL BIOCHEM, V201, P119, DOI 10.1016/0003-2697(92)90183-8; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; Clapham DE, 2007, CELL, V131, P1047, DOI 10.1016/j.cell.2007.11.028; Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238; COOPER DMF, 1994, METHOD ENZYMOL, V238, P71; COOPER DMF, 1995, NATURE, V374, P421, DOI 10.1038/374421a0; Crossthwaite AJ, 2006, MOL PHARMACOL, V69, P608, DOI 10.1124/mol.105.018275; DeMaria CD, 2001, NATURE, V411, P484, DOI 10.1038/35078091; Dick IE, 2008, NATURE, V451, P830, DOI 10.1038/nature06529; EVANS T, 1984, MOL PHARMACOL, V26, P395; Fagan KA, 1996, J BIOL CHEM, V271, P12438, DOI 10.1074/jbc.271.21.12438; Gu C, 1999, J BIOL CHEM, V274, P8012, DOI 10.1074/jbc.274.12.8012; HALLING DB, 2006, SCI STKE, pER1, DOI DOI 10.1126/STKE.3152005RE15; Hoeflich KP, 2002, CELL, V108, P739, DOI 10.1016/S0092-8674(02)00682-7; Ihling C, 2006, J AM SOC MASS SPECTR, V17, P1100, DOI 10.1016/j.jasms.2006.04.020; IKURA M, 1992, SCIENCE, V256, P632, DOI 10.1126/science.1585175; JAMES P, 1995, TRENDS BIOCHEM SCI, V20, P38, DOI 10.1016/S0968-0004(00)88949-5; KRETSINGER RH, 1973, J BIOL CHEM, V248, P3313; KUBONIWA H, 1995, NAT STRUCT BIOL, V2, P768, DOI 10.1038/nsb0995-768; Lopez-Alcala C, 2008, J BIOL CHEM, V283, P10621, DOI 10.1074/jbc.M706238200; Masada N, 2009, J BIOL CHEM, V284, P4451, DOI 10.1074/jbc.M807359200; Matsubara M, 2004, EMBO J, V23, P712, DOI 10.1038/sj.emboj.7600093; MEADOR WE, 1993, SCIENCE, V262, P1718, DOI 10.1126/science.8259515; MEADOR WE, 1992, SCIENCE, V257, P1251, DOI 10.1126/science.1519061; Mochida S, 2008, NEURON, V57, P210, DOI 10.1016/j.neuron.2007.11.036; Osawa M, 1999, NAT STRUCT BIOL, V6, P819; Ostrom RS, 2004, BRIT J PHARMACOL, V143, P235, DOI 10.1038/sj.bjp.0705930; Persechini A, 1999, J BIOL CHEM, V274, P6827, DOI 10.1074/jbc.274.11.6827; PUTNEY JW, 1986, CELL CALCIUM, V7, P1, DOI 10.1016/0143-4160(86)90026-6; Rhoads AR, 1997, FASEB J, V11, P331, DOI 10.1096/fasebj.11.5.9141499; SALOMON Y, 1974, ANAL BIOCHEM, V58, P541, DOI 10.1016/0003-2697(74)90222-X; Schumacher MA, 2001, NATURE, V410, P1120, DOI 10.1038/35074145; Shen XC, 2005, P NATL ACAD SCI USA, V102, P5969, DOI 10.1073/pnas.0407928102; Simpson RE, 2006, J BIOL CHEM, V281, P17379, DOI 10.1074/jbc.M510992200; Smith KE, 2002, J BIOL CHEM, V277, P6025, DOI 10.1074/jbc.M109615200; Tadross MR, 2008, CELL, V133, P1228, DOI 10.1016/j.cell.2008.05.025; Tesmer JJG, 1997, SCIENCE, V278, P1907, DOI 10.1126/science.278.5345.1907; Van Petegem F, 2005, NAT STRUCT MOL BIOL, V12, P1108, DOI 10.1038/nsmb1027; Vetter SW, 2003, EUR J BIOCHEM, V270, P404, DOI 10.1046/j.1432-1033.2003.03414.x; White RR, 1998, J BIOL CHEM, V273, P3166, DOI 10.1074/jbc.273.6.3166; Willoughby D, 2006, J CELL SCI, V119, P828, DOI 10.1242/jcs.02812; Willoughby D, 2008, NAT METHODS, V5, P29, DOI 10.1038/NMETH1135	48	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15573	15588		10.1074/jbc.M809585200	http://dx.doi.org/10.1074/jbc.M809585200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19305019	Green Published			2022-12-27	WOS:000266501000026
J	Royer, MC; Lemaire-Ewing, S; Desrumaux, C; Monier, S; de Barros, JPP; Athias, A; Neel, D; Lagrost, L				Royer, Marie-Charlotte; Lemaire-Ewing, Stephanie; Desrumaux, Catherine; Monier, Serge; de Barros, Jean-Paul Pais; Athias, Anne; Neel, Dominique; Lagrost, Laurent			7-Ketocholesterol Incorporation into Sphingolipid/Cholesterol-enriched (Lipid Raft) Domains Is Impaired by Vitamin E A SPECIFIC ROLE FOR alpha-TOCOPHEROL WITH CONSEQUENCES ON CELL DEATH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LOW-DENSITY-LIPOPROTEIN; INDUCED APOPTOSIS; GAMMA-TOCOPHEROL; PHOSPHORYLATION; CHROMATOGRAPHY; TRANSDUCTION; ANTIOXIDANT; RECRUITMENT; INVOLVEMENT; ACTIVATION	Cholesterol oxides, in particular 7-ketocholesterol, are proatherogenic compounds that induce cell death in the vascular wall when localized in lipid raft domains of the cell membrane. Deleterious effects of 7-ketocholesterol can be prevented by vitamin E, but the molecular mechanism involved is unclear. In this study, unlike gamma-tocopherol, the alpha-tocopherol vitamin E form was found to prevent 7-ketocholesterol-mediated apoptosis of A7R5 smooth muscle cells. To be operative, alpha-tocopherol needed to be added to the cells before 7-ketocholesterol, and its anti-apoptotic effect was reduced and even suppressed when added together or after 7-ketocholesterol, respectively. Both pre- and co-treatment of the cells with alpha-tocopherol resulted in the redistribution of 7-ketocholesterol out of the sphingolipid/cholesterol-enriched ( lipid raft) domains. In turn, fewer amounts of alpha-tocopherol associated with lipid rafts on 7-ketocholesterol-pretreated cells compared with untreated cells, with no prevention of cell death in this case. In further support of the implication of lipid raft domains, the dephosphorylation/inactivation of Akt-PKB was involved in the 7-ketocholesterol-induced apoptosis. Akt-PKB dephosphorylation was prevented by alpha-tocopherol, but not gamma-tocopherol pretreatment.	[Neel, Dominique] INSERM, Ctr Rech, UMR866, Fac Med, F-21079 Dijon, France; Univ Bourgogne, F-21079 Dijon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Universite de Bourgogne	Neel, D (corresponding author), INSERM, Ctr Rech, UMR866, Fac Med, 7 Blvd Jeanne Arc,BP 87900, F-21079 Dijon, France.	dominique.neel@chu-dijon.fr; laurent.lagrost@u-bourgogne.fr	Desrumaux, Catherine/O-1925-2018	PAIS DE BARROS, Jean-Paul/0000-0002-5124-2283	Universite de Bourgogne; Centre Hospitalier Universitaire de Dijon; Conseil Regional de Bourgogne; INSERM; Agence Nationale de la Recherche; Fondation de France	Universite de Bourgogne; Centre Hospitalier Universitaire de Dijon; Conseil Regional de Bourgogne(Region Bourgogne-Franche-Comte); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR)); Fondation de France(Fondation de France)	This work was supported by grants from the Universite de Bourgogne, the Centre Hospitalier Universitaire de Dijon, the Conseil Regional de Bourgogne, INSERM, the Agence Nationale de la Recherche, and the Fondation de France.	Azzi A, 2000, PROG LIPID RES, V39, P231, DOI 10.1016/S0163-7827(00)00006-0; Bauriedel G, 1999, CARDIOVASC RES, V41, P480, DOI 10.1016/S0008-6363(98)00318-6; BECART J, 1990, HRC-J HIGH RES CHROM, V13, P126; Berthier A, 2005, FEBS J, V272, P3093, DOI 10.1111/j.1742-4658.2005.04723.x; Berthier A, 2004, CELL DEATH DIFFER, V11, P897, DOI 10.1038/sj.cdd.4401434; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; CHATELAIN E, 1993, BIOCHIM BIOPHYS ACTA, V1176, P83, DOI 10.1016/0167-4889(93)90181-N; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; de Nigris F, 2000, BIOCHEM PHARMACOL, V59, P1477, DOI 10.1016/S0006-2952(00)00275-6; DEL PL, 1997, SCIENCE, V278, P687; Delmas D, 2003, J BIOL CHEM, V278, P41482, DOI 10.1074/jbc.M304896200; Foster LJ, 2003, P NATL ACAD SCI USA, V100, P5813, DOI 10.1073/pnas.0631608100; GAMBERT P, 1979, J CHROMATOGR, V162, P1, DOI 10.1016/S0378-4347(00)82057-5; Grazide S, 2002, FASEB J, V16, P1685, DOI 10.1096/fj.01-0794fje; Jessup W, 2005, REJUV RES, V8, P9, DOI 10.1089/rej.2005.8.9; Lasserre R, 2008, NAT CHEM BIOL, V4, P538, DOI 10.1038/nchembio.103; Lizard G, 1999, ARTERIOSCL THROM VAS, V19, P1190, DOI 10.1161/01.ATV.19.5.1190; Lyons NM, 2001, FREE RADICAL RES, V35, P329, DOI 10.1080/10715760100300861; Miguet C, 2001, CELL DEATH DIFFER, V8, P83, DOI 10.1038/sj.cdd.4400792; Munteanu A, 2004, J CELL MOL MED, V8, P59, DOI 10.1111/j.1582-4934.2004.tb00260.x; Munteanu A, 2007, MOL ASPECTS MED, V28, P538, DOI 10.1016/j.mam.2007.07.001; Princen K, 2003, CYTOM PART A, V51A, P35, DOI 10.1002/cyto.a.10008; Ricciarelli R, 1998, BIOCHEM J, V334, P243, DOI 10.1042/bj3340243; Scheid MP, 2003, FEBS LETT, V546, P108, DOI 10.1016/S0014-5793(03)00562-3; Simons K, 2000, NAT REV MOL CELL BIO, V1, P31, DOI 10.1038/35036052; SMITH AJ, 1985, J IMMUNOL METHODS, V84, P125, DOI 10.1016/0022-1759(85)90421-1; Terasaka N, 2007, P NATL ACAD SCI USA, V104, P15093, DOI 10.1073/pnas.0704602104; Traber MG, 2007, FREE RADICAL BIO MED, V43, P4, DOI 10.1016/j.freeradbiomed.2007.03.024; TRABER MG, 1995, AM J CLIN NUTR, V62, P1501; Uemura M, 2002, EUR J PHARMACOL, V456, P29, DOI 10.1016/S0014-2999(02)02639-0; Vejux A, 2009, J NUTR BIOCHEM, V20, P45, DOI 10.1016/j.jnutbio.2007.12.001; Wang XY, 1999, PROG LIPID RES, V38, P309, DOI 10.1016/S0163-7827(99)00008-9; YEH CJG, 1981, J IMMUNOL METHODS, V43, P269, DOI 10.1016/0022-1759(81)90174-5	33	63	66	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15826	15834		10.1074/jbc.M808641200	http://dx.doi.org/10.1074/jbc.M808641200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19351882	hybrid, Green Published			2022-12-27	WOS:000266501000051
J	Zaks-Makhina, E; Li, H; Grishin, A; Salvador-Recatala, V; Levitan, ES				Zaks-Makhina, Elena; Li, Hui; Grishin, Anatoly; Salvador-Recatala, Vicenta; Levitan, Edwin S.			Specific and Slow Inhibition of the Kir2.1 K+ Channel by Gambogic Acid	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LIPID RAFTS; POTASSIUM CHANNELS; ACTIVATION; BLOCKERS; ASSAY; RECTIFICATION; MECHANISM; APOPTOSIS; CAVEOLAE; YEAST	Although Kir2.1 channels are important in the heart and other excitable cells, there are virtually no specific drugs for this K+ channel. In search of Kir2.1 modulators, we screened a library of 720 naturally occurring compounds using a yeast strain in which mammalian Kir2.1 enables growth at low [K+]. One of the identified compounds, gambogic acid (GA), potently (EC50 <= 100 nM) inhibited Kir2.1 channels in mammalian cells when applied chronically for 3 h. This potent and slow inhibition was not seen with Kv2.1, HERG or Kir1.1 channels. However, ;acutely applied GA acted as a weak (EC50 = similar to 10 mu M) nonselective K+ channel blocker. Intracellular delivery of GA via a patch pipette did not potentiate the acute effect of GA on Kir2.1, showing that slow uptake is not responsible for the delayed, potent effect. Immunoblots showed that total Kir2.1 protein expression was not altered by GA. Similarly, immunostaining of intact cells expressing Kir2.1 with an extracellular epitope tag demonstrated that GA does not affect Kir2.1 surface expression. However, the 3-h treatment with GA caused redistribution of Kir2.1 and Kv2.1 from the Triton X-100-insoluble to the Triton X-100-soluble membrane fraction. Thus, GA changes the K+ channel membrane microenvironment resulting in potent, specific, and slow acting inhibition of Kir2.1 channels.	[Zaks-Makhina, Elena; Li, Hui; Grishin, Anatoly; Salvador-Recatala, Vicenta; Levitan, Edwin S.] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Levitan, ES (corresponding author), Univ Pittsburgh, Dept Pharmacol & Chem Biol, E1351 BST,200 Lothrop St, Pittsburgh, PA 15261 USA.	elevitan@pitt.edu	Salvador, Vicenta/AAE-9733-2020	Salvador Recatala, Vicenta/0000-0002-6094-1422	National Institutes of Health [NSO48089-01, HL80632]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080632] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants NSO48089-01 ( to E. Z. M.) and HL80632 ( to E. S. L.).	FAKLER B, 1995, CELL, V80, P149, DOI 10.1016/0092-8674(95)90459-X; GHOSE AK, 1987, J CHEM INF COMP SCI, V27, P21, DOI 10.1021/ci00053a005; Hibino H, 2007, EUR J NEUROSCI, V26, P2539, DOI 10.1111/j.1460-9568.2007.05876.x; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Kasibhatla S, 2005, P NATL ACAD SCI USA, V102, P12095, DOI 10.1073/pnas.0406731102; Lingwood D, 2007, NAT PROTOC, V2, P2159, DOI 10.1038/nprot.2007.294; Liu H, 2007, J MED CHEM, V50, P83, DOI 10.1021/jm060414o; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; Maguy A, 2006, CARDIOVASC RES, V69, P798, DOI 10.1016/j.cardiores.2005.11.013; Martens JR, 2000, J BIOL CHEM, V275, P7443, DOI 10.1074/jbc.275.11.7443; Martens JR, 2001, J BIOL CHEM, V276, P8409, DOI 10.1074/jbc.M009948200; MATSUDA H, 1987, NATURE, V325, P156, DOI 10.1038/325156a0; Plaster NM, 2001, CELL, V105, P511, DOI 10.1016/S0092-8674(01)00342-7; Priori SG, 2005, CIRC RES, V96, P800, DOI 10.1161/01.RES.0000162101.76263.8c; Rapedius M, 2005, J BIOL CHEM, V280, P30760, DOI 10.1074/jbc.M503503200; Romanenko VG, 2004, BIOPHYS J, V87, P3850, DOI 10.1529/biophysj.104.043273; Sabirov RZ, 1997, J GEN PHYSIOL, V110, P665, DOI 10.1085/jgp.110.6.665; Slack M, 2006, J BIOMOL SCREEN, V11, P57, DOI 10.1177/1087057105282712; Sun HY, 2006, J BIOL CHEM, V281, P5877, DOI 10.1074/jbc.M600072200; TANG WM, 1995, MOL BIOL CELL, V6, P1231, DOI 10.1091/mbc.6.9.1231; Weaver AK, 2007, J BIOL CHEM, V282, P31558, DOI 10.1074/jbc.M702866200; Zaks-Makhina E, 2004, MOL PHARMACOL, V65, P214, DOI 10.1124/mol.65.1.214; Zhang HL, 1999, NAT CELL BIOL, V1, P183, DOI 10.1038/11103; Zhang HZ, 2004, BIOORGAN MED CHEM, V12, P309, DOI 10.1016/j.bmc.2003.11.013	24	21	23	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15432	15438		10.1074/jbc.M901586200	http://dx.doi.org/10.1074/jbc.M901586200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19366693	Green Published, hybrid			2022-12-27	WOS:000266501000011
J	Wang, L; Lawrence, JC; Sturgill, TW; Harris, TE				Wang, Lifu; Lawrence, John C., Jr.; Sturgill, Thomas W.; Harris, Thurl E.			Mammalian Target of Rapamycin Complex 1 (mTORC1) Activity Is Associated with Phosphorylation of Raptor by mTOR	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RICH AKT SUBSTRATE; 40 KDA PRAS40; PROTEIN-KINASE; CELL-GROWTH; TOS MOTIF; BINDING; INSULIN; IDENTIFICATION; INHIBITOR; PARTNER	mTORC1 contains multiple proteins and plays a central role in cell growth and metabolism. Raptor (regulatory-associated protein of mammalian target of rapamycin (mTOR)), a constitutively binding protein of mTORC1, is essential for mTORC1 activity and critical for the regulation of mTORC1 activity in response to insulin signaling and nutrient and energy sufficiency. Herein we demonstrate that mTOR phosphorylates raptor in vitro and in vivo. The phosphorylated residues were identified by using phosphopeptide mapping and mutagenesis. The phosphorylation of raptor is stimulated by insulin and inhibited by rapamycin. Importantly, the site-directed mutation of raptor at one phosphorylation site, Ser(863), reduced mTORC1 activity both in vitro and in vivo. Moreover, the Ser863 mutant prevented small GTP-binding protein Rheb from enhancing the phosphorylation of S6 kinase (S6K) in cells. Therefore, our findings indicate that mTOR-mediated raptor phosphorylation plays an important role on activation of mTORC1.	[Wang, Lifu; Lawrence, John C., Jr.; Sturgill, Thomas W.; Harris, Thurl E.] Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA	University of Virginia	Wang, L (corresponding author), Univ Virginia Hlth Syst, Dept Pharmacol, POB 800735,1300 Jefferson Pk Ave, Charlottesville, VA 22908 USA.	lw6j@virginia.edu	wang, lifu/E-1436-2012		National Institutes of Health [DK52753, DK28312]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK067629, R01DK052753, R01DK028312] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK52753 and DK28312 (to J.C.L.).	Adami A, 2007, MOL CELL, V27, P509, DOI 10.1016/j.molcel.2007.05.040; Carriere A, 2008, CURR BIOL, V18, P1269, DOI 10.1016/j.cub.2008.07.078; Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120; Fonseca BD, 2007, J BIOL CHEM, V282, P24514, DOI 10.1074/jbc.M704406200; Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003; Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2; Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839; Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Mothe-Satney I, 2000, J BIOL CHEM, V275, P33836, DOI 10.1074/jbc.M006005200; Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Oshiro N, 2007, J BIOL CHEM, V282, P20329, DOI 10.1074/jbc.M702636200; Peterson RT, 2000, J BIOL CHEM, V275, P7416, DOI 10.1074/jbc.275.10.7416; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5; Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547; Wang L, 2008, J BIOL CHEM, V283, P15619, DOI 10.1074/jbc.M800723200; Wang LF, 2007, J BIOL CHEM, V282, P20036, DOI 10.1074/jbc.M702376200; Wang LF, 2006, J BIOL CHEM, V281, P24293, DOI 10.1074/jbc.M603566200; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016	27	85	88	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					14693	14697		10.1074/jbc.C109.002907	http://dx.doi.org/10.1074/jbc.C109.002907			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19346248	hybrid, Green Published			2022-12-27	WOS:000266288200005
J	Zhou, ZM; Hashimoto, Y; Kobayashi, M				Zhou, Zhemin; Hashimoto, Yoshiteru; Kobayashi, Michihiko			Self-subunit Swapping Chaperone Needed for the Maturation of Multimeric Metalloenzyme Nitrile Hydratase by a Subunit Exchange Mechanism Also Carries Out the Oxidation of the Metal Ligand Cysteine Residues and Insertion of Cobalt	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RHODOCOCCUS-RHODOCHROUS J1; PROTEIN-SULFENIC ACIDS; ACYL-COA SYNTHETASE; POSTTRANSLATIONAL MODIFICATION; THIOCYANATE HYDROLASE; PEPTIDE DEFORMYLASE; CRYSTAL-STRUCTURE; FUNCTIONAL EXPRESSION; ESCHERICHIA-COLI; REACTION-PRODUCT	The incorporation of cobalt into low molecular mass nitrile hydratase (L-NHase) of Rhodococcus rhodochrous J1 has been found to depend on the alpha-subunit exchange between cobalt-free L-NHase (apo-L-NHase lacking oxidized cysteine residues) and its cobalt-containing mediator (holo-NhlAE containing Cys-SO2- and Cys-SO- metal ligands), this novel mode of post-translational maturation having been named self-subunit swapping, and NhlE having been recognized as a self-subunit swapping chaperone (Zhou, Z., Hashimoto, Y., Shiraki, K., and Kobayashi, M. (2008) Proc. Natl. Acad. Sci. U. S. A. 105, 14849-14854). We discovered here that cobalt was inserted into both the cobalt-free NhlAE (apo-NhlAE) and the cobalt-free alpha-subunit (apo-alpha-subunit) in an NhlE-dependent manner in the presence of cobalt and dithiothreitol in vitro. Matrix-assisted laser desorption ionization time-of-flight mass spectroscopy analysis revealed that the non-oxidized cysteine residues in apo-NhlAE were post-translationally oxidized after cobalt insertion. These findings suggested that NhlE has two activities, i.e. cobalt insertion and cysteine oxidation. NhlE not only functions as a self-subunit swapping chaperone but also a metallochaperone that includes a redox function. Cobalt insertion and cysteine oxidation occurred under both aerobic and anaerobic conditions when Co3+ was used as a cobalt donor, suggesting that the oxygen atoms in the oxidized cysteines were derived from water molecules but not from dissolved oxygen. Additionally, we isolated apo-NhlAE after the self-subunit swapping event and found that it was recycled for cobalt transfer into L-NHase.	[Kobayashi, Michihiko] Univ Tsukuba, Inst Appl Biochem, Tsukuba, Ibaraki 3058572, Japan; Univ Tsukuba, Grad Sch Life & Environm Sci, Tsukuba, Ibaraki 3058572, Japan	University of Tsukuba; University of Tsukuba	Kobayashi, M (corresponding author), Univ Tsukuba, Inst Appl Biochem, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058572, Japan.				Ministry of Education, Culture, Sports, Science, and Technology	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Culture, Sports, Science, and Technology.	Abe T, 2008, J BIOL CHEM, V283, P11312, DOI 10.1074/jbc.M709654200; Arakawa T, 2007, J MOL BIOL, V366, P1497, DOI 10.1016/j.jmb.2006.12.011; Brennan BA, 1996, J AM CHEM SOC, V118, P9194, DOI 10.1021/ja961920d; Cai JH, 2006, PROTEIN SCI, V15, P2071, DOI 10.1110/ps.062238406; Chae PS, 2005, J AM CHEM SOC, V127, P2396, DOI 10.1021/ja044043h; Claiborne A, 1999, BIOCHEMISTRY-US, V38, P15407, DOI 10.1021/bi992025k; Deng H, 2002, BIOCHEMISTRY-US, V41, P10563, DOI 10.1021/bi026137e; Endo I, 1999, TRENDS BIOTECHNOL, V17, P244, DOI 10.1016/S0167-7799(99)01303-7; Greene SN, 2006, INORG CHEM, V45, P17, DOI 10.1021/ic050965p; Hashimoto Y, 2005, J BIOL CHEM, V280, P8660, DOI 10.1074/jbc.M405686200; HASHIMOTO Y, 1994, BIOSCI BIOTECH BIOCH, V58, P1859, DOI 10.1271/bbb.58.1859; Hourai S, 2003, BIOCHEM BIOPH RES CO, V312, P340, DOI 10.1016/j.bbrc.2003.10.124; Huang WJ, 1997, STRUCTURE, V5, P691, DOI 10.1016/S0969-2126(97)00223-2; Jonsson TJ, 2008, J BIOL CHEM, V283, P22890, DOI [10.1074/jbc.C800124200, 10.1074/jbc.M803244200]; Kataoka S, 2006, FEBS LETT, V580, P4667, DOI 10.1016/j.febslet.2006.07.051; Katayama Y, 2006, J AM CHEM SOC, V128, P728, DOI 10.1021/ja057010q; Kobayashi M, 1997, P NATL ACAD SCI USA, V94, P11986, DOI 10.1073/pnas.94.22.11986; Kobayashi M, 1999, EUR J BIOCHEM, V261, P1, DOI 10.1046/j.1432-1327.1999.00186.x; Kobayashi M, 1998, NAT BIOTECHNOL, V16, P733, DOI 10.1038/nbt0898-733; KOBAYASHI M, 1992, TRENDS BIOTECHNOL, V10, P402, DOI 10.1016/0167-7799(92)90283-2; Komeda H, 1996, P NATL ACAD SCI USA, V93, P4267, DOI 10.1073/pnas.93.9.4267; Komeda H, 1996, J BIOL CHEM, V271, P15796, DOI 10.1074/jbc.271.26.15796; Komeda H, 1997, P NATL ACAD SCI USA, V94, P36, DOI 10.1073/pnas.94.1.36; Kuchar J, 2004, CHEM REV, V104, P509, DOI 10.1021/cr020613p; Lu J, 2003, FEBS LETT, V553, P391, DOI 10.1016/S0014-5793(03)01070-6; Miyanaga A, 2004, EUR J BIOCHEM, V271, P429, DOI 10.1046/j.1432-1033.2003.03943.x; Miyanaga A, 2001, BIOCHEM BIOPH RES CO, V288, P1169, DOI 10.1006/bbrc.2001.5897; Murakami T, 2000, PROTEIN SCI, V9, P1024, DOI 10.1110/ps.9.5.1024; Nagashima S, 1998, NAT STRUCT BIOL, V5, P347, DOI 10.1038/nsb0598-347; Nakamura T, 2008, P NATL ACAD SCI USA, V105, P6238, DOI 10.1073/pnas.0709822105; Noguchi T, 2003, BIOCHEMISTRY-US, V42, P11642, DOI 10.1021/bi035260i; Nojiri M, 1999, J BIOCHEM-TOKYO, V125, P696, DOI 10.1093/oxfordjournals.jbchem.a022339; Ogata H, 2005, STRUCTURE, V13, P1635, DOI 10.1016/j.str.2005.07.018; Payne MS, 1997, BIOCHEMISTRY-US, V36, P5447, DOI 10.1021/bi962794t; Poole LB, 2004, ANNU REV PHARMACOL, V44, P325, DOI 10.1146/annurev.pharmtox.44.101802.121735; Stevens JM, 2003, J MASS SPECTROM, V38, P955, DOI 10.1002/jms.509; Tsujimura M, 2003, J AM CHEM SOC, V125, P11532, DOI 10.1021/ja035018z; Volbeda A, 2005, J BIOL INORG CHEM, V10, P239, DOI 10.1007/s00775-005-0632-x; Wu S, 1997, APPL MICROBIOL BIOT, V48, P704, DOI 10.1007/s002530051119; Zhou Z-M, 2005, ACTINOMYCETOLOGICA, V19, P18; Zhou Z, 2008, P NATL ACAD SCI USA, V105, P14849, DOI 10.1073/pnas.0803428105	41	42	44	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					14930	14938		10.1074/jbc.M808464200	http://dx.doi.org/10.1074/jbc.M808464200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19346246	Green Published, hybrid			2022-12-27	WOS:000266288200029
J	Berti, DA; Morano, C; Russo, LC; Castro, LM; Cunha, FM; Zhang, X; Sironi, J; Klitzke, CF; Ferro, ES; Fricker, LD				Berti, Denise A.; Morano, Cain; Russo, Lilian C.; Castro, Leandro M.; Cunha, Fernanda M.; Zhang, Xin; Sironi, Juan; Klitzke, Clecio F.; Ferro, Emer S.; Fricker, Lloyd D.			Analysis of Intracellular Substrates and Products of Thimet Oligopeptidase in Human Embryonic Kidney 293 Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MHC CLASS-I; ANGIOTENSIN-CONVERTING ENZYME; ENDOPEPTIDASE EC 3.4.24.15; ANTIGEN PRESENTATION; RAT-BRAIN; SOLUBLE METALLOENDOPEPTIDASE; QUANTITATIVE PEPTIDOMICS; DEGRADATION-PRODUCTS; PROTEIN-DEGRADATION; NATURAL REGULATORS	Thimet oligopeptidase (EC 3.4.24.15; EP24.15) is an intracellular enzyme that has been proposed to metabolize peptides within cells, thereby affecting antigen presentation and G protein-coupled receptor signal transduction. However, only a small number of intracellular substrates of EP24.15 have been reported previously. Here we have identified over 100 peptides in human embryonic kidney 293 (HEK293) cells that are derived from intracellular proteins; many but not all of these peptides are substrates or products of EP24.15. First, cellular peptides were extracted from HEK293 cells and incubated in vitro with purified EP24.15. Then the peptides were labeled with isotopic tags and analyzed by mass spectrometry to obtain quantitative data on the extent of cleavage. A related series of experiments tested the effect of overexpression of EP24.15 on the cellular levels of peptides in HEK293 cells. Finally, synthetic peptides that corresponded to 10 of the cellular peptides were incubated with purified EP24.15 in vitro, and the cleavage was monitored by high pressure liquid chromatography and mass spectrometry. Many of the EP24.15 substrates identified by these approaches are 9-11 amino acids in length, supporting the proposal that EP24.15 can function in the degradation of peptides that could be used for antigen presentation. However, EP24.15 also converts some peptides into products that are 8-10 amino acids, thus contributing to the formation of peptides for antigen presentation. In addition, the intracellular peptides described here are potential candidates to regulate protein interactions within cells.	[Berti, Denise A.; Castro, Leandro M.; Cunha, Fernanda M.; Ferro, Emer S.] Univ Sao Paulo, Dept Dev & Cell Biol, Inst Biomed Sci, BR-05508900 Sao Paulo, Brazil; [Russo, Lilian C.] Univ Sao Paulo, Dept Pharmacol, Inst Biomed Sci, BR-05508900 Sao Paulo, Brazil; [Cunha, Fernanda M.] Univ Fed Sao Paulo, Dept Biochem, BR-04044020 Sao Paulo, Brazil; [Klitzke, Clecio F.] Butantan Inst, CAT CEPID, Ctr Appl Toxicol, BR-05503900 Sao Paulo, Brazil; [Morano, Cain; Zhang, Xin; Sironi, Juan; Fricker, Lloyd D.] Yeshiva Univ Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10461 USA	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Federal de Sao Paulo (UNIFESP); Instituto Butantan; Yeshiva University; Albert Einstein College of Medicine	Ferro, ES (corresponding author), Univ Sao Paulo, Dept Dev & Cell Biol, Inst Biomed Sci, Av Lineu Prestes 1524,Sala 435, BR-05508900 Sao Paulo, Brazil.	eferro@usp.br; fricker@aecom.yu.edu	da Cunha, Fernanda M/G-3575-2012; Castro, Leandro M/E-5654-2014; Castro, Leandro/ABI-5520-2020; Russo, Lilian Cristina/O-7838-2014; Klitzke, Clecio Fernando/A-8920-2010; DA CUNHA, FERNANDA MARQUES/AAY-4000-2020; Ferro, Emer S/D-3908-2012; Castro, Leandro/O-6762-2019	da Cunha, Fernanda M/0000-0002-1583-5380; Castro, Leandro/0000-0002-7156-2006; Russo, Lilian Cristina/0000-0002-9846-1352; Klitzke, Clecio Fernando/0000-0001-5973-6088; Ferro, Emer S/0000-0003-1651-9192; Castro, Leandro/0000-0002-7156-2006	National Institutes of Health [DK-51271, DA-04494]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [04/04933-2, 04/14846-0]; Financiadora de Estudos e Projetos [A-03/134]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de Pesquisa; Instituto UNIEMP; Pro-reitoria de Posgraduacao, Universidade de Sao Paulo; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK051271] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA004494] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Financiadora de Estudos e Projetos(Financiadora de Inovacao e Pesquisa (Finep)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Pesquisa; Instituto UNIEMP; Pro-reitoria de Posgraduacao, Universidade de Sao Paulo; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported, in whole or in part, by National Institutes of Health Grants DK-51271 and DA-04494 (to L. D. F.). This work was also supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo Grants 04/04933-2 and 04/14846-0 (to E. S. F.), Financiadora de Estudos e Projetos A-03/134 (to E. S. F.), and fellowships from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (to D. A. B.), Conselho Nacional de Pesquisa (to F. M. C. and E. S. F.), Instituto UNIEMP (to C. F. K.), and Pro-reitoria de Posgraduacao, Universidade de Sao Paulo (to L. D. F.).	Akopian TN, 1997, J BIOL CHEM, V272, P1791, DOI 10.1074/jbc.272.3.1791; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brandt I, 2005, PEPTIDES, V26, P2536, DOI 10.1016/j.peptides.2005.05.016; Brent R, 2006, NATURE, V440, P416, DOI 10.1038/440416a; Bruce LA, 2008, FEBS J, V275, P5607, DOI 10.1111/j.1742-4658.2008.06685.x; Carreno FR, 2005, J NEUROCHEM, V93, P10, DOI 10.1111/j.1471-4159.2004.02967.x; Che FY, 2007, J PROTEOME RES, V6, P4667, DOI 10.1021/pr060690r; Che FY, 2006, J MOL NEUROSCI, V28, P265, DOI 10.1385/JMN:28:3:265; Che FY, 2005, MOL CELL PROTEOMICS, V4, P1391, DOI 10.1074/mcp.T500010-MCP200; Che FY, 2005, J MASS SPECTROM, V40, P238, DOI 10.1002/jms.743; CHU TG, 1984, BIOCHEMISTRY-US, V23, P3598, DOI 10.1021/bi00311a005; Ciechanover A, 2004, BBA-MOL CELL RES, V1695, P3, DOI 10.1016/j.bbamcr.2004.09.018; Cohen BA, 1998, P NATL ACAD SCI USA, V95, P14272, DOI 10.1073/pnas.95.24.14272; Colas P, 2000, P NATL ACAD SCI USA, V97, P13720, DOI 10.1073/pnas.97.25.13720; Cunha FM, 2008, J BIOL CHEM, V283, P24448, DOI 10.1074/jbc.M801252200; DANDO PM, 1993, BIOCHEM J, V294, P451, DOI 10.1042/bj2940451; Demasi M, 2008, FREE RADICAL BIO MED, V44, P1180, DOI 10.1016/j.freeradbiomed.2007.12.012; Doherty MK, 2009, J PROTEOME RES, V8, P104, DOI 10.1021/pr800641v; FALK K, 1990, NATURE, V348, P248, DOI 10.1038/348248a0; Ferro ES, 2004, J NEUROCHEM, V91, P769, DOI 10.1111/j.1471-4159.2004.02757.x; Ferro ES, 1999, DNA CELL BIOL, V18, P781, DOI 10.1089/104454999314926; Fontenele-Neto JD, 2001, J COMP NEUROL, V438, P399, DOI 10.1002/cne.1323; Fulop V, 1998, CELL, V94, P161, DOI 10.1016/S0092-8674(00)81416-6; Geier E, 1999, SCIENCE, V283, P978, DOI 10.1126/science.283.5404.978; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Goldberg AL, 2002, MOL IMMUNOL, V39, P147, DOI 10.1016/S0161-5890(02)00098-6; GRASSO G, 2009, J MASS SPEC IN PRESS; Harris JL, 2001, CHEM BIOL, V8, P1131, DOI 10.1016/S1074-5521(01)00080-1; Heimann AS, 2005, PHYSIOL GENOMICS, V20, P173, DOI 10.1152/physiolgenomics.00145.2004; Hershko A, 2000, NAT MED, V6, P1073, DOI 10.1038/80384; Kessler BM, 2002, MOL IMMUNOL, V39, P171, DOI 10.1016/S0161-5890(02)00100-1; Kim SI, 2003, J NEUROSCI RES, V74, P456, DOI 10.1002/jnr.10779; Kim SI, 2003, BIOCHEM J, V375, P111, DOI 10.1042/BJ20030490; Kisselev AF, 2003, J BIOL CHEM, V278, P35869, DOI 10.1074/jbc.M303725200; Kisselev AF, 1998, J BIOL CHEM, V273, P1982, DOI 10.1074/jbc.273.4.1982; Kisselev AF, 1999, J BIOL CHEM, V274, P3363, DOI 10.1074/jbc.274.6.3363; KNIGHT CG, 1995, BIOCHEM J, V308, P145, DOI 10.1042/bj3080145; Lecker SH, 2002, J PHYSIOL-LONDON, V545, P729, DOI 10.1113/jphysiol.2002.030429; Lim J, 2006, J NEUROCHEM, V96, P1169, DOI 10.1111/j.1471-4159.2005.03614.x; LIPPINCOTTSCHWARTZ J, 1988, CELL, V54, P209, DOI 10.1016/0092-8674(88)90553-3; Machado MFM, 2006, BIOCHEM BIOPH RES CO, V339, P520, DOI 10.1016/j.bbrc.2005.11.041; Montiel JL, 1997, J NEUROCHEM, V68, P354; Morano C, 2008, ANAL CHEM, V80, P9298, DOI 10.1021/ac801654h; Oliveira V, 2001, BIOCHEMISTRY-US, V40, P4417, DOI 10.1021/bi002715k; Oliveira V, 2001, ANAL BIOCHEM, V292, P257, DOI 10.1006/abio.2001.5083; ORLOWSKI M, 1983, EUR J BIOCHEM, V135, P81, DOI 10.1111/j.1432-1033.1983.tb07620.x; ORLOWSKI M, 1989, BIOCHEM J, V261, P951, DOI 10.1042/bj2610951; Pan H, 2006, J NEUROCHEM, V98, P1763, DOI 10.1111/j.1471-4159.2006.04067.x; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; Pawson T, 2003, SCIENCE, V300, P445, DOI 10.1126/science.1083653; PIEROTTI A, 1990, BIOCHEMISTRY-US, V29, P10323, DOI 10.1021/bi00497a006; Portaro FCV, 1999, BIOCHEM BIOPH RES CO, V255, P596, DOI 10.1006/bbrc.1999.0251; Rammensee HG, 2002, NATURE, V419, P443, DOI 10.1038/419443a; Ray K, 2004, J BIOL CHEM, V279, P20480, DOI 10.1074/jbc.M400795200; Reits E, 2004, IMMUNITY, V20, P495, DOI 10.1016/S1074-7613(04)00074-3; Reits E, 2003, IMMUNITY, V18, P97, DOI 10.1016/S1074-7613(02)00511-3; Rioli V, 2003, J BIOL CHEM, V278, P8547, DOI 10.1074/jbc.M212030200; Rioli V, 1998, BIOCHEM BIOPH RES CO, V250, P5, DOI 10.1006/bbrc.1998.8941; Rock KL, 2002, ADV IMMUNOL, V80, P1, DOI 10.1016/S0065-2776(02)80012-8; Saric T, 2004, J BIOL CHEM, V279, P46723, DOI 10.1074/jbc.M406537200; Saric T, 2001, J BIOL CHEM, V276, P36474, DOI 10.1074/jbc.M105517200; Schirle M, 2003, MOL CELL PROTEOMICS, V2, P1297, DOI 10.1074/mcp.M300087-MCP200; Shrimpton CN, 2000, BIOCHEM J, V345, P351, DOI 10.1042/0264-6021:3450351; Shrimpton CN, 1997, J BIOL CHEM, V272, P17395, DOI 10.1074/jbc.272.28.17395; Silva CL, 1999, BIOCHEM BIOPH RES CO, V255, P591, DOI 10.1006/bbrc.1999.0250; Tam EM, 2004, P NATL ACAD SCI USA, V101, P6917, DOI 10.1073/pnas.0305862101; Turner AJ, 2007, INT REV NEUROBIOL, V82, P113, DOI 10.1016/S0074-7742(07)82006-X; UDENFRIEND S, 1972, SCIENCE, V178, P871, DOI 10.1126/science.178.4063.871; WENZEL T, 1994, FEBS LETT, V349, P205, DOI 10.1016/0014-5793(94)00665-2; Yang XD, 1998, PHARMACEUT RES, V15, P1480, DOI 10.1023/A:1011926310666; York IA, 2003, IMMUNITY, V18, P429, DOI 10.1016/S1074-7613(03)00058-X; Zhang RJ, 2002, ANAL CHEM, V74, P3662, DOI 10.1021/ac025614w	72	54	55	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14105	14116		10.1074/jbc.M807916200	http://dx.doi.org/10.1074/jbc.M807916200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19282285	Green Published, hybrid			2022-12-27	WOS:000266286100017
J	Mahmood, NABN; Biemans-Oldehinkel, E; Poolman, B				Mahmood, Nik A. B. N.; Biemans-Oldehinkel, Esther; Poolman, Bert			Engineering of Ion Sensing by the Cystathionine beta-Synthase Module of the ABC Transporter OpuA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CBS DOMAIN PROTEIN; CRYSTAL-STRUCTURE; TEMPERATURE-DEPENDENCE; PHOSPHATIDIC-ACID; ESCHERICHIA-COLI; MG2+ TRANSPORTER; GLYCINE BETAINE; MEMBRANE; MECHANISM; CHANNEL	We have previously shown that the C-terminal cystathionine beta-synthase (CBS) domains of the nucleotide-binding domains of the ABC transporter OpuA, in conjunction with an anionic membrane surface function, act as sensor of internal ionic strength (I-in). Here, we show that a surface-exposed cationic region in the CBS module domain is critical for ion sensing. The consecutive substitution of up to five cationic residues led to a gradual decrease of the ionic strength dependence of transport. In fact, a 5-fold mutant was essentially independent of salt in the range from 0 to 250 mM KCl (or NaCl), supplemented to medium of 30 mM potassium phosphate. Importantly, the threshold temperature for transport was lowered by 5-7 degrees C and the temperature coefficient Q(10) was lowered from 8 to similar to 1.5 in the 5-fold mutant, indicating that large conformational changes are accompanying the CBS-mediated regulation of transport. Furthermore, by replacing the anionic C-terminal tail residues that extend the CBS module with histidines, the transport of OpuA became pH-dependent, presumably by additional charge interactions of the histidine residues with the membrane. The pH dependence was not observed at high ionic strength. Altogether the analyses of the CBS mutants support the notion that the osmotic regulation of OpuA involves a simple biophysical switching mechanism, in which nonspecific electrostatic interactions of a protein module with the membrane are sufficient to lock the transporter in the inactive state.	[Poolman, Bert] Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Biochem, NL-9747 AG Groningen, Netherlands; Univ Groningen, Zernike Inst Adv Mat, NL-9747 AG Groningen, Netherlands; Univ Groningen, Ctr Synthet Biol, NL-9747 AG Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	Poolman, B (corresponding author), Univ Groningen, Groningen Biomol Sci & Biotechnol Inst, Dept Biochem, Nijenborgh 4, NL-9747 AG Groningen, Netherlands.	b.poolman@rug.nl	Institute, Zernike/W-7033-2019; Poolman, Bert/D-1882-2012		NWO-CW [700-50-302, 700-56-302]; Netherlands Proteomics Centre; European Union [504601]	NWO-CW(Netherlands Organization for Scientific Research (NWO)); Netherlands Proteomics Centre; European Union(European Commission)	This work was supported by "Top-subsidie" NWO-CW Grants 700-50-302 and 700-56-302 and funds from the Netherlands Proteomics Centre and European Union E-MeP (504601) programs.	Arnold RS, 1996, BIOCHEMISTRY-US, V35, P9917, DOI 10.1021/bi960397c; Athenstaedt K, 1999, EUR J BIOCHEM, V266, P1, DOI 10.1046/j.1432-1327.1999.00822.x; Bateman A, 1997, TRENDS BIOCHEM SCI, V22, P12, DOI 10.1016/S0968-0004(96)30046-7; Biemans-Oldehinkel E, 2003, EMBO J, V22, P5983, DOI 10.1093/emboj/cdg581; Biemans-Oldehinkel E, 2006, P NATL ACAD SCI USA, V103, P10624, DOI 10.1073/pnas.0603871103; Chemin J, 2005, EMBO J, V24, P44, DOI 10.1038/sj.emboj.7600494; Chraibi A, 2002, J GEN PHYSIOL, V120, P133, DOI 10.1085/jgp.20028612; DRIESSEN AJM, 1988, BIOCHEMISTRY-US, V27, P865, DOI 10.1021/bi00403a005; Geertsma ER, 2008, NAT PROTOC, V3, P256, DOI 10.1038/nprot.2007.519; Hattori M, 2007, NATURE, V448, P1072, DOI 10.1038/nature06093; Ishitani R, 2008, P NATL ACAD SCI USA, V105, P15393, DOI 10.1073/pnas.0802991105; Johnson JE, 1997, BBA-BIOMEMBRANES, V1324, P273, DOI 10.1016/S0005-2736(96)00233-7; Kooijman EE, 2005, BIOCHEMISTRY-US, V44, P17007, DOI 10.1021/bi0518794; LANDFALD B, 1986, J BACTERIOL, V165, P849, DOI 10.1128/jb.165.3.849-855.1986; Law CJ, 2007, BIOCHEMISTRY-US, V46, P12190, DOI 10.1021/bi701383g; Mahmood NABN, 2006, J BIOL CHEM, V281, P29830, DOI 10.1074/jbc.M604907200; McLaughlin S, 2005, NATURE, V438, P605, DOI 10.1038/nature04398; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; MEIJER S, 2006, STRUCTURE, V14, P199; Miller MD, 2004, PROTEINS, V57, P213, DOI 10.1002/prot.20024; Poolman B, 2004, BBA-BIOMEMBRANES, V1666, P88, DOI 10.1016/j.bbamem.2004.06.013; POOLMAN B, 2009, MICROBIOL M IN PRESS; Proudfoot M, 2008, J MOL BIOL, V375, P301, DOI 10.1016/j.jmb.2007.10.060; Ptak CP, 2005, BIOCHEMISTRY-US, V44, P62, DOI 10.1021/bi048390f; Pusch M, 1997, J GEN PHYSIOL, V109, P105, DOI 10.1085/jgp.109.1.105; Racher KI, 2001, BIOCHEMISTRY-US, V40, P7324, DOI 10.1021/bi002331u; Ragunathan P, 2008, BIOCHEM BIOPH RES CO, V375, P124, DOI 10.1016/j.bbrc.2008.07.140; Rubenhagen R, 2001, EMBO J, V20, P5412, DOI 10.1093/emboj/20.19.5412; van der Heide T, 2000, P NATL ACAD SCI USA, V97, P7102, DOI 10.1073/pnas.97.13.7102; van der Heide T, 2001, EMBO J, V20, P7022, DOI 10.1093/emboj/20.24.7022; Wood JM, 1999, MICROBIOL MOL BIOL R, V63, P230, DOI 10.1128/MMBR.63.1.230-262.1999; Zhang RG, 1999, BIOCHEMISTRY-US, V38, P4691, DOI 10.1021/bi982858v	32	33	35	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14368	14376		10.1074/jbc.M901238200	http://dx.doi.org/10.1074/jbc.M901238200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19329426	Green Published, hybrid			2022-12-27	WOS:000266286100043
J	Olmos, Y; Valle, I; Borniquel, S; Tierrez, A; Soria, E; Lamas, S; Monsalve, M				Olmos, Yolanda; Valle, Inmaculada; Borniquel, Sara; Tierrez, Alberto; Soria, Estrella; Lamas, Santiago; Monsalve, Maria			Mutual Dependence of Foxo3a and PGC-1 alpha in the Induction of Oxidative Stress Genes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL COACTIVATOR PGC-1-ALPHA; ENDOTHELIAL-CELLS; FORKHEAD PROTEINS; ACTIVATION; EXPRESSION; DYSFUNCTION; REGULATOR; NEURODEGENERATION; ANGIOGENESIS; INVOLVEMENT	Oxidative stress is a hallmark of metabolism-related diseases and a risk factor for atherosclerosis. FoxO factors have been shown to play a key role in vascular endothelial development and homeostasis. Foxo3a can protect quiescent cells from oxidative stress through the regulation of detoxification genes such as sod2 and catalase. Here we show that Foxo3a is a direct transcriptional regulator of a group of oxidative stress protection genes in vascular endothelial cells. Importantly, Foxo3a activity requires the transcriptional co-activator PGC-1 alpha, because it is severely curtailed in PGC-1 alpha-deficient endothelial cells. Foxo3a and PGC-1 alpha appear to interact directly, as shown by co-immunoprecipitation and in vitro interaction assays, and are recruited to the same promoter regions. The notion that Foxo3a and PGC-1 alpha interact directly to regulate oxidative stress protection genes in the vascular endothelium is supported by the observation that PGC-1 alpha transcriptional activity at the sod2 ( manganese superoxide dismutase) promoter requires a functional FoxO site. We also demonstrate that Foxo3a is a direct transcriptional regulator of PGC-1 alpha, suggesting that an auto-regulatory cycle regulates Foxo3a/PGC-1 alpha control of the oxidative stress response.	[Olmos, Yolanda; Valle, Inmaculada; Borniquel, Sara; Tierrez, Alberto; Monsalve, Maria] Fdn Ctr Nacl Invest Cardiovasc Carlos III, Madrid 28029, Spain; [Soria, Estrella; Lamas, Santiago] CSIC, Ctr Invest Biol, Madrid 28040, Spain; [Soria, Estrella; Lamas, Santiago] CSIC Friat Fisiopatol Vasc & Renal, Lab Mixto, Madrid 28040, Spain	Centro Nacional de Investigaciones Cardiovasculares (CNIC); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consejo Superior de Investigaciones Cientificas (CSIC)	Monsalve, M (corresponding author), Ctr Nacl Invest Cardiovasc, Melchor Fernandez Almagro 3,Rm S3M, Madrid 28029, Spain.	mmonsalve@cnic.es	Monsalve, Maria/K-4416-2014; Olmos, Yolanda/AAX-6661-2021; Lamas, Santiago/G-7308-2015	Monsalve, Maria/0000-0003-2796-1453; Olmos, Yolanda/0000-0002-5952-1607; Lamas, Santiago/0000-0001-5166-4155	Ministerio de Educacion y Ciencia [2007-00020, SAF2006-02410]; Spanish Society of Nephrology; Spanish Ministry of Health and Consumer Affairs; Pro-Centro Nacional de Investigaciones Cardiovasculares Foundation	Ministerio de Educacion y Ciencia(Spanish Government); Spanish Society of Nephrology; Spanish Ministry of Health and Consumer Affairs(Spanish Government); Pro-Centro Nacional de Investigaciones Cardiovasculares Foundation	This work was supported in part by Grant SAF2006-01619 from the Plan Nacional de I+D+I of the Ministerio de Educacion y Ciencia (to M. M.), Grant CSD 2007-00020 from the Ministerio de Educacion y Ciencia (to M. M. and S. L.), and Grant SAF2006-02410 from the Ministerio de Educacion y Ciencia and a grant-in-aid from the Spanish Society of Nephrology (to S. L.). The Centro Nacional de Investigaciones Cardiovasculares is supported by the Spanish Ministry of Health and Consumer Affairs and the Pro-Centro Nacional de Investigaciones Cardiovasculares Foundation.	Anderson MJ, 1998, GENOMICS, V47, P187, DOI 10.1006/geno.1997.5122; Balakumar P, 2008, TOXICOLOGY, V245, P49, DOI 10.1016/j.tox.2007.12.011; Borniquel S, 2006, FASEB J, V20, P1889, DOI 10.1096/fj.05-5189fje; Chiribau CB, 2008, J BIOL CHEM, V283, P8211, DOI 10.1074/jbc.M710610200; del Peso L, 1999, ONCOGENE, V18, P7328, DOI 10.1038/sj.onc.1203159; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Essers MAG, 2004, EMBO J, V23, P4802, DOI 10.1038/sj.emboj.7600476; Finkel T, 2000, FEBS LETT, V476, P52, DOI 10.1016/S0014-5793(00)01669-0; Giannotti G, 2007, HERZ, V32, P568, DOI 10.1007/s00059-007-3073-1; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; JACKS T, 1994, CURR BIOL, V4, P1, DOI 10.1016/S0960-9822(00)00002-6; Kops GJPL, 2002, NATURE, V419, P316, DOI 10.1038/nature01036; Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861; Liang HY, 2006, ADV PHYSIOL EDUC, V30, P145, DOI 10.1152/advan.00052.2006; Liu JW, 2005, ONCOGENE, V24, P2020, DOI 10.1038/sj.onc.1208385; Maulik N, 2002, ANTIOXID REDOX SIGN, V4, P805, DOI 10.1089/152308602760598963; Monsalve M, 2000, MOL CELL, V6, P307, DOI 10.1016/S1097-2765(00)00031-9; Monsalve M, 2007, FRONT BIOSCI-LANDMRK, V12, P1131, DOI 10.2741/2132; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Munoz C, 1996, J IMMUNOL, V157, P3587; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; Oblander SA, 2005, DEV BIOL, V277, P255, DOI 10.1016/j.ydbio.2004.09.033; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; PIERROU S, 1994, EMBO J, V13, P5002, DOI 10.1002/j.1460-2075.1994.tb06827.x; Potente M, 2005, J CLIN INVEST, V115, P2382, DOI 10.1172/JCI23126; Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368; Rangwala SM, 2007, BIOCHEM BIOPH RES CO, V357, P231, DOI 10.1016/j.bbrc.2007.03.126; Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103; Sano M, 2005, CELL METAB, V1, P216, DOI 10.1016/j.cmet.2005.03.009; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Suh SH, 1999, PFLUG ARCH EUR J PHY, V438, P612, DOI 10.1007/s004240051084; Tran H, 2002, SCIENCE, V296, P530, DOI 10.1126/science.1068712; Ueki K, 1998, J BIOL CHEM, V273, P5315, DOI 10.1074/jbc.273.9.5315; Valle I, 2005, CARDIOVASC RES, V66, P562, DOI 10.1016/j.cardiores.2005.01.026; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Wang F, 2007, AGING CELL, V6, P505, DOI 10.1111/j.1474-9726.2007.00304.x; Wersto RP, 1996, P NATL ACAD SCI USA, V93, P1167, DOI 10.1073/pnas.93.3.1167; Weydt P, 2006, CELL METAB, V4, P349, DOI 10.1016/j.cmet.2006.10.004	39	163	169	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14476	14484		10.1074/jbc.M807397200	http://dx.doi.org/10.1074/jbc.M807397200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19324885	Green Published, hybrid			2022-12-27	WOS:000266286100054
J	Mou, ZM; Tapper, AR; Gardner, PD				Mou, Zhongming; Tapper, Andrew R.; Gardner, Paul D.			The Armadillo Repeat-containing Protein, ARMCX3, Physically and Functionally Interacts with the Developmental Regulatory Factor Sox10	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOCHONDRIAL OUTER-MEMBRANE; ACETYLCHOLINE-RECEPTOR GENES; TRANSCRIPTION FACTOR SOX10; NEURAL CREST DEVELOPMENT; SEGMENT POLARITY GENE; MOBILITY-GROUP DOMAIN; 4 SUBUNIT GENE; HIRSCHSPRUNG-DISEASE; BETA-CATENIN; MOUSE MODEL	Sox10 is a member of the group E Sox transcription factor family and plays key roles in neural crest development and subsequent cellular differentiation. Sox10 binds to regulatory sequences in target genes via its conserved high mobility group domain. In most cases, Sox10 exerts its transcriptional effects in concert with other DNA-binding factors, adaptor proteins, and nuclear import proteins. These interactions can lead to synergistic gene activation and can be cell type-specific. In earlier work, we demonstrated that Sox10 transactivates the nicotinic acetylcholine receptor alpha 3 and beta 4 subunit genes and does so only in neuronal-like cell lines, raising the possibility that Sox10 mediates its effects via interactions with co-regulatory factors. Here we describe the identification of the armadillo repeat-containing protein, ARMCX3, as a Sox10-interacting protein. Biochemical analyses indicate that ARMCX3 is an integral membrane protein of the mitochondrial outer membrane. Others have shown that Sox10 is a nucleocytoplasmic shuttling protein. We extend this observation and demonstrate that, in the cytoplasm, Sox10 is peripherally associated with the mitochondrial outer membrane. Both Sox10 and ARMCX3 are expressed in mouse brain and spinal cord as well as several cell lines. Over-expression of ARMCX3 increased the amount of mitochondrially associated Sox10. In addition, although ARMCX3 does not possess intrinsic transcriptional activity, it does enhance transactivation of the nicotinic acetylcholine receptor alpha 3 and beta 4 subunit gene promoters by Sox10. These results suggest that Sox10 is a membrane-associated factor whose transcriptional function is increased by direct interactions with ARMCX3 and raise the possibility of a signal transduction cascade between the nucleus and mitochondria through Sox10/ARMCX3 interactions.	[Mou, Zhongming; Tapper, Andrew R.; Gardner, Paul D.] Univ Massachusetts, Sch Med, Brudnick Neuropsychiat Res Inst, Dept Psychiat, Worcester, MA 01064 USA	University of Massachusetts System; University of Massachusetts Worcester	Gardner, PD (corresponding author), Univ Massachusetts, Sch Med, Brudnick Neuropsychiat Res Inst, Dept Psychiat, 303 Belmont St, Worcester, MA 01064 USA.	paul.gardner@umassmed.edu			National Institutes of Health [R01NS030243]; Philip Morris USA Inc; Philip Morris International; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS030243] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Philip Morris USA Inc; Philip Morris International; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01NS030243 (to P. D. G.) from NINDS. This work was also supported by a grant from Philip Morris USA Inc. and Philip Morris International to (P. D. G.).	Akiyama H, 2004, GENE DEV, V18, P1072, DOI 10.1101/gad.1171104; Armstrong LC, 1999, J CELL BIOCHEM, V74, P11, DOI 10.1002/(SICI)1097-4644(19990701)74:1<11::AID-JCB2>3.0.CO;2-V; Bashor CJ, 2008, SCIENCE, V319, P1539, DOI 10.1126/science.1151153; Bhattacharyya RP, 2006, ANNU REV BIOCHEM, V75, P655, DOI 10.1146/annurev.biochem.75.103004.142710; Bigger CB, 1996, J BIOL CHEM, V271, P32842, DOI 10.1074/jbc.271.51.32842; Bigger CB, 1997, J BIOL CHEM, V272, P25976, DOI 10.1074/jbc.272.41.25976; Bondurand N, 2007, AM J HUM GENET, V81, P1169, DOI 10.1086/522090; Bowles J, 2000, DEV BIOL, V227, P239, DOI 10.1006/dbio.2000.9883; Britsch S, 2001, GENE DEV, V15, P66, DOI 10.1101/gad.186601; Burack WR, 2000, CURR OPIN CELL BIOL, V12, P211, DOI 10.1016/S0955-0674(99)00078-2; CAPALDI RA, 1990, ANNU REV BIOCHEM, V59, P569, DOI 10.1146/annurev.bi.59.070190.003033; Carney TJ, 2006, DEVELOPMENT, V133, P4619, DOI 10.1242/dev.02668; Coates JC, 2003, TRENDS CELL BIOL, V13, P463, DOI 10.1016/S0962-8924(03)00167-3; Du Q, 1998, J BIOL CHEM, V273, P19877, DOI 10.1074/jbc.273.31.19877; Du Q, 1997, J BIOL CHEM, V272, P14990, DOI 10.1074/jbc.272.23.14990; Elworthy S, 2005, MECH DEVELOP, V122, P659, DOI 10.1016/j.mod.2004.12.008; Elworthy S, 2003, DEVELOPMENT, V130, P2809, DOI 10.1242/dev.00461; Finzsch M, 2008, DEVELOPMENT, V135, P637, DOI 10.1242/dev.010454; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Medel YFF, 2007, J BIOL CHEM, V282, P19062, DOI 10.1074/jbc.M702354200; Gasca S, 2002, P NATL ACAD SCI USA, V99, P11199, DOI 10.1073/pnas.172383099; Girard M, 2006, FEBS LETT, V580, P1635, DOI 10.1016/j.febslet.2006.02.011; Hattori T, 2006, J BIOL CHEM, V281, P14417, DOI 10.1074/jbc.M511330200; Hatzfeld M, 1999, INT REV CYTOL, V186, P179; Hay JC, 1996, J BIOL CHEM, V271, P5671, DOI 10.1074/jbc.271.10.5671; Herbarth B, 1998, P NATL ACAD SCI USA, V95, P5161, DOI 10.1073/pnas.95.9.5161; Hsia N, 2004, BIOL REPROD, V70, P448, DOI 10.1095/biolreprod.103.021493; HU MJ, 1994, J NEUROCHEM, V62, P392; Huang WD, 2000, MOL CELL BIOL, V20, P4149, DOI 10.1128/MCB.20.11.4149-4158.2000; Huang WD, 2001, P NATL ACAD SCI USA, V98, P160, DOI 10.1073/pnas.011393998; Iguchi H, 2007, J BIOL CHEM, V282, P19052, DOI 10.1074/jbc.M700460200; Kaufmann T, 2003, J CELL BIOL, V160, P53, DOI 10.1083/jcb.200210084; Kelsh RN, 2006, BIOESSAYS, V28, P788, DOI 10.1002/bies.20445; Kim J, 2003, NEURON, V38, P17, DOI 10.1016/S0896-6273(03)00163-6; Kuhlbrodt K, 1998, J NEUROSCI, V18, P237, DOI 10.1523/jneurosci.18-01-00237.1998; Kurochkin IV, 2001, BIOCHEM BIOPH RES CO, V280, P340, DOI 10.1006/bbrc.2000.4125; Lang D, 2003, HUM MOL GENET, V12, P937, DOI 10.1093/hmg/ddg107; Liu Q, 1999, J NEUROSCI, V19, P9747; Maka M, 2005, DEV BIOL, V277, P155, DOI 10.1016/j.ydbio.2004.09.014; McBride HM, 2006, CURR BIOL, V16, pR551, DOI 10.1016/j.cub.2006.06.054; Melnikova IN, 2000, NEUROPHARMACOLOGY, V39, P2615, DOI 10.1016/S0028-3908(00)00125-8; Melnikova IN, 2000, EUR J PHARMACOL, V393, P75, DOI 10.1016/S0014-2999(99)00884-5; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; OLMSTED JB, 1970, P NATL ACAD SCI USA, V65, P129, DOI 10.1073/pnas.65.1.129; Pagliarini DJ, 2006, TRENDS BIOCHEM SCI, V31, P26, DOI 10.1016/j.tibs.2005.11.005; Paratore C, 2001, DEVELOPMENT, V128, P3949; Pawson T, 1997, SCIENCE, V278, P2075, DOI 10.1126/science.278.5346.2075; PEIFER M, 1994, CELL, V76, P789, DOI 10.1016/0092-8674(94)90353-0; Pingault V, 1998, NAT GENET, V18, P171, DOI 10.1038/ng0298-171; Prior HM, 1996, MOL MED, V2, P405, DOI 10.1007/BF03401900; Rapaport D, 2003, EMBO REP, V4, P948, DOI 10.1038/sj.embor.embor937; Rehberg S, 2002, MOL CELL BIOL, V22, P5826, DOI 10.1128/MCB.22.16.5826-5834.2002; RIGGLEMAN B, 1989, GENE DEV, V3, P96, DOI 10.1101/gad.3.1.96; Ryan MT, 2007, ANNU REV BIOCHEM, V76, P701, DOI 10.1146/annurev.biochem.76.052305.091720; RYDER EF, 1990, J NEUROBIOL, V21, P356, DOI 10.1002/neu.480210209; Schepers GE, 2002, DEV CELL, V3, P167, DOI 10.1016/S1534-5807(02)00223-X; Smith CA, 2005, DEV DYNAM, V233, P188, DOI 10.1002/dvdy.20309; Smith JM, 2004, TRENDS GENET, V20, P4, DOI 10.1016/j.tig.2003.11.007; Southard-Smith EM, 1998, NAT GENET, V18, P60, DOI 10.1038/ng0198-60; Srinivas KS, 2004, J BIOCHEM BIOPH METH, V60, P23, DOI 10.1016/j.jbbm.2004.04.011; Taylor KM, 2005, DEV CELL, V9, P593, DOI 10.1016/j.devcel.2005.09.016; Wegner M, 2005, TRENDS NEUROSCI, V28, P583, DOI 10.1016/j.tins.2005.08.008; Wegner M, 2005, PIGM CELL RES, V18, P74, DOI 10.1111/j.1600-0749.2005.00218.x; Wegner M, 1999, NUCLEIC ACIDS RES, V27, P1409, DOI 10.1093/nar/27.6.1409; WIESCHAUS E, 1987, CELL, V49, P177, DOI 10.1016/0092-8674(87)90558-7; Wilson M, 2002, CURR OPIN GENET DEV, V12, P441, DOI 10.1016/S0959-437X(02)00323-4; Wissmuller S, 2006, NUCLEIC ACIDS RES, V34, P1735, DOI 10.1093/nar/gkl105; Zorn AM, 1999, MOL CELL, V4, P487, DOI 10.1016/S1097-2765(00)80200-2	68	24	33	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13629	13640		10.1074/jbc.M901177200	http://dx.doi.org/10.1074/jbc.M901177200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19304657	hybrid, Green Published			2022-12-27	WOS:000265877300040
J	Thieman, JR; Mishra, SK; Ling, K; Doray, B; Anderson, RA; Traub, LM				Thieman, James R.; Mishra, Sanjay K.; Ling, Kun; Doray, Balraj; Anderson, Richard A.; Traub, Linton M.			Clathrin Regulates the Association of PIPKI gamma 661 with the AP-2 Adaptor beta 2 Appendage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOSPHATIDYLINOSITOL PHOSPHATE KINASE; COATED PITS; MEDIATED ENDOCYTOSIS; PLASMA-MEMBRANE; PHOSPHOLIPASE-D; PIPKI-GAMMA; RECEPTOR INTERNALIZATION; FUNCTIONAL DISSECTION; STRUCTURAL BASIS; TERMINAL DOMAIN	The AP-2 clathrin adaptor differs fundamentally from the related AP-1, AP-3, and AP-4 sorting complexes because membrane deposition does not depend directly on an Arf family GTPase. Instead phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P-2) appears to act as the principal compartmental cue for AP-2 placement at the plasma membrane as well as for the docking of numerous other important clathrin coat components at the nascent bud site. This PtdIns(4,5)P-2 dependence makes type I phosphatidylinositol 4-phosphate 5-kinases (PIPKIs) lynchpin enzymes in the assembly of clathrin-coated structures at the cell surface. PIPKI gamma is the chief 5-kinase at nerve terminals, and here we show that the 26-amino acid, alternatively spliced C terminus of PIPKI gamma 661 is an intrinsically unstructured polypeptide that binds directly to the sandwich subdomain of the AP-2 beta 2 subunit appendage. An aromatic side chain-based, extended interaction motif that also includes the two bulky C-terminal residues of the short PIPKI gamma 635 variant is necessary for beta 2 appendage engagement. The clathrin heavy chain accesses the same contact surface on the AP-2 beta 2 appendage, but because of additional clathrin binding sites located within the unstructured hinge segment of the beta 2 subunit, clathrin binds the beta 2 chain with a higher apparent affinity than PIPKI gamma 661. A clathrin-regulated interaction with AP-2 could allow PIPKI gamma 661 to be strategically positioned for regional PtdIns(4,5)P-2 generation during clathrin-coated vesicle assembly at the synapse.	[Thieman, James R.; Mishra, Sanjay K.; Traub, Linton M.] Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, Pittsburgh, PA 15261 USA; [Ling, Kun] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Rochester, MN 55905 USA; [Doray, Balraj] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Anderson, Richard A.] Univ Wisconsin, Sch Med, Dept Pharmacol, Madison, WI 53706 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Mayo Clinic; Washington University (WUSTL); University of Wisconsin System; University of Wisconsin Madison	Traub, LM (corresponding author), Univ Pittsburgh, Sch Med, Dept Cell Biol & Physiol, 3500 Terrace St,S311BST, Pittsburgh, PA 15261 USA.	traub@pitt.edu		Traub, Linton/0000-0002-1303-0298; Doray, Balraj/0000-0003-3347-5013; Anderson, Richard/0000-0001-6265-8359	National Institutes of Health [R01 DK53249, T32 DK061296, R01 CA104708]; American Heart Association Established Investigator Award [0540007N]; NATIONAL CANCER INSTITUTE [R01CA104708] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK053249, T32DK061296] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Established Investigator Award(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 DK53249 ( to L. M. T.), T32 DK061296 ( to J. R. T.), and R01 CA104708 ( to R. A. A.). This work was also supported in part by American Heart Association Established Investigator Award 0540007N.	Abe N, 2008, J CELL SCI, V121, P1488, DOI 10.1242/jcs.020792; Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; Arneson LS, 1999, J BIOL CHEM, V274, P17794, DOI 10.1074/jbc.274.25.17794; Bairstow SF, 2006, J BIOL CHEM, V281, P20632, DOI 10.1074/jbc.M601465200; Barriere H, 2006, TRAFFIC, V7, P282, DOI 10.1111/j.1600-0854.2006.00384.x; Boucrot E, 2006, EXP CELL RES, V312, P4036, DOI 10.1016/j.yexcr.2006.09.025; Brough D, 2005, J CELL SCI, V118, P3019, DOI 10.1242/jcs.02426; Carvou N, 2007, CELL SIGNAL, V19, P42, DOI 10.1016/j.cellsig.2006.05.023; Chi S, 2008, MOL BIOL CELL, V19, P3564, DOI 10.1091/mbc.E07-10-0997; COLLAWN JF, 1990, CELL, V63, P1061, DOI 10.1016/0092-8674(90)90509-D; Collins BM, 2002, CELL, V109, P523, DOI 10.1016/S0092-8674(02)00735-3; Cremona O, 1999, CELL, V99, P179, DOI 10.1016/S0092-8674(00)81649-9; Crottet P, 2002, MOL BIOL CELL, V13, P3672, DOI 10.1091/mbc.E02-05-0309; Cupers P, 1998, J BIOL CHEM, V273, P1847, DOI 10.1074/jbc.273.4.1847; de Pereda JM, 2005, J BIOL CHEM, V280, P8381, DOI 10.1074/jbc.M413180200; Di Paolo G, 2004, NATURE, V431, P415, DOI 10.1038/nature02896; Di Paolo G, 2002, NATURE, V420, P85, DOI 10.1038/nature01147; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Doray B, 2007, MOL BIOL CELL, V18, P1887, DOI 10.1091/mbc.E07-01-0012; Drake MT, 2000, J BIOL CHEM, V275, P6479, DOI 10.1074/jbc.275.9.6479; Edeling MA, 2006, DEV CELL, V10, P329, DOI 10.1016/j.devcel.2006.01.016; Eden ER, 2007, HUM MOL GENET, V16, P2751, DOI 10.1093/hmg/ddm232; FISCHER V, 1991, NATURE, V349, P79; GALLUSSER A, 1993, EMBO J, V12, P5237, DOI 10.1002/j.1460-2075.1993.tb06219.x; Giudici ML, 2006, FEBS LETT, V580, P6933, DOI 10.1016/j.febslet.2006.11.052; Giudici ML, 2004, BIOCHEM J, V379, P489, DOI 10.1042/BJ20031394; Golebiewska U, 2008, MOL BIOL CELL, V19, P1663, DOI 10.1091/mbc.E07-12-1208; Haffner C, 2000, CURR BIOL, V10, P471, DOI 10.1016/S0960-9822(00)00446-2; Hammond GRV, 2009, J CELL BIOL, V184, P297, DOI 10.1083/jcb.200809073; Harris TW, 2000, J CELL BIOL, V150, P589, DOI 10.1083/jcb.150.3.589; Hawryluk MJ, 2006, TRAFFIC, V7, P262, DOI 10.1111/j.1600-0854.2006.00383.x; He GC, 2002, J BIOL CHEM, V277, P44044, DOI 10.1074/jbc.M208539200; Hinrichsen L, 2003, J BIOL CHEM, V278, P45160, DOI 10.1074/jbc.M307290200; Huang FT, 2004, J BIOL CHEM, V279, P16657, DOI 10.1074/jbc.C400046200; Ishihara H, 1998, J BIOL CHEM, V273, P8741, DOI 10.1074/jbc.273.15.8741; JADOT M, 1992, J BIOL CHEM, V267, P11069; JENKINS GH, 1994, J BIOL CHEM, V269, P11547; Jenkins GM, 2005, CELL MOL LIFE SCI, V62, P2305, DOI 10.1007/s00018-005-5195-z; Jha A, 2004, J BIOL CHEM, V279, P2281, DOI 10.1074/jbc.M305644200; Jost M, 1998, CURR BIOL, V8, P1399, DOI 10.1016/S0960-9822(98)00022-0; Kalthoff C, 2002, J BIOL CHEM, V277, P8209, DOI 10.1074/jbc.M111587200; Kawasaki T, 2008, BIOCHEM J, V409, P471, DOI 10.1042/BJ20070755; Keyel PA, 2006, MOL BIOL CELL, V17, P4300, DOI 10.1091/mbc.E06-05-0421; Keyel PA, 2008, MOL BIOL CELL, V19, P5309, DOI 10.1091/mbc.E08-07-0712; Knuehl C, 2006, TRAFFIC, V7, P1688, DOI 10.1111/j.1600-0854.2006.00499.x; Kong XM, 2006, J MOL BIOL, V359, P47, DOI 10.1016/j.jmb.2006.02.048; Krauss M, 2006, P NATL ACAD SCI USA, V103, P11934, DOI 10.1073/pnas.0510306103; Kunz J, 2000, MOL CELL, V5, P1, DOI 10.1016/S1097-2765(00)80398-6; Laporte SA, 2002, J BIOL CHEM, V277, P9247, DOI 10.1074/jbc.M108490200; Lee DW, 2006, J CELL SCI, V119, P3502, DOI 10.1242/jcs.03092; Lee SY, 2005, J CELL BIOL, V168, P789, DOI 10.1083/jcb.200409028; Leftowitz RJ, 2005, SCIENCE, V308, P512, DOI 10.1126/science.1109237; Ling K, 2003, J CELL BIOL, V163, P1339, DOI 10.1083/jcb.200310067; Ling K, 2002, NATURE, V420, P89, DOI 10.1038/nature01082; Maldonado-Baez L, 2006, TRENDS CELL BIOL, V16, P505, DOI 10.1016/j.tcb.2006.08.001; Mao YS, 2009, J CELL BIOL, V184, P281, DOI 10.1083/jcb.200806121; Marchese A, 2008, ANNU REV PHARMACOL, V48, P601, DOI 10.1146/annurev.pharmtox.48.113006.094646; Maurer ME, 2006, J CELL SCI, V119, P4235, DOI 10.1242/jcs.03217; Merida I, 2008, BIOCHEM J, V409, P1, DOI 10.1042/BJ20071040; Mishra SK, 2005, J BIOL CHEM, V280, P19270, DOI 10.1074/jbc.M501029200; Mishra SK, 2004, J BIOL CHEM, V279, P46191, DOI 10.1074/jbc.M408095200; Mishra SK, 2002, P NATL ACAD SCI USA, V99, P16099, DOI 10.1073/pnas.252630799; Mishra SK, 2001, J BIOL CHEM, V276, P46230, DOI 10.1074/jbc.M108177200; Morris AJ, 2007, BIOCHEM SOC SYMP, V74, P247, DOI 10.1042/BSS2007c20; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Nakano-Kobayashi A, 2007, EMBO J, V26, P1105, DOI 10.1038/sj.emboj.7601573; Narkis G, 2007, AM J HUM GENET, V81, P530, DOI 10.1086/520771; Nelson CD, 2008, J BIOL CHEM, V283, P21093, DOI 10.1074/jbc.M800431200; Nelson CD, 2007, SCIENCE, V315, P663, DOI 10.1126/science.1134562; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; Olusanya O, 2001, CURR BIOL, V11, P896, DOI 10.1016/S0960-9822(01)00240-8; Owen DJ, 2000, EMBO J, V19, P4216, DOI 10.1093/emboj/19.16.4216; Owen DJ, 1998, SCIENCE, V282, P1327, DOI 10.1126/science.282.5392.1327; Padron D, 2003, J CELL BIOL, V162, P693, DOI 10.1083/jcb.200302051; Perera RM, 2006, P NATL ACAD SCI USA, V103, P19332, DOI 10.1073/pnas.0609795104; Ramjaun AR, 1996, J BIOL CHEM, V271, P24856, DOI 10.1074/jbc.271.40.24856; Ritter B, 2004, EMBO J, V23, P3701, DOI 10.1038/sj.emboj.7600378; Sakane F, 2002, J BIOL CHEM, V277, P43519, DOI 10.1074/jbc.M206895200; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Schmid EM, 2007, NATURE, V448, P883, DOI 10.1038/nature06031; Schmid EM, 2006, PLOS BIOL, V4, P1532, DOI 10.1371/journal.pbio.0040262; Stefan CJ, 2002, MOL BIOL CELL, V13, P542, DOI 10.1091/mbc.01-10-0476; Sun YD, 2007, J CELL BIOL, V177, P355, DOI 10.1083/jcb.200611011; Sun Y, 2007, J CELL BIOL, V178, P297, DOI 10.1083/jcb.200701078; Tebar F, 1996, J BIOL CHEM, V271, P28727, DOI 10.1074/jbc.271.46.28727; ter Haar E, 2000, P NATL ACAD SCI USA, V97, P1096, DOI 10.1073/pnas.97.3.1096; ter Haar E, 1998, CELL, V95, P563, DOI 10.1016/S0092-8674(00)81623-2; Traub LM, 1999, P NATL ACAD SCI USA, V96, P8907, DOI 10.1073/pnas.96.16.8907; Ungewickell EJ, 2007, CURR OPIN CELL BIOL, V19, P417, DOI 10.1016/j.ceb.2007.05.003; Vallis Y, 1999, CURR BIOL, V9, P257, DOI 10.1016/S0960-9822(99)80114-6; van Rheenen J, 2005, EMBO J, V24, P1664, DOI 10.1038/sj.emboj.7600655; Varnai P, 2006, J CELL BIOL, V175, P377, DOI 10.1083/jcb.200607116; Walther K, 2004, P NATL ACAD SCI USA, V101, P964, DOI 10.1073/pnas.0307862100; Wang YF, 2007, P NATL ACAD SCI USA, V104, P11748, DOI 10.1073/pnas.0700019104; Wenk MR, 2001, NEURON, V32, P79, DOI 10.1016/S0896-6273(01)00456-1; Yaradanakul A, 2007, J MEMBRANE BIOL, V220, P53, DOI 10.1007/s00232-007-9074-4; Ybe JA, 1999, NATURE, V399, P371, DOI 10.1038/20708; Yu JW, 2004, MOL CELL, V13, P677, DOI 10.1016/S1097-2765(04)00083-8; Zoncu R, 2007, P NATL ACAD SCI USA, V104, P3793, DOI 10.1073/pnas.0611733104	100	38	41	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13924	13939		10.1074/jbc.M901017200	http://dx.doi.org/10.1074/jbc.M901017200			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19287005	Green Published, hybrid			2022-12-27	WOS:000265877300068
J	Yamane, D; Zahoor, MA; Mohamed, YM; Azab, W; Kato, K; Tohya, Y; Akashi, H				Yamane, Daisuke; Zahoor, Muhammad A.; Mohamed, Yassir M.; Azab, Walid; Kato, Kentaro; Tohya, Yukinobu; Akashi, Hiroomi			Inhibition of Sphingosine Kinase by Bovine Viral Diarrhea Virus NS3 Is Crucial for Efficient Viral Replication and Cytopathogenesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATITIS-C-VIRUS; INNATE IMMUNITY; APOPTOSIS; PROTEIN; ACTIVATION; CELLS; SPHINGOSINE-1-PHOSPHATE; CLEAVAGE; AUTOPROTEASE; EXPRESSION	Sphingosine 1-phosphate (S1P) is a bioactive sphingolipid implicated in diverse cellular functions including survival, proliferation, tumorigenesis, inflammation, and immunity. Sphingosine kinase (SphK) contributes to these functions by converting sphingosine to S1P. We report here that the nonstructural protein NS3 from bovine viral diarrhea virus (BVDV), a close relative of hepatitis C virus (HCV), binds to and inhibits the catalytic activity of SphK1 independently of its serine protease activity, whereas HCV NS3 does not affect SphK1 activity. Uncleaved NS2-3 from BVDV was also found to interact with and inhibit SphK1. We suspect that inhibition of SphK1 activity by BVDV NS3 and NS2-3 may benefit viral replication, because SphK1 inhibition by small interfering RNA, chemical inhibitor, or overexpression of catalytically inactive SphK1 results in enhanced viral replication, although the mechanisms by which SphK1 inhibition leads to enhanced viral replication remain unknown. A role of SphK1 inhibition in viral cytopathogenesis is also suggested as overexpression of SphK1 significantly attenuates the induction of apoptosis in cells infected with cytopathogenic BVDV. These findings suggest that SphK is targeted by this virus to regulate its catalytic activity.	[Yamane, Daisuke; Zahoor, Muhammad A.; Mohamed, Yassir M.; Azab, Walid; Kato, Kentaro; Tohya, Yukinobu; Akashi, Hiroomi] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Microbiol, Bunkyo Ku, Tokyo 1138657, Japan	University of Tokyo	Akashi, H (corresponding author), Univ Tokyo, Grad Sch Agr & Life Sci, Dept Vet Microbiol, Bunkyo Ku, 1-1-1 Yayoi, Tokyo 1138657, Japan.	akashih@mail.ecc.u-tokyo.ac.jp	Zahoor, Muhammad/ADH-5812-2022	Zahoor, Muhammad/0000-0003-2302-3689; Azab, Walid/0000-0003-2880-7255	Ministry of Agriculture, Forestry and Fisheries of Japan; Ministry of Education, Culture, Sports, Science and Technology, Japan,; Japan Society for the Promotion of Science	Ministry of Agriculture, Forestry and Fisheries of Japan(Ministry of Agriculture Forestry & Fisheries - Japan); Ministry of Education, Culture, Sports, Science and Technology, Japan,(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by grants-in-aid from the Ministry of Agriculture, Forestry and Fisheries of Japan, the Ministry of Education, Culture, Sports, Science and Technology, Japan, and the Japan Society for the Promotion of Science.	Aizaki H, 2004, VIROLOGY, V324, P450, DOI 10.1016/j.virol.2004.03.034; Buckwold VE, 2003, ANTIVIR RES, V60, P1, DOI 10.1016/S0166-3542(03)00174-8; Chen ZH, 2007, J VIROL, V81, P964, DOI 10.1128/JVI.02076-06; Choi KH, 2004, P NATL ACAD SCI USA, V101, P4425, DOI 10.1073/pnas.0400660101; French KJ, 2003, CANCER RES, V63, P5962; Gao L, 2004, J VIROL, V78, P3480, DOI 10.1128/JVI.78.7.3480-3488.2004; Jordan R, 2002, J VIROL, V76, P9588, DOI 10.1128/JVI.76.19.9588-9599.2002; Kihara A, 2006, J BIOL CHEM, V281, P4532, DOI 10.1074/jbc.M510308200; Lackner T, 2005, J VIROL, V79, P9746, DOI 10.1128/JVI.79.15.9746-9755.2005; Lackner T, 2004, J VIROL, V78, P10765, DOI 10.1128/JVI.78.19.10765-10775.2004; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; Li XD, 2005, P NATL ACAD SCI USA, V102, P17717, DOI 10.1073/pnas.0508531102; Maceyka M, 2005, J BIOL CHEM, V280, P37118, DOI 10.1074/jbc.M502207200; Machesky NJ, 2008, J BIOL CHEM, V283, P26148, DOI 10.1074/jbc.M710181200; Makino A, 2006, J VIROL, V80, P4482, DOI 10.1128/JVI.80.9.4482-4490.2006; Monick MM, 2004, AM J RESP CELL MOL, V30, P844, DOI 10.1165/rcmb.2003-0424OC; Nagai M, 2003, J GEN VIROL, V84, P447, DOI 10.1099/vir.0.18773-0; Olivera A, 1998, J BIOL CHEM, V273, P12576, DOI 10.1074/jbc.273.20.12576; OLIVERA A, 1993, NATURE, V365, P557, DOI 10.1038/365557a0; Olivera A, 1999, J CELL BIOL, V147, P545, DOI 10.1083/jcb.147.3.545; Pitson SM, 2000, J BIOL CHEM, V275, P33945, DOI 10.1074/jbc.M006176200; Pitson SM, 2003, EMBO J, V22, P5491, DOI 10.1093/emboj/cdg540; Sakamoto H, 2005, NAT CHEM BIOL, V1, P333, DOI 10.1038/nchembio742; Schweizer M, 1999, J GEN VIROL, V80, P1147, DOI 10.1099/0022-1317-80-5-1147; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Shida D, 2008, CURR DRUG TARGETS, V9, P662, DOI 10.2174/138945008785132402; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; St-Louis MC, 2005, VET RES, V36, P213, DOI 10.1051/vetres:2004059; Sutherland CM, 2006, J BIOL CHEM, V281, P11693, DOI 10.1074/jbc.M601042200; Taha TA, 2006, J BIOCHEM MOL BIOL, V39, P113; Vassilev VB, 2000, VIRUS RES, V69, P95, DOI 10.1016/S0168-1702(00)00176-3; Xia P, 1999, J BIOL CHEM, V274, P34499, DOI 10.1074/jbc.274.48.34499; Xu JA, 1997, J VIROL, V71, P5312, DOI 10.1128/JVI.71.7.5312-5322.1997; Yamane D, 2005, MICROBES INFECT, V7, P1482, DOI 10.1016/j.micinf.2005.05.006; Yamane D, 2008, VET MICROBIOL, V129, P69, DOI 10.1016/j.vetmic.2007.11.004; Yamane D, 2006, J GEN VIROL, V87, P2961, DOI 10.1099/vir.0.81820-0; Zhang G, 2003, VIRUS RES, V97, P89, DOI 10.1016/S0168-1702(03)00223-5	37	42	42	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13648	13659		10.1074/jbc.M807498200	http://dx.doi.org/10.1074/jbc.M807498200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19293152	Green Published, hybrid			2022-12-27	WOS:000265877300042
J	Kitatani, K; Sheldon, K; Anelli, V; Jenkins, RW; Sun, Y; Grabowski, GA; Obeid, LM; Hannun, YA				Kitatani, Kazuyuki; Sheldon, Kely; Anelli, Viviana; Jenkins, Russell W.; Sun, Ying; Grabowski, Gregory A.; Obeid, Lina M.; Hannun, Yusuf A.			Acid beta-Glucosidase 1 Counteracts p38 delta-dependent Induction of Interleukin-6 POSSIBLE ROLE FOR CERAMIDE AS AN ANTI-INFLAMMATORY LIPID	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TUMOR-NECROSIS-FACTOR; PROTEIN-KINASE-C; P38 MAP-KINASES; GAUCHER-DISEASE; FACTOR-ALPHA; EPITHELIAL-CELLS; TRANSDUCTION PATHWAYS; TRANSCRIPTION FACTORS; SELECTIVE-INHIBITION; CELLULAR-RESPONSES	Activation of protein kinase C (PKC) by the phorbol ester (phorbol 12-myristate 13-acetate) induces ceramide formation through the salvage pathway involving, in part, acid beta-glucosidase 1 (GBA1), which cleaves glucosylceramide to ceramide. Here, we examine the role of the GBA1-ceramide pathway, in regulating a pro-inflammatory pathway initiated by PKC and leading to activation of p38 and induction of interleukin 6 (IL-6). Inhibition of ceramide formation by fumonisin B1 or down-regulation of PKC delta potentiated PMA-induced activation of p38 in human breast cancer MCF-7 cells. Similarly, knockdown of GBA1 by small interfering RNAs or pharmacological inhibition of GBA1 promoted further activation of p38 after PMA treatment, implicating the GBA1-ceramide pathway in the termination of p38 activation. Knockdown of GBA1 also evoked the hyperproduction of IL-6 in response to 4 beta phorbol 12-myristate 13-acetate. On the other hand, increasing cellular ceramide with cell-permeable ceramide treatment resulted in attenuation of the IL-6 response. Importantly, silencing the delta isoform of the p38 family significantly attenuated the hyperproduction of IL-6. Reciprocally, p38 delta overexpression induced IL-6 biosynthesis. Thus, the GBA1-ceramide pathway is suggested to play an important role in terminating p38 delta activation responsible for IL-6 biosynthesis. Furthermore, the p38 delta isoform was identified as a novel and predominant target of ceramide signaling as well as a regulator of IL-6 biosynthesis.	[Kitatani, Kazuyuki; Sheldon, Kely; Anelli, Viviana; Jenkins, Russell W.; Hannun, Yusuf A.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Obeid, Lina M.] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; [Sun, Ying; Grabowski, Gregory A.] Cincinnati Childrens Hosp, Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA; [Sun, Ying; Grabowski, Gregory A.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45229 USA; [Obeid, Lina M.] Med Ctr, Dept Vet Affairs, Charleston, SC 29401 USA	Medical University of South Carolina; Medical University of South Carolina; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Hannun, YA (corresponding author), 173 Ashley Ave, Charleston, SC 29425 USA.	hannun@musc.edu	Kitatani, Kazuyuki/H-7100-2019	Kitatani, Kazuyuki/0000-0002-8516-6135; ANELLI, Viviana Vittoria/0000-0003-1964-3252; obeid, lina/0000-0002-0734-0847	NATIONAL CANCER INSTITUTE [R01CA087584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036729] Funding Source: NIH RePORTER; NCI NIH HHS [CA87584, R01 CA087584] Funding Source: Medline; NIA NIH HHS [AG01683] Funding Source: Medline; NIDDK NIH HHS [DK36729] Funding Source: Medline; OCPHP CDC HHS [C06 PR018823] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); OCPHP CDC HHS		Allen M, 2000, J EXP MED, V191, P859, DOI 10.1084/jem.191.5.859; Allen MJ, 1997, QJM-MON J ASSOC PHYS, V90, P19; Asgeirsson KS, 1998, CYTOKINE, V10, P720, DOI 10.1006/cyto.1998.0349; Barak V, 1999, EUR CYTOKINE NETW, V10, P205; Becker KP, 2005, J BIOL CHEM, V280, P2606, DOI 10.1074/jbc.M409066200; Beyaert R, 1996, EMBO J, V15, P1914, DOI 10.1002/j.1460-2075.1996.tb00542.x; Bin Hong Y, 2006, J KOREAN MED SCI, V21, P733, DOI 10.3346/jkms.2006.21.4.733; Boot RG, 2007, J BIOL CHEM, V282, P1305, DOI 10.1074/jbc.M610544200; BRUNE K, 1978, CANCER LETT, V4, P333, DOI 10.1016/S0304-3835(78)95612-4; Chalfant CE, 1999, J BIOL CHEM, V274, P20313, DOI 10.1074/jbc.274.29.20313; Charrow J, 2007, CLIN GENET, V71, P205, DOI 10.1111/j.1399-0004.2007.00769.x; Chen CL, 2008, BLOOD, V111, P4365, DOI 10.1182/blood-2007-08-106336; Chiba N, 2007, J CELL PHYSIOL, V213, P126, DOI 10.1002/jcp.21101; Clarke CJ, 2008, MOL PHARMACOL, V74, P1022, DOI 10.1124/mol.108.046250; Costello R, 2006, LEUKEMIA LYMPHOMA, V47, P1365, DOI 10.1080/10428190600565453; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Dbaibo GS, 2001, FEBS LETT, V503, P7, DOI 10.1016/S0014-5793(01)02625-4; De Cesaris P, 1998, J BIOL CHEM, V273, P7566, DOI 10.1074/jbc.273.13.7566; DINUR T, 1986, P NATL ACAD SCI USA, V83, P1660, DOI 10.1073/pnas.83.6.1660; Efimova T, 2003, J BIOL CHEM, V278, P34277, DOI 10.1074/jbc.M302759200; Eftmova T, 2002, J BIOL CHEM, V277, P31753, DOI 10.1074/jbc.M205098200; Fearns C, 2000, J LEUKOCYTE BIOL, V67, P705, DOI 10.1002/jlb.67.5.705; Futerman AH, 2004, NAT REV MOL CELL BIO, V5, P554, DOI 10.1038/nrm1423; Galadari S, 1998, BIOCHEMISTRY-US, V37, P11232, DOI 10.1021/bi980911+; Goedert M, 1997, EMBO J, V16, P3563, DOI 10.1093/emboj/16.12.3563; Grabowski GA, 1997, BAILLIERE CLIN HAEM, V10, P635, DOI 10.1016/S0950-3536(97)80032-7; Griner EM, 2007, NAT REV CANCER, V7, P281, DOI 10.1038/nrc2110; HANEMAAIJER R, 1993, BIOCHEM J, V296, P803, DOI 10.1042/bj2960803; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; Hayashi Y, 2007, J BIOL CHEM, V282, P30889, DOI 10.1074/jbc.M700832200; HECKER E, 1967, NATURWISSENSCHAFTEN, V54, P282, DOI 10.1007/BF00620887; Hideshima T, 2004, BLOOD, V104, P607, DOI 10.1182/blood-2004-01-0037; Hsu YW, 2001, J IMMUNOL, V166, P5388, DOI 10.4049/jimmunol.166.9.5388; Jiang Y, 1997, J BIOL CHEM, V272, P30122, DOI 10.1074/jbc.272.48.30122; Jmoudiak M, 2005, BRIT J HAEMATOL, V129, P178, DOI 10.1111/j.1365-2141.2004.05351.x; Jones JA, 2002, J BIOL CHEM, V277, P15530, DOI 10.1074/jbc.M111555200; Junttila MR, 2007, ONCOGENE, V26, P5267, DOI 10.1038/sj.onc.1210332; KIM MY, 1991, J BIOL CHEM, V266, P484; Kitatani K, 2004, CELL SIGNAL, V16, P967, DOI 10.1016/j.cellsig.2004.02.003; Kitatani K, 2001, ARCH BIOCHEM BIOPHYS, V395, P208, DOI 10.1006/abbi.2001.2573; Kitatani K, 2008, CELL SIGNAL, V20, P1010, DOI 10.1016/j.cellsig.2007.12.006; Kitatani K, 2006, J BIOL CHEM, V281, P36793, DOI 10.1074/jbc.M608137200; Kitatani K, 2009, J BIOL CHEM, V284, P12972, DOI 10.1074/jbc.M802790200; Kolter T, 2005, ANNU REV CELL DEV BI, V21, P81, DOI 10.1146/annurev.cellbio.21.122303.120013; Kumar S, 2003, NAT REV DRUG DISCOV, V2, P717, DOI 10.1038/nrd1177; Lloyd-Evans E, 2003, J BIOL CHEM, V278, P23594, DOI 10.1074/jbc.M300212200; Lu H, 2005, MOL BIOL CELL, V16, P4954, DOI 10.1091/mbc.E05-05-0426; MARTINYBARON G, 1993, J BIOL CHEM, V268, P9194; Mizukami H, 2002, J CLIN INVEST, V109, P1215, DOI 10.1172/JCI200214530; NAKADATE T, 1989, JPN J PHARMACOL, V49, P1, DOI 10.1254/jjp.49.1; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; Ogretmen B, 2002, J BIOL CHEM, V277, P12960, DOI 10.1074/jbc.M110699200; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; Pastores GM, 2004, SEMIN HEMATOL, V41, P4, DOI 10.1053/j.seminhematol.2004.07.009; Premkumar L, 2005, J BIOL CHEM, V280, P23815, DOI 10.1074/jbc.M502799200; Pritts T, 2002, AM J SURG, V183, P372, DOI 10.1016/S0002-9610(02)00812-7; Roodman GD, 2001, J CLIN ONCOL, V19, P3562, DOI 10.1200/JCO.2001.19.15.3562; Rosenbloom BE, 2005, BLOOD, V105, P4569, DOI 10.1182/blood-2004-12-4672; Ruvolo PP, 2003, PHARMACOL RES, V47, P383, DOI 10.1016/S1043-6618(03)00050-1; Saklatvala J, 2004, CURR OPIN PHARMACOL, V4, P372, DOI 10.1016/j.coph.2004.03.009; Sansone P, 2007, J CLIN INVEST, V117, P3988, DOI 10.1172/JCI32533; Segui B, 2001, J CLIN INVEST, V108, P143, DOI 10.1172/JCI200111498; Song H, 2006, CANCER RES, V66, P10487, DOI 10.1158/0008-5472.CAN-06-1461; Stoica BA, 2005, MOL CELL NEUROSCI, V29, P355, DOI 10.1016/j.mcn.2005.02.009; Suarez-Cuervo C, 2004, CLIN EXP METASTAS, V21, P525, DOI 10.1007/s10585-004-3503-x; Sun Y, 2008, J LEUKOCYTE BIOL, V83, P1512, DOI 10.1189/jlb.0108076; Takeda S, 2006, J BIOCHEM, V139, P255, DOI 10.1093/jb/mvj026; Tettamanti G, 2003, BIOCHIMIE, V85, P423, DOI 10.1016/S0300-9084(03)00047-6; UPDYKE LW, 1989, CARCINOGENESIS, V10, P1107, DOI 10.1093/carcin/10.6.1107; Wang L, 2004, J BIOL CHEM, V279, P33213, DOI 10.1074/jbc.M403758200; Willaime S, 2001, EUR J NEUROSCI, V13, P2037, DOI 10.1046/j.0953-816x.2001.01581.x; Yildiz Y, 2006, J CLIN INVEST, V116, P2985, DOI 10.1172/JCI29224; Yoganathan S, 2003, LIPIDS, V38, P603, DOI 10.1007/s11745-003-1104-y; Zeidan YH, 2007, J BIOL CHEM, V282, P11549, DOI 10.1074/jbc.M609424200; Zhang JY, 2007, TRENDS PHARMACOL SCI, V28, P286, DOI 10.1016/j.tips.2007.04.008	75	46	47	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12979	12988		10.1074/jbc.M809500200	http://dx.doi.org/10.1074/jbc.M809500200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19279008	Green Published, hybrid			2022-12-27	WOS:000265688300045
J	Lee, HE; Berkowitz, P; Jolly, PS; Diaz, LA; Chua, MP; Rubenstein, DS				Lee, Hua En; Berkowitz, Paula; Jolly, Puneet S.; Diaz, Luis A.; Chua, Michael P.; Rubenstein, David S.			Biphasic Activation of p38MAPK Suggests That Apoptosis Is a Downstream Event in Pemphigus Acantholysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK PROTEIN-27; SCALDED-SKIN SYNDROME; P38 MAP-KINASES; VULGARIS-IGG; HUMAN KERATINOCYTES; BULLOUS IMPETIGO; FAMILY PROTEASES; PASSIVE TRANSFER; PHOSPHORYLATION; DISEASE	In pemphigus vulgaris and pemphigus foliaceus (PF), autoantibodies against desmoglein-3 and desmoglein-1 induce epidermal cell detachment (acantholysis) and blistering. Activation of keratinocyte intracellular signaling pathways is emerging as an important component of pemphigus IgG-mediated acantholysis. We previously reported activation of p38 mitogen-activated protein kinase (MAPK) in response to pathogenic pemphigus vulgaris and PF IgG. Inhibition of p38MAPK blocked pemphigus IgG-induced cytoskeletal reorganization in tissue culture and blistering in pemphigus mouse models. We now extend these observations by demonstrating two peaks of p38MAPK activation in pemphigus tissue culture and mouse models. Administration of the p38MAPK inhibitor SB202190 before PF IgG injection blocked both peaks of p38MAPK phosphorylation and blister formation, consistent with our previous findings; however, administration of the inhibitor 4 h after PF IgG injection blocked only the later peak of p38MAPK activation but failed to block blistering. Examination of the temporal relationship of p38MAPK phosphorylation and apoptosis showed that apoptosis occurs at or after the second peak of p38MAPK activation. The time course of p38MAPK activation and apoptotic markers, as well as the ability of inhibitors of p38MAPK to block activation of the proapoptotic proteinase caspase-3, suggest that activation of apoptosis is downstream to, and a consequence of, p38MAPK activation in pemphigus acantholysis. Furthermore, these observations suggest that the earlier peak of p38MAPK activation is part of the mechanism leading to acantholysis, whereas the later peak of p38MAPK and apoptosis may not be essential for acantholysis.	[Rubenstein, David S.] Univ N Carolina, Sch Med, Dept Dermatol, Chapel Hill, NC 27599 USA; [Chua, Michael P.] Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA; [Rubenstein, David S.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Lee, Hua En] Chang Gung Mem Hosp, Dept Dermatol, Tao Yuan 320338, Taiwan; [Lee, Hua En] Chang Gung Univ, Coll Med, Tao Yuan 320338, Taiwan	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Chang Gung Memorial Hospital	Rubenstein, DS (corresponding author), Univ N Carolina, Sch Med, Dept Dermatol, Ste 3100 Thurston Bowles CB 7287, Chapel Hill, NC 27599 USA.	druben@med.unc.edu	Lee, Hua/AAC-9489-2021	Diaz, Luis/0000-0002-7079-8914	National Institutes of Health [RO1 AI49427, AR32599]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI049427] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR032599] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1 AI49427 ( to D. S. R.) and AR32599 ( to L. A. D.).	Amagai M, 2000, NAT MED, V6, P1275, DOI 10.1038/81385; AMAGAI M, 1991, CELL, V67, P869, DOI 10.1016/0092-8674(91)90360-B; Amagai M, 1999, J AM ACAD DERMATOL, V40, P167, DOI 10.1016/S0190-9622(99)70183-0; ANHALT GJ, 1982, NEW ENGL J MED, V306, P1189, DOI 10.1056/NEJM198205203062001; Aoyama Y, 1999, EUR J IMMUNOL, V29, P2233, DOI 10.1002/(SICI)1521-4141(199907)29:07<2233::AID-IMMU2233>3.0.CO;2-4; Berkowitz P, 2005, J BIOL CHEM, V280, P23778, DOI 10.1074/jbc.M501365200; Berkowitz P, 2008, J INVEST DERMATOL, V128, P738, DOI 10.1038/sj.jid.5701080; Berkowitz P, 2006, P NATL ACAD SCI USA, V103, P12855, DOI 10.1073/pnas.0602973103; Berkowitz P, 2008, AM J PATHOL, V173, P1628, DOI 10.2353/ajpath.2008.080391; Caldelari R, 2001, J CELL BIOL, V153, P823, DOI 10.1083/jcb.153.4.823; Calkins CC, 2006, J BIOL CHEM, V281, P7623, DOI 10.1074/jbc.M512447200; Caulin C, 1997, J CELL BIOL, V138, P1379, DOI 10.1083/jcb.138.6.1379; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Delva E, 2008, J BIOL CHEM, V283, P18303, DOI 10.1074/jbc.M710046200; Ding X, 1997, J INVEST DERMATOL, V109, P592, DOI 10.1111/1523-1747.ep12337524; Dusek RL, 2006, J BIOL CHEM, V281, P3614, DOI 10.1074/jbc.M508258200; Evgrafov OV, 2004, NAT GENET, V36, P602, DOI 10.1038/ng1354; EYRE RW, 1988, J CLIN INVEST, V81, P807, DOI 10.1172/JCI113387; Feng L, 1999, J CELL SCI, V112, P2081; Frusic-Zlotkin M, 2006, AUTOIMMUNITY, V39, P563, DOI 10.1080/08916930600971836; Gniadecki R, 1998, ARCH DERMATOL RES, V290, P528, DOI 10.1007/s004030050347; Guay J, 1997, J CELL SCI, V110, P357; Hanakawa Y, 2002, J CLIN INVEST, V110, P53, DOI 10.1172/JCI200215766; Henkart PA, 1996, IMMUNITY, V4, P195, DOI 10.1016/S1074-7613(00)80428-8; Hu P, 2001, J INVEST DERMATOL, V117, P481; Juo P, 1997, MOL CELL BIOL, V17, P24, DOI 10.1128/MCB.17.1.24; Kawasaki Y, 2006, AUTOIMMUNITY, V39, P587, DOI 10.1080/08916930600971943; Ku NO, 1997, J BIOL CHEM, V272, P33197, DOI 10.1074/jbc.272.52.33197; LAVOIE JN, 1993, J BIOL CHEM, V268, P24210; LAVOIE JN, 1995, MOL CELL BIOL, V15, P505, DOI 10.1128/MCB.15.1.505; Miyagawa S, 1999, BRIT J DERMATOL, V141, P1084, DOI 10.1046/j.1365-2133.1999.03209.x; Nebreda AR, 2000, TRENDS BIOCHEM SCI, V25, P257, DOI 10.1016/S0968-0004(00)01595-4; Pelacho B, 2004, FEBS LETT, V566, P6, DOI 10.1016/j.febslet.2004.03.107; Perng MD, 1999, J CELL SCI, V112, P2099; ROSCOE JT, 1985, J INVEST DERMATOL, V85, P538, DOI 10.1111/1523-1747.ep12277362; SEISHIMA M, 1995, J INVEST DERMATOL, V104, P33, DOI 10.1111/1523-1747.ep12613469; Wang X, 2004, FEBS LETT, V567, P281, DOI 10.1016/j.febslet.2004.04.083; Wang X, 2004, APOPTOSIS, V9, P131, DOI 10.1023/B:APPT.0000018795.05766.1f; Waschke J, 2005, J CLIN INVEST, V115, P3157, DOI 10.1172/JCI23475; Waschke J, 2006, J CELL BIOL, V175, P721, DOI 10.1083/jcb.200605125; Weiske J, 2001, J BIOL CHEM, V276, P41175, DOI 10.1074/jbc.M105769200; Woll S, 2007, J CELL BIOL, V177, P795, DOI 10.1083/jcb.200703174; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326	43	52	53	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12524	12532		10.1074/jbc.M808204200	http://dx.doi.org/10.1074/jbc.M808204200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19270308	Green Published, hybrid			2022-12-27	WOS:000265494600081
J	McMichael, BK; Wysolmerski, RB; Lee, BS				McMichael, Brooke K.; Wysolmerski, Robert B.; Lee, Beth S.			Regulated Proteolysis of Nonmuscle Myosin IIA Stimulates Osteoclast Fusion	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VACUOLAR H+-ATPASE; CELL-CELL FUSION; CATHEPSIN-B; DIFFERENTIAL LOCALIZATION; IN-VITRO; MACROPHAGE MULTINUCLEATION; MYOBLAST DIFFERENTIATION; ADHESION STRUCTURES; PLASMA-MEMBRANE; BONE-RESORPTION	The nonmuscle myosin IIA heavy chain (Myh9) is strongly associated with adhesion structures of osteoclasts. In this study, we demonstrate that during osteoclastogenesis, myosin IIA heavy chain levels are temporarily suppressed, an event that stimulates the onset of cell fusion. This suppression is not mediated by changes in mRNA or translational levels but instead is due to a temporary increase in the rate of myosin IIA degradation. Intracellular activity of cathepsin B is significantly enhanced at the onset of osteoclast precursor fusion, and specific inhibition of its activity prevents myosin IIA degradation. Further, treatment of normal cells with cathepsin B inhibitors during the differentiation process reduces cell fusion and bone resorption capacity, whereas overexpression of cathepsin B enhances fusion. Ongoing suppression of the myosin IIA heavy chain via RNA interference results in formation of large osteoclasts with significantly increased numbers of nuclei, whereas overexpression of myosin IIA results in less osteoclast fusion. Increased multinucleation caused by myosin IIA suppression does not require RANKL. Further, knockdown of myosin IIA enhances cell spreading and lessens motility. These data taken together strongly suggest that base-line expression of nonmuscle myosin IIA inhibits osteoclast precursor fusion and that a temporary, cathepsin B-mediated decrease in myosin IIA levels triggers precursor fusion during osteoclastogenesis.	[McMichael, Brooke K.; Lee, Beth S.] Ohio State Univ, Coll Med, Dept Physiol & Cell Biol, Columbus, OH 43210 USA; [Wysolmerski, Robert B.] W Virginia Univ, Dept Neurobiol & Anat, Morgantown, WV 26506 USA; [Wysolmerski, Robert B.] W Virginia Univ, Mary Babb Randolph Canc Ctr, Morgantown, WV 26506 USA	University System of Ohio; Ohio State University; West Virginia University; West Virginia University	Lee, BS (corresponding author), Ohio State Univ, Coll Med, Dept Physiol & Cell Biol, 304 Hamilton Hall,1645 Neil Ave, Columbus, OH 43210 USA.	lee.2076@osu.edu	Lee, Beth S/E-9578-2010	Lee, Beth S/0000-0002-1468-6387	National Institutes of Health [AR051515, DK052131, HL-45788, P20RR16440]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016440] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL045788, R29HL045788] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051515] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052131] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants AR051515 and DK052131 (to B. S. L.) and HL-45788 and P20RR16440 (to R. B. W.).	Akisaka T, 2001, J BONE MINER RES, V16, P1248, DOI 10.1359/jbmr.2001.16.7.1248; Betapudi V, 2006, CANCER RES, V66, P4725, DOI 10.1158/0008-5472.CAN-05-4236; Bien S, 2004, MOL PHARMACOL, V65, P1092, DOI 10.1124/mol.65.5.1092; Blair HC, 2000, J CELL BIOCHEM, V78, P627, DOI 10.1002/1097-4644(20000915)78:4<627::AID-JCB12>3.0.CO;2-3; Cai YF, 2006, BIOPHYS J, V91, P3907, DOI 10.1529/biophysj.106.084806; Chen EH, 2007, FEBS LETT, V581, P2181, DOI 10.1016/j.febslet.2007.03.033; Choi SJ, 2001, J BONE MINER RES, V16, P814, DOI 10.1359/jbmr.2001.16.5.814; CONRAD AH, 1995, CELL MOTIL CYTOSKEL, V31, P93, DOI 10.1002/cm.970310203; Conti MA, 2004, J BIOL CHEM, V279, P41263, DOI 10.1074/jbc.C400352200; Cui WG, 2006, BLOOD, V107, P796, DOI 10.1182/blood-2005-05-1902; Destaing O, 2003, MOL BIOL CELL, V14, P407, DOI 10.1091/mbc.E02-07-0389; Even-Ram S, 2007, NAT CELL BIOL, V9, P299, DOI 10.1038/ncb1540; Golomb E, 2004, J BIOL CHEM, V279, P2800, DOI 10.1074/jbc.M309981200; Graber S, 2004, NEUROPHARMACOLOGY, V47, P706, DOI 10.1016/j.neuropharm.2004.08.004; GRAINGER DJ, 1991, BIOCHEM J, V277, P145, DOI 10.1042/bj2770145; Ha SD, 2008, J IMMUNOL, V181, P690, DOI 10.4049/jimmunol.181.1.690; Han X, 2000, J BIOL CHEM, V275, P37984, DOI 10.1074/jbc.M002334200; HILL PA, 1994, J CELL BIOCHEM, V56, P118, DOI 10.1002/jcb.240560116; Jane DT, 2006, BIOL CHEM, V387, P223, DOI 10.1515/BC.2006.030; Jane DT, 2002, J CELL BIOCHEM, V84, P520, DOI 10.1002/jcb.10042; Jane DT, 2002, BIOCHEM CELL BIOL, V80, P457, DOI 10.1139/O02-134; JANE DT, 1994, BIOCHEM CELL BIOL, V72, P267, DOI 10.1139/o94-038; Jeyaraj S, 2005, J BIOL CHEM, V280, P37957, DOI 10.1074/jbc.M502883200; Jurdic P, 2006, EUR J CELL BIOL, V85, P195, DOI 10.1016/j.ejcb.2005.09.008; Kim MH, 2008, AMINO ACIDS, V34, P497, DOI 10.1007/s00726-006-0461-4; Kolega J, 1998, J CELL SCI, V111, P2085; Kornak U, 2000, HUM MOL GENET, V9, P2059, DOI 10.1093/hmg/9.13.2059; Kotadiya P, 2008, BONE, V43, P951, DOI 10.1016/j.bone.2008.06.017; Kovacs M, 2003, J BIOL CHEM, V278, P38132, DOI 10.1074/jbc.M305453200; Krits I, 2002, CALCIFIED TISSUE INT, V71, P530, DOI 10.1007/s00223-001-1112-0; Kukita T, 2004, J EXP MED, V200, P941, DOI 10.1084/jem.20040518; Lee BS, 1999, J BIOL CHEM, V274, P29164, DOI 10.1074/jbc.274.41.29164; Lee BS, 1999, J BONE MINER RES, V14, P2127, DOI 10.1359/jbmr.1999.14.12.2127; Lee SH, 2006, NAT MED, V12, P1403, DOI 10.1038/nm1514; Linder S, 2005, J CELL SCI, V118, P2079, DOI 10.1242/jcs.02390; Lundberg P, 2007, BIOCHEM BIOPH RES CO, V352, P444, DOI 10.1016/j.bbrc.2006.11.057; Luxenburg C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000179; MAUPIN P, 1994, J CELL SCI, V107, P3077; McHugh KP, 2001, J CELL BIOCHEM, V81, P320, DOI 10.1002/1097-4644(20010501)81:2<320::AID-JCB1047>3.0.CO;2-M; McMichael BK, 2008, EXP CELL RES, V314, P564, DOI 10.1016/j.yexcr.2007.10.018; McMichael BK, 2006, BONE, V39, P694, DOI 10.1016/j.bone.2006.04.031; ROCHLIN MW, 1995, J CELL SCI, V108, P3661; Rosenfeld SS, 2003, J BIOL CHEM, V278, P27449, DOI 10.1074/jbc.M302555200; SAEZ CG, 1990, P NATL ACAD SCI USA, V87, P1164, DOI 10.1073/pnas.87.3.1164; Saginario C, 1998, MOL CELL BIOL, V18, P6213, DOI 10.1128/MCB.18.11.6213; Sandquist JC, 2006, J BIOL CHEM, V281, P35873, DOI 10.1074/jbc.M605343200; SIMONS M, 1991, CIRC RES, V69, P530, DOI 10.1161/01.RES.69.2.530; Steinberg TH, 2007, PURINERG SIGNAL, V3, P53, DOI 10.1007/s11302-006-9036-9; Sterling H, 1998, J CELL BIOL, V143, P837, DOI 10.1083/jcb.143.3.837; Swailes NT, 2006, J CELL SCI, V119, P3561, DOI 10.1242/jcs.03096; TAKAHASHI N, 1994, DEV BIOL, V163, P212, DOI 10.1006/dbio.1994.1137; Takizawa N, 2007, J CELL SCI, V120, P3792, DOI 10.1242/jcs.008219; TANAKA S, 1993, J CLIN INVEST, V91, P257, DOI 10.1172/JCI116179; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Toyomura T, 2000, J BIOL CHEM, V275, P8760, DOI 10.1074/jbc.275.12.8760; Tullio AN, 1997, P NATL ACAD SCI USA, V94, P12407, DOI 10.1073/pnas.94.23.12407; TURKSEN K, 1988, J BONE MINER RES, V3, P389; Wang F, 2003, J BIOL CHEM, V278, P27439, DOI 10.1074/jbc.M302510200; Wei QZ, 2000, MOL BIOL CELL, V11, P3617, DOI 10.1091/mbc.11.10.3617; Wylie SR, 2003, MOL BIOL CELL, V14, P4654, DOI 10.1091/mbc.E03-03-0187; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645	61	27	28	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12266	12275		10.1074/jbc.M808621200	http://dx.doi.org/10.1074/jbc.M808621200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19269977	hybrid, Green Published			2022-12-27	WOS:000265494600058
J	Westman, EL; McNally, DJ; Charchoglyan, A; Brewer, D; Field, RA; Lam, JS				Westman, Erin L.; McNally, David J.; Charchoglyan, Armen; Brewer, Dyanne; Field, Robert A.; Lam, Joseph S.			Characterization of WbpB, WbpE, and WbpD and Reconstitution of a Pathway for the Biosynthesis of UDP-2,3-diacetamido-2,3-dideoxy-D-mannuronic Acid in Pseudomonas aeruginosa	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							O-ANTIGEN BIOSYNTHESIS; BIOCHEMICAL-CHARACTERIZATION; PROTEIN; PAO1; LIPOPOLYSACCHARIDES; BACTERIA; ENZYMES	The lipopolysaccharide of Pseudomonas aeruginosa PAO1 contains an unusual sugar, 2,3-diacetamido-2,3-dideoxy-D-mannuronic acid (D-ManNAc3NAcA). wbpB, wbpE, and wbpD are thought to encode oxidase, transaminase, and N-acetyl-transferase enzymes. To characterize their functions, recombinant proteins were overexpressed and purified from heterologous hosts. Activities of His(6)-WbpB and His(6)-WbpE were detected only when both proteins were combined in the same reaction. Using a direct MALDI-TOF mass spectrometry approach, we identified ions that corresponded to the predicted products of WbpB (UDP-3-keto-D-GlcNAcA) and WbpE (UDP-D-GlcNAc3NA) in the coupled enzyme-substrate reaction. Additionally, in reactions involving WbpB, WbpE, and WbpD, an ion consistent with the expected product of WbpD (UDP-D-GlcNAc3NAcA) was identified. Preparative quantities of UDP-D-GlcNAc3NA and UDP-D-GlcNAc3NAcA were enzymatically synthesized. These compounds were purified by high-performance liquid chromatography, and their structures were elucidated by NMR spectroscopy. This is the first report of the functional characterization of these proteins, and the enzymatic synthesis of UDP-D-GlcNAc3NA and UDP-D-GlcNAc3NAcA.	[Westman, Erin L.; Charchoglyan, Armen; Brewer, Dyanne; Lam, Joseph S.] Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada; [McNally, David J.] Univ Toronto, Dept Chem, Toronto, ON M5S 3H6, Canada; [Field, Robert A.] John Innes Ctr Plant Sci Res, Dept Biol Chem, Norwich NR4 7UH, Norfolk, England	University of Guelph; University of Toronto; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Lam, JS (corresponding author), Univ Guelph, Dept Mol & Cellular Biol, Guelph, ON N1G 2W1, Canada.	jlam@uoguelph.ca		Field, Rob/0000-0001-8574-0275; Westman, Erin/0000-0003-3756-470X	Canadian Institutes of Health Research (CIHR) [MOP14687]; Biotechnology and Biological Sciences and Research Council; Biotechnology and Biological Sciences Research Council [BBS/E/J/000C0618] Funding Source: researchfish; BBSRC [BBS/E/J/000C0618] Funding Source: UKRI	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Biotechnology and Biological Sciences and Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported in part by the Canadian Institutes of Health Research (CIHR) (Grant MOP14687 to J.S.L.). Studies in the Field laboratory are supported by the Biotechnology and Biological Sciences and Research Council.	BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burrows LL, 2000, FEMS MICROBIOL LETT, V189, P135, DOI 10.1111/j.1574-6968.2000.tb09219.x; Burrows LL, 1996, MOL MICROBIOL, V22, P481, DOI 10.1046/j.1365-2958.1996.1351503.x; DIFABIO JL, 1992, FEMS MICROBIOL LETT, V97, P275, DOI 10.1111/j.1574-6968.1992.tb05475.x; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; HANCOCK REW, 1979, J BACTERIOL, V140, P902, DOI 10.1128/JB.140.3.902-910.1979; King JD, 2007, J MOL BIOL, V374, P749, DOI 10.1016/j.jmb.2007.09.055; KNIREL YA, 1994, BIOCHEMISTRY-MOSCOW+, V59, P1325; KNIREL YA, 1988, ACTA MICROBIOL HUNG, V35, P3; LIU PHV, 1990, J CLIN MICROBIOL, V28, P922, DOI 10.1128/JCM.28.5.922-925.1990; Miller WL, 2008, J BIOL CHEM, V283, P3507, DOI 10.1074/jbc.M708894200; Miller WL, 2004, J BIOL CHEM, V279, P37551, DOI 10.1074/jbc.M404749200; Newton DT, 1999, BIOCHEM J, V339, P63, DOI 10.1042/0264-6021:3390063; Newton GJ, 2001, MOL MICROBIOL, V39, P1237, DOI 10.1046/j.1365-2958.2001.02311.x; Pfoestl A, 2003, J BIOL CHEM, V278, P26410, DOI 10.1074/jbc.M300858200; Pfostl A, 2008, BIOCHEM J, V410, P187, DOI 10.1042/BJ20071044; Preston A, 1999, INFECT IMMUN, V67, P3763, DOI 10.1128/IAI.67.8.3763-3767.1999; Raymond CK, 2002, J BACTERIOL, V184, P3614, DOI 10.1128/JB.184.13.3614-3622.2002; Rejzek M, 2009, ORG BIOMOL CHEM, V7, P1203, DOI 10.1039/b819607a; Rocchetta HL, 1999, MICROBIOL MOL BIOL R, V63, P523, DOI 10.1128/MMBR.63.3.523-553.1999; Sismey-Ragatz AE, 2007, J BIOL CHEM, V282, P28321, DOI 10.1074/jbc.M701599200; Sweet CR, 2004, J BIOL CHEM, V279, P25400, DOI 10.1074/jbc.M400596200; VUORIO R, 1991, FEBS LETT, V292, P90, DOI 10.1016/0014-5793(91)80841-P; Wang Y, 2007, J BACTERIOL, V189, P8626, DOI 10.1128/JB.00777-07; Wenzel CQ, 2005, MOL MICROBIOL, V57, P1288, DOI 10.1111/j.1365-2958.2004.04767.x; Westman EL, 2008, J BACTERIOL, V190, P6060, DOI 10.1128/JB.00579-08; Westman EL, 2007, BIOCHEM J, V405, P123, DOI 10.1042/BJ20070017	27	19	23	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					11854	11862		10.1074/jbc.M808583200	http://dx.doi.org/10.1074/jbc.M808583200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19282284	hybrid, Green Published			2022-12-27	WOS:000265494600017
J	Kawahara, M; Morita, S; Takahashi, N; Kono, T				Kawahara, Manabu; Morita, Shinnosuke; Takahashi, Nozomi; Kono, Tomohiro			Defining Contributions of Paternally Methylated Imprinted Genes at the Igf2-H19 and Dlk1-Gtl2 Domains to Mouse Placentation by Transcriptomic Analysis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DE-NOVO METHYLATION; FETAL GROWTH; MICE; PROTEIN; EXPRESSION; DIFFERENTIATION; OVEREXPRESSION; PROLIFERATION; ACTIVATION; EMBRYOS	Parental genome functions in ontogeny are determined by interactions among transcripts from the maternal and paternal genomes, which contain many genes whose expression is strictly dependent on their parental origin as a result of genomic imprinting. Comprehensive recognition of the interactions between parental genomes is important for understanding genomic imprinting in mammalian development. The placenta is a key organ for exploring the biological significance of genomic imprinting. To decipher the unknown roles of paternally methylated imprinted genes on chromosomes 7 and 12 in mouse placentation, we performed a transcriptomic analysis on placentae in three types of bimaternal conceptuses that contained genomes derived from both non-growing and fully grown oocytes. Furthermore, we used the Ingenuity pathway analysis software to predict key networks and identify functions specific to paternally methylated imprinted genes regulated by the Igf2-H19 imprinting control region and Dlk1-Dio3 imprinting control region. The data suggested that dynamic conversion of the gene expression profile by restoring the expression of paternally methylated imprinted genes resulted in phenotypic improvements in bimaternal placentae. These results provide a framework to further explore the role of epigenetic modifications in paternal genome during mouse placentation.	[Kawahara, Manabu; Morita, Shinnosuke; Takahashi, Nozomi; Kono, Tomohiro] Tokyo Univ Agr, Dept Biosci, Setagaya Ku, Tokyo 1568502, Japan; [Kawahara, Manabu] Saga Univ, Fac Agr, Lab Anim Resource Dev, Saga 8408502, Japan	Tokyo University of Agriculture; Saga University	Kono, T (corresponding author), Tokyo Univ Agr, Dept Biosci, Setagaya Ku, Tokyo 1568502, Japan.	tomohiro@nodai.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [18208024, 20780201]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grant-in-Aid for Scientific Research 18208024 (to T. K.) and Young Scientists 20780201 (to M. K.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	*AFF INC, 2009, GENECHIP EXPR AN TEC; Apel ED, 2000, J BIOL CHEM, V275, P31986, DOI 10.1074/jbc.M004775200; Arima T, 2006, DEV BIOL, V297, P361, DOI 10.1016/j.ydbio.2006.05.003; Baladron V, 2005, EXP CELL RES, V303, P343, DOI 10.1016/j.yexcr.2004.10.001; Bauer SR, 1998, MOL CELL BIOL, V18, P5247, DOI 10.1128/MCB.18.9.5247; Benarafa C, 2007, J EXP MED, V204, P1901, DOI 10.1084/jem.20070494; CHARD T, 1994, GROWTH REGULAT, V4, P91; Chedin F, 2002, P NATL ACAD SCI USA, V99, P16916, DOI 10.1073/pnas.262443999; Coan PM, 2005, PLACENTA, V26, pS10, DOI 10.1016/j.placenta.2004.12.009; Constancia M, 2002, NATURE, V417, P945, DOI 10.1038/nature00819; Jincho Y, 2008, BIOL REPROD, V78, P568, DOI 10.1095/biolreprod.107.064634; Kawahara M, 2008, NAT PROTOC, V3, P197, DOI 10.1038/nprot.2007.531; Kawahara M, 2007, NAT BIOTECHNOL, V25, P1045, DOI 10.1038/nbt1331; Kawahara M, 2006, HUM MOL GENET, V15, P2869, DOI 10.1093/hmg/ddl228; Kono T, 2006, CYTOGENET GENOME RES, V113, P31, DOI 10.1159/000090812; Kono T, 1996, NAT GENET, V13, P91, DOI 10.1038/ng0596-91; LEIGHTON PA, 1995, NATURE, V375, P34, DOI 10.1038/375034a0; Lin SP, 2003, NAT GENET, V35, P97, DOI 10.1038/ng1233; Lucifero D, 2004, HUM MOL GENET, V13, P839, DOI 10.1093/hmg/ddh104; Mann JR, 2001, STEM CELLS, V19, P287, DOI 10.1634/stemcells.19-4-287; MCGRATH J, 1984, CELL, V37, P179, DOI 10.1016/0092-8674(84)90313-1; Nagpal ML, 2006, BBA-MOL BASIS DIS, V1762, P811, DOI 10.1016/j.bbadis.2006.06.017; Nagpal ML, 2004, J ENDOCRINOL, V183, P585, DOI 10.1677/joe.1.05795; Nagy A., 2002, MANIPULATING MOUSE E; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Saitou M, 2002, NATURE, V418, P293, DOI 10.1038/nature00927; SCROCCHI LA, 1993, ENDOCRINOLOGY, V132, P903, DOI 10.1210/en.132.2.903; Smas CM, 1997, CRIT REV EUKAR GENE, V7, P281, DOI 10.1615/CritRevEukarGeneExpr.v7.i4.10; Su YQ, 2007, DEV BIOL, V302, P104, DOI 10.1016/j.ydbio.2006.09.008; SURANI MAH, 1984, NATURE, V308, P548, DOI 10.1038/308548a0; VANLIMPT VA, 2009, INT J CANCER, V105, P61; Yevtodiyenko A, 2006, DEV DYNAM, V235, P1115, DOI 10.1002/dvdy.20705; Zeng FY, 2005, DEV BIOL, V283, P40, DOI 10.1016/j.ydbio.2005.03.038; Zhang QP, 2005, J CELL SCI, V118, P673, DOI 10.1242/jcs.01642	34	17	17	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17751	17765		10.1074/jbc.M109.000299	http://dx.doi.org/10.1074/jbc.M109.000299			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19380578	Green Published, hybrid			2022-12-27	WOS:000267202500041
J	Meinild, AK; Loo, DDF; Skovstrup, S; Gether, U; MacAulay, N				Meinild, Anne-Kristine; Loo, Donald D. F.; Skovstrup, Soren; Gether, Ulrik; MacAulay, Nanna			Elucidating Conformational Changes in the gamma-Aminobutyric Acid Transporter-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSMEMBRANE DOMAIN-I; GABA TRANSPORTER; VOLTAGE-CLAMP; FLUOROMETRIC MEASUREMENTS; SEROTONIN TRANSPORTER; ALTERNATING ACCESS; TRANSIENT CURRENTS; BACTERIAL HOMOLOG; CHARGE MOVEMENTS; ION-BINDING	The GABA transporter-1 (GAT-1) has three current-generating modes: GABA-coupled current, Li+-induced leak current, and Na+-dependent transient currents. We earlier hypothesized that Li+ is able to substitute for the first Na+ in the transport cycle and thereby induce a distinct conformation in GAT-1 and that the onset of the Li+-induced leak current at membrane potentials more negative than -50 mV was due to a voltage-dependent conformational change of the Li+-bound transporter. In this study, we set out to verify this hypothesis and seek insight into the structural dynamics underlying the leak current, as well as the sodium-dependent transient currents, by applying voltage clamp fluorometry to tetramethylrhodamine 6-maleimide-labeled GAT-1 expressed in Xenopus laevis oocytes. MTSET accessibility studies demonstrated the presence of two distinct conformations of GAT-1 in the presence of Na+ or Li+. The voltage-dependent fluorescence intensity changes obtained in Li+ buffer correlated with the Li+-induced leak currents, i.e. both were highly voltage-dependent and only present at hyperpolarized potentials (<-50 mV). The transient currents correlated directly with the voltage-dependent fluorescence data obtained in sodium buffer and the associated conformational changes were distinct from those associated with the Li+-induced leak current. The inhibitor potency of SKF89976A of the Li+-versus Na+-bound transporter confirmed the cationic dependence of the conformational occupancy. Our observations suggest that the microdomain situated at the external end of transmembrane I is involved in different conformational changes taking place either during the binding and release of sodium or during the initiation of the Li+-induced leak current.	[Meinild, Anne-Kristine] Univ Copenhagen, Dept Biol, DK-2100 Copenhagen, Denmark; [Skovstrup, Soren] Univ Copenhagen, Dept Med Chem, DK-2100 Copenhagen, Denmark; [Gether, Ulrik] Univ Copenhagen, Dept Neurosci & Pharmacol, DK-2100 Copenhagen, Denmark; [MacAulay, Nanna] Univ Copenhagen, Dept Cellular & Mol Med, DK-2100 Copenhagen, Denmark; [Loo, Donald D. F.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Physiol, Los Angeles, CA 90095 USA	University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Meinild, AK (corresponding author), August Krogh Bldg,Univ Pk 13, DK-2100 Copenhagen, Denmark.	smeinild@bio.ku.dk	MacAulay, Nanna/AER-7709-2022	MacAulay, Nanna/0000-0002-7800-6600; Gether, Ulrik/0000-0002-0020-3807	Danish Health Science Research Council; Novo Nordisk Foundation; Carlsberg Foundation; Lundbeck Foundation; John and Birthe Meyer Foundation	Danish Health Science Research Council; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Carlsberg Foundation(Carlsberg Foundation); Lundbeck Foundation(Lundbeckfonden); John and Birthe Meyer Foundation	The work was supported by the Danish Health Science Research Council, the Novo Nordisk Foundation, the Carlsberg Foundation, the Lundbeck Foundation, and the John and Birthe Meyer Foundation.	Bennett ER, 2000, J BIOL CHEM, V275, P34106, DOI 10.1074/jbc.M004229200; Beuming T, 2006, MOL PHARMACOL, V70, P1630, DOI 10.1124/mol.106.026120; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Bicho A, 2005, BIOPHYS J, V89, P211, DOI 10.1529/biophysj.105.061002; Bismuth Y, 1997, J BIOL CHEM, V272, P16096, DOI 10.1074/jbc.272.26.16096; Borden LA, 1996, NEUROCHEM INT, V29, P335, DOI 10.1016/0197-0186(95)00158-1; BORDEN LA, 1994, EUR J PHARM-MOLEC PH, V269, P219, DOI 10.1016/0922-4106(94)90089-2; Chen JG, 1997, BIOCHEMISTRY-US, V36, P1479, DOI 10.1021/bi962256g; DeLano W.L, PYMOL MOL GRAPHICS S; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; GALLI A, 1995, J EXP BIOL, V198, P2197; Golovanevsky V, 1999, J BIOL CHEM, V274, P23020, DOI 10.1074/jbc.274.33.23020; Hazama A, 1997, J MEMBRANE BIOL, V155, P175, DOI 10.1007/s002329900169; Hilgemann DW, 1999, J GEN PHYSIOL, V114, P459, DOI 10.1085/jgp.114.3.459; Hirayama BA, 1997, J BIOL CHEM, V272, P2110; Kanner BI, 2003, J BIOL CHEM, V278, P3705, DOI 10.1074/jbc.M210525200; KEYNAN S, 1988, BIOCHEMISTRY-US, V27, P12, DOI 10.1021/bi00401a003; Larsson HP, 2004, P NATL ACAD SCI USA, V101, P3951, DOI 10.1073/pnas.0306737101; Li M, 2002, FEBS LETT, V513, P247, DOI 10.1016/S0014-5793(02)02322-0; Li M, 2000, J GEN PHYSIOL, V115, P491, DOI 10.1085/jgp.115.4.491; Lin F, 1996, BIOPHYS J, V71, P3126, DOI 10.1016/S0006-3495(96)79506-1; Liu YH, 1998, BBA-BIOMEMBRANES, V1415, P246, DOI 10.1016/S0005-2736(98)00200-4; Loo DDF, 1998, P NATL ACAD SCI USA, V95, P7789, DOI 10.1073/pnas.95.13.7789; LOO DDF, 1993, P NATL ACAD SCI USA, V90, P5767, DOI 10.1073/pnas.90.12.5767; Lopez-Corcuera B, 2001, J BIOL CHEM, V276, P43463, DOI 10.1074/jbc.M107438200; MacAulay N, 2003, J BIOL CHEM, V278, P28771, DOI 10.1074/jbc.M213023200; MacAulay N, 2002, J PHYSIOL-LONDON, V544, P447, DOI 10.1113/jphysiol.2002.022897; MacAulay N, 2001, J BIOL CHEM, V276, P40476, DOI 10.1074/jbc.M105578200; Mager S, 1996, J NEUROSCI, V16, P5405; MAGER S, 1994, NEURON, V12, P845, DOI 10.1016/0896-6273(94)90337-9; MAGER S, 1993, NEURON, V10, P177, DOI 10.1016/0896-6273(93)90309-F; Mannuzzu LM, 2000, J GEN PHYSIOL, V115, P257, DOI 10.1085/jgp.115.3.257; Meinild AK, 2002, BIOCHEMISTRY-US, V41, P1250, DOI 10.1021/bi011661r; Melamed N, 2004, MOL PHARMACOL, V65, P1452, DOI 10.1124/mol.65.6.1452; Ni YG, 2001, J BIOL CHEM, V276, P30942, DOI 10.1074/jbc.M104653200; RADIAN R, 1983, BIOCHEMISTRY-US, V22, P1236, DOI 10.1021/bi00274a038; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Schrodinger LLC, 2008, SCHRODINGER SUITE 20; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Sonders MS, 1997, J NEUROSCI, V17, P960; UMBACH JA, 1990, BIOPHYS J, V57, P1217, DOI 10.1016/S0006-3495(90)82640-0; Virkki LV, 2006, J BIOL CHEM, V281, P28837, DOI 10.1074/jbc.M603861200; Virkki LV, 2006, J GEN PHYSIOL, V127, P539, DOI 10.1085/jgp.200609496; WADICHE JI, 1995, NEURON, V14, P1019, DOI 10.1016/0896-6273(95)90340-2; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Yu N, 1998, FEBS LETT, V426, P174, DOI 10.1016/S0014-5793(98)00333-0; Zhang H, 1997, BIOCHEMISTRY-US, V36, P15856, DOI 10.1021/bi972357u; Zhou YG, 2005, J BIOL CHEM, V280, P20316, DOI 10.1074/jbc.M412937200; Zhou YG, 2004, J BIOL CHEM, V279, P13800, DOI 10.1074/jbc.M311579200; Zhou YG, 2006, J BIOL CHEM, V281, P22092, DOI 10.1074/jbc.M602319200; Zomot E, 2005, J BIOL CHEM, V280, P25512, DOI 10.1074/jbc.M503864200; Zomot E, 2003, J BIOL CHEM, V278, P42950, DOI 10.1074/jbc.M209307200	52	18	18	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16226	16235		10.1074/jbc.M109.003137	http://dx.doi.org/10.1074/jbc.M109.003137			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19363027	Green Published, hybrid			2022-12-27	WOS:000266730900020
J	Derler, I; Fahrner, M; Carugo, O; Muik, M; Bergsmann, J; Schindl, R; Frischauf, I; Eshaghi, S; Romanin, C				Derler, Isabella; Fahrner, Marc; Carugo, Oliviero; Muik, Martin; Bergsmann, Judith; Schindl, Rainer; Frischauf, Irene; Eshaghi, Said; Romanin, Christoph			Increased Hydrophobicity at the N Terminus/Membrane Interface Impairs Gating of the Severe Combined Immunodeficiency-related ORAI1 Mutant	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; MECHANOSENSITIVE CHANNEL; MEMBRANE-PROTEIN; CA2+ RELEASE; CRAC CHANNEL; ION-CHANNEL; K+ CHANNEL; 2 SETS; CALCIUM; SELECTIVITY	Patients with severe combined immune deficiency (SCID) suffer from defective T-cell Ca2+ signaling. A loss of Ca2+ entry has been linked at the molecular level to single missense mutation R91W in the store-operated Ca2+ channel ORAI1. However, the mechanistic impact of this mutation on ORAI1 function remains unclear. Confocal Forster resonance energy transfer microscopy revealed that dynamic store-operated coupling of STIM1 to ORAI1 R91W was largely sustained similar to wild-type ORAI1. Characterization of various point mutants at position 91 by whole cell patch clamp recordings displayed that neutral or even negatively charged amino acids did not abolish ORAI1 function. However, substitution by hydrophobic leucine, valine, or phenylalanine resulted in non-functional ORAI1 channels, despite preserved STIM1 coupling. Besides conformational constraints at the N terminus/membrane interface predicted for the hydrophobic mutants, additional key factor(s) were suggested to determine ORAI1 functionality. Calculation of the probability for the 1st transmembrane domain and its hydrophobicity revealed a substantial increase for all hydrophobic substitutions that lead to non-functional ORAI1 R91X mutants in contrast to those with hydrophilic residues. Hence, increased hydrophobicity might lead to disrupted permeation/gating, as an ORAI1 channel with increased pore size and R91W mutation failed to recover activity. In conclusion, the increase in hydrophobicity at the N terminus/membrane interface represents the major cause for yielding nonfunctional ORAI1 channels.	[Derler, Isabella; Fahrner, Marc; Muik, Martin; Bergsmann, Judith; Schindl, Rainer; Frischauf, Irene; Romanin, Christoph] Univ Linz, Inst Biophys, A-4040 Linz, Austria; [Carugo, Oliviero] Vienna Bio Ctr, Max Perutz Labs, A-1030 Vienna, Austria; [Carugo, Oliviero] Univ Pavia, Dept Gen Chem, I-27100 Pavia, Italy; [Eshaghi, Said] Karolinska Inst, Div Biophys, Dept Med Biochem & Biophys, SE-17177 Stockholm, Sweden	Johannes Kepler University Linz; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); University of Pavia; Karolinska Institutet	Romanin, C (corresponding author), Univ Linz, Inst Biophys, Altenbergerstr 69, A-4040 Linz, Austria.	christoph.romanin@jku.at	Frischauf, Irene/AAG-2007-2019; Schindl, Rainer/V-4205-2019; Derler, Isabella/B-7871-2019; Romanin, Christoph/D-5399-2009; Schindl, Rainer/E-3959-2013; Fahrner, Marc/AAI-7927-2021	Frischauf, Irene/0000-0003-0661-2932; Derler, Isabella/0000-0002-4768-146X; Romanin, Christoph/0000-0003-3756-4136; Schindl, Rainer/0000-0003-0896-8887; Fahrner, Marc/0000-0002-2689-0158	Austrian Science Fund [P18169, P21118]	Austrian Science Fund(Austrian Science Fund (FWF))	This work was supported by Austrian Science Fund Projects P18169 and P21118 and Subproject 11 within W1201 ( to C. R.).	Beckstein O, 2006, PHYS BIOL, V3, P147, DOI 10.1088/1478-3975/3/2/007; Bergmeier W, 2009, BLOOD, V113, P675, DOI 10.1182/blood-2008-08-174516; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Berney C, 2003, BIOPHYS J, V84, P3992, DOI 10.1016/S0006-3495(03)75126-1; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Buckley RH, 2004, J CLIN INVEST, V114, P1409, DOI 10.1172/JCI200423571; Carroll HR, 2006, MOL INTERV, V6, P253, DOI 10.1124/mi.6.5.6; Chakrabarti R, 2006, J CELL BIOCHEM, V99, P1503, DOI 10.1002/jcb.21102; DeHaven WI, 2008, J BIOL CHEM, V283, P19265, DOI 10.1074/jbc.M801535200; Derler I, 2006, J PHYSIOL-LONDON, V577, P31, DOI 10.1113/jphysiol.2006.118661; Dutta D, 2000, J BIOSCIENCE, V25, P397, DOI 10.1007/BF02703793; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Feske S, 2005, J EXP MED, V202, P651, DOI 10.1084/jem.20050687; Frischauf I, 2008, CHANNELS, V2, P261, DOI 10.4161/chan.2.4.6705; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Garnier J, 1996, METHOD ENZYMOL, V266, P540; Gaspar HB, 2001, ARCH DIS CHILD, V84, P169, DOI 10.1136/adc.84.2.169; Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681; Gwack Y, 2007, J BIOL CHEM, V282, P16232, DOI 10.1074/jbc.M609630200; HARIS PI, 1994, FEBS LETT, V349, P371, DOI 10.1016/0014-5793(94)00704-7; Huang F, 2003, ANGEW CHEM INT EDIT, V42, P2269, DOI 10.1002/anie.200250684; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; KABSCH W, 1978, ACTA CRYSTALLOGR A, V34, P827, DOI 10.1107/S0567739478001680; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; Kuhn FJP, 2007, J BIOL CHEM, V282, P27598, DOI 10.1074/jbc.M702247200; Kuo AL, 2005, STRUCTURE, V13, P1463, DOI 10.1016/j.str.2005.07.011; Levin JM, 1997, PROTEIN ENG, V10, P771, DOI 10.1093/protein/10.7.771; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Micheletti C, 2000, PROTEINS, V40, P662, DOI 10.1002/1097-0134(20000901)40:4<662::AID-PROT90>3.0.CO;2-F; Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748; Muik M, 2008, J BIOL CHEM, V283, P8014, DOI 10.1074/jbc.M708898200; Navarro-Borelly L, 2008, J PHYSIOL-LONDON, V586, P5383, DOI 10.1113/jphysiol.2008.162503; Nyholm TKM, 2007, BIOCHEMISTRY-US, V46, P1457, DOI 10.1021/bi061941c; Ozdirekcan S, 2005, BIOCHEMISTRY-US, V44, P1004, DOI 10.1021/bi0481242; Parekh AB, 2006, NATURE, V441, P163, DOI 10.1038/441163a; Parekh AB, 2005, PHYSIOL REV, V85, P757, DOI 10.1152/physrev.00057.2003; Payandeh J, 2008, J BIOL CHEM, V283, P11721, DOI 10.1074/jbc.M707889200; PEINELT C, 2008, J PHYSL, V583, P3061; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Perozo E, 2006, NAT REV MOL CELL BIO, V7, P109, DOI 10.1038/nrm1833; Powl AM, 2005, BIOCHEMISTRY-US, V44, P5873, DOI 10.1021/bi047439e; Powl AM, 2003, BIOCHEMISTRY-US, V42, P14306, DOI 10.1021/bi034995k; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Raybaud A, 2007, J BIOL CHEM, V282, P27944, DOI 10.1074/jbc.M703895200; Roos J, 2005, J CELL BIOL, V169, P435, DOI 10.1083/jcb.200502019; ROSE GD, 1985, SCIENCE, V229, P834, DOI 10.1126/science.4023714; Schindl R, 2008, J BIOL CHEM, V283, P20261, DOI 10.1074/jbc.M803101200; Singh A, 2006, NAT NEUROSCI, V9, P1108, DOI 10.1038/nn1751; Soboloff J, 2006, BBA-MOL CELL RES, V1763, P1161, DOI 10.1016/j.bbamcr.2006.09.023; Thompson JL, 2009, J BIOL CHEM, V284, P6620, DOI 10.1074/jbc.M808346200; THUNNISSEN MMGM, 1993, J MOL BIOL, V232, P839, DOI 10.1006/jmbi.1993.1435; TSONG TY, 1979, P NATL ACAD SCI USA, V76, P1109, DOI 10.1073/pnas.76.3.1109; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Wieprecht T, 1999, J MOL BIOL, V294, P785, DOI 10.1006/jmbi.1999.3268; Xia ZP, 2001, BIOPHYS J, V81, P2395, DOI 10.1016/S0006-3495(01)75886-9; Yamashita M, 2007, J GEN PHYSIOL, V130, P525, DOI 10.1085/jgp.200709872; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Yoshimura K, 2001, BIOPHYS J, V80, P2198, DOI 10.1016/S0006-3495(01)76192-9; Zhang SYL, 2008, J BIOL CHEM, V283, P17662, DOI 10.1074/jbc.M801536200	61	68	71	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15903	15915		10.1074/jbc.M808312200	http://dx.doi.org/10.1074/jbc.M808312200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19366689	Green Published, hybrid			2022-12-27	WOS:000266501000058
J	Namkung, W; Song, Y; Mills, AD; Padmawar, P; Finkbeiner, WE; Verkman, AS				Namkung, Wan; Song, Yuanlin; Mills, Aaron D.; Padmawar, Prashant; Finkbeiner, Walter E.; Verkman, A. S.			In Situ Measurement of Airway Surface Liquid [K+] Using a Ratioable K+-sensitive Fluorescent Dye	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN BRONCHIAL EPITHELIA; CELL-LINE CALU-3; CYSTIC-FIBROSIS; ANION SECRETION; POTASSIUM CHANNEL; ION COMPOSITION; NA+ ABSORPTION; CL-SECRETION; WILD-TYPE; DISEASE	The airway surface liquid (ASL) is the thin fluid layer lining airway surface epithelial cells, whose volume and composition are tightly regulated and may be abnormal in cystic fibrosis (CF). We synthesized a two-color fluorescent dextran to measure ASL [K+], TAC-Lime-dextran-TMR, consisting of a green-fluorescing triazacryptand K+ ionophore-Bodipy conjugate, coupled to dextran, together with a red fluorescing tetramethylrhodamine reference chromophore. TAC-Lime-dextran-TMR fluorescence was K+-selective, increasing >4-fold with increasing [K+] from 0 to 40 mM. In well differentiated human airway epithelial cells, ASL [K+] was 20.8 +/- 0.3 mM and decreased by inhibition of the Na+/K+ pump ( ouabain), ENaC ( amiloride), CF transmembrane conductance regulator (CFTRinh-172), or K+ channels ( TEA or XE991). ASL [K+] was increased by forskolin but not affected by Na+/K+/2Cl(-) cotransporter inhibition ( bumetanide). Functional and expression studies indicated the involvement of [K+] channels KCNQ1, KCNQ3, and KCNQ5 as determinants of ASL [K+]. [K+] in CF cultures was similar to that in non-CF cultures, suggesting that abnormal ASL [K+] is not a factor in CF lung disease. In intact airways, ASL [K+] was also well above extracellular [K+]: 22 +/- 1 mM in pig trachea ex vivo and 16 +/- 1 mM in mouse trachea in vivo. Our results provide the first noninvasive measurements of [K+] in the ASL and indicate the involvement of apical and basolateral membrane ion transporters in maintaining a high ASL [K+].	[Namkung, Wan; Mills, Aaron D.; Padmawar, Prashant; Verkman, A. S.] Univ Calif San Francisco, Dept Physiol & Med, San Francisco, CA 94143 USA; [Song, Yuanlin] Univ Calif San Francisco, Dept Anesthesia & Perioperat Care, San Francisco, CA 94143 USA; [Finkbeiner, Walter E.] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Verkman, AS (corresponding author), Univ Calif San Francisco, Dept Physiol & Med, San Francisco, CA 94143 USA.	Alan.Verkman@ucsf.edu			National Institutes of Health [HL73856, EB00415, DK72517, HL59198, DK35124, EY13574]; Cystic Fibrosis Foundation; Korean Government [KRF-2007-357-C00091]; NATIONAL EYE INSTITUTE [R01EY013574] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059198, R01HL073856] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB000415, R37EB000415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK035124, R01DK035124, P30DK072517] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Korean Government(Korean Government); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants HL73856, EB00415, DK72517, HL59198, DK35124, and EY13574. This work was also supported by Research Development Program and Drug Discovery grants from the Cystic Fibrosis Foundation and Postdoctoral Fellowship Program of Korea Research Foundation Grant MOEHRD, KRF-2007-357-C00091 from the Korean Government ( to W. N.).	Boucher RC, 2007, ANNU REV MED, V58, P157, DOI 10.1146/annurev.med.58.071905.105316; Clarke LL, 1997, AM J PHYSIOL-LUNG C, V272, pL1084, DOI 10.1152/ajplung.1997.272.6.L1084; Coakley RD, 2003, P NATL ACAD SCI USA, V100, P16083, DOI 10.1073/pnas.2634339100; Cowley EA, 2002, J PHYSIOL-LONDON, V538, P747, DOI 10.1113/jphysiol.2001.013300; Davis KA, 2006, PFLUG ARCH EUR J PHY, V451, P631, DOI 10.1007/s00424-005-1505-4; De la Fuente R, 2008, MOL PHARMACOL, V73, P758, DOI 10.1124/mol.107.043208; Devor DC, 2000, AM J PHYSIOL-CELL PH, V279, pC461, DOI 10.1152/ajpcell.2000.279.2.C461; Devor DC, 1999, AM J PHYSIOL-CELL PH, V276, pC827, DOI 10.1152/ajpcell.1999.276.4.C827; Fulcher M Leslie, 2005, Methods Mol Med, V107, P183; HARTMANN T, 1990, BIOPHYS J, V58, P391, DOI 10.1016/S0006-3495(90)82385-7; He HR, 2003, J AM CHEM SOC, V125, P1468, DOI 10.1021/ja0284761; Jayaraman S, 2001, J GEN PHYSIOL, V117, P423, DOI 10.1085/jgp.117.5.423; Jayaraman S, 2001, J CLIN INVEST, V107, P317, DOI 10.1172/JCI11154; Knowles MR, 1997, J CLIN INVEST, V100, P2588, DOI 10.1172/JCI119802; KNOWLES MR, 1981, AM REV RESPIR DIS, V124, P484; Kozlova I, 2006, UPSALA J MED SCI, V111, P137, DOI 10.3109/2000-1967-016; Levin MH, 2006, INVEST OPHTH VIS SCI, V47, P306, DOI 10.1167/iovs.05-1082; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; Magzoub M, 2006, J PHYS CHEM B, V110, P21216, DOI 10.1021/jp0633392; Mall M, 2003, PEDIATR RES, V53, P608, DOI 10.1203/01.PDR.0000057204.51420.DC; Mall M, 2000, AM J RESP CELL MOL, V23, P283, DOI 10.1165/ajrcmb.23.3.4060; Matsui H, 1998, CELL, V95, P1005, DOI 10.1016/S0092-8674(00)81724-9; Moser SL, 2008, J MEMBRANE BIOL, V221, P153, DOI 10.1007/s00232-008-9093-9; Namkung W, 2008, J AM CHEM SOC, V130, P7794, DOI 10.1021/ja8014499; Padmawar P, 2005, NAT METHODS, V2, P825, DOI 10.1038/NMETH801; Smith JJ, 1996, CELL, V85, P229, DOI 10.1016/S0092-8674(00)81099-5; Song YL, 2003, J GEN PHYSIOL, V122, P511, DOI 10.1085/jgp.200308866; Tarran R, 2006, J GEN PHYSIOL, V127, P591, DOI 10.1085/jgp.200509468; Tarran R, 2006, ANNU REV PHYSIOL, V68, P543, DOI 10.1146/annurev.physiol.68.072304.112754; Verkman AS, 2003, AM J PHYSIOL-CELL PH, V284, pC2, DOI 10.1152/ajpcell.00417.2002; Wu JV, 2004, J BIOL CHEM, V279, P46558, DOI 10.1074/jbc.M406058200; YAMAYA M, 1992, AM J PHYSIOL, V262, pL713, DOI 10.1152/ajplung.1992.262.6.L713	32	36	39	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15916	15926		10.1074/jbc.M808021200	http://dx.doi.org/10.1074/jbc.M808021200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19364771	Green Published, hybrid			2022-12-27	WOS:000266501000059
J	Betterle, N; Ballottari, M; Zorzan, S; de Bianchi, S; Cazzaniga, S; Dall'Osto, L; Morosinotto, T; Bassi, R				Betterle, Nico; Ballottari, Matteo; Zorzan, Simone; de Bianchi, Silvia; Cazzaniga, Stefano; Dall'Osto, Luca; Morosinotto, Tomas; Bassi, Roberto			Light-induced Dissociation of an Antenna Hetero-oligomer Is Needed for Non-photochemical Quenching Induction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PHOTOSYSTEM-II MEMBRANES; HARVESTING COMPLEX; CHLOROPHYLL FLUORESCENCE; ENERGY-DISSIPATION; GRANA MEMBRANES; HIGHER-PLANTS; SUPRAMOLECULAR ORGANIZATION; CHLAMYDOMONAS-REINHARDTII; PHOTOSYNTHETIC MEMBRANES; THYLAKOID MEMBRANES	PsbS plays a major role in activating the photoprotection mechanism known as "non-photochemical quenching," which dissipates chlorophyll excited states exceeding the capacity for photosynthetic electron transport. PsbS activity is known to be triggered by low lumenal pH. However, the molecular mechanism by which this subunit regulates light harvesting efficiency is still unknown. Here we show that PsbS controls the association/dissociation of a five-subunit membrane complex, composed of two monomeric Lhcb proteins (CP29 and CP24) and the trimeric LHCII-M. Dissociation of this supercomplex is indispensable for the onset of non-photochemical fluorescence quenching in high light, strongly suggesting that protein subunits catalyzing the reaction of heat dissipation are buried into the complex and thus not available for interaction with PsbS. Consistently, we showed that knock-out mutants on two subunits participating to the B4C complex were strongly affected in heat dissipation. Direct observation by electron microscopy and image analysis showed that B4C dissociation leads to the redistribution of PSII within grana membranes. We interpreted these results to mean that the dissociation of B4C makes quenching sites, possibly CP29 and CP24, available for the switch to an energy-quenching conformation. These changes are reversible and do not require protein synthesis/degradation, thus allowing for changes in PSII antenna size and adaptation to rapidly changing environmental conditions.	[Bassi, Roberto] Univ Verona, Dipartimento Sci & Tecnol, I-37134 Verona, Italy; [Morosinotto, Tomas] Univ Padua, Dipartimento Biol, I-35131 Padua, Italy	University of Verona; University of Padua	Bassi, R (corresponding author), Univ Verona, Dipartimento Sci & Tecnol, Str Le Grazie 15, I-37134 Verona, Italy.	bassi@sci.univr.it	Cazzaniga, Stefano/ABG-3898-2021; Morosinotto, Tomas/AAC-3188-2019; Dall'Osto, Luca/A-9384-2010; Ballottari, Matteo/N-1916-2019; Betterle, Nico/AAE-1004-2021	Cazzaniga, Stefano/0000-0002-2824-7916; Morosinotto, Tomas/0000-0002-0803-7591; Ballottari, Matteo/0000-0001-8410-3397; Betterle, Nico/0000-0002-7556-6696; bassi, roberto/0000-0002-4140-8446; Dall'Osto, Luca/0000-0001-9497-5156	FISR IDROBIO; Italian Ministry of Research Special Fund for Basic Research;  [PRIN 20073YHRLE];  [FIRB RBLA0345SF002]	FISR IDROBIO; Italian Ministry of Research Special Fund for Basic Research(Ministry of Education, Universities and Research (MIUR)); ; 	Supported by Grant PRIN 20073YHRLE.; Supported by Grants FIRB RBLA0345SF002 (Solanacee) and FISR IDROBIO. from the Italian Ministry of Research Special Fund for Basic Research. To whom correspondence should be addressed: Dipartimento Scientifico e Tecnologico, Universita di Verona, Strada Le Grazie 15, I-37134 Verona, Italy. Tel.: 39-045-802-7915; Fax: 39-045-802-7929; E-mail: bassi@sci.univr.it.	Ahn TK, 2008, SCIENCE, V320, P794, DOI 10.1126/science.1154800; Alboresi A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002033; Andersson J, 2003, PLANT J, V35, P350, DOI 10.1046/j.1365-313X.2003.01811.x; Andersson J, 2001, PLANT CELL, V13, P1193, DOI 10.1105/tpc.13.5.1193; Asada K, 1999, ANNU REV PLANT PHYS, V50, P601, DOI 10.1146/annurev.arplant.50.1.601; Avenson TJ, 2008, J BIOL CHEM, V283, P3550, DOI 10.1074/jbc.M705645200; Bailey S, 2001, PLANTA, V213, P794, DOI 10.1007/s004250100556; Ballottari M, 2007, J BIOL CHEM, V282, P8947, DOI 10.1074/jbc.M606417200; BARBER J, 1992, TRENDS BIOCHEM SCI, V17, P61, DOI 10.1016/0968-0004(92)90503-2; BASSI R, 1988, BIOCHIM BIOPHYS ACTA, V936, P29, DOI 10.1016/0005-2728(88)90248-4; BASSI R, 1992, EUR J BIOCHEM, V204, P317, DOI 10.1111/j.1432-1033.1992.tb16640.x; Bellafiore S, 2005, NATURE, V433, P892, DOI 10.1038/nature03286; Boekema EJ, 1999, BIOCHEMISTRY-US, V38, P2233, DOI 10.1021/bi9827161; Boekema EJ, 1999, EUR J BIOCHEM, V266, P444, DOI 10.1046/j.1432-1327.1999.00876.x; BOEKEMA EJ, 1995, P NATL ACAD SCI USA, V92, P175, DOI 10.1073/pnas.92.1.175; Bonente G, 2008, J BIOL CHEM, V283, P8434, DOI 10.1074/jbc.M708291200; Bonente G, 2008, PHOTOCHEM PHOTOBIOL, V84, P1359, DOI 10.1111/j.1751-1097.2008.00456.x; BRIANTAIS JM, 1994, PHOTOSYNTH RES, V40, P287, DOI 10.1007/BF00034778; Caffarri S, 2004, BIOCHEMISTRY-US, V43, P9467, DOI 10.1021/bi036265i; Dall'Osto L, 2005, PLANT CELL, V17, P1217, DOI 10.1105/tpc.104.030601; de Bianchi S, 2008, PLANT CELL, V20, P1012, DOI 10.1105/tpc.107.055749; Dekker JP, 2005, BBA-BIOENERGETICS, V1706, P12, DOI 10.1016/j.bbabio.2004.09.009; DEMMIGADAMS B, 1990, BIOCHIM BIOPHYS ACTA, V1020, P1, DOI 10.1016/0005-2728(90)90088-L; Dominici P, 2002, J BIOL CHEM, V277, P22750, DOI 10.1074/jbc.M200604200; Finazzi G, 2006, BIOCHEMISTRY-US, V45, P1490, DOI 10.1021/bi0521588; Frigerio S, 2007, J BIOL CHEM, V282, P29457, DOI 10.1074/jbc.M705132200; GILMORE AM, 1991, PLANT PHYSIOL, V96, P635, DOI 10.1104/pp.96.2.635; Harrer R, 1998, EUR J BIOCHEM, V255, P196, DOI 10.1046/j.1432-1327.1998.2550196.x; Holt NE, 2005, SCIENCE, V307, P433, DOI 10.1126/science.1105833; Horton P, 2005, J EXP BOT, V56, P365, DOI 10.1093/jxb/eri023; Horton P, 2008, FEBS J, V275, P1069, DOI 10.1111/j.1742-4658.2008.06263.x; Kirchhoff H, 2008, TRENDS PLANT SCI, V13, P201, DOI 10.1016/j.tplants.2008.03.001; Kirchhoff H, 2008, PLANT PHYSIOL, V146, P1571, DOI 10.1104/pp.107.115170; Kirchhoff H, 2008, BIOCHEMISTRY-US, V47, P431, DOI 10.1021/bi7017877; Kiss AZ, 2008, J BIOL CHEM, V283, P3972, DOI 10.1074/jbc.M707410200; Kovacs L, 2006, PLANT CELL, V18, P3106, DOI 10.1105/tpc.106.045641; Kulheim C, 2002, SCIENCE, V297, P91, DOI 10.1126/science.1072359; KYLE DJ, 1983, ARCH BIOCHEM BIOPHYS, V222, P527, DOI 10.1016/0003-9861(83)90551-9; Li XP, 2004, J BIOL CHEM, V279, P22866, DOI 10.1074/jbc.M402461200; Li XP, 2002, FUNCT PLANT BIOL, V29, P1131, DOI 10.1071/FP02065; Li XP, 2000, NATURE, V403, P391, DOI 10.1038/35000131; LINDAHL M, 1995, EUR J BIOCHEM, V231, P503, DOI 10.1111/j.1432-1033.1995.tb20725.x; Morosinotto T, 2006, FEBS J, V273, P4616, DOI 10.1111/j.1742-4658.2006.05465.x; Nelson N, 2004, NAT REV MOL CELL BIO, V5, P971, DOI 10.1038/nrm1525; Nield J, 2000, NAT STRUCT BIOL, V7, P44; Niyogi KK, 1998, PLANT CELL, V10, P1121, DOI 10.1105/tpc.10.7.1121; Niyogi KK, 1997, PLANT CELL, V9, P1369, DOI 10.2307/3870388; Niyogi KK, 2000, CURR OPIN PLANT BIOL, V3, P455, DOI 10.1016/S1369-5266(00)00113-8; Ruban AV, 2007, NATURE, V450, P575, DOI 10.1038/nature06262; Teardo E, 2007, BBA-BIOENERGETICS, V1767, P703, DOI 10.1016/j.bbabio.2006.12.002; Tikkanen M, 2006, PLANT MOL BIOL, V62, P779, DOI 10.1007/s11103-006-9044-8; Tremmel IG, 2003, BBA-BIOENERGETICS, V1607, P97, DOI 10.1016/j.bbabio.2003.09.004; TREMOLIERES A, 1994, EUR J BIOCHEM, V221, P721, DOI 10.1111/j.1432-1033.1994.tb18785.x; VANKOOTEN O, 1990, PHOTOSYNTH RES, V25, P147, DOI 10.1007/BF00033156; Wollman FA, 2001, EMBO J, V20, P3623, DOI 10.1093/emboj/20.14.3623; Yakushevska AE, 2003, BIOCHEMISTRY-US, V42, P608, DOI 10.1021/bi027109z	56	245	249	2	63	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					15255	15266		10.1074/jbc.M808625200	http://dx.doi.org/10.1074/jbc.M808625200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19307183	Green Published, hybrid			2022-12-27	WOS:000266288200060
J	Makarenkova, HP; Gonzalez, KN; Kiosses, WB; Meech, R				Makarenkova, Helen P.; Gonzalez, Katie N.; Kiosses, William B.; Meech, Robyn			Barx2 Controls Myoblast Fusion and Promotes MyoD-mediated Activation of the Smooth Muscle alpha-Actin Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SERUM RESPONSE FACTOR; HELIX-LOOP-HELIX; HOMEODOMAIN PROTEIN; SKELETAL-MUSCLE; MADS-BOX; EXPRESSION; TRANSCRIPTION; BINDING; DIFFERENTIATION; ELEMENTS	Remodeling of the actin cytoskeleton is a critical early step in skeletal muscle differentiation. Smooth muscle alpha-actin (SMA) is one of the earliest markers of myoblast differentiation and is important for the migration and cell shape changes that precede fusion. We have found that satellite cell-derived primary myoblasts from mice lacking the Barx2 homeobox gene show altered patterns of actin remodeling, reduced cell migration, and delayed differentiation. Consistent with the role of SMA in these processes, Barx2(-/-) myoblasts also show reduced expression of SMA mRNA and protein. The proximal SMA promoter contains binding sites for muscle regulatory factors and serum response factor as well as a conserved homeodomain binding site (HBS). We found that Barx2 binds to the HBS element and potentiates up-regulation of SMA promoter activity by MyoD. We also show that Barx2, MyoD, and serum response factor simultaneously occupy the SMA promoter in cells and that Barx2 interacts with MyoD. Overall these data indicate that Barx2 cooperates with other muscle-expressed transcription factors to regulate the early cytoskeletal remodeling events that underlie efficient myoblast differentiation.	Scripps Res Inst, Dept Neurobiol, La Jolla, CA 92037 USA; [Kiosses, William B.] Scripps Res Inst, Core Microscopy Facil, La Jolla, CA 92037 USA; [Makarenkova, Helen P.] Inst Neurosci, San Diego, CA 92121 USA	Scripps Research Institute; Scripps Research Institute	Meech, R (corresponding author), Flinders Univ S Australia, Dept Clin Pharmacol, Bedford Pk, SA 5042, Australia.	robyn.meech@flinders.edu.au		Meech, Robyn/0000-0002-6831-0801	National Institutes of Health [1R03AR051131, 5R01AR053163-02]; Association Francaise contre les Myopathies; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R03AR051131, R01AR053163] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants 1R03AR051131 (to R. M.) and 5R01AR053163-02 (to H. P. M.). This work was also supported by a grant from the Association Francaise contre les Myopathies (to H. P. M.).	Amthor H, 2004, DEV BIOL, V270, P19, DOI 10.1016/j.ydbio.2004.01.046; Berkes CA, 2004, MOL CELL, V14, P465, DOI 10.1016/S1097-2765(04)00260-6; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Biressi S, 2008, CELL DEATH DIFFER, V15, P94, DOI 10.1038/sj.cdd.4402230; BLANK RS, 1992, J BIOL CHEM, V267, P984; Busson M, 2006, ENDOCRINOLOGY, V147, P3408, DOI 10.1210/en.2006-0101; Clement S, 2007, J CELL SCI, V120, P229, DOI 10.1242/jcs.03340; Copeland JW, 2002, MOL BIOL CELL, V13, P4088, DOI 10.1091/mbc.02-06-0092; COX RD, 1990, DIFFERENTIATION, V43, P183, DOI 10.1111/j.1432-0436.1990.tb00445.x; DUPREY P, 1994, INT J DEV BIOL, V38, P591; Edelman DB, 2000, J BIOL CHEM, V275, P21737, DOI 10.1074/jbc.M909998199; EDMONDSON DG, 1993, J BIOL CHEM, V268, P755; FOSTER DN, 1992, J BIOL CHEM, V267, P11995; Groisman R, 1996, J BIOL CHEM, V271, P5258; Hautmann MB, 1997, CIRC RES, V81, P600, DOI 10.1161/01.RES.81.4.600; Herring BP, 2001, J BIOL CHEM, V276, P14482, DOI 10.1074/jbc.M011585200; Hinz B, 2003, THROMB HAEMOSTASIS, V90, P993, DOI 10.1160/TH03-05-0328; Hinz B, 2003, MOL BIOL CELL, V14, P2508, DOI 10.1091/mbc.E02-11-0729; Hinz B, 2002, J CELL BIOL, V157, P657, DOI 10.1083/jcb.200201049; Johnson AD, 1999, AM J PHYSIOL-CELL PH, V276, pC1420, DOI 10.1152/ajpcell.1999.276.6.C1420; Jones FS, 1997, P NATL ACAD SCI USA, V94, P2632, DOI 10.1073/pnas.94.6.2632; Knoepfler PS, 1999, NUCLEIC ACIDS RES, V27, P3752, DOI 10.1093/nar/27.18.3752; Kumar A, 2004, PLOS BIOL, V2, P1168, DOI 10.1371/journal.pbio.0020218; Kuwahara K, 2005, MOL CELL BIOL, V25, P3173, DOI 10.1128/MCB.25.8.3173-3181.2005; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Makarenkova H, 1997, J CELL BIOL, V138, P1125, DOI 10.1083/jcb.138.5.1125; Mann RS, 1998, CURR OPIN GENET DEV, V8, P423, DOI 10.1016/S0959-437X(98)80113-5; Meech R, 2003, J BIOL CHEM, V278, P8269, DOI 10.1074/jbc.M207617200; Meech R, 2005, DEVELOPMENT, V132, P2135, DOI 10.1242/dev.01811; MIN BH, 1990, J BIOL CHEM, V265, P16667; Molkentin JD, 1996, P NATL ACAD SCI USA, V93, P9366, DOI 10.1073/pnas.93.18.9366; Olson LE, 2005, P NATL ACAD SCI USA, V102, P3708, DOI 10.1073/pnas.0500519102; Ostle B., 1975, STAT RES, V3rd, P596; Phiel CJ, 2001, J BIOL CHEM, V276, P34637, DOI 10.1074/jbc.M105826200; Posern G, 2002, MOL BIOL CELL, V13, P4167, DOI 10.1091/mbc.02-05-0068; Qu G, 1997, J CELL BIOCHEM, V67, P514, DOI 10.1002/(SICI)1097-4644(19971215)67:4<514::AID-JCB9>3.3.CO;2-I; Ramirez S, 1997, J BIOL CHEM, V272, P31016, DOI 10.1074/jbc.272.49.31016; Rando TA, 1997, METHOD CELL BIOL, V52, P261, DOI 10.1016/S0091-679X(08)60382-9; Rodriguez-Calvo R, 2006, J GERONTOL A-BIOL, V61, P773, DOI 10.1093/gerona/61.8.773; SARTORELLI V, 1990, GENE DEV, V4, P1811, DOI 10.1101/gad.4.10.1811; Sartorelli V, 1997, MOL CELL BIOL, V17, P1010, DOI 10.1128/MCB.17.2.1010; SCHEVZOV G, 1992, J CELL BIOL, V117, P775, DOI 10.1083/jcb.117.4.775; Schildmeyer LA, 2000, FASEB J, V14, P2213, DOI 10.1096/fj.99-0927com; SHIMIZU RT, 1995, J BIOL CHEM, V270, P7631, DOI 10.1074/jbc.270.13.7631; Springer ML, 2002, CELL MOTIL CYTOSKEL, V51, P177, DOI 10.1002/cm.10022; Stevens TA, 2006, ONCOGENE, V25, P5426, DOI 10.1038/sj.onc.1209529; Stevens TA, 2004, J BIOL CHEM, V279, P14520, DOI 10.1074/jbc.M310259200; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; VANDEKERCKHOVE J, 1978, J MOL BIOL, V126, P783, DOI 10.1016/0022-2836(78)90020-7; VOGEL A, 1993, DEVELOPMENT, V119, P199; WOODCOCKMITCHELL J, 1988, DIFFERENTIATION, V39, P161, DOI 10.1111/j.1432-0436.1988.tb00091.x; Yoshida T, 2004, CIRC RES, V94, P1075, DOI 10.1161/01.RES.0000125622.46280.95; Zorn AM, 1999, MOL CELL, V4, P487, DOI 10.1016/S1097-2765(00)80200-2	53	17	17	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					14866	14874		10.1074/jbc.M807208200	http://dx.doi.org/10.1074/jbc.M807208200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19269978	Green Published, hybrid			2022-12-27	WOS:000266288200022
J	Tewari, N; Kalkunte, S; Murray, DW; Sharma, S				Tewari, Neetu; Kalkunte, Satyan; Murray, David W.; Sharma, Surendra			The Water Channel Aquaporin 1 Is a Novel Molecular Target of Polychlorinated Biphenyls for in Utero Anomalies	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AMNIOTIC-FLUID VOLUME; PRETERM LABOR; NK CELLS; EXPRESSION; IL-10; WOMEN; CONSUMPTION; EXPOSURE; PCBS; INTERLEUKIN-10	Despite serious health risks in humans and wild life, the underlying mechanisms that explain the gene-environment effects of chemical toxicants are largely unknown. Polychlorinated biphenyls (PCBs) are one of the most ubiquitous environmental toxicants worldwide, with reported epidemiological evidence for reproductive and neurocognitive anomalies in humans. Here, we show that Aroclor 1254, a mixture of structurally distinct PCBs, causes preterm birth in interleukin (IL)-10(-/-) mice at a dose that does not show any adverse effects in wild type mice, highlighting the significance of IL-10 as an anti-toxicant cytokine. Aroclor 1254-treated IL-10(-/-) mice demonstrated increased amniotic fluid, intrauterine growth restriction, and reduced litter size with postnatal neuromotor defects. Further, our results identify aquaporin 1 (AQP1), a potent effector of fluid volume regulation and angiogenic activity, as a novel placental target of PCBs. In vivo or in vitro exposure to Aroclor 1254 coupled with IL-10 deficiency significantly reduced the protein content of AQP1. Reduced uterine AQP1 levels were associated with defective spiral artery transformation. Importantly, recombinant IL-10 reversed PCB-induced in vivo and in vitro effects. These data demonstrate for the first time that the IL-10-AQP1 axis is a novel regulator of PCB-induced in utero effects.	Brown Univ, Women & Infants Hosp Rhode Isl, Warren Alpert Med Sch, Dept Pediat, Providence, RI 02905 USA; [Murray, David W.] Brown Univ, Ctr Environm Studies, Providence, RI 02912 USA	Brown University; Women & Infants Hospital Rhode Island; Brown University	Sharma, S (corresponding author), 101 Dudley St, Providence, RI 02905 USA.	ssharma@wihri.org	Moore, Thomas/F-2033-2010		National Institutes of Health Award [P20RR018728]; National Center for Research Resources; Superfund Basic Research Program Award [P42ES013660]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018728] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES013660] Funding Source: NIH RePORTER	National Institutes of Health Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Superfund Basic Research Program Award; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported, in whole or in part, by National Institutes of Health Award P20RR018728 through the National Center for Research Resources. This work was also supported in part by Superfund Basic Research Program Award P42ES013660.	Agre P, 2002, J PHYSIOL-LONDON, V542, P3, DOI 10.1113/jphysiol.2002.020818; Aldo PB, 2007, AM J REPROD IMMUNOL, V58, P98, DOI 10.1111/j.1600-0897.2007.00493.x; ARNOLD DL, 1995, FOOD CHEM TOXICOL, V33, P457, DOI 10.1016/0278-6915(95)00018-W; Baibergenova A, 2003, ENVIRON HEALTH PERSP, V111, P1352, DOI 10.1289/ehp.6053; Beall MH, 2007, PLACENTA, V28, P824, DOI 10.1016/j.placenta.2006.12.004; Beall MH, 2007, PLACENTA, V28, P421, DOI 10.1016/j.placenta.2006.06.005; Carpenter David O., 2006, Reviews on Environmental Health, V21, P1; Dumont FJ, 2003, EXPERT OPIN THER PAT, V13, P1551, DOI 10.1517/13543776.13.10.1551; Gerhard I, 1998, ENVIRON HEALTH PERSP, V106, P675, DOI 10.2307/3434097; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; Grandjean P, 2006, LANCET, V368, P2167, DOI 10.1016/S0140-6736(06)69665-7; Gray KA, 2005, AM J EPIDEMIOL, V162, P17, DOI 10.1093/aje/kwi158; Hanna N, 2000, J IMMUNOL, V164, P5721, DOI 10.4049/jimmunol.164.11.5721; Hanna N, 2006, AM J REPROD IMMUNOL, V55, P19, DOI 10.1111/j.1600-0897.2005.00342.x; Harman CR, 2008, SEMIN PERINATOL, V32, P288, DOI 10.1053/j.semperi.2008.04.012; Hennig B, 2002, TOXICOL APPL PHARM, V181, P174, DOI 10.1006/taap.2002.9408; HENSEN LG, 2008, PCBS HUMAN ENV DISPO, P1; Jacobsson B, 2003, ACTA OBSTET GYN SCAN, V82, P120, DOI 10.1080/j.1600-0412.2003.00047.x; Kaikunte S, 2008, PLACENTA, V29, P871, DOI 10.1016/j.placenta.2008.07.009; Kim YM, 2003, AM J OBSTET GYNECOL, V189, P1063, DOI 10.1067/S0002-9378(03)00838-X; KINSKY R, 1990, AM J REPROD IMMUNOL, V23, P73, DOI 10.1111/j.1600-0897.1990.tb00675.x; Kostyniak PJ, 1999, ENVIRON RES, V80, pS166, DOI 10.1006/enrs.1998.3939; Krishnan L, 1996, J IMMUNOL, V156, P644; Lee CK, 2007, REPROD FERT DEVELOP, V19, P539, DOI 10.1071/RD06117; Lee SE, 2008, J MATERN-FETAL NEO M, V21, P89, DOI 10.1080/14767050701830514; Liu H, 2008, PLACENTA, V29, P840, DOI 10.1016/j.placenta.2008.07.010; Mann SE, 2005, AM J OBSTET GYNECOL, V192, P2041, DOI 10.1016/j.ajog.2005.02.046; MEDAWAR PB, 1953, SYM SOC EXP BIOL, V7, P320; Mendola P, 1997, AM J EPIDEMIOL, V146, P955, DOI 10.1093/oxfordjournals.aje.a009222; Moffett A, 2006, NAT REV IMMUNOL, V6, P584, DOI 10.1038/nri1897; Moffett-King A, 2002, NAT REV IMMUNOL, V2, P656, DOI 10.1038/nri886; Murphy SP, 2005, J IMMUNOL, V175, P4084, DOI 10.4049/jimmunol.175.6.4084; Norwitz ER, 2001, NEW ENGL J MED, V345, P1400, DOI 10.1056/NEJMra000763; Parham P, 2004, J EXP MED, V200, P951, DOI 10.1084/jem.20041783; Paria BC, 2002, SCIENCE, V296, P2185, DOI 10.1126/science.1071601; Plevyak M, 2002, AM J REPROD IMMUNOL, V47, P242, DOI 10.1034/j.1600-0897.2002.01060.x; Robertson SA, 2006, J IMMUNOL, V177, P4888, DOI 10.4049/jimmunol.177.7.4888; Ross PS, 2000, SCIENCE, V289, P1878; Saadoun S, 2005, NATURE, V434, P786, DOI 10.1038/nature03460; Sadowsky DW, 2003, AM J OBSTET GYNECOL, V188, P252, DOI 10.1067/mob.2003.70; SAFE S, 1987, POLYCHLORINATED BIPH, P1; Sugawara N, 2006, ARCH TOXICOL, V80, P286, DOI 10.1007/s00204-005-0042-4; Trautman MS, 1997, J SOC GYNECOL INVEST, V4, P247, DOI 10.1016/S1071-5576(97)00045-2; Tsukimori K, 2008, ENVIRON HEALTH PERSP, V116, P626, DOI 10.1289/ehp.10686; *US EPA, 1996, 8082A18082A56 US EPA; Wang HB, 2006, NAT REV GENET, V7, P185, DOI 10.1038/nrg1808; Weintraub M, 2008, ENVIRON RES, V107, P412, DOI 10.1016/j.envres.2008.03.001; *WHO, 2003, 55 CICADS WHO INT PR; Yu ML, 2000, INT J EPIDEMIOL, V29, P672, DOI 10.1093/ije/29.4.672; [No title captured]	50	32	35	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					15224	15232		10.1074/jbc.M808892200	http://dx.doi.org/10.1074/jbc.M808892200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19332547	Green Published, hybrid			2022-12-27	WOS:000266288200057
J	Wiseman, RL; Chin, KT; Haynes, CM; Stanhill, A; Xu, CF; Roguev, A; Krogan, NJ; Neubert, TA; Ron, D				Wiseman, R. Luke; Chin, King-Tung; Haynes, Cole M.; Stanhill, Ariel; Xu, Chong-Feng; Roguev, Assen; Krogan, Nevan J.; Neubert, Thomas A.; Ron, David			Thioredoxin-related Protein 32 Is an Arsenite-regulated Thiol Reductase of the Proteasome 19 S Particle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SCHIZOSACCHAROMYCES-POMBE; UBIQUITINATED PROTEINS; MOLECULAR-CLONING; FISSION YEAST; CELLS; PROTEOTOXICITY; IDENTIFICATION; DESTRUCTION; DOMAIN; CUT8	Perturbation of the cytoplasmic protein folding environment by exposure to oxidative stress-inducing As(III)-containing compounds challenges the ubiquitin-proteasome system. Here we report on mass spectrometric analysis of As(III)-induced changes in the proteasome's composition in samples prepared by stable isotope labeling with amino acids in cell culture, using mammalian cells in which TRP32 (thioredoxin-related protein of 32 kDa; also referred to as TXNL1) was identified as a novel subunit of the 26 S proteasome. Quantitative genetic interaction mapping, using the epistatic miniarray profiling approach, identified a functional connection between TRP32 and the proteasome. Deletion of txl1, the Schizosaccharomyces pombe homolog of TRP32, results in a slow growth phenotype when combined with deletion of cut8, a gene required for normal proteasome localization. Deletion analysis in vivo, chemical crosslinking, and manipulation of the ATP concentration in vitro during proteasome immunopurification revealed that the C-terminal domain of mammalian TRP32 binds the 19 S regulatory particle in proximity to the proteasome substrate binding site. Thiol modification with polyethylene glycol-maleimide showed disulfide bond formation at the active site of TRP32 in cells exposed to As(III). Pulse-chase labeling showed that TRP32 is a stable protein whose half-life of >6 h is surprisingly reduced to 1 h upon exposure of cells to As(III). These findings reveal a previously undescribed thiol reductase at the proteasome's regulatory particle.	[Neubert, Thomas A.; Ron, David] NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst, New York, NY 10016 USA; [Ron, David] NYU, Sch Med, Dept Med, New York, NY 10016 USA; [Ron, David] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Neubert, Thomas A.] NYU, Sch Med, Dept Pharmacol, New York, NY 10016 USA; [Roguev, Assen; Krogan, Nevan J.] Univ Calif San Francisco, Dept Cell & Mol Pharmacol, San Francisco, CA 94158 USA; [Roguev, Assen; Krogan, Nevan J.] Univ Calif San Francisco, Calif Inst Quantitat Biomed Res, San Francisco, CA 94158 USA	New York University; New York University; New York University; New York University; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Ron, D (corresponding author), NYU, Sch Med, Kimmel Ctr Biol & Med, Skirball Inst, New York, NY 10016 USA.	david.ron@med.nyu.edu		Ron, David/0000-0002-3014-5636; stanhill, ariel/0000-0002-0318-2212; Wiseman, Luke/0000-0001-9287-6840	National Institutes of Health [RO1-ES08681, F32-ES014775, MC-IRG203123, P30-NS050276, F32-NS050901, RO1-GM084279]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [F32ES014775, R01ES008681] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084279] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS050276, F32NS050901] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants RO1-ES08681 (to D.R.), F32-ES014775 (to R.L.W.), MC-IRG203123 (to A.S.), P30-NS050276 (to T.A.N.), F32-NS050901 (to C.M.H.), and RO1-GM084279 (to N.J.K.).	Andersen KM, 2009, J BIOL CHEM, V284, P15246, DOI 10.1074/jbc.M900016200; Aposhian H, 1989, REV BIOCHEM TOXICOL, V10, P265; Appenzeller-Herzog C, 2008, ANTIOXID REDOX SIGN, V10, P55, DOI 10.1089/ars.2007.1837; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Blagoev B, 2003, NAT BIOTECHNOL, V21, P315, DOI 10.1038/nbt790; BOND U, 1988, J BIOL CHEM, V263, P2384; DUNCAN RF, 1987, ARCH BIOCHEM BIOPHYS, V256, P651, DOI 10.1016/0003-9861(87)90622-9; Elsasser S, 2005, NAT CELL BIOL, V7, P742, DOI 10.1038/ncb0805-742; EYTAN E, 1989, P NATL ACAD SCI USA, V86, P7751, DOI 10.1073/pnas.86.20.7751; Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263; Hanna J, 2007, FEBS LETT, V581, P2854, DOI 10.1016/j.febslet.2007.03.053; Ishii T, 2005, BIOCHEMISTRY-US, V44, P13893, DOI 10.1021/bi051336u; Jimenez A, 2006, FEBS LETT, V580, P960, DOI 10.1016/j.febslet.2006.01.025; Jimenez A, 2007, YEAST, V24, P481, DOI 10.1002/yea.1483; Jin J, 2002, EUR J BIOCHEM, V269, P2060, DOI 10.1046/j.1432-1033.2002.02844.x; JOHNSTON D, 1980, J BIOL CHEM, V255, P6975; Kirkpatrick DS, 2003, TOXICOL APPL PHARM, V186, P101, DOI 10.1016/S0041-008X(02)00019-4; Lee KK, 1998, J BIOL CHEM, V273, P19160, DOI 10.1074/jbc.273.30.19160; LEVINSON W, 1980, BIOCHIM BIOPHYS ACTA, V606, P170, DOI 10.1016/0005-2787(80)90108-2; Lu JL, 2001, BIOCHEMISTRY-US, V40, P13288, DOI 10.1021/bi0107647; Lundgren J, 2005, MOL CELL BIOL, V25, P4662, DOI 10.1128/MCB.25.11.4662-4675.2005; Miranda-Vizuete A, 1998, BIOCHEM BIOPH RES CO, V243, P284, DOI 10.1006/bbrc.1997.8003; ORINO E, 1991, FEBS LETT, V284, P206, DOI 10.1016/0014-5793(91)80686-W; Roguev A, 2008, SCIENCE, V322, P405, DOI 10.1126/science.1162609; Roguev A, 2007, NAT METHODS, V4, P861, DOI 10.1038/NMETH1098; Rosenzweig R, 2008, NAT STRUCT MOL BIOL, V15, P573, DOI 10.1038/nsmb.1427; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Song JK, 2005, PROTEIN SCI, V14, P1059, DOI 10.1110/ps.041246805; Stanhill A, 2006, MOL CELL, V23, P875, DOI 10.1016/j.molcel.2006.07.023; Takeda K, 2005, CELL, V122, P393, DOI 10.1016/j.cell.2005.05.023; Tatebe H, 2000, CURR BIOL, V10, P1329, DOI 10.1016/S0960-9822(00)00773-9; Yun C, 2008, P NATL ACAD SCI USA, V105, P7094, DOI 10.1073/pnas.0707025105; Zheng PZ, 2005, P NATL ACAD SCI USA, V102, P7653, DOI 10.1073/pnas.0502825102	34	34	35	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					15233	15245		10.1074/jbc.M109.002121	http://dx.doi.org/10.1074/jbc.M109.002121			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19349280	Green Published, hybrid			2022-12-27	WOS:000266288200058
J	Frydenvang, K; Lash, LL; Naur, P; Postila, PA; Pickering, DS; Smith, CM; Gajhede, M; Sasaki, M; Sakai, R; Pentikainen, OT; Swanson, GT; Kastrup, JS				Frydenvang, Karla; Lash, L. Leanne; Naur, Peter; Postila, Pekka A.; Pickering, Darryl S.; Smith, Caleb M.; Gajhede, Michael; Sasaki, Makoto; Sakai, Ryuichi; Pentikainen, Olli T.; Swanson, Geoffrey T.; Kastrup, Jette S.			Full Domain Closure of the Ligand-binding Core of the Ionotropic Glutamate Receptor iGluR5 Induced by the High Affinity Agonist Dysiherbaine and the Functional Antagonist 8,9-Dideoxyneodysiherbaine	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR-DYNAMICS; CRYSTAL-STRUCTURES; AMINO-ACID; PHARMACOLOGICAL-PROPERTIES; KAINATE; GLUR5; DESENSITIZATION; ACTIVATION; MECHANISM; CRYSTALLOGRAPHY	The prevailing structural model for ligand activation of ionotropic glutamate receptors posits that agonist efficacy arises from the stability and magnitude of induced domain closure in the ligand-binding core structure. Here we describe an exception to the correlation between ligand efficacy and domain closure. A weakly efficacious partial agonist of very low potency for homomeric iGluR5 kainate receptors, 8,9-dideoxyneodysiherbaine (MSVIII-19), induced a fully closed iGluR5 ligand-binding core. The degree of relative domain closure, similar to 30 degrees, was similar to that we resolved with the structurally related high affinity agonist dysiherbaine and to that of L-glutamate. The pharmacological activity of MSVIII-19 was confirmed in patch clamp recordings from transfected HEK293 cells, where MSVIII-19 predominantly inhibits iGluR5-2a, with little activation apparent at a high concentration (1 mM) of MSVIII-19 (<1% of mean glutamate-evoked currents). To determine the efficacy of the ligand quantitatively, we constructed concentration-response relationships for MSVIII-19 following potentiation of steady-state currents with concanavalin A (EC50 = 3.6 mu M) and on the nondesensitizing receptor mutant iGluR5-2b(Y506C/L768C) (EC50 = 8.1 mu M). MSVIII-19 exhibited a maximum of 16% of full agonist efficacy, as measured in parallel recordings with glutamate. Molecular dynamics simulations and electrophysiological recordings confirm that the specificity of MSVIII-19 for iGluR5 is partly attributable to interdomain hydrogen bond residues Glu(441) and Ser(721) in the iGluR5-S1S2 structure. The weaker interactions of MSVIII-19 with iGluR5 compared with dysiherbaine, together with altered stability of the interdomain interaction, may be responsible for the apparent uncoupling of domain closure and channel opening in this kainate receptor subunit.	[Frydenvang, Karla; Naur, Peter; Gajhede, Michael; Kastrup, Jette S.] Univ Copenhagen, Dept Med Chem, Fac Pharmaceut Sci, DK-2100 Copenhagen, Denmark; [Pickering, Darryl S.] Univ Copenhagen, Dept Pharmacol & Pharmacotherapy, Fac Pharmaceut Sci, DK-2100 Copenhagen, Denmark; [Lash, L. Leanne; Smith, Caleb M.; Swanson, Geoffrey T.] Northwestern Univ, Feinberg Sch Med, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA; [Postila, Pekka A.; Pentikainen, Olli T.] Univ Jyvaskyla, Dept Biol & Environm Sci, FI-40014 Jyvaskyla, Finland; [Postila, Pekka A.; Pentikainen, Olli T.] Univ Jyvaskyla, Nanosci Ctr, FI-40014 Jyvaskyla, Finland; [Sasaki, Makoto] Tohoku Univ, Grad Sch Life Sci, Lab Biostruct Chem, Aoba Ku, Sendai, Miyagi 9818555, Japan; [Sakai, Ryuichi] Hokkaido Univ, Grad Sch Fisheries Sci, Hakodate, Hokkaido 0418611, Japan	University of Copenhagen; University of Copenhagen; Northwestern University; Feinberg School of Medicine; University of Jyvaskyla; University of Jyvaskyla; Tohoku University; Hokkaido University	Kastrup, JS (corresponding author), Univ Copenhagen, Dept Med Chem, Fac Pharmaceut Sci, Univ Pk 2, DK-2100 Copenhagen, Denmark.	jsk@farma.ku.dk	Postila, Pekka/Z-1177-2019; Pentikäinen, Olli T/E-1980-2012; Sasaki, Makoto/AAE-5204-2019	Postila, Pekka/0000-0002-2947-7991; Pentikäinen, Olli T/0000-0001-7188-4016; Sasaki, Makoto/0000-0003-2964-7986; Kastrup, Jette Sandholm/0000-0003-2654-1510; Gajhede, Michael/0000-0001-9864-2287	National Institutes of Health, NINDS [R01 NS44322]; Dansync Center for Synchrotron Radiation; Danish Medical Research Council; European Community; Sigrid Juselius Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS044322] Funding Source: NIH RePORTER	National Institutes of Health, NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Dansync Center for Synchrotron Radiation; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Community(European Commission); Sigrid Juselius Foundation(Sigrid Juselius Foundation); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health, NINDS, Grant R01 NS44322 (to G. T. S.). This work was also supported by grants from the Dansync Center for Synchrotron Radiation, the Danish Medical Research Council, the European Community (Access to Research Infrastructure Action of the Improving Human Potential Programme) (to K. F., P. N., M. G., and J.S.K.) and by the Sigrid Juselius Foundation (to O.T.P.).	Armstrong N, 2003, P NATL ACAD SCI USA, V100, P5736, DOI 10.1073/pnas.1037393100; Armstrong N, 2000, NEURON, V28, P165, DOI 10.1016/S0896-6273(00)00094-5; Armstrong N, 2006, CELL, V127, P85, DOI 10.1016/j.cell.2006.08.037; Bahar M, 2006, ACTA CRYSTALLOGR D, V62, P1170, DOI 10.1107/S0907444906032197; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; Bowie D, 2003, J PHYSIOL-LONDON, V547, P373, DOI 10.1113/jphysiol.2002.033076; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; DeLano W.L, PYMOL MOL GRAPHICS S; Dingledine R, 1999, PHARMACOL REV, V51, P7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Frisch M.J., 2009, GAUSSIAN 09 REV A02; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Hald H, 2007, J BIOL CHEM, V282, P25726, DOI 10.1074/jbc.M700137200; Hansen KB, 2007, CURR OPIN NEUROBIOL, V17, P281, DOI 10.1016/j.conb.2007.03.014; Hayward S, 2002, J MOL GRAPH MODEL, V21, P181, DOI 10.1016/S1093-3263(02)00140-7; Inanobe A, 2005, NEURON, V47, P71, DOI 10.1016/j.neuron.2005.05.022; Jin RS, 2003, NAT NEUROSCI, V6, P803, DOI 10.1038/nn1091; Kleywegt GJ, 1996, STRUCTURE, V4, P1395, DOI 10.1016/S0969-2126(96)00147-5; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Krissinel E, 2005, LECT NOTES COMPUT SC, V3695, P163; Kubo M, 2004, PROTEINS, V56, P411, DOI 10.1002/prot.20154; Lash LL, 2008, J PHARMACOL EXP THER, V324, P484, DOI 10.1124/jpet.107.129890; Lehtonen JV, 2004, J COMPUT AID MOL DES, V18, P401, DOI 10.1007/s10822-004-3752-4; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB, P26; LOMELI H, 1992, FEBS LETT, V307, P139, DOI 10.1016/0014-5793(92)80753-4; Madden DR, 2004, BIOCHEMISTRY-US, V43, P15838, DOI 10.1021/bi048447y; Mayer ML, 2005, NEURON, V45, P539, DOI 10.1016/j.neuron.2005.01.031; Mayer ML, 2006, J NEUROSCI, V26, P2852, DOI 10.1523/JNEUROSCI.0123-06.2005; Menuz K, 2007, SCIENCE, V318, P815, DOI 10.1126/science.1146317; Merritt EA, 1997, METHOD ENZYMOL, V277, P505, DOI 10.1016/S0076-6879(97)77028-9; Naur P, 2005, FEBS LETT, V579, P1154, DOI 10.1016/j.febslet.2005.01.012; Naur P, 2007, P NATL ACAD SCI USA, V104, P14116, DOI 10.1073/pnas.0703718104; Nielsen BS, 1998, EUR J PHARMACOL, V360, P227, DOI 10.1016/S0014-2999(98)00668-2; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126; Ramanoudjame G, 2006, P NATL ACAD SCI USA, V103, P10473, DOI 10.1073/pnas.0603225103; Rosenmund C, 1998, SCIENCE, V280, P1596, DOI 10.1126/science.280.5369.1596; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Sakai R, 1997, J AM CHEM SOC, V119, P4112, DOI 10.1021/ja963953z; Sakai R, 2001, J PHARMACOL EXP THER, V296, P650; Sanders JM, 2005, J PHARMACOL EXP THER, V314, P1068, DOI 10.1124/jpet.105.086389; Sasaki M, 1999, TETRAHEDRON LETT, V40, P3195, DOI 10.1016/S0040-4039(99)00413-X; Schlick T, 1999, J COMPUT PHYS, V151, P9, DOI 10.1006/jcph.1999.6182; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Sun Y, 2002, NATURE, V417, P245, DOI 10.1038/417245a; Swanson GT, 2002, NEURON, V34, P589, DOI 10.1016/S0896-6273(02)00676-1; Swanson GT, 1997, NEURON, V19, P913, DOI 10.1016/S0896-6273(00)80972-1; TRUSSELL LO, 1989, NEURON, V3, P209, DOI 10.1016/0896-6273(89)90034-2; Wang JM, 2006, J MOL GRAPH MODEL, V25, P247, DOI 10.1016/j.jmgm.2005.12.005; Weston MC, 2006, NAT STRUCT MOL BIOL, V13, P1120, DOI 10.1038/nsmb1178	52	50	50	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14219	14229		10.1074/jbc.M808547200	http://dx.doi.org/10.1074/jbc.M808547200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19297335	Green Published, hybrid			2022-12-27	WOS:000266286100028
J	Rambaud, J; Desroches, J; Balsalobre, A; Drouin, J				Rambaud, Juliette; Desroches, Julien; Balsalobre, Aurelio; Drouin, Jacques			TIF1 beta/KAP-1 Is a Coactivator of the Orphan Nuclear Receptor NGFI-B/Nur77	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ZINC-FINGER PROTEINS; CORTICOTROPIN-RELEASING HORMONE; T-BOX FACTOR; PROOPIOMELANOCORTIN GENE; NGFI-B; TRANSCRIPTION FACTOR; GLUCOCORTICOID-RECEPTOR; PARAVENTRICULAR NUCLEUS; COREPRESSOR COMPLEX; REPRESSOR DOMAIN	In efforts to define mechanisms of transcriptional activation by the orphan nuclear receptor NGFI-B (Nur77), we identified TIF1 beta by mass spectrometry within a nuclear protein complex containing NGFI-B. TIF1 beta, also known as KAP-1 (KRAB domain-associated protein) or KRIP-1, acts as a transcriptional corepressor for many transcription factors, in particular for the Kruppel-associated box domain-containing zinc finger transcription factors. TIF1 beta is also an intrinsic component of two chromatin remodeling and histone deacetylase complexes, the N-CoR1 and nucleosome remodeling and deacetylation complexes. In contrast to these activities, we report that TIF1 beta is a coactivator of NGFI-B and that it is as potent as the SRC coactivators in this context. Using pull-down assays and immunoprecipitation, we showed that TIF1 beta interacts directly with NGFI-B and with other Nur family members. NGFI-B is an important mediator of hypothalamic corticotropin-releasing hormone (CRH) activation of proopiomelanocortin (POMC) transcription, and TIF1 beta enhances transcription mediated through the NGFI-B target, the Nur response element (NurRE). The NurRE binds Nur factor dimers and is responsive to signaling pathways. In keeping with the role of NGFI-B as mediator of CRH signaling, we found that TIF1 beta is recruited to the POMC promoter following CRH stimulation and that TIF1 beta potentiates CRH and protein kinase A signaling through the NurRE; it acts synergistically with the SRC2 coactivator. However, the actions of TIF1 beta and SRC2 were mapped to different NGFI-B AF-1 subdomains. Taken together, these results indicate that TIF1 beta is an important coactivator of NGFI-B-dependent transcription.	[Rambaud, Juliette; Desroches, Julien; Balsalobre, Aurelio; Drouin, Jacques] Inst Rech Clin Montreal, Mol Genet Lab, Montreal, PQ H2W 1R7, Canada	Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Balsalobre, A (corresponding author), 110 Ave Pins O, Montreal, PQ H2W 1R7, Canada.	Aurelio.Balsalobre@ircm.qc.ca; Jacques.Drouin@ircm.qc.ca		Drouin, Jacques/0000-0001-8226-5691	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by grants from the Canadian Institutes of Health Research (to J.D.).	Abrink M, 2001, P NATL ACAD SCI USA, V98, P1422, DOI 10.1073/pnas.041616998; Agata Y, 1999, J BIOL CHEM, V274, P16412, DOI 10.1074/jbc.274.23.16412; Bandoh S, 1997, J NEUROENDOCRINOL, V9, P3, DOI 10.1046/j.1365-2826.1997.00571.x; Batsche E, 2005, J BIOL CHEM, V280, P19746, DOI 10.1074/jbc.M413428200; Beckstead R, 2001, MOL CELL, V7, P753, DOI 10.1016/S1097-2765(01)00220-9; Belandia B, 2002, EMBO J, V21, P4094, DOI 10.1093/emboj/cdf412; Benecke A, 2000, EMBO REP, V1, P151, DOI 10.1093/embo-reports/kvd028; Bilodeau S, 2006, GENE DEV, V20, P2871, DOI 10.1101/gad.1444606; BIRNBERG NC, 1983, P NATL ACAD SCI-BIOL, V80, P6982, DOI 10.1073/pnas.80.22.6982; Cammas F, 2000, DEVELOPMENT, V127, P2955; Chang CJ, 1998, MOL CELL BIOL, V18, P5880, DOI 10.1128/MCB.18.10.5880; Enmark E, 1996, MOL ENDOCRINOL, V10, P1293, DOI 10.1210/me.10.11.1293; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; GAGNER JP, 1987, MOL ENDOCRINOL, V1, P677, DOI 10.1210/mend-1-10-677; GAGNER JP, 1985, MOL CELL ENDOCRINOL, V40, P25, DOI 10.1016/0303-7207(85)90154-6; HONKANIEMI J, 1994, MOL BRAIN RES, V25, P234, DOI 10.1016/0169-328X(94)90158-9; Khetchoumian K, 2004, J BIOL CHEM, V279, P48329, DOI 10.1074/jbc.M404779200; Kim SS, 1996, P NATL ACAD SCI USA, V93, P15299, DOI 10.1073/pnas.93.26.15299; Kovalovsky D, 2002, MOL ENDOCRINOL, V16, P1638, DOI 10.1210/me.16.7.1638; Krogan NJ, 2002, MOL CELL BIOL, V22, P6979, DOI 10.1128/MCB.22.20.6979-6992.2002; LABRIE F, 1982, SCIENCE, V216, P1007, DOI 10.1126/science.6281886; Lamolet B, 2001, CELL, V104, P849, DOI 10.1016/S0092-8674(01)00282-3; Lamonerie T, 1996, GENE DEV, V10, P1284, DOI 10.1101/gad.10.10.1284; LAW SW, 1992, MOL ENDOCRINOL, V6, P2129, DOI 10.1210/me.6.12.2129; LE DB, 1996, EMBO J, V15, P6701; LEDOUARIN B, 1995, EMBO J, V14, P2020, DOI 10.1002/j.1460-2075.1995.tb07194.x; Maira M, 2003, J BIOL CHEM, V278, P46523, DOI 10.1074/jbc.M305626200; Maira M, 2003, MOL CELL BIOL, V23, P763, DOI 10.1128/MCB.23.3.763-776.2003; Maira M, 1999, MOL CELL BIOL, V19, P7549; Martens C, 2005, MOL ENDOCRINOL, V19, P885, DOI 10.1210/me.2004-0333; Mascle XH, 2007, J BIOL CHEM, V282, P10190, DOI 10.1074/jbc.M611429200; MILBRANDT J, 1988, NEURON, V1, P183, DOI 10.1016/0896-6273(88)90138-9; Moosmann P, 1996, NUCLEIC ACIDS RES, V24, P4859, DOI 10.1093/nar/24.24.4859; Murphy EP, 1997, MOL ENDOCRINOL, V11, P39, DOI 10.1210/me.11.1.39; Nielsen AL, 1999, EMBO J, V18, P6385, DOI 10.1093/emboj/18.22.6385; NORDEEN SK, 1988, BIOTECHNIQUES, V6, P454; OHKURA N, 1994, BIOCHEM BIOPH RES CO, V205, P1959, DOI 10.1006/bbrc.1994.2900; PARKES D, 1993, MOL ENDOCRINOL, V7, P1357, DOI 10.1210/me.7.10.1357; Phillips A, 1997, MOL CELL BIOL, V17, P5946, DOI 10.1128/MCB.17.10.5946; Poulin G, 1997, MOL CELL BIOL, V17, P6673, DOI 10.1128/MCB.17.11.6673; Ransom DG, 2004, PLOS BIOL, V2, P1188, DOI 10.1371/journal.pbio.0020237; REISINE T, 1985, P NATL ACAD SCI USA, V82, P8261, DOI 10.1073/pnas.82.23.8261; Ryan RF, 1999, MOL CELL BIOL, V19, P4366; Satou A, 2001, J BIOL CHEM, V276, P46562, DOI 10.1074/jbc.M104937200; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; THERRIEN M, 1991, MOL CELL BIOL, V11, P3492, DOI 10.1128/MCB.11.7.3492; Timpl P, 1998, NAT GENET, V19, P162, DOI 10.1038/520; TREMBLAY Y, 1988, P NATL ACAD SCI USA, V85, P8890, DOI 10.1073/pnas.85.23.8890; UMESONO K, 1991, CELL, V65, P1255, DOI 10.1016/0092-8674(91)90020-Y; Underhill C, 2000, J BIOL CHEM, V275, P40463, DOI 10.1074/jbc.M007864200; Venturini L, 1999, ONCOGENE, V18, P1209, DOI 10.1038/sj.onc.1202655; Wansa KDSA, 2002, J BIOL CHEM, V277, P33001, DOI 10.1074/jbc.M203572200; WATSON MA, 1990, DEVELOPMENT, V110, P173; Xu JM, 2003, MOL ENDOCRINOL, V17, P1681, DOI 10.1210/me.2003-0116	55	44	45	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14147	14156		10.1074/jbc.M809023200	http://dx.doi.org/10.1074/jbc.M809023200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19321449	hybrid, Green Published			2022-12-27	WOS:000266286100021
J	Randall, A; Griffith, JD				Randall, Adrian; Griffith, Jack D.			Structure of Long Telomeric RNA Transcripts THE G-RICH RNA FORMS A COMPACT REPEATING STRUCTURE CONTAINING G-QUARTETS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MAMMALIAN TELOMERES; G-QUADRUPLEX; VISUALIZATION; CHROMATIN	Recent studies have identified RNA transcripts arising from mammalian telomeres with the transcript of the C-rich strand (r(5'-UUAGGG-3')(n)) being much more abundant than transcripts of the G-rich strand. Here we used transmission electron microscopy, CD, and nuclease digestion to investigate the structure of similar to 640-nucleotide (nt) RNA transcripts of the C-rich and G-rich strands of mammalian telomeric DNA. The CD spectrum of the C-rich RNA in low salt (10 mM KCl) or high salt (100 mM KCl) was typical of mixed sequence RNA, whereas the CD spectrum for the G-rich RNA differed with changes characteristic of parallel G-quadruplexes at the higher salt concentration. Electron microscopy visualization of the C-rich RNA revealed relatively extended unstructured molecules 59.7 +/- 17.8 nm in length and with a width consistent with single-stranded RNA following metal coating. In contrast, the G-rich RNA was observed as round particles and short, thick rods with the rods being most prevalent in high salt conditions and absent in low salt. The rods were 22.7 +/- 4.8 nm in length and 7.6 nm in width. Digestion of the G-rich RNA with T1 RNA nuclease revealed a ladder of bands whose sizes were integral multiples of 24 nt plus a 4-nt overhang. These observations suggest a model in which G-rich telomeric RNA folds into chains of particles each consisting of four (UUAGGG) repeats stabilized by parallel G-quartets and joined by UUA linkers. These chains further condense to form short rods and round particles.	[Randall, Adrian; Griffith, Jack D.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill	Griffith, JD (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA.	jdg@med.unc.edu			National Institutes of Health [GM31819, ES013773]; Glenn Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES013773] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031819] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Glenn Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM31819 and ES013773 (to J.D.G.). This work was also supported by an award from the Glenn Foundation.	Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Cesare AJ, 2003, PLANT J, V36, P271, DOI 10.1046/j.1365-313X.2003.01882.x; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; FAJKUS J, 1995, MOL GEN GENET, V247, P633, DOI 10.1007/BF00290355; GRIFFITH JD, 1978, ANNU REV BIOPHYS BIO, V7, P19, DOI 10.1146/annurev.bb.07.060178.000315; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Keniry MA, 2001, BIOPOLYMERS, V56, P123, DOI 10.1002/1097-0282(2000/2001)56:3<123::AID-BIP10010>3.0.CO;2-3; Kumari S, 2007, NAT CHEM BIOL, V3, P218, DOI 10.1038/nchembio864; NAKAMURA TM, 1995, EMBO J, V14, P4849, DOI 10.1002/j.1460-2075.1995.tb00166.x; Ng K, 2007, EMBO REP, V8, P34, DOI 10.1038/sj.embor.7400871; Nosek J., 2008, ORIGIN EVOLUTION TEL; Parkinson GN, 2002, NATURE, V417, P876, DOI 10.1038/nature755; Pedroso IM, 2009, NUCLEIC ACIDS RES, V37, P1541, DOI 10.1093/nar/gkn1081; Phan AT, 2007, NUCLEIC ACIDS RES, V35, P6517, DOI 10.1093/nar/gkm706; Qi JY, 2007, BIOCHEMISTRY-US, V46, P7599, DOI 10.1021/bi602392u; Raices M, 2008, CELL, V132, P745, DOI 10.1016/j.cell.2007.12.039; Schoeftner S, 2008, NAT CELL BIOL, V10, P228, DOI 10.1038/ncb1685; Stansel RM, 2001, EMBO J, V20, P5532; Tang CF, 2006, J AM CHEM SOC, V128, P5966, DOI 10.1021/ja0603958; WANG Y, 1993, STRUCTURE, V1, P263, DOI 10.1016/0969-2126(93)90015-9; WANG YH, 1994, J MOL BIOL, V236, P64, DOI 10.1006/jmbi.1994.1118; Westhof E, 2000, STRUCTURE, V8, pR55, DOI 10.1016/S0969-2126(00)00112-X; Wieland M, 2007, CHEM BIOL, V14, P757, DOI 10.1016/j.chembiol.2007.06.005; Xu Y, 2008, J AM CHEM SOC, V130, P11179, DOI 10.1021/ja8031532; Yu HQ, 2006, J AM CHEM SOC, V128, P15461, DOI 10.1021/ja064536h	25	59	60	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					13980	13986		10.1074/jbc.M900631200	http://dx.doi.org/10.1074/jbc.M900631200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19329435	Green Published, hybrid			2022-12-27	WOS:000266286100004
J	Shi, B; Tran, T; Sobkoviak, R; Pope, RM				Shi, Bo; Tran, Tri; Sobkoviak, Rudina; Pope, Richard M.			Activation-induced Degradation of FLIPL Is Mediated via the Phosphatidylinositol 3-Kinase/Akt Signaling Pathway in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; FLICE-INHIBITORY PROTEIN; TRAIL-INDUCED APOPTOSIS; ARTHRITIS SYNOVIAL MACROPHAGES; INDUCED CELL-DEATH; C-FLIP; RHEUMATOID-ARTHRITIS; TUMOR-CELLS; CD95-INDUCED APOPTOSIS; CONFERS RESISTANCE	Cellular FLIP (Flice-like inhibitory protein) is critical for the protection against death receptor-mediated cell apoptosis. In macrophages, FLIP long (FLIPL) and FLIP short (FLIPS) mRNA was induced by tumor necrosis factor (TNF) alpha, mediated through NF-kappa B. However, we observed TNF alpha reduced the protein level of FLIPL, but not FLIPS, at 1 and 2 h. Similar results were observed with lipopolysaccharide. The reduction of FLIPL by TNF alpha was not mediated by caspase 8, or through JNK or Itch, but was suppressed by inhibition of the phosphatidylinositol 3-kinase/Akt pathway employing chemical inhibitors, a dominant negative Akt-1, or Akt-1 small interfering RNA. The reduction of FLIPL resulted in the short term induction of caspase 8-like activity, which augmented NF-kappa B activation. A co-immunoprecipitation assay demonstrated that Akt-1 physically interacts with FLIPL. Moreover, TNF alpha enhanced FLIPL serine phosphorylation, which was increased by activated Akt-1. Serine 273, a putative Akt-1 phosphorylation site in FLIPL, was critical for the activation-induced reduction of FLIPL. Thus, these observations document a novel mechanism where by TNF alpha facilitates the reduction of FLIPL protein, which is dependent on the phosphatidylinositol 3-kinase/Akt signaling.	[Shi, Bo; Tran, Tri; Sobkoviak, Rudina; Pope, Richard M.] Northwestern Univ, Feinberg Sch Med, Div Rheumatol, Chicago, IL 60611 USA; [Pope, Richard M.] Jesse Brown Vet Affairs Chicago Healthcare Syst, Chicago, IL 61612 USA	Northwestern University; Feinberg School of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center	Pope, RM (corresponding author), Northwestern Univ, Feinberg Sch Med, Div Rheumatol, 240 E Huron,McGaw M300, Chicago, IL 60611 USA.	rmp158@northwestern.edu		Pope, Richard M./0000-0003-2416-8660; Shi, Bo/0000-0002-0780-0372	National Institutes of Health [AR049217, AR048269]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR049217, R01AR048269] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grants AR049217 and AR048269.	Albee L, 2006, INFLAMM RES, V55, P2, DOI 10.1007/s00011-005-0001-9; Bai SC, 2004, ARTHRITIS RHEUM-US, V50, P3844, DOI 10.1002/art.20680; Bannerman DD, 2001, J BIOL CHEM, V276, P14924, DOI 10.1074/jbc.M100819200; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Chang LF, 2006, CELL, V124, P601, DOI 10.1016/j.cell.2006.01.021; Chanvorachote P, 2005, J BIOL CHEM, V280, P42044, DOI 10.1074/jbc.M510080200; Davies CC, 2004, J BIOL CHEM, V279, P1010, DOI 10.1074/jbc.M303820200; Day TW, 2006, BIOCHEM PHARMACOL, V71, P1551, DOI 10.1016/j.bcp.2006.02.015; Djerbi M, 2001, SCAND J IMMUNOL, V54, P180, DOI 10.1046/j.1365-3083.2001.00941.x; Fujio Y, 1999, J BIOL CHEM, V274, P16349, DOI 10.1074/jbc.274.23.16349; Fukazawa T, 2001, ONCOGENE, V20, P5225, DOI 10.1038/sj.onc.1204673; Geisler F, 2007, GASTROENTEROLOGY, V132, P2489, DOI 10.1053/j.gastro.2007.03.033; Gordon S, 2007, J CLIN INVEST, V117, P89, DOI 10.1172/JCI30992; Haase R, 2003, J IMMUNOL, V171, P4294, DOI 10.4049/jimmunol.171.8.4294; Higuchi H, 2003, J BIOL CHEM, V278, P454, DOI 10.1074/jbc.M209387200; Inoue H, 2004, INT J MOL MED, V14, P271; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; Kamata H, 2005, CELL, V120, P649, DOI 10.1016/j.cell.2004.12.041; Kang YC, 2004, CELL DEATH DIFFER, V11, P1287, DOI 10.1038/sj.cdd.4401489; Karin M, 2002, NAT IMMUNOL, V3, P221, DOI 10.1038/ni0302-221; Keane J, 1997, INFECT IMMUN, V65, P298, DOI 10.1128/IAI.65.1.298-304.1997; Kim Y, 2002, J BIOL CHEM, V277, P22320, DOI 10.1074/jbc.M202458200; Kreuz S, 2001, MOL CELL BIOL, V21, P3964, DOI 10.1128/MCB.21.12.3964-3973.2001; Liu HT, 2006, ARTHRITIS RHEUM-US, V54, P3174, DOI 10.1002/art.22132; Liu HT, 2005, J IMMUNOL, V175, P8337, DOI 10.4049/jimmunol.175.12.8337; Liu HT, 2004, J IMMUNOL, V172, P1907, DOI 10.4049/jimmunol.172.3.1907; Liu HT, 2003, BLOOD, V102, P344, DOI 10.1182/blood-2002-11-3396; Liu HT, 2001, J EXP MED, V194, P113, DOI 10.1084/jem.194.2.113; Longley DB, 2006, ONCOGENE, V25, P838, DOI 10.1038/sj.onc.1209122; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Ma YY, 2005, J BIOL CHEM, V280, P41827, DOI 10.1074/jbc.M510849200; Ma YY, 2005, CURR PHARM DESIGN, V11, P569, DOI 10.2174/1381612053381927; Medema JP, 1997, EMBO J, V16, P2794, DOI 10.1093/emboj/16.10.2794; Micheau O, 2001, MOL CELL BIOL, V21, P5299, DOI 10.1128/MCB.21.16.5299-5305.2001; Misra RS, 2007, J BIOL CHEM, V282, P19365, DOI 10.1074/jbc.M610610200; Nakajima A, 2006, EMBO J, V25, P5549, DOI 10.1038/sj.emboj.7601423; Nam SY, 2003, CANCER SCI, V94, P1066, DOI 10.1111/j.1349-7006.2003.tb01402.x; O'Donnell R, 2006, THORAX, V61, P448, DOI 10.1136/thx.2004.024463; Obenauer JC, 2003, NUCLEIC ACIDS RES, V31, P3635, DOI 10.1093/nar/gkg584; Oyarzo MP, 2006, BLOOD, V107, P2544, DOI 10.1182/blood-2005-06-2601; Ozes ON, 1999, NATURE, V401, P82; Pagliari LJ, 2000, MOL CELL BIOL, V20, P8855, DOI 10.1128/MCB.20.23.8855-8865.2000; Palacios C, 2006, CANCER RES, V66, P8858, DOI 10.1158/0008-5472.CAN-06-0808; Panka DJ, 2001, J BIOL CHEM, V276, P6893, DOI 10.1074/jbc.C000569200; Papa S, 2006, CELL DEATH DIFFER, V13, P712, DOI 10.1038/sj.cdd.4401865; Perlman H, 1999, J EXP MED, V190, P1679, DOI 10.1084/jem.190.11.1679; Perlman H, 2001, ARTHRITIS RHEUM, V44, P21, DOI 10.1002/1529-0131(200101)44:1<21::AID-ANR4>3.0.CO;2-8; Perlman H, 2001, EUR J IMMUNOL, V31, P2421, DOI 10.1002/1521-4141(200108)31:8<2421::AID-IMMU2421>3.0.CO;2-W; Poukkula M, 2005, J BIOL CHEM, V280, P27345, DOI 10.1074/jbc.M504019200; Rasper DM, 1998, CELL DEATH DIFFER, V5, P271, DOI 10.1038/sj.cdd.4400370; Rebe C, 2007, BLOOD, V109, P1442, DOI 10.1182/blood-2006-03-011585; Riendeau CJ, 2003, INFECT IMMUN, V71, P254, DOI 10.1128/IAI.71.1.254-259.2003; Sade H, 2004, J BIOL CHEM, V279, P2937, DOI 10.1074/jbc.M309924200; Scaffidi C, 1999, J BIOL CHEM, V274, P1541, DOI 10.1074/jbc.274.3.1541; Skurk C, 2004, J BIOL CHEM, V279, P1513, DOI 10.1074/jbc.M304736200; Sordet O, 2002, BLOOD, V100, P4446, DOI 10.1182/blood-2002-06-1778; Su H, 2005, SCIENCE, V307, P1465, DOI 10.1126/science.1104765; Suhara T, 2001, CIRC RES, V89, P13, DOI 10.1161/hh1301.092506; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Ueffing N, 2008, BLOOD, V112, P690, DOI 10.1182/blood-2008-02-141382; Uriarte SM, 2005, CELL DEATH DIFFER, V12, P233, DOI 10.1038/sj.cdd.4401549; Valente G, 2006, BRIT J HAEMATOL, V132, P560, DOI 10.1111/j.1365-2141.2005.05898.x; Wajant H, 2003, CELL DEATH DIFFER, V10, P45, DOI 10.1038/sj.cdd.4401189; Woo KJ, 2006, BIOCHEM BIOPH RES CO, V342, P1334, DOI 10.1016/j.bbrc.2006.02.105; Yang BF, 2003, J BIOL CHEM, V278, P7043, DOI 10.1074/jbc.M211278200; Yeh WC, 2000, IMMUNITY, V12, P633, DOI 10.1016/S1074-7613(00)80214-9; Zhang SY, 2005, MOL CANCER THER, V4, P1972, DOI 10.1158/1535-7163.MCT-05-0249	67	17	18	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14513	14523		10.1074/jbc.M807918200	http://dx.doi.org/10.1074/jbc.M807918200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19339247	hybrid, Green Published			2022-12-27	WOS:000266286100058
J	Droppelmann, CA; Gutierrez, J; Vial, C; Brandan, E				Droppelmann, Cristian A.; Gutierrez, Jaime; Vial, Cecilia; Brandan, Enrique			Matrix Metalloproteinase-2-deficient Fibroblasts Exhibit an Alteration in the Fibrotic Response to Connective Tissue Growth Factor/CCN2 because of an Increase in the Levels of Endogenous Fibronectin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR GENE-EXPRESSION; TGF-BETA; SKELETAL-MUSCLE; INTEGRIN ALPHA(V)BETA(3); ADHESION RECEPTOR; RNA EXPRESSION; HUMAN LIVER; FACTOR CCN2; ACTIVATION; INHIBITORS	Matrix metalloproteinase-2 (MMP-2) is an important extracellular matrix remodeling enzyme, and it has been involved in different fibrotic disorders. The connective tissue growth factor (CTGF/CCN2), which is increased in these pathologies, induces the production of extracellular matrix proteins. To understand the fibrotic process observed in diverse pathologies, we analyzed the fibroblast response to CTGF when MMP-2 activity is inhibited. CTGF increased fibronectin (FN) amount, MMP-2 mRNA expression, and gelatinase activity in 3T3 cells. When MMP-2 activity was inhibited either by the metalloproteinase inhibitor GM-6001 or in MMP-2-deficient fibroblasts, an increase in the basal amount of FN together with a decrease of its levels in response to CTGF was observed. This paradoxical effect could be explained by the fact that the excess of FN could block the access to other ligands, such as CTGF, to integrins. This effect was emulated in fibroblasts by adding exogenous FN or RGDS peptides or using anti-integrin alpha(V) subunit-blocking antibodies. Additionally, in MMP-2-deficient cells CTGF did not induce the formation of stress fibers, focal adhesion sites, and ERK phosphorylation. Anti-integrin alpha(V) subunit-blocking antibodies inhibited ERK phosphorylation in control cells. Finally, in MMP-2-deficient cells, FN mRNA expression was not affected by CTGF, but degradation of I-125-FN was increased. These results suggest that expression, regulation, and activity of MMP-2 can play an important role in the initial steps of fibrosis and shows that FN levels can regulate the cellular response to CTGF.	[Droppelmann, Cristian A.; Gutierrez, Jaime; Vial, Cecilia; Brandan, Enrique] Pontificia Univ Catolica Chile, Ctr Regulac Celular & Patol, Ctr Regenerac Envejecimiento, Dept Biol Celular & Mol,Millenium Inst Fundamenta, Santiago, Chile	Pontificia Universidad Catolica de Chile	Brandan, E (corresponding author), Catholic Univ Chile, Dept Cell & Mol Biol, Fac Biol Sci, POB 114-D, Santiago, Chile.	ebrandan@bio.puc.cl	Vial, Maria Cecilia/GVS-4266-2022; Brandan, Enrique/A-7063-2017	Droppelmann, Cristian A./0000-0002-0474-6112; Brandan, Enrique/0000-0002-6820-5059; Vial, Cecilia/0000-0002-0399-6144	Fondo de Financiamiento de Centros de Excelencia en Investigacion (FONDAP-Biomedicine) [13980001]; Center for Aging and Regeneration (CARE) [PFB12/2007]; Muscular Dystrophy Association [89419]; FONDECYT [3060100]; Ministerio de Planificacion y Cooperacion (Chile)	Fondo de Financiamiento de Centros de Excelencia en Investigacion (FONDAP-Biomedicine)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP); Center for Aging and Regeneration (CARE)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT PIA/BASAL); Muscular Dystrophy Association(Muscular Dystrophy Association); FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Ministerio de Planificacion y Cooperacion (Chile)	This work was supported in part by Fondo de Financiamiento de Centros de Excelencia en Investigacion (FONDAP-Biomedicine) Grant 13980001, Center for Aging and Regeneration (CARE) Grant PFB12/2007, Muscular Dystrophy Association Grant 89419, FONDECYT Grant 3060100 (to C. D.), and funds from the Ministerio de Planificacion y Cooperacion (Chile).	Arthur MJP, 2000, AM J PHYSIOL-GASTR L, V279, pG245; Auge N, 2004, CIRCULATION, V110, P571, DOI 10.1161/01.CIR.0000136995.83451.1D; Babic AM, 1999, MOL CELL BIOL, V19, P2958; Balcerzak D, 2001, J ANIM SCI, V79, P94; Benyon RC, 2001, SEMIN LIVER DIS, V21, P373, DOI 10.1055/s-2001-17552; BIRKEDALHANSEN H, 1995, CURR OPIN CELL BIOL, V7, P728, DOI 10.1016/0955-0674(95)80116-2; Brigstock DR, 2003, J ENDOCRINOL, V178, P169, DOI 10.1677/joe.0.1780169; Cabello-Verrugio C, 2007, J BIOL CHEM, V282, P18842, DOI 10.1074/jbc.M700243200; Chen YJ, 2001, EXP CELL RES, V271, P109, DOI 10.1006/excr.2001.5364; Denton CP, 2001, CURR OPIN RHEUMATOL, V13, P505, DOI 10.1097/00002281-200111000-00010; Deryugina EI, 2001, EXP CELL RES, V263, P209, DOI 10.1006/excr.2000.5118; Droguett R, 2006, MATRIX BIOL, V25, P332, DOI 10.1016/j.matbio.2006.04.004; Esparza J, 2004, FASEB J, V18, P1682, DOI 10.1096/fj.04-2445com; Fan WH, 2002, J BIOL CHEM, V277, P9800, DOI 10.1074/jbc.M111213200; Fukushima K, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-54; Gao RP, 2004, J BIOL CHEM, V279, P8848, DOI 10.1074/jbc.M313204200; Garcia-Alvarez J, 2006, SARCOIDOSIS VASC DIF, V23, P13; Giannelli G, 1997, SCIENCE, V277, P225, DOI 10.1126/science.277.5323.225; GRANELLIPIPERNO A, 1978, J EXP MED, V148, P223, DOI 10.1084/jem.148.1.223; Grotendorst Gary R., 1997, Cytokine and Growth Factor Reviews, V8, P171, DOI 10.1016/S1359-6101(97)00010-5; HERBST H, 1991, VIRCHOWS ARCH B, V60, P295, DOI 10.1007/BF02899560; HEUSSEN C, 1980, ANAL BIOCHEM, V102, P196, DOI 10.1016/0003-2697(80)90338-3; Holmes A, 2001, J BIOL CHEM, V276, P10594, DOI 10.1074/jbc.M010149200; Hsu CC, 2007, INT J EXP PATHOL, V88, P437, DOI 10.1111/j.1365-2613.2007.00554.x; IGARASHI A, 1995, J INVEST DERMATOL, V105, P280, DOI 10.1111/1523-1747.ep12318465; Igarashi A, 1996, J INVEST DERMATOL, V106, P729, DOI 10.1111/1523-1747.ep12345771; Ihn H, 2002, CURR OPIN RHEUMATOL, V14, P681, DOI 10.1097/00002281-200211000-00009; Issa R, 2004, GASTROENTEROLOGY, V126, P1795, DOI 10.1053/j.gastro.2004.03.009; Ito Y, 1998, KIDNEY INT, V53, P853, DOI 10.1046/j.1523-1755.1998.00820.x; Jansen PL, 2007, J INVEST DERMATOL, V127, P1762, DOI 10.1038/sj.jid.5700765; Jedsadayanmata A, 1999, J BIOL CHEM, V274, P24321, DOI 10.1074/jbc.274.34.24321; Knittel T, 1999, J HEPATOL, V30, P48, DOI 10.1016/S0168-8278(99)80007-5; Knittel T, 2000, HISTOCHEM CELL BIOL, V113, P443; Kossakowska AE, 1998, AM J PATHOL, V153, P1895, DOI 10.1016/S0002-9440(10)65703-3; Kumar V., 2005, ROBBINS PATHOLOGIC B, V7th ed., P87; Lasky JA, 1998, AM J PHYSIOL-LUNG C, V275, pL365, DOI 10.1152/ajplung.1998.275.2.L365; Leask A, 2004, J INVEST DERMATOL, V122, P1, DOI 10.1046/j.0022-202X.2003.22133.x; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Levi E, 1996, P NATL ACAD SCI USA, V93, P7069, DOI 10.1073/pnas.93.14.7069; Makowski GS, 1996, ANAL BIOCHEM, V236, P353, DOI 10.1006/abio.1996.0179; MATRISIAN LM, 1992, BIOESSAYS, V14, P455, DOI 10.1002/bies.950140705; Mezzano V, 2007, J CELL COMMUN SIGNAL, V1, P205, DOI 10.1007/s12079-008-0018-2; MOULD AP, 1991, J BIOL CHEM, V266, P3579; Murphy G, 1999, APMIS, V107, P38, DOI 10.1111/j.1699-0463.1999.tb01524.x; MURPHY G, 1992, AM J RESP CELL MOL, V7, P120, DOI 10.1165/ajrcmb/7.2.120; Nguyen TQ, 2008, J AM SOC NEPHROL, V19, P2098, DOI 10.1681/ASN.2007111261; Nie QH, 2004, WORLD J GASTROENTERO, V10, P86; Nishida T, 2003, J CELL PHYSIOL, V196, P265, DOI 10.1002/jcp.10277; Oggionni T, 2006, EUR J HISTOCHEM, V50, P317; OVERALL CM, 1989, J BIOL CHEM, V264, P1860; Paradis V, 1999, HEPATOLOGY, V30, P968, DOI 10.1002/hep.510300425; Perbal B, 2004, LANCET, V363, P62, DOI 10.1016/S0140-6736(03)15172-0; PIERSCHBACHER MD, 1984, NATURE, V309, P30, DOI 10.1038/309030a0; Plow EF, 2000, J BIOL CHEM, V275, P21785, DOI 10.1074/jbc.R000003200; Rajendran R, 2006, Indian J Dent Res, V17, P161; Ratnikov B, 2000, ANAL BIOCHEM, V286, P149, DOI 10.1006/abio.2000.4798; ROBERTS AB, 1992, KIDNEY INT, V41, P557, DOI 10.1038/ki.1992.81; Roestenberg P, 2004, DIABETES CARE, V27, P1164, DOI 10.2337/diacare.27.5.1164; Sakamoto Y, 2006, J BIOL CHEM, V281, P19631, DOI 10.1074/jbc.M600301200; SANCHEZAPARICIO P, 1994, J CELL BIOL, V126, P271, DOI 10.1083/jcb.126.1.271; Schober JM, 2002, BLOOD, V99, P4457, DOI 10.1182/blood.V99.12.4457; Segarini PR, 2001, J BIOL CHEM, V276, P40659, DOI 10.1074/jbc.M105180200; Shyy JYJ, 1997, CURR OPIN CELL BIOL, V9, P707, DOI 10.1016/S0955-0674(97)80125-1; STEDMAN HH, 1991, NATURE, V352, P536, DOI 10.1038/352536a0; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; STRONGIN AY, 1995, J BIOL CHEM, V270, P5331, DOI 10.1074/jbc.270.10.5331; Sun G, 2008, J NEUROL SCI, V267, P48, DOI 10.1016/j.jns.2007.09.043; Vial C, 2008, J CELL PHYSIOL, V215, P410, DOI 10.1002/jcp.21324; WAYNER EA, 1989, J CELL BIOL, V109, P1321, DOI 10.1083/jcb.109.3.1321; Werb Z, 1997, CELL, V91, P439, DOI 10.1016/S0092-8674(00)80429-8; Werbajh SE, 1998, FEBS LETT, V440, P277, DOI 10.1016/S0014-5793(98)01473-2; Williams EJ, 2000, J HEPATOL, V32, P754, DOI 10.1016/S0168-8278(00)80244-5; Yang M, 2007, WOUND REPAIR REGEN, V15, P817, DOI 10.1111/j.1524-475X.2007.00284.x; Yu Q, 2000, GENE DEV, V14, P163; Zanotti S, 2007, MATRIX BIOL, V26, P615, DOI 10.1016/j.matbio.2007.06.004	75	29	30	1	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13551	13561		10.1074/jbc.M807352200	http://dx.doi.org/10.1074/jbc.M807352200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19276073	Green Published, hybrid			2022-12-27	WOS:000265877300032
J	Sundararaj, KP; Samuvel, DJ; Li, YC; Sanders, JJ; Lopes-Virella, MF; Huang, Y				Sundararaj, Kamala P.; Samuvel, Devadoss J.; Li, Yanchun; Sanders, John J.; Lopes-Virella, Maria F.; Huang, Yan			Interleukin-6 Released from Fibroblasts Is Essential for Up-regulation of Matrix Metalloproteinase-1 Expression by U937 Macrophages in Coculture CROSS-TALKING BETWEEN FIBROBLASTS AND U937 MACROPHAGES EXPOSED TO HIGH GLUCOSE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PERIODONTAL-DISEASE; TISSUE INHIBITOR; GENE-EXPRESSION; KAPPA-B; COLLAGENASE; INVOLVEMENT; ACTIVATION; MONOCYTES; TIMP-1; KINASE	Matrix metalloproteinases (MMPs) play a key role in periodontal disease. Although it is known that macrophages and fibroblasts are co-localized and express MMPs in the diseased periodontal tissue, the effect of interaction between these two cell types on MMP expression has not been well elucidated. Furthermore although it is known that diabetes is associated with accelerated periodontal tissue destruction, it remains unknown whether hyperglycemia, a major metabolic abnormality in diabetes, regulates MMP expression by affecting the cross-talking between fibroblasts and macrophages. In this study, human gingival fibroblasts and U937 macrophages were cocultured in a two-compartment transwell culture system, and the cells were treated with normal or high glucose. We found that coculture of fibroblasts and U937 macrophages led to an augmentation of MMP-1 expression by U937 macrophages, and high glucose further enhanced this augmentation. Similar observations were also made in the coculture of fibroblasts and human primary monocytes. We also found that interleukin 6 (IL-6) released by fibroblasts was essential for the augmentation of MMP-1 expression by U937 macrophages. Furthermore our results showed that high glucose, IL-6, and lipopolysaccharide had a synergistic effect on MMP-1 expression. Finally our study indicated that MAPK pathways and activator protein-1 transcription factor were involved in the coculture- and high glucose-augmented MMP-1 expression. In conclusion, this study demonstrates that IL-6 derived from fibroblasts is essential for MMP-1 up-regulation by cross-talking between fibroblasts and U937 macrophages exposed to high glucose, revealing an IL-6-dependent mechanism in MMP-1 up-regulation.	[Li, Yanchun; Lopes-Virella, Maria F.; Huang, Yan] Med Univ S Carolina, Dept Med, Div Endocrinol Diabet & Med Genet, Charleston, SC 29403 USA; [Sundararaj, Kamala P.; Samuvel, Devadoss J.; Lopes-Virella, Maria F.; Huang, Yan] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29403 USA; [Sanders, John J.] Med Univ S Carolina, Coll Dent Med, Dept Stomatol, Charleston, SC 29403 USA	Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; Medical University of South Carolina	Huang, Y (corresponding author), Med Univ S Carolina, Dept Med, Div Endocrinol Diabet & Med Genet, 114 Doughty St, Charleston, SC 29403 USA.	huangyan@musc.edu	li, yan/GTI-4638-2022		National Institutes of Health [DE16353]; Department of Veterans Affairs; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE016353] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported, in whole or in part, by National Institutes of Health Grant DE16353 (to Y. H.). This work was also supported by a merit review grant from the Department of Veterans Affairs (to Y. H.).	Aho S, 1997, EUR J BIOCHEM, V247, P503, DOI 10.1111/j.1432-1033.1997.00503.x; Aiba T, 1996, EUR J ORAL SCI, V104, P562, DOI 10.1111/j.1600-0722.1996.tb00142.x; ANGEL P, 1987, MOL CELL BIOL, V7, P2256, DOI 10.1128/MCB.7.6.2256; Cole CM, 2008, J PERIODONTAL RES, V43, P717, DOI 10.1111/j.1600-0765.2008.01082.x; Danciger JS, 2004, J IMMUNOL METHODS, V288, P123, DOI 10.1016/j.jim.2004.03.003; de Souza AP, 2003, J CLIN PERIODONTOL, V30, P154, DOI 10.1034/j.1600-051X.2003.300202.x; Dennison DK, 1997, PERIODONTOL 2000, V14, P54, DOI 10.1111/j.1600-0757.1997.tb00192.x; DIGIROLAMO M, 1992, FASEB J, V6, P2405, DOI 10.1096/fasebj.6.7.1563593; Domeij H, 2005, BIOCHEM BIOPH RES CO, V338, P1825, DOI 10.1016/j.bbrc.2005.10.137; Ejeil AL, 2003, J PERIODONTOL, V74, P188, DOI 10.1902/jop.2003.74.2.188; Hou LT, 2003, J PERIODONTAL RES, V38, P247, DOI 10.1034/j.1600-0765.2003.02601.x; HUYBRECHTSGODIN G, 1979, BIOCHEM J, V184, P643, DOI 10.1042/bj1840643; Irwin CR, 2002, J PERIODONTOL, V73, P741, DOI 10.1902/jop.2002.73.7.741; Kim S, 2003, J PHARMACOL SCI, V91, P177; Kishimoto T, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1916; Kristiansen OP, 2005, DIABETES, V54, pS114, DOI 10.2337/diabetes.54.suppl_2.S114; Kumar MS, 2006, J PERIODONTOL, V77, P1803, DOI 10.1902/jop.2006.050293; Legendre F, 2005, J RHEUMATOL, V32, P1307; Maldonado A, 2004, J PERIODONTAL RES, V39, P415, DOI 10.1111/j.1600-0765.2004.00756.x; Mealey B, 1999, J PERIODONTOL, V70, P935; Nareika A, 2005, AM J PHYSIOL-ENDOC M, V289, pE534, DOI 10.1152/ajpendo.00462.2004; Nareika A, 2008, J ENDOCRINOL, V196, P45, DOI 10.1677/JOE-07-0145; Offenbacher S, 1996, Ann Periodontol, V1, P821, DOI 10.1902/annals.1996.1.1.821; PETROVICH I, 1983, VOP PITANIYA, V5, P28; Reynolds J J, 1996, Oral Dis, V2, P70; RIFKIN BR, 1993, J PERIODONTOL, V64, P819, DOI 10.1902/jop.1993.64.8s.819; Romanelli R, 1999, INFECT IMMUN, V67, P2319, DOI 10.1128/IAI.67.5.2319-2326.1999; RUTTER GA, 1995, CURR BIOL, V5, P890, DOI 10.1016/S0960-9822(95)00179-5; Ryan ME, 2000, PERIODONTOL 2000, V24, P226, DOI 10.1034/j.1600-0757.2000.2240111.x; Skaleric U, 2006, INFECT IMMUN, V74, P7010, DOI 10.1128/IAI.00071-06; SOCRANSKY SS, 1991, J PERIODONTAL RES, V26, P195, DOI 10.1111/j.1600-0765.1991.tb01646.x; SUNDSTROM C, 1976, INT J CANCER, V17, P565, DOI 10.1002/ijc.2910170504; Tuter G, 2002, J PERIODONTOL, V73, P487, DOI 10.1902/jop.2002.73.5.487; WOESSNER JF, 1991, FASEB J, V5, P2145, DOI 10.1096/fasebj.5.8.1850705; Yu CY, 2002, ONCOGENE, V21, P3949, DOI 10.1038/sj.onc.1205499	35	68	68	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13714	13724		10.1074/jbc.M806573200	http://dx.doi.org/10.1074/jbc.M806573200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19307187	hybrid, Green Published			2022-12-27	WOS:000265877300049
J	Lyu, J; Wesselschmidt, RL; Lu, WG				Lyu, Jungmook; Wesselschmidt, Robin L.; Lu, Wange			Cdc37 Regulates Ryk Signaling by Stabilizing the Cleaved Ryk Intracellular Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							WNT RECEPTOR RYK; GAMMA-SECRETASE; AXON GUIDANCE; HSP90; DIFFERENTIATION; P50(CDC37); PROTEASOME; EXPRESSION; BINDING; GROWTH	Ryk is a Wnt receptor that plays an important role in neurogenesis, neurite outgrowth, and axon guidance. We have reported that the Ryk receptor is cleaved by gamma-secretase and that its intracellular domain (ICD) translocates to the nucleus upon Wnt stimulation. Cleavage of Ryk and its ICD is important for the function of Ryk in neurogenesis. However, the question of how the Ryk ICD is stabilized and translocated into the nucleus remains unanswered. Here, we show that the Ryk ICD undergoes ubiquitination and proteasomal degradation. We have identified Cdc37, a subunit of the molecular chaperone Hsp90 complex, as a Ryk ICD-interacting protein that inhibits proteasomal degradation of the Ryk ICD. Overexpression of Cdc37 increases Ryk ICD levels and promotes its nuclear localization, whereas Cdc37 knockdown reduces Ryk ICD stability. Furthermore, we have discovered that the Cdc37-Ryk ICD complex is disrupted during neural differentiation of embryonic stem cells, resulting in Ryk ICD degradation. These results suggest that Cdc37 plays an essential role in regulating Ryk ICD stability and therefore in Ryk-mediated signal transduction.	[Lyu, Jungmook; Lu, Wange] Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, Los Angeles, CA 90033 USA; [Lyu, Jungmook; Wesselschmidt, Robin L.; Lu, Wange] Univ So Calif, Keck Sch Med, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Los Angeles, CA 90033 USA	University of Southern California; University of Southern California	Lu, WG (corresponding author), Univ So Calif, Keck Sch Med, Dept Biochem & Mol Biol, 1501 San Pablo St,ZNI 523, Los Angeles, CA 90033 USA.				Korea Research Foundation [KRF-2006-214-C00076]; California Institute for Regenerative Medicine	Korea Research Foundation(National Research Foundation of Korea); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine)	Supported by Korea Research Foundation Award KRF-2006-214-C00076 and a fellowship from the California Institute for Regenerative Medicine.	Brown MS, 2000, CELL, V100, P391, DOI 10.1016/S0092-8674(00)80675-3; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Fang JM, 2005, NAT BIOTECHNOL, V23, P584, DOI 10.1038/nbt1087; Grammatikakis N, 1999, MOL CELL BIOL, V19, P1661; Grbovic OM, 2006, P NATL ACAD SCI USA, V103, P57, DOI 10.1073/pnas.0609973103; Green JL, 2008, CELL, V134, P646, DOI 10.1016/j.cell.2008.06.026; Halford MM, 2001, BIOESSAYS, V23, P34, DOI 10.1002/1521-1878(200101)23:1<34::AID-BIES1005>3.3.CO;2-4; Halford MM, 2000, NAT GENET, V25, P414, DOI 10.1038/78099; Harris KE, 2007, DEVELOPMENT, V134, P2017, DOI 10.1242/dev.001164; Hunter T, 1997, TRENDS CELL BIOL, V7, P157, DOI 10.1016/S0962-8924(97)01027-1; Katso RM, 1999, MOL CELL BIOL, V19, P6427; Keeble TR, 2006, J NEUROSCI, V26, P5840, DOI 10.1523/JNEUROSCI.1175-06.2006; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Liu YB, 2005, NAT NEUROSCI, V8, P1151, DOI 10.1038/nn1520; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Lu WG, 2004, CELL, V119, P97, DOI 10.1016/j.cell.2004.09.019; Lyu J, 2008, DEV CELL, V15, P773, DOI 10.1016/j.devcel.2008.10.004; MacLean M, 2003, CELL STRESS CHAPERON, V8, P114, DOI 10.1379/1466-1268(2003)008<0114:CGBHAK>2.0.CO;2; Millar JBA, 2002, GENOME BIOL, V3; Moon RT, 2002, SCIENCE, V296, P1644, DOI 10.1126/science.1071549; Ni CY, 2001, SCIENCE, V294, P2179, DOI 10.1126/science.1065412; NICHOLS J, 1990, DEVELOPMENT, V110, P1341; Patthy L, 2000, TRENDS BIOCHEM SCI, V25, P12, DOI 10.1016/S0968-0004(99)01504-2; Prince T, 2004, J BIOL CHEM, V279, P39975, DOI 10.1074/jbc.M406882200; Sardi SP, 2006, CELL, V127, P185, DOI 10.1016/j.cell.2006.07.037; Schmitt AM, 2006, NATURE, V439, P31, DOI 10.1038/nature04334; Scholz G, 2000, MOL CELL BIOL, V20, P6984, DOI 10.1128/MCB.20.18.6984-6995.2000; SCHULTE TW, 1995, J BIOL CHEM, V270, P24585, DOI 10.1074/jbc.270.41.24585; Stepanova L, 1996, GENE DEV, V10, P1491, DOI 10.1101/gad.10.12.1491; Terasawa K, 2006, MOL CELL BIOL, V26, P3378, DOI 10.1128/MCB.26.9.3378-3389.2006; Terasawa K, 2005, FEBS J, V272, P4684, DOI 10.1111/j.1742-4658.2005.04884.x; Urlinger S, 2000, P NATL ACAD SCI USA, V97, P7963, DOI 10.1073/pnas.130192197; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Wang HM, 2002, EMBO J, V21, P930, DOI 10.1093/emboj/21.5.930; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Ying QL, 2003, CELL, V115, P281, DOI 10.1016/S0092-8674(03)00847-X; Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522	38	20	20	0	7	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12940	12948		10.1074/jbc.M900207200	http://dx.doi.org/10.1074/jbc.M900207200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19269974	hybrid, Green Published			2022-12-27	WOS:000265688300040
J	Maddika, S; Sy, SMH; Chen, JJ				Maddika, Subbareddy; Sy, Shirley M. -H.; Chen, Junjie			Functional Interaction between Chfr and Kif22 Controls Genomic Stability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOTIC CHECKPOINT PROTEIN; CHROMOKINESIN KID; CHROMOSOME ALIGNMENT; METAPHASE; SPINDLE; LIGASE; DOMAIN; ENTRY; XKID	Proper activation of checkpoint during mitotic stress is an important mechanism to prevent genomic instability. Chfr (Check point protein with FHA (Forkhead-associated domain) and RING domains) is a ubiquitin-protein isopeptide ligase (E3) that is important for the control of an early mitotic checkpoint, which delays entry into metaphase in response to mitotic stress. Because several lines of evidence indicate that Chfr is a potential tumor suppressor, it is critically important for us to identify Chfr substrates and understand how Chfr may regulate these substrates, control mitotic transitions, and thus, act as a tumor suppressor in vivo. Here, we report the discovery of a new Chfr-associated protein Kif22, a chromokinesin that binds to both DNA and microtubules. We demonstrated that Kif22 is a novel substrate of Chfr. We showed that Chfr-mediated Kif22 down-regulation is critical for the maintenance of chromosome stability. Collectively, our results reveal a new substrate of Chfr that plays a role in the maintenance of genome integrity.	[Maddika, Subbareddy; Sy, Shirley M. -H.; Chen, Junjie] Yale Univ, Sch Med, Dept Therapeut Radiol, New Haven, CT 06520 USA	Yale University	Chen, JJ (corresponding author), Yale Univ, Sch Med, Dept Therapeut Radiol, POB 208040, New Haven, CT 06520 USA.	Junjie.chen@yale.edu		Sy, Ming Hui/0000-0002-2731-6692	National Institutes of Health [CA113381]; NATIONAL CANCER INSTITUTE [R01CA113381] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant CA113381 (to J.C).	Ahel I, 2008, NATURE, V451, P81, DOI 10.1038/nature06420; Antonio C, 2000, CELL, V102, P425, DOI 10.1016/S0092-8674(00)00048-9; Bothos J, 2003, ONCOGENE, V22, P7101, DOI 10.1038/sj.onc.1206831; Chaturvedi P, 2002, CANCER RES, V62, P1797; Daniels MJ, 2004, NAT STRUCT MOL BIOL, V11, P1114, DOI 10.1038/nsmb837; Durocher D, 1999, MOL CELL, V4, P387, DOI 10.1016/S1097-2765(00)80340-8; Funabiki H, 2000, CELL, V102, P411, DOI 10.1016/S0092-8674(00)00047-7; Kang DM, 2002, J CELL BIOL, V156, P249, DOI 10.1083/jcb.200108016; Levesque AA, 2001, J CELL BIOL, V154, P1135, DOI 10.1083/jcb.200106093; Matsusaka T, 2004, J CELL BIOL, V166, P507, DOI 10.1083/jcb.200401139; Privette LM, 2008, TRANSL ONCOL, V1, P57, DOI 10.1593/tlo.08109; Scolnick DM, 2000, NATURE, V406, P430, DOI 10.1038/35019108; Summers MK, 2005, ONCOGENE, V24, P2589, DOI 10.1038/sj.onc.1208428; Tokai N, 1996, EMBO J, V15, P457, DOI 10.1002/j.1460-2075.1996.tb00378.x; Tokai-Nishizumi N, 2005, MOL BIOL CELL, V16, P5455, DOI 10.1091/mbc.E05-03-0244; Toyota M, 2003, P NATL ACAD SCI USA, V100, P7818, DOI 10.1073/pnas.1337066100; Yajima J, 2003, EMBO J, V22, P1067, DOI 10.1093/emboj/cdg102; Yu XC, 2005, NAT GENET, V37, P401, DOI 10.1038/ng1538	18	21	22	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12998	13003		10.1074/jbc.M900333200	http://dx.doi.org/10.1074/jbc.M900333200			6	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19321445	Green Published, hybrid			2022-12-27	WOS:000265688300047
J	Su, DM; Zhu, S; Han, XF; Feng, YP; Huang, H; Ren, GL; Pan, LA; Zhang, Y; Lu, J; Huang, B				Su, Dongmei; Zhu, Shan; Han, Xuefang; Feng, Yunpeng; Huang, Hui; Ren, Guoling; Pan, Lina; Zhang, Yu; Lu, Jun; Huang, Baiqu			BMP4-Smad Signaling Pathway Mediates Adriamycin-induced Premature Senescence in Lung Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BONE MORPHOGENETIC PROTEIN; TUMOR-CELLS; CARCINOMA-CELLS; IN-VIVO; CELLULAR SENESCENCE; ENDOTHELIAL-CELLS; FUNCTIONAL P53; GROWTH ARREST; EXPRESSION; SUPPRESSION	Cell senescence, an irreversible cell cycle arrest, reflects a safeguard program that limits the capacity of uncontrolled cell proliferation. Treatment of tumor cells with certain chemotherapeutic agents activates premature senescence to decrease the tumorigenecity. Here we show that sublethal concentrations of adriamycin could induce premature senescence in lung cancer cells. Adriamycin treatment resulted in the up-regulation of BMP4,which is underexpressed in NSCLC (non-small cell lung cancers). Moreover, the BMP4-Smad pathway played a key role in mediating adriamycin-induced senescence. Overexpression of BMP4 was able to induce premature senescence in lung cancer cells and this process required the participation of cyclin/cyclin-dependent kinase (cdk) inhibitors p16(INK4a) and p21(WAF1/cip1). We also show that increases of p16(INK4a) and p21(WAF1/cip1) expression in response to BMP4 were mediated by the Smad signaling pathway. Furthermore, our data revealed that p300 was recruited to P16(INK4a) and P21(WAF1/cip1) promoters by Smad1/5/8 to induce the hyperacetylation of histones H3 and H4 at the promoters. The present study provides useful clues to the evaluation of the potentiality of BMP4 as a responsive molecular target for cancer chemotherapy.	[Su, Dongmei; Feng, Yunpeng; Ren, Guoling; Zhang, Yu; Huang, Baiqu] NE Normal Univ, Inst Cytol & Genet, Changchun 130024, Peoples R China; [Zhu, Shan; Han, Xuefang; Huang, Hui; Pan, Lina; Lu, Jun] NE Normal Univ, Minist Educ, Key Lab Mol Epigenet, Changchun 130024, Peoples R China	Northeast Normal University - China; Northeast Normal University - China	Huang, B (corresponding author), 5268 Renmin St, Changchun 130024, Peoples R China.	huangbq705@nenu.edu.cn		Feng, Yunpeng/0000-0002-6912-3338	National Basic Research Program of China [2005CB522404, 2006CB910506]; The Program for Changjiang Scholars and Innovative Research Team (PCSIRT) in Universities [IRT0519]; National Natural Science Foundation of China [30771232, 30671184]	National Basic Research Program of China(National Basic Research Program of China); The Program for Changjiang Scholars and Innovative Research Team (PCSIRT) in Universities(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Basic Research Program of China Grants 2005CB522404 and 2006CB910506, The Program for Changjiang Scholars and Innovative Research Team (PCSIRT) in Universities (IRT0519), and National Natural Science Foundation of China Grants 30771232 and 30671184.	Beck SE, 2006, AM J PHYSIOL-GASTR L, V291, pG135, DOI 10.1152/ajpgi.00482.2005; Buckley S, 2004, AM J PHYSIOL-LUNG C, V286, pL81, DOI 10.1152/ajplung.00160.2003; Cammarano MS, 2005, MOL CELL BIOL, V25, P9532, DOI 10.1128/MCB.25.21.9532-9542.2005; Chen J, 2006, AM J PHYSIOL-HEART C, V290, pH1575, DOI 10.1152/ajpheart.00364.2005; Deng QD, 2005, CANCER RES, V65, P8298, DOI 10.1158/0008-5472.CAN-05-0054; Ding B, 2007, J CELL SCI, V120, P2284, DOI 10.1242/jcs.002345; Elmore LW, 2002, J BIOL CHEM, V277, P35509, DOI 10.1074/jbc.M205477200; Ghebranious N, 1998, ONCOGENE, V17, P3385, DOI 10.1038/sj.onc.1202573; Halbrooks Peter J, 2007, J Mol Signal, V2, P4, DOI 10.1186/1750-2187-2-4; Hanyu A, 2001, J CELL BIOL, V155, P1017, DOI 10.1083/jcb.200106023; Hata A, 1998, GENE DEV, V12, P186, DOI 10.1101/gad.12.2.186; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; Huang WF, 2006, BIOCHEM BIOPH RES CO, V339, P165, DOI 10.1016/j.bbrc.2005.11.010; Ishisaki A, 1999, J BIOL CHEM, V274, P13637, DOI 10.1074/jbc.274.19.13637; Jackson JG, 2006, MOL CELL BIOL, V26, P2501, DOI 10.1128/MCB.26.7.2501-2510.2006; Katakura Y, 1999, BIOCHEM BIOPH RES CO, V255, P110, DOI 10.1006/bbrc.1999.0129; Katakura Y, 2003, BIOSCI BIOTECH BIOCH, V67, P815, DOI 10.1271/bbb.67.815; Langenfeld EM, 2005, ANN THORAC SURG, V80, P1028, DOI 10.1016/j.athoracsur.2005.03.094; Massague J, 2000, EMBO J, V19, P1745, DOI 10.1093/emboj/19.8.1745; Miyazaki H, 2004, ONCOGENE, V23, P9326, DOI 10.1038/sj.onc.1208127; Miyazono K, 2005, CYTOKINE GROWTH F R, V16, P251, DOI 10.1016/j.cytogfr.2005.01.009; Miyazono K, 2000, ADV IMMUNOL, V75, P115, DOI 10.1016/S0065-2776(00)75003-6; NODA A, 1994, EXP CELL RES, V211, P90, DOI 10.1006/excr.1994.1063; Park C, 2006, MOL CANCER THER, V5, P3191, DOI 10.1158/1535-7163.MCT-06-0570; Pouliot F, 2002, J ENDOCRINOL, V172, P187, DOI 10.1677/joe.0.1720187; Rao A, 2004, CANCER RES, V64, P2143, DOI 10.1158/0008-5472.CAN-03-3480; Roberson RS, 2005, CANCER RES, V65, P2795, DOI 10.1158/0008-5472.CAN-04-1270; Schmitt CA, 2007, BBA-REV CANCER, V1775, P5, DOI 10.1016/j.bbcan.2006.08.005; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Sorescu GP, 2004, CIRC RES, V95, P773, DOI 10.1161/01.RES.0000145728.22878.45; Sugrue MM, 1997, P NATL ACAD SCI USA, V94, P9648, DOI 10.1073/pnas.94.18.9648; te Poele RH, 2002, CANCER RES, V62, P1876; ten Dijke P, 2003, MOL CELL ENDOCRINOL, V211, P105, DOI 10.1016/j.mce.2003.09.016; Trost TM, 2005, CANCER RES, V65, P840; Vance KW, 2005, CANCER RES, V65, P2260, DOI 10.1158/0008-5472.CAN-04-3045; von Bubnoff A, 2001, DEV BIOL, V239, P1, DOI 10.1006/dbio.2001.0388; Voorhoeve PM, 2003, CANCER CELL, V4, P311, DOI 10.1016/S1535-6108(03)00223-X; Wang X, 2008, ONCOGENE, V27, P1894, DOI 10.1038/sj.onc.1210821; Wang YC, 1999, ONCOGENE, V18, P2643, DOI 10.1038/sj.onc.1202632; Xu HJ, 1997, ONCOGENE, V15, P2589, DOI 10.1038/sj.onc.1201446; Zhang XW, 2006, MOL CELL BIOL, V26, P8252, DOI 10.1128/MCB.00604-06; Zwijsen A, 2003, FEBS LETT, V546, P133, DOI 10.1016/S0014-5793(03)00566-0	42	45	53	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12153	12164		10.1074/jbc.M807930200	http://dx.doi.org/10.1074/jbc.M807930200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19269967	Green Published, hybrid			2022-12-27	WOS:000265494600047
J	Claggett, SB; Plancher, M; Dunn, SD; Cain, BD				Claggett, Shane B.; Plancher, Mac O'Neil; Dunn, Stanley D.; Cain, Brian D.			The b Subunits in the Peripheral Stalk of F1F0 ATP Synthase Preferentially Adopt an Offset Relationship	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ESCHERICHIA-COLI F1F0-ATPASE; DIMERIZATION DOMAIN; STATOR STALK; 2ND STALK; F0F1-ATP SYNTHASE; DIMER; F-1; F-1-ATPASE; RESOLUTION; ACID	The peripheral stalk of F1F0 ATP synthase is essential for the binding of F-1 to F-0 and for proper transfer of energy between the two sectors of the enzyme. The peripheral stalk of Escherichia coli is composed of a dimer of identical b subunits. In contrast, photosynthetic organisms express two b-like genes that form a heterodimeric peripheral stalk. Previously we generated chimeric peripheral stalks in which a portion of the tether and dimerization domains of the E. coli b subunits were replaced with homologous sequences from the b and b' subunits of Thermosynechococcus elongatus (Claggett, S. B., Grabar, T. B., Dunn, S. D., and Cain, B. D. (2007) J. Bacteriol. 189, 5463-5471). The spatial arrangement of the chimeric b and b' subunits, abbreviated Tb and Tb', has been investigated by Cu2+-mediated disulfide cross-link formation. Disulfide formation was studied both in soluble model polypeptides and between full-length subunits within intact functional F1F0 ATP synthase complexes. In both cases, disulfides were preferentially formed between Tb-A83C and Tb'(A90C), indicating the existence of a staggered relationship between helices of the two chimeric subunits. Even under stringent conditions rapid formation of disulfides between these positions occurred. Importantly, formation of this cross-link had no detectable effect on ATP-driven proton pumping, indicating that the staggered conformation is compatible with normal enzymatic activity. Under less stringent reaction conditions, it was also possible to detect b subunits cross-linked through identical positions, suggesting that an in-register, non-staggered parallel conformation may also exist.	[Claggett, Shane B.; Plancher, Mac O'Neil; Cain, Brian D.] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32605 USA; [Dunn, Stanley D.] Univ Western Ontario, Dept Biochem, London, ON N6A 5C1, Canada	State University System of Florida; University of Florida; Western University (University of Western Ontario)	Cain, BD (corresponding author), Univ Florida, Dept Biochem & Mol Biol, Box 100245, Gainesville, FL 32610 USA.	bcain@biochem.med.ufl.edu	Dunn, Stanley/D-3418-2013		United States Public Health Service [GM70978]; University of Florida; Canadian Institutes of Health [MOP-10237]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070978] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); University of Florida(University of Florida); Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by United States Public Health Service Grant GM70978 (to B. D. C.), a University of Florida Alumni Fellowship (to S. B. C.), and Canadian Institutes of Health Grant MOP-10237 (to S. D. D.).	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; Caviston TL, 1998, FEBS LETT, V429, P201, DOI 10.1016/S0014-5793(98)00597-3; Claggett SB, 2007, J BACTERIOL, V189, P5463, DOI 10.1128/JB.00191-07; Del Rizzo PA, 2002, BIOCHEMISTRY-US, V41, P6875, DOI 10.1021/bi025736i; Del Rizzo PA, 2006, J MOL BIOL, V364, P735, DOI 10.1016/j.jmb.2006.09.028; Devenish RJ, 2008, INT REV CEL MOL BIO, V267, P1, DOI 10.1016/S1937-6448(08)00601-1; Dimroth P, 2006, EMBO REP, V7, P276, DOI 10.1038/sj.embor.7400646; Dmitriev O, 1999, J BIOL CHEM, V274, P15598, DOI 10.1074/jbc.274.22.15598; Dunn SD, 1998, J BIOL CHEM, V273, P8646, DOI 10.1074/jbc.273.15.8646; Dykxhoorn DM, 1996, GENE, V177, P133, DOI 10.1016/0378-1119(96)00289-2; Gardner JL, 1999, ARCH BIOCHEM BIOPHYS, V361, P302, DOI 10.1006/abbi.1998.0995; Grabar TB, 2004, J BIOL CHEM, V279, P31205, DOI 10.1074/jbc.M404420200; Grabar TB, 2003, J BIOL CHEM, V278, P34751, DOI 10.1074/jbc.M303361200; Hornung T, 2008, BIOPHYS J, V94, P5053, DOI 10.1529/biophysj.107.121038; MCCORMICK KA, 1991, J BACTERIOL, V173, P7240, DOI 10.1128/jb.173.22.7240-7248.1991; McLachlin DT, 1997, J BIOL CHEM, V272, P21233, DOI 10.1074/jbc.272.34.21233; MESELSON M, 1968, NATURE, V217, P1110, DOI 10.1038/2171110a0; Nakamoto RK, 2008, ARCH BIOCHEM BIOPHYS, V476, P43, DOI 10.1016/j.abb.2008.05.004; Priya R, 2008, J BIOENERG BIOMEMBR, V40, P245, DOI 10.1007/s10863-008-9154-x; Revington M, 1999, J BIOL CHEM, V274, P31094, DOI 10.1074/jbc.274.43.31094; Rodgers AJW, 1997, J BIOL CHEM, V272, P31058, DOI 10.1074/jbc.272.49.31058; Rodgers AJW, 1998, J BIOL CHEM, V273, P29406, DOI 10.1074/jbc.273.45.29406; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Sorgen PL, 1998, BIOCHEMISTRY-US, V37, P923, DOI 10.1021/bi972309+; Sorgen PL, 1998, J BIOL CHEM, V273, P27873, DOI 10.1074/jbc.273.43.27873; Steigmiller S, 2005, BBA-BIOENERGETICS, V1708, P143, DOI 10.1016/j.bbabio.2005.03.013; von Ballmoos C, 2008, ANNU REV BIOPHYS, V37, P43, DOI 10.1146/annurev.biophys.37.032807.130018; Walker JE, 2006, BBA-BIOENERGETICS, V1757, P286, DOI 10.1016/j.bbabio.2006.01.001; WEBB MR, 1992, P NATL ACAD SCI USA, V89, P4884, DOI 10.1073/pnas.89.11.4884; Weber J, 2007, TRENDS BIOCHEM SCI, V32, P53, DOI 10.1016/j.tibs.2006.12.006; Weber J, 2006, BBA-BIOENERGETICS, V1757, P1162, DOI 10.1016/j.bbabio.2006.04.007; Wise JG, 2008, BIOPHYS J, V94, P5040, DOI 10.1529/biophysj.107.121012; Wood KS, 2007, J BIOL CHEM, V282, P31920, DOI 10.1074/jbc.M706259200; Zaida TM, 2008, J BIOENERG BIOMEMBR, V40, P551, DOI 10.1007/s10863-008-9189-z	34	13	13	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16531	16540		10.1074/jbc.M109.002980	http://dx.doi.org/10.1074/jbc.M109.002980			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19369253	hybrid, Green Published			2022-12-27	WOS:000266730900050
J	Nickerson, JG; Alkhateeb, H; Benton, CR; Lally, J; Nickerson, J; Han, XX; Wilson, MH; Jain, SS; Snook, LA; Glatz, JFC; Chabowski, A; Luiken, JJFP; Bonen, A				Nickerson, James G.; Alkhateeb, Hakam; Benton, Carley R.; Lally, James; Nickerson, Jennifer; Han, Xiao-Xia; Wilson, Meredith H.; Jain, Swati S.; Snook, Laelie A.; Glatz, Jan F. C.; Chabowski, Adrian; Luiken, Joost J. F. P.; Bonen, Arend			Greater Transport Efficiencies of the Membrane Fatty Acid Transporters FAT/CD36 and FATP4 Compared with FABPpm and FATP1 and Differential Effects on Fatty Acid Esterification and Oxidation in Rat Skeletal Muscle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED INSULIN-RESISTANCE; STIMULATED GLUCOSE-UPTAKE; IN-VIVO; TRIACYLGLYCEROL STORAGE; CARDIAC MYOCYTES; CELLULAR UPTAKE; EXPRESSION; PROTEIN; METABOLISM; PALMITATE	In selected mammalian tissues, long chain fatty acid transporters (FABPpm, FAT/CD36, FATP1, and FATP4) are co-expressed. There is controversy as to whether they all function as membrane-bound transporters and whether they channel fatty acids to oxidation and/or esterification. Among skeletal muscles, the protein expression of FABPpm, FAT/CD36, and FATP4, but not FATP1, correlated highly with the capacities for oxidative metabolism (r >= 0.94), fatty acid oxidation (r >= 0.88), and triacylglycerol esterification (r >= 0.87). We overexpressed independently FABPpm, FAT/CD36, FATP1, and FATP4, within a normal physiologic range, in rat skeletal muscle, to determine the effects on fatty acid transport and metabolism. Independent overexpression of each fatty acid transporter occurred without altering either the expression or plasmalemmal content of other fatty acid transporters. All transporters increased fatty acid transport, but FAT/CD36 and FATP4 were 2.3-and 1.7-fold more effective than FABPpm and FATP1, respectively. Fatty acid transporters failed to alter the rates of fatty acid esterification into triacylglycerols. In contrast, all transporters increased the rates of long chain fatty acid oxidation, but the effects of FABPpm and FAT/CD36 were 3-fold greater than for FATP1 and FATP4. Thus, fatty acid transporters exhibit different capacities for fatty acid transport and metabolism. In vivo, FAT/CD36 and FATP4 are the most effective fatty acid transporters, whereas FABPpm and FAT/CD36 are key for stimulating fatty acid oxidation.	[Nickerson, James G.; Benton, Carley R.; Lally, James; Nickerson, Jennifer; Han, Xiao-Xia; Wilson, Meredith H.; Jain, Swati S.; Snook, Laelie A.; Bonen, Arend] Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada; [Alkhateeb, Hakam] Hashemite Univ, Dept Lab Med Sci, Zarqa 13115, Jordan; [Glatz, Jan F. C.; Luiken, Joost J. F. P.] Maastricht Univ, Dept Mol Genet, NL-6200 MD Maastricht, Netherlands; [Chabowski, Adrian] Med Univ Bialystok, Dept Physiol, PL-15222 Bialystok, Poland	University of Guelph; Hashemite University; Maastricht University; Medical University of Bialystok	Bonen, A (corresponding author), Univ Guelph, Dept Human Hlth & Nutr Sci, Guelph, ON N1G 2W1, Canada.	abonen@uoguelph.ca	Chabowski, Adrian/T-2225-2018; Alkhateeb, Hakam/AAD-8566-2019	Chabowski, Adrian/0000-0002-7407-8156; Wilson, Meredith/0000-0002-6152-7127	Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Heart and Stroke Foundation of Ontario; Netherlands Organization for Health Research and Development [40-00812-98-03075]; European Commission [LSHM-CT-2004-005272]; Canada Research Chair program; Ontario graduate scholarship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); European Commission(European CommissionEuropean Commission Joint Research Centre); Canada Research Chair program(Canada Research Chairs); Ontario graduate scholarship(Ontario Graduate Scholarship)	This work was supported in part by grants from the Canadian Institutes of Health Research (to A. B.), the Natural Sciences and Engineering Research Council of Canada (to A. B.), the Heart and Stroke Foundation of Ontario (to A. B.), the Netherlands Organization for Health Research and Development (NWO-ZonMw Grant 40-00812-98-03075) (to J. L. and J. G.), the European Commission (Integrated Project LSHM-CT-2004-005272, Exgenesis) (to J. L. and J. G.), and the Canada Research Chair program (to A. B.). Supported by an Ontario graduate scholarship.	Alkhateeb H, 2007, AM J PHYSIOL-ENDOC M, V293, pE783, DOI 10.1152/ajpendo.00685.2006; Alkhateeb H, 2006, APPL PHYSIOL NUTR ME, V31, P467, DOI 10.1139/H06-022; Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002; Bandyopadhyay GK, 2006, DIABETES, V55, P2277, DOI 10.2337/db06-0062; Bastie CC, 2004, DIABETES, V53, P2209, DOI 10.2337/diabetes.53.9.2209; Benton CR, 2008, J PHYSIOL-LONDON, V586, P1755, DOI 10.1113/jphysiol.2007.146563; Benton CR, 2008, J BIOL CHEM, V283, P4228, DOI 10.1074/jbc.M704332200; Benton CR, 2006, J PHYSIOL-LONDON, V573, P199, DOI 10.1113/jphysiol.2006.106013; Benton CR, 2008, PHYSIOL GENOMICS, V35, P45, DOI 10.1152/physiolgenomics.90217.2008; Bonen A, 2000, J BIOL CHEM, V275, P14501, DOI 10.1074/jbc.275.19.14501; Bonen A, 2004, FASEB J, V18, P1144, DOI 10.1096/fj.03-1065fje; BONEN A, 1994, AM J PHYSIOL, V266, pE1, DOI 10.1152/ajpendo.1994.266.1.E1; Bonen A, 1998, AM J PHYSIOL-ENDOC M, V275, pE471, DOI 10.1152/ajpendo.1998.275.3.E471; Bonen A, 2007, AM J PHYSIOL-ENDOC M, V292, pE1740, DOI 10.1152/ajpendo.00579.2006; Bonen A, 2007, PHYSIOLOGY, V22, P15, DOI 10.1152/physiologyonline.2007.22.1.15; Chabowski A, 2005, FEBS LETT, V579, P2428, DOI 10.1016/j.febslet.2004.11.118; Chabowski A, 2004, AM J PHYSIOL-ENDOC M, V287, pE781, DOI 10.1152/ajpendo.00573.2003; Chabowski A, 2007, PROSTAG LEUKOTR ESS, V77, P345, DOI 10.1016/j.plefa.2007.10.017; Chabowski A, 2006, MOL CELL BIOCHEM, V288, P201, DOI 10.1007/s11010-006-9140-8; Chiu HC, 2005, CIRC RES, V96, P225, DOI 10.1161/01.RES.0000154079.20681.B9; Clarke DC, 2004, PHYSIOL GENOMICS, V17, P31, DOI 10.1152/physiolgenomics.00190.2003; Coort SLM, 2004, DIABETES, V53, P1655, DOI 10.2337/diabetes.53.7.1655; DiRusso CC, 2005, J BIOL CHEM, V280, P16829, DOI 10.1074/jbc.M409598200; Doege H, 2006, PHYSIOLOGY, V21, P259, DOI 10.1152/physiol.00014.2006; Dyck DJ, 1997, AM J PHYSIOL-ENDOC M, V272, pE340, DOI 10.1152/ajpendo.1997.272.3.E340; Eyre NS, 2008, BIOCHEM BIOPH RES CO, V370, P404, DOI 10.1016/j.bbrc.2008.02.164; Gimeno RE, 2003, J BIOL CHEM, V278, P16039, DOI 10.1074/jbc.M211412200; Habets DDJ, 2007, BIOCHEM BIOPH RES CO, V355, P204, DOI 10.1016/j.bbrc.2007.01.141; Hall AM, 2005, J BIOL CHEM, V280, P11948, DOI 10.1074/jbc.M412629200; Hall AM, 2003, J BIOL CHEM, V278, P43008, DOI 10.1074/jbc.M306575200; Han XX, 2007, AM J PHYSIOL-ENDOC M, V293, pE566, DOI 10.1152/ajpendo.00106.2007; Hatch GM, 2002, J LIPID RES, V43, P1380, DOI 10.1194/jlr.M200130-JLR200; Hirsch D, 1998, P NATL ACAD SCI USA, V95, P8625, DOI 10.1073/pnas.95.15.8625; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Holloway GP, 2007, J PHYSIOL-LONDON, V582, P393, DOI 10.1113/jphysiol.2007.135301; Holloway GP, 2009, AM J PHYSIOL-ENDOC M, V296, pE738, DOI 10.1152/ajpendo.90896.2008; Houmard JA, 2008, AM J PHYSIOL-REG I, V294, pR1111, DOI 10.1152/ajpregu.00396.2007; Ibrahimi A, 1999, J BIOL CHEM, V274, P26761, DOI 10.1074/jbc.274.38.26761; Kampf JP, 2007, PHYSIOLOGY, V22, P295; Kampf JP, 2007, PHYSIOLOGY, V22, P7, DOI 10.1152/physiol.00011.2006; Kim JK, 2004, J CLIN INVEST, V113, P756, DOI 10.1172/JCI200418917; Koonen DPY, 2004, AM J PHYSIOL-ENDOC M, V286, pE1042, DOI 10.1152/ajpendo.00531.2003; Koonen DPY, 2002, MOL CELL BIOCHEM, V239, P121, DOI 10.1023/A:1020549311455; Kramer HF, 2007, DIABETES, V56, P2854, DOI 10.2337/db07-0681; Kramer HF, 2006, J BIOL CHEM, V281, P31478, DOI 10.1074/jbc.M605461200; Lobo S, 2007, J LIPID RES, V48, P609, DOI 10.1194/jlr.M600441-JLR200; Luiken JJFP, 2002, AM J PHYSIOL-ENDOC M, V283, pE612, DOI 10.1152/ajpendo.00011.2002; Luiken JJFP, 2002, AM J PHYSIOL-ENDOC M, V282, pE491, DOI 10.1152/ajpendo.00419.2001; Luiken JJFP, 2001, J BIOL CHEM, V276, P40567, DOI 10.1074/jbc.M100052200; Luiken JJFP, 1999, J LIPID RES, V40, P1007; Matsuno K, 1996, BRIT J HAEMATOL, V92, P960, DOI 10.1046/j.1365-2141.1996.422962.x; Milger K, 2006, J CELL SCI, V119, P4678, DOI 10.1242/jcs.03280; Richards MR, 2006, J LIPID RES, V47, P665, DOI 10.1194/jlr.M500514-JLR200; Smith AC, 2007, AM J PHYSIOL-ENDOC M, V293, pE172, DOI 10.1152/ajpendo.00677.2006; van Oort MM, 2008, BBA-MOL CELL BIOL L, V1781, P61, DOI 10.1016/j.bbalip.2007.11.006; Wu QW, 2006, MOL CELL BIOL, V26, P3455, DOI 10.1128/MCB.26.9.3455-3467.2006	56	136	143	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16522	16530		10.1074/jbc.M109.004788	http://dx.doi.org/10.1074/jbc.M109.004788			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19380575	hybrid, Green Published			2022-12-27	WOS:000266730900049
J	Weaver, KL; Ivester, P; Seeds, M; Case, LD; Arm, JP; Chilton, FH				Weaver, Kelly L.; Ivester, Priscilla; Seeds, Michael; Case, L. Douglas; Arm, Jonathan P.; Chilton, Floyd H.			Effect of Dietary Fatty Acids on Inflammatory Gene Expression in Healthy Humans	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GAMMA-LINOLENIC ACID; PHOSPHATIDYLINOSITOL 3-KINASE-AKT PATHWAY; FISH-OIL; EICOSAPENTAENOIC ACID; RHEUMATOID-ARTHRITIS; VENTILATED PATIENTS; CONTROLLED-TRIAL; DOUBLE-BLIND; DISEASE; OMEGA-3-FATTY-ACIDS	Over the past 100 years, changes in the food supply in Western nations have resulted in alterations in dietary fatty acid consumption, leading to a dramatic increase in the ratio of omega-6 (omega 6) to omega 3 polyunsaturated fatty acids (PUFA) in circulation and in tissues. Increased omega 6/omega 3 ratios are hypothesized to increase inflammatory mediator production, leading to higher incidence of inflammatory diseases, and may impact inflammatory gene expression. To determine the effect of reducing the omega 6/omega 3 ratio on expression of inflammatory pathway genes in mononuclear cells, healthy humans were placed on a controlled diet for 1 week, then given fish oil and borage oil for an additional 4 weeks. Serum and neutrophil fatty acid composition and ex vivo leukotriene B-4 production from stimulated neutrophils were measured at the start and end of the supplementation period and after a 2-week washout. RNA was isolated from mononuclear cells and expression of PI3K, Akt, NF kappa B, and inflammatory cytokines was measured by real-time PCR. A marked increase was seen in serum and neutrophil levels of long-chain omega 3 PUFA concomitant with a reduction in the omega 6/omega 3 PUFA ratio (40%). The ex vivo capacity of stimulated neutrophils to produce leukotriene B-4 was decreased by 31%. Expression of PI3K alpha and PI3K gamma and the quantity of PI3K alpha protein in mononuclear cells was reduced after supplementation, as was the expression of several proinflammatory cytokines. These data reveal that PUFA may exert their clinical effects via their capacity to regulate the expression of signal transduction genes and genes for proinflammatory cytokines.	[Weaver, Kelly L.; Ivester, Priscilla; Chilton, Floyd H.] Wake Forest Univ, Bowman Gray Sch Med, Dept Physiol & Pharmacol, Winston Salem, NC 27157 USA; [Weaver, Kelly L.; Seeds, Michael] Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med, Sect Mol Med, Winston Salem, NC 27157 USA; [Case, L. Douglas] Wake Forest Univ, Bowman Gray Sch Med, Dept Publ Hlth Sci, Winston Salem, NC 27157 USA; [Arm, Jonathan P.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Arm, Jonathan P.] Harvard Univ, Sch Med, Boston, MA 02115 USA	Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Wake Forest University; Wake Forest Baptist Medical Center; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Ivester, P (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Dept Physiol & Pharmacol, Med Ctr Blvd, Winston Salem, NC 27157 USA.	ivester@wfubmc.edu		Chilton, Floyd/0000-0002-3686-0198; Weaver, Kelly/0000-0002-6826-0015	National Institutes of Health NCCAM [1P50AT0027820]; The GCRC at Wake Forest University Baptist Medical Center [M01-RR07122]; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE [P50AT002782] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR007122] Funding Source: NIH RePORTER	National Institutes of Health NCCAM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); The GCRC at Wake Forest University Baptist Medical Center; NATIONAL CENTER FOR COMPLEMENTARY & ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by National Institutes of Health NCCAM Grant 1P50AT0027820.; We thank B. Undem for critical editing of the manuscript, M. Wilson for technical support with FAME analysis, and M. Pace for administrative assistance. All authors discussed the results and commented on the manuscript. K. L. W. had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis. The GCRC at Wake Forest University Baptist Medical Center provided the diets and nutritional counseling to study participants and is supported by Grant Number M01-RR07122. Potential Conflicts of Interest: F. H. C. has published books Inflammation Nation, Win the War Within, and The Gene Smart Diet and is a founder and a consultant to Pilot Therapeutics Holdings, which may be partially related to his research. His conflict of interest has been disclosed to Wake Forest University Health Sciences and outside sponsors and is institutionally managed.	Bach JF, 2002, NEW ENGL J MED, V347, P911, DOI 10.1056/NEJMra020100; Barham JB, 2000, J NUTR, V130, P1925, DOI 10.1093/jn/130.8.1925; Calder PC, 2002, P NUTR SOC, V61, P345, DOI 10.1079/PNS2002166; Calder PC, 2001, LIPIDS, V36, P1007, DOI 10.1007/s11745-001-0812-7; CHILTON FH, 1993, J CLIN INVEST, V91, P115, DOI 10.1172/JCI116159; Christensen JH, 1996, BMJ-BRIT MED J, V312, P677, DOI 10.1136/bmj.312.7032.677; Cordain, 2002, PALEO DIET; Cordain L, 2002, EUR J CLIN NUTR, V56, P181, DOI 10.1038/sj.ejcn.1601307; Curtis CL, 2000, J BIOL CHEM, V275, P721, DOI 10.1074/jbc.275.2.721; FORTIN PR, 1995, J CLIN EPIDEMIOL, V48, P1379, DOI 10.1016/0895-4356(95)00028-3; Fukao T, 2002, NAT IMMUNOL, V3, P295, DOI 10.1038/ni768; Fukao T, 2002, NAT IMMUNOL, V3, P875, DOI 10.1038/ni825; Guha M, 2002, J BIOL CHEM, V277, P32124, DOI 10.1074/jbc.M203298200; HerreraVelit P, 1997, J BIOL CHEM, V272, P16445, DOI 10.1074/jbc.272.26.16445; High K P, 2003, J Nutr Health Aging, V7, P378; Hirsch E, 2000, SCIENCE, V287, P1049, DOI 10.1126/science.287.5455.1049; Hughes-Fulford M, 2006, CANCER RES, V66, P1427, DOI 10.1158/0008-5472.CAN-05-0914; Johnson MM, 1997, J NUTR, V127, P1435, DOI 10.1093/jn/127.8.1435; KREMER JM, 1985, LANCET, V1, P184; Kris-Etherton PM, 2002, CIRCULATION, V106, P2747, DOI 10.1161/01.CIR.0000038493.65177.94; Li Z, 2000, SCIENCE, V287, P1046, DOI 10.1126/science.287.5455.1046; METCALFE LD, 1966, ANAL CHEM, V38, P514, DOI 10.1021/ac60235a044; MILLER AM, 1993, PROSTAG LEUKOTR ESS, V49, P561, DOI 10.1016/0952-3278(93)90161-O; Monjazeb AM, 2006, CARCINOGENESIS, V27, P1950, DOI 10.1093/carcin/bgl023; Moser M, 2000, NAT IMMUNOL, V1, P199, DOI 10.1038/79734; Pontes-Arruda A, 2006, CRIT CARE MED, V34, P2325, DOI 10.1097/01.CCM.0000234033.65657.B6; Sasaki T, 2000, SCIENCE, V287, P1040, DOI 10.1126/science.287.5455.1040; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Simopoulos AP, 2002, J AM COLL NUTR, V21, P495, DOI 10.1080/07315724.2002.10719248; Singer P, 2006, CRIT CARE MED, V34, P1033, DOI 10.1097/01.CCM.0000206111.23629.0A; Su KP, 2003, EUR NEUROPSYCHOPHARM, V13, P267, DOI 10.1016/S0924-977X(03)00032-4; TRINCHIERI G, 1995, ANNU REV IMMUNOL, V13, P251, DOI 10.1146/annurev.immunol.13.1.251; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839	33	113	183	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15400	15407		10.1074/jbc.M109.004861	http://dx.doi.org/10.1074/jbc.M109.004861			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19359242	hybrid, Green Published			2022-12-27	WOS:000266501000007
J	Cao, G; van der Wijst, J; van der Kemp, A; van Zeeland, F; Bindels, RJ; Hoenderop, JG				Cao, Gang; van der Wijst, Jenny; van der Kemp, AnneMiete; van Zeeland, Femke; Bindels, Rene J.; Hoenderop, Joost G.			Regulation of the Epithelial Mg2+ Channel TRPM6 by Estrogen and the Associated Repressor Protein of Estrogen Receptor Activity (REA)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MOLECULAR DETERMINANTS; SECONDARY HYPOCALCEMIA; MAGNESIUM TRANSPORT; TRANSIENT RECEPTOR; CATION CHANNEL; KINASE DOMAIN; ALPHA; HYPOMAGNESEMIA; CA2+; PHOSPHORYLATION	The maintenance of the Mg2+ balance of the body is essential for neuromuscular excitability, protein synthesis, nucleic acid stability, and numerous enzymatic systems. The Transient Receptor Potential Melastatin 6 (TRPM6) functions as the gatekeeper of transepithelial Mg2+ transport. However, the molecular regulation of TRPM6 channel activity remains elusive. Here, we identified the repressor of estrogen receptor activity ( REA) as an interacting protein of TRPM6 that binds to the 6(th), 7(th), and 8(th) beta-sheets in its alpha-kinase domain. Importantly, REA and TRPM6 are coexpressed in renal Mg2+-transporting distal convoluted tubules (DCT). We demonstrated that REA significantly inhibits TRPM6, but not its closest homologue TRPM7, channel activity. This inhibition occurs in a phosphorylation-dependent manner, since REA has no effect on the TRPM6 phosphotransferase-deficient mutant (K1804R), while it still binds to this mutant. Moreover, activation of protein kinase C by phorbol 12-myristate 13-acetate-PMA potentiated the inhibitory effect of REA on TRPM6 channel activity. Finally, we showed that the interaction between REA and TRPM6 is a dynamic process, as short-term 17 beta-estradiol treatment disassociates the binding between these proteins. In agreement with this, 17 beta-estradiol treatment significantly stimulates the TRPM6-mediated current in HEK293 cells. These results suggest a rapid pathway for the effect of estrogen on Mg2+ homeostasis in addition to its transcriptional effect. Together, these data indicate that REA operates as a negative feedback modulator of TRPM6 in the regulation of active Mg2+ (re) absorption and provides new insight into the molecular mechanism of renal transepithelial Mg2+ transport.	[Cao, Gang; van der Wijst, Jenny; van der Kemp, AnneMiete; van Zeeland, Femke; Bindels, Rene J.; Hoenderop, Joost G.] Radboud Univ Nijmegen, Med Ctr, Inst Genet & Metab Dis, Nijmegen Ctr Mol Life Sci,Dept Physiol, NL-6500 HB Nijmegen, Netherlands	Radboud University Nijmegen	Hoenderop, JG (corresponding author), Radboud Univ Nijmegen, Med Ctr, Inst Genet & Metab Dis, Nijmegen Ctr Mol Life Sci,Dept Physiol, 286 Psysiol,POB 9101, NL-6500 HB Nijmegen, Netherlands.	j.hoenderop@ncmls.ru.nl	Hoenderop, Joost G.J./H-8047-2014; van der Wijst, Jenny/T-1620-2019; van der Wijst, Jenny/D-9726-2016; Bindels, René JM/B-9824-2013	Hoenderop, Joost G.J./0000-0002-1816-8544; van der Wijst, Jenny/0000-0002-1547-516X; van der Wijst, Jenny/0000-0002-1547-516X; Bindels, René JM/0000-0003-1167-1339	Netherlands Organization of Scientific Research [ZonMW 9120.6110, ALW818.02.001]; European Science Foundation; Dutch Kidney Foundation [C03.6017, C08.2252]	Netherlands Organization of Scientific Research(Netherlands Organization for Scientific Research (NWO)); European Science Foundation(European Science Foundation (ESF)European Commission); Dutch Kidney Foundation	This work was supported by the Netherlands Organization of Scientific Research (ZonMW 9120.6110, ALW818.02.001), the EURYI award from the European Science Foundation, and the Dutch Kidney Foundation (C03.6017, C08.2252).	BOGOROCH R, 1975, ANAT REC, V183, P437, DOI 10.1002/ar.1091830308; Cabodi S, 2004, J CELL SCI, V117, P1603, DOI 10.1242/jcs.01025; Cao G, 2008, CURR BIOL, V18, P168, DOI 10.1016/j.cub.2007.12.058; Chubanov V, 2005, PFLUG ARCH EUR J PHY, V451, P228, DOI 10.1007/s00424-005-1470-y; Chubanov V, 2007, J BIOL CHEM, V282, P7656, DOI 10.1074/jbc.M611117200; Clark K, 2006, EMBO J, V25, P290, DOI 10.1038/sj.emboj.7600931; Dai LJ, 2001, PHYSIOL REV, V81, P51, DOI 10.1152/physrev.2001.81.1.51; Demeuse P, 2006, J GEN PHYSIOL, V127, P421, DOI 10.1085/jgp.200509410; Drennan D, 2004, PROG BIOPHYS MOL BIO, V85, P1, DOI 10.1016/S0079-6107(03)00060-9; Fu XD, 2007, SEMIN REPROD MED, V25, P178, DOI 10.1055/s-2007-973430; Gkika D, 2006, AM J PHYSIOL-RENAL, V290, pF1253, DOI 10.1152/ajprenal.00298.2005; Groenestege WMT, 2007, J CLIN INVEST, V117, P2260, DOI 10.1172/JCI31680; Groenestege WMT, 2006, J AM SOC NEPHROL, V17, P1035, DOI 10.1681/ASN.2005070700; Grubbs RD, 2002, BIOMETALS, V15, P251, DOI 10.1023/A:1016026831789; He B, 2008, MOL ENDOCRINOL, V22, P344, DOI 10.1210/me.2007-0400; Hoenderop JGJ, 2002, FASEB J, V16, P1398, DOI 10.1096/fj.02-0225com; Hoenderop JGJ, 1999, BIOCHEM BIOPH RES CO, V261, P488, DOI 10.1006/bbrc.1999.1059; Konrad M, 2004, AM J PHYSIOL-RENAL, V286, pF599, DOI 10.1152/ajprenal.00312.2003; Levin ER, 2002, STEROIDS, V67, P471, DOI 10.1016/S0039-128X(01)00179-9; Li MJ, 2007, J BIOL CHEM, V282, P25817, DOI 10.1074/jbc.M608972200; Matsushita M, 2005, J BIOL CHEM, V280, P20793, DOI 10.1074/jbc.M413671200; MCNAIR P, 1984, MINER ELECTROL METAB, V10, P84; Montano MM, 1999, P NATL ACAD SCI USA, V96, P6947, DOI 10.1073/pnas.96.12.6947; Montell C, 2003, CURR BIOL, V13, pR799, DOI 10.1016/j.cub.2003.09.048; Moriarty K, 2006, ENDOCRINOLOGY, V147, P5557, DOI 10.1210/en.2006-0729; Muneyyirci-Delale O, 1999, FERTIL STERIL, V71, P869, DOI 10.1016/S0015-0282(99)00065-5; Okada T, 1999, J BIOL CHEM, V274, P27359, DOI 10.1074/jbc.274.39.27359; Olsen JV, 2004, MOL CELL PROTEOMICS, V3, P608, DOI 10.1074/mcp.T400003-MCP200; Park SE, 2005, MOL CELL BIOL, V25, P1989, DOI 10.1128/MCB.25.5.1989-1999.2005; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; ROMANI A, 1992, ARCH BIOCHEM BIOPHYS, V298, P1, DOI 10.1016/0003-9861(92)90086-C; Runnels LW, 2001, SCIENCE, V291, P1043, DOI 10.1126/science.1058519; Schlingmann KP, 2002, NAT GENET, V31, P166, DOI 10.1038/ng889; Schmitz C, 2005, J BIOL CHEM, V280, P37763, DOI 10.1074/jbc.M509175200; Schmitz C, 2003, CELL, V114, P191, DOI 10.1016/S0092-8674(03)00556-7; SEELIG MS, 1993, J AM COLL NUTR, V12, P442, DOI 10.1080/07315724.1993.10718335; Simoncini T, 2006, ANN NY ACAD SCI, V1089, P424, DOI 10.1196/annals.1386.001; Thebault S, 2008, J BIOL CHEM, V283, P19999, DOI 10.1074/jbc.M800167200; Topala CN, 2007, CELL CALCIUM, V41, P513, DOI 10.1016/j.ceca.2006.10.003; Van de Graaf SFJ, 2003, EMBO J, V22, P1478, DOI 10.1093/emboj/cdg162; Vetter T, 2002, CURR OPIN NEPHROL HY, V11, P403, DOI 10.1097/00041552-200207000-00006; Voets T, 2004, J BIOL CHEM, V279, P19, DOI 10.1074/jbc.M311201200; Walder RY, 2002, NAT GENET, V31, P171, DOI 10.1038/ng901; Yamaguchi H, 2001, MOL CELL, V7, P1047, DOI 10.1016/S1097-2765(01)00256-8; Zheng FHF, 2005, MOL CELL BIOL, V25, P8273, DOI 10.1128/MCB.25.18.8273-8284.2005	45	53	56	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					14788	14795		10.1074/jbc.M808752200	http://dx.doi.org/10.1074/jbc.M808752200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19329436	hybrid, Green Published			2022-12-27	WOS:000266288200014
J	Molina-Ortiz, I; Bartolome, RA; Hernandez-Varas, P; Colo, GP; Teixido, J				Molina-Ortiz, Isabel; Bartolome, Ruben A.; Hernandez-Varas, Pablo; Colo, Georgina P.; Teixido, Joaquin			Overexpression of E-cadherin on Melanoma Cells Inhibits Chemokine- promoted Invasion Involving p190RhoGAP/p120ctn-dependent Inactivation of RhoA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							C-SRC; TYROSINE PHOSPHORYLATION; MATRIX-METALLOPROTEINASE; ACTIN CYTOSKELETON; TUMOR PROGRESSION; EPITHELIAL-CELLS; P120 CATENIN; IN-VITRO; ADHESION; EXPRESSION	Melanoma cells express the chemokine receptor CXCR4 that confers high invasiveness upon binding to its ligand CXCL12. Melanoma cells at initial stages of the disease show reduction or loss of E-cadherin expression, but recovery of its expression is frequently found at advanced phases. We overexpressed E-cadherin in the highly invasive BRO lung metastatic cell melanoma cell line to investigate whether it could influence CXCL12-promoted cell invasion. Overexpression of E-cadherin led to defective invasion of melanoma cells across Matrigel and type I collagen in response to CXCL12. A decrease in individual cell migration directionality toward the chemokine and reduced adhesion accounted for the impaired invasion. A p190RhoGAP-dependent inhibition of RhoA activation was responsible for the impairment in chemokine-stimulated E-cadherin melanoma transfectant invasion. Furthermore, we show that p190RhoGAP and p120ctn associated predominantly on the plasma membrane of cells overexpressing E-cadherin, and that E-cadherin-bound p120ctn contributed to RhoA inactivation by favoring p190RhoGAP-RhoA association. These results suggest that melanoma cells at advanced stages of the disease could have reduced metastatic potency in response to chemotactic stimuli compared with cells lacking E-cadherin, and the results indicate that p190RhoGAP is a central molecule controlling melanoma cell invasion.	[Molina-Ortiz, Isabel; Bartolome, Ruben A.; Hernandez-Varas, Pablo; Colo, Georgina P.; Teixido, Joaquin] Ctr Invest Biol, Dept Cellular & Mol Physiopathol, Madrid 28040, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB)	Teixido, J (corresponding author), Ctr Invest Biol, Dept Cellular & Mol Physiopathol, Ramiro Maeztu 9, Madrid 28040, Spain.	joaquint@cib.csic.es	Teixidó, Joaquin/J-8543-2014; Bartolome, Ruben A/M-1873-2014	Bartolome, Ruben A/0000-0002-3292-1491; Hernandez-Varas, Pablo/0000-0001-8664-9203	Ministerio de Ciencia e Innovacion [SAF2005-02119, SAF2008-00479]; RETICS [RD06/0020/0011]; Fundacion de Investigacion Medica Mutua Madrilena	Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); RETICS; Fundacion de Investigacion Medica Mutua Madrilena	This work was supported in part by Grants SAF2005-02119 and SAF2008-00479 from the Ministerio de Ciencia e Innovacion, by RETICS RD06/0020/0011, and by a grant from the Fundacion de Investigacion Medica Mutua Madrilena.	Anastasiadis PZ, 2000, NAT CELL BIOL, V2, P637, DOI 10.1038/35023588; Arthur WT, 2000, CURR BIOL, V10, P719, DOI 10.1016/S0960-9822(00)00537-6; Balkwill F, 2004, NAT REV CANCER, V4, P540, DOI 10.1038/nrc1388; Bartolome RA, 2006, CANCER RES, V66, P248, DOI 10.1158/0008-5472.CAN-05-2489; Bartolome RA, 2004, CANCER RES, V64, P2534, DOI 10.1158/0008-5472.CAN-03-3398; Bartolome RA, 2008, CANCER RES, V68, P8221, DOI 10.1158/0008-5472.CAN-08-0561; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; BOUTON AH, 1991, MOL CELL BIOL, V11, P945, DOI 10.1128/MCB.11.2.945; Castano J, 2007, MOL CELL BIOL, V27, P1745, DOI 10.1128/MCB.01974-06; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; CHANG JH, 1995, J CELL BIOL, V130, P355, DOI 10.1083/jcb.130.2.355; Clark EA, 2000, NATURE, V406, P532, DOI 10.1038/35020106; Cowley GP, 1996, J PATHOL, V179, P183, DOI 10.1002/(SICI)1096-9896(199606)179:2<183::AID-PATH554>3.0.CO;2-W; Danen EHJ, 1996, MELANOMA RES, V6, P127, DOI 10.1097/00008390-199604000-00007; ELLIS C, 1990, NATURE, V343, P377, DOI 10.1038/343377a0; Fincham VJ, 1999, J CELL SCI, V112, P947; Fritz G, 1999, INT J CANCER, V81, P682, DOI 10.1002/(SICI)1097-0215(19990531)81:5<682::AID-IJC2>3.0.CO;2-B; FRIXEN UH, 1991, J CELL BIOL, V113, P173, DOI 10.1083/jcb.113.1.173; Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699; Haskell MD, 2001, J CELL SCI, V114, P1699; Hsu MY, 2000, J CELL SCI, V113, P1535; Hsu MY, 2000, AM J PATHOL, V156, P1515, DOI 10.1016/S0002-9440(10)65023-7; Hu KQ, 1997, EMBO J, V16, P473, DOI 10.1093/emboj/16.3.473; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Longo-Imedio MI, 2005, INT J CANCER, V117, P861, DOI 10.1002/ijc.21269; Magie Craig R., 2002, Development (Cambridge), V129, P3771; Miller AJ, 2006, NEW ENGL J MED, V355, P51, DOI 10.1056/NEJMra052166; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Murakami T, 2002, CANCER RES, V62, P7328; Nakahara H, 1998, J BIOL CHEM, V273, P9, DOI 10.1074/jbc.273.1.9; NAVARRO P, 1991, J CELL BIOL, V115, P517, DOI 10.1083/jcb.115.2.517; Noren NK, 2003, J BIOL CHEM, V278, P13615, DOI 10.1074/jbc.C200657200; Noren NK, 2000, J CELL BIOL, V150, P567, DOI 10.1083/jcb.150.3.567; Olofsson B, 1999, CELL SIGNAL, V11, P545, DOI 10.1016/S0898-6568(98)00063-1; Reynolds AB, 2004, ONCOGENE, V23, P7947, DOI 10.1038/sj.onc.1208161; RIDLEY AJ, 1993, EMBO J, V12, P5151, DOI 10.1002/j.1460-2075.1993.tb06210.x; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Robledo MM, 2001, J BIOL CHEM, V276, P45098, DOI 10.1074/jbc.M106912200; Roof RW, 1998, MOL CELL BIOL, V18, P7052, DOI 10.1128/MCB.18.12.7052; Sahai E, 2002, NAT REV CANCER, V2, P133, DOI 10.1038/nrc725; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Scala S, 2005, CLIN CANCER RES, V11, P1835, DOI 10.1158/1078-0432.CCR-04-1887; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; SETTLEMAN J, 1992, NATURE, V359, P153, DOI 10.1038/359153a0; Silye R, 1998, J PATHOL, V186, P350, DOI 10.1002/(SICI)1096-9896(199812)186:4<350::AID-PATH181>3.0.CO;2-K; TANG A, 1994, J CELL SCI, V107, P983; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thoreson MA, 2000, J CELL BIOL, V148, P189, DOI 10.1083/jcb.148.1.189; Tikoo A, 2000, GENE, V257, P23, DOI 10.1016/S0378-1119(00)00387-5; van Golen KL, 2000, CANCER RES, V60, P5832; vanderGeer P, 1997, MOL CELL BIOL, V17, P1840, DOI 10.1128/MCB.17.4.1840; VLEMINCKX K, 1991, CELL, V66, P107, DOI 10.1016/0092-8674(91)90143-M; Wildenberg GA, 2006, CELL, V127, P1027, DOI 10.1016/j.cell.2006.09.046; Wolf RM, 2003, GENE DEV, V17, P476, DOI 10.1101/gad.1040003; Yagi T, 2000, GENE DEV, V14, P1169	55	48	49	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					15147	15157		10.1074/jbc.M807834200	http://dx.doi.org/10.1074/jbc.M807834200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19293150	Green Published, hybrid			2022-12-27	WOS:000266288200050
J	Ranjan, R; Ahmed, A; Gourinath, S; Sharma, P				Ranjan, Ravikant; Ahmed, Anwar; Gourinath, Samudrala; Sharma, Pushkar			Dissection of Mechanisms Involved in the Regulation of Plasmodium falciparum Calcium-dependent Protein Kinase 4	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CALMODULIN-LIKE DOMAIN; B-LIKE ENZYME; MALARIA PARASITE; PHOSPHOINOSITIDE HYDROLYSIS; SIGNALING PATHWAY; XANTHURENIC ACID; GAMETE FORMATION; IDENTIFICATION; MOSQUITO; CDPK	Recent studies have demonstrated that calcium-dependent protein kinases (CDPKs) are used by calcium to regulate a variety of biological processes in the malaria parasite Plasmodium. CDPK4 has emerged as an important enzyme for parasite development, because its gene disruption in rodent parasite Plasmodium berghei causes major defects in sexual differentiation of the parasite (Billker, O., Dechamps, S., Tewari, R., Wenig, G., Franke-Fayard, B., and Brinkmann, V. (2004) Cell 117, 503514). Despite these findings, it is not very clear how PfCDPK4 or any other PfCDPK is regulated by calcium at the molecular level. We report the biochemical characterization and elucidation of molecular mechanisms involved in the regulation of PfCDPK4. PfCDPK4 was detected on gametocyte periphery, and its activity in the parasite was regulated by phospholipase C. Even though the Junction Domain (JD) of PfCDPK4 shares moderate sequence homology with that of the plant CDPKs, it plays a pivotal role in PfCDPK4 regulation as previously reported for some plant CDPKs. The regions of the J-domain involved in interaction with both the kinase domain and the calmodulin-like domain were mapped. We propose a model for PfCDPK regulation by calcium, which may also prove useful for design of inhibitors against PfCDPK4 and other members of the PfCDPK family.	[Ranjan, Ravikant; Ahmed, Anwar; Sharma, Pushkar] Natl Inst Immunol, Eukaryot Gene Express Lab, New Delhi 110067, India; [Gourinath, Samudrala] Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Jawaharlal Nehru University, New Delhi	Sharma, P (corresponding author), Natl Inst Immunol, Eukaryot Gene Express Lab, New Delhi 110067, India.	pushkar@nii.res.in	Ahmed, Anwar/AAL-7789-2021; Ranjan, Ravikant/AAT-1000-2021; Ahmed, Anwar/ADH-1445-2022	Ranjan, Ravikant/0000-0002-3997-4879; Ahmed, Anwar/0000-0001-8147-714X	National Institutes of Health [RO1AI075459]; Wellcome Trust Senior Research Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI075459] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust Senior Research Fellowship(Wellcome Trust); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant RO1AI075459 from NIAID. This work was also supported by a Wellcome Trust Senior Research Fellowship awarded to ( to P. S.).	Arai M, 2001, MOL BIOCHEM PARASIT, V116, P17, DOI 10.1016/S0166-6851(01)00299-7; Bahl A, 2003, NUCLEIC ACIDS RES, V31, P212, DOI 10.1093/nar/gkg081; Billker O, 1998, NATURE, V392, P289, DOI 10.1038/32667; Billker O, 2004, CELL, V117, P503, DOI 10.1016/S0092-8674(04)00449-0; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chandran V, 2006, J MOL BIOL, V357, P400, DOI 10.1016/j.jmb.2005.11.093; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Farias SL, 2005, MOL BIOCHEM PARASIT, V141, P71, DOI 10.1016/j.molbiopara.2005.01.015; Garcia CRS, 1999, PARASITOL TODAY, V15, P488, DOI 10.1016/S0169-4758(99)01571-9; Gazarini ML, 2004, BIOCHEM BIOPH RES CO, V321, P138, DOI 10.1016/j.bbrc.2004.06.141; Gazarini ML, 2003, J CELL BIOL, V161, P103, DOI 10.1083/jcb.200212130; HARMON AC, 1994, BIOCHEMISTRY-US, V33, P7278, DOI 10.1021/bi00189a032; Harper JE, 2004, ANNU REV PLANT BIOL, V55, P263, DOI 10.1146/annurev.arplant.55.031903.141627; Harper JF, 2005, NAT REV MOL CELL BIO, V6, P555, DOI 10.1038/nrm1679; HARPER JF, 1994, BIOCHEMISTRY-US, V33, P7267, DOI 10.1021/bi00189a031; HASHIMOTO Y, 1987, ARCH BIOCHEM BIOPHYS, V252, P418, DOI 10.1016/0003-9861(87)90048-8; Hegeman AD, 2006, PROTEOMICS, V6, P3649, DOI 10.1002/pmic.200500926; Hotta CT, 2000, NAT CELL BIOL, V2, P466, DOI 10.1038/35017112; Ishino T, 2006, MOL MICROBIOL, V59, P1175, DOI 10.1111/j.1365-2958.2005.05014.x; Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2; Kato N, 2008, NAT CHEM BIOL, V4, P347, DOI 10.1038/nchembio.87; KAWAMOTO F, 1990, MOL BIOCHEM PARASIT, V42, P101, DOI 10.1016/0166-6851(90)90117-5; Khan SM, 2005, CELL, V121, P675, DOI 10.1016/j.cell.2005.03.027; Kumar A, 2004, J BIOL CHEM, V279, P24255, DOI 10.1074/jbc.M312855200; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lin DT, 1996, MOL BIOCHEM PARASIT, V78, P67, DOI 10.1016/S0166-6851(96)02608-4; MARTIN SK, 1994, J PARASITOL, V80, P371, DOI 10.2307/3283406; MCCALLUMDEIGHTON N, 1992, MOL BIOCHEM PARASIT, V50, P317, DOI 10.1016/0166-6851(92)90229-D; McRobert L, 2008, PLOS BIOL, V6, P1243, DOI 10.1371/journal.pbio.0060139; Moskes C, 2004, MOL MICROBIOL, V54, P676, DOI 10.1111/j.1365-2958.2004.04313.x; OGWANG R, 1993, BIOCHEM PHARMACOL, V46, P1601, DOI 10.1016/0006-2952(93)90329-U; Siden-Kiamos I, 2006, MOL MICROBIOL, V60, P1355, DOI 10.1111/j.1365-2958.2006.05189.x; SONNICHSEN FD, 1992, BIOCHEMISTRY-US, V31, P8790, DOI 10.1021/bi00152a015; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; Vaid A, 2008, J BIOL CHEM, V283, P5589, DOI 10.1074/jbc.M708465200; Vaid A, 2006, J BIOL CHEM, V281, P27126, DOI 10.1074/jbc.M601914200; Vitart V, 2000, BIOCHEMISTRY-US, V39, P4004, DOI 10.1021/bi992373m; Ward P, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-79; Williams JL, 1999, AM J TROP MED HYG, V60, P7, DOI 10.4269/ajtmh.1999.60.7; WOODY RW, 1995, METHOD ENZYMOL, V246, P34; Yoo BC, 1996, BIOCHEMISTRY-US, V35, P12029, DOI 10.1021/bi9606612; Zhang L, 2002, BIOCHEM J, V368, P145, DOI 10.1042/BJ20020780; ZHAO Y, 1994, MOL BIOCHEM PARASIT, V66, P329, DOI 10.1016/0166-6851(94)90159-7	43	43	46	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					15267	15276		10.1074/jbc.M900656200	http://dx.doi.org/10.1074/jbc.M900656200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19307175	hybrid, Green Published			2022-12-27	WOS:000266288200061
J	Panov, A; Schonfeld, P; Dikalov, S; Hemendinger, R; Bonkovsky, HL; Brooks, BR				Panov, Alexander; Schonfeld, Peter; Dikalov, Sergey; Hemendinger, Richelle; Bonkovsky, Herbert L.; Brooks, Benjamin Rix			The Neuromediator Glutamate, through Specific Substrate Interactions, Enhances Mitochondrial ATP Production and Reactive Oxygen Species Generation in Nonsynaptic Brain Mitochondria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PURKINJE-CELL SYNAPSE; SUCCINATE-DEHYDROGENASE; RAT-BRAIN; COMPLEX-I; ASPARTATE-AMINOTRANSFERASE; METABOLIC COMPARTMENTATION; TRANSPORTER EAAT4; BOVINE BRAIN; DISEASE; ACID	The finding that upon neuronal activation glutamate is transported postsynaptically from synaptic clefts and increased lactate availability for neurons suggest that brain mitochondria (BM) utilize a mixture of substrates, namely pyruvate, glutamate, and the tricarboxylic acid cycle metabolites. We studied how glutamate affected oxidative phosphorylation and reactive oxygen species (ROS) production in rat BM oxidizing pyruvate + malate or succinate. Simultaneous oxidation of glutamate + pyruvate + malate increased state 3 and uncoupled respiration by 52 and 71%, respectively. The state 4 ROS generation increased 100% overBMoxidizing pyruvate + malate and 900% over that of BM oxidizing glutamate + malate. Up to 70% of ROS generation was associated with reverse electron transport. These effects of pyruvate + glutamate + malate were observed only with BM and not with liver or heart mitochondria. The effects of glutamate + pyruvate on succinate-supported respiration and ROS generation were not organ-specific and depended only on whether mitochondria were isolated with or without bovine serum albumin. With the non-bovine serum albumin brain and heart mitochondria oxidizing succinate, the addition of pyruvate and glutamate abrogated inhibition of Complex II by oxaloacetate. We conclude that (i) during neuronal activation, simultaneous oxidation of glutamate + pyruvate temporarily enhances neuronal mitochondrial ATP production, and (ii) intrinsic inhibition of Complex II by oxaloacetate is an inherent mechanism that protects against ROS generation during reverse electron transport.	[Panov, Alexander] Carolinas Med Ctr, Carolinas Neuromuscular ALS Ctr, Cannon Res Ctr, Charlotte, NC 28203 USA; [Schonfeld, Peter] Otto Von Guericke Univ, Fak Med, Inst Biochem, D-39120 Magdeburg, Germany; [Dikalov, Sergey] Emory Univ, Div Cardiol, Atlanta, GA 30322 USA	Carolinas Medical Center; Otto von Guericke University; Emory University	Panov, A (corresponding author), Carolinas Med Ctr, Carolinas Neuromuscular ALS Ctr, Cannon Res Ctr, 1000 Blythe Blvd, Charlotte, NC 28203 USA.	alexander.panov@carolinashealthcare.org	Bonkovsky, Herbert L./AAH-1892-2021	Bonkovsky, Herbert L./0000-0001-7387-3230; Dikalov, Sergey/0000-0003-2976-6184	DK [RO1 38825]; Carolinas HealthCare Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK038825] Funding Source: NIH RePORTER	DK; Carolinas HealthCare Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Grant DK RO1 38825 (to H. L. B.). This work was also supported by the Carolinas HealthCare Foundation. Some of the data in this work have been presented at scientific meetings and published as abstracts (35, 36).	Abeles M., 1991, CORTICONICS NEURAL C, DOI DOI 10.1017/CBO9780511574566; ACKRELL BAC, 1974, J BIOL CHEM, V249, P2021; ACKRELL BAC, 1975, J BIOL CHEM, V250, P7114; Attwell D, 2001, J CEREBR BLOOD F MET, V21, P1133, DOI 10.1097/00004647-200110000-00001; Auger C, 2000, NEURON, V28, P547, DOI 10.1016/S0896-6273(00)00132-X; BALAZS R, 1965, BIOCHEM J, V95, P497, DOI 10.1042/bj0950497; BALAZS R, 1965, J NEUROCHEM, V12, P63, DOI 10.1111/j.1471-4159.1965.tb11940.x; Bergles DE, 1999, CURR OPIN NEUROBIOL, V9, P293, DOI 10.1016/S0959-4388(99)80043-9; Berkich DA, 2007, J NEUROSCI RES, V85, P3367, DOI 10.1002/jnr.21500; Bohr VA, 2007, NEUROSCIENCE, V145, P1183, DOI 10.1016/j.neuroscience.2007.03.015; Brasnjo G, 2004, P NATL ACAD SCI USA, V101, P6273, DOI 10.1073/pnas.0308149101; CHO SW, 1995, EUR J BIOCHEM, V233, P340, DOI 10.1111/j.1432-1033.1995.340_1.x; COOPER AJL, 1987, PHYSIOL REV, V67, P440, DOI 10.1152/physrev.1987.67.2.440; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Dehnes Y, 1998, J NEUROSCI, V18, P3606; ERECINSKA M, 1994, J NEUROCHEM, V63, P1033; Furness DN, 2008, NEUROSCIENCE, V157, P80, DOI 10.1016/j.neuroscience.2008.08.043; Greenamyre JT, 2001, IUBMB LIFE, V52, P135, DOI 10.1080/15216540152845939; Halliwell B, 2006, J NEUROCHEM, V97, P1634, DOI 10.1111/j.1471-4159.2006.03907.x; Hertz L, 2004, NEUROCHEM INT, V45, P285, DOI 10.1016/j.neuint.2003.08.016; Hertz L, 2007, J CEREBR BLOOD F MET, V27, P219, DOI 10.1038/sj.jcbfm.9600343; KANAI Y, 1993, FASEB J, V7, P1450, DOI 10.1096/fasebj.7.15.7903261; KAUPPINEN RA, 1986, EUR J BIOCHEM, V158, P159, DOI 10.1111/j.1432-1033.1986.tb09733.x; Kudin AP, 2008, BBA-BIOENERGETICS, V1777, P689, DOI 10.1016/j.bbabio.2008.05.010; Kwong JQ, 2006, J NEUROCHEM, V97, P1659, DOI 10.1111/j.1471-4159.2006.03990.x; LAI JCK, 1977, J NEUROCHEM, V28, P625, DOI 10.1111/j.1471-4159.1977.tb10434.x; LANOUE KF, 1979, ANNU REV BIOCHEM, V48, P871, DOI 10.1146/annurev.bi.48.070179.004255; Li Z, 2004, CELL, V119, P873, DOI 10.1016/j.cell.2004.11.003; Martin LJ, 2007, J COMP NEUROL, V500, P20, DOI 10.1002/cne.21160; Massie A, 2008, J COMP NEUROL, V511, P155, DOI 10.1002/cne.21823; MCCORMACK JG, 1979, BIOCHEM J, V180, P533, DOI 10.1042/bj1800533; McKenna MC, 2006, BIOCHEM PHARMACOL, V71, P399, DOI 10.1016/j.bcp.2005.10.011; McKenna MC, 2000, NEUROCHEM INT, V37, P229, DOI 10.1016/S0197-0186(00)00042-5; Mim C, 2005, J GEN PHYSIOL, V126, P571, DOI 10.1085/jgp.200509365; Muller FL, 2008, BIOCHEM J, V409, P491, DOI 10.1042/BJ20071162; NICHOLLS DG, 1993, EUR J BIOCHEM, V212, P613, DOI 10.1111/j.1432-1033.1993.tb17700.x; Otis TS, 1997, SCIENCE, V277, P1515, DOI 10.1126/science.277.5331.1515; Panov A, 2005, J BIOL CHEM, V280, P42026, DOI 10.1074/jbc.M508628200; PANOV A, 2008, AMYOTR LAT SCLER, V9, pS2; Panov A, 2007, AM J PHYSIOL-CELL PH, V292, pC708, DOI 10.1152/ajpcell.00202.2006; Panov AV, 2006, FREE RADICAL BIO MED, V41, pS167; PELLERIN L, 1994, P NATL ACAD SCI USA, V91, P10625, DOI 10.1073/pnas.91.22.10625; ROTHSTEIN JD, 1994, NEURON, V13, P713, DOI 10.1016/0896-6273(94)90038-8; RUSCAK M, 1982, J NEUROCHEM, V39, P210, DOI 10.1111/j.1471-4159.1982.tb04720.x; Schagger H, 2001, J BIOL CHEM, V276, P37861; Shaw PJ, 2005, J NEUROL NEUROSUR PS, V76, P1046, DOI 10.1136/jnnp.2004.048652; SIMS NR, 1990, J NEUROCHEM, V55, P698, DOI 10.1111/j.1471-4159.1990.tb04189.x; TILLAKARATNE NJK, 1995, COMP BIOCHEM PHYS A, V112, P247, DOI 10.1016/0300-9629(95)00099-2; Torres-Salazar D, 2007, J BIOL CHEM, V282, P34719, DOI 10.1074/jbc.M704118200; Tretter L, 2007, NEUROCHEM INT, V50, P139, DOI 10.1016/j.neuint.2006.07.010; VINOGRAD.AD, 1972, BIOCHEM BIOPH RES CO, V49, P441, DOI 10.1016/0006-291X(72)90430-5; YUDKOFF M, 1994, J BIOL CHEM, V269, P27414; Zoccarato F, 2007, BIOCHEM J, V406, P125, DOI 10.1042/BJ20070215	53	48	53	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14448	14456		10.1074/jbc.M900985200	http://dx.doi.org/10.1074/jbc.M900985200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19304986	Green Published, hybrid			2022-12-27	WOS:000266286100051
J	Saleh, O; Gust, B; Boll, B; Fiedler, HP; Heide, L				Saleh, Orwah; Gust, Bertolt; Boll, Bjoern; Fiedler, Hans-Peter; Heide, Lutz			Aromatic Prenylation in Phenazine Biosynthesis DIHYDROPHENAZINE-1-CARBOXYLATE DIMETHYLALLYLTRANSFERASE FROM STREPTOMYCES ANULATUS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STREPTOMYCES-CINNAMONENSIS DSM-1042; SIMILAR-TO-D; GENE-CLUSTER; HETEROLOGOUS EXPRESSION; NATURAL-PRODUCTS; FURANONAPHTHOQUINONE; PRENYLTRANSFERASES; ANTIBIOTICS; DIVERSITY; CATALYZES	The bacterium Streptomyces anulatus 9663, isolated from the intestine of different arthropods, produces prenylated derivatives of phenazine 1-carboxylic acid. From this organism, we have identified the prenyltransferase gene PpzP. PpzP resides in a gene cluster containing orthologs of all genes known to be involved in phenazine 1-carboxylic acid biosynthesis in Pseudomonas strains as well as genes for the six enzymes required to generate dimethylallyl diphosphate via the mevalonate pathway. This is the first complete gene cluster of a phenazine natural compound from streptomycetes. Heterologous expression of this cluster in Streptomyces coelicolor M512 resulted in the formation of prenylated derivatives of phenazine 1-carboxylic acid. After inactivation of PpzP, only nonprenylated phenazine 1-carboxylic acid was formed. Cloning, overexpression, and purification of PpzP resulted in a 37-kDa soluble protein, which was identified as a 5,10-dihydrophenazine 1-carboxylate dimethylallyltransferase, forming a C-C bond between C-1 of the isoprenoid substrate and C-9 of the aromatic substrate. In contrast to many other prenyltransferases, the reaction of PpzP is independent of the presence of magnesium or other divalent cations. The K-m value for dimethylallyl diphosphate was determined as 116 mu M. For dihydro-PCA, half-maximal velocity was observed at 35 mu M. K-cat was calculated as 0.435 s(-1). PpzP shows obvious sequence similarity to a recently discovered family of prenyltransferases with aromatic substrates, the ABBA prenyltransferases. The present finding extends the substrate range of this family, previously limited to phenolic compounds, to include also phenazine derivatives.	[Saleh, Orwah; Gust, Bertolt; Boll, Bjoern; Heide, Lutz] Univ Tubingen, Inst Pharmazeut, D-72076 Tubingen, Germany; [Fiedler, Hans-Peter] Univ Tubingen, Inst Mikrobiol, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen	Heide, L (corresponding author), Univ Tubingen, Inst Pharmazeut, Morgenstelle 8, D-72076 Tubingen, Germany.	heide@uni-tuebingen.de	Boll, Björn/AAJ-2892-2020	Heide, Lutz/0000-0001-7809-7453	Deutsche Forschungsgemeinschaft [1152]; Tishrin University, Syria	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Tishrin University, Syria	This work was supported by Deutsche Forschungsgemeinschaft Grant SPP 1152 EVOMET (to L. H.) and by a scholarship from Tishrin University, Syria (to O.S.).	Ahuja EG, 2008, J AM CHEM SOC, V130, P17053, DOI 10.1021/ja806325k; Bringmann G, 2007, J ORG CHEM, V72, P4198, DOI 10.1021/jo0703404; Dairi T, 2005, J ANTIBIOT, V58, P227, DOI 10.1038/ja.2005.27; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Eustaquio AS, 2005, APPL ENVIRON MICROB, V71, P2452, DOI 10.1128/AEM.71.5.2452-2459.2005; Gebhardt K, 2002, J ANTIBIOT, V55, P794, DOI 10.7164/antibiotics.55.794; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; Gust B, 2004, ADV APPL MICROBIOL, V54, P107, DOI 10.1016/S0065-2164(04)54004-2; Haagen Y, 2007, FEBS LETT, V581, P2889, DOI 10.1016/j.febslet.2007.05.031; Haagen Y, 2006, CHEMBIOCHEM, V7, P2016, DOI 10.1002/cbic.200600338; Hopwood DA, 2007, STREPTOMYCES NATURE; ISSHIKI K, 1986, J ANTIBIOT, V39, P1634, DOI 10.7164/antibiotics.39.1634; Jez JM, 2000, BIOCHEMISTRY-US, V39, P890, DOI 10.1021/bi991489f; Kawasaki T, 2006, J BACTERIOL, V188, P1236, DOI 10.1128/JB.188.4.1236-1244.2006; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Krastel P, 2002, J ANTIBIOT, V55, P801, DOI 10.7164/antibiotics.55.801; Kumano T, 2008, BIOORGAN MED CHEM, V16, P8117, DOI 10.1016/j.bmc.2008.07.052; Kuzuyama T, 2003, NAT PROD REP, V20, P171, DOI 10.1039/b109860h; Kuzuyama T, 2005, NATURE, V435, P983, DOI 10.1038/nature03668; Laursen JB, 2004, CHEM REV, V104, P1663, DOI 10.1021/cr020473j; Mavrodi D.V., 2008, PSEUDOMONAS MODEL OR, P331; Mavrodi DV, 2001, J BACTERIOL, V183, P6454, DOI 10.1128/JB.183.21.6454-6465.2001; Pojer F, 2003, P NATL ACAD SCI USA, V100, P2316, DOI 10.1073/pnas.0337708100; Poulter C. Dale, 2006, Phytochemistry Reviews, V5, P17, DOI 10.1007/s11101-005-4887-1; Sambrook J., 2001, MOL CLONING LAB MANU; SEDMERA P, 1991, J NAT PROD, V54, P870, DOI 10.1021/np50075a022; Sigmund JM, 2003, MICROB ECOL, V46, P106, DOI 10.1007/s00248-002-2029-5; Takagi M, 2000, J BACTERIOL, V182, P4153, DOI 10.1128/JB.182.15.4153-4157.2000; TAX J, 1983, COLLECT CZECH CHEM C, V48, P527, DOI 10.1135/cccc19830527; Tello M, 2008, CELL MOL LIFE SCI, V65, P1459, DOI 10.1007/s00018-008-7579-3; WOODSIDE AB, 1988, ORG SYNTH, V66, P211	31	45	46	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14439	14447		10.1074/jbc.M901312200	http://dx.doi.org/10.1074/jbc.M901312200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19339241	hybrid, Green Published			2022-12-27	WOS:000266286100050
J	Sotillo, E; Garriga, J; Padgaonkar, A; Kurimchak, A; Cook, JG; Grana, X				Sotillo, Elena; Garriga, Judit; Padgaonkar, Amol; Kurimchak, Alison; Cook, Jeanette Gowen; Grana, Xavier			Coordinated Activation of the Origin Licensing Factor CDC6 and CDK2 in Resting Human Fibroblasts Expressing SV40 Small T Antigen and Cyclin E	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-CYCLE; DNA-REPLICATION; MAMMALIAN CDC6; A PROMOTER; E2F; GROWTH; TRANSFORMATION; TRANSCRIPTION; KINASE; PHOSPHORYLATION	We have previously shown that SV40 small t antigen (st) cooperates with deregulated cyclin E to activate CDK2 and bypass quiescence in normal human fibroblasts (NHF). Here we show that st expression in serum-starved and density-arrested NHF specifically induces up-regulation and loading of CDC6 onto chromatin. Coexpression of cyclin E results in further accumulation of CDC6 onto chromatin concomitantly with phosphorylation of CDK2 on Thr-160 and CDC6 on Ser-54. Investigation of the mechanism leading to CDC6 accumulation and chromatin loading indicates that st is a potent inducer of cdc6 mRNA expression and increases CDC6 protein stability. We also show that CDC6 expression in quiescent NHF efficiently promotes cyclin E loading onto chromatin, but it is not sufficient to activate CDK2. Moreover, we show that CDC6 expression is linked to phosphorylation of the activating T loop of CDK2 in serum-starved NHF stimulated with mitogens or ectopically expressing cyclin E and st. Our data suggest a model where the combination of st and deregulated cyclin E result in cooperative and coordinated activation of both an essential origin licensing factor, CDC6, and an activity required for origin firing, CDK2, resulting in progression from quiescence to S phase.	[Sotillo, Elena; Garriga, Judit; Padgaonkar, Amol; Kurimchak, Alison; Grana, Xavier] Temple Univ, Sch Med, Fels Inst Canc Res & Mol Biol, Philadelphia, PA 19140 USA; [Kurimchak, Alison; Grana, Xavier] Temple Univ, Sch Med, Dept Biochem, Philadelphia, PA 19140 USA; [Cook, Jeanette Gowen] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of North Carolina; University of North Carolina Chapel Hill	Grana, X (corresponding author), Temple Univ, Sch Med, Fels Inst Canc Res & Mol Biol, AHP Bldg Rm 308,3307 N Broad St, Philadelphia, PA 19140 USA.	xavier@temple.edu		Cook, Jeanette/0000-0003-0849-7405; Sotillo, Elena/0000-0002-3993-1932; Grana, Xavier/0000-0001-7134-0473	National Institutes of Health [CA095569]; Career Development Award [K02 AI01823]; NATIONAL CANCER INSTITUTE [P01CA095569, K01CA094907] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K02AI001823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083024] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Career Development Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant CA095569 (to X. G. and J. G.) and a Career Development Award (K02 AI01823) (to X. G.).	Abbas T, 2007, CELL CYCLE, V6, P843, DOI 10.4161/cc.6.7.4000; Araki K, 2008, ONCOGENE, V27, P5696, DOI 10.1038/onc.2008.184; Ausubel FM., 1988, CURRENT PROTOCOLS MO; Bartkova J, 2005, NATURE, V434, P864, DOI 10.1038/nature03482; Bhattacharya S, 2003, ONCOGENE, V22, P2443, DOI 10.1038/sj.onc.1206339; Calbo J, 2002, J BIOL CHEM, V277, P50263, DOI 10.1074/jbc.M209181200; Cook JG, 2002, P NATL ACAD SCI USA, V99, P1347, DOI 10.1073/pnas.032677499; Davis AJ, 2008, J BIOL CHEM, V283, P16104, DOI 10.1074/jbc.M710313200; Deeb KK, 2007, CANCER RES, V67, P8065, DOI 10.1158/0008-5472.CAN-07-1515; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; Duursma AM, 2005, CELL CYCLE, V4, P1725, DOI 10.4161/cc.4.12.2193; Furstenthal L, 2001, J CELL BIOL, V152, P1267, DOI 10.1083/jcb.152.6.1267; Garriga J, 2003, MOL CELL BIOL, V23, P5165, DOI 10.1128/MCB.23.15.5165-5173.2003; Geng Y, 2003, CELL, V114, P431, DOI 10.1016/S0092-8674(03)00645-7; Geng Y, 2007, MOL CELL, V25, P127, DOI 10.1016/j.molcel.2006.11.029; Grana X, 1998, ONCOGENE, V17, P3365, DOI 10.1038/sj.onc.1202575; Hahn WC, 2002, MOL CELL BIOL, V22, P2111, DOI 10.1128/MCB.22.7.2111-2123.2002; Hateboer G, 1998, MOL CELL BIOL, V18, P6679, DOI 10.1128/MCB.18.11.6679; Hwang HC, 2005, ONCOGENE, V24, P2776, DOI 10.1038/sj.onc.1208613; Kan QM, 2008, P NATL ACAD SCI USA, V105, P4757, DOI 10.1073/pnas.0706392105; Lolli G, 2005, CELL CYCLE, V4, P572, DOI 10.4161/cc.4.4.1607; Lolli G, 2004, STRUCTURE, V12, P2067, DOI 10.1016/j.str.2004.08.013; Machida YJ, 2005, CELL, V123, P13, DOI 10.1016/j.cell.2005.09.019; Machida YJ, 2005, J BIOL CHEM, V280, P6253, DOI 10.1074/jbc.R400037200; Mailand N, 2005, CELL, V122, P915, DOI 10.1016/j.cell.2005.08.013; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Melixetian M, 2004, J CELL BIOL, V165, P473, DOI 10.1083/jcb.200403106; Moroy T, 2004, INT J BIOCHEM CELL B, V36, P1424, DOI 10.1016/S1357-2725(03)00432-1; Ohtani K, 1998, ONCOGENE, V17, P1777, DOI 10.1038/sj.onc.1202105; OHTSUBO M, 1993, SCIENCE, V259, P1908, DOI 10.1126/science.8384376; Ortega S, 2003, NAT GENET, V35, P25, DOI 10.1038/ng1232; Petersen BO, 2000, GENE DEV, V14, P2330, DOI 10.1101/gad.832500; Porras A, 1996, J VIROL, V70, P6902; RESNITZKY D, 1994, MOL CELL BIOL, V14, P1669, DOI 10.1128/MCB.14.3.1669; Rowland BD, 2006, CELL, V127, P871, DOI 10.1016/j.cell.2006.11.019; Schlisio S, 2002, EMBO J, V21, P5775, DOI 10.1093/emboj/cdf577; Sclafani RA, 2007, ANNU REV GENET, V41, P237, DOI 10.1146/annurev.genet.41.110306.130308; SELLERS WR, 1995, P NATL ACAD SCI USA, V92, P11544, DOI 10.1073/pnas.92.25.11544; Skoczylas C, 2005, VIROLOGY, V332, P596, DOI 10.1016/j.virol.2004.12.017; Sotillo E, 2008, J BIOL CHEM, V283, P11280, DOI 10.1074/jbc.M709055200; Vilaboa N, 2004, NUCLEIC ACIDS RES, V32, P6454, DOI 10.1093/nar/gkh981; Yan Z, 1998, P NATL ACAD SCI USA, V95, P3603, DOI 10.1073/pnas.95.7.3603	42	10	10	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14126	14135		10.1074/jbc.M900687200	http://dx.doi.org/10.1074/jbc.M900687200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19321444	Green Published, hybrid			2022-12-27	WOS:000266286100019
J	Wydau, S; van der Rest, G; Aubard, C; Plateau, P; Blanquet, S				Wydau, Sandra; van der Rest, Guillaume; Aubard, Caroline; Plateau, Pierre; Blanquet, Sylvain			Widespread Distribution of Cell Defense against D-Aminoacyl-tRNAs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RADICAL SAM SUPERFAMILY; ESCHERICHIA-COLI; D-TYR-TRNA(TYR) DEACYLASE; D-TYROSINE; SACCHAROMYCES-CEREVISIAE; PROTEIN-SYNTHESIS; CRYSTAL-STRUCTURE; ACTIVE-SITE; BINDING; SYNTHETASE	Several L-aminoacyl-tRNA synthetases can transfer a D-amino acid onto their cognate tRNA(s). This harmful reaction is counteracted by the enzyme D-aminoacyl-tRNA deacylase. Two distinct deacylases were already identified in bacteria (DTD1) and in archaea (DTD2), respectively. Evidence was given that DTD1 homologs also exist in nearly all eukaryotes, whereas DTD2 homologs occur in plants. On the other hand, several bacteria, including most cyanobacteria, lack genes encoding a DTD1 homolog. Here we show that Synechocystis sp. PCC6803 produces a third type of deacylase (DTD3). Inactivation of the corresponding gene (dtd3) renders the growth of Synechocystis sp. hypersensitive to the presence of D-tyrosine. Based on the available genomes, DTD3-like proteins are predicted to occur in all cyanobacteria. Moreover, one or several dtd3-like genes can be recognized in all cellular types, arguing in favor of the near-ubiquity of an enzymatic function involved in the defense of translational systems against invasion by D-amino acids.	[Wydau, Sandra; Aubard, Caroline; Plateau, Pierre; Blanquet, Sylvain] Ecole Polytech, CNRS, Biochim Lab, F-91128 Palaiseau, France; [van der Rest, Guillaume] Ecole Polytech, CNRS, Lab Mecanismes React, F-91128 Palaiseau, France	Centre National de la Recherche Scientifique (CNRS); Institut Polytechnique de Paris; Centre National de la Recherche Scientifique (CNRS); Institut Polytechnique de Paris	Plateau, P (corresponding author), Ecole Polytech, CNRS, Biochim Lab, F-91128 Palaiseau, France.	pierre.plateau@polytechnique.edu	van der Rest, Guillaume/AAW-7349-2020	van der Rest, Guillaume/0000-0002-1176-620X; launay, caroline/0000-0002-6587-6631; Wydau-Dematteis, Sandra/0000-0003-2023-3656	Agence Nationale de la Recherche, 2005-2008	Agence Nationale de la Recherche, 2005-2008(French National Research Agency (ANR))	This work was supported by a grant from the Agence Nationale de la Recherche, 2005-2008.	CALENDAR R, 1966, BIOCHEMISTRY-US, V5, P1690, DOI 10.1021/bi00869a034; CALENDAR R, 1967, J MOL BIOL, V26, P39, DOI 10.1016/0022-2836(67)90259-8; Chong YE, 2008, J BIOL CHEM, V283, P30073, DOI 10.1074/jbc.M805943200; DARDEL F, 1994, COMPUT APPL BIOSCI, V10, P273; Ferri-Fioni ML, 2006, J BIOL CHEM, V281, P27575, DOI 10.1074/jbc.M605860200; Ferri-Fioni ML, 2001, J BIOL CHEM, V276, P47285, DOI 10.1074/jbc.M106550200; Frey PA, 2008, CRIT REV BIOCHEM MOL, V43, P63, DOI [10.1080/10409230701829169, 10.1080/10409230701829169 ]; GomezOrtiz M, 1997, FEBS LETT, V400, P336, DOI 10.1016/S0014-5793(96)01412-3; Guillon L, 2005, BIOCHEMISTRY-US, V44, P15594, DOI 10.1021/bi051514j; HOLLAND DR, 1995, PROTEIN SCI, V4, P1955, DOI 10.1002/pro.5560041001; Holm L, 1997, PROTEINS, V28, P72, DOI 10.1002/(SICI)1097-0134(199705)28:1<72::AID-PROT7>3.0.CO;2-L; Kemp M, 2007, J BIOL CHEM, V282, P10441, DOI 10.1074/jbc.M609632200; Lai WL, 2004, J BIOL CHEM, V279, P13962, DOI 10.1074/jbc.M308849200; Liaw SH, 2003, J BIOL CHEM, V278, P4957, DOI 10.1074/jbc.M210795200; MENNINGER JR, 1976, J BIOL CHEM, V251, P3392; Nakabachi A, 2006, SCIENCE, V314, P267, DOI 10.1126/science.1134196; Qiu JZ, 2005, J BIOL CHEM, V280, P15370, DOI 10.1074/jbc.M413547200; Schmitt E, 1997, EMBO J, V16, P4760, DOI 10.1093/emboj/16.15.4760; Sheoran A, 2008, J BIOL CHEM, V283, P12971, DOI 10.1074/jbc.M801650200; Sheoran A, 2008, J BIOL CHEM, V283, P12960, DOI 10.1074/jbc.M801649200; Soutourina J, 2000, J BIOL CHEM, V275, P32535, DOI 10.1074/jbc.M005166200; Soutourina J, 1999, J BIOL CHEM, V274, P19109, DOI 10.1074/jbc.274.27.19109; Soutourina J, 2000, J BIOL CHEM, V275, P11626, DOI 10.1074/jbc.275.16.11626; Soutourina O, 2004, J BIOL CHEM, V279, P42560, DOI 10.1074/jbc.M402931200; Takayama T, 2005, BIOSCI BIOTECH BIOCH, V69, P1040, DOI 10.1271/bbb.69.1040; Tamames J, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-181; van den Bremer ETJ, 2002, PROTEIN SCI, V11, P1738, DOI 10.1110/ps.0200502; VIEIRA J, 1991, GENE, V100, P189, DOI 10.1016/0378-1119(91)90365-I; Wakayama M, 2000, BIOSCI BIOTECH BIOCH, V64, P1, DOI 10.1271/bbb.64.1; Wang SC, 2007, TRENDS BIOCHEM SCI, V32, P101, DOI 10.1016/j.tibs.2007.01.002; Wexler M, 2000, J BIOL CHEM, V275, P16717, DOI 10.1074/jbc.M000800200; Wydau S, 2007, NUCLEIC ACIDS RES, V35, P930, DOI 10.1093/nar/gkl1145; YAMANE T, 1981, BIOCHEMISTRY-US, V20, P7059, DOI 10.1021/bi00528a001; Yang HB, 2003, FEBS LETT, V552, P95, DOI 10.1016/S0014-5793(03)00858-5; YANG YB, 1992, BIOSCI BIOTECH BIOCH, V56, P1392, DOI 10.1271/bbb.56.1392; Zheng G, 2009, BIOCHEM J, V417, P85, DOI 10.1042/BJ20080617	36	30	34	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14096	14104		10.1074/jbc.M808173200	http://dx.doi.org/10.1074/jbc.M808173200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19332551	hybrid, Green Published			2022-12-27	WOS:000266286100016
J	Roohvand, F; Maillard, P; Lavergne, JP; Boulant, S; Walic, M; Andreo, U; Goueslain, L; Helle, F; Mallet, A; McLauchlan, J; Budkowska, A				Roohvand, Farzin; Maillard, Patrick; Lavergne, Jean-Pierre; Boulant, Steeve; Walic, Marine; Andreo, Ursula; Goueslain, Lucie; Helle, Francois; Mallet, Adeline; McLauchlan, John; Budkowska, Agata			Initiation of Hepatitis C Virus Infection Requires the Dynamic Microtubule Network ROLE OF THE VIRAL NUCLEOCAPSID PROTEIN	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORE PROTEIN; LIPID DROPLET; MATRIX PROTEIN; TUBULIN; ASSOCIATION; TRANSPORT; ENTRY; DYNEIN; DETERMINANTS; TRAFFICKING	Early events leading to the establishment of hepatitis C virus (HCV) infection are not completely understood. We show that intact and dynamic microtubules play a key role in the initiation of productive HCV infection. Microtubules were required for virus entry into cells, as evidenced using virus pseudotypes presenting HCV envelope proteins on their surface. Studies carried out using the recent infectious HCV model revealed that microtubules also play an essential role in early, postfusion steps of the virus cycle. Moreover, low concentrations of vinblastin and nocodazol, microtubule-affecting drugs, and paclitaxel, which stabilizes microtubules, inhibited infection, suggesting that microtubule dynamic instability and/or treadmilling mechanisms are involved in HCV internalization and early transport. By protein chip and direct core-dependent pull-down assays, followed by mass spectrometry, we identified beta- and alpha-tubulin as cellular partners of the HCV core protein. Surface plasmon resonance analyses confirmed that core directly binds to tubulin with high affinity via amino acids 2-117. The interaction of core with tubulin in vitro promoted its polymerization and enhanced the formation of microtubules. Immune electron microscopy showed that HCV core associates, at least temporarily, with microtubules polymerized in its presence. Studies by confocal microscopy showed a juxtaposition of core with microtubules in HCV-infected cells. In summary, we report that intact and dynamic microtubules are required for virus entry into cells and for early postfusion steps of infection. HCV may exploit a direct interaction of core with tubulin, enhancing microtubule polymerization, to establish efficient infection and promote virus transport and/or assembly in infected cells.	[Roohvand, Farzin; Maillard, Patrick; Walic, Marine; Andreo, Ursula; Budkowska, Agata] Inst Pasteur, Unite Hepacivirus & Immunite Innee, F-75724 Paris, France; [Lavergne, Jean-Pierre] Univ Lyon 1, CNRS, IBCP UMR 5086, F-69367 Lyon, France; [Boulant, Steeve; McLauchlan, John] Med Res Council Virol Unit, Glasgow G11 5JR, Lanark, Scotland; [Goueslain, Lucie; Helle, Francois] Univ Lille 1, CNRS, Inst Pasteur Lille, Inst Biol Lille,UMR8161, F-59021 Lille, France; [Goueslain, Lucie; Helle, Francois] Univ Lille 2, CNRS, Inst Pasteur Lille, Inst Biol Lille,UMR8161, F-59021 Lille, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille	Budkowska, A (corresponding author), Inst Pasteur, Unite Hepacivirus & Immunite Innee, 25-28 Rue Dr Roux, F-75724 Paris, France.	agata.budkowska@pasteur.fr	Roohvand, Farzin/K-8931-2018; Boulant, Steeve/W-3754-2019; HELLE, Francois/G-7427-2011	Roohvand, Farzin/0000-0002-9597-3555; Boulant, Steeve/0000-0001-8614-4993; HELLE, Francois/0000-0001-6884-2456	Agence Nationale de Recherche sur le SIDA et les Hepatites Virales (ANRS); Action Concerte de l'Institut Pasteur; Reseau de l'Institut Pasteur (RIP); MRC [MC_U130184143] Funding Source: UKRI; Medical Research Council [MC_U130184143] Funding Source: researchfish	Agence Nationale de Recherche sur le SIDA et les Hepatites Virales (ANRS)(ANRSFrench National Research Agency (ANR)); Action Concerte de l'Institut Pasteur; Reseau de l'Institut Pasteur (RIP); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported in part by grants from the Agence Nationale de Recherche sur le SIDA et les Hepatites Virales (ANRS) and Action Concerte de l'Institut Pasteur.; Supported by fellowship grants from the Reseau de l'Institut Pasteur (RIP) and the ANRS.; Supported by doctoral fellowship grants from the ANRS.	Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Blanchard E, 2006, J VIROL, V80, P6964, DOI 10.1128/JVI.00024-06; Boulant S, 2003, J BIOL CHEM, V278, P45785, DOI 10.1074/jbc.M307174200; Boulant S, 2008, TRAFFIC, V9, P1268, DOI 10.1111/j.1600-0854.2008.00767.x; Boulant S, 2007, J GEN VIROL, V88, P2204, DOI 10.1099/vir.0.82898-0; Boulant S, 2006, J BIOL CHEM, V281, P22236, DOI 10.1074/jbc.M601031200; Boyko V, 2000, PLANT J, V22, P315, DOI 10.1046/j.1365-313x.2000.00740.x; BURLONE M, 2009, J GEN VIROL IN PRESS, V90; de Mareuil J, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-5; de Soultrait VR, 2002, BBA-GENE STRUCT EXPR, V1575, P40, DOI 10.1016/S0167-4781(02)00241-5; Dohner K, 2005, TRENDS MICROBIOL, V13, P320, DOI 10.1016/j.tim.2005.05.010; Drukman S, 2002, INT J ONCOL, V21, P621; Drummer HE, 2003, FEBS LETT, V546, P385, DOI 10.1016/S0014-5793(03)00635-5; Elliott G, 1998, J VIROL, V72, P6448, DOI 10.1128/JVI.72.8.6448-6455.1998; Fan ZY, 1999, J MED VIROL, V59, P131, DOI 10.1002/(SICI)1096-9071(199910)59:2<131::AID-JMV1>3.3.CO;2-3; Funk A, 2004, J VIROL, V78, P8289, DOI 10.1128/jvi.78.15.8289-8300.2004; GEORGI A, 1990, P NATL ACAD SCI USA, V87, P6579, DOI 10.1073/pnas.87.17.6579; Gosert R, 2003, J VIROL, V77, P5487, DOI 10.1128/JVI.77.9.5487-5492.2003; Greber UF, 2006, CELL, V124, P741, DOI 10.1016/j.cell.2006.02.018; Gross SP, 2007, CURR BIOL, V17, pR478, DOI 10.1016/j.cub.2007.04.025; Heald R, 2002, J CELL SCI, V115, P3; Hope RG, 2000, J GEN VIROL, V81, P1913, DOI 10.1099/0022-1317-81-8-1913; Hsu M, 2003, P NATL ACAD SCI USA, V100, P7271, DOI 10.1073/pnas.0832180100; Jones DM, 2007, J GEN VIROL, V88, P470, DOI 10.1099/vir.0.82363-0; JORDAN MA, 1992, J CELL SCI, V102, P401; Jordan MA, 1998, METHOD ENZYMOL, V298, P252, DOI 10.1016/S0076-6879(98)98024-7; Kaelin K, 2000, J VIROL, V74, P474, DOI 10.1128/JVI.74.1.474-482.2000; Kalicharran K, 1996, TRENDS MICROBIOL, V4, P264, DOI 10.1016/0966-842X(96)10045-7; Lai CK, 2008, J VIROL, V82, P8838, DOI 10.1128/JVI.00398-08; Luby-Phelps K, 2000, INT REV CYTOL, V192, P189; Luduena RF, 1998, INT REV CYTOL, V178, P207; Mabit H, 2002, J VIROL, V76, P9962, DOI 10.1128/JVI.76.19.9962-9971.2002; Maillard P, 2004, J BIOL CHEM, V279, P2430, DOI 10.1074/jbc.M311470200; Maillard P, 2006, FASEB J, V20, P735, DOI 10.1096/fj.05-4728fje; MAMBER SW, 1995, J PHARMACOL EXP THER, V274, P877; McLauchlan J, 2002, EMBO J, V21, P3980, DOI 10.1093/emboj/cdf414; Meertens L, 2006, J VIROL, V80, P11571, DOI 10.1128/JVI.01717-06; MELKI R, 1994, VIROLOGY, V202, P339, DOI 10.1006/viro.1994.1350; Miller LM, 2008, BIOCHEMISTRY-US, V47, P7572, DOI 10.1021/bi8005225; Miyanari Y, 2007, NAT CELL BIOL, V9, P1089, DOI 10.1038/ncb1631; Naranatt PP, 2005, J VIROL, V79, P1191, DOI 10.1128/JVI.79.2.1191-1206.2005; Nejmeddine M, 2000, J VIROL, V74, P3313, DOI 10.1128/JVI.74.7.3313-3320.2000; Nogales E, 2000, ANNU REV BIOCHEM, V69, P277, DOI 10.1146/annurev.biochem.69.1.277; Ogawa-Goto K, 2003, J VIROL, V77, P8541, DOI 10.1128/JVI.77.15.8541-8547.2003; Ogino T, 2003, BIOCHEM BIOPH RES CO, V311, P283, DOI 10.1016/j.bbrc.2003.09.205; Pawlotsky JM, 2004, TRENDS MICROBIOL, V12, P96, DOI 10.1016/j.tim.2003.12.005; Penin F, 2004, HEPATOLOGY, V39, P5, DOI 10.1002/hep.20032; Ploubidou A, 2000, EMBO J, V19, P3932, DOI 10.1093/emboj/19.15.3932; Ploubidou A, 2001, CURR OPIN CELL BIOL, V13, P97, DOI 10.1016/S0955-0674(00)00180-0; Quarmby L, 2000, J CELL SCI, V113, P2821; Rodionov VI, 1997, SCIENCE, V275, P215, DOI 10.1126/science.275.5297.215; Ruthel G, 2005, J VIROL, V79, P4709, DOI 10.1128/JVI.79.8.4709-4719.2005; Sanjuan N, 2003, VIROLOGY, V313, P105, DOI 10.1016/S0042-6822(03)00309-X; Schliwa M, 2003, NATURE, V422, P759, DOI 10.1038/nature01601; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sodeik B, 2000, TRENDS MICROBIOL, V8, P465, DOI 10.1016/S0966-842X(00)01824-2; Sodeik B, 1997, J CELL BIOL, V136, P1007, DOI 10.1083/jcb.136.5.1007; SULLIVAN KF, 1988, ANNU REV CELL BIOL, V4, P687, DOI 10.1146/annurev.cb.04.110188.003351; Suomalainen M, 1999, J CELL BIOL, V144, P657, DOI 10.1083/jcb.144.4.657; Suzuki R, 2005, J VIROL, V79, P1271, DOI 10.1128/JVI.79.2.1271-1281.2005; TAKAHASHI K, 1992, VIROLOGY, V191, P431, DOI 10.1016/0042-6822(92)90204-3; Targett-Adams P, 2005, J GEN VIROL, V86, P3075, DOI 10.1099/vir.0.81334-0; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Welte MA, 2004, CURR BIOL, V14, pR525, DOI 10.1016/j.cub.2004.06.045; Wolk B, 2008, J VIROL, V82, P10519, DOI 10.1128/JVI.00640-08; Yonezawa A, 2005, J VIROL, V79, P918, DOI 10.1128/JVI.79.2.918-926.2005	66	64	67	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13778	13791		10.1074/jbc.M807873200	http://dx.doi.org/10.1074/jbc.M807873200			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19269968	Green Published, hybrid			2022-12-27	WOS:000265877300055
J	Smriti; Zou, P; Mchaourab, HS				Smriti; Zou, Ping; Mchaourab, Hassane S.			Mapping Daunorubicin-binding Sites in the ATP-binding Cassette Transporter MsbA Using Site-specific Quenching by Spin Labels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ABC FAMILY TRANSPORTER; ESCHERICHIA-COLI MSBA; P-GLYCOPROTEIN; MULTIDRUG TRANSPORTER; DRUG-BINDING; STRUCTURAL MECHANISMS; ANTIBIOTIC-RESISTANCE; FEMTOSECOND DYNAMICS; CYTOPLASMIC MEMBRANE; MUTATIONAL ANALYSIS	ATP-binding cassette (ABC) transporters transduce the free energy of ATP hydrolysis to power the mechanical work of substrate translocation across cell membranes. MsbA is an ABC transporter implicated in trafficking lipid A across the inner membrane of Escherichia coli. It has sequence similarity and overlapping substrate specificity with multidrug ABC transporters that export cytotoxic molecules in humans and prokaryotes. Despite rapid advances in structure determination of ABC efflux transporters, little is known regarding the location of substrate-binding sites in the transmembrane segment and the translocation pathway across the membrane. In this study, we have mapped residues proximal to the daunorubicin (DNR)-binding site in MsbA using site-specific, ATP-dependent quenching of DNR intrinsic fluorescence by spin labels. In the nucleotide-free MsbA intermediate, DNR-binding residues cluster at the cytoplasmic end of helices 3 and 6 at a site accessible from the membrane/water interface and extending into an aqueous chamber formed at the interface between the two transmembrane domains. Binding of a nonhydrolyzable ATP analog inverts the transporter to an outward-facing conformation and relieves DNR quenching by spin labels suggesting DNR exclusion from proximity to the spin labels. The simplest model consistent with our data has DNR entering near an elbow helix parallel to the water/membrane interface, partitioning into the open chamber, and then translocating toward the periplasm upon ATP binding.	[Smriti; Zou, Ping; Mchaourab, Hassane S.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	Vanderbilt University	Mchaourab, HS (corresponding author), 2215 Garland Ave,741 Light Hall, Nashville, TN 37232 USA.	mchaourab@vanderbilt.edu	Mishra, Smriti/D-4034-2009	Mishra, Smriti/0000-0002-6765-5007	National Institutes of Health [R01-GM077659]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077659] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-GM077659 from the NIGMS.	Bolhuis H, 1996, EMBO J, V15, P4239, DOI 10.1002/j.1460-2075.1996.tb00798.x; Borbat PP, 2007, PLOS BIOL, V5, P2211, DOI 10.1371/journal.pbio.0050271; Borst P, 2002, ANNU REV BIOCHEM, V71, P537, DOI 10.1146/annurev.biochem.71.102301.093055; Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07; Davidson AL, 2007, TRENDS MICROBIOL, V15, P448, DOI 10.1016/j.tim.2007.09.005; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Doerrler WT, 2006, MOL MICROBIOL, V60, P542, DOI 10.1111/j.1365-2958.2006.05130.x; Doerrler WT, 2002, J BIOL CHEM, V277, P36697, DOI 10.1074/jbc.M205857200; Doerrler WT, 2001, J BIOL CHEM, V276, P11461, DOI 10.1074/jbc.C100091200; Dong JH, 2005, SCIENCE, V308, P1023, DOI 10.1126/science.1106592; Eckford PDW, 2008, J BIOL CHEM, V283, P12840, DOI 10.1074/jbc.M708274200; EFTINK MR, 1981, ANAL BIOCHEM, V114, P199, DOI 10.1016/0003-2697(81)90474-7; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Gottesman MM, 2001, J BIOENERG BIOMEMBR, V33, P453, DOI 10.1023/A:1012866803188; GOTTESMAN MM, 1993, ANNU REV BIOCHEM, V62, P385, DOI 10.1146/annurev.bi.62.070193.002125; HIGGINS CF, 1992, TRENDS BIOCHEM SCI, V17, P18, DOI 10.1016/0968-0004(92)90419-A; Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836; HIGGINS CF, 1986, NATURE, V323, P448, DOI 10.1038/323448a0; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; Koteiche HA, 2003, BIOCHEMISTRY-US, V42, P6099, DOI 10.1021/bi0342867; Linton KJ, 2007, PFLUG ARCH EUR J PHY, V453, P555, DOI 10.1007/s00424-006-0126-x; Liu RH, 1996, BIOCHEMISTRY-US, V35, P11865, DOI 10.1021/bi960823u; LONDON E, 1982, MOL CELL BIOCHEM, V45, P181; Loo TW, 2008, ARCH BIOCHEM BIOPHYS, V476, P51, DOI 10.1016/j.abb.2008.02.025; Lugo MR, 2005, BIOCHEMISTRY-US, V44, P643, DOI 10.1021/bi0485326; Martin C, 2000, BIOCHEMISTRY-US, V39, P11901, DOI 10.1021/bi000559b; Martin C, 2001, BIOCHEMISTRY-US, V40, P15733, DOI 10.1021/bi011211z; Monaco HL, 1997, EMBO J, V16, P1475, DOI 10.1093/emboj/16.7.1475; Murakami S, 2008, CURR OPIN STRUC BIOL, V18, P459, DOI 10.1016/j.sbi.2008.06.007; Murakami S, 2006, NATURE, V443, P173, DOI 10.1038/nature05076; Omote H, 2006, BIOPHYS J, V90, P4046, DOI 10.1529/biophysj.105.077743; Poelarends GJ, 2002, BBA-BIOENERGETICS, V1555, P1, DOI 10.1016/S0005-2728(02)00246-3; Polissi A, 1996, MOL MICROBIOL, V20, P1221, DOI 10.1111/j.1365-2958.1996.tb02642.x; Qu Q, 2002, BIOCHEMISTRY-US, V41, P4744, DOI 10.1021/bi0120897; Reuter G, 2003, J BIOL CHEM, V278, P35193, DOI 10.1074/jbc.M306226200; Rosenberg MF, 2001, EMBO J, V20, P5615, DOI 10.1093/emboj/20.20.5615; Schumacher MA, 2001, SCIENCE, V294, P2158, DOI 10.1126/science.1066020; Schumacher MA, 2002, MOL MICROBIOL, V45, P885, DOI 10.1046/j.1365-2958.2002.03039.x; Shapiro AB, 1997, EUR J BIOCHEM, V250, P122, DOI 10.1111/j.1432-1033.1997.00122.x; Sonveaux N, 1999, J BIOL CHEM, V274, P17649, DOI 10.1074/jbc.274.25.17649; van Veen HW, 1998, NATURE, V391, P291, DOI 10.1038/34669; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Woebking B, 2005, J BACTERIOL, V187, P6363, DOI 10.1128/JB.187.18.6363-6369.2005; Woebking B, 2008, BIOCHEMISTRY-US, V47, P10904, DOI 10.1021/bi800778d; Zhong DP, 2001, P NATL ACAD SCI USA, V98, P11867, DOI 10.1073/pnas.211440398; Zhong DP, 2001, P NATL ACAD SCI USA, V98, P11873, DOI 10.1073/pnas.211440298; Zhou ZM, 1998, J BIOL CHEM, V273, P12466, DOI 10.1074/jbc.273.20.12466	48	33	33	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13904	13913		10.1074/jbc.M900837200	http://dx.doi.org/10.1074/jbc.M900837200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19278995	Green Published, hybrid			2022-12-27	WOS:000265877300066
J	Kim, SJ; Nian, C; McIntosh, CHS				Kim, Su-Jin; Nian, Cuilan; McIntosh, Christopher H. S.			Glucose-dependent Insulinotropic Polypeptide and Glucagon-like Peptide-1 Modulate beta-Cell Chromatin Structure	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MITOSIS-SPECIFIC PHOSPHORYLATION; MITOTIC CHROMOSOME CONDENSATION; ACTIVATED PROTEIN-KINASE; HISTONE H3; TRANSCRIPTIONAL REGULATION; GENE-EXPRESSION; CREB; PATHWAY; STRESS; P38	Chromatin can exert a regulatory effect on gene transcription by modulating the access of transcription factors to target genes. In the present study, we examined whether nuclear actions of the incretin hormones, glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1, involve modulation of beta-cell chromatin structure. Stimulation of INS-1(832/13) beta-cells or dispersed mouse islets with glucose-dependent insulinotropic polypeptide or glucagon-like peptide1 resulted in the post-translational modification of core H3 histones, through acetylation and phosphorylation. Both increased histone H3 acetyltransferase and reduced histone deacetylase activities contributed. Subsequent studies demonstrated that incretin-mediated histone H3 modifications involved activation of protein kinase A, p42/44 mitogen-activated protein kinase (MAPK), and p38 MAPK signaling modules, resulting in the activation of mitogen-and stress-activated kinase-1. Additionally, modification of histone H3 increased its association with the transcription factor, phosphorylated cAMP-response element-binding protein (phosphoCREB) and with cAMP-responsive CREB coactivator 2. Incretin-activated CREB-related Bcl-2 transcription was greatly reduced by a histone acetyltransferase inhibitor, demonstrating the functional importance of histone H3 modification. This appears to be the first demonstration of beta-cell chromatin modification in response to the incretins and the studies indicate that their regulatory effects involve coordinated nuclear interactions between specific signaling modules, chromatin-modifying enzymes and transcription factors.	Univ British Columbia, Inst Life Sci, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada; Univ British Columbia, Inst Life Sci, Diabet Res Grp, Vancouver, BC V6T 1Z3, Canada	University of British Columbia; University of British Columbia	McIntosh, CHS (corresponding author), Univ British Columbia, Fac Med, Dept Cellular Physiol Sci, 2350 Hlth Sci Mall, Vancouver, BC V6T 1Z3, Canada.	mcintoch@interchange.ubc.ca			Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research ( to C. H. S. M.).	Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Berger SL, 2007, NATURE, V447, P407, DOI 10.1038/nature05915; Berger SL, 2002, CURR OPIN GENET DEV, V12, P142, DOI 10.1016/S0959-437X(02)00279-4; Bernstein BE, 2002, CHEM BIOL, V9, P1167, DOI 10.1016/S1074-5521(02)00265-X; Brubaker PL, 2004, ENDOCRINOLOGY, V145, P2653, DOI 10.1210/en.2004-0015; Cai R, 2001, BIOCHEM BIOPH RES CO, V283, P445, DOI 10.1006/bbrc.2001.4786; Canettieri G, 2003, NAT STRUCT BIOL, V10, P175, DOI 10.1038/nsb895; Chen YJ, 2007, J BIOL CHEM, V282, P27215, DOI 10.1074/jbc.M700264200; Cheung P, 2000, CELL, V103, P263, DOI 10.1016/S0092-8674(00)00118-5; CHRIVIA JC, 1993, NATURE, V365, P855, DOI 10.1038/365855a0; Chwang WB, 2007, J NEUROSCI, V27, P12732, DOI 10.1523/JNEUROSCI.2522-07.2007; Cress WD, 2000, J CELL PHYSIOL, V184, P1, DOI 10.1002/(SICI)1097-4652(200007)184:1<1::AID-JCP1>3.0.CO;2-7; Davie James R, 2003, Sci STKE, V2003, pPE33; DE CD, 1999, TRENDS BIOCHEM SCI, V24, P281; Deak M, 1998, EMBO J, V17, P4426, DOI 10.1093/emboj/17.15.4426; Delghandi MP, 2005, CELL SIGNAL, V17, P1343, DOI 10.1016/j.cellsig.2005.02.003; Drucker DJ, 2007, J CLIN INVEST, V117, P24, DOI 10.1172/JCI30076; Ehses JA, 2003, ENDOCRINOLOGY, V144, P4433, DOI 10.1210/en.2002-0068; Ehses JA, 2002, J BIOL CHEM, V277, P37088, DOI 10.1074/jbc.M205055200; Ferdaoussi M, 2008, DIABETES, V57, P1205, DOI 10.2337/db07-1214; Goto H, 1999, J BIOL CHEM, V274, P25543, DOI 10.1074/jbc.274.36.25543; Gray SG, 2001, EXP CELL RES, V262, P75, DOI 10.1006/excr.2000.5080; Gregory PD, 2001, EXP CELL RES, V265, P195, DOI 10.1006/excr.2001.5187; Hansen JC, 1998, BIOCHEMISTRY-US, V37, P17637, DOI 10.1021/bi982409v; Hendzel MJ, 1997, CHROMOSOMA, V106, P348, DOI 10.1007/s004120050256; Huang WC, 2005, MOL CELL BIOL, V25, P6592, DOI 10.1128/MCB.25.15.6592-6602.2005; Hui HX, 2003, ENDOCRINOLOGY, V144, P1444, DOI 10.1210/en.2002-220897; KARNWOWSKADESAU.P, 2007, BIOCHEM BIOPH RES CO, V361, P349; Kemp DM, 2001, ENDOCRINOLOGY, V142, P1179, DOI 10.1210/en.142.3.1179; Kim SJ, 2005, J BIOL CHEM, V280, P28692, DOI 10.1074/jbc.M504913200; Kim SJ, 2005, J BIOL CHEM, V280, P22297, DOI 10.1074/jbc.M500540200; Kim SJ, 2008, MOL CELL BIOL, V28, P1644, DOI 10.1128/MCB.00325-07; Klinger S, 2008, DIABETES, V57, P584, DOI 10.2337/db07-1414; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Larsen L, 2007, DIABETOLOGIA, V50, P779, DOI 10.1007/s00125-006-0562-3; MacDonald PE, 2001, MOL ENDOCRINOL, V15, P1423, DOI 10.1210/me.15.8.1423; Marmorstein R, 2001, CELL MOL LIFE SCI, V58, P693, DOI 10.1007/PL00000893; Merienne K, 2001, MOL CELL BIOL, V21, P7089, DOI 10.1128/MCB.21.20.7089-7096.2001; Michael LF, 2000, MOL CELL BIOL, V20, P1596, DOI 10.1128/MCB.20.5.1596-1603.2000; Preuss U, 2003, NUCLEIC ACIDS RES, V31, P878, DOI 10.1093/nar/gkg176; Saha RN, 2007, J IMMUNOL, V179, P7101, DOI 10.4049/jimmunol.179.10.7101; SCHREIBER E, 1989, NUCLEIC ACIDS RES, V17, P6419, DOI 10.1093/nar/17.15.6419; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Soloaga A, 2003, EMBO J, V22, P2788, DOI 10.1093/emboj/cdg273; Strahl BD, 2000, NATURE, V403, P41, DOI 10.1038/47412; Thiagalingam S, 2003, ANN NY ACAD SCI, V983, P84, DOI 10.1111/j.1749-6632.2003.tb05964.x; THORNE AW, 1990, EUR J BIOCHEM, V193, P701, DOI 10.1111/j.1432-1033.1990.tb19390.x; Workman JL, 1998, ANNU REV BIOCHEM, V67, P545, DOI 10.1146/annurev.biochem.67.1.545; Yusta B, 2006, CELL METAB, V4, P391, DOI 10.1016/j.cmet.2006.10.001	49	29	29	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12896	12904		10.1074/jbc.M809046200	http://dx.doi.org/10.1074/jbc.M809046200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19279000	Green Published, hybrid			2022-12-27	WOS:000265688300035
J	Qiu, ZJ; Dyer, KD; Xie, ZH; Radinger, M; Rosenberg, HF				Qiu, Zhijun; Dyer, Kimberly D.; Xie, Zhihui; Radinger, Madeleine; Rosenberg, Helene F.			GATA Transcription Factors Regulate the Expression of the Human Eosinophil-derived Neurotoxin (RNase 2) Gene	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LEUKEMIA-CELL LINE; INTRONIC ENHANCER; CATIONIC PROTEIN; RIBONUCLEASE GENES; RNS2 GENE; PROMOTER; FAMILY; DIFFERENTIATION; EVOLUTION; SEQUENCE	The transcription factors GATA-1 and GATA-2 have been implicated in promoting differentiation of eosinophilic leukocytes. In this study, we examined the roles of GATA-1 and GATA-2 in activating transcription of the secretory ribonuclease, the eosinophil- derived neurotoxin (EDN/RNase 2). Augmented expression of both GATA-1 and GATA-2 was detected in eosinophil promyelocyte HL-60 clone 15 cells in response to biochemical differentiation with butyric acid. Deletion or mutation of one or both of the two consensus GATA-binding sites in the extended 1000-bp 5' promoter of the EDN gene resulted in profound reduction in reporter gene activity. Antibody-augmented electrophoretic mobility shift and chromatin immunoprecipitation analyses indicate that GATA-1 and GATA-2 proteins bind to both functional GATA consensus sequences in the EDN promoter. Interestingly, RNA silencing of GATA-1 alone had no impact on EDN expression; silencing of GATA-2 resulted in diminished expression of EDN, and also diminished expression of GATA-1 in both butyric acid-induced HL-60 clone 15 cells and in differentiating human eosinophils derived from CD34(+) hematopoietic progenitors. Likewise, overexpression of GATA-2 in uninduced HL-60 clone 15 cells resulted in augmented transcription of both EDN and GATA-1. Taken together, our data suggest that GATA-2 functions directly via interactions with the EDN promoter and also indirectly, via its ability to regulate the expression of GATA-1 in differentiating eosinophils and eosinophil cell lines.	[Qiu, Zhijun; Dyer, Kimberly D.; Xie, Zhihui; Radinger, Madeleine; Rosenberg, Helene F.] NIAID, Lab Allerg Dis, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Rosenberg, HF (corresponding author), NIAID, Lab Allerg Dis, NIH, Bldg 10,Rm 11C215,9000 Rockville Pike, Bethesda, MD 20892 USA.	hrosenberg@niaid.nih.gov		Radinger, Madeleine/0000-0002-0652-7378	National Institutes of Health [AI00941, AI00942]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grants AI00941 and AI00942 NIAID (Division of Intramural Research).	Baltus B, 1999, J LEUKOCYTE BIOL, V66, P683, DOI 10.1002/jlb.66.4.683; Barnes PJ, 2001, J ALLERGY CLIN IMMUN, V108, pS72, DOI 10.1067/mai.2001.116435; Bedi R, 2009, BLOOD, V113, P317, DOI 10.1182/blood-2008-02-139741; Cantor AB, 2005, INT J HEMATOL, V81, P378, DOI 10.1532/IJH97.04180; DURACK DT, 1981, P NATL ACAD SCI-BIOL, V78, P5165, DOI 10.1073/pnas.78.8.5165; Dyer KD, 2004, MAMM GENOME, V15, P126, DOI 10.1007/s00335-003-2304-x; Dyer KD, 2007, J IMMUNOL, V179, P1693, DOI 10.4049/jimmunol.179.3.1693; Escoubet-Lozach L, 2002, J ALLERGY CLIN IMMUN, V110, P553, DOI 10.1067/mai.2002.128076; FISCHKOFF SA, 1984, J EXP MED, V160, P179, DOI 10.1084/jem.160.1.179; Foster PS, 2008, CURR MOL MED, V8, P585, DOI 10.2174/156652408785748013; FREDENS K, 1982, J ALLERGY CLIN IMMUN, V70, P361, DOI 10.1016/0091-6749(82)90025-2; Grass JA, 2003, P NATL ACAD SCI USA, V100, P8811, DOI 10.1073/pnas.1432147100; Handen JS, 1997, J BIOL CHEM, V272, P1665, DOI 10.1074/jbc.272.3.1665; Hirasawa R, 2002, J EXP MED, V195, P1379, DOI 10.1084/jem.20020170; Iwasaki H, 2006, GENE DEV, V20, P3010, DOI 10.1101/gad.1493506; Kirshenbaum AS, 1999, BLOOD, V94, P2333, DOI 10.1182/blood.V94.7.2333.419k30_2333_2342; KO LJ, 1993, MOL CELL BIOL, V13, P4011, DOI 10.1128/MCB.13.7.4011; Koury MJ, 2002, CURR OPIN HEMATOL, V9, P93, DOI 10.1097/00062752-200203000-00002; KULESSA H, 1995, GENE DEV, V9, P1250, DOI 10.1101/gad.9.10.1250; Larson KA, 1996, P NATL ACAD SCI USA, V93, P12370, DOI 10.1073/pnas.93.22.12370; Leckie Maggie J, 2003, Am J Respir Med, V2, P245; Lowry JA, 2006, INT J BIOCHEM CELL B, V38, P6, DOI 10.1016/j.biocel.2005.06.017; McNagny K, 2002, J EXP MED, V195, pf43, DOI 10.1084/jem.20020636; Migliaccio AR, 2005, ANN NY ACAD SCI, V1044, P142, DOI 10.1196/annals.1349.019; NICOLIS S, 1991, NUCLEIC ACIDS RES, V19, P5285, DOI 10.1093/nar/19.19.5285; Ohneda K, 2002, ACTA HAEMATOL-BASEL, V108, P237, DOI 10.1159/000065660; Roboz G J, 1999, Curr Opin Hematol, V6, P164, DOI 10.1097/00062752-199905000-00007; Rosenberg HF, 2008, CURR PHARM BIOTECHNO, V9, P135, DOI 10.2174/138920108784567236; Rosenberg HF, 2008, J LEUKOCYTE BIOL, V83, P1079, DOI 10.1189/jlb.1107725; ROSENBERG HF, 1995, J BIOL CHEM, V270, P21539, DOI 10.1074/jbc.270.37.21539; ROSENBERG HF, 1989, P NATL ACAD SCI USA, V86, P4460, DOI 10.1073/pnas.86.12.4460; ROSENBERG HF, 1995, NAT GENET, V10, P219, DOI 10.1038/ng0695-219; Rothenberg ME, 2006, ANNU REV IMMUNOL, V24, P147, DOI 10.1146/annurev.immunol.24.021605.090720; Shimizu R, 2005, SEMIN CELL DEV BIOL, V16, P129, DOI 10.1016/j.semcdb.2004.11.001; Tang XB, 2001, CELL MOL LIFE SCI, V58, P2008, DOI 10.1007/PL00000833; Tiffany HL, 1996, J BIOL CHEM, V271, P12387, DOI 10.1074/jbc.271.21.12387; TIFFANY HL, 1995, J LEUKOCYTE BIOL, V58, P49; TSAI SF, 1991, GENE DEV, V5, P919, DOI 10.1101/gad.5.6.919; van Dijk TB, 1998, BLOOD, V91, P2126, DOI 10.1182/blood.V91.6.2126.2126_2126_2132; Wang HY, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-89; WEISS MJ, 1995, EXP HEMATOL, V23, P99; WEISS MJ, 1994, GENE DEV, V8, P1184, DOI 10.1101/gad.8.10.1184; Yamaguchi Y, 1999, BLOOD, V94, P1429, DOI 10.1182/blood.V94.4.1429.416k13_1429_1439; Yang D, 2000, J BIOL CHEM, V275, P9425, DOI 10.1074/jbc.275.13.9425; Yang D, 2008, J EXP MED, V205, P79, DOI 10.1084/jem.20062027; Yu CN, 2002, J EXP MED, V195, P1387, DOI 10.1084/jem.20020656; Zhang JZ, 2000, P NATL ACAD SCI USA, V97, P4701, DOI 10.1073/pnas.080071397; ZON LI, 1992, NUCLEIC ACIDS RES, V20, P1812, DOI 10.1093/nar/20.7.1812; ZON LI, 1993, BLOOD, V81, P3234	49	20	21	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					13099	13109		10.1074/jbc.M807307200	http://dx.doi.org/10.1074/jbc.M807307200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19279013	Green Published, hybrid			2022-12-27	WOS:000265688300057
J	Ferrari, SR; Grubb, J; Bishop, DK				Ferrari, Susan R.; Grubb, Jennifer; Bishop, Douglas K.			The Mei5-Sae3 Protein Complex Mediates Dmc1 Activity in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SINGLE-STRANDED-DNA; YEAST RAD52 PROTEIN; COLI RECA-PROTEIN; MEIOTIC RECOMBINATION; ESCHERICHIA-COLI; BINDING-PROTEIN; RAD51-MEDIATED RECOMBINATION; SCHIZOSACCHAROMYCES-POMBE; HOMOLOGOUS RECOMBINATION; SSB PROTEIN	During homologous recombination, a number of proteins cooperate to catalyze the loading of recombinases onto single-stranded DNA. Single-stranded DNA-binding proteins stimulate recombination by coating single-stranded DNA and keeping it free of secondary structure; however, in order for recombinases to load on single-stranded-DNA-binding protein-coated DNA, the activity of a class of proteins known as recombination mediators is required. Mediator proteins coordinate the handoff of single-stranded DNA from single-stranded DNA-binding protein to recombinase. Here we show that a complex of Mei5 and Sae3 from Saccharomyces cerevisiae preferentially binds single-stranded DNA and relieves the inhibition of the strand assimilation and DNA binding abilities of the meiotic recombinase Dmc1 imposed by the single-stranded DNA-binding protein replication protein A. Additionally, we demonstrate the physical interaction of Mei5-Sae3 with replication protein A. Our results, together with previous in vivo studies, indicate that Mei5-Sae3 is a mediator of Dmc1 assembly during meiotic recombination in S. cerevisiae.	[Bishop, Douglas K.] Univ Chicago, Cummings Life Sci Ctr, Comm Canc Biol, Chicago, IL 60637 USA; [Bishop, Douglas K.] Univ Chicago, Comm Genet, Chicago, IL 60637 USA; [Bishop, Douglas K.] Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA; [Ferrari, Susan R.; Grubb, Jennifer; Bishop, Douglas K.] Univ Chicago, Dept Radiat & Cellular Oncol, Chicago, IL 60637 USA	University of Chicago; University of Chicago; University of Chicago; University of Chicago	Bishop, DK (corresponding author), Univ Chicago, Cummings Life Sci Ctr, Comm Canc Biol, 920 E 58th St, Chicago, IL 60637 USA.	dbishop@midway.uchicago.edu			National Institutes of Health [RO1-50936]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institutes of Health Grant RO1-50936 from NIGMS.	Benson FE, 1998, NATURE, V391, P401, DOI 10.1038/34937; BIANCHI M, 1983, CELL, V34, P931, DOI 10.1016/0092-8674(83)90550-0; BISHOP DK, 1994, CELL, V79, P1081, DOI 10.1016/0092-8674(94)90038-8; BISHOP DK, 1992, CELL, V69, P439, DOI 10.1016/0092-8674(92)90446-J; Blat Y, 2002, CELL, V111, P791, DOI 10.1016/S0092-8674(02)01167-4; Ellermeier C, 2004, GENETICS, V168, P1891, DOI 10.1534/genetics.104.034280; Fukushima K, 2000, NUCLEIC ACIDS RES, V28, P2709, DOI 10.1093/nar/28.14.2709; Gasior SL, 2001, P NATL ACAD SCI USA, V98, P8411, DOI 10.1073/pnas.121046198; Gasior SL, 1998, GENE DEV, V12, P2208, DOI 10.1101/gad.12.14.2208; Golub EI, 1998, NUCLEIC ACIDS RES, V26, P5388, DOI 10.1093/nar/26.23.5388; Haruta N, 2006, NAT STRUCT MOL BIOL, V13, P823, DOI 10.1038/nsmb1136; Hayase A, 2004, CELL, V119, P927, DOI 10.1016/j.cell.2004.10.031; Hobbs MD, 2007, J BIOL CHEM, V282, P11058, DOI 10.1074/jbc.M611007200; Hong ERL, 2001, J BIOL CHEM, V276, P41906, DOI 10.1074/jbc.M105563200; JIANG H, 1993, J BIOL CHEM, V268, P7904; KIM CS, 1992, MOL CELL BIOL, V12, P3050, DOI 10.1128/MCB.12.7.3050; KOWALCZYKOWSKI SC, 1987, J MOL BIOL, V193, P81, DOI 10.1016/0022-2836(87)90629-2; Li ZF, 1997, P NATL ACAD SCI USA, V94, P11221, DOI 10.1073/pnas.94.21.11221; Lichten M, 1995, ANNU REV GENET, V29, P423, DOI 10.1146/annurev.ge.29.120195.002231; McKee AHZ, 1997, GENETICS, V146, P817; MODESTI M, 1996, THESIS WAYNE STATE U; Morimatsu K, 2003, MOL CELL, V11, P1337, DOI 10.1016/S1097-2765(03)00188-6; MORRICAL SW, 1986, BIOCHEMISTRY-US, V25, P1482, DOI 10.1021/bi00355a003; Mortensen UH, 1996, P NATL ACAD SCI USA, V93, P10729, DOI 10.1073/pnas.93.20.10729; MUNIYAPPA K, 1990, NUCLEIC ACIDS RES, V18, P3967, DOI 10.1093/nar/18.13.3967; Neale MJ, 2006, NATURE, V442, P153, DOI 10.1038/nature04885; New JH, 1998, NATURE, V391, P407, DOI 10.1038/34950; Pant K, 2008, J MOL BIOL, V380, P799, DOI 10.1016/j.jmb.2008.05.039; Park MS, 1996, J BIOL CHEM, V271, P18996, DOI 10.1074/jbc.271.31.18996; Plate I, 2008, J BIOL CHEM, V283, P29077, DOI 10.1074/jbc.M804881200; San Filippo J, 2006, J BIOL CHEM, V281, P11649, DOI 10.1074/jbc.M601249200; Shinohara A, 1997, GENES CELLS, V2, P615, DOI 10.1046/j.1365-2443.1997.1480347.x; SHINOHARA A, 1992, CELL, V69, P457, DOI 10.1016/0092-8674(92)90447-K; Shinohara A, 1998, NATURE, V391, P404, DOI 10.1038/34943; Shinohara A, 1998, GENES CELLS, V3, P145, DOI 10.1046/j.1365-2443.1998.00176.x; Sibenaller ZA, 1998, BIOCHEMISTRY-US, V37, P12496, DOI 10.1021/bi981110+; SIKORSKI RS, 1989, GENETICS, V122, P19; Sugawara N, 2003, MOL CELL, V12, P209, DOI 10.1016/S1097-2765(03)00269-7; Sugiyama T, 2002, J BIOL CHEM, V277, P31663, DOI 10.1074/jbc.M203494200; Sugiyama T, 1998, P NATL ACAD SCI USA, V95, P6049, DOI 10.1073/pnas.95.11.6049; SUNG P, 1994, SCIENCE, V265, P1241, DOI 10.1126/science.8066464; Sung P, 1997, GENE DEV, V11, P1111, DOI 10.1101/gad.11.9.1111; Sung P, 1997, J BIOL CHEM, V272, P28194, DOI 10.1074/jbc.272.45.28194; Sweezy MA, 1999, BIOCHEMISTRY-US, V38, P936, DOI 10.1021/bi9817055; Tsubouchi H, 2004, GENETICS, V168, P1219, DOI 10.1534/genetics.103.025700; UMEZU K, 1994, J BIOL CHEM, V269, P30005; Wolner B, 2003, MOL CELL, V12, P221, DOI 10.1016/S1097-2765(03)00242-9; Yang HJ, 2005, NATURE, V433, P653, DOI 10.1038/nature03234; YONESAKI T, 1989, J BIOL CHEM, V264, P7814; Young JA, 2004, GENETICS, V167, P593, DOI 10.1534/genetics.103.023762; Yuan SSF, 1999, CANCER RES, V59, P3547	51	38	39	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					11766	11770		10.1074/jbc.C900023200	http://dx.doi.org/10.1074/jbc.C900023200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19270307	Green Published, hybrid			2022-12-27	WOS:000265494600007
J	Dai, HM; Meng, XW; Lee, SH; Schneider, PA; Kaufmann, SH				Dai, Haiming; Meng, X. Wei; Lee, Sun-Hee; Schneider, Paula A.; Kaufmann, Scott H.			Context-dependent Bcl-2/Bak Interactions Regulate Lymphoid Cell Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEMBRANE PERMEABILIZATION; BH3-ONLY PROTEINS; BH3 DOMAINS; MITOCHONDRIAL APOPTOSIS; MEDIATED APOPTOSIS; FAMILY-MEMBERS; LEUKEMIA-CELLS; DEATH DOMAIN; ANNEXIN-V; B-CELLS	The release of cytochrome c from mitochondria, which leads to activation of the intrinsic apoptotic pathway, is regulated by interactions of Bax and Bak with antiapoptotic Bcl-2 family members. The factors that regulate these interactions are, at the present time, incompletely understood. Recent studies showing preferences in binding between synthetic Bcl-2 homology domain 3 and antiapoptotic Bcl-2 family members in vitro have suggested that the antiapoptotic proteins Mcl-1 and Bcl-xL, but not Bcl-2, restrain proapoptotic Bak from inducing mitochondrial membrane permeabilization and apoptosis. Here we show that Bak protein has a much higher affinity than the 26-amino acid Bak Bcl-2 homology domain 3 for Bcl-2, that some naturally occurring Bcl-2 allelic variants have an affinity for full-length Bak that is only 3-fold lower than that of Mcl-1, and that endogenous levels of these Bcl-2 variants ( which are asmuchas 40-fold more abundant than Mcl-1) restrain part of the Bak in intact lymphoid cells. In addition, we demonstrate that Bcl-2 variants can, depending on their affinity for Bak, substitute for Mcl-1 in protecting cells. Thus, the ability of Bcl-2 to protect cells from activated Bak depends on two important contextual variables, the identity of the Bcl-2 present and the amount expressed.	[Dai, Haiming; Meng, X. Wei; Schneider, Paula A.; Kaufmann, Scott H.] Mayo Clin, Div Oncol Res, Rochester, MN 55905 USA; [Meng, X. Wei; Lee, Sun-Hee; Kaufmann, Scott H.] Mayo Clin, Dept Mol Pharmacol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Kaufmann, SH (corresponding author), Mayo Clin, Div Oncol Res, Gonda 19-212,200 1st St SW, Rochester, MN 55905 USA.	Kaufmann.scott@mayo.edu		Kaufmann, Scott/0000-0002-4900-7145; Dai, Haiming/0000-0002-0484-7407	National Institutes of Health [R01 CA69008]; Mayo Foundation for Education and Research; NATIONAL CANCER INSTITUTE [R01CA069008] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Foundation for Education and Research; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA69008. This work was also supported by a Mayo Foundation for Education and Research predoctoral fellowship ( to S.-H. L.).	Adams JM, 2007, CURR OPIN IMMUNOL, V19, P488, DOI 10.1016/j.coi.2007.05.004; Adams KW, 2007, J BIOL CHEM, V282, P6192, DOI 10.1074/jbc.M610643200; Amundson SA, 2000, CANCER RES, V60, P6101; Berggard T, 2007, PROTEOMICS, V7, P2833, DOI 10.1002/pmic.200700131; Billen LP, 2008, PLOS BIOL, V6, P1268, DOI 10.1371/journal.pbio.0060147; Brumatti G, 2008, METHODS, V44, P235, DOI 10.1016/j.ymeth.2007.11.010; Certo M, 2006, CANCER CELL, V9, P351, DOI 10.1016/j.ccr.2006.03.027; Chen L, 2005, MOL CELL, V17, P393, DOI 10.1016/j.molcel.2004.12.030; Cheng EHY, 2003, SCIENCE, V301, P513, DOI 10.1126/science.1083995; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; CHITTENDEN T, 1995, NATURE, V374, P733, DOI 10.1038/374733a0; Chittenden T, 2002, CANCER CELL, V2, P165, DOI 10.1016/S1535-6108(02)00128-9; CHITTENDEN T, 1995, EMBO J, V14, P5589, DOI 10.1002/j.1460-2075.1995.tb00246.x; CLEARY ML, 1986, CELL, V47, P19, DOI 10.1016/0092-8674(86)90362-4; Cliby WA, 2002, J BIOL CHEM, V277, P1599, DOI 10.1074/jbc.M106287200; Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883; Czabotar PE, 2007, P NATL ACAD SCI USA, V104, P6217, DOI 10.1073/pnas.0701297104; Fletchera JI, 2008, P NATL ACAD SCI USA, V105, P18081, DOI 10.1073/pnas.0808691105; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Gomez TS, 2006, IMMUNITY, V24, P741, DOI 10.1016/j.immuni.2006.03.022; Griffiths GJ, 2001, ONCOGENE, V20, P7668, DOI 10.1038/sj.onc.1204995; Hackbarth JS, 2004, BIOTECHNIQUES, V37, P835; Harlow E, 1988, ANTIBODIES LABORATOR, P521; Hsu YT, 1997, J BIOL CHEM, V272, P13829, DOI 10.1074/jbc.272.21.13829; Hsu YT, 1998, J BIOL CHEM, V273, P10777, DOI 10.1074/jbc.273.17.10777; Jason-Moller L., 2006, CURRENT PROTOCOLS PR, DOI [10.1002/0471140864.ps1913-45, DOI 10.1002/0471140864.PS1913-45]; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Joseph MK, 2004, ONCOGENE, V23, P835, DOI 10.1038/sj.onc.1207141; Kim H, 2006, NAT CELL BIOL, V8, P1348, DOI 10.1038/ncb1499; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Lessene G, 2008, NAT REV DRUG DISCOV, V7, P989, DOI 10.1038/nrd2658; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Letai AG, 2008, NAT REV CANCER, V8, P121, DOI 10.1038/nrc2297; Lovell JF, 2008, CELL, V135, P1074, DOI 10.1016/j.cell.2008.11.010; MAUNG ZT, 1994, BRIT J HAEMATOL, V88, P105, DOI 10.1111/j.1365-2141.1994.tb04984.x; Meng XW, 2007, J BIOL CHEM, V282, P29831, DOI 10.1074/jbc.M706110200; Meng XW, 2003, J BIOL CHEM, V278, P47326, DOI 10.1074/jbc.M304793200; Meng XW, 2002, J BIOL CHEM, V277, P3776, DOI 10.1074/jbc.M107218200; Mesa RA, 2005, BLOOD, V106, P318, DOI 10.1182/blood-2004-09-3523; MIYASHITA T, 1992, CANCER RES, V52, P5407; Moldoveanu T, 2006, MOL CELL, V24, P677, DOI 10.1016/j.molcel.2006.10.014; Moulding DA, 2000, BLOOD, V96, P1756, DOI 10.1182/blood.V96.5.1756.h8001756_1756_1763; Opferman JT, 2005, SCIENCE, V307, P1101, DOI 10.1126/science.1106114; Petros AM, 2001, P NATL ACAD SCI USA, V98, P3012, DOI 10.1073/pnas.041619798; Puthalakath H, 2002, CELL DEATH DIFFER, V9, P505, DOI 10.1038/sj.cdd.4400998; RAFF MC, 1992, NATURE, V356, P397, DOI 10.1038/356397a0; Sattler M, 1997, SCIENCE, V275, P983, DOI 10.1126/science.275.5302.983; SETO M, 1988, EMBO J, V7, P123, DOI 10.1002/j.1460-2075.1988.tb02791.x; Shivakumar L, 2006, CLIN LYMPHOMA MYELOM, V6, P455, DOI 10.3816/CLM.2006.n.025; STEVENSON R, 1991, AM BIOTECHNOL LAB, V9, P12; STRASSER A, 1990, NATURE, V348, P331, DOI 10.1038/348331a0; TSUJIMOTO Y, 1985, SCIENCE, V228, P1440, DOI 10.1126/science.3874430; van Delft MF, 2006, CELL RES, V16, P203, DOI 10.1038/sj.cr.7310028; VANDENHOFF MJB, 1992, NUCLEIC ACIDS RES, V20, P2902, DOI 10.1093/nar/20.11.2902; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; Walensky LD, 2004, SCIENCE, V305, P1466, DOI 10.1126/science.1099191; Willis SN, 2007, SCIENCE, V315, P856, DOI 10.1126/science.1133289; Willis SN, 2005, GENE DEV, V19, P1294, DOI 10.1101/gad.1304105; Willis SN, 2005, CURR OPIN CELL BIOL, V17, P617, DOI 10.1016/j.ceb.2005.10.001; YIN XM, 1994, NATURE, V369, P321, DOI 10.1038/369321a0; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Zhai DY, 2008, J BIOL CHEM, V283, P9580, DOI 10.1074/jbc.M708426200	63	39	39	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 3	2009	284	27					18311	18322		10.1074/jbc.M109.004770	http://dx.doi.org/10.1074/jbc.M109.004770			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BW	19351886	Green Published, hybrid			2022-12-27	WOS:000267712400044
J	Kuhn, C; Frank, D; Will, R; Jaschinski, C; Frauen, R; Katus, HA; Frey, N				Kuhn, Christian; Frank, Derk; Will, Rainer; Jaschinski, Christoph; Frauen, Robert; Katus, Hugo A.; Frey, Norbert			DYRK1A Is a Novel Negative Regulator of Cardiomyocyte Hypertrophy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CARDIAC-HYPERTROPHY; IN-VIVO; PROTEIN-KINASE; PHOSPHORYLATION SITE; TARGETED INHIBITION; THERAPEUTIC TARGET; CALCINEURIN; HEART; SPECIFICITY; EXPRESSION	Activation of the phosphatase calcineurin and its downstream targets, transcription factors of the NFAT family, results in cardiomyocyte hypertrophy. Recently, it has been shown that the dual specificity tyrosine (Y) phosphorylation-regulated kinase 1A (DYRK1A) is able to antagonize calcineurin signaling by directly phosphorylating NFATs. We thus hypothesized that DYRK1A might modulate the hypertrophic response of cardiomyocytes. In a model of phenylephrine-induced hypertrophy, adenovirus-mediated overexpression of DYKR1A completely abrogated the hypertrophic response and significantly reduced the expression of the natriuretic peptides ANF and BNP. Furthermore, DYRK1A blunted cardiomyocyte hypertrophy induced by overexpression of constitutively active calcineurin and attenuated the induction of the hypertrophic gene program. Conversely, knockdown of DYRK1A, utilizing adenoviruses encoding for a specific synthetic miRNA, resulted in an increase in cell surface area accompanied by up-regulation of ANF-mRNA. Similarly, treatment of cardiomyocytes with harmine, a specific inhibitor of DYRK1A, revealed cardiomyocyte hypertrophy on morphological and molecular level. Moreover, constitutively active calcineurin led to robust induction of an NFAT-dependent luciferase reporter, whereas DYRK1A attenuated calcineurin-induced reporter activation in cardiomyocytes. Conversely, both knockdown and pharmacological inhibition of DYRK1A significantly augmented the effect of calcineurin in this assay. In summary, we identified DYRK1A as a novel negative regulator of cardiomyocyte hypertrophy. Mechanistically, this effect appears to be mediated via inhibition of NFAT transcription factors.	[Kuhn, Christian; Frey, Norbert] Univ Kiel, Dept Cardiol & Angiol, D-24105 Kiel, Germany; Univ Heidelberg Hosp, Dept Internal Med Cardiol Angiol & Pneumol 3, D-69120 Heidelberg, Germany	University of Kiel; Ruprecht Karls University Heidelberg	Frey, N (corresponding author), Univ Kiel, Dept Cardiol & Angiol, Schittenhelmstr 12, D-24105 Kiel, Germany.	norbert.frey@uk-sh.de	Frey, Norbert/A-9695-2010; Frey, Norbert/M-7749-2019	Frey, Norbert/0000-0001-7611-378X; Will, Rainer/0000-0001-6049-2690	Deutsche Forschungsgemeinschaft [FR1289/5-1]; Bundesministerium fur Bildung und Forschung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This work was supported by a grant from the Deutsche Forschungsgemeinschaft (DFG, FR1289/5-1) as well as by a grant from the Bundesministerium fur Bildung und Forschung (Nationales Genomforschungsnetz: NGFNplus, Germany) (to N.F. and H.A.K.).	Altafaj X, 2001, HUM MOL GENET, V10, P1915, DOI 10.1093/hmg/10.18.1915; Antos CL, 2002, P NATL ACAD SCI USA, V99, P907, DOI 10.1073/pnas.231619298; Arron JR, 2006, NATURE, V441, P595, DOI 10.1038/nature04678; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Becker W, 1998, J BIOL CHEM, V273, P25893, DOI 10.1074/jbc.273.40.25893; Branchi I, 2004, J NEUROPATH EXP NEUR, V63, P429, DOI 10.1093/jnen/63.5.429; Bueno OF, 2002, P NATL ACAD SCI USA, V99, P4586, DOI 10.1073/pnas.072647999; Davies KJA, 2007, FASEB J, V21, P3023, DOI 10.1096/fj.06-7246com; De Windt LJ, 2000, CIRC RES, V86, P255, DOI 10.1161/01.RES.86.3.255; De Windt LJ, 2001, P NATL ACAD SCI USA, V98, P3322, DOI 10.1073/pnas.031371998; Frank D, 2007, CIRCULATION, V116, P2587, DOI 10.1161/CIRCULATIONAHA.107.711317; Frey N, 2003, ANNU REV PHYSIOL, V65, P45, DOI 10.1146/annurev.physiol.65.092101.142243; Frey N, 2004, CIRCULATION, V109, P1580, DOI 10.1161/01.CIR.0000120390.68287.BB; Gwack Y, 2006, NATURE, V441, P646, DOI 10.1038/nature04631; Haq S, 2000, J CELL BIOL, V151, P117, DOI 10.1083/jcb.151.1.117; Hill JA, 2008, NEW ENGL J MED, V358, P1370, DOI 10.1056/NEJMra072139; Kentrup H, 1996, J BIOL CHEM, V271, P3488; LEVY D, 1990, NEW ENGL J MED, V322, P1561, DOI 10.1056/NEJM199005313222203; Mao JH, 2002, J BIOL CHEM, V277, P35156, DOI 10.1074/jbc.M206743200; Matsuo R, 2001, J IMMUNOL METHODS, V247, P141, DOI 10.1016/S0022-1759(00)00313-6; Molkentin JD, 1998, CELL, V93, P215, DOI 10.1016/S0092-8674(00)81573-1; Okui M, 1999, GENOMICS, V62, P165, DOI 10.1006/geno.1999.5998; Rothermel BA, 2001, P NATL ACAD SCI USA, V98, P3328, DOI 10.1073/pnas.041614798; Seifert A, 2008, FEBS J, V275, P6268, DOI 10.1111/j.1742-4658.2008.06751.x; Sitz JH, 2008, NEUROSCIENCE, V157, P596, DOI 10.1016/j.neuroscience.2008.09.034; Sugden PH, 2008, BRIT J PHARMACOL, V153, pS137, DOI 10.1038/sj.bjp.0707659; Taigen T, 2000, P NATL ACAD SCI USA, V97, P1196, DOI 10.1073/pnas.97.3.1196; Wilkins BJ, 2004, BIOCHEM BIOPH RES CO, V322, P1178, DOI 10.1016/j.bbrc.2004.07.121; Woods YL, 2001, BIOCHEM J, V355, P597, DOI 10.1042/bj3550597; Yang EJ, 2001, J BIOL CHEM, V276, P39819, DOI 10.1074/jbc.M104091200; Yang J, 2000, CIRC RES, V87, pE61, DOI 10.1161/01.RES.87.12.e61	31	59	61	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					17320	17327		10.1074/jbc.M109.006759	http://dx.doi.org/10.1074/jbc.M109.006759			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19372220	Green Published, hybrid			2022-12-27	WOS:000266962400067
J	Greig, SL; Radjainia, M; Mitra, AK				Greig, Sarah L.; Radjainia, Mazdak; Mitra, Alok K.			Oligomeric Structure of Colicin Ia Channel in Lipid Bilayer Membranes	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; FORMING DOMAIN; ION-CHANNEL; PROTEIN TRANSLOCATION; STATE; WATER; IDENTIFICATION; PURIFICATION; REFINEMENT; INSERTION	Colicin Ia is a soluble, harpoon-shaped bacteriocin which translocates across the periplasmic space of sensitive Escherichia coli cell by parasitizing an outer membrane receptor and forms voltage-gated ion channels in the inner membrane. This process leads to cell death, which has been thought to be caused by a single colicin Ia molecule. To directly visualize the three-dimensional structure of the channel, we generated two-dimensional crystals of colicin Ia inserted in lipid-bilayer membranes and determined a similar to 17 angstrom three-dimensional model by electron crystallography. Supported by velocity sedimentation, chemical cross-linking and single-particle image analysis, the three-dimensional structure is a crown-shaped oligomer enclosing a similar to 35 angstrom-wide extrabilayer vestibule. Our study suggests that lipid insertion instigates a global conformational change in colicin Ia and that more than one molecule participates in the channel architecture with the vestibule, possibly facilitating the known large scale peptide translocation upon channel opening.	[Greig, Sarah L.; Radjainia, Mazdak; Mitra, Alok K.] Univ Auckland, Sch Biol Sci, Auckland 1142, New Zealand	University of Auckland	Mitra, AK (corresponding author), Univ Auckland, Sch Biol Sci, Thomas Bldg,3A Symonds St, Auckland 1142, New Zealand.	a.mitra@auckland.ac.nz	Mitra, Alok/P-7800-2016	Mitra, Alok/0000-0003-0891-5697	National Institutes of Health [R21 DK060827]; Marsden Fund (New Zealand); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK060827] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marsden Fund (New Zealand)(Royal Society of New ZealandMarsden Fund (NZ)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grant R21 DK060827 (NIDDK). This work was also supported by a Marsden Fund (New Zealand) grant (to A. K. M.).	Antonsson B, 2000, BIOCHEM J, V345, P271, DOI 10.1042/0264-6021:3450271; Buchanan SK, 2007, EMBO J, V26, P2594, DOI 10.1038/sj.emboj.7601693; Cascales E, 2007, MICROBIOL MOL BIOL R, V71, P158, DOI 10.1128/MMBR.00036-06; CRAMER WA, 1995, ANNU REV BIOPH BIOM, V24, P611, DOI 10.1146/annurev.biophys.24.1.611; Crowther RA, 1996, J STRUCT BIOL, V116, P9, DOI 10.1006/jsbi.1996.0003; DUCHE D, 1994, J BIOL CHEM, V269, P6332; Dutzler R, 2007, FEBS LETT, V581, P2839, DOI 10.1016/j.febslet.2007.04.016; Elkins P, 1997, STRUCTURE, V5, P443, DOI 10.1016/S0969-2126(97)00200-1; Fivaz M, 2001, CURR TOP MICROBIOL, V257, P35; Hyun JK, 2007, J VIROL, V81, P11075, DOI 10.1128/JVI.00594-07; Jakes KS, 1999, Q REV BIOPHYS, V32, P189, DOI 10.1017/S0033583599003492; JARVIS LJ, 1995, CURR EYE RES, V14, P799, DOI 10.3109/02713689508995802; Kienker PK, 2008, J GEN PHYSIOL, V132, P693, DOI 10.1085/jgp.200810042; Kienker PK, 2000, J GEN PHYSIOL, V116, P587, DOI 10.1085/jgp.116.4.587; Kienker PK, 1997, J MEMBRANE BIOL, V157, P27, DOI 10.1007/s002329900213; Kienker PK, 2003, J GEN PHYSIOL, V122, P161, DOI 10.1085/jgp.200308852; Koebnik R, 2000, MOL MICROBIOL, V37, P239, DOI 10.1046/j.1365-2958.2000.01983.x; Krasilnikov OV, 1998, J MEMBRANE BIOL, V161, P83; KUHLBRANDT W, 1992, Q REV BIOPHYS, V25, P1; LEVINTHAL F, 1991, PROTEINS, V11, P254, DOI 10.1002/prot.340110404; Lindeberg M, 2000, J MOL BIOL, V295, P679, DOI 10.1006/jmbi.1999.3396; Luo WB, 2005, J AM CHEM SOC, V127, P6402, DOI 10.1021/ja0433121; MEL SF, 1993, BIOCHEMISTRY-US, V32, P2082, DOI 10.1021/bi00059a028; MIERCKE LJW, 1991, BIOCHEMISTRY-US, V30, P3088, DOI 10.1021/bi00226a016; Minn AJ, 1997, NATURE, V385, P353, DOI 10.1038/385353a0; Padmavathi PVL, 2008, J MOL BIOL, V378, P204, DOI 10.1016/j.jmb.2008.02.038; PARKER MW, 1992, J MOL BIOL, V224, P639, DOI 10.1016/0022-2836(92)90550-4; PARKER MW, 1993, TRENDS BIOCHEM SCI, V18, P391, DOI 10.1016/0968-0004(93)90096-6; Post PL, 2002, J BIOL CHEM, V277, P11679, DOI 10.1074/jbc.M111173200; Qiu XQ, 1996, J GEN PHYSIOL, V107, P313, DOI 10.1085/jgp.107.3.313; RADERMACHER M, 1987, J MICROSC-OXFORD, V146, P113, DOI 10.1111/j.1365-2818.1987.tb01333.x; Scheres SHW, 2005, BIOINFORMATICS, V21, P243, DOI 10.1093/bioinformatics/bti1140; Scheres SHW, 2005, J MOL BIOL, V348, P139, DOI 10.1016/j.jmb.2005.02.031; Scheres SHW, 2007, NAT METHODS, V4, P27, DOI 10.1038/NMETH992; SLATIN SL, 1988, INT J BIOCHEM, V20, P737, DOI 10.1016/0020-711X(88)90058-4; SLATIN SL, 1994, NATURE, V371, P158, DOI 10.1038/371158a0; Slatin SL, 2003, CEL MOL MEC TOX ACT, V5, P102; Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006; Stroud RM, 1998, CURR OPIN STRUC BIOL, V8, P525, DOI 10.1016/S0959-440X(98)80132-2; Verkman AS, 2000, AM J PHYSIOL-RENAL, V278, pF13, DOI 10.1152/ajprenal.2000.278.1.F13; Vetter IR, 1998, STRUCTURE, V6, P863, DOI 10.1016/S0969-2126(98)00088-4; Vinothkumar KR, 2006, J BIOL CHEM, V281, P4795, DOI 10.1074/jbc.M508993200; Wei ZK, 2007, BIOCHEMISTRY-US, V46, P6074, DOI 10.1021/bi700317k; Wiener M, 1997, NATURE, V385, P461, DOI 10.1038/385461a0; Yao XL, 2006, BIOCHEMISTRY-US, V45, P289, DOI 10.1021/bi051540h; Yeager M, 1999, Methods Enzymol, V294, P135	47	13	13	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16126	16134		10.1074/jbc.M900292200	http://dx.doi.org/10.1074/jbc.M900292200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19357078	Green Published, hybrid			2022-12-27	WOS:000266730900009
J	Lucas, ME; Crider, KS; Powell, DR; Kapoor-Vazirani, P; Vertino, PM				Lucas, Mary E.; Crider, Krista S.; Powell, Doris R.; Kapoor-Vazirani, Priya; Vertino, Paula M.			Methylation-sensitive Regulation of TMS1/ASC by the Ets Factor, GA-binding Protein-alpha	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION FACTOR GABP; LYSOZYME DOWNSTREAM ENHANCER; CASPASE RECRUITMENT DOMAIN; ABERRANT METHYLATION; DNA METHYLATION; ACTIVATING ADAPTER; PROSTATE-CANCER; GENE-EXPRESSION; BREAST-CANCER; RECEPTOR GENE	Epigenetic silencing involving the aberrant DNA methylation of promoter-associated CpG islands is one mechanism leading to the inactivation of tumor suppressor genes in human cancers. However, the molecular mechanisms underlying this event remains poorly understood. TMS1/ASC is a novel proapoptotic signaling factor that is subject to epigenetic silencing in human breast and other cancers. The TMS1 promoter is embedded within a CpG island that is unmethylated in normal cells and is spanned by three DNase I-hypersensitive sites (HS). Silencing of TMS1 in cancer cells is accompanied by local alterations in histone modification, remodeling of the HS, and hypermethylation of DNA. In this study, we probed the functional significance of the CpG island-specific HS. We identified a methylation-sensitive complex that bound a 55-bp intronic element corresponding to HS2. Affinity chromatography and mass spectrometry identified a component of this complex to be the GA-binding protein (GABP)alpha. Supershift analysis indicated that the GABP alpha binding partner, GABP beta 1, was also present in the complex. The HS2 element conferred a 3-fold enhancement in TMS1 promoter activity, which was dependent on both intact tandem ets binding sites and the presence of GABP alpha/beta 1 in trans. GABP alpha was selectively enriched at HS2 in human cells, and its occupancy was inversely correlated with CpG island methylation. Down-regulation of GABP alpha led to a concomitant decrease in TMS1 expression. These data indicate that the intronic HS2 element acts in cis to maintain transcriptional competency at the TMS1 locus and that this activity is mediated by the ets transcription factor, GABP alpha.	Emory Univ, Winship Canc Inst, Grad Program Genet & Mol Biol, Atlanta, GA 30322 USA; [Lucas, Mary E.; Powell, Doris R.; Kapoor-Vazirani, Priya; Vertino, Paula M.] Emory Univ, Winship Canc Inst, Dept Radiat Oncol & Hematol, Atlanta, GA 30322 USA; [Lucas, Mary E.; Powell, Doris R.; Kapoor-Vazirani, Priya; Vertino, Paula M.] Emory Univ, Winship Canc Inst, Dept Med Oncol, Atlanta, GA 30322 USA	Emory University; Emory University; Emory University	Vertino, PM (corresponding author), 1365-C Clifton Rd NE,Rm 4086, Atlanta, GA 30322 USA.	pvertin@emory.edu		Crider, Krista/0000-0001-6997-5955	National Institutes of Health NCI [2RO1 CA077337]; NATIONAL CANCER INSTITUTE [R01CA077337] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM078787, T32GM008490] Funding Source: NIH RePORTER	National Institutes of Health NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health NCI Grant 2RO1 CA077337.	Ammerpohl O, 1997, GENE, V200, P75, DOI 10.1016/S0378-1119(97)00377-6; Atlas E, 2001, ONCOGENE, V20, P7110, DOI 10.1038/sj.onc.1204890; Aurrekoetxea-Hernandez K, 2000, J VIROL, V74, P4988, DOI 10.1128/JVI.74.11.4988-4998.2000; BROWN TA, 1992, GENE DEV, V6, P2502, DOI 10.1101/gad.6.12b.2502; CARDOT P, 1994, BIOCHEMISTRY-US, V33, P12139, DOI 10.1021/bi00206a017; Collard RL, 2006, PROSTATE, V66, P687, DOI 10.1002/pros.20371; Conway KE, 2000, CANCER RES, V60, P6236; CROSS SH, 1995, CURR OPIN GENET DEV, V5, P309, DOI 10.1016/0959-437X(95)80044-1; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Flory E, 1996, J VIROL, V70, P2260, DOI 10.1128/JVI.70.4.2260-2268.1996; Guan X, 2003, INT J CANCER, V107, P202, DOI 10.1002/ijc.11376; Hasegawa M, 2007, ONCOGENE, V26, P1748, DOI 10.1038/sj.onc.1209965; Hashimshony T, 2003, NAT GENET, V34, P187, DOI 10.1038/ng1158; Herman JG, 2003, NEW ENGL J MED, V349, P2042, DOI 10.1056/NEJMra023075; Hoare S, 1999, ENDOCRINOLOGY, V140, P2268, DOI 10.1210/en.140.5.2268; Hollenhorst PC, 2007, GENE DEV, V21, P1882, DOI 10.1101/gad.1561707; Imaki H, 2003, CANCER RES, V63, P4607; Kang HS, 2008, J MOL BIOL, V377, P636, DOI 10.1016/j.jmb.2008.01.054; Kapoor-Vazirani P, 2008, CANCER RES, V68, P6810, DOI 10.1158/0008-5472.CAN-08-0141; Levine JJ, 2003, ONCOGENE, V22, P3475, DOI 10.1038/sj.onc.1206430; Masumoto J, 2003, BIOCHEM BIOPH RES CO, V303, P69, DOI 10.1016/S0006-291X(03)00309-7; McConnell BB, 2004, APOPTOSIS, V9, P5, DOI 10.1023/B:APPT.0000012117.32430.0c; Nickel J, 1995, NUCLEIC ACIDS RES, V23, P4785, DOI 10.1093/nar/23.23.4785; Ohtsuka T, 2004, NAT CELL BIOL, V6, P121, DOI 10.1038/ncb1087; Parsons MJ, 2006, ONCOGENE, V25, P6948, DOI 10.1038/sj.onc.1209684; Parsons MJ, 2009, CANCER RES, V69, P1706, DOI 10.1158/0008-5472.CAN-08-2351; Plass C, 2002, HUM MOL GENET, V11, P2479, DOI 10.1093/hmg/11.20.2479; Resendes KK, 2006, MOL CELL BIOL, V26, P3060, DOI 10.1128/MCB.26.8.3060-3070.2006; Ristevski S, 2004, MOL CELL BIOL, V24, P5844, DOI 10.1128/MCB.24.13.5844-5849.2004; Rosmarin  AG, 2004, BLOOD CELL MOL DIS, V32, P143, DOI 10.1016/j.bcmd.2003.09.005; Sawa C, 1996, NUCLEIC ACIDS RES, V24, P4954, DOI 10.1093/nar/24.24.4954; Schmitz A, 1997, J BIOL CHEM, V272, P20850, DOI 10.1074/jbc.272.33.20850; Schweppe RE, 2003, J BIOL CHEM, V278, P16863, DOI 10.1074/jbc.M213063200; Shiohara M, 2002, BIOCHEM BIOPH RES CO, V293, P1314, DOI 10.1016/S0006-291X(02)00384-4; Song JZ, 2002, ONCOGENE, V21, P1048, DOI 10.1038/sj.onc.1205153; Stehlik C, 2003, J IMMUNOL, V171, P6154, DOI 10.4049/jimmunol.171.11.6154; Stimson KM, 2002, J BIOL CHEM, V277, P4951, DOI 10.1074/jbc.M109809200; Stone AR, 2004, AM J PATHOL, V165, P1151, DOI 10.1016/S0002-9440(10)63376-7; Swigut T, 2007, CELL, V131, P29, DOI 10.1016/j.cell.2007.09.026; TATE PH, 1993, CURR OPIN GENET DEV, V3, P226, DOI 10.1016/0959-437X(93)90027-M; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; VIRBASIUS JV, 1991, MOL CELL BIOL, V11, P5631, DOI 10.1128/MCB.11.11.5631; Virmani A, 2003, INT J CANCER, V106, P198, DOI 10.1002/ijc.11206; Yang ZF, 2007, NAT CELL BIOL, V9, P339, DOI 10.1038/ncb1548; Yokomori N, 1998, MOL ENDOCRINOL, V12, P1241, DOI 10.1210/me.12.8.1241; YOKOMORI N, 1995, MOL CELL BIOL, V15, P5355; Yokoyama T, 2003, CANCER LETT, V202, P101, DOI 10.1016/j.canlet.2003.08.027; Zhao H, 2006, J BIOL CHEM, V281, P30573, DOI 10.1074/jbc.M606803200	49	14	16	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					14698	14709		10.1074/jbc.M901104200	http://dx.doi.org/10.1074/jbc.M901104200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19324871	Green Published, hybrid			2022-12-27	WOS:000266288200006
J	Sallee, JL; Burridge, K				Sallee, Jennifer L.; Burridge, Keith			Density-enhanced Phosphatase 1 Regulates Phosphorylation of Tight Junction Proteins and Enhances Barrier Function of Epithelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SITE-SELECTIVE DEPHOSPHORYLATION; TYROSINE-PHOSPHATASE; BETA-CATENIN; POSSIBLE INVOLVEMENT; ENDOTHELIAL-CELLS; ADHERENS JUNCTION; ETA SUPPRESSES; OCCLUDIN; RECEPTOR; GROWTH	Cell-cell adhesion is a dynamic process that can activate multiple signaling pathways. These signaling pathways can be regulated through reversible tyrosine phosphorylation events. The level of tyrosine phosphorylation of junctional proteins reflects the balance between protein-tyrosine kinase and protein-tyrosine phosphatase activity. The receptor-tyrosine phosphatase DEP-1 (CD148/PTP-eta) has been implicated in cell growth and differentiation as well as in regulating phosphorylation of junctional proteins. However, the role of DEP-1 in regulating tight junction phosphorylation and the integrity of cell-cell junctions is still under investigation. In this study, we used a catalytically dead substrate-trapping mutant of DEP-1 to identify potential substrates at cell-cell junctions. We have shown that in epithelial cells the trapping mutant of DEP-1 interacts with the tight junction proteins occludin and ZO-1 in a tyrosine phosphorylation-dependent manner. In contrast, PTP-PEST, Shp2, and PTP mu did not interact with these proteins, suggesting that the interaction of DEP-1 with occludin and ZO-1 is specific. In addition, occludin and ZO-1 were dephosphorylated by DEP-1 but not these other phosphatases in vitro. Overexpression of DEP-1 increased barrier function as measured by transepithelial electrical resistance and also reduced paracellular flux of fluorescein isothiocyanate-dextran following a calcium switch. Reduced DEP-1 expression by small interfering RNA had a small but significant increase in junction permeability. These data suggest that DEP-1 can modify the phosphorylation state of tight junction proteins and play a role in regulating permeability.	[Sallee, Jennifer L.; Burridge, Keith] Univ N Carolina, Dept Cell & Dev Biol, Chapel Hill, NC 27599 USA; [Burridge, Keith] Univ N Carolina, Lineberger Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Sallee, JL (corresponding author), 12-026 Lineberger Canc Ctr, Chapel Hill, NC 27599 USA.	jennifer_sallee@med.unc.edu			National Institutes of Health [GM29860, HL45100]; Department of Defense Breast Cancer Research Program [W81XWH-06-1-033]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL045100] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029860] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Defense Breast Cancer Research Program(United States Department of Defense); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM29860 and HL45100.; Supported by Department of Defense Breast Cancer Research Program pre-doctoral fellowship W81XWH-06-1-0333. To whom correspondence should be addressed: 12-026 Lineberger Cancer Center, Chapel Hill, NC 27599-7295. Tel.: 919-966-5783; E-mail: jennifer_sallee@med.unc.edu.	Andreeva AY, 2001, J BIOL CHEM, V276, P38480, DOI 10.1074/jbc.M104923200; Antonetti DA, 1999, J BIOL CHEM, V274, P23463, DOI 10.1074/jbc.274.33.23463; Balavenkatraman KK, 2006, ONCOGENE, V25, P6319, DOI 10.1038/sj.onc.1209647; Balsamo J, 1996, J CELL BIOL, V134, P801, DOI 10.1083/jcb.134.3.801; BEHRENS J, 1993, J CELL BIOL, V120, P757, DOI 10.1083/jcb.120.3.757; Borges LG, 1996, CIRC RES, V79, P570, DOI 10.1161/01.RES.79.3.570; BRADYKALNAY SM, 1995, J CELL BIOL, V130, P977, DOI 10.1083/jcb.130.4.977; CEREIJIDO M, 1978, J CELL BIOL, V77, P853, DOI 10.1083/jcb.77.3.853; Chen YH, 2002, MOL BIOL CELL, V13, P1227, DOI 10.1091/mbc.01-08-0423; Collares-Buzato CB, 1998, EUR J CELL BIOL, V76, P85, DOI 10.1016/S0171-9335(98)80020-4; Elias BC, 2009, J BIOL CHEM, V284, P1559, DOI 10.1074/jbc.M804783200; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Flint AJ, 1997, P NATL ACAD SCI USA, V94, P1680, DOI 10.1073/pnas.94.5.1680; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; FURUSE M, 1993, J CELL BIOL, V123, P1777, DOI 10.1083/jcb.123.6.1777; FURUSE M, 1994, J CELL BIOL, V127, P1617, DOI 10.1083/jcb.127.6.1617; Gonzalez-Mariscal L, 2008, BBA-BIOMEMBRANES, V1778, P729, DOI 10.1016/j.bbamem.2007.08.018; GONZALEZMARISCAL L, 1985, J MEMBRANE BIOL, V86, P113, DOI 10.1007/BF01870778; GRAZIA LM, 2003, J CELL BIOL, V161, P793, DOI 10.1083/jcb.200209019; GUMBINER B, 1986, J CELL BIOL, V102, P457, DOI 10.1083/jcb.102.2.457; Harhaj NS, 2002, J CELL PHYSIOL, V193, P349, DOI 10.1002/jcp.10183; Haskins J, 1998, J CELL BIOL, V141, P199, DOI 10.1083/jcb.141.1.199; Hollande F, 2001, AM J PHYSIOL-GASTR L, V280, pG910, DOI 10.1152/ajpgi.2001.280.5.G910; Holsinger LJ, 2002, ONCOGENE, V21, P7067, DOI 10.1038/sj.onc.1205858; Huyer G, 1997, J BIOL CHEM, V272, P843, DOI 10.1074/jbc.272.2.843; Iuliano R, 2003, CANCER RES, V63, P882; Jallal B, 1997, J BIOL CHEM, V272, P12158, DOI 10.1074/jbc.272.18.12158; Kale G, 2003, BIOCHEM BIOPH RES CO, V302, P324, DOI 10.1016/S0006-291X(03)00167-0; Keane MM, 1996, CANCER RES, V56, P4236; Kellie S, 2004, J CELL SCI, V117, P609, DOI 10.1242/jcs.00879; Kovalenko M, 2000, J BIOL CHEM, V275, P16219, DOI 10.1074/jbc.275.21.16219; Lampugnani MG, 1997, J CELL SCI, V110, P2065; Le Pera I, 2005, ONCOGENE, V24, P3187, DOI 10.1038/sj.onc.1208510; Li YH, 2005, J MOL BIOL, V352, P151, DOI 10.1016/j.jmb.2005.07.017; Martelli ML, 1998, EXP CELL RES, V245, P195, DOI 10.1006/excr.1998.4257; MATSUYOSHI N, 1992, J CELL BIOL, V118, P703, DOI 10.1083/jcb.118.3.703; Matter K, 2005, CURR OPIN CELL BIOL, V17, P453, DOI 10.1016/j.ceb.2005.08.003; Mitic LL, 1999, J CELL BIOL, V146, P683, DOI 10.1083/jcb.146.3.683; Nawroth R, 2002, EMBO J, V21, P4885, DOI 10.1093/emboj/cdf497; Nusrat A, 2000, J BIOL CHEM, V275, P29816, DOI 10.1074/jbc.M002450200; OSTMAN A, 1994, P NATL ACAD SCI USA, V91, P9680, DOI 10.1073/pnas.91.21.9680; Palka HL, 2003, J BIOL CHEM, V278, P5728, DOI 10.1074/jbc.M210656200; Persson C, 2002, FEBS LETT, V517, P27, DOI 10.1016/S0014-5793(02)02570-X; Potter MD, 2005, J BIOL CHEM, V280, P31906, DOI 10.1074/jbc.M505568200; Rao RK, 2002, BIOCHEM J, V368, P471, DOI 10.1042/BJ20011804; Sakakibara A, 1997, J CELL BIOL, V137, P1393, DOI 10.1083/jcb.137.6.1393; Sallee JL, 2006, J BIOL CHEM, V281, P16189, DOI 10.1074/jbc.R600003200; Schneeberger EE, 2004, AM J PHYSIOL-CELL PH, V286, pC1213, DOI 10.1152/ajpcell.00558.2003; Seth A, 2007, J BIOL CHEM, V282, P11487, DOI 10.1074/jbc.M610597200; STADDON JM, 1995, J CELL SCI, V108, P609; Takahashi T, 1999, J AM SOC NEPHROL, V10, P2135; Takahashi T, 2006, BLOOD, V108, P1234, DOI 10.1182/blood-2005-10-4296; Trapasso F, 2000, MOL CELL BIOL, V20, P9236, DOI 10.1128/MCB.20.24.9236-9246.2000; Trapasso F, 2006, DNA CELL BIOL, V25, P376, DOI 10.1089/dna.2006.25.376; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Ukropec JA, 2000, J BIOL CHEM, V275, P5983, DOI 10.1074/jbc.275.8.5983; VANITALLIE CM, 1995, J CELL SCI, V108, P1735; Wachtel M, 1999, J CELL SCI, V112, P4347; Wittchen ES, 1999, J BIOL CHEM, V274, P35179, DOI 10.1074/jbc.274.49.35179; Zhang L, 1997, EXP CELL RES, V235, P62, DOI 10.1006/excr.1997.3659; Zondag GCM, 2000, J BIOL CHEM, V275, P11264, DOI 10.1074/jbc.275.15.11264	61	44	47	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					14997	15006		10.1074/jbc.M901901200	http://dx.doi.org/10.1074/jbc.M901901200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19332538	Green Published, hybrid			2022-12-27	WOS:000266288200036
J	Lama, A; Pawaria, S; Bidon-Chanal, A; Anand, A; Gelpi, JL; Arya, S; Marti, M; Estrin, DA; Luque, FJ; Dikshit, KL				Lama, Amrita; Pawaria, Sudesh; Bidon-Chanal, Axel; Anand, Arvind; Gelpi, Jose Luis; Arya, Swati; Marti, Marcelo; Estrin, Dario A.; Luque, F. Javier; Dikshit, Kanak L.			Role of Pre-A Motif in Nitric Oxide Scavenging by Truncated Hemoglobin, HbN, of Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENTERICA SEROVAR TYPHIMURIUM; ESCHERICHIA-COLI; DYNAMICAL REGULATION; MOLECULAR-DYNAMICS; MIGRATION PATHWAYS; NO DETOXIFICATION; OXYGEN-BINDING; PROTEIN; O-2; MACROPHAGES	Mycobacterium tuberculosis truncated hemoglobin, HbN, is endowed with a potent nitric-oxide dioxygenase activity and has been found to relieve nitrosative stress and enhance in vivo survival of a heterologous host, Salmonella enterica Typhimurium, within the macrophages. These findings implicate involvement of HbN in the defense of M. tuberculosis against nitrosative stress. The protein carries a tunnel system composed of a short and a long tunnel branch that has been proposed to facilitate diatomic ligand migration to the heme and an unusual Pre-A motif at the N terminus, which does not contribute significantly to the structural integrity of the protein, as it protrudes out of the compact globin fold. Strikingly, deletion of Pre-A region from the M. tuberculosis HbN drastically reduces its ability to scavenge nitric oxide (NO), whereas its insertion at the N terminus of Pre-A lacking HbN of Mycobacterium smegmatis improved its nitric-oxide dioxygenase activity. Titration of the oxygenated adduct of HbN and its mutants with NO indicated that the stoichiometric oxidation of protein is severalfold slower when the Pre-A region is deleted in HbN. Molecular dynamics simulations show that the excision of Pre-A motif results in distinct changes in the protein dynamics, which cause the gate of the tunnel long branch to be trapped into a closed conformation, thus impeding migration of diatomic ligands toward the heme active site. The present study, thus, unequivocally demonstrates vital function of Pre-A region in NO scavenging and unravels its unique role by which HbN might attain its efficient NO-detoxification ability.	[Lama, Amrita; Pawaria, Sudesh; Anand, Arvind; Arya, Swati; Dikshit, Kanak L.] Council Sci & Ind Res India, Inst Microbial Technol, Chandigarh 160036, India; [Marti, Marcelo; Estrin, Dario A.] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Inorgan Analit & Quim Fis, Inst Quim Mat Medio Ambiente & Energia, Buenos Aires, DF, Argentina; [Bidon-Chanal, Axel; Gelpi, Jose Luis; Luque, F. Javier] Univ Barcelona, Fac Pharm, Dept Phys Chem, E-08028 Barcelona, Spain; [Bidon-Chanal, Axel; Gelpi, Jose Luis; Luque, F. Javier] Univ Barcelona, Fac Pharm, Inst Biomed IBUB, E-08028 Barcelona, Spain	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); University of Buenos Aires; University of Barcelona; University of Barcelona	Dikshit, KL (corresponding author), Council Sci & Ind Res India, Inst Microbial Technol, Sector 39 A, Chandigarh 160036, India.	kanak@imtech.res.in	Estrin, Dario/AAY-7549-2020; Luque, F. Javier/L-9652-2014; Bidon-Chanal, Axel/C-4536-2017; Gelpí, Josep Ll./M-6401-2013	Luque, F. Javier/0000-0002-8049-3567; Bidon-Chanal, Axel/0000-0002-1666-1490; Gelpí, Josep Ll./0000-0002-0566-7723; Marti, Marcelo/0000-0002-7911-9340; Estrin, Dario/0000-0002-5006-7225	Department of Biotechnology, Government of India; Council of Scientific and Industrial Research, Spanish Ministerio de Ciencia e Innovacion [SAF2008-05595-C02-01, PCI2006-A7-0688]; Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 25667]; Consejo Nacional de Investigaciones Cientificas y Tecnicas, Universidad de Buenos Aires; John Simon Guggenheim Foundation; European Union	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Council of Scientific and Industrial Research, Spanish Ministerio de Ciencia e Innovacion(Council of Scientific & Industrial Research (CSIR) - IndiaMinistry of Science and Innovation, Spain (MICINN)Spanish Government); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Consejo Nacional de Investigaciones Cientificas y Tecnicas, Universidad de Buenos Aires(University of Buenos AiresConsejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); John Simon Guggenheim Foundation; European Union(European Commission)	This work was supported by the Department of Biotechnology, Government of India, and Council of Scientific and Industrial Research, Spanish Ministerio de Ciencia e Innovacion Grants SAF2008-05595-C02-01 and PCI2006-A7-0688, Agencia Nacional de Promocion Cientifica y Tecnologica Grant PICT 25667, Consejo Nacional de Investigaciones Cientificas y Tecnicas, Universidad de Buenos Aires, the John Simon Guggenheim Foundation, and the European Union FP7 program (project NOstress).	AMADEI A, 1993, PROTEINS, V17, P412, DOI 10.1002/prot.340170408; BECKMAN JS, 1990, P NATL ACAD SCI USA, V87, P1620, DOI 10.1073/pnas.87.4.1620; Bidon-Chanal A, 2007, J AM CHEM SOC, V129, P6782, DOI 10.1021/ja0689987; Bidon-Chanal A, 2006, PROTEINS, V64, P457, DOI 10.1002/prot.21004; CHAN J, 1992, J EXP MED, V175, P1111, DOI 10.1084/jem.175.4.1111; Cohen J, 2008, METHOD ENZYMOL, V437, P439, DOI 10.1016/S0076-6879(07)37022-5; Cohen J, 2007, BIOPHYS J, V93, P3591, DOI 10.1529/biophysj.107.108712; Cohen J, 2006, BIOPHYS J, V91, P1844, DOI 10.1529/biopbysj.106.085746; COUTURE M, 1994, MOL GEN GENET, V243, P185, DOI 10.1007/BF00280316; Couture M, 1999, P NATL ACAD SCI USA, V96, P11223, DOI 10.1073/pnas.96.20.11223; Crespo A, 2005, J AM CHEM SOC, V127, P4433, DOI 10.1021/ja0450004; Das TK, 1999, BIOCHEMISTRY-US, V38, P15360, DOI 10.1021/bi991237e; Fenton M J, 1998, Curr Opin Hematol, V5, P72, DOI 10.1097/00062752-199801000-00012; Fenton MJ, 1996, INFECT IMMUN, V64, P683, DOI 10.1128/IAI.64.3.683-690.1996; Gardner PR, 2008, METHOD ENZYMOL, V436, P217, DOI 10.1016/S0076-6879(08)36012-1; Gardner PR, 1998, P NATL ACAD SCI USA, V95, P10378, DOI 10.1073/pnas.95.18.10378; Gardner PR, 1997, J BIOL CHEM, V272, P25071, DOI 10.1074/jbc.272.40.25071; Gardner PR, 1998, J BIOL CHEM, V273, P26528, DOI 10.1074/jbc.273.41.26528; Hill DR, 1996, J BACTERIOL, V178, P6587, DOI 10.1128/jb.178.22.6587-6598.1996; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Johnson BJ, 2007, J BIOL CHEM, V282, P17767, DOI 10.1074/jbc.M701308200; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kaur R, 2002, APPL ENVIRON MICROB, V68, P152, DOI 10.1128/AEM.68.1.152-160.2002; Lama A, 2006, FEBS LETT, V580, P4031, DOI 10.1016/j.febslet.2006.06.037; MacMicking JD, 1997, P NATL ACAD SCI USA, V94, P5243, DOI 10.1073/pnas.94.10.5243; Marti MA, 2008, J AM CHEM SOC, V130, P1688, DOI 10.1021/ja076853+; Milani M, 2004, J BIOL CHEM, V279, P21520, DOI 10.1074/jbc.M401320200; Milani M, 2001, EMBO J, V20, P3902, DOI 10.1093/emboj/20.15.3902; Ouellett H, 2002, P NATL ACAD SCI USA, V99, P5902, DOI 10.1073/pnas.092017799; Pathania R, 2002, MOL MICROBIOL, V45, P1303, DOI 10.1046/j.1365-2958.2002.03095.x; Pawaria S, 2008, APPL ENVIRON MICROB, V74, P3512, DOI 10.1128/AEM.02663-07; Pawaria S, 2007, MICROB PATHOGENESIS, V42, P119, DOI 10.1016/j.micpath.2006.12.001; PEARLMAN DA, 1995, COMPUT PHYS COMMUN, V91, P1, DOI 10.1016/0010-4655(95)00041-D; Petrek M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-316; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Scott EE, 2001, J BIOL CHEM, V276, P5177, DOI 10.1074/jbc.M008282200; Stevanin TM, 2002, INFECT IMMUN, V70, P4399, DOI 10.1128/IAI.70.8.4399-4405.2002; Vuletich DA, 2006, J MOL EVOL, V62, P196, DOI 10.1007/s00239-005-0077-4; Wittenberg JB, 2002, J BIOL CHEM, V277, P871, DOI 10.1074/jbc.R100058200	39	49	49	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14457	14468		10.1074/jbc.M807436200	http://dx.doi.org/10.1074/jbc.M807436200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19329431	hybrid, Green Published			2022-12-27	WOS:000266286100052
J	Wang, J; Lou, HY; Pedersen, CJ; Smith, AD; Perez, RG				Wang, Jian; Lou, Haiyan; Pedersen, Courtney J.; Smith, Amanda D.; Perez, Ruth G.			14-3-3 zeta Contributes to Tyrosine Hydroxylase Activity in MN9D Cells LOCALIZATION OF DOPAMINE REGULATORY PROTEINS TO MITOCHONDRIA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACTIVATES TRYPTOPHAN 5-MONOOXYGENASE; LEWY BODY DISEASE; ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; CEREBRAL-CORTEX; PHOSPHATASE 2A; PHOSPHORYLATION; KINASE; BRAIN; BODIES	The 14-3-3 proteins stimulate the activation of tyrosine hydroxylase (TH), the rate-limiting catecholamine biosynthetic enzyme. To explore if particular endogenous 14-3-3 isoforms specifically affected TH activity and dopamine synthesis, we utilized rodent nigrostriatal tissues and midbrain-derived MN9D dopaminergic cells. Extracts from ventral midbrain and MN9D cells contained similar pools of 14-3-3 mRNAs, with 14-3-3 zeta being relatively abundant in both. Protein levels of 14-3-3 zeta were also abundant. [P-32]Orthophosphate labeling of MN9D cells, followed by co-immunoprecipitation with pan-TH and pan-14-3-3 antibodies brought down similar amounts of phosphorylated TH in each, confirming that 14-3-3-bound phosphorylated TH in our cells. Co-immunoprecipitation of striatal tissues with a pan-TH antibody precipitated 14-3-3 zeta but not another potential TH regulatory isoform, 14-3-3 eta. In whole cell extracts from MN9D cells after 14-3-3 small interfering RNA treatments, we found that 14-3-3 zeta knockdown significantly reduced TH activity and dopamine synthesis whereas knockdown of 14-3-3 eta had no effect. 14-3-3 zeta was found co-localized on mitochondria with TH, and its knockdown by small interfering RNA reduced TH phosphorylation and TH activity in the mitochondrial pool. Together the data support a role for 14-3-3 zeta as an endogenous activator of TH in midbrain dopaminergic neurons and furthermore, identify mitochondria as a potential novel site for dopamine synthesis, with implications for Parkinson disease.	[Wang, Jian; Lou, Haiyan; Pedersen, Courtney J.; Smith, Amanda D.; Perez, Ruth G.] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15260 USA; [Wang, Jian; Perez, Ruth G.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA; [Wang, Jian; Lou, Haiyan; Pedersen, Courtney J.; Smith, Amanda D.; Perez, Ruth G.] Univ Pittsburgh, Sch Med, Pittsburgh Inst Neurodegenerat Dis, Pittsburgh, PA 15260 USA; [Wang, Jian] Fudan Univ, Dept Neurol, Huashan Hosp, Shanghai 200042, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Fudan University	Perez, RG (corresponding author), 3501 5th Ave,BST3 7021, Pittsburgh, PA 15260 USA.	perezrg@pitt.edu	Perez, Ruth G./AAK-9844-2020	Pedersen, Courtney/0000-0002-5917-2742	National Institutes of Health NINDS [NS42094]; Michael J. Fox Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042094, R21NS045336] Funding Source: NIH RePORTER	National Institutes of Health NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Michael J. Fox Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health NINDS Grant NS42094. This work was also supported by the Michael J. Fox Foundation.	Aitken A, 2006, SEMIN CANCER BIOL, V16, P162, DOI 10.1016/j.semcancer.2006.03.005; Baxter HC, 2002, BIOCHEM SOC T, V30, P387, DOI 10.1042/bst0300387; Baxter HC, 2002, NEUROSCIENCE, V109, P5, DOI 10.1016/S0306-4522(01)00492-4; Berg D, 2003, NAT REV NEUROSCI, V4, P752, DOI 10.1038/nrn1197; Berg D, 2003, ANN NEUROL, V54, P135, DOI 10.1002/ana.10621; BERNHEIMER H, 1973, J NEUROL SCI, V20, P415, DOI 10.1016/0022-510X(73)90175-5; Bevilaqua LRM, 2001, J BIOL CHEM, V276, P40411, DOI 10.1074/jbc.M105280200; Bobrovskaya L, 2004, J NEUROCHEM, V90, P857, DOI 10.1111/j.1471-4159.2004.02550.x; Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; Chen XQ, 2005, J CEREBR BLOOD F MET, V25, P338, DOI 10.1038/sj.jcbfm.9600032; CHOI HK, 1991, BRAIN RES, V552, P67, DOI 10.1016/0006-8993(91)90661-E; Dagda RK, 2003, J BIOL CHEM, V278, P24976, DOI 10.1074/jbc.M302832200; DAMUNI Z, 1987, J BIOL CHEM, V262, P5133; DAUBNER SC, 1993, PROTEIN SCI, V2, P1452, DOI 10.1002/pro.5560020909; Dong Y, 2008, J NEUROCHEM, V107, P1589, DOI 10.1111/j.1471-4159.2008.05721.x; Dunkley PR, 2004, J NEUROCHEM, V91, P1025, DOI 10.1111/j.1471-4159.2004.02797.x; FUKUDA T, 1993, ACTA PATHOL JAPON, V43, P545; Horbinski C, 2005, FREE RADICAL BIO MED, V38, P2, DOI 10.1016/j.freeradbiomed.2004.09.030; Hornykiewicz O, 1975, Natl Inst Drug Abuse Res Monogr Ser, P13; ICHIMURA T, 1988, P NATL ACAD SCI USA, V85, P7084, DOI 10.1073/pnas.85.19.7084; ICHIMURA T, 1987, FEBS LETT, V219, P79, DOI 10.1016/0014-5793(87)81194-8; Itagaki C, 1999, BIOCHEMISTRY-US, V38, P15673, DOI 10.1021/bi9914255; JACKSON D, 1993, J PHARMACOL EXP THER, V267, P912; JONES DHA, 1995, J MOL BIOL, V245, P375, DOI 10.1006/jmbi.1994.0031; Kaneko K, 2006, MED HYPOTHESES, V67, P169, DOI 10.1016/j.mehy.2006.01.019; Kawamoto Y, 2002, J NEUROPATH EXP NEUR, V61, P245, DOI 10.1093/jnen/61.3.245; Kleppe R, 2001, J NEUROCHEM, V77, P1097, DOI 10.1046/j.1471-4159.2001.00318.x; KULJIS RO, 1989, NEUROSCI LETT, V106, P49, DOI 10.1016/0304-3940(89)90200-0; Kumer SC, 1996, J NEUROCHEM, V67, P443; LEVITT M, 1965, J PHARMACOL EXP THER, V148, P1; Liang XB, 2006, J BIOL CHEM, V281, P16323, DOI 10.1074/jbc.M601360200; MARTIN H, 1994, J NEUROCHEM, V63, P2259; MOORE RY, 1978, ANNU REV NEUROSCI, V1, P129, DOI 10.1146/annurev.ne.01.030178.001021; NAKASHIMA S, 1984, J NEUROL SCI, V66, P91, DOI 10.1016/0022-510X(84)90144-8; Obsilova V, 2008, BIOCHEMISTRY-US, V47, P1768, DOI 10.1021/bi7019468; Okauchi H, 2004, HISTOCHEM CELL BIOL, V121, P181, DOI 10.1007/s00418-004-0622-z; Ostrerova N, 1999, J NEUROSCI, V19, P5782, DOI 10.1523/JNEUROSCI.19-14-05782.1999; Peng XMM, 2005, J CELL SCI, V118, P3523, DOI 10.1242/jcs.02481; Perez RG, 2002, J NEUROSCI, V22, P3090, DOI 10.1523/JNEUROSCI.22-08-03090.2002; ROSS ME, 1981, BRAIN RES, V208, P493; Royo M, 2005, ARCH BIOCHEM BIOPHYS, V434, P266, DOI 10.1016/j.abb.2004.11.007; Salvatore MF, 2000, J NEUROCHEM, V75, P225, DOI 10.1046/j.1471-4159.2000.0750225.x; Samii A, 2004, LANCET, V363, P1783, DOI 10.1016/S0140-6736(04)16305-8; Sato S, 2006, EMBO J, V25, P211, DOI 10.1038/sj.emboj.7600774; SCHAPIRA AHV, 1992, MUTAT RES, V275, P133, DOI 10.1016/0921-8734(92)90018-K; Schindler CK, 2006, J NEUROCHEM, V99, P561, DOI 10.1111/j.1471-4159.2006.04153.x; Smith AD, 2002, NEUROPSYCHOPHARMACOL, V26, P756, DOI 10.1016/S0893-133X(01)00420-1; Spillantini MG, 1998, P NATL ACAD SCI USA, V95, P6469, DOI 10.1073/pnas.95.11.6469; SUTHERLAND C, 1993, EUR J BIOCHEM, V217, P715, DOI 10.1111/j.1432-1033.1993.tb18297.x; Tehranian R, 2006, J NEUROCHEM, V99, P1188, DOI 10.1111/j.1471-4159.2006.04146.x; Toska K, 2002, ANN NY ACAD SCI, V971, P66, DOI 10.1111/j.1749-6632.2002.tb04435.x; Toska K, 2002, J NEUROCHEM, V83, P775, DOI 10.1046/j.1471-4159.2002.01172.x; Toyooka K, 2002, MOL BRAIN RES, V100, P13, DOI 10.1016/S0169-328X(02)00129-8; Tzivion G, 2001, ONCOGENE, V20, P6331, DOI 10.1038/sj.onc.1204777; Tzivion G, 1998, NATURE, V394, P88, DOI 10.1038/27938; Ubl A, 2002, MOL BRAIN RES, V108, P33, DOI 10.1016/S0169-328X(02)00510-7; UNGERSTEDT U, 1971, ACTA PHYSIOL SCAND, P1; WAGNER J, 1979, J CHROMATOGR, V164, P41, DOI 10.1016/S0378-4347(00)81570-4; Yaffe MB, 2002, FEBS LETT, V513, P53, DOI 10.1016/S0014-5793(01)03288-4; YAMAUCHI T, 1981, BIOCHEM BIOPH RES CO, V100, P807, DOI 10.1016/S0006-291X(81)80246-X; YAMAUCHI T, 1981, J BIOL CHEM, V256, P5404; Yano M, 2006, MOL BIOL CELL, V17, P4769, DOI 10.1091/mbc.E06-03-0229	62	60	60	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14011	14019		10.1074/jbc.M901310200	http://dx.doi.org/10.1074/jbc.M901310200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19289463	Green Published, hybrid			2022-12-27	WOS:000266286100007
J	Himmel, M; Ritter, A; Rothemund, S; Pauling, BV; Rottner, K; Gingras, AR; Ziegler, WH				Himmel, Mirko; Ritter, Anett; Rothemund, Sven; Pauling, Bjoerg V.; Rottner, Klemens; Gingras, Alexandre R.; Ziegler, Wolfgang H.			Control of High Affinity Interactions in the Talin C Terminus HOW TALIN DOMAINS COORDINATE PROTEIN DYNAMICS IN CELL ADHESIONS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VINCULIN-BINDING-SITES; F-ACTIN-BINDING; I/LWEQ MODULE; INTEGRIN ACTIVATION; STRUCTURAL BASIS; CYTOPLASMIC DOMAIN; FOCAL ADHESIONS; SEQUENCE; IBS2	In cell-extracellular matrix junctions (focal adhesions), the cytoskeletal protein talin is central to the connection of integrins to the actin cytoskeleton. Talin is thought to mediate this connection via its two integrin, (at least) three actin, and several vinculin binding sites. The binding sites are cryptic in the head-to-rod autoinhibited cytoplasmic form of the protein and require (stepwise) conformational activation. This activation process, however, remains poorly understood, and there are contradictory models with respect to the determinants of adhesion site localization. Here, we report turnover rates and protein-protein interactions in a range of talin rod domain constructs varying in helix bundle structure. We conclude that several bundles of the C terminus cooperate to regulate targeting and concomitantly tailor high affinity interactions of the talin rod in cell adhesions. Intrinsic control of ligand binding activities is essential for the coordination of adhesion site function of talin.	[Himmel, Mirko; Ritter, Anett; Rothemund, Sven; Ziegler, Wolfgang H.] Univ Leipzig, Fac Med, IZKF Leipzig, Inselstr 22, D-04103 Leipzig, Germany; [Pauling, Bjoerg V.] Tech Univ Carolo Wilhelmina Braunschweig, Inst Zool, D-38106 Braunschweig, Germany; [Rottner, Klemens] Helmholtz Ctr Infect Res, Cytoskeleton Dynam Grp, D-38124 Braunschweig, Germany; [Gingras, Alexandre R.] Univ Leicester, Dept Biochem, Leicester LE1 9HN, Leics, England	Leipzig University; Braunschweig University of Technology; Helmholtz Association; Helmholtz-Center for Infection Research; University of Leicester	Ziegler, WH (corresponding author), Univ Leipzig, Fac Med, IZKF Leipzig, Inselstr 22, D-04103 Leipzig, Germany.	wolfgang.ziegler@medizin.uni-leipzig.de	Gingras, Alexandre R/E-1867-2011; Rottner, Klemens/AAE-5030-2020	Gingras, Alexandre R/0000-0002-5373-0176; Himmel, Mirko/0000-0001-7872-8016; Rottner, Klemens/0000-0003-4244-4198; Ziegler, Wolfgang H./0000-0003-4529-1916	Deutsche Forschungsgemeinschaft [Zi545/3 (SPP1150), Zi545/5-1, Ro2414/1-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Deutsche Forschungsgemeinschaft Grants Zi545/3 (SPP1150) and Zi545/5-1 ( to W. H. Z.) and Ro2414/1-1 ( to K. R.).	Bakolitsa C, 2004, NATURE, V430, P583, DOI 10.1038/nature02610; Barsukov IL, 2003, J BIOL CHEM, V278, P31202, DOI 10.1074/jbc.M303850200; Bass MD, 1999, BIOCHEM J, V341, P257, DOI 10.1042/0264-6021:3410257; Bass MD, 2002, BIOCHEM J, V362, P761, DOI 10.1042/0264-6021:3620761; Beaudouin JL, 2006, BIOPHYS J, V90, P1878, DOI 10.1529/biophysj.105.071241; Bois PRJ, 2006, J BIOL CHEM, V281, P7228, DOI 10.1074/jbc.M510397200; Brett TJ, 2006, NAT STRUCT MOL BIOL, V13, P121, DOI 10.1038/nsmb1043; Bulinski JC, 2001, J CELL SCI, V114, P3885; Chandrasekar I, 2005, J CELL SCI, V118, P1461, DOI 10.1242/jcs.01734; Chen H, 2006, J BIOL CHEM, V281, P40389, DOI 10.1074/jbc.M607324200; Cohen DM, 2006, J BIOL CHEM, V281, P16006, DOI 10.1074/jbc.M600738200; Critchley DR, 2005, BIOCHEM SOC T, V33, P1308, DOI 10.1042/BST0331308; Critchley DR, 2000, CURR OPIN CELL BIOL, V12, P133, DOI 10.1016/S0955-0674(99)00067-8; Franco SJ, 2006, CELL MOTIL CYTOSKEL, V63, P563, DOI 10.1002/cm.20145; Garcia-Alvarez B, 2003, MOL CELL, V11, P49, DOI 10.1016/S1097-2765(02)00823-7; Gingras AR, 2008, EMBO J, V27, P458, DOI 10.1038/sj.emboj.7601965; Gingras AR, 2005, J BIOL CHEM, V280, P37217, DOI 10.1074/jbc.M508060200; Goksoy E, 2008, MOL CELL, V31, P124, DOI 10.1016/j.molcel.2008.06.011; Hemmings L, 1996, J CELL SCI, V109, P2715; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jiang GY, 2003, NATURE, V424, P334, DOI 10.1038/nature01805; Lee HS, 2004, J MOL BIOL, V343, P771, DOI 10.1016/j.jmb.2004.08.069; Legate KR, 2006, NAT REV MOL CELL BIO, V7, P20, DOI 10.1038/nrm1789; Lele TP, 2006, J CELL PHYSIOL, V207, P187, DOI 10.1002/jcp.20550; Liu SC, 2000, J CELL SCI, V113, P3563; Martel V, 2001, J BIOL CHEM, V276, P21217, DOI 10.1074/jbc.M102373200; McCann RO, 1997, P NATL ACAD SCI USA, V94, P5679, DOI 10.1073/pnas.94.11.5679; Moes M, 2007, J BIOL CHEM, V282, P17280, DOI 10.1074/jbc.M611846200; Monkley SJ, 2000, DEV DYNAM, V219, P560, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1079>3.0.CO;2-Y; Nayal A, 2004, CURR OPIN CELL BIOL, V16, P94, DOI 10.1016/j.ceb.2003.11.007; Nieswandt B, 2007, J EXP MED, V204, P3113, DOI 10.1084/jem.20071827; Patel B, 2006, J BIOL CHEM, V281, P7458, DOI 10.1074/jbc.M508058200; Petrich BG, 2007, J EXP MED, V204, P3103, DOI 10.1084/jem.20071800; Rabut G., 2005, LIVE CELL IMAGING LA, P101; Rodius S, 2008, J BIOL CHEM, V283, P24212, DOI 10.1074/jbc.M709704200; Senetar MA, 2004, BIOCHEMISTRY-US, V43, P15418, DOI 10.1021/bi0487239; Smith SJ, 2007, BIOCHEMISTRY-US, V46, P10886, DOI 10.1021/bi700637a; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Tanentzapf G, 2006, NAT CELL BIOL, V8, P601, DOI 10.1038/ncb1411; Tremuth L, 2004, J BIOL CHEM, V279, P22258, DOI 10.1074/jbc.M400947200; van der Ven PFM, 2000, J CELL BIOL, V151, P235, DOI 10.1083/jcb.151.2.235; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Xu WM, 1998, DEVELOPMENT, V125, P327; Ziegler WH, 2006, TRENDS CELL BIOL, V16, P453, DOI 10.1016/j.tcb.2006.07.004	45	36	37	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13832	13842		10.1074/jbc.M900266200	http://dx.doi.org/10.1074/jbc.M900266200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19278997	Green Published, hybrid			2022-12-27	WOS:000265877300060
J	Woollard, KJ; Sturgeon, S; Chin-Dusting, JPF; Salem, HH; Jackson, SP				Woollard, Kevin J.; Sturgeon, Sharelle; Chin-Dusting, Jaye P. F.; Salem, Hatem H.; Jackson, Shaun P.			Erythrocyte Hemolysis and Hemoglobin Oxidation Promote Ferric Chloride-induced Vascular Injury	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CROSS-LINKED HEMOGLOBIN; HEME OXYGENASE-1 DEFICIENCY; ENDOTHELIAL-CELL INJURY; THROMBUS FORMATION; ARTERIAL THROMBOSIS; LIPID-PEROXIDATION; MURINE MODEL; NITRIC-OXIDE; E-SELECTIN; IN-VIVO	The release of redox-active iron and heme into the bloodstream is toxic to the vasculature, contributing to the development of vascular diseases. How iron induces endothelial injury remains ill defined. To investigate this, we developed a novel ex vivo perfusion chamber that enables direct analysis of the effects of FeCl3 on the vasculature. We demonstrate that FeCl3 treatment of isolated mouse aorta, perfused with whole blood, was associated with endothelial denudation, collagen exposure, and occlusive thrombus formation. Strikingly exposing vessels to FeCl3 alone, in the absence of perfused blood, was associated with only minor vascular injury. Whole blood fractionation studies revealed that FeCl3-induced vascular injury was red blood cell (erythrocyte)-dependent, requiring erythrocyte hemolysis and hemoglobin oxidation for endothelial denudation. Overall these studies define a unique mechanism of Fe3+-induced vascular injury that has implications for the understanding of FeCl3-dependent models of thrombosis and vascular dysfunction associated with severe intravascular hemolysis.	[Sturgeon, Sharelle; Salem, Hatem H.; Jackson, Shaun P.] Monash Univ, Australian Ctr Blood Dis, Melbourne, Vic 3004, Australia; [Woollard, Kevin J.; Chin-Dusting, Jaye P. F.] Monash Univ, Baker IDI Heart & Diabet Inst, Melbourne, Vic 3004, Australia	Monash University; Baker Heart and Diabetes Institute; Monash University	Jackson, SP (corresponding author), Monash Univ, Australian Ctr Blood Dis, Burnet Tower,6th Floor,89 Commercial Rd, Melbourne, Vic 3004, Australia.	shaun.jackson@med.monash.edu.au		Jackson, Shaun/0000-0002-4750-1991; Woollard, Kevin/0000-0002-9839-5463	Australian National Health and Medical Research Council	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants from the Australian National Health and Medical Research Council.	Alayash AI, 2004, NAT REV DRUG DISCOV, V3, P152, DOI 10.1038/nrd1307; Andrews NC, 2008, BLOOD, V112, P219, DOI 10.1182/blood-2007-12-077388; BALLA G, 1991, ARTERIOSCLER THROMB, V11, P1700, DOI 10.1161/01.ATV.11.6.1700; Balla J, 2005, MOL NUTR FOOD RES, V49, P1030, DOI 10.1002/mnfr.200500076; CADROY Y, 1990, BLOOD, V75, P2185; Carmichael FJL, 2000, CRIT CARE MED, V28, P2283, DOI 10.1097/00003246-200007000-00017; Denis CV, 2007, ARTERIOSCL THROM VAS, V27, P728, DOI 10.1161/01.ATV.0000259359.52265.62; Everse J, 1997, FREE RADICAL BIO MED, V22, P1075, DOI 10.1016/S0891-5849(96)00499-6; Frei AC, 2008, BLOOD, V112, P398, DOI 10.1182/blood-2007-12-126714; Furie B, 2005, J CLIN INVEST, V115, P3355, DOI 10.1172/JCI26987; Gachet C, 2008, THROMB HAEMOSTASIS, V99, P466, DOI 10.1160/TH07-11-0673; Gladwin MT, 2004, NEW ENGL J MED, V350, P886, DOI 10.1056/NEJMoa035477; Graca-Souza AV, 2002, BLOOD, V99, P4160, DOI 10.1182/blood.V99.11.4160; GUTTERIDGE JMC, 1987, BIOCHIM BIOPHYS ACTA, V917, P219, DOI 10.1016/0005-2760(87)90125-1; HALLIWELL B, 1985, MOL ASPECTS MED, V8, P89, DOI 10.1016/0098-2997(85)90001-9; Jeney V, 2002, BLOOD, V100, P879, DOI 10.1182/blood.V100.3.879; KO KM, 1990, MOL CELL BIOCHEM, V95, P125; Kulkarni S, 2007, BLOOD, V110, P1879, DOI 10.1182/blood-2006-08-040980; Lamy ML, 2000, ANESTHESIOLOGY, V92, P646, DOI 10.1097/00000542-200003000-00007; Levy AP, 2006, CURR MOL MED, V6, P479, DOI 10.2174/156652406778018626; Liu XY, 2003, AM J PHYSIOL-CELL PH, V285, pC1036, DOI 10.1152/ajpcell.00164.2003; Lubos E, 2008, FRONT BIOSCI-LANDMRK, V13, P5323, DOI 10.2741/3084; Morita T, 2005, ARTERIOSCL THROM VAS, V25, P1786, DOI 10.1161/01.ATV.0000178169.95781.49; MOTTERLINI R, 1995, AM J PHYSIOL-HEART C, V269, pH648, DOI 10.1152/ajpheart.1995.269.2.H648; Nagababu E, 2000, BIOCHEMISTRY-US, V39, P12503, DOI 10.1021/bi992170y; Nagababu E, 2000, BIOCHEM BIOPH RES CO, V273, P839, DOI 10.1006/bbrc.2000.3025; Olsen SB, 1996, CIRCULATION, V93, P327, DOI 10.1161/01.CIR.93.2.327; Olson JS, 2004, FREE RADICAL BIO MED, V36, P685, DOI 10.1016/j.freeradbiomed.2003.11.030; Reeder BJ, 2002, BIOCHEM SOC T, V30, P745, DOI 10.1042/bst0300745; Reiter CD, 2002, NAT MED, V8, P1383, DOI 10.1038/nm799; Roest M, 1999, CIRCULATION, V100, P1268, DOI 10.1161/01.CIR.100.12.1268; Rother RP, 2005, JAMA-J AM MED ASSOC, V293, P1653, DOI 10.1001/jama.293.13.1653; Sachs UJH, 2007, CIRC RES, V100, P979, DOI 10.1161/01.RES.0000261936.85776.5f; Sloan EP, 1999, JAMA-J AM MED ASSOC, V282, P1857, DOI 10.1001/jama.282.19.1857; SULLIVAN JL, 1981, LANCET, V1, P1293; TABBARA IA, 1992, MED CLIN N AM, V76, P649, DOI 10.1016/S0025-7125(16)30345-5; Tolosano E, 2002, BLOOD, V100, P4201, DOI 10.1182/blood-2002-04-1270; True AL, 2007, CIRC RES, V101, P893, DOI 10.1161/CIRCRESAHA.107.158998; Tse WT, 1999, BRIT J HAEMATOL, V104, P2, DOI 10.1111/j.1365-2141.1999.01130.x; Tseng MT, 2006, THROMB RES, V118, P275, DOI 10.1016/j.thromres.2005.09.004; Wagener FADTG, 1997, P SOC EXP BIOL MED, V216, P456; Wagener FADTG, 2001, BLOOD, V98, P1802, DOI 10.1182/blood.V98.6.1802; Wagner KR, 2003, J CEREBR BLOOD F MET, V23, P629, DOI 10.1097/01.WCB.0000073905.87928.6D; Wang XK, 2005, THROMB RES, V115, P95, DOI 10.1016/j.thromres.2004.07.009; Woollard KJ, 2008, CIRC RES, V103, P1128, DOI 10.1161/CIRCRESAHA.108.180273; Yachie A, 1999, J CLIN INVEST, V103, P129, DOI 10.1172/JCI4165	46	81	83	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					13110	13118		10.1074/jbc.M809095200	http://dx.doi.org/10.1074/jbc.M809095200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19276082	Green Published, hybrid			2022-12-27	WOS:000265688300058
J	Esteban, MA; Xu, JY; Yang, JY; Peng, MX; Qin, DJ; Li, W; Jiang, ZX; Chen, JK; Den, K; Zhong, M; Cai, JL; Lai, LX; Pei, DQ				Esteban, Miguel A.; Xu, Jianyong; Yang, Jiayin; Peng, Meixiu; Qin, Dajiang; Li, Wen; Jiang, Zhuoxin; Chen, Jiekai; Den, Kang; Zhong, Mei; Cai, Jinglei; Lai, Liangxue; Pei, Duanqing			Generation of Induced Pluripotent Stem Cell Lines from Tibetan Miniature Pig	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR TRANSFER; ADULT; FIBROBLASTS; EFFICIENCY; INDUCTION; SOX2	Induced pluripotent stem cell (iPS) technology appears to be a general strategy to generate pluripotent stem cells from any given mammalian species. So far, iPS cells have been reported for mouse, human, rat, and monkey. These four species have also established embryonic stem cell (ESC) lines that serve as the gold standard for pluripotency comparisons. Attempts have been made to generate porcine ESC by various means without success. Here we report the successful generation of pluripotent stem cells from fibroblasts isolated from the Tibetan miniature pig using a modified iPS protocol. The resulting iPS cell lines more closely resemble human ESC than cells from other species, have normal karyotype, stain positive for alkaline phosphatase, express high levels of ESC-like markers (Nanog, Rex1, Lin28, and SSEA4), and can differentiate into teratomas composed of the three germ layers. Because porcine physiology closely resembles human, the iPS cells reported here provide an attractive model to study certain human diseases or assess therapeutic applications of iPS in a large animal model.	[Cai, Jinglei; Lai, Liangxue; Pei, Duanqing] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, S China Inst Stem Cell Biol & Regenerat Med, Stem Cell & Canc Biol Grp,Key Lab Regenerat Biol, Guangzhou 510663, Guangdong, Peoples R China; [Den, Kang; Zhong, Mei] Nanfang Hosp, Ctr Prenatal & Hereditary Dis Diag, Guangzhou 510515, Guangdong, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Southern Medical University - China	Pei, DQ (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, S China Inst Stem Cell Biol & Regenerat Med, Stem Cell & Canc Biol Grp,Key Lab Regenerat Biol, Guangzhou 510663, Guangdong, Peoples R China.	pei_duanqing@gibh.ac.cn	zhou, xingru/G-4442-2012; Lai, Liangxue/H-4545-2011	Chen, Jiekai/0000-0001-5168-7074; Yang, Jiayin/0000-0001-9134-1959	National Natural Science Foundation of China [30725012, 30630039]; Chinese Academy of Sciences [KSCX2-YW-R-48]; Guangzhou Science and Technology [2006A50104002]; Ministry of Science and Technology 973 [2006CB701504, 2006CB943600, 2007CB948002, 2007CB947804, 2009CB941000]; National High Technology Project 863 [2005AA210930]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); Guangzhou Science and Technology; Ministry of Science and Technology 973(National Basic Research Program of China); National High Technology Project 863(National High Technology Research and Development Program of China)	This work was supported by National Natural Science Foundation of China Grants 30725012 and 30630039, Chinese Academy of Sciences Grant KSCX2-YW-R-48, Guangzhou Science and Technology Grant 2006A50104002, Ministry of Science and Technology 973 Grants 2006CB701504, 2006CB943600, 2007CB948002, 2007CB947804, and 2009CB941000, and National High Technology Project 863 Grant 2005AA210930.	Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; Ebert AD, 2009, NATURE, V457, P277, DOI 10.1038/nature07677; Eminli S, 2008, STEM CELLS, V26, P2467, DOI 10.1634/stemcells.2008-0317; Hall V, 2008, STEM CELL REV, V4, P275, DOI 10.1007/s12015-008-9040-2; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hao YH, 2009, CLONING STEM CELLS, V11, P101, DOI 10.1089/clo.2008.0063; Kaji K, 2009, NATURE, V458, P771, DOI 10.1038/nature07864; Kim JB, 2009, CELL, V136, P411, DOI 10.1016/j.cell.2009.01.023; Kolber-Simonds D, 2004, P NATL ACAD SCI USA, V101, P7335, DOI 10.1073/pnas.0307819101; Lai LX, 2002, SCIENCE, V295, P1089, DOI 10.1126/science.1068228; Li WL, 2009, CELL STEM CELL, V4, P16, DOI 10.1016/j.stem.2008.11.014; Liao J, 2009, CELL STEM CELL, V4, P11, DOI 10.1016/j.stem.2008.11.013; Liu HS, 2008, CELL STEM CELL, V3, P587, DOI 10.1016/j.stem.2008.10.014; Mali P, 2008, STEM CELLS, V26, P1998, DOI 10.1634/stemcells.2008-0346; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Pei DQ, 2008, CELL RES, V18, P221, DOI 10.1038/cr.2008.21; Qin DJ, 2008, J BIOL CHEM, V283, P33730, DOI 10.1074/jbc.M806788200; Shi Y, 2008, CELL STEM CELL, V2, P525, DOI 10.1016/j.stem.2008.05.011; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Soldner F, 2009, CELL, V136, P964, DOI 10.1016/j.cell.2009.02.013; Stadtfeld M, 2008, SCIENCE, V322, P945, DOI 10.1126/science.1162494; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Talbot NC, 2008, STEM CELL REV, V4, P235, DOI 10.1007/s12015-008-9026-0; THOMSON JA, 1995, P NATL ACAD SCI USA, V92, P7844, DOI 10.1073/pnas.92.17.7844; Tweedell KS, 2008, CURR STEM CELL RES T, V3, P151, DOI 10.2174/157488808785740361; Vackova I, 2007, J REPROD DEVELOP, V53, P1137, DOI 10.1262/jrd.19108; Wang XM, 2006, ANIM BIOTECHNOL, V17, P99, DOI 10.1080/10495390600608794; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Wilmut I, 1997, NATURE, V385, P810, DOI 10.1038/385810a0; Woltjen K, 2009, NATURE, V458, P766, DOI 10.1038/nature07863; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	35	322	376	3	71	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 26	2009	284	26					17634	17640		10.1074/jbc.M109.008938	http://dx.doi.org/10.1074/jbc.M109.008938			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	460QP	19376775	hybrid, Green Published			2022-12-27	WOS:000267202500029
J	Srinivasan, S; Mir, F; Huang, JS; Khasawneh, FT; Lam, SCT; Le Breton, GC				Srinivasan, Subhashini; Mir, Fozia; Huang, Jin-Sheng; Khasawneh, Fadi T.; Lam, Stephen C. -T.; Le Breton, Guy C.			The P2Y(12) Antagonists, 2-Methylthioadenosine 5 '-Monophosphate Triethylammonium Salt and Cangrelor (ARC69931MX), Can Inhibit Human Platelet Aggregation through a G(i)-independent Increase in cAMP Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROSTAGLANDIN DP-RECEPTORS; A(2A) ADENOSINE RECEPTORS; ADP RECEPTORS; INTEGRIN ALPHA(IIB)BETA(3); PROCOAGULANT ACTIVITY; ADENYLYL-CYCLASE; SHAPE CHANGE; G-PROTEINS; ACTIVATION; AGONISTS	ADP plays an integral role in the process of hemostasis by signaling through two platelet G-protein-coupled receptors, P2Y(1) and P2Y(12). The recent use of antagonists against these two receptors has contributed a substantial body of data characterizing the ADP signaling pathways in human platelets. Specifically, the results have indicated that although P2Y(1) receptors are involved in the initiation of platelet aggregation, P2Y(12) receptor activation appears to account for the bulk of the ADP-mediated effects. Based on this consideration, emphasis has been placed on the development of a new class of P2Y(12) antagonists (separate from clopidogrel and ticlopidine) as an approach to the treatment of thromboembolic disorders. The present work examined the molecular mechanisms by which two of these widely used adenosine-based P2Y(12) antagonists (2-methylthioadenosine 5'-monophosphate triethylammonium salt (2MeSAMP) and ARC69931MX), inhibit human platelet activation. It was found that both of these compounds raise platelet cAMP to levels that substantially inhibit platelet aggregation. Furthermore, the results demonstrated that this elevation of cAMP did not require G(i) signaling or functional P2Y(12) receptors but was mediated through activation of a separate G protein-coupled pathway, presumably involving G(s). However, additional experiments revealed that neither 2MeSAMP nor ARC69931MX (cangrelor) increased cAMP through activation of A2a, IP, DP, or EP2 receptors, which are known to couple to G(s). Collectively, these findings indicate that 2MeSAMP and ARC69931MX interact with an unidentified platelet G protein-coupled receptor that stimulates cAMP-mediated inhibition of platelet function. This inhibition is in addition to that derived from antagonism of P2Y(12) receptors.	[Le Breton, Guy C.] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Le Breton, GC (corresponding author), Univ Illinois, Coll Med, Dept Pharmacol, 835 S Wolcott Ave M-C 868, Chicago, IL 60612 USA.	gcl@uic.edu			National Institutes of Health [HL23540-25]; American Heart Association [0815654G]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association)	This work was supported, in whole or in part, by National Institutes of Health Grant HL23540-25 ( to G. C. L.).; Recipient of a predoctoral fellowship from the American Heart Association ( Grant 0815654G).	Baurand A, 2005, MOL PHARMACOL, V67, P721, DOI 10.1124/mol.104.004846; Beltramo M, 1997, SCIENCE, V277, P1094, DOI 10.1126/science.277.5329.1094; BERTELE V, 1984, THROMB HAEMOSTASIS, V51, P125; BRASS LF, 1988, J BIOL CHEM, V263, P5348; Brass LF, 1997, THROMB HAEMOSTASIS, V78, P581; BRASS LF, 1986, J BIOL CHEM, V261, P6838; CHARO IF, 1977, J CLIN INVEST, V60, P866, DOI 10.1172/JCI108841; COLLER BS, 1990, NEW ENGL J MED, V322, P33, DOI 10.1056/NEJM199001043220107; Crider JY, 1999, BRIT J PHARMACOL, V127, P204, DOI 10.1038/sj.bjp.0702490; Daniel JL, 1998, J BIOL CHEM, V273, P2024, DOI 10.1074/jbc.273.4.2024; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Dionisotti S, 1996, J PHARMACOL EXP THER, V278, P1209; Dorsam RT, 2004, J CLIN INVEST, V113, P340, DOI 10.1172/JCI200420986; EVANS T, 1984, MOL PHARMACOL, V26, P395; Foster CJ, 2001, J CLIN INVEST, V107, P1591, DOI 10.1172/JCI12242; GILES H, 1989, BRIT J PHARMACOL, V96, P291, DOI 10.1111/j.1476-5381.1989.tb11816.x; GILMAN AG, 1970, P NATL ACAD SCI USA, V67, P305, DOI 10.1073/pnas.67.1.305; Hardy AR, 2005, BLOOD, V105, P3552, DOI 10.1182/blood-2004-07-2893; HIGGS EA, 1978, BRIT J PHARMACOL, V63, P535, DOI 10.1111/j.1476-5381.1978.tb07809.x; Jin JG, 2002, BLOOD, V99, P193, DOI 10.1182/blood.V99.1.193; Jung SM, 2001, EUR J BIOCHEM, V268, P3513, DOI 10.1046/j.1432-1327.2001.02252.x; Khasawneh FT, 2008, BIOCHEM PHARMACOL, V75, P2301, DOI 10.1016/j.bcp.2008.03.014; Kim S, 2002, BLOOD, V99, P3629, DOI 10.1182/blood.V99.10.3629; KINLOUGHRATHBONE RL, 1976, SCIENCE, V192, P1011, DOI 10.1126/science.1273582; Kunapuli SP, 2003, CURR PHARM DESIGN, V9, P2303, DOI 10.2174/1381612033453947; Le Breton G C, 1980, Adv Prostaglandin Thromboxane Res, V6, P497; Leon C, 2003, ARTERIOSCL THROM VAS, V23, P1941, DOI 10.1161/01.ATV.0000092127.16125.E6; MICHAL F, 1971, NATURE-NEW BIOL, V231, P220, DOI 10.1038/newbio231220a0; Nieswandt B, 2002, J BIOL CHEM, V277, P39493, DOI 10.1074/jbc.M207256200; Salomon Y, 1979, Adv Cyclic Nucleotide Res, V10, P35; Storey RF, 2000, BRIT J HAEMATOL, V110, P925, DOI 10.1046/j.1365-2141.2000.02208.x; Storey RF, 2001, PLATELETS, V12, P197, DOI 10.1080/09537100120058739; Storey RF, 2001, PLATELETS, V12, P443, DOI 10.1080/09537100120085450; TATESON JE, 1977, PROSTAGLANDINS, V13, P389, DOI 10.1016/0090-6980(77)90019-3; Trumel C, 1999, BLOOD, V94, P4156, DOI 10.1182/blood.V94.12.4156.424k29_4156_4165; Van Kolen K, 2004, J NEUROCHEM, V89, P442, DOI 10.1111/j.1471-4159.2004.02339.x; Varani K, 1999, CIRCULATION, V99, P2499, DOI 10.1161/01.CIR.99.19.2499; WOODWARD DF, 1995, BIOCHEM PHARMACOL, V50, P1731, DOI 10.1016/0006-2952(95)02035-7; Yang J, 2000, P NATL ACAD SCI USA, V97, P9984, DOI 10.1073/pnas.180194597; Yoneda K, 2004, BRIT J PHARMACOL, V142, P551, DOI 10.1038/sj.bjp.0705808; Yu HX, 1999, DRUG DEVELOP RES, V48, P84	41	43	44	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16108	16117		10.1074/jbc.M809780200	http://dx.doi.org/10.1074/jbc.M809780200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19346255	Green Published, hybrid			2022-12-27	WOS:000266730900007
J	Xu, W; Yi, L; Feng, YM; Chen, L; Liu, JS				Xu, Wei; Yi, Lina; Feng, Yumei; Chen, Ling; Liu, Jinsong			Structural Insight into the Activation Mechanism of Human Pancreatic Prophospholipase A2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SECRETORY PHOSPHOLIPASE A(2); CRYSTAL-STRUCTURE; GROUP IB; BINDING; CRYSTALLOGRAPHY; PURIFICATION; PROPEPTIDE; PROGRAM; ZYMOGEN; ENZYME	Pancreatic phospholipase A2 (phospholipase A2 group 1B, G1B) belongs to the superfamily of secreted phospholipase A2 (PLA2) enzymes. G1B has been proposed to be a potential target for diseases such as hypertension, obesity, and diabetes. Human pancreatic prophospholipase A2 (pro-hG1B) is activated by cleavage of the first seven-residue propeptide (phospholipase A2 propeptide, PROP). However, questions still remain on the mode of action for pro-hG1B. In this work, we expressed pro-hG1B in Pichia pastoris and determined the crystal structure at 1.55-angstrom resolution. The x-ray structure demonstrates that pro-hG1B forms a trimer. In addition, PROP occupies the catalytic cavity and can be self-cleaved at 37 degrees C. A new membrane-bound surface and activation mechanism are proposed based on the trimeric model of pro-hG1B. We also propose a new autoproteolytic mechanism for pro-hG1B by the reaction triad Asp49-Arg0-Ser(-2) that is similar to the serine protease catalytic triad.	[Xu, Wei; Yi, Lina; Feng, Yumei; Chen, Ling; Liu, Jinsong] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangzhou 510663, Guangdong, Peoples R China; [Xu, Wei] Chinese Acad Sci, Grad Univ, Beijing 100049, Peoples R China; [Chen, Ling; Liu, Jinsong] Univ Sci & Technol China, Sch Life Sci, Hefei 230027, Peoples R China	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Chen, L (corresponding author), 3rd Floor,Guangzhou Int Business Incubator,Guangz, Guangzhou 510663, Guangdong, Peoples R China.	chen_ling@gibh.ac.cn; liu_jinsong@gibh.ac.cn	Xu, Wei/GQZ-2075-2022	Xu, Wei/0000-0002-3135-5010	National Basic Research Program of China [2007CB914301, 2006CB910202, 2005CB523008]	National Basic Research Program of China(National Basic Research Program of China)	This work was supported by the National Basic Research Program of China (973 Program) (No. 2007CB914301, 2006CB910202, and 2005CB523008).	Bahnson BJ, 2005, ARCH BIOCHEM BIOPHYS, V433, P96, DOI 10.1016/j.abb.2004.08.013; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cheng HQ, 2004, ACTA BIOCH BIOPH SIN, V36, P583, DOI 10.1093/abbs/36.9.583; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DEHAAS GH, 1968, BIOCHIM BIOPHYS ACTA, V159, P118, DOI 10.1016/0005-2744(68)90249-0; DELANO WL, 2002, PYMOL VERSION 1 0R1; DIJKSTRA BW, 1978, J MOL BIOL, V124, P53, DOI 10.1016/0022-2836(78)90146-8; DIJKSTRA BW, 1981, J MOL BIOL, V147, P97, DOI 10.1016/0022-2836(81)90081-4; DIJKSTRA BW, 1981, NATURE, V289, P604, DOI 10.1038/289604a0; DIJKSTRA BW, 1983, J MOL BIOL, V168, P163, DOI 10.1016/S0022-2836(83)80328-3; EGMOND MR, 1983, BIOCHIM BIOPHYS ACTA, V744, P23, DOI 10.1016/0167-4838(83)90335-7; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Epstein TM, 2001, BIOCHEMISTRY-US, V40, P11411, DOI 10.1021/bi011228h; ESKOLA JU, 1983, CLIN CHEM, V29, P1772; FREMONT DH, 1993, P NATL ACAD SCI USA, V90, P342, DOI 10.1073/pnas.90.1.342; Frossard PM, 1995, CLIN GENET, V48, P284; GRATAROLI R, 1982, EUR J BIOCHEM, V122, P111, DOI 10.1111/j.1432-1033.1982.tb05855.x; GUDGEON AM, 1991, ANN CLIN BIOCHEM, V28, P497, DOI 10.1177/000456329102800513; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95; Huggins KW, 2002, AM J PHYSIOL-ENDOC M, V283, pE994, DOI 10.1152/ajpendo.00110.2002; KABSCH W, 1988, J APPL CRYSTALLOGR, V21, P916, DOI 10.1107/S0021889888007903; Kolko M, 2007, ACTA OPHTHALMOL SCAN, V85, P317, DOI 10.1111/j.1600-0420.2006.00809.x; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; KUOPIO T, 1995, APMIS, V103, P69, DOI 10.1111/j.1699-0463.1995.tb01081.x; Labonte ED, 2006, DIABETES, V55, P935, DOI 10.2337/diabetes.55.04.06.db05-1286; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Lebedev AA, 2008, ACTA CRYSTALLOGR D, V64, P33, DOI 10.1107/S0907444907049839; Mayer JM, 2000, DIGESTION, V62, P164, DOI 10.1159/000007809; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; *OXF DIFFR, 2008, CRYSALIS VERS 1 171; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Pan YH, 2001, BIOCHEMISTRY-US, V40, P609, DOI 10.1021/bi002514g; PETERS AR, 1992, BIOCHEMISTRY-US, V31, P10024, DOI 10.1021/bi00156a023; Qin S, 2005, J BIOL CHEM, V280, P36773, DOI 10.1074/jbc.M506789200; Qin S, 2004, J MOL BIOL, V344, P71, DOI 10.1016/j.jmb.2004.09.034; Rae D, 1996, SCAND J GASTROENTERO, V31, P24, DOI 10.3109/00365529609104995; RAE D, 1995, CLIN BIOCHEM, V28, P71, DOI 10.1016/0009-9120(94)00068-7; Schaloske RH, 2006, BBA-MOL CELL BIOL L, V1761, P1246, DOI 10.1016/j.bbalip.2006.07.011; Schoenberg MH, 1997, CHIRURG, V68, P1112, DOI 10.1007/s001040050330; Segelke BW, 1998, J MOL BIOL, V279, P223, DOI 10.1006/jmbi.1998.1759; Steiner RA, 2001, ACTA CRYSTALLOGR D, V57, P516, DOI 10.1107/S0907444901002530; THUNNISSEN MMGM, 1993, J MOL BIOL, V232, P839, DOI 10.1006/jmbi.1993.1435; Tomoo K, 1997, BBA-PROTEIN STRUCT M, V1340, P178, DOI 10.1016/S0167-4838(97)00041-1; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Winget JM, 2006, BBA-MOL CELL BIOL L, V1761, P1260, DOI 10.1016/j.bbalip.2006.08.002	49	20	24	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16659	16666		10.1074/jbc.M808029200	http://dx.doi.org/10.1074/jbc.M808029200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19297324	Green Published, hybrid			2022-12-27	WOS:000266730900061
J	Dutta, T; Deutscher, MP				Dutta, Tanmay; Deutscher, Murray P.			Catalytic Properties of RNase BN/RNase Z from Escherichia coli RNase BN IS BOTH AN EXO- AND ENDORIBONUCLEASE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRNASE-Z-FAMILY; SUBSTRATE; CCA; EXORIBONUCLEASES; PRECURSORS; MATURATION; PROTEINS; CLEAVAGE; GROWTH	Processing of the 3' terminus of tRNA in many organisms is carried out by an endoribonuclease termed RNase Z or 3'-tRNase, which cleaves after the discriminator nucleotide to allow addition of the universal -CCA sequence. In some eubacteria, such as Escherichia coli, the -CCA sequence is encoded in all known tRNA genes. Nevertheless, an RNase Z homologue (RNase BN) is still present, even though its action is not needed for tRNA maturation. To help identify which RNA molecules might be potential substrates for RNase BN, we carried out a detailed examination of its specificity and catalytic potential using a variety of synthetic substrates. We show here that RNase BN is active on both double-and single-stranded RNA but that duplex RNA is preferred. The enzyme displays a profound base specificity, showing no activity on runs of C residues. RNase BN is strongly inhibited by the presence of a 3'-CCA sequence or a 3'-phosphoryl group. Digestion by RNase BN leads to 3-mers as the limit products, but the rate slows on molecules shorter than 10 nucleotides in length. Most interestingly, RNase BN acts as a distributive exoribonuclease on some substrates, releasing mononucleotides and a ladder of digestion products. However, RNase BN also cleaves endonucleolytically, releasing 3' fragments as short as 4 nucleotides. Although the presence of a 3'-phosphoryl group abolishes exoribonuclease action, it has no effect on the endoribonucleolytic cleavages. These data suggest that RNase BN may differ from other members of the RNase Z family, and they provide important information to be considered in identifying a physiological role for this enzyme.	[Dutta, Tanmay; Deutscher, Murray P.] Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, Miami, FL 33101 USA	University of Miami	Deutscher, MP (corresponding author), Univ Miami, Miller Sch Med, Dept Biochem & Mol Biol, POB 016129, Miami, FL 33101 USA.	mdeutsch@med.miami.edu	Dutta, Tanmay/ABH-2431-2021		National Institutes of Health [GM16317]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM016317, F32GM016317] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM16317.	ASHA PK, 1983, P NATL ACAD SCI-BIOL, V80, P3301, DOI 10.1073/pnas.80.11.3301; de la Sierra-Gallay IL, 2006, NAT STRUCT MOL BIOL, V13, P376, DOI 10.1038/nsmb1066; de la Sierra-Gallay IL, 2005, NATURE, V433, P657, DOI 10.1038/nature03284; de la Sierra-Gallay IL, 2008, NAT STRUCT MOL BIOL, V15, P206, DOI 10.1038/nsmb.1376; DEUTSCHER MP, 1993, J BACTERIOL, V175, P4577, DOI 10.1128/JB.175.15.4577-4583.1993; Deutscher Murray P., 1995, P51; Elbarbary RA, 2008, BBA-PROTEINS PROTEOM, V1784, P2079, DOI 10.1016/j.bbapap.2008.08.019; Ezraty B, 2005, J BIOL CHEM, V280, P16542, DOI 10.1074/jbc.C500098200; KELLY KO, 1992, J BACTERIOL, V174, P6682, DOI 10.1128/JB.174.20.6682-6684.1992; Kostelecky B, 2006, J BACTERIOL, V188, P1607, DOI 10.1128/JB.188.4.1607-1614.2006; Li ZW, 1996, CELL, V86, P503, DOI 10.1016/S0092-8674(00)80123-3; Minagawa A, 2004, J BIOL CHEM, V279, P15688, DOI 10.1074/jbc.M313951200; Mohan A, 1999, RNA, V5, P245, DOI 10.1017/S1355838299981256; Pellegrini O, 2003, EMBO J, V22, P4534, DOI 10.1093/emboj/cdg435; Perwez T, 2006, MOL MICROBIOL, V60, P723, DOI 10.1111/j.1365-2958.2006.05124.x; Redko Y, 2007, NAT REV MICROBIOL, V5, P278, DOI 10.1038/nrmicro1622; REUVEN NB, 1993, FASEB J, V7, P143, DOI 10.1096/fasebj.7.1.8422961; Schierling K, 2002, J MOL BIOL, V316, P895, DOI 10.1006/jmbi.2001.5395; Schiffer S, 2003, BIOL CHEM, V384, P333, DOI 10.1515/BC.2003.039; Schiffer S, 2002, EMBO J, V21, P2769, DOI 10.1093/emboj/21.11.2769; Schilling O, 2005, J BIOL CHEM, V280, P17857, DOI 10.1074/jbc.M500591200; Schilling O, 2004, BIOCHEM BIOPH RES CO, V320, P1365, DOI 10.1016/j.bbrc.2004.05.227; SEIDMAN JG, 1975, CELL, V5, P389, DOI 10.1016/0092-8674(75)90058-6; Shibata HS, 2006, BIOCHEMISTRY-US, V45, P5486, DOI 10.1021/bi051972s; Takaku H, 2008, GENES CELLS, V13, P1087, DOI 10.1111/j.1365-2443.2008.01230.x; UZIEL M, 1973, BIOCHEMISTRY-US, V12, P938, DOI 10.1021/bi00729a023; Vogel A, 2005, BIOL CHEM, V386, P1253, DOI 10.1515/BC.2005.142; Vogel A, 2002, J BIOL CHEM, V277, P29078, DOI 10.1074/jbc.M112047200; Weiner AM, 2004, CURR BIOL, V14, pR883, DOI 10.1016/j.cub.2004.09.069; Yang XC, 2009, MOL CELL BIOL, V29, P31, DOI 10.1128/MCB.00776-08; Zareen N, 2006, RNA, V12, P1104, DOI 10.1261/rna.4206	32	24	25	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15425	15431		10.1074/jbc.M109.005462	http://dx.doi.org/10.1074/jbc.M109.005462			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19366704	Green Published, hybrid			2022-12-27	WOS:000266501000010
J	Bodrato, N; Franco, L; Fresia, C; Guida, L; Usai, C; Salis, A; Moreschi, I; Ferraris, C; Verderio, C; Basile, G; Bruzzone, S; Scarfi, S; De Flora, A; Zocchi, E				Bodrato, Nicoletta; Franco, Luisa; Fresia, Chiara; Guida, Lucrezia; Usai, Cesare; Salis, Annalisa; Moreschi, Iliana; Ferraris, Chiara; Verderio, Claudia; Basile, Giovanna; Bruzzone, Santina; Scarfi, Sonia; De Flora, Antonio; Zocchi, Elena			Abscisic Acid Activates the Murine Microglial Cell Line N9 through the Second Messenger Cyclic ADP-ribose	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ADENINE-DINUCLEOTIDE PHOSPHATE; TEMPERATURE-SIGNALING CASCADE; INTRACELLULAR CALCIUM; STIMULATES PROLIFERATION; EXTRACELLULAR NAD(+); TRPM2 CHANNELS; HIGH-AFFINITY; RECEPTOR; CD38; CHEMOTAXIS	Abscisic acid (ABA) is a phytohormone regulating important functions in higher plants, notably responses to abiotic stress. Recently, chemical or physical stimulation of human granulocytes was shown to induce production and release of endogenous ABA, which activates specific cell functions. Here we provide evidence that ABA stimulates several functional activities of the murine microglial cell line N9 (NO and tumor necrosis factor-alpha production, cell migration) through the second messenger cyclic ADP-ribose and an increase of intracellular calcium. ABA production and release occur in N9 cells stimulated with bacterial lipopolysaccharide, phorbol myristate acetate, the chemoattractant peptide f-MLP, or beta-amyloid, the primary plaque component in Alzheimer disease. Finally, ABA priming stimulates N9 cell migration toward beta-amyloid. These results indicate that ABA is a pro-inflammatory hormone inducing autocrine microglial activation, potentially representing a new target for anti-inflammatory therapies aimed at limiting microglia-induced tissue damage in the central nervous system.	[Ferraris, Chiara; Basile, Giovanna; Bruzzone, Santina; Scarfi, Sonia; De Flora, Antonio; Zocchi, Elena] Univ Genoa, Biochem Sect, Dept Expt Med, I-16132 Genoa, Italy; [Ferraris, Chiara; Basile, Giovanna; Bruzzone, Santina; Scarfi, Sonia; De Flora, Antonio] Univ Genoa, Ctr Excellence Biomed Res, I-16132 Genoa, Italy; [Fresia, Chiara; Guida, Lucrezia; Ferraris, Chiara; Bruzzone, Santina; Scarfi, Sonia; Zocchi, Elena] Adv Biotechnol Ctr, I-16132 Genoa, Italy; [Usai, Cesare] CNR, Inst Biophys, I-16149 Genoa, Italy; [Verderio, Claudia] Univ Milan, Dept Pharmacol, CNR, Inst Neurosci, I-20129 Milan, Italy	University of Genoa; University of Genoa; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); Consiglio Nazionale delle Ricerche (CNR); University of Milan	Zocchi, E (corresponding author), Univ Genoa, Biochem Sect, Dept Expt Med, Viale Benedetto 15-1, I-16132 Genoa, Italy.	ezocchi@unige.it	Scarfi, Sonia/AAJ-2387-2020; Verderio, Claudia/K-4415-2016; Bruzzone, Santina/A-4264-2015; Salis, Annalisa/R-9241-2018	Scarfi, Sonia/0000-0002-7079-6919; Verderio, Claudia/0000-0001-7216-5873; Bruzzone, Santina/0000-0003-2034-3716; FRESIA, CHIARA MARTA/0000-0002-9177-4655; Salis, Annalisa/0000-0002-3082-2908; Usai, Cesare/0000-0001-8863-7759	Associazione Italiana per la Ricerca sul Cancro, Italian Ministry of Education; University and Scientific Research [MIUR-PRIN 2005, MIUR FIRB RBAUO19A3C, MIUR FIRB RBNE01ERXR, MIUR FIRB RBLA039LSF, MIUR FIRB RBIP06LSS2]; Regione Liguria; University of Genova and Fondazione Cassa di Risparmio di Genova e Imperia	Associazione Italiana per la Ricerca sul Cancro, Italian Ministry of Education(Fondazione AIRC per la ricerca sul cancro); University and Scientific Research; Regione Liguria(Regione Liguria); University of Genova and Fondazione Cassa di Risparmio di Genova e Imperia	This work was supported in part by grants from the Associazione Italiana per la Ricerca sul Cancro, Italian Ministry of Education; University and Scientific Research Grants MIUR-PRIN 2005, MIUR FIRB RBAUO19A3C, MIUR FIRB RBNE01ERXR, MIUR FIRB RBLA039LSF, and MIUR FIRB RBIP06LSS2; grants from Regione Liguria, and grants from the University of Genova and Fondazione Cassa di Risparmio di Genova e Imperia.	Adler MW, 2005, J LEUKOCYTE BIOL, V78, P1204, DOI 10.1189/jlb.0405222; Aschner M, 1999, ANNU REV PHARMACOL, V39, P151, DOI 10.1146/annurev.pharmtox.39.1.151; Beck A, 2006, FASEB J, V20, P962, DOI 10.1096/fj.05-5538fje; Berruet L, 1998, BIOCHEM MOL BIOL INT, V46, P847; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruzzone S, 2006, BIOCHEM J, V393, P697, DOI 10.1042/BJ20051302; Bruzzone S, 2003, BIOCHEM J, V375, P395, DOI 10.1042/BJ20030556; Bruzzone S, 1998, FEBS LETT, V433, P275, DOI 10.1016/S0014-5793(98)00929-6; Bruzzone S, 2007, P NATL ACAD SCI USA, V104, P5759, DOI 10.1073/pnas.0609379104; CHAO CC, 1995, CRIT REV NEUROBIOL, V9, P189; CHEN FSC, 1988, AGR BIOL CHEM TOKYO, V52, P1273; Cui YH, 2002, J IMMUNOL, V168, P434, DOI 10.4049/jimmunol.168.1.434; De Simone R, 2007, J NEUROIMMUNOL, V190, P53, DOI 10.1016/j.jneuroim.2007.07.020; DICKSON DW, 1993, GLIA, V7, P75, DOI 10.1002/glia.440070113; Eikelenboom P, 2006, J NEURAL TRANSM, V113, P1685, DOI 10.1007/s00702-006-0575-6; Farber K, 2005, BRAIN RES REV, V48, P133, DOI 10.1016/j.brainresrev.2004.12.003; Franco L, 2001, J BIOL CHEM, V276, P21642, DOI 10.1074/jbc.M010536200; Franco L, 2006, J NEUROCHEM, V99, P165, DOI 10.1111/j.1471-4159.2006.04031.x; Gebicke-Haerter PJ, 2001, MICROSC RES TECHNIQ, V54, P47, DOI 10.1002/jemt.1120; GebickeHaerter PJ, 1996, NEUROCHEM INT, V29, P1; Ghoshal A, 2007, GLIA, V55, P483, DOI 10.1002/glia.20474; Gonzalez-Scarano F, 1999, ANNU REV NEUROSCI, V22, P219, DOI 10.1146/annurev.neuro.22.1.219; Graeff R, 2002, BIOCHEM J, V367, P163, DOI 10.1042/BJ20020644; GRAEFF RM, 1994, J BIOL CHEM, V269, P30260; Grill E, 1998, CURR OPIN PLANT BIOL, V1, P412, DOI 10.1016/S1369-5266(98)80265-3; Guida L, 2004, J BIOL CHEM, V279, P22066, DOI 10.1074/jbc.M314137200; Guida L, 2002, J BIOL CHEM, V277, P47097, DOI 10.1074/jbc.M207793200; Guse AH, 1997, J BIOL CHEM, V272, P8546, DOI 10.1074/jbc.272.13.8546; Hirsch EC, 2003, ANN NY ACAD SCI, V991, P214; Hoffmann A, 2003, J NEUROSCI, V23, P4410; Idzko M, 2002, BLOOD, V100, P925, DOI 10.1182/blood.V100.3.925; INESI G, 1992, ARCH BIOCHEM BIOPHYS, V298, P313, DOI 10.1016/0003-9861(92)90416-T; Khoo KM, 1998, BIOCHEM MOL BIOL INT, V44, P841; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Lange I, 2008, CELL CALCIUM, V44, P604, DOI 10.1016/j.ceca.2008.05.001; Lee H, 2004, J NEUROIMMUNOL, V156, P88, DOI 10.1016/j.jneuroim.2004.07.008; LEE HC, 2002, CYCLIC ADP RIBOSE NA; LEPAGEDEGIVRY MT, 1986, P NATL ACAD SCI USA, V83, P1155; Liu XG, 2007, SCIENCE, V315, P1712, DOI 10.1126/science.1135882; Moreno-Garcia ME, 2004, EUR J BIOCHEM, V271, P1025, DOI 10.1111/j.1432-1033.2004.04006.x; Moreschi I, 2006, J BIOL CHEM, V281, P31419, DOI 10.1074/jbc.M606625200; Nakamura Y, 2003, BRAIN RES, V962, P122, DOI 10.1016/S0006-8993(02)03979-3; Paris D, 2000, NEUROSCI LETT, V278, P5, DOI 10.1016/S0304-3940(99)00901-5; Partida-Sanchez S, 2001, NAT MED, V7, P1209, DOI 10.1038/nm1101-1209; Podesta M, 2005, J BIOL CHEM, V280, P5343, DOI 10.1074/jbc.M408085200; Podesta M, 2000, FASEB J, V14, P680, DOI 10.1096/fasebj.14.5.680; RIGHI M, 1989, EUR J IMMUNOL, V19, P1443, DOI 10.1002/eji.1830190815; Rogers J, 2001, NEUROCHEM INT, V39, P333, DOI 10.1016/S0197-0186(01)00040-7; Saura J, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-26; Tan J, 1999, J NEUROIMMUNOL, V97, P77, DOI 10.1016/S0165-5728(99)00053-3; Togashi K, 2006, EMBO J, V25, P1804, DOI 10.1038/sj.emboj.7601083; Town T, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-24; Vercammen D, 1997, CYTOKINE, V9, P801, DOI 10.1006/cyto.1997.0252; Verderio C, 2001, J NEUROCHEM, V78, P646, DOI 10.1046/j.1471-4159.2001.00455.x; Vitkovic L, 2000, J NEUROCHEM, V74, P457, DOI 10.1046/j.1471-4159.2000.740457.x; WALSETH TF, 1993, BIOCHIM BIOPHYS ACTA, V1178, P235, DOI 10.1016/0167-4889(93)90199-Y; Wilms H, 2007, CURR PHARM DESIGN, V13, P1925; Wu Y, 1997, SCIENCE, V278, P2126, DOI 10.1126/science.278.5346.2126; Zocchi E, 1998, J BIOL CHEM, V273, P8017, DOI 10.1074/jbc.273.14.8017; Zocchi E, 2003, J CELL SCI, V116, P629, DOI 10.1242/jcs.00277; Zocchi E, 2001, P NATL ACAD SCI USA, V98, P14859, DOI 10.1073/pnas.261448698	61	59	63	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					14777	14787		10.1074/jbc.M802604200	http://dx.doi.org/10.1074/jbc.M802604200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19329433	Green Published, hybrid			2022-12-27	WOS:000266288200013
J	Salomon, D; Bonshtien, A; Mayrose, M; Zhang, C; Shokat, KM; Sessa, G				Salomon, Dor; Bonshtien, Arale; Mayrose, Maya; Zhang, Chao; Shokat, Kevan M.; Sessa, Guido			Bypassing Kinase Activity of the Tomato Pto Resistance Protein with Small Molecule Ligands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PLANT-DISEASE RESISTANCE; BACTERIAL SPECK DISEASE; CHEMICAL-GENETIC APPROACH; HYPERSENSITIVE RESPONSE; CELL-DEATH; INNATE IMMUNITY; SALICYLIC-ACID; LEUCINE-RICH; AVRPTO; RECEPTOR	The tomato (Solanum lycopersicum) protein kinase Pto confers resistance to Pseudomonas syringae pv. tomato bacteria expressing the AvrPto and AvrPtoB effector proteins. Pto specifically recognizes both effectors by direct physical interactions triggering activation of immune responses. Here, we used a chemical-genetic approach to sensitize Pto to analogs of PP1, an ATP-competitive small molecule inhibitor. By using PP1 analogs in combination with the sensitized Pto (Pto(as)), we examined the role of Pto kinase activity in effector recognition and signal transduction. Strikingly, while PP1 analogs efficiently inhibited kinase activity of Ptoas in vitro, they enhanced interactions of Pto(as) with AvrPto and AvrPtoB in a yeast two-hybrid system. In addition, in the presence of PP1 analogs, Pto(as) bypassed mutations either at an autophosphorylation site critical for the Pto-AvrPto interaction or at catalytically essential residues and interacted with both effectors. Moreover, in the presence of the PP1 analog 3MB-PP1, a kinase-deficient form of Pto(as) triggered an AvrPto-dependent hypersensitive response in planta. These findings suggest that, rather than phosphorylation per se, a conformational change likely triggered by autophosphorylation in Pto and mimicked by ligand binding in Ptoas is a prerequisite for recognition of bacterial effectors. Following recognition, kinase activity appears to be dispensable for Pto signaling in planta. The chemical-genetic strategy applied here to develop specific small molecule inhibitors of Pto represents an invaluable tool for the study of biological functions of other plant protein kinases in vivo.	[Sessa, Guido] Tel Aviv Univ, Dept Plant Sci, IL-69978 Tel Aviv, Israel; [Zhang, Chao; Shokat, Kevan M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Zhang, Chao; Shokat, Kevan M.] Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94158 USA	Tel Aviv University; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Sessa, G (corresponding author), Tel Aviv Univ, Dept Plant Sci, IL-69978 Tel Aviv, Israel.	guidos@post.tau.ac.il		Salomon, Dor/0000-0002-2009-9453	Binational Science Foundation [2001124, 2007091]	Binational Science Foundation(US-Israel Binational Science Foundation)	This work was supported by Binational Science Foundation Grants 2001124 and 2007091.	Abramovitch RB, 2003, EMBO J, V22, P60, DOI 10.1093/emboj/cdg006; Benjamin KR, 2003, GENE DEV, V17, P1524, DOI 10.1101/gad.1101503; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Bishop AC, 1998, CURR BIOL, V8, P257, DOI 10.1016/S0960-9822(98)70198-8; Bishop AC, 1999, J AM CHEM SOC, V121, P627, DOI 10.1021/ja983267v; Bishop AC, 2001, TRENDS CELL BIOL, V11, P167, DOI 10.1016/S0962-8924(01)01928-6; Bohmer M, 2007, PLANT MOL BIOL, V65, P817, DOI 10.1007/s11103-007-9245-9; Brodersen P, 2006, PLANT J, V47, P532, DOI 10.1111/j.1365-313X.2006.02806.x; Brueggeman R, 2008, P NATL ACAD SCI USA, V105, P14970, DOI 10.1073/pnas.0807270105; Caplan J, 2008, CELL HOST MICROBE, V3, P126, DOI 10.1016/j.chom.2008.02.010; Chinchilla D, 2006, PLANT CELL, V18, P465, DOI 10.1105/tpc.105.036574; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; Cohn JR, 2005, PLANT J, V44, P139, DOI 10.1111/j.1365-313X.2005.02516.x; Dardick C, 2007, PLANT PHYSIOL, V143, P579, DOI 10.1104/pp.106.087270; del Pozo O, 2004, EMBO J, V23, P3072, DOI 10.1038/sj.emboj.7600283; Ekengren SK, 2003, PLANT J, V36, P905, DOI 10.1046/j.1365-313X.2003.01944.x; Frederick RD, 1998, MOL CELL, V2, P241, DOI 10.1016/S1097-2765(00)80134-3; GOLEMIS EA, 1995, CURRENT PROTOCOLS MO, V3; Gu YQ, 2000, PLANT CELL, V12, P771, DOI 10.1105/tpc.12.5.771; Hauck P, 2003, P NATL ACAD SCI USA, V100, P8577, DOI 10.1073/pnas.1431173100; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Jones MH, 2005, CURR BIOL, V15, P160, DOI 10.1016/j.cub.2005.01.010; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kim YJ, 2002, CELL, V109, P589, DOI 10.1016/S0092-8674(02)00743-2; Levin SE, 2008, J BIOL CHEM, V283, P15419, DOI 10.1074/jbc.M709000200; Martin GB, 2003, ANNU REV PLANT BIOL, V54, P23, DOI 10.1146/annurev.arplant.54.031902.135035; Mucyn TS, 2006, PLANT CELL, V18, P2792, DOI 10.1105/tpc.106.044016; Mur LAJ, 2008, J EXP BOT, V59, P501, DOI 10.1093/jxb/erm239; Navarro L, 2008, SCIENCE, V321, P964, DOI 10.1126/science.1159505; Papa FR, 2003, SCIENCE, V302, P1533, DOI 10.1126/science.1090031; Pedley KF, 2004, J BIOL CHEM, V279, P49229, DOI 10.1074/jbc.M410323200; Pedley KF, 2003, ANNU REV PHYTOPATHOL, V41, P215, DOI 10.1146/annurev.phyto.41.121602.143032; Quintaje SB, 2008, MOL CELL PROTEOMICS, V7, P1409, DOI 10.1074/mcp.R700001-MCP200; Rathjen JP, 1999, EMBO J, V18, P3232, DOI 10.1093/emboj/18.12.3232; REYNOLDS A, 1989, CURRENT PROTOCOLS MO, V2; Salmeron JM, 1996, CELL, V86, P123, DOI 10.1016/S0092-8674(00)80083-5; Scheeff ED, 2005, PLOS COMPUT BIOL, V1, P359, DOI 10.1371/journal.pcbi.0010049; Scofield SR, 1996, SCIENCE, V274, P2063, DOI 10.1126/science.274.5295.2063; Sessa G, 2000, EMBO J, V19, P2257, DOI 10.1093/emboj/19.10.2257; Sessa G, 1998, J BIOL CHEM, V273, P15860, DOI 10.1074/jbc.273.25.15860; Shan LB, 2000, PLANT CELL, V12, P2323, DOI 10.1105/tpc.12.12.2323; Shan LB, 2008, CELL HOST MICROBE, V4, P17, DOI 10.1016/j.chom.2008.05.017; Tang XY, 1996, SCIENCE, V274, P2060, DOI 10.1126/science.274.5295.2060; Weiss EL, 2000, NAT CELL BIOL, V2, P677, DOI 10.1038/35036300; Wu AJ, 2004, PLANT CELL, V16, P2809, DOI 10.1105/tpc.104.024141; Xiang TT, 2008, CURR BIOL, V18, P74, DOI 10.1016/j.cub.2007.12.020; Xiao FM, 2007, PLANT J, V52, P595, DOI 10.1111/j.1365-313X.2007.03259.x; Xing W, 2007, NATURE, V449, P243, DOI 10.1038/nature06109; Zhang C, 2005, NAT METHODS, V2, P435, DOI 10.1038/NMETH764; Zhou JM, 1997, EMBO J, V16, P3207, DOI 10.1093/emboj/16.11.3207; ZHOU JM, 1995, CELL, V83, P925, DOI 10.1016/0092-8674(95)90208-2; Zipfel C, 2008, CURR OPIN IMMUNOL, V20, P10, DOI 10.1016/j.coi.2007.11.003; Zipfel C, 2006, CELL, V125, P749, DOI 10.1016/j.cell.2006.03.037	53	12	13	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					15289	15298		10.1074/jbc.M809724200	http://dx.doi.org/10.1074/jbc.M809724200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19332544	Green Published, hybrid			2022-12-27	WOS:000266288200063
J	Bourdeau, RW; Malito, E; Chenal, A; Bishop, BL; Musch, MW; Villereal, ML; Chang, EB; Mosser, EM; Rest, RF; Tang, WJ				Bourdeau, Raymond W.; Malito, Enrico; Chenal, Alexandre; Bishop, Brian L.; Musch, Mark W.; Villereal, Mitch L.; Chang, Eugene B.; Mosser, Elise M.; Rest, Richard F.; Tang, Wei-Jen			Cellular Functions and X-ray Structure of Anthrolysin O, a Cholesterol-dependent Cytolysin Secreted by Bacillus anthracis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IN-VITRO MODEL; PERFRINGOLYSIN-O; LISTERIOLYSIN-O; MEMBRANE INSERTION; BIOLOGICAL WEAPON; THETA-TOXIN; MECHANISM; CALCIUM; PROTEIN; ENTRY	Anthrolysin O (ALO) is a pore-forming, cholesterol-dependent cytolysin (CDC) secreted by Bacillus anthracis, the etiologic agent for anthrax. Growing evidence suggests the involvement of ALO in anthrax pathogenesis. Here, we show that the apical application of ALO decreases the barrier function of human polarized epithelial cells as well as increases intracellular calcium and the internalization of the tight junction protein occludin. Using pharmacological agents, we also found that barrier function disruption requires increased intracellular calcium and protein degradation. We also report a crystal structure of the soluble state of ALO. Based on our analytical ultracentrifugation and light scattering studies, ALO exists as a monomer. Our ALO structure provides the molecular basis as to how ALO is locked in a monomeric state, in contrast to other CDCs that undergo antiparallel dimerization or higher order oligomerization in solution. ALO has four domains and is globally similar to perfringolysinO(PFO) and intermedilysin (ILY), yet the highly conserved undecapeptide region in domain 4 (D4) adopts a completely different conformation in all three CDCs. Consistent with the differences within D4 and at the D2-D4 interface, we found that ALO D4 plays a key role in affecting the barrier function of C2BBE cells, whereas PFO domain 4 cannot substitute for this role. Novel structural elements and unique cellular functions of ALO revealed by our studies provide new insight into the molecular basis for the diverse nature of the CDC family.	[Bourdeau, Raymond W.; Malito, Enrico; Bishop, Brian L.; Tang, Wei-Jen] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA; [Musch, Mark W.; Chang, Eugene B.] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Villereal, Mitch L.] Univ Chicago, Dept Neurobiol Pharmacol & Physiol, Chicago, IL 60637 USA; [Chenal, Alexandre] Inst Pasteur, CNRS, URA 2185,Dept Biol Struct & Chim, Unite Biochim Interact Macromol, F-75724 Paris 15, France; [Mosser, Elise M.; Rest, Richard F.] Drexel Univ, Coll Med, Dept Microbiol & Immunol, Philadelphia, PA 19129 USA	University of Chicago; University of Chicago; University of Chicago; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Drexel University	Tang, WJ (corresponding author), Univ Chicago, Ben May Dept Canc Res, 929 E 57th St, Chicago, IL 60637 USA.	wtang@uchicago.edu	Chenal, Alexandre/C-2240-2009	Chenal, Alexandre/0000-0002-4959-1003; Bourdeau, Raymond/0000-0003-2202-1980; Tang, Wei-Jen/0000-0002-8267-8995	National Institutes of Health [DK38510, GM62548, AI66503]; University of Chicago [DK42086]; American Health Assistance Foundation; Great Lakes Regional Center of Excellence; University of Chicago FACCTS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062548] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Chicago(University of Chicago); American Health Assistance Foundation; Great Lakes Regional Center of Excellence(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); University of Chicago FACCTS(University of Chicago); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant DK38510 (to E. B. C.), National Institutes of Health Grants GM62548 and AI66503, and a pilot grant from Digestive Disease Research Core Center of the University of Chicago (National Institutes of Health Grant DK42086). This work was also supported by the American Health Assistance Foundation (to E. M. M.), a pilot grant from the Great Lakes Regional Center of Excellence, and a University of Chicago FACCTS grant (to W. J. T.).	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Beatty ME, 2003, ARCH INTERN MED, V163, P2527, DOI 10.1001/archinte.163.20.2527; Beauregard KE, 1999, INFECT IMMUN, V67, P3026, DOI 10.1128/IAI.67.6.3026-3030.1999; Berg RD, 1999, ADV EXP MED BIOL, V473, P11; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Chitlaru T, 2006, J BACTERIOL, V188, P3551, DOI 10.1128/JB.188.10.3551-3571.2006; Czajkowsky DM, 2004, EMBO J, V23, P3206, DOI 10.1038/sj.emboj.7600350; Dixon TC, 1999, NEW ENGL J MED, V341, P815, DOI 10.1056/NEJM199909093411107; Dramsi S, 2003, INFECT IMMUN, V71, P3614, DOI 10.1128/IAI.71.6.3614-3618.2003; DROBNIEWSKI FA, 1993, CLIN MICROBIOL REV, V6, P324, DOI 10.1128/CMR.6.4.324-338.1993; Duesbery NS, 1998, SCIENCE, V280, P734, DOI 10.1126/science.280.5364.734; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gekara NO, 2007, CELL MICROBIOL, V9, P2008, DOI 10.1111/j.1462-5822.2007.00932.x; Giddings KS, 2004, NAT STRUCT MOL BIOL, V11, P1173, DOI 10.1038/nsmb862; Giddings KS, 2003, P NATL ACAD SCI USA, V100, P11315, DOI 10.1073/pnas.2033520100; Gilbert RJC, 1998, J MOL BIOL, V284, P1223, DOI 10.1006/jmbi.1998.2258; Gilbert RJC, 2005, STRUCTURE, V13, P1097, DOI 10.1016/j.str.2005.04.019; Glomski IJ, 2007, PLOS PATHOG, V3, P699, DOI 10.1371/journal.ppat.0030076; Gonzalez-Mariscal L, 2008, BBA-BIOMEMBRANES, V1778, P729, DOI 10.1016/j.bbamem.2007.08.018; Guttmann DM, 2000, FEMS MICROBIOL LETT, V188, P7, DOI 10.1111/j.1574-6968.2000.tb09160.x; Heffernan BJ, 2007, FEMS MICROBIOL LETT, V271, P98, DOI 10.1111/j.1574-6968.2007.00713.x; Heuck AP, 2000, MOL CELL, V6, P1233, DOI 10.1016/S1097-2765(00)00119-2; Inglesby TV, 2002, JAMA-J AM MED ASSOC, V287, P2236, DOI 10.1001/jama.287.17.2236; Inglesby TV, 1999, JAMA-J AM MED ASSOC, V281, P1735, DOI 10.1001/jama.281.18.1735; IWAMOTO M, 1990, EUR J BIOCHEM, V194, P25, DOI 10.1111/j.1432-1033.1990.tb19422.x; Kumar P, 2002, INFECT IMMUN, V70, P4997, DOI 10.1128/IAI.70.9.4997-5007.2002; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; LEPPLA SH, 1982, P NATL ACAD SCI-BIOL, V79, P3162, DOI 10.1073/pnas.79.10.3162; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Ma TY, 2000, MICROSC RES TECHNIQ, V51, P156, DOI 10.1002/1097-0029(20001015)51:2<156::AID-JEMT7>3.0.CO;2-J; MADARA JL, 1990, AM J PATHOL, V137, P1273; Mitic LL, 1998, ANNU REV PHYSIOL, V60, P121, DOI 10.1146/annurev.physiol.60.1.121; Mock M, 2003, CELL MICROBIOL, V5, P15, DOI 10.1046/j.1462-5822.2003.00253.x; Mosser EM, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-56; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paccani SR, 2005, J EXP MED, V201, P325, DOI 10.1084/jem.20041557; Park JH, 1999, AM J PHYSIOL-CELL PH, V277, pC1066, DOI 10.1152/ajpcell.1999.277.6.C1066; Park JM, 2004, J EXP MED, V200, P1647, DOI 10.1084/jem.20041215; PETERSON MD, 1993, J CELL SCI, V105, P461; PETERSON MD, 1992, J CELL SCI, V102, P581; PETERSON MD, 1993, J CELL SCI, V105, P445; Polekhina G, 2005, P NATL ACAD SCI USA, V102, P600, DOI 10.1073/pnas.0403229101; Qian B, 2007, NATURE, V450, P259, DOI 10.1038/nature06249; Ramachandran R, 2004, NAT STRUCT MOL BIOL, V11, P697, DOI 10.1038/nsmb793; Ramachandran R, 2002, NAT STRUCT BIOL, V9, P823, DOI 10.1038/nsb855; Raymond B, 2007, PLOS PATHOG, V3, P1907, DOI 10.1371/journal.ppat.0030187; Rosado CJ, 2008, CELL MICROBIOL, V10, P1765, DOI 10.1111/j.1462-5822.2008.01191.x; Rosado CJ, 2007, SCIENCE, V317, P1548, DOI 10.1126/science.1144706; Ross CL, 2006, J BACTERIOL, V188, P7823, DOI 10.1128/JB.00525-06; Rossjohn J, 1997, CELL, V89, P685, DOI 10.1016/S0092-8674(00)80251-2; Rossjohn J, 2007, J MOL BIOL, V367, P1227, DOI 10.1016/j.jmb.2007.01.042; RUTTEN MJ, 1991, PHARMACOLOGY, V42, P156, DOI 10.1159/000138793; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shannon JG, 2003, INFECT IMMUN, V71, P3183, DOI 10.1128/IAI.71.6.3183-3189.2003; Shatursky O, 1999, CELL, V99, P293, DOI 10.1016/S0092-8674(00)81660-8; Shepard LA, 1998, BIOCHEMISTRY-US, V37, P14563, DOI 10.1021/bi981452f; Solovyova AS, 2004, BIOPHYS J, V87, P540, DOI 10.1529/biophysj.104.039974; Soltani CE, 2007, P NATL ACAD SCI USA, V104, P20226, DOI 10.1073/pnas.0708104105; Soltani CE, 2007, J BIOL CHEM, V282, P15709, DOI 10.1074/jbc.M701173200; Somosy Z, 2003, CELL MOL BIOL, V49, P59; Tai YH, 1996, J MEMBRANE BIOL, V149, P71; Tilley SJ, 2005, CELL, V121, P247, DOI 10.1016/j.cell.2005.02.033; Tournier JN, 2005, J IMMUNOL, V174, P4934, DOI 10.4049/jimmunol.174.8.4934; Tsuchiya K, 2005, INFECT IMMUN, V73, P3869, DOI 10.1128/IAI.73.7.3869-3877.2005; TWETEN RK, 1991, J BIOL CHEM, V266, P12449; Tweten RK, 2005, INFECT IMMUN, V73, P6199, DOI 10.1128/IAI.73.10.6199-6209.2005; Wu XY, 2004, J BIOL CHEM, V279, P43392, DOI 10.1074/jbc.M408959200; Yu D, 2008, BBA-BIOMEMBRANES, V1778, P709, DOI 10.1016/j.bbamem.2007.07.027	71	69	70	0	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14645	14656		10.1074/jbc.M807631200	http://dx.doi.org/10.1074/jbc.M807631200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19307185	Green Published, hybrid			2022-12-27	WOS:000266286100070
J	Chan, SW; Lim, CJ; Loo, LS; Chong, YF; Huang, CX; Hong, WJ				Chan, Siew Wee; Lim, Chun Jye; Loo, Li Shen; Chong, Yaan Fun; Huang, Caixia; Hong, Wanjin			TEADs Mediate Nuclear Retention of TAZ to Promote Oncogenic Transformation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; REGULATE CELL-PROLIFERATION; HIPPO SIGNALING PATHWAY; TUMOR-SUPPRESSOR GENE; ORGAN SIZE; CONTACT INHIBITION; TEAD/TEF FAMILY; BANTAM MICRORNA; YAP; PROTEIN	The transcriptional coactivators YAP and TAZ are downstream targets inhibited by the Hippo tumor suppressor pathway. The expression level of TAZ is recently shown to be elevated in invasive breast cancer cells and some primary breast cancers. TAZ is important for breast cancer cell migration, invasion, and tumorigenesis, but the underlying mechanism is not defined. In this study, we show that TAZ interacts with TEAD transcriptional factors. Knockdown of TEADs suppresses TAZ-mediated oncogenic transformation of MCF10A cells. Uncoupling TAZ from Hippo regulation by S89A mutation enhances its transforming ability. Several residues located in the N-terminal region of TAZ are identified to be important for interaction with TEADs, and these same residues are equally important for TAZ to transform MCF10A cells. Mechanistically, TAZ mutants defective in interaction with TEADs fail to accumulate in the nucleus. Live cell imaging of enhanced green fluorescent protein-TAZ and its mutant defective in TEAD interaction suggests that TEAD interaction mediates nuclear retention. These results reveal a novel mechanism for TEADs to regulate nuclear retention and thus the transforming ability of TAZ.	[Chan, Siew Wee; Lim, Chun Jye; Loo, Li Shen; Chong, Yaan Fun; Huang, Caixia; Hong, Wanjin] Inst Mol & Cell Biol, Canc & Dev Cell Biol Div, Singapore 138673, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB)	Hong, WJ (corresponding author), 61 Biopolis Dr, Singapore 138673, Singapore.	mcbhwj@imcb.a-star.edu.sg	HONG, Wanjin/E-9927-2010		Agency for Science, Technology and Research (A*STAR), Singapore	Agency for Science, Technology and Research (A*STAR), Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by the Agency for Science, Technology and Research (A*STAR), Singapore.	Adelaide J, 2007, CANCER RES, V67, P11565, DOI 10.1158/0008-5472.CAN-07-2536; Almstrup K, 2004, CANCER RES, V64, P4736, DOI 10.1158/0008-5472.CAN-04-0679; Bandura JL, 2008, DEV CELL, V14, P315, DOI 10.1016/j.devcel.2008.02.010; Cao XW, 2008, GENE DEV, V22, P3320, DOI 10.1101/gad.1726608; Chan SW, 2008, CANCER RES, V68, P2592, DOI 10.1158/0008-5472.CAN-07-2696; Cho E, 2006, NAT GENET, V38, P1142, DOI 10.1038/ng1887; Cui CB, 2003, MOL CELL BIOL, V23, P1004, DOI 10.1128/MCB.23.3.1004-1013.2003; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Ehrbrecht A, 2006, J PATHOL, V208, P554, DOI 10.1002/path.1925; Goulev Y, 2008, CURR BIOL, V18, P435, DOI 10.1016/j.cub.2008.02.034; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Han W, 2008, GENE CHROMOSOME CANC, V47, P490, DOI 10.1002/gcc.20550; Harvey K, 2007, NAT REV CANCER, V7, P182, DOI 10.1038/nrc2070; Hong JH, 2006, CELL CYCLE, V5, P176, DOI 10.4161/cc.5.2.2362; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Hossain Z, 2007, P NATL ACAD SCI USA, V104, P1631, DOI 10.1073/pnas.0605266104; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Kanai F, 2000, EMBO J, V19, P6778, DOI 10.1093/emboj/19.24.6778; Kitagawa M, 2007, BIOCHEM BIOPH RES CO, V361, P1022, DOI 10.1016/j.bbrc.2007.07.129; Kudo N, 1999, P NATL ACAD SCI USA, V96, P9112, DOI 10.1073/pnas.96.16.9112; Lam-Himlin DM, 2006, J GASTROINTEST CANC, V37, P103, DOI 10.1007/s12029-007-0010-8; Lei QY, 2008, MOL CELL BIOL, V28, P2426, DOI 10.1128/MCB.01874-07; Mahoney WM, 2005, BIOCHEM J, V388, P217, DOI 10.1042/BJ20041434; Makita R, 2008, AM J PHYSIOL-RENAL, V294, pF542, DOI 10.1152/ajprenal.00201.2007; Morin-Kensicki EM, 2006, MOL CELL BIOL, V26, P77, DOI 10.1128/MCB.26.1.77-87.2006; Murakami M, 2006, BIOCHEM BIOPH RES CO, V339, P533, DOI 10.1016/j.bbrc.2005.10.214; Murakami M, 2005, P NATL ACAD SCI USA, V102, P18034, DOI 10.1073/pnas.0509109102; Nolo R, 2006, CURR BIOL, V16, P1895, DOI 10.1016/j.cub.2006.08.057; Nowee ME, 2007, J PATHOL, V213, P46, DOI 10.1002/path.2217; Ota M, 2008, DEVELOPMENT, V135, P4059, DOI 10.1242/dev.027151; Overholtzer M, 2006, P NATL ACAD SCI USA, V103, P12405, DOI 10.1073/pnas.0605579103; Pan DJ, 2007, GENE DEV, V21, P886, DOI 10.1101/gad.1536007; Park KS, 2004, J BIOL CHEM, V279, P17384, DOI 10.1074/jbc.M312569200; Phair RD, 2004, METHOD ENZYMOL, V375, P393; Porter LA, 2003, BLOOD, V101, P1928, DOI 10.1182/blood-2002-04-1103; Qi C, 2009, INT J CANCER, V124, P793, DOI 10.1002/ijc.23775; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Rodriguez S, 2005, CANCER GENET CYTOGEN, V157, P140, DOI 10.1016/j.cancergencyto.2004.08.017; Saucedo LJ, 2007, NAT REV MOL CELL BIO, V8, P613, DOI 10.1038/nrm2221; Singh B, 2001, CANCER RES, V61, P4506; Skotheim RI, 2006, CELL ONCOL, V28, P315; Steinhardt AA, 2008, HUM PATHOL, V39, P1582, DOI 10.1016/j.humpath.2008.04.012; Striedinger K, 2008, NEOPLASIA, V10, P1204, DOI 10.1593/neo.08642; Thompson BJ, 2006, CELL, V126, P767, DOI 10.1016/j.cell.2006.07.013; Tian Y, 2004, J VIROL, V78, P12657, DOI 10.1128/JVI.78.22.12657-12664.2004; Tian Y, 2007, MOL CELL BIOL, V27, P6383, DOI 10.1128/MCB.00254-07; Varelas X, 2008, NAT CELL BIOL, V10, P837, DOI 10.1038/ncb1748; Vassilev A, 2001, GENE DEV, V15, P1229, DOI 10.1101/gad.888601; Wang KN, 2009, BIOCHEM CELL BIOL, V87, P77, DOI 10.1139/O08-114; Weber RG, 1996, ONCOGENE, V13, P983; Willecke M, 2008, P NATL ACAD SCI USA, V105, P14897, DOI 10.1073/pnas.0805201105; Wu S, 2008, DEV CELL, V14, P388, DOI 10.1016/j.devcel.2008.01.007; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhang JM, 2008, CANCER RES, V68, P2789, DOI 10.1158/0008-5472.CAN-07-6205; Zhang L, 2008, DEV CELL, V14, P377, DOI 10.1016/j.devcel.2008.01.006; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2009, CANCER RES, V69, P1089, DOI 10.1158/0008-5472.CAN-08-2997; Zhao B, 2008, CURR OPIN CELL BIOL, V20, P638, DOI 10.1016/j.ceb.2008.10.001	59	179	184	0	24	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14347	14358		10.1074/jbc.M901568200	http://dx.doi.org/10.1074/jbc.M901568200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19324876	Green Published, hybrid			2022-12-27	WOS:000266286100041
J	Minig, V; Kattan, Z; van Beeumen, J; Brunner, E; Becuwe, P				Minig, Vanessa; Kattan, Zilal; van Beeumen, Josef; Brunner, Emilie; Becuwe, Philippe			Identification of DDB2 Protein as a Transcriptional Regulator of Constitutive SOD2 Gene Expression in Human Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MANGANESE SUPEROXIDE-DISMUTASE; DAMAGED DNA; MNSOD OVEREXPRESSION; GROWTH; GENERATION; PEROXIDE; PROMOTER; AP-2	Manganese superoxide dismutase plays a role in breast tumor cell growth, which depends on its constitutive expression. However, the mechanisms responsible for the regulation of constitutive SOD2 gene expression at different malignant phenotype in breast cancers remain to be determined. The present study reports the identification and characterization of a DNA sequence located in the proximal promoter of the SOD2 gene, which forms a complex with a nuclear protein from breast tumor MCF-7 cells. Purification of this complex showed that it contained DDB2 (damaged DNA binding 2), a well known protein involved in nucleotide excision DNA repair and cell cycle regulation. Functional analysis of the proximal promoter of the SOD2 gene or modulation of DDB2 expression allowed us to demonstrate that DDB2 regulates negatively the constitutive expression of the SOD2 gene in breast cancer cells. We demonstrate that the binding of DDB2 was associated with the loss of acetylated H3 histones and the decrease in the binding of Sp1 but not AP-2 alpha transcription factors to the SOD2 proximal promoter. In addition, we show that DDB2 exerts, at least in part, a control of breast cancer cell growth through its negative regulation of constitutive expression of the SOD2 gene. For the first time, these data give supporting evidence that DDB2 is a new transcriptional regulator, and they provide insight into the molecular function of breast cancer cell growth, which will have an important clinical interest.	[Minig, Vanessa; Kattan, Zilal; Brunner, Emilie; Becuwe, Philippe] Henri Poincare Univ Nancy 1, Canc Res Unit, EA SIGRETO, F-54506 Vandoeuvre Les Nancy, France; [van Beeumen, Josef] Univ Ghent, Lab Prot Biochem & Prot Engn, B-9000 Ghent, Belgium	Universite de Lorraine; Ghent University	Becuwe, P (corresponding author), BP 239, F-54506 Vandoeuvre Les Nancy, France.	becuwe@scbiol.uhp-nancy.fr			Ligue contre le Cancer (Comites Meuse and Meurthe et Moselle); Henri Poincare's Nancy University	Ligue contre le Cancer (Comites Meuse and Meurthe et Moselle); Henri Poincare's Nancy University	This work was supported by grants from the Ligue contre le Cancer (Comites Meuse and Meurthe et Moselle) and Henri Poincare's Nancy University.	Bevilacqua MA, 2005, J BIOL CHEM, V280, P31809, DOI 10.1074/jbc.M414677200; CHU G, 1988, SCIENCE, V242, P564, DOI 10.1126/science.3175673; Hayes S, 1998, MOL CELL BIOL, V18, P240, DOI 10.1128/MCB.18.1.240; Hitchiler MJ, 2008, FREE RADICAL BIO MED, V45, P1573, DOI 10.1016/j.freeradbiomed.2008.09.005; Hitchler MJ, 2006, EPIGENETICS-US, V1, P163, DOI 10.4161/epi.1.4.3401; Hodge DR, 2005, CANCER BIOL THER, V4, P585, DOI 10.4161/cbt.4.5.1704; Huang YH, 1999, DNA CELL BIOL, V18, P643, DOI 10.1089/104454999315051; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kattan Z, 2008, BREAST CANCER RES TR, V108, P203, DOI 10.1007/s10549-007-9597-5; Kattan Z, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002002; Kim HP, 1999, J BIOL CHEM, V274, P37455, DOI 10.1074/jbc.274.52.37455; Kim KH, 2001, ANTIOXID REDOX SIGN, V3, P361, DOI 10.1089/15230860152409013; Kiningham KK, 1999, FASEB J, V13, P1601, DOI 10.1096/fasebj.13.12.1601; Kiningham KK, 1997, CANCER RES, V57, P5265; Kinnula VL, 2004, FREE RADICAL BIO MED, V36, P718, DOI 10.1016/j.freeradbiomed.2003.12.010; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LI JJ, 1995, ONCOGENE, V10, P1989; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Maehara K, 2002, BIOCHEM BIOPH RES CO, V295, P187, DOI 10.1016/S0006-291X(02)00646-0; Martinez E, 2001, MOL CELL BIOL, V21, P6782, DOI 10.1128/MCB.21.20.6782-6795.2001; Mates JM, 2000, TOXICOLOGY, V153, P83, DOI 10.1016/S0300-483X(00)00306-1; MERRIL CR, 1981, SCIENCE, V211, P1437, DOI 10.1126/science.6162199; Nelson KK, 2003, CLIN CANCER RES, V9, P424; Oberley LW, 2005, BIOMED PHARMACOTHER, V59, P143, DOI 10.1016/j.biopha.2005.03.006; OLNES MJ, 1994, BIOTECHNIQUES, V17, P828; Pani G, 2004, CURR MED CHEM, V11, P1299, DOI 10.2174/0929867043365297; Ridnour LA, 2004, ANTIOXID REDOX SIGN, V6, P501, DOI 10.1089/152308604773934260; St Clair DK, 2002, METHOD ENZYMOL, V349, P306, DOI 10.1016/S0076-6879(02)49345-7; STCLAIR DK, 1992, MOL CARCINOGEN, V6, P238, DOI 10.1002/mc.2940060404; STCLAIR DK, 1991, CANCER RES, V51, P939; Tang J, 2002, DNA REPAIR, V1, P601, DOI 10.1016/S1568-7864(02)00052-6; Tsanou E, 2004, HISTOL HISTOPATHOL, V19, P807, DOI 10.14670/HH-19.807; Xu Y, 2002, BIOCHEM J, V362, P401, DOI 10.1042/0264-6021:3620401; Xu Y, 1999, ONCOGENE, V18, P93, DOI 10.1038/sj.onc.1202265; Yang JQ, 1999, MOL CARCINOGEN, V26, P180; Yeh CC, 1998, DNA CELL BIOL, V17, P921, DOI 10.1089/dna.1998.17.921; Zhu CH, 2001, J BIOL CHEM, V276, P14407, DOI 10.1074/jbc.M009708200	37	36	36	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14165	14176		10.1074/jbc.M808208200	http://dx.doi.org/10.1074/jbc.M808208200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19339246	hybrid, Green Published			2022-12-27	WOS:000266286100023
J	Liu, Q; Li, J; Khoury, J; Colgan, SP; Ibla, JC				Liu, Qian; Li, Jing; Khoury, Joseph; Colgan, Sean P.; Ibla, Juan C.			Adenosine Signaling Mediates SUMO-1 Modification of I kappa B alpha during Hypoxia and Reoxygenation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GTPASE-ACTIVATING PROTEIN; UBIQUITIN-LIKE PROTEIN; NUCLEAR-PORE COMPLEX; ACUTE LUNG INJURY; TRANSCRIPTIONAL ACTIVITY; SUMOYLATION; CD73; INTERLEUKIN-6; RANGAP1; ECTONUCLEOTIDASES	Small ubiquitin-like modifier 1 (SUMO-1) modification of I kappa B alpha has been described to actively participate in NF kappa B regulation. Following proteosomal degradation of I kappa B alpha, an auto-regulatory loop consisting of transcriptional activation of I kappa B alpha gene and SUMO-1 modification of newly synthesized I kappa B alpha proceeds. The SUMOylated I kappa B alpha form is resistant to signal-induced degradation, consequently halting NF kappa B activation. We describe a mechanistic model by which adenosine (Ado) signaling results in significant accumulation of SUMO-1 modified I kappa B alpha with subsequent attenuation of NF kappa B activation. Using models of hypoxia followed by reoxygenation (H/R), we have documented an H/R cycle-dependent increase in extracellular Ado correlating with increases in the cytoplasmic pool of I kappa B alpha/SUMO-1. We demonstrate a dose-dependent increase in I kappa B alpha/SUMO in cells treated with the general Ado receptor agonist NECA and abolished by Ado receptor antagonists. Experiments in cells exposed to cycles of H/R followed by hypoxia demonstrated differential patterns of SUMOylation and phosphorylation of I kappa B alpha, greatly impacting its proteosomal degradation by the 26 S proteasome. Assays targeting knockdown and overexpression of SUMO-1 demonstrated significant regulation of NF kappa B activation and NF kappa B-mediated gene transcription (interleukin-6). These results were confirmed in vivo using wild type and cd73 null mouse lung tissue. In summary, we present an endogenous mechanism by which cells and tissues acquire anti-inflammatory properties by recruiting a nondegradable form of I kappa B alpha, a major control point for NF kappa B activation via Ado signaling.	[Liu, Qian; Li, Jing; Khoury, Joseph; Ibla, Juan C.] Harvard Univ, Sch Med, Childrens Hosp Boston, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA; [Liu, Qian] Chongqing Med Univ, Childrens Hosp, Dept Surg, Chongqing 400014, Peoples R China; [Li, Jing] Chongqing Med Univ, Dept Histol & Embryol, Lab Stem Cell & Tissue Engn, Chongqing 400016, Peoples R China; [Colgan, Sean P.] Univ Colorado, Hlth Sci Ctr, Div Gastroenterol, Mucosal Inflammat Program, Denver, CO 80220 USA	Harvard University; Boston Children's Hospital; Harvard Medical School; Chongqing Medical University; Chongqing Medical University; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Ibla, JC (corresponding author), Harvard Univ, Sch Med, Childrens Hosp Boston, Dept Anesthesiol Perioperat & Pain Med, Bader 3,300 Longwood Ave, Boston, MA 02115 USA.	juan.ibla@childrens.harvard.edu			Robert M. Smith Award; Department of Anesthesiology; Eleanor and Miles Shore 50th Anniversary Fellowship Program	Robert M. Smith Award; Department of Anesthesiology; Eleanor and Miles Shore 50th Anniversary Fellowship Program	This work was supported by Funds from the Robert M. Smith Award, the Department of Anesthesiology, Perioperative and Pain Medicine, Children's Hospital, and the Eleanor and Miles Shore 50th Anniversary Fellowship Program for Scholars in Medicine, Children's Hospital Boston, and Harvard Medical School (to J.C.I.).	ArenzanaSeisdedos F, 1997, J CELL SCI, V110, P369; Bae SH, 2004, BIOCHEM BIOPH RES CO, V324, P394, DOI 10.1016/j.bbrc.2004.09.068; Baldwin AS, 1996, ANNU REV IMMUNOL, V14, P649, DOI 10.1146/annurev.immunol.14.1.649; Berta MA, 2007, BIOCHEM BIOPH RES CO, V360, P646, DOI 10.1016/j.bbrc.2007.06.103; Boddy MN, 1996, ONCOGENE, V13, P971; Carbia-Nagashima A, 2007, CELL, V131, P309, DOI 10.1016/j.cell.2007.07.044; Colgan Sean P, 2006, Purinergic Signal, V2, P351, DOI 10.1007/s11302-005-5302-5; Crisostomo PR, 2008, AM J PHYSIOL-CELL PH, V294, pC675, DOI 10.1152/ajpcell.00437.2007; Desterro JMP, 1998, MOL CELL, V2, P233, DOI 10.1016/S1097-2765(00)80133-1; Desterro JMP, 1997, FEBS LETT, V417, P297, DOI 10.1016/S0014-5793(97)01305-7; Eckle T, 2008, J CLIN INVEST, V118, P3301, DOI 10.1172/JCI34203; Eckle T, 2008, BLOOD, V111, P2024, DOI 10.1182/blood-2007-10-117044; Eckle T, 2007, J IMMUNOL, V178, P8127, DOI 10.4049/jimmunol.178.12.8127; Eltzschig HK, 2003, J EXP MED, V198, P783, DOI 10.1084/jem.20030891; Furuta GT, 2001, J EXP MED, V193, P1027, DOI 10.1084/jem.193.9.1027; Hay RT, 1999, PHILOS T R SOC B, V354, P1601, DOI 10.1098/rstb.1999.0504; Jennewein C, 2008, J IMMUNOL, V181, P5646, DOI 10.4049/jimmunol.181.8.5646; JOHNSON ES, 1995, J BIOL CHEM, V270, P17442, DOI 10.1074/jbc.270.29.17442; Johnson ES, 1997, J BIOL CHEM, V272, P26799, DOI 10.1074/jbc.272.43.26799; Khoury J, 2007, J CLIN INVEST, V117, P703, DOI 10.1172/JCI30049; Kroetz Mary B, 2005, Yale J Biol Med, V78, P197; Lee Ji-Won, 2004, Experimental & Molecular Medicine, V36, P1; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; MATSUSAKA T, 1993, P NATL ACAD SCI USA, V90, P10193, DOI 10.1073/pnas.90.21.10193; Matunis MJ, 1996, J CELL BIOL, V135, P1457, DOI 10.1083/jcb.135.6.1457; Matunis MJ, 1998, J CELL BIOL, V140, P499, DOI 10.1083/jcb.140.3.499; Mikolajczyk J, 2007, J BIOL CHEM, V282, P26217, DOI 10.1074/jbc.M702444200; Muraoka A, 2008, BIOCHEM BIOPH RES CO, V377, P1031, DOI 10.1016/j.bbrc.2008.09.149; Pascual G, 2005, NATURE, V437, P759, DOI 10.1038/nature03988; Reutershan J, 2009, FASEB J, V23, P473, DOI 10.1096/fj.08-119701; Saitoh H, 1998, CURR BIOL, V8, P121, DOI 10.1016/S0960-9822(98)70044-2; Shao RJ, 2004, FEBS LETT, V569, P293, DOI 10.1016/j.febslet.2004.05.079; Synnestvedt K, 2002, J CLIN INVEST, V110, P993, DOI 10.1172/JCI200215337; Thompson LF, 2004, J EXP MED, V200, P1395, DOI 10.1084/Jem.20040915; ZHANG Y, 1990, MOL CELL BIOL, V10, P3818, DOI 10.1128/MCB.10.7.3818	35	30	34	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13686	13695		10.1074/jbc.M809275200	http://dx.doi.org/10.1074/jbc.M809275200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19297320	hybrid, Green Published			2022-12-27	WOS:000265877300046
J	Nayak, D; Guo, Q; Sousa, R				Nayak, Dhananjaya; Guo, Qing; Sousa, Rui			A Promoter Recognition Mechanism Common to Yeast Mitochondrial and Phage T7 RNA Polymerases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION INITIATION; CRYSTAL-STRUCTURE; SIGMA-70 SUBUNIT; MUTANT FORMS; IN-VITRO; SPECIFICITY; RELEASE; COMPLEX; DNA; BACTERIOPHAGE-T3	Yeast mitochondrial (YMt) and phage T7 RNA polymerases (RNAPs) are two divergent representatives of a large family of single subunit RNAPs that are also found in the mitochondria and chloroplasts of higher eukaryotes, mammalian nuclei, and many other bacteriophage. YMt and phage T7 promoters differ greatly in sequence and length, and the YMt RNAP uses an accessory factor for initiation, whereas T7 RNAP does not. We obtain evidence here that, despite these apparent differences, both the YMt and T7 RNAPs utilize a similar promoter recognition loop to bind their respective promoters. Mutations in this element in YMt RNAP specifically disrupt mitochondrial promoter utilization, and experiments with site-specifically tethered chemical nucleases indicate that this element binds the mitochondrial promoter almost identically to how the promoter recognition loop from the phage RNAP binds its promoter. Sequence comparisons reveal that the other members of the single subunit RNAP family display loops of variable sequence and size at a position corresponding to the YMt and T7 RNAP promoter recognition loops. We speculate that these elements may be involved in promoter recognition in most or all of these enzymes and that this element's structure allows it to accommodate significant sequence and length variation to provide a mechanism for rapid evolution of new promoter specificities in this RNAP family.	[Nayak, Dhananjaya; Guo, Qing; Sousa, Rui] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Sousa, R (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA.	sousa@biochem.uthscsa.edu	Nayak, Dhananjaya/B-2802-2015	Nayak, Dhananjaya/0000-0003-0529-9411; Sousa, Rui/0000-0003-4314-121X	National Institutes of Health [GMS52522]; Welch Foundation [AQ-1486]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM052522] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GMS52522. This work was also supported by Welch Foundation Grant AQ-1486 (to R. S.).	BAILEY JN, 1983, P NATL ACAD SCI-BIOL, V80, P2814, DOI 10.1073/pnas.80.10.2814; BISWAS TK, 1987, J BIOL CHEM, V262, P13690; BROWN JE, 1986, NUCLEIC ACIDS RES, V14, P3521, DOI 10.1093/nar/14.8.3521; Cermakian N, 1997, J MOL EVOL, V45, P671, DOI 10.1007/PL00006271; CHAMBERLIN M, 1983, METHOD ENZYMOL, V101, P540; Cheetham GMT, 1999, SCIENCE, V286, P2305, DOI 10.1126/science.286.5448.2305; Cheetham GMT, 1999, NATURE, V399, P80, DOI 10.1038/19999; Durniak KJ, 2008, SCIENCE, V322, P553, DOI 10.1126/science.1163433; GARDELLA T, 1989, J MOL BIOL, V206, P579, DOI 10.1016/0022-2836(89)90567-6; Gaspari M, 2004, EMBO J, V23, P4606, DOI 10.1038/sj.emboj.7600465; Greiner DP, 1997, BIOCONJUGATE CHEM, V8, P44, DOI 10.1021/bc9600731; Guo Q, 2005, J MOL BIOL, V353, P256, DOI 10.1016/j.jmb.2005.08.016; Guo Q, 2005, J BIOL CHEM, V280, P14956, DOI 10.1074/jbc.M500518200; Guo Q, 2005, J BIOL CHEM, V280, P3474, DOI 10.1074/jbc.M412287200; JAEHNING JA, 1993, MOL MICROBIOL, V8, P1, DOI 10.1111/j.1365-2958.1993.tb01197.x; Liere K, 1999, EMBO J, V18, P249, DOI 10.1093/emboj/18.1.249; MANGUS DA, 1994, J BIOL CHEM, V269, P26568; MASTERS BS, 1987, CELL, V51, P89, DOI 10.1016/0092-8674(87)90013-4; Matsunaga M, 2004, J BIOL CHEM, V279, P44239, DOI 10.1074/jbc.C400384200; Matsunaga M, 2004, PROTEIN EXPRES PURIF, V35, P126, DOI 10.1016/j.pep.2003.12.022; Mukherjee S, 2002, CELL, V110, P81, DOI 10.1016/S0092-8674(02)00815-2; MULLER DK, 1989, BIOCHEMISTRY-US, V28, P3306, DOI 10.1021/bi00434a028; Murakami KS, 2008, P NATL ACAD SCI USA, V105, P5046, DOI 10.1073/pnas.0712325105; Nayak D, 2007, J MOL BIOL, V371, P490, DOI 10.1016/j.jmb.2007.05.070; RASKIN CA, 1992, J MOL BIOL, V228, P506, DOI 10.1016/0022-2836(92)90838-B; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Schubot FD, 2001, PROTEIN SCI, V10, P1980, DOI 10.1110/ps.11201; SIEGELE DA, 1989, J MOL BIOL, V206, P591, DOI 10.1016/0022-2836(89)90568-8; Sousa R, 1996, TRENDS BIOCHEM SCI, V21, P186, DOI 10.1016/S0968-0004(96)10023-2; Tang GQ, 2006, BIOCHEMISTRY-US, V45, P4936, DOI 10.1021/bi0522910; Tang GQ, 2008, MOL CELL, V30, P567, DOI 10.1016/j.molcel.2008.04.003; Turingan RS, 2007, BIOCHEMISTRY-US, V46, P6165, DOI 10.1021/bi700058b; Turingan RS, 2007, BIOCHEMISTRY-US, V46, P1714, DOI 10.1021/bi061905d; WALDBURGER C, 1990, J MOL BIOL, V215, P267, DOI 10.1016/S0022-2836(05)80345-6; Yin YW, 2004, CELL, V116, P393, DOI 10.1016/S0092-8674(04)00120-5	35	32	33	1	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13641	13647		10.1074/jbc.M900718200	http://dx.doi.org/10.1074/jbc.M900718200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19307179	hybrid, Green Published			2022-12-27	WOS:000265877300041
J	Popescu, M; Gurel, Z; Ronni, T; Song, CH; Hung, KY; Payne, KJ; Dovat, S				Popescu, Marcela; Gurel, Zafer; Ronni, Tapani; Song, Chunhua; Hung, Ka Ying; Payne, Kimberly J.; Dovat, Sinisa			Ikaros Stability and Pericentromeric Localization Are Regulated by Protein Phosphatase 1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; DNA-BINDING PROTEINS; TRANSCRIPTION FACTOR; CENTROMERIC HETEROCHROMATIN; UBIQUITIN LIGASE; MUTANT MICE; GENE; PHOSPHORYLATION; EXPRESSION; ISOFORMS	Ikaros encodes a zinc finger protein that is involved in gene regulation and chromatin remodeling. The majority of Ikaros localizes at pericentromeric heterochromatin (PC-HC) where it regulates expression of target genes. Ikaros function is controlled by posttranslational modification. Phosphorylation of Ikaros by CK2 kinase determines its ability to bind DNA and exert cell cycle control as well as its subcellular localization. We report that Ikaros interacts with protein phosphatase 1 (PP1) via a conserved PP1 binding motif, RVXF, in the C-terminal end of the Ikaros protein. Point mutations of the RVXF motif abolish Ikaros-PP1 interaction and result in decreased DNA binding, an inability to localize to PC-HC, and rapid degradation of the Ikaros protein. The introduction of alanine mutations at CK2-phosphorylated residues increases the half-life of the PP1-non-binding Ikaros mutant. This suggests that dephosphorylation of these sites by PP1 stabilizes the Ikaros protein and prevents its degradation. In the nucleus, Ikaros forms complexes with ubiquitin, providing evidence that Ikaros degradation involves the ubiquitin/proteasome pathway. In vivo, Ikaros can target PP1 to the nucleus, and a fraction of PP1 colocalizes with Ikaros at PC-HC. These data suggest a novel function for the Ikaros protein; that is, the targeting of PP1 to PC-HC and other chromatin structures. We propose a model whereby the function of Ikaros is controlled by the CK2 and PP1 pathways and that a balance between these two signal transduction pathways is essential for normal cellular function and for the prevention of malignant transformation.	[Dovat, Sinisa] Univ Wisconsin, Dept Pediat, Div Pediat Hematol Oncol, Madison, WI 53792 USA; [Payne, Kimberly J.] Loma Linda Univ, Sch Med, Ctr Hlth Dispar & Mol Med, Loma Linda, CA 92350 USA; [Payne, Kimberly J.] Loma Linda Univ, Sch Med, Dept Pathol & Human Anat, Loma Linda, CA 92350 USA	University of Wisconsin System; University of Wisconsin Madison; Loma Linda University; Loma Linda University	Dovat, S (corresponding author), Univ Wisconsin, Dept Pediat, Div Pediat Hematol Oncol, 600 Highland Ave, Madison, WI 53792 USA.	dovat@wisc.edu	song, chunhua/K-7882-2016; Payne, Kimberly/AAS-6814-2020; Gurel, Zafer/AAF-3072-2021; Hung, Ka Ying Sharon/AAI-1685-2021; song, chunhua/K-7882-2016	song, chunhua/0000-0001-7563-0339; Payne, Kimberly/0000-0002-7025-5821; Hung, Ka Ying Sharon/0000-0002-4084-6030; song, chunhua/0000-0002-4081-2543; Dovat, Sinisa/0000-0003-3906-6165	National Institutes of Health [T32 HL07899, K12 CA 087718, 5K01 DK066163, K22 CA 111392]; University of Wisconsin Institute for Clinical and Translational Research through National Institutes of Health Clinical and Translational Science Award [1UL1RR025011]; Midwest Athletes Against Childhood Cancer Award; St. Baldrick's Foundation Career Development; University of Wisconsin Medical Education and Research Committee New Investigator Program; NATIONAL CANCER INSTITUTE [K22CA111392, K12CA087718] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025011] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007899] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK066163] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Wisconsin Institute for Clinical and Translational Research through National Institutes of Health Clinical and Translational Science Award; Midwest Athletes Against Childhood Cancer Award; St. Baldrick's Foundation Career Development; University of Wisconsin Medical Education and Research Committee New Investigator Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants T32 HL07899 and K12 CA 087718 ( to M. P.), 5K01 DK066163 ( to K. J. P.), and K22 CA 111392 ( to S. D.). This project was supported in part by the University of Wisconsin Institute for Clinical and Translational Research, funded through National Institutes of Health Clinical and Translational Science Award 1UL1RR025011. This work was also supported by a Midwest Athletes Against Childhood Cancer Award, St. Baldrick's Foundation Career Development grant, and by the University of Wisconsin Medical Education and Research Committee New Investigator Program ( to S. D.).	Adler HT, 1999, MOL CELL BIOL, V19, P7050; ALESSANDRINI A, 1987, P NATL ACAD SCI USA, V84, P1799, DOI 10.1073/pnas.84.7.1799; Andreassen PR, 1998, J CELL BIOL, V141, P1207, DOI 10.1083/jcb.141.5.1207; Arco PGD, 2005, MOL CELL BIOL, V25, P2688, DOI 10.1128/MCB.25.7.2688-2697.2005; Avitahl N, 1999, IMMUNITY, V10, P333, DOI 10.1016/S1074-7613(00)80033-3; Bennett D, 2005, BIOCHEM SOC T, V33, P1444, DOI 10.1042/BST0331444; Bhatia N, 2006, J BIOL CHEM, V281, P19320, DOI 10.1074/jbc.M513203200; Brown KE, 1997, CELL, V91, P845, DOI 10.1016/S0092-8674(00)80472-9; Canettieri G, 2003, NAT STRUCT BIOL, V10, P175, DOI 10.1038/nsb895; Ceulemans H, 2004, PHYSIOL REV, V84, P1, DOI 10.1152/physrev.00013.2003; Cobb BS, 2000, GENE DEV, V14, P2146, DOI 10.1101/gad.816400; Cohen PTW, 2002, J CELL SCI, V115, P241; Crescenzi B, 2004, HAEMATOLOGICA, V89, P281; Dovat S, 2002, GENE DEV, V16, P2985, DOI 10.1101/gad.1040502; Dumortier A, 2003, BLOOD, V101, P2219, DOI 10.1182/blood-2002-05-1336; Gomez-del Arco P, 2004, MOL CELL BIOL, V24, P2797, DOI 10.1128/MCB.24.7.2797-2807.2004; GROVES T, 1995, J IMMUNOL, V154, P5011; Gurel Z, 2008, J BIOL CHEM, V283, P8291, DOI 10.1074/jbc.M707906200; Hahm K, 1998, GENE DEV, V12, P782, DOI 10.1101/gad.12.6.782; HAHM KM, 1994, MOL CELL BIOL, V14, P7111, DOI 10.1128/MCB.14.11.7111; Kim J, 1999, IMMUNITY, V10, P345, DOI 10.1016/S1074-7613(00)80034-5; Kim TK, 1996, SCIENCE, V273, P1717, DOI 10.1126/science.273.5282.1717; Klug CA, 1998, P NATL ACAD SCI USA, V95, P657, DOI 10.1073/pnas.95.2.657; Koipally J, 2000, J BIOL CHEM, V275, P19594, DOI 10.1074/jbc.M000254200; Koipally J, 2002, J BIOL CHEM, V277, P13007, DOI 10.1074/jbc.M111371200; Koipally J, 1999, EMBO J, V18, P3090, DOI 10.1093/emboj/18.11.3090; Lesage B, 2004, J BIOL CHEM, V279, P55978, DOI 10.1074/jbc.M411911200; Li Y, 2004, MOL CELL BIOL, V24, P4038, DOI 10.1128/MCB.24.9.4038-4048.2004; Liberg D, 2003, TRENDS IMMUNOL, V24, P567, DOI 10.1016/j.it.2003.09.008; MIZUGUCHI J, 1986, J IMMUNOL, V137, P2162; MOLNAR A, 1994, MOL CELL BIOL, V14, P8292, DOI 10.1128/MCB.14.12.8292; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Nakase K, 2000, CANCER RES, V60, P4062; Nakayama H, 1999, CANCER RES, V59, P3931; Nichogiannopoulou A, 1999, J EXP MED, V190, P1201, DOI 10.1084/jem.190.9.1201; Niu HF, 1998, GENE DEV, V12, P1953, DOI 10.1101/gad.12.13.1953; O'Neill DW, 2000, MOL CELL BIOL, V20, P7572, DOI 10.1128/MCB.20.20.7572-7582.2000; Rechsteiner M, 1996, TRENDS BIOCHEM SCI, V21, P267, DOI 10.1016/S0968-0004(96)10031-1; ROCK KL, 1994, CELL, V78, P761, DOI 10.1016/S0092-8674(94)90462-6; ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518; Ronni T, 2007, J BIOL CHEM, V282, P2538, DOI 10.1074/jbc.M605627200; Rudenko A, 2003, EMBO REP, V4, P59, DOI 10.1038/sj.embor.embor712; Sun L, 1999, P NATL ACAD SCI USA, V96, P680, DOI 10.1073/pnas.96.2.680; Thompson EC, 2007, IMMUNITY, V26, P335, DOI 10.1016/j.immuni.2007.02.010; Trinh LA, 2001, GENE DEV, V15, P1817, DOI 10.1101/gad.905601; Wakula P, 2003, J BIOL CHEM, V278, P18817, DOI 10.1074/jbc.M300175200; Wang XJ, 2008, J BIOL CHEM, V283, P12076, DOI 10.1074/jbc.M801571200; WINANDY S, 1995, CELL, V83, P289, DOI 10.1016/0092-8674(95)90170-1; Winandy S, 1999, J EXP MED, V190, P1039, DOI 10.1084/jem.190.8.1039; Wu DY, 2002, J BIOL CHEM, V277, P27706, DOI 10.1074/jbc.M200955200; Wu L, 1997, IMMUNITY, V7, P483, DOI 10.1016/S1074-7613(00)80370-2; Yagi T, 2002, BLOOD, V99, P1350, DOI 10.1182/blood.V99.4.1350; Zhao SM, 1997, J BIOL CHEM, V272, P28368, DOI 10.1074/jbc.272.45.28368	54	56	63	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13869	13880		10.1074/jbc.M900209200	http://dx.doi.org/10.1074/jbc.M900209200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19282287	Green Published			2022-12-27	WOS:000265877300063
J	Wilcox, KC; Zhou, L; Jordon, JK; Huang, Y; Yu, YB; Redler, RL; Chen, X; Caplow, M; Dokholyan, NV				Wilcox, Kyle C.; Zhou, Li; Jordon, Joshua K.; Huang, Yi; Yu, Yanbao; Redler, Rachel L.; Chen, Xian; Caplow, Michael; Dokholyan, Nikolay V.			Modifications of Superoxide Dismutase (SOD1) in Human Erythrocytes A POSSIBLE ROLE IN AMYOTROPHIC LATERAL SCLEROSIS	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							S-GLUTATHIOLATION; CRYSTAL-STRUCTURE; DISULFIDE BOND; FAMILIAL ALS; AGGREGATION; BINDING; CU; GLUTATHIONYLATION; OXIDATION; MUTANTS	Over 100 mutations in Cu/Zn-superoxide dismutase (SOD1) result in familial amyotrophic lateral sclerosis. Dimer dissociation is the first step in SOD1 aggregation, and studies suggest nearly every amino acid residue in SOD1 is dynamically connected to the dimer interface. Post-translational modifications of SOD1 residues might be expected to have similar effects to mutations, but few modifications have been identified. Here we show, using SOD1 isolated from human erythrocytes, that human SOD1 is phosphorylated at threonine 2 and glutathionylated at cysteine 111. A second SOD1 phosphorylation was observed and mapped to either Thr-58 or Ser-59. Cysteine 111 glutathionylation promotes SOD1 monomer formation, a necessary initiating step in SOD1 aggregation, by causing a 2-fold increase in the K-d. This change in the dimer stability is expected to result in a 67% increase in monomer concentration, 315 nM rather than 212 nM at physiological SOD1 concentrations. Because protein glutathionylation is associated with redox regulation, our finding that glutathionylation promotes SOD1 monomer formation supports a model in which increased oxidative stress promotes SOD1 aggregation.	[Wilcox, Kyle C.; Zhou, Li; Jordon, Joshua K.; Redler, Rachel L.; Chen, Xian; Caplow, Michael; Dokholyan, Nikolay V.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27510 USA; [Wilcox, Kyle C.; Chen, Xian; Dokholyan, Nikolay V.] Univ N Carolina, Program Mol & Cellular Biophys, Chapel Hill, NC 27510 USA; [Zhou, Li; Chen, Xian] Univ N Carolina, Duke Michael Hooker Proteom Ctr, Chapel Hill, NC 27510 USA; [Dokholyan, Nikolay V.] Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27510 USA; [Huang, Yi; Yu, Yanbao] Fudan Univ, Dept Chem, Shanghai 200433, Peoples R China; [Huang, Yi; Yu, Yanbao] Fudan Univ, Inst Biomed Sci, Shanghai 200433, Peoples R China	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; Fudan University; Fudan University	Chen, X (corresponding author), 120 Mason Farm Rd,3072 Genet Med Bldg, Chapel Hill, NC 27599 USA.	xian_chen@med.unc.edu; dokh@med.unc.edu	Dokholyan, Nikolay/D-8081-2018; , Proteomics Core UNC/AFQ-7201-2022; Wilcox, Kyle/C-2383-2011; Yu, Yanbao/G-3035-2010	Dokholyan, Nikolay/0000-0002-8225-4025; Yu, Yanbao/0000-0003-2994-1974	National Institutes of Health [R01GM080742, 1R01AI064806-01A2]; United States Department of Energy Grant (BER) [DE-FG02-07ER64422]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI064806] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080742] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United States Department of Energy Grant (BER)(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants R01GM080742 ( to N. V. D.) and 1R01AI064806-01A2 ( to X. C.). This work was also supported by United States Department of Energy Grant ( BER) DE-FG02-07ER64422 ( to X. C.).	Adachi T, 2004, J BIOL CHEM, V279, P29857, DOI 10.1074/jbc.M313320200; Baker JMR, 2007, NAT STRUCT MOL BIOL, V14, P738, DOI 10.1038/nsmb1278; Banci L, 2007, P NATL ACAD SCI USA, V104, P11263, DOI 10.1073/pnas.0704307104; Borchers CH, 2006, P NATL ACAD SCI USA, V103, P3094, DOI 10.1073/pnas.0511289103; Bruijn LI, 1998, SCIENCE, V281, P1851, DOI 10.1126/science.281.5384.1851; Cleveland DW, 2001, NAT REV NEUROSCI, V2, P806, DOI 10.1038/35097565; Cross JV, 2004, BIOCHEM J, V381, P675, DOI 10.1042/BJ20040591; Ding F, 2008, P NATL ACAD SCI USA, V105, P19696, DOI 10.1073/pnas.0803266105; Doucette PA, 2004, J BIOL CHEM, V279, P54558, DOI 10.1074/jbc.M409744200; Ferraroni M, 1999, J MOL BIOL, V288, P413, DOI 10.1006/jmbi.1999.2681; Fujiwara N, 2007, J BIOL CHEM, V282, P35933, DOI 10.1074/jbc.M702941200; Furukawa Y, 2005, J BIOL CHEM, V280, P17266, DOI 10.1074/jbc.M500482200; Ghezzi P, 2005, FREE RADICAL RES, V39, P573, DOI 10.1080/10715760500072172; GOSCIN SA, 1972, BIOCHIM BIOPHYS ACTA, V289, P276, DOI 10.1016/0005-2744(72)90078-2; Harraz MM, 2008, J CLIN INVEST, V118, P659, DOI 10.1172/JCI34060; HEIKKILA RE, 1976, ANAL BIOCHEM, V75, P356, DOI 10.1016/0003-2697(76)90089-0; Hu JH, 2003, J NEUROCHEM, V85, P432, DOI 10.1046/j.1471-4159.2003.01670.x; Juarez JC, 2008, P NATL ACAD SCI USA, V105, P7147, DOI 10.1073/pnas.0709451105; Khare SD, 2006, P NATL ACAD SCI USA, V103, P3147, DOI 10.1073/pnas.0511266103; Khare SD, 2004, P NATL ACAD SCI USA, V101, P15094, DOI 10.1073/pnas.0406650101; Khare SD, 2003, J MOL BIOL, V334, P515, DOI 10.1016/j.jmb.2003.09.069; Klatt P, 1999, FASEB J, V13, P1481, DOI 10.1096/fasebj.13.12.1481; KUROBE N, 1990, CLIN CHIM ACTA, V187, P11, DOI 10.1016/0009-8981(90)90257-S; Leier I, 1996, BIOCHEM J, V314, P433, DOI 10.1042/bj3140433; Maher P, 2006, ANTIOXID REDOX SIGN, V8, P1941, DOI 10.1089/ars.2006.8.1941; Marklund SL, 1997, J NEUROCHEM, V69, P675; MCCORD JM, 1969, J BIOL CHEM, V244, P6049; Nakanishi T, 1998, J NEUROSCI METH, V81, P41, DOI 10.1016/S0165-0270(98)00012-0; Pflieger D, 2008, MOL CELL PROTEOMICS, V7, P326, DOI 10.1074/mcp.M700282-MCP200; Rakhit R, 2004, J BIOL CHEM, V279, P15499, DOI 10.1074/jbc.M313295200; Rakhit R, 2002, J BIOL CHEM, V277, P47551, DOI 10.1074/jbc.M207356200; Ray SS, 2004, BIOCHEMISTRY-US, V43, P4899, DOI 10.1021/bi030246r; Ray SS, 2005, P NATL ACAD SCI USA, V102, P3639, DOI 10.1073/pnas.0408277102; Reaume AG, 1996, NAT GENET, V13, P43, DOI 10.1038/ng0596-43; RICHARDSON JS, 1975, P NATL ACAD SCI USA, V72, P1349, DOI 10.1073/pnas.72.4.1349; Schafer FQ, 2001, FREE RADICAL BIO MED, V30, P1191, DOI 10.1016/S0891-5849(01)00480-4; Wang J, 2001, J BIOL CHEM, V276, P47763, DOI 10.1074/jbc.C100415200	37	92	94	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13940	13947		10.1074/jbc.M809687200	http://dx.doi.org/10.1074/jbc.M809687200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19299510	hybrid, Green Published			2022-12-27	WOS:000265877300069
J	Holinger, EP; Old, WM; Giddings, TH; Wong, C; Yates, JR; Winey, M				Holinger, Eric P.; Old, William M.; Giddings, Thomas H., Jr.; Wong, Catherine; Yates, John R., III; Winey, Mark			Budding Yeast Centrosome Duplication Requires Stabilization of Spc29 via Mps1-mediated Phosphorylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SPINDLE POLE BODY; SACCHAROMYCES-CEREVISIAE; MASS-SPECTROMETRY; SPB DUPLICATION; COMPONENT; SPC110P; PROTEIN; IDENTIFICATION; COMPLEX; MITOSIS	Protein phosphorylation plays an important role in the regulation of centrosome duplication. In budding yeast, numerous lines of evidence suggest a requirement for multiple phosphorylation events on individual components of the centrosome to ensure their proper assembly and function. Here, we report the first example of a single phosphorylation event on a component of the yeast centrosome, or spindle pole body (SPB), that is required for SPB duplication and cell viability. This phosphorylation event is on the essential SPB component Spc29 at a conserved Thr residue, Thr(240). Mutation of Thr(240) to Ala is lethal at normal gene dosage, but an increased copy number of this mutant allele results in a conditional phenotype. Phosphorylation of Thr(240) was found to promote the stability of the protein in vivo and is catalyzed in vitro by the Mps1 kinase. Furthermore, the stability of newly synthesized Spc29 is reduced in a mutant strain with reduced Mps1 kinase activity. These results demonstrate the first evidence for a single phosphorylation event on an SPB component that is absolutely required for SPB duplication and suggest that the Mps1 kinase is responsible for this protein-stabilizing phosphorylation.	[Holinger, Eric P.; Giddings, Thomas H., Jr.; Winey, Mark] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Old, William M.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Wong, Catherine; Yates, John R., III] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Scripps Research Institute	Winey, M (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Porter Biosci Bldg,CB347, Boulder, CO 80309 USA.	mark.winey@colorado.edu		OLD, WILLIAM/0000-0002-9499-8478; Wong, Catherine CL/0000-0001-7270-980X	National Institutes of Health [GM51312]; NATIONAL CANCER INSTITUTE [R01CA126240] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR011823] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008759, R01GM051312] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM51312 (to M. W.) and Grant CA126240-01 from NCI (to Katheryn A. Resing).	Adams IR, 1999, J CELL BIOL, V145, P809, DOI 10.1083/jcb.145.4.809; Cantin GT, 2007, ANAL CHEM, V79, P4666, DOI 10.1021/ac0618730; Casenghi M, 2005, J CELL SCI, V118, P5101, DOI 10.1242/jcs.02622; Castillo AR, 2002, J CELL BIOL, V156, P453, DOI 10.1083/jcb.200111025; Cha H, 2004, BIOCHEM J, V378, P857, DOI 10.1042/BJ20031173; Chen ZH, 2002, DEV CELL, V3, P339, DOI 10.1016/S1534-5807(02)00258-7; Donaldson AD, 1996, J CELL BIOL, V132, P887, DOI 10.1083/jcb.132.5.887; Elliott S, 1999, P NATL ACAD SCI USA, V96, P6205, DOI 10.1073/pnas.96.11.6205; Ficarro SB, 2002, NAT BIOTECHNOL, V20, P301, DOI 10.1038/nbt0302-301; Fisk HA, 2001, CELL, V106, P95, DOI 10.1016/S0092-8674(01)00411-1; Friedman DB, 1996, J CELL BIOL, V132, P903, DOI 10.1083/jcb.132.5.903; Friedman DB, 2001, J BIOL CHEM, V276, P17958, DOI 10.1074/jbc.M010461200; Fumoto K, 2006, EMBO J, V25, P5670, DOI 10.1038/sj.emboj.7601459; Giddings TH, 2001, METHOD CELL BIOL, V67, P27; HERGOVICH A, 2007, BIOCHIM BIOPHYS ACTA, V1784, P3; Huang P, 2007, ONCOGENE, V26, P4357, DOI 10.1038/sj.onc.1210217; Huisman SM, 2007, J CELL SCI, V120, P435, DOI 10.1242/jcs.03342; Jaspersen SL, 2004, DEV CELL, V7, P263, DOI 10.1016/j.devcel.2004.07.006; Jaspersen SL, 2004, ANNU REV CELL DEV BI, V20, P1, DOI 10.1146/annurev.cellbio.20.022003.114106; Jasperson SL, 2002, J CELL BIOL, V159, P945, DOI 10.1083/jcb.200208169; Kinoshita K, 2005, J CELL BIOL, V170, P1047, DOI 10.1083/jcb.200503023; MacCoss MJ, 2002, P NATL ACAD SCI USA, V99, P7900, DOI 10.1073/pnas.122231399; Niepel M, 2005, J CELL BIOL, V170, P225, DOI 10.1083/jcb.200504140; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Pereira G, 1998, MOL BIOL CELL, V9, P775, DOI 10.1091/mbc.9.4.775; Tarapore P, 2002, CELL CYCLE, V1, P75, DOI 10.4161/cc.1.1.103; Venable JD, 2004, ANAL CHEM, V76, P2928, DOI 10.1021/ac0348219; Vogel J, 2001, DEV CELL, V1, P621, DOI 10.1016/S1534-5807(01)00073-9; Wigge PA, 1998, J CELL BIOL, V141, P967, DOI 10.1083/jcb.141.4.967; WINEY M, 1991, J CELL BIOL, V114, P745, DOI 10.1083/jcb.114.4.745	30	16	18	0	1	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12949	12955		10.1074/jbc.M900088200	http://dx.doi.org/10.1074/jbc.M900088200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19269975	Green Published, hybrid			2022-12-27	WOS:000265688300041
J	Saito, Y; Ashida, H; Sakiyama, T; de Marsac, NT; Danchin, A; Sekowska, A; Yokota, A				Saito, Yohtaro; Ashida, Hiroki; Sakiyama, Tomoko; de Marsac, Nicole Tandeau; Danchin, Antoine; Sekowska, Agnieszka; Yokota, Akiho			Structural and Functional Similarities between a Ribulose-1,5-bisphosphate Carboxylase/Oxygenase (RuBisCO)-like Protein from Bacillus subtilis and Photosynthetic RuBisCO	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RIBULOSE BISPHOSPHATE CARBOXYLASE; METHIONINE SALVAGE PATHWAY; 5-METHYLTHIORIBOSE 1-PHOSPHATE ISOMERASE; LARGE-SUBUNIT GENES; RIBULOSEBISPHOSPHATE CARBOXYLASE; 1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE; ENZYMATIC CHARACTERIZATION; SULFUR METABOLISM; CRYSTAL-STRUCTURE; OXYGENASE	The sequences classified as genes for various ribulose-1,5-bisphosphate (RuBP) carboxylase/oxygenase (RuBisCO)-like proteins (RLPs) are widely distributed among bacteria, archaea, and eukaryota. In the phylogenic tree constructed with these sequences, RuBisCOs and RLPs are grouped into four separate clades, forms I-IV. In RuBisCO enzymes encoded by form I, II, and III sequences, 19 conserved amino acid residues are essential for CO2 fixation; however, 1-11 of these 19 residues are substituted with other amino acids in form IV RLPs. Among form IV RLPs, the only enzymatic activity detected to date is a 2,3-diketo-5-methylthiopentyl 1-phosphate (DK-MTP-1-P) enolase reaction catalyzed by Bacillus subtilis, Microcystis aeruginosa, and Geobacillus kaustophilus form IV RLPs. RLPs from Rhodospirillum rubrum, Rhodopseudomonas palustris, Chlorobium tepidum, and Bordetella bronchiseptica were inactive in the enolase reaction. DK-MTP-1-P enolase activity of B. subtilis RLP required Mg2+ for catalysis and, like RuBisCO, was stimulated by CO2. Four residues that are essential for the enolization reaction of RuBisCO, Lys175, Lys201, Asp203, and Glu204, were conserved in RLPs and were essential for DK-MTP-1-P enolase catalysis. Lys123, the residue conserved in DK-MTP-1-P enolases, was also essential for B. subtilis RLP enolase activity. Similarities between the active site structures of RuBisCO and B. subtilis RLP were examined by analyzing the effects of structural analogs of RuBP on DK-MTP-1-P enolase activity. A transition state analog for the RuBP carboxylation of RuBisCO was a competitive inhibitor in the DK-MTP-1-P enolase reaction with a K-i value of 103 mu M. RuBP and D-phosphoglyceric acid, the substrate and product, respectively, of RuBisCO, were weaker competitive inhibitors. These results suggest that the amino acid residues utilized in the B. subtilis RLP enolase reaction are the same as those utilized in the RuBisCO RuBP enolization reaction.	[Saito, Yohtaro; Ashida, Hiroki; Sakiyama, Tomoko; Yokota, Akiho] Nara Inst Sci & Technol, Grad Sch Biol Sci, Nara 6300192, Japan; [de Marsac, Nicole Tandeau] Inst Pasteur, Dept Microbiol, F-75724 Paris 15, France; [Danchin, Antoine; Sekowska, Agnieszka] Inst Pasteur, Dept Genet Bacterial Genomes, F-75724 Paris 15, France	Nara Institute of Science & Technology; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Yokota, A (corresponding author), 8916-5 Takayama, Nara 6300192, Japan.	yokota@bs.naist.jp	Saito, Yohtaro/C-9838-2017	Saito, Yohtaro/0000-0002-1024-5154; Danchin, Antoine/0000-0002-6350-5001	Japan Society for the Promotion of Science [17208031, 18688021]; Asahi Glass Foundation [FY2004-2006]; Nissan Science Foundation [FY2005-2007]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Asahi Glass Foundation; Nissan Science Foundation	This work was supported in part by Japan Society for the Promotion of Science Grants-in-aid for Scientific Research 17208031 and 18688021, Asahi Glass Foundation Grant FY2004-2006 for General Science and Technology, and Nissan Science Foundation Grant FY2005-2007.	Ames B.N., 1966, METHOD ENZYMOL, V8, P115, DOI [10.1016/0076-6879(66)08014-5, DOI 10.1016/0076-6879(66)08014-5]; Andersson I, 1996, J MOL BIOL, V259, P160, DOI 10.1006/jmbi.1996.0310; Andrews T.J., 1987, BIOCH PLANTS, P131, DOI 10.1016/B978-0-12-675410-0.50009-9; Andrews TJ, 2003, ARCH BIOCHEM BIOPHYS, V414, P159, DOI 10.1016/S0003-9861(03)00100-0; Ashida H, 2005, RES MICROBIOL, V156, P611, DOI 10.1016/j.resmic.2005.01.014; Ashida H, 2003, SCIENCE, V302, P286, DOI 10.1126/science.1086997; Ashida H, 2008, BIOSCI BIOTECH BIOCH, V72, P959, DOI 10.1271/bbb.70651; Ashida H, 2008, J EXP BOT, V59, P1543, DOI 10.1093/jxb/ern104; BADGER MR, 1981, BIOCHEMISTRY-US, V20, P2219, DOI 10.1021/bi00511a023; Benkovic SJ, 2003, SCIENCE, V301, P1196, DOI 10.1126/science.1085515; Carre-Mlouka A, 2006, J BIOL CHEM, V281, P24462, DOI 10.1074/jbc.M602973200; CHRAMBACH A, 1971, SCIENCE, V172, P440, DOI 10.1126/science.172.3982.440; CHU DK, 1975, PLANT PHYSIOL, V55, P720, DOI 10.1104/pp.55.4.720; Cleland WW, 1998, CHEM REV, V98, P549, DOI 10.1021/cr970010r; Feller U, 2008, J EXP BOT, V59, P1615, DOI 10.1093/jxb/erm242; Hanson TE, 2001, P NATL ACAD SCI USA, V98, P4397, DOI 10.1073/pnas.081610398; HARTMAN FC, 1985, J BIOL CHEM, V260, P3968; HARTMAN FC, 1994, ANNU REV BIOCHEM, V63, P197, DOI 10.1146/annurev.biochem.63.1.197; Imker HJ, 2007, BIOCHEMISTRY-US, V46, P4077, DOI 10.1021/bi7000483; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LORIMER GH, 1981, BIOCHEMISTRY-US, V20, P1236, DOI 10.1021/bi00508a028; Matsuda Y, 1996, PLANT PHYSIOL, V110, P1283, DOI 10.1104/pp.110.4.1283; MCCURRY SD, 1977, J BIOL CHEM, V252, P8344; MIZIORKO HM, 1983, ANNU REV BIOCHEM, V52, P507, DOI 10.1146/annurev.bi.52.070183.002451; MORITA N, 1981, AGR BIOL CHEM TOKYO, V45, P2665, DOI 10.1080/00021369.1981.10864947; Mueller-Cajar O, 2007, BIOCHEMISTRY-US, V46, P14067, DOI 10.1021/bi700820a; Parry MAJ, 2003, J EXP BOT, V54, P1321, DOI 10.1093/jxb/erg141; PAULSEN JM, 1966, BIOCHEMISTRY-US, V5, P2350, DOI 10.1021/bi00871a025; PIERCE J, 1980, BIOCHEMISTRY-US, V19, P934, DOI 10.1021/bi00546a018; Portis AR, 2007, PHOTOSYNTH RES, V94, P121, DOI 10.1007/s11120-007-9225-6; Roy Harry, 2000, VVolume 9, P53; Saito Y, 2007, BIOSCI BIOTECH BIOCH, V71, P2021, DOI 10.1271/bbb.70209; Sato T, 2007, SCIENCE, V315, P1003, DOI 10.1126/science.1135999; Schramm VL, 1998, ANNU REV BIOCHEM, V67, P693, DOI 10.1146/annurev.biochem.67.1.693; Selesi D, 2005, APPL ENVIRON MICROB, V71, P175, DOI 10.1128/AEM.71.1.175-184.2005; Smith SA, 2003, J MOL BIOL, V331, P557, DOI 10.1016/S0022-2836(03)00786-1; STRAGIER P, 1988, CELL, V52, P697, DOI 10.1016/0092-8674(88)90407-2; Tabita FR, 2007, MICROBIOL MOL BIOL R, V71, P576, DOI 10.1128/MMBR.00015-07; Tamura H, 2008, PROTEIN SCI, V17, P126, DOI 10.1110/ps.073169008; Taylor TC, 1997, J MOL BIOL, V265, P432, DOI 10.1006/jmbi.1996.0738; Tcherkez GGB, 2006, P NATL ACAD SCI USA, V103, P7246, DOI 10.1073/pnas.0600605103; Uemura K, 1997, BIOCHEM BIOPH RES CO, V233, P568, DOI 10.1006/bbrc.1997.6497; van der Wielen PWJJ, 2006, FEMS MICROBIOL LETT, V259, P326, DOI 10.1111/j.1574-6968.2006.00284.x; Vislisel JM, 2007, ANAL BIOCHEM, V365, P31, DOI 10.1016/j.ab.2007.03.002; Watson GMF, 1999, J BACTERIOL, V181, P1569, DOI 10.1128/JB.181.5.1569-1575.1999; YOKOTA A, 1991, PLANT CELL PHYSIOL, V32, P755; YOKOTA A, 1985, BIOCHEM BIOPH RES CO, V131, P1075, DOI 10.1016/0006-291X(85)90200-1; YOKOTA A, 1991, J BIOCHEM-TOKYO, V110, P246, DOI 10.1093/oxfordjournals.jbchem.a123565; Yokota A, 2008, ADV PL BIOCH MOL BIO, V1, P81, DOI 10.1016/S1755-0408(07)01004-1	49	20	20	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					13256	13264		10.1074/jbc.M807095200	http://dx.doi.org/10.1074/jbc.M807095200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19279009	hybrid, Green Published			2022-12-27	WOS:000265688300072
J	Yin, W; Romeo, S; Chang, S; Grishin, NV; Hobbs, HH; Cohen, JC				Yin, Wu; Romeo, Stefano; Chang, Shurong; Grishin, Nick V.; Hobbs, Helen H.; Cohen, Jonathan C.			Genetic Variation in ANGPTL4 Provides Insights into Protein Processing and Function	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ANGIOPOIETIN-LIKE PROTEIN-4; LIPOPROTEIN-LIPASE; TARGET GENE; INHIBITION; OLIGOMERIZATION; MICE; LPL	Angiopoietin-like protein 4 (ANGPTL4) is a secreted protein that modulates the disposition of circulating triglycerides (TG) by inhibiting lipoprotein lipase (LPL). Here we examine the steps involved in the synthesis and post-translational processing of ANGPTL4, and the effects of a naturally occurring sequence variant (E40K) that is associated with lower plasma TG levels in humans. Expression of the wild-type and mutant proteins in HEK-293A cells indicated that ANGPTL4 formed dimers and tetramers in cells prior to secretion and cleavage of the protein. After cleavage at a canonical proprotein convertase cleavage site ((RRKR164)-R-161), the oligomeric structure of the N-terminal domain was retained whereas the C-terminal fibrinogen-like domain dissociated into monomers. Inhibition of cleavage did not interfere with oligomerization of ANGPTL4 or with its ability to inhibit LPL, whereas mutations that prevented oligomerization severely compromised the capacity of the protein to inhibit LPL. ANGPTL4 containing the E40K substitution was synthesized and processed normally, but no monomers or oligomers of the N-terminal fragments accumulated in the medium; medium from these cells failed to inhibit LPL activity. Parallel experiments performed in mice recapitulated these results. Our findings indicate that oligomerization, but not cleavage, of ANGPTL4 is required for LPL inhibition, and that the E40K substitution destabilizes the protein after secretion, preventing the extracellular accumulation of oligomers and abolishing the ability of the protein to inhibit LPL activity.	[Yin, Wu; Romeo, Stefano; Chang, Shurong; Hobbs, Helen H.; Cohen, Jonathan C.] Univ Texas SW Med Ctr Dallas, Eugene McDermott Ctr Human Growth & Dev, Dept Mol Genet, Dallas, TX 75390 USA; [Grishin, Nick V.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Grishin, Nick V.; Hobbs, Helen H.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Cohen, Jonathan C.] Univ Texas SW Med Ctr Dallas, Ctr Human Nutr, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Hobbs, HH (corresponding author), Univ Texas SW Med Ctr Dallas, Eugene McDermott Ctr Human Growth & Dev, Dept Mol Genet, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	Helen.hobbs@utsouthwestern.edu; Jonathan.Cohen@utsouthwestern.edu	Romeo, Stefano/L-6861-2015	Romeo, Stefano/0000-0001-9168-4898	National Institutes of Health [HL092550]; Donald W. Reynolds Foundation; American Heart Association; Welch Foundation [I-1505]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RL1HL092550] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Donald W. Reynolds Foundation; American Heart Association(American Heart Association); Welch Foundation(The Welch Foundation); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grant HL092550, the Donald W. Reynolds Foundation, the American Heart Association, and a Welch Foundation grant I-1505 (to N.V.G.).	ALTSCHUL SF, 1997, NUCLEIC ACIDS RES, V25, P3402; Berbee JFP, 2005, J LIPID RES, V46, P297, DOI 10.1194/jlr.M400301-JLR200; Chomel C, 2009, FASEB J, V23, P940, DOI 10.1096/fj.08-115170; Ge HF, 2005, J LIPID RES, V46, P1484, DOI 10.1194/jlr.M500005-JLR200; Ge HF, 2004, J LIPID RES, V45, P2071, DOI 10.1194/jlr.M400138-JLR200; Ge HF, 2004, J BIOL CHEM, V279, P2038, DOI 10.1074/jbc.M307583200; Kersten S, 2000, J BIOL CHEM, V275, P28488, DOI 10.1074/jbc.M004029200; Koster A, 2005, ENDOCRINOLOGY, V146, P4943, DOI 10.1210/en.2005-0476; Lichtenstein L, 2007, ARTERIOSCL THROM VAS, V27, P2420, DOI 10.1161/ATVBAHA.107.151894; NILSSONEHLE P, 1976, J LIPID RES, V17, P536; Oike Y, 2005, TRENDS MOL MED, V11, P473, DOI 10.1016/j.molmed.2005.08.002; Pei JM, 2008, NUCLEIC ACIDS RES, V36, P2295, DOI 10.1093/nar/gkn072; Romeo S, 2007, NAT GENET, V39, P513, DOI 10.1038/ng1984; Romeo S, 2009, J CLIN INVEST, V119, P70, DOI 10.1172/JCI37118; Shan L, 2009, J BIOL CHEM, V284, P1419, DOI 10.1074/jbc.M808477200; Sukonina V, 2006, P NATL ACAD SCI USA, V103, P17450, DOI 10.1073/pnas.0604026103; Thomas G, 2002, NAT REV MOL CELL BIO, V3, P753, DOI 10.1038/nrm934; Yang YH, 2008, ARTERIOSCL THROM VAS, V28, P835, DOI 10.1161/ATVBAHA.107.157776; Yoon JC, 2000, MOL CELL BIOL, V20, P5343, DOI 10.1128/MCB.20.14.5343-5349.2000; Yoshida K, 2002, J LIPID RES, V43, P1770, DOI 10.1194/jlr.C200010-JLR200	20	92	99	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					13213	13222		10.1074/jbc.M900553200	http://dx.doi.org/10.1074/jbc.M900553200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19270337	hybrid, Green Published			2022-12-27	WOS:000265688300068
J	Eide, DJ				Eide, David J.			Homeostatic and Adaptive Responses to Zinc Deficiency in Saccharomyces cerevisiae	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Review							DIACYLGLYCEROL PYROPHOSPHATE PHOSPHATASE; ZAP1 TRANSCRIPTIONAL ACTIVATOR; DNA-BINDING; PHOSPHOLIPID-SYNTHESIS; OXIDATIVE STRESS; GENE-EXPRESSION; REGULATED GENES; YEAST; PROTEIN; DOMAIN	Zinc is an essential nutrient and serves as a structural or catalytic cofactor for many proteins. Thus, cells need mechanisms to maintain zinc homeostasis when available zinc supplies decrease. In addition, cells require other mechanisms to adapt intracellular processes to suboptimal levels of zinc. By exploring the transcriptional responses to zinc deficiency, studies of the yeast Saccharomyces cerevisiae have revealed both homeostatic and adaptive responses to low zinc. The Zap1 zinc-responsive transcription factor regulates several genes in yeast, and the identity of these genes has led to new insights regarding how cells respond to the stress of zinc deficiency.	Univ Wisconsin, Dept Nutr Sci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Eide, DJ (corresponding author), Univ Wisconsin, Dept Nutr Sci, Madison, WI 53706 USA.	eide@nutrisci.wisc.edu			National Institutes of Health [GM56285, GM69786]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069786, R01GM056285] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM56285 and GM69786. This is the second article of five in the second Thematic Minireview Series on Metals in Biology. This minireview will be reprinted in the 2009 Minireview Compendium, which will be available in January, 2010.	Bird A, 2000, J BIOL CHEM, V275, P16160, DOI 10.1074/jbc.M000664200; Bird AJ, 2004, EMBO J, V23, P1123, DOI 10.1038/sj.emboj.7600122; Bird AJ, 2000, EMBO J, V19, P3704, DOI 10.1093/emboj/19.14.3704; Bird AJ, 2003, EMBO J, V22, P5137, DOI 10.1093/emboj/cdg484; Bird AJ, 2006, J BIOL CHEM, V281, P25326, DOI 10.1074/jbc.M600655200; Bird AJ, 2006, EMBO J, V25, P5726, DOI 10.1038/sj.emboj.7601453; Carman GM, 2007, BBA-MOL CELL BIOL L, V1771, P322, DOI 10.1016/j.bbalip.2006.05.006; De Nicola R, 2007, APPL ENVIRON MICROB, V73, P7680, DOI 10.1128/AEM.01445-07; DREWKE C, 1988, BIOCHIM BIOPHYS ACTA, V950, P54, DOI 10.1016/0167-4781(88)90072-3; Ellis CD, 2005, J BIOL CHEM, V280, P28811, DOI 10.1074/jbc.M505500200; Evans-Galea MV, 2003, BIOCHEMISTRY-US, V42, P1053, DOI 10.1021/bi0263199; Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046; Guerinot ML, 2000, BBA-BIOMEMBRANES, V1465, P190, DOI 10.1016/S0005-2736(00)00138-3; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Han GS, 2004, J BIOL CHEM, V279, P5338, DOI 10.1074/jbc.M311779200; Han GS, 2001, J BIOL CHEM, V276, P10126, DOI 10.1074/jbc.M011421200; Han SH, 2005, J BIOL CHEM, V280, P29017, DOI 10.1074/jbc.M505881200; Herbig A, 2005, MOL MICROBIOL, V57, P834, DOI 10.1111/j.1365-2958.2005.04734.x; Higgins VJ, 2003, APPL ENVIRON MICROB, V69, P7535, DOI 10.1128/AEM.69.12.7535-7540.2003; Ho E, 2004, J NUTR BIOCHEM, V15, P572, DOI 10.1016/j.jnutbio.2004.07.005; Iwanyshyn WM, 2004, J BIOL CHEM, V279, P21976, DOI 10.1074/jbc.M402047200; Jensen LT, 2003, J BIOL CHEM, V278, P42036, DOI 10.1074/jbc.M307413200; Kaiser P, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-16; Kambe Taiho, 2006, Genomics Proteomics & Bioinformatics, V4, P1, DOI 10.1016/S1672-0229(06)60010-7; Kersting MC, 2006, J BIOL CHEM, V281, P13110, DOI 10.1074/jbc.M601612200; Kissova I, 2004, J BIOL CHEM, V279, P39068, DOI 10.1074/jbc.M406960200; Kosugi A, 2001, BIOSCI BIOTECH BIOCH, V65, P728, DOI 10.1271/bbb.65.728; Lyons TJ, 2000, P NATL ACAD SCI USA, V97, P7957, DOI 10.1073/pnas.97.14.7957; MacDiarmid CW, 2003, J BIOL CHEM, V278, P15065, DOI 10.1074/jbc.M300568200; MacDiarmid CW, 2000, EMBO J, V19, P2845, DOI 10.1093/emboj/19.12.2845; Mann KJ, 2001, BIOCHEMISTRY-US, V40, P1205, DOI 10.1021/bi0024512; Miyabe S, 2000, BIOCHEM BIOPH RES CO, V276, P879, DOI 10.1006/bbrc.2000.3580; Powell SR, 2000, J NUTR, V130, p1447S, DOI 10.1093/jn/130.5.1447S; Qiao W, 2006, P NATL ACAD SCI USA, V103, P8674, DOI 10.1073/pnas.0600928103; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; Rouillon A, 1999, J BIOL CHEM, V274, P28096, DOI 10.1074/jbc.274.40.28096; Simm C, 2007, EUKARYOT CELL, V6, P1166, DOI 10.1128/EC.00077-07; Slekar KH, 1996, J BIOL CHEM, V271, P28831, DOI 10.1074/jbc.271.46.28831; Soto A, 2008, J BIOL CHEM, V283, P10079, DOI 10.1074/jbc.M800502200; Thomas D, 1997, MICROBIOL MOL BIOL R, V61, P503, DOI 10.1128/.61.4.503-532.1997; Wang ZH, 2006, J MOL BIOL, V357, P1167, DOI 10.1016/j.jmb.2006.01.010; Waters BM, 2002, J BIOL CHEM, V277, P33749, DOI 10.1074/jbc.M206214200; Wu CY, 2007, J BIOL CHEM, V282, P2184, DOI 10.1074/jbc.M606639200; Wu CY, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-370; WU CY, 2008, THESIS U WISCONSIN M; Yuan DS, 2000, GENETICS, V156, P45; Zhao H, 1998, J BIOL CHEM, V273, P28713, DOI 10.1074/jbc.273.44.28713; Zhao H, 1997, MOL CELL BIOL, V17, P5044, DOI 10.1128/MCB.17.9.5044; Zhao H, 1996, J BIOL CHEM, V271, P23203, DOI 10.1074/jbc.271.38.23203; Zhao H, 1996, P NATL ACAD SCI USA, V93, P2454, DOI 10.1073/pnas.93.6.2454	50	107	108	2	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUL 10	2009	284	28					18565	18569		10.1074/jbc.R900014200	http://dx.doi.org/10.1074/jbc.R900014200			5	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	467BP	19363031	hybrid, Green Published			2022-12-27	WOS:000267711500003
J	Manolaridis, I; Mumtsidu, E; Konarev, P; Makhov, AM; Fullerton, SW; Sinz, A; Kalkhof, S; McGeehan, JE; Cary, PD; Griffith, JD; Svergun, D; Kneale, GG; Tucker, PA				Manolaridis, Ioannis; Mumtsidu, Eleni; Konarev, Peter; Makhov, Alexander M.; Fullerton, Stephen W.; Sinz, Andrea; Kalkhof, Stefan; McGeehan, John E.; Cary, Peter D.; Griffith, Jack D.; Svergun, Dmitri; Kneale, Geoff G.; Tucker, Paul A.			Structural and Biophysical Characterization of the Proteins Interacting with the Herpes Simplex Virus 1 Origin of Replication	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING PROTEIN; SINGLE-STRANDED-DNA; RAY SOLUTION SCATTERING; TYPE-1 UL9 PROTEIN; I ORIGIN; VIRAL ORIGIN; BOX I; BIOLOGICAL MACROMOLECULES; TRIPHOSPHATASE-ACTIVITY; ICP8	The C terminus of the herpes simplex virus type 1 origin-binding protein, UL9ct, interacts directly with the viral single-stranded DNA-binding protein ICP8. We show that a 60-amino acid C-terminal deletion mutant of ICP8 (ICP8 Delta C) also binds very strongly to UL9ct. Using small angle x-ray scattering, the low resolution solution structures of UL9ct alone, in complex with ICP8 Delta C, and in complex with a 15-mer double-stranded DNA containing Box I of the origin of replication are described. Size exclusion chromatography, analytical ultracentrifugation, and electrophoretic mobility shift assays, backed up by isothermal titration calorimetry measurements, are used to show that the stoichiometry of the UL9ct-dsDNA(15-mer) complex is 2: 1 at micromolar protein concentrations. The reaction occurs in two steps with initial binding of UL9ct to DNA (K-d similar to 6 nM) followed by a second binding event (K-d similar to 0.8 nM). It is also shown that the stoichiometry of the ternary UL9ct-ICP8 Delta C-dsDNA(15-mer) complex is 2: 1: 1, at the concentrations used in the different assays. Electron microscopy indicates that the complex assembled on the extended origin, oriS, rather than Box I alone, is much larger. The results are consistent with a simple model whereby a conformational switch of the UL9 DNA-binding domain upon binding to Box I allows the recruitment of a UL9-ICP8 complex by interaction between the UL9 DNA-binding domains.	[Manolaridis, Ioannis; Mumtsidu, Eleni; Konarev, Peter; Fullerton, Stephen W.; Svergun, Dmitri; Tucker, Paul A.] European Mol Biol Lab, Hamburg Outstn, D-22603 Hamburg, Germany; [Manolaridis, Ioannis; McGeehan, John E.; Cary, Peter D.; Kneale, Geoff G.] Univ Portsmouth, Inst Biomed & Biomol Sci, Biophys Labs, Portsmouth PO1 2DT, Hants, England; [Makhov, Alexander M.; Griffith, Jack D.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Sinz, Andrea; Kalkhof, Stefan] Univ Halle Wittenberg, Inst Pharm, D-06120 Halle, Germany; [Konarev, Peter; Svergun, Dmitri] Russian Acad Sci, Inst Crystallog, Moscow 117333, Russia	European Molecular Biology Laboratory (EMBL); University of Portsmouth; University of North Carolina; University of North Carolina Chapel Hill; Martin Luther University Halle Wittenberg; Russian Academy of Sciences; FSRC Crystallography & Photonics RAS	Tucker, PA (corresponding author), European Mol Biol Lab, Hamburg Outstn, Notkestr 85, D-22603 Hamburg, Germany.	tucker@embl-hamburg.de	Kalkhof, Stefan/Z-2000-2019; Konarev, Petr V/W-1380-2017	Kalkhof, Stefan/0000-0001-6121-7105; McGeehan, John/0000-0002-6750-1462; Svergun, Dmitri/0000-0003-0830-5696; Konarev, Petr/0000-0002-5606-1596	European Union [LSHG-CT-2004-S11960]; National Institutes of Health [GM31819, CA19014]; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill; Engineering and Physical Sciences Research Council [EP/E500595/1] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P01CA019014] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031819] Funding Source: NIH RePORTER	European Union(European Commission); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by contract LSHG-CT-2004-S11960 from the European Union Integrated Project "VIZIER."; We thank the staff of EMBL-SAXS group for support and for access to the X33 beamline and Borries Demeler for invaluable advice on the interpretation of the analytical ultracentrifugation measurements. We thank Luminita Damian for help in ITC data analysis and interpretation. Electron microscopic work was supported by National Institutes of Health Grants GM31819 and CA19014 to J. D. Griffith, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill.	Arana ME, 2001, J BIOL CHEM, V276, P6840, DOI 10.1074/jbc.M007219200; Aslani A, 2000, J BIOL CHEM, V275, P5880, DOI 10.1074/jbc.275.8.5880; Aslani A, 2002, J BIOL CHEM, V277, P41204, DOI 10.1074/jbc.M208270200; Aslani A, 2001, P NATL ACAD SCI USA, V98, P7194, DOI 10.1073/pnas.121177198; Boehmer PE, 1998, J BIOL CHEM, V273, P2676, DOI 10.1074/jbc.273.5.2676; BOEHMER PE, 1993, J BIOL CHEM, V268, P1220; BOEHMER PE, 1994, J BIOL CHEM, V269, P29329; BOEHMER PE, 1993, P NATL ACAD SCI USA, V90, P8444, DOI 10.1073/pnas.90.18.8444; Boehmer PE, 1997, ANNU REV BIOCHEM, V66, P347, DOI 10.1146/annurev.biochem.66.1.347; Burkham J, 1998, J VIROL, V72, P10100, DOI 10.1128/JVI.72.12.10100-10107.1998; DEB S, 1991, J VIROL, V65, P2829, DOI 10.1128/JVI.65.6.2829-2838.1991; DODSON MS, 1993, J BIOL CHEM, V268, P1213; DURCHSCHLAG H, 1986, THERMODYNAMIC DATA B, P80; ELIAS P, 1992, J BIOL CHEM, V267, P17424; FIERER DS, 1995, J BIOL CHEM, V270, P7330, DOI 10.1074/jbc.270.13.7330; GRIFFITH JD, 1995, J MOL BIOL, V246, P576, DOI 10.1016/S0022-2836(05)80107-X; GRIFFITH JD, 1978, ANNU REV BIOPHYS BIO, V7, P19, DOI 10.1146/annurev.bb.07.060178.000315; GUSTAFSSON CM, 1994, P NATL ACAD SCI USA, V91, P4629, DOI 10.1073/pnas.91.11.4629; GUSTAFSSON CM, 1995, J BIOL CHEM, V270, P19028, DOI 10.1074/jbc.270.32.19028; Hammarsten O, 1997, NUCLEIC ACIDS RES, V25, P1753, DOI 10.1093/nar/25.9.1753; HAZUDA DJ, 1991, J BIOL CHEM, V266, P24621; He XD, 2001, P NATL ACAD SCI USA, V98, P3024, DOI 10.1073/pnas.061028298; KOFF A, 1991, J VIROL, V65, P3284, DOI 10.1128/JVI.65.6.3284-3292.1991; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Laue T.M., 1992, ANAL ULTRACENTRIFUGA, P90; LEE CK, 1985, J VIROL, V54, P731, DOI 10.1128/JVI.54.3.731-738.1985; Lee SSK, 1999, J BIOL CHEM, V274, P18613, DOI 10.1074/jbc.274.26.18613; Lee SSK, 1997, P NATL ACAD SCI USA, V94, P2838, DOI 10.1073/pnas.94.7.2838; Macao B, 2004, J BIOL CHEM, V279, P29211, DOI 10.1074/jbc.M400371200; Makhov AM, 1996, J MOL BIOL, V258, P789, DOI 10.1006/jmbi.1996.0287; Makhov AM, 2003, P NATL ACAD SCI USA, V100, P898, DOI 10.1073/pnas.0237171100; Makhov AM, 1996, EMBO J, V15, P1742, DOI 10.1002/j.1460-2075.1996.tb00520.x; Mapelli M, 2005, J BIOL CHEM, V280, P2990, DOI 10.1074/jbc.M406780200; MARTIN DW, 1994, J VIROL, V68, P3674, DOI 10.1128/JVI.68.6.3674-3681.1994; MCLEAN GW, 1994, J GEN VIROL, V75, P2699, DOI 10.1099/0022-1317-75-10-2699; Monahan SJ, 1998, VIROLOGY, V241, P122, DOI 10.1006/viro.1997.8953; Murata LB, 1999, J BIOL CHEM, V274, P37079, DOI 10.1074/jbc.274.52.37079; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Porod G, 1982, GEN THEORY SMALL ANG, P17; Rasimas JJ, 2003, J BIOL CHEM, V278, P7973, DOI 10.1074/jbc.M211854200; Roessle MW, 2007, J APPL CRYSTALLOGR, V40, pS190, DOI 10.1107/S0021889806055506; Simonsson S, 1998, J BIOL CHEM, V273, P24633, DOI 10.1074/jbc.273.38.24633; STABELL EC, 1993, NUCLEIC ACIDS RES, V21, P5203, DOI 10.1093/nar/21.22.5203; Stow ND, 1998, VIROLOGY, V240, P183, DOI 10.1006/viro.1997.8910; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Svergun DI, 2000, J BIOL CHEM, V275, P14432, DOI 10.1074/jbc.275.19.14432; SVERGUN DI, 1992, J APPL CRYSTALLOGR, V25, P495, DOI 10.1107/S0021889892001663; Svergun DI, 2001, BIOPHYS J, V80, P2946, DOI 10.1016/S0006-3495(01)76260-1; WEIR HM, 1989, NUCLEIC ACIDS RES, V17, P1409, DOI 10.1093/nar/17.4.1409; WEIR HM, 1990, J GEN VIROL, V71, P1379, DOI 10.1099/0022-1317-71-6-1379; WONG SW, 1991, J VIROL, V65, P2601, DOI 10.1128/JVI.65.5.2601-2611.1991	52	12	12	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16343	16353		10.1074/jbc.M806134200	http://dx.doi.org/10.1074/jbc.M806134200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19329432	Green Published, hybrid			2022-12-27	WOS:000266730900032
J	Savas, U; Machemer, DEW; Hsu, MH; Gaynor, P; Lasker, JM; Tukey, RH; Johnson, EF				Savas, Uezen; Machemer, Daniel E. W.; Hsu, Mei-Hui; Gaynor, Pryce; Lasker, Jerome M.; Tukey, Robert H.; Johnson, Eric F.			Opposing Roles of Peroxisome Proliferator-activated Receptor alpha and Growth Hormone in the Regulation of CYP4A11 Expression in a Transgenic Mouse Model	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEPATIC GENE-EXPRESSION; ACID OMEGA-HYDROXYLASE; HUMAN LIVER SLICES; PPAR-ALPHA; ARACHIDONIC-ACID; 20-HYDROXYEICOSATETRAENOIC ACID; ESSENTIAL-HYPERTENSION; ADAPTIVE RESPONSE; HUMAN HEPATOCYTES; CYTOCHROMES P450	CYP4A11 transgenic mice (CYP4A11 Tg) were generated to examine in vivo regulation of the human CYP4A11 gene. Expression of CYP4A11 in mice yields liver and kidney P450 4A11 levels similar to those found in the corresponding human tissues and leads to an increased microsomal capacity for omega-hydroxylation of lauric acid. Fasted CYP4A11 Tg mice exhibit 2-3-fold increases in hepatic CYP4A11 mRNA and protein, and this response is absent in peroxisome proliferator-activated receptor alpha (PPAR alpha) null mice. Dietary administration of either of the PPAR alpha agonists, fenofibrate or clofibric acid, increases hepatic and renal CYP4A11 levels by 2-3-fold, and these responses were also abrogated in PPAR alpha null mice. Basal liver CYP4A11 levels are reduced differentially in PPAR alpha(-/-) females (> 95%) and males (< 50%) compared with PPAR alpha(-/+) mice. Quantitative and temporal differences in growth hormone secretion are known to alter hepatic lipid metabolism and to underlie sexually dimorphic gene expression, respectively. Continuous infusion of low levels of growth hormone reduced CYP4A11 expression by 50% in PPAR alpha-proficient male and female transgenic mice. A larger decrease was observed for the expression of CYP4A11 in PPAR alpha(-/-) CYP4A11 Tg male mice to levels similar to that of female PPAR alpha-deficient mice. These results suggest that PPAR alpha contributes to the maintenance of basal CYP4A11 expression and mediates CYP4A11 induction in response to fibrates or fasting. In contrast, increased exposure to growth hormone down-regulates CYP4A11 expression in liver.	[Johnson, Eric F.] Scripps Res Inst, MEM 255, Dept Mol & Expt Med, La Jolla, CA 92037 USA; [Machemer, Daniel E. W.; Tukey, Robert H.] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Gaynor, Pryce; Lasker, Jerome M.] Hackensack Univ, Med Ctr, Inst Biomed Res, Hackensack, NJ 07601 USA	Scripps Research Institute; University of California System; University of California San Diego; Hackensack University Medical Center	Johnson, EF (corresponding author), Scripps Res Inst, MEM 255, Dept Mol & Expt Med, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	johnson@scripps.edu			United States Public Health Service [HD 04445, GM 49135, AA07842]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD004445] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD004445] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049135] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA007842] Funding Source: NIH RePORTER	United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported by United States Public Health Service Grants HD 04445 (to E.F.J.), GM 49135 (to R.H.T.), and AA07842 (to J.M.L.).	Adas F, 1999, J LIPID RES, V40, P1990; Aoyama T, 1998, J BIOL CHEM, V273, P5678, DOI 10.1074/jbc.273.10.5678; Bell AR, 1998, BIOCHEM J, V332, P689, DOI 10.1042/bj3320689; Boucher JL, 1996, DRUG METAB DISPOS, V24, P462; Cheon YW, 2005, AM J PHYSIOL-REG I, V288, pR1525, DOI 10.1152/ajpregu.00751.2004; Corton JC, 2004, J BIOL CHEM, V279, P46204, DOI 10.1074/jbc.M406739200; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Duez H, 2005, ARTERIOSCL THROM VAS, V25, P585, DOI 10.1161/01.ATV.0000154140.73570.00; Edwards RJ, 2003, DRUG METAB DISPOS, V31, P282, DOI 10.1124/dmd.31.3.282; Fu Z, 2008, J HYPERTENS, V26, P453, DOI 10.1097/HJH.0b013e3282f2f10c; Gainer JV, 2005, CIRCULATION, V111, P63, DOI 10.1161/01.CIR.0000151309.82473.59; Graham RA, 2006, TOXICOL SCI, V92, P356, DOI 10.1093/toxsci/kfl009; Hardwick JP, 2008, BIOCHEM PHARMACOL, V75, P2263, DOI 10.1016/j.bcp.2008.03.004; Hashimoto T, 2000, J BIOL CHEM, V275, P28918, DOI 10.1074/jbc.M910350199; Heng YM, 1997, BIOCHEM J, V325, P741, DOI 10.1042/bj3250741; Holla VR, 2001, P NATL ACAD SCI USA, V98, P5211, DOI 10.1073/pnas.081627898; Holloway MG, 2006, MOL ENDOCRINOL, V20, P647, DOI 10.1210/me.2005-0328; Hsu MH, 2007, DRUG METAB REV, V39, P515, DOI 10.1080/03602530701468573; Hsu MH, 2001, J BIOL CHEM, V276, P27950, DOI 10.1074/jbc.M100258200; Jalouli M, 2003, ENDOCRINOLOGY, V144, P101, DOI 10.1210/en.2002-220630; Jeffery B, 2004, ARCH BIOCHEM BIOPHYS, V429, P231, DOI 10.1016/j.abb.2004.06.025; Johnson EF, 2002, TOXICOLOGY, V181, P203, DOI 10.1016/S0300-483X(02)00282-2; Johnson EF, 1996, FASEB J, V10, P1241, DOI 10.1096/fasebj.10.11.8836037; Kersten S, 1999, J CLIN INVEST, V103, P1489, DOI 10.1172/JCI6223; Kroetz DL, 1998, J BIOL CHEM, V273, P31581, DOI 10.1074/jbc.273.47.31581; LAETHEM RM, 1992, J BIOL CHEM, V267, P5552; Lake BG, 1996, XENOBIOTICA, V26, P297, DOI 10.3109/00498259609046709; Lasker JM, 2000, J BIOL CHEM, V275, P4118, DOI 10.1074/jbc.275.6.4118; Lawrence JW, 2001, J BIOL CHEM, V276, P31521, DOI 10.1074/jbc.M103306200; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Leone TC, 1999, P NATL ACAD SCI USA, V96, P7473, DOI 10.1073/pnas.96.13.7473; Ljungberg A, 2007, GROWTH HORM IGF RES, V17, P154, DOI 10.1016/j.ghir.2007.01.003; Mayer B, 2005, HYPERTENSION, V46, P766, DOI 10.1161/01.HYP.0000182658.04299.15; Nakagawa K, 2003, AM J PHYSIOL-REG I, V284, pR1055, DOI 10.1152/ajpregu.00459.2002; Nakagawa K, 2006, J CLIN INVEST, V116, P1696, DOI 10.1172/JCI27546; Ngo SNT, 2006, GENE, V376, P123, DOI 10.1016/j.gene.2006.02.020; Okita RT, 2001, CURR DRUG METAB, V2, P265; Olsson B, 2003, AM J PHYSIOL-ENDOC M, V285, pE504, DOI 10.1152/ajpendo.00444.2002; Osoegawa K, 2001, GENOME RES, V11, P483, DOI 10.1101/gr.169601; PALMER CNA, 1993, BIOCHIM BIOPHYS ACTA, V1172, P161, DOI 10.1016/0167-4781(93)90285-L; Patsouris D, 2006, ENDOCRINOLOGY, V147, P1508, DOI 10.1210/en.2005-1132; Powell PK, 1996, ARCH BIOCHEM BIOPHYS, V335, P219, DOI 10.1006/abbi.1996.0501; Powell PK, 1998, J PHARMACOL EXP THER, V285, P1327; Raucy JL, 2004, TOXICOL SCI, V79, P233, DOI 10.1093/toxsci/kfh126; Richert L, 2003, TOXICOL APPL PHARM, V191, P130, DOI 10.1016/S0041-008X(03)00231-X; Roman RJ, 2002, PHYSIOL REV, V82, P131, DOI 10.1152/physrev.00021.2001; Sanguino E, 2004, BIOCHEM PHARMACOL, V67, P157, DOI 10.1016/j.bcp.2003.08.034; Savas U, 2003, ARCH BIOCHEM BIOPHYS, V409, P212, DOI 10.1016/S0003-9861(02)00499-X; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Wada F, 1977, Biochim Biophys Acta, V487, P361; Waring JF, 2008, J PHARMACOL EXP THER, V324, P507, DOI 10.1124/jpet.107.126938; Waxman DJ, 2006, MOL ENDOCRINOL, V20, P2613, DOI 10.1210/me.2006-0007	53	22	24	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 12	2009	284	24					16541	16552		10.1074/jbc.M902074200	http://dx.doi.org/10.1074/jbc.M902074200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	455BM	19366684	Green Published, hybrid			2022-12-27	WOS:000266730900051
J	Hu, J; Sharma, M; Qin, HJ; Gao, FP; Cross, TA				Hu, Jian; Sharma, Mukesh; Qin, Huajun; Gao, Fei Philip; Cross, Timothy A.			Ligand Binding in the Conserved Interhelical Loop of CorA, a Magnesium Transporter from Mycobacterium tuberculosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN SECONDARY STRUCTURE; FAMILY INTRAMEMBRANE PROTEASE; NUCLEAR-MAGNETIC-RESONANCE; CHEMICAL-SHIFT DATA; MEMBRANE-PROTEINS; CRYSTAL-STRUCTURE; FUNCTIONAL DOMAINS; POTASSIUM CHANNEL; DIVALENT-CATIONS; LIPID-BILAYERS	CorA is a constitutively expressed magnesium transporter in many bacteria. The crystal structures of Thermotoga maritima CorA provide an excellent structural framework for continuing studies. Here, the ligand binding properties of the conserved interhelical loop, the only portion of the protein exposed to the periplasmic space, are characterized by solution nuclear magnetic resonance spectroscopy. Through titration experiments performed on the isolated transmembrane domain of Mycobacterium tuberculosis CorA, it was found that two CorA substrates (Mg2+ and Co2+) and the CorA-specific inhibitor (Co(III) hexamine chloride) bind in the loop at the same binding site. This site includes the glutamic acid residue from the conserved "MPEL" motif. The relatively large dissociation constants indicate that such interactions are weak but not atypical for channels. The present data support the hypothesis that the negatively charged loop could act as an electrostatic ring, increasing local substrate concentrations before transport across the membrane.	[Hu, Jian; Sharma, Mukesh; Qin, Huajun; Gao, Fei Philip; Cross, Timothy A.] Florida State Univ, Dept Chem & Biochem, Tallahassee, FL 32306 USA; [Hu, Jian; Sharma, Mukesh; Gao, Fei Philip; Cross, Timothy A.] Natl High Magnet Field Lab, Tallahassee, FL 32310 USA; [Cross, Timothy A.] Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University; State University System of Florida; Florida State University	Cross, TA (corresponding author), 1800 E Paul Dirac Dr, Tallahassee, FL 32310 USA.	cross@magnet.fsu.edu	Sharma, Mukesh/F-8328-2010; Smirnov, Alex I/Q-9818-2016	Sharma, Mukesh/0000-0003-3036-1846; Smirnov, Alex I/0000-0002-0037-2555; Cross, Timothy/0000-0002-9413-0505	National Institutes of Health [GM064676, AI073891]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073891] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM064676] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM064676 and AI073891.	BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8; Bonvin AMJJ, 2005, CURR OPIN CHEM BIOL, V9, P501, DOI 10.1016/j.cbpa.2005.08.011; Chill JH, 2006, PROTEIN SCI, V15, P684, DOI 10.1110/ps.051954706; CLORE GM, 1990, BIOCHEMISTRY-US, V29, P8172, DOI 10.1021/bi00487a027; Doyle DA, 2004, EUR BIOPHYS J BIOPHY, V33, P175, DOI 10.1007/s00249-003-0382-z; DUFF KC, 1992, VIROLOGY, V190, P485, DOI 10.1016/0042-6822(92)91239-Q; Eshaghi S, 2006, SCIENCE, V313, P354, DOI 10.1126/science.1127121; Feng L, 2007, SCIENCE, V318, P1608, DOI 10.1126/science.1150755; Forrest LR, 2007, P NATL ACAD SCI USA, V104, P12761, DOI 10.1073/pnas.0705600104; Franzin CM, 2007, METHODS, V41, P398, DOI 10.1016/j.ymeth.2006.08.011; Gelev V, 2006, J MOL BIOL, V364, P352, DOI 10.1016/j.jmb.2006.08.077; Hill AV, 1910, J PHYSIOL-LONDON, V40, P190; Hu J, 2006, P NATL ACAD SCI USA, V103, P6865, DOI 10.1073/pnas.0601944103; Hu J, 2007, PROTEIN SCI, V16, P2153, DOI 10.1110/ps.072996707; IMOTO K, 1988, NATURE, V335, P645, DOI 10.1038/335645a0; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Knoop V, 2005, MOL GENET GENOMICS, V274, P205, DOI 10.1007/s00438-005-0011-x; Kucharski LM, 2000, J BIOL CHEM, V275, P16767, DOI 10.1074/jbc.M001507200; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Lunin VV, 2006, NATURE, V440, P833, DOI 10.1038/nature04642; Ma C, 2002, PROTEIN SCI, V11, P546, DOI 10.1110/ps.37302; Maguire ME, 2006, CURR OPIN STRUC BIOL, V16, P432, DOI 10.1016/j.sbi.2006.06.006; Marassi FM, 1999, P NATL ACAD SCI USA, V96, P14336, DOI 10.1073/pnas.96.25.14336; MCLAUGHLIN A, 1978, BIOCHIM BIOPHYS ACTA, V513, P338, DOI 10.1016/0005-2736(78)90203-1; Moncrief MBC, 1999, J BIOL INORG CHEM, V4, P523, DOI 10.1007/s007750050374; Niegowski D, 2007, CELL MOL LIFE SCI, V64, P2564, DOI 10.1007/s00018-007-7174-z; PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120; Page Richard C., 2006, Journal of Structural and Functional Genomics, V7, P51, DOI 10.1007/s10969-006-9009-9; Papp-Wallace KM, 2007, MOL MEMBR BIOL, V24, P351, DOI 10.1080/09687680701441883; Payandeh J, 2008, J BIOL CHEM, V283, P11721, DOI 10.1074/jbc.M707889200; Payandeh J, 2006, EMBO J, V25, P3762, DOI 10.1038/sj.emboj.7601269; Pfeiffer J, 2002, INFECT IMMUN, V70, P3930, DOI 10.1128/IAI.70.7.3930-3934.2002; Ramjeesingh M, 1999, BIOCHEM J, V342, P119, DOI 10.1042/0264-6021:3420119; Schindl R, 2007, BIOPHYS J, V93, P3872, DOI 10.1529/biophysj.107.112318; Smith RL, 1998, J BACTERIOL, V180, P2788, DOI 10.1128/JB.180.10.2788-2791.1998; Takeuchi K, 2006, CURR OPIN STRUC BIOL, V16, P109, DOI 10.1016/j.sbi.2006.01.006; Tian CL, 2003, PROTEIN SCI, V12, P2597, DOI 10.1110/ps.03168503; Wachek M, 2006, FEBS J, V273, P4236, DOI 10.1111/j.1742-4658.2006.05424.x; Wang JF, 2001, PROTEIN SCI, V10, P2241, DOI 10.1110/ps.17901; Wang YJ, 2002, PROTEIN SCI, V11, P852, DOI 10.1110/ps.3180102; Wang YC, 2006, NATURE, V444, P179, DOI 10.1038/nature05255; Weghuber J, 2006, FEBS J, V273, P1198, DOI 10.1111/j.1742-4658.2006.05157.x; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Wu ZR, 2006, NAT STRUCT MOL BIOL, V13, P1084, DOI 10.1038/nsmb1179	44	17	17	1	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15619	15628		10.1074/jbc.M901581200	http://dx.doi.org/10.1074/jbc.M901581200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19346249	hybrid, Green Published			2022-12-27	WOS:000266501000030
J	Klein, G; Lindner, B; Brabetz, W; Brade, H; Raina, S				Klein, Gracjana; Lindner, Buko; Brabetz, Werner; Brade, Helmut; Raina, Satish			Escherichia coli K-12 Suppressor-free Mutants Lacking Early Glycosyltransferases and Late Acyltransferases MINIMAL LIPOPOLYSACCHARIDE STRUCTURE AND INDUCTION OF ENVELOPE STRESS RESPONSE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EXTRACYTOPLASMIC COMPARTMENTS; ACYL CHAINS; OUTER CORE; GENE; BIOSYNTHESIS; SHOCK; MSBA; MEMBRANE; EPITOPE; INNER	To elucidate the minimal lipopolysaccharide (LPS) structure needed for the viability of Escherichia coli, suppressor-free strains lacking either the 3-deoxy-D-manno-oct-2-ulosonic acid transferase waaA gene or derivatives of the heptosyltransferase I waaC deletion with lack of one or all late acyltransferases (lpxL/M/P) and/or various outer membrane biogenesis factors were constructed. Delta(waaC lpxL lpxM lpxP) and waaA mutants exhibited highly attenuated growth, whereas simultaneous deletion of waaC and surA was lethal. Analyses of LPS of suppressor-free waaA mutants grown at 21 degrees C, besides showing accumulation of free lipid IVA precursor, also revealed the presence of its pentaacylated and hexaacylated derivatives, indicating in vivo late acylation can occur without Kdo. In contrast, LPS of Delta(waaC lpxL lpxM lpxP) strains showed primarily Kdo(2)-lipid IVA, indicating that these minimal LPS structures are sufficient to support growth of E. coli under slow-growth conditions at 21/23 degrees C. These lipid IVA derivatives could be modified biosynthetically by phosphoethanolamine, but not by 4-amino-4-deoxy-L-arabinose, indicating export defects of such minimal LPS. Delta waaA and Delta(waaC lpxL lpxM lpxP) exhibited cell-division defects with a decrease in the levels of FtsZ and OMP-folding factor PpiD. These mutations led to strong constitutive additive induction of envelope responsive CpxR/A and sigma(E) signal transduction pathways. Delta(lpxL lpxM lpxP) mutant, with intact waaC, synthesized tetraacylated lipid A and constitutively incorporated a third Kdo in growth medium inducing synthesis of P-EtN and L-Ara4N. Overexpression of msbA restored growth of Delta(lpxL lpxM lpxP) under fast-growing conditions, but only partially that of the Delta(waaC lpxL lpxM lpxP) mutant. This suppression could be alleviated by overexpression of certain mutant msbA alleles or the single-copy chromosomal MsbA-498V variant in the vicinity of Walker-box II.	[Klein, Gracjana; Lindner, Buko; Brabetz, Werner; Brade, Helmut; Raina, Satish] Leibniz Ctr Med & Biosci, Res Ctr Borstel, D-23845 Borstel, Germany	Forschungszentrum Borstel	Raina, S (corresponding author), Leibniz Ctr Med & Biosci, Res Ctr Borstel, Parkallee 22, D-23845 Borstel, Germany.	sraina@fz-borstel.de	Raina, Satish/AAU-9550-2021; Lindner, Buko/G-9731-2014	Raina, Satish/0000-0003-3175-4932; Klein, Gracjana/0000-0001-8695-8065	Deutsche Forschungsgemeinschaft [448/4]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by Deutsche Forschungsgemeinschaft Grant DFG LI 448/4 (to B. L.).	Antonoaea R, 2008, BIOCHEMISTRY-US, V47, P5649, DOI 10.1021/bi800233w; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BELUNIS CJ, 1992, J BIOL CHEM, V267, P9988; Bishop RE, 2000, EMBO J, V19, P5071, DOI 10.1093/emboj/19.19.5071; Brabetz W, 1997, EUR J BIOCHEM, V247, P716, DOI 10.1111/j.1432-1033.1997.00716.x; Carty SM, 1999, J BIOL CHEM, V274, P9677, DOI 10.1074/jbc.274.14.9677; Clementz T, 1996, J BIOL CHEM, V271, P12095, DOI 10.1074/jbc.271.20.12095; Clementz T, 1997, J BIOL CHEM, V272, P10353; Dartigalongue C, 1998, EMBO J, V17, P3968, DOI 10.1093/emboj/17.14.3968; Dartigalongue C, 2001, J BIOL CHEM, V276, P20866, DOI 10.1074/jbc.M100464200; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DeLasPenas A, 1997, MOL MICROBIOL, V24, P373, DOI 10.1046/j.1365-2958.1997.3611718.x; Doerrler WT, 2004, J BIOL CHEM, V279, P45102, DOI 10.1074/jbc.M408106200; Doerrler WT, 2002, J BIOL CHEM, V277, P36697, DOI 10.1074/jbc.M205857200; Frirdich E, 2003, J BACTERIOL, V185, P1659, DOI 10.1128/JB.185.5.1659-1671.2003; GALANOS C, 1969, EUR J BIOCHEM, V9, P245, DOI 10.1111/j.1432-1033.1969.tb00601.x; Gronow S, 2001, J ENDOTOXIN RES, V7, P3, DOI 10.1179/096805101101532468; Gronow S, 2000, EUR J BIOCHEM, V267, P6602, DOI 10.1046/j.1432-1327.2000.01754.x; Hagiwara D, 2004, BIOSCI BIOTECH BIOCH, V68, P1758, DOI 10.1271/bbb.68.1758; Kanipes MI, 2001, J BIOL CHEM, V276, P1156, DOI 10.1074/jbc.M009019200; KAROW M, 1991, RES MICROBIOL, V142, P289, DOI 10.1016/0923-2508(91)90043-A; KAROW M, 1991, J BACTERIOL, V173, P741, DOI 10.1128/jb.173.2.741-750.1991; Kondakov A, 2005, EUR J MASS SPECTROM, V11, P535, DOI 10.1255/ejms.721; KUHN HM, 1992, INFECT IMMUN, V60, P2201, DOI 10.1128/IAI.60.6.2201-2210.1992; LERNER CG, 1990, NUCLEIC ACIDS RES, V18, P4631, DOI 10.1093/nar/18.15.4631; Mamat U, 2008, MOL MICROBIOL, V67, P633, DOI 10.1111/j.1365-2958.2007.06074.x; Meredith TC, 2006, ACS CHEM BIOL, V1, P33, DOI 10.1021/cb0500015; Missiakas D, 1997, MOL MICROBIOL, V24, P355, DOI 10.1046/j.1365-2958.1997.3601713.x; Missiakas D, 1997, EMBO J, V16, P1670, DOI 10.1093/emboj/16.7.1670; Missiakas D, 1996, MOL MICROBIOL, V21, P871, DOI 10.1046/j.1365-2958.1996.561412.x; Muller-Loennies S, 2006, GLYCOBIOLOGY, V16, P184, DOI 10.1093/glycob/cwj055; Muller-Loennies S, 2003, J BIOL CHEM, V278, P34090, DOI 10.1074/jbc.M303985200; Raetz CRH, 2007, ANNU REV BIOCHEM, V76, P295, DOI 10.1146/annurev.biochem.76.010307.145803; Raetz CRH, 2002, ANNU REV BIOCHEM, V71, P635, DOI 10.1146/annurev.biochem.71.110601.135414; RAINA S, 1995, EMBO J, V14, P1043, DOI 10.1002/j.1460-2075.1995.tb07085.x; RAINA S, 1991, NUCLEIC ACIDS RES, V19, P3811, DOI 10.1093/nar/19.14.3811; Reynolds CM, 2005, J BIOL CHEM, V280, P21202, DOI 10.1074/jbc.M500964200; ROZALSKI A, 1989, INFECT IMMUN, V57, P2645, DOI 10.1128/IAI.57.9.2645-2652.1989; SCHNAITMAN CA, 1993, MICROBIOL REV, V57, P655, DOI 10.1128/MMBR.57.3.655-682.1993; Tam C, 2005, MOL MICROBIOL, V55, P1403, DOI 10.1111/j.1365-2958.2005.04497.x; TORRIANI A, 1960, BIOCHIM BIOPHYS ACTA, V38, P460, DOI 10.1016/0006-3002(60)91281-6; Tran AX, 2005, J BIOL CHEM, V280, P28186, DOI 10.1074/jbc.M505020200; Vorachek-Warren MK, 2002, J BIOL CHEM, V277, P14194, DOI 10.1074/jbc.M200409200; Vorachek-Warren MK, 2002, J BIOL CHEM, V277, P14186, DOI 10.1074/jbc.M200408200; Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104; Zhou ZM, 1998, J BIOL CHEM, V273, P12466, DOI 10.1074/jbc.273.20.12466	46	70	73	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15369	15389		10.1074/jbc.M900490200	http://dx.doi.org/10.1074/jbc.M900490200			21	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19346244	Green Published, hybrid			2022-12-27	WOS:000266501000005
J	Liu, XJ; Bellamy, COC; Bailey, MA; Mullins, LJ; Dunbar, DR; Kenyon, CJ; Brooker, G; Kantachuvesiri, S; Maratou, K; Ashek, A; Clark, AF; Fleming, S; Mullins, JJ				Liu, Xiaojun; Bellamy, Christopher O. C.; Bailey, Matthew A.; Mullins, Linda J.; Dunbar, Donald R.; Kenyon, Christopher J.; Brooker, Gillian; Kantachuvesiri, Surasak; Maratou, Klio; Ashek, Ali; Clark, Allan F.; Fleming, Stewart; Mullins, John J.			Angiotensin-converting Enzyme Is a Modifier of Hypertensive End Organ Damage	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYP1A1-REN2 TRANSGENIC RATS; DEPENDENT MALIGNANT HYPERTENSION; TERMINAL CATALYTIC DOMAIN; ASP-LYS-PRO; BLOOD-PRESSURE; PHASE HYPERTENSION; NITRIC-OXIDE; AC-SDKP; GENE; TGR(MREN2)27	Severe forms of hypertension are characterized by high blood pressure combined with end organ damage. Through the development and refinement of a transgenic rat model of malignant hypertension incorporating the mouse renin gene, we previously identified a quantitative trait locus on chromosome 10, which affects malignant hypertension severity and morbidity. We next generated an inducible malignant hypertensive model where the timing, severity, and duration of hypertension was placed under the control of the researcher, allowing development of and recovery from end organ damage to be investigated. We have now generated novel consomic Lewis and Fischer rat strains with inducible hypertension and additional strains that are reciprocally congenic for the refined chromosome 10 quantitative trait locus. We have captured a modifier of end organ damage within the congenic region and, using a range of bioinformatic, biochemical and molecular biological techniques, have identified angiotensin-converting enzyme as the modifier of hypertension-induced tissue microvascular injury. Reciprocal differences between angiotensin-converting enzyme and the anti-inflammatory tetrapeptide, N-acetyl-Ser-Asp-Lys-Pro in the kidney, a tissue susceptible to end organ damage, suggest a mechanism for the amelioration of hypertension-dependent damage.	[Liu, Xiaojun; Bailey, Matthew A.; Mullins, Linda J.; Dunbar, Donald R.; Kenyon, Christopher J.; Brooker, Gillian; Ashek, Ali; Clark, Allan F.; Mullins, John J.] Univ Edinburgh, Mol Physiol Lab, Ctr Cardiovasc Sci, Queens Med Res Inst, Edinburgh EH16 4TJ, Midlothian, Scotland; [Bellamy, Christopher O. C.] Royal Edinburgh Infirm, Dept Pathol, Edinburgh EH16 4SA, Midlothian, Scotland; [Kantachuvesiri, Surasak] Mahidol Univ, Bangkok 10400, Thailand; [Maratou, Klio] Hammersmith Hosp, Ctr Clin Sci, MRC, London W12 ONN, England; [Fleming, Stewart] Ninewells Hosp, Dundee DD1 9SY, Scotland	University of Edinburgh; Royal Infirmary of Edinburgh; Mahidol University; Imperial College London; University of Dundee	Mullins, JJ (corresponding author), Univ Edinburgh, Mol Physiol Lab, Ctr Cardiovasc Sci, Queens Med Res Inst, 47 Little France Crescent, Edinburgh EH16 4TJ, Midlothian, Scotland.	j.mullins@ed.ac.uk	Bailey, Matthew A./AAH-3395-2020; Dunbar, Donald R/A-7093-2012	Bailey, Matthew A./0000-0003-4244-5668; Mullins, Linda/0000-0002-6743-8707; Maratou, Klio/0000-0001-6061-2322	Kidney Research UK; Wellcome Trust [WTO53646]; EURATools consortium; MRC [G0701528] Funding Source: UKRI; Medical Research Council [G0701528, G9900991B] Funding Source: researchfish	Kidney Research UK(Kidney Research UK (KRUK)); Wellcome Trust(Wellcome TrustEuropean Commission); EURATools consortium; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Kidney Research UK( formerly National Kidney Research Fund) award ( to J. M. and S. F.), Wellcome Trust Programme Grant WTO53646, the Wellcome Trust Cardiovascular Research and Functional Genomics initiatives, and the EURATools consortium.	Bader M, 1996, CLIN EXP PHARMACOL P, V23, pS81, DOI 10.1111/j.1440-1681.1996.tb02818.x; Bailey MA, 1998, AM J PHYSIOL-RENAL, V275, pF878, DOI 10.1152/ajprenal.1998.275.6.F878; Becker KG, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-61; Cavasin MA, 2007, HYPERTENSION, V50, P130, DOI 10.1161/HYPERTENSIONAHA.106.084103; Challah M, 1998, ARTERIOSCL THROM VAS, V18, P235, DOI 10.1161/01.ATV.18.2.235; Collidge TA, 2004, PROG BIOPHYS MOL BIO, V84, P301, DOI 10.1016/j.pbiomolbio.2003.11.003; Edmunds E, 2000, J HUM HYPERTENS, V14, P159, DOI 10.1038/sj.jhh.1000967; Engler S, 1998, REGUL PEPTIDES, V77, P3, DOI 10.1016/S0167-0115(98)00120-7; Espinel Eugenia, 2005, J Clin Hypertens (Greenwich), V7, P11, DOI 10.1111/j.1524-6175.2005.03879.x; Evans RG, 2004, J HYPERTENS, V22, P1439, DOI 10.1097/01.hjh.0000133744.85490.9d; Fleming S, 2000, J PATHOL, V192, P135; Fuchs S, 2004, J BIOL CHEM, V279, P15946, DOI 10.1074/jbc.M400149200; Fuchs S, 2008, HYPERTENSION, V51, P267, DOI 10.1161/HYPERTENSIONAHA.107.097865; Graciano ML, 2007, AM J PHYSIOL-RENAL, V292, pF1858, DOI 10.1152/ajprenal.00469.2006; Howard LL, 2005, AM J PHYSIOL-RENAL, V288, pF810, DOI 10.1152/ajprenal.00148.2004; Hubbard T, 2002, NUCLEIC ACIDS RES, V30, P38, DOI 10.1093/nar/30.1.38; Iwai N, 1999, CIRCULATION, V100, P1923, DOI 10.1161/01.CIR.100.18.1923; Jafarian-Tehrani M, 2000, MOL MED, V6, P319, DOI 10.1007/BF03401940; Kantachuvesiri S, 1999, KIDNEY INT, V56, P414, DOI 10.1046/j.1523-1755.1999.00571.x; Kantachuvesiri S, 2001, J BIOL CHEM, V276, P36727, DOI 10.1074/jbc.M103296200; Kincaid-Smith P, 1981, Aust N Z J Med, V11, P64, DOI 10.1111/j.1445-5994.1981.tb03564.x; Krege JH, 1997, HYPERTENSION, V29, P150, DOI 10.1161/01.HYP.29.1.150; Langheinrich M, 1996, AM J HYPERTENS, V9, P506, DOI 10.1016/0895-7061(95)00400-9; Lee MA, 1996, AM J PHYSIOL-ENDOC M, V270, pE919, DOI 10.1152/ajpendo.1996.270.6.E919; LIP GYH, 1994, J HYPERTENS, V12, P1297; LIP GYH, 1995, J HYPERTENS, V13, P915, DOI 10.1097/00004872-199508000-00013; Mitchell KD, 2005, AM J PHYSIOL-RENAL, V289, pF1210, DOI 10.1152/ajprenal.00461.2004; Mitchell KD, 2006, J RENIN-ANGIO-ALDO S, V7, P74, DOI 10.3317/jraas.2006.013; Montgomery HE, 1998, J HYPERTENS, V16, P635, DOI 10.1097/00004872-199816050-00011; MORTON JJ, 1983, CLIN SCI, V64, P359, DOI 10.1042/cs0640359; MULLINS JJ, 1990, NATURE, V344, P541, DOI 10.1038/344541a0; Natesh R, 2003, NATURE, V421, P551, DOI 10.1038/nature01370; Opay AL, 2006, AM J PHYSIOL-RENAL, V291, pF612, DOI 10.1152/ajprenal.00032.2006; Ortiz RM, 2007, AM J PHYSIOL-RENAL, V293, pF1584, DOI 10.1152/ajprenal.00124.2007; Patterson ME, 2008, AM J PHYSIOL-RENAL, V294, pF205, DOI 10.1152/ajprenal.00150.2007; Patterson ME, 2005, AM J PHYSIOL-RENAL, V289, pF754, DOI 10.1152/ajprenal.00419.2004; Peng HM, 2007, HYPERTENSION, V49, P695, DOI 10.1161/01.HYP.0000258406.66954.4f; Peters B, 2008, J HYPERTENS, V26, P102, DOI 10.1097/HJH.0b013e3282f0ab66; Pool JL, 2000, INT J CLIN PRACT, P4; Rasoul S, 2004, J HYPERTENS, V22, P593, DOI 10.1097/00004872-200403000-00023; ROUSSEAU A, 1995, J BIOL CHEM, V270, P3656, DOI 10.1074/jbc.270.8.3656; SANTOS RAS, 1985, HYPERTENSION, V7, P244, DOI 10.1161/01.HYP.7.2.244; Sharma U, 2008, AM J PHYSIOL-HEART C, V294, pH1226, DOI 10.1152/ajpheart.00305.2007; Stefansson B, 2000, BLOOD PRESSURE, V9, P104, DOI 10.1080/080370500453429; Tian XL, 2003, BIOCHEM PHARMACOL, V66, P1037, DOI 10.1016/S0006-2952(03)00457-X; Wei Y, 2007, HYPERTENSION, V50, P384, DOI 10.1161/HYPERTENSIONAHA.107.089284; Whaley-Connell A, 2007, AM J PHYSIOL-ENDOC M, V293, pE355, DOI 10.1152/ajpendo.00632.2006; WHITWORTH CE, 1994, KIDNEY INT, V46, P1528, DOI 10.1038/ki.1994.437	48	21	23	0	0	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15564	15572		10.1074/jbc.M806584200	http://dx.doi.org/10.1074/jbc.M806584200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19307186	Green Published, hybrid			2022-12-27	WOS:000266501000025
J	Upton, PD; Davies, RJ; Trembath, RC; Morrell, NW				Upton, Paul D.; Davies, Rachel J.; Trembath, Richard C.; Morrell, Nicholas W.			Bone Morphogenetic Protein (BMP) and Activin Type II Receptors Balance BMP9 Signals Mediated by Activin Receptor-like Kinase-1 in Human Pulmonary Artery Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEREDITARY HEMORRHAGIC TELANGIECTASIA; TGF-BETA; SMOOTH-MUSCLE; E-SELECTIN; HYPERTENSION; MUTATIONS; GROWTH; ALK1; ACTIVATION; GENE	Mutations in transforming growth factor-beta(TGF-beta) receptor superfamily members underlie conditions characterized by vascular dysplasia. Mutations in endoglin and activin-like kinase receptor 1 (ALK1) cause hereditary hemorrhagic telangiectasia, whereas bone morphogenetic protein type II receptor (BMPR-II) mutations underlie familial pulmonary arterial hypertension. To understand the functional roles of these receptors, we examined their relative contributions to BMP signaling in human pulmonary artery endothelial cells (HPAECs). BMP9 potently and selectively induced Smad1/5 phosphorylation and Id gene expression in HPAECs. Contrary to expectations, BMP9 also stimulated Smad2 activation. Furthermore, BMP9 induced the expression of interleukin 8 and E-selectin. Using small interfering RNA, we demonstrate that the type I receptor, ALK1, is essential for these responses. However, small interfering RNA and inhibitor studies showed no involvement of ALK5 or endoglin. We further demonstrate that, of the candidate type II receptors, BMPR-II predominantly mediated IL-8 and E-selectin induction and mitogenic inhibition by BMP9. Conversely, activin receptor type II (ActR-II) contributed more to BMP9-mediated Smad2 activation. Only abolition of both type II receptors significantly reduced the Smad1/5 and Id responses. Both ALK1 and BMPR-II contributed to growth inhibition of HPAECs, whereas ActR-II was not involved. Taken together, our findings demonstrate the critical role of type II receptors in balancing BMP9 signaling via ALK1 and emphasize the essential role for BMPR-II in a subset of BMP9 responses (interleukin 8, E-selectin, and proliferation). This differential signaling may contribute to the contrasting pathologies of hereditary hemorrhagic telangiectasia and pulmonary arterial hypertension.	[Upton, Paul D.; Davies, Rachel J.; Morrell, Nicholas W.] Univ Cambridge, Addenbrookes Hosp, Sch Clin Med, Dept Med, Cambridge CB2 2QQ, England; [Upton, Paul D.; Davies, Rachel J.; Morrell, Nicholas W.] Papworth Hosp, Cambridge CB2 2QQ, England; [Trembath, Richard C.] Kings Coll London, Guys Hosp, Dept Med & Mol Genet, London SE1 9RT, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Papworth Hospital; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London	Upton, PD (corresponding author), Dept Med, Div Resp Med, Box 157,Level 5,Hills Rd, Cambridge CB2 2QQ, England.	pdu21@medschl.cam.ac.uk	wei, wei/HHR-8613-2022	Trembath, Richard/0000-0003-0550-3400; Morrell, Nicholas/0000-0001-5700-9792	British Heart Foundation Programme Grant [RG/03/005]; Wellcome Trust Clinical Research Training Fellowship [GR077167MA]; British Heart Foundation [RG/08/002/24718] Funding Source: researchfish; National Institute for Health Research [NF-SI-0507-10379] Funding Source: researchfish	British Heart Foundation Programme Grant; Wellcome Trust Clinical Research Training Fellowship(Wellcome Trust); British Heart Foundation(British Heart Foundation); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by British Heart Foundation Programme Grant RG/03/005 (to N. W. M. and R. C. T.).; Supported by a Wellcome Trust Clinical Research Training Fellowship GR077167MA.	Abdalla SA, 2004, EUR RESPIR J, V23, P373, DOI 10.1183/09031936.04.00085504; Bullard DC, 1996, J EXP MED, V183, P2329, DOI 10.1084/jem.183.5.2329; Chen X, 1997, NATURE, V389, P85, DOI 10.1038/38008; Chen YG, 1999, J BIOL CHEM, V274, P3672, DOI 10.1074/jbc.274.6.3672; Cottin V, 2004, AM J RESP CRIT CARE, V169, P994, DOI 10.1164/rccm.200310-1441OC; Cowburn AS, 2004, EUR J IMMUNOL, V34, P1733, DOI 10.1002/eji.200425091; David L, 2008, CIRC RES, V102, P914, DOI 10.1161/CIRCRESAHA.107.165530; David L, 2007, BLOOD, V109, P1953, DOI 10.1182/blood-2006-07-034124; Deng ZM, 2000, AM J HUM GENET, V67, P737, DOI 10.1086/303059; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Ebisawa T, 1999, J CELL SCI, V112, P3519; Fernandez-L A, 2005, CARDIOVASC RES, V68, P235, DOI 10.1016/j.cardiores.2005.06.009; Gallione CJ, 2006, J MED GENET, V43, P793, DOI 10.1136/jmg.2006.041517; Gallione CJ, 2004, LANCET, V363, P852, DOI 10.1016/S0140-6736(04)15732-2; Goumans MJ, 2002, EMBO J, V21, P1743, DOI 10.1093/emboj/21.7.1743; Goumans MJ, 2003, MOL CELL, V12, P817, DOI 10.1016/S1097-2765(03)00386-1; Harrison RE, 2003, J MED GENET, V40, P865, DOI 10.1136/jmg.40.12.865; Hoodless PA, 1996, CELL, V85, P489, DOI 10.1016/S0092-8674(00)81250-7; Hoodless PA, 1999, DEV BIOL, V207, P364, DOI 10.1006/dbio.1998.9168; Johnson DW, 1996, NAT GENET, V13, P189, DOI 10.1038/ng0696-189; Lamouille S, 2002, BLOOD, V100, P4495, DOI 10.1182/blood.V100.13.4495; Lane KB, 2000, NAT GENET, V26, P81, DOI 10.1038/79226; Lee NY, 2008, J BIOL CHEM, V283, P32527, DOI 10.1074/jbc.M803059200; Liu F, 1996, NATURE, V381, P620, DOI 10.1038/381620a0; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lux Andreas, 2006, BMC Cardiovasc Disord, V6, P13, DOI 10.1186/1471-2261-6-13; Machado RD, 2006, HUM MUTAT, V27, P121, DOI 10.1002/humu.20285; MCALLISTER KA, 1994, NAT GENET, V8, P345, DOI 10.1038/ng1294-345; McClintock JY, 2005, J APPL PHYSIOL, V99, P861, DOI 10.1152/japplphysiol.00006.2005; Morrell NW, 1999, AM J PHYSIOL-LUNG C, V277, pL440, DOI 10.1152/ajplung.1999.277.3.L440; Morrell NW, 2001, CIRCULATION, V104, P790, DOI 10.1161/hc3201.094152; NGUYEN M, 1993, NATURE, V365, P267, DOI 10.1038/365267a0; Park SO, 2008, BLOOD, V111, P633, DOI 10.1182/blood-2007-08-107359; Pece-Barbara N, 2005, J BIOL CHEM, V280, P27800, DOI 10.1074/jbc.M503471200; Pepper Michael S., 1997, Cytokine and Growth Factor Reviews, V8, P21, DOI 10.1016/S1359-6101(96)00048-2; Sadick H, 2006, WIEN KLIN WOCHENSCHR, V118, P72, DOI 10.1007/s00508-006-0561-x; Scharpfenecker M, 2007, J CELL SCI, V120, P964, DOI 10.1242/jcs.002949; Seki T, 2006, LAB INVEST, V86, P116, DOI 10.1038/labinvest.3700376; Sobolewski A, 2008, HUM MOL GENET, V17, P3180, DOI 10.1093/hmg/ddn214; Szekanecz Z, 2000, ARTHRITIS RES, V2, P368, DOI 10.1186/ar114; Trembath R. C., 2001, Journal of Heart and Lung Transplantation, V20, P175, DOI 10.1016/S1053-2498(00)00352-1; Trembath RC, 2001, NEW ENGL J MED, V345, P325, DOI 10.1056/NEJM200108023450503; Tuder RM, 2007, CLIN CHEST MED, V28, P23, DOI 10.1016/j.ccm.2006.11.010; Uhl M, 2004, CANCER RES, V64, P7954, DOI 10.1158/0008-5472.CAN-04-1013; Upton PD, 2008, MOL PHARMACOL, V73, P539, DOI 10.1124/mol.107.041673; Valdimarsdottir G, 2002, CIRCULATION, V106, P2263, DOI 10.1161/01.CIR.0000033830.36431.46; van den Driesche S, 2003, CARDIOVASC RES, V58, P20, DOI 10.1016/S0008-6363(02)00852-0; Verrecchia F, 2001, ONCOGENE, V20, P3332, DOI 10.1038/sj.onc.1204448; Yu Y, 2004, P NATL ACAD SCI USA, V101, P8005, DOI 10.1073/pnas.0402551101; YUE TL, 1994, CIRC RES, V75, P1, DOI 10.1161/01.RES.75.1.1	50	146	155	2	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15794	15804		10.1074/jbc.M109.002881	http://dx.doi.org/10.1074/jbc.M109.002881			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19366699	Green Published, hybrid			2022-12-27	WOS:000266501000048
J	Watzlich, D; Brocker, MJ; Uliczka, F; Ribbe, M; Virus, S; Jahn, D; Moser, J				Waetzlich, Denise; Broecker, Markus J.; Uliczka, Frank; Ribbe, Markus; Virus, Simone; Jahn, Dieter; Moser, Juergen			Chimeric Nitrogenase-like Enzymes of (Bacterio)chlorophyll Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							OPERATIVE PROTOCHLOROPHYLLIDE OXIDOREDUCTASE; RHODOBACTER-CAPSULATUS; KLEBSIELLA-PNEUMONIAE; BACTERIOCHLOROPHYLL BIOSYNTHESIS; AZOTOBACTER-VINELANDII; CHLOROBIUM-TEPIDUM; CROSS-REACTIONS; IRON PROTEIN; MOFE-PROTEIN; FE PROTEIN	Nitrogenase-like light-independent protochlorophyllide oxidoreductase (DPOR) is involved in chlorophyll biosynthesis. Bacteriochlorophyll formation additionally requires the structurally related chlorophyllide oxidoreductase (COR). During catalysis, homodimeric subunit BchL(2) or ChlL(2) of DPOR transfers electrons to the corresponding heterotetrameric catalytic subunit, (BchNB)(2) or (ChlNB)(2). Analogously, subunit BchX(2) of the COR enzymes delivers electrons to subunit (BchYZ)(2). Various chimeric DPOR enzymes formed between recombinant subunits (BchNB)(2) and BchL(2) from Chlorobaculum tepidum or (ChlNB)(2) and ChlL(2) from Prochlorococcus marinus and Thermosynechococcus elongatus were found to be enzymatically active, indicating a conserved docking surface for the interaction of both DPOR protein subunits. Biotin label transfer experiments revealed the interaction of P. marinus ChlL(2) with both subunits, ChlN and ChlB, of the (ChlNB)(2) tetramer. Based on these findings and on structural information from the homologous nitrogenase system, a site-directed mutagenesis approach yielded 10 DPOR mutants for the characterization of amino acid residues involved in protein-protein interaction. Surface-exposed residues Tyr(127) of subunit ChlL, Leu(70) and Val(107) of subunit ChlN, and Gly(66) of subunit ChlB were found essential for P. marinus DPOR activity. Next, the BchL(2) or ChlL(2) part of DPOR was exchanged with electron-transferring BchX(2) subunits of COR and NifH(2) of nitrogenase. Active chimeric DPOR was generated via a combination of BchX(2) from C. tepidum or Roseobacter denitrificans with (BchNB)(2) from C. tepidum. No DPOR activity was observed for the chimeric enzyme consisting of NifH(2) from Azotobacter vinelandii in combination with (BchNB)(2) from C. tepidum or (ChlNB)(2) from P. marinus and T. elongatus, respectively.	[Waetzlich, Denise; Broecker, Markus J.; Uliczka, Frank; Virus, Simone; Jahn, Dieter; Moser, Juergen] Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, D-38106 Braunschweig, Germany; [Ribbe, Markus] Univ Calif Irvine, Dept Mol Biol & Biochem, Irvine, CA 92697 USA	Braunschweig University of Technology; University of California System; University of California Irvine	Moser, J (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Inst Microbiol, Spielmannstr 7, D-38106 Braunschweig, Germany.	j.moser@tu-bs.de		Jahn, Dieter/0000-0002-4064-9205	Deutsche Forschungsgemeinschaft	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by grants from the Deutsche Forschungsgemeinschaft.	BIGGINS DR, 1971, EUR J BIOCHEM, V20, P140, DOI 10.1111/j.1432-1033.1971.tb01371.x; BOLLIVAR DW, 1994, J MOL BIOL, V237, P622, DOI 10.1006/jmbi.1994.1260; Brocker MJ, 2008, J BIOL CHEM, V283, P29873, DOI 10.1074/jbc.M805206200; Brocker MJ, 2008, J BIOL CHEM, V283, P10559, DOI 10.1074/jbc.M708010200; BURKE DH, 1993, P NATL ACAD SCI USA, V90, P7134, DOI 10.1073/pnas.90.15.7134; BURKE DH, 1993, J BACTERIOL, V175, P2407, DOI 10.1128/JB.175.8.2407-2413.1993; Burris RH, 1971, CHEMISTRY BIOCHEMIST, P105; Bursey EH, 1998, J BIOL CHEM, V273, P29678, DOI 10.1074/jbc.273.45.29678; Chiu HJ, 2001, BIOCHEMISTRY-US, V40, P641, DOI 10.1021/bi001645e; DEAN DR, 1993, J BACTERIOL, V175, P6737, DOI 10.1128/jb.175.21.6737-6744.1993; EADY RR, 1974, NATURE, V249, P805, DOI 10.1038/249805a0; EMERICH DW, 1978, J BACTERIOL, V134, P936, DOI 10.1128/JB.134.3.936-943.1978; Fujita Y, 2000, J BIOL CHEM, V275, P23583, DOI 10.1074/jbc.M002904200; FUJITA Y, 1993, PLANT CELL PHYSIOL, V34, P305; GEORGIADIS MM, 1992, SCIENCE, V257, P1653, DOI 10.1126/science.1529353; Hu YL, 2006, P NATL ACAD SCI USA, V103, P17125, DOI 10.1073/pnas.0602651103; Jang SB, 2000, BIOCHEMISTRY-US, V39, P14745, DOI 10.1021/bi001705g; KELLY M, 1969, BIOCHIM BIOPHYS ACTA, V191, P527, DOI 10.1016/0005-2744(69)90346-5; Kim EJ, 2008, J BIOL CHEM, V283, P3718, DOI 10.1074/jbc.M707774200; LOVENBERG W, 1963, J BIOL CHEM, V238, P3899; MAY HD, 1991, BIOCHEM J, V277, P457, DOI 10.1042/bj2770457; MCFEETERS RF, 1971, PLANT PHYSIOL, V47, P609, DOI 10.1104/pp.47.5.609; MOORE LR, 1995, MAR ECOL PROG SER, V116, P259, DOI 10.3354/meps116259; Moss G P, 1988, Eur J Biochem, V178, P277, DOI 10.1111/j.1432-1033.1988.tb14453.x; MURPHY PM, 1971, BIOCHIM BIOPHYS ACTA, V253, P295, DOI 10.1016/0005-2728(71)90257-X; Nakamura Y, 2002, DNA RES, V9, P123, DOI 10.1093/dnares/9.4.123; Nomata J, 2008, FEBS LETT, V582, P1346, DOI 10.1016/j.febslet.2008.03.018; Nomata J, 2006, J BIOL CHEM, V281, P15021, DOI 10.1074/jbc.M601750200; PETERS JW, 1995, ANNU REV MICROBIOL, V49, P335, DOI 10.1146/annurev.mi.49.100195.002003; Rees D. C., 2005, PHILOS T A, V363; Rees DC, 2005, PHILOS T R SOC A, V363, P971, DOI 10.1098/rsta.2004.1539; Roe SM, 1997, ACTA CRYSTALLOGR D, V53, P227, DOI 10.1107/S0907444996012681; Rost B, 2004, NUCLEIC ACIDS RES, V32, pW321, DOI 10.1093/nar/gkh377; Sambrook J., 2001, MOL CLONING LAB MANU; Sarma R, 2008, BIOCHEMISTRY-US, V47, P13004, DOI 10.1021/bi801058r; Schindelin N, 1997, NATURE, V387, P370, DOI 10.1038/387370a0; Schmid B, 2002, BIOCHEMISTRY-US, V41, P15557, DOI 10.1021/bi026642b; SMITH BE, 1976, BIOCHEM J, V157, P439, DOI 10.1042/bj1570439; Suzuki JY, 1997, ANNU REV GENET, V31, P61, DOI 10.1146/annurev.genet.31.1.61; Tezcan FA, 2005, SCIENCE, V309, P1377, DOI 10.1126/science.1115653; WAHLUND TM, 1993, J BACTERIOL, V175, P474, DOI 10.1128/JB.175.2.474-478.1993; WHERLAND S, 1981, BIOCHEMISTRY-US, V20, P5132, DOI 10.1021/bi00521a006	42	26	26	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15530	15540		10.1074/jbc.M901331200	http://dx.doi.org/10.1074/jbc.M901331200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19336405	hybrid, Green Published			2022-12-27	WOS:000266501000021
J	Zhang, ZH; Xu, XH; Zhang, Y; Zhou, JF; Yu, ZW; He, C				Zhang, Zhaohuan; Xu, Xiaohui; Zhang, Yong; Zhou, Jianfeng; Yu, Zhongwang; He, Cheng			LINGO-1 Interacts with WNK1 to Regulate Nogo-induced Inhibition of Neurite Extension	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MYELIN-ASSOCIATED GLYCOPROTEIN; RECEPTOR FAMILY-MEMBER; PROTEIN-KINASE; OUTGROWTH INHIBITOR; CL-COTRANSPORTER; CELL-ADHESION; RHO; IDENTIFICATION; REGENERATION; EXPRESSION	LINGO-1 is a component of the tripartite receptor complexes, which act as a convergent mediator of the intracellular signaling in response to myelin-associated inhibitors and lead to collapse of growth cone and inhibition of neurite extension. Although the function of LINGO-1 has been intensively studied, its downstream signaling remains elusive. In the present study, a novel interaction between LINGO-1 and a serine-threonine kinase WNK1 was identified by yeast two-hybrid screen. The interaction was further validated by fluorescence resonance energy transfer and co-immunoprecipitation, and this interaction was intensified by Nogo66 treatment. Morphological evidences showed that WNK1 and LINGO-1 were co-localized in cortical neurons. Furthermore, either suppressing WNK1 expression by RNA interference or overexpression of WNK1-(123-510) attenuated Nogo66-induced inhibition of neurite extension and inhibited the activation of RhoA. Moreover, WNK1 was identified to interact with Rho-GDI1, and this interaction was attenuated by Nogo66 treatment, further indicating its regulatory effect on RhoA activation. Taken together, our results suggest that WNK1 is a novel signaling molecule involved in regulation of LINGO-1 mediated inhibition of neurite extension.	Second Mil Med Univ, Changzheng Hosp, Neurosci Res Ctr, Minist Educ,Inst Neurosci, Shanghai 200433, Peoples R China; Second Mil Med Univ, Changzheng Hosp, Neurosci Res Ctr, Minist Educ,Key Lab Mol Neurobiol, Shanghai 200433, Peoples R China	Naval Medical University; Naval Medical University	He, C (corresponding author), 800 Xiangying Rd, Shanghai 200433, Peoples R China.	chenghe@smmu.edu.cn		Zhang, Zhaohuan/0000-0001-6882-9761	National Key Basic Research Program [2006CB500702]; Ministry of Science and Technology of China [2007CB947100]; National Natural Science Foundation [30500151, 30530240, 30770657]; National 863 Program [2006AA02A114]; Program for Changjiang Scholars and Innovative Research Team in University [IRT0528]; Shanghai Metropolitan Fund for Research and Development [07DJ14005]	National Key Basic Research Program(National Basic Research Program of China); Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); National 863 Program(National High Technology Research and Development Program of China); Program for Changjiang Scholars and Innovative Research Team in University(Program for Changjiang Scholars & Innovative Research Team in University (PCSIRT)); Shanghai Metropolitan Fund for Research and Development	This work was supported by National Key Basic Research Program 2006CB500702, Ministry of Science and Technology of China Grant 2007CB947100, National Natural Science Foundation Grants 30500151, 30530240, and 30770657, National 863 Program 2006AA02A114, Program for Changjiang Scholars and Innovative Research Team in University IRT0528, and Shanghai Metropolitan Fund for Research and Development Grant 07DJ14005	Anselmo AN, 2006, P NATL ACAD SCI USA, V103, P10883, DOI 10.1073/pnas.0604607103; Barker PA, 2004, NEURON, V42, P529, DOI 10.1016/j.neuron.2004.04.001; Barton WA, 2003, EMBO J, V22, P3291, DOI 10.1093/emboj/cdg325; BOKOCH GM, 1994, J BIOL CHEM, V269, P31674; Carim-Todd L, 2003, EUR J NEUROSCI, V18, P3167, DOI 10.1111/j.1460-9568.2003.03003.x; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Chen YN, 2006, BRAIN RES REV, V51, P265, DOI 10.1016/j.brainresrev.2005.11.005; Choate KA, 2003, P NATL ACAD SCI USA, V100, P663, DOI 10.1073/pnas.242728499; Cope G, 2005, PHARMACOL THERAPEUT, V106, P221, DOI 10.1016/j.pharmthera.2004.11.010; Dechant G, 2002, NAT NEUROSCI, V5, P1131, DOI 10.1038/nn1102-1131; Delaloy C, 2006, AM J PATHOL, V169, P105, DOI 10.2353/ajpath.2006.051290; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; Erickson MG, 2003, NEURON, V39, P97, DOI 10.1016/S0896-6273(03)00395-7; Fournier AE, 2003, J NEUROSCI, V23, P1416, DOI 10.1523/JNEUROSCI.23-04-01416.2003; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Fu G, 2006, BIOCHEM BIOPH RES CO, V351, P847, DOI 10.1016/j.bbrc.2006.10.127; Fu Y, 2006, AM J PHYSIOL-RENAL, V290, pF1305, DOI 10.1152/ajprenal.00391.2005; Golbang AP, 2005, HYPERTENSION, V46, P295, DOI 10.1161/01.HYP.0000174326.96918.d6; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; Harrington AW, 2008, J BIOL CHEM, V283, P24690, DOI 10.1074/jbc.M802188200; Hong CB, 2007, P NATL ACAD SCI USA, V104, P10974, DOI 10.1073/pnas.0700683104; Inoue H, 2007, P NATL ACAD SCI USA, V104, P14430, DOI 10.1073/pnas.0700901104; Ji B, 2006, MOL CELL NEUROSCI, V33, P311, DOI 10.1016/j.mcn.2006.08.003; Kahle KT, 2008, ANNU REV PHYSIOL, V70, P329, DOI 10.1146/annurev.physiol.70.113006.100651; Kahle KT, 2006, PHYSIOLOGY, V21, P326, DOI 10.1152/physiol.00015.2006; Lehmann M, 1999, J NEUROSCI, V19, P7537, DOI 10.1523/JNEUROSCI.19-17-07537.1999; Liu BP, 2002, SCIENCE, V297, P1190, DOI 10.1126/science.1073031; Llorens F, 2008, DEV NEUROBIOL, V68, P521, DOI 10.1002/dneu.20607; MCKERRACHER L, 1994, NEURON, V13, P805, DOI 10.1016/0896-6273(94)90247-X; Mi S, 2005, NAT NEUROSCI, V8, P745, DOI 10.1038/nn1460; Mi S, 2004, NAT NEUROSCI, V7, P221, DOI 10.1038/nn1188; Mi S, 2007, NAT MED, V13, P1228, DOI 10.1038/nm1664; Min XS, 2004, STRUCTURE, V12, P1303, DOI 10.1016/j.str.2004.04.014; Mosyak L, 2006, J BIOL CHEM, V281, P36378, DOI 10.1074/jbc.M607314200; MUKHOPADHYAY G, 1994, NEURON, V13, P757, DOI 10.1016/0896-6273(94)90042-6; Niederost B, 2002, J NEUROSCI, V22, P10368; Niederost BP, 1999, J NEUROSCI, V19, P8979, DOI 10.1523/JNEUROSCI.19-20-08979.1999; Olofsson B, 1999, CELL SIGNAL, V11, P545, DOI 10.1016/S0898-6568(98)00063-1; Park JB, 2005, NEURON, V45, P345, DOI 10.1016/j.neuron.2004.12.040; Prinjha R, 2000, NATURE, V403, P383, DOI 10.1038/35000287; Qiu J, 2000, GLIA, V29, P166, DOI 10.1002/(SICI)1098-1136(20000115)29:2<166::AID-GLIA10>3.0.CO;2-G; Ren XD, 1999, EMBO J, V18, P578, DOI 10.1093/emboj/18.3.578; Richardson C, 2008, J CELL SCI, V121, P675, DOI 10.1242/jcs.025312; Schmidt A, 2002, GENE DEV, V16, P1587, DOI 10.1101/gad.1003302; Shao ZH, 2005, NEURON, V45, P353, DOI 10.1016/j.neuron.2004.12.050; Shekarabi M, 2008, J CLIN INVEST, V118, P2496, DOI 10.1172/JCI34088; Stephens P, 2005, NAT GENET, V37, P590, DOI 10.1038/ng1571; Sun XT, 2006, J NEUROCHEM, V99, P1114, DOI 10.1111/j.1471-4159.2006.04159.x; Verissimo F, 2006, ONCOGENE, V25, P4172, DOI 10.1038/sj.onc.1209449; Verissimo F, 2001, ONCOGENE, V20, P5562, DOI 10.1038/sj.onc.1204726; Wade JB, 2006, P NATL ACAD SCI USA, V103, P8558, DOI 10.1073/pnas.0603109103; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Wang KC, 2002, NATURE, V417, P941, DOI 10.1038/nature00867; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Xie J, 2006, PEDIATR NEPHROL, V21, P1231, DOI 10.1007/s00467-006-0106-6; Xu BE, 2005, P NATL ACAD SCI USA, V102, P10315, DOI 10.1073/pnas.0504422102; Xu BE, 2005, CELL RES, V15, P6, DOI 10.1038/sj.cr.7290256; Xu BE, 2004, J BIOL CHEM, V279, P7826, DOI 10.1074/jbc.M313465200; Xu BE, 2000, J BIOL CHEM, V275, P16795, DOI 10.1074/jbc.275.22.16795; Xu XH, 2006, J CELL SCI, V119, P452, DOI 10.1242/jcs.02750; Yamashita T, 2003, NAT NEUROSCI, V6, P461, DOI 10.1038/nn1045; Yang CL, 2007, J CLIN INVEST, V117, P3403, DOI 10.1172/JCI32033; Zalcman G, 1999, Prog Mol Subcell Biol, V22, P85; ZHANG F, 2008, MOL IMAGING IN PRESS; Zhang Y, 2006, J CELL SCI, V119, P1666, DOI 10.1242/jcs.02845; Zhang Y, 2004, J MOL BIOL, V343, P1147, DOI 10.1016/j.jmb.2004.08.072	67	46	51	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15717	15728		10.1074/jbc.M808751200	http://dx.doi.org/10.1074/jbc.M808751200			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19363035	Green Published, hybrid			2022-12-27	WOS:000266501000041
J	Dumas, JF; Argaud, L; Cottet-Rousselle, C; Vial, G; Gonzalez, C; Detaille, D; Leverve, X; Fontaine, E				Dumas, Jean Francois; Argaud, Laurent; Cottet-Rousselle, Cecile; Vial, Guillaume; Gonzalez, Cecile; Detaille, Dominique; Leverve, Xavier; Fontaine, Eric			Effect of Transient and Permanent Permeability Transition Pore Opening on NAD(P)H Localization in Intact Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLOPHILIN-D; BAX TRANSLOCATION; CYTOSOLIC NAD(+); MITOCHONDRIAL; DEATH; RELEASE; CALCIUM	To study the effect of mitochondrial permeability transition pore (PTP) opening on NAD(P)H localization, intact cells were exposed to the Ca2+ ionophore A23187. PTP opening, mitochondrial membrane potential, mitochondrial volume, and NAD(P)H localization were assessed by time-lapse laser confocal microscopy using the calcein-cobalt technique, tetramethylrhodamine methyl ester, MitoTracker, and NAD(P)H auto-fluorescence, respectively. Concomitant with PTP opening, NAD(P)H fluorescence increased outside mitochondria. These events occurred in all cells and were prevented by cyclosporin A. Mitochondrial membrane potential was not systematically collapsed, whereas mitochondrial volume did not change, confirming that A23187 induced transient PTP opening in a subpopulation of cells and suggesting that mitochondrial swelling did not immediately occur after PTP opening in intact cells. NAD(P)H autofluorescence remained elevated after PTP opening, particularly after membrane potential had been collapsed by an uncoupler. Extraction of nucleotide for NAD(P)H quantification confirmed that PTP opening led to an increase in NAD(P)H content. Because the oxygen consumption rate decreased, whereas the lactate/pyruvate ratio increased after PTP opening in intact cells, we conclude that PTP opening inhibits respiration and dramatically affects the cytosolic redox potential in intact cells.	[Dumas, Jean Francois; Argaud, Laurent; Cottet-Rousselle, Cecile; Vial, Guillaume; Gonzalez, Cecile; Detaille, Dominique; Leverve, Xavier; Fontaine, Eric] Univ Grenoble 1, INSERM, U884, F-38041 Grenoble, France; [Dumas, Jean Francois; Argaud, Laurent; Cottet-Rousselle, Cecile; Vial, Guillaume; Gonzalez, Cecile; Detaille, Dominique; Leverve, Xavier; Fontaine, Eric] Univ Grenoble 1, Lab Bioenerget Fondamentale & Appl, F-38041 Grenoble, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Fontaine, E (corresponding author), Univ Grenoble 1, INSERM, U884, BP 53, F-38041 Grenoble, France.	eric.fontaine@ujf-grenoble.fr	Fontaine, Eric/ABA-8853-2020; Dumas, Jean-François/AAN-5035-2020; Dumas, Jean-François/S-7486-2017	Fontaine, Eric/0000-0002-5204-9477; Dumas, Jean-François/0000-0002-2293-6606; Dumas, Jean-François/0000-0002-2293-6606; COTTET-ROUSSELLE, Cecile/0000-0003-1208-8911; Vial, Guillaume/0000-0002-7333-8526	INSERM; Agence Nationale de la Recherche (PTPischemia); Ministere de l'Enseignement de la Recherche et de la Technologie; Nestle; AGIR a dom	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Agence Nationale de la Recherche (PTPischemia)(French National Research Agency (ANR)); Ministere de l'Enseignement de la Recherche et de la Technologie; Nestle(Nestle SA); AGIR a dom	This work was supported by grants from INSERM, Agence Nationale de la Recherche (PTPischemia), and the Ministere de l'Enseignement de la Recherche et de la Technologie.; Supported by fellowships from Nestle and AGIR a dom.	Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; Batandier C, 2004, J BIOL CHEM, V279, P17197, DOI 10.1074/jbc.M310329200; Bergmeyer HU, 1974, METHODS ENZYMATIC AN; Bernardi P, 2006, FEBS J, V273, P2077, DOI 10.1111/j.1742-4658.2006.05213.x; BERRY MN, 1969, J CELL BIOL, V43, P506, DOI 10.1083/jcb.43.3.506; Blinova K, 2005, BIOCHEMISTRY-US, V44, P2585, DOI 10.1021/bi0485124; CROMPTON M, 1987, BIOCHEM J, V245, P915, DOI 10.1042/bj2450915; De Giorgi F, 2002, FASEB J, V16, P607, DOI 10.1096/fj.01-0269fje; Detaille D, 2005, DIABETES, V54, P2179, DOI 10.2337/diabetes.54.7.2179; Devin A, 1997, FEBS LETT, V410, P329, DOI 10.1016/S0014-5793(97)00612-1; Di Lisa F, 2001, J BIOL CHEM, V276, P2571, DOI 10.1074/jbc.M006825200; Elmore SP, 2004, ARCH BIOCHEM BIOPHYS, V422, P145, DOI 10.1016/j.abb.2003.12.031; Fontaine E, 1998, J BIOL CHEM, V273, P12662, DOI 10.1074/jbc.273.20.12662; Friberg H, 1998, J NEUROSCI, V18, P5151, DOI 10.1523/JNEUROSCI.18-14-05151.1998; GROEN AK, 1982, EUR J BIOCHEM, V122, P87, DOI 10.1111/j.1432-1033.1982.tb05851.x; HAWORTH RA, 1979, ARCH BIOCHEM BIOPHYS, V195, P460, DOI 10.1016/0003-9861(79)90372-2; Huser J, 1999, BIOCHEM J, V343, P311, DOI 10.1042/0264-6021:3430311; Koopman WJH, 2008, METHODS, V46, P304, DOI 10.1016/j.ymeth.2008.09.018; MASSARI S, 1972, BIOCHIM BIOPHYS ACTA, V238, P23, DOI 10.1016/0005-2728(72)90094-1; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; NIEMINEN AL, 1995, BIOCHEM J, V307, P99, DOI 10.1042/bj3070099; Palmieri F, 2004, PFLUG ARCH EUR J PHY, V447, P689, DOI 10.1007/s00424-003-1099-7; PETRONILLI V, 1994, BBA-BIOENERGETICS, V1187, P255, DOI 10.1016/0005-2728(94)90122-8; Petronilli V, 1999, BIOPHYS J, V76, P725, DOI 10.1016/S0006-3495(99)77239-5; Petronilli V, 2001, J BIOL CHEM, V276, P12030, DOI 10.1074/jbc.M010604200; Precht TA, 2005, CELL DEATH DIFFER, V12, P255, DOI 10.1038/sj.cdd.4401552; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; VINOGRADOV A, 1972, ARCH BIOCHEM BIOPHYS, V152, P646, DOI 10.1016/0003-9861(72)90261-5; ZORATTI M, 1995, BBA-REV BIOMEMBRANES, V1241, P139, DOI 10.1016/0304-4157(95)00003-A; Zorov DB, 2000, J EXP MED, V192, P1001, DOI 10.1084/jem.192.7.1001; Zuurendonk P F, 1979, Methods Enzymol, V56, P207	31	42	43	0	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					15117	15125		10.1074/jbc.M900926200	http://dx.doi.org/10.1074/jbc.M900926200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19346250	hybrid, Green Published			2022-12-27	WOS:000266288200047
J	Rangaswami, H; Marathe, N; Zhuang, SH; Chen, YC; Yeh, JC; Frangos, JA; Boss, GR; Pilz, RB				Rangaswami, Hema; Marathe, Nisha; Zhuang, Shunhui; Chen, Yongchang; Yeh, Jiunn-Chern; Frangos, John A.; Boss, Gerry R.; Pilz, Renate B.			Type II cGMP-dependent Protein Kinase Mediates Osteoblast Mechanotransduction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NITRIC-OXIDE SYNTHASE; FLUID SHEAR-STRESS; REQUIRES NUCLEAR TRANSLOCATION; INCREASES BONE-FORMATION; C-FOS EXPRESSION; GENE-EXPRESSION; CYCLIC-GMP; SIGNAL-TRANSDUCTION; HYPERTROPHIC DIFFERENTIATION; TRANSCRIPTIONAL REGULATION	Continuous bone remodeling in response to mechanical loading is critical for skeletal integrity, and interstitial fluid flow is an important stimulus for osteoblast/osteocyte growth and differentiation. However, the biochemical signals mediating osteoblast anabolic responses to mechanical stimulation are incompletely understood. In primary human osteoblasts and murine MC3T3-E1 cells, we found that fluid shear stress induced rapid expression of c-fos, fra-1, fra-2, and fosB/Delta fosB mRNAs; these genes encode transcriptional regulators that maintain skeletal integrity. Fluid shear stress increased osteoblast nitric oxide (NO) synthesis, leading to activation of cGMP-dependent protein kinase (PKG). Pharmacological inhibition of the NO/cGMP/PKG signaling pathway blocked shear-induced expression of all four fos family genes. Induction of these genes required signaling through MEK/Erk, and Erk activation was NO/cGMP/PKG-dependent. Treating cells with a membrane-permeable cGMP analog partly mimicked the effects of fluid shear stress on Erk activity and fos family gene expression. In cells transfected with small interfering RNAs (siRNA) specific for membrane-bound PKG II, shear- and cGMP-induced Erk activation and fos family gene expression was nearly abolished and could be restored by transducing cells with a virus encoding an siRNA-resistant form of PKG II; in contrast, siRNA-mediated repression of the more abundant cytosolic PKG I isoform was without effect. Thus, we report a novel function for PKG II in osteoblast mechanotransduction, and we propose a model wherebyNO/cGMP/PKGII-mediated Erk activation and induction of c-fos, fra-1, fra-2, and fosB/Delta fosB play a key role in the osteoblast anabolic response to mechanical stimulation.	[Boss, Gerry R.; Pilz, Renate B.] Univ Calif San Diego, Dept Med & Canc Ctr, La Jolla, CA 92093 USA; [Yeh, Jiunn-Chern; Frangos, John A.] La Jolla Bioengn Inst, La Jolla, CA 92037 USA	University of California System; University of California San Diego; La Jolla Bioengineering Institute	Pilz, RB (corresponding author), Univ Calif San Diego, Dept Med & Canc Ctr, La Jolla, CA 92093 USA.	rpilz@ucsd.edu		Boss, Gerry/0000-0002-9758-8714	National Institutes of Health [R01-AR051300]; Training [T32-HL007261]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051300, R01AR046797] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Training; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported, in whole or in part, by National Institutes of Health Grant R01-AR051300 (to R. B. P., H. R., S. Z., and J.-C.Y.) and Training Grant T32-HL007261 (to N.M.).	Adiseshaiah P, 2005, ONCOGENE, V24, P4193, DOI 10.1038/sj.onc.1208583; Adiseshaiah P, 2003, J BIOL CHEM, V278, P47423, DOI 10.1074/jbc.M303505200; Adiseshaiah P, 2008, BIOCHEM BIOPH RES CO, V371, P304, DOI 10.1016/j.bbrc.2008.04.063; Aguirre J, 2001, AM J PATHOL, V158, P247, DOI 10.1016/S0002-9440(10)63963-6; Ajubi NE, 1999, AM J PHYSIOL-ENDOC M, V276, pE171, DOI 10.1152/ajpendo.1999.276.1.E171; Armour KE, 2001, ENDOCRINOLOGY, V142, P760, DOI 10.1210/en.142.2.760; Bacabac RG, 2004, BIOCHEM BIOPH RES CO, V315, P823, DOI 10.1016/j.bbrc.2004.01.138; Bakker AD, 2001, J BIOMECH, V34, P671, DOI 10.1016/S0021-9290(00)00231-1; Bergula AP, 2004, BONE, V34, P562, DOI 10.1016/j.bone.2003.11.025; Boo YC, 2003, AM J PHYSIOL-CELL PH, V285, pC499, DOI 10.1152/ajpcell.00122.2003; Broderick KE, 2007, MOL ENDOCRINOL, V21, P1148, DOI 10.1210/me.2005-0389; Casteel DE, 2002, J BIOL CHEM, V277, P32003, DOI 10.1074/jbc.M112332200; Chae HJ, 1997, J PHARM PHARMACOL, V49, P897, DOI 10.1111/j.2042-7158.1997.tb06132.x; Chen NX, 2000, AM J PHYSIOL-CELL PH, V278, pC989, DOI 10.1152/ajpcell.2000.278.5.C989; Chen YC, 2003, MOL CELL BIOL, V23, P4066, DOI 10.1128/MCB.23.12.4066-4082.2003; Chikuda H, 2005, J BONE MINER METAB, V23, P200, DOI 10.1007/s00774-004-0598-8; Chikuda H, 2004, GENE DEV, V18, P2418, DOI 10.1101/gad.1224204; Chow JWM, 1998, J BONE MINER RES, V13, P1039, DOI 10.1359/jbmr.1998.13.6.1039; D'Alonzo RC, 2002, J BIOL CHEM, V277, P816, DOI 10.1074/jbc.M107082200; Demiralp B, 2002, ENDOCRINOLOGY, V143, P4038, DOI 10.1210/en.2002-220221; Donahue SW, 2003, J BIOMECH, V36, P35, DOI 10.1016/S0021-9290(02)00318-4; Eferl R, 2004, EMBO J, V23, P2789, DOI 10.1038/sj.emboj.7600282; Ehrlich PJ, 2002, OSTEOPOROSIS INT, V13, P688, DOI 10.1007/s001980200095; Fitzgerald J, 1999, FASEB J, V13, P553, DOI 10.1096/fasebj.13.3.553; Fleming I, 2003, AM J PHYSIOL-REG I, V284, pR1, DOI 10.1152/ajpregu.00323.2002; Fox SW, 1996, AM J PHYSIOL-ENDOC M, V270, pE955, DOI 10.1152/ajpendo.1996.270.6.E955; Gallagher JA, 2003, METH MOLEC MED, V80, P3; GAMM DM, 1995, J BIOL CHEM, V270, P27380, DOI 10.1074/jbc.270.45.27380; Gille H, 1996, MOL CELL BIOL, V16, P1094; Granet C, 2002, CELL SIGNAL, V14, P679, DOI 10.1016/S0898-6568(02)00008-6; GRIGORIADIS AE, 1993, J CELL BIOL, V122, P685, DOI 10.1083/jcb.122.3.685; Gudi S, 1998, P NATL ACAD SCI USA, V95, P2515, DOI 10.1073/pnas.95.5.2515; Gudi T, 2000, ONCOGENE, V19, P6324, DOI 10.1038/sj.onc.1204007; Gudi T, 1996, J BIOL CHEM, V271, P4597; Gudi T, 1997, MOL CELL BIOL, V17, P5244, DOI 10.1128/MCB.17.9.5244; Gudi T, 1999, FASEB J, V13, P2143, DOI 10.1096/fasebj.13.15.2143; Hatton JP, 2003, J BONE MINER RES, V18, P58, DOI 10.1359/jbmr.2003.18.1.58; Hazzalin CA, 2002, NAT REV MOL CELL BIO, V3, P30, DOI 10.1038/nrm715; Hikiji H, 1997, FEBS LETT, V410, P238, DOI 10.1016/S0014-5793(97)00597-8; HILLSLEY MV, 1994, BIOTECHNOL BIOENG, V43, P573, DOI 10.1002/bit.260430706; Hughes-Fulford Millie, 2004, Sci STKE, V2004, pRE12; Idriss SD, 1999, J BIOL CHEM, V274, P9489, DOI 10.1074/jbc.274.14.9489; Inoue D, 2004, J BIOL CHEM, V279, P49795, DOI 10.1074/jbc.M404096200; Jacobs CR, 1998, J BIOMECH, V31, P969, DOI 10.1016/S0021-9290(98)00114-6; Jamal SA, 2004, J BONE MINER RES, V19, P1512, DOI 10.1359/JBMR.040716; JARCHAU T, 1994, P NATL ACAD SCI USA, V91, P9426, DOI 10.1073/pnas.91.20.9426; Jiang GL, 2002, AM J PHYSIOL-ENDOC M, V283, pE383, DOI 10.1152/ajpendo.00547.2001; Jochum W, 2000, NAT MED, V6, P980, DOI 10.1038/79676; Johnson DL, 1996, AM J PHYSIOL-ENDOC M, V271, pE205, DOI 10.1152/ajpendo.1996.271.1.E205; Kapur S, 2003, BONE, V32, P241, DOI 10.1016/S8756-3282(02)00979-1; Kawasaki Y, 2008, J CLIN INVEST, V118, P2506, DOI 10.1172/JCI35243; Kenner L, 2004, J CELL BIOL, V164, P613, DOI 10.1083/jcb.200308155; Klein-Nulend J, 1998, BIOCHEM BIOPH RES CO, V250, P108, DOI 10.1006/bbrc.1998.9270; Kletsas D, 2002, J CELL PHYSIOL, V190, P313, DOI 10.1002/jcp.10052; KUCHAN MJ, 1994, AM J PHYSIOL, V267, pC753, DOI 10.1152/ajpcell.1994.267.3.C753; Lai CF, 2001, J BIOL CHEM, V276, P14443, DOI 10.1074/jbc.M010021200; Lean JM, 1996, AM J PHYSIOL-ENDOC M, V270, pE937, DOI 10.1152/ajpendo.1996.270.6.E937; LIAN JB, 1998, J CELL BIOCHEM, V30, pS62; Liu DW, 2008, BONE, V42, P644, DOI 10.1016/j.bone.2007.09.058; MacPherson H, 1999, BONE, V24, P179, DOI 10.1016/S8756-3282(98)00173-2; Mancini L, 2000, BIOCHEM BIOPH RES CO, V274, P477, DOI 10.1006/bbrc.2000.3164; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; McAllister TN, 1999, J BONE MINER RES, V14, P930, DOI 10.1359/jbmr.1999.14.6.930; McCabe LR, 1996, ENDOCRINOLOGY, V137, P4398, DOI 10.1210/en.137.10.4398; Moalli MR, 2000, J BONE MINER RES, V15, P1346, DOI 10.1359/jbmr.2000.15.7.1346; Munzel T, 2003, CIRCULATION, V108, P2172, DOI 10.1161/01.CIR.0000094403.78467.C3; Murakami M, 1999, CELL GROWTH DIFFER, V10, P333; Naruse K, 2003, J BONE MINER RES, V18, P360, DOI 10.1359/jbmr.2003.18.2.360; Ogasawara A, 2001, J BIOL CHEM, V276, P7048, DOI 10.1074/jbc.M008070200; Orr AW, 2006, DEV CELL, V10, P11, DOI 10.1016/j.devcel.2005.12.006; Pavalko FM, 1998, AM J PHYSIOL-CELL PH, V275, pC1591; Peake MA, 2000, J APPL PHYSIOL, V89, P2498, DOI 10.1152/jappl.2000.89.6.2498; Pfeifer A, 1996, SCIENCE, V274, P2082, DOI 10.1126/science.274.5295.2082; Pfeifer A, 1998, EMBO J, V17, P3045, DOI 10.1093/emboj/17.11.3045; PILZ RB, 1995, FASEB J, V9, P552, DOI 10.1096/fasebj.9.7.7737465; RAABCULLEN DM, 1994, CALCIFIED TISSUE INT, V55, P473, DOI 10.1007/BF00298562; Rubin J, 2006, GENE, V367, P1, DOI 10.1016/j.gene.2005.10.028; RUTHER U, 1987, NATURE, V325, P412, DOI 10.1038/325412a0; Sabatakos G, 2000, NAT MED, V6, P985, DOI 10.1038/79683; Schlossmann J, 2005, FRONT BIOSCI-LANDMRK, V10, P1279, DOI 10.2741/1618; Serulle Y, 2007, NEURON, V56, P670, DOI 10.1016/j.neuron.2007.09.016; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; Smolenski A, 1998, J BIOL CHEM, V273, P20029, DOI 10.1074/jbc.273.32.20029; Stevens HY, 2003, METH MOLEC MED, V80, P381; Sunters A, 2004, J BIOL CHEM, V279, P9882, DOI 10.1074/jbc.M310184200; Vaandrager AB, 1997, J BIOL CHEM, V272, P11816, DOI 10.1074/jbc.272.18.11816; van't Hof RJ, 2001, IMMUNOLOGY, V103, P255, DOI 10.1046/j.1365-2567.2001.01261.x; Wagner EF, 2005, IMMUNOL REV, V208, P126, DOI 10.1111/j.0105-2896.2005.00332.x; Wang HG, 2005, NEURON, V45, P389, DOI 10.1016/j.neuron.2005.01.011; Wang Y, 2000, ONCOGENE, V19, P1379, DOI 10.1038/sj.onc.1203443; Wimalawansa SJ, 1996, BONE, V18, P301, DOI 10.1016/8756-3282(96)00005-1; You J, 2001, J BIOL CHEM, V276, P13365, DOI 10.1074/jbc.M009846200; Zeng Y, 2006, J BIOL CHEM, V281, P16951, DOI 10.1074/jbc.M602099200; Zhao X, 2005, J BIOL CHEM, V280, P32683, DOI 10.1074/jbc.M505486200	94	71	78	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					14796	14808		10.1074/jbc.M806486200	http://dx.doi.org/10.1074/jbc.M806486200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19282289	Green Published, hybrid			2022-12-27	WOS:000266288200015
J	Yu, W; Lin, Y; Yao, J; Huang, W; Lei, QY; Xiong, Y; Zhao, SM; Guan, KL				Yu, Wei; Lin, Yan; Yao, Jun; Huang, Wei; Lei, Qunying; Xiong, Yue; Zhao, Shimin; Guan, Kun-Liang			Lysine 88 Acetylation Negatively Regulates Ornithine Carbamoyltransferase Activity in Response to Nutrient Signals	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCARBAMYLASE DEFICIENCY; HISTONE ACETYLTRANSFERASE; COA SYNTHETASE; ACTIVATION; MUTATIONS; SUBSTRATE; GENE; DEACETYLATION; METABOLISM; REPRESSES	Ornithine carbamoyltransferase (OTC) is a key enzyme in the urea cycle to detoxify ammonium produced from amino acid catabolism. OTC deficiency is an X-linked genetic disorder ranging from fatal in newborns to hyperammonemia and anorexia in adults. Through affinity purification of acetylated peptides and mass spectrometry, we identified that OTC is acetylated on lysine residues, including Lys(88), which is also mutated in OTC-deficient patients. OTC acetylation was confirmed to occur under physiological conditions. Biochemical characterizations revealed that OTC Lys(88) acetylation decreases the affinity for carbamoyl phosphate, one of the two OTC substrates, and the maximum velocity, whereas the Km for ornithine, the other OTC substrate, is not affected. Furthermore, Lys(88) acetylation is regulated by both extracellular glucose and amino acid availability, indicating that OTC activity may be regulated by cellular metabolic status. Our results provide an example of the novel mechanism of regulating metabolic enzyme activity through protein acetylation.	[Yu, Wei; Huang, Wei; Zhao, Shimin] Fudan Univ, Sch Life Sci, Shanghai 200032, Peoples R China; [Yu, Wei; Lin, Yan; Yao, Jun; Huang, Wei; Lei, Qunying; Xiong, Yue; Zhao, Shimin; Guan, Kun-Liang] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China; [Lei, Qunying] Fudan Univ, Sch Med, Dept Biol Chem, Shanghai 200032, Peoples R China; [Xiong, Yue] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Guan, Kun-Liang] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Guan, Kun-Liang] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	Fudan University; Fudan University; Fudan University; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California San Diego; University of California System; University of California San Diego	Zhao, SM (corresponding author), Fudan Univ, Sch Life Sci, Ming Dao Bldg 805,138 Yixue Yuan Rd, Shanghai 200032, Peoples R China.	zhaosm@fudan.edu.cn; kuguan@ucsd.edu	Lei, Qun-Ying/J-1390-2017; YU, WEI/C-3822-2012; Guan, Kun-Liang/ADK-7088-2022	Lei, Qun-Ying/0000-0002-8547-8518; YU, WEI/0000-0001-9898-4607	Chinese Ministry of Education; State Key Development Programs of Basic Research of China [2009CB918401, 2006CB806700]; National High Technology Research and Development Program of China [2006AA02A308]; Chinese National Science Foundation [30600112, 30871255]; Shanghai Key Basic Research Project [06JC14086, 07PJ14011, 08JC1400900]	Chinese Ministry of Education(Ministry of Education, China); State Key Development Programs of Basic Research of China; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); Chinese National Science Foundation(National Natural Science Foundation of China (NSFC)); Shanghai Key Basic Research Project	This work was supported by the 985 Program from the Chinese Ministry of Education, the State Key Development Programs of Basic Research of China (Grants 2009CB918401 and 2006CB806700), the National High Technology Research and Development Program of China (Grant 2006AA02A308), the Chinese National Science Foundation (Grants 30600112 and 30871255), and the Shanghai Key Basic Research Project (Grants 06JC14086, 07PJ14011, and 08JC1400900).	ALLFREY VG, 1964, P NATL ACAD SCI USA, V51, P786, DOI 10.1073/pnas.51.5.786; ARN PH, 1990, NEW ENGL J MED, V322, P1652, DOI 10.1056/NEJM199006073222307; Arranz JA, 2007, J INHERIT METAB DIS, V30, P217, DOI 10.1007/s10545-007-0429-x; Bouras T, 2005, J BIOL CHEM, V280, P10264, DOI 10.1074/jbc.M408748200; Brownell JE, 1996, CELL, V84, P843, DOI 10.1016/S0092-8674(00)81063-6; BROWNELL JE, 1995, P NATL ACAD SCI USA, V92, P6364, DOI 10.1073/pnas.92.14.6364; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Ha Y, 1997, P NATL ACAD SCI USA, V94, P9550, DOI 10.1073/pnas.94.18.9550; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; HAUSER ER, 1990, NEW ENGL J MED, V322, P1641, DOI 10.1056/NEJM199006073222305; HAYASE K, 1992, J NUTR, V122, P1143, DOI 10.1093/jn/122.5.1143; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; LERMANSAGIE T, 1995, CLIN PEDIATR, V34, P163, DOI 10.1177/000992289503400310; McCullough BA, 2000, AM J MED GENET, V93, P313, DOI 10.1002/1096-8628(20000814)93:4<313::AID-AJMG11>3.0.CO;2-M; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Oechsner M, 1998, J NEUROL NEUROSUR PS, V64, P680, DOI 10.1136/jnnp.64.5.680; PAUSCH J, 1985, EUR J BIOCHEM, V150, P189, DOI 10.1111/j.1432-1033.1985.tb09006.x; REISH O, 1993, BIOCHEM MED METAB B, V50, P169, DOI 10.1006/bmmb.1993.1058; Scaglia F, 2004, J NUTR, V134, p2775S, DOI 10.1093/jn/134.10.2775S; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Shi DS, 1998, J BIOL CHEM, V273, P34247, DOI 10.1074/jbc.273.51.34247; Shi DS, 2001, BIOCHEM J, V354, P501, DOI 10.1042/0264-6021:3540501; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Valentini G, 1996, EUR J BIOCHEM, V239, P397, DOI 10.1111/j.1432-1033.1996.0397u.x; Waltzer L, 1998, NATURE, V395, P521, DOI 10.1038/26785; Yamaguchi S, 2006, HUM MUTAT, V27, P626, DOI 10.1002/humu.20339; Yang XJ, 1996, NATURE, V382, P319, DOI 10.1038/382319a0; Ye XH, 1996, J BIOL CHEM, V271, P3639; YOSHIDA M, 1990, J BIOL CHEM, V265, P17174; Zhang JM, 2009, MOL CELL PROTEOMICS, V8, P215, DOI 10.1074/mcp.M800187-MCP200	31	45	52	0	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13669	13675		10.1074/jbc.M901921200	http://dx.doi.org/10.1074/jbc.M901921200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19318352	hybrid, Green Published			2022-12-27	WOS:000265877300044
J	Budzik, JM; Oh, SY; Schneewind, O				Budzik, Jonathan M.; Oh, So-Young; Schneewind, Olaf			Sortase D Forms the Covalent Bond That Links BcpB to the Tip of Bacillus cereus Pili	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL-WALL ANCHOR; SURFACE-PROTEINS; STAPHYLOCOCCUS-AUREUS; STREPTOCOCCUS-PYOGENES; LPXTG MOTIF; ADHESION; SUBSTRATE	Bacillus cereus and other Gram-positive bacteria elaborate pili via a sortase D-catalyzed transpeptidation mechanism from major and minor pilin precursor substrates. After cleavage of the LPXTG sorting signal of the major pilin, BcpA, sortase D forms an amide bond between the C-terminal threonine and the amino group of lysine within the YPKN motif of another BcpA subunit. Pilus assembly terminates upon sortase A cleavage of the BcpA sorting signal, resulting in a covalent bond between BcpA and the cell wall cross-bridge. Here, we show that the IPNTG sorting signal of BcpB, the minor pilin, is cleaved by sortase D but not by sortase A. The C-terminal threonine of BcpB is amide-linked to the YPKN motif of BcpA, thereby positioning BcpB at the tip of pili. Thus, unique attributes of the sorting signals of minor pilins provide Gram-positive bacteria with a universal mechanism ordering assembly of pili.	[Budzik, Jonathan M.; Oh, So-Young; Schneewind, Olaf] Univ Chicago, Dept Microbiol, Chicago, IL 60637 USA	University of Chicago	Schneewind, O (corresponding author), Univ Chicago, Dept Microbiol, 920 E 58th St, Chicago, IL 60637 USA.	oschnee@bsd.uchicago.edu			National Institutes of Health [AI38897]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153, R01AI038897] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007281] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant AI38897 (United States Public Health Service grant, to O.S.).	Abbot EL, 2007, CELL MICROBIOL, V9, P1822, DOI 10.1111/j.1462-5822.2007.00918.x; Bagnoli F, 2008, J BACTERIOL, V190, P5480, DOI 10.1128/JB.00384-08; Barocchi MA, 2006, P NATL ACAD SCI USA, V103, P2857, DOI 10.1073/pnas.0511017103; Budzik JM, 2008, P NATL ACAD SCI USA, V105, P10215, DOI 10.1073/pnas.0803565105; Budzik JM, 2007, MOL MICROBIOL, V66, P495, DOI 10.1111/j.1365-2958.2007.05939.x; Budzik JM, 2006, J CLIN INVEST, V116, P2582, DOI 10.1172/JCI30088; Budzik JM, 2008, J BIOL CHEM, V283, P36676, DOI 10.1074/jbc.M806796200; Connolly KM, 2003, J BIOL CHEM, V278, P34061, DOI 10.1074/jbc.M305245200; Dramsi S, 2005, RES MICROBIOL, V156, P289, DOI 10.1016/j.resmic.2004.10.011; Dramsi S, 2006, MOL MICROBIOL, V60, P1401, DOI 10.1111/j.1365-2958.2006.05190.x; Edwards AM, 2008, MOL MICROBIOL, V68, P1378, DOI 10.1111/j.1365-2958.2008.06220.x; Falugi F, 2008, J INFECT DIS, V198, P1834, DOI 10.1086/593176; Gaspar AH, 2005, J BACTERIOL, V187, P4646, DOI 10.1128/JB.187.13.4646-4655.2005; Hilleringmann M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000026; Huang XY, 2003, BIOCHEMISTRY-US, V42, P11307, DOI 10.1021/bi034391g; Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806; Maisey HC, 2007, J BACTERIOL, V189, P1464, DOI 10.1128/JB.01153-06; Mandlik A, 2008, P NATL ACAD SCI USA, V105, P14147, DOI 10.1073/pnas.0806350105; Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010; Mandlik A, 2007, MOL MICROBIOL, V64, P111, DOI 10.1111/j.1365-2958.2007.05630.x; Manetti AGO, 2007, MOL MICROBIOL, V64, P968, DOI 10.1111/j.1365-2958.2007.05704.x; Maresso AW, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000132; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Marraffini LA, 2005, J BIOL CHEM, V280, P16263, DOI 10.1074/jbc.M500071200; Marraffini LA, 2007, J BACTERIOL, V189, P6425, DOI 10.1128/JB.00702-07; Marraffini LA, 2006, MOL MICROBIOL, V62, P1402, DOI 10.1111/j.1365-2958.2006.05469.x; Mazmanian SK, 2002, P NATL ACAD SCI USA, V99, P2293, DOI 10.1073/pnas.032523999; Mazmanian SK, 2000, P NATL ACAD SCI USA, V97, P5510, DOI 10.1073/pnas.080520697; Mishra A, 2007, J BACTERIOL, V189, P3156, DOI 10.1128/JB.01952-06; NAVARRE WW, 1994, MOL MICROBIOL, V14, P115, DOI 10.1111/j.1365-2958.1994.tb01271.x; Nelson AL, 2007, MOL MICROBIOL, V66, P329, DOI 10.1111/j.1365-2958.2007.05908.x; Oh SY, 2008, P NATL ACAD SCI USA, V105, P13703, DOI 10.1073/pnas.0807334105; Perry AM, 2002, J BIOL CHEM, V277, P16241, DOI 10.1074/jbc.M109194200; SCHNEEWIND O, 1995, SCIENCE, V268, P103, DOI 10.1126/science.7701329; SCHNEEWIND O, 1993, EMBO J, V12, P4803, DOI 10.1002/j.1460-2075.1993.tb06169.x; Telford JL, 2006, NAT REV MICROBIOL, V4, P509, DOI 10.1038/nrmicro1443; Ton-That H, 2003, MOL MICROBIOL, V50, P1429, DOI 10.1046/j.1365-2958.2003.03782.x; Ton-That H, 2004, TRENDS MICROBIOL, V12, P228, DOI 10.1016/j.tim.2004.03.004; Ton-That H, 1999, P NATL ACAD SCI USA, V96, P12424, DOI 10.1073/pnas.96.22.12424	39	37	38	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12989	12997		10.1074/jbc.M900927200	http://dx.doi.org/10.1074/jbc.M900927200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19269972	Green Published, hybrid			2022-12-27	WOS:000265688300046
J	Kitatani, K; Sheldon, K; Rajagopalan, V; Anelli, V; Jenkins, RW; Sun, Y; Grabowski, GA; Obeid, LM; Hannun, YA				Kitatani, Kazuyuki; Sheldon, Kely; Rajagopalan, Vinodh; Anelli, Viviana; Jenkins, Russell W.; Sun, Ying; Grabowski, Gregory A.; Obeid, Lina M.; Hannun, Yusuf A.			Involvement of Acid beta-Glucosidase 1 in the Salvage Pathway of Ceramide Formation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							KINASE-C-DELTA; NOVO SPHINGOLIPID BIOSYNTHESIS; DE-NOVO; RECYCLING PATHWAYS; CANCER CELLS; SAPOSIN-C; PROTEIN; METABOLISM; SPHINGOMYELIN; SPHINGOSINE	Activation of protein kinase C (PKC) promotes the salvage pathway of ceramide formation, and acid sphingomyelinase has been implicated, in part, in providing substrate for this pathway (Zeidan, Y. H., and Hannun, Y. A. (2007) J. Biol. Chem. 282, 11549-11561). In the present study, we examined whether acid beta-glucosidase 1 (GBA1), which hydrolyzes glucosylceramide to form lysosomal ceramide, was involved in PKC-regulated formation of ceramide from recycled sphingosine. Glucosylceramide levels declined after treatment of MCF-7 cells with a potent PKC activator, phorbol 12-myristate 13-acetate (PMA). Silencing GBA1 by small interfering RNAs significantly attenuated acid glucocerebrosidase activity and decreased PMA-induced formation of ceramide by 50%. Silencing GBA1 blocked PMA-induced degradation of glucosylceramide and generation of sphingosine, the source for ceramide biosynthesis. Reciprocally, forced expression of GBA1 increased ceramide levels. These observations indicate that GBA1 activation can generate the source (sphingosine) for PMA-induced formation of ceramide through the salvage pathway. Next, the role of PKC delta, a direct effector of PMA, in the formation of ceramide was determined. By attenuating expression of PKC delta, cells failed to trigger PMA-induced alterations in levels of ceramide, sphingomyelin, and glucosylceramide. Thus, PKC delta activation is suggested to stimulate the degradation of both sphingomyelin and glucosylceramide leading to the salvage pathway of ceramide formation. Collectively, GBA1 is identified as a novel source of regulated formation of ceramide, and PKC delta is an upstream regulator of this pathway.	[Kitatani, Kazuyuki; Sheldon, Kely; Rajagopalan, Vinodh; Anelli, Viviana; Jenkins, Russell W.; Hannun, Yusuf A.] Med Univ S Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Obeid, Lina M.] Med Univ S Carolina, Dept Med, Charleston, SC 29425 USA; [Sun, Ying; Grabowski, Gregory A.] Cincinnati Childrens Hosp, Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA; [Sun, Ying; Grabowski, Gregory A.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH 45229 USA; [Obeid, Lina M.] Med Ctr, Dept Vet Affairs, Charleston, SC 29401 USA	Medical University of South Carolina; Medical University of South Carolina; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati	Hannun, YA (corresponding author), 173 Ashley Ave, Charleston, SC 29425 USA.	hannun@musc.edu	Rajagopalan, Vinodh/AAG-4769-2020; Kitatani, Kazuyuki/H-7100-2019	Kitatani, Kazuyuki/0000-0002-8516-6135; obeid, lina/0000-0002-0734-0847; ANELLI, Viviana Vittoria/0000-0003-1964-3252	National Institutes of Health [CA87584, AG01683, DK36729, C06 PR018823]; Medical Scientist Training Program training [GM08716]; Medical University of South Carolina.; NATIONAL CANCER INSTITUTE [R01CA087584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036729] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Scientist Training Program training; Medical University of South Carolina.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants CA87584 (to Y.A.H.), AG01683 (to L.M.O.), and DK36729 (to G.A.G.). This work was also supported by Medical Scientist Training Program training Grant GM08716 (to R.W.J.) and the Lipidomics Core, supported in part by National Institutes of Health Grant C06 PR018823, at the Medical University of South Carolina.	Alattia JR, 2007, P NATL ACAD SCI USA, V104, P17394, DOI 10.1073/pnas.0704998104; Becker KP, 2005, J BIOL CHEM, V280, P2606, DOI 10.1074/jbc.M409066200; BERNARDO K, 1995, J BIOL CHEM, V270, P11098, DOI 10.1074/jbc.270.19.11098; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boot RG, 2007, J BIOL CHEM, V282, P1305, DOI 10.1074/jbc.M610544200; Brodie C, 2003, APOPTOSIS, V8, P19, DOI 10.1023/A:1021640817208; Degner SC, 2006, J NUTR, V136, P421, DOI 10.1093/jn/136.2.421; DINUR T, 1986, P NATL ACAD SCI USA, V83, P1660, DOI 10.1073/pnas.83.6.1660; FABBRO D, 1991, J BIOL CHEM, V266, P15021; Futerman AH, 2005, TRENDS CELL BIOL, V15, P312, DOI 10.1016/j.tcb.2005.04.006; Futerman AH, 2004, NAT REV MOL CELL BIO, V5, P554, DOI 10.1038/nrm1423; Garzotto M, 1998, CANCER RES, V58, P2260; Gillard BK, 1998, GLYCOBIOLOGY, V8, P885, DOI 10.1093/glycob/8.9.885; Grabowski GA, 1997, BAILLIERE CLIN HAEM, V10, P635, DOI 10.1016/S0950-3536(97)80032-7; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; HANNUN YA, 1994, J BIOL CHEM, V269, P3125; Hayashi Y, 2007, J BIOL CHEM, V282, P30889, DOI 10.1074/jbc.M700832200; HECKER E, 1967, NATURWISSENSCHAFTEN, V54, P282, DOI 10.1007/BF00620887; Hollingshead BD, 2008, CANCER RES, V68, P3609, DOI 10.1158/0008-5472.CAN-07-6168; Jmoudiak M, 2005, BRIT J HAEMATOL, V129, P178, DOI 10.1111/j.1365-2141.2004.05351.x; Kitatani K, 2008, CELL SIGNAL, V20, P1010, DOI 10.1016/j.cellsig.2007.12.006; Kitatani K, 2006, J BIOL CHEM, V281, P36793, DOI 10.1074/jbc.M608137200; Kitatani K, 2009, J BIOL CHEM, V284, P12979, DOI 10.1074/jbc.M809500200; Kolter T, 2005, ANNU REV CELL DEV BI, V21, P81, DOI 10.1146/annurev.cellbio.21.122303.120013; Kolter T, 2006, BBA-BIOMEMBRANES, V1758, P2057, DOI 10.1016/j.bbamem.2006.05.027; Lee SO, 2007, BIOCHEM BIOPH RES CO, V354, P165, DOI 10.1016/j.bbrc.2006.12.181; Linn SC, 2001, BIOCHEM SOC T, V29, P831, DOI 10.1042/0300-5127:0290831; QUINTERN LE, 1989, EMBO J, V8, P2469, DOI 10.1002/j.1460-2075.1989.tb08382.x; REVAK SD, 1985, J CLIN INVEST, V76, P1182, DOI 10.1172/JCI112074; Riboni L, 1997, PROG LIPID RES, V36, P153, DOI 10.1016/S0163-7827(97)00008-8; RIBONI L, 1994, FEBS LETT, V352, P323, DOI 10.1016/0014-5793(94)00984-8; RIBONI L, 1993, FEBS LETT, V322, P257, DOI 10.1016/0014-5793(93)81582-K; Riboni L, 1998, ANN NY ACAD SCI, V845, P46, DOI 10.1111/j.1749-6632.1998.tb09661.x; SCHUCHMAN EH, 1991, J BIOL CHEM, V266, P8531; SMITH ER, 1995, J BIOL CHEM, V270, P18749, DOI 10.1074/jbc.270.32.18749; Sumitomo M, 2002, J CLIN INVEST, V109, P827, DOI 10.1172/JCI200214146; Swanton C, 2007, CANCER CELL, V11, P498, DOI 10.1016/j.ccr.2007.04.011; Tettamanti G, 2003, BIOCHIMIE, V85, P423, DOI 10.1016/S0300-9084(03)00047-6; TRINCHERA M, 1990, BIOCHEM J, V270, P815, DOI 10.1042/bj2700815; Yildiz Y, 2006, J CLIN INVEST, V116, P2985, DOI 10.1172/JCI29224; Zeidan YH, 2007, J BIOL CHEM, V282, P11549, DOI 10.1074/jbc.M609424200; Ziulkoski AL, 2001, BIOCHEM BIOPH RES CO, V281, P971, DOI 10.1006/bbrc.2001.4440	43	39	40	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 8	2009	284	19					12972	12978		10.1074/jbc.M802790200	http://dx.doi.org/10.1074/jbc.M802790200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	440GH	19279011	Green Published, hybrid			2022-12-27	WOS:000265688300044
J	Liu, Y; Zhang, YW; Wang, X; Zhang, H; You, XQ; Liao, FF; Xu, HX				Liu, Yun; Zhang, Yun-wu; Wang, Xin; Zhang, Han; You, Xiaoqing; Liao, Francesca-Fang; Xu, Huaxi			Intracellular Trafficking of Presenilin 1 Is Regulated by beta-Amyloid Precursor Protein and Phospholipase D1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FAMILIAL ALZHEIMERS-DISEASE; TRANS-GOLGI NETWORK; GAMMA-SECRETASE COMPLEX; AXONAL-TRANSPORT; ANTEROGRADE TRANSPORT; CELLULAR MECHANISMS; MAMMALIAN-CELLS; CLEAVING ENZYME; DISTINCT SITES; APP	Excessive accumulation of beta-amyloid peptides in the brain is a major cause for the pathogenesis of Alzheimer disease. beta-Amyloid is derived from beta-amyloid precursor protein (APP) through sequential cleavages by beta- and gamma-secretases, whose enzymatic activities are tightly controlled by subcellular localization. Delineation of how intracellular trafficking of these secretases and APP is regulated is important for understanding Alzheimer disease pathogenesis. Although APP trafficking is regulated by multiple factors including presenilin 1 (PS1), a major component of the gamma-secretase complex, and phospholipase D1 (PLD1), a phospholipid-modifying enzyme, regulation of intracellular trafficking of PS1/gamma-secretase and beta-secretase is less clear. Here we demonstrate that APP can reciprocally regulate PS1 trafficking; APP deficiency results in faster transport of PS1 from the trans-Golgi network to the cell surface and increased steady state levels of PS1 at the cell surface, which can be reversed by restoring APP levels. Restoration of APP in APP-deficient cells also reduces steady state levels of other gamma-secretase components (nicastrin, APH-1, and PEN-2) and the cleavage of Notch by PS1/gamma-secretase that is more highly correlated with cell surface levels of PS1 than with APP overexpression levels, supporting the notion that Notch is mainly cleaved at the cell surface. In contrast, intracellular trafficking of beta-secretase (BACE1) is not regulated by APP. Moreover, we find that PLD1 also regulates PS1 trafficking and that PLD1 overexpression promotes cell surface accumulation of PS1 in an APP-independent manner. Our results clearly elucidate a physiological function of APP in regulating protein trafficking and suggest that intracellular trafficking of PS1/gamma-secretase is regulated by multiple factors, including APP and PLD1.	[Liu, Yun; Zhang, Yun-wu; Wang, Xin; Zhang, Han; You, Xiaoqing; Liao, Francesca-Fang; Xu, Huaxi] Burnham Inst Med Res, La Jolla, CA 92037 USA; [Zhang, Yun-wu; Zhang, Han; You, Xiaoqing; Xu, Huaxi] Xiamen Univ, Inst Biomed Res, Xiamen 361005, Peoples R China	Sanford Burnham Prebys Medical Discovery Institute; Xiamen University	Xu, HX (corresponding author), Burnham Inst Med Res, La Jolla, CA 92037 USA.	xuh@burnham.org	Zhang, YW/G-3999-2010; Wang, Xin/A-8119-2017; Xu, Huaxi/AAV-7177-2021	Zhang, Yun-wu/0000-0002-7152-7630	National Institutes of Health [R01 NS046673, R01 AG030197, R01 AG021173, R01 NS054880]; Alzheimer's Association; American Health Assistance Foundation; National Natural Science Foundation of China [30672198, 30840036]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046673, R01NS054880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG030197, R01AG021173] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer's Association(Alzheimer's Association); American Health Assistance Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants R01 NS046673, R01 AG030197, and R01 AG021173 ( to H. X.) and R01 NS054880 ( to F.- F. L.). This work was also supported by grants from the Alzheimer's Association ( to H. X. and F.- F. L.), the American Health Assistance Foundation ( to H. X.), and National Natural Science Foundation of China Grants 30672198 and 30840036 ( to Y. Z.).	Andersen OM, 2005, P NATL ACAD SCI USA, V102, P13461, DOI 10.1073/pnas.0503689102; Bennett BD, 2000, J BIOL CHEM, V275, P37712, DOI 10.1074/jbc.M005339200; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Borg JP, 1996, MOL CELL BIOL, V16, P6229; Borg JP, 1998, J BIOL CHEM, V273, P14761, DOI 10.1074/jbc.273.24.14761; BUXBAUM JD, 1990, P NATL ACAD SCI USA, V87, P6003, DOI 10.1073/pnas.87.15.6003; Cai DM, 2006, P NATL ACAD SCI USA, V103, P1941, DOI 10.1073/pnas.0510708103; Cai DM, 2006, P NATL ACAD SCI USA, V103, P1936, DOI 10.1073/pnas.0510710103; Cai DM, 2003, J BIOL CHEM, V278, P3446, DOI 10.1074/jbc.M209065200; CAPORASO GL, 1994, J NEUROSCI, V14, P3122; Chen FS, 2006, NATURE, V440, P1208, DOI 10.1038/nature04667; Creemers JWM, 2001, J BIOL CHEM, V276, P4211, DOI 10.1074/jbc.M006947200; Cupers P, 2001, J CELL BIOL, V154, P731, DOI 10.1083/jcb.200104045; Dumanchin C, 1999, HUM MOL GENET, V8, P1263, DOI 10.1093/hmg/8.7.1263; Furukawa K, 1996, J NEUROCHEM, V67, P1882, DOI 10.1046/j.1471-4159.1996.67051882.x; Gasparini L, 2001, J NEUROSCI, V21, P2561, DOI 10.1523/JNEUROSCI.21-08-02561.2001; Greenfield JP, 1999, P NATL ACAD SCI USA, V96, P742, DOI 10.1073/pnas.96.2.742; Gunawardena S, 2001, NEURON, V32, P389, DOI 10.1016/S0896-6273(01)00496-2; HAASS C, 1993, ANN NY ACAD SCI, V695, P109, DOI 10.1111/j.1749-6632.1993.tb23037.x; Haass C, 1999, SCIENCE, V286, P916, DOI 10.1126/science.286.5441.916; HAASS C, 1993, J BIOL CHEM, V268, P3021; Han P, 2005, J NEUROSCI, V25, P11542, DOI 10.1523/JNEUROSCI.3831-05.2005; Hartmann T, 1997, NAT MED, V3, P1016, DOI 10.1038/nm0997-1016; He XY, 2005, J BIOL CHEM, V280, P11696, DOI 10.1074/jbc.M411296200; Huse JT, 2000, J BIOL CHEM, V275, P33729, DOI 10.1074/jbc.M004175200; Kamal A, 2000, NEURON, V28, P449, DOI 10.1016/S0896-6273(00)00124-0; Kamal A, 2001, NATURE, V414, P643, DOI 10.1038/414643a; Kimberly WT, 2003, P NATL ACAD SCI USA, V100, P6382, DOI 10.1073/pnas.1037392100; King GD, 2004, EXP NEUROL, V185, P208, DOI 10.1016/j.expneurol.2003.10.011; Kopan R, 1996, P NATL ACAD SCI USA, V93, P1683, DOI 10.1073/pnas.93.4.1683; Kopan R, 2000, GENE DEV, V14, P2799, DOI 10.1101/gad.836900; Kovacs DM, 1996, NAT MED, V2, P224, DOI 10.1038/nm0296-224; Kuzuya A, 2007, J NEUROSCI RES, V85, P153, DOI 10.1002/jnr.21104; Lau KF, 2000, MOL CELL NEUROSCI, V16, P557, DOI 10.1006/mcne.2000.0898; Lee SF, 2002, J BIOL CHEM, V277, P45013, DOI 10.1074/jbc.M208164200; Leem JY, 2002, J BIOL CHEM, V277, P19236, DOI 10.1074/jbc.C200148200; LEVYLAHAD E, 1995, SCIENCE, V269, P973, DOI 10.1126/science.7638622; Li YM, 2000, P NATL ACAD SCI USA, V97, P6138, DOI 10.1073/pnas.110126897; Lin P, 2007, J NEUROCHEM, V100, P1505, DOI 10.1111/j.1471-4159.2006.07336.x; Liu Q, 2007, NEURON, V56, P66, DOI 10.1016/j.neuron.2007.08.008; Luo WJ, 2003, J BIOL CHEM, V278, P7850, DOI 10.1074/jbc.C200648200; Luo Y, 2001, NAT NEUROSCI, V4, P231, DOI 10.1038/85059; Mattson MP, 1997, PHYSIOL REV, V77, P1081, DOI 10.1152/physrev.1997.77.4.1081; Multhaup G, 2006, NEURODEGENER DIS, V3, P270, DOI 10.1159/000095266; NORDSTEDT C, 1993, J BIOL CHEM, V268, P608; Rogelj B, 2006, BRAIN RES REV, V52, P305, DOI 10.1016/j.brainresrev.2006.04.005; Salehi A, 2006, NEURON, V51, P29, DOI 10.1016/j.neuron.2006.05.022; Satpute-Krishnan P, 2003, AGING CELL, V2, P305, DOI 10.1046/j.1474-9728.2003.00069.x; Satpute-Krishnan P, 2006, P NATL ACAD SCI USA, V103, P16532, DOI 10.1073/pnas.0607527103; Scheper W, 2000, HUM MOL GENET, V9, P303, DOI 10.1093/hmg/9.2.303; Scheper W, 2004, MOL BRAIN RES, V122, P17, DOI 10.1016/j.molbrainres.2003.11.013; Schmechel A, 2004, J BIOL CHEM, V279, P39710, DOI 10.1074/jbc.M402785200; Schroeter EH, 1998, NATURE, V393, P382, DOI 10.1038/30756; Selkoe DJ, 1998, TRENDS CELL BIOL, V8, P447, DOI 10.1016/S0962-8924(98)01363-4; SHERRINGTON R, 1995, NATURE, V375, P754, DOI 10.1038/375754a0; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; SISODIA SS, 1992, P NATL ACAD SCI USA, V89, P6075, DOI 10.1073/pnas.89.13.6075; Sisodia SS, 2002, SCIENCE, V295, P805, DOI 10.1126/science.1069661; Spoelgen R, 2006, J NEUROSCI, V26, P418, DOI 10.1523/JNEUROSCI.3882-05.2006; Takasugi N, 2003, NATURE, V422, P438, DOI 10.1038/nature01506; Tarassishin L, 2004, P NATL ACAD SCI USA, V101, P17050, DOI 10.1073/pnas.0408007101; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vetrivel KS, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-4; Wahle T, 2005, MOL CELL NEUROSCI, V29, P453, DOI 10.1016/j.mcn.2005.03.014; Walter J, 2001, J BIOL CHEM, V276, P14634, DOI 10.1074/jbc.M011116200; Wang H, 2004, J BIOL CHEM, V279, P40560, DOI 10.1074/jbc.M404345200; Wang RS, 2006, FASEB J, V20, P1275, DOI 10.1096/fj.06-5839fje; Waragai M, 1997, BIOCHEM BIOPH RES CO, V239, P480, DOI 10.1006/bbrc.1997.7488; WASCO W, 1993, NAT GENET, V5, P95, DOI 10.1038/ng0993-95; WASCO W, 1992, P NATL ACAD SCI USA, V89, P10758, DOI 10.1073/pnas.89.22.10758; Xia WM, 1997, P NATL ACAD SCI USA, V94, P8208, DOI 10.1073/pnas.94.15.8208; Xu HX, 1998, NAT MED, V4, P447, DOI 10.1038/nm0498-447; Xu HX, 1997, P NATL ACAD SCI USA, V94, P3748, DOI 10.1073/pnas.94.8.3748; Yan RQ, 2001, J BIOL CHEM, V276, P36788, DOI 10.1074/jbc.M104350200; Zhang YW, 2007, CURR MOL MED, V7, P687, DOI 10.2174/156652407782564462; Zhang YW, 2007, P NATL ACAD SCI USA, V104, P10613, DOI 10.1073/pnas.0703903104; Zhang YW, 2005, J BIOL CHEM, V280, P17020, DOI 10.1074/jbc.M409467200; Zheng H, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-5	79	34	34	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12145	12152		10.1074/jbc.M808497200	http://dx.doi.org/10.1074/jbc.M808497200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19276086	hybrid, Green Published			2022-12-27	WOS:000265494600046
J	Yin, H; Chu, A; Li, W; Wang, B; Shelton, F; Otero, F; Nguyen, DG; Caldwell, JS; Chen, YA				Yin, Hong; Chu, Alan; Li, Wei; Wang, Bin; Shelton, Fabiola; Otero, Francella; Nguyen, Deborah G.; Caldwell, Jeremy S.; Chen, Yu Alice			Lipid G Protein-coupled Receptor Ligand Identification Using beta-Arrestin PathHunter (TM) Assay	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOPHOSPHATIDIC ACID RECEPTOR; BREAST-CANCER CELLS; CB2 CANNABINOID RECEPTORS; CHAIN FATTY-ACIDS; SPHINGOSINE 1-PHOSPHATE; N-ARACHIDONYLGLYCINE; NEUROPATHIC PAIN; ORPHAN RECEPTOR; GENE-EXPRESSION; IN-VITRO	A growing number of orphan G-protein-coupled receptors (GPCRs) have been reported to be activated by lipid ligands, such as lysophosphatidic acid, sphingosine 1-phosphate (S1P), and cannabinoids, for which there are already well established receptors. These new ligand claims are controversial due to either lack of independent confirmations or conflicting reports. We used the beta-arrestin PathHunter (TM) assay system, a newly developed, generic GPCR assay format that measures beta-arrestin binding to GPCRs, to evaluate lipid receptor and ligand pairing. This assay eliminates interference from endogenous receptors on the parental cells because it measures a signal that is specifically generated by the tagged receptor and is immediately downstream of receptor activation. We screened a large number of newly "deorphaned" receptors (GPR23, GPR92, GPR55, G2A, GPR18, GPR3, GPR6, GPR12, and GPR63) and control receptors against a collection of similar to 400 lipid molecules to try to identify the receptor ligand in an unbiased fashion. GPR92 was confirmed to be a lysophosphatidic acid receptor with weaker responses to farnesyl pyrophosphate and geranylgeranyl diphosphate. The putative cannabinoid receptor GPR55 responded strongly to AM251, rimonabant, and lysophosphatidylinositol but only very weakly to endocannabinoids. G2A receptor was confirmed to be an oxidized free fatty acid receptor. In addition, we discovered that 3,3'-diindolylmethane, a dietary molecule from cruciferous vegetables, which has known anti-cancer properties, to be a CB2 receptor partial agonist, with binding affinity around 1 mu M. The anti-inflammatory effect of 3,3-diindolylmethane in RAW264.7 cells was shown to be partially mediated by CB2.	[Yin, Hong; Chu, Alan; Li, Wei; Wang, Bin; Shelton, Fabiola; Otero, Francella; Nguyen, Deborah G.; Caldwell, Jeremy S.; Chen, Yu Alice] Novartis Res Fdn, Genom Inst, GPCR Platform, San Diego, CA 92121 USA	Novartis	Chen, YA (corresponding author), Novartis Res Fdn, Genom Inst, GPCR Platform, San Diego, CA 92121 USA.	achen@gnf.org		Nguyen, Deborah/0000-0002-1694-0617				Aggarwal BB, 2005, CELL CYCLE, V4, P1201, DOI 10.4161/cc.4.9.1993; Arevalo-Martin A, 2008, BRIT J PHARMACOL, V153, P216, DOI 10.1038/sj.bjp.0707466; Bab I, 2008, J NEUROENDOCRINOL, V20, P69, DOI 10.1111/j.1365-2826.2008.01675.x; Baker D, 2006, TRENDS PHARMACOL SCI, V27, P1, DOI 10.1016/j.tips.2005.11.003; Benito C, 2008, BRIT J PHARMACOL, V153, P277, DOI 10.1038/sj.bjp.0707505; BJELDANES LF, 1991, P NATL ACAD SCI USA, V88, P9543, DOI 10.1073/pnas.88.21.9543; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; Chen I, 1998, CARCINOGENESIS, V19, P1631, DOI 10.1093/carcin/19.9.1631; Chen I, 1996, BIOCHEM PHARMACOL, V51, P1069, DOI 10.1016/0006-2952(96)00060-3; Cho HJ, 2008, J NUTR, V138, P17, DOI 10.1093/jn/138.1.17; Dyson A, 2005, PAIN, V116, P129, DOI 10.1016/j.pain.2005.03.037; Flygare J, 2008, SEMIN CANCER BIOL, V18, P176, DOI 10.1016/j.semcancer.2007.12.008; Ge XK, 1996, BIOCHEM BIOPH RES CO, V228, P153, DOI 10.1006/bbrc.1996.1631; Gong YX, 2006, CANCER RES, V66, P4880, DOI 10.1158/0008-5472.CAN-05-4162; Guzman M, 2003, NAT REV CANCER, V3, P745, DOI 10.1038/nrc1188; Hirose M, 2003, BIOORG MED CHEM LETT, V13, P4497, DOI 10.1016/j.bmcl.2003.08.038; Ignatov A, 2003, BIOCHEM BIOPH RES CO, V311, P329, DOI 10.1016/j.bbrc.2003.10.006; Ignatov A, 2003, J NEUROSCI, V23, P907; JELLINCK PH, 1993, BIOCHEM PHARMACOL, V45, P1129, DOI 10.1016/0006-2952(93)90258-X; Johns DG, 2007, BRIT J PHARMACOL, V152, P825, DOI 10.1038/sj.bjp.0707419; Kabarowski JHS, 2001, SCIENCE, V293, P702, DOI 10.1126/science.1061781; Klein TW, 2003, J LEUKOCYTE BIOL, V74, P486, DOI 10.1189/jlb.0303101; Kohno M, 2006, BIOCHEM BIOPH RES CO, V347, P827, DOI 10.1016/j.bbrc.2006.06.175; Kotarsky K, 2006, J PHARMACOL EXP THER, V318, P619, DOI 10.1124/jpet.105.098848; Lauckner JE, 2008, P NATL ACAD SCI USA, V105, P2699, DOI 10.1073/pnas.0711278105; Le HT, 2003, J BIOL CHEM, V278, P21136, DOI 10.1074/jbc.M300588200; Lee CW, 2007, J BIOL CHEM, V282, P4310, DOI 10.1074/jbc.M610826200; Lee CW, 2006, J BIOL CHEM, V281, P23589, DOI 10.1074/jbc.M603670200; Lin P, 2003, J BIOL CHEM, V278, P14379, DOI 10.1074/jbc.M209101200; Lotersztajn S, 2008, BRIT J PHARMACOL, V153, P286, DOI 10.1038/sj.bjp.0707511; Maccarrone M, 2008, BRIT J PHARMACOL, V153, P189, DOI 10.1038/sj.bjp.0707444; McKallip RJ, 2002, BLOOD, V100, P627, DOI 10.1182/blood-2002-01-0098; Murakami M, 2008, BIOCHEM BIOPH RES CO, V371, P707, DOI 10.1016/j.bbrc.2008.04.145; Murakami N, 2004, J BIOL CHEM, V279, P42484, DOI 10.1074/jbc.M406561200; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Niedernberg A, 2003, CELL SIGNAL, V15, P435, DOI 10.1016/S0898-6568(02)00119-5; Noguchi K, 2003, J BIOL CHEM, V278, P25600, DOI 10.1074/jbc.M302648200; Obinata H, 2005, J BIOL CHEM, V280, P40676, DOI 10.1074/jbc.M507787200; Oh DY, 2008, J BIOL CHEM, V283, P21054, DOI 10.1074/jbc.M708908200; Oka S, 2007, BIOCHEM BIOPH RES CO, V362, P928, DOI 10.1016/j.bbrc.2007.08.078; Pacher P, 2008, BRIT J PHARMACOL, V153, P252, DOI 10.1038/sj.bjp.0707582; Pasternack SM, 2008, NAT GENET, V40, P329, DOI 10.1038/ng.84; Paugh SW, 2006, MOL PHARMACOL, V70, P41, DOI 10.1124/mol.105.020552; Peter C, 2008, J BIOL CHEM, V283, P5296, DOI 10.1074/jbc.M706586200; Radu CG, 2005, P NATL ACAD SCI USA, V102, P1632, DOI 10.1073/pnas.0409415102; Radu CG, 2004, P NATL ACAD SCI USA, V101, P245, DOI 10.1073/pnas.2536801100; Ryberg E, 2007, BRIT J PHARMACOL, V152, P1092, DOI 10.1038/sj.bjp.0707460; Siehler Sandra, 2008, Biotechnology Journal, V3, P471, DOI 10.1002/biot.200800001; Staton PC, 2008, PAIN, V139, P225, DOI 10.1016/j.pain.2008.04.006; Steffens S, 2005, NATURE, V434, P782, DOI 10.1038/nature03389; Sugo T, 2006, BIOCHEM BIOPH RES CO, V341, P1078, DOI 10.1016/j.bbrc.2006.01.069; Tabata KI, 2007, BIOCHEM BIOPH RES CO, V363, P861, DOI 10.1016/j.bbrc.2007.09.063; Uhlenbrock K, 2002, CELL SIGNAL, V14, P941, DOI 10.1016/S0898-6568(02)00041-4; Wang JH, 2006, J BIOL CHEM, V281, P34457, DOI 10.1074/jbc.M608019200; Weng JR, 2007, CANCER RES, V67, P7815, DOI 10.1158/0008-5472.CAN-07-0794; Weng ZG, 1998, P NATL ACAD SCI USA, V95, P12334, DOI 10.1073/pnas.95.21.12334; Wright KL, 2008, BRIT J PHARMACOL, V153, P263, DOI 10.1038/sj.bjp.0707486; Xue L, 2005, ONCOGENE, V24, P2343, DOI 10.1038/sj.onc.1208434; Xue L, 2008, J NUTR BIOCHEM, V19, P336, DOI 10.1016/j.jnutbio.2007.05.004; Yamamoto W, 2008, EUR J PHARMACOL, V583, P56, DOI 10.1016/j.ejphar.2008.01.010; Yan YX, 2002, J BIOMOL SCREEN, V7, P451, DOI 10.1177/108705702237677	62	251	261	1	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 1	2009	284	18					12328	12338		10.1074/jbc.M806516200	http://dx.doi.org/10.1074/jbc.M806516200			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	437NQ	19286662	hybrid, Green Published			2022-12-27	WOS:000265494600064
J	Hosszu, LLP; Trevitt, CR; Jones, S; Batchelor, M; Scott, DJ; Jackson, GS; Collinge, J; Waltho, JP; Clarke, AR				Hosszu, Laszlo L. P.; Trevitt, Clare R.; Jones, Samantha; Batchelor, Mark; Scott, David J.; Jackson, Graham S.; Collinge, John; Waltho, Jonathan P.; Clarke, Anthony R.			Conformational Properties of beta-PrP	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN PRION PROTEIN; CHEMICAL-SHIFT; MOLTEN GLOBULE; INTERMEDIATE STATES; DOMAIN PRP(121-231); SECONDARY STRUCTURE; AMYLOID FORMATION; NMR-SPECTROSCOPY; FOLDING PATHWAY; COPPER-BINDING	Prion propagation involves a conformational transition of the cellular form of prion protein (PrPC) to a disease-specific isomer (PrPSc), shifting from a predominantly alpha-helical conformation to one dominated by beta-sheet structure. This conformational transition is of critical importance in understanding the molecular basis for prion disease. Here, we elucidate the conformational properties of a disulfide-reduced fragment of human PrP spanning residues 91-231 under acidic conditions, using a combination of heteronuclear NMR, analytical ultracentrifugation, and circular dichroism. We find that this form of the protein, which similarly to PrPSc, is a potent inhibitor of the 26 S proteasome, assembles into soluble oligomers that have significant beta-sheet content. The monomeric precursor to these oligomers exhibits many of the characteristics of a molten globule intermediate with some helical character in regions that form helices I and III in the PrPC conformation, whereas helix II exhibits little evidence for adopting a helical conformation, suggesting that this region is a likely source of interaction within the initial phases of the transformation to a beta-rich conformation. This precursor state is almost as compact as the folded PrPC structure and, as it assembles, only residues 126-227 are immobilized within the oligomeric structure, leaving the remainder in a mobile, random-coil state.	[Hosszu, Laszlo L. P.; Trevitt, Clare R.; Jones, Samantha; Batchelor, Mark; Jackson, Graham S.; Collinge, John; Clarke, Anthony R.] Inst Neurol, Dept Neurodegenerat Dis, MRC Prion Unit, London WC1N 3BG, England; [Hosszu, Laszlo L. P.; Waltho, Jonathan P.] Univ Sheffield, Krebs Inst Biomol Res, Dept Mol Biol & Biotechnol, Sheffield S10 2TN, S Yorkshire, England; [Scott, David J.] Univ Nottingham, Sch Biosci, Natl Ctr Macromol Hydrodynam, Loughborough LE12 5RD, Leics, England	University of London; University College London; University of Sheffield; University of Nottingham	Clarke, AR (corresponding author), Inst Neurol, Dept Neurodegenerat Dis, MRC Prion Unit, Queen Sq, London WC1N 3BG, England.	a.r.clarke@prion.ucl.ac.uk		Scott, David/0000-0002-6726-2078; Jackson, Graham/0000-0002-3125-2011; Waltho, Jonathan/0000-0002-7402-5492	Medical Research Council; Biotechnology and Biological Sciences Research Council [B17948] Funding Source: researchfish; Medical Research Council [MC_U123160656, MC_U123170362, MC_U123192748] Funding Source: researchfish; MRC [MC_U123160656, MC_U123170362, MC_U123192748] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council.	Baskakov IV, 2002, J BIOL CHEM, V277, P21140, DOI 10.1074/jbc.M111402200; Baskakov IV, 2004, PROTEIN SCI, V13, P586, DOI 10.1110/ps.03457204; BAX A, 1991, Journal of Biomolecular NMR, V1, P99, DOI 10.1007/BF01874573; BESSEN RA, 1995, NATURE, V375, P698, DOI 10.1038/375698a0; Brown DR, 1996, NATURE, V380, P345, DOI 10.1038/380345a0; BROWN P, 1990, P NATL ACAD SCI USA, V87, P7240, DOI 10.1073/pnas.87.18.7240; Calloni G, 2008, J AM CHEM SOC, V130, P13040, DOI 10.1021/ja8029224; Caughey B, 2003, ANNU REV NEUROSCI, V26, P267, DOI 10.1146/annurev.neuro.26.010302.081142; Cavagnero S, 2001, BIOCHEMISTRY-US, V40, P14459, DOI 10.1021/bi011500n; Cobb NJ, 2007, P NATL ACAD SCI USA, V104, P18946, DOI 10.1073/pnas.0706522104; Collinge J, 2001, ANNU REV NEUROSCI, V24, P519, DOI 10.1146/annurev.neuro.24.1.519; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Davies P, 2008, BIOCHEM J, V410, P237, DOI 10.1042/BJ20071477; DeLano W.L, PYMOL MOL GRAPHICS S; Fitzmaurice TJ, 2008, BIOCHEM J, V409, P367, DOI 10.1042/BJ20071122; Gerber R, 2008, PROTEIN SCI, V17, P537, DOI 10.1110/ps.073163308; Gerber R, 2007, J BIOL CHEM, V282, P6300, DOI 10.1074/jbc.M608926200; GRIFFITH JS, 1967, NATURE, V215, P1043, DOI 10.1038/2151043a0; Herrmann LM, 1998, NEUROREPORT, V9, P2457, DOI 10.1097/00001756-199808030-00006; HOMANS SW, 1989, DICT CONCEPTS NMR; Hornemann S, 1998, P NATL ACAD SCI USA, V95, P6010, DOI 10.1073/pnas.95.11.6010; Hosszu LLP, 2005, BIOCHEMISTRY-US, V44, P16649, DOI 10.1021/bi051277k; Hosszu LLP, 2004, J BIOL CHEM, V279, P28515, DOI 10.1074/jbc.M313762200; Hosszu LLP, 1999, NAT STRUCT BIOL, V6, P740, DOI 10.1038/11507; Hou LM, 2004, J AM CHEM SOC, V126, P1992, DOI 10.1021/ja036813f; Jackson GS, 2001, P NATL ACAD SCI USA, V98, P8531, DOI 10.1073/pnas.151038498; Jackson GS, 1999, BBA-PROTEIN STRUCT M, V1431, P1, DOI 10.1016/S0167-4838(99)00038-2; Jackson GS, 1999, SCIENCE, V283, P1935, DOI 10.1126/science.283.5409.1935; Kachel N, 2006, BMC STRUCT BIOL, V6, DOI 10.1186/1472-6807-6-16; KAY LE, 1994, J MAGN RESON SER A, V109, P129, DOI 10.1006/jmra.1994.1145; Khalili-Shirazi A, 2005, J IMMUNOL, V174, P3256, DOI 10.4049/jimmunol.174.6.3256; Khalill-Shirazi A, 2007, BBA-PROTEINS PROTEOM, V1774, P1438, DOI 10.1016/j.bbapap.2007.08.028; Klewpatinond M, 2008, J BIOL CHEM, V283, P1870, DOI 10.1074/jbc.M708472200; Knaus KJ, 2001, NAT STRUCT BIOL, V8, P770, DOI 10.1038/nsb0901-770; Kristiansen M, 2007, MOL CELL, V26, P175, DOI 10.1016/j.molcel.2007.04.001; Kuwata K, 2002, BIOCHEMISTRY-US, V41, P12277, DOI 10.1021/bi026129y; Lee S, 2003, NAT STRUCT BIOL, V10, P725, DOI 10.1038/nsb961; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Liu K, 2000, J MOL BIOL, V303, P555, DOI 10.1006/jmbi.2000.4164; Luhrs TT, 2006, J MOL BIOL, V357, P833, DOI 10.1016/j.jmb.2006.01.016; Maiti NR, 2001, J BIOL CHEM, V276, P2427, DOI 10.1074/jbc.M007862200; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; McParland VJ, 2002, NAT STRUCT BIOL, V9, P326, DOI 10.1038/nsb791; MUHANDIRAM DR, 1994, J MAGN RESON SER B, V103, P203, DOI 10.1006/jmrb.1994.1032; Muramoto T, 1996, P NATL ACAD SCI USA, V93, P15457, DOI 10.1073/pnas.93.26.15457; Nandi PK, 2002, J MOL BIOL, V322, P153, DOI 10.1016/S0022-2836(02)00750-7; O'Sullivan DBD, 2007, BIOCHEM J, V401, P533, DOI 10.1042/BJ20060668; Paquet S, 2007, J GEN VIROL, V88, P706, DOI 10.1099/vir.0.82336-0; Peretz D, 1997, J MOL BIOL, V273, P614, DOI 10.1006/jmbi.1997.1328; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Redfield C, 1999, NAT STRUCT BIOL, V6, P948, DOI 10.1038/13318; Redfield Christina, 2004, Methods Mol Biol, V278, P233; Reed MAC, 2003, J MOL BIOL, V330, P1189, DOI 10.1016/S0022-2836(03)00625-9; Riek R, 1996, NATURE, V382, P180, DOI 10.1038/382180a0; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Sasaki K, 2008, PRION, V2, P118, DOI 10.4161/pri.2.3.7148; SCHLEUCHER J, 1994, J BIOMOL NMR, V4, P301; Schuck P, 2002, BIOPHYS J, V82, P1096, DOI 10.1016/S0006-3495(02)75469-6; Schulman BA, 1997, NAT STRUCT BIOL, V4, P630, DOI 10.1038/nsb0897-630; Schwarzinger S, 2008, PROTEIN SCI, V17, P313, DOI 10.1110/ps.073187208; Sipe JD, 2000, J STRUCT BIOL, V130, P88, DOI 10.1006/jsbi.2000.4221; Supattapone S, 2004, J MOL MED, V82, P348, DOI 10.1007/s00109-004-0534-3; Suzuki T, 2002, BIOCHEM BIOPH RES CO, V294, P912, DOI 10.1016/S0006-291X(02)00546-6; Swietnicki W, 2000, BIOCHEMISTRY-US, V39, P424, DOI 10.1021/bi991967m; Tartaglia GG, 2008, J MOL BIOL, V380, P425, DOI 10.1016/j.jmb.2008.05.013; Tattum MH, 2006, J MOL BIOL, V357, P975, DOI 10.1016/j.jmb.2006.01.052; TURK E, 1988, EUR J BIOCHEM, V176, P21, DOI 10.1111/j.1432-1033.1988.tb14246.x; Uversky VN, 2004, BBA-PROTEINS PROTEOM, V1698, P131, DOI 10.1016/j.bbapap.2003.12.008; Walter ED, 2006, BIOCHEMISTRY-US, V45, P13083, DOI 10.1021/bi060948r; WANG Y, 1995, PHILOS T ROY SOC B, V348, P27, DOI 10.1098/rstb.1995.0042; Wells MA, 2006, BIOCHEM J, V400, P501, DOI 10.1042/BJ20060721; Wells MA, 2006, BIOCHEM J, V399, P435, DOI 10.1042/BJ20060458; Wilkins DK, 1999, BIOCHEMISTRY-US, V38, P16424, DOI 10.1021/bi991765q; WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777; Wishart DS, 1998, BIOCHEM CELL BIOL, V76, P153, DOI 10.1139/bcb-76-2-3-153; WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010; WITTEKIND M, 1993, J MAGN RESON SER B, V101, P201, DOI 10.1006/jmrb.1993.1033; Yao J, 1997, FEBS LETT, V419, P285, DOI 10.1016/S0014-5793(97)01474-9; Zahn R, 2000, P NATL ACAD SCI USA, V97, P145, DOI 10.1073/pnas.97.1.145; Zahn R, 1997, FEBS LETT, V417, P400, DOI 10.1016/S0014-5793(97)01330-6; Zandomeneghi G, 2004, PROTEIN SCI, V13, P3314, DOI 10.1110/ps.041024904; Ziegler J, 2003, J BIOL CHEM, V278, P50175, DOI 10.1074/jbc.M305234200	84	28	29	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	AUG 14	2009	284	33					21981	21990		10.1074/jbc.M809173200	http://dx.doi.org/10.1074/jbc.M809173200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	481CE	19369250	Green Published, hybrid			2022-12-27	WOS:000268783700022
J	Slugoski, MD; Ng, AML; Yao, SYM; Lin, CC; Mulinta, R; Cass, CE; Baldwin, SA; Young, JD				Slugoski, Melissa D.; Ng, Amy M. L.; Yao, Sylvia Y. M.; Lin, Colin C.; Mulinta, Ras; Cass, Carol E.; Baldwin, Stephen A.; Young, James D.			Substituted Cysteine Accessibility Method Analysis of Human Concentrative Nucleoside Transporter hCNT3 Reveals a Novel Discontinuous Region of Functional Importance within the CNT Family Motif (G/A)XKX(3)NEFVA(Y/M/F)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONSERVED GLUTAMATE RESIDUES; NUCLEOBASE TRANSPORT; MECHANISTIC INSIGHTS; MOLECULAR-CLONING; RECOMBINANT HUMAN; CRYSTAL-STRUCTURE; NA+; IDENTIFICATION; EXPRESSION; PURINE	The human SLC28 family of integral membrane CNT (concentrative nucleoside transporter) proteins has three members, hCNT1, hCNT2, and hCNT3. Na+-coupled hCNT1 and hCNT2 transport pyrimidine and purine nucleosides, respectively, whereas hCNT3 mediates transport of both pyrimidine and purine nucleosides utilizing Na+ and/or H+ electrochemical gradients. These and other eukaryote CNTs are currently defined by a putative 13-transmembrane helix (TM) topology model with an intracellular N terminus and a glycosylated extracellular C terminus. Recent mutagenesis studies, however, have provided evidence supporting an alternative 15-TM membrane architecture. In the absence of CNT crystal structures, valuable information can be gained about residue localization and function using substituted cysteine accessibility method analysis with thiol-reactive reagents, such as p-chloromercuribenzene sulfonate. Using heterologous expression in Xenopus oocytes and the cysteineless hCNT3 protein hCNT3C-, substituted cysteine accessibility method analysis with p-chloromercuribenzene sulfonate was performed on the TM 11-13 region, including bridging extramembranous loops. The results identified residues of functional importance and, consistent with a new revised 15-TM CNT membrane architecture, suggest a novel membrane-associated topology for a region of the protein (TM 11A) that includes the highly conserved CNT family motif (G/A)XKX(3)NEFVA(Y/M/F).	[Slugoski, Melissa D.; Ng, Amy M. L.; Yao, Sylvia Y. M.; Lin, Colin C.; Mulinta, Ras; Young, James D.] Univ Alberta, Dept Physiol, Membrane Prot Res Grp, Edmonton, AB T6G 2H7, Canada; [Cass, Carol E.] Univ Alberta, Dept Oncol, Membrane Prot Res Grp, Edmonton, AB T6G 2H7, Canada; [Cass, Carol E.] Cross Canc Inst, Edmonton, AB T6G 1Z2, Canada; [Baldwin, Stephen A.] Univ Leeds, Inst Membrane & Syst Biol, Astbury Ctr Struct Mol Biol, Leeds LS2 9JT, W Yorkshire, England	University of Alberta; University of Alberta; University of Alberta; University of Leeds	Young, JD (corresponding author), Univ Alberta, Dept Physiol, Membrane Prot Res Grp, 7-55 Med Sci Bldg, Edmonton, AB T6G 2H7, Canada.	james.young@ualberta.ca	Cass, Carol E/F-5861-2010		National Cancer Institute of Canada; Alberta Cancer Board, Canada	National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Alberta Cancer Board, Canada	This work was supported in part by the National Cancer Institute of Canada, with funds from the Canadian Cancer Society and the Alberta Cancer Board, Canada.	Baldwin SA, 2004, PFLUG ARCH EUR J PHY, V447, P735, DOI 10.1007/s00424-003-1103-2; Boudker O, 2007, NATURE, V445, P387, DOI 10.1038/nature05455; CASS CE, 1995, DRUG TRANSPORT ANTIM, P403; CHE MX, 1995, J BIOL CHEM, V270, P13596, DOI 10.1074/jbc.270.23.13596; CRAIG JE, 1994, MOL MICROBIOL, V11, P1159, DOI 10.1111/j.1365-2958.1994.tb00392.x; Damaraju VL, 2007, AM J PHYSIOL-RENAL, V293, pF200, DOI 10.1152/ajprenal.00007.2007; Elwi AN, 2006, BIOCHEM CELL BIOL, V84, P844, DOI 10.1139/O06-198; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Gray JH, 2004, PFLUG ARCH EUR J PHY, V447, P728, DOI 10.1007/s00424-003-1107-y; Griffith DA, 1996, BBA-REV BIOMEMBRANES, V1286, P153, DOI 10.1016/S0304-4157(96)00008-1; Hamilton SR, 2001, J BIOL CHEM, V276, P27981, DOI 10.1074/jbc.M100518200; HUANG QQ, 1994, J BIOL CHEM, V269, P17757; King AE, 2006, TRENDS PHARMACOL SCI, V27, P416, DOI 10.1016/j.tips.2006.06.004; Latini S, 2001, J NEUROCHEM, V79, P463, DOI 10.1046/j.1471-4159.2001.00607.x; LIMAN ER, 1992, NEURON, V9, P861, DOI 10.1016/0896-6273(92)90239-A; Loewen SK, 2004, MOL MEMBR BIOL, V21, P1, DOI 10.1080/0968768031000140836; Ritzel MWL, 1998, MOL MEMBR BIOL, V15, P203; Ritzel MWL, 1997, AM J PHYSIOL-CELL PH, V272, pC707, DOI 10.1152/ajpcell.1997.272.2.C707; Ritzel MWL, 2001, J BIOL CHEM, V276, P2914, DOI 10.1074/jbc.M007746200; Screpanti E, 2007, J STRUCT BIOL, V159, P261, DOI 10.1016/j.jsb.2007.01.011; Slugoski MD, 2008, J BIOL CHEM, V283, P24922, DOI 10.1074/jbc.M801793200; Slugoski MD, 2008, J BIOL CHEM, V283, P8496, DOI 10.1074/jbc.M710433200; Slugoski MD, 2007, BIOCHEMISTRY-US, V46, P1684, DOI 10.1021/bi061692s; Slugoski MD, 2009, J BIOL CHEM, V284, P17266, DOI 10.1074/jbc.M109.009613; Smith FM, 2007, MOL MEMBR BIOL, V24, P53, DOI 10.1080/09687860600942534; Smith KM, 2005, J BIOL CHEM, V280, P25436, DOI 10.1074/jbc.M409454200; Smith KM, 2004, J PHYSIOL-LONDON, V558, P807, DOI 10.1113/jphysiol.2004.068189; Wang J, 1997, AM J PHYSIOL-RENAL, V273, pF1058, DOI 10.1152/ajprenal.1997.273.6.F1058; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; YAN RT, 1993, CELL, V75, P37, DOI 10.1016/S0092-8674(05)80082-0; YAN RT, 1995, P NATL ACAD SCI USA, V92, P5973, DOI 10.1073/pnas.92.13.5973; Yao SY, 2002, AM J PHYSIOL-CELL PH, V283, pC155, DOI 10.1152/ajpcell.00587.2001; Yao SYM, 2007, J BIOL CHEM, V282, P30607, DOI 10.1074/jbc.M703285200; Yao SYM, 2000, PRACT APPROACH SER, P47; Yao SYM, 2002, J BIOL CHEM, V277, P24938, DOI 10.1074/jbc.M200966200; Yao SYM, 2001, BIOCHEM J, V353, P387, DOI 10.1042/0264-6021:3530387; Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018; Young JD, 2008, XENOBIOTICA, V38, P995, DOI [10.1080/00498250801927427, 10.1080/00498250801927427 ]; Young JD, 2001, CURR TOP MEMBR, V50, P329; Zhang J, 2006, BIOCHEM J, V394, P389, DOI 10.1042/BJ20051476	41	14	14	1	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 19	2009	284	25					17281	17292		10.1074/jbc.M109.009704	http://dx.doi.org/10.1074/jbc.M109.009704			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	457VM	19380585	Green Published, hybrid			2022-12-27	WOS:000266962400064
J	Antos, JM; Popp, MWL; Ernst, R; Chew, GL; Spooner, E; Ploegh, HL				Antos, John M.; Popp, Maximilian Wei-Lin; Ernst, Robert; Chew, Guo-Liang; Spooner, Eric; Ploegh, Hidde L.			A Straight Path to Circular Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GREEN FLUORESCENT PROTEIN; CELL-WALL ANCHOR; STAPHYLOCOCCUS-AUREUS; SURFACE-PROTEINS; BACKBONE CYCLIZATION; IN-VIVO; CHEMICAL-SYNTHESIS; CYSTINE KNOT; SORTASE-A; KALATA B1	Folding and stability are parameters that control protein behavior. The possibility of conferring additional stability on proteins has implications for their use in vivo and for their structural analysis in the laboratory. Cyclic polypeptides ranging in size from 14 to 78 amino acids occur naturally and often show enhanced resistance toward denaturation and proteolysis when compared with their linear counterparts. Native chemical ligation and intein-based methods allow production of circular derivatives of larger proteins, resulting in improved stability and refolding properties. Here we show that circular proteins can be made reversibly with excellent efficiency by means of a sortase-catalyzed cyclization reaction, requiring only minimal modification of the protein to be circularized.	[Antos, John M.; Popp, Maximilian Wei-Lin; Ernst, Robert; Chew, Guo-Liang; Spooner, Eric; Ploegh, Hidde L.] MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Popp, Maximilian Wei-Lin; Ploegh, Hidde L.] MIT, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT)	Ploegh, HL (corresponding author), MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA.	ploegh@wi.mit.edu	Chew, Guo-Liang/R-9904-2019; Ernst, Robert/H-9513-2013	Chew, Guo-Liang/0000-0003-4357-1404; Ernst, Robert/0000-0001-5016-8694	National Institutes of Health [R21-EB008875]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB008875] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported, in whole or in part, by National Institutes of Health Grant R21-EB008875.	Antos JM, 2008, J AM CHEM SOC, V130, P16338, DOI 10.1021/ja806779e; Borodovsky A, 2002, CHEM BIOL, V9, P1149, DOI 10.1016/S1074-5521(02)00248-X; Budzik JM, 2008, P NATL ACAD SCI USA, V105, P10215, DOI 10.1073/pnas.0803565105; Budzik JM, 2008, J BIOL CHEM, V283, P36676, DOI 10.1074/jbc.M806796200; Camarero JA, 1998, ANGEW CHEM INT EDIT, V37, P347, DOI 10.1002/(SICI)1521-3773(19980216)37:3<347::AID-ANIE347>3.0.CO;2-5; Camarero JA, 2001, J MOL BIOL, V308, P1045, DOI 10.1006/jmbi.2001.4631; Camarero JA, 1997, CHEM COMMUN, P1369, DOI 10.1039/a702083j; Camarero JA, 2007, CHEMBIOCHEM, V8, P1363, DOI 10.1002/cbic.200700183; Chan LY, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001164; Clow F, 2008, BIOTECHNOL LETT, V30, P1603, DOI 10.1007/s10529-008-9718-1; Colgrave ML, 2004, BIOCHEMISTRY-US, V43, P5965, DOI 10.1021/bi049711q; Craik DJ, 2006, SCIENCE, V311, P1563, DOI 10.1126/science.1125248; Daly NL, 1999, BIOCHEMISTRY-US, V38, P10606, DOI 10.1021/bi990605b; Davies JM, 2008, STRUCTURE, V16, P715, DOI 10.1016/j.str.2008.02.010; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans TC, 2000, J BIOL CHEM, V275, P9091, DOI 10.1074/jbc.275.13.9091; Falker S, 2008, MOL MICROBIOL, V70, P595, DOI 10.1111/j.1365-2958.2008.06396.x; Gillon AD, 2008, PLANT J, V53, P505, DOI 10.1111/j.1365-313X.2007.03357.x; Hartgerink JD, 1996, J AM CHEM SOC, V118, P43, DOI 10.1021/ja953070s; Huang XY, 2003, BIOCHEMISTRY-US, V42, P11307, DOI 10.1021/bi034391g; Iwai H, 1999, FEBS LETT, V459, P166, DOI 10.1016/S0014-5793(99)01220-X; Iwai H, 2001, J BIOL CHEM, V276, P16548, DOI 10.1074/jbc.M011639200; JACKSON DY, 1995, J AM CHEM SOC, V117, P819, DOI 10.1021/ja00107a027; Kruger RG, 2004, BIOCHEMISTRY-US, V43, P1541, DOI 10.1021/bi035920j; Love KR, 2007, NAT CHEM BIOL, V3, P697, DOI 10.1038/nchembio.2007.43; Mao HY, 2004, PROTEIN EXPRES PURIF, V37, P253, DOI 10.1016/j.pep.2004.06.013; Mao HY, 2004, J AM CHEM SOC, V126, P2670, DOI 10.1021/ja039915e; Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006; Martin SS, 2002, J MOL BIOL, V319, P107, DOI 10.1016/S0022-2836(02)00246-2; Misaghi S, 2005, J BIOL CHEM, V280, P1512, DOI 10.1074/jbc.M410770200; Pallen MJ, 2001, TRENDS MICROBIOL, V9, P97, DOI 10.1016/S0966-842X(01)01956-4; Parthasarathy R, 2007, BIOCONJUGATE CHEM, V18, P469, DOI 10.1021/bc060339w; Paterson GK, 2004, TRENDS MICROBIOL, V12, P89, DOI 10.1016/j.tim.2003.12.007; Peitz M, 2007, GENESIS, V45, P508, DOI 10.1002/dvg.20321; Popp MW, 2007, NAT CHEM BIOL, V3, P707, DOI 10.1038/nchembio.2007.31; Popp MW, 2009, J BIOL CHEM, V284, P3593, DOI 10.1074/jbc.M807172200; Pritz S, 2007, J ORG CHEM, V72, P3909, DOI 10.1021/jo062331l; Samantaray S, 2008, J AM CHEM SOC, V130, P2132, DOI 10.1021/ja077358g; Saska I, 2008, TRENDS BIOCHEM SCI, V33, P363, DOI 10.1016/j.tibs.2008.04.016; Saska I, 2007, J BIOL CHEM, V282, P29721, DOI 10.1074/jbc.M705185200; SCHNEEWIND O, 1995, SCIENCE, V268, P103, DOI 10.1126/science.7701329; Scott CP, 1999, P NATL ACAD SCI USA, V96, P13638, DOI 10.1073/pnas.96.24.13638; Tanaka T, 2008, CHEMBIOCHEM, V9, P802, DOI 10.1002/cbic.200700614; Ton-That H, 1999, J BIOL CHEM, V274, P24316, DOI 10.1074/jbc.274.34.24316; Ton-That H, 2000, J BIOL CHEM, V275, P9876, DOI 10.1074/jbc.275.13.9876; Ton-That H, 1999, P NATL ACAD SCI USA, V96, P12424, DOI 10.1073/pnas.96.22.12424; Trabi M, 2002, TRENDS BIOCHEM SCI, V27, P132, DOI 10.1016/S0968-0004(02)02057-1; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246	49	119	128	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					16028	16036		10.1074/jbc.M901752200	http://dx.doi.org/10.1074/jbc.M901752200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19359246	Green Published, hybrid			2022-12-27	WOS:000266501000068
J	Chen, PY; Simons, M; Friesel, R				Chen, Pei-Yu; Simons, Michael; Friesel, Robert			FRS2 via Fibroblast Growth Factor Receptor 1 Is Required for Platelet-derived Growth Factor Receptor beta-mediated Regulation of Vascular Smooth Muscle Marker Gene Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CELL PROLIFERATION; HEPARAN-SULFATE; FGF; ASSOCIATION; ACTIVATION; BINDING; RECRUITMENT; ARTERIES; MUTATION; COMPLEX	Vascular smooth muscle cells (VSMC) exhibit phenotypic plasticity and change from a quiescent contractile phenotype to a proliferative synthetic phenotype during physiological arteriogenesis and pathological conditions such as atherosclerosis and restenosis. Platelet-derived growth factor (PDGF)-BB is a potent inducer of the VSMC synthetic phenotype; however, much less is known about the role of fibroblast growth factor-2 (FGF2) in this process. Here, we show using signal transduction mutants of FGF receptor 1 (FGFR1) expressed in rat VSMC that the adaptor protein FRS2 is essential for FGFR1-mediated phenotypic modulation and down-regulation of VSMC smooth muscle alpha-actin (SMA) gene expression. In addition, we show that PDGF-BB and FGF2 act synergistically to induce cell proliferation and down-regulate SMA and SM22 alpha in VSMC. Furthermore, we show that PDGF-BB induces tyrosine phosphorylation of FGFR1 and that this phosphorylation is mediated by PDGF receptor-beta (PDGFR beta), but not c-Src. We demonstrate that FRS2 co-immunoprecipitates with PDGFR beta in a complex that requires FGFR1 and that both the extracellular and the intracellular domains of FGFR1 are required for association with PDGFR beta, whereas the cytoplasmic domain of FGFR1 is required for FRS2 association with the FGFR1-PDGFR beta complex. Knockdown of FRS2 in VSMC by RNA interference inhibited PDGF-BB-mediated down-regulation of SMA and SM22 alpha without affecting PDGF-BB mediated cell proliferation or ERK activation. Together, these data support the notion that PDGFR beta down-regulates SMA and SM22 alpha through formation of a complex that requires FGFR1 and FRS2 and prove novel insight into VSMC phenotypic plasticity.	[Chen, Pei-Yu; Friesel, Robert] Maine Med Ctr, Ctr Mol Med, Res Inst, Scarborough, ME 04074 USA; [Chen, Pei-Yu] Univ Maine, Cooperat Grad Program Mol Genet & Cell Biol, Orono, ME 04469 USA; [Simons, Michael] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06520 USA	Maine Medical Center; University of Maine System; University of Maine Orono; Yale University	Chen, PY (corresponding author), 81 Res Dr, Scarborough, ME 04074 USA.	chenp@mmc.org; friesr@mmc.org	Chen, Pei-Yu/H-1669-2013; Simons, Michael/G-8553-2014	Simons, Michael/0000-0003-0348-7734	National Institutes of Health [R01-DK073871, R01-HL53793, P20 RR1555]; American Heart Association [0715788T]; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018789, P40RR001555] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL053793] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK073871] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants R01-DK073871 ( to R. F.), R01-HL53793 ( to M. S.), and P20 RR1555 ( to R. F.). This work was also supported by American Heart Association Founders Affiliate Predoctoral Fellowship 0715788T ( to P.-Y.C.).	Allen BL, 2001, J CELL BIOL, V155, P845, DOI 10.1083/jcb.200106075; Andrae J, 2008, GENE DEV, V22, P1276, DOI 10.1101/gad.1653708; BENJAMIN CW, 1994, J BIOL CHEM, V269, P30911; Burgar HR, 2002, J BIOL CHEM, V277, P4018, DOI 10.1074/jbc.M107785200; Chen PY, 2009, BIOCHEM BIOPH RES CO, V382, P424, DOI 10.1016/j.bbrc.2009.03.040; Chiara F, 2004, J BIOL CHEM, V279, P42516, DOI 10.1074/jbc.M406051200; Firulli AB, 1998, IN VITRO CELL DEV-AN, V34, P217; HOLYCROSS BJ, 1992, CIRC RES, V71, P1525, DOI 10.1161/01.RES.71.6.1525; Larsson H, 1999, J BIOL CHEM, V274, P25726, DOI 10.1074/jbc.274.36.25726; LINDNER V, 1991, P NATL ACAD SCI USA, V88, P3739, DOI 10.1073/pnas.88.9.3739; LINDNER V, 1993, CIRC RES, V73, P589, DOI 10.1161/01.RES.73.3.589; Lindner V, 1995, Z KARDIOL, V84, P137; Lundgren TK, 2006, J BIOL CHEM, V281, P29886, DOI 10.1074/jbc.M600473200; Mack CP, 1999, CIRC RES, V84, P852; Millette E, 2006, TRENDS CARDIOVAS MED, V16, P25, DOI 10.1016/j.tcm.2005.11.003; Millette E, 2005, CIRC RES, V96, P172, DOI 10.1161/01.RES.0000154595.87608.db; MOHAMMADI M, 1992, NATURE, V358, P681, DOI 10.1038/358681a0; Mood K, 2002, J BIOL CHEM, V277, P33196, DOI 10.1074/jbc.M203894200; Muto A, 2007, J VASC SURG, V45, p15A, DOI 10.1016/j.jvs.2007.02.061; Neilson KM, 1996, J BIOL CHEM, V271, P25049, DOI 10.1074/jbc.271.40.25049; Ong SH, 2001, P NATL ACAD SCI USA, V98, P6074, DOI 10.1073/pnas.111114298; Ong SH, 2000, MOL CELL BIOL, V20, P979, DOI 10.1128/MCB.20.3.979-989.2000; Ornitz DM, 2000, BIOESSAYS, V22, P108, DOI 10.1002/(SICI)1521-1878(200002)22:2<108::AID-BIES2>3.0.CO;2-M; Owens Gary K, 2007, Novartis Found Symp, V283, P174; Rauch BH, 2005, J BIOL CHEM, V280, P17507, DOI 10.1074/jbc.M410848200; Rzucidlo EM, 2007, J VASC SURG, V45, p25A, DOI 10.1016/j.jvs.2007.03.001; Sachsenmaier C, 1999, ONCOGENE, V18, P3583, DOI 10.1038/sj.onc.1202694; Saito Y, 2001, MOL CELL BIOL, V21, P6387, DOI 10.1128/MCB.21.19.6387-6394.2001; Tanimoto T, 2004, CIRC RES, V94, P1050, DOI 10.1161/01.RES.0000126404.41421.BE; Thisse B, 2005, DEV BIOL, V287, P390, DOI 10.1016/j.ydbio.2005.09.011; VAINIKKA S, 1994, J BIOL CHEM, V269, P18320; WANG JK, 1994, MOL CELL BIOL, V14, P181, DOI 10.1128/MCB.14.1.181; Xu H, 1998, J BIOL CHEM, V273, P17987, DOI 10.1074/jbc.273.29.17987; Yang X, 2006, CALCIFIED TISSUE INT, V78, P233, DOI 10.1007/s00223-005-0231-4; Yoshida T, 2003, CIRC RES, V92, P856, DOI 10.1161/01.RES.0000068405.49081.09	36	41	44	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN 5	2009	284	23					15980	15992		10.1074/jbc.M809399200	http://dx.doi.org/10.1074/jbc.M809399200			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	451WG	19339244	Green Published, hybrid			2022-12-27	WOS:000266501000064
J	Kim, TH; Kim, H; Park, JM; Im, SS; Bae, JS; Kim, MY; Yoon, HG; Cha, JY; Kim, KS; Ahn, YH				Kim, Tae-Hyun; Kim, Hail; Park, Joo-Man; Im, Seung-Soon; Bae, Jin-Sik; Kim, Mi-Young; Yoon, Ho-Geun; Cha, Ji-Young; Kim, Kyung-Sup; Ahn, Yong-Ho			Interrelationship between Liver X Receptor alpha, Sterol Regulatory Element-binding Protein-1c, Peroxisome Proliferator-activated Receptor gamma, and Small Heterodimer Partner in the Transcriptional Regulation of Glucokinase Gene Expression in Liver	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ORPHAN NUCLEAR RECEPTOR; ACID SYNTHASE GENE; LXR-ALPHA; HEPATIC GLUCOKINASE; GLUCOSE-METABOLISM; RESPONSE ELEMENT; TRANSGENIC MICE; GLUT2 PROMOTER; PPAR-GAMMA; CELL-LINE	Liver glucokinase (LGK) plays an essential role in controlling blood glucose levels and maintaining cellular metabolic functions. Expression of LGK is induced mainly regulated by insulin through sterol regulatory element-binding protein-1c (SREBP-1c) as a mediator. Since LGK expression is known to be decreased in the liver of liver X receptor (LXR) knockout mice, we have investigated whether LGK might be directly activated by LXR alpha. Furthermore, we have studied interrelationship between transcription factors that control gene expression of LGK. In the current studies, we demonstrated that LXR alpha increased LGK expression in primary hepatocytes and that there is a functional LXR response element in the LGK gene promoter as shown by electrophoretic mobility shift and chromatin precipitation assay. In addition, our studies demonstrate that LXR alpha and insulin activation of the LGK gene promoter occurs through a multifaceted indirect mechanism. LXR alpha increases SREBP-1c expression and then insulin stimulates the processing of the membrane-bound precursor SREBP-1c protein, and it activates LGK expression through SREBP sites in its promoter. LXR alpha also activates the LGK promoter by increasing the transcriptional activity and induction of peroxisome proliferator-activated receptor (PPAR)-gamma, which also stimulates LGK expression through a peroxisome proliferator-responsive element. This activation is tempered through a negative mechanism, where a small heterodimer partner (SHP) decreases LGK gene expression by inhibiting the transcriptional activity of LXR alpha and PPAR gamma by directly interacting with their common heterodimer partner RXR alpha. From these data, we propose a mechanism for LXR alpha in controlling the gene expression of LGK that involves activation through SREBP-1c and PPAR gamma and inhibition through SHP.	[Kim, Tae-Hyun; Kim, Hail; Park, Joo-Man; Im, Seung-Soon; Bae, Jin-Sik; Kim, Mi-Young; Yoon, Ho-Geun; Kim, Kyung-Sup; Ahn, Yong-Ho] Yonsei Univ, Dept Biochem & Mol Biol, Coll Med, Seoul 120752, South Korea; [Kim, Tae-Hyun; Park, Joo-Man; Yoon, Ho-Geun; Kim, Kyung-Sup; Ahn, Yong-Ho] Yonsei Univ, Brain Korea Project Med Sci 21, Coll Med, Seoul 120752, South Korea; [Kim, Tae-Hyun; Kim, Hail; Park, Joo-Man; Im, Seung-Soon; Bae, Jin-Sik; Kim, Mi-Young; Yoon, Ho-Geun; Kim, Kyung-Sup; Ahn, Yong-Ho] Yonsei Univ, Ctr Chron Metab Dis Res, Coll Med, Seoul 120752, South Korea; [Kim, Kyung-Sup] Yonsei Univ, Inst Genet Sci, Coll Med, Seoul 120752, South Korea; [Cha, Ji-Young] Gachon Univ Med & Sci, Lee Gil Ya Canc & Diabet Inst, Inchon 406840, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Gachon University	Ahn, YH (corresponding author), Yonsei Univ, Dept Biochem & Mol Biol, Coll Med, 134 Shinchon Dong, Seoul 120752, South Korea.	yha111@yuhs.ac	Kim, Hail/C-1849-2011; AHN, Yong Ho/H-6712-2017; Kim, Hail/C-5608-2018	Kim, Hail/0000-0002-6652-1349; AHN, Yong Ho/0000-0002-4133-0757; Yoon, Ho-Geun Yoon/0000-0003-2718-3372; Kim, Kyung-sup/0000-0001-8483-8537	Korean government [R13-2002-054-03001-0]; Yonsei University College of Medicine [2005 6-2005-0047]; Yonsei University Research Fund [6-2005-0084]	Korean government(Korean Government); Yonsei University College of Medicine(General Electric); Yonsei University Research Fund	This work was supported by Korea Science and Engineering Foundation Grant R13-2002-054-03001-0 funded by the Korean government, Yonsei University College of Medicine faculty research grant for 2005 6-2005-0047, and Yonsei University Research Fund of 2005 Grant 6-2005-0084 (to H. K.). Downloaded from www.jbc.org at ISI, Thomson Scientific on May 26, 2009	Aiston S, 1999, J BIOL CHEM, V274, P24559, DOI 10.1074/jbc.274.35.24559; Brendel C, 2002, MOL ENDOCRINOL, V16, P2065, DOI 10.1210/me.2001-0194; Cao GQ, 2003, J BIOL CHEM, V278, P1131, DOI 10.1074/jbc.M210208200; Chen GX, 2004, P NATL ACAD SCI USA, V101, P11245, DOI 10.1073/pnas.0404297101; Dalen KT, 2003, J BIOL CHEM, V278, P48283, DOI 10.1074/jbc.M302287200; Ferre T, 1996, FASEB J, V10, P1213, DOI 10.1096/fasebj.10.10.8751724; Foretz M, 1999, P NATL ACAD SCI USA, V96, P12737, DOI 10.1073/pnas.96.22.12737; Goodwin B, 2003, MOL ENDOCRINOL, V17, P386, DOI 10.1210/me.2002-0246; Hariharan N, 1997, DIABETES, V46, P11, DOI 10.2337/diabetes.46.1.11; Hegarty BD, 2005, P NATL ACAD SCI USA, V102, P791, DOI 10.1073/pnas.0405067102; Im SS, 2005, EXP MOL MED, V37, P101, DOI 10.1038/emm.2005.14; IYNEDJIAN PB, 1989, P NATL ACAD SCI USA, V86, P7838, DOI 10.1073/pnas.86.20.7838; IYNEDJIAN PB, 1989, J BIOL CHEM, V264, P21824; Janowski BA, 1999, P NATL ACAD SCI USA, V96, P266, DOI 10.1073/pnas.96.1.266; Joseph SB, 2002, J BIOL CHEM, V277, P11019, DOI 10.1074/jbc.M111041200; Kalaany NY, 2005, CELL METAB, V1, P231, DOI 10.1016/j.cmet.2005.03.001; Kim H, 2000, DIABETES, V49, P1517, DOI 10.2337/diabetes.49.9.1517; Kim HI, 2007, BIOCHEM BIOPH RES CO, V360, P301, DOI 10.1016/j.bbrc.2007.05.171; Kim HI, 2002, DIABETES, V51, P676, DOI 10.2337/diabetes.51.3.676; Kim JB, 1998, P NATL ACAD SCI USA, V95, P4333, DOI 10.1073/pnas.95.8.4333; Kim JY, 2004, MOL ENDOCRINOL, V18, P776, DOI 10.1210/me.2003-0311; Kim S, 2004, DIABETES, V53, pS66, DOI 10.2337/diabetes.53.2007.S66; Kim SY, 2004, J BIOL CHEM, V279, P30823, DOI 10.1074/jbc.M313223200; Kim YS, 2001, J BIOL CHEM, V276, P33736, DOI 10.1074/jbc.M101977200; Laffitte BA, 2003, P NATL ACAD SCI USA, V100, P5419, DOI 10.1073/pnas.0830671100; Latasa MJ, 2003, MOL CELL BIOL, V23, P5896, DOI 10.1128/MCB.23.16.5896-5907.2003; Lee HK, 1998, J BIOL CHEM, V273, P14398, DOI 10.1074/jbc.273.23.14398; Lee YK, 2000, MOL CELL BIOL, V20, P187, DOI 10.1128/MCB.20.1.187-195.2000; Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200; MAGNUSON MA, 1990, DIABETES, V39, P523, DOI 10.2337/diabetes.39.5.523; MAGNUSON MA, 1989, P NATL ACAD SCI USA, V86, P4838, DOI 10.1073/pnas.86.13.4838; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Nishizawa H, 2002, J BIOL CHEM, V277, P1586, DOI 10.1074/jbc.M104301200; Niswender KD, 1997, J BIOL CHEM, V272, P22570, DOI 10.1074/jbc.272.36.22570; Nordlie RC, 1999, ANNU REV NUTR, V19, P379, DOI 10.1146/annurev.nutr.19.1.379; Oosterveer MH, 2008, J BIOL CHEM, V283, P25437, DOI 10.1074/jbc.M801922200; Park KG, 2007, DIABETES, V56, P431, DOI 10.2337/db06-0753; Peet DJ, 1998, CELL, V93, P693, DOI 10.1016/S0092-8674(00)81432-4; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Repa JJ, 2002, NAT MED, V8, P1243, DOI 10.1038/nm1102-1243; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Seo JB, 2004, MOL CELL BIOL, V24, P3430, DOI 10.1128/MCB.24.8.3430-3444.2004; Seol W, 1996, SCIENCE, V272, P1336, DOI 10.1126/science.272.5266.1336; Shulman AI, 2005, NEW ENGL J MED, V353, P604, DOI 10.1056/NEJMra043590; Sinal CJ, 2000, CELL, V102, P731, DOI 10.1016/S0092-8674(00)00062-3; Tontonoz P, 2003, MOL ENDOCRINOL, V17, P985, DOI 10.1210/me.2003-0061; Wagner BL, 2003, MOL CELL BIOL, V23, P5780, DOI 10.1128/MCB.23.16.5780-5789.2003; WILLY PJ, 1995, GENE DEV, V9, P1033, DOI 10.1101/gad.9.9.1033; Yamagata K, 2004, J BIOL CHEM, V279, P23158, DOI 10.1074/jbc.M314322200; Zhang Y, 2004, VITAM HORM, V68, P1	50	68	70	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					15071	15083		10.1074/jbc.M109.006742	http://dx.doi.org/10.1074/jbc.M109.006742			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19366697	Green Published, hybrid			2022-12-27	WOS:000266288200043
J	Usatyuk, PV; Gorshkova, IA; He, DH; Zhao, YT; Kalari, SK; Garcia, JGN; Natarajan, V				Usatyuk, Peter V.; Gorshkova, Irina A.; He, Donghong; Zhao, Yutong; Kalari, Satish K.; Garcia, Joe G. N.; Natarajan, Viswanathan			Phospholipase D-mediated Activation of IQGAP1 through Rac1 Regulates Hyperoxia-induced p47(phox) Translocation and Reactive Oxygen Species Generation in Lung Endothelial Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-KINASE-C; BRONCHIAL EPITHELIAL-CELLS; NADPH OXIDASE ACTIVATION; SMOOTH-MUSCLE-CELLS; PHOSPHATIDIC-ACID; NAD(P)H OXIDASE; ACTIN CYTOSKELETON; PLASMA-MEMBRANE; BINDING PROTEIN; ANGIOTENSIN-II	Phosphatidic acid generated by the activation of phospholipase D (PLD) functions as a second messenger and plays a vital role in cell signaling. Here we demonstrate that PLD-dependent generation of phosphatidic acid is critical for Rac1/IQGAP1 signal transduction, translocation of p47(phox) to cell periphery, and ROS production. Exposure of [P-32] orthophosphate-labeled human pulmonary artery endothelial cells (HPAECs) to hyperoxia (95% O-2 and 5% CO2) in the presence of 0.05% 1-butanol, but not tertiary-butanol, stimulated PLD as evidenced by accumulation of [P-32] phosphatidylbutanol. Infection of HPAECs with adenoviral constructs of PLD1 and PLD2 wild-type potentiated hyperoxia-induced PLD activation and accumulation of O-2(radical anion)/reactive oxygen species (ROS). Conversely, overexpression of catalytically inactive mutants of PLD (hPLD1-K898R or mPLD2-K758R) or down-regulation of expression of PLD with PLD1 or PLD2 siRNA did not augment hyperoxia-induced [P-32] phosphatidylbutanol accumulation and ROS generation. Hyperoxia caused rapid activation and redistribution of Rac1, and IQGAP1 to cell periphery, and down-regulation of Rac1, and IQGAP1 attenuated hyperoxia-induced tyrosine phosphorylation of Src and cortactin and ROS generation. Further, hyperoxia-mediated redistribution of Rac1, and IQGAP1 to membrane ruffles, was attenuated by PLD1 or PLD2 small interference RNA, suggesting that PLD is upstream of the Rac1/IQGAP1 signaling cascade. Finally, small interference RNA for PLD1 or PLD2 attenuated hyperoxia-induced cortactin tyrosine phosphorylation and abolished Src, cortactin, and p47(phox) redistribution to cell periphery. These results demonstrate a role of PLD in hyperoxia-mediated IQGAP1 activation through Rac1 in tyrosine phosphorylation of Src and cortactin, as well as in p47(phox) translocation and ROS formation in human lung endothelial cells.	[Usatyuk, Peter V.; Gorshkova, Irina A.; He, Donghong; Zhao, Yutong; Kalari, Satish K.; Garcia, Joe G. N.; Natarajan, Viswanathan] Univ Chicago, Dept Med, Chicago, IL 60637 USA	University of Chicago	Natarajan, V (corresponding author), Univ Chicago, Dept Med, CIS Bldg,Rm W408B,929 East 57th St, Chicago, IL 60637 USA.	vnataraj@medicine.bsd.uchicago.edu	Kalari, Satish/C-6967-2012; Garcia, Joe GN/E-8862-2010		National Institutes of Health [PO1 HL 58064]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL058064] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grant PO1 HL 58064 (to V.N. and J.G.N.G.).	ABO A, 1994, BIOCHEM J, V298, P585, DOI 10.1042/bj2980585; Ago T, 2004, CIRCULATION, V109, P227, DOI 10.1161/01.CIR.0000105680.92873.70; AGWU DE, 1991, J CLIN INVEST, V88, P531, DOI 10.1172/JCI115336; Al-Mehdi AB, 1998, CIRC RES, V83, P730, DOI 10.1161/01.RES.83.7.730; Allen LAH, 1999, BLOOD, V93, P3521, DOI 10.1182/blood.V93.10.3521.410k21_3521_3530; ANDO S, 1992, J BIOL CHEM, V267, P25709; BENGISGARBER C, 1995, CELL SIGNAL, V7, P721, DOI 10.1016/0898-6568(95)00040-V; Bokoch GM, 2006, ANTIOXID REDOX SIGN, V8, P1533, DOI 10.1089/ars.2006.8.1533; Briggs MW, 2003, EMBO REP, V4, P571, DOI 10.1038/sj.embor.embor867; Brown HA, 2007, METHOD ENZYMOL, V434, P49, DOI 10.1016/S0076-6879(07)34004-4; Brown MD, 2006, TRENDS CELL BIOL, V16, P242, DOI 10.1016/j.tcb.2006.03.002; Brueckl C, 2006, AM J RESP CELL MOL, V34, P453, DOI 10.1165/rcmb.2005-0223OC; Cave AC, 2006, ANTIOXID REDOX SIGN, V8, P691, DOI 10.1089/ars.2006.8.691; Chae YC, 2008, MOL BIOL CELL, V19, P3111, DOI 10.1091/mbc.E07-04-0337; Chowdhury AK, 2005, J BIOL CHEM, V280, P20700, DOI 10.1074/jbc.M411722200; Clark RA, 1999, J INFECT DIS, V179, pS309, DOI 10.1086/513849; Cummings R, 2002, MOL CELL BIOCHEM, V234, P99, DOI 10.1023/A:1015944828973; Exton JH, 2002, REV PHYSIOL BIOCH P, V144, P1, DOI 10.1007/BFb0116585; Faraudo J, 2007, BIOPHYS J, V92, P2806, DOI 10.1529/biophysj.106.092015; Fontayne A, 2002, BIOCHEMISTRY-US, V41, P7743, DOI 10.1021/bi011953s; Foster DA, 2007, CANCER RES, V67, P1, DOI 10.1158/0008-5472.CAN-06-3016; Frey RS, 2009, ANTIOXID REDOX SIGN, V11, P791, DOI [10.1089/ars.2008.2220, 10.1089/ARS.2008.2220]; Fukata M, 2002, CELL, V109, P873, DOI 10.1016/S0092-8674(02)00800-0; Fukata M, 2001, MOL CELL BIOL, V21, P2165, DOI 10.1128/MCB.21.6.2165-2183.2001; Gorshkova I, 2008, J BIOL CHEM, V283, P11794, DOI 10.1074/jbc.M800250200; Gorzalczany Y, 2000, J BIOL CHEM, V275, P40073, DOI 10.1074/jbc.M006013200; Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494; Hammond SM, 1997, J BIOL CHEM, V272, P3860, DOI 10.1074/jbc.272.6.3860; Henderson LM, 1996, BBA-BIOENERGETICS, V1273, P87, DOI 10.1016/0005-2728(95)00140-9; HEYWORTH PG, 1994, J BIOL CHEM, V269, P30749; Hordijk PL, 2006, CIRC RES, V98, P453, DOI 10.1161/01.RES.0000204727.46710.5e; Ikeda S, 2005, ARTERIOSCL THROM VAS, V25, P2295, DOI 10.1161/01.ATV.0000187472.55437.af; Jadeski L, 2008, J BIOL CHEM, V283, P1008, DOI 10.1074/jbc.M708466200; Jenkins GM, 2005, CELL MOL LIFE SCI, V62, P2305, DOI 10.1007/s00018-005-5195-z; Kooijman EE, 2007, J BIOL CHEM, V282, P11356, DOI 10.1074/jbc.M609737200; Kuroda S, 1996, J BIOL CHEM, V271, P23363, DOI 10.1074/jbc.271.38.23363; Mataraza JM, 2007, CELL SIGNAL, V19, P1857, DOI 10.1016/j.cellsig.2007.04.011; McPhail LC, 1999, BBA-MOL CELL BIOL L, V1439, P277, DOI 10.1016/S1388-1981(99)00100-6; Morris AJ, 1997, ANAL BIOCHEM, V252, P1, DOI 10.1006/abio.1997.2299; Natarajan V, 1996, CHEM PHYS LIPIDS, V80, P103, DOI 10.1016/0009-3084(96)02548-0; Ohguchi K, 1997, J BIOL CHEM, V272, P1990, DOI 10.1074/jbc.272.3.1990; Owen D, 2008, J BIOL CHEM, V283, P1692, DOI 10.1074/jbc.M707257200; Palicz A, 2001, J BIOL CHEM, V276, P3090, DOI 10.1074/jbc.M007759200; Parinandi NL, 1999, ANTIOXID REDOX SIGN, V1, P193, DOI 10.1089/ars.1999.1.2-193; Parinandi NL, 2003, AM J PHYSIOL-LUNG C, V284, pL26, DOI 10.1152/ajplung.00123.2002; Parinandi NL, 2001, ARCH BIOCHEM BIOPHYS, V396, P231, DOI 10.1006/abbi.2001.2609; Pendyala S, 2008, ANTIOXID REDOX SIGNA; Pendyala S, 2009, ANTIOXID REDOX SIGN, V11, P747, DOI [10.1089/ars.2008.2203, 10.1089/ARS.2008.2203]; Pettitt TR, 2001, BIOCHEM J, V360, P707, DOI 10.1042/0264-6021:3600707; Powner DJ, 2002, MOL BIOL CELL, V13, P1252, DOI 10.1091/mbc.01-05-0235; QUINN MT, 1993, J BIOL CHEM, V268, P20983; Regier DS, 2000, J BIOL CHEM, V275, P28406, DOI 10.1074/jbc.M004703200; Regier DS, 1999, J BIOL CHEM, V274, P36601, DOI 10.1074/jbc.274.51.36601; Roy S, 2003, ANTIOXID REDOX SIGN, V5, P217, DOI 10.1089/152308603764816578; Sohn HY, 2000, J BIOL CHEM, V275, P18745, DOI 10.1074/jbc.M000026200; Tamura M, 2000, BIOCHEM BIOPH RES CO, V276, P1186, DOI 10.1006/bbrc.2000.3598; Touyz RM, 2005, ARTERIOSCL THROM VAS, V25, P512, DOI 10.1161/01.ATV.0000154141.66879.98; Touyz RM, 2003, ARTERIOSCL THROM VAS, V23, P981, DOI 10.1161/01.ATV.0000069236.27911.68; Ugolev Y, 2008, J BIOL CHEM, V283, P22257, DOI 10.1074/jbc.M800734200; Usatyuk PV, 2007, J BIOL CHEM, V282, P23284, DOI 10.1074/jbc.M700535200; Usatyuk PV, 2003, ANTIOXID REDOX SIGN, V5, P723, DOI 10.1089/152308603770380025; Ushio-Fukai M, 2006, CARDIOVASC RES, V71, P226, DOI 10.1016/j.cardiores.2006.04.015; Waite KA, 1997, J BIOL CHEM, V272, P15569, DOI 10.1074/jbc.272.24.15569; Wang LX, 2002, BIOCHEM J, V367, P751, DOI 10.1042/BJ20020586; Wang YP, 2008, EXP MOL PATHOL, V85, P122, DOI 10.1016/j.yexmp.2008.06.001; Wang YP, 2008, INT J MOL MED, V22, P79; Watanabe T, 2004, DEV CELL, V7, P871, DOI 10.1016/j.devcel.2004.10.017; WOLFSON M, 1985, J IMMUNOL, V135, P2057; Yamaoka-Tojo M, 2004, CIRC RES, V95, P276, DOI 10.1161/01.RES.0000136522.58649.60; Yamaoka-Tojo M, 2006, ARTERIOSCL THROM VAS, V26, P1991, DOI 10.1161/01.ATV.0000231524.14873.e7; Zhan Y, 2004, J CELL BIOCHEM, V92, P795, DOI 10.1002/jcb.20084; Zhao YT, 2000, BIOCHEM BIOPH RES CO, V278, P140, DOI 10.1006/bbrc.2000.3719	72	53	55	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 29	2009	284	22					15339	15352		10.1074/jbc.M109.005439	http://dx.doi.org/10.1074/jbc.M109.005439			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448UT	19366706	hybrid, Green Published			2022-12-27	WOS:000266288200068
J	Jansen, S; Andries, M; Derua, R; Waelkens, E; Bollen, M				Jansen, Silvia; Andries, Maria; Derua, Rita; Waelkens, Etienne; Bollen, Mathieu			Domain Interplay Mediated by an Essential Disulfide Linkage Is Critical for the Activity and Secretion of the Metastasis-promoting Enzyme Autotaxin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LYSOPHOSPHATIDIC ACID; NUCLEOTIDE PYROPHOSPHATASES/PHOSPHODIESTERASES; LYSOPHOSPHOLIPASE-D; IDENTIFICATION; INVOLVEMENT	Autotaxin or NPP2 (nucleotide pyrophosphatase/phosphodiesterase 2) is a secreted lysophospholipase-D that promotes metastasis and tumor growth by its ability to generate lysophosphatidic acid. Considerable evidence suggests that inhibitors of NPP2 can be used as a novel therapy for the treatment of cancer. Although most attention is currently directed toward the development of inhibitors of the catalytic site, we have explored whether NPP2 can also be targeted through its non-catalytic nuclease-like domain. We demonstrate here that the catalytic and nuclease-like domains are covalently linked by an essential disulfide bridge between Cys(413) and Cys(805). Within the nuclease-like domain, residues 829-850 are involved in the secretion of NPP2, and Lys(852) is required for the expression of catalytic activity. These data show that the nuclease-like domain is crucial for catalysis by NPP2 and is a possible target to generate inhibitors.	[Jansen, Silvia; Andries, Maria; Bollen, Mathieu] Univ Louvain, Dept Mol Cell Biol, Lab Biosignalling & Therapeut, B-3000 Louvain, Belgium; [Derua, Rita; Waelkens, Etienne] Univ Louvain, Dept Mol Cell Biol, Lab Prot Phosphorylat & Prote, B-3000 Louvain, Belgium		Bollen, M (corresponding author), KULeuven, Dept Mol Celbiol, Campus Gasthuisberg,Herestraat 49,Box 901, B-3000 Louvain, Belgium.	Mathieu.Bollen@med.kuleuven.be			Scientific Research Flanders [0524.06]; Flemish Concerted Research Action; Prime Minister's office [IAP/V-05]	Scientific Research Flanders(FWO); Flemish Concerted Research Action; Prime Minister's office	This work was supported by grants from the Fund for Scientific Research Flanders (Grant G. 0524.06), a Flemish Concerted Research Action, and the Prime Minister's office (Grant IAP/V-05).	Baumforth KRN, 2005, BLOOD, V106, P2138, DOI 10.1182/blood-2005-02-0471; CARRINGTON JC, 1988, P NATL ACAD SCI USA, V85, P3391, DOI 10.1073/pnas.85.10.3391; Choi JW, 2008, BBA-MOL CELL BIOL L, V1781, P531, DOI 10.1016/j.bbalip.2008.03.004; Cimpean A, 2004, BIOCHEM J, V381, P71, DOI 10.1042/BJ20040465; Federico L, 2008, CURR DRUG TARGETS, V9, P698, DOI 10.2174/138945008785132439; Gijsbers R, 2003, BIOCHEM J, V371, P321, DOI 10.1042/BJ20021943; Gijsbers R, 2001, J BIOL CHEM, V276, P1361, DOI 10.1074/jbc.M007552200; Hoelzinger DB, 2008, J NEURO-ONCOL, V86, P297, DOI 10.1007/s11060-007-9480-6; Jansen S, 2005, J CELL SCI, V118, P3081, DOI 10.1242/jcs.02438; Jansen S, 2007, J BIOL CHEM, V282, P11084, DOI 10.1074/jbc.M611503200; Kanda H, 2008, NAT IMMUNOL, V9, P415, DOI 10.1038/ni1573; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Mazereeuw-Hautier J, 2005, J INVEST DERMATOL, V125, P421, DOI 10.1111/j.0022-202X.2005.23855.x; Nakasaki T, 2008, AM J PATHOL, V173, P1566, DOI 10.2353/ajpath.2008.071153; Parrill AL, 2008, BIOORGAN MED CHEM, V16, P1784, DOI 10.1016/j.bmc.2007.11.018; Rigden DJ, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-9; Saunders LP, 2008, MOL CANCER THER, V7, P3352, DOI 10.1158/1535-7163.MCT-08-0463; Stefan C, 2005, TRENDS BIOCHEM SCI, V30, P542, DOI 10.1016/j.tibs.2005.08.005; Tanaka M, 2006, J BIOL CHEM, V281, P25822, DOI 10.1074/jbc.M605142200; van Meeteren LA, 2008, CANCER LETT, V266, P203, DOI 10.1016/j.canlet.2008.02.052; van Meeteren LA, 2006, MOL CELL BIOL, V26, P5015, DOI 10.1128/MCB.02419-05; Yang SY, 2002, CLIN EXP METASTAS, V19, P603, DOI 10.1023/A:1020950420196	22	21	24	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14296	14302		10.1074/jbc.M900790200	http://dx.doi.org/10.1074/jbc.M900790200			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19329427	Green Published, hybrid			2022-12-27	WOS:000266286100036
J	Sakaguchi, M; Kataoka, K; Abarzua, F; Tanimoto, R; Watanabe, M; Murata, H; Than, SS; Kurose, K; Kashiwakura, Y; Ochiai, K; Nasu, Y; Kumon, H; Huh, N				Sakaguchi, Masakiyo; Kataoka, Ken; Abarzua, Fernando; Tanimoto, Ryuta; Watanabe, Masami; Murata, Hitoshi; Than, Swe Swe; Kurose, Kaoru; Kashiwakura, Yuji; Ochiai, Kazuhiko; Nasu, Yasutomo; Kumon, Hiromi; Huh, Nam-ho			Overexpression of REIC/Dkk-3 in Normal Fibroblasts Suppresses Tumor Growth via Induction of Interleukin-7	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ENDOPLASMIC-RETICULUM STRESS; REDUCED EXPRESSION; GENE-EXPRESSION; DOWN-REGULATION; CANCER-CELLS; T-CELLS; ACTIVATION; APOPTOSIS; MICE; MICROENVIRONMENT	We previously showed that the tumor suppressor gene REIC/Dkk-3, when overexpressed by an adenovirus (Ad-REIC), exhibited a dramatic therapeutic effect on human cancers through a mechanism triggered by endoplasmic reticulum stress. Adenovirus vectors show no target cell specificity and thus may elicit unfavorable side effects through infection of normal cells even upon intra-tumoral injection. In this study, we examined possible effects of Ad-REIC on normal cells. We found that infection of normal human fibroblasts (NHF) did not cause apoptosis but induced production of interleukin (IL)-7. The induction was triggered by endoplasmic reticulum stress and mediated through IRE1 alpha, ASK1, p38, and IRF-1. When Ad-REIC-infected NHF were transplanted in a mixture with untreated human prostate cancer cells, the growth of the cancer cells was significantly suppressed. Injection of an IL-7 antibody partially abrogated the suppressive effect of Ad-REIC-infected NHF. These results indicate that Ad-REIC has another arm against human cancer, an indirect host-mediated effect because of overproduction of IL-7 by mis-targeted NHF, in addition to its direct effect on cancer cells.	[Sakaguchi, Masakiyo; Kataoka, Ken; Abarzua, Fernando; Tanimoto, Ryuta; Murata, Hitoshi; Than, Swe Swe; Kurose, Kaoru; Huh, Nam-ho] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cell Biol, Okayama 7008558, Japan; [Abarzua, Fernando; Tanimoto, Ryuta; Watanabe, Masami; Kashiwakura, Yuji; Nasu, Yasutomo; Kumon, Hiromi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Urol, Okayama 7008558, Japan; [Ochiai, Kazuhiko] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Innovat Ctr Okayama Nanobiotargeted Therapy, Okayama 7008558, Japan	Okayama University; Okayama University; Okayama University	Huh, N (corresponding author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Cell Biol, 2-5-1 Shikatachou, Okayama 7008558, Japan.	namu@md.okayama-u.ac.jp	MURATA, Hitoshi/B-2327-2011; KATAOKA, Ken/B-1607-2011; Sakaguchi, Masakiyo/B-2280-2011	OCHIAI, Kazuhiko/0000-0002-5736-0598	Ministry of Education, Culture, Sports, Science, and Technology of Japan [20015031]; Special Coordination Funds for Promoting Science and Technology	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Special Coordination Funds for Promoting Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by Grant 20015031 from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (to N.H.) and by Special Coordination Funds for Promoting Science and Technology (to H. K.).	Abarzua F, 2005, CANCER RES, V65, P9617, DOI 10.1158/0008-5472.CAN-05-0829; Aragane Y, 1997, J IMMUNOL, V158, P5393; BAI L, 1993, INT J CANCER, V53, P451, DOI 10.1002/ijc.2910530317; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; BUDZYNSKI W, 1994, IMMUNOPHARM IMMUNOT, V16, P319, DOI 10.3109/08923979409007097; Edamura K, 2007, CANCER GENE THER, V14, P765, DOI 10.1038/sj.cgt.7701071; Fricker J, 1996, MOL MED TODAY, V2, P2, DOI 10.1016/1357-4310(96)88745-4; Fry TJ, 2002, BLOOD, V99, P3892, DOI 10.1182/blood.V99.11.3892; Gollob JA, 1999, J IMMUNOL, V162, P4472; He B, 2006, CELL DEATH DIFFER, V13, P393, DOI 10.1038/sj.cdd.4401833; Jiang Q, 2005, CYTOKINE GROWTH F R, V16, P513, DOI 10.1016/j.cytogfr.2005.05.004; Kashiwakura Y, 2008, CANCER RES, V68, P8333, DOI 10.1158/0008-5472.CAN-08-0080; Kawasaki K, 2009, CANCER GENE THER, V16, P65, DOI 10.1038/cgt.2008.58; Kenny PA, 2003, INT J CANCER, V107, P688, DOI 10.1002/ijc.11491; Kenny PA, 2007, FRONT BIOSCI-LANDMRK, V12, P3468, DOI 10.2741/2327; Kim BG, 2006, NATURE, V441, P1015, DOI 10.1038/nature04846; Kobayashi K, 2002, GENE, V282, P151, DOI 10.1016/S0378-1119(01)00838-1; Kurose K, 2004, J UROLOGY, V171, P1314, DOI 10.1097/01.ju.0000101047.64379.d4; Li XX, 1996, J BIOL CHEM, V271, P5790, DOI 10.1074/jbc.271.10.5790; Matsuzawa A, 2005, NAT IMMUNOL, V6, P587, DOI 10.1038/ni1200; Miller PW, 2000, HUM GENE THER, V11, P53, DOI 10.1089/10430340050016157; MINTZ B, 1975, P NATL ACAD SCI USA, V72, P3585, DOI 10.1073/pnas.72.9.3585; Mueller MM, 2004, NAT REV CANCER, V4, P839, DOI 10.1038/nrc1477; Nozaki I, 2001, INT J ONCOL, V19, P117; Oshima S, 2004, MOL CELL BIOL, V24, P6298, DOI 10.1128/MCB.24.14.6298-6310.2004; Postovit LM, 2008, P NATL ACAD SCI USA, V105, P4329, DOI 10.1073/pnas.0800467105; Rein Daniel T, 2006, Future Oncol, V2, P137, DOI 10.2217/14796694.2.1.137; Sakaguchi M, 2008, MOL BIOL CELL, V19, P78, DOI 10.1091/mbc.E07-07-0682; Sauane M, 2004, CANCER RES, V64, P2988, DOI 10.1158/0008-5472.CAN-04-0200; Sekine Y, 2006, CURR MOL MED, V6, P87, DOI 10.2174/156652406775574541; Smith JA, 2008, EUR J IMMUNOL, V38, P1194, DOI 10.1002/eji.200737882; Sportes C, 2007, ADV EXP MED BIOL, V601, P321; STOKER AW, 1990, J CELL BIOL, V111, P217, DOI 10.1083/jcb.111.1.217; Tanimoto R, 2007, INT J MOL MED, V19, P363; Tsuji T, 2000, BIOCHEM BIOPH RES CO, V268, P20, DOI 10.1006/bbrc.1999.2067; Vosshenrich CAJ, 2006, NAT IMMUNOL, V7, P1217, DOI 10.1038/ni1395; Wang LX, 2005, CANCER RES, V65, P10569, DOI 10.1158/0008-5472.CAN-05-2117; Wittig B, 2001, HUM GENE THER, V12, P267, DOI 10.1089/10430340150218404; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373	39	57	60	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 22	2009	284	21					14236	14244		10.1074/jbc.M808002200	http://dx.doi.org/10.1074/jbc.M808002200			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	448TY	19279003	Green Published, hybrid, Green Submitted			2022-12-27	WOS:000266286100030
J	van Dieck, J; Fernandez-Fernandez, MR; Veprintsev, DB; Fersht, AR				van Dieck, Jan; Fernandez-Fernandez, Maria R.; Veprintsev, Dmitry B.; Fersht, Alan R.			Modulation of the Oligomerization State of p53 by Differential Binding of Proteins of the S100 Family to p53 Monomers and Tetramers	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DNA-BINDING; CALCIUM; METASTASIS; ACTIVATION; DOMAIN; MUTATIONS; STABILITY; INSIGHTS; GROWTH	We investigated the ways S100B, S100A1, S100A2, S100A4, and S100A6 bind to the different oligomeric forms of the tumor suppressor p53 in vitro, using analytical ultracentrifugation and multiangle light scattering. It is established that members of the S100 protein family bind to the tetramerization domain (residues 325-355) of p53 when it is uncovered in the monomer, and so binding can disrupt the tetramer. We found a stoichiometry of one dimer of S100 bound to a monomer of p53. We discovered that some S100 proteins could also bind to the tetramer. S100B bound the tetramer and also disrupted the dimer by binding monomeric p53. S100A2 bound monomeric p53 as well as tetrameric, whereas S100A1 only bound monomeric p53. S100A6 bound more tightly to tetrameric than to monomeric p53. We also identified an additional binding site for S100 proteins in the transactivation domain (1-57) of p53. Based on our results and published observations in vivo, we propose a model for the binding of S100 proteins to p53 that can explain both activation and inhibition of p53-mediated transcription. Depending on the concentration of p53 and the member of the S100 family, binding can alter the balance between monomer and tetramer in either direction.	[Fersht, Alan R.] MRC Ctr Prot Engn, Cambridge CB2 0QH, England; MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology; MRC Laboratory Molecular Biology	Fersht, AR (corresponding author), MRC Ctr Prot Engn, Hills Rd, Cambridge CB2 0QH, England.	arf25@cam.ac.uk	Veprintsev, Dmitry B/H-2228-2012; Fersht, Alan R/B-2189-2008	Veprintsev, Dmitry B/0000-0002-3583-5409; Fernandez-Fernandez, Maria Rosario/0000-0002-9128-5296	MRC [MC_U105474168] Funding Source: UKRI; Medical Research Council [MC_U105474168] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Ang HC, 2006, J BIOL CHEM, V281, P21934, DOI 10.1074/jbc.M604209200; Appella E, 2000, PATHOL BIOL, V48, P227; BAUDIER J, 1992, P NATL ACAD SCI USA, V89, P11627, DOI 10.1073/pnas.89.23.11627; Bell S, 2002, J MOL BIOL, V322, P917, DOI 10.1016/S0022-2836(02)00848-3; Braithwaite AW, 2006, CELL DEATH DIFFER, V13, P984, DOI 10.1038/sj.cdd.4401924; Chene Patrick, 2001, Current Medicinal Chemistry - Anti-Cancer Agents, V1, P151, DOI 10.2174/1568011013354741; Davies MPA, 1996, ONCOGENE, V13, P1631; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Donato R, 2003, MICROSC RES TECHNIQ, V60, P540, DOI 10.1002/jemt.10296; Drohat AC, 1997, PROTEIN SCI, V6, P1577, DOI 10.1002/pro.5560060721; Fernandez-Fernandez MR, 2008, PROTEIN SCI, V17, P1663, DOI 10.1110/ps.035527.108; Fernandez-Fernandez MR, 2005, P NATL ACAD SCI USA, V102, P4735, DOI 10.1073/pnas.0501459102; Grigorian M, 2001, J BIOL CHEM, V276, P22699, DOI 10.1074/jbc.M010231200; Hiratsuka S, 2006, NAT CELL BIOL, V8, P1369, DOI 10.1038/ncb1507; Joerger AC, 2004, J BIOL CHEM, V279, P1291, DOI 10.1074/jbc.M309732200; Kim C, 2008, J CHROMATOGR A, V1213, P181, DOI 10.1016/j.chroma.2008.10.052; Koch M, 2007, BBA-MOL CELL RES, V1773, P457, DOI 10.1016/j.bbamcr.2006.12.006; Kriajevska M, 2000, BBA-MOL CELL RES, V1498, P252, DOI 10.1016/S0167-4889(00)00100-2; Lavin MF, 2006, CELL DEATH DIFFER, V13, P941, DOI 10.1038/sj.cdd.4401925; Levine AJ, 1997, CELL, V88, P323, DOI 10.1016/S0092-8674(00)81871-1; Lin J, 2001, J BIOL CHEM, V276, P35037, DOI 10.1074/jbc.M104379200; Lomax ME, 1998, ONCOGENE, V17, P643, DOI 10.1038/sj.onc.1201974; MacGregor IK, 2004, BIOPHYS CHEM, V108, P165, DOI 10.1016/j.bpc.2003.10.018; Mateu MG, 1998, EMBO J, V17, P2748, DOI 10.1093/emboj/17.10.2748; MOORE BW, 1965, BIOCHEM BIOPH RES CO, V19, P739, DOI 10.1016/0006-291X(65)90320-7; Mueller A, 2005, J BIOL CHEM, V280, P29186, DOI 10.1074/jbc.M505000200; Nikolova PV, 1998, P NATL ACAD SCI USA, V95, P14675, DOI 10.1073/pnas.95.25.14675; Ostendorp T, 2007, EMBO J, V26, P3868, DOI 10.1038/sj.emboj.7601805; Rajagopalan S, 2008, NUCLEIC ACIDS RES, V36, P5983, DOI 10.1093/nar/gkn598; Salama I, 2008, EJSO-EUR J SURG ONC, V34, P357, DOI 10.1016/j.ejso.2007.04.009; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Scotto C, 1998, MOL CELL BIOL, V18, P4272, DOI 10.1128/MCB.18.7.4272; Scotto C, 1999, MOL CELL BIOL, V19, P7168; Slomnicki LP, 2009, INT J BIOCHEM CELL B, V41, P784, DOI 10.1016/j.biocel.2008.08.007; Teufel DP, 2007, P NATL ACAD SCI USA, V104, P7009, DOI 10.1073/pnas.0702010104; TRATHNIGG B, 1995, PROG POLYM SCI, V20, P615, DOI 10.1016/0079-6700(95)00005-Z; Vousden KH, 2000, CELL, V103, P691, DOI 10.1016/S0092-8674(00)00171-9	37	88	89	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13804	13811		10.1074/jbc.M901351200	http://dx.doi.org/10.1074/jbc.M901351200			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19297317	Green Published, hybrid			2022-12-27	WOS:000265877300057
J	Zheng, J; Huang, J; Mao, YT; Liu, SQ; Sun, X; Zhu, XH; Ma, T; Zhang, L; Ji, JF; Zhang, YH; Yin, CC; Qiu, XY				Zheng, Jie; Huang, Jing; Mao, Yuntao; Liu, Shiqing; Sun, Xin; Zhu, Xiaohui; Ma, Teng; Zhang, Li; Ji, Jiafu; Zhang, Youhui; Yin, C. Cameron; Qiu, Xiaoyan			Immunoglobulin Gene Transcripts Have Distinct V(H)DJ(H) Recombination Characteristics in Human Epithelial Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							INDUCED CYTIDINE DEAMINASE; CHAIN CONSTANT-REGION; DNA-POLYMERASE-ETA; SOMATIC HYPERMUTATION; ABERRANT EXPRESSION; BREAST-CANCER; TUMOR-CELLS; B-CELLS; REARRANGEMENT; LYMPHOCYTES	It was well accepted that only B-lymphocytes and plasma cells expressed immunoglobulin (Ig) gene. However, our group and others have confirmed that non-B-cells, such as epithelial cancer cells, can also express Ig. The aim of this work is to elucidate the role of non-B-cell-derived Ig by investigating the characteristics of the Ig heavy chain (IgH) gene repertoire in epithelial cancer cells. We cloned and sequenced 89 V(H)DJ(H) (V-D-J recombination of the IgH variable region) transcripts by microdissecting cells from eight different types of epithelial cancers and two cancer cell lines (HT-29 and HeLa S3). The cancer-derived Ig gene repertoire showed specific restricted patterns of V(H)DJ(H) recombination with seven sets of predominant V(H)DJ(H) sequences. Surprisingly, within a set of V(H)DJ(H) recombination, the variable (V) sequences derived from different cancer types had not only identical heavy chain variable (V-H), diversity (D), and joining (JH) segments usage, but also identical junctions and mutation targets in the V-H region. The V(H gamma)DJ(H gamma) (but not V(H mu)DJ(H mu)) in the cancer-derived sequences had a high mutation rate; however, it was shown that the mechanism of hypermutation was different from antigen selection in B-cell-derived V(H gamma)DJ(H gamma) sequences. In contrast to V(H mu)DJ(H mu), the V(H gamma)DJ(H gamma) sequences did not appear to originate from classical class switching. These results suggest that cancer-derived Ig genes have a distinct repertoire that may have implications for their role in carcinogenesis.	[Zheng, Jie; Huang, Jing; Mao, Yuntao; Liu, Shiqing; Sun, Xin; Zhu, Xiaohui; Ma, Teng; Zhang, Li; Qiu, Xiaoyan] Peking Univ, Ctr Human Dis Genom, Beijing 100191, Peoples R China; [Zhang, Youhui] Chinese Acad Med Sci, Inst Canc, Dept Immunol, Beijing 100021, Peoples R China; [Zhang, Youhui] Peking Union Med Coll, Beijing 100021, Peoples R China; [Ji, Jiafu] Peking Univ, Sch Oncol, Dept Surg, Beijing 100142, Peoples R China; [Yin, C. Cameron] Univ Texas MD Anderson Canc Ctr, Dept Hematopathol, Houston, TX 77030 USA	Peking University; Chinese Academy of Medical Sciences - Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Peking University; University of Texas System; UTMD Anderson Cancer Center	Qiu, XY (corresponding author), Peking Univ, Ctr Human Dis Genom, 38 Xue Yuan Rd, Beijing 100191, Peoples R China.	qiuxy@bjmu.edu.cn	Mao, Yuntao/E-9168-2012; ma, teng/C-3274-2014	ma, teng/0000-0003-2826-721X; JI, JIAFU/0000-0001-6878-5543; Ma, Teng/0000-0002-8360-1543	Natural Sciences Foundation, China [30371609, 30572094]	Natural Sciences Foundation, China(National Natural Science Foundation of China (NSFC))	This work was supported by Fundamental Research Grants 30371609 and 30572094 from the Natural Sciences Foundation, China.	Babbage G, 2006, CANCER RES, V66, P3996, DOI 10.1158/0008-5472.CAN-05-3704; BARTRAM CR, 1986, BLUT, V52, P203, DOI 10.1007/BF00321079; BREZINSCHEK HP, 1995, J IMMUNOL, V155, P190; CLEARY ML, 1984, P NATL ACAD SCI-BIOL, V81, P593, DOI 10.1073/pnas.81.2.593; Delbos F, 2005, J EXP MED, V201, P1191, DOI 10.1084/jem.20050292; Dorner T, 1997, J IMMUNOL, V158, P2779; Fraternali-Orcioni G, 1999, AM J SURG PATHOL, V23, P717, DOI 10.1097/00000478-199906000-00012; GLICK B, 1956, POULTRY SCI, V35, P224, DOI 10.3382/ps.0350224; Gregersen H, 2001, HAEMATOLOGICA, V86, P1172; Hansen MH, 2001, P NATL ACAD SCI USA, V98, P12659, DOI 10.1073/pnas.171460798; Hori H, 2000, Nihon Shokakibyo Gakkai Zasshi, V97, P1373; HOZUMI N, 1976, P NATL ACAD SCI USA, V73, P3628, DOI 10.1073/pnas.73.10.3628; JERNE NK, 1955, P NATL ACAD SCI USA, V41, P849, DOI 10.1073/pnas.41.11.849; Kimoto Y, 1998, GENE CHROMOSOME CANC, V22, P83, DOI 10.1002/(SICI)1098-2264(1998)22:1<83::AID-GCC12>3.0.CO;2-O; Lefranc MP, 1999, NUCLEIC ACIDS RES, V27, P209, DOI 10.1093/nar/27.1.209; Li M, 2004, INT J BIOCHEM CELL B, V36, P2250, DOI 10.1016/j.biocel.2004.03.017; MANJULA S, 1992, ACTA NEUROCHIR, V115, P103, DOI 10.1007/BF01406366; Martin A, 2002, NATURE, V415, P802, DOI 10.1038/nature714; Matsumoto Y, 2007, NAT MED, V13, P470, DOI 10.1038/nm1566; Mayorov VI, 2005, J IMMUNOL, V174, P7781, DOI 10.4049/jimmunol.174.12.7781; Messmer BT, 2004, BLOOD, V103, P3490, DOI 10.1182/blood-2003-10-3407; MITCHELL GF, 1968, J EXP MED, V128, P821, DOI 10.1084/jem.128.4.821; NERI A, 1987, BLOOD, V70, P1519; Neuberger MS, 2005, NAT REV IMMUNOL, V5, P171, DOI 10.1038/nri1553; Nzula S, 2003, CANCER RES, V63, P3275; O'Brien PM, 2001, CANCER IMMUNOL IMMUN, V50, P523, DOI 10.1007/s00262-001-0234-6; Olubuyide I O, 1993, Afr J Med Med Sci, V22, P57; Oprea M, 2001, J IMMUNOL, V166, P892, DOI 10.4049/jimmunol.166.2.892; Qiu XY, 2003, CANCER RES, V63, P6488; Qu X., 1996, CHINESE J IMMUNOLOGY, V5, P296; ROGOZIN IB, 1992, BIOCHIM BIOPHYS ACTA, V1171, P11, DOI 10.1016/0167-4781(92)90134-L; Souto-Carneiro MM, 2004, J IMMUNOL, V172, P6790, DOI 10.4049/jimmunol.172.11.6790; Spencer J, 1999, J IMMUNOL, V162, P6596; TAMARU J, 1995, AM J PATHOL, V147, P1398; Taylor DD, 1998, ONCOL REP, V5, P1519; TENENBAUM N, 1992, ANN MED INTERNE, V143, P89; TONEGAWA S, 1976, P NATL ACAD SCI USA, V73, P203, DOI 10.1073/pnas.73.1.203; Wang D., 2000, J BEIJING MED U, V32, P310; YAMADA M, 1991, J EXP MED, V173, P395, DOI 10.1084/jem.173.2.395; Yoshikawa K, 2002, SCIENCE, V296, P2033, DOI 10.1126/science.1071556; Zhu XH, 2008, APPL IMMUNOHISTO M M, V16, P232, DOI 10.1097/PAI.0b013e31814c915a; ZUNIGA MC, 1982, P NATL ACAD SCI-BIOL, V79, P3015, DOI 10.1073/pnas.79.9.3015	42	55	73	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY 15	2009	284	20					13610	13619		10.1074/jbc.M809524200	http://dx.doi.org/10.1074/jbc.M809524200			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	442YL	19293154	Green Published, hybrid			2022-12-27	WOS:000265877300038
